data_2kui_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kui _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 . . . . . 0 C--O 1.246 0.887 0 N-CA-C 106.196 -1.779 . . . . 71.040000000000006 106.196 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 24.4 m -113.85 142.35 26.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-O 121.779 0.799 . . . . 74.540000000000006 110.3 -170.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . 0.519 ' NE2' ' HA ' ' A' ' 407' ' ' ASN . 0.8 OUTLIER -95.01 126.64 40.49 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 106.291 -1.744 . . . . 75.409999999999997 106.291 -176.62 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 64.0 t -97.35 121.25 59.11 Favored Pre-proline 0 C--N 1.286 -2.18 0 CA-C-N 114.616 -1.174 . . . . 75.329999999999998 111.577 -169.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.29 135.8 56.19 Favored 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 123.026 2.484 . . . . 74.319999999999993 111.658 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -105.14 149.81 25.57 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.917 -1.142 . . . . 75.109999999999999 107.917 -176.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.503 ' CG2' ' HA ' ' A' ' 373' ' ' ALA . 26.1 m -134.63 20.06 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 C-N-CA 122.415 0.286 . . . . 71.129999999999995 111.032 -177.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.54 146.5 9.83 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 112.797 0.666 . . . . 74.329999999999998 112.797 177.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.07 0.83 41.65 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 115.83 -0.623 . . . . 74.329999999999998 112.357 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . 0.417 HE21 ' HB ' ' A' ' 365' ' ' VAL . 32.7 mt-30 -111.1 -89.35 0.5 Allowed 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 120.299 -0.561 . . . . 64.150000000000006 111.081 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 59.9 p -152.57 165.53 34.89 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.018 -0.734 . . . . 63.140000000000001 109.018 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.41 -46.14 87.76 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.721 -0.844 . . . . 74.120000000000005 108.721 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -59.53 -45.51 91.56 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 115.305 -0.861 . . . . 75.219999999999999 112.05 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -67.3 -41.38 85.46 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.087 0.47 . . . . 61.039999999999999 110.328 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . 0.503 ' HA ' ' CG2' ' A' ' 365' ' ' VAL . . . -65.79 -48.97 69.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.106 -0.497 . . . . 73.140000000000001 111.261 -179.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.17 -38.2 81.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.01 -0.541 . . . . 73.400000000000006 110.511 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.65 -42.03 87.41 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.259 0.623 . . . . 71.439999999999998 111.11 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.3 m -65.69 -49.02 70.05 Favored 'General case' 0 C--O 1.248 1.014 0 CA-C-O 121.58 0.705 . . . . 75.329999999999998 110.206 -178.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 9.9 mp -65.51 -42.63 91.84 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.572 -0.74 . . . . 73.409999999999997 111.74 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -64.46 -38.44 91.05 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.006 -0.543 . . . . 73.430000000000007 110.314 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -59.89 -39.08 84.15 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 116.023 -0.535 . . . . 73.340000000000003 110.687 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . 0.407 ' HA ' ' HD3' ' A' ' 380' ' ' ARG . 25.2 mmt180 -81.37 -12.35 59.01 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.613 -0.721 . . . . 74.0 112.193 -177.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.32 7.27 52.23 Favored Glycine 0 C--N 1.303 -1.27 0 C-N-CA 120.636 -0.792 . . . . 71.230000000000004 112.694 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.511 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 47.7 m-85 -81.66 159.46 23.97 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-O 121.355 0.598 . . . . 75.120000000000005 111.621 177.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 46.4 mtmt -115.23 161.8 17.95 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 115.005 -0.998 . . . . 74.230000000000004 108.826 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.21 157.38 41.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-O 120.862 0.363 . . . . 74.450000000000003 110.698 -177.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 61.6 ttp85 -120.16 126.84 51.66 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 107.138 -1.43 . . . . 74.409999999999997 107.138 170.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 17.6 m -108.27 125.13 51.33 Favored 'General case' 0 C--N 1.281 -2.408 0 N-CA-C 108.694 -0.854 . . . . 73.230000000000004 108.694 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -111.71 119.74 39.68 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.663 -0.866 . . . . 74.420000000000002 108.663 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -96.61 139.26 32.96 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 110.138 -0.319 . . . . 72.109999999999999 110.138 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -131.31 127.53 21.78 Favored Pre-proline 0 C--N 1.307 -1.247 0 N-CA-C 108.278 -1.008 . . . . 75.540000000000006 108.278 174.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -63.3 142.95 88.02 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.245 1.963 . . . . 74.409999999999997 111.794 177.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 7.3 t70 87.03 148.04 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 126.864 2.065 . . . . 72.540000000000006 110.368 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 13.0 t -103.12 11.96 36.44 Favored 'General case' 0 CA--C 1.552 1.058 0 CA-C-O 120.991 0.424 . . . . 65.230000000000004 110.546 -175.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 8.4 t -73.44 -18.08 61.17 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.97 0.891 . . . . 75.439999999999998 109.016 175.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -104.48 151.24 39.15 Favored Pre-proline 0 N--CA 1.427 -1.576 0 N-CA-C 107.459 -1.311 . . . . 73.450000000000003 107.459 173.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -23.33 114.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.678 1 C-N-CA 126.205 4.603 . . . . 64.519999999999996 115.7 -175.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.06 160.29 10.69 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 123.922 3.081 . . . . 64.200000000000003 112.833 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -57.97 -12.88 3.66 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 113.545 0.942 . . . . 75.5 113.545 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 28.7 m170 -91.89 148.46 22.2 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 108.257 -1.016 . . . . 73.010000000000005 108.257 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 30.0 m -77.75 117.17 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.255 0 C-N-CA 118.687 -1.205 . . . . 72.310000000000002 111.089 -171.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 35.6 pt -106.68 -28.8 2.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 115.198 -0.91 . . . . 75.549999999999997 108.729 173.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.72 158.0 27.58 Favored Glycine 0 N--CA 1.417 -2.607 0 N-CA-C 109.489 -1.444 . . . . 51.140000000000001 109.489 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 3.9 p -137.93 -178.58 5.32 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 123.623 0.769 . . . . 74.340000000000003 109.476 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -102.1 132.16 21.85 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 108.154 -1.054 . . . . 61.420000000000002 108.154 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.34 3.09 0.89 Allowed 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.307 2.671 . . . . 75.439999999999998 115.632 -176.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -52.87 -47.59 67.72 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 109.673 -0.492 . . . . 72.409999999999997 109.673 175.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -69.95 -28.97 66.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.639 -0.71 . . . . 64.019999999999996 110.464 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . 0.519 ' HA ' ' NE2' ' A' ' 361' ' ' GLN . 5.9 m120 -81.35 -6.14 58.6 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 122.014 0.911 . . . . 75.319999999999993 109.753 -176.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 28.3 m -101.92 160.66 14.3 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.538 -1.653 . . . . 71.230000000000004 106.538 175.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 20.2 m -76.48 113.11 13.72 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 119.55 -0.86 . . . . 73.439999999999998 109.067 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.3 m -123.66 170.02 14.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 122.86 0.464 . . . . 65.239999999999995 111.018 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 19.2 m -74.25 141.05 45.39 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.887 -0.783 . . . . 65.200000000000003 108.887 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . 0.511 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -69.08 108.94 3.77 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.072 0.463 . . . . 75.109999999999999 110.468 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 121.38 37.76 0.67 Allowed Glycine 0 C--N 1.311 -0.819 0 CA-C-N 115.194 -0.912 . . . . 41.329999999999998 111.744 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -100.02 179.07 4.61 Favored 'General case' 0 C--O 1.245 0.861 0 N-CA-C 107.7 -1.222 . . . . 73.040000000000006 107.7 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 44.8 mt-10 -116.41 115.0 25.05 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 118.249 0.477 . . . . 74.540000000000006 109.957 -178.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 42.6 mm -97.94 129.47 48.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 121.062 0.458 . . . . 75.450000000000003 110.072 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 2.2 p -79.81 131.21 35.84 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 123.866 0.866 . . . . 73.25 111.776 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 10.7 p -119.13 134.35 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.872 0 N-CA-C 109.01 -0.737 . . . . 71.430000000000007 109.01 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -95.4 120.77 36.21 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.546 -0.909 . . . . 74.450000000000003 108.546 -176.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 50.5 t -128.45 149.1 32.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 122.869 0.468 . . . . 74.239999999999995 109.885 -176.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 44.2 m -126.24 148.98 49.37 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.573 -0.529 . . . . 73.329999999999998 109.573 173.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 1.5 m -103.65 157.94 16.72 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 106.897 -1.52 . . . . 75.519999999999996 106.897 -175.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.73 0 N-CA-C 115.626 1.011 . . . . 74.549999999999997 115.626 -178.563 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 . . . . . 0 N--CA 1.429 -1.504 0 N-CA-C 107.404 -1.332 . . . . 71.340000000000003 107.404 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 447' ' ' ALA . 2.4 mmp_? -122.78 143.74 49.63 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-O 120.717 0.294 . . . . 74.200000000000003 110.655 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -86.27 138.98 31.43 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 107.079 -1.452 . . . . 75.209999999999994 107.079 173.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 67.6 mt -78.78 121.97 84.14 Favored Pre-proline 0 C--N 1.3 -1.545 0 CA-C-O 121.115 0.483 . . . . 74.239999999999995 110.825 -172.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.91 148.62 58.0 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.636 2.224 . . . . 74.409999999999997 111.434 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -87.48 145.15 26.38 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.666 -0.494 . . . . 74.420000000000002 109.666 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.28 153.05 16.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.839 -0.8 . . . . 75.109999999999999 108.839 -175.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 2.7 p -64.47 137.0 57.63 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 121.399 0.618 . . . . 62.350000000000001 110.294 175.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 23.6 p -69.1 -21.21 64.07 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 125.053 1.341 . . . . 75.140000000000001 112.128 -171.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . 0.404 ' H ' HD21 ' A' ' 435' ' ' LEU . 0.6 OUTLIER -88.56 -11.02 46.83 Favored 'General case' 0 C--N 1.275 -2.632 0 CA-C-N 115.668 -0.696 . . . . 64.230000000000004 110.502 179.422 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.8 m -108.61 66.4 0.64 Allowed 'General case' 0 N--CA 1.426 -1.637 0 CA-C-O 121.835 0.826 . . . . 74.019999999999996 111.125 -175.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -53.38 -38.52 63.43 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 124.462 1.105 . . . . 74.299999999999997 111.859 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -58.89 -42.65 90.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.89 0.376 . . . . 74.430000000000007 110.85 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -70.96 -36.21 72.47 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.925 -0.58 . . . . 74.340000000000003 109.988 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.617 ' O ' HD21 ' A' ' 444' ' ' LEU . . . -60.39 -52.58 64.65 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 116.686 -0.234 . . . . 72.5 111.551 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 26.9 m -63.63 -36.5 76.67 Favored 'Isoleucine or valine' 0 C--O 1.245 0.828 0 CA-C-O 121.402 0.62 . . . . 74.030000000000001 110.773 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 41.5 tptt -59.18 -45.79 90.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.911 -1.041 . . . . 74.140000000000001 109.464 175.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -64.21 -39.76 94.65 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 113.381 0.882 . . . . 72.230000000000004 113.381 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.617 HD21 ' O ' ' A' ' 440' ' ' ALA . 1.4 mm? -68.01 -33.03 73.83 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 119.056 -1.057 . . . . 74.310000000000002 110.762 175.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 45.5 m -70.12 -42.69 72.29 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.293 0.568 . . . . 70.129999999999995 110.074 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.98 -15.49 62.58 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.845 -0.616 . . . . 75.409999999999997 110.651 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . 0.446 ' O ' ' HG3' ' A' ' 427' ' ' ARG . . . -86.92 2.87 47.86 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.061 -0.518 . . . . 73.430000000000007 111.454 177.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 106.35 -76.59 0.23 Allowed Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.172 -1.013 . . . . 72.040000000000006 112.127 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -46.28 -57.3 4.7 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 114.377 1.251 . . . . 72.140000000000001 114.377 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 59.41 28.41 64.7 Favored Glycine 0 CA--C 1.508 -0.382 0 O-C-N 123.5 0.5 . . . . 61.450000000000003 112.271 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -105.04 111.0 23.62 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 107.385 -1.339 . . . . 75.239999999999995 107.385 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . 0.502 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 18.1 p90 -144.89 157.38 44.17 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-O 120.81 0.338 . . . . 73.25 111.451 -175.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -131.1 149.08 52.76 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 124.483 1.113 . . . . 73.299999999999997 108.22 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -116.86 119.42 35.32 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.937 -0.764 . . . . 75.129999999999995 108.937 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.6 143.01 48.87 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.001 -0.741 . . . . 74.409999999999997 109.001 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -112.98 135.02 54.22 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 107.269 -1.382 . . . . 73.329999999999998 107.269 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 38.2 t -137.44 134.81 18.75 Favored Pre-proline 0 C--N 1.289 -2.032 0 N-CA-C 109.118 -0.697 . . . . 74.239999999999995 109.118 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.639 ' HA ' ' O ' ' A' ' 490' ' ' SER . 37.1 Cg_endo -65.89 122.45 10.03 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 121.715 1.61 . . . . 75.319999999999993 108.549 175.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 15.3 m -131.82 179.34 6.13 Favored 'General case' 0 C--N 1.286 -2.157 0 C-N-CA 120.06 -0.656 . . . . 71.329999999999998 110.893 -173.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.7 t -55.78 141.49 65.77 Favored Pre-proline 0 N--CA 1.422 -1.853 0 C-N-CA 125.008 1.323 . . . . 75.209999999999994 108.458 173.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . 0.412 ' HB3' ' OG1' ' A' ' 494' ' ' THR . 9.6 Cg_endo -50.58 -30.11 27.16 Favored 'Trans proline' 0 N--CA 1.481 0.777 0 C-N-CA 124.766 3.644 . . . . 71.450000000000003 114.781 -171.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -75.89 -27.2 57.61 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 113.103 0.779 . . . . 72.400000000000006 113.103 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -92.95 -19.88 21.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.939 0.4 . . . . 75.209999999999994 111.688 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 90.5 t -60.78 134.89 26.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 109.423 -0.584 . . . . 75.140000000000001 109.423 175.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 101.35 -15.74 57.33 Favored Glycine 0 N--CA 1.431 -1.647 0 C-N-CA 121.085 -0.579 . . . . 65.329999999999998 113.248 177.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.2 166.59 24.27 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 117.521 0.661 . . . . 75.400000000000006 110.751 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.466 ' O ' ' HB ' ' A' ' 434' ' ' THR . 54.6 t -67.12 142.5 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.336 0 N-CA-C 108.478 -0.934 . . . . 72.439999999999998 108.478 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 42.5 mt -97.59 -28.22 3.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 107.689 -1.226 . . . . 74.319999999999993 107.689 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 150.23 -150.99 23.12 Favored Glycine 0 N--CA 1.411 -2.997 0 CA-C-N 114.646 -1.161 . . . . 71.109999999999999 110.661 176.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 470' ' ' THR . . . . . 0.467 HG23 HG12 ' A' ' 486' ' ' ILE . 43.7 p -115.26 151.62 34.17 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 105.352 -2.092 . . . . 74.310000000000002 105.352 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -69.91 -50.67 16.58 Favored Pre-proline 0 C--N 1.304 -1.378 0 C-N-CA 118.698 -1.201 . . . . 75.409999999999997 111.055 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -68.46 162.07 42.31 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 121.289 1.326 . . . . 74.010000000000005 109.36 172.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . 0.481 ' HB2' ' OE1' ' A' ' 476' ' ' GLN . 20.7 Cg_endo -61.64 127.73 22.52 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.294 1.996 . . . . 73.109999999999999 111.988 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.463 ' HB1' ' OG1' ' A' ' 470' ' ' THR . . . -91.27 0.39 57.53 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 113.556 0.947 . . . . 60.439999999999998 113.556 -170.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -108.96 -12.99 14.81 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 119.677 -0.809 . . . . 74.040000000000006 109.672 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . 0.481 ' OE1' ' HB2' ' A' ' 473' ' ' PRO . 20.1 mp0 -92.35 -175.28 3.97 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 114.143 -1.39 . . . . 63.219999999999999 111.474 -172.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 1.4 p -93.79 141.13 28.84 Favored 'General case' 0 N--CA 1.404 -2.746 0 N-CA-C 113.387 0.884 . . . . 71.329999999999998 113.387 -176.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 12.7 p -127.08 148.05 50.15 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-N 114.618 -1.174 . . . . 73.5 108.269 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -75.58 163.72 27.06 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 116.845 -0.161 . . . . 63.149999999999999 110.857 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 22.6 mm -80.04 -5.15 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.019 0 CA-C-O 122.264 1.03 . . . . 75.340000000000003 109.552 -176.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.5 t -110.64 5.13 20.77 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.726 0.774 . . . . 75.540000000000006 109.259 175.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -93.01 143.05 26.62 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.835 -0.621 . . . . 75.239999999999995 110.686 -175.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.25 127.1 64.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 C-N-CA 123.11 0.564 . . . . 64.439999999999998 111.475 -177.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 27.8 m -105.12 125.46 60.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-O 121.864 0.84 . . . . 73.109999999999999 111.788 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.66 125.19 45.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.813 -0.81 . . . . 62.439999999999998 108.813 177.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . 0.467 HG12 HG23 ' A' ' 470' ' ' THR . 42.5 mt -110.28 128.65 66.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 C-N-CA 124.465 1.106 . . . . 75.25 110.999 -176.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 4.8 tt -111.15 127.13 68.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 115.357 -0.838 . . . . 70.450000000000003 111.122 -174.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 467' ' ' VAL . 2.5 p -115.19 135.47 55.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 115.218 -0.901 . . . . 71.510000000000005 109.92 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -72.66 125.87 10.5 Favored Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 110.517 -1.033 . . . . 72.540000000000006 110.517 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.639 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 8.6 t . . . . . 0 N--CA 1.424 -1.77 0 N-CA-C 108.268 -1.012 . . . . 60.240000000000002 108.268 -176.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo . . . . . 0 N--CA 1.44 -1.618 0 CA-C-O 121.01 0.338 . . . . 74.430000000000007 111.655 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -128.99 23.9 5.65 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 122.748 1.261 . . . . 60.109999999999999 108.261 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 494' ' ' THR . . . . . 0.412 ' OG1' ' HB3' ' A' ' 461' ' ' PRO . 14.6 p -127.22 143.54 51.23 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 112.909 -1.95 . . . . 73.030000000000001 109.309 -176.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -147.03 161.85 39.98 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.042 -1.096 . . . . 64.530000000000001 108.042 176.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -93.87 135.24 35.4 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 109.517 -0.549 . . . . 73.349999999999994 109.517 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 40.3 pt -80.18 137.77 52.8 Favored Pre-proline 0 C--N 1.302 -1.467 0 CA-C-N 115.952 -0.567 . . . . 74.420000000000002 111.37 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.63 168.31 19.74 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.653 2.236 . . . . 74.310000000000002 112.859 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -70.87 121.73 18.62 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.642 -0.873 . . . . 70.319999999999993 108.642 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.01 87.89 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.178 0 CA-C-O 122.475 1.131 . . . . 71.349999999999994 110.845 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -146.97 122.5 10.42 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 113.703 -1.59 . . . . 74.109999999999999 108.08 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 112.43 -11.98 25.94 Favored Glycine 0 CA--C 1.493 -1.282 0 N-CA-C 109.888 -1.285 . . . . 73.450000000000003 109.888 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -94.71 169.32 10.25 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 114.888 -0.656 . . . . 74.430000000000007 109.677 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 5.5 m -84.39 157.16 21.51 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.458 -0.941 . . . . 73.519999999999996 108.458 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 17.5 t -55.65 -41.96 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.227 0.611 . . . . 75.129999999999995 110.933 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -62.1 -40.58 96.33 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.669 -0.696 . . . . 71.420000000000002 110.836 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 48.8 t -73.94 -38.9 50.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.839 -0.619 . . . . 74.319999999999993 109.558 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -62.81 -49.43 74.97 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.566 -0.743 . . . . 73.319999999999993 111.356 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -63.15 -35.71 81.21 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 109.629 -0.508 . . . . 74.25 109.629 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.461 ' O ' HG22 ' A' ' 514' ' ' VAL . 48.4 tttp -64.79 -45.33 86.74 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.674 -0.694 . . . . 72.129999999999995 109.976 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . 0.402 ' O ' ' HD1' ' A' ' 515' ' ' TYR . 92.1 m-20 -62.34 -42.39 99.35 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 120.6 0.238 . . . . 73.519999999999996 110.734 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.33 -42.83 96.07 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 116.596 -0.274 . . . . 74.430000000000007 111.381 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -63.23 -37.69 88.23 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.785 -0.189 . . . . 74.140000000000001 111.041 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 510' ' ' LYS . 56.9 t -59.88 -35.03 58.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.085 0.469 . . . . 73.450000000000003 110.844 176.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . 0.402 ' HD1' ' O ' ' A' ' 511' ' ' ASN . 31.3 m-85 -79.45 -8.21 58.96 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.881 0.372 . . . . 72.310000000000002 111.936 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 103.23 -0.4 47.24 Favored Glycine 0 C--N 1.303 -1.279 0 C-N-CA 120.075 -1.06 . . . . 62.229999999999997 112.55 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.595 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 79.2 m-85 -84.59 96.33 9.14 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.451 -1.314 . . . . 74.030000000000001 107.451 177.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 6.3 p -87.19 -13.89 42.71 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 113.234 0.827 . . . . 75.430000000000007 113.234 -174.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -108.83 114.73 28.75 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.166 0.508 . . . . 75.230000000000004 109.676 -178.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -131.42 154.44 48.67 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.755 -0.657 . . . . 75.420000000000002 110.619 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 43.8 m -141.54 140.94 33.54 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 107.772 -1.196 . . . . 70.340000000000003 107.772 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . 0.492 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 0.0 OUTLIER -117.56 128.46 54.97 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 118.468 0.576 . . . . 53.530000000000001 111.551 -177.273 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -111.66 116.22 30.41 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.039 -0.726 . . . . 75.0 109.039 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 35.4 m -95.08 124.72 39.28 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 120.743 0.306 . . . . 70.219999999999999 111.03 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 18.7 m -122.8 151.29 26.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 108.539 -0.912 . . . . 73.439999999999998 108.539 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . 0.475 ' HA ' ' O ' ' A' ' 557' ' ' LYS . 3.8 p30 -66.59 136.13 55.15 Favored 'General case' 0 CA--C 1.495 -1.169 0 CA-C-O 121.681 0.753 . . . . 73.040000000000006 110.423 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 20.0 m -146.43 158.34 47.23 Favored Pre-proline 0 C--N 1.281 -2.404 0 CA-C-N 114.737 -1.119 . . . . 52.409999999999997 108.596 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -69.68 -21.76 33.43 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 121.551 1.501 . . . . 70.310000000000002 108.802 170.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . 0.453 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 60.0 mtm-85 -69.71 135.12 88.05 Favored Pre-proline 0 N--CA 1.436 -1.152 0 CA-C-N 114.188 -1.369 . . . . 72.549999999999997 108.4 176.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.8 149.12 79.85 Favored 'Trans proline' 0 C--O 1.251 1.154 0 C-N-CA 123.26 2.64 . . . . 74.430000000000007 113.491 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.569 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -64.39 117.4 7.23 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.613 -0.721 . . . . 64.329999999999998 110.917 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 129.81 -23.41 4.73 Favored Glycine 0 C--N 1.302 -1.311 0 C-N-CA 120.212 -0.994 . . . . 74.439999999999998 111.99 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -79.4 125.74 29.92 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.235 -0.654 . . . . 74.340000000000003 109.235 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 88.8 t -73.19 119.41 20.08 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 109.774 -0.454 . . . . 74.329999999999998 109.774 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 57.6 m -66.36 -40.31 89.7 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 124.687 1.195 . . . . 72.219999999999999 109.436 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 162.86 -159.81 32.22 Favored Glycine 0 N--CA 1.424 -2.113 0 N-CA-C 109.392 -1.483 . . . . 72.310000000000002 109.392 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 7.1 p -126.57 161.07 28.86 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 117.056 0.428 . . . . 72.150000000000006 110.317 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . 0.452 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 24.8 t-20 -59.63 -51.99 77.19 Favored Pre-proline 0 CA--C 1.545 0.78 0 O-C-N 123.537 0.523 . . . . 74.400000000000006 111.198 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . 0.452 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 1.2 Cg_endo -87.37 143.08 6.36 Favored 'Trans proline' 0 N--CA 1.441 -1.595 0 CA-C-N 120.257 1.128 . . . . 63.140000000000001 109.301 170.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -70.16 163.6 37.98 Favored 'Trans proline' 0 C--O 1.249 1.065 0 C-N-CA 122.428 2.085 . . . . 73.230000000000004 112.556 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.8 142.49 57.27 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.777 -0.647 . . . . 71.219999999999999 110.61 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 88.94 -5.95 84.1 Favored Glycine 0 N--CA 1.431 -1.666 0 C-N-CA 120.844 -0.693 . . . . 71.219999999999999 112.212 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 30.8 m -77.91 123.28 26.59 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.646 -0.501 . . . . 74.230000000000004 109.646 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 33.3 m -80.56 122.44 27.05 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 108.697 -0.853 . . . . 65.420000000000002 108.697 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 19.7 m -136.71 160.38 66.68 Favored Pre-proline 0 C--N 1.311 -1.108 0 N-CA-C 109.179 -0.674 . . . . 74.230000000000004 109.179 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -68.35 141.13 50.49 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.25 1.966 . . . . 70.439999999999998 111.458 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.595 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 26.9 m -66.79 -20.52 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 121.749 0.785 . . . . 73.200000000000003 111.927 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -90.59 3.68 53.42 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.137 -0.938 . . . . 74.299999999999997 111.13 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.0 t -83.77 164.23 19.69 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.291 -0.633 . . . . 73.049999999999997 109.291 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 41.3 t -98.18 112.71 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 N-CA-C 107.998 -1.112 . . . . 72.25 107.998 178.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 1.8 mp -91.74 135.64 26.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-O 120.938 0.399 . . . . 74.439999999999998 110.272 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -101.9 122.26 43.68 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-O 121.473 0.654 . . . . 74.5 110.777 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 65.3 mt -97.8 116.16 29.47 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 106.562 -1.644 . . . . 75.439999999999998 106.562 176.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -91.83 121.98 33.94 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 108.489 -0.93 . . . . 74.140000000000001 108.489 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 60.3 t -111.12 133.74 55.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-N 115.82 -0.627 . . . . 73.239999999999995 112.149 -170.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.569 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 9.6 m -71.69 128.66 36.51 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 114.925 -1.034 . . . . 63.219999999999999 109.065 174.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 526' ' ' ASP . 0.8 OUTLIER -116.97 110.74 18.66 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 109.317 -0.623 . . . . 74.310000000000002 109.317 175.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -72.49 -33.38 61.17 Favored Glycine 0 CA--C 1.49 -1.526 0 CA-C-N 115.707 -0.678 . . . . 71.420000000000002 111.448 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 44.32 36.34 1.56 Allowed 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 126.345 1.858 . . . . 73.230000000000004 113.007 178.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 12.1 tp60 -140.05 146.22 38.71 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.488 -1.301 . . . . 65.510000000000005 107.488 -174.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -147.16 142.62 27.51 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.604 -0.887 . . . . 74.099999999999994 108.604 174.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 54.2 t -76.62 128.38 37.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-O 120.911 0.386 . . . . 75.420000000000002 111.76 -174.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 58.7 ttp -97.7 132.4 25.11 Favored Pre-proline 0 C--O 1.247 0.951 0 CA-C-N 115.99 -0.55 . . . . 75.340000000000003 110.198 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -66.57 169.67 13.87 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 123.051 2.501 . . . . 72.030000000000001 112.932 176.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -72.16 132.27 43.92 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 113.299 0.851 . . . . 71.099999999999994 113.299 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 96.5 mt -136.22 21.85 3.22 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.566 0.746 . . . . 72.530000000000001 109.003 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 10.3 m -75.4 130.29 38.74 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 116.147 -0.479 . . . . 75.049999999999997 112.224 -173.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 65.65 29.22 74.66 Favored Glycine 0 C--O 1.212 -1.247 0 CA-C-N 115.498 -0.774 . . . . 74.230000000000004 114.873 173.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 18.1 ptp -112.61 178.85 4.15 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 117.798 0.799 . . . . 74.329999999999998 109.136 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . 0.403 ' HB3' ' OD1' ' A' ' 601' ' ' ASN . 89.7 m-85 -84.87 154.27 22.38 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 120.302 -0.559 . . . . 74.239999999999995 109.67 178.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 28.0 t90 -68.47 -20.15 64.59 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.387 -0.597 . . . . 75.510000000000005 109.387 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 33.8 m -71.28 -13.31 16.87 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.355 0 CA-C-N 115.936 -0.575 . . . . 74.400000000000006 110.985 176.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -101.06 -44.13 5.81 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 109.417 -0.586 . . . . 70.420000000000002 109.417 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -59.57 -46.27 89.4 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.817 -1.083 . . . . 71.129999999999995 112.214 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.487 ' O ' ' HG3' ' A' ' 579' ' ' ARG . 55.8 tt0 -57.92 -59.87 11.81 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 113.323 0.861 . . . . 55.420000000000002 113.323 -178.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.54 -35.59 89.55 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 121.183 1.255 . . . . 72.040000000000006 112.406 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -65.0 -43.38 92.76 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.031 0.382 . . . . 74.540000000000006 112.031 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.402 HD11 ' N ' ' A' ' 579' ' ' ARG . 4.4 pp -67.58 -40.71 84.85 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 119.607 -0.837 . . . . 75.209999999999994 111.259 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . 0.487 ' HG3' ' O ' ' A' ' 575' ' ' GLU . 20.1 mtp180 -65.14 -40.32 94.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.085 -0.507 . . . . 75.519999999999996 110.094 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -63.96 -35.73 81.64 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.982 -0.554 . . . . 74.430000000000007 112.468 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 4.2 pp -81.66 2.03 31.43 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.988 0.736 . . . . 74.450000000000003 112.988 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 82.97 39.67 9.99 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.484 -0.865 . . . . 72.099999999999994 112.227 176.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 89.6 t90 -79.57 133.91 36.46 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.939 -0.393 . . . . 71.010000000000005 109.939 176.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 61.5 m -147.86 90.85 1.87 Allowed 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.375 -0.602 . . . . 73.209999999999994 109.375 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -147.01 -131.52 2.19 Favored Glycine 0 N--CA 1.433 -1.549 0 N-CA-C 111.088 -0.805 . . . . 74.200000000000003 111.088 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 59.7 mtt -119.67 125.65 49.22 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.763 -0.829 . . . . 75.019999999999996 108.763 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -105.17 130.94 53.22 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 107.799 -1.185 . . . . 73.109999999999999 107.799 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -100.71 101.89 12.87 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 120.601 -0.439 . . . . 74.5 110.698 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . 0.404 ' HD3' ' C ' ' A' ' 589' ' ' LYS . 11.8 tmtt? -113.02 111.7 22.61 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 107.252 -1.388 . . . . 74.209999999999994 107.252 174.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -93.97 -149.52 25.48 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.958 -0.639 . . . . 74.319999999999993 113.197 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -76.16 146.23 39.33 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 120.776 0.322 . . . . 63.530000000000001 111.083 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -84.97 125.32 32.59 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 106.405 -1.702 . . . . 75.219999999999999 106.405 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 57.5 t -128.73 116.58 41.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 N-CA-C 109.956 -0.387 . . . . 70.019999999999996 109.956 -171.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -77.59 108.11 10.54 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.24 -1.393 . . . . 74.120000000000005 107.24 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -121.42 -5.12 9.33 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.717 -0.674 . . . . 75.439999999999998 111.744 -176.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 119.69 -177.97 16.46 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 120.507 -0.854 . . . . 64.510000000000005 112.341 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -58.71 -37.01 88.89 Favored Glycine 0 C--N 1.319 -0.365 0 O-C-N 124.084 0.52 . . . . 74.420000000000002 114.381 -175.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 14.4 m -64.89 -24.29 67.49 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 117.264 0.532 . . . . 64.439999999999998 111.365 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -108.11 -0.56 21.03 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 113.096 0.776 . . . . 72.430000000000007 113.096 -173.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . 0.464 ' HA ' ' O ' ' A' ' 626' ' ' GLN . 14.9 p-80 -70.39 103.22 2.36 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 119.194 -1.002 . . . . 74.349999999999994 111.644 -174.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . 0.403 ' OD1' ' HB3' ' A' ' 570' ' ' PHE . 18.9 t-20 58.37 5.32 0.42 Allowed 'General case' 0 CA--C 1.569 1.7 0 C-N-CA 125.924 1.69 . . . . 74.129999999999995 113.59 178.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -78.98 140.22 38.05 Favored 'General case' 0 C--N 1.317 -0.804 0 O-C-N 121.66 -0.65 . . . . 75.099999999999994 110.455 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 97.6 t -69.48 131.63 33.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 107.911 -1.144 . . . . 74.450000000000003 107.911 174.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 56.9 t -87.71 -46.05 16.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-O 121.263 0.554 . . . . 64.319999999999993 109.649 -175.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -156.24 152.4 27.71 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 107.684 -1.228 . . . . 74.230000000000004 107.684 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -116.68 112.39 21.16 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.356 -1.35 . . . . 70.420000000000002 107.356 171.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.409 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 38.7 t30 -48.45 -52.13 45.86 Favored Pre-proline 0 CA--C 1.556 1.204 0 N-CA-C 113.622 0.971 . . . . 73.439999999999998 113.622 -177.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.409 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 5.4 Cg_exo -82.29 124.64 4.3 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.121 1.214 . . . . 74.439999999999998 109.562 172.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . 0.473 ' O ' HG22 ' A' ' 612' ' ' THR . 13.4 Cg_endo -65.0 135.84 45.77 Favored 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 122.045 1.83 . . . . 73.200000000000003 113.144 -177.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -65.75 130.69 44.18 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.248 -0.887 . . . . 75.209999999999994 110.025 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.09 -8.44 45.37 Favored Glycine 0 N--CA 1.433 -1.537 0 C-N-CA 120.132 -1.032 . . . . 64.420000000000002 113.066 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 612' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 609' ' ' PRO . 10.1 t -113.75 175.93 5.25 Favored 'General case' 0 C--O 1.258 1.514 0 C-N-CA 118.919 -1.112 . . . . 74.319999999999993 109.541 177.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -79.77 128.3 8.44 Favored Glycine 0 N--CA 1.416 -2.684 0 CA-C-N 115.448 -0.796 . . . . 53.439999999999998 111.546 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 23.4 m -102.2 144.49 13.33 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 C-N-CA 124.031 0.932 . . . . 75.200000000000003 108.709 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . 0.415 HD22 HG23 ' A' ' 619' ' ' ILE . 24.8 p-10 -50.01 152.59 1.59 Allowed 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 124.452 1.101 . . . . 71.120000000000005 111.857 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -26.25 13.59 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.123 0.969 . . . . 73.299999999999997 113.061 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.34 -38.53 74.88 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.662 -0.866 . . . . 75.150000000000006 108.662 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 82.33 22.12 59.33 Favored Glycine 0 N--CA 1.424 -2.159 0 C-N-CA 120.923 -0.656 . . . . 34.43 111.886 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . 0.415 HG23 HD22 ' A' ' 615' ' ' ASN . 0.0 OUTLIER -68.16 119.19 13.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-O 122.621 1.2 . . . . 73.349999999999994 110.459 -168.833 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 4.4 tp -115.67 119.17 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.876 0 CA-C-N 113.899 -1.5 . . . . 75.140000000000001 109.614 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 25.7 m -105.4 117.45 34.06 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 106.543 -1.651 . . . . 72.450000000000003 106.543 174.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -138.96 153.77 48.23 Favored 'General case' 0 CA--C 1.479 -1.758 0 N-CA-C 106.447 -1.686 . . . . 70.230000000000004 106.447 -177.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -136.45 153.67 50.99 Favored 'General case' 0 C--N 1.268 -2.974 0 N-CA-C 107.464 -1.31 . . . . 74.329999999999998 107.464 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -140.62 163.01 34.01 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 105.383 -2.081 . . . . 74.209999999999994 105.383 172.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -82.46 -86.52 0.76 Allowed Glycine 0 N--CA 1.424 -2.155 0 C-N-CA 119.677 -1.249 . . . . 72.230000000000004 110.282 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' A' ' 600' ' ' HIS . 35.6 tt0 . . . . . 0 C--N 1.29 -1.991 0 CA-C-O 117.7 -1.143 . . . . 73.040000000000006 108.428 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 . . . . . 0 N--CA 1.435 -1.193 0 N-CA-C 103.728 -2.693 . . . . 62.310000000000002 103.728 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 35.7 m -116.08 151.3 17.88 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.664 0 C-N-CA 120.074 -0.65 . . . . 72.230000000000004 109.805 -172.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -95.05 136.04 35.85 Favored 'General case' 0 N--CA 1.411 -2.406 0 N-CA-C 106.579 -1.637 . . . . 74.140000000000001 106.579 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 89.8 t -111.07 118.19 48.47 Favored Pre-proline 0 C--N 1.275 -2.632 0 CA-C-O 121.141 0.496 . . . . 72.129999999999995 111.198 -173.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -81.38 123.54 4.43 Favored 'Trans proline' 0 N--CA 1.44 -1.674 0 C-N-CA 121.814 1.676 . . . . 74.209999999999994 109.717 172.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . 0.56 ' OD2' ' HB3' ' A' ' 366' ' ' ARG . 7.5 p-10 -101.43 137.91 39.13 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 122.237 1.017 . . . . 64.450000000000003 110.646 -176.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.522 ' HB ' ' NE2' ' A' ' 368' ' ' GLN . 27.7 m -82.93 36.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 114.381 -1.281 . . . . 72.040000000000006 112.471 -174.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.56 ' HB3' ' OD2' ' A' ' 364' ' ' ASP . 0.0 OUTLIER -56.04 146.72 21.85 Favored 'General case' 0 C--O 1.247 0.934 0 C-N-CA 124.452 1.101 . . . . 71.219999999999999 110.97 176.314 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.28 1.21 41.13 Favored Glycine 0 C--N 1.309 -0.944 0 N-CA-C 111.927 -0.469 . . . . 73.109999999999999 111.927 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . 0.522 ' NE2' ' HB ' ' A' ' 365' ' ' VAL . 36.1 mt-30 -110.87 -153.2 0.51 Allowed 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 108.076 -1.083 . . . . 74.409999999999997 108.076 176.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 54.9 p -93.32 168.68 10.92 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.215 -0.661 . . . . 55.450000000000003 109.215 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 20.6 p -63.28 -46.36 87.12 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 109.828 -0.434 . . . . 74.530000000000001 109.828 176.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -63.36 -46.43 86.6 Favored 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 112.851 0.686 . . . . 73.519999999999996 112.851 -177.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -67.03 -45.23 78.12 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 120.546 -0.462 . . . . 70.409999999999997 110.095 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -66.59 -46.62 75.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.868 -0.606 . . . . 71.209999999999994 111.514 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 67.7 mt -64.73 -37.91 81.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.616 -0.266 . . . . 73.430000000000007 110.806 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.88 -43.29 99.14 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 110.273 -0.269 . . . . 73.319999999999993 110.273 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 33.3 m -63.45 -48.33 78.15 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.866 -0.606 . . . . 73.430000000000007 110.313 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.45 -41.6 96.44 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 112.353 0.501 . . . . 74.230000000000004 112.353 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -67.01 -38.79 86.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.666 -0.243 . . . . 74.219999999999999 110.515 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -70.19 -21.01 63.09 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.027 0.442 . . . . 71.319999999999993 111.601 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . 0.448 ' HA ' ' NE ' ' A' ' 380' ' ' ARG . 3.3 mmp_? -81.06 -15.09 57.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.027 0.441 . . . . 74.219999999999999 109.919 174.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.26 5.58 54.33 Favored Glycine 0 C--N 1.306 -1.114 0 CA-C-N 115.789 -0.641 . . . . 73.109999999999999 112.548 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -85.42 148.65 25.9 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-O 121.117 0.484 . . . . 62.109999999999999 110.73 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -101.13 149.39 24.02 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 107.741 -1.207 . . . . 75.209999999999994 107.741 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.62 157.19 41.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.891 0 C-N-CA 120.717 -0.393 . . . . 74.510000000000005 110.009 -178.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -132.46 126.86 34.01 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.165 -1.42 . . . . 74.239999999999995 107.165 173.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 28.8 m -109.12 126.53 53.31 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 108.367 -0.975 . . . . 74.299999999999997 108.367 -177.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 51.2 tp -111.46 120.09 41.0 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.57 -0.53 . . . . 75.019999999999996 109.57 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -89.83 122.09 32.57 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.148 -0.686 . . . . 74.519999999999996 109.148 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 421' ' ' SER . 56.9 mtpt -135.4 125.5 16.73 Favored Pre-proline 0 C--N 1.311 -1.069 0 N-CA-C 109.937 -0.394 . . . . 74.439999999999998 109.937 177.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -80.39 128.37 7.04 Favored 'Trans proline' 0 C--O 1.253 1.252 0 C-N-CA 121.39 1.393 . . . . 64.129999999999995 109.238 173.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 13.5 t70 174.99 158.46 0.18 Allowed 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.195 -1.409 . . . . 74.510000000000005 107.195 -174.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 13.5 m -100.72 -11.98 19.5 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 120.86 0.362 . . . . 74.109999999999999 111.697 -177.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 11.1 m -109.11 2.1 20.88 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 122.121 0.963 . . . . 70.409999999999997 110.343 -176.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 34.6 mm -88.86 140.52 29.37 Favored Pre-proline 0 C--N 1.306 -1.297 0 CA-C-N 115.769 -0.651 . . . . 65.519999999999996 109.33 178.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -39.97 129.92 2.11 Favored 'Trans proline' 0 C--N 1.365 1.401 0 C-N-CA 124.4 3.4 . . . . 74.519999999999996 113.719 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.8 161.24 13.07 Favored 'Trans proline' 0 N--CA 1.483 0.855 0 C-N-CA 123.535 2.824 . . . . 71.299999999999997 112.699 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . 0.413 ' HA ' HG13 ' A' ' 420' ' ' VAL . 2.5 p30 -59.78 -8.47 2.14 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 122.022 0.915 . . . . 62.32 112.853 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 43.8 m170 -102.42 123.71 46.68 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 105.188 -2.153 . . . . 72.200000000000003 105.188 173.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 32.4 m -68.08 119.54 13.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 112.98 0.733 . . . . 74.430000000000007 112.98 -165.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . 0.42 ' O ' HD13 ' A' ' 400' ' ' ILE . 0.0 OUTLIER -102.99 -28.12 3.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 106.767 -1.568 . . . . 75.349999999999994 106.767 175.361 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.52 166.3 27.76 Favored Glycine 0 N--CA 1.414 -2.793 0 N-CA-C 110.546 -1.022 . . . . 63.049999999999997 110.546 -177.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 40.5 p -146.8 -173.91 4.34 Favored 'General case' 0 C--N 1.286 -2.178 0 C-N-CA 126.078 1.751 . . . . 73.420000000000002 106.331 -174.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -98.43 126.52 39.17 Favored Pre-proline 0 C--N 1.296 -1.756 0 N-CA-C 107.699 -1.223 . . . . 71.049999999999997 107.699 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.31 -4.65 0.79 Allowed 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 124.864 3.709 . . . . 73.239999999999995 116.324 -174.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.67 -39.81 71.45 Favored 'General case' 0 C--O 1.204 -1.294 0 N-CA-C 109.767 -0.457 . . . . 74.109999999999999 109.767 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -63.53 -40.05 96.01 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-O 121.365 0.603 . . . . 72.430000000000007 110.77 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -80.61 -4.58 54.67 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.389 0.614 . . . . 74.140000000000001 110.456 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 27.8 m -98.23 160.61 14.18 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 105.423 -2.066 . . . . 55.130000000000003 105.423 173.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 13.4 m -76.52 112.6 13.22 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 118.829 -1.148 . . . . 75.540000000000006 108.871 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 23.0 m -128.33 170.05 18.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.077 0.465 . . . . 73.140000000000001 111.198 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 36.7 t -74.35 143.3 44.94 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 108.782 -0.822 . . . . 73.329999999999998 108.782 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -63.09 131.14 47.55 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.065 -0.516 . . . . 45.310000000000002 111.293 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 90.89 29.71 12.6 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.714 -0.676 . . . . 72.209999999999994 112.655 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -83.07 -175.7 5.97 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 109.52 -0.548 . . . . 72.310000000000002 109.52 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -110.72 117.47 33.54 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 123.358 0.663 . . . . 72.540000000000006 111.291 -174.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.0 mm -105.77 115.08 46.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.405 0.622 . . . . 74.510000000000005 110.358 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 40.6 p -87.05 130.8 34.33 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 123.655 0.782 . . . . 73.420000000000002 110.691 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 8.2 p -124.19 134.55 66.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 109.736 -0.468 . . . . 73.099999999999994 109.736 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.66 122.81 46.43 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.851 -0.739 . . . . 65.299999999999997 110.357 176.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.413 HG13 ' HA ' ' A' ' 397' ' ' ASP . 34.7 t -111.75 131.87 61.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 114.705 -1.134 . . . . 72.400000000000006 110.588 -175.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 34.2 p -85.93 125.97 33.75 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 120.285 -0.566 . . . . 63.140000000000001 109.577 176.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.1 t -117.49 105.47 12.13 Favored 'General case' 0 N--CA 1.407 -2.621 0 C-N-CA 119.509 -0.876 . . . . 63.240000000000002 109.221 175.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.303 0 CA-C-N 115.494 -0.776 . . . . 71.239999999999995 113.318 179.469 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.514 ' OE1' ' HB ' ' A' ' 477' ' ' THR . 34.0 tt0 . . . . . 0 N--CA 1.42 -1.933 0 N-CA-C 107.387 -1.338 . . . . 73.010000000000005 107.387 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.621 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 1.6 mmp_? -122.32 139.87 53.31 Favored 'General case' 0 CA--C 1.479 -1.769 0 N-CA-C 112.795 0.665 . . . . 74.040000000000006 112.795 -174.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 42.2 tt0 -85.26 132.99 34.18 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.627 -1.17 . . . . 65.150000000000006 108.256 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 57.8 mt -80.92 124.43 81.47 Favored Pre-proline 0 C--N 1.307 -1.259 0 N-CA-C 109.812 -0.44 . . . . 73.329999999999998 109.812 -178.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -70.77 147.0 55.43 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.332 2.021 . . . . 72.150000000000006 110.397 175.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -81.21 102.19 10.17 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.494 0.664 . . . . 73.239999999999995 110.243 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 61.0 t -96.93 140.42 17.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 106.882 -1.525 . . . . 75.530000000000001 106.882 177.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 2.4 p -63.97 146.96 53.16 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 112.619 0.6 . . . . 71.010000000000005 112.619 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 25.7 p -60.63 -32.71 71.86 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 124.811 1.245 . . . . 72.409999999999997 113.774 -173.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.9 pp -81.04 -10.74 59.65 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.48 0.657 . . . . 74.239999999999995 111.588 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.3 m -106.61 40.95 1.52 Allowed 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.627 -0.879 . . . . 65.099999999999994 108.627 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -51.69 -37.98 53.07 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.943 1.297 . . . . 75.310000000000002 112.401 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -59.82 -38.85 83.18 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.046 0.45 . . . . 63.210000000000001 111.26 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . 0.465 ' CD ' ' HE3' ' A' ' 442' ' ' LYS . 16.2 tp10 -70.4 -37.15 74.44 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.881 -0.785 . . . . 70.010000000000005 108.881 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.571 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -60.7 -51.24 70.19 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.518 -0.764 . . . . 75.209999999999994 111.162 -178.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 27.5 m -63.97 -40.55 89.48 Favored 'Isoleucine or valine' 0 C--O 1.249 1.029 0 N-CA-C 112.627 0.603 . . . . 73.310000000000002 112.627 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.465 ' HE3' ' CD ' ' A' ' 439' ' ' GLU . 41.9 pttt -68.61 -35.1 76.88 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 119.134 -1.026 . . . . 74.409999999999997 112.104 177.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -65.09 -38.31 90.33 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.347 -0.388 . . . . 75.329999999999998 110.882 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 94.3 mt -63.2 -38.59 91.78 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.332 -0.618 . . . . 74.310000000000002 109.332 177.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.451 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 86.4 m -66.14 -45.23 81.75 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.718 -0.674 . . . . 75.439999999999998 111.129 178.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.62 -15.87 63.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.038 0.447 . . . . 64.299999999999997 111.632 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -88.62 4.0 48.58 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.997 0.427 . . . . 70.439999999999998 111.396 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 112.47 -73.35 0.22 Allowed Glycine 0 CA--C 1.496 -1.152 0 C-N-CA 120.351 -0.928 . . . . 73.129999999999995 111.829 175.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . 0.488 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 0.4 OUTLIER -45.57 -68.27 0.21 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 114.021 1.119 . . . . 75.430000000000007 114.021 177.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . 0.451 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 60.36 27.33 65.41 Favored Glycine 0 C--N 1.315 -0.605 0 N-CA-C 111.38 -0.688 . . . . 75.129999999999995 111.38 -173.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.433 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 32.3 mmt180 -100.16 110.4 22.67 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 106.424 -1.695 . . . . 73.349999999999994 106.424 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -143.6 147.0 33.73 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 109.592 -0.521 . . . . 73.349999999999994 109.592 -177.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -137.75 123.1 19.46 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 108.43 -0.952 . . . . 75.219999999999999 108.43 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -87.38 124.71 33.68 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 123.598 0.561 . . . . 73.329999999999998 109.933 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -121.61 142.26 50.29 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 107.343 -1.354 . . . . 74.319999999999993 107.343 176.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -125.14 143.06 51.12 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 119.536 -0.865 . . . . 64.409999999999997 109.955 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 48.9 m -141.55 139.28 18.44 Favored Pre-proline 0 C--N 1.285 -2.197 0 N-CA-C 107.911 -1.144 . . . . 73.400000000000006 107.911 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.68 ' HA ' ' O ' ' A' ' 490' ' ' SER . 34.1 Cg_endo -65.44 122.56 10.28 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 121.746 1.631 . . . . 75.519999999999996 111.116 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 47.2 m -135.46 179.64 6.21 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.794 -1.094 . . . . 74.5 109.692 -174.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.9 t -49.3 133.71 17.07 Favored Pre-proline 0 C--O 1.251 1.179 0 O-C-N 124.103 0.877 . . . . 72.409999999999997 112.392 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.92 -29.62 35.95 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 124.566 3.51 . . . . 70.099999999999994 113.913 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -74.79 -23.8 58.56 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.652 0.612 . . . . 73.329999999999998 112.652 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -100.23 -6.05 26.64 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.975 0.416 . . . . 73.420000000000002 111.488 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 86.6 t -60.58 128.6 21.98 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 CA-C-N 116.192 -0.458 . . . . 72.5 109.841 176.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 97.07 -3.14 61.93 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.969 -0.634 . . . . 72.349999999999994 112.148 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -122.53 165.85 15.75 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 108.322 -0.992 . . . . 74.299999999999997 108.322 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 70.9 t -73.97 146.54 10.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.792 -1.188 . . . . 75.439999999999998 107.792 173.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 45.5 mt -98.08 -35.64 5.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 107.747 -1.205 . . . . 75.209999999999994 107.747 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 161.86 -162.24 33.93 Favored Glycine 0 N--CA 1.417 -2.631 0 N-CA-C 109.851 -1.3 . . . . 65.319999999999993 109.851 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 28.5 p -130.52 153.86 48.4 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 109.869 -0.419 . . . . 72.420000000000002 109.869 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -75.03 -56.31 2.06 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 109.017 -0.734 . . . . 72.200000000000003 109.017 172.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.28 163.9 35.37 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 121.405 1.403 . . . . 75.430000000000007 108.927 172.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -71.88 126.98 12.44 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.168 1.245 . . . . 71.310000000000002 112.241 -177.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -99.93 2.04 43.27 Favored 'General case' 0 C--O 1.212 -0.893 0 CA-C-O 121.532 0.682 . . . . 62.409999999999997 110.55 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -110.7 5.49 20.93 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 120.202 -0.599 . . . . 73.340000000000003 110.48 175.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -122.92 -177.57 3.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.896 0.379 . . . . 74.439999999999998 110.507 -175.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 477' ' ' THR . . . . . 0.514 ' HB ' ' OE1' ' A' ' 426' ' ' GLN . 1.0 OUTLIER -71.37 132.12 44.39 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 124.987 1.315 . . . . 72.019999999999996 113.471 179.296 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 69.6 m -130.55 144.28 51.31 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 115.517 -0.765 . . . . 73.349999999999994 109.578 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -79.34 161.53 26.17 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.342 -0.845 . . . . 74.420000000000002 110.893 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . 0.488 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 1.8 mp -70.08 -25.23 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.834 0.826 . . . . 74.549999999999997 111.265 -177.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 17.2 m -93.28 -9.28 39.55 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.543 0.687 . . . . 72.299999999999997 110.401 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -85.76 129.33 34.86 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.44 -0.8 . . . . 75.010000000000005 110.49 -175.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . 0.433 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 10.7 p -97.52 126.81 50.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.176 0.512 . . . . 73.400000000000006 111.742 -178.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 35.9 m -100.2 127.31 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-O 121.711 0.767 . . . . 74.340000000000003 110.915 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.57 124.55 45.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.667 -0.697 . . . . 73.25 109.544 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 34.3 mm -107.5 116.7 51.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.482 -1.303 . . . . 70.25 107.482 -177.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 11.7 tt -100.19 125.97 53.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 121.556 0.694 . . . . 75.540000000000006 110.025 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 33.6 m -110.3 151.13 12.59 Favored 'Isoleucine or valine' 0 C--O 1.258 1.536 0 CA-C-N 115.375 -0.829 . . . . 74.239999999999995 111.097 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -80.9 128.64 8.56 Favored Glycine 0 N--CA 1.419 -2.45 0 CA-C-N 115.307 -0.861 . . . . 64.140000000000001 111.158 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.68 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 31.3 t . . . . . 0 C--N 1.291 -1.939 0 N-CA-C 104.113 -2.551 . . . . 73.219999999999999 104.113 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo . . . . . 0 N--CA 1.416 -3.06 0 N-CA-C 109.265 -1.091 . . . . 70.310000000000002 109.265 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . -88.99 65.45 7.52 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.442 -0.947 . . . . 72.519999999999996 108.442 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 2.6 p -117.44 143.31 46.15 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 114.464 -1.244 . . . . 73.430000000000007 111.579 -175.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -135.95 151.23 49.73 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.499 -0.926 . . . . 73.409999999999997 108.499 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.5 p-10 -85.41 130.49 34.58 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.469 -0.938 . . . . 75.129999999999995 108.469 176.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . 0.407 HG12 ' O ' ' A' ' 543' ' ' THR . 28.8 pt -92.11 121.91 65.9 Favored Pre-proline 0 C--N 1.29 -2.01 0 CA-C-N 116.109 -0.496 . . . . 73.239999999999995 111.038 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -85.73 -164.08 0.21 Allowed 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.552 2.168 . . . . 74.329999999999998 110.24 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -94.35 145.93 24.41 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 118.722 -1.191 . . . . 64.340000000000003 108.449 177.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 10.2 p -137.58 16.84 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 122.826 1.298 . . . . 72.5 107.505 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . 0.405 ' HB2' ' HA2' ' A' ' 536' ' ' GLY . . . -87.75 145.65 26.03 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 113.706 -1.588 . . . . 74.219999999999999 110.363 -174.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 107.02 -10.33 40.29 Favored Glycine 0 C--N 1.293 -1.845 0 N-CA-C 108.922 -1.671 . . . . 72.129999999999995 108.922 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -103.84 175.42 5.49 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 114.351 -0.925 . . . . 74.329999999999998 108.836 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 20.7 p -85.75 163.97 17.88 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-O 120.584 0.231 . . . . 71.310000000000002 111.069 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.1 p -54.96 -41.44 58.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.73 -0.668 . . . . 75.230000000000004 112.331 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -66.27 -41.7 89.52 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 120.521 -0.471 . . . . 72.200000000000003 110.864 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 90.5 t -67.89 -41.27 84.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.223 -0.444 . . . . 73.409999999999997 110.184 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.3 -46.64 85.77 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.31 -0.404 . . . . 53.140000000000001 110.629 178.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -59.56 -43.32 93.6 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.313 0.645 . . . . 73.030000000000001 109.761 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.421 ' O ' HG23 ' A' ' 514' ' ' VAL . 17.9 ttmm -59.51 -46.98 87.27 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.804 -1.089 . . . . 73.230000000000004 109.776 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -62.48 -46.02 90.37 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.257 -0.429 . . . . 74.510000000000005 111.032 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 10.3 mp -60.15 -43.48 95.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.396 -0.365 . . . . 73.099999999999994 111.297 178.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.71 -39.84 92.92 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.336 0.397 . . . . 71.299999999999997 110.91 178.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 510' ' ' LYS . 70.3 t -64.86 -32.41 58.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 116.019 -0.537 . . . . 74.109999999999999 111.053 177.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -85.74 2.51 45.21 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.346 -0.542 . . . . 74.319999999999993 111.785 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 98.86 -18.07 57.35 Favored Glycine 0 C--O 1.243 0.696 0 C-N-CA 120.847 -0.692 . . . . 73.239999999999995 112.797 176.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.484 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 83.4 m-85 -68.7 98.89 0.94 Allowed 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.955 0.883 . . . . 65.310000000000002 109.706 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.54 9.99 29.37 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.797 -1.092 . . . . 74.219999999999999 112.674 -174.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . 0.431 ' HD2' ' O ' ' A' ' 548' ' ' ASP . 63.6 mttp -122.72 113.46 19.24 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.536 -0.913 . . . . 74.230000000000004 108.536 173.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -132.2 156.57 46.22 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.581 -0.736 . . . . 74.540000000000006 111.653 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 521' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 52.6 m -135.64 136.53 41.06 Favored 'General case' 0 C--N 1.276 -2.605 0 N-CA-C 106.987 -1.486 . . . . 70.510000000000005 106.987 173.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -117.08 124.27 48.83 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.418 0.628 . . . . 65.25 109.913 -177.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -110.81 125.54 53.68 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 115.682 -0.69 . . . . 53.420000000000002 109.189 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 2.9 p -92.01 120.73 32.92 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 109.085 -0.709 . . . . 64.329999999999998 109.085 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . 0.493 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 26.9 m -121.24 152.22 24.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 116.548 -0.296 . . . . 73.030000000000001 110.465 -175.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -66.94 135.23 53.48 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 108.796 -0.816 . . . . 72.510000000000005 108.796 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 66.3 m -152.98 166.54 15.23 Favored Pre-proline 0 C--N 1.307 -1.278 0 C-N-CA 120.912 -0.315 . . . . 75.540000000000006 111.24 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -91.13 -7.16 3.73 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.099 1.866 . . . . 75.230000000000004 109.859 168.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -81.98 136.43 47.36 Favored Pre-proline 0 N--CA 1.42 -1.932 0 C-N-CA 124.924 1.29 . . . . 74.530000000000001 108.143 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.23 149.38 80.99 Favored 'Trans proline' 0 C--O 1.259 1.563 0 C-N-CA 122.61 2.207 . . . . 74.510000000000005 113.74 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -61.61 126.16 26.35 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 114.114 -1.403 . . . . 75.319999999999993 111.59 -176.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 120.94 -24.23 7.52 Favored Glycine 0 C--N 1.305 -1.161 0 CA-C-N 115.646 -0.706 . . . . 63.119999999999997 111.973 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -82.67 125.79 31.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.801 0.334 . . . . 64.0 110.282 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 85.9 t -75.39 113.27 14.01 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 107.921 -1.14 . . . . 71.340000000000003 107.921 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 535' ' ' THR . . . . . 0.605 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 12.6 t -78.35 -18.84 54.58 Favored 'General case' 0 C--N 1.314 -0.941 0 O-C-N 123.593 0.558 . . . . 72.430000000000007 110.998 -176.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . 0.405 ' HA2' ' HB2' ' A' ' 501' ' ' ALA . . . 160.08 -174.27 36.83 Favored Glycine 0 N--CA 1.422 -2.25 0 C-N-CA 120.499 -0.858 . . . . 64.150000000000006 111.213 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 19.4 p -117.42 157.47 26.15 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 108.607 -0.886 . . . . 70.349999999999994 108.607 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . 0.405 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 19.4 t30 -71.17 -52.3 9.39 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 109.987 -0.375 . . . . 60.43 109.987 176.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . 0.405 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 38.1 Cg_exo -66.13 131.92 28.34 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 120.914 1.076 . . . . 75.239999999999995 109.563 171.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -66.23 147.94 84.17 Favored 'Trans proline' 0 C--O 1.243 0.767 0 C-N-CA 122.84 2.36 . . . . 73.439999999999998 113.24 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.21 134.42 55.9 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.672 -0.695 . . . . 64.129999999999995 109.583 176.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.47 -20.51 32.24 Favored Glycine 0 C--N 1.301 -1.395 0 N-CA-C 111.191 -0.764 . . . . 64.030000000000001 111.191 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 543' ' ' THR . . . . . 0.407 ' O ' HG12 ' A' ' 497' ' ' ILE . 44.9 m -67.43 134.8 52.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.98 0.419 . . . . 75.319999999999993 110.655 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 30.6 m -96.4 122.59 39.45 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 108.924 -0.769 . . . . 71.019999999999996 108.924 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 22.1 m -136.45 155.21 77.18 Favored Pre-proline 0 C--N 1.312 -1.022 0 CA-C-N 116.158 -0.474 . . . . 74.200000000000003 109.963 -177.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 37.5 Cg_exo -62.72 148.11 93.83 Favored 'Trans proline' 0 C--O 1.221 -0.363 0 C-N-CA 122.411 2.074 . . . . 72.400000000000006 111.929 176.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.484 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 35.5 m -65.81 -19.92 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-O 121.864 0.84 . . . . 73.230000000000004 111.005 177.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . 0.431 ' O ' ' HD2' ' A' ' 519' ' ' LYS . 37.6 t70 -92.79 3.43 55.67 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.581 -1.19 . . . . 72.409999999999997 110.058 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 30.2 t -84.06 159.48 21.15 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.562 -0.903 . . . . 63.240000000000002 108.562 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 18.1 t -96.38 122.55 48.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 109.01 -0.737 . . . . 74.439999999999998 109.01 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 61.5 mt -100.56 131.72 47.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 109.585 -0.524 . . . . 75.120000000000005 109.585 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . 0.469 ' HA ' ' O ' ' A' ' 521' ' ' SER . 35.6 tt0 -102.46 115.81 31.33 Favored 'General case' 0 N--CA 1.418 -2.03 0 N-CA-C 109.395 -0.595 . . . . 64.329999999999998 109.395 178.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.01 134.04 48.78 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.023 -0.99 . . . . 70.109999999999999 110.238 175.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -102.81 119.72 39.34 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.471 0.653 . . . . 74.019999999999996 110.639 -175.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 41.7 t -100.06 138.94 22.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-N 115.138 -0.937 . . . . 64.319999999999993 108.627 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.626 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 5.0 m -85.52 141.5 29.84 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.929 -0.578 . . . . 74.329999999999998 110.41 -178.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 525' ' ' VAL . 23.0 ptmt -110.28 147.55 33.64 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 105.485 -2.042 . . . . 74.140000000000001 105.485 167.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -79.29 -23.7 62.64 Favored Glycine 0 C--N 1.3 -1.472 0 C-N-CA 119.881 -1.152 . . . . 61.009999999999998 112.126 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 17.2 m120 59.34 37.65 23.32 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.09 -0.707 . . . . 73.230000000000004 109.09 -174.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 48.4 mt-30 -112.16 141.91 45.27 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.806 -0.633 . . . . 74.430000000000007 110.286 -172.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -123.77 146.76 48.08 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.708 -0.849 . . . . 75.140000000000001 108.708 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 56.9 t -72.55 117.52 16.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 121.086 0.47 . . . . 64.329999999999998 110.024 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 55.9 ttp -97.23 126.15 43.04 Favored Pre-proline 0 C--N 1.309 -1.18 0 CA-C-N 115.473 -0.785 . . . . 72.409999999999997 110.352 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -61.27 170.53 5.05 Favored 'Trans proline' 0 CA--C 1.548 1.22 0 C-N-CA 123.143 2.562 . . . . 71.209999999999994 111.804 171.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . 0.491 ' O ' ' HE2' ' A' ' 569' ' ' MET . 10.9 p-10 -60.69 143.6 53.87 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 123.663 0.785 . . . . 73.510000000000005 111.466 -178.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -123.94 -42.53 2.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.051 0.453 . . . . 73.209999999999994 110.315 -176.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 22.7 t -76.37 144.73 39.9 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.473 -0.936 . . . . 71.019999999999996 108.473 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 110.7 -7.1 29.76 Favored Glycine 0 C--N 1.31 -0.915 0 N-CA-C 110.636 -0.986 . . . . 74.109999999999999 110.636 -176.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 569' ' ' MET . . . . . 0.491 ' HE2' ' O ' ' A' ' 565' ' ' ASP . 14.8 mtm -114.69 156.39 24.87 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 122.886 0.475 . . . . 74.230000000000004 110.739 -176.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -87.38 143.55 27.19 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 106.196 -1.779 . . . . 71.540000000000006 106.196 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 33.3 t90 -51.24 -31.73 21.84 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 113.195 0.813 . . . . 72.439999999999998 113.195 -175.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 29.7 m -78.27 -19.38 13.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-O 121.398 0.618 . . . . 70.430000000000007 110.909 -176.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -100.99 -35.54 9.34 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.991 0.9 . . . . 73.200000000000003 108.86 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -67.98 -40.19 83.15 Favored 'General case' 0 C--O 1.205 -1.257 0 CA-C-N 114.264 -1.335 . . . . 73.549999999999997 111.623 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.44 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 36.0 tt0 -54.08 -57.57 17.47 Favored Pre-proline 0 CA--C 1.563 1.48 0 N-CA-C 112.595 0.591 . . . . 73.409999999999997 112.595 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . 0.44 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 44.8 Cg_exo -59.79 -39.66 70.69 Favored 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 121.514 1.476 . . . . 72.299999999999997 111.619 177.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -39.1 90.95 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-O 120.955 0.407 . . . . 74.400000000000006 109.921 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.524 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 58.3 tp -66.82 -48.15 69.84 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 123.482 0.713 . . . . 72.209999999999994 110.914 -178.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -66.34 -35.09 79.46 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.033 -0.667 . . . . 62.509999999999998 111.11 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -65.68 -29.58 70.15 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.962 -0.563 . . . . 74.019999999999996 111.735 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 578' ' ' LEU . 4.3 pp -81.62 1.39 34.15 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.066 0.46 . . . . 74.299999999999997 111.588 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 92.67 22.91 27.35 Favored Glycine 0 CA--C 1.496 -1.144 0 C-N-CA 120.809 -0.71 . . . . 73.549999999999997 113.509 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 84.0 t90 -80.92 136.94 36.12 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 120.352 -0.539 . . . . 72.200000000000003 111.128 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 10.8 m -154.24 101.68 2.4 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 106.933 -1.506 . . . . 64.420000000000002 106.933 172.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -158.24 -149.65 5.53 Favored Glycine 0 CA--C 1.491 -1.453 0 N-CA-C 109.714 -1.354 . . . . 55.439999999999998 109.714 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 58.5 ttp -94.75 127.13 40.53 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 117.68 0.74 . . . . 74.239999999999995 110.203 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -102.3 130.01 48.89 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.534 -1.654 . . . . 73.019999999999996 106.534 176.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -95.87 105.23 17.22 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.276 0.56 . . . . 75.129999999999995 110.517 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -94.42 126.52 39.75 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 106.709 -1.589 . . . . 70.230000000000004 106.709 177.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . 0.497 ' HA3' ' NH1' ' A' ' 623' ' ' ARG . . . -120.8 -116.32 2.48 Favored Glycine 0 N--CA 1.423 -2.184 0 C-N-CA 120.596 -0.812 . . . . 64.200000000000003 112.257 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -137.13 144.72 43.15 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.682 -0.488 . . . . 61.240000000000002 109.682 -177.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -80.47 140.46 35.92 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.114 -1.069 . . . . 73.420000000000002 108.114 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 57.3 t -137.2 120.74 21.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 109.517 -0.549 . . . . 75.340000000000003 109.517 -172.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.28 106.96 5.33 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.54 -1.281 . . . . 73.329999999999998 107.54 173.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -138.64 8.25 2.59 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.899 0.703 . . . . 74.019999999999996 112.899 -174.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 117.96 139.83 6.34 Favored Glycine 0 C--N 1.299 -1.503 0 C-N-CA 120.088 -1.053 . . . . 72.140000000000001 110.92 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -55.39 -33.73 58.84 Favored Glycine 0 C--O 1.223 -0.558 0 N-CA-C 114.845 0.698 . . . . 71.439999999999998 114.845 -173.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 18.5 m -65.63 -24.59 67.08 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 117.503 0.651 . . . . 74.5 111.727 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -98.58 -12.46 21.14 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.212 0.53 . . . . 64.439999999999998 109.759 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 67.1 m170 -76.67 137.27 39.31 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.981 -0.554 . . . . 75.540000000000006 111.183 -176.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 9.5 p30 46.34 12.8 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 126.929 2.092 . . . . 70.230000000000004 115.964 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -126.61 146.72 50.05 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.598 -0.89 . . . . 72.549999999999997 108.598 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.31 131.33 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.268 0.627 . . . . 73.010000000000005 111.392 -177.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 60.2 t -90.49 -38.85 11.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 120.992 0.425 . . . . 71.319999999999993 111.159 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -151.83 162.4 41.11 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.992 -0.373 . . . . 75.340000000000003 109.992 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -131.85 127.62 36.94 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 123.845 0.715 . . . . 75.420000000000002 109.669 -176.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.514 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 50.7 t-20 -71.86 -62.11 1.75 Allowed Pre-proline 0 CA--C 1.562 1.422 0 N-CA-C 112.744 0.646 . . . . 75.129999999999995 112.744 -178.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.514 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 3.3 Cg_endo -87.41 134.14 3.38 Favored 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 121.38 1.387 . . . . 75.019999999999996 110.7 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.49 137.39 59.62 Favored 'Trans proline' 0 C--O 1.252 1.213 0 C-N-CA 122.853 2.369 . . . . 61.229999999999997 114.042 -177.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.9 131.12 44.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.984 -1.007 . . . . 74.230000000000004 110.319 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 89.58 0.19 79.46 Favored Glycine 0 C--N 1.312 -0.779 0 C-N-CA 120.694 -0.765 . . . . 64.329999999999998 112.271 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 22.5 m -101.31 157.92 16.43 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.919 -0.771 . . . . 74.150000000000006 108.919 178.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -73.1 113.83 4.49 Favored Glycine 0 N--CA 1.429 -1.816 0 N-CA-C 108.767 -1.733 . . . . 55.240000000000002 108.767 174.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 24.4 m -96.01 141.94 14.57 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-O 121.24 0.543 . . . . 75.239999999999995 112.03 -176.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -47.64 140.63 6.01 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 126.322 1.849 . . . . 74.019999999999996 111.518 175.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -54.06 -25.93 24.17 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 114.326 1.232 . . . . 74.340000000000003 114.326 -175.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -75.37 -25.49 57.74 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.165 -0.679 . . . . 72.140000000000001 109.165 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 67.79 21.36 73.06 Favored Glycine 0 N--CA 1.428 -1.897 0 CA-C-O 119.296 -0.725 . . . . 71.340000000000003 113.744 172.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.87 118.31 11.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-O 123.312 1.53 . . . . 73.040000000000006 111.138 -168.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 3.2 tp -112.12 119.13 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.958 0 CA-C-N 112.96 -1.927 . . . . 75.420000000000002 108.649 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 7.0 m -98.6 117.49 33.18 Favored 'General case' 0 N--CA 1.406 -2.665 0 N-CA-C 105.958 -1.867 . . . . 73.540000000000006 105.958 175.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -139.28 160.7 39.2 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.23 -1.396 . . . . 75.120000000000005 107.23 -178.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . 0.497 ' NH1' ' HA3' ' A' ' 590' ' ' GLY . 13.0 tpt180 -151.16 150.96 31.26 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 105.755 -1.943 . . . . 74.420000000000002 105.755 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -138.84 160.98 38.38 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 106.0 -1.852 . . . . 65.140000000000001 106.0 173.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -78.2 -96.02 0.24 Allowed Glycine 0 N--CA 1.421 -2.331 0 N-CA-C 110.987 -0.845 . . . . 73.430000000000007 110.987 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 . . . . . 0 C--N 1.283 -2.295 0 N-CA-C 108.159 -1.052 . . . . 75.409999999999997 108.159 179.277 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 CA--C 1.509 -0.61 0 N-CA-C 108.484 -0.932 . . . . 70.109999999999999 108.484 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 409' ' ' SER . 35.8 m -117.45 163.92 14.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 109.393 -0.595 . . . . 73.099999999999994 109.393 -174.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -93.19 138.0 32.0 Favored 'General case' 0 N--CA 1.421 -1.875 0 N-CA-C 106.378 -1.712 . . . . 74.329999999999998 106.378 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 60.5 t -95.24 120.04 64.66 Favored Pre-proline 0 C--N 1.28 -2.425 0 CA-C-N 115.744 -0.662 . . . . 71.140000000000001 110.005 -167.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -65.7 122.82 10.54 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.54 2.16 . . . . 74.340000000000003 112.225 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -108.59 153.72 22.98 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 114.523 -1.217 . . . . 64.549999999999997 108.894 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.474 ' HB ' ' NE2' ' A' ' 368' ' ' GLN . 15.9 m -134.84 28.52 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 115.361 -0.836 . . . . 72.299999999999997 109.852 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.47 148.0 24.84 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 115.221 -0.899 . . . . 75.239999999999995 112.304 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.95 -5.25 39.39 Favored Glycine 0 C--N 1.321 -0.285 0 CA-C-N 116.332 -0.395 . . . . 75.140000000000001 112.251 -176.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . 0.474 ' NE2' ' HB ' ' A' ' 365' ' ' VAL . 40.6 mt-30 -106.48 -85.08 0.51 Allowed 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 120.868 0.365 . . . . 74.219999999999999 110.831 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 41.9 p -153.46 157.82 40.45 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 108.449 -0.945 . . . . 65.420000000000002 108.449 -178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 49.0 m -63.95 -35.67 81.44 Favored 'General case' 0 C--O 1.203 -1.359 0 N-CA-C 109.692 -0.484 . . . . 72.219999999999999 109.692 175.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.81 -46.77 88.09 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 116.348 -0.387 . . . . 73.310000000000002 111.973 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -68.1 -38.78 82.7 Favored 'General case' 0 C--O 1.245 0.828 0 C-N-CA 120.289 -0.564 . . . . 70.540000000000006 110.163 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . 0.444 ' HA ' ' CG2' ' A' ' 365' ' ' VAL . . . -66.59 -51.09 60.23 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.66 -0.7 . . . . 75.299999999999997 111.092 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . 0.402 HG22 HG12 ' A' ' 384' ' ' ILE . 60.1 mt -60.08 -43.52 92.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 123.167 0.587 . . . . 72.549999999999997 110.517 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -60.47 -47.22 87.07 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.101 0.477 . . . . 73.540000000000006 110.59 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' THR . . . . . 0.53 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 58.9 m -66.61 -47.79 71.57 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.811 -0.631 . . . . 72.150000000000006 111.402 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 9.8 mp -64.24 -37.69 88.39 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 112.001 0.371 . . . . 75.030000000000001 112.001 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -64.02 -41.5 97.43 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 109.518 -0.549 . . . . 64.25 109.518 176.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -67.31 -22.38 65.63 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 116.24 -0.436 . . . . 74.25 111.452 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 376' ' ' THR . 13.7 mmm180 -80.94 -14.54 57.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.983 0.421 . . . . 74.340000000000003 109.963 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 96.8 14.9 41.56 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.904 -0.665 . . . . 72.420000000000002 112.244 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.496 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 55.1 m-85 -93.22 167.72 11.57 Favored 'General case' 0 N--CA 1.427 -1.621 0 O-C-N 122.488 -0.419 . . . . 72.219999999999999 110.969 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -105.51 143.83 33.13 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 106.528 -1.656 . . . . 73.439999999999998 106.528 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . 0.402 HG12 HG22 ' A' ' 374' ' ' ILE . 1.2 pp -125.6 131.94 71.48 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 CA-C-O 121.593 0.711 . . . . 74.510000000000005 111.939 -177.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -111.04 129.34 55.94 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 114.707 -1.133 . . . . 75.140000000000001 108.035 -176.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 10.5 m -121.66 123.98 43.19 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 110.101 -0.333 . . . . 63.240000000000002 110.101 -176.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -111.57 122.82 48.83 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.536 -0.542 . . . . 72.420000000000002 109.536 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.93 126.97 50.31 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.962 0.41 . . . . 74.209999999999994 110.536 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -135.14 136.27 24.42 Favored Pre-proline 0 C--N 1.297 -1.696 0 CA-C-N 115.994 -0.548 . . . . 71.209999999999994 110.394 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.07 147.24 93.85 Favored 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 123.055 2.503 . . . . 73.239999999999995 111.846 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 6.4 t70 86.41 178.59 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.515 1.926 . . . . 74.409999999999997 108.949 -178.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 25.7 m -132.41 14.66 4.55 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 121.692 0.758 . . . . 72.400000000000006 110.366 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 10.1 t -69.08 -28.05 66.17 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 107.889 -1.152 . . . . 73.310000000000002 107.889 172.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . 0.406 ' H ' HD13 ' A' ' 394' ' ' ILE . 0.2 OUTLIER -88.55 151.73 48.5 Favored Pre-proline 0 N--CA 1.433 -1.308 0 N-CA-C 107.59 -1.263 . . . . 74.209999999999994 107.59 174.003 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -28.97 116.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.306 0 C-N-CA 125.148 3.899 . . . . 72.340000000000003 115.034 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . 0.572 ' HA ' ' OG ' ' A' ' 421' ' ' SER . 48.5 Cg_exo -58.55 161.03 15.45 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 123.805 3.003 . . . . 62.350000000000001 113.626 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -57.63 -9.24 1.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.13 0.972 . . . . 63.310000000000002 113.077 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -107.37 119.86 40.55 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 104.504 -2.406 . . . . 71.239999999999995 104.504 171.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 11.0 m -62.84 118.24 4.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.196 0 O-C-N 123.681 0.613 . . . . 63.299999999999997 111.574 -168.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.38 -34.96 8.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 108.029 -1.1 . . . . 73.310000000000002 108.029 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -152.73 157.92 27.58 Favored Glycine 0 N--CA 1.409 -3.153 0 N-CA-C 109.369 -1.492 . . . . 71.299999999999997 109.369 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.2 p -117.89 -178.82 3.58 Favored 'General case' 0 C--N 1.277 -2.58 0 N-CA-C 108.435 -0.95 . . . . 74.439999999999998 108.435 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -100.74 146.28 31.81 Favored Pre-proline 0 C--N 1.295 -1.795 0 C-N-CA 119.306 -0.958 . . . . 75.430000000000007 111.006 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.12 -16.36 1.78 Allowed 'Trans proline' 0 C--N 1.364 1.347 0 C-N-CA 125.221 3.947 . . . . 65.430000000000007 114.868 -176.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.43 -33.86 63.93 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.365 0.666 . . . . 72.030000000000001 111.042 176.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -82.34 -30.69 30.27 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.434 0.635 . . . . 71.349999999999994 111.135 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -86.56 -1.84 57.98 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.335 0.588 . . . . 74.209999999999994 110.573 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 47.2 m -107.54 148.38 29.32 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.094 -1.447 . . . . 75.439999999999998 107.094 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 360' ' ' VAL . 65.3 m -74.5 113.34 11.64 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 120.055 -0.658 . . . . 72.150000000000006 110.319 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 33.4 m -129.31 169.49 20.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.774 -0.648 . . . . 63.520000000000003 109.467 177.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 22.6 t -79.84 156.39 27.39 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.094 -0.706 . . . . 60.549999999999997 109.094 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . 0.496 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -70.87 143.13 51.13 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 116.101 -0.499 . . . . 63.399999999999999 110.703 -178.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 103.02 10.6 36.54 Favored Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 120.398 -0.906 . . . . 72.230000000000004 112.98 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -80.53 174.51 11.54 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.244 -1.021 . . . . 72.219999999999999 108.244 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -110.01 114.69 28.42 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.945 -0.761 . . . . 74.310000000000002 108.945 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 46.6 mm -97.7 127.37 50.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 109.179 -0.674 . . . . 75.140000000000001 109.179 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 1.7 p -86.66 130.67 34.39 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 114.028 1.121 . . . . 73.450000000000003 114.028 -176.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 2.1 t -123.34 134.89 64.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 C-N-CA 125.126 1.37 . . . . 75.430000000000007 110.007 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -106.49 129.12 54.5 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 115.457 -0.792 . . . . 53.039999999999999 109.871 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 5.3 p -118.76 131.22 72.17 Favored 'Isoleucine or valine' 0 C--O 1.256 1.408 0 N-CA-C 109.707 -0.479 . . . . 73.019999999999996 109.707 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' SER . . . . . 0.572 ' OG ' ' HA ' ' A' ' 396' ' ' PRO . 54.6 p -84.75 125.54 32.64 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 115.904 -0.589 . . . . 75.140000000000001 110.43 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.8 m -97.82 156.9 16.37 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 107.132 -1.433 . . . . 74.230000000000004 107.132 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.411 0 N-CA-C 114.815 0.686 . . . . 64.329999999999998 114.815 -177.101 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 . . . . . 0 N--CA 1.436 -1.134 0 N-CA-C 108.284 -1.006 . . . . 74.140000000000001 108.284 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.539 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 1.5 mmp_? -123.56 159.57 28.9 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 112.698 0.629 . . . . 74.540000000000006 112.698 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -82.66 141.18 32.68 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.534 -1.212 . . . . 74.420000000000002 108.169 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.434 HD13 ' O ' ' A' ' 473' ' ' PRO . 63.9 mt -77.84 125.98 84.77 Favored Pre-proline 0 N--CA 1.43 -1.449 0 N-CA-C 107.685 -1.228 . . . . 75.299999999999997 107.685 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -69.7 140.85 43.92 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.639 1.559 . . . . 73.099999999999994 111.35 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -95.4 130.2 42.28 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.302 -1.74 . . . . 71.010000000000005 106.302 175.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 13.2 p -129.59 150.51 34.69 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.259 0 C-N-CA 120.346 -0.542 . . . . 73.120000000000005 110.515 -172.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 5.7 m -63.23 137.89 58.36 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 107.657 -1.238 . . . . 72.430000000000007 107.657 173.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 52.9 p -60.16 -28.77 68.19 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 123.989 0.916 . . . . 74.129999999999995 113.293 -171.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 1.1 pp -88.15 -10.73 49.04 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 113.558 0.947 . . . . 74.450000000000003 113.558 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 3.6 m -102.65 49.96 0.83 Allowed 'General case' 0 CA--C 1.563 1.459 0 CA-C-O 121.62 0.724 . . . . 75.519999999999996 111.056 -175.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -52.72 -37.63 59.51 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.93 0.892 . . . . 75.140000000000001 112.58 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.494 ' O ' ' HG3' ' A' ' 442' ' ' LYS . . . -58.82 -40.1 83.18 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.101 0.477 . . . . 72.140000000000001 111.367 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -69.42 -35.47 75.74 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.604 -0.887 . . . . 61.509999999999998 108.604 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.483 ' O ' HD12 ' A' ' 444' ' ' LEU . . . -60.78 -51.67 68.35 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.591 -0.732 . . . . 60.240000000000002 111.036 -178.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 33.5 m -62.31 -44.61 99.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 120.829 -0.348 . . . . 73.450000000000003 111.829 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 438' ' ' ALA 0.339 0.0 OUTLIER -68.66 -33.7 74.44 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 113.432 0.901 . . . . 74.099999999999994 113.432 178.881 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -65.01 -43.05 93.79 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 122.197 -0.314 . . . . 73.439999999999998 111.108 174.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 440' ' ' ALA . 8.9 mp -63.37 -35.24 79.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.347 -0.388 . . . . 75.120000000000005 110.325 177.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.454 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 38.6 m -67.28 -44.29 79.66 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 116.11 -0.495 . . . . 74.140000000000001 110.671 178.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.71 -22.94 65.24 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.22 -0.446 . . . . 72.140000000000001 111.435 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -80.09 5.16 15.02 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 116.061 -0.518 . . . . 55.229999999999997 111.737 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 102.23 -61.21 0.53 Allowed Glycine 0 CA--C 1.492 -1.374 0 C-N-CA 120.739 -0.743 . . . . 70.310000000000002 112.348 173.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . 0.405 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 0.9 OUTLIER -53.28 -63.4 1.16 Allowed 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 112.885 0.698 . . . . 74.010000000000005 112.885 178.224 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . 0.454 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 60.01 23.22 59.07 Favored Glycine 0 C--N 1.316 -0.572 0 O-C-N 123.199 0.312 . . . . 63.109999999999999 113.15 -178.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -108.2 110.82 22.54 Favored 'General case' 0 N--CA 1.422 -1.856 0 N-CA-C 107.337 -1.357 . . . . 74.310000000000002 107.337 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -131.29 146.02 52.12 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.651 -0.704 . . . . 63.340000000000003 110.499 -175.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -131.58 132.79 44.39 Favored 'General case' 0 C--N 1.286 -2.196 0 N-CA-C 108.397 -0.964 . . . . 74.400000000000006 108.397 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -101.05 126.98 47.77 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 120.956 0.408 . . . . 75.129999999999995 110.244 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.27 153.31 36.55 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.539 -1.282 . . . . 70.219999999999999 107.539 175.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -127.36 144.84 50.98 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.602 -0.518 . . . . 74.420000000000002 109.602 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 28.2 t -141.81 142.99 27.1 Favored Pre-proline 0 C--N 1.291 -1.963 0 N-CA-C 107.932 -1.136 . . . . 71.120000000000005 107.932 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.636 ' HA ' ' O ' ' A' ' 490' ' ' SER . 19.3 Cg_exo -65.83 138.73 54.4 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.872 1.715 . . . . 73.349999999999994 110.251 176.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 65.9 m -150.82 174.42 13.09 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 109.522 -0.547 . . . . 75.010000000000005 109.522 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.0 t -52.83 136.91 45.52 Favored Pre-proline 0 N--CA 1.437 -1.112 0 C-N-CA 123.739 0.816 . . . . 64.040000000000006 110.571 174.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.89 -30.24 38.12 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 124.624 3.549 . . . . 74.200000000000003 113.478 -175.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -67.43 -27.83 67.39 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.184 -0.462 . . . . 74.129999999999995 111.624 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -99.23 -13.38 19.73 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 111.717 0.266 . . . . 64.430000000000007 111.717 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 56.9 t -59.25 130.56 22.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.268 -0.424 . . . . 73.129999999999995 110.79 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.08 -10.26 60.05 Favored Glycine 0 N--CA 1.435 -1.399 0 CA-C-N 115.92 -0.582 . . . . 65.340000000000003 111.84 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -118.03 166.57 12.38 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-O 120.886 0.375 . . . . 72.409999999999997 110.899 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.43 ' O ' ' HB ' ' A' ' 434' ' ' THR . 74.4 t -73.35 143.07 14.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 108.167 -1.049 . . . . 71.400000000000006 108.167 176.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 48.9 mm -98.02 -27.07 3.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.313 -0.995 . . . . 74.120000000000005 108.313 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 157.94 -161.48 31.52 Favored Glycine 0 N--CA 1.428 -1.894 0 CA-C-N 115.643 -0.708 . . . . 72.409999999999997 111.572 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 40.0 p -115.21 141.29 48.22 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.593 -1.262 . . . . 62.420000000000002 107.593 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.406 ' CB ' HG23 ' A' ' 485' ' ' ILE . 6.7 t30 -64.73 -50.42 64.28 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 109.791 -0.448 . . . . 63.119999999999997 109.791 176.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -75.29 155.44 41.62 Favored 'Trans proline' 0 C--N 1.377 2.035 0 N-CA-C 108.951 -1.211 . . . . 74.329999999999998 108.951 173.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . 0.434 ' O ' HD13 ' A' ' 429' ' ' ILE . 37.3 Cg_exo -62.96 126.19 17.5 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.173 1.248 . . . . 74.450000000000003 109.819 177.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -74.4 -0.7 18.16 Favored 'General case' 0 C--O 1.194 -1.838 0 N-CA-C 112.984 0.735 . . . . 63.520000000000003 112.984 -173.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . 0.465 ' N ' HD21 ' A' ' 475' ' ' ASN . 0.7 OUTLIER -108.96 3.86 22.68 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 121.78 -0.575 . . . . 50.240000000000002 110.071 -179.374 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -98.17 175.71 5.99 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 112.269 0.47 . . . . 74.239999999999995 112.269 -177.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 1.3 m -105.87 112.29 25.29 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.464 -0.789 . . . . 65.340000000000003 109.455 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 12.7 p -101.12 145.98 28.07 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.038 0.447 . . . . 65.450000000000003 110.858 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -75.33 150.57 38.42 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.547 -0.751 . . . . 71.439999999999998 110.739 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . 0.405 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 1.7 mp -67.85 -26.05 33.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 123.519 0.728 . . . . 75.549999999999997 111.59 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 12.5 t -89.46 2.58 54.33 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.822 0.82 . . . . 74.219999999999999 110.342 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -102.82 144.14 31.54 Favored 'General case' 0 C--N 1.318 -0.802 0 O-C-N 121.936 -0.478 . . . . 75.420000000000002 110.78 -175.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 6.4 p -108.15 127.21 64.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 C-N-CA 123.067 0.547 . . . . 73.140000000000001 111.566 -177.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 35.7 m -104.73 141.86 19.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.771 -0.65 . . . . 74.219999999999999 111.391 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.406 HG23 ' CB ' ' A' ' 471' ' ' ASN . 0.0 OUTLIER -108.93 130.13 62.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.401 0.62 . . . . 71.120000000000005 111.795 -178.513 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 13.1 mt -113.81 129.72 69.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 C-N-CA 125.084 1.354 . . . . 70.510000000000005 111.206 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 9.9 tt -105.33 126.96 60.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.586 -0.734 . . . . 73.439999999999998 111.388 -174.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 35.7 m -109.68 151.65 11.9 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 C-N-CA 123.519 0.728 . . . . 75.200000000000003 110.326 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -92.28 132.51 11.3 Favored Glycine 0 C--N 1.311 -0.809 0 N-CA-C 111.053 -0.819 . . . . 74.310000000000002 111.053 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.636 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 23.3 t . . . . . 0 N--CA 1.43 -1.428 0 N-CA-C 109.642 -0.503 . . . . 72.109999999999999 109.642 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo . . . . . 0 CA--C 1.531 0.347 0 N-CA-C 110.798 -0.501 . . . . 73.420000000000002 110.798 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . -112.19 25.9 11.1 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.582 0.706 . . . . 63.109999999999999 111.101 -176.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 6.6 p -116.94 143.47 45.67 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 114.93 -1.032 . . . . 72.310000000000002 110.659 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -151.2 147.09 26.59 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 108.419 -0.956 . . . . 75.310000000000002 108.419 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.487 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 7.6 p-10 -85.71 132.5 34.13 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.699 0.761 . . . . 75.230000000000004 112.543 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 33.7 pt -77.18 137.45 64.91 Favored Pre-proline 0 C--N 1.308 -1.22 0 CA-C-N 114.461 -1.245 . . . . 75.230000000000004 111.247 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -85.7 175.02 6.3 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.417 2.078 . . . . 72.329999999999998 112.528 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -97.21 132.46 42.94 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.59 -0.732 . . . . 75.409999999999997 109.654 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.2 104.11 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.626 0 CA-C-O 122.017 0.913 . . . . 73.200000000000003 110.598 -177.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -146.55 139.91 25.74 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.958 -1.019 . . . . 74.430000000000007 108.725 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 113.9 -18.48 19.24 Favored Glycine 0 CA--C 1.485 -1.837 0 N-CA-C 110.412 -1.075 . . . . 74.540000000000006 110.412 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . 0.408 ' O ' HG11 ' A' ' 534' ' ' VAL . 50.6 mt-30 -95.87 -179.52 4.73 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 109.22 -0.659 . . . . 74.549999999999997 109.22 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 15.0 t -91.87 157.16 17.01 Favored 'General case' 0 N--CA 1.421 -1.896 0 C-N-CA 118.184 -1.406 . . . . 71.530000000000001 107.885 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 6.0 p -53.77 -42.5 52.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 O-C-N 123.742 0.651 . . . . 64.400000000000006 112.344 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -65.48 -41.52 93.19 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.265 0.353 . . . . 72.030000000000001 110.976 -176.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 81.8 t -70.59 -44.49 76.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.878 0.371 . . . . 71.25 110.798 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . 0.403 ' O ' ' HG ' ' A' ' 512' ' ' LEU . . . -61.44 -48.49 80.94 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.01 -0.541 . . . . 73.310000000000002 111.147 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -60.4 -43.11 96.98 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.249 -0.887 . . . . 75.319999999999993 109.939 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.473 ' O ' HG22 ' A' ' 514' ' ' VAL . 35.4 ttmt -63.21 -42.37 99.29 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.967 -1.015 . . . . 74.319999999999993 110.127 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -62.33 -41.7 98.77 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.057 0.456 . . . . 74.319999999999993 110.136 178.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 508' ' ' ALA . 89.4 mt -65.73 -37.1 85.47 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.717 -0.674 . . . . 74.239999999999995 110.923 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -64.23 -37.76 88.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.253 -0.431 . . . . 75.430000000000007 110.051 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 510' ' ' LYS . 93.3 t -62.55 -31.17 51.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 115.889 -0.596 . . . . 73.400000000000006 110.673 177.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -77.24 -6.75 54.25 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 120.818 0.342 . . . . 74.140000000000001 111.062 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 106.96 -0.06 35.9 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.401 -0.904 . . . . 53.340000000000003 113.239 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -90.86 99.37 12.42 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 107.56 -1.274 . . . . 75.299999999999997 107.56 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.1 m -91.0 -11.35 39.16 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.972 -1.013 . . . . 75.150000000000006 112.076 -172.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . 0.518 ' HD2' ' O ' ' A' ' 548' ' ' ASP . 95.7 mttt -108.62 118.18 36.12 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.239 -0.652 . . . . 74.430000000000007 109.239 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -129.63 155.0 46.55 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.147 0.498 . . . . 72.040000000000006 111.01 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 4.8 p -141.11 148.17 39.69 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 107.457 -1.312 . . . . 65.120000000000005 107.457 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . 0.454 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 4.0 pt20 -132.64 132.61 42.63 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-O 121.235 0.54 . . . . 71.439999999999998 111.062 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -113.56 141.51 47.08 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.457 -1.682 . . . . 61.43 106.457 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 45.3 p -121.22 129.16 53.06 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 120.397 -0.521 . . . . 72.349999999999994 111.459 -177.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . 0.565 ' O ' ' HB3' ' A' ' 557' ' ' LYS . 19.5 m -121.82 166.67 16.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 109.267 -0.642 . . . . 65.519999999999996 109.267 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -92.38 137.85 32.01 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.997 -1.483 . . . . 75.099999999999994 106.997 174.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 10.3 m -141.65 173.22 4.99 Favored Pre-proline 0 C--N 1.276 -2.625 0 N-CA-C 108.477 -0.934 . . . . 65.040000000000006 108.477 -172.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -79.22 -17.52 11.67 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 121.651 1.567 . . . . 64.319999999999993 109.19 168.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . 0.504 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 18.0 mmm180 -67.38 152.19 96.41 Favored Pre-proline 0 N--CA 1.441 -0.905 0 C-N-CA 125.752 1.621 . . . . 65.310000000000002 108.581 177.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.44 156.32 61.82 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.335 2.023 . . . . 62.539999999999999 112.791 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' A' ' 557' ' ' LYS . . . -70.93 124.92 25.48 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.937 -0.574 . . . . 73.219999999999999 111.038 -178.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 107.82 -10.95 38.14 Favored Glycine 0 C--N 1.305 -1.182 0 C-N-CA 120.589 -0.815 . . . . 55.310000000000002 111.395 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -82.46 138.64 34.31 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.469 -1.678 . . . . 70.319999999999993 106.469 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . 0.408 HG11 ' O ' ' A' ' 503' ' ' GLN . 11.6 p -95.22 118.29 41.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 119.896 -0.722 . . . . 75.519999999999996 110.163 -178.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 535' ' ' THR . . . . . 0.561 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 13.2 t -84.05 0.09 49.64 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.364 -0.38 . . . . 73.150000000000006 111.614 -175.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 135.49 -160.94 24.63 Favored Glycine 0 CA--C 1.495 -1.204 0 C-N-CA 120.887 -0.673 . . . . 75.209999999999994 111.921 175.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 37.2 p -117.77 155.3 30.26 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.794 -0.817 . . . . 73.120000000000005 108.794 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -76.16 -50.34 2.98 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-O 119.437 -0.316 . . . . 71.010000000000005 110.507 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -66.95 135.95 39.6 Favored 'Trans proline' 0 C--N 1.369 1.609 0 N-CA-C 108.991 -1.196 . . . . 73.329999999999998 108.991 169.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.56 150.56 86.49 Favored 'Trans proline' 0 C--O 1.244 0.784 0 C-N-CA 122.378 2.052 . . . . 72.409999999999997 112.799 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.22 138.02 57.39 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.924 -0.769 . . . . 74.120000000000005 108.924 176.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.47 -11.34 58.13 Favored Glycine 0 C--N 1.294 -1.789 0 C-N-CA 120.606 -0.807 . . . . 65.409999999999997 111.767 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 59.5 m -69.87 120.86 16.24 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.595 -0.521 . . . . 73.010000000000005 109.595 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 11.5 t -85.89 123.16 30.92 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 109.079 -0.711 . . . . 73.030000000000001 109.079 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 29.1 m -135.88 159.96 69.22 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 108.349 -0.982 . . . . 74.409999999999997 108.349 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . 0.508 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 32.3 Cg_exo -61.54 141.1 90.48 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 121.711 1.608 . . . . 75.230000000000004 110.8 174.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 35.2 m -61.05 -19.65 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-O 121.811 0.815 . . . . 74.519999999999996 111.978 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . 0.518 ' O ' ' HD2' ' A' ' 519' ' ' LYS . 25.1 t70 -90.12 -1.23 57.92 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.242 -0.89 . . . . 75.150000000000006 110.897 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 67.2 m -86.29 172.95 10.07 Favored 'General case' 0 C--N 1.313 -1.018 0 O-C-N 121.697 -0.627 . . . . 73.409999999999997 112.547 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 14.3 p -100.14 136.49 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 115.255 -0.884 . . . . 73.439999999999998 110.886 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.97 145.67 15.51 Favored 'Isoleucine or valine' 0 C--O 1.252 1.228 0 N-CA-C 109.245 -0.65 . . . . 75.230000000000004 109.245 174.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -109.13 115.15 29.5 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 121.303 0.573 . . . . 74.230000000000004 111.035 -176.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 5.1 mp -95.5 135.2 37.45 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.612 -1.177 . . . . 74.420000000000002 109.425 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -110.43 118.12 35.41 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.68 0.752 . . . . 73.409999999999997 110.318 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.88 141.1 16.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 114.731 -1.122 . . . . 72.540000000000006 110.288 -174.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.561 ' OG ' ' HB ' ' A' ' 535' ' ' THR . 7.8 m -86.29 147.95 25.84 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 115.35 -0.841 . . . . 64.310000000000002 110.653 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.565 ' HB3' ' O ' ' A' ' 525' ' ' VAL . 0.5 OUTLIER -123.58 130.12 52.19 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.111 -0.95 . . . . 73.540000000000006 109.691 173.69 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -66.25 -43.46 92.9 Favored Glycine 0 CA--C 1.486 -1.769 0 N-CA-C 111.36 -0.696 . . . . 65.129999999999995 111.36 -176.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 64.3 t30 72.53 -8.74 1.16 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.968 1.307 . . . . 74.230000000000004 110.56 176.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.477 ' H ' ' C ' ' A' ' 558' ' ' GLY . 97.0 mt-30 -127.21 155.34 43.58 Favored 'General case' 0 N--CA 1.423 -1.81 0 C-N-CA 125.567 1.547 . . . . 70.329999999999998 107.375 177.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -126.48 147.65 49.79 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.844 -0.798 . . . . 74.120000000000005 108.844 177.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 62.8 t -63.43 116.98 3.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 O-C-N 123.408 0.442 . . . . 74.329999999999998 110.079 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 58.3 ttp -75.49 124.77 89.12 Favored Pre-proline 0 C--N 1.306 -1.314 0 CA-C-N 115.979 -0.555 . . . . 73.25 110.788 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -65.89 169.41 13.32 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.095 2.53 . . . . 74.439999999999998 110.32 174.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -89.19 114.17 25.46 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 118.72 -1.192 . . . . 53.200000000000003 111.688 -177.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -125.81 0.18 7.37 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.567 -1.271 . . . . 74.409999999999997 107.567 173.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 23.9 m -65.07 151.2 46.63 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 113.777 -1.556 . . . . 74.040000000000006 112.238 -174.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 90.79 35.97 7.01 Favored Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 110.213 -1.155 . . . . 50.420000000000002 110.213 -175.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 15.9 ptm -117.53 157.5 26.21 Favored 'General case' 0 C--O 1.25 1.089 0 N-CA-C 109.529 -0.545 . . . . 73.25 109.529 -174.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . 0.53 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 86.3 m-85 -84.53 171.52 12.43 Favored 'General case' 0 CA--C 1.502 -0.9 0 O-C-N 123.322 0.389 . . . . 70.400000000000006 110.821 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 29.4 t90 -62.6 -34.0 76.12 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.941 -0.762 . . . . 72.450000000000003 108.941 172.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 29.1 m -72.33 -7.96 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.318 -0.855 . . . . 75.450000000000003 110.97 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . 0.565 ' O ' ' HD3' ' A' ' 577' ' ' ARG . 31.6 m-20 -100.92 -44.83 5.63 Favored 'General case' 0 CA--C 1.492 -1.276 0 N-CA-C 109.407 -0.59 . . . . 74.040000000000006 109.407 174.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . 0.629 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -61.04 -53.2 60.07 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.081 -0.963 . . . . 75.140000000000001 112.539 -175.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.95 -50.69 86.67 Favored Pre-proline 0 CA--C 1.574 1.892 0 O-C-N 123.547 0.529 . . . . 70.409999999999997 112.005 -174.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -58.25 -38.42 91.04 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 121.847 1.698 . . . . 72.239999999999995 112.268 174.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . 0.565 ' HD3' ' O ' ' A' ' 573' ' ' ASP . 5.7 mpt_? -67.67 -34.26 76.57 Favored 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 121.111 -0.236 . . . . 74.530000000000001 111.555 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 76.2 mt -60.7 -43.11 98.17 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.976 -0.75 . . . . 74.409999999999997 108.976 177.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -64.28 -45.9 85.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.147 -0.933 . . . . 74.400000000000006 109.302 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.11 92.27 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.854 -1.066 . . . . 64.510000000000005 113.44 -176.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 11.1 mp -82.22 -9.09 59.62 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 113.127 0.788 . . . . 73.319999999999993 113.127 -177.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 68.78 32.36 74.01 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 109.255 -1.538 . . . . 75.019999999999996 109.255 -174.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 44.8 t90 -60.61 134.07 56.72 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.021 0.928 . . . . 74.129999999999995 110.284 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 8.9 t -126.61 19.33 7.34 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.858 -0.61 . . . . 73.549999999999997 109.917 -176.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -79.97 -155.22 10.27 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 115.808 -0.633 . . . . 63.240000000000002 113.511 -176.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 86.1 mtp -124.94 132.62 53.26 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.551 -0.907 . . . . 73.540000000000006 108.551 -178.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 61.9 tp -106.8 130.69 54.46 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.328 -0.619 . . . . 74.439999999999998 109.328 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -114.2 121.92 45.2 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 120.898 0.38 . . . . 73.340000000000003 110.206 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -105.5 118.38 36.42 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 116.153 -0.476 . . . . 74.209999999999994 110.216 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -88.19 -163.09 38.85 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.691 -0.964 . . . . 72.200000000000003 110.691 177.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -67.19 147.8 52.6 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 120.742 0.306 . . . . 72.329999999999998 110.699 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . 0.412 ' HB3' ' NE2' ' A' ' 626' ' ' GLN . 21.6 m-20 -93.72 124.51 37.76 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.138 0.494 . . . . 73.340000000000003 111.448 -178.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 91.2 t -114.73 126.39 72.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 106.664 -1.606 . . . . 73.049999999999997 106.664 175.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . 0.451 ' HA ' ' HB2' ' A' ' 626' ' ' GLN . 6.2 p-10 -102.44 125.35 49.13 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 120.445 -0.502 . . . . 65.019999999999996 109.877 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -133.04 -28.68 1.51 Allowed 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.464 -0.789 . . . . 74.319999999999993 110.428 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 130.37 125.29 2.69 Favored Glycine 0 CA--C 1.486 -1.752 0 N-CA-C 109.979 -1.248 . . . . 73.239999999999995 109.979 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.29 -36.07 67.81 Favored Glycine 0 C--O 1.21 -1.363 0 N-CA-C 114.641 0.617 . . . . 74.230000000000004 114.641 -172.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 18.6 m -62.67 -32.06 73.06 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 117.58 0.69 . . . . 75.540000000000006 112.194 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -109.37 -1.92 18.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.62 -0.264 . . . . 62.509999999999998 111.525 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . 0.519 ' CE1' ' HA3' ' A' ' 625' ' ' GLY . 5.9 t-160 -150.49 -148.92 0.28 Allowed 'General case' 0 C--O 1.204 -1.328 0 N-CA-C 108.78 -0.822 . . . . 65.430000000000007 108.78 -170.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . 0.473 ' H ' ' CG ' ' A' ' 600' ' ' HIS . 3.1 t-20 62.22 2.87 0.9 Allowed 'General case' 0 N--CA 1.516 2.828 0 C-N-CA 125.1 1.36 . . . . 75.299999999999997 112.282 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 9.2 ptp85 -110.64 171.58 7.38 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.036 -0.984 . . . . 73.430000000000007 109.355 -177.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 7.6 p -57.03 130.78 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 O-C-N 124.469 1.105 . . . . 64.530000000000001 109.039 176.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 29.2 m -101.22 -37.17 5.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 121.504 0.669 . . . . 75.019999999999996 109.561 -175.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . 0.454 ' CE2' ' HD3' ' A' ' 623' ' ' ARG . 35.4 p90 -151.28 152.86 33.8 Favored 'General case' 0 N--CA 1.409 -2.524 0 N-CA-C 105.768 -1.938 . . . . 74.109999999999999 105.768 172.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -128.49 144.45 51.15 Favored 'General case' 0 C--N 1.27 -2.865 0 N-CA-C 107.972 -1.121 . . . . 75.439999999999998 107.972 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.478 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 42.8 t30 -72.44 -51.92 7.11 Favored Pre-proline 0 C--N 1.286 -2.162 0 CA-C-N 115.652 -0.704 . . . . 74.420000000000002 111.054 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 10.3 Cg_endo -97.78 111.48 0.1 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.582 0 C-N-CA 121.594 1.529 . . . . 74.409999999999997 110.309 170.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -68.25 159.07 54.81 Favored 'Trans proline' 0 C--O 1.248 0.978 0 C-N-CA 121.974 1.783 . . . . 64.400000000000006 110.465 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -60.11 132.91 55.4 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.789 -0.448 . . . . 73.129999999999995 109.789 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.25 -11.06 47.67 Favored Glycine 0 C--N 1.308 -0.997 0 C-N-CA 120.532 -0.842 . . . . 62.43 111.585 -176.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 22.7 m -89.95 156.34 18.5 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.775 -0.824 . . . . 72.439999999999998 108.775 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -80.84 125.17 6.75 Favored Glycine 0 N--CA 1.419 -2.454 0 N-CA-C 111.704 -0.558 . . . . 61.119999999999997 111.704 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 29.1 m -107.64 141.48 22.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 108.177 -1.045 . . . . 73.209999999999994 108.177 175.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . 0.596 ' ND2' ' HB3' ' A' ' 617' ' ' ASP . 31.4 p-10 -63.22 164.52 8.62 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 122.903 0.481 . . . . 74.349999999999994 111.873 -177.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -61.84 -25.6 67.62 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.213 0.53 . . . . 73.540000000000006 111.242 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . 0.596 ' HB3' ' ND2' ' A' ' 615' ' ' ASN . 16.0 t70 -68.11 -37.44 81.16 Favored 'General case' 0 C--O 1.245 0.856 0 CA-C-N 115.535 -0.757 . . . . 63.439999999999998 109.321 176.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 89.65 19.71 47.23 Favored Glycine 0 N--CA 1.429 -1.79 0 CA-C-N 115.283 -0.872 . . . . 74.420000000000002 113.147 174.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.09 118.13 14.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 122.457 1.122 . . . . 72.010000000000005 109.192 -174.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.09 129.4 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 N-CA-C 107.691 -1.226 . . . . 71.430000000000007 107.691 -175.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.439 ' HB ' ' CB ' ' A' ' 607' ' ' ASN . 32.8 m -99.71 118.31 35.94 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 109.473 -0.566 . . . . 73.530000000000001 109.473 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -133.86 150.47 51.37 Favored 'General case' 0 CA--C 1.477 -1.852 0 N-CA-C 105.089 -2.189 . . . . 73.5 105.089 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . 0.454 ' HD3' ' CE2' ' A' ' 605' ' ' TYR . 79.7 ttt180 -132.94 139.41 47.31 Favored 'General case' 0 C--N 1.262 -3.208 0 N-CA-C 107.17 -1.418 . . . . 75.120000000000005 107.17 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -140.16 163.8 31.76 Favored 'General case' 0 C--N 1.289 -2.052 0 O-C-N 124.048 0.842 . . . . 71.310000000000002 109.439 -175.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . 0.519 ' HA3' ' CE1' ' A' ' 600' ' ' HIS . . . -123.64 -141.67 5.88 Favored Glycine 0 N--CA 1.416 -2.685 0 N-CA-C 109.992 -1.243 . . . . 44.149999999999999 109.992 174.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 601' ' ' ASN . 38.6 mt-30 . . . . . 0 C--N 1.297 -1.681 0 N-CA-C 108.314 -0.995 . . . . 74.040000000000006 108.314 177.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 . . . . . 0 N--CA 1.436 -1.154 0 N-CA-C 107.289 -1.374 . . . . 70.420000000000002 107.289 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.8 m -116.93 161.15 15.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 108.905 -0.776 . . . . 71.409999999999997 108.905 -177.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -95.04 136.84 34.87 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.008 -1.077 . . . . 70.239999999999995 108.142 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 95.6 t -97.58 127.81 36.55 Favored Pre-proline 0 C--N 1.285 -2.227 0 CA-C-N 115.798 -0.637 . . . . 74.340000000000003 110.281 -173.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.17 137.66 57.7 Favored 'Trans proline' 0 C--O 1.242 0.695 0 C-N-CA 122.66 2.24 . . . . 70.209999999999994 111.015 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -79.1 130.36 35.42 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 122.055 0.931 . . . . 70.299999999999997 109.706 -178.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 7.9 p -107.94 5.25 9.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-O 122.656 1.217 . . . . 73.420000000000002 110.622 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.13 145.01 52.51 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.952 -1.022 . . . . 73.209999999999994 110.66 173.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 91.68 0.51 72.3 Favored Glycine 0 N--CA 1.434 -1.439 0 CA-C-N 116.216 -0.447 . . . . 70.530000000000001 112.303 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -107.82 -82.06 0.56 Allowed 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.263 0.468 . . . . 73.239999999999995 112.263 -176.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 11.8 t -154.29 150.88 28.47 Favored 'General case' 0 CA--C 1.503 -0.861 0 O-C-N 121.644 -0.66 . . . . 62.109999999999999 110.501 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.621 ' HB3' ' O ' ' A' ' 397' ' ' ASP . 1.4 p -63.68 -47.22 82.08 Favored 'General case' 0 N--CA 1.435 -1.181 0 O-C-N 123.799 0.687 . . . . 74.010000000000005 109.896 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -68.8 -45.59 70.86 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 115.158 -0.928 . . . . 72.239999999999995 110.691 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -68.88 -34.66 75.79 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 119.458 -0.897 . . . . 75.329999999999998 111.783 -176.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . 0.4 ' O ' HD13 ' A' ' 377' ' ' LEU . . . -67.93 -51.11 51.46 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.662 0.267 . . . . 61.539999999999999 110.834 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.37 -37.36 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 116.239 -0.437 . . . . 74.340000000000003 110.697 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.58 -47.08 85.5 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 120.893 0.378 . . . . 71.010000000000005 111.062 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 42.2 m -62.53 -47.77 82.43 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-O 121.576 0.703 . . . . 73.409999999999997 110.081 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . 0.4 HD13 ' O ' ' A' ' 373' ' ' ALA . 9.6 mp -64.33 -39.1 93.22 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.495 -0.775 . . . . 75.010000000000005 112.096 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -61.79 -44.45 96.85 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.131 0.572 . . . . 73.329999999999998 110.373 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -68.35 -19.38 64.64 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.29 0.567 . . . . 74.239999999999995 112.07 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . 0.495 ' HA ' ' NE ' ' A' ' 380' ' ' ARG . 3.9 mmp_? -96.45 -13.95 22.74 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 112.515 0.561 . . . . 74.310000000000002 112.515 177.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.13 14.51 54.32 Favored Glycine 0 C--O 1.25 1.12 0 C-N-CA 120.87 -0.681 . . . . 71.150000000000006 112.367 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -76.62 140.05 40.84 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-O 121.141 0.496 . . . . 74.310000000000002 110.121 177.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -85.08 134.77 34.19 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 107.628 -1.249 . . . . 74.230000000000004 107.628 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.13 157.15 40.46 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 CA-C-O 120.999 0.428 . . . . 71.450000000000003 110.338 -175.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -134.99 137.36 42.95 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 106.636 -1.616 . . . . 71.310000000000002 106.636 172.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 13.1 m -135.09 116.76 14.94 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.802 -0.814 . . . . 62.130000000000003 108.802 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -113.78 123.43 49.83 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.491 -0.929 . . . . 72.299999999999997 108.491 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -89.79 125.22 35.22 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.54 -0.541 . . . . 75.430000000000007 109.54 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . 0.565 ' HB2' ' HZ2' ' A' ' 389' ' ' LYS . 7.2 mtmp? -114.84 133.31 22.62 Favored Pre-proline 0 C--N 1.307 -1.26 0 N-CA-C 108.159 -1.052 . . . . 73.329999999999998 108.159 176.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . 0.422 ' O ' ' HB3' ' A' ' 391' ' ' ASP . 3.3 Cg_exo -85.76 128.47 3.35 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.769 1.646 . . . . 64.219999999999999 109.517 172.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' A' ' 390' ' ' PRO . 2.0 p30 158.43 159.25 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.055 -1.461 . . . . 74.150000000000006 107.055 -175.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 20.3 p -126.68 23.9 6.67 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.456 0.646 . . . . 71.019999999999996 110.165 177.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 39.5 m -90.85 -37.72 13.41 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 108.624 -0.88 . . . . 70.439999999999998 108.624 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 37.6 mm -89.71 141.89 28.81 Favored Pre-proline 0 N--CA 1.432 -1.332 0 N-CA-C 106.666 -1.605 . . . . 73.510000000000005 106.666 178.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -51.39 161.04 2.0 Favored 'Trans proline' 0 CA--C 1.56 1.782 0 C-N-CA 123.267 2.645 . . . . 72.430000000000007 113.606 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -54.65 162.89 4.31 Favored 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 124.675 3.584 . . . . 72.049999999999997 114.155 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . 0.621 ' O ' ' HB3' ' A' ' 370' ' ' SER . 5.9 p-10 -56.38 -9.88 0.8 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.381 1.473 . . . . 62.020000000000003 113.973 -172.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -67.62 145.89 54.4 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.185 -1.413 . . . . 73.209999999999994 107.185 176.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.42 HG11 ' HA ' ' A' ' 370' ' ' SER . 10.3 m -63.29 118.43 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 C-N-CA 119.298 -0.961 . . . . 75.109999999999999 112.324 -171.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.29 -34.75 7.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.226 -1.027 . . . . 64.140000000000001 108.226 178.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -156.59 157.62 28.09 Favored Glycine 0 N--CA 1.423 -2.174 0 N-CA-C 110.731 -0.948 . . . . 74.219999999999999 110.731 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 11.5 p -126.77 -178.21 4.3 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.811 -1.181 . . . . 75.150000000000006 107.811 175.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -100.5 139.44 20.63 Favored Pre-proline 0 C--N 1.296 -1.731 0 C-N-CA 119.596 -0.842 . . . . 72.409999999999997 109.364 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -52.8 -3.09 0.11 Allowed 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 124.599 3.533 . . . . 53.32 115.765 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.7 -37.19 65.52 Favored 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 122.947 0.499 . . . . 44.420000000000002 109.673 173.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -69.11 -41.06 77.93 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-O 121.666 0.746 . . . . 72.349999999999994 109.988 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -77.65 -1.24 30.02 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.261 -0.881 . . . . 72.040000000000006 110.563 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 75.2 m -98.68 147.07 25.22 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.345 -1.724 . . . . 74.129999999999995 106.345 172.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 34.8 m -74.23 112.05 10.0 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 107.385 -1.339 . . . . 52.420000000000002 107.385 175.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 23.1 m -133.27 169.64 21.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 121.28 0.562 . . . . 71.219999999999999 110.772 -176.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 10.1 t -84.29 154.98 22.63 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 106.557 -1.646 . . . . 75.409999999999997 106.557 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -67.91 108.13 2.91 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 121.369 0.604 . . . . 74.319999999999993 110.411 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 133.06 54.4 0.08 OUTLIER Glycine 0 N--CA 1.427 -1.952 0 CA-C-N 115.262 -0.881 . . . . 74.329999999999998 112.005 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -104.28 -173.2 2.25 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.035 -1.468 . . . . 71.030000000000001 107.035 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -115.42 125.63 53.38 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 118.97 0.805 . . . . 73.329999999999998 111.085 -176.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.6 mm -122.56 117.99 53.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 121.158 0.504 . . . . 72.209999999999994 110.03 177.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 23.8 p -95.26 127.83 41.62 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 123.108 0.563 . . . . 75.109999999999999 110.392 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 18.5 t -120.77 134.91 62.68 Favored 'Isoleucine or valine' 0 C--O 1.25 1.131 0 C-N-CA 123.786 0.834 . . . . 73.140000000000001 111.843 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -108.78 128.59 55.02 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-O 121.47 0.652 . . . . 74.25 111.008 174.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.428 HG12 ' CB ' ' A' ' 397' ' ' ASP . 2.9 t -106.52 144.2 16.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 C-N-CA 125.075 1.35 . . . . 64.340000000000003 110.843 -175.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 10.4 m -118.66 123.36 44.76 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 109.556 -0.535 . . . . 71.519999999999996 109.556 176.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 20.6 p -107.78 107.93 18.91 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 105.879 -1.897 . . . . 74.540000000000006 105.879 173.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.27 0 N-CA-C 116.858 1.503 . . . . 73.519999999999996 116.858 -170.501 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 N--CA 1.43 -1.46 0 CA-C-O 120.536 0.207 . . . . 74.540000000000006 110.758 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -127.89 159.61 34.38 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 121.097 0.475 . . . . 75.150000000000006 111.322 -178.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -103.59 139.0 39.48 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.067 -0.969 . . . . 72.510000000000005 109.027 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.707 ' HB ' ' O ' ' A' ' 474' ' ' ALA . 2.7 mp -90.11 124.04 64.33 Favored Pre-proline 0 C--N 1.319 -0.753 0 C-N-CA 119.578 -0.849 . . . . 73.510000000000005 109.123 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -66.69 148.37 82.89 Favored 'Trans proline' 0 C--O 1.24 0.604 0 C-N-CA 122.32 2.013 . . . . 75.310000000000002 111.393 177.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -76.37 103.89 6.61 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-O 121.491 0.663 . . . . 73.209999999999994 110.926 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 60.9 t -98.24 150.01 5.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 107.222 -1.399 . . . . 72.25 107.222 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 35.6 m -73.43 154.88 39.8 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 121.07 0.462 . . . . 70.040000000000006 111.055 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' THR . . . . . 0.552 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 33.5 p -68.3 -30.14 69.07 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 123.692 0.797 . . . . 74.019999999999996 112.403 -174.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 1.6 pp -80.09 -11.46 59.76 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 113.007 0.743 . . . . 73.540000000000006 113.007 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.42 65.15 0.61 Allowed 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 113.582 0.956 . . . . 75.120000000000005 113.582 -178.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -59.01 -38.58 79.57 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.52 0.728 . . . . 74.510000000000005 111.908 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -62.48 -36.83 83.72 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.397 0.618 . . . . 74.420000000000002 110.548 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -70.12 -40.53 74.82 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.781 -0.822 . . . . 75.129999999999995 108.781 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.554 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -60.86 -51.13 70.61 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.8 -0.637 . . . . 64.409999999999997 111.269 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 32.5 m -64.26 -39.73 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 112.78 0.659 . . . . 75.409999999999997 112.78 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -68.43 -36.89 79.71 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 119.488 -0.885 . . . . 75.319999999999993 110.34 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -66.14 -38.29 87.75 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.96 -0.563 . . . . 74.430000000000007 110.936 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 93.7 mt -63.42 -36.3 83.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.157 0.504 . . . . 74.400000000000006 109.647 175.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.43 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 33.2 m -70.09 -43.81 70.33 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.579 -0.737 . . . . 70.010000000000005 110.444 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -66.96 -21.62 65.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.033 -0.53 . . . . 74.25 111.386 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.7 4.93 26.58 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.018 0.437 . . . . 53.399999999999999 111.418 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . 0.419 ' HA3' HD13 ' A' ' 480' ' ' ILE . . . 111.2 -84.94 0.38 Allowed Glycine 0 CA--C 1.484 -1.845 0 C-N-CA 120.525 -0.845 . . . . 64.109999999999999 111.793 175.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -38.53 -60.28 0.82 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.432 1.271 . . . . 74.019999999999996 114.432 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . 0.43 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 61.3 30.13 73.22 Favored Glycine 0 CA--C 1.501 -0.799 0 C-N-CA 121.22 -0.514 . . . . 74.329999999999998 112.047 -177.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.405 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 40.9 mmm-85 -104.37 110.92 23.35 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 108.477 -0.934 . . . . 74.5 108.477 -177.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -136.09 140.31 43.64 Favored 'General case' 0 N--CA 1.423 -1.778 0 CA-C-N 115.818 -0.628 . . . . 71.239999999999995 111.585 -176.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -131.67 140.04 49.23 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.936 -1.029 . . . . 65.120000000000005 108.238 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -109.33 129.28 55.53 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.128 0.49 . . . . 74.129999999999995 111.531 -176.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.88 150.67 40.7 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.112 -1.07 . . . . 72.200000000000003 108.112 176.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -121.97 140.68 52.16 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.762 -0.829 . . . . 73.299999999999997 108.762 -177.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 24.3 t -144.7 137.34 13.55 Favored Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 109.338 -0.616 . . . . 64.340000000000003 109.338 176.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 490' ' ' SER . 47.3 Cg_endo -71.03 134.56 25.55 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.939 1.759 . . . . 74.040000000000006 110.538 175.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 70.2 m -152.76 -179.42 7.61 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 122.801 0.44 . . . . 75.409999999999997 110.155 -177.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.2 t -47.64 137.28 9.75 Favored Pre-proline 0 C--O 1.254 1.316 0 C-N-CA 124.276 1.03 . . . . 71.230000000000004 110.899 173.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -52.81 -30.94 49.34 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 124.375 3.383 . . . . 73.450000000000003 113.451 -175.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -68.5 -26.79 65.64 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.712 0.634 . . . . 75.340000000000003 112.712 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -95.33 -15.78 22.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.935 0.398 . . . . 74.540000000000006 111.135 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 83.4 t -60.7 128.73 22.36 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 115.996 -0.547 . . . . 73.299999999999997 110.304 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.06 -11.23 60.42 Favored Glycine 0 N--CA 1.433 -1.531 0 CA-C-N 115.495 -0.775 . . . . 73.230000000000004 111.757 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -119.1 167.18 12.04 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.033 -0.729 . . . . 74.239999999999995 109.033 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.552 ' O ' ' HB ' ' A' ' 434' ' ' THR . 79.3 t -75.68 147.11 8.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.114 -1.439 . . . . 75.109999999999999 107.114 173.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 65.2 mt -97.88 -35.15 5.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 107.296 -1.372 . . . . 70.340000000000003 107.296 176.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 160.06 -160.38 31.57 Favored Glycine 0 N--CA 1.416 -2.682 0 N-CA-C 109.729 -1.348 . . . . 73.420000000000002 109.729 177.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 26.3 p -115.98 145.73 42.71 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 107.335 -1.357 . . . . 74.420000000000002 107.335 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -64.3 -56.15 25.61 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 119.968 -0.693 . . . . 73.200000000000003 110.401 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -80.69 149.49 18.42 Favored 'Trans proline' 0 C--N 1.37 1.699 0 N-CA-C 107.842 -1.638 . . . . 74.25 107.842 169.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -64.81 126.93 17.56 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.588 1.525 . . . . 71.329999999999998 113.039 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.707 ' O ' ' HB ' ' A' ' 429' ' ' ILE . . . -86.11 -34.67 20.56 Favored 'General case' 0 C--O 1.198 -1.631 0 CA-C-O 122.224 1.011 . . . . 75.0 108.383 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -72.21 12.37 0.44 Allowed 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.528 -1.215 . . . . 71.040000000000006 111.717 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . 0.421 ' H ' ' C ' ' A' ' 474' ' ' ALA . 80.0 mm-40 -119.81 -165.49 1.18 Allowed 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 107.978 -1.119 . . . . 75.109999999999999 107.978 175.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.44 140.1 37.93 Favored 'General case' 0 N--CA 1.402 -2.874 0 CA-C-O 121.44 0.638 . . . . 74.239999999999995 111.883 -178.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 39.5 m -136.99 139.05 41.17 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.852 -0.613 . . . . 72.209999999999994 109.473 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -67.85 165.09 18.28 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.869 -0.605 . . . . 74.420000000000002 110.776 177.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . 0.419 HD13 ' HA3' ' A' ' 448' ' ' GLY . 29.0 mm -70.57 -15.38 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 121.914 0.864 . . . . 75.329999999999998 110.616 -176.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.2 t -92.41 2.9 56.39 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.996 -0.547 . . . . 75.430000000000007 110.801 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -92.36 140.95 29.08 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.178 0.513 . . . . 73.140000000000001 111.798 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . 0.405 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.3 p -108.31 127.07 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 CA-C-N 115.23 -0.895 . . . . 73.349999999999994 109.946 177.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 29.9 m -104.09 132.74 49.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-O 121.779 0.799 . . . . 73.120000000000005 111.029 178.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.72 124.25 55.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 115.258 -0.883 . . . . 75.200000000000003 110.552 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 1.7 mp -100.84 125.52 54.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 125.542 1.537 . . . . 73.450000000000003 108.671 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 8.8 tt -107.03 126.41 63.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 109.479 -0.563 . . . . 72.340000000000003 109.479 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 33.6 m -110.29 151.21 12.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 116.18 -0.464 . . . . 64.299999999999997 110.7 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -83.58 121.58 5.53 Favored Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 109.43 -1.468 . . . . 71.299999999999997 109.43 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 23.3 t . . . . . 0 N--CA 1.426 -1.632 0 N-CA-C 108.28 -1.008 . . . . 72.420000000000002 108.28 -176.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.451 -1.022 0 N-CA-C 110.923 -0.453 . . . . 74.120000000000005 110.923 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -94.77 26.58 3.47 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 122.422 1.106 . . . . 72.400000000000006 110.491 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 12.8 p -118.07 147.54 43.16 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 114.134 -1.394 . . . . 75.120000000000005 110.295 -178.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . 0.477 ' HD3' ' N ' ' A' ' 496' ' ' ASP . 6.8 tmtm? -150.6 140.2 21.6 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 105.559 -2.015 . . . . 74.129999999999995 105.559 175.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.504 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 11.4 p-10 -89.07 127.1 35.68 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.526 0.679 . . . . 72.319999999999993 111.179 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 28.3 pt -75.89 130.15 79.24 Favored Pre-proline 0 C--N 1.306 -1.321 0 CA-C-N 114.865 -1.061 . . . . 70.310000000000002 110.878 -177.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -85.61 -174.72 1.69 Allowed 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.342 2.028 . . . . 73.319999999999993 110.737 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -80.04 133.14 36.11 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.033 -1.099 . . . . 71.209999999999994 108.033 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . 0.423 HG21 ' NE2' ' A' ' 503' ' ' GLN . 13.0 p -133.09 -7.25 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-O 121.551 0.691 . . . . 70.230000000000004 111.187 -174.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.97 114.8 9.39 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.273 0.559 . . . . 74.319999999999993 110.338 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 130.84 -21.94 4.63 Favored Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 109.685 -1.366 . . . . 70.319999999999993 109.685 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . 0.423 ' NE2' HG21 ' A' ' 500' ' ' VAL . 21.3 mt-30 -87.08 168.9 12.86 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 109.285 -0.635 . . . . 74.239999999999995 109.285 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 47.5 p -85.59 162.32 18.91 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 109.817 -0.438 . . . . 62.530000000000001 109.817 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 18.8 m -54.24 -42.23 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.045 0 C-N-CA 123.667 0.787 . . . . 73.140000000000001 113.004 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -67.35 -42.27 83.78 Favored 'General case' 0 CA--C 1.507 -0.683 0 C-N-CA 120.643 -0.423 . . . . 73.310000000000002 110.856 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 97.7 t -69.74 -40.16 78.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.808 -0.633 . . . . 74.549999999999997 110.369 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.24 -49.4 74.32 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.55 -0.295 . . . . 73.109999999999999 111.026 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -63.11 -35.42 80.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.068 0.461 . . . . 63.240000000000002 110.121 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -62.47 -44.03 97.39 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.171 -0.922 . . . . 75.25 109.037 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.56 -49.0 78.4 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 109.723 -0.473 . . . . 71.120000000000005 109.723 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.89 -47.66 83.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.182 -0.463 . . . . 74.439999999999998 111.494 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -66.41 -39.19 88.83 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 112.231 0.456 . . . . 74.5 112.231 -176.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.43 -29.14 45.61 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 CA-C-O 121.164 0.507 . . . . 64.329999999999998 110.837 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 -87.11 -5.39 59.04 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.154 -0.618 . . . . 75.340000000000003 111.525 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . 0.433 ' O ' ' HB ' ' A' ' 547' ' ' VAL . . . 110.21 -4.7 30.05 Favored Glycine 0 CA--C 1.492 -1.369 0 C-N-CA 120.525 -0.845 . . . . 71.409999999999997 114.246 175.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.519 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 88.9 m-85 -77.8 119.0 20.68 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.849 -0.797 . . . . 71.319999999999993 108.849 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 17.0 p -89.9 -31.67 17.19 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 115.384 -0.826 . . . . 73.319999999999993 112.933 -174.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -108.59 119.23 38.92 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.681 0.753 . . . . 74.450000000000003 112.457 -172.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -130.32 145.82 51.83 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.071 -0.968 . . . . 73.310000000000002 109.442 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 61.2 m -141.23 142.89 33.92 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 108.319 -0.993 . . . . 65.019999999999996 108.319 175.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -117.55 135.3 54.04 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.501 -0.555 . . . . 71.140000000000001 109.501 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -124.05 119.44 29.51 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.973 -0.751 . . . . 74.430000000000007 108.973 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 524' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 55.1 m -84.77 130.85 34.62 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.512 0.672 . . . . 73.319999999999993 112.545 -177.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 28.0 m -121.86 150.63 25.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 106.648 -1.612 . . . . 74.230000000000004 106.648 173.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . 0.481 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 1.4 p-10 -92.71 137.14 32.62 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 117.839 -1.545 . . . . 64.299999999999997 110.483 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 49.0 m -150.28 -179.02 0.91 Allowed Pre-proline 0 C--N 1.293 -1.867 0 N-CA-C 106.111 -1.811 . . . . 72.430000000000007 106.111 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -87.04 -11.34 5.43 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 121.549 1.499 . . . . 71.099999999999994 111.033 171.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -69.15 127.75 92.88 Favored Pre-proline 0 N--CA 1.441 -0.919 0 N-CA-C 108.344 -0.984 . . . . 75.230000000000004 108.344 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -55.7 141.51 84.07 Favored 'Trans proline' 0 C--O 1.255 1.373 0 C-N-CA 122.982 2.454 . . . . 75.230000000000004 114.371 -171.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.555 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -59.67 125.94 25.64 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 114.313 -1.312 . . . . 72.5 110.949 -176.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 123.83 -19.26 7.44 Favored Glycine 0 N--CA 1.427 -1.962 0 C-N-CA 120.732 -0.747 . . . . 54.329999999999998 111.244 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -82.78 129.61 35.01 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.801 -0.444 . . . . 74.530000000000001 109.801 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 91.0 t -78.6 110.3 14.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 107.909 -1.145 . . . . 74.310000000000002 107.909 174.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 18.3 m -75.89 -34.62 59.97 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 123.892 0.877 . . . . 72.230000000000004 111.232 -176.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -173.65 179.91 44.73 Favored Glycine 0 CA--C 1.496 -1.143 0 N-CA-C 110.79 -0.924 . . . . 65.349999999999994 110.79 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 35.7 p -128.66 152.7 48.08 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.434 -0.58 . . . . 75.540000000000006 109.434 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -62.88 -57.47 21.39 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-O 119.174 -0.441 . . . . 72.299999999999997 110.99 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -75.5 139.39 22.97 Favored 'Trans proline' 0 C--N 1.369 1.618 0 CA-C-N 120.135 1.084 . . . . 74.040000000000006 109.858 171.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -71.35 142.79 41.87 Favored 'Trans proline' 0 C--O 1.251 1.141 0 C-N-CA 122.531 2.154 . . . . 75.420000000000002 112.963 -178.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -65.11 135.32 55.38 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.514 -0.766 . . . . 63.210000000000001 110.92 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.61 -18.91 34.46 Favored Glycine 0 N--CA 1.433 -1.5 0 CA-C-N 115.709 -0.678 . . . . 72.239999999999995 111.421 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 25.9 m -77.77 132.26 38.0 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.767 0.318 . . . . 75.439999999999998 111.094 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 36.0 m -81.92 122.56 27.91 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 107.645 -1.242 . . . . 75.329999999999998 107.645 176.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.5 m -134.81 159.5 71.92 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 109.601 -0.518 . . . . 75.040000000000006 109.601 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -67.29 137.55 43.92 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.334 2.023 . . . . 75.219999999999999 111.545 176.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.519 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 34.1 m -63.04 -19.97 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-O 121.863 0.84 . . . . 74.209999999999994 112.044 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -80.83 -12.24 59.47 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.072 -0.967 . . . . 65.219999999999999 111.856 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 8.5 t -81.78 171.94 13.94 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 120.33 -0.548 . . . . 75.230000000000004 111.653 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 44.4 t -99.0 122.38 50.65 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 CA-C-N 115.636 -0.711 . . . . 74.150000000000006 110.107 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 2.5 mp -102.6 124.06 56.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.175 -1.046 . . . . 64.329999999999998 108.175 175.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -102.02 123.47 45.97 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-O 121.167 0.508 . . . . 74.349999999999994 109.897 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 53.3 mt -98.26 120.99 39.62 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 114.534 -1.212 . . . . 72.439999999999998 108.872 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -83.23 119.73 24.93 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 106.69 -1.596 . . . . 72.230000000000004 106.69 173.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 524' ' ' SER . 45.0 t -113.06 129.32 68.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 N-CA-C 109.252 -0.647 . . . . 73.409999999999997 109.252 -177.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.555 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 23.8 p -82.55 146.87 28.95 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-O 120.884 0.373 . . . . 65.319999999999993 111.457 178.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.481 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 14.5 ptpt -97.18 152.52 18.74 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 103.732 -2.692 . . . . 75.120000000000005 103.732 167.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -80.18 -32.82 34.24 Favored Glycine 0 CA--C 1.491 -1.437 0 C-N-CA 119.408 -1.377 . . . . 73.450000000000003 111.186 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 64.2 t30 61.9 17.02 8.54 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.614 1.166 . . . . 71.109999999999999 110.575 176.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -144.76 158.96 43.58 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 107.969 -1.123 . . . . 74.519999999999996 107.969 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -143.53 148.59 36.21 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.838 -1.171 . . . . 73.540000000000006 107.838 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 61.1 t -76.13 116.06 18.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.741 -0.837 . . . . 70.120000000000005 108.741 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 54.0 ttp -89.96 138.21 27.79 Favored Pre-proline 0 C--N 1.298 -1.651 0 CA-C-N 115.761 -0.654 . . . . 73.109999999999999 111.156 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -63.51 170.47 8.19 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.321 2.681 . . . . 74.400000000000006 111.414 172.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . 0.405 ' HA ' ' HB1' ' A' ' 610' ' ' ALA . 25.1 t70 -84.33 115.14 22.34 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.04 0.448 . . . . 74.319999999999993 111.503 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 5.5 mp -125.89 -4.8 6.93 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.785 -0.643 . . . . 75.450000000000003 109.93 175.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 16.4 t -79.45 146.89 32.5 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 109.582 -0.525 . . . . 75.420000000000002 109.582 -176.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 91.14 3.53 69.82 Favored Glycine 0 C--N 1.312 -0.788 0 C-N-CA 120.83 -0.7 . . . . 72.209999999999994 112.231 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 85.8 mtp -100.72 177.64 4.93 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 107.332 -1.359 . . . . 75.209999999999994 107.332 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . 0.536 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 63.2 m-85 -80.47 160.16 25.35 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 119.675 -0.81 . . . . 74.310000000000002 110.124 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 78.0 t90 -62.89 -28.76 70.27 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.821 -0.807 . . . . 72.219999999999999 108.821 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 21.8 m -76.42 -10.01 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.1 -0.954 . . . . 74.409999999999997 111.049 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . 0.413 ' O ' ' HD2' ' A' ' 576' ' ' PRO . 20.6 m-20 -96.04 -44.45 7.33 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 107.567 -1.272 . . . . 74.200000000000003 107.567 173.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -56.51 -48.69 76.67 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 114.613 -1.176 . . . . 64.230000000000004 111.783 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -50.88 -59.61 7.16 Favored Pre-proline 0 CA--C 1.555 1.162 0 N-CA-C 114.045 1.128 . . . . 75.349999999999994 114.045 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . 0.413 ' HD2' ' O ' ' A' ' 573' ' ' ASP . 39.9 Cg_exo -61.99 -41.5 36.19 Favored 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 121.5 1.467 . . . . 71.209999999999994 113.115 176.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 11.9 mmt180 -61.29 -41.01 96.25 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 120.575 0.226 . . . . 73.200000000000003 111.016 -177.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 8.8 mp -65.79 -47.17 76.03 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 120.95 0.405 . . . . 75.230000000000004 110.987 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -65.14 -34.98 79.68 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.279 -0.419 . . . . 74.549999999999997 111.151 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -67.74 -38.27 83.29 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.344 -0.389 . . . . 74.510000000000005 111.75 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 4.2 pp -83.4 2.23 37.51 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.564 0.697 . . . . 72.439999999999998 111.639 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 83.92 29.46 31.6 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.391 -0.822 . . . . 52.43 113.718 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -81.09 127.49 32.69 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 117.14 0.47 . . . . 73.239999999999995 110.399 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 57.0 m -142.87 90.89 2.24 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.393 -1.336 . . . . 73.209999999999994 107.393 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -142.21 -133.73 2.87 Favored Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 110.86 -0.896 . . . . 72.409999999999997 110.86 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 51.5 ttm -126.6 128.56 46.99 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.445 -0.576 . . . . 75.200000000000003 109.445 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 7.3 tt -100.92 114.99 29.36 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.374 -1.343 . . . . 72.010000000000005 107.374 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -119.33 112.39 19.37 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.711 0.767 . . . . 54.240000000000002 111.954 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . 0.501 ' HE3' ' H ' ' A' ' 624' ' ' PHE . 1.5 tmtp? -87.92 112.84 22.98 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.241 -1.762 . . . . 75.540000000000006 106.241 176.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -80.72 -111.67 0.3 Allowed Glycine 0 C--O 1.25 1.095 0 C-N-CA 121.308 -0.473 . . . . 72.049999999999997 113.682 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -65.74 144.76 56.68 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 110.032 -0.358 . . . . 74.519999999999996 110.032 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . 0.491 ' OD1' ' HB2' ' A' ' 626' ' ' GLN . 4.5 t0 -116.25 152.14 34.4 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 120.088 -0.645 . . . . 73.409999999999997 110.029 -177.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 96.1 t -137.4 116.32 14.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 108.593 -0.892 . . . . 64.530000000000001 108.593 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . 0.469 ' HA ' ' HB3' ' A' ' 626' ' ' GLN . 7.2 p-10 -78.15 124.53 28.16 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.211 -0.449 . . . . 65.219999999999999 109.854 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -156.33 -9.56 0.1 Allowed 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 113.11 0.782 . . . . 72.129999999999995 113.11 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 104.92 41.5 1.96 Allowed Glycine 0 CA--C 1.505 -0.568 0 N-CA-C 109.069 -1.613 . . . . 54.030000000000001 109.069 -174.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 626' ' ' GLN . . . -56.95 -31.04 60.92 Favored Glycine 0 C--O 1.203 -1.789 0 C-N-CA 125.78 1.657 . . . . 74.140000000000001 115.004 -174.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 2.4 p -55.2 -24.82 29.08 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 113.148 0.796 . . . . 74.430000000000007 113.148 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -102.31 -12.52 17.88 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 111.975 0.361 . . . . 73.439999999999998 111.975 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -145.09 37.29 1.14 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.081 0.771 . . . . 75.299999999999997 113.081 -173.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -68.7 90.37 0.41 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 122.222 1.01 . . . . 71.439999999999998 111.15 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . 0.536 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 32.6 ttp85 -115.63 143.56 45.18 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.173 -1.376 . . . . 71.140000000000001 109.391 -176.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.48 130.02 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 106.757 -1.572 . . . . 73.340000000000003 106.757 176.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 94.6 t -96.46 -51.99 9.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 121.619 0.723 . . . . 71.439999999999998 109.065 -175.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -145.08 160.02 42.06 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 104.441 -2.429 . . . . 62.509999999999998 104.441 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' ' 621' ' ' THR . 13.8 pt20 -147.19 139.29 24.46 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 106.98 -1.489 . . . . 73.200000000000003 106.98 173.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . 0.255 93.9 m-20 -61.06 -42.67 87.66 Favored Pre-proline 0 C--N 1.306 -1.286 0 N-CA-C 114.668 1.359 . . . . 72.150000000000006 114.668 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -69.39 108.67 2.06 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 121.192 1.262 . . . . 74.310000000000002 109.946 171.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -70.74 135.23 27.64 Favored 'Trans proline' 0 C--O 1.25 1.113 0 C-N-CA 121.981 1.787 . . . . 70.409999999999997 112.403 -175.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . 0.405 ' HB1' ' HA ' ' A' ' 565' ' ' ASP . . . -67.69 134.76 51.65 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.573 -0.739 . . . . 60.140000000000001 109.538 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 86.67 -2.38 87.26 Favored Glycine 0 N--CA 1.434 -1.444 0 C-N-CA 120.707 -0.759 . . . . 52.229999999999997 112.466 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 9.6 m -111.54 161.72 15.89 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.488 -0.56 . . . . 64.510000000000005 109.488 -176.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -71.68 113.19 4.47 Favored Glycine 0 N--CA 1.435 -1.407 0 N-CA-C 110.084 -1.206 . . . . 65.430000000000007 110.084 174.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 32.3 m -107.74 143.05 18.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 123.065 0.546 . . . . 75.530000000000001 110.544 -177.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -42.53 136.72 2.35 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 124.867 1.355 . . . . 73.439999999999998 112.079 176.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -58.71 -24.95 62.38 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 124.854 1.261 . . . . 73.409999999999997 110.014 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -55.67 -45.21 77.77 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.588 -0.733 . . . . 74.409999999999997 109.797 173.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 71.48 19.41 77.7 Favored Glycine 0 N--CA 1.423 -2.186 0 CA-C-N 115.649 -0.705 . . . . 71.439999999999998 112.396 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.7 119.78 16.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 107.879 -1.156 . . . . 74.329999999999998 107.879 -176.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.92 119.66 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.575 0 CA-C-O 122.345 1.069 . . . . 74.010000000000005 111.352 -170.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 606' ' ' GLN . 0.2 OUTLIER -104.38 121.68 43.89 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-N 114.073 -1.421 . . . . 73.129999999999995 109.542 175.723 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 2.3 pt? -138.4 165.35 27.01 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 123.851 0.86 . . . . 75.329999999999998 110.345 -174.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 21.6 ttp85 -134.54 137.51 43.88 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 107.716 -1.216 . . . . 74.349999999999994 107.716 174.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.501 ' H ' ' HE3' ' A' ' 589' ' ' LYS . 35.3 p90 -141.52 157.76 44.72 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.862 -1.162 . . . . 73.519999999999996 107.862 176.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -56.9 150.94 27.01 Favored Glycine 0 C--N 1.314 -0.68 0 O-C-N 124.597 1.186 . . . . 63.0 114.711 -177.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . 0.491 ' HB2' ' OD1' ' A' ' 592' ' ' ASP . 8.9 tt0 . . . . . 0 C--N 1.302 -1.468 0 C-N-CA 124.741 1.216 . . . . 73.200000000000003 108.472 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 . . . . . 0 CA--C 1.493 -1.247 0 N-CA-C 105.54 -2.022 . . . . 73.200000000000003 105.54 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 31.8 m -117.56 164.34 13.94 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 N-CA-C 109.836 -0.431 . . . . 72.230000000000004 109.836 -172.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -92.43 136.36 33.27 Favored 'General case' 1 N--CA 1.378 -4.037 0 N-CA-C 106.458 -1.682 . . . . 74.329999999999998 106.458 175.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 72.2 t -96.96 121.22 59.84 Favored Pre-proline 0 C--N 1.255 -3.517 0 CA-C-N 114.576 -1.193 . . . . 73.540000000000006 109.899 -171.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.48 114.81 3.78 Favored 'Trans proline' 0 N--CA 1.43 -2.231 0 C-N-CA 121.165 1.243 . . . . 71.340000000000003 109.877 174.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . 0.469 ' OD2' ' HB ' ' A' ' 402' ' ' THR . 8.1 p-10 -100.83 141.21 34.03 Favored 'General case' 0 C--N 1.272 -2.8 0 CA-C-N 115.18 -0.918 . . . . 74.319999999999993 109.728 -177.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.424 ' H ' HD22 ' A' ' 377' ' ' LEU . 38.2 t -89.23 15.69 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 CA-C-N 114.326 -1.307 . . . . 64.540000000000006 111.12 -171.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.415 ' HB2' HG21 ' A' ' 402' ' ' THR . 30.1 mtp180 -65.33 147.21 53.84 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.075 -0.966 . . . . 73.209999999999994 110.966 175.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . 0.508 ' H ' ' HB ' ' A' ' 399' ' ' VAL . . . 107.7 -6.14 35.39 Favored Glycine 0 C--N 1.307 -1.049 0 N-CA-C 110.956 -0.858 . . . . 63.439999999999998 110.956 -171.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -110.58 -154.0 0.53 Allowed 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 107.215 -1.402 . . . . 75.519999999999996 107.215 170.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 78.4 p -82.77 162.45 21.7 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 118.872 0.76 . . . . 74.140000000000001 109.305 -176.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 54.6 p -57.18 -46.67 82.61 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 123.265 0.353 . . . . 73.120000000000005 110.528 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.82 -46.24 82.8 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 116.086 -0.506 . . . . 72.140000000000001 112.226 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -67.07 -42.61 84.39 Favored 'General case' 0 C--O 1.255 1.349 0 CA-C-O 121.663 0.744 . . . . 72.150000000000006 109.673 -176.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.05 -51.14 63.18 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.751 -1.113 . . . . 75.340000000000003 110.795 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 74.6 mt -60.13 -43.29 92.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 CA-C-N 116.284 -0.417 . . . . 73.519999999999996 111.137 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.51 -44.38 89.44 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 123.63 0.581 . . . . 72.409999999999997 110.849 -177.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' THR . . . . . 0.517 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 12.9 m -69.1 -46.81 66.8 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 116.013 -0.54 . . . . 75.120000000000005 111.359 -178.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . 0.424 HD22 ' H ' ' A' ' 365' ' ' VAL . 4.5 mm? -59.66 -43.03 94.1 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 120.647 0.261 . . . . 74.519999999999996 111.486 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -64.42 -42.29 96.12 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.11 -0.495 . . . . 73.5 110.516 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -69.07 -17.82 63.92 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 111.941 0.348 . . . . 74.030000000000001 111.941 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . 0.517 ' HG2' ' O ' ' A' ' 376' ' ' THR . 22.1 mmm180 -90.0 -11.76 40.64 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.183 0.516 . . . . 64.530000000000001 110.826 176.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.17 9.18 48.89 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.178 -1.01 . . . . 72.310000000000002 112.546 177.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -90.68 159.36 16.42 Favored 'General case' 0 N--CA 1.415 -2.223 0 N-CA-C 109.514 -0.551 . . . . 73.25 109.514 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -105.91 158.11 17.01 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 109.065 -0.717 . . . . 75.319999999999993 109.065 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.64 150.97 33.74 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.523 0 N-CA-C 108.19 -1.041 . . . . 71.329999999999998 108.19 177.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -118.28 126.88 53.05 Favored 'General case' 0 C--N 1.273 -2.741 0 N-CA-C 105.421 -2.066 . . . . 72.120000000000005 105.421 173.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 28.0 m -118.79 119.97 35.98 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 109.527 -0.546 . . . . 74.329999999999998 109.527 -173.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -112.15 125.59 54.29 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.369 -0.604 . . . . 75.540000000000006 109.369 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -100.31 121.92 42.26 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.175 -0.676 . . . . 74.010000000000005 109.175 177.067 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -120.86 117.52 30.97 Favored Pre-proline 0 C--N 1.304 -1.41 0 CA-C-N 115.674 -0.694 . . . . 74.420000000000002 110.222 -172.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -87.68 129.87 2.64 Favored 'Trans proline' 0 C--O 1.254 1.282 0 C-N-CA 122.27 1.98 . . . . 74.409999999999997 111.291 176.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.411 ' HB3' HG12 ' A' ' 394' ' ' ILE . 27.1 t70 176.85 162.47 0.43 Allowed 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.483 -0.562 . . . . 74.099999999999994 109.483 -177.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 7.7 m -89.64 -14.61 34.5 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 113.047 0.758 . . . . 73.310000000000002 113.047 -175.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 10.1 t -123.04 8.52 9.26 Favored 'General case' 0 C--O 1.249 1.079 0 C-N-CA 118.519 -1.272 . . . . 72.209999999999994 113.06 -175.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . 0.411 HG12 ' HB3' ' A' ' 391' ' ' ASP . 33.6 mm -88.36 133.76 35.95 Favored Pre-proline 0 C--N 1.31 -1.151 0 N-CA-C 107.214 -1.402 . . . . 71.200000000000003 107.214 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.58 145.56 47.3 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.483 2.789 . . . . 75.129999999999995 114.429 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -55.32 162.08 6.36 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 123.758 2.972 . . . . 75.120000000000005 111.804 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -57.21 -8.69 0.76 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.476 1.11 . . . . 73.329999999999998 113.311 -175.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 46.1 m170 -76.62 124.85 28.25 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.825 -1.176 . . . . 75.209999999999994 107.825 175.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.508 ' HB ' ' H ' ' A' ' 367' ' ' GLY . 8.9 t -76.48 132.43 33.01 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.577 0 CA-C-N 115.508 -0.769 . . . . 74.409999999999997 111.041 -167.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 28.9 pt -98.58 -27.97 3.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 114.959 -1.019 . . . . 64.140000000000001 113.504 -175.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.52 174.2 25.62 Favored Glycine 0 CA--C 1.503 -0.711 0 N-CA-C 110.439 -1.064 . . . . 73.319999999999993 110.439 -173.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' THR . . . . . 0.469 ' HB ' ' OD2' ' A' ' 364' ' ' ASP . 60.2 p -111.14 -178.67 3.52 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 118.164 0.982 . . . . 72.239999999999995 111.391 -174.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . 0.414 ' HB2' ' NH1' ' A' ' 366' ' ' ARG . 7.6 t70 -110.72 129.03 24.39 Favored Pre-proline 0 C--N 1.314 -0.96 0 N-CA-C 109.231 -0.655 . . . . 61.399999999999999 109.231 -176.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.67 -26.63 66.27 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 123.358 2.705 . . . . 70.019999999999996 113.804 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.95 -42.22 75.88 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.942 -0.572 . . . . 61.049999999999997 110.347 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -79.97 -31.84 39.86 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 121.688 0.756 . . . . 64.420000000000002 110.485 -178.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -84.74 2.39 42.25 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.721 -0.672 . . . . 71.209999999999994 111.099 -173.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 25.4 m -109.82 154.23 23.29 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.293 -1.743 . . . . 75.109999999999999 106.293 172.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 26.7 m -74.91 113.01 11.72 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 119.58 -0.848 . . . . 71.010000000000005 109.295 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 30.9 m -129.99 169.2 21.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-O 120.815 0.341 . . . . 65.310000000000002 110.283 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 33.5 m -69.75 143.45 53.02 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.17 -1.048 . . . . 53.109999999999999 108.17 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -68.04 109.03 3.31 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.174 0.512 . . . . 74.239999999999995 110.505 -177.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 129.97 69.1 0.11 Allowed Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 110.367 -1.093 . . . . 72.049999999999997 110.367 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -130.16 -175.38 3.61 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.227 -1.397 . . . . 73.519999999999996 107.227 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -114.49 132.62 56.22 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.355 0.598 . . . . 75.549999999999997 111.342 -176.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . 0.404 HG22 ' CB ' ' A' ' 403' ' ' ASP . 36.4 mm -112.14 115.4 49.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 106.707 -1.59 . . . . 71.400000000000006 106.707 177.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 54.5 m -91.61 118.6 30.76 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.157 0.503 . . . . 75.439999999999998 111.987 -172.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 14.1 p -110.71 135.06 50.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 C-N-CA 124.294 1.038 . . . . 72.019999999999996 111.32 -175.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -102.53 116.1 31.91 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.05 -0.722 . . . . 74.219999999999999 109.05 176.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 72.6 t -108.54 131.63 58.61 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 106.66 -1.607 . . . . 72.140000000000001 106.66 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' SER . . . . . 0.41 ' OG ' ' HB ' ' A' ' 394' ' ' ILE . 33.0 t -119.79 137.12 54.16 Favored 'General case' 0 C--N 1.288 -2.096 0 C-N-CA 119.276 -0.969 . . . . 65.120000000000005 111.93 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.1 p -96.1 156.33 16.38 Favored 'General case' 0 N--CA 1.408 -2.564 0 N-CA-C 106.148 -1.797 . . . . 70.030000000000001 106.148 170.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.262 1.886 0 N-CA-C 116.073 1.189 . . . . 75.340000000000003 116.073 -172.58 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.422 ' HG2' ' HA ' ' A' ' 479' ' ' ALA . 45.9 mt-30 . . . . . 0 N--CA 1.409 -2.52 0 N-CA-C 107.277 -1.379 . . . . 72.519999999999996 107.277 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.538 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 3.4 mmp_? -122.91 147.63 46.38 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-O 121.217 0.532 . . . . 74.420000000000002 110.881 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -83.36 133.68 34.94 Favored 'General case' 0 C--N 1.272 -2.792 0 CA-C-N 114.61 -1.177 . . . . 71.209999999999994 107.98 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.513 ' HB ' ' O ' ' A' ' 474' ' ' ALA . 63.5 mt -80.51 125.57 80.5 Favored Pre-proline 0 N--CA 1.429 -1.5 0 C-N-CA 120.121 -0.631 . . . . 72.340000000000003 109.461 -175.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.88 146.11 52.38 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 122.28 1.987 . . . . 73.129999999999995 111.014 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -78.9 144.56 34.79 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.718 -0.845 . . . . 74.409999999999997 108.718 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 13.1 p -143.25 160.87 17.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 108.379 -0.971 . . . . 73.239999999999995 108.379 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 19.2 m -68.89 138.0 54.31 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 108.486 -0.931 . . . . 75.25 108.486 174.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 35.2 p -69.21 -29.57 67.55 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 123.088 0.555 . . . . 74.450000000000003 111.612 -175.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.2 pp -80.32 -10.47 59.75 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.103 0.477 . . . . 73.230000000000004 111.611 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 5.1 m -105.95 57.41 0.66 Allowed 'General case' 0 CA--C 1.566 1.562 0 CA-C-O 121.669 0.747 . . . . 72.129999999999995 110.609 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.26 -38.42 58.13 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.465 1.106 . . . . 73.230000000000004 112.0 175.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.82 -42.81 85.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.189 0.519 . . . . 72.040000000000006 110.764 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -71.59 -35.44 70.53 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 116.02 -0.536 . . . . 75.299999999999997 110.517 178.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.501 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -59.5 -51.31 70.41 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.548 -0.296 . . . . 75.319999999999993 111.016 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 22.2 m -64.65 -36.96 78.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 CA-C-O 120.648 0.261 . . . . 74.219999999999999 111.441 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 37.9 tptt -59.39 -47.54 85.05 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.815 -0.63 . . . . 73.109999999999999 109.507 175.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -64.97 -37.92 89.26 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.762 -0.654 . . . . 74.319999999999993 112.258 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 90.1 mt -63.39 -37.23 86.49 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.883 -0.414 . . . . 72.409999999999997 109.883 175.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.418 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 28.5 m -67.77 -44.55 77.16 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.958 -0.564 . . . . 75.120000000000005 109.972 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.13 -16.09 62.53 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.445 -0.798 . . . . 75.450000000000003 112.14 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . 0.483 ' O ' ' HG3' ' A' ' 427' ' ' ARG . . . -87.87 5.82 38.5 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.005 0.431 . . . . 75.200000000000003 111.666 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 107.14 -73.57 0.21 Allowed Glycine 0 CA--C 1.491 -1.457 0 C-N-CA 120.006 -1.092 . . . . 71.420000000000002 111.883 175.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -42.43 -65.97 0.41 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.806 1.039 . . . . 72.430000000000007 113.806 176.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . 0.418 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 62.9 17.34 58.27 Favored Glycine 0 C--N 1.317 -0.479 0 C-N-CA 121.447 -0.406 . . . . 72.230000000000004 112.545 -176.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 16.4 mmm-85 -93.07 110.73 22.21 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 106.416 -1.698 . . . . 73.519999999999996 106.416 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . 0.512 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 15.4 p90 -141.03 150.12 42.6 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-O 121.066 0.46 . . . . 75.430000000000007 111.69 -177.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -132.22 123.33 26.77 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.147 -1.057 . . . . 74.209999999999994 108.147 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -90.46 132.56 35.58 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.037 -0.727 . . . . 75.209999999999994 109.037 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . 0.424 ' O ' HD11 ' A' ' 487' ' ' ILE . . . -132.72 134.62 45.01 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 109.175 -0.676 . . . . 75.010000000000005 109.175 176.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . 0.424 ' HA ' ' O ' ' A' ' 488' ' ' VAL . 34.7 p30 -118.98 139.54 51.51 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 120.961 0.41 . . . . 74.140000000000001 110.397 174.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 34.2 t -135.44 143.01 43.43 Favored Pre-proline 0 C--N 1.288 -2.084 0 N-CA-C 108.299 -1.0 . . . . 70.140000000000001 108.299 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 490' ' ' SER . 24.5 Cg_exo -65.56 132.31 30.61 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 121.728 1.619 . . . . 65.409999999999997 109.519 174.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 28.5 p -152.19 179.68 8.3 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 108.32 -0.993 . . . . 64.510000000000005 108.32 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.8 t -47.18 137.25 8.45 Favored Pre-proline 0 C--O 1.247 0.949 0 C-N-CA 123.732 0.813 . . . . 74.409999999999997 111.959 176.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.81 -29.38 34.14 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 124.533 3.488 . . . . 73.329999999999998 113.842 -176.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -64.17 -29.28 70.41 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 120.955 0.407 . . . . 71.209999999999994 111.403 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 79.7 mt -94.87 11.79 30.44 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 112.334 0.494 . . . . 75.230000000000004 112.334 -176.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 13.0 p -60.71 127.18 19.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 C-N-CA 120.156 -0.617 . . . . 73.25 110.022 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 76.38 2.29 73.45 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.347 -0.842 . . . . 72.329999999999998 113.308 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -107.83 139.74 41.97 Favored 'General case' 0 N--CA 1.413 -2.303 0 CA-C-O 121.39 0.614 . . . . 73.409999999999997 110.908 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 79.0 t -67.2 134.22 30.44 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 CA-C-N 114.005 -1.452 . . . . 72.140000000000001 107.6 173.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 55.6 mt -96.64 -28.32 3.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 108.278 -1.008 . . . . 61.420000000000002 108.278 -176.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 159.72 -164.01 33.91 Favored Glycine 0 N--CA 1.416 -2.695 0 N-CA-C 110.659 -0.977 . . . . 61.520000000000003 110.659 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 12.1 p -135.66 145.4 46.75 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 107.218 -1.401 . . . . 75.209999999999994 107.218 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -62.89 -52.74 61.53 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 119.799 -0.761 . . . . 71.010000000000005 110.495 177.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -69.45 134.82 29.59 Favored 'Trans proline' 0 C--N 1.366 1.497 0 N-CA-C 107.408 -1.804 . . . . 73.400000000000006 107.408 168.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . 0.453 ' HB2' ' CG ' ' A' ' 476' ' ' GLN . 28.7 Cg_exo -61.84 127.75 22.37 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 121.623 1.549 . . . . 71.140000000000001 112.231 -175.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.513 ' O ' ' HB ' ' A' ' 429' ' ' ILE . . . -77.89 -3.68 42.92 Favored 'General case' 0 C--O 1.204 -1.338 0 CA-C-N 115.073 -0.967 . . . . 72.129999999999995 113.514 -171.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -110.25 0.56 18.17 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.244 -0.91 . . . . 72.430000000000007 111.174 174.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . 0.453 ' CG ' ' HB2' ' A' ' 473' ' ' PRO . 15.5 mm100 -100.22 -177.35 3.5 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.671 -0.695 . . . . 73.319999999999993 110.613 -176.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.38 130.26 35.78 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 115.979 -0.555 . . . . 63.240000000000002 109.906 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 41.3 t -124.56 142.19 51.54 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.698 -0.853 . . . . 43.310000000000002 108.698 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.422 ' HA ' ' HG2' ' A' ' 426' ' ' GLN . . . -72.7 152.87 41.45 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 112.586 0.587 . . . . 73.219999999999999 112.586 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 43.2 mm -64.68 -24.97 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-O 121.835 0.826 . . . . 75.430000000000007 110.874 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 7.8 p -96.9 5.7 50.03 Favored 'General case' 0 C--N 1.291 -1.977 0 O-C-N 121.839 -0.538 . . . . 74.219999999999999 111.589 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -100.15 144.91 28.62 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.018 -0.537 . . . . 72.120000000000005 110.641 -174.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.8 p -94.48 127.38 46.52 Favored 'Isoleucine or valine' 0 C--O 1.249 1.039 0 CA-C-O 121.531 0.681 . . . . 64.049999999999997 112.367 -177.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 56.4 t -101.34 120.59 51.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 108.838 -0.801 . . . . 73.200000000000003 108.838 177.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.73 123.37 50.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-O 121.128 0.489 . . . . 75.019999999999996 109.747 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 29.2 mm -100.83 110.11 27.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 C-N-CA 124.789 1.236 . . . . 73.120000000000005 109.293 -177.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.424 HD11 ' O ' ' A' ' 455' ' ' ALA . 5.9 tp -99.44 126.9 52.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 109.349 -0.611 . . . . 72.329999999999998 109.349 177.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 456' ' ' ASN . 2.4 p -120.53 142.06 38.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 C-N-CA 123.946 0.898 . . . . 75.349999999999994 108.882 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -90.01 142.48 16.53 Favored Glycine 0 N--CA 1.431 -1.681 0 C-N-CA 120.666 -0.778 . . . . 63.119999999999997 113.567 -176.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 22.8 t . . . . . 0 C--N 1.299 -1.607 0 N-CA-C 106.152 -1.795 . . . . 70.450000000000003 106.152 174.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo . . . . . 0 CA--C 1.546 1.087 0 CA-C-O 121.41 0.504 . . . . 64.549999999999997 113.395 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -147.43 37.5 0.92 Allowed 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 106.869 -1.53 . . . . 71.5 106.869 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 494' ' ' THR . . . . . 0.427 ' HB ' HG23 ' A' ' 544' ' ' THR . 1.0 OUTLIER -116.45 146.17 42.74 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 113.493 -1.685 . . . . 62.229999999999997 113.055 -169.902 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . 0.4 ' HA ' ' HE3' ' A' ' 495' ' ' LYS . 1.0 OUTLIER -142.26 146.68 35.38 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 124.468 1.107 . . . . 73.239999999999995 108.395 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -80.42 131.15 35.55 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 109.134 -0.691 . . . . 55.039999999999999 109.134 176.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 35.1 pt -77.09 130.45 75.29 Favored Pre-proline 0 C--N 1.3 -1.552 0 C-N-CA 120.532 -0.467 . . . . 65.129999999999995 111.55 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . 0.413 ' HD2' HD11 ' A' ' 512' ' ' LEU . 41.7 Cg_endo -69.02 165.97 28.28 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.615 2.21 . . . . 71.519999999999996 111.029 175.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -92.8 147.33 22.94 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.832 -0.622 . . . . 62.43 110.695 -177.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.3 p -162.54 89.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 122.401 1.096 . . . . 73.120000000000005 110.829 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -137.53 114.48 10.67 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.14 -0.936 . . . . 75.519999999999996 108.743 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 101.11 17.51 22.41 Favored Glycine 0 N--CA 1.429 -1.791 0 N-CA-C 109.899 -1.281 . . . . 43.329999999999998 109.899 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . 0.47 ' OE1' HG12 ' A' ' 507' ' ' VAL . 44.7 mt-30 -124.65 174.23 8.0 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 108.044 -1.095 . . . . 63.43 108.044 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 9.4 t -92.2 168.16 11.54 Favored 'General case' 0 C--O 1.256 1.397 0 C-N-CA 119.694 -0.803 . . . . 63.140000000000001 110.791 -175.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 89.7 t -49.87 -41.38 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.832 1.253 . . . . 74.400000000000006 111.603 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -57.67 -39.25 76.64 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.556 -0.747 . . . . 64.109999999999999 111.381 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . 0.47 HG12 ' OE1' ' A' ' 503' ' ' GLN . 23.0 t -75.48 -38.54 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-N 115.686 -0.688 . . . . 71.219999999999999 110.107 -175.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . 0.41 ' O ' HD22 ' A' ' 512' ' ' LEU . . . -62.6 -49.76 73.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.624 -0.716 . . . . 63.350000000000001 110.998 -177.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -65.43 -35.83 82.11 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.318 -0.401 . . . . 74.25 110.862 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -50.7 67.92 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.734 -0.666 . . . . 74.5 109.837 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -62.01 -47.24 85.65 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 120.662 0.268 . . . . 75.040000000000006 111.125 -177.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . 0.413 HD11 ' HD2' ' A' ' 498' ' ' PRO . 4.3 mm? -63.93 -43.16 96.73 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.458 -0.337 . . . . 73.510000000000005 111.788 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -60.07 -42.75 95.23 Favored 'General case' 0 N--CA 1.423 -1.816 0 C-N-CA 122.859 0.464 . . . . 62.439999999999998 111.384 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 48.9 t -59.5 -31.98 47.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 123.322 0.649 . . . . 72.239999999999995 111.653 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -85.59 -5.0 59.32 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 112.045 0.387 . . . . 74.049999999999997 112.045 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 116.87 -10.94 15.45 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 119.826 -1.178 . . . . 61.43 113.742 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -74.01 125.69 28.83 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 117.335 0.567 . . . . 75.209999999999994 111.589 -176.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 11.7 p -104.54 -23.98 13.07 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.479 -0.782 . . . . 74.540000000000006 112.0 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . 0.453 ' O ' HD12 ' A' ' 551' ' ' ILE . 10.0 mtmp? -111.46 114.69 27.97 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 120.322 -0.551 . . . . 74.310000000000002 110.757 -176.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -114.59 132.63 56.28 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.135 -1.061 . . . . 74.420000000000002 108.135 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 25.4 p -115.52 134.21 55.29 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 107.305 -1.369 . . . . 72.329999999999998 107.305 173.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -117.27 120.37 38.04 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 109.156 -0.683 . . . . 75.439999999999998 109.156 -175.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -106.68 138.52 42.69 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.802 -0.635 . . . . 71.150000000000006 109.845 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 57.2 m -92.52 123.9 36.17 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.513 -0.551 . . . . 72.219999999999999 109.513 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 60.6 t -120.88 148.43 24.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 106.845 -1.539 . . . . 73.510000000000005 106.845 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.53 135.96 38.26 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-O 120.965 0.412 . . . . 74.400000000000006 111.607 -178.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 527' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 38.7 m -154.13 172.5 5.72 Favored Pre-proline 0 N--CA 1.429 -1.521 0 N-CA-C 106.162 -1.792 . . . . 74.329999999999998 106.162 175.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -90.93 -0.91 4.98 Favored 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 121.938 1.759 . . . . 74.349999999999994 109.842 167.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . 0.523 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 0.0 OUTLIER -78.31 132.6 65.8 Favored Pre-proline 0 C--O 1.216 -0.681 0 CA-C-N 114.912 -1.04 . . . . 73.010000000000005 109.229 178.406 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' A' ' 533' ' ' GLU . 31.2 Cg_exo -56.03 143.68 82.28 Favored 'Trans proline' 0 C--O 1.246 0.88 0 C-N-CA 123.1 2.534 . . . . 72.329999999999998 113.692 -175.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.601 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -56.7 132.01 50.76 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.287 -0.87 . . . . 72.310000000000002 111.045 -178.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 110.9 -8.91 29.64 Favored Glycine 0 C--N 1.306 -1.127 0 N-CA-C 110.357 -1.097 . . . . 72.420000000000002 110.357 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 530' ' ' PRO . 7.5 tp10 -82.62 125.55 31.32 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 106.811 -1.551 . . . . 71.239999999999995 106.811 178.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 91.2 t -89.1 110.03 20.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 107.564 -1.273 . . . . 73.109999999999999 107.564 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 535' ' ' THR . . . . . 0.466 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 11.4 t -78.32 -12.48 60.01 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.884 -0.598 . . . . 72.239999999999995 110.683 -176.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.98 -159.45 28.33 Favored Glycine 0 N--CA 1.428 -1.844 0 C-N-CA 120.952 -0.642 . . . . 73.129999999999995 111.743 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 40.7 p -117.67 148.52 41.89 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 107.323 -1.362 . . . . 73.409999999999997 107.323 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . 0.42 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 51.0 t30 -66.07 -50.57 50.88 Favored Pre-proline 0 C--N 1.315 -0.908 0 C-N-CA 120.603 -0.439 . . . . 75.540000000000006 111.543 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . 0.42 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 11.2 Cg_exo -75.8 141.55 24.53 Favored 'Trans proline' 0 C--N 1.367 1.525 0 N-CA-C 108.304 -1.46 . . . . 74.430000000000007 108.304 170.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.51 143.35 97.16 Favored 'Trans proline' 0 C--O 1.249 1.063 0 C-N-CA 122.068 1.845 . . . . 74.510000000000005 111.756 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.02 138.15 58.34 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.289 0.566 . . . . 33.020000000000003 111.818 -177.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 96.1 -10.35 67.78 Favored Glycine 0 C--N 1.308 -0.977 0 CA-C-N 115.942 -0.572 . . . . 74.340000000000003 112.439 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 42.8 m -70.77 134.4 47.38 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.506 -0.553 . . . . 72.120000000000005 109.506 178.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.427 HG23 ' HB ' ' A' ' 494' ' ' THR . 24.8 m -84.06 123.08 29.65 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 109.177 -0.675 . . . . 70.430000000000007 109.177 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.68 157.47 78.08 Favored Pre-proline 0 C--N 1.313 -0.982 0 N-CA-C 108.444 -0.947 . . . . 62.509999999999998 108.444 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -68.19 141.68 53.07 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.804 1.67 . . . . 74.239999999999995 111.045 176.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 35.0 m -65.14 -20.2 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-O 121.842 0.829 . . . . 75.319999999999993 110.443 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -74.37 -18.63 60.65 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.607 -1.178 . . . . 74.409999999999997 110.493 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.1 t -87.37 150.96 23.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.113 -1.069 . . . . 70.129999999999995 108.113 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 12.5 p -88.82 135.84 24.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.003 -1.11 . . . . 74.010000000000005 108.003 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . 0.453 HD12 ' O ' ' A' ' 519' ' ' LYS . 0.2 OUTLIER -96.33 145.9 8.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 C-N-CA 118.738 -1.185 . . . . 72.109999999999999 109.701 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -109.74 115.83 30.57 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-O 121.579 0.704 . . . . 74.329999999999998 110.857 -175.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -94.94 133.88 38.21 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 106.169 -1.789 . . . . 74.209999999999994 106.169 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -108.48 116.45 32.0 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 122.099 0.952 . . . . 74.140000000000001 110.143 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 54.6 t -103.7 139.68 23.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 CA-C-N 114.403 -1.271 . . . . 74.340000000000003 108.573 -175.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.601 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 73.5 m -82.4 136.52 34.94 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-O 122.068 0.937 . . . . 71.319999999999993 113.006 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -85.18 139.45 31.67 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 104.5 -2.408 . . . . 74.129999999999995 104.5 167.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -83.18 -43.87 7.3 Favored Glycine 0 CA--C 1.484 -1.845 0 C-N-CA 119.768 -1.206 . . . . 71.450000000000003 113.547 -174.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 64.46 18.72 11.5 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 112.69 0.626 . . . . 71.439999999999998 112.69 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -124.21 145.75 49.14 Favored 'General case' 0 N--CA 1.417 -2.111 0 C-N-CA 120.283 -0.567 . . . . 72.25 110.547 -169.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -139.54 153.06 47.36 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.883 -0.784 . . . . 65.430000000000007 108.883 174.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 8.9 p -78.17 125.4 37.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.448 0.642 . . . . 74.540000000000006 112.446 -173.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 52.8 ttp -97.34 130.81 28.63 Favored Pre-proline 0 C--O 1.248 1.009 0 CA-C-N 115.92 -0.582 . . . . 73.439999999999998 111.065 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -74.22 170.49 20.05 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.939 2.426 . . . . 71.219999999999999 111.298 174.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -69.36 120.07 14.61 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.51 0.671 . . . . 71.109999999999999 110.902 177.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 87.2 mt -104.05 -7.04 20.57 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.647 -0.706 . . . . 75.120000000000005 110.102 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 47.4 m -66.65 132.01 47.22 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.598 -0.728 . . . . 72.140000000000001 109.875 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 93.91 -11.51 70.8 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.716 -0.754 . . . . 64.530000000000001 112.327 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 89.4 mtp -83.84 146.17 28.25 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.493 -0.558 . . . . 75.519999999999996 109.493 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -92.21 137.95 31.94 Favored 'General case' 0 N--CA 1.414 -2.247 0 N-CA-C 107.027 -1.471 . . . . 75.219999999999999 107.027 177.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 41.1 t90 -57.84 -25.82 61.18 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 123.399 0.437 . . . . 75.329999999999998 111.916 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 14.3 p -64.16 -29.95 48.73 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-O 120.996 0.427 . . . . 74.209999999999994 110.831 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -101.3 -34.3 9.69 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-O 121.687 0.756 . . . . 72.230000000000004 109.452 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . 0.446 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -63.6 -40.31 96.61 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-N 115.168 -0.924 . . . . 74.120000000000005 111.875 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.446 ' O ' ' HG2' ' A' ' 579' ' ' ARG . 17.4 tp10 -51.4 -59.34 8.06 Favored Pre-proline 0 CA--C 1.562 1.421 0 C-N-CA 123.074 0.55 . . . . 73.310000000000002 112.047 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.46 -35.26 83.64 Favored 'Trans proline' 0 C--N 1.375 1.929 0 CA-C-N 120.684 1.28 . . . . 75.010000000000005 112.6 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . 0.503 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 83.2 mmt-85 -66.51 -39.77 88.84 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 120.469 -0.492 . . . . 74.409999999999997 111.817 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 93.8 mt -65.89 -43.71 87.48 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.459 -0.337 . . . . 75.439999999999998 111.134 -177.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 29.5 mmt180 -65.04 -37.41 87.48 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.731 -0.47 . . . . 74.120000000000005 109.731 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.13 -31.16 71.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.441 -0.799 . . . . 73.310000000000002 111.422 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 99.1 mt -81.88 -7.81 59.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.399 -0.364 . . . . 64.319999999999993 111.531 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 87.13 34.47 10.71 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.698 -0.763 . . . . 53.450000000000003 111.855 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 44.4 t90 -86.67 127.67 34.96 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.574 -0.528 . . . . 74.120000000000005 109.574 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 13.9 m -133.16 28.28 4.12 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 122.618 1.199 . . . . 75.409999999999997 108.117 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -82.97 -164.78 36.37 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 114.883 -1.053 . . . . 74.239999999999995 112.065 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 586' ' ' MET . . . . . 0.401 ' HE1' ' HB2' ' A' ' 588' ' ' ASP . 55.0 ttp -108.93 130.98 55.46 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 122.615 -0.344 . . . . 73.439999999999998 110.463 -177.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 41.7 tp -90.56 116.28 28.34 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.401 -1.333 . . . . 74.099999999999994 107.401 175.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . 0.401 ' HB2' ' HE1' ' A' ' 586' ' ' MET . 31.8 t70 -107.26 107.73 18.8 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.408 0.623 . . . . 74.239999999999995 111.574 -177.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -112.77 124.7 53.17 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.675 -1.232 . . . . 74.340000000000003 107.675 174.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -88.54 -120.56 1.7 Allowed Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 109.944 -1.262 . . . . 61.5 109.944 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -82.09 133.6 35.29 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.524 -0.917 . . . . 73.420000000000002 108.524 176.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -78.82 124.9 28.68 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.262 -1.014 . . . . 74.140000000000001 108.262 177.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 44.0 t -121.85 116.2 48.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 116.064 -0.516 . . . . 75.219999999999999 110.555 -174.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -90.46 107.64 19.29 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.495 -1.298 . . . . 73.310000000000002 107.495 176.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -132.01 4.46 4.13 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.763 -0.775 . . . . 75.209999999999994 111.603 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 116.11 -175.75 16.01 Favored Glycine 0 N--CA 1.424 -2.12 0 C-N-CA 120.403 -0.903 . . . . 74.049999999999997 111.051 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -58.69 -33.32 72.11 Favored Glycine 0 C--N 1.322 -0.196 0 C-N-CA 123.455 0.55 . . . . 41.32 114.18 -175.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 19.9 m -64.41 -27.56 69.09 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 120.9 0.381 . . . . 64.129999999999995 111.433 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -109.13 -1.44 18.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.981 0.419 . . . . 73.319999999999993 111.329 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -81.73 113.01 19.42 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 112.241 0.46 . . . . 72.230000000000004 112.241 -173.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 57.48 -2.11 0.06 Allowed 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 126.506 1.922 . . . . 62.299999999999997 115.46 172.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -96.54 145.98 25.22 Favored 'General case' 0 CA--C 1.501 -0.91 0 O-C-N 121.015 -1.053 . . . . 74.109999999999999 111.722 -174.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 97.8 t -65.43 130.04 30.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 107.045 -1.465 . . . . 71.420000000000002 107.045 173.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 87.9 t -89.02 -41.81 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-O 121.311 0.577 . . . . 73.109999999999999 110.061 -175.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -151.03 158.15 43.75 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.823 -1.177 . . . . 74.219999999999999 107.823 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -119.19 127.24 53.12 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 107.517 -1.29 . . . . 71.209999999999994 107.517 175.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.475 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 27.0 t-20 -54.53 -58.07 15.85 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-O 118.785 -0.626 . . . . 64.400000000000006 112.623 -179.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.475 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 2.9 Cg_endo -84.44 136.49 6.53 Favored 'Trans proline' 0 C--N 1.363 1.305 0 CA-C-N 120.926 1.366 . . . . 74.209999999999994 109.921 174.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -63.94 158.62 46.36 Favored 'Trans proline' 0 C--O 1.243 0.755 0 C-N-CA 122.37 2.047 . . . . 75.209999999999994 111.882 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.59 130.42 42.98 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 116.305 -0.407 . . . . 73.400000000000006 109.94 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 98.16 -2.27 59.52 Favored Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 120.532 -0.842 . . . . 75.310000000000002 111.663 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 15.0 m -92.76 155.87 17.39 Favored 'General case' 0 C--O 1.253 1.25 0 N-CA-C 108.484 -0.932 . . . . 74.319999999999993 108.484 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -80.8 134.08 12.92 Favored Glycine 0 N--CA 1.415 -2.725 0 C-N-CA 120.883 -0.675 . . . . 42.210000000000001 112.211 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 28.8 m -110.61 142.95 21.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 C-N-CA 123.0 0.52 . . . . 64.129999999999995 109.715 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -54.99 172.57 0.11 Allowed 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 125.545 1.538 . . . . 63.450000000000003 113.256 -178.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -48.22 -43.44 32.11 Favored 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 124.279 1.032 . . . . 73.140000000000001 112.462 -174.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -85.99 -19.22 30.7 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.966 -0.561 . . . . 74.040000000000006 111.43 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 81.31 21.98 61.49 Favored Glycine 0 CA--C 1.494 -1.227 0 C-N-CA 120.233 -0.984 . . . . 63.399999999999999 113.722 173.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.95 119.26 13.36 Favored 'Isoleucine or valine' 0 C--O 1.252 1.218 0 CA-C-O 123.549 1.642 . . . . 75.549999999999997 110.545 -171.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.76 132.34 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.521 0 CA-C-N 112.257 -2.247 . . . . 75.450000000000003 106.036 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.415 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 31.5 m -96.41 118.88 33.84 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.789 -0.819 . . . . 75.209999999999994 108.789 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 1.6 pp -130.34 165.5 22.39 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 113.518 -1.674 . . . . 63.210000000000001 109.178 -176.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 7.7 tpp180 -142.45 139.06 31.46 Favored 'General case' 0 C--N 1.269 -2.918 0 N-CA-C 105.86 -1.904 . . . . 71.319999999999993 105.86 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -139.67 149.45 43.71 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.332 -0.988 . . . . 71.400000000000006 108.332 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -75.14 -98.44 0.11 Allowed Glycine 0 N--CA 1.438 -1.182 0 O-C-N 123.764 0.665 . . . . 64.430000000000007 113.628 -173.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 . . . . . 0 N--CA 1.429 -1.512 0 N-CA-C 108.991 -0.744 . . . . 74.540000000000006 108.991 179.84 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 CA--C 1.486 -1.511 0 N-CA-C 106.112 -1.81 . . . . 72.420000000000002 106.112 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 32.3 m -117.75 136.74 53.94 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.525 0 N-CA-C 108.908 -0.775 . . . . 74.129999999999995 108.908 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . 0.509 ' NE2' ' HA ' ' A' ' 407' ' ' ASN . 0.8 OUTLIER -97.94 122.26 40.84 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 105.262 -2.125 . . . . 74.430000000000007 105.262 178.452 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 59.1 t -96.82 122.86 55.65 Favored Pre-proline 0 C--N 1.285 -2.207 0 CA-C-N 115.723 -0.671 . . . . 73.409999999999997 111.844 -166.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.14 140.91 67.23 Favored 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 122.857 2.371 . . . . 74.430000000000007 112.001 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -91.63 141.99 28.1 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 115.636 -0.711 . . . . 75.540000000000006 109.94 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 12.1 t -119.97 25.96 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.459 0 CA-C-O 122.74 1.257 . . . . 73.510000000000005 108.884 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? -63.38 144.62 56.81 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.175 -0.92 . . . . 73.430000000000007 113.181 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 91.29 0.38 73.72 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.968 -0.635 . . . . 74.430000000000007 112.847 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -104.08 -81.86 0.51 Allowed 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 120.543 -0.463 . . . . 63.509999999999998 110.46 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 87.8 p -169.1 163.34 11.14 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 107.512 -1.292 . . . . 75.049999999999997 107.512 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 12.0 m -63.77 -41.0 98.05 Favored 'General case' 0 N--CA 1.422 -1.873 0 O-C-N 123.987 0.804 . . . . 64.150000000000006 109.15 176.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.25 -46.69 87.71 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 115.871 -0.604 . . . . 75.109999999999999 111.484 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -64.97 -43.66 91.91 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 120.972 0.415 . . . . 64.549999999999997 110.978 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . 0.4 ' O ' HD12 ' A' ' 377' ' ' LEU . . . -66.53 -47.6 72.39 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.841 -0.618 . . . . 63.130000000000003 110.622 -178.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 80.5 mt -67.15 -40.32 84.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.933 -0.122 . . . . 71.340000000000003 111.296 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.91 -41.72 98.25 Favored 'General case' 0 C--O 1.246 0.877 0 N-CA-C 112.399 0.518 . . . . 51.43 112.399 -177.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' THR . . . . . 0.41 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 21.2 m -67.19 -47.46 70.84 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.87 -0.605 . . . . 73.030000000000001 109.959 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 373' ' ' ALA . 10.8 mp -64.28 -38.21 90.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.918 -0.583 . . . . 74.129999999999995 111.508 178.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -60.29 -44.33 95.48 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 123.356 0.662 . . . . 73.239999999999995 109.722 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -70.26 -20.58 63.05 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 112.352 0.501 . . . . 72.540000000000006 112.352 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 376' ' ' THR . 35.2 mmt180 -85.52 -14.03 47.16 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.706 -0.398 . . . . 73.340000000000003 110.056 174.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 96.09 8.29 57.95 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.074 -0.584 . . . . 62.350000000000001 112.743 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -77.75 157.37 30.07 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 112.941 0.719 . . . . 75.120000000000005 112.941 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -96.84 151.22 19.87 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.795 -1.093 . . . . 72.209999999999994 108.947 176.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 0.2 OUTLIER -129.94 136.39 59.01 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 CA-C-N 115.87 -0.604 . . . . 60.130000000000003 109.496 178.569 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -108.97 126.52 53.18 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 105.359 -2.089 . . . . 75.340000000000003 105.359 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 20.9 m -106.48 118.39 36.54 Favored 'General case' 0 C--N 1.282 -2.34 0 C-N-CA 120.351 -0.539 . . . . 74.409999999999997 110.429 -170.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -120.46 129.32 53.82 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.242 -1.021 . . . . 72.340000000000003 108.242 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -103.92 143.05 33.37 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.976 -0.379 . . . . 74.5 109.976 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -126.57 115.76 22.89 Favored Pre-proline 0 C--N 1.306 -1.289 0 N-CA-C 109.521 -0.548 . . . . 74.510000000000005 109.521 174.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -98.46 129.76 0.23 Allowed 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.38 2.053 . . . . 75.519999999999996 112.526 175.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.472 ' HB3' HG12 ' A' ' 394' ' ' ILE . 9.7 t70 173.71 160.49 0.15 Allowed 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 109.302 -0.629 . . . . 75.209999999999994 109.302 174.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 35.3 t -75.57 -24.32 56.63 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.317 0.579 . . . . 75.340000000000003 110.084 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 3.3 m -83.42 -4.7 58.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.239 1.019 . . . . 65.329999999999998 108.986 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . 0.472 HG12 ' HB3' ' A' ' 391' ' ' ASP . 15.1 mm -88.53 134.55 33.99 Favored Pre-proline 0 N--CA 1.427 -1.578 0 CA-C-N 114.568 -1.197 . . . . 73.299999999999997 110.367 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . 0.456 ' HG3' HD13 ' A' ' 400' ' ' ILE . 60.6 Cg_endo -66.14 -173.6 0.35 Allowed 'Trans proline' 0 CA--C 1.573 2.468 0 C-N-CA 125.003 3.802 . . . . 64.420000000000002 114.698 -176.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -58.47 159.41 19.9 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 122.872 2.381 . . . . 75.140000000000001 113.761 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -57.88 -9.81 1.47 Allowed 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 126.885 2.074 . . . . 74.400000000000006 113.362 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -90.18 177.38 6.45 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 116.112 -0.494 . . . . 63.140000000000001 111.56 -176.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 19.2 m -83.12 119.23 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 C-N-CA 120.51 -0.476 . . . . 72.430000000000007 110.912 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . 0.456 HD13 ' HG3' ' A' ' 395' ' ' PRO . 30.0 pt -86.77 -32.24 6.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.277 0.56 . . . . 73.420000000000002 109.707 177.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -147.99 170.36 28.64 Favored Glycine 0 N--CA 1.413 -2.845 0 N-CA-C 110.348 -1.101 . . . . 63.549999999999997 110.348 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.24 -179.42 3.63 Favored 'General case' 0 C--N 1.278 -2.54 0 CA-C-O 120.744 0.307 . . . . 70.349999999999994 110.678 178.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -102.1 129.74 25.73 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 107.974 -1.121 . . . . 72.010000000000005 107.974 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.94 -17.67 24.98 Favored 'Trans proline' 0 C--O 1.25 1.094 0 C-N-CA 124.01 3.14 . . . . 73.400000000000006 114.972 -173.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.5 -35.42 75.9 Favored 'General case' 0 C--O 1.21 -1.0 0 N-CA-C 109.657 -0.497 . . . . 70.349999999999994 109.657 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -69.33 -39.51 78.13 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.375 0.607 . . . . 62.210000000000001 110.265 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . 0.509 ' HA ' ' NE2' ' A' ' 361' ' ' GLN . 17.4 m120 -75.65 -7.28 53.9 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.434 0.635 . . . . 72.230000000000004 110.987 -178.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 29.6 m -98.67 153.91 18.35 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 106.998 -1.482 . . . . 74.209999999999994 106.998 174.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 61.0 m -75.07 113.04 11.94 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 118.974 -1.09 . . . . 71.109999999999999 109.104 176.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 18.7 m -121.24 169.81 12.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 122.867 0.467 . . . . 75.299999999999997 109.744 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 3.4 p -76.75 147.87 37.06 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 120.567 -0.453 . . . . 73.209999999999994 110.479 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -62.34 126.83 28.7 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 116.119 -0.492 . . . . 75.019999999999996 110.186 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 96.81 28.35 8.89 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 120.884 -0.674 . . . . 72.150000000000006 111.692 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -83.34 177.52 8.47 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.246 -1.02 . . . . 64.209999999999994 108.246 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -111.3 108.94 18.72 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.216 0.531 . . . . 72.540000000000006 109.974 -174.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 46.2 mm -102.22 129.13 54.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 115.215 -0.902 . . . . 74.200000000000003 108.83 -178.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 30.1 m -85.86 130.58 34.51 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.083 0.468 . . . . 72.109999999999999 111.205 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 7.5 p -110.81 134.87 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 107.676 -1.231 . . . . 74.540000000000006 107.676 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -110.76 122.19 47.21 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.069 0.461 . . . . 75.099999999999994 110.855 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 99.3 t -102.89 131.16 51.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 114.866 -1.061 . . . . 74.219999999999999 108.249 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' SER . . . . . 0.428 ' HB3' ' CG2' ' A' ' 394' ' ' ILE . 8.8 m -98.7 125.04 43.89 Favored 'General case' 0 C--N 1.274 -2.7 0 CA-C-N 115.358 -0.837 . . . . 71.109999999999999 110.112 -176.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 2.5 p -111.07 149.95 30.07 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.152 -0.685 . . . . 62.030000000000001 109.152 176.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.11 0 N-CA-C 116.098 1.199 . . . . 74.349999999999994 116.098 -172.226 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 41.2 mt-30 . . . . . 0 N--CA 1.415 -2.181 0 N-CA-C 106.781 -1.563 . . . . 74.409999999999997 106.781 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -133.59 144.89 49.58 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-O 121.0 0.428 . . . . 74.409999999999997 110.497 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.74 133.34 34.79 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 107.899 -1.149 . . . . 63.409999999999997 107.899 176.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 63.1 mt -80.82 129.92 65.99 Favored Pre-proline 0 C--N 1.312 -1.052 0 CA-C-N 116.612 -0.267 . . . . 73.129999999999995 111.714 -172.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.93 147.13 54.66 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.206 1.937 . . . . 64.540000000000006 111.498 173.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -83.57 105.26 14.35 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.485 -0.561 . . . . 75.150000000000006 109.485 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 11.6 p -94.77 161.18 2.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 107.972 -1.122 . . . . 73.430000000000007 107.972 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.443 ' HB3' ' OG1' ' A' ' 436' ' ' THR . 29.7 t -83.86 157.52 21.97 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 108.964 -0.754 . . . . 72.530000000000001 108.964 177.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 32.0 p -70.2 -27.02 64.16 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 112.987 0.736 . . . . 74.239999999999995 112.987 -172.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.54 -13.77 42.05 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.313 0.577 . . . . 75.409999999999997 110.778 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.443 ' OG1' ' HB3' ' A' ' 433' ' ' SER . 1.4 m -92.54 41.4 1.07 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.782 -0.645 . . . . 75.239999999999995 110.409 -175.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -53.07 -40.35 63.97 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.974 0.909 . . . . 71.439999999999998 112.273 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.14 98.73 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 120.812 0.339 . . . . 73.049999999999997 110.918 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . 0.414 ' HB3' HG21 ' A' ' 436' ' ' THR . 31.4 tt0 -71.14 -34.92 71.48 Favored 'General case' 0 C--O 1.201 -1.489 0 C-N-CA 120.441 -0.503 . . . . 75.329999999999998 110.684 175.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.599 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -58.52 -51.34 70.3 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 122.219 0.208 . . . . 62.32 111.018 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 36.0 m -61.39 -37.78 78.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-O 121.211 0.529 . . . . 73.219999999999999 110.401 177.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -60.43 -47.46 86.02 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.641 0.776 . . . . 72.510000000000005 111.147 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -64.8 -38.31 90.55 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 123.318 0.647 . . . . 74.230000000000004 111.184 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.599 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 83.9 mt -63.76 -37.86 88.96 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.683 -0.488 . . . . 73.230000000000004 109.683 176.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.52 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 37.1 m -70.03 -42.92 72.31 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.902 -0.59 . . . . 73.409999999999997 110.32 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -65.15 -26.44 68.18 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.051 -0.522 . . . . 74.319999999999993 111.111 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -81.04 4.95 17.98 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.065 -0.516 . . . . 75.430000000000007 111.879 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 108.03 -67.94 0.22 Allowed Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.334 -0.936 . . . . 63.240000000000002 112.795 174.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . 0.464 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 1.8 p90 -50.54 -60.75 2.7 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.679 0.992 . . . . 73.430000000000007 113.679 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . 0.52 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 60.92 23.46 61.45 Favored Glycine 0 CA--C 1.499 -0.914 0 C-N-CA 121.255 -0.497 . . . . 72.030000000000001 112.203 -176.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -105.04 110.98 23.59 Favored 'General case' 0 N--CA 1.414 -2.258 0 N-CA-C 109.073 -0.714 . . . . 74.340000000000003 109.073 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -131.97 143.32 50.02 Favored 'General case' 0 N--CA 1.415 -2.223 0 CA-C-N 114.608 -1.178 . . . . 74.040000000000006 110.192 -177.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -134.52 123.1 23.36 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 107.499 -1.297 . . . . 73.019999999999996 107.499 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -100.03 133.33 44.57 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.35 0.595 . . . . 74.129999999999995 111.901 -174.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -119.28 144.98 46.5 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 108.437 -0.949 . . . . 71.519999999999996 108.437 176.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -114.8 135.75 53.83 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.593 -0.892 . . . . 74.510000000000005 108.593 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 40.2 m -147.48 142.33 16.69 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 109.38 -0.6 . . . . 72.540000000000006 109.38 176.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 490' ' ' SER . 12.2 Cg_exo -70.17 131.62 21.01 Favored 'Trans proline' 0 C--O 1.247 0.948 0 C-N-CA 122.204 1.936 . . . . 75.230000000000004 111.555 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 56.4 m -149.75 -179.95 7.53 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.365 -0.976 . . . . 70.010000000000005 108.365 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 10.1 t -45.12 135.72 5.12 Favored Pre-proline 0 C--O 1.246 0.903 0 C-N-CA 124.015 0.926 . . . . 73.310000000000002 112.387 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.63 -30.39 36.4 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 124.363 3.375 . . . . 70.129999999999995 113.638 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -71.37 -23.45 61.9 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.57 0.581 . . . . 74.099999999999994 112.57 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 84.5 mt -99.74 -6.33 27.23 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.66 -0.416 . . . . 75.109999999999999 110.913 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 98.0 t -61.38 127.72 21.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 116.154 -0.475 . . . . 74.049999999999997 110.716 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 91.82 -3.59 77.92 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 115.614 -0.721 . . . . 72.019999999999996 111.661 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -118.19 166.37 12.67 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 108.278 -1.008 . . . . 72.150000000000006 108.278 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 93.8 t -76.12 145.7 10.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 108.306 -0.998 . . . . 74.5 108.306 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 68.5 mt -97.61 -35.25 5.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.262 -1.384 . . . . 74.430000000000007 107.262 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 159.68 -167.33 35.2 Favored Glycine 0 N--CA 1.423 -2.212 0 CA-C-N 115.356 -0.838 . . . . 70.329999999999998 111.012 176.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 470' ' ' THR . . . . . 0.479 HG21 HG12 ' A' ' 486' ' ' ILE . 72.8 p -116.2 144.85 43.64 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 106.969 -1.493 . . . . 73.510000000000005 106.969 178.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -67.1 -58.38 9.28 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 119.153 -1.019 . . . . 72.150000000000006 110.101 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -68.2 130.18 20.82 Favored 'Trans proline' 0 C--N 1.376 2.015 0 N-CA-C 106.364 -2.206 . . . . 73.349999999999994 106.364 168.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . 0.418 ' C ' ' H ' ' A' ' 475' ' ' ASN . 23.8 Cg_exo -61.82 138.6 75.22 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 121.55 1.5 . . . . 74.519999999999996 112.774 -172.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -75.85 11.17 1.48 Allowed 'General case' 0 C--O 1.202 -1.431 0 CA-C-N 115.324 -0.853 . . . . 53.119999999999997 111.468 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . 0.418 ' H ' ' C ' ' A' ' 473' ' ' PRO . 13.6 m120 -109.56 -1.54 18.15 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.799 -0.637 . . . . 72.430000000000007 109.427 177.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -94.24 172.55 8.14 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.867 -0.606 . . . . 65.430000000000007 111.778 -178.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 1.9 m -99.42 108.16 20.57 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 107.994 -1.113 . . . . 73.239999999999995 107.994 -178.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 50.1 m -100.64 138.66 37.41 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 120.901 0.382 . . . . 61.409999999999997 110.815 -176.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -77.37 154.53 32.67 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.659 -0.7 . . . . 73.439999999999998 111.134 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . 0.464 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 1.7 mp -65.32 -24.74 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-N 115.493 -0.776 . . . . 73.329999999999998 111.555 178.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 4.4 p -93.48 6.04 49.54 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.72 0.771 . . . . 74.099999999999994 111.565 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -107.88 131.71 54.22 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.693 -0.685 . . . . 74.409999999999997 111.435 -176.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 55.0 t -94.65 126.9 46.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.752 -0.658 . . . . 74.540000000000006 110.095 -177.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 34.4 m -98.36 133.7 39.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-O 121.51 0.672 . . . . 64.310000000000002 111.033 178.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.9 129.02 51.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.851 -0.613 . . . . 73.140000000000001 109.794 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . 0.479 HG12 HG21 ' A' ' 470' ' ' THR . 4.9 mt -117.12 128.74 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 C-N-CA 124.43 1.092 . . . . 72.420000000000002 110.215 -176.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 5.8 tt -108.4 126.92 65.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-N 116.447 -0.342 . . . . 73.150000000000006 110.354 -177.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 34.6 m -111.43 152.0 13.42 Favored 'Isoleucine or valine' 0 C--O 1.252 1.236 0 CA-C-N 116.229 -0.441 . . . . 72.310000000000002 110.633 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.87 123.3 6.04 Favored Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 115.928 -0.578 . . . . 61.109999999999999 113.59 -176.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 31.0 t . . . . . 0 N--CA 1.428 -1.542 0 N-CA-C 107.728 -1.212 . . . . 64.510000000000005 107.728 177.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.443 -1.487 0 CA-C-O 121.263 0.443 . . . . 61.409999999999997 111.533 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -90.36 119.73 30.89 Favored 'General case' 0 N--CA 1.41 -2.43 0 N-CA-C 107.513 -1.291 . . . . 71.230000000000004 107.513 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 51.5 p -116.59 143.36 45.71 Favored 'General case' 0 C--N 1.27 -2.859 0 N-CA-C 109.159 -0.682 . . . . 73.519999999999996 109.159 -178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 544' ' ' THR . 10.3 ttpp -151.44 164.46 36.71 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 108.445 -0.946 . . . . 74.540000000000006 108.445 176.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -79.67 136.54 36.83 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.85 -0.796 . . . . 62.039999999999999 108.85 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 40.6 pt -75.45 131.41 77.62 Favored Pre-proline 0 C--N 1.305 -1.355 0 N-CA-C 109.374 -0.602 . . . . 74.439999999999998 109.374 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -56.65 118.15 4.94 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.592 2.861 . . . . 74.129999999999995 114.285 -174.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -84.42 94.53 8.53 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-N 115.824 -0.625 . . . . 74.329999999999998 109.532 177.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.7 p -159.75 93.75 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-O 122.247 1.022 . . . . 62.100000000000001 110.947 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -108.09 162.84 13.68 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 107.862 -1.162 . . . . 75.099999999999994 107.862 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 98.1 23.38 13.17 Favored Glycine 0 C--N 1.295 -1.747 0 N-CA-C 108.967 -1.653 . . . . 72.439999999999998 108.967 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -129.38 165.5 21.39 Favored 'General case' 0 CA--C 1.471 -2.068 0 CA-C-N 114.402 -0.899 . . . . 72.120000000000005 109.336 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 6.9 m -88.67 156.44 19.01 Favored 'General case' 0 C--N 1.275 -2.67 0 C-N-CA 120.118 -0.633 . . . . 74.310000000000002 110.208 -173.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 12.2 p -50.53 -41.24 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 124.521 1.129 . . . . 72.349999999999994 113.522 -174.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -67.41 -39.67 85.54 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.372 0.606 . . . . 55.329999999999998 110.549 -178.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 48.8 t -70.37 -43.78 77.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.344 -0.844 . . . . 73.420000000000002 109.529 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -61.68 -47.11 86.81 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.226 -0.897 . . . . 61.310000000000002 112.26 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -64.2 -35.92 82.36 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.137 0.273 . . . . 74.340000000000003 110.708 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 52.5 tttm -58.69 -53.8 54.28 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.032 -0.531 . . . . 73.25 109.831 175.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -62.61 -41.69 99.13 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.286 -0.87 . . . . 74.219999999999999 110.914 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 9.0 tt -61.46 -47.87 83.72 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.955 -0.566 . . . . 73.329999999999998 110.408 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . 0.444 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 12.8 m120 -66.68 -37.81 85.5 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 111.812 0.301 . . . . 74.409999999999997 111.812 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 54.4 t -62.74 -31.69 53.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.162 -0.472 . . . . 74.430000000000007 111.052 177.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -86.15 13.25 8.14 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 114.147 1.166 . . . . 74.030000000000001 114.147 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 102.07 -11.58 57.28 Favored Glycine 0 CA--C 1.499 -0.907 0 C-N-CA 119.925 -1.131 . . . . 74.340000000000003 114.214 171.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 88.8 m-85 -91.11 120.34 31.99 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.331 -0.618 . . . . 75.450000000000003 109.331 -177.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 22.7 p -97.96 -14.84 20.38 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 113.329 0.863 . . . . 74.019999999999996 113.329 -174.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -123.22 117.58 25.64 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.092 0.473 . . . . 75.430000000000007 112.102 -172.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -131.51 147.89 52.58 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.782 -0.645 . . . . 73.510000000000005 111.694 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 521' ' ' SER . . . . . 0.437 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 51.1 m -132.69 140.16 48.0 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.161 -1.422 . . . . 70.420000000000002 107.161 173.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.77 128.77 55.2 Favored 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 119.945 -0.702 . . . . 74.239999999999995 112.191 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -111.92 143.53 42.74 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.443 -0.947 . . . . 73.409999999999997 108.443 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 524' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 57.1 m -96.52 139.35 32.75 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 113.095 0.776 . . . . 71.430000000000007 113.095 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 40.6 t -122.22 159.14 25.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 106.778 -1.564 . . . . 74.439999999999998 106.778 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . 0.466 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 30.9 m-20 -85.0 134.58 34.22 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 107.741 -1.207 . . . . 74.120000000000005 107.741 177.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 527' ' ' SER . . . . . 0.494 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 19.0 m -153.57 178.3 1.65 Allowed Pre-proline 0 C--N 1.313 -1.016 0 N-CA-C 109.197 -0.668 . . . . 64.329999999999998 109.197 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -89.0 -8.32 4.92 Favored 'Trans proline' 0 CA--C 1.55 1.28 0 C-N-CA 122.47 2.113 . . . . 71.319999999999993 111.114 170.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.9 142.07 48.17 Favored Pre-proline 0 C--O 1.213 -0.861 0 N-CA-C 108.675 -0.861 . . . . 74.439999999999998 108.675 176.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -63.42 160.36 35.83 Favored 'Trans proline' 0 C--O 1.247 0.972 0 C-N-CA 122.558 2.172 . . . . 71.420000000000002 113.419 -176.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -58.38 118.44 5.56 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.038 -0.983 . . . . 73.540000000000006 110.334 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 121.36 -12.46 9.62 Favored Glycine 0 C--N 1.3 -1.465 0 C-N-CA 120.45 -0.881 . . . . 63.520000000000003 112.201 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -82.71 131.46 35.2 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.927 -0.768 . . . . 72.420000000000002 108.927 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 54.3 t -90.84 112.67 25.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.676 -0.861 . . . . 72.409999999999997 108.676 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 45.8 m -111.04 14.55 21.93 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 122.661 1.22 . . . . 73.409999999999997 111.611 -175.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 161.97 -173.84 38.35 Favored Glycine 0 CA--C 1.494 -1.26 0 C-N-CA 119.903 -1.141 . . . . 75.109999999999999 112.251 173.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 31.6 p -130.43 153.86 48.32 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.856 -1.165 . . . . 74.209999999999994 107.856 176.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -67.75 -54.74 16.13 Favored Pre-proline 0 C--N 1.309 -1.163 0 CA-C-O 119.31 -0.376 . . . . 74.140000000000001 111.25 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.32 153.39 45.37 Favored 'Trans proline' 0 C--N 1.371 1.717 0 N-CA-C 108.026 -1.567 . . . . 73.540000000000006 108.026 170.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.84 137.86 46.63 Favored 'Trans proline' 0 C--O 1.249 1.055 0 CA-C-N 120.119 1.078 . . . . 62.530000000000001 110.932 -177.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -69.68 137.78 52.4 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.735 -0.666 . . . . 64.299999999999997 110.396 -178.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.73 -14.34 59.01 Favored Glycine 0 C--N 1.303 -1.286 0 C-N-CA 120.61 -0.805 . . . . 71.140000000000001 111.726 -178.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 27.0 m -72.67 137.45 46.03 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 109.407 -0.59 . . . . 74.540000000000006 109.407 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 495' ' ' LYS . 8.9 t -87.2 127.12 35.16 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-O 121.536 0.684 . . . . 74.439999999999998 110.124 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.3 m -138.96 162.46 52.38 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 107.738 -1.208 . . . . 73.450000000000003 107.738 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -60.77 134.59 54.74 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 121.734 1.623 . . . . 73.019999999999996 109.784 173.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.402 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 26.9 m -63.57 -20.25 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 113.728 1.011 . . . . 70.129999999999995 113.728 -174.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -83.65 -4.47 58.62 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.395 0.617 . . . . 74.299999999999997 111.4 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 14.6 m -74.27 160.39 31.18 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.505 -0.554 . . . . 61.340000000000003 109.505 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 38.2 t -97.44 115.39 37.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.52 -0.548 . . . . 73.209999999999994 109.52 -178.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 61.2 mt -85.01 131.74 33.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 109.108 -0.701 . . . . 74.109999999999999 109.108 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 521' ' ' SER . 34.8 tt0 -103.03 116.2 32.07 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 108.296 -1.001 . . . . 73.420000000000002 108.296 176.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -103.76 134.73 46.59 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.493 -0.776 . . . . 64.409999999999997 109.285 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -102.05 118.3 36.6 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-O 122.797 1.284 . . . . 74.439999999999998 111.409 -175.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 524' ' ' SER . 92.3 t -105.01 136.28 39.44 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 CA-C-N 112.914 -1.948 . . . . 73.340000000000003 110.271 -172.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 75.0 m -75.47 148.94 38.64 Favored 'General case' 0 C--N 1.27 -2.86 0 N-CA-C 113.584 0.957 . . . . 61.409999999999997 113.584 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.466 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 9.8 ptpp? -108.84 156.01 20.14 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 105.12 -2.178 . . . . 74.140000000000001 105.12 165.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -71.73 -27.59 70.62 Favored Glycine 0 CA--C 1.496 -1.126 0 C-N-CA 120.797 -0.716 . . . . 71.400000000000006 111.683 -177.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 62.6 t30 57.85 28.98 16.81 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 122.879 1.324 . . . . 73.510000000000005 109.84 173.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.8 154.41 41.99 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 105.785 -1.932 . . . . 74.140000000000001 105.785 -175.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -143.07 156.19 44.77 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 120.354 -0.538 . . . . 73.319999999999993 110.222 175.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 78.1 t -79.15 119.66 28.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 108.519 -0.919 . . . . 75.150000000000006 108.519 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 563' ' ' MET . . . . . 0.562 ' SD ' HD11 ' A' ' 620' ' ' ILE . 52.4 ttp -90.46 129.64 44.42 Favored Pre-proline 0 C--N 1.302 -1.488 0 CA-C-N 116.588 -0.278 . . . . 73.299999999999997 111.618 -176.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -69.2 169.85 17.26 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.166 2.578 . . . . 74.120000000000005 111.649 174.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -77.23 139.38 39.85 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.83 -0.804 . . . . 70.239999999999995 108.83 177.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 25.5 tp -137.97 12.98 2.89 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.781 0.8 . . . . 74.340000000000003 109.546 -178.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 53.3 p -79.96 147.78 31.46 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.21 -0.45 . . . . 74.109999999999999 111.393 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 77.61 7.89 87.19 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.86 -0.686 . . . . 61.210000000000001 113.2 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 569' ' ' MET . . . . . 0.449 ' HE2' ' HA ' ' A' ' 569' ' ' MET . 8.2 mmt -87.61 143.67 27.07 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.6 -0.889 . . . . 74.5 108.6 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -89.45 176.73 6.79 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 110.071 -0.344 . . . . 72.120000000000005 110.071 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -60.93 -34.14 74.25 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.999 -1.112 . . . . 74.510000000000005 107.999 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.6 m -73.72 -7.62 10.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.469 -1.241 . . . . 73.329999999999998 111.291 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -101.55 -44.06 5.7 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 108.866 -0.791 . . . . 74.040000000000006 108.866 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -53.75 -53.68 48.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.006 -0.997 . . . . 73.439999999999998 113.481 -175.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -65.45 -53.51 37.85 Favored Pre-proline 0 CA--C 1.553 1.093 0 N-CA-C 113.493 0.923 . . . . 73.209999999999994 113.493 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -60.27 -39.34 68.78 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 121.783 1.655 . . . . 75.150000000000006 112.196 177.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . 0.548 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 30.2 mtt180 -68.95 -33.5 73.82 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 113.683 0.994 . . . . 72.310000000000002 113.683 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 6.8 tt -58.09 -50.19 74.34 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.663 -0.865 . . . . 74.129999999999995 108.663 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -68.23 -43.88 76.97 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.207 -0.906 . . . . 74.230000000000004 113.439 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -64.17 -40.42 96.07 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 113.389 0.885 . . . . 62.329999999999998 113.389 -175.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 577' ' ' ARG 0.308 3.7 pp -93.13 0.32 57.19 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.05 -1.06 . . . . 73.140000000000001 113.655 179.37 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 71.26 43.25 55.74 Favored Glycine 0 CA--C 1.504 -0.631 0 CA-C-N 115.986 -0.552 . . . . 75.120000000000005 112.395 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 22.4 t90 -73.21 126.85 31.02 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.073 -0.714 . . . . 74.319999999999993 109.073 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 2.5 m -105.76 2.38 27.85 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.753 -0.658 . . . . 75.219999999999999 110.491 -175.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -91.72 172.32 35.57 Favored Glycine 0 N--CA 1.436 -1.347 0 C-N-CA 120.594 -0.812 . . . . 73.549999999999997 112.433 -175.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 89.4 mmm -92.79 137.18 32.59 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.246 0.546 . . . . 74.109999999999999 111.665 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -83.0 128.19 34.25 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.623 -1.172 . . . . 75.329999999999998 108.113 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -95.39 103.37 15.23 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.992 -0.549 . . . . 73.409999999999997 109.81 -177.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . 0.467 ' HD3' ' CE2' ' A' ' 624' ' ' PHE . 52.4 tptt -112.51 110.76 21.14 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 109.107 -0.701 . . . . 75.340000000000003 109.107 176.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -91.37 -117.05 2.09 Favored Glycine 0 N--CA 1.428 -1.863 0 C-N-CA 120.512 -0.852 . . . . 63.119999999999997 112.313 178.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -84.03 155.64 22.63 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 123.132 0.573 . . . . 65.5 111.333 -177.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -94.21 124.45 38.23 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 109.657 -0.497 . . . . 73.040000000000006 109.657 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 49.9 t -125.91 127.62 71.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 107.7 -1.222 . . . . 63.32 107.7 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -73.73 121.14 20.33 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.478 -0.889 . . . . 70.319999999999993 108.924 176.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -118.95 -39.11 2.97 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.238 -0.892 . . . . 73.310000000000002 110.658 -175.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 60.5 -157.48 29.17 Favored Glycine 0 N--CA 1.423 -2.207 0 O-C-N 123.936 0.772 . . . . 72.129999999999995 111.339 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -65.33 -40.99 96.84 Favored Glycine 0 C--N 1.28 -2.528 0 N-CA-C 112.061 -0.415 . . . . 73.439999999999998 112.061 174.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 10.2 m -58.38 -40.53 82.55 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 113.121 0.786 . . . . 63.409999999999997 113.121 -171.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -108.85 -4.5 16.8 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 111.95 0.352 . . . . 74.430000000000007 111.95 177.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 65.8 m80 56.1 102.83 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.471 1.109 . . . . 73.450000000000003 113.263 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -77.15 80.25 3.67 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 122.711 1.243 . . . . 65.040000000000006 109.812 172.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -134.49 171.16 14.69 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.271 -1.751 . . . . 73.519999999999996 106.271 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 76.1 t -61.08 129.67 24.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 107.58 -1.267 . . . . 72.230000000000004 107.58 173.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 97.6 t -87.25 -50.31 13.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-O 121.591 0.71 . . . . 73.430000000000007 109.27 -175.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -149.44 157.58 43.42 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 106.871 -1.529 . . . . 74.5 106.871 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -110.14 123.3 49.48 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 107.948 -1.131 . . . . 72.349999999999994 107.948 173.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.448 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 25.3 t-20 -48.58 -54.5 26.05 Favored Pre-proline 0 CA--C 1.553 1.084 0 N-CA-C 113.468 0.914 . . . . 70.219999999999999 113.468 -177.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.448 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 4.1 Cg_endo -90.26 138.74 2.83 Favored 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 121.473 1.448 . . . . 74.120000000000005 109.944 173.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . 0.445 ' HG2' ' OG1' ' A' ' 612' ' ' THR . 29.3 Cg_endo -67.92 147.57 74.67 Favored 'Trans proline' 0 C--O 1.249 1.066 0 C-N-CA 121.985 1.79 . . . . 72.299999999999997 113.13 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.55 133.63 49.79 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.283 -0.871 . . . . 73.329999999999998 110.456 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 95.96 -8.18 67.71 Favored Glycine 0 C--N 1.305 -1.181 0 C-N-CA 120.717 -0.754 . . . . 73.129999999999995 112.113 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 612' ' ' THR . . . . . 0.445 ' OG1' ' HG2' ' A' ' 609' ' ' PRO . 15.7 m -91.28 157.91 16.87 Favored 'General case' 0 C--O 1.256 1.434 0 N-CA-C 109.052 -0.721 . . . . 73.340000000000003 109.052 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -77.01 128.63 9.15 Favored Glycine 0 N--CA 1.428 -1.861 0 N-CA-C 111.425 -0.67 . . . . 72.049999999999997 111.425 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . 0.403 ' CG2' ' HB2' ' A' ' 563' ' ' MET . 33.4 m -122.16 144.19 32.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 C-N-CA 123.528 0.731 . . . . 72.109999999999999 110.49 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -39.53 144.23 0.18 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 125.816 1.647 . . . . 74.230000000000004 112.115 174.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . 0.498 ' HG3' ' N ' ' A' ' 617' ' ' ASP . 3.2 ptp180 -54.9 -28.43 50.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 123.773 0.671 . . . . 75.010000000000005 111.021 -178.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . 0.498 ' N ' ' HG3' ' A' ' 616' ' ' ARG . 21.2 t70 -60.05 -42.06 93.65 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.783 -1.098 . . . . 74.5 109.652 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 87.08 12.54 67.88 Favored Glycine 0 N--CA 1.413 -2.846 0 CA-C-N 115.012 -0.995 . . . . 73.239999999999995 113.363 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . 0.492 ' HB ' ' OD2' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -69.4 119.76 15.89 Favored 'Isoleucine or valine' 0 C--O 1.251 1.143 0 CA-C-N 118.604 1.202 . . . . 74.310000000000002 109.631 -177.398 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . 0.562 HD11 ' SD ' ' A' ' 563' ' ' MET . 4.1 tt -124.81 132.64 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.223 0 CA-C-N 113.287 -1.779 . . . . 75.230000000000004 107.581 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 87.6 m -96.64 122.37 39.5 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 121.814 0.816 . . . . 73.219999999999999 109.707 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 61.2 mt -119.9 150.78 39.93 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 105.881 -1.896 . . . . 74.420000000000002 105.881 -178.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -128.64 135.79 49.78 Favored 'General case' 0 C--N 1.27 -2.859 0 N-CA-C 106.729 -1.582 . . . . 64.230000000000004 106.729 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.467 ' CE2' ' HD3' ' A' ' 589' ' ' LYS . 26.5 p90 -143.24 164.05 31.28 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 108.557 -0.905 . . . . 70.010000000000005 108.557 176.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -77.15 -82.06 0.58 Allowed Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 120.582 -0.818 . . . . 64.450000000000003 112.932 -177.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 . . . . . 0 C--N 1.292 -1.899 0 N-CA-C 107.878 -1.156 . . . . 71.049999999999997 107.878 -177.029 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 . . . . . 0 C--O 1.254 1.332 0 N-CA-C 104.91 -2.255 . . . . 74.299999999999997 104.91 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 29.5 m -115.49 160.68 14.72 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 CA-C-O 121.303 0.573 . . . . 72.400000000000006 110.929 -170.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . 0.406 ' HG2' ' N ' ' A' ' 362' ' ' VAL . 33.8 tt0 -94.35 139.64 30.82 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 115.872 -0.603 . . . . 73.120000000000005 110.063 -175.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.671 HG22 ' CZ ' ' A' ' 382' ' ' PHE . 60.5 t -94.68 141.1 22.93 Favored Pre-proline 0 C--N 1.28 -2.436 0 N-CA-C 106.232 -1.766 . . . . 71.310000000000002 106.232 -176.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -73.15 119.34 5.97 Favored 'Trans proline' 0 N--CA 1.436 -1.861 0 C-N-CA 120.824 1.016 . . . . 63.140000000000001 111.678 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . 0.6 ' OD2' ' HD2' ' A' ' 366' ' ' ARG . 24.8 t70 -89.98 82.51 6.14 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 105.974 -1.862 . . . . 63.310000000000002 105.974 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.478 ' HB ' ' NE2' ' A' ' 368' ' ' GLN . 3.0 m -92.46 30.35 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 113.941 -1.482 . . . . 65.310000000000002 114.017 -171.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.6 ' HD2' ' OD2' ' A' ' 364' ' ' ASP . 0.0 OUTLIER -52.66 145.26 12.33 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 124.62 1.168 . . . . 71.510000000000005 112.399 174.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.56 -0.84 45.98 Favored Glycine 0 CA--C 1.492 -1.36 0 CA-C-N 115.81 -0.632 . . . . 70.450000000000003 112.821 175.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . 0.478 ' NE2' ' HB ' ' A' ' 365' ' ' VAL . 36.4 mt-30 -112.19 -155.84 0.57 Allowed 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.009 -1.108 . . . . 71.150000000000006 108.009 178.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 21.4 p -94.58 161.53 14.16 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 108.667 -0.864 . . . . 72.319999999999993 108.667 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 19.1 p -63.13 -40.01 96.34 Favored 'General case' 0 C--O 1.209 -1.033 0 C-N-CA 120.698 -0.401 . . . . 64.209999999999994 109.943 178.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.45 -46.31 89.11 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 116.201 -0.454 . . . . 65.319999999999993 111.727 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -69.06 -44.79 71.9 Favored 'General case' 0 C--O 1.253 1.255 0 CA-C-O 121.301 0.572 . . . . 75.420000000000002 110.69 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -63.83 -44.63 92.66 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.412 -0.813 . . . . 65.150000000000006 110.981 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 70.0 mt -69.31 -37.04 75.07 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.594 0 CA-C-N 116.304 -0.407 . . . . 75.409999999999997 110.966 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.78 -43.88 90.53 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.376 0.608 . . . . 74.420000000000002 109.986 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' THR . . . . . 0.546 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 54.6 m -65.76 -47.41 75.29 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.288 -0.869 . . . . 65.510000000000005 109.859 177.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 26.1 tp -60.98 -40.18 92.46 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 123.898 0.879 . . . . 73.209999999999994 111.602 -176.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -70.29 -37.66 74.86 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.136 0.575 . . . . 64.530000000000001 110.077 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -67.98 -19.15 64.91 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 120.833 0.349 . . . . 74.409999999999997 111.527 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . 0.546 ' HG2' ' O ' ' A' ' 376' ' ' THR . 16.6 mmt85 -89.42 -8.71 52.48 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.07 0.462 . . . . 73.230000000000004 110.046 177.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 84.78 16.34 65.89 Favored Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 115.826 -0.624 . . . . 73.430000000000007 113.587 175.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.671 ' CZ ' HG22 ' A' ' 362' ' ' VAL . 71.0 m-85 -86.4 161.12 18.83 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 117.607 0.703 . . . . 74.439999999999998 111.786 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -90.4 138.34 31.62 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 107.813 -1.18 . . . . 74.219999999999999 107.813 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -117.11 141.21 36.51 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 C-N-CA 119.864 -0.734 . . . . 74.310000000000002 109.574 -175.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 6.2 tpp180 -132.13 147.65 52.44 Favored 'General case' 0 N--CA 1.408 -2.547 0 N-CA-C 107.54 -1.282 . . . . 75.409999999999997 107.54 176.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 54.5 m -134.87 132.33 38.43 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 109.552 -0.536 . . . . 74.310000000000002 109.552 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -111.68 119.84 40.01 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 105.436 -2.061 . . . . 64.409999999999997 105.436 175.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . 0.566 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -125.63 135.41 52.13 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.97 -0.692 . . . . 75.219999999999999 110.775 -177.041 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . 0.425 ' HZ2' ' HB3' ' A' ' 389' ' ' LYS . 3.1 mmmp? -136.75 135.04 19.73 Favored Pre-proline 0 C--N 1.297 -1.713 0 CA-C-N 115.525 -0.761 . . . . 74.530000000000001 109.102 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . 0.531 ' HA ' ' O ' ' A' ' 422' ' ' THR . 20.7 Cg_exo -70.81 127.51 13.85 Favored 'Trans proline' 0 C--O 1.255 1.374 0 N-CA-C 106.236 -2.255 . . . . 74.230000000000004 106.236 166.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.542 ' OD1' HG22 ' A' ' 393' ' ' THR . 7.9 t0 169.15 -165.2 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 105.743 -1.947 . . . . 73.409999999999997 105.743 -169.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 10.6 t -151.93 -1.33 0.31 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 122.153 -0.342 . . . . 71.209999999999994 110.787 175.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.542 HG22 ' OD1' ' A' ' 391' ' ' ASP . 13.4 t -94.85 -7.92 38.83 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.807 -0.558 . . . . 74.450000000000003 112.331 -173.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.01 152.07 43.42 Favored Pre-proline 0 C--N 1.312 -1.061 0 N-CA-C 108.119 -1.067 . . . . 74.25 108.119 176.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_exo -29.95 133.5 0.05 OUTLIER 'Trans proline' 0 CA--C 1.553 1.459 0 C-N-CA 125.083 3.855 . . . . 74.129999999999995 117.18 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . 0.435 ' C ' ' H ' ' A' ' 398' ' ' HIS . 36.7 Cg_endo -64.9 163.76 27.08 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 123.908 3.072 . . . . 73.150000000000006 111.836 176.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . 0.423 ' HA ' HG11 ' A' ' 420' ' ' VAL . 5.4 p-10 -57.07 -7.84 0.56 Allowed 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 123.826 0.851 . . . . 73.120000000000005 112.64 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.435 ' H ' ' C ' ' A' ' 396' ' ' PRO . 53.9 m170 -104.88 124.02 48.74 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 105.102 -2.184 . . . . 73.439999999999998 105.102 172.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 28.5 m -72.11 118.79 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.647 0 CA-C-O 121.261 0.553 . . . . 75.209999999999994 110.938 -169.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.81 -36.98 10.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 107.274 -1.38 . . . . 75.420000000000002 107.274 177.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . 0.422 ' HA2' ' HB2' ' A' ' 366' ' ' ARG . . . -146.64 156.94 27.24 Favored Glycine 0 N--CA 1.412 -2.911 0 N-CA-C 109.207 -1.557 . . . . 65.200000000000003 109.207 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' THR . . . . . 0.462 ' OG1' ' HB3' ' A' ' 366' ' ' ARG . 2.1 p -124.46 -177.71 3.89 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 107.486 -1.302 . . . . 72.120000000000005 107.486 176.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -99.64 134.28 21.21 Favored Pre-proline 0 C--N 1.293 -1.887 0 C-N-CA 118.836 -1.146 . . . . 73.319999999999993 109.23 -174.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -49.02 -12.12 0.2 Allowed 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 124.787 3.658 . . . . 72.329999999999998 115.186 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.76 -29.89 55.13 Favored 'General case' 0 C--O 1.21 -0.986 0 C-N-CA 123.439 0.695 . . . . 72.340000000000003 110.021 172.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . 0.461 ' HA ' ' HB ' ' A' ' 362' ' ' VAL . . . -66.9 -50.42 62.48 Favored 'General case' 0 N--CA 1.437 -1.079 0 O-C-N 123.603 0.565 . . . . 52.549999999999997 111.079 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -72.8 -8.6 56.24 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 121.852 -0.53 . . . . 73.299999999999997 111.393 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 90.2 m -85.52 131.4 34.37 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 106.144 -1.799 . . . . 62.329999999999998 106.144 174.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 47.1 p -74.5 112.95 11.19 Favored 'General case' 0 N--CA 1.417 -2.104 0 C-N-CA 118.653 -1.219 . . . . 72.040000000000006 108.859 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 23.7 m -114.56 169.51 5.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 109.911 -0.403 . . . . 74.420000000000002 109.911 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 17.1 m -65.11 136.51 56.79 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.808 -0.812 . . . . 74.430000000000007 108.808 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -58.02 109.56 0.76 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.144 0.497 . . . . 73.420000000000002 111.629 -175.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 105.89 36.65 2.71 Favored Glycine 0 N--CA 1.438 -1.23 0 CA-C-N 115.523 -0.762 . . . . 71.430000000000007 112.661 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -96.96 175.43 6.33 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 109.357 -0.609 . . . . 70.439999999999998 109.357 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -86.74 120.1 27.68 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.278 0.631 . . . . 75.030000000000001 111.341 -172.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 43.0 mm -113.16 111.43 36.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 N-CA-C 108.808 -0.812 . . . . 74.310000000000002 108.808 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 30.5 p -90.85 130.48 36.8 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 112.772 0.656 . . . . 75.340000000000003 112.772 -175.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 4.1 p -121.62 135.24 62.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.957 -0.757 . . . . 74.400000000000006 108.957 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -109.18 127.4 54.18 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.588 -0.523 . . . . 73.030000000000001 109.588 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 44.6 t -126.54 137.72 56.95 Favored 'Isoleucine or valine' 0 C--O 1.25 1.126 0 CA-C-N 115.04 -0.982 . . . . 75.319999999999993 111.23 -174.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 10.0 t -98.03 121.4 39.91 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.557 -1.275 . . . . 75.329999999999998 107.557 176.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' THR . . . . . 0.531 ' O ' ' HA ' ' A' ' 390' ' ' PRO . 7.5 t -120.84 107.79 13.15 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.149 0.426 . . . . 71.230000000000004 112.149 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.022 0 C-N-CA 119.388 -1.387 . . . . 64.200000000000003 112.869 176.355 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 . . . . . 0 N--CA 1.434 -1.264 0 N-CA-C 106.468 -1.679 . . . . 75.540000000000006 106.468 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 18.0 mmm-85 -122.51 154.33 38.0 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 120.022 -0.671 . . . . 73.439999999999998 110.512 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.66 141.24 29.91 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-N 114.738 -1.119 . . . . 73.25 109.401 -177.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 66.2 mt -77.38 126.9 84.24 Favored Pre-proline 0 N--CA 1.426 -1.631 0 N-CA-C 105.698 -1.964 . . . . 73.329999999999998 105.698 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.27 141.26 67.98 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 121.973 1.782 . . . . 62.439999999999998 112.477 -177.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -87.63 137.02 32.7 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.968 -1.123 . . . . 62.130000000000003 107.968 177.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 13.3 p -152.02 159.75 3.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 109.335 -0.616 . . . . 64.329999999999998 109.335 -175.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.607 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 13.6 m -78.76 152.77 31.29 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 109.068 -0.716 . . . . 74.129999999999995 109.068 177.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 32.7 p -69.07 -25.86 64.66 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 114.037 1.125 . . . . 74.5 114.037 -173.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.5 pp -90.01 -10.23 45.71 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.679 0.752 . . . . 75.219999999999999 111.245 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.607 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 1.0 OUTLIER -100.16 41.76 1.15 Allowed 'General case' 0 CA--C 1.569 1.674 0 CA-C-N 115.186 -0.915 . . . . 65.310000000000002 110.022 -175.731 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . 0.459 ' HH ' ' HB2' ' A' ' 454' ' ' GLN . 72.4 t80 -52.99 -38.2 62.05 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 113.559 0.948 . . . . 71.209999999999994 113.559 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.01 -35.71 77.58 Favored 'General case' 0 C--O 1.247 0.961 0 CA-C-O 122.016 0.912 . . . . 75.230000000000004 110.836 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 35.1 tp10 -69.63 -37.55 76.84 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.401 -0.592 . . . . 74.109999999999999 109.401 176.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.54 -51.3 70.04 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.867 -0.606 . . . . 74.450000000000003 111.095 -178.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 35.6 m -63.39 -41.56 93.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 112.104 0.409 . . . . 71.109999999999999 112.104 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -68.23 -41.61 80.97 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 119.651 -0.82 . . . . 74.109999999999999 110.713 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -65.34 -38.26 89.59 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-N 115.901 -0.59 . . . . 75.040000000000006 111.042 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.429 ' CD2' ' HB3' ' A' ' 452' ' ' PHE . 13.5 tp -63.49 -36.46 83.82 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.081 -0.711 . . . . 73.409999999999997 109.081 178.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 40.0 m -68.98 -39.48 79.39 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.573 -0.74 . . . . 74.010000000000005 110.129 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.05 -15.95 62.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.937 -0.574 . . . . 63.119999999999997 111.13 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -88.74 5.07 45.11 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.873 -0.603 . . . . 70.299999999999997 110.906 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 109.03 -87.93 0.5 Allowed Glycine 0 CA--C 1.484 -1.883 0 N-CA-C 111.077 -0.809 . . . . 74.409999999999997 111.077 174.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -35.49 -63.14 0.36 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.435 1.272 . . . . 74.129999999999995 114.435 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 55.42 30.75 56.15 Favored Glycine 0 C--O 1.217 -0.909 0 N-CA-C 114.204 0.442 . . . . 72.549999999999997 114.204 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.425 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 30.3 mmm180 -105.75 111.18 23.74 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.64 -0.874 . . . . 73.430000000000007 108.64 -177.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . 0.429 ' HB3' ' CD2' ' A' ' 444' ' ' LEU . 40.8 p90 -133.1 150.37 52.07 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 121.405 0.622 . . . . 75.430000000000007 111.869 -174.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -137.17 126.75 25.21 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.774 -1.103 . . . . 72.5 108.84 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . 0.459 ' HB2' ' HH ' ' A' ' 437' ' ' TYR . 65.0 tt0 -94.74 128.64 41.58 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 120.831 0.348 . . . . 73.239999999999995 110.593 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -128.99 157.86 40.48 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.826 -0.805 . . . . 61.210000000000001 108.826 177.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -126.19 147.94 49.55 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.95 -0.3 . . . . 73.120000000000005 110.338 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 20.9 t -152.62 147.47 19.37 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 107.631 -1.248 . . . . 63.520000000000003 107.631 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 490' ' ' SER . 35.6 Cg_endo -65.84 135.78 42.68 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.237 1.958 . . . . 75.530000000000001 111.38 178.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 459' ' ' SER . . . . . 0.405 ' HG ' ' C ' ' A' ' 458' ' ' PRO . 34.7 m -151.94 179.09 8.76 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.658 -0.867 . . . . 74.310000000000002 108.658 -177.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.5 t -47.92 133.5 11.58 Favored Pre-proline 0 C--O 1.248 1.012 0 O-C-N 123.958 0.786 . . . . 75.239999999999995 111.02 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.69 -30.87 38.74 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 124.331 3.354 . . . . 74.129999999999995 114.003 -174.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -73.21 -27.64 61.73 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 112.345 0.498 . . . . 70.129999999999995 112.345 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -94.18 -2.23 52.9 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 120.721 0.296 . . . . 71.219999999999999 111.41 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 76.7 t -61.13 127.77 21.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.091 -0.707 . . . . 74.219999999999999 109.091 174.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.99 -4.59 75.07 Favored Glycine 0 C--N 1.304 -1.205 0 N-CA-C 111.733 -0.547 . . . . 72.310000000000002 111.733 -177.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -117.68 166.45 12.41 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.135 -0.691 . . . . 72.530000000000001 109.135 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 81.6 t -75.42 144.74 11.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 115.516 -0.766 . . . . 74.340000000000003 109.771 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 47.6 mm -97.68 -30.38 3.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 107.676 -1.231 . . . . 75.420000000000002 107.676 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 158.56 -169.51 35.02 Favored Glycine 0 N--CA 1.418 -2.548 0 CA-C-N 115.179 -0.919 . . . . 75.439999999999998 112.131 174.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 470' ' ' THR . . . . . 0.457 HG23 HG12 ' A' ' 486' ' ' ILE . 20.9 p -114.79 144.55 43.32 Favored 'General case' 0 C--N 1.28 -2.413 0 N-CA-C 106.565 -1.642 . . . . 72.430000000000007 106.565 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.441 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 22.4 t-20 -52.51 -53.41 53.86 Favored Pre-proline 0 N--CA 1.48 1.058 0 N-CA-C 112.744 0.646 . . . . 64.349999999999994 112.744 178.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 2.7 Cg_endo -85.83 147.62 9.45 Favored 'Trans proline' 0 N--CA 1.442 -1.516 0 N-CA-C 108.414 -1.418 . . . . 64.230000000000004 108.414 170.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . 0.428 ' C ' ' H ' ' A' ' 475' ' ' ASN . 24.4 Cg_exo -62.67 132.32 37.18 Favored 'Trans proline' 0 C--O 1.241 0.626 0 C-N-CA 121.633 1.555 . . . . 75.019999999999996 111.194 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -75.11 18.16 0.2 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.733 0.813 . . . . 75.400000000000006 112.239 -176.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . 0.428 ' H ' ' C ' ' A' ' 473' ' ' PRO . 13.0 m120 -110.55 -10.3 14.53 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 123.491 0.716 . . . . 75.420000000000002 110.25 173.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -102.35 174.74 5.78 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.109 0.48 . . . . 73.230000000000004 111.995 -173.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.26 145.88 24.11 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.071 -0.968 . . . . 71.439999999999998 111.585 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 29.1 p -137.24 149.31 47.07 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.069 -0.715 . . . . 73.230000000000004 109.069 176.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.13 165.26 18.56 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.406 -0.361 . . . . 74.519999999999996 111.417 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 42.5 mm -74.88 -16.43 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-O 121.679 0.752 . . . . 72.239999999999995 110.444 -178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 7.3 t -98.2 5.24 48.67 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.506 -0.746 . . . . 71.510000000000005 109.74 176.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -77.43 132.38 38.45 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.999 -0.546 . . . . 63.32 110.206 -175.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . 0.425 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 43.1 t -105.04 126.17 60.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.913 -0.773 . . . . 75.349999999999994 108.913 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 20.2 m -108.29 126.38 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 CA-C-O 121.898 0.856 . . . . 73.120000000000005 111.048 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -94.22 129.3 44.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 108.326 -0.99 . . . . 72.420000000000002 108.326 176.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . 0.457 HG12 HG23 ' A' ' 470' ' ' THR . 18.2 mt -113.5 127.33 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 CA-C-N 115.17 -0.923 . . . . 75.299999999999997 109.808 -176.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 8.0 tt -107.18 126.79 63.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 115.429 -0.805 . . . . 74.5 110.161 -175.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 32.6 m -109.42 151.9 11.6 Favored 'Isoleucine or valine' 0 C--O 1.249 1.056 0 C-N-CA 123.209 0.603 . . . . 75.530000000000001 110.193 178.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.91 123.8 6.25 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 110.864 -0.894 . . . . 71.099999999999994 110.864 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 44.7 m . . . . . 0 C--N 1.306 -1.32 0 CA-C-N 117.221 0.51 . . . . 72.019999999999996 111.118 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo . . . . . 0 C--O 1.251 1.132 0 CA-C-O 120.982 0.326 . . . . 73.430000000000007 111.651 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -124.01 56.88 1.23 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.668 -0.864 . . . . 71.129999999999995 108.668 175.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 2.9 p -117.09 144.08 45.07 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 114.986 -1.006 . . . . 72.129999999999995 111.119 -176.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -140.61 163.81 31.86 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.588 -0.893 . . . . 72.219999999999999 108.588 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -97.25 126.66 42.6 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.822 -0.807 . . . . 70.219999999999999 108.822 -177.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.4 pt -78.55 127.06 81.73 Favored Pre-proline 0 C--N 1.313 -1.011 0 N-CA-C 113.138 0.792 . . . . 74.450000000000003 113.138 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -96.19 155.64 1.37 Allowed 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 122.97 2.447 . . . . 75.209999999999994 110.083 169.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -123.99 164.35 19.51 Favored 'General case' 0 C--N 1.314 -0.945 0 O-C-N 121.675 -0.641 . . . . 75.129999999999995 111.303 -176.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 6.4 p -151.9 96.28 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 CA-C-O 121.947 0.88 . . . . 73.319999999999993 110.179 177.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -102.85 100.67 10.67 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.468 -0.787 . . . . 74.200000000000003 110.732 -177.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 152.1 48.41 0.02 OUTLIER Glycine 0 C--N 1.302 -1.313 0 N-CA-C 110.329 -1.108 . . . . 73.109999999999999 110.329 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -156.15 -178.52 7.38 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.529 -1.656 . . . . 73.519999999999996 106.529 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 18.0 p -89.64 160.07 16.82 Favored 'General case' 0 C--N 1.286 -2.188 0 C-N-CA 120.0 -0.68 . . . . 73.319999999999993 109.424 174.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.464 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.3 p -52.51 -43.55 42.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 O-C-N 123.946 0.779 . . . . 72.120000000000005 111.745 178.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -62.67 -42.56 99.68 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.945 0.402 . . . . 75.209999999999994 111.069 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 57.6 t -73.44 -37.34 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 121.153 0.502 . . . . 64.219999999999999 110.283 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.6 -44.92 92.6 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.424 -0.353 . . . . 64.519999999999996 111.094 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 23.6 mt-30 -60.91 -40.76 94.38 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.448 0.467 . . . . 74.340000000000003 109.958 177.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.444 ' O ' HG22 ' A' ' 514' ' ' VAL . 58.8 tttp -57.9 -50.37 73.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.313 -0.858 . . . . 74.150000000000006 110.105 177.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -62.34 -40.82 97.62 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-N 115.479 -0.782 . . . . 74.140000000000001 111.421 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 40.9 tp -61.1 -41.15 96.15 Favored 'General case' 0 C--O 1.238 0.485 0 O-C-N 123.369 0.418 . . . . 74.329999999999998 109.958 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . 0.424 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 12.1 m120 -65.35 -37.69 87.81 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 116.014 -0.539 . . . . 64.540000000000006 110.675 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 510' ' ' LYS . 95.5 t -66.06 -28.42 43.74 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 116.117 -0.492 . . . . 73.450000000000003 110.362 177.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -75.56 -4.29 39.06 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.814 0.34 . . . . 74.109999999999999 111.171 178.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 105.6 -10.61 45.91 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.892 -0.671 . . . . 74.150000000000006 112.854 175.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 70.6 m-85 -95.77 114.11 25.81 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.157 -0.683 . . . . 73.099999999999994 109.157 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 16.5 p -87.57 -17.95 30.83 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 113.709 1.003 . . . . 74.310000000000002 113.709 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . 0.448 ' HD2' ' O ' ' A' ' 548' ' ' ASP . 96.7 mttt -108.51 119.55 39.85 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.854 0.835 . . . . 73.420000000000002 113.208 -172.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -130.46 152.14 50.18 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.507 -1.224 . . . . 74.329999999999998 111.195 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 63.5 m -142.03 156.54 45.43 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 107.51 -1.293 . . . . 63.200000000000003 107.51 170.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . 0.414 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 3.9 pt20 -116.67 148.9 40.59 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-O 121.542 0.687 . . . . 71.230000000000004 111.056 -177.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . 0.419 ' HB2' ' HG2' ' A' ' 554' ' ' GLN . . . -120.38 119.03 31.91 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.145 -1.428 . . . . 71.299999999999997 107.145 175.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 17.0 m -86.25 123.26 31.32 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 116.243 -0.435 . . . . 72.120000000000005 110.528 -176.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 45.0 t -121.43 149.07 24.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 105.672 -1.973 . . . . 73.510000000000005 105.672 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -102.04 137.05 40.83 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.654 -0.819 . . . . 71.329999999999998 108.934 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 54.2 m -155.38 -176.83 0.65 Allowed Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 107.758 -1.201 . . . . 74.140000000000001 107.758 -176.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -87.5 3.59 6.32 Favored 'Trans proline' 0 CA--C 1.551 1.35 0 C-N-CA 121.699 1.599 . . . . 71.099999999999994 112.798 173.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . 0.495 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 3.6 mpt_? -89.84 134.19 32.53 Favored Pre-proline 0 C--O 1.213 -0.832 0 N-CA-C 108.619 -0.882 . . . . 75.310000000000002 108.619 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -54.79 141.68 76.03 Favored 'Trans proline' 0 N--CA 1.483 0.866 0 C-N-CA 123.223 2.615 . . . . 72.140000000000001 114.315 -171.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -61.07 114.22 2.99 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 114.614 -1.176 . . . . 75.310000000000002 111.375 -175.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 132.49 -20.08 4.44 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 110.226 -1.15 . . . . 62.229999999999997 110.226 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -69.88 131.41 44.4 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 123.185 0.594 . . . . 75.209999999999994 109.895 177.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 7.6 p -86.58 106.15 15.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.13 -1.063 . . . . 72.540000000000006 108.13 174.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 12.0 t -78.56 -16.43 57.45 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.991 -0.55 . . . . 75.239999999999995 111.361 -174.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 163.25 -166.56 37.14 Favored Glycine 0 N--CA 1.429 -1.798 0 N-CA-C 111.194 -0.762 . . . . 72.120000000000005 111.194 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 42.4 p -128.71 149.19 50.79 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 107.706 -1.22 . . . . 75.209999999999994 107.706 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -71.71 -49.44 10.96 Favored Pre-proline 0 C--N 1.303 -1.423 0 C-N-CA 120.621 -0.431 . . . . 71.420000000000002 110.81 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -81.76 126.09 5.1 Favored 'Trans proline' 0 CA--C 1.555 1.531 0 N-CA-C 109.515 -0.994 . . . . 64.150000000000006 109.515 168.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.38 160.84 43.96 Favored 'Trans proline' 0 C--O 1.257 1.471 0 C-N-CA 122.716 2.278 . . . . 62.25 113.325 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.94 139.81 58.81 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.339 -0.846 . . . . 61.420000000000002 110.47 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.27 -17.79 43.25 Favored Glycine 0 C--N 1.297 -1.627 0 N-CA-C 111.343 -0.703 . . . . 44.119999999999997 111.343 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 34.9 m -67.57 123.05 19.37 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.827 -0.434 . . . . 75.209999999999994 109.827 178.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 10.8 m -82.77 123.22 29.12 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 108.075 -1.083 . . . . 60.299999999999997 108.075 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 32.0 m -136.5 155.0 77.23 Favored Pre-proline 0 C--N 1.308 -1.23 0 N-CA-C 108.786 -0.82 . . . . 75.129999999999995 108.786 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -60.59 146.89 96.24 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.182 1.921 . . . . 74.030000000000001 110.222 172.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 27.9 m -60.94 -20.53 22.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 113.58 0.955 . . . . 75.439999999999998 113.58 -176.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . 0.448 ' O ' ' HD2' ' A' ' 519' ' ' LYS . 11.6 t70 -97.96 4.08 49.48 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.315 0.579 . . . . 74.310000000000002 110.566 -178.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.0 t -69.7 154.48 41.92 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.12 0.486 . . . . 74.439999999999998 110.403 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 43.6 t -95.22 127.07 47.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.581 -0.896 . . . . 73.109999999999999 108.581 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 2.7 mp -103.97 136.24 38.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 109.204 -0.665 . . . . 71.430000000000007 109.204 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -102.97 119.23 38.47 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-O 121.515 0.674 . . . . 74.109999999999999 111.344 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 5.2 mp -100.23 133.87 44.0 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.64 -1.164 . . . . 75.239999999999995 108.372 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . 0.419 ' HG2' ' HB2' ' A' ' 523' ' ' ALA . 48.6 mt-30 -97.93 121.75 40.23 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-O 121.294 0.569 . . . . 75.099999999999994 110.283 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 60.7 t -109.94 133.41 55.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 115.194 -0.912 . . . . 73.299999999999997 108.797 -175.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.573 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 29.8 p -94.17 133.34 37.78 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-O 121.024 0.44 . . . . 61.509999999999998 111.811 -178.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -84.41 145.43 28.19 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 107.218 -1.401 . . . . 72.340000000000003 107.218 169.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -81.6 -28.33 43.63 Favored Glycine 0 CA--C 1.478 -2.265 0 O-C-N 123.813 0.695 . . . . 72.230000000000004 113.381 -173.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 70.3 -35.19 0.31 Allowed 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 124.49 1.116 . . . . 75.439999999999998 113.946 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.447 ' H ' ' C ' ' A' ' 558' ' ' GLY . 48.2 mt-30 -125.65 146.16 49.84 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 121.306 0.574 . . . . 74.25 111.638 -172.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -124.72 139.76 53.56 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 115.039 -0.982 . . . . 74.310000000000002 109.184 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 91.2 t -61.46 121.71 10.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 123.393 0.677 . . . . 75.439999999999998 112.333 -175.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 563' ' ' MET . . . . . 0.415 ' HG2' ' O ' ' A' ' 564' ' ' PRO . 54.2 ttp -97.25 132.83 24.79 Favored Pre-proline 0 C--O 1.245 0.864 0 CA-C-N 115.769 -0.651 . . . . 71.310000000000002 111.103 -178.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . 0.415 ' O ' ' HG2' ' A' ' 563' ' ' MET . 13.6 Cg_exo -73.39 170.27 20.3 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.268 2.645 . . . . 74.420000000000002 110.646 171.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -74.98 115.57 14.75 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.834 0.826 . . . . 72.219999999999999 111.418 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 94.8 mt -113.67 7.41 17.24 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 122.666 1.222 . . . . 74.450000000000003 107.76 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 1.4 p -79.63 153.27 29.52 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-N 113.695 -1.593 . . . . 63.130000000000003 111.18 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 88.81 14.44 61.08 Favored Glycine 0 N--CA 1.436 -1.366 0 CA-C-N 115.634 -0.712 . . . . 52.539999999999999 112.908 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 89.1 mtp -108.3 156.27 19.57 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.739 -0.467 . . . . 75.209999999999994 109.739 -175.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 96.2 m-85 -75.56 153.92 37.1 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 108.031 -1.1 . . . . 72.519999999999996 108.031 176.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 74.8 t-105 -68.13 -22.6 64.87 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.532 -0.544 . . . . 74.519999999999996 109.532 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 10.8 p -74.82 -16.92 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 115.229 -0.896 . . . . 74.120000000000005 109.358 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -101.3 -44.17 5.74 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.956 -0.565 . . . . 74.5 110.04 175.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -58.12 -52.28 66.22 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.281 -0.872 . . . . 72.510000000000005 112.674 -176.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.437 ' HA ' ' HG ' ' A' ' 578' ' ' LEU . 41.3 tt0 -60.7 -51.93 76.15 Favored Pre-proline 0 CA--C 1.557 1.22 0 N-CA-C 112.939 0.718 . . . . 74.340000000000003 112.939 -177.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -58.04 -37.23 96.66 Favored 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 121.132 1.221 . . . . 73.340000000000003 112.341 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -69.02 -37.74 78.83 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 112.915 0.709 . . . . 75.5 112.915 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.437 ' HG ' ' HA ' ' A' ' 575' ' ' GLU . 4.1 pp -67.0 -38.36 85.86 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.988 -0.685 . . . . 73.25 110.481 177.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . 0.402 ' N ' HD12 ' A' ' 578' ' ' LEU . 79.8 mtp180 -63.49 -44.52 94.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.307 -0.861 . . . . 75.340000000000003 110.136 176.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.96 -29.19 68.98 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.516 0.726 . . . . 62.229999999999997 111.873 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 64.6 tp -81.2 -7.26 59.53 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 121.381 0.61 . . . . 75.430000000000007 109.883 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 77.83 31.02 50.58 Favored Glycine 0 CA--C 1.492 -1.374 0 N-CA-C 111.305 -0.718 . . . . 72.099999999999994 111.305 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 86.8 t90 -87.36 140.68 29.29 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 109.043 -0.725 . . . . 75.540000000000006 109.043 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 5.8 t -133.33 -50.15 0.86 Allowed 'General case' 0 N--CA 1.41 -2.426 0 CA-C-N 115.708 -0.678 . . . . 71.510000000000005 109.496 175.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . 29.59 -126.6 0.11 Allowed Glycine 0 C--N 1.365 2.186 0 C-N-CA 125.352 1.453 . . . . 75.430000000000007 114.16 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 586' ' ' MET . . . . . 0.434 ' O ' HG12 ' A' ' 619' ' ' ILE . 51.6 ttm -138.03 125.13 21.48 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 105.18 -2.156 . . . . 70.530000000000001 105.18 172.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -99.15 125.2 44.65 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.912 -1.144 . . . . 72.329999999999998 107.912 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -105.14 101.47 11.02 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 115.901 -0.591 . . . . 45.0 109.61 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -99.89 109.88 22.25 Favored 'General case' 0 N--CA 1.416 -2.17 0 N-CA-C 106.833 -1.543 . . . . 74.400000000000006 106.833 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -103.85 -121.6 4.95 Favored Glycine 0 N--CA 1.425 -2.086 0 N-CA-C 110.535 -1.026 . . . . 63.219999999999999 110.535 178.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -86.9 119.75 27.45 Favored 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 120.702 -0.399 . . . . 72.209999999999994 110.788 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -77.86 152.57 33.31 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 105.273 -2.121 . . . . 72.299999999999997 105.273 169.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . 0.402 ' O ' ' HB2' ' A' ' 626' ' ' GLN . 59.5 t -103.84 116.04 46.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 C-N-CA 118.931 -1.108 . . . . 74.310000000000002 111.94 -169.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.33 107.08 17.17 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.951 -1.129 . . . . 73.099999999999994 107.951 175.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -139.47 17.98 2.55 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.288 -1.004 . . . . 75.200000000000003 108.288 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 98.33 144.21 16.41 Favored Glycine 0 N--CA 1.414 -2.816 0 CA-C-N 114.645 -1.161 . . . . 51.109999999999999 111.089 -176.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.76 -32.3 61.69 Favored Glycine 0 C--N 1.32 -0.315 0 O-C-N 123.935 0.432 . . . . 72.230000000000004 112.503 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 10.0 m -59.06 -23.61 62.17 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.212 1.005 . . . . 72.040000000000006 112.798 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -86.71 -13.72 44.57 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 121.852 -0.53 . . . . 75.430000000000007 110.397 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 56.92 161.59 0.02 OUTLIER 'General case' 0 C--O 1.243 0.757 0 N-CA-C 115.475 1.657 . . . . 75.530000000000001 115.475 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -79.56 89.62 5.09 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 114.745 -1.116 . . . . 72.140000000000001 109.455 172.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . 0.469 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 49.4 ttt180 -117.65 148.78 41.64 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 106.569 -1.641 . . . . 74.200000000000003 106.569 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 67.9 t -61.77 131.12 26.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.468 -0.938 . . . . 75.340000000000003 108.468 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 83.7 t -86.87 -46.56 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.008 0 N-CA-C 109.142 -0.688 . . . . 75.439999999999998 109.142 -174.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -156.1 164.17 38.74 Favored 'General case' 0 N--CA 1.415 -2.217 0 N-CA-C 107.647 -1.242 . . . . 72.340000000000003 107.647 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.04 150.84 44.46 Favored 'General case' 0 C--N 1.279 -2.458 0 N-CA-C 106.928 -1.508 . . . . 74.329999999999998 106.928 173.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.505 ' HB3' ' HD3' ' A' ' 608' ' ' PRO 0.294 48.7 t-20 -70.3 -79.36 0.05 OUTLIER Pre-proline 0 CA--C 1.563 1.445 0 CA-C-O 117.555 -1.212 . . . . 74.140000000000001 113.587 -171.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.505 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 14.6 Cg_exo -73.24 127.39 11.91 Favored 'Trans proline' 0 C--N 1.374 1.875 0 CA-C-N 122.729 2.01 . . . . 73.049999999999997 108.866 174.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.86 160.18 34.49 Favored 'Trans proline' 0 C--O 1.24 0.61 0 C-N-CA 122.392 2.062 . . . . 63.210000000000001 112.594 -175.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.94 127.05 29.57 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.434 -0.58 . . . . 72.219999999999999 109.434 -178.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.47 -12.48 47.36 Favored Glycine 0 N--CA 1.431 -1.651 0 C-N-CA 120.573 -0.823 . . . . 45.539999999999999 111.231 -175.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 27.8 m -97.66 164.62 12.34 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 107.936 -1.135 . . . . 64.010000000000005 107.936 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -88.81 143.41 17.59 Favored Glycine 0 N--CA 1.427 -1.95 0 C-N-CA 121.197 -0.525 . . . . 72.209999999999994 113.59 -177.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 24.3 m -107.92 142.17 21.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.989 -1.115 . . . . 71.019999999999996 107.989 173.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . 0.494 HD22 HG23 ' A' ' 619' ' ' ILE . 31.8 p30 -62.54 164.87 6.91 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 114.282 1.216 . . . . 61.43 114.282 -175.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -55.49 -25.8 39.02 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 114.788 1.403 . . . . 75.239999999999995 114.788 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -74.73 -44.53 49.44 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 106.845 -1.539 . . . . 72.319999999999993 106.845 174.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 97.56 20.65 21.6 Favored Glycine 0 N--CA 1.418 -2.511 0 CA-C-N 114.672 -1.149 . . . . 74.120000000000005 110.53 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . 0.494 HG23 HD22 ' A' ' 615' ' ' ASN . 0.0 OUTLIER -69.42 122.03 20.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 122.078 0.942 . . . . 73.409999999999997 109.928 -172.257 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 9.4 tp -121.89 132.59 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.098 0 CA-C-N 114.606 -1.179 . . . . 75.099999999999994 108.929 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.416 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 7.4 m -97.62 119.72 36.69 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.178 -1.045 . . . . 71.329999999999998 108.178 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 81.6 mt -130.76 154.43 47.99 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 123.739 0.815 . . . . 74.439999999999998 109.33 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 65.2 mmt-85 -136.71 154.9 50.47 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 104.583 -2.377 . . . . 72.030000000000001 104.583 173.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 602' ' ' ARG . 30.5 p90 -141.31 160.35 40.31 Favored 'General case' 0 C--N 1.288 -2.082 0 O-C-N 123.293 0.371 . . . . 72.450000000000003 110.403 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -73.44 -151.14 1.72 Allowed Glycine 0 C--N 1.309 -0.959 0 O-C-N 124.196 0.935 . . . . 63.43 113.446 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 593' ' ' VAL . 6.9 tp-100 . . . . . 0 C--N 1.299 -1.602 0 CA-C-O 119.31 -0.376 . . . . 70.420000000000002 110.438 -175.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 C--O 1.243 0.73 0 N-CA-C 109.725 -0.472 . . . . 72.439999999999998 109.725 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.67 163.56 34.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 109.724 -0.473 . . . . 73.239999999999995 109.724 -177.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -93.67 137.36 33.0 Favored 'General case' 0 N--CA 1.404 -2.762 0 CA-C-O 121.619 0.723 . . . . 75.129999999999995 109.245 177.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 91.4 t -98.29 134.27 22.12 Favored Pre-proline 0 C--N 1.268 -2.972 0 CA-C-N 114.337 -1.302 . . . . 72.209999999999994 110.171 -173.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -71.21 128.79 15.15 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.856 1.704 . . . . 74.109999999999999 110.214 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.39 157.92 18.44 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.288 -0.565 . . . . 75.430000000000007 109.485 -177.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.416 HG23 ' HA ' ' A' ' 373' ' ' ALA . 18.8 m -131.5 26.55 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-N 115.205 -0.907 . . . . 73.540000000000006 109.085 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -66.43 148.55 51.71 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 114.749 -1.114 . . . . 73.439999999999998 109.103 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 107.01 0.7 35.95 Favored Glycine 0 C--N 1.315 -0.625 0 N-CA-C 111.349 -0.7 . . . . 75.540000000000006 111.349 -173.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -113.03 -146.83 0.41 Allowed 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.7 -0.852 . . . . 70.420000000000002 108.7 175.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 58.4 p -89.57 160.77 16.52 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 107.929 -1.137 . . . . 65.540000000000006 107.929 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 8.8 p -63.52 -34.89 78.78 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 120.078 -0.649 . . . . 73.349999999999994 110.568 177.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -65.81 -47.58 74.61 Favored 'General case' 0 C--O 1.216 -0.692 0 N-CA-C 111.902 0.334 . . . . 74.439999999999998 111.902 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -67.19 -42.85 83.5 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.716 0.77 . . . . 74.099999999999994 109.247 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . 0.416 ' HA ' HG23 ' A' ' 365' ' ' VAL . . . -65.35 -42.65 92.61 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 114.558 -1.201 . . . . 73.120000000000005 112.27 -177.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 58.1 mt -69.58 -45.58 77.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 116.592 -0.276 . . . . 74.450000000000003 110.55 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.81 -44.56 90.84 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 123.515 0.509 . . . . 73.349999999999994 111.647 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' THR . . . . . 0.503 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 23.6 m -65.2 -46.64 79.89 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 116.13 -0.486 . . . . 71.310000000000002 110.597 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . 0.414 HD21 ' O ' ' A' ' 373' ' ' ALA . 4.6 mm? -63.17 -38.07 89.71 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 111.803 0.297 . . . . 73.420000000000002 111.803 178.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -63.65 -38.05 89.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.056 0.455 . . . . 74.430000000000007 110.068 178.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -70.07 -21.24 63.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 73.140000000000001 111.644 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' A' ' 376' ' ' THR . 38.4 mmt180 -82.6 -14.11 55.36 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.61 -0.515 . . . . 73.5 109.61 176.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 97.54 6.02 57.59 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 111.385 -0.686 . . . . 62.420000000000002 111.385 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -89.4 149.01 23.17 Favored 'General case' 0 N--CA 1.406 -2.653 0 CA-C-O 121.61 0.719 . . . . 75.530000000000001 111.244 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -96.14 155.09 16.9 Favored 'General case' 0 N--CA 1.41 -2.466 0 CA-C-N 114.548 -1.205 . . . . 72.409999999999997 107.764 -177.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.42 141.94 45.01 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 N-CA-C 109.204 -0.665 . . . . 75.219999999999999 109.204 -177.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 28.2 ttm-85 -125.53 127.57 46.63 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 108.186 -1.042 . . . . 74.209999999999994 108.186 177.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 33.5 m -115.56 123.64 48.98 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-O 120.925 0.393 . . . . 64.430000000000007 110.691 -173.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -112.24 131.09 55.69 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.994 -1.484 . . . . 71.430000000000007 106.994 175.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . 0.49 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -123.11 142.16 51.18 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 119.374 -0.931 . . . . 71.230000000000004 111.403 -179.079 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . 0.402 ' HB2' HG13 ' A' ' 394' ' ' ILE . 75.4 mmtt -131.88 131.26 22.53 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 108.646 -0.872 . . . . 75.109999999999999 108.646 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . 0.44 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 60.6 Cg_endo -83.62 129.18 4.85 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 121.626 1.55 . . . . 73.299999999999997 111.538 176.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 14.8 t70 158.58 -158.06 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 104.308 -2.478 . . . . 74.299999999999997 104.308 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' SER . . . . . 0.405 ' H ' ' CG ' ' A' ' 391' ' ' ASP . 19.3 m -136.36 2.37 2.74 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 119.213 0.915 . . . . 73.129999999999995 110.784 177.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 1.3 p -81.87 -27.65 33.36 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 112.792 0.664 . . . . 70.040000000000006 112.792 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . 0.407 ' H ' HD11 ' A' ' 394' ' ' ILE . 0.2 OUTLIER -93.04 152.09 41.08 Favored Pre-proline 0 C--N 1.29 -1.997 0 CA-C-N 115.898 -0.592 . . . . 73.239999999999995 110.399 -176.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -43.01 129.46 5.65 Favored 'Trans proline' 0 C--N 1.363 1.339 0 C-N-CA 124.159 3.239 . . . . 53.240000000000002 114.528 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -61.04 161.61 21.91 Favored 'Trans proline' 0 N--CA 1.482 0.851 0 C-N-CA 124.212 3.275 . . . . 74.120000000000005 113.489 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -59.37 -8.08 1.6 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 112.975 0.732 . . . . 75.019999999999996 112.975 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -98.02 122.38 41.08 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 103.52 -2.77 . . . . 74.200000000000003 103.52 171.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 26.8 m -77.92 117.05 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.351 0 C-N-CA 118.982 -1.087 . . . . 73.439999999999998 113.565 -162.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 43.6 pt -103.32 -27.4 3.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 114.523 -1.217 . . . . 73.340000000000003 108.548 174.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . 0.408 ' C ' ' HG1' ' A' ' 402' ' ' THR . . . -145.8 157.13 27.27 Favored Glycine 1 CA--C 1.442 -4.525 0 CA-C-O 122.397 0.998 . . . . 63.119999999999997 111.647 179.256 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' THR . . . . . 0.408 ' HG1' ' C ' ' A' ' 401' ' ' GLY . 87.2 m -156.54 -177.89 6.93 Favored 'General case' 0 N--CA 1.383 -3.783 0 N-CA-C 104.592 -2.373 . . . . 72.099999999999994 104.592 -171.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . 0.471 ' C ' ' H ' ' A' ' 405' ' ' ALA . 15.0 m-20 -98.6 131.65 25.5 Favored Pre-proline 0 C--N 1.264 -3.111 0 N-CA-C 106.117 -1.808 . . . . 71.219999999999999 106.117 174.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.6 26.31 0.12 Allowed 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 124.472 3.448 . . . . 74.099999999999994 114.761 -171.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.471 ' H ' ' C ' ' A' ' 403' ' ' ASP . . . -56.92 -35.99 69.67 Favored 'General case' 0 C--O 1.209 -1.077 0 C-N-CA 123.658 0.783 . . . . 70.450000000000003 110.635 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -70.86 -33.61 70.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.33 0.586 . . . . 74.310000000000002 111.049 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -88.12 -1.34 57.95 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 122.081 0.943 . . . . 74.140000000000001 109.406 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 26.6 m -95.28 148.51 22.34 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 104.874 -2.269 . . . . 74.010000000000005 104.874 173.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 4.1 p -74.89 111.99 10.65 Favored 'General case' 0 N--CA 1.41 -2.46 0 C-N-CA 118.603 -1.239 . . . . 62.240000000000002 108.839 176.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 30.2 m -123.71 167.46 17.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.702 -0.681 . . . . 70.299999999999997 110.344 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 38.4 m -76.94 146.91 37.25 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 108.832 -0.803 . . . . 75.420000000000002 108.832 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -64.73 109.45 2.04 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.9 0.381 . . . . 72.129999999999995 111.184 -176.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 111.67 53.12 0.53 Allowed Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.819 -0.628 . . . . 64.310000000000002 112.614 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.61 -167.65 1.29 Allowed 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.46 -0.941 . . . . 73.030000000000001 108.46 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -113.91 137.16 52.06 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.114 0.483 . . . . 72.129999999999995 110.305 -176.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 34.7 mm -110.28 110.73 33.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 108.712 -0.848 . . . . 63.25 108.712 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 21.0 p -84.1 131.22 34.81 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 123.098 0.559 . . . . 65.340000000000003 111.838 -177.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 10.6 p -127.25 135.2 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-N 115.673 -0.694 . . . . 73.230000000000004 111.441 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -105.27 124.61 49.83 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.992 -0.744 . . . . 73.430000000000007 108.992 172.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 16.7 m -126.04 152.7 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.545 0 CA-C-N 115.28 -0.873 . . . . 71.129999999999995 110.535 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 27.1 t -99.38 129.64 45.59 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-O 121.718 0.77 . . . . 71.230000000000004 110.584 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 3.0 p -93.61 158.36 15.73 Favored 'General case' 0 N--CA 1.401 -2.906 0 N-CA-C 105.008 -2.219 . . . . 65.430000000000007 105.008 166.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 2.419 0 N-CA-C 116.729 1.451 . . . . 74.25 116.729 -175.427 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 . . . . . 0 N--CA 1.422 -1.849 0 N-CA-C 106.676 -1.602 . . . . 75.340000000000003 106.676 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 -122.21 152.46 39.96 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 119.398 -0.921 . . . . 72.349999999999994 111.254 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -83.23 138.64 33.52 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 114.445 -1.252 . . . . 62.549999999999997 109.073 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 53.7 mt -84.12 122.95 75.89 Favored Pre-proline 0 N--CA 1.424 -1.733 0 N-CA-C 107.297 -1.371 . . . . 75.150000000000006 107.297 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.74 150.42 62.2 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.802 1.668 . . . . 75.209999999999994 110.892 176.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -80.5 130.13 34.95 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.167 -1.049 . . . . 72.140000000000001 108.167 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 39.5 t -127.03 152.3 34.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 107.438 -1.319 . . . . 74.409999999999997 107.438 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 42.6 t -70.29 143.64 51.99 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.833 -0.803 . . . . 72.400000000000006 108.833 176.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 18.9 p -67.56 -28.44 67.79 Favored 'General case' 0 N--CA 1.424 -1.726 0 C-N-CA 123.658 0.783 . . . . 65.409999999999997 111.532 -175.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 2.3 pp -79.36 -12.53 59.92 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.339 0.59 . . . . 73.430000000000007 111.963 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 3.2 p -104.05 62.98 0.75 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 121.567 0.699 . . . . 74.450000000000003 112.41 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -56.95 -38.58 73.13 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.078 -0.964 . . . . 73.040000000000006 111.014 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -60.04 -42.49 94.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.424 0.63 . . . . 74.5 110.254 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . 0.483 ' O ' ' HB3' ' A' ' 442' ' ' LYS . 25.8 tp10 -70.89 -34.95 72.1 Favored 'General case' 0 C--O 1.205 -1.237 0 CA-C-N 115.463 -0.79 . . . . 72.030000000000001 110.035 178.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.6 -51.42 69.47 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.303 0.112 . . . . 73.209999999999994 111.303 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 33.9 m -63.01 -36.57 76.39 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 CA-C-O 121.273 0.559 . . . . 75.299999999999997 110.839 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.483 ' HB3' ' O ' ' A' ' 439' ' ' GLU . 16.6 tppt? -60.04 -47.69 84.8 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.942 -1.026 . . . . 65.430000000000007 109.998 176.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -67.04 -38.51 86.0 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 113.067 0.765 . . . . 75.519999999999996 113.067 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 9.8 mp -63.71 -34.93 78.96 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.6 -0.44 . . . . 72.319999999999993 109.974 174.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 92.9 m -68.23 -42.2 80.09 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.884 -0.598 . . . . 74.510000000000005 110.182 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.82 -20.64 62.55 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.909 -0.587 . . . . 73.319999999999993 112.063 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -90.2 3.28 53.96 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 112.492 0.553 . . . . 65.540000000000006 112.492 -178.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 110.28 -75.28 0.21 Allowed Glycine 0 CA--C 1.497 -1.071 0 C-N-CA 119.581 -1.295 . . . . 74.349999999999994 112.98 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . 0.434 ' HA ' ' O ' ' A' ' 480' ' ' ILE . 0.2 OUTLIER -40.94 -62.36 0.83 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.902 1.075 . . . . 74.219999999999999 113.902 177.589 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 61.14 23.08 61.43 Favored Glycine 0 C--O 1.221 -0.701 0 C-N-CA 121.172 -0.537 . . . . 75.019999999999996 112.447 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -97.89 111.24 23.61 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 107.921 -1.14 . . . . 70.340000000000003 107.921 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 19.7 p90 -137.6 149.49 46.69 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 121.215 0.531 . . . . 74.209999999999994 111.576 -177.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -136.19 142.48 44.12 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.446 -1.316 . . . . 65.219999999999999 107.446 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -112.7 126.03 54.96 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 120.601 0.239 . . . . 72.120000000000005 110.558 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -123.07 136.15 54.7 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.281 -1.007 . . . . 72.400000000000006 108.281 175.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -113.34 141.52 46.94 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.834 -1.173 . . . . 65.400000000000006 107.834 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 50.0 m -144.68 140.22 16.23 Favored Pre-proline 0 C--N 1.292 -1.931 0 N-CA-C 109.939 -0.393 . . . . 73.420000000000002 109.939 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.577 ' HA ' ' O ' ' A' ' 490' ' ' SER . 21.4 Cg_endo -64.93 122.6 10.45 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.625 1.55 . . . . 72.040000000000006 108.968 176.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 19.8 m -135.84 179.64 6.22 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.55 -0.75 . . . . 63.530000000000001 110.133 -171.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 7.2 t -59.5 139.75 88.98 Favored Pre-proline 0 N--CA 1.42 -1.927 0 O-C-N 124.13 0.894 . . . . 71.310000000000002 109.399 174.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.37 -29.08 29.31 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.707 3.605 . . . . 70.010000000000005 113.492 -175.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -65.34 -37.18 86.29 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.541 -0.3 . . . . 74.329999999999998 111.807 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.07 -14.87 32.91 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 121.044 -0.262 . . . . 74.230000000000004 111.397 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 85.4 t -60.31 128.12 20.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-N 116.498 -0.319 . . . . 75.129999999999995 110.29 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 95.45 -12.11 68.1 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.519 -0.764 . . . . 72.140000000000001 112.229 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -122.47 167.45 13.33 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.204 -0.665 . . . . 74.340000000000003 109.204 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 62.4 t -72.63 143.89 13.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 107.567 -1.272 . . . . 73.439999999999998 107.567 171.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 55.3 mt -97.18 -34.03 4.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.372 -1.344 . . . . 72.230000000000004 107.372 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 163.06 -172.87 39.17 Favored Glycine 0 N--CA 1.409 -3.106 0 CA-C-N 114.802 -1.09 . . . . 64.319999999999993 110.508 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 24.5 p -116.1 147.83 40.91 Favored 'General case' 0 N--CA 1.404 -2.728 0 N-CA-C 105.931 -1.877 . . . . 75.209999999999994 105.931 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.405 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 20.3 t-20 -70.18 -49.99 16.83 Favored Pre-proline 0 C--N 1.313 -0.979 0 C-N-CA 118.237 -1.385 . . . . 72.219999999999999 110.756 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.405 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 19.2 Cg_exo -74.07 125.42 9.8 Favored 'Trans proline' 0 C--N 1.368 1.582 0 N-CA-C 106.837 -2.024 . . . . 71.519999999999996 106.837 165.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . 0.428 ' C ' ' H ' ' A' ' 475' ' ' ASN . 21.8 Cg_exo -61.98 133.64 45.47 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 122.129 1.886 . . . . 71.239999999999995 113.562 -172.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -75.34 16.87 0.3 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.057 0.943 . . . . 64.430000000000007 112.188 -176.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . 0.428 ' H ' ' C ' ' A' ' 473' ' ' PRO . 14.1 m120 -110.45 -10.93 14.54 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.887 -0.597 . . . . 64.209999999999994 109.551 177.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -90.24 176.97 6.55 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.661 -0.699 . . . . 75.430000000000007 112.473 -174.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 6.1 m -107.57 114.98 29.34 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 107.412 -1.329 . . . . 74.109999999999999 107.412 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 13.4 p -112.61 147.85 35.82 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.157 0.503 . . . . 74.239999999999995 111.635 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.58 160.22 30.42 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.843 -0.617 . . . . 72.319999999999993 111.371 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 449' ' ' PHE . 1.8 mp -67.63 -15.16 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.394 0 CA-C-O 122.145 0.974 . . . . 74.200000000000003 112.059 -178.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 11.6 p -103.49 5.3 36.76 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.436 -0.79 . . . . 75.109999999999999 111.331 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -85.36 129.39 34.82 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.094 -0.706 . . . . 73.349999999999994 109.094 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 61.5 t -91.93 126.6 44.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.864 -0.607 . . . . 74.219999999999999 110.303 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 30.2 t -106.38 120.05 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 N-CA-C 108.781 -0.822 . . . . 64.319999999999993 108.781 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.39 123.67 47.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-O 121.227 0.537 . . . . 73.430000000000007 110.124 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.59 128.09 55.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 124.976 1.31 . . . . 72.409999999999997 108.795 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 8.2 tt -109.74 126.6 66.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 109.255 -0.646 . . . . 75.209999999999994 109.255 176.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 34.1 m -109.17 151.34 11.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 116.251 -0.431 . . . . 72.219999999999999 110.232 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -88.78 131.58 10.76 Favored Glycine 0 N--CA 1.439 -1.104 0 C-N-CA 120.592 -0.813 . . . . 75.010000000000005 111.851 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.577 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 19.5 m . . . . . 0 C--N 1.308 -1.229 0 N-CA-C 108.65 -0.87 . . . . 74.319999999999993 108.65 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 CA--C 1.542 0.916 0 CA-C-O 120.964 0.319 . . . . 74.540000000000006 112.603 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -84.65 67.08 9.88 Favored 'General case' 0 C--O 1.25 1.095 0 CA-C-O 122.158 0.98 . . . . 74.040000000000006 110.461 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 494' ' ' THR . . . . . 0.421 ' HB ' HG23 ' A' ' 544' ' ' THR . 11.1 p -117.64 153.67 32.9 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 114.735 -1.121 . . . . 62.43 110.559 -178.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -149.73 150.38 31.99 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.689 -0.856 . . . . 64.319999999999993 108.689 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.7 p-10 -81.74 138.95 35.13 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 123.588 0.755 . . . . 71.120000000000005 110.903 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 543' ' ' THR . 22.2 pt -92.85 117.92 67.72 Favored Pre-proline 0 C--N 1.307 -1.254 0 CA-C-N 115.954 -0.567 . . . . 74.040000000000006 110.876 176.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -92.99 146.45 2.44 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.422 2.081 . . . . 71.129999999999995 111.373 175.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -83.39 96.07 8.42 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 122.803 1.287 . . . . 72.200000000000003 110.634 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.6 p -100.44 23.26 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 123.258 1.504 . . . . 75.409999999999997 107.432 177.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -77.07 171.6 14.55 Favored 'General case' 0 N--CA 1.416 -2.149 0 CA-C-N 113.368 -1.742 . . . . 73.349999999999994 110.295 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 96.74 22.4 18.47 Favored Glycine 0 C--N 1.285 -2.278 0 N-CA-C 108.258 -1.937 . . . . 63.310000000000002 108.258 -177.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -133.68 174.73 10.13 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 108.265 -1.013 . . . . 73.230000000000004 108.265 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 41.7 p -77.91 164.32 25.24 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 117.966 0.348 . . . . 62.409999999999997 110.998 -176.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 17.4 m -51.42 -44.49 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.652 0 C-N-CA 123.79 0.836 . . . . 73.219999999999999 112.982 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -68.01 -41.78 81.68 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.215 0.531 . . . . 73.099999999999994 111.079 -178.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 62.5 t -72.55 -46.45 55.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 115.361 -0.836 . . . . 74.439999999999998 111.535 -175.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.72 -40.44 96.75 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.655 -0.248 . . . . 71.319999999999993 110.812 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -59.96 -43.55 94.98 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.387 -0.598 . . . . 75.040000000000006 109.387 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.499 ' O ' HG21 ' A' ' 514' ' ' VAL . 59.7 tttm -58.1 -50.95 71.71 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.729 -1.123 . . . . 74.219999999999999 109.801 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -62.59 -46.75 86.88 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.575 -0.739 . . . . 75.420000000000002 112.046 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.94 -40.51 89.19 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 120.878 -0.329 . . . . 72.340000000000003 110.729 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.97 -37.98 89.42 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.127 -0.488 . . . . 55.130000000000003 111.309 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.499 HG21 ' O ' ' A' ' 510' ' ' LYS . 77.3 t -62.48 -30.47 49.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 121.006 0.431 . . . . 74.230000000000004 110.785 178.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -83.07 7.96 14.28 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.161 0.505 . . . . 75.540000000000006 111.715 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 93.99 -10.47 71.95 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.988 -0.625 . . . . 72.409999999999997 111.81 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -87.56 81.45 7.74 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-O 121.882 0.849 . . . . 74.010000000000005 109.433 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 3.5 p -89.89 3.34 53.32 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.917 -1.038 . . . . 75.439999999999998 110.98 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -108.74 113.45 26.42 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.061 -1.089 . . . . 73.030000000000001 108.061 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -131.56 156.64 45.39 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.024 -0.989 . . . . 72.239999999999995 111.791 -174.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 50.3 m -137.0 145.55 44.26 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 106.041 -1.837 . . . . 73.510000000000005 106.041 171.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -117.09 132.99 56.55 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 120.856 0.36 . . . . 73.319999999999993 110.267 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -124.58 141.11 52.34 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.179 -1.045 . . . . 75.510000000000005 108.179 176.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 6.4 m -110.28 120.75 43.45 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.62 -0.881 . . . . 72.0 108.62 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 34.9 m -120.9 164.12 17.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 110.294 -0.262 . . . . 73.109999999999999 110.294 -175.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . 0.573 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 8.0 p-10 -90.63 135.26 33.82 Favored 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 120.274 -0.57 . . . . 74.010000000000005 111.343 -177.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 527' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 67.5 m -160.75 -179.92 1.18 Allowed Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 108.914 -0.773 . . . . 75.329999999999998 108.914 176.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -85.55 -19.15 3.62 Favored 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 121.505 1.47 . . . . 72.5 111.158 171.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -69.11 137.16 89.36 Favored Pre-proline 0 N--CA 1.437 -1.092 0 C-N-CA 124.018 0.927 . . . . 75.129999999999995 109.628 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -56.73 144.56 86.4 Favored 'Trans proline' 0 C--O 1.245 0.863 0 C-N-CA 123.624 2.883 . . . . 73.319999999999993 115.505 -170.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.627 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -67.4 115.51 7.12 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 114.258 -1.337 . . . . 75.230000000000004 109.907 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 133.93 -21.47 3.94 Favored Glycine 0 C--N 1.297 -1.61 0 N-CA-C 110.777 -0.929 . . . . 54.310000000000002 110.777 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -83.07 128.9 34.9 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 120.951 0.405 . . . . 75.019999999999996 110.596 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . 0.404 HG23 HG22 ' A' ' 555' ' ' VAL . 84.2 t -83.22 105.74 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 N-CA-C 104.791 -2.3 . . . . 72.319999999999993 104.791 170.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 74.1 m -83.69 -16.85 43.45 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 112.312 0.486 . . . . 75.439999999999998 112.312 -173.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 173.44 -161.78 32.66 Favored Glycine 0 CA--C 1.49 -1.505 0 C-N-CA 120.099 -1.048 . . . . 61.520000000000003 111.251 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 23.7 p -127.77 160.07 32.85 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.782 -0.822 . . . . 74.219999999999999 108.782 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -73.01 -51.57 6.1 Favored Pre-proline 0 C--N 1.307 -1.243 0 CA-C-O 119.337 -0.363 . . . . 73.5 110.034 176.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -66.55 130.86 24.58 Favored 'Trans proline' 0 C--N 1.378 2.103 0 N-CA-C 108.487 -1.39 . . . . 73.420000000000002 108.487 170.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -61.66 142.11 93.24 Favored 'Trans proline' 0 C--O 1.241 0.673 0 C-N-CA 122.59 2.193 . . . . 74.219999999999999 114.161 -176.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.54 141.72 57.76 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.125 -0.943 . . . . 61.240000000000002 109.996 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.11 -20.65 46.61 Favored Glycine 0 C--N 1.302 -1.322 0 N-CA-C 110.545 -1.022 . . . . 72.120000000000005 110.545 -177.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 543' ' ' THR . . . . . 0.416 ' O ' HG12 ' A' ' 497' ' ' ILE . 63.5 m -76.47 137.66 39.81 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-O 121.507 0.67 . . . . 73.400000000000006 109.868 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 18.4 m -94.14 123.92 37.82 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 115.373 -0.83 . . . . 74.510000000000005 109.749 -176.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 31.6 m -129.12 157.96 74.36 Favored Pre-proline 0 C--N 1.312 -1.044 0 N-CA-C 109.217 -0.661 . . . . 75.209999999999994 109.217 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -66.07 143.61 72.58 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.067 1.845 . . . . 74.430000000000007 110.793 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 36.0 m -66.26 -19.04 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-O 121.521 0.677 . . . . 70.420000000000002 111.842 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -87.53 -2.05 58.35 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 115.297 -0.865 . . . . 73.230000000000004 110.703 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 32.3 t -89.09 157.24 18.39 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.485 -0.561 . . . . 74.239999999999995 109.485 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 25.8 t -96.33 136.65 26.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 109.24 -0.652 . . . . 71.140000000000001 109.24 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 2.7 mp -113.66 138.56 42.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.379 -0.6 . . . . 75.299999999999997 109.379 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -101.98 121.13 41.56 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 121.36 0.6 . . . . 74.349999999999994 110.472 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.3 mp -95.56 132.08 41.08 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.364 -1.289 . . . . 74.120000000000005 107.859 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -106.84 120.17 41.31 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 122.013 0.911 . . . . 63.340000000000003 110.953 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . 0.404 HG22 HG23 ' A' ' 534' ' ' VAL . 47.0 t -99.61 135.65 34.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-N 114.111 -1.404 . . . . 71.439999999999998 108.211 -178.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.627 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 68.2 m -90.73 149.2 22.13 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 116.464 -0.335 . . . . 62.530000000000001 110.455 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.573 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 15.8 ptmt -105.65 146.68 29.39 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 105.226 -2.138 . . . . 74.510000000000005 105.226 172.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -84.15 -24.72 47.06 Favored Glycine 0 N--CA 1.433 -1.549 0 C-N-CA 119.479 -1.343 . . . . 73.209999999999994 112.239 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 70.02 5.91 5.5 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.687 1.195 . . . . 74.319999999999993 111.004 -177.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 15.3 tp60 -148.53 141.87 25.2 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 106.891 -1.522 . . . . 75.150000000000006 106.891 -171.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -143.86 149.52 37.06 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.945 -0.761 . . . . 74.239999999999995 108.945 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.52 119.79 32.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 121.286 0.565 . . . . 72.099999999999994 111.413 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 60.4 ttp -97.75 134.0 22.84 Favored Pre-proline 0 C--N 1.316 -0.873 0 N-CA-C 108.537 -0.912 . . . . 73.040000000000006 108.537 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -64.18 169.52 10.61 Favored 'Trans proline' 0 C--O 1.245 0.872 0 C-N-CA 122.864 2.376 . . . . 75.409999999999997 112.378 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -69.0 131.07 44.48 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 113.802 1.038 . . . . 72.140000000000001 113.802 -177.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 93.8 mt -147.12 23.19 1.19 Allowed 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 125.141 1.377 . . . . 75.349999999999994 107.942 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 2.8 m -79.25 146.28 33.1 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 116.25 -0.432 . . . . 75.430000000000007 110.824 -175.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 82.75 33.63 24.02 Favored Glycine 0 CA--C 1.496 -1.105 0 C-N-CA 120.796 -0.716 . . . . 74.329999999999998 112.137 174.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 25.0 mmt -108.04 -175.12 2.69 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.089 0.471 . . . . 72.430000000000007 110.387 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -110.25 155.9 21.41 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 108.845 -0.798 . . . . 73.299999999999997 108.845 -176.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 26.6 t90 -59.9 -30.68 69.19 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 123.217 0.323 . . . . 74.140000000000001 111.207 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 11.7 p -63.9 -21.51 28.91 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 CA-C-O 121.355 0.597 . . . . 74.230000000000004 110.791 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . 0.639 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 17.9 t70 -101.69 -41.74 6.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.715 -0.675 . . . . 75.530000000000001 109.703 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -62.79 -46.76 86.48 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 113.189 0.811 . . . . 73.319999999999993 113.189 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -54.33 -55.32 38.41 Favored Pre-proline 0 CA--C 1.577 2.016 0 O-C-N 123.215 0.322 . . . . 74.310000000000002 110.76 -178.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.37 -28.48 84.23 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.446 2.098 . . . . 65.239999999999995 114.24 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . 0.639 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 29.1 mmt180 -58.15 -47.13 84.3 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.818 -0.438 . . . . 72.25 109.818 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 9.9 mp -61.11 -40.41 93.66 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.589 -0.732 . . . . 73.299999999999997 110.993 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -64.76 -46.83 80.46 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.931 -0.577 . . . . 75.409999999999997 110.206 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -67.63 -34.95 78.0 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.739 -0.664 . . . . 72.340000000000003 112.786 -177.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 92.4 mt -81.49 -7.55 59.6 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 112.61 0.596 . . . . 74.519999999999996 112.61 -176.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 74.41 40.16 40.75 Favored Glycine 0 CA--C 1.504 -0.627 0 C-N-CA 119.712 -1.232 . . . . 64.140000000000001 110.128 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . 0.441 ' CH2' ' HB2' ' A' ' 587' ' ' LEU . 77.0 t90 -72.51 136.09 45.82 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.59 -0.805 . . . . 74.430000000000007 111.166 -178.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 34.1 m -146.94 95.28 2.55 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.578 -0.527 . . . . 74.310000000000002 109.578 175.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -161.73 -144.98 4.17 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 108.871 -1.692 . . . . 71.200000000000003 108.871 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 87.5 mtp -111.34 133.7 53.46 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 118.085 0.943 . . . . 74.420000000000002 110.827 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . 0.441 ' HB2' ' CH2' ' A' ' 583' ' ' TRP . 61.6 tp -114.52 129.23 56.65 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.964 -1.124 . . . . 73.409999999999997 107.964 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -101.55 100.07 10.45 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 119.16 -1.016 . . . . 74.420000000000002 109.007 176.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -114.38 110.56 20.07 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 115.269 -0.878 . . . . 73.040000000000006 108.954 175.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . 0.427 ' HA3' ' NH1' ' A' ' 623' ' ' ARG . . . -90.8 -151.08 25.77 Favored Glycine 0 N--CA 1.433 -1.512 0 C-N-CA 120.991 -0.623 . . . . 72.239999999999995 113.069 -178.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -100.21 154.49 18.42 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 110.025 -0.361 . . . . 65.340000000000003 110.025 -177.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -73.49 149.82 42.04 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 123.896 0.748 . . . . 74.109999999999999 110.634 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 94.8 t -138.45 130.2 37.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 115.476 -0.784 . . . . 74.329999999999998 109.763 -177.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -77.68 106.73 9.67 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 107.4 -1.333 . . . . 62.229999999999997 107.4 173.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -126.39 -20.16 4.48 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 116.03 -0.532 . . . . 73.329999999999998 111.132 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 128.2 157.93 9.52 Favored Glycine 0 C--N 1.302 -1.343 0 N-CA-C 110.412 -1.075 . . . . 64.409999999999997 110.412 -177.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.35 -35.67 66.64 Favored Glycine 0 N--CA 1.46 0.279 0 N-CA-C 113.992 0.357 . . . . 71.109999999999999 113.992 -173.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 19.9 m -62.61 -24.54 67.63 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.036 0.446 . . . . 70.239999999999995 111.701 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -107.05 -11.57 15.62 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 122.057 -0.402 . . . . 72.310000000000002 111.809 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 41.6 m170 -77.78 133.64 38.2 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 122.204 -0.31 . . . . 71.150000000000006 111.707 -176.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 58.9 t30 70.03 -21.73 0.17 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 125.488 1.515 . . . . 75.540000000000006 114.254 174.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 17.7 ttp85 -91.38 149.69 21.61 Favored 'General case' 0 C--N 1.312 -1.059 0 O-C-N 121.976 -0.453 . . . . 74.340000000000003 111.184 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . 0.431 HG22 ' HB2' ' A' ' 622' ' ' LEU . 9.0 p -62.71 133.66 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 O-C-N 123.765 0.665 . . . . 73.519999999999996 109.911 174.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 90.8 t -90.94 -48.46 14.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 108.317 -0.994 . . . . 73.340000000000003 108.317 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 622' ' ' LEU . 49.1 p90 -151.89 152.65 32.84 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 107.124 -1.435 . . . . 71.329999999999998 107.124 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -126.48 139.36 53.3 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 109.156 -0.683 . . . . 74.409999999999997 109.156 176.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.469 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 25.3 t-20 -54.91 -66.85 0.81 Allowed Pre-proline 0 C--N 1.311 -1.071 0 CA-C-N 115.407 -0.815 . . . . 72.349999999999994 112.454 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 88.2 Cg_endo -93.04 132.99 0.95 Allowed 'Trans proline' 0 N--CA 1.442 -1.55 0 CA-C-N 121.481 1.564 . . . . 73.25 110.6 173.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -70.3 134.76 27.58 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 121.102 1.201 . . . . 73.230000000000004 110.834 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -69.49 129.68 40.38 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.6 -0.889 . . . . 73.230000000000004 108.6 176.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.38 -2.89 39.96 Favored Glycine 0 C--N 1.299 -1.513 0 N-CA-C 109.707 -1.357 . . . . 64.299999999999997 109.707 -172.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 30.2 m -119.11 167.54 11.7 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 107.832 -1.174 . . . . 72.010000000000005 107.832 177.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -71.34 126.17 12.76 Favored Glycine 0 N--CA 1.432 -1.588 0 CA-C-O 120.984 0.214 . . . . 74.030000000000001 112.987 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 35.6 m -106.15 143.6 16.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 C-N-CA 124.606 1.162 . . . . 74.510000000000005 108.385 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . 0.431 ' ND2' ' HB2' ' A' ' 617' ' ' ASP . 32.2 p-10 -67.64 161.07 26.59 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.657 0.265 . . . . 73.540000000000006 111.506 -176.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.95 -30.71 36.28 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.812 -0.631 . . . . 74.340000000000003 111.796 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . 0.431 ' HB2' ' ND2' ' A' ' 615' ' ' ASN . 4.8 m-20 -71.34 -37.81 71.68 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 116.394 -0.366 . . . . 75.219999999999999 111.064 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 85.05 22.88 51.21 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 118.553 -1.784 . . . . 75.099999999999994 111.524 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.96 122.04 17.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 122.637 1.208 . . . . 73.430000000000007 109.773 -169.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 5.1 tp -126.4 123.28 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 CA-C-N 114.068 -1.423 . . . . 75.219999999999999 111.209 -174.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.468 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 55.0 m -115.0 121.87 44.47 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 107.952 -1.129 . . . . 71.340000000000003 107.952 173.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' A' ' 605' ' ' TYR . 0.0 OUTLIER -138.41 159.48 41.97 Favored 'General case' 0 CA--C 1.479 -1.781 0 N-CA-C 107.044 -1.465 . . . . 74.439999999999998 107.044 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . 0.427 ' NH1' ' HA3' ' A' ' 590' ' ' GLY . 18.2 tpt180 -135.42 149.48 49.63 Favored 'General case' 0 C--N 1.267 -2.999 0 N-CA-C 105.686 -1.968 . . . . 73.549999999999997 105.686 178.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -141.08 162.02 36.47 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 106.569 -1.641 . . . . 72.019999999999996 106.569 177.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -78.44 -101.57 0.21 Allowed Glycine 0 N--CA 1.427 -1.912 0 N-CA-C 109.832 -1.307 . . . . 74.230000000000004 109.832 177.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 . . . . . 0 C--N 1.282 -2.329 0 N-CA-C 108.664 -0.865 . . . . 73.310000000000002 108.664 175.044 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 . . . . . 0 CA--C 1.504 -0.806 0 N-CA-C 107.859 -1.163 . . . . 75.129999999999995 107.859 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 35.9 m -117.42 159.25 17.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-O 120.864 0.364 . . . . 74.099999999999994 110.145 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.5 122.96 38.79 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.609 -1.626 . . . . 71.430000000000007 106.609 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.494 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 60.7 t -96.46 133.17 25.13 Favored Pre-proline 0 C--N 1.294 -1.843 0 CA-C-N 116.2 -0.455 . . . . 54.240000000000002 110.627 -170.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -68.9 127.63 15.57 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 121.682 1.588 . . . . 73.150000000000006 111.3 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -82.35 100.48 10.0 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 122.575 1.179 . . . . 74.030000000000001 110.039 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 20.0 m -74.32 9.11 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 113.587 -1.642 . . . . 74.299999999999997 114.522 -174.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -63.34 144.62 56.8 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 123.025 0.53 . . . . 64.200000000000003 111.252 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.52 0.35 43.25 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.959 -0.564 . . . . 74.329999999999998 112.395 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -112.16 -160.6 0.72 Allowed 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.538 -1.282 . . . . 72.329999999999998 107.538 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 84.0 p -91.58 166.01 13.04 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 106.696 -1.594 . . . . 61.329999999999998 106.696 177.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 40.2 t -60.63 -42.33 96.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 118.376 0.534 . . . . 62.439999999999998 109.608 177.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.19 -46.56 76.92 Favored 'General case' 0 C--O 1.214 -0.804 0 CA-C-N 115.892 -0.594 . . . . 70.219999999999999 111.727 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -65.91 -44.55 84.89 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 120.648 0.261 . . . . 75.409999999999997 111.161 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -61.86 -48.64 79.62 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.762 -0.653 . . . . 74.540000000000006 111.121 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 66.7 mt -67.21 -40.0 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 116.049 -0.523 . . . . 73.230000000000004 110.936 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.19 -39.73 91.27 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-O 120.626 0.251 . . . . 72.030000000000001 111.212 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' THR . . . . . 0.416 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 90.4 m -63.96 -48.52 76.17 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 116.088 -0.506 . . . . 63.539999999999999 109.953 177.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.9 -38.9 92.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.312 -0.404 . . . . 75.510000000000005 111.081 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -62.92 -43.8 97.82 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.824 -0.625 . . . . 74.030000000000001 111.113 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -67.64 -23.66 65.37 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.488 0.661 . . . . 74.319999999999993 111.569 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . 0.416 ' HG2' ' O ' ' A' ' 376' ' ' THR . 27.9 mmt180 -84.7 -14.16 49.25 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.747 -0.66 . . . . 71.200000000000003 111.088 177.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.81 16.3 45.75 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.309 -0.948 . . . . 71.099999999999994 112.447 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.429 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 53.8 m-85 -83.99 173.73 10.92 Favored 'General case' 0 N--CA 1.421 -1.875 0 CA-C-O 120.946 0.403 . . . . 74.530000000000001 111.537 177.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -116.17 150.46 37.42 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 107.186 -1.413 . . . . 74.230000000000004 107.186 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.69 140.35 49.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 CA-C-O 121.094 0.473 . . . . 75.239999999999995 110.801 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' A' ' 417' ' ' THR . 39.9 ttt180 -116.06 127.95 55.3 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 105.995 -1.854 . . . . 73.439999999999998 105.995 174.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 22.8 m -111.87 131.88 55.07 Favored 'General case' 0 C--N 1.276 -2.623 0 C-N-CA 119.988 -0.685 . . . . 72.510000000000005 110.403 -175.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -111.11 119.46 39.06 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 105.264 -2.124 . . . . 75.25 105.264 175.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . 0.711 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -129.73 123.13 30.32 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.774 0.321 . . . . 72.329999999999998 111.28 -176.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -138.52 138.04 21.46 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 116.252 -0.431 . . . . 74.519999999999996 111.525 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 422' ' ' THR . 8.4 Cg_exo -77.84 131.29 11.07 Favored 'Trans proline' 0 C--O 1.259 1.541 0 C-N-CA 122.472 2.115 . . . . 74.329999999999998 110.223 169.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.414 ' HB3' HG12 ' A' ' 394' ' ' ILE . 22.8 t70 169.01 136.87 0.02 OUTLIER 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 124.304 1.042 . . . . 65.239999999999995 108.328 -177.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 14.3 m -93.64 4.59 53.72 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 113.015 0.746 . . . . 64.219999999999999 113.015 -173.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 86.0 m -99.8 -30.15 12.22 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.578 -0.701 . . . . 72.129999999999995 110.248 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . 0.414 HG12 ' HB3' ' A' ' 391' ' ' ASP . 16.9 pt -87.6 148.63 44.51 Favored Pre-proline 0 N--CA 1.433 -1.323 0 CA-C-N 116.097 -0.501 . . . . 75.430000000000007 110.297 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -55.2 138.47 79.33 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.057 3.171 . . . . 75.109999999999999 115.397 -173.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -55.62 164.47 4.28 Favored 'Trans proline' 0 C--N 1.361 1.192 0 C-N-CA 124.949 3.766 . . . . 74.140000000000001 112.274 175.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -55.58 -7.93 0.32 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 113.176 0.806 . . . . 74.310000000000002 113.176 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -77.72 111.56 13.64 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 104.914 -2.254 . . . . 74.209999999999994 104.914 169.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 33.3 m -77.16 122.74 32.38 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 N-CA-C 113.329 0.863 . . . . 63.229999999999997 113.329 -165.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 47.3 pt -89.8 -27.79 5.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 115.861 -0.608 . . . . 74.019999999999996 109.942 176.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.05 162.61 28.13 Favored Glycine 0 N--CA 1.419 -2.445 0 C-N-CA 119.714 -1.232 . . . . 73.209999999999994 114.035 -175.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 12.9 p -142.09 -176.84 4.96 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 126.767 2.027 . . . . 65.329999999999998 105.955 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -98.34 134.54 21.83 Favored Pre-proline 0 C--N 1.299 -1.627 0 C-N-CA 119.339 -0.944 . . . . 72.209999999999994 109.981 -175.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -59.92 -0.89 0.98 Allowed 'Trans proline' 0 C--N 1.362 1.284 0 C-N-CA 124.589 3.526 . . . . 71.530000000000001 115.205 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.0 -29.56 68.56 Favored 'General case' 0 C--O 1.203 -1.385 0 N-CA-C 108.243 -1.021 . . . . 64.340000000000003 108.243 172.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . 0.494 ' HA ' ' HB ' ' A' ' 362' ' ' VAL . . . -62.93 -44.04 97.16 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.236 -0.893 . . . . 64.150000000000006 109.761 175.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -80.64 -4.04 52.74 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.234 -0.894 . . . . 73.129999999999995 111.555 -175.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 23.1 m -98.74 150.45 21.81 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 105.534 -2.024 . . . . 73.230000000000004 105.534 173.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 52.2 p -75.27 111.93 11.04 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 117.695 -1.602 . . . . 73.400000000000006 107.091 175.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.5 m -125.54 169.04 17.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 120.846 0.355 . . . . 74.239999999999995 111.136 -177.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 13.7 m -64.63 134.58 54.59 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.455 -0.793 . . . . 74.340000000000003 109.686 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -64.56 128.66 36.74 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 116.057 -0.519 . . . . 73.319999999999993 110.127 -176.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 89.36 47.43 4.06 Favored Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 120.412 -0.899 . . . . 73.109999999999999 111.016 -177.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -106.83 161.31 14.8 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.794 -1.187 . . . . 73.540000000000006 107.794 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -86.27 108.9 18.6 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 121.398 0.618 . . . . 74.540000000000006 110.698 -176.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 41.9 mm -97.24 120.77 47.01 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 N-CA-C 108.217 -1.031 . . . . 72.099999999999994 108.217 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 385' ' ' ARG . 22.5 m -79.24 129.26 34.28 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.298 0.57 . . . . 71.219999999999999 111.124 -177.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 9.0 p -116.84 135.7 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-N 114.885 -1.052 . . . . 73.109999999999999 108.456 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.5 120.95 36.65 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 120.889 0.376 . . . . 72.439999999999998 110.718 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.711 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 99.2 t -127.25 131.68 70.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 108.488 -0.931 . . . . 70.549999999999997 108.488 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 4.1 m -131.43 143.11 50.2 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.504 -0.878 . . . . 64.349999999999994 109.568 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 390' ' ' PRO . 63.6 p -98.68 118.06 34.54 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 105.459 -2.052 . . . . 64.450000000000003 105.459 172.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.254 0 N-CA-C 116.084 1.194 . . . . 63.340000000000003 116.084 -170.876 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 . . . . . 0 N--CA 1.42 -1.94 0 N-CA-C 107.139 -1.43 . . . . 73.209999999999994 107.139 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.632 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 1.1 mmp_? -122.6 149.49 43.91 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-O 121.495 0.664 . . . . 73.540000000000006 112.141 -176.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -83.12 138.17 33.78 Favored 'General case' 0 C--N 1.276 -2.615 0 CA-C-N 113.836 -1.529 . . . . 72.549999999999997 108.566 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 58.2 mt -98.46 125.91 41.34 Favored Pre-proline 0 C--N 1.286 -2.155 0 N-CA-C 108.007 -1.109 . . . . 62.539999999999999 108.007 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -70.35 142.85 46.37 Favored 'Trans proline' 0 C--O 1.24 0.603 0 C-N-CA 122.216 1.944 . . . . 75.319999999999993 110.191 174.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -68.13 116.42 8.73 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.854 0.359 . . . . 70.200000000000003 110.369 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.05 140.25 27.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 109.216 -0.661 . . . . 73.530000000000001 109.216 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.584 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 19.6 m -68.94 158.29 34.96 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-O 120.864 0.364 . . . . 74.5 111.124 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 36.9 p -69.76 -28.87 66.13 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 114.309 1.225 . . . . 64.420000000000002 114.309 -171.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.0 pp -88.39 -11.55 45.8 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.655 0.741 . . . . 73.239999999999995 111.57 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.584 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 0.2 OUTLIER -92.53 40.87 1.06 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.663 -0.699 . . . . 71.010000000000005 110.743 -175.188 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -52.87 -38.28 61.37 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.545 0.738 . . . . 74.239999999999995 112.503 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.18 -41.82 97.48 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.979 0.418 . . . . 65.140000000000001 110.703 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -70.49 -34.66 72.61 Favored 'General case' 0 C--O 1.207 -1.137 0 CA-C-N 116.195 -0.457 . . . . 72.409999999999997 110.185 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.572 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -59.69 -51.7 68.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 119.766 -0.159 . . . . 73.019999999999996 111.119 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.6 m -62.01 -38.18 80.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-O 121.305 0.574 . . . . 73.430000000000007 110.463 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -60.63 -47.77 84.77 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.341 1.057 . . . . 64.540000000000006 110.971 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -65.75 -38.84 90.21 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 123.189 0.596 . . . . 63.420000000000002 111.428 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 85.3 mt -64.02 -36.88 85.43 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.167 -0.47 . . . . 72.209999999999994 110.176 177.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 33.1 m -70.11 -44.37 69.12 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.016 -0.538 . . . . 72.109999999999999 110.164 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.21 -18.31 65.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.854 -0.612 . . . . 75.510000000000005 111.246 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -90.04 5.48 46.48 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.129 -0.487 . . . . 72.420000000000002 111.824 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 109.71 -83.7 0.34 Allowed Glycine 0 CA--C 1.494 -1.225 0 C-N-CA 120.039 -1.077 . . . . 74.409999999999997 112.081 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -36.71 -61.85 0.51 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.734 1.383 . . . . 75.099999999999994 114.734 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 60.05 27.71 65.26 Favored Glycine 0 CA--C 1.508 -0.355 0 C-N-CA 120.842 -0.694 . . . . 63.219999999999999 111.434 -175.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -102.36 111.17 23.35 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 109.28 -0.637 . . . . 73.140000000000001 109.28 -176.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 11.5 p90 -139.64 152.03 46.44 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.653 -0.703 . . . . 75.540000000000006 110.298 -177.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -142.65 122.95 13.87 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.906 -1.146 . . . . 72.329999999999998 107.906 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -96.36 130.81 43.39 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 120.96 0.409 . . . . 75.530000000000001 111.758 -177.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -135.15 150.04 50.09 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 123.498 0.719 . . . . 73.140000000000001 109.199 175.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -123.1 149.82 44.0 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 119.915 -0.714 . . . . 73.010000000000005 110.491 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 46.1 m -151.18 151.65 29.78 Favored Pre-proline 0 C--N 1.295 -1.798 0 N-CA-C 107.184 -1.413 . . . . 71.310000000000002 107.184 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 490' ' ' SER . 19.2 Cg_exo -65.48 144.58 79.94 Favored 'Trans proline' 0 C--O 1.243 0.738 0 C-N-CA 121.747 1.631 . . . . 75.209999999999994 112.018 -177.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 14.9 t -152.55 179.37 8.65 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 106.709 -1.589 . . . . 74.540000000000006 106.709 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.5 t -56.17 142.94 65.6 Favored Pre-proline 0 C--N 1.305 -1.347 0 C-N-CA 123.947 0.899 . . . . 74.209999999999994 110.621 177.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -51.49 -29.73 32.77 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 124.464 3.443 . . . . 75.409999999999997 113.121 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.51 -19.39 60.93 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.942 0.401 . . . . 71.140000000000001 112.057 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -108.13 -1.93 19.92 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.112 0.412 . . . . 65.540000000000006 112.112 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 84.4 t -61.06 127.14 20.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.266 -0.642 . . . . 71.5 109.266 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.68 -13.09 68.26 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 116.065 -0.516 . . . . 40.240000000000002 111.812 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.413 ' O ' HG21 ' A' ' 488' ' ' VAL . 11.8 mptt -109.76 159.0 17.55 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.167 0.508 . . . . 74.530000000000001 110.12 -178.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 76.8 t -71.85 145.8 11.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 115.071 -0.968 . . . . 73.219999999999999 109.711 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 62.1 mt -98.39 -35.44 5.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 107.83 -1.174 . . . . 73.140000000000001 107.83 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 164.72 -174.52 40.71 Favored Glycine 0 N--CA 1.43 -1.757 0 CA-C-N 115.468 -0.787 . . . . 72.120000000000005 112.176 176.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 470' ' ' THR . . . . . 0.527 HG23 HG12 ' A' ' 486' ' ' ILE . 58.8 p -115.2 141.94 47.34 Favored 'General case' 0 N--CA 1.422 -1.825 0 N-CA-C 106.933 -1.506 . . . . 72.049999999999997 106.933 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.469 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 2.8 t-20 -64.46 -57.3 17.73 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 119.85 -0.74 . . . . 74.049999999999997 111.358 178.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 17.2 Cg_exo -74.19 138.53 25.31 Favored 'Trans proline' 0 C--N 1.363 1.311 0 N-CA-C 107.026 -1.951 . . . . 63.399999999999999 107.026 168.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -63.0 126.14 17.37 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 121.749 1.633 . . . . 75.409999999999997 113.669 -173.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -86.16 10.73 13.64 Favored 'General case' 0 C--O 1.205 -1.272 0 CA-C-N 115.275 -0.875 . . . . 61.039999999999999 111.047 -177.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -110.65 -0.68 17.1 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.54 -0.755 . . . . 75.019999999999996 110.455 176.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -124.46 -168.48 1.81 Allowed 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.024 -0.535 . . . . 74.430000000000007 110.548 -173.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.09 131.46 35.24 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 115.54 -0.755 . . . . 73.140000000000001 110.544 -177.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 49.5 m -127.98 148.16 50.51 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 122.902 0.481 . . . . 75.209999999999994 110.097 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -77.87 158.77 29.3 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.932 -0.576 . . . . 73.519999999999996 110.931 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 35.0 mm -73.16 -23.06 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 121.552 0.692 . . . . 73.340000000000003 110.57 -175.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 17.0 m -95.94 1.8 53.1 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 122.081 0.943 . . . . 73.430000000000007 109.93 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -93.06 130.19 38.76 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.751 -0.659 . . . . 73.409999999999997 110.705 -175.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.2 p -100.34 126.41 53.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.25 0.548 . . . . 72.439999999999998 111.487 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 32.7 m -95.75 121.68 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-O 121.816 0.817 . . . . 71.120000000000005 110.327 178.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.61 129.28 43.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.971 -1.122 . . . . 75.140000000000001 107.971 177.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . 0.527 HG12 HG23 ' A' ' 470' ' ' THR . 11.6 mt -113.73 124.61 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 CA-C-N 114.83 -1.077 . . . . 74.340000000000003 110.274 -175.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 8.5 tt -104.94 126.19 59.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 115.256 -0.883 . . . . 74.439999999999998 109.33 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 466' ' ' LYS . 2.3 p -111.41 145.53 17.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 C-N-CA 124.252 1.021 . . . . 73.439999999999998 109.447 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -80.14 124.41 6.48 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.991 -0.623 . . . . 72.230000000000004 111.662 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 18.3 t . . . . . 0 C--N 1.31 -1.138 0 N-CA-C 108.84 -0.8 . . . . 74.400000000000006 108.84 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo . . . . . 0 N--CA 1.456 -0.698 0 CA-C-O 120.831 0.263 . . . . 63.409999999999997 112.414 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -136.7 21.38 3.1 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 122.154 0.978 . . . . 73.400000000000006 110.521 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 27.5 p -130.19 151.69 50.43 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-N 114.334 -1.303 . . . . 74.400000000000006 110.61 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 18.7 mmtt -147.82 164.33 33.97 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.679 -0.691 . . . . 75.129999999999995 110.245 175.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -95.73 136.77 35.72 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.988 -0.551 . . . . 73.349999999999994 110.428 -175.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 27.7 pt -92.08 117.78 67.86 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 109.283 -0.636 . . . . 73.150000000000006 109.283 175.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.22 -179.39 5.38 Favored 'Trans proline' 0 C--O 1.249 1.058 0 C-N-CA 121.966 1.777 . . . . 74.319999999999993 111.934 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -79.07 111.26 15.1 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.471 -0.566 . . . . 74.420000000000002 109.471 177.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 9.9 p -113.35 18.97 7.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 122.424 1.107 . . . . 75.430000000000007 109.191 -176.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -83.46 119.16 24.33 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.432 -0.803 . . . . 70.340000000000003 110.783 -177.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 120.33 22.12 3.22 Favored Glycine 0 N--CA 1.436 -1.338 0 C-N-CA 121.054 -0.593 . . . . 74.530000000000001 112.888 177.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . 0.491 HE22 ' N ' ' A' ' 508' ' ' ALA . 0.0 OUTLIER -137.14 -172.19 3.14 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 122.591 -0.358 . . . . 74.420000000000002 110.876 178.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 8.6 m -91.01 154.88 19.11 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 118.483 -1.287 . . . . 74.209999999999994 110.303 -173.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 9.5 p -58.34 -41.3 80.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 123.342 0.657 . . . . 75.239999999999995 112.415 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -59.73 -39.8 85.93 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.455 0.645 . . . . 71.540000000000006 109.877 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 29.3 t -73.52 -36.7 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 CA-C-N 115.314 -0.857 . . . . 64.340000000000003 109.955 -177.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . 0.491 ' N ' HE22 ' A' ' 503' ' ' GLN . . . -63.39 -49.78 72.45 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.397 -0.365 . . . . 64.0 111.593 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -63.23 -35.15 79.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.012 0.434 . . . . 75.010000000000005 110.554 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.426 ' O ' HG23 ' A' ' 514' ' ' VAL . 5.0 tppp? -61.99 -53.1 60.31 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.249 -0.887 . . . . 75.150000000000006 109.893 176.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -61.59 -44.91 96.15 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-N 116.163 -0.471 . . . . 64.019999999999996 111.632 -176.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -61.0 -44.07 97.96 Favored 'General case' 0 C--O 1.247 0.924 0 O-C-N 123.236 0.335 . . . . 74.010000000000005 111.442 178.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 10.2 m120 -63.84 -38.8 92.42 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 120.317 -0.553 . . . . 74.209999999999994 111.109 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 510' ' ' LYS . 73.0 t -61.88 -35.04 65.73 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 CA-C-N 116.052 -0.522 . . . . 75.420000000000002 111.087 177.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -74.63 -13.87 60.7 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.573 -0.451 . . . . 74.230000000000004 111.017 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 115.24 -2.06 22.38 Favored Glycine 0 N--CA 1.436 -1.335 0 C-N-CA 120.437 -0.887 . . . . 72.140000000000001 112.503 178.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.456 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 65.7 m-85 -85.27 109.36 18.3 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.517 -0.919 . . . . 74.140000000000001 108.517 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 17.5 p -88.18 -14.7 37.97 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 113.674 0.99 . . . . 75.430000000000007 113.674 -173.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -117.64 122.5 43.75 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 120.952 0.406 . . . . 73.310000000000002 111.497 -175.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 551' ' ' ILE . 46.3 p90 -129.88 153.47 48.27 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 116.002 -0.545 . . . . 75.329999999999998 111.366 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 521' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 58.5 m -139.9 152.26 46.26 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.193 -1.41 . . . . 74.019999999999996 107.193 174.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.39 135.91 54.37 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-O 121.163 0.506 . . . . 70.140000000000001 111.068 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -131.55 130.79 42.73 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.28 -1.007 . . . . 75.230000000000004 108.28 176.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 524' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 19.8 m -96.03 132.55 41.27 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 110.129 -0.323 . . . . 64.519999999999996 110.129 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 34.0 m -121.54 149.57 24.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 108.154 -1.054 . . . . 74.140000000000001 108.154 178.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -74.6 135.47 42.04 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 121.029 -0.269 . . . . 74.209999999999994 111.432 -173.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 527' ' ' SER . . . . . 0.467 ' HB2' ' OG ' ' A' ' 556' ' ' SER . 70.3 m -159.43 174.65 3.81 Favored Pre-proline 0 C--N 1.314 -0.968 0 C-N-CA 123.771 0.828 . . . . 75.010000000000005 108.789 178.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -89.44 -3.05 5.93 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.969 1.779 . . . . 71.209999999999994 111.147 174.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . 0.497 ' HB2' ' OG ' ' A' ' 556' ' ' SER . 23.8 mmt85 -79.93 133.31 58.43 Favored Pre-proline 0 N--CA 1.444 -0.753 0 N-CA-C 107.741 -1.207 . . . . 72.319999999999993 107.741 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -56.14 144.44 80.47 Favored 'Trans proline' 0 C--O 1.254 1.314 0 C-N-CA 123.065 2.51 . . . . 72.140000000000001 113.4 -175.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -57.8 113.66 1.95 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.69 -1.141 . . . . 75.030000000000001 110.69 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 138.71 -26.79 2.74 Favored Glycine 0 C--N 1.306 -1.126 0 CA-C-N 115.785 -0.643 . . . . 61.009999999999998 111.536 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -76.49 127.86 33.65 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.166 -0.679 . . . . 73.439999999999998 109.166 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 83.6 t -79.6 117.76 25.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.041 -1.096 . . . . 74.019999999999996 108.041 176.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 13.7 t -91.92 -1.86 57.08 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.678 -0.692 . . . . 54.109999999999999 110.757 -176.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 149.95 -166.07 29.84 Favored Glycine 0 CA--C 1.489 -1.557 0 C-N-CA 120.685 -0.769 . . . . 75.319999999999993 111.874 177.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 13.3 p -119.0 158.7 25.25 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 109.391 -0.596 . . . . 74.540000000000006 109.391 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . 0.457 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 27.3 t-20 -65.89 -52.36 41.79 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-O 119.083 -0.484 . . . . 72.530000000000001 111.097 177.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 4.8 Cg_exo -78.96 142.6 17.52 Favored 'Trans proline' 0 C--N 1.368 1.591 0 N-CA-C 108.2 -1.5 . . . . 73.109999999999999 108.2 171.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.79 144.65 99.41 Favored 'Trans proline' 0 C--O 1.253 1.229 0 C-N-CA 122.297 1.998 . . . . 71.420000000000002 113.107 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -64.33 137.37 57.87 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 115.896 -0.593 . . . . 74.140000000000001 109.819 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 102.44 -12.44 56.86 Favored Glycine 0 C--N 1.298 -1.578 0 C-N-CA 121.018 -0.61 . . . . 71.430000000000007 111.919 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 23.9 m -75.33 130.97 39.93 Favored 'General case' 0 C--O 1.245 0.843 0 N-CA-C 109.752 -0.462 . . . . 75.340000000000003 109.752 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 14.6 m -84.4 122.9 29.6 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 107.291 -1.374 . . . . 74.040000000000006 107.291 176.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.5 m -131.51 157.32 78.49 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.907 -0.405 . . . . 75.299999999999997 109.907 -177.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -64.86 140.47 67.01 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.4 2.066 . . . . 74.430000000000007 111.607 176.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.456 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 27.0 m -63.98 -20.14 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-O 121.761 0.791 . . . . 70.150000000000006 111.834 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -87.06 -11.2 50.99 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.058 -0.973 . . . . 54.229999999999997 111.873 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 80.5 p -82.09 175.98 9.89 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 120.017 -0.673 . . . . 71.129999999999995 112.343 -176.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 27.0 t -101.72 119.17 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 116.012 -0.54 . . . . 75.349999999999994 110.737 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 520' ' ' PHE . 1.8 mp -101.17 124.6 54.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 108.842 -0.799 . . . . 74.420000000000002 108.842 177.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 521' ' ' SER . 35.0 tt0 -102.86 128.84 49.47 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-O 121.211 0.529 . . . . 73.349999999999994 110.236 -178.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -93.37 133.98 36.07 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.329 -0.989 . . . . 74.129999999999995 108.329 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.85 114.25 25.96 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.944 -1.502 . . . . 75.310000000000002 106.944 176.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 524' ' ' SER . 40.5 t -99.79 141.3 17.21 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 108.391 -0.966 . . . . 72.200000000000003 108.391 -177.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.626 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 36.0 t -78.84 129.71 34.88 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 121.214 0.53 . . . . 74.510000000000005 111.27 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 12.2 ttpp -93.65 121.51 35.15 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 106.747 -1.575 . . . . 74.430000000000007 106.747 169.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -81.39 -24.24 57.12 Favored Glycine 0 CA--C 1.494 -1.269 0 C-N-CA 120.48 -0.867 . . . . 53.43 112.099 -177.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 4.8 p30 58.62 6.96 0.66 Allowed 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 127.257 2.223 . . . . 71.519999999999996 114.26 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -134.21 170.91 14.99 Favored 'General case' 0 C--O 1.253 1.244 0 CA-C-O 121.688 0.756 . . . . 73.209999999999994 112.286 -173.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -145.99 148.33 32.62 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.88 -1.526 . . . . 73.239999999999995 106.88 173.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 9.4 p -71.18 127.75 33.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-O 121.176 0.512 . . . . 73.010000000000005 110.229 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 58.7 ttp -96.26 115.29 65.52 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 109.272 -0.64 . . . . 75.310000000000002 109.272 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.98 154.9 72.1 Favored 'Trans proline' 0 C--O 1.242 0.684 0 C-N-CA 122.08 1.853 . . . . 64.129999999999995 110.367 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . 0.419 ' HA ' ' HB2' ' A' ' 610' ' ' ALA . 4.2 p-10 -76.03 118.1 18.44 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 121.822 0.82 . . . . 74.209999999999994 111.236 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 96.2 mt -137.52 34.09 2.49 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.009 -1.45 . . . . 65.239999999999995 107.184 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 14.8 m -71.25 132.72 45.35 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.008 -0.996 . . . . 64.239999999999995 111.342 -175.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 99.86 38.8 3.53 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 121.114 -0.565 . . . . 65.530000000000001 113.312 174.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 83.6 mtp -109.69 155.26 21.75 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.435 -0.58 . . . . 74.120000000000005 109.435 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -74.96 149.73 39.27 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 107.286 -1.375 . . . . 74.540000000000006 107.286 175.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . 0.506 ' O ' ' HG3' ' A' ' 575' ' ' GLU . 41.0 t90 -60.47 -29.81 69.28 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 123.274 0.359 . . . . 64.420000000000002 110.855 -177.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 33.2 m -80.16 -10.42 12.49 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.612 0 CA-C-O 121.568 0.699 . . . . 65.019999999999996 110.894 -176.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -101.78 -31.84 10.56 Favored 'General case' 0 C--O 1.266 1.927 0 CA-C-O 122.885 1.326 . . . . 72.109999999999999 107.88 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . 0.441 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -68.77 -36.72 78.68 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 113.885 -1.507 . . . . 73.299999999999997 110.392 176.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 571' ' ' TRP . 43.4 mt-10 -51.75 -57.79 13.42 Favored Pre-proline 0 CA--C 1.559 1.3 0 CA-C-O 118.87 -0.586 . . . . 74.510000000000005 111.66 177.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . 0.485 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 64.3 Cg_exo -56.63 -39.5 90.93 Favored 'Trans proline' 0 C--N 1.387 2.598 0 C-N-CA 121.768 1.645 . . . . 74.120000000000005 112.542 175.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -59.03 -43.59 91.64 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 119.782 -0.767 . . . . 75.140000000000001 112.269 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 96.2 mt -65.97 -47.22 75.33 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.521 0.677 . . . . 73.530000000000001 110.307 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -65.03 -34.98 79.72 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.412 -0.813 . . . . 75.510000000000005 111.643 -177.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.65 -33.38 70.91 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.367 0.506 . . . . 72.040000000000006 112.367 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 4.0 pp -88.4 -3.61 58.8 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.474 0.916 . . . . 72.430000000000007 113.474 -176.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 86.12 37.77 8.93 Favored Glycine 0 C--N 1.314 -0.648 0 C-N-CA 120.183 -1.008 . . . . 73.439999999999998 112.001 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 82.3 t90 -71.87 127.94 34.17 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 123.19 0.596 . . . . 74.010000000000005 110.808 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 23.0 m -138.3 67.9 1.4 Allowed 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 122.183 0.992 . . . . 70.120000000000005 109.404 174.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -124.44 -149.88 7.75 Favored Glycine 0 N--CA 1.436 -1.313 0 N-CA-C 110.07 -1.212 . . . . 73.340000000000003 110.07 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 586' ' ' MET . . . . . 0.477 ' O ' HG12 ' A' ' 619' ' ' ILE . 8.6 mmt -122.79 139.03 54.44 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.6 -0.519 . . . . 74.409999999999997 109.6 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -101.16 127.55 47.67 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 106.524 -1.658 . . . . 75.239999999999995 106.524 174.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -97.25 99.85 11.31 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 120.19 -0.604 . . . . 72.010000000000005 110.822 -175.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -114.42 109.19 17.92 Favored 'General case' 0 N--CA 1.409 -2.51 0 N-CA-C 108.154 -1.054 . . . . 73.120000000000005 108.154 170.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -143.97 -62.36 0.02 OUTLIER Glycine 0 CA--C 1.477 -2.319 0 N-CA-C 108.849 -1.7 . . . . 62.200000000000003 108.849 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . 0.418 ' O ' ' HD2' ' A' ' 623' ' ' ARG . . . -89.86 136.54 32.98 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.541 -0.911 . . . . 72.209999999999994 108.541 173.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -116.72 157.08 26.05 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.608 -0.516 . . . . 75.439999999999998 109.608 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . 0.406 ' O ' ' HA2' ' A' ' 625' ' ' GLY . 38.5 t -107.15 132.01 55.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 120.336 -0.546 . . . . 71.439999999999998 110.232 -177.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . 0.611 ' HA ' ' OE1' ' A' ' 626' ' ' GLN . 5.8 p-10 -73.76 112.4 9.83 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.102 0.477 . . . . 74.239999999999995 112.255 -178.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -176.6 19.97 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 114.56 -1.2 . . . . 74.040000000000006 110.647 175.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 83.74 127.6 1.39 Allowed Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 110.326 -1.11 . . . . 61.329999999999998 110.326 -174.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' A' ' 601' ' ' ASN . . . -62.12 -49.55 73.84 Favored Glycine 0 C--O 1.2 -2.0 0 C-N-CA 120.478 -0.868 . . . . 74.299999999999997 112.478 -176.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 47.0 m -71.56 -24.13 61.87 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.315 0.578 . . . . 53.149999999999999 111.689 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -89.64 -7.69 54.14 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.925 -0.58 . . . . 75.239999999999995 112.169 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -145.45 28.61 1.18 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.836 0.827 . . . . 74.540000000000006 109.547 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . 0.547 ' HB2' ' O ' ' A' ' 597' ' ' GLY . 8.5 t30 -86.55 62.94 7.71 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 122.425 1.107 . . . . 64.409999999999997 108.575 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 37.1 ptt85 -143.0 171.84 13.51 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 107.453 -1.314 . . . . 75.340000000000003 107.453 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 11.7 p -62.84 129.87 26.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 107.388 -1.338 . . . . 70.230000000000004 107.388 174.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 87.2 t -95.98 -36.4 6.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 119.833 -0.747 . . . . 73.129999999999995 109.09 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -154.79 158.96 40.26 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 105.892 -1.892 . . . . 71.010000000000005 105.892 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -128.86 124.93 36.54 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.047 -0.723 . . . . 73.030000000000001 109.047 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.443 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 21.9 t-20 -59.36 -50.66 86.26 Favored Pre-proline 0 CA--C 1.559 1.327 0 CA-C-N 115.792 -0.64 . . . . 74.219999999999999 112.453 -177.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 4.3 Cg_exo -90.09 124.89 1.21 Allowed 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 121.908 1.739 . . . . 51.119999999999997 110.764 173.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.79 139.09 66.95 Favored 'Trans proline' 0 C--O 1.252 1.189 0 C-N-CA 122.414 2.076 . . . . 64.310000000000002 111.909 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . 0.419 ' HB2' ' HA ' ' A' ' 565' ' ' ASP . . . -64.09 138.44 58.46 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.594 -0.73 . . . . 54.420000000000002 110.363 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 99.69 -5.86 58.59 Favored Glycine 0 N--CA 1.435 -1.425 0 N-CA-C 111.441 -0.664 . . . . 73.310000000000002 111.441 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 12.1 m -99.96 160.22 14.48 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 108.772 -0.825 . . . . 73.120000000000005 108.772 -178.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -75.08 125.3 8.15 Favored Glycine 0 N--CA 1.423 -2.199 0 N-CA-C 109.883 -1.287 . . . . 55.509999999999998 109.883 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 34.7 m -112.22 142.62 24.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 108.612 -0.884 . . . . 73.299999999999997 108.612 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 30.5 p30 -43.68 152.79 0.14 Allowed 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.745 1.017 . . . . 73.299999999999997 113.745 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -56.8 -25.72 56.35 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.345 1.058 . . . . 73.310000000000002 112.604 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -63.84 -42.9 97.5 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 108.401 -0.963 . . . . 73.129999999999995 108.401 176.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . 0.412 ' O ' HG12 ' A' ' 620' ' ' ILE . . . 81.97 19.25 65.64 Favored Glycine 0 N--CA 1.42 -2.386 0 N-CA-C 109.324 -1.51 . . . . 62.100000000000001 109.324 -177.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 586' ' ' MET . 0.0 OUTLIER -70.71 117.76 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-O 122.274 1.035 . . . . 73.340000000000003 108.594 -175.407 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 618' ' ' GLY . 47.7 mm -115.32 130.31 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.195 0 N-CA-C 105.941 -1.874 . . . . 75.420000000000002 105.941 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.409 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 27.7 m -96.87 114.64 26.29 Favored 'General case' 0 N--CA 1.401 -2.918 0 C-N-CA 117.175 -1.81 . . . . 75.549999999999997 106.977 175.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 4.4 pp -140.9 150.3 43.01 Favored 'General case' 0 N--CA 1.406 -2.627 0 N-CA-C 105.753 -1.943 . . . . 74.310000000000002 105.753 176.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . 0.418 ' HD2' ' O ' ' A' ' 591' ' ' ALA . 28.5 mtm180 -133.81 156.71 47.53 Favored 'General case' 0 C--N 1.269 -2.893 0 N-CA-C 108.502 -0.925 . . . . 75.340000000000003 108.502 175.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -133.18 166.87 21.44 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 124.444 1.09 . . . . 74.219999999999999 111.405 -173.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 593' ' ' VAL . . . -66.18 139.41 37.97 Favored Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 115.214 0.846 . . . . 54.100000000000001 115.214 -176.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . 0.611 ' OE1' ' HA ' ' A' ' 594' ' ' ASP . 1.3 mp0 . . . . . 0 N--CA 1.473 0.689 0 N-CA-C 116.118 1.896 . . . . 74.200000000000003 116.118 176.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 . . . . . 0 CA--C 1.491 -1.321 0 N-CA-C 106.972 -1.492 . . . . 64.319999999999993 106.972 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 409' ' ' SER . 24.0 m -121.54 163.56 19.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.354 0 N-CA-C 109.654 -0.499 . . . . 63.340000000000003 109.654 -177.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.37 129.81 39.37 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.365 -1.346 . . . . 72.340000000000003 107.365 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 55.6 t -97.16 129.85 31.18 Favored Pre-proline 0 C--N 1.282 -2.366 0 CA-C-N 115.427 -0.806 . . . . 72.129999999999995 109.494 -171.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -68.86 128.59 17.1 Favored 'Trans proline' 0 C--O 1.241 0.629 0 C-N-CA 122.124 1.883 . . . . 73.420000000000002 111.925 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -89.21 144.67 25.94 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-O 121.633 0.73 . . . . 73.129999999999995 109.291 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.05 21.69 3.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 CA-C-N 114.817 -1.083 . . . . 72.549999999999997 112.036 -174.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -56.01 144.37 28.98 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.021 -0.99 . . . . 74.310000000000002 112.529 175.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.5 -0.08 46.46 Favored Glycine 0 C--N 1.311 -0.843 0 CA-C-N 115.71 -0.677 . . . . 44.020000000000003 112.486 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -111.34 -150.77 0.47 Allowed 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.11 -1.07 . . . . 73.109999999999999 108.11 176.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 80.0 p -97.77 161.53 13.71 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.36 -1.348 . . . . 75.519999999999996 107.36 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 42.3 m -63.32 -37.6 87.87 Favored 'General case' 0 C--O 1.21 -1.022 0 C-N-CA 120.838 -0.345 . . . . 74.109999999999999 110.305 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.06 -46.14 85.69 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 111.831 0.308 . . . . 73.140000000000001 111.831 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -68.92 -41.66 77.85 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 121.618 0.723 . . . . 74.310000000000002 109.24 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.81 -50.88 69.25 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.983 -1.008 . . . . 72.049999999999997 111.197 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 78.7 mt -64.74 -40.11 87.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.904 -0.589 . . . . 71.439999999999998 110.68 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.79 -38.07 77.73 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.139 0.495 . . . . 73.230000000000004 111.054 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 27.3 m -65.64 -47.09 76.77 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.074 -0.512 . . . . 73.409999999999997 110.334 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.85 -37.57 87.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.294 -0.412 . . . . 74.319999999999993 111.873 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.59 -37.91 88.09 Favored 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 122.296 0.239 . . . . 74.049999999999997 110.367 176.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -68.45 -21.22 64.65 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 121.19 0.519 . . . . 73.450000000000003 111.171 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -86.96 -14.13 42.63 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.982 -0.554 . . . . 74.099999999999994 110.224 174.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 95.63 9.48 57.56 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.567 -0.825 . . . . 64.209999999999994 112.474 176.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -82.55 155.48 24.48 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-O 121.13 0.49 . . . . 74.129999999999995 111.655 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -100.77 132.52 46.13 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 106.65 -1.611 . . . . 73.420000000000002 106.65 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 1.8 mp -119.11 146.38 23.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 107.665 -1.235 . . . . 74.230000000000004 107.665 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 46.2 ttt180 -111.75 127.96 55.95 Favored 'General case' 0 C--N 1.259 -3.361 0 N-CA-C 106.542 -1.651 . . . . 75.040000000000006 106.542 177.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 27.4 m -113.72 117.87 32.74 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 106.998 -1.482 . . . . 74.0 106.998 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.17 119.99 40.27 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.406 -0.961 . . . . 73.209999999999994 108.406 -177.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -94.1 122.51 36.69 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.219 -0.66 . . . . 74.200000000000003 109.219 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . 0.4 ' HA ' ' HE2' ' A' ' 389' ' ' LYS . 4.5 mmpt? -125.51 119.44 24.65 Favored Pre-proline 0 C--N 1.3 -1.55 0 C-N-CA 121.141 -0.223 . . . . 74.329999999999998 111.058 176.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . 0.585 ' HA ' ' O ' ' A' ' 422' ' ' THR . 38.0 Cg_exo -69.23 128.32 16.34 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.93 1.753 . . . . 72.530000000000001 108.993 171.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.567 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 7.0 t70 143.04 -171.42 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 104.923 -2.251 . . . . 75.040000000000006 104.923 -175.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 23.3 t -131.31 2.91 4.25 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.338 -0.616 . . . . 64.319999999999993 109.338 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 14.7 t -77.47 -5.6 50.48 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 122.918 0.487 . . . . 74.439999999999998 112.004 -178.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.8 151.96 45.93 Favored Pre-proline 0 C--N 1.303 -1.427 0 CA-C-O 118.998 -0.525 . . . . 74.340000000000003 109.69 -177.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -44.05 138.49 6.54 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 124.025 3.15 . . . . 74.140000000000001 114.105 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.5 161.71 16.73 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.417 2.745 . . . . 75.25 112.788 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -57.15 -8.3 0.67 Allowed 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 113.434 0.901 . . . . 71.519999999999996 113.434 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -111.56 130.2 55.82 Favored 'General case' 0 CA--C 1.478 -1.821 0 N-CA-C 106.581 -1.637 . . . . 73.400000000000006 106.581 171.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 20.1 m -66.37 119.32 11.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 O-C-N 123.787 0.679 . . . . 71.530000000000001 111.293 -169.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 8.7 tp -94.51 -29.33 4.16 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 108.508 -0.923 . . . . 71.329999999999998 108.508 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.84 170.6 27.77 Favored Glycine 0 N--CA 1.411 -3.025 0 N-CA-C 110.312 -1.115 . . . . 71.209999999999994 110.312 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 3.3 p -121.64 -179.28 4.05 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 107.712 -1.218 . . . . 75.140000000000001 107.712 176.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -101.4 134.58 20.19 Favored Pre-proline 0 C--N 1.293 -1.87 0 N-CA-C 107.703 -1.221 . . . . 70.099999999999994 107.703 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -51.59 -13.36 1.43 Allowed 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 124.33 3.353 . . . . 72.530000000000001 115.493 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.49 -39.4 70.39 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-O 120.703 0.287 . . . . 71.239999999999995 110.285 176.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -71.17 -33.54 70.11 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.859 0.838 . . . . 74.120000000000005 110.227 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -86.15 3.97 40.45 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.927 -1.033 . . . . 72.219999999999999 111.162 -177.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 27.1 m -109.7 154.36 22.99 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 105.514 -2.032 . . . . 74.409999999999997 105.514 171.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 360' ' ' VAL . 50.5 m -74.88 112.42 11.08 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 119.737 -0.785 . . . . 60.109999999999999 109.433 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 21.7 m -124.81 164.88 22.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 116.332 -0.394 . . . . 71.430000000000007 109.972 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 15.4 m -72.41 146.25 47.1 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.958 -0.386 . . . . 75.140000000000001 109.958 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -65.58 131.82 47.32 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.997 -0.371 . . . . 74.010000000000005 109.997 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 89.57 38.89 6.44 Favored Glycine 0 C--N 1.311 -0.836 0 C-N-CA 120.752 -0.737 . . . . 33.549999999999997 111.955 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -100.51 -175.99 3.07 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.328 -1.36 . . . . 75.310000000000002 107.328 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -108.83 123.25 48.76 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.137 0.494 . . . . 72.109999999999999 110.741 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 48.4 mm -112.18 137.4 45.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 106.538 -1.652 . . . . 73.329999999999998 106.538 175.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.4 t -116.76 132.0 56.81 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.842 -0.536 . . . . 73.349999999999994 110.892 -174.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 9.9 p -116.28 134.6 59.17 Favored 'Isoleucine or valine' 0 C--O 1.253 1.249 0 N-CA-C 109.567 -0.531 . . . . 73.239999999999995 109.567 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -102.42 116.07 31.86 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.997 -0.742 . . . . 71.140000000000001 108.997 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 77.0 t -104.93 130.88 55.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 116.116 -0.493 . . . . 71.319999999999993 110.775 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 30.6 t -85.92 123.85 31.72 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 115.593 -0.731 . . . . 74.409999999999997 110.241 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' THR . . . . . 0.585 ' O ' ' HA ' ' A' ' 390' ' ' PRO . 12.2 p -116.39 138.92 50.96 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 106.216 -1.772 . . . . 75.140000000000001 106.216 171.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.484 0 N-CA-C 116.598 1.399 . . . . 71.219999999999999 116.598 -172.12 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 . . . . . 0 N--CA 1.428 -1.573 0 N-CA-C 106.308 -1.738 . . . . 75.329999999999998 106.308 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -120.79 165.32 15.3 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 109.469 -0.567 . . . . 72.450000000000003 109.469 -178.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -115.25 142.1 47.13 Favored 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 108.229 -1.026 . . . . 74.430000000000007 108.229 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.467 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 74.0 mt -77.17 121.02 83.95 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 108.95 -0.759 . . . . 65.040000000000006 108.95 -175.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -68.16 160.25 49.61 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 123.499 2.799 . . . . 73.219999999999999 114.411 -177.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -77.79 155.42 31.14 Favored 'General case' 0 C--O 1.249 1.077 0 CA-C-N 115.522 -0.763 . . . . 51.329999999999998 109.765 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 13.6 p -164.43 144.41 2.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 116.267 -0.424 . . . . 74.120000000000005 110.255 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 24.3 t -77.03 150.62 35.78 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 108.651 -0.87 . . . . 63.340000000000003 108.651 178.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' THR . . . . . 0.479 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 25.1 p -67.09 -23.41 65.84 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 121.578 0.704 . . . . 73.209999999999994 111.807 -176.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 2.5 pp -86.69 -11.26 51.75 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 113.046 0.758 . . . . 75.120000000000005 113.046 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -113.9 69.53 0.71 Allowed 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 114.049 1.129 . . . . 73.230000000000004 114.049 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -61.91 -37.55 85.05 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.211 -0.45 . . . . 75.349999999999994 110.261 175.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -58.83 -37.22 75.95 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 120.707 0.289 . . . . 73.540000000000006 111.025 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -66.68 -36.78 83.35 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.712 -0.847 . . . . 72.200000000000003 108.712 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.408 ' O ' HD12 ' A' ' 444' ' ' LEU . . . -63.55 -43.61 96.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.873 -0.603 . . . . 75.010000000000005 109.672 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 86.6 t -58.73 -50.43 79.27 Favored 'Isoleucine or valine' 0 C--O 1.244 0.773 0 CA-C-N 115.532 -0.758 . . . . 64.340000000000003 110.764 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . 0.342 0.0 OUTLIER -68.63 -34.08 75.12 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 113.945 1.091 . . . . 72.209999999999994 113.945 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -62.91 -47.5 83.02 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.778 0.323 . . . . 74.400000000000006 110.898 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.408 HD12 ' O ' ' A' ' 440' ' ' ALA . 9.1 mp -65.5 -32.84 74.66 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.156 -0.475 . . . . 74.5 111.846 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 70.8 m -69.25 -46.77 66.5 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.913 0.387 . . . . 72.109999999999999 110.505 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.14 -15.49 62.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.146 0.498 . . . . 74.099999999999994 111.244 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.63 -1.4 37.92 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 116.007 -0.542 . . . . 73.319999999999993 111.2 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 114.58 -83.95 0.35 Allowed Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.807 -0.711 . . . . 51.520000000000003 111.584 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -40.68 -62.43 0.79 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 114.596 1.332 . . . . 75.25 114.596 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 67.61 29.46 73.96 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.941 -0.647 . . . . 50.109999999999999 112.356 -177.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 31.7 mmm180 -105.54 111.44 24.15 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-O 121.507 0.67 . . . . 75.030000000000001 109.263 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -130.99 159.97 35.92 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 108.254 -1.017 . . . . 73.5 108.254 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -152.16 135.94 16.28 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 108.128 -1.064 . . . . 73.329999999999998 108.128 177.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -103.22 128.06 50.34 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.1 0.476 . . . . 65.510000000000005 109.964 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.37 149.08 42.9 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 107.364 -1.347 . . . . 70.340000000000003 107.364 174.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -125.53 138.8 53.98 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.142 0.496 . . . . 74.109999999999999 109.942 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 457' ' ' SER . . . . . 0.403 ' HB2' HD12 ' A' ' 487' ' ' ILE . 48.5 t -128.37 142.38 44.5 Favored Pre-proline 0 C--N 1.291 -1.943 0 N-CA-C 108.019 -1.104 . . . . 74.409999999999997 108.019 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.623 ' HA ' ' O ' ' A' ' 490' ' ' SER . 58.1 Cg_endo -76.27 122.56 6.67 Favored 'Trans proline' 0 N--CA 1.428 -2.361 0 C-N-CA 121.204 1.27 . . . . 74.450000000000003 109.691 176.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 48.8 m -144.69 179.21 7.44 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 108.887 -0.783 . . . . 73.109999999999999 108.887 -177.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 9.7 t -49.93 134.34 21.51 Favored Pre-proline 0 C--O 1.255 1.386 0 O-C-N 123.982 0.802 . . . . 73.540000000000006 111.902 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . 0.408 ' HA ' ' CG2' ' A' ' 464' ' ' VAL . 6.2 Cg_endo -50.93 -29.93 28.8 Favored 'Trans proline' 0 C--N 1.361 1.193 0 C-N-CA 124.187 3.258 . . . . 73.340000000000003 113.935 -175.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -66.44 -21.38 66.2 Favored 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 113.217 0.821 . . . . 42.039999999999999 113.217 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -100.24 -7.23 24.89 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 122.005 -0.435 . . . . 73.129999999999995 111.566 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.408 ' CG2' ' HA ' ' A' ' 461' ' ' PRO . 82.4 t -60.84 131.37 25.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 116.165 -0.471 . . . . 74.120000000000005 111.757 -178.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 96.26 -10.64 67.47 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.779 -0.646 . . . . 63.450000000000003 112.145 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -118.73 166.16 13.11 Favored 'General case' 0 N--CA 1.416 -2.149 0 N-CA-C 109.075 -0.713 . . . . 74.219999999999999 109.075 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.479 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 68.9 t -77.8 145.31 10.11 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 108.635 -0.876 . . . . 72.239999999999995 108.635 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 51.5 mt -97.74 -25.77 4.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 107.202 -1.407 . . . . 63.310000000000002 107.202 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 154.42 -167.73 32.51 Favored Glycine 0 N--CA 1.419 -2.444 0 CA-C-N 114.868 -1.06 . . . . 75.340000000000003 111.304 175.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.22 137.17 52.32 Favored 'General case' 0 N--CA 1.405 -2.688 0 N-CA-C 105.482 -2.044 . . . . 72.329999999999998 105.482 176.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -66.14 -53.31 33.52 Favored Pre-proline 0 C--N 1.323 -0.584 0 C-N-CA 119.388 -0.925 . . . . 72.329999999999998 110.772 -177.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -68.98 124.72 11.7 Favored 'Trans proline' 0 C--N 1.364 1.394 0 N-CA-C 107.24 -1.869 . . . . 64.129999999999995 107.24 167.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . 0.542 ' C ' ' H ' ' A' ' 475' ' ' ASN . 19.8 Cg_exo -62.34 145.47 95.89 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.928 1.752 . . . . 75.239999999999995 113.271 -174.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.467 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -69.05 11.31 0.21 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.237 1.015 . . . . 72.430000000000007 111.28 175.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . 0.542 ' H ' ' C ' ' A' ' 473' ' ' PRO . 12.9 m120 -108.62 -10.87 15.17 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 124.204 1.002 . . . . 63.340000000000003 108.623 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -98.49 171.12 8.36 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 121.485 0.659 . . . . 73.340000000000003 111.36 -176.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.02 129.71 51.65 Favored 'General case' 0 N--CA 1.402 -2.846 0 CA-C-N 114.664 -1.153 . . . . 74.430000000000007 111.721 -176.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 6.2 p -108.27 148.17 30.39 Favored 'General case' 0 N--CA 1.418 -2.059 0 C-N-CA 123.903 0.881 . . . . 54.340000000000003 110.038 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -89.28 175.25 7.42 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 116.369 -0.378 . . . . 72.400000000000006 110.148 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 32.9 mm -81.15 -6.67 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-O 122.197 0.999 . . . . 73.530000000000001 109.871 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 40.1 m -112.76 5.04 17.39 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 122.238 1.018 . . . . 72.219999999999999 109.061 175.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -80.69 134.49 35.86 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.597 -0.729 . . . . 72.25 111.514 -173.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.92 126.03 53.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 116.039 -0.528 . . . . 75.150000000000006 110.362 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 65.2 t -100.66 120.61 50.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 121.014 0.435 . . . . 75.239999999999995 110.093 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.62 118.96 44.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-O 121.828 0.823 . . . . 74.310000000000002 110.022 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 42.7 mt -111.3 128.64 67.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 114.534 -1.212 . . . . 75.219999999999999 109.976 -178.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.403 HD12 ' HB2' ' A' ' 457' ' ' SER . 17.3 tt -110.84 127.08 68.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.839 -0.619 . . . . 74.25 111.96 -173.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 35.5 m -108.32 152.35 10.21 Favored 'Isoleucine or valine' 0 C--O 1.248 1.023 0 C-N-CA 123.806 0.842 . . . . 75.310000000000002 111.156 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -88.1 133.5 11.85 Favored Glycine 0 N--CA 1.434 -1.44 0 CA-C-N 115.831 -0.622 . . . . 44.329999999999998 112.223 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.623 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 44.4 m . . . . . 0 C--N 1.303 -1.454 0 N-CA-C 107.344 -1.354 . . . . 73.329999999999998 107.344 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo . . . . . 0 N--CA 1.444 -1.41 0 CA-C-O 121.981 0.742 . . . . 75.019999999999996 113.735 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -104.02 41.5 1.29 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.447 -1.316 . . . . 75.439999999999998 107.447 176.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 494' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 546' ' ' PRO . 72.7 p -117.24 153.77 32.33 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 114.34 -1.3 . . . . 75.420000000000002 108.945 -176.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . 0.426 ' HD3' ' H ' ' A' ' 496' ' ' ASP . 6.0 tmtt? -150.16 151.65 33.44 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 107.47 -1.307 . . . . 75.409999999999997 107.47 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.426 ' H ' ' HD3' ' A' ' 495' ' ' LYS . 9.8 p-10 -79.83 138.08 37.12 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 123.587 0.755 . . . . 62.43 109.489 177.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 36.4 pt -86.39 137.41 34.56 Favored Pre-proline 0 C--N 1.303 -1.418 0 CA-C-N 116.182 -0.463 . . . . 72.209999999999994 110.792 178.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -89.15 179.9 2.23 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.656 2.237 . . . . 75.510000000000005 112.339 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -84.38 142.05 30.43 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.832 -1.173 . . . . 73.140000000000001 107.832 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 10.6 p -139.32 19.23 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 CA-C-O 122.179 0.99 . . . . 74.540000000000006 110.052 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -72.41 114.52 10.62 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.199 -0.91 . . . . 52.439999999999998 110.893 -177.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 115.3 -8.12 20.67 Favored Glycine 0 CA--C 1.482 -1.973 0 N-CA-C 111.311 -0.716 . . . . 70.439999999999998 111.311 176.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -100.47 165.75 11.28 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 108.199 -1.037 . . . . 72.140000000000001 108.199 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 5.6 t -91.73 164.73 13.61 Favored 'General case' 0 C--N 1.285 -2.239 0 C-N-CA 120.217 -0.593 . . . . 65.099999999999994 109.889 -175.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 48.4 t -54.27 -41.26 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.606 0.762 . . . . 63.32 110.976 -177.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -57.68 -42.6 83.94 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 115.506 -0.77 . . . . 74.540000000000006 111.12 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 63.8 t -75.35 -42.54 43.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 116.028 -0.533 . . . . 73.310000000000002 109.738 -178.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -61.26 -49.69 76.05 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.71 -0.677 . . . . 72.219999999999999 111.853 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.472 ' O ' ' HB2' ' A' ' 513' ' ' ASN . 10.2 tt0 -65.35 -37.03 85.82 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.374 0.607 . . . . 74.329999999999998 110.04 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.48 ' O ' HG21 ' A' ' 514' ' ' VAL . 37.6 ttmt -65.93 -48.79 70.2 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.82 -1.082 . . . . 70.340000000000003 111.696 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -62.03 -48.58 79.66 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 121.149 0.5 . . . . 73.239999999999995 110.924 -177.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . 0.435 ' HB3' ' HB2' ' A' ' 517' ' ' PHE . 4.2 mm? -64.9 -36.54 84.7 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.578 -0.737 . . . . 74.150000000000006 110.885 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 509' ' ' GLN . 0.6 OUTLIER -60.92 -39.86 90.97 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 122.564 0.346 . . . . 75.450000000000003 110.553 178.378 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.48 HG21 ' O ' ' A' ' 510' ' ' LYS . 78.4 t -59.37 -36.65 65.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.645 -0.707 . . . . 73.5 110.758 178.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -79.58 -21.55 44.89 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.105 0.479 . . . . 73.239999999999995 110.639 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 127.5 -2.78 7.1 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 120.524 -0.846 . . . . 63.420000000000002 113.902 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.586 ' HA ' ' O ' ' A' ' 547' ' ' VAL . 95.1 m-85 -82.8 117.25 22.56 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.738 -1.208 . . . . 72.340000000000003 107.738 -176.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.6 m -118.8 -4.24 10.72 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 118.823 -1.151 . . . . 75.349999999999994 112.375 -174.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . 0.407 ' O ' HD12 ' A' ' 551' ' ' ILE . 64.3 mttp -112.26 115.21 28.42 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.637 -0.664 . . . . 73.5 110.82 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -126.25 154.37 43.45 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.256 -0.429 . . . . 73.209999999999994 110.909 -174.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 49.2 m -141.45 141.11 33.7 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.414 -1.328 . . . . 72.140000000000001 107.414 171.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -117.57 138.22 52.07 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-O 121.016 0.436 . . . . 73.0 110.94 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -124.39 116.77 23.11 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.038 -1.097 . . . . 74.530000000000001 108.038 176.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 524' ' ' SER . . . . . 0.561 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 19.7 m -97.82 136.03 38.73 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.601 0.238 . . . . 64.109999999999999 111.326 -176.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 61.5 t -129.47 148.87 33.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 107.031 -1.47 . . . . 75.25 107.031 177.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.38 136.63 37.71 Favored 'General case' 0 C--O 1.248 0.975 0 N-CA-C 108.727 -0.842 . . . . 72.530000000000001 108.727 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 77.6 p -153.33 179.56 1.26 Allowed Pre-proline 0 C--N 1.294 -1.819 0 N-CA-C 107.871 -1.159 . . . . 74.129999999999995 107.871 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -85.09 -0.7 9.19 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 121.69 1.594 . . . . 64.129999999999995 111.367 172.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . 0.427 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 12.7 mtp180 -88.39 139.74 30.14 Favored Pre-proline 0 N--CA 1.432 -1.345 0 N-CA-C 108.096 -1.075 . . . . 72.099999999999994 108.096 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.27 153.95 31.26 Favored 'Trans proline' 0 C--O 1.254 1.309 0 C-N-CA 123.304 2.669 . . . . 71.519999999999996 113.949 -176.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.625 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -74.75 116.29 15.29 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.347 -0.842 . . . . 71.209999999999994 110.527 -176.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 118.88 -7.42 13.15 Favored Glycine 0 CA--C 1.49 -1.481 0 C-N-CA 120.049 -1.072 . . . . 54.020000000000003 111.203 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -83.67 140.46 32.14 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 108.321 -0.992 . . . . 73.540000000000006 108.321 174.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 60.9 t -88.45 118.29 33.68 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 N-CA-C 108.063 -1.088 . . . . 74.310000000000002 108.063 178.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 535' ' ' THR . . . . . 0.477 ' OG1' ' HB3' ' A' ' 556' ' ' SER . 90.5 m -78.19 -24.2 47.26 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.776 -1.102 . . . . 73.430000000000007 109.802 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 153.54 -164.75 31.22 Favored Glycine 0 N--CA 1.424 -2.132 0 N-CA-C 110.435 -1.066 . . . . 44.310000000000002 110.435 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 18.0 p -117.71 159.29 23.22 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 109.327 -0.62 . . . . 62.119999999999997 109.327 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -63.11 -57.49 20.67 Favored Pre-proline 0 C--N 1.315 -0.924 0 O-C-N 123.625 0.578 . . . . 73.430000000000007 110.328 177.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -73.23 133.01 18.73 Favored 'Trans proline' 0 C--N 1.363 1.319 0 N-CA-C 109.136 -1.14 . . . . 73.239999999999995 109.136 171.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.14 156.73 48.48 Favored 'Trans proline' 0 C--O 1.252 1.203 0 C-N-CA 122.492 2.128 . . . . 73.409999999999997 112.354 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -57.31 140.52 49.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.786 -0.643 . . . . 73.540000000000006 110.97 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.26 -16.38 56.94 Favored Glycine 0 N--CA 1.433 -1.528 0 CA-C-N 115.708 -0.678 . . . . 73.329999999999998 111.687 -178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 99.7 m -65.28 123.93 20.86 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.071 0.462 . . . . 74.109999999999999 110.436 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 54.1 m -88.41 123.47 32.99 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 115.466 -0.788 . . . . 74.099999999999994 109.674 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 31.2 m -137.85 154.81 74.86 Favored Pre-proline 0 C--N 1.312 -1.053 0 N-CA-C 108.288 -1.004 . . . . 73.099999999999994 108.288 177.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' A' ' 494' ' ' THR . 52.6 Cg_exo -60.76 142.56 98.09 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.293 1.996 . . . . 74.230000000000004 110.863 173.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 517' ' ' PHE . 27.2 m -62.27 -20.45 24.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.799 0.809 . . . . 74.010000000000005 111.815 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . 0.402 ' O ' ' HD2' ' A' ' 519' ' ' LYS . 26.8 t70 -90.26 -5.59 56.15 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.38 -0.827 . . . . 72.0 111.713 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 72.1 m -83.35 166.01 18.81 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 121.751 -0.593 . . . . 74.209999999999994 111.567 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 21.5 t -92.67 129.54 43.08 Favored 'Isoleucine or valine' 0 C--O 1.254 1.294 0 CA-C-N 115.671 -0.695 . . . . 65.5 110.452 -176.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . 0.407 HD12 ' O ' ' A' ' 519' ' ' LYS . 0.2 OUTLIER -111.55 134.99 52.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.176 0.512 . . . . 75.310000000000002 110.256 174.383 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -102.98 121.11 41.86 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.566 -0.743 . . . . 74.510000000000005 109.885 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.2 mp -104.36 134.08 48.18 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.189 -0.914 . . . . 70.109999999999999 110.355 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -90.83 123.99 34.8 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.646 -0.872 . . . . 72.239999999999995 108.646 174.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 524' ' ' SER . 64.1 t -109.53 129.15 64.85 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 N-CA-C 108.509 -0.923 . . . . 73.319999999999993 108.509 -177.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.625 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 24.4 p -77.07 140.98 40.45 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-O 121.481 0.658 . . . . 75.340000000000003 112.183 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -104.3 131.92 51.11 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 107.057 -1.46 . . . . 75.329999999999998 107.057 168.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -69.5 -30.22 71.22 Favored Glycine 0 CA--C 1.489 -1.546 0 O-C-N 123.805 0.691 . . . . 65.219999999999999 111.515 -177.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 63.2 t30 70.28 9.43 6.99 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.581 1.152 . . . . 74.25 110.423 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 96.3 mt-30 -121.99 145.14 48.41 Favored 'General case' 0 N--CA 1.412 -2.375 0 CA-C-N 114.773 -1.103 . . . . 71.439999999999998 110.482 -178.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -123.27 147.96 46.41 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.371 -0.974 . . . . 74.430000000000007 108.371 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 59.0 t -69.74 121.2 18.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-O 121.08 0.467 . . . . 73.420000000000002 112.163 -173.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 53.7 ttp -97.88 132.01 25.64 Favored Pre-proline 0 C--O 1.25 1.102 0 CA-C-N 115.812 -0.631 . . . . 72.409999999999997 110.944 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -65.52 170.63 10.73 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 123.306 2.671 . . . . 75.329999999999998 111.764 173.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -72.34 132.44 43.99 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.429 0.633 . . . . 74.439999999999998 110.823 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 94.9 mt -120.62 -4.64 9.77 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.157 -0.929 . . . . 72.209999999999994 108.597 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 38.3 t -79.11 149.39 32.08 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.783 -1.099 . . . . 74.0 109.829 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 72.88 39.97 53.39 Favored Glycine 0 C--O 1.221 -0.714 0 C-N-CA 120.894 -0.67 . . . . 73.019999999999996 111.64 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 89.3 mtp -146.06 158.11 43.87 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.337 -1.727 . . . . 75.239999999999995 106.337 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . 0.527 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 96.6 m-85 -84.48 155.95 21.94 Favored 'General case' 0 N--CA 1.424 -1.741 0 C-N-CA 120.019 -0.673 . . . . 72.319999999999993 109.506 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 55.4 t90 -65.91 -22.87 66.53 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.148 0.499 . . . . 73.329999999999998 109.735 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 33.7 m -72.75 -12.06 15.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.803 -0.635 . . . . 72.439999999999998 110.697 177.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . 0.461 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 41.8 m-20 -101.48 -39.72 7.4 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 108.401 -0.963 . . . . 74.150000000000006 108.401 175.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -60.31 -40.72 91.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.436 -0.802 . . . . 72.349999999999994 111.503 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.474 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 1.2 tm-20 -57.32 -59.03 14.06 Favored Pre-proline 0 CA--C 1.578 2.052 0 C-N-CA 123.308 0.643 . . . . 71.140000000000001 110.477 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.33 -29.89 86.68 Favored 'Trans proline' 0 C--N 1.373 1.86 0 CA-C-N 120.912 1.362 . . . . 74.349999999999994 113.159 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 16.3 mmt180 -65.82 -43.32 88.95 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 121.103 -0.239 . . . . 72.540000000000006 110.808 177.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.4 pp -66.1 -38.03 87.23 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.046 0.451 . . . . 74.319999999999993 110.311 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -65.33 -35.29 80.54 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 115.863 -0.608 . . . . 73.319999999999993 110.794 175.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.55 -25.52 64.96 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 122.719 0.407 . . . . 75.120000000000005 110.928 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 89.9 mt -92.29 -8.17 45.94 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.85 -0.614 . . . . 74.450000000000003 110.503 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 65.4 41.95 96.21 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 110.71 -0.956 . . . . 45.030000000000001 110.71 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 74.2 t90 -77.51 136.63 38.34 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.296 0.57 . . . . 74.400000000000006 112.083 -175.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 81.7 m -151.79 99.53 2.59 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.526 -0.916 . . . . 74.219999999999999 108.526 173.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -140.26 -119.52 1.63 Allowed Glycine 0 N--CA 1.433 -1.507 0 N-CA-C 109.939 -1.264 . . . . 73.099999999999994 109.939 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 586' ' ' MET . . . . . 0.422 ' HE2' ' HA ' ' A' ' 586' ' ' MET . 0.4 OUTLIER -130.62 124.52 31.9 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.054 -0.721 . . . . 75.219999999999999 109.054 176.64 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -108.13 128.86 55.07 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 105.97 -1.863 . . . . 73.129999999999995 105.97 177.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -104.27 115.41 30.34 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.54 -0.911 . . . . 70.329999999999998 108.54 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -87.76 125.2 34.29 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 116.168 -0.469 . . . . 73.439999999999998 110.114 -176.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -103.9 173.9 22.04 Favored Glycine 0 N--CA 1.426 -2.008 0 N-CA-C 110.186 -1.166 . . . . 72.109999999999999 110.186 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -87.38 154.78 20.4 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.804 -0.443 . . . . 64.019999999999996 109.804 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 625' ' ' GLY . 4.3 p-10 -69.59 124.8 24.88 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.261 0.553 . . . . 73.430000000000007 109.557 178.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 95.3 t -129.04 115.73 37.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.812 -0.81 . . . . 54.439999999999998 108.812 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -84.48 118.82 24.54 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.349 -0.982 . . . . 73.219999999999999 108.349 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . 0.404 ' HB2' ' HG3' ' A' ' 599' ' ' GLN . . . -142.8 9.0 1.73 Allowed 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.941 -0.704 . . . . 72.510000000000005 112.004 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 125.49 -176.71 17.22 Favored Glycine 0 N--CA 1.435 -1.375 0 C-N-CA 120.152 -1.023 . . . . 74.099999999999994 111.955 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -63.44 -40.48 98.88 Favored Glycine 0 N--CA 1.45 -0.393 0 O-C-N 124.215 0.597 . . . . 63.450000000000003 113.066 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 23.8 m -63.18 -23.87 67.63 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 122.895 0.478 . . . . 74.530000000000001 111.628 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . 0.404 ' HG3' ' HB2' ' A' ' 595' ' ' ALA . 82.4 mm-40 -105.08 -1.64 25.35 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 111.979 0.363 . . . . 74.019999999999996 111.979 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -84.81 109.96 18.47 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 119.861 -0.736 . . . . 74.349999999999994 110.621 -176.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 57.01 0.27 0.07 Allowed 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 126.805 2.042 . . . . 73.329999999999998 114.973 176.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . 0.527 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 8.2 ptm180 -108.08 157.22 18.45 Favored 'General case' 0 C--N 1.289 -2.036 0 O-C-N 120.812 -1.18 . . . . 74.400000000000006 113.871 -173.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 66.5 t -69.11 130.77 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 113.908 -1.497 . . . . 73.450000000000003 108.502 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 46.5 t -84.31 -50.09 15.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 121.49 0.662 . . . . 72.340000000000003 109.669 -176.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -154.6 164.15 39.15 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 106.129 -1.804 . . . . 70.400000000000006 106.129 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -115.05 128.6 56.35 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 107.289 -1.374 . . . . 71.409999999999997 107.289 174.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.467 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 16.6 t-20 -48.25 -58.17 8.72 Favored Pre-proline 0 N--CA 1.48 1.025 0 O-C-N 123.798 0.686 . . . . 72.409999999999997 112.475 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 2.8 Cg_endo -86.34 120.87 1.88 Allowed 'Trans proline' 0 N--CA 1.442 -1.534 0 N-CA-C 108.097 -1.54 . . . . 75.120000000000005 108.097 169.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -63.31 160.27 35.85 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.371 2.047 . . . . 74.120000000000005 113.132 -177.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -57.85 127.28 31.29 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.437 -0.801 . . . . 72.439999999999998 111.055 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 91.95 -1.29 74.11 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.321 -0.942 . . . . 74.109999999999999 112.118 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 24.7 m -99.15 160.58 14.17 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.459 -0.941 . . . . 75.109999999999999 108.459 178.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -87.64 143.17 18.3 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 121.494 -0.384 . . . . 65.299999999999997 114.047 -175.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 27.8 m -113.81 142.55 25.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 C-N-CA 124.004 0.922 . . . . 73.439999999999998 109.42 176.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -58.89 176.26 0.22 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.731 1.011 . . . . 73.549999999999997 113.731 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -60.92 -25.86 67.06 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.96 -0.564 . . . . 73.349999999999994 112.421 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.31 -33.67 65.29 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.698 -0.853 . . . . 70.420000000000002 108.698 174.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 79.51 21.93 65.76 Favored Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 110.428 -1.069 . . . . 63.140000000000001 110.428 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.16 119.5 15.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 122.319 1.057 . . . . 72.0 111.29 -168.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 2.8 tp -116.56 126.5 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 CA-C-N 113.582 -1.645 . . . . 64.409999999999997 109.561 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.406 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 93.8 m -100.98 118.79 37.69 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 108.851 -0.796 . . . . 75.040000000000006 108.851 173.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -132.74 151.85 51.89 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 107.605 -1.257 . . . . 72.340000000000003 107.605 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -131.51 141.76 49.82 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 109.1 -0.704 . . . . 74.540000000000006 109.1 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -127.97 143.4 51.09 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 106.793 -1.558 . . . . 71.209999999999994 106.793 172.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 592' ' ' ASP . . . -85.87 -89.81 0.92 Allowed Glycine 0 N--CA 1.436 -1.319 0 C-N-CA 120.639 -0.791 . . . . 70.430000000000007 112.394 -176.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 . . . . . 0 C--N 1.309 -1.177 0 CA-C-O 118.866 -0.588 . . . . 71.329999999999998 110.554 -179.898 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 121.168 0.508 . . . . 75.150000000000006 110.39 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 30.2 m -137.56 162.98 31.85 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 107.671 -1.233 . . . . 64.349999999999994 107.671 178.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -94.09 139.37 31.06 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 106.067 -1.827 . . . . 75.230000000000004 106.067 175.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.518 HG21 ' CZ ' ' A' ' 382' ' ' PHE . 90.6 t -93.48 128.82 40.83 Favored Pre-proline 0 C--N 1.281 -2.389 0 N-CA-C 108.28 -1.007 . . . . 74.239999999999995 108.28 -168.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -61.09 120.59 8.37 Favored 'Trans proline' 0 C--N 1.361 1.204 0 C-N-CA 122.468 2.112 . . . . 75.400000000000006 112.304 -174.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -87.71 84.36 7.08 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 114.571 -1.195 . . . . 75.200000000000003 108.053 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.423 ' HB ' HE21 ' A' ' 368' ' ' GLN . 28.2 m -92.09 16.03 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.078 -0.964 . . . . 72.329999999999998 112.707 -174.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . 0.296 0.2 OUTLIER -65.29 148.38 51.79 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.926 -0.579 . . . . 74.329999999999998 112.546 176.705 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 106.4 -1.78 37.2 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 110.125 -1.19 . . . . 75.530000000000001 110.125 -170.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . 0.423 HE21 ' HB ' ' A' ' 365' ' ' VAL . 39.5 mt-30 -109.27 -158.93 0.66 Allowed 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 107.588 -1.264 . . . . 71.310000000000002 107.588 173.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 369' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 65.4 p -90.52 160.56 15.91 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 109.94 -0.393 . . . . 73.140000000000001 109.94 -175.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 27.1 p -56.13 -46.47 79.18 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 123.556 0.535 . . . . 74.239999999999995 110.451 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.31 -46.27 84.31 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 115.843 -0.617 . . . . 64.530000000000001 112.291 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -66.67 -44.1 82.74 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 120.153 -0.619 . . . . 65.040000000000006 110.471 -178.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -63.17 -48.6 77.72 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.519 -0.764 . . . . 74.409999999999997 111.771 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 90.1 mt -65.83 -42.23 91.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 CA-C-N 116.547 -0.297 . . . . 74.430000000000007 110.301 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.79 -43.33 94.46 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.417 -0.356 . . . . 74.310000000000002 111.189 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 33.8 m -63.0 -47.51 82.8 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.026 -0.534 . . . . 75.010000000000005 111.457 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 11.1 mp -64.59 -41.64 96.12 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.137 -0.225 . . . . 74.329999999999998 111.545 178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -38.72 92.19 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.301 -0.409 . . . . 74.340000000000003 110.186 -179.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -64.97 -30.81 71.82 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.894 0.378 . . . . 63.520000000000003 111.155 176.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -81.72 -8.66 59.72 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.131 -0.486 . . . . 71.510000000000005 110.826 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 99.49 0.18 56.79 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.603 -0.808 . . . . 72.340000000000003 112.491 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.518 ' CZ ' HG21 ' A' ' 362' ' ' VAL . 62.7 m-85 -78.26 147.67 34.24 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 109.124 -0.695 . . . . 74.0 109.124 178.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . 0.435 ' HB2' ' HG2' ' A' ' 415' ' ' GLU . 40.9 mmtm -100.35 144.53 29.24 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.497 -1.668 . . . . 75.319999999999993 106.497 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 1.5 mp -129.0 140.46 49.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 108.353 -0.981 . . . . 74.230000000000004 108.353 -179.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -109.85 128.05 55.08 Favored 'General case' 0 C--N 1.264 -3.113 0 N-CA-C 104.893 -2.262 . . . . 75.129999999999995 104.893 175.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 19.3 m -115.26 127.86 55.76 Favored 'General case' 0 C--N 1.257 -3.446 0 N-CA-C 108.095 -1.076 . . . . 71.239999999999995 108.095 -175.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.87 120.83 43.27 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.67 -1.233 . . . . 63.119999999999997 107.67 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -95.89 132.82 40.77 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.823 -0.436 . . . . 63.149999999999999 109.823 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 421' ' ' SER . 93.3 mttt -136.04 134.24 20.22 Favored Pre-proline 0 C--N 1.297 -1.703 0 N-CA-C 108.39 -0.967 . . . . 74.530000000000001 108.39 173.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . 0.501 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 29.5 Cg_endo -91.51 127.31 1.07 Allowed 'Trans proline' 0 C--O 1.251 1.146 0 C-N-CA 121.296 1.331 . . . . 61.340000000000003 111.259 175.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.501 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 12.2 t70 150.97 -164.92 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 103.203 -2.888 . . . . 74.099999999999994 103.203 -177.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 13.1 t -141.83 2.91 1.6 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 119.369 0.986 . . . . 75.439999999999998 110.539 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 11.5 t -87.74 -7.74 56.95 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.265 1.031 . . . . 75.030000000000001 109.787 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . 0.425 ' CD1' ' HB3' ' A' ' 391' ' ' ASP . 0.2 OUTLIER -109.25 151.81 42.25 Favored Pre-proline 0 N--CA 1.417 -2.088 0 N-CA-C 106.737 -1.579 . . . . 74.329999999999998 106.737 178.414 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -22.92 113.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.087 1 C-N-CA 125.739 4.293 . . . . 73.450000000000003 115.736 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -61.63 164.09 16.71 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 124.252 3.301 . . . . 74.319999999999993 112.605 -178.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . 0.489 ' HA ' ' CG2' ' A' ' 420' ' ' VAL . 31.4 t70 -56.53 -9.23 0.68 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 122.504 1.145 . . . . 61.039999999999999 111.937 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 64.1 m170 -103.96 111.33 23.84 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 103.5 -2.778 . . . . 64.5 103.5 168.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 27.4 m -63.14 119.49 7.3 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 O-C-N 124.403 1.065 . . . . 72.430000000000007 112.425 -168.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 9.1 tp -91.19 -29.14 4.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-N 115.515 -0.766 . . . . 71.329999999999998 110.443 -176.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.93 162.37 28.32 Favored Glycine 0 N--CA 1.42 -2.375 0 C-N-CA 119.533 -1.318 . . . . 63.509999999999998 113.554 -174.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 10.6 p -132.36 -175.7 3.84 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 125.7 1.6 . . . . 62.229999999999997 109.116 -177.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -101.37 134.3 20.37 Favored Pre-proline 0 C--N 1.293 -1.879 0 N-CA-C 107.28 -1.378 . . . . 74.049999999999997 107.28 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -47.03 -24.95 3.62 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 124.412 3.408 . . . . 73.540000000000006 115.122 -177.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.51 -28.23 68.23 Favored 'General case' 0 C--O 1.209 -1.067 0 CA-C-N 116.27 -0.423 . . . . 54.340000000000003 111.327 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -73.99 -32.54 63.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.825 0.821 . . . . 71.019999999999996 110.014 178.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -87.27 -2.15 58.41 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.522 -0.763 . . . . 74.349999999999994 109.498 -178.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 24.9 m -102.18 151.85 21.71 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.44 -1.689 . . . . 73.420000000000002 106.44 173.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 46.2 m -79.92 112.41 17.18 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 119.125 -1.03 . . . . 54.5 109.306 176.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.8 m -121.36 168.67 13.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 116.371 -0.377 . . . . 73.030000000000001 110.124 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 57.1 m -61.88 133.17 55.11 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.245 0.545 . . . . 72.019999999999996 110.936 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -61.77 112.44 2.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.316 -0.856 . . . . 72.120000000000005 112.754 -174.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 119.55 6.5 10.46 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.602 -0.808 . . . . 65.230000000000004 113.383 177.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -69.49 179.19 2.16 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 122.442 0.297 . . . . 73.209999999999994 111.233 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . 0.435 ' HG2' ' HB2' ' A' ' 383' ' ' LYS . 40.2 mt-10 -106.49 122.8 47.02 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 122.848 0.459 . . . . 75.319999999999993 110.569 -174.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 49.2 mm -112.41 130.6 65.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 108.78 -0.822 . . . . 74.319999999999993 108.78 178.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 81.4 m -96.95 132.35 42.83 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.116 0.484 . . . . 63.240000000000002 111.003 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 5.6 p -122.86 134.59 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 CA-C-N 115.78 -0.646 . . . . 74.530000000000001 109.762 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -95.59 129.23 42.85 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.982 -0.747 . . . . 73.099999999999994 108.982 174.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.489 ' CG2' ' HA ' ' A' ' 397' ' ' ASP . 8.6 p -138.7 141.51 36.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 109.617 -0.512 . . . . 75.530000000000001 109.617 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 11.5 p -100.15 121.97 42.26 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-O 121.699 0.761 . . . . 73.340000000000003 112.184 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 9.3 t -121.44 121.33 37.33 Favored 'General case' 0 N--CA 1.41 -2.449 0 N-CA-C 108.001 -1.111 . . . . 72.219999999999999 108.001 170.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.588 0 C-N-CA 119.701 -1.238 . . . . 73.150000000000006 112.597 177.971 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 . . . . . 0 N--CA 1.442 -0.854 0 N-CA-C 108.727 -0.842 . . . . 73.540000000000006 108.727 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' A' ' 447' ' ' ALA . 3.9 mmp_? -122.39 152.99 39.64 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.747 0.308 . . . . 74.510000000000005 111.162 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -91.02 139.04 31.14 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 115.759 -0.655 . . . . 75.540000000000006 110.642 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 50.4 mt -86.04 126.3 65.82 Favored Pre-proline 0 N--CA 1.421 -1.887 0 N-CA-C 106.914 -1.513 . . . . 74.439999999999998 106.914 176.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -73.12 141.43 32.64 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.174 1.916 . . . . 73.040000000000006 110.537 169.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -80.91 116.15 20.74 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.828 -1.175 . . . . 72.25 107.828 173.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 61.4 t -107.34 154.17 8.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 108.035 -1.098 . . . . 74.329999999999998 108.035 -175.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.5 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 19.6 m -67.13 152.35 45.91 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 120.818 0.342 . . . . 71.319999999999993 110.805 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 35.5 p -67.28 -27.93 67.6 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 113.979 1.103 . . . . 63.340000000000003 113.979 -172.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 2.4 pp -88.38 -10.34 49.65 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.719 0.771 . . . . 73.409999999999997 111.439 176.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.5 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 1.6 m -96.84 37.0 1.33 Allowed 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.428 0.632 . . . . 74.329999999999998 110.35 -175.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -52.76 -38.78 61.5 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.705 0.802 . . . . 72.209999999999994 112.56 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.33 -40.31 93.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.932 0.396 . . . . 71.519999999999996 111.33 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 29.3 tp10 -70.84 -34.53 71.77 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.523 -0.547 . . . . 75.150000000000006 109.523 176.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.513 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.02 -50.98 71.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.594 -0.276 . . . . 71.430000000000007 111.218 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.1 m -60.71 -37.34 75.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 121.301 0.572 . . . . 74.340000000000003 110.634 177.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -60.37 -47.66 85.1 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.257 -0.883 . . . . 71.239999999999995 110.81 175.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -65.02 -39.5 93.48 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.817 0.341 . . . . 75.120000000000005 111.609 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.513 HD13 ' O ' ' A' ' 440' ' ' ALA . 6.2 mp -65.21 -36.19 83.4 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.968 -0.56 . . . . 72.439999999999998 110.999 177.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 65.8 m -70.18 -42.7 72.09 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-O 120.825 0.345 . . . . 75.519999999999996 110.091 177.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -65.93 -21.87 66.46 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-O 121.438 0.637 . . . . 63.310000000000002 110.844 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . 0.406 ' O ' ' HG3' ' A' ' 427' ' ' ARG . . . -82.65 5.42 21.18 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.451 -0.795 . . . . 72.420000000000002 111.465 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 100.69 -73.68 0.41 Allowed Glycine 0 CA--C 1.501 -0.79 0 C-N-CA 120.408 -0.901 . . . . 74.439999999999998 112.525 174.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -43.88 -59.36 2.3 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.955 1.094 . . . . 74.099999999999994 113.955 176.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 59.31 29.71 66.49 Favored Glycine 0 C--O 1.224 -0.53 0 C-N-CA 121.24 -0.505 . . . . 74.109999999999999 112.652 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -102.59 110.56 22.53 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 108.385 -0.968 . . . . 65.109999999999999 108.385 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -140.71 143.05 34.82 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.865 -0.607 . . . . 73.349999999999994 111.05 -177.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -131.22 122.95 27.42 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.592 -0.892 . . . . 74.519999999999996 108.592 178.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -91.36 128.16 37.08 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.371 -0.603 . . . . 74.430000000000007 109.371 176.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -116.74 139.44 50.57 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 106.911 -1.514 . . . . 64.430000000000007 106.911 175.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -115.32 130.87 57.03 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.374 -0.973 . . . . 64.420000000000002 108.374 -176.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 41.9 t -132.59 140.15 36.92 Favored Pre-proline 0 C--N 1.283 -2.306 0 N-CA-C 108.793 -0.817 . . . . 55.229999999999997 108.793 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.681 ' HA ' ' O ' ' A' ' 490' ' ' SER . 49.7 Cg_endo -72.52 121.76 7.7 Favored 'Trans proline' 0 N--CA 1.437 -1.805 0 C-N-CA 121.045 1.163 . . . . 73.230000000000004 109.726 174.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 48.8 m -142.69 179.38 7.02 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.661 -0.7 . . . . 71.299999999999997 110.55 -173.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 14.1 t -52.12 138.63 36.06 Favored Pre-proline 0 CA--C 1.562 1.412 0 C-N-CA 124.198 0.999 . . . . 72.310000000000002 111.274 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.77 -30.0 36.17 Favored 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 124.868 3.712 . . . . 65.510000000000005 114.058 -173.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -73.17 -19.84 61.03 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.608 0.596 . . . . 75.230000000000004 112.608 -176.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -101.79 -6.83 23.15 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.232 -0.292 . . . . 74.109999999999999 111.32 177.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 94.4 t -61.09 128.09 21.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 120.854 0.359 . . . . 63.200000000000003 110.341 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.42 -11.85 71.13 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.432 -0.804 . . . . 72.230000000000004 111.831 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -110.93 165.36 11.92 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 109.636 -0.505 . . . . 63.509999999999998 109.636 -177.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 80.6 t -76.98 145.3 10.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 107.086 -1.449 . . . . 73.209999999999994 107.086 171.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 64.8 mt -97.32 -31.96 3.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 107.031 -1.47 . . . . 71.439999999999998 107.031 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 160.39 -178.36 36.45 Favored Glycine 0 N--CA 1.417 -2.625 0 CA-C-N 114.983 -1.008 . . . . 61.43 110.858 175.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 470' ' ' THR . . . . . 0.438 HG22 HG12 ' A' ' 486' ' ' ILE . 54.3 p -114.39 146.44 40.57 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 106.117 -1.809 . . . . 74.439999999999998 106.117 175.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -67.19 -54.51 19.28 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 120.054 -0.658 . . . . 74.109999999999999 110.675 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -73.15 138.81 28.53 Favored 'Trans proline' 0 C--N 1.368 1.585 0 N-CA-C 107.797 -1.655 . . . . 71.219999999999999 107.797 169.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -62.62 132.28 37.13 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.611 1.541 . . . . 72.430000000000007 111.888 -177.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -73.75 16.69 0.2 Allowed 'General case' 0 C--O 1.195 -1.768 0 C-N-CA 124.214 1.006 . . . . 53.43 112.355 -177.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -111.8 -8.87 14.12 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 122.645 0.378 . . . . 65.530000000000001 111.2 173.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -77.61 171.1 15.45 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 113.606 0.965 . . . . 74.310000000000002 113.606 -172.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 1.1 m -105.37 115.53 30.42 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 107.592 -1.262 . . . . 65.409999999999997 107.592 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 22.0 m -115.1 142.62 46.4 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 120.613 0.244 . . . . 74.129999999999995 110.401 -176.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -71.72 166.57 21.69 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.813 -0.63 . . . . 72.120000000000005 110.19 176.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 29.4 mm -70.95 -3.18 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.362 0 CA-C-O 121.821 0.82 . . . . 63.530000000000001 111.797 -173.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 14.6 t -112.19 5.29 18.38 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.18 -0.95 . . . . 72.230000000000004 110.711 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -79.79 132.66 36.2 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.803 -0.56 . . . . 75.230000000000004 111.377 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 46.0 t -106.61 121.7 59.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 108.35 -0.981 . . . . 70.409999999999997 108.35 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 28.7 m -104.72 134.62 45.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-O 121.518 0.675 . . . . 73.319999999999993 111.929 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.13 125.99 50.02 Favored 'Isoleucine or valine' 0 C--O 1.252 1.195 0 N-CA-C 108.91 -0.774 . . . . 74.510000000000005 108.91 178.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . 0.438 HG12 HG22 ' A' ' 470' ' ' THR . 7.9 mt -119.62 127.44 75.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.259 -0.882 . . . . 71.150000000000006 109.381 -178.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 7.1 tt -108.38 127.14 64.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.07 0.462 . . . . 62.32 111.287 -177.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 31.9 m -111.23 151.75 13.3 Favored 'Isoleucine or valine' 0 C--O 1.252 1.203 0 CA-C-N 115.849 -0.614 . . . . 72.5 109.933 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.17 133.97 12.2 Favored Glycine 0 N--CA 1.43 -1.702 0 C-N-CA 121.022 -0.609 . . . . 74.0 111.946 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.681 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 33.4 m . . . . . 0 C--N 1.29 -1.982 0 N-CA-C 105.779 -1.934 . . . . 74.420000000000002 105.779 176.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo . . . . . 0 N--CA 1.44 -1.633 0 CA-C-O 121.281 0.45 . . . . 74.329999999999998 111.63 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -110.6 35.3 3.53 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 122.404 1.097 . . . . 75.329999999999998 108.506 177.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 17.2 p -117.22 150.06 39.37 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 113.758 -1.564 . . . . 72.420000000000002 110.994 -174.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . 0.442 ' HA ' ' HE3' ' A' ' 495' ' ' LYS . 0.0 OUTLIER -137.04 164.28 28.75 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.694 -1.224 . . . . 75.040000000000006 107.694 175.474 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -90.36 138.34 31.62 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 109.531 -0.544 . . . . 74.420000000000002 109.531 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 543' ' ' THR . 35.9 pt -95.54 124.54 52.72 Favored Pre-proline 0 C--N 1.306 -1.286 0 C-N-CA 120.787 -0.365 . . . . 63.229999999999997 110.754 177.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -89.38 171.14 4.51 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.391 2.061 . . . . 72.040000000000006 110.51 174.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -87.87 154.57 20.42 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.386 -0.968 . . . . 70.409999999999997 108.386 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.5 p -145.91 104.31 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 108.954 -0.758 . . . . 75.129999999999995 108.954 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -140.68 119.85 12.89 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.732 -0.667 . . . . 74.299999999999997 110.497 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 122.97 -12.38 8.63 Favored Glycine 0 CA--C 1.486 -1.77 0 C-N-CA 120.119 -1.039 . . . . 74.530000000000001 111.779 177.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . 0.472 ' O ' HG13 ' A' ' 534' ' ' VAL . 20.2 mt-30 -99.0 171.09 8.26 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.438 -0.949 . . . . 65.150000000000006 108.438 176.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 14.5 t -90.15 157.78 17.57 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.358 -0.979 . . . . 72.420000000000002 108.358 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 12.4 p -52.78 -41.1 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 113.084 0.772 . . . . 64.25 113.084 -176.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -61.54 -41.87 98.0 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.125 0.488 . . . . 72.230000000000004 110.6 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 93.5 t -69.54 -43.38 80.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.441 -0.799 . . . . 73.409999999999997 110.196 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -61.31 -49.5 76.75 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.081 -0.508 . . . . 70.019999999999996 111.412 -178.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -63.07 -38.09 89.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.042 0.449 . . . . 73.230000000000004 111.285 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.452 ' O ' HG21 ' A' ' 514' ' ' VAL . 33.6 ttmt -62.54 -42.29 99.43 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.343 -0.844 . . . . 74.430000000000007 109.719 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -62.82 -48.37 79.36 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.056 -0.52 . . . . 74.129999999999995 110.79 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.93 -36.54 79.6 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.076 0.399 . . . . 75.209999999999994 112.076 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.36 -37.43 80.68 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 116.351 -0.386 . . . . 75.049999999999997 111.145 176.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.452 HG21 ' O ' ' A' ' 510' ' ' LYS . 94.2 t -61.48 -36.43 73.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.117 -0.492 . . . . 74.430000000000007 110.387 177.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -76.46 -15.03 60.0 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.573 -0.285 . . . . 74.409999999999997 111.354 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 110.91 -8.65 29.57 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.793 -0.717 . . . . 75.209999999999994 112.846 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.454 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 76.2 m-85 -80.06 113.82 18.52 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 108.085 -1.08 . . . . 75.519999999999996 108.085 -177.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.4 m -116.71 -8.95 11.37 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 118.548 -1.261 . . . . 71.140000000000001 114.113 -171.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . 0.402 ' O ' HD12 ' A' ' 551' ' ' ILE . 62.6 mttp -108.34 120.81 43.45 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.391 -0.818 . . . . 74.530000000000001 110.397 -178.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -120.93 156.04 32.94 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 113.338 0.866 . . . . 72.140000000000001 113.338 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 46.9 m -141.85 138.52 32.2 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 106.296 -1.742 . . . . 61.509999999999998 106.296 169.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . 0.491 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 0.0 OUTLIER -121.63 141.35 51.2 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 119.601 -0.84 . . . . 73.219999999999999 111.094 179.523 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -119.89 122.61 41.66 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.683 -1.228 . . . . 74.409999999999997 107.683 176.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 524' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 67.1 m -88.86 128.02 35.65 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 121.214 0.531 . . . . 73.319999999999993 110.508 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 24.7 m -121.44 149.82 24.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.96 -0.756 . . . . 65.129999999999995 108.96 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -73.94 135.03 43.22 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 108.354 -0.98 . . . . 71.530000000000001 108.354 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 45.4 m -152.16 172.55 5.37 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 108.628 -0.879 . . . . 72.319999999999993 108.628 -176.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -82.67 -10.31 10.77 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 121.452 1.435 . . . . 72.030000000000001 110.424 174.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . 0.438 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 27.3 mmt180 -81.36 138.18 48.43 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-N 114.862 -1.063 . . . . 64.530000000000001 108.18 -178.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -62.46 149.65 90.15 Favored 'Trans proline' 0 C--O 1.249 1.03 0 C-N-CA 122.351 2.034 . . . . 74.329999999999998 112.316 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -58.57 118.26 5.44 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.224 -0.898 . . . . 73.510000000000005 110.79 -178.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 127.59 -23.73 5.33 Favored Glycine 0 N--CA 1.434 -1.442 0 N-CA-C 111.113 -0.795 . . . . 70.319999999999993 111.113 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -81.14 134.96 35.73 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.468 -0.938 . . . . 74.349999999999994 108.468 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 503' ' ' GLN . 13.4 p -80.96 135.24 25.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 CA-C-O 121.3 0.571 . . . . 71.120000000000005 110.519 -178.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 77.5 m -88.91 -32.83 17.53 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.168 -0.924 . . . . 73.239999999999995 109.889 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.38 -152.1 24.21 Favored Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 110.091 -1.203 . . . . 74.219999999999999 110.091 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 27.3 p -117.56 157.19 26.78 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.551 -0.537 . . . . 72.109999999999999 109.551 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -73.09 -50.04 6.87 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 109.59 -0.522 . . . . 74.409999999999997 109.59 175.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.12 146.92 78.29 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 121.217 1.278 . . . . 74.409999999999997 109.649 171.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.43 143.81 53.66 Favored 'Trans proline' 0 C--O 1.25 1.122 0 C-N-CA 122.181 1.921 . . . . 75.239999999999995 113.089 -176.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.86 133.51 50.2 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.815 -0.809 . . . . 74.129999999999995 108.815 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.47 -5.31 35.32 Favored Glycine 0 C--N 1.299 -1.506 0 C-N-CA 120.053 -1.07 . . . . 72.120000000000005 111.111 -176.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 543' ' ' THR . . . . . 0.456 ' O ' HG12 ' A' ' 497' ' ' ILE . 62.4 m -82.26 133.69 35.25 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.516 -0.55 . . . . 75.239999999999995 109.516 176.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 11.9 t -96.44 130.84 43.5 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 119.984 -0.686 . . . . 73.040000000000006 109.571 176.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.1 m -139.44 159.24 66.6 Favored Pre-proline 0 C--N 1.316 -0.891 0 N-CA-C 109.175 -0.676 . . . . 75.209999999999994 109.175 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -63.39 142.04 83.69 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.367 2.045 . . . . 75.219999999999999 111.374 176.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.454 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 27.7 m -66.72 -23.19 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-O 121.445 0.64 . . . . 73.030000000000001 112.32 -177.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -79.68 -13.41 59.49 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.517 -0.765 . . . . 74.129999999999995 110.574 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 56.7 m -77.5 164.97 24.94 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 113.463 0.912 . . . . 72.200000000000003 113.463 -175.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 23.9 t -90.9 131.39 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-N 114.629 -1.169 . . . . 75.519999999999996 109.179 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . 0.402 HD12 ' O ' ' A' ' 519' ' ' LYS . 0.2 OUTLIER -116.51 142.39 30.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 109.721 -0.474 . . . . 73.450000000000003 109.721 175.317 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -103.78 116.66 32.72 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.839 -0.619 . . . . 74.219999999999999 110.713 -175.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 7.3 mp -103.27 134.4 46.74 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.238 -0.892 . . . . 75.120000000000005 109.738 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -101.29 125.38 47.92 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 108.834 -0.802 . . . . 71.010000000000005 108.834 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 524' ' ' SER . 59.5 t -114.8 138.59 44.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-N 115.44 -0.8 . . . . 71.129999999999995 110.002 -174.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.501 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 63.2 m -69.35 140.57 54.28 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 113.606 0.965 . . . . 74.310000000000002 113.606 178.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -103.26 139.76 38.29 Favored 'General case' 0 N--CA 1.422 -1.825 0 N-CA-C 104.915 -2.254 . . . . 74.439999999999998 104.915 166.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -67.68 -36.56 87.86 Favored Glycine 0 CA--C 1.484 -1.905 0 C-N-CA 120.55 -0.833 . . . . 75.319999999999993 112.395 -172.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 66.2 t30 67.33 -3.84 0.97 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.808 1.243 . . . . 64.340000000000003 112.857 171.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -151.38 142.06 22.74 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.172 -1.418 . . . . 74.340000000000003 107.172 -174.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -136.18 134.93 38.72 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 120.627 0.251 . . . . 75.129999999999995 111.092 174.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.1 p -60.27 123.23 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.737 0.815 . . . . 74.230000000000004 112.931 -175.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 563' ' ' MET . . . . . 0.429 ' HG2' ' O ' ' A' ' 612' ' ' THR . 25.5 ptm -98.11 141.19 22.55 Favored Pre-proline 0 C--O 1.253 1.259 0 CA-C-N 115.9 -0.591 . . . . 62.119999999999997 111.421 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.35 169.85 21.55 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.793 2.328 . . . . 72.230000000000004 110.555 171.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -72.52 130.45 40.65 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.163 0.506 . . . . 74.010000000000005 110.021 177.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 93.2 mt -116.6 -9.78 11.3 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.656 -0.702 . . . . 61.420000000000002 110.943 -177.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 10.5 p -70.36 129.88 40.47 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 109.952 -0.388 . . . . 75.129999999999995 109.952 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 90.3 -0.26 77.87 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.581 -0.819 . . . . 74.409999999999997 111.942 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 26.4 mmt -91.32 151.21 20.96 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 108.845 -0.798 . . . . 71.310000000000002 108.845 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -93.28 140.79 29.15 Favored 'General case' 0 N--CA 1.416 -2.165 0 N-CA-C 109.35 -0.611 . . . . 75.219999999999999 109.35 -176.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 60.7 t-105 -71.53 -15.65 62.3 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.659 -0.701 . . . . 75.420000000000002 110.276 -174.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 14.0 p -72.31 -19.3 19.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.896 0.855 . . . . 72.25 108.908 178.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -102.27 -44.77 5.32 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 114.511 -1.222 . . . . 70.510000000000005 110.359 176.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . 0.41 ' O ' ' HG3' ' A' ' 577' ' ' ARG . . . -65.42 -41.34 93.68 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 113.923 1.083 . . . . 73.439999999999998 113.923 -176.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.575 ' O ' ' HG2' ' A' ' 579' ' ' ARG . 32.0 tt0 -65.54 -53.55 36.81 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 120.176 -0.61 . . . . 73.439999999999998 111.907 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . 0.404 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 52.4 Cg_exo -55.88 -39.26 92.21 Favored 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 121.91 1.74 . . . . 74.439999999999998 113.136 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' ' 574' ' ' ALA . 3.2 ppt_? -67.76 -37.19 81.76 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 119.536 -0.865 . . . . 75.430000000000007 110.809 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.427 HD11 ' N ' ' A' ' 579' ' ' ARG 0.275 3.5 pp -66.55 -36.41 82.59 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 120.498 -0.481 . . . . 75.219999999999999 111.507 179.865 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . 0.575 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 45.8 mmm-85 -57.21 -42.75 81.92 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.169 -0.923 . . . . 75.120000000000005 108.711 176.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -67.8 -28.05 67.26 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.716 -0.675 . . . . 74.540000000000006 111.912 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 10.5 mp -80.56 -8.06 59.46 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.145 0.498 . . . . 73.530000000000001 111.164 177.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 77.77 16.28 80.25 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-N 115.759 -0.655 . . . . 71.030000000000001 111.95 179.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -70.78 140.46 51.29 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 109.523 -0.547 . . . . 74.510000000000005 109.523 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 9.6 t -137.21 -50.01 0.62 Allowed 'General case' 0 N--CA 1.406 -2.638 0 CA-C-O 118.871 -0.585 . . . . 73.230000000000004 110.238 175.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . 30.67 -126.69 0.16 Allowed Glycine 0 C--N 1.371 2.488 0 O-C-N 124.631 1.207 . . . . 73.439999999999998 113.734 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 25.7 ptm -137.93 125.54 22.21 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.881 -1.526 . . . . 74.400000000000006 106.881 170.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -87.41 123.84 32.78 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.69 -0.855 . . . . 75.329999999999998 108.69 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -95.96 107.33 19.6 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.669 -0.696 . . . . 72.310000000000002 109.277 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -112.5 113.3 25.4 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 108.582 -0.895 . . . . 71.010000000000005 108.582 176.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -83.25 -126.09 1.1 Allowed Glycine 0 N--CA 1.435 -1.367 0 N-CA-C 111.066 -0.814 . . . . 62.130000000000003 111.066 175.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -70.98 137.73 49.35 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.873 0.368 . . . . 74.239999999999995 111.124 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -97.49 126.95 43.06 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 106.903 -1.518 . . . . 72.150000000000006 106.903 176.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 48.8 t -137.27 128.95 41.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 C-N-CA 120.955 -0.298 . . . . 75.129999999999995 110.463 -172.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -77.38 108.35 10.46 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 105.173 -2.158 . . . . 63.020000000000003 105.173 170.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -105.1 0.19 27.24 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-O 121.216 0.531 . . . . 75.450000000000003 111.44 -174.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 100.82 171.47 28.93 Favored Glycine 0 N--CA 1.433 -1.56 0 N-CA-C 109.584 -1.406 . . . . 75.120000000000005 109.584 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -63.46 -48.16 80.82 Favored Glycine 0 C--N 1.306 -1.126 0 C-N-CA 120.721 -0.752 . . . . 64.010000000000005 113.382 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 42.0 p -69.25 -26.79 64.95 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.502 0.668 . . . . 74.400000000000006 112.243 -175.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -105.91 -1.64 23.88 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 118.926 -0.559 . . . . 73.439999999999998 110.992 -174.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . 0.521 ' CG ' ' H ' ' A' ' 601' ' ' ASN . 0.3 OUTLIER -35.32 -115.74 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.616 0 N-CA-C 117.677 2.473 . . . . 71.219999999999999 117.677 -167.866 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . 0.521 ' H ' ' CG ' ' A' ' 600' ' ' HIS . 4.6 p30 -92.96 83.92 4.81 Favored 'General case' 0 C--N 1.287 -2.109 0 O-C-N 120.558 -1.339 . . . . 74.120000000000005 109.92 178.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -126.11 150.85 47.93 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 115.548 -0.751 . . . . 73.120000000000005 109.678 175.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 85.7 t -67.84 130.9 33.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 O-C-N 123.875 0.734 . . . . 74.150000000000006 109.358 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 60.1 t -93.11 -52.14 10.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.363 0.601 . . . . 74.450000000000003 109.786 -176.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -136.41 158.81 43.55 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.405 -0.961 . . . . 72.109999999999999 108.405 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -125.32 122.3 36.46 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.564 -1.273 . . . . 74.140000000000001 107.564 174.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.499 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 41.8 t30 -51.47 -59.0 8.81 Favored Pre-proline 0 CA--C 1.555 1.17 0 CA-C-O 119.094 -0.479 . . . . 75.329999999999998 112.175 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 2.7 Cg_endo -85.03 129.65 3.94 Favored 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 121.322 1.348 . . . . 74.430000000000007 109.123 171.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.81 161.52 35.84 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 122.696 2.264 . . . . 64.340000000000003 112.905 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -59.21 129.99 44.81 Favored 'General case' 0 C--O 1.249 1.051 0 CA-C-N 115.754 -0.657 . . . . 64.209999999999994 110.959 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 95.59 -10.76 68.83 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 120.863 -0.684 . . . . 74.019999999999996 111.706 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 612' ' ' THR . . . . . 0.429 ' O ' ' HG2' ' A' ' 563' ' ' MET . 24.0 m -89.27 161.97 16.11 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.642 -1.244 . . . . 73.25 107.642 178.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -99.12 143.19 16.45 Favored Glycine 0 N--CA 1.418 -2.518 0 C-N-CA 119.985 -1.102 . . . . 60.240000000000002 113.237 -177.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 13.6 m -94.12 143.42 11.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.374 -0.973 . . . . 75.400000000000006 108.374 175.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -58.24 175.41 0.23 Allowed 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 114.21 1.189 . . . . 75.219999999999999 114.21 -175.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -55.95 -38.36 70.24 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 125.458 1.503 . . . . 74.430000000000007 110.986 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.91 -33.91 68.67 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 115.607 -0.724 . . . . 63.240000000000002 109.501 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 82.5 19.74 63.48 Favored Glycine 0 N--CA 1.417 -2.618 0 N-CA-C 109.974 -1.25 . . . . 63.310000000000002 109.974 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.62 119.44 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 108.629 -0.878 . . . . 73.329999999999998 108.629 -174.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 8.5 tp -116.26 132.42 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 0 CA-C-N 114.73 -1.123 . . . . 73.519999999999996 109.678 -174.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.411 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 32.8 m -105.28 117.53 34.24 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 108.912 -0.773 . . . . 75.340000000000003 108.912 178.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 72.9 mt -139.09 165.65 26.59 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 105.747 -1.946 . . . . 74.530000000000001 105.747 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -142.94 139.54 30.75 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 106.468 -1.678 . . . . 74.209999999999994 106.468 173.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -138.77 160.89 38.57 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.145 -1.057 . . . . 73.140000000000001 108.145 -177.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -87.15 -117.46 1.14 Allowed Glycine 0 N--CA 1.43 -1.734 0 O-C-N 123.915 0.759 . . . . 62.32 113.35 -177.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 . . . . . 0 C--N 1.298 -1.666 0 N-CA-C 109.21 -0.663 . . . . 74.010000000000005 109.21 -174.682 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 . . . . . 0 CA--C 1.498 -1.03 0 N-CA-C 107.179 -1.415 . . . . 75.030000000000001 107.179 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.15 163.51 34.06 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.46 0 N-CA-C 108.226 -1.028 . . . . 70.049999999999997 108.226 -177.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -94.46 138.15 32.74 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 105.007 -2.22 . . . . 65.430000000000007 105.007 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 91.9 t -95.3 123.53 56.53 Favored Pre-proline 0 C--N 1.271 -2.825 0 N-CA-C 109.308 -0.627 . . . . 72.019999999999996 109.308 -171.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -60.89 126.28 19.25 Favored 'Trans proline' 0 N--CA 1.445 -1.349 0 C-N-CA 122.316 2.011 . . . . 72.400000000000006 110.995 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -84.62 114.2 21.82 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-O 122.639 1.209 . . . . 75.230000000000004 109.326 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.41 HG13 ' HB2' ' A' ' 373' ' ' ALA . 9.2 p -88.21 15.12 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 CA-C-N 113.832 -1.531 . . . . 74.319999999999993 111.554 -173.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -56.5 146.69 23.98 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.191 1.396 . . . . 75.209999999999994 111.954 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.41 0.47 43.68 Favored Glycine 0 CA--C 1.503 -0.673 0 CA-C-N 116.263 -0.426 . . . . 72.430000000000007 113.354 177.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -115.75 -159.39 0.71 Allowed 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 108.273 -1.01 . . . . 75.519999999999996 108.273 177.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 60.1 p -90.96 166.83 12.82 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 108.66 -0.867 . . . . 72.510000000000005 108.66 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 66.7 m -62.85 -41.13 99.23 Favored 'General case' 0 C--O 1.208 -1.101 0 C-N-CA 120.004 -0.678 . . . . 74.129999999999995 110.026 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.49 -46.68 81.97 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 116.728 -0.214 . . . . 74.209999999999994 111.563 -178.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -69.09 -39.83 78.77 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.475 0.655 . . . . 72.030000000000001 110.002 -176.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . 0.41 ' HB2' HG13 ' A' ' 365' ' ' VAL . . . -67.24 -46.47 73.66 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.582 -0.735 . . . . 74.319999999999993 111.285 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 75.9 mt -64.44 -40.98 90.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-N 116.353 -0.385 . . . . 74.030000000000001 110.302 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.99 -41.85 88.61 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.378 0.608 . . . . 72.340000000000003 110.619 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 87.2 m -63.17 -47.62 81.86 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.655 -0.702 . . . . 74.049999999999997 110.756 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 97.6 mt -64.05 -37.99 89.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.337 -0.392 . . . . 65.530000000000001 110.7 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.67 -38.66 91.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.799 -0.637 . . . . 73.030000000000001 110.775 178.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -68.9 -24.63 64.33 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 120.981 0.42 . . . . 75.549999999999997 111.382 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -82.09 -14.76 55.32 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.153 -0.476 . . . . 75.349999999999994 110.757 176.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.95 16.82 43.16 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.212 -0.994 . . . . 64.109999999999999 112.257 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -88.16 159.59 18.12 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 121.395 0.617 . . . . 75.329999999999998 111.829 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -100.64 132.6 45.95 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 106.824 -1.547 . . . . 75.209999999999994 106.824 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.89 137.29 56.87 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 N-CA-C 106.824 -1.547 . . . . 74.319999999999993 106.824 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 417' ' ' THR . 32.5 ttt180 -116.82 138.58 51.41 Favored 'General case' 0 C--N 1.255 -3.533 0 N-CA-C 105.724 -1.954 . . . . 74.319999999999993 105.724 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 41.0 m -130.23 132.51 46.0 Favored 'General case' 0 C--N 1.272 -2.786 0 O-C-N 121.771 -0.581 . . . . 75.129999999999995 109.483 -174.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.7 121.89 42.95 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.649 -1.241 . . . . 74.519999999999996 107.649 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -89.53 122.5 32.75 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.941 -0.763 . . . . 75.420000000000002 108.941 -178.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . 0.601 ' O ' ' HA ' ' A' ' 421' ' ' SER . 51.8 mtmt -132.98 135.78 26.49 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 109.028 -0.73 . . . . 74.319999999999993 109.028 177.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -76.14 176.6 9.83 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.32 2.014 . . . . 61.32 112.609 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 11.2 t70 87.92 167.82 0.06 Allowed 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 126.351 1.861 . . . . 73.439999999999998 110.707 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 32.6 t -105.7 -12.7 15.81 Favored 'General case' 0 N--CA 1.439 -1.022 0 O-C-N 122.35 -0.219 . . . . 74.450000000000003 111.222 -175.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 6.0 t -82.63 -3.38 56.12 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 119.198 -1.001 . . . . 73.140000000000001 109.548 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 47.6 mm -88.14 146.15 37.65 Favored Pre-proline 0 C--N 1.302 -1.475 0 N-CA-C 106.17 -1.789 . . . . 72.420000000000002 106.17 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -37.94 116.31 0.21 Allowed 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 123.772 2.981 . . . . 74.530000000000001 113.12 177.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . 0.477 ' HA ' ' OG ' ' A' ' 421' ' ' SER . 12.2 Cg_endo -57.72 151.99 52.02 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.041 2.494 . . . . 72.219999999999999 112.732 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -59.19 -8.17 1.49 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.874 1.27 . . . . 74.510000000000005 113.638 -178.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -106.55 109.96 22.03 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 104.327 -2.471 . . . . 64.019999999999996 104.327 171.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 28.0 m -62.78 119.07 5.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 124.647 1.217 . . . . 74.530000000000001 112.567 -165.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -92.25 -28.22 4.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.4 -0.818 . . . . 73.150000000000006 109.89 179.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.75 160.11 28.06 Favored Glycine 0 N--CA 1.399 -3.824 0 CA-C-N 115.232 -0.895 . . . . 73.129999999999995 111.054 -176.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -114.83 -175.99 2.81 Favored 'General case' 0 C--N 1.27 -2.87 0 C-N-CA 125.351 1.46 . . . . 73.400000000000006 108.339 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -99.3 137.3 20.35 Favored Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 107.095 -1.446 . . . . 64.310000000000002 107.095 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -54.91 -16.28 11.49 Favored 'Trans proline' 0 C--N 1.365 1.411 0 C-N-CA 124.313 3.342 . . . . 72.319999999999993 114.662 -174.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.65 -28.69 68.76 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 116.308 -0.406 . . . . 72.219999999999999 110.249 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -73.96 -38.27 64.26 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.507 0.67 . . . . 61.149999999999999 110.392 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -81.2 -5.18 57.45 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.499 0.666 . . . . 74.219999999999999 110.629 -177.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 30.9 m -95.29 143.56 26.58 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.307 -1.738 . . . . 65.200000000000003 106.307 173.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 47.7 m -74.51 112.48 10.73 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 118.441 -1.304 . . . . 63.439999999999998 108.666 176.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 28.7 m -127.58 169.2 19.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 115.876 -0.602 . . . . 55.399999999999999 109.862 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 29.6 t -71.85 132.62 44.67 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 106.761 -1.57 . . . . 71.319999999999993 106.761 175.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -65.46 133.4 51.2 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-O 121.22 0.533 . . . . 75.319999999999993 111.157 -175.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 104.89 54.81 0.75 Allowed Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 110.816 -0.914 . . . . 22.510000000000002 110.816 -177.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -113.32 -177.23 3.08 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.818 -1.178 . . . . 73.120000000000005 107.818 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -107.67 108.88 20.32 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.153 -0.684 . . . . 71.109999999999999 109.153 -177.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.6 mm -98.01 116.77 41.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.37 -0.974 . . . . 71.329999999999998 108.37 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 417' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 385' ' ' ARG . 58.1 m -97.74 130.82 44.68 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 120.849 0.357 . . . . 72.230000000000004 110.535 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 4.8 p -118.96 136.18 56.99 Favored 'Isoleucine or valine' 0 C--O 1.252 1.223 0 C-N-CA 123.577 0.751 . . . . 75.230000000000004 110.232 -177.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -93.96 120.07 33.72 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.013 -0.736 . . . . 70.439999999999998 109.013 176.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 14.7 p -113.81 132.45 62.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 109.7 -0.481 . . . . 72.230000000000004 109.7 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' SER . . . . . 0.601 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 11.9 p -88.26 125.36 34.61 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.075 0.464 . . . . 73.349999999999994 111.301 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 5.6 t -118.36 106.52 12.83 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-O 121.191 0.519 . . . . 74.019999999999996 111.379 177.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.398 0 N-CA-C 115.226 0.85 . . . . 73.430000000000007 115.226 175.481 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 . . . . . 0 CA--C 1.52 -0.187 0 CA-C-O 120.634 0.254 . . . . 74.340000000000003 111.522 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 477' ' ' THR . 10.9 mmp_? -122.23 153.81 38.35 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-N 116.312 -0.404 . . . . 72.310000000000002 110.456 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 40.6 tt0 -84.83 141.47 30.45 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.418 -1.327 . . . . 72.129999999999995 107.418 174.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 68.2 mt -78.08 125.92 84.48 Favored Pre-proline 0 N--CA 1.437 -1.121 0 N-CA-C 107.212 -1.403 . . . . 73.25 107.212 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -67.62 145.05 68.68 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.473 2.115 . . . . 75.150000000000006 113.093 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -75.44 104.81 6.16 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 108.992 -0.744 . . . . 64.409999999999997 108.992 175.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 46.1 t -116.78 138.01 48.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 107.93 -1.137 . . . . 73.099999999999994 107.93 178.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.401 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 18.5 m -68.97 152.33 45.4 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 121.053 0.454 . . . . 74.319999999999993 111.025 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 434' ' ' THR . . . . . 0.5 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 58.3 p -63.89 -34.44 77.95 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 113.535 0.939 . . . . 73.329999999999998 113.535 -170.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.6 pp -84.22 -11.32 56.71 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 120.98 0.419 . . . . 73.239999999999995 111.842 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.401 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 0.8 OUTLIER -93.95 42.77 1.1 Allowed 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 115.687 -0.688 . . . . 71.319999999999993 109.731 -177.6 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -52.14 -39.65 60.25 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.725 1.21 . . . . 75.349999999999994 112.989 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.19 -41.79 99.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.085 0.469 . . . . 74.209999999999994 110.218 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -71.17 -33.97 70.5 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 116.19 -0.459 . . . . 71.420000000000002 110.286 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.446 ' O ' HD12 ' A' ' 444' ' ' LEU . . . -59.43 -51.25 70.68 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.497 -0.127 . . . . 63.140000000000001 110.888 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.4 m -61.45 -37.63 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 CA-C-O 121.111 0.481 . . . . 75.430000000000007 110.458 177.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -60.52 -48.19 82.86 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.244 1.018 . . . . 65.219999999999999 110.908 176.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -66.42 -38.5 87.57 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 123.777 0.831 . . . . 72.400000000000006 111.466 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 440' ' ' ALA . 6.9 mp -66.15 -33.96 76.95 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.877 -0.601 . . . . 73.319999999999993 110.927 176.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.497 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 56.2 m -70.13 -45.07 67.6 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.251 0.548 . . . . 73.530000000000001 109.874 177.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.69 -16.36 64.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.541 -0.754 . . . . 74.010000000000005 110.917 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.84 5.67 20.9 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.081 -0.509 . . . . 74.120000000000005 111.74 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 100.72 -67.39 0.5 Allowed Glycine 0 CA--C 1.497 -1.088 0 C-N-CA 120.552 -0.832 . . . . 72.129999999999995 111.938 175.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -51.54 -59.39 4.31 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.264 0.839 . . . . 71.430000000000007 113.264 178.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . 0.497 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 60.76 19.89 55.99 Favored Glycine 0 CA--C 1.505 -0.569 0 CA-C-O 121.25 0.361 . . . . 74.340000000000003 113.059 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.49 ' NH2' ' HA ' ' A' ' 481' ' ' THR . 13.6 mtm180 -105.29 111.35 24.06 Favored 'General case' 0 N--CA 1.415 -2.209 0 CA-C-O 121.258 0.552 . . . . 74.010000000000005 110.172 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . 0.489 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 15.0 p90 -135.3 145.34 47.4 Favored 'General case' 0 N--CA 1.412 -2.364 0 CA-C-N 114.151 -1.386 . . . . 75.540000000000006 109.55 -175.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 26.1 mmtm -136.43 127.24 27.38 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.349 -0.842 . . . . 74.439999999999998 108.877 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -90.72 127.26 36.25 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 123.644 0.59 . . . . 74.400000000000006 111.369 -174.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -126.85 147.29 50.05 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.905 -1.146 . . . . 75.510000000000005 107.905 175.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -122.06 146.5 47.13 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 120.376 -0.53 . . . . 71.219999999999999 109.937 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 23.2 t -142.79 137.53 15.21 Favored Pre-proline 0 C--N 1.297 -1.713 0 N-CA-C 107.686 -1.227 . . . . 54.549999999999997 107.686 177.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.548 ' HA ' ' O ' ' A' ' 490' ' ' SER . 23.9 Cg_exo -64.92 123.01 10.98 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.738 1.625 . . . . 62.149999999999999 110.471 176.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 54.9 m -148.94 -178.31 6.29 Favored 'General case' 0 C--N 1.287 -2.117 0 C-N-CA 124.971 1.308 . . . . 55.420000000000002 108.136 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 11.2 t -45.27 134.39 5.58 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 123.727 0.811 . . . . 75.099999999999994 112.283 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.92 -29.21 34.34 Favored 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 124.814 3.676 . . . . 74.450000000000003 114.067 -175.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -71.77 -19.42 62.02 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 112.055 0.391 . . . . 75.340000000000003 112.055 -178.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 72.6 mt -96.09 -2.54 46.4 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 111.601 0.223 . . . . 75.299999999999997 111.601 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 87.9 t -60.81 127.39 20.3 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 CA-C-O 120.891 0.377 . . . . 74.519999999999996 110.315 178.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 84.7 -10.57 61.86 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.312 -0.858 . . . . 74.049999999999997 112.065 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -111.98 166.23 11.41 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 108.182 -1.044 . . . . 75.420000000000002 108.182 -176.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.5 ' O ' ' HB ' ' A' ' 434' ' ' THR . 87.2 t -80.41 146.83 7.01 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.294 0 CA-C-N 116.261 -0.427 . . . . 72.510000000000005 109.957 -177.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 63.9 mt -98.57 -35.21 4.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 107.439 -1.319 . . . . 75.349999999999994 107.439 174.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 156.68 -152.1 23.48 Favored Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 110.166 -1.174 . . . . 64.25 110.166 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 3.6 p -132.15 157.15 45.02 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.547 -0.908 . . . . 73.450000000000003 108.547 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -71.82 -46.46 12.17 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 119.728 -0.789 . . . . 75.510000000000005 110.625 175.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -71.15 141.69 40.23 Favored 'Trans proline' 0 C--N 1.374 1.89 0 N-CA-C 107.304 -1.845 . . . . 70.219999999999999 107.304 167.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -62.34 127.54 21.26 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 121.508 1.472 . . . . 65.019999999999996 112.063 -177.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -73.99 2.03 9.6 Favored 'General case' 0 C--O 1.201 -1.448 0 C-N-CA 123.646 0.778 . . . . 73.230000000000004 112.444 -175.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -110.4 5.4 21.45 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.603 0.716 . . . . 74.319999999999993 110.005 175.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -109.12 176.78 4.97 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-N 115.616 -0.72 . . . . 72.010000000000005 111.529 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 477' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 2.3 p -96.8 145.9 25.41 Favored 'General case' 0 N--CA 1.391 -3.406 0 CA-C-N 114.663 -1.153 . . . . 73.409999999999997 110.773 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 49.7 m -137.29 148.06 46.11 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 107.548 -1.279 . . . . 73.299999999999997 107.548 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -77.96 159.57 28.74 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 120.715 0.293 . . . . 73.340000000000003 110.441 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.61 -18.37 23.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.524 0.678 . . . . 71.409999999999997 111.316 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 481' ' ' THR . . . . . 0.49 ' HA ' ' NH2' ' A' ' 451' ' ' ARG . 7.7 t -87.28 1.91 51.77 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.943 -0.571 . . . . 72.0 111.065 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -93.05 148.91 21.6 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.045 0.45 . . . . 74.239999999999995 110.863 -177.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.9 p -108.6 126.34 65.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.568 -1.271 . . . . 72.310000000000002 107.568 172.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 26.9 m -105.33 134.25 47.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 121.903 0.859 . . . . 73.209999999999994 111.852 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.87 122.61 44.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 114.968 -1.015 . . . . 74.140000000000001 110.288 -178.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 36.2 mm -97.94 113.13 31.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 107.462 -1.31 . . . . 74.439999999999998 107.462 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 9.5 tt -99.08 126.24 52.38 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 108.911 -0.774 . . . . 70.349999999999994 108.911 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 27.2 m -111.25 151.92 13.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 123.345 0.658 . . . . 74.400000000000006 110.668 -178.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -77.37 132.64 12.25 Favored Glycine 0 N--CA 1.424 -2.136 0 CA-C-N 115.562 -0.744 . . . . 71.420000000000002 112.553 -178.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.548 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 31.3 t . . . . . 0 N--CA 1.419 -2.005 0 N-CA-C 104.401 -2.444 . . . . 63.119999999999997 104.401 175.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo . . . . . 0 N--CA 1.445 -1.348 0 N-CA-C 110.731 -0.527 . . . . 74.409999999999997 110.731 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . -75.14 84.85 2.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.777 0.799 . . . . 73.409999999999997 109.305 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 9.7 p -122.5 144.3 49.16 Favored 'General case' 0 N--CA 1.419 -2.014 0 CA-C-N 114.776 -1.102 . . . . 73.150000000000006 111.393 -173.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -139.96 149.48 43.33 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.713 -0.847 . . . . 75.439999999999998 108.713 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 6.5 p-10 -90.65 137.35 32.42 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 109.465 -0.568 . . . . 73.209999999999994 109.465 177.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 28.0 pt -91.01 110.45 42.22 Favored Pre-proline 0 C--N 1.304 -1.409 0 CA-C-N 115.698 -0.683 . . . . 74.010000000000005 109.856 177.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 496' ' ' ASP . 66.0 Cg_endo -90.71 150.4 4.14 Favored 'Trans proline' 0 N--CA 1.441 -1.562 0 C-N-CA 122.292 1.995 . . . . 72.120000000000005 111.97 178.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -78.88 91.5 4.78 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 122.517 1.151 . . . . 74.310000000000002 109.976 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 15.3 t -104.37 2.91 10.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.336 -1.357 . . . . 64.140000000000001 107.336 177.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -53.79 107.56 0.27 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.293 -1.321 . . . . 60.219999999999999 112.754 -175.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 177.85 27.85 0.04 OUTLIER Glycine 0 C--N 1.306 -1.117 0 N-CA-C 111.327 -0.709 . . . . 65.329999999999998 111.327 176.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.05 -170.85 3.43 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.267 -0.642 . . . . 71.400000000000006 109.267 -178.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 532' ' ' GLY . 8.8 t -84.13 157.91 21.55 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 109.076 -0.713 . . . . 70.549999999999997 109.076 -176.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.4 p -48.67 -41.77 12.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 124.194 0.997 . . . . 75.140000000000001 112.304 -177.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -61.53 -41.54 97.48 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.72 0.295 . . . . 74.239999999999995 111.778 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 47.3 t -76.01 -40.74 38.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-O 121.185 0.517 . . . . 74.299999999999997 110.602 -176.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.36 -46.88 84.49 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.068 -0.515 . . . . 61.020000000000003 110.224 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -61.95 -35.69 79.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.679 -0.691 . . . . 73.230000000000004 110.232 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.44 ' O ' HG23 ' A' ' 514' ' ' VAL . 0.3 OUTLIER -60.55 -43.08 97.63 Favored 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 109.016 -0.735 . . . . 75.420000000000002 109.016 177.13 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -62.57 -47.29 84.47 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.598 -0.274 . . . . 72.120000000000005 111.445 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.84 -40.07 94.03 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.733 0.301 . . . . 74.319999999999993 111.135 178.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.31 -38.16 88.37 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.055 -0.52 . . . . 73.099999999999994 110.636 178.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 510' ' ' LYS . 70.1 t -65.99 -31.16 52.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 115.886 -0.597 . . . . 74.239999999999995 110.746 176.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -78.44 -8.6 58.68 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.725 -0.39 . . . . 75.349999999999994 111.572 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 104.73 0.36 42.58 Favored Glycine 0 CA--C 1.504 -0.624 0 C-N-CA 120.859 -0.686 . . . . 70.310000000000002 112.557 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 83.8 m-85 -82.1 101.54 10.45 Favored 'General case' 0 CA--C 1.484 -1.595 0 N-CA-C 108.161 -1.051 . . . . 74.319999999999993 108.161 -178.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.5 m -100.0 -4.06 30.83 Favored 'General case' 0 N--CA 1.415 -2.205 0 CA-C-N 114.693 -1.139 . . . . 74.120000000000005 110.988 -173.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -116.61 114.25 23.84 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.589 -0.893 . . . . 75.519999999999996 108.589 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -132.16 152.11 51.44 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.483 -0.78 . . . . 74.129999999999995 112.451 -175.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 46.4 m -141.04 134.17 29.39 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.49 -1.3 . . . . 65.25 107.49 171.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 0.0 OUTLIER -118.82 138.84 52.43 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 117.907 0.321 . . . . 72.129999999999995 110.214 179.631 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -131.77 143.52 50.28 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.348 -1.353 . . . . 72.540000000000006 107.348 177.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 524' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 14.9 t -121.24 132.61 54.92 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.083 0.468 . . . . 73.340000000000003 110.089 -178.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 34.0 t -124.9 149.57 29.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 106.998 -1.482 . . . . 74.209999999999994 106.998 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . 0.527 ' HA ' ' HB3' ' A' ' 557' ' ' LYS . 4.1 p30 -66.59 134.69 52.85 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.892 0.853 . . . . 75.25 109.172 178.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 70.8 m -153.14 167.09 14.12 Favored Pre-proline 0 C--N 1.28 -2.442 0 CA-C-N 114.472 -1.24 . . . . 74.540000000000006 108.526 -173.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.86 -24.91 45.9 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.655 1.57 . . . . 73.319999999999993 113.055 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.98 142.2 79.26 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.595 -0.275 . . . . 74.430000000000007 111.183 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.61 151.78 60.41 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 123.263 2.642 . . . . 75.109999999999999 113.232 -178.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -62.47 119.66 9.57 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.366 -0.834 . . . . 74.310000000000002 111.44 -176.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 504' ' ' THR . . . 118.09 -22.19 9.85 Favored Glycine 0 N--CA 1.425 -2.049 0 C-N-CA 120.403 -0.903 . . . . 71.310000000000002 112.351 177.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -80.1 127.59 32.49 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.496 -0.927 . . . . 74.030000000000001 108.496 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 57.4 t -75.98 122.95 31.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 109.212 -0.662 . . . . 75.019999999999996 109.212 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 535' ' ' THR . . . . . 0.671 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 14.0 t -90.05 -14.86 32.96 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.186 -0.461 . . . . 63.409999999999997 110.898 -177.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 153.11 -158.01 27.67 Favored Glycine 0 N--CA 1.429 -1.819 0 N-CA-C 111.325 -0.71 . . . . 75.400000000000006 111.325 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 20.9 p -128.68 156.8 42.88 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 109.753 -0.462 . . . . 65.049999999999997 109.753 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -70.49 -50.39 14.43 Favored Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 116.298 -0.41 . . . . 72.150000000000006 110.077 176.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -63.11 135.32 50.29 Favored 'Trans proline' 0 C--N 1.371 1.738 0 N-CA-C 108.368 -1.435 . . . . 71.439999999999998 108.368 168.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.44 140.7 95.43 Favored 'Trans proline' 0 C--O 1.249 1.073 0 C-N-CA 122.656 2.237 . . . . 65.530000000000001 113.552 -176.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -67.83 134.66 51.3 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.646 -0.872 . . . . 73.040000000000006 108.646 176.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 103.82 -6.83 48.57 Favored Glycine 0 C--N 1.298 -1.551 0 C-N-CA 120.817 -0.706 . . . . 60.450000000000003 111.346 -176.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 23.6 m -81.57 131.6 35.28 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.891 -0.411 . . . . 74.420000000000002 109.891 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 27.9 m -90.33 122.89 33.62 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 108.087 -1.079 . . . . 70.129999999999995 108.087 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 13.0 m -134.88 157.72 76.51 Favored Pre-proline 0 C--N 1.309 -1.159 0 C-N-CA 122.659 0.384 . . . . 74.400000000000006 110.188 -177.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . 0.456 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 22.6 Cg_exo -67.62 139.93 50.16 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.492 2.128 . . . . 74.129999999999995 111.746 177.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.465 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 33.2 m -65.87 -20.04 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 122.265 1.031 . . . . 72.430000000000007 110.819 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -78.67 -10.05 59.62 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 113.666 -1.606 . . . . 75.299999999999997 111.252 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 94.4 p -96.5 172.96 7.6 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 120.631 -0.428 . . . . 64.519999999999996 110.868 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 7.1 p -102.65 129.66 53.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-O 120.904 0.383 . . . . 70.239999999999995 111.604 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.33 146.12 13.32 Favored 'Isoleucine or valine' 0 C--O 1.247 0.939 0 CA-C-O 121.181 0.515 . . . . 72.239999999999995 109.974 177.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -107.63 116.18 31.48 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-O 121.56 0.695 . . . . 74.030000000000001 110.861 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 51.7 mt -94.09 134.17 36.79 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 125.129 1.372 . . . . 74.120000000000005 108.864 -178.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -113.89 118.86 35.37 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 122.088 0.947 . . . . 74.239999999999995 110.921 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 524' ' ' SER . 39.7 t -101.26 139.75 21.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 CA-C-N 114.356 -1.293 . . . . 71.219999999999999 109.637 -175.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.671 ' OG ' ' HB ' ' A' ' 535' ' ' THR . 50.2 m -79.02 134.61 36.78 Favored 'General case' 0 N--CA 1.418 -2.032 0 CA-C-O 121.792 0.806 . . . . 73.209999999999994 111.172 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.527 ' HB3' ' HA ' ' A' ' 526' ' ' ASP . 11.3 tppt? -101.76 126.08 48.55 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 105.112 -2.181 . . . . 74.219999999999999 105.112 171.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -71.64 -45.29 45.85 Favored Glycine 0 CA--C 1.484 -1.906 0 C-N-CA 120.187 -1.006 . . . . 71.540000000000006 112.238 -172.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 57.1 t30 62.84 25.17 14.95 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-O 122.701 1.239 . . . . 71.010000000000005 109.042 177.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.44 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 94.4 mt-30 -129.35 156.96 43.2 Favored 'General case' 0 C--O 1.25 1.114 0 CA-C-N 114.538 -1.21 . . . . 70.430000000000007 110.733 -176.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -130.18 144.12 51.18 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.252 -0.885 . . . . 74.239999999999995 108.636 176.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 54.3 t -66.17 125.99 24.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 121.128 0.489 . . . . 64.310000000000002 112.278 -178.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 53.8 ttp -92.08 130.02 39.59 Favored Pre-proline 0 C--O 1.25 1.126 0 CA-C-N 115.501 -0.772 . . . . 64.310000000000002 110.853 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -71.85 169.9 20.09 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.087 2.524 . . . . 75.530000000000001 111.512 173.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -67.96 142.19 56.06 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 116.179 -0.464 . . . . 62.409999999999997 111.295 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.16 16.92 5.58 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.6 0.714 . . . . 72.129999999999995 111.266 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 16.9 m -64.37 130.54 44.19 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.427 -0.806 . . . . 55.310000000000002 109.74 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 100.15 24.23 9.85 Favored Glycine 0 C--N 1.308 -1.025 0 C-N-CA 120.655 -0.783 . . . . 64.450000000000003 112.478 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 90.6 mtp -109.54 144.51 37.73 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.274 -0.639 . . . . 74.409999999999997 109.274 177.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . 0.525 ' CD2' ' HB3' ' A' ' 602' ' ' ARG . 80.5 m-85 -101.34 140.08 36.12 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 107.048 -1.464 . . . . 75.329999999999998 107.048 -176.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 55.2 t90 -57.96 -28.72 64.6 Favored 'General case' 0 C--O 1.25 1.108 0 CA-C-O 121.139 0.495 . . . . 74.519999999999996 111.886 -177.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 35.8 m -73.4 -22.63 19.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.389 0.614 . . . . 74.209999999999994 111.196 -177.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . 0.612 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 12.4 t70 -101.53 -35.43 9.16 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.679 -0.691 . . . . 71.409999999999997 109.901 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . 0.414 ' O ' HD12 ' A' ' 578' ' ' LEU . . . -57.82 -50.84 71.93 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.193 0.997 . . . . 73.239999999999995 112.818 -177.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.503 ' O ' ' HG2' ' A' ' 579' ' ' ARG . 49.5 mt-10 -55.51 -56.22 31.68 Favored Pre-proline 0 N--CA 1.469 0.515 0 N-CA-C 112.9 0.704 . . . . 64.549999999999997 112.9 -178.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -53.95 -33.61 73.06 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 121.54 1.494 . . . . 73.25 113.465 176.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . 0.612 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 35.1 mmt180 -63.81 -47.59 80.22 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.894 -0.78 . . . . 63.409999999999997 108.894 177.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 574' ' ' ALA . 9.4 mp -66.08 -39.68 90.22 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.0 -1.0 . . . . 72.099999999999994 111.308 -177.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 11.6 mmm180 -65.05 -37.14 86.61 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.376 -0.375 . . . . 74.310000000000002 110.855 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.93 -30.87 69.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.362 0.601 . . . . 75.430000000000007 110.587 178.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 95.4 mt -81.65 -8.16 59.67 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.428 -0.805 . . . . 74.25 111.085 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 70.81 28.63 70.42 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.702 -0.559 . . . . 70.120000000000005 111.702 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 73.3 t90 -62.03 127.9 33.57 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 123.224 0.61 . . . . 73.310000000000002 110.569 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 12.1 m -128.24 84.5 2.25 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-O 121.24 0.543 . . . . 62.409999999999997 109.734 177.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -135.33 -145.21 5.1 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 109.243 -1.543 . . . . 65.120000000000005 109.243 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 26.5 ttt -134.77 125.92 27.91 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 117.262 0.531 . . . . 75.140000000000001 110.17 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -115.83 123.26 47.74 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 105.629 -1.989 . . . . 70.340000000000003 105.629 173.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -107.83 106.45 16.75 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 116.303 -0.408 . . . . 74.030000000000001 111.048 -175.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.62 110.14 22.62 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 106.239 -1.763 . . . . 74.540000000000006 106.239 174.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -98.92 -87.4 1.91 Allowed Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 109.663 -1.375 . . . . 73.329999999999998 109.663 176.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -102.53 133.02 48.19 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 120.763 0.316 . . . . 70.540000000000006 110.749 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -83.86 157.38 22.02 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.9 -1.148 . . . . 61.5 107.9 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 46.4 t -117.62 125.25 73.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 119.617 -0.833 . . . . 75.400000000000006 111.503 -175.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -81.63 106.66 13.75 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 105.495 -2.039 . . . . 75.209999999999994 105.495 172.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -132.69 -6.72 3.21 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 112.171 0.434 . . . . 71.549999999999997 112.171 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 82.94 -178.95 53.1 Favored Glycine 0 N--CA 1.418 -2.527 0 C-N-CA 120.79 -0.719 . . . . 51.229999999999997 111.565 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -62.92 -33.56 87.46 Favored Glycine 0 C--N 1.303 -1.28 0 CA-C-N 115.575 -0.312 . . . . 73.129999999999995 112.769 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 22.6 m -56.57 -33.63 66.34 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.782 0.66 . . . . 61.100000000000001 112.782 -176.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -108.23 -14.59 14.67 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 119.897 -0.721 . . . . 72.209999999999994 110.162 178.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . 0.413 ' CG ' ' H ' ' A' ' 601' ' ' ASN . 6.7 t-160 39.89 -160.19 0.0 OUTLIER 'General case' 0 CA--C 1.587 2.368 0 C-N-CA 126.095 1.758 . . . . 71.310000000000002 113.379 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . 0.413 ' H ' ' CG ' ' A' ' 600' ' ' HIS . 9.0 p30 -87.55 28.33 1.0 Allowed 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.288 -0.882 . . . . 73.219999999999999 110.053 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . 0.525 ' HB3' ' CD2' ' A' ' 570' ' ' PHE 0.254 3.1 ppt_? -102.15 168.5 9.33 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.833 -0.747 . . . . 74.450000000000003 112.824 -176.335 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 7.6 p -56.72 134.52 20.88 Favored 'Isoleucine or valine' 0 C--O 1.25 1.094 0 O-C-N 124.55 1.156 . . . . 62.25 112.23 -176.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 10.5 p -101.64 -32.57 3.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 119.581 -0.847 . . . . 73.310000000000002 109.018 177.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -154.81 140.47 18.0 Favored 'General case' 0 C--O 1.25 1.08 0 N-CA-C 107.168 -1.419 . . . . 64.349999999999994 107.168 174.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -98.23 122.12 41.0 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.745 -0.835 . . . . 72.140000000000001 108.745 173.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -55.08 -56.15 31.27 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 114.313 1.227 . . . . 73.230000000000004 114.313 -177.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -84.09 123.0 3.02 Favored 'Trans proline' 0 N--CA 1.438 -1.755 0 CA-C-N 120.643 1.265 . . . . 74.439999999999998 109.43 176.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -64.02 144.82 88.68 Favored 'Trans proline' 0 C--O 1.246 0.912 0 C-N-CA 122.159 1.906 . . . . 70.219999999999999 111.193 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -62.69 132.33 51.93 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.121 -0.696 . . . . 74.299999999999997 109.121 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 100.1 0.67 56.0 Favored Glycine 0 N--CA 1.437 -1.289 0 C-N-CA 119.766 -1.207 . . . . 72.430000000000007 111.994 -177.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 14.2 m -100.97 154.68 18.49 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.596 -0.89 . . . . 73.420000000000002 108.596 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -80.13 132.85 11.67 Favored Glycine 0 N--CA 1.431 -1.694 0 N-CA-C 112.111 -0.396 . . . . 73.219999999999999 112.111 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 34.9 m -114.5 142.48 27.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 109.35 -0.611 . . . . 64.400000000000006 109.35 176.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . 0.44 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 23.3 m-20 -57.75 169.6 0.7 Allowed 'General case' 0 CA--C 1.492 -1.255 0 C-N-CA 124.235 1.014 . . . . 72.530000000000001 111.803 -177.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -60.74 -24.6 65.85 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 113.774 -1.557 . . . . 73.040000000000006 110.22 172.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -77.07 -35.58 56.53 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 119.831 -0.748 . . . . 72.319999999999993 110.058 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 81.02 22.71 60.64 Favored Glycine 0 N--CA 1.426 -2.024 0 C-N-CA 118.484 -1.817 . . . . 74.120000000000005 113.409 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.73 119.66 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 122.489 1.138 . . . . 75.010000000000005 108.876 -174.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.72 132.93 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 N-CA-C 107.281 -1.377 . . . . 71.340000000000003 107.281 -173.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 19.0 m -111.09 134.95 52.29 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 121.786 -0.571 . . . . 72.329999999999998 111.095 -177.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 84.3 mt -137.54 154.1 49.88 Favored 'General case' 0 CA--C 1.497 -1.087 0 C-N-CA 125.106 1.363 . . . . 74.239999999999995 107.775 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 51.0 mmm-85 -128.22 137.36 51.99 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 104.431 -2.433 . . . . 74.340000000000003 104.431 169.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -141.87 165.49 27.32 Favored 'General case' 0 C--N 1.28 -2.423 0 O-C-N 124.263 0.977 . . . . 74.430000000000007 109.627 -174.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -97.02 -134.62 8.25 Favored Glycine 0 N--CA 1.417 -2.598 0 C-N-CA 120.464 -0.874 . . . . 73.209999999999994 112.034 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 . . . . . 0 C--N 1.295 -1.767 0 C-N-CA 123.991 0.916 . . . . 63.219999999999999 109.381 -177.629 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 . . . . . 0 CA--C 1.506 -0.731 0 N-CA-C 109.421 -0.585 . . . . 75.219999999999999 109.421 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.2 m -116.84 159.05 17.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 108.756 -0.831 . . . . 74.219999999999999 108.756 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -95.46 136.14 36.21 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 103.697 -2.705 . . . . 70.120000000000005 103.697 177.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 94.0 t -95.46 127.85 40.45 Favored Pre-proline 0 C--N 1.28 -2.443 0 C-N-CA 119.89 -0.724 . . . . 71.209999999999994 112.415 -163.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -67.56 113.35 2.9 Favored 'Trans proline' 0 N--CA 1.441 -1.597 0 C-N-CA 122.529 2.153 . . . . 75.530000000000001 110.306 174.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . 0.407 ' HB2' HG23 ' A' ' 402' ' ' THR . 19.9 p-10 -101.3 111.94 24.31 Favored 'General case' 0 C--N 1.262 -3.196 0 CA-C-N 113.959 -1.473 . . . . 62.420000000000002 110.819 -176.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.698 ' HB ' ' NE2' ' A' ' 368' ' ' GLN . 7.0 m -85.73 37.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 114.132 -1.394 . . . . 75.209999999999994 113.598 -176.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.38 146.79 54.46 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.337 -0.847 . . . . 74.120000000000005 110.601 172.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.35 -4.53 44.18 Favored Glycine 0 C--N 1.304 -1.249 0 N-CA-C 110.781 -0.927 . . . . 54.109999999999999 110.781 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . 0.698 ' NE2' ' HB ' ' A' ' 365' ' ' VAL . 16.4 mt-30 -109.19 -156.8 0.59 Allowed 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 107.658 -1.238 . . . . 74.209999999999994 107.658 177.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 60.4 p -99.1 167.15 10.89 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 109.087 -0.708 . . . . 74.5 109.087 -177.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 18.2 p -57.87 -46.67 84.5 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 123.438 0.461 . . . . 72.319999999999993 110.63 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.31 -41.9 89.03 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.756 -0.656 . . . . 53.420000000000002 112.327 -177.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -69.3 -42.58 75.23 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 121.504 0.669 . . . . 73.439999999999998 109.307 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.77 -47.61 74.6 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.381 -0.827 . . . . 75.239999999999995 111.577 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 65.6 mt -62.77 -39.99 86.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 65.219999999999999 110.836 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.09 -43.86 91.87 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.125 0.488 . . . . 71.129999999999995 110.558 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 18.1 m -63.73 -47.22 81.95 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.59 -0.732 . . . . 75.019999999999996 109.963 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 98.4 mt -61.91 -41.78 98.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.833 -0.621 . . . . 75.310000000000002 110.824 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -63.83 -41.16 97.91 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.896 -0.593 . . . . 72.019999999999996 110.51 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -63.12 -27.14 69.18 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 120.907 0.384 . . . . 75.030000000000001 111.412 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -90.79 -7.68 51.72 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 112.304 0.483 . . . . 75.310000000000002 112.304 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 95.23 7.99 59.1 Favored Glycine 0 C--N 1.307 -1.071 0 C-N-CA 120.856 -0.688 . . . . 71.340000000000003 113.055 177.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 75.0 m-85 -80.13 145.11 32.54 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-O 121.18 0.514 . . . . 74.299999999999997 111.385 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -92.07 143.41 26.49 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.603 -1.258 . . . . 73.450000000000003 107.603 -178.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.82 154.75 35.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 121.274 0.559 . . . . 73.310000000000002 111.267 -178.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -136.35 135.2 38.64 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 107.507 -1.294 . . . . 75.319999999999993 107.507 174.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 26.4 m -103.06 120.9 41.5 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 108.279 -1.008 . . . . 75.299999999999997 108.279 178.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -111.46 119.68 39.62 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 106.786 -1.561 . . . . 75.099999999999994 106.786 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . 0.472 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -102.61 131.87 49.09 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.56 0.695 . . . . 73.319999999999993 111.851 -177.218 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . 0.648 ' O ' ' HA ' ' A' ' 421' ' ' SER . 99.1 mttt -128.93 150.34 74.93 Favored Pre-proline 0 C--N 1.293 -1.855 0 N-CA-C 106.703 -1.591 . . . . 73.219999999999999 106.703 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -71.84 166.29 29.98 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 121.489 1.459 . . . . 75.129999999999995 110.558 176.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -76.35 87.4 3.14 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-O 121.848 0.833 . . . . 75.439999999999998 110.526 176.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' SER . . . . . 0.505 ' O ' ' HB ' ' A' ' 393' ' ' THR . 19.6 m -112.38 42.5 1.8 Allowed 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 106.735 -1.579 . . . . 74.409999999999997 106.735 173.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.505 ' HB ' ' O ' ' A' ' 392' ' ' SER . 99.6 m 70.88 29.32 3.1 Favored 'General case' 0 CA--C 1.573 1.861 0 CA-C-O 123.58 1.657 . . . . 73.209999999999994 109.551 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 1.7 pt -116.43 151.25 46.73 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 113.6 0.963 . . . . 75.209999999999994 113.6 -176.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -24.46 110.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.366 1.498 1 C-N-CA 126.584 4.856 . . . . 73.450000000000003 118.258 -175.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -68.45 162.3 41.28 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.262 3.308 . . . . 74.409999999999997 110.651 172.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.21 -13.88 3.6 Favored 'General case' 0 N--CA 1.507 2.396 0 CA-C-O 121.098 0.475 . . . . 74.109999999999999 111.882 -176.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -84.01 111.04 18.92 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 105.295 -2.113 . . . . 75.140000000000001 105.295 178.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 28.0 m -63.0 118.02 4.61 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 O-C-N 124.602 1.189 . . . . 72.329999999999998 112.335 -166.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.04 -28.59 2.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 114.84 -1.073 . . . . 64.409999999999997 109.727 -176.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -144.77 165.46 27.62 Favored Glycine 0 N--CA 1.428 -1.858 0 N-CA-C 110.289 -1.124 . . . . 73.129999999999995 110.289 -175.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' THR . . . . . 0.407 HG23 ' HB2' ' A' ' 364' ' ' ASP . 9.1 p -118.03 -178.85 3.6 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 113.341 0.867 . . . . 75.109999999999999 113.341 -173.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -102.32 140.42 21.12 Favored Pre-proline 0 N--CA 1.437 -1.117 0 N-CA-C 106.607 -1.627 . . . . 74.400000000000006 106.607 176.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -55.77 -24.63 47.52 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.314 2.676 . . . . 75.129999999999995 114.131 -176.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -62.38 -35.02 77.87 Favored 'General case' 0 C--O 1.209 -1.051 0 CA-C-N 116.543 -0.299 . . . . 72.430000000000007 111.368 -177.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -77.92 -35.75 50.21 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.492 0.663 . . . . 63.439999999999998 110.928 -178.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -82.02 -10.92 59.08 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.911 -0.586 . . . . 74.409999999999997 111.711 -175.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 25.0 m -103.35 160.28 14.83 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 106.428 -1.693 . . . . 73.340000000000003 106.428 177.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 5.9 p -76.68 113.0 13.84 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 118.322 0.51 . . . . 72.109999999999999 110.744 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 33.4 m -130.76 166.85 27.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.443 -0.577 . . . . 61.140000000000001 109.443 177.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 56.3 m -70.07 139.4 52.58 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.819 -0.808 . . . . 65.140000000000001 108.819 175.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -61.7 109.79 1.32 Allowed 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 120.92 0.391 . . . . 75.239999999999995 110.5 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 128.72 38.84 0.34 Allowed Glycine 0 N--CA 1.441 -1.003 0 CA-C-N 115.525 -0.761 . . . . 74.049999999999997 112.055 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -97.33 -171.7 2.26 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 108.028 -1.101 . . . . 73.25 108.028 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -111.86 124.78 53.1 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 122.771 0.429 . . . . 72.109999999999999 111.387 -173.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 46.7 mm -119.24 117.59 54.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 120.756 0.312 . . . . 74.530000000000001 110.17 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 13.5 t -89.86 131.03 36.0 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-O 121.348 0.594 . . . . 74.420000000000002 109.679 176.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 10.8 p -105.25 135.71 42.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 C-N-CA 124.105 0.962 . . . . 74.5 108.932 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.37 128.19 42.02 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 120.822 -0.351 . . . . 75.209999999999994 110.607 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 3.4 p -128.04 131.33 69.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 115.877 -0.601 . . . . 73.450000000000003 109.787 173.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' SER . . . . . 0.648 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 3.0 p -94.72 122.77 37.67 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-O 121.051 0.453 . . . . 64.329999999999998 109.929 174.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.8 t -119.24 106.62 12.51 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-O 121.41 0.624 . . . . 73.010000000000005 111.86 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.188 0 CA-C-N 115.572 -0.74 . . . . 75.340000000000003 114.136 174.9 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 16.3 tp60 . . . . . 0 N--CA 1.41 -2.468 0 N-CA-C 105.572 -2.01 . . . . 74.25 105.572 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.565 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 2.9 mmp_? -122.25 140.89 52.08 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.888 -0.725 . . . . 73.030000000000001 111.678 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . 0.408 ' O ' ' HD3' ' A' ' 430' ' ' PRO . 9.5 pt-20 -83.74 139.06 32.97 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 114.393 -1.276 . . . . 74.129999999999995 110.186 -177.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 57.9 mt -98.41 112.61 62.71 Favored Pre-proline 0 N--CA 1.418 -2.068 0 N-CA-C 106.81 -1.552 . . . . 75.319999999999993 106.81 174.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 428' ' ' GLU . 16.3 Cg_exo -73.07 141.07 32.22 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 N-CA-C 107.885 -1.621 . . . . 72.219999999999999 107.885 165.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -84.43 132.71 34.54 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 118.205 -1.398 . . . . 73.010000000000005 108.833 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 59.4 t -105.7 151.7 7.73 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 N-CA-C 105.968 -1.864 . . . . 75.319999999999993 105.968 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 39.2 m -57.08 141.21 46.78 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.213 0.53 . . . . 72.099999999999994 111.138 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 434' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 36.5 p -64.26 -26.71 68.62 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 114.102 1.149 . . . . 54.43 114.102 -172.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.5 pp -82.93 -15.84 49.76 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 119.841 -0.744 . . . . 73.209999999999994 110.92 176.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.81 40.04 1.15 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.284 1.034 . . . . 73.010000000000005 109.362 -177.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -52.0 -38.76 57.93 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.522 1.129 . . . . 75.230000000000004 112.592 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -60.99 -41.8 97.15 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.037 0.446 . . . . 70.25 110.573 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -70.64 -35.97 73.19 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.963 -0.562 . . . . 61.25 109.602 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.509 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.47 -51.51 69.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.981 -0.554 . . . . 72.420000000000002 110.992 -178.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 36.0 m -63.08 -40.89 90.78 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 N-CA-C 112.279 0.474 . . . . 72.310000000000002 112.279 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . 0.267 0.1 OUTLIER -68.63 -34.54 75.91 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 113.338 0.866 . . . . 74.239999999999995 113.338 177.729 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -64.52 -41.03 96.64 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.284 -1.006 . . . . 75.519999999999996 108.284 179.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.509 HD13 ' O ' ' A' ' 440' ' ' ALA . 7.0 mp -63.49 -32.92 74.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.507 -0.77 . . . . 63.030000000000001 110.92 176.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.407 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 61.5 m -69.42 -43.02 74.25 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 116.067 -0.515 . . . . 74.030000000000001 110.354 177.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.44 -26.01 66.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.638 -0.71 . . . . 75.129999999999995 111.209 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.65 -6.15 56.55 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.072 0.463 . . . . 74.349999999999994 111.834 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 121.33 -77.1 0.33 Allowed Glycine 0 CA--C 1.495 -1.194 0 C-N-CA 120.314 -0.946 . . . . 60.229999999999997 112.227 176.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . 0.431 ' HA ' ' O ' ' A' ' 480' ' ' ILE . 0.5 OUTLIER -40.13 -68.51 0.17 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.134 1.161 . . . . 74.400000000000006 114.134 176.738 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . 0.407 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 58.93 25.68 59.7 Favored Glycine 0 C--N 1.318 -0.458 0 C-N-CA 121.589 -0.338 . . . . 61.219999999999999 112.645 -177.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.459 ' CB ' ' HA ' ' A' ' 483' ' ' VAL . 52.6 mmt-85 -101.82 111.82 24.22 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 107.258 -1.386 . . . . 74.109999999999999 107.258 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -139.14 145.77 39.81 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-O 120.973 0.416 . . . . 74.430000000000007 111.175 -176.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -131.47 123.42 28.04 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.046 -1.094 . . . . 72.109999999999999 108.046 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -99.3 121.46 41.11 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.98 0.419 . . . . 75.310000000000002 110.755 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -116.97 154.47 30.83 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.254 -1.017 . . . . 72.239999999999995 108.254 177.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -130.55 141.94 50.47 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.3 -0.63 . . . . 64.200000000000003 109.3 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 50.3 m -145.44 149.86 42.27 Favored Pre-proline 0 C--N 1.291 -1.938 0 N-CA-C 109.494 -0.558 . . . . 64.140000000000001 109.494 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.661 ' HA ' ' O ' ' A' ' 490' ' ' SER . 36.8 Cg_endo -67.49 127.38 16.35 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.321 2.014 . . . . 74.439999999999998 110.651 177.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 50.6 m -147.22 179.51 7.58 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.974 -0.38 . . . . 73.439999999999998 109.974 -177.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.8 t -54.31 135.97 60.44 Favored Pre-proline 0 N--CA 1.437 -1.079 0 C-N-CA 123.958 0.903 . . . . 61.140000000000001 110.315 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.16 -30.41 32.27 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 124.461 3.441 . . . . 64.129999999999995 115.192 -172.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -73.12 -27.83 61.91 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.829 -0.748 . . . . 75.200000000000003 112.546 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 83.5 mt -89.23 -11.86 42.44 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.217 0.532 . . . . 72.420000000000002 110.252 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.402 HG12 ' HA ' ' A' ' 490' ' ' SER . 70.6 t -60.61 128.76 22.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.447 -0.797 . . . . 74.439999999999998 110.457 177.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 96.22 -13.63 65.54 Favored Glycine 0 N--CA 1.432 -1.633 0 CA-C-N 115.058 -0.974 . . . . 73.519999999999996 111.553 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -117.27 166.65 12.02 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 109.201 -0.666 . . . . 75.230000000000004 109.201 -176.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.467 ' O ' ' HB ' ' A' ' 434' ' ' THR . 72.0 t -70.68 147.22 11.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 N-CA-C 107.993 -1.114 . . . . 75.5 107.993 173.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 64.3 mt -97.74 -35.88 5.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 107.008 -1.479 . . . . 65.140000000000001 107.008 176.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 169.3 -178.84 42.25 Favored Glycine 0 N--CA 1.416 -2.64 0 N-CA-C 109.789 -1.324 . . . . 72.5 109.789 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 470' ' ' THR . . . . . 0.441 HG22 HG12 ' A' ' 486' ' ' ILE . 41.4 p -115.65 137.95 51.56 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 107.262 -1.384 . . . . 73.409999999999997 107.262 178.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.453 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 0.2 OUTLIER -62.85 -47.43 87.15 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 120.726 -0.389 . . . . 73.209999999999994 110.058 -179.494 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.453 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 12.9 Cg_exo -77.05 132.77 13.03 Favored 'Trans proline' 0 C--N 1.365 1.438 0 N-CA-C 106.852 -2.019 . . . . 63.520000000000003 106.852 167.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.88 127.04 20.29 Favored 'Trans proline' 0 C--O 1.239 0.564 0 C-N-CA 121.902 1.735 . . . . 65.140000000000001 112.739 -174.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -85.24 16.78 3.38 Favored 'General case' 0 C--O 1.203 -1.35 0 CA-C-N 114.949 -1.023 . . . . 74.430000000000007 110.89 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -112.27 -6.09 14.11 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.771 -0.65 . . . . 74.400000000000006 110.089 173.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -111.62 -175.29 2.66 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 115.598 -0.728 . . . . 72.400000000000006 110.96 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.89 148.82 22.21 Favored 'General case' 0 N--CA 1.404 -2.774 0 CA-C-N 115.32 -0.854 . . . . 64.400000000000006 111.45 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 27.1 t -133.65 149.67 51.56 Favored 'General case' 0 C--O 1.26 1.658 0 N-CA-C 108.683 -0.858 . . . . 70.409999999999997 108.683 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -79.63 157.46 27.28 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.139 -0.482 . . . . 74.400000000000006 109.739 178.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 449' ' ' PHE . 37.6 mm -71.07 -21.03 21.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.877 0.846 . . . . 74.400000000000006 109.919 -176.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 17.4 p -100.02 5.92 45.08 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.786 -0.643 . . . . 75.5 112.045 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -87.76 128.93 35.32 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.348 -0.612 . . . . 74.420000000000002 109.348 -176.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . 0.459 ' HA ' ' CB ' ' A' ' 451' ' ' ARG . 40.0 t -96.81 113.47 31.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.318 -0.993 . . . . 74.340000000000003 108.318 177.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 21.2 m -91.37 129.04 42.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 121.479 0.656 . . . . 74.099999999999994 111.378 -177.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -94.27 125.43 46.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-O 121.537 0.684 . . . . 74.200000000000003 109.259 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . 0.441 HG12 HG22 ' A' ' 470' ' ' THR . 6.0 mt -115.2 124.37 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 CA-C-N 114.658 -1.156 . . . . 73.019999999999996 109.566 -176.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 10.8 tt -104.75 126.82 59.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-O 121.021 0.439 . . . . 74.140000000000001 110.386 -176.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 32.9 m -108.22 151.77 10.27 Favored 'Isoleucine or valine' 0 C--O 1.252 1.232 0 CA-C-N 115.878 -0.601 . . . . 65.549999999999997 110.221 178.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.7 136.2 13.86 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 110.746 -0.942 . . . . 74.129999999999995 110.746 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.661 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 12.5 t . . . . . 0 C--N 1.297 -1.682 0 N-CA-C 109.041 -0.726 . . . . 74.319999999999993 109.041 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo . . . . . 0 N--CA 1.439 -1.704 0 N-CA-C 110.54 -0.6 . . . . 71.349999999999994 110.54 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -101.09 23.95 10.09 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 122.465 1.126 . . . . 72.519999999999996 109.649 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 494' ' ' THR . . . . . 0.457 ' HB ' ' OG1' ' A' ' 544' ' ' THR . 9.9 p -120.43 143.42 48.49 Favored 'General case' 0 C--N 1.273 -2.726 0 CA-C-N 113.695 -1.593 . . . . 72.040000000000006 110.267 -177.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -138.58 151.68 47.5 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.002 -1.111 . . . . 72.209999999999994 108.002 177.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.585 ' OD1' ' HB ' ' A' ' 544' ' ' THR . 69.0 m-20 -80.62 126.42 31.24 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.538 -1.282 . . . . 74.519999999999996 107.538 176.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 28.4 pt -76.06 126.54 86.66 Favored Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 123.381 0.425 . . . . 74.299999999999997 111.957 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -92.51 156.78 2.99 Favored 'Trans proline' 0 N--CA 1.445 -1.363 0 C-N-CA 122.674 2.249 . . . . 72.209999999999994 110.454 173.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -79.32 109.61 13.83 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 122.301 1.048 . . . . 61.520000000000003 109.972 178.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.2 p -95.05 17.08 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 122.871 1.32 . . . . 73.010000000000005 108.08 178.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -81.74 72.26 8.79 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 114.319 -1.309 . . . . 71.329999999999998 110.949 -177.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . -158.17 10.04 0.21 Allowed Glycine 0 C--N 1.291 -1.935 0 CA-C-N 114.793 -1.094 . . . . 75.430000000000007 110.71 177.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -139.92 176.44 8.75 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 106.378 -1.712 . . . . 73.400000000000006 106.378 -173.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 30.2 p -83.01 159.98 22.08 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 109.405 -0.591 . . . . 75.219999999999999 109.405 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.7 p -50.54 -41.11 19.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 123.84 0.856 . . . . 74.409999999999997 112.47 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -63.68 -42.41 98.03 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.344 0.593 . . . . 63.200000000000003 111.089 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 61.6 t -75.9 -38.62 36.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.806 -0.634 . . . . 72.109999999999999 110.105 -177.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.18 -48.56 77.86 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.105 -0.498 . . . . 62.340000000000003 111.442 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -61.95 -38.56 88.96 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.234 0.334 . . . . 74.439999999999998 110.541 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.473 ' O ' HG22 ' A' ' 514' ' ' VAL . 6.3 tmtm? -59.2 -48.96 79.66 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.937 -0.764 . . . . 74.109999999999999 108.937 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -62.65 -42.26 99.51 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 116.274 -0.421 . . . . 73.140000000000001 111.346 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 97.4 mt -65.26 -40.65 94.23 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.335 -0.393 . . . . 75.430000000000007 111.494 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -61.78 -37.98 86.37 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.951 -0.388 . . . . 62.020000000000003 109.951 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 510' ' ' LYS . 73.2 t -61.97 -35.75 70.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 115.633 -0.712 . . . . 65.140000000000001 110.83 176.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -78.92 -8.1 58.57 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 112.101 0.408 . . . . 73.019999999999996 112.101 -178.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 112.47 -13.44 25.48 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.439 -0.886 . . . . 74.340000000000003 112.381 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -81.43 95.75 7.16 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 106.905 -1.517 . . . . 73.219999999999999 106.905 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.8 m -98.17 -3.6 37.3 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 119.695 -0.802 . . . . 73.439999999999998 111.497 -172.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -120.54 114.56 21.92 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.457 -0.572 . . . . 75.010000000000005 109.457 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -131.35 150.76 52.02 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.903 -0.59 . . . . 71.540000000000006 110.775 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 49.7 m -127.94 143.23 51.09 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 107.445 -1.317 . . . . 73.310000000000002 107.445 174.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.31 125.6 51.34 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-O 120.906 0.384 . . . . 71.299999999999997 111.641 -178.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -116.31 117.17 29.25 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.617 -0.883 . . . . 70.239999999999995 108.617 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 524' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 19.5 m -94.92 131.63 40.63 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.089 0.471 . . . . 73.530000000000001 112.144 -176.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 28.6 m -121.29 153.29 24.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 107.703 -1.221 . . . . 72.430000000000007 107.703 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -84.83 139.33 31.99 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.77 -0.772 . . . . 74.239999999999995 111.626 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 64.9 p -162.27 156.71 18.81 Favored Pre-proline 0 C--O 1.19 -2.066 0 N-CA-C 106.549 -1.649 . . . . 70.129999999999995 106.549 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -61.07 -12.89 24.82 Favored 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 122.005 1.803 . . . . 74.019999999999996 113.383 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -70.59 130.86 88.45 Favored Pre-proline 0 N--CA 1.45 -0.443 0 N-CA-C 108.52 -0.918 . . . . 74.400000000000006 108.52 178.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.3 147.26 78.07 Favored 'Trans proline' 0 C--O 1.253 1.25 0 C-N-CA 122.761 2.307 . . . . 74.409999999999997 113.301 -177.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -59.15 127.85 34.22 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.896 -1.047 . . . . 73.030000000000001 111.367 -175.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 119.43 -19.15 9.96 Favored Glycine 0 C--N 1.3 -1.424 0 N-CA-C 111.16 -0.776 . . . . 64.299999999999997 111.16 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -72.54 132.45 43.83 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.227 -0.657 . . . . 74.239999999999995 109.227 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 59.6 t -89.42 113.96 26.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 108.664 -0.865 . . . . 75.439999999999998 108.664 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 535' ' ' THR . . . . . 0.428 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 11.4 t -86.96 -20.49 27.22 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.695 -0.402 . . . . 72.310000000000002 111.173 -176.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 169.92 -163.4 36.82 Favored Glycine 0 CA--C 1.494 -1.239 0 C-N-CA 120.412 -0.899 . . . . 75.340000000000003 111.29 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 46.0 p -129.45 154.8 46.61 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.181 -1.414 . . . . 75.420000000000002 107.181 176.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -68.53 -54.2 14.78 Favored Pre-proline 0 C--N 1.309 -1.153 0 C-N-CA 119.959 -0.697 . . . . 63.32 110.446 177.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.32 136.91 29.94 Favored 'Trans proline' 0 C--N 1.371 1.74 0 CA-C-N 119.887 0.996 . . . . 73.239999999999995 110.009 175.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.1 145.08 65.85 Favored 'Trans proline' 0 C--O 1.254 1.284 0 C-N-CA 122.692 2.262 . . . . 74.439999999999998 113.186 -178.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.94 141.72 57.86 Favored 'General case' 0 C--O 1.247 0.952 0 CA-C-N 115.804 -0.634 . . . . 74.519999999999996 110.5 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 99.32 -12.03 61.75 Favored Glycine 0 N--CA 1.432 -1.604 0 CA-C-N 115.695 -0.684 . . . . 72.329999999999998 111.428 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 49.8 m -77.28 132.7 38.79 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 108.875 -0.787 . . . . 72.510000000000005 108.875 177.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.585 ' HB ' ' OD1' ' A' ' 496' ' ' ASP . 10.0 t -87.69 124.05 33.16 Favored 'General case' 0 N--CA 1.419 -2.006 0 CA-C-O 121.304 0.573 . . . . 72.430000000000007 109.699 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 19.6 m -125.88 154.89 73.59 Favored Pre-proline 0 C--N 1.297 -1.697 0 N-CA-C 108.15 -1.056 . . . . 73.310000000000002 108.15 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -71.82 136.22 27.28 Favored 'Trans proline' 0 N--CA 1.443 -1.472 0 C-N-CA 121.842 1.694 . . . . 75.319999999999993 110.168 175.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 32.6 m -64.96 -19.89 26.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.941 0.877 . . . . 75.219999999999999 110.512 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -76.12 -14.86 60.17 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.247 -1.342 . . . . 74.450000000000003 111.027 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 67.4 m -94.51 -171.93 2.63 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.215 -0.448 . . . . 73.120000000000005 111.92 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 18.1 t -116.02 126.61 73.59 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 CA-C-N 116.262 -0.426 . . . . 63.340000000000003 110.325 -174.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -102.49 145.91 11.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.556 -0.535 . . . . 64.5 109.556 175.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -108.82 121.46 45.11 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-O 121.406 0.622 . . . . 75.120000000000005 111.085 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 59.4 mt -97.99 134.5 41.02 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.389 -1.278 . . . . 74.120000000000005 108.315 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -106.33 119.5 39.41 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-O 122.158 0.98 . . . . 74.329999999999998 109.847 177.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 524' ' ' SER . 57.2 t -105.82 145.5 13.77 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 CA-C-N 113.898 -1.501 . . . . 75.420000000000002 109.977 -171.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.646 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 63.3 m -83.41 133.65 34.92 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-O 121.602 0.715 . . . . 75.099999999999994 111.613 178.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.77 137.35 42.71 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 104.829 -2.285 . . . . 75.219999999999999 104.829 169.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -75.87 -47.82 11.07 Favored Glycine 0 N--CA 1.433 -1.524 0 C-N-CA 118.42 -1.847 . . . . 63.439999999999998 110.763 -175.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 5.7 t30 61.24 -7.51 0.09 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 113.458 0.91 . . . . 71.510000000000005 113.458 175.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.504 ' H ' ' C ' ' A' ' 558' ' ' GLY . 25.4 tp60 -139.32 141.23 37.7 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 103.354 -2.832 . . . . 73.200000000000003 103.354 -177.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -141.82 153.26 44.39 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 118.653 0.66 . . . . 72.239999999999995 111.067 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 70.2 t -69.58 118.19 13.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 N-CA-C 108.764 -0.828 . . . . 75.409999999999997 108.764 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 58.8 ttp -88.87 134.36 33.78 Favored Pre-proline 0 C--N 1.304 -1.395 0 C-N-CA 120.376 -0.529 . . . . 72.310000000000002 110.392 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -66.03 161.92 37.72 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.518 2.146 . . . . 75.230000000000004 109.92 171.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -80.89 132.68 35.46 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.147 -0.621 . . . . 75.530000000000001 111.793 -177.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . 0.455 HD13 ' SD ' ' A' ' 569' ' ' MET . 39.7 tp -138.16 19.28 2.79 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.326 -1.361 . . . . 74.140000000000001 107.326 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 11.9 m -73.72 131.37 41.53 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.25 -0.886 . . . . 64.200000000000003 110.707 -173.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 71.56 9.87 69.95 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 114.397 0.519 . . . . 64.519999999999996 114.397 176.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 569' ' ' MET . . . . . 0.455 ' SD ' HD13 ' A' ' 566' ' ' LEU . 86.7 mtp -90.73 153.63 20.13 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.197 -0.668 . . . . 73.540000000000006 109.197 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 98.8 m-85 -73.24 140.28 46.78 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 120.721 0.296 . . . . 75.310000000000002 110.757 -175.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 32.1 t90 -66.01 -17.89 64.98 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 123.859 0.864 . . . . 74.0 110.335 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 35.3 m -78.05 -24.2 13.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.244 0.545 . . . . 72.209999999999994 109.96 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . 0.629 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 31.4 t70 -101.43 -28.26 12.68 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.341 -0.845 . . . . 73.230000000000004 109.637 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -65.92 -32.37 73.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.86 -0.609 . . . . 73.430000000000007 110.851 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.531 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 12.9 tp10 -57.79 -53.29 67.24 Favored Pre-proline 0 CA--C 1.583 2.235 0 CA-C-N 115.879 -0.6 . . . . 75.219999999999999 111.136 177.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . 0.498 ' HD2' ' O ' ' A' ' 573' ' ' ASP . 50.6 Cg_exo -59.56 -36.64 92.29 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 121.32 1.346 . . . . 72.109999999999999 112.699 171.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . 0.629 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 22.8 mmt180 -59.8 -44.66 93.85 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 120.75 0.309 . . . . 73.530000000000001 110.677 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.4 pp -65.44 -40.43 93.27 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.024 -0.535 . . . . 74.010000000000005 112.247 -175.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . 0.447 ' N ' HD13 ' A' ' 578' ' ' LEU . 73.6 mtp180 -65.72 -35.39 80.61 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.148 0.499 . . . . 73.040000000000006 110.951 176.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.33 -39.11 74.93 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.001 -0.545 . . . . 74.430000000000007 111.192 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 89.0 mt -83.03 -7.27 59.68 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.385 0.513 . . . . 74.349999999999994 112.385 -177.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 74.28 39.52 43.49 Favored Glycine 0 C--O 1.241 0.585 0 C-N-CA 120.638 -0.791 . . . . 72.239999999999995 111.533 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 33.2 t90 -67.72 127.16 31.73 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 109.579 -0.526 . . . . 74.439999999999998 109.579 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 3.7 m -116.76 10.3 14.21 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.466 -0.938 . . . . 73.0 108.466 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -77.69 177.4 53.0 Favored Glycine 0 N--CA 1.431 -1.67 0 CA-C-N 115.354 -0.839 . . . . 74.5 113.51 -173.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 52.4 tpp -104.24 140.3 38.04 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 109.235 -0.654 . . . . 74.239999999999995 109.235 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -80.58 130.23 35.0 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.071 -1.826 . . . . 74.439999999999998 106.071 176.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -95.04 102.07 13.86 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.486 0.66 . . . . 75.5 110.592 -176.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -88.38 110.17 20.58 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.914 -1.039 . . . . 74.519999999999996 109.228 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . 0.42 ' HA3' ' NH2' ' A' ' 623' ' ' ARG . . . -114.22 -86.73 1.46 Allowed Glycine 0 N--CA 1.43 -1.706 0 N-CA-C 109.7 -1.36 . . . . 63.119999999999997 109.7 176.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.19 147.99 42.54 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.21 -1.034 . . . . 73.310000000000002 108.21 176.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -90.74 141.39 28.85 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.214 -1.032 . . . . 64.349999999999994 108.214 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 60.8 t -107.43 121.7 60.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 110.575 -0.157 . . . . 65.450000000000003 110.575 -173.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -86.55 107.5 18.15 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.165 -1.014 . . . . 65.239999999999995 108.577 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -150.03 22.67 0.86 Allowed 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.974 -0.75 . . . . 74.439999999999998 108.974 -177.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 92.06 82.35 1.46 Allowed Glycine 0 N--CA 1.424 -2.147 0 N-CA-C 109.385 -1.486 . . . . 71.230000000000004 109.385 -176.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.18 -43.85 88.9 Favored Glycine 0 C--O 1.208 -1.49 0 O-C-N 123.93 0.429 . . . . 72.200000000000003 112.645 -175.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 25.5 m -59.23 -28.72 66.94 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 113.377 0.88 . . . . 73.040000000000006 113.377 -178.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -106.85 -12.59 15.45 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.367 0.603 . . . . 71.540000000000006 111.456 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . 0.503 ' C ' ' H ' ' A' ' 602' ' ' ARG . 35.6 m80 -130.62 22.22 5.07 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 113.49 0.922 . . . . 65.150000000000006 113.49 -173.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -77.41 37.57 0.22 Allowed 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 122.429 1.109 . . . . 74.319999999999993 109.761 175.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . 0.503 ' H ' ' C ' ' A' ' 600' ' ' HIS . 12.1 ptt180 -125.44 166.53 16.44 Favored 'General case' 0 N--CA 1.412 -2.368 0 C-N-CA 125.703 1.601 . . . . 74.340000000000003 108.305 -176.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 55.6 t -63.46 129.84 27.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.458 -0.941 . . . . 75.340000000000003 108.458 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 35.3 m -94.66 -45.02 13.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 119.999 -0.681 . . . . 72.439999999999998 110.464 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -131.02 146.59 52.44 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 106.062 -1.829 . . . . 73.239999999999995 106.062 174.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -120.51 129.33 53.78 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 107.331 -1.359 . . . . 74.230000000000004 107.331 -175.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.478 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 30.5 t30 -84.9 -71.76 0.1 Allowed Pre-proline 0 CA--C 1.563 1.465 0 N-CA-C 114.687 1.366 . . . . 64.099999999999994 114.687 -173.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 6.1 Cg_exo -76.14 114.77 3.98 Favored 'Trans proline' 0 C--N 1.372 1.775 0 CA-C-N 122.05 1.768 . . . . 73.129999999999995 109.547 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -63.29 135.57 50.98 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 122.476 2.117 . . . . 63.509999999999998 114.205 -171.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.84 138.69 56.3 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.041 -0.981 . . . . 73.409999999999997 109.379 177.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 94.45 -19.54 53.02 Favored Glycine 0 C--N 1.302 -1.319 0 N-CA-C 110.662 -0.975 . . . . 74.310000000000002 110.662 -176.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 28.9 m -98.58 162.75 12.97 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 107.878 -1.156 . . . . 73.409999999999997 107.878 178.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -74.39 116.47 5.2 Favored Glycine 0 N--CA 1.424 -2.137 0 CA-C-O 121.43 0.461 . . . . 64.310000000000002 112.462 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 20.5 m -104.94 144.48 14.68 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 107.194 -1.409 . . . . 71.120000000000005 107.194 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . 0.467 HD22 HG23 ' A' ' 619' ' ' ILE . 28.4 p30 -48.43 148.59 1.9 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 112.513 0.561 . . . . 70.239999999999995 112.513 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -55.38 -24.42 29.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.598 -0.728 . . . . 72.25 112.408 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . 0.47 ' OD2' ' HB ' ' A' ' 619' ' ' ILE . 19.2 t70 -61.52 -53.22 59.19 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.569 -1.271 . . . . 73.340000000000003 107.569 175.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 96.5 19.33 27.93 Favored Glycine 0 N--CA 1.419 -2.445 0 CA-C-N 114.992 -1.004 . . . . 63.109999999999999 111.416 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . 0.47 ' HB ' ' OD2' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -69.18 119.93 15.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 122.151 0.977 . . . . 60.130000000000003 109.73 -173.433 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.27 130.37 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.602 0 CA-C-N 114.611 -1.177 . . . . 75.030000000000001 108.158 -176.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 6.5 m -98.26 118.01 33.95 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.38 -0.97 . . . . 75.409999999999997 108.38 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . 0.582 ' O ' ' HD2' ' A' ' 623' ' ' ARG . 2.4 pt? -138.78 157.69 45.61 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.063 -0.517 . . . . 74.400000000000006 109.814 -177.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . 0.582 ' HD2' ' O ' ' A' ' 622' ' ' LEU . 6.9 mpt_? -129.63 143.08 50.66 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 105.202 -2.147 . . . . 75.340000000000003 105.202 171.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -141.22 165.23 28.1 Favored 'General case' 0 C--N 1.293 -1.861 0 O-C-N 123.896 0.747 . . . . 75.430000000000007 110.51 -178.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -66.55 138.74 36.23 Favored Glycine 0 N--CA 1.426 -2.004 0 CA-C-N 114.813 -1.085 . . . . 72.439999999999998 112.726 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 C--N 1.286 -2.158 0 C-N-CA 124.736 1.214 . . . . 74.439999999999998 109.02 -178.349 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 CA--C 1.48 -1.725 0 N-CA-C 108.887 -0.783 . . . . 71.019999999999996 108.887 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 409' ' ' SER . 31.2 m -133.81 159.51 42.45 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 CA-C-N 115.332 -0.849 . . . . 55.009999999999998 108.747 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -93.99 138.26 32.3 Favored 'General case' 0 N--CA 1.39 -3.437 0 N-CA-C 107.45 -1.315 . . . . 72.430000000000007 107.45 174.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 78.1 t -95.72 129.43 34.52 Favored Pre-proline 0 C--N 1.267 -3.001 0 CA-C-N 115.297 -0.865 . . . . 73.120000000000005 109.056 -172.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -57.77 127.71 26.28 Favored 'Trans proline' 0 CA--C 1.498 -1.302 0 C-N-CA 122.233 1.955 . . . . 73.439999999999998 110.153 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -80.21 126.36 31.02 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.196 -1.039 . . . . 75.319999999999993 108.196 -174.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.423 ' CG2' ' HB2' ' A' ' 373' ' ' ALA . 10.7 m -88.88 1.24 7.15 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 N-CA-C 113.387 0.884 . . . . 71.450000000000003 113.387 -173.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -56.48 144.7 30.31 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 123.584 0.552 . . . . 73.409999999999997 111.206 176.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.69 -16.6 47.43 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.728 -0.669 . . . . 53.119999999999997 112.398 -178.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -99.27 -156.12 0.53 Allowed 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 108.368 -0.975 . . . . 73.129999999999995 108.368 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 95.8 p -98.86 175.1 6.07 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 107.375 -1.343 . . . . 54.340000000000003 107.375 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.0 p -63.17 -44.71 94.66 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 109.799 -0.445 . . . . 71.340000000000003 109.799 175.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.58 -46.27 83.44 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 116.216 -0.447 . . . . 72.030000000000001 111.299 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.52 -38.47 91.14 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 121.0 0.429 . . . . 73.540000000000006 111.64 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . 0.423 ' HB2' ' CG2' ' A' ' 365' ' ' VAL . . . -67.49 -47.88 68.72 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.98 -0.554 . . . . 64.219999999999999 110.575 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 82.1 mt -60.98 -43.72 96.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-N 115.728 -0.669 . . . . 75.519999999999996 110.411 176.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.76 -42.75 89.63 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 115.856 -0.611 . . . . 65.200000000000003 111.002 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' THR . . . . . 0.56 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 31.2 m -67.37 -48.01 68.7 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.738 -0.664 . . . . 74.329999999999998 110.228 -178.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 92.0 mt -64.64 -39.0 92.92 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 112.152 0.427 . . . . 75.530000000000001 112.152 -178.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -64.43 -41.21 96.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.803 0.335 . . . . 72.340000000000003 110.176 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -70.05 -20.56 63.23 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 112.176 0.436 . . . . 71.409999999999997 112.176 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . 0.56 ' HG2' ' O ' ' A' ' 376' ' ' THR . 5.9 mmp_? -86.43 -12.62 48.6 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.023 0.439 . . . . 71.420000000000002 109.869 176.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.09 3.95 55.53 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 121.182 -0.532 . . . . 72.530000000000001 112.982 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -80.66 164.81 22.56 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-O 120.954 0.407 . . . . 74.400000000000006 110.301 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -108.43 141.52 40.17 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 107.531 -1.285 . . . . 73.420000000000002 107.531 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.58 152.79 30.86 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.491 0 CA-C-O 121.323 0.583 . . . . 75.430000000000007 110.199 -177.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -133.07 127.05 33.18 Favored 'General case' 0 N--CA 1.4 -2.974 0 N-CA-C 106.644 -1.613 . . . . 73.209999999999994 106.644 175.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 21.0 m -118.36 123.27 44.89 Favored 'General case' 0 C--N 1.271 -2.821 0 N-CA-C 107.887 -1.153 . . . . 74.239999999999995 107.887 -175.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.17 121.37 44.74 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.873 -1.158 . . . . 72.340000000000003 107.873 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -94.08 126.67 39.43 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.3 -0.629 . . . . 75.049999999999997 109.3 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -130.87 136.57 29.11 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 110.055 -0.35 . . . . 65.129999999999995 110.055 175.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . 0.59 ' HA ' ' O ' ' A' ' 422' ' ' THR . 23.5 Cg_exo -68.06 166.45 24.85 Favored 'Trans proline' 0 C--O 1.248 0.984 0 C-N-CA 122.066 1.844 . . . . 71.420000000000002 110.125 172.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 2.9 m-20 85.04 170.25 0.08 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.349 1.059 . . . . 73.329999999999998 110.645 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 69.3 p -108.82 9.28 26.84 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 120.677 0.275 . . . . 70.340000000000003 111.39 -176.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 15.4 t -78.43 -7.02 56.91 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.627 0.727 . . . . 71.329999999999998 110.901 -177.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.87 151.5 46.47 Favored Pre-proline 0 C--N 1.298 -1.656 0 N-CA-C 107.882 -1.155 . . . . 73.400000000000006 107.882 175.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -32.79 131.24 0.1 Allowed 'Trans proline' 0 C--N 1.363 1.316 0 C-N-CA 124.569 3.513 . . . . 75.430000000000007 114.928 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.25 164.37 3.85 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 124.476 3.451 . . . . 74.140000000000001 113.352 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -56.43 -8.64 0.56 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.525 1.13 . . . . 75.239999999999995 112.355 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 60.3 m170 -115.79 131.61 56.89 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 104.563 -2.384 . . . . 65.430000000000007 104.563 170.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 24.7 m -71.03 117.15 13.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-O 121.978 0.894 . . . . 75.400000000000006 111.453 -169.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 50.0 mm -102.99 -26.66 3.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.078 -1.082 . . . . 71.040000000000006 108.078 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -144.31 157.53 27.2 Favored Glycine 0 N--CA 1.399 -3.807 0 N-CA-C 109.486 -1.446 . . . . 51.119999999999997 109.486 -178.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 8.0 p -146.56 -176.17 5.08 Favored 'General case' 0 C--N 1.275 -2.662 0 C-N-CA 125.111 1.364 . . . . 74.040000000000006 107.808 -172.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -100.58 139.74 20.85 Favored Pre-proline 0 C--N 1.29 -2.004 0 N-CA-C 108.272 -1.01 . . . . 72.120000000000005 108.272 -174.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.21 -12.89 6.02 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 123.951 3.101 . . . . 74.510000000000005 114.691 -176.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -50.05 -41.29 47.44 Favored 'General case' 0 C--O 1.212 -0.902 0 C-N-CA 123.742 0.817 . . . . 73.349999999999994 111.584 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -71.46 -32.77 68.68 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.291 0.567 . . . . 74.140000000000001 111.398 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -85.32 -1.17 56.68 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.709 0.766 . . . . 72.409999999999997 110.683 -177.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 19.0 m -102.19 151.01 22.71 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 107.1 -1.444 . . . . 73.420000000000002 107.1 174.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 409' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 360' ' ' VAL . 20.2 m -74.68 113.83 12.4 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 108.876 -0.787 . . . . 71.120000000000005 108.876 178.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.6 m -120.24 170.3 10.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 116.272 -0.422 . . . . 73.230000000000004 110.551 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 25.8 t -77.38 150.97 35.04 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.096 -1.076 . . . . 73.430000000000007 108.096 176.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -65.61 122.12 16.52 Favored 'General case' 0 C--O 1.245 0.836 0 N-CA-C 109.413 -0.588 . . . . 71.400000000000006 109.413 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 94.62 68.25 1.04 Allowed Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 110.25 -1.14 . . . . 42.200000000000003 110.25 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -127.96 -179.51 5.01 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.528 -1.286 . . . . 63.530000000000001 107.528 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -111.4 119.65 39.53 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.049 0.452 . . . . 74.340000000000003 110.674 -174.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 46.1 mm -106.21 120.83 57.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 109.203 -0.666 . . . . 70.209999999999994 109.203 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 22.4 p -92.55 130.88 38.07 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.016 0.436 . . . . 74.450000000000003 111.307 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 5.4 p -126.82 135.33 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 109.072 -0.714 . . . . 70.439999999999998 109.072 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.81 125.76 54.35 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 109.41 -0.589 . . . . 74.340000000000003 109.41 178.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 11.5 p -121.51 143.93 32.32 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 115.478 -0.783 . . . . 73.510000000000005 110.727 -174.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 31.3 t -84.16 121.46 27.48 Favored 'General case' 0 C--O 1.252 1.197 0 CA-C-N 115.682 -0.69 . . . . 54.43 109.679 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' THR . . . . . 0.59 ' O ' ' HA ' ' A' ' 390' ' ' PRO . 14.4 t -121.08 107.73 12.97 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 115.83 -0.623 . . . . 74.430000000000007 111.759 175.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.357 0 C-N-CA 119.099 -1.524 . . . . 72.129999999999995 115.424 172.426 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 106.291 -1.744 . . . . 73.239999999999995 106.291 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' A' ' 447' ' ' ALA . 5.0 mmp_? -127.7 148.89 50.41 Favored 'General case' 0 C--O 1.209 -1.073 0 N-CA-C 113.815 1.043 . . . . 75.230000000000004 113.815 -178.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -83.42 138.52 33.44 Favored 'General case' 0 C--N 1.286 -2.157 0 C-N-CA 126.237 1.815 . . . . 74.420000000000002 110.548 178.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.403 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 66.5 mt -83.59 119.28 73.5 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 108.684 -0.858 . . . . 73.219999999999999 108.684 177.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.83 152.53 63.85 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.909 2.406 . . . . 73.430000000000007 113.823 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -91.42 110.1 21.39 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 115.763 -0.653 . . . . 71.219999999999999 109.457 176.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 42.2 t -116.77 150.34 18.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.354 -0.98 . . . . 74.019999999999996 108.354 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.579 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 17.0 m -68.62 150.88 47.47 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 121.071 0.462 . . . . 71.209999999999994 110.975 -179.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 40.5 p -69.77 -27.33 64.84 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 123.75 0.82 . . . . 71.530000000000001 113.179 -172.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.9 pp -88.07 -11.13 48.06 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.46 0.647 . . . . 74.129999999999995 111.349 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.579 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 0.8 OUTLIER -99.59 45.37 0.99 Allowed 'General case' 0 CA--C 1.56 1.341 0 CA-C-N 115.464 -0.789 . . . . 74.25 109.869 -175.672 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -52.65 -38.91 61.2 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 114.198 1.184 . . . . 73.150000000000006 114.198 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.488 ' O ' ' HG3' ' A' ' 442' ' ' LYS . . . -64.69 -39.56 93.87 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 120.527 -0.469 . . . . 52.439999999999998 110.544 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -65.77 -36.17 82.78 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 108.684 -0.858 . . . . 75.109999999999999 108.684 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.525 ' O ' HD11 ' A' ' 444' ' ' LEU . . . -60.91 -51.63 68.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.172 -0.467 . . . . 71.299999999999997 111.46 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 27.2 m -65.86 -39.02 83.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 112.321 0.489 . . . . 74.319999999999993 112.321 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 438' ' ' ALA 0.3 0.0 OUTLIER -68.37 -34.07 75.4 Favored 'General case' 0 C--O 1.214 -0.764 0 N-CA-C 112.985 0.735 . . . . 75.549999999999997 112.985 176.483 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -61.25 -43.38 98.98 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.047 0.451 . . . . 73.340000000000003 110.056 175.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.525 HD11 ' O ' ' A' ' 440' ' ' ALA . 7.1 mp -63.67 -35.75 81.56 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.599 -0.728 . . . . 73.439999999999998 110.706 177.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.605 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 26.9 m -71.16 -45.98 62.41 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.108 -0.496 . . . . 64.230000000000004 111.078 178.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -65.41 -20.05 66.21 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.227 0.611 . . . . 74.420000000000002 110.995 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . 0.544 ' O ' ' HG3' ' A' ' 427' ' ' ARG . . . -79.35 -3.92 48.5 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.853 -0.612 . . . . 62.340000000000003 111.433 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 118.05 -78.6 0.3 Allowed Glycine 0 CA--C 1.49 -1.503 0 C-N-CA 120.716 -0.754 . . . . 75.209999999999994 111.562 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . 0.441 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 2.8 p90 -43.48 -66.82 0.33 Allowed 'General case' 0 C--O 1.241 0.652 0 N-CA-C 113.473 0.916 . . . . 64.150000000000006 113.473 177.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . 0.605 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 62.19 27.63 69.4 Favored Glycine 0 CA--C 1.487 -1.671 0 N-CA-C 111.037 -0.825 . . . . 74.420000000000002 111.037 -175.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -103.91 110.11 22.11 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 106.701 -1.592 . . . . 75.430000000000007 106.701 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . 0.415 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 27.9 p90 -135.67 154.71 51.2 Favored 'General case' 0 N--CA 1.408 -2.547 0 CA-C-N 115.66 -0.7 . . . . 74.319999999999993 109.721 -176.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -130.77 122.9 28.03 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 107.783 -1.191 . . . . 74.150000000000006 107.783 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -86.8 129.98 34.65 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.975 -0.75 . . . . 73.219999999999999 108.975 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -136.43 140.95 43.52 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 116.358 -0.383 . . . . 63.32 110.084 177.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -114.14 146.24 40.57 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 106.903 -1.517 . . . . 75.129999999999995 106.903 175.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 52.7 m -148.6 150.22 33.08 Favored Pre-proline 0 C--N 1.28 -2.449 0 N-CA-C 108.487 -0.931 . . . . 60.43 108.487 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.647 ' HA ' ' O ' ' A' ' 490' ' ' SER . 37.5 Cg_endo -66.69 132.77 29.69 Favored 'Trans proline' 0 N--CA 1.442 -1.536 0 C-N-CA 121.667 1.578 . . . . 72.209999999999994 110.423 177.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 21.2 m -142.38 178.12 7.8 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.042 -0.725 . . . . 74.239999999999995 109.042 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 6.9 t -62.34 137.54 96.06 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 109.691 -0.485 . . . . 74.019999999999996 109.691 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.42 -29.36 30.73 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 124.415 3.41 . . . . 73.349999999999994 113.62 -176.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -67.92 -33.36 74.54 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-O 120.943 0.401 . . . . 73.219999999999999 111.398 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.35 -20.04 23.32 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 111.904 0.335 . . . . 75.450000000000003 111.904 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 78.0 t -52.28 133.35 14.25 Favored 'Isoleucine or valine' 0 C--O 1.245 0.85 0 O-C-N 123.603 0.564 . . . . 75.540000000000006 111.016 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.88 -20.3 48.48 Favored Glycine 0 N--CA 1.438 -1.191 0 CA-C-N 115.646 -0.706 . . . . 71.140000000000001 112.292 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -113.33 166.28 11.63 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 117.103 0.451 . . . . 74.5 110.21 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 77.6 t -72.85 143.3 14.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 115.563 -0.744 . . . . 71.340000000000003 109.237 177.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 50.5 mm -96.89 -31.78 4.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 107.532 -1.285 . . . . 75.439999999999998 107.532 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 153.4 -163.96 30.87 Favored Glycine 0 N--CA 1.422 -2.287 0 CA-C-N 115.539 -0.755 . . . . 65.200000000000003 111.893 175.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.71 139.14 50.89 Favored 'General case' 0 N--CA 1.413 -2.277 0 N-CA-C 106.62 -1.622 . . . . 74.420000000000002 106.62 176.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.428 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 27.4 t-20 -64.96 -51.04 59.14 Favored Pre-proline 0 N--CA 1.471 0.605 0 CA-C-O 119.228 -0.415 . . . . 74.010000000000005 111.003 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.428 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 21.8 Cg_exo -70.29 130.52 18.83 Favored 'Trans proline' 0 C--N 1.371 1.761 0 N-CA-C 107.131 -1.911 . . . . 72.140000000000001 107.131 169.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . 0.538 ' C ' ' H ' ' A' ' 475' ' ' ASN . 39.7 Cg_exo -62.06 133.51 44.5 Favored 'Trans proline' 0 C--O 1.24 0.595 0 C-N-CA 121.856 1.704 . . . . 74.129999999999995 113.212 -174.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.403 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -70.92 14.49 0.14 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.159 1.384 . . . . 51.43 111.588 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . 0.538 ' H ' ' C ' ' A' ' 473' ' ' PRO . 16.3 m120 -109.19 -13.72 14.61 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 108.484 -0.932 . . . . 75.540000000000006 108.484 -178.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -104.79 178.86 4.44 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.547 -0.751 . . . . 73.439999999999998 111.344 -175.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.59 137.84 43.86 Favored 'General case' 0 N--CA 1.396 -3.142 0 CA-C-N 115.573 -0.74 . . . . 72.129999999999995 110.898 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 12.3 p -117.13 149.65 40.0 Favored 'General case' 0 N--CA 1.424 -1.75 0 C-N-CA 123.97 0.908 . . . . 74.319999999999993 110.145 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -80.83 158.53 25.36 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.916 -0.584 . . . . 74.209999999999994 110.129 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . 0.441 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 37.0 mm -69.72 -17.53 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 122.231 1.015 . . . . 63.229999999999997 110.318 -178.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 7.4 p -100.09 2.02 42.8 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.654 -0.703 . . . . 71.439999999999998 111.403 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -95.75 134.9 38.14 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.048 -0.524 . . . . 64.510000000000005 110.846 -175.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 37.6 t -99.88 116.44 43.16 Favored 'Isoleucine or valine' 0 C--O 1.243 0.754 0 N-CA-C 109.228 -0.656 . . . . 74.219999999999999 109.228 -177.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 32.1 m -99.72 136.79 29.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 121.436 0.636 . . . . 71.340000000000003 111.384 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.418 HG22 ' HB3' ' A' ' 471' ' ' ASN . 0.0 OUTLIER -99.98 128.35 51.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 121.452 0.644 . . . . 74.329999999999998 111.742 -176.841 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 16.3 mt -112.56 128.25 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 CA-C-N 114.599 -1.182 . . . . 73.25 109.88 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 6.1 tt -111.03 126.71 68.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-N 115.151 -0.931 . . . . 71.019999999999996 110.515 -173.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 35.0 m -105.56 149.52 8.93 Favored 'Isoleucine or valine' 0 C--O 1.254 1.306 0 CA-C-N 115.933 -0.576 . . . . 74.540000000000006 110.032 177.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -84.22 125.97 7.37 Favored Glycine 0 N--CA 1.437 -1.279 0 N-CA-C 111.372 -0.691 . . . . 73.150000000000006 111.372 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.647 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 25.5 t . . . . . 0 N--CA 1.422 -1.865 0 N-CA-C 107.075 -1.454 . . . . 73.439999999999998 107.075 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo . . . . . 0 C--O 1.249 1.057 0 CA-C-O 121.052 0.355 . . . . 75.420000000000002 111.853 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -104.37 118.99 37.95 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-O 121.44 0.638 . . . . 61.140000000000001 109.677 -177.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 11.0 p -116.82 143.15 46.02 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 115.018 -0.992 . . . . 74.430000000000007 109.66 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -146.86 151.67 37.45 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 123.168 0.587 . . . . 73.540000000000006 109.837 -179.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.2 p-10 -87.24 135.38 33.33 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.84 -1.17 . . . . 73.319999999999993 107.84 174.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 26.2 pt -75.26 121.01 84.31 Favored Pre-proline 0 C--N 1.294 -1.813 0 CA-C-N 115.784 -0.644 . . . . 72.219999999999999 109.729 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -75.25 159.9 39.92 Favored 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 122.184 1.923 . . . . 74.409999999999997 111.765 -177.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -77.84 90.27 4.08 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 106.272 -1.751 . . . . 74.329999999999998 106.272 174.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 10.0 p -96.65 7.5 7.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-O 122.319 1.056 . . . . 75.019999999999996 110.427 -171.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -78.06 79.05 4.53 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.203 -0.908 . . . . 72.319999999999993 111.932 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . -178.13 31.75 0.07 OUTLIER Glycine 0 C--N 1.304 -1.197 0 N-CA-C 110.703 -0.959 . . . . 63.43 110.703 177.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -157.51 -177.37 6.54 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 107.956 -1.127 . . . . 73.299999999999997 107.956 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 5.9 t -91.23 156.81 17.56 Favored 'General case' 0 N--CA 1.426 -1.642 0 C-N-CA 119.02 -1.072 . . . . 64.430000000000007 109.738 -177.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.5 p -54.16 -40.27 46.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 C-N-CA 124.707 1.203 . . . . 75.109999999999999 111.271 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -60.9 -43.38 98.59 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.624 -0.716 . . . . 71.409999999999997 110.697 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 64.0 t -76.77 -37.13 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-N 116.042 -0.526 . . . . 74.319999999999993 110.241 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . 0.472 ' O ' ' HG ' ' A' ' 512' ' ' LEU . . . -62.9 -48.87 77.11 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.93 -0.577 . . . . 74.209999999999994 111.662 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -65.18 -35.66 81.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.762 0.315 . . . . 72.019999999999996 110.246 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.518 ' O ' HG22 ' A' ' 514' ' ' VAL . 26.2 tptp -64.15 -45.37 88.75 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.848 -0.797 . . . . 74.230000000000004 108.848 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -62.27 -42.69 99.56 Favored 'General case' 0 CA--C 1.505 -0.78 0 O-C-N 123.609 0.568 . . . . 71.230000000000004 110.775 177.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 508' ' ' ALA . 87.5 mt -59.93 -42.94 95.07 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 116.447 -0.342 . . . . 74.239999999999995 110.612 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -62.28 -37.86 87.09 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 116.253 -0.431 . . . . 64.450000000000003 110.586 177.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 510' ' ' LYS . 92.6 t -61.87 -35.68 69.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.898 -0.592 . . . . 74.25 110.735 177.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -78.26 -19.58 53.41 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.213 0.53 . . . . 75.439999999999998 110.213 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 117.93 -5.98 15.78 Favored Glycine 0 N--CA 1.436 -1.326 0 C-N-CA 120.639 -0.791 . . . . 71.530000000000001 112.678 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.609 ' HA ' ' O ' ' A' ' 547' ' ' VAL . 74.6 m-85 -68.83 122.18 18.07 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 121.214 0.53 . . . . 74.510000000000005 110.642 -178.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 10.7 p -93.64 -39.7 10.67 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.567 -0.742 . . . . 72.109999999999999 112.357 -178.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . 0.453 ' HZ2' ' CG ' ' A' ' 548' ' ' ASP . 58.8 mttp -108.43 114.94 29.18 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 122.152 0.977 . . . . 74.140000000000001 113.139 -171.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 551' ' ' ILE . 46.2 p90 -130.72 151.58 51.01 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.566 -1.197 . . . . 73.109999999999999 110.167 176.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 25.1 m -125.17 143.03 51.14 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.111 -1.07 . . . . 74.239999999999995 108.111 176.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -117.91 119.71 35.67 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.827 -0.434 . . . . 73.329999999999998 109.827 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 554' ' ' GLN . . . -127.39 125.94 41.56 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.72 -0.844 . . . . 74.209999999999994 108.72 178.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 524' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 20.6 m -101.65 138.5 38.56 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.878 -0.329 . . . . 54.240000000000002 111.568 -178.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 30.1 m -123.71 149.38 27.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 108.415 -0.957 . . . . 74.219999999999999 108.415 176.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . 0.447 ' HA ' ' HB3' ' A' ' 557' ' ' LYS . 4.7 p-10 -69.57 136.02 50.77 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 121.248 0.547 . . . . 71.530000000000001 110.717 -177.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 25.6 p -163.01 167.56 11.64 Favored Pre-proline 0 C--N 1.307 -1.257 0 CA-C-N 115.237 -0.892 . . . . 75.019999999999996 109.046 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -77.39 6.56 4.31 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 122.483 2.122 . . . . 73.120000000000005 112.839 176.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -96.52 140.51 22.22 Favored Pre-proline 0 N--CA 1.445 -0.679 0 N-CA-C 108.206 -1.035 . . . . 74.310000000000002 108.206 175.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -64.42 161.4 34.96 Favored 'Trans proline' 0 C--O 1.246 0.908 0 C-N-CA 122.996 2.464 . . . . 75.530000000000001 113.962 -174.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.58 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -66.38 120.77 13.91 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.289 -0.868 . . . . 75.209999999999994 110.078 -178.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 122.94 -27.25 5.95 Favored Glycine 0 N--CA 1.434 -1.435 0 C-N-CA 120.657 -0.782 . . . . 72.219999999999999 111.594 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -69.63 125.61 27.23 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.358 -0.608 . . . . 65.340000000000003 109.358 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 94.0 t -81.48 111.6 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 N-CA-C 107.568 -1.271 . . . . 62.100000000000001 107.568 176.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 11.7 t -95.05 -16.22 22.86 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 120.63 -0.428 . . . . 62.130000000000003 111.982 -174.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 174.68 -175.13 46.89 Favored Glycine 0 CA--C 1.489 -1.564 0 C-N-CA 120.326 -0.94 . . . . 73.299999999999997 111.33 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 23.4 p -129.33 157.18 42.61 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.414 -0.958 . . . . 73.129999999999995 108.414 176.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . 0.404 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 26.0 t-20 -73.06 -53.16 5.14 Favored Pre-proline 0 C--N 1.309 -1.186 0 C-N-CA 120.634 -0.427 . . . . 63.219999999999999 111.283 177.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . 0.404 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 13.8 Cg_exo -72.86 136.45 25.24 Favored 'Trans proline' 0 C--N 1.368 1.605 0 N-CA-C 108.375 -1.433 . . . . 73.040000000000006 108.375 172.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -59.45 139.92 91.75 Favored 'Trans proline' 0 C--O 1.262 1.702 0 C-N-CA 122.2 1.933 . . . . 74.099999999999994 112.258 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -67.88 141.34 56.44 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.438 -0.801 . . . . 62.549999999999997 109.276 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 102.14 -12.27 57.28 Favored Glycine 0 N--CA 1.427 -1.932 0 C-N-CA 120.976 -0.63 . . . . 60.409999999999997 111.664 -176.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 45.8 m -72.57 126.94 31.08 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 116.943 0.372 . . . . 73.530000000000001 110.327 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 10.2 t -83.73 123.17 29.58 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.455 0.645 . . . . 73.530000000000001 110.029 177.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.9 m -138.21 157.46 72.69 Favored Pre-proline 0 C--N 1.305 -1.348 0 N-CA-C 108.972 -0.751 . . . . 74.540000000000006 108.972 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -65.89 150.5 85.69 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 121.554 1.503 . . . . 75.329999999999998 110.108 173.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 517' ' ' PHE . 26.9 m -59.97 -20.2 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 113.316 0.858 . . . . 75.519999999999996 113.316 -177.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . 0.453 ' CG ' ' HZ2' ' A' ' 519' ' ' LYS . 9.7 t70 -95.09 4.92 53.17 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.603 0.716 . . . . 64.209999999999994 111.454 -177.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.1 t -71.62 171.58 11.2 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 109.4 -0.593 . . . . 74.109999999999999 109.4 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 49.1 t -101.12 112.82 35.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 109.836 -0.431 . . . . 54.009999999999998 109.836 -177.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 520' ' ' PHE . 2.9 mp -101.14 121.85 52.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.763 -0.829 . . . . 73.519999999999996 108.763 178.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -102.69 116.41 32.53 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.17 0.509 . . . . 73.519999999999996 110.082 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 4.6 mp -97.22 134.13 40.93 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.05 -0.977 . . . . 71.219999999999999 108.682 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . 0.439 ' HA ' ' O ' ' A' ' 523' ' ' ALA . 49.6 mt-30 -105.21 114.83 29.26 Favored 'General case' 0 N--CA 1.414 -2.26 0 CA-C-O 122.03 0.919 . . . . 73.200000000000003 108.852 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 524' ' ' SER . 22.1 t -101.85 147.6 8.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 CA-C-N 113.967 -1.469 . . . . 70.010000000000005 108.855 -172.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.58 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 23.4 m -76.43 130.84 38.6 Favored 'General case' 0 N--CA 1.412 -2.35 0 CA-C-O 121.863 0.84 . . . . 61.210000000000001 112.447 177.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.447 ' HB3' ' HA ' ' A' ' 526' ' ' ASP . 10.2 tppt? -90.88 123.71 34.61 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 104.096 -2.557 . . . . 74.420000000000002 104.096 167.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -66.69 -42.3 93.34 Favored Glycine 0 CA--C 1.482 -2.009 0 N-CA-C 109.98 -1.248 . . . . 73.540000000000006 109.98 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 9.5 t30 65.57 21.15 11.72 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 122.171 0.986 . . . . 73.329999999999998 110.352 172.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -134.8 156.23 49.24 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.509 -0.769 . . . . 73.25 111.537 -176.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -133.4 156.73 47.14 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.395 -0.965 . . . . 73.530000000000001 108.395 176.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 54.9 t -73.22 124.47 30.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 120.777 0.322 . . . . 64.340000000000003 110.155 -178.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 52.9 ttp -97.26 137.52 21.18 Favored Pre-proline 0 C--N 1.311 -1.109 0 CA-C-N 116.159 -0.473 . . . . 75.319999999999993 111.962 -178.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -65.49 170.99 10.09 Favored 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 124.148 3.232 . . . . 72.340000000000003 112.535 172.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -82.14 134.25 35.31 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.31 -0.626 . . . . 60.039999999999999 109.31 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -120.38 -26.04 5.5 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.614 -0.884 . . . . 63.350000000000001 108.614 171.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 12.2 p -71.67 139.23 49.13 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.48 -0.782 . . . . 74.040000000000006 110.48 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 79.58 39.33 18.3 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 110.99 -0.844 . . . . 71.340000000000003 110.99 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 89.2 mtp -144.69 170.32 16.32 Favored 'General case' 0 C--O 1.249 1.075 0 N-CA-C 108.263 -1.014 . . . . 63.32 108.263 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -95.53 148.97 21.94 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 108.559 -0.904 . . . . 71.329999999999998 108.559 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 73.8 t-105 -61.73 -28.39 69.4 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 123.406 0.682 . . . . 75.209999999999994 109.968 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 13.8 p -71.54 -21.04 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-N 115.247 -0.888 . . . . 64.129999999999995 110.667 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -101.19 -30.82 11.33 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.812 -0.81 . . . . 74.200000000000003 108.812 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -59.06 -45.94 89.52 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.199 -0.91 . . . . 63.450000000000003 112.441 -178.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' A' ' 579' ' ' ARG . 31.5 mt-10 -59.51 -57.65 25.34 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 113.7 1.0 . . . . 64.430000000000007 113.7 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -58.07 -34.75 98.81 Favored 'Trans proline' 0 C--N 1.364 1.394 0 C-N-CA 121.173 1.248 . . . . 74.010000000000005 112.26 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -59.21 -48.13 82.77 Favored 'General case' 0 N--CA 1.42 -1.925 0 C-N-CA 122.506 0.322 . . . . 74.519999999999996 110.526 177.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . 0.286 4.2 pp -68.04 -38.3 82.33 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 112.813 0.672 . . . . 75.109999999999999 112.813 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 35.3 mmt180 -65.12 -47.56 76.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.472 -0.331 . . . . 72.430000000000007 110.458 178.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.93 -17.15 62.69 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.904 -0.589 . . . . 71.540000000000006 112.365 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 60.4 tp -85.84 -9.11 57.54 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 109.603 -0.517 . . . . 75.209999999999994 109.603 178.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 73.87 38.66 48.8 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 111.219 -0.752 . . . . 61.229999999999997 111.219 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 50.5 t90 -83.36 135.08 34.85 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-O 121.266 0.555 . . . . 73.329999999999998 111.015 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 10.1 t -145.89 106.34 4.07 Favored 'General case' 0 N--CA 1.408 -2.545 0 CA-C-N 114.783 -1.099 . . . . 74.319999999999993 108.126 173.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -159.18 -154.68 7.34 Favored Glycine 0 N--CA 1.429 -1.828 0 N-CA-C 108.774 -1.73 . . . . 73.109999999999999 108.774 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 60.9 mtt -107.58 125.23 51.05 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.68 -0.808 . . . . 64.040000000000006 112.324 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 59.2 tp -93.88 130.16 40.04 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.642 -0.873 . . . . 74.450000000000003 108.642 178.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -99.28 113.22 25.38 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 120.972 0.415 . . . . 74.019999999999996 111.232 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -91.86 109.4 20.73 Favored 'General case' 0 N--CA 1.408 -2.554 0 N-CA-C 106.4 -1.704 . . . . 71.439999999999998 106.4 171.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -87.9 -95.25 0.96 Allowed Glycine 0 N--CA 1.424 -2.124 0 C-N-CA 120.599 -0.81 . . . . 74.409999999999997 111.399 -178.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.44 151.28 46.11 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.214 -0.662 . . . . 74.420000000000002 109.214 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -84.84 132.07 34.45 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.719 -1.215 . . . . 72.5 107.719 175.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 73.5 t -123.63 127.7 74.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 CA-C-N 116.275 -0.421 . . . . 74.319999999999993 110.539 -171.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -78.53 107.25 11.05 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.018 -1.475 . . . . 74.5 107.018 175.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -127.47 0.86 6.26 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.81 -0.632 . . . . 72.140000000000001 110.736 -176.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 104.99 141.33 10.77 Favored Glycine 0 N--CA 1.431 -1.639 0 N-CA-C 108.8 -1.72 . . . . 74.349999999999994 108.8 -177.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -55.77 -39.31 76.4 Favored Glycine 0 C--O 1.224 -0.491 0 CA-C-N 117.193 0.497 . . . . 64.310000000000002 112.793 -173.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 3.9 m -60.37 -24.63 65.25 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.995 0.918 . . . . 72.409999999999997 111.923 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -108.76 -1.57 19.23 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.137 0.421 . . . . 73.140000000000001 112.137 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 59.5 m170 -72.38 -42.28 65.41 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.463 0.542 . . . . 75.430000000000007 112.463 -176.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -92.77 32.4 1.25 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 122.04 0.924 . . . . 74.340000000000003 108.749 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 603' ' ' VAL . 29.9 ttt180 -118.7 141.8 48.27 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.609 -0.682 . . . . 74.150000000000006 109.729 -178.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . 0.402 ' O ' ' HG2' ' A' ' 602' ' ' ARG . 71.4 t -73.15 130.9 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 106.094 -1.817 . . . . 75.140000000000001 106.094 172.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 73.6 t -80.05 -53.35 13.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-O 121.71 0.767 . . . . 63.5 109.292 -172.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -156.78 164.23 38.34 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 104.67 -2.345 . . . . 73.340000000000003 104.67 177.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -115.86 142.51 46.67 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 107.571 -1.27 . . . . 64.430000000000007 107.571 174.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.421 ' CB ' ' HB ' ' A' ' 621' ' ' THR . 41.1 t30 -64.21 -52.52 54.17 Favored Pre-proline 0 C--N 1.285 -2.211 0 N-CA-C 114.441 1.275 . . . . 75.420000000000002 114.441 -176.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -87.38 148.99 7.72 Favored 'Trans proline' 0 CA--C 1.549 1.238 0 CA-C-N 121.444 1.551 . . . . 74.109999999999999 110.594 176.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . 0.403 ' HB2' ' OG1' ' A' ' 612' ' ' THR . 15.8 Cg_exo -70.06 134.24 26.9 Favored 'Trans proline' 0 C--O 1.248 0.994 0 C-N-CA 121.731 1.621 . . . . 72.420000000000002 113.152 -177.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -68.56 134.32 49.83 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.678 -0.692 . . . . 75.299999999999997 110.724 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 86.48 -1.62 87.31 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.674 -0.774 . . . . 33.329999999999998 111.75 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 612' ' ' THR . . . . . 0.403 ' OG1' ' HB2' ' A' ' 609' ' ' PRO . 19.8 m -105.52 161.04 14.69 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 108.26 -1.015 . . . . 74.409999999999997 108.26 -178.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -73.17 129.99 13.24 Favored Glycine 0 N--CA 1.432 -1.575 0 N-CA-C 111.877 -0.489 . . . . 62.329999999999998 111.877 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 34.0 m -118.44 144.12 27.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.922 -0.77 . . . . 64.439999999999998 108.922 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . 0.432 ' ND2' ' HB3' ' A' ' 617' ' ' ASP . 27.4 p-10 -43.6 155.59 0.07 Allowed 'General case' 0 C--O 1.216 -0.699 0 C-N-CA 124.73 1.212 . . . . 73.019999999999996 113.158 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -56.24 -25.92 49.45 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.048 0.758 . . . . 75.230000000000004 113.048 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . 0.432 ' HB3' ' ND2' ' A' ' 615' ' ' ASN . 30.8 t70 -65.83 -37.94 87.55 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.262 -0.644 . . . . 74.450000000000003 109.262 174.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 85.69 21.56 53.15 Favored Glycine 0 N--CA 1.424 -2.14 0 CA-C-N 115.681 -0.69 . . . . 61.409999999999997 112.182 176.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.44 118.52 12.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 122.448 1.118 . . . . 63.130000000000003 110.404 -169.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.97 124.55 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.946 0 N-CA-C 106.976 -1.49 . . . . 74.299999999999997 106.976 -177.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.421 ' HB ' ' CB ' ' A' ' 607' ' ' ASN . 3.0 m -105.36 127.39 52.94 Favored 'General case' 0 N--CA 1.42 -1.944 0 C-N-CA 120.492 -0.483 . . . . 73.5 109.908 -177.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.0 mp -120.98 149.81 42.09 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 105.434 -2.062 . . . . 72.329999999999998 105.434 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -137.53 148.16 45.74 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 107.615 -1.254 . . . . 73.530000000000001 107.615 173.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -123.78 167.6 13.82 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 107.713 -1.217 . . . . 74.319999999999993 107.713 -177.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -67.0 -105.19 0.02 OUTLIER Glycine 0 CA--C 1.533 1.157 0 O-C-N 123.927 0.767 . . . . 74.109999999999999 111.824 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 . . . . . 0 C--N 1.296 -1.751 0 CA-C-O 118.575 -0.726 . . . . 73.299999999999997 109.185 177.032 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 . . . . . 0 N--CA 1.431 -1.376 0 N-CA-C 106.847 -1.538 . . . . 72.129999999999995 106.847 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 28.4 m -116.8 149.67 18.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.231 0 C-N-CA 120.538 -0.465 . . . . 70.319999999999993 110.417 -173.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . 0.552 ' NE2' ' HA ' ' A' ' 407' ' ' ASN . 0.8 OUTLIER -93.9 128.98 40.48 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 105.172 -2.159 . . . . 73.340000000000003 105.172 -179.072 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 92.9 t -95.43 122.37 59.52 Favored Pre-proline 0 C--N 1.28 -2.435 0 CA-C-N 115.266 -0.879 . . . . 71.239999999999995 110.864 -167.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -61.94 125.61 16.93 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 122.312 2.008 . . . . 74.230000000000004 110.163 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . 0.422 ' HB2' ' HG3' ' A' ' 366' ' ' ARG . 3.7 p-10 -71.85 125.87 28.28 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.339 -0.846 . . . . 71.430000000000007 109.714 -176.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 17.9 t -98.33 0.11 10.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-O 122.085 0.945 . . . . 75.0 108.728 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.422 ' HG3' ' HB2' ' A' ' 364' ' ' ASP 0.298 0.0 OUTLIER -64.96 146.6 54.77 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.963 -1.017 . . . . 73.200000000000003 113.047 179.325 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.26 -9.34 45.81 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 109.806 -1.318 . . . . 72.150000000000006 109.806 -172.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -110.7 -163.53 0.86 Allowed 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 107.35 -1.352 . . . . 71.230000000000004 107.35 178.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 369' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 76.2 p -86.87 160.42 18.74 Favored 'General case' 0 C--N 1.286 -2.157 0 O-C-N 121.865 -0.522 . . . . 71.319999999999993 111.602 -170.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 34.2 p -58.95 -46.43 88.03 Favored 'General case' 0 N--CA 1.435 -1.208 0 O-C-N 123.622 0.576 . . . . 41.240000000000002 110.6 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.85 -46.79 80.41 Favored 'General case' 0 C--O 1.214 -0.797 0 CA-C-N 116.235 -0.439 . . . . 75.420000000000002 111.667 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -67.63 -37.74 82.9 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.259 0.552 . . . . 74.219999999999999 111.259 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -69.46 -48.53 60.53 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.619 -0.719 . . . . 72.230000000000004 111.318 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 89.0 mt -64.9 -42.11 93.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 CA-C-N 116.449 -0.341 . . . . 70.329999999999998 110.922 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.95 -45.57 90.15 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 120.717 0.294 . . . . 72.230000000000004 111.348 -178.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 32.7 m -64.38 -47.57 78.75 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.998 -0.546 . . . . 73.409999999999997 111.147 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.1 -38.74 92.16 Favored 'General case' 0 C--O 1.24 0.597 0 O-C-N 122.094 -0.379 . . . . 71.409999999999997 111.709 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -63.43 -42.12 98.69 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.986 -0.552 . . . . 73.540000000000006 110.189 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -67.89 -28.13 67.25 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 112.027 0.381 . . . . 75.549999999999997 112.027 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -79.96 -15.7 56.75 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.494 -0.482 . . . . 72.439999999999998 110.253 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 96.07 15.89 40.28 Favored Glycine 0 N--CA 1.434 -1.461 0 C-N-CA 120.289 -0.957 . . . . 71.340000000000003 113.021 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -77.75 143.06 38.3 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 108.667 -0.864 . . . . 72.219999999999999 108.667 175.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -84.64 131.86 34.55 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 105.805 -1.924 . . . . 74.219999999999999 105.805 176.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 2.4 pp -130.83 138.24 54.05 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 CA-C-O 121.85 0.833 . . . . 74.510000000000005 113.23 -175.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -113.8 141.28 47.49 Favored 'General case' 0 C--N 1.276 -2.588 0 N-CA-C 107.053 -1.462 . . . . 74.129999999999995 107.053 175.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 20.9 m -122.37 121.16 36.02 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 108.127 -1.064 . . . . 72.109999999999999 108.127 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -111.61 127.82 55.86 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.819 -1.178 . . . . 72.5 107.819 -176.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -93.04 131.91 37.63 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.925 0.393 . . . . 73.439999999999998 111.504 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . 0.573 ' O ' ' HA ' ' A' ' 421' ' ' SER . 71.6 mmtt -126.36 132.91 24.49 Favored Pre-proline 0 C--N 1.304 -1.393 0 CA-C-N 115.797 -0.638 . . . . 72.409999999999997 109.465 175.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . 0.736 ' HA ' ' O ' ' A' ' 422' ' ' THR . 12.2 Cg_exo -72.37 140.26 33.21 Favored 'Trans proline' 0 C--O 1.247 0.95 0 C-N-CA 122.177 1.918 . . . . 74.129999999999995 109.901 175.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . 0.324 3.8 p30 -73.97 118.87 17.43 Favored 'General case' 0 CA--C 1.466 -2.26 0 C-N-CA 118.187 -1.405 . . . . 75.030000000000001 114.172 -178.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' SER . . . . . 0.621 ' O ' ' HB ' ' A' ' 393' ' ' THR . 50.1 m -143.94 81.69 1.69 Allowed 'General case' 0 N--CA 1.39 -3.462 0 N-CA-C 105.335 -2.098 . . . . 72.239999999999995 105.335 166.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.621 ' HB ' ' O ' ' A' ' 392' ' ' SER . 85.5 m 96.52 2.52 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 113.961 -1.472 . . . . 75.219999999999999 110.98 174.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 5.6 pt -104.92 151.58 39.44 Favored Pre-proline 0 C--N 1.291 -1.971 0 CA-C-N 114.843 -1.072 . . . . 71.049999999999997 109.341 176.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.56 -172.94 1.33 Allowed 'Trans proline' 0 CA--C 1.563 1.962 0 C-N-CA 123.305 2.67 . . . . 61.219999999999999 113.927 -172.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -55.17 163.16 4.76 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 123.277 2.651 . . . . 75.230000000000004 112.018 172.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -56.02 -8.5 0.46 Allowed 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 125.43 1.492 . . . . 73.430000000000007 112.929 -174.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 50.0 m170 -64.88 121.57 14.93 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 107.187 -1.412 . . . . 73.200000000000003 107.187 175.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 29.6 m -68.7 117.92 11.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 115.167 -0.924 . . . . 73.120000000000005 110.927 -168.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . 0.449 ' O ' HD11 ' A' ' 400' ' ' ILE . 0.0 OUTLIER -92.52 -29.34 4.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 115.989 -0.551 . . . . 75.310000000000002 110.265 -174.677 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.55 160.53 28.11 Favored Glycine 0 N--CA 1.417 -2.592 0 C-N-CA 119.528 -1.32 . . . . 74.040000000000006 112.409 -174.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' THR . . . . . 0.42 ' OG1' ' HG2' ' A' ' 366' ' ' ARG . 2.9 p -145.01 -176.83 5.24 Favored 'General case' 0 C--N 1.283 -2.321 0 C-N-CA 125.963 1.705 . . . . 64.540000000000006 107.72 -176.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -99.52 138.19 20.42 Favored Pre-proline 0 C--N 1.291 -1.977 0 N-CA-C 107.718 -1.216 . . . . 75.310000000000002 107.718 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -48.11 -15.04 0.35 Allowed 'Trans proline' 0 C--N 1.364 1.375 0 C-N-CA 124.758 3.638 . . . . 73.409999999999997 115.509 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -52.73 -43.7 65.9 Favored 'General case' 0 C--O 1.213 -0.866 0 N-CA-C 109.947 -0.39 . . . . 70.239999999999995 109.947 176.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -65.96 -35.19 79.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.622 0.725 . . . . 75.329999999999998 109.887 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . 0.552 ' HA ' ' NE2' ' A' ' 361' ' ' GLN . 17.0 m120 -84.64 1.69 45.07 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.209 -0.905 . . . . 73.540000000000006 111.378 -177.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 29.6 m -109.27 167.51 10.06 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.324 -1.732 . . . . 74.109999999999999 106.324 174.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 15.9 m -76.56 112.79 13.48 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 108.615 -0.883 . . . . 75.299999999999997 108.615 175.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 14.2 m -122.13 170.39 12.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 120.807 0.337 . . . . 73.5 111.703 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 2.7 m -56.1 141.61 39.73 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.144 -0.935 . . . . 62.25 110.501 -178.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -66.56 109.69 2.89 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.058 -1.089 . . . . 74.409999999999997 108.058 176.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 86.51 42.7 6.41 Favored Glycine 0 N--CA 1.433 -1.536 0 N-CA-C 110.708 -0.957 . . . . 43.340000000000003 110.708 -176.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -79.94 -171.91 3.13 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.805 -0.813 . . . . 72.340000000000003 108.805 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -108.41 112.68 25.22 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 122.882 0.473 . . . . 73.400000000000006 110.412 -176.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 49.1 mm -116.57 137.47 50.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 109.575 -0.528 . . . . 73.530000000000001 109.575 -177.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 14.0 t -111.56 131.77 55.01 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.773 -0.825 . . . . 74.400000000000006 108.773 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 5.9 p -115.75 135.26 56.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.616 -0.512 . . . . 72.510000000000005 109.616 -177.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -100.8 128.6 46.78 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.277 -0.638 . . . . 74.150000000000006 109.277 178.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 8.3 p -126.3 137.31 58.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.794 -0.639 . . . . 73.519999999999996 109.871 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 2.3 p -92.59 120.68 33.28 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-O 122.024 0.916 . . . . 70.0 112.017 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' THR . . . . . 0.736 ' O ' ' HA ' ' A' ' 390' ' ' PRO . 6.2 t -122.46 155.0 37.05 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 108.095 -1.076 . . . . 72.120000000000005 108.095 174.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.029 0 C-N-CA 119.984 -1.103 . . . . 42.100000000000001 113.643 174.069 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 . . . . . 0 N--CA 1.44 -0.941 0 N-CA-C 108.279 -1.008 . . . . 75.450000000000003 108.279 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.43 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 2.2 mmp_? -119.82 138.16 53.54 Favored 'General case' 0 CA--C 1.492 -1.268 0 CA-C-O 121.147 0.498 . . . . 75.409999999999997 109.938 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -88.16 136.28 33.04 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.493 -0.776 . . . . 71.010000000000005 109.489 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 59.5 mt -80.67 130.71 63.32 Favored Pre-proline 0 C--N 1.298 -1.661 0 CA-C-N 115.854 -0.612 . . . . 71.329999999999998 109.368 -177.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -71.71 141.77 38.34 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 121.877 1.718 . . . . 63.25 110.736 170.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -82.84 111.53 18.83 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.901 -1.148 . . . . 65.430000000000007 107.901 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 60.9 t -103.5 143.46 15.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.137 -1.06 . . . . 74.420000000000002 108.137 -175.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 15.8 m -60.41 155.06 18.97 Favored 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 112.632 0.604 . . . . 74.540000000000006 112.632 -176.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 21.9 p -69.14 -24.98 64.16 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 115.339 1.607 . . . . 74.239999999999995 115.339 -170.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.1 pp -90.3 -11.6 40.3 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.953 0.883 . . . . 72.239999999999995 110.414 177.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.95 34.43 2.3 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 114.914 -1.039 . . . . 74.310000000000002 109.643 -175.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -55.84 -38.33 69.9 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.172 0.989 . . . . 75.120000000000005 113.028 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.46 -36.78 84.88 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.868 0.842 . . . . 64.239999999999995 110.102 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . 0.499 ' OE2' ' HD2' ' A' ' 442' ' ' LYS . 24.9 tp10 -70.92 -35.4 72.23 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.121 -0.945 . . . . 74.0 109.336 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.552 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -63.63 -50.55 68.89 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.001 -0.545 . . . . 61.240000000000002 110.988 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 31.2 m -62.1 -38.67 81.45 Favored 'Isoleucine or valine' 0 C--O 1.25 1.129 0 N-CA-C 112.606 0.595 . . . . 74.340000000000003 112.606 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.499 ' HD2' ' OE2' ' A' ' 439' ' ' GLU . 17.4 ptpt -67.93 -38.44 82.88 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 120.061 -0.656 . . . . 71.519999999999996 109.973 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -62.76 -38.56 91.07 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.336 -0.393 . . . . 75.319999999999993 110.924 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 77.8 mt -63.42 -37.66 88.13 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.933 -0.576 . . . . 75.140000000000001 109.453 177.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 41.0 m -69.93 -43.2 72.12 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.278 -0.873 . . . . 53.039999999999999 110.321 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -65.72 -27.37 68.28 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.048 0.539 . . . . 71.299999999999997 111.707 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.7 -13.56 59.38 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.477 -0.329 . . . . 64.329999999999998 111.459 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 130.05 -81.27 0.34 Allowed Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 120.868 -0.682 . . . . 74.25 111.749 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -36.64 -68.9 0.12 Allowed 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 115.003 1.483 . . . . 74.549999999999997 115.003 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 59.65 35.15 84.96 Favored Glycine 0 C--N 1.318 -0.463 0 C-N-CA 121.007 -0.616 . . . . 72.310000000000002 112.551 -177.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.407 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 36.1 mmt180 -107.2 110.95 23.14 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.516 -1.29 . . . . 75.019999999999996 107.516 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -143.97 146.57 33.01 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 121.087 0.47 . . . . 74.340000000000003 111.532 -173.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -131.58 148.35 52.61 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 115.421 -0.809 . . . . 72.409999999999997 109.215 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -113.64 125.94 54.71 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.798 -0.816 . . . . 75.439999999999998 108.798 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -126.17 137.22 53.55 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.923 -1.14 . . . . 73.349999999999994 107.923 176.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . 0.508 ' HB2' ' OG ' ' A' ' 490' ' ' SER . 8.3 p30 -114.25 144.64 42.9 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 109.29 -0.633 . . . . 74.140000000000001 109.29 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 50.9 m -148.69 148.59 28.44 Favored Pre-proline 0 C--N 1.296 -1.734 0 N-CA-C 108.507 -0.923 . . . . 75.409999999999997 108.507 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.654 ' HA ' ' O ' ' A' ' 490' ' ' SER . 19.6 Cg_endo -64.33 125.49 15.19 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.189 1.926 . . . . 74.129999999999995 112.238 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 49.7 m -133.49 179.53 6.16 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.187 -1.042 . . . . 72.129999999999995 108.187 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.8 t -59.1 137.38 88.06 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 109.907 -0.405 . . . . 72.530000000000001 109.907 176.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -51.27 -29.74 30.92 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 124.528 3.485 . . . . 75.420000000000002 113.228 -176.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -72.99 -23.61 60.67 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.555 0.576 . . . . 65.340000000000003 112.555 -178.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 67.0 mt -101.42 -3.3 28.93 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.669 0.248 . . . . 74.209999999999994 111.669 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.414 HG12 ' HA ' ' A' ' 490' ' ' SER . 76.9 t -60.12 128.96 21.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 116.089 -0.505 . . . . 74.530000000000001 110.489 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.48 -11.76 59.77 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 115.742 -0.663 . . . . 64.25 112.392 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -114.04 165.81 12.25 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 109.355 -0.609 . . . . 74.239999999999995 109.355 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 71.1 t -74.33 146.22 10.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 116.062 -0.517 . . . . 75.510000000000005 109.832 177.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 49.3 mm -98.18 -35.11 4.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 107.839 -1.171 . . . . 72.140000000000001 107.839 177.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 169.61 -179.49 42.05 Favored Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 110.813 -0.915 . . . . 63.530000000000001 110.813 177.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 470' ' ' THR . . . . . 0.4 HG23 HG12 ' A' ' 486' ' ' ILE . 61.4 p -115.49 141.85 47.5 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 105.171 -2.159 . . . . 64.549999999999997 105.171 176.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.425 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 25.2 t-20 -69.1 -53.78 13.21 Favored Pre-proline 0 C--N 1.319 -0.733 0 C-N-CA 118.882 -1.127 . . . . 73.239999999999995 111.692 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.425 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 8.5 Cg_exo -76.61 139.88 20.68 Favored 'Trans proline' 0 C--N 1.364 1.389 0 N-CA-C 107.621 -1.723 . . . . 73.319999999999993 107.621 170.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.93 126.76 18.75 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.043 1.829 . . . . 71.430000000000007 112.461 -175.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -86.48 19.13 2.93 Favored 'General case' 0 C--O 1.206 -1.221 0 CA-C-N 115.111 -0.95 . . . . 74.099999999999994 109.797 -177.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -110.01 -13.64 14.37 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.449 -0.796 . . . . 72.530000000000001 109.563 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -93.18 168.87 10.82 Favored 'General case' 0 C--O 1.247 0.954 0 N-CA-C 114.396 1.258 . . . . 72.340000000000003 114.396 -170.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -82.79 109.5 16.99 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-N 113.6 -1.636 . . . . 73.430000000000007 108.296 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 64.7 m -104.97 145.7 30.06 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-O 121.465 0.65 . . . . 73.430000000000007 111.5 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -84.68 169.42 14.33 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 107.566 -1.272 . . . . 72.450000000000003 107.566 175.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 34.6 mm -72.46 -11.07 14.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 122.078 0.942 . . . . 74.409999999999997 110.356 -177.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 4.5 p -97.68 5.19 49.66 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.585 -0.734 . . . . 73.319999999999993 112.462 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -81.11 129.54 34.61 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 122.081 -0.387 . . . . 74.540000000000006 111.705 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . 0.407 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.1 p -108.64 125.93 65.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.817 -0.628 . . . . 71.120000000000005 109.88 176.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . 0.424 ' HA ' ' HG2' ' A' ' 472' ' ' PRO . 27.3 m -106.02 120.46 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 CA-C-O 121.941 0.877 . . . . 72.319999999999993 112.23 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.86 121.52 43.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.415 -1.328 . . . . 75.010000000000005 107.415 175.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . 0.4 HG12 HG23 ' A' ' 470' ' ' THR . 35.1 mt -114.35 128.75 71.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.044 -0.98 . . . . 73.340000000000003 111.379 -174.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 5.8 tt -101.87 126.56 55.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 116.031 -0.531 . . . . 73.329999999999998 110.649 -176.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 28.0 m -108.38 151.35 10.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 123.435 0.694 . . . . 73.230000000000004 109.893 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -84.14 128.9 8.86 Favored Glycine 0 N--CA 1.434 -1.465 0 C-N-CA 120.97 -0.633 . . . . 74.109999999999999 111.731 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.654 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 49.1 m . . . . . 0 C--N 1.301 -1.533 0 N-CA-C 108.725 -0.842 . . . . 63.520000000000003 108.725 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo . . . . . 0 N--CA 1.442 -1.53 0 CA-C-O 121.434 0.514 . . . . 75.040000000000006 112.32 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -108.56 77.06 1.06 Allowed 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.661 -0.866 . . . . 75.040000000000006 108.661 177.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 19.1 p -117.86 144.9 45.0 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 114.911 -1.04 . . . . 54.009999999999998 110.918 -176.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -150.25 165.13 33.9 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 112.124 0.416 . . . . 73.120000000000005 112.124 175.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.79 133.74 36.32 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 107.399 -1.334 . . . . 74.239999999999995 107.399 -178.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 39.5 pt -78.85 133.16 62.41 Favored Pre-proline 0 C--N 1.294 -1.841 0 C-N-CA 120.137 -0.625 . . . . 75.219999999999999 109.968 175.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.84 -179.35 5.38 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.782 2.322 . . . . 75.099999999999994 111.893 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -108.68 141.49 40.57 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.911 -0.774 . . . . 74.319999999999993 108.911 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . 0.402 ' O ' ' HA2' ' A' ' 536' ' ' GLY . 4.8 p -143.95 103.58 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 CA-C-O 121.555 0.693 . . . . 74.319999999999993 110.137 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -141.71 106.71 4.94 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.181 -0.918 . . . . 53.200000000000003 109.219 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 123.13 -16.13 8.17 Favored Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 120.173 -1.013 . . . . 74.109999999999999 111.376 178.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -89.74 173.45 8.27 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.854 -0.424 . . . . 74.430000000000007 109.854 177.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 13.9 t -91.79 157.74 16.72 Favored 'General case' 0 N--CA 1.425 -1.707 0 C-N-CA 119.771 -0.772 . . . . 71.329999999999998 109.984 -176.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 9.5 p -53.27 -41.19 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 124.229 1.012 . . . . 74.200000000000003 112.158 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -62.57 -41.98 99.27 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.128 0.49 . . . . 63.420000000000002 111.2 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 86.3 t -71.79 -37.35 61.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-N 116.092 -0.504 . . . . 72.430000000000007 110.513 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . 0.457 ' O ' HD22 ' A' ' 512' ' ' LEU . . . -61.5 -49.12 78.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.835 -0.62 . . . . 72.219999999999999 111.242 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -60.23 -46.91 88.16 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.019 0.438 . . . . 74.030000000000001 110.72 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.443 ' O ' HG21 ' A' ' 514' ' ' VAL . 55.8 tptt -65.44 -49.97 67.17 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 113.027 0.751 . . . . 74.420000000000002 113.027 -174.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -63.07 -37.76 88.5 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 120.142 -0.623 . . . . 71.540000000000006 110.45 -175.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . 0.457 HD22 ' O ' ' A' ' 508' ' ' ALA . 4.6 mm? -62.75 -43.3 99.15 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 116.551 -0.295 . . . . 64.0 111.007 175.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -62.98 -38.25 90.41 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 120.987 0.422 . . . . 61.409999999999997 110.699 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.443 HG21 ' O ' ' A' ' 510' ' ' LYS . 81.2 t -62.96 -34.25 65.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.562 -0.745 . . . . 71.439999999999998 110.554 177.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -85.27 3.2 40.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.89 0.376 . . . . 72.409999999999997 111.12 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . 0.533 ' O ' ' HB ' ' A' ' 547' ' ' VAL . . . 109.62 -20.84 26.81 Favored Glycine 0 N--CA 1.437 -1.289 0 C-N-CA 120.827 -0.701 . . . . 61.539999999999999 113.811 174.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -77.32 98.58 5.24 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.437 -1.319 . . . . 73.540000000000006 107.437 -175.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.91 -17.11 30.27 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.592 -0.731 . . . . 71.329999999999998 112.307 -169.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 28.1 mtpp -112.18 122.15 46.95 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.168 0.509 . . . . 71.540000000000006 111.604 -176.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -129.77 152.44 49.26 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.496 -0.775 . . . . 74.25 110.725 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.9 m -141.39 152.68 44.53 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 108.134 -1.061 . . . . 70.239999999999995 108.134 173.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . 0.426 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 4.1 pt20 -117.19 151.07 37.66 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-O 121.365 0.602 . . . . 71.120000000000005 111.199 -178.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 554' ' ' GLN . . . -132.79 118.69 19.33 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.23 -1.396 . . . . 54.409999999999997 107.23 174.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 11.7 p -85.92 128.86 34.93 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.013 0.435 . . . . 61.130000000000003 111.341 -177.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 28.7 m -127.3 160.02 36.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 109.485 -0.561 . . . . 73.340000000000003 109.485 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -72.76 136.18 45.44 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.565 -0.531 . . . . 72.450000000000003 109.565 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 52.1 m -152.58 161.92 27.91 Favored Pre-proline 0 C--N 1.304 -1.38 0 O-C-N 121.958 -0.464 . . . . 71.219999999999999 110.58 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -84.4 -2.55 9.98 Favored 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 122.392 2.061 . . . . 75.409999999999997 110.322 173.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . 0.415 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 23.3 mmt180 -84.73 145.67 44.77 Favored Pre-proline 0 N--CA 1.44 -0.935 0 N-CA-C 106.81 -1.552 . . . . 75.430000000000007 106.81 177.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.88 162.48 41.96 Favored 'Trans proline' 0 C--O 1.246 0.878 0 C-N-CA 122.148 1.899 . . . . 72.519999999999996 111.874 177.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -57.11 126.03 25.35 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.298 -0.864 . . . . 55.130000000000003 111.679 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 116.64 -17.45 13.66 Favored Glycine 0 C--N 1.309 -0.938 0 C-N-CA 120.917 -0.658 . . . . 75.239999999999995 111.903 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -78.18 144.77 36.05 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.346 -0.983 . . . . 61.25 108.346 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 64.0 t -95.03 121.51 45.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 O-C-N 121.675 -0.64 . . . . 74.219999999999999 110.409 176.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 36.6 m -72.59 -40.85 66.25 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 124.588 1.155 . . . . 75.409999999999997 110.85 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 500' ' ' VAL . . . 162.16 -157.31 29.13 Favored Glycine 0 N--CA 1.432 -1.577 0 N-CA-C 110.602 -0.999 . . . . 75.430000000000007 110.602 -178.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 57.7 p -118.89 151.86 37.35 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.046 -0.724 . . . . 63.43 109.046 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -73.24 -54.4 4.28 Favored Pre-proline 0 C--N 1.313 -1.0 0 CA-C-O 119.44 -0.314 . . . . 74.099999999999994 110.712 177.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -74.06 143.24 32.2 Favored 'Trans proline' 0 C--N 1.36 1.164 0 N-CA-C 109.089 -1.158 . . . . 73.420000000000002 109.089 170.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.26 149.82 85.04 Favored 'Trans proline' 0 C--O 1.253 1.241 0 C-N-CA 122.313 2.008 . . . . 73.439999999999998 112.448 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -65.89 144.31 56.88 Favored 'General case' 0 C--O 1.249 1.049 0 N-CA-C 109.574 -0.528 . . . . 64.140000000000001 109.574 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.8 -12.5 57.82 Favored Glycine 0 N--CA 1.423 -2.195 0 C-N-CA 120.23 -0.985 . . . . 74.420000000000002 111.489 -176.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 54.2 m -66.59 120.94 14.28 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.251 -0.648 . . . . 63.299999999999997 109.251 176.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 41.1 m -85.32 122.61 29.74 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 108.614 -0.884 . . . . 64.049999999999997 108.614 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.61 158.26 70.61 Favored Pre-proline 0 C--N 1.311 -1.082 0 N-CA-C 108.834 -0.802 . . . . 73.430000000000007 108.834 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -64.78 149.18 90.04 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.073 1.849 . . . . 74.310000000000002 110.921 174.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.533 ' HB ' ' O ' ' A' ' 516' ' ' GLY . 36.0 m -63.14 -20.14 25.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-O 121.952 0.882 . . . . 73.140000000000001 111.6 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -77.43 -16.16 58.95 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.416 -1.266 . . . . 71.530000000000001 110.768 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 42.3 m -81.79 158.6 24.06 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 121.273 0.559 . . . . 72.400000000000006 111.784 -176.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 92.1 t -89.03 128.74 40.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 115.073 -0.967 . . . . 70.310000000000002 110.159 -178.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -100.05 132.77 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 108.023 -1.102 . . . . 75.140000000000001 108.023 171.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -103.24 115.91 31.46 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-O 121.536 0.684 . . . . 71.450000000000003 111.329 -176.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 1.9 mm? -98.3 133.79 42.21 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.275 -1.329 . . . . 73.310000000000002 109.03 -179.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 523' ' ' ALA . 45.2 mt-30 -97.62 121.79 39.94 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.517 -0.549 . . . . 73.430000000000007 109.517 176.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 48.3 t -103.63 137.53 31.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 115.573 -0.74 . . . . 65.230000000000004 110.373 -173.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.415 ' HB3' ' HB2' ' A' ' 529' ' ' ARG . 22.0 m -69.58 129.47 39.76 Favored 'General case' 0 N--CA 1.427 -1.612 0 C-N-CA 124.071 0.948 . . . . 75.209999999999994 112.211 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -110.57 123.02 49.18 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 106.502 -1.666 . . . . 75.400000000000006 106.502 170.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -80.23 -30.38 41.89 Favored Glycine 0 C--N 1.311 -0.841 0 C-N-CA 120.984 -0.627 . . . . 74.099999999999994 113.845 -172.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 73.52 -2.52 2.73 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.687 1.195 . . . . 73.400000000000006 112.152 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.414 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 87.5 mt-30 -113.25 141.95 46.39 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.767 0.317 . . . . 65.329999999999998 110.859 -176.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -125.41 136.51 53.49 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.026 -0.533 . . . . 74.420000000000002 109.816 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 59.1 t -68.89 116.01 8.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 120.999 0.428 . . . . 65.420000000000002 110.612 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 59.5 ttp -97.1 132.01 26.52 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 109.148 -0.686 . . . . 70.310000000000002 109.148 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.85 168.99 15.61 Favored 'Trans proline' 0 C--O 1.244 0.787 0 C-N-CA 122.255 1.97 . . . . 72.420000000000002 111.045 176.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -89.44 114.99 26.54 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-O 122.291 1.043 . . . . 63.439999999999998 112.395 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 4.5 mp -118.16 7.1 12.06 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 106.188 -1.782 . . . . 74.439999999999998 106.188 171.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 32.5 t -80.34 153.71 28.22 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 113.577 -1.647 . . . . 53.340000000000003 109.946 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 97.71 44.81 2.6 Favored Glycine 0 N--CA 1.432 -1.599 0 N-CA-C 110.293 -1.123 . . . . 60.420000000000002 110.293 -177.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 62.1 mtp -140.79 -176.79 4.79 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.41 -1.33 . . . . 75.329999999999998 107.41 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -97.03 156.41 16.37 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.072 -1.084 . . . . 71.400000000000006 108.072 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -59.01 -29.39 67.22 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 122.987 0.515 . . . . 74.349999999999994 111.204 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 31.4 m -62.57 -23.95 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 116.122 -0.49 . . . . 74.129999999999995 111.302 178.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . 0.525 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 1.3 m-20 -101.13 -25.88 13.87 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-N 115.983 -0.553 . . . . 74.409999999999997 110.524 176.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -72.91 -33.35 65.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.724 -0.671 . . . . 62.43 112.26 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.438 ' O ' ' HB3' ' A' ' 578' ' ' LEU . 32.4 tt0 -60.57 -49.6 89.24 Favored Pre-proline 0 CA--C 1.56 1.363 0 C-N-CA 120.237 -0.585 . . . . 73.549999999999997 111.05 176.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -56.22 -35.65 95.74 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 121.459 1.439 . . . . 75.430000000000007 111.999 171.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . 0.525 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 37.0 mmt180 -59.27 -46.76 87.64 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 109.616 -0.512 . . . . 75.299999999999997 109.616 176.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.438 ' HB3' ' O ' ' A' ' 575' ' ' GLU . 6.6 tt -57.77 -46.62 84.31 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 125.011 1.324 . . . . 74.439999999999998 109.626 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 575' ' ' GLU . 64.8 mtt-85 -65.31 -44.33 88.21 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.072 -0.967 . . . . 74.099999999999994 111.157 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -69.78 -28.26 65.61 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.04 0.448 . . . . 62.439999999999998 112.074 -177.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 97.6 mt -84.35 -8.08 59.11 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.613 -0.267 . . . . 73.420000000000002 110.914 177.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 61.68 42.42 99.75 Favored Glycine 0 CA--C 1.505 -0.579 0 N-CA-C 110.85 -0.9 . . . . 61.350000000000001 110.85 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 83.2 t90 -71.32 135.13 47.23 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.246 0.546 . . . . 75.230000000000004 111.688 -176.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 23.3 m -147.42 102.85 3.5 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 108.365 -0.976 . . . . 60.020000000000003 108.365 174.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -161.64 -124.07 0.7 Allowed Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 111.241 -0.744 . . . . 60.520000000000003 111.241 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -137.5 125.68 23.06 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.926 -0.768 . . . . 74.439999999999998 108.926 177.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 59.9 tp -97.24 117.58 31.77 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.818 -0.808 . . . . 74.109999999999999 108.818 176.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . 0.428 ' OD2' HD12 ' A' ' 619' ' ' ILE . 13.4 m-20 -101.24 101.94 12.73 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.157 -0.683 . . . . 75.0 109.157 174.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -88.04 126.43 35.09 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 106.352 -1.721 . . . . 74.239999999999995 106.352 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -73.67 -151.91 2.12 Favored Glycine 0 C--N 1.302 -1.336 0 CA-C-N 115.828 -0.624 . . . . 52.340000000000003 114.631 -177.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -58.82 143.65 46.74 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.371 0.605 . . . . 75.299999999999997 112.435 -177.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -94.2 124.74 38.41 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.398 -0.964 . . . . 73.310000000000002 108.398 175.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 47.5 t -123.08 117.77 52.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 109.177 -0.675 . . . . 73.040000000000006 109.177 -177.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -80.14 106.71 12.36 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.244 -0.65 . . . . 74.040000000000006 109.244 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -153.52 17.44 0.53 Allowed 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.93 -0.577 . . . . 72.25 110.584 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 99.96 101.53 2.39 Favored Glycine 0 N--CA 1.427 -1.939 0 N-CA-C 110.213 -1.155 . . . . 60.350000000000001 110.213 -175.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -60.9 -40.3 98.14 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-O 119.893 -0.393 . . . . 75.040000000000006 113.387 -176.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 15.6 m -56.99 -33.19 66.88 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.341 0.867 . . . . 73.549999999999997 113.341 -174.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -108.19 -10.59 15.38 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 112.993 0.738 . . . . 74.530000000000001 112.993 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . 0.453 ' C ' ' H ' ' A' ' 602' ' ' ARG . 68.9 m-70 -107.54 14.97 25.26 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.737 0.78 . . . . 75.030000000000001 110.929 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -81.47 15.35 2.09 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.762 -1.108 . . . . 74.409999999999997 108.371 175.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . 0.453 ' H ' ' C ' ' A' ' 600' ' ' HIS . 33.1 ttp180 -97.32 152.09 19.25 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.345 -0.843 . . . . 74.519999999999996 109.064 -175.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 10.0 p -65.26 137.16 25.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 O-C-N 123.45 0.469 . . . . 71.349999999999994 109.959 175.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 92.1 t -102.27 -52.95 7.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 120.36 -0.536 . . . . 73.530000000000001 109.561 177.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -154.07 164.32 38.67 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 107.789 -1.189 . . . . 65.319999999999993 107.789 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . 0.445 ' HA ' ' O ' ' A' ' 621' ' ' THR . 18.6 pt20 -143.88 155.1 43.97 Favored 'General case' 0 C--N 1.314 -0.976 0 O-C-N 124.097 0.873 . . . . 75.340000000000003 109.414 177.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . 0.278 81.8 m-20 -80.64 -55.46 0.72 Allowed Pre-proline 0 C--N 1.312 -1.062 0 N-CA-C 114.306 1.224 . . . . 74.530000000000001 114.306 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -85.85 107.83 0.94 Allowed 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.912 1.741 . . . . 71.519999999999996 109.287 173.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -70.38 144.93 52.15 Favored 'Trans proline' 0 C--O 1.243 0.756 0 C-N-CA 122.846 2.364 . . . . 75.310000000000002 113.467 -176.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -68.67 137.58 54.28 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 108.562 -0.903 . . . . 74.239999999999995 108.562 175.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 99.81 -12.95 60.99 Favored Glycine 0 C--N 1.299 -1.481 0 N-CA-C 110.427 -1.069 . . . . 55.140000000000001 110.427 -175.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 25.8 m -106.78 162.82 13.45 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 107.898 -1.149 . . . . 74.540000000000006 107.898 178.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -72.19 117.18 6.21 Favored Glycine 0 N--CA 1.431 -1.635 0 N-CA-C 110.435 -1.066 . . . . 72.340000000000003 110.435 175.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.7 m -91.29 141.66 14.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.154 0.502 . . . . 75.409999999999997 110.55 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . 0.466 HD22 HG23 ' A' ' 619' ' ' ILE . 8.9 p-10 -58.0 145.41 36.17 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 114.099 -1.409 . . . . 73.109999999999999 112.786 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -57.55 -25.25 59.65 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.483 1.113 . . . . 71.450000000000003 111.39 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -59.78 -45.26 92.84 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 115.351 -0.84 . . . . 74.200000000000003 109.261 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 79.12 12.17 84.32 Favored Glycine 0 N--CA 1.412 -2.915 0 N-CA-C 110.159 -1.176 . . . . 72.129999999999995 110.159 -175.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . 0.476 HD13 ' N ' ' A' ' 620' ' ' ILE . 0.0 OUTLIER -70.39 126.29 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 108.335 -0.987 . . . . 73.519999999999996 108.335 -176.594 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . 0.476 ' N ' HD13 ' A' ' 619' ' ' ILE . 7.5 tp -126.54 129.91 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.675 0 CA-C-N 115.645 -0.707 . . . . 74.230000000000004 110.991 -174.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 606' ' ' GLN . 39.7 m -104.66 127.19 52.34 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.27 -1.011 . . . . 74.310000000000002 108.27 175.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 96.0 mt -138.0 150.79 47.3 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 108.558 -0.905 . . . . 73.0 108.558 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -128.24 136.98 51.79 Favored 'General case' 0 C--N 1.278 -2.506 0 N-CA-C 107.295 -1.372 . . . . 74.200000000000003 107.295 172.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -141.9 165.61 26.99 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 104.42 -2.437 . . . . 75.040000000000006 104.42 170.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -61.26 -100.08 0.01 OUTLIER Glycine 0 C--N 1.301 -1.374 0 O-C-N 124.056 0.847 . . . . 73.109999999999999 113.683 -174.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . 0.405 HE21 ' HA ' ' A' ' 626' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.291 -1.941 0 N-CA-C 108.123 -1.066 . . . . 75.439999999999998 108.123 178.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 . . . . . 0 CA--C 1.49 -1.358 0 N-CA-C 108.504 -0.925 . . . . 75.540000000000006 108.504 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 34.5 m -117.24 145.92 22.39 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 108.896 -0.779 . . . . 61.039999999999999 108.896 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -95.35 121.5 37.08 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 106.01 -1.848 . . . . 75.150000000000006 106.01 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 63.7 t -97.39 121.58 58.13 Favored Pre-proline 0 C--N 1.291 -1.94 0 CA-C-N 114.942 -1.026 . . . . 73.219999999999999 110.849 -171.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.5 158.26 46.5 Favored 'Trans proline' 0 C--O 1.242 0.688 0 C-N-CA 122.217 1.944 . . . . 71.400000000000006 110.229 177.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -103.42 168.85 8.9 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 120.355 -0.538 . . . . 73.420000000000002 109.898 -173.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 9.9 t -128.61 2.57 2.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-O 121.638 0.732 . . . . 74.409999999999997 109.15 -177.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.522 ' HD3' ' OG1' ' A' ' 402' ' ' THR . 16.8 ptt-85 -58.2 144.46 40.66 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.439 0.638 . . . . 75.010000000000005 111.723 178.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.4 -7.11 50.62 Favored Glycine 0 N--CA 1.425 -2.041 0 CA-C-N 115.004 -0.998 . . . . 72.420000000000002 111.607 -178.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -109.76 -87.89 0.51 Allowed 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 113.018 0.747 . . . . 74.439999999999998 113.018 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 369' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 81.3 p -159.44 159.51 33.7 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 109.213 -0.662 . . . . 73.510000000000005 109.213 -175.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 46.4 t -63.12 -40.5 97.78 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.788 -0.819 . . . . 73.310000000000002 108.788 175.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -63.92 -47.15 81.68 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 118.997 -0.525 . . . . 72.030000000000001 112.188 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -69.77 -35.88 75.28 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 119.721 -0.792 . . . . 75.349999999999994 110.607 -178.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -64.87 -51.26 62.99 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.789 -0.641 . . . . 62.299999999999997 109.935 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 68.5 mt -60.98 -46.27 96.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.687 -0.233 . . . . 64.209999999999994 110.591 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.83 -44.45 90.89 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 116.073 -0.512 . . . . 72.420000000000002 112.065 -176.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 28.3 m -67.67 -48.95 65.18 Favored 'General case' 0 C--O 1.249 1.067 0 CA-C-O 120.865 0.364 . . . . 74.099999999999994 111.068 -177.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.04 -40.44 94.79 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.092 0.404 . . . . 73.030000000000001 112.092 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.62 -36.62 83.03 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.263 -0.426 . . . . 74.0 110.484 -177.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -70.16 -24.71 63.2 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 120.721 0.296 . . . . 71.239999999999995 111.727 176.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -86.91 -8.69 57.02 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.087 0.47 . . . . 74.540000000000006 111.389 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 97.83 4.15 57.96 Favored Glycine 0 C--N 1.309 -0.922 0 C-N-CA 120.378 -0.915 . . . . 73.450000000000003 112.306 176.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -79.91 148.37 31.29 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 109.129 -0.693 . . . . 72.310000000000002 109.129 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -95.01 132.67 39.62 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 107.704 -1.221 . . . . 75.129999999999995 107.704 -177.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 1.4 pp -118.83 131.07 72.68 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 CA-C-O 121.755 0.788 . . . . 75.230000000000004 112.688 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -113.15 127.6 56.24 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 107.881 -1.155 . . . . 71.450000000000003 107.881 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 27.5 m -119.38 128.1 53.75 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 109.968 -0.382 . . . . 75.340000000000003 109.968 -177.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -111.3 119.76 39.97 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.645 -0.872 . . . . 75.099999999999994 108.645 176.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . 0.462 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -100.57 122.72 43.72 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.054 -0.721 . . . . 74.310000000000002 109.054 179.502 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -119.63 134.36 23.86 Favored Pre-proline 0 C--N 1.293 -1.877 0 CA-C-N 115.96 -0.564 . . . . 72.430000000000007 110.004 -177.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . 0.48 ' O ' HD13 ' A' ' 394' ' ' ILE . 11.1 Cg_exo -72.52 157.47 52.73 Favored 'Trans proline' 0 C--O 1.248 0.979 0 C-N-CA 121.935 1.757 . . . . 73.099999999999994 110.116 175.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 32.7 t70 88.34 152.6 0.05 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 125.267 1.427 . . . . 73.099999999999994 111.938 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 17.9 m -101.5 13.0 36.32 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 113.262 0.838 . . . . 73.329999999999998 113.262 -174.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 26.9 m -76.03 -25.93 56.13 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.654 -1.239 . . . . 74.299999999999997 107.654 172.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . 0.48 HD13 ' O ' ' A' ' 390' ' ' PRO . 0.0 OUTLIER -88.82 149.45 43.71 Favored Pre-proline 0 N--CA 1.433 -1.313 0 CA-C-N 114.764 -1.107 . . . . 73.310000000000002 108.67 172.524 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.31 133.66 41.5 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.198 2.599 . . . . 74.230000000000004 114.709 -174.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -55.5 163.03 5.47 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 124.268 3.312 . . . . 72.019999999999996 111.934 175.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -56.47 -8.1 0.49 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.729 0.812 . . . . 75.310000000000002 113.165 -175.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 32.7 m170 -83.26 104.21 13.25 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 105.248 -2.13 . . . . 74.299999999999997 105.248 168.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 25.2 m -64.92 120.18 11.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 CA-C-N 114.798 -1.092 . . . . 72.340000000000003 111.216 -168.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 9.8 tp -98.17 -29.22 3.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 120.519 -0.472 . . . . 73.409999999999997 110.244 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.81 157.98 27.53 Favored Glycine 0 N--CA 1.428 -1.861 0 N-CA-C 110.867 -0.893 . . . . 75.400000000000006 110.867 -177.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' THR . . . . . 0.522 ' OG1' ' HD3' ' A' ' 366' ' ' ARG . 17.3 p -139.43 -177.69 5.05 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 124.213 1.005 . . . . 73.0 109.246 -177.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . 0.42 ' HA ' ' HD3' ' A' ' 404' ' ' PRO . 16.8 t70 -101.17 133.48 20.93 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 107.342 -1.355 . . . . 71.340000000000003 107.342 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 403' ' ' ASP . 17.4 Cg_exo -67.76 11.02 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 123.473 2.782 . . . . 71.409999999999997 115.147 -173.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.86 -49.12 71.92 Favored 'General case' 0 C--O 1.216 -0.686 0 N-CA-C 109.756 -0.461 . . . . 52.420000000000002 109.756 176.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -69.82 -30.96 68.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.522 0.677 . . . . 64.329999999999998 110.239 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -76.8 -6.67 53.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.741 0.781 . . . . 74.430000000000007 110.354 -176.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 31.9 m -101.73 155.97 17.79 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 106.337 -1.727 . . . . 74.109999999999999 106.337 174.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 46.0 m -74.49 112.06 10.29 Favored 'General case' 0 N--CA 1.415 -2.197 0 N-CA-C 107.485 -1.302 . . . . 61.43 107.485 177.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 24.2 m -128.33 162.13 35.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 110.274 -0.269 . . . . 73.299999999999997 110.274 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 11.4 m -67.14 131.65 46.23 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.75 -0.833 . . . . 74.099999999999994 108.75 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -59.94 136.94 58.17 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 112.719 0.637 . . . . 73.420000000000002 112.719 -174.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 88.92 49.36 3.59 Favored Glycine 0 N--CA 1.434 -1.497 0 CA-C-N 114.887 -1.051 . . . . 71.409999999999997 111.599 -178.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -103.64 -173.66 2.36 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.688 -0.856 . . . . 75.150000000000006 108.688 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -109.08 120.66 43.19 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 123.274 0.629 . . . . 74.319999999999993 110.009 -176.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 48.6 mm -110.7 122.47 65.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 109.086 -0.709 . . . . 73.140000000000001 109.086 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 41.6 m -101.46 131.15 47.73 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.86 0.362 . . . . 72.409999999999997 111.301 -178.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 4.8 p -126.58 135.94 62.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 123.829 0.852 . . . . 75.230000000000004 109.643 -179.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -113.75 125.34 54.0 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.181 0.515 . . . . 73.510000000000005 109.855 176.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 22.0 m -124.72 150.3 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.185 0 CA-C-N 115.097 -0.956 . . . . 73.019999999999996 111.483 -176.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 16.3 t -88.77 145.57 25.53 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.214 1.007 . . . . 72.439999999999998 112.473 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.3 p -117.14 157.83 25.26 Favored 'General case' 0 N--CA 1.412 -2.369 0 CA-C-N 113.207 -1.815 . . . . 72.329999999999998 106.191 171.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.667 0 N-CA-C 116.997 1.559 . . . . 42.409999999999997 116.997 -175.144 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 . . . . . 0 N--CA 1.424 -1.765 0 N-CA-C 106.924 -1.509 . . . . 73.209999999999994 106.924 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -121.13 142.15 50.13 Favored 'General case' 0 CA--C 1.486 -1.483 0 C-N-CA 119.809 -0.756 . . . . 75.319999999999993 111.992 -178.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 11.2 pt-20 -83.09 131.83 35.13 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.172 -1.377 . . . . 74.319999999999993 110.191 -176.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 60.6 mt -88.52 127.77 55.37 Favored Pre-proline 0 C--N 1.305 -1.346 0 N-CA-C 108.722 -0.844 . . . . 74.299999999999997 108.722 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -71.41 142.82 41.68 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 121.624 1.55 . . . . 70.230000000000004 110.152 174.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -77.89 115.14 17.41 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.443 -0.577 . . . . 71.340000000000003 109.443 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 48.0 t -109.85 146.17 15.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 108.237 -1.023 . . . . 72.129999999999995 108.237 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 2.5 p -67.32 153.04 44.61 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 122.915 0.486 . . . . 71.329999999999998 112.105 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 434' ' ' THR . . . . . 0.426 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 18.6 p -65.15 -31.77 73.12 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 113.302 0.853 . . . . 75.040000000000006 113.302 -173.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 2.2 pp -82.13 -10.95 59.01 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 112.272 0.471 . . . . 74.430000000000007 112.272 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 3.7 m -103.96 44.84 0.99 Allowed 'General case' 0 CA--C 1.563 1.463 0 CA-C-O 121.722 0.772 . . . . 73.150000000000006 110.214 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -52.36 -38.22 58.21 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.153 0.981 . . . . 75.5 112.457 177.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -60.04 -42.7 95.01 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.551 0.691 . . . . 50.310000000000002 110.559 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -70.91 -35.64 72.37 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.724 -0.671 . . . . 65.109999999999999 110.47 178.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.548 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -60.18 -49.39 77.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.124 -0.489 . . . . 64.409999999999997 110.884 -178.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.7 m -66.05 -39.52 84.73 Favored 'Isoleucine or valine' 0 C--O 1.25 1.107 0 N-CA-C 112.292 0.478 . . . . 72.209999999999994 112.292 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.31 -34.65 76.52 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 119.751 -0.78 . . . . 73.420000000000002 112.083 177.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -64.09 -38.85 92.56 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.54 -0.3 . . . . 75.230000000000004 110.738 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 92.9 mt -63.46 -39.67 95.08 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.962 -0.563 . . . . 75.430000000000007 110.219 178.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.507 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 15.7 m -70.89 -39.3 72.88 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.929 -0.578 . . . . 74.430000000000007 111.197 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.98 -20.96 64.18 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.384 0.611 . . . . 75.420000000000002 110.94 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -85.69 5.35 32.48 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 115.53 -0.759 . . . . 74.299999999999997 111.923 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 110.22 -85.13 0.39 Allowed Glycine 0 CA--C 1.491 -1.418 0 C-N-CA 120.052 -1.07 . . . . 64.439999999999998 112.054 175.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -35.3 -62.36 0.39 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.4 1.259 . . . . 73.420000000000002 114.4 176.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . 0.507 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 58.39 26.17 58.89 Favored Glycine 0 CA--C 1.504 -0.622 0 C-N-CA 121.343 -0.456 . . . . 74.230000000000004 113.183 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -105.3 110.8 23.3 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 107.892 -1.151 . . . . 74.150000000000006 107.892 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . 0.49 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 33.1 p90 -140.66 152.46 45.39 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 116.315 -0.402 . . . . 75.409999999999997 110.132 -177.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -138.0 123.01 19.05 Favored 'General case' 0 C--N 1.291 -1.943 0 O-C-N 124.002 0.813 . . . . 75.329999999999998 109.392 176.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -87.26 126.58 34.92 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.292 -1.003 . . . . 73.150000000000006 108.292 178.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.09 146.1 43.35 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 107.276 -1.379 . . . . 65.140000000000001 107.276 177.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -120.03 140.24 51.3 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 109.477 -0.564 . . . . 73.409999999999997 109.477 -175.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 49.4 m -147.69 132.59 8.98 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 109.489 -0.559 . . . . 72.420000000000002 109.489 174.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.586 ' HA ' ' O ' ' A' ' 490' ' ' SER . 38.9 Cg_exo -64.75 122.73 10.67 Favored 'Trans proline' 0 C--O 1.238 0.505 0 C-N-CA 122.225 1.95 . . . . 72.439999999999998 110.684 177.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 17.6 m -143.4 175.03 10.23 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 108.142 -1.059 . . . . 73.319999999999993 108.142 -176.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.9 t -47.6 139.36 8.56 Favored Pre-proline 0 C--O 1.249 1.076 0 C-N-CA 124.259 1.023 . . . . 70.310000000000002 112.251 178.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.13 -29.29 28.12 Favored 'Trans proline' 0 C--N 1.36 1.175 0 C-N-CA 124.74 3.626 . . . . 75.409999999999997 113.612 -177.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.25 -22.87 63.82 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 112.089 0.403 . . . . 75.540000000000006 112.089 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -104.25 -8.91 18.98 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 111.681 0.252 . . . . 61.009999999999998 111.681 178.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 98.6 t -60.84 127.25 20.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.974 0.416 . . . . 72.549999999999997 110.179 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.05 -16.18 60.19 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.934 -0.576 . . . . 73.430000000000007 112.41 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -107.63 166.04 10.97 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 108.352 -0.981 . . . . 75.510000000000005 108.352 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 75.2 t -76.72 143.08 13.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 108.571 -0.9 . . . . 75.439999999999998 108.571 176.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 63.8 mt -98.18 -30.9 3.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 107.961 -1.125 . . . . 75.019999999999996 107.961 177.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 167.17 179.26 40.03 Favored Glycine 0 N--CA 1.425 -2.096 0 N-CA-C 110.862 -0.895 . . . . 74.549999999999997 110.862 177.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 470' ' ' THR . . . . . 0.429 HG21 HG12 ' A' ' 486' ' ' ILE . 59.2 p -115.64 140.66 48.98 Favored 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 107.41 -1.329 . . . . 74.129999999999995 107.41 177.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.479 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 7.2 t30 -63.7 -50.31 72.31 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 120.756 -0.377 . . . . 60.229999999999997 110.471 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.479 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 1.4 Cg_endo -88.35 152.87 6.65 Favored 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 121.593 1.529 . . . . 75.25 108.94 171.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -63.74 126.76 18.1 Favored 'Trans proline' 0 C--O 1.243 0.726 0 C-N-CA 121.313 1.342 . . . . 72.420000000000002 111.681 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -93.88 14.38 19.66 Favored 'General case' 0 C--O 1.202 -1.432 0 CA-C-O 121.68 0.753 . . . . 75.430000000000007 110.12 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -110.02 -1.99 17.31 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.715 -0.675 . . . . 75.120000000000005 109.318 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -109.75 174.68 5.75 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.36 -0.836 . . . . 70.230000000000004 112.578 -173.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 477' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 2.5 m -86.33 114.32 23.02 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 114.108 -1.405 . . . . 72.019999999999996 108.776 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 15.7 m -109.42 148.08 31.72 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 109.877 -0.416 . . . . 71.340000000000003 109.877 -176.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.98 157.74 36.12 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.478 -0.328 . . . . 63.43 110.809 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 37.6 mm -72.35 -17.73 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-O 122.084 0.945 . . . . 72.450000000000003 110.518 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 2.7 p -99.52 5.47 46.08 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.898 -0.592 . . . . 73.519999999999996 111.437 177.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -84.61 129.97 34.78 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.519 -0.549 . . . . 73.310000000000002 109.519 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 42.7 t -102.43 120.59 52.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.748 -0.834 . . . . 75.319999999999993 108.748 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 28.3 m -100.66 120.92 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-O 122.022 0.915 . . . . 74.099999999999994 111.239 -178.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.51 128.99 46.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 109.352 -0.61 . . . . 72.310000000000002 109.352 178.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . 0.429 HG12 HG21 ' A' ' 470' ' ' THR . 9.8 mt -120.36 128.14 75.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 C-N-CA 124.393 1.077 . . . . 64.25 110.267 -174.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 6.4 tt -100.85 127.17 54.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 C-N-CA 122.587 0.355 . . . . 73.239999999999995 111.342 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 34.3 m -113.07 152.17 14.84 Favored 'Isoleucine or valine' 0 C--O 1.254 1.3 0 C-N-CA 123.347 0.659 . . . . 72.340000000000003 110.241 178.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -81.24 130.91 10.02 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 121.042 -0.599 . . . . 71.430000000000007 113.537 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.586 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 35.6 t . . . . . 0 C--N 1.309 -1.171 0 N-CA-C 106.067 -1.827 . . . . 71.340000000000003 106.067 176.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 C--O 1.249 1.026 0 N-CA-C 111.091 -0.388 . . . . 74.030000000000001 111.091 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -129.19 32.32 4.73 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-O 121.879 0.847 . . . . 75.530000000000001 110.582 -177.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 19.6 p -118.12 142.13 47.75 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 114.686 -1.143 . . . . 74.329999999999998 109.885 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? -139.65 163.2 33.2 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.393 -0.595 . . . . 75.120000000000005 109.393 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.4 p-10 -85.74 138.81 31.84 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.809 -0.632 . . . . 73.239999999999995 110.001 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 38.2 pt -88.1 133.74 36.47 Favored Pre-proline 0 C--N 1.295 -1.771 0 C-N-CA 120.536 -0.465 . . . . 75.340000000000003 109.823 175.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -87.04 175.18 5.05 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.649 2.233 . . . . 74.209999999999994 111.819 177.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -92.63 157.24 16.6 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.547 -0.909 . . . . 73.010000000000005 108.547 177.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . 0.425 HG23 ' HA ' ' A' ' 508' ' ' ALA . 9.4 p -159.97 12.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.256 0 CA-C-O 121.531 0.681 . . . . 74.239999999999995 111.587 -177.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -74.59 95.05 2.74 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 121.417 0.627 . . . . 75.329999999999998 110.947 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 159.64 -22.64 0.28 Allowed Glycine 0 N--CA 1.427 -1.914 0 CA-C-N 115.39 -0.823 . . . . 74.010000000000005 111.497 -177.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -102.11 -177.85 3.53 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.02 -0.672 . . . . 72.140000000000001 109.241 176.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 20.3 p -83.41 158.93 21.92 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 110.036 -0.357 . . . . 72.420000000000002 110.036 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.488 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 9.5 p -52.99 -41.14 39.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 O-C-N 123.703 0.627 . . . . 73.540000000000006 111.92 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . 0.46 ' O ' ' HD3' ' A' ' 510' ' ' LYS . 3.4 m-20 -57.57 -42.02 82.26 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.746 0.419 . . . . 74.140000000000001 111.166 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 59.4 t -68.85 -38.29 78.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.231 0.538 . . . . 72.400000000000006 109.888 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . 0.425 ' HA ' HG23 ' A' ' 500' ' ' VAL . . . -62.96 -44.09 97.01 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.633 -0.712 . . . . 70.319999999999993 110.821 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 26.5 mt-30 -60.18 -39.58 86.97 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.0 -0.545 . . . . 73.540000000000006 110.836 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 506' ' ' ASP . 14.4 mptt -65.88 -50.62 63.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.698 -0.683 . . . . 72.540000000000006 111.047 177.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -61.89 -40.89 97.0 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 116.394 -0.367 . . . . 75.430000000000007 111.474 -177.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 94.0 mt -62.71 -44.76 95.38 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 110.358 -0.238 . . . . 73.010000000000005 110.358 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.46 -41.45 94.18 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.017 -0.538 . . . . 60.130000000000003 110.88 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.405 HG21 ' O ' ' A' ' 510' ' ' LYS . 73.5 t -57.85 -36.46 55.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.871 -0.604 . . . . 74.450000000000003 111.71 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -87.18 0.26 55.6 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.249 -0.58 . . . . 75.530000000000001 112.365 -177.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 98.97 14.16 37.5 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.754 -0.736 . . . . 75.239999999999995 113.719 175.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -101.03 110.19 22.19 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.344 -0.984 . . . . 74.430000000000007 108.344 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.39 -14.66 22.31 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 116.011 -0.54 . . . . 62.240000000000002 111.871 -175.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . 0.496 ' HD2' ' O ' ' A' ' 548' ' ' ASP . 99.2 mttt -108.03 115.5 30.25 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.608 0.718 . . . . 74.409999999999997 111.871 -175.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . 0.41 ' HA ' ' O ' ' A' ' 551' ' ' ILE . 51.7 p90 -130.21 150.94 51.23 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.084 -0.962 . . . . 63.439999999999998 109.65 177.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 521' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 51.1 m -136.42 140.55 43.25 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 106.983 -1.488 . . . . 74.409999999999997 106.983 174.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . 0.464 ' NE2' HG23 ' A' ' 505' ' ' VAL . 3.6 pt20 -122.97 125.21 44.84 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.544 0.688 . . . . 75.010000000000005 112.35 -175.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -116.33 116.49 27.83 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.728 -1.124 . . . . 75.239999999999995 108.047 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 524' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 12.4 p -91.8 130.18 37.62 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.148 0.499 . . . . 64.239999999999995 111.173 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 27.2 m -121.89 158.54 25.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.252 -1.018 . . . . 75.510000000000005 108.252 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -73.35 137.72 44.92 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 119.87 -0.732 . . . . 72.430000000000007 109.189 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 24.6 m -148.35 171.06 6.73 Favored Pre-proline 0 C--N 1.287 -2.142 0 N-CA-C 107.941 -1.133 . . . . 73.200000000000003 107.941 -178.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -81.61 -11.08 11.75 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 121.508 1.472 . . . . 71.510000000000005 110.783 172.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . 0.475 ' HD3' ' OE2' ' A' ' 533' ' ' GLU . 88.4 mtt180 -80.91 145.39 57.18 Favored Pre-proline 0 N--CA 1.444 -0.735 0 CA-C-N 115.276 -0.874 . . . . 73.099999999999994 108.932 178.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.26 151.47 82.16 Favored 'Trans proline' 0 C--O 1.253 1.235 0 C-N-CA 122.787 2.325 . . . . 64.400000000000006 112.855 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.666 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -62.43 112.12 2.31 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.932 -1.031 . . . . 71.319999999999993 111.739 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 134.11 -20.88 3.96 Favored Glycine 0 C--N 1.308 -0.977 0 C-N-CA 120.829 -0.701 . . . . 64.200000000000003 112.617 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . 0.475 ' OE2' ' HD3' ' A' ' 529' ' ' ARG . 34.3 tt0 -83.02 142.37 31.38 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.702 -0.481 . . . . 74.299999999999997 109.702 179.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 63.1 t -81.92 123.41 38.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 108.666 -0.864 . . . . 74.099999999999994 108.666 178.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 535' ' ' THR . . . . . 0.683 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 10.3 t -96.44 -19.74 18.94 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.36 -0.536 . . . . 75.120000000000005 110.742 -178.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 177.48 179.13 47.58 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.244 -0.979 . . . . 73.209999999999994 111.509 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 72.1 p -124.16 149.82 45.86 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.562 -1.273 . . . . 75.25 107.562 177.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -67.75 -59.82 6.25 Favored Pre-proline 0 C--N 1.323 -0.555 0 C-N-CA 120.548 -0.461 . . . . 74.109999999999999 109.931 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -76.29 130.56 12.1 Favored 'Trans proline' 0 N--CA 1.44 -1.653 0 N-CA-C 108.298 -1.462 . . . . 71.010000000000005 108.298 170.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -66.63 150.69 83.73 Favored 'Trans proline' 0 C--O 1.255 1.371 0 C-N-CA 122.01 1.807 . . . . 75.310000000000002 112.178 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -58.98 142.74 50.27 Favored 'General case' 0 C--O 1.249 1.067 0 CA-C-N 115.759 -0.655 . . . . 74.140000000000001 109.787 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 102.9 -17.33 52.9 Favored Glycine 0 C--N 1.291 -1.917 0 C-N-CA 120.508 -0.853 . . . . 55.450000000000003 111.677 -179.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 61.5 m -68.9 127.49 33.28 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 109.959 -0.385 . . . . 73.409999999999997 109.959 178.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 20.6 m -91.62 122.99 34.68 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.384 -0.969 . . . . 74.409999999999997 108.384 177.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 29.4 m -137.37 161.26 61.84 Favored Pre-proline 0 C--N 1.311 -1.102 0 N-CA-C 109.033 -0.728 . . . . 74.409999999999997 109.033 -176.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -61.33 151.68 77.65 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 121.809 1.673 . . . . 74.340000000000003 110.821 173.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 30.5 m -63.3 -20.31 25.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.596 0.712 . . . . 65.219999999999999 112.166 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . 0.496 ' O ' ' HD2' ' A' ' 519' ' ' LYS . 26.8 t70 -90.42 4.25 51.5 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.628 -0.715 . . . . 73.329999999999998 110.863 178.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.1 t -71.15 162.61 29.14 Favored 'General case' 0 C--O 1.241 0.62 0 O-C-N 121.474 -0.766 . . . . 71.030000000000001 109.402 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 18.0 t -109.32 116.75 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 CA-C-O 121.152 0.501 . . . . 74.450000000000003 109.961 -176.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 520' ' ' PHE . 2.5 mp -91.95 123.86 44.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 109.124 -0.695 . . . . 74.340000000000003 109.124 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 521' ' ' SER . 37.7 tt0 -102.87 120.14 40.08 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-O 121.056 0.455 . . . . 73.239999999999995 110.029 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -96.65 134.27 40.11 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.96 -1.018 . . . . 72.010000000000005 109.817 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -92.47 114.88 27.56 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.513 -1.291 . . . . 74.140000000000001 107.513 171.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 524' ' ' SER . 47.6 t -100.73 141.72 17.01 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.39 0 N-CA-C 108.684 -0.858 . . . . 72.420000000000002 108.684 -177.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.683 ' OG ' ' HB ' ' A' ' 535' ' ' THR . 71.7 m -81.45 138.76 35.5 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-O 121.124 0.488 . . . . 74.209999999999994 111.75 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.11 135.72 52.4 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 105.678 -1.971 . . . . 73.010000000000005 105.678 169.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -71.12 -41.95 59.45 Favored Glycine 0 CA--C 1.497 -1.039 0 N-CA-C 111.297 -0.721 . . . . 64.540000000000006 111.297 -175.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 65.4 t30 66.43 8.12 5.49 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.686 1.194 . . . . 75.5 111.21 175.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -113.78 162.3 16.48 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.127 -0.942 . . . . 74.010000000000005 109.152 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -137.19 144.92 43.12 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.414 -0.588 . . . . 74.430000000000007 109.414 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 96.8 t -72.83 122.61 25.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 123.528 0.517 . . . . 61.340000000000003 110.233 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 48.7 ttm -78.22 126.11 83.96 Favored Pre-proline 0 C--N 1.308 -1.231 0 CA-C-N 115.714 -0.676 . . . . 73.140000000000001 109.964 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.3 169.33 18.57 Favored 'Trans proline' 0 C--O 1.243 0.774 0 C-N-CA 122.569 2.18 . . . . 64.129999999999995 110.7 176.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -83.08 119.7 24.82 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.834 0.826 . . . . 71.219999999999999 111.338 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 95.0 mt -127.34 14.04 7.15 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.083 -1.417 . . . . 73.420000000000002 107.453 176.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 9.3 m -72.04 130.7 41.56 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.431 -1.258 . . . . 75.409999999999997 109.356 -178.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 85.02 22.91 51.24 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.345 -0.931 . . . . 75.329999999999998 112.028 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 87.9 mtp -116.14 -178.91 3.52 Favored 'General case' 0 C--O 1.25 1.105 0 N-CA-C 109.282 -0.636 . . . . 74.0 109.282 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . 0.4 ' HB3' ' OD1' ' A' ' 601' ' ' ASN . 97.1 m-85 -97.47 153.17 18.3 Favored 'General case' 0 N--CA 1.414 -2.226 0 N-CA-C 109.176 -0.676 . . . . 75.439999999999998 109.176 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 64.1 t90 -64.57 -27.37 68.91 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 123.441 0.697 . . . . 73.530000000000001 110.142 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 10.3 p -71.66 -16.44 18.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.779 -0.646 . . . . 73.109999999999999 109.694 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . 0.488 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 22.9 m-20 -101.14 -44.91 5.54 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.6 -0.519 . . . . 75.400000000000006 109.6 176.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -62.91 -52.68 62.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.596 -0.729 . . . . 74.430000000000007 112.664 -175.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.408 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 4.1 tm-20 -55.55 -52.11 74.59 Favored Pre-proline 0 CA--C 1.567 1.623 0 C-N-CA 122.784 0.434 . . . . 74.540000000000006 111.851 -176.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 52.3 Cg_exo -61.12 -29.46 87.25 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 121.785 1.657 . . . . 75.299999999999997 113.038 174.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . 0.534 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 20.0 mmt180 -66.43 -40.41 89.51 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 111.479 0.177 . . . . 73.540000000000006 111.479 178.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.13 -45.53 90.68 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.202 0.525 . . . . 64.540000000000006 109.952 177.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -59.68 -39.64 85.18 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.362 -0.835 . . . . 75.129999999999995 110.961 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.29 -21.39 62.95 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.341 -0.39 . . . . 44.420000000000002 111.717 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 92.3 mt -82.66 -6.8 59.57 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 120.956 0.407 . . . . 65.310000000000002 111.43 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 88.36 20.07 50.07 Favored Glycine 0 C--O 1.238 0.37 0 C-N-CA 120.135 -1.031 . . . . 60.140000000000001 111.495 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 89.9 t90 -70.92 129.84 40.07 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.006 -0.738 . . . . 75.019999999999996 109.006 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 1.2 m -127.56 13.92 7.02 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.606 -0.516 . . . . 63.340000000000003 109.606 -176.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -88.98 -156.82 32.07 Favored Glycine 0 CA--C 1.498 -1.029 0 C-N-CA 120.538 -0.839 . . . . 65.439999999999998 114.987 -173.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 50.0 ttm -108.1 131.36 54.7 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 122.873 0.469 . . . . 73.209999999999994 111.37 -178.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -101.37 128.96 47.32 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.653 -1.24 . . . . 72.340000000000003 107.653 176.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -107.0 122.36 46.28 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 116.2 -0.454 . . . . 75.409999999999997 109.837 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -90.28 132.97 35.24 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.404 -0.816 . . . . 71.329999999999998 110.158 -178.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -85.34 177.64 50.42 Favored Glycine 0 N--CA 1.431 -1.682 0 C-N-CA 120.987 -0.625 . . . . 64.109999999999999 112.227 175.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -72.53 144.74 47.85 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 123.067 0.547 . . . . 63.109999999999999 111.451 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -63.42 151.35 41.29 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.866 -0.607 . . . . 74.310000000000002 111.402 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 47.0 t -138.39 116.97 13.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 107.954 -1.128 . . . . 72.019999999999996 107.954 -178.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -74.43 124.06 25.84 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.085 -1.08 . . . . 74.230000000000004 108.085 177.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -160.19 12.9 0.12 Allowed 'General case' 0 C--O 1.244 0.801 0 N-CA-C 112.376 0.51 . . . . 74.209999999999994 112.376 -176.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 89.8 166.67 41.79 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.172 -1.013 . . . . 50.020000000000003 112.086 -178.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -59.56 -48.23 87.04 Favored Glycine 0 CA--C 1.519 0.301 0 N-CA-C 114.724 0.649 . . . . 71.519999999999996 114.724 -175.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 28.2 m -61.23 -25.22 66.92 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-O 121.224 0.535 . . . . 75.519999999999996 112.136 -176.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -108.36 -1.52 19.9 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 112.477 0.547 . . . . 75.439999999999998 112.477 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.53 -51.65 11.29 Favored 'General case' 0 C--O 1.195 -1.791 0 C-N-CA 119.624 -0.83 . . . . 74.040000000000006 111.864 -173.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . 0.4 ' OD1' ' HB3' ' A' ' 570' ' ' PHE . 16.7 t-20 -92.19 19.39 6.98 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 120.857 -1.152 . . . . 73.340000000000003 109.429 -177.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 20.0 tpp85 -91.08 139.77 30.45 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.015 -0.993 . . . . 74.400000000000006 109.936 -176.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 13.5 p -65.05 139.97 20.52 Favored 'Isoleucine or valine' 0 C--O 1.247 0.94 0 N-CA-C 108.597 -0.89 . . . . 74.540000000000006 108.597 175.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 95.5 t -100.15 -46.88 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.056 0 N-CA-C 108.427 -0.953 . . . . 73.310000000000002 108.427 -177.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -156.15 157.23 35.59 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 105.872 -1.899 . . . . 73.420000000000002 105.872 176.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -123.4 131.94 53.81 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 106.918 -1.512 . . . . 73.019999999999996 106.918 173.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.519 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 25.8 t-20 -50.8 -58.09 11.34 Favored Pre-proline 0 C--N 1.312 -1.028 0 CA-C-O 118.844 -0.598 . . . . 73.239999999999995 112.366 -177.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 11.1 Cg_endo -96.76 121.5 0.2 Allowed 'Trans proline' 0 N--CA 1.44 -1.674 0 C-N-CA 121.733 1.622 . . . . 75.450000000000003 109.716 173.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -66.46 158.36 55.79 Favored 'Trans proline' 0 C--O 1.25 1.077 0 C-N-CA 122.116 1.877 . . . . 72.109999999999999 112.277 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.86 130.91 47.92 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.854 -0.612 . . . . 62.310000000000002 110.679 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 104.29 -3.77 43.93 Favored Glycine 0 C--N 1.3 -1.425 0 C-N-CA 120.635 -0.793 . . . . 74.340000000000003 112.119 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 6.1 m -93.13 148.13 22.28 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.235 -0.654 . . . . 65.409999999999997 109.235 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -84.5 115.79 4.16 Favored Glycine 0 N--CA 1.425 -2.056 0 N-CA-C 109.272 -1.531 . . . . 61.399999999999999 109.272 175.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.4 m -100.98 143.7 13.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 C-N-CA 122.854 0.461 . . . . 74.510000000000005 111.067 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -44.4 166.53 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.637 1.975 . . . . 75.129999999999995 113.354 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.0 -26.08 61.93 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.943 0.401 . . . . 73.140000000000001 111.59 -176.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . 0.499 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 25.8 t70 -79.68 -37.23 36.27 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.592 -0.731 . . . . 75.219999999999999 109.315 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 81.42 22.76 59.83 Favored Glycine 0 N--CA 1.429 -1.789 0 C-N-CA 118.948 -1.596 . . . . 64.239999999999995 111.527 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.81 119.8 12.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 122.286 1.041 . . . . 73.030000000000001 109.165 -168.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.15 126.76 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-N 114.513 -1.221 . . . . 73.209999999999994 110.594 -172.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.439 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 32.2 m -100.9 125.8 47.48 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.128 -0.693 . . . . 74.430000000000007 109.128 175.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.5 pp -133.85 154.63 50.89 Favored 'General case' 0 CA--C 1.479 -1.759 0 N-CA-C 108.612 -0.885 . . . . 72.420000000000002 108.612 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -127.98 141.57 51.49 Favored 'General case' 0 C--N 1.257 -3.414 0 N-CA-C 105.43 -2.063 . . . . 72.239999999999995 105.43 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -137.41 166.82 22.91 Favored 'General case' 0 C--N 1.277 -2.561 0 N-CA-C 107.129 -1.434 . . . . 74.510000000000005 107.129 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -70.7 -137.34 0.14 Allowed Glycine 0 N--CA 1.427 -1.921 0 O-C-N 124.325 1.016 . . . . 65.010000000000005 115.343 -174.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 C--N 1.289 -2.05 0 CA-C-O 118.967 -0.54 . . . . 65.140000000000001 109.575 -171.159 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 . . . . . 0 CA--C 1.5 -0.949 0 N-CA-C 106.019 -1.845 . . . . 73.439999999999998 106.019 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 31.4 m -115.51 154.14 16.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-O 121.633 0.73 . . . . 74.209999999999994 111.053 -172.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . 0.542 ' NE2' ' HA ' ' A' ' 407' ' ' ASN . 0.9 OUTLIER -94.92 136.77 34.83 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 106.425 -1.694 . . . . 74.430000000000007 106.425 -176.16 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.572 HG21 ' CZ ' ' A' ' 382' ' ' PHE . 98.0 t -95.12 118.63 66.49 Favored Pre-proline 0 C--N 1.297 -1.68 0 CA-C-N 116.028 -0.533 . . . . 74.299999999999997 110.773 -169.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -64.59 130.92 27.86 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 123.027 2.485 . . . . 73.540000000000006 112.271 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -93.66 121.16 34.8 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.238 -0.892 . . . . 70.340000000000003 110.342 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 5.7 m -104.65 23.91 2.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 122.005 0.907 . . . . 75.140000000000001 110.986 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.457 ' HD2' ' O ' ' A' ' 366' ' ' ARG . 4.5 ppt_? -54.85 145.54 19.61 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.551 -1.204 . . . . 74.219999999999999 110.781 172.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.15 -11.8 51.94 Favored Glycine 0 C--N 1.302 -1.344 0 N-CA-C 110.356 -1.098 . . . . 71.299999999999997 110.356 -175.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -108.18 -151.66 0.47 Allowed 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 108.464 -0.939 . . . . 72.040000000000006 108.464 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 80.6 p -98.21 157.44 16.16 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.43 -0.582 . . . . 72.129999999999995 109.43 -174.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.5 p -63.67 -41.06 98.22 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 112.306 0.484 . . . . 75.239999999999995 112.306 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -67.14 -42.83 83.74 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-O 119.462 -0.304 . . . . 50.399999999999999 111.495 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.02 -35.12 74.09 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 119.558 -0.857 . . . . 63.130000000000003 110.594 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.22 -47.95 75.04 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.788 -0.642 . . . . 63.229999999999997 110.611 177.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . 0.403 HG23 HG13 ' A' ' 384' ' ' ILE . 70.6 mt -61.71 -43.19 96.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-N 116.039 -0.528 . . . . 71.219999999999999 110.309 175.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.57 -44.77 89.87 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.126 -0.488 . . . . 74.430000000000007 110.112 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 87.9 m -60.74 -46.81 89.02 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.964 -0.562 . . . . 64.530000000000001 110.753 178.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 93.7 mt -62.98 -40.33 97.42 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.346 -0.388 . . . . 74.420000000000002 110.22 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -62.12 -43.29 99.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.671 -0.695 . . . . 64.150000000000006 110.3 178.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.0 -31.85 70.31 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 120.982 0.42 . . . . 71.109999999999999 111.384 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -85.86 -12.24 51.23 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.957 -0.565 . . . . 75.409999999999997 111.751 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 94.49 14.57 50.08 Favored Glycine 0 C--N 1.307 -1.059 0 C-N-CA 120.761 -0.733 . . . . 73.510000000000005 112.701 177.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.572 ' CZ ' HG21 ' A' ' 362' ' ' VAL . 52.2 m-85 -81.04 150.82 28.67 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-O 121.076 0.465 . . . . 75.530000000000001 111.221 177.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . 0.406 ' CB ' ' HG2' ' A' ' 415' ' ' GLU . 7.7 mmtp -84.49 144.78 28.49 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.854 -1.165 . . . . 75.200000000000003 107.854 175.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . 0.403 HG13 HG23 ' A' ' 374' ' ' ILE . 0.2 OUTLIER -129.93 133.83 63.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-O 121.495 0.664 . . . . 74.430000000000007 111.015 -177.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . 0.431 ' HA ' ' NE ' ' A' ' 385' ' ' ARG . 3.6 tpm_? -115.89 147.13 41.43 Favored 'General case' 0 N--CA 1.41 -2.437 0 N-CA-C 106.519 -1.66 . . . . 72.400000000000006 106.519 173.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 39.1 m -129.55 127.64 41.13 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 109.507 -0.553 . . . . 75.150000000000006 109.507 -177.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -119.12 130.52 55.61 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 105.488 -2.042 . . . . 75.430000000000007 105.488 176.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . 0.468 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -121.55 135.9 54.98 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 118.452 0.569 . . . . 63.43 110.062 -178.716 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -134.42 115.92 12.83 Favored Pre-proline 0 C--N 1.314 -0.952 0 C-N-CA 121.335 -0.146 . . . . 62.340000000000003 111.1 177.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . 0.47 ' CA ' ' HB ' ' A' ' 422' ' ' THR . 64.8 Cg_endo -87.91 135.49 3.4 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.43 2.087 . . . . 74.510000000000005 111.146 174.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.438 ' HB3' HG12 ' A' ' 394' ' ' ILE . 13.1 t70 -179.82 153.65 0.54 Allowed 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 109.022 -0.733 . . . . 55.420000000000002 109.022 177.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 9.9 m -73.87 -18.53 60.91 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 123.186 0.594 . . . . 65.420000000000002 111.959 -177.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 3.1 m -87.63 -17.37 32.02 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-O 121.741 0.781 . . . . 65.310000000000002 109.975 -178.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . 0.469 HG22 ' HB3' ' A' ' 421' ' ' SER . 45.4 mm -90.22 135.68 29.55 Favored Pre-proline 0 C--N 1.301 -1.513 0 CA-C-N 115.446 -0.797 . . . . 75.540000000000006 111.311 -171.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . 0.434 ' O ' ' HB3' ' A' ' 421' ' ' SER . 95.7 Cg_exo -50.14 179.0 0.02 OUTLIER 'Trans proline' 0 CA--C 1.585 3.072 1 C-N-CA 126.104 4.536 . . . . 71.109999999999999 116.021 179.223 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 395' ' ' PRO . 37.6 Cg_endo -67.14 160.96 44.98 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 123.191 2.594 . . . . 72.340000000000003 113.13 173.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -62.58 -6.24 3.3 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 124.591 1.156 . . . . 73.239999999999995 113.618 -177.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -65.6 158.04 28.23 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.946 -0.761 . . . . 72.040000000000006 108.946 177.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 6.4 m -86.36 117.77 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 C-N-CA 118.49 -1.284 . . . . 73.329999999999998 108.893 176.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . 0.408 HD13 ' N ' ' A' ' 401' ' ' GLY . 2.7 pp -88.96 -28.52 5.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 113.007 0.743 . . . . 73.430000000000007 113.007 -177.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . 0.408 ' N ' HD13 ' A' ' 400' ' ' ILE . . . -167.97 169.3 41.28 Favored Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 110.659 -0.976 . . . . 61.399999999999999 110.659 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 18.6 p -114.95 172.71 6.88 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.69 -0.856 . . . . 72.420000000000002 108.69 177.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -102.71 155.42 36.56 Favored Pre-proline 0 C--N 1.292 -1.9 0 N-CA-C 109.028 -0.73 . . . . 71.420000000000002 109.028 177.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -50.1 -20.13 4.98 Favored 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 124.043 3.162 . . . . 74.109999999999999 115.384 -175.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -62.23 -42.82 99.65 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 110.044 -0.354 . . . . 75.129999999999995 110.044 -178.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . 0.436 ' O ' ' HB ' ' A' ' 362' ' ' VAL . . . -71.3 -33.09 69.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.87 0.843 . . . . 72.340000000000003 109.741 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . 0.542 ' HA ' ' NE2' ' A' ' 361' ' ' GLN . 18.2 m120 -86.52 2.18 48.92 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.326 -0.852 . . . . 74.109999999999999 112.27 -176.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 36.3 m -103.21 152.16 21.8 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 105.783 -1.932 . . . . 65.310000000000002 105.783 172.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 409' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 361' ' ' GLN . 24.6 m -74.8 112.85 11.43 Favored 'General case' 0 N--CA 1.429 -1.517 0 C-N-CA 119.56 -0.856 . . . . 74.150000000000006 109.252 178.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 35.1 m -113.36 169.06 5.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 121.048 0.451 . . . . 75.420000000000002 110.256 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 19.9 m -66.45 134.7 53.01 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.637 -0.875 . . . . 74.239999999999995 108.637 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -54.78 112.37 1.02 Allowed 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 122.994 0.518 . . . . 74.420000000000002 111.086 -178.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 105.49 27.74 5.68 Favored Glycine 0 N--CA 1.433 -1.552 0 C-N-CA 120.591 -0.814 . . . . 64.329999999999998 112.86 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -85.16 177.22 7.95 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.418 -0.956 . . . . 75.439999999999998 108.418 177.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . 0.406 ' HG2' ' CB ' ' A' ' 383' ' ' LYS . 27.5 mt-10 -97.87 110.88 23.37 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.65 0.738 . . . . 74.120000000000005 110.97 -172.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 44.9 mm -98.33 122.62 50.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 CA-C-N 115.064 -0.971 . . . . 75.239999999999995 108.977 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 15.6 p -89.22 130.73 35.58 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.831 -0.622 . . . . 75.400000000000006 111.419 -177.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 7.5 p -114.36 134.3 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 N-CA-C 109.118 -0.697 . . . . 73.230000000000004 109.118 175.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -106.03 115.39 30.15 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.993 -1.484 . . . . 71.420000000000002 106.993 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 48.6 t -106.93 130.64 58.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-O 122.047 0.927 . . . . 74.510000000000005 109.727 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 421' ' ' SER . . . . . 0.469 ' HB3' HG22 ' A' ' 394' ' ' ILE . 49.6 m -87.71 123.34 32.43 Favored 'General case' 0 C--N 1.273 -2.751 0 CA-C-N 114.164 -1.38 . . . . 64.439999999999998 108.746 179.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 422' ' ' THR . . . . . 0.47 ' HB ' ' CA ' ' A' ' 390' ' ' PRO . 6.2 m -106.08 157.6 17.42 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 108.131 -1.063 . . . . 74.310000000000002 108.131 -177.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.651 0 N-CA-C 116.645 1.418 . . . . 71.299999999999997 116.645 -173.954 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 . . . . . 0 N--CA 1.428 -1.555 0 N-CA-C 107.677 -1.231 . . . . 74.409999999999997 107.677 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.554 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 4.2 mmp_? -126.17 141.8 51.79 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.369 0.604 . . . . 72.200000000000003 111.152 176.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -83.11 129.63 35.04 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 106.724 -1.584 . . . . 75.040000000000006 106.724 175.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 53.0 mt -80.42 131.22 62.37 Favored Pre-proline 0 N--CA 1.428 -1.556 0 N-CA-C 108.947 -0.76 . . . . 64.230000000000004 108.947 -174.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -69.35 140.72 44.96 Favored 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 121.468 1.446 . . . . 73.209999999999994 110.993 176.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -89.46 114.39 25.87 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.305 -1.368 . . . . 74.519999999999996 107.305 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.7 p -110.82 159.29 10.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 108.663 -0.866 . . . . 74.420000000000002 108.663 -175.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 22.6 p -68.31 137.76 54.91 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 108.141 -1.059 . . . . 71.209999999999994 108.141 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 434' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 18.3 p -63.38 -21.56 66.35 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 113.675 0.991 . . . . 74.120000000000005 113.675 -174.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.2 pp -78.2 -11.48 59.93 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 120.103 -0.639 . . . . 64.140000000000001 111.606 177.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.3 m -106.79 61.79 0.63 Allowed 'General case' 0 N--CA 1.432 -1.351 0 CA-C-O 121.725 0.774 . . . . 73.310000000000002 111.729 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -52.32 -38.25 58.08 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.363 1.065 . . . . 74.5 111.507 174.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -59.39 -42.53 91.9 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.34 0.591 . . . . 73.5 110.904 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -70.92 -36.89 72.86 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.574 -0.739 . . . . 74.439999999999998 109.23 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.519 ' O ' HD11 ' A' ' 444' ' ' LEU . . . -60.03 -51.69 68.58 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.748 -0.66 . . . . 64.120000000000005 111.095 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 35.5 m -64.86 -40.73 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 N-CA-C 112.589 0.588 . . . . 64.439999999999998 112.589 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -68.77 -36.37 78.23 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 119.862 -0.735 . . . . 73.209999999999994 111.276 178.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -63.9 -41.86 97.59 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.27 -0.423 . . . . 74.349999999999994 110.908 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.519 HD11 ' O ' ' A' ' 440' ' ' ALA . 7.3 mp -63.75 -32.69 74.27 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.918 -0.583 . . . . 71.25 110.322 176.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 85.2 m -69.97 -44.9 68.52 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.653 -0.703 . . . . 72.439999999999998 110.293 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.22 -22.26 65.72 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.361 0.601 . . . . 73.040000000000006 110.814 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.83 5.09 14.58 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.44 -0.8 . . . . 71.310000000000002 112.321 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 104.31 -82.95 0.38 Allowed Glycine 0 CA--C 1.492 -1.366 0 C-N-CA 120.261 -0.971 . . . . 70.25 111.816 175.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -41.09 -56.16 2.4 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.012 1.116 . . . . 75.129999999999995 114.012 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 59.25 27.25 62.62 Favored Glycine 0 C--N 1.322 -0.202 0 C-N-CA 121.528 -0.368 . . . . 73.140000000000001 113.239 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -101.34 111.21 23.37 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 109.526 -0.546 . . . . 75.329999999999998 109.526 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . 0.5 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 27.8 p90 -134.48 150.83 50.85 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 115.485 -0.78 . . . . 74.420000000000002 109.712 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 21.4 tptp -138.46 127.81 24.49 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 106.558 -1.645 . . . . 72.510000000000005 106.558 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -98.31 127.86 44.45 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.367 0.603 . . . . 74.299999999999997 111.938 -176.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -126.92 139.88 52.74 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.23 -1.026 . . . . 75.450000000000003 108.23 176.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -112.85 143.58 43.87 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.658 -0.867 . . . . 72.310000000000002 108.658 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 22.8 t -139.92 134.33 15.83 Favored Pre-proline 0 C--N 1.295 -1.779 0 N-CA-C 109.054 -0.721 . . . . 72.439999999999998 109.054 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.5 ' HA ' ' O ' ' A' ' 490' ' ' SER . 52.7 Cg_endo -74.27 128.15 11.83 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 121.859 1.706 . . . . 74.519999999999996 110.59 176.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 35.0 m -147.14 179.93 7.27 Favored 'General case' 0 C--N 1.288 -2.098 0 C-N-CA 123.247 0.619 . . . . 74.409999999999997 109.466 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.5 t -48.85 143.87 7.84 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 125.189 1.396 . . . . 74.239999999999995 112.148 178.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.68 -29.29 32.64 Favored 'Trans proline' 0 C--N 1.362 1.275 0 C-N-CA 124.761 3.64 . . . . 74.230000000000004 113.484 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -74.89 -8.36 56.24 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 112.767 0.654 . . . . 71.530000000000001 112.767 -176.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -111.4 -6.93 14.41 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.969 0.359 . . . . 70.140000000000001 111.969 177.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 59.7 t -60.92 127.09 19.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.068 0.461 . . . . 74.010000000000005 111.736 -176.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.26 -8.12 77.74 Favored Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 115.754 -0.657 . . . . 70.140000000000001 112.49 177.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -108.06 151.68 25.53 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 109.826 -0.435 . . . . 74.430000000000007 109.826 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.411 ' O ' ' HB ' ' A' ' 434' ' ' THR . 67.1 t -68.68 142.92 15.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 106.41 -1.7 . . . . 73.409999999999997 106.41 170.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 60.0 mt -97.23 -35.22 5.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 108.704 -0.851 . . . . 64.219999999999999 108.704 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 164.99 -165.08 37.47 Favored Glycine 0 N--CA 1.418 -2.532 0 C-N-CA 120.43 -0.89 . . . . 71.409999999999997 111.292 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -143.37 149.92 38.4 Favored 'General case' 0 N--CA 1.408 -2.561 0 N-CA-C 107.453 -1.314 . . . . 61.439999999999998 107.453 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -67.49 -55.32 15.13 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 120.623 -0.431 . . . . 74.319999999999993 110.703 178.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -74.09 128.3 12.1 Favored 'Trans proline' 0 C--N 1.367 1.548 0 N-CA-C 108.009 -1.573 . . . . 72.219999999999999 108.009 169.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -62.54 129.85 27.92 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.248 1.966 . . . . 74.349999999999994 112.887 -176.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -81.98 13.68 3.21 Favored 'General case' 0 C--O 1.206 -1.188 0 CA-C-N 115.194 -0.912 . . . . 73.219999999999999 110.718 -178.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -110.07 0.13 18.25 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.583 0.706 . . . . 74.400000000000006 109.398 174.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -103.32 175.79 5.36 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.91 -0.587 . . . . 65.109999999999999 112.154 -176.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 2.3 m -98.38 114.43 26.77 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 108.056 -1.09 . . . . 54.039999999999999 108.056 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 23.0 p -110.02 147.01 34.33 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 116.283 -0.417 . . . . 70.219999999999999 110.057 -176.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -77.55 167.32 21.82 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.634 -0.257 . . . . 54.32 110.387 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 25.3 mm -71.61 -3.93 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-O 122.679 1.228 . . . . 62.420000000000002 110.398 -176.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 1.5 p -104.76 5.99 33.73 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.123 -0.944 . . . . 73.120000000000005 111.756 178.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -88.92 142.93 27.23 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.03 0.443 . . . . 75.120000000000005 111.821 -178.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.65 127.08 65.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.514 -0.767 . . . . 70.310000000000002 109.453 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 44.3 t -102.89 120.72 53.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 109.285 -0.635 . . . . 71.409999999999997 109.285 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.63 119.41 44.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 108.733 -0.84 . . . . 72.239999999999995 108.733 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 48.7 mm -104.48 109.26 26.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-N 115.599 -0.728 . . . . 74.439999999999998 109.558 -175.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.467 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 9.6 tt -99.96 121.82 51.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.719 -0.474 . . . . 71.319999999999993 109.719 178.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 35.9 m -103.61 151.13 6.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.943 -0.572 . . . . 72.400000000000006 110.817 -178.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -92.8 127.31 8.93 Favored Glycine 0 N--CA 1.424 -2.12 0 CA-C-N 115.615 -0.721 . . . . 74.519999999999996 111.714 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 25.1 m . . . . . 0 C--N 1.29 -1.989 0 N-CA-C 106.384 -1.71 . . . . 71.099999999999994 106.384 176.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo . . . . . 0 N--CA 1.442 -1.506 0 N-CA-C 110.287 -0.697 . . . . 75.120000000000005 110.287 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -90.47 27.49 1.7 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.925 0.869 . . . . 73.310000000000002 111.408 -177.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 16.4 p -117.51 143.13 46.37 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 114.708 -1.133 . . . . 73.209999999999994 109.806 -178.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -139.9 155.2 47.31 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 116.356 -0.384 . . . . 74.109999999999999 110.578 177.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -84.17 119.48 25.06 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.831 -1.174 . . . . 74.109999999999999 107.831 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 27.2 pt -75.64 120.26 80.87 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 112.347 0.499 . . . . 75.109999999999999 112.347 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -93.33 138.45 1.44 Allowed 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 122.672 2.248 . . . . 64.219999999999999 111.677 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -90.81 135.35 33.78 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.745 -0.835 . . . . 74.420000000000002 108.745 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 19.1 t -134.75 94.08 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 107.523 -1.288 . . . . 74.400000000000006 107.523 175.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -88.73 123.99 33.69 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.71 -0.677 . . . . 74.540000000000006 109.822 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 125.18 9.69 4.99 Favored Glycine 0 N--CA 1.425 -2.074 0 C-N-CA 119.949 -1.119 . . . . 54.299999999999997 112.843 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -106.25 168.18 9.32 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.701 -0.851 . . . . 74.239999999999995 108.701 176.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 7.0 m -83.35 157.12 22.67 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.835 -1.172 . . . . 74.230000000000004 107.835 176.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 48.8 t -51.11 -44.61 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 122.911 0.484 . . . . 74.140000000000001 111.606 -178.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -63.37 -41.91 98.83 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.718 -0.674 . . . . 61.119999999999997 111.845 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 33.1 t -72.26 -40.41 65.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 116.121 -0.49 . . . . 73.0 109.912 -176.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.73 -49.44 73.02 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.641 -0.709 . . . . 71.099999999999994 111.243 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -65.08 -35.26 80.59 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.705 -0.225 . . . . 72.099999999999994 110.663 -178.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.443 ' O ' HG23 ' A' ' 514' ' ' VAL . 47.4 tttp -57.38 -52.29 65.97 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 124.088 0.867 . . . . 74.510000000000005 110.237 -178.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -62.74 -44.58 95.84 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 116.099 -0.501 . . . . 71.099999999999994 110.139 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.08 -45.81 91.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.751 -0.659 . . . . 74.439999999999998 111.137 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.26 -43.18 92.46 Favored 'General case' 0 CA--C 1.5 -0.949 0 O-C-N 123.495 0.497 . . . . 65.329999999999998 110.744 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 510' ' ' LYS . 78.7 t -59.72 -38.31 75.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.53 -0.759 . . . . 74.510000000000005 111.015 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -74.87 -22.76 58.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.041 0.448 . . . . 72.030000000000001 111.239 -178.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 134.44 -16.79 4.32 Favored Glycine 0 N--CA 1.428 -1.844 0 C-N-CA 119.747 -1.216 . . . . 54.32 112.665 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.677 ' HA ' ' O ' ' A' ' 547' ' ' VAL . 91.2 m-85 -75.89 96.79 3.79 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.744 -0.465 . . . . 65.549999999999997 109.744 -177.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 3.1 p -95.73 -12.81 24.84 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 113.38 0.882 . . . . 71.230000000000004 113.38 -175.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 64.6 mttp -108.74 115.85 30.88 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.434 -0.506 . . . . 74.120000000000005 110.364 178.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -130.2 151.25 50.93 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 109.739 -0.467 . . . . 72.329999999999998 109.739 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 61.3 m -141.1 140.82 34.23 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 107.909 -1.145 . . . . 75.549999999999997 107.909 175.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . 0.426 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 0.0 OUTLIER -117.41 137.15 52.69 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 121.326 0.584 . . . . 73.409999999999997 111.332 -176.648 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -111.58 116.95 31.69 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.767 -1.197 . . . . 73.010000000000005 107.767 176.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 19.3 m -96.96 124.46 40.94 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.487 -0.561 . . . . 72.019999999999996 109.487 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 28.4 m -129.13 150.02 34.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.753 -0.832 . . . . 75.040000000000006 108.753 177.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . 0.422 ' C ' ' HG ' ' A' ' 527' ' ' SER . 4.6 p30 -68.74 135.64 51.59 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.937 -0.764 . . . . 72.340000000000003 108.937 178.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 527' ' ' SER . . . . . 0.422 ' HG ' ' C ' ' A' ' 526' ' ' ASP . 50.8 m -156.54 171.95 6.72 Favored Pre-proline 0 C--N 1.297 -1.697 0 N-CA-C 108.558 -0.904 . . . . 74.5 108.558 -176.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -71.72 -19.93 27.05 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 121.835 1.69 . . . . 71.319999999999993 113.356 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.01 138.59 49.46 Favored Pre-proline 0 N--CA 1.469 0.495 0 C-N-CA 120.535 -0.466 . . . . 74.340000000000003 110.204 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.89 141.56 93.19 Favored 'Trans proline' 0 C--O 1.261 1.652 0 C-N-CA 122.726 2.284 . . . . 73.409999999999997 112.068 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.663 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -57.99 118.37 5.32 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 115.128 -0.942 . . . . 72.409999999999997 111.513 -176.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 135.92 -25.79 3.18 Favored Glycine 0 N--CA 1.432 -1.616 0 CA-C-N 115.59 -0.732 . . . . 71.310000000000002 111.32 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -83.73 134.47 34.75 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.104 0.478 . . . . 72.299999999999997 111.523 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 57.3 t -79.5 128.81 38.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 115.834 -0.621 . . . . 73.310000000000002 110.307 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 90.7 m -81.64 -33.8 31.17 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 124.781 1.232 . . . . 74.409999999999997 110.049 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.59 -150.82 22.79 Favored Glycine 0 N--CA 1.434 -1.452 0 N-CA-C 109.758 -1.337 . . . . 62.420000000000002 109.758 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 40.0 p -116.87 156.83 26.66 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 117.291 0.545 . . . . 72.129999999999995 110.063 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -82.11 -48.29 0.93 Allowed Pre-proline 0 C--N 1.31 -1.131 0 CA-C-N 115.496 -0.774 . . . . 73.540000000000006 110.014 173.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -66.63 133.55 32.32 Favored 'Trans proline' 0 C--N 1.37 1.675 0 N-CA-C 108.923 -1.222 . . . . 73.430000000000007 108.923 169.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.96 140.63 96.16 Favored 'Trans proline' 0 C--O 1.251 1.171 0 C-N-CA 122.51 2.14 . . . . 74.109999999999999 112.961 -177.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.33 140.95 58.13 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.76 -0.654 . . . . 74.040000000000006 109.671 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 98.54 -9.98 62.73 Favored Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 111.385 -0.686 . . . . 62.020000000000003 111.385 -178.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 41.9 m -75.28 126.26 30.66 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.603 -0.517 . . . . 72.219999999999999 109.603 178.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 15.2 t -83.48 129.81 34.99 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 108.12 -1.067 . . . . 71.329999999999998 108.12 174.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 11.4 p -142.43 153.43 62.4 Favored Pre-proline 0 C--N 1.294 -1.835 0 N-CA-C 106.649 -1.611 . . . . 75.430000000000007 106.649 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.5 140.27 93.98 Favored 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 121.78 1.654 . . . . 74.120000000000005 111.185 175.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 517' ' ' PHE . 27.1 m -65.22 -23.16 32.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 121.234 0.54 . . . . 75.230000000000004 112.33 -176.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.89 2.12 52.32 Favored 'General case' 0 N--CA 1.421 -1.896 0 O-C-N 122.028 -0.42 . . . . 70.25 111.116 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 66.2 m -84.96 170.49 13.0 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 121.16 0.505 . . . . 75.530000000000001 111.172 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 10.0 p -93.0 128.53 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-O 121.605 0.717 . . . . 74.219999999999999 111.842 -178.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . 0.429 HD12 ' O ' ' A' ' 519' ' ' LYS . 0.2 OUTLIER -108.52 136.11 45.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 108.572 -0.899 . . . . 72.409999999999997 108.572 172.717 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -103.53 118.44 36.74 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.445 0.641 . . . . 74.530000000000001 111.091 -176.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 2.3 mm? -95.94 134.35 39.04 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.499 -1.228 . . . . 70.329999999999998 109.525 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -98.3 124.52 42.97 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 108.77 -0.826 . . . . 74.129999999999995 108.77 175.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 57.2 t -114.43 128.64 71.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 115.899 -0.591 . . . . 75.219999999999999 110.662 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.663 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 69.4 m -69.8 131.57 44.72 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.698 -0.683 . . . . 63.100000000000001 111.565 174.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt -104.45 133.32 49.53 Favored 'General case' 0 C--O 1.202 -1.412 0 N-CA-C 107.435 -1.32 . . . . 73.439999999999998 107.435 169.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -70.16 -37.69 72.36 Favored Glycine 0 CA--C 1.503 -0.667 0 C-N-CA 120.184 -1.008 . . . . 61.310000000000002 111.279 -177.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 65.7 t30 65.35 28.56 11.76 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.603 1.161 . . . . 75.349999999999994 108.486 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -137.09 150.59 48.11 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 114.513 -1.221 . . . . 73.209999999999994 108.887 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -130.34 157.18 43.27 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.313 -0.625 . . . . 73.030000000000001 109.313 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 58.8 t -71.96 118.54 17.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 109.984 -0.376 . . . . 71.439999999999998 109.984 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 563' ' ' MET . . . . . 0.443 ' HB2' ' CG2' ' A' ' 614' ' ' VAL . 55.8 ttp -97.37 138.1 21.16 Favored Pre-proline 0 C--N 1.31 -1.145 0 CA-C-N 116.147 -0.478 . . . . 62.039999999999999 110.465 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.64 169.77 9.44 Favored 'Trans proline' 0 CA--C 1.552 1.395 0 C-N-CA 123.098 2.532 . . . . 73.299999999999997 111.422 172.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -88.37 129.78 35.32 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 113.064 0.764 . . . . 72.349999999999994 113.064 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . 0.412 ' O ' ' HB3' ' A' ' 569' ' ' MET . 2.8 mm? -114.25 -9.67 12.82 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.196 -1.039 . . . . 71.340000000000003 108.196 173.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 3.0 p -74.31 132.07 41.73 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 114.7 -1.136 . . . . 75.209999999999994 110.21 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 76.48 20.9 76.24 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 111.026 -0.829 . . . . 72.329999999999998 111.026 -176.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 569' ' ' MET . . . . . 0.412 ' HB3' ' O ' ' A' ' 566' ' ' LEU . 51.7 ttm -121.76 149.47 43.24 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.732 -0.84 . . . . 64.140000000000001 108.732 -178.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -82.62 142.61 31.61 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 108.655 -0.869 . . . . 71.519999999999996 108.655 177.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 72.1 t-105 -51.62 -27.22 10.66 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 124.707 1.203 . . . . 73.439999999999998 111.877 177.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 34.9 m -70.53 -20.39 22.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.58 -0.282 . . . . 61.32 111.525 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . 0.411 ' O ' ' HG3' ' A' ' 577' ' ' ARG . 9.6 t70 -101.57 -36.14 8.88 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.151 -1.055 . . . . 73.140000000000001 108.151 177.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.02 95.65 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 114.964 -1.016 . . . . 71.049999999999997 112.678 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.422 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 37.4 tt0 -57.63 -51.1 84.24 Favored Pre-proline 0 CA--C 1.563 1.458 0 CA-C-O 119.524 -0.274 . . . . 71.409999999999997 111.487 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . 0.422 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 54.1 Cg_exo -56.12 -39.69 89.6 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 121.46 1.44 . . . . 74.200000000000003 112.662 173.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 573' ' ' ASP . 51.4 mtt180 -64.25 -41.91 96.74 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.51 -0.476 . . . . 75.140000000000001 112.062 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.489 HD11 ' N ' ' A' ' 579' ' ' ARG 0.25 4.1 pp -66.28 -43.73 85.59 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 119.91 -0.716 . . . . 74.120000000000005 111.792 -177.575 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . 0.489 ' N ' HD11 ' A' ' 578' ' ' LEU . 15.8 ptm180 -66.43 -35.75 81.08 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 120.914 -0.314 . . . . 74.040000000000006 111.197 176.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.72 -28.29 66.69 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 122.638 0.375 . . . . 64.329999999999998 111.801 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 9.7 mp -81.52 -7.37 59.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.037 0.446 . . . . 75.019999999999996 111.217 174.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 80.36 15.16 79.0 Favored Glycine 0 N--CA 1.437 -1.244 0 C-N-CA 121.126 -0.559 . . . . 71.239999999999995 111.883 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 73.4 t90 -66.02 130.73 44.24 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.386 0.613 . . . . 73.409999999999997 110.01 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 75.5 m -143.83 93.65 2.49 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.833 -1.173 . . . . 71.299999999999997 107.833 176.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -150.6 -161.42 9.94 Favored Glycine 0 N--CA 1.419 -2.448 0 N-CA-C 109.409 -1.476 . . . . 73.430000000000007 109.409 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 55.0 ttp -91.04 124.89 35.61 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 120.832 0.349 . . . . 75.349999999999994 110.271 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -98.46 121.3 40.22 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 105.738 -1.949 . . . . 74.439999999999998 105.738 173.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -98.52 101.59 13.08 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.948 -0.76 . . . . 71.519999999999996 108.948 -177.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -99.6 130.44 45.84 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.606 -1.257 . . . . 75.099999999999994 107.606 -177.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -77.17 -97.93 0.19 Allowed Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.387 -1.085 . . . . 75.209999999999994 110.387 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.2 153.79 47.94 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.878 -0.786 . . . . 74.219999999999999 108.878 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -83.7 124.9 31.33 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.055 -1.091 . . . . 65.109999999999999 108.055 175.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 58.4 t -127.79 116.88 44.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 CA-C-N 115.881 -0.6 . . . . 74.120000000000005 109.944 -175.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -78.4 111.46 14.42 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.29 -1.374 . . . . 74.409999999999997 107.29 175.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -133.46 2.82 3.55 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.305 -0.558 . . . . 71.200000000000003 112.251 -176.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 127.85 166.06 11.98 Favored Glycine 0 N--CA 1.437 -1.29 0 N-CA-C 111.145 -0.782 . . . . 75.230000000000004 111.145 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -59.05 -35.64 84.82 Favored Glycine 0 C--O 1.227 -0.339 0 O-C-N 123.639 0.258 . . . . 71.409999999999997 113.532 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 13.4 p -65.78 -23.92 66.82 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.203 0.525 . . . . 72.209999999999994 111.722 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -102.37 -1.54 30.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.077 -0.51 . . . . 72.329999999999998 110.034 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -77.81 111.09 13.27 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.605 -0.517 . . . . 72.319999999999993 109.605 -177.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 12.6 m120 62.9 -11.99 0.08 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.325 1.85 . . . . 74.310000000000002 115.159 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -77.51 138.68 39.34 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 118.449 0.568 . . . . 74.299999999999997 112.404 -174.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 71.7 t -72.86 131.82 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 114.835 -1.075 . . . . 74.439999999999998 108.689 176.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . 0.409 HG21 ' O ' ' A' ' 623' ' ' ARG . 27.7 m -94.35 -41.14 12.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 C-N-CA 119.627 -0.829 . . . . 75.510000000000005 111.039 -176.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -151.4 154.69 37.14 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 106.678 -1.601 . . . . 72.239999999999995 106.678 175.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . 0.585 ' HA ' ' O ' ' A' ' 621' ' ' THR . 13.3 pt20 -133.82 142.43 47.85 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 106.646 -1.612 . . . . 72.25 106.646 174.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.45 ' HB2' ' OG1' ' A' ' 621' ' ' THR 0.33 91.4 m-20 -76.33 -57.39 1.37 Allowed Pre-proline 0 C--N 1.306 -1.29 0 N-CA-C 114.34 1.237 . . . . 75.239999999999995 114.34 -179.168 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.66 119.53 6.62 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 121.785 1.657 . . . . 75.0 110.048 175.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . 0.405 ' HB2' ' OG1' ' A' ' 612' ' ' THR . 6.2 Cg_exo -70.97 134.52 25.61 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 121.8 1.667 . . . . 60.130000000000003 113.762 -176.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -69.33 132.17 46.0 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.082 -0.963 . . . . 70.329999999999998 110.317 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 89.34 -8.58 79.53 Favored Glycine 0 C--N 1.309 -0.923 0 N-CA-C 111.435 -0.666 . . . . 74.219999999999999 111.435 -178.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 612' ' ' THR . . . . . 0.405 ' OG1' ' HB2' ' A' ' 609' ' ' PRO . 17.9 m -104.88 160.17 15.22 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 108.048 -1.093 . . . . 70.129999999999995 108.048 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -71.68 114.26 5.01 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.944 -0.862 . . . . 45.310000000000002 110.944 176.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . 0.443 ' CG2' ' HB2' ' A' ' 563' ' ' MET . 20.6 m -103.31 144.99 13.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 C-N-CA 124.234 1.013 . . . . 74.299999999999997 109.929 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -38.85 134.03 1.04 Allowed 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 125.665 1.586 . . . . 72.349999999999994 110.565 177.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . 0.413 ' HD3' ' N ' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -51.18 -25.06 4.83 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 114.494 1.294 . . . . 71.420000000000002 114.494 -171.367 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . 0.413 ' N ' ' HD3' ' A' ' 616' ' ' ARG . 3.4 p30 -77.43 -26.06 51.22 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.846 -0.616 . . . . 70.140000000000001 110.716 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 78.0 20.29 73.38 Favored Glycine 0 N--CA 1.433 -1.526 0 CA-C-O 119.081 -0.844 . . . . 74.219999999999999 114.461 173.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.76 119.58 13.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 118.429 1.115 . . . . 74.310000000000002 108.755 -176.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 7.0 tp -106.77 127.39 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.027 0 CA-C-N 114.207 -1.361 . . . . 74.430000000000007 110.504 -173.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.585 ' O ' ' HA ' ' A' ' 606' ' ' GLN . 1.6 p -107.71 117.72 34.86 Favored 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 109.241 -0.652 . . . . 62.350000000000001 109.241 176.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.1 pp -138.54 150.68 46.62 Favored 'General case' 0 CA--C 1.486 -1.496 0 C-N-CA 124.4 1.08 . . . . 74.299999999999997 108.431 -177.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . 0.409 ' O ' HG21 ' A' ' 604' ' ' VAL . 2.7 tmt_? -132.88 137.11 46.57 Favored 'General case' 0 C--N 1.273 -2.738 0 N-CA-C 104.861 -2.274 . . . . 73.519999999999996 104.861 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -129.78 165.23 22.35 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 107.962 -1.125 . . . . 75.25 107.962 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -82.5 -88.04 0.71 Allowed Glycine 0 N--CA 1.426 -1.985 0 N-CA-C 109.851 -1.3 . . . . 65.409999999999997 109.851 178.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 . . . . . 0 C--N 1.286 -2.176 0 N-CA-C 109.087 -0.708 . . . . 72.209999999999994 109.087 178.419 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 C--O 1.245 0.853 0 CA-C-O 120.77 0.319 . . . . 72.099999999999994 111.042 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 28.0 m -127.74 156.75 39.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 C-N-CA 123.583 0.753 . . . . 75.310000000000002 109.66 -178.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . 0.447 HE21 ' C ' ' A' ' 361' ' ' GLN . 0.0 OUTLIER -95.89 122.79 39.07 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.221 -1.77 . . . . 63.340000000000003 106.221 179.328 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.424 HG23 ' CZ ' ' A' ' 382' ' ' PHE . 48.0 t -98.81 139.15 20.87 Favored Pre-proline 0 C--N 1.283 -2.313 0 CA-C-N 115.782 -0.645 . . . . 71.310000000000002 110.761 -171.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -70.61 150.07 62.46 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.25 1.967 . . . . 73.519999999999996 111.442 175.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . 0.438 ' OD2' ' HD2' ' A' ' 366' ' ' ARG . 27.9 t0 -102.76 152.66 20.99 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 107.247 -1.39 . . . . 64.299999999999997 107.247 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 10.2 t -122.67 11.64 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.374 0 CA-C-O 121.818 0.818 . . . . 61.210000000000001 109.675 -174.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.524 ' HB3' ' OG1' ' A' ' 402' ' ' THR . 8.8 ptm180 -52.37 144.33 13.27 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 115.606 -0.724 . . . . 74.109999999999999 111.858 177.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.5 -11.07 54.02 Favored Glycine 0 C--N 1.312 -0.771 0 CA-C-N 115.593 -0.73 . . . . 71.150000000000006 111.843 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -110.39 -151.3 0.47 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 123.074 0.55 . . . . 75.5 110.312 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 71.8 p -97.81 159.28 15.03 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.253 -0.647 . . . . 60.329999999999998 109.253 -173.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 5.6 p -63.55 -35.89 81.98 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 120.862 -0.335 . . . . 72.319999999999993 110.839 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -65.78 -46.42 78.78 Favored 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 111.733 0.271 . . . . 75.430000000000007 111.733 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -68.11 -41.31 81.96 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 121.452 0.644 . . . . 74.239999999999995 109.281 -177.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.54 -51.52 59.27 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.005 -0.998 . . . . 64.420000000000002 111.53 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 77.1 mt -63.96 -39.2 84.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 CA-C-N 116.355 -0.384 . . . . 75.230000000000004 110.854 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.05 -44.05 91.76 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 120.946 0.403 . . . . 74.219999999999999 110.495 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 44.5 m -65.48 -47.13 77.13 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.834 -0.621 . . . . 74.319999999999993 111.455 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 10.8 mp -61.76 -45.43 93.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.812 -0.177 . . . . 75.540000000000006 111.193 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -65.81 -35.42 80.64 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.178 -0.465 . . . . 74.510000000000005 110.344 -178.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -67.2 -25.24 66.02 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 120.972 0.415 . . . . 73.310000000000002 111.786 176.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -86.45 -8.07 57.91 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.945 0.402 . . . . 74.219999999999999 110.25 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . 0.446 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 100.42 0.69 55.62 Favored Glycine 0 CA--C 1.502 -0.748 0 CA-C-N 115.587 -0.733 . . . . 72.219999999999999 112.389 178.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.617 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 47.4 m-85 -80.0 153.97 28.51 Favored 'General case' 0 N--CA 1.418 -2.074 0 CA-C-O 121.443 0.639 . . . . 74.120000000000005 110.901 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 74.8 mmtt -113.01 161.42 17.06 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 114.916 -1.038 . . . . 75.299999999999997 108.414 -176.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.31 146.0 33.85 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 CA-C-O 121.461 0.648 . . . . 73.239999999999995 111.207 -176.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -110.26 127.98 55.28 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 104.64 -2.356 . . . . 64.319999999999993 104.64 174.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 25.5 m -117.37 127.0 53.62 Favored 'General case' 0 C--N 1.271 -2.828 0 C-N-CA 120.185 -0.606 . . . . 73.140000000000001 110.073 -174.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -112.12 128.64 56.28 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 105.472 -2.047 . . . . 75.25 105.472 177.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . 0.467 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -120.65 145.5 47.37 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.815 -0.754 . . . . 63.509999999999998 111.397 -177.661 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -139.38 143.01 34.26 Favored Pre-proline 0 C--N 1.298 -1.669 0 CA-C-N 115.431 -0.804 . . . . 75.099999999999994 109.263 176.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . 0.43 ' HA ' ' HG1' ' A' ' 422' ' ' THR . 10.2 Cg_exo -74.89 158.03 42.87 Favored 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 122.229 1.953 . . . . 72.450000000000003 110.452 172.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 8.5 t70 87.43 -169.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 126.468 1.907 . . . . 73.129999999999995 108.869 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 37.4 m -144.02 14.29 1.68 Allowed 'General case' 0 C--N 1.316 -0.868 0 O-C-N 121.573 -0.704 . . . . 75.109999999999999 110.835 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 12.6 t -81.67 -19.12 42.31 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.807 -1.183 . . . . 74.540000000000006 107.807 176.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -97.61 152.84 38.38 Favored Pre-proline 0 N--CA 1.431 -1.418 0 N-CA-C 106.571 -1.64 . . . . 72.519999999999996 106.571 176.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -27.78 111.78 0.03 OUTLIER 'Trans proline' 0 CA--C 1.553 1.449 0 C-N-CA 125.089 3.86 . . . . 73.209999999999994 114.907 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . 0.526 ' HA ' ' OG ' ' A' ' 421' ' ' SER . 42.2 Cg_endo -63.73 160.92 34.39 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 124.159 3.239 . . . . 73.140000000000001 115.242 -174.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -60.11 -8.6 2.5 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 125.078 1.351 . . . . 74.209999999999994 113.091 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 37.0 m170 -106.39 132.31 52.56 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 105.746 -1.946 . . . . 74.439999999999998 105.746 175.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 27.7 m -75.21 117.6 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.256 0 C-N-CA 119.381 -0.927 . . . . 75.349999999999994 111.761 -165.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -97.24 -28.76 3.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 107.292 -1.373 . . . . 70.030000000000001 107.292 174.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.54 157.53 27.43 Favored Glycine 1 N--CA 1.395 -4.079 0 N-CA-C 108.938 -1.665 . . . . 73.310000000000002 108.938 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' THR . . . . . 0.524 ' OG1' ' HB3' ' A' ' 366' ' ' ARG . 0.8 OUTLIER -146.25 -176.25 5.09 Favored 'General case' 0 C--N 1.262 -3.207 0 N-CA-C 105.878 -1.897 . . . . 73.530000000000001 105.878 -177.726 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -100.28 126.95 34.44 Favored Pre-proline 0 C--N 1.289 -2.025 0 C-N-CA 118.208 -1.397 . . . . 53.420000000000002 109.731 -173.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.84 0.18 1.7 Allowed 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 124.067 3.178 . . . . 65.349999999999994 114.791 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.1 -34.46 68.34 Favored 'General case' 0 C--O 1.209 -1.046 0 N-CA-C 109.206 -0.664 . . . . 64.420000000000002 109.206 173.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . 0.423 ' O ' ' HB ' ' A' ' 362' ' ' VAL . . . -63.85 -40.7 97.19 Favored 'General case' 0 C--O 1.212 -0.887 0 CA-C-N 115.805 -0.634 . . . . 65.310000000000002 110.042 176.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -83.71 0.6 46.42 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.122 0.487 . . . . 65.040000000000006 111.513 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 34.0 m -95.21 157.41 15.91 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 104.92 -2.252 . . . . 72.230000000000004 104.92 171.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 49.0 m -74.35 112.47 10.55 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 118.55 -1.26 . . . . 71.409999999999997 108.928 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 18.6 m -128.48 169.1 20.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 C-N-CA 122.49 0.316 . . . . 74.420000000000002 110.366 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 15.6 m -79.86 145.18 32.87 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.762 -0.459 . . . . 73.040000000000006 109.762 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . 0.617 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -66.69 113.73 5.05 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.293 0.568 . . . . 52.399999999999999 110.56 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 110.35 44.68 0.98 Allowed Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 110.776 -0.93 . . . . 75.209999999999994 110.776 -178.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -109.21 166.29 10.97 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.198 -1.038 . . . . 75.120000000000005 108.198 -177.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 49.2 mt-10 -100.23 118.5 36.66 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 118.212 0.46 . . . . 71.439999999999998 110.837 -177.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 44.4 mm -103.61 133.18 48.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 109.188 -0.671 . . . . 75.430000000000007 109.188 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 11.5 t -85.18 130.46 34.6 Favored 'General case' 0 C--O 1.252 1.217 0 CA-C-O 121.303 0.573 . . . . 75.109999999999999 112.306 -176.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 5.3 p -127.3 135.78 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 C-N-CA 124.052 0.941 . . . . 73.010000000000005 109.544 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -101.99 129.18 48.22 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.77 -0.456 . . . . 71.209999999999994 109.77 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 8.9 p -123.1 133.1 70.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 109.356 -0.609 . . . . 74.230000000000004 109.356 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 421' ' ' SER . . . . . 0.526 ' OG ' ' HA ' ' A' ' 396' ' ' PRO . 74.6 p -103.61 130.9 51.12 Favored 'General case' 0 N--CA 1.428 -1.541 0 O-C-N 122.086 -0.384 . . . . 62.32 110.55 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 422' ' ' THR . . . . . 0.43 ' HG1' ' HA ' ' A' ' 390' ' ' PRO . 41.0 p -97.02 107.97 20.61 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.987 -1.486 . . . . 72.049999999999997 106.987 173.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.708 0 N-CA-C 116.653 1.421 . . . . 74.420000000000002 116.653 -170.089 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 . . . . . 0 N--CA 1.434 -1.269 0 N-CA-C 107.09 -1.448 . . . . 63.310000000000002 107.09 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 8.5 mmp_? -121.98 150.17 42.43 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-O 121.017 0.437 . . . . 72.200000000000003 111.217 -176.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -85.8 138.51 32.02 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.427 -0.806 . . . . 72.209999999999994 109.729 -177.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 56.9 mt -87.55 131.57 43.42 Favored Pre-proline 0 C--N 1.295 -1.769 0 N-CA-C 108.733 -0.839 . . . . 75.420000000000002 108.733 178.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -70.76 141.45 41.21 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.715 1.61 . . . . 64.109999999999999 110.634 172.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -84.61 99.86 11.05 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.801 -1.185 . . . . 74.349999999999994 107.801 178.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 60.9 t -101.9 136.94 31.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 108.597 -0.89 . . . . 72.409999999999997 108.597 -174.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 18.9 m -57.22 149.8 19.11 Favored 'General case' 0 N--CA 1.435 -1.209 0 O-C-N 124.252 0.97 . . . . 74.019999999999996 112.517 -177.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 434' ' ' THR . . . . . 0.415 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 24.8 p -69.45 -25.06 63.91 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 115.283 1.586 . . . . 73.420000000000002 115.283 -170.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.7 pp -85.97 -11.67 52.42 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.628 -0.829 . . . . 74.420000000000002 110.768 176.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.68 42.53 1.09 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.183 -0.917 . . . . 63.219999999999999 110.152 -175.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . 0.417 ' HH ' ' HB2' ' A' ' 454' ' ' GLN . 86.6 t80 -52.56 -38.71 60.43 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.396 1.079 . . . . 72.099999999999994 112.749 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -62.27 -39.57 93.35 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.559 0.695 . . . . 73.319999999999993 110.681 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -70.53 -37.39 74.08 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.266 -0.879 . . . . 65.310000000000002 109.158 177.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -62.66 -51.82 65.74 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.936 -0.575 . . . . 74.409999999999997 111.078 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 28.8 m -61.88 -38.89 81.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 112.476 0.547 . . . . 73.450000000000003 112.476 -177.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -68.28 -38.08 81.35 Favored 'General case' 0 C--N 1.35 0.623 0 C-N-CA 119.255 -0.978 . . . . 75.5 110.908 177.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -66.35 -38.66 88.11 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.462 0.542 . . . . 75.120000000000005 112.462 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -63.38 -35.8 81.6 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.881 -0.414 . . . . 71.129999999999995 109.881 174.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.477 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 47.0 m -70.49 -48.3 56.37 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.918 -0.583 . . . . 74.519999999999996 110.804 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.5 -16.65 63.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.949 -0.569 . . . . 64.400000000000006 111.91 -177.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.05 -13.14 59.95 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.279 -0.419 . . . . 64.430000000000007 111.751 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 124.98 -69.88 0.48 Allowed Glycine 0 CA--C 1.492 -1.348 0 C-N-CA 120.068 -1.063 . . . . 65.109999999999999 111.932 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.52 -65.81 0.51 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.542 0.571 . . . . 74.230000000000004 112.542 177.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . 0.477 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 64.28 21.93 66.79 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 116.123 -0.49 . . . . 70.310000000000002 113.287 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.418 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 28.5 mmm180 -104.27 110.49 22.73 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 107.466 -1.309 . . . . 75.109999999999999 107.466 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -137.13 147.01 45.72 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 115.662 -0.699 . . . . 75.519999999999996 109.875 -177.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -132.77 148.95 52.33 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 108.264 -1.013 . . . . 75.409999999999997 108.264 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . 0.417 ' HB2' ' HH ' ' A' ' 437' ' ' TYR . 62.4 tt0 -117.67 125.75 51.27 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 110.212 -0.292 . . . . 65.430000000000007 110.212 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.19 148.13 41.88 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.293 -1.002 . . . . 74.140000000000001 108.293 176.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -114.17 140.85 48.19 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.141 -0.689 . . . . 74.530000000000001 109.141 -177.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 68.4 m -148.41 137.93 12.38 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 110.46 -0.2 . . . . 70.200000000000003 110.46 173.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.719 ' HA ' ' O ' ' A' ' 490' ' ' SER . 29.6 Cg_endo -65.75 128.09 19.24 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.348 2.032 . . . . 75.010000000000005 110.426 175.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 48.5 m -140.57 -179.83 6.25 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 116.489 -0.323 . . . . 75.239999999999995 110.589 -176.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 9.9 t -45.58 130.99 6.44 Favored Pre-proline 0 CA--C 1.556 1.192 0 C-N-CA 124.53 1.132 . . . . 75.439999999999998 111.934 178.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . 0.559 ' O ' HG23 ' A' ' 464' ' ' VAL . 11.3 Cg_endo -51.72 -28.24 29.28 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 125.18 3.92 . . . . 73.450000000000003 114.466 -174.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.74 -32.08 67.35 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.147 0.498 . . . . 75.120000000000005 111.83 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . 0.531 HD11 ' O ' ' A' ' 463' ' ' LEU . 3.3 tm? -97.2 -13.46 22.05 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.984 -0.553 . . . . 72.439999999999998 110.66 -171.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 461' ' ' PRO . 19.4 m -60.09 131.09 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 CA-C-O 121.47 0.652 . . . . 70.519999999999996 111.174 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.65 2.18 55.34 Favored Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 115.294 -0.866 . . . . 63.509999999999998 111.655 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -128.28 166.46 18.56 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.978 -0.749 . . . . 75.099999999999994 108.978 176.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.415 ' O ' ' HB ' ' A' ' 434' ' ' THR . 70.8 t -72.41 148.8 9.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.354 -0.98 . . . . 74.219999999999999 108.354 175.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 47.5 mt -97.36 -35.25 5.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 106.61 -1.626 . . . . 73.540000000000006 106.61 174.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 153.6 -168.67 32.22 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 110.377 -1.089 . . . . 73.150000000000006 110.377 176.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 470' ' ' THR . . . . . 0.441 ' HB ' HG12 ' A' ' 486' ' ' ILE . 0.6 OUTLIER -115.83 141.11 48.53 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 107.929 -1.137 . . . . 60.539999999999999 107.929 176.266 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.443 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 46.2 t-20 -63.36 -51.4 68.42 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 123.529 0.518 . . . . 74.430000000000007 110.512 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 27.3 Cg_exo -70.55 124.09 10.44 Favored 'Trans proline' 0 C--N 1.373 1.856 0 N-CA-C 107.0 -1.961 . . . . 74.340000000000003 107.0 166.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . 0.459 ' C ' ' H ' ' A' ' 475' ' ' ASN . 18.2 Cg_endo -61.94 127.78 22.37 Favored 'Trans proline' 0 C--O 1.241 0.673 0 C-N-CA 122.467 2.112 . . . . 74.420000000000002 114.248 -172.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -77.68 16.53 0.66 Allowed 'General case' 0 C--O 1.198 -1.642 0 CA-C-N 114.676 -1.147 . . . . 63.210000000000001 110.475 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . 0.459 ' H ' ' C ' ' A' ' 473' ' ' PRO . 0.9 OUTLIER -109.14 -9.19 15.05 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.601 -0.727 . . . . 75.219999999999999 109.618 178.414 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -107.07 175.47 5.49 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-O 121.722 0.773 . . . . 74.109999999999999 112.902 -174.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 4.1 m -92.38 106.14 18.2 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 114.421 -1.263 . . . . 65.040000000000006 108.842 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 68.2 m -100.87 149.32 23.99 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 123.263 0.625 . . . . 72.239999999999995 111.119 -176.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -78.3 154.43 30.91 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.328 -0.396 . . . . 70.340000000000003 111.448 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.56 -23.06 27.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 C-N-CA 123.61 0.764 . . . . 72.129999999999995 111.622 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 17.7 p -94.42 5.55 51.44 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.365 0.602 . . . . 75.219999999999999 111.16 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -98.83 140.71 32.61 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.17 -0.468 . . . . 75.549999999999997 111.113 -175.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . 0.418 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.5 p -107.34 127.11 63.42 Favored 'Isoleucine or valine' 0 C--O 1.245 0.824 0 CA-C-N 115.977 -0.556 . . . . 73.340000000000003 111.803 -178.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 32.5 m -97.05 140.97 16.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.34 0.59 . . . . 71.209999999999994 110.392 177.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.95 114.0 45.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.893 -0.78 . . . . 74.049999999999997 108.893 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . 0.441 HG12 ' HB ' ' A' ' 470' ' ' THR . 61.4 mt -98.69 124.84 52.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 114.618 -1.174 . . . . 72.540000000000006 109.707 -178.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 5.2 tt -109.43 126.72 66.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 109.458 -0.571 . . . . 72.430000000000007 109.458 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 32.6 m -105.34 151.13 7.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 115.871 -0.604 . . . . 71.150000000000006 110.758 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -90.16 122.89 6.76 Favored Glycine 0 N--CA 1.416 -2.635 0 N-CA-C 109.33 -1.508 . . . . 73.310000000000002 109.33 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.719 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 8.5 t . . . . . 0 C--N 1.279 -2.471 0 N-CA-C 107.575 -1.269 . . . . 63.219999999999999 107.575 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 N--CA 1.446 -1.288 0 CA-C-O 121.409 0.504 . . . . 74.310000000000002 113.129 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -81.07 92.61 6.27 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 108.929 -0.767 . . . . 73.439999999999998 108.929 177.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 9.4 p -117.22 143.82 45.46 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.0 -1.0 . . . . 70.219999999999999 109.727 -177.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -150.99 157.46 42.91 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.46 -0.941 . . . . 64.530000000000001 108.46 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.5 m-20 -80.37 128.23 33.32 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 107.544 -1.28 . . . . 70.209999999999994 107.544 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . 0.413 HD12 ' HB2' ' A' ' 539' ' ' PRO . 40.7 pt -76.11 136.49 69.3 Favored Pre-proline 0 C--N 1.299 -1.611 0 O-C-N 123.121 0.263 . . . . 73.340000000000003 111.42 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -88.55 155.59 6.42 Favored 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 122.265 1.977 . . . . 72.329999999999998 108.938 168.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.92 165.44 11.71 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.664 -1.236 . . . . 74.420000000000002 107.664 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.77 117.14 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.354 0 CA-C-O 121.989 0.9 . . . . 70.439999999999998 111.279 -174.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -131.32 110.33 11.0 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 114.423 -1.262 . . . . 72.239999999999995 107.968 174.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 135.89 -14.58 4.1 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 119.768 -1.206 . . . . 71.329999999999998 112.553 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -98.02 172.59 7.53 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.324 -0.551 . . . . 73.319999999999993 110.074 177.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 11.4 t -90.3 157.28 17.74 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 107.959 -1.126 . . . . 72.420000000000002 107.959 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.448 ' HA ' ' CG2' ' A' ' 534' ' ' VAL . 7.6 p -50.05 -46.92 24.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 O-C-N 124.26 0.975 . . . . 55.240000000000002 112.594 -175.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.24 -42.08 80.24 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.389 -0.524 . . . . 72.450000000000003 111.923 -177.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 95.6 t -72.42 -36.24 54.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.091 -0.504 . . . . 65.150000000000006 111.255 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.65 -49.02 74.86 Favored 'General case' 0 C--N 1.31 -1.111 0 O-C-N 122.21 -0.306 . . . . 74.530000000000001 110.859 178.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -60.22 -36.4 77.61 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.8 0.81 . . . . 73.400000000000006 109.823 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -65.23 -46.54 80.2 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 114.401 -1.272 . . . . 73.120000000000005 109.666 -177.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -61.77 -47.97 82.77 Favored 'General case' 0 CA--C 1.495 -1.172 0 O-C-N 124.188 0.93 . . . . 75.329999999999998 111.263 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.75 -41.84 91.88 Favored 'General case' 0 CA--C 1.513 -0.468 0 O-C-N 123.159 0.287 . . . . 73.430000000000007 111.053 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . 0.421 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 1.0 OUTLIER -62.68 -38.19 89.4 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.341 -0.391 . . . . 71.140000000000001 111.215 178.739 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 73.9 t -70.13 -29.18 38.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.962 -0.563 . . . . 70.230000000000004 110.866 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -76.74 -12.13 59.94 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.191 0.519 . . . . 72.040000000000006 110.001 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . 0.477 ' O ' ' HB ' ' A' ' 547' ' ' VAL . . . 121.48 -25.52 6.92 Favored Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 120.837 -0.696 . . . . 71.310000000000002 111.974 177.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.588 ' HA ' ' O ' ' A' ' 547' ' ' VAL . 66.1 m-85 -76.22 103.81 6.43 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.529 0.68 . . . . 65.430000000000007 109.685 -176.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 3.3 p -86.17 -28.41 23.94 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 113.896 1.073 . . . . 72.519999999999996 113.896 -170.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 67.9 mttm -109.07 126.24 52.96 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.443 0.639 . . . . 74.010000000000005 112.34 -174.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -129.82 157.49 42.06 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 123.756 0.822 . . . . 73.319999999999993 110.398 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 71.1 m -137.44 143.55 41.87 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 107.022 -1.473 . . . . 75.019999999999996 107.022 170.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -125.06 147.68 48.86 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 120.75 0.309 . . . . 74.510000000000005 110.357 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -141.08 129.5 22.48 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 107.817 -1.179 . . . . 75.109999999999999 107.817 174.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 524' ' ' SER . . . . . 0.538 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 52.4 m -89.2 139.46 30.46 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 109.865 -0.42 . . . . 72.209999999999994 109.865 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 26.8 m -120.98 164.73 17.23 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 107.631 -1.248 . . . . 63.229999999999997 107.631 178.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . 0.565 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 2.2 p-10 -82.62 134.69 35.17 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 118.963 -1.095 . . . . 73.310000000000002 108.671 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 527' ' ' SER . . . . . 0.402 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 48.3 m -155.29 168.06 12.88 Favored Pre-proline 0 N--CA 1.441 -0.877 0 C-N-CA 120.482 -0.487 . . . . 75.329999999999998 110.554 -176.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -83.24 -10.7 9.99 Favored 'Trans proline' 0 CA--C 1.546 1.113 0 C-N-CA 122.014 1.809 . . . . 64.430000000000007 111.23 171.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.35 135.16 50.6 Favored Pre-proline 0 CA--C 1.506 -0.73 0 N-CA-C 107.695 -1.224 . . . . 75.239999999999995 107.695 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.95 150.88 52.73 Favored 'Trans proline' 0 C--O 1.256 1.417 0 C-N-CA 122.686 2.257 . . . . 73.430000000000007 113.446 -176.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -64.41 121.77 15.15 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.856 -1.066 . . . . 75.230000000000004 110.966 -175.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 126.7 -16.29 6.56 Favored Glycine 0 N--CA 1.424 -2.123 0 C-N-CA 120.455 -0.878 . . . . 63.450000000000003 111.864 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -83.19 128.43 34.48 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 120.448 -0.501 . . . . 71.030000000000001 110.143 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . 0.448 ' CG2' ' HA ' ' A' ' 505' ' ' VAL . 59.9 t -84.66 114.19 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.337 0 N-CA-C 106.08 -1.822 . . . . 75.140000000000001 106.08 174.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 9.1 m -113.73 9.86 17.79 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 119.526 -0.87 . . . . 74.430000000000007 111.918 -173.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 179.02 168.51 38.24 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 119.284 -1.436 . . . . 73.230000000000004 112.821 176.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 45.4 p -132.1 155.08 48.74 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.789 -1.189 . . . . 74.310000000000002 107.789 176.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . 0.455 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 23.3 t-20 -73.37 -57.46 2.73 Favored Pre-proline 0 C--N 1.314 -0.952 0 C-N-CA 120.189 -0.604 . . . . 73.140000000000001 111.477 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . 0.455 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 1.1 Cg_endo -84.0 140.9 9.16 Favored 'Trans proline' 0 N--CA 1.436 -1.909 0 CA-C-N 120.053 1.055 . . . . 72.409999999999997 109.509 175.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.45 158.42 48.03 Favored 'Trans proline' 0 C--O 1.267 1.97 0 C-N-CA 121.977 1.785 . . . . 74.209999999999994 112.528 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.17 139.88 58.82 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 115.113 -0.948 . . . . 74.219999999999999 109.81 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 104.21 -8.75 49.33 Favored Glycine 0 N--CA 1.422 -2.28 0 C-N-CA 120.347 -0.93 . . . . 43.340000000000003 111.625 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 26.4 m -75.76 120.45 21.15 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.732 -0.84 . . . . 71.340000000000003 108.732 175.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 10.9 t -88.16 124.88 34.26 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-O 121.366 0.603 . . . . 60.530000000000001 110.864 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 33.8 m -141.95 165.3 28.71 Favored Pre-proline 0 C--N 1.315 -0.895 0 N-CA-C 108.164 -1.05 . . . . 74.150000000000006 108.164 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.61 144.44 94.25 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 121.92 1.747 . . . . 72.120000000000005 110.399 172.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.588 ' O ' ' HA ' ' A' ' 517' ' ' PHE . 34.8 m -64.71 -20.29 27.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 121.942 0.877 . . . . 74.120000000000005 112.166 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -92.78 4.8 53.13 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 115.773 -0.649 . . . . 73.200000000000003 111.65 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 12.8 t -86.6 170.72 11.6 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.424 -0.954 . . . . 64.239999999999995 108.424 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 99.7 t -95.92 131.98 41.3 Favored 'Isoleucine or valine' 0 C--O 1.247 0.925 0 N-CA-C 112.586 0.587 . . . . 74.25 112.586 -175.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . 0.528 HD12 ' O ' ' A' ' 519' ' ' LYS . 0.2 OUTLIER -105.34 134.22 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 108.574 -0.899 . . . . 72.209999999999994 108.574 169.13 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -102.97 117.08 33.8 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 116.446 -0.343 . . . . 72.409999999999997 110.167 -176.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 5.3 mp -103.9 134.43 47.21 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.07 0.948 . . . . 74.030000000000001 111.239 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -96.89 121.84 39.21 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.66 -0.867 . . . . 74.329999999999998 108.66 174.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 524' ' ' SER . 24.5 t -107.9 139.6 29.35 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 N-CA-C 108.612 -0.885 . . . . 63.43 108.612 -178.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.573 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 69.1 m -81.42 143.79 31.88 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 111.88 0.326 . . . . 74.299999999999997 111.88 178.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.565 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 12.2 ptmt -105.47 156.43 18.22 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 104.591 -2.374 . . . . 74.299999999999997 104.591 167.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -83.5 -24.31 50.99 Favored Glycine 0 CA--C 1.498 -1.03 0 C-N-CA 119.864 -1.16 . . . . 62.100000000000001 115.446 -168.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . 0.43 ' HB3' ' HD2' ' A' ' 616' ' ' ARG . 85.6 m-20 62.67 27.62 16.22 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.112 0.482 . . . . 71.329999999999998 110.586 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -128.58 149.28 50.7 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.231 -1.026 . . . . 53.420000000000002 108.231 -172.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -140.89 149.2 41.61 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.167 -1.049 . . . . 53.009999999999998 108.167 173.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.4 p -83.67 116.86 28.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 121.849 0.833 . . . . 75.120000000000005 112.081 -176.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 60.0 ttp -89.5 127.05 56.21 Favored Pre-proline 0 C--N 1.312 -1.033 0 CA-C-N 115.283 -0.871 . . . . 61.5 108.689 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.62 154.8 66.83 Favored 'Trans proline' 0 C--O 1.239 0.555 0 C-N-CA 122.261 1.974 . . . . 74.120000000000005 111.811 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -83.13 115.5 21.93 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.351 0.596 . . . . 73.010000000000005 111.782 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . 0.567 ' O ' ' HG3' ' A' ' 569' ' ' MET . 95.2 mt -136.87 18.33 3.04 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.536 -1.211 . . . . 70.349999999999994 109.001 178.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 24.0 t -52.69 131.07 34.26 Favored 'General case' 0 CA--C 1.553 1.093 0 O-C-N 123.384 0.427 . . . . 73.219999999999999 110.748 -175.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 107.37 41.54 1.61 Allowed Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 109.382 -1.487 . . . . 74.540000000000006 109.382 -174.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 569' ' ' MET . . . . . 0.567 ' HG3' ' O ' ' A' ' 566' ' ' LEU . 79.0 mtp -101.02 158.11 16.25 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.167 -0.517 . . . . 75.010000000000005 110.518 -177.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . 0.42 ' HB3' ' OD1' ' A' ' 601' ' ' ASN . 98.7 m-85 -102.69 168.13 9.45 Favored 'General case' 0 N--CA 1.416 -2.13 0 N-CA-C 106.886 -1.524 . . . . 75.319999999999993 106.886 170.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 79.9 t90 -64.23 -32.37 73.92 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.902 -0.777 . . . . 74.299999999999997 108.902 174.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.1 p -67.94 -20.19 25.66 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 CA-C-N 115.511 -0.768 . . . . 73.239999999999995 110.612 177.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -85.43 -38.06 19.08 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 108.444 -0.946 . . . . 71.540000000000006 108.444 175.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -57.66 -41.38 81.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.043 -0.981 . . . . 73.530000000000001 112.185 -177.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -55.59 -59.82 10.23 Favored Pre-proline 0 CA--C 1.591 2.529 0 N-CA-C 112.795 0.665 . . . . 71.340000000000003 112.795 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.1 -43.02 26.2 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 121.622 1.548 . . . . 64.400000000000006 112.88 175.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -59.79 -33.81 72.2 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 111.772 0.286 . . . . 74.439999999999998 111.772 -177.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 6.9 tt -57.4 -46.65 83.25 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.622 0.769 . . . . 74.319999999999993 109.422 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -65.38 -47.42 76.4 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.86 -0.609 . . . . 75.219999999999999 111.634 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.64 -39.16 88.12 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.605 -0.725 . . . . 70.099999999999994 112.598 -175.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 88.9 mt -84.49 -8.01 59.08 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 111.677 0.251 . . . . 74.299999999999997 111.677 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 66.76 41.57 93.61 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 111.481 -0.647 . . . . 73.140000000000001 111.481 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 90.9 t90 -83.61 134.77 34.78 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.039 0.447 . . . . 70.439999999999998 111.798 -176.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 91.4 m -154.13 96.38 1.94 Allowed 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 124.561 1.144 . . . . 72.430000000000007 108.314 170.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -147.19 -147.16 4.49 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 108.569 -1.812 . . . . 74.420000000000002 108.569 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 586' ' ' MET . . . . . 0.477 ' HB3' HG12 ' A' ' 619' ' ' ILE . 23.2 ttt -98.28 124.23 42.78 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 117.888 0.844 . . . . 74.040000000000006 109.028 178.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 57.4 tp -94.92 115.53 27.57 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 107.361 -1.348 . . . . 74.329999999999998 107.361 177.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -95.67 104.5 16.42 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.639 -0.825 . . . . 74.239999999999995 109.697 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -110.6 134.25 52.58 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.996 -0.547 . . . . 73.329999999999998 109.686 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -102.8 -173.4 26.71 Favored Glycine 0 N--CA 1.432 -1.577 0 N-CA-C 110.072 -1.211 . . . . 73.109999999999999 110.072 174.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -65.85 148.74 51.29 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 122.449 0.3 . . . . 72.120000000000005 110.799 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . 0.418 ' HA ' ' O ' ' A' ' 625' ' ' GLY . 3.7 m-20 -78.98 123.61 27.45 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.688 -1.227 . . . . 75.200000000000003 107.688 177.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 88.6 t -137.54 120.3 20.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 116.291 -0.413 . . . . 73.549999999999997 110.538 -173.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -80.53 106.86 12.87 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.001 -1.111 . . . . 70.439999999999998 108.001 174.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -126.37 2.05 7.01 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.84 -0.618 . . . . 65.120000000000005 111.361 -176.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 123.2 163.58 11.83 Favored Glycine 0 N--CA 1.43 -1.704 0 C-N-CA 119.815 -1.183 . . . . 75.230000000000004 111.084 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.24 -36.6 69.38 Favored Glycine 0 C--O 1.223 -0.573 0 N-CA-C 114.151 0.421 . . . . 63.340000000000003 114.151 -173.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 25.8 m -64.59 -24.5 67.61 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 117.176 0.488 . . . . 73.450000000000003 111.939 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -107.05 -8.32 16.58 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 122.044 -0.41 . . . . 73.409999999999997 110.876 -178.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 59.3 m170 -74.38 103.48 4.77 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 112.901 0.704 . . . . 74.319999999999993 112.901 -175.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . 0.42 ' OD1' ' HB3' ' A' ' 570' ' ' PHE . 4.5 t-20 69.04 -4.27 1.29 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.14 1.776 . . . . 75.219999999999999 112.695 172.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -86.78 140.65 29.51 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.31 1.044 . . . . 74.439999999999998 108.254 -177.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 96.8 t -69.82 130.79 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 107.444 -1.317 . . . . 73.430000000000007 107.444 176.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . 0.424 HG11 ' O ' ' A' ' 623' ' ' ARG . 9.0 p -99.42 -32.89 3.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 119.204 -0.998 . . . . 65.010000000000005 110.899 -174.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -147.62 153.47 39.44 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 106.356 -1.72 . . . . 75.409999999999997 106.356 176.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -123.42 -172.09 2.44 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 108.557 -0.905 . . . . 71.150000000000006 108.557 177.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.43 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 55.2 t30 -113.36 -65.02 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.534 0 C-N-CA 119.152 -1.019 . . . . 71.219999999999999 112.277 -177.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.43 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 59.1 Cg_endo -88.99 157.96 5.87 Favored 'Trans proline' 0 CA--C 1.552 1.404 0 CA-C-N 120.835 1.334 . . . . 74.129999999999995 110.65 174.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -70.73 135.0 27.13 Favored 'Trans proline' 0 C--O 1.249 1.026 0 C-N-CA 122.304 2.002 . . . . 74.010000000000005 112.623 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -68.89 132.62 47.02 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.642 -0.708 . . . . 72.420000000000002 109.665 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 93.07 -0.48 69.2 Favored Glycine 0 C--N 1.316 -0.548 0 N-CA-C 111.153 -0.779 . . . . 65.099999999999994 111.153 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 43.2 m -110.98 164.36 12.88 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 108.429 -0.952 . . . . 72.310000000000002 108.429 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -70.4 122.66 11.09 Favored Glycine 0 N--CA 1.416 -2.683 0 N-CA-C 111.371 -0.692 . . . . 75.420000000000002 111.371 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 33.1 m -105.82 144.51 15.16 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 108.074 -1.084 . . . . 63.450000000000003 108.074 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . 0.424 ' ND2' ' HB3' ' A' ' 617' ' ' ASP . 29.5 p-10 -53.85 149.21 9.06 Favored 'General case' 0 C--O 1.22 -0.482 0 O-C-N 123.309 0.38 . . . . 74.409999999999997 110.536 -178.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . 0.43 ' HD2' ' HB3' ' A' ' 559' ' ' ASN . 0.1 OUTLIER -54.71 -25.44 27.35 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 112.696 0.628 . . . . 74.219999999999999 112.696 -178.388 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . 0.424 ' HB3' ' ND2' ' A' ' 615' ' ' ASN . 31.5 t70 -67.73 -37.07 81.7 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.724 -0.671 . . . . 73.319999999999993 109.486 177.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 85.53 21.39 54.15 Favored Glycine 0 C--O 1.202 -1.876 0 C-N-CA 120.655 -0.784 . . . . 65.299999999999997 112.627 176.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . 0.477 HG12 ' HB3' ' A' ' 586' ' ' MET . 0.1 OUTLIER -68.69 119.72 14.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 122.563 1.173 . . . . 75.310000000000002 111.333 -170.548 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 40.2 mm -121.04 119.76 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-N 114.027 -1.442 . . . . 65.150000000000006 107.747 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 51.8 m -98.87 118.64 36.09 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.354 -1.351 . . . . 73.430000000000007 107.354 174.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -138.04 165.39 26.7 Favored 'General case' 0 CA--C 1.484 -1.558 0 N-CA-C 108.162 -1.051 . . . . 74.319999999999993 108.162 -174.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . 0.424 ' O ' HG11 ' A' ' 604' ' ' VAL . 14.2 tpt180 -148.14 141.63 25.38 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 106.617 -1.623 . . . . 75.230000000000004 106.617 176.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -136.52 158.89 43.38 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 105.818 -1.919 . . . . 73.340000000000003 105.818 173.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 592' ' ' ASP . . . -77.8 -90.96 0.31 Allowed Glycine 0 N--CA 1.426 -1.99 0 N-CA-C 110.355 -1.098 . . . . 61.549999999999997 110.355 178.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 . . . . . 0 C--N 1.288 -2.098 0 CA-C-O 118.132 -0.937 . . . . 72.439999999999998 109.143 176.417 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 . . . . . 0 CA--C 1.505 -0.785 0 CA-C-O 121.011 0.434 . . . . 74.219999999999999 110.89 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 28.5 m -116.89 147.93 19.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 109.209 -0.663 . . . . 74.420000000000002 109.209 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . 0.417 ' NE2' ' HA ' ' A' ' 407' ' ' ASN . 0.8 OUTLIER -94.09 130.07 40.4 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 105.18 -2.156 . . . . 74.430000000000007 105.18 -178.759 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 79.8 t -95.8 132.13 27.84 Favored Pre-proline 0 C--N 1.288 -2.093 0 CA-C-N 115.46 -0.791 . . . . 71.530000000000001 111.025 -166.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -61.5 122.43 11.06 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.531 2.154 . . . . 72.430000000000007 111.938 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -89.08 111.42 22.16 Favored 'General case' 0 C--N 1.272 -2.779 0 CA-C-N 114.072 -1.422 . . . . 63.340000000000003 110.465 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 7.1 t -86.72 24.0 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.558 0 CA-C-O 122.807 1.289 . . . . 75.450000000000003 111.24 -174.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.516 ' HD2' ' O ' ' A' ' 366' ' ' ARG . 1.9 ppt_? -52.86 144.63 14.16 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.691 -1.14 . . . . 74.200000000000003 112.225 172.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 98.51 -14.47 62.03 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 120.82 -0.705 . . . . 71.299999999999997 112.54 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -102.07 -89.38 0.37 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 120.222 -0.591 . . . . 74.140000000000001 111.104 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 369' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 81.0 p -164.74 168.79 17.54 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.138 -1.06 . . . . 62.420000000000002 108.138 177.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 28.7 m -63.37 -40.82 98.3 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 109.053 -0.721 . . . . 73.200000000000003 109.053 176.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.79 -45.83 90.84 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.835 -0.621 . . . . 72.230000000000004 110.983 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -64.05 -42.38 97.05 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.355 0.41 . . . . 75.239999999999995 111.043 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -66.74 -50.11 63.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.14 -0.482 . . . . 64.030000000000001 111.06 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 78.4 mt -61.98 -40.23 86.54 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 CA-C-N 116.228 -0.442 . . . . 74.030000000000001 110.996 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.8 -47.2 85.6 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.195 0.522 . . . . 71.549999999999997 110.363 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' THR . . . . . 0.673 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 27.9 m -66.04 -47.96 72.65 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 115.104 -0.953 . . . . 71.310000000000002 110.024 -179.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.89 -44.68 96.3 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.604 -0.271 . . . . 72.25 111.694 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -63.37 -42.81 98.88 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.267 -0.424 . . . . 70.030000000000001 110.6 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -70.42 -17.5 63.01 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.102 0.477 . . . . 73.349999999999994 112.237 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . 0.673 ' HG2' ' O ' ' A' ' 376' ' ' THR . 17.5 mmm180 -89.56 -13.75 36.6 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 120.882 -0.327 . . . . 73.439999999999998 110.665 176.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.08 13.49 36.45 Favored Glycine 0 C--N 1.309 -0.968 0 C-N-CA 120.315 -0.945 . . . . 42.43 112.301 177.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -87.84 156.61 19.3 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 121.003 0.43 . . . . 73.230000000000004 110.725 175.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -105.6 154.27 20.64 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.946 -1.131 . . . . 75.109999999999999 107.946 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.68 149.09 32.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 119.65 -0.82 . . . . 74.299999999999997 112.406 -176.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . 0.434 ' HD2' ' OG1' ' A' ' 417' ' ' THR . 41.6 ttm180 -116.92 128.12 54.91 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 105.283 -2.117 . . . . 75.129999999999995 105.283 173.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 31.1 m -122.8 124.67 43.85 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 109.123 -0.695 . . . . 72.420000000000002 109.123 -175.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -111.76 119.8 39.85 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.141 -1.799 . . . . 74.099999999999994 106.141 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . 0.503 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -116.9 134.85 54.25 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.455 -0.498 . . . . 74.420000000000002 110.891 -177.541 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -135.86 145.0 50.95 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-N 115.787 -0.642 . . . . 72.310000000000002 110.658 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . 0.414 ' HA ' ' HG1' ' A' ' 422' ' ' THR . 33.9 Cg_exo -68.5 153.62 73.43 Favored 'Trans proline' 0 C--O 1.252 1.188 0 C-N-CA 122.628 2.219 . . . . 74.430000000000007 108.85 169.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.419 ' C ' ' HG ' ' A' ' 392' ' ' SER . 25.8 t70 -62.64 124.94 22.3 Favored 'General case' 0 CA--C 1.487 -1.453 0 CA-C-O 122.519 1.152 . . . . 70.140000000000001 112.739 -175.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' SER . . . . . 0.42 ' O ' ' HB ' ' A' ' 393' ' ' THR . 49.5 m -154.37 34.19 0.42 Allowed 'General case' 0 C--N 1.279 -2.5 0 CA-C-N 112.525 -2.125 . . . . 71.25 106.134 178.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' A' ' 392' ' ' SER . 23.2 m 81.38 46.1 0.03 OUTLIER 'General case' 0 CA--C 1.57 1.736 0 C-N-CA 125.862 1.665 . . . . 72.150000000000006 111.515 -178.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.25 151.59 46.94 Favored Pre-proline 0 C--N 1.313 -1.009 0 CA-C-N 115.431 -0.804 . . . . 74.129999999999995 110.68 174.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -50.8 136.54 43.01 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 C-N-CA 124.007 3.138 . . . . 75.049999999999997 114.654 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.99 163.02 17.39 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.733 2.955 . . . . 75.140000000000001 111.841 176.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -56.86 -8.41 0.6 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 112.885 0.698 . . . . 65.140000000000001 112.885 -179.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 33.8 m170 -85.51 114.47 22.56 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 106.959 -1.497 . . . . 73.209999999999994 106.959 173.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 15.5 m -68.3 119.53 14.21 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-N 116.067 -0.515 . . . . 75.239999999999995 112.005 -174.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 3.9 mp -87.25 -30.55 5.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 108.083 -1.08 . . . . 74.200000000000003 108.083 176.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.39 171.02 27.35 Favored Glycine 0 N--CA 1.422 -2.239 0 N-CA-C 110.774 -0.93 . . . . 51.439999999999998 110.774 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 4.1 p -114.6 -178.06 3.28 Favored 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 123.059 0.544 . . . . 74.030000000000001 110.75 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -100.62 136.93 19.79 Favored Pre-proline 0 C--N 1.293 -1.881 0 N-CA-C 107.862 -1.162 . . . . 64.319999999999993 107.862 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -47.51 -22.64 2.92 Favored 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 124.503 3.468 . . . . 61.43 115.275 -176.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -64.74 -29.29 70.27 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 120.729 0.3 . . . . 72.209999999999994 110.961 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -85.28 -40.78 16.2 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.571 0.7 . . . . 63.439999999999998 110.327 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . 0.417 ' HA ' ' NE2' ' A' ' 361' ' ' GLN . 13.0 m120 -77.14 -11.18 59.78 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.421 -0.809 . . . . 75.319999999999993 112.126 -173.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 57.2 m -100.94 157.51 16.69 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 107.558 -1.275 . . . . 75.439999999999998 107.558 177.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 44.1 m -74.53 112.77 11.04 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 108.066 -1.086 . . . . 74.219999999999999 108.066 177.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.5 169.33 20.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 120.972 0.415 . . . . 71.530000000000001 111.202 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 22.8 t -73.64 133.05 43.37 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 107.096 -1.446 . . . . 73.409999999999997 107.096 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -61.88 138.5 58.36 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.134 0.492 . . . . 72.219999999999999 111.56 -176.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 93.1 39.48 5.13 Favored Glycine 0 N--CA 1.437 -1.286 0 CA-C-N 115.704 -0.68 . . . . 53.530000000000001 111.943 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -102.49 -174.33 2.54 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.191 -1.411 . . . . 75.299999999999997 107.191 177.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -109.83 116.27 31.34 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 118.374 0.534 . . . . 74.310000000000002 109.897 -177.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 32.2 mm -99.37 129.19 50.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 109.154 -0.684 . . . . 73.120000000000005 109.154 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 417' ' ' THR . . . . . 0.434 ' OG1' ' HD2' ' A' ' 385' ' ' ARG . 44.7 m -91.74 131.13 37.33 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 112.38 0.511 . . . . 73.129999999999995 112.38 -177.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 3.5 p -123.33 134.96 64.78 Favored 'Isoleucine or valine' 0 C--O 1.252 1.226 0 N-CA-C 108.351 -0.981 . . . . 75.510000000000005 108.351 176.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -107.24 124.99 50.56 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.244 -0.65 . . . . 72.109999999999999 109.244 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 2.7 p -125.79 131.46 71.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-N 115.49 -0.777 . . . . 73.239999999999995 111.176 -177.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 29.3 t -107.61 131.34 54.47 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-O 121.941 0.877 . . . . 54.509999999999998 110.23 176.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 422' ' ' THR . . . . . 0.414 ' HG1' ' HA ' ' A' ' 390' ' ' PRO . 24.2 p -87.15 158.48 19.15 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 105.363 -2.088 . . . . 63.119999999999997 105.363 170.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 2.191 0 CA-C-N 118.679 0.672 . . . . 75.340000000000003 114.092 -179.035 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.463 ' HG2' HG23 ' A' ' 477' ' ' THR . 45.9 tt0 . . . . . 0 N--CA 1.408 -2.572 0 N-CA-C 104.23 -2.507 . . . . 71.340000000000003 104.23 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.42 ' HA ' ' HE ' ' A' ' 427' ' ' ARG . 3.2 mmp_? -122.53 156.68 33.68 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 120.492 -0.483 . . . . 75.420000000000002 111.847 -173.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -83.22 139.98 32.81 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.788 -1.19 . . . . 73.409999999999997 107.788 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 73.3 mt -78.96 122.5 84.62 Favored Pre-proline 0 N--CA 1.425 -1.693 0 N-CA-C 108.298 -1.001 . . . . 74.209999999999994 108.298 -178.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -69.97 140.82 42.79 Favored 'Trans proline' 0 N--CA 1.429 -2.323 0 C-N-CA 121.256 1.304 . . . . 63.229999999999997 110.05 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -100.85 155.95 17.64 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 115.677 -0.692 . . . . 73.219999999999999 109.479 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.422 HG12 ' HB3' ' A' ' 440' ' ' ALA . 8.5 p -153.2 170.94 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 N-CA-C 107.452 -1.314 . . . . 74.219999999999999 107.452 -174.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.446 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 14.5 m -73.09 146.36 45.84 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 108.713 -0.847 . . . . 63.32 108.713 176.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 15.7 p -68.4 -23.92 64.7 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 113.59 0.959 . . . . 72.450000000000003 113.59 -174.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.5 pp -80.39 -11.87 59.64 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 120.113 -0.635 . . . . 73.239999999999995 110.383 177.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.446 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 1.3 m -101.84 44.15 1.03 Allowed 'General case' 0 CA--C 1.555 1.135 0 CA-C-N 115.592 -0.731 . . . . 65.129999999999995 110.902 -175.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . 0.436 ' HH ' ' HB2' ' A' ' 454' ' ' GLN . 61.7 t80 -52.42 -38.18 58.49 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.387 0.675 . . . . 71.510000000000005 112.389 177.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.0 -45.03 83.31 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.209 0.528 . . . . 65.540000000000006 111.025 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -70.7 -33.26 70.69 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.68 -0.691 . . . . 74.120000000000005 110.51 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.521 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -58.95 -51.27 70.78 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.088 0.155 . . . . 71.230000000000004 110.658 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 33.6 m -62.52 -37.12 78.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-O 121.201 0.524 . . . . 73.450000000000003 110.849 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -60.39 -47.99 83.71 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.312 -0.858 . . . . 73.319999999999993 110.437 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -66.03 -38.75 89.18 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.904 -0.589 . . . . 73.010000000000005 111.725 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 93.1 mt -63.66 -33.66 76.13 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.791 0.329 . . . . 74.319999999999993 110.383 176.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 66.3 m -70.28 -44.9 67.45 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 115.912 -0.586 . . . . 74.349999999999994 110.1 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.75 -21.69 65.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.597 -0.729 . . . . 72.140000000000001 110.907 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.22 5.09 21.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.622 -0.717 . . . . 74.409999999999997 112.436 -179.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 105.18 -79.47 0.28 Allowed Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.11 -1.043 . . . . 72.239999999999995 111.998 175.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -39.62 -61.07 0.87 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.358 1.244 . . . . 73.319999999999993 114.358 176.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 62.15 18.45 57.73 Favored Glycine 0 C--N 1.321 -0.293 0 C-N-CA 121.634 -0.317 . . . . 75.340000000000003 113.186 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 14.3 mmt180 -95.15 111.29 23.14 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.356 -0.979 . . . . 74.329999999999998 108.356 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -136.49 153.88 50.9 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 120.689 0.281 . . . . 72.439999999999998 110.795 -178.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -142.37 133.16 25.56 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.545 -1.28 . . . . 73.219999999999999 107.545 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . 0.436 ' HB2' ' HH ' ' A' ' 437' ' ' TYR . 56.4 tt0 -101.5 134.52 44.48 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.832 -0.433 . . . . 74.510000000000005 109.832 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -124.37 138.83 54.33 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.036 -1.468 . . . . 63.030000000000001 107.036 173.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -121.07 136.67 54.93 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 109.479 -0.563 . . . . 65.230000000000004 109.479 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 32.5 t -135.72 141.2 36.13 Favored Pre-proline 0 C--N 1.296 -1.746 0 N-CA-C 108.708 -0.849 . . . . 72.340000000000003 108.708 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.677 ' HA ' ' O ' ' A' ' 490' ' ' SER . 37.6 Cg_endo -69.43 131.16 21.11 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.18 1.92 . . . . 73.030000000000001 110.521 175.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 61.1 m -151.22 -179.38 7.29 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.638 -0.875 . . . . 60.32 108.638 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 11.9 t -48.22 138.81 10.62 Favored Pre-proline 0 C--O 1.25 1.104 0 C-N-CA 123.941 0.897 . . . . 61.140000000000001 111.11 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -51.39 -29.39 30.59 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 124.401 3.401 . . . . 72.209999999999994 113.817 -175.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -75.27 -26.57 58.9 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.026 -0.67 . . . . 63.039999999999999 111.939 -177.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -88.58 -14.96 36.33 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 120.689 0.28 . . . . 71.0 111.07 178.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 86.5 t -60.87 127.56 20.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 109.385 -0.598 . . . . 75.150000000000006 109.385 176.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 96.92 -5.81 63.94 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 115.799 -0.637 . . . . 73.510000000000005 112.945 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' A' ' 466' ' ' LYS . 8.2 mptt -124.46 160.18 28.82 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 108.393 -0.965 . . . . 73.230000000000004 108.393 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 77.7 t -70.95 142.62 15.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 107.612 -1.255 . . . . 73.150000000000006 107.612 173.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 59.0 mt -97.57 -35.65 5.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 107.566 -1.272 . . . . 75.299999999999997 107.566 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 173.24 -172.43 45.15 Favored Glycine 0 N--CA 1.412 -2.931 0 N-CA-C 109.707 -1.357 . . . . 73.140000000000001 109.707 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 30.2 p -121.18 146.24 46.99 Favored 'General case' 0 C--N 1.271 -2.832 0 N-CA-C 107.216 -1.401 . . . . 74.049999999999997 107.216 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -72.07 -46.2 11.35 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 119.096 -1.042 . . . . 75.109999999999999 110.153 176.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -82.61 146.44 13.47 Favored 'Trans proline' 0 C--N 1.374 1.906 0 N-CA-C 108.517 -1.378 . . . . 75.5 108.517 169.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -65.36 127.29 17.88 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 121.778 1.652 . . . . 73.439999999999998 111.691 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -86.3 8.95 19.35 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.643 0.735 . . . . 70.540000000000006 111.299 -175.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -109.4 -6.73 15.36 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 116.039 -0.528 . . . . 72.510000000000005 110.364 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -97.24 172.2 7.95 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 116.01 -0.541 . . . . 71.040000000000006 111.791 -174.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 477' ' ' THR . . . . . 0.463 HG23 ' HG2' ' A' ' 426' ' ' GLN . 1.3 m -92.91 119.01 31.77 Favored 'General case' 0 N--CA 1.418 -2.032 0 CA-C-N 115.272 -0.876 . . . . 73.219999999999999 108.688 -177.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 54.9 m -115.49 148.04 39.94 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 123.171 0.588 . . . . 74.010000000000005 110.719 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -73.26 159.07 33.97 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.767 -0.651 . . . . 74.019999999999996 111.066 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 43.7 mm -69.09 -21.09 25.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.748 0.785 . . . . 74.140000000000001 110.295 -177.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 3.7 p -100.15 5.33 44.82 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.734 -0.604 . . . . 73.299999999999997 111.87 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -94.1 133.9 37.1 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.216 -0.447 . . . . 75.109999999999999 109.926 -177.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 33.0 t -100.64 126.77 54.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.082 -0.508 . . . . 72.319999999999993 110.621 -174.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 35.0 m -103.0 137.47 31.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.429 0.633 . . . . 72.329999999999998 111.143 178.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.16 128.45 62.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.495 0.664 . . . . 73.319999999999993 110.096 -178.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 38.5 mm -109.21 128.23 65.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 C-N-CA 125.046 1.338 . . . . 75.540000000000006 108.858 -174.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 13.4 tt -112.07 126.47 69.47 Favored 'Isoleucine or valine' 0 C--O 1.246 0.887 0 CA-C-O 121.453 0.644 . . . . 71.129999999999995 110.977 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 34.5 m -113.29 151.64 15.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 0 CA-C-N 115.448 -0.796 . . . . 74.549999999999997 111.495 -177.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.0 132.53 11.22 Favored Glycine 0 N--CA 1.433 -1.548 0 N-CA-C 109.534 -1.426 . . . . 64.109999999999999 109.534 177.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.677 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 21.5 p . . . . . 0 C--N 1.294 -1.815 0 CA-C-N 116.958 0.379 . . . . 74.120000000000005 110.48 -176.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo . . . . . 0 C--O 1.252 1.205 0 N-CA-C 110.891 -0.465 . . . . 75.420000000000002 110.891 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -91.32 78.09 5.79 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.718 0.771 . . . . 73.450000000000003 110.043 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 18.2 p -117.79 142.94 46.72 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.98 -1.009 . . . . 72.409999999999997 110.697 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . 0.422 ' HB3' ' HZ3' ' A' ' 495' ' ' LYS . 4.8 mmmp? -141.15 152.62 44.84 Favored 'General case' 0 CA--C 1.494 -1.183 0 CA-C-O 121.524 0.678 . . . . 74.140000000000001 110.792 178.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 12.4 p-10 -80.62 134.41 35.89 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 114.265 -1.334 . . . . 73.400000000000006 108.518 175.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 31.8 pt -83.35 125.28 74.6 Favored Pre-proline 0 C--N 1.3 -1.55 0 C-N-CA 120.527 -0.469 . . . . 74.439999999999998 109.834 177.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -79.8 -175.81 2.91 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.279 1.986 . . . . 64.439999999999998 111.107 178.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -84.22 90.17 7.46 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.678 0.752 . . . . 73.329999999999998 110.675 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 12.8 p -104.96 3.17 10.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 123.353 1.549 . . . . 74.349999999999994 106.985 175.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . 0.49 ' HB3' ' HA2' ' A' ' 536' ' ' GLY . . . -83.6 63.59 7.48 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 113.161 -1.836 . . . . 75.310000000000002 111.446 -174.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 165.95 28.65 0.02 OUTLIER Glycine 0 C--N 1.309 -0.962 0 C-N-CA 119.253 -1.451 . . . . 72.120000000000005 113.244 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -118.74 -169.13 1.66 Allowed 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 106.753 -1.573 . . . . 73.430000000000007 106.753 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 11.4 m -81.96 155.45 25.22 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.038 -1.467 . . . . 75.439999999999998 107.038 175.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.615 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 6.0 p -55.1 -46.36 77.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.231 0.456 . . . . 74.340000000000003 112.231 -176.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -66.51 -41.63 88.58 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 116.475 -0.329 . . . . 62.32 111.326 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 60.0 t -66.43 -42.04 89.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.694 -0.685 . . . . 74.519999999999996 109.817 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -61.86 -44.91 95.86 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 115.424 -0.807 . . . . 71.200000000000003 111.253 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.615 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 21.2 mt-30 -60.29 -40.41 90.38 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 121.191 0.519 . . . . 72.140000000000001 110.887 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.434 ' O ' HG23 ' A' ' 514' ' ' VAL . 64.0 mttm -64.47 -53.6 45.74 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.417 -0.81 . . . . 74.099999999999994 109.626 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -62.77 -37.8 88.08 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 115.514 -0.766 . . . . 75.140000000000001 111.288 -177.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 8.4 tt -59.04 -44.79 91.83 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 109.108 -0.701 . . . . 73.239999999999995 109.108 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . 0.541 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 0.8 OUTLIER -64.62 -37.64 88.28 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.173 -0.467 . . . . 72.040000000000006 111.426 177.292 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 510' ' ' LYS . 92.7 t -63.71 -30.25 49.42 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 CA-C-N 116.028 -0.533 . . . . 63.439999999999998 111.088 177.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -77.15 -4.53 45.01 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.82 0.343 . . . . 75.329999999999998 111.353 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 106.42 -10.69 42.81 Favored Glycine 0 CA--C 1.496 -1.122 0 C-N-CA 120.664 -0.779 . . . . 52.420000000000002 112.226 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.541 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 82.4 m-85 -88.52 114.42 25.12 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 107.377 -1.342 . . . . 73.109999999999999 107.377 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 5.0 p -89.56 -19.4 25.04 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 112.983 0.735 . . . . 73.230000000000004 112.983 -175.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -107.93 119.51 39.67 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.404 0.621 . . . . 75.219999999999999 111.924 -172.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -129.8 156.4 44.39 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.346 -0.843 . . . . 73.310000000000002 110.524 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 10.1 p -141.64 147.05 36.94 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.381 -1.34 . . . . 71.109999999999999 107.381 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.51 133.48 53.31 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 121.169 0.509 . . . . 62.350000000000001 111.427 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -132.97 126.39 31.88 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.436 -0.95 . . . . 74.349999999999994 108.436 178.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 11.0 m -98.1 134.64 40.9 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-O 120.828 0.347 . . . . 74.010000000000005 110.423 -177.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . 0.412 ' O ' ' HB3' ' A' ' 557' ' ' LYS . 30.5 m -123.01 149.96 26.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.083 -1.081 . . . . 72.5 108.083 176.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -66.33 135.67 54.71 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.998 -0.741 . . . . 75.329999999999998 108.998 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 74.2 m -149.91 166.99 13.9 Favored Pre-proline 0 C--N 1.293 -1.863 0 CA-C-N 115.754 -0.657 . . . . 73.219999999999999 111.162 -173.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -79.48 -23.36 7.32 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 121.805 1.67 . . . . 74.430000000000007 110.658 170.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -70.79 147.28 94.2 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 108.607 -0.886 . . . . 73.109999999999999 108.607 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -61.77 158.95 35.13 Favored 'Trans proline' 0 C--O 1.251 1.13 0 C-N-CA 122.835 2.357 . . . . 72.510000000000005 113.129 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -67.24 120.46 13.83 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.581 -0.736 . . . . 54.119999999999997 110.783 -179.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 118.52 -17.21 11.28 Favored Glycine 0 C--N 1.309 -0.924 0 C-N-CA 120.651 -0.785 . . . . 54.399999999999999 111.646 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -77.42 133.1 38.74 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.095 -1.076 . . . . 71.299999999999997 108.095 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 77.3 t -82.41 117.58 28.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 108.216 -1.031 . . . . 64.340000000000003 108.216 177.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 535' ' ' THR . . . . . 0.501 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 13.7 t -82.07 -17.66 45.83 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.781 0.8 . . . . 75.109999999999999 109.727 -177.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . 0.49 ' HA2' ' HB3' ' A' ' 501' ' ' ALA . . . 162.35 -163.31 34.95 Favored Glycine 0 N--CA 1.411 -3.021 0 N-CA-C 110.618 -0.993 . . . . 74.420000000000002 110.618 177.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 22.8 p -124.98 154.88 40.53 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 107.749 -1.204 . . . . 70.540000000000006 107.749 176.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -66.31 -55.88 18.29 Favored Pre-proline 0 C--N 1.306 -1.306 0 N-CA-C 109.606 -0.516 . . . . 74.120000000000005 109.606 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.46 127.06 10.09 Favored 'Trans proline' 0 C--N 1.368 1.561 0 N-CA-C 109.128 -1.143 . . . . 74.150000000000006 109.128 169.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.6 152.99 64.7 Favored 'Trans proline' 0 C--O 1.245 0.873 0 C-N-CA 123.14 2.56 . . . . 75.230000000000004 112.944 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -67.12 138.26 56.94 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.118 -0.492 . . . . 71.430000000000007 110.096 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 104.41 -20.82 38.83 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 111.469 -0.652 . . . . 65.019999999999996 111.469 -177.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 32.8 m -65.41 135.61 55.46 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.5 -0.556 . . . . 73.150000000000006 109.5 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 17.2 m -97.7 123.18 41.52 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 109.333 -0.617 . . . . 73.409999999999997 109.333 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.0 m -136.53 159.81 69.08 Favored Pre-proline 0 C--N 1.31 -1.141 0 N-CA-C 109.161 -0.681 . . . . 73.430000000000007 109.161 -178.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -63.88 147.6 92.08 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.221 1.947 . . . . 74.540000000000006 111.435 174.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 29.5 m -64.97 -19.62 25.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.703 0.763 . . . . 63.119999999999997 111.557 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -93.55 3.64 55.21 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.169 -0.923 . . . . 64.109999999999999 110.256 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 11.7 t -85.71 162.19 18.86 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.546 -0.909 . . . . 44.299999999999997 108.546 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 21.6 t -97.36 128.06 49.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 109.604 -0.517 . . . . 71.519999999999996 109.604 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 2.3 mp -101.68 131.58 49.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 108.863 -0.791 . . . . 75.319999999999993 108.863 176.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -102.67 116.69 33.09 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 121.489 0.661 . . . . 71.450000000000003 110.669 -178.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 84.4 mt -90.31 128.84 36.55 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.768 -1.197 . . . . 75.140000000000001 107.768 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -103.82 113.76 27.53 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 122.379 1.085 . . . . 71.099999999999994 109.379 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 23.0 t -94.38 147.13 5.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-N 114.02 -1.446 . . . . 74.109999999999999 110.019 -172.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 7.5 m -86.31 131.58 34.18 Favored 'General case' 0 N--CA 1.414 -2.268 0 CA-C-N 115.636 -0.711 . . . . 73.219999999999999 109.769 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 525' ' ' VAL . 9.4 ttmm -99.12 119.44 37.85 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 107.107 -1.442 . . . . 75.349999999999994 107.107 171.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -67.69 -37.48 89.06 Favored Glycine 0 CA--C 1.495 -1.203 0 N-CA-C 110.955 -0.858 . . . . 72.150000000000006 110.955 -177.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . 0.481 ' OD1' ' HD2' ' A' ' 616' ' ' ARG . 52.3 t30 65.8 4.47 2.94 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.964 1.706 . . . . 74.219999999999999 111.284 175.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 -142.89 141.24 31.48 Favored 'General case' 0 N--CA 1.415 -2.177 0 N-CA-C 104.702 -2.333 . . . . 74.25 104.702 -173.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -142.25 135.93 29.32 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 118.663 0.665 . . . . 75.329999999999998 111.027 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 6.6 p -70.14 116.42 11.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.732 0.777 . . . . 75.439999999999998 112.206 -176.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 61.4 ttp -98.2 139.77 21.44 Favored Pre-proline 0 C--N 1.309 -1.178 0 CA-C-N 115.222 -0.899 . . . . 75.209999999999994 108.774 177.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -60.68 161.86 20.01 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.764 2.309 . . . . 75.420000000000002 111.798 176.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . 0.488 ' HA ' ' CB ' ' A' ' 610' ' ' ALA . 0.5 OUTLIER -68.16 128.53 36.9 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.797 0.808 . . . . 74.040000000000006 112.761 -175.051 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 57.1 tp -131.13 4.29 4.41 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 107.509 -1.293 . . . . 71.530000000000001 107.509 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 7.7 m -77.34 134.68 38.42 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 113.983 -1.462 . . . . 65.140000000000001 109.842 -176.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 88.0 16.89 58.79 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.643 -0.789 . . . . 72.109999999999999 112.119 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 85.7 mtp -114.96 178.15 4.39 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.452 -0.944 . . . . 72.549999999999997 108.452 -178.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . 0.526 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 66.7 m-85 -89.61 155.52 19.2 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 121.27 0.557 . . . . 74.25 111.492 -176.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -62.35 -29.18 70.27 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 124.909 1.283 . . . . 75.420000000000002 109.602 175.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 10.1 p -73.13 -12.51 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 CA-C-N 115.385 -0.825 . . . . 73.519999999999996 109.864 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -101.21 -37.23 8.63 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.737 -0.665 . . . . 74.019999999999996 109.653 175.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . 0.516 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -63.47 -54.76 31.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.114 -0.948 . . . . 75.349999999999994 113.343 -174.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 579' ' ' ARG . 30.3 mt-10 -62.13 -50.2 81.32 Favored Pre-proline 0 N--CA 1.466 0.366 0 N-CA-C 113.921 1.082 . . . . 72.209999999999994 113.921 -179.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -52.77 -42.98 59.49 Favored 'Trans proline' 0 C--N 1.366 1.461 0 C-N-CA 122.082 1.855 . . . . 72.430000000000007 113.096 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -67.96 -37.62 81.79 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 119.948 -0.701 . . . . 73.129999999999995 111.012 179.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 94.5 mt -63.42 -47.16 83.09 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 121.427 0.632 . . . . 74.030000000000001 110.156 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' A' ' 575' ' ' GLU . 97.7 mtt180 -62.68 -38.05 88.85 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.271 -0.877 . . . . 75.319999999999993 110.26 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.2 -33.14 71.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.968 -0.56 . . . . 64.319999999999993 112.151 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 4.3 pp -82.64 -8.31 59.61 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 120.562 -0.455 . . . . 71.340000000000003 111.777 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 90.47 33.93 8.29 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.779 -0.724 . . . . 73.120000000000005 112.488 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 65.9 t90 -66.29 137.18 56.76 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 122.542 0.337 . . . . 74.200000000000003 110.153 176.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 49.9 m -145.04 102.0 3.7 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.573 -0.899 . . . . 75.129999999999995 108.573 176.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -172.5 -156.34 12.41 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 110.102 -1.199 . . . . 65.030000000000001 110.102 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 14.4 tpt -102.71 127.93 49.65 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.082 0.467 . . . . 72.019999999999996 111.138 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -97.7 126.04 42.81 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.065 -1.458 . . . . 74.5 107.065 176.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -123.28 110.33 15.07 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.374 0.607 . . . . 74.25 110.196 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -99.96 135.41 41.43 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.094 -0.957 . . . . 62.420000000000002 111.399 -174.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -68.76 143.31 39.91 Favored Glycine 0 C--N 1.306 -1.089 0 N-CA-C 109.165 -1.574 . . . . 64.230000000000004 109.165 169.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -61.22 130.5 46.55 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 122.878 0.471 . . . . 63.109999999999999 111.001 -176.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -55.23 135.16 49.91 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.541 0.941 . . . . 72.129999999999995 113.541 -172.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 85.8 t -137.99 115.9 12.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 114.814 -1.084 . . . . 75.109999999999999 109.013 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -90.78 111.88 23.45 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.742 -1.183 . . . . 70.299999999999997 108.612 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -148.56 20.75 1.04 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.938 0.718 . . . . 71.0 112.938 -174.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 140.31 155.65 6.62 Favored Glycine 0 CA--C 1.498 -0.994 0 C-N-CA 118.482 -1.818 . . . . 62.340000000000003 112.936 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.435 ' HA2' ' CD2' ' A' ' 600' ' ' HIS . . . -62.96 -49.77 69.42 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 114.262 0.465 . . . . 71.340000000000003 114.262 -175.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 25.4 m -71.98 -24.6 61.61 Favored 'General case' 0 C--N 1.312 -1.063 0 O-C-N 122.118 -0.636 . . . . 61.340000000000003 111.535 -176.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -93.12 -11.39 33.01 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 115.955 -0.566 . . . . 75.329999999999998 112.4 -177.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . 0.512 ' HB2' ' H ' ' A' ' 626' ' ' GLN . 0.5 OUTLIER -101.04 143.37 31.25 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 118.073 -1.451 . . . . 74.540000000000006 110.544 -176.866 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 69.98 -30.9 0.2 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.573 1.549 . . . . 71.519999999999996 112.005 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . 0.526 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 46.4 ttt180 -72.88 139.54 46.95 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.598 -0.689 . . . . 75.120000000000005 110.74 -177.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 94.2 t -77.99 130.79 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 107.604 -1.258 . . . . 72.230000000000004 107.604 177.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 58.8 t -98.23 -55.73 5.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 108.562 -0.903 . . . . 75.420000000000002 108.562 -177.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 622' ' ' LEU . 49.7 p90 -129.9 151.84 50.03 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 108.294 -1.002 . . . . 73.040000000000006 108.294 175.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . 0.53 ' HA ' ' O ' ' A' ' 621' ' ' THR . 17.7 pt20 -127.71 139.3 52.78 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 107.138 -1.43 . . . . 73.5 107.138 175.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.482 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 24.5 t-20 -46.43 -66.9 0.44 Allowed Pre-proline 0 CA--C 1.55 0.964 0 O-C-N 124.167 0.917 . . . . 63.140000000000001 112.607 -176.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.482 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 84.2 Cg_endo -91.22 124.1 0.86 Allowed 'Trans proline' 0 N--CA 1.436 -1.887 0 CA-C-N 121.233 1.476 . . . . 74.099999999999994 108.822 169.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.5 134.9 32.04 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.934 1.756 . . . . 73.400000000000006 112.399 -175.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . 0.488 ' CB ' ' HA ' ' A' ' 565' ' ' ASP . . . -68.79 138.93 55.21 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 115.537 -0.756 . . . . 74.519999999999996 110.024 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 101.57 -12.82 58.2 Favored Glycine 0 C--N 1.302 -1.317 0 N-CA-C 108.963 -1.655 . . . . 70.239999999999995 108.963 -173.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 16.5 m -118.06 168.76 10.25 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 107.143 -1.428 . . . . 71.310000000000002 107.143 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -71.22 126.5 13.32 Favored Glycine 0 N--CA 1.423 -2.222 0 N-CA-C 111.756 -0.538 . . . . 74.430000000000007 111.756 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 31.4 m -94.27 141.69 14.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 109.271 -0.64 . . . . 74.530000000000001 109.271 177.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.15 144.03 36.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.888 -0.596 . . . . 72.329999999999998 111.753 177.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . 0.481 ' HD2' ' OD1' ' A' ' 559' ' ' ASN . 0.9 OUTLIER -54.03 -25.74 22.92 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.066 0.946 . . . . 73.430000000000007 112.26 179.771 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -61.13 -32.1 71.8 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 123.738 0.815 . . . . 74.299999999999997 109.879 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 73.08 8.43 74.03 Favored Glycine 0 N--CA 1.418 -2.506 0 N-CA-C 110.805 -0.918 . . . . 71.530000000000001 110.805 -176.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . 0.418 HD12 ' N ' ' A' ' 620' ' ' ILE . 0.0 OUTLIER -68.99 121.08 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 CA-C-O 122.068 0.937 . . . . 73.319999999999993 108.516 -174.461 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . 0.418 ' N ' HD12 ' A' ' 619' ' ' ILE . 0.0 OUTLIER -129.18 119.57 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.549 0 CA-C-N 114.183 -1.372 . . . . 62.409999999999997 109.591 -176.265 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' A' ' 606' ' ' GLN . 55.8 m -101.68 128.86 47.8 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.027 -1.471 . . . . 73.540000000000006 107.027 175.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . 0.451 ' HA ' ' O ' ' A' ' 605' ' ' TYR . 2.3 pt? -132.06 154.46 49.39 Favored 'General case' 0 CA--C 1.475 -1.926 0 N-CA-C 108.829 -0.804 . . . . 74.140000000000001 108.829 -176.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.94 135.19 49.61 Favored 'General case' 0 N--CA 1.398 -3.067 0 N-CA-C 105.672 -1.973 . . . . 71.030000000000001 105.672 177.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -142.79 165.67 26.75 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 106.128 -1.804 . . . . 75.530000000000001 106.128 177.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -77.43 -102.72 0.17 Allowed Glycine 0 N--CA 1.428 -1.863 0 C-N-CA 119.705 -1.236 . . . . 54.219999999999999 110.214 172.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . 0.512 ' H ' ' HB2' ' A' ' 600' ' ' HIS . 8.4 tt0 . . . . . 0 C--N 1.298 -1.642 0 N-CA-C 108.7 -0.852 . . . . 75.109999999999999 108.7 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 . . . . . 0 CA--C 1.494 -1.183 0 CA-C-O 120.832 0.349 . . . . 54.229999999999997 110.159 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 409' ' ' SER . 21.5 m -141.51 164.51 19.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 107.852 -1.166 . . . . 73.310000000000002 107.852 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -92.59 138.07 31.82 Favored 'General case' 0 N--CA 1.397 -3.085 0 N-CA-C 107.076 -1.453 . . . . 71.150000000000006 107.076 174.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.406 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 76.0 t -94.91 125.05 52.44 Favored Pre-proline 0 C--N 1.266 -3.045 0 N-CA-C 107.218 -1.401 . . . . 72.540000000000006 107.218 -173.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 28.0 Cg_exo -57.35 136.82 78.5 Favored 'Trans proline' 0 CA--C 1.499 -1.234 0 C-N-CA 123.252 2.635 . . . . 71.340000000000003 113.185 -169.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -75.49 101.53 4.89 Favored 'General case' 0 N--CA 1.421 -1.915 0 CA-C-O 122.742 1.258 . . . . 73.409999999999997 109.699 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.449 ' CG2' ' HB2' ' A' ' 373' ' ' ALA . 5.8 m -81.86 7.08 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-N 114.112 -1.404 . . . . 74.219999999999999 112.643 -178.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -58.66 146.01 37.83 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 125.132 1.373 . . . . 74.310000000000002 111.667 175.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.97 -10.46 51.9 Favored Glycine 0 N--CA 1.436 -1.345 0 N-CA-C 111.11 -0.796 . . . . 62.109999999999999 111.11 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -110.46 -161.62 0.76 Allowed 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.988 -1.115 . . . . 75.230000000000004 107.988 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 75.8 p -94.11 158.69 15.49 Favored 'General case' 0 C--N 1.276 -2.623 0 N-CA-C 108.24 -1.022 . . . . 74.319999999999993 108.24 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.431 ' O ' ' HB ' ' A' ' 374' ' ' ILE . 46.8 t -60.32 -36.06 77.06 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 109.722 -0.473 . . . . 72.340000000000003 109.722 176.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.56 -47.78 71.72 Favored 'General case' 0 C--O 1.213 -0.841 0 CA-C-O 119.24 -0.409 . . . . 74.409999999999997 111.763 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -70.09 -40.62 74.87 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 119.722 -0.791 . . . . 71.120000000000005 110.901 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . 0.449 ' HB2' ' CG2' ' A' ' 365' ' ' VAL . . . -61.54 -47.31 86.11 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.257 -0.883 . . . . 75.209999999999994 110.599 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . 0.431 ' HB ' ' O ' ' A' ' 370' ' ' SER . 1.6 mp -69.07 -38.3 78.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.926 -0.579 . . . . 72.239999999999995 111.209 177.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -60.14 -38.35 82.84 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.535 0.683 . . . . 74.129999999999995 110.353 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 86.1 m -63.76 -45.48 89.61 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.443 -0.799 . . . . 62.219999999999999 110.167 177.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 85.4 mt -64.24 -38.83 92.46 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.13 -0.486 . . . . 74.329999999999998 110.629 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -62.1 -40.41 95.77 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.56 -0.533 . . . . 74.420000000000002 109.56 177.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -63.13 -30.05 71.28 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.131 0.572 . . . . 64.409999999999997 111.585 176.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -84.48 -14.07 50.19 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.097 -0.502 . . . . 74.219999999999999 110.885 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 94.94 12.91 54.81 Favored Glycine 0 C--N 1.311 -0.836 0 C-N-CA 120.779 -0.724 . . . . 73.340000000000003 112.702 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -80.56 157.77 25.96 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-O 121.195 0.522 . . . . 75.219999999999999 111.395 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -98.86 132.78 43.95 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 106.698 -1.593 . . . . 73.209999999999994 106.698 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.09 154.93 28.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 CA-C-O 121.822 0.82 . . . . 72.209999999999994 110.861 -177.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -135.58 134.04 38.93 Favored 'General case' 0 N--CA 1.399 -2.997 0 CA-C-N 114.235 -1.348 . . . . 71.319999999999993 107.432 173.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 52.2 m -125.0 121.98 35.97 Favored 'General case' 0 C--N 1.271 -2.838 0 N-CA-C 106.631 -1.618 . . . . 74.239999999999995 106.631 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.21 119.23 38.23 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 105.854 -1.906 . . . . 74.519999999999996 105.854 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . 0.57 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -123.0 129.1 51.09 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 119.964 -0.694 . . . . 73.519999999999996 111.384 -176.395 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 421' ' ' SER . 96.1 mttt -134.7 148.68 68.24 Favored Pre-proline 0 C--N 1.308 -1.207 0 N-CA-C 107.61 -1.255 . . . . 74.030000000000001 107.61 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -69.28 127.47 15.02 Favored 'Trans proline' 0 C--O 1.249 1.027 0 N-CA-C 105.909 -2.381 . . . . 65.040000000000006 105.909 168.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -177.41 157.4 1.3 Allowed 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 118.993 -1.083 . . . . 75.409999999999997 110.962 -169.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 10.9 m -112.08 -4.95 14.32 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.776 0.322 . . . . 64.420000000000002 110.93 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 42.4 m -92.45 -42.2 9.87 Favored 'General case' 0 N--CA 1.435 -1.184 0 O-C-N 122.118 -0.364 . . . . 75.140000000000001 111.101 -175.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 21.1 pt -88.02 148.36 42.98 Favored Pre-proline 0 C--N 1.31 -1.123 0 C-N-CA 120.47 -0.492 . . . . 74.129999999999995 110.623 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -49.04 147.08 11.21 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 124.493 3.462 . . . . 70.129999999999995 115.443 -177.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . 0.424 ' C ' ' H ' ' A' ' 398' ' ' HIS . 51.8 Cg_exo -56.5 165.64 4.3 Favored 'Trans proline' 0 C--O 1.22 -0.418 0 C-N-CA 124.593 3.529 . . . . 75.230000000000004 110.813 170.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . 0.443 ' HA ' HG12 ' A' ' 420' ' ' VAL . 6.1 p-10 -55.17 -7.84 0.24 Allowed 'General case' 0 N--CA 1.505 2.308 0 C-N-CA 123.468 0.707 . . . . 74.040000000000006 112.538 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.424 ' H ' ' C ' ' A' ' 396' ' ' PRO . 32.7 m170 -91.87 117.3 29.67 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 106.118 -1.808 . . . . 70.430000000000007 106.118 172.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 16.2 m -73.62 118.65 19.36 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-O 120.9 0.381 . . . . 72.140000000000001 110.827 -173.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 9.2 tp -89.78 -28.7 5.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-O 121.396 0.617 . . . . 71.030000000000001 110.51 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.43 169.59 27.65 Favored Glycine 0 N--CA 1.425 -2.068 0 N-CA-C 110.234 -1.147 . . . . 64.540000000000006 110.234 -177.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 10.5 p -114.15 -178.66 3.43 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 123.545 0.203 . . . . 75.420000000000002 110.59 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -100.74 139.79 20.85 Favored Pre-proline 0 C--N 1.307 -1.247 0 N-CA-C 107.777 -1.194 . . . . 64.209999999999994 107.777 -177.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -43.18 -30.25 2.06 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 124.391 3.394 . . . . 73.409999999999997 114.313 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.28 -31.53 70.32 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 123.309 0.381 . . . . 72.239999999999995 111.459 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -86.14 -34.39 20.59 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.701 0.762 . . . . 74.129999999999995 110.188 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -82.8 -1.99 53.25 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.259 -0.882 . . . . 74.319999999999993 111.426 -175.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 26.8 m -110.76 153.54 25.18 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 106.194 -1.78 . . . . 74.549999999999997 106.194 175.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 409' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 360' ' ' VAL . 39.3 m -73.87 112.73 10.27 Favored 'General case' 0 N--CA 1.425 -1.686 0 C-N-CA 120.205 -0.598 . . . . 74.040000000000006 109.749 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 23.9 m -122.54 166.71 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 115.403 -0.817 . . . . 75.239999999999995 109.719 178.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 42.7 m -75.74 138.77 41.47 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 109.228 -0.656 . . . . 74.230000000000004 109.228 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -61.31 109.43 1.14 Allowed 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.184 0.516 . . . . 74.25 110.55 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 116.79 67.26 0.38 Allowed Glycine 0 N--CA 1.428 -1.873 0 N-CA-C 110.203 -1.159 . . . . 61.210000000000001 110.203 -178.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -135.5 -168.58 2.22 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.888 -1.152 . . . . 74.219999999999999 107.888 -177.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -106.99 131.09 54.44 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 123.622 0.769 . . . . 71.129999999999995 110.518 -176.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 42.4 mm -119.37 115.86 49.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.928 -0.767 . . . . 74.010000000000005 108.928 176.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 13.7 p -98.82 130.94 45.27 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 123.929 0.891 . . . . 75.310000000000002 111.127 -177.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 8.7 p -126.96 135.06 64.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 120.905 0.384 . . . . 72.239999999999995 111.496 178.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -101.15 120.83 40.81 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.099 0.476 . . . . 75.040000000000006 110.059 176.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 44.8 t -126.49 144.36 36.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 C-N-CA 123.939 0.896 . . . . 75.430000000000007 111.252 -174.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 421' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 27.3 p -101.25 127.13 47.98 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.384 0.611 . . . . 73.420000000000002 110.832 176.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.1 t -117.69 106.05 12.67 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 115.888 -0.597 . . . . 75.120000000000005 109.42 177.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.888 0 C-N-CA 119.589 -1.291 . . . . 55.530000000000001 112.344 179.943 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 . . . . . 0 N--CA 1.446 -0.67 0 CA-C-O 120.881 0.372 . . . . 73.25 110.51 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -121.03 152.92 38.05 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-O 121.803 0.811 . . . . 70.140000000000001 111.041 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . 0.491 ' CD ' ' H ' ' A' ' 428' ' ' GLU . 0.3 OUTLIER -86.81 140.34 29.79 Favored 'General case' 0 C--N 1.268 -2.942 0 CA-C-N 114.05 -1.432 . . . . 65.510000000000005 111.764 -174.552 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.455 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 65.7 mt -79.79 116.6 62.2 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 109.239 -0.652 . . . . 71.409999999999997 109.239 -177.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.51 147.26 51.62 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.851 2.368 . . . . 74.439999999999998 113.081 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -92.32 131.89 37.15 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 106.553 -1.647 . . . . 75.349999999999994 106.553 175.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.425 HG12 ' HB1' ' A' ' 440' ' ' ALA . 11.4 p -132.33 159.68 42.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 C-N-CA 120.855 -0.338 . . . . 71.329999999999998 110.852 -171.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.591 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 15.3 m -68.6 152.93 44.68 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 108.772 -0.825 . . . . 71.120000000000005 108.772 175.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 81.8 p -69.13 -33.5 73.56 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 114.413 1.264 . . . . 74.140000000000001 114.413 -167.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.8 pp -90.65 -11.67 39.12 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.629 -1.228 . . . . 72.340000000000003 111.553 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.591 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 1.2 m -86.83 42.05 1.0 Allowed 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.472 -0.786 . . . . 73.040000000000006 111.081 -174.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -56.58 -37.05 70.07 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.953 0.901 . . . . 74.510000000000005 110.632 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -54.97 -41.42 71.15 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.158 -0.474 . . . . 72.319999999999993 111.254 175.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -70.4 -35.65 73.58 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.777 -0.453 . . . . 72.099999999999994 109.777 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.612 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -60.9 -51.41 69.4 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.543 -0.753 . . . . 73.049999999999997 110.477 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 33.8 m -65.53 -39.7 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 112.482 0.549 . . . . 72.25 112.482 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.421 ' HD3' ' N ' ' A' ' 443' ' ' LYS . 0.1 OUTLIER -67.89 -34.92 77.59 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 120.131 -0.628 . . . . 70.239999999999995 111.971 178.096 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . 0.421 ' N ' ' HD3' ' A' ' 442' ' ' LYS . 0.9 OUTLIER -66.14 -40.63 90.75 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.084 -0.507 . . . . 74.239999999999995 109.747 177.875 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 76.8 mt -67.45 -32.86 74.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.597 -0.729 . . . . 74.519999999999996 110.18 177.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 90.5 m -69.89 -42.55 73.27 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.128 0.49 . . . . 63.329999999999998 109.975 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.46 -15.75 62.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.434 0.635 . . . . 71.430000000000007 110.767 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -85.49 5.25 32.11 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.422 -0.808 . . . . 42.229999999999997 111.459 178.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 104.92 -74.48 0.24 Allowed Glycine 0 CA--C 1.495 -1.176 0 C-N-CA 120.747 -0.739 . . . . 53.119999999999997 111.874 176.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . 0.483 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 3.6 p90 -49.19 -59.57 3.55 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 113.975 1.102 . . . . 73.230000000000004 113.975 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 60.59 29.32 69.41 Favored Glycine 0 C--O 1.217 -0.912 0 N-CA-C 111.028 -0.829 . . . . 72.420000000000002 111.028 -174.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -103.55 111.42 23.87 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.965 -1.124 . . . . 75.310000000000002 107.965 -178.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -141.54 150.11 41.69 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 120.84 0.352 . . . . 71.310000000000002 111.326 -176.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -136.79 146.83 46.18 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.768 -1.197 . . . . 72.219999999999999 107.768 178.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 486' ' ' ILE . 53.4 tt0 -117.31 128.52 55.13 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 109.931 -0.396 . . . . 75.409999999999997 109.931 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -116.89 154.82 30.12 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.027 -1.101 . . . . 75.109999999999999 108.027 177.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -125.1 137.74 54.18 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 108.935 -0.765 . . . . 74.010000000000005 108.935 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 26.6 t -137.97 141.79 33.73 Favored Pre-proline 0 C--N 1.292 -1.929 0 N-CA-C 109.538 -0.541 . . . . 75.319999999999993 109.538 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.682 ' HA ' ' O ' ' A' ' 490' ' ' SER . 44.4 Cg_endo -70.32 124.28 10.7 Favored 'Trans proline' 0 C--O 1.25 1.079 0 C-N-CA 122.417 2.078 . . . . 65.120000000000005 111.679 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 50.3 m -152.04 179.85 8.12 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.51 -0.552 . . . . 73.140000000000001 109.51 -177.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.6 t -49.17 139.46 13.16 Favored Pre-proline 0 CA--C 1.56 1.333 0 C-N-CA 123.702 0.801 . . . . 65.310000000000002 112.126 176.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.57 -28.5 29.01 Favored 'Trans proline' 0 C--N 1.365 1.419 0 C-N-CA 125.112 3.875 . . . . 75.0 113.966 -177.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -68.63 -21.24 64.49 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 116.162 -0.472 . . . . 73.299999999999997 111.635 -178.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 91.6 mt -103.61 -13.18 16.63 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 120.859 0.361 . . . . 74.510000000000005 110.913 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 70.0 t -60.97 127.62 20.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.001 -0.545 . . . . 64.340000000000003 110.954 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 95.64 -15.82 62.41 Favored Glycine 0 N--CA 1.441 -1.031 0 CA-C-N 115.639 -0.71 . . . . 73.549999999999997 112.114 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.65 166.83 12.27 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 110.211 -0.292 . . . . 70.219999999999999 110.211 -178.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 73.2 t -72.19 143.39 14.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 115.826 -0.625 . . . . 75.420000000000002 109.643 179.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 70.0 mt -97.38 -31.04 3.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 107.244 -1.391 . . . . 75.299999999999997 107.244 176.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 159.74 -159.22 30.42 Favored Glycine 0 N--CA 1.425 -2.086 0 N-CA-C 109.977 -1.249 . . . . 54.5 109.977 177.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 470' ' ' THR . . . . . 0.458 HG21 HG12 ' A' ' 486' ' ' ILE . 61.9 p -114.7 146.67 40.65 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 105.608 -1.997 . . . . 62.109999999999999 105.608 178.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.426 ' HB3' HG22 ' A' ' 485' ' ' ILE . 28.5 t-20 -72.85 -53.86 5.05 Favored Pre-proline 0 C--N 1.314 -0.947 0 C-N-CA 118.871 -1.132 . . . . 73.030000000000001 110.236 178.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -67.75 134.54 32.85 Favored 'Trans proline' 0 C--N 1.368 1.604 0 N-CA-C 107.904 -1.614 . . . . 75.329999999999998 107.904 168.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . 0.484 ' C ' ' H ' ' A' ' 475' ' ' ASN . 24.7 Cg_exo -62.12 139.21 77.21 Favored 'Trans proline' 0 C--O 1.242 0.702 0 C-N-CA 122.216 1.944 . . . . 74.329999999999998 112.632 -175.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.455 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -75.84 19.91 0.2 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 122.163 0.983 . . . . 75.040000000000006 110.979 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . 0.484 ' H ' ' C ' ' A' ' 473' ' ' PRO . 10.1 m120 -109.21 -17.65 13.79 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.412 -0.959 . . . . 75.329999999999998 108.412 178.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -87.33 170.43 11.42 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.696 -0.683 . . . . 74.340000000000003 111.733 -174.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 4.5 m -106.3 127.02 52.94 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 108.304 -0.998 . . . . 72.420000000000002 108.304 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 9.8 p -105.95 146.06 30.52 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 123.031 0.533 . . . . 71.230000000000004 111.236 -177.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -90.26 162.75 15.05 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.452 -0.34 . . . . 74.140000000000001 110.815 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . 0.483 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 1.7 mp -70.93 -20.58 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.966 0.889 . . . . 71.310000000000002 111.187 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 12.2 p -93.39 1.17 56.99 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.988 0.899 . . . . 62.0 111.029 178.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -104.93 138.17 41.57 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.004 -0.998 . . . . 75.120000000000005 111.649 -173.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.4 p -108.06 127.03 64.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.809 -0.632 . . . . 73.239999999999995 111.027 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 35.8 m -95.45 141.57 14.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-O 121.299 0.571 . . . . 74.299999999999997 111.294 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.426 HG22 ' HB3' ' A' ' 471' ' ' ASN . 0.0 OUTLIER -109.43 125.91 66.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.196 0 CA-C-O 121.485 0.66 . . . . 74.329999999999998 110.251 -178.441 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . 0.458 HG12 HG21 ' A' ' 470' ' ' THR . 8.9 mt -112.62 128.61 69.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 115.067 -0.97 . . . . 74.409999999999997 110.919 -178.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 8.8 tt -105.17 127.21 59.99 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 123.41 0.684 . . . . 64.519999999999996 111.905 -174.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 28.6 m -111.61 152.07 13.57 Favored 'Isoleucine or valine' 0 C--O 1.25 1.097 0 C-N-CA 124.017 0.927 . . . . 64.510000000000005 110.241 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -81.9 140.76 21.15 Favored Glycine 0 C--O 1.246 0.854 0 C-N-CA 120.99 -0.624 . . . . 72.349999999999994 111.979 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.682 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 13.2 t . . . . . 0 C--N 1.308 -1.212 0 N-CA-C 109.017 -0.735 . . . . 74.219999999999999 109.017 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo . . . . . 0 CA--C 1.544 0.996 0 CA-C-O 121.035 0.348 . . . . 73.239999999999995 112.194 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -84.99 65.73 9.39 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-O 122.083 0.944 . . . . 72.040000000000006 111.875 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 1.3 p -118.03 143.42 46.43 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 114.899 -1.046 . . . . 74.510000000000005 109.673 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -146.34 148.83 32.78 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.84 -1.17 . . . . 74.120000000000005 107.84 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 9.5 p-10 -87.54 130.07 34.86 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.475 0.655 . . . . 73.120000000000005 110.985 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 38.3 pt -75.92 137.82 69.46 Favored Pre-proline 0 C--N 1.307 -1.28 0 CA-C-N 114.862 -1.063 . . . . 75.219999999999999 110.418 -178.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -93.86 -170.72 0.24 Allowed 'Trans proline' 0 N--CA 1.443 -1.482 0 C-N-CA 122.269 1.979 . . . . 61.439999999999998 111.211 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -83.9 145.91 28.34 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.666 -1.235 . . . . 72.450000000000003 107.666 174.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 9.2 p -136.22 8.58 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.455 0 CA-C-O 122.616 1.198 . . . . 65.230000000000004 108.469 177.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -71.17 121.43 18.32 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 114.019 -1.446 . . . . 71.409999999999997 109.628 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 108.73 30.57 3.7 Favored Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 110.789 -0.924 . . . . 74.140000000000001 110.789 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -142.03 176.09 9.22 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.907 -0.775 . . . . 74.0 108.907 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 29.6 p -91.67 160.02 15.58 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 110.021 -0.362 . . . . 74.209999999999994 110.021 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 30.7 m -53.73 -40.24 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 C-N-CA 124.181 0.993 . . . . 71.530000000000001 112.255 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -66.72 -42.44 86.35 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.655 -0.702 . . . . 64.219999999999999 110.791 -178.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 64.8 t -74.77 -35.06 35.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 116.432 -0.349 . . . . 73.329999999999998 110.253 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -59.61 -49.74 76.6 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.134 -0.485 . . . . 72.010000000000005 111.573 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -65.58 -35.89 82.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 74.030000000000001 110.725 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.41 ' O ' HG23 ' A' ' 514' ' ' VAL . 58.6 tptt -61.47 -47.35 86.06 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.706 -0.679 . . . . 72.040000000000006 109.647 178.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -62.08 -44.83 95.81 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 116.382 -0.372 . . . . 73.519999999999996 110.165 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.73 -47.52 85.31 Favored 'General case' 0 C--O 1.242 0.664 0 O-C-N 123.422 0.451 . . . . 73.540000000000006 110.376 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.92 -38.15 87.32 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 116.182 -0.463 . . . . 74.400000000000006 111.105 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 510' ' ' LYS . 55.2 t -64.01 -35.6 74.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 122.828 0.451 . . . . 74.230000000000004 111.366 177.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -79.29 -12.77 59.94 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.374 -0.53 . . . . 74.209999999999994 110.695 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . 0.432 ' O ' ' HB ' ' A' ' 547' ' ' VAL . . . 113.11 -0.14 25.41 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.69 -0.767 . . . . 64.040000000000006 113.154 177.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 547' ' ' VAL . 79.2 m-85 -82.82 115.77 21.86 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.454 -0.572 . . . . 71.450000000000003 109.454 -178.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.7 p -88.69 -26.04 22.04 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 113.643 0.979 . . . . 73.450000000000003 113.643 -176.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . 0.435 ' HE2' ' HA ' ' A' ' 519' ' ' LYS . 6.4 mmpt? -110.13 120.66 43.15 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 113.613 0.968 . . . . 74.450000000000003 113.613 -176.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -131.82 140.2 49.08 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 113.809 -1.541 . . . . 73.120000000000005 111.242 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 54.0 m -134.47 144.42 48.08 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.627 -0.879 . . . . 70.540000000000006 108.627 176.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -117.35 122.57 44.24 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.721 0.772 . . . . 63.25 110.807 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -100.89 140.29 35.38 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.685 -0.688 . . . . 71.209999999999994 109.663 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 15.9 m -88.79 116.01 26.75 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.982 -0.554 . . . . 73.319999999999993 109.646 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 35.7 m -121.98 158.56 25.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.935 -0.765 . . . . 74.329999999999998 108.935 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . 0.469 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 5.2 p-10 -94.71 136.83 34.55 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.838 -0.745 . . . . 71.420000000000002 109.89 179.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 527' ' ' SER . . . . . 0.412 ' HG ' ' C ' ' A' ' 526' ' ' ASP . 38.6 m -153.81 173.57 4.56 Favored Pre-proline 0 C--N 1.305 -1.331 0 N-CA-C 106.442 -1.688 . . . . 65.109999999999999 106.442 174.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -81.88 -8.3 12.2 Favored 'Trans proline' 0 CA--C 1.547 1.16 0 CA-C-N 120.642 1.265 . . . . 74.310000000000002 111.6 173.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . 0.431 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 4.1 mpt_? -76.39 134.61 69.94 Favored Pre-proline 0 C--O 1.223 -0.328 0 CA-C-N 116.046 -0.524 . . . . 75.030000000000001 109.813 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -57.08 154.93 30.89 Favored 'Trans proline' 0 C--O 1.255 1.368 0 C-N-CA 123.225 2.616 . . . . 75.299999999999997 114.032 -177.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.5 117.02 4.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.87 -1.059 . . . . 72.299999999999997 111.892 -178.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 132.21 -20.02 4.52 Favored Glycine 0 CA--C 1.49 -1.497 0 N-CA-C 110.797 -0.921 . . . . 62.329999999999998 110.797 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -74.27 125.25 28.02 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.922 -0.639 . . . . 74.230000000000004 110.04 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 85.9 t -84.34 107.39 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 N-CA-C 106.36 -1.718 . . . . 74.519999999999996 106.36 172.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 26.8 m -75.01 -25.96 59.19 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.632 -1.167 . . . . 64.140000000000001 111.002 -174.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 162.03 -163.78 35.02 Favored Glycine 0 N--CA 1.427 -1.963 0 N-CA-C 110.311 -1.115 . . . . 62.340000000000003 110.311 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 19.5 p -117.73 155.3 30.22 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.987 -0.746 . . . . 73.549999999999997 108.987 178.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -75.52 -52.97 2.73 Favored Pre-proline 0 C--N 1.305 -1.34 0 N-CA-C 109.614 -0.513 . . . . 73.319999999999993 109.614 176.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -64.32 130.33 26.64 Favored 'Trans proline' 0 C--N 1.365 1.405 0 N-CA-C 107.951 -1.596 . . . . 74.450000000000003 107.951 167.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -63.21 143.67 90.22 Favored 'Trans proline' 0 C--O 1.246 0.879 0 C-N-CA 122.226 1.951 . . . . 74.140000000000001 112.479 -177.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -65.14 136.1 56.29 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.604 -0.517 . . . . 74.310000000000002 109.604 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.95 -19.46 32.74 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 111.446 -0.662 . . . . 72.200000000000003 111.446 -176.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 35.2 m -68.51 134.48 50.13 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.699 0.285 . . . . 73.140000000000001 110.329 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 28.2 m -85.41 122.8 30.08 Favored 'General case' 0 N--CA 1.416 -2.138 0 N-CA-C 107.741 -1.207 . . . . 72.209999999999994 107.741 177.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 52.9 t -127.72 152.27 76.68 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 107.147 -1.427 . . . . 73.510000000000005 107.147 -176.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -66.2 139.52 55.6 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 121.512 1.475 . . . . 74.510000000000005 109.701 171.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 517' ' ' PHE . 28.7 m -63.28 -20.12 25.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.665 0.745 . . . . 75.319999999999993 112.548 -177.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -93.45 3.48 55.5 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.465 -0.788 . . . . 72.400000000000006 110.727 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 8.6 t -92.4 -178.43 4.92 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.761 -0.587 . . . . 75.230000000000004 109.916 -178.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 45.5 t -102.1 122.74 54.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 122.948 0.499 . . . . 73.239999999999995 111.181 -174.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 1.9 mp -103.58 126.77 58.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.158 -1.053 . . . . 55.43 108.158 175.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -103.56 120.48 40.96 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-O 121.488 0.661 . . . . 73.239999999999995 111.989 -176.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 69.2 mt -94.75 134.3 37.51 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 125.569 1.547 . . . . 73.019999999999996 108.249 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -104.02 118.66 37.19 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 109.15 -0.685 . . . . 73.439999999999998 109.15 176.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 43.4 t -109.79 129.5 64.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 CA-C-N 115.17 -0.923 . . . . 71.400000000000006 109.191 -175.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 32.0 p -80.07 143.5 33.95 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 113.494 0.924 . . . . 62.539999999999999 113.494 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.469 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 45.1 pttt -92.41 152.42 19.73 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 102.863 -3.014 . . . . 75.519999999999996 102.863 165.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -75.53 -32.14 55.28 Favored Glycine 0 CA--C 1.479 -2.17 0 C-N-CA 119.079 -1.534 . . . . 73.140000000000001 111.166 -176.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 64.3 t30 71.98 -28.99 0.19 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.516 1.526 . . . . 74.340000000000003 111.839 173.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.492 ' H ' ' C ' ' A' ' 558' ' ' GLY . 92.8 mt-30 -135.23 145.88 48.06 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 106.75 -1.574 . . . . 71.450000000000003 106.75 174.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -123.07 138.09 54.76 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 109.383 -0.599 . . . . 74.519999999999996 109.383 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 90.2 t -59.94 116.88 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 O-C-N 123.933 0.771 . . . . 73.25 110.321 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 25.7 ptm -80.62 146.74 61.45 Favored Pre-proline 0 C--O 1.249 1.031 0 CA-C-N 116.103 -0.498 . . . . 75.319999999999993 110.475 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -71.39 169.76 20.04 Favored 'Trans proline' 0 C--O 1.243 0.77 0 C-N-CA 122.862 2.374 . . . . 74.230000000000004 111.592 174.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -74.34 125.66 28.97 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 112.776 0.658 . . . . 65.310000000000002 112.776 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 96.1 mt -142.03 18.91 2.12 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.595 -1.184 . . . . 72.129999999999995 108.125 177.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 60.2 p -79.84 139.13 37.3 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 112.455 0.539 . . . . 72.420000000000002 112.455 -175.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 83.83 25.36 45.97 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 121.137 -0.554 . . . . 75.5 112.707 176.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 84.4 mtp -108.23 174.92 5.66 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.839 -0.43 . . . . 61.240000000000002 109.839 -178.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -102.5 136.96 41.4 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 106.922 -1.51 . . . . 75.129999999999995 106.922 177.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 81.8 t90 -54.66 -29.58 53.0 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 124.021 0.929 . . . . 75.420000000000002 112.356 -176.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 16.7 m -74.57 -19.16 16.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.342 0.592 . . . . 71.420000000000002 111.347 -177.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -102.29 -36.54 8.44 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.862 0.839 . . . . 73.230000000000004 109.644 178.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -67.46 -43.21 81.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.83 -1.077 . . . . 73.450000000000003 112.54 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -57.15 -50.56 87.47 Favored Pre-proline 0 CA--C 1.558 1.283 0 CA-C-O 119.44 -0.314 . . . . 75.200000000000003 111.481 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -53.53 -37.96 83.12 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.095 1.863 . . . . 65.540000000000006 112.617 172.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . 0.519 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 45.4 mmt-85 -64.96 -39.14 93.04 Favored 'General case' 0 C--O 1.214 -0.799 0 C-N-CA 120.242 -0.583 . . . . 75.120000000000005 110.586 177.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 96.3 mt -62.24 -43.12 99.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.336 0.589 . . . . 73.310000000000002 109.452 177.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -61.85 -38.81 89.62 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.375 -0.83 . . . . 75.530000000000001 110.317 178.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.21 -30.0 66.98 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.063 -0.517 . . . . 75.109999999999999 111.415 177.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 93.0 mt -81.97 -7.19 59.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.826 0.346 . . . . 75.109999999999999 111.332 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 82.7 35.64 18.71 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 120.974 -0.632 . . . . 63.130000000000003 111.914 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 83.5 t90 -77.51 130.44 36.97 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.129 0.49 . . . . 74.510000000000005 110.177 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 50.4 m -145.05 89.43 1.96 Allowed 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.158 -1.052 . . . . 75.430000000000007 108.158 175.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -153.58 -146.84 4.48 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 110.208 -1.157 . . . . 75.129999999999995 110.208 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 23.8 ttt -115.93 135.33 54.08 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 117.182 0.491 . . . . 74.439999999999998 110.894 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -100.47 130.78 46.59 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.05 -1.834 . . . . 71.510000000000005 106.05 175.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -102.36 118.67 37.38 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.867 -0.733 . . . . 74.409999999999997 110.637 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 4.0 mmmp? -87.76 111.94 21.88 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-O 121.5 0.666 . . . . 72.549999999999997 112.15 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -81.23 -173.41 47.75 Favored Glycine 0 N--CA 1.427 -1.907 0 N-CA-C 109.676 -1.37 . . . . 41.310000000000002 109.676 171.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -70.51 145.02 51.16 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.998 0.399 . . . . 64.510000000000005 110.977 -175.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -85.59 124.67 32.4 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.925 -1.139 . . . . 72.230000000000004 107.925 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.92 124.85 68.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 C-N-CA 122.903 0.481 . . . . 75.329999999999998 110.863 -174.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -75.67 111.8 11.38 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.489 -0.93 . . . . 74.120000000000005 108.489 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -114.19 -19.78 11.18 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 112.081 0.4 . . . . 75.319999999999993 112.081 -176.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 126.96 145.83 6.34 Favored Glycine 0 CA--C 1.492 -1.391 0 N-CA-C 108.663 -1.775 . . . . 74.140000000000001 108.663 -176.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.17 -40.1 82.86 Favored Glycine 0 N--CA 1.47 0.912 0 CA-C-N 117.512 0.656 . . . . 42.109999999999999 113.955 -173.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 15.8 m -66.38 -24.31 66.47 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 122.951 0.501 . . . . 70.120000000000005 111.46 -178.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -108.7 -1.11 19.69 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.269 0.841 . . . . 74.319999999999993 113.269 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -68.07 150.64 48.17 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.943 -0.392 . . . . 74.239999999999995 109.943 177.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 63.42 -6.31 0.21 Allowed 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 124.878 1.271 . . . . 70.439999999999998 114.122 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . 0.504 ' HD2' ' O ' ' A' ' 603' ' ' VAL . 5.5 tmm_? -79.15 138.62 37.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 118.459 0.572 . . . . 74.409999999999997 109.883 -178.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . 0.504 ' O ' ' HD2' ' A' ' 602' ' ' ARG . 13.9 p -64.0 142.2 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.85 0.86 . . . . 64.219999999999999 111.171 -177.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 7.5 p -96.13 -47.79 12.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 118.687 -1.205 . . . . 71.400000000000006 109.216 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -156.99 155.82 31.91 Favored 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 105.337 -2.097 . . . . 75.349999999999994 105.337 173.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -115.75 128.78 56.12 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 107.356 -1.349 . . . . 73.109999999999999 107.356 173.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.51 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 25.2 t-20 -48.77 -52.55 44.71 Favored Pre-proline 0 CA--C 1.545 0.779 0 O-C-N 123.99 0.806 . . . . 65.109999999999999 111.634 -177.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.51 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 13.7 Cg_endo -100.86 110.19 0.05 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.054 0 C-N-CA 121.659 1.573 . . . . 73.340000000000003 109.441 169.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.95 160.37 34.01 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.494 2.13 . . . . 73.420000000000002 111.485 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -57.32 126.96 29.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.576 0.227 . . . . 65.219999999999999 110.46 -177.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 102.03 -5.43 53.15 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.227 -0.987 . . . . 74.219999999999999 112.329 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 23.7 m -92.24 155.33 18.05 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.946 -0.761 . . . . 75.340000000000003 108.946 177.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -82.98 126.05 7.28 Favored Glycine 0 N--CA 1.426 -1.988 0 N-CA-C 111.368 -0.693 . . . . 71.420000000000002 111.368 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.3 m -103.81 142.18 17.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-O 120.598 0.237 . . . . 74.209999999999994 110.419 178.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.05 146.12 11.83 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 123.822 0.849 . . . . 72.120000000000005 112.267 177.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.02 -35.97 16.71 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 125.976 1.71 . . . . 72.319999999999993 112.874 -175.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -73.94 -30.26 62.45 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.883 -1.053 . . . . 71.209999999999994 111.484 -175.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 93.29 12.13 57.69 Favored Glycine 0 N--CA 1.414 -2.776 0 CA-C-O 119.211 -0.772 . . . . 62.100000000000001 114.078 174.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.67 119.78 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 C-N-CA 117.715 -1.594 . . . . 74.340000000000003 107.736 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.84 132.14 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 114.793 -1.094 . . . . 74.019999999999996 108.349 -175.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 90.2 m -106.23 116.89 32.71 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 121.221 0.534 . . . . 72.510000000000005 110.507 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . 0.421 ' HB2' HG22 ' A' ' 603' ' ' VAL . 0.0 OUTLIER -139.92 149.97 43.98 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 104.558 -2.386 . . . . 73.5 104.558 173.04 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -128.78 156.13 44.05 Favored 'General case' 0 C--N 1.254 -3.578 0 N-CA-C 105.987 -1.857 . . . . 73.519999999999996 105.987 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -125.2 166.08 17.11 Favored 'General case' 0 C--N 1.26 -3.292 0 N-CA-C 105.367 -2.086 . . . . 72.230000000000004 105.367 175.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -61.28 -89.25 0.02 OUTLIER Glycine 0 C--N 1.314 -0.687 0 C-N-CA 120.104 -1.046 . . . . 64.030000000000001 110.708 176.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 . . . . . 0 C--N 1.289 -2.054 0 N-CA-C 107.03 -1.47 . . . . 54.340000000000003 107.03 175.047 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 C--O 1.241 0.643 0 N-CA-C 108.477 -0.934 . . . . 74.319999999999993 108.477 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 31.5 m -121.49 163.67 19.17 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-O 120.76 0.314 . . . . 74.219999999999999 110.74 -175.031 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -94.41 136.59 34.54 Favored 'General case' 0 N--CA 1.383 -3.793 0 N-CA-C 107.439 -1.319 . . . . 73.510000000000005 107.439 175.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 72.1 t -97.42 135.06 21.93 Favored Pre-proline 0 C--N 1.265 -3.093 0 CA-C-N 114.624 -1.171 . . . . 74.150000000000006 109.911 -171.17 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -65.99 121.9 9.33 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 121.65 1.566 . . . . 75.030000000000001 110.948 179.244 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -88.77 147.48 24.42 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.749 -1.575 . . . . 74.409999999999997 106.749 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 4.8 t -120.84 11.54 6.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 CA-C-N 116.052 -0.522 . . . . 71.409999999999997 109.947 -172.511 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.69 143.11 54.9 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 119.158 -1.017 . . . . 74.109999999999999 110.03 176.535 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.94 -9.28 46.93 Favored Glycine 0 C--N 1.301 -1.395 0 N-CA-C 111.233 -0.747 . . . . 55.43 111.233 -172.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -109.03 -145.86 0.4 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.483 -0.932 . . . . 73.150000000000006 108.483 174.386 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 369' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 96.4 p -107.13 167.04 10.18 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.426 -0.909 . . . . 71.019999999999996 108.899 -176.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 25.2 t -59.69 -39.55 84.9 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 109.167 -0.679 . . . . 64.239999999999995 109.167 176.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.37 -46.66 75.95 Favored 'General case' 0 C--O 1.213 -0.843 0 CA-C-N 116.102 -0.499 . . . . 63.439999999999998 111.357 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -64.11 -41.42 97.25 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.359 0.599 . . . . 72.420000000000002 110.924 -179.251 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.06 -51.34 62.03 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.389 -0.823 . . . . 61.310000000000002 111.073 -178.539 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 39.8 mm -66.08 -39.98 85.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.042 -0.526 . . . . 73.510000000000005 110.955 -179.303 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.24 -38.82 88.01 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 120.937 0.399 . . . . 74.310000000000002 111.15 -179.111 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 376' ' ' THR . . . . . 0.528 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 79.5 m -66.41 -47.28 73.78 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.845 -0.616 . . . . 74.040000000000006 111.177 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.75 -37.99 89.44 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.557 0.218 . . . . 74.420000000000002 111.159 178.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -59.9 -48.03 83.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.95 -0.568 . . . . 64.019999999999996 109.747 177.096 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -61.03 -30.88 70.57 Favored 'General case' 0 CA--C 1.495 -1.17 0 N-CA-C 113.096 0.776 . . . . 72.409999999999997 113.096 177.231 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 376' ' ' THR . 13.3 mmt180 -78.44 -14.08 59.54 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.272 -0.422 . . . . 70.200000000000003 110.735 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 91.14 16.11 54.49 Favored Glycine 0 CA--C 1.501 -0.842 0 C-N-CA 119.772 -1.204 . . . . 73.129999999999995 111.506 177.412 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -88.92 162.89 15.85 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-O 121.385 0.612 . . . . 74.310000000000002 110.518 178.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . 0.451 ' HB2' ' HG2' ' A' ' 415' ' ' GLU . 75.2 mmtt -94.43 148.87 21.8 Favored 'General case' 0 N--CA 1.411 -2.375 0 N-CA-C 106.862 -1.533 . . . . 75.040000000000006 106.862 178.848 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.28 141.3 44.11 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-O 121.622 0.725 . . . . 74.530000000000001 110.968 -175.546 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . 0.412 ' HB3' ' HA ' ' A' ' 417' ' ' THR . 44.3 ttt180 -125.08 127.53 47.05 Favored 'General case' 0 N--CA 1.406 -2.632 0 N-CA-C 106.384 -1.709 . . . . 75.140000000000001 106.384 174.362 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 26.8 m -129.95 127.86 40.93 Favored 'General case' 0 C--N 1.276 -2.589 0 N-CA-C 108.97 -0.752 . . . . 62.219999999999999 108.97 -177.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -112.05 120.34 41.53 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.565 -0.531 . . . . 73.239999999999995 109.565 176.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -100.66 121.97 42.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.703 -0.851 . . . . 74.099999999999994 108.703 -179.007 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 421' ' ' SER . 44.5 mtmt -137.24 138.25 24.74 Favored Pre-proline 0 C--N 1.301 -1.509 0 C-N-CA 120.398 -0.521 . . . . 73.430000000000007 109.717 175.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -75.42 128.78 11.42 Favored 'Trans proline' 0 C--O 1.257 1.454 0 N-CA-C 107.972 -1.588 . . . . 73.040000000000006 107.972 172.54 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.442 ' OD1' HG21 ' A' ' 393' ' ' THR . 7.3 t70 -174.62 -172.67 0.67 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.086 -1.82 . . . . 75.510000000000005 106.086 -172.745 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 41.4 m -150.97 -2.6 0.34 Allowed 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 122.545 0.338 . . . . 73.519999999999996 111.605 175.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.442 HG21 ' OD1' ' A' ' 391' ' ' ASP . 10.7 t -105.91 -24.87 12.34 Favored 'General case' 0 C--O 1.244 0.764 0 O-C-N 121.696 -0.627 . . . . 75.530000000000001 109.898 -178.677 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . 0.43 HG13 ' HB2' ' A' ' 421' ' ' SER . 49.1 pt -88.66 152.54 49.34 Favored Pre-proline 0 N--CA 1.439 -1.021 0 N-CA-C 107.805 -1.183 . . . . 73.430000000000007 107.805 176.525 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -32.9 111.58 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 124.634 3.556 . . . . 73.439999999999998 116.398 179.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -56.48 166.86 3.14 Favored 'Trans proline' 0 C--O 1.221 -0.343 0 C-N-CA 124.943 3.762 . . . . 72.150000000000006 110.676 170.062 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . 0.475 ' HA ' ' CG2' ' A' ' 420' ' ' VAL . 4.6 p-10 -54.94 -8.58 0.27 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 112.684 0.624 . . . . 73.430000000000007 112.684 -178.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 63.1 m170 -98.01 106.16 18.41 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 103.319 -2.845 . . . . 70.439999999999998 103.319 166.59 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 18.6 m -63.08 118.43 5.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 O-C-N 124.185 0.928 . . . . 73.239999999999995 113.209 -166.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 41.7 mm -98.2 -27.47 3.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 114.575 -1.193 . . . . 73.200000000000003 109.881 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.42 157.14 27.25 Favored Glycine 0 N--CA 1.414 -2.777 0 C-N-CA 119.901 -1.142 . . . . 71.120000000000005 112.026 -176.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 4.7 p -148.08 -176.15 5.17 Favored 'General case' 0 C--N 1.284 -2.242 0 C-N-CA 126.253 1.821 . . . . 72.129999999999995 107.412 -175.36 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -99.82 137.26 20.14 Favored Pre-proline 0 C--N 1.299 -1.602 0 N-CA-C 107.894 -1.15 . . . . 74.230000000000004 107.894 176.337 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.27 -2.86 3.46 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.824 3.016 . . . . 73.010000000000005 113.36 -177.085 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -52.61 -35.28 54.17 Favored 'General case' 0 C--O 1.21 -1.013 0 C-N-CA 124.656 1.183 . . . . 71.219999999999999 111.165 176.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -68.35 -37.47 80.53 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 121.533 0.682 . . . . 74.319999999999993 110.211 178.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -82.69 -3.91 57.06 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.579 0.704 . . . . 75.019999999999996 109.452 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 32.0 m -93.55 152.5 18.99 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.398 -1.705 . . . . 61.329999999999998 106.398 176.506 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 13.2 p -77.37 111.57 13.18 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 108.554 -0.906 . . . . 74.239999999999995 108.554 176.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 28.8 m -127.51 169.16 19.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-O 121.095 0.474 . . . . 74.109999999999999 110.876 -179.524 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 3.4 m -78.69 146.74 33.82 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.961 -0.755 . . . . 64.519999999999996 108.961 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -71.51 109.91 5.77 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.015 0.435 . . . . 73.510000000000005 110.529 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 122.8 23.23 2.31 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 120.852 -0.69 . . . . 72.109999999999999 112.749 178.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -86.68 -173.77 4.65 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.642 -0.873 . . . . 71.010000000000005 108.642 177.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . 0.451 ' HG2' ' HB2' ' A' ' 383' ' ' LYS . 32.9 mt-10 -111.21 119.19 38.11 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.263 -0.643 . . . . 73.200000000000003 109.263 -175.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.1 mm -98.17 120.25 47.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-O 120.837 0.351 . . . . 72.310000000000002 110.091 -178.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 417' ' ' THR . . . . . 0.412 ' HA ' ' HB3' ' A' ' 385' ' ' ARG . 36.4 m -90.7 125.88 35.81 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.972 -0.558 . . . . 73.230000000000004 111.726 -178.599 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 4.3 p -116.55 134.82 58.8 Favored 'Isoleucine or valine' 0 C--O 1.255 1.384 0 N-CA-C 109.261 -0.644 . . . . 73.409999999999997 109.261 174.533 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -99.29 116.89 32.52 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.515 -1.661 . . . . 75.340000000000003 106.515 177.028 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.475 ' CG2' ' HA ' ' A' ' 397' ' ' ASP . 10.7 p -127.61 136.0 61.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 121.32 0.581 . . . . 73.040000000000006 110.608 -175.531 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 421' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 14.1 t -102.39 122.58 44.56 Favored 'General case' 0 N--CA 1.415 -2.223 0 C-N-CA 119.839 -0.744 . . . . 64.140000000000001 110.031 178.295 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 8.9 t -118.94 107.53 13.68 Favored 'General case' 0 N--CA 1.411 -2.377 0 CA-C-N 115.175 -0.92 . . . . 61.229999999999997 108.753 176.387 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.4 0 C-N-CA 120.871 -0.68 . . . . 52.140000000000001 111.923 -178.514 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 . . . . . 0 N--CA 1.424 -1.728 0 N-CA-C 109.674 -0.491 . . . . 71.5 109.674 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.512 ' HG3' ' O ' ' A' ' 447' ' ' ALA . 4.3 mmp_? -120.33 155.6 33.01 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 109.653 -0.499 . . . . 75.519999999999996 109.653 -178.574 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -91.66 137.37 32.42 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 115.086 -0.961 . . . . 72.329999999999998 110.101 -176.153 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 59.7 mt -96.12 118.67 65.48 Favored Pre-proline 0 N--CA 1.421 -1.88 0 N-CA-C 107.519 -1.289 . . . . 71.430000000000007 107.519 177.017 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -71.6 141.48 38.14 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 N-CA-C 108.125 -1.529 . . . . 75.340000000000003 108.125 171.08 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -80.13 134.46 36.17 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 118.229 -1.389 . . . . 72.209999999999994 108.592 178.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 8.9 p -101.23 161.99 3.49 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.374 0 N-CA-C 108.39 -0.967 . . . . 73.430000000000007 108.39 -172.332 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 26.7 m -75.68 158.02 32.88 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 107.33 -1.359 . . . . 75.329999999999998 107.33 174.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 434' ' ' THR . . . . . 0.404 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 74.3 p -67.99 -40.34 83.09 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.943 0.878 . . . . 75.209999999999994 111.32 -173.458 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.5 -28.78 68.12 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 113.784 1.031 . . . . 74.25 113.784 178.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.6 p -89.9 59.2 4.49 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 114.511 1.3 . . . . 75.430000000000007 114.511 -172.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -64.26 -37.86 88.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.115 -0.493 . . . . 74.239999999999995 111.364 177.294 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -62.43 -36.3 81.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.899 0.38 . . . . 72.319999999999993 110.457 178.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -67.51 -39.35 85.14 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.64 -0.504 . . . . 72.439999999999998 109.64 175.22 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.46 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.19 -50.38 73.89 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.969 -0.56 . . . . 74.140000000000001 110.924 -178.489 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.0 m -62.14 -40.77 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 111.935 0.346 . . . . 72.129999999999995 111.935 -179.178 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -36.41 80.03 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 120.366 -0.534 . . . . 73.439999999999998 112.3 178.455 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -63.22 -47.1 83.92 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 120.931 0.396 . . . . 74.430000000000007 110.384 177.008 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.46 HD13 ' O ' ' A' ' 440' ' ' ALA . 2.6 mp -63.68 -35.54 80.88 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.361 -0.836 . . . . 74.530000000000001 110.601 179.866 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 89.4 m -69.33 -45.8 68.61 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 116.172 -0.467 . . . . 71.109999999999999 110.488 177.162 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.13 -16.49 62.56 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 120.848 0.356 . . . . 74.310000000000002 111.88 -178.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . 0.512 ' O ' ' HG3' ' A' ' 427' ' ' ARG . . . -84.6 -4.66 59.11 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.177 -0.465 . . . . 73.450000000000003 111.488 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 117.66 -83.48 0.35 Allowed Glycine 0 CA--C 1.498 -1.017 0 C-N-CA 120.121 -1.038 . . . . 63.140000000000001 111.963 177.085 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -36.99 -63.52 0.42 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.374 1.249 . . . . 74.129999999999995 114.374 177.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 62.71 20.2 61.51 Favored Glycine 0 C--O 1.221 -0.668 0 CA-C-N 116.384 -0.371 . . . . 54.439999999999998 113.322 -178.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -96.97 110.43 22.97 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.079 -1.082 . . . . 74.439999999999998 108.079 -178.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . 0.42 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 21.2 p90 -138.91 158.95 43.28 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 115.972 -0.558 . . . . 73.420000000000002 110.437 -177.453 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -144.98 148.23 33.54 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.447 -1.316 . . . . 75.409999999999997 107.447 179.177 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -119.05 127.36 53.34 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 117.877 0.308 . . . . 74.420000000000002 110.323 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -124.52 150.58 45.67 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.395 -0.965 . . . . 71.319999999999993 108.395 175.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -114.03 141.53 47.32 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.922 -0.399 . . . . 74.120000000000005 109.922 -177.201 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 23.2 t -138.37 137.59 20.9 Favored Pre-proline 0 C--N 1.307 -1.242 0 N-CA-C 108.898 -0.778 . . . . 74.519999999999996 108.898 176.285 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 490' ' ' SER . 8.0 Cg_exo -71.05 122.78 9.09 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 121.819 1.679 . . . . 70.450000000000003 111.36 177.19 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 49.5 m -147.09 179.88 7.31 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.09 -1.078 . . . . 74.519999999999996 108.09 -178.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.8 t -43.74 137.78 3.23 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 124.333 1.053 . . . . 74.299999999999997 113.193 179.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . 0.497 ' O ' HG13 ' A' ' 464' ' ' VAL . 9.3 Cg_endo -51.58 -28.84 30.25 Favored 'Trans proline' 0 C--N 1.363 1.298 0 C-N-CA 124.815 3.676 . . . . 65.329999999999998 113.963 -177.419 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.73 -18.6 63.53 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.315 0.579 . . . . 75.540000000000006 111.406 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 82.7 mt -102.73 6.62 39.55 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 116.176 -0.465 . . . . 71.310000000000002 112.02 -179.353 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 461' ' ' PRO . 14.8 p -61.54 127.35 21.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 119.491 -0.883 . . . . 74.200000000000003 109.406 176.716 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 78.85 -1.24 74.65 Favored Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 121.171 -0.538 . . . . 70.109999999999999 112.204 179.064 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -101.35 159.29 15.39 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 108.265 -1.013 . . . . 71.420000000000002 108.265 -178.552 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.404 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 75.1 t -80.54 140.9 15.99 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 CA-C-N 115.426 -0.806 . . . . 74.409999999999997 109.569 176.468 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 63.2 mt -98.28 -35.25 5.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 108.249 -1.019 . . . . 74.420000000000002 108.249 176.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 168.86 -177.4 42.71 Favored Glycine 0 N--CA 1.425 -2.064 0 C-N-CA 120.526 -0.845 . . . . 75.219999999999999 112.215 178.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 470' ' ' THR . . . . . 0.478 HG22 HG12 ' A' ' 486' ' ' ILE . 72.3 p -116.14 144.24 44.43 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.432 -1.692 . . . . 73.099999999999994 106.432 179.081 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.454 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 22.3 t-20 -64.31 -57.68 16.74 Favored Pre-proline 0 C--N 1.319 -0.724 0 C-N-CA 120.064 -0.654 . . . . 71.129999999999995 112.051 177.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.454 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 24.4 Cg_exo -73.25 139.92 29.95 Favored 'Trans proline' 0 C--N 1.361 1.188 0 N-CA-C 108.041 -1.561 . . . . 54.409999999999997 108.041 170.152 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . 0.474 ' C ' ' H ' ' A' ' 475' ' ' ASN . 23.8 Cg_exo -62.59 128.1 22.55 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.373 2.048 . . . . 75.040000000000006 114.234 -173.474 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -83.84 18.58 1.95 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 122.431 1.11 . . . . 54.539999999999999 109.375 179.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . 0.474 ' H ' ' C ' ' A' ' 473' ' ' PRO . 15.5 m120 -111.88 -9.96 14.02 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.038 -1.437 . . . . 74.420000000000002 109.427 -179.427 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -119.75 -179.35 3.87 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-O 121.454 0.645 . . . . 75.409999999999997 112.564 -170.144 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.97 134.38 34.52 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.621 -1.251 . . . . 71.129999999999995 107.621 178.136 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 24.4 m -128.96 145.56 51.2 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.151 -0.685 . . . . 63.530000000000001 109.151 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -78.44 167.48 21.24 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 120.861 0.362 . . . . 73.140000000000001 111.862 -178.098 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 40.0 mm -71.43 -17.17 19.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.633 0.73 . . . . 75.010000000000005 110.272 -178.217 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 15.9 p -94.88 5.24 52.46 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.658 -0.651 . . . . 54.539999999999999 112.14 179.254 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -83.69 139.54 32.71 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.273 0.559 . . . . 75.409999999999997 112.194 -177.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 60.2 t -108.3 126.52 64.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 107.842 -1.17 . . . . 74.540000000000006 107.842 176.27 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 34.1 m -110.11 120.57 61.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-O 121.426 0.631 . . . . 74.0 111.158 178.823 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.75 129.1 44.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.219 -1.03 . . . . 74.129999999999995 108.219 174.187 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . 0.478 HG12 HG22 ' A' ' 470' ' ' THR . 18.4 mt -113.06 128.26 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 CA-C-N 115.117 -0.947 . . . . 73.200000000000003 110.366 -177.438 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 4.9 tt -104.48 126.6 59.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-N 115.566 -0.743 . . . . 71.129999999999995 109.695 -178.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 34.2 m -111.96 151.74 13.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 115.523 -0.762 . . . . 73.530000000000001 109.571 179.275 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -90.23 144.53 17.59 Favored Glycine 0 N--CA 1.424 -2.131 0 C-N-CA 121.167 -0.539 . . . . 72.140000000000001 112.959 -176.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 23.2 t . . . . . 0 N--CA 1.42 -1.957 0 N-CA-C 106.192 -1.781 . . . . 72.019999999999996 106.192 174.176 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo . . . . . 0 C--O 1.248 0.983 0 N-CA-C 110.476 -0.625 . . . . 72.109999999999999 110.476 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -88.57 72.41 8.77 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.749 0.785 . . . . 61.340000000000003 111.371 -177.098 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 22.1 p -126.0 146.46 49.87 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.361 -0.836 . . . . 73.439999999999998 110.823 -178.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -138.14 146.35 42.69 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.498 -0.927 . . . . 74.129999999999995 108.498 178.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 13.7 t70 -99.59 111.66 23.97 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.424 -0.954 . . . . 72.439999999999998 108.424 -178.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . 0.581 HD13 ' O ' ' A' ' 543' ' ' THR . 0.2 OUTLIER -75.79 127.1 86.27 Favored Pre-proline 0 C--O 1.236 0.357 0 N-CA-C 113.797 1.036 . . . . 71.230000000000004 113.797 -174.114 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -94.98 151.23 1.71 Allowed 'Trans proline' 0 CA--C 1.55 1.314 0 C-N-CA 123.111 2.54 . . . . 64.430000000000007 110.84 171.178 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -89.94 129.94 36.22 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.382 0.611 . . . . 74.129999999999995 110.323 -179.088 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.79 81.7 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-O 122.806 1.289 . . . . 75.329999999999998 109.533 177.268 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -97.44 145.78 25.85 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 113.814 -1.539 . . . . 64.129999999999995 108.885 -177.656 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 111.47 44.39 0.91 Allowed Glycine 0 CA--C 1.476 -2.378 0 N-CA-C 109.27 -1.532 . . . . 44.340000000000003 109.27 -177.082 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -141.22 167.05 23.11 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 108.826 -0.805 . . . . 65.329999999999998 108.826 -177.161 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 13.2 t -91.41 161.84 14.83 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 108.061 -1.088 . . . . 73.340000000000003 108.061 176.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 31.2 m -51.44 -42.07 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.668 0 C-N-CA 124.49 1.116 . . . . 72.239999999999995 113.396 -174.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -68.16 -41.8 81.02 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.253 0.549 . . . . 74.450000000000003 111.04 -177.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 51.7 t -72.66 -36.53 53.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.365 -0.834 . . . . 75.329999999999998 110.46 -176.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -62.51 -48.48 79.37 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.611 -0.268 . . . . 72.010000000000005 110.696 178.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -60.18 -41.77 93.61 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.298 0.571 . . . . 75.129999999999995 109.758 178.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.5 -43.19 99.3 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.546 -1.206 . . . . 71.239999999999995 110.173 -177.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -62.4 -42.91 99.79 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 116.438 -0.347 . . . . 74.099999999999994 111.281 179.416 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.31 -40.9 97.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.54 -0.3 . . . . 75.310000000000002 110.504 177.805 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -61.83 -43.02 99.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.965 0.412 . . . . 75.150000000000006 110.161 178.173 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 93.7 t -67.1 -26.34 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-N 115.656 -0.702 . . . . 74.329999999999998 111.583 178.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -76.17 -25.38 55.18 Favored 'General case' 0 CA--C 1.514 -0.416 0 O-C-N 121.666 -0.646 . . . . 72.030000000000001 109.908 177.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 111.87 36.35 1.7 Allowed Glycine 0 N--CA 1.436 -1.359 0 C-N-CA 120.822 -0.704 . . . . 73.25 111.944 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -120.34 122.82 41.66 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 107.484 -1.302 . . . . 75.5 107.484 178.441 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.6 m -101.81 -18.17 15.89 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 115.831 -0.622 . . . . 74.439999999999998 110.628 -175.629 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -113.61 113.22 24.75 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.82 0.819 . . . . 72.540000000000006 110.907 -179.394 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -132.28 155.94 47.43 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.379 -1.282 . . . . 74.030000000000001 110.155 -177.611 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 48.8 m -141.34 138.84 33.37 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 108.122 -1.066 . . . . 73.25 108.122 173.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.09 119.57 35.16 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.644 0.735 . . . . 73.140000000000001 112.15 179.733 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -107.15 118.86 37.83 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.258 -0.883 . . . . 73.510000000000005 109.726 -178.255 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 67.4 m -84.54 123.01 29.82 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.087 -0.709 . . . . 55.530000000000001 109.087 176.023 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 32.7 m -121.4 150.98 24.55 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 N-CA-C 107.554 -1.276 . . . . 72.099999999999994 107.554 -179.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.53 137.54 32.27 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.58 -1.248 . . . . 72.230000000000004 109.981 -177.374 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 69.0 m -155.96 -176.12 0.58 Allowed Pre-proline 0 C--N 1.304 -1.413 0 N-CA-C 107.445 -1.317 . . . . 75.299999999999997 107.445 -176.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -73.45 -28.21 12.39 Favored 'Trans proline' 0 C--N 1.36 1.148 0 CA-C-N 120.941 1.372 . . . . 74.120000000000005 111.739 173.396 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -64.84 137.14 97.05 Favored Pre-proline 0 N--CA 1.475 0.812 0 CA-C-N 116.405 -0.362 . . . . 64.109999999999999 111.813 -178.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.58 151.9 43.91 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 124.032 3.155 . . . . 74.129999999999995 114.965 -173.318 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -69.35 107.97 3.52 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 115.047 -0.978 . . . . 74.310000000000002 110.875 -178.496 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 128.69 -10.87 6.35 Favored Glycine 0 C--N 1.292 -1.899 0 N-CA-C 110.393 -1.083 . . . . 63.240000000000002 110.393 -178.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -82.52 125.02 30.65 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 109.238 -0.653 . . . . 75.319999999999993 109.238 176.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 62.0 t -87.8 107.53 17.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 106.788 -1.56 . . . . 73.219999999999999 106.788 175.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 6.1 t -83.87 -8.7 59.13 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.631 -0.713 . . . . 75.239999999999995 111.336 -172.056 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.16 -155.5 26.46 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 120.693 -0.765 . . . . 64.530000000000001 111.299 177.448 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 24.6 p -122.99 159.43 28.37 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 109.348 -0.612 . . . . 74.25 109.348 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -72.97 -53.05 5.33 Favored Pre-proline 0 C--N 1.306 -1.292 0 CA-C-O 118.876 -0.583 . . . . 64.540000000000006 110.578 174.062 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -61.57 128.09 23.68 Favored 'Trans proline' 0 C--N 1.378 2.084 0 N-CA-C 109.008 -1.189 . . . . 72.129999999999995 109.008 170.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -64.65 141.44 72.8 Favored 'Trans proline' 0 C--O 1.253 1.259 0 C-N-CA 122.177 1.918 . . . . 74.099999999999994 112.599 -177.656 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -67.65 139.74 56.82 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 108.13 -1.063 . . . . 73.299999999999997 108.13 175.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.82 -5.0 39.54 Favored Glycine 0 N--CA 1.416 -2.668 0 N-CA-C 110.313 -1.115 . . . . 71.319999999999993 110.313 -175.513 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 543' ' ' THR . . . . . 0.581 ' O ' HD13 ' A' ' 497' ' ' ILE . 27.2 m -88.85 136.61 32.92 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 120.49 -0.484 . . . . 74.120000000000005 109.767 177.275 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 28.9 m -89.82 122.84 33.26 Favored 'General case' 0 N--CA 1.416 -2.147 0 N-CA-C 107.148 -1.427 . . . . 71.319999999999993 107.148 172.276 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.4 m -127.01 154.54 76.5 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 110.222 -0.288 . . . . 75.109999999999999 110.222 -177.453 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -68.84 151.88 73.98 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.305 2.003 . . . . 64.120000000000005 110.113 173.136 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 26.3 m -67.32 -20.28 26.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.724 0.773 . . . . 73.200000000000003 110.063 177.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -77.56 -11.4 59.85 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 114.94 -1.027 . . . . 72.219999999999999 112.258 -179.454 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 49.0 m -78.72 154.65 29.89 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 121.863 -0.523 . . . . 72.319999999999993 111.021 178.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 41.7 t -97.72 116.04 39.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 108.679 -0.859 . . . . 74.239999999999995 108.679 179.434 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.42 126.61 40.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.171 -0.677 . . . . 74.409999999999997 109.171 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -102.43 115.78 31.27 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-O 121.775 0.798 . . . . 74.230000000000004 109.636 -178.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 67.3 mt -87.65 134.25 33.68 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 113.856 -1.52 . . . . 75.510000000000005 107.551 178.096 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -112.32 115.36 28.63 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 122.257 1.027 . . . . 73.040000000000006 110.137 178.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 41.7 t -101.15 139.45 22.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 CA-C-N 114.441 -1.254 . . . . 75.019999999999996 108.446 -176.16 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.589 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 50.6 m -92.46 147.29 23.02 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-O 121.413 0.625 . . . . 54.109999999999999 112.093 179.786 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 0.2 OUTLIER -118.58 132.49 56.2 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 105.247 -2.131 . . . . 75.0 105.247 170.772 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -82.47 -24.1 54.78 Favored Glycine 0 CA--C 1.492 -1.371 0 N-CA-C 114.638 0.615 . . . . 72.120000000000005 114.638 -169.017 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 68.13 31.81 5.19 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 107.548 -1.278 . . . . 64.420000000000002 107.548 -174.362 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 -135.11 141.72 46.08 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 106.281 -1.748 . . . . 74.329999999999998 106.281 -175.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -143.09 147.66 35.38 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 109.731 -0.47 . . . . 72.409999999999997 109.731 176.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 612' ' ' THR . 63.1 t -67.99 118.37 11.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-O 121.149 0.5 . . . . 75.150000000000006 110.303 -179.34 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 53.7 ttp -83.15 132.96 48.85 Favored Pre-proline 0 C--N 1.306 -1.293 0 CA-C-N 115.759 -0.655 . . . . 74.420000000000002 111.251 -177.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.29 170.14 20.87 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.048 2.498 . . . . 73.120000000000005 110.597 172.69 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -67.17 142.44 57.02 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.913 0.387 . . . . 74.430000000000007 110.905 179.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 94.0 mt -121.56 17.56 11.25 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.745 -0.661 . . . . 74.310000000000002 109.593 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 11.3 m -63.04 130.5 44.98 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.314 -0.857 . . . . 74.409999999999997 109.851 -179.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 88.43 46.2 4.72 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 119.916 -1.135 . . . . 54.039999999999999 112.197 177.427 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 26.8 ptm -118.71 157.72 26.92 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.162 -1.051 . . . . 74.109999999999999 108.162 176.401 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . 0.448 ' HB3' ' OD1' ' A' ' 601' ' ' ASN . 91.9 m-85 -130.81 163.68 26.82 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.608 -1.256 . . . . 73.25 107.608 -176.502 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 35.8 t90 -65.44 -36.54 84.22 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.41 0.624 . . . . 74.510000000000005 109.612 176.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.7 m -75.58 -8.88 12.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.363 -0.835 . . . . 74.0 110.433 -178.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' A' ' 577' ' ' ARG . 13.7 t70 -101.21 -37.32 8.59 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.97 -1.013 . . . . 75.420000000000002 109.287 178.217 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -61.47 -34.71 75.92 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 124.314 1.046 . . . . 72.420000000000002 111.892 -179.404 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.403 ' HB2' ' HD3' ' A' ' 576' ' ' PRO . 9.3 mm-40 -60.1 -58.83 16.53 Favored Pre-proline 0 CA--C 1.559 1.291 0 N-CA-C 112.672 0.619 . . . . 34.340000000000003 112.672 177.241 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 51.0 Cg_exo -61.59 -35.1 83.04 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 121.57 1.513 . . . . 71.25 111.782 171.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 573' ' ' ASP . 0.4 OUTLIER -59.54 -40.59 87.72 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.039 0.535 . . . . 73.420000000000002 110.394 -178.106 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 7.1 tt -57.63 -47.37 82.41 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.702 0.801 . . . . 75.519999999999996 109.237 179.666 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -66.63 -46.93 74.23 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.563 -0.744 . . . . 74.25 110.248 -178.65 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -62.79 -39.03 92.97 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.749 0.82 . . . . 75.010000000000005 112.803 -177.517 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 96.4 mt -89.45 -8.57 52.69 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 120.719 -0.392 . . . . 73.209999999999994 111.457 -179.029 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 63.52 43.38 98.19 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 109.679 -1.369 . . . . 63.450000000000003 109.679 -175.503 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 22.1 t90 -73.75 126.63 30.79 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 114.845 -0.677 . . . . 75.340000000000003 111.14 -172.389 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 24.0 m -99.86 -8.07 24.54 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.575 0.702 . . . . 73.439999999999998 109.749 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . 0.416 ' HA2' ' OD1' ' A' ' 617' ' ' ASP . . . -69.14 170.35 41.52 Favored Glycine 0 N--CA 1.428 -1.874 0 CA-C-N 115.127 -0.942 . . . . 74.450000000000003 113.804 -177.129 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 36.1 ttm -105.48 135.14 47.42 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.101 -1.05 . . . . 73.340000000000003 109.997 -177.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 56.7 tp -88.59 131.13 35.09 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.51 -0.922 . . . . 74.230000000000004 108.51 175.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -94.37 104.78 16.76 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.002 0.429 . . . . 72.299999999999997 110.797 -176.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . 0.432 ' HZ3' ' CG ' ' A' ' 592' ' ' ASP . 27.4 tptp -114.24 112.41 23.09 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 109.415 -0.587 . . . . 75.319999999999993 109.415 174.182 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -127.48 -40.76 0.31 Allowed Glycine 0 C--N 1.309 -0.97 0 C-N-CA 119.435 -1.364 . . . . 63.299999999999997 112.943 177.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . 0.467 ' HB2' ' NH2' ' A' ' 623' ' ' ARG . . . -139.58 157.5 45.7 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 122.577 0.351 . . . . 53.210000000000001 110.643 -177.788 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . 0.432 ' CG ' ' HZ3' ' A' ' 589' ' ' LYS . 11.5 m-20 -110.39 124.26 51.39 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.457 -1.312 . . . . 74.209999999999994 107.457 176.422 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 35.9 t -109.02 115.89 50.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 C-N-CA 120.063 -0.655 . . . . 74.549999999999997 110.365 -176.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -100.03 116.78 32.86 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.995 -0.682 . . . . 64.030000000000001 110.425 179.658 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -132.69 -27.94 1.66 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 116.092 -0.504 . . . . 75.310000000000002 110.898 179.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 141.24 -169.41 25.05 Favored Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 110.494 -1.042 . . . . 54.240000000000002 110.494 -177.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.53 -35.18 65.58 Favored Glycine 0 CA--C 1.509 -0.307 0 O-C-N 123.877 0.398 . . . . 61.340000000000003 113.851 -175.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 42.6 m -58.68 -32.3 68.99 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.102 0.408 . . . . 65.329999999999998 112.102 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -108.61 -1.59 19.46 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.071 0.462 . . . . 75.439999999999998 110.651 -178.095 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -67.1 99.72 0.7 Allowed 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.211 -0.45 . . . . 75.439999999999998 112.051 -175.611 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . 0.448 ' OD1' ' HB3' ' A' ' 570' ' ' PHE . 11.7 t-20 67.15 -3.25 1.02 Allowed 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 125.251 1.42 . . . . 75.439999999999998 112.367 174.384 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -93.18 152.93 18.93 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 123.963 0.905 . . . . 75.150000000000006 111.326 -175.186 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . 0.431 HG22 ' HB2' ' A' ' 622' ' ' LEU . 12.9 p -57.06 138.76 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 124.554 1.142 . . . . 70.299999999999997 110.697 178.631 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 61.0 t -93.97 -56.12 5.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 108.118 -1.068 . . . . 74.430000000000007 108.118 179.119 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -151.42 154.62 36.98 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 107.78 -1.193 . . . . 74.230000000000004 107.78 -179.59 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -109.06 122.1 46.55 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.038 -1.467 . . . . 73.439999999999998 107.038 172.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.491 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 42.7 t-20 -53.21 -57.95 14.52 Favored Pre-proline 0 N--CA 1.483 1.189 0 CA-C-O 119.31 -0.376 . . . . 71.430000000000007 111.926 -178.659 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 1.2 Cg_endo -85.7 131.33 3.9 Favored 'Trans proline' 0 N--CA 1.44 -1.635 0 C-N-CA 121.262 1.308 . . . . 71.099999999999994 109.947 174.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . 0.49 ' O ' HG23 ' A' ' 612' ' ' THR . 53.2 Cg_endo -70.38 156.22 62.2 Favored 'Trans proline' 0 C--O 1.243 0.739 0 C-N-CA 122.069 1.846 . . . . 72.409999999999997 111.541 178.625 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -64.41 128.33 35.33 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.371 -0.603 . . . . 74.109999999999999 109.371 178.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 106.02 -3.57 38.38 Favored Glycine 0 C--N 1.3 -1.432 0 C-N-CA 120.394 -0.908 . . . . 52.409999999999997 112.92 -177.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 612' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 609' ' ' PRO . 9.1 t -96.17 176.88 5.91 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-N 117.858 0.829 . . . . 74.109999999999999 109.111 175.504 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -97.87 119.47 6.44 Favored Glycine 0 N--CA 1.425 -2.082 0 CA-C-N 116.194 -0.457 . . . . 62.140000000000001 112.041 -177.075 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 26.8 m -104.95 144.3 14.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 C-N-CA 123.479 0.712 . . . . 73.549999999999997 109.523 177.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . 0.54 ' ND2' ' HB3' ' A' ' 617' ' ' ASP . 36.6 p-10 -57.8 161.13 4.0 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 123.684 0.794 . . . . 75.519999999999996 111.968 -178.074 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -63.21 -25.9 68.55 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 120.82 0.343 . . . . 72.549999999999997 111.218 -178.015 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . 0.54 ' HB3' ' ND2' ' A' ' 615' ' ' ASN . 13.9 t70 -60.08 -40.05 88.21 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.667 -0.864 . . . . 74.439999999999998 108.667 174.308 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 87.96 20.98 48.14 Favored Glycine 0 N--CA 1.428 -1.885 0 CA-C-N 115.408 -0.814 . . . . 73.25 112.115 176.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . 0.412 ' HB ' ' OD1' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -69.24 119.28 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-O 122.762 1.268 . . . . 72.030000000000001 109.883 -173.523 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 3.2 tp -117.55 125.69 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.939 0 CA-C-N 113.422 -1.717 . . . . 74.219999999999999 107.714 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 17.5 m -98.26 116.39 30.39 Favored 'General case' 0 N--CA 1.412 -2.367 0 C-N-CA 118.877 -1.129 . . . . 74.510000000000005 108.097 178.436 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . 0.431 ' HB2' HG22 ' A' ' 603' ' ' VAL . 0.0 OUTLIER -139.64 155.4 47.43 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 106.961 -1.496 . . . . 73.510000000000005 106.961 179.653 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . 0.467 ' NH2' ' HB2' ' A' ' 591' ' ' ALA . 57.2 mtp180 -128.74 156.63 43.21 Favored 'General case' 0 C--N 1.272 -2.782 0 N-CA-C 105.271 -2.122 . . . . 71.329999999999998 105.271 175.186 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -131.14 158.05 41.5 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 106.637 -1.616 . . . . 73.329999999999998 106.637 175.184 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -81.88 -117.32 0.47 Allowed Glycine 0 N--CA 1.423 -2.181 0 C-N-CA 120.073 -1.06 . . . . 74.530000000000001 113.414 -177.252 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 . . . . . 0 C--N 1.297 -1.709 0 N-CA-C 108.886 -0.783 . . . . 74.430000000000007 108.886 -174.134 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 . . . . . 0 CA--C 1.502 -0.886 0 N-CA-C 109.412 -0.588 . . . . 71.120000000000005 109.412 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 34.6 m -121.22 153.93 24.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 N-CA-C 107.019 -1.474 . . . . 72.430000000000007 107.019 177.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -94.56 136.2 35.13 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 117.578 -1.649 . . . . 74.230000000000004 107.284 179.274 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 98.1 t -96.8 124.24 50.91 Favored Pre-proline 0 C--N 1.274 -2.704 0 N-CA-C 109.666 -0.494 . . . . 73.420000000000002 109.666 -172.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -64.12 125.87 16.06 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.935 1.757 . . . . 74.209999999999994 110.058 178.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . 0.576 ' OD1' ' HG2' ' A' ' 366' ' ' ARG . 16.5 t70 -85.69 138.36 32.18 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-O 121.726 0.774 . . . . 73.340000000000003 112.044 -176.608 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 18.5 m -108.22 4.93 9.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 113.981 -1.463 . . . . 61.530000000000001 111.777 -175.421 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.576 ' HG2' ' OD1' ' A' ' 364' ' ' ASP . 25.7 mmt-85 -62.54 147.48 48.87 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 112.624 0.602 . . . . 74.519999999999996 112.624 178.568 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.64 -9.59 44.7 Favored Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 110.709 -0.957 . . . . 74.340000000000003 110.709 -174.624 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -103.75 -150.68 0.42 Allowed 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.481 -0.933 . . . . 71.019999999999996 108.481 178.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 60.3 p -98.05 155.04 17.31 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.464 -0.939 . . . . 73.209999999999994 108.464 -178.162 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 23.0 t -61.42 -33.79 74.3 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.587 -0.523 . . . . 70.239999999999995 109.587 179.104 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -65.59 -46.46 79.3 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 116.24 -0.436 . . . . 73.349999999999994 111.138 178.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.54 -44.87 73.6 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-O 121.426 0.632 . . . . 64.219999999999999 110.376 -179.505 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -60.21 -48.11 83.13 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.582 -1.19 . . . . 54.420000000000002 111.567 -178.23 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.53 -39.31 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 116.644 -0.253 . . . . 74.340000000000003 111.27 177.721 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.9 -44.48 91.24 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-O 121.302 0.572 . . . . 74.299999999999997 111.112 -178.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 376' ' ' THR . . . . . 0.437 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 70.9 m -64.18 -47.34 80.19 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.438 -0.801 . . . . 71.540000000000006 110.648 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 95.5 mt -64.16 -38.79 92.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.474 -0.33 . . . . 74.230000000000004 111.169 -179.265 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -62.29 -43.02 99.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.981 -0.554 . . . . 73.540000000000006 110.787 179.053 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -64.19 -31.86 73.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.274 0.559 . . . . 74.25 111.279 176.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 376' ' ' THR . 29.8 mmm180 -80.11 -13.55 59.19 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.989 -0.55 . . . . 74.450000000000003 111.388 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 94.06 15.65 47.55 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.65 -0.786 . . . . 52.119999999999997 112.578 177.335 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -80.39 156.54 26.62 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 122.451 -0.441 . . . . 74.209999999999994 111.266 177.248 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -99.76 133.81 43.57 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 107.129 -1.434 . . . . 73.219999999999999 107.129 177.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.33 155.1 38.32 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 C-N-CA 120.1 -0.64 . . . . 72.109999999999999 111.124 -175.404 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -136.08 141.28 44.22 Favored 'General case' 0 N--CA 1.403 -2.817 0 CA-C-N 114.571 -1.195 . . . . 74.310000000000002 108.011 169.763 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.2 m -127.22 134.9 50.04 Favored 'General case' 0 C--N 1.271 -2.846 0 N-CA-C 104.55 -2.389 . . . . 65.319999999999993 104.55 179.634 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.57 124.34 45.09 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 119.317 -0.953 . . . . 72.140000000000001 109.201 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -91.34 121.79 33.39 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.086 -0.709 . . . . 74.099999999999994 109.086 -177.306 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 421' ' ' SER . 55.0 mtpt -136.79 130.32 17.68 Favored Pre-proline 0 C--N 1.308 -1.22 0 N-CA-C 110.215 -0.291 . . . . 73.409999999999997 110.215 176.352 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . 0.511 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 54.0 Cg_endo -79.4 127.95 7.69 Favored 'Trans proline' 0 C--O 1.254 1.324 0 C-N-CA 120.956 1.104 . . . . 63.229999999999997 109.836 173.823 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.511 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 8.6 t70 154.33 -164.92 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 103.802 -2.666 . . . . 71.329999999999998 103.802 -177.649 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 26.7 t -142.7 4.7 1.53 Allowed 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 118.098 0.408 . . . . 60.210000000000001 110.187 176.512 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 15.3 t -79.62 -18.13 52.24 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-O 121.338 0.589 . . . . 73.310000000000002 109.781 179.661 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -99.58 150.43 36.78 Favored Pre-proline 0 N--CA 1.424 -1.743 0 N-CA-C 107.012 -1.477 . . . . 74.319999999999993 107.012 176.704 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -49.72 132.89 32.08 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.139 2.559 . . . . 70.430000000000007 114.228 -177.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . 0.573 ' HA ' ' OG ' ' A' ' 421' ' ' SER . 17.5 Cg_endo -60.75 164.03 14.58 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.595 2.863 . . . . 72.450000000000003 110.832 174.302 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.51 -8.91 0.93 Allowed 'General case' 0 N--CA 1.511 2.583 0 CA-C-O 121.915 0.864 . . . . 74.099999999999994 111.012 179.023 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.459 ' H ' ' C ' ' A' ' 396' ' ' PRO . 33.7 m170 -93.57 101.23 13.4 Favored 'General case' 0 CA--C 1.477 -1.841 0 N-CA-C 102.398 -3.186 . . . . 74.420000000000002 102.398 170.205 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 16.5 m -63.32 118.19 5.15 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.488 0 O-C-N 124.197 0.936 . . . . 70.430000000000007 112.491 -166.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 49.3 mm -103.61 -39.3 5.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 115.259 -0.882 . . . . 73.420000000000002 111.08 -177.34 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.41 157.32 27.35 Favored Glycine 0 N--CA 1.433 -1.54 0 C-N-CA 119.739 -1.219 . . . . 71.530000000000001 112.627 -175.51 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -156.31 -174.98 5.19 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 126.062 1.745 . . . . 74.409999999999997 109.797 -176.261 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' A' ' 405' ' ' ALA . 10.7 t70 -96.96 136.15 21.7 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 105.942 -1.873 . . . . 74.420000000000002 105.942 176.252 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . 0.498 ' HA ' ' OD1' ' A' ' 407' ' ' ASN . 38.0 Cg_endo -63.01 23.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 124.823 3.682 . . . . 74.120000000000005 115.622 -173.092 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.468 ' H ' ' C ' ' A' ' 403' ' ' ASP . . . -54.01 -42.16 68.79 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 124.075 0.95 . . . . 72.219999999999999 110.92 177.569 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -79.24 -31.1 43.46 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.593 0.711 . . . . 73.5 110.516 -179.666 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . 0.498 ' OD1' ' HA ' ' A' ' 404' ' ' PRO . 8.9 m120 -79.68 -7.75 58.78 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.354 -0.839 . . . . 74.450000000000003 110.194 -175.782 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 89.9 m -99.42 148.71 23.93 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.564 -1.643 . . . . 74.25 106.564 176.623 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 17.3 m -74.45 111.89 10.09 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 107.814 -1.18 . . . . 75.340000000000003 107.814 177.445 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.36 169.86 20.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 C-N-CA 123.089 0.556 . . . . 74.120000000000005 110.262 -177.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 49.7 m -68.49 131.9 46.07 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.447 -0.946 . . . . 75.319999999999993 108.447 174.303 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -58.51 111.07 1.11 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.334 0.588 . . . . 64.019999999999996 110.683 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 111.1 73.81 0.72 Allowed Glycine 0 N--CA 1.432 -1.577 0 N-CA-C 110.58 -1.008 . . . . 65.209999999999994 110.58 -179.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -129.44 -175.0 3.44 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 105.853 -1.906 . . . . 54.240000000000002 105.853 179.935 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -102.76 123.45 46.45 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 118.401 0.546 . . . . 73.510000000000005 110.545 -177.02 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 27.1 mm -113.12 120.69 63.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 109.043 -0.725 . . . . 73.329999999999998 109.043 -179.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 17.1 p -100.62 131.44 46.53 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 112.006 0.373 . . . . 72.310000000000002 112.006 -178.488 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 7.7 p -126.81 134.91 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-O 120.892 0.377 . . . . 65.430000000000007 110.846 176.279 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -101.6 128.46 47.87 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.816 -1.179 . . . . 75.450000000000003 107.816 175.201 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 54.0 t -124.55 135.92 62.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 C-N-CA 122.999 0.52 . . . . 73.040000000000006 110.352 -175.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 421' ' ' SER . . . . . 0.573 ' OG ' ' HA ' ' A' ' 396' ' ' PRO . 77.7 p -84.9 121.12 27.29 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 109.086 -0.709 . . . . 71.540000000000006 109.086 177.897 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 33.8 m -118.69 106.2 12.35 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 109.07 -0.715 . . . . 75.310000000000002 109.07 177.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.045 0 C-N-CA 120.6 -0.81 . . . . 72.150000000000006 111.687 -178.514 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 . . . . . 0 N--CA 1.431 -1.386 0 N-CA-C 108.036 -1.098 . . . . 72.219999999999999 108.036 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -121.08 143.03 49.29 Favored 'General case' 0 CA--C 1.479 -1.779 0 CA-C-O 121.367 0.603 . . . . 72.150000000000006 112.145 -173.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -82.96 134.71 35.05 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.271 -1.331 . . . . 75.450000000000003 108.755 178.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 474' ' ' ALA . 50.2 mt -83.02 125.96 73.67 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 109.144 -0.688 . . . . 73.0 109.144 -179.45 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -71.03 154.68 62.57 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.426 2.084 . . . . 74.239999999999995 110.905 173.077 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -74.07 158.86 33.51 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 108.986 -0.746 . . . . 74.420000000000002 108.986 178.068 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 12.2 p -142.4 147.05 21.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 109.949 -0.389 . . . . 64.030000000000001 109.949 -178.447 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 19.5 m -72.84 137.01 45.45 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 108.65 -0.87 . . . . 74.329999999999998 108.65 175.806 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 54.4 p -62.44 -31.19 71.86 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 113.822 1.045 . . . . 72.409999999999997 113.822 -171.349 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.4 pp -81.67 -11.5 59.05 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.224 -0.99 . . . . 72.140000000000001 111.382 179.11 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 5.5 m -105.41 62.68 0.68 Allowed 'General case' 0 N--CA 1.432 -1.341 0 CA-C-O 122.191 0.996 . . . . 73.430000000000007 112.0 -176.21 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -56.12 -37.1 68.99 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.593 1.157 . . . . 73.540000000000006 111.397 176.25 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.33 -40.61 78.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.124 0.488 . . . . 64.319999999999993 111.016 178.077 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -70.28 -34.97 73.4 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.308 -0.627 . . . . 73.439999999999998 109.308 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.55 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -60.8 -51.39 69.52 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.74 -0.664 . . . . 63.109999999999999 111.345 179.15 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 35.4 m -65.47 -39.11 84.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 112.31 0.485 . . . . 74.0 112.31 -177.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -34.76 77.41 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 120.607 -0.437 . . . . 73.230000000000004 111.572 178.111 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 27.3 mmtm -61.76 -39.81 92.95 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-N 116.4 -0.363 . . . . 75.420000000000002 110.452 177.427 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 75.5 mt -63.88 -43.25 96.6 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.369 -0.832 . . . . 61.299999999999997 110.073 179.252 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 61.1 m -65.35 -42.68 92.57 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.362 -0.381 . . . . 74.219999999999999 111.646 177.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -63.35 -29.25 70.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.708 0.766 . . . . 73.319999999999993 110.611 178.455 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -85.02 5.22 30.28 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.454 -0.794 . . . . 42.020000000000003 111.889 179.194 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 105.48 -66.5 0.27 Allowed Glycine 0 CA--C 1.496 -1.142 0 C-N-CA 120.374 -0.917 . . . . 71.120000000000005 112.96 172.749 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -46.65 -65.88 0.49 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 114.353 1.242 . . . . 74.129999999999995 114.353 177.767 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 59.09 26.22 60.83 Favored Glycine 0 N--CA 1.469 0.887 0 C-N-CA 120.948 -0.644 . . . . 73.319999999999993 112.65 -176.005 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.46 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 16.3 mmt85 -100.73 111.37 23.59 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 107.148 -1.427 . . . . 75.409999999999997 107.148 -177.221 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -140.2 153.44 46.59 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 112.487 0.551 . . . . 72.219999999999999 112.487 -174.247 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -138.81 148.53 43.9 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 124.77 1.228 . . . . 71.549999999999997 108.996 176.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -121.1 124.94 45.99 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 122.967 0.507 . . . . 74.219999999999999 110.609 -176.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -128.19 162.79 26.13 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.016 -0.735 . . . . 72.230000000000004 109.016 178.05 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -129.11 146.76 50.98 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 120.969 0.414 . . . . 73.209999999999994 110.072 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 36.8 t -143.47 149.14 46.52 Favored Pre-proline 0 C--N 1.29 -1.985 0 N-CA-C 107.453 -1.314 . . . . 61.549999999999997 107.453 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.688 ' HA ' ' O ' ' A' ' 490' ' ' SER . 24.3 Cg_exo -64.83 134.77 41.74 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.874 1.716 . . . . 73.010000000000005 109.722 176.545 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 62.6 m -152.07 172.17 16.73 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 116.181 -0.463 . . . . 75.010000000000005 109.855 -178.191 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 7.0 t -53.78 141.46 46.79 Favored Pre-proline 0 N--CA 1.438 -1.043 0 C-N-CA 124.487 1.115 . . . . 71.049999999999997 111.072 177.22 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -52.72 -30.67 47.34 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 124.698 3.598 . . . . 74.5 113.342 -176.302 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -72.97 -28.63 62.51 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.958 -0.565 . . . . 60.539999999999999 111.791 -178.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 11.2 mp -98.57 -0.61 42.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.592 0.234 . . . . 73.209999999999994 111.555 178.736 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 53.3 t -61.69 126.65 20.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-O 121.035 0.445 . . . . 75.030000000000001 109.92 175.229 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 87.58 0.21 84.44 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.711 -0.677 . . . . 70.340000000000003 111.75 -178.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.32 158.95 17.87 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.861 -0.792 . . . . 72.230000000000004 108.861 179.363 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 70.2 t -75.19 138.78 20.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 N-CA-C 108.728 -0.842 . . . . 63.25 108.728 176.382 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 48.9 mm -97.26 -27.86 3.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.395 -1.335 . . . . 73.540000000000006 107.395 179.062 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 156.57 -168.79 33.82 Favored Glycine 0 N--CA 1.422 -2.272 0 CA-C-N 115.209 -0.905 . . . . 70.25 112.052 175.472 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 470' ' ' THR . . . . . 0.512 HG22 HG12 ' A' ' 486' ' ' ILE . 39.7 p -115.64 147.2 41.08 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 104.905 -2.258 . . . . 73.209999999999994 104.905 177.375 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.402 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 9.8 t30 -68.38 -55.13 12.84 Favored Pre-proline 0 C--N 1.31 -1.12 0 C-N-CA 118.542 -1.263 . . . . 74.099999999999994 111.815 176.394 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.402 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 23.9 Cg_exo -70.01 155.42 65.16 Favored 'Trans proline' 0 C--N 1.371 1.725 0 N-CA-C 108.769 -1.281 . . . . 73.230000000000004 108.769 172.428 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -62.27 126.66 19.07 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 121.82 1.68 . . . . 73.109999999999999 112.123 -176.687 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.421 ' O ' ' HB ' ' A' ' 429' ' ' ILE . . . -84.7 -2.08 57.06 Favored 'General case' 0 C--O 1.204 -1.322 0 CA-C-N 115.437 -0.801 . . . . 73.219999999999999 112.068 -174.491 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -110.71 6.37 21.55 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 120.108 -0.637 . . . . 71.150000000000006 111.874 175.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -110.23 173.75 6.18 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.517 0.932 . . . . 72.299999999999997 113.517 -174.014 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.11 117.11 21.4 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.803 -1.09 . . . . 71.120000000000005 110.969 -177.368 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 49.0 m -117.12 148.26 41.71 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.709 -0.849 . . . . 73.340000000000003 108.709 177.449 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -81.32 161.11 23.98 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.601 -0.518 . . . . 65.150000000000006 109.601 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.01 -17.82 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 CA-C-O 121.732 0.777 . . . . 72.450000000000003 112.353 -178.179 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.1 t -95.96 4.79 52.41 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.583 -0.698 . . . . 63.119999999999997 111.772 179.093 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -86.92 129.49 34.86 Favored 'General case' 0 CA--C 1.508 -0.638 0 O-C-N 121.961 -0.462 . . . . 75.120000000000005 111.091 -177.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . 0.46 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.1 p -104.79 123.51 58.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.459 0.647 . . . . 70.340000000000003 110.509 178.687 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 34.7 m -101.28 126.91 55.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 121.787 0.803 . . . . 72.099999999999994 111.122 -179.1 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.71 125.22 45.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 108.213 -1.032 . . . . 74.430000000000007 108.213 176.36 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . 0.512 HG12 HG22 ' A' ' 470' ' ' THR . 37.1 mt -109.53 126.3 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 CA-C-N 115.076 -0.965 . . . . 70.010000000000005 110.809 -178.003 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 4.4 tt -104.64 127.0 59.41 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 CA-C-N 114.887 -1.051 . . . . 72.219999999999999 110.011 -177.213 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 33.1 m -110.18 151.57 12.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 C-N-CA 122.786 0.434 . . . . 72.519999999999996 110.012 177.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -84.62 135.48 13.64 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.674 -0.57 . . . . 71.120000000000005 111.674 -179.226 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.688 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 46.4 m . . . . . 0 C--N 1.306 -1.285 0 CA-C-N 117.155 0.477 . . . . 73.540000000000006 110.176 178.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo . . . . . 0 N--CA 1.445 -1.367 0 N-CA-C 111.122 -0.376 . . . . 74.030000000000001 111.122 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -85.02 45.87 1.22 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.682 0.754 . . . . 62.530000000000001 110.151 178.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 10.8 p -122.58 145.95 47.87 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.511 -0.768 . . . . 75.510000000000005 110.485 -178.29 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -143.39 150.04 38.53 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 123.104 0.561 . . . . 74.049999999999997 111.32 178.464 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 11.1 p-10 -86.85 127.83 35.03 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.164 -0.926 . . . . 65.400000000000006 110.319 178.911 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 31.1 pt -81.17 134.1 52.89 Favored Pre-proline 0 C--N 1.304 -1.396 0 CA-C-N 115.658 -0.701 . . . . 74.319999999999993 110.426 179.029 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -82.43 175.99 8.39 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.658 2.239 . . . . 75.230000000000004 112.978 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -83.08 142.13 31.51 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.365 -0.834 . . . . 71.120000000000005 108.765 177.048 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 51.3 t -138.57 91.11 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 N-CA-C 107.74 -1.207 . . . . 74.409999999999997 107.74 -179.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -151.1 121.08 7.13 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.775 -0.454 . . . . 70.549999999999997 109.775 178.455 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 102.69 25.63 7.56 Favored Glycine 0 CA--C 1.489 -1.557 0 C-N-CA 120.164 -1.017 . . . . 51.420000000000002 111.243 176.447 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -131.95 170.3 15.1 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 109.118 -0.697 . . . . 73.439999999999998 109.118 178.829 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 15.1 t -91.57 160.63 15.31 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.284 -1.006 . . . . 71.030000000000001 108.284 178.359 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 47.5 t -51.88 -42.5 33.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 C-N-CA 123.709 0.803 . . . . 73.030000000000001 111.788 -175.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -67.86 -42.34 81.46 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.25 0.463 . . . . 74.109999999999999 112.25 -177.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 66.3 t -75.2 -34.68 31.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-O 121.281 0.562 . . . . 64.230000000000004 110.172 -177.769 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -61.95 -50.0 73.89 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.911 -0.586 . . . . 63.149999999999999 110.661 178.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -65.89 -34.91 79.22 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 120.819 -0.352 . . . . 75.310000000000002 110.95 178.498 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -55.84 -48.25 75.81 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.5 0.72 . . . . 72.209999999999994 110.166 178.437 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -62.31 -45.93 91.02 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-N 116.091 -0.504 . . . . 75.230000000000004 110.436 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 90.1 mt -61.76 -38.25 87.29 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.823 -0.626 . . . . 73.510000000000005 111.335 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -61.42 -42.48 98.8 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.954 0.407 . . . . 73.109999999999999 110.124 177.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 85.8 t -66.61 -29.55 46.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-N 115.601 -0.727 . . . . 72.420000000000002 110.666 178.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -84.23 3.02 37.2 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 121.872 -0.518 . . . . 73.329999999999998 112.066 179.402 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 82.54 39.41 10.85 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 121.006 -0.616 . . . . 70.120000000000005 112.791 177.251 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -124.77 138.59 54.27 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.994 -1.113 . . . . 74.420000000000002 107.994 176.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 3.6 m -131.84 -11.58 3.4 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.708 -0.797 . . . . 72.409999999999997 111.677 -176.212 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -107.64 115.01 29.39 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.25 -0.648 . . . . 73.25 109.25 -174.394 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -130.01 155.94 45.29 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.565 -0.743 . . . . 73.230000000000004 110.005 -175.069 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 521' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 66.9 m -141.83 127.85 19.56 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 106.999 -1.482 . . . . 75.049999999999997 106.999 170.625 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . 0.471 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 0.0 OUTLIER -117.3 133.35 56.08 Favored 'General case' 0 N--CA 1.418 -2.053 0 CA-C-O 121.23 0.538 . . . . 55.109999999999999 111.129 -179.3 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -113.87 143.13 45.19 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.442 -0.948 . . . . 73.439999999999998 108.442 178.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 61.0 m -102.71 126.98 50.02 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.0 0.428 . . . . 73.120000000000005 110.833 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 26.7 m -121.3 168.3 13.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.68 -1.23 . . . . 64.200000000000003 107.68 177.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . 0.53 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 5.4 p-10 -102.65 136.42 42.52 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.31 -0.956 . . . . 61.219999999999999 111.178 -179.476 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 18.7 m -152.85 178.15 1.68 Allowed Pre-proline 0 C--N 1.308 -1.219 0 N-CA-C 108.343 -0.984 . . . . 74.299999999999997 108.343 178.368 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -83.8 -0.37 9.65 Favored 'Trans proline' 0 C--N 1.361 1.216 0 C-N-CA 121.848 1.699 . . . . 62.109999999999999 111.135 173.435 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . 0.506 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 8.1 mmm180 -76.73 138.84 66.28 Favored Pre-proline 0 C--O 1.211 -0.943 0 N-CA-C 106.826 -1.546 . . . . 74.409999999999997 106.826 178.532 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.08 150.41 86.66 Favored 'Trans proline' 0 C--O 1.246 0.879 0 C-N-CA 122.387 2.058 . . . . 75.120000000000005 112.074 -177.651 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.67 107.9 0.76 Allowed 'General case' 0 C--O 1.239 0.534 0 CA-C-N 116.21 -0.45 . . . . 71.510000000000005 110.439 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 133.51 -17.77 4.44 Favored Glycine 0 C--N 1.298 -1.562 0 N-CA-C 110.602 -0.999 . . . . 73.319999999999993 110.602 -177.612 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -75.58 124.73 27.7 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.272 -1.011 . . . . 73.25 108.272 177.292 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 47.1 t -82.92 115.61 25.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 106.711 -1.588 . . . . 64.450000000000003 106.711 175.172 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 535' ' ' THR . . . . . 0.428 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 10.6 t -83.48 -20.44 33.99 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.055 0.455 . . . . 71.109999999999999 110.5 -175.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 166.12 -159.37 32.62 Favored Glycine 0 N--CA 1.428 -1.849 0 C-N-CA 120.638 -0.791 . . . . 73.239999999999995 111.169 178.573 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 21.7 p -132.77 158.74 41.66 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.668 -0.864 . . . . 74.430000000000007 108.668 178.653 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -74.84 -53.35 3.11 Favored Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 109.886 -0.412 . . . . 70.129999999999995 109.886 176.34 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -70.42 140.22 39.72 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 120.906 1.071 . . . . 65.209999999999994 110.176 173.476 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.23 142.01 53.97 Favored 'Trans proline' 0 C--O 1.247 0.938 0 C-N-CA 122.592 2.195 . . . . 74.340000000000003 112.731 -179.123 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -65.76 135.58 55.09 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.746 -0.661 . . . . 72.319999999999993 109.683 178.605 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 103.67 -14.34 53.52 Favored Glycine 0 C--N 1.304 -1.199 0 C-N-CA 120.78 -0.724 . . . . 64.310000000000002 112.31 -179.853 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 27.6 m -67.2 129.77 40.98 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 110.349 -0.241 . . . . 73.510000000000005 110.349 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 56.7 m -92.11 122.69 34.84 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 108.223 -1.029 . . . . 73.530000000000001 108.223 177.265 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 26.0 m -132.4 164.72 41.43 Favored Pre-proline 0 C--N 1.307 -1.271 0 N-CA-C 109.404 -0.591 . . . . 74.540000000000006 109.404 -176.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -62.61 150.86 86.36 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.194 1.929 . . . . 72.010000000000005 110.18 174.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 27.4 m -64.21 -20.53 27.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 112.661 0.615 . . . . 72.120000000000005 112.661 -177.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -83.14 3.43 30.81 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 123.841 0.856 . . . . 64.120000000000005 111.805 178.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 11.7 t -80.46 158.67 25.84 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.111 0.482 . . . . 72.340000000000003 111.041 -176.481 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 70.0 t -101.37 135.12 39.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.842 -0.617 . . . . 73.439999999999998 110.19 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . 0.418 HD13 ' N ' ' A' ' 551' ' ' ILE . 2.6 mp -97.15 126.13 50.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 107.462 -1.31 . . . . 75.319999999999993 107.462 176.282 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 521' ' ' SER . 36.6 tt0 -103.53 116.29 32.1 Favored 'General case' 0 N--CA 1.428 -1.56 0 C-N-CA 120.602 -0.439 . . . . 72.239999999999995 109.978 -179.237 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 4.6 mp -101.5 134.48 44.53 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.154 -0.93 . . . . 74.319999999999993 109.032 -178.652 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -110.01 114.14 27.42 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 122.11 0.957 . . . . 64.400000000000006 109.553 177.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 48.6 t -103.0 141.44 18.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-N 114.342 -1.299 . . . . 74.129999999999995 109.087 -174.464 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 67.9 m -96.65 147.6 23.73 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.205 0.526 . . . . 74.310000000000002 112.212 -179.161 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.53 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 15.1 ptpt -96.78 150.72 20.38 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 105.282 -2.118 . . . . 72.340000000000003 105.282 170.692 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -73.39 -37.55 53.76 Favored Glycine 0 CA--C 1.485 -1.842 0 N-CA-C 110.931 -0.868 . . . . 44.520000000000003 110.931 -178.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 63.2 t30 69.79 -0.86 2.52 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 122.54 1.162 . . . . 74.109999999999999 110.609 175.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.48 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 77.9 mt-30 -142.57 144.42 32.88 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 106.509 -1.663 . . . . 75.420000000000002 106.509 179.565 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -123.71 140.94 52.49 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 120.75 -0.38 . . . . 73.319999999999993 110.402 179.33 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.99 123.16 11.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.575 0.702 . . . . 70.519999999999996 112.037 -178.122 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 59.6 ttp -97.28 134.66 22.45 Favored Pre-proline 0 C--N 1.305 -1.352 0 CA-C-N 115.43 -0.805 . . . . 70.340000000000003 109.874 178.463 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.15 169.62 13.34 Favored 'Trans proline' 0 C--O 1.244 0.821 0 C-N-CA 122.805 2.336 . . . . 72.219999999999999 111.197 175.496 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . 0.434 ' HA ' ' CB ' ' A' ' 610' ' ' ALA . 28.1 t70 -66.83 114.69 5.88 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.401 0.62 . . . . 71.310000000000002 112.085 -178.274 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 93.2 mt -133.87 10.0 3.91 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.208 -1.034 . . . . 72.430000000000007 108.208 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 14.6 m -79.17 134.08 36.7 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.935 -1.03 . . . . 63.420000000000002 110.575 -175.238 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 77.19 33.98 42.91 Favored Glycine 0 C--O 1.221 -0.66 0 C-N-CA 120.724 -0.751 . . . . 71.540000000000006 111.94 -179.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 569' ' ' MET . . . . . 0.531 ' SD ' ' HD3' ' A' ' 577' ' ' ARG . 36.0 ttp -100.27 146.37 26.99 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.814 -0.439 . . . . 73.430000000000007 109.814 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . 0.425 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 93.4 m-85 -76.59 147.87 37.36 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.279 -1.008 . . . . 63.149999999999999 108.279 178.92 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 72.4 t-105 -59.67 -22.84 62.5 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 112.057 0.392 . . . . 75.340000000000003 112.057 -178.231 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 29.5 m -70.52 -23.14 24.14 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.438 0 CA-C-N 115.951 -0.568 . . . . 71.120000000000005 111.335 -178.582 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -101.06 -33.37 10.18 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.939 -0.763 . . . . 74.140000000000001 108.939 175.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . 0.48 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -58.23 -53.48 57.8 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.469 0.914 . . . . 62.329999999999998 113.469 -176.03 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.411 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 34.7 tt0 -58.5 -51.9 78.49 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 120.51 -0.476 . . . . 71.5 112.021 -178.253 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . 0.411 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 51.2 Cg_exo -57.8 -40.76 76.26 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 121.918 1.745 . . . . 53.119999999999997 112.789 176.58 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . 0.531 ' HD3' ' SD ' ' A' ' 569' ' ' MET . 80.9 mtp180 -69.09 -33.94 74.32 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 120.326 -0.55 . . . . 74.340000000000003 112.139 -179.249 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 92.8 mt -65.36 -47.55 76.04 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.008 0.433 . . . . 72.530000000000001 110.454 178.706 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -65.31 -34.81 79.22 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.964 -0.562 . . . . 74.340000000000003 111.176 177.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -65.4 -32.43 74.05 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.924 0.393 . . . . 52.530000000000001 111.093 178.417 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . 0.431 HD22 ' O ' ' A' ' 577' ' ' ARG . 4.1 mm? -81.46 -5.2 57.69 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.251 -0.431 . . . . 75.540000000000006 111.179 177.42 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 72.78 31.71 62.12 Favored Glycine 0 N--CA 1.431 -1.649 0 C-N-CA 121.018 -0.61 . . . . 63.240000000000002 111.6 -179.783 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 78.6 t90 -65.1 139.05 58.67 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.678 0.275 . . . . 74.030000000000001 110.286 177.093 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 29.2 m -151.62 103.03 2.92 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.361 -0.607 . . . . 75.040000000000006 109.361 175.357 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -161.39 -138.26 2.38 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 109.497 -1.441 . . . . 75.049999999999997 109.497 177.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 16.4 mmt -117.71 132.09 56.53 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.214 0.53 . . . . 64.25 110.766 175.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 24.8 tp -98.91 118.18 35.09 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 106.347 -1.723 . . . . 75.319999999999993 106.347 178.375 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -120.35 100.45 7.17 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 118.112 -1.435 . . . . 52.32 111.962 178.447 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . 0.455 ' HZ1' ' CG ' ' A' ' 592' ' ' ASP . 0.1 OUTLIER -113.79 133.8 55.16 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.143 -1.389 . . . . 74.530000000000001 108.391 171.476 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -73.2 -102.33 0.07 OUTLIER Glycine 0 C--N 1.301 -1.361 0 C-N-CA 120.745 -0.741 . . . . 64.310000000000002 113.842 -176.31 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -91.81 135.8 33.64 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 120.591 0.234 . . . . 73.030000000000001 111.489 -177.612 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . 0.455 ' CG ' ' HZ1' ' A' ' 589' ' ' LYS . 11.0 m-20 -89.3 125.97 35.33 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 106.915 -1.513 . . . . 43.420000000000002 106.915 177.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 78.4 t -124.67 115.63 45.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 110.158 -0.312 . . . . 70.030000000000001 110.158 -175.127 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -74.49 113.42 11.71 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.683 -0.858 . . . . 75.25 108.683 177.06 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -125.32 -28.98 3.3 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 115.648 -0.705 . . . . 75.420000000000002 110.373 177.593 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 107.74 147.97 13.78 Favored Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 110.015 -1.234 . . . . 74.230000000000004 110.015 -176.351 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -62.5 -33.57 86.83 Favored Glycine 0 C--N 1.32 -0.348 0 CA-C-N 116.915 0.357 . . . . 64.019999999999996 112.776 -177.602 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 27.4 m -65.89 -23.97 66.75 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-O 121.144 0.497 . . . . 75.140000000000001 111.206 178.333 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -87.11 0.47 55.22 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.54 0.736 . . . . 63.340000000000003 110.765 -179.573 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . 0.4 10.3 p-80 69.65 92.0 0.09 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 126.545 1.938 . . . . 75.439999999999998 116.123 176.671 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -90.66 69.35 6.66 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 123.033 1.397 . . . . 54.119999999999997 107.999 171.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 37.2 ptt85 -106.82 162.44 13.8 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.227 -1.351 . . . . 74.140000000000001 110.178 -176.574 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 75.9 t -68.98 130.86 34.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 106.133 -1.803 . . . . 64.109999999999999 106.133 172.72 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 28.3 m -107.48 -31.18 2.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 119.494 -0.882 . . . . 72.430000000000007 111.937 -176.332 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -145.05 157.13 44.21 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 106.942 -1.503 . . . . 75.349999999999994 106.942 176.058 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -148.98 160.2 43.52 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 106.872 -1.529 . . . . 65.430000000000007 106.872 -179.321 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.476 ' HB2' ' HD3' ' A' ' 608' ' ' PRO . 88.6 m-20 -68.56 -57.85 7.85 Favored Pre-proline 0 C--N 1.315 -0.893 0 C-N-CA 120.185 -0.606 . . . . 72.329999999999998 112.022 -179.492 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.476 ' HD3' ' HB2' ' A' ' 607' ' ' ASN . 10.1 Cg_endo -99.07 127.02 0.17 Allowed 'Trans proline' 0 N--CA 1.44 -1.674 0 C-N-CA 122.123 1.882 . . . . 75.120000000000005 112.245 178.877 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.45 158.67 54.21 Favored 'Trans proline' 0 C--O 1.246 0.891 0 C-N-CA 121.927 1.751 . . . . 75.310000000000002 111.432 176.545 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 565' ' ' ASP . . . -68.02 137.39 55.03 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.776 -0.824 . . . . 74.340000000000003 108.776 177.337 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 90.04 -0.05 78.35 Favored Glycine 0 C--N 1.309 -0.932 0 C-N-CA 120.337 -0.935 . . . . 62.43 111.144 -177.469 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 27.6 m -111.48 159.62 17.91 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 107.514 -1.291 . . . . 73.349999999999994 107.514 177.5 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -77.92 133.62 13.26 Favored Glycine 0 N--CA 1.427 -1.944 0 N-CA-C 111.743 -0.543 . . . . 71.25 111.743 177.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 21.6 m -96.72 141.18 15.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 109.032 -0.729 . . . . 75.329999999999998 109.032 177.336 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -55.77 148.85 15.68 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.91 0.884 . . . . 74.519999999999996 110.358 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -52.63 -30.68 32.84 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 112.962 0.727 . . . . 74.030000000000001 112.962 -174.143 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . 0.565 ' OD2' ' HB ' ' A' ' 619' ' ' ILE . 32.7 t70 -79.78 -31.42 40.82 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.951 0.405 . . . . 75.120000000000005 110.739 -178.535 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 77.74 20.71 73.35 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.902 -0.666 . . . . 54.509999999999998 112.789 179.013 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . 0.565 ' HB ' ' OD2' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -68.3 121.01 16.69 Favored 'Isoleucine or valine' 0 C--O 1.246 0.872 0 CA-C-O 122.536 1.16 . . . . 74.150000000000006 109.209 -173.796 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 6.3 tp -115.08 120.09 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.093 0 CA-C-N 113.957 -1.474 . . . . 75.329999999999998 112.379 -171.763 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 14.5 m -99.4 117.25 33.4 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 105.565 -2.013 . . . . 74.209999999999994 105.565 170.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -140.09 162.69 34.63 Favored 'General case' 0 CA--C 1.483 -1.631 0 N-CA-C 108.987 -0.746 . . . . 74.099999999999994 108.987 -175.429 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -134.79 137.23 43.19 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 107.442 -1.318 . . . . 75.409999999999997 107.442 172.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -142.02 166.06 25.74 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 105.281 -2.118 . . . . 75.439999999999998 105.281 173.389 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -66.4 -86.74 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.426 -1.07 . . . . 75.239999999999995 110.426 175.616 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 . . . . . 0 C--N 1.299 -1.624 0 N-CA-C 105.95 -1.87 . . . . 74.519999999999996 105.95 175.763 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 N--CA 1.44 -0.943 0 N-CA-C 108.241 -1.022 . . . . 74.530000000000001 108.241 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.9 m -134.52 163.27 37.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.494 -0.928 . . . . 74.319999999999993 108.494 178.027 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -94.23 140.59 29.58 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 106.455 -1.683 . . . . 70.340000000000003 106.455 175.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.514 HG22 ' CZ ' ' A' ' 382' ' ' PHE . 75.7 t -93.92 134.48 26.07 Favored Pre-proline 0 C--N 1.277 -2.565 0 N-CA-C 107.559 -1.274 . . . . 73.5 107.559 -174.719 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.84 149.48 66.46 Favored 'Trans proline' 0 C--O 1.253 1.259 0 C-N-CA 123.042 2.495 . . . . 63.229999999999997 113.308 -171.279 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -87.24 75.15 9.39 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 115.076 -0.966 . . . . 62.450000000000003 111.258 -177.409 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 27.7 m -91.54 -5.25 10.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 122.917 1.341 . . . . 72.030000000000001 108.005 173.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -66.39 146.43 54.57 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 112.329 -2.214 . . . . 72.450000000000003 108.21 177.05 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 399' ' ' VAL . . . 104.53 1.23 43.51 Favored Glycine 0 C--N 1.304 -1.237 0 C-N-CA 119.475 -1.345 . . . . 44.219999999999999 114.042 178.674 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -110.29 -77.39 0.59 Allowed 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.094 -0.706 . . . . 73.439999999999998 109.094 -177.65 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 78.7 p -149.78 153.13 36.34 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 106.767 -1.568 . . . . 65.319999999999993 106.767 178.248 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 22.6 t -62.64 -33.72 75.61 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.964 -0.754 . . . . 63.409999999999997 108.964 177.278 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -68.69 -47.83 65.43 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 112.53 0.567 . . . . 64.430000000000007 112.53 -178.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -69.69 -45.27 68.66 Favored 'General case' 0 CA--C 1.503 -0.859 0 C-N-CA 119.482 -0.887 . . . . 75.010000000000005 110.631 -178.097 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . 0.457 ' O ' ' HG ' ' A' ' 377' ' ' LEU . . . -61.17 -50.57 72.61 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.407 -0.815 . . . . 73.219999999999999 110.96 -178.361 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.28 -38.97 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 120.727 -0.389 . . . . 73.120000000000005 111.778 -177.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.71 -44.02 93.88 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.226 0.536 . . . . 75.230000000000004 110.884 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 21.0 m -66.52 -47.1 74.03 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.572 -0.74 . . . . 73.340000000000003 110.104 -179.171 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 373' ' ' ALA . 94.0 mt -61.49 -42.45 98.8 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.271 -0.422 . . . . 74.439999999999998 110.629 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -61.21 -42.46 98.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.129 -0.487 . . . . 75.319999999999993 111.157 -179.532 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -67.57 -24.52 65.52 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 112.072 0.397 . . . . 75.239999999999995 112.072 179.31 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -81.42 -13.76 57.88 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.106 0.479 . . . . 73.420000000000002 110.123 176.518 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.67 7.43 51.06 Favored Glycine 0 N--CA 1.437 -1.297 0 CA-C-N 115.701 -0.681 . . . . 74.530000000000001 112.337 178.381 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.514 ' CZ ' HG22 ' A' ' 362' ' ' VAL . 57.4 m-85 -74.36 148.72 41.03 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-O 121.431 0.634 . . . . 74.420000000000002 110.322 178.159 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 47.0 mmtm -98.61 146.24 26.02 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 106.548 -1.649 . . . . 72.400000000000006 106.548 178.293 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.71 150.68 27.16 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.302 0 C-N-CA 119.735 -0.786 . . . . 73.450000000000003 110.095 -179.14 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -117.06 146.15 43.28 Favored 'General case' 0 N--CA 1.404 -2.769 0 N-CA-C 106.372 -1.714 . . . . 74.329999999999998 106.372 171.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 89.0 m -135.02 117.85 16.18 Favored 'General case' 0 C--N 1.256 -3.496 0 N-CA-C 106.371 -1.714 . . . . 73.239999999999995 106.371 -179.342 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 20.8 tp -117.83 130.89 56.54 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 108.967 -0.753 . . . . 74.109999999999999 108.967 -176.107 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -91.12 131.0 36.96 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-O 121.099 0.476 . . . . 74.409999999999997 110.311 -178.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . 0.558 ' O ' ' HA ' ' A' ' 421' ' ' SER . 76.0 mmtt -125.85 143.31 44.86 Favored Pre-proline 0 C--N 1.297 -1.69 0 N-CA-C 107.396 -1.335 . . . . 75.209999999999994 107.396 177.643 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . 0.415 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 13.7 Cg_endo -98.14 127.25 0.22 Allowed 'Trans proline' 0 N--CA 1.449 -1.137 0 N-CA-C 108.867 -1.243 . . . . 74.510000000000005 108.867 166.563 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 6.7 t70 168.09 -170.04 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.286 -1.375 . . . . 74.150000000000006 107.286 -174.899 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 31.7 t -136.74 -11.36 1.79 Allowed 'General case' 0 N--CA 1.428 -1.573 0 C-N-CA 123.22 0.608 . . . . 71.420000000000002 110.376 178.136 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 14.6 t -71.42 -28.85 64.28 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 108.089 -1.078 . . . . 74.230000000000004 108.089 176.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.1 129.97 23.36 Favored Pre-proline 0 N--CA 1.41 -2.426 0 N-CA-C 104.278 -2.49 . . . . 74.540000000000006 104.278 167.051 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -92.91 -175.49 0.54 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.698 2.265 . . . . 73.239999999999995 113.798 -172.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . 0.429 ' C ' ' H ' ' A' ' 398' ' ' HIS . 79.3 Cg_exo -53.16 167.25 0.78 Allowed 'Trans proline' 0 C--N 1.365 1.419 0 C-N-CA 124.25 3.3 . . . . 74.019999999999996 111.351 169.816 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -53.08 -6.22 0.06 Allowed 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 126.427 1.891 . . . . 73.239999999999995 113.667 -170.573 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.429 ' H ' ' C ' ' A' ' 396' ' ' PRO . 27.9 m170 -77.21 93.1 3.9 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 105.453 -2.055 . . . . 75.329999999999998 105.453 170.984 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.436 ' O ' ' HA2' ' A' ' 367' ' ' GLY . 16.6 m -67.54 119.57 13.41 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 113.546 -1.661 . . . . 74.420000000000002 112.534 -166.911 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.88 -35.81 8.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 108.763 -0.828 . . . . 71.340000000000003 108.763 178.756 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.84 163.53 28.58 Favored Glycine 0 N--CA 1.414 -2.77 0 CA-C-N 115.513 -0.767 . . . . 64.120000000000005 111.198 -177.391 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.3 p -150.06 -176.4 5.43 Favored 'General case' 0 C--N 1.288 -2.109 0 C-N-CA 126.207 1.803 . . . . 52.5 107.558 -178.358 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -98.88 139.72 21.25 Favored Pre-proline 0 C--N 1.3 -1.563 0 C-N-CA 120.157 -0.617 . . . . 64.209999999999994 109.476 -174.16 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.86 1.61 0.21 Allowed 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 124.93 3.753 . . . . 73.540000000000006 115.624 -179.569 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.08 -33.82 63.09 Favored 'General case' 0 C--O 1.213 -0.854 0 CA-C-O 120.968 0.413 . . . . 72.209999999999994 110.084 175.56 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -70.49 -30.84 67.73 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-N 115.515 -0.766 . . . . 64.439999999999998 111.06 178.455 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -87.74 -5.02 58.86 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.841 0.829 . . . . 73.439999999999998 109.286 -178.271 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 31.0 m -91.8 149.13 21.75 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 105.821 -1.918 . . . . 75.230000000000004 105.821 175.159 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 12.6 p -78.73 112.25 15.66 Favored 'General case' 0 N--CA 1.418 -2.049 0 C-N-CA 119.23 -0.988 . . . . 64.340000000000003 109.624 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 35.2 m -119.57 159.92 20.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 115.971 -0.559 . . . . 73.540000000000006 109.714 178.623 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 56.0 m -67.0 134.86 52.79 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.347 -0.612 . . . . 74.200000000000003 109.347 178.102 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -53.71 114.5 1.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.125 0.57 . . . . 74.200000000000003 111.62 -178.046 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 112.42 14.05 11.07 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.663 -0.698 . . . . 55.329999999999998 112.042 -178.706 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -75.27 -174.56 2.4 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 109.907 -0.405 . . . . 73.109999999999999 109.907 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . 0.626 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 9.7 pt-20 -119.38 130.93 55.57 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 113.275 0.843 . . . . 75.219999999999999 113.275 -171.101 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.4 mm -116.89 127.49 74.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.916 -0.584 . . . . 70.450000000000003 110.551 -179.314 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 35.3 m -93.06 130.72 38.57 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 120.733 0.302 . . . . 60.32 111.307 178.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 5.2 p -120.41 135.35 60.94 Favored 'Isoleucine or valine' 0 C--O 1.248 0.994 0 N-CA-C 109.565 -0.532 . . . . 62.549999999999997 109.565 178.003 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -100.39 124.83 46.39 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.121 -0.696 . . . . 74.439999999999998 109.121 177.137 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 70.8 t -118.54 131.79 70.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 107.717 -1.216 . . . . 73.140000000000001 107.717 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 421' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 32.6 t -101.74 120.89 41.08 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 117.635 -1.626 . . . . 62.409999999999997 110.497 179.777 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 4.1 t -121.67 107.29 12.19 Favored 'General case' 0 N--CA 1.403 -2.781 0 CA-C-N 114.492 -1.231 . . . . 75.439999999999998 108.624 171.677 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -2.004 0 C-N-CA 119.695 -1.241 . . . . 64.430000000000007 112.274 179.532 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 . . . . . 0 N--CA 1.437 -1.092 0 N-CA-C 106.891 -1.522 . . . . 72.310000000000002 106.891 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.51 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 5.0 mmp_? -121.49 151.96 39.69 Favored 'General case' 0 CA--C 1.485 -1.534 0 CA-C-O 121.594 0.711 . . . . 73.129999999999995 111.527 -177.241 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.85 140.42 32.92 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 114.355 -1.293 . . . . 75.420000000000002 108.109 -176.218 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.436 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 78.2 mt -78.86 113.43 35.28 Favored Pre-proline 0 C--N 1.299 -1.588 0 N-CA-C 108.215 -1.031 . . . . 73.510000000000005 108.215 -179.641 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.77 141.06 40.24 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 121.849 1.7 . . . . 63.219999999999999 110.936 178.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -92.0 127.09 37.33 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.935 -1.135 . . . . 70.319999999999993 107.935 176.315 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 90.6 t -121.73 150.03 24.99 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 N-CA-C 108.104 -1.072 . . . . 73.230000000000004 108.104 -176.054 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.493 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 19.4 m -55.3 144.84 23.56 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 123.818 0.699 . . . . 72.420000000000002 110.579 -179.811 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 434' ' ' THR . . . . . 0.447 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 41.8 p -69.16 -25.77 64.53 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 113.341 0.867 . . . . 70.0 113.341 -169.386 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.16 -12.07 39.28 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 116.05 -0.523 . . . . 71.230000000000004 110.744 178.084 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.493 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 2.6 m -98.06 43.42 1.06 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.956 0.884 . . . . 74.439999999999998 109.176 -176.691 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . 0.481 ' HH ' ' HB2' ' A' ' 454' ' ' GLN . 67.6 t80 -53.48 -38.93 64.12 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.351 1.061 . . . . 74.519999999999996 112.954 179.736 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -62.07 -40.51 96.04 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 121.537 0.684 . . . . 75.5 109.992 179.543 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -71.47 -34.06 69.87 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.862 -0.608 . . . . 64.409999999999997 111.199 177.154 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.47 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -59.35 -47.02 87.0 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.389 0.137 . . . . 71.530000000000001 110.833 -178.726 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 21.5 m -65.53 -36.98 78.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-O 121.337 0.589 . . . . 72.319999999999993 110.189 177.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -60.23 -47.25 86.79 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.803 0.841 . . . . 73.439999999999998 110.952 176.295 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -64.17 -38.79 92.33 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 123.663 0.785 . . . . 74.409999999999997 111.6 179.726 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 93.8 mt -63.93 -34.7 78.55 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.0 0.428 . . . . 72.209999999999994 109.988 175.619 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.442 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 43.8 m -70.16 -42.76 72.09 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.884 -0.598 . . . . 65.109999999999999 110.625 178.618 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.49 -23.09 65.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.364 0.602 . . . . 74.010000000000005 111.064 179.123 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.95 5.21 22.74 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.016 -0.538 . . . . 72.209999999999994 111.495 178.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 108.61 -84.15 0.36 Allowed Glycine 0 N--CA 1.435 -1.42 0 C-N-CA 120.429 -0.891 . . . . 62.140000000000001 112.072 175.552 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -37.08 -57.3 0.86 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.133 1.16 . . . . 73.109999999999999 114.133 179.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . 0.442 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 56.15 30.89 58.49 Favored Glycine 0 CA--C 1.505 -0.559 0 O-C-N 123.362 0.414 . . . . 73.329999999999998 113.347 179.44 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 61.3 mmt-85 -112.73 122.86 48.91 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 108.096 -1.076 . . . . 75.439999999999998 108.096 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . 0.518 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 18.0 p90 -144.28 152.11 40.34 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.98 -0.554 . . . . 74.530000000000001 111.448 -174.632 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -131.72 138.58 48.71 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.565 -0.902 . . . . 65.439999999999998 108.565 175.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . 0.481 ' HB2' ' HH ' ' A' ' 437' ' ' TYR . 62.8 tt0 -98.08 121.08 39.56 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.628 -0.879 . . . . 71.120000000000005 108.628 176.598 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -116.98 148.55 41.34 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 107.881 -1.155 . . . . 72.329999999999998 107.881 178.011 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 -113.86 146.19 40.37 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 108.481 -0.933 . . . . 74.219999999999999 108.481 -176.477 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 26.9 t -143.92 134.46 12.17 Favored Pre-proline 0 C--N 1.294 -1.813 0 N-CA-C 108.645 -0.872 . . . . 72.0 108.645 175.296 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.607 ' HA ' ' O ' ' A' ' 490' ' ' SER . 68.1 Cg_endo -76.78 124.13 7.3 Favored 'Trans proline' 0 N--CA 1.439 -1.691 0 C-N-CA 121.898 1.732 . . . . 75.310000000000002 111.134 178.253 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 69.6 m -151.17 179.87 7.92 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.779 -0.646 . . . . 72.420000000000002 109.416 -178.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.9 t -46.77 139.22 6.67 Favored Pre-proline 0 C--O 1.25 1.114 0 C-N-CA 125.061 1.344 . . . . 72.230000000000004 112.684 178.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.61 -29.55 33.08 Favored 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 124.609 3.54 . . . . 72.049999999999997 113.567 -177.734 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -66.95 -24.51 66.07 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 120.959 0.409 . . . . 62.020000000000003 111.582 -178.603 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 91.1 mt -99.27 -13.47 19.66 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 120.707 0.289 . . . . 65.310000000000002 111.289 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 88.8 t -60.73 127.61 20.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.154 -0.475 . . . . 74.430000000000007 110.481 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.57 -11.7 71.5 Favored Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 116.083 -0.508 . . . . 73.540000000000006 112.175 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.97 159.42 16.56 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 107.577 -1.268 . . . . 74.310000000000002 107.577 179.37 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.447 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 76.1 t -75.45 146.97 8.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 106.998 -1.482 . . . . 75.420000000000002 106.998 173.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 61.3 mt -97.53 -29.82 3.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 107.557 -1.275 . . . . 64.310000000000002 107.557 177.33 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 158.8 -160.65 31.27 Favored Glycine 0 N--CA 1.423 -2.178 0 N-CA-C 111.014 -0.834 . . . . 74.409999999999997 111.014 176.163 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 470' ' ' THR . . . . . 0.486 HG21 HG12 ' A' ' 486' ' ' ILE . 52.8 p -115.04 140.88 48.69 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 105.016 -2.216 . . . . 74.5 105.016 177.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -65.11 -54.6 32.42 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 119.135 -1.026 . . . . 74.019999999999996 110.03 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.84 135.03 29.24 Favored 'Trans proline' 0 C--N 1.368 1.594 0 N-CA-C 108.42 -1.416 . . . . 72.439999999999998 108.42 170.756 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . 0.558 ' C ' ' H ' ' A' ' 475' ' ' ASN . 35.5 Cg_exo -62.3 141.82 88.97 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 122.177 1.918 . . . . 73.109999999999999 112.482 -177.054 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.436 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -75.16 22.86 0.11 Allowed 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 122.441 1.115 . . . . 72.349999999999994 110.792 178.812 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . 0.558 ' H ' ' C ' ' A' ' 473' ' ' PRO . 10.2 m120 -109.36 -17.65 13.75 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 114.293 -1.321 . . . . 61.329999999999998 108.25 179.342 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -95.78 165.6 12.22 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 113.226 0.824 . . . . 63.229999999999997 113.226 -172.603 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.7 113.46 26.97 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 113.944 -1.48 . . . . 71.420000000000002 108.203 -179.735 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 18.5 p -102.67 145.55 29.51 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 110.132 -0.321 . . . . 72.129999999999995 110.132 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -71.73 164.36 26.1 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.284 -0.416 . . . . 63.009999999999998 110.519 179.234 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 37.6 mm -74.78 -8.67 11.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 122.122 0.963 . . . . 71.150000000000006 110.745 -174.564 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.0 t -100.1 5.16 44.92 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.844 -0.616 . . . . 75.540000000000006 110.53 177.4 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -87.12 147.45 25.64 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 112.628 0.603 . . . . 74.099999999999994 112.628 -176.198 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 44.2 t -107.38 117.49 53.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 108.737 -0.838 . . . . 75.329999999999998 108.737 177.606 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 58.8 t -89.55 120.08 37.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-O 121.289 0.566 . . . . 65.109999999999999 109.772 -179.119 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.93 123.76 46.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 121.491 0.662 . . . . 73.299999999999997 110.006 179.104 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . 0.486 HG12 HG21 ' A' ' 470' ' ' THR . 14.1 mt -113.59 128.28 70.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 114.766 -1.106 . . . . 73.349999999999994 110.547 -178.072 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 5.1 tt -103.89 126.41 58.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 115.386 -0.825 . . . . 74.349999999999994 110.816 -175.481 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 33.5 m -110.1 151.35 12.35 Favored 'Isoleucine or valine' 0 C--O 1.251 1.152 0 CA-C-N 115.824 -0.625 . . . . 73.409999999999997 109.714 178.658 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.78 132.19 10.92 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 120.65 -0.786 . . . . 71.120000000000005 112.156 -179.268 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.607 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 49.0 m . . . . . 0 C--N 1.3 -1.568 0 N-CA-C 107.267 -1.383 . . . . 71.200000000000003 107.267 176.392 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo . . . . . 0 C--O 1.244 0.778 0 N-CA-C 110.822 -0.491 . . . . 74.530000000000001 110.822 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -81.89 55.47 2.76 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.931 0.872 . . . . 73.329999999999998 110.963 -178.215 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 58.0 p -120.23 142.93 48.58 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.29 -1.004 . . . . 74.109999999999999 108.29 -179.066 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -130.48 152.78 49.5 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.798 0.332 . . . . 74.049999999999997 110.872 -179.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -83.88 115.9 22.5 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 124.007 0.923 . . . . 75.400000000000006 109.905 -176.485 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 543' ' ' THR . 38.0 pt -83.82 130.09 56.69 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 116.396 -0.365 . . . . 75.219999999999999 111.156 -178.696 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -83.26 -169.27 0.69 Allowed 'Trans proline' 0 C--O 1.239 0.534 0 C-N-CA 122.969 2.446 . . . . 73.010000000000005 112.165 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -78.49 138.59 38.51 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.804 -0.813 . . . . 72.439999999999998 108.804 177.301 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 14.7 p -126.92 -15.0 3.49 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-O 121.448 0.642 . . . . 74.140000000000001 110.737 -177.338 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -66.73 112.18 4.08 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.082 -0.71 . . . . 62.210000000000001 109.082 178.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 136.81 -25.54 3.07 Favored Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.901 -0.666 . . . . 64.200000000000003 111.715 -178.374 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -103.01 172.33 6.88 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 122.47 -0.429 . . . . 54.25 111.068 178.336 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 21.8 p -89.77 160.97 16.26 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 116.495 -0.32 . . . . 74.5 111.069 -176.654 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 532' ' ' GLY . 25.0 t -54.1 -42.08 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 123.645 0.59 . . . . 71.519999999999996 111.403 -177.13 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.67 -42.13 95.6 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.075 -0.511 . . . . 55.539999999999999 112.007 -178.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 67.2 t -71.35 -41.76 73.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 109.657 -0.498 . . . . 73.239999999999995 109.657 179.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -60.38 -49.64 76.78 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.254 -0.885 . . . . 74.230000000000004 111.645 -179.393 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -64.96 -35.66 81.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.712 0.292 . . . . 70.329999999999998 110.691 -178.387 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.473 ' O ' HG22 ' A' ' 514' ' ' VAL . 4.6 tppp? -64.84 -47.13 79.07 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.846 -0.615 . . . . 74.310000000000002 109.364 179.192 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -63.38 -48.15 79.12 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.882 -0.599 . . . . 74.340000000000003 111.952 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -61.77 -39.75 92.74 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 116.658 -0.246 . . . . 75.25 111.467 178.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.79 -37.79 85.65 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 120.682 0.277 . . . . 73.510000000000005 111.011 177.933 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 510' ' ' LYS . 73.3 t -62.34 -37.14 77.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.011 -0.541 . . . . 74.439999999999998 110.416 176.885 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -71.91 -23.57 61.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.906 0.384 . . . . 74.409999999999997 111.553 178.357 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 124.59 -12.69 7.84 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 120.394 -0.908 . . . . 74.329999999999998 112.317 178.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' A' ' 547' ' ' VAL . 90.5 m-85 -80.44 101.17 8.88 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 107.591 -1.263 . . . . 74.200000000000003 107.591 -177.349 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.87 -8.89 27.33 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 120.058 -0.657 . . . . 74.439999999999998 112.413 -171.736 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . 0.499 ' O ' HD12 ' A' ' 551' ' ' ILE . 63.6 mttp -108.21 114.59 28.59 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.037 -0.665 . . . . 72.420000000000002 109.984 -178.037 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -131.01 140.34 50.11 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 116.01 -0.541 . . . . 74.129999999999995 111.218 -177.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 521' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 33.0 m -128.43 142.29 51.14 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.277 -1.379 . . . . 74.209999999999994 107.277 175.866 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.94 141.04 48.88 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.043 0.449 . . . . 65.540000000000006 111.091 179.778 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -135.43 128.51 31.65 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.894 -1.15 . . . . 74.319999999999993 107.894 178.045 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 70.2 m -93.74 134.07 36.46 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.096 0.475 . . . . 75.519999999999996 111.818 -177.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . 0.438 ' O ' ' HB3' ' A' ' 557' ' ' LYS . 35.2 m -121.98 150.11 25.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 107.972 -1.121 . . . . 72.319999999999993 107.972 177.795 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -66.75 136.74 55.93 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.525 -0.47 . . . . 63.549999999999997 110.547 -179.226 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 20.2 m -149.93 169.1 9.71 Favored Pre-proline 0 C--N 1.307 -1.278 0 CA-C-N 116.049 -0.523 . . . . 74.430000000000007 109.985 -177.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -84.41 -25.46 2.08 Favored 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 121.892 1.728 . . . . 60.32 111.5 173.508 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -81.06 150.03 67.67 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 109.7 -0.481 . . . . 74.239999999999995 109.7 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.78 149.0 62.68 Favored 'Trans proline' 0 C--O 1.26 1.601 0 C-N-CA 123.82 3.014 . . . . 72.430000000000007 115.909 -175.206 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.654 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -62.87 121.2 12.91 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 113.914 -1.494 . . . . 75.129999999999995 110.701 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . 0.441 ' O ' HG21 ' A' ' 505' ' ' VAL . . . 130.69 -23.46 4.47 Favored Glycine 0 C--N 1.303 -1.25 0 C-N-CA 120.763 -0.732 . . . . 72.519999999999996 111.462 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -83.48 144.29 29.65 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.422 -0.584 . . . . 75.140000000000001 109.422 177.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 67.0 t -89.54 125.75 42.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 109.275 -0.639 . . . . 73.209999999999994 109.275 179.395 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 535' ' ' THR . . . . . 0.578 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 14.4 t -100.84 -10.57 20.58 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-O 120.66 0.267 . . . . 74.120000000000005 111.611 -178.261 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 171.46 -175.41 44.98 Favored Glycine 0 CA--C 1.498 -0.984 0 C-N-CA 119.912 -1.137 . . . . 64.540000000000006 111.411 179.156 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 8.1 p -139.29 157.97 44.98 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 117.168 0.484 . . . . 75.299999999999997 111.314 179.495 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . 0.413 ' HB3' ' HB3' ' A' ' 552' ' ' GLU . 21.2 t-20 -64.01 -54.87 36.8 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-N 115.27 -0.877 . . . . 73.450000000000003 109.72 176.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -73.53 122.59 7.98 Favored 'Trans proline' 0 C--N 1.373 1.867 0 N-CA-C 108.014 -1.571 . . . . 70.200000000000003 108.014 169.127 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.17 141.13 61.92 Favored 'Trans proline' 0 C--O 1.254 1.317 0 C-N-CA 122.01 1.807 . . . . 74.230000000000004 112.519 -176.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -58.78 134.26 56.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.498 -0.774 . . . . 73.340000000000003 109.963 -179.191 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 102.73 -5.93 51.57 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 120.544 -0.836 . . . . 72.409999999999997 111.973 -177.639 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 543' ' ' THR . . . . . 0.484 ' O ' HG12 ' A' ' 497' ' ' ILE . 79.3 m -88.94 137.74 32.04 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.852 0.326 . . . . 73.200000000000003 110.794 177.134 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 17.9 m -89.27 122.73 32.81 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.03 -1.47 . . . . 64.150000000000006 107.03 173.461 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 16.1 m -131.73 156.15 80.48 Favored Pre-proline 0 C--N 1.313 -0.981 0 CA-C-O 119.423 -0.323 . . . . 73.5 110.56 -177.278 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -59.54 139.55 89.75 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 123.043 2.495 . . . . 75.230000000000004 111.774 178.645 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 517' ' ' PHE . 27.3 m -65.41 -21.31 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 113.487 0.921 . . . . 73.340000000000003 113.487 -175.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -87.15 -11.96 48.44 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.045 0.45 . . . . 74.109999999999999 111.108 178.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 73.7 m -69.88 155.11 41.04 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.61 0.719 . . . . 72.400000000000006 112.719 -177.375 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 27.3 t -88.79 125.97 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-N 114.884 -1.053 . . . . 72.129999999999995 110.065 -176.282 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . 0.499 HD12 ' O ' ' A' ' 519' ' ' LYS . 0.2 OUTLIER -102.39 129.03 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 119.684 -0.807 . . . . 74.25 109.228 174.228 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 521' ' ' SER . 38.1 tt0 -102.73 119.27 38.54 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 108.899 -0.778 . . . . 73.239999999999995 108.899 -179.427 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 47.6 mt -92.19 122.88 35.09 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.117 -0.947 . . . . 73.200000000000003 109.443 -179.107 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -85.93 112.71 21.43 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.782 -1.192 . . . . 73.239999999999995 107.782 171.78 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 42.8 t -95.64 140.16 17.56 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 CA-C-N 115.207 -0.906 . . . . 63.530000000000001 109.283 -176.505 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.654 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 66.5 m -76.17 141.33 41.89 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-O 121.448 0.642 . . . . 73.219999999999999 111.533 177.45 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.438 ' HB3' ' O ' ' A' ' 525' ' ' VAL . 16.7 ttmt -114.66 119.64 37.41 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 125.613 1.565 . . . . 74.140000000000001 107.003 173.724 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -74.74 -24.31 72.66 Favored Glycine 0 C--N 1.314 -0.662 0 C-N-CA 120.574 -0.822 . . . . 75.209999999999994 113.831 -174.072 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 615' ' ' ASN . 48.5 m-80 74.53 18.14 2.92 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.069 1.348 . . . . 74.140000000000001 110.658 -178.539 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -131.89 141.19 49.3 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.566 -0.531 . . . . 73.510000000000005 109.566 -173.462 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -137.74 139.24 40.01 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 108.342 -0.984 . . . . 75.430000000000007 108.342 173.137 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 11.4 p -62.77 129.27 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 N-CA-C 113.3 0.852 . . . . 73.319999999999993 113.3 -173.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 57.2 ttp -97.56 128.94 32.88 Favored Pre-proline 0 C--O 1.254 1.328 0 CA-C-N 115.649 -0.705 . . . . 75.409999999999997 110.006 177.11 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.35 170.23 19.72 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.072 2.514 . . . . 64.299999999999997 112.048 176.224 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . 0.404 ' HB3' ' CB ' ' A' ' 610' ' ' ALA . 6.4 p-10 -86.34 122.37 30.21 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.424 0.63 . . . . 65.530000000000001 112.368 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.08 13.2 1.11 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 122.24 1.019 . . . . 74.230000000000004 109.423 174.102 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 1.8 m -72.57 153.19 41.41 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 114.588 -1.187 . . . . 73.140000000000001 111.355 -175.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 77.14 36.24 35.85 Favored Glycine 0 CA--C 1.519 0.297 0 N-CA-C 114.637 0.615 . . . . 74.140000000000001 114.637 174.667 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 25.1 ptm -129.12 174.67 9.35 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.421 -0.585 . . . . 73.400000000000006 109.421 -179.627 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . 0.492 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 90.6 m-85 -79.63 144.34 33.88 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-O 120.881 0.372 . . . . 75.200000000000003 110.527 -174.856 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . 0.43 ' HB3' ' OD1' ' A' ' 601' ' ' ASN . 74.9 t-105 -67.76 -17.83 64.67 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.729 -0.668 . . . . 75.439999999999998 111.292 -174.574 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 30.1 m -68.24 -28.24 40.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.755 -0.657 . . . . 74.140000000000001 110.444 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . 0.589 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 26.0 m-20 -101.77 -34.21 9.53 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 115.904 -0.589 . . . . 70.409999999999997 109.966 176.33 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -57.27 -46.8 82.74 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.942 1.09 . . . . 75.349999999999994 113.942 -175.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.463 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 5.9 tm-20 -59.14 -53.11 69.58 Favored Pre-proline 0 CA--C 1.566 1.566 0 N-CA-C 109.438 -0.579 . . . . 74.430000000000007 109.438 179.063 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . 0.463 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 79.6 Cg_exo -53.95 -38.06 86.18 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.329 2.019 . . . . 62.049999999999997 113.27 171.587 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . 0.589 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 69.0 mmt-85 -58.92 -43.17 91.08 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 110.344 -0.243 . . . . 75.099999999999994 110.344 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.09 -42.31 99.58 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.959 -0.564 . . . . 71.310000000000002 109.938 -179.076 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -64.36 -41.12 96.89 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.753 -0.658 . . . . 74.140000000000001 110.554 178.178 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.18 -24.1 64.93 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.803 -0.635 . . . . 71.329999999999998 111.636 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 89.0 mt -83.82 -8.0 59.32 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.006 0.431 . . . . 74.439999999999998 110.16 176.789 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 86.02 20.74 54.8 Favored Glycine 0 N--CA 1.438 -1.23 0 C-N-CA 120.622 -0.799 . . . . 75.420000000000002 111.476 -179.244 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 86.9 t90 -88.09 127.88 35.41 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 121.077 0.465 . . . . 74.109999999999999 109.829 178.133 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 36.4 m -149.92 66.24 0.98 Allowed 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.608 -1.256 . . . . 62.5 107.608 170.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -103.44 -129.75 6.72 Favored Glycine 0 N--CA 1.434 -1.498 0 CA-C-N 114.627 -1.169 . . . . 53.409999999999997 110.189 179.414 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 24.5 ttt -121.03 126.8 50.82 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.49 -0.559 . . . . 71.430000000000007 109.49 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -103.58 131.14 50.97 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.16 -1.422 . . . . 74.219999999999999 107.16 177.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -94.56 108.46 20.41 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.82 -0.807 . . . . 74.230000000000004 108.82 177.321 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -89.61 113.16 24.56 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.594 -1.262 . . . . 72.450000000000003 107.594 179.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -83.23 -105.3 0.51 Allowed Glycine 0 N--CA 1.432 -1.595 0 C-N-CA 120.464 -0.874 . . . . 64.349999999999994 110.968 178.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.99 146.72 39.45 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.121 -1.437 . . . . 61.420000000000002 107.121 176.277 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -75.44 129.07 36.71 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.293 0.568 . . . . 72.319999999999993 109.816 -178.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 26.0 t -112.16 132.53 60.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 116.253 -0.43 . . . . 74.409999999999997 111.616 -172.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -76.13 107.21 8.2 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 106.734 -1.58 . . . . 75.430000000000007 106.734 171.291 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -111.82 -10.49 14.01 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 112.673 0.62 . . . . 74.450000000000003 112.673 -172.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 600' ' ' HIS . . . 127.16 170.67 12.91 Favored Glycine 0 CA--C 1.49 -1.516 0 N-CA-C 109.653 -1.379 . . . . 61.310000000000002 109.653 179.472 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -64.59 -50.5 58.7 Favored Glycine 0 C--N 1.316 -0.567 0 C-N-CA 119.478 -1.344 . . . . 75.129999999999995 112.531 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 10.4 p -70.44 -23.71 62.77 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 112.485 0.55 . . . . 55.130000000000003 112.485 -176.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -108.01 -0.72 21.11 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 118.709 -0.662 . . . . 73.329999999999998 112.619 -175.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . 0.479 ' HB3' ' O ' ' A' ' 596' ' ' GLY 0.289 25.1 p-80 -55.39 -74.69 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 114.675 1.361 . . . . 71.329999999999998 114.675 -169.473 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . 0.43 ' OD1' ' HB3' ' A' ' 571' ' ' TRP . 13.5 t-20 -97.13 71.14 2.41 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.247 -0.908 . . . . 75.299999999999997 108.965 -175.636 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . 0.492 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 44.1 ttt180 -143.15 150.97 40.15 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.552 -0.749 . . . . 74.549999999999997 110.558 -173.62 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 93.0 t -66.78 132.46 32.13 Favored 'Isoleucine or valine' 0 C--O 1.246 0.921 0 N-CA-C 107.3 -1.37 . . . . 73.030000000000001 107.3 174.611 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 54.9 t -92.25 -52.96 9.32 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 N-CA-C 108.307 -0.997 . . . . 64.340000000000003 108.307 -172.408 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . 0.423 ' O ' ' HA ' ' A' ' 622' ' ' LEU . 45.1 p90 -156.08 160.39 39.92 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 107.297 -1.372 . . . . 71.019999999999996 107.297 177.422 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.54 140.18 52.29 Favored 'General case' 0 C--N 1.283 -2.296 0 O-C-N 124.364 1.04 . . . . 72.230000000000004 110.047 176.012 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.472 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 25.6 t-20 -52.22 -55.27 32.92 Favored Pre-proline 0 CA--C 1.558 1.272 0 C-N-CA 124.611 1.165 . . . . 71.030000000000001 113.822 -177.721 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.472 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 9.4 Cg_endo -97.42 128.69 0.27 Allowed 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 122.176 1.918 . . . . 75.329999999999998 111.572 177.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.87 154.71 66.98 Favored 'Trans proline' 0 C--O 1.247 0.945 0 C-N-CA 121.661 1.574 . . . . 63.340000000000003 110.59 176.554 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . 0.404 ' CB ' ' HB3' ' A' ' 565' ' ' ASP . . . -53.44 130.29 35.03 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 123.184 0.594 . . . . 63.439999999999998 111.774 -178.379 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 97.79 -0.0 59.17 Favored Glycine 0 N--CA 1.432 -1.569 0 C-N-CA 119.875 -1.155 . . . . 72.439999999999998 112.379 -179.142 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 22.5 m -98.36 155.64 17.12 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.882 -1.155 . . . . 73.329999999999998 107.882 176.388 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -88.15 138.3 14.96 Favored Glycine 0 N--CA 1.412 -2.963 0 C-N-CA 120.871 -0.68 . . . . 75.109999999999999 111.956 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 18.7 m -104.09 143.59 15.6 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 C-N-CA 123.637 0.775 . . . . 63.219999999999999 109.918 176.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . 0.47 HD22 HG23 ' A' ' 619' ' ' ILE . 1.9 p-10 -55.96 140.78 41.98 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 125.336 1.454 . . . . 75.209999999999994 111.347 178.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -50.63 -31.59 16.52 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 113.939 1.088 . . . . 75.129999999999995 113.939 -174.048 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -71.77 -23.86 61.66 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 120.829 0.347 . . . . 75.230000000000004 110.696 -177.417 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 86.09 19.52 57.25 Favored Glycine 0 N--CA 1.41 -3.079 0 C-N-CA 120.465 -0.874 . . . . 74.519999999999996 114.155 172.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . 0.47 HG23 HD22 ' A' ' 615' ' ' ASN . 0.2 OUTLIER -73.51 124.43 30.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 C-N-CA 116.823 -1.951 . . . . 75.140000000000001 108.94 176.198 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . 0.454 ' N ' HD12 ' A' ' 619' ' ' ILE . 6.6 tp -120.05 128.87 75.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.5 -0.773 . . . . 71.310000000000002 109.423 -178.956 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.454 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 35.9 m -102.68 116.8 33.31 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 108.925 -0.768 . . . . 74.219999999999999 108.925 178.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' A' ' 605' ' ' TYR . 3.9 pp -139.89 160.3 40.22 Favored 'General case' 0 CA--C 1.478 -1.814 0 N-CA-C 106.41 -1.7 . . . . 75.319999999999993 106.41 178.646 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -128.7 147.14 50.73 Favored 'General case' 0 C--N 1.259 -3.353 0 N-CA-C 106.394 -1.706 . . . . 74.299999999999997 106.394 179.598 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -128.62 165.25 21.17 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.347 -0.983 . . . . 74.510000000000005 108.347 176.119 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -92.95 -114.37 2.25 Favored Glycine 0 N--CA 1.413 -2.884 0 O-C-N 123.889 0.743 . . . . 72.329999999999998 112.748 -179.383 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . 0.401 HE21 ' HA ' ' A' ' 626' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.46 0 CA-C-O 118.876 -0.583 . . . . 74.120000000000005 110.822 -173.865 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 . . . . . 0 C--O 1.246 0.871 0 N-CA-C 108.54 -0.911 . . . . 73.329999999999998 108.54 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 30.3 m -119.56 151.83 22.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.517 -0.92 . . . . 73.129999999999995 108.517 -178.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -95.08 135.84 36.13 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 106.169 -1.789 . . . . 72.450000000000003 106.169 176.589 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.438 HG22 ' CZ ' ' A' ' 382' ' ' PHE . 59.4 t -97.39 132.06 26.1 Favored Pre-proline 0 C--N 1.286 -2.178 0 CA-C-N 115.987 -0.551 . . . . 74.420000000000002 110.826 -169.249 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -66.56 134.03 34.11 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.17 1.913 . . . . 72.510000000000005 112.389 -179.301 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . 0.402 ' OD1' ' HG2' ' A' ' 366' ' ' ARG . 3.5 p30 -100.5 144.15 29.84 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.705 -1.22 . . . . 64.109999999999999 107.705 176.774 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 4.3 t -123.09 28.2 2.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 107.544 -1.28 . . . . 75.319999999999993 107.544 -179.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.428 ' HD3' ' OG1' ' A' ' 402' ' ' THR . 14.1 ptt180 -61.07 143.91 54.49 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.597 -1.183 . . . . 72.530000000000001 110.61 178.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.06 -13.89 55.74 Favored Glycine 0 N--CA 1.429 -1.779 0 CA-C-N 116.063 -0.517 . . . . 74.400000000000006 112.294 178.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -105.16 -87.29 0.45 Allowed 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 121.173 -0.211 . . . . 70.319999999999993 111.323 -178.722 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 89.5 p -156.32 160.67 39.93 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 108.227 -1.027 . . . . 74.439999999999998 108.227 179.557 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 1.4 p -63.49 -34.68 78.31 Favored 'General case' 0 N--CA 1.422 -1.847 0 O-C-N 123.498 0.499 . . . . 65.510000000000005 109.716 174.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.07 -46.37 89.4 Favored 'General case' 0 C--O 1.214 -0.771 0 CA-C-N 116.044 -0.525 . . . . 72.129999999999995 110.487 178.22 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -63.91 -41.91 97.56 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 120.826 0.346 . . . . 64.049999999999997 111.206 178.157 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -68.33 -45.6 72.48 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.237 -0.438 . . . . 64.310000000000002 111.356 -178.39 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 73.6 mt -65.9 -44.43 92.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.408 -0.36 . . . . 75.239999999999995 110.818 178.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.9 -43.89 91.1 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 120.922 0.392 . . . . 64.150000000000006 111.607 -177.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 38.9 m -64.29 -48.46 75.57 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.006 -0.543 . . . . 74.239999999999995 110.435 -178.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 10.8 mp -65.19 -37.92 88.84 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.163 -0.471 . . . . 64.439999999999998 111.862 178.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -61.11 -42.35 98.37 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.795 0.838 . . . . 75.120000000000005 109.867 178.541 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -66.2 -28.53 68.83 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.988 -0.551 . . . . 71.420000000000002 111.333 177.745 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -86.18 -14.41 44.1 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.907 0.384 . . . . 71.049999999999997 111.416 178.419 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 90.57 16.21 55.47 Favored Glycine 0 C--N 1.307 -1.076 0 C-N-CA 120.444 -0.884 . . . . 71.25 112.633 177.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.438 ' CZ ' HG22 ' A' ' 362' ' ' VAL . 26.1 m-85 -78.23 161.24 27.44 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-O 121.374 0.606 . . . . 72.329999999999998 111.542 178.02 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 48.5 mmtm -100.73 132.43 46.13 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 108.946 -0.761 . . . . 73.439999999999998 108.946 178.164 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.0 154.8 19.98 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.721 0 N-CA-C 108.615 -0.883 . . . . 75.25 108.615 175.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -124.99 135.22 52.58 Favored 'General case' 0 C--N 1.265 -3.069 0 N-CA-C 106.182 -1.785 . . . . 73.430000000000007 106.182 177.508 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 31.1 m -119.04 117.58 29.14 Favored 'General case' 0 C--N 1.271 -2.841 0 N-CA-C 109.157 -0.683 . . . . 74.010000000000005 109.157 -177.383 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 419' ' ' ASN . 2.9 tm? -116.07 127.58 54.99 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 106.292 -1.744 . . . . 75.230000000000004 106.292 179.479 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . 0.439 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -114.22 147.5 38.84 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.997 -0.681 . . . . 74.420000000000002 111.439 -177.979 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -136.39 137.52 24.49 Favored Pre-proline 0 C--N 1.308 -1.234 0 N-CA-C 107.849 -1.167 . . . . 75.439999999999998 107.849 175.193 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -72.64 148.73 47.79 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 121.425 1.417 . . . . 74.129999999999995 109.505 172.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . 0.279 27.8 t70 -61.55 115.37 3.86 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 116.934 2.198 . . . . 72.329999999999998 116.934 -171.916 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 392' ' ' SER . . . . . 0.53 ' O ' ' HB ' ' A' ' 393' ' ' THR . 3.2 p -143.75 65.89 1.3 Allowed 'General case' 0 N--CA 1.383 -3.778 0 CA-C-N 111.822 -2.444 . . . . 72.040000000000006 106.744 166.622 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.544 ' O ' HG22 ' A' ' 393' ' ' THR . 63.4 m 87.38 39.08 0.02 OUTLIER 'General case' 0 CA--C 1.571 1.771 0 CA-C-O 123.703 1.716 . . . . 74.109999999999999 111.471 176.545 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -117.14 149.51 44.48 Favored Pre-proline 0 C--N 1.291 -1.967 0 O-C-N 121.032 -1.042 . . . . 73.230000000000004 112.125 175.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.02 178.49 6.44 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.911 2.407 . . . . 73.150000000000006 111.131 -179.051 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -55.91 161.11 8.86 Favored 'Trans proline' 0 C--N 1.362 1.252 0 C-N-CA 122.765 2.31 . . . . 74.129999999999995 112.328 176.034 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -58.09 -8.35 1.04 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.953 1.301 . . . . 71.510000000000005 113.142 -178.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -74.25 172.05 12.52 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.285 -0.635 . . . . 74.140000000000001 109.285 -179.468 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 13.9 m -97.32 118.7 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.999 0 N-CA-C 108.417 -0.957 . . . . 71.340000000000003 108.417 176.677 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 2.2 mp -94.88 -32.05 4.46 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 107.592 -1.262 . . . . 70.019999999999996 107.592 178.345 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.88 170.85 27.75 Favored Glycine 0 N--CA 1.418 -2.536 0 N-CA-C 109.101 -1.599 . . . . 55.109999999999999 109.101 179.307 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 402' ' ' THR . . . . . 0.428 ' OG1' ' HD3' ' A' ' 366' ' ' ARG . 2.5 p -129.34 -177.87 4.42 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 122.572 0.349 . . . . 75.340000000000003 110.443 -179.262 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -100.14 135.96 20.22 Favored Pre-proline 0 C--N 1.293 -1.866 0 N-CA-C 106.626 -1.62 . . . . 63.450000000000003 106.626 178.771 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -55.52 -12.18 5.77 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 124.034 3.156 . . . . 72.519999999999996 114.836 -175.469 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -53.88 -35.61 61.76 Favored 'General case' 0 C--O 1.212 -0.874 0 C-N-CA 122.899 0.48 . . . . 75.439999999999998 110.548 176.641 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.11 -39.51 68.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.338 0.589 . . . . 74.409999999999997 110.879 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -83.61 2.28 38.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.365 0.602 . . . . 73.519999999999996 110.639 -179.048 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 27.1 m -102.17 145.89 28.74 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 106.326 -1.731 . . . . 74.25 106.326 172.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 48.8 m -75.01 113.03 11.85 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 119.039 -1.064 . . . . 74.510000000000005 108.822 175.255 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.5 m -118.95 170.24 8.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.889 -0.596 . . . . 74.040000000000006 110.037 179.766 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 22.8 t -69.19 152.08 45.54 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.797 -0.445 . . . . 74.329999999999998 109.797 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -63.91 109.4 1.76 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.362 0.601 . . . . 74.409999999999997 111.185 -178.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 100.56 44.64 2.1 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 115.185 -0.916 . . . . 73.510000000000005 113.05 178.074 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -92.03 -174.21 3.71 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.984 -1.117 . . . . 63.25 107.984 178.456 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . 0.522 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 44.8 mt-10 -109.16 133.0 53.58 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 121.53 0.681 . . . . 72.150000000000006 112.582 -177.624 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 44.6 mm -118.76 113.82 42.9 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 107.697 -1.223 . . . . 72.040000000000006 107.697 174.087 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 14.8 t -89.63 131.16 35.76 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.441 0.638 . . . . 73.140000000000001 111.274 -179.541 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 9.2 p -115.49 135.1 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 CA-C-N 115.329 -0.85 . . . . 73.439999999999998 109.562 -177.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' A' ' 387' ' ' LEU . 2.8 t-20 -97.74 116.0 29.09 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.887 -0.725 . . . . 75.200000000000003 109.339 176.236 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 98.4 t -102.44 136.0 36.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.109 -1.071 . . . . 64.540000000000006 108.109 179.232 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 15.8 m -99.09 135.05 41.05 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-O 121.543 0.687 . . . . 63.549999999999997 111.418 -178.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 17.6 p -105.95 160.06 15.56 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.492 -1.299 . . . . 71.519999999999996 107.492 172.409 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 1.999 0 N-CA-C 114.789 0.675 . . . . 51.119999999999997 114.789 -178.063 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 . . . . . 0 N--CA 1.423 -1.815 0 N-CA-C 106.975 -1.491 . . . . 74.409999999999997 106.975 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.467 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 4.2 mmp_? -122.35 147.37 46.34 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-O 120.797 0.332 . . . . 74.439999999999998 110.472 177.802 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -88.71 139.1 30.81 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 107.496 -1.298 . . . . 74.150000000000006 107.496 178.624 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 63.4 mt -80.43 118.99 75.01 Favored Pre-proline 0 N--CA 1.428 -1.536 0 N-CA-C 108.241 -1.022 . . . . 72.129999999999995 108.241 179.569 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -71.08 154.12 62.56 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 121.872 1.715 . . . . 75.200000000000003 110.549 177.409 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -77.4 89.43 3.79 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.53 0.681 . . . . 64.430000000000007 110.079 177.667 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 42.0 t -93.18 131.19 40.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 105.765 -1.939 . . . . 73.239999999999995 105.765 175.572 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.48 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 15.7 m -64.44 151.89 43.01 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 120.929 0.395 . . . . 72.140000000000001 111.197 -176.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 26.9 p -59.76 -33.41 71.64 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 123.427 0.691 . . . . 63.240000000000002 112.275 -176.621 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . 0.434 ' HB3' ' HG3' ' A' ' 466' ' ' LYS . 1.9 pp -81.56 -11.23 59.23 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.465 0.65 . . . . 74.299999999999997 112.601 178.336 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.48 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 3.5 m -97.9 34.27 1.94 Allowed 'General case' 0 CA--C 1.564 1.509 0 N-CA-C 108.971 -0.752 . . . . 71.519999999999996 108.971 -178.703 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -51.41 -39.27 56.92 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.495 1.118 . . . . 72.049999999999997 113.391 179.745 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.1 -42.27 99.54 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-O 121.866 0.841 . . . . 72.329999999999998 110.268 -179.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . 0.416 ' HB3' HG22 ' A' ' 436' ' ' THR . 26.8 tt0 -70.56 -33.96 71.69 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.451 -0.795 . . . . 75.219999999999999 109.468 178.691 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.612 ' O ' HD21 ' A' ' 444' ' ' LEU . . . -59.51 -50.19 74.89 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.378 -0.374 . . . . 73.329999999999998 110.961 -179.35 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.4 m -62.53 -38.61 81.88 Favored 'Isoleucine or valine' 0 C--O 1.257 1.46 0 N-CA-C 112.058 0.392 . . . . 75.519999999999996 112.058 179.637 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.0 -33.51 74.75 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 119.33 -0.948 . . . . 74.129999999999995 111.329 175.321 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -61.61 -42.96 99.61 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.368 -0.378 . . . . 75.010000000000005 111.262 175.559 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.612 HD21 ' O ' ' A' ' 440' ' ' ALA . 0.9 OUTLIER -63.79 -33.14 75.01 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 119.714 -0.794 . . . . 65.540000000000006 110.395 177.147 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 91.3 m -65.42 -44.02 88.69 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 116.174 -0.466 . . . . 74.430000000000007 110.456 177.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.76 -22.28 63.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.465 0.65 . . . . 71.5 110.979 179.225 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.69 5.46 13.26 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.64 -0.709 . . . . 74.200000000000003 112.182 -178.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 101.53 -73.79 0.36 Allowed Glycine 0 CA--C 1.493 -1.338 0 C-N-CA 119.977 -1.106 . . . . 63.219999999999999 112.232 174.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -47.83 -56.81 6.63 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 113.255 0.835 . . . . 75.409999999999997 113.255 178.041 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 61.97 25.43 66.04 Favored Glycine 0 CA--C 1.507 -0.418 0 C-N-CA 121.27 -0.49 . . . . 62.32 112.664 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -100.98 110.86 22.94 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.596 -1.261 . . . . 71.439999999999998 107.596 -177.628 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . 0.598 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 32.3 p90 -139.12 151.33 46.58 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 120.731 0.301 . . . . 73.209999999999994 110.826 -179.194 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -131.25 130.2 42.56 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.435 -0.95 . . . . 71.409999999999997 108.435 177.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -97.62 123.16 41.42 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 123.649 0.593 . . . . 62.210000000000001 110.039 179.204 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.22 135.47 53.77 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 107.043 -1.466 . . . . 44.329999999999998 107.043 173.191 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -112.67 139.42 48.29 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.771 -0.825 . . . . 74.200000000000003 108.771 179.703 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 457' ' ' SER . . . . . 0.481 ' O ' ' HA2' ' A' ' 489' ' ' GLY . 23.2 t -141.94 136.34 15.1 Favored Pre-proline 0 C--N 1.287 -2.118 0 N-CA-C 108.898 -0.778 . . . . 74.349999999999994 108.898 179.708 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.695 ' HA ' ' O ' ' A' ' 490' ' ' SER . 30.4 Cg_endo -65.8 131.35 27.18 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.169 1.913 . . . . 72.120000000000005 110.54 175.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 46.1 m -147.34 174.88 11.24 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 122.259 -0.276 . . . . 62.439999999999998 110.402 -177.491 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 3.9 t -50.66 142.98 15.16 Favored Pre-proline 0 N--CA 1.446 -0.658 0 C-N-CA 124.973 1.309 . . . . 74.420000000000002 111.716 176.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.54 -29.73 33.13 Favored 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 124.653 3.569 . . . . 74.510000000000005 113.153 -177.481 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -68.53 -35.06 76.94 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.379 -0.373 . . . . 75.140000000000001 111.197 179.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -96.18 -9.11 31.32 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 113.057 0.762 . . . . 75.319999999999993 113.057 -178.345 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 92.9 t -60.5 127.11 19.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.795 -0.817 . . . . 74.420000000000002 108.795 175.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.98 -1.43 67.92 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 111.788 -0.525 . . . . 65.519999999999996 111.788 -178.567 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.434 ' HG3' ' HB3' ' A' ' 435' ' ' LEU . 10.0 mptt -122.89 155.18 37.2 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-O 121.595 0.712 . . . . 74.109999999999999 111.336 -178.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 73.4 t -68.45 137.77 23.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 114.115 -1.402 . . . . 75.019999999999996 109.718 175.861 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 40.3 mm -97.95 -28.02 3.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 108.386 -0.968 . . . . 73.510000000000005 108.386 -179.811 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 168.36 164.43 24.04 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.238 -0.982 . . . . 60.340000000000003 113.088 177.556 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 1.1 t -116.96 142.8 46.47 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 107.468 -1.308 . . . . 75.129999999999995 107.468 176.369 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -70.65 -53.14 9.81 Favored Pre-proline 0 C--N 1.321 -0.642 0 C-N-CA 119.493 -0.883 . . . . 73.200000000000003 111.242 177.457 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.41 ' HG2' ' HA ' ' A' ' 484' ' ' VAL . 27.6 Cg_exo -65.95 134.79 38.52 Favored 'Trans proline' 0 C--N 1.368 1.589 0 N-CA-C 108.269 -1.473 . . . . 74.310000000000002 108.269 171.58 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -62.48 127.6 21.29 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.213 1.942 . . . . 72.420000000000002 111.791 -176.823 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -71.43 2.17 5.33 Favored 'General case' 0 C--O 1.209 -1.058 0 CA-C-N 115.816 -0.629 . . . . 75.340000000000003 112.578 -177.401 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -108.89 -12.96 14.83 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.164 0.507 . . . . 75.140000000000001 111.402 179.283 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -102.26 173.05 6.54 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.235 0.54 . . . . 74.200000000000003 112.02 -172.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 1.3 m -91.69 119.92 31.98 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 115.277 -0.874 . . . . 74.450000000000003 108.902 -177.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 13.1 p -102.46 145.96 28.8 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.148 0.499 . . . . 63.43 110.925 -177.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -80.38 154.16 27.89 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.909 -0.587 . . . . 73.129999999999995 111.376 -176.252 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 23.1 mm -74.02 -6.19 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 CA-C-O 122.154 0.978 . . . . 72.120000000000005 110.498 -177.793 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 6.4 p -108.48 5.42 25.22 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.488 0.661 . . . . 62.25 111.156 177.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -97.36 150.59 20.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.52 -0.764 . . . . 71.409999999999997 111.251 -173.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 59.8 t -108.14 126.4 64.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 123.667 0.787 . . . . 72.120000000000005 110.452 -177.054 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 61.0 t -101.03 120.03 49.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 120.892 0.377 . . . . 74.439999999999998 110.361 -179.985 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.98 126.03 59.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 109.022 -0.732 . . . . 74.310000000000002 109.022 177.525 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 16.8 mt -120.55 128.35 76.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 114.749 -1.114 . . . . 71.120000000000005 111.506 -177.132 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 6.9 tt -103.62 126.95 58.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 115.481 -0.781 . . . . 73.230000000000004 109.849 177.795 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 2.4 p -119.02 139.04 47.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 123.39 0.676 . . . . 74.109999999999999 110.076 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 457' ' ' SER . . . -77.08 127.64 8.55 Favored Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 111.034 -0.827 . . . . 72.420000000000002 111.034 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.695 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 23.0 t . . . . . 0 C--N 1.301 -1.513 0 N-CA-C 108.05 -1.093 . . . . 71.349999999999994 108.05 -178.289 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo . . . . . 0 N--CA 1.444 -1.403 0 CA-C-O 121.283 0.451 . . . . 73.329999999999998 112.312 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -96.7 24.28 6.19 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 122.655 1.217 . . . . 65.129999999999995 108.601 178.012 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 18.7 p -117.07 149.25 40.6 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 112.615 -2.084 . . . . 72.239999999999995 109.296 -175.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -137.01 147.71 46.41 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.263 -0.643 . . . . 72.109999999999999 109.263 174.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -80.7 129.92 34.8 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 124.014 0.821 . . . . 73.340000000000003 109.418 179.071 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 543' ' ' THR . 36.3 pt -87.19 131.31 44.87 Favored Pre-proline 0 C--N 1.295 -1.762 0 CA-C-N 115.825 -0.625 . . . . 75.299999999999997 110.506 179.391 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.56 -172.34 1.46 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.216 1.944 . . . . 73.150000000000006 109.377 173.302 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -82.01 149.47 28.11 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.4 -1.334 . . . . 71.510000000000005 107.4 176.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.56 85.98 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 CA-C-O 122.59 1.186 . . . . 75.030000000000001 108.94 177.111 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -149.86 128.54 12.4 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 114.218 -1.355 . . . . 75.140000000000001 108.876 -178.038 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 122.77 -20.8 7.66 Favored Glycine 0 N--CA 1.435 -1.429 0 C-N-CA 120.246 -0.978 . . . . 73.209999999999994 111.673 177.354 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.87 177.39 4.86 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 120.952 0.406 . . . . 74.430000000000007 110.843 178.619 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 9.4 t -87.95 157.88 18.82 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.102 -0.703 . . . . 75.519999999999996 109.102 -178.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.3 p -50.6 -41.63 20.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 124.317 1.047 . . . . 73.109999999999999 112.043 -179.181 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -61.74 -41.53 97.79 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.043 0.386 . . . . 74.409999999999997 112.043 179.129 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 89.6 t -71.21 -42.43 75.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-O 121.243 0.544 . . . . 73.219999999999999 109.891 179.084 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -60.41 -42.45 96.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.489 -0.778 . . . . 65.430000000000007 110.633 179.143 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -59.41 -46.22 89.33 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.27 -0.877 . . . . 74.040000000000006 109.953 179.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.411 ' O ' HG23 ' A' ' 514' ' ' VAL . 2.8 tmmm? -60.49 -44.3 96.09 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.163 -0.926 . . . . 71.430000000000007 108.904 -179.09 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -61.97 -48.09 81.91 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 116.117 -0.492 . . . . 70.299999999999997 111.035 -179.407 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.93 -38.89 92.76 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 111.804 0.298 . . . . 75.349999999999994 111.804 179.402 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -63.14 -38.17 90.12 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 121.232 -0.187 . . . . 73.329999999999998 110.939 179.014 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 510' ' ' LYS . 72.2 t -61.17 -35.46 65.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.027 0.441 . . . . 72.5 110.648 176.605 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -79.06 -4.53 50.67 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 120.886 0.374 . . . . 75.519999999999996 110.99 -178.631 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 97.62 3.12 58.48 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 120.653 -0.784 . . . . 35.130000000000003 112.685 177.021 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.491 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 85.2 m-85 -86.44 115.24 23.82 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 108.032 -1.099 . . . . 74.310000000000002 108.032 -178.881 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.4 m -114.77 11.26 16.74 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 119.489 -0.884 . . . . 72.310000000000002 111.166 -176.27 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . 0.403 ' O ' HD11 ' A' ' 551' ' ' ILE . 67.7 mttm -129.41 114.23 15.9 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.279 -0.637 . . . . 75.140000000000001 109.279 176.249 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -130.86 150.54 51.97 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 115.645 -0.707 . . . . 74.340000000000003 110.075 178.743 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 68.9 m -126.73 146.76 50.1 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 107.174 -1.417 . . . . 74.420000000000002 107.174 172.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -117.94 129.37 55.57 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 120.251 -0.58 . . . . 73.430000000000007 109.956 -179.392 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -105.33 115.99 31.19 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 106.867 -1.531 . . . . 71.349999999999994 106.867 175.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 19.4 m -88.89 114.74 25.84 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 121.676 0.751 . . . . 64.519999999999996 110.602 -176.509 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 28.1 m -121.47 168.83 13.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-N 114.464 -1.244 . . . . 75.329999999999998 108.232 -178.014 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . 0.49 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 7.0 p-10 -103.74 149.65 24.8 Favored 'General case' 0 C--N 1.282 -2.336 0 C-N-CA 120.049 -0.66 . . . . 73.109999999999999 111.748 -177.778 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 19.8 m -149.44 178.13 1.58 Allowed Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 105.286 -2.116 . . . . 73.230000000000004 105.286 177.012 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -87.65 -12.44 4.46 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 121.29 1.327 . . . . 73.530000000000001 111.523 172.168 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . 0.418 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 35.5 mtp85 -87.01 148.42 45.25 Favored Pre-proline 0 N--CA 1.428 -1.546 0 C-N-CA 123.484 0.714 . . . . 74.530000000000001 109.332 179.033 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -56.14 148.47 59.28 Favored 'Trans proline' 0 C--O 1.259 1.556 0 C-N-CA 124.019 3.146 . . . . 74.340000000000003 117.13 -170.598 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -61.2 137.39 58.24 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 113.367 -1.742 . . . . 73.430000000000007 111.054 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 108.9 -17.95 32.0 Favored Glycine 0 N--CA 1.429 -1.828 0 N-CA-C 110.895 -0.882 . . . . 74.430000000000007 110.895 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -80.38 136.63 36.41 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 109.731 -0.47 . . . . 74.209999999999994 109.731 178.314 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 60.0 t -86.14 120.74 36.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.037 -1.097 . . . . 72.209999999999994 108.037 178.329 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 535' ' ' THR . . . . . 0.506 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 9.7 t -92.91 -1.97 56.25 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.946 -0.57 . . . . 73.450000000000003 110.78 -176.882 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 144.27 -167.19 26.99 Favored Glycine 0 CA--C 1.496 -1.095 0 N-CA-C 111.216 -0.754 . . . . 74.129999999999995 111.216 176.238 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 12.6 p -118.55 160.1 22.37 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 117.398 0.599 . . . . 72.299999999999997 110.288 176.036 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -71.2 -51.64 10.05 Favored Pre-proline 0 C--N 1.31 -1.144 0 CA-C-N 116.244 -0.434 . . . . 72.219999999999999 110.104 175.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -72.59 135.87 24.84 Favored 'Trans proline' 0 C--N 1.38 2.208 0 N-CA-C 109.134 -1.141 . . . . 75.409999999999997 109.134 171.287 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.69 154.51 67.92 Favored 'Trans proline' 0 C--O 1.254 1.285 0 C-N-CA 122.364 2.042 . . . . 74.230000000000004 113.415 -177.094 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.06 138.11 58.21 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.429 -0.805 . . . . 73.219999999999999 110.163 178.747 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.56 -20.4 34.63 Favored Glycine 0 C--N 1.305 -1.174 0 N-CA-C 111.755 -0.538 . . . . 75.530000000000001 111.755 -179.362 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 543' ' ' THR . . . . . 0.415 ' O ' HG12 ' A' ' 497' ' ' ILE . 25.6 m -70.63 133.39 46.64 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.34 -0.245 . . . . 75.310000000000002 110.34 -178.443 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 15.0 t -98.12 129.58 44.92 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 109.083 -0.71 . . . . 74.530000000000001 109.083 177.037 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 7.1 m -136.43 154.4 76.91 Favored Pre-proline 0 C--N 1.297 -1.675 0 CA-C-N 115.668 -0.696 . . . . 72.450000000000003 109.218 179.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -64.57 139.01 62.02 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.435 2.09 . . . . 71.319999999999993 111.244 178.414 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.491 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 35.3 m -63.85 -20.87 27.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 113.313 0.857 . . . . 74.219999999999999 113.313 -175.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -94.43 4.03 54.39 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.848 0.832 . . . . 44.439999999999998 110.508 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 39.4 m -93.54 179.49 5.37 Favored 'General case' 0 N--CA 1.437 -1.101 0 O-C-N 121.911 -0.493 . . . . 74.530000000000001 110.524 178.606 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 19.8 t -106.83 131.6 56.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 116.468 -0.333 . . . . 74.420000000000002 111.078 -174.117 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . 0.403 HD11 ' O ' ' A' ' 519' ' ' LYS . 0.2 OUTLIER -114.44 136.69 50.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 108.396 -0.964 . . . . 60.140000000000001 108.396 172.164 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -103.68 124.14 48.3 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 121.421 0.629 . . . . 72.140000000000001 111.726 -178.622 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.3 mp -97.37 134.77 40.2 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.681 -1.145 . . . . 75.25 110.014 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.97 119.06 26.78 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.505 -1.665 . . . . 73.310000000000002 106.505 177.313 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 59.6 t -114.41 131.07 67.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.793 -0.567 . . . . 64.209999999999994 109.866 -178.13 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.553 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 69.8 m -81.35 157.89 24.88 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 113.407 0.892 . . . . 73.019999999999996 113.407 -178.242 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.49 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 14.2 ptpt -119.08 158.34 26.06 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 105.326 -2.102 . . . . 74.5 105.326 167.519 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . 0.494 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -75.03 -42.65 29.01 Favored Glycine 0 CA--C 1.485 -1.808 0 C-N-CA 119.949 -1.12 . . . . 63.340000000000003 112.432 -174.597 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 55.7 t30 67.35 -12.4 0.26 Allowed 'General case' 0 CA--C 1.569 1.696 0 C-N-CA 124.186 0.994 . . . . 74.430000000000007 112.759 173.48 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.494 ' H ' ' C ' ' A' ' 558' ' ' GLY . 71.3 mt-30 -136.63 160.73 37.92 Favored 'General case' 0 C--O 1.253 1.289 0 C-N-CA 125.859 1.663 . . . . 72.239999999999995 107.505 176.373 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -138.92 136.6 35.65 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 110.117 -0.327 . . . . 65.439999999999998 110.117 176.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 8.3 p -59.89 121.68 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 121.599 0.714 . . . . 74.430000000000007 112.176 -178.013 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 21.4 ptm -87.6 147.05 40.72 Favored Pre-proline 0 C--O 1.252 1.211 0 CA-C-N 115.654 -0.703 . . . . 73.049999999999997 112.803 -175.085 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.69 170.78 19.56 Favored 'Trans proline' 0 CA--C 1.551 1.329 0 C-N-CA 124.566 3.511 . . . . 64.420000000000002 112.902 175.457 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.5 124.07 28.62 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.995 -0.548 . . . . 75.209999999999994 112.15 177.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -112.61 -3.31 14.35 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 122.045 0.926 . . . . 74.319999999999993 108.815 174.398 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 11.1 m -68.24 137.53 54.83 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.103 -1.408 . . . . 72.120000000000005 111.455 -177.587 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 80.4 30.92 39.15 Favored Glycine 0 N--CA 1.438 -1.203 0 C-N-CA 121.103 -0.57 . . . . 62.219999999999999 112.019 176.338 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 64.6 mtt -137.3 173.23 11.9 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.899 -0.778 . . . . 74.540000000000006 108.899 -178.677 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 89.0 m-85 -100.28 166.26 11.07 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 109.29 -0.633 . . . . 75.120000000000005 109.29 179.252 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 69.9 t90 -67.73 -28.47 67.67 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.327 -0.619 . . . . 72.519999999999996 109.327 178.059 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 10.2 p -68.56 -10.02 12.41 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 CA-C-N 115.63 -0.713 . . . . 75.129999999999995 110.409 176.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 577' ' ' ARG . 38.0 m-20 -100.59 -44.51 5.82 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 108.163 -1.051 . . . . 73.230000000000004 108.163 173.611 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . 0.451 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -59.35 -51.74 68.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.112 -0.949 . . . . 65.109999999999999 112.564 -177.33 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.561 ' OE2' ' HD3' ' A' ' 579' ' ' ARG . 21.0 tp10 -52.95 -56.77 20.27 Favored Pre-proline 0 CA--C 1.562 1.431 0 CA-C-O 119.02 -0.514 . . . . 74.040000000000006 112.09 -179.666 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.77 -38.16 93.91 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.126 1.884 . . . . 74.230000000000004 112.595 176.332 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 573' ' ' ASP . 80.8 mtp180 -65.79 -36.85 84.69 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 120.864 -0.335 . . . . 74.340000000000003 111.332 -179.558 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 96.1 mt -63.36 -38.77 92.45 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.128 0.49 . . . . 73.510000000000005 109.797 178.192 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . 0.561 ' HD3' ' OE2' ' A' ' 575' ' ' GLU . 7.0 mmm180 -65.3 -45.79 82.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.509 -0.769 . . . . 75.340000000000003 108.941 179.562 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.22 -29.81 70.14 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.369 -0.832 . . . . 70.409999999999997 112.213 -178.318 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 95.5 mt -81.59 -6.3 58.86 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.843 0.354 . . . . 75.140000000000001 110.833 178.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 72.87 35.77 58.08 Favored Glycine 0 N--CA 1.439 -1.114 0 N-CA-C 111.456 -0.657 . . . . 65.530000000000001 111.456 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . 0.427 ' C ' ' HG1' ' A' ' 584' ' ' THR . 79.1 t90 -76.22 128.65 35.35 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.782 -0.451 . . . . 75.010000000000005 109.782 -179.79 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 584' ' ' THR . . . . . 0.427 ' HG1' ' C ' ' A' ' 583' ' ' TRP . 17.6 m -150.54 86.56 1.4 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.899 -0.778 . . . . 64.150000000000006 108.899 174.106 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -147.73 -142.92 3.74 Favored Glycine 0 C--N 1.309 -0.943 0 N-CA-C 110.244 -1.142 . . . . 63.240000000000002 110.244 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 47.7 tpp -96.51 125.21 40.84 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 117.538 0.669 . . . . 72.200000000000003 110.964 177.409 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -96.23 128.96 43.62 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.54 -1.652 . . . . 74.409999999999997 106.54 175.434 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -94.99 123.26 38.37 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 105.241 -2.133 . . . . 65.109999999999999 105.241 178.439 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -85.52 121.42 28.2 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 113.251 0.834 . . . . 74.109999999999999 113.251 -162.483 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -105.47 144.0 15.74 Favored Glycine 0 N--CA 1.407 -3.237 0 N-CA-C 107.875 -2.09 . . . . 75.219999999999999 107.875 171.3 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -94.21 150.93 19.85 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 117.072 0.436 . . . . 75.329999999999998 110.018 -179.251 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -73.44 124.8 26.51 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.314 -1.365 . . . . 75.239999999999995 107.314 173.271 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 41.1 t -105.94 123.35 60.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 CA-C-N 116.188 -0.46 . . . . 73.510000000000005 111.367 -175.235 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -81.32 107.8 14.41 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.477 -1.305 . . . . 75.420000000000002 107.477 173.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -136.08 21.1 3.24 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.615 -0.72 . . . . 73.239999999999995 109.725 -177.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 101.18 173.46 28.75 Favored Glycine 0 N--CA 1.427 -1.914 0 C-N-CA 120.267 -0.968 . . . . 41.049999999999997 110.812 -177.505 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -62.18 -33.42 85.84 Favored Glycine 0 C--O 1.218 -0.865 0 N-CA-C 114.188 0.435 . . . . 53.329999999999998 114.188 -175.093 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 13.7 m -58.31 -24.44 59.64 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 113.806 1.039 . . . . 64.420000000000002 113.806 -175.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -98.49 -0.31 43.63 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 113.343 0.868 . . . . 74.450000000000003 113.343 -175.339 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . 0.48 ' HA ' ' OXT' ' A' ' 626' ' ' GLN . 5.7 p80 -35.46 98.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 115.682 1.734 . . . . 70.510000000000005 115.682 -174.264 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 52.95 10.29 0.15 Allowed 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 126.075 1.75 . . . . 64.319999999999993 115.381 172.09 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 38.4 ttt180 -79.83 143.34 34.46 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.945 -1.097 . . . . 75.129999999999995 110.945 -175.408 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 87.9 t -74.58 131.0 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 108.224 -1.028 . . . . 73.209999999999994 108.224 179.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 46.5 t -94.04 -48.09 13.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.332 0.587 . . . . 74.340000000000003 110.248 -175.345 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -148.34 151.19 34.93 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.635 -0.711 . . . . 75.519999999999996 110.049 179.099 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 621' ' ' THR . 14.4 pt20 -115.57 141.7 47.71 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.869 -1.16 . . . . 71.140000000000001 107.869 174.372 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.528 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 17.0 t-20 -51.35 -57.16 15.16 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 123.66 0.6 . . . . 74.310000000000002 112.274 -175.915 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 9.6 Cg_endo -100.01 138.66 0.27 Allowed 'Trans proline' 0 N--CA 1.433 -2.069 0 C-N-CA 121.742 1.628 . . . . 73.549999999999997 110.096 172.271 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -70.13 147.14 59.82 Favored 'Trans proline' 0 C--O 1.252 1.177 0 C-N-CA 121.313 1.342 . . . . 72.099999999999994 109.918 175.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -62.37 138.98 58.55 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.886 0.375 . . . . 74.340000000000003 110.551 -178.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.16 -8.21 44.84 Favored Glycine 0 N--CA 1.431 -1.649 0 N-CA-C 110.598 -1.001 . . . . 73.120000000000005 110.598 -175.032 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 6.1 m -100.83 157.29 16.83 Favored 'General case' 0 C--O 1.249 1.066 0 N-CA-C 108.384 -0.969 . . . . 71.430000000000007 108.384 178.174 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -85.69 132.18 10.95 Favored Glycine 0 N--CA 1.428 -1.867 0 N-CA-C 111.227 -0.749 . . . . 64.030000000000001 111.227 178.35 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 21.8 m -97.43 142.47 14.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 110.055 -0.35 . . . . 71.340000000000003 110.055 178.166 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . 0.442 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 30.1 p-10 -57.05 167.13 0.88 Allowed 'General case' 0 N--CA 1.436 -1.164 0 O-C-N 124.476 1.11 . . . . 74.129999999999995 112.478 -178.821 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -61.02 -25.33 66.83 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.832 -1.077 . . . . 65.109999999999999 111.847 -178.035 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -78.44 -37.04 44.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.445 -0.343 . . . . 65.239999999999995 110.536 176.298 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 90.5 22.4 34.45 Favored Glycine 0 C--O 1.211 -1.307 0 C-N-CA 119.254 -1.451 . . . . 40.219999999999999 112.444 179.153 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.82 123.14 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 CA-C-O 122.63 1.205 . . . . 73.030000000000001 110.819 -168.754 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 6.3 tp -129.34 132.37 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 113.839 -1.528 . . . . 74.019999999999996 111.256 -174.085 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 606' ' ' GLN . 44.2 m -104.45 137.27 42.57 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 107.971 -1.122 . . . . 71.019999999999996 107.971 174.629 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 88.7 mt -138.15 157.01 47.16 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.243 -1.391 . . . . 71.109999999999999 107.243 178.638 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -144.25 136.6 26.59 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 104.178 -2.527 . . . . 72.5 104.178 177.063 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' A' ' 602' ' ' ARG . 6.8 p90 -143.06 161.65 37.6 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 123.658 0.599 . . . . 73.209999999999994 111.526 -177.463 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -88.18 -163.62 39.4 Favored Glycine 0 N--CA 1.426 -2.004 0 C-N-CA 120.836 -0.697 . . . . 41.130000000000003 111.797 177.648 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . 0.48 ' OXT' ' HA ' ' A' ' 600' ' ' HIS . 8.7 tp-100 . . . . . 0 C--N 1.303 -1.444 0 C-N-CA 123.166 0.586 . . . . 75.120000000000005 110.352 -177.72 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 CA--C 1.506 -0.736 0 CA-C-O 121.07 0.462 . . . . 72.439999999999998 109.944 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 409' ' ' SER . 35.9 m -120.73 163.06 18.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 115.724 -0.671 . . . . 72.430000000000007 109.411 -175.475 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -94.05 136.94 33.8 Favored 'General case' 0 N--CA 1.39 -3.45 0 N-CA-C 108.733 -0.84 . . . . 62.240000000000002 108.733 176.103 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 94.7 t -97.8 129.28 31.67 Favored Pre-proline 0 C--N 1.269 -2.908 0 CA-C-N 114.289 -1.323 . . . . 73.140000000000001 109.566 -173.521 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -65.33 120.3 7.48 Favored 'Trans proline' 0 N--CA 1.443 -1.489 0 C-N-CA 121.769 1.646 . . . . 73.329999999999998 110.37 176.905 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -97.03 83.17 3.31 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 106.981 -1.488 . . . . 73.420000000000002 106.981 -175.473 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.475 ' HB ' ' NE2' ' A' ' 368' ' ' GLN . 30.2 m -71.65 34.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 125.997 1.719 . . . . 73.340000000000003 115.053 -171.748 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.419 ' HG3' ' OG1' ' A' ' 402' ' ' THR . 21.0 mmt180 -65.41 148.38 51.81 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 125.315 1.446 . . . . 75.239999999999995 111.795 177.377 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 106.47 0.67 37.52 Favored Glycine 0 CA--C 1.501 -0.791 0 N-CA-C 111.028 -0.829 . . . . 65.319999999999993 111.028 -175.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . 0.475 ' NE2' ' HB ' ' A' ' 365' ' ' VAL . 41.8 mt-30 -111.03 -154.53 0.54 Allowed 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 108.392 -0.966 . . . . 70.409999999999997 108.392 175.025 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 61.8 p -96.26 168.24 10.7 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 109.765 -0.457 . . . . 74.540000000000006 109.765 -176.701 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.88 -46.99 85.25 Favored 'General case' 0 N--CA 1.421 -1.918 0 CA-C-N 115.339 -0.846 . . . . 73.230000000000004 109.329 179.706 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.38 -44.83 82.04 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.701 -0.681 . . . . 71.200000000000003 112.411 -176.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -66.94 -47.2 72.39 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.885 0.374 . . . . 61.539999999999999 110.097 -177.144 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -67.35 -41.12 85.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.87 -0.604 . . . . 73.019999999999996 111.873 -177.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 66.5 mt -68.09 -39.8 81.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 116.692 -0.231 . . . . 75.349999999999994 110.399 177.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.16 -38.65 89.85 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 120.799 0.333 . . . . 54.119999999999997 110.34 179.61 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 376' ' ' THR . . . . . 0.613 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 52.0 m -63.14 -47.9 80.75 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.725 -0.67 . . . . 71.540000000000006 110.199 179.307 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 98.2 mt -64.01 -42.33 97.18 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 116.33 -0.396 . . . . 74.219999999999999 110.506 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.21 -41.67 96.95 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.967 -0.561 . . . . 72.099999999999994 109.758 179.826 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -69.82 -17.64 63.41 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 112.969 0.729 . . . . 75.099999999999994 112.969 177.404 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 376' ' ' THR . 6.9 mmp_? -88.78 -10.8 46.89 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.653 -0.499 . . . . 73.109999999999999 109.653 175.468 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.48 2.9 55.51 Favored Glycine 0 C--N 1.32 -0.36 0 CA-C-N 115.948 -0.569 . . . . 65.299999999999997 112.786 178.157 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -82.62 154.23 25.04 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-O 121.254 0.55 . . . . 71.400000000000006 111.895 -177.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -101.26 145.8 28.38 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.224 -1.399 . . . . 75.140000000000001 107.224 179.8 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 1.1 mp -129.38 144.01 39.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.171 -1.048 . . . . 72.530000000000001 108.171 179.252 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 13.9 ttm180 -110.56 127.87 55.4 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 105.714 -1.958 . . . . 74.510000000000005 105.714 174.203 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 23.7 m -114.04 117.41 31.22 Favored 'General case' 0 C--N 1.271 -2.827 0 N-CA-C 108.074 -1.084 . . . . 74.400000000000006 108.074 -178.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.55 128.77 56.56 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.361 -0.977 . . . . 72.040000000000006 108.361 -177.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -99.78 127.94 45.9 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.666 -0.494 . . . . 73.109999999999999 109.666 -178.507 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 421' ' ' SER . 98.0 mttt -132.74 123.35 18.23 Favored Pre-proline 0 C--N 1.313 -1.017 0 N-CA-C 111.781 0.289 . . . . 73.340000000000003 111.781 178.61 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -82.69 128.09 5.16 Favored 'Trans proline' 0 C--O 1.254 1.288 0 C-N-CA 121.865 1.71 . . . . 72.209999999999994 109.032 171.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.539 ' HB3' ' CD1' ' A' ' 394' ' ' ILE . 10.2 t70 171.95 -162.17 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 105.174 -2.158 . . . . 75.239999999999995 105.174 -174.956 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 36.1 p -141.57 2.3 1.61 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.171 0.51 . . . . 61.5 111.186 178.157 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 25.6 m -98.92 -25.99 14.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.395 0.617 . . . . 75.519999999999996 111.381 -175.011 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . 0.539 ' CD1' ' HB3' ' A' ' 391' ' ' ASP . 0.2 OUTLIER -88.53 152.29 49.31 Favored Pre-proline 0 C--N 1.298 -1.636 0 CA-C-N 116.075 -0.511 . . . . 72.340000000000003 109.911 -178.167 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -35.59 150.71 0.03 OUTLIER 'Trans proline' 0 CA--C 1.553 1.453 1 C-N-CA 125.468 4.112 . . . . 75.549999999999997 116.924 177.631 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.72 162.58 10.46 Favored 'Trans proline' 0 C--N 1.364 1.388 0 C-N-CA 124.147 3.231 . . . . 64.219999999999999 110.619 172.088 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . 0.422 ' HA ' HG11 ' A' ' 420' ' ' VAL . 0.9 OUTLIER -59.12 -9.69 2.22 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 113.181 0.808 . . . . 74.310000000000002 113.181 -176.232 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -95.06 -178.82 4.61 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 108.77 -0.826 . . . . 74.040000000000006 108.77 178.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 27.6 m -97.73 117.46 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.825 0 C-N-CA 117.065 -1.854 . . . . 72.010000000000005 110.575 179.597 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.89 -47.4 7.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 109.44 -0.578 . . . . 74.129999999999995 109.44 175.337 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.75 169.19 27.94 Favored Glycine 0 N--CA 1.427 -1.947 0 N-CA-C 111.141 -0.784 . . . . 65.120000000000005 111.141 -177.5 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 402' ' ' THR . . . . . 0.419 ' OG1' ' HG3' ' A' ' 366' ' ' ARG . 0.6 OUTLIER -155.67 -176.08 5.77 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 125.479 1.511 . . . . 74.430000000000007 109.935 -176.911 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . 0.437 ' C ' ' H ' ' A' ' 405' ' ' ALA . 6.6 p-10 -99.0 155.41 36.6 Favored Pre-proline 0 C--N 1.299 -1.61 0 N-CA-C 106.605 -1.628 . . . . 72.319999999999993 106.605 -178.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -59.93 10.56 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 124.575 3.517 . . . . 73.209999999999994 116.156 -172.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.437 ' H ' ' C ' ' A' ' 403' ' ' ASP . . . -53.45 -43.94 68.47 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 122.868 0.467 . . . . 60.439999999999998 111.855 -179.355 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -79.53 -32.33 42.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.251 0.548 . . . . 74.129999999999995 111.019 -179.177 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -79.74 1.57 26.1 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.108 0.48 . . . . 74.120000000000005 111.211 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 51.0 m -105.47 149.56 26.07 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.676 -1.601 . . . . 75.439999999999998 106.676 172.382 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 409' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 360' ' ' VAL . 15.0 p -76.0 113.48 13.56 Favored 'General case' 0 N--CA 1.422 -1.826 0 C-N-CA 119.806 -0.758 . . . . 71.219999999999999 110.975 178.77 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.4 m -121.93 170.0 12.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.377 -0.829 . . . . 71.430000000000007 109.482 178.869 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 33.3 t -76.52 157.15 32.34 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.145 -0.687 . . . . 70.5 109.145 179.759 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -69.24 109.87 4.32 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-O 121.289 0.566 . . . . 52.200000000000003 110.079 179.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 108.38 55.61 0.59 Allowed Glycine 0 N--CA 1.433 -1.514 0 CA-C-N 115.095 -0.957 . . . . 73.019999999999996 111.413 179.152 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -100.32 -173.18 2.35 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.739 -1.208 . . . . 74.439999999999998 107.739 178.057 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -120.08 113.86 21.12 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.414 -0.587 . . . . 74.150000000000006 109.414 -177.34 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 44.9 mm -104.32 133.71 47.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 108.822 -0.807 . . . . 75.549999999999997 108.822 -179.058 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 80.3 m -101.82 132.24 47.68 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 122.022 -0.424 . . . . 75.200000000000003 110.192 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 9.7 p -115.44 134.36 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 108.888 -0.782 . . . . 73.409999999999997 108.888 176.622 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -105.26 114.2 28.24 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.812 0.815 . . . . 75.439999999999998 109.286 177.805 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.422 HG11 ' HA ' ' A' ' 397' ' ' ASP . 96.3 t -111.22 131.39 62.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 114.569 -1.196 . . . . 74.109999999999999 108.846 -174.209 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 421' ' ' SER . . . . . 0.429 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 17.3 t -92.67 121.82 34.47 Favored 'General case' 0 N--CA 1.428 -1.553 0 C-N-CA 119.53 -0.868 . . . . 74.319999999999993 110.0 179.265 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 33.9 p -120.09 107.28 12.85 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 116.152 -0.476 . . . . 73.140000000000001 110.225 174.244 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.193 0 C-N-CA 119.94 -1.124 . . . . 73.5 113.438 176.255 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 . . . . . 0 N--CA 1.43 -1.47 0 N-CA-C 107.334 -1.358 . . . . 70.140000000000001 107.334 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -121.22 151.79 39.58 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 119.585 -0.846 . . . . 74.549999999999997 112.428 -169.817 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 34.9 tt0 -83.63 138.77 33.19 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.299 -1.319 . . . . 75.439999999999998 109.009 -176.488 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 70.7 mt -80.59 116.65 63.44 Favored Pre-proline 0 C--N 1.306 -1.305 0 N-CA-C 108.082 -1.081 . . . . 70.200000000000003 108.082 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -71.29 140.62 37.42 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.476 1.451 . . . . 75.129999999999995 110.201 176.398 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.28 128.62 35.48 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.413 -1.328 . . . . 74.219999999999999 107.413 175.603 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 42.9 t -118.28 157.45 19.72 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 107.514 -1.291 . . . . 73.450000000000003 107.514 -177.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.501 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 15.4 m -63.74 146.64 53.49 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-O 120.961 0.41 . . . . 74.140000000000001 110.985 -179.511 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 34.8 p -69.14 -25.91 64.62 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 124.66 1.184 . . . . 71.450000000000003 112.574 -170.511 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.61 -10.94 41.47 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 115.431 -0.804 . . . . 74.310000000000002 111.109 179.334 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.501 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 2.4 m -100.66 46.14 0.96 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.424 0.63 . . . . 74.439999999999998 109.729 -176.197 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -52.24 -42.79 63.92 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 113.892 1.071 . . . . 73.549999999999997 113.892 -178.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.52 -44.48 94.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.633 0.254 . . . . 73.209999999999994 110.996 -176.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . 0.524 ' O ' ' HB3' ' A' ' 442' ' ' LYS . 28.1 tt0 -70.62 -33.11 70.66 Favored 'General case' 0 C--O 1.195 -1.775 0 CA-C-N 116.474 -0.33 . . . . 73.109999999999999 110.777 174.484 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.407 ' O ' HD23 ' A' ' 444' ' ' LEU . . . -59.66 -52.28 66.18 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.988 -0.285 . . . . 63.329999999999998 110.75 179.127 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 33.7 m -62.48 -36.33 74.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.614 0.721 . . . . 73.430000000000007 110.398 177.437 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.524 ' HB3' ' O ' ' A' ' 439' ' ' GLU . 20.7 ttmm -59.46 -46.79 87.76 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 124.97 1.308 . . . . 70.310000000000002 110.229 176.019 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -65.9 -38.76 89.59 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 123.282 0.633 . . . . 73.310000000000002 111.727 -179.64 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.407 HD23 ' O ' ' A' ' 440' ' ' ALA . 4.6 mm? -63.32 -34.64 78.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.054 -0.35 . . . . 75.010000000000005 110.054 174.859 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.511 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 32.4 m -69.66 -45.67 67.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.25 0.548 . . . . 71.329999999999998 110.221 178.129 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.63 -24.95 64.62 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.635 -0.711 . . . . 64.109999999999999 112.455 -178.118 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.57 -4.77 53.01 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.326 0.491 . . . . 73.219999999999999 112.326 -177.651 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 125.88 -79.59 0.37 Allowed Glycine 0 CA--C 1.497 -1.074 0 C-N-CA 119.96 -1.114 . . . . 71.109999999999999 111.98 177.447 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -42.65 -66.87 0.32 Allowed 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.372 1.069 . . . . 62.0 113.858 178.354 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . 0.511 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 63.1 25.54 68.24 Favored Glycine 0 CA--C 1.502 -0.766 0 O-C-N 123.362 0.414 . . . . 65.430000000000007 112.626 -178.338 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.423 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 8.6 mmt180 -105.31 110.61 23.03 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.432 -1.692 . . . . 74.439999999999998 106.432 -179.711 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -141.03 154.42 45.99 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-O 121.228 0.537 . . . . 74.319999999999993 112.091 -176.177 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 5.4 tppp? -137.11 135.0 37.04 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.477 -1.305 . . . . 74.200000000000003 107.477 177.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -100.03 133.08 44.93 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.312 -0.625 . . . . 74.400000000000006 109.312 176.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -126.67 151.73 47.69 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.724 -0.473 . . . . 71.140000000000001 109.724 177.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -113.9 141.3 47.53 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.589 -1.263 . . . . 74.420000000000002 107.589 179.245 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 37.3 t -138.1 135.34 18.48 Favored Pre-proline 0 C--N 1.283 -2.323 0 N-CA-C 109.122 -0.695 . . . . 72.239999999999995 109.122 178.394 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.613 ' HA ' ' O ' ' A' ' 490' ' ' SER . 51.0 Cg_endo -73.07 122.9 8.45 Favored 'Trans proline' 0 N--CA 1.439 -1.679 0 C-N-CA 121.521 1.481 . . . . 75.049999999999997 109.403 174.608 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 51.0 m -148.44 -179.79 7.22 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 109.685 -0.487 . . . . 64.239999999999995 109.685 -175.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.1 t -47.69 137.86 9.6 Favored Pre-proline 0 C--O 1.251 1.158 0 C-N-CA 124.556 1.143 . . . . 73.239999999999995 112.03 178.371 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -52.73 -29.31 41.49 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 124.642 3.562 . . . . 72.140000000000001 113.668 -175.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -71.33 -26.61 62.91 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 112.718 0.636 . . . . 74.099999999999994 112.718 -178.53 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -93.89 -4.52 49.81 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.806 -0.559 . . . . 71.409999999999997 111.624 179.566 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 85.3 t -60.68 127.79 20.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-N 116.006 -0.543 . . . . 72.329999999999998 110.524 178.224 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 95.88 -7.27 67.5 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 115.613 -0.721 . . . . 74.450000000000003 113.862 176.456 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.427 ' O ' HG21 ' A' ' 488' ' ' VAL . 6.8 mptt -122.35 158.96 28.47 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.586 -0.894 . . . . 65.409999999999997 108.586 -179.707 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 66.2 t -72.13 143.81 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.739 0 N-CA-C 107.999 -1.112 . . . . 63.109999999999999 107.999 176.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 58.3 mt -97.26 -27.73 3.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 107.492 -1.299 . . . . 73.439999999999998 107.492 179.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 153.18 -165.83 31.38 Favored Glycine 0 N--CA 1.419 -2.457 0 C-N-CA 120.541 -0.837 . . . . 61.140000000000001 111.956 175.558 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.13 142.69 46.48 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 106.991 -1.485 . . . . 72.010000000000005 106.991 176.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -67.68 -55.72 13.64 Favored Pre-proline 0 CA--C 1.548 0.879 0 N-CA-C 109.712 -0.477 . . . . 73.120000000000005 109.712 179.064 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -61.15 133.84 49.16 Favored 'Trans proline' 0 C--N 1.37 1.659 0 N-CA-C 108.276 -1.471 . . . . 72.25 108.276 168.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . 0.439 ' C ' ' H ' ' A' ' 475' ' ' ASN . 32.5 Cg_exo -62.14 127.96 22.65 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.742 2.295 . . . . 74.340000000000003 113.821 -173.862 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -74.03 12.8 0.63 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.968 0.907 . . . . 73.140000000000001 111.234 178.59 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . 0.439 ' H ' ' C ' ' A' ' 473' ' ' PRO . 12.4 m120 -111.03 -7.65 14.51 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.852 -0.613 . . . . 74.5 109.846 176.188 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -116.25 174.7 5.91 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 113.542 0.942 . . . . 73.310000000000002 113.542 -170.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 477' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 0.9 OUTLIER -99.09 141.12 32.27 Favored 'General case' 0 N--CA 1.411 -2.414 0 C-N-CA 124.513 1.125 . . . . 70.109999999999999 112.6 -179.173 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 28.3 p -137.82 149.17 46.12 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.11 -0.95 . . . . 74.319999999999993 109.362 177.765 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.93 162.11 27.37 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 120.846 0.355 . . . . 75.409999999999997 110.948 178.477 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.9 mp -67.57 -15.19 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-O 122.133 0.968 . . . . 74.409999999999997 110.976 -178.543 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.2 p -94.41 0.75 55.66 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 115.953 -0.567 . . . . 71.450000000000003 112.067 177.437 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -83.69 133.88 34.79 Favored 'General case' 0 CA--C 1.503 -0.855 0 O-C-N 122.005 -0.434 . . . . 73.439999999999998 111.414 -178.581 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . 0.423 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.3 p -96.53 126.71 49.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.658 -0.701 . . . . 63.399999999999999 109.728 178.089 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 22.3 m -101.48 136.75 31.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-O 121.313 0.578 . . . . 75.120000000000005 110.346 178.703 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.79 120.24 58.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 109.005 -0.739 . . . . 75.230000000000004 109.005 178.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 37.2 mt -109.49 122.91 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 114.663 -1.153 . . . . 73.299999999999997 109.9 -177.249 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.4 tt -106.61 127.0 62.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 115.062 -0.972 . . . . 74.519999999999996 111.631 -173.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 466' ' ' LYS . 2.5 p -111.34 142.78 22.72 Favored 'Isoleucine or valine' 0 C--O 1.247 0.967 0 N-CA-C 109.088 -0.708 . . . . 64.109999999999999 109.088 176.411 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -88.17 141.11 16.69 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.88 -0.676 . . . . 70.310000000000002 113.468 -176.059 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.613 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 11.1 t . . . . . 0 N--CA 1.431 -1.414 0 N-CA-C 106.804 -1.554 . . . . 63.219999999999999 106.804 176.131 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo . . . . . 0 C--O 1.244 0.805 0 CA-C-O 120.987 0.328 . . . . 74.200000000000003 112.535 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -118.19 53.46 0.96 Allowed 'General case' 0 C--O 1.244 0.805 0 CA-C-O 122.302 1.048 . . . . 74.420000000000002 108.239 177.446 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 22.8 p -117.78 147.95 42.52 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.762 -1.108 . . . . 75.209999999999994 111.233 -176.022 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -141.47 161.79 37.05 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.139 -1.06 . . . . 71.549999999999997 108.139 177.495 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.3 p-10 -100.4 138.25 37.72 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.267 0.556 . . . . 74.329999999999998 110.754 178.951 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 30.9 pt -77.04 137.51 65.46 Favored Pre-proline 0 C--N 1.308 -1.234 0 CA-C-N 115.293 -0.867 . . . . 73.120000000000005 111.967 -178.56 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -81.79 176.32 8.51 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.692 2.261 . . . . 74.140000000000001 111.22 176.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -86.7 118.88 26.39 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 108.843 -0.799 . . . . 75.450000000000003 108.843 178.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.09 8.78 7.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-O 122.107 0.956 . . . . 72.540000000000006 109.967 -177.426 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -68.19 108.02 3.0 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.93 -1.032 . . . . 74.329999999999998 109.719 -179.343 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 132.13 -19.11 4.66 Favored Glycine 0 N--CA 1.432 -1.621 0 C-N-CA 120.689 -0.767 . . . . 53.020000000000003 111.36 -177.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -99.58 172.94 6.98 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.045 -0.662 . . . . 74.420000000000002 109.344 177.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 533' ' ' GLU . 40.2 p -90.81 157.69 17.23 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.105 -0.638 . . . . 64.549999999999997 110.866 -176.078 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 10.0 p -53.7 -40.75 44.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.848 0.685 . . . . 75.430000000000007 112.848 -175.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -62.76 -42.93 99.91 Favored 'General case' 0 C--O 1.249 1.064 0 CA-C-O 121.236 0.541 . . . . 73.400000000000006 110.387 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 87.8 t -74.66 -37.05 42.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.631 -0.713 . . . . 74.310000000000002 110.065 -178.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . 0.438 ' HA ' ' ND2' ' A' ' 511' ' ' ASN . . . -63.29 -50.24 70.87 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.261 -0.882 . . . . 71.329999999999998 111.957 -179.015 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -64.82 -35.53 81.41 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.853 0.359 . . . . 73.25 110.712 -178.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.436 ' O ' HG23 ' A' ' 514' ' ' VAL . 3.6 tppp? -65.63 -52.97 47.78 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.672 -0.695 . . . . 75.409999999999997 111.627 179.756 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . 0.438 ' ND2' ' HA ' ' A' ' 508' ' ' ALA . 8.0 p30 -66.02 -37.82 86.85 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 120.342 -0.543 . . . . 75.040000000000006 111.539 -176.452 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . 0.419 HD22 ' O ' ' A' ' 508' ' ' ALA . 4.6 mm? -60.08 -41.32 92.18 Favored 'General case' 0 C--O 1.246 0.904 0 C-N-CA 121.032 -0.267 . . . . 75.120000000000005 110.617 176.052 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.11 -38.22 90.31 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 116.414 -0.357 . . . . 64.140000000000001 111.158 178.336 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 510' ' ' LYS . 96.9 t -63.77 -30.98 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 CA-C-N 115.889 -0.596 . . . . 73.540000000000006 111.223 179.198 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -80.26 -13.22 59.39 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 120.502 -0.479 . . . . 73.099999999999994 111.647 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 119.0 -14.7 11.16 Favored Glycine 0 N--CA 1.434 -1.445 0 C-N-CA 119.955 -1.117 . . . . 73.319999999999993 112.504 178.716 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -77.44 102.56 6.91 Favored 'General case' 0 CA--C 1.481 -1.692 0 N-CA-C 106.182 -1.784 . . . . 71.450000000000003 106.182 -178.678 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.5 m -88.91 -28.86 20.03 Favored 'General case' 0 N--CA 1.407 -2.58 0 C-N-CA 119.479 -0.888 . . . . 75.430000000000007 113.03 -167.152 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 61.7 mttp -108.32 125.36 51.62 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.736 -0.785 . . . . 74.209999999999994 111.659 -174.508 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -130.64 149.49 52.27 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.727 -0.669 . . . . 75.439999999999998 110.851 -178.38 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 46.9 m -132.29 143.71 50.08 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.33 -1.359 . . . . 73.230000000000004 107.33 173.786 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.04 144.32 44.74 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 109.381 -0.6 . . . . 72.439999999999998 109.381 179.327 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -130.64 129.99 43.37 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.3 -0.63 . . . . 72.439999999999998 109.3 178.814 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 50.8 m -84.11 120.97 26.8 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.542 -0.54 . . . . 63.219999999999999 109.542 179.529 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 32.3 m -121.4 162.71 20.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 108.149 -1.056 . . . . 74.0 108.149 179.229 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . 0.571 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 6.9 p-10 -82.52 134.38 35.2 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 119.26 -0.976 . . . . 73.530000000000001 109.378 -178.57 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 527' ' ' SER . . . . . 0.443 ' HG ' ' C ' ' A' ' 526' ' ' ASP . 51.1 m -152.73 167.99 12.28 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 110.231 -0.285 . . . . 72.409999999999997 110.231 177.13 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -85.7 -8.05 8.35 Favored 'Trans proline' 0 C--N 1.36 1.148 0 C-N-CA 122.284 1.99 . . . . 72.010000000000005 111.295 174.555 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . 0.507 ' HD3' ' OE2' ' A' ' 533' ' ' GLU . 50.4 mtt180 -80.07 145.53 61.18 Favored Pre-proline 0 N--CA 1.445 -0.71 0 N-CA-C 107.589 -1.263 . . . . 73.209999999999994 107.589 178.467 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -61.31 152.29 73.42 Favored 'Trans proline' 0 C--O 1.256 1.422 0 C-N-CA 122.364 2.043 . . . . 64.109999999999999 112.585 -179.327 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -62.93 115.58 4.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.132 -0.94 . . . . 74.129999999999995 111.352 -176.238 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 134.3 -24.64 3.55 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 120.564 -0.827 . . . . 53.130000000000003 112.224 178.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . 0.507 ' OE2' ' HD3' ' A' ' 529' ' ' ARG . 32.0 tt0 -82.99 137.85 33.99 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.349 -0.541 . . . . 73.319999999999993 109.797 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 88.2 t -81.83 120.2 32.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.86 -0.793 . . . . 74.310000000000002 108.86 178.413 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 535' ' ' THR . . . . . 0.441 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 9.3 t -80.94 -13.27 59.05 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.314 -0.403 . . . . 64.340000000000003 110.154 -179.075 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.91 -170.76 29.29 Favored Glycine 0 N--CA 1.426 -2.005 0 N-CA-C 109.987 -1.245 . . . . 72.030000000000001 109.987 178.222 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 14.1 p -116.88 160.4 20.93 Favored 'General case' 0 C--N 1.273 -2.729 0 N-CA-C 108.384 -0.969 . . . . 74.140000000000001 108.384 178.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . 0.445 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 38.1 t30 -67.02 -51.75 35.03 Favored Pre-proline 0 C--N 1.317 -0.841 0 C-N-CA 120.443 -0.503 . . . . 64.420000000000002 110.762 178.305 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . 0.445 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 3.9 Cg_exo -77.45 131.13 11.35 Favored 'Trans proline' 0 C--N 1.367 1.538 0 N-CA-C 107.601 -1.73 . . . . 74.430000000000007 107.601 170.576 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.93 162.15 39.23 Favored 'Trans proline' 0 C--O 1.25 1.117 0 C-N-CA 122.142 1.895 . . . . 73.25 112.555 -177.215 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -56.99 131.33 49.52 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 109.415 -0.587 . . . . 52.210000000000001 109.415 175.783 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.9 -12.06 38.04 Favored Glycine 0 C--N 1.301 -1.399 0 C-N-CA 120.928 -0.654 . . . . 63.439999999999998 111.929 -177.656 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 56.5 m -68.16 120.68 14.74 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.222 -0.659 . . . . 75.530000000000001 109.222 177.111 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 31.8 m -90.77 122.18 33.28 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 109.266 -0.642 . . . . 63.399999999999999 109.266 -179.464 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 28.7 m -136.88 158.68 72.47 Favored Pre-proline 0 C--N 1.311 -1.087 0 N-CA-C 108.96 -0.756 . . . . 75.299999999999997 108.96 -177.57 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -62.5 148.02 93.95 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 122.28 1.986 . . . . 73.200000000000003 110.723 175.527 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 27.0 m -64.13 -27.52 42.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 121.482 0.658 . . . . 75.530000000000001 111.882 -178.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -88.85 2.91 52.88 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 116.159 -0.473 . . . . 73.299999999999997 110.755 -179.25 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 9.7 t -82.14 172.16 13.5 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 120.862 0.363 . . . . 74.319999999999993 110.243 -176.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 7.8 t -110.58 124.01 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 CA-C-N 115.883 -0.599 . . . . 75.430000000000007 109.618 -176.653 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . 0.446 HD11 ' O ' ' A' ' 519' ' ' LYS . 0.2 OUTLIER -107.39 145.87 14.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 120.313 -0.555 . . . . 71.040000000000006 110.297 176.567 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -103.3 117.25 34.07 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.209 0.528 . . . . 73.310000000000002 111.037 -176.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 5.5 mp -98.77 130.7 45.23 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.562 -1.199 . . . . 75.230000000000004 108.6 178.641 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -102.08 120.03 39.76 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 121.489 0.661 . . . . 65.109999999999999 109.651 179.759 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 40.0 t -100.37 137.35 28.17 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 CA-C-N 115.191 -0.913 . . . . 75.209999999999994 109.413 -175.629 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.646 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 6.2 m -79.64 123.23 27.44 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.99 -1.004 . . . . 70.340000000000003 109.239 -179.015 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.571 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 17.6 ptmt -92.17 145.7 24.3 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 104.313 -2.477 . . . . 71.340000000000003 104.313 169.351 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . 0.479 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -79.14 -30.42 46.54 Favored Glycine 0 CA--C 1.486 -1.775 0 C-N-CA 118.964 -1.589 . . . . 55.219999999999999 113.486 -172.344 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 70.34 -29.15 0.18 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.663 1.185 . . . . 74.340000000000003 113.008 179.491 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.479 ' H ' ' C ' ' A' ' 558' ' ' GLY . 76.6 mt-30 -128.14 154.4 45.8 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 123.839 0.856 . . . . 74.450000000000003 112.015 -176.099 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -138.96 151.09 46.6 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.76 -0.83 . . . . 70.340000000000003 108.76 176.528 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 8.5 p -65.78 122.71 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 CA-C-O 121.262 0.554 . . . . 73.439999999999998 111.745 -178.912 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 563' ' ' MET . . . . . 0.476 ' HG2' ' O ' ' A' ' 564' ' ' PRO . 57.6 ttp -97.82 137.56 20.96 Favored Pre-proline 0 C--O 1.249 1.046 0 CA-C-N 116.182 -0.463 . . . . 65.140000000000001 111.311 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . 0.476 ' O ' ' HG2' ' A' ' 563' ' ' MET . 12.6 Cg_exo -73.4 169.39 22.4 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.633 2.222 . . . . 71.430000000000007 109.829 169.674 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -83.04 141.13 32.28 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.165 0.507 . . . . 72.219999999999999 110.722 -179.25 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 89.4 mt -122.99 15.32 9.96 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.96 -1.126 . . . . 72.319999999999993 107.96 177.034 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 7.7 m -72.17 141.21 49.07 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 114.437 -1.256 . . . . 72.400000000000006 109.837 -178.046 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 80.37 13.99 80.91 Favored Glycine 0 C--O 1.217 -0.945 0 C-N-CA 120.523 -0.846 . . . . 62.130000000000003 113.185 178.271 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 26.2 mmt -105.13 165.14 11.3 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 122.295 -0.532 . . . . 75.540000000000006 110.485 178.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -86.42 161.21 18.77 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.858 -1.164 . . . . 73.239999999999995 107.858 -179.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 30.8 t90 -71.22 -25.93 62.72 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.946 -0.761 . . . . 72.219999999999999 108.946 177.667 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.0 p -73.78 -17.72 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 115.27 -0.877 . . . . 72.010000000000005 109.407 179.475 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . 0.606 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 25.0 t70 -97.26 -34.97 10.89 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.362 -0.607 . . . . 75.140000000000001 109.362 178.5 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -64.03 -33.62 76.17 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.736 -0.665 . . . . 71.010000000000005 111.436 178.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.453 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 40.0 tt0 -55.99 -57.11 23.94 Favored Pre-proline 0 CA--C 1.576 1.953 0 CA-C-N 115.923 -0.58 . . . . 73.450000000000003 111.973 177.472 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . 0.507 ' HD2' ' O ' ' A' ' 573' ' ' ASP . 38.9 Cg_exo -61.05 -31.46 90.99 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 121.59 1.527 . . . . 74.340000000000003 112.835 173.656 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . 0.606 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 24.2 mmt180 -58.9 -47.82 83.63 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 110.123 -0.325 . . . . 75.510000000000005 110.123 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.507 HD11 ' N ' ' A' ' 579' ' ' ARG . 4.4 pp -64.09 -45.98 86.29 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 112.372 0.508 . . . . 75.239999999999995 112.372 -174.595 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . 0.507 ' N ' HD11 ' A' ' 578' ' ' LEU . 4.1 ptp180 -66.02 -35.23 80.0 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.682 -0.407 . . . . 73.230000000000004 112.074 178.618 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.85 -36.42 72.86 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.23 0.538 . . . . 75.140000000000001 111.605 178.44 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 86.8 mt -81.84 -3.3 53.7 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 112.418 0.525 . . . . 55.420000000000002 112.418 -177.42 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 73.39 40.68 47.68 Favored Glycine 0 CA--C 1.506 -0.528 0 C-N-CA 120.581 -0.818 . . . . 70.510000000000005 111.178 -179.632 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 75.6 t90 -70.04 137.64 51.46 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.999 -0.6 . . . . 74.430000000000007 110.739 -179.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 5.9 t -156.49 75.23 0.85 Allowed 'General case' 0 N--CA 1.424 -1.748 0 CA-C-O 122.283 1.04 . . . . 75.299999999999997 109.399 178.432 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -141.38 -137.71 3.44 Favored Glycine 0 N--CA 1.434 -1.457 0 N-CA-C 110.923 -0.871 . . . . 70.420000000000002 110.923 -178.587 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 65.7 mtt -126.8 136.87 52.96 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.057 -1.09 . . . . 74.109999999999999 108.057 177.622 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -97.38 128.51 44.25 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.796 -1.187 . . . . 75.400000000000006 107.796 -176.837 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -105.01 101.86 11.4 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.949 -0.7 . . . . 74.439999999999998 110.346 179.453 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -102.45 133.57 47.19 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 107.746 -1.205 . . . . 74.439999999999998 107.746 175.597 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -90.99 -154.44 30.52 Favored Glycine 0 N--CA 1.418 -2.558 0 N-CA-C 110.312 -1.115 . . . . 65.230000000000004 110.312 177.107 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -71.0 133.6 46.48 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 110.153 -0.314 . . . . 73.209999999999994 110.153 179.048 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -77.23 123.24 26.18 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 105.469 -2.048 . . . . 72.340000000000003 105.469 177.282 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 94.5 t -136.03 135.68 50.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-O 120.971 0.415 . . . . 74.239999999999995 111.895 -171.315 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -97.58 106.54 18.87 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 105.86 -1.904 . . . . 71.109999999999999 105.86 173.16 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -145.15 9.54 1.26 Allowed 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 112.777 0.658 . . . . 71.349999999999994 112.777 -175.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 122.91 167.04 12.82 Favored Glycine 0 C--N 1.302 -1.327 0 C-N-CA 119.84 -1.171 . . . . 72.209999999999994 111.583 179.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.75 -43.13 91.93 Favored Glycine 0 C--O 1.239 0.433 0 O-C-N 123.864 0.391 . . . . 74.310000000000002 114.052 -172.565 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 15.8 m -65.65 -34.11 77.46 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.181 0.515 . . . . 71.019999999999996 111.231 -179.112 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . 0.451 ' O ' ' HA3' ' A' ' 625' ' ' GLY . 80.9 mm-40 -92.49 -0.97 57.28 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 112.511 0.56 . . . . 72.439999999999998 112.511 -178.644 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -89.86 -106.56 0.09 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.424 0.898 . . . . 75.010000000000005 113.424 -178.515 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -92.46 54.86 2.38 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.185 0.517 . . . . 74.400000000000006 110.005 -173.227 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -144.12 140.85 29.65 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.891 -0.781 . . . . 74.140000000000001 108.891 176.802 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 95.8 t -64.34 130.15 29.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 107.509 -1.293 . . . . 73.319999999999993 107.509 173.322 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 58.0 t -89.2 -52.32 11.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.046 0.45 . . . . 71.099999999999994 110.429 -177.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -135.52 155.85 49.83 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.134 -1.061 . . . . 75.25 108.134 179.391 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -118.9 100.29 7.28 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 107.194 -1.41 . . . . 73.439999999999998 107.194 178.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.493 ' CB ' ' HB ' ' A' ' 621' ' ' THR . 26.7 t-20 -54.75 -51.58 77.7 Favored Pre-proline 0 CA--C 1.554 1.111 0 N-CA-C 113.772 1.027 . . . . 63.039999999999999 113.772 -177.72 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.402 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 7.8 Cg_exo -75.84 128.95 11.2 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 121.094 1.196 . . . . 63.439999999999998 109.229 173.072 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . 0.509 ' HB2' ' OG1' ' A' ' 612' ' ' THR . 12.6 Cg_exo -70.31 135.8 30.02 Favored 'Trans proline' 0 C--O 1.242 0.7 0 C-N-CA 122.395 2.064 . . . . 62.409999999999997 113.196 -177.533 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -68.35 134.47 50.32 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.216 -0.661 . . . . 73.109999999999999 109.216 176.125 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 88.27 0.39 82.73 Favored Glycine 0 C--N 1.305 -1.182 0 C-N-CA 120.136 -1.031 . . . . 73.129999999999995 111.108 -178.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 612' ' ' THR . . . . . 0.509 ' OG1' ' HB2' ' A' ' 609' ' ' PRO . 39.7 m -111.8 160.6 17.18 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.631 -1.248 . . . . 75.329999999999998 107.631 178.321 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -75.89 135.68 18.35 Favored Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 111.223 -0.751 . . . . 74.349999999999994 111.223 178.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.18 142.18 37.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 108.113 -1.069 . . . . 74.219999999999999 108.113 176.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . 0.486 ' ND2' ' HB2' ' A' ' 617' ' ' ASP . 34.9 p-10 -50.61 153.09 1.75 Allowed 'General case' 0 C--O 1.217 -0.648 0 N-CA-C 113.169 0.803 . . . . 72.230000000000004 113.169 179.174 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . 0.437 ' HD3' ' N ' ' A' ' 616' ' ' ARG . 0.0 OUTLIER -48.65 -30.82 5.86 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.952 1.301 . . . . 73.450000000000003 112.196 177.624 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . 0.486 ' HB2' ' ND2' ' A' ' 615' ' ' ASN . 1.0 OUTLIER -66.04 -44.41 84.69 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.578 -0.737 . . . . 71.430000000000007 110.325 176.736 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 87.45 23.1 41.19 Favored Glycine 0 N--CA 1.426 -1.986 0 C-N-CA 118.65 -1.738 . . . . 71.409999999999997 111.34 -178.266 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.84 119.2 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 123.238 1.494 . . . . 70.409999999999997 109.359 -167.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 4.2 tp -115.19 119.94 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.118 0 CA-C-N 113.215 -1.811 . . . . 73.319999999999993 110.528 -172.596 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.493 ' HB ' ' CB ' ' A' ' 607' ' ' ASN . 24.9 m -98.98 117.13 32.8 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 106.181 -1.785 . . . . 74.340000000000003 106.181 171.912 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -138.93 165.37 27.26 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 107.536 -1.283 . . . . 75.109999999999999 107.536 -175.835 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -134.11 135.77 43.42 Favored 'General case' 0 C--N 1.272 -2.786 0 N-CA-C 107.623 -1.251 . . . . 72.340000000000003 107.623 178.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -143.68 165.41 27.7 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 124.857 1.348 . . . . 72.439999999999998 107.578 172.709 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 599' ' ' GLN . . . -113.37 -110.87 2.99 Favored Glycine 0 C--N 1.279 -2.623 0 N-CA-C 111.586 -0.606 . . . . 63.119999999999997 111.586 -179.092 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.17 0 C-N-CA 121.034 -0.266 . . . . 74.420000000000002 111.03 179.02 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--O 1.239 0.513 0 N-CA-C 105.424 -2.065 . . . . 72.519999999999996 105.424 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 31.5 m -116.12 157.79 16.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-O 121.488 0.661 . . . . 73.010000000000005 111.63 -169.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . 0.429 HE21 ' C ' ' A' ' 361' ' ' GLN . 0.0 OUTLIER -94.76 124.3 38.72 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 106.606 -1.627 . . . . 74.040000000000006 106.606 -176.196 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.423 ' HB ' ' O ' ' A' ' 406' ' ' ALA . 89.7 t -101.35 129.53 26.76 Favored Pre-proline 0 C--N 1.287 -2.109 0 CA-C-N 114.993 -1.003 . . . . 73.409999999999997 111.335 -172.58 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -73.41 132.75 18.11 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.138 1.892 . . . . 73.219999999999999 109.42 174.637 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -91.76 158.89 16.1 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 120.291 -0.564 . . . . 74.329999999999998 109.648 -175.551 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 4.0 m -114.17 6.34 7.71 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 C-N-CA 124.203 1.001 . . . . 72.030000000000001 111.673 -176.026 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.77 145.38 12.39 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 112.757 0.651 . . . . 73.409999999999997 112.757 172.725 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.85 -6.02 43.54 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.254 -0.884 . . . . 75.409999999999997 112.307 -176.478 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -104.97 -92.44 0.37 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.73 0.3 . . . . 63.450000000000003 111.075 179.608 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 64.9 p -156.31 157.11 35.15 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 107.619 -1.252 . . . . 74.340000000000003 107.619 -179.133 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 7.9 p -64.1 -37.52 87.75 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 118.307 0.503 . . . . 64.109999999999999 111.221 179.702 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.21 -45.45 94.5 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 116.07 -0.514 . . . . 74.510000000000005 111.206 178.789 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -69.12 -39.24 79.03 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.609 -0.515 . . . . 71.140000000000001 109.609 179.692 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -61.91 -51.36 68.45 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.679 -0.692 . . . . 71.439999999999998 111.403 -178.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 78.5 mt -65.56 -39.97 86.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.188 -0.46 . . . . 60.310000000000002 110.124 179.122 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.26 -47.35 85.7 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.063 -0.517 . . . . 72.140000000000001 110.907 -179.496 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 376' ' ' THR . . . . . 0.521 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 51.3 m -64.97 -47.46 77.51 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.953 -0.567 . . . . 74.019999999999996 110.982 -179.085 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 10.8 mp -62.9 -39.02 93.23 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 112.145 0.424 . . . . 75.25 112.145 -179.248 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -64.99 -38.81 92.2 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.764 0.316 . . . . 71.230000000000004 110.205 179.349 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -68.37 -26.59 65.65 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.142 0.496 . . . . 63.219999999999999 111.355 176.744 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 376' ' ' THR . 9.7 mmm180 -82.15 -14.26 55.94 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.284 -0.416 . . . . 73.319999999999993 110.846 178.71 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 92.88 16.37 48.43 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.475 -0.869 . . . . 63.140000000000001 111.157 179.639 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.423 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 29.3 m-85 -93.16 154.77 17.87 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-O 121.454 0.645 . . . . 72.209999999999994 110.427 179.396 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 32.6 mmtp -103.75 145.01 30.72 Favored 'General case' 0 N--CA 1.409 -2.508 0 N-CA-C 107.184 -1.413 . . . . 75.540000000000006 107.184 -176.626 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.86 142.45 33.8 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 C-N-CA 119.868 -0.733 . . . . 74.200000000000003 110.545 -176.726 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 23.7 tpt180 -111.75 147.32 35.89 Favored 'General case' 0 N--CA 1.408 -2.527 0 N-CA-C 105.172 -2.158 . . . . 75.120000000000005 105.172 171.829 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 42.9 m -132.77 121.67 23.37 Favored 'General case' 0 C--N 1.269 -2.925 0 C-N-CA 120.229 -0.588 . . . . 71.519999999999996 109.56 -175.782 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 66.0 tp -111.22 119.1 37.81 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 107.406 -1.331 . . . . 64.200000000000003 107.406 -179.783 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -102.96 131.7 49.74 Favored 'General case' 0 N--CA 1.425 -1.702 0 C-N-CA 119.845 -0.742 . . . . 71.129999999999995 110.408 177.966 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . 0.528 ' O ' ' HA ' ' A' ' 421' ' ' SER . 13.2 mmmm -126.01 148.32 62.49 Favored Pre-proline 0 C--N 1.282 -2.367 0 N-CA-C 106.152 -1.796 . . . . 74.319999999999993 106.152 -178.264 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -69.35 158.04 58.97 Favored 'Trans proline' 0 C--O 1.243 0.765 0 N-CA-C 108.751 -1.288 . . . . 73.239999999999995 108.751 173.135 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -74.82 82.88 2.14 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-O 121.818 0.818 . . . . 74.400000000000006 109.688 178.019 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 392' ' ' SER . . . . . 0.514 ' O ' ' HB ' ' A' ' 393' ' ' THR . 17.1 m -103.29 49.3 0.83 Allowed 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 114.593 -1.185 . . . . 74.409999999999997 108.843 178.709 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.514 ' HB ' ' O ' ' A' ' 392' ' ' SER . 99.2 m 69.54 20.28 7.17 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-O 123.206 1.479 . . . . 71.310000000000002 110.02 -179.715 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 5.4 pt -115.75 152.3 47.22 Favored Pre-proline 0 C--N 1.301 -1.536 0 CA-C-N 114.85 -1.068 . . . . 73.299999999999997 111.155 -174.357 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -21.5 116.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.364 1.388 1 C-N-CA 126.48 4.786 . . . . 70.540000000000006 116.831 -177.82 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . 0.45 ' HA ' ' OG ' ' A' ' 421' ' ' SER . 41.9 Cg_exo -59.02 161.86 14.89 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 124.267 3.311 . . . . 64.319999999999993 114.52 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -57.89 -8.46 0.99 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.996 1.318 . . . . 74.439999999999998 113.438 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -98.72 137.14 37.76 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.016 -1.846 . . . . 74.430000000000007 106.016 176.21 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 18.8 m -72.34 118.2 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 C-N-CA 119.039 -1.064 . . . . 74.310000000000002 112.514 -167.86 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.4 -30.6 2.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 105.843 -1.91 . . . . 74.230000000000004 105.843 171.386 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.7 157.89 27.55 Favored Glycine 0 N--CA 1.416 -2.673 0 CA-C-N 114.618 -1.174 . . . . 64.030000000000001 111.099 -178.399 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 9.3 p -144.83 -175.71 4.78 Favored 'General case' 0 C--N 1.278 -2.523 0 C-N-CA 127.314 2.246 . . . . 75.140000000000001 105.369 -177.119 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . 0.412 ' HA ' ' HD3' ' A' ' 404' ' ' PRO . 13.9 t70 -98.92 125.95 40.22 Favored Pre-proline 0 C--N 1.295 -1.789 0 C-N-CA 118.118 -1.433 . . . . 72.450000000000003 107.673 178.895 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 403' ' ' ASP . 52.6 Cg_exo -59.29 6.25 0.09 OUTLIER 'Trans proline' 0 C--N 1.365 1.397 0 C-N-CA 124.691 3.594 . . . . 71.439999999999998 115.91 -176.585 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.26 -33.58 67.74 Favored 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 109.467 -0.568 . . . . 73.040000000000006 109.467 174.907 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . 0.423 ' O ' ' HB ' ' A' ' 362' ' ' VAL . . . -67.04 -36.32 81.82 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-O 121.512 0.672 . . . . 71.219999999999999 110.319 177.275 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -85.77 0.72 52.12 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.914 0.864 . . . . 63.439999999999998 110.16 -179.147 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 28.5 m -97.33 158.39 15.48 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 104.896 -2.261 . . . . 74.219999999999999 104.896 171.588 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 33.7 p -74.32 112.08 10.13 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 118.649 -1.22 . . . . 72.150000000000006 108.712 179.236 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 17.1 m -129.53 159.11 41.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 121.296 0.569 . . . . 73.209999999999994 112.037 -179.456 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 3.0 p -60.94 140.82 57.66 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.083 -0.962 . . . . 63.240000000000002 110.869 177.944 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -65.0 111.01 2.67 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 121.477 0.656 . . . . 74.439999999999998 110.372 -177.538 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 107.07 39.92 1.9 Allowed Glycine 0 N--CA 1.423 -2.21 0 CA-C-N 115.05 -0.977 . . . . 73.519999999999996 112.001 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -92.18 -179.31 5.21 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.931 -0.766 . . . . 55.229999999999997 108.931 -178.319 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 43.9 mt-10 -104.69 114.91 29.43 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 110.005 -0.368 . . . . 75.129999999999995 110.005 -176.855 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 45.4 mm -107.41 128.78 62.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 109.188 -0.671 . . . . 64.409999999999997 109.188 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 25.5 m -85.2 130.29 34.63 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.307 0.575 . . . . 65.409999999999997 111.782 -178.023 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 9.4 p -114.68 135.49 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 CA-C-N 115.041 -0.981 . . . . 74.219999999999999 108.902 177.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -97.67 128.71 44.56 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 110.153 -0.314 . . . . 75.040000000000006 110.153 179.27 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 94.6 t -123.72 131.11 73.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 109.235 -0.654 . . . . 73.140000000000001 109.235 176.667 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 421' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 95.8 p -99.49 123.66 43.96 Favored 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 120.403 -0.519 . . . . 63.439999999999998 109.912 177.152 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 5.5 t -119.7 108.68 14.73 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 112.735 0.642 . . . . 74.409999999999997 112.735 -179.712 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.332 0 N-CA-C 115.373 0.909 . . . . 74.430000000000007 115.373 171.871 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 . . . . . 0 N--CA 1.423 -1.787 0 N-CA-C 104.775 -2.306 . . . . 54.32 104.775 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 477' ' ' THR . 20.5 mmm180 -121.66 147.16 46.23 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 119.593 -0.843 . . . . 73.150000000000006 111.679 -173.54 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 15.6 pt-20 -82.05 139.19 34.62 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.184 -0.916 . . . . 74.540000000000006 108.635 -178.963 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 65.1 mt -78.93 125.79 83.31 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 107.806 -1.183 . . . . 74.329999999999998 107.806 -178.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -70.51 141.49 42.31 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 121.848 1.699 . . . . 71.329999999999998 110.693 175.612 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -80.63 112.55 18.1 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.603 -0.517 . . . . 71.329999999999998 109.603 177.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 28.2 t -115.78 147.16 19.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 107.528 -1.286 . . . . 65.230000000000004 107.528 -179.045 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 1.6 p -58.01 138.17 56.18 Favored 'General case' 0 N--CA 1.432 -1.355 0 O-C-N 123.638 0.586 . . . . 74.319999999999993 111.463 179.961 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 31.7 p -64.57 -34.88 79.28 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 123.931 0.893 . . . . 74.140000000000001 112.05 -171.047 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . 0.402 ' H ' HD23 ' A' ' 435' ' ' LEU . 0.7 OUTLIER -75.02 -16.88 60.59 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-N 115.198 -0.91 . . . . 73.319999999999993 111.464 -179.775 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.1 m -105.03 50.6 0.78 Allowed 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.517 0.675 . . . . 73.129999999999995 109.26 -175.075 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . 0.41 ' O ' HG21 ' A' ' 441' ' ' VAL . 38.9 t80 -52.61 -38.82 60.88 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.893 0.877 . . . . 74.549999999999997 112.913 -179.683 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -59.44 -40.6 87.35 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-O 121.066 0.46 . . . . 75.219999999999999 110.918 179.444 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -70.04 -35.63 74.43 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.968 -0.753 . . . . 71.420000000000002 108.968 179.621 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.96 -43.62 98.48 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.893 -0.594 . . . . 71.530000000000001 110.054 178.732 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . 0.41 HG21 ' O ' ' A' ' 437' ' ' TYR . 84.9 t -58.48 -47.85 87.04 Favored 'Isoleucine or valine' 0 C--O 1.246 0.9 0 CA-C-N 115.232 -0.894 . . . . 74.019999999999996 110.911 178.669 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -67.38 -34.53 77.47 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 119.789 -0.765 . . . . 74.0 110.708 -179.376 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -62.53 -42.63 99.65 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 116.826 -0.17 . . . . 75.239999999999995 111.291 178.515 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 10.2 mp -63.76 -35.09 79.43 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 120.871 0.367 . . . . 74.400000000000006 110.389 176.277 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.457 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 22.2 m -68.19 -46.23 71.23 Favored 'General case' 0 C--O 1.249 1.033 0 CA-C-N 115.936 -0.574 . . . . 74.109999999999999 110.557 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.36 -17.39 62.42 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-O 121.105 0.479 . . . . 72.129999999999995 111.401 179.53 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.34 5.26 24.0 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.888 -0.596 . . . . 64.010000000000005 112.272 -179.871 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 110.48 -82.08 0.3 Allowed Glycine 0 CA--C 1.488 -1.615 0 C-N-CA 119.514 -1.327 . . . . 75.299999999999997 112.034 175.778 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -39.91 -65.22 0.41 Allowed 'General case' 0 C--O 1.248 0.995 0 N-CA-C 113.917 1.08 . . . . 71.030000000000001 113.917 175.573 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . 0.457 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 59.35 29.69 66.59 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.859 -0.496 . . . . 74.340000000000003 111.859 -175.232 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -105.06 111.23 23.93 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.472 -1.677 . . . . 72.510000000000005 106.472 -179.291 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 35.5 p90 -134.17 153.4 51.86 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 120.871 0.367 . . . . 72.030000000000001 110.939 -175.422 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -148.32 122.9 9.79 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.944 -0.761 . . . . 74.25 108.944 177.825 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -83.83 129.39 34.94 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 123.359 0.664 . . . . 73.030000000000001 111.458 179.752 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.08 144.66 47.47 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.274 -1.38 . . . . 64.299999999999997 107.274 173.342 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -122.29 136.83 54.97 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.521 -0.918 . . . . 71.340000000000003 108.521 -177.635 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 49.4 m -149.45 138.31 12.39 Favored Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 122.356 -0.215 . . . . 71.519999999999996 110.595 176.785 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.702 ' HA ' ' O ' ' A' ' 490' ' ' SER . 22.5 Cg_exo -65.82 129.39 22.02 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.404 2.07 . . . . 74.239999999999995 111.014 176.358 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 60.6 m -152.21 -179.28 7.39 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.951 -0.568 . . . . 64.299999999999997 109.884 -178.042 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 9.7 t -45.0 136.71 4.74 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.952 1.301 . . . . 72.019999999999996 112.432 178.643 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.76 -29.48 34.12 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 124.752 3.635 . . . . 75.120000000000005 113.933 -175.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -70.38 -30.7 67.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.571 -0.286 . . . . 51.310000000000002 111.722 -178.932 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -95.75 -8.81 33.44 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 111.66 0.244 . . . . 73.209999999999994 111.66 179.738 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 80.5 t -60.57 127.66 20.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.473 -0.566 . . . . 74.299999999999997 109.473 176.696 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 91.06 -15.07 61.82 Favored Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 116.002 -0.544 . . . . 73.430000000000007 112.107 -179.529 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -108.69 166.55 10.71 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 109.424 -0.584 . . . . 65.540000000000006 109.424 -177.852 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 79.4 t -73.51 140.82 17.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 108.182 -1.044 . . . . 74.150000000000006 108.182 173.572 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 65.5 mt -97.33 -35.28 5.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.56 -1.274 . . . . 72.010000000000005 107.56 177.253 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 172.76 -179.06 44.49 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 120.297 -0.954 . . . . 74.099999999999994 112.031 177.741 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 470' ' ' THR . . . . . 0.457 HG23 HG12 ' A' ' 486' ' ' ILE . 33.1 p -115.17 143.93 44.46 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 105.929 -1.878 . . . . 75.349999999999994 105.929 178.805 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -60.32 -57.19 28.45 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 119.888 -0.725 . . . . 72.519999999999996 112.146 178.607 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -71.94 152.57 57.7 Favored 'Trans proline' 0 C--N 1.361 1.196 0 N-CA-C 108.001 -1.577 . . . . 72.540000000000006 108.001 170.58 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.31 127.82 22.09 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 121.601 1.534 . . . . 75.439999999999998 111.44 -179.035 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -76.63 6.45 5.89 Favored 'General case' 0 C--O 1.211 -0.928 0 C-N-CA 124.239 1.016 . . . . 71.239999999999995 111.932 -175.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -109.78 -4.97 15.73 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 116.106 -0.497 . . . . 73.230000000000004 109.808 172.625 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -117.26 176.0 5.35 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 112.981 0.734 . . . . 73.209999999999994 112.981 -171.421 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 477' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 3.7 p -83.41 131.14 35.05 Favored 'General case' 0 N--CA 1.413 -2.295 0 C-N-CA 124.633 1.173 . . . . 74.420000000000002 113.145 -177.782 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 43.8 m -121.23 148.64 43.99 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 106.971 -1.492 . . . . 73.219999999999999 106.971 175.611 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -74.48 156.44 36.93 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.725 -0.39 . . . . 73.25 111.442 -176.585 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 43.5 mm -69.36 -26.8 32.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.823 0.82 . . . . 75.319999999999993 110.25 -177.006 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.4 t -97.9 5.07 49.39 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.69 0.757 . . . . 75.439999999999998 109.904 179.021 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -94.63 135.63 35.87 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.54 -0.755 . . . . 74.25 110.301 -176.597 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.3 p -89.86 126.75 42.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-O 121.283 0.564 . . . . 72.120000000000005 111.444 -177.043 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 60.6 t -96.77 118.53 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.91 0 N-CA-C 107.844 -1.169 . . . . 72.530000000000001 107.844 176.207 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.27 129.08 50.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 108.063 -1.088 . . . . 73.230000000000004 108.063 177.606 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . 0.457 HG12 HG23 ' A' ' 470' ' ' THR . 15.2 mt -118.54 128.23 75.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-N 115.158 -0.928 . . . . 73.209999999999994 110.635 -174.758 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 6.2 tt -103.19 126.17 57.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 115.69 -0.687 . . . . 74.439999999999998 110.428 -179.452 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 33.8 m -109.26 151.2 11.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 115.692 -0.685 . . . . 74.030000000000001 109.547 178.387 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.42 135.55 14.29 Favored Glycine 0 N--CA 1.423 -2.179 0 C-N-CA 121.125 -0.56 . . . . 74.420000000000002 111.744 -178.482 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.702 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 12.8 t . . . . . 0 C--N 1.283 -2.326 0 N-CA-C 105.825 -1.917 . . . . 55.229999999999997 105.825 177.234 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo . . . . . 0 C--O 1.251 1.129 0 CA-C-O 120.797 0.249 . . . . 73.310000000000002 111.736 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -91.25 81.17 5.52 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.532 -0.914 . . . . 62.100000000000001 108.532 175.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 5.9 p -117.81 153.56 33.26 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.263 -0.88 . . . . 72.439999999999998 112.209 -175.193 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 8.0 mmtm -137.24 136.85 38.47 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.242 -0.89 . . . . 73.049999999999997 109.746 179.986 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -82.27 121.61 26.87 Favored 'General case' 0 CA--C 1.485 -1.527 0 N-CA-C 105.508 -2.034 . . . . 62.409999999999997 105.508 168.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 543' ' ' THR . 44.1 pt -75.38 123.69 88.75 Favored Pre-proline 0 C--N 1.292 -1.905 0 N-CA-C 113.348 0.87 . . . . 73.239999999999995 113.348 -172.6 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -86.58 164.6 9.31 Favored 'Trans proline' 0 N--CA 1.429 -2.301 0 C-N-CA 122.472 2.114 . . . . 64.219999999999999 108.871 171.784 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -82.35 147.26 28.93 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 120.383 -0.527 . . . . 61.43 109.99 -178.487 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.1 p -130.35 8.29 2.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-O 122.045 0.926 . . . . 75.430000000000007 109.832 -176.824 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -81.23 157.11 25.31 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 115.43 -0.805 . . . . 72.519999999999996 110.185 -175.994 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 108.55 1.51 32.77 Favored Glycine 0 C--N 1.287 -2.145 0 N-CA-C 109.573 -1.411 . . . . 62.25 109.573 -178.49 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -120.62 175.43 6.01 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.414 -0.958 . . . . 75.239999999999995 108.414 -179.267 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 15.0 t -83.89 159.83 21.24 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.82 -1.178 . . . . 74.099999999999994 107.82 178.544 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 532' ' ' GLY . 48.2 t -46.84 -48.94 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 123.905 0.882 . . . . 73.420000000000002 111.239 -176.54 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -63.46 -41.85 98.62 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.188 -0.915 . . . . 72.439999999999998 111.571 -175.158 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 88.2 t -76.35 -40.61 35.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.908 -0.587 . . . . 61.240000000000002 110.857 -177.695 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.26 -45.8 89.8 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.378 -0.374 . . . . 72.200000000000003 110.881 -179.307 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -65.21 -35.45 81.11 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.402 -0.363 . . . . 74.319999999999993 110.893 178.573 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.419 ' O ' HG23 ' A' ' 514' ' ' VAL . 51.1 tptt -62.79 -45.88 90.6 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.37 -0.604 . . . . 74.530000000000001 109.37 178.204 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -63.62 -37.42 87.28 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 115.951 -0.568 . . . . 74.549999999999997 111.08 177.37 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 59.4 tp -59.8 -43.18 94.6 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.826 -0.625 . . . . 73.409999999999997 109.457 177.122 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . 0.45 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 13.5 m120 -63.25 -38.03 89.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.611 -0.722 . . . . 73.430000000000007 110.192 177.711 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 510' ' ' LYS . 94.9 t -63.69 -33.37 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 115.564 -0.743 . . . . 63.340000000000003 110.651 176.829 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -68.01 -27.49 66.6 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.85 0.357 . . . . 70.049999999999997 110.138 178.568 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 131.57 -18.31 4.91 Favored Glycine 0 CA--C 1.506 -0.499 0 C-N-CA 121.006 -0.616 . . . . 73.409999999999997 112.267 178.721 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 85.9 m-85 -78.63 115.15 18.14 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.347 0.594 . . . . 71.549999999999997 110.001 -177.025 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 12.5 p -86.87 -16.69 35.28 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.796 -0.638 . . . . 74.129999999999995 112.71 -176.83 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -117.29 130.87 56.83 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.232 0.539 . . . . 72.140000000000001 112.001 -174.612 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -130.07 156.81 43.9 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.346 -0.843 . . . . 73.049999999999997 112.398 -177.852 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 49.2 m -140.17 158.36 44.16 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 106.831 -1.544 . . . . 74.400000000000006 106.831 173.174 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 0.0 OUTLIER -135.37 145.24 47.16 Favored 'General case' 0 N--CA 1.413 -2.312 0 CA-C-N 118.293 0.497 . . . . 62.509999999999998 109.986 179.395 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -129.82 116.13 18.25 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.239 -1.022 . . . . 73.209999999999994 108.239 176.072 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 18.4 m -88.12 120.89 29.9 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.726 -0.472 . . . . 61.310000000000002 109.726 178.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 47.5 t -120.8 148.12 24.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 107.258 -1.386 . . . . 75.5 107.258 -179.616 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -68.86 136.41 52.63 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.185 0.517 . . . . 44.420000000000002 111.55 -175.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 69.6 m -156.78 176.36 2.65 Favored Pre-proline 0 C--N 1.3 -1.549 0 N-CA-C 108.709 -0.849 . . . . 70.310000000000002 108.709 -179.285 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -83.32 -14.48 8.2 Favored 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 121.947 1.764 . . . . 62.210000000000001 111.598 171.349 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . 0.577 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 0.0 OUTLIER -76.04 140.75 70.35 Favored Pre-proline 0 C--O 1.215 -0.716 0 CA-C-N 115.925 -0.579 . . . . 74.010000000000005 109.542 -179.743 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -56.61 144.82 84.22 Favored 'Trans proline' 0 C--O 1.249 1.026 0 C-N-CA 123.399 2.733 . . . . 74.25 113.432 -176.962 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.628 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -62.7 117.51 6.39 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 114.498 -1.228 . . . . 73.140000000000001 110.472 -178.329 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . 0.42 ' O ' HG23 ' A' ' 505' ' ' VAL . . . 126.82 -19.3 6.18 Favored Glycine 0 C--N 1.3 -1.431 0 C-N-CA 120.48 -0.867 . . . . 74.120000000000005 111.48 179.828 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -83.58 125.81 32.18 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 120.735 0.302 . . . . 74.25 110.548 177.752 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 62.0 t -81.92 118.84 30.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.093 -1.077 . . . . 64.239999999999995 108.093 178.357 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 99.2 m -104.66 -21.54 13.38 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 120.295 -0.562 . . . . 75.439999999999998 112.46 -177.013 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -159.16 -178.4 33.13 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 119.433 -1.365 . . . . 50.32 112.12 178.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 25.5 p -124.84 156.6 37.58 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.409 -1.33 . . . . 73.140000000000001 107.409 175.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . 0.451 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 23.0 t-20 -60.03 -56.99 30.05 Favored Pre-proline 0 CA--C 1.55 0.965 0 CA-C-O 119.307 -0.377 . . . . 54.149999999999999 110.777 179.617 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . 0.451 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 98.1 Cg_endo -84.09 143.65 10.37 Favored 'Trans proline' 0 C--N 1.367 1.51 0 CA-C-N 120.307 1.146 . . . . 74.510000000000005 110.095 172.849 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.97 148.98 58.42 Favored 'Trans proline' 0 C--O 1.258 1.506 0 C-N-CA 122.164 1.909 . . . . 62.039999999999999 112.026 179.642 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.06 134.53 57.07 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 115.908 -0.587 . . . . 75.5 109.681 178.179 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.83 -5.8 34.88 Favored Glycine 0 C--N 1.304 -1.235 0 C-N-CA 120.058 -1.068 . . . . 55.25 111.365 -175.266 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 543' ' ' THR . . . . . 0.466 ' O ' HG12 ' A' ' 497' ' ' ILE . 88.5 m -82.65 131.08 35.21 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.266 -1.013 . . . . 74.209999999999994 108.266 173.636 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 9.7 t -101.03 127.5 47.52 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-O 121.172 0.511 . . . . 72.310000000000002 109.891 178.669 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 31.0 m -138.55 165.12 35.16 Favored Pre-proline 0 C--N 1.313 -1.015 0 N-CA-C 108.547 -0.909 . . . . 71.25 108.547 -178.244 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -62.49 143.28 92.9 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.214 1.943 . . . . 75.230000000000004 111.547 175.094 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 32.4 m -62.38 -19.78 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.606 0.762 . . . . 73.450000000000003 113.016 -176.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -87.96 -14.88 38.03 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.251 -0.431 . . . . 73.129999999999995 111.246 -175.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 51.8 m -62.71 161.87 11.69 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 114.677 1.362 . . . . 75.349999999999994 114.677 -173.397 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 7.7 p -93.95 123.89 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-N 115.193 -0.912 . . . . 65.549999999999997 110.269 -179.507 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 52.3 mt -108.17 138.85 32.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 120.379 -0.528 . . . . 74.230000000000004 111.094 179.472 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -101.77 120.93 41.14 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 115.617 -0.719 . . . . 72.030000000000001 109.782 -179.077 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 1.5 mm? -95.73 126.34 40.93 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.153 -1.425 . . . . 75.319999999999993 107.153 176.671 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . 0.29 1.7 pt20 -102.19 120.5 40.57 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 122.698 1.237 . . . . 74.0 111.091 179.716 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 42.7 t -101.38 145.04 12.16 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-N 112.83 -1.986 . . . . 71.409999999999997 109.986 -169.076 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.628 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 73.9 m -82.07 133.06 35.26 Favored 'General case' 0 N--CA 1.41 -2.452 0 CA-C-O 121.552 0.691 . . . . 61.109999999999999 111.529 175.631 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -88.26 137.95 31.87 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 104.966 -2.235 . . . . 61.409999999999997 104.966 168.577 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . 0.577 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -81.69 -43.15 8.55 Favored Glycine 0 CA--C 1.475 -2.446 0 C-N-CA 120.252 -0.975 . . . . 74.219999999999999 113.786 -170.434 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' A' ' 615' ' ' ASN . 78.5 m-20 67.83 -31.77 0.19 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.043 0.937 . . . . 74.439999999999998 113.286 -176.785 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.515 ' H ' ' C ' ' A' ' 558' ' ' GLY . 3.0 tp60 -126.57 140.48 52.41 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 108.903 -0.777 . . . . 74.200000000000003 108.903 -175.047 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -143.45 139.09 29.73 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.765 -0.828 . . . . 64.420000000000002 108.765 174.741 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 9.6 p -59.81 124.11 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-O 121.647 0.737 . . . . 72.430000000000007 112.709 -176.252 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 57.9 ttp -95.34 137.76 22.03 Favored Pre-proline 0 C--O 1.249 1.039 0 CA-C-N 115.886 -0.597 . . . . 75.109999999999999 110.512 -179.93 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -64.22 170.01 9.91 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 123.246 2.631 . . . . 65.140000000000001 111.311 172.165 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -70.92 138.26 49.96 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.723 0.773 . . . . 63.100000000000001 112.51 -176.554 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 94.5 mt -136.15 15.53 3.26 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.287 -1.324 . . . . 75.010000000000005 107.938 174.844 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 27.7 t -67.37 134.2 51.05 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 115.302 -0.863 . . . . 72.439999999999998 109.885 -177.407 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 86.07 40.11 7.68 Favored Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 110.41 -1.076 . . . . 63.32 110.41 179.953 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 21.5 ptm -109.29 158.0 18.3 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.979 -0.749 . . . . 72.140000000000001 108.979 -179.831 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -108.75 165.16 11.76 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 106.739 -1.578 . . . . 73.200000000000003 106.739 175.603 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 24.6 t90 -71.59 -30.31 65.68 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 108.979 -0.749 . . . . 75.329999999999998 108.979 177.101 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 30.0 m -80.08 -6.06 9.07 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 CA-C-O 121.793 0.806 . . . . 64.519999999999996 109.798 176.677 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . 0.418 ' C ' ' HD2' ' A' ' 576' ' ' PRO . 14.1 t70 -99.38 -30.03 12.43 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.905 -1.146 . . . . 74.010000000000005 107.905 177.199 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -62.86 -42.01 99.59 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 114.496 -1.229 . . . . 75.129999999999995 110.735 177.476 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 578' ' ' LEU . 44.2 tt0 -57.4 -52.25 75.62 Favored Pre-proline 0 CA--C 1.577 1.982 0 N-CA-C 113.014 0.746 . . . . 75.239999999999995 113.014 179.261 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . 0.418 ' HD2' ' C ' ' A' ' 573' ' ' ASP . 75.0 Cg_exo -55.38 -40.03 87.77 Favored 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 121.963 1.776 . . . . 75.510000000000005 112.172 173.114 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -68.3 -34.1 75.54 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.43 -0.508 . . . . 74.310000000000002 112.078 177.853 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.424 ' HB3' ' O ' ' A' ' 575' ' ' GLU . 5.9 tt -58.77 -49.47 77.54 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.268 0.627 . . . . 74.349999999999994 109.724 178.848 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -67.37 -40.96 85.78 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.286 0.847 . . . . 74.129999999999995 113.286 177.138 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.57 -39.86 88.69 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.186 0.439 . . . . 64.310000000000002 112.186 -177.666 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 10.4 mp -86.3 -8.97 57.31 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 111.971 0.36 . . . . 75.340000000000003 111.971 -179.276 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 68.34 21.81 74.35 Favored Glycine 0 C--O 1.241 0.559 0 N-CA-C 111.317 -0.713 . . . . 62.409999999999997 111.317 -177.54 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 42.9 t90 -60.61 126.96 29.37 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 123.198 0.599 . . . . 73.439999999999998 111.031 -177.359 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 8.8 m -130.41 89.44 2.78 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 115.517 -0.765 . . . . 72.230000000000004 109.122 178.153 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -144.14 -142.67 3.94 Favored Glycine 0 N--CA 1.426 -2.023 0 N-CA-C 109.479 -1.448 . . . . 65.129999999999995 109.479 177.43 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 14.4 tpt -129.0 131.41 47.42 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.768 -0.827 . . . . 72.340000000000003 108.768 179.099 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -98.03 123.1 41.89 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.07 -1.456 . . . . 73.319999999999993 107.07 177.066 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -98.11 107.38 19.85 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.995 -0.548 . . . . 72.430000000000007 109.994 -178.422 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.49 133.26 36.97 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.98 -0.554 . . . . 75.310000000000002 110.954 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -97.95 -164.83 31.38 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.737 -0.665 . . . . 62.329999999999998 113.406 -175.086 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -74.84 141.3 44.26 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 123.178 0.591 . . . . 73.409999999999997 110.834 -178.266 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -85.64 133.26 34.04 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.622 -0.717 . . . . 73.430000000000007 109.646 -177.096 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 73.4 t -125.34 115.41 43.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 107.206 -1.405 . . . . 75.420000000000002 107.206 175.337 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -86.02 107.64 17.88 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.221 -0.992 . . . . 54.210000000000001 110.213 -179.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -124.05 -11.17 7.59 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.212 -0.904 . . . . 74.25 111.495 -178.788 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 119.18 -172.67 14.7 Favored Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 121.099 -0.572 . . . . 73.319999999999993 111.673 177.779 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.87 -34.03 64.56 Favored Glycine 0 C--O 1.222 -0.623 0 N-CA-C 114.514 0.566 . . . . 60.399999999999999 114.514 -175.53 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 19.0 m -66.14 -24.72 66.72 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 117.344 0.572 . . . . 74.140000000000001 111.997 -178.445 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -109.66 -0.83 18.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.282 0.563 . . . . 74.099999999999994 111.286 178.616 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -67.62 105.42 1.87 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.195 -0.911 . . . . 74.209999999999994 113.099 -175.261 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 62.87 0.94 0.75 Allowed 'General case' 0 CA--C 1.56 1.352 0 C-N-CA 125.773 1.629 . . . . 72.109999999999999 114.081 171.713 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . 0.411 ' HD2' ' O ' ' A' ' 603' ' ' VAL . 8.7 tmm_? -90.93 148.47 22.42 Favored 'General case' 0 C--N 1.313 -0.995 0 O-C-N 121.911 -0.493 . . . . 72.140000000000001 110.607 -178.174 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . 0.411 ' O ' ' HD2' ' A' ' 602' ' ' ARG . 7.1 p -56.11 131.76 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.01 0.924 . . . . 70.219999999999999 111.465 -177.634 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 14.7 p -106.91 -34.89 2.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 C-N-CA 119.9 -0.72 . . . . 73.120000000000005 109.385 -178.728 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -154.12 148.43 26.0 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 105.114 -2.18 . . . . 75.099999999999994 105.114 171.559 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -122.39 136.56 54.92 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 108.713 -0.847 . . . . 74.010000000000005 108.713 176.627 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.5 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 24.5 t-20 -59.37 -52.39 74.65 Favored Pre-proline 0 C--N 1.309 -1.164 0 CA-C-N 115.443 -0.799 . . . . 65.519999999999996 111.298 -178.436 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.5 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 29.6 Cg_endo -105.27 110.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.962 0 C-N-CA 121.883 1.722 . . . . 72.329999999999998 111.389 173.341 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -67.76 156.86 64.33 Favored 'Trans proline' 0 C--O 1.239 0.545 0 C-N-CA 122.139 1.893 . . . . 70.439999999999998 110.705 176.408 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -60.07 137.35 58.11 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 110.009 -0.367 . . . . 72.010000000000005 110.009 178.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 90.05 0.96 76.83 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 119.44 -1.362 . . . . 64.120000000000005 111.564 -178.355 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 9.8 m -107.95 155.62 20.11 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.999 -1.111 . . . . 75.140000000000001 107.999 178.182 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -81.64 132.16 10.96 Favored Glycine 0 N--CA 1.418 -2.515 0 CA-C-N 116.352 -0.386 . . . . 74.200000000000003 112.525 -179.433 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 22.2 m -101.14 142.55 15.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 123.222 0.609 . . . . 75.0 110.375 177.008 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . 0.506 ' OD1' HG23 ' A' ' 619' ' ' ILE . 0.0 OUTLIER -54.55 149.39 10.69 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.234 0.959 . . . . 74.439999999999998 111.96 178.171 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . 0.255 0.0 OUTLIER -61.0 -24.38 66.1 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.752 1.019 . . . . 75.510000000000005 113.752 179.929 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -68.62 -31.3 70.36 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 109.159 -0.682 . . . . 74.540000000000006 109.159 176.062 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 88.91 9.52 67.93 Favored Glycine 0 N--CA 1.418 -2.525 0 CA-C-N 115.006 -0.997 . . . . 75.519999999999996 113.264 176.855 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . 0.506 HG23 ' OD1' ' A' ' 615' ' ' ASN . 0.0 OUTLIER -69.59 119.57 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 CA-C-N 118.547 1.174 . . . . 73.349999999999994 109.103 -175.675 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.51 131.93 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 N-CA-C 108.836 -0.801 . . . . 75.409999999999997 108.836 -176.881 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 60.1 m -118.08 127.84 54.18 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 120.867 0.365 . . . . 73.329999999999998 111.627 -178.585 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.5 150.91 46.89 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 105.455 -2.054 . . . . 75.310000000000002 105.455 174.048 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -127.74 156.17 42.85 Favored 'General case' 0 C--N 1.266 -3.044 0 N-CA-C 106.079 -1.823 . . . . 73.109999999999999 106.079 179.248 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -131.13 165.63 22.86 Favored 'General case' 0 C--N 1.275 -2.634 0 N-CA-C 106.847 -1.538 . . . . 72.010000000000005 106.847 179.644 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -71.72 -84.96 0.2 Allowed Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 109.224 -1.551 . . . . 71.530000000000001 109.224 175.408 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 . . . . . 0 C--N 1.299 -1.594 0 N-CA-C 108.697 -0.853 . . . . 74.140000000000001 108.697 174.346 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 . . . . . 0 C--O 1.244 0.79 0 N-CA-C 109.012 -0.736 . . . . 74.140000000000001 109.012 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.76 142.93 27.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 109.725 -0.472 . . . . 63.130000000000003 109.725 -176.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . 0.456 HE21 ' C ' ' A' ' 361' ' ' GLN . 0.0 OUTLIER -95.41 118.63 32.5 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.934 -1.506 . . . . 71.120000000000005 106.934 -176.853 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.448 ' HB ' ' O ' ' A' ' 406' ' ' ALA . 65.3 t -97.09 141.07 22.5 Favored Pre-proline 0 C--N 1.288 -2.093 0 CA-C-N 115.181 -0.918 . . . . 63.229999999999997 110.927 -170.284 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -66.49 142.87 66.97 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 121.84 1.693 . . . . 75.5 109.741 174.859 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . 0.443 ' HB2' ' ND2' ' A' ' 407' ' ' ASN . 35.1 t0 -95.83 142.61 27.89 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.915 -1.143 . . . . 72.329999999999998 107.915 -177.931 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.5 ' CG2' ' HA ' ' A' ' 373' ' ' ALA . 11.4 p -106.2 -7.47 10.22 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.676 0 CA-C-N 115.253 -0.885 . . . . 72.140000000000001 112.45 -168.472 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . 0.254 2.2 ppt_? -54.39 146.56 15.51 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.834 1.42 . . . . 74.219999999999999 114.834 175.884 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.44 0.79 40.55 Favored Glycine 0 C--O 1.24 0.482 0 CA-C-N 115.333 -0.848 . . . . 64.239999999999995 111.698 -177.219 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -119.33 -153.48 0.54 Allowed 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.545 -0.909 . . . . 75.200000000000003 108.545 177.672 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 51.5 p -96.35 153.47 17.8 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.503 -0.925 . . . . 75.129999999999995 108.503 -178.215 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 32.1 t -57.39 -37.34 72.52 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 123.322 0.389 . . . . 71.140000000000001 110.14 178.503 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.09 -47.04 75.51 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 119.287 -0.387 . . . . 71.150000000000006 111.412 179.78 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -70.05 -34.72 73.58 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 119.734 -0.786 . . . . 63.310000000000002 109.999 179.685 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . 0.5 ' HA ' ' CG2' ' A' ' 365' ' ' VAL . . . -63.39 -51.47 65.7 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.107 -0.951 . . . . 71.430000000000007 111.162 179.801 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 82.3 mt -64.05 -40.26 88.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.957 -0.565 . . . . 74.409999999999997 109.908 176.654 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.71 -47.35 84.88 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.107 -0.497 . . . . 52.200000000000003 111.007 -178.12 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 376' ' ' THR . . . . . 0.455 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 37.3 m -63.14 -47.27 83.44 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.794 -0.639 . . . . 72.219999999999999 110.16 -178.901 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 95.4 mt -64.04 -41.4 97.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.006 -0.543 . . . . 63.039999999999999 111.11 -178.842 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -63.12 -42.43 99.53 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.284 -0.416 . . . . 73.530000000000001 110.662 179.375 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -68.52 -20.33 64.56 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 111.915 0.339 . . . . 75.040000000000006 111.915 179.323 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 376' ' ' THR . 34.0 mmt180 -88.05 -14.18 39.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.345 -0.389 . . . . 72.329999999999998 110.335 176.164 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.46 16.72 45.13 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 120.655 -0.783 . . . . 74.510000000000005 112.463 179.231 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -88.85 156.21 19.07 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-O 121.327 0.584 . . . . 75.430000000000007 112.062 179.597 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -93.16 143.78 25.92 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 115.014 -0.993 . . . . 74.129999999999995 108.741 -177.712 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.37 146.04 34.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-O 121.172 0.51 . . . . 74.519999999999996 110.223 -178.356 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -128.02 126.85 42.1 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 105.971 -1.863 . . . . 74.439999999999998 105.971 171.233 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 8.0 m -115.06 123.62 49.49 Favored 'General case' 0 C--N 1.274 -2.713 0 N-CA-C 107.212 -1.403 . . . . 70.329999999999998 107.212 -178.137 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -110.87 121.47 45.42 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.527 -0.916 . . . . 73.430000000000007 108.527 -177.774 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -90.55 133.79 34.83 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.678 -0.692 . . . . 72.129999999999995 110.441 -176.626 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 421' ' ' SER . 98.1 mttt -136.93 145.34 50.28 Favored Pre-proline 0 C--N 1.312 -1.044 0 N-CA-C 108.896 -0.779 . . . . 74.340000000000003 108.896 172.918 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . 0.488 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 56.7 Cg_endo -101.28 135.78 0.16 Allowed 'Trans proline' 0 CA--C 1.554 1.498 0 C-N-CA 122.0 1.8 . . . . 71.150000000000006 111.5 169.569 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.565 ' OD2' HG22 ' A' ' 393' ' ' THR . 12.9 t70 161.64 -168.03 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 126.073 1.749 . . . . 72.129999999999995 107.339 174.911 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 392' ' ' SER . . . . . 0.45 ' H ' ' CG ' ' A' ' 391' ' ' ASP . 32.3 t -128.17 -15.6 4.67 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 118.03 0.377 . . . . 64.019999999999996 110.558 179.421 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.565 HG22 ' OD2' ' A' ' 391' ' ' ASP . 13.1 t -79.75 -29.97 40.64 Favored 'General case' 0 C--O 1.252 1.209 0 N-CA-C 108.836 -0.802 . . . . 73.150000000000006 108.836 177.125 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.88 126.02 55.06 Favored Pre-proline 0 N--CA 1.417 -2.101 0 N-CA-C 105.22 -2.141 . . . . 74.099999999999994 105.22 165.519 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.51 155.06 27.93 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 N-CA-C 117.343 2.017 . . . . 64.230000000000004 117.343 -167.23 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 421' ' ' SER . 74.0 Cg_exo -53.9 167.73 1.02 Allowed 'Trans proline' 0 CA--C 1.492 -1.585 1 C-N-CA 126.081 4.52 . . . . 72.409999999999997 111.709 170.888 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . 0.473 ' HA ' ' CG2' ' A' ' 420' ' ' VAL . 4.5 p-10 -51.57 -5.93 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 127.149 2.18 . . . . 74.450000000000003 115.836 -164.523 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -80.42 109.06 14.56 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.069 -1.456 . . . . 70.549999999999997 107.069 170.104 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 24.7 m -83.94 120.99 35.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 115.14 -0.937 . . . . 63.539999999999999 113.418 -168.558 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -84.92 -27.71 6.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.611 -0.722 . . . . 74.25 109.822 177.18 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.9 157.53 27.4 Favored Glycine 0 N--CA 1.42 -2.427 0 C-N-CA 119.389 -1.386 . . . . 73.230000000000004 113.988 -176.597 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 11.7 p -136.29 -173.83 3.51 Favored 'General case' 0 C--N 1.273 -2.721 0 C-N-CA 128.701 2.8 . . . . 74.209999999999994 104.825 -177.588 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -97.8 129.34 31.52 Favored Pre-proline 0 C--N 1.286 -2.154 0 N-CA-C 106.633 -1.617 . . . . 65.239999999999995 106.633 179.688 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.18 -1.26 0.17 Allowed 'Trans proline' 0 C--N 1.367 1.548 0 C-N-CA 124.731 3.621 . . . . 74.219999999999999 115.512 -176.368 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -50.45 -36.88 35.31 Favored 'General case' 0 C--O 1.209 -1.074 0 C-N-CA 124.15 0.98 . . . . 44.530000000000001 109.484 173.511 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . 0.448 ' O ' ' HB ' ' A' ' 362' ' ' VAL . . . -59.31 -50.05 75.47 Favored 'General case' 0 C--O 1.217 -0.651 0 O-C-N 123.54 0.525 . . . . 72.120000000000005 110.902 178.678 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . 0.443 ' ND2' ' HB2' ' A' ' 364' ' ' ASP . 13.3 m120 -82.56 0.16 44.05 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 120.448 -0.501 . . . . 75.510000000000005 111.991 -178.989 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 30.2 m -86.31 150.07 24.6 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 105.134 -2.173 . . . . 74.230000000000004 105.134 173.104 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 19.4 m -75.79 112.34 12.07 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 106.372 -1.714 . . . . 74.0 106.372 175.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 31.0 m -125.92 169.52 17.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-O 121.009 0.433 . . . . 74.340000000000003 111.192 -174.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 21.4 t -77.46 140.79 39.89 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 107.353 -1.351 . . . . 71.409999999999997 107.353 176.896 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -57.86 109.71 0.78 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.026 0.441 . . . . 72.400000000000006 111.277 -178.652 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 105.32 61.64 0.64 Allowed Glycine 0 N--CA 1.436 -1.358 0 N-CA-C 111.183 -0.767 . . . . 72.030000000000001 111.183 -179.99 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -111.01 177.18 4.74 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.163 -0.68 . . . . 71.120000000000005 109.163 179.92 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -90.06 112.67 24.18 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 124.296 1.038 . . . . 71.310000000000002 111.345 -174.38 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 39.5 mm -107.11 109.23 27.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 109.71 -0.478 . . . . 73.400000000000006 109.71 177.657 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 40.9 p -88.38 131.18 34.95 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 122.705 0.402 . . . . 70.230000000000004 110.308 179.765 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 6.1 p -127.19 133.29 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 109.448 -0.575 . . . . 74.519999999999996 109.448 176.736 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -97.41 128.94 44.63 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.736 -0.839 . . . . 71.349999999999994 108.736 174.552 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.473 ' CG2' ' HA ' ' A' ' 397' ' ' ASP . 7.0 p -129.57 143.89 39.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.886 -0.783 . . . . 73.319999999999993 108.886 -176.509 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 421' ' ' SER . . . . . 0.525 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 14.5 m -119.58 130.01 54.92 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 119.156 -1.017 . . . . 72.540000000000006 111.359 -178.821 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 5.3 t -119.09 107.06 13.02 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.483 -0.78 . . . . 71.200000000000003 111.285 -179.504 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.903 0 CA-C-N 116.276 -0.42 . . . . 71.420000000000002 113.63 177.159 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 . . . . . 0 N--CA 1.428 -1.561 0 N-CA-C 106.434 -1.691 . . . . 74.010000000000005 106.434 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 57.4 mmm-85 -126.61 163.73 22.79 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.594 -0.691 . . . . 74.400000000000006 111.977 -178.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.1 138.74 33.57 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 114.535 -1.211 . . . . 63.140000000000001 108.832 -179.084 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 62.4 mt -91.27 123.72 63.41 Favored Pre-proline 0 N--CA 1.425 -1.701 0 N-CA-C 108.515 -0.921 . . . . 74.109999999999999 108.515 177.103 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -71.4 141.01 37.85 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 121.617 1.545 . . . . 63.520000000000003 109.733 171.588 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -87.75 168.34 13.05 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.261 -1.014 . . . . 72.030000000000001 108.261 177.372 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.406 HG12 ' HB3' ' A' ' 440' ' ' ALA . 13.8 p -153.98 164.94 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.266 -1.013 . . . . 75.140000000000001 108.266 -175.546 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 37.6 m -75.95 147.9 38.57 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.435 -0.95 . . . . 62.149999999999999 108.435 174.139 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 47.0 p -66.45 -27.99 68.24 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 114.486 1.291 . . . . 74.409999999999997 114.486 -170.877 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.1 pp -79.49 -15.83 57.08 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.295 -0.878 . . . . 64.239999999999995 112.35 176.522 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.01 47.91 1.16 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.09 0.471 . . . . 72.019999999999996 111.34 -174.568 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . 0.47 ' OH ' ' HB2' ' A' ' 454' ' ' GLN . 71.2 t80 -52.95 -38.65 62.23 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.27 0.628 . . . . 74.200000000000003 112.634 178.629 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.36 -39.61 91.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.427 0.632 . . . . 73.230000000000004 110.731 179.79 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -70.3 -35.37 73.64 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.509 -0.769 . . . . 74.219999999999999 109.879 178.857 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.512 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -59.64 -51.23 70.69 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.839 -0.619 . . . . 74.310000000000002 111.092 -178.892 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.1 m -65.44 -39.09 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 112.275 0.472 . . . . 75.409999999999997 112.275 -178.28 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . 0.273 0.1 OUTLIER -68.17 -34.43 76.29 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 119.556 -0.858 . . . . 75.019999999999996 112.1 176.602 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -63.35 -42.01 98.9 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 116.565 -0.289 . . . . 73.230000000000004 110.584 174.885 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 93.3 mt -63.57 -33.15 74.96 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.11 -0.495 . . . . 75.109999999999999 110.551 178.916 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 48.2 m -70.08 -43.84 70.29 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.13 -0.486 . . . . 75.140000000000001 110.065 179.493 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.23 -15.36 62.45 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.675 0.75 . . . . 72.109999999999999 110.706 178.801 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -87.01 -0.9 57.38 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.451 -0.795 . . . . 74.430000000000007 111.659 179.531 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 112.79 -77.56 0.24 Allowed Glycine 0 CA--C 1.499 -0.963 0 C-N-CA 120.201 -1.0 . . . . 74.439999999999998 112.28 176.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . 0.412 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 0.1 OUTLIER -43.55 -65.55 0.48 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.521 0.934 . . . . 74.409999999999997 113.521 177.318 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 62.11 21.64 61.85 Favored Glycine 0 C--O 1.226 -0.354 0 C-N-CA 121.077 -0.582 . . . . 74.340000000000003 111.704 -175.421 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -102.91 110.78 22.83 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 108.213 -1.032 . . . . 70.140000000000001 108.213 -178.004 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . 0.43 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 27.8 p90 -142.68 163.93 31.49 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 115.59 -0.732 . . . . 74.019999999999996 109.665 -175.95 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -151.89 124.14 8.22 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.862 -0.792 . . . . 75.450000000000003 108.862 176.356 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . 0.47 ' HB2' ' OH ' ' A' ' 437' ' ' TYR . 57.3 tt0 -87.22 128.4 35.15 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 123.454 0.471 . . . . 74.340000000000003 109.959 179.897 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -122.17 138.03 54.62 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.23 -1.026 . . . . 73.329999999999998 108.23 175.025 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -114.44 133.16 55.95 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.84 -1.171 . . . . 75.519999999999996 107.84 -179.13 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 49.1 m -151.73 145.35 17.69 Favored Pre-proline 0 C--N 1.298 -1.638 0 N-CA-C 109.676 -0.49 . . . . 72.120000000000005 109.676 176.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.669 ' HA ' ' O ' ' A' ' 490' ' ' SER . 29.2 Cg_endo -65.3 122.54 10.29 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.147 1.898 . . . . 74.030000000000001 109.264 177.398 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 35.2 m -134.04 179.88 5.98 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 115.634 -0.712 . . . . 43.299999999999997 109.734 -173.276 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 6.0 t -54.16 135.84 59.12 Favored Pre-proline 0 N--CA 1.436 -1.166 0 O-C-N 124.26 0.975 . . . . 74.439999999999998 109.552 178.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -50.97 -29.76 28.47 Favored 'Trans proline' 0 N--CA 1.477 0.512 0 C-N-CA 124.689 3.592 . . . . 72.310000000000002 115.085 -171.679 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -75.58 -22.38 57.01 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.973 0.416 . . . . 64.129999999999995 112.018 179.272 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -98.37 -5.91 31.8 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.842 0.353 . . . . 71.420000000000002 110.692 177.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 62.3 t -61.42 127.72 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 109.163 -0.681 . . . . 74.319999999999993 109.163 174.233 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 85.93 -4.02 86.41 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 111.415 -0.674 . . . . 75.030000000000001 111.415 -179.162 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -122.46 156.82 33.28 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 121.558 0.695 . . . . 70.420000000000002 109.433 -177.064 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 47.4 t -71.09 142.59 15.38 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.503 0 CA-C-N 114.599 -1.182 . . . . 73.510000000000005 108.128 173.089 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 52.1 mt -97.59 -28.99 3.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 108.809 -0.811 . . . . 73.450000000000003 108.809 179.71 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 154.74 -170.11 33.01 Favored Glycine 0 N--CA 1.427 -1.957 0 C-N-CA 120.337 -0.935 . . . . 70.120000000000005 112.16 177.042 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 470' ' ' THR . . . . . 0.452 HG23 HG12 ' A' ' 486' ' ' ILE . 36.1 p -115.45 139.9 49.62 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.803 -1.555 . . . . 75.109999999999999 106.803 -179.824 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.413 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 9.0 t30 -63.43 -50.9 71.36 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 119.361 -0.935 . . . . 74.129999999999995 112.037 177.481 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.413 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 22.0 Cg_exo -75.06 151.11 38.84 Favored 'Trans proline' 0 C--N 1.36 1.157 0 N-CA-C 108.5 -1.385 . . . . 72.209999999999994 108.5 170.456 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.24 127.07 20.06 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.004 1.802 . . . . 73.150000000000006 112.173 -178.508 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -89.06 3.86 50.32 Favored 'General case' 0 C--O 1.207 -1.175 0 CA-C-N 115.511 -0.768 . . . . 75.209999999999994 110.732 -177.928 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -111.08 8.14 21.7 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.524 -0.762 . . . . 75.129999999999995 109.933 179.499 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -125.69 179.59 5.09 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 116.198 -0.455 . . . . 74.209999999999994 111.043 -174.247 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 3.6 m -89.84 117.57 28.78 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 115.516 -0.766 . . . . 60.119999999999997 109.481 179.917 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 50.1 m -118.94 148.68 42.69 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.471 -0.566 . . . . 53.109999999999999 109.471 -179.172 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -73.16 153.38 40.75 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.67 0.619 . . . . 70.099999999999994 112.67 -174.503 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . 0.412 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 2.2 mp -65.03 -26.82 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-O 121.756 0.788 . . . . 70.430000000000007 110.695 178.75 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 12.2 p -90.85 5.38 48.7 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.477 -0.783 . . . . 65.340000000000003 111.502 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -103.33 129.6 50.41 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.084 -0.507 . . . . 74.150000000000006 109.958 -176.55 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.2 p -98.58 127.19 51.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.706 -0.679 . . . . 70.049999999999997 111.408 -176.086 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 33.5 m -96.67 123.45 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-O 121.403 0.62 . . . . 72.340000000000003 110.618 178.121 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.95 128.99 43.27 Favored 'Isoleucine or valine' 0 C--O 1.256 1.435 0 N-CA-C 107.994 -1.113 . . . . 73.239999999999995 107.994 176.844 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . 0.452 HG12 HG23 ' A' ' 470' ' ' THR . 42.2 mt -119.72 119.59 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 CA-C-N 114.996 -1.002 . . . . 72.230000000000004 110.269 -175.692 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 5.8 tt -103.03 127.12 57.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 115.295 -0.866 . . . . 73.530000000000001 111.176 -178.513 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 1.9 p -107.93 136.21 44.09 Favored 'Isoleucine or valine' 0 C--O 1.256 1.403 0 CA-C-N 115.361 -0.836 . . . . 74.430000000000007 108.973 176.05 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -73.53 127.95 11.0 Favored Glycine 0 N--CA 1.419 -2.483 0 N-CA-C 110.619 -0.993 . . . . 71.209999999999994 110.619 179.328 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.669 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 14.4 t . . . . . 0 C--N 1.28 -2.455 0 N-CA-C 106.907 -1.516 . . . . 73.310000000000002 106.907 178.345 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo . . . . . 0 N--CA 1.448 -1.178 0 N-CA-C 110.897 -0.463 . . . . 74.5 110.897 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . -84.86 52.78 2.51 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.997 -0.742 . . . . 54.399999999999999 108.997 179.888 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 24.3 p -116.5 148.14 41.08 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 115.231 -0.895 . . . . 74.019999999999996 110.423 -174.234 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -145.45 155.06 42.89 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 108.138 -1.06 . . . . 74.450000000000003 108.138 178.353 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -89.82 122.9 33.32 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.638 -0.505 . . . . 65.0 109.638 -177.565 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 37.0 pt -79.55 136.29 55.95 Favored Pre-proline 0 C--N 1.307 -1.264 0 O-C-N 123.271 0.357 . . . . 73.540000000000006 111.341 -179.433 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -85.18 -174.32 1.66 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.643 2.229 . . . . 75.239999999999995 110.266 174.719 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -92.59 147.17 23.1 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.376 -0.601 . . . . 64.120000000000005 109.376 179.83 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 41.2 t -129.28 93.86 2.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 107.314 -1.365 . . . . 70.299999999999997 107.314 178.6 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -148.22 112.9 5.37 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 107.223 -1.399 . . . . 74.340000000000003 107.223 179.566 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 110.24 36.35 1.97 Allowed Glycine 0 N--CA 1.421 -2.314 0 N-CA-C 110.172 -1.171 . . . . 74.109999999999999 110.172 -178.016 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -143.1 166.79 23.7 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 108.33 -0.989 . . . . 75.299999999999997 108.33 178.651 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 532' ' ' GLY . 11.8 t -93.32 157.43 16.25 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.043 -1.465 . . . . 74.510000000000005 107.043 173.869 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 10.5 p -55.37 -40.43 57.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 112.235 0.457 . . . . 74.510000000000005 112.235 -178.599 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -58.32 -42.82 87.59 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.496 0.665 . . . . 74.019999999999996 110.949 179.503 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 99.6 t -76.37 -36.73 29.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.641 -0.708 . . . . 74.450000000000003 110.107 -179.219 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -61.35 -49.21 77.86 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.762 -0.654 . . . . 73.420000000000002 111.229 178.856 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -63.21 -37.19 86.26 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 120.485 -0.486 . . . . 72.400000000000006 110.32 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -62.64 -45.7 91.61 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.11 -0.7 . . . . 75.319999999999993 109.11 179.442 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -62.16 -48.66 79.07 Favored 'General case' 0 CA--C 1.494 -1.197 0 O-C-N 123.107 0.254 . . . . 63.100000000000001 111.291 179.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.77 -40.5 97.49 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 112.261 0.467 . . . . 73.439999999999998 112.261 -179.073 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -65.48 -37.98 88.42 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 120.718 -0.393 . . . . 72.519999999999996 110.99 179.146 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 68.7 t -68.92 -26.87 33.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.07 0.462 . . . . 72.299999999999997 110.741 176.755 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 17.4 m-30 -81.33 -1.78 46.59 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.262 -0.575 . . . . 75.25 110.14 178.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . 0.532 ' O ' ' HB ' ' A' ' 547' ' ' VAL . . . 101.78 -4.92 53.57 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.925 -0.655 . . . . 71.120000000000005 113.318 176.08 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -83.85 112.81 20.46 Favored 'General case' 0 CA--C 1.476 -1.899 0 N-CA-C 106.548 -1.649 . . . . 70.420000000000002 106.548 -177.541 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.3 m -89.19 -25.42 21.79 Favored 'General case' 0 N--CA 1.406 -2.656 0 CA-C-N 115.033 -0.985 . . . . 74.310000000000002 112.651 -167.66 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 96.8 mttt -116.15 125.06 51.82 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 120.117 -0.633 . . . . 74.430000000000007 111.035 -177.207 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -129.73 153.14 48.48 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 123.37 0.668 . . . . 74.420000000000002 109.909 -179.437 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 50.5 m -141.09 147.25 38.24 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 108.253 -1.017 . . . . 62.109999999999999 108.253 174.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -116.76 130.9 57.0 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-O 121.229 0.537 . . . . 74.420000000000002 110.417 179.81 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -105.34 119.79 39.95 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 107.68 -1.23 . . . . 71.319999999999993 107.68 176.149 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 42.3 m -90.0 121.27 31.93 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.271 0.558 . . . . 74.519999999999996 110.31 -178.423 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 26.9 m -121.77 153.64 25.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.427 -0.953 . . . . 60.100000000000001 108.427 178.345 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . 0.436 ' C ' ' HG ' ' A' ' 527' ' ' SER . 1.1 p-10 -89.04 136.44 33.01 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.036 -1.098 . . . . 73.319999999999993 108.036 178.135 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 527' ' ' SER . . . . . 0.436 ' HG ' ' C ' ' A' ' 526' ' ' ASP . 19.7 m -153.48 166.97 14.47 Favored Pre-proline 0 C--N 1.292 -1.912 0 N-CA-C 108.575 -0.898 . . . . 73.310000000000002 108.575 179.618 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -73.6 -3.71 14.19 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 121.775 1.65 . . . . 64.219999999999999 112.132 175.602 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . 0.447 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 2.1 mpt_? -85.21 134.57 40.51 Favored Pre-proline 0 CA--C 1.515 -0.396 0 N-CA-C 108.093 -1.077 . . . . 75.430000000000007 108.093 179.476 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -56.23 143.95 83.2 Favored 'Trans proline' 0 C--O 1.242 0.724 0 C-N-CA 123.064 2.51 . . . . 64.319999999999993 113.723 -175.512 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -53.18 125.6 18.05 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 114.615 -1.175 . . . . 72.299999999999997 112.629 -174.801 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 504' ' ' THR . . . 114.41 -16.31 19.63 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.482 -0.781 . . . . 51.43 111.294 178.124 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -74.33 125.73 29.13 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.674 -0.491 . . . . 64.519999999999996 109.674 179.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 53.3 t -82.78 112.01 19.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.1 -1.444 . . . . 75.120000000000005 107.1 176.222 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 15.0 t -80.5 -18.51 48.37 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.755 -0.657 . . . . 75.430000000000007 111.114 -175.778 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 163.81 -170.0 38.96 Favored Glycine 0 CA--C 1.495 -1.182 0 C-N-CA 119.94 -1.124 . . . . 73.140000000000001 111.828 178.514 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 65.0 p -117.31 153.86 32.24 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.183 -1.043 . . . . 71.420000000000002 108.183 -179.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . 0.502 ' CA ' HE22 ' A' ' 554' ' ' GLN . 34.5 t30 -77.25 -53.87 1.59 Allowed Pre-proline 0 C--N 1.314 -0.948 0 C-N-CA 120.116 -0.633 . . . . 74.420000000000002 110.565 177.813 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -70.63 126.94 13.25 Favored 'Trans proline' 0 C--N 1.357 0.993 0 N-CA-C 107.739 -1.677 . . . . 74.420000000000002 107.739 167.707 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.88 156.57 63.62 Favored 'Trans proline' 0 C--O 1.247 0.974 0 C-N-CA 122.499 2.132 . . . . 74.510000000000005 113.358 -175.348 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.09 138.71 58.43 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.661 -0.7 . . . . 64.540000000000006 109.914 178.423 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 98.12 -6.34 61.76 Favored Glycine 0 N--CA 1.433 -1.554 0 C-N-CA 120.261 -0.971 . . . . 71.439999999999998 112.088 -178.778 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 59.0 m -76.23 132.96 40.21 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 109.392 -0.595 . . . . 74.219999999999999 109.392 176.803 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 5.0 m -95.11 122.02 37.34 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 107.745 -1.205 . . . . 74.129999999999995 107.745 179.294 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 24.3 m -138.16 156.23 73.95 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 109.895 -0.409 . . . . 75.0 109.895 -178.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 37.5 Cg_exo -63.6 139.94 72.54 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.114 1.876 . . . . 75.5 111.375 175.417 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.532 ' HB ' ' O ' ' A' ' 516' ' ' GLY . 30.8 m -64.57 -20.31 26.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 121.841 0.829 . . . . 74.439999999999998 111.912 -179.746 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -77.88 -18.0 56.7 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.04 -0.982 . . . . 72.140000000000001 110.628 178.816 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 24.6 m -77.76 179.06 6.88 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 112.841 0.682 . . . . 75.209999999999994 112.841 -174.977 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 39.1 t -105.78 124.91 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 CA-C-N 115.108 -0.951 . . . . 74.420000000000002 109.644 -176.666 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . 0.413 HD11 ' O ' ' A' ' 519' ' ' LYS . 0.2 OUTLIER -104.87 135.87 40.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.96 -0.756 . . . . 75.430000000000007 108.96 173.43 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -106.85 119.71 40.08 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 116.02 -0.536 . . . . 62.229999999999997 111.21 -176.103 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -101.77 134.12 45.44 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.664 -1.153 . . . . 74.25 109.444 179.814 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . 0.502 HE22 ' CA ' ' A' ' 538' ' ' ASN . 2.0 mp0 -93.74 122.44 36.21 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.074 0.464 . . . . 75.120000000000005 109.844 175.659 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 50.3 t -112.58 130.37 66.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 107.95 -1.13 . . . . 73.420000000000002 107.95 -178.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 74.6 m -88.15 137.28 32.47 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-O 121.667 0.746 . . . . 63.329999999999998 112.318 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.429 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 4.1 ptpt -90.75 147.7 23.06 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 103.986 -2.598 . . . . 75.439999999999998 103.986 169.925 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . 0.457 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -83.25 -24.9 50.15 Favored Glycine 0 CA--C 1.479 -2.158 0 C-N-CA 120.318 -0.944 . . . . 75.409999999999997 113.57 -171.08 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . 0.43 ' O ' ' HA ' ' A' ' 615' ' ' ASN . 88.0 m-20 72.06 -44.03 0.58 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.578 1.151 . . . . 74.239999999999995 111.183 -177.283 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.457 ' H ' ' C ' ' A' ' 558' ' ' GLY . 97.5 mt-30 -119.81 141.73 49.24 Favored 'General case' 0 N--CA 1.424 -1.766 0 C-N-CA 123.548 0.739 . . . . 73.439999999999998 111.432 -175.767 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . 0.434 ' O ' ' HA2' ' A' ' 613' ' ' GLY . 45.4 p90 -126.99 149.74 49.74 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.489 -0.56 . . . . 74.310000000000002 109.489 178.46 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 99.8 t -59.49 120.3 5.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.06 0.457 . . . . 74.010000000000005 111.881 -177.945 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 57.1 ttp -97.09 137.09 21.25 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 116.031 -0.532 . . . . 62.329999999999998 111.19 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -68.68 170.28 15.59 Favored 'Trans proline' 0 CA--C 1.551 1.332 0 C-N-CA 123.5 2.8 . . . . 74.219999999999999 112.684 174.162 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.18 129.47 40.0 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 112.669 0.618 . . . . 63.109999999999999 112.669 179.385 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . 0.439 ' O ' ' HG2' ' A' ' 569' ' ' MET . 95.3 mt -114.74 12.38 17.04 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 122.271 1.034 . . . . 75.420000000000002 108.409 175.865 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 20.3 m -79.58 144.52 33.79 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.847 -1.069 . . . . 73.349999999999994 110.886 -178.863 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 80.62 9.62 86.19 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 114.616 0.606 . . . . 63.439999999999998 114.616 175.285 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 569' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 26.5 ptm -112.44 164.05 13.73 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 117.427 0.614 . . . . 74.049999999999997 109.502 -179.006 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -103.98 163.97 12.02 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.487 0.661 . . . . 71.140000000000001 111.291 -177.281 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 19.6 t90 -62.07 -29.66 70.46 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 125.073 1.349 . . . . 72.109999999999999 109.488 176.422 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 34.3 m -71.29 -15.12 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 115.845 -0.616 . . . . 74.409999999999997 110.771 177.531 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -96.9 -34.84 11.1 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.336 -0.987 . . . . 72.310000000000002 108.336 175.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -60.86 -41.53 96.08 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.8 -1.091 . . . . 63.43 112.188 -178.259 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.485 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 38.7 mt-10 -59.73 -54.54 54.67 Favored Pre-proline 0 CA--C 1.554 1.127 0 N-CA-C 112.928 0.714 . . . . 73.340000000000003 112.928 -179.705 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . 0.421 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 52.2 Cg_exo -59.58 -37.04 90.93 Favored 'Trans proline' 0 C--N 1.369 1.615 0 C-N-CA 121.388 1.392 . . . . 74.439999999999998 112.249 174.781 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -59.11 -47.88 83.65 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.347 0.659 . . . . 74.239999999999995 110.451 177.894 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.6 pp -67.16 -41.01 86.72 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.151 0.426 . . . . 73.040000000000006 112.151 -175.853 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -65.35 -40.03 93.1 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.571 -0.74 . . . . 75.420000000000002 110.968 -179.744 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.19 -38.34 87.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.611 -0.722 . . . . 64.239999999999995 112.025 -178.201 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.26 -8.51 48.17 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.676 0.621 . . . . 74.0 112.676 -178.851 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 68.09 40.37 88.36 Favored Glycine 0 C--N 1.311 -0.822 0 C-N-CA 119.927 -1.13 . . . . 74.420000000000002 110.567 -175.669 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 83.2 t90 -82.25 135.33 35.25 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.469 -0.567 . . . . 74.239999999999995 109.469 179.113 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 9.0 t -148.06 87.58 1.62 Allowed 'General case' 0 N--CA 1.418 -2.042 0 CA-C-O 122.754 1.264 . . . . 73.109999999999999 111.045 175.762 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -123.76 -109.74 1.9 Allowed Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 109.094 -1.602 . . . . 72.329999999999998 109.094 177.867 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 69.7 mtp -137.27 124.15 21.33 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 120.714 -0.394 . . . . 75.140000000000001 111.99 176.78 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -87.39 121.58 30.02 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 103.073 -2.936 . . . . 71.109999999999999 103.073 166.251 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -122.3 111.54 17.03 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 119.362 -0.935 . . . . 74.109999999999999 113.15 -168.709 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . 0.488 ' HD3' ' O ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -113.33 110.24 20.02 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 109.412 -0.588 . . . . 75.140000000000001 109.412 170.853 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -90.48 -55.65 1.9 Allowed Glycine 0 CA--C 1.492 -1.352 0 C-N-CA 120.628 -0.796 . . . . 71.430000000000007 111.867 -178.214 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -127.42 134.62 49.87 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 109.817 -0.438 . . . . 74.219999999999999 109.817 -179.277 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -86.8 123.01 31.48 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 105.683 -1.969 . . . . 55.32 105.683 174.731 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 88.0 t -132.72 126.32 54.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.066 0.46 . . . . 74.129999999999995 111.343 -174.388 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . 0.542 ' HA ' ' NE2' ' A' ' 600' ' ' HIS . 21.5 t70 -83.14 110.68 18.24 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 109.067 -0.716 . . . . 64.239999999999995 109.067 175.628 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -131.32 2.14 4.2 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 120.988 0.423 . . . . 70.219999999999999 111.897 -179.608 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 111.81 155.99 13.3 Favored Glycine 0 CA--C 1.499 -0.954 0 N-CA-C 110.798 -0.921 . . . . 44.200000000000003 110.798 179.574 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -55.56 -37.06 65.99 Favored Glycine 0 N--CA 1.464 0.541 0 N-CA-C 114.418 0.527 . . . . 73.439999999999998 114.418 -171.614 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 23.6 m -64.81 -23.55 67.27 Favored 'General case' 0 CA--C 1.552 1.058 0 CA-C-O 120.943 0.402 . . . . 61.130000000000003 111.956 178.832 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -99.43 -13.07 19.7 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 121.968 -0.458 . . . . 75.420000000000002 111.308 -179.118 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . 0.542 ' NE2' ' HA ' ' A' ' 594' ' ' ASP . 12.0 m170 -85.66 137.21 32.99 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 109.518 -0.549 . . . . 65.230000000000004 109.518 -178.164 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 65.82 -11.11 0.2 Allowed 'General case' 0 C--O 1.206 -1.214 0 C-N-CA 124.505 1.122 . . . . 75.439999999999998 113.374 -175.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . 0.455 ' HD2' ' O ' ' A' ' 603' ' ' VAL . 3.3 tmm_? -86.68 138.37 31.71 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.417 -0.957 . . . . 74.400000000000006 108.417 -175.78 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . 0.455 ' O ' ' HD2' ' A' ' 602' ' ' ARG . 97.7 t -74.73 129.29 36.8 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 108.164 -1.05 . . . . 72.540000000000006 108.164 -179.889 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 68.9 t -84.97 -51.57 13.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 109.717 -0.475 . . . . 73.120000000000005 109.717 -172.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -147.09 157.96 43.78 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 107.647 -1.242 . . . . 74.239999999999995 107.647 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -113.43 120.88 42.56 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 106.407 -1.701 . . . . 63.149999999999999 106.407 174.077 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.434 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 51.2 t30 -52.75 -52.91 60.01 Favored Pre-proline 0 N--CA 1.477 0.876 0 N-CA-C 112.979 0.733 . . . . 64.25 112.979 -177.141 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.434 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 3.0 Cg_exo -83.69 119.26 2.57 Favored 'Trans proline' 0 C--O 1.253 1.245 0 C-N-CA 121.118 1.212 . . . . 73.219999999999999 109.425 171.073 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.97 145.46 89.99 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 122.609 2.206 . . . . 72.049999999999997 112.219 -178.443 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.68 131.41 45.53 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.695 -0.684 . . . . 75.420000000000002 109.219 178.216 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.67 -19.61 38.55 Favored Glycine 0 C--N 1.296 -1.674 0 N-CA-C 110.082 -1.207 . . . . 73.0 110.082 -173.416 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 27.8 m -91.06 158.53 16.62 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.911 -1.144 . . . . 74.430000000000007 107.911 176.562 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 561' ' ' PHE . . . -84.3 132.78 11.31 Favored Glycine 0 N--CA 1.419 -2.458 0 C-N-CA 121.527 -0.368 . . . . 75.219999999999999 112.238 -179.879 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 34.2 m -113.98 142.42 26.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 C-N-CA 123.67 0.788 . . . . 72.230000000000004 109.541 177.007 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . 0.521 ' ND2' ' HB2' ' A' ' 617' ' ' ASP . 26.5 p-10 -52.66 162.02 0.64 Allowed 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 124.078 0.951 . . . . 74.299999999999997 112.98 177.65 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -58.41 -25.13 61.78 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 112.702 0.63 . . . . 73.319999999999993 112.702 177.406 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . 0.521 ' HB2' ' ND2' ' A' ' 615' ' ' ASN . 19.6 m-20 -70.53 -28.51 64.99 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.98 -0.554 . . . . 75.239999999999995 109.745 177.108 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 74.22 21.01 79.55 Favored Glycine 0 N--CA 1.432 -1.608 0 CA-C-N 115.689 -0.687 . . . . 63.439999999999998 112.488 177.401 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.83 118.83 13.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 122.322 1.058 . . . . 75.200000000000003 109.994 -169.963 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . 0.467 ' O ' HD13 ' A' ' 620' ' ' ILE . 2.8 pp -125.94 133.4 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.385 0 CA-C-N 114.218 -1.355 . . . . 74.409999999999997 109.702 -178.038 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 83.4 m -98.38 120.39 38.71 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 109.087 -0.709 . . . . 70.439999999999998 109.087 176.464 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.7 pp -119.82 165.94 13.93 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.669 -1.151 . . . . 72.420000000000002 109.065 -179.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -146.55 146.95 30.65 Favored 'General case' 0 C--N 1.269 -2.9 0 N-CA-C 106.364 -1.717 . . . . 73.299999999999997 106.364 177.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -138.79 165.53 26.77 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 105.691 -1.966 . . . . 74.200000000000003 105.691 175.581 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -66.12 -95.35 0.03 OUTLIER Glycine 0 C--N 1.313 -0.701 0 C-N-CA 120.112 -1.042 . . . . 64.349999999999994 111.372 178.865 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . 0.422 ' HB3' ' CE1' ' A' ' 600' ' ' HIS . 8.9 tt0 . . . . . 0 C--N 1.292 -1.897 0 N-CA-C 108.447 -0.945 . . . . 73.340000000000003 108.447 173.223 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 . . . . . 0 N--CA 1.421 -1.911 0 N-CA-C 105.848 -1.908 . . . . 73.209999999999994 105.848 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.7 m -125.83 161.44 30.98 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.48 0 N-CA-C 109.422 -0.584 . . . . 74.310000000000002 109.422 -177.19 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -94.12 137.95 32.73 Favored 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 105.489 -2.041 . . . . 73.299999999999997 105.489 176.534 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.471 HG12 ' CE2' ' A' ' 382' ' ' PHE . 91.0 t -95.12 126.14 47.66 Favored Pre-proline 0 C--N 1.278 -2.542 0 N-CA-C 109.711 -0.477 . . . . 65.209999999999994 109.711 -166.34 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -62.22 123.49 12.6 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 122.095 1.864 . . . . 65.140000000000001 111.232 -178.495 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -81.64 143.2 32.08 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 107.713 -1.217 . . . . 72.209999999999994 107.713 179.974 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.435 HG13 ' HB2' ' A' ' 373' ' ' ALA . 7.1 p -126.93 18.02 3.51 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.699 0 CA-C-O 122.605 1.193 . . . . 63.5 110.595 -170.129 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.16 146.83 53.59 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.309 -1.314 . . . . 74.150000000000006 113.132 -179.289 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.02 0.5 41.67 Favored Glycine 0 CA--C 1.502 -0.744 0 CA-C-N 115.943 -0.571 . . . . 74.430000000000007 112.794 179.094 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -115.0 -158.48 0.67 Allowed 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 107.966 -1.124 . . . . 75.310000000000002 107.966 175.705 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 70.6 p -91.35 155.77 18.25 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 108.135 -1.061 . . . . 72.030000000000001 108.135 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 23.2 m -63.0 -33.99 76.6 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 120.688 0.28 . . . . 64.439999999999998 110.674 -179.029 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.9 -46.54 74.56 Favored 'General case' 0 C--O 1.212 -0.892 0 CA-C-O 119.435 -0.317 . . . . 74.349999999999994 111.051 178.807 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -69.12 -43.1 75.11 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-O 121.164 0.507 . . . . 75.219999999999999 110.579 179.659 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . 0.435 ' HB2' HG13 ' A' ' 365' ' ' VAL . . . -63.32 -49.11 75.27 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.371 -0.831 . . . . 64.319999999999993 111.728 -178.108 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.15 -38.1 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-N 116.52 -0.309 . . . . 73.239999999999995 110.834 179.322 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -60.64 -47.08 87.82 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.828 0.347 . . . . 64.549999999999997 110.885 178.839 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 60.0 m -60.91 -46.88 88.88 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.258 0.551 . . . . 75.420000000000002 110.215 179.678 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 7.6 tt -63.4 -38.87 92.83 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 115.546 -0.752 . . . . 62.509999999999998 110.752 -179.265 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -63.88 -40.37 96.38 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.135 0.574 . . . . 71.329999999999998 109.826 177.624 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -70.25 -17.61 63.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.166 0.508 . . . . 75.439999999999998 112.024 178.181 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -84.33 -14.72 48.86 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.077 0.465 . . . . 73.340000000000003 110.18 174.397 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 96.37 8.13 57.74 Favored Glycine 0 N--CA 1.435 -1.426 0 C-N-CA 120.586 -0.816 . . . . 71.120000000000005 112.728 175.822 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.471 ' CE2' HG12 ' A' ' 362' ' ' VAL . 66.4 m-85 -80.69 169.13 18.03 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-O 120.768 0.318 . . . . 64.319999999999993 110.688 178.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -112.44 150.24 31.46 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.17 -1.048 . . . . 74.010000000000005 108.17 -179.099 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.76 149.13 33.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 CA-C-O 121.572 0.701 . . . . 73.25 112.035 177.181 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.72 139.7 45.77 Favored 'General case' 0 N--CA 1.4 -2.954 0 N-CA-C 103.444 -2.798 . . . . 75.430000000000007 103.444 169.797 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 52.0 m -133.76 119.14 18.89 Favored 'General case' 0 C--N 1.252 -3.649 0 N-CA-C 108.468 -0.938 . . . . 63.340000000000003 108.468 -175.011 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -110.95 119.36 38.82 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.159 -0.682 . . . . 73.409999999999997 109.159 -179.664 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . 0.465 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -102.08 120.78 40.99 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 107.054 -1.461 . . . . 74.439999999999998 107.054 176.485 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 421' ' ' SER . 55.8 mtmt -139.29 140.96 27.6 Favored Pre-proline 0 C--N 1.285 -2.198 0 CA-C-N 115.834 -0.621 . . . . 74.030000000000001 109.789 -175.755 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' A' ' 422' ' ' THR . 24.1 Cg_exo -69.14 174.31 9.15 Favored 'Trans proline' 0 C--O 1.246 0.911 0 C-N-CA 121.972 1.781 . . . . 74.109999999999999 110.016 169.286 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 90.15 173.74 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.768 1.627 . . . . 72.519999999999996 111.471 -179.2 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 38.6 m -119.53 13.48 12.58 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.642 0.734 . . . . 75.530000000000001 109.384 -176.818 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 10.7 m -78.02 -15.73 58.68 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 122.297 1.046 . . . . 74.219999999999999 109.45 -179.726 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . 0.584 HG12 ' OG ' ' A' ' 421' ' ' SER . 0.1 OUTLIER -113.69 151.82 44.96 Favored Pre-proline 0 N--CA 1.42 -1.938 0 CA-C-N 114.54 -1.209 . . . . 74.319999999999993 108.975 179.339 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.31 158.0 2.79 Favored 'Trans proline' 0 CA--C 1.554 1.483 0 C-N-CA 124.756 3.637 . . . . 74.349999999999994 115.854 -175.487 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.13 161.41 8.89 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 123.967 3.111 . . . . 75.439999999999998 112.716 178.339 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . 0.414 ' HA ' HG23 ' A' ' 420' ' ' VAL . 6.6 p-10 -58.99 -9.42 1.88 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.889 0.876 . . . . 74.030000000000001 113.324 -176.867 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 59.6 m170 -114.51 145.99 41.25 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.265 -1.384 . . . . 70.450000000000003 107.265 177.016 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 30.6 m -72.28 118.95 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 N-CA-C 112.9 0.704 . . . . 73.439999999999998 112.9 -167.817 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . 0.432 ' O ' HD13 ' A' ' 400' ' ' ILE . 0.0 OUTLIER -97.97 -29.02 3.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 106.613 -1.625 . . . . 75.010000000000005 106.613 176.275 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.7 163.16 28.56 Favored Glycine 0 N--CA 1.409 -3.13 0 CA-C-N 114.808 -1.087 . . . . 73.239999999999995 110.446 -178.055 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.8 p -119.55 -176.56 3.18 Favored 'General case' 0 C--N 1.282 -2.331 0 C-N-CA 124.832 1.253 . . . . 71.540000000000006 109.265 179.101 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . 0.483 ' HB2' ' O ' ' A' ' 417' ' ' THR . 20.2 t70 -99.4 134.78 20.97 Favored Pre-proline 0 C--N 1.299 -1.612 0 N-CA-C 108.814 -0.81 . . . . 74.150000000000006 108.814 -174.581 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.24 -17.1 7.92 Favored 'Trans proline' 0 C--N 1.363 1.318 0 C-N-CA 124.335 3.357 . . . . 74.129999999999995 115.134 -176.389 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -61.0 -32.99 72.56 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.967 -0.383 . . . . 75.450000000000003 109.967 177.062 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . 0.444 ' HA ' ' HB ' ' A' ' 362' ' ' VAL . . . -72.75 -30.91 64.53 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.663 0.744 . . . . 54.020000000000003 110.052 179.256 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -81.0 -10.79 59.67 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.345 -0.843 . . . . 73.439999999999998 109.843 -178.722 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 40.0 m -96.5 150.09 21.01 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.928 -1.508 . . . . 63.350000000000001 106.928 175.727 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 23.2 m -81.28 111.99 18.18 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 107.964 -1.125 . . . . 54.200000000000003 107.964 176.795 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.3 m -123.75 169.29 15.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-O 120.967 0.413 . . . . 65.510000000000005 110.587 -178.544 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 15.7 m -65.88 136.9 56.76 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.966 -0.753 . . . . 73.25 108.966 178.133 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -67.07 114.23 5.68 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.556 0.693 . . . . 75.209999999999994 111.223 -174.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 110.06 40.3 1.43 Allowed Glycine 0 N--CA 1.423 -2.193 0 CA-C-N 115.032 -0.985 . . . . 72.120000000000005 111.667 -179.798 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -114.53 -176.62 2.94 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.538 -0.465 . . . . 74.209999999999994 109.856 -179.015 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -87.21 119.51 27.52 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 123.842 0.857 . . . . 52.340000000000003 111.651 -167.619 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 38.8 mm -112.28 121.49 64.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 107.902 -1.147 . . . . 65.400000000000006 107.902 174.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 417' ' ' THR . . . . . 0.483 ' O ' ' HB2' ' A' ' 403' ' ' ASP . 35.5 m -93.05 129.32 39.03 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 113.348 0.87 . . . . 72.409999999999997 113.348 -173.98 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 4.2 p -124.42 135.84 62.47 Favored 'Isoleucine or valine' 0 C--O 1.247 0.934 0 CA-C-N 116.237 -0.438 . . . . 73.530000000000001 110.34 179.773 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -107.35 128.57 54.57 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.503 -0.317 . . . . 62.5 110.168 178.321 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.414 HG23 ' HA ' ' A' ' 397' ' ' ASP . 7.5 p -123.81 131.49 72.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 109.285 -0.635 . . . . 63.100000000000001 109.285 177.382 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 421' ' ' SER . . . . . 0.584 ' OG ' HG12 ' A' ' 394' ' ' ILE . 43.4 m -95.83 122.9 39.11 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.544 0.687 . . . . 62.32 112.12 -177.208 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 422' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 390' ' ' PRO . 6.0 t -119.49 106.99 12.77 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.392 -0.822 . . . . 74.120000000000005 109.993 175.525 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.203 0 C-N-CA 120.318 -0.944 . . . . 74.0 113.134 179.041 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 . . . . . 0 N--CA 1.427 -1.61 0 N-CA-C 106.965 -1.494 . . . . 74.140000000000001 106.965 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.494 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 5.4 mmp_? -122.71 154.81 37.61 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 120.982 0.42 . . . . 74.549999999999997 110.847 176.337 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -83.57 138.99 33.13 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 115.292 -0.867 . . . . 75.530000000000001 110.117 -175.829 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.421 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 60.4 mt -86.39 127.49 60.85 Favored Pre-proline 0 N--CA 1.425 -1.695 0 N-CA-C 107.085 -1.45 . . . . 73.150000000000006 107.085 176.048 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.42 ' HG2' ' HB3' ' A' ' 443' ' ' LYS . 12.1 Cg_exo -70.19 151.16 66.49 Favored 'Trans proline' 0 C--O 1.239 0.527 0 C-N-CA 122.08 1.853 . . . . 74.150000000000006 110.918 176.157 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -69.19 137.73 53.51 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 107.868 -1.16 . . . . 71.540000000000006 107.868 178.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 2.4 p -116.97 111.27 34.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 C-N-CA 120.306 -0.557 . . . . 75.129999999999995 112.206 -176.462 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 1.8 p -65.63 139.52 58.43 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 107.265 -1.383 . . . . 75.129999999999995 107.265 171.622 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 434' ' ' THR . . . . . 0.518 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 62.7 p -63.28 -30.87 71.93 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 113.767 1.025 . . . . 73.329999999999998 113.767 -164.117 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.42 -11.1 41.46 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 115.867 -0.606 . . . . 65.049999999999997 111.767 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.4 m -105.66 45.75 0.95 Allowed 'General case' 0 CA--C 1.573 1.841 0 CA-C-O 122.462 1.125 . . . . 75.010000000000005 110.788 -173.158 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -58.58 -38.2 77.39 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.955 -1.021 . . . . 75.409999999999997 113.27 177.037 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -62.52 -36.52 82.85 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 118.508 0.595 . . . . 62.109999999999999 110.657 179.397 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -62.66 -39.41 93.83 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.729 -0.841 . . . . 74.530000000000001 108.729 175.645 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.405 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -63.82 -42.97 97.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.04 -0.527 . . . . 64.140000000000001 110.343 178.038 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 78.5 t -58.28 -48.95 83.48 Favored 'Isoleucine or valine' 0 C--O 1.256 1.443 0 CA-C-N 115.998 -0.547 . . . . 64.030000000000001 111.034 -179.114 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -67.67 -40.85 84.42 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.134 -0.626 . . . . 74.25 110.804 -177.858 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . 0.42 ' HB3' ' HG2' ' A' ' 430' ' ' PRO . 27.5 mmtp -66.45 -40.87 89.66 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.622 -0.717 . . . . 73.150000000000006 112.032 -177.517 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.405 HD13 ' O ' ' A' ' 440' ' ' ALA . 8.2 mp -63.67 -38.46 91.19 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.25 0.344 . . . . 75.439999999999998 110.159 175.879 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.42 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 98.3 m -64.08 -47.49 79.9 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 120.984 0.421 . . . . 71.439999999999998 110.972 179.225 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.49 -15.65 62.32 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.167 -0.469 . . . . 72.140000000000001 112.11 -179.598 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -85.54 5.34 31.89 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.035 0.445 . . . . 64.409999999999997 111.724 179.699 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 104.56 -66.97 0.29 Allowed Glycine 0 CA--C 1.497 -1.045 0 C-N-CA 120.139 -1.029 . . . . 64.010000000000005 112.406 175.212 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 480' ' ' ILE . 1.3 p90 -49.65 -61.44 2.11 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 113.193 0.812 . . . . 74.239999999999995 113.193 177.627 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . 0.42 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 57.94 25.12 55.92 Favored Glycine 0 CA--C 1.504 -0.611 0 O-C-N 123.056 0.222 . . . . 70.219999999999999 113.301 -179.923 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 62.7 mtt180 -106.63 113.72 27.39 Favored 'General case' 0 N--CA 1.419 -2.017 0 N-CA-C 108.989 -0.745 . . . . 75.010000000000005 108.989 -178.042 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 43.2 p90 -137.8 151.8 48.49 Favored 'General case' 0 C--N 1.279 -2.459 0 CA-C-N 115.192 -0.913 . . . . 74.049999999999997 110.012 -175.756 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -142.39 122.85 14.03 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.124 -0.944 . . . . 74.430000000000007 110.189 176.663 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -93.95 125.57 38.65 Favored 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 123.778 0.831 . . . . 75.120000000000005 109.654 178.626 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -119.18 147.15 44.54 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.99 -1.115 . . . . 72.540000000000006 107.99 175.314 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 488' ' ' VAL . 11.5 m120 -120.61 133.49 55.37 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 120.855 0.359 . . . . 75.420000000000002 111.365 -179.869 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 27.3 t -135.79 139.45 30.72 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 108.979 -0.749 . . . . 72.310000000000002 108.979 179.704 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.624 ' HA ' ' O ' ' A' ' 490' ' ' SER . 32.9 Cg_endo -65.94 127.39 17.63 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.292 1.994 . . . . 72.519999999999996 110.977 177.495 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 69.5 m -147.76 179.47 7.68 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 122.912 0.485 . . . . 75.519999999999996 109.945 -179.7 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 460' ' ' THR . . . . . 0.468 ' O ' HG22 ' A' ' 464' ' ' VAL . 5.2 t -50.23 139.29 19.09 Favored Pre-proline 0 C--O 1.248 0.986 0 C-N-CA 125.125 1.37 . . . . 73.209999999999994 111.753 178.223 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.33 -29.8 31.62 Favored 'Trans proline' 0 C--N 1.36 1.132 0 C-N-CA 124.644 3.563 . . . . 74.140000000000001 113.45 -177.439 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -72.92 -25.12 60.93 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.293 0.479 . . . . 75.319999999999993 112.293 -178.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -104.13 -5.38 22.07 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.879 0.371 . . . . 70.239999999999995 111.488 177.427 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 460' ' ' THR . 54.0 t -60.36 127.75 20.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.19 -0.459 . . . . 74.340000000000003 110.025 177.117 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 90.02 0.5 77.61 Favored Glycine 0 N--CA 1.422 -2.236 0 C-N-CA 121.037 -0.602 . . . . 61.520000000000003 112.534 179.001 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.12 163.18 28.23 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 119.604 -0.838 . . . . 70.519999999999996 111.213 -179.813 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.518 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 67.7 t -67.01 133.42 31.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 114.711 -1.131 . . . . 74.140000000000001 111.216 -177.088 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 53.8 mt -98.3 -24.28 4.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.226 -1.027 . . . . 75.140000000000001 108.226 179.15 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 165.33 169.62 29.19 Favored Glycine 0 N--CA 1.427 -1.907 0 CA-C-N 115.471 -0.786 . . . . 73.420000000000002 112.65 177.317 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 1.7 t -116.89 137.94 51.87 Favored 'General case' 0 N--CA 1.406 -2.66 0 N-CA-C 106.341 -1.726 . . . . 71.450000000000003 106.341 174.783 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.453 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 49.0 t30 -65.52 -53.44 37.73 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 119.822 -0.751 . . . . 64.140000000000001 111.055 179.523 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.453 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 9.7 Cg_exo -74.84 122.43 7.27 Favored 'Trans proline' 0 C--N 1.366 1.497 0 N-CA-C 107.195 -1.887 . . . . 51.439999999999998 107.195 170.811 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . 0.514 ' C ' ' H ' ' A' ' 475' ' ' ASN . 26.9 Cg_exo -62.61 139.26 74.69 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 121.743 1.629 . . . . 73.209999999999994 112.565 -176.142 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.421 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -74.67 11.6 1.0 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 122.611 1.196 . . . . 64.349999999999994 110.843 -179.632 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . 0.514 ' H ' ' C ' ' A' ' 473' ' ' PRO . 13.9 m120 -110.4 -4.8 15.4 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-N 114.385 -1.279 . . . . 75.109999999999999 108.852 -178.854 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -115.83 170.93 8.1 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 121.512 0.672 . . . . 73.329999999999998 111.808 -175.243 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.32 137.62 37.56 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.518 -1.219 . . . . 75.239999999999995 108.713 -178.378 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 21.1 p -126.27 149.2 49.27 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 120.999 0.428 . . . . 74.209999999999994 111.049 -179.146 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -72.97 160.72 31.66 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.431 -0.804 . . . . 70.239999999999995 110.537 178.213 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 449' ' ' PHE . 1.9 mp -72.65 -16.81 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-O 121.947 0.88 . . . . 74.439999999999998 111.014 -179.867 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 15.3 t -96.05 5.16 51.79 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-O 121.772 0.796 . . . . 70.140000000000001 109.853 177.48 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -89.55 137.61 32.18 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.993 -0.549 . . . . 75.349999999999994 109.941 -175.633 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.2 p -104.37 126.05 59.12 Favored 'Isoleucine or valine' 0 C--O 1.245 0.841 0 CA-C-O 121.336 0.588 . . . . 75.049999999999997 110.849 179.705 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 61.8 t -95.83 119.99 44.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.981 -0.554 . . . . 74.530000000000001 109.859 -179.271 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.18 123.98 55.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 108.863 -0.792 . . . . 71.099999999999994 108.863 178.598 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 39.5 mt -120.15 128.11 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 CA-C-N 114.723 -1.126 . . . . 75.400000000000006 110.184 -176.774 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 9.3 tt -101.9 125.15 56.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 115.891 -0.595 . . . . 75.299999999999997 110.074 -179.148 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 456' ' ' ASN . 10.6 t -113.18 139.03 40.53 Favored 'Isoleucine or valine' 0 C--O 1.251 1.14 0 N-CA-C 106.569 -1.641 . . . . 74.209999999999994 106.569 179.236 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -75.53 153.76 44.79 Favored Glycine 0 C--N 1.299 -1.522 0 CA-C-O 121.346 0.414 . . . . 75.120000000000005 113.275 -176.665 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.624 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 48.6 m . . . . . 0 C--N 1.285 -2.201 0 N-CA-C 106.6 -1.63 . . . . 74.129999999999995 106.6 176.012 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo . . . . . 0 N--CA 1.446 -1.312 0 CA-C-O 121.563 0.568 . . . . 70.0 112.69 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -95.6 99.94 11.74 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 109.219 -0.66 . . . . 64.230000000000004 109.219 176.705 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 13.7 p -117.83 143.0 46.68 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.35 -0.841 . . . . 64.049999999999997 109.595 179.208 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -144.76 154.23 42.5 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.674 -0.862 . . . . 72.420000000000002 108.674 176.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 11.9 p-10 -94.63 136.66 34.68 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.757 -0.831 . . . . 75.329999999999998 108.757 176.038 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 30.1 pt -75.62 137.38 70.58 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-N 115.369 -0.832 . . . . 75.349999999999994 112.038 -176.314 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -87.34 -170.18 0.57 Allowed 'Trans proline' 0 C--O 1.248 1.023 0 C-N-CA 122.995 2.464 . . . . 70.420000000000002 110.947 175.414 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -94.8 122.98 37.99 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.615 0.721 . . . . 64.219999999999999 109.687 177.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.6 p -113.42 7.57 7.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-O 122.374 1.083 . . . . 72.040000000000006 109.993 -177.62 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -73.72 121.22 20.44 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.204 -0.907 . . . . 61.130000000000003 109.788 -179.251 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 124.28 -17.75 7.44 Favored Glycine 0 C--N 1.289 -2.057 0 N-CA-C 110.105 -1.198 . . . . 63.340000000000003 110.105 -179.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -94.11 171.98 8.51 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 109.654 -0.498 . . . . 71.5 109.654 178.148 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 61.1 m -87.69 155.65 19.83 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.145 -1.057 . . . . 71.230000000000004 108.145 -179.302 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.6 p -54.17 -41.96 53.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 123.522 0.729 . . . . 75.430000000000007 112.316 -178.693 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -60.77 -42.24 97.1 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 123.368 0.667 . . . . 75.319999999999993 111.324 178.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.27 -40.75 50.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 115.419 -0.81 . . . . 72.530000000000001 109.769 -179.202 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -60.69 -49.51 77.23 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.464 -0.789 . . . . 63.329999999999998 111.339 -178.481 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -64.6 -36.05 82.98 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.596 -0.274 . . . . 71.510000000000005 110.264 -178.614 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.417 ' O ' HG23 ' A' ' 514' ' ' VAL . 87.7 tttt -61.47 -47.19 86.83 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.786 -0.643 . . . . 72.439999999999998 109.95 179.457 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -61.92 -48.17 81.63 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 116.192 -0.458 . . . . 74.400000000000006 110.818 -178.735 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.7 -45.65 93.4 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.4 -0.364 . . . . 75.319999999999993 111.182 178.793 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.18 -37.96 89.3 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 120.727 0.299 . . . . 74.25 111.711 -178.681 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 510' ' ' LYS . 79.4 t -65.1 -33.73 65.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-N 116.266 -0.425 . . . . 75.239999999999995 110.967 177.392 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -79.63 -9.38 59.62 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.399 0.518 . . . . 61.350000000000001 112.399 179.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 115.53 -20.43 13.64 Favored Glycine 0 CA--C 1.495 -1.159 0 C-N-CA 120.454 -0.879 . . . . 73.030000000000001 111.747 179.109 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.442 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 74.9 m-85 -78.25 81.74 4.6 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.41 -0.959 . . . . 74.319999999999993 108.41 179.625 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.6 p -87.91 -8.99 54.99 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 114.96 -1.018 . . . . 61.200000000000003 113.355 -173.102 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -108.01 115.52 30.28 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-O 121.407 0.622 . . . . 75.019999999999996 109.725 -177.563 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -130.48 156.37 44.89 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.454 -0.794 . . . . 71.439999999999998 111.253 -178.847 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 38.4 m -132.45 140.79 48.55 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 106.301 -1.74 . . . . 72.129999999999995 106.301 173.423 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.54 139.43 50.96 Favored 'General case' 0 N--CA 1.422 -1.869 0 C-N-CA 120.018 -0.673 . . . . 74.140000000000001 110.312 179.634 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -115.94 124.38 50.43 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 107.349 -1.352 . . . . 75.319999999999993 107.349 175.269 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 39.5 m -89.33 114.54 25.96 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.403 -0.962 . . . . 71.430000000000007 108.403 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 33.4 m -121.32 165.99 16.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 N-CA-C 109.309 -0.626 . . . . 74.420000000000002 109.309 -177.454 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -104.43 137.48 42.24 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.607 -0.886 . . . . 72.120000000000005 108.607 177.367 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 17.3 m -151.27 179.95 1.14 Allowed Pre-proline 0 C--N 1.295 -1.801 0 N-CA-C 109.292 -0.633 . . . . 75.409999999999997 109.292 -177.77 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -80.42 -7.04 13.83 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 121.695 1.597 . . . . 74.200000000000003 110.49 170.05 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -82.72 137.43 44.22 Favored Pre-proline 0 N--CA 1.447 -0.611 0 N-CA-C 107.892 -1.151 . . . . 55.039999999999999 107.892 177.995 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -58.8 160.23 18.53 Favored 'Trans proline' 0 N--CA 1.484 0.946 0 C-N-CA 123.566 2.844 . . . . 74.109999999999999 115.267 -175.04 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -66.71 113.6 4.96 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.686 -1.143 . . . . 62.049999999999997 111.435 -178.977 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 117.25 -19.56 11.7 Favored Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 110.856 -0.898 . . . . 34.109999999999999 110.856 178.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -83.11 134.62 35.0 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.533 -0.914 . . . . 72.340000000000003 108.533 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 58.8 t -80.42 126.36 39.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 109.321 -0.622 . . . . 72.120000000000005 109.321 -179.609 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 535' ' ' THR . . . . . 0.649 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 15.1 t -81.13 -18.03 47.85 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 121.506 0.669 . . . . 74.109999999999999 109.602 179.131 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.24 -161.44 28.61 Favored Glycine 0 N--CA 1.439 -1.148 0 C-N-CA 120.989 -0.624 . . . . 71.099999999999994 112.153 176.293 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 15.4 p -117.2 160.26 21.33 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.543 -0.54 . . . . 75.439999999999998 109.543 179.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -68.99 -55.34 10.62 Favored Pre-proline 0 C--N 1.325 -0.491 0 C-N-CA 120.514 -0.475 . . . . 74.519999999999996 110.241 177.441 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.82 134.2 25.23 Favored 'Trans proline' 0 C--N 1.366 1.463 0 N-CA-C 109.191 -1.119 . . . . 73.219999999999999 109.191 171.447 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.59 157.52 58.02 Favored 'Trans proline' 0 C--O 1.253 1.245 0 C-N-CA 122.578 2.185 . . . . 74.099999999999994 112.724 179.971 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.88 134.96 57.34 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.044 -0.525 . . . . 75.099999999999994 109.812 178.315 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.57 -13.34 39.16 Favored Glycine 0 C--N 1.307 -1.048 0 C-N-CA 120.844 -0.693 . . . . 71.129999999999995 111.739 -177.731 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 543' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 496' ' ' ASP . 81.7 m -70.92 120.89 17.15 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 109.072 -0.714 . . . . 54.130000000000003 109.072 178.359 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 31.9 m -86.62 122.88 31.16 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.026 -0.731 . . . . 71.230000000000004 109.026 -179.661 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 12.2 m -135.1 154.93 79.32 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 109.686 -0.487 . . . . 71.540000000000006 109.686 -179.327 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.43 149.77 45.22 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.964 1.776 . . . . 64.310000000000002 110.029 175.805 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.442 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 25.8 m -59.54 -19.58 16.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 112.673 0.62 . . . . 74.439999999999998 112.673 178.961 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -81.21 3.55 23.38 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.24 1.016 . . . . 72.510000000000005 112.64 179.479 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 77.5 p -88.16 175.16 7.83 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 121.996 -0.44 . . . . 74.439999999999998 112.17 -176.869 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 39.0 t -112.58 119.24 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 108.79 -0.818 . . . . 52.420000000000002 108.79 179.086 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 1.8 mp -98.13 131.21 45.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-O 121.113 0.483 . . . . 75.129999999999995 110.223 -179.179 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -103.23 117.82 35.38 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-O 121.258 0.551 . . . . 75.200000000000003 110.9 179.822 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -98.89 132.89 43.88 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.311 -1.313 . . . . 64.140000000000001 108.746 179.002 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -100.48 118.59 37.0 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.849 -1.167 . . . . 74.230000000000004 107.849 172.157 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 46.0 t -104.42 131.18 53.93 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 107.385 -1.339 . . . . 62.539999999999999 107.385 -178.22 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.649 ' OG ' ' HB ' ' A' ' 535' ' ' THR . 50.2 m -95.92 158.13 15.59 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 114.044 1.127 . . . . 74.549999999999997 114.044 -175.131 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 19.0 ptpt -113.68 148.2 36.78 Favored 'General case' 0 N--CA 1.414 -2.272 0 N-CA-C 105.888 -1.894 . . . . 71.349999999999994 105.888 164.092 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -75.08 -22.26 76.87 Favored Glycine 0 C--N 1.292 -1.874 0 O-C-N 124.103 0.877 . . . . 74.439999999999998 111.929 -178.586 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 73.67 10.38 4.8 Favored 'General case' 0 CA--C 1.485 -1.524 0 C-N-CA 124.654 1.181 . . . . 64.450000000000003 109.284 -171.786 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -128.39 141.26 51.47 Favored 'General case' 0 N--CA 1.408 -2.537 0 CA-C-N 115.525 -0.761 . . . . 75.319999999999993 109.42 -176.857 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -138.82 155.1 48.42 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.564 -0.743 . . . . 75.530000000000001 109.394 -179.33 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.4 p -63.64 130.58 28.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 O-C-N 123.614 0.571 . . . . 74.349999999999994 111.081 -179.157 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 56.4 ttp -94.78 126.41 47.38 Favored Pre-proline 0 C--O 1.253 1.263 0 CA-C-N 115.886 -0.597 . . . . 73.340000000000003 109.543 178.36 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -63.43 169.78 9.11 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.068 2.512 . . . . 61.219999999999999 112.551 175.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -75.19 133.61 41.39 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.871 -0.604 . . . . 73.519999999999996 111.29 -179.526 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . 0.432 ' HB3' ' SD ' ' A' ' 569' ' ' MET . 92.8 mt -137.66 27.97 2.72 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.828 -0.804 . . . . 75.010000000000005 108.828 -177.674 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 17.7 m -77.86 130.31 36.48 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.907 -0.588 . . . . 75.310000000000002 111.228 -174.705 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 67.48 38.05 90.46 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.957 -0.565 . . . . 61.109999999999999 112.937 176.447 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 569' ' ' MET . . . . . 0.432 ' SD ' ' HB3' ' A' ' 566' ' ' LEU . 23.6 ptm -99.46 168.77 9.77 Favored 'General case' 0 C--O 1.255 1.363 0 N-CA-C 108.839 -0.8 . . . . 62.509999999999998 108.839 -179.413 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -106.76 148.98 27.81 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 109.471 -0.566 . . . . 74.400000000000006 109.471 -178.077 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 61.2 t-105 -62.31 -25.01 67.64 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 124.129 0.972 . . . . 71.010000000000005 110.269 -178.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 13.7 p -68.82 -21.72 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 115.548 -0.751 . . . . 71.219999999999999 110.386 179.498 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -101.28 -29.76 11.89 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 109.501 -0.555 . . . . 70.319999999999993 109.501 176.103 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -61.7 -49.96 74.39 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.164 -0.925 . . . . 65.540000000000006 111.92 -179.385 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 579' ' ' ARG . 38.0 mt-10 -54.21 -53.85 54.37 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 113.283 0.846 . . . . 70.109999999999999 113.283 -179.267 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.87 -45.03 44.02 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 121.887 1.725 . . . . 63.399999999999999 112.337 176.825 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . 0.548 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 20.6 mmm180 -64.0 -41.43 97.48 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.512 -0.313 . . . . 73.25 111.174 -179.961 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 7.1 tt -63.64 -49.27 73.89 Favored 'General case' 0 C--O 1.247 0.926 0 C-N-CA 123.403 0.681 . . . . 74.510000000000005 109.858 -176.094 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 4.6 ptp180 -67.27 -37.9 84.21 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.616 -0.72 . . . . 74.25 112.595 179.03 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.22 -39.16 75.26 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 112.575 0.583 . . . . 73.430000000000007 112.575 -178.148 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 4.0 pp -84.62 -1.23 55.71 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.66 -0.816 . . . . 71.420000000000002 112.437 -179.117 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 67.03 47.46 65.17 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 115.366 -0.834 . . . . 53.100000000000001 112.093 177.351 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 22.5 t90 -63.67 127.15 30.06 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.923 -0.399 . . . . 74.140000000000001 109.923 179.039 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 3.6 m -125.23 24.22 7.46 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.122 -0.696 . . . . 74.209999999999994 109.122 -176.726 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -92.43 -170.2 40.7 Favored Glycine 0 CA--C 1.508 -0.406 0 C-N-CA 120.71 -0.757 . . . . 74.019999999999996 113.904 -175.438 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 64.7 mtt -98.7 126.39 44.29 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.87 0.367 . . . . 74.5 110.474 -179.311 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 55.0 tp -96.84 102.25 14.0 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.12 -1.067 . . . . 71.049999999999997 108.12 177.504 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -96.43 101.46 13.09 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.268 0.556 . . . . 71.400000000000006 110.463 -178.851 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.32 114.22 28.31 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.547 -1.279 . . . . 75.219999999999999 107.547 178.631 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -75.97 -88.45 0.27 Allowed Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 120.622 -0.799 . . . . 73.5 111.206 177.45 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -125.58 154.66 41.89 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 122.436 -0.449 . . . . 63.109999999999999 110.48 -178.898 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -82.15 141.47 33.05 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.346 -0.983 . . . . 75.319999999999993 108.346 173.933 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 42.5 t -124.24 116.53 48.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 108.935 -0.765 . . . . 73.310000000000002 108.935 -177.473 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -89.2 107.81 19.26 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 107.778 -1.193 . . . . 72.049999999999997 107.778 177.573 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -127.18 9.54 6.76 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.887 -0.597 . . . . 74.109999999999999 111.197 -178.814 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 128.65 169.73 12.66 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.302 -0.951 . . . . 62.439999999999998 111.701 178.175 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -57.11 -46.46 91.51 Favored Glycine 0 C--O 1.237 0.329 0 O-C-N 123.933 0.431 . . . . 71.120000000000005 113.034 -177.112 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 30.9 t -65.87 -29.69 70.18 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.313 0.578 . . . . 73.409999999999997 110.514 -178.722 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . 0.619 ' O ' ' HA3' ' A' ' 625' ' ' GLY . 87.4 mm-40 -87.31 -1.02 57.62 Favored 'General case' 0 C--O 1.211 -0.97 0 CA-C-N 115.65 -0.705 . . . . 74.310000000000002 112.788 -174.114 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . 0.44 ' HA ' ' H ' ' A' ' 626' ' ' GLN . 19.8 m80 -63.52 -71.77 0.16 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.952 0.882 . . . . 73.25 110.921 176.919 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -95.62 31.13 2.1 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.798 -0.637 . . . . 73.209999999999994 111.023 -173.575 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 1.3 mmm-85 -105.15 140.23 38.63 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 116.064 -0.516 . . . . 73.129999999999995 110.233 -177.904 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 97.3 t -73.7 138.18 21.78 Favored 'Isoleucine or valine' 0 C--O 1.252 1.218 0 N-CA-C 107.306 -1.368 . . . . 73.349999999999994 107.306 174.819 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 57.8 t -94.43 -50.55 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.973 0 CA-C-O 121.743 0.782 . . . . 70.540000000000006 109.421 -174.084 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -146.9 155.88 42.65 Favored 'General case' 0 N--CA 1.415 -2.219 0 N-CA-C 107.701 -1.222 . . . . 75.540000000000006 107.701 -178.537 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -120.84 121.88 39.08 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 106.465 -1.68 . . . . 74.310000000000002 106.465 171.123 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.477 ' CB ' ' HB ' ' A' ' 621' ' ' THR . 26.3 t-20 -59.03 -52.79 72.27 Favored Pre-proline 0 C--N 1.299 -1.623 0 CA-C-N 115.539 -0.755 . . . . 55.32 112.67 -177.893 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.433 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 1.0 OUTLIER -87.8 123.28 1.74 Allowed 'Trans proline' 0 N--CA 1.442 -1.544 0 C-N-CA 121.275 1.317 . . . . 74.230000000000004 109.668 173.546 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.06 156.15 60.53 Favored 'Trans proline' 0 C--O 1.244 0.793 0 C-N-CA 122.287 1.992 . . . . 74.409999999999997 111.36 177.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -59.09 127.96 34.79 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.828 -0.434 . . . . 72.329999999999998 109.828 178.559 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.18 -7.81 44.3 Favored Glycine 0 C--N 1.31 -0.891 0 C-N-CA 120.343 -0.932 . . . . 73.310000000000002 111.755 -177.613 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 26.9 m -89.13 157.26 18.36 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 107.988 -1.116 . . . . 70.329999999999998 107.988 178.247 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -90.98 143.52 16.68 Favored Glycine 0 N--CA 1.422 -2.238 0 C-N-CA 120.787 -0.721 . . . . 75.510000000000005 113.092 -177.42 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 19.0 m -115.71 141.65 32.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 109.376 -0.601 . . . . 62.439999999999998 109.376 174.388 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -70.82 -179.71 2.33 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 123.852 0.861 . . . . 72.299999999999997 113.066 -177.386 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -61.95 -36.03 80.21 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.072 0.949 . . . . 75.140000000000001 109.718 -179.728 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . 0.412 ' OD2' ' HB ' ' A' ' 619' ' ' ILE . 21.2 t70 -63.28 -40.33 97.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.008 -0.997 . . . . 72.439999999999998 108.656 174.588 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 87.97 22.03 43.83 Favored Glycine 0 N--CA 1.425 -2.09 0 C-N-CA 120.14 -1.029 . . . . 73.129999999999995 111.919 176.385 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . 0.412 ' HB ' ' OD2' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -68.76 118.46 12.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 122.422 1.106 . . . . 63.539999999999999 110.19 -170.398 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.34 130.38 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.743 0 N-CA-C 106.336 -1.727 . . . . 72.530000000000001 106.336 -179.923 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.477 ' HB ' ' CB ' ' A' ' 607' ' ' ASN . 6.4 m -100.77 117.19 34.36 Favored 'General case' 0 N--CA 1.421 -1.908 0 C-N-CA 119.455 -0.898 . . . . 73.310000000000002 109.428 -178.533 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -139.26 150.78 45.87 Favored 'General case' 0 CA--C 1.48 -1.736 0 N-CA-C 106.054 -1.832 . . . . 64.0 106.054 178.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -134.36 151.54 51.28 Favored 'General case' 0 C--N 1.266 -3.057 0 N-CA-C 105.132 -2.173 . . . . 75.430000000000007 105.132 176.523 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -120.4 165.55 14.76 Favored 'General case' 0 C--N 1.274 -2.705 0 N-CA-C 107.266 -1.383 . . . . 74.010000000000005 107.266 177.461 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . 0.619 ' HA3' ' O ' ' A' ' 599' ' ' GLN . . . -70.46 -108.29 0.04 OUTLIER Glycine 0 C--N 1.302 -1.344 0 O-C-N 123.915 0.759 . . . . 74.219999999999999 114.317 -174.409 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . 0.44 ' H ' ' HA ' ' A' ' 600' ' ' HIS . 8.6 tp-100 . . . . . 0 C--N 1.296 -1.746 0 CA-C-O 118.998 -0.525 . . . . 74.230000000000004 110.0 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.148 0 N-CA-C 110.827 -0.909 . . . . 72.230000000000004 110.827 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 49.9 mm -75.99 130.05 36.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-O 120.903 0.383 . . . . 74.239999999999995 109.98 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.81 133.75 47.76 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.531 -0.759 . . . . 71.140000000000001 110.839 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.21 -10.28 57.84 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 122.006 0.907 . . . . 74.239999999999995 108.682 175.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.66 150.56 44.47 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 106.196 -1.779 . . . . 71.040000000000006 106.196 172.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 24.4 m -113.85 142.35 26.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-O 121.779 0.799 . . . . 74.540000000000006 110.3 -170.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . 0.519 ' NE2' ' HA ' ' A' ' 407' ' ' ASN . 0.8 OUTLIER -95.01 126.64 40.49 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 106.291 -1.744 . . . . 75.409999999999997 106.291 -176.62 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 64.0 t -97.35 121.25 59.11 Favored Pre-proline 0 C--N 1.286 -2.18 0 CA-C-N 114.616 -1.174 . . . . 75.329999999999998 111.577 -169.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.29 135.8 56.19 Favored 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 123.026 2.484 . . . . 74.319999999999993 111.658 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -105.14 149.81 25.57 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.917 -1.142 . . . . 75.109999999999999 107.917 -176.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.503 ' CG2' ' HA ' ' A' ' 373' ' ' ALA . 26.1 m -134.63 20.06 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 C-N-CA 122.415 0.286 . . . . 71.129999999999995 111.032 -177.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.54 146.5 9.83 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 112.797 0.666 . . . . 74.329999999999998 112.797 177.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.07 0.83 41.65 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 115.83 -0.623 . . . . 74.329999999999998 112.357 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . 0.417 HE21 ' HB ' ' A' ' 365' ' ' VAL . 32.7 mt-30 -111.1 -89.35 0.5 Allowed 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 120.299 -0.561 . . . . 64.150000000000006 111.081 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 59.9 p -152.57 165.53 34.89 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.018 -0.734 . . . . 63.140000000000001 109.018 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.41 -46.14 87.76 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.721 -0.844 . . . . 74.120000000000005 108.721 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -59.53 -45.51 91.56 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 115.305 -0.861 . . . . 75.219999999999999 112.05 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -67.3 -41.38 85.46 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.087 0.47 . . . . 61.039999999999999 110.328 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . 0.503 ' HA ' ' CG2' ' A' ' 365' ' ' VAL . . . -65.79 -48.97 69.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.106 -0.497 . . . . 73.140000000000001 111.261 -179.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.17 -38.2 81.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.01 -0.541 . . . . 73.400000000000006 110.511 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.65 -42.03 87.41 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.259 0.623 . . . . 71.439999999999998 111.11 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.3 m -65.69 -49.02 70.05 Favored 'General case' 0 C--O 1.248 1.014 0 CA-C-O 121.58 0.705 . . . . 75.329999999999998 110.206 -178.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 9.9 mp -65.51 -42.63 91.84 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.572 -0.74 . . . . 73.409999999999997 111.74 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -64.46 -38.44 91.05 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.006 -0.543 . . . . 73.430000000000007 110.314 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -59.89 -39.08 84.15 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 116.023 -0.535 . . . . 73.340000000000003 110.687 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . 0.407 ' HA ' ' HD3' ' A' ' 380' ' ' ARG . 25.2 mmt180 -81.37 -12.35 59.01 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.613 -0.721 . . . . 74.0 112.193 -177.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.32 7.27 52.23 Favored Glycine 0 C--N 1.303 -1.27 0 C-N-CA 120.636 -0.792 . . . . 71.230000000000004 112.694 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.511 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 47.7 m-85 -81.66 159.46 23.97 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-O 121.355 0.598 . . . . 75.120000000000005 111.621 177.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 46.4 mtmt -115.23 161.8 17.95 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 115.005 -0.998 . . . . 74.230000000000004 108.826 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.21 157.38 41.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-O 120.862 0.363 . . . . 74.450000000000003 110.698 -177.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 61.6 ttp85 -120.16 126.84 51.66 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 107.138 -1.43 . . . . 74.409999999999997 107.138 170.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 17.6 m -108.27 125.13 51.33 Favored 'General case' 0 C--N 1.281 -2.408 0 N-CA-C 108.694 -0.854 . . . . 73.230000000000004 108.694 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -111.71 119.74 39.68 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.663 -0.866 . . . . 74.420000000000002 108.663 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -96.61 139.26 32.96 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 110.138 -0.319 . . . . 72.109999999999999 110.138 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -131.31 127.53 21.78 Favored Pre-proline 0 C--N 1.307 -1.247 0 N-CA-C 108.278 -1.008 . . . . 75.540000000000006 108.278 174.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -63.3 142.95 88.02 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.245 1.963 . . . . 74.409999999999997 111.794 177.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 7.3 t70 87.03 148.04 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 126.864 2.065 . . . . 72.540000000000006 110.368 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 13.0 t -103.12 11.96 36.44 Favored 'General case' 0 CA--C 1.552 1.058 0 CA-C-O 120.991 0.424 . . . . 65.230000000000004 110.546 -175.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 8.4 t -73.44 -18.08 61.17 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.97 0.891 . . . . 75.439999999999998 109.016 175.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -104.48 151.24 39.15 Favored Pre-proline 0 N--CA 1.427 -1.576 0 N-CA-C 107.459 -1.311 . . . . 73.450000000000003 107.459 173.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -23.33 114.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.678 1 C-N-CA 126.205 4.603 . . . . 64.519999999999996 115.7 -175.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.06 160.29 10.69 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 123.922 3.081 . . . . 64.200000000000003 112.833 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -57.97 -12.88 3.66 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 113.545 0.942 . . . . 75.5 113.545 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 28.7 m170 -91.89 148.46 22.2 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 108.257 -1.016 . . . . 73.010000000000005 108.257 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 30.0 m -77.75 117.17 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.255 0 C-N-CA 118.687 -1.205 . . . . 72.310000000000002 111.089 -171.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 35.6 pt -106.68 -28.8 2.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 115.198 -0.91 . . . . 75.549999999999997 108.729 173.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.72 158.0 27.58 Favored Glycine 0 N--CA 1.417 -2.607 0 N-CA-C 109.489 -1.444 . . . . 51.140000000000001 109.489 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 3.9 p -137.93 -178.58 5.32 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 123.623 0.769 . . . . 74.340000000000003 109.476 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -102.1 132.16 21.85 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 108.154 -1.054 . . . . 61.420000000000002 108.154 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.34 3.09 0.89 Allowed 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.307 2.671 . . . . 75.439999999999998 115.632 -176.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -52.87 -47.59 67.72 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 109.673 -0.492 . . . . 72.409999999999997 109.673 175.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -69.95 -28.97 66.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.639 -0.71 . . . . 64.019999999999996 110.464 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . 0.519 ' HA ' ' NE2' ' A' ' 361' ' ' GLN . 5.9 m120 -81.35 -6.14 58.6 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 122.014 0.911 . . . . 75.319999999999993 109.753 -176.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 28.3 m -101.92 160.66 14.3 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.538 -1.653 . . . . 71.230000000000004 106.538 175.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 20.2 m -76.48 113.11 13.72 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 119.55 -0.86 . . . . 73.439999999999998 109.067 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.3 m -123.66 170.02 14.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 122.86 0.464 . . . . 65.239999999999995 111.018 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 19.2 m -74.25 141.05 45.39 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.887 -0.783 . . . . 65.200000000000003 108.887 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . 0.511 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -69.08 108.94 3.77 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.072 0.463 . . . . 75.109999999999999 110.468 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 121.38 37.76 0.67 Allowed Glycine 0 C--N 1.311 -0.819 0 CA-C-N 115.194 -0.912 . . . . 41.329999999999998 111.744 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -100.02 179.07 4.61 Favored 'General case' 0 C--O 1.245 0.861 0 N-CA-C 107.7 -1.222 . . . . 73.040000000000006 107.7 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 44.8 mt-10 -116.41 115.0 25.05 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 118.249 0.477 . . . . 74.540000000000006 109.957 -178.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 42.6 mm -97.94 129.47 48.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 121.062 0.458 . . . . 75.450000000000003 110.072 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 2.2 p -79.81 131.21 35.84 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 123.866 0.866 . . . . 73.25 111.776 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 10.7 p -119.13 134.35 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.872 0 N-CA-C 109.01 -0.737 . . . . 71.430000000000007 109.01 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -95.4 120.77 36.21 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.546 -0.909 . . . . 74.450000000000003 108.546 -176.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 50.5 t -128.45 149.1 32.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 122.869 0.468 . . . . 74.239999999999995 109.885 -176.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 44.2 m -126.24 148.98 49.37 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.573 -0.529 . . . . 73.329999999999998 109.573 173.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 1.5 m -103.65 157.94 16.72 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 106.897 -1.52 . . . . 75.519999999999996 106.897 -175.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -53.9 179.76 0.15 Allowed Glycine 0 CA--C 1.542 1.73 0 N-CA-C 115.626 1.011 . . . . 74.549999999999997 115.626 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.7 142.8 91.27 Favored 'Trans proline' 0 C--O 1.246 0.888 0 C-N-CA 123.818 3.012 . . . . 75.25 113.213 -175.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -81.14 126.01 30.94 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.286 -0.87 . . . . 74.409999999999997 110.929 -175.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -136.14 155.5 50.08 Favored 'General case' 0 C--N 1.266 -3.057 0 N-CA-C 107.404 -1.332 . . . . 71.340000000000003 107.404 173.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 447' ' ' ALA . 2.4 mmp_? -122.78 143.74 49.63 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-O 120.717 0.294 . . . . 74.200000000000003 110.655 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -86.27 138.98 31.43 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 107.079 -1.452 . . . . 75.209999999999994 107.079 173.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 67.6 mt -78.78 121.97 84.14 Favored Pre-proline 0 C--N 1.3 -1.545 0 CA-C-O 121.115 0.483 . . . . 74.239999999999995 110.825 -172.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.91 148.62 58.0 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.636 2.224 . . . . 74.409999999999997 111.434 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -87.48 145.15 26.38 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.666 -0.494 . . . . 74.420000000000002 109.666 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.28 153.05 16.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.839 -0.8 . . . . 75.109999999999999 108.839 -175.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 2.7 p -64.47 137.0 57.63 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 121.399 0.618 . . . . 62.350000000000001 110.294 175.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 23.6 p -69.1 -21.21 64.07 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 125.053 1.341 . . . . 75.140000000000001 112.128 -171.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . 0.404 ' H ' HD21 ' A' ' 435' ' ' LEU . 0.6 OUTLIER -88.56 -11.02 46.83 Favored 'General case' 0 C--N 1.275 -2.632 0 CA-C-N 115.668 -0.696 . . . . 64.230000000000004 110.502 179.422 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.8 m -108.61 66.4 0.64 Allowed 'General case' 0 N--CA 1.426 -1.637 0 CA-C-O 121.835 0.826 . . . . 74.019999999999996 111.125 -175.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -53.38 -38.52 63.43 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 124.462 1.105 . . . . 74.299999999999997 111.859 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -58.89 -42.65 90.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.89 0.376 . . . . 74.430000000000007 110.85 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -70.96 -36.21 72.47 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.925 -0.58 . . . . 74.340000000000003 109.988 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.617 ' O ' HD21 ' A' ' 444' ' ' LEU . . . -60.39 -52.58 64.65 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 116.686 -0.234 . . . . 72.5 111.551 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 26.9 m -63.63 -36.5 76.67 Favored 'Isoleucine or valine' 0 C--O 1.245 0.828 0 CA-C-O 121.402 0.62 . . . . 74.030000000000001 110.773 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 41.5 tptt -59.18 -45.79 90.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.911 -1.041 . . . . 74.140000000000001 109.464 175.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -64.21 -39.76 94.65 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 113.381 0.882 . . . . 72.230000000000004 113.381 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.617 HD21 ' O ' ' A' ' 440' ' ' ALA . 1.4 mm? -68.01 -33.03 73.83 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 119.056 -1.057 . . . . 74.310000000000002 110.762 175.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 45.5 m -70.12 -42.69 72.29 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.293 0.568 . . . . 70.129999999999995 110.074 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.98 -15.49 62.58 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.845 -0.616 . . . . 75.409999999999997 110.651 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . 0.446 ' O ' ' HG3' ' A' ' 427' ' ' ARG . . . -86.92 2.87 47.86 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.061 -0.518 . . . . 73.430000000000007 111.454 177.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 106.35 -76.59 0.23 Allowed Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.172 -1.013 . . . . 72.040000000000006 112.127 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -46.28 -57.3 4.7 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 114.377 1.251 . . . . 72.140000000000001 114.377 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 59.41 28.41 64.7 Favored Glycine 0 CA--C 1.508 -0.382 0 O-C-N 123.5 0.5 . . . . 61.450000000000003 112.271 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -105.04 111.0 23.62 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 107.385 -1.339 . . . . 75.239999999999995 107.385 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . 0.502 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 18.1 p90 -144.89 157.38 44.17 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-O 120.81 0.338 . . . . 73.25 111.451 -175.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -131.1 149.08 52.76 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 124.483 1.113 . . . . 73.299999999999997 108.22 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -116.86 119.42 35.32 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.937 -0.764 . . . . 75.129999999999995 108.937 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.6 143.01 48.87 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.001 -0.741 . . . . 74.409999999999997 109.001 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -112.98 135.02 54.22 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 107.269 -1.382 . . . . 73.329999999999998 107.269 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 38.2 t -137.44 134.81 18.75 Favored Pre-proline 0 C--N 1.289 -2.032 0 N-CA-C 109.118 -0.697 . . . . 74.239999999999995 109.118 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.639 ' HA ' ' O ' ' A' ' 490' ' ' SER . 37.1 Cg_endo -65.89 122.45 10.03 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 121.715 1.61 . . . . 75.319999999999993 108.549 175.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 15.3 m -131.82 179.34 6.13 Favored 'General case' 0 C--N 1.286 -2.157 0 C-N-CA 120.06 -0.656 . . . . 71.329999999999998 110.893 -173.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.7 t -55.78 141.49 65.77 Favored Pre-proline 0 N--CA 1.422 -1.853 0 C-N-CA 125.008 1.323 . . . . 75.209999999999994 108.458 173.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . 0.412 ' HB3' ' OG1' ' A' ' 494' ' ' THR . 9.6 Cg_endo -50.58 -30.11 27.16 Favored 'Trans proline' 0 N--CA 1.481 0.777 0 C-N-CA 124.766 3.644 . . . . 71.450000000000003 114.781 -171.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -75.89 -27.2 57.61 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 113.103 0.779 . . . . 72.400000000000006 113.103 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -92.95 -19.88 21.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.939 0.4 . . . . 75.209999999999994 111.688 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 90.5 t -60.78 134.89 26.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 109.423 -0.584 . . . . 75.140000000000001 109.423 175.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 101.35 -15.74 57.33 Favored Glycine 0 N--CA 1.431 -1.647 0 C-N-CA 121.085 -0.579 . . . . 65.329999999999998 113.248 177.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.2 166.59 24.27 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 117.521 0.661 . . . . 75.400000000000006 110.751 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.466 ' O ' ' HB ' ' A' ' 434' ' ' THR . 54.6 t -67.12 142.5 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.336 0 N-CA-C 108.478 -0.934 . . . . 72.439999999999998 108.478 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 42.5 mt -97.59 -28.22 3.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 107.689 -1.226 . . . . 74.319999999999993 107.689 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 150.23 -150.99 23.12 Favored Glycine 0 N--CA 1.411 -2.997 0 CA-C-N 114.646 -1.161 . . . . 71.109999999999999 110.661 176.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 470' ' ' THR . . . . . 0.467 HG23 HG12 ' A' ' 486' ' ' ILE . 43.7 p -115.26 151.62 34.17 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 105.352 -2.092 . . . . 74.310000000000002 105.352 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -69.91 -50.67 16.58 Favored Pre-proline 0 C--N 1.304 -1.378 0 C-N-CA 118.698 -1.201 . . . . 75.409999999999997 111.055 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -68.46 162.07 42.31 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 121.289 1.326 . . . . 74.010000000000005 109.36 172.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . 0.481 ' HB2' ' OE1' ' A' ' 476' ' ' GLN . 20.7 Cg_endo -61.64 127.73 22.52 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.294 1.996 . . . . 73.109999999999999 111.988 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.463 ' HB1' ' OG1' ' A' ' 470' ' ' THR . . . -91.27 0.39 57.53 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 113.556 0.947 . . . . 60.439999999999998 113.556 -170.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -108.96 -12.99 14.81 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 119.677 -0.809 . . . . 74.040000000000006 109.672 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . 0.481 ' OE1' ' HB2' ' A' ' 473' ' ' PRO . 20.1 mp0 -92.35 -175.28 3.97 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 114.143 -1.39 . . . . 63.219999999999999 111.474 -172.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 1.4 p -93.79 141.13 28.84 Favored 'General case' 0 N--CA 1.404 -2.746 0 N-CA-C 113.387 0.884 . . . . 71.329999999999998 113.387 -176.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 12.7 p -127.08 148.05 50.15 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-N 114.618 -1.174 . . . . 73.5 108.269 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -75.58 163.72 27.06 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 116.845 -0.161 . . . . 63.149999999999999 110.857 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 22.6 mm -80.04 -5.15 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.019 0 CA-C-O 122.264 1.03 . . . . 75.340000000000003 109.552 -176.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.5 t -110.64 5.13 20.77 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.726 0.774 . . . . 75.540000000000006 109.259 175.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -93.01 143.05 26.62 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.835 -0.621 . . . . 75.239999999999995 110.686 -175.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.25 127.1 64.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 C-N-CA 123.11 0.564 . . . . 64.439999999999998 111.475 -177.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 27.8 m -105.12 125.46 60.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-O 121.864 0.84 . . . . 73.109999999999999 111.788 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.66 125.19 45.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.813 -0.81 . . . . 62.439999999999998 108.813 177.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . 0.467 HG12 HG23 ' A' ' 470' ' ' THR . 42.5 mt -110.28 128.65 66.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 C-N-CA 124.465 1.106 . . . . 75.25 110.999 -176.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 4.8 tt -111.15 127.13 68.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 115.357 -0.838 . . . . 70.450000000000003 111.122 -174.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 467' ' ' VAL . 2.5 p -115.19 135.47 55.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 115.218 -0.901 . . . . 71.510000000000005 109.92 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -72.66 125.87 10.5 Favored Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 110.517 -1.033 . . . . 72.540000000000006 110.517 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.639 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 8.6 t -142.52 148.36 37.51 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 108.268 -1.012 . . . . 60.240000000000002 108.268 -176.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 85.32 87.26 0.94 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.238 -0.982 . . . . 71.549999999999997 113.162 177.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -92.23 146.13 2.89 Favored 'Trans proline' 0 N--CA 1.44 -1.618 0 C-N-CA 122.391 2.061 . . . . 74.430000000000007 111.655 176.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -128.99 23.9 5.65 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 122.748 1.261 . . . . 60.109999999999999 108.261 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 494' ' ' THR . . . . . 0.412 ' OG1' ' HB3' ' A' ' 461' ' ' PRO . 14.6 p -127.22 143.54 51.23 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 112.909 -1.95 . . . . 73.030000000000001 109.309 -176.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -147.03 161.85 39.98 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.042 -1.096 . . . . 64.530000000000001 108.042 176.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -93.87 135.24 35.4 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 109.517 -0.549 . . . . 73.349999999999994 109.517 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 40.3 pt -80.18 137.77 52.8 Favored Pre-proline 0 C--N 1.302 -1.467 0 CA-C-N 115.952 -0.567 . . . . 74.420000000000002 111.37 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.63 168.31 19.74 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.653 2.236 . . . . 74.310000000000002 112.859 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -70.87 121.73 18.62 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.642 -0.873 . . . . 70.319999999999993 108.642 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.01 87.89 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.178 0 CA-C-O 122.475 1.131 . . . . 71.349999999999994 110.845 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -146.97 122.5 10.42 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 113.703 -1.59 . . . . 74.109999999999999 108.08 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 112.43 -11.98 25.94 Favored Glycine 0 CA--C 1.493 -1.282 0 N-CA-C 109.888 -1.285 . . . . 73.450000000000003 109.888 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -94.71 169.32 10.25 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 114.888 -0.656 . . . . 74.430000000000007 109.677 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 5.5 m -84.39 157.16 21.51 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.458 -0.941 . . . . 73.519999999999996 108.458 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 17.5 t -55.65 -41.96 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.227 0.611 . . . . 75.129999999999995 110.933 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -62.1 -40.58 96.33 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.669 -0.696 . . . . 71.420000000000002 110.836 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 48.8 t -73.94 -38.9 50.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.839 -0.619 . . . . 74.319999999999993 109.558 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -62.81 -49.43 74.97 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.566 -0.743 . . . . 73.319999999999993 111.356 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -63.15 -35.71 81.21 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 109.629 -0.508 . . . . 74.25 109.629 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.461 ' O ' HG22 ' A' ' 514' ' ' VAL . 48.4 tttp -64.79 -45.33 86.74 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.674 -0.694 . . . . 72.129999999999995 109.976 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . 0.402 ' O ' ' HD1' ' A' ' 515' ' ' TYR . 92.1 m-20 -62.34 -42.39 99.35 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 120.6 0.238 . . . . 73.519999999999996 110.734 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.33 -42.83 96.07 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 116.596 -0.274 . . . . 74.430000000000007 111.381 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -63.23 -37.69 88.23 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.785 -0.189 . . . . 74.140000000000001 111.041 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 510' ' ' LYS . 56.9 t -59.88 -35.03 58.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.085 0.469 . . . . 73.450000000000003 110.844 176.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . 0.402 ' HD1' ' O ' ' A' ' 511' ' ' ASN . 31.3 m-85 -79.45 -8.21 58.96 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.881 0.372 . . . . 72.310000000000002 111.936 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 103.23 -0.4 47.24 Favored Glycine 0 C--N 1.303 -1.279 0 C-N-CA 120.075 -1.06 . . . . 62.229999999999997 112.55 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.595 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 79.2 m-85 -84.59 96.33 9.14 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.451 -1.314 . . . . 74.030000000000001 107.451 177.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 6.3 p -87.19 -13.89 42.71 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 113.234 0.827 . . . . 75.430000000000007 113.234 -174.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -108.83 114.73 28.75 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.166 0.508 . . . . 75.230000000000004 109.676 -178.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -131.42 154.44 48.67 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.755 -0.657 . . . . 75.420000000000002 110.619 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 43.8 m -141.54 140.94 33.54 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 107.772 -1.196 . . . . 70.340000000000003 107.772 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . 0.492 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 0.0 OUTLIER -117.56 128.46 54.97 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 118.468 0.576 . . . . 53.530000000000001 111.551 -177.273 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -111.66 116.22 30.41 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.039 -0.726 . . . . 75.0 109.039 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 35.4 m -95.08 124.72 39.28 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 120.743 0.306 . . . . 70.219999999999999 111.03 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 18.7 m -122.8 151.29 26.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 108.539 -0.912 . . . . 73.439999999999998 108.539 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . 0.475 ' HA ' ' O ' ' A' ' 557' ' ' LYS . 3.8 p30 -66.59 136.13 55.15 Favored 'General case' 0 CA--C 1.495 -1.169 0 CA-C-O 121.681 0.753 . . . . 73.040000000000006 110.423 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 20.0 m -146.43 158.34 47.23 Favored Pre-proline 0 C--N 1.281 -2.404 0 CA-C-N 114.737 -1.119 . . . . 52.409999999999997 108.596 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -69.68 -21.76 33.43 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 121.551 1.501 . . . . 70.310000000000002 108.802 170.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . 0.453 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 60.0 mtm-85 -69.71 135.12 88.05 Favored Pre-proline 0 N--CA 1.436 -1.152 0 CA-C-N 114.188 -1.369 . . . . 72.549999999999997 108.4 176.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.8 149.12 79.85 Favored 'Trans proline' 0 C--O 1.251 1.154 0 C-N-CA 123.26 2.64 . . . . 74.430000000000007 113.491 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.569 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -64.39 117.4 7.23 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.613 -0.721 . . . . 64.329999999999998 110.917 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 129.81 -23.41 4.73 Favored Glycine 0 C--N 1.302 -1.311 0 C-N-CA 120.212 -0.994 . . . . 74.439999999999998 111.99 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -79.4 125.74 29.92 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.235 -0.654 . . . . 74.340000000000003 109.235 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 88.8 t -73.19 119.41 20.08 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 109.774 -0.454 . . . . 74.329999999999998 109.774 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 57.6 m -66.36 -40.31 89.7 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 124.687 1.195 . . . . 72.219999999999999 109.436 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 162.86 -159.81 32.22 Favored Glycine 0 N--CA 1.424 -2.113 0 N-CA-C 109.392 -1.483 . . . . 72.310000000000002 109.392 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 7.1 p -126.57 161.07 28.86 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 117.056 0.428 . . . . 72.150000000000006 110.317 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . 0.452 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 24.8 t-20 -59.63 -51.99 77.19 Favored Pre-proline 0 CA--C 1.545 0.78 0 O-C-N 123.537 0.523 . . . . 74.400000000000006 111.198 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . 0.452 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 1.2 Cg_endo -87.37 143.08 6.36 Favored 'Trans proline' 0 N--CA 1.441 -1.595 0 CA-C-N 120.257 1.128 . . . . 63.140000000000001 109.301 170.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -70.16 163.6 37.98 Favored 'Trans proline' 0 C--O 1.249 1.065 0 C-N-CA 122.428 2.085 . . . . 73.230000000000004 112.556 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.8 142.49 57.27 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.777 -0.647 . . . . 71.219999999999999 110.61 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 88.94 -5.95 84.1 Favored Glycine 0 N--CA 1.431 -1.666 0 C-N-CA 120.844 -0.693 . . . . 71.219999999999999 112.212 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 30.8 m -77.91 123.28 26.59 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.646 -0.501 . . . . 74.230000000000004 109.646 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 33.3 m -80.56 122.44 27.05 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 108.697 -0.853 . . . . 65.420000000000002 108.697 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 19.7 m -136.71 160.38 66.68 Favored Pre-proline 0 C--N 1.311 -1.108 0 N-CA-C 109.179 -0.674 . . . . 74.230000000000004 109.179 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -68.35 141.13 50.49 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.25 1.966 . . . . 70.439999999999998 111.458 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.595 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 26.9 m -66.79 -20.52 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 121.749 0.785 . . . . 73.200000000000003 111.927 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -90.59 3.68 53.42 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.137 -0.938 . . . . 74.299999999999997 111.13 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.0 t -83.77 164.23 19.69 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.291 -0.633 . . . . 73.049999999999997 109.291 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 41.3 t -98.18 112.71 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 N-CA-C 107.998 -1.112 . . . . 72.25 107.998 178.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 1.8 mp -91.74 135.64 26.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-O 120.938 0.399 . . . . 74.439999999999998 110.272 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -101.9 122.26 43.68 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-O 121.473 0.654 . . . . 74.5 110.777 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 65.3 mt -97.8 116.16 29.47 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 106.562 -1.644 . . . . 75.439999999999998 106.562 176.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -91.83 121.98 33.94 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 108.489 -0.93 . . . . 74.140000000000001 108.489 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 60.3 t -111.12 133.74 55.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-N 115.82 -0.627 . . . . 73.239999999999995 112.149 -170.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.569 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 9.6 m -71.69 128.66 36.51 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 114.925 -1.034 . . . . 63.219999999999999 109.065 174.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 526' ' ' ASP . 0.8 OUTLIER -116.97 110.74 18.66 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 109.317 -0.623 . . . . 74.310000000000002 109.317 175.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -72.49 -33.38 61.17 Favored Glycine 0 CA--C 1.49 -1.526 0 CA-C-N 115.707 -0.678 . . . . 71.420000000000002 111.448 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 44.32 36.34 1.56 Allowed 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 126.345 1.858 . . . . 73.230000000000004 113.007 178.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 12.1 tp60 -140.05 146.22 38.71 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.488 -1.301 . . . . 65.510000000000005 107.488 -174.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -147.16 142.62 27.51 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.604 -0.887 . . . . 74.099999999999994 108.604 174.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 54.2 t -76.62 128.38 37.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-O 120.911 0.386 . . . . 75.420000000000002 111.76 -174.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 58.7 ttp -97.7 132.4 25.11 Favored Pre-proline 0 C--O 1.247 0.951 0 CA-C-N 115.99 -0.55 . . . . 75.340000000000003 110.198 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -66.57 169.67 13.87 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 123.051 2.501 . . . . 72.030000000000001 112.932 176.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -72.16 132.27 43.92 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 113.299 0.851 . . . . 71.099999999999994 113.299 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 96.5 mt -136.22 21.85 3.22 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.566 0.746 . . . . 72.530000000000001 109.003 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 10.3 m -75.4 130.29 38.74 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 116.147 -0.479 . . . . 75.049999999999997 112.224 -173.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 65.65 29.22 74.66 Favored Glycine 0 C--O 1.212 -1.247 0 CA-C-N 115.498 -0.774 . . . . 74.230000000000004 114.873 173.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 18.1 ptp -112.61 178.85 4.15 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 117.798 0.799 . . . . 74.329999999999998 109.136 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . 0.403 ' HB3' ' OD1' ' A' ' 601' ' ' ASN . 89.7 m-85 -84.87 154.27 22.38 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 120.302 -0.559 . . . . 74.239999999999995 109.67 178.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 28.0 t90 -68.47 -20.15 64.59 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.387 -0.597 . . . . 75.510000000000005 109.387 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 33.8 m -71.28 -13.31 16.87 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.355 0 CA-C-N 115.936 -0.575 . . . . 74.400000000000006 110.985 176.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -101.06 -44.13 5.81 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 109.417 -0.586 . . . . 70.420000000000002 109.417 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -59.57 -46.27 89.4 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.817 -1.083 . . . . 71.129999999999995 112.214 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.487 ' O ' ' HG3' ' A' ' 579' ' ' ARG . 55.8 tt0 -57.92 -59.87 11.81 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 113.323 0.861 . . . . 55.420000000000002 113.323 -178.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.54 -35.59 89.55 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 121.183 1.255 . . . . 72.040000000000006 112.406 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -65.0 -43.38 92.76 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.031 0.382 . . . . 74.540000000000006 112.031 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.402 HD11 ' N ' ' A' ' 579' ' ' ARG . 4.4 pp -67.58 -40.71 84.85 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 119.607 -0.837 . . . . 75.209999999999994 111.259 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . 0.487 ' HG3' ' O ' ' A' ' 575' ' ' GLU . 20.1 mtp180 -65.14 -40.32 94.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.085 -0.507 . . . . 75.519999999999996 110.094 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -63.96 -35.73 81.64 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.982 -0.554 . . . . 74.430000000000007 112.468 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 4.2 pp -81.66 2.03 31.43 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.988 0.736 . . . . 74.450000000000003 112.988 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 82.97 39.67 9.99 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.484 -0.865 . . . . 72.099999999999994 112.227 176.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 89.6 t90 -79.57 133.91 36.46 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.939 -0.393 . . . . 71.010000000000005 109.939 176.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 61.5 m -147.86 90.85 1.87 Allowed 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.375 -0.602 . . . . 73.209999999999994 109.375 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -147.01 -131.52 2.19 Favored Glycine 0 N--CA 1.433 -1.549 0 N-CA-C 111.088 -0.805 . . . . 74.200000000000003 111.088 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 59.7 mtt -119.67 125.65 49.22 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.763 -0.829 . . . . 75.019999999999996 108.763 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -105.17 130.94 53.22 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 107.799 -1.185 . . . . 73.109999999999999 107.799 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -100.71 101.89 12.87 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 120.601 -0.439 . . . . 74.5 110.698 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . 0.404 ' HD3' ' C ' ' A' ' 589' ' ' LYS . 11.8 tmtt? -113.02 111.7 22.61 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 107.252 -1.388 . . . . 74.209999999999994 107.252 174.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -93.97 -149.52 25.48 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.958 -0.639 . . . . 74.319999999999993 113.197 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -76.16 146.23 39.33 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 120.776 0.322 . . . . 63.530000000000001 111.083 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -84.97 125.32 32.59 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 106.405 -1.702 . . . . 75.219999999999999 106.405 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 57.5 t -128.73 116.58 41.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 N-CA-C 109.956 -0.387 . . . . 70.019999999999996 109.956 -171.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -77.59 108.11 10.54 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.24 -1.393 . . . . 74.120000000000005 107.24 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -121.42 -5.12 9.33 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.717 -0.674 . . . . 75.439999999999998 111.744 -176.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 119.69 -177.97 16.46 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 120.507 -0.854 . . . . 64.510000000000005 112.341 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -58.71 -37.01 88.89 Favored Glycine 0 C--N 1.319 -0.365 0 O-C-N 124.084 0.52 . . . . 74.420000000000002 114.381 -175.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 14.4 m -64.89 -24.29 67.49 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 117.264 0.532 . . . . 64.439999999999998 111.365 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -108.11 -0.56 21.03 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 113.096 0.776 . . . . 72.430000000000007 113.096 -173.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . 0.464 ' HA ' ' O ' ' A' ' 626' ' ' GLN . 14.9 p-80 -70.39 103.22 2.36 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 119.194 -1.002 . . . . 74.349999999999994 111.644 -174.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . 0.403 ' OD1' ' HB3' ' A' ' 570' ' ' PHE . 18.9 t-20 58.37 5.32 0.42 Allowed 'General case' 0 CA--C 1.569 1.7 0 C-N-CA 125.924 1.69 . . . . 74.129999999999995 113.59 178.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -78.98 140.22 38.05 Favored 'General case' 0 C--N 1.317 -0.804 0 O-C-N 121.66 -0.65 . . . . 75.099999999999994 110.455 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 97.6 t -69.48 131.63 33.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 107.911 -1.144 . . . . 74.450000000000003 107.911 174.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 56.9 t -87.71 -46.05 16.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-O 121.263 0.554 . . . . 64.319999999999993 109.649 -175.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -156.24 152.4 27.71 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 107.684 -1.228 . . . . 74.230000000000004 107.684 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -116.68 112.39 21.16 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.356 -1.35 . . . . 70.420000000000002 107.356 171.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.409 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 38.7 t30 -48.45 -52.13 45.86 Favored Pre-proline 0 CA--C 1.556 1.204 0 N-CA-C 113.622 0.971 . . . . 73.439999999999998 113.622 -177.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.409 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 5.4 Cg_exo -82.29 124.64 4.3 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.121 1.214 . . . . 74.439999999999998 109.562 172.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . 0.473 ' O ' HG22 ' A' ' 612' ' ' THR . 13.4 Cg_endo -65.0 135.84 45.77 Favored 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 122.045 1.83 . . . . 73.200000000000003 113.144 -177.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -65.75 130.69 44.18 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.248 -0.887 . . . . 75.209999999999994 110.025 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.09 -8.44 45.37 Favored Glycine 0 N--CA 1.433 -1.537 0 C-N-CA 120.132 -1.032 . . . . 64.420000000000002 113.066 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 612' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 609' ' ' PRO . 10.1 t -113.75 175.93 5.25 Favored 'General case' 0 C--O 1.258 1.514 0 C-N-CA 118.919 -1.112 . . . . 74.319999999999993 109.541 177.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -79.77 128.3 8.44 Favored Glycine 0 N--CA 1.416 -2.684 0 CA-C-N 115.448 -0.796 . . . . 53.439999999999998 111.546 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 23.4 m -102.2 144.49 13.33 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 C-N-CA 124.031 0.932 . . . . 75.200000000000003 108.709 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . 0.415 HD22 HG23 ' A' ' 619' ' ' ILE . 24.8 p-10 -50.01 152.59 1.59 Allowed 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 124.452 1.101 . . . . 71.120000000000005 111.857 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -26.25 13.59 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.123 0.969 . . . . 73.299999999999997 113.061 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.34 -38.53 74.88 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.662 -0.866 . . . . 75.150000000000006 108.662 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 82.33 22.12 59.33 Favored Glycine 0 N--CA 1.424 -2.159 0 C-N-CA 120.923 -0.656 . . . . 34.43 111.886 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . 0.415 HG23 HD22 ' A' ' 615' ' ' ASN . 0.0 OUTLIER -68.16 119.19 13.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-O 122.621 1.2 . . . . 73.349999999999994 110.459 -168.833 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 4.4 tp -115.67 119.17 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.876 0 CA-C-N 113.899 -1.5 . . . . 75.140000000000001 109.614 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 25.7 m -105.4 117.45 34.06 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 106.543 -1.651 . . . . 72.450000000000003 106.543 174.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -138.96 153.77 48.23 Favored 'General case' 0 CA--C 1.479 -1.758 0 N-CA-C 106.447 -1.686 . . . . 70.230000000000004 106.447 -177.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -136.45 153.67 50.99 Favored 'General case' 0 C--N 1.268 -2.974 0 N-CA-C 107.464 -1.31 . . . . 74.329999999999998 107.464 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -140.62 163.01 34.01 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 105.383 -2.081 . . . . 74.209999999999994 105.383 172.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -82.46 -86.52 0.76 Allowed Glycine 0 N--CA 1.424 -2.155 0 C-N-CA 119.677 -1.249 . . . . 72.230000000000004 110.282 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' A' ' 600' ' ' HIS . 35.6 tt0 . . . . . 0 C--N 1.29 -1.991 0 CA-C-O 117.7 -1.143 . . . . 73.040000000000006 108.428 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.918 0 N-CA-C 110.145 -1.182 . . . . 73.409999999999997 110.145 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 9.0 tp -75.46 124.07 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.559 0 CA-C-N 117.824 0.812 . . . . 73.099999999999994 110.047 177.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.82 137.95 31.99 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 109.031 -0.729 . . . . 72.120000000000005 109.031 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -90.76 -19.06 23.92 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.459 -0.941 . . . . 75.340000000000003 108.459 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -76.7 139.19 40.42 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 103.728 -2.693 . . . . 62.310000000000002 103.728 169.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 35.7 m -116.08 151.3 17.88 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.664 0 C-N-CA 120.074 -0.65 . . . . 72.230000000000004 109.805 -172.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -95.05 136.04 35.85 Favored 'General case' 0 N--CA 1.411 -2.406 0 N-CA-C 106.579 -1.637 . . . . 74.140000000000001 106.579 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 89.8 t -111.07 118.19 48.47 Favored Pre-proline 0 C--N 1.275 -2.632 0 CA-C-O 121.141 0.496 . . . . 72.129999999999995 111.198 -173.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -81.38 123.54 4.43 Favored 'Trans proline' 0 N--CA 1.44 -1.674 0 C-N-CA 121.814 1.676 . . . . 74.209999999999994 109.717 172.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . 0.56 ' OD2' ' HB3' ' A' ' 366' ' ' ARG . 7.5 p-10 -101.43 137.91 39.13 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 122.237 1.017 . . . . 64.450000000000003 110.646 -176.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.522 ' HB ' ' NE2' ' A' ' 368' ' ' GLN . 27.7 m -82.93 36.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 114.381 -1.281 . . . . 72.040000000000006 112.471 -174.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.56 ' HB3' ' OD2' ' A' ' 364' ' ' ASP . 0.0 OUTLIER -56.04 146.72 21.85 Favored 'General case' 0 C--O 1.247 0.934 0 C-N-CA 124.452 1.101 . . . . 71.219999999999999 110.97 176.314 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.28 1.21 41.13 Favored Glycine 0 C--N 1.309 -0.944 0 N-CA-C 111.927 -0.469 . . . . 73.109999999999999 111.927 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . 0.522 ' NE2' ' HB ' ' A' ' 365' ' ' VAL . 36.1 mt-30 -110.87 -153.2 0.51 Allowed 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 108.076 -1.083 . . . . 74.409999999999997 108.076 176.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 54.9 p -93.32 168.68 10.92 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.215 -0.661 . . . . 55.450000000000003 109.215 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 20.6 p -63.28 -46.36 87.12 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 109.828 -0.434 . . . . 74.530000000000001 109.828 176.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -63.36 -46.43 86.6 Favored 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 112.851 0.686 . . . . 73.519999999999996 112.851 -177.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -67.03 -45.23 78.12 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 120.546 -0.462 . . . . 70.409999999999997 110.095 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -66.59 -46.62 75.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.868 -0.606 . . . . 71.209999999999994 111.514 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 67.7 mt -64.73 -37.91 81.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.616 -0.266 . . . . 73.430000000000007 110.806 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.88 -43.29 99.14 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 110.273 -0.269 . . . . 73.319999999999993 110.273 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 33.3 m -63.45 -48.33 78.15 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.866 -0.606 . . . . 73.430000000000007 110.313 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.45 -41.6 96.44 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 112.353 0.501 . . . . 74.230000000000004 112.353 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -67.01 -38.79 86.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.666 -0.243 . . . . 74.219999999999999 110.515 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -70.19 -21.01 63.09 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.027 0.442 . . . . 71.319999999999993 111.601 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . 0.448 ' HA ' ' NE ' ' A' ' 380' ' ' ARG . 3.3 mmp_? -81.06 -15.09 57.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.027 0.441 . . . . 74.219999999999999 109.919 174.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.26 5.58 54.33 Favored Glycine 0 C--N 1.306 -1.114 0 CA-C-N 115.789 -0.641 . . . . 73.109999999999999 112.548 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -85.42 148.65 25.9 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-O 121.117 0.484 . . . . 62.109999999999999 110.73 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -101.13 149.39 24.02 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 107.741 -1.207 . . . . 75.209999999999994 107.741 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.62 157.19 41.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.891 0 C-N-CA 120.717 -0.393 . . . . 74.510000000000005 110.009 -178.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -132.46 126.86 34.01 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.165 -1.42 . . . . 74.239999999999995 107.165 173.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 28.8 m -109.12 126.53 53.31 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 108.367 -0.975 . . . . 74.299999999999997 108.367 -177.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 51.2 tp -111.46 120.09 41.0 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.57 -0.53 . . . . 75.019999999999996 109.57 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -89.83 122.09 32.57 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.148 -0.686 . . . . 74.519999999999996 109.148 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 421' ' ' SER . 56.9 mtpt -135.4 125.5 16.73 Favored Pre-proline 0 C--N 1.311 -1.069 0 N-CA-C 109.937 -0.394 . . . . 74.439999999999998 109.937 177.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -80.39 128.37 7.04 Favored 'Trans proline' 0 C--O 1.253 1.252 0 C-N-CA 121.39 1.393 . . . . 64.129999999999995 109.238 173.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.478 ' HA ' ' CG ' ' A' ' 425' ' ' GLU . 13.5 t70 174.99 158.46 0.18 Allowed 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.195 -1.409 . . . . 74.510000000000005 107.195 -174.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 13.5 m -100.72 -11.98 19.5 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 120.86 0.362 . . . . 74.109999999999999 111.697 -177.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 11.1 m -109.11 2.1 20.88 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 122.121 0.963 . . . . 70.409999999999997 110.343 -176.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 34.6 mm -88.86 140.52 29.37 Favored Pre-proline 0 C--N 1.306 -1.297 0 CA-C-N 115.769 -0.651 . . . . 65.519999999999996 109.33 178.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -39.97 129.92 2.11 Favored 'Trans proline' 0 C--N 1.365 1.401 0 C-N-CA 124.4 3.4 . . . . 74.519999999999996 113.719 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.8 161.24 13.07 Favored 'Trans proline' 0 N--CA 1.483 0.855 0 C-N-CA 123.535 2.824 . . . . 71.299999999999997 112.699 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . 0.413 ' HA ' HG13 ' A' ' 420' ' ' VAL . 2.5 p30 -59.78 -8.47 2.14 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 122.022 0.915 . . . . 62.32 112.853 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 43.8 m170 -102.42 123.71 46.68 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 105.188 -2.153 . . . . 72.200000000000003 105.188 173.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 32.4 m -68.08 119.54 13.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 112.98 0.733 . . . . 74.430000000000007 112.98 -165.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . 0.42 ' O ' HD13 ' A' ' 400' ' ' ILE . 0.0 OUTLIER -102.99 -28.12 3.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 106.767 -1.568 . . . . 75.349999999999994 106.767 175.361 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.52 166.3 27.76 Favored Glycine 0 N--CA 1.414 -2.793 0 N-CA-C 110.546 -1.022 . . . . 63.049999999999997 110.546 -177.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 40.5 p -146.8 -173.91 4.34 Favored 'General case' 0 C--N 1.286 -2.178 0 C-N-CA 126.078 1.751 . . . . 73.420000000000002 106.331 -174.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -98.43 126.52 39.17 Favored Pre-proline 0 C--N 1.296 -1.756 0 N-CA-C 107.699 -1.223 . . . . 71.049999999999997 107.699 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.31 -4.65 0.79 Allowed 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 124.864 3.709 . . . . 73.239999999999995 116.324 -174.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.67 -39.81 71.45 Favored 'General case' 0 C--O 1.204 -1.294 0 N-CA-C 109.767 -0.457 . . . . 74.109999999999999 109.767 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -63.53 -40.05 96.01 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-O 121.365 0.603 . . . . 72.430000000000007 110.77 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -80.61 -4.58 54.67 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.389 0.614 . . . . 74.140000000000001 110.456 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 27.8 m -98.23 160.61 14.18 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 105.423 -2.066 . . . . 55.130000000000003 105.423 173.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 13.4 m -76.52 112.6 13.22 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 118.829 -1.148 . . . . 75.540000000000006 108.871 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 23.0 m -128.33 170.05 18.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.077 0.465 . . . . 73.140000000000001 111.198 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 36.7 t -74.35 143.3 44.94 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 108.782 -0.822 . . . . 73.329999999999998 108.782 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -63.09 131.14 47.55 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.065 -0.516 . . . . 45.310000000000002 111.293 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 90.89 29.71 12.6 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.714 -0.676 . . . . 72.209999999999994 112.655 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -83.07 -175.7 5.97 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 109.52 -0.548 . . . . 72.310000000000002 109.52 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -110.72 117.47 33.54 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 123.358 0.663 . . . . 72.540000000000006 111.291 -174.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.0 mm -105.77 115.08 46.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.405 0.622 . . . . 74.510000000000005 110.358 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 40.6 p -87.05 130.8 34.33 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 123.655 0.782 . . . . 73.420000000000002 110.691 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 8.2 p -124.19 134.55 66.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 109.736 -0.468 . . . . 73.099999999999994 109.736 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.66 122.81 46.43 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.851 -0.739 . . . . 65.299999999999997 110.357 176.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.413 HG13 ' HA ' ' A' ' 397' ' ' ASP . 34.7 t -111.75 131.87 61.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 114.705 -1.134 . . . . 72.400000000000006 110.588 -175.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 34.2 p -85.93 125.97 33.75 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 120.285 -0.566 . . . . 63.140000000000001 109.577 176.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.1 t -117.49 105.47 12.13 Favored 'General case' 0 N--CA 1.407 -2.621 0 C-N-CA 119.509 -0.876 . . . . 63.240000000000002 109.221 175.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 79.04 120.37 0.28 Allowed Glycine 0 N--CA 1.436 -1.303 0 CA-C-N 115.494 -0.776 . . . . 71.239999999999995 113.318 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -63.78 154.23 70.75 Favored 'Trans proline' 0 C--O 1.251 1.133 0 C-N-CA 121.776 1.651 . . . . 71.420000000000002 109.112 171.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.478 ' CG ' ' HA ' ' A' ' 391' ' ' ASP . 28.8 mt-10 -75.55 140.58 42.81 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 109.496 -0.557 . . . . 71.540000000000006 109.496 -177.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.514 ' OE1' ' HB ' ' A' ' 477' ' ' THR . 34.0 tt0 -102.58 144.86 30.45 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 107.387 -1.338 . . . . 73.010000000000005 107.387 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.621 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 1.6 mmp_? -122.32 139.87 53.31 Favored 'General case' 0 CA--C 1.479 -1.769 0 N-CA-C 112.795 0.665 . . . . 74.040000000000006 112.795 -174.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 42.2 tt0 -85.26 132.99 34.18 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.627 -1.17 . . . . 65.150000000000006 108.256 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 57.8 mt -80.92 124.43 81.47 Favored Pre-proline 0 C--N 1.307 -1.259 0 N-CA-C 109.812 -0.44 . . . . 73.329999999999998 109.812 -178.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -70.77 147.0 55.43 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.332 2.021 . . . . 72.150000000000006 110.397 175.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -81.21 102.19 10.17 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.494 0.664 . . . . 73.239999999999995 110.243 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 61.0 t -96.93 140.42 17.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 106.882 -1.525 . . . . 75.530000000000001 106.882 177.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 2.4 p -63.97 146.96 53.16 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 112.619 0.6 . . . . 71.010000000000005 112.619 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 25.7 p -60.63 -32.71 71.86 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 124.811 1.245 . . . . 72.409999999999997 113.774 -173.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.9 pp -81.04 -10.74 59.65 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.48 0.657 . . . . 74.239999999999995 111.588 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.3 m -106.61 40.95 1.52 Allowed 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.627 -0.879 . . . . 65.099999999999994 108.627 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -51.69 -37.98 53.07 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.943 1.297 . . . . 75.310000000000002 112.401 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -59.82 -38.85 83.18 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.046 0.45 . . . . 63.210000000000001 111.26 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . 0.465 ' CD ' ' HE3' ' A' ' 442' ' ' LYS . 16.2 tp10 -70.4 -37.15 74.44 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.881 -0.785 . . . . 70.010000000000005 108.881 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.571 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -60.7 -51.24 70.19 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.518 -0.764 . . . . 75.209999999999994 111.162 -178.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 27.5 m -63.97 -40.55 89.48 Favored 'Isoleucine or valine' 0 C--O 1.249 1.029 0 N-CA-C 112.627 0.603 . . . . 73.310000000000002 112.627 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.465 ' HE3' ' CD ' ' A' ' 439' ' ' GLU . 41.9 pttt -68.61 -35.1 76.88 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 119.134 -1.026 . . . . 74.409999999999997 112.104 177.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -65.09 -38.31 90.33 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.347 -0.388 . . . . 75.329999999999998 110.882 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 94.3 mt -63.2 -38.59 91.78 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.332 -0.618 . . . . 74.310000000000002 109.332 177.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.451 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 86.4 m -66.14 -45.23 81.75 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.718 -0.674 . . . . 75.439999999999998 111.129 178.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.62 -15.87 63.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.038 0.447 . . . . 64.299999999999997 111.632 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -88.62 4.0 48.58 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.997 0.427 . . . . 70.439999999999998 111.396 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 112.47 -73.35 0.22 Allowed Glycine 0 CA--C 1.496 -1.152 0 C-N-CA 120.351 -0.928 . . . . 73.129999999999995 111.829 175.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . 0.488 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 0.4 OUTLIER -45.57 -68.27 0.21 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 114.021 1.119 . . . . 75.430000000000007 114.021 177.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . 0.451 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 60.36 27.33 65.41 Favored Glycine 0 C--N 1.315 -0.605 0 N-CA-C 111.38 -0.688 . . . . 75.129999999999995 111.38 -173.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.433 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 32.3 mmt180 -100.16 110.4 22.67 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 106.424 -1.695 . . . . 73.349999999999994 106.424 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -143.6 147.0 33.73 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 109.592 -0.521 . . . . 73.349999999999994 109.592 -177.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -137.75 123.1 19.46 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 108.43 -0.952 . . . . 75.219999999999999 108.43 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -87.38 124.71 33.68 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 123.598 0.561 . . . . 73.329999999999998 109.933 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -121.61 142.26 50.29 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 107.343 -1.354 . . . . 74.319999999999993 107.343 176.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -125.14 143.06 51.12 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 119.536 -0.865 . . . . 64.409999999999997 109.955 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 48.9 m -141.55 139.28 18.44 Favored Pre-proline 0 C--N 1.285 -2.197 0 N-CA-C 107.911 -1.144 . . . . 73.400000000000006 107.911 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.68 ' HA ' ' O ' ' A' ' 490' ' ' SER . 34.1 Cg_endo -65.44 122.56 10.28 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 121.746 1.631 . . . . 75.519999999999996 111.116 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 47.2 m -135.46 179.64 6.21 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.794 -1.094 . . . . 74.5 109.692 -174.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.9 t -49.3 133.71 17.07 Favored Pre-proline 0 C--O 1.251 1.179 0 O-C-N 124.103 0.877 . . . . 72.409999999999997 112.392 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.92 -29.62 35.95 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 124.566 3.51 . . . . 70.099999999999994 113.913 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -74.79 -23.8 58.56 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.652 0.612 . . . . 73.329999999999998 112.652 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -100.23 -6.05 26.64 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.975 0.416 . . . . 73.420000000000002 111.488 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 86.6 t -60.58 128.6 21.98 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 CA-C-N 116.192 -0.458 . . . . 72.5 109.841 176.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 97.07 -3.14 61.93 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.969 -0.634 . . . . 72.349999999999994 112.148 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -122.53 165.85 15.75 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 108.322 -0.992 . . . . 74.299999999999997 108.322 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 70.9 t -73.97 146.54 10.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.792 -1.188 . . . . 75.439999999999998 107.792 173.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 45.5 mt -98.08 -35.64 5.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 107.747 -1.205 . . . . 75.209999999999994 107.747 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 161.86 -162.24 33.93 Favored Glycine 0 N--CA 1.417 -2.631 0 N-CA-C 109.851 -1.3 . . . . 65.319999999999993 109.851 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 28.5 p -130.52 153.86 48.4 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 109.869 -0.419 . . . . 72.420000000000002 109.869 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -75.03 -56.31 2.06 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 109.017 -0.734 . . . . 72.200000000000003 109.017 172.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.28 163.9 35.37 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 121.405 1.403 . . . . 75.430000000000007 108.927 172.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -71.88 126.98 12.44 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.168 1.245 . . . . 71.310000000000002 112.241 -177.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -99.93 2.04 43.27 Favored 'General case' 0 C--O 1.212 -0.893 0 CA-C-O 121.532 0.682 . . . . 62.409999999999997 110.55 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -110.7 5.49 20.93 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 120.202 -0.599 . . . . 73.340000000000003 110.48 175.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -122.92 -177.57 3.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.896 0.379 . . . . 74.439999999999998 110.507 -175.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 477' ' ' THR . . . . . 0.514 ' HB ' ' OE1' ' A' ' 426' ' ' GLN . 1.0 OUTLIER -71.37 132.12 44.39 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 124.987 1.315 . . . . 72.019999999999996 113.471 179.296 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 69.6 m -130.55 144.28 51.31 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 115.517 -0.765 . . . . 73.349999999999994 109.578 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -79.34 161.53 26.17 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.342 -0.845 . . . . 74.420000000000002 110.893 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . 0.488 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 1.8 mp -70.08 -25.23 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.834 0.826 . . . . 74.549999999999997 111.265 -177.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 17.2 m -93.28 -9.28 39.55 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.543 0.687 . . . . 72.299999999999997 110.401 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -85.76 129.33 34.86 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.44 -0.8 . . . . 75.010000000000005 110.49 -175.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . 0.433 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 10.7 p -97.52 126.81 50.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.176 0.512 . . . . 73.400000000000006 111.742 -178.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 35.9 m -100.2 127.31 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-O 121.711 0.767 . . . . 74.340000000000003 110.915 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.57 124.55 45.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.667 -0.697 . . . . 73.25 109.544 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 34.3 mm -107.5 116.7 51.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.482 -1.303 . . . . 70.25 107.482 -177.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 11.7 tt -100.19 125.97 53.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 121.556 0.694 . . . . 75.540000000000006 110.025 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 33.6 m -110.3 151.13 12.59 Favored 'Isoleucine or valine' 0 C--O 1.258 1.536 0 CA-C-N 115.375 -0.829 . . . . 74.239999999999995 111.097 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -80.9 128.64 8.56 Favored Glycine 0 N--CA 1.419 -2.45 0 CA-C-N 115.307 -0.861 . . . . 64.140000000000001 111.158 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.68 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 31.3 t -130.59 160.64 33.58 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 104.113 -2.551 . . . . 73.219999999999999 104.113 177.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 156.07 107.25 0.26 Allowed Glycine 0 N--CA 1.423 -2.185 0 C-N-CA 117.604 -2.236 . . . . 70.019999999999996 114.329 177.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -85.74 101.76 0.68 Allowed 'Trans proline' 0 N--CA 1.416 -3.06 0 C-N-CA 121.959 1.772 . . . . 70.310000000000002 109.265 169.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . -88.99 65.45 7.52 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.442 -0.947 . . . . 72.519999999999996 108.442 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 2.6 p -117.44 143.31 46.15 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 114.464 -1.244 . . . . 73.430000000000007 111.579 -175.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -135.95 151.23 49.73 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.499 -0.926 . . . . 73.409999999999997 108.499 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.5 p-10 -85.41 130.49 34.58 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.469 -0.938 . . . . 75.129999999999995 108.469 176.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . 0.407 HG12 ' O ' ' A' ' 543' ' ' THR . 28.8 pt -92.11 121.91 65.9 Favored Pre-proline 0 C--N 1.29 -2.01 0 CA-C-N 116.109 -0.496 . . . . 73.239999999999995 111.038 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -85.73 -164.08 0.21 Allowed 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.552 2.168 . . . . 74.329999999999998 110.24 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -94.35 145.93 24.41 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 118.722 -1.191 . . . . 64.340000000000003 108.449 177.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 10.2 p -137.58 16.84 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 122.826 1.298 . . . . 72.5 107.505 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . 0.405 ' HB2' ' HA2' ' A' ' 536' ' ' GLY . . . -87.75 145.65 26.03 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 113.706 -1.588 . . . . 74.219999999999999 110.363 -174.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 107.02 -10.33 40.29 Favored Glycine 0 C--N 1.293 -1.845 0 N-CA-C 108.922 -1.671 . . . . 72.129999999999995 108.922 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -103.84 175.42 5.49 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 114.351 -0.925 . . . . 74.329999999999998 108.836 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 20.7 p -85.75 163.97 17.88 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-O 120.584 0.231 . . . . 71.310000000000002 111.069 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.1 p -54.96 -41.44 58.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.73 -0.668 . . . . 75.230000000000004 112.331 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -66.27 -41.7 89.52 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 120.521 -0.471 . . . . 72.200000000000003 110.864 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 90.5 t -67.89 -41.27 84.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.223 -0.444 . . . . 73.409999999999997 110.184 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.3 -46.64 85.77 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.31 -0.404 . . . . 53.140000000000001 110.629 178.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -59.56 -43.32 93.6 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.313 0.645 . . . . 73.030000000000001 109.761 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.421 ' O ' HG23 ' A' ' 514' ' ' VAL . 17.9 ttmm -59.51 -46.98 87.27 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.804 -1.089 . . . . 73.230000000000004 109.776 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -62.48 -46.02 90.37 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.257 -0.429 . . . . 74.510000000000005 111.032 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 10.3 mp -60.15 -43.48 95.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.396 -0.365 . . . . 73.099999999999994 111.297 178.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.71 -39.84 92.92 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.336 0.397 . . . . 71.299999999999997 110.91 178.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 510' ' ' LYS . 70.3 t -64.86 -32.41 58.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 116.019 -0.537 . . . . 74.109999999999999 111.053 177.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -85.74 2.51 45.21 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.346 -0.542 . . . . 74.319999999999993 111.785 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 98.86 -18.07 57.35 Favored Glycine 0 C--O 1.243 0.696 0 C-N-CA 120.847 -0.692 . . . . 73.239999999999995 112.797 176.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.484 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 83.4 m-85 -68.7 98.89 0.94 Allowed 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.955 0.883 . . . . 65.310000000000002 109.706 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.54 9.99 29.37 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.797 -1.092 . . . . 74.219999999999999 112.674 -174.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . 0.431 ' HD2' ' O ' ' A' ' 548' ' ' ASP . 63.6 mttp -122.72 113.46 19.24 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.536 -0.913 . . . . 74.230000000000004 108.536 173.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -132.2 156.57 46.22 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.581 -0.736 . . . . 74.540000000000006 111.653 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 521' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 52.6 m -135.64 136.53 41.06 Favored 'General case' 0 C--N 1.276 -2.605 0 N-CA-C 106.987 -1.486 . . . . 70.510000000000005 106.987 173.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -117.08 124.27 48.83 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.418 0.628 . . . . 65.25 109.913 -177.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -110.81 125.54 53.68 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 115.682 -0.69 . . . . 53.420000000000002 109.189 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 2.9 p -92.01 120.73 32.92 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 109.085 -0.709 . . . . 64.329999999999998 109.085 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . 0.493 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 26.9 m -121.24 152.22 24.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 116.548 -0.296 . . . . 73.030000000000001 110.465 -175.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -66.94 135.23 53.48 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 108.796 -0.816 . . . . 72.510000000000005 108.796 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 66.3 m -152.98 166.54 15.23 Favored Pre-proline 0 C--N 1.307 -1.278 0 C-N-CA 120.912 -0.315 . . . . 75.540000000000006 111.24 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -91.13 -7.16 3.73 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.099 1.866 . . . . 75.230000000000004 109.859 168.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -81.98 136.43 47.36 Favored Pre-proline 0 N--CA 1.42 -1.932 0 C-N-CA 124.924 1.29 . . . . 74.530000000000001 108.143 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.23 149.38 80.99 Favored 'Trans proline' 0 C--O 1.259 1.563 0 C-N-CA 122.61 2.207 . . . . 74.510000000000005 113.74 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -61.61 126.16 26.35 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 114.114 -1.403 . . . . 75.319999999999993 111.59 -176.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 120.94 -24.23 7.52 Favored Glycine 0 C--N 1.305 -1.161 0 CA-C-N 115.646 -0.706 . . . . 63.119999999999997 111.973 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -82.67 125.79 31.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.801 0.334 . . . . 64.0 110.282 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 85.9 t -75.39 113.27 14.01 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 107.921 -1.14 . . . . 71.340000000000003 107.921 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 535' ' ' THR . . . . . 0.605 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 12.6 t -78.35 -18.84 54.58 Favored 'General case' 0 C--N 1.314 -0.941 0 O-C-N 123.593 0.558 . . . . 72.430000000000007 110.998 -176.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . 0.405 ' HA2' ' HB2' ' A' ' 501' ' ' ALA . . . 160.08 -174.27 36.83 Favored Glycine 0 N--CA 1.422 -2.25 0 C-N-CA 120.499 -0.858 . . . . 64.150000000000006 111.213 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 19.4 p -117.42 157.47 26.15 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 108.607 -0.886 . . . . 70.349999999999994 108.607 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . 0.405 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 19.4 t30 -71.17 -52.3 9.39 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 109.987 -0.375 . . . . 60.43 109.987 176.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . 0.405 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 38.1 Cg_exo -66.13 131.92 28.34 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 120.914 1.076 . . . . 75.239999999999995 109.563 171.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -66.23 147.94 84.17 Favored 'Trans proline' 0 C--O 1.243 0.767 0 C-N-CA 122.84 2.36 . . . . 73.439999999999998 113.24 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.21 134.42 55.9 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.672 -0.695 . . . . 64.129999999999995 109.583 176.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.47 -20.51 32.24 Favored Glycine 0 C--N 1.301 -1.395 0 N-CA-C 111.191 -0.764 . . . . 64.030000000000001 111.191 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 543' ' ' THR . . . . . 0.407 ' O ' HG12 ' A' ' 497' ' ' ILE . 44.9 m -67.43 134.8 52.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.98 0.419 . . . . 75.319999999999993 110.655 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 30.6 m -96.4 122.59 39.45 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 108.924 -0.769 . . . . 71.019999999999996 108.924 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 22.1 m -136.45 155.21 77.18 Favored Pre-proline 0 C--N 1.312 -1.022 0 CA-C-N 116.158 -0.474 . . . . 74.200000000000003 109.963 -177.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 37.5 Cg_exo -62.72 148.11 93.83 Favored 'Trans proline' 0 C--O 1.221 -0.363 0 C-N-CA 122.411 2.074 . . . . 72.400000000000006 111.929 176.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.484 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 35.5 m -65.81 -19.92 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-O 121.864 0.84 . . . . 73.230000000000004 111.005 177.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . 0.431 ' O ' ' HD2' ' A' ' 519' ' ' LYS . 37.6 t70 -92.79 3.43 55.67 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.581 -1.19 . . . . 72.409999999999997 110.058 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 30.2 t -84.06 159.48 21.15 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.562 -0.903 . . . . 63.240000000000002 108.562 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 18.1 t -96.38 122.55 48.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 109.01 -0.737 . . . . 74.439999999999998 109.01 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 61.5 mt -100.56 131.72 47.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 109.585 -0.524 . . . . 75.120000000000005 109.585 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . 0.469 ' HA ' ' O ' ' A' ' 521' ' ' SER . 35.6 tt0 -102.46 115.81 31.33 Favored 'General case' 0 N--CA 1.418 -2.03 0 N-CA-C 109.395 -0.595 . . . . 64.329999999999998 109.395 178.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.01 134.04 48.78 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.023 -0.99 . . . . 70.109999999999999 110.238 175.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -102.81 119.72 39.34 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.471 0.653 . . . . 74.019999999999996 110.639 -175.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 41.7 t -100.06 138.94 22.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-N 115.138 -0.937 . . . . 64.319999999999993 108.627 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.626 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 5.0 m -85.52 141.5 29.84 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.929 -0.578 . . . . 74.329999999999998 110.41 -178.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 525' ' ' VAL . 23.0 ptmt -110.28 147.55 33.64 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 105.485 -2.042 . . . . 74.140000000000001 105.485 167.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -79.29 -23.7 62.64 Favored Glycine 0 C--N 1.3 -1.472 0 C-N-CA 119.881 -1.152 . . . . 61.009999999999998 112.126 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 17.2 m120 59.34 37.65 23.32 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.09 -0.707 . . . . 73.230000000000004 109.09 -174.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 48.4 mt-30 -112.16 141.91 45.27 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.806 -0.633 . . . . 74.430000000000007 110.286 -172.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -123.77 146.76 48.08 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.708 -0.849 . . . . 75.140000000000001 108.708 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 56.9 t -72.55 117.52 16.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 121.086 0.47 . . . . 64.329999999999998 110.024 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 55.9 ttp -97.23 126.15 43.04 Favored Pre-proline 0 C--N 1.309 -1.18 0 CA-C-N 115.473 -0.785 . . . . 72.409999999999997 110.352 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -61.27 170.53 5.05 Favored 'Trans proline' 0 CA--C 1.548 1.22 0 C-N-CA 123.143 2.562 . . . . 71.209999999999994 111.804 171.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . 0.491 ' O ' ' HE2' ' A' ' 569' ' ' MET . 10.9 p-10 -60.69 143.6 53.87 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 123.663 0.785 . . . . 73.510000000000005 111.466 -178.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -123.94 -42.53 2.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.051 0.453 . . . . 73.209999999999994 110.315 -176.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 22.7 t -76.37 144.73 39.9 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.473 -0.936 . . . . 71.019999999999996 108.473 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 110.7 -7.1 29.76 Favored Glycine 0 C--N 1.31 -0.915 0 N-CA-C 110.636 -0.986 . . . . 74.109999999999999 110.636 -176.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 569' ' ' MET . . . . . 0.491 ' HE2' ' O ' ' A' ' 565' ' ' ASP . 14.8 mtm -114.69 156.39 24.87 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 122.886 0.475 . . . . 74.230000000000004 110.739 -176.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -87.38 143.55 27.19 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 106.196 -1.779 . . . . 71.540000000000006 106.196 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 33.3 t90 -51.24 -31.73 21.84 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 113.195 0.813 . . . . 72.439999999999998 113.195 -175.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 29.7 m -78.27 -19.38 13.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-O 121.398 0.618 . . . . 70.430000000000007 110.909 -176.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -100.99 -35.54 9.34 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.991 0.9 . . . . 73.200000000000003 108.86 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -67.98 -40.19 83.15 Favored 'General case' 0 C--O 1.205 -1.257 0 CA-C-N 114.264 -1.335 . . . . 73.549999999999997 111.623 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.44 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 36.0 tt0 -54.08 -57.57 17.47 Favored Pre-proline 0 CA--C 1.563 1.48 0 N-CA-C 112.595 0.591 . . . . 73.409999999999997 112.595 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . 0.44 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 44.8 Cg_exo -59.79 -39.66 70.69 Favored 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 121.514 1.476 . . . . 72.299999999999997 111.619 177.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -39.1 90.95 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-O 120.955 0.407 . . . . 74.400000000000006 109.921 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.524 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 58.3 tp -66.82 -48.15 69.84 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 123.482 0.713 . . . . 72.209999999999994 110.914 -178.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -66.34 -35.09 79.46 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.033 -0.667 . . . . 62.509999999999998 111.11 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -65.68 -29.58 70.15 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.962 -0.563 . . . . 74.019999999999996 111.735 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 578' ' ' LEU . 4.3 pp -81.62 1.39 34.15 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.066 0.46 . . . . 74.299999999999997 111.588 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 92.67 22.91 27.35 Favored Glycine 0 CA--C 1.496 -1.144 0 C-N-CA 120.809 -0.71 . . . . 73.549999999999997 113.509 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 84.0 t90 -80.92 136.94 36.12 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 120.352 -0.539 . . . . 72.200000000000003 111.128 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 10.8 m -154.24 101.68 2.4 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 106.933 -1.506 . . . . 64.420000000000002 106.933 172.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -158.24 -149.65 5.53 Favored Glycine 0 CA--C 1.491 -1.453 0 N-CA-C 109.714 -1.354 . . . . 55.439999999999998 109.714 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 58.5 ttp -94.75 127.13 40.53 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 117.68 0.74 . . . . 74.239999999999995 110.203 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -102.3 130.01 48.89 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.534 -1.654 . . . . 73.019999999999996 106.534 176.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -95.87 105.23 17.22 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.276 0.56 . . . . 75.129999999999995 110.517 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -94.42 126.52 39.75 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 106.709 -1.589 . . . . 70.230000000000004 106.709 177.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . 0.497 ' HA3' ' NH1' ' A' ' 623' ' ' ARG . . . -120.8 -116.32 2.48 Favored Glycine 0 N--CA 1.423 -2.184 0 C-N-CA 120.596 -0.812 . . . . 64.200000000000003 112.257 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -137.13 144.72 43.15 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.682 -0.488 . . . . 61.240000000000002 109.682 -177.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -80.47 140.46 35.92 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.114 -1.069 . . . . 73.420000000000002 108.114 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 57.3 t -137.2 120.74 21.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 109.517 -0.549 . . . . 75.340000000000003 109.517 -172.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.28 106.96 5.33 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.54 -1.281 . . . . 73.329999999999998 107.54 173.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -138.64 8.25 2.59 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.899 0.703 . . . . 74.019999999999996 112.899 -174.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 117.96 139.83 6.34 Favored Glycine 0 C--N 1.299 -1.503 0 C-N-CA 120.088 -1.053 . . . . 72.140000000000001 110.92 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -55.39 -33.73 58.84 Favored Glycine 0 C--O 1.223 -0.558 0 N-CA-C 114.845 0.698 . . . . 71.439999999999998 114.845 -173.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 18.5 m -65.63 -24.59 67.08 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 117.503 0.651 . . . . 74.5 111.727 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -98.58 -12.46 21.14 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.212 0.53 . . . . 64.439999999999998 109.759 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 67.1 m170 -76.67 137.27 39.31 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.981 -0.554 . . . . 75.540000000000006 111.183 -176.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 9.5 p30 46.34 12.8 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 126.929 2.092 . . . . 70.230000000000004 115.964 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -126.61 146.72 50.05 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.598 -0.89 . . . . 72.549999999999997 108.598 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.31 131.33 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.268 0.627 . . . . 73.010000000000005 111.392 -177.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 60.2 t -90.49 -38.85 11.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 120.992 0.425 . . . . 71.319999999999993 111.159 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -151.83 162.4 41.11 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.992 -0.373 . . . . 75.340000000000003 109.992 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -131.85 127.62 36.94 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 123.845 0.715 . . . . 75.420000000000002 109.669 -176.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.514 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 50.7 t-20 -71.86 -62.11 1.75 Allowed Pre-proline 0 CA--C 1.562 1.422 0 N-CA-C 112.744 0.646 . . . . 75.129999999999995 112.744 -178.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.514 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 3.3 Cg_endo -87.41 134.14 3.38 Favored 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 121.38 1.387 . . . . 75.019999999999996 110.7 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.49 137.39 59.62 Favored 'Trans proline' 0 C--O 1.252 1.213 0 C-N-CA 122.853 2.369 . . . . 61.229999999999997 114.042 -177.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.9 131.12 44.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.984 -1.007 . . . . 74.230000000000004 110.319 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 89.58 0.19 79.46 Favored Glycine 0 C--N 1.312 -0.779 0 C-N-CA 120.694 -0.765 . . . . 64.329999999999998 112.271 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 22.5 m -101.31 157.92 16.43 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.919 -0.771 . . . . 74.150000000000006 108.919 178.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -73.1 113.83 4.49 Favored Glycine 0 N--CA 1.429 -1.816 0 N-CA-C 108.767 -1.733 . . . . 55.240000000000002 108.767 174.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 24.4 m -96.01 141.94 14.57 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-O 121.24 0.543 . . . . 75.239999999999995 112.03 -176.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -47.64 140.63 6.01 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 126.322 1.849 . . . . 74.019999999999996 111.518 175.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -54.06 -25.93 24.17 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 114.326 1.232 . . . . 74.340000000000003 114.326 -175.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -75.37 -25.49 57.74 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.165 -0.679 . . . . 72.140000000000001 109.165 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 67.79 21.36 73.06 Favored Glycine 0 N--CA 1.428 -1.897 0 CA-C-O 119.296 -0.725 . . . . 71.340000000000003 113.744 172.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.87 118.31 11.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-O 123.312 1.53 . . . . 73.040000000000006 111.138 -168.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 3.2 tp -112.12 119.13 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.958 0 CA-C-N 112.96 -1.927 . . . . 75.420000000000002 108.649 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 7.0 m -98.6 117.49 33.18 Favored 'General case' 0 N--CA 1.406 -2.665 0 N-CA-C 105.958 -1.867 . . . . 73.540000000000006 105.958 175.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -139.28 160.7 39.2 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.23 -1.396 . . . . 75.120000000000005 107.23 -178.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . 0.497 ' NH1' ' HA3' ' A' ' 590' ' ' GLY . 13.0 tpt180 -151.16 150.96 31.26 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 105.755 -1.943 . . . . 74.420000000000002 105.755 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -138.84 160.98 38.38 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 106.0 -1.852 . . . . 65.140000000000001 106.0 173.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -78.2 -96.02 0.24 Allowed Glycine 0 N--CA 1.421 -2.331 0 N-CA-C 110.987 -0.845 . . . . 73.430000000000007 110.987 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 . . . . . 0 C--N 1.283 -2.295 0 N-CA-C 108.159 -1.052 . . . . 75.409999999999997 108.159 179.277 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.752 0 N-CA-C 110.783 -0.927 . . . . 51.340000000000003 110.783 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 11.2 tp -90.98 152.5 3.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 109.529 -0.545 . . . . 74.129999999999995 109.529 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 23.7 m -92.85 161.32 14.54 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 108.392 -0.966 . . . . 61.409999999999997 108.392 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.24 81.24 1.45 Allowed 'General case' 0 N--CA 1.428 -1.55 0 CA-C-O 122.315 1.055 . . . . 74.120000000000005 110.376 -177.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.4 128.96 38.48 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 113.568 -1.651 . . . . 70.109999999999999 108.484 175.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 409' ' ' SER . 35.8 m -117.45 163.92 14.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 109.393 -0.595 . . . . 73.099999999999994 109.393 -174.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -93.19 138.0 32.0 Favored 'General case' 0 N--CA 1.421 -1.875 0 N-CA-C 106.378 -1.712 . . . . 74.329999999999998 106.378 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 60.5 t -95.24 120.04 64.66 Favored Pre-proline 0 C--N 1.28 -2.425 0 CA-C-N 115.744 -0.662 . . . . 71.140000000000001 110.005 -167.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -65.7 122.82 10.54 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.54 2.16 . . . . 74.340000000000003 112.225 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -108.59 153.72 22.98 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 114.523 -1.217 . . . . 64.549999999999997 108.894 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.474 ' HB ' ' NE2' ' A' ' 368' ' ' GLN . 15.9 m -134.84 28.52 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 115.361 -0.836 . . . . 72.299999999999997 109.852 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.47 148.0 24.84 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 115.221 -0.899 . . . . 75.239999999999995 112.304 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.95 -5.25 39.39 Favored Glycine 0 C--N 1.321 -0.285 0 CA-C-N 116.332 -0.395 . . . . 75.140000000000001 112.251 -176.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . 0.474 ' NE2' ' HB ' ' A' ' 365' ' ' VAL . 40.6 mt-30 -106.48 -85.08 0.51 Allowed 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 120.868 0.365 . . . . 74.219999999999999 110.831 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 41.9 p -153.46 157.82 40.45 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 108.449 -0.945 . . . . 65.420000000000002 108.449 -178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 49.0 m -63.95 -35.67 81.44 Favored 'General case' 0 C--O 1.203 -1.359 0 N-CA-C 109.692 -0.484 . . . . 72.219999999999999 109.692 175.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.81 -46.77 88.09 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 116.348 -0.387 . . . . 73.310000000000002 111.973 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -68.1 -38.78 82.7 Favored 'General case' 0 C--O 1.245 0.828 0 C-N-CA 120.289 -0.564 . . . . 70.540000000000006 110.163 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . 0.444 ' HA ' ' CG2' ' A' ' 365' ' ' VAL . . . -66.59 -51.09 60.23 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.66 -0.7 . . . . 75.299999999999997 111.092 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . 0.402 HG22 HG12 ' A' ' 384' ' ' ILE . 60.1 mt -60.08 -43.52 92.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 123.167 0.587 . . . . 72.549999999999997 110.517 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -60.47 -47.22 87.07 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.101 0.477 . . . . 73.540000000000006 110.59 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' THR . . . . . 0.53 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 58.9 m -66.61 -47.79 71.57 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.811 -0.631 . . . . 72.150000000000006 111.402 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 9.8 mp -64.24 -37.69 88.39 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 112.001 0.371 . . . . 75.030000000000001 112.001 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -64.02 -41.5 97.43 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 109.518 -0.549 . . . . 64.25 109.518 176.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -67.31 -22.38 65.63 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 116.24 -0.436 . . . . 74.25 111.452 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 376' ' ' THR . 13.7 mmm180 -80.94 -14.54 57.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.983 0.421 . . . . 74.340000000000003 109.963 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 96.8 14.9 41.56 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.904 -0.665 . . . . 72.420000000000002 112.244 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.496 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 55.1 m-85 -93.22 167.72 11.57 Favored 'General case' 0 N--CA 1.427 -1.621 0 O-C-N 122.488 -0.419 . . . . 72.219999999999999 110.969 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -105.51 143.83 33.13 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 106.528 -1.656 . . . . 73.439999999999998 106.528 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . 0.402 HG12 HG22 ' A' ' 374' ' ' ILE . 1.2 pp -125.6 131.94 71.48 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 CA-C-O 121.593 0.711 . . . . 74.510000000000005 111.939 -177.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -111.04 129.34 55.94 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 114.707 -1.133 . . . . 75.140000000000001 108.035 -176.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 10.5 m -121.66 123.98 43.19 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 110.101 -0.333 . . . . 63.240000000000002 110.101 -176.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -111.57 122.82 48.83 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.536 -0.542 . . . . 72.420000000000002 109.536 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.93 126.97 50.31 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.962 0.41 . . . . 74.209999999999994 110.536 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -135.14 136.27 24.42 Favored Pre-proline 0 C--N 1.297 -1.696 0 CA-C-N 115.994 -0.548 . . . . 71.209999999999994 110.394 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.07 147.24 93.85 Favored 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 123.055 2.503 . . . . 73.239999999999995 111.846 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 6.4 t70 86.41 178.59 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.515 1.926 . . . . 74.409999999999997 108.949 -178.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 25.7 m -132.41 14.66 4.55 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 121.692 0.758 . . . . 72.400000000000006 110.366 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 10.1 t -69.08 -28.05 66.17 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 107.889 -1.152 . . . . 73.310000000000002 107.889 172.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . 0.406 ' H ' HD13 ' A' ' 394' ' ' ILE . 0.2 OUTLIER -88.55 151.73 48.5 Favored Pre-proline 0 N--CA 1.433 -1.308 0 N-CA-C 107.59 -1.263 . . . . 74.209999999999994 107.59 174.003 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -28.97 116.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.306 0 C-N-CA 125.148 3.899 . . . . 72.340000000000003 115.034 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . 0.572 ' HA ' ' OG ' ' A' ' 421' ' ' SER . 48.5 Cg_exo -58.55 161.03 15.45 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 123.805 3.003 . . . . 62.350000000000001 113.626 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -57.63 -9.24 1.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.13 0.972 . . . . 63.310000000000002 113.077 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -107.37 119.86 40.55 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 104.504 -2.406 . . . . 71.239999999999995 104.504 171.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 11.0 m -62.84 118.24 4.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.196 0 O-C-N 123.681 0.613 . . . . 63.299999999999997 111.574 -168.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.38 -34.96 8.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 108.029 -1.1 . . . . 73.310000000000002 108.029 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -152.73 157.92 27.58 Favored Glycine 0 N--CA 1.409 -3.153 0 N-CA-C 109.369 -1.492 . . . . 71.299999999999997 109.369 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.2 p -117.89 -178.82 3.58 Favored 'General case' 0 C--N 1.277 -2.58 0 N-CA-C 108.435 -0.95 . . . . 74.439999999999998 108.435 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -100.74 146.28 31.81 Favored Pre-proline 0 C--N 1.295 -1.795 0 C-N-CA 119.306 -0.958 . . . . 75.430000000000007 111.006 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.12 -16.36 1.78 Allowed 'Trans proline' 0 C--N 1.364 1.347 0 C-N-CA 125.221 3.947 . . . . 65.430000000000007 114.868 -176.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.43 -33.86 63.93 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.365 0.666 . . . . 72.030000000000001 111.042 176.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -82.34 -30.69 30.27 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.434 0.635 . . . . 71.349999999999994 111.135 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -86.56 -1.84 57.98 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.335 0.588 . . . . 74.209999999999994 110.573 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 47.2 m -107.54 148.38 29.32 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.094 -1.447 . . . . 75.439999999999998 107.094 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 360' ' ' VAL . 65.3 m -74.5 113.34 11.64 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 120.055 -0.658 . . . . 72.150000000000006 110.319 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 33.4 m -129.31 169.49 20.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.774 -0.648 . . . . 63.520000000000003 109.467 177.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 22.6 t -79.84 156.39 27.39 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.094 -0.706 . . . . 60.549999999999997 109.094 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . 0.496 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -70.87 143.13 51.13 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 116.101 -0.499 . . . . 63.399999999999999 110.703 -178.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 103.02 10.6 36.54 Favored Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 120.398 -0.906 . . . . 72.230000000000004 112.98 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -80.53 174.51 11.54 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.244 -1.021 . . . . 72.219999999999999 108.244 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -110.01 114.69 28.42 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.945 -0.761 . . . . 74.310000000000002 108.945 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 46.6 mm -97.7 127.37 50.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 109.179 -0.674 . . . . 75.140000000000001 109.179 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 1.7 p -86.66 130.67 34.39 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 114.028 1.121 . . . . 73.450000000000003 114.028 -176.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 2.1 t -123.34 134.89 64.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 C-N-CA 125.126 1.37 . . . . 75.430000000000007 110.007 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -106.49 129.12 54.5 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 115.457 -0.792 . . . . 53.039999999999999 109.871 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 5.3 p -118.76 131.22 72.17 Favored 'Isoleucine or valine' 0 C--O 1.256 1.408 0 N-CA-C 109.707 -0.479 . . . . 73.019999999999996 109.707 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' SER . . . . . 0.572 ' OG ' ' HA ' ' A' ' 396' ' ' PRO . 54.6 p -84.75 125.54 32.64 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 115.904 -0.589 . . . . 75.140000000000001 110.43 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.8 m -97.82 156.9 16.37 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 107.132 -1.433 . . . . 74.230000000000004 107.132 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -44.08 148.78 0.96 Allowed Glycine 0 C--O 1.255 1.411 0 N-CA-C 114.815 0.686 . . . . 64.329999999999998 114.815 -177.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.07 152.12 19.3 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 123.788 2.992 . . . . 64.310000000000002 112.638 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.41 ' O ' HD12 ' A' ' 480' ' ' ILE . 31.6 mt-10 -72.36 145.76 47.53 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.276 -0.875 . . . . 73.420000000000002 109.593 -174.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -122.29 157.38 31.85 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.284 -1.006 . . . . 74.140000000000001 108.284 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.539 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 1.5 mmp_? -123.56 159.57 28.9 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 112.698 0.629 . . . . 74.540000000000006 112.698 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -82.66 141.18 32.68 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.534 -1.212 . . . . 74.420000000000002 108.169 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.434 HD13 ' O ' ' A' ' 473' ' ' PRO . 63.9 mt -77.84 125.98 84.77 Favored Pre-proline 0 N--CA 1.43 -1.449 0 N-CA-C 107.685 -1.228 . . . . 75.299999999999997 107.685 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -69.7 140.85 43.92 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.639 1.559 . . . . 73.099999999999994 111.35 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -95.4 130.2 42.28 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.302 -1.74 . . . . 71.010000000000005 106.302 175.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 13.2 p -129.59 150.51 34.69 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.259 0 C-N-CA 120.346 -0.542 . . . . 73.120000000000005 110.515 -172.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 5.7 m -63.23 137.89 58.36 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 107.657 -1.238 . . . . 72.430000000000007 107.657 173.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 52.9 p -60.16 -28.77 68.19 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 123.989 0.916 . . . . 74.129999999999995 113.293 -171.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 1.1 pp -88.15 -10.73 49.04 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 113.558 0.947 . . . . 74.450000000000003 113.558 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 3.6 m -102.65 49.96 0.83 Allowed 'General case' 0 CA--C 1.563 1.459 0 CA-C-O 121.62 0.724 . . . . 75.519999999999996 111.056 -175.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -52.72 -37.63 59.51 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.93 0.892 . . . . 75.140000000000001 112.58 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.494 ' O ' ' HG3' ' A' ' 442' ' ' LYS . . . -58.82 -40.1 83.18 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.101 0.477 . . . . 72.140000000000001 111.367 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -69.42 -35.47 75.74 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.604 -0.887 . . . . 61.509999999999998 108.604 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.483 ' O ' HD12 ' A' ' 444' ' ' LEU . . . -60.78 -51.67 68.35 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.591 -0.732 . . . . 60.240000000000002 111.036 -178.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 33.5 m -62.31 -44.61 99.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 120.829 -0.348 . . . . 73.450000000000003 111.829 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 438' ' ' ALA 0.339 0.0 OUTLIER -68.66 -33.7 74.44 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 113.432 0.901 . . . . 74.099999999999994 113.432 178.881 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -65.01 -43.05 93.79 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 122.197 -0.314 . . . . 73.439999999999998 111.108 174.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 440' ' ' ALA . 8.9 mp -63.37 -35.24 79.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.347 -0.388 . . . . 75.120000000000005 110.325 177.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.454 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 38.6 m -67.28 -44.29 79.66 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 116.11 -0.495 . . . . 74.140000000000001 110.671 178.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.71 -22.94 65.24 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.22 -0.446 . . . . 72.140000000000001 111.435 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -80.09 5.16 15.02 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 116.061 -0.518 . . . . 55.229999999999997 111.737 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 102.23 -61.21 0.53 Allowed Glycine 0 CA--C 1.492 -1.374 0 C-N-CA 120.739 -0.743 . . . . 70.310000000000002 112.348 173.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . 0.405 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 0.9 OUTLIER -53.28 -63.4 1.16 Allowed 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 112.885 0.698 . . . . 74.010000000000005 112.885 178.224 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . 0.454 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 60.01 23.22 59.07 Favored Glycine 0 C--N 1.316 -0.572 0 O-C-N 123.199 0.312 . . . . 63.109999999999999 113.15 -178.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -108.2 110.82 22.54 Favored 'General case' 0 N--CA 1.422 -1.856 0 N-CA-C 107.337 -1.357 . . . . 74.310000000000002 107.337 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -131.29 146.02 52.12 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.651 -0.704 . . . . 63.340000000000003 110.499 -175.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -131.58 132.79 44.39 Favored 'General case' 0 C--N 1.286 -2.196 0 N-CA-C 108.397 -0.964 . . . . 74.400000000000006 108.397 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -101.05 126.98 47.77 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 120.956 0.408 . . . . 75.129999999999995 110.244 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.27 153.31 36.55 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.539 -1.282 . . . . 70.219999999999999 107.539 175.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -127.36 144.84 50.98 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.602 -0.518 . . . . 74.420000000000002 109.602 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 28.2 t -141.81 142.99 27.1 Favored Pre-proline 0 C--N 1.291 -1.963 0 N-CA-C 107.932 -1.136 . . . . 71.120000000000005 107.932 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.636 ' HA ' ' O ' ' A' ' 490' ' ' SER . 19.3 Cg_exo -65.83 138.73 54.4 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.872 1.715 . . . . 73.349999999999994 110.251 176.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 65.9 m -150.82 174.42 13.09 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 109.522 -0.547 . . . . 75.010000000000005 109.522 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.0 t -52.83 136.91 45.52 Favored Pre-proline 0 N--CA 1.437 -1.112 0 C-N-CA 123.739 0.816 . . . . 64.040000000000006 110.571 174.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.89 -30.24 38.12 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 124.624 3.549 . . . . 74.200000000000003 113.478 -175.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -67.43 -27.83 67.39 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.184 -0.462 . . . . 74.129999999999995 111.624 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -99.23 -13.38 19.73 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 111.717 0.266 . . . . 64.430000000000007 111.717 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 56.9 t -59.25 130.56 22.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.268 -0.424 . . . . 73.129999999999995 110.79 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.08 -10.26 60.05 Favored Glycine 0 N--CA 1.435 -1.399 0 CA-C-N 115.92 -0.582 . . . . 65.340000000000003 111.84 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -118.03 166.57 12.38 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-O 120.886 0.375 . . . . 72.409999999999997 110.899 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.43 ' O ' ' HB ' ' A' ' 434' ' ' THR . 74.4 t -73.35 143.07 14.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 108.167 -1.049 . . . . 71.400000000000006 108.167 176.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 48.9 mm -98.02 -27.07 3.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.313 -0.995 . . . . 74.120000000000005 108.313 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 157.94 -161.48 31.52 Favored Glycine 0 N--CA 1.428 -1.894 0 CA-C-N 115.643 -0.708 . . . . 72.409999999999997 111.572 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 40.0 p -115.21 141.29 48.22 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.593 -1.262 . . . . 62.420000000000002 107.593 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.406 ' CB ' HG23 ' A' ' 485' ' ' ILE . 6.7 t30 -64.73 -50.42 64.28 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 109.791 -0.448 . . . . 63.119999999999997 109.791 176.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -75.29 155.44 41.62 Favored 'Trans proline' 0 C--N 1.377 2.035 0 N-CA-C 108.951 -1.211 . . . . 74.329999999999998 108.951 173.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . 0.434 ' O ' HD13 ' A' ' 429' ' ' ILE . 37.3 Cg_exo -62.96 126.19 17.5 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.173 1.248 . . . . 74.450000000000003 109.819 177.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -74.4 -0.7 18.16 Favored 'General case' 0 C--O 1.194 -1.838 0 N-CA-C 112.984 0.735 . . . . 63.520000000000003 112.984 -173.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . 0.465 ' N ' HD21 ' A' ' 475' ' ' ASN . 0.7 OUTLIER -108.96 3.86 22.68 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 121.78 -0.575 . . . . 50.240000000000002 110.071 -179.374 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -98.17 175.71 5.99 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 112.269 0.47 . . . . 74.239999999999995 112.269 -177.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 1.3 m -105.87 112.29 25.29 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.464 -0.789 . . . . 65.340000000000003 109.455 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 12.7 p -101.12 145.98 28.07 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.038 0.447 . . . . 65.450000000000003 110.858 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -75.33 150.57 38.42 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.547 -0.751 . . . . 71.439999999999998 110.739 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . 0.41 HD12 ' O ' ' A' ' 425' ' ' GLU . 1.7 mp -67.85 -26.05 33.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 123.519 0.728 . . . . 75.549999999999997 111.59 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 12.5 t -89.46 2.58 54.33 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.822 0.82 . . . . 74.219999999999999 110.342 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -102.82 144.14 31.54 Favored 'General case' 0 C--N 1.318 -0.802 0 O-C-N 121.936 -0.478 . . . . 75.420000000000002 110.78 -175.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 6.4 p -108.15 127.21 64.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 C-N-CA 123.067 0.547 . . . . 73.140000000000001 111.566 -177.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 35.7 m -104.73 141.86 19.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.771 -0.65 . . . . 74.219999999999999 111.391 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.406 HG23 ' CB ' ' A' ' 471' ' ' ASN . 0.0 OUTLIER -108.93 130.13 62.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.401 0.62 . . . . 71.120000000000005 111.795 -178.513 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 13.1 mt -113.81 129.72 69.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 C-N-CA 125.084 1.354 . . . . 70.510000000000005 111.206 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 9.9 tt -105.33 126.96 60.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.586 -0.734 . . . . 73.439999999999998 111.388 -174.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 35.7 m -109.68 151.65 11.9 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 C-N-CA 123.519 0.728 . . . . 75.200000000000003 110.326 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -92.28 132.51 11.3 Favored Glycine 0 C--N 1.311 -0.809 0 N-CA-C 111.053 -0.819 . . . . 74.310000000000002 111.053 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.636 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 23.3 t -134.51 160.41 38.11 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 109.642 -0.503 . . . . 72.109999999999999 109.642 -177.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 108.5 80.51 1.24 Allowed Glycine 0 N--CA 1.443 -0.837 0 CA-C-O 119.704 -0.498 . . . . 74.430000000000007 112.725 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -68.42 146.27 67.94 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.346 2.031 . . . . 73.420000000000002 110.798 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . -112.19 25.9 11.1 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.582 0.706 . . . . 63.109999999999999 111.101 -176.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 6.6 p -116.94 143.47 45.67 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 114.93 -1.032 . . . . 72.310000000000002 110.659 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -151.2 147.09 26.59 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 108.419 -0.956 . . . . 75.310000000000002 108.419 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.487 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 7.6 p-10 -85.71 132.5 34.13 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.699 0.761 . . . . 75.230000000000004 112.543 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 33.7 pt -77.18 137.45 64.91 Favored Pre-proline 0 C--N 1.308 -1.22 0 CA-C-N 114.461 -1.245 . . . . 75.230000000000004 111.247 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -85.7 175.02 6.3 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.417 2.078 . . . . 72.329999999999998 112.528 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -97.21 132.46 42.94 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.59 -0.732 . . . . 75.409999999999997 109.654 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.2 104.11 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.626 0 CA-C-O 122.017 0.913 . . . . 73.200000000000003 110.598 -177.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -146.55 139.91 25.74 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.958 -1.019 . . . . 74.430000000000007 108.725 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 113.9 -18.48 19.24 Favored Glycine 0 CA--C 1.485 -1.837 0 N-CA-C 110.412 -1.075 . . . . 74.540000000000006 110.412 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . 0.408 ' O ' HG11 ' A' ' 534' ' ' VAL . 50.6 mt-30 -95.87 -179.52 4.73 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 109.22 -0.659 . . . . 74.549999999999997 109.22 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 15.0 t -91.87 157.16 17.01 Favored 'General case' 0 N--CA 1.421 -1.896 0 C-N-CA 118.184 -1.406 . . . . 71.530000000000001 107.885 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 6.0 p -53.77 -42.5 52.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 O-C-N 123.742 0.651 . . . . 64.400000000000006 112.344 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -65.48 -41.52 93.19 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.265 0.353 . . . . 72.030000000000001 110.976 -176.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 81.8 t -70.59 -44.49 76.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.878 0.371 . . . . 71.25 110.798 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . 0.403 ' O ' ' HG ' ' A' ' 512' ' ' LEU . . . -61.44 -48.49 80.94 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.01 -0.541 . . . . 73.310000000000002 111.147 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -60.4 -43.11 96.98 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.249 -0.887 . . . . 75.319999999999993 109.939 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.473 ' O ' HG22 ' A' ' 514' ' ' VAL . 35.4 ttmt -63.21 -42.37 99.29 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.967 -1.015 . . . . 74.319999999999993 110.127 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -62.33 -41.7 98.77 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.057 0.456 . . . . 74.319999999999993 110.136 178.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 508' ' ' ALA . 89.4 mt -65.73 -37.1 85.47 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.717 -0.674 . . . . 74.239999999999995 110.923 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -64.23 -37.76 88.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.253 -0.431 . . . . 75.430000000000007 110.051 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 510' ' ' LYS . 93.3 t -62.55 -31.17 51.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 115.889 -0.596 . . . . 73.400000000000006 110.673 177.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -77.24 -6.75 54.25 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 120.818 0.342 . . . . 74.140000000000001 111.062 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 106.96 -0.06 35.9 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.401 -0.904 . . . . 53.340000000000003 113.239 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -90.86 99.37 12.42 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 107.56 -1.274 . . . . 75.299999999999997 107.56 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.1 m -91.0 -11.35 39.16 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.972 -1.013 . . . . 75.150000000000006 112.076 -172.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . 0.518 ' HD2' ' O ' ' A' ' 548' ' ' ASP . 95.7 mttt -108.62 118.18 36.12 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.239 -0.652 . . . . 74.430000000000007 109.239 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -129.63 155.0 46.55 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.147 0.498 . . . . 72.040000000000006 111.01 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 4.8 p -141.11 148.17 39.69 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 107.457 -1.312 . . . . 65.120000000000005 107.457 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . 0.454 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 4.0 pt20 -132.64 132.61 42.63 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-O 121.235 0.54 . . . . 71.439999999999998 111.062 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -113.56 141.51 47.08 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.457 -1.682 . . . . 61.43 106.457 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 45.3 p -121.22 129.16 53.06 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 120.397 -0.521 . . . . 72.349999999999994 111.459 -177.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . 0.565 ' O ' ' HB3' ' A' ' 557' ' ' LYS . 19.5 m -121.82 166.67 16.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 109.267 -0.642 . . . . 65.519999999999996 109.267 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -92.38 137.85 32.01 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.997 -1.483 . . . . 75.099999999999994 106.997 174.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 10.3 m -141.65 173.22 4.99 Favored Pre-proline 0 C--N 1.276 -2.625 0 N-CA-C 108.477 -0.934 . . . . 65.040000000000006 108.477 -172.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -79.22 -17.52 11.67 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 121.651 1.567 . . . . 64.319999999999993 109.19 168.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . 0.504 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 18.0 mmm180 -67.38 152.19 96.41 Favored Pre-proline 0 N--CA 1.441 -0.905 0 C-N-CA 125.752 1.621 . . . . 65.310000000000002 108.581 177.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.44 156.32 61.82 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.335 2.023 . . . . 62.539999999999999 112.791 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' A' ' 557' ' ' LYS . . . -70.93 124.92 25.48 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.937 -0.574 . . . . 73.219999999999999 111.038 -178.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 107.82 -10.95 38.14 Favored Glycine 0 C--N 1.305 -1.182 0 C-N-CA 120.589 -0.815 . . . . 55.310000000000002 111.395 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -82.46 138.64 34.31 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.469 -1.678 . . . . 70.319999999999993 106.469 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . 0.408 HG11 ' O ' ' A' ' 503' ' ' GLN . 11.6 p -95.22 118.29 41.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 119.896 -0.722 . . . . 75.519999999999996 110.163 -178.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 535' ' ' THR . . . . . 0.561 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 13.2 t -84.05 0.09 49.64 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.364 -0.38 . . . . 73.150000000000006 111.614 -175.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 135.49 -160.94 24.63 Favored Glycine 0 CA--C 1.495 -1.204 0 C-N-CA 120.887 -0.673 . . . . 75.209999999999994 111.921 175.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 37.2 p -117.77 155.3 30.26 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.794 -0.817 . . . . 73.120000000000005 108.794 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -76.16 -50.34 2.98 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-O 119.437 -0.316 . . . . 71.010000000000005 110.507 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -66.95 135.95 39.6 Favored 'Trans proline' 0 C--N 1.369 1.609 0 N-CA-C 108.991 -1.196 . . . . 73.329999999999998 108.991 169.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.56 150.56 86.49 Favored 'Trans proline' 0 C--O 1.244 0.784 0 C-N-CA 122.378 2.052 . . . . 72.409999999999997 112.799 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.22 138.02 57.39 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.924 -0.769 . . . . 74.120000000000005 108.924 176.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.47 -11.34 58.13 Favored Glycine 0 C--N 1.294 -1.789 0 C-N-CA 120.606 -0.807 . . . . 65.409999999999997 111.767 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 59.5 m -69.87 120.86 16.24 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.595 -0.521 . . . . 73.010000000000005 109.595 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 11.5 t -85.89 123.16 30.92 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 109.079 -0.711 . . . . 73.030000000000001 109.079 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 29.1 m -135.88 159.96 69.22 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 108.349 -0.982 . . . . 74.409999999999997 108.349 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . 0.508 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 32.3 Cg_exo -61.54 141.1 90.48 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 121.711 1.608 . . . . 75.230000000000004 110.8 174.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 35.2 m -61.05 -19.65 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-O 121.811 0.815 . . . . 74.519999999999996 111.978 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . 0.518 ' O ' ' HD2' ' A' ' 519' ' ' LYS . 25.1 t70 -90.12 -1.23 57.92 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.242 -0.89 . . . . 75.150000000000006 110.897 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 67.2 m -86.29 172.95 10.07 Favored 'General case' 0 C--N 1.313 -1.018 0 O-C-N 121.697 -0.627 . . . . 73.409999999999997 112.547 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 14.3 p -100.14 136.49 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 115.255 -0.884 . . . . 73.439999999999998 110.886 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.97 145.67 15.51 Favored 'Isoleucine or valine' 0 C--O 1.252 1.228 0 N-CA-C 109.245 -0.65 . . . . 75.230000000000004 109.245 174.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -109.13 115.15 29.5 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 121.303 0.573 . . . . 74.230000000000004 111.035 -176.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 5.1 mp -95.5 135.2 37.45 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.612 -1.177 . . . . 74.420000000000002 109.425 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -110.43 118.12 35.41 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.68 0.752 . . . . 73.409999999999997 110.318 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.88 141.1 16.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 114.731 -1.122 . . . . 72.540000000000006 110.288 -174.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.561 ' OG ' ' HB ' ' A' ' 535' ' ' THR . 7.8 m -86.29 147.95 25.84 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 115.35 -0.841 . . . . 64.310000000000002 110.653 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.565 ' HB3' ' O ' ' A' ' 525' ' ' VAL . 0.5 OUTLIER -123.58 130.12 52.19 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.111 -0.95 . . . . 73.540000000000006 109.691 173.69 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -66.25 -43.46 92.9 Favored Glycine 0 CA--C 1.486 -1.769 0 N-CA-C 111.36 -0.696 . . . . 65.129999999999995 111.36 -176.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 64.3 t30 72.53 -8.74 1.16 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.968 1.307 . . . . 74.230000000000004 110.56 176.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.477 ' H ' ' C ' ' A' ' 558' ' ' GLY . 97.0 mt-30 -127.21 155.34 43.58 Favored 'General case' 0 N--CA 1.423 -1.81 0 C-N-CA 125.567 1.547 . . . . 70.329999999999998 107.375 177.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -126.48 147.65 49.79 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.844 -0.798 . . . . 74.120000000000005 108.844 177.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 62.8 t -63.43 116.98 3.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 O-C-N 123.408 0.442 . . . . 74.329999999999998 110.079 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 58.3 ttp -75.49 124.77 89.12 Favored Pre-proline 0 C--N 1.306 -1.314 0 CA-C-N 115.979 -0.555 . . . . 73.25 110.788 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -65.89 169.41 13.32 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.095 2.53 . . . . 74.439999999999998 110.32 174.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -89.19 114.17 25.46 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 118.72 -1.192 . . . . 53.200000000000003 111.688 -177.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -125.81 0.18 7.37 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.567 -1.271 . . . . 74.409999999999997 107.567 173.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 23.9 m -65.07 151.2 46.63 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 113.777 -1.556 . . . . 74.040000000000006 112.238 -174.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 90.79 35.97 7.01 Favored Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 110.213 -1.155 . . . . 50.420000000000002 110.213 -175.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 15.9 ptm -117.53 157.5 26.21 Favored 'General case' 0 C--O 1.25 1.089 0 N-CA-C 109.529 -0.545 . . . . 73.25 109.529 -174.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . 0.53 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 86.3 m-85 -84.53 171.52 12.43 Favored 'General case' 0 CA--C 1.502 -0.9 0 O-C-N 123.322 0.389 . . . . 70.400000000000006 110.821 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 29.4 t90 -62.6 -34.0 76.12 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.941 -0.762 . . . . 72.450000000000003 108.941 172.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 29.1 m -72.33 -7.96 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.318 -0.855 . . . . 75.450000000000003 110.97 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . 0.565 ' O ' ' HD3' ' A' ' 577' ' ' ARG . 31.6 m-20 -100.92 -44.83 5.63 Favored 'General case' 0 CA--C 1.492 -1.276 0 N-CA-C 109.407 -0.59 . . . . 74.040000000000006 109.407 174.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . 0.629 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -61.04 -53.2 60.07 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.081 -0.963 . . . . 75.140000000000001 112.539 -175.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.95 -50.69 86.67 Favored Pre-proline 0 CA--C 1.574 1.892 0 O-C-N 123.547 0.529 . . . . 70.409999999999997 112.005 -174.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -58.25 -38.42 91.04 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 121.847 1.698 . . . . 72.239999999999995 112.268 174.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . 0.565 ' HD3' ' O ' ' A' ' 573' ' ' ASP . 5.7 mpt_? -67.67 -34.26 76.57 Favored 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 121.111 -0.236 . . . . 74.530000000000001 111.555 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 76.2 mt -60.7 -43.11 98.17 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.976 -0.75 . . . . 74.409999999999997 108.976 177.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -64.28 -45.9 85.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.147 -0.933 . . . . 74.400000000000006 109.302 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.11 92.27 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.854 -1.066 . . . . 64.510000000000005 113.44 -176.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 11.1 mp -82.22 -9.09 59.62 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 113.127 0.788 . . . . 73.319999999999993 113.127 -177.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 68.78 32.36 74.01 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 109.255 -1.538 . . . . 75.019999999999996 109.255 -174.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 44.8 t90 -60.61 134.07 56.72 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.021 0.928 . . . . 74.129999999999995 110.284 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 8.9 t -126.61 19.33 7.34 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.858 -0.61 . . . . 73.549999999999997 109.917 -176.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -79.97 -155.22 10.27 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 115.808 -0.633 . . . . 63.240000000000002 113.511 -176.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 86.1 mtp -124.94 132.62 53.26 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.551 -0.907 . . . . 73.540000000000006 108.551 -178.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 61.9 tp -106.8 130.69 54.46 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.328 -0.619 . . . . 74.439999999999998 109.328 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -114.2 121.92 45.2 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 120.898 0.38 . . . . 73.340000000000003 110.206 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -105.5 118.38 36.42 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 116.153 -0.476 . . . . 74.209999999999994 110.216 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -88.19 -163.09 38.85 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.691 -0.964 . . . . 72.200000000000003 110.691 177.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -67.19 147.8 52.6 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 120.742 0.306 . . . . 72.329999999999998 110.699 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . 0.412 ' HB3' ' NE2' ' A' ' 626' ' ' GLN . 21.6 m-20 -93.72 124.51 37.76 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.138 0.494 . . . . 73.340000000000003 111.448 -178.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 91.2 t -114.73 126.39 72.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 106.664 -1.606 . . . . 73.049999999999997 106.664 175.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . 0.451 ' HA ' ' HB2' ' A' ' 626' ' ' GLN . 6.2 p-10 -102.44 125.35 49.13 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 120.445 -0.502 . . . . 65.019999999999996 109.877 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -133.04 -28.68 1.51 Allowed 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.464 -0.789 . . . . 74.319999999999993 110.428 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 130.37 125.29 2.69 Favored Glycine 0 CA--C 1.486 -1.752 0 N-CA-C 109.979 -1.248 . . . . 73.239999999999995 109.979 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.29 -36.07 67.81 Favored Glycine 0 C--O 1.21 -1.363 0 N-CA-C 114.641 0.617 . . . . 74.230000000000004 114.641 -172.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 18.6 m -62.67 -32.06 73.06 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 117.58 0.69 . . . . 75.540000000000006 112.194 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -109.37 -1.92 18.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.62 -0.264 . . . . 62.509999999999998 111.525 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . 0.519 ' CE1' ' HA3' ' A' ' 625' ' ' GLY . 5.9 t-160 -150.49 -148.92 0.28 Allowed 'General case' 0 C--O 1.204 -1.328 0 N-CA-C 108.78 -0.822 . . . . 65.430000000000007 108.78 -170.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . 0.473 ' H ' ' CG ' ' A' ' 600' ' ' HIS . 3.1 t-20 62.22 2.87 0.9 Allowed 'General case' 0 N--CA 1.516 2.828 0 C-N-CA 125.1 1.36 . . . . 75.299999999999997 112.282 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 9.2 ptp85 -110.64 171.58 7.38 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.036 -0.984 . . . . 73.430000000000007 109.355 -177.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 7.6 p -57.03 130.78 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 O-C-N 124.469 1.105 . . . . 64.530000000000001 109.039 176.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 29.2 m -101.22 -37.17 5.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 121.504 0.669 . . . . 75.019999999999996 109.561 -175.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . 0.454 ' CE2' ' HD3' ' A' ' 623' ' ' ARG . 35.4 p90 -151.28 152.86 33.8 Favored 'General case' 0 N--CA 1.409 -2.524 0 N-CA-C 105.768 -1.938 . . . . 74.109999999999999 105.768 172.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -128.49 144.45 51.15 Favored 'General case' 0 C--N 1.27 -2.865 0 N-CA-C 107.972 -1.121 . . . . 75.439999999999998 107.972 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.478 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 42.8 t30 -72.44 -51.92 7.11 Favored Pre-proline 0 C--N 1.286 -2.162 0 CA-C-N 115.652 -0.704 . . . . 74.420000000000002 111.054 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 10.3 Cg_endo -97.78 111.48 0.1 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.582 0 C-N-CA 121.594 1.529 . . . . 74.409999999999997 110.309 170.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -68.25 159.07 54.81 Favored 'Trans proline' 0 C--O 1.248 0.978 0 C-N-CA 121.974 1.783 . . . . 64.400000000000006 110.465 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -60.11 132.91 55.4 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.789 -0.448 . . . . 73.129999999999995 109.789 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.25 -11.06 47.67 Favored Glycine 0 C--N 1.308 -0.997 0 C-N-CA 120.532 -0.842 . . . . 62.43 111.585 -176.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 22.7 m -89.95 156.34 18.5 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.775 -0.824 . . . . 72.439999999999998 108.775 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -80.84 125.17 6.75 Favored Glycine 0 N--CA 1.419 -2.454 0 N-CA-C 111.704 -0.558 . . . . 61.119999999999997 111.704 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 29.1 m -107.64 141.48 22.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 108.177 -1.045 . . . . 73.209999999999994 108.177 175.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . 0.596 ' ND2' ' HB3' ' A' ' 617' ' ' ASP . 31.4 p-10 -63.22 164.52 8.62 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 122.903 0.481 . . . . 74.349999999999994 111.873 -177.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -61.84 -25.6 67.62 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.213 0.53 . . . . 73.540000000000006 111.242 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . 0.596 ' HB3' ' ND2' ' A' ' 615' ' ' ASN . 16.0 t70 -68.11 -37.44 81.16 Favored 'General case' 0 C--O 1.245 0.856 0 CA-C-N 115.535 -0.757 . . . . 63.439999999999998 109.321 176.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 89.65 19.71 47.23 Favored Glycine 0 N--CA 1.429 -1.79 0 CA-C-N 115.283 -0.872 . . . . 74.420000000000002 113.147 174.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.09 118.13 14.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 122.457 1.122 . . . . 72.010000000000005 109.192 -174.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.09 129.4 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 N-CA-C 107.691 -1.226 . . . . 71.430000000000007 107.691 -175.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.439 ' HB ' ' CB ' ' A' ' 607' ' ' ASN . 32.8 m -99.71 118.31 35.94 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 109.473 -0.566 . . . . 73.530000000000001 109.473 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -133.86 150.47 51.37 Favored 'General case' 0 CA--C 1.477 -1.852 0 N-CA-C 105.089 -2.189 . . . . 73.5 105.089 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . 0.454 ' HD3' ' CE2' ' A' ' 605' ' ' TYR . 79.7 ttt180 -132.94 139.41 47.31 Favored 'General case' 0 C--N 1.262 -3.208 0 N-CA-C 107.17 -1.418 . . . . 75.120000000000005 107.17 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -140.16 163.8 31.76 Favored 'General case' 0 C--N 1.289 -2.052 0 O-C-N 124.048 0.842 . . . . 71.310000000000002 109.439 -175.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . 0.519 ' HA3' ' CE1' ' A' ' 600' ' ' HIS . . . -123.64 -141.67 5.88 Favored Glycine 0 N--CA 1.416 -2.685 0 N-CA-C 109.992 -1.243 . . . . 44.149999999999999 109.992 174.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 601' ' ' ASN . 38.6 mt-30 . . . . . 0 C--N 1.297 -1.681 0 N-CA-C 108.314 -0.995 . . . . 74.040000000000006 108.314 177.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.92 0 N-CA-C 110.668 -0.973 . . . . 45.219999999999999 110.668 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 8.6 tp -78.63 125.56 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.921 0 CA-C-O 121.364 0.602 . . . . 74.230000000000004 110.651 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.45 140.59 29.38 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.218 -0.66 . . . . 74.349999999999994 109.218 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -87.83 -12.5 44.78 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 122.219 1.009 . . . . 63.119999999999997 108.358 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -92.81 149.52 21.23 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.142 -1.39 . . . . 70.420000000000002 107.289 178.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.8 m -116.93 161.15 15.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 108.905 -0.776 . . . . 71.409999999999997 108.905 -177.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -95.04 136.84 34.87 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.008 -1.077 . . . . 70.239999999999995 108.142 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 95.6 t -97.58 127.81 36.55 Favored Pre-proline 0 C--N 1.285 -2.227 0 CA-C-N 115.798 -0.637 . . . . 74.340000000000003 110.281 -173.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.17 137.66 57.7 Favored 'Trans proline' 0 C--O 1.242 0.695 0 C-N-CA 122.66 2.24 . . . . 70.209999999999994 111.015 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -79.1 130.36 35.42 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 122.055 0.931 . . . . 70.299999999999997 109.706 -178.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 7.9 p -107.94 5.25 9.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-O 122.656 1.217 . . . . 73.420000000000002 110.622 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.13 145.01 52.51 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.952 -1.022 . . . . 73.209999999999994 110.66 173.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 91.68 0.51 72.3 Favored Glycine 0 N--CA 1.434 -1.439 0 CA-C-N 116.216 -0.447 . . . . 70.530000000000001 112.303 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -107.82 -82.06 0.56 Allowed 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.263 0.468 . . . . 73.239999999999995 112.263 -176.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 11.8 t -154.29 150.88 28.47 Favored 'General case' 0 CA--C 1.503 -0.861 0 O-C-N 121.644 -0.66 . . . . 62.109999999999999 110.501 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.621 ' HB3' ' O ' ' A' ' 397' ' ' ASP . 1.4 p -63.68 -47.22 82.08 Favored 'General case' 0 N--CA 1.435 -1.181 0 O-C-N 123.799 0.687 . . . . 74.010000000000005 109.896 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -68.8 -45.59 70.86 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 115.158 -0.928 . . . . 72.239999999999995 110.691 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -68.88 -34.66 75.79 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 119.458 -0.897 . . . . 75.329999999999998 111.783 -176.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . 0.4 ' O ' HD13 ' A' ' 377' ' ' LEU . . . -67.93 -51.11 51.46 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.662 0.267 . . . . 61.539999999999999 110.834 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.37 -37.36 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 116.239 -0.437 . . . . 74.340000000000003 110.697 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.58 -47.08 85.5 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 120.893 0.378 . . . . 71.010000000000005 111.062 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 42.2 m -62.53 -47.77 82.43 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-O 121.576 0.703 . . . . 73.409999999999997 110.081 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . 0.4 HD13 ' O ' ' A' ' 373' ' ' ALA . 9.6 mp -64.33 -39.1 93.22 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.495 -0.775 . . . . 75.010000000000005 112.096 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -61.79 -44.45 96.85 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.131 0.572 . . . . 73.329999999999998 110.373 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -68.35 -19.38 64.64 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.29 0.567 . . . . 74.239999999999995 112.07 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . 0.495 ' HA ' ' NE ' ' A' ' 380' ' ' ARG . 3.9 mmp_? -96.45 -13.95 22.74 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 112.515 0.561 . . . . 74.310000000000002 112.515 177.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.13 14.51 54.32 Favored Glycine 0 C--O 1.25 1.12 0 C-N-CA 120.87 -0.681 . . . . 71.150000000000006 112.367 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -76.62 140.05 40.84 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-O 121.141 0.496 . . . . 74.310000000000002 110.121 177.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -85.08 134.77 34.19 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 107.628 -1.249 . . . . 74.230000000000004 107.628 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.13 157.15 40.46 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 CA-C-O 120.999 0.428 . . . . 71.450000000000003 110.338 -175.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -134.99 137.36 42.95 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 106.636 -1.616 . . . . 71.310000000000002 106.636 172.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 13.1 m -135.09 116.76 14.94 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.802 -0.814 . . . . 62.130000000000003 108.802 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -113.78 123.43 49.83 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.491 -0.929 . . . . 72.299999999999997 108.491 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -89.79 125.22 35.22 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.54 -0.541 . . . . 75.430000000000007 109.54 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . 0.565 ' HB2' ' HZ2' ' A' ' 389' ' ' LYS . 7.2 mtmp? -114.84 133.31 22.62 Favored Pre-proline 0 C--N 1.307 -1.26 0 N-CA-C 108.159 -1.052 . . . . 73.329999999999998 108.159 176.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . 0.422 ' O ' ' HB3' ' A' ' 391' ' ' ASP . 3.3 Cg_exo -85.76 128.47 3.35 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.769 1.646 . . . . 64.219999999999999 109.517 172.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' A' ' 390' ' ' PRO . 2.0 p30 158.43 159.25 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.055 -1.461 . . . . 74.150000000000006 107.055 -175.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 20.3 p -126.68 23.9 6.67 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.456 0.646 . . . . 71.019999999999996 110.165 177.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 39.5 m -90.85 -37.72 13.41 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 108.624 -0.88 . . . . 70.439999999999998 108.624 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 37.6 mm -89.71 141.89 28.81 Favored Pre-proline 0 N--CA 1.432 -1.332 0 N-CA-C 106.666 -1.605 . . . . 73.510000000000005 106.666 178.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -51.39 161.04 2.0 Favored 'Trans proline' 0 CA--C 1.56 1.782 0 C-N-CA 123.267 2.645 . . . . 72.430000000000007 113.606 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -54.65 162.89 4.31 Favored 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 124.675 3.584 . . . . 72.049999999999997 114.155 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . 0.621 ' O ' ' HB3' ' A' ' 370' ' ' SER . 5.9 p-10 -56.38 -9.88 0.8 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.381 1.473 . . . . 62.020000000000003 113.973 -172.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -67.62 145.89 54.4 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.185 -1.413 . . . . 73.209999999999994 107.185 176.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.42 HG11 ' HA ' ' A' ' 370' ' ' SER . 10.3 m -63.29 118.43 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 C-N-CA 119.298 -0.961 . . . . 75.109999999999999 112.324 -171.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.29 -34.75 7.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.226 -1.027 . . . . 64.140000000000001 108.226 178.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -156.59 157.62 28.09 Favored Glycine 0 N--CA 1.423 -2.174 0 N-CA-C 110.731 -0.948 . . . . 74.219999999999999 110.731 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 11.5 p -126.77 -178.21 4.3 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.811 -1.181 . . . . 75.150000000000006 107.811 175.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -100.5 139.44 20.63 Favored Pre-proline 0 C--N 1.296 -1.731 0 C-N-CA 119.596 -0.842 . . . . 72.409999999999997 109.364 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -52.8 -3.09 0.11 Allowed 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 124.599 3.533 . . . . 53.32 115.765 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.7 -37.19 65.52 Favored 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 122.947 0.499 . . . . 44.420000000000002 109.673 173.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -69.11 -41.06 77.93 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-O 121.666 0.746 . . . . 72.349999999999994 109.988 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -77.65 -1.24 30.02 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.261 -0.881 . . . . 72.040000000000006 110.563 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 75.2 m -98.68 147.07 25.22 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.345 -1.724 . . . . 74.129999999999995 106.345 172.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 34.8 m -74.23 112.05 10.0 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 107.385 -1.339 . . . . 52.420000000000002 107.385 175.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 23.1 m -133.27 169.64 21.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 121.28 0.562 . . . . 71.219999999999999 110.772 -176.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 10.1 t -84.29 154.98 22.63 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 106.557 -1.646 . . . . 75.409999999999997 106.557 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -67.91 108.13 2.91 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 121.369 0.604 . . . . 74.319999999999993 110.411 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 133.06 54.4 0.08 OUTLIER Glycine 0 N--CA 1.427 -1.952 0 CA-C-N 115.262 -0.881 . . . . 74.329999999999998 112.005 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -104.28 -173.2 2.25 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.035 -1.468 . . . . 71.030000000000001 107.035 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -115.42 125.63 53.38 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 118.97 0.805 . . . . 73.329999999999998 111.085 -176.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.6 mm -122.56 117.99 53.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 121.158 0.504 . . . . 72.209999999999994 110.03 177.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 23.8 p -95.26 127.83 41.62 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 123.108 0.563 . . . . 75.109999999999999 110.392 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 18.5 t -120.77 134.91 62.68 Favored 'Isoleucine or valine' 0 C--O 1.25 1.131 0 C-N-CA 123.786 0.834 . . . . 73.140000000000001 111.843 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -108.78 128.59 55.02 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-O 121.47 0.652 . . . . 74.25 111.008 174.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.428 HG12 ' CB ' ' A' ' 397' ' ' ASP . 2.9 t -106.52 144.2 16.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 C-N-CA 125.075 1.35 . . . . 64.340000000000003 110.843 -175.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 10.4 m -118.66 123.36 44.76 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 109.556 -0.535 . . . . 71.519999999999996 109.556 176.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 20.6 p -107.78 107.93 18.91 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 105.879 -1.897 . . . . 74.540000000000006 105.879 173.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -44.21 -88.12 0.01 OUTLIER Glycine 0 C--O 1.252 1.27 0 N-CA-C 116.858 1.503 . . . . 73.519999999999996 116.858 -170.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.5 128.84 16.85 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.65 2.233 . . . . 74.019999999999996 114.551 -172.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -102.4 136.42 42.26 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.44 -1.689 . . . . 64.530000000000001 106.44 174.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -133.5 137.52 45.67 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 120.673 -0.411 . . . . 74.540000000000006 110.758 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -127.89 159.61 34.38 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 121.097 0.475 . . . . 75.150000000000006 111.322 -178.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -103.59 139.0 39.48 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.067 -0.969 . . . . 72.510000000000005 109.027 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.707 ' HB ' ' O ' ' A' ' 474' ' ' ALA . 2.7 mp -90.11 124.04 64.33 Favored Pre-proline 0 C--N 1.319 -0.753 0 C-N-CA 119.578 -0.849 . . . . 73.510000000000005 109.123 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -66.69 148.37 82.89 Favored 'Trans proline' 0 C--O 1.24 0.604 0 C-N-CA 122.32 2.013 . . . . 75.310000000000002 111.393 177.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -76.37 103.89 6.61 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-O 121.491 0.663 . . . . 73.209999999999994 110.926 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 60.9 t -98.24 150.01 5.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 107.222 -1.399 . . . . 72.25 107.222 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 35.6 m -73.43 154.88 39.8 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 121.07 0.462 . . . . 70.040000000000006 111.055 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' THR . . . . . 0.552 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 33.5 p -68.3 -30.14 69.07 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 123.692 0.797 . . . . 74.019999999999996 112.403 -174.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 1.6 pp -80.09 -11.46 59.76 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 113.007 0.743 . . . . 73.540000000000006 113.007 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.42 65.15 0.61 Allowed 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 113.582 0.956 . . . . 75.120000000000005 113.582 -178.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -59.01 -38.58 79.57 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.52 0.728 . . . . 74.510000000000005 111.908 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -62.48 -36.83 83.72 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.397 0.618 . . . . 74.420000000000002 110.548 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -70.12 -40.53 74.82 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.781 -0.822 . . . . 75.129999999999995 108.781 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.554 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -60.86 -51.13 70.61 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.8 -0.637 . . . . 64.409999999999997 111.269 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 32.5 m -64.26 -39.73 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 112.78 0.659 . . . . 75.409999999999997 112.78 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -68.43 -36.89 79.71 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 119.488 -0.885 . . . . 75.319999999999993 110.34 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -66.14 -38.29 87.75 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.96 -0.563 . . . . 74.430000000000007 110.936 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 93.7 mt -63.42 -36.3 83.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.157 0.504 . . . . 74.400000000000006 109.647 175.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.43 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 33.2 m -70.09 -43.81 70.33 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.579 -0.737 . . . . 70.010000000000005 110.444 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -66.96 -21.62 65.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.033 -0.53 . . . . 74.25 111.386 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.7 4.93 26.58 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.018 0.437 . . . . 53.399999999999999 111.418 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . 0.419 ' HA3' HD13 ' A' ' 480' ' ' ILE . . . 111.2 -84.94 0.38 Allowed Glycine 0 CA--C 1.484 -1.845 0 C-N-CA 120.525 -0.845 . . . . 64.109999999999999 111.793 175.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -38.53 -60.28 0.82 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.432 1.271 . . . . 74.019999999999996 114.432 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . 0.43 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 61.3 30.13 73.22 Favored Glycine 0 CA--C 1.501 -0.799 0 C-N-CA 121.22 -0.514 . . . . 74.329999999999998 112.047 -177.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.405 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 40.9 mmm-85 -104.37 110.92 23.35 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 108.477 -0.934 . . . . 74.5 108.477 -177.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -136.09 140.31 43.64 Favored 'General case' 0 N--CA 1.423 -1.778 0 CA-C-N 115.818 -0.628 . . . . 71.239999999999995 111.585 -176.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -131.67 140.04 49.23 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.936 -1.029 . . . . 65.120000000000005 108.238 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -109.33 129.28 55.53 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.128 0.49 . . . . 74.129999999999995 111.531 -176.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.88 150.67 40.7 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.112 -1.07 . . . . 72.200000000000003 108.112 176.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -121.97 140.68 52.16 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.762 -0.829 . . . . 73.299999999999997 108.762 -177.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 24.3 t -144.7 137.34 13.55 Favored Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 109.338 -0.616 . . . . 64.340000000000003 109.338 176.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 490' ' ' SER . 47.3 Cg_endo -71.03 134.56 25.55 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.939 1.759 . . . . 74.040000000000006 110.538 175.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 70.2 m -152.76 -179.42 7.61 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 122.801 0.44 . . . . 75.409999999999997 110.155 -177.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.2 t -47.64 137.28 9.75 Favored Pre-proline 0 C--O 1.254 1.316 0 C-N-CA 124.276 1.03 . . . . 71.230000000000004 110.899 173.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -52.81 -30.94 49.34 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 124.375 3.383 . . . . 73.450000000000003 113.451 -175.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -68.5 -26.79 65.64 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.712 0.634 . . . . 75.340000000000003 112.712 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -95.33 -15.78 22.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.935 0.398 . . . . 74.540000000000006 111.135 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 83.4 t -60.7 128.73 22.36 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 115.996 -0.547 . . . . 73.299999999999997 110.304 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.06 -11.23 60.42 Favored Glycine 0 N--CA 1.433 -1.531 0 CA-C-N 115.495 -0.775 . . . . 73.230000000000004 111.757 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -119.1 167.18 12.04 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.033 -0.729 . . . . 74.239999999999995 109.033 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.552 ' O ' ' HB ' ' A' ' 434' ' ' THR . 79.3 t -75.68 147.11 8.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.114 -1.439 . . . . 75.109999999999999 107.114 173.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 65.2 mt -97.88 -35.15 5.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 107.296 -1.372 . . . . 70.340000000000003 107.296 176.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 160.06 -160.38 31.57 Favored Glycine 0 N--CA 1.416 -2.682 0 N-CA-C 109.729 -1.348 . . . . 73.420000000000002 109.729 177.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 26.3 p -115.98 145.73 42.71 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 107.335 -1.357 . . . . 74.420000000000002 107.335 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -64.3 -56.15 25.61 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 119.968 -0.693 . . . . 73.200000000000003 110.401 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -80.69 149.49 18.42 Favored 'Trans proline' 0 C--N 1.37 1.699 0 N-CA-C 107.842 -1.638 . . . . 74.25 107.842 169.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -64.81 126.93 17.56 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.588 1.525 . . . . 71.329999999999998 113.039 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.707 ' O ' ' HB ' ' A' ' 429' ' ' ILE . . . -86.11 -34.67 20.56 Favored 'General case' 0 C--O 1.198 -1.631 0 CA-C-O 122.224 1.011 . . . . 75.0 108.383 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -72.21 12.37 0.44 Allowed 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.528 -1.215 . . . . 71.040000000000006 111.717 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . 0.421 ' H ' ' C ' ' A' ' 474' ' ' ALA . 80.0 mm-40 -119.81 -165.49 1.18 Allowed 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 107.978 -1.119 . . . . 75.109999999999999 107.978 175.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.44 140.1 37.93 Favored 'General case' 0 N--CA 1.402 -2.874 0 CA-C-O 121.44 0.638 . . . . 74.239999999999995 111.883 -178.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 39.5 m -136.99 139.05 41.17 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.852 -0.613 . . . . 72.209999999999994 109.473 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -67.85 165.09 18.28 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.869 -0.605 . . . . 74.420000000000002 110.776 177.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . 0.419 HD13 ' HA3' ' A' ' 448' ' ' GLY . 29.0 mm -70.57 -15.38 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 121.914 0.864 . . . . 75.329999999999998 110.616 -176.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.2 t -92.41 2.9 56.39 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.996 -0.547 . . . . 75.430000000000007 110.801 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -92.36 140.95 29.08 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.178 0.513 . . . . 73.140000000000001 111.798 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . 0.405 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.3 p -108.31 127.07 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 CA-C-N 115.23 -0.895 . . . . 73.349999999999994 109.946 177.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 29.9 m -104.09 132.74 49.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-O 121.779 0.799 . . . . 73.120000000000005 111.029 178.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.72 124.25 55.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 115.258 -0.883 . . . . 75.200000000000003 110.552 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 1.7 mp -100.84 125.52 54.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 125.542 1.537 . . . . 73.450000000000003 108.671 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 8.8 tt -107.03 126.41 63.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 109.479 -0.563 . . . . 72.340000000000003 109.479 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 33.6 m -110.29 151.21 12.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 116.18 -0.464 . . . . 64.299999999999997 110.7 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -83.58 121.58 5.53 Favored Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 109.43 -1.468 . . . . 71.299999999999997 109.43 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 23.3 t -141.07 128.99 21.82 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 108.28 -1.008 . . . . 72.420000000000002 108.28 -176.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 83.36 98.62 0.56 Allowed Glycine 0 N--CA 1.434 -1.454 0 C-N-CA 120.819 -0.705 . . . . 72.010000000000005 113.064 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -77.86 140.87 18.68 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.499 2.132 . . . . 74.120000000000005 110.923 177.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -94.77 26.58 3.47 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 122.422 1.106 . . . . 72.400000000000006 110.491 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 12.8 p -118.07 147.54 43.16 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 114.134 -1.394 . . . . 75.120000000000005 110.295 -178.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . 0.477 ' HD3' ' N ' ' A' ' 496' ' ' ASP . 6.8 tmtm? -150.6 140.2 21.6 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 105.559 -2.015 . . . . 74.129999999999995 105.559 175.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.504 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 11.4 p-10 -89.07 127.1 35.68 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.526 0.679 . . . . 72.319999999999993 111.179 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 28.3 pt -75.89 130.15 79.24 Favored Pre-proline 0 C--N 1.306 -1.321 0 CA-C-N 114.865 -1.061 . . . . 70.310000000000002 110.878 -177.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -85.61 -174.72 1.69 Allowed 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.342 2.028 . . . . 73.319999999999993 110.737 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -80.04 133.14 36.11 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.033 -1.099 . . . . 71.209999999999994 108.033 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . 0.423 HG21 ' NE2' ' A' ' 503' ' ' GLN . 13.0 p -133.09 -7.25 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-O 121.551 0.691 . . . . 70.230000000000004 111.187 -174.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.97 114.8 9.39 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.273 0.559 . . . . 74.319999999999993 110.338 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 130.84 -21.94 4.63 Favored Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 109.685 -1.366 . . . . 70.319999999999993 109.685 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . 0.423 ' NE2' HG21 ' A' ' 500' ' ' VAL . 21.3 mt-30 -87.08 168.9 12.86 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 109.285 -0.635 . . . . 74.239999999999995 109.285 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 47.5 p -85.59 162.32 18.91 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 109.817 -0.438 . . . . 62.530000000000001 109.817 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 18.8 m -54.24 -42.23 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.045 0 C-N-CA 123.667 0.787 . . . . 73.140000000000001 113.004 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -67.35 -42.27 83.78 Favored 'General case' 0 CA--C 1.507 -0.683 0 C-N-CA 120.643 -0.423 . . . . 73.310000000000002 110.856 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 97.7 t -69.74 -40.16 78.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.808 -0.633 . . . . 74.549999999999997 110.369 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.24 -49.4 74.32 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.55 -0.295 . . . . 73.109999999999999 111.026 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -63.11 -35.42 80.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.068 0.461 . . . . 63.240000000000002 110.121 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -62.47 -44.03 97.39 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.171 -0.922 . . . . 75.25 109.037 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.56 -49.0 78.4 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 109.723 -0.473 . . . . 71.120000000000005 109.723 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.89 -47.66 83.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.182 -0.463 . . . . 74.439999999999998 111.494 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -66.41 -39.19 88.83 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 112.231 0.456 . . . . 74.5 112.231 -176.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.43 -29.14 45.61 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 CA-C-O 121.164 0.507 . . . . 64.329999999999998 110.837 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 -87.11 -5.39 59.04 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.154 -0.618 . . . . 75.340000000000003 111.525 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . 0.433 ' O ' ' HB ' ' A' ' 547' ' ' VAL . . . 110.21 -4.7 30.05 Favored Glycine 0 CA--C 1.492 -1.369 0 C-N-CA 120.525 -0.845 . . . . 71.409999999999997 114.246 175.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.519 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 88.9 m-85 -77.8 119.0 20.68 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.849 -0.797 . . . . 71.319999999999993 108.849 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 17.0 p -89.9 -31.67 17.19 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 115.384 -0.826 . . . . 73.319999999999993 112.933 -174.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -108.59 119.23 38.92 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.681 0.753 . . . . 74.450000000000003 112.457 -172.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -130.32 145.82 51.83 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.071 -0.968 . . . . 73.310000000000002 109.442 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 61.2 m -141.23 142.89 33.92 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 108.319 -0.993 . . . . 65.019999999999996 108.319 175.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -117.55 135.3 54.04 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.501 -0.555 . . . . 71.140000000000001 109.501 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -124.05 119.44 29.51 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.973 -0.751 . . . . 74.430000000000007 108.973 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 524' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 55.1 m -84.77 130.85 34.62 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.512 0.672 . . . . 73.319999999999993 112.545 -177.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 28.0 m -121.86 150.63 25.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 106.648 -1.612 . . . . 74.230000000000004 106.648 173.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . 0.481 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 1.4 p-10 -92.71 137.14 32.62 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 117.839 -1.545 . . . . 64.299999999999997 110.483 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 49.0 m -150.28 -179.02 0.91 Allowed Pre-proline 0 C--N 1.293 -1.867 0 N-CA-C 106.111 -1.811 . . . . 72.430000000000007 106.111 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -87.04 -11.34 5.43 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 121.549 1.499 . . . . 71.099999999999994 111.033 171.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -69.15 127.75 92.88 Favored Pre-proline 0 N--CA 1.441 -0.919 0 N-CA-C 108.344 -0.984 . . . . 75.230000000000004 108.344 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -55.7 141.51 84.07 Favored 'Trans proline' 0 C--O 1.255 1.373 0 C-N-CA 122.982 2.454 . . . . 75.230000000000004 114.371 -171.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.555 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -59.67 125.94 25.64 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 114.313 -1.312 . . . . 72.5 110.949 -176.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 123.83 -19.26 7.44 Favored Glycine 0 N--CA 1.427 -1.962 0 C-N-CA 120.732 -0.747 . . . . 54.329999999999998 111.244 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -82.78 129.61 35.01 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.801 -0.444 . . . . 74.530000000000001 109.801 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 91.0 t -78.6 110.3 14.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 107.909 -1.145 . . . . 74.310000000000002 107.909 174.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 18.3 m -75.89 -34.62 59.97 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 123.892 0.877 . . . . 72.230000000000004 111.232 -176.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -173.65 179.91 44.73 Favored Glycine 0 CA--C 1.496 -1.143 0 N-CA-C 110.79 -0.924 . . . . 65.349999999999994 110.79 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 35.7 p -128.66 152.7 48.08 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.434 -0.58 . . . . 75.540000000000006 109.434 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -62.88 -57.47 21.39 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-O 119.174 -0.441 . . . . 72.299999999999997 110.99 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -75.5 139.39 22.97 Favored 'Trans proline' 0 C--N 1.369 1.618 0 CA-C-N 120.135 1.084 . . . . 74.040000000000006 109.858 171.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -71.35 142.79 41.87 Favored 'Trans proline' 0 C--O 1.251 1.141 0 C-N-CA 122.531 2.154 . . . . 75.420000000000002 112.963 -178.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -65.11 135.32 55.38 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.514 -0.766 . . . . 63.210000000000001 110.92 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.61 -18.91 34.46 Favored Glycine 0 N--CA 1.433 -1.5 0 CA-C-N 115.709 -0.678 . . . . 72.239999999999995 111.421 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 25.9 m -77.77 132.26 38.0 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.767 0.318 . . . . 75.439999999999998 111.094 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 36.0 m -81.92 122.56 27.91 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 107.645 -1.242 . . . . 75.329999999999998 107.645 176.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.5 m -134.81 159.5 71.92 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 109.601 -0.518 . . . . 75.040000000000006 109.601 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -67.29 137.55 43.92 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.334 2.023 . . . . 75.219999999999999 111.545 176.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.519 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 34.1 m -63.04 -19.97 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-O 121.863 0.84 . . . . 74.209999999999994 112.044 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -80.83 -12.24 59.47 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.072 -0.967 . . . . 65.219999999999999 111.856 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 8.5 t -81.78 171.94 13.94 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 120.33 -0.548 . . . . 75.230000000000004 111.653 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 44.4 t -99.0 122.38 50.65 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 CA-C-N 115.636 -0.711 . . . . 74.150000000000006 110.107 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 2.5 mp -102.6 124.06 56.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.175 -1.046 . . . . 64.329999999999998 108.175 175.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -102.02 123.47 45.97 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-O 121.167 0.508 . . . . 74.349999999999994 109.897 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 53.3 mt -98.26 120.99 39.62 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 114.534 -1.212 . . . . 72.439999999999998 108.872 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -83.23 119.73 24.93 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 106.69 -1.596 . . . . 72.230000000000004 106.69 173.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 524' ' ' SER . 45.0 t -113.06 129.32 68.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 N-CA-C 109.252 -0.647 . . . . 73.409999999999997 109.252 -177.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.555 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 23.8 p -82.55 146.87 28.95 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-O 120.884 0.373 . . . . 65.319999999999993 111.457 178.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.481 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 14.5 ptpt -97.18 152.52 18.74 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 103.732 -2.692 . . . . 75.120000000000005 103.732 167.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -80.18 -32.82 34.24 Favored Glycine 0 CA--C 1.491 -1.437 0 C-N-CA 119.408 -1.377 . . . . 73.450000000000003 111.186 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 64.2 t30 61.9 17.02 8.54 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.614 1.166 . . . . 71.109999999999999 110.575 176.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -144.76 158.96 43.58 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 107.969 -1.123 . . . . 74.519999999999996 107.969 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -143.53 148.59 36.21 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.838 -1.171 . . . . 73.540000000000006 107.838 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 61.1 t -76.13 116.06 18.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.741 -0.837 . . . . 70.120000000000005 108.741 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 54.0 ttp -89.96 138.21 27.79 Favored Pre-proline 0 C--N 1.298 -1.651 0 CA-C-N 115.761 -0.654 . . . . 73.109999999999999 111.156 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -63.51 170.47 8.19 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.321 2.681 . . . . 74.400000000000006 111.414 172.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . 0.405 ' HA ' ' HB1' ' A' ' 610' ' ' ALA . 25.1 t70 -84.33 115.14 22.34 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.04 0.448 . . . . 74.319999999999993 111.503 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 5.5 mp -125.89 -4.8 6.93 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.785 -0.643 . . . . 75.450000000000003 109.93 175.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 16.4 t -79.45 146.89 32.5 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 109.582 -0.525 . . . . 75.420000000000002 109.582 -176.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 91.14 3.53 69.82 Favored Glycine 0 C--N 1.312 -0.788 0 C-N-CA 120.83 -0.7 . . . . 72.209999999999994 112.231 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 85.8 mtp -100.72 177.64 4.93 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 107.332 -1.359 . . . . 75.209999999999994 107.332 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . 0.536 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 63.2 m-85 -80.47 160.16 25.35 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 119.675 -0.81 . . . . 74.310000000000002 110.124 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 78.0 t90 -62.89 -28.76 70.27 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.821 -0.807 . . . . 72.219999999999999 108.821 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 21.8 m -76.42 -10.01 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.1 -0.954 . . . . 74.409999999999997 111.049 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . 0.413 ' O ' ' HD2' ' A' ' 576' ' ' PRO . 20.6 m-20 -96.04 -44.45 7.33 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 107.567 -1.272 . . . . 74.200000000000003 107.567 173.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -56.51 -48.69 76.67 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 114.613 -1.176 . . . . 64.230000000000004 111.783 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -50.88 -59.61 7.16 Favored Pre-proline 0 CA--C 1.555 1.162 0 N-CA-C 114.045 1.128 . . . . 75.349999999999994 114.045 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . 0.413 ' HD2' ' O ' ' A' ' 573' ' ' ASP . 39.9 Cg_exo -61.99 -41.5 36.19 Favored 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 121.5 1.467 . . . . 71.209999999999994 113.115 176.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 11.9 mmt180 -61.29 -41.01 96.25 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 120.575 0.226 . . . . 73.200000000000003 111.016 -177.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 8.8 mp -65.79 -47.17 76.03 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 120.95 0.405 . . . . 75.230000000000004 110.987 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -65.14 -34.98 79.68 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.279 -0.419 . . . . 74.549999999999997 111.151 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -67.74 -38.27 83.29 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.344 -0.389 . . . . 74.510000000000005 111.75 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 4.2 pp -83.4 2.23 37.51 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.564 0.697 . . . . 72.439999999999998 111.639 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 83.92 29.46 31.6 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.391 -0.822 . . . . 52.43 113.718 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -81.09 127.49 32.69 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 117.14 0.47 . . . . 73.239999999999995 110.399 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 57.0 m -142.87 90.89 2.24 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.393 -1.336 . . . . 73.209999999999994 107.393 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -142.21 -133.73 2.87 Favored Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 110.86 -0.896 . . . . 72.409999999999997 110.86 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 51.5 ttm -126.6 128.56 46.99 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.445 -0.576 . . . . 75.200000000000003 109.445 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 7.3 tt -100.92 114.99 29.36 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.374 -1.343 . . . . 72.010000000000005 107.374 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -119.33 112.39 19.37 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.711 0.767 . . . . 54.240000000000002 111.954 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . 0.501 ' HE3' ' H ' ' A' ' 624' ' ' PHE . 1.5 tmtp? -87.92 112.84 22.98 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.241 -1.762 . . . . 75.540000000000006 106.241 176.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -80.72 -111.67 0.3 Allowed Glycine 0 C--O 1.25 1.095 0 C-N-CA 121.308 -0.473 . . . . 72.049999999999997 113.682 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -65.74 144.76 56.68 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 110.032 -0.358 . . . . 74.519999999999996 110.032 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . 0.491 ' OD1' ' HB2' ' A' ' 626' ' ' GLN . 4.5 t0 -116.25 152.14 34.4 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 120.088 -0.645 . . . . 73.409999999999997 110.029 -177.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 96.1 t -137.4 116.32 14.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 108.593 -0.892 . . . . 64.530000000000001 108.593 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . 0.469 ' HA ' ' HB3' ' A' ' 626' ' ' GLN . 7.2 p-10 -78.15 124.53 28.16 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.211 -0.449 . . . . 65.219999999999999 109.854 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -156.33 -9.56 0.1 Allowed 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 113.11 0.782 . . . . 72.129999999999995 113.11 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 104.92 41.5 1.96 Allowed Glycine 0 CA--C 1.505 -0.568 0 N-CA-C 109.069 -1.613 . . . . 54.030000000000001 109.069 -174.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 626' ' ' GLN . . . -56.95 -31.04 60.92 Favored Glycine 0 C--O 1.203 -1.789 0 C-N-CA 125.78 1.657 . . . . 74.140000000000001 115.004 -174.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 2.4 p -55.2 -24.82 29.08 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 113.148 0.796 . . . . 74.430000000000007 113.148 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -102.31 -12.52 17.88 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 111.975 0.361 . . . . 73.439999999999998 111.975 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -145.09 37.29 1.14 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.081 0.771 . . . . 75.299999999999997 113.081 -173.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -68.7 90.37 0.41 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 122.222 1.01 . . . . 71.439999999999998 111.15 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . 0.536 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 32.6 ttp85 -115.63 143.56 45.18 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.173 -1.376 . . . . 71.140000000000001 109.391 -176.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.48 130.02 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 106.757 -1.572 . . . . 73.340000000000003 106.757 176.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 94.6 t -96.46 -51.99 9.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 121.619 0.723 . . . . 71.439999999999998 109.065 -175.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -145.08 160.02 42.06 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 104.441 -2.429 . . . . 62.509999999999998 104.441 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' ' 621' ' ' THR . 13.8 pt20 -147.19 139.29 24.46 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 106.98 -1.489 . . . . 73.200000000000003 106.98 173.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . 0.255 93.9 m-20 -61.06 -42.67 87.66 Favored Pre-proline 0 C--N 1.306 -1.286 0 N-CA-C 114.668 1.359 . . . . 72.150000000000006 114.668 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -69.39 108.67 2.06 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 121.192 1.262 . . . . 74.310000000000002 109.946 171.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -70.74 135.23 27.64 Favored 'Trans proline' 0 C--O 1.25 1.113 0 C-N-CA 121.981 1.787 . . . . 70.409999999999997 112.403 -175.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . 0.405 ' HB1' ' HA ' ' A' ' 565' ' ' ASP . . . -67.69 134.76 51.65 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.573 -0.739 . . . . 60.140000000000001 109.538 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 86.67 -2.38 87.26 Favored Glycine 0 N--CA 1.434 -1.444 0 C-N-CA 120.707 -0.759 . . . . 52.229999999999997 112.466 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 9.6 m -111.54 161.72 15.89 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.488 -0.56 . . . . 64.510000000000005 109.488 -176.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -71.68 113.19 4.47 Favored Glycine 0 N--CA 1.435 -1.407 0 N-CA-C 110.084 -1.206 . . . . 65.430000000000007 110.084 174.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 32.3 m -107.74 143.05 18.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 123.065 0.546 . . . . 75.530000000000001 110.544 -177.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -42.53 136.72 2.35 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 124.867 1.355 . . . . 73.439999999999998 112.079 176.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -58.71 -24.95 62.38 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 124.854 1.261 . . . . 73.409999999999997 110.014 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -55.67 -45.21 77.77 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.588 -0.733 . . . . 74.409999999999997 109.797 173.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 71.48 19.41 77.7 Favored Glycine 0 N--CA 1.423 -2.186 0 CA-C-N 115.649 -0.705 . . . . 71.439999999999998 112.396 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.7 119.78 16.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 107.879 -1.156 . . . . 74.329999999999998 107.879 -176.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.92 119.66 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.575 0 CA-C-O 122.345 1.069 . . . . 74.010000000000005 111.352 -170.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 606' ' ' GLN . 0.2 OUTLIER -104.38 121.68 43.89 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-N 114.073 -1.421 . . . . 73.129999999999995 109.542 175.723 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 2.3 pt? -138.4 165.35 27.01 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 123.851 0.86 . . . . 75.329999999999998 110.345 -174.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 21.6 ttp85 -134.54 137.51 43.88 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 107.716 -1.216 . . . . 74.349999999999994 107.716 174.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.501 ' H ' ' HE3' ' A' ' 589' ' ' LYS . 35.3 p90 -141.52 157.76 44.72 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.862 -1.162 . . . . 73.519999999999996 107.862 176.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -56.9 150.94 27.01 Favored Glycine 0 C--N 1.314 -0.68 0 O-C-N 124.597 1.186 . . . . 63.0 114.711 -177.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . 0.491 ' HB2' ' OD1' ' A' ' 592' ' ' ASP . 8.9 tt0 . . . . . 0 C--N 1.302 -1.468 0 C-N-CA 124.741 1.216 . . . . 73.200000000000003 108.472 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.615 0 N-CA-C 110.537 -1.025 . . . . 63.109999999999999 110.537 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 9.2 tp -74.25 126.88 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.558 0 CA-C-O 121.668 0.747 . . . . 74.450000000000003 108.993 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 2.7 m -99.84 145.07 28.17 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 115.654 -0.703 . . . . 73.129999999999995 109.231 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.95 -33.29 0.93 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.174 0.512 . . . . 75.400000000000006 109.721 176.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -107.34 122.47 46.65 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 105.54 -2.022 . . . . 73.200000000000003 105.54 170.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 31.8 m -117.56 164.34 13.94 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 N-CA-C 109.836 -0.431 . . . . 72.230000000000004 109.836 -172.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -92.43 136.36 33.27 Favored 'General case' 1 N--CA 1.378 -4.037 0 N-CA-C 106.458 -1.682 . . . . 74.329999999999998 106.458 175.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 72.2 t -96.96 121.22 59.84 Favored Pre-proline 0 C--N 1.255 -3.517 0 CA-C-N 114.576 -1.193 . . . . 73.540000000000006 109.899 -171.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.48 114.81 3.78 Favored 'Trans proline' 0 N--CA 1.43 -2.231 0 C-N-CA 121.165 1.243 . . . . 71.340000000000003 109.877 174.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . 0.469 ' OD2' ' HB ' ' A' ' 402' ' ' THR . 8.1 p-10 -100.83 141.21 34.03 Favored 'General case' 0 C--N 1.272 -2.8 0 CA-C-N 115.18 -0.918 . . . . 74.319999999999993 109.728 -177.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.424 ' H ' HD22 ' A' ' 377' ' ' LEU . 38.2 t -89.23 15.69 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 CA-C-N 114.326 -1.307 . . . . 64.540000000000006 111.12 -171.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.415 ' HB2' HG21 ' A' ' 402' ' ' THR . 30.1 mtp180 -65.33 147.21 53.84 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.075 -0.966 . . . . 73.209999999999994 110.966 175.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . 0.508 ' H ' ' HB ' ' A' ' 399' ' ' VAL . . . 107.7 -6.14 35.39 Favored Glycine 0 C--N 1.307 -1.049 0 N-CA-C 110.956 -0.858 . . . . 63.439999999999998 110.956 -171.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -110.58 -154.0 0.53 Allowed 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 107.215 -1.402 . . . . 75.519999999999996 107.215 170.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 78.4 p -82.77 162.45 21.7 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 118.872 0.76 . . . . 74.140000000000001 109.305 -176.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 54.6 p -57.18 -46.67 82.61 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 123.265 0.353 . . . . 73.120000000000005 110.528 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.82 -46.24 82.8 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 116.086 -0.506 . . . . 72.140000000000001 112.226 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -67.07 -42.61 84.39 Favored 'General case' 0 C--O 1.255 1.349 0 CA-C-O 121.663 0.744 . . . . 72.150000000000006 109.673 -176.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.05 -51.14 63.18 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.751 -1.113 . . . . 75.340000000000003 110.795 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 74.6 mt -60.13 -43.29 92.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 CA-C-N 116.284 -0.417 . . . . 73.519999999999996 111.137 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.51 -44.38 89.44 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 123.63 0.581 . . . . 72.409999999999997 110.849 -177.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' THR . . . . . 0.517 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 12.9 m -69.1 -46.81 66.8 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 116.013 -0.54 . . . . 75.120000000000005 111.359 -178.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . 0.424 HD22 ' H ' ' A' ' 365' ' ' VAL . 4.5 mm? -59.66 -43.03 94.1 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 120.647 0.261 . . . . 74.519999999999996 111.486 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -64.42 -42.29 96.12 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.11 -0.495 . . . . 73.5 110.516 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -69.07 -17.82 63.92 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 111.941 0.348 . . . . 74.030000000000001 111.941 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . 0.517 ' HG2' ' O ' ' A' ' 376' ' ' THR . 22.1 mmm180 -90.0 -11.76 40.64 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.183 0.516 . . . . 64.530000000000001 110.826 176.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.17 9.18 48.89 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.178 -1.01 . . . . 72.310000000000002 112.546 177.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -90.68 159.36 16.42 Favored 'General case' 0 N--CA 1.415 -2.223 0 N-CA-C 109.514 -0.551 . . . . 73.25 109.514 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -105.91 158.11 17.01 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 109.065 -0.717 . . . . 75.319999999999993 109.065 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.64 150.97 33.74 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.523 0 N-CA-C 108.19 -1.041 . . . . 71.329999999999998 108.19 177.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -118.28 126.88 53.05 Favored 'General case' 0 C--N 1.273 -2.741 0 N-CA-C 105.421 -2.066 . . . . 72.120000000000005 105.421 173.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 28.0 m -118.79 119.97 35.98 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 109.527 -0.546 . . . . 74.329999999999998 109.527 -173.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -112.15 125.59 54.29 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.369 -0.604 . . . . 75.540000000000006 109.369 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -100.31 121.92 42.26 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.175 -0.676 . . . . 74.010000000000005 109.175 177.067 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -120.86 117.52 30.97 Favored Pre-proline 0 C--N 1.304 -1.41 0 CA-C-N 115.674 -0.694 . . . . 74.420000000000002 110.222 -172.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -87.68 129.87 2.64 Favored 'Trans proline' 0 C--O 1.254 1.282 0 C-N-CA 122.27 1.98 . . . . 74.409999999999997 111.291 176.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.411 ' HB3' HG12 ' A' ' 394' ' ' ILE . 27.1 t70 176.85 162.47 0.43 Allowed 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.483 -0.562 . . . . 74.099999999999994 109.483 -177.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 7.7 m -89.64 -14.61 34.5 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 113.047 0.758 . . . . 73.310000000000002 113.047 -175.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 10.1 t -123.04 8.52 9.26 Favored 'General case' 0 C--O 1.249 1.079 0 C-N-CA 118.519 -1.272 . . . . 72.209999999999994 113.06 -175.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . 0.411 HG12 ' HB3' ' A' ' 391' ' ' ASP . 33.6 mm -88.36 133.76 35.95 Favored Pre-proline 0 C--N 1.31 -1.151 0 N-CA-C 107.214 -1.402 . . . . 71.200000000000003 107.214 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.58 145.56 47.3 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.483 2.789 . . . . 75.129999999999995 114.429 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -55.32 162.08 6.36 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 123.758 2.972 . . . . 75.120000000000005 111.804 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -57.21 -8.69 0.76 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.476 1.11 . . . . 73.329999999999998 113.311 -175.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 46.1 m170 -76.62 124.85 28.25 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.825 -1.176 . . . . 75.209999999999994 107.825 175.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.508 ' HB ' ' H ' ' A' ' 367' ' ' GLY . 8.9 t -76.48 132.43 33.01 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.577 0 CA-C-N 115.508 -0.769 . . . . 74.409999999999997 111.041 -167.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 28.9 pt -98.58 -27.97 3.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 114.959 -1.019 . . . . 64.140000000000001 113.504 -175.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.52 174.2 25.62 Favored Glycine 0 CA--C 1.503 -0.711 0 N-CA-C 110.439 -1.064 . . . . 73.319999999999993 110.439 -173.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.469 ' HB ' ' OD2' ' A' ' 364' ' ' ASP . 60.2 p -111.14 -178.67 3.52 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 118.164 0.982 . . . . 72.239999999999995 111.391 -174.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . 0.414 ' HB2' ' NH1' ' A' ' 366' ' ' ARG . 7.6 t70 -110.72 129.03 24.39 Favored Pre-proline 0 C--N 1.314 -0.96 0 N-CA-C 109.231 -0.655 . . . . 61.399999999999999 109.231 -176.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.67 -26.63 66.27 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 123.358 2.705 . . . . 70.019999999999996 113.804 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.95 -42.22 75.88 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.942 -0.572 . . . . 61.049999999999997 110.347 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -79.97 -31.84 39.86 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 121.688 0.756 . . . . 64.420000000000002 110.485 -178.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -84.74 2.39 42.25 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.721 -0.672 . . . . 71.209999999999994 111.099 -173.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 25.4 m -109.82 154.23 23.29 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.293 -1.743 . . . . 75.109999999999999 106.293 172.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 26.7 m -74.91 113.01 11.72 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 119.58 -0.848 . . . . 71.010000000000005 109.295 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 30.9 m -129.99 169.2 21.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-O 120.815 0.341 . . . . 65.310000000000002 110.283 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 33.5 m -69.75 143.45 53.02 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.17 -1.048 . . . . 53.109999999999999 108.17 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -68.04 109.03 3.31 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.174 0.512 . . . . 74.239999999999995 110.505 -177.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 129.97 69.1 0.11 Allowed Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 110.367 -1.093 . . . . 72.049999999999997 110.367 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -130.16 -175.38 3.61 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.227 -1.397 . . . . 73.519999999999996 107.227 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -114.49 132.62 56.22 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.355 0.598 . . . . 75.549999999999997 111.342 -176.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . 0.404 HG22 ' CB ' ' A' ' 403' ' ' ASP . 36.4 mm -112.14 115.4 49.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 106.707 -1.59 . . . . 71.400000000000006 106.707 177.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 54.5 m -91.61 118.6 30.76 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.157 0.503 . . . . 75.439999999999998 111.987 -172.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 14.1 p -110.71 135.06 50.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 C-N-CA 124.294 1.038 . . . . 72.019999999999996 111.32 -175.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -102.53 116.1 31.91 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.05 -0.722 . . . . 74.219999999999999 109.05 176.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 72.6 t -108.54 131.63 58.61 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 106.66 -1.607 . . . . 72.140000000000001 106.66 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' SER . . . . . 0.41 ' OG ' ' HB ' ' A' ' 394' ' ' ILE . 33.0 t -119.79 137.12 54.16 Favored 'General case' 0 C--N 1.288 -2.096 0 C-N-CA 119.276 -0.969 . . . . 65.120000000000005 111.93 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.1 p -96.1 156.33 16.38 Favored 'General case' 0 N--CA 1.408 -2.564 0 N-CA-C 106.148 -1.797 . . . . 70.030000000000001 106.148 170.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -66.42 -162.71 1.31 Allowed Glycine 0 C--O 1.262 1.886 0 N-CA-C 116.073 1.189 . . . . 75.340000000000003 116.073 -172.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.41 137.39 80.12 Favored 'Trans proline' 0 CA--C 1.503 -1.028 0 C-N-CA 123.626 2.884 . . . . 75.219999999999999 111.459 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.454 ' O ' HG12 ' A' ' 480' ' ' ILE . 28.7 mt-10 -74.87 145.5 42.7 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-O 121.897 0.856 . . . . 75.439999999999998 111.524 -177.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.422 ' HG2' ' HA ' ' A' ' 479' ' ' ALA . 45.9 mt-30 -134.06 142.63 47.63 Favored 'General case' 0 N--CA 1.409 -2.52 0 N-CA-C 107.277 -1.379 . . . . 72.519999999999996 107.277 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.538 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 3.4 mmp_? -122.91 147.63 46.38 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-O 121.217 0.532 . . . . 74.420000000000002 110.881 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -83.36 133.68 34.94 Favored 'General case' 0 C--N 1.272 -2.792 0 CA-C-N 114.61 -1.177 . . . . 71.209999999999994 107.98 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.513 ' HB ' ' O ' ' A' ' 474' ' ' ALA . 63.5 mt -80.51 125.57 80.5 Favored Pre-proline 0 N--CA 1.429 -1.5 0 C-N-CA 120.121 -0.631 . . . . 72.340000000000003 109.461 -175.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.88 146.11 52.38 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 122.28 1.987 . . . . 73.129999999999995 111.014 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -78.9 144.56 34.79 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.718 -0.845 . . . . 74.409999999999997 108.718 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 13.1 p -143.25 160.87 17.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 108.379 -0.971 . . . . 73.239999999999995 108.379 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 19.2 m -68.89 138.0 54.31 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 108.486 -0.931 . . . . 75.25 108.486 174.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 35.2 p -69.21 -29.57 67.55 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 123.088 0.555 . . . . 74.450000000000003 111.612 -175.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.2 pp -80.32 -10.47 59.75 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.103 0.477 . . . . 73.230000000000004 111.611 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 5.1 m -105.95 57.41 0.66 Allowed 'General case' 0 CA--C 1.566 1.562 0 CA-C-O 121.669 0.747 . . . . 72.129999999999995 110.609 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.26 -38.42 58.13 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.465 1.106 . . . . 73.230000000000004 112.0 175.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.82 -42.81 85.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.189 0.519 . . . . 72.040000000000006 110.764 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -71.59 -35.44 70.53 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 116.02 -0.536 . . . . 75.299999999999997 110.517 178.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.501 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -59.5 -51.31 70.41 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.548 -0.296 . . . . 75.319999999999993 111.016 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 22.2 m -64.65 -36.96 78.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 CA-C-O 120.648 0.261 . . . . 74.219999999999999 111.441 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 37.9 tptt -59.39 -47.54 85.05 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.815 -0.63 . . . . 73.109999999999999 109.507 175.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -64.97 -37.92 89.26 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.762 -0.654 . . . . 74.319999999999993 112.258 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 90.1 mt -63.39 -37.23 86.49 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.883 -0.414 . . . . 72.409999999999997 109.883 175.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.418 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 28.5 m -67.77 -44.55 77.16 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.958 -0.564 . . . . 75.120000000000005 109.972 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.13 -16.09 62.53 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.445 -0.798 . . . . 75.450000000000003 112.14 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . 0.483 ' O ' ' HG3' ' A' ' 427' ' ' ARG . . . -87.87 5.82 38.5 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.005 0.431 . . . . 75.200000000000003 111.666 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 107.14 -73.57 0.21 Allowed Glycine 0 CA--C 1.491 -1.457 0 C-N-CA 120.006 -1.092 . . . . 71.420000000000002 111.883 175.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -42.43 -65.97 0.41 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.806 1.039 . . . . 72.430000000000007 113.806 176.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . 0.418 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 62.9 17.34 58.27 Favored Glycine 0 C--N 1.317 -0.479 0 C-N-CA 121.447 -0.406 . . . . 72.230000000000004 112.545 -176.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 16.4 mmm-85 -93.07 110.73 22.21 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 106.416 -1.698 . . . . 73.519999999999996 106.416 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . 0.512 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 15.4 p90 -141.03 150.12 42.6 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-O 121.066 0.46 . . . . 75.430000000000007 111.69 -177.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -132.22 123.33 26.77 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.147 -1.057 . . . . 74.209999999999994 108.147 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -90.46 132.56 35.58 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.037 -0.727 . . . . 75.209999999999994 109.037 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . 0.424 ' O ' HD11 ' A' ' 487' ' ' ILE . . . -132.72 134.62 45.01 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 109.175 -0.676 . . . . 75.010000000000005 109.175 176.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . 0.424 ' HA ' ' O ' ' A' ' 488' ' ' VAL . 34.7 p30 -118.98 139.54 51.51 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 120.961 0.41 . . . . 74.140000000000001 110.397 174.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 34.2 t -135.44 143.01 43.43 Favored Pre-proline 0 C--N 1.288 -2.084 0 N-CA-C 108.299 -1.0 . . . . 70.140000000000001 108.299 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 490' ' ' SER . 24.5 Cg_exo -65.56 132.31 30.61 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 121.728 1.619 . . . . 65.409999999999997 109.519 174.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 28.5 p -152.19 179.68 8.3 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 108.32 -0.993 . . . . 64.510000000000005 108.32 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.8 t -47.18 137.25 8.45 Favored Pre-proline 0 C--O 1.247 0.949 0 C-N-CA 123.732 0.813 . . . . 74.409999999999997 111.959 176.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.81 -29.38 34.14 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 124.533 3.488 . . . . 73.329999999999998 113.842 -176.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -64.17 -29.28 70.41 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 120.955 0.407 . . . . 71.209999999999994 111.403 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 79.7 mt -94.87 11.79 30.44 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 112.334 0.494 . . . . 75.230000000000004 112.334 -176.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 13.0 p -60.71 127.18 19.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 C-N-CA 120.156 -0.617 . . . . 73.25 110.022 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 76.38 2.29 73.45 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.347 -0.842 . . . . 72.329999999999998 113.308 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -107.83 139.74 41.97 Favored 'General case' 0 N--CA 1.413 -2.303 0 CA-C-O 121.39 0.614 . . . . 73.409999999999997 110.908 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 79.0 t -67.2 134.22 30.44 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 CA-C-N 114.005 -1.452 . . . . 72.140000000000001 107.6 173.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 55.6 mt -96.64 -28.32 3.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 108.278 -1.008 . . . . 61.420000000000002 108.278 -176.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 159.72 -164.01 33.91 Favored Glycine 0 N--CA 1.416 -2.695 0 N-CA-C 110.659 -0.977 . . . . 61.520000000000003 110.659 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 12.1 p -135.66 145.4 46.75 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 107.218 -1.401 . . . . 75.209999999999994 107.218 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -62.89 -52.74 61.53 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 119.799 -0.761 . . . . 71.010000000000005 110.495 177.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -69.45 134.82 29.59 Favored 'Trans proline' 0 C--N 1.366 1.497 0 N-CA-C 107.408 -1.804 . . . . 73.400000000000006 107.408 168.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . 0.453 ' HB2' ' CG ' ' A' ' 476' ' ' GLN . 28.7 Cg_exo -61.84 127.75 22.37 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 121.623 1.549 . . . . 71.140000000000001 112.231 -175.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.513 ' O ' ' HB ' ' A' ' 429' ' ' ILE . . . -77.89 -3.68 42.92 Favored 'General case' 0 C--O 1.204 -1.338 0 CA-C-N 115.073 -0.967 . . . . 72.129999999999995 113.514 -171.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -110.25 0.56 18.17 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.244 -0.91 . . . . 72.430000000000007 111.174 174.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . 0.453 ' CG ' ' HB2' ' A' ' 473' ' ' PRO . 15.5 mm100 -100.22 -177.35 3.5 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.671 -0.695 . . . . 73.319999999999993 110.613 -176.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.38 130.26 35.78 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 115.979 -0.555 . . . . 63.240000000000002 109.906 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 41.3 t -124.56 142.19 51.54 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.698 -0.853 . . . . 43.310000000000002 108.698 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.422 ' HA ' ' HG2' ' A' ' 426' ' ' GLN . . . -72.7 152.87 41.45 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 112.586 0.587 . . . . 73.219999999999999 112.586 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 425' ' ' GLU . 43.2 mm -64.68 -24.97 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-O 121.835 0.826 . . . . 75.430000000000007 110.874 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 7.8 p -96.9 5.7 50.03 Favored 'General case' 0 C--N 1.291 -1.977 0 O-C-N 121.839 -0.538 . . . . 74.219999999999999 111.589 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -100.15 144.91 28.62 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.018 -0.537 . . . . 72.120000000000005 110.641 -174.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.8 p -94.48 127.38 46.52 Favored 'Isoleucine or valine' 0 C--O 1.249 1.039 0 CA-C-O 121.531 0.681 . . . . 64.049999999999997 112.367 -177.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 56.4 t -101.34 120.59 51.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 108.838 -0.801 . . . . 73.200000000000003 108.838 177.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.73 123.37 50.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-O 121.128 0.489 . . . . 75.019999999999996 109.747 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 29.2 mm -100.83 110.11 27.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 C-N-CA 124.789 1.236 . . . . 73.120000000000005 109.293 -177.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.424 HD11 ' O ' ' A' ' 455' ' ' ALA . 5.9 tp -99.44 126.9 52.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 109.349 -0.611 . . . . 72.329999999999998 109.349 177.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 456' ' ' ASN . 2.4 p -120.53 142.06 38.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 C-N-CA 123.946 0.898 . . . . 75.349999999999994 108.882 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -90.01 142.48 16.53 Favored Glycine 0 N--CA 1.431 -1.681 0 C-N-CA 120.666 -0.778 . . . . 63.119999999999997 113.567 -176.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 22.8 t -114.36 129.74 56.66 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.152 -1.795 . . . . 70.450000000000003 106.152 174.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -156.64 90.85 0.12 Allowed Glycine 0 C--N 1.304 -1.247 0 C-N-CA 119.183 -1.484 . . . . 54.219999999999999 112.846 -177.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -64.85 148.63 90.02 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 122.998 2.465 . . . . 64.549999999999997 113.395 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -147.43 37.5 0.92 Allowed 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 106.869 -1.53 . . . . 71.5 106.869 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 494' ' ' THR . . . . . 0.427 ' HB ' HG23 ' A' ' 544' ' ' THR . 1.0 OUTLIER -116.45 146.17 42.74 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 113.493 -1.685 . . . . 62.229999999999997 113.055 -169.902 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . 0.4 ' HA ' ' HE3' ' A' ' 495' ' ' LYS . 1.0 OUTLIER -142.26 146.68 35.38 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 124.468 1.107 . . . . 73.239999999999995 108.395 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -80.42 131.15 35.55 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 109.134 -0.691 . . . . 55.039999999999999 109.134 176.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 35.1 pt -77.09 130.45 75.29 Favored Pre-proline 0 C--N 1.3 -1.552 0 C-N-CA 120.532 -0.467 . . . . 65.129999999999995 111.55 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . 0.413 ' HD2' HD11 ' A' ' 512' ' ' LEU . 41.7 Cg_endo -69.02 165.97 28.28 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.615 2.21 . . . . 71.519999999999996 111.029 175.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -92.8 147.33 22.94 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.832 -0.622 . . . . 62.43 110.695 -177.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.3 p -162.54 89.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 122.401 1.096 . . . . 73.120000000000005 110.829 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -137.53 114.48 10.67 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.14 -0.936 . . . . 75.519999999999996 108.743 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 101.11 17.51 22.41 Favored Glycine 0 N--CA 1.429 -1.791 0 N-CA-C 109.899 -1.281 . . . . 43.329999999999998 109.899 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . 0.47 ' OE1' HG12 ' A' ' 507' ' ' VAL . 44.7 mt-30 -124.65 174.23 8.0 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 108.044 -1.095 . . . . 63.43 108.044 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 9.4 t -92.2 168.16 11.54 Favored 'General case' 0 C--O 1.256 1.397 0 C-N-CA 119.694 -0.803 . . . . 63.140000000000001 110.791 -175.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 89.7 t -49.87 -41.38 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.832 1.253 . . . . 74.400000000000006 111.603 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -57.67 -39.25 76.64 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.556 -0.747 . . . . 64.109999999999999 111.381 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . 0.47 HG12 ' OE1' ' A' ' 503' ' ' GLN . 23.0 t -75.48 -38.54 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-N 115.686 -0.688 . . . . 71.219999999999999 110.107 -175.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . 0.41 ' O ' HD22 ' A' ' 512' ' ' LEU . . . -62.6 -49.76 73.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.624 -0.716 . . . . 63.350000000000001 110.998 -177.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -65.43 -35.83 82.11 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.318 -0.401 . . . . 74.25 110.862 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -50.7 67.92 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.734 -0.666 . . . . 74.5 109.837 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -62.01 -47.24 85.65 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 120.662 0.268 . . . . 75.040000000000006 111.125 -177.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . 0.413 HD11 ' HD2' ' A' ' 498' ' ' PRO . 4.3 mm? -63.93 -43.16 96.73 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.458 -0.337 . . . . 73.510000000000005 111.788 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -60.07 -42.75 95.23 Favored 'General case' 0 N--CA 1.423 -1.816 0 C-N-CA 122.859 0.464 . . . . 62.439999999999998 111.384 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 48.9 t -59.5 -31.98 47.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 123.322 0.649 . . . . 72.239999999999995 111.653 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -85.59 -5.0 59.32 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 112.045 0.387 . . . . 74.049999999999997 112.045 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 116.87 -10.94 15.45 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 119.826 -1.178 . . . . 61.43 113.742 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -74.01 125.69 28.83 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 117.335 0.567 . . . . 75.209999999999994 111.589 -176.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 11.7 p -104.54 -23.98 13.07 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.479 -0.782 . . . . 74.540000000000006 112.0 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . 0.453 ' O ' HD12 ' A' ' 551' ' ' ILE . 10.0 mtmp? -111.46 114.69 27.97 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 120.322 -0.551 . . . . 74.310000000000002 110.757 -176.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -114.59 132.63 56.28 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.135 -1.061 . . . . 74.420000000000002 108.135 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 25.4 p -115.52 134.21 55.29 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 107.305 -1.369 . . . . 72.329999999999998 107.305 173.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -117.27 120.37 38.04 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 109.156 -0.683 . . . . 75.439999999999998 109.156 -175.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -106.68 138.52 42.69 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.802 -0.635 . . . . 71.150000000000006 109.845 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 57.2 m -92.52 123.9 36.17 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.513 -0.551 . . . . 72.219999999999999 109.513 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 60.6 t -120.88 148.43 24.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 106.845 -1.539 . . . . 73.510000000000005 106.845 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.53 135.96 38.26 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-O 120.965 0.412 . . . . 74.400000000000006 111.607 -178.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 527' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 38.7 m -154.13 172.5 5.72 Favored Pre-proline 0 N--CA 1.429 -1.521 0 N-CA-C 106.162 -1.792 . . . . 74.329999999999998 106.162 175.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -90.93 -0.91 4.98 Favored 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 121.938 1.759 . . . . 74.349999999999994 109.842 167.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . 0.523 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 0.0 OUTLIER -78.31 132.6 65.8 Favored Pre-proline 0 C--O 1.216 -0.681 0 CA-C-N 114.912 -1.04 . . . . 73.010000000000005 109.229 178.406 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' A' ' 533' ' ' GLU . 31.2 Cg_exo -56.03 143.68 82.28 Favored 'Trans proline' 0 C--O 1.246 0.88 0 C-N-CA 123.1 2.534 . . . . 72.329999999999998 113.692 -175.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.601 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -56.7 132.01 50.76 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.287 -0.87 . . . . 72.310000000000002 111.045 -178.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 110.9 -8.91 29.64 Favored Glycine 0 C--N 1.306 -1.127 0 N-CA-C 110.357 -1.097 . . . . 72.420000000000002 110.357 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 530' ' ' PRO . 7.5 tp10 -82.62 125.55 31.32 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 106.811 -1.551 . . . . 71.239999999999995 106.811 178.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 91.2 t -89.1 110.03 20.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 107.564 -1.273 . . . . 73.109999999999999 107.564 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 535' ' ' THR . . . . . 0.466 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 11.4 t -78.32 -12.48 60.01 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.884 -0.598 . . . . 72.239999999999995 110.683 -176.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.98 -159.45 28.33 Favored Glycine 0 N--CA 1.428 -1.844 0 C-N-CA 120.952 -0.642 . . . . 73.129999999999995 111.743 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 40.7 p -117.67 148.52 41.89 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 107.323 -1.362 . . . . 73.409999999999997 107.323 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . 0.42 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 51.0 t30 -66.07 -50.57 50.88 Favored Pre-proline 0 C--N 1.315 -0.908 0 C-N-CA 120.603 -0.439 . . . . 75.540000000000006 111.543 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . 0.42 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 11.2 Cg_exo -75.8 141.55 24.53 Favored 'Trans proline' 0 C--N 1.367 1.525 0 N-CA-C 108.304 -1.46 . . . . 74.430000000000007 108.304 170.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.51 143.35 97.16 Favored 'Trans proline' 0 C--O 1.249 1.063 0 C-N-CA 122.068 1.845 . . . . 74.510000000000005 111.756 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.02 138.15 58.34 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.289 0.566 . . . . 33.020000000000003 111.818 -177.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 96.1 -10.35 67.78 Favored Glycine 0 C--N 1.308 -0.977 0 CA-C-N 115.942 -0.572 . . . . 74.340000000000003 112.439 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 42.8 m -70.77 134.4 47.38 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.506 -0.553 . . . . 72.120000000000005 109.506 178.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.427 HG23 ' HB ' ' A' ' 494' ' ' THR . 24.8 m -84.06 123.08 29.65 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 109.177 -0.675 . . . . 70.430000000000007 109.177 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.68 157.47 78.08 Favored Pre-proline 0 C--N 1.313 -0.982 0 N-CA-C 108.444 -0.947 . . . . 62.509999999999998 108.444 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -68.19 141.68 53.07 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.804 1.67 . . . . 74.239999999999995 111.045 176.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 35.0 m -65.14 -20.2 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-O 121.842 0.829 . . . . 75.319999999999993 110.443 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -74.37 -18.63 60.65 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.607 -1.178 . . . . 74.409999999999997 110.493 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.1 t -87.37 150.96 23.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.113 -1.069 . . . . 70.129999999999995 108.113 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 12.5 p -88.82 135.84 24.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.003 -1.11 . . . . 74.010000000000005 108.003 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . 0.453 HD12 ' O ' ' A' ' 519' ' ' LYS . 0.2 OUTLIER -96.33 145.9 8.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 C-N-CA 118.738 -1.185 . . . . 72.109999999999999 109.701 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -109.74 115.83 30.57 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-O 121.579 0.704 . . . . 74.329999999999998 110.857 -175.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -94.94 133.88 38.21 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 106.169 -1.789 . . . . 74.209999999999994 106.169 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -108.48 116.45 32.0 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 122.099 0.952 . . . . 74.140000000000001 110.143 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 54.6 t -103.7 139.68 23.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 CA-C-N 114.403 -1.271 . . . . 74.340000000000003 108.573 -175.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.601 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 73.5 m -82.4 136.52 34.94 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-O 122.068 0.937 . . . . 71.319999999999993 113.006 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -85.18 139.45 31.67 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 104.5 -2.408 . . . . 74.129999999999995 104.5 167.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -83.18 -43.87 7.3 Favored Glycine 0 CA--C 1.484 -1.845 0 C-N-CA 119.768 -1.206 . . . . 71.450000000000003 113.547 -174.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 64.46 18.72 11.5 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 112.69 0.626 . . . . 71.439999999999998 112.69 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -124.21 145.75 49.14 Favored 'General case' 0 N--CA 1.417 -2.111 0 C-N-CA 120.283 -0.567 . . . . 72.25 110.547 -169.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -139.54 153.06 47.36 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.883 -0.784 . . . . 65.430000000000007 108.883 174.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 8.9 p -78.17 125.4 37.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.448 0.642 . . . . 74.540000000000006 112.446 -173.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 52.8 ttp -97.34 130.81 28.63 Favored Pre-proline 0 C--O 1.248 1.009 0 CA-C-N 115.92 -0.582 . . . . 73.439999999999998 111.065 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -74.22 170.49 20.05 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.939 2.426 . . . . 71.219999999999999 111.298 174.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -69.36 120.07 14.61 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.51 0.671 . . . . 71.109999999999999 110.902 177.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 87.2 mt -104.05 -7.04 20.57 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.647 -0.706 . . . . 75.120000000000005 110.102 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 47.4 m -66.65 132.01 47.22 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.598 -0.728 . . . . 72.140000000000001 109.875 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 93.91 -11.51 70.8 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.716 -0.754 . . . . 64.530000000000001 112.327 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 89.4 mtp -83.84 146.17 28.25 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.493 -0.558 . . . . 75.519999999999996 109.493 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -92.21 137.95 31.94 Favored 'General case' 0 N--CA 1.414 -2.247 0 N-CA-C 107.027 -1.471 . . . . 75.219999999999999 107.027 177.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 41.1 t90 -57.84 -25.82 61.18 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 123.399 0.437 . . . . 75.329999999999998 111.916 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 14.3 p -64.16 -29.95 48.73 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-O 120.996 0.427 . . . . 74.209999999999994 110.831 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -101.3 -34.3 9.69 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-O 121.687 0.756 . . . . 72.230000000000004 109.452 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . 0.446 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -63.6 -40.31 96.61 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-N 115.168 -0.924 . . . . 74.120000000000005 111.875 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.446 ' O ' ' HG2' ' A' ' 579' ' ' ARG . 17.4 tp10 -51.4 -59.34 8.06 Favored Pre-proline 0 CA--C 1.562 1.421 0 C-N-CA 123.074 0.55 . . . . 73.310000000000002 112.047 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.46 -35.26 83.64 Favored 'Trans proline' 0 C--N 1.375 1.929 0 CA-C-N 120.684 1.28 . . . . 75.010000000000005 112.6 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . 0.503 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 83.2 mmt-85 -66.51 -39.77 88.84 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 120.469 -0.492 . . . . 74.409999999999997 111.817 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 93.8 mt -65.89 -43.71 87.48 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.459 -0.337 . . . . 75.439999999999998 111.134 -177.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 29.5 mmt180 -65.04 -37.41 87.48 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.731 -0.47 . . . . 74.120000000000005 109.731 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.13 -31.16 71.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.441 -0.799 . . . . 73.310000000000002 111.422 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 99.1 mt -81.88 -7.81 59.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.399 -0.364 . . . . 64.319999999999993 111.531 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 87.13 34.47 10.71 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.698 -0.763 . . . . 53.450000000000003 111.855 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 44.4 t90 -86.67 127.67 34.96 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.574 -0.528 . . . . 74.120000000000005 109.574 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 13.9 m -133.16 28.28 4.12 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 122.618 1.199 . . . . 75.409999999999997 108.117 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -82.97 -164.78 36.37 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 114.883 -1.053 . . . . 74.239999999999995 112.065 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 586' ' ' MET . . . . . 0.401 ' HE1' ' HB2' ' A' ' 588' ' ' ASP . 55.0 ttp -108.93 130.98 55.46 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 122.615 -0.344 . . . . 73.439999999999998 110.463 -177.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 41.7 tp -90.56 116.28 28.34 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.401 -1.333 . . . . 74.099999999999994 107.401 175.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . 0.401 ' HB2' ' HE1' ' A' ' 586' ' ' MET . 31.8 t70 -107.26 107.73 18.8 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.408 0.623 . . . . 74.239999999999995 111.574 -177.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -112.77 124.7 53.17 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.675 -1.232 . . . . 74.340000000000003 107.675 174.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -88.54 -120.56 1.7 Allowed Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 109.944 -1.262 . . . . 61.5 109.944 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -82.09 133.6 35.29 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.524 -0.917 . . . . 73.420000000000002 108.524 176.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -78.82 124.9 28.68 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.262 -1.014 . . . . 74.140000000000001 108.262 177.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 44.0 t -121.85 116.2 48.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 116.064 -0.516 . . . . 75.219999999999999 110.555 -174.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -90.46 107.64 19.29 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.495 -1.298 . . . . 73.310000000000002 107.495 176.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -132.01 4.46 4.13 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.763 -0.775 . . . . 75.209999999999994 111.603 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 116.11 -175.75 16.01 Favored Glycine 0 N--CA 1.424 -2.12 0 C-N-CA 120.403 -0.903 . . . . 74.049999999999997 111.051 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -58.69 -33.32 72.11 Favored Glycine 0 C--N 1.322 -0.196 0 C-N-CA 123.455 0.55 . . . . 41.32 114.18 -175.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 19.9 m -64.41 -27.56 69.09 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 120.9 0.381 . . . . 64.129999999999995 111.433 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -109.13 -1.44 18.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.981 0.419 . . . . 73.319999999999993 111.329 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -81.73 113.01 19.42 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 112.241 0.46 . . . . 72.230000000000004 112.241 -173.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 57.48 -2.11 0.06 Allowed 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 126.506 1.922 . . . . 62.299999999999997 115.46 172.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -96.54 145.98 25.22 Favored 'General case' 0 CA--C 1.501 -0.91 0 O-C-N 121.015 -1.053 . . . . 74.109999999999999 111.722 -174.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 97.8 t -65.43 130.04 30.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 107.045 -1.465 . . . . 71.420000000000002 107.045 173.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 87.9 t -89.02 -41.81 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-O 121.311 0.577 . . . . 73.109999999999999 110.061 -175.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -151.03 158.15 43.75 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.823 -1.177 . . . . 74.219999999999999 107.823 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -119.19 127.24 53.12 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 107.517 -1.29 . . . . 71.209999999999994 107.517 175.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.475 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 27.0 t-20 -54.53 -58.07 15.85 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-O 118.785 -0.626 . . . . 64.400000000000006 112.623 -179.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.475 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 2.9 Cg_endo -84.44 136.49 6.53 Favored 'Trans proline' 0 C--N 1.363 1.305 0 CA-C-N 120.926 1.366 . . . . 74.209999999999994 109.921 174.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -63.94 158.62 46.36 Favored 'Trans proline' 0 C--O 1.243 0.755 0 C-N-CA 122.37 2.047 . . . . 75.209999999999994 111.882 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.59 130.42 42.98 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 116.305 -0.407 . . . . 73.400000000000006 109.94 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 98.16 -2.27 59.52 Favored Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 120.532 -0.842 . . . . 75.310000000000002 111.663 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 15.0 m -92.76 155.87 17.39 Favored 'General case' 0 C--O 1.253 1.25 0 N-CA-C 108.484 -0.932 . . . . 74.319999999999993 108.484 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -80.8 134.08 12.92 Favored Glycine 0 N--CA 1.415 -2.725 0 C-N-CA 120.883 -0.675 . . . . 42.210000000000001 112.211 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 28.8 m -110.61 142.95 21.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 C-N-CA 123.0 0.52 . . . . 64.129999999999995 109.715 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -54.99 172.57 0.11 Allowed 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 125.545 1.538 . . . . 63.450000000000003 113.256 -178.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -48.22 -43.44 32.11 Favored 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 124.279 1.032 . . . . 73.140000000000001 112.462 -174.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -85.99 -19.22 30.7 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.966 -0.561 . . . . 74.040000000000006 111.43 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 81.31 21.98 61.49 Favored Glycine 0 CA--C 1.494 -1.227 0 C-N-CA 120.233 -0.984 . . . . 63.399999999999999 113.722 173.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.95 119.26 13.36 Favored 'Isoleucine or valine' 0 C--O 1.252 1.218 0 CA-C-O 123.549 1.642 . . . . 75.549999999999997 110.545 -171.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.76 132.34 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.521 0 CA-C-N 112.257 -2.247 . . . . 75.450000000000003 106.036 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.415 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 31.5 m -96.41 118.88 33.84 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.789 -0.819 . . . . 75.209999999999994 108.789 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 1.6 pp -130.34 165.5 22.39 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 113.518 -1.674 . . . . 63.210000000000001 109.178 -176.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 7.7 tpp180 -142.45 139.06 31.46 Favored 'General case' 0 C--N 1.269 -2.918 0 N-CA-C 105.86 -1.904 . . . . 71.319999999999993 105.86 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -139.67 149.45 43.71 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.332 -0.988 . . . . 71.400000000000006 108.332 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -75.14 -98.44 0.11 Allowed Glycine 0 N--CA 1.438 -1.182 0 O-C-N 123.764 0.665 . . . . 64.430000000000007 113.628 -173.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 . . . . . 0 N--CA 1.429 -1.512 0 N-CA-C 108.991 -0.744 . . . . 74.540000000000006 108.991 179.84 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.646 0 N-CA-C 110.596 -1.002 . . . . 62.130000000000003 110.596 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 11.2 tp -87.06 143.67 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-N 117.187 0.493 . . . . 72.510000000000005 109.889 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 20.2 m -110.11 152.16 26.35 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.497 -1.668 . . . . 72.400000000000006 106.497 174.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . 0.304 0.0 OUTLIER -100.38 72.44 1.61 Allowed 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 122.389 1.09 . . . . 74.239999999999995 112.497 -176.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -96.97 143.74 27.55 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 106.112 -1.81 . . . . 72.420000000000002 106.112 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 32.3 m -117.75 136.74 53.94 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.525 0 N-CA-C 108.908 -0.775 . . . . 74.129999999999995 108.908 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . 0.509 ' NE2' ' HA ' ' A' ' 407' ' ' ASN . 0.8 OUTLIER -97.94 122.26 40.84 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 105.262 -2.125 . . . . 74.430000000000007 105.262 178.452 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 59.1 t -96.82 122.86 55.65 Favored Pre-proline 0 C--N 1.285 -2.207 0 CA-C-N 115.723 -0.671 . . . . 73.409999999999997 111.844 -166.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.14 140.91 67.23 Favored 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 122.857 2.371 . . . . 74.430000000000007 112.001 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -91.63 141.99 28.1 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 115.636 -0.711 . . . . 75.540000000000006 109.94 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 12.1 t -119.97 25.96 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.459 0 CA-C-O 122.74 1.257 . . . . 73.510000000000005 108.884 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? -63.38 144.62 56.81 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.175 -0.92 . . . . 73.430000000000007 113.181 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 91.29 0.38 73.72 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.968 -0.635 . . . . 74.430000000000007 112.847 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -104.08 -81.86 0.51 Allowed 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 120.543 -0.463 . . . . 63.509999999999998 110.46 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 87.8 p -169.1 163.34 11.14 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 107.512 -1.292 . . . . 75.049999999999997 107.512 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 12.0 m -63.77 -41.0 98.05 Favored 'General case' 0 N--CA 1.422 -1.873 0 O-C-N 123.987 0.804 . . . . 64.150000000000006 109.15 176.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.25 -46.69 87.71 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 115.871 -0.604 . . . . 75.109999999999999 111.484 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -64.97 -43.66 91.91 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 120.972 0.415 . . . . 64.549999999999997 110.978 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . 0.4 ' O ' HD12 ' A' ' 377' ' ' LEU . . . -66.53 -47.6 72.39 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.841 -0.618 . . . . 63.130000000000003 110.622 -178.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 80.5 mt -67.15 -40.32 84.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.933 -0.122 . . . . 71.340000000000003 111.296 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.91 -41.72 98.25 Favored 'General case' 0 C--O 1.246 0.877 0 N-CA-C 112.399 0.518 . . . . 51.43 112.399 -177.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' THR . . . . . 0.41 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 21.2 m -67.19 -47.46 70.84 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.87 -0.605 . . . . 73.030000000000001 109.959 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 373' ' ' ALA . 10.8 mp -64.28 -38.21 90.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.918 -0.583 . . . . 74.129999999999995 111.508 178.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -60.29 -44.33 95.48 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 123.356 0.662 . . . . 73.239999999999995 109.722 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -70.26 -20.58 63.05 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 112.352 0.501 . . . . 72.540000000000006 112.352 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 376' ' ' THR . 35.2 mmt180 -85.52 -14.03 47.16 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.706 -0.398 . . . . 73.340000000000003 110.056 174.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 96.09 8.29 57.95 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.074 -0.584 . . . . 62.350000000000001 112.743 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -77.75 157.37 30.07 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 112.941 0.719 . . . . 75.120000000000005 112.941 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -96.84 151.22 19.87 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.795 -1.093 . . . . 72.209999999999994 108.947 176.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 0.2 OUTLIER -129.94 136.39 59.01 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 CA-C-N 115.87 -0.604 . . . . 60.130000000000003 109.496 178.569 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -108.97 126.52 53.18 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 105.359 -2.089 . . . . 75.340000000000003 105.359 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 20.9 m -106.48 118.39 36.54 Favored 'General case' 0 C--N 1.282 -2.34 0 C-N-CA 120.351 -0.539 . . . . 74.409999999999997 110.429 -170.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -120.46 129.32 53.82 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.242 -1.021 . . . . 72.340000000000003 108.242 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -103.92 143.05 33.37 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.976 -0.379 . . . . 74.5 109.976 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -126.57 115.76 22.89 Favored Pre-proline 0 C--N 1.306 -1.289 0 N-CA-C 109.521 -0.548 . . . . 74.510000000000005 109.521 174.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -98.46 129.76 0.23 Allowed 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.38 2.053 . . . . 75.519999999999996 112.526 175.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.472 ' HB3' HG12 ' A' ' 394' ' ' ILE . 9.7 t70 173.71 160.49 0.15 Allowed 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 109.302 -0.629 . . . . 75.209999999999994 109.302 174.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 35.3 t -75.57 -24.32 56.63 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.317 0.579 . . . . 75.340000000000003 110.084 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 3.3 m -83.42 -4.7 58.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.239 1.019 . . . . 65.329999999999998 108.986 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . 0.472 HG12 ' HB3' ' A' ' 391' ' ' ASP . 15.1 mm -88.53 134.55 33.99 Favored Pre-proline 0 N--CA 1.427 -1.578 0 CA-C-N 114.568 -1.197 . . . . 73.299999999999997 110.367 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . 0.456 ' HG3' HD13 ' A' ' 400' ' ' ILE . 60.6 Cg_endo -66.14 -173.6 0.35 Allowed 'Trans proline' 0 CA--C 1.573 2.468 0 C-N-CA 125.003 3.802 . . . . 64.420000000000002 114.698 -176.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -58.47 159.41 19.9 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 122.872 2.381 . . . . 75.140000000000001 113.761 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -57.88 -9.81 1.47 Allowed 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 126.885 2.074 . . . . 74.400000000000006 113.362 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -90.18 177.38 6.45 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 116.112 -0.494 . . . . 63.140000000000001 111.56 -176.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 19.2 m -83.12 119.23 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 C-N-CA 120.51 -0.476 . . . . 72.430000000000007 110.912 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . 0.456 HD13 ' HG3' ' A' ' 395' ' ' PRO . 30.0 pt -86.77 -32.24 6.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.277 0.56 . . . . 73.420000000000002 109.707 177.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -147.99 170.36 28.64 Favored Glycine 0 N--CA 1.413 -2.845 0 N-CA-C 110.348 -1.101 . . . . 63.549999999999997 110.348 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.24 -179.42 3.63 Favored 'General case' 0 C--N 1.278 -2.54 0 CA-C-O 120.744 0.307 . . . . 70.349999999999994 110.678 178.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -102.1 129.74 25.73 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 107.974 -1.121 . . . . 72.010000000000005 107.974 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.94 -17.67 24.98 Favored 'Trans proline' 0 C--O 1.25 1.094 0 C-N-CA 124.01 3.14 . . . . 73.400000000000006 114.972 -173.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.5 -35.42 75.9 Favored 'General case' 0 C--O 1.21 -1.0 0 N-CA-C 109.657 -0.497 . . . . 70.349999999999994 109.657 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -69.33 -39.51 78.13 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.375 0.607 . . . . 62.210000000000001 110.265 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . 0.509 ' HA ' ' NE2' ' A' ' 361' ' ' GLN . 17.4 m120 -75.65 -7.28 53.9 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.434 0.635 . . . . 72.230000000000004 110.987 -178.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 29.6 m -98.67 153.91 18.35 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 106.998 -1.482 . . . . 74.209999999999994 106.998 174.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 61.0 m -75.07 113.04 11.94 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 118.974 -1.09 . . . . 71.109999999999999 109.104 176.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 18.7 m -121.24 169.81 12.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 122.867 0.467 . . . . 75.299999999999997 109.744 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 3.4 p -76.75 147.87 37.06 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 120.567 -0.453 . . . . 73.209999999999994 110.479 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -62.34 126.83 28.7 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 116.119 -0.492 . . . . 75.019999999999996 110.186 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 96.81 28.35 8.89 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 120.884 -0.674 . . . . 72.150000000000006 111.692 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -83.34 177.52 8.47 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.246 -1.02 . . . . 64.209999999999994 108.246 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -111.3 108.94 18.72 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.216 0.531 . . . . 72.540000000000006 109.974 -174.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 46.2 mm -102.22 129.13 54.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 115.215 -0.902 . . . . 74.200000000000003 108.83 -178.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 30.1 m -85.86 130.58 34.51 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.083 0.468 . . . . 72.109999999999999 111.205 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 7.5 p -110.81 134.87 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 107.676 -1.231 . . . . 74.540000000000006 107.676 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -110.76 122.19 47.21 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.069 0.461 . . . . 75.099999999999994 110.855 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 99.3 t -102.89 131.16 51.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 114.866 -1.061 . . . . 74.219999999999999 108.249 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' SER . . . . . 0.428 ' HB3' ' CG2' ' A' ' 394' ' ' ILE . 8.8 m -98.7 125.04 43.89 Favored 'General case' 0 C--N 1.274 -2.7 0 CA-C-N 115.358 -0.837 . . . . 71.109999999999999 110.112 -176.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 2.5 p -111.07 149.95 30.07 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.152 -0.685 . . . . 62.030000000000001 109.152 176.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -64.81 -162.46 0.68 Allowed Glycine 0 C--O 1.25 1.11 0 N-CA-C 116.098 1.199 . . . . 74.349999999999994 116.098 -172.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.56 139.97 83.02 Favored 'Trans proline' 0 C--N 1.362 1.271 0 C-N-CA 123.342 2.695 . . . . 62.25 111.365 -178.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -73.29 146.85 45.05 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 113.773 1.027 . . . . 72.519999999999996 113.773 -172.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 41.2 mt-30 -131.84 151.16 51.87 Favored 'General case' 0 N--CA 1.415 -2.181 0 CA-C-N 113.273 -1.785 . . . . 74.409999999999997 106.781 172.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -133.59 144.89 49.58 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-O 121.0 0.428 . . . . 74.409999999999997 110.497 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.74 133.34 34.79 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 107.899 -1.149 . . . . 63.409999999999997 107.899 176.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 63.1 mt -80.82 129.92 65.99 Favored Pre-proline 0 C--N 1.312 -1.052 0 CA-C-N 116.612 -0.267 . . . . 73.129999999999995 111.714 -172.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.93 147.13 54.66 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.206 1.937 . . . . 64.540000000000006 111.498 173.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -83.57 105.26 14.35 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.485 -0.561 . . . . 75.150000000000006 109.485 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 11.6 p -94.77 161.18 2.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 107.972 -1.122 . . . . 73.430000000000007 107.972 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.443 ' HB3' ' OG1' ' A' ' 436' ' ' THR . 29.7 t -83.86 157.52 21.97 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 108.964 -0.754 . . . . 72.530000000000001 108.964 177.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 32.0 p -70.2 -27.02 64.16 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 112.987 0.736 . . . . 74.239999999999995 112.987 -172.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.54 -13.77 42.05 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.313 0.577 . . . . 75.409999999999997 110.778 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.443 ' OG1' ' HB3' ' A' ' 433' ' ' SER . 1.4 m -92.54 41.4 1.07 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.782 -0.645 . . . . 75.239999999999995 110.409 -175.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -53.07 -40.35 63.97 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.974 0.909 . . . . 71.439999999999998 112.273 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.14 98.73 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 120.812 0.339 . . . . 73.049999999999997 110.918 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . 0.414 ' HB3' HG21 ' A' ' 436' ' ' THR . 31.4 tt0 -71.14 -34.92 71.48 Favored 'General case' 0 C--O 1.201 -1.489 0 C-N-CA 120.441 -0.503 . . . . 75.329999999999998 110.684 175.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.599 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -58.52 -51.34 70.3 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 122.219 0.208 . . . . 62.32 111.018 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 36.0 m -61.39 -37.78 78.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-O 121.211 0.529 . . . . 73.219999999999999 110.401 177.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -60.43 -47.46 86.02 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.641 0.776 . . . . 72.510000000000005 111.147 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -64.8 -38.31 90.55 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 123.318 0.647 . . . . 74.230000000000004 111.184 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.599 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 83.9 mt -63.76 -37.86 88.96 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.683 -0.488 . . . . 73.230000000000004 109.683 176.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.52 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 37.1 m -70.03 -42.92 72.31 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.902 -0.59 . . . . 73.409999999999997 110.32 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -65.15 -26.44 68.18 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.051 -0.522 . . . . 74.319999999999993 111.111 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -81.04 4.95 17.98 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.065 -0.516 . . . . 75.430000000000007 111.879 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 108.03 -67.94 0.22 Allowed Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.334 -0.936 . . . . 63.240000000000002 112.795 174.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . 0.464 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 1.8 p90 -50.54 -60.75 2.7 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.679 0.992 . . . . 73.430000000000007 113.679 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . 0.52 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 60.92 23.46 61.45 Favored Glycine 0 CA--C 1.499 -0.914 0 C-N-CA 121.255 -0.497 . . . . 72.030000000000001 112.203 -176.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -105.04 110.98 23.59 Favored 'General case' 0 N--CA 1.414 -2.258 0 N-CA-C 109.073 -0.714 . . . . 74.340000000000003 109.073 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -131.97 143.32 50.02 Favored 'General case' 0 N--CA 1.415 -2.223 0 CA-C-N 114.608 -1.178 . . . . 74.040000000000006 110.192 -177.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -134.52 123.1 23.36 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 107.499 -1.297 . . . . 73.019999999999996 107.499 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -100.03 133.33 44.57 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.35 0.595 . . . . 74.129999999999995 111.901 -174.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -119.28 144.98 46.5 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 108.437 -0.949 . . . . 71.519999999999996 108.437 176.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -114.8 135.75 53.83 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.593 -0.892 . . . . 74.510000000000005 108.593 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 40.2 m -147.48 142.33 16.69 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 109.38 -0.6 . . . . 72.540000000000006 109.38 176.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 490' ' ' SER . 12.2 Cg_exo -70.17 131.62 21.01 Favored 'Trans proline' 0 C--O 1.247 0.948 0 C-N-CA 122.204 1.936 . . . . 75.230000000000004 111.555 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 56.4 m -149.75 -179.95 7.53 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.365 -0.976 . . . . 70.010000000000005 108.365 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 10.1 t -45.12 135.72 5.12 Favored Pre-proline 0 C--O 1.246 0.903 0 C-N-CA 124.015 0.926 . . . . 73.310000000000002 112.387 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.63 -30.39 36.4 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 124.363 3.375 . . . . 70.129999999999995 113.638 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -71.37 -23.45 61.9 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.57 0.581 . . . . 74.099999999999994 112.57 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 84.5 mt -99.74 -6.33 27.23 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.66 -0.416 . . . . 75.109999999999999 110.913 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 98.0 t -61.38 127.72 21.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 116.154 -0.475 . . . . 74.049999999999997 110.716 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 91.82 -3.59 77.92 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 115.614 -0.721 . . . . 72.019999999999996 111.661 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -118.19 166.37 12.67 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 108.278 -1.008 . . . . 72.150000000000006 108.278 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 93.8 t -76.12 145.7 10.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 108.306 -0.998 . . . . 74.5 108.306 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 68.5 mt -97.61 -35.25 5.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.262 -1.384 . . . . 74.430000000000007 107.262 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 159.68 -167.33 35.2 Favored Glycine 0 N--CA 1.423 -2.212 0 CA-C-N 115.356 -0.838 . . . . 70.329999999999998 111.012 176.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 470' ' ' THR . . . . . 0.479 HG21 HG12 ' A' ' 486' ' ' ILE . 72.8 p -116.2 144.85 43.64 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 106.969 -1.493 . . . . 73.510000000000005 106.969 178.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -67.1 -58.38 9.28 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 119.153 -1.019 . . . . 72.150000000000006 110.101 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -68.2 130.18 20.82 Favored 'Trans proline' 0 C--N 1.376 2.015 0 N-CA-C 106.364 -2.206 . . . . 73.349999999999994 106.364 168.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . 0.418 ' C ' ' H ' ' A' ' 475' ' ' ASN . 23.8 Cg_exo -61.82 138.6 75.22 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 121.55 1.5 . . . . 74.519999999999996 112.774 -172.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -75.85 11.17 1.48 Allowed 'General case' 0 C--O 1.202 -1.431 0 CA-C-N 115.324 -0.853 . . . . 53.119999999999997 111.468 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . 0.418 ' H ' ' C ' ' A' ' 473' ' ' PRO . 13.6 m120 -109.56 -1.54 18.15 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.799 -0.637 . . . . 72.430000000000007 109.427 177.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -94.24 172.55 8.14 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.867 -0.606 . . . . 65.430000000000007 111.778 -178.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 1.9 m -99.42 108.16 20.57 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 107.994 -1.113 . . . . 73.239999999999995 107.994 -178.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 50.1 m -100.64 138.66 37.41 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 120.901 0.382 . . . . 61.409999999999997 110.815 -176.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -77.37 154.53 32.67 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.659 -0.7 . . . . 73.439999999999998 111.134 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . 0.464 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 1.7 mp -65.32 -24.74 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-N 115.493 -0.776 . . . . 73.329999999999998 111.555 178.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 4.4 p -93.48 6.04 49.54 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.72 0.771 . . . . 74.099999999999994 111.565 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -107.88 131.71 54.22 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.693 -0.685 . . . . 74.409999999999997 111.435 -176.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 55.0 t -94.65 126.9 46.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.752 -0.658 . . . . 74.540000000000006 110.095 -177.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 34.4 m -98.36 133.7 39.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-O 121.51 0.672 . . . . 64.310000000000002 111.033 178.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.9 129.02 51.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.851 -0.613 . . . . 73.140000000000001 109.794 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . 0.479 HG12 HG21 ' A' ' 470' ' ' THR . 4.9 mt -117.12 128.74 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 C-N-CA 124.43 1.092 . . . . 72.420000000000002 110.215 -176.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 5.8 tt -108.4 126.92 65.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-N 116.447 -0.342 . . . . 73.150000000000006 110.354 -177.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 34.6 m -111.43 152.0 13.42 Favored 'Isoleucine or valine' 0 C--O 1.252 1.236 0 CA-C-N 116.229 -0.441 . . . . 72.310000000000002 110.633 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.87 123.3 6.04 Favored Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 115.928 -0.578 . . . . 61.109999999999999 113.59 -176.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 31.0 t -101.89 153.72 19.59 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 107.728 -1.212 . . . . 64.510000000000005 107.728 177.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -92.62 179.19 40.06 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 120.914 -0.66 . . . . 75.230000000000004 113.751 -175.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.33 166.0 22.84 Favored 'Trans proline' 0 N--CA 1.443 -1.487 0 C-N-CA 122.644 2.229 . . . . 61.409999999999997 111.533 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -90.36 119.73 30.89 Favored 'General case' 0 N--CA 1.41 -2.43 0 N-CA-C 107.513 -1.291 . . . . 71.230000000000004 107.513 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 51.5 p -116.59 143.36 45.71 Favored 'General case' 0 C--N 1.27 -2.859 0 N-CA-C 109.159 -0.682 . . . . 73.519999999999996 109.159 -178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 544' ' ' THR . 10.3 ttpp -151.44 164.46 36.71 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 108.445 -0.946 . . . . 74.540000000000006 108.445 176.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -79.67 136.54 36.83 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.85 -0.796 . . . . 62.039999999999999 108.85 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 40.6 pt -75.45 131.41 77.62 Favored Pre-proline 0 C--N 1.305 -1.355 0 N-CA-C 109.374 -0.602 . . . . 74.439999999999998 109.374 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -56.65 118.15 4.94 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.592 2.861 . . . . 74.129999999999995 114.285 -174.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -84.42 94.53 8.53 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-N 115.824 -0.625 . . . . 74.329999999999998 109.532 177.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.7 p -159.75 93.75 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-O 122.247 1.022 . . . . 62.100000000000001 110.947 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -108.09 162.84 13.68 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 107.862 -1.162 . . . . 75.099999999999994 107.862 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 98.1 23.38 13.17 Favored Glycine 0 C--N 1.295 -1.747 0 N-CA-C 108.967 -1.653 . . . . 72.439999999999998 108.967 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -129.38 165.5 21.39 Favored 'General case' 0 CA--C 1.471 -2.068 0 CA-C-N 114.402 -0.899 . . . . 72.120000000000005 109.336 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 6.9 m -88.67 156.44 19.01 Favored 'General case' 0 C--N 1.275 -2.67 0 C-N-CA 120.118 -0.633 . . . . 74.310000000000002 110.208 -173.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 12.2 p -50.53 -41.24 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 124.521 1.129 . . . . 72.349999999999994 113.522 -174.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -67.41 -39.67 85.54 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.372 0.606 . . . . 55.329999999999998 110.549 -178.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 48.8 t -70.37 -43.78 77.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.344 -0.844 . . . . 73.420000000000002 109.529 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -61.68 -47.11 86.81 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.226 -0.897 . . . . 61.310000000000002 112.26 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -64.2 -35.92 82.36 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.137 0.273 . . . . 74.340000000000003 110.708 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 52.5 tttm -58.69 -53.8 54.28 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.032 -0.531 . . . . 73.25 109.831 175.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -62.61 -41.69 99.13 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.286 -0.87 . . . . 74.219999999999999 110.914 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 9.0 tt -61.46 -47.87 83.72 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.955 -0.566 . . . . 73.329999999999998 110.408 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . 0.444 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 12.8 m120 -66.68 -37.81 85.5 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 111.812 0.301 . . . . 74.409999999999997 111.812 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 54.4 t -62.74 -31.69 53.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.162 -0.472 . . . . 74.430000000000007 111.052 177.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -86.15 13.25 8.14 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 114.147 1.166 . . . . 74.030000000000001 114.147 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 102.07 -11.58 57.28 Favored Glycine 0 CA--C 1.499 -0.907 0 C-N-CA 119.925 -1.131 . . . . 74.340000000000003 114.214 171.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 88.8 m-85 -91.11 120.34 31.99 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.331 -0.618 . . . . 75.450000000000003 109.331 -177.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 22.7 p -97.96 -14.84 20.38 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 113.329 0.863 . . . . 74.019999999999996 113.329 -174.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -123.22 117.58 25.64 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.092 0.473 . . . . 75.430000000000007 112.102 -172.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -131.51 147.89 52.58 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.782 -0.645 . . . . 73.510000000000005 111.694 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 521' ' ' SER . . . . . 0.437 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 51.1 m -132.69 140.16 48.0 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.161 -1.422 . . . . 70.420000000000002 107.161 173.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.77 128.77 55.2 Favored 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 119.945 -0.702 . . . . 74.239999999999995 112.191 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -111.92 143.53 42.74 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.443 -0.947 . . . . 73.409999999999997 108.443 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 524' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 57.1 m -96.52 139.35 32.75 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 113.095 0.776 . . . . 71.430000000000007 113.095 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 40.6 t -122.22 159.14 25.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 106.778 -1.564 . . . . 74.439999999999998 106.778 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . 0.466 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 30.9 m-20 -85.0 134.58 34.22 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 107.741 -1.207 . . . . 74.120000000000005 107.741 177.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 527' ' ' SER . . . . . 0.494 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 19.0 m -153.57 178.3 1.65 Allowed Pre-proline 0 C--N 1.313 -1.016 0 N-CA-C 109.197 -0.668 . . . . 64.329999999999998 109.197 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -89.0 -8.32 4.92 Favored 'Trans proline' 0 CA--C 1.55 1.28 0 C-N-CA 122.47 2.113 . . . . 71.319999999999993 111.114 170.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.9 142.07 48.17 Favored Pre-proline 0 C--O 1.213 -0.861 0 N-CA-C 108.675 -0.861 . . . . 74.439999999999998 108.675 176.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -63.42 160.36 35.83 Favored 'Trans proline' 0 C--O 1.247 0.972 0 C-N-CA 122.558 2.172 . . . . 71.420000000000002 113.419 -176.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -58.38 118.44 5.56 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.038 -0.983 . . . . 73.540000000000006 110.334 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 121.36 -12.46 9.62 Favored Glycine 0 C--N 1.3 -1.465 0 C-N-CA 120.45 -0.881 . . . . 63.520000000000003 112.201 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -82.71 131.46 35.2 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.927 -0.768 . . . . 72.420000000000002 108.927 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 54.3 t -90.84 112.67 25.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.676 -0.861 . . . . 72.409999999999997 108.676 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 45.8 m -111.04 14.55 21.93 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 122.661 1.22 . . . . 73.409999999999997 111.611 -175.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 161.97 -173.84 38.35 Favored Glycine 0 CA--C 1.494 -1.26 0 C-N-CA 119.903 -1.141 . . . . 75.109999999999999 112.251 173.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 31.6 p -130.43 153.86 48.32 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.856 -1.165 . . . . 74.209999999999994 107.856 176.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -67.75 -54.74 16.13 Favored Pre-proline 0 C--N 1.309 -1.163 0 CA-C-O 119.31 -0.376 . . . . 74.140000000000001 111.25 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.32 153.39 45.37 Favored 'Trans proline' 0 C--N 1.371 1.717 0 N-CA-C 108.026 -1.567 . . . . 73.540000000000006 108.026 170.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.84 137.86 46.63 Favored 'Trans proline' 0 C--O 1.249 1.055 0 CA-C-N 120.119 1.078 . . . . 62.530000000000001 110.932 -177.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -69.68 137.78 52.4 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.735 -0.666 . . . . 64.299999999999997 110.396 -178.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.73 -14.34 59.01 Favored Glycine 0 C--N 1.303 -1.286 0 C-N-CA 120.61 -0.805 . . . . 71.140000000000001 111.726 -178.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 27.0 m -72.67 137.45 46.03 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 109.407 -0.59 . . . . 74.540000000000006 109.407 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 495' ' ' LYS . 8.9 t -87.2 127.12 35.16 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-O 121.536 0.684 . . . . 74.439999999999998 110.124 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.3 m -138.96 162.46 52.38 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 107.738 -1.208 . . . . 73.450000000000003 107.738 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -60.77 134.59 54.74 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 121.734 1.623 . . . . 73.019999999999996 109.784 173.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.402 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 26.9 m -63.57 -20.25 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 113.728 1.011 . . . . 70.129999999999995 113.728 -174.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -83.65 -4.47 58.62 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.395 0.617 . . . . 74.299999999999997 111.4 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 14.6 m -74.27 160.39 31.18 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.505 -0.554 . . . . 61.340000000000003 109.505 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 38.2 t -97.44 115.39 37.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.52 -0.548 . . . . 73.209999999999994 109.52 -178.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 61.2 mt -85.01 131.74 33.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 109.108 -0.701 . . . . 74.109999999999999 109.108 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 521' ' ' SER . 34.8 tt0 -103.03 116.2 32.07 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 108.296 -1.001 . . . . 73.420000000000002 108.296 176.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -103.76 134.73 46.59 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.493 -0.776 . . . . 64.409999999999997 109.285 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -102.05 118.3 36.6 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-O 122.797 1.284 . . . . 74.439999999999998 111.409 -175.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 524' ' ' SER . 92.3 t -105.01 136.28 39.44 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 CA-C-N 112.914 -1.948 . . . . 73.340000000000003 110.271 -172.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 75.0 m -75.47 148.94 38.64 Favored 'General case' 0 C--N 1.27 -2.86 0 N-CA-C 113.584 0.957 . . . . 61.409999999999997 113.584 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.466 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 9.8 ptpp? -108.84 156.01 20.14 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 105.12 -2.178 . . . . 74.140000000000001 105.12 165.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -71.73 -27.59 70.62 Favored Glycine 0 CA--C 1.496 -1.126 0 C-N-CA 120.797 -0.716 . . . . 71.400000000000006 111.683 -177.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 62.6 t30 57.85 28.98 16.81 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 122.879 1.324 . . . . 73.510000000000005 109.84 173.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.8 154.41 41.99 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 105.785 -1.932 . . . . 74.140000000000001 105.785 -175.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -143.07 156.19 44.77 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 120.354 -0.538 . . . . 73.319999999999993 110.222 175.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 78.1 t -79.15 119.66 28.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 108.519 -0.919 . . . . 75.150000000000006 108.519 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 563' ' ' MET . . . . . 0.562 ' SD ' HD11 ' A' ' 620' ' ' ILE . 52.4 ttp -90.46 129.64 44.42 Favored Pre-proline 0 C--N 1.302 -1.488 0 CA-C-N 116.588 -0.278 . . . . 73.299999999999997 111.618 -176.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -69.2 169.85 17.26 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.166 2.578 . . . . 74.120000000000005 111.649 174.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -77.23 139.38 39.85 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.83 -0.804 . . . . 70.239999999999995 108.83 177.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 25.5 tp -137.97 12.98 2.89 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.781 0.8 . . . . 74.340000000000003 109.546 -178.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 53.3 p -79.96 147.78 31.46 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.21 -0.45 . . . . 74.109999999999999 111.393 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 77.61 7.89 87.19 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.86 -0.686 . . . . 61.210000000000001 113.2 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 569' ' ' MET . . . . . 0.449 ' HE2' ' HA ' ' A' ' 569' ' ' MET . 8.2 mmt -87.61 143.67 27.07 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.6 -0.889 . . . . 74.5 108.6 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -89.45 176.73 6.79 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 110.071 -0.344 . . . . 72.120000000000005 110.071 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -60.93 -34.14 74.25 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.999 -1.112 . . . . 74.510000000000005 107.999 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.6 m -73.72 -7.62 10.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.469 -1.241 . . . . 73.329999999999998 111.291 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -101.55 -44.06 5.7 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 108.866 -0.791 . . . . 74.040000000000006 108.866 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -53.75 -53.68 48.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.006 -0.997 . . . . 73.439999999999998 113.481 -175.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -65.45 -53.51 37.85 Favored Pre-proline 0 CA--C 1.553 1.093 0 N-CA-C 113.493 0.923 . . . . 73.209999999999994 113.493 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -60.27 -39.34 68.78 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 121.783 1.655 . . . . 75.150000000000006 112.196 177.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . 0.548 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 30.2 mtt180 -68.95 -33.5 73.82 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 113.683 0.994 . . . . 72.310000000000002 113.683 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 6.8 tt -58.09 -50.19 74.34 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.663 -0.865 . . . . 74.129999999999995 108.663 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -68.23 -43.88 76.97 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.207 -0.906 . . . . 74.230000000000004 113.439 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -64.17 -40.42 96.07 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 113.389 0.885 . . . . 62.329999999999998 113.389 -175.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 577' ' ' ARG 0.308 3.7 pp -93.13 0.32 57.19 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.05 -1.06 . . . . 73.140000000000001 113.655 179.37 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 71.26 43.25 55.74 Favored Glycine 0 CA--C 1.504 -0.631 0 CA-C-N 115.986 -0.552 . . . . 75.120000000000005 112.395 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 22.4 t90 -73.21 126.85 31.02 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.073 -0.714 . . . . 74.319999999999993 109.073 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 2.5 m -105.76 2.38 27.85 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.753 -0.658 . . . . 75.219999999999999 110.491 -175.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -91.72 172.32 35.57 Favored Glycine 0 N--CA 1.436 -1.347 0 C-N-CA 120.594 -0.812 . . . . 73.549999999999997 112.433 -175.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 89.4 mmm -92.79 137.18 32.59 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.246 0.546 . . . . 74.109999999999999 111.665 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -83.0 128.19 34.25 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.623 -1.172 . . . . 75.329999999999998 108.113 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -95.39 103.37 15.23 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.992 -0.549 . . . . 73.409999999999997 109.81 -177.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . 0.467 ' HD3' ' CE2' ' A' ' 624' ' ' PHE . 52.4 tptt -112.51 110.76 21.14 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 109.107 -0.701 . . . . 75.340000000000003 109.107 176.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -91.37 -117.05 2.09 Favored Glycine 0 N--CA 1.428 -1.863 0 C-N-CA 120.512 -0.852 . . . . 63.119999999999997 112.313 178.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -84.03 155.64 22.63 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 123.132 0.573 . . . . 65.5 111.333 -177.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -94.21 124.45 38.23 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 109.657 -0.497 . . . . 73.040000000000006 109.657 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 49.9 t -125.91 127.62 71.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 107.7 -1.222 . . . . 63.32 107.7 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -73.73 121.14 20.33 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.478 -0.889 . . . . 70.319999999999993 108.924 176.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -118.95 -39.11 2.97 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.238 -0.892 . . . . 73.310000000000002 110.658 -175.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 60.5 -157.48 29.17 Favored Glycine 0 N--CA 1.423 -2.207 0 O-C-N 123.936 0.772 . . . . 72.129999999999995 111.339 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -65.33 -40.99 96.84 Favored Glycine 0 C--N 1.28 -2.528 0 N-CA-C 112.061 -0.415 . . . . 73.439999999999998 112.061 174.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 10.2 m -58.38 -40.53 82.55 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 113.121 0.786 . . . . 63.409999999999997 113.121 -171.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -108.85 -4.5 16.8 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 111.95 0.352 . . . . 74.430000000000007 111.95 177.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 65.8 m80 56.1 102.83 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.471 1.109 . . . . 73.450000000000003 113.263 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -77.15 80.25 3.67 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 122.711 1.243 . . . . 65.040000000000006 109.812 172.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -134.49 171.16 14.69 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.271 -1.751 . . . . 73.519999999999996 106.271 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 76.1 t -61.08 129.67 24.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 107.58 -1.267 . . . . 72.230000000000004 107.58 173.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 97.6 t -87.25 -50.31 13.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-O 121.591 0.71 . . . . 73.430000000000007 109.27 -175.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -149.44 157.58 43.42 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 106.871 -1.529 . . . . 74.5 106.871 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -110.14 123.3 49.48 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 107.948 -1.131 . . . . 72.349999999999994 107.948 173.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.448 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 25.3 t-20 -48.58 -54.5 26.05 Favored Pre-proline 0 CA--C 1.553 1.084 0 N-CA-C 113.468 0.914 . . . . 70.219999999999999 113.468 -177.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.448 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 4.1 Cg_endo -90.26 138.74 2.83 Favored 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 121.473 1.448 . . . . 74.120000000000005 109.944 173.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . 0.445 ' HG2' ' OG1' ' A' ' 612' ' ' THR . 29.3 Cg_endo -67.92 147.57 74.67 Favored 'Trans proline' 0 C--O 1.249 1.066 0 C-N-CA 121.985 1.79 . . . . 72.299999999999997 113.13 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.55 133.63 49.79 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.283 -0.871 . . . . 73.329999999999998 110.456 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 95.96 -8.18 67.71 Favored Glycine 0 C--N 1.305 -1.181 0 C-N-CA 120.717 -0.754 . . . . 73.129999999999995 112.113 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 612' ' ' THR . . . . . 0.445 ' OG1' ' HG2' ' A' ' 609' ' ' PRO . 15.7 m -91.28 157.91 16.87 Favored 'General case' 0 C--O 1.256 1.434 0 N-CA-C 109.052 -0.721 . . . . 73.340000000000003 109.052 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -77.01 128.63 9.15 Favored Glycine 0 N--CA 1.428 -1.861 0 N-CA-C 111.425 -0.67 . . . . 72.049999999999997 111.425 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . 0.403 ' CG2' ' HB2' ' A' ' 563' ' ' MET . 33.4 m -122.16 144.19 32.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 C-N-CA 123.528 0.731 . . . . 72.109999999999999 110.49 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -39.53 144.23 0.18 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 125.816 1.647 . . . . 74.230000000000004 112.115 174.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . 0.498 ' HG3' ' N ' ' A' ' 617' ' ' ASP . 3.2 ptp180 -54.9 -28.43 50.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 123.773 0.671 . . . . 75.010000000000005 111.021 -178.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . 0.498 ' N ' ' HG3' ' A' ' 616' ' ' ARG . 21.2 t70 -60.05 -42.06 93.65 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.783 -1.098 . . . . 74.5 109.652 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 87.08 12.54 67.88 Favored Glycine 0 N--CA 1.413 -2.846 0 CA-C-N 115.012 -0.995 . . . . 73.239999999999995 113.363 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . 0.492 ' HB ' ' OD2' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -69.4 119.76 15.89 Favored 'Isoleucine or valine' 0 C--O 1.251 1.143 0 CA-C-N 118.604 1.202 . . . . 74.310000000000002 109.631 -177.398 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . 0.562 HD11 ' SD ' ' A' ' 563' ' ' MET . 4.1 tt -124.81 132.64 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.223 0 CA-C-N 113.287 -1.779 . . . . 75.230000000000004 107.581 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 87.6 m -96.64 122.37 39.5 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 121.814 0.816 . . . . 73.219999999999999 109.707 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 61.2 mt -119.9 150.78 39.93 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 105.881 -1.896 . . . . 74.420000000000002 105.881 -178.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -128.64 135.79 49.78 Favored 'General case' 0 C--N 1.27 -2.859 0 N-CA-C 106.729 -1.582 . . . . 64.230000000000004 106.729 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.467 ' CE2' ' HD3' ' A' ' 589' ' ' LYS . 26.5 p90 -143.24 164.05 31.28 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 108.557 -0.905 . . . . 70.010000000000005 108.557 176.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -77.15 -82.06 0.58 Allowed Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 120.582 -0.818 . . . . 64.450000000000003 112.932 -177.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 . . . . . 0 C--N 1.292 -1.899 0 N-CA-C 107.878 -1.156 . . . . 71.049999999999997 107.878 -177.029 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.488 0 N-CA-C 109.647 -1.381 . . . . 51.219999999999999 109.647 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 11.2 tp -78.42 137.16 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 CA-C-N 117.608 0.704 . . . . 75.209999999999994 111.568 -176.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 17.9 m -120.23 147.83 44.45 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 104.536 -2.394 . . . . 71.109999999999999 104.536 170.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 23.6 mtt85 -93.11 77.41 4.63 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 114.506 1.298 . . . . 75.219999999999999 114.506 -171.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -71.47 148.57 46.68 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 104.91 -2.255 . . . . 74.299999999999997 104.91 166.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 29.5 m -115.49 160.68 14.72 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 CA-C-O 121.303 0.573 . . . . 72.400000000000006 110.929 -170.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . 0.406 ' HG2' ' N ' ' A' ' 362' ' ' VAL . 33.8 tt0 -94.35 139.64 30.82 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 115.872 -0.603 . . . . 73.120000000000005 110.063 -175.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.671 HG22 ' CZ ' ' A' ' 382' ' ' PHE . 60.5 t -94.68 141.1 22.93 Favored Pre-proline 0 C--N 1.28 -2.436 0 N-CA-C 106.232 -1.766 . . . . 71.310000000000002 106.232 -176.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -73.15 119.34 5.97 Favored 'Trans proline' 0 N--CA 1.436 -1.861 0 C-N-CA 120.824 1.016 . . . . 63.140000000000001 111.678 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . 0.6 ' OD2' ' HD2' ' A' ' 366' ' ' ARG . 24.8 t70 -89.98 82.51 6.14 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 105.974 -1.862 . . . . 63.310000000000002 105.974 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.478 ' HB ' ' NE2' ' A' ' 368' ' ' GLN . 3.0 m -92.46 30.35 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 113.941 -1.482 . . . . 65.310000000000002 114.017 -171.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.6 ' HD2' ' OD2' ' A' ' 364' ' ' ASP . 0.0 OUTLIER -52.66 145.26 12.33 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 124.62 1.168 . . . . 71.510000000000005 112.399 174.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.56 -0.84 45.98 Favored Glycine 0 CA--C 1.492 -1.36 0 CA-C-N 115.81 -0.632 . . . . 70.450000000000003 112.821 175.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . 0.478 ' NE2' ' HB ' ' A' ' 365' ' ' VAL . 36.4 mt-30 -112.19 -155.84 0.57 Allowed 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.009 -1.108 . . . . 71.150000000000006 108.009 178.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 21.4 p -94.58 161.53 14.16 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 108.667 -0.864 . . . . 72.319999999999993 108.667 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 19.1 p -63.13 -40.01 96.34 Favored 'General case' 0 C--O 1.209 -1.033 0 C-N-CA 120.698 -0.401 . . . . 64.209999999999994 109.943 178.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.45 -46.31 89.11 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 116.201 -0.454 . . . . 65.319999999999993 111.727 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -69.06 -44.79 71.9 Favored 'General case' 0 C--O 1.253 1.255 0 CA-C-O 121.301 0.572 . . . . 75.420000000000002 110.69 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -63.83 -44.63 92.66 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.412 -0.813 . . . . 65.150000000000006 110.981 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 70.0 mt -69.31 -37.04 75.07 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.594 0 CA-C-N 116.304 -0.407 . . . . 75.409999999999997 110.966 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.78 -43.88 90.53 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.376 0.608 . . . . 74.420000000000002 109.986 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' THR . . . . . 0.546 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 54.6 m -65.76 -47.41 75.29 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.288 -0.869 . . . . 65.510000000000005 109.859 177.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 26.1 tp -60.98 -40.18 92.46 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 123.898 0.879 . . . . 73.209999999999994 111.602 -176.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -70.29 -37.66 74.86 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.136 0.575 . . . . 64.530000000000001 110.077 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -67.98 -19.15 64.91 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 120.833 0.349 . . . . 74.409999999999997 111.527 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . 0.546 ' HG2' ' O ' ' A' ' 376' ' ' THR . 16.6 mmt85 -89.42 -8.71 52.48 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.07 0.462 . . . . 73.230000000000004 110.046 177.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 84.78 16.34 65.89 Favored Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 115.826 -0.624 . . . . 73.430000000000007 113.587 175.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.671 ' CZ ' HG22 ' A' ' 362' ' ' VAL . 71.0 m-85 -86.4 161.12 18.83 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 117.607 0.703 . . . . 74.439999999999998 111.786 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -90.4 138.34 31.62 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 107.813 -1.18 . . . . 74.219999999999999 107.813 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -117.11 141.21 36.51 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 C-N-CA 119.864 -0.734 . . . . 74.310000000000002 109.574 -175.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 6.2 tpp180 -132.13 147.65 52.44 Favored 'General case' 0 N--CA 1.408 -2.547 0 N-CA-C 107.54 -1.282 . . . . 75.409999999999997 107.54 176.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 54.5 m -134.87 132.33 38.43 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 109.552 -0.536 . . . . 74.310000000000002 109.552 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -111.68 119.84 40.01 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 105.436 -2.061 . . . . 64.409999999999997 105.436 175.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.566 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -125.63 135.41 52.13 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.97 -0.692 . . . . 75.219999999999999 110.775 -177.041 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . 0.425 ' HZ2' ' HB3' ' A' ' 389' ' ' LYS . 3.1 mmmp? -136.75 135.04 19.73 Favored Pre-proline 0 C--N 1.297 -1.713 0 CA-C-N 115.525 -0.761 . . . . 74.530000000000001 109.102 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . 0.531 ' HA ' ' O ' ' A' ' 422' ' ' THR . 20.7 Cg_exo -70.81 127.51 13.85 Favored 'Trans proline' 0 C--O 1.255 1.374 0 N-CA-C 106.236 -2.255 . . . . 74.230000000000004 106.236 166.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.542 ' OD1' HG22 ' A' ' 393' ' ' THR . 7.9 t0 169.15 -165.2 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 105.743 -1.947 . . . . 73.409999999999997 105.743 -169.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 10.6 t -151.93 -1.33 0.31 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 122.153 -0.342 . . . . 71.209999999999994 110.787 175.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.542 HG22 ' OD1' ' A' ' 391' ' ' ASP . 13.4 t -94.85 -7.92 38.83 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.807 -0.558 . . . . 74.450000000000003 112.331 -173.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.01 152.07 43.42 Favored Pre-proline 0 C--N 1.312 -1.061 0 N-CA-C 108.119 -1.067 . . . . 74.25 108.119 176.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_exo -29.95 133.5 0.05 OUTLIER 'Trans proline' 0 CA--C 1.553 1.459 0 C-N-CA 125.083 3.855 . . . . 74.129999999999995 117.18 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . 0.435 ' C ' ' H ' ' A' ' 398' ' ' HIS . 36.7 Cg_endo -64.9 163.76 27.08 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 123.908 3.072 . . . . 73.150000000000006 111.836 176.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . 0.423 ' HA ' HG11 ' A' ' 420' ' ' VAL . 5.4 p-10 -57.07 -7.84 0.56 Allowed 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 123.826 0.851 . . . . 73.120000000000005 112.64 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.435 ' H ' ' C ' ' A' ' 396' ' ' PRO . 53.9 m170 -104.88 124.02 48.74 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 105.102 -2.184 . . . . 73.439999999999998 105.102 172.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 28.5 m -72.11 118.79 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.647 0 CA-C-O 121.261 0.553 . . . . 75.209999999999994 110.938 -169.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.81 -36.98 10.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 107.274 -1.38 . . . . 75.420000000000002 107.274 177.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . 0.422 ' HA2' ' HB2' ' A' ' 366' ' ' ARG . . . -146.64 156.94 27.24 Favored Glycine 0 N--CA 1.412 -2.911 0 N-CA-C 109.207 -1.557 . . . . 65.200000000000003 109.207 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.462 ' OG1' ' HB3' ' A' ' 366' ' ' ARG . 2.1 p -124.46 -177.71 3.89 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 107.486 -1.302 . . . . 72.120000000000005 107.486 176.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -99.64 134.28 21.21 Favored Pre-proline 0 C--N 1.293 -1.887 0 C-N-CA 118.836 -1.146 . . . . 73.319999999999993 109.23 -174.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -49.02 -12.12 0.2 Allowed 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 124.787 3.658 . . . . 72.329999999999998 115.186 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.76 -29.89 55.13 Favored 'General case' 0 C--O 1.21 -0.986 0 C-N-CA 123.439 0.695 . . . . 72.340000000000003 110.021 172.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . 0.461 ' HA ' ' HB ' ' A' ' 362' ' ' VAL . . . -66.9 -50.42 62.48 Favored 'General case' 0 N--CA 1.437 -1.079 0 O-C-N 123.603 0.565 . . . . 52.549999999999997 111.079 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -72.8 -8.6 56.24 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 121.852 -0.53 . . . . 73.299999999999997 111.393 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 90.2 m -85.52 131.4 34.37 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 106.144 -1.799 . . . . 62.329999999999998 106.144 174.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 47.1 p -74.5 112.95 11.19 Favored 'General case' 0 N--CA 1.417 -2.104 0 C-N-CA 118.653 -1.219 . . . . 72.040000000000006 108.859 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 23.7 m -114.56 169.51 5.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 109.911 -0.403 . . . . 74.420000000000002 109.911 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 17.1 m -65.11 136.51 56.79 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.808 -0.812 . . . . 74.430000000000007 108.808 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -58.02 109.56 0.76 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.144 0.497 . . . . 73.420000000000002 111.629 -175.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 105.89 36.65 2.71 Favored Glycine 0 N--CA 1.438 -1.23 0 CA-C-N 115.523 -0.762 . . . . 71.430000000000007 112.661 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -96.96 175.43 6.33 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 109.357 -0.609 . . . . 70.439999999999998 109.357 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -86.74 120.1 27.68 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.278 0.631 . . . . 75.030000000000001 111.341 -172.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 43.0 mm -113.16 111.43 36.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 N-CA-C 108.808 -0.812 . . . . 74.310000000000002 108.808 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 30.5 p -90.85 130.48 36.8 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 112.772 0.656 . . . . 75.340000000000003 112.772 -175.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 4.1 p -121.62 135.24 62.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.957 -0.757 . . . . 74.400000000000006 108.957 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -109.18 127.4 54.18 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.588 -0.523 . . . . 73.030000000000001 109.588 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 44.6 t -126.54 137.72 56.95 Favored 'Isoleucine or valine' 0 C--O 1.25 1.126 0 CA-C-N 115.04 -0.982 . . . . 75.319999999999993 111.23 -174.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 10.0 t -98.03 121.4 39.91 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.557 -1.275 . . . . 75.329999999999998 107.557 176.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' THR . . . . . 0.531 ' O ' ' HA ' ' A' ' 390' ' ' PRO . 7.5 t -120.84 107.79 13.15 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.149 0.426 . . . . 71.230000000000004 112.149 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 103.46 128.88 6.45 Favored Glycine 0 C--N 1.308 -1.022 0 C-N-CA 119.388 -1.387 . . . . 64.200000000000003 112.869 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -64.05 157.83 51.03 Favored 'Trans proline' 0 C--O 1.245 0.866 0 C-N-CA 123.273 2.649 . . . . 75.420000000000002 112.395 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.419 ' HG2' ' HA ' ' A' ' 391' ' ' ASP . 38.4 mt-10 -74.73 156.05 37.02 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.836 -1.074 . . . . 71.010000000000005 111.184 -178.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -89.09 147.34 24.28 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 106.468 -1.679 . . . . 75.540000000000006 106.468 173.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 18.0 mmm-85 -122.51 154.33 38.0 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 120.022 -0.671 . . . . 73.439999999999998 110.512 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.66 141.24 29.91 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-N 114.738 -1.119 . . . . 73.25 109.401 -177.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 66.2 mt -77.38 126.9 84.24 Favored Pre-proline 0 N--CA 1.426 -1.631 0 N-CA-C 105.698 -1.964 . . . . 73.329999999999998 105.698 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.27 141.26 67.98 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 121.973 1.782 . . . . 62.439999999999998 112.477 -177.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -87.63 137.02 32.7 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.968 -1.123 . . . . 62.130000000000003 107.968 177.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 13.3 p -152.02 159.75 3.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 109.335 -0.616 . . . . 64.329999999999998 109.335 -175.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.607 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 13.6 m -78.76 152.77 31.29 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 109.068 -0.716 . . . . 74.129999999999995 109.068 177.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 32.7 p -69.07 -25.86 64.66 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 114.037 1.125 . . . . 74.5 114.037 -173.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.5 pp -90.01 -10.23 45.71 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.679 0.752 . . . . 75.219999999999999 111.245 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.607 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 1.0 OUTLIER -100.16 41.76 1.15 Allowed 'General case' 0 CA--C 1.569 1.674 0 CA-C-N 115.186 -0.915 . . . . 65.310000000000002 110.022 -175.731 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . 0.459 ' HH ' ' HB2' ' A' ' 454' ' ' GLN . 72.4 t80 -52.99 -38.2 62.05 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 113.559 0.948 . . . . 71.209999999999994 113.559 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.01 -35.71 77.58 Favored 'General case' 0 C--O 1.247 0.961 0 CA-C-O 122.016 0.912 . . . . 75.230000000000004 110.836 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 35.1 tp10 -69.63 -37.55 76.84 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.401 -0.592 . . . . 74.109999999999999 109.401 176.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.54 -51.3 70.04 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.867 -0.606 . . . . 74.450000000000003 111.095 -178.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 35.6 m -63.39 -41.56 93.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 112.104 0.409 . . . . 71.109999999999999 112.104 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -68.23 -41.61 80.97 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 119.651 -0.82 . . . . 74.109999999999999 110.713 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -65.34 -38.26 89.59 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-N 115.901 -0.59 . . . . 75.040000000000006 111.042 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.429 ' CD2' ' HB3' ' A' ' 452' ' ' PHE . 13.5 tp -63.49 -36.46 83.82 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.081 -0.711 . . . . 73.409999999999997 109.081 178.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 40.0 m -68.98 -39.48 79.39 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.573 -0.74 . . . . 74.010000000000005 110.129 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.05 -15.95 62.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.937 -0.574 . . . . 63.119999999999997 111.13 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -88.74 5.07 45.11 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.873 -0.603 . . . . 70.299999999999997 110.906 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 109.03 -87.93 0.5 Allowed Glycine 0 CA--C 1.484 -1.883 0 N-CA-C 111.077 -0.809 . . . . 74.409999999999997 111.077 174.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -35.49 -63.14 0.36 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.435 1.272 . . . . 74.129999999999995 114.435 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 55.42 30.75 56.15 Favored Glycine 0 C--O 1.217 -0.909 0 N-CA-C 114.204 0.442 . . . . 72.549999999999997 114.204 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.425 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 30.3 mmm180 -105.75 111.18 23.74 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.64 -0.874 . . . . 73.430000000000007 108.64 -177.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . 0.429 ' HB3' ' CD2' ' A' ' 444' ' ' LEU . 40.8 p90 -133.1 150.37 52.07 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 121.405 0.622 . . . . 75.430000000000007 111.869 -174.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -137.17 126.75 25.21 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.774 -1.103 . . . . 72.5 108.84 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . 0.459 ' HB2' ' HH ' ' A' ' 437' ' ' TYR . 65.0 tt0 -94.74 128.64 41.58 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 120.831 0.348 . . . . 73.239999999999995 110.593 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -128.99 157.86 40.48 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.826 -0.805 . . . . 61.210000000000001 108.826 177.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -126.19 147.94 49.55 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.95 -0.3 . . . . 73.120000000000005 110.338 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 20.9 t -152.62 147.47 19.37 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 107.631 -1.248 . . . . 63.520000000000003 107.631 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 490' ' ' SER . 35.6 Cg_endo -65.84 135.78 42.68 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.237 1.958 . . . . 75.530000000000001 111.38 178.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 459' ' ' SER . . . . . 0.405 ' HG ' ' C ' ' A' ' 458' ' ' PRO . 34.7 m -151.94 179.09 8.76 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.658 -0.867 . . . . 74.310000000000002 108.658 -177.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.5 t -47.92 133.5 11.58 Favored Pre-proline 0 C--O 1.248 1.012 0 O-C-N 123.958 0.786 . . . . 75.239999999999995 111.02 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.69 -30.87 38.74 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 124.331 3.354 . . . . 74.129999999999995 114.003 -174.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -73.21 -27.64 61.73 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 112.345 0.498 . . . . 70.129999999999995 112.345 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -94.18 -2.23 52.9 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 120.721 0.296 . . . . 71.219999999999999 111.41 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 76.7 t -61.13 127.77 21.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.091 -0.707 . . . . 74.219999999999999 109.091 174.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.99 -4.59 75.07 Favored Glycine 0 C--N 1.304 -1.205 0 N-CA-C 111.733 -0.547 . . . . 72.310000000000002 111.733 -177.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -117.68 166.45 12.41 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.135 -0.691 . . . . 72.530000000000001 109.135 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 81.6 t -75.42 144.74 11.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 115.516 -0.766 . . . . 74.340000000000003 109.771 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 47.6 mm -97.68 -30.38 3.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 107.676 -1.231 . . . . 75.420000000000002 107.676 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 158.56 -169.51 35.02 Favored Glycine 0 N--CA 1.418 -2.548 0 CA-C-N 115.179 -0.919 . . . . 75.439999999999998 112.131 174.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 470' ' ' THR . . . . . 0.457 HG23 HG12 ' A' ' 486' ' ' ILE . 20.9 p -114.79 144.55 43.32 Favored 'General case' 0 C--N 1.28 -2.413 0 N-CA-C 106.565 -1.642 . . . . 72.430000000000007 106.565 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.441 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 22.4 t-20 -52.51 -53.41 53.86 Favored Pre-proline 0 N--CA 1.48 1.058 0 N-CA-C 112.744 0.646 . . . . 64.349999999999994 112.744 178.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 2.7 Cg_endo -85.83 147.62 9.45 Favored 'Trans proline' 0 N--CA 1.442 -1.516 0 N-CA-C 108.414 -1.418 . . . . 64.230000000000004 108.414 170.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . 0.428 ' C ' ' H ' ' A' ' 475' ' ' ASN . 24.4 Cg_exo -62.67 132.32 37.18 Favored 'Trans proline' 0 C--O 1.241 0.626 0 C-N-CA 121.633 1.555 . . . . 75.019999999999996 111.194 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -75.11 18.16 0.2 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.733 0.813 . . . . 75.400000000000006 112.239 -176.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . 0.428 ' H ' ' C ' ' A' ' 473' ' ' PRO . 13.0 m120 -110.55 -10.3 14.53 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 123.491 0.716 . . . . 75.420000000000002 110.25 173.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -102.35 174.74 5.78 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.109 0.48 . . . . 73.230000000000004 111.995 -173.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.26 145.88 24.11 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.071 -0.968 . . . . 71.439999999999998 111.585 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 29.1 p -137.24 149.31 47.07 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.069 -0.715 . . . . 73.230000000000004 109.069 176.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.13 165.26 18.56 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.406 -0.361 . . . . 74.519999999999996 111.417 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 42.5 mm -74.88 -16.43 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-O 121.679 0.752 . . . . 72.239999999999995 110.444 -178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 7.3 t -98.2 5.24 48.67 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.506 -0.746 . . . . 71.510000000000005 109.74 176.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -77.43 132.38 38.45 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.999 -0.546 . . . . 63.32 110.206 -175.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . 0.425 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 43.1 t -105.04 126.17 60.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.913 -0.773 . . . . 75.349999999999994 108.913 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 20.2 m -108.29 126.38 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 CA-C-O 121.898 0.856 . . . . 73.120000000000005 111.048 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -94.22 129.3 44.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 108.326 -0.99 . . . . 72.420000000000002 108.326 176.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . 0.457 HG12 HG23 ' A' ' 470' ' ' THR . 18.2 mt -113.5 127.33 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 CA-C-N 115.17 -0.923 . . . . 75.299999999999997 109.808 -176.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 8.0 tt -107.18 126.79 63.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 115.429 -0.805 . . . . 74.5 110.161 -175.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 32.6 m -109.42 151.9 11.6 Favored 'Isoleucine or valine' 0 C--O 1.249 1.056 0 C-N-CA 123.209 0.603 . . . . 75.530000000000001 110.193 178.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.91 123.8 6.25 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 110.864 -0.894 . . . . 71.099999999999994 110.864 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 44.7 m -142.73 129.87 20.86 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 117.221 0.51 . . . . 72.019999999999996 111.118 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 107.77 82.47 1.46 Allowed Glycine 0 C--N 1.31 -0.897 0 C-N-CA 120.732 -0.747 . . . . 51.439999999999998 113.548 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -92.17 160.76 3.18 Favored 'Trans proline' 0 C--O 1.251 1.132 0 C-N-CA 122.299 1.999 . . . . 73.430000000000007 111.651 174.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -124.01 56.88 1.23 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.668 -0.864 . . . . 71.129999999999995 108.668 175.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 2.9 p -117.09 144.08 45.07 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 114.986 -1.006 . . . . 72.129999999999995 111.119 -176.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -140.61 163.81 31.86 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.588 -0.893 . . . . 72.219999999999999 108.588 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -97.25 126.66 42.6 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.822 -0.807 . . . . 70.219999999999999 108.822 -177.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.4 pt -78.55 127.06 81.73 Favored Pre-proline 0 C--N 1.313 -1.011 0 N-CA-C 113.138 0.792 . . . . 74.450000000000003 113.138 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -96.19 155.64 1.37 Allowed 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 122.97 2.447 . . . . 75.209999999999994 110.083 169.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -123.99 164.35 19.51 Favored 'General case' 0 C--N 1.314 -0.945 0 O-C-N 121.675 -0.641 . . . . 75.129999999999995 111.303 -176.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 6.4 p -151.9 96.28 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 CA-C-O 121.947 0.88 . . . . 73.319999999999993 110.179 177.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -102.85 100.67 10.67 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.468 -0.787 . . . . 74.200000000000003 110.732 -177.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 152.1 48.41 0.02 OUTLIER Glycine 0 C--N 1.302 -1.313 0 N-CA-C 110.329 -1.108 . . . . 73.109999999999999 110.329 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -156.15 -178.52 7.38 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.529 -1.656 . . . . 73.519999999999996 106.529 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 18.0 p -89.64 160.07 16.82 Favored 'General case' 0 C--N 1.286 -2.188 0 C-N-CA 120.0 -0.68 . . . . 73.319999999999993 109.424 174.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.464 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.3 p -52.51 -43.55 42.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 O-C-N 123.946 0.779 . . . . 72.120000000000005 111.745 178.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -62.67 -42.56 99.68 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.945 0.402 . . . . 75.209999999999994 111.069 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 57.6 t -73.44 -37.34 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 121.153 0.502 . . . . 64.219999999999999 110.283 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.6 -44.92 92.6 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.424 -0.353 . . . . 64.519999999999996 111.094 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 23.6 mt-30 -60.91 -40.76 94.38 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.448 0.467 . . . . 74.340000000000003 109.958 177.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.444 ' O ' HG22 ' A' ' 514' ' ' VAL . 58.8 tttp -57.9 -50.37 73.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.313 -0.858 . . . . 74.150000000000006 110.105 177.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -62.34 -40.82 97.62 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-N 115.479 -0.782 . . . . 74.140000000000001 111.421 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 40.9 tp -61.1 -41.15 96.15 Favored 'General case' 0 C--O 1.238 0.485 0 O-C-N 123.369 0.418 . . . . 74.329999999999998 109.958 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . 0.424 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 12.1 m120 -65.35 -37.69 87.81 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 116.014 -0.539 . . . . 64.540000000000006 110.675 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 510' ' ' LYS . 95.5 t -66.06 -28.42 43.74 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 116.117 -0.492 . . . . 73.450000000000003 110.362 177.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -75.56 -4.29 39.06 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.814 0.34 . . . . 74.109999999999999 111.171 178.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 105.6 -10.61 45.91 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.892 -0.671 . . . . 74.150000000000006 112.854 175.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 70.6 m-85 -95.77 114.11 25.81 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.157 -0.683 . . . . 73.099999999999994 109.157 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 16.5 p -87.57 -17.95 30.83 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 113.709 1.003 . . . . 74.310000000000002 113.709 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . 0.448 ' HD2' ' O ' ' A' ' 548' ' ' ASP . 96.7 mttt -108.51 119.55 39.85 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.854 0.835 . . . . 73.420000000000002 113.208 -172.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -130.46 152.14 50.18 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.507 -1.224 . . . . 74.329999999999998 111.195 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 63.5 m -142.03 156.54 45.43 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 107.51 -1.293 . . . . 63.200000000000003 107.51 170.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . 0.414 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 3.9 pt20 -116.67 148.9 40.59 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-O 121.542 0.687 . . . . 71.230000000000004 111.056 -177.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . 0.419 ' HB2' ' HG2' ' A' ' 554' ' ' GLN . . . -120.38 119.03 31.91 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.145 -1.428 . . . . 71.299999999999997 107.145 175.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 17.0 m -86.25 123.26 31.32 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 116.243 -0.435 . . . . 72.120000000000005 110.528 -176.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 45.0 t -121.43 149.07 24.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 105.672 -1.973 . . . . 73.510000000000005 105.672 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -102.04 137.05 40.83 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.654 -0.819 . . . . 71.329999999999998 108.934 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 54.2 m -155.38 -176.83 0.65 Allowed Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 107.758 -1.201 . . . . 74.140000000000001 107.758 -176.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -87.5 3.59 6.32 Favored 'Trans proline' 0 CA--C 1.551 1.35 0 C-N-CA 121.699 1.599 . . . . 71.099999999999994 112.798 173.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . 0.495 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 3.6 mpt_? -89.84 134.19 32.53 Favored Pre-proline 0 C--O 1.213 -0.832 0 N-CA-C 108.619 -0.882 . . . . 75.310000000000002 108.619 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -54.79 141.68 76.03 Favored 'Trans proline' 0 N--CA 1.483 0.866 0 C-N-CA 123.223 2.615 . . . . 72.140000000000001 114.315 -171.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -61.07 114.22 2.99 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 114.614 -1.176 . . . . 75.310000000000002 111.375 -175.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 132.49 -20.08 4.44 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 110.226 -1.15 . . . . 62.229999999999997 110.226 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -69.88 131.41 44.4 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 123.185 0.594 . . . . 75.209999999999994 109.895 177.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 7.6 p -86.58 106.15 15.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.13 -1.063 . . . . 72.540000000000006 108.13 174.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 12.0 t -78.56 -16.43 57.45 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.991 -0.55 . . . . 75.239999999999995 111.361 -174.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 163.25 -166.56 37.14 Favored Glycine 0 N--CA 1.429 -1.798 0 N-CA-C 111.194 -0.762 . . . . 72.120000000000005 111.194 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 42.4 p -128.71 149.19 50.79 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 107.706 -1.22 . . . . 75.209999999999994 107.706 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -71.71 -49.44 10.96 Favored Pre-proline 0 C--N 1.303 -1.423 0 C-N-CA 120.621 -0.431 . . . . 71.420000000000002 110.81 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -81.76 126.09 5.1 Favored 'Trans proline' 0 CA--C 1.555 1.531 0 N-CA-C 109.515 -0.994 . . . . 64.150000000000006 109.515 168.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.38 160.84 43.96 Favored 'Trans proline' 0 C--O 1.257 1.471 0 C-N-CA 122.716 2.278 . . . . 62.25 113.325 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.94 139.81 58.81 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.339 -0.846 . . . . 61.420000000000002 110.47 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.27 -17.79 43.25 Favored Glycine 0 C--N 1.297 -1.627 0 N-CA-C 111.343 -0.703 . . . . 44.119999999999997 111.343 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 34.9 m -67.57 123.05 19.37 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.827 -0.434 . . . . 75.209999999999994 109.827 178.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 10.8 m -82.77 123.22 29.12 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 108.075 -1.083 . . . . 60.299999999999997 108.075 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 32.0 m -136.5 155.0 77.23 Favored Pre-proline 0 C--N 1.308 -1.23 0 N-CA-C 108.786 -0.82 . . . . 75.129999999999995 108.786 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -60.59 146.89 96.24 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.182 1.921 . . . . 74.030000000000001 110.222 172.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 27.9 m -60.94 -20.53 22.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 113.58 0.955 . . . . 75.439999999999998 113.58 -176.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . 0.448 ' O ' ' HD2' ' A' ' 519' ' ' LYS . 11.6 t70 -97.96 4.08 49.48 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.315 0.579 . . . . 74.310000000000002 110.566 -178.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.0 t -69.7 154.48 41.92 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.12 0.486 . . . . 74.439999999999998 110.403 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 43.6 t -95.22 127.07 47.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.581 -0.896 . . . . 73.109999999999999 108.581 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 2.7 mp -103.97 136.24 38.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 109.204 -0.665 . . . . 71.430000000000007 109.204 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -102.97 119.23 38.47 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-O 121.515 0.674 . . . . 74.109999999999999 111.344 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 5.2 mp -100.23 133.87 44.0 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.64 -1.164 . . . . 75.239999999999995 108.372 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . 0.419 ' HG2' ' HB2' ' A' ' 523' ' ' ALA . 48.6 mt-30 -97.93 121.75 40.23 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-O 121.294 0.569 . . . . 75.099999999999994 110.283 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 60.7 t -109.94 133.41 55.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 115.194 -0.912 . . . . 73.299999999999997 108.797 -175.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.573 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 29.8 p -94.17 133.34 37.78 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-O 121.024 0.44 . . . . 61.509999999999998 111.811 -178.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -84.41 145.43 28.19 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 107.218 -1.401 . . . . 72.340000000000003 107.218 169.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -81.6 -28.33 43.63 Favored Glycine 0 CA--C 1.478 -2.265 0 O-C-N 123.813 0.695 . . . . 72.230000000000004 113.381 -173.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 70.3 -35.19 0.31 Allowed 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 124.49 1.116 . . . . 75.439999999999998 113.946 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.447 ' H ' ' C ' ' A' ' 558' ' ' GLY . 48.2 mt-30 -125.65 146.16 49.84 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 121.306 0.574 . . . . 74.25 111.638 -172.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -124.72 139.76 53.56 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 115.039 -0.982 . . . . 74.310000000000002 109.184 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 91.2 t -61.46 121.71 10.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 123.393 0.677 . . . . 75.439999999999998 112.333 -175.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 563' ' ' MET . . . . . 0.415 ' HG2' ' O ' ' A' ' 564' ' ' PRO . 54.2 ttp -97.25 132.83 24.79 Favored Pre-proline 0 C--O 1.245 0.864 0 CA-C-N 115.769 -0.651 . . . . 71.310000000000002 111.103 -178.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . 0.415 ' O ' ' HG2' ' A' ' 563' ' ' MET . 13.6 Cg_exo -73.39 170.27 20.3 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.268 2.645 . . . . 74.420000000000002 110.646 171.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -74.98 115.57 14.75 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.834 0.826 . . . . 72.219999999999999 111.418 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 94.8 mt -113.67 7.41 17.24 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 122.666 1.222 . . . . 74.450000000000003 107.76 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 1.4 p -79.63 153.27 29.52 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-N 113.695 -1.593 . . . . 63.130000000000003 111.18 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 88.81 14.44 61.08 Favored Glycine 0 N--CA 1.436 -1.366 0 CA-C-N 115.634 -0.712 . . . . 52.539999999999999 112.908 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 89.1 mtp -108.3 156.27 19.57 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.739 -0.467 . . . . 75.209999999999994 109.739 -175.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 96.2 m-85 -75.56 153.92 37.1 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 108.031 -1.1 . . . . 72.519999999999996 108.031 176.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 74.8 t-105 -68.13 -22.6 64.87 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.532 -0.544 . . . . 74.519999999999996 109.532 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 10.8 p -74.82 -16.92 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 115.229 -0.896 . . . . 74.120000000000005 109.358 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -101.3 -44.17 5.74 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.956 -0.565 . . . . 74.5 110.04 175.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -58.12 -52.28 66.22 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.281 -0.872 . . . . 72.510000000000005 112.674 -176.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.437 ' HA ' ' HG ' ' A' ' 578' ' ' LEU . 41.3 tt0 -60.7 -51.93 76.15 Favored Pre-proline 0 CA--C 1.557 1.22 0 N-CA-C 112.939 0.718 . . . . 74.340000000000003 112.939 -177.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -58.04 -37.23 96.66 Favored 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 121.132 1.221 . . . . 73.340000000000003 112.341 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -69.02 -37.74 78.83 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 112.915 0.709 . . . . 75.5 112.915 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.437 ' HG ' ' HA ' ' A' ' 575' ' ' GLU . 4.1 pp -67.0 -38.36 85.86 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.988 -0.685 . . . . 73.25 110.481 177.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . 0.402 ' N ' HD12 ' A' ' 578' ' ' LEU . 79.8 mtp180 -63.49 -44.52 94.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.307 -0.861 . . . . 75.340000000000003 110.136 176.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.96 -29.19 68.98 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.516 0.726 . . . . 62.229999999999997 111.873 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 64.6 tp -81.2 -7.26 59.53 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 121.381 0.61 . . . . 75.430000000000007 109.883 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 77.83 31.02 50.58 Favored Glycine 0 CA--C 1.492 -1.374 0 N-CA-C 111.305 -0.718 . . . . 72.099999999999994 111.305 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 86.8 t90 -87.36 140.68 29.29 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 109.043 -0.725 . . . . 75.540000000000006 109.043 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 5.8 t -133.33 -50.15 0.86 Allowed 'General case' 0 N--CA 1.41 -2.426 0 CA-C-N 115.708 -0.678 . . . . 71.510000000000005 109.496 175.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . 29.59 -126.6 0.11 Allowed Glycine 0 C--N 1.365 2.186 0 C-N-CA 125.352 1.453 . . . . 75.430000000000007 114.16 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 586' ' ' MET . . . . . 0.434 ' O ' HG12 ' A' ' 619' ' ' ILE . 51.6 ttm -138.03 125.13 21.48 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 105.18 -2.156 . . . . 70.530000000000001 105.18 172.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -99.15 125.2 44.65 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.912 -1.144 . . . . 72.329999999999998 107.912 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -105.14 101.47 11.02 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 115.901 -0.591 . . . . 45.0 109.61 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -99.89 109.88 22.25 Favored 'General case' 0 N--CA 1.416 -2.17 0 N-CA-C 106.833 -1.543 . . . . 74.400000000000006 106.833 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -103.85 -121.6 4.95 Favored Glycine 0 N--CA 1.425 -2.086 0 N-CA-C 110.535 -1.026 . . . . 63.219999999999999 110.535 178.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -86.9 119.75 27.45 Favored 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 120.702 -0.399 . . . . 72.209999999999994 110.788 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -77.86 152.57 33.31 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 105.273 -2.121 . . . . 72.299999999999997 105.273 169.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . 0.402 ' O ' ' HB2' ' A' ' 626' ' ' GLN . 59.5 t -103.84 116.04 46.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 C-N-CA 118.931 -1.108 . . . . 74.310000000000002 111.94 -169.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.33 107.08 17.17 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.951 -1.129 . . . . 73.099999999999994 107.951 175.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -139.47 17.98 2.55 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.288 -1.004 . . . . 75.200000000000003 108.288 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 98.33 144.21 16.41 Favored Glycine 0 N--CA 1.414 -2.816 0 CA-C-N 114.645 -1.161 . . . . 51.109999999999999 111.089 -176.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.76 -32.3 61.69 Favored Glycine 0 C--N 1.32 -0.315 0 O-C-N 123.935 0.432 . . . . 72.230000000000004 112.503 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 10.0 m -59.06 -23.61 62.17 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.212 1.005 . . . . 72.040000000000006 112.798 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -86.71 -13.72 44.57 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 121.852 -0.53 . . . . 75.430000000000007 110.397 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 56.92 161.59 0.02 OUTLIER 'General case' 0 C--O 1.243 0.757 0 N-CA-C 115.475 1.657 . . . . 75.530000000000001 115.475 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -79.56 89.62 5.09 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 114.745 -1.116 . . . . 72.140000000000001 109.455 172.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . 0.469 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 49.4 ttt180 -117.65 148.78 41.64 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 106.569 -1.641 . . . . 74.200000000000003 106.569 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 67.9 t -61.77 131.12 26.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.468 -0.938 . . . . 75.340000000000003 108.468 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 83.7 t -86.87 -46.56 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.008 0 N-CA-C 109.142 -0.688 . . . . 75.439999999999998 109.142 -174.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -156.1 164.17 38.74 Favored 'General case' 0 N--CA 1.415 -2.217 0 N-CA-C 107.647 -1.242 . . . . 72.340000000000003 107.647 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.04 150.84 44.46 Favored 'General case' 0 C--N 1.279 -2.458 0 N-CA-C 106.928 -1.508 . . . . 74.329999999999998 106.928 173.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.505 ' HB3' ' HD3' ' A' ' 608' ' ' PRO 0.294 48.7 t-20 -70.3 -79.36 0.05 OUTLIER Pre-proline 0 CA--C 1.563 1.445 0 CA-C-O 117.555 -1.212 . . . . 74.140000000000001 113.587 -171.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.505 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 14.6 Cg_exo -73.24 127.39 11.91 Favored 'Trans proline' 0 C--N 1.374 1.875 0 CA-C-N 122.729 2.01 . . . . 73.049999999999997 108.866 174.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.86 160.18 34.49 Favored 'Trans proline' 0 C--O 1.24 0.61 0 C-N-CA 122.392 2.062 . . . . 63.210000000000001 112.594 -175.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.94 127.05 29.57 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.434 -0.58 . . . . 72.219999999999999 109.434 -178.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.47 -12.48 47.36 Favored Glycine 0 N--CA 1.431 -1.651 0 C-N-CA 120.573 -0.823 . . . . 45.539999999999999 111.231 -175.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 27.8 m -97.66 164.62 12.34 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 107.936 -1.135 . . . . 64.010000000000005 107.936 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -88.81 143.41 17.59 Favored Glycine 0 N--CA 1.427 -1.95 0 C-N-CA 121.197 -0.525 . . . . 72.209999999999994 113.59 -177.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 24.3 m -107.92 142.17 21.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.989 -1.115 . . . . 71.019999999999996 107.989 173.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . 0.494 HD22 HG23 ' A' ' 619' ' ' ILE . 31.8 p30 -62.54 164.87 6.91 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 114.282 1.216 . . . . 61.43 114.282 -175.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -55.49 -25.8 39.02 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 114.788 1.403 . . . . 75.239999999999995 114.788 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -74.73 -44.53 49.44 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 106.845 -1.539 . . . . 72.319999999999993 106.845 174.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 97.56 20.65 21.6 Favored Glycine 0 N--CA 1.418 -2.511 0 CA-C-N 114.672 -1.149 . . . . 74.120000000000005 110.53 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . 0.494 HG23 HD22 ' A' ' 615' ' ' ASN . 0.0 OUTLIER -69.42 122.03 20.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 122.078 0.942 . . . . 73.409999999999997 109.928 -172.257 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 9.4 tp -121.89 132.59 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.098 0 CA-C-N 114.606 -1.179 . . . . 75.099999999999994 108.929 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.416 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 7.4 m -97.62 119.72 36.69 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.178 -1.045 . . . . 71.329999999999998 108.178 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 81.6 mt -130.76 154.43 47.99 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 123.739 0.815 . . . . 74.439999999999998 109.33 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 65.2 mmt-85 -136.71 154.9 50.47 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 104.583 -2.377 . . . . 72.030000000000001 104.583 173.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 602' ' ' ARG . 30.5 p90 -141.31 160.35 40.31 Favored 'General case' 0 C--N 1.288 -2.082 0 O-C-N 123.293 0.371 . . . . 72.450000000000003 110.403 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -73.44 -151.14 1.72 Allowed Glycine 0 C--N 1.309 -0.959 0 O-C-N 124.196 0.935 . . . . 63.43 113.446 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 593' ' ' VAL . 6.9 tp-100 . . . . . 0 C--N 1.299 -1.602 0 CA-C-O 119.31 -0.376 . . . . 70.420000000000002 110.438 -175.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.592 0 N-CA-C 111.045 -0.822 . . . . 74.450000000000003 111.045 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 8.2 tp -75.48 126.28 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 CA-C-O 121.515 0.674 . . . . 74.150000000000006 109.391 177.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.61 140.94 51.76 Favored 'General case' 0 N--CA 1.389 -3.479 0 CA-C-N 115.384 -0.826 . . . . 73.140000000000001 112.12 -177.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 2.1 ppt_? -145.99 86.2 1.71 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 122.614 1.197 . . . . 73.150000000000006 110.8 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -107.56 148.08 29.73 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.063 -1.426 . . . . 72.439999999999998 109.725 -176.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.67 163.56 34.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 109.724 -0.473 . . . . 73.239999999999995 109.724 -177.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -93.67 137.36 33.0 Favored 'General case' 0 N--CA 1.404 -2.762 0 CA-C-O 121.619 0.723 . . . . 75.129999999999995 109.245 177.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 91.4 t -98.29 134.27 22.12 Favored Pre-proline 0 C--N 1.268 -2.972 0 CA-C-N 114.337 -1.302 . . . . 72.209999999999994 110.171 -173.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -71.21 128.79 15.15 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.856 1.704 . . . . 74.109999999999999 110.214 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.39 157.92 18.44 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.288 -0.565 . . . . 75.430000000000007 109.485 -177.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.416 HG23 ' HA ' ' A' ' 373' ' ' ALA . 18.8 m -131.5 26.55 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-N 115.205 -0.907 . . . . 73.540000000000006 109.085 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -66.43 148.55 51.71 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 114.749 -1.114 . . . . 73.439999999999998 109.103 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 107.01 0.7 35.95 Favored Glycine 0 C--N 1.315 -0.625 0 N-CA-C 111.349 -0.7 . . . . 75.540000000000006 111.349 -173.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -113.03 -146.83 0.41 Allowed 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.7 -0.852 . . . . 70.420000000000002 108.7 175.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 58.4 p -89.57 160.77 16.52 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 107.929 -1.137 . . . . 65.540000000000006 107.929 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 8.8 p -63.52 -34.89 78.78 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 120.078 -0.649 . . . . 73.349999999999994 110.568 177.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -65.81 -47.58 74.61 Favored 'General case' 0 C--O 1.216 -0.692 0 N-CA-C 111.902 0.334 . . . . 74.439999999999998 111.902 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -67.19 -42.85 83.5 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.716 0.77 . . . . 74.099999999999994 109.247 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . 0.416 ' HA ' HG23 ' A' ' 365' ' ' VAL . . . -65.35 -42.65 92.61 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 114.558 -1.201 . . . . 73.120000000000005 112.27 -177.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 58.1 mt -69.58 -45.58 77.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 116.592 -0.276 . . . . 74.450000000000003 110.55 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.81 -44.56 90.84 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 123.515 0.509 . . . . 73.349999999999994 111.647 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' THR . . . . . 0.503 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 23.6 m -65.2 -46.64 79.89 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 116.13 -0.486 . . . . 71.310000000000002 110.597 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . 0.414 HD21 ' O ' ' A' ' 373' ' ' ALA . 4.6 mm? -63.17 -38.07 89.71 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 111.803 0.297 . . . . 73.420000000000002 111.803 178.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -63.65 -38.05 89.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.056 0.455 . . . . 74.430000000000007 110.068 178.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -70.07 -21.24 63.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 73.140000000000001 111.644 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' A' ' 376' ' ' THR . 38.4 mmt180 -82.6 -14.11 55.36 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.61 -0.515 . . . . 73.5 109.61 176.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 97.54 6.02 57.59 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 111.385 -0.686 . . . . 62.420000000000002 111.385 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -89.4 149.01 23.17 Favored 'General case' 0 N--CA 1.406 -2.653 0 CA-C-O 121.61 0.719 . . . . 75.530000000000001 111.244 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -96.14 155.09 16.9 Favored 'General case' 0 N--CA 1.41 -2.466 0 CA-C-N 114.548 -1.205 . . . . 72.409999999999997 107.764 -177.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.42 141.94 45.01 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 N-CA-C 109.204 -0.665 . . . . 75.219999999999999 109.204 -177.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 28.2 ttm-85 -125.53 127.57 46.63 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 108.186 -1.042 . . . . 74.209999999999994 108.186 177.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 33.5 m -115.56 123.64 48.98 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-O 120.925 0.393 . . . . 64.430000000000007 110.691 -173.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -112.24 131.09 55.69 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.994 -1.484 . . . . 71.430000000000007 106.994 175.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.49 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -123.11 142.16 51.18 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 119.374 -0.931 . . . . 71.230000000000004 111.403 -179.079 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . 0.402 ' HB2' HG13 ' A' ' 394' ' ' ILE . 75.4 mmtt -131.88 131.26 22.53 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 108.646 -0.872 . . . . 75.109999999999999 108.646 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . 0.44 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 60.6 Cg_endo -83.62 129.18 4.85 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 121.626 1.55 . . . . 73.299999999999997 111.538 176.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 14.8 t70 158.58 -158.06 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 104.308 -2.478 . . . . 74.299999999999997 104.308 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.405 ' H ' ' CG ' ' A' ' 391' ' ' ASP . 19.3 m -136.36 2.37 2.74 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 119.213 0.915 . . . . 73.129999999999995 110.784 177.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 1.3 p -81.87 -27.65 33.36 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 112.792 0.664 . . . . 70.040000000000006 112.792 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . 0.407 ' H ' HD11 ' A' ' 394' ' ' ILE . 0.2 OUTLIER -93.04 152.09 41.08 Favored Pre-proline 0 C--N 1.29 -1.997 0 CA-C-N 115.898 -0.592 . . . . 73.239999999999995 110.399 -176.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -43.01 129.46 5.65 Favored 'Trans proline' 0 C--N 1.363 1.339 0 C-N-CA 124.159 3.239 . . . . 53.240000000000002 114.528 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -61.04 161.61 21.91 Favored 'Trans proline' 0 N--CA 1.482 0.851 0 C-N-CA 124.212 3.275 . . . . 74.120000000000005 113.489 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -59.37 -8.08 1.6 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 112.975 0.732 . . . . 75.019999999999996 112.975 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -98.02 122.38 41.08 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 103.52 -2.77 . . . . 74.200000000000003 103.52 171.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 26.8 m -77.92 117.05 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.351 0 C-N-CA 118.982 -1.087 . . . . 73.439999999999998 113.565 -162.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 43.6 pt -103.32 -27.4 3.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 114.523 -1.217 . . . . 73.340000000000003 108.548 174.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . 0.408 ' C ' ' HG1' ' A' ' 402' ' ' THR . . . -145.8 157.13 27.27 Favored Glycine 1 CA--C 1.442 -4.525 0 CA-C-O 122.397 0.998 . . . . 63.119999999999997 111.647 179.256 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.408 ' HG1' ' C ' ' A' ' 401' ' ' GLY . 87.2 m -156.54 -177.89 6.93 Favored 'General case' 0 N--CA 1.383 -3.783 0 N-CA-C 104.592 -2.373 . . . . 72.099999999999994 104.592 -171.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . 0.471 ' C ' ' H ' ' A' ' 405' ' ' ALA . 15.0 m-20 -98.6 131.65 25.5 Favored Pre-proline 0 C--N 1.264 -3.111 0 N-CA-C 106.117 -1.808 . . . . 71.219999999999999 106.117 174.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.6 26.31 0.12 Allowed 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 124.472 3.448 . . . . 74.099999999999994 114.761 -171.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.471 ' H ' ' C ' ' A' ' 403' ' ' ASP . . . -56.92 -35.99 69.67 Favored 'General case' 0 C--O 1.209 -1.077 0 C-N-CA 123.658 0.783 . . . . 70.450000000000003 110.635 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -70.86 -33.61 70.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.33 0.586 . . . . 74.310000000000002 111.049 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -88.12 -1.34 57.95 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 122.081 0.943 . . . . 74.140000000000001 109.406 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 26.6 m -95.28 148.51 22.34 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 104.874 -2.269 . . . . 74.010000000000005 104.874 173.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 4.1 p -74.89 111.99 10.65 Favored 'General case' 0 N--CA 1.41 -2.46 0 C-N-CA 118.603 -1.239 . . . . 62.240000000000002 108.839 176.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 30.2 m -123.71 167.46 17.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.702 -0.681 . . . . 70.299999999999997 110.344 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 38.4 m -76.94 146.91 37.25 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 108.832 -0.803 . . . . 75.420000000000002 108.832 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -64.73 109.45 2.04 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.9 0.381 . . . . 72.129999999999995 111.184 -176.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 111.67 53.12 0.53 Allowed Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.819 -0.628 . . . . 64.310000000000002 112.614 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.61 -167.65 1.29 Allowed 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.46 -0.941 . . . . 73.030000000000001 108.46 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -113.91 137.16 52.06 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.114 0.483 . . . . 72.129999999999995 110.305 -176.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 34.7 mm -110.28 110.73 33.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 108.712 -0.848 . . . . 63.25 108.712 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 21.0 p -84.1 131.22 34.81 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 123.098 0.559 . . . . 65.340000000000003 111.838 -177.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 10.6 p -127.25 135.2 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-N 115.673 -0.694 . . . . 73.230000000000004 111.441 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -105.27 124.61 49.83 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.992 -0.744 . . . . 73.430000000000007 108.992 172.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 16.7 m -126.04 152.7 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.545 0 CA-C-N 115.28 -0.873 . . . . 71.129999999999995 110.535 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 27.1 t -99.38 129.64 45.59 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-O 121.718 0.77 . . . . 71.230000000000004 110.584 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 3.0 p -93.61 158.36 15.73 Favored 'General case' 0 N--CA 1.401 -2.906 0 N-CA-C 105.008 -2.219 . . . . 65.430000000000007 105.008 166.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -56.83 -141.85 0.01 OUTLIER Glycine 0 CA--C 1.553 2.419 0 N-CA-C 116.729 1.451 . . . . 74.25 116.729 -175.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -70.86 154.61 63.29 Favored 'Trans proline' 0 C--O 1.263 1.763 0 C-N-CA 121.782 1.655 . . . . 71.120000000000005 113.355 -173.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -74.79 166.57 23.39 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 114.561 -1.2 . . . . 72.230000000000004 110.015 177.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -113.23 157.58 21.55 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 106.676 -1.602 . . . . 75.340000000000003 106.676 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 -122.21 152.46 39.96 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 119.398 -0.921 . . . . 72.349999999999994 111.254 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -83.23 138.64 33.52 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 114.445 -1.252 . . . . 62.549999999999997 109.073 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 53.7 mt -84.12 122.95 75.89 Favored Pre-proline 0 N--CA 1.424 -1.733 0 N-CA-C 107.297 -1.371 . . . . 75.150000000000006 107.297 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.74 150.42 62.2 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.802 1.668 . . . . 75.209999999999994 110.892 176.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -80.5 130.13 34.95 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.167 -1.049 . . . . 72.140000000000001 108.167 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 39.5 t -127.03 152.3 34.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 107.438 -1.319 . . . . 74.409999999999997 107.438 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 42.6 t -70.29 143.64 51.99 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.833 -0.803 . . . . 72.400000000000006 108.833 176.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 18.9 p -67.56 -28.44 67.79 Favored 'General case' 0 N--CA 1.424 -1.726 0 C-N-CA 123.658 0.783 . . . . 65.409999999999997 111.532 -175.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 2.3 pp -79.36 -12.53 59.92 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.339 0.59 . . . . 73.430000000000007 111.963 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 3.2 p -104.05 62.98 0.75 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 121.567 0.699 . . . . 74.450000000000003 112.41 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -56.95 -38.58 73.13 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.078 -0.964 . . . . 73.040000000000006 111.014 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -60.04 -42.49 94.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.424 0.63 . . . . 74.5 110.254 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . 0.483 ' O ' ' HB3' ' A' ' 442' ' ' LYS . 25.8 tp10 -70.89 -34.95 72.1 Favored 'General case' 0 C--O 1.205 -1.237 0 CA-C-N 115.463 -0.79 . . . . 72.030000000000001 110.035 178.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.6 -51.42 69.47 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.303 0.112 . . . . 73.209999999999994 111.303 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 33.9 m -63.01 -36.57 76.39 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 CA-C-O 121.273 0.559 . . . . 75.299999999999997 110.839 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.483 ' HB3' ' O ' ' A' ' 439' ' ' GLU . 16.6 tppt? -60.04 -47.69 84.8 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.942 -1.026 . . . . 65.430000000000007 109.998 176.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -67.04 -38.51 86.0 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 113.067 0.765 . . . . 75.519999999999996 113.067 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 9.8 mp -63.71 -34.93 78.96 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.6 -0.44 . . . . 72.319999999999993 109.974 174.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 92.9 m -68.23 -42.2 80.09 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.884 -0.598 . . . . 74.510000000000005 110.182 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.82 -20.64 62.55 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.909 -0.587 . . . . 73.319999999999993 112.063 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -90.2 3.28 53.96 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 112.492 0.553 . . . . 65.540000000000006 112.492 -178.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 110.28 -75.28 0.21 Allowed Glycine 0 CA--C 1.497 -1.071 0 C-N-CA 119.581 -1.295 . . . . 74.349999999999994 112.98 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . 0.434 ' HA ' ' O ' ' A' ' 480' ' ' ILE . 0.2 OUTLIER -40.94 -62.36 0.83 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.902 1.075 . . . . 74.219999999999999 113.902 177.589 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 61.14 23.08 61.43 Favored Glycine 0 C--O 1.221 -0.701 0 C-N-CA 121.172 -0.537 . . . . 75.019999999999996 112.447 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -97.89 111.24 23.61 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 107.921 -1.14 . . . . 70.340000000000003 107.921 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 19.7 p90 -137.6 149.49 46.69 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 121.215 0.531 . . . . 74.209999999999994 111.576 -177.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -136.19 142.48 44.12 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.446 -1.316 . . . . 65.219999999999999 107.446 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -112.7 126.03 54.96 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 120.601 0.239 . . . . 72.120000000000005 110.558 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -123.07 136.15 54.7 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.281 -1.007 . . . . 72.400000000000006 108.281 175.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -113.34 141.52 46.94 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.834 -1.173 . . . . 65.400000000000006 107.834 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 50.0 m -144.68 140.22 16.23 Favored Pre-proline 0 C--N 1.292 -1.931 0 N-CA-C 109.939 -0.393 . . . . 73.420000000000002 109.939 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.577 ' HA ' ' O ' ' A' ' 490' ' ' SER . 21.4 Cg_endo -64.93 122.6 10.45 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.625 1.55 . . . . 72.040000000000006 108.968 176.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 19.8 m -135.84 179.64 6.22 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.55 -0.75 . . . . 63.530000000000001 110.133 -171.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 7.2 t -59.5 139.75 88.98 Favored Pre-proline 0 N--CA 1.42 -1.927 0 O-C-N 124.13 0.894 . . . . 71.310000000000002 109.399 174.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.37 -29.08 29.31 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.707 3.605 . . . . 70.010000000000005 113.492 -175.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -65.34 -37.18 86.29 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.541 -0.3 . . . . 74.329999999999998 111.807 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.07 -14.87 32.91 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 121.044 -0.262 . . . . 74.230000000000004 111.397 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 85.4 t -60.31 128.12 20.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-N 116.498 -0.319 . . . . 75.129999999999995 110.29 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 95.45 -12.11 68.1 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.519 -0.764 . . . . 72.140000000000001 112.229 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -122.47 167.45 13.33 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.204 -0.665 . . . . 74.340000000000003 109.204 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 62.4 t -72.63 143.89 13.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 107.567 -1.272 . . . . 73.439999999999998 107.567 171.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 55.3 mt -97.18 -34.03 4.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.372 -1.344 . . . . 72.230000000000004 107.372 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 163.06 -172.87 39.17 Favored Glycine 0 N--CA 1.409 -3.106 0 CA-C-N 114.802 -1.09 . . . . 64.319999999999993 110.508 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 24.5 p -116.1 147.83 40.91 Favored 'General case' 0 N--CA 1.404 -2.728 0 N-CA-C 105.931 -1.877 . . . . 75.209999999999994 105.931 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.405 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 20.3 t-20 -70.18 -49.99 16.83 Favored Pre-proline 0 C--N 1.313 -0.979 0 C-N-CA 118.237 -1.385 . . . . 72.219999999999999 110.756 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.405 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 19.2 Cg_exo -74.07 125.42 9.8 Favored 'Trans proline' 0 C--N 1.368 1.582 0 N-CA-C 106.837 -2.024 . . . . 71.519999999999996 106.837 165.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . 0.428 ' C ' ' H ' ' A' ' 475' ' ' ASN . 21.8 Cg_exo -61.98 133.64 45.47 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 122.129 1.886 . . . . 71.239999999999995 113.562 -172.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -75.34 16.87 0.3 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.057 0.943 . . . . 64.430000000000007 112.188 -176.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . 0.428 ' H ' ' C ' ' A' ' 473' ' ' PRO . 14.1 m120 -110.45 -10.93 14.54 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.887 -0.597 . . . . 64.209999999999994 109.551 177.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -90.24 176.97 6.55 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.661 -0.699 . . . . 75.430000000000007 112.473 -174.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 6.1 m -107.57 114.98 29.34 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 107.412 -1.329 . . . . 74.109999999999999 107.412 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 13.4 p -112.61 147.85 35.82 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.157 0.503 . . . . 74.239999999999995 111.635 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.58 160.22 30.42 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.843 -0.617 . . . . 72.319999999999993 111.371 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 449' ' ' PHE . 1.8 mp -67.63 -15.16 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.394 0 CA-C-O 122.145 0.974 . . . . 74.200000000000003 112.059 -178.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 11.6 p -103.49 5.3 36.76 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.436 -0.79 . . . . 75.109999999999999 111.331 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -85.36 129.39 34.82 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.094 -0.706 . . . . 73.349999999999994 109.094 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 61.5 t -91.93 126.6 44.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.864 -0.607 . . . . 74.219999999999999 110.303 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 30.2 t -106.38 120.05 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 N-CA-C 108.781 -0.822 . . . . 64.319999999999993 108.781 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.39 123.67 47.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-O 121.227 0.537 . . . . 73.430000000000007 110.124 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.59 128.09 55.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 124.976 1.31 . . . . 72.409999999999997 108.795 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 8.2 tt -109.74 126.6 66.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 109.255 -0.646 . . . . 75.209999999999994 109.255 176.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 34.1 m -109.17 151.34 11.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 116.251 -0.431 . . . . 72.219999999999999 110.232 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -88.78 131.58 10.76 Favored Glycine 0 N--CA 1.439 -1.104 0 C-N-CA 120.592 -0.813 . . . . 75.010000000000005 111.851 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.577 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 19.5 m -123.64 155.78 37.09 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.65 -0.87 . . . . 74.319999999999993 108.65 177.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 135.08 90.88 0.35 Allowed Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.51 -0.852 . . . . 73.319999999999993 112.009 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.96 151.45 24.11 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.202 1.935 . . . . 74.540000000000006 112.603 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -84.65 67.08 9.88 Favored 'General case' 0 C--O 1.25 1.095 0 CA-C-O 122.158 0.98 . . . . 74.040000000000006 110.461 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 494' ' ' THR . . . . . 0.421 ' HB ' HG23 ' A' ' 544' ' ' THR . 11.1 p -117.64 153.67 32.9 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 114.735 -1.121 . . . . 62.43 110.559 -178.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -149.73 150.38 31.99 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.689 -0.856 . . . . 64.319999999999993 108.689 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.7 p-10 -81.74 138.95 35.13 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 123.588 0.755 . . . . 71.120000000000005 110.903 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 543' ' ' THR . 22.2 pt -92.85 117.92 67.72 Favored Pre-proline 0 C--N 1.307 -1.254 0 CA-C-N 115.954 -0.567 . . . . 74.040000000000006 110.876 176.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -92.99 146.45 2.44 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.422 2.081 . . . . 71.129999999999995 111.373 175.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -83.39 96.07 8.42 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 122.803 1.287 . . . . 72.200000000000003 110.634 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.6 p -100.44 23.26 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 123.258 1.504 . . . . 75.409999999999997 107.432 177.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -77.07 171.6 14.55 Favored 'General case' 0 N--CA 1.416 -2.149 0 CA-C-N 113.368 -1.742 . . . . 73.349999999999994 110.295 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 96.74 22.4 18.47 Favored Glycine 0 C--N 1.285 -2.278 0 N-CA-C 108.258 -1.937 . . . . 63.310000000000002 108.258 -177.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -133.68 174.73 10.13 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 108.265 -1.013 . . . . 73.230000000000004 108.265 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 41.7 p -77.91 164.32 25.24 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 117.966 0.348 . . . . 62.409999999999997 110.998 -176.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 17.4 m -51.42 -44.49 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.652 0 C-N-CA 123.79 0.836 . . . . 73.219999999999999 112.982 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -68.01 -41.78 81.68 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.215 0.531 . . . . 73.099999999999994 111.079 -178.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 62.5 t -72.55 -46.45 55.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 115.361 -0.836 . . . . 74.439999999999998 111.535 -175.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.72 -40.44 96.75 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.655 -0.248 . . . . 71.319999999999993 110.812 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -59.96 -43.55 94.98 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.387 -0.598 . . . . 75.040000000000006 109.387 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.499 ' O ' HG21 ' A' ' 514' ' ' VAL . 59.7 tttm -58.1 -50.95 71.71 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.729 -1.123 . . . . 74.219999999999999 109.801 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -62.59 -46.75 86.88 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.575 -0.739 . . . . 75.420000000000002 112.046 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.94 -40.51 89.19 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 120.878 -0.329 . . . . 72.340000000000003 110.729 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.97 -37.98 89.42 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.127 -0.488 . . . . 55.130000000000003 111.309 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.499 HG21 ' O ' ' A' ' 510' ' ' LYS . 77.3 t -62.48 -30.47 49.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 121.006 0.431 . . . . 74.230000000000004 110.785 178.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -83.07 7.96 14.28 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.161 0.505 . . . . 75.540000000000006 111.715 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 93.99 -10.47 71.95 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.988 -0.625 . . . . 72.409999999999997 111.81 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -87.56 81.45 7.74 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-O 121.882 0.849 . . . . 74.010000000000005 109.433 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 3.5 p -89.89 3.34 53.32 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.917 -1.038 . . . . 75.439999999999998 110.98 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -108.74 113.45 26.42 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.061 -1.089 . . . . 73.030000000000001 108.061 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -131.56 156.64 45.39 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.024 -0.989 . . . . 72.239999999999995 111.791 -174.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 50.3 m -137.0 145.55 44.26 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 106.041 -1.837 . . . . 73.510000000000005 106.041 171.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -117.09 132.99 56.55 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 120.856 0.36 . . . . 73.319999999999993 110.267 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -124.58 141.11 52.34 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.179 -1.045 . . . . 75.510000000000005 108.179 176.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 6.4 m -110.28 120.75 43.45 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.62 -0.881 . . . . 72.0 108.62 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 34.9 m -120.9 164.12 17.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 110.294 -0.262 . . . . 73.109999999999999 110.294 -175.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . 0.573 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 8.0 p-10 -90.63 135.26 33.82 Favored 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 120.274 -0.57 . . . . 74.010000000000005 111.343 -177.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 527' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 67.5 m -160.75 -179.92 1.18 Allowed Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 108.914 -0.773 . . . . 75.329999999999998 108.914 176.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -85.55 -19.15 3.62 Favored 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 121.505 1.47 . . . . 72.5 111.158 171.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -69.11 137.16 89.36 Favored Pre-proline 0 N--CA 1.437 -1.092 0 C-N-CA 124.018 0.927 . . . . 75.129999999999995 109.628 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -56.73 144.56 86.4 Favored 'Trans proline' 0 C--O 1.245 0.863 0 C-N-CA 123.624 2.883 . . . . 73.319999999999993 115.505 -170.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.627 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -67.4 115.51 7.12 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 114.258 -1.337 . . . . 75.230000000000004 109.907 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 133.93 -21.47 3.94 Favored Glycine 0 C--N 1.297 -1.61 0 N-CA-C 110.777 -0.929 . . . . 54.310000000000002 110.777 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -83.07 128.9 34.9 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 120.951 0.405 . . . . 75.019999999999996 110.596 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . 0.404 HG23 HG22 ' A' ' 555' ' ' VAL . 84.2 t -83.22 105.74 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 N-CA-C 104.791 -2.3 . . . . 72.319999999999993 104.791 170.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 74.1 m -83.69 -16.85 43.45 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 112.312 0.486 . . . . 75.439999999999998 112.312 -173.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 173.44 -161.78 32.66 Favored Glycine 0 CA--C 1.49 -1.505 0 C-N-CA 120.099 -1.048 . . . . 61.520000000000003 111.251 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 23.7 p -127.77 160.07 32.85 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.782 -0.822 . . . . 74.219999999999999 108.782 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -73.01 -51.57 6.1 Favored Pre-proline 0 C--N 1.307 -1.243 0 CA-C-O 119.337 -0.363 . . . . 73.5 110.034 176.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -66.55 130.86 24.58 Favored 'Trans proline' 0 C--N 1.378 2.103 0 N-CA-C 108.487 -1.39 . . . . 73.420000000000002 108.487 170.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -61.66 142.11 93.24 Favored 'Trans proline' 0 C--O 1.241 0.673 0 C-N-CA 122.59 2.193 . . . . 74.219999999999999 114.161 -176.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.54 141.72 57.76 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.125 -0.943 . . . . 61.240000000000002 109.996 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.11 -20.65 46.61 Favored Glycine 0 C--N 1.302 -1.322 0 N-CA-C 110.545 -1.022 . . . . 72.120000000000005 110.545 -177.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 543' ' ' THR . . . . . 0.416 ' O ' HG12 ' A' ' 497' ' ' ILE . 63.5 m -76.47 137.66 39.81 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-O 121.507 0.67 . . . . 73.400000000000006 109.868 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 18.4 m -94.14 123.92 37.82 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 115.373 -0.83 . . . . 74.510000000000005 109.749 -176.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 31.6 m -129.12 157.96 74.36 Favored Pre-proline 0 C--N 1.312 -1.044 0 N-CA-C 109.217 -0.661 . . . . 75.209999999999994 109.217 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -66.07 143.61 72.58 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.067 1.845 . . . . 74.430000000000007 110.793 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 36.0 m -66.26 -19.04 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-O 121.521 0.677 . . . . 70.420000000000002 111.842 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -87.53 -2.05 58.35 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 115.297 -0.865 . . . . 73.230000000000004 110.703 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 32.3 t -89.09 157.24 18.39 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.485 -0.561 . . . . 74.239999999999995 109.485 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 25.8 t -96.33 136.65 26.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 109.24 -0.652 . . . . 71.140000000000001 109.24 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 2.7 mp -113.66 138.56 42.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.379 -0.6 . . . . 75.299999999999997 109.379 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -101.98 121.13 41.56 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 121.36 0.6 . . . . 74.349999999999994 110.472 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.3 mp -95.56 132.08 41.08 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.364 -1.289 . . . . 74.120000000000005 107.859 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -106.84 120.17 41.31 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 122.013 0.911 . . . . 63.340000000000003 110.953 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . 0.404 HG22 HG23 ' A' ' 534' ' ' VAL . 47.0 t -99.61 135.65 34.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-N 114.111 -1.404 . . . . 71.439999999999998 108.211 -178.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.627 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 68.2 m -90.73 149.2 22.13 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 116.464 -0.335 . . . . 62.530000000000001 110.455 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.573 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 15.8 ptmt -105.65 146.68 29.39 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 105.226 -2.138 . . . . 74.510000000000005 105.226 172.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -84.15 -24.72 47.06 Favored Glycine 0 N--CA 1.433 -1.549 0 C-N-CA 119.479 -1.343 . . . . 73.209999999999994 112.239 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 70.02 5.91 5.5 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.687 1.195 . . . . 74.319999999999993 111.004 -177.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 15.3 tp60 -148.53 141.87 25.2 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 106.891 -1.522 . . . . 75.150000000000006 106.891 -171.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -143.86 149.52 37.06 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.945 -0.761 . . . . 74.239999999999995 108.945 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.52 119.79 32.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 121.286 0.565 . . . . 72.099999999999994 111.413 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 60.4 ttp -97.75 134.0 22.84 Favored Pre-proline 0 C--N 1.316 -0.873 0 N-CA-C 108.537 -0.912 . . . . 73.040000000000006 108.537 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -64.18 169.52 10.61 Favored 'Trans proline' 0 C--O 1.245 0.872 0 C-N-CA 122.864 2.376 . . . . 75.409999999999997 112.378 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -69.0 131.07 44.48 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 113.802 1.038 . . . . 72.140000000000001 113.802 -177.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 93.8 mt -147.12 23.19 1.19 Allowed 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 125.141 1.377 . . . . 75.349999999999994 107.942 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 2.8 m -79.25 146.28 33.1 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 116.25 -0.432 . . . . 75.430000000000007 110.824 -175.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 82.75 33.63 24.02 Favored Glycine 0 CA--C 1.496 -1.105 0 C-N-CA 120.796 -0.716 . . . . 74.329999999999998 112.137 174.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 25.0 mmt -108.04 -175.12 2.69 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.089 0.471 . . . . 72.430000000000007 110.387 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -110.25 155.9 21.41 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 108.845 -0.798 . . . . 73.299999999999997 108.845 -176.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 26.6 t90 -59.9 -30.68 69.19 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 123.217 0.323 . . . . 74.140000000000001 111.207 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 11.7 p -63.9 -21.51 28.91 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 CA-C-O 121.355 0.597 . . . . 74.230000000000004 110.791 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . 0.639 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 17.9 t70 -101.69 -41.74 6.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.715 -0.675 . . . . 75.530000000000001 109.703 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -62.79 -46.76 86.48 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 113.189 0.811 . . . . 73.319999999999993 113.189 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -54.33 -55.32 38.41 Favored Pre-proline 0 CA--C 1.577 2.016 0 O-C-N 123.215 0.322 . . . . 74.310000000000002 110.76 -178.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.37 -28.48 84.23 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.446 2.098 . . . . 65.239999999999995 114.24 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . 0.639 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 29.1 mmt180 -58.15 -47.13 84.3 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.818 -0.438 . . . . 72.25 109.818 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 9.9 mp -61.11 -40.41 93.66 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.589 -0.732 . . . . 73.299999999999997 110.993 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -64.76 -46.83 80.46 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.931 -0.577 . . . . 75.409999999999997 110.206 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -67.63 -34.95 78.0 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.739 -0.664 . . . . 72.340000000000003 112.786 -177.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 92.4 mt -81.49 -7.55 59.6 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 112.61 0.596 . . . . 74.519999999999996 112.61 -176.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 74.41 40.16 40.75 Favored Glycine 0 CA--C 1.504 -0.627 0 C-N-CA 119.712 -1.232 . . . . 64.140000000000001 110.128 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . 0.441 ' CH2' ' HB2' ' A' ' 587' ' ' LEU . 77.0 t90 -72.51 136.09 45.82 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.59 -0.805 . . . . 74.430000000000007 111.166 -178.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 34.1 m -146.94 95.28 2.55 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.578 -0.527 . . . . 74.310000000000002 109.578 175.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -161.73 -144.98 4.17 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 108.871 -1.692 . . . . 71.200000000000003 108.871 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 87.5 mtp -111.34 133.7 53.46 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 118.085 0.943 . . . . 74.420000000000002 110.827 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . 0.441 ' HB2' ' CH2' ' A' ' 583' ' ' TRP . 61.6 tp -114.52 129.23 56.65 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.964 -1.124 . . . . 73.409999999999997 107.964 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -101.55 100.07 10.45 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 119.16 -1.016 . . . . 74.420000000000002 109.007 176.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -114.38 110.56 20.07 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 115.269 -0.878 . . . . 73.040000000000006 108.954 175.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . 0.427 ' HA3' ' NH1' ' A' ' 623' ' ' ARG . . . -90.8 -151.08 25.77 Favored Glycine 0 N--CA 1.433 -1.512 0 C-N-CA 120.991 -0.623 . . . . 72.239999999999995 113.069 -178.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -100.21 154.49 18.42 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 110.025 -0.361 . . . . 65.340000000000003 110.025 -177.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -73.49 149.82 42.04 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 123.896 0.748 . . . . 74.109999999999999 110.634 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 94.8 t -138.45 130.2 37.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 115.476 -0.784 . . . . 74.329999999999998 109.763 -177.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -77.68 106.73 9.67 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 107.4 -1.333 . . . . 62.229999999999997 107.4 173.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -126.39 -20.16 4.48 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 116.03 -0.532 . . . . 73.329999999999998 111.132 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 128.2 157.93 9.52 Favored Glycine 0 C--N 1.302 -1.343 0 N-CA-C 110.412 -1.075 . . . . 64.409999999999997 110.412 -177.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.35 -35.67 66.64 Favored Glycine 0 N--CA 1.46 0.279 0 N-CA-C 113.992 0.357 . . . . 71.109999999999999 113.992 -173.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 19.9 m -62.61 -24.54 67.63 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.036 0.446 . . . . 70.239999999999995 111.701 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -107.05 -11.57 15.62 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 122.057 -0.402 . . . . 72.310000000000002 111.809 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 41.6 m170 -77.78 133.64 38.2 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 122.204 -0.31 . . . . 71.150000000000006 111.707 -176.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 58.9 t30 70.03 -21.73 0.17 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 125.488 1.515 . . . . 75.540000000000006 114.254 174.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 17.7 ttp85 -91.38 149.69 21.61 Favored 'General case' 0 C--N 1.312 -1.059 0 O-C-N 121.976 -0.453 . . . . 74.340000000000003 111.184 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . 0.431 HG22 ' HB2' ' A' ' 622' ' ' LEU . 9.0 p -62.71 133.66 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 O-C-N 123.765 0.665 . . . . 73.519999999999996 109.911 174.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 90.8 t -90.94 -48.46 14.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 108.317 -0.994 . . . . 73.340000000000003 108.317 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 622' ' ' LEU . 49.1 p90 -151.89 152.65 32.84 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 107.124 -1.435 . . . . 71.329999999999998 107.124 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -126.48 139.36 53.3 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 109.156 -0.683 . . . . 74.409999999999997 109.156 176.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.469 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 25.3 t-20 -54.91 -66.85 0.81 Allowed Pre-proline 0 C--N 1.311 -1.071 0 CA-C-N 115.407 -0.815 . . . . 72.349999999999994 112.454 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 88.2 Cg_endo -93.04 132.99 0.95 Allowed 'Trans proline' 0 N--CA 1.442 -1.55 0 CA-C-N 121.481 1.564 . . . . 73.25 110.6 173.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -70.3 134.76 27.58 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 121.102 1.201 . . . . 73.230000000000004 110.834 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -69.49 129.68 40.38 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.6 -0.889 . . . . 73.230000000000004 108.6 176.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.38 -2.89 39.96 Favored Glycine 0 C--N 1.299 -1.513 0 N-CA-C 109.707 -1.357 . . . . 64.299999999999997 109.707 -172.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 30.2 m -119.11 167.54 11.7 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 107.832 -1.174 . . . . 72.010000000000005 107.832 177.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -71.34 126.17 12.76 Favored Glycine 0 N--CA 1.432 -1.588 0 CA-C-O 120.984 0.214 . . . . 74.030000000000001 112.987 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 35.6 m -106.15 143.6 16.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 C-N-CA 124.606 1.162 . . . . 74.510000000000005 108.385 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . 0.431 ' ND2' ' HB2' ' A' ' 617' ' ' ASP . 32.2 p-10 -67.64 161.07 26.59 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.657 0.265 . . . . 73.540000000000006 111.506 -176.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.95 -30.71 36.28 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.812 -0.631 . . . . 74.340000000000003 111.796 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . 0.431 ' HB2' ' ND2' ' A' ' 615' ' ' ASN . 4.8 m-20 -71.34 -37.81 71.68 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 116.394 -0.366 . . . . 75.219999999999999 111.064 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 85.05 22.88 51.21 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 118.553 -1.784 . . . . 75.099999999999994 111.524 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.96 122.04 17.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 122.637 1.208 . . . . 73.430000000000007 109.773 -169.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 5.1 tp -126.4 123.28 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 CA-C-N 114.068 -1.423 . . . . 75.219999999999999 111.209 -174.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.468 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 55.0 m -115.0 121.87 44.47 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 107.952 -1.129 . . . . 71.340000000000003 107.952 173.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' A' ' 605' ' ' TYR . 0.0 OUTLIER -138.41 159.48 41.97 Favored 'General case' 0 CA--C 1.479 -1.781 0 N-CA-C 107.044 -1.465 . . . . 74.439999999999998 107.044 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . 0.427 ' NH1' ' HA3' ' A' ' 590' ' ' GLY . 18.2 tpt180 -135.42 149.48 49.63 Favored 'General case' 0 C--N 1.267 -2.999 0 N-CA-C 105.686 -1.968 . . . . 73.549999999999997 105.686 178.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -141.08 162.02 36.47 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 106.569 -1.641 . . . . 72.019999999999996 106.569 177.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -78.44 -101.57 0.21 Allowed Glycine 0 N--CA 1.427 -1.912 0 N-CA-C 109.832 -1.307 . . . . 74.230000000000004 109.832 177.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 . . . . . 0 C--N 1.282 -2.329 0 N-CA-C 108.664 -0.865 . . . . 73.310000000000002 108.664 175.044 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.265 0 N-CA-C 110.105 -1.198 . . . . 74.019999999999996 110.105 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 9.9 tp -75.75 134.34 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 N-CA-C 109.062 -0.718 . . . . 74.129999999999995 109.062 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.04 128.85 36.6 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 108.415 -0.957 . . . . 74.340000000000003 108.415 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -92.82 -11.49 33.55 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.348 -0.842 . . . . 72.120000000000005 109.262 -176.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -112.26 149.12 32.79 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.859 -1.163 . . . . 75.129999999999995 107.859 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 35.9 m -117.42 159.25 17.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-O 120.864 0.364 . . . . 74.099999999999994 110.145 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.5 122.96 38.79 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.609 -1.626 . . . . 71.430000000000007 106.609 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.494 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 60.7 t -96.46 133.17 25.13 Favored Pre-proline 0 C--N 1.294 -1.843 0 CA-C-N 116.2 -0.455 . . . . 54.240000000000002 110.627 -170.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -68.9 127.63 15.57 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 121.682 1.588 . . . . 73.150000000000006 111.3 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -82.35 100.48 10.0 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 122.575 1.179 . . . . 74.030000000000001 110.039 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 20.0 m -74.32 9.11 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 113.587 -1.642 . . . . 74.299999999999997 114.522 -174.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -63.34 144.62 56.8 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 123.025 0.53 . . . . 64.200000000000003 111.252 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.52 0.35 43.25 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.959 -0.564 . . . . 74.329999999999998 112.395 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -112.16 -160.6 0.72 Allowed 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.538 -1.282 . . . . 72.329999999999998 107.538 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 84.0 p -91.58 166.01 13.04 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 106.696 -1.594 . . . . 61.329999999999998 106.696 177.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 40.2 t -60.63 -42.33 96.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 118.376 0.534 . . . . 62.439999999999998 109.608 177.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.19 -46.56 76.92 Favored 'General case' 0 C--O 1.214 -0.804 0 CA-C-N 115.892 -0.594 . . . . 70.219999999999999 111.727 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -65.91 -44.55 84.89 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 120.648 0.261 . . . . 75.409999999999997 111.161 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -61.86 -48.64 79.62 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.762 -0.653 . . . . 74.540000000000006 111.121 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 66.7 mt -67.21 -40.0 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 116.049 -0.523 . . . . 73.230000000000004 110.936 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.19 -39.73 91.27 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-O 120.626 0.251 . . . . 72.030000000000001 111.212 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' THR . . . . . 0.416 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 90.4 m -63.96 -48.52 76.17 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 116.088 -0.506 . . . . 63.539999999999999 109.953 177.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.9 -38.9 92.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.312 -0.404 . . . . 75.510000000000005 111.081 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -62.92 -43.8 97.82 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.824 -0.625 . . . . 74.030000000000001 111.113 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -67.64 -23.66 65.37 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.488 0.661 . . . . 74.319999999999993 111.569 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . 0.416 ' HG2' ' O ' ' A' ' 376' ' ' THR . 27.9 mmt180 -84.7 -14.16 49.25 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.747 -0.66 . . . . 71.200000000000003 111.088 177.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.81 16.3 45.75 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.309 -0.948 . . . . 71.099999999999994 112.447 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.429 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 53.8 m-85 -83.99 173.73 10.92 Favored 'General case' 0 N--CA 1.421 -1.875 0 CA-C-O 120.946 0.403 . . . . 74.530000000000001 111.537 177.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -116.17 150.46 37.42 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 107.186 -1.413 . . . . 74.230000000000004 107.186 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.69 140.35 49.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 CA-C-O 121.094 0.473 . . . . 75.239999999999995 110.801 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' A' ' 417' ' ' THR . 39.9 ttt180 -116.06 127.95 55.3 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 105.995 -1.854 . . . . 73.439999999999998 105.995 174.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 22.8 m -111.87 131.88 55.07 Favored 'General case' 0 C--N 1.276 -2.623 0 C-N-CA 119.988 -0.685 . . . . 72.510000000000005 110.403 -175.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -111.11 119.46 39.06 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 105.264 -2.124 . . . . 75.25 105.264 175.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.711 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -129.73 123.13 30.32 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.774 0.321 . . . . 72.329999999999998 111.28 -176.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -138.52 138.04 21.46 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 116.252 -0.431 . . . . 74.519999999999996 111.525 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 422' ' ' THR . 8.4 Cg_exo -77.84 131.29 11.07 Favored 'Trans proline' 0 C--O 1.259 1.541 0 C-N-CA 122.472 2.115 . . . . 74.329999999999998 110.223 169.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.414 ' HB3' HG12 ' A' ' 394' ' ' ILE . 22.8 t70 169.01 136.87 0.02 OUTLIER 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 124.304 1.042 . . . . 65.239999999999995 108.328 -177.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 14.3 m -93.64 4.59 53.72 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 113.015 0.746 . . . . 64.219999999999999 113.015 -173.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 86.0 m -99.8 -30.15 12.22 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.578 -0.701 . . . . 72.129999999999995 110.248 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . 0.414 HG12 ' HB3' ' A' ' 391' ' ' ASP . 16.9 pt -87.6 148.63 44.51 Favored Pre-proline 0 N--CA 1.433 -1.323 0 CA-C-N 116.097 -0.501 . . . . 75.430000000000007 110.297 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -55.2 138.47 79.33 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.057 3.171 . . . . 75.109999999999999 115.397 -173.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -55.62 164.47 4.28 Favored 'Trans proline' 0 C--N 1.361 1.192 0 C-N-CA 124.949 3.766 . . . . 74.140000000000001 112.274 175.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -55.58 -7.93 0.32 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 113.176 0.806 . . . . 74.310000000000002 113.176 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -77.72 111.56 13.64 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 104.914 -2.254 . . . . 74.209999999999994 104.914 169.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 33.3 m -77.16 122.74 32.38 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 N-CA-C 113.329 0.863 . . . . 63.229999999999997 113.329 -165.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 47.3 pt -89.8 -27.79 5.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 115.861 -0.608 . . . . 74.019999999999996 109.942 176.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.05 162.61 28.13 Favored Glycine 0 N--CA 1.419 -2.445 0 C-N-CA 119.714 -1.232 . . . . 73.209999999999994 114.035 -175.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 12.9 p -142.09 -176.84 4.96 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 126.767 2.027 . . . . 65.329999999999998 105.955 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -98.34 134.54 21.83 Favored Pre-proline 0 C--N 1.299 -1.627 0 C-N-CA 119.339 -0.944 . . . . 72.209999999999994 109.981 -175.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -59.92 -0.89 0.98 Allowed 'Trans proline' 0 C--N 1.362 1.284 0 C-N-CA 124.589 3.526 . . . . 71.530000000000001 115.205 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.0 -29.56 68.56 Favored 'General case' 0 C--O 1.203 -1.385 0 N-CA-C 108.243 -1.021 . . . . 64.340000000000003 108.243 172.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . 0.494 ' HA ' ' HB ' ' A' ' 362' ' ' VAL . . . -62.93 -44.04 97.16 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.236 -0.893 . . . . 64.150000000000006 109.761 175.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -80.64 -4.04 52.74 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.234 -0.894 . . . . 73.129999999999995 111.555 -175.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 23.1 m -98.74 150.45 21.81 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 105.534 -2.024 . . . . 73.230000000000004 105.534 173.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 52.2 p -75.27 111.93 11.04 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 117.695 -1.602 . . . . 73.400000000000006 107.091 175.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.5 m -125.54 169.04 17.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 120.846 0.355 . . . . 74.239999999999995 111.136 -177.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 13.7 m -64.63 134.58 54.59 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.455 -0.793 . . . . 74.340000000000003 109.686 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -64.56 128.66 36.74 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 116.057 -0.519 . . . . 73.319999999999993 110.127 -176.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 89.36 47.43 4.06 Favored Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 120.412 -0.899 . . . . 73.109999999999999 111.016 -177.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -106.83 161.31 14.8 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.794 -1.187 . . . . 73.540000000000006 107.794 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -86.27 108.9 18.6 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 121.398 0.618 . . . . 74.540000000000006 110.698 -176.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 41.9 mm -97.24 120.77 47.01 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 N-CA-C 108.217 -1.031 . . . . 72.099999999999994 108.217 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 385' ' ' ARG . 22.5 m -79.24 129.26 34.28 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.298 0.57 . . . . 71.219999999999999 111.124 -177.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 9.0 p -116.84 135.7 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-N 114.885 -1.052 . . . . 73.109999999999999 108.456 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.5 120.95 36.65 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 120.889 0.376 . . . . 72.439999999999998 110.718 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.711 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 99.2 t -127.25 131.68 70.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 108.488 -0.931 . . . . 70.549999999999997 108.488 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 4.1 m -131.43 143.11 50.2 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.504 -0.878 . . . . 64.349999999999994 109.568 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 390' ' ' PRO . 63.6 p -98.68 118.06 34.54 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 105.459 -2.052 . . . . 64.450000000000003 105.459 172.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -51.04 -87.81 0.01 OUTLIER Glycine 0 C--O 1.252 1.254 0 N-CA-C 116.084 1.194 . . . . 63.340000000000003 116.084 -170.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -69.44 131.77 22.4 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.148 1.899 . . . . 73.340000000000003 113.366 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -94.51 123.18 37.78 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 107.824 -1.176 . . . . 74.409999999999997 107.824 177.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -128.81 142.6 50.93 Favored 'General case' 0 C--N 1.253 -3.623 0 N-CA-C 107.139 -1.43 . . . . 73.209999999999994 107.139 174.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.632 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 1.1 mmp_? -122.6 149.49 43.91 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-O 121.495 0.664 . . . . 73.540000000000006 112.141 -176.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -83.12 138.17 33.78 Favored 'General case' 0 C--N 1.276 -2.615 0 CA-C-N 113.836 -1.529 . . . . 72.549999999999997 108.566 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 58.2 mt -98.46 125.91 41.34 Favored Pre-proline 0 C--N 1.286 -2.155 0 N-CA-C 108.007 -1.109 . . . . 62.539999999999999 108.007 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -70.35 142.85 46.37 Favored 'Trans proline' 0 C--O 1.24 0.603 0 C-N-CA 122.216 1.944 . . . . 75.319999999999993 110.191 174.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -68.13 116.42 8.73 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.854 0.359 . . . . 70.200000000000003 110.369 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.05 140.25 27.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 109.216 -0.661 . . . . 73.530000000000001 109.216 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.584 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 19.6 m -68.94 158.29 34.96 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-O 120.864 0.364 . . . . 74.5 111.124 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 36.9 p -69.76 -28.87 66.13 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 114.309 1.225 . . . . 64.420000000000002 114.309 -171.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.0 pp -88.39 -11.55 45.8 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.655 0.741 . . . . 73.239999999999995 111.57 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.584 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 0.2 OUTLIER -92.53 40.87 1.06 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.663 -0.699 . . . . 71.010000000000005 110.743 -175.188 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -52.87 -38.28 61.37 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.545 0.738 . . . . 74.239999999999995 112.503 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.18 -41.82 97.48 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.979 0.418 . . . . 65.140000000000001 110.703 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -70.49 -34.66 72.61 Favored 'General case' 0 C--O 1.207 -1.137 0 CA-C-N 116.195 -0.457 . . . . 72.409999999999997 110.185 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.572 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -59.69 -51.7 68.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 119.766 -0.159 . . . . 73.019999999999996 111.119 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.6 m -62.01 -38.18 80.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-O 121.305 0.574 . . . . 73.430000000000007 110.463 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -60.63 -47.77 84.77 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.341 1.057 . . . . 64.540000000000006 110.971 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -65.75 -38.84 90.21 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 123.189 0.596 . . . . 63.420000000000002 111.428 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 85.3 mt -64.02 -36.88 85.43 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.167 -0.47 . . . . 72.209999999999994 110.176 177.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 33.1 m -70.11 -44.37 69.12 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.016 -0.538 . . . . 72.109999999999999 110.164 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.21 -18.31 65.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.854 -0.612 . . . . 75.510000000000005 111.246 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -90.04 5.48 46.48 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.129 -0.487 . . . . 72.420000000000002 111.824 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 109.71 -83.7 0.34 Allowed Glycine 0 CA--C 1.494 -1.225 0 C-N-CA 120.039 -1.077 . . . . 74.409999999999997 112.081 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -36.71 -61.85 0.51 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.734 1.383 . . . . 75.099999999999994 114.734 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 60.05 27.71 65.26 Favored Glycine 0 CA--C 1.508 -0.355 0 C-N-CA 120.842 -0.694 . . . . 63.219999999999999 111.434 -175.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -102.36 111.17 23.35 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 109.28 -0.637 . . . . 73.140000000000001 109.28 -176.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 11.5 p90 -139.64 152.03 46.44 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.653 -0.703 . . . . 75.540000000000006 110.298 -177.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -142.65 122.95 13.87 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.906 -1.146 . . . . 72.329999999999998 107.906 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -96.36 130.81 43.39 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 120.96 0.409 . . . . 75.530000000000001 111.758 -177.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -135.15 150.04 50.09 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 123.498 0.719 . . . . 73.140000000000001 109.199 175.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -123.1 149.82 44.0 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 119.915 -0.714 . . . . 73.010000000000005 110.491 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 46.1 m -151.18 151.65 29.78 Favored Pre-proline 0 C--N 1.295 -1.798 0 N-CA-C 107.184 -1.413 . . . . 71.310000000000002 107.184 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 490' ' ' SER . 19.2 Cg_exo -65.48 144.58 79.94 Favored 'Trans proline' 0 C--O 1.243 0.738 0 C-N-CA 121.747 1.631 . . . . 75.209999999999994 112.018 -177.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 14.9 t -152.55 179.37 8.65 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 106.709 -1.589 . . . . 74.540000000000006 106.709 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.5 t -56.17 142.94 65.6 Favored Pre-proline 0 C--N 1.305 -1.347 0 C-N-CA 123.947 0.899 . . . . 74.209999999999994 110.621 177.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -51.49 -29.73 32.77 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 124.464 3.443 . . . . 75.409999999999997 113.121 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.51 -19.39 60.93 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.942 0.401 . . . . 71.140000000000001 112.057 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -108.13 -1.93 19.92 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.112 0.412 . . . . 65.540000000000006 112.112 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 84.4 t -61.06 127.14 20.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.266 -0.642 . . . . 71.5 109.266 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.68 -13.09 68.26 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 116.065 -0.516 . . . . 40.240000000000002 111.812 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.413 ' O ' HG21 ' A' ' 488' ' ' VAL . 11.8 mptt -109.76 159.0 17.55 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.167 0.508 . . . . 74.530000000000001 110.12 -178.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 76.8 t -71.85 145.8 11.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 115.071 -0.968 . . . . 73.219999999999999 109.711 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 62.1 mt -98.39 -35.44 5.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 107.83 -1.174 . . . . 73.140000000000001 107.83 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 164.72 -174.52 40.71 Favored Glycine 0 N--CA 1.43 -1.757 0 CA-C-N 115.468 -0.787 . . . . 72.120000000000005 112.176 176.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 470' ' ' THR . . . . . 0.527 HG23 HG12 ' A' ' 486' ' ' ILE . 58.8 p -115.2 141.94 47.34 Favored 'General case' 0 N--CA 1.422 -1.825 0 N-CA-C 106.933 -1.506 . . . . 72.049999999999997 106.933 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.469 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 2.8 t-20 -64.46 -57.3 17.73 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 119.85 -0.74 . . . . 74.049999999999997 111.358 178.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 17.2 Cg_exo -74.19 138.53 25.31 Favored 'Trans proline' 0 C--N 1.363 1.311 0 N-CA-C 107.026 -1.951 . . . . 63.399999999999999 107.026 168.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -63.0 126.14 17.37 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 121.749 1.633 . . . . 75.409999999999997 113.669 -173.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -86.16 10.73 13.64 Favored 'General case' 0 C--O 1.205 -1.272 0 CA-C-N 115.275 -0.875 . . . . 61.039999999999999 111.047 -177.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -110.65 -0.68 17.1 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.54 -0.755 . . . . 75.019999999999996 110.455 176.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -124.46 -168.48 1.81 Allowed 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.024 -0.535 . . . . 74.430000000000007 110.548 -173.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.09 131.46 35.24 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 115.54 -0.755 . . . . 73.140000000000001 110.544 -177.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 49.5 m -127.98 148.16 50.51 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 122.902 0.481 . . . . 75.209999999999994 110.097 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -77.87 158.77 29.3 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.932 -0.576 . . . . 73.519999999999996 110.931 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 35.0 mm -73.16 -23.06 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 121.552 0.692 . . . . 73.340000000000003 110.57 -175.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 17.0 m -95.94 1.8 53.1 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 122.081 0.943 . . . . 73.430000000000007 109.93 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -93.06 130.19 38.76 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.751 -0.659 . . . . 73.409999999999997 110.705 -175.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.2 p -100.34 126.41 53.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.25 0.548 . . . . 72.439999999999998 111.487 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 32.7 m -95.75 121.68 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-O 121.816 0.817 . . . . 71.120000000000005 110.327 178.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.61 129.28 43.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.971 -1.122 . . . . 75.140000000000001 107.971 177.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . 0.527 HG12 HG23 ' A' ' 470' ' ' THR . 11.6 mt -113.73 124.61 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 CA-C-N 114.83 -1.077 . . . . 74.340000000000003 110.274 -175.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 8.5 tt -104.94 126.19 59.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 115.256 -0.883 . . . . 74.439999999999998 109.33 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 466' ' ' LYS . 2.3 p -111.41 145.53 17.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 C-N-CA 124.252 1.021 . . . . 73.439999999999998 109.447 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -80.14 124.41 6.48 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.991 -0.623 . . . . 72.230000000000004 111.662 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 18.3 t -142.78 132.15 23.5 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.84 -0.8 . . . . 74.400000000000006 108.84 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 138.52 107.07 0.75 Allowed Glycine 0 N--CA 1.437 -1.295 0 N-CA-C 109.89 -1.284 . . . . 74.450000000000003 109.89 -177.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -71.31 142.76 41.93 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.296 1.997 . . . . 63.409999999999997 112.414 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -136.7 21.38 3.1 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 122.154 0.978 . . . . 73.400000000000006 110.521 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 27.5 p -130.19 151.69 50.43 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-N 114.334 -1.303 . . . . 74.400000000000006 110.61 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 18.7 mmtt -147.82 164.33 33.97 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.679 -0.691 . . . . 75.129999999999995 110.245 175.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -95.73 136.77 35.72 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.988 -0.551 . . . . 73.349999999999994 110.428 -175.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 27.7 pt -92.08 117.78 67.86 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 109.283 -0.636 . . . . 73.150000000000006 109.283 175.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.22 -179.39 5.38 Favored 'Trans proline' 0 C--O 1.249 1.058 0 C-N-CA 121.966 1.777 . . . . 74.319999999999993 111.934 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -79.07 111.26 15.1 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.471 -0.566 . . . . 74.420000000000002 109.471 177.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 9.9 p -113.35 18.97 7.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 122.424 1.107 . . . . 75.430000000000007 109.191 -176.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -83.46 119.16 24.33 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.432 -0.803 . . . . 70.340000000000003 110.783 -177.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 120.33 22.12 3.22 Favored Glycine 0 N--CA 1.436 -1.338 0 C-N-CA 121.054 -0.593 . . . . 74.530000000000001 112.888 177.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . 0.491 HE22 ' N ' ' A' ' 508' ' ' ALA . 0.0 OUTLIER -137.14 -172.19 3.14 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 122.591 -0.358 . . . . 74.420000000000002 110.876 178.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 8.6 m -91.01 154.88 19.11 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 118.483 -1.287 . . . . 74.209999999999994 110.303 -173.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 9.5 p -58.34 -41.3 80.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 123.342 0.657 . . . . 75.239999999999995 112.415 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -59.73 -39.8 85.93 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.455 0.645 . . . . 71.540000000000006 109.877 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 29.3 t -73.52 -36.7 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 CA-C-N 115.314 -0.857 . . . . 64.340000000000003 109.955 -177.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . 0.491 ' N ' HE22 ' A' ' 503' ' ' GLN . . . -63.39 -49.78 72.45 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.397 -0.365 . . . . 64.0 111.593 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -63.23 -35.15 79.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.012 0.434 . . . . 75.010000000000005 110.554 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.426 ' O ' HG23 ' A' ' 514' ' ' VAL . 5.0 tppp? -61.99 -53.1 60.31 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.249 -0.887 . . . . 75.150000000000006 109.893 176.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -61.59 -44.91 96.15 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-N 116.163 -0.471 . . . . 64.019999999999996 111.632 -176.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -61.0 -44.07 97.96 Favored 'General case' 0 C--O 1.247 0.924 0 O-C-N 123.236 0.335 . . . . 74.010000000000005 111.442 178.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 10.2 m120 -63.84 -38.8 92.42 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 120.317 -0.553 . . . . 74.209999999999994 111.109 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 510' ' ' LYS . 73.0 t -61.88 -35.04 65.73 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 CA-C-N 116.052 -0.522 . . . . 75.420000000000002 111.087 177.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -74.63 -13.87 60.7 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.573 -0.451 . . . . 74.230000000000004 111.017 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 115.24 -2.06 22.38 Favored Glycine 0 N--CA 1.436 -1.335 0 C-N-CA 120.437 -0.887 . . . . 72.140000000000001 112.503 178.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.456 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 65.7 m-85 -85.27 109.36 18.3 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.517 -0.919 . . . . 74.140000000000001 108.517 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 17.5 p -88.18 -14.7 37.97 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 113.674 0.99 . . . . 75.430000000000007 113.674 -173.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -117.64 122.5 43.75 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 120.952 0.406 . . . . 73.310000000000002 111.497 -175.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 551' ' ' ILE . 46.3 p90 -129.88 153.47 48.27 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 116.002 -0.545 . . . . 75.329999999999998 111.366 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 521' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 58.5 m -139.9 152.26 46.26 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.193 -1.41 . . . . 74.019999999999996 107.193 174.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.39 135.91 54.37 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-O 121.163 0.506 . . . . 70.140000000000001 111.068 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -131.55 130.79 42.73 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.28 -1.007 . . . . 75.230000000000004 108.28 176.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 524' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 19.8 m -96.03 132.55 41.27 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 110.129 -0.323 . . . . 64.519999999999996 110.129 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 34.0 m -121.54 149.57 24.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 108.154 -1.054 . . . . 74.140000000000001 108.154 178.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -74.6 135.47 42.04 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 121.029 -0.269 . . . . 74.209999999999994 111.432 -173.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 527' ' ' SER . . . . . 0.467 ' HB2' ' OG ' ' A' ' 556' ' ' SER . 70.3 m -159.43 174.65 3.81 Favored Pre-proline 0 C--N 1.314 -0.968 0 C-N-CA 123.771 0.828 . . . . 75.010000000000005 108.789 178.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -89.44 -3.05 5.93 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.969 1.779 . . . . 71.209999999999994 111.147 174.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . 0.497 ' HB2' ' OG ' ' A' ' 556' ' ' SER . 23.8 mmt85 -79.93 133.31 58.43 Favored Pre-proline 0 N--CA 1.444 -0.753 0 N-CA-C 107.741 -1.207 . . . . 72.319999999999993 107.741 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -56.14 144.44 80.47 Favored 'Trans proline' 0 C--O 1.254 1.314 0 C-N-CA 123.065 2.51 . . . . 72.140000000000001 113.4 -175.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -57.8 113.66 1.95 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.69 -1.141 . . . . 75.030000000000001 110.69 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 138.71 -26.79 2.74 Favored Glycine 0 C--N 1.306 -1.126 0 CA-C-N 115.785 -0.643 . . . . 61.009999999999998 111.536 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -76.49 127.86 33.65 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.166 -0.679 . . . . 73.439999999999998 109.166 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 83.6 t -79.6 117.76 25.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.041 -1.096 . . . . 74.019999999999996 108.041 176.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 13.7 t -91.92 -1.86 57.08 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.678 -0.692 . . . . 54.109999999999999 110.757 -176.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 149.95 -166.07 29.84 Favored Glycine 0 CA--C 1.489 -1.557 0 C-N-CA 120.685 -0.769 . . . . 75.319999999999993 111.874 177.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 13.3 p -119.0 158.7 25.25 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 109.391 -0.596 . . . . 74.540000000000006 109.391 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . 0.457 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 27.3 t-20 -65.89 -52.36 41.79 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-O 119.083 -0.484 . . . . 72.530000000000001 111.097 177.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 4.8 Cg_exo -78.96 142.6 17.52 Favored 'Trans proline' 0 C--N 1.368 1.591 0 N-CA-C 108.2 -1.5 . . . . 73.109999999999999 108.2 171.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.79 144.65 99.41 Favored 'Trans proline' 0 C--O 1.253 1.229 0 C-N-CA 122.297 1.998 . . . . 71.420000000000002 113.107 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -64.33 137.37 57.87 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 115.896 -0.593 . . . . 74.140000000000001 109.819 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 102.44 -12.44 56.86 Favored Glycine 0 C--N 1.298 -1.578 0 C-N-CA 121.018 -0.61 . . . . 71.430000000000007 111.919 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 23.9 m -75.33 130.97 39.93 Favored 'General case' 0 C--O 1.245 0.843 0 N-CA-C 109.752 -0.462 . . . . 75.340000000000003 109.752 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 14.6 m -84.4 122.9 29.6 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 107.291 -1.374 . . . . 74.040000000000006 107.291 176.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.5 m -131.51 157.32 78.49 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.907 -0.405 . . . . 75.299999999999997 109.907 -177.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -64.86 140.47 67.01 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.4 2.066 . . . . 74.430000000000007 111.607 176.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.456 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 27.0 m -63.98 -20.14 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-O 121.761 0.791 . . . . 70.150000000000006 111.834 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -87.06 -11.2 50.99 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.058 -0.973 . . . . 54.229999999999997 111.873 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 80.5 p -82.09 175.98 9.89 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 120.017 -0.673 . . . . 71.129999999999995 112.343 -176.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 27.0 t -101.72 119.17 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 116.012 -0.54 . . . . 75.349999999999994 110.737 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 520' ' ' PHE . 1.8 mp -101.17 124.6 54.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 108.842 -0.799 . . . . 74.420000000000002 108.842 177.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 521' ' ' SER . 35.0 tt0 -102.86 128.84 49.47 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-O 121.211 0.529 . . . . 73.349999999999994 110.236 -178.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -93.37 133.98 36.07 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.329 -0.989 . . . . 74.129999999999995 108.329 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.85 114.25 25.96 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.944 -1.502 . . . . 75.310000000000002 106.944 176.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 524' ' ' SER . 40.5 t -99.79 141.3 17.21 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 108.391 -0.966 . . . . 72.200000000000003 108.391 -177.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.626 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 36.0 t -78.84 129.71 34.88 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 121.214 0.53 . . . . 74.510000000000005 111.27 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 12.2 ttpp -93.65 121.51 35.15 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 106.747 -1.575 . . . . 74.430000000000007 106.747 169.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -81.39 -24.24 57.12 Favored Glycine 0 CA--C 1.494 -1.269 0 C-N-CA 120.48 -0.867 . . . . 53.43 112.099 -177.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 4.8 p30 58.62 6.96 0.66 Allowed 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 127.257 2.223 . . . . 71.519999999999996 114.26 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -134.21 170.91 14.99 Favored 'General case' 0 C--O 1.253 1.244 0 CA-C-O 121.688 0.756 . . . . 73.209999999999994 112.286 -173.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -145.99 148.33 32.62 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.88 -1.526 . . . . 73.239999999999995 106.88 173.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 9.4 p -71.18 127.75 33.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-O 121.176 0.512 . . . . 73.010000000000005 110.229 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 58.7 ttp -96.26 115.29 65.52 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 109.272 -0.64 . . . . 75.310000000000002 109.272 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.98 154.9 72.1 Favored 'Trans proline' 0 C--O 1.242 0.684 0 C-N-CA 122.08 1.853 . . . . 64.129999999999995 110.367 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . 0.419 ' HA ' ' HB2' ' A' ' 610' ' ' ALA . 4.2 p-10 -76.03 118.1 18.44 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 121.822 0.82 . . . . 74.209999999999994 111.236 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 96.2 mt -137.52 34.09 2.49 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.009 -1.45 . . . . 65.239999999999995 107.184 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 14.8 m -71.25 132.72 45.35 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.008 -0.996 . . . . 64.239999999999995 111.342 -175.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 99.86 38.8 3.53 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 121.114 -0.565 . . . . 65.530000000000001 113.312 174.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 83.6 mtp -109.69 155.26 21.75 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.435 -0.58 . . . . 74.120000000000005 109.435 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -74.96 149.73 39.27 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 107.286 -1.375 . . . . 74.540000000000006 107.286 175.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . 0.506 ' O ' ' HG3' ' A' ' 575' ' ' GLU . 41.0 t90 -60.47 -29.81 69.28 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 123.274 0.359 . . . . 64.420000000000002 110.855 -177.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 33.2 m -80.16 -10.42 12.49 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.612 0 CA-C-O 121.568 0.699 . . . . 65.019999999999996 110.894 -176.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -101.78 -31.84 10.56 Favored 'General case' 0 C--O 1.266 1.927 0 CA-C-O 122.885 1.326 . . . . 72.109999999999999 107.88 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . 0.441 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -68.77 -36.72 78.68 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 113.885 -1.507 . . . . 73.299999999999997 110.392 176.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 571' ' ' TRP . 43.4 mt-10 -51.75 -57.79 13.42 Favored Pre-proline 0 CA--C 1.559 1.3 0 CA-C-O 118.87 -0.586 . . . . 74.510000000000005 111.66 177.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . 0.485 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 64.3 Cg_exo -56.63 -39.5 90.93 Favored 'Trans proline' 0 C--N 1.387 2.598 0 C-N-CA 121.768 1.645 . . . . 74.120000000000005 112.542 175.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -59.03 -43.59 91.64 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 119.782 -0.767 . . . . 75.140000000000001 112.269 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 96.2 mt -65.97 -47.22 75.33 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.521 0.677 . . . . 73.530000000000001 110.307 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -65.03 -34.98 79.72 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.412 -0.813 . . . . 75.510000000000005 111.643 -177.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.65 -33.38 70.91 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.367 0.506 . . . . 72.040000000000006 112.367 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 4.0 pp -88.4 -3.61 58.8 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.474 0.916 . . . . 72.430000000000007 113.474 -176.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 86.12 37.77 8.93 Favored Glycine 0 C--N 1.314 -0.648 0 C-N-CA 120.183 -1.008 . . . . 73.439999999999998 112.001 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 82.3 t90 -71.87 127.94 34.17 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 123.19 0.596 . . . . 74.010000000000005 110.808 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 23.0 m -138.3 67.9 1.4 Allowed 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 122.183 0.992 . . . . 70.120000000000005 109.404 174.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -124.44 -149.88 7.75 Favored Glycine 0 N--CA 1.436 -1.313 0 N-CA-C 110.07 -1.212 . . . . 73.340000000000003 110.07 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 586' ' ' MET . . . . . 0.477 ' O ' HG12 ' A' ' 619' ' ' ILE . 8.6 mmt -122.79 139.03 54.44 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.6 -0.519 . . . . 74.409999999999997 109.6 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -101.16 127.55 47.67 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 106.524 -1.658 . . . . 75.239999999999995 106.524 174.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -97.25 99.85 11.31 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 120.19 -0.604 . . . . 72.010000000000005 110.822 -175.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -114.42 109.19 17.92 Favored 'General case' 0 N--CA 1.409 -2.51 0 N-CA-C 108.154 -1.054 . . . . 73.120000000000005 108.154 170.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -143.97 -62.36 0.02 OUTLIER Glycine 0 CA--C 1.477 -2.319 0 N-CA-C 108.849 -1.7 . . . . 62.200000000000003 108.849 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . 0.418 ' O ' ' HD2' ' A' ' 623' ' ' ARG . . . -89.86 136.54 32.98 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.541 -0.911 . . . . 72.209999999999994 108.541 173.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -116.72 157.08 26.05 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.608 -0.516 . . . . 75.439999999999998 109.608 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . 0.406 ' O ' ' HA2' ' A' ' 625' ' ' GLY . 38.5 t -107.15 132.01 55.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 120.336 -0.546 . . . . 71.439999999999998 110.232 -177.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . 0.611 ' HA ' ' OE1' ' A' ' 626' ' ' GLN . 5.8 p-10 -73.76 112.4 9.83 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.102 0.477 . . . . 74.239999999999995 112.255 -178.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -176.6 19.97 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 114.56 -1.2 . . . . 74.040000000000006 110.647 175.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 83.74 127.6 1.39 Allowed Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 110.326 -1.11 . . . . 61.329999999999998 110.326 -174.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' A' ' 601' ' ' ASN . . . -62.12 -49.55 73.84 Favored Glycine 0 C--O 1.2 -2.0 0 C-N-CA 120.478 -0.868 . . . . 74.299999999999997 112.478 -176.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 47.0 m -71.56 -24.13 61.87 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.315 0.578 . . . . 53.149999999999999 111.689 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -89.64 -7.69 54.14 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.925 -0.58 . . . . 75.239999999999995 112.169 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -145.45 28.61 1.18 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.836 0.827 . . . . 74.540000000000006 109.547 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . 0.547 ' HB2' ' O ' ' A' ' 597' ' ' GLY . 8.5 t30 -86.55 62.94 7.71 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 122.425 1.107 . . . . 64.409999999999997 108.575 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 37.1 ptt85 -143.0 171.84 13.51 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 107.453 -1.314 . . . . 75.340000000000003 107.453 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 11.7 p -62.84 129.87 26.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 107.388 -1.338 . . . . 70.230000000000004 107.388 174.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 87.2 t -95.98 -36.4 6.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 119.833 -0.747 . . . . 73.129999999999995 109.09 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -154.79 158.96 40.26 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 105.892 -1.892 . . . . 71.010000000000005 105.892 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -128.86 124.93 36.54 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.047 -0.723 . . . . 73.030000000000001 109.047 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.443 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 21.9 t-20 -59.36 -50.66 86.26 Favored Pre-proline 0 CA--C 1.559 1.327 0 CA-C-N 115.792 -0.64 . . . . 74.219999999999999 112.453 -177.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 4.3 Cg_exo -90.09 124.89 1.21 Allowed 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 121.908 1.739 . . . . 51.119999999999997 110.764 173.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.79 139.09 66.95 Favored 'Trans proline' 0 C--O 1.252 1.189 0 C-N-CA 122.414 2.076 . . . . 64.310000000000002 111.909 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . 0.419 ' HB2' ' HA ' ' A' ' 565' ' ' ASP . . . -64.09 138.44 58.46 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.594 -0.73 . . . . 54.420000000000002 110.363 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 99.69 -5.86 58.59 Favored Glycine 0 N--CA 1.435 -1.425 0 N-CA-C 111.441 -0.664 . . . . 73.310000000000002 111.441 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 12.1 m -99.96 160.22 14.48 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 108.772 -0.825 . . . . 73.120000000000005 108.772 -178.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -75.08 125.3 8.15 Favored Glycine 0 N--CA 1.423 -2.199 0 N-CA-C 109.883 -1.287 . . . . 55.509999999999998 109.883 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 34.7 m -112.22 142.62 24.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 108.612 -0.884 . . . . 73.299999999999997 108.612 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 30.5 p30 -43.68 152.79 0.14 Allowed 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.745 1.017 . . . . 73.299999999999997 113.745 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -56.8 -25.72 56.35 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.345 1.058 . . . . 73.310000000000002 112.604 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -63.84 -42.9 97.5 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 108.401 -0.963 . . . . 73.129999999999995 108.401 176.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . 0.412 ' O ' HG12 ' A' ' 620' ' ' ILE . . . 81.97 19.25 65.64 Favored Glycine 0 N--CA 1.42 -2.386 0 N-CA-C 109.324 -1.51 . . . . 62.100000000000001 109.324 -177.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 586' ' ' MET . 0.0 OUTLIER -70.71 117.76 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-O 122.274 1.035 . . . . 73.340000000000003 108.594 -175.407 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 618' ' ' GLY . 47.7 mm -115.32 130.31 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.195 0 N-CA-C 105.941 -1.874 . . . . 75.420000000000002 105.941 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.409 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 27.7 m -96.87 114.64 26.29 Favored 'General case' 0 N--CA 1.401 -2.918 0 C-N-CA 117.175 -1.81 . . . . 75.549999999999997 106.977 175.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 4.4 pp -140.9 150.3 43.01 Favored 'General case' 0 N--CA 1.406 -2.627 0 N-CA-C 105.753 -1.943 . . . . 74.310000000000002 105.753 176.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . 0.418 ' HD2' ' O ' ' A' ' 591' ' ' ALA . 28.5 mtm180 -133.81 156.71 47.53 Favored 'General case' 0 C--N 1.269 -2.893 0 N-CA-C 108.502 -0.925 . . . . 75.340000000000003 108.502 175.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -133.18 166.87 21.44 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 124.444 1.09 . . . . 74.219999999999999 111.405 -173.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 593' ' ' VAL . . . -66.18 139.41 37.97 Favored Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 115.214 0.846 . . . . 54.100000000000001 115.214 -176.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . 0.611 ' OE1' ' HA ' ' A' ' 594' ' ' ASP . 1.3 mp0 . . . . . 0 N--CA 1.473 0.689 0 N-CA-C 116.118 1.896 . . . . 74.200000000000003 116.118 176.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.076 0 N-CA-C 111.267 -0.733 . . . . 54.409999999999997 111.267 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 11.3 tp -85.14 146.6 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 N-CA-C 108.534 -0.913 . . . . 73.420000000000002 108.534 177.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 4.6 m -88.71 155.81 19.37 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 106.716 -1.587 . . . . 75.219999999999999 106.716 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -72.14 -24.56 61.48 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 120.045 -0.662 . . . . 75.040000000000006 110.035 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -83.24 126.76 33.0 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 106.972 -1.492 . . . . 64.319999999999993 106.972 170.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 409' ' ' SER . 24.0 m -121.54 163.56 19.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.354 0 N-CA-C 109.654 -0.499 . . . . 63.340000000000003 109.654 -177.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.37 129.81 39.37 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.365 -1.346 . . . . 72.340000000000003 107.365 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 55.6 t -97.16 129.85 31.18 Favored Pre-proline 0 C--N 1.282 -2.366 0 CA-C-N 115.427 -0.806 . . . . 72.129999999999995 109.494 -171.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -68.86 128.59 17.1 Favored 'Trans proline' 0 C--O 1.241 0.629 0 C-N-CA 122.124 1.883 . . . . 73.420000000000002 111.925 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -89.21 144.67 25.94 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-O 121.633 0.73 . . . . 73.129999999999995 109.291 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.05 21.69 3.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 CA-C-N 114.817 -1.083 . . . . 72.549999999999997 112.036 -174.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -56.01 144.37 28.98 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.021 -0.99 . . . . 74.310000000000002 112.529 175.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.5 -0.08 46.46 Favored Glycine 0 C--N 1.311 -0.843 0 CA-C-N 115.71 -0.677 . . . . 44.020000000000003 112.486 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -111.34 -150.77 0.47 Allowed 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.11 -1.07 . . . . 73.109999999999999 108.11 176.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 80.0 p -97.77 161.53 13.71 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.36 -1.348 . . . . 75.519999999999996 107.36 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 42.3 m -63.32 -37.6 87.87 Favored 'General case' 0 C--O 1.21 -1.022 0 C-N-CA 120.838 -0.345 . . . . 74.109999999999999 110.305 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.06 -46.14 85.69 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 111.831 0.308 . . . . 73.140000000000001 111.831 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -68.92 -41.66 77.85 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 121.618 0.723 . . . . 74.310000000000002 109.24 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.81 -50.88 69.25 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.983 -1.008 . . . . 72.049999999999997 111.197 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 78.7 mt -64.74 -40.11 87.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.904 -0.589 . . . . 71.439999999999998 110.68 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.79 -38.07 77.73 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.139 0.495 . . . . 73.230000000000004 111.054 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 27.3 m -65.64 -47.09 76.77 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.074 -0.512 . . . . 73.409999999999997 110.334 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.85 -37.57 87.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.294 -0.412 . . . . 74.319999999999993 111.873 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.59 -37.91 88.09 Favored 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 122.296 0.239 . . . . 74.049999999999997 110.367 176.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -68.45 -21.22 64.65 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 121.19 0.519 . . . . 73.450000000000003 111.171 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -86.96 -14.13 42.63 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.982 -0.554 . . . . 74.099999999999994 110.224 174.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 95.63 9.48 57.56 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.567 -0.825 . . . . 64.209999999999994 112.474 176.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -82.55 155.48 24.48 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-O 121.13 0.49 . . . . 74.129999999999995 111.655 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -100.77 132.52 46.13 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 106.65 -1.611 . . . . 73.420000000000002 106.65 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 1.8 mp -119.11 146.38 23.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 107.665 -1.235 . . . . 74.230000000000004 107.665 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 46.2 ttt180 -111.75 127.96 55.95 Favored 'General case' 0 C--N 1.259 -3.361 0 N-CA-C 106.542 -1.651 . . . . 75.040000000000006 106.542 177.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 27.4 m -113.72 117.87 32.74 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 106.998 -1.482 . . . . 74.0 106.998 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.17 119.99 40.27 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.406 -0.961 . . . . 73.209999999999994 108.406 -177.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -94.1 122.51 36.69 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.219 -0.66 . . . . 74.200000000000003 109.219 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . 0.4 ' HA ' ' HE2' ' A' ' 389' ' ' LYS . 4.5 mmpt? -125.51 119.44 24.65 Favored Pre-proline 0 C--N 1.3 -1.55 0 C-N-CA 121.141 -0.223 . . . . 74.329999999999998 111.058 176.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . 0.585 ' HA ' ' O ' ' A' ' 422' ' ' THR . 38.0 Cg_exo -69.23 128.32 16.34 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.93 1.753 . . . . 72.530000000000001 108.993 171.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.567 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 7.0 t70 143.04 -171.42 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 104.923 -2.251 . . . . 75.040000000000006 104.923 -175.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 23.3 t -131.31 2.91 4.25 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.338 -0.616 . . . . 64.319999999999993 109.338 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 14.7 t -77.47 -5.6 50.48 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 122.918 0.487 . . . . 74.439999999999998 112.004 -178.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.8 151.96 45.93 Favored Pre-proline 0 C--N 1.303 -1.427 0 CA-C-O 118.998 -0.525 . . . . 74.340000000000003 109.69 -177.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -44.05 138.49 6.54 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 124.025 3.15 . . . . 74.140000000000001 114.105 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.5 161.71 16.73 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.417 2.745 . . . . 75.25 112.788 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -57.15 -8.3 0.67 Allowed 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 113.434 0.901 . . . . 71.519999999999996 113.434 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -111.56 130.2 55.82 Favored 'General case' 0 CA--C 1.478 -1.821 0 N-CA-C 106.581 -1.637 . . . . 73.400000000000006 106.581 171.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 20.1 m -66.37 119.32 11.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 O-C-N 123.787 0.679 . . . . 71.530000000000001 111.293 -169.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 8.7 tp -94.51 -29.33 4.16 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 108.508 -0.923 . . . . 71.329999999999998 108.508 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.84 170.6 27.77 Favored Glycine 0 N--CA 1.411 -3.025 0 N-CA-C 110.312 -1.115 . . . . 71.209999999999994 110.312 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 3.3 p -121.64 -179.28 4.05 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 107.712 -1.218 . . . . 75.140000000000001 107.712 176.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -101.4 134.58 20.19 Favored Pre-proline 0 C--N 1.293 -1.87 0 N-CA-C 107.703 -1.221 . . . . 70.099999999999994 107.703 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -51.59 -13.36 1.43 Allowed 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 124.33 3.353 . . . . 72.530000000000001 115.493 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.49 -39.4 70.39 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-O 120.703 0.287 . . . . 71.239999999999995 110.285 176.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -71.17 -33.54 70.11 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.859 0.838 . . . . 74.120000000000005 110.227 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -86.15 3.97 40.45 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.927 -1.033 . . . . 72.219999999999999 111.162 -177.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 27.1 m -109.7 154.36 22.99 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 105.514 -2.032 . . . . 74.409999999999997 105.514 171.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 360' ' ' VAL . 50.5 m -74.88 112.42 11.08 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 119.737 -0.785 . . . . 60.109999999999999 109.433 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 21.7 m -124.81 164.88 22.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 116.332 -0.394 . . . . 71.430000000000007 109.972 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 15.4 m -72.41 146.25 47.1 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.958 -0.386 . . . . 75.140000000000001 109.958 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -65.58 131.82 47.32 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.997 -0.371 . . . . 74.010000000000005 109.997 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 89.57 38.89 6.44 Favored Glycine 0 C--N 1.311 -0.836 0 C-N-CA 120.752 -0.737 . . . . 33.549999999999997 111.955 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -100.51 -175.99 3.07 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.328 -1.36 . . . . 75.310000000000002 107.328 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -108.83 123.25 48.76 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.137 0.494 . . . . 72.109999999999999 110.741 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 48.4 mm -112.18 137.4 45.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 106.538 -1.652 . . . . 73.329999999999998 106.538 175.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.4 t -116.76 132.0 56.81 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.842 -0.536 . . . . 73.349999999999994 110.892 -174.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 9.9 p -116.28 134.6 59.17 Favored 'Isoleucine or valine' 0 C--O 1.253 1.249 0 N-CA-C 109.567 -0.531 . . . . 73.239999999999995 109.567 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -102.42 116.07 31.86 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.997 -0.742 . . . . 71.140000000000001 108.997 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 77.0 t -104.93 130.88 55.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 116.116 -0.493 . . . . 71.319999999999993 110.775 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 30.6 t -85.92 123.85 31.72 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 115.593 -0.731 . . . . 74.409999999999997 110.241 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' THR . . . . . 0.585 ' O ' ' HA ' ' A' ' 390' ' ' PRO . 12.2 p -116.39 138.92 50.96 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 106.216 -1.772 . . . . 75.140000000000001 106.216 171.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -55.22 -92.98 0.01 OUTLIER Glycine 0 CA--C 1.538 1.484 0 N-CA-C 116.598 1.399 . . . . 71.219999999999999 116.598 -172.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.43 130.34 24.96 Favored 'Trans proline' 0 C--O 1.248 0.988 0 C-N-CA 123.296 2.664 . . . . 65.099999999999994 115.106 -171.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.531 ' HA ' ' CB ' ' A' ' 390' ' ' PRO . 35.3 mt-10 -72.77 158.15 36.13 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 113.597 -1.638 . . . . 73.530000000000001 111.882 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -92.71 133.87 35.59 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 106.308 -1.738 . . . . 75.329999999999998 106.308 177.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -120.79 165.32 15.3 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 109.469 -0.567 . . . . 72.450000000000003 109.469 -178.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -115.25 142.1 47.13 Favored 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 108.229 -1.026 . . . . 74.430000000000007 108.229 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.467 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 74.0 mt -77.17 121.02 83.95 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 108.95 -0.759 . . . . 65.040000000000006 108.95 -175.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -68.16 160.25 49.61 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 123.499 2.799 . . . . 73.219999999999999 114.411 -177.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -77.79 155.42 31.14 Favored 'General case' 0 C--O 1.249 1.077 0 CA-C-N 115.522 -0.763 . . . . 51.329999999999998 109.765 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 13.6 p -164.43 144.41 2.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 116.267 -0.424 . . . . 74.120000000000005 110.255 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 24.3 t -77.03 150.62 35.78 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 108.651 -0.87 . . . . 63.340000000000003 108.651 178.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' THR . . . . . 0.479 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 25.1 p -67.09 -23.41 65.84 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 121.578 0.704 . . . . 73.209999999999994 111.807 -176.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 2.5 pp -86.69 -11.26 51.75 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 113.046 0.758 . . . . 75.120000000000005 113.046 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -113.9 69.53 0.71 Allowed 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 114.049 1.129 . . . . 73.230000000000004 114.049 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -61.91 -37.55 85.05 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.211 -0.45 . . . . 75.349999999999994 110.261 175.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -58.83 -37.22 75.95 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 120.707 0.289 . . . . 73.540000000000006 111.025 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -66.68 -36.78 83.35 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.712 -0.847 . . . . 72.200000000000003 108.712 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.408 ' O ' HD12 ' A' ' 444' ' ' LEU . . . -63.55 -43.61 96.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.873 -0.603 . . . . 75.010000000000005 109.672 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 86.6 t -58.73 -50.43 79.27 Favored 'Isoleucine or valine' 0 C--O 1.244 0.773 0 CA-C-N 115.532 -0.758 . . . . 64.340000000000003 110.764 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . 0.342 0.0 OUTLIER -68.63 -34.08 75.12 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 113.945 1.091 . . . . 72.209999999999994 113.945 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -62.91 -47.5 83.02 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.778 0.323 . . . . 74.400000000000006 110.898 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.408 HD12 ' O ' ' A' ' 440' ' ' ALA . 9.1 mp -65.5 -32.84 74.66 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.156 -0.475 . . . . 74.5 111.846 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 70.8 m -69.25 -46.77 66.5 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.913 0.387 . . . . 72.109999999999999 110.505 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.14 -15.49 62.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.146 0.498 . . . . 74.099999999999994 111.244 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.63 -1.4 37.92 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 116.007 -0.542 . . . . 73.319999999999993 111.2 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 114.58 -83.95 0.35 Allowed Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.807 -0.711 . . . . 51.520000000000003 111.584 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -40.68 -62.43 0.79 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 114.596 1.332 . . . . 75.25 114.596 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 67.61 29.46 73.96 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.941 -0.647 . . . . 50.109999999999999 112.356 -177.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 31.7 mmm180 -105.54 111.44 24.15 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-O 121.507 0.67 . . . . 75.030000000000001 109.263 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -130.99 159.97 35.92 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 108.254 -1.017 . . . . 73.5 108.254 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -152.16 135.94 16.28 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 108.128 -1.064 . . . . 73.329999999999998 108.128 177.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -103.22 128.06 50.34 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.1 0.476 . . . . 65.510000000000005 109.964 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.37 149.08 42.9 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 107.364 -1.347 . . . . 70.340000000000003 107.364 174.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -125.53 138.8 53.98 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.142 0.496 . . . . 74.109999999999999 109.942 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 457' ' ' SER . . . . . 0.403 ' HB2' HD12 ' A' ' 487' ' ' ILE . 48.5 t -128.37 142.38 44.5 Favored Pre-proline 0 C--N 1.291 -1.943 0 N-CA-C 108.019 -1.104 . . . . 74.409999999999997 108.019 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.623 ' HA ' ' O ' ' A' ' 490' ' ' SER . 58.1 Cg_endo -76.27 122.56 6.67 Favored 'Trans proline' 0 N--CA 1.428 -2.361 0 C-N-CA 121.204 1.27 . . . . 74.450000000000003 109.691 176.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 48.8 m -144.69 179.21 7.44 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 108.887 -0.783 . . . . 73.109999999999999 108.887 -177.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 9.7 t -49.93 134.34 21.51 Favored Pre-proline 0 C--O 1.255 1.386 0 O-C-N 123.982 0.802 . . . . 73.540000000000006 111.902 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . 0.408 ' HA ' ' CG2' ' A' ' 464' ' ' VAL . 6.2 Cg_endo -50.93 -29.93 28.8 Favored 'Trans proline' 0 C--N 1.361 1.193 0 C-N-CA 124.187 3.258 . . . . 73.340000000000003 113.935 -175.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -66.44 -21.38 66.2 Favored 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 113.217 0.821 . . . . 42.039999999999999 113.217 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -100.24 -7.23 24.89 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 122.005 -0.435 . . . . 73.129999999999995 111.566 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.408 ' CG2' ' HA ' ' A' ' 461' ' ' PRO . 82.4 t -60.84 131.37 25.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 116.165 -0.471 . . . . 74.120000000000005 111.757 -178.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 96.26 -10.64 67.47 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.779 -0.646 . . . . 63.450000000000003 112.145 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -118.73 166.16 13.11 Favored 'General case' 0 N--CA 1.416 -2.149 0 N-CA-C 109.075 -0.713 . . . . 74.219999999999999 109.075 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.479 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 68.9 t -77.8 145.31 10.11 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 108.635 -0.876 . . . . 72.239999999999995 108.635 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 51.5 mt -97.74 -25.77 4.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 107.202 -1.407 . . . . 63.310000000000002 107.202 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 154.42 -167.73 32.51 Favored Glycine 0 N--CA 1.419 -2.444 0 CA-C-N 114.868 -1.06 . . . . 75.340000000000003 111.304 175.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.22 137.17 52.32 Favored 'General case' 0 N--CA 1.405 -2.688 0 N-CA-C 105.482 -2.044 . . . . 72.329999999999998 105.482 176.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -66.14 -53.31 33.52 Favored Pre-proline 0 C--N 1.323 -0.584 0 C-N-CA 119.388 -0.925 . . . . 72.329999999999998 110.772 -177.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -68.98 124.72 11.7 Favored 'Trans proline' 0 C--N 1.364 1.394 0 N-CA-C 107.24 -1.869 . . . . 64.129999999999995 107.24 167.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . 0.542 ' C ' ' H ' ' A' ' 475' ' ' ASN . 19.8 Cg_exo -62.34 145.47 95.89 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.928 1.752 . . . . 75.239999999999995 113.271 -174.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.467 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -69.05 11.31 0.21 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.237 1.015 . . . . 72.430000000000007 111.28 175.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . 0.542 ' H ' ' C ' ' A' ' 473' ' ' PRO . 12.9 m120 -108.62 -10.87 15.17 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 124.204 1.002 . . . . 63.340000000000003 108.623 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -98.49 171.12 8.36 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 121.485 0.659 . . . . 73.340000000000003 111.36 -176.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.02 129.71 51.65 Favored 'General case' 0 N--CA 1.402 -2.846 0 CA-C-N 114.664 -1.153 . . . . 74.430000000000007 111.721 -176.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 6.2 p -108.27 148.17 30.39 Favored 'General case' 0 N--CA 1.418 -2.059 0 C-N-CA 123.903 0.881 . . . . 54.340000000000003 110.038 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -89.28 175.25 7.42 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 116.369 -0.378 . . . . 72.400000000000006 110.148 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 32.9 mm -81.15 -6.67 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-O 122.197 0.999 . . . . 73.530000000000001 109.871 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 40.1 m -112.76 5.04 17.39 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 122.238 1.018 . . . . 72.219999999999999 109.061 175.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -80.69 134.49 35.86 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.597 -0.729 . . . . 72.25 111.514 -173.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.92 126.03 53.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 116.039 -0.528 . . . . 75.150000000000006 110.362 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 65.2 t -100.66 120.61 50.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 121.014 0.435 . . . . 75.239999999999995 110.093 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.62 118.96 44.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-O 121.828 0.823 . . . . 74.310000000000002 110.022 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 42.7 mt -111.3 128.64 67.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 114.534 -1.212 . . . . 75.219999999999999 109.976 -178.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.403 HD12 ' HB2' ' A' ' 457' ' ' SER . 17.3 tt -110.84 127.08 68.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.839 -0.619 . . . . 74.25 111.96 -173.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 35.5 m -108.32 152.35 10.21 Favored 'Isoleucine or valine' 0 C--O 1.248 1.023 0 C-N-CA 123.806 0.842 . . . . 75.310000000000002 111.156 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -88.1 133.5 11.85 Favored Glycine 0 N--CA 1.434 -1.44 0 CA-C-N 115.831 -0.622 . . . . 44.329999999999998 112.223 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.623 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 44.4 m -132.98 160.66 36.48 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.344 -1.354 . . . . 73.329999999999998 107.344 177.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 151.11 149.58 5.09 Favored Glycine 0 C--N 1.296 -1.684 0 C-N-CA 120.262 -0.97 . . . . 73.310000000000002 110.711 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -91.94 162.55 3.3 Favored 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 122.478 2.119 . . . . 75.019999999999996 113.735 -177.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -104.02 41.5 1.29 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.447 -1.316 . . . . 75.439999999999998 107.447 176.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 494' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 546' ' ' PRO . 72.7 p -117.24 153.77 32.33 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 114.34 -1.3 . . . . 75.420000000000002 108.945 -176.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . 0.426 ' HD3' ' H ' ' A' ' 496' ' ' ASP . 6.0 tmtt? -150.16 151.65 33.44 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 107.47 -1.307 . . . . 75.409999999999997 107.47 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.426 ' H ' ' HD3' ' A' ' 495' ' ' LYS . 9.8 p-10 -79.83 138.08 37.12 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 123.587 0.755 . . . . 62.43 109.489 177.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 36.4 pt -86.39 137.41 34.56 Favored Pre-proline 0 C--N 1.303 -1.418 0 CA-C-N 116.182 -0.463 . . . . 72.209999999999994 110.792 178.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -89.15 179.9 2.23 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.656 2.237 . . . . 75.510000000000005 112.339 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -84.38 142.05 30.43 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.832 -1.173 . . . . 73.140000000000001 107.832 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 10.6 p -139.32 19.23 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 CA-C-O 122.179 0.99 . . . . 74.540000000000006 110.052 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -72.41 114.52 10.62 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.199 -0.91 . . . . 52.439999999999998 110.893 -177.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 115.3 -8.12 20.67 Favored Glycine 0 CA--C 1.482 -1.973 0 N-CA-C 111.311 -0.716 . . . . 70.439999999999998 111.311 176.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -100.47 165.75 11.28 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 108.199 -1.037 . . . . 72.140000000000001 108.199 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 5.6 t -91.73 164.73 13.61 Favored 'General case' 0 C--N 1.285 -2.239 0 C-N-CA 120.217 -0.593 . . . . 65.099999999999994 109.889 -175.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 48.4 t -54.27 -41.26 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.606 0.762 . . . . 63.32 110.976 -177.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -57.68 -42.6 83.94 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 115.506 -0.77 . . . . 74.540000000000006 111.12 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 63.8 t -75.35 -42.54 43.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 116.028 -0.533 . . . . 73.310000000000002 109.738 -178.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -61.26 -49.69 76.05 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.71 -0.677 . . . . 72.219999999999999 111.853 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.472 ' O ' ' HB2' ' A' ' 513' ' ' ASN . 10.2 tt0 -65.35 -37.03 85.82 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.374 0.607 . . . . 74.329999999999998 110.04 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.48 ' O ' HG21 ' A' ' 514' ' ' VAL . 37.6 ttmt -65.93 -48.79 70.2 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.82 -1.082 . . . . 70.340000000000003 111.696 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -62.03 -48.58 79.66 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 121.149 0.5 . . . . 73.239999999999995 110.924 -177.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . 0.435 ' HB3' ' HB2' ' A' ' 517' ' ' PHE . 4.2 mm? -64.9 -36.54 84.7 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.578 -0.737 . . . . 74.150000000000006 110.885 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 509' ' ' GLN . 0.6 OUTLIER -60.92 -39.86 90.97 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 122.564 0.346 . . . . 75.450000000000003 110.553 178.378 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.48 HG21 ' O ' ' A' ' 510' ' ' LYS . 78.4 t -59.37 -36.65 65.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.645 -0.707 . . . . 73.5 110.758 178.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -79.58 -21.55 44.89 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.105 0.479 . . . . 73.239999999999995 110.639 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 127.5 -2.78 7.1 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 120.524 -0.846 . . . . 63.420000000000002 113.902 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.586 ' HA ' ' O ' ' A' ' 547' ' ' VAL . 95.1 m-85 -82.8 117.25 22.56 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.738 -1.208 . . . . 72.340000000000003 107.738 -176.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.6 m -118.8 -4.24 10.72 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 118.823 -1.151 . . . . 75.349999999999994 112.375 -174.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . 0.407 ' O ' HD12 ' A' ' 551' ' ' ILE . 64.3 mttp -112.26 115.21 28.42 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.637 -0.664 . . . . 73.5 110.82 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -126.25 154.37 43.45 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.256 -0.429 . . . . 73.209999999999994 110.909 -174.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 49.2 m -141.45 141.11 33.7 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.414 -1.328 . . . . 72.140000000000001 107.414 171.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -117.57 138.22 52.07 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-O 121.016 0.436 . . . . 73.0 110.94 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -124.39 116.77 23.11 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.038 -1.097 . . . . 74.530000000000001 108.038 176.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 524' ' ' SER . . . . . 0.561 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 19.7 m -97.82 136.03 38.73 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.601 0.238 . . . . 64.109999999999999 111.326 -176.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 61.5 t -129.47 148.87 33.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 107.031 -1.47 . . . . 75.25 107.031 177.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.38 136.63 37.71 Favored 'General case' 0 C--O 1.248 0.975 0 N-CA-C 108.727 -0.842 . . . . 72.530000000000001 108.727 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 77.6 p -153.33 179.56 1.26 Allowed Pre-proline 0 C--N 1.294 -1.819 0 N-CA-C 107.871 -1.159 . . . . 74.129999999999995 107.871 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -85.09 -0.7 9.19 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 121.69 1.594 . . . . 64.129999999999995 111.367 172.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . 0.427 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 12.7 mtp180 -88.39 139.74 30.14 Favored Pre-proline 0 N--CA 1.432 -1.345 0 N-CA-C 108.096 -1.075 . . . . 72.099999999999994 108.096 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.27 153.95 31.26 Favored 'Trans proline' 0 C--O 1.254 1.309 0 C-N-CA 123.304 2.669 . . . . 71.519999999999996 113.949 -176.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.625 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -74.75 116.29 15.29 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.347 -0.842 . . . . 71.209999999999994 110.527 -176.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 118.88 -7.42 13.15 Favored Glycine 0 CA--C 1.49 -1.481 0 C-N-CA 120.049 -1.072 . . . . 54.020000000000003 111.203 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -83.67 140.46 32.14 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 108.321 -0.992 . . . . 73.540000000000006 108.321 174.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 60.9 t -88.45 118.29 33.68 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 N-CA-C 108.063 -1.088 . . . . 74.310000000000002 108.063 178.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 535' ' ' THR . . . . . 0.477 ' OG1' ' HB3' ' A' ' 556' ' ' SER . 90.5 m -78.19 -24.2 47.26 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.776 -1.102 . . . . 73.430000000000007 109.802 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 153.54 -164.75 31.22 Favored Glycine 0 N--CA 1.424 -2.132 0 N-CA-C 110.435 -1.066 . . . . 44.310000000000002 110.435 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 18.0 p -117.71 159.29 23.22 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 109.327 -0.62 . . . . 62.119999999999997 109.327 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -63.11 -57.49 20.67 Favored Pre-proline 0 C--N 1.315 -0.924 0 O-C-N 123.625 0.578 . . . . 73.430000000000007 110.328 177.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -73.23 133.01 18.73 Favored 'Trans proline' 0 C--N 1.363 1.319 0 N-CA-C 109.136 -1.14 . . . . 73.239999999999995 109.136 171.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.14 156.73 48.48 Favored 'Trans proline' 0 C--O 1.252 1.203 0 C-N-CA 122.492 2.128 . . . . 73.409999999999997 112.354 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -57.31 140.52 49.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.786 -0.643 . . . . 73.540000000000006 110.97 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.26 -16.38 56.94 Favored Glycine 0 N--CA 1.433 -1.528 0 CA-C-N 115.708 -0.678 . . . . 73.329999999999998 111.687 -178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 99.7 m -65.28 123.93 20.86 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.071 0.462 . . . . 74.109999999999999 110.436 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 54.1 m -88.41 123.47 32.99 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 115.466 -0.788 . . . . 74.099999999999994 109.674 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 31.2 m -137.85 154.81 74.86 Favored Pre-proline 0 C--N 1.312 -1.053 0 N-CA-C 108.288 -1.004 . . . . 73.099999999999994 108.288 177.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' A' ' 494' ' ' THR . 52.6 Cg_exo -60.76 142.56 98.09 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.293 1.996 . . . . 74.230000000000004 110.863 173.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 517' ' ' PHE . 27.2 m -62.27 -20.45 24.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.799 0.809 . . . . 74.010000000000005 111.815 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . 0.402 ' O ' ' HD2' ' A' ' 519' ' ' LYS . 26.8 t70 -90.26 -5.59 56.15 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.38 -0.827 . . . . 72.0 111.713 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 72.1 m -83.35 166.01 18.81 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 121.751 -0.593 . . . . 74.209999999999994 111.567 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 21.5 t -92.67 129.54 43.08 Favored 'Isoleucine or valine' 0 C--O 1.254 1.294 0 CA-C-N 115.671 -0.695 . . . . 65.5 110.452 -176.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . 0.407 HD12 ' O ' ' A' ' 519' ' ' LYS . 0.2 OUTLIER -111.55 134.99 52.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.176 0.512 . . . . 75.310000000000002 110.256 174.383 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -102.98 121.11 41.86 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.566 -0.743 . . . . 74.510000000000005 109.885 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.2 mp -104.36 134.08 48.18 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.189 -0.914 . . . . 70.109999999999999 110.355 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -90.83 123.99 34.8 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.646 -0.872 . . . . 72.239999999999995 108.646 174.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 524' ' ' SER . 64.1 t -109.53 129.15 64.85 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 N-CA-C 108.509 -0.923 . . . . 73.319999999999993 108.509 -177.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.625 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 24.4 p -77.07 140.98 40.45 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-O 121.481 0.658 . . . . 75.340000000000003 112.183 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -104.3 131.92 51.11 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 107.057 -1.46 . . . . 75.329999999999998 107.057 168.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -69.5 -30.22 71.22 Favored Glycine 0 CA--C 1.489 -1.546 0 O-C-N 123.805 0.691 . . . . 65.219999999999999 111.515 -177.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 63.2 t30 70.28 9.43 6.99 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.581 1.152 . . . . 74.25 110.423 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 96.3 mt-30 -121.99 145.14 48.41 Favored 'General case' 0 N--CA 1.412 -2.375 0 CA-C-N 114.773 -1.103 . . . . 71.439999999999998 110.482 -178.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -123.27 147.96 46.41 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.371 -0.974 . . . . 74.430000000000007 108.371 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 59.0 t -69.74 121.2 18.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-O 121.08 0.467 . . . . 73.420000000000002 112.163 -173.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 53.7 ttp -97.88 132.01 25.64 Favored Pre-proline 0 C--O 1.25 1.102 0 CA-C-N 115.812 -0.631 . . . . 72.409999999999997 110.944 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -65.52 170.63 10.73 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 123.306 2.671 . . . . 75.329999999999998 111.764 173.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -72.34 132.44 43.99 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.429 0.633 . . . . 74.439999999999998 110.823 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 94.9 mt -120.62 -4.64 9.77 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.157 -0.929 . . . . 72.209999999999994 108.597 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 38.3 t -79.11 149.39 32.08 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.783 -1.099 . . . . 74.0 109.829 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 72.88 39.97 53.39 Favored Glycine 0 C--O 1.221 -0.714 0 C-N-CA 120.894 -0.67 . . . . 73.019999999999996 111.64 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 89.3 mtp -146.06 158.11 43.87 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.337 -1.727 . . . . 75.239999999999995 106.337 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . 0.527 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 96.6 m-85 -84.48 155.95 21.94 Favored 'General case' 0 N--CA 1.424 -1.741 0 C-N-CA 120.019 -0.673 . . . . 72.319999999999993 109.506 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 55.4 t90 -65.91 -22.87 66.53 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.148 0.499 . . . . 73.329999999999998 109.735 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 33.7 m -72.75 -12.06 15.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.803 -0.635 . . . . 72.439999999999998 110.697 177.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . 0.461 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 41.8 m-20 -101.48 -39.72 7.4 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 108.401 -0.963 . . . . 74.150000000000006 108.401 175.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -60.31 -40.72 91.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.436 -0.802 . . . . 72.349999999999994 111.503 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.474 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 1.2 tm-20 -57.32 -59.03 14.06 Favored Pre-proline 0 CA--C 1.578 2.052 0 C-N-CA 123.308 0.643 . . . . 71.140000000000001 110.477 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.33 -29.89 86.68 Favored 'Trans proline' 0 C--N 1.373 1.86 0 CA-C-N 120.912 1.362 . . . . 74.349999999999994 113.159 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 16.3 mmt180 -65.82 -43.32 88.95 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 121.103 -0.239 . . . . 72.540000000000006 110.808 177.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.4 pp -66.1 -38.03 87.23 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.046 0.451 . . . . 74.319999999999993 110.311 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -65.33 -35.29 80.54 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 115.863 -0.608 . . . . 73.319999999999993 110.794 175.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.55 -25.52 64.96 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 122.719 0.407 . . . . 75.120000000000005 110.928 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 89.9 mt -92.29 -8.17 45.94 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.85 -0.614 . . . . 74.450000000000003 110.503 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 65.4 41.95 96.21 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 110.71 -0.956 . . . . 45.030000000000001 110.71 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 74.2 t90 -77.51 136.63 38.34 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.296 0.57 . . . . 74.400000000000006 112.083 -175.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 81.7 m -151.79 99.53 2.59 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.526 -0.916 . . . . 74.219999999999999 108.526 173.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -140.26 -119.52 1.63 Allowed Glycine 0 N--CA 1.433 -1.507 0 N-CA-C 109.939 -1.264 . . . . 73.099999999999994 109.939 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 586' ' ' MET . . . . . 0.422 ' HE2' ' HA ' ' A' ' 586' ' ' MET . 0.4 OUTLIER -130.62 124.52 31.9 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.054 -0.721 . . . . 75.219999999999999 109.054 176.64 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -108.13 128.86 55.07 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 105.97 -1.863 . . . . 73.129999999999995 105.97 177.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -104.27 115.41 30.34 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.54 -0.911 . . . . 70.329999999999998 108.54 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -87.76 125.2 34.29 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 116.168 -0.469 . . . . 73.439999999999998 110.114 -176.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -103.9 173.9 22.04 Favored Glycine 0 N--CA 1.426 -2.008 0 N-CA-C 110.186 -1.166 . . . . 72.109999999999999 110.186 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -87.38 154.78 20.4 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.804 -0.443 . . . . 64.019999999999996 109.804 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 625' ' ' GLY . 4.3 p-10 -69.59 124.8 24.88 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.261 0.553 . . . . 73.430000000000007 109.557 178.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 95.3 t -129.04 115.73 37.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.812 -0.81 . . . . 54.439999999999998 108.812 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -84.48 118.82 24.54 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.349 -0.982 . . . . 73.219999999999999 108.349 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . 0.404 ' HB2' ' HG3' ' A' ' 599' ' ' GLN . . . -142.8 9.0 1.73 Allowed 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.941 -0.704 . . . . 72.510000000000005 112.004 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 125.49 -176.71 17.22 Favored Glycine 0 N--CA 1.435 -1.375 0 C-N-CA 120.152 -1.023 . . . . 74.099999999999994 111.955 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -63.44 -40.48 98.88 Favored Glycine 0 N--CA 1.45 -0.393 0 O-C-N 124.215 0.597 . . . . 63.450000000000003 113.066 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 23.8 m -63.18 -23.87 67.63 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 122.895 0.478 . . . . 74.530000000000001 111.628 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . 0.404 ' HG3' ' HB2' ' A' ' 595' ' ' ALA . 82.4 mm-40 -105.08 -1.64 25.35 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 111.979 0.363 . . . . 74.019999999999996 111.979 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -84.81 109.96 18.47 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 119.861 -0.736 . . . . 74.349999999999994 110.621 -176.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 57.01 0.27 0.07 Allowed 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 126.805 2.042 . . . . 73.329999999999998 114.973 176.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . 0.527 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 8.2 ptm180 -108.08 157.22 18.45 Favored 'General case' 0 C--N 1.289 -2.036 0 O-C-N 120.812 -1.18 . . . . 74.400000000000006 113.871 -173.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 66.5 t -69.11 130.77 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 113.908 -1.497 . . . . 73.450000000000003 108.502 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 46.5 t -84.31 -50.09 15.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 121.49 0.662 . . . . 72.340000000000003 109.669 -176.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -154.6 164.15 39.15 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 106.129 -1.804 . . . . 70.400000000000006 106.129 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -115.05 128.6 56.35 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 107.289 -1.374 . . . . 71.409999999999997 107.289 174.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.467 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 16.6 t-20 -48.25 -58.17 8.72 Favored Pre-proline 0 N--CA 1.48 1.025 0 O-C-N 123.798 0.686 . . . . 72.409999999999997 112.475 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 2.8 Cg_endo -86.34 120.87 1.88 Allowed 'Trans proline' 0 N--CA 1.442 -1.534 0 N-CA-C 108.097 -1.54 . . . . 75.120000000000005 108.097 169.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -63.31 160.27 35.85 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.371 2.047 . . . . 74.120000000000005 113.132 -177.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -57.85 127.28 31.29 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.437 -0.801 . . . . 72.439999999999998 111.055 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 91.95 -1.29 74.11 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.321 -0.942 . . . . 74.109999999999999 112.118 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 24.7 m -99.15 160.58 14.17 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.459 -0.941 . . . . 75.109999999999999 108.459 178.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -87.64 143.17 18.3 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 121.494 -0.384 . . . . 65.299999999999997 114.047 -175.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 27.8 m -113.81 142.55 25.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 C-N-CA 124.004 0.922 . . . . 73.439999999999998 109.42 176.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -58.89 176.26 0.22 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.731 1.011 . . . . 73.549999999999997 113.731 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -60.92 -25.86 67.06 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.96 -0.564 . . . . 73.349999999999994 112.421 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.31 -33.67 65.29 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.698 -0.853 . . . . 70.420000000000002 108.698 174.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 79.51 21.93 65.76 Favored Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 110.428 -1.069 . . . . 63.140000000000001 110.428 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.16 119.5 15.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 122.319 1.057 . . . . 72.0 111.29 -168.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 2.8 tp -116.56 126.5 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 CA-C-N 113.582 -1.645 . . . . 64.409999999999997 109.561 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.406 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 93.8 m -100.98 118.79 37.69 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 108.851 -0.796 . . . . 75.040000000000006 108.851 173.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -132.74 151.85 51.89 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 107.605 -1.257 . . . . 72.340000000000003 107.605 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -131.51 141.76 49.82 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 109.1 -0.704 . . . . 74.540000000000006 109.1 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -127.97 143.4 51.09 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 106.793 -1.558 . . . . 71.209999999999994 106.793 172.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 592' ' ' ASP . . . -85.87 -89.81 0.92 Allowed Glycine 0 N--CA 1.436 -1.319 0 C-N-CA 120.639 -0.791 . . . . 70.430000000000007 112.394 -176.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 . . . . . 0 C--N 1.309 -1.177 0 CA-C-O 118.866 -0.588 . . . . 71.329999999999998 110.554 -179.898 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.79 0 N-CA-C 111.108 -0.797 . . . . 64.129999999999995 111.108 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 10.6 tp -76.46 134.48 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 N-CA-C 108.992 -0.744 . . . . 73.540000000000006 108.992 175.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 1.3 p -83.21 155.78 23.53 Favored 'General case' 0 N--CA 1.394 -3.227 0 C-N-CA 123.22 0.608 . . . . 75.430000000000007 110.677 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -98.03 72.17 2.18 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.665 -1.235 . . . . 73.439999999999998 107.665 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -82.05 148.52 28.55 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.224 -1.353 . . . . 75.150000000000006 110.39 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 30.2 m -137.56 162.98 31.85 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 107.671 -1.233 . . . . 64.349999999999994 107.671 178.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -94.09 139.37 31.06 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 106.067 -1.827 . . . . 75.230000000000004 106.067 175.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.518 HG21 ' CZ ' ' A' ' 382' ' ' PHE . 90.6 t -93.48 128.82 40.83 Favored Pre-proline 0 C--N 1.281 -2.389 0 N-CA-C 108.28 -1.007 . . . . 74.239999999999995 108.28 -168.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -61.09 120.59 8.37 Favored 'Trans proline' 0 C--N 1.361 1.204 0 C-N-CA 122.468 2.112 . . . . 75.400000000000006 112.304 -174.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -87.71 84.36 7.08 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 114.571 -1.195 . . . . 75.200000000000003 108.053 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.423 ' HB ' HE21 ' A' ' 368' ' ' GLN . 28.2 m -92.09 16.03 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.078 -0.964 . . . . 72.329999999999998 112.707 -174.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . 0.296 0.2 OUTLIER -65.29 148.38 51.79 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.926 -0.579 . . . . 74.329999999999998 112.546 176.705 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 106.4 -1.78 37.2 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 110.125 -1.19 . . . . 75.530000000000001 110.125 -170.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . 0.423 HE21 ' HB ' ' A' ' 365' ' ' VAL . 39.5 mt-30 -109.27 -158.93 0.66 Allowed 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 107.588 -1.264 . . . . 71.310000000000002 107.588 173.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 65.4 p -90.52 160.56 15.91 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 109.94 -0.393 . . . . 73.140000000000001 109.94 -175.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 27.1 p -56.13 -46.47 79.18 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 123.556 0.535 . . . . 74.239999999999995 110.451 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.31 -46.27 84.31 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 115.843 -0.617 . . . . 64.530000000000001 112.291 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -66.67 -44.1 82.74 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 120.153 -0.619 . . . . 65.040000000000006 110.471 -178.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -63.17 -48.6 77.72 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.519 -0.764 . . . . 74.409999999999997 111.771 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 90.1 mt -65.83 -42.23 91.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 CA-C-N 116.547 -0.297 . . . . 74.430000000000007 110.301 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.79 -43.33 94.46 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.417 -0.356 . . . . 74.310000000000002 111.189 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 33.8 m -63.0 -47.51 82.8 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.026 -0.534 . . . . 75.010000000000005 111.457 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 11.1 mp -64.59 -41.64 96.12 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.137 -0.225 . . . . 74.329999999999998 111.545 178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -38.72 92.19 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.301 -0.409 . . . . 74.340000000000003 110.186 -179.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -64.97 -30.81 71.82 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.894 0.378 . . . . 63.520000000000003 111.155 176.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -81.72 -8.66 59.72 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.131 -0.486 . . . . 71.510000000000005 110.826 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 99.49 0.18 56.79 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.603 -0.808 . . . . 72.340000000000003 112.491 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.518 ' CZ ' HG21 ' A' ' 362' ' ' VAL . 62.7 m-85 -78.26 147.67 34.24 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 109.124 -0.695 . . . . 74.0 109.124 178.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . 0.435 ' HB2' ' HG2' ' A' ' 415' ' ' GLU . 40.9 mmtm -100.35 144.53 29.24 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.497 -1.668 . . . . 75.319999999999993 106.497 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 1.5 mp -129.0 140.46 49.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 108.353 -0.981 . . . . 74.230000000000004 108.353 -179.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -109.85 128.05 55.08 Favored 'General case' 0 C--N 1.264 -3.113 0 N-CA-C 104.893 -2.262 . . . . 75.129999999999995 104.893 175.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 19.3 m -115.26 127.86 55.76 Favored 'General case' 0 C--N 1.257 -3.446 0 N-CA-C 108.095 -1.076 . . . . 71.239999999999995 108.095 -175.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.87 120.83 43.27 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.67 -1.233 . . . . 63.119999999999997 107.67 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -95.89 132.82 40.77 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.823 -0.436 . . . . 63.149999999999999 109.823 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 421' ' ' SER . 93.3 mttt -136.04 134.24 20.22 Favored Pre-proline 0 C--N 1.297 -1.703 0 N-CA-C 108.39 -0.967 . . . . 74.530000000000001 108.39 173.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . 0.501 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 29.5 Cg_endo -91.51 127.31 1.07 Allowed 'Trans proline' 0 C--O 1.251 1.146 0 C-N-CA 121.296 1.331 . . . . 61.340000000000003 111.259 175.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.501 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 12.2 t70 150.97 -164.92 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 103.203 -2.888 . . . . 74.099999999999994 103.203 -177.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 13.1 t -141.83 2.91 1.6 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 119.369 0.986 . . . . 75.439999999999998 110.539 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 11.5 t -87.74 -7.74 56.95 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.265 1.031 . . . . 75.030000000000001 109.787 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . 0.425 ' CD1' ' HB3' ' A' ' 391' ' ' ASP . 0.2 OUTLIER -109.25 151.81 42.25 Favored Pre-proline 0 N--CA 1.417 -2.088 0 N-CA-C 106.737 -1.579 . . . . 74.329999999999998 106.737 178.414 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -22.92 113.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.087 1 C-N-CA 125.739 4.293 . . . . 73.450000000000003 115.736 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -61.63 164.09 16.71 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 124.252 3.301 . . . . 74.319999999999993 112.605 -178.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . 0.489 ' HA ' ' CG2' ' A' ' 420' ' ' VAL . 31.4 t70 -56.53 -9.23 0.68 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 122.504 1.145 . . . . 61.039999999999999 111.937 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 64.1 m170 -103.96 111.33 23.84 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 103.5 -2.778 . . . . 64.5 103.5 168.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 27.4 m -63.14 119.49 7.3 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 O-C-N 124.403 1.065 . . . . 72.430000000000007 112.425 -168.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 9.1 tp -91.19 -29.14 4.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-N 115.515 -0.766 . . . . 71.329999999999998 110.443 -176.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.93 162.37 28.32 Favored Glycine 0 N--CA 1.42 -2.375 0 C-N-CA 119.533 -1.318 . . . . 63.509999999999998 113.554 -174.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 10.6 p -132.36 -175.7 3.84 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 125.7 1.6 . . . . 62.229999999999997 109.116 -177.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -101.37 134.3 20.37 Favored Pre-proline 0 C--N 1.293 -1.879 0 N-CA-C 107.28 -1.378 . . . . 74.049999999999997 107.28 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -47.03 -24.95 3.62 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 124.412 3.408 . . . . 73.540000000000006 115.122 -177.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.51 -28.23 68.23 Favored 'General case' 0 C--O 1.209 -1.067 0 CA-C-N 116.27 -0.423 . . . . 54.340000000000003 111.327 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -73.99 -32.54 63.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.825 0.821 . . . . 71.019999999999996 110.014 178.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -87.27 -2.15 58.41 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.522 -0.763 . . . . 74.349999999999994 109.498 -178.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 24.9 m -102.18 151.85 21.71 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.44 -1.689 . . . . 73.420000000000002 106.44 173.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 46.2 m -79.92 112.41 17.18 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 119.125 -1.03 . . . . 54.5 109.306 176.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.8 m -121.36 168.67 13.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 116.371 -0.377 . . . . 73.030000000000001 110.124 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 57.1 m -61.88 133.17 55.11 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.245 0.545 . . . . 72.019999999999996 110.936 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -61.77 112.44 2.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.316 -0.856 . . . . 72.120000000000005 112.754 -174.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 119.55 6.5 10.46 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.602 -0.808 . . . . 65.230000000000004 113.383 177.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -69.49 179.19 2.16 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 122.442 0.297 . . . . 73.209999999999994 111.233 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . 0.435 ' HG2' ' HB2' ' A' ' 383' ' ' LYS . 40.2 mt-10 -106.49 122.8 47.02 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 122.848 0.459 . . . . 75.319999999999993 110.569 -174.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 49.2 mm -112.41 130.6 65.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 108.78 -0.822 . . . . 74.319999999999993 108.78 178.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 81.4 m -96.95 132.35 42.83 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.116 0.484 . . . . 63.240000000000002 111.003 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 5.6 p -122.86 134.59 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 CA-C-N 115.78 -0.646 . . . . 74.530000000000001 109.762 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -95.59 129.23 42.85 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.982 -0.747 . . . . 73.099999999999994 108.982 174.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.489 ' CG2' ' HA ' ' A' ' 397' ' ' ASP . 8.6 p -138.7 141.51 36.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 109.617 -0.512 . . . . 75.530000000000001 109.617 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 11.5 p -100.15 121.97 42.26 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-O 121.699 0.761 . . . . 73.340000000000003 112.184 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 9.3 t -121.44 121.33 37.33 Favored 'General case' 0 N--CA 1.41 -2.449 0 N-CA-C 108.001 -1.111 . . . . 72.219999999999999 108.001 170.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 121.08 137.36 5.27 Favored Glycine 0 C--N 1.297 -1.588 0 C-N-CA 119.701 -1.238 . . . . 73.150000000000006 112.597 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -74.69 157.87 43.77 Favored 'Trans proline' 0 C--O 1.251 1.142 0 C-N-CA 122.949 2.433 . . . . 74.439999999999998 113.272 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -74.75 164.79 26.18 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.042 -1.436 . . . . 75.310000000000002 110.13 178.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -92.94 156.72 16.74 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.727 -0.842 . . . . 73.540000000000006 108.727 175.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' A' ' 447' ' ' ALA . 3.9 mmp_? -122.39 152.99 39.64 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.747 0.308 . . . . 74.510000000000005 111.162 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -91.02 139.04 31.14 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 115.759 -0.655 . . . . 75.540000000000006 110.642 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 50.4 mt -86.04 126.3 65.82 Favored Pre-proline 0 N--CA 1.421 -1.887 0 N-CA-C 106.914 -1.513 . . . . 74.439999999999998 106.914 176.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -73.12 141.43 32.64 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.174 1.916 . . . . 73.040000000000006 110.537 169.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -80.91 116.15 20.74 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.828 -1.175 . . . . 72.25 107.828 173.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 61.4 t -107.34 154.17 8.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 108.035 -1.098 . . . . 74.329999999999998 108.035 -175.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.5 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 19.6 m -67.13 152.35 45.91 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 120.818 0.342 . . . . 71.319999999999993 110.805 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 35.5 p -67.28 -27.93 67.6 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 113.979 1.103 . . . . 63.340000000000003 113.979 -172.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 2.4 pp -88.38 -10.34 49.65 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.719 0.771 . . . . 73.409999999999997 111.439 176.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.5 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 1.6 m -96.84 37.0 1.33 Allowed 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.428 0.632 . . . . 74.329999999999998 110.35 -175.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -52.76 -38.78 61.5 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.705 0.802 . . . . 72.209999999999994 112.56 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.33 -40.31 93.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.932 0.396 . . . . 71.519999999999996 111.33 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 29.3 tp10 -70.84 -34.53 71.77 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.523 -0.547 . . . . 75.150000000000006 109.523 176.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.513 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.02 -50.98 71.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.594 -0.276 . . . . 71.430000000000007 111.218 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.1 m -60.71 -37.34 75.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 121.301 0.572 . . . . 74.340000000000003 110.634 177.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -60.37 -47.66 85.1 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.257 -0.883 . . . . 71.239999999999995 110.81 175.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -65.02 -39.5 93.48 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.817 0.341 . . . . 75.120000000000005 111.609 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.513 HD13 ' O ' ' A' ' 440' ' ' ALA . 6.2 mp -65.21 -36.19 83.4 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.968 -0.56 . . . . 72.439999999999998 110.999 177.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 65.8 m -70.18 -42.7 72.09 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-O 120.825 0.345 . . . . 75.519999999999996 110.091 177.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -65.93 -21.87 66.46 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-O 121.438 0.637 . . . . 63.310000000000002 110.844 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . 0.406 ' O ' ' HG3' ' A' ' 427' ' ' ARG . . . -82.65 5.42 21.18 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.451 -0.795 . . . . 72.420000000000002 111.465 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 100.69 -73.68 0.41 Allowed Glycine 0 CA--C 1.501 -0.79 0 C-N-CA 120.408 -0.901 . . . . 74.439999999999998 112.525 174.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -43.88 -59.36 2.3 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.955 1.094 . . . . 74.099999999999994 113.955 176.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 59.31 29.71 66.49 Favored Glycine 0 C--O 1.224 -0.53 0 C-N-CA 121.24 -0.505 . . . . 74.109999999999999 112.652 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -102.59 110.56 22.53 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 108.385 -0.968 . . . . 65.109999999999999 108.385 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -140.71 143.05 34.82 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.865 -0.607 . . . . 73.349999999999994 111.05 -177.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -131.22 122.95 27.42 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.592 -0.892 . . . . 74.519999999999996 108.592 178.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -91.36 128.16 37.08 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.371 -0.603 . . . . 74.430000000000007 109.371 176.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -116.74 139.44 50.57 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 106.911 -1.514 . . . . 64.430000000000007 106.911 175.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -115.32 130.87 57.03 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.374 -0.973 . . . . 64.420000000000002 108.374 -176.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 41.9 t -132.59 140.15 36.92 Favored Pre-proline 0 C--N 1.283 -2.306 0 N-CA-C 108.793 -0.817 . . . . 55.229999999999997 108.793 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.681 ' HA ' ' O ' ' A' ' 490' ' ' SER . 49.7 Cg_endo -72.52 121.76 7.7 Favored 'Trans proline' 0 N--CA 1.437 -1.805 0 C-N-CA 121.045 1.163 . . . . 73.230000000000004 109.726 174.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 48.8 m -142.69 179.38 7.02 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.661 -0.7 . . . . 71.299999999999997 110.55 -173.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 14.1 t -52.12 138.63 36.06 Favored Pre-proline 0 CA--C 1.562 1.412 0 C-N-CA 124.198 0.999 . . . . 72.310000000000002 111.274 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.77 -30.0 36.17 Favored 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 124.868 3.712 . . . . 65.510000000000005 114.058 -173.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -73.17 -19.84 61.03 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.608 0.596 . . . . 75.230000000000004 112.608 -176.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -101.79 -6.83 23.15 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.232 -0.292 . . . . 74.109999999999999 111.32 177.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 94.4 t -61.09 128.09 21.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 120.854 0.359 . . . . 63.200000000000003 110.341 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.42 -11.85 71.13 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.432 -0.804 . . . . 72.230000000000004 111.831 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -110.93 165.36 11.92 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 109.636 -0.505 . . . . 63.509999999999998 109.636 -177.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 80.6 t -76.98 145.3 10.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 107.086 -1.449 . . . . 73.209999999999994 107.086 171.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 64.8 mt -97.32 -31.96 3.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 107.031 -1.47 . . . . 71.439999999999998 107.031 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 160.39 -178.36 36.45 Favored Glycine 0 N--CA 1.417 -2.625 0 CA-C-N 114.983 -1.008 . . . . 61.43 110.858 175.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 470' ' ' THR . . . . . 0.438 HG22 HG12 ' A' ' 486' ' ' ILE . 54.3 p -114.39 146.44 40.57 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 106.117 -1.809 . . . . 74.439999999999998 106.117 175.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -67.19 -54.51 19.28 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 120.054 -0.658 . . . . 74.109999999999999 110.675 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -73.15 138.81 28.53 Favored 'Trans proline' 0 C--N 1.368 1.585 0 N-CA-C 107.797 -1.655 . . . . 71.219999999999999 107.797 169.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -62.62 132.28 37.13 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.611 1.541 . . . . 72.430000000000007 111.888 -177.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -73.75 16.69 0.2 Allowed 'General case' 0 C--O 1.195 -1.768 0 C-N-CA 124.214 1.006 . . . . 53.43 112.355 -177.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -111.8 -8.87 14.12 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 122.645 0.378 . . . . 65.530000000000001 111.2 173.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -77.61 171.1 15.45 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 113.606 0.965 . . . . 74.310000000000002 113.606 -172.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 1.1 m -105.37 115.53 30.42 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 107.592 -1.262 . . . . 65.409999999999997 107.592 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 22.0 m -115.1 142.62 46.4 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 120.613 0.244 . . . . 74.129999999999995 110.401 -176.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -71.72 166.57 21.69 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.813 -0.63 . . . . 72.120000000000005 110.19 176.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 29.4 mm -70.95 -3.18 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.362 0 CA-C-O 121.821 0.82 . . . . 63.530000000000001 111.797 -173.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 14.6 t -112.19 5.29 18.38 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.18 -0.95 . . . . 72.230000000000004 110.711 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -79.79 132.66 36.2 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.803 -0.56 . . . . 75.230000000000004 111.377 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 46.0 t -106.61 121.7 59.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 108.35 -0.981 . . . . 70.409999999999997 108.35 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 28.7 m -104.72 134.62 45.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-O 121.518 0.675 . . . . 73.319999999999993 111.929 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.13 125.99 50.02 Favored 'Isoleucine or valine' 0 C--O 1.252 1.195 0 N-CA-C 108.91 -0.774 . . . . 74.510000000000005 108.91 178.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . 0.438 HG12 HG22 ' A' ' 470' ' ' THR . 7.9 mt -119.62 127.44 75.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.259 -0.882 . . . . 71.150000000000006 109.381 -178.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 7.1 tt -108.38 127.14 64.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.07 0.462 . . . . 62.32 111.287 -177.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 31.9 m -111.23 151.75 13.3 Favored 'Isoleucine or valine' 0 C--O 1.252 1.203 0 CA-C-N 115.849 -0.614 . . . . 72.5 109.933 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.17 133.97 12.2 Favored Glycine 0 N--CA 1.43 -1.702 0 C-N-CA 121.022 -0.609 . . . . 74.0 111.946 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.681 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 33.4 m -135.01 161.02 36.48 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 105.779 -1.934 . . . . 74.420000000000002 105.779 176.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 151.29 134.02 2.11 Favored Glycine 0 C--N 1.295 -1.695 0 C-N-CA 118.468 -1.825 . . . . 45.130000000000003 113.925 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -97.97 152.7 0.85 Allowed 'Trans proline' 0 N--CA 1.44 -1.633 0 C-N-CA 122.756 2.304 . . . . 74.329999999999998 111.63 172.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -110.6 35.3 3.53 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 122.404 1.097 . . . . 75.329999999999998 108.506 177.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 17.2 p -117.22 150.06 39.37 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 113.758 -1.564 . . . . 72.420000000000002 110.994 -174.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . 0.442 ' HA ' ' HE3' ' A' ' 495' ' ' LYS . 0.0 OUTLIER -137.04 164.28 28.75 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.694 -1.224 . . . . 75.040000000000006 107.694 175.474 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -90.36 138.34 31.62 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 109.531 -0.544 . . . . 74.420000000000002 109.531 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 543' ' ' THR . 35.9 pt -95.54 124.54 52.72 Favored Pre-proline 0 C--N 1.306 -1.286 0 C-N-CA 120.787 -0.365 . . . . 63.229999999999997 110.754 177.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -89.38 171.14 4.51 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.391 2.061 . . . . 72.040000000000006 110.51 174.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -87.87 154.57 20.42 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.386 -0.968 . . . . 70.409999999999997 108.386 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.5 p -145.91 104.31 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 108.954 -0.758 . . . . 75.129999999999995 108.954 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -140.68 119.85 12.89 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.732 -0.667 . . . . 74.299999999999997 110.497 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 122.97 -12.38 8.63 Favored Glycine 0 CA--C 1.486 -1.77 0 C-N-CA 120.119 -1.039 . . . . 74.530000000000001 111.779 177.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . 0.472 ' O ' HG13 ' A' ' 534' ' ' VAL . 20.2 mt-30 -99.0 171.09 8.26 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.438 -0.949 . . . . 65.150000000000006 108.438 176.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 14.5 t -90.15 157.78 17.57 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.358 -0.979 . . . . 72.420000000000002 108.358 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 12.4 p -52.78 -41.1 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 113.084 0.772 . . . . 64.25 113.084 -176.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -61.54 -41.87 98.0 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.125 0.488 . . . . 72.230000000000004 110.6 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 93.5 t -69.54 -43.38 80.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.441 -0.799 . . . . 73.409999999999997 110.196 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -61.31 -49.5 76.75 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.081 -0.508 . . . . 70.019999999999996 111.412 -178.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -63.07 -38.09 89.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.042 0.449 . . . . 73.230000000000004 111.285 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.452 ' O ' HG21 ' A' ' 514' ' ' VAL . 33.6 ttmt -62.54 -42.29 99.43 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.343 -0.844 . . . . 74.430000000000007 109.719 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -62.82 -48.37 79.36 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.056 -0.52 . . . . 74.129999999999995 110.79 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.93 -36.54 79.6 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.076 0.399 . . . . 75.209999999999994 112.076 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.36 -37.43 80.68 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 116.351 -0.386 . . . . 75.049999999999997 111.145 176.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.452 HG21 ' O ' ' A' ' 510' ' ' LYS . 94.2 t -61.48 -36.43 73.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.117 -0.492 . . . . 74.430000000000007 110.387 177.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -76.46 -15.03 60.0 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.573 -0.285 . . . . 74.409999999999997 111.354 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 110.91 -8.65 29.57 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.793 -0.717 . . . . 75.209999999999994 112.846 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.454 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 76.2 m-85 -80.06 113.82 18.52 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 108.085 -1.08 . . . . 75.519999999999996 108.085 -177.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.4 m -116.71 -8.95 11.37 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 118.548 -1.261 . . . . 71.140000000000001 114.113 -171.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . 0.402 ' O ' HD12 ' A' ' 551' ' ' ILE . 62.6 mttp -108.34 120.81 43.45 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.391 -0.818 . . . . 74.530000000000001 110.397 -178.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -120.93 156.04 32.94 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 113.338 0.866 . . . . 72.140000000000001 113.338 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 46.9 m -141.85 138.52 32.2 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 106.296 -1.742 . . . . 61.509999999999998 106.296 169.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . 0.491 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 0.0 OUTLIER -121.63 141.35 51.2 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 119.601 -0.84 . . . . 73.219999999999999 111.094 179.523 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -119.89 122.61 41.66 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.683 -1.228 . . . . 74.409999999999997 107.683 176.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 524' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 67.1 m -88.86 128.02 35.65 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 121.214 0.531 . . . . 73.319999999999993 110.508 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 24.7 m -121.44 149.82 24.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.96 -0.756 . . . . 65.129999999999995 108.96 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -73.94 135.03 43.22 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 108.354 -0.98 . . . . 71.530000000000001 108.354 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 45.4 m -152.16 172.55 5.37 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 108.628 -0.879 . . . . 72.319999999999993 108.628 -176.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -82.67 -10.31 10.77 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 121.452 1.435 . . . . 72.030000000000001 110.424 174.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . 0.438 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 27.3 mmt180 -81.36 138.18 48.43 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-N 114.862 -1.063 . . . . 64.530000000000001 108.18 -178.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -62.46 149.65 90.15 Favored 'Trans proline' 0 C--O 1.249 1.03 0 C-N-CA 122.351 2.034 . . . . 74.329999999999998 112.316 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -58.57 118.26 5.44 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.224 -0.898 . . . . 73.510000000000005 110.79 -178.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 127.59 -23.73 5.33 Favored Glycine 0 N--CA 1.434 -1.442 0 N-CA-C 111.113 -0.795 . . . . 70.319999999999993 111.113 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -81.14 134.96 35.73 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.468 -0.938 . . . . 74.349999999999994 108.468 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 503' ' ' GLN . 13.4 p -80.96 135.24 25.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 CA-C-O 121.3 0.571 . . . . 71.120000000000005 110.519 -178.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 77.5 m -88.91 -32.83 17.53 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.168 -0.924 . . . . 73.239999999999995 109.889 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.38 -152.1 24.21 Favored Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 110.091 -1.203 . . . . 74.219999999999999 110.091 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 27.3 p -117.56 157.19 26.78 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.551 -0.537 . . . . 72.109999999999999 109.551 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -73.09 -50.04 6.87 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 109.59 -0.522 . . . . 74.409999999999997 109.59 175.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.12 146.92 78.29 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 121.217 1.278 . . . . 74.409999999999997 109.649 171.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.43 143.81 53.66 Favored 'Trans proline' 0 C--O 1.25 1.122 0 C-N-CA 122.181 1.921 . . . . 75.239999999999995 113.089 -176.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.86 133.51 50.2 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.815 -0.809 . . . . 74.129999999999995 108.815 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.47 -5.31 35.32 Favored Glycine 0 C--N 1.299 -1.506 0 C-N-CA 120.053 -1.07 . . . . 72.120000000000005 111.111 -176.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 543' ' ' THR . . . . . 0.456 ' O ' HG12 ' A' ' 497' ' ' ILE . 62.4 m -82.26 133.69 35.25 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.516 -0.55 . . . . 75.239999999999995 109.516 176.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 11.9 t -96.44 130.84 43.5 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 119.984 -0.686 . . . . 73.040000000000006 109.571 176.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.1 m -139.44 159.24 66.6 Favored Pre-proline 0 C--N 1.316 -0.891 0 N-CA-C 109.175 -0.676 . . . . 75.209999999999994 109.175 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -63.39 142.04 83.69 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.367 2.045 . . . . 75.219999999999999 111.374 176.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.454 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 27.7 m -66.72 -23.19 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-O 121.445 0.64 . . . . 73.030000000000001 112.32 -177.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -79.68 -13.41 59.49 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.517 -0.765 . . . . 74.129999999999995 110.574 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 56.7 m -77.5 164.97 24.94 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 113.463 0.912 . . . . 72.200000000000003 113.463 -175.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 23.9 t -90.9 131.39 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-N 114.629 -1.169 . . . . 75.519999999999996 109.179 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . 0.402 HD12 ' O ' ' A' ' 519' ' ' LYS . 0.2 OUTLIER -116.51 142.39 30.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 109.721 -0.474 . . . . 73.450000000000003 109.721 175.317 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -103.78 116.66 32.72 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.839 -0.619 . . . . 74.219999999999999 110.713 -175.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 7.3 mp -103.27 134.4 46.74 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.238 -0.892 . . . . 75.120000000000005 109.738 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -101.29 125.38 47.92 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 108.834 -0.802 . . . . 71.010000000000005 108.834 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 524' ' ' SER . 59.5 t -114.8 138.59 44.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-N 115.44 -0.8 . . . . 71.129999999999995 110.002 -174.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.501 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 63.2 m -69.35 140.57 54.28 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 113.606 0.965 . . . . 74.310000000000002 113.606 178.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -103.26 139.76 38.29 Favored 'General case' 0 N--CA 1.422 -1.825 0 N-CA-C 104.915 -2.254 . . . . 74.439999999999998 104.915 166.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -67.68 -36.56 87.86 Favored Glycine 0 CA--C 1.484 -1.905 0 C-N-CA 120.55 -0.833 . . . . 75.319999999999993 112.395 -172.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 66.2 t30 67.33 -3.84 0.97 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.808 1.243 . . . . 64.340000000000003 112.857 171.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -151.38 142.06 22.74 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.172 -1.418 . . . . 74.340000000000003 107.172 -174.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -136.18 134.93 38.72 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 120.627 0.251 . . . . 75.129999999999995 111.092 174.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.1 p -60.27 123.23 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.737 0.815 . . . . 74.230000000000004 112.931 -175.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 563' ' ' MET . . . . . 0.429 ' HG2' ' O ' ' A' ' 612' ' ' THR . 25.5 ptm -98.11 141.19 22.55 Favored Pre-proline 0 C--O 1.253 1.259 0 CA-C-N 115.9 -0.591 . . . . 62.119999999999997 111.421 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.35 169.85 21.55 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.793 2.328 . . . . 72.230000000000004 110.555 171.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -72.52 130.45 40.65 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.163 0.506 . . . . 74.010000000000005 110.021 177.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 93.2 mt -116.6 -9.78 11.3 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.656 -0.702 . . . . 61.420000000000002 110.943 -177.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 10.5 p -70.36 129.88 40.47 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 109.952 -0.388 . . . . 75.129999999999995 109.952 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 90.3 -0.26 77.87 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.581 -0.819 . . . . 74.409999999999997 111.942 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 26.4 mmt -91.32 151.21 20.96 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 108.845 -0.798 . . . . 71.310000000000002 108.845 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -93.28 140.79 29.15 Favored 'General case' 0 N--CA 1.416 -2.165 0 N-CA-C 109.35 -0.611 . . . . 75.219999999999999 109.35 -176.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 60.7 t-105 -71.53 -15.65 62.3 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.659 -0.701 . . . . 75.420000000000002 110.276 -174.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 14.0 p -72.31 -19.3 19.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.896 0.855 . . . . 72.25 108.908 178.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -102.27 -44.77 5.32 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 114.511 -1.222 . . . . 70.510000000000005 110.359 176.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . 0.41 ' O ' ' HG3' ' A' ' 577' ' ' ARG . . . -65.42 -41.34 93.68 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 113.923 1.083 . . . . 73.439999999999998 113.923 -176.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.575 ' O ' ' HG2' ' A' ' 579' ' ' ARG . 32.0 tt0 -65.54 -53.55 36.81 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 120.176 -0.61 . . . . 73.439999999999998 111.907 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . 0.404 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 52.4 Cg_exo -55.88 -39.26 92.21 Favored 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 121.91 1.74 . . . . 74.439999999999998 113.136 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' ' 574' ' ' ALA . 3.2 ppt_? -67.76 -37.19 81.76 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 119.536 -0.865 . . . . 75.430000000000007 110.809 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.427 HD11 ' N ' ' A' ' 579' ' ' ARG 0.275 3.5 pp -66.55 -36.41 82.59 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 120.498 -0.481 . . . . 75.219999999999999 111.507 179.865 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . 0.575 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 45.8 mmm-85 -57.21 -42.75 81.92 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.169 -0.923 . . . . 75.120000000000005 108.711 176.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -67.8 -28.05 67.26 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.716 -0.675 . . . . 74.540000000000006 111.912 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 10.5 mp -80.56 -8.06 59.46 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.145 0.498 . . . . 73.530000000000001 111.164 177.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 77.77 16.28 80.25 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-N 115.759 -0.655 . . . . 71.030000000000001 111.95 179.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -70.78 140.46 51.29 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 109.523 -0.547 . . . . 74.510000000000005 109.523 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 9.6 t -137.21 -50.01 0.62 Allowed 'General case' 0 N--CA 1.406 -2.638 0 CA-C-O 118.871 -0.585 . . . . 73.230000000000004 110.238 175.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . 30.67 -126.69 0.16 Allowed Glycine 0 C--N 1.371 2.488 0 O-C-N 124.631 1.207 . . . . 73.439999999999998 113.734 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 25.7 ptm -137.93 125.54 22.21 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.881 -1.526 . . . . 74.400000000000006 106.881 170.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -87.41 123.84 32.78 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.69 -0.855 . . . . 75.329999999999998 108.69 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -95.96 107.33 19.6 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.669 -0.696 . . . . 72.310000000000002 109.277 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -112.5 113.3 25.4 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 108.582 -0.895 . . . . 71.010000000000005 108.582 176.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -83.25 -126.09 1.1 Allowed Glycine 0 N--CA 1.435 -1.367 0 N-CA-C 111.066 -0.814 . . . . 62.130000000000003 111.066 175.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -70.98 137.73 49.35 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.873 0.368 . . . . 74.239999999999995 111.124 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -97.49 126.95 43.06 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 106.903 -1.518 . . . . 72.150000000000006 106.903 176.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 48.8 t -137.27 128.95 41.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 C-N-CA 120.955 -0.298 . . . . 75.129999999999995 110.463 -172.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -77.38 108.35 10.46 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 105.173 -2.158 . . . . 63.020000000000003 105.173 170.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -105.1 0.19 27.24 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-O 121.216 0.531 . . . . 75.450000000000003 111.44 -174.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 100.82 171.47 28.93 Favored Glycine 0 N--CA 1.433 -1.56 0 N-CA-C 109.584 -1.406 . . . . 75.120000000000005 109.584 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -63.46 -48.16 80.82 Favored Glycine 0 C--N 1.306 -1.126 0 C-N-CA 120.721 -0.752 . . . . 64.010000000000005 113.382 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 42.0 p -69.25 -26.79 64.95 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.502 0.668 . . . . 74.400000000000006 112.243 -175.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -105.91 -1.64 23.88 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 118.926 -0.559 . . . . 73.439999999999998 110.992 -174.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . 0.521 ' CG ' ' H ' ' A' ' 601' ' ' ASN . 0.3 OUTLIER -35.32 -115.74 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.616 0 N-CA-C 117.677 2.473 . . . . 71.219999999999999 117.677 -167.866 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . 0.521 ' H ' ' CG ' ' A' ' 600' ' ' HIS . 4.6 p30 -92.96 83.92 4.81 Favored 'General case' 0 C--N 1.287 -2.109 0 O-C-N 120.558 -1.339 . . . . 74.120000000000005 109.92 178.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -126.11 150.85 47.93 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 115.548 -0.751 . . . . 73.120000000000005 109.678 175.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 85.7 t -67.84 130.9 33.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 O-C-N 123.875 0.734 . . . . 74.150000000000006 109.358 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 60.1 t -93.11 -52.14 10.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.363 0.601 . . . . 74.450000000000003 109.786 -176.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -136.41 158.81 43.55 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.405 -0.961 . . . . 72.109999999999999 108.405 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -125.32 122.3 36.46 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.564 -1.273 . . . . 74.140000000000001 107.564 174.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.499 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 41.8 t30 -51.47 -59.0 8.81 Favored Pre-proline 0 CA--C 1.555 1.17 0 CA-C-O 119.094 -0.479 . . . . 75.329999999999998 112.175 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 2.7 Cg_endo -85.03 129.65 3.94 Favored 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 121.322 1.348 . . . . 74.430000000000007 109.123 171.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.81 161.52 35.84 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 122.696 2.264 . . . . 64.340000000000003 112.905 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -59.21 129.99 44.81 Favored 'General case' 0 C--O 1.249 1.051 0 CA-C-N 115.754 -0.657 . . . . 64.209999999999994 110.959 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 95.59 -10.76 68.83 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 120.863 -0.684 . . . . 74.019999999999996 111.706 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 612' ' ' THR . . . . . 0.429 ' O ' ' HG2' ' A' ' 563' ' ' MET . 24.0 m -89.27 161.97 16.11 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.642 -1.244 . . . . 73.25 107.642 178.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -99.12 143.19 16.45 Favored Glycine 0 N--CA 1.418 -2.518 0 C-N-CA 119.985 -1.102 . . . . 60.240000000000002 113.237 -177.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 13.6 m -94.12 143.42 11.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.374 -0.973 . . . . 75.400000000000006 108.374 175.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -58.24 175.41 0.23 Allowed 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 114.21 1.189 . . . . 75.219999999999999 114.21 -175.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -55.95 -38.36 70.24 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 125.458 1.503 . . . . 74.430000000000007 110.986 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.91 -33.91 68.67 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 115.607 -0.724 . . . . 63.240000000000002 109.501 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 82.5 19.74 63.48 Favored Glycine 0 N--CA 1.417 -2.618 0 N-CA-C 109.974 -1.25 . . . . 63.310000000000002 109.974 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.62 119.44 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 108.629 -0.878 . . . . 73.329999999999998 108.629 -174.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 8.5 tp -116.26 132.42 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 0 CA-C-N 114.73 -1.123 . . . . 73.519999999999996 109.678 -174.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.411 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 32.8 m -105.28 117.53 34.24 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 108.912 -0.773 . . . . 75.340000000000003 108.912 178.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 72.9 mt -139.09 165.65 26.59 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 105.747 -1.946 . . . . 74.530000000000001 105.747 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -142.94 139.54 30.75 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 106.468 -1.678 . . . . 74.209999999999994 106.468 173.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -138.77 160.89 38.57 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.145 -1.057 . . . . 73.140000000000001 108.145 -177.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -87.15 -117.46 1.14 Allowed Glycine 0 N--CA 1.43 -1.734 0 O-C-N 123.915 0.759 . . . . 62.32 113.35 -177.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 . . . . . 0 C--N 1.298 -1.666 0 N-CA-C 109.21 -0.663 . . . . 74.010000000000005 109.21 -174.682 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.822 0 N-CA-C 112.045 -0.422 . . . . 60.329999999999998 112.045 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 9.7 tp -75.41 122.3 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 CA-C-O 121.666 0.746 . . . . 75.109999999999999 109.224 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 1.5 m -76.47 151.81 36.34 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.342 -0.845 . . . . 63.149999999999999 110.166 -176.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -88.1 -28.39 21.33 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.636 -1.246 . . . . 73.450000000000003 107.636 176.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -73.41 141.48 46.95 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 107.179 -1.415 . . . . 75.030000000000001 107.179 175.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.15 163.51 34.06 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.46 0 N-CA-C 108.226 -1.028 . . . . 70.049999999999997 108.226 -177.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -94.46 138.15 32.74 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 105.007 -2.22 . . . . 65.430000000000007 105.007 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 91.9 t -95.3 123.53 56.53 Favored Pre-proline 0 C--N 1.271 -2.825 0 N-CA-C 109.308 -0.627 . . . . 72.019999999999996 109.308 -171.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -60.89 126.28 19.25 Favored 'Trans proline' 0 N--CA 1.445 -1.349 0 C-N-CA 122.316 2.011 . . . . 72.400000000000006 110.995 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -84.62 114.2 21.82 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-O 122.639 1.209 . . . . 75.230000000000004 109.326 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.41 HG13 ' HB2' ' A' ' 373' ' ' ALA . 9.2 p -88.21 15.12 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 CA-C-N 113.832 -1.531 . . . . 74.319999999999993 111.554 -173.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -56.5 146.69 23.98 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.191 1.396 . . . . 75.209999999999994 111.954 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.41 0.47 43.68 Favored Glycine 0 CA--C 1.503 -0.673 0 CA-C-N 116.263 -0.426 . . . . 72.430000000000007 113.354 177.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -115.75 -159.39 0.71 Allowed 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 108.273 -1.01 . . . . 75.519999999999996 108.273 177.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 60.1 p -90.96 166.83 12.82 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 108.66 -0.867 . . . . 72.510000000000005 108.66 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 66.7 m -62.85 -41.13 99.23 Favored 'General case' 0 C--O 1.208 -1.101 0 C-N-CA 120.004 -0.678 . . . . 74.129999999999995 110.026 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.49 -46.68 81.97 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 116.728 -0.214 . . . . 74.209999999999994 111.563 -178.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -69.09 -39.83 78.77 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.475 0.655 . . . . 72.030000000000001 110.002 -176.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . 0.41 ' HB2' HG13 ' A' ' 365' ' ' VAL . . . -67.24 -46.47 73.66 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.582 -0.735 . . . . 74.319999999999993 111.285 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 75.9 mt -64.44 -40.98 90.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-N 116.353 -0.385 . . . . 74.030000000000001 110.302 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.99 -41.85 88.61 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.378 0.608 . . . . 72.340000000000003 110.619 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 87.2 m -63.17 -47.62 81.86 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.655 -0.702 . . . . 74.049999999999997 110.756 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 97.6 mt -64.05 -37.99 89.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.337 -0.392 . . . . 65.530000000000001 110.7 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.67 -38.66 91.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.799 -0.637 . . . . 73.030000000000001 110.775 178.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -68.9 -24.63 64.33 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 120.981 0.42 . . . . 75.549999999999997 111.382 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -82.09 -14.76 55.32 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.153 -0.476 . . . . 75.349999999999994 110.757 176.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.95 16.82 43.16 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.212 -0.994 . . . . 64.109999999999999 112.257 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -88.16 159.59 18.12 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 121.395 0.617 . . . . 75.329999999999998 111.829 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -100.64 132.6 45.95 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 106.824 -1.547 . . . . 75.209999999999994 106.824 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.89 137.29 56.87 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 N-CA-C 106.824 -1.547 . . . . 74.319999999999993 106.824 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 417' ' ' THR . 32.5 ttt180 -116.82 138.58 51.41 Favored 'General case' 0 C--N 1.255 -3.533 0 N-CA-C 105.724 -1.954 . . . . 74.319999999999993 105.724 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 41.0 m -130.23 132.51 46.0 Favored 'General case' 0 C--N 1.272 -2.786 0 O-C-N 121.771 -0.581 . . . . 75.129999999999995 109.483 -174.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.7 121.89 42.95 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.649 -1.241 . . . . 74.519999999999996 107.649 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -89.53 122.5 32.75 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.941 -0.763 . . . . 75.420000000000002 108.941 -178.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . 0.601 ' O ' ' HA ' ' A' ' 421' ' ' SER . 51.8 mtmt -132.98 135.78 26.49 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 109.028 -0.73 . . . . 74.319999999999993 109.028 177.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -76.14 176.6 9.83 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.32 2.014 . . . . 61.32 112.609 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 11.2 t70 87.92 167.82 0.06 Allowed 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 126.351 1.861 . . . . 73.439999999999998 110.707 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 32.6 t -105.7 -12.7 15.81 Favored 'General case' 0 N--CA 1.439 -1.022 0 O-C-N 122.35 -0.219 . . . . 74.450000000000003 111.222 -175.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 6.0 t -82.63 -3.38 56.12 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 119.198 -1.001 . . . . 73.140000000000001 109.548 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 47.6 mm -88.14 146.15 37.65 Favored Pre-proline 0 C--N 1.302 -1.475 0 N-CA-C 106.17 -1.789 . . . . 72.420000000000002 106.17 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -37.94 116.31 0.21 Allowed 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 123.772 2.981 . . . . 74.530000000000001 113.12 177.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . 0.477 ' HA ' ' OG ' ' A' ' 421' ' ' SER . 12.2 Cg_endo -57.72 151.99 52.02 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.041 2.494 . . . . 72.219999999999999 112.732 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -59.19 -8.17 1.49 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.874 1.27 . . . . 74.510000000000005 113.638 -178.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -106.55 109.96 22.03 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 104.327 -2.471 . . . . 64.019999999999996 104.327 171.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 28.0 m -62.78 119.07 5.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 124.647 1.217 . . . . 74.530000000000001 112.567 -165.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -92.25 -28.22 4.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.4 -0.818 . . . . 73.150000000000006 109.89 179.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.75 160.11 28.06 Favored Glycine 0 N--CA 1.399 -3.824 0 CA-C-N 115.232 -0.895 . . . . 73.129999999999995 111.054 -176.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -114.83 -175.99 2.81 Favored 'General case' 0 C--N 1.27 -2.87 0 C-N-CA 125.351 1.46 . . . . 73.400000000000006 108.339 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -99.3 137.3 20.35 Favored Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 107.095 -1.446 . . . . 64.310000000000002 107.095 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -54.91 -16.28 11.49 Favored 'Trans proline' 0 C--N 1.365 1.411 0 C-N-CA 124.313 3.342 . . . . 72.319999999999993 114.662 -174.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.65 -28.69 68.76 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 116.308 -0.406 . . . . 72.219999999999999 110.249 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -73.96 -38.27 64.26 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.507 0.67 . . . . 61.149999999999999 110.392 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -81.2 -5.18 57.45 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.499 0.666 . . . . 74.219999999999999 110.629 -177.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 30.9 m -95.29 143.56 26.58 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.307 -1.738 . . . . 65.200000000000003 106.307 173.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 47.7 m -74.51 112.48 10.73 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 118.441 -1.304 . . . . 63.439999999999998 108.666 176.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 28.7 m -127.58 169.2 19.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 115.876 -0.602 . . . . 55.399999999999999 109.862 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 29.6 t -71.85 132.62 44.67 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 106.761 -1.57 . . . . 71.319999999999993 106.761 175.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -65.46 133.4 51.2 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-O 121.22 0.533 . . . . 75.319999999999993 111.157 -175.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 104.89 54.81 0.75 Allowed Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 110.816 -0.914 . . . . 22.510000000000002 110.816 -177.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -113.32 -177.23 3.08 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.818 -1.178 . . . . 73.120000000000005 107.818 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -107.67 108.88 20.32 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.153 -0.684 . . . . 71.109999999999999 109.153 -177.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.6 mm -98.01 116.77 41.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.37 -0.974 . . . . 71.329999999999998 108.37 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 385' ' ' ARG . 58.1 m -97.74 130.82 44.68 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 120.849 0.357 . . . . 72.230000000000004 110.535 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 4.8 p -118.96 136.18 56.99 Favored 'Isoleucine or valine' 0 C--O 1.252 1.223 0 C-N-CA 123.577 0.751 . . . . 75.230000000000004 110.232 -177.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -93.96 120.07 33.72 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.013 -0.736 . . . . 70.439999999999998 109.013 176.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 14.7 p -113.81 132.45 62.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 109.7 -0.481 . . . . 72.230000000000004 109.7 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' SER . . . . . 0.601 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 11.9 p -88.26 125.36 34.61 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.075 0.464 . . . . 73.349999999999994 111.301 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 5.6 t -118.36 106.52 12.83 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-O 121.191 0.519 . . . . 74.019999999999996 111.379 177.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 70.63 114.1 0.04 OUTLIER Glycine 0 CA--C 1.536 1.398 0 N-CA-C 115.226 0.85 . . . . 73.430000000000007 115.226 175.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.53 144.5 97.88 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 122.467 2.111 . . . . 63.009999999999998 111.104 174.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.435 ' O ' HD11 ' A' ' 480' ' ' ILE . 33.6 mt-10 -101.05 166.55 10.75 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 109.679 -0.489 . . . . 71.040000000000006 109.679 -177.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -88.32 157.58 18.69 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.634 0.254 . . . . 74.340000000000003 111.522 -176.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 477' ' ' THR . 10.9 mmp_? -122.23 153.81 38.35 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-N 116.312 -0.404 . . . . 72.310000000000002 110.456 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 40.6 tt0 -84.83 141.47 30.45 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.418 -1.327 . . . . 72.129999999999995 107.418 174.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 68.2 mt -78.08 125.92 84.48 Favored Pre-proline 0 N--CA 1.437 -1.121 0 N-CA-C 107.212 -1.403 . . . . 73.25 107.212 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -67.62 145.05 68.68 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.473 2.115 . . . . 75.150000000000006 113.093 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -75.44 104.81 6.16 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 108.992 -0.744 . . . . 64.409999999999997 108.992 175.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 46.1 t -116.78 138.01 48.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 107.93 -1.137 . . . . 73.099999999999994 107.93 178.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.401 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 18.5 m -68.97 152.33 45.4 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 121.053 0.454 . . . . 74.319999999999993 111.025 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' THR . . . . . 0.5 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 58.3 p -63.89 -34.44 77.95 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 113.535 0.939 . . . . 73.329999999999998 113.535 -170.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.6 pp -84.22 -11.32 56.71 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 120.98 0.419 . . . . 73.239999999999995 111.842 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.401 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 0.8 OUTLIER -93.95 42.77 1.1 Allowed 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 115.687 -0.688 . . . . 71.319999999999993 109.731 -177.6 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -52.14 -39.65 60.25 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.725 1.21 . . . . 75.349999999999994 112.989 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.19 -41.79 99.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.085 0.469 . . . . 74.209999999999994 110.218 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -71.17 -33.97 70.5 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 116.19 -0.459 . . . . 71.420000000000002 110.286 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.446 ' O ' HD12 ' A' ' 444' ' ' LEU . . . -59.43 -51.25 70.68 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.497 -0.127 . . . . 63.140000000000001 110.888 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.4 m -61.45 -37.63 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 CA-C-O 121.111 0.481 . . . . 75.430000000000007 110.458 177.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -60.52 -48.19 82.86 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.244 1.018 . . . . 65.219999999999999 110.908 176.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -66.42 -38.5 87.57 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 123.777 0.831 . . . . 72.400000000000006 111.466 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 440' ' ' ALA . 6.9 mp -66.15 -33.96 76.95 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.877 -0.601 . . . . 73.319999999999993 110.927 176.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.497 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 56.2 m -70.13 -45.07 67.6 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.251 0.548 . . . . 73.530000000000001 109.874 177.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.69 -16.36 64.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.541 -0.754 . . . . 74.010000000000005 110.917 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.84 5.67 20.9 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.081 -0.509 . . . . 74.120000000000005 111.74 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 100.72 -67.39 0.5 Allowed Glycine 0 CA--C 1.497 -1.088 0 C-N-CA 120.552 -0.832 . . . . 72.129999999999995 111.938 175.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -51.54 -59.39 4.31 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.264 0.839 . . . . 71.430000000000007 113.264 178.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . 0.497 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 60.76 19.89 55.99 Favored Glycine 0 CA--C 1.505 -0.569 0 CA-C-O 121.25 0.361 . . . . 74.340000000000003 113.059 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.49 ' NH2' ' HA ' ' A' ' 481' ' ' THR . 13.6 mtm180 -105.29 111.35 24.06 Favored 'General case' 0 N--CA 1.415 -2.209 0 CA-C-O 121.258 0.552 . . . . 74.010000000000005 110.172 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . 0.489 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 15.0 p90 -135.3 145.34 47.4 Favored 'General case' 0 N--CA 1.412 -2.364 0 CA-C-N 114.151 -1.386 . . . . 75.540000000000006 109.55 -175.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 26.1 mmtm -136.43 127.24 27.38 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.349 -0.842 . . . . 74.439999999999998 108.877 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -90.72 127.26 36.25 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 123.644 0.59 . . . . 74.400000000000006 111.369 -174.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -126.85 147.29 50.05 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.905 -1.146 . . . . 75.510000000000005 107.905 175.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -122.06 146.5 47.13 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 120.376 -0.53 . . . . 71.219999999999999 109.937 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 23.2 t -142.79 137.53 15.21 Favored Pre-proline 0 C--N 1.297 -1.713 0 N-CA-C 107.686 -1.227 . . . . 54.549999999999997 107.686 177.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.548 ' HA ' ' O ' ' A' ' 490' ' ' SER . 23.9 Cg_exo -64.92 123.01 10.98 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.738 1.625 . . . . 62.149999999999999 110.471 176.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 54.9 m -148.94 -178.31 6.29 Favored 'General case' 0 C--N 1.287 -2.117 0 C-N-CA 124.971 1.308 . . . . 55.420000000000002 108.136 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 11.2 t -45.27 134.39 5.58 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 123.727 0.811 . . . . 75.099999999999994 112.283 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.92 -29.21 34.34 Favored 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 124.814 3.676 . . . . 74.450000000000003 114.067 -175.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -71.77 -19.42 62.02 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 112.055 0.391 . . . . 75.340000000000003 112.055 -178.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 72.6 mt -96.09 -2.54 46.4 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 111.601 0.223 . . . . 75.299999999999997 111.601 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 87.9 t -60.81 127.39 20.3 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 CA-C-O 120.891 0.377 . . . . 74.519999999999996 110.315 178.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 84.7 -10.57 61.86 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.312 -0.858 . . . . 74.049999999999997 112.065 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -111.98 166.23 11.41 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 108.182 -1.044 . . . . 75.420000000000002 108.182 -176.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.5 ' O ' ' HB ' ' A' ' 434' ' ' THR . 87.2 t -80.41 146.83 7.01 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.294 0 CA-C-N 116.261 -0.427 . . . . 72.510000000000005 109.957 -177.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 63.9 mt -98.57 -35.21 4.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 107.439 -1.319 . . . . 75.349999999999994 107.439 174.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 156.68 -152.1 23.48 Favored Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 110.166 -1.174 . . . . 64.25 110.166 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 3.6 p -132.15 157.15 45.02 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.547 -0.908 . . . . 73.450000000000003 108.547 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -71.82 -46.46 12.17 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 119.728 -0.789 . . . . 75.510000000000005 110.625 175.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -71.15 141.69 40.23 Favored 'Trans proline' 0 C--N 1.374 1.89 0 N-CA-C 107.304 -1.845 . . . . 70.219999999999999 107.304 167.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -62.34 127.54 21.26 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 121.508 1.472 . . . . 65.019999999999996 112.063 -177.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -73.99 2.03 9.6 Favored 'General case' 0 C--O 1.201 -1.448 0 C-N-CA 123.646 0.778 . . . . 73.230000000000004 112.444 -175.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -110.4 5.4 21.45 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.603 0.716 . . . . 74.319999999999993 110.005 175.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -109.12 176.78 4.97 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-N 115.616 -0.72 . . . . 72.010000000000005 111.529 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 477' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 2.3 p -96.8 145.9 25.41 Favored 'General case' 0 N--CA 1.391 -3.406 0 CA-C-N 114.663 -1.153 . . . . 73.409999999999997 110.773 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 49.7 m -137.29 148.06 46.11 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 107.548 -1.279 . . . . 73.299999999999997 107.548 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -77.96 159.57 28.74 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 120.715 0.293 . . . . 73.340000000000003 110.441 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . 0.435 HD11 ' O ' ' A' ' 425' ' ' GLU . 1.7 mp -65.61 -18.37 23.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.524 0.678 . . . . 71.409999999999997 111.316 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 481' ' ' THR . . . . . 0.49 ' HA ' ' NH2' ' A' ' 451' ' ' ARG . 7.7 t -87.28 1.91 51.77 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.943 -0.571 . . . . 72.0 111.065 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -93.05 148.91 21.6 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.045 0.45 . . . . 74.239999999999995 110.863 -177.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.9 p -108.6 126.34 65.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.568 -1.271 . . . . 72.310000000000002 107.568 172.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 26.9 m -105.33 134.25 47.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 121.903 0.859 . . . . 73.209999999999994 111.852 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.87 122.61 44.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 114.968 -1.015 . . . . 74.140000000000001 110.288 -178.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 36.2 mm -97.94 113.13 31.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 107.462 -1.31 . . . . 74.439999999999998 107.462 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 9.5 tt -99.08 126.24 52.38 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 108.911 -0.774 . . . . 70.349999999999994 108.911 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 27.2 m -111.25 151.92 13.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 123.345 0.658 . . . . 74.400000000000006 110.668 -178.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -77.37 132.64 12.25 Favored Glycine 0 N--CA 1.424 -2.136 0 CA-C-N 115.562 -0.744 . . . . 71.420000000000002 112.553 -178.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.548 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 31.3 t -122.64 160.69 25.25 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 104.401 -2.444 . . . . 63.119999999999997 104.401 175.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 169.45 128.49 1.01 Allowed Glycine 0 C--N 1.291 -1.94 0 C-N-CA 118.083 -2.008 . . . . 70.439999999999998 112.805 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -84.01 149.46 12.25 Favored 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 122.499 2.133 . . . . 74.409999999999997 110.731 176.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . -75.14 84.85 2.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.777 0.799 . . . . 73.409999999999997 109.305 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 9.7 p -122.5 144.3 49.16 Favored 'General case' 0 N--CA 1.419 -2.014 0 CA-C-N 114.776 -1.102 . . . . 73.150000000000006 111.393 -173.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -139.96 149.48 43.33 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.713 -0.847 . . . . 75.439999999999998 108.713 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 6.5 p-10 -90.65 137.35 32.42 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 109.465 -0.568 . . . . 73.209999999999994 109.465 177.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 28.0 pt -91.01 110.45 42.22 Favored Pre-proline 0 C--N 1.304 -1.409 0 CA-C-N 115.698 -0.683 . . . . 74.010000000000005 109.856 177.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 496' ' ' ASP . 66.0 Cg_endo -90.71 150.4 4.14 Favored 'Trans proline' 0 N--CA 1.441 -1.562 0 C-N-CA 122.292 1.995 . . . . 72.120000000000005 111.97 178.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -78.88 91.5 4.78 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 122.517 1.151 . . . . 74.310000000000002 109.976 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 15.3 t -104.37 2.91 10.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.336 -1.357 . . . . 64.140000000000001 107.336 177.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -53.79 107.56 0.27 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.293 -1.321 . . . . 60.219999999999999 112.754 -175.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 177.85 27.85 0.04 OUTLIER Glycine 0 C--N 1.306 -1.117 0 N-CA-C 111.327 -0.709 . . . . 65.329999999999998 111.327 176.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.05 -170.85 3.43 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.267 -0.642 . . . . 71.400000000000006 109.267 -178.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 532' ' ' GLY . 8.8 t -84.13 157.91 21.55 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 109.076 -0.713 . . . . 70.549999999999997 109.076 -176.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.4 p -48.67 -41.77 12.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 124.194 0.997 . . . . 75.140000000000001 112.304 -177.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -61.53 -41.54 97.48 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.72 0.295 . . . . 74.239999999999995 111.778 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 47.3 t -76.01 -40.74 38.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-O 121.185 0.517 . . . . 74.299999999999997 110.602 -176.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.36 -46.88 84.49 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.068 -0.515 . . . . 61.020000000000003 110.224 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -61.95 -35.69 79.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.679 -0.691 . . . . 73.230000000000004 110.232 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.44 ' O ' HG23 ' A' ' 514' ' ' VAL . 0.3 OUTLIER -60.55 -43.08 97.63 Favored 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 109.016 -0.735 . . . . 75.420000000000002 109.016 177.13 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -62.57 -47.29 84.47 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.598 -0.274 . . . . 72.120000000000005 111.445 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.84 -40.07 94.03 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.733 0.301 . . . . 74.319999999999993 111.135 178.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.31 -38.16 88.37 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.055 -0.52 . . . . 73.099999999999994 110.636 178.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 510' ' ' LYS . 70.1 t -65.99 -31.16 52.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 115.886 -0.597 . . . . 74.239999999999995 110.746 176.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -78.44 -8.6 58.68 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.725 -0.39 . . . . 75.349999999999994 111.572 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 104.73 0.36 42.58 Favored Glycine 0 CA--C 1.504 -0.624 0 C-N-CA 120.859 -0.686 . . . . 70.310000000000002 112.557 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 83.8 m-85 -82.1 101.54 10.45 Favored 'General case' 0 CA--C 1.484 -1.595 0 N-CA-C 108.161 -1.051 . . . . 74.319999999999993 108.161 -178.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.5 m -100.0 -4.06 30.83 Favored 'General case' 0 N--CA 1.415 -2.205 0 CA-C-N 114.693 -1.139 . . . . 74.120000000000005 110.988 -173.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -116.61 114.25 23.84 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.589 -0.893 . . . . 75.519999999999996 108.589 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -132.16 152.11 51.44 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.483 -0.78 . . . . 74.129999999999995 112.451 -175.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 46.4 m -141.04 134.17 29.39 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.49 -1.3 . . . . 65.25 107.49 171.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 0.0 OUTLIER -118.82 138.84 52.43 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 117.907 0.321 . . . . 72.129999999999995 110.214 179.631 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -131.77 143.52 50.28 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.348 -1.353 . . . . 72.540000000000006 107.348 177.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 524' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 14.9 t -121.24 132.61 54.92 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.083 0.468 . . . . 73.340000000000003 110.089 -178.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 34.0 t -124.9 149.57 29.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 106.998 -1.482 . . . . 74.209999999999994 106.998 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . 0.527 ' HA ' ' HB3' ' A' ' 557' ' ' LYS . 4.1 p30 -66.59 134.69 52.85 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.892 0.853 . . . . 75.25 109.172 178.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 70.8 m -153.14 167.09 14.12 Favored Pre-proline 0 C--N 1.28 -2.442 0 CA-C-N 114.472 -1.24 . . . . 74.540000000000006 108.526 -173.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.86 -24.91 45.9 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.655 1.57 . . . . 73.319999999999993 113.055 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.98 142.2 79.26 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.595 -0.275 . . . . 74.430000000000007 111.183 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.61 151.78 60.41 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 123.263 2.642 . . . . 75.109999999999999 113.232 -178.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -62.47 119.66 9.57 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.366 -0.834 . . . . 74.310000000000002 111.44 -176.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 504' ' ' THR . . . 118.09 -22.19 9.85 Favored Glycine 0 N--CA 1.425 -2.049 0 C-N-CA 120.403 -0.903 . . . . 71.310000000000002 112.351 177.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -80.1 127.59 32.49 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.496 -0.927 . . . . 74.030000000000001 108.496 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 57.4 t -75.98 122.95 31.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 109.212 -0.662 . . . . 75.019999999999996 109.212 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 535' ' ' THR . . . . . 0.671 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 14.0 t -90.05 -14.86 32.96 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.186 -0.461 . . . . 63.409999999999997 110.898 -177.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 153.11 -158.01 27.67 Favored Glycine 0 N--CA 1.429 -1.819 0 N-CA-C 111.325 -0.71 . . . . 75.400000000000006 111.325 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 20.9 p -128.68 156.8 42.88 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 109.753 -0.462 . . . . 65.049999999999997 109.753 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -70.49 -50.39 14.43 Favored Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 116.298 -0.41 . . . . 72.150000000000006 110.077 176.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -63.11 135.32 50.29 Favored 'Trans proline' 0 C--N 1.371 1.738 0 N-CA-C 108.368 -1.435 . . . . 71.439999999999998 108.368 168.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.44 140.7 95.43 Favored 'Trans proline' 0 C--O 1.249 1.073 0 C-N-CA 122.656 2.237 . . . . 65.530000000000001 113.552 -176.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -67.83 134.66 51.3 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.646 -0.872 . . . . 73.040000000000006 108.646 176.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 103.82 -6.83 48.57 Favored Glycine 0 C--N 1.298 -1.551 0 C-N-CA 120.817 -0.706 . . . . 60.450000000000003 111.346 -176.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 23.6 m -81.57 131.6 35.28 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.891 -0.411 . . . . 74.420000000000002 109.891 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 27.9 m -90.33 122.89 33.62 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 108.087 -1.079 . . . . 70.129999999999995 108.087 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 13.0 m -134.88 157.72 76.51 Favored Pre-proline 0 C--N 1.309 -1.159 0 C-N-CA 122.659 0.384 . . . . 74.400000000000006 110.188 -177.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . 0.456 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 22.6 Cg_exo -67.62 139.93 50.16 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.492 2.128 . . . . 74.129999999999995 111.746 177.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.465 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 33.2 m -65.87 -20.04 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 122.265 1.031 . . . . 72.430000000000007 110.819 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -78.67 -10.05 59.62 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 113.666 -1.606 . . . . 75.299999999999997 111.252 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 94.4 p -96.5 172.96 7.6 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 120.631 -0.428 . . . . 64.519999999999996 110.868 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 7.1 p -102.65 129.66 53.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-O 120.904 0.383 . . . . 70.239999999999995 111.604 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.33 146.12 13.32 Favored 'Isoleucine or valine' 0 C--O 1.247 0.939 0 CA-C-O 121.181 0.515 . . . . 72.239999999999995 109.974 177.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -107.63 116.18 31.48 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-O 121.56 0.695 . . . . 74.030000000000001 110.861 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 51.7 mt -94.09 134.17 36.79 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 125.129 1.372 . . . . 74.120000000000005 108.864 -178.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -113.89 118.86 35.37 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 122.088 0.947 . . . . 74.239999999999995 110.921 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 524' ' ' SER . 39.7 t -101.26 139.75 21.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 CA-C-N 114.356 -1.293 . . . . 71.219999999999999 109.637 -175.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.671 ' OG ' ' HB ' ' A' ' 535' ' ' THR . 50.2 m -79.02 134.61 36.78 Favored 'General case' 0 N--CA 1.418 -2.032 0 CA-C-O 121.792 0.806 . . . . 73.209999999999994 111.172 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.527 ' HB3' ' HA ' ' A' ' 526' ' ' ASP . 11.3 tppt? -101.76 126.08 48.55 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 105.112 -2.181 . . . . 74.219999999999999 105.112 171.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -71.64 -45.29 45.85 Favored Glycine 0 CA--C 1.484 -1.906 0 C-N-CA 120.187 -1.006 . . . . 71.540000000000006 112.238 -172.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 57.1 t30 62.84 25.17 14.95 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-O 122.701 1.239 . . . . 71.010000000000005 109.042 177.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.44 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 94.4 mt-30 -129.35 156.96 43.2 Favored 'General case' 0 C--O 1.25 1.114 0 CA-C-N 114.538 -1.21 . . . . 70.430000000000007 110.733 -176.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -130.18 144.12 51.18 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.252 -0.885 . . . . 74.239999999999995 108.636 176.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 54.3 t -66.17 125.99 24.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 121.128 0.489 . . . . 64.310000000000002 112.278 -178.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 53.8 ttp -92.08 130.02 39.59 Favored Pre-proline 0 C--O 1.25 1.126 0 CA-C-N 115.501 -0.772 . . . . 64.310000000000002 110.853 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -71.85 169.9 20.09 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.087 2.524 . . . . 75.530000000000001 111.512 173.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -67.96 142.19 56.06 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 116.179 -0.464 . . . . 62.409999999999997 111.295 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.16 16.92 5.58 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.6 0.714 . . . . 72.129999999999995 111.266 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 16.9 m -64.37 130.54 44.19 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.427 -0.806 . . . . 55.310000000000002 109.74 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 100.15 24.23 9.85 Favored Glycine 0 C--N 1.308 -1.025 0 C-N-CA 120.655 -0.783 . . . . 64.450000000000003 112.478 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 90.6 mtp -109.54 144.51 37.73 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.274 -0.639 . . . . 74.409999999999997 109.274 177.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . 0.525 ' CD2' ' HB3' ' A' ' 602' ' ' ARG . 80.5 m-85 -101.34 140.08 36.12 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 107.048 -1.464 . . . . 75.329999999999998 107.048 -176.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 55.2 t90 -57.96 -28.72 64.6 Favored 'General case' 0 C--O 1.25 1.108 0 CA-C-O 121.139 0.495 . . . . 74.519999999999996 111.886 -177.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 35.8 m -73.4 -22.63 19.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.389 0.614 . . . . 74.209999999999994 111.196 -177.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . 0.612 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 12.4 t70 -101.53 -35.43 9.16 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.679 -0.691 . . . . 71.409999999999997 109.901 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . 0.414 ' O ' HD12 ' A' ' 578' ' ' LEU . . . -57.82 -50.84 71.93 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.193 0.997 . . . . 73.239999999999995 112.818 -177.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.503 ' O ' ' HG2' ' A' ' 579' ' ' ARG . 49.5 mt-10 -55.51 -56.22 31.68 Favored Pre-proline 0 N--CA 1.469 0.515 0 N-CA-C 112.9 0.704 . . . . 64.549999999999997 112.9 -178.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -53.95 -33.61 73.06 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 121.54 1.494 . . . . 73.25 113.465 176.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . 0.612 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 35.1 mmt180 -63.81 -47.59 80.22 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.894 -0.78 . . . . 63.409999999999997 108.894 177.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 574' ' ' ALA . 9.4 mp -66.08 -39.68 90.22 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.0 -1.0 . . . . 72.099999999999994 111.308 -177.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 11.6 mmm180 -65.05 -37.14 86.61 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.376 -0.375 . . . . 74.310000000000002 110.855 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.93 -30.87 69.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.362 0.601 . . . . 75.430000000000007 110.587 178.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 95.4 mt -81.65 -8.16 59.67 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.428 -0.805 . . . . 74.25 111.085 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 70.81 28.63 70.42 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.702 -0.559 . . . . 70.120000000000005 111.702 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 73.3 t90 -62.03 127.9 33.57 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 123.224 0.61 . . . . 73.310000000000002 110.569 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 12.1 m -128.24 84.5 2.25 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-O 121.24 0.543 . . . . 62.409999999999997 109.734 177.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -135.33 -145.21 5.1 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 109.243 -1.543 . . . . 65.120000000000005 109.243 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 26.5 ttt -134.77 125.92 27.91 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 117.262 0.531 . . . . 75.140000000000001 110.17 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -115.83 123.26 47.74 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 105.629 -1.989 . . . . 70.340000000000003 105.629 173.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -107.83 106.45 16.75 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 116.303 -0.408 . . . . 74.030000000000001 111.048 -175.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.62 110.14 22.62 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 106.239 -1.763 . . . . 74.540000000000006 106.239 174.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -98.92 -87.4 1.91 Allowed Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 109.663 -1.375 . . . . 73.329999999999998 109.663 176.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -102.53 133.02 48.19 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 120.763 0.316 . . . . 70.540000000000006 110.749 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -83.86 157.38 22.02 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.9 -1.148 . . . . 61.5 107.9 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 46.4 t -117.62 125.25 73.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 119.617 -0.833 . . . . 75.400000000000006 111.503 -175.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -81.63 106.66 13.75 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 105.495 -2.039 . . . . 75.209999999999994 105.495 172.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -132.69 -6.72 3.21 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 112.171 0.434 . . . . 71.549999999999997 112.171 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 82.94 -178.95 53.1 Favored Glycine 0 N--CA 1.418 -2.527 0 C-N-CA 120.79 -0.719 . . . . 51.229999999999997 111.565 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -62.92 -33.56 87.46 Favored Glycine 0 C--N 1.303 -1.28 0 CA-C-N 115.575 -0.312 . . . . 73.129999999999995 112.769 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 22.6 m -56.57 -33.63 66.34 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.782 0.66 . . . . 61.100000000000001 112.782 -176.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -108.23 -14.59 14.67 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 119.897 -0.721 . . . . 72.209999999999994 110.162 178.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . 0.413 ' CG ' ' H ' ' A' ' 601' ' ' ASN . 6.7 t-160 39.89 -160.19 0.0 OUTLIER 'General case' 0 CA--C 1.587 2.368 0 C-N-CA 126.095 1.758 . . . . 71.310000000000002 113.379 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . 0.413 ' H ' ' CG ' ' A' ' 600' ' ' HIS . 9.0 p30 -87.55 28.33 1.0 Allowed 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.288 -0.882 . . . . 73.219999999999999 110.053 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . 0.525 ' HB3' ' CD2' ' A' ' 570' ' ' PHE 0.254 3.1 ppt_? -102.15 168.5 9.33 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.833 -0.747 . . . . 74.450000000000003 112.824 -176.335 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 7.6 p -56.72 134.52 20.88 Favored 'Isoleucine or valine' 0 C--O 1.25 1.094 0 O-C-N 124.55 1.156 . . . . 62.25 112.23 -176.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 10.5 p -101.64 -32.57 3.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 119.581 -0.847 . . . . 73.310000000000002 109.018 177.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -154.81 140.47 18.0 Favored 'General case' 0 C--O 1.25 1.08 0 N-CA-C 107.168 -1.419 . . . . 64.349999999999994 107.168 174.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -98.23 122.12 41.0 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.745 -0.835 . . . . 72.140000000000001 108.745 173.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -55.08 -56.15 31.27 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 114.313 1.227 . . . . 73.230000000000004 114.313 -177.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -84.09 123.0 3.02 Favored 'Trans proline' 0 N--CA 1.438 -1.755 0 CA-C-N 120.643 1.265 . . . . 74.439999999999998 109.43 176.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -64.02 144.82 88.68 Favored 'Trans proline' 0 C--O 1.246 0.912 0 C-N-CA 122.159 1.906 . . . . 70.219999999999999 111.193 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -62.69 132.33 51.93 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.121 -0.696 . . . . 74.299999999999997 109.121 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 100.1 0.67 56.0 Favored Glycine 0 N--CA 1.437 -1.289 0 C-N-CA 119.766 -1.207 . . . . 72.430000000000007 111.994 -177.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 14.2 m -100.97 154.68 18.49 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.596 -0.89 . . . . 73.420000000000002 108.596 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -80.13 132.85 11.67 Favored Glycine 0 N--CA 1.431 -1.694 0 N-CA-C 112.111 -0.396 . . . . 73.219999999999999 112.111 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 34.9 m -114.5 142.48 27.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 109.35 -0.611 . . . . 64.400000000000006 109.35 176.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . 0.44 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 23.3 m-20 -57.75 169.6 0.7 Allowed 'General case' 0 CA--C 1.492 -1.255 0 C-N-CA 124.235 1.014 . . . . 72.530000000000001 111.803 -177.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -60.74 -24.6 65.85 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 113.774 -1.557 . . . . 73.040000000000006 110.22 172.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -77.07 -35.58 56.53 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 119.831 -0.748 . . . . 72.319999999999993 110.058 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 81.02 22.71 60.64 Favored Glycine 0 N--CA 1.426 -2.024 0 C-N-CA 118.484 -1.817 . . . . 74.120000000000005 113.409 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.73 119.66 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 122.489 1.138 . . . . 75.010000000000005 108.876 -174.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.72 132.93 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 N-CA-C 107.281 -1.377 . . . . 71.340000000000003 107.281 -173.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 19.0 m -111.09 134.95 52.29 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 121.786 -0.571 . . . . 72.329999999999998 111.095 -177.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 84.3 mt -137.54 154.1 49.88 Favored 'General case' 0 CA--C 1.497 -1.087 0 C-N-CA 125.106 1.363 . . . . 74.239999999999995 107.775 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 51.0 mmm-85 -128.22 137.36 51.99 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 104.431 -2.433 . . . . 74.340000000000003 104.431 169.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -141.87 165.49 27.32 Favored 'General case' 0 C--N 1.28 -2.423 0 O-C-N 124.263 0.977 . . . . 74.430000000000007 109.627 -174.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -97.02 -134.62 8.25 Favored Glycine 0 N--CA 1.417 -2.598 0 C-N-CA 120.464 -0.874 . . . . 73.209999999999994 112.034 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 . . . . . 0 C--N 1.295 -1.767 0 C-N-CA 123.991 0.916 . . . . 63.219999999999999 109.381 -177.629 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.095 0 N-CA-C 110.521 -1.032 . . . . 72.25 110.521 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 9.6 tp -75.86 104.67 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 CA-C-O 122.728 1.251 . . . . 71.109999999999999 112.651 -178.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' THR . . . . . 0.425 ' C ' ' H ' ' A' ' 359' ' ' ASP . 0.0 OUTLIER -85.71 -155.89 0.25 Allowed 'General case' 0 C--N 1.281 -2.377 0 CA-C-N 114.277 -1.329 . . . . 70.510000000000005 108.087 174.12 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -71.66 3.15 4.28 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 122.064 0.935 . . . . 71.299999999999997 111.132 174.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' A' ' 357' ' ' THR . 65.7 m-20 -70.06 151.21 45.76 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 125.396 1.479 . . . . 75.219999999999999 109.421 175.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.2 m -116.84 159.05 17.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 108.756 -0.831 . . . . 74.219999999999999 108.756 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -95.46 136.14 36.21 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 103.697 -2.705 . . . . 70.120000000000005 103.697 177.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 94.0 t -95.46 127.85 40.45 Favored Pre-proline 0 C--N 1.28 -2.443 0 C-N-CA 119.89 -0.724 . . . . 71.209999999999994 112.415 -163.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -67.56 113.35 2.9 Favored 'Trans proline' 0 N--CA 1.441 -1.597 0 C-N-CA 122.529 2.153 . . . . 75.530000000000001 110.306 174.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . 0.407 ' HB2' HG23 ' A' ' 402' ' ' THR . 19.9 p-10 -101.3 111.94 24.31 Favored 'General case' 0 C--N 1.262 -3.196 0 CA-C-N 113.959 -1.473 . . . . 62.420000000000002 110.819 -176.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.698 ' HB ' ' NE2' ' A' ' 368' ' ' GLN . 7.0 m -85.73 37.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 114.132 -1.394 . . . . 75.209999999999994 113.598 -176.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.38 146.79 54.46 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.337 -0.847 . . . . 74.120000000000005 110.601 172.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.35 -4.53 44.18 Favored Glycine 0 C--N 1.304 -1.249 0 N-CA-C 110.781 -0.927 . . . . 54.109999999999999 110.781 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . 0.698 ' NE2' ' HB ' ' A' ' 365' ' ' VAL . 16.4 mt-30 -109.19 -156.8 0.59 Allowed 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 107.658 -1.238 . . . . 74.209999999999994 107.658 177.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 60.4 p -99.1 167.15 10.89 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 109.087 -0.708 . . . . 74.5 109.087 -177.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 18.2 p -57.87 -46.67 84.5 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 123.438 0.461 . . . . 72.319999999999993 110.63 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.31 -41.9 89.03 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.756 -0.656 . . . . 53.420000000000002 112.327 -177.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -69.3 -42.58 75.23 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 121.504 0.669 . . . . 73.439999999999998 109.307 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.77 -47.61 74.6 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.381 -0.827 . . . . 75.239999999999995 111.577 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 65.6 mt -62.77 -39.99 86.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 65.219999999999999 110.836 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.09 -43.86 91.87 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.125 0.488 . . . . 71.129999999999995 110.558 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 18.1 m -63.73 -47.22 81.95 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.59 -0.732 . . . . 75.019999999999996 109.963 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 98.4 mt -61.91 -41.78 98.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.833 -0.621 . . . . 75.310000000000002 110.824 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -63.83 -41.16 97.91 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.896 -0.593 . . . . 72.019999999999996 110.51 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -63.12 -27.14 69.18 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 120.907 0.384 . . . . 75.030000000000001 111.412 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -90.79 -7.68 51.72 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 112.304 0.483 . . . . 75.310000000000002 112.304 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 95.23 7.99 59.1 Favored Glycine 0 C--N 1.307 -1.071 0 C-N-CA 120.856 -0.688 . . . . 71.340000000000003 113.055 177.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 75.0 m-85 -80.13 145.11 32.54 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-O 121.18 0.514 . . . . 74.299999999999997 111.385 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -92.07 143.41 26.49 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.603 -1.258 . . . . 73.450000000000003 107.603 -178.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.82 154.75 35.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 121.274 0.559 . . . . 73.310000000000002 111.267 -178.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -136.35 135.2 38.64 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 107.507 -1.294 . . . . 75.319999999999993 107.507 174.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 26.4 m -103.06 120.9 41.5 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 108.279 -1.008 . . . . 75.299999999999997 108.279 178.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -111.46 119.68 39.62 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 106.786 -1.561 . . . . 75.099999999999994 106.786 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.472 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -102.61 131.87 49.09 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.56 0.695 . . . . 73.319999999999993 111.851 -177.218 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . 0.648 ' O ' ' HA ' ' A' ' 421' ' ' SER . 99.1 mttt -128.93 150.34 74.93 Favored Pre-proline 0 C--N 1.293 -1.855 0 N-CA-C 106.703 -1.591 . . . . 73.219999999999999 106.703 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -71.84 166.29 29.98 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 121.489 1.459 . . . . 75.129999999999995 110.558 176.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.436 ' HB2' ' HA ' ' A' ' 424' ' ' PRO . 3.4 m-20 -76.35 87.4 3.14 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-O 121.848 0.833 . . . . 75.439999999999998 110.526 176.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.505 ' O ' ' HB ' ' A' ' 393' ' ' THR . 19.6 m -112.38 42.5 1.8 Allowed 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 106.735 -1.579 . . . . 74.409999999999997 106.735 173.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.505 ' HB ' ' O ' ' A' ' 392' ' ' SER . 99.6 m 70.88 29.32 3.1 Favored 'General case' 0 CA--C 1.573 1.861 0 CA-C-O 123.58 1.657 . . . . 73.209999999999994 109.551 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 1.7 pt -116.43 151.25 46.73 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 113.6 0.963 . . . . 75.209999999999994 113.6 -176.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -24.46 110.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.366 1.498 1 C-N-CA 126.584 4.856 . . . . 73.450000000000003 118.258 -175.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -68.45 162.3 41.28 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.262 3.308 . . . . 74.409999999999997 110.651 172.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.21 -13.88 3.6 Favored 'General case' 0 N--CA 1.507 2.396 0 CA-C-O 121.098 0.475 . . . . 74.109999999999999 111.882 -176.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -84.01 111.04 18.92 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 105.295 -2.113 . . . . 75.140000000000001 105.295 178.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 28.0 m -63.0 118.02 4.61 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 O-C-N 124.602 1.189 . . . . 72.329999999999998 112.335 -166.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.04 -28.59 2.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 114.84 -1.073 . . . . 64.409999999999997 109.727 -176.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -144.77 165.46 27.62 Favored Glycine 0 N--CA 1.428 -1.858 0 N-CA-C 110.289 -1.124 . . . . 73.129999999999995 110.289 -175.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.407 HG23 ' HB2' ' A' ' 364' ' ' ASP . 9.1 p -118.03 -178.85 3.6 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 113.341 0.867 . . . . 75.109999999999999 113.341 -173.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -102.32 140.42 21.12 Favored Pre-proline 0 N--CA 1.437 -1.117 0 N-CA-C 106.607 -1.627 . . . . 74.400000000000006 106.607 176.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -55.77 -24.63 47.52 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.314 2.676 . . . . 75.129999999999995 114.131 -176.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -62.38 -35.02 77.87 Favored 'General case' 0 C--O 1.209 -1.051 0 CA-C-N 116.543 -0.299 . . . . 72.430000000000007 111.368 -177.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -77.92 -35.75 50.21 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.492 0.663 . . . . 63.439999999999998 110.928 -178.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -82.02 -10.92 59.08 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.911 -0.586 . . . . 74.409999999999997 111.711 -175.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 25.0 m -103.35 160.28 14.83 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 106.428 -1.693 . . . . 73.340000000000003 106.428 177.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 5.9 p -76.68 113.0 13.84 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 118.322 0.51 . . . . 72.109999999999999 110.744 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 33.4 m -130.76 166.85 27.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.443 -0.577 . . . . 61.140000000000001 109.443 177.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 56.3 m -70.07 139.4 52.58 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.819 -0.808 . . . . 65.140000000000001 108.819 175.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -61.7 109.79 1.32 Allowed 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 120.92 0.391 . . . . 75.239999999999995 110.5 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 128.72 38.84 0.34 Allowed Glycine 0 N--CA 1.441 -1.003 0 CA-C-N 115.525 -0.761 . . . . 74.049999999999997 112.055 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -97.33 -171.7 2.26 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 108.028 -1.101 . . . . 73.25 108.028 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -111.86 124.78 53.1 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 122.771 0.429 . . . . 72.109999999999999 111.387 -173.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 46.7 mm -119.24 117.59 54.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 120.756 0.312 . . . . 74.530000000000001 110.17 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 13.5 t -89.86 131.03 36.0 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-O 121.348 0.594 . . . . 74.420000000000002 109.679 176.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 10.8 p -105.25 135.71 42.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 C-N-CA 124.105 0.962 . . . . 74.5 108.932 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.37 128.19 42.02 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 120.822 -0.351 . . . . 75.209999999999994 110.607 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 3.4 p -128.04 131.33 69.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 115.877 -0.601 . . . . 73.450000000000003 109.787 173.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' SER . . . . . 0.648 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 3.0 p -94.72 122.77 37.67 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-O 121.051 0.453 . . . . 64.329999999999998 109.929 174.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.8 t -119.24 106.62 12.51 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-O 121.41 0.624 . . . . 73.010000000000005 111.86 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 77.1 124.38 0.24 Allowed Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 115.572 -0.74 . . . . 75.340000000000003 114.136 174.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . 0.436 ' HA ' ' HB2' ' A' ' 391' ' ' ASP . 38.2 Cg_exo -64.66 155.4 67.14 Favored 'Trans proline' 0 C--O 1.249 1.063 0 C-N-CA 122.264 1.976 . . . . 65.420000000000002 110.207 173.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -72.73 150.22 43.07 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 121.978 0.894 . . . . 73.420000000000002 112.414 -174.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 16.3 tp60 -88.35 139.49 30.43 Favored 'General case' 0 N--CA 1.41 -2.468 0 N-CA-C 105.572 -2.01 . . . . 74.25 105.572 178.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.565 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 2.9 mmp_? -122.25 140.89 52.08 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.888 -0.725 . . . . 73.030000000000001 111.678 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . 0.408 ' O ' ' HD3' ' A' ' 430' ' ' PRO . 9.5 pt-20 -83.74 139.06 32.97 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 114.393 -1.276 . . . . 74.129999999999995 110.186 -177.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 57.9 mt -98.41 112.61 62.71 Favored Pre-proline 0 N--CA 1.418 -2.068 0 N-CA-C 106.81 -1.552 . . . . 75.319999999999993 106.81 174.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 428' ' ' GLU . 16.3 Cg_exo -73.07 141.07 32.22 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 N-CA-C 107.885 -1.621 . . . . 72.219999999999999 107.885 165.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -84.43 132.71 34.54 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 118.205 -1.398 . . . . 73.010000000000005 108.833 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 59.4 t -105.7 151.7 7.73 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 N-CA-C 105.968 -1.864 . . . . 75.319999999999993 105.968 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 39.2 m -57.08 141.21 46.78 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.213 0.53 . . . . 72.099999999999994 111.138 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 36.5 p -64.26 -26.71 68.62 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 114.102 1.149 . . . . 54.43 114.102 -172.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.5 pp -82.93 -15.84 49.76 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 119.841 -0.744 . . . . 73.209999999999994 110.92 176.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.81 40.04 1.15 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.284 1.034 . . . . 73.010000000000005 109.362 -177.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -52.0 -38.76 57.93 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.522 1.129 . . . . 75.230000000000004 112.592 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -60.99 -41.8 97.15 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.037 0.446 . . . . 70.25 110.573 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -70.64 -35.97 73.19 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.963 -0.562 . . . . 61.25 109.602 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.509 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.47 -51.51 69.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.981 -0.554 . . . . 72.420000000000002 110.992 -178.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 36.0 m -63.08 -40.89 90.78 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 N-CA-C 112.279 0.474 . . . . 72.310000000000002 112.279 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . 0.267 0.1 OUTLIER -68.63 -34.54 75.91 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 113.338 0.866 . . . . 74.239999999999995 113.338 177.729 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -64.52 -41.03 96.64 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.284 -1.006 . . . . 75.519999999999996 108.284 179.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.509 HD13 ' O ' ' A' ' 440' ' ' ALA . 7.0 mp -63.49 -32.92 74.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.507 -0.77 . . . . 63.030000000000001 110.92 176.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.407 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 61.5 m -69.42 -43.02 74.25 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 116.067 -0.515 . . . . 74.030000000000001 110.354 177.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.44 -26.01 66.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.638 -0.71 . . . . 75.129999999999995 111.209 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.65 -6.15 56.55 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.072 0.463 . . . . 74.349999999999994 111.834 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 121.33 -77.1 0.33 Allowed Glycine 0 CA--C 1.495 -1.194 0 C-N-CA 120.314 -0.946 . . . . 60.229999999999997 112.227 176.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . 0.431 ' HA ' ' O ' ' A' ' 480' ' ' ILE . 0.5 OUTLIER -40.13 -68.51 0.17 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.134 1.161 . . . . 74.400000000000006 114.134 176.738 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . 0.407 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 58.93 25.68 59.7 Favored Glycine 0 C--N 1.318 -0.458 0 C-N-CA 121.589 -0.338 . . . . 61.219999999999999 112.645 -177.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.459 ' CB ' ' HA ' ' A' ' 483' ' ' VAL . 52.6 mmt-85 -101.82 111.82 24.22 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 107.258 -1.386 . . . . 74.109999999999999 107.258 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -139.14 145.77 39.81 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-O 120.973 0.416 . . . . 74.430000000000007 111.175 -176.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -131.47 123.42 28.04 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.046 -1.094 . . . . 72.109999999999999 108.046 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -99.3 121.46 41.11 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.98 0.419 . . . . 75.310000000000002 110.755 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -116.97 154.47 30.83 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.254 -1.017 . . . . 72.239999999999995 108.254 177.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -130.55 141.94 50.47 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.3 -0.63 . . . . 64.200000000000003 109.3 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 50.3 m -145.44 149.86 42.27 Favored Pre-proline 0 C--N 1.291 -1.938 0 N-CA-C 109.494 -0.558 . . . . 64.140000000000001 109.494 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.661 ' HA ' ' O ' ' A' ' 490' ' ' SER . 36.8 Cg_endo -67.49 127.38 16.35 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.321 2.014 . . . . 74.439999999999998 110.651 177.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 50.6 m -147.22 179.51 7.58 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.974 -0.38 . . . . 73.439999999999998 109.974 -177.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.8 t -54.31 135.97 60.44 Favored Pre-proline 0 N--CA 1.437 -1.079 0 C-N-CA 123.958 0.903 . . . . 61.140000000000001 110.315 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.16 -30.41 32.27 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 124.461 3.441 . . . . 64.129999999999995 115.192 -172.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -73.12 -27.83 61.91 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.829 -0.748 . . . . 75.200000000000003 112.546 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 83.5 mt -89.23 -11.86 42.44 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.217 0.532 . . . . 72.420000000000002 110.252 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.402 HG12 ' HA ' ' A' ' 490' ' ' SER . 70.6 t -60.61 128.76 22.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.447 -0.797 . . . . 74.439999999999998 110.457 177.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 96.22 -13.63 65.54 Favored Glycine 0 N--CA 1.432 -1.633 0 CA-C-N 115.058 -0.974 . . . . 73.519999999999996 111.553 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -117.27 166.65 12.02 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 109.201 -0.666 . . . . 75.230000000000004 109.201 -176.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.467 ' O ' ' HB ' ' A' ' 434' ' ' THR . 72.0 t -70.68 147.22 11.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 N-CA-C 107.993 -1.114 . . . . 75.5 107.993 173.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 64.3 mt -97.74 -35.88 5.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 107.008 -1.479 . . . . 65.140000000000001 107.008 176.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 169.3 -178.84 42.25 Favored Glycine 0 N--CA 1.416 -2.64 0 N-CA-C 109.789 -1.324 . . . . 72.5 109.789 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 470' ' ' THR . . . . . 0.441 HG22 HG12 ' A' ' 486' ' ' ILE . 41.4 p -115.65 137.95 51.56 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 107.262 -1.384 . . . . 73.409999999999997 107.262 178.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.453 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 0.2 OUTLIER -62.85 -47.43 87.15 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 120.726 -0.389 . . . . 73.209999999999994 110.058 -179.494 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.453 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 12.9 Cg_exo -77.05 132.77 13.03 Favored 'Trans proline' 0 C--N 1.365 1.438 0 N-CA-C 106.852 -2.019 . . . . 63.520000000000003 106.852 167.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.88 127.04 20.29 Favored 'Trans proline' 0 C--O 1.239 0.564 0 C-N-CA 121.902 1.735 . . . . 65.140000000000001 112.739 -174.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -85.24 16.78 3.38 Favored 'General case' 0 C--O 1.203 -1.35 0 CA-C-N 114.949 -1.023 . . . . 74.430000000000007 110.89 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -112.27 -6.09 14.11 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.771 -0.65 . . . . 74.400000000000006 110.089 173.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -111.62 -175.29 2.66 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 115.598 -0.728 . . . . 72.400000000000006 110.96 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.89 148.82 22.21 Favored 'General case' 0 N--CA 1.404 -2.774 0 CA-C-N 115.32 -0.854 . . . . 64.400000000000006 111.45 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 27.1 t -133.65 149.67 51.56 Favored 'General case' 0 C--O 1.26 1.658 0 N-CA-C 108.683 -0.858 . . . . 70.409999999999997 108.683 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -79.63 157.46 27.28 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.139 -0.482 . . . . 74.400000000000006 109.739 178.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 449' ' ' PHE . 37.6 mm -71.07 -21.03 21.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.877 0.846 . . . . 74.400000000000006 109.919 -176.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 17.4 p -100.02 5.92 45.08 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.786 -0.643 . . . . 75.5 112.045 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -87.76 128.93 35.32 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.348 -0.612 . . . . 74.420000000000002 109.348 -176.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . 0.459 ' HA ' ' CB ' ' A' ' 451' ' ' ARG . 40.0 t -96.81 113.47 31.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.318 -0.993 . . . . 74.340000000000003 108.318 177.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 21.2 m -91.37 129.04 42.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 121.479 0.656 . . . . 74.099999999999994 111.378 -177.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -94.27 125.43 46.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-O 121.537 0.684 . . . . 74.200000000000003 109.259 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . 0.441 HG12 HG22 ' A' ' 470' ' ' THR . 6.0 mt -115.2 124.37 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 CA-C-N 114.658 -1.156 . . . . 73.019999999999996 109.566 -176.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 10.8 tt -104.75 126.82 59.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-O 121.021 0.439 . . . . 74.140000000000001 110.386 -176.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 32.9 m -108.22 151.77 10.27 Favored 'Isoleucine or valine' 0 C--O 1.252 1.232 0 CA-C-N 115.878 -0.601 . . . . 65.549999999999997 110.221 178.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.7 136.2 13.86 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 110.746 -0.942 . . . . 74.129999999999995 110.746 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.661 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 12.5 t -139.15 160.37 39.95 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.041 -0.726 . . . . 74.319999999999993 109.041 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 86.92 76.97 1.25 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 114.963 0.745 . . . . 74.430000000000007 114.963 176.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -87.26 122.23 1.77 Allowed 'Trans proline' 0 N--CA 1.439 -1.704 0 C-N-CA 121.892 1.728 . . . . 71.349999999999994 110.54 175.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -101.09 23.95 10.09 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 122.465 1.126 . . . . 72.519999999999996 109.649 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 494' ' ' THR . . . . . 0.457 ' HB ' ' OG1' ' A' ' 544' ' ' THR . 9.9 p -120.43 143.42 48.49 Favored 'General case' 0 C--N 1.273 -2.726 0 CA-C-N 113.695 -1.593 . . . . 72.040000000000006 110.267 -177.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -138.58 151.68 47.5 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.002 -1.111 . . . . 72.209999999999994 108.002 177.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.585 ' OD1' ' HB ' ' A' ' 544' ' ' THR . 69.0 m-20 -80.62 126.42 31.24 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.538 -1.282 . . . . 74.519999999999996 107.538 176.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 28.4 pt -76.06 126.54 86.66 Favored Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 123.381 0.425 . . . . 74.299999999999997 111.957 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -92.51 156.78 2.99 Favored 'Trans proline' 0 N--CA 1.445 -1.363 0 C-N-CA 122.674 2.249 . . . . 72.209999999999994 110.454 173.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -79.32 109.61 13.83 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 122.301 1.048 . . . . 61.520000000000003 109.972 178.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.2 p -95.05 17.08 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 122.871 1.32 . . . . 73.010000000000005 108.08 178.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -81.74 72.26 8.79 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 114.319 -1.309 . . . . 71.329999999999998 110.949 -177.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . -158.17 10.04 0.21 Allowed Glycine 0 C--N 1.291 -1.935 0 CA-C-N 114.793 -1.094 . . . . 75.430000000000007 110.71 177.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -139.92 176.44 8.75 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 106.378 -1.712 . . . . 73.400000000000006 106.378 -173.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 30.2 p -83.01 159.98 22.08 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 109.405 -0.591 . . . . 75.219999999999999 109.405 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.7 p -50.54 -41.11 19.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 123.84 0.856 . . . . 74.409999999999997 112.47 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -63.68 -42.41 98.03 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.344 0.593 . . . . 63.200000000000003 111.089 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 61.6 t -75.9 -38.62 36.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.806 -0.634 . . . . 72.109999999999999 110.105 -177.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.18 -48.56 77.86 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.105 -0.498 . . . . 62.340000000000003 111.442 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -61.95 -38.56 88.96 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.234 0.334 . . . . 74.439999999999998 110.541 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.473 ' O ' HG22 ' A' ' 514' ' ' VAL . 6.3 tmtm? -59.2 -48.96 79.66 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.937 -0.764 . . . . 74.109999999999999 108.937 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -62.65 -42.26 99.51 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 116.274 -0.421 . . . . 73.140000000000001 111.346 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 97.4 mt -65.26 -40.65 94.23 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.335 -0.393 . . . . 75.430000000000007 111.494 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -61.78 -37.98 86.37 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.951 -0.388 . . . . 62.020000000000003 109.951 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 510' ' ' LYS . 73.2 t -61.97 -35.75 70.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 115.633 -0.712 . . . . 65.140000000000001 110.83 176.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -78.92 -8.1 58.57 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 112.101 0.408 . . . . 73.019999999999996 112.101 -178.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 112.47 -13.44 25.48 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.439 -0.886 . . . . 74.340000000000003 112.381 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -81.43 95.75 7.16 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 106.905 -1.517 . . . . 73.219999999999999 106.905 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.8 m -98.17 -3.6 37.3 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 119.695 -0.802 . . . . 73.439999999999998 111.497 -172.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -120.54 114.56 21.92 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.457 -0.572 . . . . 75.010000000000005 109.457 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -131.35 150.76 52.02 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.903 -0.59 . . . . 71.540000000000006 110.775 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 49.7 m -127.94 143.23 51.09 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 107.445 -1.317 . . . . 73.310000000000002 107.445 174.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.31 125.6 51.34 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-O 120.906 0.384 . . . . 71.299999999999997 111.641 -178.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -116.31 117.17 29.25 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.617 -0.883 . . . . 70.239999999999995 108.617 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 524' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 19.5 m -94.92 131.63 40.63 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.089 0.471 . . . . 73.530000000000001 112.144 -176.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 28.6 m -121.29 153.29 24.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 107.703 -1.221 . . . . 72.430000000000007 107.703 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -84.83 139.33 31.99 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.77 -0.772 . . . . 74.239999999999995 111.626 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 64.9 p -162.27 156.71 18.81 Favored Pre-proline 0 C--O 1.19 -2.066 0 N-CA-C 106.549 -1.649 . . . . 70.129999999999995 106.549 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -61.07 -12.89 24.82 Favored 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 122.005 1.803 . . . . 74.019999999999996 113.383 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -70.59 130.86 88.45 Favored Pre-proline 0 N--CA 1.45 -0.443 0 N-CA-C 108.52 -0.918 . . . . 74.400000000000006 108.52 178.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.3 147.26 78.07 Favored 'Trans proline' 0 C--O 1.253 1.25 0 C-N-CA 122.761 2.307 . . . . 74.409999999999997 113.301 -177.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -59.15 127.85 34.22 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.896 -1.047 . . . . 73.030000000000001 111.367 -175.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 119.43 -19.15 9.96 Favored Glycine 0 C--N 1.3 -1.424 0 N-CA-C 111.16 -0.776 . . . . 64.299999999999997 111.16 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -72.54 132.45 43.83 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.227 -0.657 . . . . 74.239999999999995 109.227 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 59.6 t -89.42 113.96 26.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 108.664 -0.865 . . . . 75.439999999999998 108.664 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 535' ' ' THR . . . . . 0.428 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 11.4 t -86.96 -20.49 27.22 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.695 -0.402 . . . . 72.310000000000002 111.173 -176.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 169.92 -163.4 36.82 Favored Glycine 0 CA--C 1.494 -1.239 0 C-N-CA 120.412 -0.899 . . . . 75.340000000000003 111.29 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 46.0 p -129.45 154.8 46.61 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.181 -1.414 . . . . 75.420000000000002 107.181 176.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -68.53 -54.2 14.78 Favored Pre-proline 0 C--N 1.309 -1.153 0 C-N-CA 119.959 -0.697 . . . . 63.32 110.446 177.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.32 136.91 29.94 Favored 'Trans proline' 0 C--N 1.371 1.74 0 CA-C-N 119.887 0.996 . . . . 73.239999999999995 110.009 175.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.1 145.08 65.85 Favored 'Trans proline' 0 C--O 1.254 1.284 0 C-N-CA 122.692 2.262 . . . . 74.439999999999998 113.186 -178.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.94 141.72 57.86 Favored 'General case' 0 C--O 1.247 0.952 0 CA-C-N 115.804 -0.634 . . . . 74.519999999999996 110.5 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 99.32 -12.03 61.75 Favored Glycine 0 N--CA 1.432 -1.604 0 CA-C-N 115.695 -0.684 . . . . 72.329999999999998 111.428 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 49.8 m -77.28 132.7 38.79 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 108.875 -0.787 . . . . 72.510000000000005 108.875 177.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.585 ' HB ' ' OD1' ' A' ' 496' ' ' ASP . 10.0 t -87.69 124.05 33.16 Favored 'General case' 0 N--CA 1.419 -2.006 0 CA-C-O 121.304 0.573 . . . . 72.430000000000007 109.699 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 19.6 m -125.88 154.89 73.59 Favored Pre-proline 0 C--N 1.297 -1.697 0 N-CA-C 108.15 -1.056 . . . . 73.310000000000002 108.15 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -71.82 136.22 27.28 Favored 'Trans proline' 0 N--CA 1.443 -1.472 0 C-N-CA 121.842 1.694 . . . . 75.319999999999993 110.168 175.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 32.6 m -64.96 -19.89 26.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.941 0.877 . . . . 75.219999999999999 110.512 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -76.12 -14.86 60.17 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.247 -1.342 . . . . 74.450000000000003 111.027 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 67.4 m -94.51 -171.93 2.63 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.215 -0.448 . . . . 73.120000000000005 111.92 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 18.1 t -116.02 126.61 73.59 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 CA-C-N 116.262 -0.426 . . . . 63.340000000000003 110.325 -174.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -102.49 145.91 11.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.556 -0.535 . . . . 64.5 109.556 175.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -108.82 121.46 45.11 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-O 121.406 0.622 . . . . 75.120000000000005 111.085 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 59.4 mt -97.99 134.5 41.02 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.389 -1.278 . . . . 74.120000000000005 108.315 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -106.33 119.5 39.41 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-O 122.158 0.98 . . . . 74.329999999999998 109.847 177.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 524' ' ' SER . 57.2 t -105.82 145.5 13.77 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 CA-C-N 113.898 -1.501 . . . . 75.420000000000002 109.977 -171.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.646 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 63.3 m -83.41 133.65 34.92 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-O 121.602 0.715 . . . . 75.099999999999994 111.613 178.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.77 137.35 42.71 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 104.829 -2.285 . . . . 75.219999999999999 104.829 169.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -75.87 -47.82 11.07 Favored Glycine 0 N--CA 1.433 -1.524 0 C-N-CA 118.42 -1.847 . . . . 63.439999999999998 110.763 -175.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 5.7 t30 61.24 -7.51 0.09 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 113.458 0.91 . . . . 71.510000000000005 113.458 175.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.504 ' H ' ' C ' ' A' ' 558' ' ' GLY . 25.4 tp60 -139.32 141.23 37.7 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 103.354 -2.832 . . . . 73.200000000000003 103.354 -177.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -141.82 153.26 44.39 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 118.653 0.66 . . . . 72.239999999999995 111.067 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 70.2 t -69.58 118.19 13.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 N-CA-C 108.764 -0.828 . . . . 75.409999999999997 108.764 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 58.8 ttp -88.87 134.36 33.78 Favored Pre-proline 0 C--N 1.304 -1.395 0 C-N-CA 120.376 -0.529 . . . . 72.310000000000002 110.392 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -66.03 161.92 37.72 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.518 2.146 . . . . 75.230000000000004 109.92 171.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -80.89 132.68 35.46 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.147 -0.621 . . . . 75.530000000000001 111.793 -177.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . 0.455 HD13 ' SD ' ' A' ' 569' ' ' MET . 39.7 tp -138.16 19.28 2.79 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.326 -1.361 . . . . 74.140000000000001 107.326 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 11.9 m -73.72 131.37 41.53 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.25 -0.886 . . . . 64.200000000000003 110.707 -173.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 71.56 9.87 69.95 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 114.397 0.519 . . . . 64.519999999999996 114.397 176.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 569' ' ' MET . . . . . 0.455 ' SD ' HD13 ' A' ' 566' ' ' LEU . 86.7 mtp -90.73 153.63 20.13 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.197 -0.668 . . . . 73.540000000000006 109.197 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 98.8 m-85 -73.24 140.28 46.78 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 120.721 0.296 . . . . 75.310000000000002 110.757 -175.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 32.1 t90 -66.01 -17.89 64.98 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 123.859 0.864 . . . . 74.0 110.335 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 35.3 m -78.05 -24.2 13.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.244 0.545 . . . . 72.209999999999994 109.96 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . 0.629 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 31.4 t70 -101.43 -28.26 12.68 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.341 -0.845 . . . . 73.230000000000004 109.637 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -65.92 -32.37 73.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.86 -0.609 . . . . 73.430000000000007 110.851 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.531 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 12.9 tp10 -57.79 -53.29 67.24 Favored Pre-proline 0 CA--C 1.583 2.235 0 CA-C-N 115.879 -0.6 . . . . 75.219999999999999 111.136 177.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . 0.498 ' HD2' ' O ' ' A' ' 573' ' ' ASP . 50.6 Cg_exo -59.56 -36.64 92.29 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 121.32 1.346 . . . . 72.109999999999999 112.699 171.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . 0.629 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 22.8 mmt180 -59.8 -44.66 93.85 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 120.75 0.309 . . . . 73.530000000000001 110.677 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.4 pp -65.44 -40.43 93.27 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.024 -0.535 . . . . 74.010000000000005 112.247 -175.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . 0.447 ' N ' HD13 ' A' ' 578' ' ' LEU . 73.6 mtp180 -65.72 -35.39 80.61 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.148 0.499 . . . . 73.040000000000006 110.951 176.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.33 -39.11 74.93 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.001 -0.545 . . . . 74.430000000000007 111.192 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 89.0 mt -83.03 -7.27 59.68 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.385 0.513 . . . . 74.349999999999994 112.385 -177.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 74.28 39.52 43.49 Favored Glycine 0 C--O 1.241 0.585 0 C-N-CA 120.638 -0.791 . . . . 72.239999999999995 111.533 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 33.2 t90 -67.72 127.16 31.73 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 109.579 -0.526 . . . . 74.439999999999998 109.579 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 3.7 m -116.76 10.3 14.21 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.466 -0.938 . . . . 73.0 108.466 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -77.69 177.4 53.0 Favored Glycine 0 N--CA 1.431 -1.67 0 CA-C-N 115.354 -0.839 . . . . 74.5 113.51 -173.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 52.4 tpp -104.24 140.3 38.04 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 109.235 -0.654 . . . . 74.239999999999995 109.235 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -80.58 130.23 35.0 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.071 -1.826 . . . . 74.439999999999998 106.071 176.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -95.04 102.07 13.86 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.486 0.66 . . . . 75.5 110.592 -176.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -88.38 110.17 20.58 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.914 -1.039 . . . . 74.519999999999996 109.228 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . 0.42 ' HA3' ' NH2' ' A' ' 623' ' ' ARG . . . -114.22 -86.73 1.46 Allowed Glycine 0 N--CA 1.43 -1.706 0 N-CA-C 109.7 -1.36 . . . . 63.119999999999997 109.7 176.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.19 147.99 42.54 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.21 -1.034 . . . . 73.310000000000002 108.21 176.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -90.74 141.39 28.85 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.214 -1.032 . . . . 64.349999999999994 108.214 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 60.8 t -107.43 121.7 60.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 110.575 -0.157 . . . . 65.450000000000003 110.575 -173.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -86.55 107.5 18.15 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.165 -1.014 . . . . 65.239999999999995 108.577 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -150.03 22.67 0.86 Allowed 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.974 -0.75 . . . . 74.439999999999998 108.974 -177.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 92.06 82.35 1.46 Allowed Glycine 0 N--CA 1.424 -2.147 0 N-CA-C 109.385 -1.486 . . . . 71.230000000000004 109.385 -176.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.18 -43.85 88.9 Favored Glycine 0 C--O 1.208 -1.49 0 O-C-N 123.93 0.429 . . . . 72.200000000000003 112.645 -175.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 25.5 m -59.23 -28.72 66.94 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 113.377 0.88 . . . . 73.040000000000006 113.377 -178.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -106.85 -12.59 15.45 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.367 0.603 . . . . 71.540000000000006 111.456 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . 0.503 ' C ' ' H ' ' A' ' 602' ' ' ARG . 35.6 m80 -130.62 22.22 5.07 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 113.49 0.922 . . . . 65.150000000000006 113.49 -173.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -77.41 37.57 0.22 Allowed 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 122.429 1.109 . . . . 74.319999999999993 109.761 175.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . 0.503 ' H ' ' C ' ' A' ' 600' ' ' HIS . 12.1 ptt180 -125.44 166.53 16.44 Favored 'General case' 0 N--CA 1.412 -2.368 0 C-N-CA 125.703 1.601 . . . . 74.340000000000003 108.305 -176.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 55.6 t -63.46 129.84 27.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.458 -0.941 . . . . 75.340000000000003 108.458 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 35.3 m -94.66 -45.02 13.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 119.999 -0.681 . . . . 72.439999999999998 110.464 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -131.02 146.59 52.44 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 106.062 -1.829 . . . . 73.239999999999995 106.062 174.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -120.51 129.33 53.78 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 107.331 -1.359 . . . . 74.230000000000004 107.331 -175.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.478 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 30.5 t30 -84.9 -71.76 0.1 Allowed Pre-proline 0 CA--C 1.563 1.465 0 N-CA-C 114.687 1.366 . . . . 64.099999999999994 114.687 -173.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 6.1 Cg_exo -76.14 114.77 3.98 Favored 'Trans proline' 0 C--N 1.372 1.775 0 CA-C-N 122.05 1.768 . . . . 73.129999999999995 109.547 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -63.29 135.57 50.98 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 122.476 2.117 . . . . 63.509999999999998 114.205 -171.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.84 138.69 56.3 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.041 -0.981 . . . . 73.409999999999997 109.379 177.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 94.45 -19.54 53.02 Favored Glycine 0 C--N 1.302 -1.319 0 N-CA-C 110.662 -0.975 . . . . 74.310000000000002 110.662 -176.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 28.9 m -98.58 162.75 12.97 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 107.878 -1.156 . . . . 73.409999999999997 107.878 178.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -74.39 116.47 5.2 Favored Glycine 0 N--CA 1.424 -2.137 0 CA-C-O 121.43 0.461 . . . . 64.310000000000002 112.462 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 20.5 m -104.94 144.48 14.68 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 107.194 -1.409 . . . . 71.120000000000005 107.194 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . 0.467 HD22 HG23 ' A' ' 619' ' ' ILE . 28.4 p30 -48.43 148.59 1.9 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 112.513 0.561 . . . . 70.239999999999995 112.513 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -55.38 -24.42 29.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.598 -0.728 . . . . 72.25 112.408 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . 0.47 ' OD2' ' HB ' ' A' ' 619' ' ' ILE . 19.2 t70 -61.52 -53.22 59.19 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.569 -1.271 . . . . 73.340000000000003 107.569 175.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 96.5 19.33 27.93 Favored Glycine 0 N--CA 1.419 -2.445 0 CA-C-N 114.992 -1.004 . . . . 63.109999999999999 111.416 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . 0.47 ' HB ' ' OD2' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -69.18 119.93 15.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 122.151 0.977 . . . . 60.130000000000003 109.73 -173.433 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.27 130.37 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.602 0 CA-C-N 114.611 -1.177 . . . . 75.030000000000001 108.158 -176.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 6.5 m -98.26 118.01 33.95 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.38 -0.97 . . . . 75.409999999999997 108.38 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . 0.582 ' O ' ' HD2' ' A' ' 623' ' ' ARG . 2.4 pt? -138.78 157.69 45.61 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.063 -0.517 . . . . 74.400000000000006 109.814 -177.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . 0.582 ' HD2' ' O ' ' A' ' 622' ' ' LEU . 6.9 mpt_? -129.63 143.08 50.66 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 105.202 -2.147 . . . . 75.340000000000003 105.202 171.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -141.22 165.23 28.1 Favored 'General case' 0 C--N 1.293 -1.861 0 O-C-N 123.896 0.747 . . . . 75.430000000000007 110.51 -178.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -66.55 138.74 36.23 Favored Glycine 0 N--CA 1.426 -2.004 0 CA-C-N 114.813 -1.085 . . . . 72.439999999999998 112.726 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 C--N 1.286 -2.158 0 C-N-CA 124.736 1.214 . . . . 74.439999999999998 109.02 -178.349 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.967 0 N-CA-C 110.188 -1.165 . . . . 43.049999999999997 110.188 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 10.3 tp -74.69 139.68 18.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.923 -0.769 . . . . 74.219999999999999 108.923 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 19.2 m -105.03 150.79 24.67 Favored 'General case' 0 N--CA 1.416 -2.138 0 N-CA-C 109.171 -0.678 . . . . 75.319999999999993 109.171 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.08 86.38 2.47 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 106.126 -1.805 . . . . 74.519999999999996 106.126 174.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.49 130.63 43.85 Favored 'General case' 0 CA--C 1.48 -1.725 0 CA-C-N 112.999 -1.91 . . . . 71.019999999999996 108.887 -176.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 409' ' ' SER . 31.2 m -133.81 159.51 42.45 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 CA-C-N 115.332 -0.849 . . . . 55.009999999999998 108.747 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -93.99 138.26 32.3 Favored 'General case' 0 N--CA 1.39 -3.437 0 N-CA-C 107.45 -1.315 . . . . 72.430000000000007 107.45 174.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 78.1 t -95.72 129.43 34.52 Favored Pre-proline 0 C--N 1.267 -3.001 0 CA-C-N 115.297 -0.865 . . . . 73.120000000000005 109.056 -172.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -57.77 127.71 26.28 Favored 'Trans proline' 0 CA--C 1.498 -1.302 0 C-N-CA 122.233 1.955 . . . . 73.439999999999998 110.153 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -80.21 126.36 31.02 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.196 -1.039 . . . . 75.319999999999993 108.196 -174.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.423 ' CG2' ' HB2' ' A' ' 373' ' ' ALA . 10.7 m -88.88 1.24 7.15 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 N-CA-C 113.387 0.884 . . . . 71.450000000000003 113.387 -173.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -56.48 144.7 30.31 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 123.584 0.552 . . . . 73.409999999999997 111.206 176.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.69 -16.6 47.43 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.728 -0.669 . . . . 53.119999999999997 112.398 -178.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -99.27 -156.12 0.53 Allowed 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 108.368 -0.975 . . . . 73.129999999999995 108.368 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 95.8 p -98.86 175.1 6.07 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 107.375 -1.343 . . . . 54.340000000000003 107.375 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.0 p -63.17 -44.71 94.66 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 109.799 -0.445 . . . . 71.340000000000003 109.799 175.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.58 -46.27 83.44 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 116.216 -0.447 . . . . 72.030000000000001 111.299 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.52 -38.47 91.14 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 121.0 0.429 . . . . 73.540000000000006 111.64 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . 0.423 ' HB2' ' CG2' ' A' ' 365' ' ' VAL . . . -67.49 -47.88 68.72 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.98 -0.554 . . . . 64.219999999999999 110.575 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 82.1 mt -60.98 -43.72 96.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-N 115.728 -0.669 . . . . 75.519999999999996 110.411 176.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.76 -42.75 89.63 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 115.856 -0.611 . . . . 65.200000000000003 111.002 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' THR . . . . . 0.56 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 31.2 m -67.37 -48.01 68.7 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.738 -0.664 . . . . 74.329999999999998 110.228 -178.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 92.0 mt -64.64 -39.0 92.92 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 112.152 0.427 . . . . 75.530000000000001 112.152 -178.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -64.43 -41.21 96.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.803 0.335 . . . . 72.340000000000003 110.176 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -70.05 -20.56 63.23 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 112.176 0.436 . . . . 71.409999999999997 112.176 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . 0.56 ' HG2' ' O ' ' A' ' 376' ' ' THR . 5.9 mmp_? -86.43 -12.62 48.6 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.023 0.439 . . . . 71.420000000000002 109.869 176.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.09 3.95 55.53 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 121.182 -0.532 . . . . 72.530000000000001 112.982 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -80.66 164.81 22.56 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-O 120.954 0.407 . . . . 74.400000000000006 110.301 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -108.43 141.52 40.17 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 107.531 -1.285 . . . . 73.420000000000002 107.531 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.58 152.79 30.86 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.491 0 CA-C-O 121.323 0.583 . . . . 75.430000000000007 110.199 -177.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -133.07 127.05 33.18 Favored 'General case' 0 N--CA 1.4 -2.974 0 N-CA-C 106.644 -1.613 . . . . 73.209999999999994 106.644 175.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 21.0 m -118.36 123.27 44.89 Favored 'General case' 0 C--N 1.271 -2.821 0 N-CA-C 107.887 -1.153 . . . . 74.239999999999995 107.887 -175.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.17 121.37 44.74 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.873 -1.158 . . . . 72.340000000000003 107.873 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -94.08 126.67 39.43 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.3 -0.629 . . . . 75.049999999999997 109.3 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -130.87 136.57 29.11 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 110.055 -0.35 . . . . 65.129999999999995 110.055 175.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . 0.59 ' HA ' ' O ' ' A' ' 422' ' ' THR . 23.5 Cg_exo -68.06 166.45 24.85 Favored 'Trans proline' 0 C--O 1.248 0.984 0 C-N-CA 122.066 1.844 . . . . 71.420000000000002 110.125 172.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 2.9 m-20 85.04 170.25 0.08 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.349 1.059 . . . . 73.329999999999998 110.645 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 69.3 p -108.82 9.28 26.84 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 120.677 0.275 . . . . 70.340000000000003 111.39 -176.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 15.4 t -78.43 -7.02 56.91 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.627 0.727 . . . . 71.329999999999998 110.901 -177.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.87 151.5 46.47 Favored Pre-proline 0 C--N 1.298 -1.656 0 N-CA-C 107.882 -1.155 . . . . 73.400000000000006 107.882 175.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -32.79 131.24 0.1 Allowed 'Trans proline' 0 C--N 1.363 1.316 0 C-N-CA 124.569 3.513 . . . . 75.430000000000007 114.928 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.25 164.37 3.85 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 124.476 3.451 . . . . 74.140000000000001 113.352 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -56.43 -8.64 0.56 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.525 1.13 . . . . 75.239999999999995 112.355 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 60.3 m170 -115.79 131.61 56.89 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 104.563 -2.384 . . . . 65.430000000000007 104.563 170.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 24.7 m -71.03 117.15 13.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-O 121.978 0.894 . . . . 75.400000000000006 111.453 -169.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 50.0 mm -102.99 -26.66 3.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.078 -1.082 . . . . 71.040000000000006 108.078 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -144.31 157.53 27.2 Favored Glycine 0 N--CA 1.399 -3.807 0 N-CA-C 109.486 -1.446 . . . . 51.119999999999997 109.486 -178.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 8.0 p -146.56 -176.17 5.08 Favored 'General case' 0 C--N 1.275 -2.662 0 C-N-CA 125.111 1.364 . . . . 74.040000000000006 107.808 -172.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -100.58 139.74 20.85 Favored Pre-proline 0 C--N 1.29 -2.004 0 N-CA-C 108.272 -1.01 . . . . 72.120000000000005 108.272 -174.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.21 -12.89 6.02 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 123.951 3.101 . . . . 74.510000000000005 114.691 -176.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -50.05 -41.29 47.44 Favored 'General case' 0 C--O 1.212 -0.902 0 C-N-CA 123.742 0.817 . . . . 73.349999999999994 111.584 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -71.46 -32.77 68.68 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.291 0.567 . . . . 74.140000000000001 111.398 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -85.32 -1.17 56.68 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.709 0.766 . . . . 72.409999999999997 110.683 -177.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 19.0 m -102.19 151.01 22.71 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 107.1 -1.444 . . . . 73.420000000000002 107.1 174.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 360' ' ' VAL . 20.2 m -74.68 113.83 12.4 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 108.876 -0.787 . . . . 71.120000000000005 108.876 178.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.6 m -120.24 170.3 10.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 116.272 -0.422 . . . . 73.230000000000004 110.551 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 25.8 t -77.38 150.97 35.04 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.096 -1.076 . . . . 73.430000000000007 108.096 176.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -65.61 122.12 16.52 Favored 'General case' 0 C--O 1.245 0.836 0 N-CA-C 109.413 -0.588 . . . . 71.400000000000006 109.413 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 94.62 68.25 1.04 Allowed Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 110.25 -1.14 . . . . 42.200000000000003 110.25 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -127.96 -179.51 5.01 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.528 -1.286 . . . . 63.530000000000001 107.528 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -111.4 119.65 39.53 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.049 0.452 . . . . 74.340000000000003 110.674 -174.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 46.1 mm -106.21 120.83 57.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 109.203 -0.666 . . . . 70.209999999999994 109.203 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 22.4 p -92.55 130.88 38.07 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.016 0.436 . . . . 74.450000000000003 111.307 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 5.4 p -126.82 135.33 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 109.072 -0.714 . . . . 70.439999999999998 109.072 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.81 125.76 54.35 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 109.41 -0.589 . . . . 74.340000000000003 109.41 178.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 11.5 p -121.51 143.93 32.32 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 115.478 -0.783 . . . . 73.510000000000005 110.727 -174.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 31.3 t -84.16 121.46 27.48 Favored 'General case' 0 C--O 1.252 1.197 0 CA-C-N 115.682 -0.69 . . . . 54.43 109.679 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' THR . . . . . 0.59 ' O ' ' HA ' ' A' ' 390' ' ' PRO . 14.4 t -121.08 107.73 12.97 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 115.83 -0.623 . . . . 74.430000000000007 111.759 175.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 97.78 152.18 28.07 Favored Glycine 0 C--N 1.302 -1.357 0 C-N-CA 119.099 -1.524 . . . . 72.129999999999995 115.424 172.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -72.52 158.7 50.59 Favored 'Trans proline' 0 C--O 1.243 0.744 0 C-N-CA 124.205 3.27 . . . . 72.129999999999995 113.74 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -76.85 163.95 26.28 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.155 -1.384 . . . . 75.140000000000001 111.637 -175.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -88.73 138.99 30.92 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 106.291 -1.744 . . . . 73.239999999999995 106.291 178.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' A' ' 447' ' ' ALA . 5.0 mmp_? -127.7 148.89 50.41 Favored 'General case' 0 C--O 1.209 -1.073 0 N-CA-C 113.815 1.043 . . . . 75.230000000000004 113.815 -178.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -83.42 138.52 33.44 Favored 'General case' 0 C--N 1.286 -2.157 0 C-N-CA 126.237 1.815 . . . . 74.420000000000002 110.548 178.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.403 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 66.5 mt -83.59 119.28 73.5 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 108.684 -0.858 . . . . 73.219999999999999 108.684 177.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.83 152.53 63.85 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.909 2.406 . . . . 73.430000000000007 113.823 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -91.42 110.1 21.39 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 115.763 -0.653 . . . . 71.219999999999999 109.457 176.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 42.2 t -116.77 150.34 18.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.354 -0.98 . . . . 74.019999999999996 108.354 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.579 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 17.0 m -68.62 150.88 47.47 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 121.071 0.462 . . . . 71.209999999999994 110.975 -179.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 40.5 p -69.77 -27.33 64.84 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 123.75 0.82 . . . . 71.530000000000001 113.179 -172.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.9 pp -88.07 -11.13 48.06 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.46 0.647 . . . . 74.129999999999995 111.349 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.579 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 0.8 OUTLIER -99.59 45.37 0.99 Allowed 'General case' 0 CA--C 1.56 1.341 0 CA-C-N 115.464 -0.789 . . . . 74.25 109.869 -175.672 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -52.65 -38.91 61.2 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 114.198 1.184 . . . . 73.150000000000006 114.198 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.488 ' O ' ' HG3' ' A' ' 442' ' ' LYS . . . -64.69 -39.56 93.87 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 120.527 -0.469 . . . . 52.439999999999998 110.544 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -65.77 -36.17 82.78 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 108.684 -0.858 . . . . 75.109999999999999 108.684 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.525 ' O ' HD11 ' A' ' 444' ' ' LEU . . . -60.91 -51.63 68.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.172 -0.467 . . . . 71.299999999999997 111.46 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 27.2 m -65.86 -39.02 83.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 112.321 0.489 . . . . 74.319999999999993 112.321 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 438' ' ' ALA 0.3 0.0 OUTLIER -68.37 -34.07 75.4 Favored 'General case' 0 C--O 1.214 -0.764 0 N-CA-C 112.985 0.735 . . . . 75.549999999999997 112.985 176.483 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -61.25 -43.38 98.98 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.047 0.451 . . . . 73.340000000000003 110.056 175.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.525 HD11 ' O ' ' A' ' 440' ' ' ALA . 7.1 mp -63.67 -35.75 81.56 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.599 -0.728 . . . . 73.439999999999998 110.706 177.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.605 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 26.9 m -71.16 -45.98 62.41 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.108 -0.496 . . . . 64.230000000000004 111.078 178.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -65.41 -20.05 66.21 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.227 0.611 . . . . 74.420000000000002 110.995 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . 0.544 ' O ' ' HG3' ' A' ' 427' ' ' ARG . . . -79.35 -3.92 48.5 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.853 -0.612 . . . . 62.340000000000003 111.433 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 118.05 -78.6 0.3 Allowed Glycine 0 CA--C 1.49 -1.503 0 C-N-CA 120.716 -0.754 . . . . 75.209999999999994 111.562 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . 0.441 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 2.8 p90 -43.48 -66.82 0.33 Allowed 'General case' 0 C--O 1.241 0.652 0 N-CA-C 113.473 0.916 . . . . 64.150000000000006 113.473 177.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . 0.605 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 62.19 27.63 69.4 Favored Glycine 0 CA--C 1.487 -1.671 0 N-CA-C 111.037 -0.825 . . . . 74.420000000000002 111.037 -175.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -103.91 110.11 22.11 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 106.701 -1.592 . . . . 75.430000000000007 106.701 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . 0.415 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 27.9 p90 -135.67 154.71 51.2 Favored 'General case' 0 N--CA 1.408 -2.547 0 CA-C-N 115.66 -0.7 . . . . 74.319999999999993 109.721 -176.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -130.77 122.9 28.03 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 107.783 -1.191 . . . . 74.150000000000006 107.783 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -86.8 129.98 34.65 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.975 -0.75 . . . . 73.219999999999999 108.975 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -136.43 140.95 43.52 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 116.358 -0.383 . . . . 63.32 110.084 177.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -114.14 146.24 40.57 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 106.903 -1.517 . . . . 75.129999999999995 106.903 175.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 52.7 m -148.6 150.22 33.08 Favored Pre-proline 0 C--N 1.28 -2.449 0 N-CA-C 108.487 -0.931 . . . . 60.43 108.487 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.647 ' HA ' ' O ' ' A' ' 490' ' ' SER . 37.5 Cg_endo -66.69 132.77 29.69 Favored 'Trans proline' 0 N--CA 1.442 -1.536 0 C-N-CA 121.667 1.578 . . . . 72.209999999999994 110.423 177.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 21.2 m -142.38 178.12 7.8 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.042 -0.725 . . . . 74.239999999999995 109.042 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 6.9 t -62.34 137.54 96.06 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 109.691 -0.485 . . . . 74.019999999999996 109.691 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.42 -29.36 30.73 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 124.415 3.41 . . . . 73.349999999999994 113.62 -176.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -67.92 -33.36 74.54 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-O 120.943 0.401 . . . . 73.219999999999999 111.398 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.35 -20.04 23.32 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 111.904 0.335 . . . . 75.450000000000003 111.904 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 78.0 t -52.28 133.35 14.25 Favored 'Isoleucine or valine' 0 C--O 1.245 0.85 0 O-C-N 123.603 0.564 . . . . 75.540000000000006 111.016 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.88 -20.3 48.48 Favored Glycine 0 N--CA 1.438 -1.191 0 CA-C-N 115.646 -0.706 . . . . 71.140000000000001 112.292 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -113.33 166.28 11.63 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 117.103 0.451 . . . . 74.5 110.21 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 77.6 t -72.85 143.3 14.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 115.563 -0.744 . . . . 71.340000000000003 109.237 177.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 50.5 mm -96.89 -31.78 4.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 107.532 -1.285 . . . . 75.439999999999998 107.532 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 153.4 -163.96 30.87 Favored Glycine 0 N--CA 1.422 -2.287 0 CA-C-N 115.539 -0.755 . . . . 65.200000000000003 111.893 175.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.71 139.14 50.89 Favored 'General case' 0 N--CA 1.413 -2.277 0 N-CA-C 106.62 -1.622 . . . . 74.420000000000002 106.62 176.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.428 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 27.4 t-20 -64.96 -51.04 59.14 Favored Pre-proline 0 N--CA 1.471 0.605 0 CA-C-O 119.228 -0.415 . . . . 74.010000000000005 111.003 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.428 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 21.8 Cg_exo -70.29 130.52 18.83 Favored 'Trans proline' 0 C--N 1.371 1.761 0 N-CA-C 107.131 -1.911 . . . . 72.140000000000001 107.131 169.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . 0.538 ' C ' ' H ' ' A' ' 475' ' ' ASN . 39.7 Cg_exo -62.06 133.51 44.5 Favored 'Trans proline' 0 C--O 1.24 0.595 0 C-N-CA 121.856 1.704 . . . . 74.129999999999995 113.212 -174.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.403 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -70.92 14.49 0.14 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.159 1.384 . . . . 51.43 111.588 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . 0.538 ' H ' ' C ' ' A' ' 473' ' ' PRO . 16.3 m120 -109.19 -13.72 14.61 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 108.484 -0.932 . . . . 75.540000000000006 108.484 -178.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -104.79 178.86 4.44 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.547 -0.751 . . . . 73.439999999999998 111.344 -175.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.59 137.84 43.86 Favored 'General case' 0 N--CA 1.396 -3.142 0 CA-C-N 115.573 -0.74 . . . . 72.129999999999995 110.898 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 12.3 p -117.13 149.65 40.0 Favored 'General case' 0 N--CA 1.424 -1.75 0 C-N-CA 123.97 0.908 . . . . 74.319999999999993 110.145 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -80.83 158.53 25.36 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.916 -0.584 . . . . 74.209999999999994 110.129 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . 0.441 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 37.0 mm -69.72 -17.53 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 122.231 1.015 . . . . 63.229999999999997 110.318 -178.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 7.4 p -100.09 2.02 42.8 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.654 -0.703 . . . . 71.439999999999998 111.403 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -95.75 134.9 38.14 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.048 -0.524 . . . . 64.510000000000005 110.846 -175.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 37.6 t -99.88 116.44 43.16 Favored 'Isoleucine or valine' 0 C--O 1.243 0.754 0 N-CA-C 109.228 -0.656 . . . . 74.219999999999999 109.228 -177.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 32.1 m -99.72 136.79 29.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 121.436 0.636 . . . . 71.340000000000003 111.384 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.418 HG22 ' HB3' ' A' ' 471' ' ' ASN . 0.0 OUTLIER -99.98 128.35 51.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 121.452 0.644 . . . . 74.329999999999998 111.742 -176.841 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 16.3 mt -112.56 128.25 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 CA-C-N 114.599 -1.182 . . . . 73.25 109.88 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 6.1 tt -111.03 126.71 68.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-N 115.151 -0.931 . . . . 71.019999999999996 110.515 -173.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 35.0 m -105.56 149.52 8.93 Favored 'Isoleucine or valine' 0 C--O 1.254 1.306 0 CA-C-N 115.933 -0.576 . . . . 74.540000000000006 110.032 177.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -84.22 125.97 7.37 Favored Glycine 0 N--CA 1.437 -1.279 0 N-CA-C 111.372 -0.691 . . . . 73.150000000000006 111.372 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.647 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 25.5 t -135.99 160.65 37.97 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 107.075 -1.454 . . . . 73.439999999999998 107.075 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 146.99 166.32 12.29 Favored Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 119.637 -1.268 . . . . 74.420000000000002 111.399 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -71.69 156.16 57.72 Favored 'Trans proline' 0 C--O 1.249 1.057 0 C-N-CA 123.254 2.636 . . . . 75.420000000000002 111.853 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -104.37 118.99 37.95 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-O 121.44 0.638 . . . . 61.140000000000001 109.677 -177.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 11.0 p -116.82 143.15 46.02 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 115.018 -0.992 . . . . 74.430000000000007 109.66 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -146.86 151.67 37.45 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 123.168 0.587 . . . . 73.540000000000006 109.837 -179.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.2 p-10 -87.24 135.38 33.33 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.84 -1.17 . . . . 73.319999999999993 107.84 174.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 26.2 pt -75.26 121.01 84.31 Favored Pre-proline 0 C--N 1.294 -1.813 0 CA-C-N 115.784 -0.644 . . . . 72.219999999999999 109.729 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -75.25 159.9 39.92 Favored 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 122.184 1.923 . . . . 74.409999999999997 111.765 -177.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -77.84 90.27 4.08 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 106.272 -1.751 . . . . 74.329999999999998 106.272 174.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 10.0 p -96.65 7.5 7.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-O 122.319 1.056 . . . . 75.019999999999996 110.427 -171.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -78.06 79.05 4.53 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.203 -0.908 . . . . 72.319999999999993 111.932 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . -178.13 31.75 0.07 OUTLIER Glycine 0 C--N 1.304 -1.197 0 N-CA-C 110.703 -0.959 . . . . 63.43 110.703 177.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -157.51 -177.37 6.54 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 107.956 -1.127 . . . . 73.299999999999997 107.956 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 5.9 t -91.23 156.81 17.56 Favored 'General case' 0 N--CA 1.426 -1.642 0 C-N-CA 119.02 -1.072 . . . . 64.430000000000007 109.738 -177.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.5 p -54.16 -40.27 46.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 C-N-CA 124.707 1.203 . . . . 75.109999999999999 111.271 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -60.9 -43.38 98.59 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.624 -0.716 . . . . 71.409999999999997 110.697 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 64.0 t -76.77 -37.13 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-N 116.042 -0.526 . . . . 74.319999999999993 110.241 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . 0.472 ' O ' ' HG ' ' A' ' 512' ' ' LEU . . . -62.9 -48.87 77.11 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.93 -0.577 . . . . 74.209999999999994 111.662 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -65.18 -35.66 81.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.762 0.315 . . . . 72.019999999999996 110.246 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.518 ' O ' HG22 ' A' ' 514' ' ' VAL . 26.2 tptp -64.15 -45.37 88.75 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.848 -0.797 . . . . 74.230000000000004 108.848 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -62.27 -42.69 99.56 Favored 'General case' 0 CA--C 1.505 -0.78 0 O-C-N 123.609 0.568 . . . . 71.230000000000004 110.775 177.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 508' ' ' ALA . 87.5 mt -59.93 -42.94 95.07 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 116.447 -0.342 . . . . 74.239999999999995 110.612 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -62.28 -37.86 87.09 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 116.253 -0.431 . . . . 64.450000000000003 110.586 177.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 510' ' ' LYS . 92.6 t -61.87 -35.68 69.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.898 -0.592 . . . . 74.25 110.735 177.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -78.26 -19.58 53.41 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.213 0.53 . . . . 75.439999999999998 110.213 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 117.93 -5.98 15.78 Favored Glycine 0 N--CA 1.436 -1.326 0 C-N-CA 120.639 -0.791 . . . . 71.530000000000001 112.678 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.609 ' HA ' ' O ' ' A' ' 547' ' ' VAL . 74.6 m-85 -68.83 122.18 18.07 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 121.214 0.53 . . . . 74.510000000000005 110.642 -178.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 10.7 p -93.64 -39.7 10.67 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.567 -0.742 . . . . 72.109999999999999 112.357 -178.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . 0.453 ' HZ2' ' CG ' ' A' ' 548' ' ' ASP . 58.8 mttp -108.43 114.94 29.18 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 122.152 0.977 . . . . 74.140000000000001 113.139 -171.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 551' ' ' ILE . 46.2 p90 -130.72 151.58 51.01 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.566 -1.197 . . . . 73.109999999999999 110.167 176.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 25.1 m -125.17 143.03 51.14 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.111 -1.07 . . . . 74.239999999999995 108.111 176.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -117.91 119.71 35.67 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.827 -0.434 . . . . 73.329999999999998 109.827 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 554' ' ' GLN . . . -127.39 125.94 41.56 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.72 -0.844 . . . . 74.209999999999994 108.72 178.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 524' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 20.6 m -101.65 138.5 38.56 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.878 -0.329 . . . . 54.240000000000002 111.568 -178.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 30.1 m -123.71 149.38 27.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 108.415 -0.957 . . . . 74.219999999999999 108.415 176.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . 0.447 ' HA ' ' HB3' ' A' ' 557' ' ' LYS . 4.7 p-10 -69.57 136.02 50.77 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 121.248 0.547 . . . . 71.530000000000001 110.717 -177.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 25.6 p -163.01 167.56 11.64 Favored Pre-proline 0 C--N 1.307 -1.257 0 CA-C-N 115.237 -0.892 . . . . 75.019999999999996 109.046 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -77.39 6.56 4.31 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 122.483 2.122 . . . . 73.120000000000005 112.839 176.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -96.52 140.51 22.22 Favored Pre-proline 0 N--CA 1.445 -0.679 0 N-CA-C 108.206 -1.035 . . . . 74.310000000000002 108.206 175.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -64.42 161.4 34.96 Favored 'Trans proline' 0 C--O 1.246 0.908 0 C-N-CA 122.996 2.464 . . . . 75.530000000000001 113.962 -174.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.58 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -66.38 120.77 13.91 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.289 -0.868 . . . . 75.209999999999994 110.078 -178.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 122.94 -27.25 5.95 Favored Glycine 0 N--CA 1.434 -1.435 0 C-N-CA 120.657 -0.782 . . . . 72.219999999999999 111.594 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -69.63 125.61 27.23 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.358 -0.608 . . . . 65.340000000000003 109.358 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 94.0 t -81.48 111.6 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 N-CA-C 107.568 -1.271 . . . . 62.100000000000001 107.568 176.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 11.7 t -95.05 -16.22 22.86 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 120.63 -0.428 . . . . 62.130000000000003 111.982 -174.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 174.68 -175.13 46.89 Favored Glycine 0 CA--C 1.489 -1.564 0 C-N-CA 120.326 -0.94 . . . . 73.299999999999997 111.33 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 23.4 p -129.33 157.18 42.61 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.414 -0.958 . . . . 73.129999999999995 108.414 176.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . 0.404 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 26.0 t-20 -73.06 -53.16 5.14 Favored Pre-proline 0 C--N 1.309 -1.186 0 C-N-CA 120.634 -0.427 . . . . 63.219999999999999 111.283 177.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . 0.404 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 13.8 Cg_exo -72.86 136.45 25.24 Favored 'Trans proline' 0 C--N 1.368 1.605 0 N-CA-C 108.375 -1.433 . . . . 73.040000000000006 108.375 172.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -59.45 139.92 91.75 Favored 'Trans proline' 0 C--O 1.262 1.702 0 C-N-CA 122.2 1.933 . . . . 74.099999999999994 112.258 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -67.88 141.34 56.44 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.438 -0.801 . . . . 62.549999999999997 109.276 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 102.14 -12.27 57.28 Favored Glycine 0 N--CA 1.427 -1.932 0 C-N-CA 120.976 -0.63 . . . . 60.409999999999997 111.664 -176.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 45.8 m -72.57 126.94 31.08 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 116.943 0.372 . . . . 73.530000000000001 110.327 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 10.2 t -83.73 123.17 29.58 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.455 0.645 . . . . 73.530000000000001 110.029 177.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.9 m -138.21 157.46 72.69 Favored Pre-proline 0 C--N 1.305 -1.348 0 N-CA-C 108.972 -0.751 . . . . 74.540000000000006 108.972 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -65.89 150.5 85.69 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 121.554 1.503 . . . . 75.329999999999998 110.108 173.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 517' ' ' PHE . 26.9 m -59.97 -20.2 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 113.316 0.858 . . . . 75.519999999999996 113.316 -177.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . 0.453 ' CG ' ' HZ2' ' A' ' 519' ' ' LYS . 9.7 t70 -95.09 4.92 53.17 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.603 0.716 . . . . 64.209999999999994 111.454 -177.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.1 t -71.62 171.58 11.2 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 109.4 -0.593 . . . . 74.109999999999999 109.4 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 49.1 t -101.12 112.82 35.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 109.836 -0.431 . . . . 54.009999999999998 109.836 -177.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 520' ' ' PHE . 2.9 mp -101.14 121.85 52.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.763 -0.829 . . . . 73.519999999999996 108.763 178.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -102.69 116.41 32.53 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.17 0.509 . . . . 73.519999999999996 110.082 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 4.6 mp -97.22 134.13 40.93 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.05 -0.977 . . . . 71.219999999999999 108.682 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . 0.439 ' HA ' ' O ' ' A' ' 523' ' ' ALA . 49.6 mt-30 -105.21 114.83 29.26 Favored 'General case' 0 N--CA 1.414 -2.26 0 CA-C-O 122.03 0.919 . . . . 73.200000000000003 108.852 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 524' ' ' SER . 22.1 t -101.85 147.6 8.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 CA-C-N 113.967 -1.469 . . . . 70.010000000000005 108.855 -172.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.58 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 23.4 m -76.43 130.84 38.6 Favored 'General case' 0 N--CA 1.412 -2.35 0 CA-C-O 121.863 0.84 . . . . 61.210000000000001 112.447 177.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.447 ' HB3' ' HA ' ' A' ' 526' ' ' ASP . 10.2 tppt? -90.88 123.71 34.61 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 104.096 -2.557 . . . . 74.420000000000002 104.096 167.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -66.69 -42.3 93.34 Favored Glycine 0 CA--C 1.482 -2.009 0 N-CA-C 109.98 -1.248 . . . . 73.540000000000006 109.98 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 9.5 t30 65.57 21.15 11.72 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 122.171 0.986 . . . . 73.329999999999998 110.352 172.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -134.8 156.23 49.24 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.509 -0.769 . . . . 73.25 111.537 -176.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -133.4 156.73 47.14 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.395 -0.965 . . . . 73.530000000000001 108.395 176.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 54.9 t -73.22 124.47 30.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 120.777 0.322 . . . . 64.340000000000003 110.155 -178.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 52.9 ttp -97.26 137.52 21.18 Favored Pre-proline 0 C--N 1.311 -1.109 0 CA-C-N 116.159 -0.473 . . . . 75.319999999999993 111.962 -178.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -65.49 170.99 10.09 Favored 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 124.148 3.232 . . . . 72.340000000000003 112.535 172.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -82.14 134.25 35.31 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.31 -0.626 . . . . 60.039999999999999 109.31 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -120.38 -26.04 5.5 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.614 -0.884 . . . . 63.350000000000001 108.614 171.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 12.2 p -71.67 139.23 49.13 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.48 -0.782 . . . . 74.040000000000006 110.48 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 79.58 39.33 18.3 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 110.99 -0.844 . . . . 71.340000000000003 110.99 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 89.2 mtp -144.69 170.32 16.32 Favored 'General case' 0 C--O 1.249 1.075 0 N-CA-C 108.263 -1.014 . . . . 63.32 108.263 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -95.53 148.97 21.94 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 108.559 -0.904 . . . . 71.329999999999998 108.559 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 73.8 t-105 -61.73 -28.39 69.4 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 123.406 0.682 . . . . 75.209999999999994 109.968 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 13.8 p -71.54 -21.04 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-N 115.247 -0.888 . . . . 64.129999999999995 110.667 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -101.19 -30.82 11.33 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.812 -0.81 . . . . 74.200000000000003 108.812 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -59.06 -45.94 89.52 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.199 -0.91 . . . . 63.450000000000003 112.441 -178.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' A' ' 579' ' ' ARG . 31.5 mt-10 -59.51 -57.65 25.34 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 113.7 1.0 . . . . 64.430000000000007 113.7 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -58.07 -34.75 98.81 Favored 'Trans proline' 0 C--N 1.364 1.394 0 C-N-CA 121.173 1.248 . . . . 74.010000000000005 112.26 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -59.21 -48.13 82.77 Favored 'General case' 0 N--CA 1.42 -1.925 0 C-N-CA 122.506 0.322 . . . . 74.519999999999996 110.526 177.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . 0.286 4.2 pp -68.04 -38.3 82.33 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 112.813 0.672 . . . . 75.109999999999999 112.813 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 35.3 mmt180 -65.12 -47.56 76.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.472 -0.331 . . . . 72.430000000000007 110.458 178.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.93 -17.15 62.69 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.904 -0.589 . . . . 71.540000000000006 112.365 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 60.4 tp -85.84 -9.11 57.54 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 109.603 -0.517 . . . . 75.209999999999994 109.603 178.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 73.87 38.66 48.8 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 111.219 -0.752 . . . . 61.229999999999997 111.219 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 50.5 t90 -83.36 135.08 34.85 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-O 121.266 0.555 . . . . 73.329999999999998 111.015 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 10.1 t -145.89 106.34 4.07 Favored 'General case' 0 N--CA 1.408 -2.545 0 CA-C-N 114.783 -1.099 . . . . 74.319999999999993 108.126 173.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -159.18 -154.68 7.34 Favored Glycine 0 N--CA 1.429 -1.828 0 N-CA-C 108.774 -1.73 . . . . 73.109999999999999 108.774 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 60.9 mtt -107.58 125.23 51.05 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.68 -0.808 . . . . 64.040000000000006 112.324 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 59.2 tp -93.88 130.16 40.04 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.642 -0.873 . . . . 74.450000000000003 108.642 178.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -99.28 113.22 25.38 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 120.972 0.415 . . . . 74.019999999999996 111.232 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -91.86 109.4 20.73 Favored 'General case' 0 N--CA 1.408 -2.554 0 N-CA-C 106.4 -1.704 . . . . 71.439999999999998 106.4 171.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -87.9 -95.25 0.96 Allowed Glycine 0 N--CA 1.424 -2.124 0 C-N-CA 120.599 -0.81 . . . . 74.409999999999997 111.399 -178.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.44 151.28 46.11 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.214 -0.662 . . . . 74.420000000000002 109.214 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -84.84 132.07 34.45 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.719 -1.215 . . . . 72.5 107.719 175.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 73.5 t -123.63 127.7 74.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 CA-C-N 116.275 -0.421 . . . . 74.319999999999993 110.539 -171.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -78.53 107.25 11.05 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.018 -1.475 . . . . 74.5 107.018 175.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -127.47 0.86 6.26 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.81 -0.632 . . . . 72.140000000000001 110.736 -176.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 104.99 141.33 10.77 Favored Glycine 0 N--CA 1.431 -1.639 0 N-CA-C 108.8 -1.72 . . . . 74.349999999999994 108.8 -177.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -55.77 -39.31 76.4 Favored Glycine 0 C--O 1.224 -0.491 0 CA-C-N 117.193 0.497 . . . . 64.310000000000002 112.793 -173.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 3.9 m -60.37 -24.63 65.25 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.995 0.918 . . . . 72.409999999999997 111.923 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -108.76 -1.57 19.23 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.137 0.421 . . . . 73.140000000000001 112.137 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 59.5 m170 -72.38 -42.28 65.41 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.463 0.542 . . . . 75.430000000000007 112.463 -176.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -92.77 32.4 1.25 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 122.04 0.924 . . . . 74.340000000000003 108.749 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 603' ' ' VAL . 29.9 ttt180 -118.7 141.8 48.27 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.609 -0.682 . . . . 74.150000000000006 109.729 -178.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . 0.402 ' O ' ' HG2' ' A' ' 602' ' ' ARG . 71.4 t -73.15 130.9 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 106.094 -1.817 . . . . 75.140000000000001 106.094 172.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 73.6 t -80.05 -53.35 13.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-O 121.71 0.767 . . . . 63.5 109.292 -172.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -156.78 164.23 38.34 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 104.67 -2.345 . . . . 73.340000000000003 104.67 177.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -115.86 142.51 46.67 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 107.571 -1.27 . . . . 64.430000000000007 107.571 174.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.421 ' CB ' ' HB ' ' A' ' 621' ' ' THR . 41.1 t30 -64.21 -52.52 54.17 Favored Pre-proline 0 C--N 1.285 -2.211 0 N-CA-C 114.441 1.275 . . . . 75.420000000000002 114.441 -176.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -87.38 148.99 7.72 Favored 'Trans proline' 0 CA--C 1.549 1.238 0 CA-C-N 121.444 1.551 . . . . 74.109999999999999 110.594 176.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . 0.403 ' HB2' ' OG1' ' A' ' 612' ' ' THR . 15.8 Cg_exo -70.06 134.24 26.9 Favored 'Trans proline' 0 C--O 1.248 0.994 0 C-N-CA 121.731 1.621 . . . . 72.420000000000002 113.152 -177.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -68.56 134.32 49.83 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.678 -0.692 . . . . 75.299999999999997 110.724 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 86.48 -1.62 87.31 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.674 -0.774 . . . . 33.329999999999998 111.75 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 612' ' ' THR . . . . . 0.403 ' OG1' ' HB2' ' A' ' 609' ' ' PRO . 19.8 m -105.52 161.04 14.69 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 108.26 -1.015 . . . . 74.409999999999997 108.26 -178.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -73.17 129.99 13.24 Favored Glycine 0 N--CA 1.432 -1.575 0 N-CA-C 111.877 -0.489 . . . . 62.329999999999998 111.877 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 34.0 m -118.44 144.12 27.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.922 -0.77 . . . . 64.439999999999998 108.922 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . 0.432 ' ND2' ' HB3' ' A' ' 617' ' ' ASP . 27.4 p-10 -43.6 155.59 0.07 Allowed 'General case' 0 C--O 1.216 -0.699 0 C-N-CA 124.73 1.212 . . . . 73.019999999999996 113.158 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -56.24 -25.92 49.45 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.048 0.758 . . . . 75.230000000000004 113.048 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . 0.432 ' HB3' ' ND2' ' A' ' 615' ' ' ASN . 30.8 t70 -65.83 -37.94 87.55 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.262 -0.644 . . . . 74.450000000000003 109.262 174.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 85.69 21.56 53.15 Favored Glycine 0 N--CA 1.424 -2.14 0 CA-C-N 115.681 -0.69 . . . . 61.409999999999997 112.182 176.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.44 118.52 12.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 122.448 1.118 . . . . 63.130000000000003 110.404 -169.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.97 124.55 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.946 0 N-CA-C 106.976 -1.49 . . . . 74.299999999999997 106.976 -177.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.421 ' HB ' ' CB ' ' A' ' 607' ' ' ASN . 3.0 m -105.36 127.39 52.94 Favored 'General case' 0 N--CA 1.42 -1.944 0 C-N-CA 120.492 -0.483 . . . . 73.5 109.908 -177.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.0 mp -120.98 149.81 42.09 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 105.434 -2.062 . . . . 72.329999999999998 105.434 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -137.53 148.16 45.74 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 107.615 -1.254 . . . . 73.530000000000001 107.615 173.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -123.78 167.6 13.82 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 107.713 -1.217 . . . . 74.319999999999993 107.713 -177.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -67.0 -105.19 0.02 OUTLIER Glycine 0 CA--C 1.533 1.157 0 O-C-N 123.927 0.767 . . . . 74.109999999999999 111.824 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 . . . . . 0 C--N 1.296 -1.751 0 CA-C-O 118.575 -0.726 . . . . 73.299999999999997 109.185 177.032 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.486 0 N-CA-C 110.061 -1.216 . . . . 51.140000000000001 110.061 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 10.1 tp -77.35 125.03 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.785 0 CA-C-O 121.869 0.842 . . . . 72.310000000000002 111.627 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 24.3 m -144.66 152.39 40.39 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 104.797 -2.297 . . . . 73.420000000000002 104.797 177.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . 0.338 0.0 OUTLIER -87.78 72.69 9.4 Favored 'General case' 0 CA--C 1.492 -1.253 0 CA-C-O 122.763 1.268 . . . . 73.349999999999994 112.445 -178.278 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -92.33 148.57 22.03 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 113.123 -1.853 . . . . 72.129999999999995 106.847 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 28.4 m -116.8 149.67 18.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.231 0 C-N-CA 120.538 -0.465 . . . . 70.319999999999993 110.417 -173.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . 0.552 ' NE2' ' HA ' ' A' ' 407' ' ' ASN . 0.8 OUTLIER -93.9 128.98 40.48 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 105.172 -2.159 . . . . 73.340000000000003 105.172 -179.072 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 92.9 t -95.43 122.37 59.52 Favored Pre-proline 0 C--N 1.28 -2.435 0 CA-C-N 115.266 -0.879 . . . . 71.239999999999995 110.864 -167.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -61.94 125.61 16.93 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 122.312 2.008 . . . . 74.230000000000004 110.163 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . 0.422 ' HB2' ' HG3' ' A' ' 366' ' ' ARG . 3.7 p-10 -71.85 125.87 28.28 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.339 -0.846 . . . . 71.430000000000007 109.714 -176.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 17.9 t -98.33 0.11 10.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-O 122.085 0.945 . . . . 75.0 108.728 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.422 ' HG3' ' HB2' ' A' ' 364' ' ' ASP 0.298 0.0 OUTLIER -64.96 146.6 54.77 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.963 -1.017 . . . . 73.200000000000003 113.047 179.325 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.26 -9.34 45.81 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 109.806 -1.318 . . . . 72.150000000000006 109.806 -172.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -110.7 -163.53 0.86 Allowed 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 107.35 -1.352 . . . . 71.230000000000004 107.35 178.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 76.2 p -86.87 160.42 18.74 Favored 'General case' 0 C--N 1.286 -2.157 0 O-C-N 121.865 -0.522 . . . . 71.319999999999993 111.602 -170.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 34.2 p -58.95 -46.43 88.03 Favored 'General case' 0 N--CA 1.435 -1.208 0 O-C-N 123.622 0.576 . . . . 41.240000000000002 110.6 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.85 -46.79 80.41 Favored 'General case' 0 C--O 1.214 -0.797 0 CA-C-N 116.235 -0.439 . . . . 75.420000000000002 111.667 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -67.63 -37.74 82.9 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.259 0.552 . . . . 74.219999999999999 111.259 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -69.46 -48.53 60.53 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.619 -0.719 . . . . 72.230000000000004 111.318 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 89.0 mt -64.9 -42.11 93.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 CA-C-N 116.449 -0.341 . . . . 70.329999999999998 110.922 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.95 -45.57 90.15 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 120.717 0.294 . . . . 72.230000000000004 111.348 -178.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 32.7 m -64.38 -47.57 78.75 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.998 -0.546 . . . . 73.409999999999997 111.147 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.1 -38.74 92.16 Favored 'General case' 0 C--O 1.24 0.597 0 O-C-N 122.094 -0.379 . . . . 71.409999999999997 111.709 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -63.43 -42.12 98.69 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.986 -0.552 . . . . 73.540000000000006 110.189 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -67.89 -28.13 67.25 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 112.027 0.381 . . . . 75.549999999999997 112.027 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -79.96 -15.7 56.75 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.494 -0.482 . . . . 72.439999999999998 110.253 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 96.07 15.89 40.28 Favored Glycine 0 N--CA 1.434 -1.461 0 C-N-CA 120.289 -0.957 . . . . 71.340000000000003 113.021 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -77.75 143.06 38.3 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 108.667 -0.864 . . . . 72.219999999999999 108.667 175.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -84.64 131.86 34.55 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 105.805 -1.924 . . . . 74.219999999999999 105.805 176.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 2.4 pp -130.83 138.24 54.05 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 CA-C-O 121.85 0.833 . . . . 74.510000000000005 113.23 -175.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -113.8 141.28 47.49 Favored 'General case' 0 C--N 1.276 -2.588 0 N-CA-C 107.053 -1.462 . . . . 74.129999999999995 107.053 175.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 20.9 m -122.37 121.16 36.02 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 108.127 -1.064 . . . . 72.109999999999999 108.127 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -111.61 127.82 55.86 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.819 -1.178 . . . . 72.5 107.819 -176.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -93.04 131.91 37.63 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.925 0.393 . . . . 73.439999999999998 111.504 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . 0.573 ' O ' ' HA ' ' A' ' 421' ' ' SER . 71.6 mmtt -126.36 132.91 24.49 Favored Pre-proline 0 C--N 1.304 -1.393 0 CA-C-N 115.797 -0.638 . . . . 72.409999999999997 109.465 175.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . 0.736 ' HA ' ' O ' ' A' ' 422' ' ' THR . 12.2 Cg_exo -72.37 140.26 33.21 Favored 'Trans proline' 0 C--O 1.247 0.95 0 C-N-CA 122.177 1.918 . . . . 74.129999999999995 109.901 175.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . 0.324 3.8 p30 -73.97 118.87 17.43 Favored 'General case' 0 CA--C 1.466 -2.26 0 C-N-CA 118.187 -1.405 . . . . 75.030000000000001 114.172 -178.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.621 ' O ' ' HB ' ' A' ' 393' ' ' THR . 50.1 m -143.94 81.69 1.69 Allowed 'General case' 0 N--CA 1.39 -3.462 0 N-CA-C 105.335 -2.098 . . . . 72.239999999999995 105.335 166.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.621 ' HB ' ' O ' ' A' ' 392' ' ' SER . 85.5 m 96.52 2.52 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 113.961 -1.472 . . . . 75.219999999999999 110.98 174.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 5.6 pt -104.92 151.58 39.44 Favored Pre-proline 0 C--N 1.291 -1.971 0 CA-C-N 114.843 -1.072 . . . . 71.049999999999997 109.341 176.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.56 -172.94 1.33 Allowed 'Trans proline' 0 CA--C 1.563 1.962 0 C-N-CA 123.305 2.67 . . . . 61.219999999999999 113.927 -172.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -55.17 163.16 4.76 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 123.277 2.651 . . . . 75.230000000000004 112.018 172.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -56.02 -8.5 0.46 Allowed 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 125.43 1.492 . . . . 73.430000000000007 112.929 -174.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 50.0 m170 -64.88 121.57 14.93 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 107.187 -1.412 . . . . 73.200000000000003 107.187 175.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 29.6 m -68.7 117.92 11.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 115.167 -0.924 . . . . 73.120000000000005 110.927 -168.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . 0.449 ' O ' HD11 ' A' ' 400' ' ' ILE . 0.0 OUTLIER -92.52 -29.34 4.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 115.989 -0.551 . . . . 75.310000000000002 110.265 -174.677 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.55 160.53 28.11 Favored Glycine 0 N--CA 1.417 -2.592 0 C-N-CA 119.528 -1.32 . . . . 74.040000000000006 112.409 -174.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.42 ' OG1' ' HG2' ' A' ' 366' ' ' ARG . 2.9 p -145.01 -176.83 5.24 Favored 'General case' 0 C--N 1.283 -2.321 0 C-N-CA 125.963 1.705 . . . . 64.540000000000006 107.72 -176.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -99.52 138.19 20.42 Favored Pre-proline 0 C--N 1.291 -1.977 0 N-CA-C 107.718 -1.216 . . . . 75.310000000000002 107.718 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -48.11 -15.04 0.35 Allowed 'Trans proline' 0 C--N 1.364 1.375 0 C-N-CA 124.758 3.638 . . . . 73.409999999999997 115.509 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -52.73 -43.7 65.9 Favored 'General case' 0 C--O 1.213 -0.866 0 N-CA-C 109.947 -0.39 . . . . 70.239999999999995 109.947 176.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -65.96 -35.19 79.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.622 0.725 . . . . 75.329999999999998 109.887 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . 0.552 ' HA ' ' NE2' ' A' ' 361' ' ' GLN . 17.0 m120 -84.64 1.69 45.07 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.209 -0.905 . . . . 73.540000000000006 111.378 -177.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 29.6 m -109.27 167.51 10.06 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.324 -1.732 . . . . 74.109999999999999 106.324 174.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 15.9 m -76.56 112.79 13.48 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 108.615 -0.883 . . . . 75.299999999999997 108.615 175.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 14.2 m -122.13 170.39 12.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 120.807 0.337 . . . . 73.5 111.703 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 2.7 m -56.1 141.61 39.73 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.144 -0.935 . . . . 62.25 110.501 -178.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -66.56 109.69 2.89 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.058 -1.089 . . . . 74.409999999999997 108.058 176.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 86.51 42.7 6.41 Favored Glycine 0 N--CA 1.433 -1.536 0 N-CA-C 110.708 -0.957 . . . . 43.340000000000003 110.708 -176.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -79.94 -171.91 3.13 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.805 -0.813 . . . . 72.340000000000003 108.805 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -108.41 112.68 25.22 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 122.882 0.473 . . . . 73.400000000000006 110.412 -176.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 49.1 mm -116.57 137.47 50.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 109.575 -0.528 . . . . 73.530000000000001 109.575 -177.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 14.0 t -111.56 131.77 55.01 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.773 -0.825 . . . . 74.400000000000006 108.773 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 5.9 p -115.75 135.26 56.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.616 -0.512 . . . . 72.510000000000005 109.616 -177.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -100.8 128.6 46.78 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.277 -0.638 . . . . 74.150000000000006 109.277 178.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 8.3 p -126.3 137.31 58.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.794 -0.639 . . . . 73.519999999999996 109.871 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 2.3 p -92.59 120.68 33.28 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-O 122.024 0.916 . . . . 70.0 112.017 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' THR . . . . . 0.736 ' O ' ' HA ' ' A' ' 390' ' ' PRO . 6.2 t -122.46 155.0 37.05 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 108.095 -1.076 . . . . 72.120000000000005 108.095 174.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 79.59 99.37 0.27 Allowed Glycine 0 C--N 1.307 -1.029 0 C-N-CA 119.984 -1.103 . . . . 42.100000000000001 113.643 174.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.38 152.8 75.19 Favored 'Trans proline' 0 C--O 1.253 1.235 0 C-N-CA 122.868 2.379 . . . . 75.209999999999994 112.517 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -72.46 164.41 26.43 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.24 -0.891 . . . . 72.340000000000003 112.537 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -135.2 160.61 37.82 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 114.529 -1.214 . . . . 75.450000000000003 108.279 -175.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.43 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 2.2 mmp_? -119.82 138.16 53.54 Favored 'General case' 0 CA--C 1.492 -1.268 0 CA-C-O 121.147 0.498 . . . . 75.409999999999997 109.938 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -88.16 136.28 33.04 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.493 -0.776 . . . . 71.010000000000005 109.489 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 59.5 mt -80.67 130.71 63.32 Favored Pre-proline 0 C--N 1.298 -1.661 0 CA-C-N 115.854 -0.612 . . . . 71.329999999999998 109.368 -177.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -71.71 141.77 38.34 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 121.877 1.718 . . . . 63.25 110.736 170.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -82.84 111.53 18.83 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.901 -1.148 . . . . 65.430000000000007 107.901 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 60.9 t -103.5 143.46 15.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.137 -1.06 . . . . 74.420000000000002 108.137 -175.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 15.8 m -60.41 155.06 18.97 Favored 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 112.632 0.604 . . . . 74.540000000000006 112.632 -176.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 21.9 p -69.14 -24.98 64.16 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 115.339 1.607 . . . . 74.239999999999995 115.339 -170.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.1 pp -90.3 -11.6 40.3 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.953 0.883 . . . . 72.239999999999995 110.414 177.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.95 34.43 2.3 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 114.914 -1.039 . . . . 74.310000000000002 109.643 -175.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -55.84 -38.33 69.9 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.172 0.989 . . . . 75.120000000000005 113.028 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.46 -36.78 84.88 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.868 0.842 . . . . 64.239999999999995 110.102 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . 0.499 ' OE2' ' HD2' ' A' ' 442' ' ' LYS . 24.9 tp10 -70.92 -35.4 72.23 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.121 -0.945 . . . . 74.0 109.336 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.552 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -63.63 -50.55 68.89 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.001 -0.545 . . . . 61.240000000000002 110.988 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 31.2 m -62.1 -38.67 81.45 Favored 'Isoleucine or valine' 0 C--O 1.25 1.129 0 N-CA-C 112.606 0.595 . . . . 74.340000000000003 112.606 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.499 ' HD2' ' OE2' ' A' ' 439' ' ' GLU . 17.4 ptpt -67.93 -38.44 82.88 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 120.061 -0.656 . . . . 71.519999999999996 109.973 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -62.76 -38.56 91.07 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.336 -0.393 . . . . 75.319999999999993 110.924 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 77.8 mt -63.42 -37.66 88.13 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.933 -0.576 . . . . 75.140000000000001 109.453 177.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 41.0 m -69.93 -43.2 72.12 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.278 -0.873 . . . . 53.039999999999999 110.321 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -65.72 -27.37 68.28 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.048 0.539 . . . . 71.299999999999997 111.707 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.7 -13.56 59.38 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.477 -0.329 . . . . 64.329999999999998 111.459 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 130.05 -81.27 0.34 Allowed Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 120.868 -0.682 . . . . 74.25 111.749 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -36.64 -68.9 0.12 Allowed 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 115.003 1.483 . . . . 74.549999999999997 115.003 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 59.65 35.15 84.96 Favored Glycine 0 C--N 1.318 -0.463 0 C-N-CA 121.007 -0.616 . . . . 72.310000000000002 112.551 -177.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.407 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 36.1 mmt180 -107.2 110.95 23.14 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.516 -1.29 . . . . 75.019999999999996 107.516 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -143.97 146.57 33.01 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 121.087 0.47 . . . . 74.340000000000003 111.532 -173.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -131.58 148.35 52.61 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 115.421 -0.809 . . . . 72.409999999999997 109.215 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -113.64 125.94 54.71 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.798 -0.816 . . . . 75.439999999999998 108.798 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -126.17 137.22 53.55 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.923 -1.14 . . . . 73.349999999999994 107.923 176.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . 0.508 ' HB2' ' OG ' ' A' ' 490' ' ' SER . 8.3 p30 -114.25 144.64 42.9 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 109.29 -0.633 . . . . 74.140000000000001 109.29 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 50.9 m -148.69 148.59 28.44 Favored Pre-proline 0 C--N 1.296 -1.734 0 N-CA-C 108.507 -0.923 . . . . 75.409999999999997 108.507 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.654 ' HA ' ' O ' ' A' ' 490' ' ' SER . 19.6 Cg_endo -64.33 125.49 15.19 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.189 1.926 . . . . 74.129999999999995 112.238 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 49.7 m -133.49 179.53 6.16 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.187 -1.042 . . . . 72.129999999999995 108.187 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.8 t -59.1 137.38 88.06 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 109.907 -0.405 . . . . 72.530000000000001 109.907 176.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -51.27 -29.74 30.92 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 124.528 3.485 . . . . 75.420000000000002 113.228 -176.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -72.99 -23.61 60.67 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.555 0.576 . . . . 65.340000000000003 112.555 -178.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 67.0 mt -101.42 -3.3 28.93 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.669 0.248 . . . . 74.209999999999994 111.669 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.414 HG12 ' HA ' ' A' ' 490' ' ' SER . 76.9 t -60.12 128.96 21.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 116.089 -0.505 . . . . 74.530000000000001 110.489 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.48 -11.76 59.77 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 115.742 -0.663 . . . . 64.25 112.392 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -114.04 165.81 12.25 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 109.355 -0.609 . . . . 74.239999999999995 109.355 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 71.1 t -74.33 146.22 10.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 116.062 -0.517 . . . . 75.510000000000005 109.832 177.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 49.3 mm -98.18 -35.11 4.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 107.839 -1.171 . . . . 72.140000000000001 107.839 177.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 169.61 -179.49 42.05 Favored Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 110.813 -0.915 . . . . 63.530000000000001 110.813 177.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 470' ' ' THR . . . . . 0.4 HG23 HG12 ' A' ' 486' ' ' ILE . 61.4 p -115.49 141.85 47.5 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 105.171 -2.159 . . . . 64.549999999999997 105.171 176.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.425 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 25.2 t-20 -69.1 -53.78 13.21 Favored Pre-proline 0 C--N 1.319 -0.733 0 C-N-CA 118.882 -1.127 . . . . 73.239999999999995 111.692 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.425 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 8.5 Cg_exo -76.61 139.88 20.68 Favored 'Trans proline' 0 C--N 1.364 1.389 0 N-CA-C 107.621 -1.723 . . . . 73.319999999999993 107.621 170.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.93 126.76 18.75 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.043 1.829 . . . . 71.430000000000007 112.461 -175.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -86.48 19.13 2.93 Favored 'General case' 0 C--O 1.206 -1.221 0 CA-C-N 115.111 -0.95 . . . . 74.099999999999994 109.797 -177.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -110.01 -13.64 14.37 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.449 -0.796 . . . . 72.530000000000001 109.563 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -93.18 168.87 10.82 Favored 'General case' 0 C--O 1.247 0.954 0 N-CA-C 114.396 1.258 . . . . 72.340000000000003 114.396 -170.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -82.79 109.5 16.99 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-N 113.6 -1.636 . . . . 73.430000000000007 108.296 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 64.7 m -104.97 145.7 30.06 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-O 121.465 0.65 . . . . 73.430000000000007 111.5 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -84.68 169.42 14.33 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 107.566 -1.272 . . . . 72.450000000000003 107.566 175.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 34.6 mm -72.46 -11.07 14.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 122.078 0.942 . . . . 74.409999999999997 110.356 -177.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 4.5 p -97.68 5.19 49.66 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.585 -0.734 . . . . 73.319999999999993 112.462 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -81.11 129.54 34.61 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 122.081 -0.387 . . . . 74.540000000000006 111.705 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . 0.407 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.1 p -108.64 125.93 65.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.817 -0.628 . . . . 71.120000000000005 109.88 176.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . 0.424 ' HA ' ' HG2' ' A' ' 472' ' ' PRO . 27.3 m -106.02 120.46 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 CA-C-O 121.941 0.877 . . . . 72.319999999999993 112.23 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.86 121.52 43.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.415 -1.328 . . . . 75.010000000000005 107.415 175.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . 0.4 HG12 HG23 ' A' ' 470' ' ' THR . 35.1 mt -114.35 128.75 71.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.044 -0.98 . . . . 73.340000000000003 111.379 -174.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 5.8 tt -101.87 126.56 55.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 116.031 -0.531 . . . . 73.329999999999998 110.649 -176.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 28.0 m -108.38 151.35 10.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 123.435 0.694 . . . . 73.230000000000004 109.893 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -84.14 128.9 8.86 Favored Glycine 0 N--CA 1.434 -1.465 0 C-N-CA 120.97 -0.633 . . . . 74.109999999999999 111.731 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.654 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 49.1 m -129.8 160.74 32.55 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.725 -0.842 . . . . 63.520000000000003 108.725 178.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 152.79 173.49 22.25 Favored Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 110.186 -1.166 . . . . 72.420000000000002 110.186 179.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -93.2 155.6 2.59 Favored 'Trans proline' 0 N--CA 1.442 -1.53 0 C-N-CA 122.661 2.241 . . . . 75.040000000000006 112.32 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -108.56 77.06 1.06 Allowed 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.661 -0.866 . . . . 75.040000000000006 108.661 177.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 19.1 p -117.86 144.9 45.0 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 114.911 -1.04 . . . . 54.009999999999998 110.918 -176.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -150.25 165.13 33.9 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 112.124 0.416 . . . . 73.120000000000005 112.124 175.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.79 133.74 36.32 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 107.399 -1.334 . . . . 74.239999999999995 107.399 -178.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 39.5 pt -78.85 133.16 62.41 Favored Pre-proline 0 C--N 1.294 -1.841 0 C-N-CA 120.137 -0.625 . . . . 75.219999999999999 109.968 175.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.84 -179.35 5.38 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.782 2.322 . . . . 75.099999999999994 111.893 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -108.68 141.49 40.57 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.911 -0.774 . . . . 74.319999999999993 108.911 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . 0.402 ' O ' ' HA2' ' A' ' 536' ' ' GLY . 4.8 p -143.95 103.58 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 CA-C-O 121.555 0.693 . . . . 74.319999999999993 110.137 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -141.71 106.71 4.94 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.181 -0.918 . . . . 53.200000000000003 109.219 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 123.13 -16.13 8.17 Favored Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 120.173 -1.013 . . . . 74.109999999999999 111.376 178.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -89.74 173.45 8.27 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.854 -0.424 . . . . 74.430000000000007 109.854 177.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 13.9 t -91.79 157.74 16.72 Favored 'General case' 0 N--CA 1.425 -1.707 0 C-N-CA 119.771 -0.772 . . . . 71.329999999999998 109.984 -176.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 9.5 p -53.27 -41.19 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 124.229 1.012 . . . . 74.200000000000003 112.158 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -62.57 -41.98 99.27 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.128 0.49 . . . . 63.420000000000002 111.2 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 86.3 t -71.79 -37.35 61.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-N 116.092 -0.504 . . . . 72.430000000000007 110.513 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . 0.457 ' O ' HD22 ' A' ' 512' ' ' LEU . . . -61.5 -49.12 78.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.835 -0.62 . . . . 72.219999999999999 111.242 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -60.23 -46.91 88.16 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.019 0.438 . . . . 74.030000000000001 110.72 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.443 ' O ' HG21 ' A' ' 514' ' ' VAL . 55.8 tptt -65.44 -49.97 67.17 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 113.027 0.751 . . . . 74.420000000000002 113.027 -174.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -63.07 -37.76 88.5 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 120.142 -0.623 . . . . 71.540000000000006 110.45 -175.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . 0.457 HD22 ' O ' ' A' ' 508' ' ' ALA . 4.6 mm? -62.75 -43.3 99.15 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 116.551 -0.295 . . . . 64.0 111.007 175.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -62.98 -38.25 90.41 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 120.987 0.422 . . . . 61.409999999999997 110.699 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.443 HG21 ' O ' ' A' ' 510' ' ' LYS . 81.2 t -62.96 -34.25 65.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.562 -0.745 . . . . 71.439999999999998 110.554 177.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -85.27 3.2 40.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.89 0.376 . . . . 72.409999999999997 111.12 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . 0.533 ' O ' ' HB ' ' A' ' 547' ' ' VAL . . . 109.62 -20.84 26.81 Favored Glycine 0 N--CA 1.437 -1.289 0 C-N-CA 120.827 -0.701 . . . . 61.539999999999999 113.811 174.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -77.32 98.58 5.24 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.437 -1.319 . . . . 73.540000000000006 107.437 -175.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.91 -17.11 30.27 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.592 -0.731 . . . . 71.329999999999998 112.307 -169.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 28.1 mtpp -112.18 122.15 46.95 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.168 0.509 . . . . 71.540000000000006 111.604 -176.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -129.77 152.44 49.26 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.496 -0.775 . . . . 74.25 110.725 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.9 m -141.39 152.68 44.53 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 108.134 -1.061 . . . . 70.239999999999995 108.134 173.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . 0.426 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 4.1 pt20 -117.19 151.07 37.66 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-O 121.365 0.602 . . . . 71.120000000000005 111.199 -178.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 554' ' ' GLN . . . -132.79 118.69 19.33 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.23 -1.396 . . . . 54.409999999999997 107.23 174.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 11.7 p -85.92 128.86 34.93 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.013 0.435 . . . . 61.130000000000003 111.341 -177.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 28.7 m -127.3 160.02 36.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 109.485 -0.561 . . . . 73.340000000000003 109.485 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -72.76 136.18 45.44 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.565 -0.531 . . . . 72.450000000000003 109.565 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 52.1 m -152.58 161.92 27.91 Favored Pre-proline 0 C--N 1.304 -1.38 0 O-C-N 121.958 -0.464 . . . . 71.219999999999999 110.58 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -84.4 -2.55 9.98 Favored 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 122.392 2.061 . . . . 75.409999999999997 110.322 173.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . 0.415 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 23.3 mmt180 -84.73 145.67 44.77 Favored Pre-proline 0 N--CA 1.44 -0.935 0 N-CA-C 106.81 -1.552 . . . . 75.430000000000007 106.81 177.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.88 162.48 41.96 Favored 'Trans proline' 0 C--O 1.246 0.878 0 C-N-CA 122.148 1.899 . . . . 72.519999999999996 111.874 177.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -57.11 126.03 25.35 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.298 -0.864 . . . . 55.130000000000003 111.679 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 116.64 -17.45 13.66 Favored Glycine 0 C--N 1.309 -0.938 0 C-N-CA 120.917 -0.658 . . . . 75.239999999999995 111.903 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -78.18 144.77 36.05 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.346 -0.983 . . . . 61.25 108.346 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 64.0 t -95.03 121.51 45.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 O-C-N 121.675 -0.64 . . . . 74.219999999999999 110.409 176.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 36.6 m -72.59 -40.85 66.25 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 124.588 1.155 . . . . 75.409999999999997 110.85 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 500' ' ' VAL . . . 162.16 -157.31 29.13 Favored Glycine 0 N--CA 1.432 -1.577 0 N-CA-C 110.602 -0.999 . . . . 75.430000000000007 110.602 -178.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 57.7 p -118.89 151.86 37.35 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.046 -0.724 . . . . 63.43 109.046 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -73.24 -54.4 4.28 Favored Pre-proline 0 C--N 1.313 -1.0 0 CA-C-O 119.44 -0.314 . . . . 74.099999999999994 110.712 177.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -74.06 143.24 32.2 Favored 'Trans proline' 0 C--N 1.36 1.164 0 N-CA-C 109.089 -1.158 . . . . 73.420000000000002 109.089 170.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.26 149.82 85.04 Favored 'Trans proline' 0 C--O 1.253 1.241 0 C-N-CA 122.313 2.008 . . . . 73.439999999999998 112.448 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -65.89 144.31 56.88 Favored 'General case' 0 C--O 1.249 1.049 0 N-CA-C 109.574 -0.528 . . . . 64.140000000000001 109.574 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.8 -12.5 57.82 Favored Glycine 0 N--CA 1.423 -2.195 0 C-N-CA 120.23 -0.985 . . . . 74.420000000000002 111.489 -176.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 54.2 m -66.59 120.94 14.28 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.251 -0.648 . . . . 63.299999999999997 109.251 176.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 41.1 m -85.32 122.61 29.74 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 108.614 -0.884 . . . . 64.049999999999997 108.614 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.61 158.26 70.61 Favored Pre-proline 0 C--N 1.311 -1.082 0 N-CA-C 108.834 -0.802 . . . . 73.430000000000007 108.834 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -64.78 149.18 90.04 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.073 1.849 . . . . 74.310000000000002 110.921 174.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.533 ' HB ' ' O ' ' A' ' 516' ' ' GLY . 36.0 m -63.14 -20.14 25.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-O 121.952 0.882 . . . . 73.140000000000001 111.6 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -77.43 -16.16 58.95 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.416 -1.266 . . . . 71.530000000000001 110.768 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 42.3 m -81.79 158.6 24.06 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 121.273 0.559 . . . . 72.400000000000006 111.784 -176.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 92.1 t -89.03 128.74 40.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 115.073 -0.967 . . . . 70.310000000000002 110.159 -178.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -100.05 132.77 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 108.023 -1.102 . . . . 75.140000000000001 108.023 171.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -103.24 115.91 31.46 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-O 121.536 0.684 . . . . 71.450000000000003 111.329 -176.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 1.9 mm? -98.3 133.79 42.21 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.275 -1.329 . . . . 73.310000000000002 109.03 -179.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 523' ' ' ALA . 45.2 mt-30 -97.62 121.79 39.94 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.517 -0.549 . . . . 73.430000000000007 109.517 176.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 48.3 t -103.63 137.53 31.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 115.573 -0.74 . . . . 65.230000000000004 110.373 -173.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.415 ' HB3' ' HB2' ' A' ' 529' ' ' ARG . 22.0 m -69.58 129.47 39.76 Favored 'General case' 0 N--CA 1.427 -1.612 0 C-N-CA 124.071 0.948 . . . . 75.209999999999994 112.211 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -110.57 123.02 49.18 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 106.502 -1.666 . . . . 75.400000000000006 106.502 170.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -80.23 -30.38 41.89 Favored Glycine 0 C--N 1.311 -0.841 0 C-N-CA 120.984 -0.627 . . . . 74.099999999999994 113.845 -172.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 73.52 -2.52 2.73 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.687 1.195 . . . . 73.400000000000006 112.152 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.414 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 87.5 mt-30 -113.25 141.95 46.39 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.767 0.317 . . . . 65.329999999999998 110.859 -176.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -125.41 136.51 53.49 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.026 -0.533 . . . . 74.420000000000002 109.816 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 59.1 t -68.89 116.01 8.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 120.999 0.428 . . . . 65.420000000000002 110.612 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 59.5 ttp -97.1 132.01 26.52 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 109.148 -0.686 . . . . 70.310000000000002 109.148 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.85 168.99 15.61 Favored 'Trans proline' 0 C--O 1.244 0.787 0 C-N-CA 122.255 1.97 . . . . 72.420000000000002 111.045 176.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -89.44 114.99 26.54 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-O 122.291 1.043 . . . . 63.439999999999998 112.395 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 4.5 mp -118.16 7.1 12.06 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 106.188 -1.782 . . . . 74.439999999999998 106.188 171.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 32.5 t -80.34 153.71 28.22 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 113.577 -1.647 . . . . 53.340000000000003 109.946 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 97.71 44.81 2.6 Favored Glycine 0 N--CA 1.432 -1.599 0 N-CA-C 110.293 -1.123 . . . . 60.420000000000002 110.293 -177.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 62.1 mtp -140.79 -176.79 4.79 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.41 -1.33 . . . . 75.329999999999998 107.41 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -97.03 156.41 16.37 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.072 -1.084 . . . . 71.400000000000006 108.072 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -59.01 -29.39 67.22 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 122.987 0.515 . . . . 74.349999999999994 111.204 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 31.4 m -62.57 -23.95 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 116.122 -0.49 . . . . 74.129999999999995 111.302 178.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . 0.525 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 1.3 m-20 -101.13 -25.88 13.87 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-N 115.983 -0.553 . . . . 74.409999999999997 110.524 176.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -72.91 -33.35 65.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.724 -0.671 . . . . 62.43 112.26 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.438 ' O ' ' HB3' ' A' ' 578' ' ' LEU . 32.4 tt0 -60.57 -49.6 89.24 Favored Pre-proline 0 CA--C 1.56 1.363 0 C-N-CA 120.237 -0.585 . . . . 73.549999999999997 111.05 176.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -56.22 -35.65 95.74 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 121.459 1.439 . . . . 75.430000000000007 111.999 171.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . 0.525 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 37.0 mmt180 -59.27 -46.76 87.64 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 109.616 -0.512 . . . . 75.299999999999997 109.616 176.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.438 ' HB3' ' O ' ' A' ' 575' ' ' GLU . 6.6 tt -57.77 -46.62 84.31 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 125.011 1.324 . . . . 74.439999999999998 109.626 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 575' ' ' GLU . 64.8 mtt-85 -65.31 -44.33 88.21 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.072 -0.967 . . . . 74.099999999999994 111.157 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -69.78 -28.26 65.61 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.04 0.448 . . . . 62.439999999999998 112.074 -177.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 97.6 mt -84.35 -8.08 59.11 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.613 -0.267 . . . . 73.420000000000002 110.914 177.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 61.68 42.42 99.75 Favored Glycine 0 CA--C 1.505 -0.579 0 N-CA-C 110.85 -0.9 . . . . 61.350000000000001 110.85 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 83.2 t90 -71.32 135.13 47.23 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.246 0.546 . . . . 75.230000000000004 111.688 -176.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 23.3 m -147.42 102.85 3.5 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 108.365 -0.976 . . . . 60.020000000000003 108.365 174.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -161.64 -124.07 0.7 Allowed Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 111.241 -0.744 . . . . 60.520000000000003 111.241 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -137.5 125.68 23.06 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.926 -0.768 . . . . 74.439999999999998 108.926 177.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 59.9 tp -97.24 117.58 31.77 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.818 -0.808 . . . . 74.109999999999999 108.818 176.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . 0.428 ' OD2' HD12 ' A' ' 619' ' ' ILE . 13.4 m-20 -101.24 101.94 12.73 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.157 -0.683 . . . . 75.0 109.157 174.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -88.04 126.43 35.09 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 106.352 -1.721 . . . . 74.239999999999995 106.352 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -73.67 -151.91 2.12 Favored Glycine 0 C--N 1.302 -1.336 0 CA-C-N 115.828 -0.624 . . . . 52.340000000000003 114.631 -177.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -58.82 143.65 46.74 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.371 0.605 . . . . 75.299999999999997 112.435 -177.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -94.2 124.74 38.41 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.398 -0.964 . . . . 73.310000000000002 108.398 175.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 47.5 t -123.08 117.77 52.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 109.177 -0.675 . . . . 73.040000000000006 109.177 -177.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -80.14 106.71 12.36 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.244 -0.65 . . . . 74.040000000000006 109.244 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -153.52 17.44 0.53 Allowed 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.93 -0.577 . . . . 72.25 110.584 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 99.96 101.53 2.39 Favored Glycine 0 N--CA 1.427 -1.939 0 N-CA-C 110.213 -1.155 . . . . 60.350000000000001 110.213 -175.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -60.9 -40.3 98.14 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-O 119.893 -0.393 . . . . 75.040000000000006 113.387 -176.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 15.6 m -56.99 -33.19 66.88 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.341 0.867 . . . . 73.549999999999997 113.341 -174.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -108.19 -10.59 15.38 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 112.993 0.738 . . . . 74.530000000000001 112.993 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . 0.453 ' C ' ' H ' ' A' ' 602' ' ' ARG . 68.9 m-70 -107.54 14.97 25.26 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.737 0.78 . . . . 75.030000000000001 110.929 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -81.47 15.35 2.09 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.762 -1.108 . . . . 74.409999999999997 108.371 175.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . 0.453 ' H ' ' C ' ' A' ' 600' ' ' HIS . 33.1 ttp180 -97.32 152.09 19.25 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.345 -0.843 . . . . 74.519999999999996 109.064 -175.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 10.0 p -65.26 137.16 25.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 O-C-N 123.45 0.469 . . . . 71.349999999999994 109.959 175.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 92.1 t -102.27 -52.95 7.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 120.36 -0.536 . . . . 73.530000000000001 109.561 177.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -154.07 164.32 38.67 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 107.789 -1.189 . . . . 65.319999999999993 107.789 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . 0.445 ' HA ' ' O ' ' A' ' 621' ' ' THR . 18.6 pt20 -143.88 155.1 43.97 Favored 'General case' 0 C--N 1.314 -0.976 0 O-C-N 124.097 0.873 . . . . 75.340000000000003 109.414 177.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . 0.278 81.8 m-20 -80.64 -55.46 0.72 Allowed Pre-proline 0 C--N 1.312 -1.062 0 N-CA-C 114.306 1.224 . . . . 74.530000000000001 114.306 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -85.85 107.83 0.94 Allowed 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.912 1.741 . . . . 71.519999999999996 109.287 173.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -70.38 144.93 52.15 Favored 'Trans proline' 0 C--O 1.243 0.756 0 C-N-CA 122.846 2.364 . . . . 75.310000000000002 113.467 -176.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -68.67 137.58 54.28 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 108.562 -0.903 . . . . 74.239999999999995 108.562 175.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 99.81 -12.95 60.99 Favored Glycine 0 C--N 1.299 -1.481 0 N-CA-C 110.427 -1.069 . . . . 55.140000000000001 110.427 -175.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 25.8 m -106.78 162.82 13.45 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 107.898 -1.149 . . . . 74.540000000000006 107.898 178.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -72.19 117.18 6.21 Favored Glycine 0 N--CA 1.431 -1.635 0 N-CA-C 110.435 -1.066 . . . . 72.340000000000003 110.435 175.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.7 m -91.29 141.66 14.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.154 0.502 . . . . 75.409999999999997 110.55 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . 0.466 HD22 HG23 ' A' ' 619' ' ' ILE . 8.9 p-10 -58.0 145.41 36.17 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 114.099 -1.409 . . . . 73.109999999999999 112.786 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -57.55 -25.25 59.65 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.483 1.113 . . . . 71.450000000000003 111.39 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -59.78 -45.26 92.84 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 115.351 -0.84 . . . . 74.200000000000003 109.261 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 79.12 12.17 84.32 Favored Glycine 0 N--CA 1.412 -2.915 0 N-CA-C 110.159 -1.176 . . . . 72.129999999999995 110.159 -175.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . 0.476 HD13 ' N ' ' A' ' 620' ' ' ILE . 0.0 OUTLIER -70.39 126.29 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 108.335 -0.987 . . . . 73.519999999999996 108.335 -176.594 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . 0.476 ' N ' HD13 ' A' ' 619' ' ' ILE . 7.5 tp -126.54 129.91 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.675 0 CA-C-N 115.645 -0.707 . . . . 74.230000000000004 110.991 -174.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 606' ' ' GLN . 39.7 m -104.66 127.19 52.34 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.27 -1.011 . . . . 74.310000000000002 108.27 175.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 96.0 mt -138.0 150.79 47.3 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 108.558 -0.905 . . . . 73.0 108.558 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -128.24 136.98 51.79 Favored 'General case' 0 C--N 1.278 -2.506 0 N-CA-C 107.295 -1.372 . . . . 74.200000000000003 107.295 172.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -141.9 165.61 26.99 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 104.42 -2.437 . . . . 75.040000000000006 104.42 170.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -61.26 -100.08 0.01 OUTLIER Glycine 0 C--N 1.301 -1.374 0 O-C-N 124.056 0.847 . . . . 73.109999999999999 113.683 -174.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . 0.405 HE21 ' HA ' ' A' ' 626' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.291 -1.941 0 N-CA-C 108.123 -1.066 . . . . 75.439999999999998 108.123 178.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.823 0 N-CA-C 110.939 -0.864 . . . . 61.25 110.939 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 8.9 tp -74.73 151.61 6.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 C-N-CA 123.146 0.578 . . . . 74.299999999999997 110.181 -177.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 1.6 m -61.33 148.65 40.61 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.745 -0.835 . . . . 71.120000000000005 108.745 178.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . 0.422 ' HD2' ' N ' ' A' ' 358' ' ' ARG . 3.3 mpt_? -100.11 70.81 1.58 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.316 -0.624 . . . . 74.200000000000003 109.316 -176.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -98.7 146.4 25.91 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 108.504 -0.925 . . . . 75.540000000000006 108.504 178.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 34.5 m -117.24 145.92 22.39 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 108.896 -0.779 . . . . 61.039999999999999 108.896 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -95.35 121.5 37.08 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 106.01 -1.848 . . . . 75.150000000000006 106.01 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 63.7 t -97.39 121.58 58.13 Favored Pre-proline 0 C--N 1.291 -1.94 0 CA-C-N 114.942 -1.026 . . . . 73.219999999999999 110.849 -171.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.5 158.26 46.5 Favored 'Trans proline' 0 C--O 1.242 0.688 0 C-N-CA 122.217 1.944 . . . . 71.400000000000006 110.229 177.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -103.42 168.85 8.9 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 120.355 -0.538 . . . . 73.420000000000002 109.898 -173.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 9.9 t -128.61 2.57 2.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-O 121.638 0.732 . . . . 74.409999999999997 109.15 -177.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.522 ' HD3' ' OG1' ' A' ' 402' ' ' THR . 16.8 ptt-85 -58.2 144.46 40.66 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.439 0.638 . . . . 75.010000000000005 111.723 178.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.4 -7.11 50.62 Favored Glycine 0 N--CA 1.425 -2.041 0 CA-C-N 115.004 -0.998 . . . . 72.420000000000002 111.607 -178.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -109.76 -87.89 0.51 Allowed 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 113.018 0.747 . . . . 74.439999999999998 113.018 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 81.3 p -159.44 159.51 33.7 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 109.213 -0.662 . . . . 73.510000000000005 109.213 -175.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 46.4 t -63.12 -40.5 97.78 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.788 -0.819 . . . . 73.310000000000002 108.788 175.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -63.92 -47.15 81.68 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 118.997 -0.525 . . . . 72.030000000000001 112.188 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -69.77 -35.88 75.28 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 119.721 -0.792 . . . . 75.349999999999994 110.607 -178.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -64.87 -51.26 62.99 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.789 -0.641 . . . . 62.299999999999997 109.935 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 68.5 mt -60.98 -46.27 96.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.687 -0.233 . . . . 64.209999999999994 110.591 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.83 -44.45 90.89 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 116.073 -0.512 . . . . 72.420000000000002 112.065 -176.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 28.3 m -67.67 -48.95 65.18 Favored 'General case' 0 C--O 1.249 1.067 0 CA-C-O 120.865 0.364 . . . . 74.099999999999994 111.068 -177.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.04 -40.44 94.79 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.092 0.404 . . . . 73.030000000000001 112.092 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.62 -36.62 83.03 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.263 -0.426 . . . . 74.0 110.484 -177.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -70.16 -24.71 63.2 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 120.721 0.296 . . . . 71.239999999999995 111.727 176.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -86.91 -8.69 57.02 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.087 0.47 . . . . 74.540000000000006 111.389 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 97.83 4.15 57.96 Favored Glycine 0 C--N 1.309 -0.922 0 C-N-CA 120.378 -0.915 . . . . 73.450000000000003 112.306 176.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -79.91 148.37 31.29 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 109.129 -0.693 . . . . 72.310000000000002 109.129 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -95.01 132.67 39.62 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 107.704 -1.221 . . . . 75.129999999999995 107.704 -177.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 1.4 pp -118.83 131.07 72.68 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 CA-C-O 121.755 0.788 . . . . 75.230000000000004 112.688 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -113.15 127.6 56.24 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 107.881 -1.155 . . . . 71.450000000000003 107.881 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 27.5 m -119.38 128.1 53.75 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 109.968 -0.382 . . . . 75.340000000000003 109.968 -177.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -111.3 119.76 39.97 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.645 -0.872 . . . . 75.099999999999994 108.645 176.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.462 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -100.57 122.72 43.72 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.054 -0.721 . . . . 74.310000000000002 109.054 179.502 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -119.63 134.36 23.86 Favored Pre-proline 0 C--N 1.293 -1.877 0 CA-C-N 115.96 -0.564 . . . . 72.430000000000007 110.004 -177.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . 0.48 ' O ' HD13 ' A' ' 394' ' ' ILE . 11.1 Cg_exo -72.52 157.47 52.73 Favored 'Trans proline' 0 C--O 1.248 0.979 0 C-N-CA 121.935 1.757 . . . . 73.099999999999994 110.116 175.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 32.7 t70 88.34 152.6 0.05 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 125.267 1.427 . . . . 73.099999999999994 111.938 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 17.9 m -101.5 13.0 36.32 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 113.262 0.838 . . . . 73.329999999999998 113.262 -174.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 26.9 m -76.03 -25.93 56.13 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.654 -1.239 . . . . 74.299999999999997 107.654 172.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . 0.48 HD13 ' O ' ' A' ' 390' ' ' PRO . 0.0 OUTLIER -88.82 149.45 43.71 Favored Pre-proline 0 N--CA 1.433 -1.313 0 CA-C-N 114.764 -1.107 . . . . 73.310000000000002 108.67 172.524 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.31 133.66 41.5 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.198 2.599 . . . . 74.230000000000004 114.709 -174.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -55.5 163.03 5.47 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 124.268 3.312 . . . . 72.019999999999996 111.934 175.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -56.47 -8.1 0.49 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.729 0.812 . . . . 75.310000000000002 113.165 -175.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 32.7 m170 -83.26 104.21 13.25 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 105.248 -2.13 . . . . 74.299999999999997 105.248 168.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 25.2 m -64.92 120.18 11.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 CA-C-N 114.798 -1.092 . . . . 72.340000000000003 111.216 -168.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 9.8 tp -98.17 -29.22 3.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 120.519 -0.472 . . . . 73.409999999999997 110.244 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.81 157.98 27.53 Favored Glycine 0 N--CA 1.428 -1.861 0 N-CA-C 110.867 -0.893 . . . . 75.400000000000006 110.867 -177.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.522 ' OG1' ' HD3' ' A' ' 366' ' ' ARG . 17.3 p -139.43 -177.69 5.05 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 124.213 1.005 . . . . 73.0 109.246 -177.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . 0.42 ' HA ' ' HD3' ' A' ' 404' ' ' PRO . 16.8 t70 -101.17 133.48 20.93 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 107.342 -1.355 . . . . 71.340000000000003 107.342 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 403' ' ' ASP . 17.4 Cg_exo -67.76 11.02 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 123.473 2.782 . . . . 71.409999999999997 115.147 -173.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.86 -49.12 71.92 Favored 'General case' 0 C--O 1.216 -0.686 0 N-CA-C 109.756 -0.461 . . . . 52.420000000000002 109.756 176.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -69.82 -30.96 68.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.522 0.677 . . . . 64.329999999999998 110.239 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -76.8 -6.67 53.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.741 0.781 . . . . 74.430000000000007 110.354 -176.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 31.9 m -101.73 155.97 17.79 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 106.337 -1.727 . . . . 74.109999999999999 106.337 174.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 46.0 m -74.49 112.06 10.29 Favored 'General case' 0 N--CA 1.415 -2.197 0 N-CA-C 107.485 -1.302 . . . . 61.43 107.485 177.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 24.2 m -128.33 162.13 35.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 110.274 -0.269 . . . . 73.299999999999997 110.274 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 11.4 m -67.14 131.65 46.23 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.75 -0.833 . . . . 74.099999999999994 108.75 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -59.94 136.94 58.17 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 112.719 0.637 . . . . 73.420000000000002 112.719 -174.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 88.92 49.36 3.59 Favored Glycine 0 N--CA 1.434 -1.497 0 CA-C-N 114.887 -1.051 . . . . 71.409999999999997 111.599 -178.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -103.64 -173.66 2.36 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.688 -0.856 . . . . 75.150000000000006 108.688 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -109.08 120.66 43.19 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 123.274 0.629 . . . . 74.319999999999993 110.009 -176.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 48.6 mm -110.7 122.47 65.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 109.086 -0.709 . . . . 73.140000000000001 109.086 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 41.6 m -101.46 131.15 47.73 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.86 0.362 . . . . 72.409999999999997 111.301 -178.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 4.8 p -126.58 135.94 62.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 123.829 0.852 . . . . 75.230000000000004 109.643 -179.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -113.75 125.34 54.0 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.181 0.515 . . . . 73.510000000000005 109.855 176.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 22.0 m -124.72 150.3 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.185 0 CA-C-N 115.097 -0.956 . . . . 73.019999999999996 111.483 -176.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 16.3 t -88.77 145.57 25.53 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.214 1.007 . . . . 72.439999999999998 112.473 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.3 p -117.14 157.83 25.26 Favored 'General case' 0 N--CA 1.412 -2.369 0 CA-C-N 113.207 -1.815 . . . . 72.329999999999998 106.191 171.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -41.7 162.07 0.02 OUTLIER Glycine 0 C--O 1.259 1.667 0 N-CA-C 116.997 1.559 . . . . 42.409999999999997 116.997 -175.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.15 156.68 28.58 Favored 'Trans proline' 0 C--O 1.253 1.268 0 C-N-CA 123.864 3.043 . . . . 73.150000000000006 112.841 -176.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -87.6 165.65 15.29 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.435 -0.802 . . . . 65.540000000000006 111.347 -176.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -89.44 159.25 17.38 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 106.924 -1.509 . . . . 73.209999999999994 106.924 175.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -121.13 142.15 50.13 Favored 'General case' 0 CA--C 1.486 -1.483 0 C-N-CA 119.809 -0.756 . . . . 75.319999999999993 111.992 -178.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 11.2 pt-20 -83.09 131.83 35.13 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.172 -1.377 . . . . 74.319999999999993 110.191 -176.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 60.6 mt -88.52 127.77 55.37 Favored Pre-proline 0 C--N 1.305 -1.346 0 N-CA-C 108.722 -0.844 . . . . 74.299999999999997 108.722 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -71.41 142.82 41.68 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 121.624 1.55 . . . . 70.230000000000004 110.152 174.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -77.89 115.14 17.41 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.443 -0.577 . . . . 71.340000000000003 109.443 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 48.0 t -109.85 146.17 15.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 108.237 -1.023 . . . . 72.129999999999995 108.237 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 2.5 p -67.32 153.04 44.61 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 122.915 0.486 . . . . 71.329999999999998 112.105 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' THR . . . . . 0.426 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 18.6 p -65.15 -31.77 73.12 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 113.302 0.853 . . . . 75.040000000000006 113.302 -173.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 2.2 pp -82.13 -10.95 59.01 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 112.272 0.471 . . . . 74.430000000000007 112.272 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 3.7 m -103.96 44.84 0.99 Allowed 'General case' 0 CA--C 1.563 1.463 0 CA-C-O 121.722 0.772 . . . . 73.150000000000006 110.214 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -52.36 -38.22 58.21 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.153 0.981 . . . . 75.5 112.457 177.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -60.04 -42.7 95.01 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.551 0.691 . . . . 50.310000000000002 110.559 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -70.91 -35.64 72.37 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.724 -0.671 . . . . 65.109999999999999 110.47 178.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.548 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -60.18 -49.39 77.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.124 -0.489 . . . . 64.409999999999997 110.884 -178.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.7 m -66.05 -39.52 84.73 Favored 'Isoleucine or valine' 0 C--O 1.25 1.107 0 N-CA-C 112.292 0.478 . . . . 72.209999999999994 112.292 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.31 -34.65 76.52 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 119.751 -0.78 . . . . 73.420000000000002 112.083 177.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -64.09 -38.85 92.56 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.54 -0.3 . . . . 75.230000000000004 110.738 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 92.9 mt -63.46 -39.67 95.08 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.962 -0.563 . . . . 75.430000000000007 110.219 178.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.507 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 15.7 m -70.89 -39.3 72.88 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.929 -0.578 . . . . 74.430000000000007 111.197 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.98 -20.96 64.18 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.384 0.611 . . . . 75.420000000000002 110.94 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -85.69 5.35 32.48 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 115.53 -0.759 . . . . 74.299999999999997 111.923 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 110.22 -85.13 0.39 Allowed Glycine 0 CA--C 1.491 -1.418 0 C-N-CA 120.052 -1.07 . . . . 64.439999999999998 112.054 175.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -35.3 -62.36 0.39 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.4 1.259 . . . . 73.420000000000002 114.4 176.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . 0.507 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 58.39 26.17 58.89 Favored Glycine 0 CA--C 1.504 -0.622 0 C-N-CA 121.343 -0.456 . . . . 74.230000000000004 113.183 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -105.3 110.8 23.3 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 107.892 -1.151 . . . . 74.150000000000006 107.892 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . 0.49 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 33.1 p90 -140.66 152.46 45.39 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 116.315 -0.402 . . . . 75.409999999999997 110.132 -177.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -138.0 123.01 19.05 Favored 'General case' 0 C--N 1.291 -1.943 0 O-C-N 124.002 0.813 . . . . 75.329999999999998 109.392 176.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -87.26 126.58 34.92 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.292 -1.003 . . . . 73.150000000000006 108.292 178.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.09 146.1 43.35 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 107.276 -1.379 . . . . 65.140000000000001 107.276 177.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -120.03 140.24 51.3 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 109.477 -0.564 . . . . 73.409999999999997 109.477 -175.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 49.4 m -147.69 132.59 8.98 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 109.489 -0.559 . . . . 72.420000000000002 109.489 174.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.586 ' HA ' ' O ' ' A' ' 490' ' ' SER . 38.9 Cg_exo -64.75 122.73 10.67 Favored 'Trans proline' 0 C--O 1.238 0.505 0 C-N-CA 122.225 1.95 . . . . 72.439999999999998 110.684 177.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 17.6 m -143.4 175.03 10.23 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 108.142 -1.059 . . . . 73.319999999999993 108.142 -176.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.9 t -47.6 139.36 8.56 Favored Pre-proline 0 C--O 1.249 1.076 0 C-N-CA 124.259 1.023 . . . . 70.310000000000002 112.251 178.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.13 -29.29 28.12 Favored 'Trans proline' 0 C--N 1.36 1.175 0 C-N-CA 124.74 3.626 . . . . 75.409999999999997 113.612 -177.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.25 -22.87 63.82 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 112.089 0.403 . . . . 75.540000000000006 112.089 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -104.25 -8.91 18.98 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 111.681 0.252 . . . . 61.009999999999998 111.681 178.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 98.6 t -60.84 127.25 20.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.974 0.416 . . . . 72.549999999999997 110.179 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.05 -16.18 60.19 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.934 -0.576 . . . . 73.430000000000007 112.41 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -107.63 166.04 10.97 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 108.352 -0.981 . . . . 75.510000000000005 108.352 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 75.2 t -76.72 143.08 13.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 108.571 -0.9 . . . . 75.439999999999998 108.571 176.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 63.8 mt -98.18 -30.9 3.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 107.961 -1.125 . . . . 75.019999999999996 107.961 177.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 167.17 179.26 40.03 Favored Glycine 0 N--CA 1.425 -2.096 0 N-CA-C 110.862 -0.895 . . . . 74.549999999999997 110.862 177.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 470' ' ' THR . . . . . 0.429 HG21 HG12 ' A' ' 486' ' ' ILE . 59.2 p -115.64 140.66 48.98 Favored 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 107.41 -1.329 . . . . 74.129999999999995 107.41 177.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.479 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 7.2 t30 -63.7 -50.31 72.31 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 120.756 -0.377 . . . . 60.229999999999997 110.471 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.479 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 1.4 Cg_endo -88.35 152.87 6.65 Favored 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 121.593 1.529 . . . . 75.25 108.94 171.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -63.74 126.76 18.1 Favored 'Trans proline' 0 C--O 1.243 0.726 0 C-N-CA 121.313 1.342 . . . . 72.420000000000002 111.681 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -93.88 14.38 19.66 Favored 'General case' 0 C--O 1.202 -1.432 0 CA-C-O 121.68 0.753 . . . . 75.430000000000007 110.12 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -110.02 -1.99 17.31 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.715 -0.675 . . . . 75.120000000000005 109.318 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -109.75 174.68 5.75 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.36 -0.836 . . . . 70.230000000000004 112.578 -173.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 477' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 2.5 m -86.33 114.32 23.02 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 114.108 -1.405 . . . . 72.019999999999996 108.776 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 15.7 m -109.42 148.08 31.72 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 109.877 -0.416 . . . . 71.340000000000003 109.877 -176.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.98 157.74 36.12 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.478 -0.328 . . . . 63.43 110.809 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 37.6 mm -72.35 -17.73 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-O 122.084 0.945 . . . . 72.450000000000003 110.518 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 2.7 p -99.52 5.47 46.08 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.898 -0.592 . . . . 73.519999999999996 111.437 177.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -84.61 129.97 34.78 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.519 -0.549 . . . . 73.310000000000002 109.519 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 42.7 t -102.43 120.59 52.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.748 -0.834 . . . . 75.319999999999993 108.748 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 28.3 m -100.66 120.92 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-O 122.022 0.915 . . . . 74.099999999999994 111.239 -178.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.51 128.99 46.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 109.352 -0.61 . . . . 72.310000000000002 109.352 178.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . 0.429 HG12 HG21 ' A' ' 470' ' ' THR . 9.8 mt -120.36 128.14 75.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 C-N-CA 124.393 1.077 . . . . 64.25 110.267 -174.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 6.4 tt -100.85 127.17 54.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 C-N-CA 122.587 0.355 . . . . 73.239999999999995 111.342 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 34.3 m -113.07 152.17 14.84 Favored 'Isoleucine or valine' 0 C--O 1.254 1.3 0 C-N-CA 123.347 0.659 . . . . 72.340000000000003 110.241 178.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -81.24 130.91 10.02 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 121.042 -0.599 . . . . 71.430000000000007 113.537 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.586 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 35.6 t -114.82 160.02 19.95 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 106.067 -1.827 . . . . 71.340000000000003 106.067 176.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -172.84 95.37 0.1 Allowed Glycine 0 C--N 1.316 -0.571 0 C-N-CA 120.078 -1.058 . . . . 73.340000000000003 112.712 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.58 134.26 9.81 Favored 'Trans proline' 0 C--O 1.249 1.026 0 C-N-CA 122.831 2.354 . . . . 74.030000000000001 111.091 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -129.19 32.32 4.73 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-O 121.879 0.847 . . . . 75.530000000000001 110.582 -177.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 19.6 p -118.12 142.13 47.75 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 114.686 -1.143 . . . . 74.329999999999998 109.885 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? -139.65 163.2 33.2 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.393 -0.595 . . . . 75.120000000000005 109.393 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.4 p-10 -85.74 138.81 31.84 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.809 -0.632 . . . . 73.239999999999995 110.001 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 38.2 pt -88.1 133.74 36.47 Favored Pre-proline 0 C--N 1.295 -1.771 0 C-N-CA 120.536 -0.465 . . . . 75.340000000000003 109.823 175.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -87.04 175.18 5.05 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.649 2.233 . . . . 74.209999999999994 111.819 177.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -92.63 157.24 16.6 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.547 -0.909 . . . . 73.010000000000005 108.547 177.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . 0.425 HG23 ' HA ' ' A' ' 508' ' ' ALA . 9.4 p -159.97 12.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.256 0 CA-C-O 121.531 0.681 . . . . 74.239999999999995 111.587 -177.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -74.59 95.05 2.74 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 121.417 0.627 . . . . 75.329999999999998 110.947 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 159.64 -22.64 0.28 Allowed Glycine 0 N--CA 1.427 -1.914 0 CA-C-N 115.39 -0.823 . . . . 74.010000000000005 111.497 -177.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -102.11 -177.85 3.53 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.02 -0.672 . . . . 72.140000000000001 109.241 176.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 20.3 p -83.41 158.93 21.92 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 110.036 -0.357 . . . . 72.420000000000002 110.036 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.488 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 9.5 p -52.99 -41.14 39.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 O-C-N 123.703 0.627 . . . . 73.540000000000006 111.92 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . 0.46 ' O ' ' HD3' ' A' ' 510' ' ' LYS . 3.4 m-20 -57.57 -42.02 82.26 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.746 0.419 . . . . 74.140000000000001 111.166 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 59.4 t -68.85 -38.29 78.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.231 0.538 . . . . 72.400000000000006 109.888 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . 0.425 ' HA ' HG23 ' A' ' 500' ' ' VAL . . . -62.96 -44.09 97.01 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.633 -0.712 . . . . 70.319999999999993 110.821 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 26.5 mt-30 -60.18 -39.58 86.97 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.0 -0.545 . . . . 73.540000000000006 110.836 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 506' ' ' ASP . 14.4 mptt -65.88 -50.62 63.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.698 -0.683 . . . . 72.540000000000006 111.047 177.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -61.89 -40.89 97.0 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 116.394 -0.367 . . . . 75.430000000000007 111.474 -177.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 94.0 mt -62.71 -44.76 95.38 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 110.358 -0.238 . . . . 73.010000000000005 110.358 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.46 -41.45 94.18 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.017 -0.538 . . . . 60.130000000000003 110.88 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.405 HG21 ' O ' ' A' ' 510' ' ' LYS . 73.5 t -57.85 -36.46 55.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.871 -0.604 . . . . 74.450000000000003 111.71 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -87.18 0.26 55.6 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.249 -0.58 . . . . 75.530000000000001 112.365 -177.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 98.97 14.16 37.5 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.754 -0.736 . . . . 75.239999999999995 113.719 175.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -101.03 110.19 22.19 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.344 -0.984 . . . . 74.430000000000007 108.344 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.39 -14.66 22.31 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 116.011 -0.54 . . . . 62.240000000000002 111.871 -175.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . 0.496 ' HD2' ' O ' ' A' ' 548' ' ' ASP . 99.2 mttt -108.03 115.5 30.25 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.608 0.718 . . . . 74.409999999999997 111.871 -175.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . 0.41 ' HA ' ' O ' ' A' ' 551' ' ' ILE . 51.7 p90 -130.21 150.94 51.23 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.084 -0.962 . . . . 63.439999999999998 109.65 177.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 521' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 51.1 m -136.42 140.55 43.25 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 106.983 -1.488 . . . . 74.409999999999997 106.983 174.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . 0.464 ' NE2' HG23 ' A' ' 505' ' ' VAL . 3.6 pt20 -122.97 125.21 44.84 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.544 0.688 . . . . 75.010000000000005 112.35 -175.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -116.33 116.49 27.83 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.728 -1.124 . . . . 75.239999999999995 108.047 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 524' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 12.4 p -91.8 130.18 37.62 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.148 0.499 . . . . 64.239999999999995 111.173 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 27.2 m -121.89 158.54 25.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.252 -1.018 . . . . 75.510000000000005 108.252 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -73.35 137.72 44.92 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 119.87 -0.732 . . . . 72.430000000000007 109.189 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 24.6 m -148.35 171.06 6.73 Favored Pre-proline 0 C--N 1.287 -2.142 0 N-CA-C 107.941 -1.133 . . . . 73.200000000000003 107.941 -178.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -81.61 -11.08 11.75 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 121.508 1.472 . . . . 71.510000000000005 110.783 172.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . 0.475 ' HD3' ' OE2' ' A' ' 533' ' ' GLU . 88.4 mtt180 -80.91 145.39 57.18 Favored Pre-proline 0 N--CA 1.444 -0.735 0 CA-C-N 115.276 -0.874 . . . . 73.099999999999994 108.932 178.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.26 151.47 82.16 Favored 'Trans proline' 0 C--O 1.253 1.235 0 C-N-CA 122.787 2.325 . . . . 64.400000000000006 112.855 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.666 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -62.43 112.12 2.31 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.932 -1.031 . . . . 71.319999999999993 111.739 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 134.11 -20.88 3.96 Favored Glycine 0 C--N 1.308 -0.977 0 C-N-CA 120.829 -0.701 . . . . 64.200000000000003 112.617 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . 0.475 ' OE2' ' HD3' ' A' ' 529' ' ' ARG . 34.3 tt0 -83.02 142.37 31.38 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.702 -0.481 . . . . 74.299999999999997 109.702 179.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 63.1 t -81.92 123.41 38.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 108.666 -0.864 . . . . 74.099999999999994 108.666 178.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 535' ' ' THR . . . . . 0.683 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 10.3 t -96.44 -19.74 18.94 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.36 -0.536 . . . . 75.120000000000005 110.742 -178.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 177.48 179.13 47.58 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.244 -0.979 . . . . 73.209999999999994 111.509 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 72.1 p -124.16 149.82 45.86 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.562 -1.273 . . . . 75.25 107.562 177.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -67.75 -59.82 6.25 Favored Pre-proline 0 C--N 1.323 -0.555 0 C-N-CA 120.548 -0.461 . . . . 74.109999999999999 109.931 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -76.29 130.56 12.1 Favored 'Trans proline' 0 N--CA 1.44 -1.653 0 N-CA-C 108.298 -1.462 . . . . 71.010000000000005 108.298 170.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -66.63 150.69 83.73 Favored 'Trans proline' 0 C--O 1.255 1.371 0 C-N-CA 122.01 1.807 . . . . 75.310000000000002 112.178 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -58.98 142.74 50.27 Favored 'General case' 0 C--O 1.249 1.067 0 CA-C-N 115.759 -0.655 . . . . 74.140000000000001 109.787 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 102.9 -17.33 52.9 Favored Glycine 0 C--N 1.291 -1.917 0 C-N-CA 120.508 -0.853 . . . . 55.450000000000003 111.677 -179.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 61.5 m -68.9 127.49 33.28 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 109.959 -0.385 . . . . 73.409999999999997 109.959 178.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 20.6 m -91.62 122.99 34.68 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.384 -0.969 . . . . 74.409999999999997 108.384 177.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 29.4 m -137.37 161.26 61.84 Favored Pre-proline 0 C--N 1.311 -1.102 0 N-CA-C 109.033 -0.728 . . . . 74.409999999999997 109.033 -176.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -61.33 151.68 77.65 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 121.809 1.673 . . . . 74.340000000000003 110.821 173.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 30.5 m -63.3 -20.31 25.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.596 0.712 . . . . 65.219999999999999 112.166 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . 0.496 ' O ' ' HD2' ' A' ' 519' ' ' LYS . 26.8 t70 -90.42 4.25 51.5 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.628 -0.715 . . . . 73.329999999999998 110.863 178.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.1 t -71.15 162.61 29.14 Favored 'General case' 0 C--O 1.241 0.62 0 O-C-N 121.474 -0.766 . . . . 71.030000000000001 109.402 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 18.0 t -109.32 116.75 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 CA-C-O 121.152 0.501 . . . . 74.450000000000003 109.961 -176.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 520' ' ' PHE . 2.5 mp -91.95 123.86 44.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 109.124 -0.695 . . . . 74.340000000000003 109.124 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 521' ' ' SER . 37.7 tt0 -102.87 120.14 40.08 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-O 121.056 0.455 . . . . 73.239999999999995 110.029 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -96.65 134.27 40.11 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.96 -1.018 . . . . 72.010000000000005 109.817 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -92.47 114.88 27.56 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.513 -1.291 . . . . 74.140000000000001 107.513 171.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 524' ' ' SER . 47.6 t -100.73 141.72 17.01 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.39 0 N-CA-C 108.684 -0.858 . . . . 72.420000000000002 108.684 -177.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.683 ' OG ' ' HB ' ' A' ' 535' ' ' THR . 71.7 m -81.45 138.76 35.5 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-O 121.124 0.488 . . . . 74.209999999999994 111.75 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.11 135.72 52.4 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 105.678 -1.971 . . . . 73.010000000000005 105.678 169.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -71.12 -41.95 59.45 Favored Glycine 0 CA--C 1.497 -1.039 0 N-CA-C 111.297 -0.721 . . . . 64.540000000000006 111.297 -175.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 65.4 t30 66.43 8.12 5.49 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.686 1.194 . . . . 75.5 111.21 175.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -113.78 162.3 16.48 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.127 -0.942 . . . . 74.010000000000005 109.152 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -137.19 144.92 43.12 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.414 -0.588 . . . . 74.430000000000007 109.414 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 96.8 t -72.83 122.61 25.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 123.528 0.517 . . . . 61.340000000000003 110.233 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 48.7 ttm -78.22 126.11 83.96 Favored Pre-proline 0 C--N 1.308 -1.231 0 CA-C-N 115.714 -0.676 . . . . 73.140000000000001 109.964 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.3 169.33 18.57 Favored 'Trans proline' 0 C--O 1.243 0.774 0 C-N-CA 122.569 2.18 . . . . 64.129999999999995 110.7 176.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -83.08 119.7 24.82 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.834 0.826 . . . . 71.219999999999999 111.338 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 95.0 mt -127.34 14.04 7.15 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.083 -1.417 . . . . 73.420000000000002 107.453 176.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 9.3 m -72.04 130.7 41.56 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.431 -1.258 . . . . 75.409999999999997 109.356 -178.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 85.02 22.91 51.24 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.345 -0.931 . . . . 75.329999999999998 112.028 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 87.9 mtp -116.14 -178.91 3.52 Favored 'General case' 0 C--O 1.25 1.105 0 N-CA-C 109.282 -0.636 . . . . 74.0 109.282 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . 0.4 ' HB3' ' OD1' ' A' ' 601' ' ' ASN . 97.1 m-85 -97.47 153.17 18.3 Favored 'General case' 0 N--CA 1.414 -2.226 0 N-CA-C 109.176 -0.676 . . . . 75.439999999999998 109.176 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 64.1 t90 -64.57 -27.37 68.91 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 123.441 0.697 . . . . 73.530000000000001 110.142 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 10.3 p -71.66 -16.44 18.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.779 -0.646 . . . . 73.109999999999999 109.694 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . 0.488 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 22.9 m-20 -101.14 -44.91 5.54 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.6 -0.519 . . . . 75.400000000000006 109.6 176.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -62.91 -52.68 62.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.596 -0.729 . . . . 74.430000000000007 112.664 -175.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.408 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 4.1 tm-20 -55.55 -52.11 74.59 Favored Pre-proline 0 CA--C 1.567 1.623 0 C-N-CA 122.784 0.434 . . . . 74.540000000000006 111.851 -176.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 52.3 Cg_exo -61.12 -29.46 87.25 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 121.785 1.657 . . . . 75.299999999999997 113.038 174.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . 0.534 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 20.0 mmt180 -66.43 -40.41 89.51 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 111.479 0.177 . . . . 73.540000000000006 111.479 178.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.13 -45.53 90.68 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.202 0.525 . . . . 64.540000000000006 109.952 177.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -59.68 -39.64 85.18 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.362 -0.835 . . . . 75.129999999999995 110.961 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.29 -21.39 62.95 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.341 -0.39 . . . . 44.420000000000002 111.717 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 92.3 mt -82.66 -6.8 59.57 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 120.956 0.407 . . . . 65.310000000000002 111.43 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 88.36 20.07 50.07 Favored Glycine 0 C--O 1.238 0.37 0 C-N-CA 120.135 -1.031 . . . . 60.140000000000001 111.495 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 89.9 t90 -70.92 129.84 40.07 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.006 -0.738 . . . . 75.019999999999996 109.006 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 1.2 m -127.56 13.92 7.02 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.606 -0.516 . . . . 63.340000000000003 109.606 -176.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -88.98 -156.82 32.07 Favored Glycine 0 CA--C 1.498 -1.029 0 C-N-CA 120.538 -0.839 . . . . 65.439999999999998 114.987 -173.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 50.0 ttm -108.1 131.36 54.7 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 122.873 0.469 . . . . 73.209999999999994 111.37 -178.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -101.37 128.96 47.32 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.653 -1.24 . . . . 72.340000000000003 107.653 176.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -107.0 122.36 46.28 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 116.2 -0.454 . . . . 75.409999999999997 109.837 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -90.28 132.97 35.24 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.404 -0.816 . . . . 71.329999999999998 110.158 -178.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -85.34 177.64 50.42 Favored Glycine 0 N--CA 1.431 -1.682 0 C-N-CA 120.987 -0.625 . . . . 64.109999999999999 112.227 175.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -72.53 144.74 47.85 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 123.067 0.547 . . . . 63.109999999999999 111.451 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -63.42 151.35 41.29 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.866 -0.607 . . . . 74.310000000000002 111.402 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 47.0 t -138.39 116.97 13.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 107.954 -1.128 . . . . 72.019999999999996 107.954 -178.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -74.43 124.06 25.84 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.085 -1.08 . . . . 74.230000000000004 108.085 177.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -160.19 12.9 0.12 Allowed 'General case' 0 C--O 1.244 0.801 0 N-CA-C 112.376 0.51 . . . . 74.209999999999994 112.376 -176.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 89.8 166.67 41.79 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.172 -1.013 . . . . 50.020000000000003 112.086 -178.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -59.56 -48.23 87.04 Favored Glycine 0 CA--C 1.519 0.301 0 N-CA-C 114.724 0.649 . . . . 71.519999999999996 114.724 -175.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 28.2 m -61.23 -25.22 66.92 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-O 121.224 0.535 . . . . 75.519999999999996 112.136 -176.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -108.36 -1.52 19.9 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 112.477 0.547 . . . . 75.439999999999998 112.477 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.53 -51.65 11.29 Favored 'General case' 0 C--O 1.195 -1.791 0 C-N-CA 119.624 -0.83 . . . . 74.040000000000006 111.864 -173.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . 0.4 ' OD1' ' HB3' ' A' ' 570' ' ' PHE . 16.7 t-20 -92.19 19.39 6.98 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 120.857 -1.152 . . . . 73.340000000000003 109.429 -177.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 20.0 tpp85 -91.08 139.77 30.45 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.015 -0.993 . . . . 74.400000000000006 109.936 -176.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 13.5 p -65.05 139.97 20.52 Favored 'Isoleucine or valine' 0 C--O 1.247 0.94 0 N-CA-C 108.597 -0.89 . . . . 74.540000000000006 108.597 175.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 95.5 t -100.15 -46.88 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.056 0 N-CA-C 108.427 -0.953 . . . . 73.310000000000002 108.427 -177.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -156.15 157.23 35.59 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 105.872 -1.899 . . . . 73.420000000000002 105.872 176.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -123.4 131.94 53.81 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 106.918 -1.512 . . . . 73.019999999999996 106.918 173.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.519 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 25.8 t-20 -50.8 -58.09 11.34 Favored Pre-proline 0 C--N 1.312 -1.028 0 CA-C-O 118.844 -0.598 . . . . 73.239999999999995 112.366 -177.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 11.1 Cg_endo -96.76 121.5 0.2 Allowed 'Trans proline' 0 N--CA 1.44 -1.674 0 C-N-CA 121.733 1.622 . . . . 75.450000000000003 109.716 173.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -66.46 158.36 55.79 Favored 'Trans proline' 0 C--O 1.25 1.077 0 C-N-CA 122.116 1.877 . . . . 72.109999999999999 112.277 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.86 130.91 47.92 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.854 -0.612 . . . . 62.310000000000002 110.679 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 104.29 -3.77 43.93 Favored Glycine 0 C--N 1.3 -1.425 0 C-N-CA 120.635 -0.793 . . . . 74.340000000000003 112.119 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 6.1 m -93.13 148.13 22.28 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.235 -0.654 . . . . 65.409999999999997 109.235 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -84.5 115.79 4.16 Favored Glycine 0 N--CA 1.425 -2.056 0 N-CA-C 109.272 -1.531 . . . . 61.399999999999999 109.272 175.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.4 m -100.98 143.7 13.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 C-N-CA 122.854 0.461 . . . . 74.510000000000005 111.067 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -44.4 166.53 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.637 1.975 . . . . 75.129999999999995 113.354 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.0 -26.08 61.93 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.943 0.401 . . . . 73.140000000000001 111.59 -176.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . 0.499 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 25.8 t70 -79.68 -37.23 36.27 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.592 -0.731 . . . . 75.219999999999999 109.315 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 81.42 22.76 59.83 Favored Glycine 0 N--CA 1.429 -1.789 0 C-N-CA 118.948 -1.596 . . . . 64.239999999999995 111.527 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.81 119.8 12.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 122.286 1.041 . . . . 73.030000000000001 109.165 -168.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.15 126.76 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-N 114.513 -1.221 . . . . 73.209999999999994 110.594 -172.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.439 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 32.2 m -100.9 125.8 47.48 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.128 -0.693 . . . . 74.430000000000007 109.128 175.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.5 pp -133.85 154.63 50.89 Favored 'General case' 0 CA--C 1.479 -1.759 0 N-CA-C 108.612 -0.885 . . . . 72.420000000000002 108.612 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -127.98 141.57 51.49 Favored 'General case' 0 C--N 1.257 -3.414 0 N-CA-C 105.43 -2.063 . . . . 72.239999999999995 105.43 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -137.41 166.82 22.91 Favored 'General case' 0 C--N 1.277 -2.561 0 N-CA-C 107.129 -1.434 . . . . 74.510000000000005 107.129 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -70.7 -137.34 0.14 Allowed Glycine 0 N--CA 1.427 -1.921 0 O-C-N 124.325 1.016 . . . . 65.010000000000005 115.343 -174.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 C--N 1.289 -2.05 0 CA-C-O 118.967 -0.54 . . . . 65.140000000000001 109.575 -171.159 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.818 0 N-CA-C 110.525 -1.03 . . . . 53.039999999999999 110.525 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 10.5 tp -76.03 145.93 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 N-CA-C 109.199 -0.667 . . . . 64.120000000000005 109.199 177.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.9 134.64 44.88 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 109.587 -0.523 . . . . 73.099999999999994 109.587 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -88.97 -21.22 23.64 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.786 -1.561 . . . . 65.140000000000001 106.786 176.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -86.36 150.62 24.2 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 106.019 -1.845 . . . . 73.439999999999998 106.019 174.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 31.4 m -115.51 154.14 16.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-O 121.633 0.73 . . . . 74.209999999999994 111.053 -172.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . 0.542 ' NE2' ' HA ' ' A' ' 407' ' ' ASN . 0.9 OUTLIER -94.92 136.77 34.83 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 106.425 -1.694 . . . . 74.430000000000007 106.425 -176.16 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.572 HG21 ' CZ ' ' A' ' 382' ' ' PHE . 98.0 t -95.12 118.63 66.49 Favored Pre-proline 0 C--N 1.297 -1.68 0 CA-C-N 116.028 -0.533 . . . . 74.299999999999997 110.773 -169.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -64.59 130.92 27.86 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 123.027 2.485 . . . . 73.540000000000006 112.271 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -93.66 121.16 34.8 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.238 -0.892 . . . . 70.340000000000003 110.342 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 5.7 m -104.65 23.91 2.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 122.005 0.907 . . . . 75.140000000000001 110.986 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.457 ' HD2' ' O ' ' A' ' 366' ' ' ARG . 4.5 ppt_? -54.85 145.54 19.61 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.551 -1.204 . . . . 74.219999999999999 110.781 172.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.15 -11.8 51.94 Favored Glycine 0 C--N 1.302 -1.344 0 N-CA-C 110.356 -1.098 . . . . 71.299999999999997 110.356 -175.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -108.18 -151.66 0.47 Allowed 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 108.464 -0.939 . . . . 72.040000000000006 108.464 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 80.6 p -98.21 157.44 16.16 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.43 -0.582 . . . . 72.129999999999995 109.43 -174.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.5 p -63.67 -41.06 98.22 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 112.306 0.484 . . . . 75.239999999999995 112.306 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -67.14 -42.83 83.74 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-O 119.462 -0.304 . . . . 50.399999999999999 111.495 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.02 -35.12 74.09 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 119.558 -0.857 . . . . 63.130000000000003 110.594 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.22 -47.95 75.04 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.788 -0.642 . . . . 63.229999999999997 110.611 177.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . 0.403 HG23 HG13 ' A' ' 384' ' ' ILE . 70.6 mt -61.71 -43.19 96.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-N 116.039 -0.528 . . . . 71.219999999999999 110.309 175.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.57 -44.77 89.87 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.126 -0.488 . . . . 74.430000000000007 110.112 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 87.9 m -60.74 -46.81 89.02 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.964 -0.562 . . . . 64.530000000000001 110.753 178.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 93.7 mt -62.98 -40.33 97.42 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.346 -0.388 . . . . 74.420000000000002 110.22 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -62.12 -43.29 99.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.671 -0.695 . . . . 64.150000000000006 110.3 178.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.0 -31.85 70.31 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 120.982 0.42 . . . . 71.109999999999999 111.384 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -85.86 -12.24 51.23 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.957 -0.565 . . . . 75.409999999999997 111.751 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 94.49 14.57 50.08 Favored Glycine 0 C--N 1.307 -1.059 0 C-N-CA 120.761 -0.733 . . . . 73.510000000000005 112.701 177.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.572 ' CZ ' HG21 ' A' ' 362' ' ' VAL . 52.2 m-85 -81.04 150.82 28.67 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-O 121.076 0.465 . . . . 75.530000000000001 111.221 177.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . 0.406 ' CB ' ' HG2' ' A' ' 415' ' ' GLU . 7.7 mmtp -84.49 144.78 28.49 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.854 -1.165 . . . . 75.200000000000003 107.854 175.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . 0.403 HG13 HG23 ' A' ' 374' ' ' ILE . 0.2 OUTLIER -129.93 133.83 63.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-O 121.495 0.664 . . . . 74.430000000000007 111.015 -177.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . 0.431 ' HA ' ' NE ' ' A' ' 385' ' ' ARG . 3.6 tpm_? -115.89 147.13 41.43 Favored 'General case' 0 N--CA 1.41 -2.437 0 N-CA-C 106.519 -1.66 . . . . 72.400000000000006 106.519 173.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 39.1 m -129.55 127.64 41.13 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 109.507 -0.553 . . . . 75.150000000000006 109.507 -177.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -119.12 130.52 55.61 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 105.488 -2.042 . . . . 75.430000000000007 105.488 176.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.468 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -121.55 135.9 54.98 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 118.452 0.569 . . . . 63.43 110.062 -178.716 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -134.42 115.92 12.83 Favored Pre-proline 0 C--N 1.314 -0.952 0 C-N-CA 121.335 -0.146 . . . . 62.340000000000003 111.1 177.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . 0.47 ' CA ' ' HB ' ' A' ' 422' ' ' THR . 64.8 Cg_endo -87.91 135.49 3.4 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.43 2.087 . . . . 74.510000000000005 111.146 174.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.438 ' HB3' HG12 ' A' ' 394' ' ' ILE . 13.1 t70 -179.82 153.65 0.54 Allowed 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 109.022 -0.733 . . . . 55.420000000000002 109.022 177.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 9.9 m -73.87 -18.53 60.91 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 123.186 0.594 . . . . 65.420000000000002 111.959 -177.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 3.1 m -87.63 -17.37 32.02 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-O 121.741 0.781 . . . . 65.310000000000002 109.975 -178.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . 0.469 HG22 ' HB3' ' A' ' 421' ' ' SER . 45.4 mm -90.22 135.68 29.55 Favored Pre-proline 0 C--N 1.301 -1.513 0 CA-C-N 115.446 -0.797 . . . . 75.540000000000006 111.311 -171.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . 0.434 ' O ' ' HB3' ' A' ' 421' ' ' SER . 95.7 Cg_exo -50.14 179.0 0.02 OUTLIER 'Trans proline' 0 CA--C 1.585 3.072 1 C-N-CA 126.104 4.536 . . . . 71.109999999999999 116.021 179.223 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 395' ' ' PRO . 37.6 Cg_endo -67.14 160.96 44.98 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 123.191 2.594 . . . . 72.340000000000003 113.13 173.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -62.58 -6.24 3.3 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 124.591 1.156 . . . . 73.239999999999995 113.618 -177.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -65.6 158.04 28.23 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.946 -0.761 . . . . 72.040000000000006 108.946 177.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 6.4 m -86.36 117.77 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 C-N-CA 118.49 -1.284 . . . . 73.329999999999998 108.893 176.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . 0.408 HD13 ' N ' ' A' ' 401' ' ' GLY . 2.7 pp -88.96 -28.52 5.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 113.007 0.743 . . . . 73.430000000000007 113.007 -177.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . 0.408 ' N ' HD13 ' A' ' 400' ' ' ILE . . . -167.97 169.3 41.28 Favored Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 110.659 -0.976 . . . . 61.399999999999999 110.659 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 18.6 p -114.95 172.71 6.88 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.69 -0.856 . . . . 72.420000000000002 108.69 177.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -102.71 155.42 36.56 Favored Pre-proline 0 C--N 1.292 -1.9 0 N-CA-C 109.028 -0.73 . . . . 71.420000000000002 109.028 177.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -50.1 -20.13 4.98 Favored 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 124.043 3.162 . . . . 74.109999999999999 115.384 -175.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -62.23 -42.82 99.65 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 110.044 -0.354 . . . . 75.129999999999995 110.044 -178.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . 0.436 ' O ' ' HB ' ' A' ' 362' ' ' VAL . . . -71.3 -33.09 69.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.87 0.843 . . . . 72.340000000000003 109.741 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . 0.542 ' HA ' ' NE2' ' A' ' 361' ' ' GLN . 18.2 m120 -86.52 2.18 48.92 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.326 -0.852 . . . . 74.109999999999999 112.27 -176.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 36.3 m -103.21 152.16 21.8 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 105.783 -1.932 . . . . 65.310000000000002 105.783 172.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 361' ' ' GLN . 24.6 m -74.8 112.85 11.43 Favored 'General case' 0 N--CA 1.429 -1.517 0 C-N-CA 119.56 -0.856 . . . . 74.150000000000006 109.252 178.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 35.1 m -113.36 169.06 5.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 121.048 0.451 . . . . 75.420000000000002 110.256 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 19.9 m -66.45 134.7 53.01 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.637 -0.875 . . . . 74.239999999999995 108.637 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -54.78 112.37 1.02 Allowed 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 122.994 0.518 . . . . 74.420000000000002 111.086 -178.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 105.49 27.74 5.68 Favored Glycine 0 N--CA 1.433 -1.552 0 C-N-CA 120.591 -0.814 . . . . 64.329999999999998 112.86 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -85.16 177.22 7.95 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.418 -0.956 . . . . 75.439999999999998 108.418 177.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . 0.406 ' HG2' ' CB ' ' A' ' 383' ' ' LYS . 27.5 mt-10 -97.87 110.88 23.37 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.65 0.738 . . . . 74.120000000000005 110.97 -172.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 44.9 mm -98.33 122.62 50.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 CA-C-N 115.064 -0.971 . . . . 75.239999999999995 108.977 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 15.6 p -89.22 130.73 35.58 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.831 -0.622 . . . . 75.400000000000006 111.419 -177.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 7.5 p -114.36 134.3 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 N-CA-C 109.118 -0.697 . . . . 73.230000000000004 109.118 175.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -106.03 115.39 30.15 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.993 -1.484 . . . . 71.420000000000002 106.993 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 48.6 t -106.93 130.64 58.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-O 122.047 0.927 . . . . 74.510000000000005 109.727 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' SER . . . . . 0.469 ' HB3' HG22 ' A' ' 394' ' ' ILE . 49.6 m -87.71 123.34 32.43 Favored 'General case' 0 C--N 1.273 -2.751 0 CA-C-N 114.164 -1.38 . . . . 64.439999999999998 108.746 179.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' THR . . . . . 0.47 ' HB ' ' CA ' ' A' ' 390' ' ' PRO . 6.2 m -106.08 157.6 17.42 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 108.131 -1.063 . . . . 74.310000000000002 108.131 -177.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -52.79 168.96 0.8 Allowed Glycine 0 CA--C 1.54 1.651 0 N-CA-C 116.645 1.418 . . . . 71.299999999999997 116.645 -173.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.93 144.0 86.89 Favored 'Trans proline' 0 C--O 1.247 0.944 0 C-N-CA 123.372 2.715 . . . . 73.140000000000001 110.573 178.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -88.24 145.55 25.82 Favored 'General case' 0 N--CA 1.42 -1.949 0 CA-C-O 121.575 0.702 . . . . 74.219999999999999 111.758 -175.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -135.43 157.26 47.34 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 107.677 -1.231 . . . . 74.409999999999997 107.677 176.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.554 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 4.2 mmp_? -126.17 141.8 51.79 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.369 0.604 . . . . 72.200000000000003 111.152 176.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -83.11 129.63 35.04 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 106.724 -1.584 . . . . 75.040000000000006 106.724 175.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 53.0 mt -80.42 131.22 62.37 Favored Pre-proline 0 N--CA 1.428 -1.556 0 N-CA-C 108.947 -0.76 . . . . 64.230000000000004 108.947 -174.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -69.35 140.72 44.96 Favored 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 121.468 1.446 . . . . 73.209999999999994 110.993 176.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -89.46 114.39 25.87 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.305 -1.368 . . . . 74.519999999999996 107.305 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.7 p -110.82 159.29 10.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 108.663 -0.866 . . . . 74.420000000000002 108.663 -175.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 22.6 p -68.31 137.76 54.91 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 108.141 -1.059 . . . . 71.209999999999994 108.141 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 18.3 p -63.38 -21.56 66.35 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 113.675 0.991 . . . . 74.120000000000005 113.675 -174.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.2 pp -78.2 -11.48 59.93 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 120.103 -0.639 . . . . 64.140000000000001 111.606 177.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.3 m -106.79 61.79 0.63 Allowed 'General case' 0 N--CA 1.432 -1.351 0 CA-C-O 121.725 0.774 . . . . 73.310000000000002 111.729 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -52.32 -38.25 58.08 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.363 1.065 . . . . 74.5 111.507 174.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -59.39 -42.53 91.9 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.34 0.591 . . . . 73.5 110.904 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -70.92 -36.89 72.86 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.574 -0.739 . . . . 74.439999999999998 109.23 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.519 ' O ' HD11 ' A' ' 444' ' ' LEU . . . -60.03 -51.69 68.58 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.748 -0.66 . . . . 64.120000000000005 111.095 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 35.5 m -64.86 -40.73 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 N-CA-C 112.589 0.588 . . . . 64.439999999999998 112.589 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -68.77 -36.37 78.23 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 119.862 -0.735 . . . . 73.209999999999994 111.276 178.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -63.9 -41.86 97.59 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.27 -0.423 . . . . 74.349999999999994 110.908 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.519 HD11 ' O ' ' A' ' 440' ' ' ALA . 7.3 mp -63.75 -32.69 74.27 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.918 -0.583 . . . . 71.25 110.322 176.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 85.2 m -69.97 -44.9 68.52 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.653 -0.703 . . . . 72.439999999999998 110.293 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.22 -22.26 65.72 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.361 0.601 . . . . 73.040000000000006 110.814 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.83 5.09 14.58 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.44 -0.8 . . . . 71.310000000000002 112.321 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 104.31 -82.95 0.38 Allowed Glycine 0 CA--C 1.492 -1.366 0 C-N-CA 120.261 -0.971 . . . . 70.25 111.816 175.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -41.09 -56.16 2.4 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.012 1.116 . . . . 75.129999999999995 114.012 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 59.25 27.25 62.62 Favored Glycine 0 C--N 1.322 -0.202 0 C-N-CA 121.528 -0.368 . . . . 73.140000000000001 113.239 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -101.34 111.21 23.37 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 109.526 -0.546 . . . . 75.329999999999998 109.526 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . 0.5 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 27.8 p90 -134.48 150.83 50.85 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 115.485 -0.78 . . . . 74.420000000000002 109.712 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 21.4 tptp -138.46 127.81 24.49 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 106.558 -1.645 . . . . 72.510000000000005 106.558 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -98.31 127.86 44.45 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.367 0.603 . . . . 74.299999999999997 111.938 -176.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -126.92 139.88 52.74 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.23 -1.026 . . . . 75.450000000000003 108.23 176.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -112.85 143.58 43.87 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.658 -0.867 . . . . 72.310000000000002 108.658 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 22.8 t -139.92 134.33 15.83 Favored Pre-proline 0 C--N 1.295 -1.779 0 N-CA-C 109.054 -0.721 . . . . 72.439999999999998 109.054 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.5 ' HA ' ' O ' ' A' ' 490' ' ' SER . 52.7 Cg_endo -74.27 128.15 11.83 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 121.859 1.706 . . . . 74.519999999999996 110.59 176.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 35.0 m -147.14 179.93 7.27 Favored 'General case' 0 C--N 1.288 -2.098 0 C-N-CA 123.247 0.619 . . . . 74.409999999999997 109.466 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.5 t -48.85 143.87 7.84 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 125.189 1.396 . . . . 74.239999999999995 112.148 178.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.68 -29.29 32.64 Favored 'Trans proline' 0 C--N 1.362 1.275 0 C-N-CA 124.761 3.64 . . . . 74.230000000000004 113.484 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -74.89 -8.36 56.24 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 112.767 0.654 . . . . 71.530000000000001 112.767 -176.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -111.4 -6.93 14.41 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.969 0.359 . . . . 70.140000000000001 111.969 177.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 59.7 t -60.92 127.09 19.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.068 0.461 . . . . 74.010000000000005 111.736 -176.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.26 -8.12 77.74 Favored Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 115.754 -0.657 . . . . 70.140000000000001 112.49 177.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -108.06 151.68 25.53 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 109.826 -0.435 . . . . 74.430000000000007 109.826 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.411 ' O ' ' HB ' ' A' ' 434' ' ' THR . 67.1 t -68.68 142.92 15.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 106.41 -1.7 . . . . 73.409999999999997 106.41 170.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 60.0 mt -97.23 -35.22 5.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 108.704 -0.851 . . . . 64.219999999999999 108.704 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 164.99 -165.08 37.47 Favored Glycine 0 N--CA 1.418 -2.532 0 C-N-CA 120.43 -0.89 . . . . 71.409999999999997 111.292 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -143.37 149.92 38.4 Favored 'General case' 0 N--CA 1.408 -2.561 0 N-CA-C 107.453 -1.314 . . . . 61.439999999999998 107.453 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -67.49 -55.32 15.13 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 120.623 -0.431 . . . . 74.319999999999993 110.703 178.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -74.09 128.3 12.1 Favored 'Trans proline' 0 C--N 1.367 1.548 0 N-CA-C 108.009 -1.573 . . . . 72.219999999999999 108.009 169.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -62.54 129.85 27.92 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.248 1.966 . . . . 74.349999999999994 112.887 -176.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -81.98 13.68 3.21 Favored 'General case' 0 C--O 1.206 -1.188 0 CA-C-N 115.194 -0.912 . . . . 73.219999999999999 110.718 -178.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -110.07 0.13 18.25 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.583 0.706 . . . . 74.400000000000006 109.398 174.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -103.32 175.79 5.36 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.91 -0.587 . . . . 65.109999999999999 112.154 -176.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 2.3 m -98.38 114.43 26.77 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 108.056 -1.09 . . . . 54.039999999999999 108.056 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 23.0 p -110.02 147.01 34.33 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 116.283 -0.417 . . . . 70.219999999999999 110.057 -176.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -77.55 167.32 21.82 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.634 -0.257 . . . . 54.32 110.387 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 25.3 mm -71.61 -3.93 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-O 122.679 1.228 . . . . 62.420000000000002 110.398 -176.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 1.5 p -104.76 5.99 33.73 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.123 -0.944 . . . . 73.120000000000005 111.756 178.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -88.92 142.93 27.23 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.03 0.443 . . . . 75.120000000000005 111.821 -178.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.65 127.08 65.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.514 -0.767 . . . . 70.310000000000002 109.453 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 44.3 t -102.89 120.72 53.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 109.285 -0.635 . . . . 71.409999999999997 109.285 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.63 119.41 44.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 108.733 -0.84 . . . . 72.239999999999995 108.733 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 48.7 mm -104.48 109.26 26.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-N 115.599 -0.728 . . . . 74.439999999999998 109.558 -175.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.467 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 9.6 tt -99.96 121.82 51.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.719 -0.474 . . . . 71.319999999999993 109.719 178.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 35.9 m -103.61 151.13 6.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.943 -0.572 . . . . 72.400000000000006 110.817 -178.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -92.8 127.31 8.93 Favored Glycine 0 N--CA 1.424 -2.12 0 CA-C-N 115.615 -0.721 . . . . 74.519999999999996 111.714 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 25.1 m -119.99 160.27 23.09 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 106.384 -1.71 . . . . 71.099999999999994 106.384 176.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -134.65 162.29 24.63 Favored Glycine 0 C--N 1.298 -1.576 0 C-N-CA 118.541 -1.79 . . . . 42.210000000000001 112.836 -176.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -75.51 109.72 2.96 Favored 'Trans proline' 0 N--CA 1.442 -1.506 0 C-N-CA 122.39 2.06 . . . . 75.120000000000005 110.287 178.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -90.47 27.49 1.7 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.925 0.869 . . . . 73.310000000000002 111.408 -177.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 16.4 p -117.51 143.13 46.37 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 114.708 -1.133 . . . . 73.209999999999994 109.806 -178.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -139.9 155.2 47.31 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 116.356 -0.384 . . . . 74.109999999999999 110.578 177.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -84.17 119.48 25.06 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.831 -1.174 . . . . 74.109999999999999 107.831 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 27.2 pt -75.64 120.26 80.87 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 112.347 0.499 . . . . 75.109999999999999 112.347 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -93.33 138.45 1.44 Allowed 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 122.672 2.248 . . . . 64.219999999999999 111.677 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -90.81 135.35 33.78 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.745 -0.835 . . . . 74.420000000000002 108.745 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 19.1 t -134.75 94.08 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 107.523 -1.288 . . . . 74.400000000000006 107.523 175.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -88.73 123.99 33.69 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.71 -0.677 . . . . 74.540000000000006 109.822 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 125.18 9.69 4.99 Favored Glycine 0 N--CA 1.425 -2.074 0 C-N-CA 119.949 -1.119 . . . . 54.299999999999997 112.843 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -106.25 168.18 9.32 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.701 -0.851 . . . . 74.239999999999995 108.701 176.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 7.0 m -83.35 157.12 22.67 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.835 -1.172 . . . . 74.230000000000004 107.835 176.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 48.8 t -51.11 -44.61 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 122.911 0.484 . . . . 74.140000000000001 111.606 -178.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -63.37 -41.91 98.83 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.718 -0.674 . . . . 61.119999999999997 111.845 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 33.1 t -72.26 -40.41 65.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 116.121 -0.49 . . . . 73.0 109.912 -176.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.73 -49.44 73.02 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.641 -0.709 . . . . 71.099999999999994 111.243 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -65.08 -35.26 80.59 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.705 -0.225 . . . . 72.099999999999994 110.663 -178.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.443 ' O ' HG23 ' A' ' 514' ' ' VAL . 47.4 tttp -57.38 -52.29 65.97 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 124.088 0.867 . . . . 74.510000000000005 110.237 -178.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -62.74 -44.58 95.84 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 116.099 -0.501 . . . . 71.099999999999994 110.139 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.08 -45.81 91.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.751 -0.659 . . . . 74.439999999999998 111.137 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.26 -43.18 92.46 Favored 'General case' 0 CA--C 1.5 -0.949 0 O-C-N 123.495 0.497 . . . . 65.329999999999998 110.744 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 510' ' ' LYS . 78.7 t -59.72 -38.31 75.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.53 -0.759 . . . . 74.510000000000005 111.015 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -74.87 -22.76 58.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.041 0.448 . . . . 72.030000000000001 111.239 -178.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 134.44 -16.79 4.32 Favored Glycine 0 N--CA 1.428 -1.844 0 C-N-CA 119.747 -1.216 . . . . 54.32 112.665 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.677 ' HA ' ' O ' ' A' ' 547' ' ' VAL . 91.2 m-85 -75.89 96.79 3.79 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.744 -0.465 . . . . 65.549999999999997 109.744 -177.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 3.1 p -95.73 -12.81 24.84 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 113.38 0.882 . . . . 71.230000000000004 113.38 -175.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 64.6 mttp -108.74 115.85 30.88 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.434 -0.506 . . . . 74.120000000000005 110.364 178.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -130.2 151.25 50.93 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 109.739 -0.467 . . . . 72.329999999999998 109.739 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 61.3 m -141.1 140.82 34.23 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 107.909 -1.145 . . . . 75.549999999999997 107.909 175.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . 0.426 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 0.0 OUTLIER -117.41 137.15 52.69 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 121.326 0.584 . . . . 73.409999999999997 111.332 -176.648 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -111.58 116.95 31.69 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.767 -1.197 . . . . 73.010000000000005 107.767 176.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 19.3 m -96.96 124.46 40.94 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.487 -0.561 . . . . 72.019999999999996 109.487 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 28.4 m -129.13 150.02 34.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.753 -0.832 . . . . 75.040000000000006 108.753 177.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . 0.422 ' C ' ' HG ' ' A' ' 527' ' ' SER . 4.6 p30 -68.74 135.64 51.59 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.937 -0.764 . . . . 72.340000000000003 108.937 178.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 527' ' ' SER . . . . . 0.422 ' HG ' ' C ' ' A' ' 526' ' ' ASP . 50.8 m -156.54 171.95 6.72 Favored Pre-proline 0 C--N 1.297 -1.697 0 N-CA-C 108.558 -0.904 . . . . 74.5 108.558 -176.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -71.72 -19.93 27.05 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 121.835 1.69 . . . . 71.319999999999993 113.356 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.01 138.59 49.46 Favored Pre-proline 0 N--CA 1.469 0.495 0 C-N-CA 120.535 -0.466 . . . . 74.340000000000003 110.204 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.89 141.56 93.19 Favored 'Trans proline' 0 C--O 1.261 1.652 0 C-N-CA 122.726 2.284 . . . . 73.409999999999997 112.068 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.663 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -57.99 118.37 5.32 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 115.128 -0.942 . . . . 72.409999999999997 111.513 -176.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 135.92 -25.79 3.18 Favored Glycine 0 N--CA 1.432 -1.616 0 CA-C-N 115.59 -0.732 . . . . 71.310000000000002 111.32 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -83.73 134.47 34.75 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.104 0.478 . . . . 72.299999999999997 111.523 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 57.3 t -79.5 128.81 38.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 115.834 -0.621 . . . . 73.310000000000002 110.307 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 90.7 m -81.64 -33.8 31.17 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 124.781 1.232 . . . . 74.409999999999997 110.049 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.59 -150.82 22.79 Favored Glycine 0 N--CA 1.434 -1.452 0 N-CA-C 109.758 -1.337 . . . . 62.420000000000002 109.758 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 40.0 p -116.87 156.83 26.66 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 117.291 0.545 . . . . 72.129999999999995 110.063 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -82.11 -48.29 0.93 Allowed Pre-proline 0 C--N 1.31 -1.131 0 CA-C-N 115.496 -0.774 . . . . 73.540000000000006 110.014 173.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -66.63 133.55 32.32 Favored 'Trans proline' 0 C--N 1.37 1.675 0 N-CA-C 108.923 -1.222 . . . . 73.430000000000007 108.923 169.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.96 140.63 96.16 Favored 'Trans proline' 0 C--O 1.251 1.171 0 C-N-CA 122.51 2.14 . . . . 74.109999999999999 112.961 -177.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.33 140.95 58.13 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.76 -0.654 . . . . 74.040000000000006 109.671 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 98.54 -9.98 62.73 Favored Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 111.385 -0.686 . . . . 62.020000000000003 111.385 -178.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 41.9 m -75.28 126.26 30.66 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.603 -0.517 . . . . 72.219999999999999 109.603 178.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 15.2 t -83.48 129.81 34.99 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 108.12 -1.067 . . . . 71.329999999999998 108.12 174.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 11.4 p -142.43 153.43 62.4 Favored Pre-proline 0 C--N 1.294 -1.835 0 N-CA-C 106.649 -1.611 . . . . 75.430000000000007 106.649 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.5 140.27 93.98 Favored 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 121.78 1.654 . . . . 74.120000000000005 111.185 175.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 517' ' ' PHE . 27.1 m -65.22 -23.16 32.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 121.234 0.54 . . . . 75.230000000000004 112.33 -176.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.89 2.12 52.32 Favored 'General case' 0 N--CA 1.421 -1.896 0 O-C-N 122.028 -0.42 . . . . 70.25 111.116 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 66.2 m -84.96 170.49 13.0 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 121.16 0.505 . . . . 75.530000000000001 111.172 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 10.0 p -93.0 128.53 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-O 121.605 0.717 . . . . 74.219999999999999 111.842 -178.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . 0.429 HD12 ' O ' ' A' ' 519' ' ' LYS . 0.2 OUTLIER -108.52 136.11 45.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 108.572 -0.899 . . . . 72.409999999999997 108.572 172.717 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -103.53 118.44 36.74 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.445 0.641 . . . . 74.530000000000001 111.091 -176.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 2.3 mm? -95.94 134.35 39.04 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.499 -1.228 . . . . 70.329999999999998 109.525 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -98.3 124.52 42.97 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 108.77 -0.826 . . . . 74.129999999999995 108.77 175.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 57.2 t -114.43 128.64 71.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 115.899 -0.591 . . . . 75.219999999999999 110.662 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.663 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 69.4 m -69.8 131.57 44.72 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.698 -0.683 . . . . 63.100000000000001 111.565 174.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt -104.45 133.32 49.53 Favored 'General case' 0 C--O 1.202 -1.412 0 N-CA-C 107.435 -1.32 . . . . 73.439999999999998 107.435 169.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -70.16 -37.69 72.36 Favored Glycine 0 CA--C 1.503 -0.667 0 C-N-CA 120.184 -1.008 . . . . 61.310000000000002 111.279 -177.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 65.7 t30 65.35 28.56 11.76 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.603 1.161 . . . . 75.349999999999994 108.486 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -137.09 150.59 48.11 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 114.513 -1.221 . . . . 73.209999999999994 108.887 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -130.34 157.18 43.27 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.313 -0.625 . . . . 73.030000000000001 109.313 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 58.8 t -71.96 118.54 17.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 109.984 -0.376 . . . . 71.439999999999998 109.984 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 563' ' ' MET . . . . . 0.443 ' HB2' ' CG2' ' A' ' 614' ' ' VAL . 55.8 ttp -97.37 138.1 21.16 Favored Pre-proline 0 C--N 1.31 -1.145 0 CA-C-N 116.147 -0.478 . . . . 62.039999999999999 110.465 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.64 169.77 9.44 Favored 'Trans proline' 0 CA--C 1.552 1.395 0 C-N-CA 123.098 2.532 . . . . 73.299999999999997 111.422 172.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -88.37 129.78 35.32 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 113.064 0.764 . . . . 72.349999999999994 113.064 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . 0.412 ' O ' ' HB3' ' A' ' 569' ' ' MET . 2.8 mm? -114.25 -9.67 12.82 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.196 -1.039 . . . . 71.340000000000003 108.196 173.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 3.0 p -74.31 132.07 41.73 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 114.7 -1.136 . . . . 75.209999999999994 110.21 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 76.48 20.9 76.24 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 111.026 -0.829 . . . . 72.329999999999998 111.026 -176.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 569' ' ' MET . . . . . 0.412 ' HB3' ' O ' ' A' ' 566' ' ' LEU . 51.7 ttm -121.76 149.47 43.24 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.732 -0.84 . . . . 64.140000000000001 108.732 -178.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -82.62 142.61 31.61 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 108.655 -0.869 . . . . 71.519999999999996 108.655 177.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 72.1 t-105 -51.62 -27.22 10.66 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 124.707 1.203 . . . . 73.439999999999998 111.877 177.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 34.9 m -70.53 -20.39 22.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.58 -0.282 . . . . 61.32 111.525 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . 0.411 ' O ' ' HG3' ' A' ' 577' ' ' ARG . 9.6 t70 -101.57 -36.14 8.88 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.151 -1.055 . . . . 73.140000000000001 108.151 177.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.02 95.65 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 114.964 -1.016 . . . . 71.049999999999997 112.678 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.422 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 37.4 tt0 -57.63 -51.1 84.24 Favored Pre-proline 0 CA--C 1.563 1.458 0 CA-C-O 119.524 -0.274 . . . . 71.409999999999997 111.487 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . 0.422 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 54.1 Cg_exo -56.12 -39.69 89.6 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 121.46 1.44 . . . . 74.200000000000003 112.662 173.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 573' ' ' ASP . 51.4 mtt180 -64.25 -41.91 96.74 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.51 -0.476 . . . . 75.140000000000001 112.062 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.489 HD11 ' N ' ' A' ' 579' ' ' ARG 0.25 4.1 pp -66.28 -43.73 85.59 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 119.91 -0.716 . . . . 74.120000000000005 111.792 -177.575 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . 0.489 ' N ' HD11 ' A' ' 578' ' ' LEU . 15.8 ptm180 -66.43 -35.75 81.08 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 120.914 -0.314 . . . . 74.040000000000006 111.197 176.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.72 -28.29 66.69 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 122.638 0.375 . . . . 64.329999999999998 111.801 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 9.7 mp -81.52 -7.37 59.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.037 0.446 . . . . 75.019999999999996 111.217 174.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 80.36 15.16 79.0 Favored Glycine 0 N--CA 1.437 -1.244 0 C-N-CA 121.126 -0.559 . . . . 71.239999999999995 111.883 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 73.4 t90 -66.02 130.73 44.24 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.386 0.613 . . . . 73.409999999999997 110.01 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 75.5 m -143.83 93.65 2.49 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.833 -1.173 . . . . 71.299999999999997 107.833 176.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -150.6 -161.42 9.94 Favored Glycine 0 N--CA 1.419 -2.448 0 N-CA-C 109.409 -1.476 . . . . 73.430000000000007 109.409 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 55.0 ttp -91.04 124.89 35.61 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 120.832 0.349 . . . . 75.349999999999994 110.271 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -98.46 121.3 40.22 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 105.738 -1.949 . . . . 74.439999999999998 105.738 173.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -98.52 101.59 13.08 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.948 -0.76 . . . . 71.519999999999996 108.948 -177.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -99.6 130.44 45.84 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.606 -1.257 . . . . 75.099999999999994 107.606 -177.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -77.17 -97.93 0.19 Allowed Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.387 -1.085 . . . . 75.209999999999994 110.387 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.2 153.79 47.94 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.878 -0.786 . . . . 74.219999999999999 108.878 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -83.7 124.9 31.33 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.055 -1.091 . . . . 65.109999999999999 108.055 175.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 58.4 t -127.79 116.88 44.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 CA-C-N 115.881 -0.6 . . . . 74.120000000000005 109.944 -175.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -78.4 111.46 14.42 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.29 -1.374 . . . . 74.409999999999997 107.29 175.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -133.46 2.82 3.55 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.305 -0.558 . . . . 71.200000000000003 112.251 -176.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 127.85 166.06 11.98 Favored Glycine 0 N--CA 1.437 -1.29 0 N-CA-C 111.145 -0.782 . . . . 75.230000000000004 111.145 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -59.05 -35.64 84.82 Favored Glycine 0 C--O 1.227 -0.339 0 O-C-N 123.639 0.258 . . . . 71.409999999999997 113.532 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 13.4 p -65.78 -23.92 66.82 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.203 0.525 . . . . 72.209999999999994 111.722 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -102.37 -1.54 30.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.077 -0.51 . . . . 72.329999999999998 110.034 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -77.81 111.09 13.27 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.605 -0.517 . . . . 72.319999999999993 109.605 -177.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 12.6 m120 62.9 -11.99 0.08 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.325 1.85 . . . . 74.310000000000002 115.159 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -77.51 138.68 39.34 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 118.449 0.568 . . . . 74.299999999999997 112.404 -174.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 71.7 t -72.86 131.82 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 114.835 -1.075 . . . . 74.439999999999998 108.689 176.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . 0.409 HG21 ' O ' ' A' ' 623' ' ' ARG . 27.7 m -94.35 -41.14 12.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 C-N-CA 119.627 -0.829 . . . . 75.510000000000005 111.039 -176.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -151.4 154.69 37.14 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 106.678 -1.601 . . . . 72.239999999999995 106.678 175.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . 0.585 ' HA ' ' O ' ' A' ' 621' ' ' THR . 13.3 pt20 -133.82 142.43 47.85 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 106.646 -1.612 . . . . 72.25 106.646 174.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.45 ' HB2' ' OG1' ' A' ' 621' ' ' THR 0.33 91.4 m-20 -76.33 -57.39 1.37 Allowed Pre-proline 0 C--N 1.306 -1.29 0 N-CA-C 114.34 1.237 . . . . 75.239999999999995 114.34 -179.168 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.66 119.53 6.62 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 121.785 1.657 . . . . 75.0 110.048 175.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . 0.405 ' HB2' ' OG1' ' A' ' 612' ' ' THR . 6.2 Cg_exo -70.97 134.52 25.61 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 121.8 1.667 . . . . 60.130000000000003 113.762 -176.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -69.33 132.17 46.0 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.082 -0.963 . . . . 70.329999999999998 110.317 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 89.34 -8.58 79.53 Favored Glycine 0 C--N 1.309 -0.923 0 N-CA-C 111.435 -0.666 . . . . 74.219999999999999 111.435 -178.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 612' ' ' THR . . . . . 0.405 ' OG1' ' HB2' ' A' ' 609' ' ' PRO . 17.9 m -104.88 160.17 15.22 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 108.048 -1.093 . . . . 70.129999999999995 108.048 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -71.68 114.26 5.01 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.944 -0.862 . . . . 45.310000000000002 110.944 176.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . 0.443 ' CG2' ' HB2' ' A' ' 563' ' ' MET . 20.6 m -103.31 144.99 13.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 C-N-CA 124.234 1.013 . . . . 74.299999999999997 109.929 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -38.85 134.03 1.04 Allowed 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 125.665 1.586 . . . . 72.349999999999994 110.565 177.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . 0.413 ' HD3' ' N ' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -51.18 -25.06 4.83 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 114.494 1.294 . . . . 71.420000000000002 114.494 -171.367 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . 0.413 ' N ' ' HD3' ' A' ' 616' ' ' ARG . 3.4 p30 -77.43 -26.06 51.22 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.846 -0.616 . . . . 70.140000000000001 110.716 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 78.0 20.29 73.38 Favored Glycine 0 N--CA 1.433 -1.526 0 CA-C-O 119.081 -0.844 . . . . 74.219999999999999 114.461 173.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.76 119.58 13.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 118.429 1.115 . . . . 74.310000000000002 108.755 -176.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 7.0 tp -106.77 127.39 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.027 0 CA-C-N 114.207 -1.361 . . . . 74.430000000000007 110.504 -173.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.585 ' O ' ' HA ' ' A' ' 606' ' ' GLN . 1.6 p -107.71 117.72 34.86 Favored 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 109.241 -0.652 . . . . 62.350000000000001 109.241 176.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.1 pp -138.54 150.68 46.62 Favored 'General case' 0 CA--C 1.486 -1.496 0 C-N-CA 124.4 1.08 . . . . 74.299999999999997 108.431 -177.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . 0.409 ' O ' HG21 ' A' ' 604' ' ' VAL . 2.7 tmt_? -132.88 137.11 46.57 Favored 'General case' 0 C--N 1.273 -2.738 0 N-CA-C 104.861 -2.274 . . . . 73.519999999999996 104.861 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -129.78 165.23 22.35 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 107.962 -1.125 . . . . 75.25 107.962 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -82.5 -88.04 0.71 Allowed Glycine 0 N--CA 1.426 -1.985 0 N-CA-C 109.851 -1.3 . . . . 65.409999999999997 109.851 178.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 . . . . . 0 C--N 1.286 -2.176 0 N-CA-C 109.087 -0.708 . . . . 72.209999999999994 109.087 178.419 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.12 0 N-CA-C 110.969 -0.852 . . . . 75.019999999999996 110.969 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 9.3 tp -75.4 137.93 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 109.615 -0.513 . . . . 73.030000000000001 109.615 178.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 5.7 m -77.39 154.72 32.44 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.566 -0.902 . . . . 74.230000000000004 108.566 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.17 84.92 2.31 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 122.208 1.004 . . . . 75.349999999999994 110.66 178.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -76.88 148.22 36.6 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 113.739 -1.573 . . . . 72.099999999999994 111.042 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 28.0 m -127.74 156.75 39.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 C-N-CA 123.583 0.753 . . . . 75.310000000000002 109.66 -178.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . 0.447 HE21 ' C ' ' A' ' 361' ' ' GLN . 0.0 OUTLIER -95.89 122.79 39.07 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.221 -1.77 . . . . 63.340000000000003 106.221 179.328 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.424 HG23 ' CZ ' ' A' ' 382' ' ' PHE . 48.0 t -98.81 139.15 20.87 Favored Pre-proline 0 C--N 1.283 -2.313 0 CA-C-N 115.782 -0.645 . . . . 71.310000000000002 110.761 -171.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -70.61 150.07 62.46 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.25 1.967 . . . . 73.519999999999996 111.442 175.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . 0.438 ' OD2' ' HD2' ' A' ' 366' ' ' ARG . 27.9 t0 -102.76 152.66 20.99 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 107.247 -1.39 . . . . 64.299999999999997 107.247 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 10.2 t -122.67 11.64 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.374 0 CA-C-O 121.818 0.818 . . . . 61.210000000000001 109.675 -174.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.524 ' HB3' ' OG1' ' A' ' 402' ' ' THR . 8.8 ptm180 -52.37 144.33 13.27 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 115.606 -0.724 . . . . 74.109999999999999 111.858 177.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.5 -11.07 54.02 Favored Glycine 0 C--N 1.312 -0.771 0 CA-C-N 115.593 -0.73 . . . . 71.150000000000006 111.843 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -110.39 -151.3 0.47 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 123.074 0.55 . . . . 75.5 110.312 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 71.8 p -97.81 159.28 15.03 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.253 -0.647 . . . . 60.329999999999998 109.253 -173.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 5.6 p -63.55 -35.89 81.98 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 120.862 -0.335 . . . . 72.319999999999993 110.839 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -65.78 -46.42 78.78 Favored 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 111.733 0.271 . . . . 75.430000000000007 111.733 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -68.11 -41.31 81.96 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 121.452 0.644 . . . . 74.239999999999995 109.281 -177.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.54 -51.52 59.27 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.005 -0.998 . . . . 64.420000000000002 111.53 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 77.1 mt -63.96 -39.2 84.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 CA-C-N 116.355 -0.384 . . . . 75.230000000000004 110.854 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.05 -44.05 91.76 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 120.946 0.403 . . . . 74.219999999999999 110.495 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 44.5 m -65.48 -47.13 77.13 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.834 -0.621 . . . . 74.319999999999993 111.455 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 10.8 mp -61.76 -45.43 93.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.812 -0.177 . . . . 75.540000000000006 111.193 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -65.81 -35.42 80.64 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.178 -0.465 . . . . 74.510000000000005 110.344 -178.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -67.2 -25.24 66.02 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 120.972 0.415 . . . . 73.310000000000002 111.786 176.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -86.45 -8.07 57.91 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.945 0.402 . . . . 74.219999999999999 110.25 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . 0.446 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 100.42 0.69 55.62 Favored Glycine 0 CA--C 1.502 -0.748 0 CA-C-N 115.587 -0.733 . . . . 72.219999999999999 112.389 178.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.617 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 47.4 m-85 -80.0 153.97 28.51 Favored 'General case' 0 N--CA 1.418 -2.074 0 CA-C-O 121.443 0.639 . . . . 74.120000000000005 110.901 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 74.8 mmtt -113.01 161.42 17.06 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 114.916 -1.038 . . . . 75.299999999999997 108.414 -176.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.31 146.0 33.85 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 CA-C-O 121.461 0.648 . . . . 73.239999999999995 111.207 -176.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -110.26 127.98 55.28 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 104.64 -2.356 . . . . 64.319999999999993 104.64 174.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 25.5 m -117.37 127.0 53.62 Favored 'General case' 0 C--N 1.271 -2.828 0 C-N-CA 120.185 -0.606 . . . . 73.140000000000001 110.073 -174.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -112.12 128.64 56.28 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 105.472 -2.047 . . . . 75.25 105.472 177.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.467 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -120.65 145.5 47.37 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.815 -0.754 . . . . 63.509999999999998 111.397 -177.661 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -139.38 143.01 34.26 Favored Pre-proline 0 C--N 1.298 -1.669 0 CA-C-N 115.431 -0.804 . . . . 75.099999999999994 109.263 176.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . 0.43 ' HA ' ' HG1' ' A' ' 422' ' ' THR . 10.2 Cg_exo -74.89 158.03 42.87 Favored 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 122.229 1.953 . . . . 72.450000000000003 110.452 172.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 8.5 t70 87.43 -169.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 126.468 1.907 . . . . 73.129999999999995 108.869 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 37.4 m -144.02 14.29 1.68 Allowed 'General case' 0 C--N 1.316 -0.868 0 O-C-N 121.573 -0.704 . . . . 75.109999999999999 110.835 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 12.6 t -81.67 -19.12 42.31 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.807 -1.183 . . . . 74.540000000000006 107.807 176.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -97.61 152.84 38.38 Favored Pre-proline 0 N--CA 1.431 -1.418 0 N-CA-C 106.571 -1.64 . . . . 72.519999999999996 106.571 176.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -27.78 111.78 0.03 OUTLIER 'Trans proline' 0 CA--C 1.553 1.449 0 C-N-CA 125.089 3.86 . . . . 73.209999999999994 114.907 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . 0.526 ' HA ' ' OG ' ' A' ' 421' ' ' SER . 42.2 Cg_endo -63.73 160.92 34.39 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 124.159 3.239 . . . . 73.140000000000001 115.242 -174.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -60.11 -8.6 2.5 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 125.078 1.351 . . . . 74.209999999999994 113.091 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 37.0 m170 -106.39 132.31 52.56 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 105.746 -1.946 . . . . 74.439999999999998 105.746 175.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 27.7 m -75.21 117.6 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.256 0 C-N-CA 119.381 -0.927 . . . . 75.349999999999994 111.761 -165.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -97.24 -28.76 3.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 107.292 -1.373 . . . . 70.030000000000001 107.292 174.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.54 157.53 27.43 Favored Glycine 1 N--CA 1.395 -4.079 0 N-CA-C 108.938 -1.665 . . . . 73.310000000000002 108.938 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.524 ' OG1' ' HB3' ' A' ' 366' ' ' ARG . 0.8 OUTLIER -146.25 -176.25 5.09 Favored 'General case' 0 C--N 1.262 -3.207 0 N-CA-C 105.878 -1.897 . . . . 73.530000000000001 105.878 -177.726 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -100.28 126.95 34.44 Favored Pre-proline 0 C--N 1.289 -2.025 0 C-N-CA 118.208 -1.397 . . . . 53.420000000000002 109.731 -173.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.84 0.18 1.7 Allowed 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 124.067 3.178 . . . . 65.349999999999994 114.791 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.1 -34.46 68.34 Favored 'General case' 0 C--O 1.209 -1.046 0 N-CA-C 109.206 -0.664 . . . . 64.420000000000002 109.206 173.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . 0.423 ' O ' ' HB ' ' A' ' 362' ' ' VAL . . . -63.85 -40.7 97.19 Favored 'General case' 0 C--O 1.212 -0.887 0 CA-C-N 115.805 -0.634 . . . . 65.310000000000002 110.042 176.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -83.71 0.6 46.42 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.122 0.487 . . . . 65.040000000000006 111.513 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 34.0 m -95.21 157.41 15.91 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 104.92 -2.252 . . . . 72.230000000000004 104.92 171.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 49.0 m -74.35 112.47 10.55 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 118.55 -1.26 . . . . 71.409999999999997 108.928 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 18.6 m -128.48 169.1 20.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 C-N-CA 122.49 0.316 . . . . 74.420000000000002 110.366 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 15.6 m -79.86 145.18 32.87 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.762 -0.459 . . . . 73.040000000000006 109.762 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . 0.617 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -66.69 113.73 5.05 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.293 0.568 . . . . 52.399999999999999 110.56 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 110.35 44.68 0.98 Allowed Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 110.776 -0.93 . . . . 75.209999999999994 110.776 -178.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -109.21 166.29 10.97 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.198 -1.038 . . . . 75.120000000000005 108.198 -177.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 49.2 mt-10 -100.23 118.5 36.66 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 118.212 0.46 . . . . 71.439999999999998 110.837 -177.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 44.4 mm -103.61 133.18 48.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 109.188 -0.671 . . . . 75.430000000000007 109.188 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 11.5 t -85.18 130.46 34.6 Favored 'General case' 0 C--O 1.252 1.217 0 CA-C-O 121.303 0.573 . . . . 75.109999999999999 112.306 -176.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 5.3 p -127.3 135.78 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 C-N-CA 124.052 0.941 . . . . 73.010000000000005 109.544 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -101.99 129.18 48.22 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.77 -0.456 . . . . 71.209999999999994 109.77 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 8.9 p -123.1 133.1 70.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 109.356 -0.609 . . . . 74.230000000000004 109.356 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' SER . . . . . 0.526 ' OG ' ' HA ' ' A' ' 396' ' ' PRO . 74.6 p -103.61 130.9 51.12 Favored 'General case' 0 N--CA 1.428 -1.541 0 O-C-N 122.086 -0.384 . . . . 62.32 110.55 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' THR . . . . . 0.43 ' HG1' ' HA ' ' A' ' 390' ' ' PRO . 41.0 p -97.02 107.97 20.61 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.987 -1.486 . . . . 72.049999999999997 106.987 173.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -44.82 -86.49 0.01 OUTLIER Glycine 0 N--CA 1.467 0.708 0 N-CA-C 116.653 1.421 . . . . 74.420000000000002 116.653 -170.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -71.95 128.46 14.08 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.697 1.598 . . . . 75.200000000000003 112.741 -175.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -92.02 153.4 19.45 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 107.737 -1.208 . . . . 75.409999999999997 107.737 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -88.47 156.23 19.22 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.09 -1.448 . . . . 63.310000000000002 107.09 174.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 8.5 mmp_? -121.98 150.17 42.43 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-O 121.017 0.437 . . . . 72.200000000000003 111.217 -176.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -85.8 138.51 32.02 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.427 -0.806 . . . . 72.209999999999994 109.729 -177.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 56.9 mt -87.55 131.57 43.42 Favored Pre-proline 0 C--N 1.295 -1.769 0 N-CA-C 108.733 -0.839 . . . . 75.420000000000002 108.733 178.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -70.76 141.45 41.21 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.715 1.61 . . . . 64.109999999999999 110.634 172.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -84.61 99.86 11.05 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.801 -1.185 . . . . 74.349999999999994 107.801 178.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 60.9 t -101.9 136.94 31.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 108.597 -0.89 . . . . 72.409999999999997 108.597 -174.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 18.9 m -57.22 149.8 19.11 Favored 'General case' 0 N--CA 1.435 -1.209 0 O-C-N 124.252 0.97 . . . . 74.019999999999996 112.517 -177.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' THR . . . . . 0.415 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 24.8 p -69.45 -25.06 63.91 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 115.283 1.586 . . . . 73.420000000000002 115.283 -170.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.7 pp -85.97 -11.67 52.42 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.628 -0.829 . . . . 74.420000000000002 110.768 176.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.68 42.53 1.09 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.183 -0.917 . . . . 63.219999999999999 110.152 -175.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . 0.417 ' HH ' ' HB2' ' A' ' 454' ' ' GLN . 86.6 t80 -52.56 -38.71 60.43 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.396 1.079 . . . . 72.099999999999994 112.749 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -62.27 -39.57 93.35 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.559 0.695 . . . . 73.319999999999993 110.681 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -70.53 -37.39 74.08 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.266 -0.879 . . . . 65.310000000000002 109.158 177.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -62.66 -51.82 65.74 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.936 -0.575 . . . . 74.409999999999997 111.078 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 28.8 m -61.88 -38.89 81.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 112.476 0.547 . . . . 73.450000000000003 112.476 -177.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -68.28 -38.08 81.35 Favored 'General case' 0 C--N 1.35 0.623 0 C-N-CA 119.255 -0.978 . . . . 75.5 110.908 177.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -66.35 -38.66 88.11 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.462 0.542 . . . . 75.120000000000005 112.462 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -63.38 -35.8 81.6 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.881 -0.414 . . . . 71.129999999999995 109.881 174.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.477 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 47.0 m -70.49 -48.3 56.37 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.918 -0.583 . . . . 74.519999999999996 110.804 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.5 -16.65 63.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.949 -0.569 . . . . 64.400000000000006 111.91 -177.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.05 -13.14 59.95 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.279 -0.419 . . . . 64.430000000000007 111.751 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 124.98 -69.88 0.48 Allowed Glycine 0 CA--C 1.492 -1.348 0 C-N-CA 120.068 -1.063 . . . . 65.109999999999999 111.932 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.52 -65.81 0.51 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.542 0.571 . . . . 74.230000000000004 112.542 177.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . 0.477 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 64.28 21.93 66.79 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 116.123 -0.49 . . . . 70.310000000000002 113.287 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.418 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 28.5 mmm180 -104.27 110.49 22.73 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 107.466 -1.309 . . . . 75.109999999999999 107.466 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -137.13 147.01 45.72 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 115.662 -0.699 . . . . 75.519999999999996 109.875 -177.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -132.77 148.95 52.33 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 108.264 -1.013 . . . . 75.409999999999997 108.264 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . 0.417 ' HB2' ' HH ' ' A' ' 437' ' ' TYR . 62.4 tt0 -117.67 125.75 51.27 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 110.212 -0.292 . . . . 65.430000000000007 110.212 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.19 148.13 41.88 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.293 -1.002 . . . . 74.140000000000001 108.293 176.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -114.17 140.85 48.19 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.141 -0.689 . . . . 74.530000000000001 109.141 -177.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 68.4 m -148.41 137.93 12.38 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 110.46 -0.2 . . . . 70.200000000000003 110.46 173.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.719 ' HA ' ' O ' ' A' ' 490' ' ' SER . 29.6 Cg_endo -65.75 128.09 19.24 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.348 2.032 . . . . 75.010000000000005 110.426 175.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 48.5 m -140.57 -179.83 6.25 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 116.489 -0.323 . . . . 75.239999999999995 110.589 -176.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 9.9 t -45.58 130.99 6.44 Favored Pre-proline 0 CA--C 1.556 1.192 0 C-N-CA 124.53 1.132 . . . . 75.439999999999998 111.934 178.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . 0.559 ' O ' HG23 ' A' ' 464' ' ' VAL . 11.3 Cg_endo -51.72 -28.24 29.28 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 125.18 3.92 . . . . 73.450000000000003 114.466 -174.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.74 -32.08 67.35 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.147 0.498 . . . . 75.120000000000005 111.83 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . 0.531 HD11 ' O ' ' A' ' 463' ' ' LEU . 3.3 tm? -97.2 -13.46 22.05 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.984 -0.553 . . . . 72.439999999999998 110.66 -171.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 461' ' ' PRO . 19.4 m -60.09 131.09 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 CA-C-O 121.47 0.652 . . . . 70.519999999999996 111.174 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.65 2.18 55.34 Favored Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 115.294 -0.866 . . . . 63.509999999999998 111.655 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -128.28 166.46 18.56 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.978 -0.749 . . . . 75.099999999999994 108.978 176.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.415 ' O ' ' HB ' ' A' ' 434' ' ' THR . 70.8 t -72.41 148.8 9.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.354 -0.98 . . . . 74.219999999999999 108.354 175.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 47.5 mt -97.36 -35.25 5.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 106.61 -1.626 . . . . 73.540000000000006 106.61 174.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 153.6 -168.67 32.22 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 110.377 -1.089 . . . . 73.150000000000006 110.377 176.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 470' ' ' THR . . . . . 0.441 ' HB ' HG12 ' A' ' 486' ' ' ILE . 0.6 OUTLIER -115.83 141.11 48.53 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 107.929 -1.137 . . . . 60.539999999999999 107.929 176.266 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.443 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 46.2 t-20 -63.36 -51.4 68.42 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 123.529 0.518 . . . . 74.430000000000007 110.512 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 27.3 Cg_exo -70.55 124.09 10.44 Favored 'Trans proline' 0 C--N 1.373 1.856 0 N-CA-C 107.0 -1.961 . . . . 74.340000000000003 107.0 166.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . 0.459 ' C ' ' H ' ' A' ' 475' ' ' ASN . 18.2 Cg_endo -61.94 127.78 22.37 Favored 'Trans proline' 0 C--O 1.241 0.673 0 C-N-CA 122.467 2.112 . . . . 74.420000000000002 114.248 -172.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -77.68 16.53 0.66 Allowed 'General case' 0 C--O 1.198 -1.642 0 CA-C-N 114.676 -1.147 . . . . 63.210000000000001 110.475 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . 0.459 ' H ' ' C ' ' A' ' 473' ' ' PRO . 0.9 OUTLIER -109.14 -9.19 15.05 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.601 -0.727 . . . . 75.219999999999999 109.618 178.414 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -107.07 175.47 5.49 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-O 121.722 0.773 . . . . 74.109999999999999 112.902 -174.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 4.1 m -92.38 106.14 18.2 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 114.421 -1.263 . . . . 65.040000000000006 108.842 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 68.2 m -100.87 149.32 23.99 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 123.263 0.625 . . . . 72.239999999999995 111.119 -176.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -78.3 154.43 30.91 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.328 -0.396 . . . . 70.340000000000003 111.448 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.56 -23.06 27.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 C-N-CA 123.61 0.764 . . . . 72.129999999999995 111.622 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 17.7 p -94.42 5.55 51.44 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.365 0.602 . . . . 75.219999999999999 111.16 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -98.83 140.71 32.61 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.17 -0.468 . . . . 75.549999999999997 111.113 -175.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . 0.418 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.5 p -107.34 127.11 63.42 Favored 'Isoleucine or valine' 0 C--O 1.245 0.824 0 CA-C-N 115.977 -0.556 . . . . 73.340000000000003 111.803 -178.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 32.5 m -97.05 140.97 16.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.34 0.59 . . . . 71.209999999999994 110.392 177.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.95 114.0 45.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.893 -0.78 . . . . 74.049999999999997 108.893 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . 0.441 HG12 ' HB ' ' A' ' 470' ' ' THR . 61.4 mt -98.69 124.84 52.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 114.618 -1.174 . . . . 72.540000000000006 109.707 -178.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 5.2 tt -109.43 126.72 66.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 109.458 -0.571 . . . . 72.430000000000007 109.458 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 32.6 m -105.34 151.13 7.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 115.871 -0.604 . . . . 71.150000000000006 110.758 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -90.16 122.89 6.76 Favored Glycine 0 N--CA 1.416 -2.635 0 N-CA-C 109.33 -1.508 . . . . 73.310000000000002 109.33 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.719 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 8.5 t -125.22 160.34 29.45 Favored 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 107.575 -1.269 . . . . 63.219999999999999 107.575 -178.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 161.5 174.52 31.47 Favored Glycine 0 N--CA 1.435 -1.372 0 C-N-CA 119.983 -1.103 . . . . 61.210000000000001 112.112 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -93.31 152.74 2.5 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 123.084 2.523 . . . . 74.310000000000002 113.129 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -81.07 92.61 6.27 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 108.929 -0.767 . . . . 73.439999999999998 108.929 177.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 9.4 p -117.22 143.82 45.46 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.0 -1.0 . . . . 70.219999999999999 109.727 -177.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -150.99 157.46 42.91 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.46 -0.941 . . . . 64.530000000000001 108.46 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.5 m-20 -80.37 128.23 33.32 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 107.544 -1.28 . . . . 70.209999999999994 107.544 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . 0.413 HD12 ' HB2' ' A' ' 539' ' ' PRO . 40.7 pt -76.11 136.49 69.3 Favored Pre-proline 0 C--N 1.299 -1.611 0 O-C-N 123.121 0.263 . . . . 73.340000000000003 111.42 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -88.55 155.59 6.42 Favored 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 122.265 1.977 . . . . 72.329999999999998 108.938 168.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.92 165.44 11.71 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.664 -1.236 . . . . 74.420000000000002 107.664 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.77 117.14 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.354 0 CA-C-O 121.989 0.9 . . . . 70.439999999999998 111.279 -174.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -131.32 110.33 11.0 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 114.423 -1.262 . . . . 72.239999999999995 107.968 174.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 135.89 -14.58 4.1 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 119.768 -1.206 . . . . 71.329999999999998 112.553 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -98.02 172.59 7.53 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.324 -0.551 . . . . 73.319999999999993 110.074 177.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 11.4 t -90.3 157.28 17.74 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 107.959 -1.126 . . . . 72.420000000000002 107.959 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.448 ' HA ' ' CG2' ' A' ' 534' ' ' VAL . 7.6 p -50.05 -46.92 24.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 O-C-N 124.26 0.975 . . . . 55.240000000000002 112.594 -175.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.24 -42.08 80.24 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.389 -0.524 . . . . 72.450000000000003 111.923 -177.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 95.6 t -72.42 -36.24 54.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.091 -0.504 . . . . 65.150000000000006 111.255 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.65 -49.02 74.86 Favored 'General case' 0 C--N 1.31 -1.111 0 O-C-N 122.21 -0.306 . . . . 74.530000000000001 110.859 178.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -60.22 -36.4 77.61 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.8 0.81 . . . . 73.400000000000006 109.823 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -65.23 -46.54 80.2 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 114.401 -1.272 . . . . 73.120000000000005 109.666 -177.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -61.77 -47.97 82.77 Favored 'General case' 0 CA--C 1.495 -1.172 0 O-C-N 124.188 0.93 . . . . 75.329999999999998 111.263 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.75 -41.84 91.88 Favored 'General case' 0 CA--C 1.513 -0.468 0 O-C-N 123.159 0.287 . . . . 73.430000000000007 111.053 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . 0.421 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 1.0 OUTLIER -62.68 -38.19 89.4 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.341 -0.391 . . . . 71.140000000000001 111.215 178.739 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 73.9 t -70.13 -29.18 38.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.962 -0.563 . . . . 70.230000000000004 110.866 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -76.74 -12.13 59.94 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.191 0.519 . . . . 72.040000000000006 110.001 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . 0.477 ' O ' ' HB ' ' A' ' 547' ' ' VAL . . . 121.48 -25.52 6.92 Favored Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 120.837 -0.696 . . . . 71.310000000000002 111.974 177.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.588 ' HA ' ' O ' ' A' ' 547' ' ' VAL . 66.1 m-85 -76.22 103.81 6.43 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.529 0.68 . . . . 65.430000000000007 109.685 -176.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 3.3 p -86.17 -28.41 23.94 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 113.896 1.073 . . . . 72.519999999999996 113.896 -170.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 67.9 mttm -109.07 126.24 52.96 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.443 0.639 . . . . 74.010000000000005 112.34 -174.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -129.82 157.49 42.06 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 123.756 0.822 . . . . 73.319999999999993 110.398 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 71.1 m -137.44 143.55 41.87 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 107.022 -1.473 . . . . 75.019999999999996 107.022 170.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -125.06 147.68 48.86 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 120.75 0.309 . . . . 74.510000000000005 110.357 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -141.08 129.5 22.48 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 107.817 -1.179 . . . . 75.109999999999999 107.817 174.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 524' ' ' SER . . . . . 0.538 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 52.4 m -89.2 139.46 30.46 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 109.865 -0.42 . . . . 72.209999999999994 109.865 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 26.8 m -120.98 164.73 17.23 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 107.631 -1.248 . . . . 63.229999999999997 107.631 178.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . 0.565 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 2.2 p-10 -82.62 134.69 35.17 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 118.963 -1.095 . . . . 73.310000000000002 108.671 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 527' ' ' SER . . . . . 0.402 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 48.3 m -155.29 168.06 12.88 Favored Pre-proline 0 N--CA 1.441 -0.877 0 C-N-CA 120.482 -0.487 . . . . 75.329999999999998 110.554 -176.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -83.24 -10.7 9.99 Favored 'Trans proline' 0 CA--C 1.546 1.113 0 C-N-CA 122.014 1.809 . . . . 64.430000000000007 111.23 171.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.35 135.16 50.6 Favored Pre-proline 0 CA--C 1.506 -0.73 0 N-CA-C 107.695 -1.224 . . . . 75.239999999999995 107.695 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.95 150.88 52.73 Favored 'Trans proline' 0 C--O 1.256 1.417 0 C-N-CA 122.686 2.257 . . . . 73.430000000000007 113.446 -176.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -64.41 121.77 15.15 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.856 -1.066 . . . . 75.230000000000004 110.966 -175.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 126.7 -16.29 6.56 Favored Glycine 0 N--CA 1.424 -2.123 0 C-N-CA 120.455 -0.878 . . . . 63.450000000000003 111.864 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -83.19 128.43 34.48 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 120.448 -0.501 . . . . 71.030000000000001 110.143 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . 0.448 ' CG2' ' HA ' ' A' ' 505' ' ' VAL . 59.9 t -84.66 114.19 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.337 0 N-CA-C 106.08 -1.822 . . . . 75.140000000000001 106.08 174.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 9.1 m -113.73 9.86 17.79 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 119.526 -0.87 . . . . 74.430000000000007 111.918 -173.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 179.02 168.51 38.24 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 119.284 -1.436 . . . . 73.230000000000004 112.821 176.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 45.4 p -132.1 155.08 48.74 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.789 -1.189 . . . . 74.310000000000002 107.789 176.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . 0.455 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 23.3 t-20 -73.37 -57.46 2.73 Favored Pre-proline 0 C--N 1.314 -0.952 0 C-N-CA 120.189 -0.604 . . . . 73.140000000000001 111.477 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . 0.455 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 1.1 Cg_endo -84.0 140.9 9.16 Favored 'Trans proline' 0 N--CA 1.436 -1.909 0 CA-C-N 120.053 1.055 . . . . 72.409999999999997 109.509 175.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.45 158.42 48.03 Favored 'Trans proline' 0 C--O 1.267 1.97 0 C-N-CA 121.977 1.785 . . . . 74.209999999999994 112.528 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.17 139.88 58.82 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 115.113 -0.948 . . . . 74.219999999999999 109.81 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 104.21 -8.75 49.33 Favored Glycine 0 N--CA 1.422 -2.28 0 C-N-CA 120.347 -0.93 . . . . 43.340000000000003 111.625 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 26.4 m -75.76 120.45 21.15 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.732 -0.84 . . . . 71.340000000000003 108.732 175.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 10.9 t -88.16 124.88 34.26 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-O 121.366 0.603 . . . . 60.530000000000001 110.864 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 33.8 m -141.95 165.3 28.71 Favored Pre-proline 0 C--N 1.315 -0.895 0 N-CA-C 108.164 -1.05 . . . . 74.150000000000006 108.164 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.61 144.44 94.25 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 121.92 1.747 . . . . 72.120000000000005 110.399 172.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.588 ' O ' ' HA ' ' A' ' 517' ' ' PHE . 34.8 m -64.71 -20.29 27.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 121.942 0.877 . . . . 74.120000000000005 112.166 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -92.78 4.8 53.13 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 115.773 -0.649 . . . . 73.200000000000003 111.65 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 12.8 t -86.6 170.72 11.6 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.424 -0.954 . . . . 64.239999999999995 108.424 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 99.7 t -95.92 131.98 41.3 Favored 'Isoleucine or valine' 0 C--O 1.247 0.925 0 N-CA-C 112.586 0.587 . . . . 74.25 112.586 -175.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . 0.528 HD12 ' O ' ' A' ' 519' ' ' LYS . 0.2 OUTLIER -105.34 134.22 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 108.574 -0.899 . . . . 72.209999999999994 108.574 169.13 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -102.97 117.08 33.8 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 116.446 -0.343 . . . . 72.409999999999997 110.167 -176.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 5.3 mp -103.9 134.43 47.21 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.07 0.948 . . . . 74.030000000000001 111.239 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -96.89 121.84 39.21 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.66 -0.867 . . . . 74.329999999999998 108.66 174.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 524' ' ' SER . 24.5 t -107.9 139.6 29.35 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 N-CA-C 108.612 -0.885 . . . . 63.43 108.612 -178.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.573 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 69.1 m -81.42 143.79 31.88 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 111.88 0.326 . . . . 74.299999999999997 111.88 178.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.565 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 12.2 ptmt -105.47 156.43 18.22 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 104.591 -2.374 . . . . 74.299999999999997 104.591 167.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -83.5 -24.31 50.99 Favored Glycine 0 CA--C 1.498 -1.03 0 C-N-CA 119.864 -1.16 . . . . 62.100000000000001 115.446 -168.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . 0.43 ' HB3' ' HD2' ' A' ' 616' ' ' ARG . 85.6 m-20 62.67 27.62 16.22 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.112 0.482 . . . . 71.329999999999998 110.586 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -128.58 149.28 50.7 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.231 -1.026 . . . . 53.420000000000002 108.231 -172.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -140.89 149.2 41.61 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.167 -1.049 . . . . 53.009999999999998 108.167 173.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.4 p -83.67 116.86 28.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 121.849 0.833 . . . . 75.120000000000005 112.081 -176.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 60.0 ttp -89.5 127.05 56.21 Favored Pre-proline 0 C--N 1.312 -1.033 0 CA-C-N 115.283 -0.871 . . . . 61.5 108.689 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.62 154.8 66.83 Favored 'Trans proline' 0 C--O 1.239 0.555 0 C-N-CA 122.261 1.974 . . . . 74.120000000000005 111.811 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -83.13 115.5 21.93 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.351 0.596 . . . . 73.010000000000005 111.782 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . 0.567 ' O ' ' HG3' ' A' ' 569' ' ' MET . 95.2 mt -136.87 18.33 3.04 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.536 -1.211 . . . . 70.349999999999994 109.001 178.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 24.0 t -52.69 131.07 34.26 Favored 'General case' 0 CA--C 1.553 1.093 0 O-C-N 123.384 0.427 . . . . 73.219999999999999 110.748 -175.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 107.37 41.54 1.61 Allowed Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 109.382 -1.487 . . . . 74.540000000000006 109.382 -174.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 569' ' ' MET . . . . . 0.567 ' HG3' ' O ' ' A' ' 566' ' ' LEU . 79.0 mtp -101.02 158.11 16.25 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.167 -0.517 . . . . 75.010000000000005 110.518 -177.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . 0.42 ' HB3' ' OD1' ' A' ' 601' ' ' ASN . 98.7 m-85 -102.69 168.13 9.45 Favored 'General case' 0 N--CA 1.416 -2.13 0 N-CA-C 106.886 -1.524 . . . . 75.319999999999993 106.886 170.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 79.9 t90 -64.23 -32.37 73.92 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.902 -0.777 . . . . 74.299999999999997 108.902 174.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.1 p -67.94 -20.19 25.66 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 CA-C-N 115.511 -0.768 . . . . 73.239999999999995 110.612 177.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -85.43 -38.06 19.08 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 108.444 -0.946 . . . . 71.540000000000006 108.444 175.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -57.66 -41.38 81.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.043 -0.981 . . . . 73.530000000000001 112.185 -177.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -55.59 -59.82 10.23 Favored Pre-proline 0 CA--C 1.591 2.529 0 N-CA-C 112.795 0.665 . . . . 71.340000000000003 112.795 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.1 -43.02 26.2 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 121.622 1.548 . . . . 64.400000000000006 112.88 175.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -59.79 -33.81 72.2 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 111.772 0.286 . . . . 74.439999999999998 111.772 -177.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 6.9 tt -57.4 -46.65 83.25 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.622 0.769 . . . . 74.319999999999993 109.422 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -65.38 -47.42 76.4 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.86 -0.609 . . . . 75.219999999999999 111.634 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.64 -39.16 88.12 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.605 -0.725 . . . . 70.099999999999994 112.598 -175.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 88.9 mt -84.49 -8.01 59.08 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 111.677 0.251 . . . . 74.299999999999997 111.677 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 66.76 41.57 93.61 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 111.481 -0.647 . . . . 73.140000000000001 111.481 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 90.9 t90 -83.61 134.77 34.78 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.039 0.447 . . . . 70.439999999999998 111.798 -176.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 91.4 m -154.13 96.38 1.94 Allowed 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 124.561 1.144 . . . . 72.430000000000007 108.314 170.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -147.19 -147.16 4.49 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 108.569 -1.812 . . . . 74.420000000000002 108.569 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 586' ' ' MET . . . . . 0.477 ' HB3' HG12 ' A' ' 619' ' ' ILE . 23.2 ttt -98.28 124.23 42.78 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 117.888 0.844 . . . . 74.040000000000006 109.028 178.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 57.4 tp -94.92 115.53 27.57 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 107.361 -1.348 . . . . 74.329999999999998 107.361 177.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -95.67 104.5 16.42 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.639 -0.825 . . . . 74.239999999999995 109.697 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -110.6 134.25 52.58 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.996 -0.547 . . . . 73.329999999999998 109.686 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -102.8 -173.4 26.71 Favored Glycine 0 N--CA 1.432 -1.577 0 N-CA-C 110.072 -1.211 . . . . 73.109999999999999 110.072 174.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -65.85 148.74 51.29 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 122.449 0.3 . . . . 72.120000000000005 110.799 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . 0.418 ' HA ' ' O ' ' A' ' 625' ' ' GLY . 3.7 m-20 -78.98 123.61 27.45 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.688 -1.227 . . . . 75.200000000000003 107.688 177.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 88.6 t -137.54 120.3 20.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 116.291 -0.413 . . . . 73.549999999999997 110.538 -173.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -80.53 106.86 12.87 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.001 -1.111 . . . . 70.439999999999998 108.001 174.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -126.37 2.05 7.01 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.84 -0.618 . . . . 65.120000000000005 111.361 -176.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 123.2 163.58 11.83 Favored Glycine 0 N--CA 1.43 -1.704 0 C-N-CA 119.815 -1.183 . . . . 75.230000000000004 111.084 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.24 -36.6 69.38 Favored Glycine 0 C--O 1.223 -0.573 0 N-CA-C 114.151 0.421 . . . . 63.340000000000003 114.151 -173.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 25.8 m -64.59 -24.5 67.61 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 117.176 0.488 . . . . 73.450000000000003 111.939 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -107.05 -8.32 16.58 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 122.044 -0.41 . . . . 73.409999999999997 110.876 -178.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 59.3 m170 -74.38 103.48 4.77 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 112.901 0.704 . . . . 74.319999999999993 112.901 -175.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . 0.42 ' OD1' ' HB3' ' A' ' 570' ' ' PHE . 4.5 t-20 69.04 -4.27 1.29 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.14 1.776 . . . . 75.219999999999999 112.695 172.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -86.78 140.65 29.51 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.31 1.044 . . . . 74.439999999999998 108.254 -177.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 96.8 t -69.82 130.79 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 107.444 -1.317 . . . . 73.430000000000007 107.444 176.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . 0.424 HG11 ' O ' ' A' ' 623' ' ' ARG . 9.0 p -99.42 -32.89 3.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 119.204 -0.998 . . . . 65.010000000000005 110.899 -174.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -147.62 153.47 39.44 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 106.356 -1.72 . . . . 75.409999999999997 106.356 176.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -123.42 -172.09 2.44 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 108.557 -0.905 . . . . 71.150000000000006 108.557 177.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.43 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 55.2 t30 -113.36 -65.02 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.534 0 C-N-CA 119.152 -1.019 . . . . 71.219999999999999 112.277 -177.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.43 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 59.1 Cg_endo -88.99 157.96 5.87 Favored 'Trans proline' 0 CA--C 1.552 1.404 0 CA-C-N 120.835 1.334 . . . . 74.129999999999995 110.65 174.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -70.73 135.0 27.13 Favored 'Trans proline' 0 C--O 1.249 1.026 0 C-N-CA 122.304 2.002 . . . . 74.010000000000005 112.623 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -68.89 132.62 47.02 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.642 -0.708 . . . . 72.420000000000002 109.665 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 93.07 -0.48 69.2 Favored Glycine 0 C--N 1.316 -0.548 0 N-CA-C 111.153 -0.779 . . . . 65.099999999999994 111.153 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 43.2 m -110.98 164.36 12.88 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 108.429 -0.952 . . . . 72.310000000000002 108.429 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -70.4 122.66 11.09 Favored Glycine 0 N--CA 1.416 -2.683 0 N-CA-C 111.371 -0.692 . . . . 75.420000000000002 111.371 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 33.1 m -105.82 144.51 15.16 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 108.074 -1.084 . . . . 63.450000000000003 108.074 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . 0.424 ' ND2' ' HB3' ' A' ' 617' ' ' ASP . 29.5 p-10 -53.85 149.21 9.06 Favored 'General case' 0 C--O 1.22 -0.482 0 O-C-N 123.309 0.38 . . . . 74.409999999999997 110.536 -178.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . 0.43 ' HD2' ' HB3' ' A' ' 559' ' ' ASN . 0.1 OUTLIER -54.71 -25.44 27.35 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 112.696 0.628 . . . . 74.219999999999999 112.696 -178.388 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . 0.424 ' HB3' ' ND2' ' A' ' 615' ' ' ASN . 31.5 t70 -67.73 -37.07 81.7 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.724 -0.671 . . . . 73.319999999999993 109.486 177.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 85.53 21.39 54.15 Favored Glycine 0 C--O 1.202 -1.876 0 C-N-CA 120.655 -0.784 . . . . 65.299999999999997 112.627 176.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . 0.477 HG12 ' HB3' ' A' ' 586' ' ' MET . 0.1 OUTLIER -68.69 119.72 14.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 122.563 1.173 . . . . 75.310000000000002 111.333 -170.548 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 40.2 mm -121.04 119.76 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-N 114.027 -1.442 . . . . 65.150000000000006 107.747 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 51.8 m -98.87 118.64 36.09 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.354 -1.351 . . . . 73.430000000000007 107.354 174.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -138.04 165.39 26.7 Favored 'General case' 0 CA--C 1.484 -1.558 0 N-CA-C 108.162 -1.051 . . . . 74.319999999999993 108.162 -174.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . 0.424 ' O ' HG11 ' A' ' 604' ' ' VAL . 14.2 tpt180 -148.14 141.63 25.38 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 106.617 -1.623 . . . . 75.230000000000004 106.617 176.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -136.52 158.89 43.38 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 105.818 -1.919 . . . . 73.340000000000003 105.818 173.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 592' ' ' ASP . . . -77.8 -90.96 0.31 Allowed Glycine 0 N--CA 1.426 -1.99 0 N-CA-C 110.355 -1.098 . . . . 61.549999999999997 110.355 178.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 . . . . . 0 C--N 1.288 -2.098 0 CA-C-O 118.132 -0.937 . . . . 72.439999999999998 109.143 176.417 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.247 0 N-CA-C 109.745 -1.342 . . . . 51.020000000000003 109.745 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 9.8 tp -74.72 120.58 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.857 0 CA-C-O 122.29 1.043 . . . . 72.450000000000003 110.302 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 23.2 m -110.43 161.45 15.65 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 114.946 -1.024 . . . . 73.329999999999998 109.004 -177.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.09 83.76 2.06 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 107.579 -1.267 . . . . 74.230000000000004 107.579 175.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -66.5 149.35 50.58 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 113.058 -1.883 . . . . 74.219999999999999 110.89 -173.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 28.5 m -116.89 147.93 19.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 109.209 -0.663 . . . . 74.420000000000002 109.209 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . 0.417 ' NE2' ' HA ' ' A' ' 407' ' ' ASN . 0.8 OUTLIER -94.09 130.07 40.4 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 105.18 -2.156 . . . . 74.430000000000007 105.18 -178.759 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 79.8 t -95.8 132.13 27.84 Favored Pre-proline 0 C--N 1.288 -2.093 0 CA-C-N 115.46 -0.791 . . . . 71.530000000000001 111.025 -166.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -61.5 122.43 11.06 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.531 2.154 . . . . 72.430000000000007 111.938 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -89.08 111.42 22.16 Favored 'General case' 0 C--N 1.272 -2.779 0 CA-C-N 114.072 -1.422 . . . . 63.340000000000003 110.465 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 7.1 t -86.72 24.0 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.558 0 CA-C-O 122.807 1.289 . . . . 75.450000000000003 111.24 -174.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.516 ' HD2' ' O ' ' A' ' 366' ' ' ARG . 1.9 ppt_? -52.86 144.63 14.16 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.691 -1.14 . . . . 74.200000000000003 112.225 172.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 98.51 -14.47 62.03 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 120.82 -0.705 . . . . 71.299999999999997 112.54 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -102.07 -89.38 0.37 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 120.222 -0.591 . . . . 74.140000000000001 111.104 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 81.0 p -164.74 168.79 17.54 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.138 -1.06 . . . . 62.420000000000002 108.138 177.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 28.7 m -63.37 -40.82 98.3 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 109.053 -0.721 . . . . 73.200000000000003 109.053 176.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.79 -45.83 90.84 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.835 -0.621 . . . . 72.230000000000004 110.983 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -64.05 -42.38 97.05 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.355 0.41 . . . . 75.239999999999995 111.043 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -66.74 -50.11 63.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.14 -0.482 . . . . 64.030000000000001 111.06 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 78.4 mt -61.98 -40.23 86.54 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 CA-C-N 116.228 -0.442 . . . . 74.030000000000001 110.996 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.8 -47.2 85.6 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.195 0.522 . . . . 71.549999999999997 110.363 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' THR . . . . . 0.673 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 27.9 m -66.04 -47.96 72.65 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 115.104 -0.953 . . . . 71.310000000000002 110.024 -179.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.89 -44.68 96.3 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.604 -0.271 . . . . 72.25 111.694 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -63.37 -42.81 98.88 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.267 -0.424 . . . . 70.030000000000001 110.6 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -70.42 -17.5 63.01 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.102 0.477 . . . . 73.349999999999994 112.237 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . 0.673 ' HG2' ' O ' ' A' ' 376' ' ' THR . 17.5 mmm180 -89.56 -13.75 36.6 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 120.882 -0.327 . . . . 73.439999999999998 110.665 176.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.08 13.49 36.45 Favored Glycine 0 C--N 1.309 -0.968 0 C-N-CA 120.315 -0.945 . . . . 42.43 112.301 177.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -87.84 156.61 19.3 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 121.003 0.43 . . . . 73.230000000000004 110.725 175.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -105.6 154.27 20.64 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.946 -1.131 . . . . 75.109999999999999 107.946 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.68 149.09 32.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 119.65 -0.82 . . . . 74.299999999999997 112.406 -176.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . 0.434 ' HD2' ' OG1' ' A' ' 417' ' ' THR . 41.6 ttm180 -116.92 128.12 54.91 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 105.283 -2.117 . . . . 75.129999999999995 105.283 173.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 31.1 m -122.8 124.67 43.85 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 109.123 -0.695 . . . . 72.420000000000002 109.123 -175.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -111.76 119.8 39.85 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.141 -1.799 . . . . 74.099999999999994 106.141 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.503 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -116.9 134.85 54.25 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.455 -0.498 . . . . 74.420000000000002 110.891 -177.541 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -135.86 145.0 50.95 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-N 115.787 -0.642 . . . . 72.310000000000002 110.658 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . 0.414 ' HA ' ' HG1' ' A' ' 422' ' ' THR . 33.9 Cg_exo -68.5 153.62 73.43 Favored 'Trans proline' 0 C--O 1.252 1.188 0 C-N-CA 122.628 2.219 . . . . 74.430000000000007 108.85 169.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.419 ' C ' ' HG ' ' A' ' 392' ' ' SER . 25.8 t70 -62.64 124.94 22.3 Favored 'General case' 0 CA--C 1.487 -1.453 0 CA-C-O 122.519 1.152 . . . . 70.140000000000001 112.739 -175.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.42 ' O ' ' HB ' ' A' ' 393' ' ' THR . 49.5 m -154.37 34.19 0.42 Allowed 'General case' 0 C--N 1.279 -2.5 0 CA-C-N 112.525 -2.125 . . . . 71.25 106.134 178.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' A' ' 392' ' ' SER . 23.2 m 81.38 46.1 0.03 OUTLIER 'General case' 0 CA--C 1.57 1.736 0 C-N-CA 125.862 1.665 . . . . 72.150000000000006 111.515 -178.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.25 151.59 46.94 Favored Pre-proline 0 C--N 1.313 -1.009 0 CA-C-N 115.431 -0.804 . . . . 74.129999999999995 110.68 174.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -50.8 136.54 43.01 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 C-N-CA 124.007 3.138 . . . . 75.049999999999997 114.654 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.99 163.02 17.39 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.733 2.955 . . . . 75.140000000000001 111.841 176.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -56.86 -8.41 0.6 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 112.885 0.698 . . . . 65.140000000000001 112.885 -179.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 33.8 m170 -85.51 114.47 22.56 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 106.959 -1.497 . . . . 73.209999999999994 106.959 173.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 15.5 m -68.3 119.53 14.21 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-N 116.067 -0.515 . . . . 75.239999999999995 112.005 -174.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 3.9 mp -87.25 -30.55 5.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 108.083 -1.08 . . . . 74.200000000000003 108.083 176.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.39 171.02 27.35 Favored Glycine 0 N--CA 1.422 -2.239 0 N-CA-C 110.774 -0.93 . . . . 51.439999999999998 110.774 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 4.1 p -114.6 -178.06 3.28 Favored 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 123.059 0.544 . . . . 74.030000000000001 110.75 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -100.62 136.93 19.79 Favored Pre-proline 0 C--N 1.293 -1.881 0 N-CA-C 107.862 -1.162 . . . . 64.319999999999993 107.862 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -47.51 -22.64 2.92 Favored 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 124.503 3.468 . . . . 61.43 115.275 -176.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -64.74 -29.29 70.27 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 120.729 0.3 . . . . 72.209999999999994 110.961 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -85.28 -40.78 16.2 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.571 0.7 . . . . 63.439999999999998 110.327 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . 0.417 ' HA ' ' NE2' ' A' ' 361' ' ' GLN . 13.0 m120 -77.14 -11.18 59.78 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.421 -0.809 . . . . 75.319999999999993 112.126 -173.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 57.2 m -100.94 157.51 16.69 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 107.558 -1.275 . . . . 75.439999999999998 107.558 177.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 44.1 m -74.53 112.77 11.04 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 108.066 -1.086 . . . . 74.219999999999999 108.066 177.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.5 169.33 20.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 120.972 0.415 . . . . 71.530000000000001 111.202 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 22.8 t -73.64 133.05 43.37 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 107.096 -1.446 . . . . 73.409999999999997 107.096 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -61.88 138.5 58.36 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.134 0.492 . . . . 72.219999999999999 111.56 -176.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 93.1 39.48 5.13 Favored Glycine 0 N--CA 1.437 -1.286 0 CA-C-N 115.704 -0.68 . . . . 53.530000000000001 111.943 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -102.49 -174.33 2.54 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.191 -1.411 . . . . 75.299999999999997 107.191 177.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -109.83 116.27 31.34 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 118.374 0.534 . . . . 74.310000000000002 109.897 -177.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 32.2 mm -99.37 129.19 50.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 109.154 -0.684 . . . . 73.120000000000005 109.154 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' THR . . . . . 0.434 ' OG1' ' HD2' ' A' ' 385' ' ' ARG . 44.7 m -91.74 131.13 37.33 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 112.38 0.511 . . . . 73.129999999999995 112.38 -177.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 3.5 p -123.33 134.96 64.78 Favored 'Isoleucine or valine' 0 C--O 1.252 1.226 0 N-CA-C 108.351 -0.981 . . . . 75.510000000000005 108.351 176.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -107.24 124.99 50.56 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.244 -0.65 . . . . 72.109999999999999 109.244 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 2.7 p -125.79 131.46 71.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-N 115.49 -0.777 . . . . 73.239999999999995 111.176 -177.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 29.3 t -107.61 131.34 54.47 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-O 121.941 0.877 . . . . 54.509999999999998 110.23 176.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' THR . . . . . 0.414 ' HG1' ' HA ' ' A' ' 390' ' ' PRO . 24.2 p -87.15 158.48 19.15 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 105.363 -2.088 . . . . 63.119999999999997 105.363 170.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -65.46 -159.08 0.49 Allowed Glycine 0 CA--C 1.549 2.191 0 CA-C-N 118.679 0.672 . . . . 75.340000000000003 114.092 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.91 153.41 75.48 Favored 'Trans proline' 0 C--O 1.243 0.731 0 C-N-CA 122.283 1.989 . . . . 70.310000000000002 111.675 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.432 ' O ' HG12 ' A' ' 480' ' ' ILE . 36.1 mt-10 -86.95 166.12 15.34 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 122.118 0.961 . . . . 71.140000000000001 113.17 -175.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.463 ' HG2' HG23 ' A' ' 477' ' ' THR . 45.9 tt0 -132.51 131.87 42.06 Favored 'General case' 0 N--CA 1.408 -2.572 0 N-CA-C 104.23 -2.507 . . . . 71.340000000000003 104.23 171.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.42 ' HA ' ' HE ' ' A' ' 427' ' ' ARG . 3.2 mmp_? -122.53 156.68 33.68 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 120.492 -0.483 . . . . 75.420000000000002 111.847 -173.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -83.22 139.98 32.81 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.788 -1.19 . . . . 73.409999999999997 107.788 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 73.3 mt -78.96 122.5 84.62 Favored Pre-proline 0 N--CA 1.425 -1.693 0 N-CA-C 108.298 -1.001 . . . . 74.209999999999994 108.298 -178.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -69.97 140.82 42.79 Favored 'Trans proline' 0 N--CA 1.429 -2.323 0 C-N-CA 121.256 1.304 . . . . 63.229999999999997 110.05 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -100.85 155.95 17.64 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 115.677 -0.692 . . . . 73.219999999999999 109.479 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.422 HG12 ' HB3' ' A' ' 440' ' ' ALA . 8.5 p -153.2 170.94 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 N-CA-C 107.452 -1.314 . . . . 74.219999999999999 107.452 -174.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.446 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 14.5 m -73.09 146.36 45.84 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 108.713 -0.847 . . . . 63.32 108.713 176.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 15.7 p -68.4 -23.92 64.7 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 113.59 0.959 . . . . 72.450000000000003 113.59 -174.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.5 pp -80.39 -11.87 59.64 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 120.113 -0.635 . . . . 73.239999999999995 110.383 177.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.446 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 1.3 m -101.84 44.15 1.03 Allowed 'General case' 0 CA--C 1.555 1.135 0 CA-C-N 115.592 -0.731 . . . . 65.129999999999995 110.902 -175.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . 0.436 ' HH ' ' HB2' ' A' ' 454' ' ' GLN . 61.7 t80 -52.42 -38.18 58.49 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.387 0.675 . . . . 71.510000000000005 112.389 177.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.0 -45.03 83.31 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.209 0.528 . . . . 65.540000000000006 111.025 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -70.7 -33.26 70.69 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.68 -0.691 . . . . 74.120000000000005 110.51 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.521 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -58.95 -51.27 70.78 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.088 0.155 . . . . 71.230000000000004 110.658 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 33.6 m -62.52 -37.12 78.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-O 121.201 0.524 . . . . 73.450000000000003 110.849 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -60.39 -47.99 83.71 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.312 -0.858 . . . . 73.319999999999993 110.437 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -66.03 -38.75 89.18 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.904 -0.589 . . . . 73.010000000000005 111.725 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 93.1 mt -63.66 -33.66 76.13 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.791 0.329 . . . . 74.319999999999993 110.383 176.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 66.3 m -70.28 -44.9 67.45 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 115.912 -0.586 . . . . 74.349999999999994 110.1 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.75 -21.69 65.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.597 -0.729 . . . . 72.140000000000001 110.907 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.22 5.09 21.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.622 -0.717 . . . . 74.409999999999997 112.436 -179.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 105.18 -79.47 0.28 Allowed Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.11 -1.043 . . . . 72.239999999999995 111.998 175.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -39.62 -61.07 0.87 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.358 1.244 . . . . 73.319999999999993 114.358 176.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 62.15 18.45 57.73 Favored Glycine 0 C--N 1.321 -0.293 0 C-N-CA 121.634 -0.317 . . . . 75.340000000000003 113.186 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 14.3 mmt180 -95.15 111.29 23.14 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.356 -0.979 . . . . 74.329999999999998 108.356 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -136.49 153.88 50.9 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 120.689 0.281 . . . . 72.439999999999998 110.795 -178.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -142.37 133.16 25.56 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.545 -1.28 . . . . 73.219999999999999 107.545 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . 0.436 ' HB2' ' HH ' ' A' ' 437' ' ' TYR . 56.4 tt0 -101.5 134.52 44.48 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.832 -0.433 . . . . 74.510000000000005 109.832 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -124.37 138.83 54.33 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.036 -1.468 . . . . 63.030000000000001 107.036 173.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -121.07 136.67 54.93 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 109.479 -0.563 . . . . 65.230000000000004 109.479 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 32.5 t -135.72 141.2 36.13 Favored Pre-proline 0 C--N 1.296 -1.746 0 N-CA-C 108.708 -0.849 . . . . 72.340000000000003 108.708 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.677 ' HA ' ' O ' ' A' ' 490' ' ' SER . 37.6 Cg_endo -69.43 131.16 21.11 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.18 1.92 . . . . 73.030000000000001 110.521 175.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 61.1 m -151.22 -179.38 7.29 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.638 -0.875 . . . . 60.32 108.638 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 11.9 t -48.22 138.81 10.62 Favored Pre-proline 0 C--O 1.25 1.104 0 C-N-CA 123.941 0.897 . . . . 61.140000000000001 111.11 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -51.39 -29.39 30.59 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 124.401 3.401 . . . . 72.209999999999994 113.817 -175.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -75.27 -26.57 58.9 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.026 -0.67 . . . . 63.039999999999999 111.939 -177.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -88.58 -14.96 36.33 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 120.689 0.28 . . . . 71.0 111.07 178.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 86.5 t -60.87 127.56 20.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 109.385 -0.598 . . . . 75.150000000000006 109.385 176.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 96.92 -5.81 63.94 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 115.799 -0.637 . . . . 73.510000000000005 112.945 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' A' ' 466' ' ' LYS . 8.2 mptt -124.46 160.18 28.82 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 108.393 -0.965 . . . . 73.230000000000004 108.393 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 77.7 t -70.95 142.62 15.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 107.612 -1.255 . . . . 73.150000000000006 107.612 173.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 59.0 mt -97.57 -35.65 5.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 107.566 -1.272 . . . . 75.299999999999997 107.566 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 173.24 -172.43 45.15 Favored Glycine 0 N--CA 1.412 -2.931 0 N-CA-C 109.707 -1.357 . . . . 73.140000000000001 109.707 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 30.2 p -121.18 146.24 46.99 Favored 'General case' 0 C--N 1.271 -2.832 0 N-CA-C 107.216 -1.401 . . . . 74.049999999999997 107.216 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -72.07 -46.2 11.35 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 119.096 -1.042 . . . . 75.109999999999999 110.153 176.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -82.61 146.44 13.47 Favored 'Trans proline' 0 C--N 1.374 1.906 0 N-CA-C 108.517 -1.378 . . . . 75.5 108.517 169.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -65.36 127.29 17.88 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 121.778 1.652 . . . . 73.439999999999998 111.691 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -86.3 8.95 19.35 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.643 0.735 . . . . 70.540000000000006 111.299 -175.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -109.4 -6.73 15.36 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 116.039 -0.528 . . . . 72.510000000000005 110.364 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -97.24 172.2 7.95 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 116.01 -0.541 . . . . 71.040000000000006 111.791 -174.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 477' ' ' THR . . . . . 0.463 HG23 ' HG2' ' A' ' 426' ' ' GLN . 1.3 m -92.91 119.01 31.77 Favored 'General case' 0 N--CA 1.418 -2.032 0 CA-C-N 115.272 -0.876 . . . . 73.219999999999999 108.688 -177.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 54.9 m -115.49 148.04 39.94 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 123.171 0.588 . . . . 74.010000000000005 110.719 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -73.26 159.07 33.97 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.767 -0.651 . . . . 74.019999999999996 111.066 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 425' ' ' GLU . 43.7 mm -69.09 -21.09 25.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.748 0.785 . . . . 74.140000000000001 110.295 -177.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 3.7 p -100.15 5.33 44.82 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.734 -0.604 . . . . 73.299999999999997 111.87 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -94.1 133.9 37.1 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.216 -0.447 . . . . 75.109999999999999 109.926 -177.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 33.0 t -100.64 126.77 54.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.082 -0.508 . . . . 72.319999999999993 110.621 -174.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 35.0 m -103.0 137.47 31.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.429 0.633 . . . . 72.329999999999998 111.143 178.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.16 128.45 62.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.495 0.664 . . . . 73.319999999999993 110.096 -178.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 38.5 mm -109.21 128.23 65.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 C-N-CA 125.046 1.338 . . . . 75.540000000000006 108.858 -174.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 13.4 tt -112.07 126.47 69.47 Favored 'Isoleucine or valine' 0 C--O 1.246 0.887 0 CA-C-O 121.453 0.644 . . . . 71.129999999999995 110.977 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 34.5 m -113.29 151.64 15.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 0 CA-C-N 115.448 -0.796 . . . . 74.549999999999997 111.495 -177.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.0 132.53 11.22 Favored Glycine 0 N--CA 1.433 -1.548 0 N-CA-C 109.534 -1.426 . . . . 64.109999999999999 109.534 177.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.677 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 21.5 p -141.79 160.98 39.08 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 116.958 0.379 . . . . 74.120000000000005 110.48 -176.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 127.07 88.32 0.64 Allowed Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 120.138 -1.029 . . . . 65.5 113.013 175.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -73.94 143.37 32.8 Favored 'Trans proline' 0 C--O 1.252 1.205 0 C-N-CA 122.403 2.069 . . . . 75.420000000000002 110.891 177.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -91.32 78.09 5.79 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.718 0.771 . . . . 73.450000000000003 110.043 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 18.2 p -117.79 142.94 46.72 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.98 -1.009 . . . . 72.409999999999997 110.697 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . 0.422 ' HB3' ' HZ3' ' A' ' 495' ' ' LYS . 4.8 mmmp? -141.15 152.62 44.84 Favored 'General case' 0 CA--C 1.494 -1.183 0 CA-C-O 121.524 0.678 . . . . 74.140000000000001 110.792 178.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 12.4 p-10 -80.62 134.41 35.89 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 114.265 -1.334 . . . . 73.400000000000006 108.518 175.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 31.8 pt -83.35 125.28 74.6 Favored Pre-proline 0 C--N 1.3 -1.55 0 C-N-CA 120.527 -0.469 . . . . 74.439999999999998 109.834 177.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -79.8 -175.81 2.91 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.279 1.986 . . . . 64.439999999999998 111.107 178.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -84.22 90.17 7.46 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.678 0.752 . . . . 73.329999999999998 110.675 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 12.8 p -104.96 3.17 10.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 123.353 1.549 . . . . 74.349999999999994 106.985 175.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . 0.49 ' HB3' ' HA2' ' A' ' 536' ' ' GLY . . . -83.6 63.59 7.48 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 113.161 -1.836 . . . . 75.310000000000002 111.446 -174.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 165.95 28.65 0.02 OUTLIER Glycine 0 C--N 1.309 -0.962 0 C-N-CA 119.253 -1.451 . . . . 72.120000000000005 113.244 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -118.74 -169.13 1.66 Allowed 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 106.753 -1.573 . . . . 73.430000000000007 106.753 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 11.4 m -81.96 155.45 25.22 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.038 -1.467 . . . . 75.439999999999998 107.038 175.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.615 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 6.0 p -55.1 -46.36 77.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.231 0.456 . . . . 74.340000000000003 112.231 -176.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -66.51 -41.63 88.58 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 116.475 -0.329 . . . . 62.32 111.326 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 60.0 t -66.43 -42.04 89.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.694 -0.685 . . . . 74.519999999999996 109.817 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -61.86 -44.91 95.86 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 115.424 -0.807 . . . . 71.200000000000003 111.253 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.615 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 21.2 mt-30 -60.29 -40.41 90.38 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 121.191 0.519 . . . . 72.140000000000001 110.887 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.434 ' O ' HG23 ' A' ' 514' ' ' VAL . 64.0 mttm -64.47 -53.6 45.74 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.417 -0.81 . . . . 74.099999999999994 109.626 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -62.77 -37.8 88.08 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 115.514 -0.766 . . . . 75.140000000000001 111.288 -177.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 8.4 tt -59.04 -44.79 91.83 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 109.108 -0.701 . . . . 73.239999999999995 109.108 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . 0.541 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 0.8 OUTLIER -64.62 -37.64 88.28 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.173 -0.467 . . . . 72.040000000000006 111.426 177.292 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 510' ' ' LYS . 92.7 t -63.71 -30.25 49.42 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 CA-C-N 116.028 -0.533 . . . . 63.439999999999998 111.088 177.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -77.15 -4.53 45.01 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.82 0.343 . . . . 75.329999999999998 111.353 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 106.42 -10.69 42.81 Favored Glycine 0 CA--C 1.496 -1.122 0 C-N-CA 120.664 -0.779 . . . . 52.420000000000002 112.226 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.541 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 82.4 m-85 -88.52 114.42 25.12 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 107.377 -1.342 . . . . 73.109999999999999 107.377 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 5.0 p -89.56 -19.4 25.04 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 112.983 0.735 . . . . 73.230000000000004 112.983 -175.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -107.93 119.51 39.67 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.404 0.621 . . . . 75.219999999999999 111.924 -172.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -129.8 156.4 44.39 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.346 -0.843 . . . . 73.310000000000002 110.524 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 10.1 p -141.64 147.05 36.94 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.381 -1.34 . . . . 71.109999999999999 107.381 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.51 133.48 53.31 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 121.169 0.509 . . . . 62.350000000000001 111.427 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -132.97 126.39 31.88 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.436 -0.95 . . . . 74.349999999999994 108.436 178.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 11.0 m -98.1 134.64 40.9 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-O 120.828 0.347 . . . . 74.010000000000005 110.423 -177.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . 0.412 ' O ' ' HB3' ' A' ' 557' ' ' LYS . 30.5 m -123.01 149.96 26.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.083 -1.081 . . . . 72.5 108.083 176.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -66.33 135.67 54.71 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.998 -0.741 . . . . 75.329999999999998 108.998 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 74.2 m -149.91 166.99 13.9 Favored Pre-proline 0 C--N 1.293 -1.863 0 CA-C-N 115.754 -0.657 . . . . 73.219999999999999 111.162 -173.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -79.48 -23.36 7.32 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 121.805 1.67 . . . . 74.430000000000007 110.658 170.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -70.79 147.28 94.2 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 108.607 -0.886 . . . . 73.109999999999999 108.607 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -61.77 158.95 35.13 Favored 'Trans proline' 0 C--O 1.251 1.13 0 C-N-CA 122.835 2.357 . . . . 72.510000000000005 113.129 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -67.24 120.46 13.83 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.581 -0.736 . . . . 54.119999999999997 110.783 -179.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 118.52 -17.21 11.28 Favored Glycine 0 C--N 1.309 -0.924 0 C-N-CA 120.651 -0.785 . . . . 54.399999999999999 111.646 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -77.42 133.1 38.74 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.095 -1.076 . . . . 71.299999999999997 108.095 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 77.3 t -82.41 117.58 28.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 108.216 -1.031 . . . . 64.340000000000003 108.216 177.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 535' ' ' THR . . . . . 0.501 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 13.7 t -82.07 -17.66 45.83 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.781 0.8 . . . . 75.109999999999999 109.727 -177.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . 0.49 ' HA2' ' HB3' ' A' ' 501' ' ' ALA . . . 162.35 -163.31 34.95 Favored Glycine 0 N--CA 1.411 -3.021 0 N-CA-C 110.618 -0.993 . . . . 74.420000000000002 110.618 177.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 22.8 p -124.98 154.88 40.53 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 107.749 -1.204 . . . . 70.540000000000006 107.749 176.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -66.31 -55.88 18.29 Favored Pre-proline 0 C--N 1.306 -1.306 0 N-CA-C 109.606 -0.516 . . . . 74.120000000000005 109.606 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.46 127.06 10.09 Favored 'Trans proline' 0 C--N 1.368 1.561 0 N-CA-C 109.128 -1.143 . . . . 74.150000000000006 109.128 169.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.6 152.99 64.7 Favored 'Trans proline' 0 C--O 1.245 0.873 0 C-N-CA 123.14 2.56 . . . . 75.230000000000004 112.944 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -67.12 138.26 56.94 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.118 -0.492 . . . . 71.430000000000007 110.096 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 104.41 -20.82 38.83 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 111.469 -0.652 . . . . 65.019999999999996 111.469 -177.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 32.8 m -65.41 135.61 55.46 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.5 -0.556 . . . . 73.150000000000006 109.5 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 17.2 m -97.7 123.18 41.52 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 109.333 -0.617 . . . . 73.409999999999997 109.333 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.0 m -136.53 159.81 69.08 Favored Pre-proline 0 C--N 1.31 -1.141 0 N-CA-C 109.161 -0.681 . . . . 73.430000000000007 109.161 -178.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -63.88 147.6 92.08 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.221 1.947 . . . . 74.540000000000006 111.435 174.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 29.5 m -64.97 -19.62 25.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.703 0.763 . . . . 63.119999999999997 111.557 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -93.55 3.64 55.21 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.169 -0.923 . . . . 64.109999999999999 110.256 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 11.7 t -85.71 162.19 18.86 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.546 -0.909 . . . . 44.299999999999997 108.546 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 21.6 t -97.36 128.06 49.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 109.604 -0.517 . . . . 71.519999999999996 109.604 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 2.3 mp -101.68 131.58 49.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 108.863 -0.791 . . . . 75.319999999999993 108.863 176.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -102.67 116.69 33.09 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 121.489 0.661 . . . . 71.450000000000003 110.669 -178.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 84.4 mt -90.31 128.84 36.55 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.768 -1.197 . . . . 75.140000000000001 107.768 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -103.82 113.76 27.53 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 122.379 1.085 . . . . 71.099999999999994 109.379 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 23.0 t -94.38 147.13 5.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-N 114.02 -1.446 . . . . 74.109999999999999 110.019 -172.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 7.5 m -86.31 131.58 34.18 Favored 'General case' 0 N--CA 1.414 -2.268 0 CA-C-N 115.636 -0.711 . . . . 73.219999999999999 109.769 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 525' ' ' VAL . 9.4 ttmm -99.12 119.44 37.85 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 107.107 -1.442 . . . . 75.349999999999994 107.107 171.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -67.69 -37.48 89.06 Favored Glycine 0 CA--C 1.495 -1.203 0 N-CA-C 110.955 -0.858 . . . . 72.150000000000006 110.955 -177.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . 0.481 ' OD1' ' HD2' ' A' ' 616' ' ' ARG . 52.3 t30 65.8 4.47 2.94 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.964 1.706 . . . . 74.219999999999999 111.284 175.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 -142.89 141.24 31.48 Favored 'General case' 0 N--CA 1.415 -2.177 0 N-CA-C 104.702 -2.333 . . . . 74.25 104.702 -173.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -142.25 135.93 29.32 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 118.663 0.665 . . . . 75.329999999999998 111.027 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 6.6 p -70.14 116.42 11.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.732 0.777 . . . . 75.439999999999998 112.206 -176.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 61.4 ttp -98.2 139.77 21.44 Favored Pre-proline 0 C--N 1.309 -1.178 0 CA-C-N 115.222 -0.899 . . . . 75.209999999999994 108.774 177.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -60.68 161.86 20.01 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.764 2.309 . . . . 75.420000000000002 111.798 176.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . 0.488 ' HA ' ' CB ' ' A' ' 610' ' ' ALA . 0.5 OUTLIER -68.16 128.53 36.9 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.797 0.808 . . . . 74.040000000000006 112.761 -175.051 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 57.1 tp -131.13 4.29 4.41 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 107.509 -1.293 . . . . 71.530000000000001 107.509 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 7.7 m -77.34 134.68 38.42 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 113.983 -1.462 . . . . 65.140000000000001 109.842 -176.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 88.0 16.89 58.79 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.643 -0.789 . . . . 72.109999999999999 112.119 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 85.7 mtp -114.96 178.15 4.39 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.452 -0.944 . . . . 72.549999999999997 108.452 -178.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . 0.526 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 66.7 m-85 -89.61 155.52 19.2 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 121.27 0.557 . . . . 74.25 111.492 -176.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -62.35 -29.18 70.27 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 124.909 1.283 . . . . 75.420000000000002 109.602 175.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 10.1 p -73.13 -12.51 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 CA-C-N 115.385 -0.825 . . . . 73.519999999999996 109.864 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -101.21 -37.23 8.63 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.737 -0.665 . . . . 74.019999999999996 109.653 175.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . 0.516 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -63.47 -54.76 31.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.114 -0.948 . . . . 75.349999999999994 113.343 -174.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 579' ' ' ARG . 30.3 mt-10 -62.13 -50.2 81.32 Favored Pre-proline 0 N--CA 1.466 0.366 0 N-CA-C 113.921 1.082 . . . . 72.209999999999994 113.921 -179.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -52.77 -42.98 59.49 Favored 'Trans proline' 0 C--N 1.366 1.461 0 C-N-CA 122.082 1.855 . . . . 72.430000000000007 113.096 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -67.96 -37.62 81.79 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 119.948 -0.701 . . . . 73.129999999999995 111.012 179.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 94.5 mt -63.42 -47.16 83.09 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 121.427 0.632 . . . . 74.030000000000001 110.156 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' A' ' 575' ' ' GLU . 97.7 mtt180 -62.68 -38.05 88.85 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.271 -0.877 . . . . 75.319999999999993 110.26 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.2 -33.14 71.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.968 -0.56 . . . . 64.319999999999993 112.151 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 4.3 pp -82.64 -8.31 59.61 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 120.562 -0.455 . . . . 71.340000000000003 111.777 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 90.47 33.93 8.29 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.779 -0.724 . . . . 73.120000000000005 112.488 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 65.9 t90 -66.29 137.18 56.76 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 122.542 0.337 . . . . 74.200000000000003 110.153 176.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 49.9 m -145.04 102.0 3.7 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.573 -0.899 . . . . 75.129999999999995 108.573 176.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -172.5 -156.34 12.41 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 110.102 -1.199 . . . . 65.030000000000001 110.102 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 14.4 tpt -102.71 127.93 49.65 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.082 0.467 . . . . 72.019999999999996 111.138 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -97.7 126.04 42.81 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.065 -1.458 . . . . 74.5 107.065 176.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -123.28 110.33 15.07 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.374 0.607 . . . . 74.25 110.196 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -99.96 135.41 41.43 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.094 -0.957 . . . . 62.420000000000002 111.399 -174.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -68.76 143.31 39.91 Favored Glycine 0 C--N 1.306 -1.089 0 N-CA-C 109.165 -1.574 . . . . 64.230000000000004 109.165 169.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -61.22 130.5 46.55 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 122.878 0.471 . . . . 63.109999999999999 111.001 -176.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -55.23 135.16 49.91 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.541 0.941 . . . . 72.129999999999995 113.541 -172.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 85.8 t -137.99 115.9 12.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 114.814 -1.084 . . . . 75.109999999999999 109.013 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -90.78 111.88 23.45 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.742 -1.183 . . . . 70.299999999999997 108.612 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -148.56 20.75 1.04 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.938 0.718 . . . . 71.0 112.938 -174.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 140.31 155.65 6.62 Favored Glycine 0 CA--C 1.498 -0.994 0 C-N-CA 118.482 -1.818 . . . . 62.340000000000003 112.936 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.435 ' HA2' ' CD2' ' A' ' 600' ' ' HIS . . . -62.96 -49.77 69.42 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 114.262 0.465 . . . . 71.340000000000003 114.262 -175.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 25.4 m -71.98 -24.6 61.61 Favored 'General case' 0 C--N 1.312 -1.063 0 O-C-N 122.118 -0.636 . . . . 61.340000000000003 111.535 -176.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -93.12 -11.39 33.01 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 115.955 -0.566 . . . . 75.329999999999998 112.4 -177.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . 0.512 ' HB2' ' H ' ' A' ' 626' ' ' GLN . 0.5 OUTLIER -101.04 143.37 31.25 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 118.073 -1.451 . . . . 74.540000000000006 110.544 -176.866 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 69.98 -30.9 0.2 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.573 1.549 . . . . 71.519999999999996 112.005 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . 0.526 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 46.4 ttt180 -72.88 139.54 46.95 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.598 -0.689 . . . . 75.120000000000005 110.74 -177.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 94.2 t -77.99 130.79 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 107.604 -1.258 . . . . 72.230000000000004 107.604 177.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 58.8 t -98.23 -55.73 5.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 108.562 -0.903 . . . . 75.420000000000002 108.562 -177.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 622' ' ' LEU . 49.7 p90 -129.9 151.84 50.03 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 108.294 -1.002 . . . . 73.040000000000006 108.294 175.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . 0.53 ' HA ' ' O ' ' A' ' 621' ' ' THR . 17.7 pt20 -127.71 139.3 52.78 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 107.138 -1.43 . . . . 73.5 107.138 175.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.482 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 24.5 t-20 -46.43 -66.9 0.44 Allowed Pre-proline 0 CA--C 1.55 0.964 0 O-C-N 124.167 0.917 . . . . 63.140000000000001 112.607 -176.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.482 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 84.2 Cg_endo -91.22 124.1 0.86 Allowed 'Trans proline' 0 N--CA 1.436 -1.887 0 CA-C-N 121.233 1.476 . . . . 74.099999999999994 108.822 169.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.5 134.9 32.04 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.934 1.756 . . . . 73.400000000000006 112.399 -175.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . 0.488 ' CB ' ' HA ' ' A' ' 565' ' ' ASP . . . -68.79 138.93 55.21 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 115.537 -0.756 . . . . 74.519999999999996 110.024 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 101.57 -12.82 58.2 Favored Glycine 0 C--N 1.302 -1.317 0 N-CA-C 108.963 -1.655 . . . . 70.239999999999995 108.963 -173.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 16.5 m -118.06 168.76 10.25 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 107.143 -1.428 . . . . 71.310000000000002 107.143 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -71.22 126.5 13.32 Favored Glycine 0 N--CA 1.423 -2.222 0 N-CA-C 111.756 -0.538 . . . . 74.430000000000007 111.756 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 31.4 m -94.27 141.69 14.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 109.271 -0.64 . . . . 74.530000000000001 109.271 177.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.15 144.03 36.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.888 -0.596 . . . . 72.329999999999998 111.753 177.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . 0.481 ' HD2' ' OD1' ' A' ' 559' ' ' ASN . 0.9 OUTLIER -54.03 -25.74 22.92 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.066 0.946 . . . . 73.430000000000007 112.26 179.771 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -61.13 -32.1 71.8 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 123.738 0.815 . . . . 74.299999999999997 109.879 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 73.08 8.43 74.03 Favored Glycine 0 N--CA 1.418 -2.506 0 N-CA-C 110.805 -0.918 . . . . 71.530000000000001 110.805 -176.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . 0.418 HD12 ' N ' ' A' ' 620' ' ' ILE . 0.0 OUTLIER -68.99 121.08 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 CA-C-O 122.068 0.937 . . . . 73.319999999999993 108.516 -174.461 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . 0.418 ' N ' HD12 ' A' ' 619' ' ' ILE . 0.0 OUTLIER -129.18 119.57 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.549 0 CA-C-N 114.183 -1.372 . . . . 62.409999999999997 109.591 -176.265 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' A' ' 606' ' ' GLN . 55.8 m -101.68 128.86 47.8 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.027 -1.471 . . . . 73.540000000000006 107.027 175.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . 0.451 ' HA ' ' O ' ' A' ' 605' ' ' TYR . 2.3 pt? -132.06 154.46 49.39 Favored 'General case' 0 CA--C 1.475 -1.926 0 N-CA-C 108.829 -0.804 . . . . 74.140000000000001 108.829 -176.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.94 135.19 49.61 Favored 'General case' 0 N--CA 1.398 -3.067 0 N-CA-C 105.672 -1.973 . . . . 71.030000000000001 105.672 177.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -142.79 165.67 26.75 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 106.128 -1.804 . . . . 75.530000000000001 106.128 177.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -77.43 -102.72 0.17 Allowed Glycine 0 N--CA 1.428 -1.863 0 C-N-CA 119.705 -1.236 . . . . 54.219999999999999 110.214 172.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . 0.512 ' H ' ' HB2' ' A' ' 600' ' ' HIS . 8.4 tt0 . . . . . 0 C--N 1.298 -1.642 0 N-CA-C 108.7 -0.852 . . . . 75.109999999999999 108.7 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.409 0 N-CA-C 110.608 -0.997 . . . . 43.049999999999997 110.608 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 6.6 tp -81.06 116.07 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.041 0 CA-C-O 121.514 0.673 . . . . 63.350000000000001 111.012 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 2.0 m -76.08 137.33 40.09 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.754 -1.573 . . . . 63.210000000000001 106.754 175.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 13.6 mmm-85 -99.55 -145.39 0.33 Allowed 'General case' 0 N--CA 1.383 -3.809 0 N-CA-C 107.69 -1.226 . . . . 74.329999999999998 107.69 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -126.2 142.25 51.6 Favored 'General case' 0 C--N 1.267 -2.987 0 CA-C-N 115.542 -0.753 . . . . 54.229999999999997 110.159 -171.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 409' ' ' SER . 21.5 m -141.51 164.51 19.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 107.852 -1.166 . . . . 73.310000000000002 107.852 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -92.59 138.07 31.82 Favored 'General case' 0 N--CA 1.397 -3.085 0 N-CA-C 107.076 -1.453 . . . . 71.150000000000006 107.076 174.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.406 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 76.0 t -94.91 125.05 52.44 Favored Pre-proline 0 C--N 1.266 -3.045 0 N-CA-C 107.218 -1.401 . . . . 72.540000000000006 107.218 -173.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 28.0 Cg_exo -57.35 136.82 78.5 Favored 'Trans proline' 0 CA--C 1.499 -1.234 0 C-N-CA 123.252 2.635 . . . . 71.340000000000003 113.185 -169.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -75.49 101.53 4.89 Favored 'General case' 0 N--CA 1.421 -1.915 0 CA-C-O 122.742 1.258 . . . . 73.409999999999997 109.699 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.449 ' CG2' ' HB2' ' A' ' 373' ' ' ALA . 5.8 m -81.86 7.08 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-N 114.112 -1.404 . . . . 74.219999999999999 112.643 -178.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -58.66 146.01 37.83 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 125.132 1.373 . . . . 74.310000000000002 111.667 175.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.97 -10.46 51.9 Favored Glycine 0 N--CA 1.436 -1.345 0 N-CA-C 111.11 -0.796 . . . . 62.109999999999999 111.11 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -110.46 -161.62 0.76 Allowed 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.988 -1.115 . . . . 75.230000000000004 107.988 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 75.8 p -94.11 158.69 15.49 Favored 'General case' 0 C--N 1.276 -2.623 0 N-CA-C 108.24 -1.022 . . . . 74.319999999999993 108.24 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.431 ' O ' ' HB ' ' A' ' 374' ' ' ILE . 46.8 t -60.32 -36.06 77.06 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 109.722 -0.473 . . . . 72.340000000000003 109.722 176.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.56 -47.78 71.72 Favored 'General case' 0 C--O 1.213 -0.841 0 CA-C-O 119.24 -0.409 . . . . 74.409999999999997 111.763 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -70.09 -40.62 74.87 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 119.722 -0.791 . . . . 71.120000000000005 110.901 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . 0.449 ' HB2' ' CG2' ' A' ' 365' ' ' VAL . . . -61.54 -47.31 86.11 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.257 -0.883 . . . . 75.209999999999994 110.599 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . 0.431 ' HB ' ' O ' ' A' ' 370' ' ' SER . 1.6 mp -69.07 -38.3 78.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.926 -0.579 . . . . 72.239999999999995 111.209 177.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -60.14 -38.35 82.84 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.535 0.683 . . . . 74.129999999999995 110.353 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 86.1 m -63.76 -45.48 89.61 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.443 -0.799 . . . . 62.219999999999999 110.167 177.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 85.4 mt -64.24 -38.83 92.46 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.13 -0.486 . . . . 74.329999999999998 110.629 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -62.1 -40.41 95.77 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.56 -0.533 . . . . 74.420000000000002 109.56 177.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -63.13 -30.05 71.28 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.131 0.572 . . . . 64.409999999999997 111.585 176.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -84.48 -14.07 50.19 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.097 -0.502 . . . . 74.219999999999999 110.885 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 94.94 12.91 54.81 Favored Glycine 0 C--N 1.311 -0.836 0 C-N-CA 120.779 -0.724 . . . . 73.340000000000003 112.702 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -80.56 157.77 25.96 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-O 121.195 0.522 . . . . 75.219999999999999 111.395 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -98.86 132.78 43.95 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 106.698 -1.593 . . . . 73.209999999999994 106.698 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.09 154.93 28.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 CA-C-O 121.822 0.82 . . . . 72.209999999999994 110.861 -177.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -135.58 134.04 38.93 Favored 'General case' 0 N--CA 1.399 -2.997 0 CA-C-N 114.235 -1.348 . . . . 71.319999999999993 107.432 173.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 52.2 m -125.0 121.98 35.97 Favored 'General case' 0 C--N 1.271 -2.838 0 N-CA-C 106.631 -1.618 . . . . 74.239999999999995 106.631 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.21 119.23 38.23 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 105.854 -1.906 . . . . 74.519999999999996 105.854 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.57 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -123.0 129.1 51.09 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 119.964 -0.694 . . . . 73.519999999999996 111.384 -176.395 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 421' ' ' SER . 96.1 mttt -134.7 148.68 68.24 Favored Pre-proline 0 C--N 1.308 -1.207 0 N-CA-C 107.61 -1.255 . . . . 74.030000000000001 107.61 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -69.28 127.47 15.02 Favored 'Trans proline' 0 C--O 1.249 1.027 0 N-CA-C 105.909 -2.381 . . . . 65.040000000000006 105.909 168.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -177.41 157.4 1.3 Allowed 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 118.993 -1.083 . . . . 75.409999999999997 110.962 -169.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 10.9 m -112.08 -4.95 14.32 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.776 0.322 . . . . 64.420000000000002 110.93 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 42.4 m -92.45 -42.2 9.87 Favored 'General case' 0 N--CA 1.435 -1.184 0 O-C-N 122.118 -0.364 . . . . 75.140000000000001 111.101 -175.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 21.1 pt -88.02 148.36 42.98 Favored Pre-proline 0 C--N 1.31 -1.123 0 C-N-CA 120.47 -0.492 . . . . 74.129999999999995 110.623 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -49.04 147.08 11.21 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 124.493 3.462 . . . . 70.129999999999995 115.443 -177.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . 0.424 ' C ' ' H ' ' A' ' 398' ' ' HIS . 51.8 Cg_exo -56.5 165.64 4.3 Favored 'Trans proline' 0 C--O 1.22 -0.418 0 C-N-CA 124.593 3.529 . . . . 75.230000000000004 110.813 170.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . 0.443 ' HA ' HG12 ' A' ' 420' ' ' VAL . 6.1 p-10 -55.17 -7.84 0.24 Allowed 'General case' 0 N--CA 1.505 2.308 0 C-N-CA 123.468 0.707 . . . . 74.040000000000006 112.538 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.424 ' H ' ' C ' ' A' ' 396' ' ' PRO . 32.7 m170 -91.87 117.3 29.67 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 106.118 -1.808 . . . . 70.430000000000007 106.118 172.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 16.2 m -73.62 118.65 19.36 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-O 120.9 0.381 . . . . 72.140000000000001 110.827 -173.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 9.2 tp -89.78 -28.7 5.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-O 121.396 0.617 . . . . 71.030000000000001 110.51 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.43 169.59 27.65 Favored Glycine 0 N--CA 1.425 -2.068 0 N-CA-C 110.234 -1.147 . . . . 64.540000000000006 110.234 -177.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 10.5 p -114.15 -178.66 3.43 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 123.545 0.203 . . . . 75.420000000000002 110.59 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -100.74 139.79 20.85 Favored Pre-proline 0 C--N 1.307 -1.247 0 N-CA-C 107.777 -1.194 . . . . 64.209999999999994 107.777 -177.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -43.18 -30.25 2.06 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 124.391 3.394 . . . . 73.409999999999997 114.313 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.28 -31.53 70.32 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 123.309 0.381 . . . . 72.239999999999995 111.459 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -86.14 -34.39 20.59 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.701 0.762 . . . . 74.129999999999995 110.188 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -82.8 -1.99 53.25 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.259 -0.882 . . . . 74.319999999999993 111.426 -175.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 26.8 m -110.76 153.54 25.18 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 106.194 -1.78 . . . . 74.549999999999997 106.194 175.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 360' ' ' VAL . 39.3 m -73.87 112.73 10.27 Favored 'General case' 0 N--CA 1.425 -1.686 0 C-N-CA 120.205 -0.598 . . . . 74.040000000000006 109.749 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 23.9 m -122.54 166.71 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 115.403 -0.817 . . . . 75.239999999999995 109.719 178.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 42.7 m -75.74 138.77 41.47 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 109.228 -0.656 . . . . 74.230000000000004 109.228 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -61.31 109.43 1.14 Allowed 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.184 0.516 . . . . 74.25 110.55 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 116.79 67.26 0.38 Allowed Glycine 0 N--CA 1.428 -1.873 0 N-CA-C 110.203 -1.159 . . . . 61.210000000000001 110.203 -178.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -135.5 -168.58 2.22 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.888 -1.152 . . . . 74.219999999999999 107.888 -177.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -106.99 131.09 54.44 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 123.622 0.769 . . . . 71.129999999999995 110.518 -176.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 42.4 mm -119.37 115.86 49.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.928 -0.767 . . . . 74.010000000000005 108.928 176.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 13.7 p -98.82 130.94 45.27 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 123.929 0.891 . . . . 75.310000000000002 111.127 -177.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 8.7 p -126.96 135.06 64.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 120.905 0.384 . . . . 72.239999999999995 111.496 178.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -101.15 120.83 40.81 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.099 0.476 . . . . 75.040000000000006 110.059 176.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 44.8 t -126.49 144.36 36.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 C-N-CA 123.939 0.896 . . . . 75.430000000000007 111.252 -174.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 27.3 p -101.25 127.13 47.98 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.384 0.611 . . . . 73.420000000000002 110.832 176.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.1 t -117.69 106.05 12.67 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 115.888 -0.597 . . . . 75.120000000000005 109.42 177.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 95.72 126.45 4.99 Favored Glycine 0 N--CA 1.428 -1.888 0 C-N-CA 119.589 -1.291 . . . . 55.530000000000001 112.344 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -73.34 157.68 49.38 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 122.851 2.367 . . . . 73.219999999999999 110.625 174.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -83.62 166.16 18.4 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.88 -0.6 . . . . 70.430000000000007 111.024 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -88.08 159.17 18.35 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.63 -0.714 . . . . 73.25 110.51 -176.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -121.03 152.92 38.05 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-O 121.803 0.811 . . . . 70.140000000000001 111.041 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . 0.491 ' CD ' ' H ' ' A' ' 428' ' ' GLU . 0.3 OUTLIER -86.81 140.34 29.79 Favored 'General case' 0 C--N 1.268 -2.942 0 CA-C-N 114.05 -1.432 . . . . 65.510000000000005 111.764 -174.552 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.455 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 65.7 mt -79.79 116.6 62.2 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 109.239 -0.652 . . . . 71.409999999999997 109.239 -177.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.51 147.26 51.62 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.851 2.368 . . . . 74.439999999999998 113.081 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -92.32 131.89 37.15 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 106.553 -1.647 . . . . 75.349999999999994 106.553 175.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.425 HG12 ' HB1' ' A' ' 440' ' ' ALA . 11.4 p -132.33 159.68 42.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 C-N-CA 120.855 -0.338 . . . . 71.329999999999998 110.852 -171.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.591 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 15.3 m -68.6 152.93 44.68 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 108.772 -0.825 . . . . 71.120000000000005 108.772 175.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 81.8 p -69.13 -33.5 73.56 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 114.413 1.264 . . . . 74.140000000000001 114.413 -167.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.8 pp -90.65 -11.67 39.12 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.629 -1.228 . . . . 72.340000000000003 111.553 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.591 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 1.2 m -86.83 42.05 1.0 Allowed 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.472 -0.786 . . . . 73.040000000000006 111.081 -174.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -56.58 -37.05 70.07 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.953 0.901 . . . . 74.510000000000005 110.632 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -54.97 -41.42 71.15 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.158 -0.474 . . . . 72.319999999999993 111.254 175.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -70.4 -35.65 73.58 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.777 -0.453 . . . . 72.099999999999994 109.777 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.612 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -60.9 -51.41 69.4 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.543 -0.753 . . . . 73.049999999999997 110.477 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 33.8 m -65.53 -39.7 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 112.482 0.549 . . . . 72.25 112.482 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.421 ' HD3' ' N ' ' A' ' 443' ' ' LYS . 0.1 OUTLIER -67.89 -34.92 77.59 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 120.131 -0.628 . . . . 70.239999999999995 111.971 178.096 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . 0.421 ' N ' ' HD3' ' A' ' 442' ' ' LYS . 0.9 OUTLIER -66.14 -40.63 90.75 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.084 -0.507 . . . . 74.239999999999995 109.747 177.875 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 76.8 mt -67.45 -32.86 74.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.597 -0.729 . . . . 74.519999999999996 110.18 177.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 90.5 m -69.89 -42.55 73.27 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.128 0.49 . . . . 63.329999999999998 109.975 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.46 -15.75 62.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.434 0.635 . . . . 71.430000000000007 110.767 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -85.49 5.25 32.11 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.422 -0.808 . . . . 42.229999999999997 111.459 178.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 104.92 -74.48 0.24 Allowed Glycine 0 CA--C 1.495 -1.176 0 C-N-CA 120.747 -0.739 . . . . 53.119999999999997 111.874 176.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . 0.483 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 3.6 p90 -49.19 -59.57 3.55 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 113.975 1.102 . . . . 73.230000000000004 113.975 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 60.59 29.32 69.41 Favored Glycine 0 C--O 1.217 -0.912 0 N-CA-C 111.028 -0.829 . . . . 72.420000000000002 111.028 -174.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -103.55 111.42 23.87 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.965 -1.124 . . . . 75.310000000000002 107.965 -178.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -141.54 150.11 41.69 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 120.84 0.352 . . . . 71.310000000000002 111.326 -176.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -136.79 146.83 46.18 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.768 -1.197 . . . . 72.219999999999999 107.768 178.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 486' ' ' ILE . 53.4 tt0 -117.31 128.52 55.13 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 109.931 -0.396 . . . . 75.409999999999997 109.931 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -116.89 154.82 30.12 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.027 -1.101 . . . . 75.109999999999999 108.027 177.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -125.1 137.74 54.18 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 108.935 -0.765 . . . . 74.010000000000005 108.935 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 26.6 t -137.97 141.79 33.73 Favored Pre-proline 0 C--N 1.292 -1.929 0 N-CA-C 109.538 -0.541 . . . . 75.319999999999993 109.538 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.682 ' HA ' ' O ' ' A' ' 490' ' ' SER . 44.4 Cg_endo -70.32 124.28 10.7 Favored 'Trans proline' 0 C--O 1.25 1.079 0 C-N-CA 122.417 2.078 . . . . 65.120000000000005 111.679 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 50.3 m -152.04 179.85 8.12 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.51 -0.552 . . . . 73.140000000000001 109.51 -177.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.6 t -49.17 139.46 13.16 Favored Pre-proline 0 CA--C 1.56 1.333 0 C-N-CA 123.702 0.801 . . . . 65.310000000000002 112.126 176.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.57 -28.5 29.01 Favored 'Trans proline' 0 C--N 1.365 1.419 0 C-N-CA 125.112 3.875 . . . . 75.0 113.966 -177.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -68.63 -21.24 64.49 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 116.162 -0.472 . . . . 73.299999999999997 111.635 -178.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 91.6 mt -103.61 -13.18 16.63 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 120.859 0.361 . . . . 74.510000000000005 110.913 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 70.0 t -60.97 127.62 20.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.001 -0.545 . . . . 64.340000000000003 110.954 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 95.64 -15.82 62.41 Favored Glycine 0 N--CA 1.441 -1.031 0 CA-C-N 115.639 -0.71 . . . . 73.549999999999997 112.114 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.65 166.83 12.27 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 110.211 -0.292 . . . . 70.219999999999999 110.211 -178.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 73.2 t -72.19 143.39 14.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 115.826 -0.625 . . . . 75.420000000000002 109.643 179.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 70.0 mt -97.38 -31.04 3.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 107.244 -1.391 . . . . 75.299999999999997 107.244 176.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 159.74 -159.22 30.42 Favored Glycine 0 N--CA 1.425 -2.086 0 N-CA-C 109.977 -1.249 . . . . 54.5 109.977 177.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 470' ' ' THR . . . . . 0.458 HG21 HG12 ' A' ' 486' ' ' ILE . 61.9 p -114.7 146.67 40.65 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 105.608 -1.997 . . . . 62.109999999999999 105.608 178.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.426 ' HB3' HG22 ' A' ' 485' ' ' ILE . 28.5 t-20 -72.85 -53.86 5.05 Favored Pre-proline 0 C--N 1.314 -0.947 0 C-N-CA 118.871 -1.132 . . . . 73.030000000000001 110.236 178.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -67.75 134.54 32.85 Favored 'Trans proline' 0 C--N 1.368 1.604 0 N-CA-C 107.904 -1.614 . . . . 75.329999999999998 107.904 168.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . 0.484 ' C ' ' H ' ' A' ' 475' ' ' ASN . 24.7 Cg_exo -62.12 139.21 77.21 Favored 'Trans proline' 0 C--O 1.242 0.702 0 C-N-CA 122.216 1.944 . . . . 74.329999999999998 112.632 -175.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.455 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -75.84 19.91 0.2 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 122.163 0.983 . . . . 75.040000000000006 110.979 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . 0.484 ' H ' ' C ' ' A' ' 473' ' ' PRO . 10.1 m120 -109.21 -17.65 13.79 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.412 -0.959 . . . . 75.329999999999998 108.412 178.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -87.33 170.43 11.42 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.696 -0.683 . . . . 74.340000000000003 111.733 -174.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 4.5 m -106.3 127.02 52.94 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 108.304 -0.998 . . . . 72.420000000000002 108.304 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 9.8 p -105.95 146.06 30.52 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 123.031 0.533 . . . . 71.230000000000004 111.236 -177.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -90.26 162.75 15.05 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.452 -0.34 . . . . 74.140000000000001 110.815 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . 0.483 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 1.7 mp -70.93 -20.58 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.966 0.889 . . . . 71.310000000000002 111.187 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 12.2 p -93.39 1.17 56.99 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.988 0.899 . . . . 62.0 111.029 178.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -104.93 138.17 41.57 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.004 -0.998 . . . . 75.120000000000005 111.649 -173.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.4 p -108.06 127.03 64.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.809 -0.632 . . . . 73.239999999999995 111.027 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 35.8 m -95.45 141.57 14.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-O 121.299 0.571 . . . . 74.299999999999997 111.294 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.426 HG22 ' HB3' ' A' ' 471' ' ' ASN . 0.0 OUTLIER -109.43 125.91 66.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.196 0 CA-C-O 121.485 0.66 . . . . 74.329999999999998 110.251 -178.441 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . 0.458 HG12 HG21 ' A' ' 470' ' ' THR . 8.9 mt -112.62 128.61 69.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 115.067 -0.97 . . . . 74.409999999999997 110.919 -178.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 8.8 tt -105.17 127.21 59.99 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 123.41 0.684 . . . . 64.519999999999996 111.905 -174.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 28.6 m -111.61 152.07 13.57 Favored 'Isoleucine or valine' 0 C--O 1.25 1.097 0 C-N-CA 124.017 0.927 . . . . 64.510000000000005 110.241 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -81.9 140.76 21.15 Favored Glycine 0 C--O 1.246 0.854 0 C-N-CA 120.99 -0.624 . . . . 72.349999999999994 111.979 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.682 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 13.2 t -142.36 160.49 40.15 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.017 -0.735 . . . . 74.219999999999999 109.017 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 81.71 78.0 1.01 Allowed Glycine 0 CA--C 1.534 1.274 0 N-CA-C 115.693 1.037 . . . . 74.209999999999994 115.693 173.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -89.51 129.73 1.87 Allowed 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 122.703 2.269 . . . . 73.239999999999995 112.194 177.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -84.99 65.73 9.39 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-O 122.083 0.944 . . . . 72.040000000000006 111.875 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 1.3 p -118.03 143.42 46.43 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 114.899 -1.046 . . . . 74.510000000000005 109.673 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -146.34 148.83 32.78 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.84 -1.17 . . . . 74.120000000000005 107.84 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 9.5 p-10 -87.54 130.07 34.86 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.475 0.655 . . . . 73.120000000000005 110.985 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 38.3 pt -75.92 137.82 69.46 Favored Pre-proline 0 C--N 1.307 -1.28 0 CA-C-N 114.862 -1.063 . . . . 75.219999999999999 110.418 -178.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -93.86 -170.72 0.24 Allowed 'Trans proline' 0 N--CA 1.443 -1.482 0 C-N-CA 122.269 1.979 . . . . 61.439999999999998 111.211 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -83.9 145.91 28.34 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.666 -1.235 . . . . 72.450000000000003 107.666 174.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 9.2 p -136.22 8.58 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.455 0 CA-C-O 122.616 1.198 . . . . 65.230000000000004 108.469 177.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -71.17 121.43 18.32 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 114.019 -1.446 . . . . 71.409999999999997 109.628 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 108.73 30.57 3.7 Favored Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 110.789 -0.924 . . . . 74.140000000000001 110.789 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -142.03 176.09 9.22 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.907 -0.775 . . . . 74.0 108.907 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 29.6 p -91.67 160.02 15.58 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 110.021 -0.362 . . . . 74.209999999999994 110.021 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 30.7 m -53.73 -40.24 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 C-N-CA 124.181 0.993 . . . . 71.530000000000001 112.255 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -66.72 -42.44 86.35 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.655 -0.702 . . . . 64.219999999999999 110.791 -178.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 64.8 t -74.77 -35.06 35.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 116.432 -0.349 . . . . 73.329999999999998 110.253 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -59.61 -49.74 76.6 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.134 -0.485 . . . . 72.010000000000005 111.573 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -65.58 -35.89 82.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 74.030000000000001 110.725 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.41 ' O ' HG23 ' A' ' 514' ' ' VAL . 58.6 tptt -61.47 -47.35 86.06 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.706 -0.679 . . . . 72.040000000000006 109.647 178.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -62.08 -44.83 95.81 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 116.382 -0.372 . . . . 73.519999999999996 110.165 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.73 -47.52 85.31 Favored 'General case' 0 C--O 1.242 0.664 0 O-C-N 123.422 0.451 . . . . 73.540000000000006 110.376 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.92 -38.15 87.32 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 116.182 -0.463 . . . . 74.400000000000006 111.105 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 510' ' ' LYS . 55.2 t -64.01 -35.6 74.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 122.828 0.451 . . . . 74.230000000000004 111.366 177.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -79.29 -12.77 59.94 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.374 -0.53 . . . . 74.209999999999994 110.695 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . 0.432 ' O ' ' HB ' ' A' ' 547' ' ' VAL . . . 113.11 -0.14 25.41 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.69 -0.767 . . . . 64.040000000000006 113.154 177.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 547' ' ' VAL . 79.2 m-85 -82.82 115.77 21.86 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.454 -0.572 . . . . 71.450000000000003 109.454 -178.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.7 p -88.69 -26.04 22.04 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 113.643 0.979 . . . . 73.450000000000003 113.643 -176.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . 0.435 ' HE2' ' HA ' ' A' ' 519' ' ' LYS . 6.4 mmpt? -110.13 120.66 43.15 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 113.613 0.968 . . . . 74.450000000000003 113.613 -176.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -131.82 140.2 49.08 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 113.809 -1.541 . . . . 73.120000000000005 111.242 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 54.0 m -134.47 144.42 48.08 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.627 -0.879 . . . . 70.540000000000006 108.627 176.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -117.35 122.57 44.24 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.721 0.772 . . . . 63.25 110.807 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -100.89 140.29 35.38 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.685 -0.688 . . . . 71.209999999999994 109.663 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 15.9 m -88.79 116.01 26.75 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.982 -0.554 . . . . 73.319999999999993 109.646 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 35.7 m -121.98 158.56 25.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.935 -0.765 . . . . 74.329999999999998 108.935 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . 0.469 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 5.2 p-10 -94.71 136.83 34.55 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.838 -0.745 . . . . 71.420000000000002 109.89 179.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 527' ' ' SER . . . . . 0.412 ' HG ' ' C ' ' A' ' 526' ' ' ASP . 38.6 m -153.81 173.57 4.56 Favored Pre-proline 0 C--N 1.305 -1.331 0 N-CA-C 106.442 -1.688 . . . . 65.109999999999999 106.442 174.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -81.88 -8.3 12.2 Favored 'Trans proline' 0 CA--C 1.547 1.16 0 CA-C-N 120.642 1.265 . . . . 74.310000000000002 111.6 173.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . 0.431 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 4.1 mpt_? -76.39 134.61 69.94 Favored Pre-proline 0 C--O 1.223 -0.328 0 CA-C-N 116.046 -0.524 . . . . 75.030000000000001 109.813 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -57.08 154.93 30.89 Favored 'Trans proline' 0 C--O 1.255 1.368 0 C-N-CA 123.225 2.616 . . . . 75.299999999999997 114.032 -177.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.5 117.02 4.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.87 -1.059 . . . . 72.299999999999997 111.892 -178.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 132.21 -20.02 4.52 Favored Glycine 0 CA--C 1.49 -1.497 0 N-CA-C 110.797 -0.921 . . . . 62.329999999999998 110.797 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -74.27 125.25 28.02 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.922 -0.639 . . . . 74.230000000000004 110.04 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 85.9 t -84.34 107.39 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 N-CA-C 106.36 -1.718 . . . . 74.519999999999996 106.36 172.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 26.8 m -75.01 -25.96 59.19 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.632 -1.167 . . . . 64.140000000000001 111.002 -174.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 162.03 -163.78 35.02 Favored Glycine 0 N--CA 1.427 -1.963 0 N-CA-C 110.311 -1.115 . . . . 62.340000000000003 110.311 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 19.5 p -117.73 155.3 30.22 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.987 -0.746 . . . . 73.549999999999997 108.987 178.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -75.52 -52.97 2.73 Favored Pre-proline 0 C--N 1.305 -1.34 0 N-CA-C 109.614 -0.513 . . . . 73.319999999999993 109.614 176.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -64.32 130.33 26.64 Favored 'Trans proline' 0 C--N 1.365 1.405 0 N-CA-C 107.951 -1.596 . . . . 74.450000000000003 107.951 167.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -63.21 143.67 90.22 Favored 'Trans proline' 0 C--O 1.246 0.879 0 C-N-CA 122.226 1.951 . . . . 74.140000000000001 112.479 -177.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -65.14 136.1 56.29 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.604 -0.517 . . . . 74.310000000000002 109.604 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.95 -19.46 32.74 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 111.446 -0.662 . . . . 72.200000000000003 111.446 -176.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 35.2 m -68.51 134.48 50.13 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.699 0.285 . . . . 73.140000000000001 110.329 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 28.2 m -85.41 122.8 30.08 Favored 'General case' 0 N--CA 1.416 -2.138 0 N-CA-C 107.741 -1.207 . . . . 72.209999999999994 107.741 177.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 52.9 t -127.72 152.27 76.68 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 107.147 -1.427 . . . . 73.510000000000005 107.147 -176.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -66.2 139.52 55.6 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 121.512 1.475 . . . . 74.510000000000005 109.701 171.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 517' ' ' PHE . 28.7 m -63.28 -20.12 25.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.665 0.745 . . . . 75.319999999999993 112.548 -177.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -93.45 3.48 55.5 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.465 -0.788 . . . . 72.400000000000006 110.727 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 8.6 t -92.4 -178.43 4.92 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.761 -0.587 . . . . 75.230000000000004 109.916 -178.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 45.5 t -102.1 122.74 54.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 122.948 0.499 . . . . 73.239999999999995 111.181 -174.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 1.9 mp -103.58 126.77 58.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.158 -1.053 . . . . 55.43 108.158 175.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -103.56 120.48 40.96 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-O 121.488 0.661 . . . . 73.239999999999995 111.989 -176.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 69.2 mt -94.75 134.3 37.51 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 125.569 1.547 . . . . 73.019999999999996 108.249 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -104.02 118.66 37.19 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 109.15 -0.685 . . . . 73.439999999999998 109.15 176.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 43.4 t -109.79 129.5 64.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 CA-C-N 115.17 -0.923 . . . . 71.400000000000006 109.191 -175.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 32.0 p -80.07 143.5 33.95 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 113.494 0.924 . . . . 62.539999999999999 113.494 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.469 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 45.1 pttt -92.41 152.42 19.73 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 102.863 -3.014 . . . . 75.519999999999996 102.863 165.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -75.53 -32.14 55.28 Favored Glycine 0 CA--C 1.479 -2.17 0 C-N-CA 119.079 -1.534 . . . . 73.140000000000001 111.166 -176.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 64.3 t30 71.98 -28.99 0.19 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.516 1.526 . . . . 74.340000000000003 111.839 173.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.492 ' H ' ' C ' ' A' ' 558' ' ' GLY . 92.8 mt-30 -135.23 145.88 48.06 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 106.75 -1.574 . . . . 71.450000000000003 106.75 174.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -123.07 138.09 54.76 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 109.383 -0.599 . . . . 74.519999999999996 109.383 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 90.2 t -59.94 116.88 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 O-C-N 123.933 0.771 . . . . 73.25 110.321 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 25.7 ptm -80.62 146.74 61.45 Favored Pre-proline 0 C--O 1.249 1.031 0 CA-C-N 116.103 -0.498 . . . . 75.319999999999993 110.475 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -71.39 169.76 20.04 Favored 'Trans proline' 0 C--O 1.243 0.77 0 C-N-CA 122.862 2.374 . . . . 74.230000000000004 111.592 174.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -74.34 125.66 28.97 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 112.776 0.658 . . . . 65.310000000000002 112.776 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 96.1 mt -142.03 18.91 2.12 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.595 -1.184 . . . . 72.129999999999995 108.125 177.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 60.2 p -79.84 139.13 37.3 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 112.455 0.539 . . . . 72.420000000000002 112.455 -175.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 83.83 25.36 45.97 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 121.137 -0.554 . . . . 75.5 112.707 176.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 84.4 mtp -108.23 174.92 5.66 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.839 -0.43 . . . . 61.240000000000002 109.839 -178.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -102.5 136.96 41.4 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 106.922 -1.51 . . . . 75.129999999999995 106.922 177.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 81.8 t90 -54.66 -29.58 53.0 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 124.021 0.929 . . . . 75.420000000000002 112.356 -176.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 16.7 m -74.57 -19.16 16.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.342 0.592 . . . . 71.420000000000002 111.347 -177.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -102.29 -36.54 8.44 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.862 0.839 . . . . 73.230000000000004 109.644 178.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -67.46 -43.21 81.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.83 -1.077 . . . . 73.450000000000003 112.54 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -57.15 -50.56 87.47 Favored Pre-proline 0 CA--C 1.558 1.283 0 CA-C-O 119.44 -0.314 . . . . 75.200000000000003 111.481 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -53.53 -37.96 83.12 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.095 1.863 . . . . 65.540000000000006 112.617 172.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . 0.519 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 45.4 mmt-85 -64.96 -39.14 93.04 Favored 'General case' 0 C--O 1.214 -0.799 0 C-N-CA 120.242 -0.583 . . . . 75.120000000000005 110.586 177.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 96.3 mt -62.24 -43.12 99.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.336 0.589 . . . . 73.310000000000002 109.452 177.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -61.85 -38.81 89.62 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.375 -0.83 . . . . 75.530000000000001 110.317 178.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.21 -30.0 66.98 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.063 -0.517 . . . . 75.109999999999999 111.415 177.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 93.0 mt -81.97 -7.19 59.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.826 0.346 . . . . 75.109999999999999 111.332 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 82.7 35.64 18.71 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 120.974 -0.632 . . . . 63.130000000000003 111.914 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 83.5 t90 -77.51 130.44 36.97 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.129 0.49 . . . . 74.510000000000005 110.177 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 50.4 m -145.05 89.43 1.96 Allowed 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.158 -1.052 . . . . 75.430000000000007 108.158 175.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -153.58 -146.84 4.48 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 110.208 -1.157 . . . . 75.129999999999995 110.208 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 23.8 ttt -115.93 135.33 54.08 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 117.182 0.491 . . . . 74.439999999999998 110.894 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -100.47 130.78 46.59 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.05 -1.834 . . . . 71.510000000000005 106.05 175.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -102.36 118.67 37.38 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.867 -0.733 . . . . 74.409999999999997 110.637 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 4.0 mmmp? -87.76 111.94 21.88 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-O 121.5 0.666 . . . . 72.549999999999997 112.15 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -81.23 -173.41 47.75 Favored Glycine 0 N--CA 1.427 -1.907 0 N-CA-C 109.676 -1.37 . . . . 41.310000000000002 109.676 171.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -70.51 145.02 51.16 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.998 0.399 . . . . 64.510000000000005 110.977 -175.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -85.59 124.67 32.4 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.925 -1.139 . . . . 72.230000000000004 107.925 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.92 124.85 68.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 C-N-CA 122.903 0.481 . . . . 75.329999999999998 110.863 -174.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -75.67 111.8 11.38 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.489 -0.93 . . . . 74.120000000000005 108.489 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -114.19 -19.78 11.18 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 112.081 0.4 . . . . 75.319999999999993 112.081 -176.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 126.96 145.83 6.34 Favored Glycine 0 CA--C 1.492 -1.391 0 N-CA-C 108.663 -1.775 . . . . 74.140000000000001 108.663 -176.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.17 -40.1 82.86 Favored Glycine 0 N--CA 1.47 0.912 0 CA-C-N 117.512 0.656 . . . . 42.109999999999999 113.955 -173.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 15.8 m -66.38 -24.31 66.47 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 122.951 0.501 . . . . 70.120000000000005 111.46 -178.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -108.7 -1.11 19.69 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.269 0.841 . . . . 74.319999999999993 113.269 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -68.07 150.64 48.17 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.943 -0.392 . . . . 74.239999999999995 109.943 177.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 63.42 -6.31 0.21 Allowed 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 124.878 1.271 . . . . 70.439999999999998 114.122 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . 0.504 ' HD2' ' O ' ' A' ' 603' ' ' VAL . 5.5 tmm_? -79.15 138.62 37.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 118.459 0.572 . . . . 74.409999999999997 109.883 -178.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . 0.504 ' O ' ' HD2' ' A' ' 602' ' ' ARG . 13.9 p -64.0 142.2 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.85 0.86 . . . . 64.219999999999999 111.171 -177.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 7.5 p -96.13 -47.79 12.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 118.687 -1.205 . . . . 71.400000000000006 109.216 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -156.99 155.82 31.91 Favored 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 105.337 -2.097 . . . . 75.349999999999994 105.337 173.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -115.75 128.78 56.12 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 107.356 -1.349 . . . . 73.109999999999999 107.356 173.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.51 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 25.2 t-20 -48.77 -52.55 44.71 Favored Pre-proline 0 CA--C 1.545 0.779 0 O-C-N 123.99 0.806 . . . . 65.109999999999999 111.634 -177.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.51 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 13.7 Cg_endo -100.86 110.19 0.05 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.054 0 C-N-CA 121.659 1.573 . . . . 73.340000000000003 109.441 169.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.95 160.37 34.01 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.494 2.13 . . . . 73.420000000000002 111.485 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -57.32 126.96 29.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.576 0.227 . . . . 65.219999999999999 110.46 -177.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 102.03 -5.43 53.15 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.227 -0.987 . . . . 74.219999999999999 112.329 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 23.7 m -92.24 155.33 18.05 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.946 -0.761 . . . . 75.340000000000003 108.946 177.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -82.98 126.05 7.28 Favored Glycine 0 N--CA 1.426 -1.988 0 N-CA-C 111.368 -0.693 . . . . 71.420000000000002 111.368 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.3 m -103.81 142.18 17.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-O 120.598 0.237 . . . . 74.209999999999994 110.419 178.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.05 146.12 11.83 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 123.822 0.849 . . . . 72.120000000000005 112.267 177.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.02 -35.97 16.71 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 125.976 1.71 . . . . 72.319999999999993 112.874 -175.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -73.94 -30.26 62.45 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.883 -1.053 . . . . 71.209999999999994 111.484 -175.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 93.29 12.13 57.69 Favored Glycine 0 N--CA 1.414 -2.776 0 CA-C-O 119.211 -0.772 . . . . 62.100000000000001 114.078 174.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.67 119.78 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 C-N-CA 117.715 -1.594 . . . . 74.340000000000003 107.736 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.84 132.14 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 114.793 -1.094 . . . . 74.019999999999996 108.349 -175.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 90.2 m -106.23 116.89 32.71 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 121.221 0.534 . . . . 72.510000000000005 110.507 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . 0.421 ' HB2' HG22 ' A' ' 603' ' ' VAL . 0.0 OUTLIER -139.92 149.97 43.98 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 104.558 -2.386 . . . . 73.5 104.558 173.04 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -128.78 156.13 44.05 Favored 'General case' 0 C--N 1.254 -3.578 0 N-CA-C 105.987 -1.857 . . . . 73.519999999999996 105.987 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -125.2 166.08 17.11 Favored 'General case' 0 C--N 1.26 -3.292 0 N-CA-C 105.367 -2.086 . . . . 72.230000000000004 105.367 175.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -61.28 -89.25 0.02 OUTLIER Glycine 0 C--N 1.314 -0.687 0 C-N-CA 120.104 -1.046 . . . . 64.030000000000001 110.708 176.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 . . . . . 0 C--N 1.289 -2.054 0 N-CA-C 107.03 -1.47 . . . . 54.340000000000003 107.03 175.047 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.14 0 N-CA-C 110.039 -1.224 . . . . 63.340000000000003 110.039 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 9.4 tp -74.22 127.26 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-O 121.946 0.879 . . . . 74.310000000000002 110.485 -178.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.75 152.3 23.36 Favored 'General case' 0 N--CA 1.387 -3.585 0 CA-C-N 114.814 -1.085 . . . . 64.329999999999998 110.665 -179.277 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.15 14.11 21.82 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.606 0.717 . . . . 74.439999999999998 109.148 -179.122 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -67.48 148.14 51.91 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.717 -1.129 . . . . 74.319999999999993 108.477 178.426 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 31.5 m -121.49 163.67 19.17 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-O 120.76 0.314 . . . . 74.219999999999999 110.74 -175.031 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -94.41 136.59 34.54 Favored 'General case' 0 N--CA 1.383 -3.793 0 N-CA-C 107.439 -1.319 . . . . 73.510000000000005 107.439 175.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 72.1 t -97.42 135.06 21.93 Favored Pre-proline 0 C--N 1.265 -3.093 0 CA-C-N 114.624 -1.171 . . . . 74.150000000000006 109.911 -171.17 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -65.99 121.9 9.33 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 121.65 1.566 . . . . 75.030000000000001 110.948 179.244 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -88.77 147.48 24.42 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.749 -1.575 . . . . 74.409999999999997 106.749 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 4.8 t -120.84 11.54 6.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 CA-C-N 116.052 -0.522 . . . . 71.409999999999997 109.947 -172.511 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.69 143.11 54.9 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 119.158 -1.017 . . . . 74.109999999999999 110.03 176.535 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.94 -9.28 46.93 Favored Glycine 0 C--N 1.301 -1.395 0 N-CA-C 111.233 -0.747 . . . . 55.43 111.233 -172.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -109.03 -145.86 0.4 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.483 -0.932 . . . . 73.150000000000006 108.483 174.386 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 369' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 96.4 p -107.13 167.04 10.18 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.426 -0.909 . . . . 71.019999999999996 108.899 -176.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 25.2 t -59.69 -39.55 84.9 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 109.167 -0.679 . . . . 64.239999999999995 109.167 176.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.37 -46.66 75.95 Favored 'General case' 0 C--O 1.213 -0.843 0 CA-C-N 116.102 -0.499 . . . . 63.439999999999998 111.357 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -64.11 -41.42 97.25 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.359 0.599 . . . . 72.420000000000002 110.924 -179.251 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.06 -51.34 62.03 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.389 -0.823 . . . . 61.310000000000002 111.073 -178.539 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 39.8 mm -66.08 -39.98 85.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.042 -0.526 . . . . 73.510000000000005 110.955 -179.303 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.24 -38.82 88.01 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 120.937 0.399 . . . . 74.310000000000002 111.15 -179.111 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 376' ' ' THR . . . . . 0.528 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 79.5 m -66.41 -47.28 73.78 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.845 -0.616 . . . . 74.040000000000006 111.177 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.75 -37.99 89.44 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.557 0.218 . . . . 74.420000000000002 111.159 178.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -59.9 -48.03 83.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.95 -0.568 . . . . 64.019999999999996 109.747 177.096 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -61.03 -30.88 70.57 Favored 'General case' 0 CA--C 1.495 -1.17 0 N-CA-C 113.096 0.776 . . . . 72.409999999999997 113.096 177.231 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 376' ' ' THR . 13.3 mmt180 -78.44 -14.08 59.54 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.272 -0.422 . . . . 70.200000000000003 110.735 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 91.14 16.11 54.49 Favored Glycine 0 CA--C 1.501 -0.842 0 C-N-CA 119.772 -1.204 . . . . 73.129999999999995 111.506 177.412 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -88.92 162.89 15.85 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-O 121.385 0.612 . . . . 74.310000000000002 110.518 178.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . 0.451 ' HB2' ' HG2' ' A' ' 415' ' ' GLU . 75.2 mmtt -94.43 148.87 21.8 Favored 'General case' 0 N--CA 1.411 -2.375 0 N-CA-C 106.862 -1.533 . . . . 75.040000000000006 106.862 178.848 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.28 141.3 44.11 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-O 121.622 0.725 . . . . 74.530000000000001 110.968 -175.546 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . 0.412 ' HB3' ' HA ' ' A' ' 417' ' ' THR . 44.3 ttt180 -125.08 127.53 47.05 Favored 'General case' 0 N--CA 1.406 -2.632 0 N-CA-C 106.384 -1.709 . . . . 75.140000000000001 106.384 174.362 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 26.8 m -129.95 127.86 40.93 Favored 'General case' 0 C--N 1.276 -2.589 0 N-CA-C 108.97 -0.752 . . . . 62.219999999999999 108.97 -177.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -112.05 120.34 41.53 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.565 -0.531 . . . . 73.239999999999995 109.565 176.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -100.66 121.97 42.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.703 -0.851 . . . . 74.099999999999994 108.703 -179.007 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 421' ' ' SER . 44.5 mtmt -137.24 138.25 24.74 Favored Pre-proline 0 C--N 1.301 -1.509 0 C-N-CA 120.398 -0.521 . . . . 73.430000000000007 109.717 175.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -75.42 128.78 11.42 Favored 'Trans proline' 0 C--O 1.257 1.454 0 N-CA-C 107.972 -1.588 . . . . 73.040000000000006 107.972 172.54 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.442 ' OD1' HG21 ' A' ' 393' ' ' THR . 7.3 t70 -174.62 -172.67 0.67 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.086 -1.82 . . . . 75.510000000000005 106.086 -172.745 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 41.4 m -150.97 -2.6 0.34 Allowed 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 122.545 0.338 . . . . 73.519999999999996 111.605 175.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.442 HG21 ' OD1' ' A' ' 391' ' ' ASP . 10.7 t -105.91 -24.87 12.34 Favored 'General case' 0 C--O 1.244 0.764 0 O-C-N 121.696 -0.627 . . . . 75.530000000000001 109.898 -178.677 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . 0.43 HG13 ' HB2' ' A' ' 421' ' ' SER . 49.1 pt -88.66 152.54 49.34 Favored Pre-proline 0 N--CA 1.439 -1.021 0 N-CA-C 107.805 -1.183 . . . . 73.430000000000007 107.805 176.525 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -32.9 111.58 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 124.634 3.556 . . . . 73.439999999999998 116.398 179.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -56.48 166.86 3.14 Favored 'Trans proline' 0 C--O 1.221 -0.343 0 C-N-CA 124.943 3.762 . . . . 72.150000000000006 110.676 170.062 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . 0.475 ' HA ' ' CG2' ' A' ' 420' ' ' VAL . 4.6 p-10 -54.94 -8.58 0.27 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 112.684 0.624 . . . . 73.430000000000007 112.684 -178.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 63.1 m170 -98.01 106.16 18.41 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 103.319 -2.845 . . . . 70.439999999999998 103.319 166.59 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 18.6 m -63.08 118.43 5.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 O-C-N 124.185 0.928 . . . . 73.239999999999995 113.209 -166.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 41.7 mm -98.2 -27.47 3.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 114.575 -1.193 . . . . 73.200000000000003 109.881 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.42 157.14 27.25 Favored Glycine 0 N--CA 1.414 -2.777 0 C-N-CA 119.901 -1.142 . . . . 71.120000000000005 112.026 -176.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 4.7 p -148.08 -176.15 5.17 Favored 'General case' 0 C--N 1.284 -2.242 0 C-N-CA 126.253 1.821 . . . . 72.129999999999995 107.412 -175.36 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -99.82 137.26 20.14 Favored Pre-proline 0 C--N 1.299 -1.602 0 N-CA-C 107.894 -1.15 . . . . 74.230000000000004 107.894 176.337 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.27 -2.86 3.46 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.824 3.016 . . . . 73.010000000000005 113.36 -177.085 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -52.61 -35.28 54.17 Favored 'General case' 0 C--O 1.21 -1.013 0 C-N-CA 124.656 1.183 . . . . 71.219999999999999 111.165 176.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -68.35 -37.47 80.53 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 121.533 0.682 . . . . 74.319999999999993 110.211 178.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -82.69 -3.91 57.06 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.579 0.704 . . . . 75.019999999999996 109.452 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 32.0 m -93.55 152.5 18.99 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.398 -1.705 . . . . 61.329999999999998 106.398 176.506 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 13.2 p -77.37 111.57 13.18 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 108.554 -0.906 . . . . 74.239999999999995 108.554 176.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 28.8 m -127.51 169.16 19.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-O 121.095 0.474 . . . . 74.109999999999999 110.876 -179.524 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 3.4 m -78.69 146.74 33.82 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.961 -0.755 . . . . 64.519999999999996 108.961 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -71.51 109.91 5.77 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.015 0.435 . . . . 73.510000000000005 110.529 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 122.8 23.23 2.31 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 120.852 -0.69 . . . . 72.109999999999999 112.749 178.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -86.68 -173.77 4.65 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.642 -0.873 . . . . 71.010000000000005 108.642 177.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . 0.451 ' HG2' ' HB2' ' A' ' 383' ' ' LYS . 32.9 mt-10 -111.21 119.19 38.11 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.263 -0.643 . . . . 73.200000000000003 109.263 -175.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.1 mm -98.17 120.25 47.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-O 120.837 0.351 . . . . 72.310000000000002 110.091 -178.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 417' ' ' THR . . . . . 0.412 ' HA ' ' HB3' ' A' ' 385' ' ' ARG . 36.4 m -90.7 125.88 35.81 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.972 -0.558 . . . . 73.230000000000004 111.726 -178.599 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 4.3 p -116.55 134.82 58.8 Favored 'Isoleucine or valine' 0 C--O 1.255 1.384 0 N-CA-C 109.261 -0.644 . . . . 73.409999999999997 109.261 174.533 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -99.29 116.89 32.52 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.515 -1.661 . . . . 75.340000000000003 106.515 177.028 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.475 ' CG2' ' HA ' ' A' ' 397' ' ' ASP . 10.7 p -127.61 136.0 61.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 121.32 0.581 . . . . 73.040000000000006 110.608 -175.531 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 421' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 14.1 t -102.39 122.58 44.56 Favored 'General case' 0 N--CA 1.415 -2.223 0 C-N-CA 119.839 -0.744 . . . . 64.140000000000001 110.031 178.295 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 8.9 t -118.94 107.53 13.68 Favored 'General case' 0 N--CA 1.411 -2.377 0 CA-C-N 115.175 -0.92 . . . . 61.229999999999997 108.753 176.387 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 106.82 103.33 2.87 Favored Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 120.871 -0.68 . . . . 52.140000000000001 111.923 -178.514 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -69.91 154.62 66.97 Favored 'Trans proline' 0 C--O 1.246 0.909 0 C-N-CA 122.223 1.949 . . . . 74.120000000000005 110.668 177.29 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -81.71 166.41 20.12 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.571 0.701 . . . . 73.310000000000002 112.509 -174.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -97.82 158.79 15.32 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 114.617 -1.174 . . . . 71.5 109.674 179.551 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.512 ' HG3' ' O ' ' A' ' 447' ' ' ALA . 4.3 mmp_? -120.33 155.6 33.01 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 109.653 -0.499 . . . . 75.519999999999996 109.653 -178.574 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -91.66 137.37 32.42 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 115.086 -0.961 . . . . 72.329999999999998 110.101 -176.153 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 59.7 mt -96.12 118.67 65.48 Favored Pre-proline 0 N--CA 1.421 -1.88 0 N-CA-C 107.519 -1.289 . . . . 71.430000000000007 107.519 177.017 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -71.6 141.48 38.14 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 N-CA-C 108.125 -1.529 . . . . 75.340000000000003 108.125 171.08 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -80.13 134.46 36.17 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 118.229 -1.389 . . . . 72.209999999999994 108.592 178.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 8.9 p -101.23 161.99 3.49 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.374 0 N-CA-C 108.39 -0.967 . . . . 73.430000000000007 108.39 -172.332 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 26.7 m -75.68 158.02 32.88 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 107.33 -1.359 . . . . 75.329999999999998 107.33 174.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 434' ' ' THR . . . . . 0.404 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 74.3 p -67.99 -40.34 83.09 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.943 0.878 . . . . 75.209999999999994 111.32 -173.458 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.5 -28.78 68.12 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 113.784 1.031 . . . . 74.25 113.784 178.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.6 p -89.9 59.2 4.49 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 114.511 1.3 . . . . 75.430000000000007 114.511 -172.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -64.26 -37.86 88.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.115 -0.493 . . . . 74.239999999999995 111.364 177.294 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -62.43 -36.3 81.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.899 0.38 . . . . 72.319999999999993 110.457 178.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -67.51 -39.35 85.14 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.64 -0.504 . . . . 72.439999999999998 109.64 175.22 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.46 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.19 -50.38 73.89 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.969 -0.56 . . . . 74.140000000000001 110.924 -178.489 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.0 m -62.14 -40.77 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 111.935 0.346 . . . . 72.129999999999995 111.935 -179.178 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -36.41 80.03 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 120.366 -0.534 . . . . 73.439999999999998 112.3 178.455 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -63.22 -47.1 83.92 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 120.931 0.396 . . . . 74.430000000000007 110.384 177.008 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.46 HD13 ' O ' ' A' ' 440' ' ' ALA . 2.6 mp -63.68 -35.54 80.88 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.361 -0.836 . . . . 74.530000000000001 110.601 179.866 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 89.4 m -69.33 -45.8 68.61 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 116.172 -0.467 . . . . 71.109999999999999 110.488 177.162 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.13 -16.49 62.56 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 120.848 0.356 . . . . 74.310000000000002 111.88 -178.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . 0.512 ' O ' ' HG3' ' A' ' 427' ' ' ARG . . . -84.6 -4.66 59.11 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.177 -0.465 . . . . 73.450000000000003 111.488 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 117.66 -83.48 0.35 Allowed Glycine 0 CA--C 1.498 -1.017 0 C-N-CA 120.121 -1.038 . . . . 63.140000000000001 111.963 177.085 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -36.99 -63.52 0.42 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.374 1.249 . . . . 74.129999999999995 114.374 177.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 62.71 20.2 61.51 Favored Glycine 0 C--O 1.221 -0.668 0 CA-C-N 116.384 -0.371 . . . . 54.439999999999998 113.322 -178.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -96.97 110.43 22.97 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.079 -1.082 . . . . 74.439999999999998 108.079 -178.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . 0.42 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 21.2 p90 -138.91 158.95 43.28 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 115.972 -0.558 . . . . 73.420000000000002 110.437 -177.453 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -144.98 148.23 33.54 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.447 -1.316 . . . . 75.409999999999997 107.447 179.177 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -119.05 127.36 53.34 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 117.877 0.308 . . . . 74.420000000000002 110.323 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -124.52 150.58 45.67 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.395 -0.965 . . . . 71.319999999999993 108.395 175.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -114.03 141.53 47.32 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.922 -0.399 . . . . 74.120000000000005 109.922 -177.201 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 23.2 t -138.37 137.59 20.9 Favored Pre-proline 0 C--N 1.307 -1.242 0 N-CA-C 108.898 -0.778 . . . . 74.519999999999996 108.898 176.285 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 490' ' ' SER . 8.0 Cg_exo -71.05 122.78 9.09 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 121.819 1.679 . . . . 70.450000000000003 111.36 177.19 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 49.5 m -147.09 179.88 7.31 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.09 -1.078 . . . . 74.519999999999996 108.09 -178.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.8 t -43.74 137.78 3.23 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 124.333 1.053 . . . . 74.299999999999997 113.193 179.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . 0.497 ' O ' HG13 ' A' ' 464' ' ' VAL . 9.3 Cg_endo -51.58 -28.84 30.25 Favored 'Trans proline' 0 C--N 1.363 1.298 0 C-N-CA 124.815 3.676 . . . . 65.329999999999998 113.963 -177.419 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.73 -18.6 63.53 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.315 0.579 . . . . 75.540000000000006 111.406 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 82.7 mt -102.73 6.62 39.55 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 116.176 -0.465 . . . . 71.310000000000002 112.02 -179.353 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 461' ' ' PRO . 14.8 p -61.54 127.35 21.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 119.491 -0.883 . . . . 74.200000000000003 109.406 176.716 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 78.85 -1.24 74.65 Favored Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 121.171 -0.538 . . . . 70.109999999999999 112.204 179.064 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -101.35 159.29 15.39 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 108.265 -1.013 . . . . 71.420000000000002 108.265 -178.552 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.404 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 75.1 t -80.54 140.9 15.99 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 CA-C-N 115.426 -0.806 . . . . 74.409999999999997 109.569 176.468 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 63.2 mt -98.28 -35.25 5.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 108.249 -1.019 . . . . 74.420000000000002 108.249 176.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 168.86 -177.4 42.71 Favored Glycine 0 N--CA 1.425 -2.064 0 C-N-CA 120.526 -0.845 . . . . 75.219999999999999 112.215 178.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 470' ' ' THR . . . . . 0.478 HG22 HG12 ' A' ' 486' ' ' ILE . 72.3 p -116.14 144.24 44.43 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.432 -1.692 . . . . 73.099999999999994 106.432 179.081 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.454 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 22.3 t-20 -64.31 -57.68 16.74 Favored Pre-proline 0 C--N 1.319 -0.724 0 C-N-CA 120.064 -0.654 . . . . 71.129999999999995 112.051 177.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.454 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 24.4 Cg_exo -73.25 139.92 29.95 Favored 'Trans proline' 0 C--N 1.361 1.188 0 N-CA-C 108.041 -1.561 . . . . 54.409999999999997 108.041 170.152 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . 0.474 ' C ' ' H ' ' A' ' 475' ' ' ASN . 23.8 Cg_exo -62.59 128.1 22.55 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.373 2.048 . . . . 75.040000000000006 114.234 -173.474 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -83.84 18.58 1.95 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 122.431 1.11 . . . . 54.539999999999999 109.375 179.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . 0.474 ' H ' ' C ' ' A' ' 473' ' ' PRO . 15.5 m120 -111.88 -9.96 14.02 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.038 -1.437 . . . . 74.420000000000002 109.427 -179.427 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -119.75 -179.35 3.87 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-O 121.454 0.645 . . . . 75.409999999999997 112.564 -170.144 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.97 134.38 34.52 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.621 -1.251 . . . . 71.129999999999995 107.621 178.136 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 24.4 m -128.96 145.56 51.2 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.151 -0.685 . . . . 63.530000000000001 109.151 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -78.44 167.48 21.24 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 120.861 0.362 . . . . 73.140000000000001 111.862 -178.098 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 40.0 mm -71.43 -17.17 19.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.633 0.73 . . . . 75.010000000000005 110.272 -178.217 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 15.9 p -94.88 5.24 52.46 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.658 -0.651 . . . . 54.539999999999999 112.14 179.254 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -83.69 139.54 32.71 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.273 0.559 . . . . 75.409999999999997 112.194 -177.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 60.2 t -108.3 126.52 64.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 107.842 -1.17 . . . . 74.540000000000006 107.842 176.27 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 34.1 m -110.11 120.57 61.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-O 121.426 0.631 . . . . 74.0 111.158 178.823 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.75 129.1 44.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.219 -1.03 . . . . 74.129999999999995 108.219 174.187 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . 0.478 HG12 HG22 ' A' ' 470' ' ' THR . 18.4 mt -113.06 128.26 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 CA-C-N 115.117 -0.947 . . . . 73.200000000000003 110.366 -177.438 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 4.9 tt -104.48 126.6 59.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-N 115.566 -0.743 . . . . 71.129999999999995 109.695 -178.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 34.2 m -111.96 151.74 13.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 115.523 -0.762 . . . . 73.530000000000001 109.571 179.275 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -90.23 144.53 17.59 Favored Glycine 0 N--CA 1.424 -2.131 0 C-N-CA 121.167 -0.539 . . . . 72.140000000000001 112.959 -176.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 23.2 t -124.38 142.91 50.92 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 106.192 -1.781 . . . . 72.019999999999996 106.192 174.176 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -130.81 105.59 0.65 Allowed Glycine 0 N--CA 1.433 -1.529 0 C-N-CA 119.639 -1.267 . . . . 63.43 112.96 -175.455 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -66.09 147.7 84.48 Favored 'Trans proline' 0 C--O 1.248 0.983 0 C-N-CA 122.939 2.426 . . . . 72.109999999999999 110.476 174.326 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -88.57 72.41 8.77 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.749 0.785 . . . . 61.340000000000003 111.371 -177.098 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 22.1 p -126.0 146.46 49.87 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.361 -0.836 . . . . 73.439999999999998 110.823 -178.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -138.14 146.35 42.69 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.498 -0.927 . . . . 74.129999999999995 108.498 178.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 13.7 t70 -99.59 111.66 23.97 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.424 -0.954 . . . . 72.439999999999998 108.424 -178.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . 0.581 HD13 ' O ' ' A' ' 543' ' ' THR . 0.2 OUTLIER -75.79 127.1 86.27 Favored Pre-proline 0 C--O 1.236 0.357 0 N-CA-C 113.797 1.036 . . . . 71.230000000000004 113.797 -174.114 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -94.98 151.23 1.71 Allowed 'Trans proline' 0 CA--C 1.55 1.314 0 C-N-CA 123.111 2.54 . . . . 64.430000000000007 110.84 171.178 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -89.94 129.94 36.22 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.382 0.611 . . . . 74.129999999999995 110.323 -179.088 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.79 81.7 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-O 122.806 1.289 . . . . 75.329999999999998 109.533 177.268 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -97.44 145.78 25.85 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 113.814 -1.539 . . . . 64.129999999999995 108.885 -177.656 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 111.47 44.39 0.91 Allowed Glycine 0 CA--C 1.476 -2.378 0 N-CA-C 109.27 -1.532 . . . . 44.340000000000003 109.27 -177.082 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -141.22 167.05 23.11 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 108.826 -0.805 . . . . 65.329999999999998 108.826 -177.161 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 13.2 t -91.41 161.84 14.83 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 108.061 -1.088 . . . . 73.340000000000003 108.061 176.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 31.2 m -51.44 -42.07 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.668 0 C-N-CA 124.49 1.116 . . . . 72.239999999999995 113.396 -174.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -68.16 -41.8 81.02 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.253 0.549 . . . . 74.450000000000003 111.04 -177.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 51.7 t -72.66 -36.53 53.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.365 -0.834 . . . . 75.329999999999998 110.46 -176.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -62.51 -48.48 79.37 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.611 -0.268 . . . . 72.010000000000005 110.696 178.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -60.18 -41.77 93.61 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.298 0.571 . . . . 75.129999999999995 109.758 178.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.5 -43.19 99.3 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.546 -1.206 . . . . 71.239999999999995 110.173 -177.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -62.4 -42.91 99.79 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 116.438 -0.347 . . . . 74.099999999999994 111.281 179.416 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.31 -40.9 97.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.54 -0.3 . . . . 75.310000000000002 110.504 177.805 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -61.83 -43.02 99.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.965 0.412 . . . . 75.150000000000006 110.161 178.173 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 93.7 t -67.1 -26.34 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-N 115.656 -0.702 . . . . 74.329999999999998 111.583 178.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -76.17 -25.38 55.18 Favored 'General case' 0 CA--C 1.514 -0.416 0 O-C-N 121.666 -0.646 . . . . 72.030000000000001 109.908 177.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 111.87 36.35 1.7 Allowed Glycine 0 N--CA 1.436 -1.359 0 C-N-CA 120.822 -0.704 . . . . 73.25 111.944 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -120.34 122.82 41.66 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 107.484 -1.302 . . . . 75.5 107.484 178.441 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.6 m -101.81 -18.17 15.89 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 115.831 -0.622 . . . . 74.439999999999998 110.628 -175.629 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -113.61 113.22 24.75 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.82 0.819 . . . . 72.540000000000006 110.907 -179.394 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -132.28 155.94 47.43 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.379 -1.282 . . . . 74.030000000000001 110.155 -177.611 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 48.8 m -141.34 138.84 33.37 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 108.122 -1.066 . . . . 73.25 108.122 173.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.09 119.57 35.16 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.644 0.735 . . . . 73.140000000000001 112.15 179.733 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -107.15 118.86 37.83 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.258 -0.883 . . . . 73.510000000000005 109.726 -178.255 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 67.4 m -84.54 123.01 29.82 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.087 -0.709 . . . . 55.530000000000001 109.087 176.023 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 32.7 m -121.4 150.98 24.55 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 N-CA-C 107.554 -1.276 . . . . 72.099999999999994 107.554 -179.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.53 137.54 32.27 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.58 -1.248 . . . . 72.230000000000004 109.981 -177.374 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 69.0 m -155.96 -176.12 0.58 Allowed Pre-proline 0 C--N 1.304 -1.413 0 N-CA-C 107.445 -1.317 . . . . 75.299999999999997 107.445 -176.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -73.45 -28.21 12.39 Favored 'Trans proline' 0 C--N 1.36 1.148 0 CA-C-N 120.941 1.372 . . . . 74.120000000000005 111.739 173.396 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -64.84 137.14 97.05 Favored Pre-proline 0 N--CA 1.475 0.812 0 CA-C-N 116.405 -0.362 . . . . 64.109999999999999 111.813 -178.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.58 151.9 43.91 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 124.032 3.155 . . . . 74.129999999999995 114.965 -173.318 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -69.35 107.97 3.52 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 115.047 -0.978 . . . . 74.310000000000002 110.875 -178.496 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 128.69 -10.87 6.35 Favored Glycine 0 C--N 1.292 -1.899 0 N-CA-C 110.393 -1.083 . . . . 63.240000000000002 110.393 -178.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -82.52 125.02 30.65 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 109.238 -0.653 . . . . 75.319999999999993 109.238 176.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 62.0 t -87.8 107.53 17.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 106.788 -1.56 . . . . 73.219999999999999 106.788 175.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 6.1 t -83.87 -8.7 59.13 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.631 -0.713 . . . . 75.239999999999995 111.336 -172.056 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.16 -155.5 26.46 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 120.693 -0.765 . . . . 64.530000000000001 111.299 177.448 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 24.6 p -122.99 159.43 28.37 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 109.348 -0.612 . . . . 74.25 109.348 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -72.97 -53.05 5.33 Favored Pre-proline 0 C--N 1.306 -1.292 0 CA-C-O 118.876 -0.583 . . . . 64.540000000000006 110.578 174.062 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -61.57 128.09 23.68 Favored 'Trans proline' 0 C--N 1.378 2.084 0 N-CA-C 109.008 -1.189 . . . . 72.129999999999995 109.008 170.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -64.65 141.44 72.8 Favored 'Trans proline' 0 C--O 1.253 1.259 0 C-N-CA 122.177 1.918 . . . . 74.099999999999994 112.599 -177.656 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -67.65 139.74 56.82 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 108.13 -1.063 . . . . 73.299999999999997 108.13 175.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.82 -5.0 39.54 Favored Glycine 0 N--CA 1.416 -2.668 0 N-CA-C 110.313 -1.115 . . . . 71.319999999999993 110.313 -175.513 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 543' ' ' THR . . . . . 0.581 ' O ' HD13 ' A' ' 497' ' ' ILE . 27.2 m -88.85 136.61 32.92 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 120.49 -0.484 . . . . 74.120000000000005 109.767 177.275 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 28.9 m -89.82 122.84 33.26 Favored 'General case' 0 N--CA 1.416 -2.147 0 N-CA-C 107.148 -1.427 . . . . 71.319999999999993 107.148 172.276 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.4 m -127.01 154.54 76.5 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 110.222 -0.288 . . . . 75.109999999999999 110.222 -177.453 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -68.84 151.88 73.98 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.305 2.003 . . . . 64.120000000000005 110.113 173.136 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 26.3 m -67.32 -20.28 26.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.724 0.773 . . . . 73.200000000000003 110.063 177.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -77.56 -11.4 59.85 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 114.94 -1.027 . . . . 72.219999999999999 112.258 -179.454 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 49.0 m -78.72 154.65 29.89 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 121.863 -0.523 . . . . 72.319999999999993 111.021 178.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 41.7 t -97.72 116.04 39.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 108.679 -0.859 . . . . 74.239999999999995 108.679 179.434 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.42 126.61 40.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.171 -0.677 . . . . 74.409999999999997 109.171 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -102.43 115.78 31.27 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-O 121.775 0.798 . . . . 74.230000000000004 109.636 -178.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 67.3 mt -87.65 134.25 33.68 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 113.856 -1.52 . . . . 75.510000000000005 107.551 178.096 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -112.32 115.36 28.63 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 122.257 1.027 . . . . 73.040000000000006 110.137 178.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 41.7 t -101.15 139.45 22.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 CA-C-N 114.441 -1.254 . . . . 75.019999999999996 108.446 -176.16 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.589 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 50.6 m -92.46 147.29 23.02 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-O 121.413 0.625 . . . . 54.109999999999999 112.093 179.786 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 0.2 OUTLIER -118.58 132.49 56.2 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 105.247 -2.131 . . . . 75.0 105.247 170.772 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -82.47 -24.1 54.78 Favored Glycine 0 CA--C 1.492 -1.371 0 N-CA-C 114.638 0.615 . . . . 72.120000000000005 114.638 -169.017 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 68.13 31.81 5.19 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 107.548 -1.278 . . . . 64.420000000000002 107.548 -174.362 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 -135.11 141.72 46.08 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 106.281 -1.748 . . . . 74.329999999999998 106.281 -175.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -143.09 147.66 35.38 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 109.731 -0.47 . . . . 72.409999999999997 109.731 176.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 612' ' ' THR . 63.1 t -67.99 118.37 11.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-O 121.149 0.5 . . . . 75.150000000000006 110.303 -179.34 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 53.7 ttp -83.15 132.96 48.85 Favored Pre-proline 0 C--N 1.306 -1.293 0 CA-C-N 115.759 -0.655 . . . . 74.420000000000002 111.251 -177.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.29 170.14 20.87 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.048 2.498 . . . . 73.120000000000005 110.597 172.69 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -67.17 142.44 57.02 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.913 0.387 . . . . 74.430000000000007 110.905 179.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 94.0 mt -121.56 17.56 11.25 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.745 -0.661 . . . . 74.310000000000002 109.593 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 11.3 m -63.04 130.5 44.98 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.314 -0.857 . . . . 74.409999999999997 109.851 -179.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 88.43 46.2 4.72 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 119.916 -1.135 . . . . 54.039999999999999 112.197 177.427 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 26.8 ptm -118.71 157.72 26.92 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.162 -1.051 . . . . 74.109999999999999 108.162 176.401 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . 0.448 ' HB3' ' OD1' ' A' ' 601' ' ' ASN . 91.9 m-85 -130.81 163.68 26.82 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.608 -1.256 . . . . 73.25 107.608 -176.502 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 35.8 t90 -65.44 -36.54 84.22 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.41 0.624 . . . . 74.510000000000005 109.612 176.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.7 m -75.58 -8.88 12.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.363 -0.835 . . . . 74.0 110.433 -178.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' A' ' 577' ' ' ARG . 13.7 t70 -101.21 -37.32 8.59 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.97 -1.013 . . . . 75.420000000000002 109.287 178.217 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -61.47 -34.71 75.92 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 124.314 1.046 . . . . 72.420000000000002 111.892 -179.404 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.403 ' HB2' ' HD3' ' A' ' 576' ' ' PRO . 9.3 mm-40 -60.1 -58.83 16.53 Favored Pre-proline 0 CA--C 1.559 1.291 0 N-CA-C 112.672 0.619 . . . . 34.340000000000003 112.672 177.241 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 51.0 Cg_exo -61.59 -35.1 83.04 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 121.57 1.513 . . . . 71.25 111.782 171.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 573' ' ' ASP . 0.4 OUTLIER -59.54 -40.59 87.72 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.039 0.535 . . . . 73.420000000000002 110.394 -178.106 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 7.1 tt -57.63 -47.37 82.41 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.702 0.801 . . . . 75.519999999999996 109.237 179.666 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -66.63 -46.93 74.23 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.563 -0.744 . . . . 74.25 110.248 -178.65 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -62.79 -39.03 92.97 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.749 0.82 . . . . 75.010000000000005 112.803 -177.517 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 96.4 mt -89.45 -8.57 52.69 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 120.719 -0.392 . . . . 73.209999999999994 111.457 -179.029 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 63.52 43.38 98.19 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 109.679 -1.369 . . . . 63.450000000000003 109.679 -175.503 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 22.1 t90 -73.75 126.63 30.79 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 114.845 -0.677 . . . . 75.340000000000003 111.14 -172.389 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 24.0 m -99.86 -8.07 24.54 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.575 0.702 . . . . 73.439999999999998 109.749 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . 0.416 ' HA2' ' OD1' ' A' ' 617' ' ' ASP . . . -69.14 170.35 41.52 Favored Glycine 0 N--CA 1.428 -1.874 0 CA-C-N 115.127 -0.942 . . . . 74.450000000000003 113.804 -177.129 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 36.1 ttm -105.48 135.14 47.42 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.101 -1.05 . . . . 73.340000000000003 109.997 -177.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 56.7 tp -88.59 131.13 35.09 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.51 -0.922 . . . . 74.230000000000004 108.51 175.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -94.37 104.78 16.76 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.002 0.429 . . . . 72.299999999999997 110.797 -176.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . 0.432 ' HZ3' ' CG ' ' A' ' 592' ' ' ASP . 27.4 tptp -114.24 112.41 23.09 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 109.415 -0.587 . . . . 75.319999999999993 109.415 174.182 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -127.48 -40.76 0.31 Allowed Glycine 0 C--N 1.309 -0.97 0 C-N-CA 119.435 -1.364 . . . . 63.299999999999997 112.943 177.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . 0.467 ' HB2' ' NH2' ' A' ' 623' ' ' ARG . . . -139.58 157.5 45.7 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 122.577 0.351 . . . . 53.210000000000001 110.643 -177.788 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . 0.432 ' CG ' ' HZ3' ' A' ' 589' ' ' LYS . 11.5 m-20 -110.39 124.26 51.39 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.457 -1.312 . . . . 74.209999999999994 107.457 176.422 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 35.9 t -109.02 115.89 50.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 C-N-CA 120.063 -0.655 . . . . 74.549999999999997 110.365 -176.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -100.03 116.78 32.86 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.995 -0.682 . . . . 64.030000000000001 110.425 179.658 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -132.69 -27.94 1.66 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 116.092 -0.504 . . . . 75.310000000000002 110.898 179.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 141.24 -169.41 25.05 Favored Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 110.494 -1.042 . . . . 54.240000000000002 110.494 -177.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.53 -35.18 65.58 Favored Glycine 0 CA--C 1.509 -0.307 0 O-C-N 123.877 0.398 . . . . 61.340000000000003 113.851 -175.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 42.6 m -58.68 -32.3 68.99 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.102 0.408 . . . . 65.329999999999998 112.102 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -108.61 -1.59 19.46 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.071 0.462 . . . . 75.439999999999998 110.651 -178.095 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -67.1 99.72 0.7 Allowed 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.211 -0.45 . . . . 75.439999999999998 112.051 -175.611 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . 0.448 ' OD1' ' HB3' ' A' ' 570' ' ' PHE . 11.7 t-20 67.15 -3.25 1.02 Allowed 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 125.251 1.42 . . . . 75.439999999999998 112.367 174.384 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -93.18 152.93 18.93 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 123.963 0.905 . . . . 75.150000000000006 111.326 -175.186 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . 0.431 HG22 ' HB2' ' A' ' 622' ' ' LEU . 12.9 p -57.06 138.76 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 124.554 1.142 . . . . 70.299999999999997 110.697 178.631 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 61.0 t -93.97 -56.12 5.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 108.118 -1.068 . . . . 74.430000000000007 108.118 179.119 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -151.42 154.62 36.98 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 107.78 -1.193 . . . . 74.230000000000004 107.78 -179.59 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -109.06 122.1 46.55 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.038 -1.467 . . . . 73.439999999999998 107.038 172.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.491 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 42.7 t-20 -53.21 -57.95 14.52 Favored Pre-proline 0 N--CA 1.483 1.189 0 CA-C-O 119.31 -0.376 . . . . 71.430000000000007 111.926 -178.659 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 1.2 Cg_endo -85.7 131.33 3.9 Favored 'Trans proline' 0 N--CA 1.44 -1.635 0 C-N-CA 121.262 1.308 . . . . 71.099999999999994 109.947 174.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . 0.49 ' O ' HG23 ' A' ' 612' ' ' THR . 53.2 Cg_endo -70.38 156.22 62.2 Favored 'Trans proline' 0 C--O 1.243 0.739 0 C-N-CA 122.069 1.846 . . . . 72.409999999999997 111.541 178.625 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -64.41 128.33 35.33 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.371 -0.603 . . . . 74.109999999999999 109.371 178.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 106.02 -3.57 38.38 Favored Glycine 0 C--N 1.3 -1.432 0 C-N-CA 120.394 -0.908 . . . . 52.409999999999997 112.92 -177.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 612' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 609' ' ' PRO . 9.1 t -96.17 176.88 5.91 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-N 117.858 0.829 . . . . 74.109999999999999 109.111 175.504 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -97.87 119.47 6.44 Favored Glycine 0 N--CA 1.425 -2.082 0 CA-C-N 116.194 -0.457 . . . . 62.140000000000001 112.041 -177.075 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 26.8 m -104.95 144.3 14.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 C-N-CA 123.479 0.712 . . . . 73.549999999999997 109.523 177.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . 0.54 ' ND2' ' HB3' ' A' ' 617' ' ' ASP . 36.6 p-10 -57.8 161.13 4.0 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 123.684 0.794 . . . . 75.519999999999996 111.968 -178.074 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -63.21 -25.9 68.55 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 120.82 0.343 . . . . 72.549999999999997 111.218 -178.015 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . 0.54 ' HB3' ' ND2' ' A' ' 615' ' ' ASN . 13.9 t70 -60.08 -40.05 88.21 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.667 -0.864 . . . . 74.439999999999998 108.667 174.308 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 87.96 20.98 48.14 Favored Glycine 0 N--CA 1.428 -1.885 0 CA-C-N 115.408 -0.814 . . . . 73.25 112.115 176.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . 0.412 ' HB ' ' OD1' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -69.24 119.28 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-O 122.762 1.268 . . . . 72.030000000000001 109.883 -173.523 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 3.2 tp -117.55 125.69 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.939 0 CA-C-N 113.422 -1.717 . . . . 74.219999999999999 107.714 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 17.5 m -98.26 116.39 30.39 Favored 'General case' 0 N--CA 1.412 -2.367 0 C-N-CA 118.877 -1.129 . . . . 74.510000000000005 108.097 178.436 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . 0.431 ' HB2' HG22 ' A' ' 603' ' ' VAL . 0.0 OUTLIER -139.64 155.4 47.43 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 106.961 -1.496 . . . . 73.510000000000005 106.961 179.653 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . 0.467 ' NH2' ' HB2' ' A' ' 591' ' ' ALA . 57.2 mtp180 -128.74 156.63 43.21 Favored 'General case' 0 C--N 1.272 -2.782 0 N-CA-C 105.271 -2.122 . . . . 71.329999999999998 105.271 175.186 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -131.14 158.05 41.5 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 106.637 -1.616 . . . . 73.329999999999998 106.637 175.184 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -81.88 -117.32 0.47 Allowed Glycine 0 N--CA 1.423 -2.181 0 C-N-CA 120.073 -1.06 . . . . 74.530000000000001 113.414 -177.252 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 . . . . . 0 C--N 1.297 -1.709 0 N-CA-C 108.886 -0.783 . . . . 74.430000000000007 108.886 -174.134 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.38 0 N-CA-C 109.715 -1.354 . . . . 43.049999999999997 109.715 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 10.7 tp -75.08 141.79 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 108.436 -0.95 . . . . 74.549999999999997 108.436 177.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 1.4 m -73.15 134.7 44.52 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 109.189 -0.671 . . . . 72.430000000000007 109.189 178.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -92.21 -37.29 12.78 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 108.494 -0.928 . . . . 72.430000000000007 108.494 -179.583 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -89.07 117.89 28.39 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.073 -0.967 . . . . 71.120000000000005 109.412 -176.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 34.6 m -121.22 153.93 24.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 N-CA-C 107.019 -1.474 . . . . 72.430000000000007 107.019 177.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -94.56 136.2 35.13 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 117.578 -1.649 . . . . 74.230000000000004 107.284 179.274 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 98.1 t -96.8 124.24 50.91 Favored Pre-proline 0 C--N 1.274 -2.704 0 N-CA-C 109.666 -0.494 . . . . 73.420000000000002 109.666 -172.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -64.12 125.87 16.06 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.935 1.757 . . . . 74.209999999999994 110.058 178.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . 0.576 ' OD1' ' HG2' ' A' ' 366' ' ' ARG . 16.5 t70 -85.69 138.36 32.18 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-O 121.726 0.774 . . . . 73.340000000000003 112.044 -176.608 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 18.5 m -108.22 4.93 9.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 113.981 -1.463 . . . . 61.530000000000001 111.777 -175.421 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.576 ' HG2' ' OD1' ' A' ' 364' ' ' ASP . 25.7 mmt-85 -62.54 147.48 48.87 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 112.624 0.602 . . . . 74.519999999999996 112.624 178.568 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.64 -9.59 44.7 Favored Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 110.709 -0.957 . . . . 74.340000000000003 110.709 -174.624 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -103.75 -150.68 0.42 Allowed 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.481 -0.933 . . . . 71.019999999999996 108.481 178.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 60.3 p -98.05 155.04 17.31 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.464 -0.939 . . . . 73.209999999999994 108.464 -178.162 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 23.0 t -61.42 -33.79 74.3 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.587 -0.523 . . . . 70.239999999999995 109.587 179.104 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -65.59 -46.46 79.3 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 116.24 -0.436 . . . . 73.349999999999994 111.138 178.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.54 -44.87 73.6 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-O 121.426 0.632 . . . . 64.219999999999999 110.376 -179.505 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -60.21 -48.11 83.13 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.582 -1.19 . . . . 54.420000000000002 111.567 -178.23 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.53 -39.31 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 116.644 -0.253 . . . . 74.340000000000003 111.27 177.721 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.9 -44.48 91.24 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-O 121.302 0.572 . . . . 74.299999999999997 111.112 -178.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 376' ' ' THR . . . . . 0.437 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 70.9 m -64.18 -47.34 80.19 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.438 -0.801 . . . . 71.540000000000006 110.648 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 95.5 mt -64.16 -38.79 92.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.474 -0.33 . . . . 74.230000000000004 111.169 -179.265 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -62.29 -43.02 99.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.981 -0.554 . . . . 73.540000000000006 110.787 179.053 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -64.19 -31.86 73.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.274 0.559 . . . . 74.25 111.279 176.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 376' ' ' THR . 29.8 mmm180 -80.11 -13.55 59.19 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.989 -0.55 . . . . 74.450000000000003 111.388 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 94.06 15.65 47.55 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.65 -0.786 . . . . 52.119999999999997 112.578 177.335 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -80.39 156.54 26.62 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 122.451 -0.441 . . . . 74.209999999999994 111.266 177.248 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -99.76 133.81 43.57 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 107.129 -1.434 . . . . 73.219999999999999 107.129 177.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.33 155.1 38.32 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 C-N-CA 120.1 -0.64 . . . . 72.109999999999999 111.124 -175.404 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -136.08 141.28 44.22 Favored 'General case' 0 N--CA 1.403 -2.817 0 CA-C-N 114.571 -1.195 . . . . 74.310000000000002 108.011 169.763 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.2 m -127.22 134.9 50.04 Favored 'General case' 0 C--N 1.271 -2.846 0 N-CA-C 104.55 -2.389 . . . . 65.319999999999993 104.55 179.634 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.57 124.34 45.09 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 119.317 -0.953 . . . . 72.140000000000001 109.201 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -91.34 121.79 33.39 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.086 -0.709 . . . . 74.099999999999994 109.086 -177.306 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 421' ' ' SER . 55.0 mtpt -136.79 130.32 17.68 Favored Pre-proline 0 C--N 1.308 -1.22 0 N-CA-C 110.215 -0.291 . . . . 73.409999999999997 110.215 176.352 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . 0.511 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 54.0 Cg_endo -79.4 127.95 7.69 Favored 'Trans proline' 0 C--O 1.254 1.324 0 C-N-CA 120.956 1.104 . . . . 63.229999999999997 109.836 173.823 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.511 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 8.6 t70 154.33 -164.92 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 103.802 -2.666 . . . . 71.329999999999998 103.802 -177.649 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 26.7 t -142.7 4.7 1.53 Allowed 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 118.098 0.408 . . . . 60.210000000000001 110.187 176.512 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 15.3 t -79.62 -18.13 52.24 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-O 121.338 0.589 . . . . 73.310000000000002 109.781 179.661 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -99.58 150.43 36.78 Favored Pre-proline 0 N--CA 1.424 -1.743 0 N-CA-C 107.012 -1.477 . . . . 74.319999999999993 107.012 176.704 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -49.72 132.89 32.08 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.139 2.559 . . . . 70.430000000000007 114.228 -177.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . 0.573 ' HA ' ' OG ' ' A' ' 421' ' ' SER . 17.5 Cg_endo -60.75 164.03 14.58 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.595 2.863 . . . . 72.450000000000003 110.832 174.302 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.51 -8.91 0.93 Allowed 'General case' 0 N--CA 1.511 2.583 0 CA-C-O 121.915 0.864 . . . . 74.099999999999994 111.012 179.023 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.459 ' H ' ' C ' ' A' ' 396' ' ' PRO . 33.7 m170 -93.57 101.23 13.4 Favored 'General case' 0 CA--C 1.477 -1.841 0 N-CA-C 102.398 -3.186 . . . . 74.420000000000002 102.398 170.205 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 16.5 m -63.32 118.19 5.15 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.488 0 O-C-N 124.197 0.936 . . . . 70.430000000000007 112.491 -166.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 49.3 mm -103.61 -39.3 5.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 115.259 -0.882 . . . . 73.420000000000002 111.08 -177.34 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.41 157.32 27.35 Favored Glycine 0 N--CA 1.433 -1.54 0 C-N-CA 119.739 -1.219 . . . . 71.530000000000001 112.627 -175.51 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -156.31 -174.98 5.19 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 126.062 1.745 . . . . 74.409999999999997 109.797 -176.261 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' A' ' 405' ' ' ALA . 10.7 t70 -96.96 136.15 21.7 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 105.942 -1.873 . . . . 74.420000000000002 105.942 176.252 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . 0.498 ' HA ' ' OD1' ' A' ' 407' ' ' ASN . 38.0 Cg_endo -63.01 23.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 124.823 3.682 . . . . 74.120000000000005 115.622 -173.092 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.468 ' H ' ' C ' ' A' ' 403' ' ' ASP . . . -54.01 -42.16 68.79 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 124.075 0.95 . . . . 72.219999999999999 110.92 177.569 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -79.24 -31.1 43.46 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.593 0.711 . . . . 73.5 110.516 -179.666 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . 0.498 ' OD1' ' HA ' ' A' ' 404' ' ' PRO . 8.9 m120 -79.68 -7.75 58.78 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.354 -0.839 . . . . 74.450000000000003 110.194 -175.782 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 89.9 m -99.42 148.71 23.93 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.564 -1.643 . . . . 74.25 106.564 176.623 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 17.3 m -74.45 111.89 10.09 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 107.814 -1.18 . . . . 75.340000000000003 107.814 177.445 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.36 169.86 20.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 C-N-CA 123.089 0.556 . . . . 74.120000000000005 110.262 -177.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 49.7 m -68.49 131.9 46.07 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.447 -0.946 . . . . 75.319999999999993 108.447 174.303 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -58.51 111.07 1.11 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.334 0.588 . . . . 64.019999999999996 110.683 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 111.1 73.81 0.72 Allowed Glycine 0 N--CA 1.432 -1.577 0 N-CA-C 110.58 -1.008 . . . . 65.209999999999994 110.58 -179.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -129.44 -175.0 3.44 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 105.853 -1.906 . . . . 54.240000000000002 105.853 179.935 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -102.76 123.45 46.45 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 118.401 0.546 . . . . 73.510000000000005 110.545 -177.02 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 27.1 mm -113.12 120.69 63.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 109.043 -0.725 . . . . 73.329999999999998 109.043 -179.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 17.1 p -100.62 131.44 46.53 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 112.006 0.373 . . . . 72.310000000000002 112.006 -178.488 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 7.7 p -126.81 134.91 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-O 120.892 0.377 . . . . 65.430000000000007 110.846 176.279 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -101.6 128.46 47.87 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.816 -1.179 . . . . 75.450000000000003 107.816 175.201 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 54.0 t -124.55 135.92 62.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 C-N-CA 122.999 0.52 . . . . 73.040000000000006 110.352 -175.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 421' ' ' SER . . . . . 0.573 ' OG ' ' HA ' ' A' ' 396' ' ' PRO . 77.7 p -84.9 121.12 27.29 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 109.086 -0.709 . . . . 71.540000000000006 109.086 177.897 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 33.8 m -118.69 106.2 12.35 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 109.07 -0.715 . . . . 75.310000000000002 109.07 177.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 92.21 118.52 2.45 Favored Glycine 0 N--CA 1.425 -2.045 0 C-N-CA 120.6 -0.81 . . . . 72.150000000000006 111.687 -178.514 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -77.96 158.12 30.87 Favored 'Trans proline' 0 C--O 1.243 0.747 0 C-N-CA 122.565 2.177 . . . . 72.329999999999998 109.692 174.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -71.72 166.1 22.65 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.726 0.774 . . . . 74.140000000000001 111.897 -175.371 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -87.63 158.32 18.89 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.502 -1.226 . . . . 72.219999999999999 108.036 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -121.08 143.03 49.29 Favored 'General case' 0 CA--C 1.479 -1.779 0 CA-C-O 121.367 0.603 . . . . 72.150000000000006 112.145 -173.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -82.96 134.71 35.05 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.271 -1.331 . . . . 75.450000000000003 108.755 178.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 474' ' ' ALA . 50.2 mt -83.02 125.96 73.67 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 109.144 -0.688 . . . . 73.0 109.144 -179.45 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -71.03 154.68 62.57 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.426 2.084 . . . . 74.239999999999995 110.905 173.077 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -74.07 158.86 33.51 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 108.986 -0.746 . . . . 74.420000000000002 108.986 178.068 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 12.2 p -142.4 147.05 21.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 109.949 -0.389 . . . . 64.030000000000001 109.949 -178.447 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 19.5 m -72.84 137.01 45.45 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 108.65 -0.87 . . . . 74.329999999999998 108.65 175.806 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 54.4 p -62.44 -31.19 71.86 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 113.822 1.045 . . . . 72.409999999999997 113.822 -171.349 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.4 pp -81.67 -11.5 59.05 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.224 -0.99 . . . . 72.140000000000001 111.382 179.11 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 5.5 m -105.41 62.68 0.68 Allowed 'General case' 0 N--CA 1.432 -1.341 0 CA-C-O 122.191 0.996 . . . . 73.430000000000007 112.0 -176.21 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -56.12 -37.1 68.99 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.593 1.157 . . . . 73.540000000000006 111.397 176.25 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.33 -40.61 78.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.124 0.488 . . . . 64.319999999999993 111.016 178.077 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -70.28 -34.97 73.4 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.308 -0.627 . . . . 73.439999999999998 109.308 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.55 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -60.8 -51.39 69.52 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.74 -0.664 . . . . 63.109999999999999 111.345 179.15 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 35.4 m -65.47 -39.11 84.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 112.31 0.485 . . . . 74.0 112.31 -177.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -34.76 77.41 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 120.607 -0.437 . . . . 73.230000000000004 111.572 178.111 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 27.3 mmtm -61.76 -39.81 92.95 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-N 116.4 -0.363 . . . . 75.420000000000002 110.452 177.427 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 75.5 mt -63.88 -43.25 96.6 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.369 -0.832 . . . . 61.299999999999997 110.073 179.252 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 61.1 m -65.35 -42.68 92.57 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.362 -0.381 . . . . 74.219999999999999 111.646 177.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -63.35 -29.25 70.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.708 0.766 . . . . 73.319999999999993 110.611 178.455 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -85.02 5.22 30.28 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.454 -0.794 . . . . 42.020000000000003 111.889 179.194 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 105.48 -66.5 0.27 Allowed Glycine 0 CA--C 1.496 -1.142 0 C-N-CA 120.374 -0.917 . . . . 71.120000000000005 112.96 172.749 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -46.65 -65.88 0.49 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 114.353 1.242 . . . . 74.129999999999995 114.353 177.767 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 59.09 26.22 60.83 Favored Glycine 0 N--CA 1.469 0.887 0 C-N-CA 120.948 -0.644 . . . . 73.319999999999993 112.65 -176.005 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.46 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 16.3 mmt85 -100.73 111.37 23.59 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 107.148 -1.427 . . . . 75.409999999999997 107.148 -177.221 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -140.2 153.44 46.59 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 112.487 0.551 . . . . 72.219999999999999 112.487 -174.247 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -138.81 148.53 43.9 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 124.77 1.228 . . . . 71.549999999999997 108.996 176.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -121.1 124.94 45.99 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 122.967 0.507 . . . . 74.219999999999999 110.609 -176.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -128.19 162.79 26.13 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.016 -0.735 . . . . 72.230000000000004 109.016 178.05 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -129.11 146.76 50.98 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 120.969 0.414 . . . . 73.209999999999994 110.072 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 36.8 t -143.47 149.14 46.52 Favored Pre-proline 0 C--N 1.29 -1.985 0 N-CA-C 107.453 -1.314 . . . . 61.549999999999997 107.453 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.688 ' HA ' ' O ' ' A' ' 490' ' ' SER . 24.3 Cg_exo -64.83 134.77 41.74 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.874 1.716 . . . . 73.010000000000005 109.722 176.545 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 62.6 m -152.07 172.17 16.73 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 116.181 -0.463 . . . . 75.010000000000005 109.855 -178.191 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 7.0 t -53.78 141.46 46.79 Favored Pre-proline 0 N--CA 1.438 -1.043 0 C-N-CA 124.487 1.115 . . . . 71.049999999999997 111.072 177.22 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -52.72 -30.67 47.34 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 124.698 3.598 . . . . 74.5 113.342 -176.302 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -72.97 -28.63 62.51 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.958 -0.565 . . . . 60.539999999999999 111.791 -178.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 11.2 mp -98.57 -0.61 42.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.592 0.234 . . . . 73.209999999999994 111.555 178.736 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 53.3 t -61.69 126.65 20.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-O 121.035 0.445 . . . . 75.030000000000001 109.92 175.229 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 87.58 0.21 84.44 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.711 -0.677 . . . . 70.340000000000003 111.75 -178.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.32 158.95 17.87 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.861 -0.792 . . . . 72.230000000000004 108.861 179.363 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 70.2 t -75.19 138.78 20.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 N-CA-C 108.728 -0.842 . . . . 63.25 108.728 176.382 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 48.9 mm -97.26 -27.86 3.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.395 -1.335 . . . . 73.540000000000006 107.395 179.062 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 156.57 -168.79 33.82 Favored Glycine 0 N--CA 1.422 -2.272 0 CA-C-N 115.209 -0.905 . . . . 70.25 112.052 175.472 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 470' ' ' THR . . . . . 0.512 HG22 HG12 ' A' ' 486' ' ' ILE . 39.7 p -115.64 147.2 41.08 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 104.905 -2.258 . . . . 73.209999999999994 104.905 177.375 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.402 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 9.8 t30 -68.38 -55.13 12.84 Favored Pre-proline 0 C--N 1.31 -1.12 0 C-N-CA 118.542 -1.263 . . . . 74.099999999999994 111.815 176.394 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.402 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 23.9 Cg_exo -70.01 155.42 65.16 Favored 'Trans proline' 0 C--N 1.371 1.725 0 N-CA-C 108.769 -1.281 . . . . 73.230000000000004 108.769 172.428 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -62.27 126.66 19.07 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 121.82 1.68 . . . . 73.109999999999999 112.123 -176.687 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.421 ' O ' ' HB ' ' A' ' 429' ' ' ILE . . . -84.7 -2.08 57.06 Favored 'General case' 0 C--O 1.204 -1.322 0 CA-C-N 115.437 -0.801 . . . . 73.219999999999999 112.068 -174.491 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -110.71 6.37 21.55 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 120.108 -0.637 . . . . 71.150000000000006 111.874 175.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -110.23 173.75 6.18 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.517 0.932 . . . . 72.299999999999997 113.517 -174.014 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.11 117.11 21.4 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.803 -1.09 . . . . 71.120000000000005 110.969 -177.368 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 49.0 m -117.12 148.26 41.71 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.709 -0.849 . . . . 73.340000000000003 108.709 177.449 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -81.32 161.11 23.98 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.601 -0.518 . . . . 65.150000000000006 109.601 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.01 -17.82 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 CA-C-O 121.732 0.777 . . . . 72.450000000000003 112.353 -178.179 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.1 t -95.96 4.79 52.41 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.583 -0.698 . . . . 63.119999999999997 111.772 179.093 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -86.92 129.49 34.86 Favored 'General case' 0 CA--C 1.508 -0.638 0 O-C-N 121.961 -0.462 . . . . 75.120000000000005 111.091 -177.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . 0.46 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.1 p -104.79 123.51 58.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.459 0.647 . . . . 70.340000000000003 110.509 178.687 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 34.7 m -101.28 126.91 55.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 121.787 0.803 . . . . 72.099999999999994 111.122 -179.1 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.71 125.22 45.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 108.213 -1.032 . . . . 74.430000000000007 108.213 176.36 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . 0.512 HG12 HG22 ' A' ' 470' ' ' THR . 37.1 mt -109.53 126.3 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 CA-C-N 115.076 -0.965 . . . . 70.010000000000005 110.809 -178.003 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 4.4 tt -104.64 127.0 59.41 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 CA-C-N 114.887 -1.051 . . . . 72.219999999999999 110.011 -177.213 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 33.1 m -110.18 151.57 12.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 C-N-CA 122.786 0.434 . . . . 72.519999999999996 110.012 177.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -84.62 135.48 13.64 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.674 -0.57 . . . . 71.120000000000005 111.674 -179.226 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.688 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 46.4 m -142.89 160.53 40.16 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 117.155 0.477 . . . . 73.540000000000006 110.176 178.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 81.17 86.9 0.65 Allowed Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 121.359 -0.448 . . . . 74.310000000000002 112.936 176.175 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -85.46 127.11 3.22 Favored 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 122.392 2.061 . . . . 74.030000000000001 111.122 178.155 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -85.02 45.87 1.22 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.682 0.754 . . . . 62.530000000000001 110.151 178.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 10.8 p -122.58 145.95 47.87 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.511 -0.768 . . . . 75.510000000000005 110.485 -178.29 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -143.39 150.04 38.53 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 123.104 0.561 . . . . 74.049999999999997 111.32 178.464 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 11.1 p-10 -86.85 127.83 35.03 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.164 -0.926 . . . . 65.400000000000006 110.319 178.911 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 31.1 pt -81.17 134.1 52.89 Favored Pre-proline 0 C--N 1.304 -1.396 0 CA-C-N 115.658 -0.701 . . . . 74.319999999999993 110.426 179.029 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -82.43 175.99 8.39 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.658 2.239 . . . . 75.230000000000004 112.978 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -83.08 142.13 31.51 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.365 -0.834 . . . . 71.120000000000005 108.765 177.048 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 51.3 t -138.57 91.11 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 N-CA-C 107.74 -1.207 . . . . 74.409999999999997 107.74 -179.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -151.1 121.08 7.13 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.775 -0.454 . . . . 70.549999999999997 109.775 178.455 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 102.69 25.63 7.56 Favored Glycine 0 CA--C 1.489 -1.557 0 C-N-CA 120.164 -1.017 . . . . 51.420000000000002 111.243 176.447 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -131.95 170.3 15.1 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 109.118 -0.697 . . . . 73.439999999999998 109.118 178.829 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 15.1 t -91.57 160.63 15.31 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.284 -1.006 . . . . 71.030000000000001 108.284 178.359 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 47.5 t -51.88 -42.5 33.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 C-N-CA 123.709 0.803 . . . . 73.030000000000001 111.788 -175.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -67.86 -42.34 81.46 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.25 0.463 . . . . 74.109999999999999 112.25 -177.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 66.3 t -75.2 -34.68 31.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-O 121.281 0.562 . . . . 64.230000000000004 110.172 -177.769 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -61.95 -50.0 73.89 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.911 -0.586 . . . . 63.149999999999999 110.661 178.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -65.89 -34.91 79.22 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 120.819 -0.352 . . . . 75.310000000000002 110.95 178.498 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -55.84 -48.25 75.81 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.5 0.72 . . . . 72.209999999999994 110.166 178.437 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -62.31 -45.93 91.02 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-N 116.091 -0.504 . . . . 75.230000000000004 110.436 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 90.1 mt -61.76 -38.25 87.29 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.823 -0.626 . . . . 73.510000000000005 111.335 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -61.42 -42.48 98.8 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.954 0.407 . . . . 73.109999999999999 110.124 177.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 85.8 t -66.61 -29.55 46.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-N 115.601 -0.727 . . . . 72.420000000000002 110.666 178.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -84.23 3.02 37.2 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 121.872 -0.518 . . . . 73.329999999999998 112.066 179.402 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 82.54 39.41 10.85 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 121.006 -0.616 . . . . 70.120000000000005 112.791 177.251 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -124.77 138.59 54.27 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.994 -1.113 . . . . 74.420000000000002 107.994 176.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 3.6 m -131.84 -11.58 3.4 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.708 -0.797 . . . . 72.409999999999997 111.677 -176.212 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -107.64 115.01 29.39 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.25 -0.648 . . . . 73.25 109.25 -174.394 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -130.01 155.94 45.29 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.565 -0.743 . . . . 73.230000000000004 110.005 -175.069 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 521' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 66.9 m -141.83 127.85 19.56 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 106.999 -1.482 . . . . 75.049999999999997 106.999 170.625 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . 0.471 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 0.0 OUTLIER -117.3 133.35 56.08 Favored 'General case' 0 N--CA 1.418 -2.053 0 CA-C-O 121.23 0.538 . . . . 55.109999999999999 111.129 -179.3 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -113.87 143.13 45.19 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.442 -0.948 . . . . 73.439999999999998 108.442 178.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 61.0 m -102.71 126.98 50.02 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.0 0.428 . . . . 73.120000000000005 110.833 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 26.7 m -121.3 168.3 13.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.68 -1.23 . . . . 64.200000000000003 107.68 177.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . 0.53 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 5.4 p-10 -102.65 136.42 42.52 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.31 -0.956 . . . . 61.219999999999999 111.178 -179.476 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 18.7 m -152.85 178.15 1.68 Allowed Pre-proline 0 C--N 1.308 -1.219 0 N-CA-C 108.343 -0.984 . . . . 74.299999999999997 108.343 178.368 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -83.8 -0.37 9.65 Favored 'Trans proline' 0 C--N 1.361 1.216 0 C-N-CA 121.848 1.699 . . . . 62.109999999999999 111.135 173.435 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . 0.506 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 8.1 mmm180 -76.73 138.84 66.28 Favored Pre-proline 0 C--O 1.211 -0.943 0 N-CA-C 106.826 -1.546 . . . . 74.409999999999997 106.826 178.532 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.08 150.41 86.66 Favored 'Trans proline' 0 C--O 1.246 0.879 0 C-N-CA 122.387 2.058 . . . . 75.120000000000005 112.074 -177.651 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.67 107.9 0.76 Allowed 'General case' 0 C--O 1.239 0.534 0 CA-C-N 116.21 -0.45 . . . . 71.510000000000005 110.439 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 133.51 -17.77 4.44 Favored Glycine 0 C--N 1.298 -1.562 0 N-CA-C 110.602 -0.999 . . . . 73.319999999999993 110.602 -177.612 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -75.58 124.73 27.7 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.272 -1.011 . . . . 73.25 108.272 177.292 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 47.1 t -82.92 115.61 25.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 106.711 -1.588 . . . . 64.450000000000003 106.711 175.172 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 535' ' ' THR . . . . . 0.428 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 10.6 t -83.48 -20.44 33.99 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.055 0.455 . . . . 71.109999999999999 110.5 -175.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 166.12 -159.37 32.62 Favored Glycine 0 N--CA 1.428 -1.849 0 C-N-CA 120.638 -0.791 . . . . 73.239999999999995 111.169 178.573 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 21.7 p -132.77 158.74 41.66 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.668 -0.864 . . . . 74.430000000000007 108.668 178.653 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -74.84 -53.35 3.11 Favored Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 109.886 -0.412 . . . . 70.129999999999995 109.886 176.34 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -70.42 140.22 39.72 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 120.906 1.071 . . . . 65.209999999999994 110.176 173.476 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.23 142.01 53.97 Favored 'Trans proline' 0 C--O 1.247 0.938 0 C-N-CA 122.592 2.195 . . . . 74.340000000000003 112.731 -179.123 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -65.76 135.58 55.09 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.746 -0.661 . . . . 72.319999999999993 109.683 178.605 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 103.67 -14.34 53.52 Favored Glycine 0 C--N 1.304 -1.199 0 C-N-CA 120.78 -0.724 . . . . 64.310000000000002 112.31 -179.853 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 27.6 m -67.2 129.77 40.98 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 110.349 -0.241 . . . . 73.510000000000005 110.349 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 56.7 m -92.11 122.69 34.84 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 108.223 -1.029 . . . . 73.530000000000001 108.223 177.265 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 26.0 m -132.4 164.72 41.43 Favored Pre-proline 0 C--N 1.307 -1.271 0 N-CA-C 109.404 -0.591 . . . . 74.540000000000006 109.404 -176.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -62.61 150.86 86.36 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.194 1.929 . . . . 72.010000000000005 110.18 174.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 27.4 m -64.21 -20.53 27.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 112.661 0.615 . . . . 72.120000000000005 112.661 -177.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -83.14 3.43 30.81 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 123.841 0.856 . . . . 64.120000000000005 111.805 178.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 11.7 t -80.46 158.67 25.84 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.111 0.482 . . . . 72.340000000000003 111.041 -176.481 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 70.0 t -101.37 135.12 39.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.842 -0.617 . . . . 73.439999999999998 110.19 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . 0.418 HD13 ' N ' ' A' ' 551' ' ' ILE . 2.6 mp -97.15 126.13 50.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 107.462 -1.31 . . . . 75.319999999999993 107.462 176.282 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 521' ' ' SER . 36.6 tt0 -103.53 116.29 32.1 Favored 'General case' 0 N--CA 1.428 -1.56 0 C-N-CA 120.602 -0.439 . . . . 72.239999999999995 109.978 -179.237 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 4.6 mp -101.5 134.48 44.53 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.154 -0.93 . . . . 74.319999999999993 109.032 -178.652 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -110.01 114.14 27.42 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 122.11 0.957 . . . . 64.400000000000006 109.553 177.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 48.6 t -103.0 141.44 18.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-N 114.342 -1.299 . . . . 74.129999999999995 109.087 -174.464 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 67.9 m -96.65 147.6 23.73 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.205 0.526 . . . . 74.310000000000002 112.212 -179.161 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.53 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 15.1 ptpt -96.78 150.72 20.38 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 105.282 -2.118 . . . . 72.340000000000003 105.282 170.692 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -73.39 -37.55 53.76 Favored Glycine 0 CA--C 1.485 -1.842 0 N-CA-C 110.931 -0.868 . . . . 44.520000000000003 110.931 -178.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 63.2 t30 69.79 -0.86 2.52 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 122.54 1.162 . . . . 74.109999999999999 110.609 175.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.48 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 77.9 mt-30 -142.57 144.42 32.88 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 106.509 -1.663 . . . . 75.420000000000002 106.509 179.565 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -123.71 140.94 52.49 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 120.75 -0.38 . . . . 73.319999999999993 110.402 179.33 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.99 123.16 11.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.575 0.702 . . . . 70.519999999999996 112.037 -178.122 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 59.6 ttp -97.28 134.66 22.45 Favored Pre-proline 0 C--N 1.305 -1.352 0 CA-C-N 115.43 -0.805 . . . . 70.340000000000003 109.874 178.463 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.15 169.62 13.34 Favored 'Trans proline' 0 C--O 1.244 0.821 0 C-N-CA 122.805 2.336 . . . . 72.219999999999999 111.197 175.496 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . 0.434 ' HA ' ' CB ' ' A' ' 610' ' ' ALA . 28.1 t70 -66.83 114.69 5.88 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.401 0.62 . . . . 71.310000000000002 112.085 -178.274 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 93.2 mt -133.87 10.0 3.91 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.208 -1.034 . . . . 72.430000000000007 108.208 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 14.6 m -79.17 134.08 36.7 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.935 -1.03 . . . . 63.420000000000002 110.575 -175.238 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 77.19 33.98 42.91 Favored Glycine 0 C--O 1.221 -0.66 0 C-N-CA 120.724 -0.751 . . . . 71.540000000000006 111.94 -179.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 569' ' ' MET . . . . . 0.531 ' SD ' ' HD3' ' A' ' 577' ' ' ARG . 36.0 ttp -100.27 146.37 26.99 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.814 -0.439 . . . . 73.430000000000007 109.814 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . 0.425 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 93.4 m-85 -76.59 147.87 37.36 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.279 -1.008 . . . . 63.149999999999999 108.279 178.92 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 72.4 t-105 -59.67 -22.84 62.5 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 112.057 0.392 . . . . 75.340000000000003 112.057 -178.231 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 29.5 m -70.52 -23.14 24.14 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.438 0 CA-C-N 115.951 -0.568 . . . . 71.120000000000005 111.335 -178.582 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -101.06 -33.37 10.18 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.939 -0.763 . . . . 74.140000000000001 108.939 175.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . 0.48 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -58.23 -53.48 57.8 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.469 0.914 . . . . 62.329999999999998 113.469 -176.03 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.411 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 34.7 tt0 -58.5 -51.9 78.49 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 120.51 -0.476 . . . . 71.5 112.021 -178.253 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . 0.411 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 51.2 Cg_exo -57.8 -40.76 76.26 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 121.918 1.745 . . . . 53.119999999999997 112.789 176.58 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . 0.531 ' HD3' ' SD ' ' A' ' 569' ' ' MET . 80.9 mtp180 -69.09 -33.94 74.32 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 120.326 -0.55 . . . . 74.340000000000003 112.139 -179.249 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 92.8 mt -65.36 -47.55 76.04 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.008 0.433 . . . . 72.530000000000001 110.454 178.706 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -65.31 -34.81 79.22 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.964 -0.562 . . . . 74.340000000000003 111.176 177.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -65.4 -32.43 74.05 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.924 0.393 . . . . 52.530000000000001 111.093 178.417 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . 0.431 HD22 ' O ' ' A' ' 577' ' ' ARG . 4.1 mm? -81.46 -5.2 57.69 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.251 -0.431 . . . . 75.540000000000006 111.179 177.42 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 72.78 31.71 62.12 Favored Glycine 0 N--CA 1.431 -1.649 0 C-N-CA 121.018 -0.61 . . . . 63.240000000000002 111.6 -179.783 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 78.6 t90 -65.1 139.05 58.67 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.678 0.275 . . . . 74.030000000000001 110.286 177.093 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 29.2 m -151.62 103.03 2.92 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.361 -0.607 . . . . 75.040000000000006 109.361 175.357 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -161.39 -138.26 2.38 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 109.497 -1.441 . . . . 75.049999999999997 109.497 177.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 16.4 mmt -117.71 132.09 56.53 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.214 0.53 . . . . 64.25 110.766 175.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 24.8 tp -98.91 118.18 35.09 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 106.347 -1.723 . . . . 75.319999999999993 106.347 178.375 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -120.35 100.45 7.17 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 118.112 -1.435 . . . . 52.32 111.962 178.447 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . 0.455 ' HZ1' ' CG ' ' A' ' 592' ' ' ASP . 0.1 OUTLIER -113.79 133.8 55.16 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.143 -1.389 . . . . 74.530000000000001 108.391 171.476 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -73.2 -102.33 0.07 OUTLIER Glycine 0 C--N 1.301 -1.361 0 C-N-CA 120.745 -0.741 . . . . 64.310000000000002 113.842 -176.31 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -91.81 135.8 33.64 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 120.591 0.234 . . . . 73.030000000000001 111.489 -177.612 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . 0.455 ' CG ' ' HZ1' ' A' ' 589' ' ' LYS . 11.0 m-20 -89.3 125.97 35.33 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 106.915 -1.513 . . . . 43.420000000000002 106.915 177.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 78.4 t -124.67 115.63 45.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 110.158 -0.312 . . . . 70.030000000000001 110.158 -175.127 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -74.49 113.42 11.71 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.683 -0.858 . . . . 75.25 108.683 177.06 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -125.32 -28.98 3.3 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 115.648 -0.705 . . . . 75.420000000000002 110.373 177.593 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 107.74 147.97 13.78 Favored Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 110.015 -1.234 . . . . 74.230000000000004 110.015 -176.351 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -62.5 -33.57 86.83 Favored Glycine 0 C--N 1.32 -0.348 0 CA-C-N 116.915 0.357 . . . . 64.019999999999996 112.776 -177.602 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 27.4 m -65.89 -23.97 66.75 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-O 121.144 0.497 . . . . 75.140000000000001 111.206 178.333 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -87.11 0.47 55.22 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.54 0.736 . . . . 63.340000000000003 110.765 -179.573 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . 0.4 10.3 p-80 69.65 92.0 0.09 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 126.545 1.938 . . . . 75.439999999999998 116.123 176.671 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -90.66 69.35 6.66 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 123.033 1.397 . . . . 54.119999999999997 107.999 171.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 37.2 ptt85 -106.82 162.44 13.8 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.227 -1.351 . . . . 74.140000000000001 110.178 -176.574 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 75.9 t -68.98 130.86 34.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 106.133 -1.803 . . . . 64.109999999999999 106.133 172.72 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 28.3 m -107.48 -31.18 2.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 119.494 -0.882 . . . . 72.430000000000007 111.937 -176.332 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -145.05 157.13 44.21 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 106.942 -1.503 . . . . 75.349999999999994 106.942 176.058 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -148.98 160.2 43.52 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 106.872 -1.529 . . . . 65.430000000000007 106.872 -179.321 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.476 ' HB2' ' HD3' ' A' ' 608' ' ' PRO . 88.6 m-20 -68.56 -57.85 7.85 Favored Pre-proline 0 C--N 1.315 -0.893 0 C-N-CA 120.185 -0.606 . . . . 72.329999999999998 112.022 -179.492 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.476 ' HD3' ' HB2' ' A' ' 607' ' ' ASN . 10.1 Cg_endo -99.07 127.02 0.17 Allowed 'Trans proline' 0 N--CA 1.44 -1.674 0 C-N-CA 122.123 1.882 . . . . 75.120000000000005 112.245 178.877 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.45 158.67 54.21 Favored 'Trans proline' 0 C--O 1.246 0.891 0 C-N-CA 121.927 1.751 . . . . 75.310000000000002 111.432 176.545 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 565' ' ' ASP . . . -68.02 137.39 55.03 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.776 -0.824 . . . . 74.340000000000003 108.776 177.337 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 90.04 -0.05 78.35 Favored Glycine 0 C--N 1.309 -0.932 0 C-N-CA 120.337 -0.935 . . . . 62.43 111.144 -177.469 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 27.6 m -111.48 159.62 17.91 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 107.514 -1.291 . . . . 73.349999999999994 107.514 177.5 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -77.92 133.62 13.26 Favored Glycine 0 N--CA 1.427 -1.944 0 N-CA-C 111.743 -0.543 . . . . 71.25 111.743 177.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 21.6 m -96.72 141.18 15.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 109.032 -0.729 . . . . 75.329999999999998 109.032 177.336 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -55.77 148.85 15.68 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.91 0.884 . . . . 74.519999999999996 110.358 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -52.63 -30.68 32.84 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 112.962 0.727 . . . . 74.030000000000001 112.962 -174.143 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . 0.565 ' OD2' ' HB ' ' A' ' 619' ' ' ILE . 32.7 t70 -79.78 -31.42 40.82 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.951 0.405 . . . . 75.120000000000005 110.739 -178.535 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 77.74 20.71 73.35 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.902 -0.666 . . . . 54.509999999999998 112.789 179.013 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . 0.565 ' HB ' ' OD2' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -68.3 121.01 16.69 Favored 'Isoleucine or valine' 0 C--O 1.246 0.872 0 CA-C-O 122.536 1.16 . . . . 74.150000000000006 109.209 -173.796 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 6.3 tp -115.08 120.09 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.093 0 CA-C-N 113.957 -1.474 . . . . 75.329999999999998 112.379 -171.763 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 14.5 m -99.4 117.25 33.4 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 105.565 -2.013 . . . . 74.209999999999994 105.565 170.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -140.09 162.69 34.63 Favored 'General case' 0 CA--C 1.483 -1.631 0 N-CA-C 108.987 -0.746 . . . . 74.099999999999994 108.987 -175.429 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -134.79 137.23 43.19 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 107.442 -1.318 . . . . 75.409999999999997 107.442 172.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -142.02 166.06 25.74 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 105.281 -2.118 . . . . 75.439999999999998 105.281 173.389 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -66.4 -86.74 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.426 -1.07 . . . . 75.239999999999995 110.426 175.616 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 . . . . . 0 C--N 1.299 -1.624 0 N-CA-C 105.95 -1.87 . . . . 74.519999999999996 105.95 175.763 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.986 0 N-CA-C 109.968 -1.253 . . . . 61.509999999999998 109.968 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 10.3 tp -75.77 131.96 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 CA-C-N 117.566 0.683 . . . . 70.109999999999999 109.77 177.075 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.4 -175.15 4.99 Favored 'General case' 0 N--CA 1.409 -2.51 0 C-N-CA 124.282 1.033 . . . . 74.420000000000002 112.288 -177.642 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -72.6 20.23 0.07 Allowed 'General case' 0 C--O 1.242 0.66 0 C-N-CA 124.496 1.119 . . . . 74.319999999999993 113.521 -177.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -74.74 127.55 33.41 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.241 -1.022 . . . . 74.530000000000001 108.241 176.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.9 m -134.52 163.27 37.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.494 -0.928 . . . . 74.319999999999993 108.494 178.027 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -94.23 140.59 29.58 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 106.455 -1.683 . . . . 70.340000000000003 106.455 175.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.514 HG22 ' CZ ' ' A' ' 382' ' ' PHE . 75.7 t -93.92 134.48 26.07 Favored Pre-proline 0 C--N 1.277 -2.565 0 N-CA-C 107.559 -1.274 . . . . 73.5 107.559 -174.719 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.84 149.48 66.46 Favored 'Trans proline' 0 C--O 1.253 1.259 0 C-N-CA 123.042 2.495 . . . . 63.229999999999997 113.308 -171.279 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -87.24 75.15 9.39 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 115.076 -0.966 . . . . 62.450000000000003 111.258 -177.409 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 27.7 m -91.54 -5.25 10.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 122.917 1.341 . . . . 72.030000000000001 108.005 173.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -66.39 146.43 54.57 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 112.329 -2.214 . . . . 72.450000000000003 108.21 177.05 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 399' ' ' VAL . . . 104.53 1.23 43.51 Favored Glycine 0 C--N 1.304 -1.237 0 C-N-CA 119.475 -1.345 . . . . 44.219999999999999 114.042 178.674 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -110.29 -77.39 0.59 Allowed 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.094 -0.706 . . . . 73.439999999999998 109.094 -177.65 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 78.7 p -149.78 153.13 36.34 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 106.767 -1.568 . . . . 65.319999999999993 106.767 178.248 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 22.6 t -62.64 -33.72 75.61 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.964 -0.754 . . . . 63.409999999999997 108.964 177.278 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -68.69 -47.83 65.43 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 112.53 0.567 . . . . 64.430000000000007 112.53 -178.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -69.69 -45.27 68.66 Favored 'General case' 0 CA--C 1.503 -0.859 0 C-N-CA 119.482 -0.887 . . . . 75.010000000000005 110.631 -178.097 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . 0.457 ' O ' ' HG ' ' A' ' 377' ' ' LEU . . . -61.17 -50.57 72.61 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.407 -0.815 . . . . 73.219999999999999 110.96 -178.361 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.28 -38.97 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 120.727 -0.389 . . . . 73.120000000000005 111.778 -177.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.71 -44.02 93.88 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.226 0.536 . . . . 75.230000000000004 110.884 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 21.0 m -66.52 -47.1 74.03 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.572 -0.74 . . . . 73.340000000000003 110.104 -179.171 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 373' ' ' ALA . 94.0 mt -61.49 -42.45 98.8 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.271 -0.422 . . . . 74.439999999999998 110.629 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -61.21 -42.46 98.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.129 -0.487 . . . . 75.319999999999993 111.157 -179.532 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -67.57 -24.52 65.52 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 112.072 0.397 . . . . 75.239999999999995 112.072 179.31 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -81.42 -13.76 57.88 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.106 0.479 . . . . 73.420000000000002 110.123 176.518 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.67 7.43 51.06 Favored Glycine 0 N--CA 1.437 -1.297 0 CA-C-N 115.701 -0.681 . . . . 74.530000000000001 112.337 178.381 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.514 ' CZ ' HG22 ' A' ' 362' ' ' VAL . 57.4 m-85 -74.36 148.72 41.03 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-O 121.431 0.634 . . . . 74.420000000000002 110.322 178.159 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 47.0 mmtm -98.61 146.24 26.02 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 106.548 -1.649 . . . . 72.400000000000006 106.548 178.293 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.71 150.68 27.16 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.302 0 C-N-CA 119.735 -0.786 . . . . 73.450000000000003 110.095 -179.14 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -117.06 146.15 43.28 Favored 'General case' 0 N--CA 1.404 -2.769 0 N-CA-C 106.372 -1.714 . . . . 74.329999999999998 106.372 171.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 89.0 m -135.02 117.85 16.18 Favored 'General case' 0 C--N 1.256 -3.496 0 N-CA-C 106.371 -1.714 . . . . 73.239999999999995 106.371 -179.342 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 20.8 tp -117.83 130.89 56.54 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 108.967 -0.753 . . . . 74.109999999999999 108.967 -176.107 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -91.12 131.0 36.96 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-O 121.099 0.476 . . . . 74.409999999999997 110.311 -178.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . 0.558 ' O ' ' HA ' ' A' ' 421' ' ' SER . 76.0 mmtt -125.85 143.31 44.86 Favored Pre-proline 0 C--N 1.297 -1.69 0 N-CA-C 107.396 -1.335 . . . . 75.209999999999994 107.396 177.643 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . 0.415 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 13.7 Cg_endo -98.14 127.25 0.22 Allowed 'Trans proline' 0 N--CA 1.449 -1.137 0 N-CA-C 108.867 -1.243 . . . . 74.510000000000005 108.867 166.563 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 6.7 t70 168.09 -170.04 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.286 -1.375 . . . . 74.150000000000006 107.286 -174.899 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 31.7 t -136.74 -11.36 1.79 Allowed 'General case' 0 N--CA 1.428 -1.573 0 C-N-CA 123.22 0.608 . . . . 71.420000000000002 110.376 178.136 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 14.6 t -71.42 -28.85 64.28 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 108.089 -1.078 . . . . 74.230000000000004 108.089 176.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.1 129.97 23.36 Favored Pre-proline 0 N--CA 1.41 -2.426 0 N-CA-C 104.278 -2.49 . . . . 74.540000000000006 104.278 167.051 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -92.91 -175.49 0.54 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.698 2.265 . . . . 73.239999999999995 113.798 -172.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . 0.429 ' C ' ' H ' ' A' ' 398' ' ' HIS . 79.3 Cg_exo -53.16 167.25 0.78 Allowed 'Trans proline' 0 C--N 1.365 1.419 0 C-N-CA 124.25 3.3 . . . . 74.019999999999996 111.351 169.816 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -53.08 -6.22 0.06 Allowed 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 126.427 1.891 . . . . 73.239999999999995 113.667 -170.573 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.429 ' H ' ' C ' ' A' ' 396' ' ' PRO . 27.9 m170 -77.21 93.1 3.9 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 105.453 -2.055 . . . . 75.329999999999998 105.453 170.984 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.436 ' O ' ' HA2' ' A' ' 367' ' ' GLY . 16.6 m -67.54 119.57 13.41 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 113.546 -1.661 . . . . 74.420000000000002 112.534 -166.911 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.88 -35.81 8.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 108.763 -0.828 . . . . 71.340000000000003 108.763 178.756 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.84 163.53 28.58 Favored Glycine 0 N--CA 1.414 -2.77 0 CA-C-N 115.513 -0.767 . . . . 64.120000000000005 111.198 -177.391 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.3 p -150.06 -176.4 5.43 Favored 'General case' 0 C--N 1.288 -2.109 0 C-N-CA 126.207 1.803 . . . . 52.5 107.558 -178.358 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -98.88 139.72 21.25 Favored Pre-proline 0 C--N 1.3 -1.563 0 C-N-CA 120.157 -0.617 . . . . 64.209999999999994 109.476 -174.16 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.86 1.61 0.21 Allowed 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 124.93 3.753 . . . . 73.540000000000006 115.624 -179.569 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.08 -33.82 63.09 Favored 'General case' 0 C--O 1.213 -0.854 0 CA-C-O 120.968 0.413 . . . . 72.209999999999994 110.084 175.56 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -70.49 -30.84 67.73 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-N 115.515 -0.766 . . . . 64.439999999999998 111.06 178.455 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -87.74 -5.02 58.86 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.841 0.829 . . . . 73.439999999999998 109.286 -178.271 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 31.0 m -91.8 149.13 21.75 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 105.821 -1.918 . . . . 75.230000000000004 105.821 175.159 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 12.6 p -78.73 112.25 15.66 Favored 'General case' 0 N--CA 1.418 -2.049 0 C-N-CA 119.23 -0.988 . . . . 64.340000000000003 109.624 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 35.2 m -119.57 159.92 20.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 115.971 -0.559 . . . . 73.540000000000006 109.714 178.623 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 56.0 m -67.0 134.86 52.79 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.347 -0.612 . . . . 74.200000000000003 109.347 178.102 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -53.71 114.5 1.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.125 0.57 . . . . 74.200000000000003 111.62 -178.046 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 112.42 14.05 11.07 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.663 -0.698 . . . . 55.329999999999998 112.042 -178.706 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -75.27 -174.56 2.4 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 109.907 -0.405 . . . . 73.109999999999999 109.907 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . 0.626 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 9.7 pt-20 -119.38 130.93 55.57 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 113.275 0.843 . . . . 75.219999999999999 113.275 -171.101 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.4 mm -116.89 127.49 74.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.916 -0.584 . . . . 70.450000000000003 110.551 -179.314 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 35.3 m -93.06 130.72 38.57 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 120.733 0.302 . . . . 60.32 111.307 178.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 5.2 p -120.41 135.35 60.94 Favored 'Isoleucine or valine' 0 C--O 1.248 0.994 0 N-CA-C 109.565 -0.532 . . . . 62.549999999999997 109.565 178.003 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -100.39 124.83 46.39 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.121 -0.696 . . . . 74.439999999999998 109.121 177.137 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 70.8 t -118.54 131.79 70.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 107.717 -1.216 . . . . 73.140000000000001 107.717 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 421' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 32.6 t -101.74 120.89 41.08 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 117.635 -1.626 . . . . 62.409999999999997 110.497 179.777 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 4.1 t -121.67 107.29 12.19 Favored 'General case' 0 N--CA 1.403 -2.781 0 CA-C-N 114.492 -1.231 . . . . 75.439999999999998 108.624 171.677 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 120.58 106.44 2.07 Favored Glycine 0 N--CA 1.426 -2.004 0 C-N-CA 119.695 -1.241 . . . . 64.430000000000007 112.274 179.532 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -70.22 157.94 57.91 Favored 'Trans proline' 0 C--O 1.247 0.965 0 C-N-CA 122.996 2.464 . . . . 74.019999999999996 110.613 174.712 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -72.15 167.43 20.3 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.883 0.849 . . . . 73.340000000000003 112.565 -174.377 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -87.13 158.08 19.24 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 106.891 -1.522 . . . . 72.310000000000002 106.891 178.147 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.51 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 5.0 mmp_? -121.49 151.96 39.69 Favored 'General case' 0 CA--C 1.485 -1.534 0 CA-C-O 121.594 0.711 . . . . 73.129999999999995 111.527 -177.241 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.85 140.42 32.92 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 114.355 -1.293 . . . . 75.420000000000002 108.109 -176.218 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.436 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 78.2 mt -78.86 113.43 35.28 Favored Pre-proline 0 C--N 1.299 -1.588 0 N-CA-C 108.215 -1.031 . . . . 73.510000000000005 108.215 -179.641 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.77 141.06 40.24 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 121.849 1.7 . . . . 63.219999999999999 110.936 178.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -92.0 127.09 37.33 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.935 -1.135 . . . . 70.319999999999993 107.935 176.315 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 90.6 t -121.73 150.03 24.99 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 N-CA-C 108.104 -1.072 . . . . 73.230000000000004 108.104 -176.054 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.493 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 19.4 m -55.3 144.84 23.56 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 123.818 0.699 . . . . 72.420000000000002 110.579 -179.811 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 434' ' ' THR . . . . . 0.447 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 41.8 p -69.16 -25.77 64.53 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 113.341 0.867 . . . . 70.0 113.341 -169.386 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.16 -12.07 39.28 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 116.05 -0.523 . . . . 71.230000000000004 110.744 178.084 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.493 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 2.6 m -98.06 43.42 1.06 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.956 0.884 . . . . 74.439999999999998 109.176 -176.691 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . 0.481 ' HH ' ' HB2' ' A' ' 454' ' ' GLN . 67.6 t80 -53.48 -38.93 64.12 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.351 1.061 . . . . 74.519999999999996 112.954 179.736 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -62.07 -40.51 96.04 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 121.537 0.684 . . . . 75.5 109.992 179.543 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -71.47 -34.06 69.87 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.862 -0.608 . . . . 64.409999999999997 111.199 177.154 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.47 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -59.35 -47.02 87.0 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.389 0.137 . . . . 71.530000000000001 110.833 -178.726 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 21.5 m -65.53 -36.98 78.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-O 121.337 0.589 . . . . 72.319999999999993 110.189 177.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -60.23 -47.25 86.79 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.803 0.841 . . . . 73.439999999999998 110.952 176.295 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -64.17 -38.79 92.33 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 123.663 0.785 . . . . 74.409999999999997 111.6 179.726 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 93.8 mt -63.93 -34.7 78.55 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.0 0.428 . . . . 72.209999999999994 109.988 175.619 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.442 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 43.8 m -70.16 -42.76 72.09 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.884 -0.598 . . . . 65.109999999999999 110.625 178.618 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.49 -23.09 65.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.364 0.602 . . . . 74.010000000000005 111.064 179.123 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.95 5.21 22.74 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.016 -0.538 . . . . 72.209999999999994 111.495 178.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 108.61 -84.15 0.36 Allowed Glycine 0 N--CA 1.435 -1.42 0 C-N-CA 120.429 -0.891 . . . . 62.140000000000001 112.072 175.552 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -37.08 -57.3 0.86 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.133 1.16 . . . . 73.109999999999999 114.133 179.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . 0.442 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 56.15 30.89 58.49 Favored Glycine 0 CA--C 1.505 -0.559 0 O-C-N 123.362 0.414 . . . . 73.329999999999998 113.347 179.44 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 61.3 mmt-85 -112.73 122.86 48.91 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 108.096 -1.076 . . . . 75.439999999999998 108.096 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . 0.518 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 18.0 p90 -144.28 152.11 40.34 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.98 -0.554 . . . . 74.530000000000001 111.448 -174.632 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -131.72 138.58 48.71 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.565 -0.902 . . . . 65.439999999999998 108.565 175.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . 0.481 ' HB2' ' HH ' ' A' ' 437' ' ' TYR . 62.8 tt0 -98.08 121.08 39.56 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.628 -0.879 . . . . 71.120000000000005 108.628 176.598 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -116.98 148.55 41.34 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 107.881 -1.155 . . . . 72.329999999999998 107.881 178.011 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 -113.86 146.19 40.37 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 108.481 -0.933 . . . . 74.219999999999999 108.481 -176.477 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 26.9 t -143.92 134.46 12.17 Favored Pre-proline 0 C--N 1.294 -1.813 0 N-CA-C 108.645 -0.872 . . . . 72.0 108.645 175.296 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.607 ' HA ' ' O ' ' A' ' 490' ' ' SER . 68.1 Cg_endo -76.78 124.13 7.3 Favored 'Trans proline' 0 N--CA 1.439 -1.691 0 C-N-CA 121.898 1.732 . . . . 75.310000000000002 111.134 178.253 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 69.6 m -151.17 179.87 7.92 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.779 -0.646 . . . . 72.420000000000002 109.416 -178.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.9 t -46.77 139.22 6.67 Favored Pre-proline 0 C--O 1.25 1.114 0 C-N-CA 125.061 1.344 . . . . 72.230000000000004 112.684 178.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.61 -29.55 33.08 Favored 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 124.609 3.54 . . . . 72.049999999999997 113.567 -177.734 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -66.95 -24.51 66.07 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 120.959 0.409 . . . . 62.020000000000003 111.582 -178.603 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 91.1 mt -99.27 -13.47 19.66 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 120.707 0.289 . . . . 65.310000000000002 111.289 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 88.8 t -60.73 127.61 20.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.154 -0.475 . . . . 74.430000000000007 110.481 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.57 -11.7 71.5 Favored Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 116.083 -0.508 . . . . 73.540000000000006 112.175 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.97 159.42 16.56 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 107.577 -1.268 . . . . 74.310000000000002 107.577 179.37 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.447 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 76.1 t -75.45 146.97 8.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 106.998 -1.482 . . . . 75.420000000000002 106.998 173.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 61.3 mt -97.53 -29.82 3.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 107.557 -1.275 . . . . 64.310000000000002 107.557 177.33 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 158.8 -160.65 31.27 Favored Glycine 0 N--CA 1.423 -2.178 0 N-CA-C 111.014 -0.834 . . . . 74.409999999999997 111.014 176.163 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 470' ' ' THR . . . . . 0.486 HG21 HG12 ' A' ' 486' ' ' ILE . 52.8 p -115.04 140.88 48.69 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 105.016 -2.216 . . . . 74.5 105.016 177.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -65.11 -54.6 32.42 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 119.135 -1.026 . . . . 74.019999999999996 110.03 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.84 135.03 29.24 Favored 'Trans proline' 0 C--N 1.368 1.594 0 N-CA-C 108.42 -1.416 . . . . 72.439999999999998 108.42 170.756 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . 0.558 ' C ' ' H ' ' A' ' 475' ' ' ASN . 35.5 Cg_exo -62.3 141.82 88.97 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 122.177 1.918 . . . . 73.109999999999999 112.482 -177.054 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.436 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -75.16 22.86 0.11 Allowed 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 122.441 1.115 . . . . 72.349999999999994 110.792 178.812 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . 0.558 ' H ' ' C ' ' A' ' 473' ' ' PRO . 10.2 m120 -109.36 -17.65 13.75 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 114.293 -1.321 . . . . 61.329999999999998 108.25 179.342 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -95.78 165.6 12.22 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 113.226 0.824 . . . . 63.229999999999997 113.226 -172.603 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.7 113.46 26.97 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 113.944 -1.48 . . . . 71.420000000000002 108.203 -179.735 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 18.5 p -102.67 145.55 29.51 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 110.132 -0.321 . . . . 72.129999999999995 110.132 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -71.73 164.36 26.1 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.284 -0.416 . . . . 63.009999999999998 110.519 179.234 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 37.6 mm -74.78 -8.67 11.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 122.122 0.963 . . . . 71.150000000000006 110.745 -174.564 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.0 t -100.1 5.16 44.92 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.844 -0.616 . . . . 75.540000000000006 110.53 177.4 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -87.12 147.45 25.64 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 112.628 0.603 . . . . 74.099999999999994 112.628 -176.198 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 44.2 t -107.38 117.49 53.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 108.737 -0.838 . . . . 75.329999999999998 108.737 177.606 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 58.8 t -89.55 120.08 37.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-O 121.289 0.566 . . . . 65.109999999999999 109.772 -179.119 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.93 123.76 46.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 121.491 0.662 . . . . 73.299999999999997 110.006 179.104 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . 0.486 HG12 HG21 ' A' ' 470' ' ' THR . 14.1 mt -113.59 128.28 70.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 114.766 -1.106 . . . . 73.349999999999994 110.547 -178.072 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 5.1 tt -103.89 126.41 58.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 115.386 -0.825 . . . . 74.349999999999994 110.816 -175.481 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 33.5 m -110.1 151.35 12.35 Favored 'Isoleucine or valine' 0 C--O 1.251 1.152 0 CA-C-N 115.824 -0.625 . . . . 73.409999999999997 109.714 178.658 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.78 132.19 10.92 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 120.65 -0.786 . . . . 71.120000000000005 112.156 -179.268 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.607 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 49.0 m -126.32 156.93 39.65 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.267 -1.383 . . . . 71.200000000000003 107.267 176.392 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -144.64 129.56 3.6 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 118.976 -1.583 . . . . 70.0 113.275 -176.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -75.61 166.57 28.21 Favored 'Trans proline' 0 C--O 1.244 0.778 0 C-N-CA 122.839 2.36 . . . . 74.530000000000001 110.822 176.562 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -81.89 55.47 2.76 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.931 0.872 . . . . 73.329999999999998 110.963 -178.215 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 58.0 p -120.23 142.93 48.58 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.29 -1.004 . . . . 74.109999999999999 108.29 -179.066 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -130.48 152.78 49.5 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.798 0.332 . . . . 74.049999999999997 110.872 -179.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -83.88 115.9 22.5 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 124.007 0.923 . . . . 75.400000000000006 109.905 -176.485 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 543' ' ' THR . 38.0 pt -83.82 130.09 56.69 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 116.396 -0.365 . . . . 75.219999999999999 111.156 -178.696 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -83.26 -169.27 0.69 Allowed 'Trans proline' 0 C--O 1.239 0.534 0 C-N-CA 122.969 2.446 . . . . 73.010000000000005 112.165 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -78.49 138.59 38.51 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.804 -0.813 . . . . 72.439999999999998 108.804 177.301 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 14.7 p -126.92 -15.0 3.49 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-O 121.448 0.642 . . . . 74.140000000000001 110.737 -177.338 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -66.73 112.18 4.08 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.082 -0.71 . . . . 62.210000000000001 109.082 178.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 136.81 -25.54 3.07 Favored Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.901 -0.666 . . . . 64.200000000000003 111.715 -178.374 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -103.01 172.33 6.88 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 122.47 -0.429 . . . . 54.25 111.068 178.336 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 21.8 p -89.77 160.97 16.26 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 116.495 -0.32 . . . . 74.5 111.069 -176.654 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 532' ' ' GLY . 25.0 t -54.1 -42.08 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 123.645 0.59 . . . . 71.519999999999996 111.403 -177.13 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.67 -42.13 95.6 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.075 -0.511 . . . . 55.539999999999999 112.007 -178.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 67.2 t -71.35 -41.76 73.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 109.657 -0.498 . . . . 73.239999999999995 109.657 179.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -60.38 -49.64 76.78 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.254 -0.885 . . . . 74.230000000000004 111.645 -179.393 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -64.96 -35.66 81.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.712 0.292 . . . . 70.329999999999998 110.691 -178.387 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.473 ' O ' HG22 ' A' ' 514' ' ' VAL . 4.6 tppp? -64.84 -47.13 79.07 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.846 -0.615 . . . . 74.310000000000002 109.364 179.192 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -63.38 -48.15 79.12 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.882 -0.599 . . . . 74.340000000000003 111.952 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -61.77 -39.75 92.74 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 116.658 -0.246 . . . . 75.25 111.467 178.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.79 -37.79 85.65 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 120.682 0.277 . . . . 73.510000000000005 111.011 177.933 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 510' ' ' LYS . 73.3 t -62.34 -37.14 77.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.011 -0.541 . . . . 74.439999999999998 110.416 176.885 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -71.91 -23.57 61.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.906 0.384 . . . . 74.409999999999997 111.553 178.357 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 124.59 -12.69 7.84 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 120.394 -0.908 . . . . 74.329999999999998 112.317 178.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' A' ' 547' ' ' VAL . 90.5 m-85 -80.44 101.17 8.88 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 107.591 -1.263 . . . . 74.200000000000003 107.591 -177.349 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.87 -8.89 27.33 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 120.058 -0.657 . . . . 74.439999999999998 112.413 -171.736 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . 0.499 ' O ' HD12 ' A' ' 551' ' ' ILE . 63.6 mttp -108.21 114.59 28.59 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.037 -0.665 . . . . 72.420000000000002 109.984 -178.037 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -131.01 140.34 50.11 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 116.01 -0.541 . . . . 74.129999999999995 111.218 -177.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 521' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 33.0 m -128.43 142.29 51.14 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.277 -1.379 . . . . 74.209999999999994 107.277 175.866 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.94 141.04 48.88 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.043 0.449 . . . . 65.540000000000006 111.091 179.778 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -135.43 128.51 31.65 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.894 -1.15 . . . . 74.319999999999993 107.894 178.045 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 70.2 m -93.74 134.07 36.46 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.096 0.475 . . . . 75.519999999999996 111.818 -177.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . 0.438 ' O ' ' HB3' ' A' ' 557' ' ' LYS . 35.2 m -121.98 150.11 25.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 107.972 -1.121 . . . . 72.319999999999993 107.972 177.795 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -66.75 136.74 55.93 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.525 -0.47 . . . . 63.549999999999997 110.547 -179.226 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 20.2 m -149.93 169.1 9.71 Favored Pre-proline 0 C--N 1.307 -1.278 0 CA-C-N 116.049 -0.523 . . . . 74.430000000000007 109.985 -177.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -84.41 -25.46 2.08 Favored 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 121.892 1.728 . . . . 60.32 111.5 173.508 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -81.06 150.03 67.67 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 109.7 -0.481 . . . . 74.239999999999995 109.7 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.78 149.0 62.68 Favored 'Trans proline' 0 C--O 1.26 1.601 0 C-N-CA 123.82 3.014 . . . . 72.430000000000007 115.909 -175.206 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.654 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -62.87 121.2 12.91 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 113.914 -1.494 . . . . 75.129999999999995 110.701 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . 0.441 ' O ' HG21 ' A' ' 505' ' ' VAL . . . 130.69 -23.46 4.47 Favored Glycine 0 C--N 1.303 -1.25 0 C-N-CA 120.763 -0.732 . . . . 72.519999999999996 111.462 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -83.48 144.29 29.65 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.422 -0.584 . . . . 75.140000000000001 109.422 177.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 67.0 t -89.54 125.75 42.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 109.275 -0.639 . . . . 73.209999999999994 109.275 179.395 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 535' ' ' THR . . . . . 0.578 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 14.4 t -100.84 -10.57 20.58 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-O 120.66 0.267 . . . . 74.120000000000005 111.611 -178.261 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 171.46 -175.41 44.98 Favored Glycine 0 CA--C 1.498 -0.984 0 C-N-CA 119.912 -1.137 . . . . 64.540000000000006 111.411 179.156 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 8.1 p -139.29 157.97 44.98 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 117.168 0.484 . . . . 75.299999999999997 111.314 179.495 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . 0.413 ' HB3' ' HB3' ' A' ' 552' ' ' GLU . 21.2 t-20 -64.01 -54.87 36.8 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-N 115.27 -0.877 . . . . 73.450000000000003 109.72 176.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -73.53 122.59 7.98 Favored 'Trans proline' 0 C--N 1.373 1.867 0 N-CA-C 108.014 -1.571 . . . . 70.200000000000003 108.014 169.127 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.17 141.13 61.92 Favored 'Trans proline' 0 C--O 1.254 1.317 0 C-N-CA 122.01 1.807 . . . . 74.230000000000004 112.519 -176.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -58.78 134.26 56.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.498 -0.774 . . . . 73.340000000000003 109.963 -179.191 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 102.73 -5.93 51.57 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 120.544 -0.836 . . . . 72.409999999999997 111.973 -177.639 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 543' ' ' THR . . . . . 0.484 ' O ' HG12 ' A' ' 497' ' ' ILE . 79.3 m -88.94 137.74 32.04 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.852 0.326 . . . . 73.200000000000003 110.794 177.134 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 17.9 m -89.27 122.73 32.81 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.03 -1.47 . . . . 64.150000000000006 107.03 173.461 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 16.1 m -131.73 156.15 80.48 Favored Pre-proline 0 C--N 1.313 -0.981 0 CA-C-O 119.423 -0.323 . . . . 73.5 110.56 -177.278 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -59.54 139.55 89.75 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 123.043 2.495 . . . . 75.230000000000004 111.774 178.645 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 517' ' ' PHE . 27.3 m -65.41 -21.31 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 113.487 0.921 . . . . 73.340000000000003 113.487 -175.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -87.15 -11.96 48.44 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.045 0.45 . . . . 74.109999999999999 111.108 178.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 73.7 m -69.88 155.11 41.04 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.61 0.719 . . . . 72.400000000000006 112.719 -177.375 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 27.3 t -88.79 125.97 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-N 114.884 -1.053 . . . . 72.129999999999995 110.065 -176.282 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . 0.499 HD12 ' O ' ' A' ' 519' ' ' LYS . 0.2 OUTLIER -102.39 129.03 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 119.684 -0.807 . . . . 74.25 109.228 174.228 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 521' ' ' SER . 38.1 tt0 -102.73 119.27 38.54 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 108.899 -0.778 . . . . 73.239999999999995 108.899 -179.427 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 47.6 mt -92.19 122.88 35.09 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.117 -0.947 . . . . 73.200000000000003 109.443 -179.107 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -85.93 112.71 21.43 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.782 -1.192 . . . . 73.239999999999995 107.782 171.78 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 42.8 t -95.64 140.16 17.56 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 CA-C-N 115.207 -0.906 . . . . 63.530000000000001 109.283 -176.505 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.654 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 66.5 m -76.17 141.33 41.89 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-O 121.448 0.642 . . . . 73.219999999999999 111.533 177.45 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.438 ' HB3' ' O ' ' A' ' 525' ' ' VAL . 16.7 ttmt -114.66 119.64 37.41 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 125.613 1.565 . . . . 74.140000000000001 107.003 173.724 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -74.74 -24.31 72.66 Favored Glycine 0 C--N 1.314 -0.662 0 C-N-CA 120.574 -0.822 . . . . 75.209999999999994 113.831 -174.072 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 615' ' ' ASN . 48.5 m-80 74.53 18.14 2.92 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.069 1.348 . . . . 74.140000000000001 110.658 -178.539 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -131.89 141.19 49.3 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.566 -0.531 . . . . 73.510000000000005 109.566 -173.462 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -137.74 139.24 40.01 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 108.342 -0.984 . . . . 75.430000000000007 108.342 173.137 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 11.4 p -62.77 129.27 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 N-CA-C 113.3 0.852 . . . . 73.319999999999993 113.3 -173.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 57.2 ttp -97.56 128.94 32.88 Favored Pre-proline 0 C--O 1.254 1.328 0 CA-C-N 115.649 -0.705 . . . . 75.409999999999997 110.006 177.11 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.35 170.23 19.72 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.072 2.514 . . . . 64.299999999999997 112.048 176.224 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . 0.404 ' HB3' ' CB ' ' A' ' 610' ' ' ALA . 6.4 p-10 -86.34 122.37 30.21 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.424 0.63 . . . . 65.530000000000001 112.368 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.08 13.2 1.11 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 122.24 1.019 . . . . 74.230000000000004 109.423 174.102 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 1.8 m -72.57 153.19 41.41 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 114.588 -1.187 . . . . 73.140000000000001 111.355 -175.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 77.14 36.24 35.85 Favored Glycine 0 CA--C 1.519 0.297 0 N-CA-C 114.637 0.615 . . . . 74.140000000000001 114.637 174.667 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 25.1 ptm -129.12 174.67 9.35 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.421 -0.585 . . . . 73.400000000000006 109.421 -179.627 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . 0.492 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 90.6 m-85 -79.63 144.34 33.88 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-O 120.881 0.372 . . . . 75.200000000000003 110.527 -174.856 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . 0.43 ' HB3' ' OD1' ' A' ' 601' ' ' ASN . 74.9 t-105 -67.76 -17.83 64.67 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.729 -0.668 . . . . 75.439999999999998 111.292 -174.574 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 30.1 m -68.24 -28.24 40.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.755 -0.657 . . . . 74.140000000000001 110.444 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . 0.589 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 26.0 m-20 -101.77 -34.21 9.53 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 115.904 -0.589 . . . . 70.409999999999997 109.966 176.33 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -57.27 -46.8 82.74 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.942 1.09 . . . . 75.349999999999994 113.942 -175.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.463 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 5.9 tm-20 -59.14 -53.11 69.58 Favored Pre-proline 0 CA--C 1.566 1.566 0 N-CA-C 109.438 -0.579 . . . . 74.430000000000007 109.438 179.063 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . 0.463 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 79.6 Cg_exo -53.95 -38.06 86.18 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.329 2.019 . . . . 62.049999999999997 113.27 171.587 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . 0.589 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 69.0 mmt-85 -58.92 -43.17 91.08 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 110.344 -0.243 . . . . 75.099999999999994 110.344 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.09 -42.31 99.58 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.959 -0.564 . . . . 71.310000000000002 109.938 -179.076 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -64.36 -41.12 96.89 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.753 -0.658 . . . . 74.140000000000001 110.554 178.178 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.18 -24.1 64.93 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.803 -0.635 . . . . 71.329999999999998 111.636 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 89.0 mt -83.82 -8.0 59.32 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.006 0.431 . . . . 74.439999999999998 110.16 176.789 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 86.02 20.74 54.8 Favored Glycine 0 N--CA 1.438 -1.23 0 C-N-CA 120.622 -0.799 . . . . 75.420000000000002 111.476 -179.244 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 86.9 t90 -88.09 127.88 35.41 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 121.077 0.465 . . . . 74.109999999999999 109.829 178.133 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 36.4 m -149.92 66.24 0.98 Allowed 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.608 -1.256 . . . . 62.5 107.608 170.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -103.44 -129.75 6.72 Favored Glycine 0 N--CA 1.434 -1.498 0 CA-C-N 114.627 -1.169 . . . . 53.409999999999997 110.189 179.414 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 24.5 ttt -121.03 126.8 50.82 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.49 -0.559 . . . . 71.430000000000007 109.49 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -103.58 131.14 50.97 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.16 -1.422 . . . . 74.219999999999999 107.16 177.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -94.56 108.46 20.41 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.82 -0.807 . . . . 74.230000000000004 108.82 177.321 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -89.61 113.16 24.56 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.594 -1.262 . . . . 72.450000000000003 107.594 179.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -83.23 -105.3 0.51 Allowed Glycine 0 N--CA 1.432 -1.595 0 C-N-CA 120.464 -0.874 . . . . 64.349999999999994 110.968 178.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.99 146.72 39.45 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.121 -1.437 . . . . 61.420000000000002 107.121 176.277 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -75.44 129.07 36.71 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.293 0.568 . . . . 72.319999999999993 109.816 -178.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 26.0 t -112.16 132.53 60.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 116.253 -0.43 . . . . 74.409999999999997 111.616 -172.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -76.13 107.21 8.2 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 106.734 -1.58 . . . . 75.430000000000007 106.734 171.291 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -111.82 -10.49 14.01 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 112.673 0.62 . . . . 74.450000000000003 112.673 -172.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 600' ' ' HIS . . . 127.16 170.67 12.91 Favored Glycine 0 CA--C 1.49 -1.516 0 N-CA-C 109.653 -1.379 . . . . 61.310000000000002 109.653 179.472 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -64.59 -50.5 58.7 Favored Glycine 0 C--N 1.316 -0.567 0 C-N-CA 119.478 -1.344 . . . . 75.129999999999995 112.531 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 10.4 p -70.44 -23.71 62.77 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 112.485 0.55 . . . . 55.130000000000003 112.485 -176.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -108.01 -0.72 21.11 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 118.709 -0.662 . . . . 73.329999999999998 112.619 -175.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . 0.479 ' HB3' ' O ' ' A' ' 596' ' ' GLY 0.289 25.1 p-80 -55.39 -74.69 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 114.675 1.361 . . . . 71.329999999999998 114.675 -169.473 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . 0.43 ' OD1' ' HB3' ' A' ' 571' ' ' TRP . 13.5 t-20 -97.13 71.14 2.41 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.247 -0.908 . . . . 75.299999999999997 108.965 -175.636 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . 0.492 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 44.1 ttt180 -143.15 150.97 40.15 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.552 -0.749 . . . . 74.549999999999997 110.558 -173.62 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 93.0 t -66.78 132.46 32.13 Favored 'Isoleucine or valine' 0 C--O 1.246 0.921 0 N-CA-C 107.3 -1.37 . . . . 73.030000000000001 107.3 174.611 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 54.9 t -92.25 -52.96 9.32 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 N-CA-C 108.307 -0.997 . . . . 64.340000000000003 108.307 -172.408 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . 0.423 ' O ' ' HA ' ' A' ' 622' ' ' LEU . 45.1 p90 -156.08 160.39 39.92 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 107.297 -1.372 . . . . 71.019999999999996 107.297 177.422 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.54 140.18 52.29 Favored 'General case' 0 C--N 1.283 -2.296 0 O-C-N 124.364 1.04 . . . . 72.230000000000004 110.047 176.012 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.472 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 25.6 t-20 -52.22 -55.27 32.92 Favored Pre-proline 0 CA--C 1.558 1.272 0 C-N-CA 124.611 1.165 . . . . 71.030000000000001 113.822 -177.721 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.472 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 9.4 Cg_endo -97.42 128.69 0.27 Allowed 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 122.176 1.918 . . . . 75.329999999999998 111.572 177.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.87 154.71 66.98 Favored 'Trans proline' 0 C--O 1.247 0.945 0 C-N-CA 121.661 1.574 . . . . 63.340000000000003 110.59 176.554 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . 0.404 ' CB ' ' HB3' ' A' ' 565' ' ' ASP . . . -53.44 130.29 35.03 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 123.184 0.594 . . . . 63.439999999999998 111.774 -178.379 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 97.79 -0.0 59.17 Favored Glycine 0 N--CA 1.432 -1.569 0 C-N-CA 119.875 -1.155 . . . . 72.439999999999998 112.379 -179.142 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 22.5 m -98.36 155.64 17.12 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.882 -1.155 . . . . 73.329999999999998 107.882 176.388 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -88.15 138.3 14.96 Favored Glycine 0 N--CA 1.412 -2.963 0 C-N-CA 120.871 -0.68 . . . . 75.109999999999999 111.956 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 18.7 m -104.09 143.59 15.6 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 C-N-CA 123.637 0.775 . . . . 63.219999999999999 109.918 176.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . 0.47 HD22 HG23 ' A' ' 619' ' ' ILE . 1.9 p-10 -55.96 140.78 41.98 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 125.336 1.454 . . . . 75.209999999999994 111.347 178.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -50.63 -31.59 16.52 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 113.939 1.088 . . . . 75.129999999999995 113.939 -174.048 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -71.77 -23.86 61.66 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 120.829 0.347 . . . . 75.230000000000004 110.696 -177.417 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 86.09 19.52 57.25 Favored Glycine 0 N--CA 1.41 -3.079 0 C-N-CA 120.465 -0.874 . . . . 74.519999999999996 114.155 172.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . 0.47 HG23 HD22 ' A' ' 615' ' ' ASN . 0.2 OUTLIER -73.51 124.43 30.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 C-N-CA 116.823 -1.951 . . . . 75.140000000000001 108.94 176.198 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . 0.454 ' N ' HD12 ' A' ' 619' ' ' ILE . 6.6 tp -120.05 128.87 75.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.5 -0.773 . . . . 71.310000000000002 109.423 -178.956 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.454 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 35.9 m -102.68 116.8 33.31 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 108.925 -0.768 . . . . 74.219999999999999 108.925 178.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' A' ' 605' ' ' TYR . 3.9 pp -139.89 160.3 40.22 Favored 'General case' 0 CA--C 1.478 -1.814 0 N-CA-C 106.41 -1.7 . . . . 75.319999999999993 106.41 178.646 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -128.7 147.14 50.73 Favored 'General case' 0 C--N 1.259 -3.353 0 N-CA-C 106.394 -1.706 . . . . 74.299999999999997 106.394 179.598 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -128.62 165.25 21.17 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.347 -0.983 . . . . 74.510000000000005 108.347 176.119 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -92.95 -114.37 2.25 Favored Glycine 0 N--CA 1.413 -2.884 0 O-C-N 123.889 0.743 . . . . 72.329999999999998 112.748 -179.383 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . 0.401 HE21 ' HA ' ' A' ' 626' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.46 0 CA-C-O 118.876 -0.583 . . . . 74.120000000000005 110.822 -173.865 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.285 0 N-CA-C 110.363 -1.095 . . . . 71.549999999999997 110.363 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 9.3 tp -75.45 119.66 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-O 121.543 0.687 . . . . 65.239999999999995 111.392 -179.836 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 3.7 m -86.3 150.68 24.18 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 105.788 -1.93 . . . . 72.329999999999998 105.788 173.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 -92.52 42.81 1.11 Allowed 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.928 -0.709 . . . . 73.409999999999997 111.454 -171.505 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -75.96 148.26 38.28 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.54 -0.911 . . . . 73.329999999999998 108.54 177.158 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 30.3 m -119.56 151.83 22.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.517 -0.92 . . . . 73.129999999999995 108.517 -178.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -95.08 135.84 36.13 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 106.169 -1.789 . . . . 72.450000000000003 106.169 176.589 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.438 HG22 ' CZ ' ' A' ' 382' ' ' PHE . 59.4 t -97.39 132.06 26.1 Favored Pre-proline 0 C--N 1.286 -2.178 0 CA-C-N 115.987 -0.551 . . . . 74.420000000000002 110.826 -169.249 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -66.56 134.03 34.11 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.17 1.913 . . . . 72.510000000000005 112.389 -179.301 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . 0.402 ' OD1' ' HG2' ' A' ' 366' ' ' ARG . 3.5 p30 -100.5 144.15 29.84 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.705 -1.22 . . . . 64.109999999999999 107.705 176.774 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 4.3 t -123.09 28.2 2.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 107.544 -1.28 . . . . 75.319999999999993 107.544 -179.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.428 ' HD3' ' OG1' ' A' ' 402' ' ' THR . 14.1 ptt180 -61.07 143.91 54.49 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.597 -1.183 . . . . 72.530000000000001 110.61 178.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.06 -13.89 55.74 Favored Glycine 0 N--CA 1.429 -1.779 0 CA-C-N 116.063 -0.517 . . . . 74.400000000000006 112.294 178.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -105.16 -87.29 0.45 Allowed 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 121.173 -0.211 . . . . 70.319999999999993 111.323 -178.722 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 89.5 p -156.32 160.67 39.93 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 108.227 -1.027 . . . . 74.439999999999998 108.227 179.557 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 1.4 p -63.49 -34.68 78.31 Favored 'General case' 0 N--CA 1.422 -1.847 0 O-C-N 123.498 0.499 . . . . 65.510000000000005 109.716 174.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.07 -46.37 89.4 Favored 'General case' 0 C--O 1.214 -0.771 0 CA-C-N 116.044 -0.525 . . . . 72.129999999999995 110.487 178.22 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -63.91 -41.91 97.56 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 120.826 0.346 . . . . 64.049999999999997 111.206 178.157 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -68.33 -45.6 72.48 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.237 -0.438 . . . . 64.310000000000002 111.356 -178.39 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 73.6 mt -65.9 -44.43 92.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.408 -0.36 . . . . 75.239999999999995 110.818 178.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.9 -43.89 91.1 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 120.922 0.392 . . . . 64.150000000000006 111.607 -177.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 38.9 m -64.29 -48.46 75.57 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.006 -0.543 . . . . 74.239999999999995 110.435 -178.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 10.8 mp -65.19 -37.92 88.84 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.163 -0.471 . . . . 64.439999999999998 111.862 178.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -61.11 -42.35 98.37 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.795 0.838 . . . . 75.120000000000005 109.867 178.541 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -66.2 -28.53 68.83 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.988 -0.551 . . . . 71.420000000000002 111.333 177.745 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -86.18 -14.41 44.1 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.907 0.384 . . . . 71.049999999999997 111.416 178.419 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 90.57 16.21 55.47 Favored Glycine 0 C--N 1.307 -1.076 0 C-N-CA 120.444 -0.884 . . . . 71.25 112.633 177.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.438 ' CZ ' HG22 ' A' ' 362' ' ' VAL . 26.1 m-85 -78.23 161.24 27.44 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-O 121.374 0.606 . . . . 72.329999999999998 111.542 178.02 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 48.5 mmtm -100.73 132.43 46.13 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 108.946 -0.761 . . . . 73.439999999999998 108.946 178.164 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.0 154.8 19.98 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.721 0 N-CA-C 108.615 -0.883 . . . . 75.25 108.615 175.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -124.99 135.22 52.58 Favored 'General case' 0 C--N 1.265 -3.069 0 N-CA-C 106.182 -1.785 . . . . 73.430000000000007 106.182 177.508 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 31.1 m -119.04 117.58 29.14 Favored 'General case' 0 C--N 1.271 -2.841 0 N-CA-C 109.157 -0.683 . . . . 74.010000000000005 109.157 -177.383 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 419' ' ' ASN . 2.9 tm? -116.07 127.58 54.99 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 106.292 -1.744 . . . . 75.230000000000004 106.292 179.479 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.439 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -114.22 147.5 38.84 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.997 -0.681 . . . . 74.420000000000002 111.439 -177.979 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -136.39 137.52 24.49 Favored Pre-proline 0 C--N 1.308 -1.234 0 N-CA-C 107.849 -1.167 . . . . 75.439999999999998 107.849 175.193 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . 0.411 ' HB2' ' HG2' ' A' ' 425' ' ' GLU . 53.9 Cg_endo -72.64 148.73 47.79 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 121.425 1.417 . . . . 74.129999999999995 109.505 172.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . 0.279 27.8 t70 -61.55 115.37 3.86 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 116.934 2.198 . . . . 72.329999999999998 116.934 -171.916 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.53 ' O ' ' HB ' ' A' ' 393' ' ' THR . 3.2 p -143.75 65.89 1.3 Allowed 'General case' 0 N--CA 1.383 -3.778 0 CA-C-N 111.822 -2.444 . . . . 72.040000000000006 106.744 166.622 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.544 ' O ' HG22 ' A' ' 393' ' ' THR . 63.4 m 87.38 39.08 0.02 OUTLIER 'General case' 0 CA--C 1.571 1.771 0 CA-C-O 123.703 1.716 . . . . 74.109999999999999 111.471 176.545 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -117.14 149.51 44.48 Favored Pre-proline 0 C--N 1.291 -1.967 0 O-C-N 121.032 -1.042 . . . . 73.230000000000004 112.125 175.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.02 178.49 6.44 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.911 2.407 . . . . 73.150000000000006 111.131 -179.051 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -55.91 161.11 8.86 Favored 'Trans proline' 0 C--N 1.362 1.252 0 C-N-CA 122.765 2.31 . . . . 74.129999999999995 112.328 176.034 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -58.09 -8.35 1.04 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.953 1.301 . . . . 71.510000000000005 113.142 -178.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -74.25 172.05 12.52 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.285 -0.635 . . . . 74.140000000000001 109.285 -179.468 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 13.9 m -97.32 118.7 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.999 0 N-CA-C 108.417 -0.957 . . . . 71.340000000000003 108.417 176.677 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 2.2 mp -94.88 -32.05 4.46 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 107.592 -1.262 . . . . 70.019999999999996 107.592 178.345 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.88 170.85 27.75 Favored Glycine 0 N--CA 1.418 -2.536 0 N-CA-C 109.101 -1.599 . . . . 55.109999999999999 109.101 179.307 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.428 ' OG1' ' HD3' ' A' ' 366' ' ' ARG . 2.5 p -129.34 -177.87 4.42 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 122.572 0.349 . . . . 75.340000000000003 110.443 -179.262 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -100.14 135.96 20.22 Favored Pre-proline 0 C--N 1.293 -1.866 0 N-CA-C 106.626 -1.62 . . . . 63.450000000000003 106.626 178.771 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -55.52 -12.18 5.77 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 124.034 3.156 . . . . 72.519999999999996 114.836 -175.469 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -53.88 -35.61 61.76 Favored 'General case' 0 C--O 1.212 -0.874 0 C-N-CA 122.899 0.48 . . . . 75.439999999999998 110.548 176.641 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.11 -39.51 68.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.338 0.589 . . . . 74.409999999999997 110.879 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -83.61 2.28 38.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.365 0.602 . . . . 73.519999999999996 110.639 -179.048 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 27.1 m -102.17 145.89 28.74 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 106.326 -1.731 . . . . 74.25 106.326 172.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 48.8 m -75.01 113.03 11.85 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 119.039 -1.064 . . . . 74.510000000000005 108.822 175.255 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.5 m -118.95 170.24 8.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.889 -0.596 . . . . 74.040000000000006 110.037 179.766 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 22.8 t -69.19 152.08 45.54 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.797 -0.445 . . . . 74.329999999999998 109.797 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -63.91 109.4 1.76 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.362 0.601 . . . . 74.409999999999997 111.185 -178.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 100.56 44.64 2.1 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 115.185 -0.916 . . . . 73.510000000000005 113.05 178.074 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -92.03 -174.21 3.71 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.984 -1.117 . . . . 63.25 107.984 178.456 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . 0.522 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 44.8 mt-10 -109.16 133.0 53.58 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 121.53 0.681 . . . . 72.150000000000006 112.582 -177.624 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 44.6 mm -118.76 113.82 42.9 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 107.697 -1.223 . . . . 72.040000000000006 107.697 174.087 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 14.8 t -89.63 131.16 35.76 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.441 0.638 . . . . 73.140000000000001 111.274 -179.541 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 9.2 p -115.49 135.1 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 CA-C-N 115.329 -0.85 . . . . 73.439999999999998 109.562 -177.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' A' ' 387' ' ' LEU . 2.8 t-20 -97.74 116.0 29.09 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.887 -0.725 . . . . 75.200000000000003 109.339 176.236 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 98.4 t -102.44 136.0 36.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.109 -1.071 . . . . 64.540000000000006 108.109 179.232 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 15.8 m -99.09 135.05 41.05 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-O 121.543 0.687 . . . . 63.549999999999997 111.418 -178.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 17.6 p -105.95 160.06 15.56 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.492 -1.299 . . . . 71.519999999999996 107.492 172.409 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -44.04 159.94 0.1 Allowed Glycine 0 CA--C 1.546 1.999 0 N-CA-C 114.789 0.675 . . . . 51.119999999999997 114.789 -178.063 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -52.5 149.9 22.53 Favored 'Trans proline' 0 C--O 1.248 0.987 0 C-N-CA 124.085 3.19 . . . . 71.099999999999994 113.163 -176.688 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.411 ' HG2' ' HB2' ' A' ' 390' ' ' PRO . 33.3 mt-10 -71.71 127.77 33.63 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-O 122.602 1.192 . . . . 64.349999999999994 111.906 -175.285 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -136.8 158.49 44.33 Favored 'General case' 0 C--N 1.27 -2.862 0 CA-C-N 112.877 -1.965 . . . . 74.409999999999997 106.975 177.54 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.467 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 4.2 mmp_? -122.35 147.37 46.34 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-O 120.797 0.332 . . . . 74.439999999999998 110.472 177.802 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -88.71 139.1 30.81 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 107.496 -1.298 . . . . 74.150000000000006 107.496 178.624 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 63.4 mt -80.43 118.99 75.01 Favored Pre-proline 0 N--CA 1.428 -1.536 0 N-CA-C 108.241 -1.022 . . . . 72.129999999999995 108.241 179.569 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -71.08 154.12 62.56 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 121.872 1.715 . . . . 75.200000000000003 110.549 177.409 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -77.4 89.43 3.79 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.53 0.681 . . . . 64.430000000000007 110.079 177.667 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 42.0 t -93.18 131.19 40.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 105.765 -1.939 . . . . 73.239999999999995 105.765 175.572 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.48 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 15.7 m -64.44 151.89 43.01 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 120.929 0.395 . . . . 72.140000000000001 111.197 -176.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 26.9 p -59.76 -33.41 71.64 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 123.427 0.691 . . . . 63.240000000000002 112.275 -176.621 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . 0.434 ' HB3' ' HG3' ' A' ' 466' ' ' LYS . 1.9 pp -81.56 -11.23 59.23 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.465 0.65 . . . . 74.299999999999997 112.601 178.336 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.48 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 3.5 m -97.9 34.27 1.94 Allowed 'General case' 0 CA--C 1.564 1.509 0 N-CA-C 108.971 -0.752 . . . . 71.519999999999996 108.971 -178.703 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -51.41 -39.27 56.92 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.495 1.118 . . . . 72.049999999999997 113.391 179.745 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.1 -42.27 99.54 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-O 121.866 0.841 . . . . 72.329999999999998 110.268 -179.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . 0.416 ' HB3' HG22 ' A' ' 436' ' ' THR . 26.8 tt0 -70.56 -33.96 71.69 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.451 -0.795 . . . . 75.219999999999999 109.468 178.691 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.612 ' O ' HD21 ' A' ' 444' ' ' LEU . . . -59.51 -50.19 74.89 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.378 -0.374 . . . . 73.329999999999998 110.961 -179.35 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.4 m -62.53 -38.61 81.88 Favored 'Isoleucine or valine' 0 C--O 1.257 1.46 0 N-CA-C 112.058 0.392 . . . . 75.519999999999996 112.058 179.637 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.0 -33.51 74.75 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 119.33 -0.948 . . . . 74.129999999999995 111.329 175.321 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -61.61 -42.96 99.61 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.368 -0.378 . . . . 75.010000000000005 111.262 175.559 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.612 HD21 ' O ' ' A' ' 440' ' ' ALA . 0.9 OUTLIER -63.79 -33.14 75.01 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 119.714 -0.794 . . . . 65.540000000000006 110.395 177.147 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 91.3 m -65.42 -44.02 88.69 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 116.174 -0.466 . . . . 74.430000000000007 110.456 177.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.76 -22.28 63.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.465 0.65 . . . . 71.5 110.979 179.225 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.69 5.46 13.26 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.64 -0.709 . . . . 74.200000000000003 112.182 -178.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 101.53 -73.79 0.36 Allowed Glycine 0 CA--C 1.493 -1.338 0 C-N-CA 119.977 -1.106 . . . . 63.219999999999999 112.232 174.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -47.83 -56.81 6.63 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 113.255 0.835 . . . . 75.409999999999997 113.255 178.041 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 61.97 25.43 66.04 Favored Glycine 0 CA--C 1.507 -0.418 0 C-N-CA 121.27 -0.49 . . . . 62.32 112.664 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -100.98 110.86 22.94 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.596 -1.261 . . . . 71.439999999999998 107.596 -177.628 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . 0.598 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 32.3 p90 -139.12 151.33 46.58 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 120.731 0.301 . . . . 73.209999999999994 110.826 -179.194 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -131.25 130.2 42.56 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.435 -0.95 . . . . 71.409999999999997 108.435 177.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -97.62 123.16 41.42 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 123.649 0.593 . . . . 62.210000000000001 110.039 179.204 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.22 135.47 53.77 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 107.043 -1.466 . . . . 44.329999999999998 107.043 173.191 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -112.67 139.42 48.29 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.771 -0.825 . . . . 74.200000000000003 108.771 179.703 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 457' ' ' SER . . . . . 0.481 ' O ' ' HA2' ' A' ' 489' ' ' GLY . 23.2 t -141.94 136.34 15.1 Favored Pre-proline 0 C--N 1.287 -2.118 0 N-CA-C 108.898 -0.778 . . . . 74.349999999999994 108.898 179.708 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.695 ' HA ' ' O ' ' A' ' 490' ' ' SER . 30.4 Cg_endo -65.8 131.35 27.18 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.169 1.913 . . . . 72.120000000000005 110.54 175.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 46.1 m -147.34 174.88 11.24 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 122.259 -0.276 . . . . 62.439999999999998 110.402 -177.491 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 3.9 t -50.66 142.98 15.16 Favored Pre-proline 0 N--CA 1.446 -0.658 0 C-N-CA 124.973 1.309 . . . . 74.420000000000002 111.716 176.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.54 -29.73 33.13 Favored 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 124.653 3.569 . . . . 74.510000000000005 113.153 -177.481 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -68.53 -35.06 76.94 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.379 -0.373 . . . . 75.140000000000001 111.197 179.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -96.18 -9.11 31.32 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 113.057 0.762 . . . . 75.319999999999993 113.057 -178.345 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 92.9 t -60.5 127.11 19.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.795 -0.817 . . . . 74.420000000000002 108.795 175.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.98 -1.43 67.92 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 111.788 -0.525 . . . . 65.519999999999996 111.788 -178.567 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.434 ' HG3' ' HB3' ' A' ' 435' ' ' LEU . 10.0 mptt -122.89 155.18 37.2 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-O 121.595 0.712 . . . . 74.109999999999999 111.336 -178.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 73.4 t -68.45 137.77 23.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 114.115 -1.402 . . . . 75.019999999999996 109.718 175.861 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 40.3 mm -97.95 -28.02 3.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 108.386 -0.968 . . . . 73.510000000000005 108.386 -179.811 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 168.36 164.43 24.04 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.238 -0.982 . . . . 60.340000000000003 113.088 177.556 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 1.1 t -116.96 142.8 46.47 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 107.468 -1.308 . . . . 75.129999999999995 107.468 176.369 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -70.65 -53.14 9.81 Favored Pre-proline 0 C--N 1.321 -0.642 0 C-N-CA 119.493 -0.883 . . . . 73.200000000000003 111.242 177.457 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.41 ' HG2' ' HA ' ' A' ' 484' ' ' VAL . 27.6 Cg_exo -65.95 134.79 38.52 Favored 'Trans proline' 0 C--N 1.368 1.589 0 N-CA-C 108.269 -1.473 . . . . 74.310000000000002 108.269 171.58 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -62.48 127.6 21.29 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.213 1.942 . . . . 72.420000000000002 111.791 -176.823 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -71.43 2.17 5.33 Favored 'General case' 0 C--O 1.209 -1.058 0 CA-C-N 115.816 -0.629 . . . . 75.340000000000003 112.578 -177.401 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -108.89 -12.96 14.83 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.164 0.507 . . . . 75.140000000000001 111.402 179.283 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -102.26 173.05 6.54 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.235 0.54 . . . . 74.200000000000003 112.02 -172.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 1.3 m -91.69 119.92 31.98 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 115.277 -0.874 . . . . 74.450000000000003 108.902 -177.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 13.1 p -102.46 145.96 28.8 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.148 0.499 . . . . 63.43 110.925 -177.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -80.38 154.16 27.89 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.909 -0.587 . . . . 73.129999999999995 111.376 -176.252 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 425' ' ' GLU . 23.1 mm -74.02 -6.19 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 CA-C-O 122.154 0.978 . . . . 72.120000000000005 110.498 -177.793 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 6.4 p -108.48 5.42 25.22 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.488 0.661 . . . . 62.25 111.156 177.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -97.36 150.59 20.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.52 -0.764 . . . . 71.409999999999997 111.251 -173.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 59.8 t -108.14 126.4 64.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 123.667 0.787 . . . . 72.120000000000005 110.452 -177.054 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 61.0 t -101.03 120.03 49.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 120.892 0.377 . . . . 74.439999999999998 110.361 -179.985 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.98 126.03 59.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 109.022 -0.732 . . . . 74.310000000000002 109.022 177.525 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 16.8 mt -120.55 128.35 76.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 114.749 -1.114 . . . . 71.120000000000005 111.506 -177.132 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 6.9 tt -103.62 126.95 58.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 115.481 -0.781 . . . . 73.230000000000004 109.849 177.795 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 2.4 p -119.02 139.04 47.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 123.39 0.676 . . . . 74.109999999999999 110.076 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 457' ' ' SER . . . -77.08 127.64 8.55 Favored Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 111.034 -0.827 . . . . 72.420000000000002 111.034 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.695 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 23.0 t -143.44 160.62 40.23 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.05 -1.093 . . . . 71.349999999999994 108.05 -178.289 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 150.0 83.66 0.04 OUTLIER Glycine 0 C--N 1.31 -0.904 0 C-N-CA 120.21 -0.995 . . . . 60.32 111.731 179.344 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -79.03 112.87 3.14 Favored 'Trans proline' 0 N--CA 1.444 -1.403 0 C-N-CA 122.505 2.137 . . . . 73.329999999999998 112.312 -178.459 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -96.7 24.28 6.19 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 122.655 1.217 . . . . 65.129999999999995 108.601 178.012 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 18.7 p -117.07 149.25 40.6 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 112.615 -2.084 . . . . 72.239999999999995 109.296 -175.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -137.01 147.71 46.41 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.263 -0.643 . . . . 72.109999999999999 109.263 174.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -80.7 129.92 34.8 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 124.014 0.821 . . . . 73.340000000000003 109.418 179.071 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 543' ' ' THR . 36.3 pt -87.19 131.31 44.87 Favored Pre-proline 0 C--N 1.295 -1.762 0 CA-C-N 115.825 -0.625 . . . . 75.299999999999997 110.506 179.391 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.56 -172.34 1.46 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.216 1.944 . . . . 73.150000000000006 109.377 173.302 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -82.01 149.47 28.11 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.4 -1.334 . . . . 71.510000000000005 107.4 176.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.56 85.98 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 CA-C-O 122.59 1.186 . . . . 75.030000000000001 108.94 177.111 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -149.86 128.54 12.4 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 114.218 -1.355 . . . . 75.140000000000001 108.876 -178.038 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 122.77 -20.8 7.66 Favored Glycine 0 N--CA 1.435 -1.429 0 C-N-CA 120.246 -0.978 . . . . 73.209999999999994 111.673 177.354 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.87 177.39 4.86 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 120.952 0.406 . . . . 74.430000000000007 110.843 178.619 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 9.4 t -87.95 157.88 18.82 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.102 -0.703 . . . . 75.519999999999996 109.102 -178.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.3 p -50.6 -41.63 20.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 124.317 1.047 . . . . 73.109999999999999 112.043 -179.181 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -61.74 -41.53 97.79 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.043 0.386 . . . . 74.409999999999997 112.043 179.129 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 89.6 t -71.21 -42.43 75.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-O 121.243 0.544 . . . . 73.219999999999999 109.891 179.084 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -60.41 -42.45 96.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.489 -0.778 . . . . 65.430000000000007 110.633 179.143 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -59.41 -46.22 89.33 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.27 -0.877 . . . . 74.040000000000006 109.953 179.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.411 ' O ' HG23 ' A' ' 514' ' ' VAL . 2.8 tmmm? -60.49 -44.3 96.09 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.163 -0.926 . . . . 71.430000000000007 108.904 -179.09 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -61.97 -48.09 81.91 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 116.117 -0.492 . . . . 70.299999999999997 111.035 -179.407 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.93 -38.89 92.76 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 111.804 0.298 . . . . 75.349999999999994 111.804 179.402 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -63.14 -38.17 90.12 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 121.232 -0.187 . . . . 73.329999999999998 110.939 179.014 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 510' ' ' LYS . 72.2 t -61.17 -35.46 65.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.027 0.441 . . . . 72.5 110.648 176.605 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -79.06 -4.53 50.67 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 120.886 0.374 . . . . 75.519999999999996 110.99 -178.631 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 97.62 3.12 58.48 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 120.653 -0.784 . . . . 35.130000000000003 112.685 177.021 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.491 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 85.2 m-85 -86.44 115.24 23.82 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 108.032 -1.099 . . . . 74.310000000000002 108.032 -178.881 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.4 m -114.77 11.26 16.74 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 119.489 -0.884 . . . . 72.310000000000002 111.166 -176.27 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . 0.403 ' O ' HD11 ' A' ' 551' ' ' ILE . 67.7 mttm -129.41 114.23 15.9 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.279 -0.637 . . . . 75.140000000000001 109.279 176.249 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -130.86 150.54 51.97 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 115.645 -0.707 . . . . 74.340000000000003 110.075 178.743 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 68.9 m -126.73 146.76 50.1 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 107.174 -1.417 . . . . 74.420000000000002 107.174 172.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -117.94 129.37 55.57 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 120.251 -0.58 . . . . 73.430000000000007 109.956 -179.392 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -105.33 115.99 31.19 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 106.867 -1.531 . . . . 71.349999999999994 106.867 175.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 19.4 m -88.89 114.74 25.84 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 121.676 0.751 . . . . 64.519999999999996 110.602 -176.509 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 28.1 m -121.47 168.83 13.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-N 114.464 -1.244 . . . . 75.329999999999998 108.232 -178.014 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . 0.49 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 7.0 p-10 -103.74 149.65 24.8 Favored 'General case' 0 C--N 1.282 -2.336 0 C-N-CA 120.049 -0.66 . . . . 73.109999999999999 111.748 -177.778 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 19.8 m -149.44 178.13 1.58 Allowed Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 105.286 -2.116 . . . . 73.230000000000004 105.286 177.012 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -87.65 -12.44 4.46 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 121.29 1.327 . . . . 73.530000000000001 111.523 172.168 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . 0.418 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 35.5 mtp85 -87.01 148.42 45.25 Favored Pre-proline 0 N--CA 1.428 -1.546 0 C-N-CA 123.484 0.714 . . . . 74.530000000000001 109.332 179.033 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -56.14 148.47 59.28 Favored 'Trans proline' 0 C--O 1.259 1.556 0 C-N-CA 124.019 3.146 . . . . 74.340000000000003 117.13 -170.598 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -61.2 137.39 58.24 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 113.367 -1.742 . . . . 73.430000000000007 111.054 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 108.9 -17.95 32.0 Favored Glycine 0 N--CA 1.429 -1.828 0 N-CA-C 110.895 -0.882 . . . . 74.430000000000007 110.895 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -80.38 136.63 36.41 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 109.731 -0.47 . . . . 74.209999999999994 109.731 178.314 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 60.0 t -86.14 120.74 36.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.037 -1.097 . . . . 72.209999999999994 108.037 178.329 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 535' ' ' THR . . . . . 0.506 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 9.7 t -92.91 -1.97 56.25 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.946 -0.57 . . . . 73.450000000000003 110.78 -176.882 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 144.27 -167.19 26.99 Favored Glycine 0 CA--C 1.496 -1.095 0 N-CA-C 111.216 -0.754 . . . . 74.129999999999995 111.216 176.238 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 12.6 p -118.55 160.1 22.37 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 117.398 0.599 . . . . 72.299999999999997 110.288 176.036 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -71.2 -51.64 10.05 Favored Pre-proline 0 C--N 1.31 -1.144 0 CA-C-N 116.244 -0.434 . . . . 72.219999999999999 110.104 175.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -72.59 135.87 24.84 Favored 'Trans proline' 0 C--N 1.38 2.208 0 N-CA-C 109.134 -1.141 . . . . 75.409999999999997 109.134 171.287 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.69 154.51 67.92 Favored 'Trans proline' 0 C--O 1.254 1.285 0 C-N-CA 122.364 2.042 . . . . 74.230000000000004 113.415 -177.094 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.06 138.11 58.21 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.429 -0.805 . . . . 73.219999999999999 110.163 178.747 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.56 -20.4 34.63 Favored Glycine 0 C--N 1.305 -1.174 0 N-CA-C 111.755 -0.538 . . . . 75.530000000000001 111.755 -179.362 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 543' ' ' THR . . . . . 0.415 ' O ' HG12 ' A' ' 497' ' ' ILE . 25.6 m -70.63 133.39 46.64 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.34 -0.245 . . . . 75.310000000000002 110.34 -178.443 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 15.0 t -98.12 129.58 44.92 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 109.083 -0.71 . . . . 74.530000000000001 109.083 177.037 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 7.1 m -136.43 154.4 76.91 Favored Pre-proline 0 C--N 1.297 -1.675 0 CA-C-N 115.668 -0.696 . . . . 72.450000000000003 109.218 179.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -64.57 139.01 62.02 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.435 2.09 . . . . 71.319999999999993 111.244 178.414 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.491 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 35.3 m -63.85 -20.87 27.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 113.313 0.857 . . . . 74.219999999999999 113.313 -175.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -94.43 4.03 54.39 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.848 0.832 . . . . 44.439999999999998 110.508 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 39.4 m -93.54 179.49 5.37 Favored 'General case' 0 N--CA 1.437 -1.101 0 O-C-N 121.911 -0.493 . . . . 74.530000000000001 110.524 178.606 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 19.8 t -106.83 131.6 56.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 116.468 -0.333 . . . . 74.420000000000002 111.078 -174.117 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . 0.403 HD11 ' O ' ' A' ' 519' ' ' LYS . 0.2 OUTLIER -114.44 136.69 50.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 108.396 -0.964 . . . . 60.140000000000001 108.396 172.164 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -103.68 124.14 48.3 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 121.421 0.629 . . . . 72.140000000000001 111.726 -178.622 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.3 mp -97.37 134.77 40.2 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.681 -1.145 . . . . 75.25 110.014 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.97 119.06 26.78 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.505 -1.665 . . . . 73.310000000000002 106.505 177.313 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 59.6 t -114.41 131.07 67.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.793 -0.567 . . . . 64.209999999999994 109.866 -178.13 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.553 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 69.8 m -81.35 157.89 24.88 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 113.407 0.892 . . . . 73.019999999999996 113.407 -178.242 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.49 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 14.2 ptpt -119.08 158.34 26.06 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 105.326 -2.102 . . . . 74.5 105.326 167.519 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . 0.494 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -75.03 -42.65 29.01 Favored Glycine 0 CA--C 1.485 -1.808 0 C-N-CA 119.949 -1.12 . . . . 63.340000000000003 112.432 -174.597 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 55.7 t30 67.35 -12.4 0.26 Allowed 'General case' 0 CA--C 1.569 1.696 0 C-N-CA 124.186 0.994 . . . . 74.430000000000007 112.759 173.48 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.494 ' H ' ' C ' ' A' ' 558' ' ' GLY . 71.3 mt-30 -136.63 160.73 37.92 Favored 'General case' 0 C--O 1.253 1.289 0 C-N-CA 125.859 1.663 . . . . 72.239999999999995 107.505 176.373 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -138.92 136.6 35.65 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 110.117 -0.327 . . . . 65.439999999999998 110.117 176.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 8.3 p -59.89 121.68 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 121.599 0.714 . . . . 74.430000000000007 112.176 -178.013 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 21.4 ptm -87.6 147.05 40.72 Favored Pre-proline 0 C--O 1.252 1.211 0 CA-C-N 115.654 -0.703 . . . . 73.049999999999997 112.803 -175.085 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.69 170.78 19.56 Favored 'Trans proline' 0 CA--C 1.551 1.329 0 C-N-CA 124.566 3.511 . . . . 64.420000000000002 112.902 175.457 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.5 124.07 28.62 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.995 -0.548 . . . . 75.209999999999994 112.15 177.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -112.61 -3.31 14.35 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 122.045 0.926 . . . . 74.319999999999993 108.815 174.398 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 11.1 m -68.24 137.53 54.83 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.103 -1.408 . . . . 72.120000000000005 111.455 -177.587 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 80.4 30.92 39.15 Favored Glycine 0 N--CA 1.438 -1.203 0 C-N-CA 121.103 -0.57 . . . . 62.219999999999999 112.019 176.338 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 64.6 mtt -137.3 173.23 11.9 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.899 -0.778 . . . . 74.540000000000006 108.899 -178.677 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 89.0 m-85 -100.28 166.26 11.07 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 109.29 -0.633 . . . . 75.120000000000005 109.29 179.252 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 69.9 t90 -67.73 -28.47 67.67 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.327 -0.619 . . . . 72.519999999999996 109.327 178.059 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 10.2 p -68.56 -10.02 12.41 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 CA-C-N 115.63 -0.713 . . . . 75.129999999999995 110.409 176.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 577' ' ' ARG . 38.0 m-20 -100.59 -44.51 5.82 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 108.163 -1.051 . . . . 73.230000000000004 108.163 173.611 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . 0.451 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -59.35 -51.74 68.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.112 -0.949 . . . . 65.109999999999999 112.564 -177.33 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.561 ' OE2' ' HD3' ' A' ' 579' ' ' ARG . 21.0 tp10 -52.95 -56.77 20.27 Favored Pre-proline 0 CA--C 1.562 1.431 0 CA-C-O 119.02 -0.514 . . . . 74.040000000000006 112.09 -179.666 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.77 -38.16 93.91 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.126 1.884 . . . . 74.230000000000004 112.595 176.332 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 573' ' ' ASP . 80.8 mtp180 -65.79 -36.85 84.69 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 120.864 -0.335 . . . . 74.340000000000003 111.332 -179.558 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 96.1 mt -63.36 -38.77 92.45 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.128 0.49 . . . . 73.510000000000005 109.797 178.192 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . 0.561 ' HD3' ' OE2' ' A' ' 575' ' ' GLU . 7.0 mmm180 -65.3 -45.79 82.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.509 -0.769 . . . . 75.340000000000003 108.941 179.562 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.22 -29.81 70.14 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.369 -0.832 . . . . 70.409999999999997 112.213 -178.318 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 95.5 mt -81.59 -6.3 58.86 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.843 0.354 . . . . 75.140000000000001 110.833 178.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 72.87 35.77 58.08 Favored Glycine 0 N--CA 1.439 -1.114 0 N-CA-C 111.456 -0.657 . . . . 65.530000000000001 111.456 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . 0.427 ' C ' ' HG1' ' A' ' 584' ' ' THR . 79.1 t90 -76.22 128.65 35.35 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.782 -0.451 . . . . 75.010000000000005 109.782 -179.79 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 584' ' ' THR . . . . . 0.427 ' HG1' ' C ' ' A' ' 583' ' ' TRP . 17.6 m -150.54 86.56 1.4 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.899 -0.778 . . . . 64.150000000000006 108.899 174.106 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -147.73 -142.92 3.74 Favored Glycine 0 C--N 1.309 -0.943 0 N-CA-C 110.244 -1.142 . . . . 63.240000000000002 110.244 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 47.7 tpp -96.51 125.21 40.84 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 117.538 0.669 . . . . 72.200000000000003 110.964 177.409 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -96.23 128.96 43.62 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.54 -1.652 . . . . 74.409999999999997 106.54 175.434 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -94.99 123.26 38.37 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 105.241 -2.133 . . . . 65.109999999999999 105.241 178.439 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -85.52 121.42 28.2 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 113.251 0.834 . . . . 74.109999999999999 113.251 -162.483 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -105.47 144.0 15.74 Favored Glycine 0 N--CA 1.407 -3.237 0 N-CA-C 107.875 -2.09 . . . . 75.219999999999999 107.875 171.3 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -94.21 150.93 19.85 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 117.072 0.436 . . . . 75.329999999999998 110.018 -179.251 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -73.44 124.8 26.51 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.314 -1.365 . . . . 75.239999999999995 107.314 173.271 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 41.1 t -105.94 123.35 60.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 CA-C-N 116.188 -0.46 . . . . 73.510000000000005 111.367 -175.235 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -81.32 107.8 14.41 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.477 -1.305 . . . . 75.420000000000002 107.477 173.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -136.08 21.1 3.24 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.615 -0.72 . . . . 73.239999999999995 109.725 -177.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 101.18 173.46 28.75 Favored Glycine 0 N--CA 1.427 -1.914 0 C-N-CA 120.267 -0.968 . . . . 41.049999999999997 110.812 -177.505 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -62.18 -33.42 85.84 Favored Glycine 0 C--O 1.218 -0.865 0 N-CA-C 114.188 0.435 . . . . 53.329999999999998 114.188 -175.093 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 13.7 m -58.31 -24.44 59.64 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 113.806 1.039 . . . . 64.420000000000002 113.806 -175.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -98.49 -0.31 43.63 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 113.343 0.868 . . . . 74.450000000000003 113.343 -175.339 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . 0.48 ' HA ' ' OXT' ' A' ' 626' ' ' GLN . 5.7 p80 -35.46 98.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 115.682 1.734 . . . . 70.510000000000005 115.682 -174.264 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 52.95 10.29 0.15 Allowed 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 126.075 1.75 . . . . 64.319999999999993 115.381 172.09 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 38.4 ttt180 -79.83 143.34 34.46 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.945 -1.097 . . . . 75.129999999999995 110.945 -175.408 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 87.9 t -74.58 131.0 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 108.224 -1.028 . . . . 73.209999999999994 108.224 179.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 46.5 t -94.04 -48.09 13.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.332 0.587 . . . . 74.340000000000003 110.248 -175.345 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -148.34 151.19 34.93 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.635 -0.711 . . . . 75.519999999999996 110.049 179.099 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 621' ' ' THR . 14.4 pt20 -115.57 141.7 47.71 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.869 -1.16 . . . . 71.140000000000001 107.869 174.372 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.528 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 17.0 t-20 -51.35 -57.16 15.16 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 123.66 0.6 . . . . 74.310000000000002 112.274 -175.915 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 9.6 Cg_endo -100.01 138.66 0.27 Allowed 'Trans proline' 0 N--CA 1.433 -2.069 0 C-N-CA 121.742 1.628 . . . . 73.549999999999997 110.096 172.271 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -70.13 147.14 59.82 Favored 'Trans proline' 0 C--O 1.252 1.177 0 C-N-CA 121.313 1.342 . . . . 72.099999999999994 109.918 175.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -62.37 138.98 58.55 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.886 0.375 . . . . 74.340000000000003 110.551 -178.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.16 -8.21 44.84 Favored Glycine 0 N--CA 1.431 -1.649 0 N-CA-C 110.598 -1.001 . . . . 73.120000000000005 110.598 -175.032 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 6.1 m -100.83 157.29 16.83 Favored 'General case' 0 C--O 1.249 1.066 0 N-CA-C 108.384 -0.969 . . . . 71.430000000000007 108.384 178.174 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -85.69 132.18 10.95 Favored Glycine 0 N--CA 1.428 -1.867 0 N-CA-C 111.227 -0.749 . . . . 64.030000000000001 111.227 178.35 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 21.8 m -97.43 142.47 14.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 110.055 -0.35 . . . . 71.340000000000003 110.055 178.166 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . 0.442 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 30.1 p-10 -57.05 167.13 0.88 Allowed 'General case' 0 N--CA 1.436 -1.164 0 O-C-N 124.476 1.11 . . . . 74.129999999999995 112.478 -178.821 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -61.02 -25.33 66.83 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.832 -1.077 . . . . 65.109999999999999 111.847 -178.035 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -78.44 -37.04 44.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.445 -0.343 . . . . 65.239999999999995 110.536 176.298 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 90.5 22.4 34.45 Favored Glycine 0 C--O 1.211 -1.307 0 C-N-CA 119.254 -1.451 . . . . 40.219999999999999 112.444 179.153 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.82 123.14 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 CA-C-O 122.63 1.205 . . . . 73.030000000000001 110.819 -168.754 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 6.3 tp -129.34 132.37 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 113.839 -1.528 . . . . 74.019999999999996 111.256 -174.085 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 606' ' ' GLN . 44.2 m -104.45 137.27 42.57 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 107.971 -1.122 . . . . 71.019999999999996 107.971 174.629 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 88.7 mt -138.15 157.01 47.16 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.243 -1.391 . . . . 71.109999999999999 107.243 178.638 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -144.25 136.6 26.59 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 104.178 -2.527 . . . . 72.5 104.178 177.063 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' A' ' 602' ' ' ARG . 6.8 p90 -143.06 161.65 37.6 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 123.658 0.599 . . . . 73.209999999999994 111.526 -177.463 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -88.18 -163.62 39.4 Favored Glycine 0 N--CA 1.426 -2.004 0 C-N-CA 120.836 -0.697 . . . . 41.130000000000003 111.797 177.648 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . 0.48 ' OXT' ' HA ' ' A' ' 600' ' ' HIS . 8.7 tp-100 . . . . . 0 C--N 1.303 -1.444 0 C-N-CA 123.166 0.586 . . . . 75.120000000000005 110.352 -177.72 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.646 0 N-CA-C 110.855 -0.898 . . . . 64.519999999999996 110.855 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 10.0 tp -74.78 117.7 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-O 121.986 0.898 . . . . 73.010000000000005 109.808 179.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 10.5 m -122.54 158.78 29.13 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.353 -0.839 . . . . 63.240000000000002 109.87 -174.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.5 96.78 4.65 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 124.326 1.05 . . . . 74.439999999999998 108.313 179.782 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.7 133.81 49.97 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 113.143 -1.844 . . . . 72.439999999999998 109.944 -179.664 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 409' ' ' SER . 35.9 m -120.73 163.06 18.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 115.724 -0.671 . . . . 72.430000000000007 109.411 -175.475 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -94.05 136.94 33.8 Favored 'General case' 0 N--CA 1.39 -3.45 0 N-CA-C 108.733 -0.84 . . . . 62.240000000000002 108.733 176.103 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 94.7 t -97.8 129.28 31.67 Favored Pre-proline 0 C--N 1.269 -2.908 0 CA-C-N 114.289 -1.323 . . . . 73.140000000000001 109.566 -173.521 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -65.33 120.3 7.48 Favored 'Trans proline' 0 N--CA 1.443 -1.489 0 C-N-CA 121.769 1.646 . . . . 73.329999999999998 110.37 176.905 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -97.03 83.17 3.31 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 106.981 -1.488 . . . . 73.420000000000002 106.981 -175.473 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.475 ' HB ' ' NE2' ' A' ' 368' ' ' GLN . 30.2 m -71.65 34.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 125.997 1.719 . . . . 73.340000000000003 115.053 -171.748 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.419 ' HG3' ' OG1' ' A' ' 402' ' ' THR . 21.0 mmt180 -65.41 148.38 51.81 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 125.315 1.446 . . . . 75.239999999999995 111.795 177.377 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 106.47 0.67 37.52 Favored Glycine 0 CA--C 1.501 -0.791 0 N-CA-C 111.028 -0.829 . . . . 65.319999999999993 111.028 -175.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . 0.475 ' NE2' ' HB ' ' A' ' 365' ' ' VAL . 41.8 mt-30 -111.03 -154.53 0.54 Allowed 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 108.392 -0.966 . . . . 70.409999999999997 108.392 175.025 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 61.8 p -96.26 168.24 10.7 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 109.765 -0.457 . . . . 74.540000000000006 109.765 -176.701 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.88 -46.99 85.25 Favored 'General case' 0 N--CA 1.421 -1.918 0 CA-C-N 115.339 -0.846 . . . . 73.230000000000004 109.329 179.706 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.38 -44.83 82.04 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.701 -0.681 . . . . 71.200000000000003 112.411 -176.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -66.94 -47.2 72.39 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.885 0.374 . . . . 61.539999999999999 110.097 -177.144 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -67.35 -41.12 85.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.87 -0.604 . . . . 73.019999999999996 111.873 -177.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 66.5 mt -68.09 -39.8 81.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 116.692 -0.231 . . . . 75.349999999999994 110.399 177.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.16 -38.65 89.85 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 120.799 0.333 . . . . 54.119999999999997 110.34 179.61 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 376' ' ' THR . . . . . 0.613 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 52.0 m -63.14 -47.9 80.75 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.725 -0.67 . . . . 71.540000000000006 110.199 179.307 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 98.2 mt -64.01 -42.33 97.18 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 116.33 -0.396 . . . . 74.219999999999999 110.506 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.21 -41.67 96.95 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.967 -0.561 . . . . 72.099999999999994 109.758 179.826 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -69.82 -17.64 63.41 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 112.969 0.729 . . . . 75.099999999999994 112.969 177.404 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 376' ' ' THR . 6.9 mmp_? -88.78 -10.8 46.89 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.653 -0.499 . . . . 73.109999999999999 109.653 175.468 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.48 2.9 55.51 Favored Glycine 0 C--N 1.32 -0.36 0 CA-C-N 115.948 -0.569 . . . . 65.299999999999997 112.786 178.157 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -82.62 154.23 25.04 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-O 121.254 0.55 . . . . 71.400000000000006 111.895 -177.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -101.26 145.8 28.38 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.224 -1.399 . . . . 75.140000000000001 107.224 179.8 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 1.1 mp -129.38 144.01 39.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.171 -1.048 . . . . 72.530000000000001 108.171 179.252 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 13.9 ttm180 -110.56 127.87 55.4 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 105.714 -1.958 . . . . 74.510000000000005 105.714 174.203 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 23.7 m -114.04 117.41 31.22 Favored 'General case' 0 C--N 1.271 -2.827 0 N-CA-C 108.074 -1.084 . . . . 74.400000000000006 108.074 -178.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.55 128.77 56.56 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.361 -0.977 . . . . 72.040000000000006 108.361 -177.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -99.78 127.94 45.9 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.666 -0.494 . . . . 73.109999999999999 109.666 -178.507 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 421' ' ' SER . 98.0 mttt -132.74 123.35 18.23 Favored Pre-proline 0 C--N 1.313 -1.017 0 N-CA-C 111.781 0.289 . . . . 73.340000000000003 111.781 178.61 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -82.69 128.09 5.16 Favored 'Trans proline' 0 C--O 1.254 1.288 0 C-N-CA 121.865 1.71 . . . . 72.209999999999994 109.032 171.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.539 ' HB3' ' CD1' ' A' ' 394' ' ' ILE . 10.2 t70 171.95 -162.17 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 105.174 -2.158 . . . . 75.239999999999995 105.174 -174.956 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 36.1 p -141.57 2.3 1.61 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.171 0.51 . . . . 61.5 111.186 178.157 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 25.6 m -98.92 -25.99 14.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.395 0.617 . . . . 75.519999999999996 111.381 -175.011 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . 0.539 ' CD1' ' HB3' ' A' ' 391' ' ' ASP . 0.2 OUTLIER -88.53 152.29 49.31 Favored Pre-proline 0 C--N 1.298 -1.636 0 CA-C-N 116.075 -0.511 . . . . 72.340000000000003 109.911 -178.167 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -35.59 150.71 0.03 OUTLIER 'Trans proline' 0 CA--C 1.553 1.453 1 C-N-CA 125.468 4.112 . . . . 75.549999999999997 116.924 177.631 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.72 162.58 10.46 Favored 'Trans proline' 0 C--N 1.364 1.388 0 C-N-CA 124.147 3.231 . . . . 64.219999999999999 110.619 172.088 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . 0.422 ' HA ' HG11 ' A' ' 420' ' ' VAL . 0.9 OUTLIER -59.12 -9.69 2.22 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 113.181 0.808 . . . . 74.310000000000002 113.181 -176.232 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -95.06 -178.82 4.61 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 108.77 -0.826 . . . . 74.040000000000006 108.77 178.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 27.6 m -97.73 117.46 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.825 0 C-N-CA 117.065 -1.854 . . . . 72.010000000000005 110.575 179.597 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.89 -47.4 7.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 109.44 -0.578 . . . . 74.129999999999995 109.44 175.337 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.75 169.19 27.94 Favored Glycine 0 N--CA 1.427 -1.947 0 N-CA-C 111.141 -0.784 . . . . 65.120000000000005 111.141 -177.5 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.419 ' OG1' ' HG3' ' A' ' 366' ' ' ARG . 0.6 OUTLIER -155.67 -176.08 5.77 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 125.479 1.511 . . . . 74.430000000000007 109.935 -176.911 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . 0.437 ' C ' ' H ' ' A' ' 405' ' ' ALA . 6.6 p-10 -99.0 155.41 36.6 Favored Pre-proline 0 C--N 1.299 -1.61 0 N-CA-C 106.605 -1.628 . . . . 72.319999999999993 106.605 -178.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -59.93 10.56 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 124.575 3.517 . . . . 73.209999999999994 116.156 -172.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.437 ' H ' ' C ' ' A' ' 403' ' ' ASP . . . -53.45 -43.94 68.47 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 122.868 0.467 . . . . 60.439999999999998 111.855 -179.355 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -79.53 -32.33 42.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.251 0.548 . . . . 74.129999999999995 111.019 -179.177 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -79.74 1.57 26.1 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.108 0.48 . . . . 74.120000000000005 111.211 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 51.0 m -105.47 149.56 26.07 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.676 -1.601 . . . . 75.439999999999998 106.676 172.382 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 409' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 360' ' ' VAL . 15.0 p -76.0 113.48 13.56 Favored 'General case' 0 N--CA 1.422 -1.826 0 C-N-CA 119.806 -0.758 . . . . 71.219999999999999 110.975 178.77 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.4 m -121.93 170.0 12.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.377 -0.829 . . . . 71.430000000000007 109.482 178.869 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 33.3 t -76.52 157.15 32.34 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.145 -0.687 . . . . 70.5 109.145 179.759 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -69.24 109.87 4.32 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-O 121.289 0.566 . . . . 52.200000000000003 110.079 179.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 108.38 55.61 0.59 Allowed Glycine 0 N--CA 1.433 -1.514 0 CA-C-N 115.095 -0.957 . . . . 73.019999999999996 111.413 179.152 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -100.32 -173.18 2.35 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.739 -1.208 . . . . 74.439999999999998 107.739 178.057 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -120.08 113.86 21.12 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.414 -0.587 . . . . 74.150000000000006 109.414 -177.34 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 44.9 mm -104.32 133.71 47.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 108.822 -0.807 . . . . 75.549999999999997 108.822 -179.058 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 80.3 m -101.82 132.24 47.68 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 122.022 -0.424 . . . . 75.200000000000003 110.192 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 9.7 p -115.44 134.36 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 108.888 -0.782 . . . . 73.409999999999997 108.888 176.622 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -105.26 114.2 28.24 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.812 0.815 . . . . 75.439999999999998 109.286 177.805 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.422 HG11 ' HA ' ' A' ' 397' ' ' ASP . 96.3 t -111.22 131.39 62.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 114.569 -1.196 . . . . 74.109999999999999 108.846 -174.209 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 421' ' ' SER . . . . . 0.429 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 17.3 t -92.67 121.82 34.47 Favored 'General case' 0 N--CA 1.428 -1.553 0 C-N-CA 119.53 -0.868 . . . . 74.319999999999993 110.0 179.265 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 33.9 p -120.09 107.28 12.85 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 116.152 -0.476 . . . . 73.140000000000001 110.225 174.244 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 101.7 124.03 5.33 Favored Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 119.94 -1.124 . . . . 73.5 113.438 176.255 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -83.31 158.95 15.01 Favored 'Trans proline' 0 C--O 1.254 1.295 0 C-N-CA 123.2 2.6 . . . . 70.349999999999994 111.227 176.149 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -72.37 166.27 22.87 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.563 -0.744 . . . . 63.240000000000002 110.798 -178.201 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -87.07 157.88 19.32 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 107.334 -1.358 . . . . 70.140000000000001 107.334 179.725 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -121.22 151.79 39.58 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 119.585 -0.846 . . . . 74.549999999999997 112.428 -169.817 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 34.9 tt0 -83.63 138.77 33.19 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.299 -1.319 . . . . 75.439999999999998 109.009 -176.488 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 70.7 mt -80.59 116.65 63.44 Favored Pre-proline 0 C--N 1.306 -1.305 0 N-CA-C 108.082 -1.081 . . . . 70.200000000000003 108.082 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -71.29 140.62 37.42 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.476 1.451 . . . . 75.129999999999995 110.201 176.398 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.28 128.62 35.48 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.413 -1.328 . . . . 74.219999999999999 107.413 175.603 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 42.9 t -118.28 157.45 19.72 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 107.514 -1.291 . . . . 73.450000000000003 107.514 -177.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.501 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 15.4 m -63.74 146.64 53.49 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-O 120.961 0.41 . . . . 74.140000000000001 110.985 -179.511 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 34.8 p -69.14 -25.91 64.62 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 124.66 1.184 . . . . 71.450000000000003 112.574 -170.511 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.61 -10.94 41.47 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 115.431 -0.804 . . . . 74.310000000000002 111.109 179.334 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.501 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 2.4 m -100.66 46.14 0.96 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.424 0.63 . . . . 74.439999999999998 109.729 -176.197 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -52.24 -42.79 63.92 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 113.892 1.071 . . . . 73.549999999999997 113.892 -178.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.52 -44.48 94.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.633 0.254 . . . . 73.209999999999994 110.996 -176.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . 0.524 ' O ' ' HB3' ' A' ' 442' ' ' LYS . 28.1 tt0 -70.62 -33.11 70.66 Favored 'General case' 0 C--O 1.195 -1.775 0 CA-C-N 116.474 -0.33 . . . . 73.109999999999999 110.777 174.484 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.407 ' O ' HD23 ' A' ' 444' ' ' LEU . . . -59.66 -52.28 66.18 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.988 -0.285 . . . . 63.329999999999998 110.75 179.127 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 33.7 m -62.48 -36.33 74.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.614 0.721 . . . . 73.430000000000007 110.398 177.437 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.524 ' HB3' ' O ' ' A' ' 439' ' ' GLU . 20.7 ttmm -59.46 -46.79 87.76 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 124.97 1.308 . . . . 70.310000000000002 110.229 176.019 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -65.9 -38.76 89.59 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 123.282 0.633 . . . . 73.310000000000002 111.727 -179.64 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.407 HD23 ' O ' ' A' ' 440' ' ' ALA . 4.6 mm? -63.32 -34.64 78.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.054 -0.35 . . . . 75.010000000000005 110.054 174.859 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.511 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 32.4 m -69.66 -45.67 67.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.25 0.548 . . . . 71.329999999999998 110.221 178.129 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.63 -24.95 64.62 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.635 -0.711 . . . . 64.109999999999999 112.455 -178.118 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.57 -4.77 53.01 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.326 0.491 . . . . 73.219999999999999 112.326 -177.651 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 125.88 -79.59 0.37 Allowed Glycine 0 CA--C 1.497 -1.074 0 C-N-CA 119.96 -1.114 . . . . 71.109999999999999 111.98 177.447 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -42.65 -66.87 0.32 Allowed 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.372 1.069 . . . . 62.0 113.858 178.354 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . 0.511 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 63.1 25.54 68.24 Favored Glycine 0 CA--C 1.502 -0.766 0 O-C-N 123.362 0.414 . . . . 65.430000000000007 112.626 -178.338 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.423 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 8.6 mmt180 -105.31 110.61 23.03 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.432 -1.692 . . . . 74.439999999999998 106.432 -179.711 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -141.03 154.42 45.99 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-O 121.228 0.537 . . . . 74.319999999999993 112.091 -176.177 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 5.4 tppp? -137.11 135.0 37.04 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.477 -1.305 . . . . 74.200000000000003 107.477 177.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -100.03 133.08 44.93 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.312 -0.625 . . . . 74.400000000000006 109.312 176.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -126.67 151.73 47.69 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.724 -0.473 . . . . 71.140000000000001 109.724 177.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -113.9 141.3 47.53 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.589 -1.263 . . . . 74.420000000000002 107.589 179.245 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 37.3 t -138.1 135.34 18.48 Favored Pre-proline 0 C--N 1.283 -2.323 0 N-CA-C 109.122 -0.695 . . . . 72.239999999999995 109.122 178.394 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.613 ' HA ' ' O ' ' A' ' 490' ' ' SER . 51.0 Cg_endo -73.07 122.9 8.45 Favored 'Trans proline' 0 N--CA 1.439 -1.679 0 C-N-CA 121.521 1.481 . . . . 75.049999999999997 109.403 174.608 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 51.0 m -148.44 -179.79 7.22 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 109.685 -0.487 . . . . 64.239999999999995 109.685 -175.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.1 t -47.69 137.86 9.6 Favored Pre-proline 0 C--O 1.251 1.158 0 C-N-CA 124.556 1.143 . . . . 73.239999999999995 112.03 178.371 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -52.73 -29.31 41.49 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 124.642 3.562 . . . . 72.140000000000001 113.668 -175.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -71.33 -26.61 62.91 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 112.718 0.636 . . . . 74.099999999999994 112.718 -178.53 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -93.89 -4.52 49.81 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.806 -0.559 . . . . 71.409999999999997 111.624 179.566 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 85.3 t -60.68 127.79 20.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-N 116.006 -0.543 . . . . 72.329999999999998 110.524 178.224 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 95.88 -7.27 67.5 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 115.613 -0.721 . . . . 74.450000000000003 113.862 176.456 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.427 ' O ' HG21 ' A' ' 488' ' ' VAL . 6.8 mptt -122.35 158.96 28.47 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.586 -0.894 . . . . 65.409999999999997 108.586 -179.707 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 66.2 t -72.13 143.81 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.739 0 N-CA-C 107.999 -1.112 . . . . 63.109999999999999 107.999 176.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 58.3 mt -97.26 -27.73 3.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 107.492 -1.299 . . . . 73.439999999999998 107.492 179.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 153.18 -165.83 31.38 Favored Glycine 0 N--CA 1.419 -2.457 0 C-N-CA 120.541 -0.837 . . . . 61.140000000000001 111.956 175.558 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.13 142.69 46.48 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 106.991 -1.485 . . . . 72.010000000000005 106.991 176.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -67.68 -55.72 13.64 Favored Pre-proline 0 CA--C 1.548 0.879 0 N-CA-C 109.712 -0.477 . . . . 73.120000000000005 109.712 179.064 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -61.15 133.84 49.16 Favored 'Trans proline' 0 C--N 1.37 1.659 0 N-CA-C 108.276 -1.471 . . . . 72.25 108.276 168.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . 0.439 ' C ' ' H ' ' A' ' 475' ' ' ASN . 32.5 Cg_exo -62.14 127.96 22.65 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.742 2.295 . . . . 74.340000000000003 113.821 -173.862 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -74.03 12.8 0.63 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.968 0.907 . . . . 73.140000000000001 111.234 178.59 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . 0.439 ' H ' ' C ' ' A' ' 473' ' ' PRO . 12.4 m120 -111.03 -7.65 14.51 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.852 -0.613 . . . . 74.5 109.846 176.188 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -116.25 174.7 5.91 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 113.542 0.942 . . . . 73.310000000000002 113.542 -170.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 477' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 0.9 OUTLIER -99.09 141.12 32.27 Favored 'General case' 0 N--CA 1.411 -2.414 0 C-N-CA 124.513 1.125 . . . . 70.109999999999999 112.6 -179.173 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 28.3 p -137.82 149.17 46.12 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.11 -0.95 . . . . 74.319999999999993 109.362 177.765 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.93 162.11 27.37 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 120.846 0.355 . . . . 75.409999999999997 110.948 178.477 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.9 mp -67.57 -15.19 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-O 122.133 0.968 . . . . 74.409999999999997 110.976 -178.543 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.2 p -94.41 0.75 55.66 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 115.953 -0.567 . . . . 71.450000000000003 112.067 177.437 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -83.69 133.88 34.79 Favored 'General case' 0 CA--C 1.503 -0.855 0 O-C-N 122.005 -0.434 . . . . 73.439999999999998 111.414 -178.581 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . 0.423 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.3 p -96.53 126.71 49.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.658 -0.701 . . . . 63.399999999999999 109.728 178.089 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 22.3 m -101.48 136.75 31.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-O 121.313 0.578 . . . . 75.120000000000005 110.346 178.703 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.79 120.24 58.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 109.005 -0.739 . . . . 75.230000000000004 109.005 178.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 37.2 mt -109.49 122.91 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 114.663 -1.153 . . . . 73.299999999999997 109.9 -177.249 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.4 tt -106.61 127.0 62.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 115.062 -0.972 . . . . 74.519999999999996 111.631 -173.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 466' ' ' LYS . 2.5 p -111.34 142.78 22.72 Favored 'Isoleucine or valine' 0 C--O 1.247 0.967 0 N-CA-C 109.088 -0.708 . . . . 64.109999999999999 109.088 176.411 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -88.17 141.11 16.69 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.88 -0.676 . . . . 70.310000000000002 113.468 -176.059 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.613 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 11.1 t -138.8 160.73 38.97 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.804 -1.554 . . . . 63.219999999999999 106.804 176.131 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 167.52 156.95 10.32 Favored Glycine 0 N--CA 1.44 -1.068 0 C-N-CA 119.174 -1.488 . . . . 75.540000000000006 113.062 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -89.6 167.15 5.07 Favored 'Trans proline' 0 C--O 1.244 0.805 0 C-N-CA 123.705 2.937 . . . . 74.200000000000003 112.535 179.38 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -118.19 53.46 0.96 Allowed 'General case' 0 C--O 1.244 0.805 0 CA-C-O 122.302 1.048 . . . . 74.420000000000002 108.239 177.446 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 22.8 p -117.78 147.95 42.52 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.762 -1.108 . . . . 75.209999999999994 111.233 -176.022 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -141.47 161.79 37.05 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.139 -1.06 . . . . 71.549999999999997 108.139 177.495 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.3 p-10 -100.4 138.25 37.72 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.267 0.556 . . . . 74.329999999999998 110.754 178.951 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 30.9 pt -77.04 137.51 65.46 Favored Pre-proline 0 C--N 1.308 -1.234 0 CA-C-N 115.293 -0.867 . . . . 73.120000000000005 111.967 -178.56 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -81.79 176.32 8.51 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.692 2.261 . . . . 74.140000000000001 111.22 176.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -86.7 118.88 26.39 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 108.843 -0.799 . . . . 75.450000000000003 108.843 178.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.09 8.78 7.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-O 122.107 0.956 . . . . 72.540000000000006 109.967 -177.426 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -68.19 108.02 3.0 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.93 -1.032 . . . . 74.329999999999998 109.719 -179.343 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 132.13 -19.11 4.66 Favored Glycine 0 N--CA 1.432 -1.621 0 C-N-CA 120.689 -0.767 . . . . 53.020000000000003 111.36 -177.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -99.58 172.94 6.98 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.045 -0.662 . . . . 74.420000000000002 109.344 177.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 533' ' ' GLU . 40.2 p -90.81 157.69 17.23 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.105 -0.638 . . . . 64.549999999999997 110.866 -176.078 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 10.0 p -53.7 -40.75 44.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.848 0.685 . . . . 75.430000000000007 112.848 -175.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -62.76 -42.93 99.91 Favored 'General case' 0 C--O 1.249 1.064 0 CA-C-O 121.236 0.541 . . . . 73.400000000000006 110.387 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 87.8 t -74.66 -37.05 42.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.631 -0.713 . . . . 74.310000000000002 110.065 -178.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . 0.438 ' HA ' ' ND2' ' A' ' 511' ' ' ASN . . . -63.29 -50.24 70.87 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.261 -0.882 . . . . 71.329999999999998 111.957 -179.015 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -64.82 -35.53 81.41 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.853 0.359 . . . . 73.25 110.712 -178.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.436 ' O ' HG23 ' A' ' 514' ' ' VAL . 3.6 tppp? -65.63 -52.97 47.78 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.672 -0.695 . . . . 75.409999999999997 111.627 179.756 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . 0.438 ' ND2' ' HA ' ' A' ' 508' ' ' ALA . 8.0 p30 -66.02 -37.82 86.85 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 120.342 -0.543 . . . . 75.040000000000006 111.539 -176.452 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . 0.419 HD22 ' O ' ' A' ' 508' ' ' ALA . 4.6 mm? -60.08 -41.32 92.18 Favored 'General case' 0 C--O 1.246 0.904 0 C-N-CA 121.032 -0.267 . . . . 75.120000000000005 110.617 176.052 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.11 -38.22 90.31 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 116.414 -0.357 . . . . 64.140000000000001 111.158 178.336 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 510' ' ' LYS . 96.9 t -63.77 -30.98 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 CA-C-N 115.889 -0.596 . . . . 73.540000000000006 111.223 179.198 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -80.26 -13.22 59.39 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 120.502 -0.479 . . . . 73.099999999999994 111.647 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 119.0 -14.7 11.16 Favored Glycine 0 N--CA 1.434 -1.445 0 C-N-CA 119.955 -1.117 . . . . 73.319999999999993 112.504 178.716 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -77.44 102.56 6.91 Favored 'General case' 0 CA--C 1.481 -1.692 0 N-CA-C 106.182 -1.784 . . . . 71.450000000000003 106.182 -178.678 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.5 m -88.91 -28.86 20.03 Favored 'General case' 0 N--CA 1.407 -2.58 0 C-N-CA 119.479 -0.888 . . . . 75.430000000000007 113.03 -167.152 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 61.7 mttp -108.32 125.36 51.62 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.736 -0.785 . . . . 74.209999999999994 111.659 -174.508 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -130.64 149.49 52.27 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.727 -0.669 . . . . 75.439999999999998 110.851 -178.38 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 46.9 m -132.29 143.71 50.08 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.33 -1.359 . . . . 73.230000000000004 107.33 173.786 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.04 144.32 44.74 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 109.381 -0.6 . . . . 72.439999999999998 109.381 179.327 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -130.64 129.99 43.37 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.3 -0.63 . . . . 72.439999999999998 109.3 178.814 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 50.8 m -84.11 120.97 26.8 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.542 -0.54 . . . . 63.219999999999999 109.542 179.529 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 32.3 m -121.4 162.71 20.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 108.149 -1.056 . . . . 74.0 108.149 179.229 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . 0.571 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 6.9 p-10 -82.52 134.38 35.2 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 119.26 -0.976 . . . . 73.530000000000001 109.378 -178.57 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 527' ' ' SER . . . . . 0.443 ' HG ' ' C ' ' A' ' 526' ' ' ASP . 51.1 m -152.73 167.99 12.28 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 110.231 -0.285 . . . . 72.409999999999997 110.231 177.13 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -85.7 -8.05 8.35 Favored 'Trans proline' 0 C--N 1.36 1.148 0 C-N-CA 122.284 1.99 . . . . 72.010000000000005 111.295 174.555 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . 0.507 ' HD3' ' OE2' ' A' ' 533' ' ' GLU . 50.4 mtt180 -80.07 145.53 61.18 Favored Pre-proline 0 N--CA 1.445 -0.71 0 N-CA-C 107.589 -1.263 . . . . 73.209999999999994 107.589 178.467 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -61.31 152.29 73.42 Favored 'Trans proline' 0 C--O 1.256 1.422 0 C-N-CA 122.364 2.043 . . . . 64.109999999999999 112.585 -179.327 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -62.93 115.58 4.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.132 -0.94 . . . . 74.129999999999995 111.352 -176.238 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 134.3 -24.64 3.55 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 120.564 -0.827 . . . . 53.130000000000003 112.224 178.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . 0.507 ' OE2' ' HD3' ' A' ' 529' ' ' ARG . 32.0 tt0 -82.99 137.85 33.99 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.349 -0.541 . . . . 73.319999999999993 109.797 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 88.2 t -81.83 120.2 32.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.86 -0.793 . . . . 74.310000000000002 108.86 178.413 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 535' ' ' THR . . . . . 0.441 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 9.3 t -80.94 -13.27 59.05 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.314 -0.403 . . . . 64.340000000000003 110.154 -179.075 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.91 -170.76 29.29 Favored Glycine 0 N--CA 1.426 -2.005 0 N-CA-C 109.987 -1.245 . . . . 72.030000000000001 109.987 178.222 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 14.1 p -116.88 160.4 20.93 Favored 'General case' 0 C--N 1.273 -2.729 0 N-CA-C 108.384 -0.969 . . . . 74.140000000000001 108.384 178.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . 0.445 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 38.1 t30 -67.02 -51.75 35.03 Favored Pre-proline 0 C--N 1.317 -0.841 0 C-N-CA 120.443 -0.503 . . . . 64.420000000000002 110.762 178.305 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . 0.445 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 3.9 Cg_exo -77.45 131.13 11.35 Favored 'Trans proline' 0 C--N 1.367 1.538 0 N-CA-C 107.601 -1.73 . . . . 74.430000000000007 107.601 170.576 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.93 162.15 39.23 Favored 'Trans proline' 0 C--O 1.25 1.117 0 C-N-CA 122.142 1.895 . . . . 73.25 112.555 -177.215 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -56.99 131.33 49.52 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 109.415 -0.587 . . . . 52.210000000000001 109.415 175.783 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.9 -12.06 38.04 Favored Glycine 0 C--N 1.301 -1.399 0 C-N-CA 120.928 -0.654 . . . . 63.439999999999998 111.929 -177.656 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 56.5 m -68.16 120.68 14.74 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.222 -0.659 . . . . 75.530000000000001 109.222 177.111 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 31.8 m -90.77 122.18 33.28 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 109.266 -0.642 . . . . 63.399999999999999 109.266 -179.464 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 28.7 m -136.88 158.68 72.47 Favored Pre-proline 0 C--N 1.311 -1.087 0 N-CA-C 108.96 -0.756 . . . . 75.299999999999997 108.96 -177.57 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -62.5 148.02 93.95 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 122.28 1.986 . . . . 73.200000000000003 110.723 175.527 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 27.0 m -64.13 -27.52 42.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 121.482 0.658 . . . . 75.530000000000001 111.882 -178.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -88.85 2.91 52.88 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 116.159 -0.473 . . . . 73.299999999999997 110.755 -179.25 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 9.7 t -82.14 172.16 13.5 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 120.862 0.363 . . . . 74.319999999999993 110.243 -176.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 7.8 t -110.58 124.01 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 CA-C-N 115.883 -0.599 . . . . 75.430000000000007 109.618 -176.653 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . 0.446 HD11 ' O ' ' A' ' 519' ' ' LYS . 0.2 OUTLIER -107.39 145.87 14.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 120.313 -0.555 . . . . 71.040000000000006 110.297 176.567 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -103.3 117.25 34.07 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.209 0.528 . . . . 73.310000000000002 111.037 -176.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 5.5 mp -98.77 130.7 45.23 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.562 -1.199 . . . . 75.230000000000004 108.6 178.641 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -102.08 120.03 39.76 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 121.489 0.661 . . . . 65.109999999999999 109.651 179.759 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 40.0 t -100.37 137.35 28.17 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 CA-C-N 115.191 -0.913 . . . . 75.209999999999994 109.413 -175.629 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.646 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 6.2 m -79.64 123.23 27.44 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.99 -1.004 . . . . 70.340000000000003 109.239 -179.015 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.571 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 17.6 ptmt -92.17 145.7 24.3 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 104.313 -2.477 . . . . 71.340000000000003 104.313 169.351 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . 0.479 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -79.14 -30.42 46.54 Favored Glycine 0 CA--C 1.486 -1.775 0 C-N-CA 118.964 -1.589 . . . . 55.219999999999999 113.486 -172.344 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 70.34 -29.15 0.18 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.663 1.185 . . . . 74.340000000000003 113.008 179.491 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.479 ' H ' ' C ' ' A' ' 558' ' ' GLY . 76.6 mt-30 -128.14 154.4 45.8 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 123.839 0.856 . . . . 74.450000000000003 112.015 -176.099 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -138.96 151.09 46.6 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.76 -0.83 . . . . 70.340000000000003 108.76 176.528 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 8.5 p -65.78 122.71 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 CA-C-O 121.262 0.554 . . . . 73.439999999999998 111.745 -178.912 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 563' ' ' MET . . . . . 0.476 ' HG2' ' O ' ' A' ' 564' ' ' PRO . 57.6 ttp -97.82 137.56 20.96 Favored Pre-proline 0 C--O 1.249 1.046 0 CA-C-N 116.182 -0.463 . . . . 65.140000000000001 111.311 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . 0.476 ' O ' ' HG2' ' A' ' 563' ' ' MET . 12.6 Cg_exo -73.4 169.39 22.4 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.633 2.222 . . . . 71.430000000000007 109.829 169.674 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -83.04 141.13 32.28 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.165 0.507 . . . . 72.219999999999999 110.722 -179.25 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 89.4 mt -122.99 15.32 9.96 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.96 -1.126 . . . . 72.319999999999993 107.96 177.034 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 7.7 m -72.17 141.21 49.07 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 114.437 -1.256 . . . . 72.400000000000006 109.837 -178.046 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 80.37 13.99 80.91 Favored Glycine 0 C--O 1.217 -0.945 0 C-N-CA 120.523 -0.846 . . . . 62.130000000000003 113.185 178.271 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 26.2 mmt -105.13 165.14 11.3 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 122.295 -0.532 . . . . 75.540000000000006 110.485 178.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -86.42 161.21 18.77 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.858 -1.164 . . . . 73.239999999999995 107.858 -179.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 30.8 t90 -71.22 -25.93 62.72 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.946 -0.761 . . . . 72.219999999999999 108.946 177.667 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.0 p -73.78 -17.72 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 115.27 -0.877 . . . . 72.010000000000005 109.407 179.475 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . 0.606 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 25.0 t70 -97.26 -34.97 10.89 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.362 -0.607 . . . . 75.140000000000001 109.362 178.5 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -64.03 -33.62 76.17 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.736 -0.665 . . . . 71.010000000000005 111.436 178.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.453 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 40.0 tt0 -55.99 -57.11 23.94 Favored Pre-proline 0 CA--C 1.576 1.953 0 CA-C-N 115.923 -0.58 . . . . 73.450000000000003 111.973 177.472 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . 0.507 ' HD2' ' O ' ' A' ' 573' ' ' ASP . 38.9 Cg_exo -61.05 -31.46 90.99 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 121.59 1.527 . . . . 74.340000000000003 112.835 173.656 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . 0.606 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 24.2 mmt180 -58.9 -47.82 83.63 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 110.123 -0.325 . . . . 75.510000000000005 110.123 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.507 HD11 ' N ' ' A' ' 579' ' ' ARG . 4.4 pp -64.09 -45.98 86.29 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 112.372 0.508 . . . . 75.239999999999995 112.372 -174.595 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . 0.507 ' N ' HD11 ' A' ' 578' ' ' LEU . 4.1 ptp180 -66.02 -35.23 80.0 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.682 -0.407 . . . . 73.230000000000004 112.074 178.618 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.85 -36.42 72.86 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.23 0.538 . . . . 75.140000000000001 111.605 178.44 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 86.8 mt -81.84 -3.3 53.7 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 112.418 0.525 . . . . 55.420000000000002 112.418 -177.42 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 73.39 40.68 47.68 Favored Glycine 0 CA--C 1.506 -0.528 0 C-N-CA 120.581 -0.818 . . . . 70.510000000000005 111.178 -179.632 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 75.6 t90 -70.04 137.64 51.46 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.999 -0.6 . . . . 74.430000000000007 110.739 -179.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 5.9 t -156.49 75.23 0.85 Allowed 'General case' 0 N--CA 1.424 -1.748 0 CA-C-O 122.283 1.04 . . . . 75.299999999999997 109.399 178.432 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -141.38 -137.71 3.44 Favored Glycine 0 N--CA 1.434 -1.457 0 N-CA-C 110.923 -0.871 . . . . 70.420000000000002 110.923 -178.587 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 65.7 mtt -126.8 136.87 52.96 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.057 -1.09 . . . . 74.109999999999999 108.057 177.622 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -97.38 128.51 44.25 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.796 -1.187 . . . . 75.400000000000006 107.796 -176.837 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -105.01 101.86 11.4 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.949 -0.7 . . . . 74.439999999999998 110.346 179.453 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -102.45 133.57 47.19 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 107.746 -1.205 . . . . 74.439999999999998 107.746 175.597 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -90.99 -154.44 30.52 Favored Glycine 0 N--CA 1.418 -2.558 0 N-CA-C 110.312 -1.115 . . . . 65.230000000000004 110.312 177.107 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -71.0 133.6 46.48 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 110.153 -0.314 . . . . 73.209999999999994 110.153 179.048 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -77.23 123.24 26.18 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 105.469 -2.048 . . . . 72.340000000000003 105.469 177.282 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 94.5 t -136.03 135.68 50.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-O 120.971 0.415 . . . . 74.239999999999995 111.895 -171.315 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -97.58 106.54 18.87 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 105.86 -1.904 . . . . 71.109999999999999 105.86 173.16 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -145.15 9.54 1.26 Allowed 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 112.777 0.658 . . . . 71.349999999999994 112.777 -175.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 122.91 167.04 12.82 Favored Glycine 0 C--N 1.302 -1.327 0 C-N-CA 119.84 -1.171 . . . . 72.209999999999994 111.583 179.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.75 -43.13 91.93 Favored Glycine 0 C--O 1.239 0.433 0 O-C-N 123.864 0.391 . . . . 74.310000000000002 114.052 -172.565 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 15.8 m -65.65 -34.11 77.46 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.181 0.515 . . . . 71.019999999999996 111.231 -179.112 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . 0.451 ' O ' ' HA3' ' A' ' 625' ' ' GLY . 80.9 mm-40 -92.49 -0.97 57.28 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 112.511 0.56 . . . . 72.439999999999998 112.511 -178.644 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -89.86 -106.56 0.09 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.424 0.898 . . . . 75.010000000000005 113.424 -178.515 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -92.46 54.86 2.38 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.185 0.517 . . . . 74.400000000000006 110.005 -173.227 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -144.12 140.85 29.65 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.891 -0.781 . . . . 74.140000000000001 108.891 176.802 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 95.8 t -64.34 130.15 29.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 107.509 -1.293 . . . . 73.319999999999993 107.509 173.322 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 58.0 t -89.2 -52.32 11.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.046 0.45 . . . . 71.099999999999994 110.429 -177.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -135.52 155.85 49.83 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.134 -1.061 . . . . 75.25 108.134 179.391 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -118.9 100.29 7.28 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 107.194 -1.41 . . . . 73.439999999999998 107.194 178.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.493 ' CB ' ' HB ' ' A' ' 621' ' ' THR . 26.7 t-20 -54.75 -51.58 77.7 Favored Pre-proline 0 CA--C 1.554 1.111 0 N-CA-C 113.772 1.027 . . . . 63.039999999999999 113.772 -177.72 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.402 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 7.8 Cg_exo -75.84 128.95 11.2 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 121.094 1.196 . . . . 63.439999999999998 109.229 173.072 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . 0.509 ' HB2' ' OG1' ' A' ' 612' ' ' THR . 12.6 Cg_exo -70.31 135.8 30.02 Favored 'Trans proline' 0 C--O 1.242 0.7 0 C-N-CA 122.395 2.064 . . . . 62.409999999999997 113.196 -177.533 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -68.35 134.47 50.32 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.216 -0.661 . . . . 73.109999999999999 109.216 176.125 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 88.27 0.39 82.73 Favored Glycine 0 C--N 1.305 -1.182 0 C-N-CA 120.136 -1.031 . . . . 73.129999999999995 111.108 -178.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 612' ' ' THR . . . . . 0.509 ' OG1' ' HB2' ' A' ' 609' ' ' PRO . 39.7 m -111.8 160.6 17.18 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.631 -1.248 . . . . 75.329999999999998 107.631 178.321 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -75.89 135.68 18.35 Favored Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 111.223 -0.751 . . . . 74.349999999999994 111.223 178.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.18 142.18 37.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 108.113 -1.069 . . . . 74.219999999999999 108.113 176.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . 0.486 ' ND2' ' HB2' ' A' ' 617' ' ' ASP . 34.9 p-10 -50.61 153.09 1.75 Allowed 'General case' 0 C--O 1.217 -0.648 0 N-CA-C 113.169 0.803 . . . . 72.230000000000004 113.169 179.174 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . 0.437 ' HD3' ' N ' ' A' ' 616' ' ' ARG . 0.0 OUTLIER -48.65 -30.82 5.86 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.952 1.301 . . . . 73.450000000000003 112.196 177.624 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . 0.486 ' HB2' ' ND2' ' A' ' 615' ' ' ASN . 1.0 OUTLIER -66.04 -44.41 84.69 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.578 -0.737 . . . . 71.430000000000007 110.325 176.736 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 87.45 23.1 41.19 Favored Glycine 0 N--CA 1.426 -1.986 0 C-N-CA 118.65 -1.738 . . . . 71.409999999999997 111.34 -178.266 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.84 119.2 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 123.238 1.494 . . . . 70.409999999999997 109.359 -167.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 4.2 tp -115.19 119.94 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.118 0 CA-C-N 113.215 -1.811 . . . . 73.319999999999993 110.528 -172.596 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.493 ' HB ' ' CB ' ' A' ' 607' ' ' ASN . 24.9 m -98.98 117.13 32.8 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 106.181 -1.785 . . . . 74.340000000000003 106.181 171.912 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -138.93 165.37 27.26 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 107.536 -1.283 . . . . 75.109999999999999 107.536 -175.835 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -134.11 135.77 43.42 Favored 'General case' 0 C--N 1.272 -2.786 0 N-CA-C 107.623 -1.251 . . . . 72.340000000000003 107.623 178.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -143.68 165.41 27.7 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 124.857 1.348 . . . . 72.439999999999998 107.578 172.709 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 599' ' ' GLN . . . -113.37 -110.87 2.99 Favored Glycine 0 C--N 1.279 -2.623 0 N-CA-C 111.586 -0.606 . . . . 63.119999999999997 111.586 -179.092 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.17 0 C-N-CA 121.034 -0.266 . . . . 74.420000000000002 111.03 179.02 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.049 0 N-CA-C 110.6 -1.0 . . . . 70.030000000000001 110.6 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 8.4 tp -74.36 109.71 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 CA-C-O 122.268 1.032 . . . . 73.409999999999997 111.068 -176.594 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 3.1 m -77.17 151.16 35.41 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.636 -1.166 . . . . 75.129999999999995 108.869 -179.814 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 21.3 mtp180 -79.32 -20.18 48.56 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.16 0.505 . . . . 71.319999999999993 110.422 -179.468 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.65 129.96 41.52 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 105.424 -2.065 . . . . 72.519999999999996 105.424 167.312 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 31.5 m -116.12 157.79 16.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-O 121.488 0.661 . . . . 73.010000000000005 111.63 -169.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . 0.429 HE21 ' C ' ' A' ' 361' ' ' GLN . 0.0 OUTLIER -94.76 124.3 38.72 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 106.606 -1.627 . . . . 74.040000000000006 106.606 -176.196 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.423 ' HB ' ' O ' ' A' ' 406' ' ' ALA . 89.7 t -101.35 129.53 26.76 Favored Pre-proline 0 C--N 1.287 -2.109 0 CA-C-N 114.993 -1.003 . . . . 73.409999999999997 111.335 -172.58 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -73.41 132.75 18.11 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.138 1.892 . . . . 73.219999999999999 109.42 174.637 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -91.76 158.89 16.1 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 120.291 -0.564 . . . . 74.329999999999998 109.648 -175.551 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 4.0 m -114.17 6.34 7.71 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 C-N-CA 124.203 1.001 . . . . 72.030000000000001 111.673 -176.026 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.77 145.38 12.39 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 112.757 0.651 . . . . 73.409999999999997 112.757 172.725 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.85 -6.02 43.54 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.254 -0.884 . . . . 75.409999999999997 112.307 -176.478 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -104.97 -92.44 0.37 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.73 0.3 . . . . 63.450000000000003 111.075 179.608 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 64.9 p -156.31 157.11 35.15 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 107.619 -1.252 . . . . 74.340000000000003 107.619 -179.133 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 7.9 p -64.1 -37.52 87.75 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 118.307 0.503 . . . . 64.109999999999999 111.221 179.702 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.21 -45.45 94.5 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 116.07 -0.514 . . . . 74.510000000000005 111.206 178.789 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -69.12 -39.24 79.03 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.609 -0.515 . . . . 71.140000000000001 109.609 179.692 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -61.91 -51.36 68.45 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.679 -0.692 . . . . 71.439999999999998 111.403 -178.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 78.5 mt -65.56 -39.97 86.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.188 -0.46 . . . . 60.310000000000002 110.124 179.122 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.26 -47.35 85.7 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.063 -0.517 . . . . 72.140000000000001 110.907 -179.496 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 376' ' ' THR . . . . . 0.521 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 51.3 m -64.97 -47.46 77.51 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.953 -0.567 . . . . 74.019999999999996 110.982 -179.085 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 10.8 mp -62.9 -39.02 93.23 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 112.145 0.424 . . . . 75.25 112.145 -179.248 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -64.99 -38.81 92.2 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.764 0.316 . . . . 71.230000000000004 110.205 179.349 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -68.37 -26.59 65.65 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.142 0.496 . . . . 63.219999999999999 111.355 176.744 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 376' ' ' THR . 9.7 mmm180 -82.15 -14.26 55.94 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.284 -0.416 . . . . 73.319999999999993 110.846 178.71 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 92.88 16.37 48.43 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.475 -0.869 . . . . 63.140000000000001 111.157 179.639 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.423 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 29.3 m-85 -93.16 154.77 17.87 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-O 121.454 0.645 . . . . 72.209999999999994 110.427 179.396 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 32.6 mmtp -103.75 145.01 30.72 Favored 'General case' 0 N--CA 1.409 -2.508 0 N-CA-C 107.184 -1.413 . . . . 75.540000000000006 107.184 -176.626 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.86 142.45 33.8 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 C-N-CA 119.868 -0.733 . . . . 74.200000000000003 110.545 -176.726 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 23.7 tpt180 -111.75 147.32 35.89 Favored 'General case' 0 N--CA 1.408 -2.527 0 N-CA-C 105.172 -2.158 . . . . 75.120000000000005 105.172 171.829 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 42.9 m -132.77 121.67 23.37 Favored 'General case' 0 C--N 1.269 -2.925 0 C-N-CA 120.229 -0.588 . . . . 71.519999999999996 109.56 -175.782 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 66.0 tp -111.22 119.1 37.81 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 107.406 -1.331 . . . . 64.200000000000003 107.406 -179.783 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -102.96 131.7 49.74 Favored 'General case' 0 N--CA 1.425 -1.702 0 C-N-CA 119.845 -0.742 . . . . 71.129999999999995 110.408 177.966 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . 0.528 ' O ' ' HA ' ' A' ' 421' ' ' SER . 13.2 mmmm -126.01 148.32 62.49 Favored Pre-proline 0 C--N 1.282 -2.367 0 N-CA-C 106.152 -1.796 . . . . 74.319999999999993 106.152 -178.264 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -69.35 158.04 58.97 Favored 'Trans proline' 0 C--O 1.243 0.765 0 N-CA-C 108.751 -1.288 . . . . 73.239999999999995 108.751 173.135 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.406 ' HB2' ' HA ' ' A' ' 424' ' ' PRO . 6.1 m-20 -74.82 82.88 2.14 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-O 121.818 0.818 . . . . 74.400000000000006 109.688 178.019 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.514 ' O ' ' HB ' ' A' ' 393' ' ' THR . 17.1 m -103.29 49.3 0.83 Allowed 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 114.593 -1.185 . . . . 74.409999999999997 108.843 178.709 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.514 ' HB ' ' O ' ' A' ' 392' ' ' SER . 99.2 m 69.54 20.28 7.17 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-O 123.206 1.479 . . . . 71.310000000000002 110.02 -179.715 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 5.4 pt -115.75 152.3 47.22 Favored Pre-proline 0 C--N 1.301 -1.536 0 CA-C-N 114.85 -1.068 . . . . 73.299999999999997 111.155 -174.357 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -21.5 116.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.364 1.388 1 C-N-CA 126.48 4.786 . . . . 70.540000000000006 116.831 -177.82 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . 0.45 ' HA ' ' OG ' ' A' ' 421' ' ' SER . 41.9 Cg_exo -59.02 161.86 14.89 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 124.267 3.311 . . . . 64.319999999999993 114.52 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -57.89 -8.46 0.99 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.996 1.318 . . . . 74.439999999999998 113.438 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -98.72 137.14 37.76 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.016 -1.846 . . . . 74.430000000000007 106.016 176.21 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 18.8 m -72.34 118.2 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 C-N-CA 119.039 -1.064 . . . . 74.310000000000002 112.514 -167.86 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.4 -30.6 2.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 105.843 -1.91 . . . . 74.230000000000004 105.843 171.386 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.7 157.89 27.55 Favored Glycine 0 N--CA 1.416 -2.673 0 CA-C-N 114.618 -1.174 . . . . 64.030000000000001 111.099 -178.399 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 9.3 p -144.83 -175.71 4.78 Favored 'General case' 0 C--N 1.278 -2.523 0 C-N-CA 127.314 2.246 . . . . 75.140000000000001 105.369 -177.119 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . 0.412 ' HA ' ' HD3' ' A' ' 404' ' ' PRO . 13.9 t70 -98.92 125.95 40.22 Favored Pre-proline 0 C--N 1.295 -1.789 0 C-N-CA 118.118 -1.433 . . . . 72.450000000000003 107.673 178.895 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 403' ' ' ASP . 52.6 Cg_exo -59.29 6.25 0.09 OUTLIER 'Trans proline' 0 C--N 1.365 1.397 0 C-N-CA 124.691 3.594 . . . . 71.439999999999998 115.91 -176.585 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.26 -33.58 67.74 Favored 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 109.467 -0.568 . . . . 73.040000000000006 109.467 174.907 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . 0.423 ' O ' ' HB ' ' A' ' 362' ' ' VAL . . . -67.04 -36.32 81.82 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-O 121.512 0.672 . . . . 71.219999999999999 110.319 177.275 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -85.77 0.72 52.12 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.914 0.864 . . . . 63.439999999999998 110.16 -179.147 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 28.5 m -97.33 158.39 15.48 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 104.896 -2.261 . . . . 74.219999999999999 104.896 171.588 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 33.7 p -74.32 112.08 10.13 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 118.649 -1.22 . . . . 72.150000000000006 108.712 179.236 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 17.1 m -129.53 159.11 41.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 121.296 0.569 . . . . 73.209999999999994 112.037 -179.456 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 3.0 p -60.94 140.82 57.66 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.083 -0.962 . . . . 63.240000000000002 110.869 177.944 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -65.0 111.01 2.67 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 121.477 0.656 . . . . 74.439999999999998 110.372 -177.538 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 107.07 39.92 1.9 Allowed Glycine 0 N--CA 1.423 -2.21 0 CA-C-N 115.05 -0.977 . . . . 73.519999999999996 112.001 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -92.18 -179.31 5.21 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.931 -0.766 . . . . 55.229999999999997 108.931 -178.319 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 43.9 mt-10 -104.69 114.91 29.43 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 110.005 -0.368 . . . . 75.129999999999995 110.005 -176.855 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 45.4 mm -107.41 128.78 62.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 109.188 -0.671 . . . . 64.409999999999997 109.188 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 25.5 m -85.2 130.29 34.63 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.307 0.575 . . . . 65.409999999999997 111.782 -178.023 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 9.4 p -114.68 135.49 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 CA-C-N 115.041 -0.981 . . . . 74.219999999999999 108.902 177.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -97.67 128.71 44.56 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 110.153 -0.314 . . . . 75.040000000000006 110.153 179.27 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 94.6 t -123.72 131.11 73.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 109.235 -0.654 . . . . 73.140000000000001 109.235 176.667 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 421' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 95.8 p -99.49 123.66 43.96 Favored 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 120.403 -0.519 . . . . 63.439999999999998 109.912 177.152 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 5.5 t -119.7 108.68 14.73 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 112.735 0.642 . . . . 74.409999999999997 112.735 -179.712 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 81.99 120.54 0.58 Allowed Glycine 0 CA--C 1.535 1.332 0 N-CA-C 115.373 0.909 . . . . 74.430000000000007 115.373 171.871 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . 0.406 ' HA ' ' HB2' ' A' ' 391' ' ' ASP . 34.8 Cg_exo -61.89 158.54 37.75 Favored 'Trans proline' 0 C--O 1.251 1.152 0 C-N-CA 123.814 3.009 . . . . 73.409999999999997 112.144 174.77 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -71.53 155.94 40.0 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.283 -0.871 . . . . 72.230000000000004 111.76 -174.721 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -127.38 150.14 49.75 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 104.775 -2.306 . . . . 54.32 104.775 172.809 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 477' ' ' THR . 20.5 mmm180 -121.66 147.16 46.23 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 119.593 -0.843 . . . . 73.150000000000006 111.679 -173.54 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 15.6 pt-20 -82.05 139.19 34.62 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.184 -0.916 . . . . 74.540000000000006 108.635 -178.963 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 65.1 mt -78.93 125.79 83.31 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 107.806 -1.183 . . . . 74.329999999999998 107.806 -178.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -70.51 141.49 42.31 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 121.848 1.699 . . . . 71.329999999999998 110.693 175.612 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -80.63 112.55 18.1 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.603 -0.517 . . . . 71.329999999999998 109.603 177.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 28.2 t -115.78 147.16 19.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 107.528 -1.286 . . . . 65.230000000000004 107.528 -179.045 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 1.6 p -58.01 138.17 56.18 Favored 'General case' 0 N--CA 1.432 -1.355 0 O-C-N 123.638 0.586 . . . . 74.319999999999993 111.463 179.961 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 31.7 p -64.57 -34.88 79.28 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 123.931 0.893 . . . . 74.140000000000001 112.05 -171.047 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . 0.402 ' H ' HD23 ' A' ' 435' ' ' LEU . 0.7 OUTLIER -75.02 -16.88 60.59 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-N 115.198 -0.91 . . . . 73.319999999999993 111.464 -179.775 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.1 m -105.03 50.6 0.78 Allowed 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.517 0.675 . . . . 73.129999999999995 109.26 -175.075 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . 0.41 ' O ' HG21 ' A' ' 441' ' ' VAL . 38.9 t80 -52.61 -38.82 60.88 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.893 0.877 . . . . 74.549999999999997 112.913 -179.683 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -59.44 -40.6 87.35 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-O 121.066 0.46 . . . . 75.219999999999999 110.918 179.444 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -70.04 -35.63 74.43 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.968 -0.753 . . . . 71.420000000000002 108.968 179.621 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.96 -43.62 98.48 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.893 -0.594 . . . . 71.530000000000001 110.054 178.732 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . 0.41 HG21 ' O ' ' A' ' 437' ' ' TYR . 84.9 t -58.48 -47.85 87.04 Favored 'Isoleucine or valine' 0 C--O 1.246 0.9 0 CA-C-N 115.232 -0.894 . . . . 74.019999999999996 110.911 178.669 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -67.38 -34.53 77.47 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 119.789 -0.765 . . . . 74.0 110.708 -179.376 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -62.53 -42.63 99.65 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 116.826 -0.17 . . . . 75.239999999999995 111.291 178.515 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 10.2 mp -63.76 -35.09 79.43 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 120.871 0.367 . . . . 74.400000000000006 110.389 176.277 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.457 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 22.2 m -68.19 -46.23 71.23 Favored 'General case' 0 C--O 1.249 1.033 0 CA-C-N 115.936 -0.574 . . . . 74.109999999999999 110.557 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.36 -17.39 62.42 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-O 121.105 0.479 . . . . 72.129999999999995 111.401 179.53 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.34 5.26 24.0 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.888 -0.596 . . . . 64.010000000000005 112.272 -179.871 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 110.48 -82.08 0.3 Allowed Glycine 0 CA--C 1.488 -1.615 0 C-N-CA 119.514 -1.327 . . . . 75.299999999999997 112.034 175.778 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -39.91 -65.22 0.41 Allowed 'General case' 0 C--O 1.248 0.995 0 N-CA-C 113.917 1.08 . . . . 71.030000000000001 113.917 175.573 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . 0.457 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 59.35 29.69 66.59 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.859 -0.496 . . . . 74.340000000000003 111.859 -175.232 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -105.06 111.23 23.93 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.472 -1.677 . . . . 72.510000000000005 106.472 -179.291 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 35.5 p90 -134.17 153.4 51.86 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 120.871 0.367 . . . . 72.030000000000001 110.939 -175.422 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -148.32 122.9 9.79 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.944 -0.761 . . . . 74.25 108.944 177.825 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -83.83 129.39 34.94 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 123.359 0.664 . . . . 73.030000000000001 111.458 179.752 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.08 144.66 47.47 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.274 -1.38 . . . . 64.299999999999997 107.274 173.342 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -122.29 136.83 54.97 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.521 -0.918 . . . . 71.340000000000003 108.521 -177.635 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 49.4 m -149.45 138.31 12.39 Favored Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 122.356 -0.215 . . . . 71.519999999999996 110.595 176.785 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.702 ' HA ' ' O ' ' A' ' 490' ' ' SER . 22.5 Cg_exo -65.82 129.39 22.02 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.404 2.07 . . . . 74.239999999999995 111.014 176.358 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 60.6 m -152.21 -179.28 7.39 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.951 -0.568 . . . . 64.299999999999997 109.884 -178.042 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 9.7 t -45.0 136.71 4.74 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.952 1.301 . . . . 72.019999999999996 112.432 178.643 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.76 -29.48 34.12 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 124.752 3.635 . . . . 75.120000000000005 113.933 -175.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -70.38 -30.7 67.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.571 -0.286 . . . . 51.310000000000002 111.722 -178.932 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -95.75 -8.81 33.44 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 111.66 0.244 . . . . 73.209999999999994 111.66 179.738 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 80.5 t -60.57 127.66 20.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.473 -0.566 . . . . 74.299999999999997 109.473 176.696 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 91.06 -15.07 61.82 Favored Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 116.002 -0.544 . . . . 73.430000000000007 112.107 -179.529 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -108.69 166.55 10.71 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 109.424 -0.584 . . . . 65.540000000000006 109.424 -177.852 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 79.4 t -73.51 140.82 17.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 108.182 -1.044 . . . . 74.150000000000006 108.182 173.572 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 65.5 mt -97.33 -35.28 5.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.56 -1.274 . . . . 72.010000000000005 107.56 177.253 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 172.76 -179.06 44.49 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 120.297 -0.954 . . . . 74.099999999999994 112.031 177.741 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 470' ' ' THR . . . . . 0.457 HG23 HG12 ' A' ' 486' ' ' ILE . 33.1 p -115.17 143.93 44.46 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 105.929 -1.878 . . . . 75.349999999999994 105.929 178.805 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -60.32 -57.19 28.45 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 119.888 -0.725 . . . . 72.519999999999996 112.146 178.607 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -71.94 152.57 57.7 Favored 'Trans proline' 0 C--N 1.361 1.196 0 N-CA-C 108.001 -1.577 . . . . 72.540000000000006 108.001 170.58 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.31 127.82 22.09 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 121.601 1.534 . . . . 75.439999999999998 111.44 -179.035 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -76.63 6.45 5.89 Favored 'General case' 0 C--O 1.211 -0.928 0 C-N-CA 124.239 1.016 . . . . 71.239999999999995 111.932 -175.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -109.78 -4.97 15.73 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 116.106 -0.497 . . . . 73.230000000000004 109.808 172.625 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -117.26 176.0 5.35 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 112.981 0.734 . . . . 73.209999999999994 112.981 -171.421 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 477' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 3.7 p -83.41 131.14 35.05 Favored 'General case' 0 N--CA 1.413 -2.295 0 C-N-CA 124.633 1.173 . . . . 74.420000000000002 113.145 -177.782 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 43.8 m -121.23 148.64 43.99 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 106.971 -1.492 . . . . 73.219999999999999 106.971 175.611 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -74.48 156.44 36.93 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.725 -0.39 . . . . 73.25 111.442 -176.585 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 43.5 mm -69.36 -26.8 32.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.823 0.82 . . . . 75.319999999999993 110.25 -177.006 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.4 t -97.9 5.07 49.39 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.69 0.757 . . . . 75.439999999999998 109.904 179.021 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -94.63 135.63 35.87 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.54 -0.755 . . . . 74.25 110.301 -176.597 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.3 p -89.86 126.75 42.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-O 121.283 0.564 . . . . 72.120000000000005 111.444 -177.043 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 60.6 t -96.77 118.53 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.91 0 N-CA-C 107.844 -1.169 . . . . 72.530000000000001 107.844 176.207 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.27 129.08 50.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 108.063 -1.088 . . . . 73.230000000000004 108.063 177.606 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . 0.457 HG12 HG23 ' A' ' 470' ' ' THR . 15.2 mt -118.54 128.23 75.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-N 115.158 -0.928 . . . . 73.209999999999994 110.635 -174.758 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 6.2 tt -103.19 126.17 57.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 115.69 -0.687 . . . . 74.439999999999998 110.428 -179.452 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 33.8 m -109.26 151.2 11.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 115.692 -0.685 . . . . 74.030000000000001 109.547 178.387 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.42 135.55 14.29 Favored Glycine 0 N--CA 1.423 -2.179 0 C-N-CA 121.125 -0.56 . . . . 74.420000000000002 111.744 -178.482 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.702 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 12.8 t -126.05 160.19 30.76 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 105.825 -1.917 . . . . 55.229999999999997 105.825 177.234 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 153.77 100.78 0.19 Allowed Glycine 0 C--N 1.297 -1.618 0 C-N-CA 119.048 -1.548 . . . . 73.239999999999995 112.157 178.864 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -72.5 150.0 50.88 Favored 'Trans proline' 0 C--O 1.251 1.129 0 C-N-CA 122.45 2.1 . . . . 73.310000000000002 111.736 179.06 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -91.25 81.17 5.52 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.532 -0.914 . . . . 62.100000000000001 108.532 175.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 5.9 p -117.81 153.56 33.26 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.263 -0.88 . . . . 72.439999999999998 112.209 -175.193 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 8.0 mmtm -137.24 136.85 38.47 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.242 -0.89 . . . . 73.049999999999997 109.746 179.986 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -82.27 121.61 26.87 Favored 'General case' 0 CA--C 1.485 -1.527 0 N-CA-C 105.508 -2.034 . . . . 62.409999999999997 105.508 168.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 543' ' ' THR . 44.1 pt -75.38 123.69 88.75 Favored Pre-proline 0 C--N 1.292 -1.905 0 N-CA-C 113.348 0.87 . . . . 73.239999999999995 113.348 -172.6 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -86.58 164.6 9.31 Favored 'Trans proline' 0 N--CA 1.429 -2.301 0 C-N-CA 122.472 2.114 . . . . 64.219999999999999 108.871 171.784 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -82.35 147.26 28.93 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 120.383 -0.527 . . . . 61.43 109.99 -178.487 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.1 p -130.35 8.29 2.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-O 122.045 0.926 . . . . 75.430000000000007 109.832 -176.824 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -81.23 157.11 25.31 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 115.43 -0.805 . . . . 72.519999999999996 110.185 -175.994 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 108.55 1.51 32.77 Favored Glycine 0 C--N 1.287 -2.145 0 N-CA-C 109.573 -1.411 . . . . 62.25 109.573 -178.49 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -120.62 175.43 6.01 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.414 -0.958 . . . . 75.239999999999995 108.414 -179.267 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 15.0 t -83.89 159.83 21.24 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.82 -1.178 . . . . 74.099999999999994 107.82 178.544 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 532' ' ' GLY . 48.2 t -46.84 -48.94 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 123.905 0.882 . . . . 73.420000000000002 111.239 -176.54 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -63.46 -41.85 98.62 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.188 -0.915 . . . . 72.439999999999998 111.571 -175.158 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 88.2 t -76.35 -40.61 35.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.908 -0.587 . . . . 61.240000000000002 110.857 -177.695 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.26 -45.8 89.8 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.378 -0.374 . . . . 72.200000000000003 110.881 -179.307 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -65.21 -35.45 81.11 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.402 -0.363 . . . . 74.319999999999993 110.893 178.573 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.419 ' O ' HG23 ' A' ' 514' ' ' VAL . 51.1 tptt -62.79 -45.88 90.6 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.37 -0.604 . . . . 74.530000000000001 109.37 178.204 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -63.62 -37.42 87.28 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 115.951 -0.568 . . . . 74.549999999999997 111.08 177.37 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 59.4 tp -59.8 -43.18 94.6 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.826 -0.625 . . . . 73.409999999999997 109.457 177.122 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . 0.45 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 13.5 m120 -63.25 -38.03 89.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.611 -0.722 . . . . 73.430000000000007 110.192 177.711 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 510' ' ' LYS . 94.9 t -63.69 -33.37 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 115.564 -0.743 . . . . 63.340000000000003 110.651 176.829 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -68.01 -27.49 66.6 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.85 0.357 . . . . 70.049999999999997 110.138 178.568 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 131.57 -18.31 4.91 Favored Glycine 0 CA--C 1.506 -0.499 0 C-N-CA 121.006 -0.616 . . . . 73.409999999999997 112.267 178.721 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 85.9 m-85 -78.63 115.15 18.14 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.347 0.594 . . . . 71.549999999999997 110.001 -177.025 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 12.5 p -86.87 -16.69 35.28 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.796 -0.638 . . . . 74.129999999999995 112.71 -176.83 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -117.29 130.87 56.83 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.232 0.539 . . . . 72.140000000000001 112.001 -174.612 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -130.07 156.81 43.9 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.346 -0.843 . . . . 73.049999999999997 112.398 -177.852 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 49.2 m -140.17 158.36 44.16 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 106.831 -1.544 . . . . 74.400000000000006 106.831 173.174 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 0.0 OUTLIER -135.37 145.24 47.16 Favored 'General case' 0 N--CA 1.413 -2.312 0 CA-C-N 118.293 0.497 . . . . 62.509999999999998 109.986 179.395 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -129.82 116.13 18.25 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.239 -1.022 . . . . 73.209999999999994 108.239 176.072 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 18.4 m -88.12 120.89 29.9 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.726 -0.472 . . . . 61.310000000000002 109.726 178.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 47.5 t -120.8 148.12 24.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 107.258 -1.386 . . . . 75.5 107.258 -179.616 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -68.86 136.41 52.63 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.185 0.517 . . . . 44.420000000000002 111.55 -175.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 69.6 m -156.78 176.36 2.65 Favored Pre-proline 0 C--N 1.3 -1.549 0 N-CA-C 108.709 -0.849 . . . . 70.310000000000002 108.709 -179.285 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -83.32 -14.48 8.2 Favored 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 121.947 1.764 . . . . 62.210000000000001 111.598 171.349 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . 0.577 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 0.0 OUTLIER -76.04 140.75 70.35 Favored Pre-proline 0 C--O 1.215 -0.716 0 CA-C-N 115.925 -0.579 . . . . 74.010000000000005 109.542 -179.743 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -56.61 144.82 84.22 Favored 'Trans proline' 0 C--O 1.249 1.026 0 C-N-CA 123.399 2.733 . . . . 74.25 113.432 -176.962 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.628 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -62.7 117.51 6.39 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 114.498 -1.228 . . . . 73.140000000000001 110.472 -178.329 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . 0.42 ' O ' HG23 ' A' ' 505' ' ' VAL . . . 126.82 -19.3 6.18 Favored Glycine 0 C--N 1.3 -1.431 0 C-N-CA 120.48 -0.867 . . . . 74.120000000000005 111.48 179.828 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -83.58 125.81 32.18 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 120.735 0.302 . . . . 74.25 110.548 177.752 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 62.0 t -81.92 118.84 30.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.093 -1.077 . . . . 64.239999999999995 108.093 178.357 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 99.2 m -104.66 -21.54 13.38 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 120.295 -0.562 . . . . 75.439999999999998 112.46 -177.013 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -159.16 -178.4 33.13 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 119.433 -1.365 . . . . 50.32 112.12 178.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 25.5 p -124.84 156.6 37.58 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.409 -1.33 . . . . 73.140000000000001 107.409 175.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . 0.451 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 23.0 t-20 -60.03 -56.99 30.05 Favored Pre-proline 0 CA--C 1.55 0.965 0 CA-C-O 119.307 -0.377 . . . . 54.149999999999999 110.777 179.617 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . 0.451 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 98.1 Cg_endo -84.09 143.65 10.37 Favored 'Trans proline' 0 C--N 1.367 1.51 0 CA-C-N 120.307 1.146 . . . . 74.510000000000005 110.095 172.849 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.97 148.98 58.42 Favored 'Trans proline' 0 C--O 1.258 1.506 0 C-N-CA 122.164 1.909 . . . . 62.039999999999999 112.026 179.642 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.06 134.53 57.07 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 115.908 -0.587 . . . . 75.5 109.681 178.179 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.83 -5.8 34.88 Favored Glycine 0 C--N 1.304 -1.235 0 C-N-CA 120.058 -1.068 . . . . 55.25 111.365 -175.266 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 543' ' ' THR . . . . . 0.466 ' O ' HG12 ' A' ' 497' ' ' ILE . 88.5 m -82.65 131.08 35.21 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.266 -1.013 . . . . 74.209999999999994 108.266 173.636 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 9.7 t -101.03 127.5 47.52 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-O 121.172 0.511 . . . . 72.310000000000002 109.891 178.669 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 31.0 m -138.55 165.12 35.16 Favored Pre-proline 0 C--N 1.313 -1.015 0 N-CA-C 108.547 -0.909 . . . . 71.25 108.547 -178.244 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -62.49 143.28 92.9 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.214 1.943 . . . . 75.230000000000004 111.547 175.094 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 32.4 m -62.38 -19.78 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.606 0.762 . . . . 73.450000000000003 113.016 -176.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -87.96 -14.88 38.03 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.251 -0.431 . . . . 73.129999999999995 111.246 -175.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 51.8 m -62.71 161.87 11.69 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 114.677 1.362 . . . . 75.349999999999994 114.677 -173.397 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 7.7 p -93.95 123.89 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-N 115.193 -0.912 . . . . 65.549999999999997 110.269 -179.507 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 52.3 mt -108.17 138.85 32.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 120.379 -0.528 . . . . 74.230000000000004 111.094 179.472 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -101.77 120.93 41.14 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 115.617 -0.719 . . . . 72.030000000000001 109.782 -179.077 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 1.5 mm? -95.73 126.34 40.93 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.153 -1.425 . . . . 75.319999999999993 107.153 176.671 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . 0.29 1.7 pt20 -102.19 120.5 40.57 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 122.698 1.237 . . . . 74.0 111.091 179.716 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 42.7 t -101.38 145.04 12.16 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-N 112.83 -1.986 . . . . 71.409999999999997 109.986 -169.076 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.628 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 73.9 m -82.07 133.06 35.26 Favored 'General case' 0 N--CA 1.41 -2.452 0 CA-C-O 121.552 0.691 . . . . 61.109999999999999 111.529 175.631 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -88.26 137.95 31.87 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 104.966 -2.235 . . . . 61.409999999999997 104.966 168.577 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . 0.577 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -81.69 -43.15 8.55 Favored Glycine 0 CA--C 1.475 -2.446 0 C-N-CA 120.252 -0.975 . . . . 74.219999999999999 113.786 -170.434 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' A' ' 615' ' ' ASN . 78.5 m-20 67.83 -31.77 0.19 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.043 0.937 . . . . 74.439999999999998 113.286 -176.785 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.515 ' H ' ' C ' ' A' ' 558' ' ' GLY . 3.0 tp60 -126.57 140.48 52.41 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 108.903 -0.777 . . . . 74.200000000000003 108.903 -175.047 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -143.45 139.09 29.73 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.765 -0.828 . . . . 64.420000000000002 108.765 174.741 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 9.6 p -59.81 124.11 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-O 121.647 0.737 . . . . 72.430000000000007 112.709 -176.252 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 57.9 ttp -95.34 137.76 22.03 Favored Pre-proline 0 C--O 1.249 1.039 0 CA-C-N 115.886 -0.597 . . . . 75.109999999999999 110.512 -179.93 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -64.22 170.01 9.91 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 123.246 2.631 . . . . 65.140000000000001 111.311 172.165 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -70.92 138.26 49.96 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.723 0.773 . . . . 63.100000000000001 112.51 -176.554 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 94.5 mt -136.15 15.53 3.26 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.287 -1.324 . . . . 75.010000000000005 107.938 174.844 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 27.7 t -67.37 134.2 51.05 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 115.302 -0.863 . . . . 72.439999999999998 109.885 -177.407 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 86.07 40.11 7.68 Favored Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 110.41 -1.076 . . . . 63.32 110.41 179.953 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 21.5 ptm -109.29 158.0 18.3 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.979 -0.749 . . . . 72.140000000000001 108.979 -179.831 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -108.75 165.16 11.76 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 106.739 -1.578 . . . . 73.200000000000003 106.739 175.603 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 24.6 t90 -71.59 -30.31 65.68 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 108.979 -0.749 . . . . 75.329999999999998 108.979 177.101 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 30.0 m -80.08 -6.06 9.07 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 CA-C-O 121.793 0.806 . . . . 64.519999999999996 109.798 176.677 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . 0.418 ' C ' ' HD2' ' A' ' 576' ' ' PRO . 14.1 t70 -99.38 -30.03 12.43 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.905 -1.146 . . . . 74.010000000000005 107.905 177.199 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -62.86 -42.01 99.59 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 114.496 -1.229 . . . . 75.129999999999995 110.735 177.476 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 578' ' ' LEU . 44.2 tt0 -57.4 -52.25 75.62 Favored Pre-proline 0 CA--C 1.577 1.982 0 N-CA-C 113.014 0.746 . . . . 75.239999999999995 113.014 179.261 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . 0.418 ' HD2' ' C ' ' A' ' 573' ' ' ASP . 75.0 Cg_exo -55.38 -40.03 87.77 Favored 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 121.963 1.776 . . . . 75.510000000000005 112.172 173.114 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -68.3 -34.1 75.54 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.43 -0.508 . . . . 74.310000000000002 112.078 177.853 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.424 ' HB3' ' O ' ' A' ' 575' ' ' GLU . 5.9 tt -58.77 -49.47 77.54 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.268 0.627 . . . . 74.349999999999994 109.724 178.848 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -67.37 -40.96 85.78 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.286 0.847 . . . . 74.129999999999995 113.286 177.138 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.57 -39.86 88.69 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.186 0.439 . . . . 64.310000000000002 112.186 -177.666 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 10.4 mp -86.3 -8.97 57.31 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 111.971 0.36 . . . . 75.340000000000003 111.971 -179.276 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 68.34 21.81 74.35 Favored Glycine 0 C--O 1.241 0.559 0 N-CA-C 111.317 -0.713 . . . . 62.409999999999997 111.317 -177.54 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 42.9 t90 -60.61 126.96 29.37 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 123.198 0.599 . . . . 73.439999999999998 111.031 -177.359 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 8.8 m -130.41 89.44 2.78 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 115.517 -0.765 . . . . 72.230000000000004 109.122 178.153 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -144.14 -142.67 3.94 Favored Glycine 0 N--CA 1.426 -2.023 0 N-CA-C 109.479 -1.448 . . . . 65.129999999999995 109.479 177.43 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 14.4 tpt -129.0 131.41 47.42 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.768 -0.827 . . . . 72.340000000000003 108.768 179.099 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -98.03 123.1 41.89 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.07 -1.456 . . . . 73.319999999999993 107.07 177.066 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -98.11 107.38 19.85 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.995 -0.548 . . . . 72.430000000000007 109.994 -178.422 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.49 133.26 36.97 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.98 -0.554 . . . . 75.310000000000002 110.954 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -97.95 -164.83 31.38 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.737 -0.665 . . . . 62.329999999999998 113.406 -175.086 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -74.84 141.3 44.26 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 123.178 0.591 . . . . 73.409999999999997 110.834 -178.266 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -85.64 133.26 34.04 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.622 -0.717 . . . . 73.430000000000007 109.646 -177.096 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 73.4 t -125.34 115.41 43.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 107.206 -1.405 . . . . 75.420000000000002 107.206 175.337 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -86.02 107.64 17.88 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.221 -0.992 . . . . 54.210000000000001 110.213 -179.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -124.05 -11.17 7.59 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.212 -0.904 . . . . 74.25 111.495 -178.788 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 119.18 -172.67 14.7 Favored Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 121.099 -0.572 . . . . 73.319999999999993 111.673 177.779 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.87 -34.03 64.56 Favored Glycine 0 C--O 1.222 -0.623 0 N-CA-C 114.514 0.566 . . . . 60.399999999999999 114.514 -175.53 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 19.0 m -66.14 -24.72 66.72 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 117.344 0.572 . . . . 74.140000000000001 111.997 -178.445 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -109.66 -0.83 18.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.282 0.563 . . . . 74.099999999999994 111.286 178.616 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -67.62 105.42 1.87 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.195 -0.911 . . . . 74.209999999999994 113.099 -175.261 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 62.87 0.94 0.75 Allowed 'General case' 0 CA--C 1.56 1.352 0 C-N-CA 125.773 1.629 . . . . 72.109999999999999 114.081 171.713 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . 0.411 ' HD2' ' O ' ' A' ' 603' ' ' VAL . 8.7 tmm_? -90.93 148.47 22.42 Favored 'General case' 0 C--N 1.313 -0.995 0 O-C-N 121.911 -0.493 . . . . 72.140000000000001 110.607 -178.174 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . 0.411 ' O ' ' HD2' ' A' ' 602' ' ' ARG . 7.1 p -56.11 131.76 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.01 0.924 . . . . 70.219999999999999 111.465 -177.634 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 14.7 p -106.91 -34.89 2.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 C-N-CA 119.9 -0.72 . . . . 73.120000000000005 109.385 -178.728 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -154.12 148.43 26.0 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 105.114 -2.18 . . . . 75.099999999999994 105.114 171.559 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -122.39 136.56 54.92 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 108.713 -0.847 . . . . 74.010000000000005 108.713 176.627 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.5 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 24.5 t-20 -59.37 -52.39 74.65 Favored Pre-proline 0 C--N 1.309 -1.164 0 CA-C-N 115.443 -0.799 . . . . 65.519999999999996 111.298 -178.436 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.5 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 29.6 Cg_endo -105.27 110.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.962 0 C-N-CA 121.883 1.722 . . . . 72.329999999999998 111.389 173.341 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -67.76 156.86 64.33 Favored 'Trans proline' 0 C--O 1.239 0.545 0 C-N-CA 122.139 1.893 . . . . 70.439999999999998 110.705 176.408 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -60.07 137.35 58.11 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 110.009 -0.367 . . . . 72.010000000000005 110.009 178.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 90.05 0.96 76.83 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 119.44 -1.362 . . . . 64.120000000000005 111.564 -178.355 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 9.8 m -107.95 155.62 20.11 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.999 -1.111 . . . . 75.140000000000001 107.999 178.182 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -81.64 132.16 10.96 Favored Glycine 0 N--CA 1.418 -2.515 0 CA-C-N 116.352 -0.386 . . . . 74.200000000000003 112.525 -179.433 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 22.2 m -101.14 142.55 15.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 123.222 0.609 . . . . 75.0 110.375 177.008 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . 0.506 ' OD1' HG23 ' A' ' 619' ' ' ILE . 0.0 OUTLIER -54.55 149.39 10.69 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.234 0.959 . . . . 74.439999999999998 111.96 178.171 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . 0.255 0.0 OUTLIER -61.0 -24.38 66.1 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.752 1.019 . . . . 75.510000000000005 113.752 179.929 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -68.62 -31.3 70.36 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 109.159 -0.682 . . . . 74.540000000000006 109.159 176.062 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 88.91 9.52 67.93 Favored Glycine 0 N--CA 1.418 -2.525 0 CA-C-N 115.006 -0.997 . . . . 75.519999999999996 113.264 176.855 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . 0.506 HG23 ' OD1' ' A' ' 615' ' ' ASN . 0.0 OUTLIER -69.59 119.57 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 CA-C-N 118.547 1.174 . . . . 73.349999999999994 109.103 -175.675 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.51 131.93 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 N-CA-C 108.836 -0.801 . . . . 75.409999999999997 108.836 -176.881 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 60.1 m -118.08 127.84 54.18 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 120.867 0.365 . . . . 73.329999999999998 111.627 -178.585 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.5 150.91 46.89 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 105.455 -2.054 . . . . 75.310000000000002 105.455 174.048 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -127.74 156.17 42.85 Favored 'General case' 0 C--N 1.266 -3.044 0 N-CA-C 106.079 -1.823 . . . . 73.109999999999999 106.079 179.248 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -131.13 165.63 22.86 Favored 'General case' 0 C--N 1.275 -2.634 0 N-CA-C 106.847 -1.538 . . . . 72.010000000000005 106.847 179.644 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -71.72 -84.96 0.2 Allowed Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 109.224 -1.551 . . . . 71.530000000000001 109.224 175.408 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 . . . . . 0 C--N 1.299 -1.594 0 N-CA-C 108.697 -0.853 . . . . 74.140000000000001 108.697 174.346 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.162 0 N-CA-C 110.1 -1.2 . . . . 75.310000000000002 110.1 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 9.2 tp -74.81 122.7 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 CA-C-N 117.787 0.794 . . . . 72.120000000000005 110.474 -179.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 1.3 m -70.57 150.7 45.82 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 108.367 -0.975 . . . . 64.25 108.367 179.411 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -84.79 -28.87 25.87 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.732 -1.21 . . . . 74.510000000000005 107.732 179.316 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -97.56 150.46 21.09 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.837 -1.528 . . . . 74.140000000000001 109.012 179.815 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.76 142.93 27.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 109.725 -0.472 . . . . 63.130000000000003 109.725 -176.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . 0.456 HE21 ' C ' ' A' ' 361' ' ' GLN . 0.0 OUTLIER -95.41 118.63 32.5 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.934 -1.506 . . . . 71.120000000000005 106.934 -176.853 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.448 ' HB ' ' O ' ' A' ' 406' ' ' ALA . 65.3 t -97.09 141.07 22.5 Favored Pre-proline 0 C--N 1.288 -2.093 0 CA-C-N 115.181 -0.918 . . . . 63.229999999999997 110.927 -170.284 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -66.49 142.87 66.97 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 121.84 1.693 . . . . 75.5 109.741 174.859 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . 0.443 ' HB2' ' ND2' ' A' ' 407' ' ' ASN . 35.1 t0 -95.83 142.61 27.89 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.915 -1.143 . . . . 72.329999999999998 107.915 -177.931 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.5 ' CG2' ' HA ' ' A' ' 373' ' ' ALA . 11.4 p -106.2 -7.47 10.22 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.676 0 CA-C-N 115.253 -0.885 . . . . 72.140000000000001 112.45 -168.472 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . 0.254 2.2 ppt_? -54.39 146.56 15.51 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.834 1.42 . . . . 74.219999999999999 114.834 175.884 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.44 0.79 40.55 Favored Glycine 0 C--O 1.24 0.482 0 CA-C-N 115.333 -0.848 . . . . 64.239999999999995 111.698 -177.219 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -119.33 -153.48 0.54 Allowed 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.545 -0.909 . . . . 75.200000000000003 108.545 177.672 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 51.5 p -96.35 153.47 17.8 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.503 -0.925 . . . . 75.129999999999995 108.503 -178.215 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 32.1 t -57.39 -37.34 72.52 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 123.322 0.389 . . . . 71.140000000000001 110.14 178.503 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.09 -47.04 75.51 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 119.287 -0.387 . . . . 71.150000000000006 111.412 179.78 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -70.05 -34.72 73.58 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 119.734 -0.786 . . . . 63.310000000000002 109.999 179.685 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . 0.5 ' HA ' ' CG2' ' A' ' 365' ' ' VAL . . . -63.39 -51.47 65.7 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.107 -0.951 . . . . 71.430000000000007 111.162 179.801 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 82.3 mt -64.05 -40.26 88.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.957 -0.565 . . . . 74.409999999999997 109.908 176.654 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.71 -47.35 84.88 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.107 -0.497 . . . . 52.200000000000003 111.007 -178.12 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 376' ' ' THR . . . . . 0.455 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 37.3 m -63.14 -47.27 83.44 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.794 -0.639 . . . . 72.219999999999999 110.16 -178.901 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 95.4 mt -64.04 -41.4 97.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.006 -0.543 . . . . 63.039999999999999 111.11 -178.842 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -63.12 -42.43 99.53 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.284 -0.416 . . . . 73.530000000000001 110.662 179.375 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -68.52 -20.33 64.56 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 111.915 0.339 . . . . 75.040000000000006 111.915 179.323 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 376' ' ' THR . 34.0 mmt180 -88.05 -14.18 39.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.345 -0.389 . . . . 72.329999999999998 110.335 176.164 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.46 16.72 45.13 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 120.655 -0.783 . . . . 74.510000000000005 112.463 179.231 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -88.85 156.21 19.07 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-O 121.327 0.584 . . . . 75.430000000000007 112.062 179.597 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -93.16 143.78 25.92 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 115.014 -0.993 . . . . 74.129999999999995 108.741 -177.712 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.37 146.04 34.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-O 121.172 0.51 . . . . 74.519999999999996 110.223 -178.356 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -128.02 126.85 42.1 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 105.971 -1.863 . . . . 74.439999999999998 105.971 171.233 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 8.0 m -115.06 123.62 49.49 Favored 'General case' 0 C--N 1.274 -2.713 0 N-CA-C 107.212 -1.403 . . . . 70.329999999999998 107.212 -178.137 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -110.87 121.47 45.42 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.527 -0.916 . . . . 73.430000000000007 108.527 -177.774 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -90.55 133.79 34.83 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.678 -0.692 . . . . 72.129999999999995 110.441 -176.626 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 421' ' ' SER . 98.1 mttt -136.93 145.34 50.28 Favored Pre-proline 0 C--N 1.312 -1.044 0 N-CA-C 108.896 -0.779 . . . . 74.340000000000003 108.896 172.918 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . 0.488 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 56.7 Cg_endo -101.28 135.78 0.16 Allowed 'Trans proline' 0 CA--C 1.554 1.498 0 C-N-CA 122.0 1.8 . . . . 71.150000000000006 111.5 169.569 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.565 ' OD2' HG22 ' A' ' 393' ' ' THR . 12.9 t70 161.64 -168.03 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 126.073 1.749 . . . . 72.129999999999995 107.339 174.911 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.45 ' H ' ' CG ' ' A' ' 391' ' ' ASP . 32.3 t -128.17 -15.6 4.67 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 118.03 0.377 . . . . 64.019999999999996 110.558 179.421 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.565 HG22 ' OD2' ' A' ' 391' ' ' ASP . 13.1 t -79.75 -29.97 40.64 Favored 'General case' 0 C--O 1.252 1.209 0 N-CA-C 108.836 -0.802 . . . . 73.150000000000006 108.836 177.125 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.88 126.02 55.06 Favored Pre-proline 0 N--CA 1.417 -2.101 0 N-CA-C 105.22 -2.141 . . . . 74.099999999999994 105.22 165.519 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.51 155.06 27.93 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 N-CA-C 117.343 2.017 . . . . 64.230000000000004 117.343 -167.23 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 421' ' ' SER . 74.0 Cg_exo -53.9 167.73 1.02 Allowed 'Trans proline' 0 CA--C 1.492 -1.585 1 C-N-CA 126.081 4.52 . . . . 72.409999999999997 111.709 170.888 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . 0.473 ' HA ' ' CG2' ' A' ' 420' ' ' VAL . 4.5 p-10 -51.57 -5.93 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 127.149 2.18 . . . . 74.450000000000003 115.836 -164.523 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -80.42 109.06 14.56 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.069 -1.456 . . . . 70.549999999999997 107.069 170.104 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 24.7 m -83.94 120.99 35.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 115.14 -0.937 . . . . 63.539999999999999 113.418 -168.558 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -84.92 -27.71 6.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.611 -0.722 . . . . 74.25 109.822 177.18 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.9 157.53 27.4 Favored Glycine 0 N--CA 1.42 -2.427 0 C-N-CA 119.389 -1.386 . . . . 73.230000000000004 113.988 -176.597 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 11.7 p -136.29 -173.83 3.51 Favored 'General case' 0 C--N 1.273 -2.721 0 C-N-CA 128.701 2.8 . . . . 74.209999999999994 104.825 -177.588 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -97.8 129.34 31.52 Favored Pre-proline 0 C--N 1.286 -2.154 0 N-CA-C 106.633 -1.617 . . . . 65.239999999999995 106.633 179.688 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.18 -1.26 0.17 Allowed 'Trans proline' 0 C--N 1.367 1.548 0 C-N-CA 124.731 3.621 . . . . 74.219999999999999 115.512 -176.368 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -50.45 -36.88 35.31 Favored 'General case' 0 C--O 1.209 -1.074 0 C-N-CA 124.15 0.98 . . . . 44.530000000000001 109.484 173.511 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . 0.448 ' O ' ' HB ' ' A' ' 362' ' ' VAL . . . -59.31 -50.05 75.47 Favored 'General case' 0 C--O 1.217 -0.651 0 O-C-N 123.54 0.525 . . . . 72.120000000000005 110.902 178.678 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . 0.443 ' ND2' ' HB2' ' A' ' 364' ' ' ASP . 13.3 m120 -82.56 0.16 44.05 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 120.448 -0.501 . . . . 75.510000000000005 111.991 -178.989 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 30.2 m -86.31 150.07 24.6 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 105.134 -2.173 . . . . 74.230000000000004 105.134 173.104 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 19.4 m -75.79 112.34 12.07 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 106.372 -1.714 . . . . 74.0 106.372 175.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 31.0 m -125.92 169.52 17.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-O 121.009 0.433 . . . . 74.340000000000003 111.192 -174.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 21.4 t -77.46 140.79 39.89 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 107.353 -1.351 . . . . 71.409999999999997 107.353 176.896 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -57.86 109.71 0.78 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.026 0.441 . . . . 72.400000000000006 111.277 -178.652 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 105.32 61.64 0.64 Allowed Glycine 0 N--CA 1.436 -1.358 0 N-CA-C 111.183 -0.767 . . . . 72.030000000000001 111.183 -179.99 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -111.01 177.18 4.74 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.163 -0.68 . . . . 71.120000000000005 109.163 179.92 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -90.06 112.67 24.18 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 124.296 1.038 . . . . 71.310000000000002 111.345 -174.38 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 39.5 mm -107.11 109.23 27.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 109.71 -0.478 . . . . 73.400000000000006 109.71 177.657 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 40.9 p -88.38 131.18 34.95 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 122.705 0.402 . . . . 70.230000000000004 110.308 179.765 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 6.1 p -127.19 133.29 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 109.448 -0.575 . . . . 74.519999999999996 109.448 176.736 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -97.41 128.94 44.63 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.736 -0.839 . . . . 71.349999999999994 108.736 174.552 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.473 ' CG2' ' HA ' ' A' ' 397' ' ' ASP . 7.0 p -129.57 143.89 39.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.886 -0.783 . . . . 73.319999999999993 108.886 -176.509 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 421' ' ' SER . . . . . 0.525 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 14.5 m -119.58 130.01 54.92 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 119.156 -1.017 . . . . 72.540000000000006 111.359 -178.821 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 5.3 t -119.09 107.06 13.02 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.483 -0.78 . . . . 71.200000000000003 111.285 -179.504 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 78.55 141.61 1.94 Allowed Glycine 0 CA--C 1.528 0.903 0 CA-C-N 116.276 -0.42 . . . . 71.420000000000002 113.63 177.159 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -83.77 156.66 13.75 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.368 2.046 . . . . 74.530000000000001 111.922 178.565 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -88.8 166.72 13.83 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 121.565 0.698 . . . . 75.200000000000003 110.867 -179.146 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -125.29 157.15 37.38 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.434 -1.691 . . . . 74.010000000000005 106.434 178.087 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 57.4 mmm-85 -126.61 163.73 22.79 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.594 -0.691 . . . . 74.400000000000006 111.977 -178.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.1 138.74 33.57 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 114.535 -1.211 . . . . 63.140000000000001 108.832 -179.084 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 62.4 mt -91.27 123.72 63.41 Favored Pre-proline 0 N--CA 1.425 -1.701 0 N-CA-C 108.515 -0.921 . . . . 74.109999999999999 108.515 177.103 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -71.4 141.01 37.85 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 121.617 1.545 . . . . 63.520000000000003 109.733 171.588 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -87.75 168.34 13.05 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.261 -1.014 . . . . 72.030000000000001 108.261 177.372 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.406 HG12 ' HB3' ' A' ' 440' ' ' ALA . 13.8 p -153.98 164.94 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.266 -1.013 . . . . 75.140000000000001 108.266 -175.546 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 37.6 m -75.95 147.9 38.57 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.435 -0.95 . . . . 62.149999999999999 108.435 174.139 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 47.0 p -66.45 -27.99 68.24 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 114.486 1.291 . . . . 74.409999999999997 114.486 -170.877 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.1 pp -79.49 -15.83 57.08 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.295 -0.878 . . . . 64.239999999999995 112.35 176.522 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.01 47.91 1.16 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.09 0.471 . . . . 72.019999999999996 111.34 -174.568 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . 0.47 ' OH ' ' HB2' ' A' ' 454' ' ' GLN . 71.2 t80 -52.95 -38.65 62.23 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.27 0.628 . . . . 74.200000000000003 112.634 178.629 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.36 -39.61 91.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.427 0.632 . . . . 73.230000000000004 110.731 179.79 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -70.3 -35.37 73.64 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.509 -0.769 . . . . 74.219999999999999 109.879 178.857 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.512 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -59.64 -51.23 70.69 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.839 -0.619 . . . . 74.310000000000002 111.092 -178.892 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.1 m -65.44 -39.09 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 112.275 0.472 . . . . 75.409999999999997 112.275 -178.28 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . 0.273 0.1 OUTLIER -68.17 -34.43 76.29 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 119.556 -0.858 . . . . 75.019999999999996 112.1 176.602 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -63.35 -42.01 98.9 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 116.565 -0.289 . . . . 73.230000000000004 110.584 174.885 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 93.3 mt -63.57 -33.15 74.96 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.11 -0.495 . . . . 75.109999999999999 110.551 178.916 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 48.2 m -70.08 -43.84 70.29 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.13 -0.486 . . . . 75.140000000000001 110.065 179.493 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.23 -15.36 62.45 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.675 0.75 . . . . 72.109999999999999 110.706 178.801 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -87.01 -0.9 57.38 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.451 -0.795 . . . . 74.430000000000007 111.659 179.531 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 112.79 -77.56 0.24 Allowed Glycine 0 CA--C 1.499 -0.963 0 C-N-CA 120.201 -1.0 . . . . 74.439999999999998 112.28 176.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . 0.412 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 0.1 OUTLIER -43.55 -65.55 0.48 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.521 0.934 . . . . 74.409999999999997 113.521 177.318 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 62.11 21.64 61.85 Favored Glycine 0 C--O 1.226 -0.354 0 C-N-CA 121.077 -0.582 . . . . 74.340000000000003 111.704 -175.421 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -102.91 110.78 22.83 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 108.213 -1.032 . . . . 70.140000000000001 108.213 -178.004 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . 0.43 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 27.8 p90 -142.68 163.93 31.49 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 115.59 -0.732 . . . . 74.019999999999996 109.665 -175.95 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -151.89 124.14 8.22 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.862 -0.792 . . . . 75.450000000000003 108.862 176.356 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . 0.47 ' HB2' ' OH ' ' A' ' 437' ' ' TYR . 57.3 tt0 -87.22 128.4 35.15 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 123.454 0.471 . . . . 74.340000000000003 109.959 179.897 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -122.17 138.03 54.62 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.23 -1.026 . . . . 73.329999999999998 108.23 175.025 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -114.44 133.16 55.95 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.84 -1.171 . . . . 75.519999999999996 107.84 -179.13 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 49.1 m -151.73 145.35 17.69 Favored Pre-proline 0 C--N 1.298 -1.638 0 N-CA-C 109.676 -0.49 . . . . 72.120000000000005 109.676 176.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.669 ' HA ' ' O ' ' A' ' 490' ' ' SER . 29.2 Cg_endo -65.3 122.54 10.29 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.147 1.898 . . . . 74.030000000000001 109.264 177.398 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 35.2 m -134.04 179.88 5.98 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 115.634 -0.712 . . . . 43.299999999999997 109.734 -173.276 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 6.0 t -54.16 135.84 59.12 Favored Pre-proline 0 N--CA 1.436 -1.166 0 O-C-N 124.26 0.975 . . . . 74.439999999999998 109.552 178.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -50.97 -29.76 28.47 Favored 'Trans proline' 0 N--CA 1.477 0.512 0 C-N-CA 124.689 3.592 . . . . 72.310000000000002 115.085 -171.679 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -75.58 -22.38 57.01 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.973 0.416 . . . . 64.129999999999995 112.018 179.272 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -98.37 -5.91 31.8 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.842 0.353 . . . . 71.420000000000002 110.692 177.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 62.3 t -61.42 127.72 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 109.163 -0.681 . . . . 74.319999999999993 109.163 174.233 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 85.93 -4.02 86.41 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 111.415 -0.674 . . . . 75.030000000000001 111.415 -179.162 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -122.46 156.82 33.28 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 121.558 0.695 . . . . 70.420000000000002 109.433 -177.064 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 47.4 t -71.09 142.59 15.38 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.503 0 CA-C-N 114.599 -1.182 . . . . 73.510000000000005 108.128 173.089 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 52.1 mt -97.59 -28.99 3.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 108.809 -0.811 . . . . 73.450000000000003 108.809 179.71 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 154.74 -170.11 33.01 Favored Glycine 0 N--CA 1.427 -1.957 0 C-N-CA 120.337 -0.935 . . . . 70.120000000000005 112.16 177.042 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 470' ' ' THR . . . . . 0.452 HG23 HG12 ' A' ' 486' ' ' ILE . 36.1 p -115.45 139.9 49.62 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.803 -1.555 . . . . 75.109999999999999 106.803 -179.824 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.413 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 9.0 t30 -63.43 -50.9 71.36 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 119.361 -0.935 . . . . 74.129999999999995 112.037 177.481 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.413 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 22.0 Cg_exo -75.06 151.11 38.84 Favored 'Trans proline' 0 C--N 1.36 1.157 0 N-CA-C 108.5 -1.385 . . . . 72.209999999999994 108.5 170.456 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.24 127.07 20.06 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.004 1.802 . . . . 73.150000000000006 112.173 -178.508 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -89.06 3.86 50.32 Favored 'General case' 0 C--O 1.207 -1.175 0 CA-C-N 115.511 -0.768 . . . . 75.209999999999994 110.732 -177.928 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -111.08 8.14 21.7 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.524 -0.762 . . . . 75.129999999999995 109.933 179.499 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -125.69 179.59 5.09 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 116.198 -0.455 . . . . 74.209999999999994 111.043 -174.247 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 3.6 m -89.84 117.57 28.78 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 115.516 -0.766 . . . . 60.119999999999997 109.481 179.917 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 50.1 m -118.94 148.68 42.69 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.471 -0.566 . . . . 53.109999999999999 109.471 -179.172 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -73.16 153.38 40.75 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.67 0.619 . . . . 70.099999999999994 112.67 -174.503 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . 0.412 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 2.2 mp -65.03 -26.82 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-O 121.756 0.788 . . . . 70.430000000000007 110.695 178.75 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 12.2 p -90.85 5.38 48.7 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.477 -0.783 . . . . 65.340000000000003 111.502 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -103.33 129.6 50.41 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.084 -0.507 . . . . 74.150000000000006 109.958 -176.55 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.2 p -98.58 127.19 51.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.706 -0.679 . . . . 70.049999999999997 111.408 -176.086 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 33.5 m -96.67 123.45 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-O 121.403 0.62 . . . . 72.340000000000003 110.618 178.121 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.95 128.99 43.27 Favored 'Isoleucine or valine' 0 C--O 1.256 1.435 0 N-CA-C 107.994 -1.113 . . . . 73.239999999999995 107.994 176.844 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . 0.452 HG12 HG23 ' A' ' 470' ' ' THR . 42.2 mt -119.72 119.59 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 CA-C-N 114.996 -1.002 . . . . 72.230000000000004 110.269 -175.692 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 5.8 tt -103.03 127.12 57.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 115.295 -0.866 . . . . 73.530000000000001 111.176 -178.513 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 1.9 p -107.93 136.21 44.09 Favored 'Isoleucine or valine' 0 C--O 1.256 1.403 0 CA-C-N 115.361 -0.836 . . . . 74.430000000000007 108.973 176.05 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -73.53 127.95 11.0 Favored Glycine 0 N--CA 1.419 -2.483 0 N-CA-C 110.619 -0.993 . . . . 71.209999999999994 110.619 179.328 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.669 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 14.4 t -115.88 158.56 22.79 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 106.907 -1.516 . . . . 73.310000000000002 106.907 178.345 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -171.57 84.25 0.08 OUTLIER Glycine 0 N--CA 1.431 -1.649 0 N-CA-C 110.417 -1.073 . . . . 75.299999999999997 110.417 -179.806 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -69.89 113.04 3.26 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.059 1.839 . . . . 74.5 110.897 -178.128 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . -84.86 52.78 2.51 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.997 -0.742 . . . . 54.399999999999999 108.997 179.888 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 24.3 p -116.5 148.14 41.08 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 115.231 -0.895 . . . . 74.019999999999996 110.423 -174.234 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -145.45 155.06 42.89 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 108.138 -1.06 . . . . 74.450000000000003 108.138 178.353 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -89.82 122.9 33.32 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.638 -0.505 . . . . 65.0 109.638 -177.565 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 37.0 pt -79.55 136.29 55.95 Favored Pre-proline 0 C--N 1.307 -1.264 0 O-C-N 123.271 0.357 . . . . 73.540000000000006 111.341 -179.433 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -85.18 -174.32 1.66 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.643 2.229 . . . . 75.239999999999995 110.266 174.719 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -92.59 147.17 23.1 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.376 -0.601 . . . . 64.120000000000005 109.376 179.83 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 41.2 t -129.28 93.86 2.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 107.314 -1.365 . . . . 70.299999999999997 107.314 178.6 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -148.22 112.9 5.37 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 107.223 -1.399 . . . . 74.340000000000003 107.223 179.566 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 110.24 36.35 1.97 Allowed Glycine 0 N--CA 1.421 -2.314 0 N-CA-C 110.172 -1.171 . . . . 74.109999999999999 110.172 -178.016 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -143.1 166.79 23.7 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 108.33 -0.989 . . . . 75.299999999999997 108.33 178.651 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 532' ' ' GLY . 11.8 t -93.32 157.43 16.25 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.043 -1.465 . . . . 74.510000000000005 107.043 173.869 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 10.5 p -55.37 -40.43 57.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 112.235 0.457 . . . . 74.510000000000005 112.235 -178.599 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -58.32 -42.82 87.59 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.496 0.665 . . . . 74.019999999999996 110.949 179.503 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 99.6 t -76.37 -36.73 29.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.641 -0.708 . . . . 74.450000000000003 110.107 -179.219 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -61.35 -49.21 77.86 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.762 -0.654 . . . . 73.420000000000002 111.229 178.856 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -63.21 -37.19 86.26 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 120.485 -0.486 . . . . 72.400000000000006 110.32 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -62.64 -45.7 91.61 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.11 -0.7 . . . . 75.319999999999993 109.11 179.442 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -62.16 -48.66 79.07 Favored 'General case' 0 CA--C 1.494 -1.197 0 O-C-N 123.107 0.254 . . . . 63.100000000000001 111.291 179.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.77 -40.5 97.49 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 112.261 0.467 . . . . 73.439999999999998 112.261 -179.073 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -65.48 -37.98 88.42 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 120.718 -0.393 . . . . 72.519999999999996 110.99 179.146 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 68.7 t -68.92 -26.87 33.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.07 0.462 . . . . 72.299999999999997 110.741 176.755 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 17.4 m-30 -81.33 -1.78 46.59 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.262 -0.575 . . . . 75.25 110.14 178.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . 0.532 ' O ' ' HB ' ' A' ' 547' ' ' VAL . . . 101.78 -4.92 53.57 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.925 -0.655 . . . . 71.120000000000005 113.318 176.08 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -83.85 112.81 20.46 Favored 'General case' 0 CA--C 1.476 -1.899 0 N-CA-C 106.548 -1.649 . . . . 70.420000000000002 106.548 -177.541 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.3 m -89.19 -25.42 21.79 Favored 'General case' 0 N--CA 1.406 -2.656 0 CA-C-N 115.033 -0.985 . . . . 74.310000000000002 112.651 -167.66 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 96.8 mttt -116.15 125.06 51.82 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 120.117 -0.633 . . . . 74.430000000000007 111.035 -177.207 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -129.73 153.14 48.48 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 123.37 0.668 . . . . 74.420000000000002 109.909 -179.437 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 50.5 m -141.09 147.25 38.24 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 108.253 -1.017 . . . . 62.109999999999999 108.253 174.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -116.76 130.9 57.0 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-O 121.229 0.537 . . . . 74.420000000000002 110.417 179.81 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -105.34 119.79 39.95 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 107.68 -1.23 . . . . 71.319999999999993 107.68 176.149 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 42.3 m -90.0 121.27 31.93 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.271 0.558 . . . . 74.519999999999996 110.31 -178.423 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 26.9 m -121.77 153.64 25.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.427 -0.953 . . . . 60.100000000000001 108.427 178.345 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . 0.436 ' C ' ' HG ' ' A' ' 527' ' ' SER . 1.1 p-10 -89.04 136.44 33.01 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.036 -1.098 . . . . 73.319999999999993 108.036 178.135 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 527' ' ' SER . . . . . 0.436 ' HG ' ' C ' ' A' ' 526' ' ' ASP . 19.7 m -153.48 166.97 14.47 Favored Pre-proline 0 C--N 1.292 -1.912 0 N-CA-C 108.575 -0.898 . . . . 73.310000000000002 108.575 179.618 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -73.6 -3.71 14.19 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 121.775 1.65 . . . . 64.219999999999999 112.132 175.602 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . 0.447 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 2.1 mpt_? -85.21 134.57 40.51 Favored Pre-proline 0 CA--C 1.515 -0.396 0 N-CA-C 108.093 -1.077 . . . . 75.430000000000007 108.093 179.476 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -56.23 143.95 83.2 Favored 'Trans proline' 0 C--O 1.242 0.724 0 C-N-CA 123.064 2.51 . . . . 64.319999999999993 113.723 -175.512 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -53.18 125.6 18.05 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 114.615 -1.175 . . . . 72.299999999999997 112.629 -174.801 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 504' ' ' THR . . . 114.41 -16.31 19.63 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.482 -0.781 . . . . 51.43 111.294 178.124 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -74.33 125.73 29.13 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.674 -0.491 . . . . 64.519999999999996 109.674 179.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 53.3 t -82.78 112.01 19.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.1 -1.444 . . . . 75.120000000000005 107.1 176.222 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 15.0 t -80.5 -18.51 48.37 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.755 -0.657 . . . . 75.430000000000007 111.114 -175.778 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 163.81 -170.0 38.96 Favored Glycine 0 CA--C 1.495 -1.182 0 C-N-CA 119.94 -1.124 . . . . 73.140000000000001 111.828 178.514 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 65.0 p -117.31 153.86 32.24 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.183 -1.043 . . . . 71.420000000000002 108.183 -179.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . 0.502 ' CA ' HE22 ' A' ' 554' ' ' GLN . 34.5 t30 -77.25 -53.87 1.59 Allowed Pre-proline 0 C--N 1.314 -0.948 0 C-N-CA 120.116 -0.633 . . . . 74.420000000000002 110.565 177.813 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -70.63 126.94 13.25 Favored 'Trans proline' 0 C--N 1.357 0.993 0 N-CA-C 107.739 -1.677 . . . . 74.420000000000002 107.739 167.707 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.88 156.57 63.62 Favored 'Trans proline' 0 C--O 1.247 0.974 0 C-N-CA 122.499 2.132 . . . . 74.510000000000005 113.358 -175.348 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.09 138.71 58.43 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.661 -0.7 . . . . 64.540000000000006 109.914 178.423 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 98.12 -6.34 61.76 Favored Glycine 0 N--CA 1.433 -1.554 0 C-N-CA 120.261 -0.971 . . . . 71.439999999999998 112.088 -178.778 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 59.0 m -76.23 132.96 40.21 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 109.392 -0.595 . . . . 74.219999999999999 109.392 176.803 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 5.0 m -95.11 122.02 37.34 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 107.745 -1.205 . . . . 74.129999999999995 107.745 179.294 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 24.3 m -138.16 156.23 73.95 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 109.895 -0.409 . . . . 75.0 109.895 -178.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 37.5 Cg_exo -63.6 139.94 72.54 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.114 1.876 . . . . 75.5 111.375 175.417 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.532 ' HB ' ' O ' ' A' ' 516' ' ' GLY . 30.8 m -64.57 -20.31 26.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 121.841 0.829 . . . . 74.439999999999998 111.912 -179.746 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -77.88 -18.0 56.7 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.04 -0.982 . . . . 72.140000000000001 110.628 178.816 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 24.6 m -77.76 179.06 6.88 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 112.841 0.682 . . . . 75.209999999999994 112.841 -174.977 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 39.1 t -105.78 124.91 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 CA-C-N 115.108 -0.951 . . . . 74.420000000000002 109.644 -176.666 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . 0.413 HD11 ' O ' ' A' ' 519' ' ' LYS . 0.2 OUTLIER -104.87 135.87 40.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.96 -0.756 . . . . 75.430000000000007 108.96 173.43 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -106.85 119.71 40.08 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 116.02 -0.536 . . . . 62.229999999999997 111.21 -176.103 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -101.77 134.12 45.44 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.664 -1.153 . . . . 74.25 109.444 179.814 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . 0.502 HE22 ' CA ' ' A' ' 538' ' ' ASN . 2.0 mp0 -93.74 122.44 36.21 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.074 0.464 . . . . 75.120000000000005 109.844 175.659 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 50.3 t -112.58 130.37 66.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 107.95 -1.13 . . . . 73.420000000000002 107.95 -178.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 74.6 m -88.15 137.28 32.47 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-O 121.667 0.746 . . . . 63.329999999999998 112.318 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.429 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 4.1 ptpt -90.75 147.7 23.06 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 103.986 -2.598 . . . . 75.439999999999998 103.986 169.925 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . 0.457 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -83.25 -24.9 50.15 Favored Glycine 0 CA--C 1.479 -2.158 0 C-N-CA 120.318 -0.944 . . . . 75.409999999999997 113.57 -171.08 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . 0.43 ' O ' ' HA ' ' A' ' 615' ' ' ASN . 88.0 m-20 72.06 -44.03 0.58 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.578 1.151 . . . . 74.239999999999995 111.183 -177.283 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.457 ' H ' ' C ' ' A' ' 558' ' ' GLY . 97.5 mt-30 -119.81 141.73 49.24 Favored 'General case' 0 N--CA 1.424 -1.766 0 C-N-CA 123.548 0.739 . . . . 73.439999999999998 111.432 -175.767 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . 0.434 ' O ' ' HA2' ' A' ' 613' ' ' GLY . 45.4 p90 -126.99 149.74 49.74 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.489 -0.56 . . . . 74.310000000000002 109.489 178.46 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 99.8 t -59.49 120.3 5.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.06 0.457 . . . . 74.010000000000005 111.881 -177.945 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 57.1 ttp -97.09 137.09 21.25 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 116.031 -0.532 . . . . 62.329999999999998 111.19 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -68.68 170.28 15.59 Favored 'Trans proline' 0 CA--C 1.551 1.332 0 C-N-CA 123.5 2.8 . . . . 74.219999999999999 112.684 174.162 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.18 129.47 40.0 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 112.669 0.618 . . . . 63.109999999999999 112.669 179.385 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . 0.439 ' O ' ' HG2' ' A' ' 569' ' ' MET . 95.3 mt -114.74 12.38 17.04 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 122.271 1.034 . . . . 75.420000000000002 108.409 175.865 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 20.3 m -79.58 144.52 33.79 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.847 -1.069 . . . . 73.349999999999994 110.886 -178.863 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 80.62 9.62 86.19 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 114.616 0.606 . . . . 63.439999999999998 114.616 175.285 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 569' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 26.5 ptm -112.44 164.05 13.73 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 117.427 0.614 . . . . 74.049999999999997 109.502 -179.006 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -103.98 163.97 12.02 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.487 0.661 . . . . 71.140000000000001 111.291 -177.281 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 19.6 t90 -62.07 -29.66 70.46 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 125.073 1.349 . . . . 72.109999999999999 109.488 176.422 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 34.3 m -71.29 -15.12 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 115.845 -0.616 . . . . 74.409999999999997 110.771 177.531 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -96.9 -34.84 11.1 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.336 -0.987 . . . . 72.310000000000002 108.336 175.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -60.86 -41.53 96.08 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.8 -1.091 . . . . 63.43 112.188 -178.259 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.485 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 38.7 mt-10 -59.73 -54.54 54.67 Favored Pre-proline 0 CA--C 1.554 1.127 0 N-CA-C 112.928 0.714 . . . . 73.340000000000003 112.928 -179.705 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . 0.421 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 52.2 Cg_exo -59.58 -37.04 90.93 Favored 'Trans proline' 0 C--N 1.369 1.615 0 C-N-CA 121.388 1.392 . . . . 74.439999999999998 112.249 174.781 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -59.11 -47.88 83.65 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.347 0.659 . . . . 74.239999999999995 110.451 177.894 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.6 pp -67.16 -41.01 86.72 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.151 0.426 . . . . 73.040000000000006 112.151 -175.853 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -65.35 -40.03 93.1 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.571 -0.74 . . . . 75.420000000000002 110.968 -179.744 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.19 -38.34 87.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.611 -0.722 . . . . 64.239999999999995 112.025 -178.201 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.26 -8.51 48.17 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.676 0.621 . . . . 74.0 112.676 -178.851 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 68.09 40.37 88.36 Favored Glycine 0 C--N 1.311 -0.822 0 C-N-CA 119.927 -1.13 . . . . 74.420000000000002 110.567 -175.669 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 83.2 t90 -82.25 135.33 35.25 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.469 -0.567 . . . . 74.239999999999995 109.469 179.113 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 9.0 t -148.06 87.58 1.62 Allowed 'General case' 0 N--CA 1.418 -2.042 0 CA-C-O 122.754 1.264 . . . . 73.109999999999999 111.045 175.762 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -123.76 -109.74 1.9 Allowed Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 109.094 -1.602 . . . . 72.329999999999998 109.094 177.867 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 69.7 mtp -137.27 124.15 21.33 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 120.714 -0.394 . . . . 75.140000000000001 111.99 176.78 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -87.39 121.58 30.02 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 103.073 -2.936 . . . . 71.109999999999999 103.073 166.251 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -122.3 111.54 17.03 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 119.362 -0.935 . . . . 74.109999999999999 113.15 -168.709 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . 0.488 ' HD3' ' O ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -113.33 110.24 20.02 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 109.412 -0.588 . . . . 75.140000000000001 109.412 170.853 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -90.48 -55.65 1.9 Allowed Glycine 0 CA--C 1.492 -1.352 0 C-N-CA 120.628 -0.796 . . . . 71.430000000000007 111.867 -178.214 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -127.42 134.62 49.87 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 109.817 -0.438 . . . . 74.219999999999999 109.817 -179.277 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -86.8 123.01 31.48 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 105.683 -1.969 . . . . 55.32 105.683 174.731 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 88.0 t -132.72 126.32 54.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.066 0.46 . . . . 74.129999999999995 111.343 -174.388 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . 0.542 ' HA ' ' NE2' ' A' ' 600' ' ' HIS . 21.5 t70 -83.14 110.68 18.24 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 109.067 -0.716 . . . . 64.239999999999995 109.067 175.628 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -131.32 2.14 4.2 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 120.988 0.423 . . . . 70.219999999999999 111.897 -179.608 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 111.81 155.99 13.3 Favored Glycine 0 CA--C 1.499 -0.954 0 N-CA-C 110.798 -0.921 . . . . 44.200000000000003 110.798 179.574 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -55.56 -37.06 65.99 Favored Glycine 0 N--CA 1.464 0.541 0 N-CA-C 114.418 0.527 . . . . 73.439999999999998 114.418 -171.614 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 23.6 m -64.81 -23.55 67.27 Favored 'General case' 0 CA--C 1.552 1.058 0 CA-C-O 120.943 0.402 . . . . 61.130000000000003 111.956 178.832 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -99.43 -13.07 19.7 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 121.968 -0.458 . . . . 75.420000000000002 111.308 -179.118 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . 0.542 ' NE2' ' HA ' ' A' ' 594' ' ' ASP . 12.0 m170 -85.66 137.21 32.99 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 109.518 -0.549 . . . . 65.230000000000004 109.518 -178.164 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 65.82 -11.11 0.2 Allowed 'General case' 0 C--O 1.206 -1.214 0 C-N-CA 124.505 1.122 . . . . 75.439999999999998 113.374 -175.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . 0.455 ' HD2' ' O ' ' A' ' 603' ' ' VAL . 3.3 tmm_? -86.68 138.37 31.71 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.417 -0.957 . . . . 74.400000000000006 108.417 -175.78 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . 0.455 ' O ' ' HD2' ' A' ' 602' ' ' ARG . 97.7 t -74.73 129.29 36.8 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 108.164 -1.05 . . . . 72.540000000000006 108.164 -179.889 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 68.9 t -84.97 -51.57 13.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 109.717 -0.475 . . . . 73.120000000000005 109.717 -172.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -147.09 157.96 43.78 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 107.647 -1.242 . . . . 74.239999999999995 107.647 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -113.43 120.88 42.56 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 106.407 -1.701 . . . . 63.149999999999999 106.407 174.077 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.434 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 51.2 t30 -52.75 -52.91 60.01 Favored Pre-proline 0 N--CA 1.477 0.876 0 N-CA-C 112.979 0.733 . . . . 64.25 112.979 -177.141 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.434 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 3.0 Cg_exo -83.69 119.26 2.57 Favored 'Trans proline' 0 C--O 1.253 1.245 0 C-N-CA 121.118 1.212 . . . . 73.219999999999999 109.425 171.073 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.97 145.46 89.99 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 122.609 2.206 . . . . 72.049999999999997 112.219 -178.443 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.68 131.41 45.53 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.695 -0.684 . . . . 75.420000000000002 109.219 178.216 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.67 -19.61 38.55 Favored Glycine 0 C--N 1.296 -1.674 0 N-CA-C 110.082 -1.207 . . . . 73.0 110.082 -173.416 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 27.8 m -91.06 158.53 16.62 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.911 -1.144 . . . . 74.430000000000007 107.911 176.562 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 561' ' ' PHE . . . -84.3 132.78 11.31 Favored Glycine 0 N--CA 1.419 -2.458 0 C-N-CA 121.527 -0.368 . . . . 75.219999999999999 112.238 -179.879 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 34.2 m -113.98 142.42 26.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 C-N-CA 123.67 0.788 . . . . 72.230000000000004 109.541 177.007 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . 0.521 ' ND2' ' HB2' ' A' ' 617' ' ' ASP . 26.5 p-10 -52.66 162.02 0.64 Allowed 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 124.078 0.951 . . . . 74.299999999999997 112.98 177.65 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -58.41 -25.13 61.78 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 112.702 0.63 . . . . 73.319999999999993 112.702 177.406 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . 0.521 ' HB2' ' ND2' ' A' ' 615' ' ' ASN . 19.6 m-20 -70.53 -28.51 64.99 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.98 -0.554 . . . . 75.239999999999995 109.745 177.108 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 74.22 21.01 79.55 Favored Glycine 0 N--CA 1.432 -1.608 0 CA-C-N 115.689 -0.687 . . . . 63.439999999999998 112.488 177.401 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.83 118.83 13.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 122.322 1.058 . . . . 75.200000000000003 109.994 -169.963 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . 0.467 ' O ' HD13 ' A' ' 620' ' ' ILE . 2.8 pp -125.94 133.4 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.385 0 CA-C-N 114.218 -1.355 . . . . 74.409999999999997 109.702 -178.038 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 83.4 m -98.38 120.39 38.71 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 109.087 -0.709 . . . . 70.439999999999998 109.087 176.464 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.7 pp -119.82 165.94 13.93 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.669 -1.151 . . . . 72.420000000000002 109.065 -179.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -146.55 146.95 30.65 Favored 'General case' 0 C--N 1.269 -2.9 0 N-CA-C 106.364 -1.717 . . . . 73.299999999999997 106.364 177.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -138.79 165.53 26.77 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 105.691 -1.966 . . . . 74.200000000000003 105.691 175.581 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -66.12 -95.35 0.03 OUTLIER Glycine 0 C--N 1.313 -0.701 0 C-N-CA 120.112 -1.042 . . . . 64.349999999999994 111.372 178.865 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . 0.422 ' HB3' ' CE1' ' A' ' 600' ' ' HIS . 8.9 tt0 . . . . . 0 C--N 1.292 -1.897 0 N-CA-C 108.447 -0.945 . . . . 73.340000000000003 108.447 173.223 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.937 0 N-CA-C 110.077 -1.209 . . . . 71.409999999999997 110.077 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 7.0 tp -75.03 115.27 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.943 0 CA-C-O 122.375 1.083 . . . . 74.310000000000002 112.61 -179.125 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 7.4 m -116.89 151.91 35.61 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 103.933 -2.617 . . . . 73.439999999999998 103.933 173.605 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 64.9 mtp180 -80.84 48.79 1.12 Allowed 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 119.089 0.859 . . . . 73.409999999999997 112.432 -176.357 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -105.11 148.53 26.74 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 105.848 -1.908 . . . . 73.209999999999994 105.848 175.536 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.7 m -125.83 161.44 30.98 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.48 0 N-CA-C 109.422 -0.584 . . . . 74.310000000000002 109.422 -177.19 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -94.12 137.95 32.73 Favored 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 105.489 -2.041 . . . . 73.299999999999997 105.489 176.534 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.471 HG12 ' CE2' ' A' ' 382' ' ' PHE . 91.0 t -95.12 126.14 47.66 Favored Pre-proline 0 C--N 1.278 -2.542 0 N-CA-C 109.711 -0.477 . . . . 65.209999999999994 109.711 -166.34 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -62.22 123.49 12.6 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 122.095 1.864 . . . . 65.140000000000001 111.232 -178.495 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -81.64 143.2 32.08 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 107.713 -1.217 . . . . 72.209999999999994 107.713 179.974 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.435 HG13 ' HB2' ' A' ' 373' ' ' ALA . 7.1 p -126.93 18.02 3.51 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.699 0 CA-C-O 122.605 1.193 . . . . 63.5 110.595 -170.129 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.16 146.83 53.59 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.309 -1.314 . . . . 74.150000000000006 113.132 -179.289 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.02 0.5 41.67 Favored Glycine 0 CA--C 1.502 -0.744 0 CA-C-N 115.943 -0.571 . . . . 74.430000000000007 112.794 179.094 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -115.0 -158.48 0.67 Allowed 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 107.966 -1.124 . . . . 75.310000000000002 107.966 175.705 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 70.6 p -91.35 155.77 18.25 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 108.135 -1.061 . . . . 72.030000000000001 108.135 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 23.2 m -63.0 -33.99 76.6 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 120.688 0.28 . . . . 64.439999999999998 110.674 -179.029 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.9 -46.54 74.56 Favored 'General case' 0 C--O 1.212 -0.892 0 CA-C-O 119.435 -0.317 . . . . 74.349999999999994 111.051 178.807 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -69.12 -43.1 75.11 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-O 121.164 0.507 . . . . 75.219999999999999 110.579 179.659 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . 0.435 ' HB2' HG13 ' A' ' 365' ' ' VAL . . . -63.32 -49.11 75.27 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.371 -0.831 . . . . 64.319999999999993 111.728 -178.108 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.15 -38.1 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-N 116.52 -0.309 . . . . 73.239999999999995 110.834 179.322 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -60.64 -47.08 87.82 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.828 0.347 . . . . 64.549999999999997 110.885 178.839 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 60.0 m -60.91 -46.88 88.88 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.258 0.551 . . . . 75.420000000000002 110.215 179.678 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 7.6 tt -63.4 -38.87 92.83 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 115.546 -0.752 . . . . 62.509999999999998 110.752 -179.265 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -63.88 -40.37 96.38 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.135 0.574 . . . . 71.329999999999998 109.826 177.624 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -70.25 -17.61 63.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.166 0.508 . . . . 75.439999999999998 112.024 178.181 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -84.33 -14.72 48.86 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.077 0.465 . . . . 73.340000000000003 110.18 174.397 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 96.37 8.13 57.74 Favored Glycine 0 N--CA 1.435 -1.426 0 C-N-CA 120.586 -0.816 . . . . 71.120000000000005 112.728 175.822 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.471 ' CE2' HG12 ' A' ' 362' ' ' VAL . 66.4 m-85 -80.69 169.13 18.03 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-O 120.768 0.318 . . . . 64.319999999999993 110.688 178.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -112.44 150.24 31.46 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.17 -1.048 . . . . 74.010000000000005 108.17 -179.099 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.76 149.13 33.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 CA-C-O 121.572 0.701 . . . . 73.25 112.035 177.181 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.72 139.7 45.77 Favored 'General case' 0 N--CA 1.4 -2.954 0 N-CA-C 103.444 -2.798 . . . . 75.430000000000007 103.444 169.797 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 52.0 m -133.76 119.14 18.89 Favored 'General case' 0 C--N 1.252 -3.649 0 N-CA-C 108.468 -0.938 . . . . 63.340000000000003 108.468 -175.011 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -110.95 119.36 38.82 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.159 -0.682 . . . . 73.409999999999997 109.159 -179.664 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.465 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -102.08 120.78 40.99 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 107.054 -1.461 . . . . 74.439999999999998 107.054 176.485 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 421' ' ' SER . 55.8 mtmt -139.29 140.96 27.6 Favored Pre-proline 0 C--N 1.285 -2.198 0 CA-C-N 115.834 -0.621 . . . . 74.030000000000001 109.789 -175.755 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' A' ' 422' ' ' THR . 24.1 Cg_exo -69.14 174.31 9.15 Favored 'Trans proline' 0 C--O 1.246 0.911 0 C-N-CA 121.972 1.781 . . . . 74.109999999999999 110.016 169.286 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 90.15 173.74 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.768 1.627 . . . . 72.519999999999996 111.471 -179.2 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.407 ' N ' ' HG3' ' A' ' 425' ' ' GLU . 38.6 m -119.53 13.48 12.58 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.642 0.734 . . . . 75.530000000000001 109.384 -176.818 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 10.7 m -78.02 -15.73 58.68 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 122.297 1.046 . . . . 74.219999999999999 109.45 -179.726 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . 0.584 HG12 ' OG ' ' A' ' 421' ' ' SER . 0.1 OUTLIER -113.69 151.82 44.96 Favored Pre-proline 0 N--CA 1.42 -1.938 0 CA-C-N 114.54 -1.209 . . . . 74.319999999999993 108.975 179.339 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.31 158.0 2.79 Favored 'Trans proline' 0 CA--C 1.554 1.483 0 C-N-CA 124.756 3.637 . . . . 74.349999999999994 115.854 -175.487 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.13 161.41 8.89 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 123.967 3.111 . . . . 75.439999999999998 112.716 178.339 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . 0.414 ' HA ' HG23 ' A' ' 420' ' ' VAL . 6.6 p-10 -58.99 -9.42 1.88 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.889 0.876 . . . . 74.030000000000001 113.324 -176.867 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 59.6 m170 -114.51 145.99 41.25 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.265 -1.384 . . . . 70.450000000000003 107.265 177.016 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 30.6 m -72.28 118.95 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 N-CA-C 112.9 0.704 . . . . 73.439999999999998 112.9 -167.817 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . 0.432 ' O ' HD13 ' A' ' 400' ' ' ILE . 0.0 OUTLIER -97.97 -29.02 3.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 106.613 -1.625 . . . . 75.010000000000005 106.613 176.275 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.7 163.16 28.56 Favored Glycine 0 N--CA 1.409 -3.13 0 CA-C-N 114.808 -1.087 . . . . 73.239999999999995 110.446 -178.055 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.8 p -119.55 -176.56 3.18 Favored 'General case' 0 C--N 1.282 -2.331 0 C-N-CA 124.832 1.253 . . . . 71.540000000000006 109.265 179.101 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . 0.483 ' HB2' ' O ' ' A' ' 417' ' ' THR . 20.2 t70 -99.4 134.78 20.97 Favored Pre-proline 0 C--N 1.299 -1.612 0 N-CA-C 108.814 -0.81 . . . . 74.150000000000006 108.814 -174.581 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.24 -17.1 7.92 Favored 'Trans proline' 0 C--N 1.363 1.318 0 C-N-CA 124.335 3.357 . . . . 74.129999999999995 115.134 -176.389 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -61.0 -32.99 72.56 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.967 -0.383 . . . . 75.450000000000003 109.967 177.062 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . 0.444 ' HA ' ' HB ' ' A' ' 362' ' ' VAL . . . -72.75 -30.91 64.53 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.663 0.744 . . . . 54.020000000000003 110.052 179.256 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -81.0 -10.79 59.67 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.345 -0.843 . . . . 73.439999999999998 109.843 -178.722 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 40.0 m -96.5 150.09 21.01 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.928 -1.508 . . . . 63.350000000000001 106.928 175.727 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 23.2 m -81.28 111.99 18.18 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 107.964 -1.125 . . . . 54.200000000000003 107.964 176.795 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.3 m -123.75 169.29 15.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-O 120.967 0.413 . . . . 65.510000000000005 110.587 -178.544 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 15.7 m -65.88 136.9 56.76 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.966 -0.753 . . . . 73.25 108.966 178.133 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -67.07 114.23 5.68 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.556 0.693 . . . . 75.209999999999994 111.223 -174.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 110.06 40.3 1.43 Allowed Glycine 0 N--CA 1.423 -2.193 0 CA-C-N 115.032 -0.985 . . . . 72.120000000000005 111.667 -179.798 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -114.53 -176.62 2.94 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.538 -0.465 . . . . 74.209999999999994 109.856 -179.015 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -87.21 119.51 27.52 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 123.842 0.857 . . . . 52.340000000000003 111.651 -167.619 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 38.8 mm -112.28 121.49 64.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 107.902 -1.147 . . . . 65.400000000000006 107.902 174.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 417' ' ' THR . . . . . 0.483 ' O ' ' HB2' ' A' ' 403' ' ' ASP . 35.5 m -93.05 129.32 39.03 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 113.348 0.87 . . . . 72.409999999999997 113.348 -173.98 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 4.2 p -124.42 135.84 62.47 Favored 'Isoleucine or valine' 0 C--O 1.247 0.934 0 CA-C-N 116.237 -0.438 . . . . 73.530000000000001 110.34 179.773 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -107.35 128.57 54.57 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.503 -0.317 . . . . 62.5 110.168 178.321 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.414 HG23 ' HA ' ' A' ' 397' ' ' ASP . 7.5 p -123.81 131.49 72.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 109.285 -0.635 . . . . 63.100000000000001 109.285 177.382 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 421' ' ' SER . . . . . 0.584 ' OG ' HG12 ' A' ' 394' ' ' ILE . 43.4 m -95.83 122.9 39.11 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.544 0.687 . . . . 62.32 112.12 -177.208 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 422' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 390' ' ' PRO . 6.0 t -119.49 106.99 12.77 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.392 -0.822 . . . . 74.120000000000005 109.993 175.525 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 103.22 90.98 2.18 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 120.318 -0.944 . . . . 74.0 113.134 179.041 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.02 158.08 26.75 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 123.831 3.02 . . . . 43.43 113.075 179.463 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.407 ' HG3' ' N ' ' A' ' 392' ' ' SER . 46.0 mt-10 -72.02 144.16 48.9 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 122.126 0.965 . . . . 74.329999999999998 113.063 -175.939 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -116.79 151.82 35.69 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 113.382 -1.735 . . . . 74.140000000000001 106.965 179.584 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.494 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 5.4 mmp_? -122.71 154.81 37.61 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 120.982 0.42 . . . . 74.549999999999997 110.847 176.337 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -83.57 138.99 33.13 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 115.292 -0.867 . . . . 75.530000000000001 110.117 -175.829 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.421 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 60.4 mt -86.39 127.49 60.85 Favored Pre-proline 0 N--CA 1.425 -1.695 0 N-CA-C 107.085 -1.45 . . . . 73.150000000000006 107.085 176.048 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.42 ' HG2' ' HB3' ' A' ' 443' ' ' LYS . 12.1 Cg_exo -70.19 151.16 66.49 Favored 'Trans proline' 0 C--O 1.239 0.527 0 C-N-CA 122.08 1.853 . . . . 74.150000000000006 110.918 176.157 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -69.19 137.73 53.51 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 107.868 -1.16 . . . . 71.540000000000006 107.868 178.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 2.4 p -116.97 111.27 34.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 C-N-CA 120.306 -0.557 . . . . 75.129999999999995 112.206 -176.462 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 1.8 p -65.63 139.52 58.43 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 107.265 -1.383 . . . . 75.129999999999995 107.265 171.622 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 434' ' ' THR . . . . . 0.518 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 62.7 p -63.28 -30.87 71.93 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 113.767 1.025 . . . . 73.329999999999998 113.767 -164.117 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.42 -11.1 41.46 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 115.867 -0.606 . . . . 65.049999999999997 111.767 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.4 m -105.66 45.75 0.95 Allowed 'General case' 0 CA--C 1.573 1.841 0 CA-C-O 122.462 1.125 . . . . 75.010000000000005 110.788 -173.158 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -58.58 -38.2 77.39 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.955 -1.021 . . . . 75.409999999999997 113.27 177.037 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -62.52 -36.52 82.85 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 118.508 0.595 . . . . 62.109999999999999 110.657 179.397 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -62.66 -39.41 93.83 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.729 -0.841 . . . . 74.530000000000001 108.729 175.645 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.405 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -63.82 -42.97 97.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.04 -0.527 . . . . 64.140000000000001 110.343 178.038 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 78.5 t -58.28 -48.95 83.48 Favored 'Isoleucine or valine' 0 C--O 1.256 1.443 0 CA-C-N 115.998 -0.547 . . . . 64.030000000000001 111.034 -179.114 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -67.67 -40.85 84.42 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.134 -0.626 . . . . 74.25 110.804 -177.858 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . 0.42 ' HB3' ' HG2' ' A' ' 430' ' ' PRO . 27.5 mmtp -66.45 -40.87 89.66 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.622 -0.717 . . . . 73.150000000000006 112.032 -177.517 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.405 HD13 ' O ' ' A' ' 440' ' ' ALA . 8.2 mp -63.67 -38.46 91.19 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.25 0.344 . . . . 75.439999999999998 110.159 175.879 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.42 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 98.3 m -64.08 -47.49 79.9 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 120.984 0.421 . . . . 71.439999999999998 110.972 179.225 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.49 -15.65 62.32 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.167 -0.469 . . . . 72.140000000000001 112.11 -179.598 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -85.54 5.34 31.89 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.035 0.445 . . . . 64.409999999999997 111.724 179.699 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 104.56 -66.97 0.29 Allowed Glycine 0 CA--C 1.497 -1.045 0 C-N-CA 120.139 -1.029 . . . . 64.010000000000005 112.406 175.212 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 480' ' ' ILE . 1.3 p90 -49.65 -61.44 2.11 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 113.193 0.812 . . . . 74.239999999999995 113.193 177.627 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . 0.42 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 57.94 25.12 55.92 Favored Glycine 0 CA--C 1.504 -0.611 0 O-C-N 123.056 0.222 . . . . 70.219999999999999 113.301 -179.923 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 62.7 mtt180 -106.63 113.72 27.39 Favored 'General case' 0 N--CA 1.419 -2.017 0 N-CA-C 108.989 -0.745 . . . . 75.010000000000005 108.989 -178.042 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 43.2 p90 -137.8 151.8 48.49 Favored 'General case' 0 C--N 1.279 -2.459 0 CA-C-N 115.192 -0.913 . . . . 74.049999999999997 110.012 -175.756 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -142.39 122.85 14.03 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.124 -0.944 . . . . 74.430000000000007 110.189 176.663 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -93.95 125.57 38.65 Favored 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 123.778 0.831 . . . . 75.120000000000005 109.654 178.626 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -119.18 147.15 44.54 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.99 -1.115 . . . . 72.540000000000006 107.99 175.314 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 488' ' ' VAL . 11.5 m120 -120.61 133.49 55.37 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 120.855 0.359 . . . . 75.420000000000002 111.365 -179.869 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 27.3 t -135.79 139.45 30.72 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 108.979 -0.749 . . . . 72.310000000000002 108.979 179.704 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.624 ' HA ' ' O ' ' A' ' 490' ' ' SER . 32.9 Cg_endo -65.94 127.39 17.63 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.292 1.994 . . . . 72.519999999999996 110.977 177.495 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 69.5 m -147.76 179.47 7.68 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 122.912 0.485 . . . . 75.519999999999996 109.945 -179.7 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 460' ' ' THR . . . . . 0.468 ' O ' HG22 ' A' ' 464' ' ' VAL . 5.2 t -50.23 139.29 19.09 Favored Pre-proline 0 C--O 1.248 0.986 0 C-N-CA 125.125 1.37 . . . . 73.209999999999994 111.753 178.223 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.33 -29.8 31.62 Favored 'Trans proline' 0 C--N 1.36 1.132 0 C-N-CA 124.644 3.563 . . . . 74.140000000000001 113.45 -177.439 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -72.92 -25.12 60.93 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.293 0.479 . . . . 75.319999999999993 112.293 -178.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -104.13 -5.38 22.07 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.879 0.371 . . . . 70.239999999999995 111.488 177.427 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 460' ' ' THR . 54.0 t -60.36 127.75 20.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.19 -0.459 . . . . 74.340000000000003 110.025 177.117 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 90.02 0.5 77.61 Favored Glycine 0 N--CA 1.422 -2.236 0 C-N-CA 121.037 -0.602 . . . . 61.520000000000003 112.534 179.001 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.12 163.18 28.23 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 119.604 -0.838 . . . . 70.519999999999996 111.213 -179.813 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.518 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 67.7 t -67.01 133.42 31.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 114.711 -1.131 . . . . 74.140000000000001 111.216 -177.088 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 53.8 mt -98.3 -24.28 4.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.226 -1.027 . . . . 75.140000000000001 108.226 179.15 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 165.33 169.62 29.19 Favored Glycine 0 N--CA 1.427 -1.907 0 CA-C-N 115.471 -0.786 . . . . 73.420000000000002 112.65 177.317 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 1.7 t -116.89 137.94 51.87 Favored 'General case' 0 N--CA 1.406 -2.66 0 N-CA-C 106.341 -1.726 . . . . 71.450000000000003 106.341 174.783 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.453 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 49.0 t30 -65.52 -53.44 37.73 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 119.822 -0.751 . . . . 64.140000000000001 111.055 179.523 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.453 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 9.7 Cg_exo -74.84 122.43 7.27 Favored 'Trans proline' 0 C--N 1.366 1.497 0 N-CA-C 107.195 -1.887 . . . . 51.439999999999998 107.195 170.811 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . 0.514 ' C ' ' H ' ' A' ' 475' ' ' ASN . 26.9 Cg_exo -62.61 139.26 74.69 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 121.743 1.629 . . . . 73.209999999999994 112.565 -176.142 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.421 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -74.67 11.6 1.0 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 122.611 1.196 . . . . 64.349999999999994 110.843 -179.632 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . 0.514 ' H ' ' C ' ' A' ' 473' ' ' PRO . 13.9 m120 -110.4 -4.8 15.4 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-N 114.385 -1.279 . . . . 75.109999999999999 108.852 -178.854 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -115.83 170.93 8.1 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 121.512 0.672 . . . . 73.329999999999998 111.808 -175.243 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.32 137.62 37.56 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.518 -1.219 . . . . 75.239999999999995 108.713 -178.378 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 21.1 p -126.27 149.2 49.27 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 120.999 0.428 . . . . 74.209999999999994 111.049 -179.146 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -72.97 160.72 31.66 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.431 -0.804 . . . . 70.239999999999995 110.537 178.213 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 449' ' ' PHE . 1.9 mp -72.65 -16.81 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-O 121.947 0.88 . . . . 74.439999999999998 111.014 -179.867 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 15.3 t -96.05 5.16 51.79 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-O 121.772 0.796 . . . . 70.140000000000001 109.853 177.48 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -89.55 137.61 32.18 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.993 -0.549 . . . . 75.349999999999994 109.941 -175.633 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.2 p -104.37 126.05 59.12 Favored 'Isoleucine or valine' 0 C--O 1.245 0.841 0 CA-C-O 121.336 0.588 . . . . 75.049999999999997 110.849 179.705 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 61.8 t -95.83 119.99 44.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.981 -0.554 . . . . 74.530000000000001 109.859 -179.271 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.18 123.98 55.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 108.863 -0.792 . . . . 71.099999999999994 108.863 178.598 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 39.5 mt -120.15 128.11 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 CA-C-N 114.723 -1.126 . . . . 75.400000000000006 110.184 -176.774 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 9.3 tt -101.9 125.15 56.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 115.891 -0.595 . . . . 75.299999999999997 110.074 -179.148 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 456' ' ' ASN . 10.6 t -113.18 139.03 40.53 Favored 'Isoleucine or valine' 0 C--O 1.251 1.14 0 N-CA-C 106.569 -1.641 . . . . 74.209999999999994 106.569 179.236 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -75.53 153.76 44.79 Favored Glycine 0 C--N 1.299 -1.522 0 CA-C-O 121.346 0.414 . . . . 75.120000000000005 113.275 -176.665 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.624 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 48.6 m -141.22 160.69 39.58 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 106.6 -1.63 . . . . 74.129999999999995 106.6 176.012 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -178.0 -156.84 17.49 Favored Glycine 0 N--CA 1.435 -1.396 0 C-N-CA 119.384 -1.388 . . . . 72.439999999999998 112.081 -178.775 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -92.56 166.18 2.8 Favored 'Trans proline' 0 N--CA 1.446 -1.312 0 C-N-CA 122.857 2.372 . . . . 70.0 112.69 -179.381 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -95.6 99.94 11.74 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 109.219 -0.66 . . . . 64.230000000000004 109.219 176.705 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 13.7 p -117.83 143.0 46.68 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.35 -0.841 . . . . 64.049999999999997 109.595 179.208 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -144.76 154.23 42.5 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.674 -0.862 . . . . 72.420000000000002 108.674 176.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 11.9 p-10 -94.63 136.66 34.68 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.757 -0.831 . . . . 75.329999999999998 108.757 176.038 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 30.1 pt -75.62 137.38 70.58 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-N 115.369 -0.832 . . . . 75.349999999999994 112.038 -176.314 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -87.34 -170.18 0.57 Allowed 'Trans proline' 0 C--O 1.248 1.023 0 C-N-CA 122.995 2.464 . . . . 70.420000000000002 110.947 175.414 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -94.8 122.98 37.99 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.615 0.721 . . . . 64.219999999999999 109.687 177.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.6 p -113.42 7.57 7.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-O 122.374 1.083 . . . . 72.040000000000006 109.993 -177.62 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -73.72 121.22 20.44 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.204 -0.907 . . . . 61.130000000000003 109.788 -179.251 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 124.28 -17.75 7.44 Favored Glycine 0 C--N 1.289 -2.057 0 N-CA-C 110.105 -1.198 . . . . 63.340000000000003 110.105 -179.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -94.11 171.98 8.51 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 109.654 -0.498 . . . . 71.5 109.654 178.148 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 61.1 m -87.69 155.65 19.83 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.145 -1.057 . . . . 71.230000000000004 108.145 -179.302 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.6 p -54.17 -41.96 53.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 123.522 0.729 . . . . 75.430000000000007 112.316 -178.693 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -60.77 -42.24 97.1 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 123.368 0.667 . . . . 75.319999999999993 111.324 178.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.27 -40.75 50.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 115.419 -0.81 . . . . 72.530000000000001 109.769 -179.202 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -60.69 -49.51 77.23 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.464 -0.789 . . . . 63.329999999999998 111.339 -178.481 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -64.6 -36.05 82.98 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.596 -0.274 . . . . 71.510000000000005 110.264 -178.614 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.417 ' O ' HG23 ' A' ' 514' ' ' VAL . 87.7 tttt -61.47 -47.19 86.83 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.786 -0.643 . . . . 72.439999999999998 109.95 179.457 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -61.92 -48.17 81.63 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 116.192 -0.458 . . . . 74.400000000000006 110.818 -178.735 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.7 -45.65 93.4 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.4 -0.364 . . . . 75.319999999999993 111.182 178.793 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.18 -37.96 89.3 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 120.727 0.299 . . . . 74.25 111.711 -178.681 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 510' ' ' LYS . 79.4 t -65.1 -33.73 65.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-N 116.266 -0.425 . . . . 75.239999999999995 110.967 177.392 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -79.63 -9.38 59.62 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.399 0.518 . . . . 61.350000000000001 112.399 179.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 115.53 -20.43 13.64 Favored Glycine 0 CA--C 1.495 -1.159 0 C-N-CA 120.454 -0.879 . . . . 73.030000000000001 111.747 179.109 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.442 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 74.9 m-85 -78.25 81.74 4.6 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.41 -0.959 . . . . 74.319999999999993 108.41 179.625 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.6 p -87.91 -8.99 54.99 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 114.96 -1.018 . . . . 61.200000000000003 113.355 -173.102 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -108.01 115.52 30.28 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-O 121.407 0.622 . . . . 75.019999999999996 109.725 -177.563 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -130.48 156.37 44.89 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.454 -0.794 . . . . 71.439999999999998 111.253 -178.847 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 38.4 m -132.45 140.79 48.55 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 106.301 -1.74 . . . . 72.129999999999995 106.301 173.423 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.54 139.43 50.96 Favored 'General case' 0 N--CA 1.422 -1.869 0 C-N-CA 120.018 -0.673 . . . . 74.140000000000001 110.312 179.634 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -115.94 124.38 50.43 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 107.349 -1.352 . . . . 75.319999999999993 107.349 175.269 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 39.5 m -89.33 114.54 25.96 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.403 -0.962 . . . . 71.430000000000007 108.403 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 33.4 m -121.32 165.99 16.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 N-CA-C 109.309 -0.626 . . . . 74.420000000000002 109.309 -177.454 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -104.43 137.48 42.24 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.607 -0.886 . . . . 72.120000000000005 108.607 177.367 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 17.3 m -151.27 179.95 1.14 Allowed Pre-proline 0 C--N 1.295 -1.801 0 N-CA-C 109.292 -0.633 . . . . 75.409999999999997 109.292 -177.77 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -80.42 -7.04 13.83 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 121.695 1.597 . . . . 74.200000000000003 110.49 170.05 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -82.72 137.43 44.22 Favored Pre-proline 0 N--CA 1.447 -0.611 0 N-CA-C 107.892 -1.151 . . . . 55.039999999999999 107.892 177.995 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -58.8 160.23 18.53 Favored 'Trans proline' 0 N--CA 1.484 0.946 0 C-N-CA 123.566 2.844 . . . . 74.109999999999999 115.267 -175.04 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -66.71 113.6 4.96 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.686 -1.143 . . . . 62.049999999999997 111.435 -178.977 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 117.25 -19.56 11.7 Favored Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 110.856 -0.898 . . . . 34.109999999999999 110.856 178.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -83.11 134.62 35.0 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.533 -0.914 . . . . 72.340000000000003 108.533 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 58.8 t -80.42 126.36 39.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 109.321 -0.622 . . . . 72.120000000000005 109.321 -179.609 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 535' ' ' THR . . . . . 0.649 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 15.1 t -81.13 -18.03 47.85 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 121.506 0.669 . . . . 74.109999999999999 109.602 179.131 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.24 -161.44 28.61 Favored Glycine 0 N--CA 1.439 -1.148 0 C-N-CA 120.989 -0.624 . . . . 71.099999999999994 112.153 176.293 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 15.4 p -117.2 160.26 21.33 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.543 -0.54 . . . . 75.439999999999998 109.543 179.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -68.99 -55.34 10.62 Favored Pre-proline 0 C--N 1.325 -0.491 0 C-N-CA 120.514 -0.475 . . . . 74.519999999999996 110.241 177.441 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.82 134.2 25.23 Favored 'Trans proline' 0 C--N 1.366 1.463 0 N-CA-C 109.191 -1.119 . . . . 73.219999999999999 109.191 171.447 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.59 157.52 58.02 Favored 'Trans proline' 0 C--O 1.253 1.245 0 C-N-CA 122.578 2.185 . . . . 74.099999999999994 112.724 179.971 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.88 134.96 57.34 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.044 -0.525 . . . . 75.099999999999994 109.812 178.315 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.57 -13.34 39.16 Favored Glycine 0 C--N 1.307 -1.048 0 C-N-CA 120.844 -0.693 . . . . 71.129999999999995 111.739 -177.731 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 543' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 496' ' ' ASP . 81.7 m -70.92 120.89 17.15 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 109.072 -0.714 . . . . 54.130000000000003 109.072 178.359 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 31.9 m -86.62 122.88 31.16 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.026 -0.731 . . . . 71.230000000000004 109.026 -179.661 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 12.2 m -135.1 154.93 79.32 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 109.686 -0.487 . . . . 71.540000000000006 109.686 -179.327 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.43 149.77 45.22 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.964 1.776 . . . . 64.310000000000002 110.029 175.805 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.442 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 25.8 m -59.54 -19.58 16.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 112.673 0.62 . . . . 74.439999999999998 112.673 178.961 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -81.21 3.55 23.38 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.24 1.016 . . . . 72.510000000000005 112.64 179.479 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 77.5 p -88.16 175.16 7.83 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 121.996 -0.44 . . . . 74.439999999999998 112.17 -176.869 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 39.0 t -112.58 119.24 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 108.79 -0.818 . . . . 52.420000000000002 108.79 179.086 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 1.8 mp -98.13 131.21 45.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-O 121.113 0.483 . . . . 75.129999999999995 110.223 -179.179 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -103.23 117.82 35.38 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-O 121.258 0.551 . . . . 75.200000000000003 110.9 179.822 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -98.89 132.89 43.88 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.311 -1.313 . . . . 64.140000000000001 108.746 179.002 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -100.48 118.59 37.0 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.849 -1.167 . . . . 74.230000000000004 107.849 172.157 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 46.0 t -104.42 131.18 53.93 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 107.385 -1.339 . . . . 62.539999999999999 107.385 -178.22 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.649 ' OG ' ' HB ' ' A' ' 535' ' ' THR . 50.2 m -95.92 158.13 15.59 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 114.044 1.127 . . . . 74.549999999999997 114.044 -175.131 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 19.0 ptpt -113.68 148.2 36.78 Favored 'General case' 0 N--CA 1.414 -2.272 0 N-CA-C 105.888 -1.894 . . . . 71.349999999999994 105.888 164.092 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -75.08 -22.26 76.87 Favored Glycine 0 C--N 1.292 -1.874 0 O-C-N 124.103 0.877 . . . . 74.439999999999998 111.929 -178.586 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 73.67 10.38 4.8 Favored 'General case' 0 CA--C 1.485 -1.524 0 C-N-CA 124.654 1.181 . . . . 64.450000000000003 109.284 -171.786 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -128.39 141.26 51.47 Favored 'General case' 0 N--CA 1.408 -2.537 0 CA-C-N 115.525 -0.761 . . . . 75.319999999999993 109.42 -176.857 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -138.82 155.1 48.42 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.564 -0.743 . . . . 75.530000000000001 109.394 -179.33 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.4 p -63.64 130.58 28.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 O-C-N 123.614 0.571 . . . . 74.349999999999994 111.081 -179.157 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 56.4 ttp -94.78 126.41 47.38 Favored Pre-proline 0 C--O 1.253 1.263 0 CA-C-N 115.886 -0.597 . . . . 73.340000000000003 109.543 178.36 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -63.43 169.78 9.11 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.068 2.512 . . . . 61.219999999999999 112.551 175.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -75.19 133.61 41.39 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.871 -0.604 . . . . 73.519999999999996 111.29 -179.526 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . 0.432 ' HB3' ' SD ' ' A' ' 569' ' ' MET . 92.8 mt -137.66 27.97 2.72 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.828 -0.804 . . . . 75.010000000000005 108.828 -177.674 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 17.7 m -77.86 130.31 36.48 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.907 -0.588 . . . . 75.310000000000002 111.228 -174.705 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 67.48 38.05 90.46 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.957 -0.565 . . . . 61.109999999999999 112.937 176.447 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 569' ' ' MET . . . . . 0.432 ' SD ' ' HB3' ' A' ' 566' ' ' LEU . 23.6 ptm -99.46 168.77 9.77 Favored 'General case' 0 C--O 1.255 1.363 0 N-CA-C 108.839 -0.8 . . . . 62.509999999999998 108.839 -179.413 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -106.76 148.98 27.81 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 109.471 -0.566 . . . . 74.400000000000006 109.471 -178.077 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 61.2 t-105 -62.31 -25.01 67.64 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 124.129 0.972 . . . . 71.010000000000005 110.269 -178.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 13.7 p -68.82 -21.72 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 115.548 -0.751 . . . . 71.219999999999999 110.386 179.498 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -101.28 -29.76 11.89 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 109.501 -0.555 . . . . 70.319999999999993 109.501 176.103 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -61.7 -49.96 74.39 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.164 -0.925 . . . . 65.540000000000006 111.92 -179.385 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 579' ' ' ARG . 38.0 mt-10 -54.21 -53.85 54.37 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 113.283 0.846 . . . . 70.109999999999999 113.283 -179.267 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.87 -45.03 44.02 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 121.887 1.725 . . . . 63.399999999999999 112.337 176.825 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . 0.548 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 20.6 mmm180 -64.0 -41.43 97.48 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.512 -0.313 . . . . 73.25 111.174 -179.961 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 7.1 tt -63.64 -49.27 73.89 Favored 'General case' 0 C--O 1.247 0.926 0 C-N-CA 123.403 0.681 . . . . 74.510000000000005 109.858 -176.094 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 4.6 ptp180 -67.27 -37.9 84.21 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.616 -0.72 . . . . 74.25 112.595 179.03 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.22 -39.16 75.26 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 112.575 0.583 . . . . 73.430000000000007 112.575 -178.148 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 4.0 pp -84.62 -1.23 55.71 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.66 -0.816 . . . . 71.420000000000002 112.437 -179.117 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 67.03 47.46 65.17 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 115.366 -0.834 . . . . 53.100000000000001 112.093 177.351 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 22.5 t90 -63.67 127.15 30.06 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.923 -0.399 . . . . 74.140000000000001 109.923 179.039 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 3.6 m -125.23 24.22 7.46 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.122 -0.696 . . . . 74.209999999999994 109.122 -176.726 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -92.43 -170.2 40.7 Favored Glycine 0 CA--C 1.508 -0.406 0 C-N-CA 120.71 -0.757 . . . . 74.019999999999996 113.904 -175.438 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 64.7 mtt -98.7 126.39 44.29 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.87 0.367 . . . . 74.5 110.474 -179.311 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 55.0 tp -96.84 102.25 14.0 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.12 -1.067 . . . . 71.049999999999997 108.12 177.504 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -96.43 101.46 13.09 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.268 0.556 . . . . 71.400000000000006 110.463 -178.851 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.32 114.22 28.31 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.547 -1.279 . . . . 75.219999999999999 107.547 178.631 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -75.97 -88.45 0.27 Allowed Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 120.622 -0.799 . . . . 73.5 111.206 177.45 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -125.58 154.66 41.89 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 122.436 -0.449 . . . . 63.109999999999999 110.48 -178.898 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -82.15 141.47 33.05 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.346 -0.983 . . . . 75.319999999999993 108.346 173.933 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 42.5 t -124.24 116.53 48.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 108.935 -0.765 . . . . 73.310000000000002 108.935 -177.473 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -89.2 107.81 19.26 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 107.778 -1.193 . . . . 72.049999999999997 107.778 177.573 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -127.18 9.54 6.76 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.887 -0.597 . . . . 74.109999999999999 111.197 -178.814 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 128.65 169.73 12.66 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.302 -0.951 . . . . 62.439999999999998 111.701 178.175 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -57.11 -46.46 91.51 Favored Glycine 0 C--O 1.237 0.329 0 O-C-N 123.933 0.431 . . . . 71.120000000000005 113.034 -177.112 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 30.9 t -65.87 -29.69 70.18 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.313 0.578 . . . . 73.409999999999997 110.514 -178.722 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . 0.619 ' O ' ' HA3' ' A' ' 625' ' ' GLY . 87.4 mm-40 -87.31 -1.02 57.62 Favored 'General case' 0 C--O 1.211 -0.97 0 CA-C-N 115.65 -0.705 . . . . 74.310000000000002 112.788 -174.114 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . 0.44 ' HA ' ' H ' ' A' ' 626' ' ' GLN . 19.8 m80 -63.52 -71.77 0.16 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.952 0.882 . . . . 73.25 110.921 176.919 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -95.62 31.13 2.1 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.798 -0.637 . . . . 73.209999999999994 111.023 -173.575 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 1.3 mmm-85 -105.15 140.23 38.63 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 116.064 -0.516 . . . . 73.129999999999995 110.233 -177.904 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 97.3 t -73.7 138.18 21.78 Favored 'Isoleucine or valine' 0 C--O 1.252 1.218 0 N-CA-C 107.306 -1.368 . . . . 73.349999999999994 107.306 174.819 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 57.8 t -94.43 -50.55 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.973 0 CA-C-O 121.743 0.782 . . . . 70.540000000000006 109.421 -174.084 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -146.9 155.88 42.65 Favored 'General case' 0 N--CA 1.415 -2.219 0 N-CA-C 107.701 -1.222 . . . . 75.540000000000006 107.701 -178.537 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -120.84 121.88 39.08 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 106.465 -1.68 . . . . 74.310000000000002 106.465 171.123 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.477 ' CB ' ' HB ' ' A' ' 621' ' ' THR . 26.3 t-20 -59.03 -52.79 72.27 Favored Pre-proline 0 C--N 1.299 -1.623 0 CA-C-N 115.539 -0.755 . . . . 55.32 112.67 -177.893 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.433 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 1.0 OUTLIER -87.8 123.28 1.74 Allowed 'Trans proline' 0 N--CA 1.442 -1.544 0 C-N-CA 121.275 1.317 . . . . 74.230000000000004 109.668 173.546 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.06 156.15 60.53 Favored 'Trans proline' 0 C--O 1.244 0.793 0 C-N-CA 122.287 1.992 . . . . 74.409999999999997 111.36 177.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -59.09 127.96 34.79 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.828 -0.434 . . . . 72.329999999999998 109.828 178.559 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.18 -7.81 44.3 Favored Glycine 0 C--N 1.31 -0.891 0 C-N-CA 120.343 -0.932 . . . . 73.310000000000002 111.755 -177.613 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 26.9 m -89.13 157.26 18.36 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 107.988 -1.116 . . . . 70.329999999999998 107.988 178.247 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -90.98 143.52 16.68 Favored Glycine 0 N--CA 1.422 -2.238 0 C-N-CA 120.787 -0.721 . . . . 75.510000000000005 113.092 -177.42 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 19.0 m -115.71 141.65 32.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 109.376 -0.601 . . . . 62.439999999999998 109.376 174.388 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -70.82 -179.71 2.33 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 123.852 0.861 . . . . 72.299999999999997 113.066 -177.386 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -61.95 -36.03 80.21 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.072 0.949 . . . . 75.140000000000001 109.718 -179.728 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . 0.412 ' OD2' ' HB ' ' A' ' 619' ' ' ILE . 21.2 t70 -63.28 -40.33 97.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.008 -0.997 . . . . 72.439999999999998 108.656 174.588 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 87.97 22.03 43.83 Favored Glycine 0 N--CA 1.425 -2.09 0 C-N-CA 120.14 -1.029 . . . . 73.129999999999995 111.919 176.385 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . 0.412 ' HB ' ' OD2' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -68.76 118.46 12.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 122.422 1.106 . . . . 63.539999999999999 110.19 -170.398 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.34 130.38 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.743 0 N-CA-C 106.336 -1.727 . . . . 72.530000000000001 106.336 -179.923 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.477 ' HB ' ' CB ' ' A' ' 607' ' ' ASN . 6.4 m -100.77 117.19 34.36 Favored 'General case' 0 N--CA 1.421 -1.908 0 C-N-CA 119.455 -0.898 . . . . 73.310000000000002 109.428 -178.533 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -139.26 150.78 45.87 Favored 'General case' 0 CA--C 1.48 -1.736 0 N-CA-C 106.054 -1.832 . . . . 64.0 106.054 178.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -134.36 151.54 51.28 Favored 'General case' 0 C--N 1.266 -3.057 0 N-CA-C 105.132 -2.173 . . . . 75.430000000000007 105.132 176.523 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -120.4 165.55 14.76 Favored 'General case' 0 C--N 1.274 -2.705 0 N-CA-C 107.266 -1.383 . . . . 74.010000000000005 107.266 177.461 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . 0.619 ' HA3' ' O ' ' A' ' 599' ' ' GLN . . . -70.46 -108.29 0.04 OUTLIER Glycine 0 C--N 1.302 -1.344 0 O-C-N 123.915 0.759 . . . . 74.219999999999999 114.317 -174.409 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . 0.44 ' H ' ' HA ' ' A' ' 600' ' ' HIS . 8.6 tp-100 . . . . . 0 C--N 1.296 -1.746 0 CA-C-O 118.998 -0.525 . . . . 74.230000000000004 110.0 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 . . . . . 0 C--O 1.246 0.887 0 N-CA-C 106.196 -1.779 . . . . 71.04 106.196 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 24.4 m -113.85 142.35 26.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-O 121.779 0.799 . . . . 74.43 110.3 -170.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -95.01 126.64 40.49 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 106.291 -1.744 . . . . 75.41 106.291 -176.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.454 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 64.0 t -97.35 121.25 59.11 Favored Pre-proline 0 C--N 1.286 -2.18 0 CA-C-N 114.616 -1.174 . . . . 75.33 111.577 -169.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 363' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 24.5 Cg_exo -62.29 135.8 56.19 Favored 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 123.026 2.484 . . . . 74.32 111.658 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -105.14 149.81 25.57 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.917 -1.142 . . . . 72.53 107.917 -176.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.518 ' CG2' ' HA ' ' A' ' 373' ' ' ALA . 26.1 m -134.63 20.06 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 C-N-CA 122.415 0.286 . . . . 71.13 111.032 -177.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.54 146.5 9.83 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 112.797 0.666 . . . . 65.32 112.797 177.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 367' ' ' GLY . . . . . 0.435 ' H ' HG23 ' A' ' 399' ' ' VAL . . . 105.07 0.83 41.65 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 115.83 -0.623 . . . . 32.43 112.357 -178.033 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -111.1 -89.35 0.5 Allowed 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 120.299 -0.561 . . . . 62.14 111.081 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 59.9 p -152.57 165.53 34.89 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.018 -0.734 . . . . 63.14 109.018 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.41 -46.14 87.76 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.721 -0.844 . . . . 73.14 108.721 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -59.53 -45.51 91.56 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 115.305 -0.861 . . . . 74.13 112.05 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -67.3 -41.38 85.46 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.087 0.47 . . . . 51.43 110.328 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 373' ' ' ALA . . . . . 0.518 ' HA ' ' CG2' ' A' ' 365' ' ' VAL . . . -65.79 -48.97 69.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.106 -0.497 . . . . 73.14 111.261 -179.033 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.17 -38.2 81.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.01 -0.541 . . . . 73.4 110.511 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.65 -42.03 87.41 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.259 0.623 . . . . 71.44 111.11 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.3 m -65.69 -49.02 70.05 Favored 'General case' 0 C--O 1.248 1.014 0 CA-C-O 121.58 0.705 . . . . 75.04 110.206 -178.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 9.9 mp -65.51 -42.63 91.84 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.572 -0.74 . . . . 73.41 111.74 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -64.46 -38.44 91.05 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.006 -0.543 . . . . 70.23 110.314 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -59.89 -39.08 84.15 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 116.023 -0.535 . . . . 62.12 110.687 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 380' ' ' ARG . . . . . 0.428 ' HA ' ' HD3' ' A' ' 380' ' ' ARG . 25.2 mmt180 -81.37 -12.35 59.01 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.613 -0.721 . . . . 74.0 112.193 -177.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.32 7.27 52.23 Favored Glycine 0 C--N 1.303 -1.27 0 C-N-CA 120.636 -0.792 . . . . 61.2 112.694 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.523 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 47.7 m-85 -81.66 159.46 23.97 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-O 121.355 0.598 . . . . 73.12 111.621 177.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.505 ' HB2' ' HG2' ' A' ' 415' ' ' GLU . 46.4 mtmt -115.23 161.8 17.95 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 115.005 -0.998 . . . . 43.12 108.826 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.21 157.38 41.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-O 120.862 0.363 . . . . 60.11 110.698 -177.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 61.6 ttp85 -120.16 126.84 51.66 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 107.138 -1.43 . . . . 72.44 107.138 170.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 17.6 m -108.27 125.13 51.33 Favored 'General case' 0 C--N 1.281 -2.408 0 N-CA-C 108.694 -0.854 . . . . 62.11 108.694 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -111.71 119.74 39.68 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.663 -0.866 . . . . 74.42 108.663 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -96.61 139.26 32.96 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 110.138 -0.319 . . . . 72.11 110.138 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -131.31 127.53 21.78 Favored Pre-proline 0 C--N 1.307 -1.247 0 N-CA-C 108.278 -1.008 . . . . 75.54 108.278 174.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -63.3 142.95 88.02 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.245 1.963 . . . . 74.23 111.794 177.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 7.3 t70 87.03 148.04 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 126.864 2.065 . . . . 65.23 110.368 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 13.0 t -103.12 11.96 36.44 Favored 'General case' 0 CA--C 1.552 1.058 0 CA-C-O 120.991 0.424 . . . . 64.41 110.546 -175.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 8.4 t -73.44 -18.08 61.17 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.97 0.891 . . . . 75.44 109.016 175.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.46 HD13 ' H ' ' A' ' 394' ' ' ILE . 0.1 OUTLIER -104.48 151.24 39.15 Favored Pre-proline 0 N--CA 1.427 -1.576 0 N-CA-C 107.459 -1.311 . . . . 61.31 107.459 173.098 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -23.33 114.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.678 1 C-N-CA 126.205 4.603 . . . . 64.52 115.7 -175.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.06 160.29 10.69 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 123.922 3.081 . . . . 64.2 112.833 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -57.97 -12.88 3.66 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 113.545 0.942 . . . . 75.5 113.545 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 28.7 m170 -91.89 148.46 22.2 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 108.257 -1.016 . . . . 71.32 108.257 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.435 HG23 ' H ' ' A' ' 367' ' ' GLY . 30.0 m -77.75 117.17 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.255 0 C-N-CA 118.687 -1.205 . . . . 70.34 111.089 -171.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 35.6 pt -106.68 -28.8 2.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 115.198 -0.91 . . . . 75.55 108.729 173.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.72 158.0 27.58 Favored Glycine 0 N--CA 1.417 -2.607 0 N-CA-C 109.489 -1.444 . . . . 31.53 109.489 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 3.9 p -137.93 -178.58 5.32 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 123.623 0.769 . . . . 73.04 109.476 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -102.1 132.16 21.85 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 108.154 -1.054 . . . . 61.42 108.154 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.34 3.09 0.89 Allowed 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.307 2.671 . . . . 72.41 115.632 -176.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -52.87 -47.59 67.72 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 109.673 -0.492 . . . . 65.33 109.673 175.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -69.95 -28.97 66.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.639 -0.71 . . . . 64.02 110.464 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -81.35 -6.14 58.6 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 122.014 0.911 . . . . 75.32 109.753 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 28.3 m -101.92 160.66 14.3 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.538 -1.653 . . . . 54.11 106.538 175.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 20.2 m -76.48 113.11 13.72 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 119.55 -0.86 . . . . 73.44 109.067 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.3 m -123.66 170.02 14.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 122.86 0.464 . . . . 65.24 111.018 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 19.2 m -74.25 141.05 45.39 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.887 -0.783 . . . . 54.32 108.887 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 412' ' ' ALA . . . . . 0.523 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -69.08 108.94 3.77 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.072 0.463 . . . . 73.31 110.468 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 121.38 37.76 0.67 Allowed Glycine 0 C--N 1.311 -0.819 0 CA-C-N 115.194 -0.912 . . . . 41.3 111.744 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -100.02 179.07 4.61 Favored 'General case' 0 C--O 1.245 0.861 0 N-CA-C 107.7 -1.222 . . . . 70.43 107.7 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 415' ' ' GLU . . . . . 0.505 ' HG2' ' HB2' ' A' ' 383' ' ' LYS . 44.8 mt-10 -116.41 115.0 25.05 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 118.249 0.477 . . . . 74.21 109.957 -178.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 42.6 mm -97.94 129.47 48.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 121.062 0.458 . . . . 75.14 110.072 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 2.2 p -79.81 131.21 35.84 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 123.866 0.866 . . . . 72.41 111.776 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 10.7 p -119.13 134.35 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.872 0 N-CA-C 109.01 -0.737 . . . . 61.51 109.01 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -95.4 120.77 36.21 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.546 -0.909 . . . . 74.45 108.546 -176.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 50.5 t -128.45 149.1 32.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 122.869 0.468 . . . . 72.4 109.885 -176.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 44.2 m -126.24 148.98 49.37 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.573 -0.529 . . . . 51.01 109.573 173.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 1.5 m -103.65 157.94 16.72 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 106.897 -1.52 . . . . 71.14 106.897 -175.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.73 0 N-CA-C 115.626 1.011 . . . . 74.55 115.626 -178.563 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 . . . . . 0 N--CA 1.429 -1.504 0 N-CA-C 107.404 -1.332 . . . . 71.34 107.404 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 447' ' ' ALA . 2.4 mmp_? -122.78 143.74 49.63 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-O 120.717 0.294 . . . . 72.1 110.655 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -86.27 138.98 31.43 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 107.079 -1.452 . . . . 54.41 107.079 173.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 67.6 mt -78.78 121.97 84.14 Favored Pre-proline 0 C--N 1.3 -1.545 0 CA-C-O 121.115 0.483 . . . . 74.24 110.825 -172.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.91 148.62 58.0 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.636 2.224 . . . . 74.41 111.434 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -87.48 145.15 26.38 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.666 -0.494 . . . . 74.42 109.666 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.28 153.05 16.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.839 -0.8 . . . . 75.11 108.839 -175.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 2.7 p -64.47 137.0 57.63 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 121.399 0.618 . . . . 62.35 110.294 175.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 434' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 23.6 p -69.1 -21.21 64.07 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 125.053 1.341 . . . . 75.14 112.128 -171.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.511 ' H ' HD23 ' A' ' 435' ' ' LEU . 0.6 OUTLIER -88.56 -11.02 46.83 Favored 'General case' 0 C--N 1.275 -2.632 0 CA-C-N 115.668 -0.696 . . . . 63.01 110.502 179.422 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.8 m -108.61 66.4 0.64 Allowed 'General case' 0 N--CA 1.426 -1.637 0 CA-C-O 121.835 0.826 . . . . 60.31 111.125 -175.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -53.38 -38.52 63.43 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 124.462 1.105 . . . . 71.44 111.859 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -58.89 -42.65 90.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.89 0.376 . . . . 74.43 110.85 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -70.96 -36.21 72.47 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.925 -0.58 . . . . 74.24 109.988 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.623 ' O ' HD22 ' A' ' 444' ' ' LEU . . . -60.39 -52.58 64.65 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 116.686 -0.234 . . . . 72.44 111.551 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 26.9 m -63.63 -36.5 76.67 Favored 'Isoleucine or valine' 0 C--O 1.245 0.828 0 CA-C-O 121.402 0.62 . . . . 55.04 110.773 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 41.5 tptt -59.18 -45.79 90.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.911 -1.041 . . . . 63.33 109.464 175.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -64.21 -39.76 94.65 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 113.381 0.882 . . . . 72.23 113.381 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.623 HD22 ' O ' ' A' ' 440' ' ' ALA . 1.4 mm? -68.01 -33.03 73.83 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 119.056 -1.057 . . . . 74.31 110.762 175.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 45.5 m -70.12 -42.69 72.29 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.293 0.568 . . . . 70.13 110.074 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.98 -15.49 62.58 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.845 -0.616 . . . . 75.41 110.651 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 447' ' ' ALA . . . . . 0.465 ' O ' ' HG3' ' A' ' 427' ' ' ARG . . . -86.92 2.87 47.86 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.061 -0.518 . . . . 44.45 111.454 177.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 106.35 -76.59 0.23 Allowed Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.172 -1.013 . . . . 42.43 112.127 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -46.28 -57.3 4.7 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 114.377 1.251 . . . . 72.14 114.377 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 59.41 28.41 64.7 Favored Glycine 0 CA--C 1.508 -0.382 0 O-C-N 123.5 0.5 . . . . 61.45 112.271 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.485 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 16.1 mmt180 -105.04 111.0 23.62 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 107.385 -1.339 . . . . 73.42 107.385 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.516 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 18.1 p90 -144.89 157.38 44.17 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-O 120.81 0.338 . . . . 72.14 111.451 -175.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -131.1 149.08 52.76 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 124.483 1.113 . . . . 73.3 108.22 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -116.86 119.42 35.32 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.937 -0.764 . . . . 75.13 108.937 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.6 143.01 48.87 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.001 -0.741 . . . . 73.2 109.001 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -112.98 135.02 54.22 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 107.269 -1.382 . . . . 73.33 107.269 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 38.2 t -137.44 134.81 18.75 Favored Pre-proline 0 C--N 1.289 -2.032 0 N-CA-C 109.118 -0.697 . . . . 51.11 109.118 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.617 ' HA ' ' O ' ' A' ' 490' ' ' SER . 37.1 Cg_endo -65.89 122.45 10.03 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 121.715 1.61 . . . . 71.53 108.549 175.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 15.3 m -131.82 179.34 6.13 Favored 'General case' 0 C--N 1.286 -2.157 0 C-N-CA 120.06 -0.656 . . . . 71.33 110.893 -173.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.7 t -55.78 141.49 65.77 Favored Pre-proline 0 N--CA 1.422 -1.853 0 C-N-CA 125.008 1.323 . . . . 75.21 108.458 173.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 461' ' ' PRO . . . . . 0.417 ' HB3' ' OG1' ' A' ' 494' ' ' THR . 9.6 Cg_endo -50.58 -30.11 27.16 Favored 'Trans proline' 0 N--CA 1.481 0.777 0 C-N-CA 124.766 3.644 . . . . 71.45 114.781 -171.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -75.89 -27.2 57.61 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 113.103 0.779 . . . . 72.4 113.103 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -92.95 -19.88 21.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.939 0.4 . . . . 75.11 111.688 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 90.5 t -60.78 134.89 26.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 109.423 -0.584 . . . . 73.22 109.423 175.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 101.35 -15.74 57.33 Favored Glycine 0 N--CA 1.431 -1.647 0 C-N-CA 121.085 -0.579 . . . . 65.33 113.248 177.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.2 166.59 24.27 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 117.521 0.661 . . . . 53.21 110.751 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.479 ' O ' ' HB ' ' A' ' 434' ' ' THR . 54.6 t -67.12 142.5 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.336 0 N-CA-C 108.478 -0.934 . . . . 61.4 108.478 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 42.5 mt -97.59 -28.22 3.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 107.689 -1.226 . . . . 64.21 107.689 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 150.23 -150.99 23.12 Favored Glycine 0 N--CA 1.411 -2.997 0 CA-C-N 114.646 -1.161 . . . . 71.11 110.661 176.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 470' ' ' THR . . . . . 0.706 HG22 HG12 ' A' ' 486' ' ' ILE . 43.7 p -115.26 151.62 34.17 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 105.352 -2.092 . . . . 62.24 105.352 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.41 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 8.8 t30 -69.91 -50.67 16.58 Favored Pre-proline 0 C--N 1.304 -1.378 0 C-N-CA 118.698 -1.201 . . . . 63.11 111.055 176.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.41 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 23.5 Cg_exo -68.46 162.07 42.31 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 121.289 1.326 . . . . 54.02 109.36 172.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.494 ' HB2' ' OE1' ' A' ' 476' ' ' GLN . 20.7 Cg_endo -61.64 127.73 22.52 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.294 1.996 . . . . 72.52 111.988 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.481 ' HB2' ' OG1' ' A' ' 470' ' ' THR . . . -91.27 0.39 57.53 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 113.556 0.947 . . . . 60.44 113.556 -170.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -108.96 -12.99 14.81 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 119.677 -0.809 . . . . 74.04 109.672 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 476' ' ' GLN . . . . . 0.494 ' OE1' ' HB2' ' A' ' 473' ' ' PRO . 20.1 mp0 -92.35 -175.28 3.97 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 114.143 -1.39 . . . . 63.22 111.474 -172.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 1.4 p -93.79 141.13 28.84 Favored 'General case' 0 N--CA 1.404 -2.746 0 N-CA-C 113.387 0.884 . . . . 71.33 113.387 -176.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 12.7 p -127.08 148.05 50.15 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-N 114.618 -1.174 . . . . 73.5 108.269 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -75.58 163.72 27.06 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 116.845 -0.161 . . . . 43.12 110.857 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 22.6 mm -80.04 -5.15 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.019 0 CA-C-O 122.264 1.03 . . . . 75.34 109.552 -176.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.5 t -110.64 5.13 20.77 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.726 0.774 . . . . 75.54 109.259 175.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -93.01 143.05 26.62 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.835 -0.621 . . . . 75.24 110.686 -175.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.485 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.1 p -108.25 127.1 64.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 C-N-CA 123.11 0.564 . . . . 53.13 111.475 -177.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 27.8 m -105.12 125.46 60.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-O 121.864 0.84 . . . . 73.11 111.788 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.66 125.19 45.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.813 -0.81 . . . . 62.44 108.813 177.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.706 HG12 HG22 ' A' ' 470' ' ' THR . 42.5 mt -110.28 128.65 66.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 C-N-CA 124.465 1.106 . . . . 75.25 110.999 -176.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 4.8 tt -111.15 127.13 68.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 115.357 -0.838 . . . . 70.12 111.122 -174.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 467' ' ' VAL . 2.5 p -115.19 135.47 55.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 115.218 -0.901 . . . . 71.51 109.92 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -72.66 125.87 10.5 Favored Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 110.517 -1.033 . . . . 64.53 110.517 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.617 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 8.6 t . . . . . 0 N--CA 1.424 -1.77 0 N-CA-C 108.268 -1.012 . . . . 60.24 108.268 -176.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo . . . . . 0 N--CA 1.44 -1.618 0 CA-C-O 121.01 0.338 . . . . 73.05 111.655 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -128.99 23.9 5.65 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 122.748 1.261 . . . . 60.11 108.261 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.417 ' OG1' ' HB3' ' A' ' 461' ' ' PRO . 14.6 p -127.22 143.54 51.23 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 112.909 -1.95 . . . . 70.15 109.309 -176.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -147.03 161.85 39.98 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.042 -1.096 . . . . 64.53 108.042 176.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.2 p-10 -93.87 135.24 35.4 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 109.517 -0.549 . . . . 73.35 109.517 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 40.3 pt -80.18 137.77 52.8 Favored Pre-proline 0 C--N 1.302 -1.467 0 CA-C-N 115.952 -0.567 . . . . 72.32 111.37 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.63 168.31 19.74 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.653 2.236 . . . . 72.41 112.859 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -70.87 121.73 18.62 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.642 -0.873 . . . . 70.32 108.642 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.01 87.89 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.178 0 CA-C-O 122.475 1.131 . . . . 71.35 110.845 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -146.97 122.5 10.42 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 113.703 -1.59 . . . . 71.04 108.08 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 112.43 -11.98 25.94 Favored Glycine 0 CA--C 1.493 -1.282 0 N-CA-C 109.888 -1.285 . . . . 73.45 109.888 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -94.71 169.32 10.25 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 114.888 -0.656 . . . . 71.02 109.677 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 5.5 m -84.39 157.16 21.51 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.458 -0.941 . . . . 72.31 108.458 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 17.5 t -55.65 -41.96 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.227 0.611 . . . . 63.23 110.933 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -62.1 -40.58 96.33 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.669 -0.696 . . . . 71.42 110.836 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 48.8 t -73.94 -38.9 50.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.839 -0.619 . . . . 71.44 109.558 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -62.81 -49.43 74.97 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.566 -0.743 . . . . 64.35 111.356 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -63.15 -35.71 81.21 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 109.629 -0.508 . . . . 74.12 109.629 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.468 ' O ' HG23 ' A' ' 514' ' ' VAL . 48.4 tttp -64.79 -45.33 86.74 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.674 -0.694 . . . . 62.02 109.976 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 511' ' ' ASN . . . . . 0.403 ' O ' ' HD1' ' A' ' 515' ' ' TYR . 92.1 m-20 -62.34 -42.39 99.35 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 120.6 0.238 . . . . 73.44 110.734 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.33 -42.83 96.07 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 116.596 -0.274 . . . . 74.43 111.381 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -63.23 -37.69 88.23 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.785 -0.189 . . . . 61.51 111.041 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 510' ' ' LYS . 56.9 t -59.88 -35.03 58.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.085 0.469 . . . . 65.33 110.844 176.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 515' ' ' TYR . . . . . 0.403 ' HD1' ' O ' ' A' ' 511' ' ' ASN . 31.3 m-85 -79.45 -8.21 58.96 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.881 0.372 . . . . 72.31 111.936 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 103.23 -0.4 47.24 Favored Glycine 0 C--N 1.303 -1.279 0 C-N-CA 120.075 -1.06 . . . . 62.23 112.55 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.601 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 79.2 m-85 -84.59 96.33 9.14 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.451 -1.314 . . . . 74.03 107.451 177.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 6.3 p -87.19 -13.89 42.71 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 113.234 0.827 . . . . 74.14 113.234 -174.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -108.83 114.73 28.75 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.166 0.508 . . . . 72.2 109.676 -178.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -131.42 154.44 48.67 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.755 -0.657 . . . . 75.42 110.619 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 43.8 m -141.54 140.94 33.54 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 107.772 -1.196 . . . . 43.32 107.772 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 522' ' ' GLN . . . . . 0.502 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 4.8 pm0 -117.56 128.46 54.97 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 118.468 0.576 . . . . 52.51 111.551 -177.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -111.66 116.22 30.41 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.039 -0.726 . . . . 53.11 109.039 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 35.4 m -95.08 124.72 39.28 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 120.743 0.306 . . . . 50.42 111.03 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 18.7 m -122.8 151.29 26.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 108.539 -0.912 . . . . 62.21 108.539 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 526' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 557' ' ' LYS . 3.8 p30 -66.59 136.13 55.15 Favored 'General case' 0 CA--C 1.495 -1.169 0 CA-C-O 121.681 0.753 . . . . 73.04 110.423 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 20.0 m -146.43 158.34 47.23 Favored Pre-proline 0 C--N 1.281 -2.404 0 CA-C-N 114.737 -1.119 . . . . 24.21 108.596 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -69.68 -21.76 33.43 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 121.551 1.501 . . . . 70.31 108.802 170.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.512 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 60.0 mtm-85 -69.71 135.12 88.05 Favored Pre-proline 0 N--CA 1.436 -1.152 0 CA-C-N 114.188 -1.369 . . . . 72.55 108.4 176.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.8 149.12 79.85 Favored 'Trans proline' 0 C--O 1.251 1.154 0 C-N-CA 123.26 2.64 . . . . 74.43 113.491 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -64.39 117.4 7.23 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.613 -0.721 . . . . 62.04 110.917 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 129.81 -23.41 4.73 Favored Glycine 0 C--N 1.302 -1.311 0 C-N-CA 120.212 -0.994 . . . . 71.13 111.99 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -79.4 125.74 29.92 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.235 -0.654 . . . . 74.34 109.235 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 88.8 t -73.19 119.41 20.08 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 109.774 -0.454 . . . . 72.3 109.774 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 57.6 m -66.36 -40.31 89.7 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 124.687 1.195 . . . . 71.42 109.436 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 162.86 -159.81 32.22 Favored Glycine 0 N--CA 1.424 -2.113 0 N-CA-C 109.392 -1.483 . . . . 34.12 109.392 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 7.1 p -126.57 161.07 28.86 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 117.056 0.428 . . . . 72.15 110.317 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.497 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 24.8 t-20 -59.63 -51.99 77.19 Favored Pre-proline 0 CA--C 1.545 0.78 0 O-C-N 123.537 0.523 . . . . 74.4 111.198 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.497 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 1.2 Cg_endo -87.37 143.08 6.36 Favored 'Trans proline' 0 N--CA 1.441 -1.595 0 CA-C-N 120.257 1.128 . . . . 53.04 109.301 170.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -70.16 163.6 37.98 Favored 'Trans proline' 0 C--O 1.249 1.065 0 C-N-CA 122.428 2.085 . . . . 73.23 112.556 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.8 142.49 57.27 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.777 -0.647 . . . . 64.14 110.61 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 88.94 -5.95 84.1 Favored Glycine 0 N--CA 1.431 -1.666 0 C-N-CA 120.844 -0.693 . . . . 71.22 112.212 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 30.8 m -77.91 123.28 26.59 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.646 -0.501 . . . . 73.24 109.646 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 33.3 m -80.56 122.44 27.05 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 108.697 -0.853 . . . . 62.12 108.697 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 19.7 m -136.71 160.38 66.68 Favored Pre-proline 0 C--N 1.311 -1.108 0 N-CA-C 109.179 -0.674 . . . . 73.51 109.179 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -68.35 141.13 50.49 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.25 1.966 . . . . 62.32 111.458 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.601 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 26.9 m -66.79 -20.52 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 121.749 0.785 . . . . 64.33 111.927 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -90.59 3.68 53.42 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.137 -0.938 . . . . 63.33 111.13 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.0 t -83.77 164.23 19.69 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.291 -0.633 . . . . 73.05 109.291 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 41.3 t -98.18 112.71 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 N-CA-C 107.998 -1.112 . . . . 72.25 107.998 178.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 1.8 mp -91.74 135.64 26.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-O 120.938 0.399 . . . . 74.44 110.272 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -101.9 122.26 43.68 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-O 121.473 0.654 . . . . 74.5 110.777 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 553' ' ' LEU . . . . . 0.502 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 65.3 mt -97.8 116.16 29.47 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 106.562 -1.644 . . . . 70.03 106.562 176.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -91.83 121.98 33.94 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 108.489 -0.93 . . . . 72.44 108.489 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 60.3 t -111.12 133.74 55.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-N 115.82 -0.627 . . . . 73.24 112.149 -170.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.578 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 9.6 m -71.69 128.66 36.51 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 114.925 -1.034 . . . . 63.22 109.065 174.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 526' ' ' ASP . 0.8 OUTLIER -116.97 110.74 18.66 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 109.317 -0.623 . . . . 64.11 109.317 175.988 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -72.49 -33.38 61.17 Favored Glycine 0 CA--C 1.49 -1.526 0 CA-C-N 115.707 -0.678 . . . . 71.42 111.448 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 44.32 36.34 1.56 Allowed 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 126.345 1.858 . . . . 73.23 113.007 178.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 12.1 tp60 -140.05 146.22 38.71 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.488 -1.301 . . . . 65.51 107.488 -174.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -147.16 142.62 27.51 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.604 -0.887 . . . . 74.1 108.604 174.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 54.2 t -76.62 128.38 37.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-O 120.911 0.386 . . . . 75.42 111.76 -174.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 58.7 ttp -97.7 132.4 25.11 Favored Pre-proline 0 C--O 1.247 0.951 0 CA-C-N 115.99 -0.55 . . . . 75.34 110.198 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -66.57 169.67 13.87 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 123.051 2.501 . . . . 55.41 112.932 176.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -72.16 132.27 43.92 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 113.299 0.851 . . . . 70.33 113.299 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 96.5 mt -136.22 21.85 3.22 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.566 0.746 . . . . 72.53 109.003 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 10.3 m -75.4 130.29 38.74 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 116.147 -0.479 . . . . 35.14 112.224 -173.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 65.65 29.22 74.66 Favored Glycine 0 C--O 1.212 -1.247 0 CA-C-N 115.498 -0.774 . . . . 74.23 114.873 173.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 18.1 ptp -112.61 178.85 4.15 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 117.798 0.799 . . . . 74.25 109.136 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 570' ' ' PHE . . . . . 0.402 ' HB3' ' OD1' ' A' ' 601' ' ' ASN . 89.7 m-85 -84.87 154.27 22.38 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 120.302 -0.559 . . . . 71.51 109.67 178.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 28.0 t90 -68.47 -20.15 64.59 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.387 -0.597 . . . . 74.22 109.387 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 33.8 m -71.28 -13.31 16.87 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.355 0 CA-C-N 115.936 -0.575 . . . . 45.34 110.985 176.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -101.06 -44.13 5.81 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 109.417 -0.586 . . . . 70.42 109.417 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -59.57 -46.27 89.4 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.817 -1.083 . . . . 71.13 112.214 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.488 ' O ' ' HG3' ' A' ' 579' ' ' ARG . 55.8 tt0 -57.92 -59.87 11.81 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 113.323 0.861 . . . . 55.42 113.323 -178.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.54 -35.59 89.55 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 121.183 1.255 . . . . 61.0 112.406 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.42 ' HD3' ' HA ' ' A' ' 577' ' ' ARG . 7.8 mmt85 -65.0 -43.38 92.76 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.031 0.382 . . . . 74.54 112.031 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.404 HD12 ' N ' ' A' ' 579' ' ' ARG . 4.4 pp -67.58 -40.71 84.85 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 119.607 -0.837 . . . . 44.4 111.259 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 579' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 575' ' ' GLU . 20.1 mtp180 -65.14 -40.32 94.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.085 -0.507 . . . . 75.52 110.094 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -63.96 -35.73 81.64 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.982 -0.554 . . . . 74.43 112.468 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 4.2 pp -81.66 2.03 31.43 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.988 0.736 . . . . 62.42 112.988 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 82.97 39.67 9.99 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.484 -0.865 . . . . 72.1 112.227 176.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 89.6 t90 -79.57 133.91 36.46 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.939 -0.393 . . . . 71.01 109.939 176.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 61.5 m -147.86 90.85 1.87 Allowed 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.375 -0.602 . . . . 73.21 109.375 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -147.01 -131.52 2.19 Favored Glycine 0 N--CA 1.433 -1.549 0 N-CA-C 111.088 -0.805 . . . . 74.2 111.088 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 586' ' ' MET . . . . . 0.461 ' HB2' HG12 ' A' ' 619' ' ' ILE . 59.7 mtt -119.67 125.65 49.22 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.763 -0.829 . . . . 73.1 108.763 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -105.17 130.94 53.22 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 107.799 -1.185 . . . . 73.11 107.799 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -100.71 101.89 12.87 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 120.601 -0.439 . . . . 70.52 110.698 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 589' ' ' LYS . . . . . 0.408 ' C ' ' HD3' ' A' ' 589' ' ' LYS . 11.8 tmtt? -113.02 111.7 22.61 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 107.252 -1.388 . . . . 74.21 107.252 174.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -93.97 -149.52 25.48 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.958 -0.639 . . . . 74.32 113.197 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -76.16 146.23 39.33 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 120.776 0.322 . . . . 34.23 111.083 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -84.97 125.32 32.59 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 106.405 -1.702 . . . . 75.22 106.405 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 57.5 t -128.73 116.58 41.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 N-CA-C 109.956 -0.387 . . . . 70.02 109.956 -171.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -77.59 108.11 10.54 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.24 -1.393 . . . . 54.13 107.24 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -121.42 -5.12 9.33 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.717 -0.674 . . . . 64.21 111.744 -176.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 119.69 -177.97 16.46 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 120.507 -0.854 . . . . 44.51 112.341 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -58.71 -37.01 88.89 Favored Glycine 0 C--N 1.319 -0.365 0 O-C-N 124.084 0.52 . . . . 64.42 114.381 -175.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 14.4 m -64.89 -24.29 67.49 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 117.264 0.532 . . . . 64.44 111.365 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -108.11 -0.56 21.03 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 113.096 0.776 . . . . 72.43 113.096 -173.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 600' ' ' HIS . . . . . 0.503 ' HA ' ' O ' ' A' ' 626' ' ' GLN . 14.9 p-80 -70.39 103.22 2.36 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 119.194 -1.002 . . . . 74.35 111.644 -174.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 601' ' ' ASN . . . . . 0.402 ' OD1' ' HB3' ' A' ' 570' ' ' PHE . 18.9 t-20 58.37 5.32 0.42 Allowed 'General case' 0 CA--C 1.569 1.7 0 C-N-CA 125.924 1.69 . . . . 74.13 113.59 178.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 602' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 624' ' ' PHE . 13.6 mmt180 -78.98 140.22 38.05 Favored 'General case' 0 C--N 1.317 -0.804 0 O-C-N 121.66 -0.65 . . . . 75.1 110.455 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 97.6 t -69.48 131.63 33.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 107.911 -1.144 . . . . 74.45 107.911 174.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 56.9 t -87.71 -46.05 16.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-O 121.263 0.554 . . . . 64.31 109.649 -175.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -156.24 152.4 27.71 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 107.684 -1.228 . . . . 72.33 107.684 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -116.68 112.39 21.16 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.356 -1.35 . . . . 70.42 107.356 171.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.475 ' HB2' ' HB ' ' A' ' 621' ' ' THR . 38.7 t30 -48.45 -52.13 45.86 Favored Pre-proline 0 CA--C 1.556 1.204 0 N-CA-C 113.622 0.971 . . . . 73.12 113.622 -177.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 5.4 Cg_exo -82.29 124.64 4.3 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.121 1.214 . . . . 64.25 109.562 172.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 609' ' ' PRO . . . . . 0.49 ' O ' HG22 ' A' ' 612' ' ' THR . 13.4 Cg_endo -65.0 135.84 45.77 Favored 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 122.045 1.83 . . . . 60.01 113.144 -177.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -65.75 130.69 44.18 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.248 -0.887 . . . . 75.21 110.025 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.09 -8.44 45.37 Favored Glycine 0 N--CA 1.433 -1.537 0 C-N-CA 120.132 -1.032 . . . . 61.22 113.066 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 612' ' ' THR . . . . . 0.49 HG22 ' O ' ' A' ' 609' ' ' PRO . 10.1 t -113.75 175.93 5.25 Favored 'General case' 0 C--O 1.258 1.514 0 C-N-CA 118.919 -1.112 . . . . 74.32 109.541 177.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -79.77 128.3 8.44 Favored Glycine 0 N--CA 1.416 -2.684 0 CA-C-N 115.448 -0.796 . . . . 33.54 111.546 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 23.4 m -102.2 144.49 13.33 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 C-N-CA 124.031 0.932 . . . . 75.2 108.709 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.48 HD21 HG22 ' A' ' 619' ' ' ILE . 24.8 p-10 -50.01 152.59 1.59 Allowed 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 124.452 1.101 . . . . 71.0 111.857 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -26.25 13.59 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.123 0.969 . . . . 61.41 113.061 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.34 -38.53 74.88 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.662 -0.866 . . . . 74.11 108.662 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 82.33 22.12 59.33 Favored Glycine 0 N--CA 1.424 -2.159 0 C-N-CA 120.923 -0.656 . . . . 34.43 111.886 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 619' ' ' ILE . . . . . 0.48 HG22 HD21 ' A' ' 615' ' ' ASN . 0.0 OUTLIER -68.16 119.19 13.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-O 122.621 1.2 . . . . 73.35 110.459 -168.833 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 4.4 tp -115.67 119.17 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.876 0 CA-C-N 113.899 -1.5 . . . . 75.14 109.614 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.475 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 25.7 m -105.4 117.45 34.06 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 106.543 -1.651 . . . . 72.45 106.543 174.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 622' ' ' LEU . . . . . 0.413 HD23 ' H ' ' A' ' 622' ' ' LEU . 2.1 pt? -138.96 153.77 48.23 Favored 'General case' 0 CA--C 1.479 -1.758 0 N-CA-C 106.447 -1.686 . . . . 54.25 106.447 -177.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -136.45 153.67 50.99 Favored 'General case' 0 C--N 1.268 -2.974 0 N-CA-C 107.464 -1.31 . . . . 74.33 107.464 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.415 ' HA ' ' O ' ' A' ' 602' ' ' ARG . 51.1 p90 -140.62 163.01 34.01 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 105.383 -2.081 . . . . 74.21 105.383 172.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -82.46 -86.52 0.76 Allowed Glycine 0 N--CA 1.424 -2.155 0 C-N-CA 119.677 -1.249 . . . . 63.35 110.282 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 626' ' ' GLN . . . . . 0.503 ' O ' ' HA ' ' A' ' 600' ' ' HIS . 35.6 tt0 . . . . . 0 C--N 1.29 -1.991 0 CA-C-O 117.7 -1.143 . . . . 53.14 108.428 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 . . . . . 0 N--CA 1.435 -1.193 0 N-CA-C 103.728 -2.693 . . . . 40.33 103.728 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 35.7 m -116.08 151.3 17.88 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.664 0 C-N-CA 120.074 -0.65 . . . . 72.23 109.805 -172.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -95.05 136.04 35.85 Favored 'General case' 0 N--CA 1.411 -2.406 0 N-CA-C 106.579 -1.637 . . . . 53.45 106.579 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 89.8 t -111.07 118.19 48.47 Favored Pre-proline 0 C--N 1.275 -2.632 0 CA-C-O 121.141 0.496 . . . . 65.32 111.198 -173.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -81.38 123.54 4.43 Favored 'Trans proline' 0 N--CA 1.44 -1.674 0 C-N-CA 121.814 1.676 . . . . 74.21 109.717 172.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 364' ' ' ASP . . . . . 0.569 ' OD2' ' HB3' ' A' ' 366' ' ' ARG . 7.5 p-10 -101.43 137.91 39.13 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 122.237 1.017 . . . . 64.45 110.646 -176.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 27.7 m -82.93 36.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 114.381 -1.281 . . . . 71.43 112.471 -174.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.569 ' HB3' ' OD2' ' A' ' 364' ' ' ASP . 0.0 OUTLIER -56.04 146.72 21.85 Favored 'General case' 0 C--O 1.247 0.934 0 C-N-CA 124.452 1.101 . . . . 71.22 110.97 176.314 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.28 1.21 41.13 Favored Glycine 0 C--N 1.309 -0.944 0 N-CA-C 111.927 -0.469 . . . . 71.32 111.927 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -110.87 -153.2 0.51 Allowed 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 108.076 -1.083 . . . . 74.41 108.076 176.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 54.9 p -93.32 168.68 10.92 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.215 -0.661 . . . . 42.43 109.215 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 20.6 p -63.28 -46.36 87.12 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 109.828 -0.434 . . . . 74.53 109.828 176.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -63.36 -46.43 86.6 Favored 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 112.851 0.686 . . . . 73.52 112.851 -177.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -67.03 -45.23 78.12 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 120.546 -0.462 . . . . 70.41 110.095 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -66.59 -46.62 75.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.868 -0.606 . . . . 64.55 111.514 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 67.7 mt -64.73 -37.91 81.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.616 -0.266 . . . . 73.43 110.806 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.88 -43.29 99.14 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 110.273 -0.269 . . . . 73.32 110.273 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 33.3 m -63.45 -48.33 78.15 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.866 -0.606 . . . . 73.43 110.313 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.45 -41.6 96.44 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 112.353 0.501 . . . . 74.23 112.353 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -67.01 -38.79 86.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.666 -0.243 . . . . 64.12 110.515 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -70.19 -21.01 63.09 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.027 0.442 . . . . 63.22 111.601 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 380' ' ' ARG . . . . . 0.466 ' NE ' ' HA ' ' A' ' 380' ' ' ARG . 3.3 mmp_? -81.06 -15.09 57.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.027 0.441 . . . . 61.13 109.919 174.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.26 5.58 54.33 Favored Glycine 0 C--N 1.306 -1.114 0 CA-C-N 115.789 -0.641 . . . . 61.55 112.548 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -85.42 148.65 25.9 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-O 121.117 0.484 . . . . 62.11 110.73 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -101.13 149.39 24.02 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 107.741 -1.207 . . . . 75.21 107.741 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 384' ' ' ILE . . . . . 0.415 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -134.62 157.19 41.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.891 0 C-N-CA 120.717 -0.393 . . . . 64.21 110.009 -178.549 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -132.46 126.86 34.01 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.165 -1.42 . . . . 63.02 107.165 173.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 28.8 m -109.12 126.53 53.31 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 108.367 -0.975 . . . . 74.3 108.367 -177.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 51.2 tp -111.46 120.09 41.0 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.57 -0.53 . . . . 75.02 109.57 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -89.83 122.09 32.57 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.148 -0.686 . . . . 64.31 109.148 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 389' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 421' ' ' SER . 56.9 mtpt -135.4 125.5 16.73 Favored Pre-proline 0 C--N 1.311 -1.069 0 N-CA-C 109.937 -0.394 . . . . 74.44 109.937 177.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -80.39 128.37 7.04 Favored 'Trans proline' 0 C--O 1.253 1.252 0 C-N-CA 121.39 1.393 . . . . 64.13 109.238 173.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 13.5 t70 174.99 158.46 0.18 Allowed 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.195 -1.409 . . . . 72.33 107.195 -174.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 13.5 m -100.72 -11.98 19.5 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 120.86 0.362 . . . . 54.22 111.697 -177.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 11.1 m -109.11 2.1 20.88 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 122.121 0.963 . . . . 70.41 110.343 -176.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 34.6 mm -88.86 140.52 29.37 Favored Pre-proline 0 C--N 1.306 -1.297 0 CA-C-N 115.769 -0.651 . . . . 65.52 109.33 178.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 395' ' ' PRO . . . . . 0.451 ' HA ' ' HD3' ' A' ' 396' ' ' PRO . 20.1 Cg_exo -39.97 129.92 2.11 Favored 'Trans proline' 0 C--N 1.365 1.401 0 C-N-CA 124.4 3.4 . . . . 62.32 113.719 176.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 396' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 395' ' ' PRO . 50.1 Cg_exo -57.8 161.24 13.07 Favored 'Trans proline' 0 N--CA 1.483 0.855 0 C-N-CA 123.535 2.824 . . . . 71.3 112.699 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 397' ' ' ASP . . . . . 0.589 ' HA ' HG13 ' A' ' 420' ' ' VAL . 2.5 p30 -59.78 -8.47 2.14 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 122.022 0.915 . . . . 62.21 112.853 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 43.8 m170 -102.42 123.71 46.68 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 105.188 -2.153 . . . . 72.2 105.188 173.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 32.4 m -68.08 119.54 13.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 112.98 0.733 . . . . 74.43 112.98 -165.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 400' ' ' ILE . . . . . 0.436 HD13 ' O ' ' A' ' 400' ' ' ILE . 0.0 OUTLIER -102.99 -28.12 3.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 106.767 -1.568 . . . . 72.4 106.767 175.361 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.52 166.3 27.76 Favored Glycine 0 N--CA 1.414 -2.793 0 N-CA-C 110.546 -1.022 . . . . 51.5 110.546 -177.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 40.5 p -146.8 -173.91 4.34 Favored 'General case' 0 C--N 1.286 -2.178 0 C-N-CA 126.078 1.751 . . . . 73.42 106.331 -174.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 403' ' ' ASP . . . . . 0.424 ' HA ' ' HD3' ' A' ' 404' ' ' PRO . 21.6 t70 -98.43 126.52 39.17 Favored Pre-proline 0 C--N 1.296 -1.756 0 N-CA-C 107.699 -1.223 . . . . 71.05 107.699 -177.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 404' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 403' ' ' ASP . 52.8 Cg_exo -56.31 -4.65 0.79 Allowed 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 124.864 3.709 . . . . 73.24 116.324 -174.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.67 -39.81 71.45 Favored 'General case' 0 C--O 1.204 -1.294 0 N-CA-C 109.767 -0.457 . . . . 70.12 109.767 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -63.53 -40.05 96.01 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-O 121.365 0.603 . . . . 72.31 110.77 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -80.61 -4.58 54.67 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.389 0.614 . . . . 71.0 110.456 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 27.8 m -98.23 160.61 14.18 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 105.423 -2.066 . . . . 55.13 105.423 173.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 13.4 m -76.52 112.6 13.22 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 118.829 -1.148 . . . . 75.54 108.871 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 23.0 m -128.33 170.05 18.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.077 0.465 . . . . 73.11 111.198 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 36.7 t -74.35 143.3 44.94 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 108.782 -0.822 . . . . 62.34 108.782 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -63.09 131.14 47.55 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.065 -0.516 . . . . 31.2 111.293 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 90.89 29.71 12.6 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.714 -0.676 . . . . 72.21 112.655 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -83.07 -175.7 5.97 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 109.52 -0.548 . . . . 72.31 109.52 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -110.72 117.47 33.54 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 123.358 0.663 . . . . 62.3 111.291 -174.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.0 mm -105.77 115.08 46.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.405 0.622 . . . . 51.43 110.358 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 40.6 p -87.05 130.8 34.33 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 123.655 0.782 . . . . 73.42 110.691 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 8.2 p -124.19 134.55 66.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 109.736 -0.468 . . . . 73.1 109.736 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -104.66 122.81 46.43 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.851 -0.739 . . . . 65.3 110.357 176.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.589 HG13 ' HA ' ' A' ' 397' ' ' ASP . 34.7 t -111.75 131.87 61.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 114.705 -1.134 . . . . 72.4 110.588 -175.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 421' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 34.2 p -85.93 125.97 33.75 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 120.285 -0.566 . . . . 45.41 109.577 176.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.1 t -117.49 105.47 12.13 Favored 'General case' 0 N--CA 1.407 -2.621 0 C-N-CA 119.509 -0.876 . . . . 53.43 109.221 175.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.303 0 CA-C-N 115.494 -0.776 . . . . 53.21 113.318 179.469 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.504 ' OE1' ' HB ' ' A' ' 477' ' ' THR . 34.0 tt0 . . . . . 0 N--CA 1.42 -1.933 0 N-CA-C 107.387 -1.338 . . . . 73.01 107.387 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.618 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 1.6 mmp_? -122.32 139.87 53.31 Favored 'General case' 0 CA--C 1.479 -1.769 0 N-CA-C 112.795 0.665 . . . . 74.04 112.795 -174.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 42.2 tt0 -85.26 132.99 34.18 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.627 -1.17 . . . . 65.15 108.256 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 57.8 mt -80.92 124.43 81.47 Favored Pre-proline 0 C--N 1.307 -1.259 0 N-CA-C 109.812 -0.44 . . . . 72.14 109.812 -178.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -70.77 147.0 55.43 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.332 2.021 . . . . 72.15 110.397 175.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -81.21 102.19 10.17 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.494 0.664 . . . . 73.24 110.243 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 61.0 t -96.93 140.42 17.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 106.882 -1.525 . . . . 72.41 106.882 177.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 2.4 p -63.97 146.96 53.16 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 112.619 0.6 . . . . 71.01 112.619 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 25.7 p -60.63 -32.71 71.86 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 124.811 1.245 . . . . 72.41 113.774 -173.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.9 pp -81.04 -10.74 59.65 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.48 0.657 . . . . 74.24 111.588 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.3 m -106.61 40.95 1.52 Allowed 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.627 -0.879 . . . . 65.1 108.627 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -51.69 -37.98 53.07 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.943 1.297 . . . . 75.31 112.401 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -59.82 -38.85 83.18 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.046 0.45 . . . . 51.21 111.26 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.483 ' CD ' ' HE3' ' A' ' 442' ' ' LYS . 16.2 tp10 -70.4 -37.15 74.44 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.881 -0.785 . . . . 70.01 108.881 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.582 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -60.7 -51.24 70.19 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.518 -0.764 . . . . 75.1 111.162 -178.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 27.5 m -63.97 -40.55 89.48 Favored 'Isoleucine or valine' 0 C--O 1.249 1.029 0 N-CA-C 112.627 0.603 . . . . 73.31 112.627 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.483 ' HE3' ' CD ' ' A' ' 439' ' ' GLU . 41.9 pttt -68.61 -35.1 76.88 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 119.134 -1.026 . . . . 74.41 112.104 177.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -65.09 -38.31 90.33 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.347 -0.388 . . . . 75.33 110.882 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 94.3 mt -63.2 -38.59 91.78 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.332 -0.618 . . . . 74.31 109.332 177.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.446 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 86.4 m -66.14 -45.23 81.75 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.718 -0.674 . . . . 75.44 111.129 178.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.62 -15.87 63.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.038 0.447 . . . . 64.3 111.632 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -88.62 4.0 48.58 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.997 0.427 . . . . 51.44 111.396 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 112.47 -73.35 0.22 Allowed Glycine 0 CA--C 1.496 -1.152 0 C-N-CA 120.351 -0.928 . . . . 72.53 111.829 175.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 449' ' ' PHE . . . . . 0.56 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 0.4 OUTLIER -45.57 -68.27 0.21 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 114.021 1.119 . . . . 75.43 114.021 177.945 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 450' ' ' GLY . . . . . 0.446 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 60.36 27.33 65.41 Favored Glycine 0 C--N 1.315 -0.605 0 N-CA-C 111.38 -0.688 . . . . 62.44 111.38 -173.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.523 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 32.3 mmt180 -100.16 110.4 22.67 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 106.424 -1.695 . . . . 73.13 106.424 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.405 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 17.3 p90 -143.6 147.0 33.73 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 109.592 -0.521 . . . . 73.35 109.592 -177.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -137.75 123.1 19.46 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 108.43 -0.952 . . . . 65.3 108.43 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -87.38 124.71 33.68 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 123.598 0.561 . . . . 73.33 109.933 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 455' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -121.61 142.26 50.29 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 107.343 -1.354 . . . . 74.32 107.343 176.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -125.14 143.06 51.12 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 119.536 -0.865 . . . . 64.41 109.955 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 48.9 m -141.55 139.28 18.44 Favored Pre-proline 0 C--N 1.285 -2.197 0 N-CA-C 107.911 -1.144 . . . . 73.4 107.911 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.715 ' HA ' ' O ' ' A' ' 490' ' ' SER . 34.1 Cg_endo -65.44 122.56 10.28 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 121.746 1.631 . . . . 75.52 111.116 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 47.2 m -135.46 179.64 6.21 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.794 -1.094 . . . . 74.5 109.692 -174.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.9 t -49.3 133.71 17.07 Favored Pre-proline 0 C--O 1.251 1.179 0 O-C-N 124.103 0.877 . . . . 72.41 112.392 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.92 -29.62 35.95 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 124.566 3.51 . . . . 53.22 113.913 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -74.79 -23.8 58.56 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.652 0.612 . . . . 64.22 112.652 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -100.23 -6.05 26.64 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.975 0.416 . . . . 62.32 111.488 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 86.6 t -60.58 128.6 21.98 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 CA-C-N 116.192 -0.458 . . . . 62.33 109.841 176.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 97.07 -3.14 61.93 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.969 -0.634 . . . . 54.03 112.148 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -122.53 165.85 15.75 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 108.322 -0.992 . . . . 74.3 108.322 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 70.9 t -73.97 146.54 10.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.792 -1.188 . . . . 75.44 107.792 173.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 45.5 mt -98.08 -35.64 5.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 107.747 -1.205 . . . . 73.24 107.747 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 161.86 -162.24 33.93 Favored Glycine 0 N--CA 1.417 -2.631 0 N-CA-C 109.851 -1.3 . . . . 63.3 109.851 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 470' ' ' THR . . . . . 0.433 HG22 HD13 ' A' ' 486' ' ' ILE . 28.5 p -130.52 153.86 48.4 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 109.869 -0.419 . . . . 70.02 109.869 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -75.03 -56.31 2.06 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 109.017 -0.734 . . . . 72.2 109.017 172.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.28 163.9 35.37 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 121.405 1.403 . . . . 51.3 108.927 172.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -71.88 126.98 12.44 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.168 1.245 . . . . 54.13 112.241 -177.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -99.93 2.04 43.27 Favored 'General case' 0 C--O 1.212 -0.893 0 CA-C-O 121.532 0.682 . . . . 62.41 110.55 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -110.7 5.49 20.93 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 120.202 -0.599 . . . . 73.34 110.48 175.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -122.92 -177.57 3.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.896 0.379 . . . . 74.01 110.507 -175.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 1.0 OUTLIER -71.37 132.12 44.39 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 124.987 1.315 . . . . 70.51 113.471 179.296 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 69.6 m -130.55 144.28 51.31 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 115.517 -0.765 . . . . 73.35 109.578 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -79.34 161.53 26.17 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.342 -0.845 . . . . 74.42 110.893 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 480' ' ' ILE . . . . . 0.56 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 1.8 mp -70.08 -25.23 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.834 0.826 . . . . 74.55 111.265 -177.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 17.2 m -93.28 -9.28 39.55 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.543 0.687 . . . . 72.3 110.401 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -85.76 129.33 34.86 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.44 -0.8 . . . . 75.01 110.49 -175.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.523 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 10.7 p -97.52 126.81 50.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.176 0.512 . . . . 71.41 111.742 -178.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 35.9 m -100.2 127.31 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-O 121.711 0.767 . . . . 63.32 110.915 177.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.57 124.55 45.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.667 -0.697 . . . . 73.25 109.544 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.433 HD13 HG22 ' A' ' 470' ' ' THR . 34.3 mm -107.5 116.7 51.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.482 -1.303 . . . . 62.21 107.482 -177.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 11.7 tt -100.19 125.97 53.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 121.556 0.694 . . . . 50.35 110.025 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 33.6 m -110.3 151.13 12.59 Favored 'Isoleucine or valine' 0 C--O 1.258 1.536 0 CA-C-N 115.375 -0.829 . . . . 73.45 111.097 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -80.9 128.64 8.56 Favored Glycine 0 N--CA 1.419 -2.45 0 CA-C-N 115.307 -0.861 . . . . 64.14 111.158 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.715 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 31.3 t . . . . . 0 C--N 1.291 -1.939 0 N-CA-C 104.113 -2.551 . . . . 65.14 104.113 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo . . . . . 0 N--CA 1.416 -3.06 0 N-CA-C 109.265 -1.091 . . . . 70.31 109.265 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 493' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . -88.99 65.45 7.52 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.442 -0.947 . . . . 65.41 108.442 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 2.6 p -117.44 143.31 46.15 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 114.464 -1.244 . . . . 73.43 111.579 -175.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -135.95 151.23 49.73 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.499 -0.926 . . . . 72.54 108.499 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.5 p-10 -85.41 130.49 34.58 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.469 -0.938 . . . . 75.13 108.469 176.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 497' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 543' ' ' THR . 28.8 pt -92.11 121.91 65.9 Favored Pre-proline 0 C--N 1.29 -2.01 0 CA-C-N 116.109 -0.496 . . . . 60.02 111.038 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -85.73 -164.08 0.21 Allowed 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.552 2.168 . . . . 74.33 110.24 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -94.35 145.93 24.41 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 118.722 -1.191 . . . . 63.11 108.449 177.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 10.2 p -137.58 16.84 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 122.826 1.298 . . . . 72.5 107.505 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 501' ' ' ALA . . . . . 0.526 ' HB2' ' HA2' ' A' ' 536' ' ' GLY . . . -87.75 145.65 26.03 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 113.706 -1.588 . . . . 61.12 110.363 -174.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 107.02 -10.33 40.29 Favored Glycine 0 C--N 1.293 -1.845 0 N-CA-C 108.922 -1.671 . . . . 52.52 108.922 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -103.84 175.42 5.49 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 114.351 -0.925 . . . . 74.23 108.836 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 20.7 p -85.75 163.97 17.88 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-O 120.584 0.231 . . . . 63.5 111.069 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.1 p -54.96 -41.44 58.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.73 -0.668 . . . . 75.23 112.331 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -66.27 -41.7 89.52 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 120.521 -0.471 . . . . 72.2 110.864 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 90.5 t -67.89 -41.27 84.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.223 -0.444 . . . . 72.02 110.184 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.3 -46.64 85.77 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.31 -0.404 . . . . 53.14 110.629 178.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -59.56 -43.32 93.6 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.313 0.645 . . . . 73.03 109.761 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.432 ' O ' HG23 ' A' ' 514' ' ' VAL . 17.9 ttmm -59.51 -46.98 87.27 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.804 -1.089 . . . . 73.23 109.776 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -62.48 -46.02 90.37 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.257 -0.429 . . . . 74.51 111.032 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 10.3 mp -60.15 -43.48 95.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.396 -0.365 . . . . 72.41 111.297 178.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -61.71 -39.84 92.92 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.336 0.397 . . . . 71.21 110.91 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 510' ' ' LYS . 70.3 t -64.86 -32.41 58.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 116.019 -0.537 . . . . 73.41 111.053 177.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -85.74 2.51 45.21 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.346 -0.542 . . . . 73.24 111.785 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 98.86 -18.07 57.35 Favored Glycine 0 C--O 1.243 0.696 0 C-N-CA 120.847 -0.692 . . . . 73.24 112.797 176.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.486 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 83.4 m-85 -68.7 98.89 0.94 Allowed 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.955 0.883 . . . . 65.31 109.706 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.54 9.99 29.37 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.797 -1.092 . . . . 74.1 112.674 -174.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 519' ' ' LYS . . . . . 0.443 ' HD2' ' O ' ' A' ' 548' ' ' ASP . 63.6 mttp -122.72 113.46 19.24 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.536 -0.913 . . . . 65.01 108.536 173.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -132.2 156.57 46.22 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.581 -0.736 . . . . 74.54 111.653 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 521' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 52.6 m -135.64 136.53 41.06 Favored 'General case' 0 C--N 1.276 -2.605 0 N-CA-C 106.987 -1.486 . . . . 70.51 106.987 173.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -117.08 124.27 48.83 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.418 0.628 . . . . 65.25 109.913 -177.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -110.81 125.54 53.68 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 115.682 -0.69 . . . . 53.42 109.189 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 2.9 p -92.01 120.73 32.92 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 109.085 -0.709 . . . . 64.33 109.085 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 525' ' ' VAL . . . . . 0.508 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 26.9 m -121.24 152.22 24.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 116.548 -0.296 . . . . 73.03 110.465 -175.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -66.94 135.23 53.48 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 108.796 -0.816 . . . . 65.02 108.796 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 66.3 m -152.98 166.54 15.23 Favored Pre-proline 0 C--N 1.307 -1.278 0 C-N-CA 120.912 -0.315 . . . . 75.54 111.24 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -91.13 -7.16 3.73 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.099 1.866 . . . . 71.01 109.859 168.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.419 ' HA ' ' HD3' ' A' ' 530' ' ' PRO . 29.0 mmm180 -81.98 136.43 47.36 Favored Pre-proline 0 N--CA 1.42 -1.932 0 C-N-CA 124.924 1.29 . . . . 74.53 108.143 177.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 530' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 529' ' ' ARG . 33.8 Cg_exo -59.23 149.38 80.99 Favored 'Trans proline' 0 C--O 1.259 1.563 0 C-N-CA 122.61 2.207 . . . . 74.51 113.74 -177.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.641 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -61.61 126.16 26.35 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 114.114 -1.403 . . . . 42.32 111.59 -176.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 120.94 -24.23 7.52 Favored Glycine 0 C--N 1.305 -1.161 0 CA-C-N 115.646 -0.706 . . . . 61.13 111.973 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -82.67 125.79 31.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.801 0.334 . . . . 63.44 110.282 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 85.9 t -75.39 113.27 14.01 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 107.921 -1.14 . . . . 63.4 107.921 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 535' ' ' THR . . . . . 0.621 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 12.6 t -78.35 -18.84 54.58 Favored 'General case' 0 C--N 1.314 -0.941 0 O-C-N 123.593 0.558 . . . . 72.43 110.998 -176.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.526 ' HA2' ' HB2' ' A' ' 501' ' ' ALA . . . 160.08 -174.27 36.83 Favored Glycine 0 N--CA 1.422 -2.25 0 C-N-CA 120.499 -0.858 . . . . 64.15 111.213 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 19.4 p -117.42 157.47 26.15 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 108.607 -0.886 . . . . 52.44 108.607 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.452 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 19.4 t30 -71.17 -52.3 9.39 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 109.987 -0.375 . . . . 55.11 109.987 176.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.457 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 38.1 Cg_exo -66.13 131.92 28.34 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 120.914 1.076 . . . . 75.24 109.563 171.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 540' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 23.6 Cg_exo -66.23 147.94 84.17 Favored 'Trans proline' 0 C--O 1.243 0.767 0 C-N-CA 122.84 2.36 . . . . 73.1 113.24 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.21 134.42 55.9 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.672 -0.695 . . . . 64.13 109.583 176.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.47 -20.51 32.24 Favored Glycine 0 C--N 1.301 -1.395 0 N-CA-C 111.191 -0.764 . . . . 41.53 111.191 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.428 ' O ' HG12 ' A' ' 497' ' ' ILE . 44.9 m -67.43 134.8 52.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.98 0.419 . . . . 75.32 110.655 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 30.6 m -96.4 122.59 39.45 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 108.924 -0.769 . . . . 71.02 108.924 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 22.1 m -136.45 155.21 77.18 Favored Pre-proline 0 C--N 1.312 -1.022 0 CA-C-N 116.158 -0.474 . . . . 62.33 109.963 -177.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 37.5 Cg_exo -62.72 148.11 93.83 Favored 'Trans proline' 0 C--O 1.221 -0.363 0 C-N-CA 122.411 2.074 . . . . 64.35 111.929 176.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.486 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 35.5 m -65.81 -19.92 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-O 121.864 0.84 . . . . 43.24 111.005 177.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 548' ' ' ASP . . . . . 0.443 ' O ' ' HD2' ' A' ' 519' ' ' LYS . 37.6 t70 -92.79 3.43 55.67 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.581 -1.19 . . . . 72.41 110.058 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 30.2 t -84.06 159.48 21.15 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.562 -0.903 . . . . 62.12 108.562 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 18.1 t -96.38 122.55 48.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 109.01 -0.737 . . . . 71.21 109.01 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 61.5 mt -100.56 131.72 47.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 109.585 -0.524 . . . . 75.12 109.585 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 552' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 521' ' ' SER . 35.6 tt0 -102.46 115.81 31.33 Favored 'General case' 0 N--CA 1.418 -2.03 0 N-CA-C 109.395 -0.595 . . . . 54.44 109.395 178.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 553' ' ' LEU . . . . . 0.503 HD13 ' H ' ' A' ' 553' ' ' LEU . 0.0 OUTLIER -105.01 134.04 48.78 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.023 -0.99 . . . . 70.11 110.238 175.884 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -102.81 119.72 39.34 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.471 0.653 . . . . 55.12 110.639 -175.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 41.7 t -100.06 138.94 22.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-N 115.138 -0.937 . . . . 42.32 108.627 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.641 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 5.0 m -85.52 141.5 29.84 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.929 -0.578 . . . . 70.22 110.41 -178.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 525' ' ' VAL . 23.0 ptmt -110.28 147.55 33.64 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 105.485 -2.042 . . . . 74.14 105.485 167.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -79.29 -23.7 62.64 Favored Glycine 0 C--N 1.3 -1.472 0 C-N-CA 119.881 -1.152 . . . . 61.01 112.126 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 17.2 m120 59.34 37.65 23.32 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.09 -0.707 . . . . 73.05 109.09 -174.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -112.16 141.91 45.27 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.806 -0.633 . . . . 54.43 110.286 -172.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -123.77 146.76 48.08 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.708 -0.849 . . . . 71.32 108.708 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 56.9 t -72.55 117.52 16.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 121.086 0.47 . . . . 64.33 110.024 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 55.9 ttp -97.23 126.15 43.04 Favored Pre-proline 0 C--N 1.309 -1.18 0 CA-C-N 115.473 -0.785 . . . . 72.41 110.352 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -61.27 170.53 5.05 Favored 'Trans proline' 0 CA--C 1.548 1.22 0 C-N-CA 123.143 2.562 . . . . 63.12 111.804 171.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -60.69 143.6 53.87 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 123.663 0.785 . . . . 73.51 111.466 -178.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -123.94 -42.53 2.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.051 0.453 . . . . 73.21 110.315 -176.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 22.7 t -76.37 144.73 39.9 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.473 -0.936 . . . . 61.44 108.473 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 110.7 -7.1 29.76 Favored Glycine 0 C--N 1.31 -0.915 0 N-CA-C 110.636 -0.986 . . . . 70.51 110.636 -176.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 14.8 mtm -114.69 156.39 24.87 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 122.886 0.475 . . . . 74.23 110.739 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -87.38 143.55 27.19 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 106.196 -1.779 . . . . 71.54 106.196 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 33.3 t90 -51.24 -31.73 21.84 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 113.195 0.813 . . . . 72.44 113.195 -175.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 29.7 m -78.27 -19.38 13.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-O 121.398 0.618 . . . . 70.43 110.909 -176.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -100.99 -35.54 9.34 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.991 0.9 . . . . 73.2 108.86 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -67.98 -40.19 83.15 Favored 'General case' 0 C--O 1.205 -1.257 0 CA-C-N 114.264 -1.335 . . . . 71.14 111.623 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.503 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 36.0 tt0 -54.08 -57.57 17.47 Favored Pre-proline 0 CA--C 1.563 1.48 0 N-CA-C 112.595 0.591 . . . . 71.15 112.595 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 576' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 44.8 Cg_exo -59.79 -39.66 70.69 Favored 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 121.514 1.476 . . . . 65.11 111.619 177.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -39.1 90.95 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-O 120.955 0.407 . . . . 65.15 109.921 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.535 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 58.3 tp -66.82 -48.15 69.84 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 123.482 0.713 . . . . 65.53 110.914 -178.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -66.34 -35.09 79.46 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.033 -0.667 . . . . 61.5 111.11 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -65.68 -29.58 70.15 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.962 -0.563 . . . . 73.24 111.735 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 581' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 578' ' ' LEU . 4.3 pp -81.62 1.39 34.15 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.066 0.46 . . . . 72.3 111.588 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 92.67 22.91 27.35 Favored Glycine 0 CA--C 1.496 -1.144 0 C-N-CA 120.809 -0.71 . . . . 33.13 113.509 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 84.0 t90 -80.92 136.94 36.12 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 120.352 -0.539 . . . . 64.12 111.128 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 10.8 m -154.24 101.68 2.4 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 106.933 -1.506 . . . . 63.35 106.933 172.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -158.24 -149.65 5.53 Favored Glycine 0 CA--C 1.491 -1.453 0 N-CA-C 109.714 -1.354 . . . . 55.44 109.714 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 58.5 ttp -94.75 127.13 40.53 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 117.68 0.74 . . . . 70.42 110.203 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -102.3 130.01 48.89 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.534 -1.654 . . . . 73.02 106.534 176.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -95.87 105.23 17.22 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.276 0.56 . . . . 73.24 110.517 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -94.42 126.52 39.75 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 106.709 -1.589 . . . . 61.1 106.709 177.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 590' ' ' GLY . . . . . 0.509 ' HA3' ' NH1' ' A' ' 623' ' ' ARG . . . -120.8 -116.32 2.48 Favored Glycine 0 N--CA 1.423 -2.184 0 C-N-CA 120.596 -0.812 . . . . 64.2 112.257 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -137.13 144.72 43.15 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.682 -0.488 . . . . 61.13 109.682 -177.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -80.47 140.46 35.92 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.114 -1.069 . . . . 73.42 108.114 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 57.3 t -137.2 120.74 21.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 109.517 -0.549 . . . . 72.11 109.517 -172.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.28 106.96 5.33 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.54 -1.281 . . . . 73.33 107.54 173.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -138.64 8.25 2.59 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.899 0.703 . . . . 72.04 112.899 -174.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 117.96 139.83 6.34 Favored Glycine 0 C--N 1.299 -1.503 0 C-N-CA 120.088 -1.053 . . . . 43.43 110.92 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -55.39 -33.73 58.84 Favored Glycine 0 C--O 1.223 -0.558 0 N-CA-C 114.845 0.698 . . . . 71.44 114.845 -173.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 18.5 m -65.63 -24.59 67.08 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 117.503 0.651 . . . . 74.5 111.727 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -98.58 -12.46 21.14 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.212 0.53 . . . . 64.44 109.759 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 67.1 m170 -76.67 137.27 39.31 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.981 -0.554 . . . . 75.54 111.183 -176.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 9.5 p30 46.34 12.8 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 126.929 2.092 . . . . 70.23 115.964 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -126.61 146.72 50.05 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.598 -0.89 . . . . 63.44 108.598 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.31 131.33 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.268 0.627 . . . . 73.01 111.392 -177.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 60.2 t -90.49 -38.85 11.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 120.992 0.425 . . . . 63.34 111.159 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -151.83 162.4 41.11 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.992 -0.373 . . . . 75.34 109.992 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -131.85 127.62 36.94 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 123.845 0.715 . . . . 75.42 109.669 -176.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.572 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 50.7 t-20 -71.86 -62.11 1.75 Allowed Pre-proline 0 CA--C 1.562 1.422 0 N-CA-C 112.744 0.646 . . . . 73.45 112.744 -178.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 3.3 Cg_endo -87.41 134.14 3.38 Favored 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 121.38 1.387 . . . . 71.01 110.7 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.49 137.39 59.62 Favored 'Trans proline' 0 C--O 1.252 1.213 0 C-N-CA 122.853 2.369 . . . . 40.44 114.042 -177.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.9 131.12 44.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.984 -1.007 . . . . 65.43 110.319 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 89.58 0.19 79.46 Favored Glycine 0 C--N 1.312 -0.779 0 C-N-CA 120.694 -0.765 . . . . 64.33 112.271 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 22.5 m -101.31 157.92 16.43 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.919 -0.771 . . . . 71.24 108.919 178.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -73.1 113.83 4.49 Favored Glycine 0 N--CA 1.429 -1.816 0 N-CA-C 108.767 -1.733 . . . . 55.24 108.767 174.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 24.4 m -96.01 141.94 14.57 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-O 121.24 0.543 . . . . 75.24 112.03 -176.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.412 HD22 ' CG ' ' A' ' 617' ' ' ASP . 1.3 p-10 -47.64 140.63 6.01 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 126.322 1.849 . . . . 74.02 111.518 175.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -54.06 -25.93 24.17 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 114.326 1.232 . . . . 62.21 114.326 -175.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 617' ' ' ASP . . . . . 0.412 ' CG ' HD22 ' A' ' 615' ' ' ASN . 9.3 p-10 -75.37 -25.49 57.74 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.165 -0.679 . . . . 72.14 109.165 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 67.79 21.36 73.06 Favored Glycine 0 N--CA 1.428 -1.897 0 CA-C-O 119.296 -0.725 . . . . 71.34 113.744 172.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.87 118.31 11.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-O 123.312 1.53 . . . . 71.14 111.138 -168.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 3.2 tp -112.12 119.13 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.958 0 CA-C-N 112.96 -1.927 . . . . 75.11 108.649 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 7.0 m -98.6 117.49 33.18 Favored 'General case' 0 N--CA 1.406 -2.665 0 N-CA-C 105.958 -1.867 . . . . 60.4 105.958 175.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -139.28 160.7 39.2 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.23 -1.396 . . . . 75.12 107.23 -178.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 623' ' ' ARG . . . . . 0.509 ' NH1' ' HA3' ' A' ' 590' ' ' GLY . 13.0 tpt180 -151.16 150.96 31.26 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 105.755 -1.943 . . . . 73.44 105.755 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -138.84 160.98 38.38 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 106.0 -1.852 . . . . 65.14 106.0 173.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -78.2 -96.02 0.24 Allowed Glycine 0 N--CA 1.421 -2.331 0 N-CA-C 110.987 -0.845 . . . . 54.14 110.987 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 . . . . . 0 C--N 1.283 -2.295 0 N-CA-C 108.159 -1.052 . . . . 75.12 108.159 179.277 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 CA--C 1.509 -0.61 0 N-CA-C 108.484 -0.932 . . . . 70.11 108.484 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 360' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 409' ' ' SER . 35.8 m -117.45 163.92 14.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 109.393 -0.595 . . . . 73.1 109.393 -174.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -93.19 138.0 32.0 Favored 'General case' 0 N--CA 1.421 -1.875 0 N-CA-C 106.378 -1.712 . . . . 72.44 106.378 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 60.5 t -95.24 120.04 64.66 Favored Pre-proline 0 C--N 1.28 -2.425 0 CA-C-N 115.744 -0.662 . . . . 61.14 110.005 -167.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -65.7 122.82 10.54 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.54 2.16 . . . . 61.13 112.225 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -108.59 153.72 22.98 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 114.523 -1.217 . . . . 62.43 108.894 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.451 ' CG2' ' HA ' ' A' ' 373' ' ' ALA . 15.9 m -134.84 28.52 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 115.361 -0.836 . . . . 64.44 109.852 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.47 148.0 24.84 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 115.221 -0.899 . . . . 73.54 112.304 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 367' ' ' GLY . . . . . 0.425 ' H ' HG23 ' A' ' 399' ' ' VAL . . . 105.95 -5.25 39.39 Favored Glycine 0 C--N 1.321 -0.285 0 CA-C-N 116.332 -0.395 . . . . 75.14 112.251 -176.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -106.48 -85.08 0.51 Allowed 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 120.868 0.365 . . . . 65.2 110.831 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 369' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 41.9 p -153.46 157.82 40.45 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 108.449 -0.945 . . . . 64.2 108.449 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 49.0 m -63.95 -35.67 81.44 Favored 'General case' 0 C--O 1.203 -1.359 0 N-CA-C 109.692 -0.484 . . . . 72.22 109.692 175.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.81 -46.77 88.09 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 116.348 -0.387 . . . . 73.0 111.973 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -68.1 -38.78 82.7 Favored 'General case' 0 C--O 1.245 0.828 0 C-N-CA 120.289 -0.564 . . . . 54.41 110.163 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 373' ' ' ALA . . . . . 0.451 ' HA ' ' CG2' ' A' ' 365' ' ' VAL . . . -66.59 -51.09 60.23 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.66 -0.7 . . . . 51.31 111.092 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 374' ' ' ILE . . . . . 0.434 HG23 HG12 ' A' ' 384' ' ' ILE . 60.1 mt -60.08 -43.52 92.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 123.167 0.587 . . . . 60.33 110.517 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -60.47 -47.22 87.07 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.101 0.477 . . . . 45.32 110.59 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 376' ' ' THR . . . . . 0.526 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 58.9 m -66.61 -47.79 71.57 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.811 -0.631 . . . . 72.15 111.402 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 9.8 mp -64.24 -37.69 88.39 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 112.001 0.371 . . . . 75.03 112.001 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -64.02 -41.5 97.43 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 109.518 -0.549 . . . . 55.32 109.518 176.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -67.31 -22.38 65.63 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 116.24 -0.436 . . . . 64.34 111.452 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 380' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 376' ' ' THR . 13.7 mmm180 -80.94 -14.54 57.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.983 0.421 . . . . 73.52 109.963 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 96.8 14.9 41.56 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.904 -0.665 . . . . 13.42 112.244 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.504 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 55.1 m-85 -93.22 167.72 11.57 Favored 'General case' 0 N--CA 1.427 -1.621 0 O-C-N 122.488 -0.419 . . . . 70.32 110.969 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -105.51 143.83 33.13 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 106.528 -1.656 . . . . 73.44 106.528 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 384' ' ' ILE . . . . . 0.434 HG12 HG23 ' A' ' 374' ' ' ILE . 1.2 pp -125.6 131.94 71.48 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 CA-C-O 121.593 0.711 . . . . 74.51 111.939 -177.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -111.04 129.34 55.94 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 114.707 -1.133 . . . . 71.51 108.035 -176.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 10.5 m -121.66 123.98 43.19 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 110.101 -0.333 . . . . 62.44 110.101 -176.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -111.57 122.82 48.83 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.536 -0.542 . . . . 64.22 109.536 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 7.6 pm0 -102.93 126.97 50.31 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.962 0.41 . . . . 73.4 110.536 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -135.14 136.27 24.42 Favored Pre-proline 0 C--N 1.297 -1.696 0 CA-C-N 115.994 -0.548 . . . . 64.41 110.394 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.07 147.24 93.85 Favored 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 123.055 2.503 . . . . 73.24 111.846 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 6.4 t70 86.41 178.59 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.515 1.926 . . . . 72.02 108.949 -178.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 25.7 m -132.41 14.66 4.55 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 121.692 0.758 . . . . 72.4 110.366 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 10.1 t -69.08 -28.05 66.17 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 107.889 -1.152 . . . . 73.31 107.889 172.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.67 HD13 ' H ' ' A' ' 394' ' ' ILE . 0.2 OUTLIER -88.55 151.73 48.5 Favored Pre-proline 0 N--CA 1.433 -1.308 0 N-CA-C 107.59 -1.263 . . . . 74.21 107.59 174.003 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -28.97 116.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.306 0 C-N-CA 125.148 3.899 . . . . 71.23 115.034 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 396' ' ' PRO . . . . . 0.602 ' HA ' ' OG ' ' A' ' 421' ' ' SER . 48.5 Cg_exo -58.55 161.03 15.45 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 123.805 3.003 . . . . 61.44 113.626 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -57.63 -9.24 1.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.13 0.972 . . . . 63.31 113.077 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 32.6 m170 -107.37 119.86 40.55 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 104.504 -2.406 . . . . 64.52 104.504 171.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.425 HG23 ' H ' ' A' ' 367' ' ' GLY . 11.0 m -62.84 118.24 4.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.196 0 O-C-N 123.681 0.613 . . . . 51.23 111.574 -168.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.38 -34.96 8.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 108.029 -1.1 . . . . 65.35 108.029 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -152.73 157.92 27.58 Favored Glycine 0 N--CA 1.409 -3.153 0 N-CA-C 109.369 -1.492 . . . . 71.3 109.369 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.2 p -117.89 -178.82 3.58 Favored 'General case' 0 C--N 1.277 -2.58 0 N-CA-C 108.435 -0.95 . . . . 72.3 108.435 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -100.74 146.28 31.81 Favored Pre-proline 0 C--N 1.295 -1.795 0 C-N-CA 119.306 -0.958 . . . . 63.03 111.006 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.12 -16.36 1.78 Allowed 'Trans proline' 0 C--N 1.364 1.347 0 C-N-CA 125.221 3.947 . . . . 60.32 114.868 -176.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.43 -33.86 63.93 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.365 0.666 . . . . 72.03 111.042 176.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -82.34 -30.69 30.27 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.434 0.635 . . . . 71.35 111.135 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -86.56 -1.84 57.98 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.335 0.588 . . . . 64.33 110.573 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 47.2 m -107.54 148.38 29.32 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.094 -1.447 . . . . 75.44 107.094 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 409' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 360' ' ' VAL . 65.3 m -74.5 113.34 11.64 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 120.055 -0.658 . . . . 25.4 110.319 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 33.4 m -129.31 169.49 20.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.774 -0.648 . . . . 63.52 109.467 177.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 22.6 t -79.84 156.39 27.39 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.094 -0.706 . . . . 60.55 109.094 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 412' ' ' ALA . . . . . 0.504 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -70.87 143.13 51.13 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 116.101 -0.499 . . . . 21.43 110.703 -178.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 103.02 10.6 36.54 Favored Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 120.398 -0.906 . . . . 44.52 112.98 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -80.53 174.51 11.54 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.244 -1.021 . . . . 72.22 108.244 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -110.01 114.69 28.42 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.945 -0.761 . . . . 74.31 108.945 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 46.6 mm -97.7 127.37 50.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 109.179 -0.674 . . . . 61.34 109.179 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 1.7 p -86.66 130.67 34.39 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 114.028 1.121 . . . . 73.45 114.028 -176.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 2.1 t -123.34 134.89 64.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 C-N-CA 125.126 1.37 . . . . 75.43 110.007 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -106.49 129.12 54.5 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 115.457 -0.792 . . . . 53.04 109.871 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 5.3 p -118.76 131.22 72.17 Favored 'Isoleucine or valine' 0 C--O 1.256 1.408 0 N-CA-C 109.707 -0.479 . . . . 64.15 109.707 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 421' ' ' SER . . . . . 0.602 ' OG ' ' HA ' ' A' ' 396' ' ' PRO . 54.6 p -84.75 125.54 32.64 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 115.904 -0.589 . . . . 75.14 110.43 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.8 m -97.82 156.9 16.37 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 107.132 -1.433 . . . . 62.14 107.132 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.411 0 N-CA-C 114.815 0.686 . . . . 64.11 114.815 -177.101 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 . . . . . 0 N--CA 1.436 -1.134 0 N-CA-C 108.284 -1.006 . . . . 74.14 108.284 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.551 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 1.5 mmp_? -123.56 159.57 28.9 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 112.698 0.629 . . . . 62.34 112.698 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -82.66 141.18 32.68 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.534 -1.212 . . . . 72.44 108.169 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.443 HD12 ' O ' ' A' ' 473' ' ' PRO . 63.9 mt -77.84 125.98 84.77 Favored Pre-proline 0 N--CA 1.43 -1.449 0 N-CA-C 107.685 -1.228 . . . . 61.52 107.685 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 429' ' ' ILE . 16.9 Cg_exo -69.7 140.85 43.92 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.639 1.559 . . . . 73.1 111.35 178.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -95.4 130.2 42.28 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.302 -1.74 . . . . 71.01 106.302 175.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.541 HG11 ' HB2' ' A' ' 440' ' ' ALA . 13.2 p -129.59 150.51 34.69 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.259 0 C-N-CA 120.346 -0.542 . . . . 73.12 110.515 -172.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 5.7 m -63.23 137.89 58.36 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 107.657 -1.238 . . . . 52.44 107.657 173.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 434' ' ' THR . . . . . 0.457 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 52.9 p -60.16 -28.77 68.19 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 123.989 0.916 . . . . 74.13 113.293 -171.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.403 ' HB3' ' HG3' ' A' ' 466' ' ' LYS . 1.1 pp -88.15 -10.73 49.04 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 113.558 0.947 . . . . 74.41 113.558 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 3.6 m -102.65 49.96 0.83 Allowed 'General case' 0 CA--C 1.563 1.459 0 CA-C-O 121.62 0.724 . . . . 75.52 111.056 -175.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -52.72 -37.63 59.51 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.93 0.892 . . . . 72.43 112.58 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' A' ' 442' ' ' LYS . . . -58.82 -40.1 83.18 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.101 0.477 . . . . 61.42 111.367 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -69.42 -35.47 75.74 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.604 -0.887 . . . . 61.51 108.604 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.541 ' HB2' HG11 ' A' ' 432' ' ' VAL . . . -60.78 -51.67 68.35 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.591 -0.732 . . . . 25.0 111.036 -178.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 33.5 m -62.31 -44.61 99.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 120.829 -0.348 . . . . 73.45 111.829 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 438' ' ' ALA 0.339 0.0 OUTLIER -68.66 -33.7 74.44 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 113.432 0.901 . . . . 71.42 113.432 178.881 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -65.01 -43.05 93.79 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 122.197 -0.314 . . . . 71.24 111.108 174.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.492 HD13 ' O ' ' A' ' 440' ' ' ALA . 8.9 mp -63.37 -35.24 79.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.347 -0.388 . . . . 75.12 110.325 177.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.461 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 38.6 m -67.28 -44.29 79.66 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 116.11 -0.495 . . . . 74.14 110.671 178.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.71 -22.94 65.24 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.22 -0.446 . . . . 72.14 111.435 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -80.09 5.16 15.02 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 116.061 -0.518 . . . . 53.11 111.737 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 102.23 -61.21 0.53 Allowed Glycine 0 CA--C 1.492 -1.374 0 C-N-CA 120.739 -0.743 . . . . 70.31 112.348 173.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 449' ' ' PHE . . . . . 0.44 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 0.9 OUTLIER -53.28 -63.4 1.16 Allowed 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 112.885 0.698 . . . . 70.1 112.885 178.224 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 450' ' ' GLY . . . . . 0.461 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 60.01 23.22 59.07 Favored Glycine 0 C--N 1.316 -0.572 0 O-C-N 123.199 0.312 . . . . 63.11 113.15 -178.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.446 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 35.6 mmt180 -108.2 110.82 22.54 Favored 'General case' 0 N--CA 1.422 -1.856 0 N-CA-C 107.337 -1.357 . . . . 74.31 107.337 -178.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -131.29 146.02 52.12 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.651 -0.704 . . . . 63.34 110.499 -175.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -131.58 132.79 44.39 Favored 'General case' 0 C--N 1.286 -2.196 0 N-CA-C 108.397 -0.964 . . . . 62.42 108.397 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -101.05 126.98 47.77 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 120.956 0.408 . . . . 75.13 110.244 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.27 153.31 36.55 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.539 -1.282 . . . . 70.22 107.539 175.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -127.36 144.84 50.98 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.602 -0.518 . . . . 74.42 109.602 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 28.2 t -141.81 142.99 27.1 Favored Pre-proline 0 C--N 1.291 -1.963 0 N-CA-C 107.932 -1.136 . . . . 60.34 107.932 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.659 ' HA ' ' O ' ' A' ' 490' ' ' SER . 19.3 Cg_exo -65.83 138.73 54.4 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.872 1.715 . . . . 63.22 110.251 176.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 65.9 m -150.82 174.42 13.09 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 109.522 -0.547 . . . . 73.41 109.522 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.0 t -52.83 136.91 45.52 Favored Pre-proline 0 N--CA 1.437 -1.112 0 C-N-CA 123.739 0.816 . . . . 52.45 110.571 174.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.89 -30.24 38.12 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 124.624 3.549 . . . . 63.04 113.478 -175.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -67.43 -27.83 67.39 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.184 -0.462 . . . . 74.13 111.624 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -99.23 -13.38 19.73 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 111.717 0.266 . . . . 64.43 111.717 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 56.9 t -59.25 130.56 22.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.268 -0.424 . . . . 73.13 110.79 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.08 -10.26 60.05 Favored Glycine 0 N--CA 1.435 -1.399 0 CA-C-N 115.92 -0.582 . . . . 65.34 111.84 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.403 ' HG3' ' HB3' ' A' ' 435' ' ' LEU . 3.8 mppt? -118.03 166.57 12.38 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-O 120.886 0.375 . . . . 53.42 110.899 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.457 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 74.4 t -73.35 143.07 14.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 108.167 -1.049 . . . . 71.24 108.167 176.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 48.9 mm -98.02 -27.07 3.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.313 -0.995 . . . . 74.12 108.313 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 157.94 -161.48 31.52 Favored Glycine 0 N--CA 1.428 -1.894 0 CA-C-N 115.643 -0.708 . . . . 52.14 111.572 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 470' ' ' THR . . . . . 0.465 HG22 HG12 ' A' ' 486' ' ' ILE . 40.0 p -115.21 141.29 48.22 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.593 -1.262 . . . . 62.42 107.593 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.492 ' HB3' HG23 ' A' ' 485' ' ' ILE . 6.7 t30 -64.73 -50.42 64.28 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 109.791 -0.448 . . . . 63.12 109.791 176.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -75.29 155.44 41.62 Favored 'Trans proline' 0 C--N 1.377 2.035 0 N-CA-C 108.951 -1.211 . . . . 74.33 108.951 173.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.443 ' O ' HD12 ' A' ' 429' ' ' ILE . 37.3 Cg_exo -62.96 126.19 17.5 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.173 1.248 . . . . 52.4 109.819 177.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -74.4 -0.7 18.16 Favored 'General case' 0 C--O 1.194 -1.838 0 N-CA-C 112.984 0.735 . . . . 63.52 112.984 -173.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -108.96 3.86 22.68 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 121.78 -0.575 . . . . 50.24 110.071 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 476' ' ' GLN . . . . . 0.417 ' HG2' ' HB2' ' A' ' 473' ' ' PRO . 84.3 mm-40 -98.17 175.71 5.99 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 112.269 0.47 . . . . 74.24 112.269 -177.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 1.3 m -105.87 112.29 25.29 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.464 -0.789 . . . . 50.13 109.455 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 12.7 p -101.12 145.98 28.07 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.038 0.447 . . . . 65.45 110.858 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -75.33 150.57 38.42 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.547 -0.751 . . . . 61.45 110.739 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 480' ' ' ILE . . . . . 0.44 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 1.7 mp -67.85 -26.05 33.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 123.519 0.728 . . . . 74.15 111.59 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 12.5 t -89.46 2.58 54.33 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.822 0.82 . . . . 74.22 110.342 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -102.82 144.14 31.54 Favored 'General case' 0 C--N 1.318 -0.802 0 O-C-N 121.936 -0.478 . . . . 62.15 110.78 -175.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.446 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 6.4 p -108.15 127.21 64.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 C-N-CA 123.067 0.547 . . . . 73.14 111.566 -177.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 35.7 m -104.73 141.86 19.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.771 -0.65 . . . . 33.34 111.391 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.492 HG23 ' HB3' ' A' ' 471' ' ' ASN . 0.0 OUTLIER -108.93 130.13 62.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.401 0.62 . . . . 64.41 111.795 -178.513 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.465 HG12 HG22 ' A' ' 470' ' ' THR . 13.1 mt -113.81 129.72 69.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 C-N-CA 125.084 1.354 . . . . 70.51 111.206 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 9.9 tt -105.33 126.96 60.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.586 -0.734 . . . . 73.31 111.388 -174.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.411 HG12 HG22 ' A' ' 467' ' ' VAL . 35.7 m -109.68 151.65 11.9 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 C-N-CA 123.519 0.728 . . . . 75.2 110.326 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -92.28 132.51 11.3 Favored Glycine 0 C--N 1.311 -0.809 0 N-CA-C 111.053 -0.819 . . . . 74.31 111.053 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.659 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 23.3 t . . . . . 0 N--CA 1.43 -1.428 0 N-CA-C 109.642 -0.503 . . . . 65.24 109.642 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo . . . . . 0 CA--C 1.531 0.347 0 N-CA-C 110.798 -0.501 . . . . 72.34 110.798 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 493' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . -112.19 25.9 11.1 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.582 0.706 . . . . 51.12 111.101 -176.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 6.6 p -116.94 143.47 45.67 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 114.93 -1.032 . . . . 72.31 110.659 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -151.2 147.09 26.59 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 108.419 -0.956 . . . . 72.25 108.419 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.524 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 7.6 p-10 -85.71 132.5 34.13 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.699 0.761 . . . . 75.23 112.543 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 33.7 pt -77.18 137.45 64.91 Favored Pre-proline 0 C--N 1.308 -1.22 0 CA-C-N 114.461 -1.245 . . . . 75.23 111.247 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -85.7 175.02 6.3 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.417 2.078 . . . . 60.35 112.528 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -97.21 132.46 42.94 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.59 -0.732 . . . . 60.52 109.654 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.2 104.11 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.626 0 CA-C-O 122.017 0.913 . . . . 61.23 110.598 -177.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -146.55 139.91 25.74 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.958 -1.019 . . . . 51.43 108.725 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 113.9 -18.48 19.24 Favored Glycine 0 CA--C 1.485 -1.837 0 N-CA-C 110.412 -1.075 . . . . 72.11 110.412 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 503' ' ' GLN . . . . . 0.432 ' O ' HG12 ' A' ' 534' ' ' VAL . 50.8 mt-30 -95.87 -179.52 4.73 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 109.22 -0.659 . . . . 70.51 109.22 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 15.0 t -91.87 157.16 17.01 Favored 'General case' 0 N--CA 1.421 -1.896 0 C-N-CA 118.184 -1.406 . . . . 64.12 107.885 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 6.0 p -53.77 -42.5 52.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 O-C-N 123.742 0.651 . . . . 64.4 112.344 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -65.48 -41.52 93.19 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.265 0.353 . . . . 72.03 110.976 -176.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 81.8 t -70.59 -44.49 76.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.878 0.371 . . . . 71.25 110.798 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 508' ' ' ALA . . . . . 0.415 ' O ' ' HG ' ' A' ' 512' ' ' LEU . . . -61.44 -48.49 80.94 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.01 -0.541 . . . . 73.31 111.147 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -60.4 -43.11 96.98 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.249 -0.887 . . . . 75.32 109.939 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.483 ' O ' HG23 ' A' ' 514' ' ' VAL . 35.4 ttmt -63.21 -42.37 99.29 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.967 -1.015 . . . . 53.42 110.127 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -62.33 -41.7 98.77 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.057 0.456 . . . . 72.23 110.136 178.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 512' ' ' LEU . . . . . 0.442 HD13 HG13 ' A' ' 551' ' ' ILE . 89.4 mt -65.73 -37.1 85.47 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.717 -0.674 . . . . 72.13 110.923 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -64.23 -37.76 88.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.253 -0.431 . . . . 75.43 110.051 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 510' ' ' LYS . 93.3 t -62.55 -31.17 51.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 115.889 -0.596 . . . . 71.12 110.673 177.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -77.24 -6.75 54.25 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 120.818 0.342 . . . . 74.14 111.062 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 106.96 -0.06 35.9 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.401 -0.904 . . . . 51.35 113.239 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -90.86 99.37 12.42 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 107.56 -1.274 . . . . 75.3 107.56 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.1 m -91.0 -11.35 39.16 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.972 -1.013 . . . . 75.15 112.076 -172.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 519' ' ' LYS . . . . . 0.517 ' HD2' ' O ' ' A' ' 548' ' ' ASP . 95.7 mttt -108.62 118.18 36.12 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.239 -0.652 . . . . 74.42 109.239 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -129.63 155.0 46.55 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.147 0.498 . . . . 70.51 111.01 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 4.8 p -141.11 148.17 39.69 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 107.457 -1.312 . . . . 65.12 107.457 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 522' ' ' GLN . . . . . 0.459 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 10.7 pt20 -132.64 132.61 42.63 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-O 121.235 0.54 . . . . 71.44 111.062 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -113.56 141.51 47.08 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.457 -1.682 . . . . 61.43 106.457 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 45.3 p -121.22 129.16 53.06 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 120.397 -0.521 . . . . 64.54 111.459 -177.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 525' ' ' VAL . . . . . 0.57 ' O ' ' HB3' ' A' ' 557' ' ' LYS . 19.5 m -121.82 166.67 16.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 109.267 -0.642 . . . . 65.52 109.267 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -92.38 137.85 32.01 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.997 -1.483 . . . . 75.1 106.997 174.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 10.3 m -141.65 173.22 4.99 Favored Pre-proline 0 C--N 1.276 -2.625 0 N-CA-C 108.477 -0.934 . . . . 54.24 108.477 -172.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -79.22 -17.52 11.67 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 121.651 1.567 . . . . 64.32 109.19 168.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.603 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 18.0 mmm180 -67.38 152.19 96.41 Favored Pre-proline 0 N--CA 1.441 -0.905 0 C-N-CA 125.752 1.621 . . . . 65.31 108.581 177.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.44 156.32 61.82 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.335 2.023 . . . . 62.54 112.791 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 557' ' ' LYS . . . -70.93 124.92 25.48 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.937 -0.574 . . . . 73.22 111.038 -178.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 107.82 -10.95 38.14 Favored Glycine 0 C--N 1.305 -1.182 0 C-N-CA 120.589 -0.815 . . . . 42.1 111.395 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -82.46 138.64 34.31 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.469 -1.678 . . . . 70.32 106.469 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.432 HG12 ' O ' ' A' ' 503' ' ' GLN . 11.6 p -95.22 118.29 41.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 119.896 -0.722 . . . . 75.52 110.163 -178.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 535' ' ' THR . . . . . 0.582 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 13.2 t -84.05 0.09 49.64 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.364 -0.38 . . . . 44.11 111.614 -175.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.424 ' H ' HG22 ' A' ' 534' ' ' VAL . . . 135.49 -160.94 24.63 Favored Glycine 0 CA--C 1.495 -1.204 0 C-N-CA 120.887 -0.673 . . . . 75.21 111.921 175.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 37.2 p -117.77 155.3 30.26 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.794 -0.817 . . . . 73.12 108.794 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -76.16 -50.34 2.98 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-O 119.437 -0.316 . . . . 64.21 110.507 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -66.95 135.95 39.6 Favored 'Trans proline' 0 C--N 1.369 1.609 0 N-CA-C 108.991 -1.196 . . . . 73.02 108.991 169.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.56 150.56 86.49 Favored 'Trans proline' 0 C--O 1.244 0.784 0 C-N-CA 122.378 2.052 . . . . 63.53 112.799 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.22 138.02 57.39 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.924 -0.769 . . . . 73.23 108.924 176.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.47 -11.34 58.13 Favored Glycine 0 C--N 1.294 -1.789 0 C-N-CA 120.606 -0.807 . . . . 53.21 111.767 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 59.5 m -69.87 120.86 16.24 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.595 -0.521 . . . . 72.3 109.595 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 11.5 t -85.89 123.16 30.92 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 109.079 -0.711 . . . . 71.41 109.079 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 29.1 m -135.88 159.96 69.22 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 108.349 -0.982 . . . . 72.04 108.349 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 32.3 Cg_exo -61.54 141.1 90.48 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 121.711 1.608 . . . . 74.0 110.8 174.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 35.2 m -61.05 -19.65 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-O 121.811 0.815 . . . . 74.52 111.978 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 548' ' ' ASP . . . . . 0.517 ' O ' ' HD2' ' A' ' 519' ' ' LYS . 25.1 t70 -90.12 -1.23 57.92 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.242 -0.89 . . . . 74.14 110.897 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 67.2 m -86.29 172.95 10.07 Favored 'General case' 0 C--N 1.313 -1.018 0 O-C-N 121.697 -0.627 . . . . 73.41 112.547 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 14.3 p -100.14 136.49 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 115.255 -0.884 . . . . 62.11 110.886 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 551' ' ' ILE . . . . . 0.502 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -108.97 145.67 15.51 Favored 'Isoleucine or valine' 0 C--O 1.252 1.228 0 N-CA-C 109.245 -0.65 . . . . 71.24 109.245 174.782 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -109.13 115.15 29.5 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 121.303 0.573 . . . . 74.23 111.035 -176.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 553' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 5.1 mp -95.5 135.2 37.45 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.612 -1.177 . . . . 55.04 109.425 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -110.43 118.12 35.41 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.68 0.752 . . . . 73.41 110.318 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.88 141.1 16.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 114.731 -1.122 . . . . 72.54 110.288 -174.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.603 ' HB3' ' HB2' ' A' ' 529' ' ' ARG . 7.8 m -86.29 147.95 25.84 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 115.35 -0.841 . . . . 63.11 110.653 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.57 ' HB3' ' O ' ' A' ' 525' ' ' VAL . 0.5 OUTLIER -123.58 130.12 52.19 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.111 -0.95 . . . . 73.54 109.691 173.69 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 558' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -66.25 -43.46 92.9 Favored Glycine 0 CA--C 1.486 -1.769 0 N-CA-C 111.36 -0.696 . . . . 31.14 111.36 -176.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 64.3 t30 72.53 -8.74 1.16 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.968 1.307 . . . . 74.23 110.56 176.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.463 ' H ' ' C ' ' A' ' 558' ' ' GLY . 97.0 mt-30 -127.21 155.34 43.58 Favored 'General case' 0 N--CA 1.423 -1.81 0 C-N-CA 125.567 1.547 . . . . 70.33 107.375 177.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -126.48 147.65 49.79 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.844 -0.798 . . . . 74.04 108.844 177.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 62.8 t -63.43 116.98 3.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 O-C-N 123.408 0.442 . . . . 74.33 110.079 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 58.3 ttp -75.49 124.77 89.12 Favored Pre-proline 0 C--N 1.306 -1.314 0 CA-C-N 115.979 -0.555 . . . . 73.25 110.788 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -65.89 169.41 13.32 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.095 2.53 . . . . 44.35 110.32 174.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -89.19 114.17 25.46 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 118.72 -1.192 . . . . 53.2 111.688 -177.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -125.81 0.18 7.37 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.567 -1.271 . . . . 64.25 107.567 173.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 23.9 m -65.07 151.2 46.63 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 113.777 -1.556 . . . . 54.31 112.238 -174.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 90.79 35.97 7.01 Favored Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 110.213 -1.155 . . . . 50.42 110.213 -175.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 15.9 ptm -117.53 157.5 26.21 Favored 'General case' 0 C--O 1.25 1.089 0 N-CA-C 109.529 -0.545 . . . . 73.15 109.529 -174.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 570' ' ' PHE . . . . . 0.59 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 86.3 m-85 -84.53 171.52 12.43 Favored 'General case' 0 CA--C 1.502 -0.9 0 O-C-N 123.322 0.389 . . . . 70.4 110.821 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 29.4 t90 -62.6 -34.0 76.12 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.941 -0.762 . . . . 72.45 108.941 172.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 29.1 m -72.33 -7.96 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.318 -0.855 . . . . 73.44 110.97 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 573' ' ' ASP . . . . . 0.584 ' O ' ' HD3' ' A' ' 577' ' ' ARG . 31.6 m-20 -100.92 -44.83 5.63 Favored 'General case' 0 CA--C 1.492 -1.276 0 N-CA-C 109.407 -0.59 . . . . 74.04 109.407 174.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 574' ' ' ALA . . . . . 0.646 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -61.04 -53.2 60.07 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.081 -0.963 . . . . 72.43 112.539 -175.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.417 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 1.0 OUTLIER -57.95 -50.69 86.67 Favored Pre-proline 0 CA--C 1.574 1.892 0 O-C-N 123.547 0.529 . . . . 70.41 112.005 -174.659 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 576' ' ' PRO . . . . . 0.417 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 67.1 Cg_exo -58.25 -38.42 91.04 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 121.847 1.698 . . . . 63.23 112.268 174.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.584 ' HD3' ' O ' ' A' ' 573' ' ' ASP . 5.7 mpt_? -67.67 -34.26 76.57 Favored 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 121.111 -0.236 . . . . 74.53 111.555 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 76.2 mt -60.7 -43.11 98.17 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.976 -0.75 . . . . 73.1 108.976 177.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -64.28 -45.9 85.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.147 -0.933 . . . . 72.3 109.302 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.11 92.27 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.854 -1.066 . . . . 64.51 113.44 -176.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 11.1 mp -82.22 -9.09 59.62 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 113.127 0.788 . . . . 72.5 113.127 -177.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 68.78 32.36 74.01 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 109.255 -1.538 . . . . 44.25 109.255 -174.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 44.8 t90 -60.61 134.07 56.72 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.021 0.928 . . . . 61.04 110.284 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 8.9 t -126.61 19.33 7.34 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.858 -0.61 . . . . 73.55 109.917 -176.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -79.97 -155.22 10.27 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 115.808 -0.633 . . . . 34.34 113.511 -176.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 586' ' ' MET . . . . . 0.44 ' H ' HG12 ' A' ' 619' ' ' ILE . 86.1 mtp -124.94 132.62 53.26 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.551 -0.907 . . . . 54.22 108.551 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 61.9 tp -106.8 130.69 54.46 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.328 -0.619 . . . . 74.44 109.328 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -114.2 121.92 45.2 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 120.898 0.38 . . . . 72.15 110.206 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -105.5 118.38 36.42 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 116.153 -0.476 . . . . 72.13 110.216 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -88.19 -163.09 38.85 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.691 -0.964 . . . . 72.2 110.691 177.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -67.19 147.8 52.6 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 120.742 0.306 . . . . 72.33 110.699 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -93.72 124.51 37.76 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.138 0.494 . . . . 54.21 111.448 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 91.2 t -114.73 126.39 72.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 106.664 -1.606 . . . . 62.13 106.664 175.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 594' ' ' ASP . . . . . 0.535 ' HA ' ' HB2' ' A' ' 626' ' ' GLN . 6.2 p-10 -102.44 125.35 49.13 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 120.445 -0.502 . . . . 65.02 109.877 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -133.04 -28.68 1.51 Allowed 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.464 -0.789 . . . . 74.32 110.428 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 130.37 125.29 2.69 Favored Glycine 0 CA--C 1.486 -1.752 0 N-CA-C 109.979 -1.248 . . . . 62.52 109.979 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.29 -36.07 67.81 Favored Glycine 0 C--O 1.21 -1.363 0 N-CA-C 114.641 0.617 . . . . 63.14 114.641 -172.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 18.6 m -62.67 -32.06 73.06 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 117.58 0.69 . . . . 75.54 112.194 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -109.37 -1.92 18.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.62 -0.264 . . . . 54.01 111.525 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 600' ' ' HIS . . . . . 0.502 ' CE1' ' HA3' ' A' ' 625' ' ' GLY . 5.9 t-160 -150.49 -148.92 0.28 Allowed 'General case' 0 C--O 1.204 -1.328 0 N-CA-C 108.78 -0.822 . . . . 65.43 108.78 -170.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 601' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 626' ' ' GLN . 3.1 t-20 62.22 2.87 0.9 Allowed 'General case' 0 N--CA 1.516 2.828 0 C-N-CA 125.1 1.36 . . . . 75.3 112.282 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 602' ' ' ARG . . . . . 0.59 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 9.2 ptp85 -110.64 171.58 7.38 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.036 -0.984 . . . . 73.43 109.355 -177.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 603' ' ' VAL . . . . . 0.422 HG23 ' HB2' ' A' ' 622' ' ' LEU . 7.6 p -57.03 130.78 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 O-C-N 124.469 1.105 . . . . 51.34 109.039 176.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 29.2 m -101.22 -37.17 5.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 121.504 0.669 . . . . 64.23 109.561 -175.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 605' ' ' TYR . . . . . 0.469 ' CE2' ' HD3' ' A' ' 623' ' ' ARG . 35.4 p90 -151.28 152.86 33.8 Favored 'General case' 0 N--CA 1.409 -2.524 0 N-CA-C 105.768 -1.938 . . . . 72.31 105.768 172.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -128.49 144.45 51.15 Favored 'General case' 0 C--N 1.27 -2.865 0 N-CA-C 107.972 -1.121 . . . . 73.12 107.972 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.501 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 42.8 t30 -72.44 -51.92 7.11 Favored Pre-proline 0 C--N 1.286 -2.162 0 CA-C-N 115.652 -0.704 . . . . 65.04 111.054 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.501 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 10.3 Cg_endo -97.78 111.48 0.1 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.582 0 C-N-CA 121.594 1.529 . . . . 74.41 110.309 170.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -68.25 159.07 54.81 Favored 'Trans proline' 0 C--O 1.248 0.978 0 C-N-CA 121.974 1.783 . . . . 64.4 110.465 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -60.11 132.91 55.4 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.789 -0.448 . . . . 61.03 109.789 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.25 -11.06 47.67 Favored Glycine 0 C--N 1.308 -0.997 0 C-N-CA 120.532 -0.842 . . . . 45.51 111.585 -176.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 22.7 m -89.95 156.34 18.5 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.775 -0.824 . . . . 71.41 108.775 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -80.84 125.17 6.75 Favored Glycine 0 N--CA 1.419 -2.454 0 N-CA-C 111.704 -0.558 . . . . 61.12 111.704 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 29.1 m -107.64 141.48 22.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 108.177 -1.045 . . . . 71.14 108.177 175.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.61 ' ND2' ' HB3' ' A' ' 617' ' ' ASP . 31.4 p-10 -63.22 164.52 8.62 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 122.903 0.481 . . . . 74.35 111.873 -177.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -61.84 -25.6 67.62 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.213 0.53 . . . . 62.45 111.242 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 617' ' ' ASP . . . . . 0.61 ' HB3' ' ND2' ' A' ' 615' ' ' ASN . 16.0 t70 -68.11 -37.44 81.16 Favored 'General case' 0 C--O 1.245 0.856 0 CA-C-N 115.535 -0.757 . . . . 63.44 109.321 176.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 89.65 19.71 47.23 Favored Glycine 0 N--CA 1.429 -1.79 0 CA-C-N 115.283 -0.872 . . . . 74.42 113.147 174.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 619' ' ' ILE . . . . . 0.44 HG12 ' H ' ' A' ' 586' ' ' MET . 0.0 OUTLIER -70.09 118.13 14.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 122.457 1.122 . . . . 63.01 109.192 -174.375 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.09 129.4 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 N-CA-C 107.691 -1.226 . . . . 71.02 107.691 -175.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.442 ' HB ' ' CB ' ' A' ' 607' ' ' ASN . 32.8 m -99.71 118.31 35.94 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 109.473 -0.566 . . . . 61.33 109.473 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 622' ' ' LEU . . . . . 0.422 ' HB2' HG23 ' A' ' 603' ' ' VAL . 2.2 pt? -133.86 150.47 51.37 Favored 'General case' 0 CA--C 1.477 -1.852 0 N-CA-C 105.089 -2.189 . . . . 61.12 105.089 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 623' ' ' ARG . . . . . 0.469 ' HD3' ' CE2' ' A' ' 605' ' ' TYR . 79.7 ttt180 -132.94 139.41 47.31 Favored 'General case' 0 C--N 1.262 -3.208 0 N-CA-C 107.17 -1.418 . . . . 75.12 107.17 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -140.16 163.8 31.76 Favored 'General case' 0 C--N 1.289 -2.052 0 O-C-N 124.048 0.842 . . . . 63.51 109.439 -175.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 625' ' ' GLY . . . . . 0.502 ' HA3' ' CE1' ' A' ' 600' ' ' HIS . . . -123.64 -141.67 5.88 Favored Glycine 0 N--CA 1.416 -2.685 0 N-CA-C 109.992 -1.243 . . . . 44.15 109.992 174.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 626' ' ' GLN . . . . . 0.535 ' HB2' ' HA ' ' A' ' 594' ' ' ASP . 47.5 mt-30 . . . . . 0 C--N 1.297 -1.681 0 N-CA-C 108.314 -0.995 . . . . 64.13 108.314 177.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 . . . . . 0 N--CA 1.436 -1.154 0 N-CA-C 107.289 -1.374 . . . . 70.42 107.289 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.8 m -116.93 161.15 15.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 108.905 -0.776 . . . . 71.41 108.905 -177.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -95.04 136.84 34.87 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.008 -1.077 . . . . 61.02 108.142 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.413 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 95.6 t -97.58 127.81 36.55 Favored Pre-proline 0 C--N 1.285 -2.227 0 CA-C-N 115.798 -0.637 . . . . 74.34 110.281 -173.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 363' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 23.9 Cg_exo -64.17 137.66 57.7 Favored 'Trans proline' 0 C--O 1.242 0.695 0 C-N-CA 122.66 2.24 . . . . 53.4 111.015 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -79.1 130.36 35.42 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 122.055 0.931 . . . . 70.3 109.706 -178.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 7.9 p -107.94 5.25 9.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-O 122.656 1.217 . . . . 73.42 110.622 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.13 145.01 52.51 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.952 -1.022 . . . . 72.12 110.66 173.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 91.68 0.51 72.3 Favored Glycine 0 N--CA 1.434 -1.439 0 CA-C-N 116.216 -0.447 . . . . 70.53 112.303 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -107.82 -82.06 0.56 Allowed 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.263 0.468 . . . . 73.24 112.263 -176.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 11.8 t -154.29 150.88 28.47 Favored 'General case' 0 CA--C 1.503 -0.861 0 O-C-N 121.644 -0.66 . . . . 62.11 110.501 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.616 ' HB3' ' O ' ' A' ' 397' ' ' ASP . 1.4 p -63.68 -47.22 82.08 Favored 'General case' 0 N--CA 1.435 -1.181 0 O-C-N 123.799 0.687 . . . . 74.01 109.896 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -68.8 -45.59 70.86 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 115.158 -0.928 . . . . 61.32 110.691 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -68.88 -34.66 75.79 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 119.458 -0.897 . . . . 75.33 111.783 -176.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 373' ' ' ALA . . . . . 0.407 ' O ' HD13 ' A' ' 377' ' ' LEU . . . -67.93 -51.11 51.46 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.662 0.267 . . . . 61.54 110.834 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.37 -37.36 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 116.239 -0.437 . . . . 74.34 110.697 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.58 -47.08 85.5 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 120.893 0.378 . . . . 71.01 111.062 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 42.2 m -62.53 -47.77 82.43 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-O 121.576 0.703 . . . . 73.24 110.081 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.407 HD13 ' O ' ' A' ' 373' ' ' ALA . 9.6 mp -64.33 -39.1 93.22 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.495 -0.775 . . . . 73.21 112.096 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 62.0 tp60 -61.79 -44.45 96.85 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.131 0.572 . . . . 44.23 110.373 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -68.35 -19.38 64.64 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.29 0.567 . . . . 71.51 112.07 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 380' ' ' ARG . . . . . 0.486 ' NE ' ' HA ' ' A' ' 380' ' ' ARG . 3.9 mmp_? -96.45 -13.95 22.74 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 112.515 0.561 . . . . 72.03 112.515 177.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.13 14.51 54.32 Favored Glycine 0 C--O 1.25 1.12 0 C-N-CA 120.87 -0.681 . . . . 63.52 112.367 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.406 ' CZ ' HG21 ' A' ' 362' ' ' VAL . 26.7 m-85 -76.62 140.05 40.84 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-O 121.141 0.496 . . . . 65.14 110.121 177.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -85.08 134.77 34.19 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 107.628 -1.249 . . . . 73.0 107.628 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 384' ' ' ILE . . . . . 0.451 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -128.13 157.15 40.46 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 CA-C-O 120.999 0.428 . . . . 64.13 110.338 -175.873 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -134.99 137.36 42.95 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 106.636 -1.616 . . . . 61.42 106.636 172.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 13.1 m -135.09 116.76 14.94 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.802 -0.814 . . . . 62.13 108.802 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -113.78 123.43 49.83 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.491 -0.929 . . . . 62.03 108.491 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -89.79 125.22 35.22 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.54 -0.541 . . . . 75.43 109.54 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 389' ' ' LYS . . . . . 0.763 ' HZ2' ' HB2' ' A' ' 389' ' ' LYS . 7.2 mtmp? -114.84 133.31 22.62 Favored Pre-proline 0 C--N 1.307 -1.26 0 N-CA-C 108.159 -1.052 . . . . 73.33 108.159 176.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 390' ' ' PRO . . . . . 0.425 ' O ' ' HB3' ' A' ' 391' ' ' ASP . 3.3 Cg_exo -85.76 128.47 3.35 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.769 1.646 . . . . 64.22 109.517 172.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.425 ' HB3' ' O ' ' A' ' 390' ' ' PRO . 2.0 p30 158.43 159.25 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.055 -1.461 . . . . 74.15 107.055 -175.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 20.3 p -126.68 23.9 6.67 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.456 0.646 . . . . 62.14 110.165 177.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 39.5 m -90.85 -37.72 13.41 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 108.624 -0.88 . . . . 70.44 108.624 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 37.6 mm -89.71 141.89 28.81 Favored Pre-proline 0 N--CA 1.432 -1.332 0 N-CA-C 106.666 -1.605 . . . . 73.4 106.666 178.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -51.39 161.04 2.0 Favored 'Trans proline' 0 CA--C 1.56 1.782 0 C-N-CA 123.267 2.645 . . . . 64.24 113.606 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -54.65 162.89 4.31 Favored 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 124.675 3.584 . . . . 72.05 114.155 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 397' ' ' ASP . . . . . 0.616 ' O ' ' HB3' ' A' ' 370' ' ' SER . 5.9 p-10 -56.38 -9.88 0.8 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.381 1.473 . . . . 62.02 113.973 -172.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -67.62 145.89 54.4 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.185 -1.413 . . . . 73.21 107.185 176.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.43 HG13 ' HA ' ' A' ' 370' ' ' SER . 10.3 m -63.29 118.43 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 C-N-CA 119.298 -0.961 . . . . 75.11 112.324 -171.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.29 -34.75 7.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.226 -1.027 . . . . 64.14 108.226 178.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -156.59 157.62 28.09 Favored Glycine 0 N--CA 1.423 -2.174 0 N-CA-C 110.731 -0.948 . . . . 72.2 110.731 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 11.5 p -126.77 -178.21 4.3 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.811 -1.181 . . . . 63.12 107.811 175.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -100.5 139.44 20.63 Favored Pre-proline 0 C--N 1.296 -1.731 0 C-N-CA 119.596 -0.842 . . . . 61.44 109.364 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -52.8 -3.09 0.11 Allowed 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 124.599 3.533 . . . . 41.5 115.765 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.7 -37.19 65.52 Favored 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 122.947 0.499 . . . . 20.42 109.673 173.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -69.11 -41.06 77.93 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-O 121.666 0.746 . . . . 52.14 109.988 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -77.65 -1.24 30.02 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.261 -0.881 . . . . 60.11 110.563 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 75.2 m -98.68 147.07 25.22 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.345 -1.724 . . . . 74.13 106.345 172.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 34.8 m -74.23 112.05 10.0 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 107.385 -1.339 . . . . 52.42 107.385 175.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 23.1 m -133.27 169.64 21.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 121.28 0.562 . . . . 65.41 110.772 -176.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 10.1 t -84.29 154.98 22.63 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 106.557 -1.646 . . . . 75.41 106.557 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -67.91 108.13 2.91 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 121.369 0.604 . . . . 44.33 110.411 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 133.06 54.4 0.08 OUTLIER Glycine 0 N--CA 1.427 -1.952 0 CA-C-N 115.262 -0.881 . . . . 73.34 112.005 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -104.28 -173.2 2.25 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.035 -1.468 . . . . 51.22 107.035 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -115.42 125.63 53.38 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 118.97 0.805 . . . . 64.04 111.085 -176.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.6 mm -122.56 117.99 53.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 121.158 0.504 . . . . 55.13 110.03 177.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 23.8 p -95.26 127.83 41.62 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 123.108 0.563 . . . . 73.2 110.392 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 18.5 t -120.77 134.91 62.68 Favored 'Isoleucine or valine' 0 C--O 1.25 1.131 0 C-N-CA 123.786 0.834 . . . . 64.13 111.843 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -108.78 128.59 55.02 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-O 121.47 0.652 . . . . 74.25 111.008 174.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.506 HG13 ' CB ' ' A' ' 397' ' ' ASP . 2.9 t -106.52 144.2 16.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 C-N-CA 125.075 1.35 . . . . 64.34 110.843 -175.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 10.4 m -118.66 123.36 44.76 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 109.556 -0.535 . . . . 64.02 109.556 176.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 20.6 p -107.78 107.93 18.91 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 105.879 -1.897 . . . . 74.54 105.879 173.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.27 0 N-CA-C 116.858 1.503 . . . . 44.02 116.858 -170.501 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 33.8 tt0 . . . . . 0 N--CA 1.43 -1.46 0 CA-C-O 120.536 0.207 . . . . 74.54 110.758 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -127.89 159.61 34.38 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 121.097 0.475 . . . . 75.13 111.322 -178.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -103.59 139.0 39.48 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.067 -0.969 . . . . 72.51 109.027 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.74 ' HB ' ' O ' ' A' ' 474' ' ' ALA . 2.7 mp -90.11 124.04 64.33 Favored Pre-proline 0 C--N 1.319 -0.753 0 C-N-CA 119.578 -0.849 . . . . 64.44 109.123 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -66.69 148.37 82.89 Favored 'Trans proline' 0 C--O 1.24 0.604 0 C-N-CA 122.32 2.013 . . . . 75.31 111.393 177.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -76.37 103.89 6.61 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-O 121.491 0.663 . . . . 71.42 110.926 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 60.9 t -98.24 150.01 5.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 107.222 -1.399 . . . . 70.11 107.222 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 35.6 m -73.43 154.88 39.8 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 121.07 0.462 . . . . 54.13 111.055 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 434' ' ' THR . . . . . 0.564 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 33.5 p -68.3 -30.14 69.07 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 123.692 0.797 . . . . 74.02 112.403 -174.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 1.6 pp -80.09 -11.46 59.76 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 113.007 0.743 . . . . 73.54 113.007 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.414 ' HB ' ' HB3' ' A' ' 439' ' ' GLU . 0.9 OUTLIER -109.42 65.15 0.61 Allowed 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 113.582 0.956 . . . . 75.12 113.582 -178.595 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -59.01 -38.58 79.57 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.52 0.728 . . . . 74.24 111.908 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -62.48 -36.83 83.72 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.397 0.618 . . . . 74.42 110.548 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.414 ' HB3' ' HB ' ' A' ' 436' ' ' THR . 7.0 tp10 -70.12 -40.53 74.82 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.781 -0.822 . . . . 75.13 108.781 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.564 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -60.86 -51.13 70.61 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.8 -0.637 . . . . 41.44 111.269 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 32.5 m -64.26 -39.73 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 112.78 0.659 . . . . 73.1 112.78 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -68.43 -36.89 79.71 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 119.488 -0.885 . . . . 75.32 110.34 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -66.14 -38.29 87.75 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.96 -0.563 . . . . 61.31 110.936 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 93.7 mt -63.42 -36.3 83.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.157 0.504 . . . . 74.4 109.647 175.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.434 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 33.2 m -70.09 -43.81 70.33 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.579 -0.737 . . . . 70.01 110.444 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -66.96 -21.62 65.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.033 -0.53 . . . . 74.25 111.386 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.7 4.93 26.58 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.018 0.437 . . . . 53.4 111.418 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 448' ' ' GLY . . . . . 0.46 ' HA3' HD12 ' A' ' 480' ' ' ILE . . . 111.2 -84.94 0.38 Allowed Glycine 0 CA--C 1.484 -1.845 0 C-N-CA 120.525 -0.845 . . . . 64.11 111.793 175.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 449' ' ' PHE . . . . . 0.4 ' N ' HG23 ' A' ' 480' ' ' ILE . 2.0 p90 -38.53 -60.28 0.82 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.432 1.271 . . . . 74.02 114.432 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 450' ' ' GLY . . . . . 0.434 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 61.3 30.13 73.22 Favored Glycine 0 CA--C 1.501 -0.799 0 C-N-CA 121.22 -0.514 . . . . 74.33 112.047 -177.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.485 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 40.9 mmm-85 -104.37 110.92 23.35 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 108.477 -0.934 . . . . 74.5 108.477 -177.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -136.09 140.31 43.64 Favored 'General case' 0 N--CA 1.423 -1.778 0 CA-C-N 115.818 -0.628 . . . . 64.22 111.585 -176.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -131.67 140.04 49.23 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.936 -1.029 . . . . 54.42 108.238 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -109.33 129.28 55.53 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.128 0.49 . . . . 74.13 111.531 -176.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.88 150.67 40.7 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.112 -1.07 . . . . 51.33 108.112 176.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -121.97 140.68 52.16 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.762 -0.829 . . . . 71.1 108.762 -177.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 24.3 t -144.7 137.34 13.55 Favored Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 109.338 -0.616 . . . . 63.35 109.338 176.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 490' ' ' SER . 47.3 Cg_endo -71.03 134.56 25.55 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.939 1.759 . . . . 74.04 110.538 175.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 70.2 m -152.76 -179.42 7.61 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 122.801 0.44 . . . . 75.41 110.155 -177.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.2 t -47.64 137.28 9.75 Favored Pre-proline 0 C--O 1.254 1.316 0 C-N-CA 124.276 1.03 . . . . 71.23 110.899 173.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -52.81 -30.94 49.34 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 124.375 3.383 . . . . 51.33 113.451 -175.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -68.5 -26.79 65.64 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.712 0.634 . . . . 75.34 112.712 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -95.33 -15.78 22.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.935 0.398 . . . . 74.54 111.135 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 83.4 t -60.7 128.73 22.36 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 115.996 -0.547 . . . . 63.44 110.304 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.06 -11.23 60.42 Favored Glycine 0 N--CA 1.433 -1.531 0 CA-C-N 115.495 -0.775 . . . . 73.23 111.757 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -119.1 167.18 12.04 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.033 -0.729 . . . . 74.24 109.033 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.564 ' O ' ' HB ' ' A' ' 434' ' ' THR . 79.3 t -75.68 147.11 8.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.114 -1.439 . . . . 72.45 107.114 173.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 65.2 mt -97.88 -35.15 5.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 107.296 -1.372 . . . . 45.43 107.296 176.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 160.06 -160.38 31.57 Favored Glycine 0 N--CA 1.416 -2.682 0 N-CA-C 109.729 -1.348 . . . . 73.42 109.729 177.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 26.3 p -115.98 145.73 42.71 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 107.335 -1.357 . . . . 42.45 107.335 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -64.3 -56.15 25.61 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 119.968 -0.693 . . . . 61.34 110.401 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -80.69 149.49 18.42 Favored 'Trans proline' 0 C--N 1.37 1.699 0 N-CA-C 107.842 -1.638 . . . . 42.31 107.842 169.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -64.81 126.93 17.56 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.588 1.525 . . . . 63.41 113.039 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.74 ' O ' ' HB ' ' A' ' 429' ' ' ILE . . . -86.11 -34.67 20.56 Favored 'General case' 0 C--O 1.198 -1.631 0 CA-C-O 122.224 1.011 . . . . 63.34 108.383 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -72.21 12.37 0.44 Allowed 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.528 -1.215 . . . . 64.5 111.717 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -119.81 -165.49 1.18 Allowed 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 107.978 -1.119 . . . . 75.11 107.978 175.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.44 140.1 37.93 Favored 'General case' 0 N--CA 1.402 -2.874 0 CA-C-O 121.44 0.638 . . . . 62.33 111.883 -178.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 39.5 m -136.99 139.05 41.17 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.852 -0.613 . . . . 52.45 109.473 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -67.85 165.09 18.28 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.869 -0.605 . . . . 72.32 110.776 177.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 480' ' ' ILE . . . . . 0.46 HD12 ' HA3' ' A' ' 448' ' ' GLY . 29.0 mm -70.57 -15.38 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 121.914 0.864 . . . . 70.12 110.616 -176.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.2 t -92.41 2.9 56.39 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.996 -0.547 . . . . 75.43 110.801 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -92.36 140.95 29.08 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.178 0.513 . . . . 73.14 111.798 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.485 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.3 p -108.31 127.07 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 CA-C-N 115.23 -0.895 . . . . 73.35 109.946 177.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 29.9 m -104.09 132.74 49.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-O 121.779 0.799 . . . . 72.01 111.029 178.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.72 124.25 55.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 115.258 -0.883 . . . . 75.2 110.552 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.443 HG23 HG13 ' A' ' 467' ' ' VAL . 1.7 mp -100.84 125.52 54.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 125.542 1.537 . . . . 61.23 108.671 -178.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 8.8 tt -107.03 126.41 63.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 109.479 -0.563 . . . . 65.42 109.479 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.447 HG12 HG22 ' A' ' 467' ' ' VAL . 33.6 m -110.29 151.21 12.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 116.18 -0.464 . . . . 61.3 110.7 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -83.58 121.58 5.53 Favored Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 109.43 -1.468 . . . . 61.13 109.43 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 23.3 t . . . . . 0 N--CA 1.426 -1.632 0 N-CA-C 108.28 -1.008 . . . . 42.45 108.28 -176.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.451 -1.022 0 N-CA-C 110.923 -0.453 . . . . 70.35 110.923 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -94.77 26.58 3.47 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 122.422 1.106 . . . . 61.23 110.491 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 12.8 p -118.07 147.54 43.16 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 114.134 -1.394 . . . . 54.14 110.295 -178.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 495' ' ' LYS . . . . . 0.485 ' HD3' ' N ' ' A' ' 496' ' ' ASP . 6.8 tmtm? -150.6 140.2 21.6 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 105.559 -2.015 . . . . 73.1 105.559 175.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 11.4 p-10 -89.07 127.1 35.68 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.526 0.679 . . . . 72.32 111.179 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 28.3 pt -75.89 130.15 79.24 Favored Pre-proline 0 C--N 1.306 -1.321 0 CA-C-N 114.865 -1.061 . . . . 70.31 110.878 -177.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -85.61 -174.72 1.69 Allowed 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.342 2.028 . . . . 73.32 110.737 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -80.04 133.14 36.11 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.033 -1.099 . . . . 71.21 108.033 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 13.0 p -133.09 -7.25 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-O 121.551 0.691 . . . . 70.23 111.187 -174.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.97 114.8 9.39 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.273 0.559 . . . . 62.0 110.338 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 130.84 -21.94 4.63 Favored Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 109.685 -1.366 . . . . 44.14 109.685 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -87.08 168.9 12.86 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 109.285 -0.635 . . . . 74.24 109.285 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 47.5 p -85.59 162.32 18.91 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 109.817 -0.438 . . . . 52.41 109.817 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 18.8 m -54.24 -42.23 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.045 0 C-N-CA 123.667 0.787 . . . . 73.14 113.004 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -67.35 -42.27 83.78 Favored 'General case' 0 CA--C 1.507 -0.683 0 C-N-CA 120.643 -0.423 . . . . 73.31 110.856 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 97.7 t -69.74 -40.16 78.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.808 -0.633 . . . . 74.55 110.369 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.24 -49.4 74.32 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.55 -0.295 . . . . 52.12 111.026 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -63.11 -35.42 80.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.068 0.461 . . . . 63.24 110.121 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -62.47 -44.03 97.39 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.171 -0.922 . . . . 75.25 109.037 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -61.56 -49.0 78.4 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 109.723 -0.473 . . . . 71.12 109.723 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.89 -47.66 83.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.182 -0.463 . . . . 72.25 111.494 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -66.41 -39.19 88.83 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 112.231 0.456 . . . . 74.5 112.231 -176.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.43 -29.14 45.61 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 CA-C-O 121.164 0.507 . . . . 54.32 110.837 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 -87.11 -5.39 59.04 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.154 -0.618 . . . . 75.34 111.525 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 516' ' ' GLY . . . . . 0.444 ' O ' ' HB ' ' A' ' 547' ' ' VAL . . . 110.21 -4.7 30.05 Favored Glycine 0 CA--C 1.492 -1.369 0 C-N-CA 120.525 -0.845 . . . . 71.41 114.246 175.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.527 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 88.9 m-85 -77.8 119.0 20.68 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.849 -0.797 . . . . 64.45 108.849 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 17.0 p -89.9 -31.67 17.19 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 115.384 -0.826 . . . . 62.4 112.933 -174.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -108.59 119.23 38.92 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.681 0.753 . . . . 74.01 112.457 -172.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -130.32 145.82 51.83 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.071 -0.968 . . . . 73.31 109.442 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 61.2 m -141.23 142.89 33.92 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 108.319 -0.993 . . . . 53.12 108.319 175.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -117.55 135.3 54.04 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.501 -0.555 . . . . 71.14 109.501 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -124.05 119.44 29.51 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.973 -0.751 . . . . 74.43 108.973 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 524' ' ' SER . . . . . 0.549 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 55.1 m -84.77 130.85 34.62 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.512 0.672 . . . . 71.12 112.545 -177.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 28.0 m -121.86 150.63 25.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 106.648 -1.612 . . . . 65.01 106.648 173.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 526' ' ' ASP . . . . . 0.548 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 1.4 p-10 -92.71 137.14 32.62 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 117.839 -1.545 . . . . 64.3 110.483 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 49.0 m -150.28 -179.02 0.91 Allowed Pre-proline 0 C--N 1.293 -1.867 0 N-CA-C 106.111 -1.811 . . . . 72.43 106.111 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -87.04 -11.34 5.43 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 121.549 1.499 . . . . 41.43 111.033 171.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -69.15 127.75 92.88 Favored Pre-proline 0 N--CA 1.441 -0.919 0 N-CA-C 108.344 -0.984 . . . . 71.52 108.344 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -55.7 141.51 84.07 Favored 'Trans proline' 0 C--O 1.255 1.373 0 C-N-CA 122.982 2.454 . . . . 75.23 114.371 -171.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -59.67 125.94 25.64 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 114.313 -1.312 . . . . 72.5 110.949 -176.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 123.83 -19.26 7.44 Favored Glycine 0 N--CA 1.427 -1.962 0 C-N-CA 120.732 -0.747 . . . . 52.32 111.244 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -82.78 129.61 35.01 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.801 -0.444 . . . . 74.53 109.801 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 91.0 t -78.6 110.3 14.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 107.909 -1.145 . . . . 74.31 107.909 174.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 18.3 m -75.89 -34.62 59.97 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 123.892 0.877 . . . . 72.23 111.232 -176.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -173.65 179.91 44.73 Favored Glycine 0 CA--C 1.496 -1.143 0 N-CA-C 110.79 -0.924 . . . . 65.35 110.79 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 35.7 p -128.66 152.7 48.08 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.434 -0.58 . . . . 75.54 109.434 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -62.88 -57.47 21.39 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-O 119.174 -0.441 . . . . 70.33 110.99 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -75.5 139.39 22.97 Favored 'Trans proline' 0 C--N 1.369 1.618 0 CA-C-N 120.135 1.084 . . . . 73.12 109.858 171.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -71.35 142.79 41.87 Favored 'Trans proline' 0 C--O 1.251 1.141 0 C-N-CA 122.531 2.154 . . . . 70.23 112.963 -178.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -65.11 135.32 55.38 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.514 -0.766 . . . . 63.21 110.92 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.61 -18.91 34.46 Favored Glycine 0 N--CA 1.433 -1.5 0 CA-C-N 115.709 -0.678 . . . . 72.24 111.421 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 25.9 m -77.77 132.26 38.0 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.767 0.318 . . . . 75.44 111.094 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 36.0 m -81.92 122.56 27.91 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 107.645 -1.242 . . . . 73.04 107.645 176.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.5 m -134.81 159.5 71.92 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 109.601 -0.518 . . . . 64.35 109.601 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -67.29 137.55 43.92 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.334 2.023 . . . . 75.22 111.545 176.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.527 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 34.1 m -63.04 -19.97 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-O 121.863 0.84 . . . . 54.44 112.044 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -80.83 -12.24 59.47 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.072 -0.967 . . . . 65.22 111.856 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 8.5 t -81.78 171.94 13.94 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 120.33 -0.548 . . . . 73.21 111.653 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 44.4 t -99.0 122.38 50.65 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 CA-C-N 115.636 -0.711 . . . . 73.23 110.107 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 2.5 mp -102.6 124.06 56.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.175 -1.046 . . . . 64.33 108.175 175.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -102.02 123.47 45.97 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-O 121.167 0.508 . . . . 74.35 109.897 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 53.3 mt -98.26 120.99 39.62 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 114.534 -1.212 . . . . 72.44 108.872 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -83.23 119.73 24.93 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 106.69 -1.596 . . . . 70.03 106.69 173.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 524' ' ' SER . 45.0 t -113.06 129.32 68.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 N-CA-C 109.252 -0.647 . . . . 61.52 109.252 -177.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.563 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 23.8 p -82.55 146.87 28.95 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-O 120.884 0.373 . . . . 65.32 111.457 178.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.548 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 14.5 ptpt -97.18 152.52 18.74 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 103.732 -2.692 . . . . 74.51 103.732 167.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -80.18 -32.82 34.24 Favored Glycine 0 CA--C 1.491 -1.437 0 C-N-CA 119.408 -1.377 . . . . 73.45 111.186 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 64.2 t30 61.9 17.02 8.54 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.614 1.166 . . . . 62.41 110.575 176.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -144.76 158.96 43.58 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 107.969 -1.123 . . . . 64.33 107.969 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -143.53 148.59 36.21 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.838 -1.171 . . . . 73.05 107.838 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 61.1 t -76.13 116.06 18.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.741 -0.837 . . . . 55.41 108.741 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 563' ' ' MET . . . . . 0.406 ' HA ' ' HD3' ' A' ' 564' ' ' PRO . 54.0 ttp -89.96 138.21 27.79 Favored Pre-proline 0 C--N 1.298 -1.651 0 CA-C-N 115.761 -0.654 . . . . 73.11 111.156 -176.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 564' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 563' ' ' MET . 33.8 Cg_exo -63.51 170.47 8.19 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.321 2.681 . . . . 72.13 111.414 172.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 565' ' ' ASP . . . . . 0.481 ' HA ' ' HB1' ' A' ' 610' ' ' ALA . 25.1 t70 -84.33 115.14 22.34 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.04 0.448 . . . . 63.02 111.503 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 5.5 mp -125.89 -4.8 6.93 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.785 -0.643 . . . . 74.02 109.93 175.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 16.4 t -79.45 146.89 32.5 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 109.582 -0.525 . . . . 72.13 109.582 -176.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 91.14 3.53 69.82 Favored Glycine 0 C--N 1.312 -0.788 0 C-N-CA 120.83 -0.7 . . . . 51.32 112.231 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 85.8 mtp -100.72 177.64 4.93 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 107.332 -1.359 . . . . 75.21 107.332 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 570' ' ' PHE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 63.2 m-85 -80.47 160.16 25.35 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 119.675 -0.81 . . . . 72.5 110.124 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 78.0 t90 -62.89 -28.76 70.27 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.821 -0.807 . . . . 71.4 108.821 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 21.8 m -76.42 -10.01 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.1 -0.954 . . . . 74.41 111.049 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 573' ' ' ASP . . . . . 0.431 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 20.6 m-20 -96.04 -44.45 7.33 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 107.567 -1.272 . . . . 74.2 107.567 173.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -56.51 -48.69 76.67 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 114.613 -1.176 . . . . 64.23 111.783 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -50.88 -59.61 7.16 Favored Pre-proline 0 CA--C 1.555 1.162 0 N-CA-C 114.045 1.128 . . . . 75.35 114.045 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 576' ' ' PRO . . . . . 0.414 ' HD2' ' O ' ' A' ' 573' ' ' ASP . 39.9 Cg_exo -61.99 -41.5 36.19 Favored 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 121.5 1.467 . . . . 71.21 113.115 176.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.431 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 11.9 mmt180 -61.29 -41.01 96.25 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 120.575 0.226 . . . . 73.2 111.016 -177.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 8.8 mp -65.79 -47.17 76.03 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 120.95 0.405 . . . . 75.23 110.987 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -65.14 -34.98 79.68 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.279 -0.419 . . . . 65.22 111.151 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -67.74 -38.27 83.29 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.344 -0.389 . . . . 74.51 111.75 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 4.2 pp -83.4 2.23 37.51 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.564 0.697 . . . . 72.44 111.639 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 83.92 29.46 31.6 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.391 -0.822 . . . . 34.32 113.718 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -81.09 127.49 32.69 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 117.14 0.47 . . . . 72.31 110.399 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 57.0 m -142.87 90.89 2.24 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.393 -1.336 . . . . 73.21 107.393 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -142.21 -133.73 2.87 Favored Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 110.86 -0.896 . . . . 72.41 110.86 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 51.5 ttm -126.6 128.56 46.99 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.445 -0.576 . . . . 65.44 109.445 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 7.3 tt -100.92 114.99 29.36 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.374 -1.343 . . . . 72.01 107.374 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 588' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 621' ' ' THR . 28.6 t70 -119.33 112.39 19.37 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.711 0.767 . . . . 54.24 111.954 -178.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 589' ' ' LYS . . . . . 0.536 ' HE3' ' H ' ' A' ' 624' ' ' PHE . 1.5 tmtp? -87.92 112.84 22.98 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.241 -1.762 . . . . 75.54 106.241 176.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -80.72 -111.67 0.3 Allowed Glycine 0 C--O 1.25 1.095 0 C-N-CA 121.308 -0.473 . . . . 33.32 113.682 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -65.74 144.76 56.68 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 110.032 -0.358 . . . . 74.52 110.032 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 592' ' ' ASP . . . . . 0.502 ' OD1' ' HB2' ' A' ' 626' ' ' GLN . 4.5 t0 -116.25 152.14 34.4 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 120.088 -0.645 . . . . 73.41 110.029 -177.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 96.1 t -137.4 116.32 14.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 108.593 -0.892 . . . . 64.53 108.593 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 594' ' ' ASP . . . . . 0.479 ' HA ' ' HB3' ' A' ' 626' ' ' GLN . 7.2 p-10 -78.15 124.53 28.16 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.211 -0.449 . . . . 65.22 109.854 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -156.33 -9.56 0.1 Allowed 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 113.11 0.782 . . . . 72.13 113.11 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 104.92 41.5 1.96 Allowed Glycine 0 CA--C 1.505 -0.568 0 N-CA-C 109.069 -1.613 . . . . 45.35 109.069 -174.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 626' ' ' GLN . . . -56.95 -31.04 60.92 Favored Glycine 0 C--O 1.203 -1.789 0 C-N-CA 125.78 1.657 . . . . 74.14 115.004 -174.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 2.4 p -55.2 -24.82 29.08 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 113.148 0.796 . . . . 74.43 113.148 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -102.31 -12.52 17.88 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 111.975 0.361 . . . . 73.44 111.975 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -145.09 37.29 1.14 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.081 0.771 . . . . 74.25 113.081 -173.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -68.7 90.37 0.41 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 122.222 1.01 . . . . 42.33 111.15 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 602' ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 32.6 ttp85 -115.63 143.56 45.18 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.173 -1.376 . . . . 71.14 109.391 -176.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.48 130.02 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 106.757 -1.572 . . . . 73.34 106.757 176.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 94.6 t -96.46 -51.99 9.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 121.619 0.723 . . . . 70.22 109.065 -175.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -145.08 160.02 42.06 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 104.441 -2.429 . . . . 62.51 104.441 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 606' ' ' GLN . . . . . 0.53 ' HA ' ' O ' ' A' ' 621' ' ' THR . 13.8 pt20 -147.19 139.29 24.46 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 106.98 -1.489 . . . . 73.2 106.98 173.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . 0.255 93.9 m-20 -61.06 -42.67 87.66 Favored Pre-proline 0 C--N 1.306 -1.286 0 N-CA-C 114.668 1.359 . . . . 65.02 114.668 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -69.39 108.67 2.06 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 121.192 1.262 . . . . 74.31 109.946 171.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -70.74 135.23 27.64 Favored 'Trans proline' 0 C--O 1.25 1.113 0 C-N-CA 121.981 1.787 . . . . 54.11 112.403 -175.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 610' ' ' ALA . . . . . 0.481 ' HB1' ' HA ' ' A' ' 565' ' ' ASP . . . -67.69 134.76 51.65 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.573 -0.739 . . . . 54.43 109.538 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 86.67 -2.38 87.26 Favored Glycine 0 N--CA 1.434 -1.444 0 C-N-CA 120.707 -0.759 . . . . 52.23 112.466 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 9.6 m -111.54 161.72 15.89 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.488 -0.56 . . . . 63.21 109.488 -176.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -71.68 113.19 4.47 Favored Glycine 0 N--CA 1.435 -1.407 0 N-CA-C 110.084 -1.206 . . . . 65.43 110.084 174.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 32.3 m -107.74 143.05 18.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 123.065 0.546 . . . . 64.12 110.544 -177.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.474 HD21 HG22 ' A' ' 619' ' ' ILE . 23.8 p-10 -42.53 136.72 2.35 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 124.867 1.355 . . . . 73.44 112.079 176.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -58.71 -24.95 62.38 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 124.854 1.261 . . . . 73.41 110.014 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -55.67 -45.21 77.77 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.588 -0.733 . . . . 74.41 109.797 173.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 71.48 19.41 77.7 Favored Glycine 0 N--CA 1.423 -2.186 0 CA-C-N 115.649 -0.705 . . . . 71.44 112.396 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 619' ' ' ILE . . . . . 0.474 HG22 HD21 ' A' ' 615' ' ' ASN . 0.0 OUTLIER -69.7 119.78 16.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 107.879 -1.156 . . . . 73.32 107.879 -176.839 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.92 119.66 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.575 0 CA-C-O 122.345 1.069 . . . . 74.01 111.352 -170.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' A' ' 606' ' ' GLN . 0.2 OUTLIER -104.38 121.68 43.89 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-N 114.073 -1.421 . . . . 53.11 109.542 175.723 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 622' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 2.3 pt? -138.4 165.35 27.01 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 123.851 0.86 . . . . 73.05 110.345 -174.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 21.6 ttp85 -134.54 137.51 43.88 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 107.716 -1.216 . . . . 70.31 107.716 174.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.536 ' H ' ' HE3' ' A' ' 589' ' ' LYS . 35.3 p90 -141.52 157.76 44.72 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.862 -1.162 . . . . 73.52 107.862 176.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -56.9 150.94 27.01 Favored Glycine 0 C--N 1.314 -0.68 0 O-C-N 124.597 1.186 . . . . 33.42 114.711 -177.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 626' ' ' GLN . . . . . 0.502 ' HB2' ' OD1' ' A' ' 592' ' ' ASP . 60.7 tt0 . . . . . 0 C--N 1.302 -1.468 0 C-N-CA 124.741 1.216 . . . . 73.2 108.472 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 . . . . . 0 CA--C 1.493 -1.247 0 N-CA-C 105.54 -2.022 . . . . 73.2 105.54 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 31.8 m -117.56 164.34 13.94 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 N-CA-C 109.836 -0.431 . . . . 63.34 109.836 -172.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -92.43 136.36 33.27 Favored 'General case' 1 N--CA 1.378 -4.037 0 N-CA-C 106.458 -1.682 . . . . 74.33 106.458 175.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 72.2 t -96.96 121.22 59.84 Favored Pre-proline 0 C--N 1.255 -3.517 0 CA-C-N 114.576 -1.193 . . . . 64.45 109.899 -171.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.48 114.81 3.78 Favored 'Trans proline' 0 N--CA 1.43 -2.231 0 C-N-CA 121.165 1.243 . . . . 71.34 109.877 174.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 364' ' ' ASP . . . . . 0.436 ' OD2' ' HB ' ' A' ' 402' ' ' THR . 8.1 p-10 -100.83 141.21 34.03 Favored 'General case' 0 C--N 1.272 -2.8 0 CA-C-N 115.18 -0.918 . . . . 71.0 109.728 -177.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.475 ' H ' HD21 ' A' ' 377' ' ' LEU . 38.2 t -89.23 15.69 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 CA-C-N 114.326 -1.307 . . . . 64.54 111.12 -171.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.467 ' HB2' HG22 ' A' ' 402' ' ' THR . 30.1 mtp180 -65.33 147.21 53.84 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.075 -0.966 . . . . 50.42 110.966 175.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 367' ' ' GLY . . . . . 0.576 ' H ' ' HB ' ' A' ' 399' ' ' VAL . . . 107.7 -6.14 35.39 Favored Glycine 0 C--N 1.307 -1.049 0 N-CA-C 110.956 -0.858 . . . . 63.44 110.956 -171.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -110.58 -154.0 0.53 Allowed 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 107.215 -1.402 . . . . 75.52 107.215 170.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 369' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 78.4 p -82.77 162.45 21.7 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 118.872 0.76 . . . . 74.1 109.305 -176.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 54.6 p -57.18 -46.67 82.61 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 123.265 0.353 . . . . 73.12 110.528 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.82 -46.24 82.8 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 116.086 -0.506 . . . . 52.01 112.226 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -67.07 -42.61 84.39 Favored 'General case' 0 C--O 1.255 1.349 0 CA-C-O 121.663 0.744 . . . . 72.15 109.673 -176.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.05 -51.14 63.18 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.751 -1.113 . . . . 75.34 110.795 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 74.6 mt -60.13 -43.29 92.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 CA-C-N 116.284 -0.417 . . . . 62.1 111.137 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.51 -44.38 89.44 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 123.63 0.581 . . . . 71.35 110.849 -177.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 376' ' ' THR . . . . . 0.52 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 12.9 m -69.1 -46.81 66.8 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 116.013 -0.54 . . . . 75.12 111.359 -178.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.475 HD21 ' H ' ' A' ' 365' ' ' VAL . 4.5 mm? -59.66 -43.03 94.1 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 120.647 0.261 . . . . 74.15 111.486 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -64.42 -42.29 96.12 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.11 -0.495 . . . . 73.5 110.516 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -69.07 -17.82 63.92 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 111.941 0.348 . . . . 74.03 111.941 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 380' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 376' ' ' THR . 22.1 mmm180 -90.0 -11.76 40.64 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.183 0.516 . . . . 64.53 110.826 176.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.17 9.18 48.89 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.178 -1.01 . . . . 72.31 112.546 177.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -90.68 159.36 16.42 Favored 'General case' 0 N--CA 1.415 -2.223 0 N-CA-C 109.514 -0.551 . . . . 72.23 109.514 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.411 ' HB2' ' HG2' ' A' ' 415' ' ' GLU . 92.0 mttt -105.91 158.11 17.01 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 109.065 -0.717 . . . . 75.32 109.065 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 384' ' ' ILE . . . . . 0.466 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -132.64 150.97 33.74 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.523 0 N-CA-C 108.19 -1.041 . . . . 71.33 108.19 177.946 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -118.28 126.88 53.05 Favored 'General case' 0 C--N 1.273 -2.741 0 N-CA-C 105.421 -2.066 . . . . 64.15 105.421 173.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 28.0 m -118.79 119.97 35.98 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 109.527 -0.546 . . . . 54.12 109.527 -173.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -112.15 125.59 54.29 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.369 -0.604 . . . . 64.32 109.369 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 388' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 13.1 pm0 -100.31 121.92 42.26 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.175 -0.676 . . . . 74.0 109.175 177.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -120.86 117.52 30.97 Favored Pre-proline 0 C--N 1.304 -1.41 0 CA-C-N 115.674 -0.694 . . . . 71.44 110.222 -172.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -87.68 129.87 2.64 Favored 'Trans proline' 0 C--O 1.254 1.282 0 C-N-CA 122.27 1.98 . . . . 74.41 111.291 176.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.503 ' HB3' HG12 ' A' ' 394' ' ' ILE . 27.1 t70 176.85 162.47 0.43 Allowed 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.483 -0.562 . . . . 73.04 109.483 -177.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 7.7 m -89.64 -14.61 34.5 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 113.047 0.758 . . . . 73.31 113.047 -175.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 10.1 t -123.04 8.52 9.26 Favored 'General case' 0 C--O 1.249 1.079 0 C-N-CA 118.519 -1.272 . . . . 72.21 113.06 -175.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.503 HG12 ' HB3' ' A' ' 391' ' ' ASP . 33.6 mm -88.36 133.76 35.95 Favored Pre-proline 0 C--N 1.31 -1.151 0 N-CA-C 107.214 -1.402 . . . . 45.54 107.214 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 395' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 396' ' ' PRO . 11.0 Cg_endo -53.58 145.56 47.3 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.483 2.789 . . . . 73.21 114.429 -178.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 396' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 395' ' ' PRO . 81.1 Cg_exo -55.32 162.08 6.36 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 123.758 2.972 . . . . 63.21 111.804 175.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 397' ' ' ASP . . . . . 0.409 ' CB ' HG13 ' A' ' 420' ' ' VAL . 2.9 p-10 -57.21 -8.69 0.76 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.476 1.11 . . . . 71.42 113.311 -175.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 46.1 m170 -76.62 124.85 28.25 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.825 -1.176 . . . . 75.21 107.825 175.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.576 ' HB ' ' H ' ' A' ' 367' ' ' GLY . 8.9 t -76.48 132.43 33.01 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.577 0 CA-C-N 115.508 -0.769 . . . . 74.41 111.041 -167.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 28.9 pt -98.58 -27.97 3.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 114.959 -1.019 . . . . 64.14 113.504 -175.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.52 174.2 25.62 Favored Glycine 0 CA--C 1.503 -0.711 0 N-CA-C 110.439 -1.064 . . . . 73.32 110.439 -173.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 402' ' ' THR . . . . . 0.467 HG22 ' HB2' ' A' ' 366' ' ' ARG . 60.2 p -111.14 -178.67 3.52 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 118.164 0.982 . . . . 72.24 111.391 -174.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 403' ' ' ASP . . . . . 0.459 ' CB ' HG23 ' A' ' 416' ' ' ILE . 7.6 t70 -110.72 129.03 24.39 Favored Pre-proline 0 C--N 1.314 -0.96 0 N-CA-C 109.231 -0.655 . . . . 41.23 109.231 -176.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.67 -26.63 66.27 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 123.358 2.705 . . . . 53.23 113.804 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.95 -42.22 75.88 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.942 -0.572 . . . . 61.05 110.347 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -79.97 -31.84 39.86 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 121.688 0.756 . . . . 64.42 110.485 -178.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -84.74 2.39 42.25 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.721 -0.672 . . . . 71.21 111.099 -173.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 25.4 m -109.82 154.23 23.29 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.293 -1.743 . . . . 75.11 106.293 172.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 26.7 m -74.91 113.01 11.72 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 119.58 -0.848 . . . . 60.04 109.295 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 30.9 m -129.99 169.2 21.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-O 120.815 0.341 . . . . 61.5 110.283 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 33.5 m -69.75 143.45 53.02 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.17 -1.048 . . . . 40.41 108.17 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -68.04 109.03 3.31 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.174 0.512 . . . . 74.24 110.505 -177.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 129.97 69.1 0.11 Allowed Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 110.367 -1.093 . . . . 72.05 110.367 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -130.16 -175.38 3.61 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.227 -1.397 . . . . 73.52 107.227 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 415' ' ' GLU . . . . . 0.411 ' HG2' ' HB2' ' A' ' 383' ' ' LYS . 43.8 mt-10 -114.49 132.62 56.22 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.355 0.598 . . . . 75.43 111.342 -176.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 416' ' ' ILE . . . . . 0.459 HG23 ' CB ' ' A' ' 403' ' ' ASP . 36.4 mm -112.14 115.4 49.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 106.707 -1.59 . . . . 71.4 106.707 177.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 54.5 m -91.61 118.6 30.76 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.157 0.503 . . . . 54.15 111.987 -172.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 14.1 p -110.71 135.06 50.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 C-N-CA 124.294 1.038 . . . . 61.13 111.32 -175.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -102.53 116.1 31.91 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.05 -0.722 . . . . 74.22 109.05 176.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 72.6 t -108.54 131.63 58.61 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 106.66 -1.607 . . . . 72.14 106.66 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 421' ' ' SER . . . . . 0.413 ' OG ' ' HB ' ' A' ' 394' ' ' ILE . 33.0 t -119.79 137.12 54.16 Favored 'General case' 0 C--N 1.288 -2.096 0 C-N-CA 119.276 -0.969 . . . . 65.11 111.93 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.1 p -96.1 156.33 16.38 Favored 'General case' 0 N--CA 1.408 -2.564 0 N-CA-C 106.148 -1.797 . . . . 70.03 106.148 170.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.262 1.886 0 N-CA-C 116.073 1.189 . . . . 75.34 116.073 -172.58 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.441 ' HG2' ' HA ' ' A' ' 479' ' ' ALA . 45.9 mt-30 . . . . . 0 N--CA 1.409 -2.52 0 N-CA-C 107.277 -1.379 . . . . 72.52 107.277 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.559 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 3.4 mmp_? -122.91 147.63 46.38 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-O 121.217 0.532 . . . . 74.04 110.881 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.423 ' HG2' ' H ' ' A' ' 428' ' ' GLU . 8.9 pt-20 -83.36 133.68 34.94 Favored 'General case' 0 C--N 1.272 -2.792 0 CA-C-N 114.61 -1.177 . . . . 71.21 107.98 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.52 ' HB ' ' O ' ' A' ' 474' ' ' ALA . 63.5 mt -80.51 125.57 80.5 Favored Pre-proline 0 N--CA 1.429 -1.5 0 C-N-CA 120.121 -0.631 . . . . 72.34 109.461 -175.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.88 146.11 52.38 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 122.28 1.987 . . . . 54.42 111.014 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -78.9 144.56 34.79 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.718 -0.845 . . . . 74.41 108.718 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.473 HG11 ' HB2' ' A' ' 440' ' ' ALA . 13.1 p -143.25 160.87 17.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 108.379 -0.971 . . . . 72.41 108.379 -175.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 19.2 m -68.89 138.0 54.31 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 108.486 -0.931 . . . . 75.25 108.486 174.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 35.2 p -69.21 -29.57 67.55 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 123.088 0.555 . . . . 53.34 111.612 -175.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.2 pp -80.32 -10.47 59.75 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.103 0.477 . . . . 73.23 111.611 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 5.1 m -105.95 57.41 0.66 Allowed 'General case' 0 CA--C 1.566 1.562 0 CA-C-O 121.669 0.747 . . . . 64.2 110.609 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.26 -38.42 58.13 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.465 1.106 . . . . 73.23 112.0 175.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.82 -42.81 85.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.189 0.519 . . . . 70.41 110.764 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -71.59 -35.44 70.53 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 116.02 -0.536 . . . . 75.3 110.517 178.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.509 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -59.5 -51.31 70.41 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.548 -0.296 . . . . 61.44 111.016 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 22.2 m -64.65 -36.96 78.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 CA-C-O 120.648 0.261 . . . . 74.22 111.441 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 37.9 tptt -59.39 -47.54 85.05 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.815 -0.63 . . . . 73.11 109.507 175.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -64.97 -37.92 89.26 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.762 -0.654 . . . . 74.32 112.258 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 90.1 mt -63.39 -37.23 86.49 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.883 -0.414 . . . . 72.41 109.883 175.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.428 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 28.5 m -67.77 -44.55 77.16 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.958 -0.564 . . . . 60.23 109.972 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.13 -16.09 62.53 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.445 -0.798 . . . . 74.22 112.14 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 447' ' ' ALA . . . . . 0.482 ' O ' ' HG3' ' A' ' 427' ' ' ARG . . . -87.87 5.82 38.5 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.005 0.431 . . . . 75.2 111.666 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 448' ' ' GLY . . . . . 0.436 ' HA3' HD12 ' A' ' 480' ' ' ILE . . . 107.14 -73.57 0.21 Allowed Glycine 0 CA--C 1.491 -1.457 0 C-N-CA 120.006 -1.092 . . . . 23.01 111.883 175.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 449' ' ' PHE . . . . . 0.436 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 1.3 p90 -42.43 -65.97 0.41 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.806 1.039 . . . . 71.4 113.806 176.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 450' ' ' GLY . . . . . 0.428 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 62.9 17.34 58.27 Favored Glycine 0 C--N 1.317 -0.479 0 C-N-CA 121.447 -0.406 . . . . 64.34 112.545 -176.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 16.4 mmm-85 -93.07 110.73 22.21 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 106.416 -1.698 . . . . 71.24 106.416 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.526 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 15.4 p90 -141.03 150.12 42.6 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-O 121.066 0.46 . . . . 75.43 111.69 -177.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -132.22 123.33 26.77 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.147 -1.057 . . . . 74.21 108.147 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -90.46 132.56 35.58 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.037 -0.727 . . . . 71.53 109.037 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 455' ' ' ALA . . . . . 0.433 ' O ' HD12 ' A' ' 487' ' ' ILE . . . -132.72 134.62 45.01 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 109.175 -0.676 . . . . 70.41 109.175 176.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 456' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 488' ' ' VAL . 34.7 p30 -118.98 139.54 51.51 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 120.961 0.41 . . . . 74.14 110.397 174.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 34.2 t -135.44 143.01 43.43 Favored Pre-proline 0 C--N 1.288 -2.084 0 N-CA-C 108.299 -1.0 . . . . 70.14 108.299 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 490' ' ' SER . 24.5 Cg_exo -65.56 132.31 30.61 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 121.728 1.619 . . . . 65.41 109.519 174.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 28.5 p -152.19 179.68 8.3 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 108.32 -0.993 . . . . 32.33 108.32 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.8 t -47.18 137.25 8.45 Favored Pre-proline 0 C--O 1.247 0.949 0 C-N-CA 123.732 0.813 . . . . 74.41 111.959 176.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.81 -29.38 34.14 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 124.533 3.488 . . . . 73.33 113.842 -176.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -64.17 -29.28 70.41 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 120.955 0.407 . . . . 64.43 111.403 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 79.7 mt -94.87 11.79 30.44 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 112.334 0.494 . . . . 62.31 112.334 -176.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 13.0 p -60.71 127.18 19.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 C-N-CA 120.156 -0.617 . . . . 73.25 110.022 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 76.38 2.29 73.45 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.347 -0.842 . . . . 72.33 113.308 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -107.83 139.74 41.97 Favored 'General case' 0 N--CA 1.413 -2.303 0 CA-C-O 121.39 0.614 . . . . 65.11 110.908 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 79.0 t -67.2 134.22 30.44 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 CA-C-N 114.005 -1.452 . . . . 65.2 107.6 173.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 55.6 mt -96.64 -28.32 3.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 108.278 -1.008 . . . . 61.31 108.278 -176.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 159.72 -164.01 33.91 Favored Glycine 0 N--CA 1.416 -2.695 0 N-CA-C 110.659 -0.977 . . . . 54.54 110.659 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 12.1 p -135.66 145.4 46.75 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 107.218 -1.401 . . . . 75.21 107.218 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -62.89 -52.74 61.53 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 119.799 -0.761 . . . . 64.43 110.495 177.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 473' ' ' PRO . 29.9 Cg_endo -69.45 134.82 29.59 Favored 'Trans proline' 0 C--N 1.366 1.497 0 N-CA-C 107.408 -1.804 . . . . 72.14 107.408 168.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.488 ' HB2' ' CG ' ' A' ' 476' ' ' GLN . 28.7 Cg_exo -61.84 127.75 22.37 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 121.623 1.549 . . . . 71.14 112.231 -175.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.52 ' O ' ' HB ' ' A' ' 429' ' ' ILE . . . -77.89 -3.68 42.92 Favored 'General case' 0 C--O 1.204 -1.338 0 CA-C-N 115.073 -0.967 . . . . 72.13 113.514 -171.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -110.25 0.56 18.17 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.244 -0.91 . . . . 72.43 111.174 174.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 476' ' ' GLN . . . . . 0.488 ' CG ' ' HB2' ' A' ' 473' ' ' PRO . 15.5 mm100 -100.22 -177.35 3.5 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.671 -0.695 . . . . 73.32 110.613 -176.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.38 130.26 35.78 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 115.979 -0.555 . . . . 63.24 109.906 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 41.3 t -124.56 142.19 51.54 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.698 -0.853 . . . . 43.31 108.698 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.441 ' HA ' ' HG2' ' A' ' 426' ' ' GLN . . . -72.7 152.87 41.45 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 112.586 0.587 . . . . 62.21 112.586 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 480' ' ' ILE . . . . . 0.436 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 43.2 mm -64.68 -24.97 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-O 121.835 0.826 . . . . 70.12 110.874 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 7.8 p -96.9 5.7 50.03 Favored 'General case' 0 C--N 1.291 -1.977 0 O-C-N 121.839 -0.538 . . . . 74.22 111.589 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -100.15 144.91 28.62 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.018 -0.537 . . . . 72.12 110.641 -174.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.8 p -94.48 127.38 46.52 Favored 'Isoleucine or valine' 0 C--O 1.249 1.039 0 CA-C-O 121.531 0.681 . . . . 62.0 112.367 -177.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 56.4 t -101.34 120.59 51.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 108.838 -0.801 . . . . 60.12 108.838 177.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.73 123.37 50.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-O 121.128 0.489 . . . . 54.13 109.747 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 29.2 mm -100.83 110.11 27.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 C-N-CA 124.789 1.236 . . . . 71.41 109.293 -177.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.433 HD12 ' O ' ' A' ' 455' ' ' ALA . 5.9 tp -99.44 126.9 52.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 109.349 -0.611 . . . . 72.33 109.349 177.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 456' ' ' ASN . 2.4 p -120.53 142.06 38.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 C-N-CA 123.946 0.898 . . . . 75.35 108.882 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -90.01 142.48 16.53 Favored Glycine 0 N--CA 1.431 -1.681 0 C-N-CA 120.666 -0.778 . . . . 63.12 113.567 -176.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 22.8 t . . . . . 0 C--N 1.299 -1.607 0 N-CA-C 106.152 -1.795 . . . . 70.45 106.152 174.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo . . . . . 0 CA--C 1.546 1.087 0 CA-C-O 121.41 0.504 . . . . 60.33 113.395 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -147.43 37.5 0.92 Allowed 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 106.869 -1.53 . . . . 71.5 106.869 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.521 ' HB ' HG22 ' A' ' 544' ' ' THR . 1.0 OUTLIER -116.45 146.17 42.74 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 113.493 -1.685 . . . . 62.23 113.055 -169.902 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 495' ' ' LYS . . . . . 0.454 ' HA ' ' HE3' ' A' ' 495' ' ' LYS . 1.0 OUTLIER -142.26 146.68 35.38 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 124.468 1.107 . . . . 73.23 108.395 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 7.3 m-20 -80.42 131.15 35.55 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 109.134 -0.691 . . . . 55.04 109.134 176.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 35.1 pt -77.09 130.45 75.29 Favored Pre-proline 0 C--N 1.3 -1.552 0 C-N-CA 120.532 -0.467 . . . . 65.13 111.55 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 498' ' ' PRO . . . . . 0.457 ' HD2' HD13 ' A' ' 512' ' ' LEU . 41.7 Cg_endo -69.02 165.97 28.28 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.615 2.21 . . . . 71.52 111.029 175.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -92.8 147.33 22.94 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.832 -0.622 . . . . 62.43 110.695 -177.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.3 p -162.54 89.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 122.401 1.096 . . . . 45.11 110.829 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -137.53 114.48 10.67 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.14 -0.936 . . . . 71.3 108.743 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 101.11 17.51 22.41 Favored Glycine 0 N--CA 1.429 -1.791 0 N-CA-C 109.899 -1.281 . . . . 43.33 109.899 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 503' ' ' GLN . . . . . 0.477 ' OE1' HG11 ' A' ' 507' ' ' VAL . 44.7 mt-30 -124.65 174.23 8.0 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 108.044 -1.095 . . . . 63.43 108.044 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 9.4 t -92.2 168.16 11.54 Favored 'General case' 0 C--O 1.256 1.397 0 C-N-CA 119.694 -0.803 . . . . 63.14 110.791 -175.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 89.7 t -49.87 -41.38 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.832 1.253 . . . . 62.3 111.603 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -57.67 -39.25 76.64 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.556 -0.747 . . . . 62.55 111.381 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 507' ' ' VAL . . . . . 0.477 HG11 ' OE1' ' A' ' 503' ' ' GLN . 23.0 t -75.48 -38.54 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-N 115.686 -0.688 . . . . 71.22 110.107 -175.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 508' ' ' ALA . . . . . 0.436 ' O ' HD23 ' A' ' 512' ' ' LEU . . . -62.6 -49.76 73.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.624 -0.716 . . . . 63.35 110.998 -177.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.413 ' O ' ' HB2' ' A' ' 513' ' ' ASN . 17.7 pt20 -65.43 -35.83 82.11 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.318 -0.401 . . . . 73.2 110.862 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -50.7 67.92 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.734 -0.666 . . . . 63.42 109.837 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -62.01 -47.24 85.65 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 120.662 0.268 . . . . 75.04 111.125 -177.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 512' ' ' LEU . . . . . 0.457 HD13 ' HD2' ' A' ' 498' ' ' PRO . 4.3 mm? -63.93 -43.16 96.73 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.458 -0.337 . . . . 73.51 111.788 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 513' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 509' ' ' GLN . 36.9 t30 -60.07 -42.75 95.23 Favored 'General case' 0 N--CA 1.423 -1.816 0 C-N-CA 122.859 0.464 . . . . 42.11 111.384 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 48.9 t -59.5 -31.98 47.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 123.322 0.649 . . . . 72.24 111.653 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -85.59 -5.0 59.32 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 112.045 0.387 . . . . 71.44 112.045 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 116.87 -10.94 15.45 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 119.826 -1.178 . . . . 61.43 113.742 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -74.01 125.69 28.83 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 117.335 0.567 . . . . 75.21 111.589 -176.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 11.7 p -104.54 -23.98 13.07 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.479 -0.782 . . . . 74.54 112.0 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 519' ' ' LYS . . . . . 0.432 ' O ' HD13 ' A' ' 551' ' ' ILE . 10.0 mtmp? -111.46 114.69 27.97 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 120.322 -0.551 . . . . 74.31 110.757 -176.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -114.59 132.63 56.28 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.135 -1.061 . . . . 74.42 108.135 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 25.4 p -115.52 134.21 55.29 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 107.305 -1.369 . . . . 72.33 107.305 173.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -117.27 120.37 38.04 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 109.156 -0.683 . . . . 73.24 109.156 -175.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -106.68 138.52 42.69 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.802 -0.635 . . . . 41.54 109.845 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 57.2 m -92.52 123.9 36.17 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.513 -0.551 . . . . 70.2 109.513 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 60.6 t -120.88 148.43 24.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 106.845 -1.539 . . . . 73.51 106.845 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.53 135.96 38.26 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-O 120.965 0.412 . . . . 74.4 111.607 -178.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 527' ' ' SER . . . . . 0.429 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 38.7 m -154.13 172.5 5.72 Favored Pre-proline 0 N--CA 1.429 -1.521 0 N-CA-C 106.162 -1.792 . . . . 54.11 106.162 175.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -90.93 -0.91 4.98 Favored 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 121.938 1.759 . . . . 73.52 109.842 167.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.558 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 0.0 OUTLIER -78.31 132.6 65.8 Favored Pre-proline 0 C--O 1.216 -0.681 0 CA-C-N 114.912 -1.04 . . . . 64.13 109.229 178.406 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 530' ' ' PRO . . . . . 0.432 ' O ' ' HB2' ' A' ' 533' ' ' GLU . 31.2 Cg_exo -56.03 143.68 82.28 Favored 'Trans proline' 0 C--O 1.246 0.88 0 C-N-CA 123.1 2.534 . . . . 72.33 113.692 -175.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.61 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -56.7 132.01 50.76 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.287 -0.87 . . . . 72.31 111.045 -178.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 110.9 -8.91 29.64 Favored Glycine 0 C--N 1.306 -1.127 0 N-CA-C 110.357 -1.097 . . . . 72.34 110.357 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 533' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 530' ' ' PRO . 7.5 tp10 -82.62 125.55 31.32 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 106.811 -1.551 . . . . 71.24 106.811 178.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 91.2 t -89.1 110.03 20.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 107.564 -1.273 . . . . 73.03 107.564 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 535' ' ' THR . . . . . 0.485 HG23 ' HG3' ' A' ' 554' ' ' GLN . 11.4 t -78.32 -12.48 60.01 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.884 -0.598 . . . . 72.24 110.683 -176.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.98 -159.45 28.33 Favored Glycine 0 N--CA 1.428 -1.844 0 C-N-CA 120.952 -0.642 . . . . 72.01 111.743 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 40.7 p -117.67 148.52 41.89 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 107.323 -1.362 . . . . 73.41 107.323 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.455 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 51.0 t30 -66.07 -50.57 50.88 Favored Pre-proline 0 C--N 1.315 -0.908 0 C-N-CA 120.603 -0.439 . . . . 75.54 111.543 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.455 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 11.2 Cg_exo -75.8 141.55 24.53 Favored 'Trans proline' 0 C--N 1.367 1.525 0 N-CA-C 108.304 -1.46 . . . . 71.42 108.304 170.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.51 143.35 97.16 Favored 'Trans proline' 0 C--O 1.249 1.063 0 C-N-CA 122.068 1.845 . . . . 63.55 111.756 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.02 138.15 58.34 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.289 0.566 . . . . 30.44 111.818 -177.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 96.1 -10.35 67.78 Favored Glycine 0 C--N 1.308 -0.977 0 CA-C-N 115.942 -0.572 . . . . 74.34 112.439 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 42.8 m -70.77 134.4 47.38 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.506 -0.553 . . . . 61.22 109.506 178.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.521 HG22 ' HB ' ' A' ' 494' ' ' THR . 24.8 m -84.06 123.08 29.65 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 109.177 -0.675 . . . . 70.43 109.177 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.68 157.47 78.08 Favored Pre-proline 0 C--N 1.313 -0.982 0 N-CA-C 108.444 -0.947 . . . . 50.14 108.444 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -68.19 141.68 53.07 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.804 1.67 . . . . 74.24 111.045 176.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 35.0 m -65.14 -20.2 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-O 121.842 0.829 . . . . 52.32 110.443 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -74.37 -18.63 60.65 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.607 -1.178 . . . . 74.41 110.493 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.1 t -87.37 150.96 23.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.113 -1.069 . . . . 64.42 108.113 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 12.5 p -88.82 135.84 24.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.003 -1.11 . . . . 74.01 108.003 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 551' ' ' ILE . . . . . 0.571 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -96.33 145.9 8.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 C-N-CA 118.738 -1.185 . . . . 72.11 109.701 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -109.74 115.83 30.57 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-O 121.579 0.704 . . . . 74.33 110.857 -175.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -94.94 133.88 38.21 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 106.169 -1.789 . . . . 65.23 106.169 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 554' ' ' GLN . . . . . 0.485 ' HG3' HG23 ' A' ' 535' ' ' THR . 13.8 pt20 -108.48 116.45 32.0 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 122.099 0.952 . . . . 72.2 110.143 -177.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 54.6 t -103.7 139.68 23.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 CA-C-N 114.403 -1.271 . . . . 74.34 108.573 -175.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.61 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 73.5 m -82.4 136.52 34.94 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-O 122.068 0.937 . . . . 64.5 113.006 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -85.18 139.45 31.67 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 104.5 -2.408 . . . . 74.13 104.5 167.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 558' ' ' GLY . . . . . 0.558 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -83.18 -43.87 7.3 Favored Glycine 0 CA--C 1.484 -1.845 0 C-N-CA 119.768 -1.206 . . . . 61.42 113.547 -174.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 64.46 18.72 11.5 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 112.69 0.626 . . . . 71.44 112.69 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -124.21 145.75 49.14 Favored 'General case' 0 N--CA 1.417 -2.111 0 C-N-CA 120.283 -0.567 . . . . 72.25 110.547 -169.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -139.54 153.06 47.36 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.883 -0.784 . . . . 65.43 108.883 174.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 8.9 p -78.17 125.4 37.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.448 0.642 . . . . 74.03 112.446 -173.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 52.8 ttp -97.34 130.81 28.63 Favored Pre-proline 0 C--O 1.248 1.009 0 CA-C-N 115.92 -0.582 . . . . 73.44 111.065 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -74.22 170.49 20.05 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.939 2.426 . . . . 64.1 111.298 174.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -69.36 120.07 14.61 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.51 0.671 . . . . 71.11 110.902 177.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 87.2 mt -104.05 -7.04 20.57 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.647 -0.706 . . . . 75.12 110.102 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 47.4 m -66.65 132.01 47.22 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.598 -0.728 . . . . 72.14 109.875 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 93.91 -11.51 70.8 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.716 -0.754 . . . . 64.53 112.327 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 89.4 mtp -83.84 146.17 28.25 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.493 -0.558 . . . . 75.52 109.493 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -92.21 137.95 31.94 Favored 'General case' 0 N--CA 1.414 -2.247 0 N-CA-C 107.027 -1.471 . . . . 75.11 107.027 177.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 571' ' ' TRP . . . . . 0.453 ' HA ' ' HB3' ' A' ' 574' ' ' ALA . 41.1 t90 -57.84 -25.82 61.18 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 123.399 0.437 . . . . 63.44 111.916 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 14.3 p -64.16 -29.95 48.73 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-O 120.996 0.427 . . . . 74.21 110.831 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -101.3 -34.3 9.69 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-O 121.687 0.756 . . . . 72.23 109.452 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 574' ' ' ALA . . . . . 0.46 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -63.6 -40.31 96.61 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-N 115.168 -0.924 . . . . 70.13 111.875 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.458 ' O ' ' HG2' ' A' ' 579' ' ' ARG . 17.4 tp10 -51.4 -59.34 8.06 Favored Pre-proline 0 CA--C 1.562 1.421 0 C-N-CA 123.074 0.55 . . . . 73.31 112.047 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.46 -35.26 83.64 Favored 'Trans proline' 0 C--N 1.375 1.929 0 CA-C-N 120.684 1.28 . . . . 60.54 112.6 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.513 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 83.2 mmt-85 -66.51 -39.77 88.84 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 120.469 -0.492 . . . . 74.41 111.817 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 93.8 mt -65.89 -43.71 87.48 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.459 -0.337 . . . . 75.44 111.134 -177.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 579' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 29.5 mmt180 -65.04 -37.41 87.48 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.731 -0.47 . . . . 74.12 109.731 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.13 -31.16 71.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.441 -0.799 . . . . 73.31 111.422 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 581' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 99.1 mt -81.88 -7.81 59.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.399 -0.364 . . . . 54.43 111.531 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 87.13 34.47 10.71 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.698 -0.763 . . . . 53.45 111.855 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 44.4 t90 -86.67 127.67 34.96 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.574 -0.528 . . . . 72.43 109.574 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 13.9 m -133.16 28.28 4.12 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 122.618 1.199 . . . . 75.41 108.117 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -82.97 -164.78 36.37 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 114.883 -1.053 . . . . 74.24 112.065 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 55.0 ttp -108.93 130.98 55.46 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 122.615 -0.344 . . . . 73.44 110.463 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 41.7 tp -90.56 116.28 28.34 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.401 -1.333 . . . . 74.1 107.401 175.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -107.26 107.73 18.8 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.408 0.623 . . . . 74.24 111.574 -177.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -112.77 124.7 53.17 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.675 -1.232 . . . . 74.34 107.675 174.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -88.54 -120.56 1.7 Allowed Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 109.944 -1.262 . . . . 61.5 109.944 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -82.09 133.6 35.29 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.524 -0.917 . . . . 73.42 108.524 176.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -78.82 124.9 28.68 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.262 -1.014 . . . . 74.14 108.262 177.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 44.0 t -121.85 116.2 48.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 116.064 -0.516 . . . . 63.21 110.555 -174.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -90.46 107.64 19.29 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.495 -1.298 . . . . 73.31 107.495 176.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -132.01 4.46 4.13 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.763 -0.775 . . . . 54.43 111.603 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 116.11 -175.75 16.01 Favored Glycine 0 N--CA 1.424 -2.12 0 C-N-CA 120.403 -0.903 . . . . 74.05 111.051 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -58.69 -33.32 72.11 Favored Glycine 0 C--N 1.322 -0.196 0 C-N-CA 123.455 0.55 . . . . 41.32 114.18 -175.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 19.9 m -64.41 -27.56 69.09 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 120.9 0.381 . . . . 64.13 111.433 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -109.13 -1.44 18.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.981 0.419 . . . . 73.22 111.329 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -81.73 113.01 19.42 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 112.241 0.46 . . . . 62.31 112.241 -173.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 57.48 -2.11 0.06 Allowed 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 126.506 1.922 . . . . 62.3 115.46 172.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -96.54 145.98 25.22 Favored 'General case' 0 CA--C 1.501 -0.91 0 O-C-N 121.015 -1.053 . . . . 74.11 111.722 -174.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 97.8 t -65.43 130.04 30.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 107.045 -1.465 . . . . 71.42 107.045 173.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 87.9 t -89.02 -41.81 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-O 121.311 0.577 . . . . 62.43 110.061 -175.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -151.03 158.15 43.75 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.823 -1.177 . . . . 72.22 107.823 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -119.19 127.24 53.12 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 107.517 -1.29 . . . . 71.21 107.517 175.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.549 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 27.0 t-20 -54.53 -58.07 15.85 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-O 118.785 -0.626 . . . . 64.4 112.623 -179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.549 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 2.9 Cg_endo -84.44 136.49 6.53 Favored 'Trans proline' 0 C--N 1.363 1.305 0 CA-C-N 120.926 1.366 . . . . 74.21 109.921 174.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 609' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 608' ' ' PRO . 22.9 Cg_exo -63.94 158.62 46.36 Favored 'Trans proline' 0 C--O 1.243 0.755 0 C-N-CA 122.37 2.047 . . . . 75.21 111.882 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.59 130.42 42.98 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 116.305 -0.407 . . . . 72.12 109.94 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 98.16 -2.27 59.52 Favored Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 120.532 -0.842 . . . . 75.31 111.663 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 15.0 m -92.76 155.87 17.39 Favored 'General case' 0 C--O 1.253 1.25 0 N-CA-C 108.484 -0.932 . . . . 74.32 108.484 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -80.8 134.08 12.92 Favored Glycine 0 N--CA 1.415 -2.725 0 C-N-CA 120.883 -0.675 . . . . 42.21 112.211 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 28.8 m -110.61 142.95 21.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 C-N-CA 123.0 0.52 . . . . 64.13 109.715 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.419 HD21 HG22 ' A' ' 619' ' ' ILE . 5.2 p-10 -54.99 172.57 0.11 Allowed 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 125.545 1.538 . . . . 63.45 113.256 -178.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 616' ' ' ARG . . . . . 0.531 ' H ' ' HD2' ' A' ' 616' ' ' ARG . 1.5 mpt_? -48.22 -43.44 32.11 Favored 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 124.279 1.032 . . . . 73.14 112.462 -174.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -85.99 -19.22 30.7 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.966 -0.561 . . . . 72.44 111.43 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 81.31 21.98 61.49 Favored Glycine 0 CA--C 1.494 -1.227 0 C-N-CA 120.233 -0.984 . . . . 63.4 113.722 173.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 619' ' ' ILE . . . . . 0.419 HG22 HD21 ' A' ' 615' ' ' ASN . 0.0 OUTLIER -67.95 119.26 13.36 Favored 'Isoleucine or valine' 0 C--O 1.252 1.218 0 CA-C-O 123.549 1.642 . . . . 75.55 110.545 -171.472 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.41 HG12 ' HD2' ' A' ' 608' ' ' PRO . 0.0 OUTLIER -117.76 132.34 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.521 0 CA-C-N 112.257 -2.247 . . . . 75.45 106.036 -178.911 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 31.5 m -96.41 118.88 33.84 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.789 -0.819 . . . . 72.45 108.789 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 1.6 pp -130.34 165.5 22.39 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 113.518 -1.674 . . . . 63.21 109.178 -176.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 7.7 tpp180 -142.45 139.06 31.46 Favored 'General case' 0 C--N 1.269 -2.918 0 N-CA-C 105.86 -1.904 . . . . 54.35 105.86 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -139.67 149.45 43.71 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.332 -0.988 . . . . 60.33 108.332 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -75.14 -98.44 0.11 Allowed Glycine 0 N--CA 1.438 -1.182 0 O-C-N 123.764 0.665 . . . . 64.43 113.628 -173.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 . . . . . 0 N--CA 1.429 -1.512 0 N-CA-C 108.991 -0.744 . . . . 74.54 108.991 179.84 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 CA--C 1.486 -1.511 0 N-CA-C 106.112 -1.81 . . . . 72.42 106.112 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 32.3 m -117.75 136.74 53.94 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.525 0 N-CA-C 108.908 -0.775 . . . . 63.4 108.908 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -97.94 122.26 40.84 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 105.262 -2.125 . . . . 71.21 105.262 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.412 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 59.1 t -96.82 122.86 55.65 Favored Pre-proline 0 C--N 1.285 -2.207 0 CA-C-N 115.723 -0.671 . . . . 73.41 111.844 -166.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 363' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 23.6 Cg_exo -65.14 140.91 67.23 Favored 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 122.857 2.371 . . . . 51.31 112.001 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -91.63 141.99 28.1 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 115.636 -0.711 . . . . 75.54 109.94 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 12.1 t -119.97 25.96 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.459 0 CA-C-O 122.74 1.257 . . . . 73.51 108.884 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? -63.38 144.62 56.81 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.175 -0.92 . . . . 63.12 113.181 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 91.29 0.38 73.72 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.968 -0.635 . . . . 74.43 112.847 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -104.08 -81.86 0.51 Allowed 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 120.543 -0.463 . . . . 63.51 110.46 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 87.8 p -169.1 163.34 11.14 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 107.512 -1.292 . . . . 73.41 107.512 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 12.0 m -63.77 -41.0 98.05 Favored 'General case' 0 N--CA 1.422 -1.873 0 O-C-N 123.987 0.804 . . . . 64.15 109.15 176.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.25 -46.69 87.71 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 115.871 -0.604 . . . . 75.11 111.484 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -64.97 -43.66 91.91 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 120.972 0.415 . . . . 64.55 110.978 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 373' ' ' ALA . . . . . 0.404 ' O ' HD13 ' A' ' 377' ' ' LEU . . . -66.53 -47.6 72.39 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.841 -0.618 . . . . 45.31 110.622 -178.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 80.5 mt -67.15 -40.32 84.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.933 -0.122 . . . . 71.34 111.296 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.91 -41.72 98.25 Favored 'General case' 0 C--O 1.246 0.877 0 N-CA-C 112.399 0.518 . . . . 25.01 112.399 -177.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 376' ' ' THR . . . . . 0.408 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 21.2 m -67.19 -47.46 70.84 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.87 -0.605 . . . . 64.33 109.959 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.404 HD13 ' O ' ' A' ' 373' ' ' ALA . 10.8 mp -64.28 -38.21 90.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.918 -0.583 . . . . 74.13 111.508 178.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -60.29 -44.33 95.48 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 123.356 0.662 . . . . 73.24 109.722 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -70.26 -20.58 63.05 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 112.352 0.501 . . . . 72.54 112.352 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 380' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 376' ' ' THR . 35.2 mmt180 -85.52 -14.03 47.16 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.706 -0.398 . . . . 71.53 110.056 174.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 96.09 8.29 57.95 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.074 -0.584 . . . . 62.35 112.743 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -77.75 157.37 30.07 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 112.941 0.719 . . . . 74.33 112.941 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.444 ' HB2' ' HG2' ' A' ' 415' ' ' GLU . 27.4 mmtp -96.84 151.22 19.87 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.795 -1.093 . . . . 72.21 108.947 176.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 384' ' ' ILE . . . . . 0.509 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 0.2 OUTLIER -129.94 136.39 59.01 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 CA-C-N 115.87 -0.604 . . . . 60.13 109.496 178.569 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -108.97 126.52 53.18 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 105.359 -2.089 . . . . 70.02 105.359 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 20.9 m -106.48 118.39 36.54 Favored 'General case' 0 C--N 1.282 -2.34 0 C-N-CA 120.351 -0.539 . . . . 74.41 110.429 -170.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -120.46 129.32 53.82 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.242 -1.021 . . . . 60.32 108.242 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -103.92 143.05 33.37 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.976 -0.379 . . . . 74.5 109.976 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -126.57 115.76 22.89 Favored Pre-proline 0 C--N 1.306 -1.289 0 N-CA-C 109.521 -0.548 . . . . 74.51 109.521 174.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 390' ' ' PRO . . . . . 0.416 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 56.7 Cg_endo -98.46 129.76 0.23 Allowed 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.38 2.053 . . . . 75.52 112.526 175.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.591 ' HB3' HG12 ' A' ' 394' ' ' ILE . 9.7 t70 173.71 160.49 0.15 Allowed 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 109.302 -0.629 . . . . 75.21 109.302 174.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 35.3 t -75.57 -24.32 56.63 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.317 0.579 . . . . 75.34 110.084 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 3.3 m -83.42 -4.7 58.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.239 1.019 . . . . 64.31 108.986 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.591 HG12 ' HB3' ' A' ' 391' ' ' ASP . 15.1 mm -88.53 134.55 33.99 Favored Pre-proline 0 N--CA 1.427 -1.578 0 CA-C-N 114.568 -1.197 . . . . 53.45 110.367 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 395' ' ' PRO . . . . . 0.545 ' HG3' HD13 ' A' ' 400' ' ' ILE . 60.6 Cg_endo -66.14 -173.6 0.35 Allowed 'Trans proline' 0 CA--C 1.573 2.468 0 C-N-CA 125.003 3.802 . . . . 53.0 114.698 -176.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -58.47 159.41 19.9 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 122.872 2.381 . . . . 75.14 113.761 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -57.88 -9.81 1.47 Allowed 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 126.885 2.074 . . . . 74.33 113.362 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -90.18 177.38 6.45 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 116.112 -0.494 . . . . 63.14 111.56 -176.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 19.2 m -83.12 119.23 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 C-N-CA 120.51 -0.476 . . . . 62.54 110.912 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 400' ' ' ILE . . . . . 0.545 HD13 ' HG3' ' A' ' 395' ' ' PRO . 30.0 pt -86.77 -32.24 6.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.277 0.56 . . . . 73.42 109.707 177.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -147.99 170.36 28.64 Favored Glycine 0 N--CA 1.413 -2.845 0 N-CA-C 110.348 -1.101 . . . . 41.21 110.348 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.24 -179.42 3.63 Favored 'General case' 0 C--N 1.278 -2.54 0 CA-C-O 120.744 0.307 . . . . 64.5 110.678 178.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -102.1 129.74 25.73 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 107.974 -1.121 . . . . 72.01 107.974 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.94 -17.67 24.98 Favored 'Trans proline' 0 C--O 1.25 1.094 0 C-N-CA 124.01 3.14 . . . . 53.23 114.972 -173.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.5 -35.42 75.9 Favored 'General case' 0 C--O 1.21 -1.0 0 N-CA-C 109.657 -0.497 . . . . 51.11 109.657 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -69.33 -39.51 78.13 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.375 0.607 . . . . 33.1 110.265 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -75.65 -7.28 53.9 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.434 0.635 . . . . 72.23 110.987 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 29.6 m -98.67 153.91 18.35 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 106.998 -1.482 . . . . 74.21 106.998 174.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 61.0 m -75.07 113.04 11.94 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 118.974 -1.09 . . . . 53.25 109.104 176.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 18.7 m -121.24 169.81 12.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 122.867 0.467 . . . . 73.52 109.744 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 3.4 p -76.75 147.87 37.06 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 120.567 -0.453 . . . . 73.21 110.479 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -62.34 126.83 28.7 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 116.119 -0.492 . . . . 75.02 110.186 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 96.81 28.35 8.89 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 120.884 -0.674 . . . . 72.15 111.692 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -83.34 177.52 8.47 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.246 -1.02 . . . . 51.14 108.246 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 415' ' ' GLU . . . . . 0.444 ' HG2' ' HB2' ' A' ' 383' ' ' LYS . 39.0 mt-10 -111.3 108.94 18.72 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.216 0.531 . . . . 62.52 109.974 -174.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 416' ' ' ILE . . . . . 0.509 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 46.2 mm -102.22 129.13 54.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 115.215 -0.902 . . . . 74.2 108.83 -178.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 30.1 m -85.86 130.58 34.51 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.083 0.468 . . . . 72.11 111.205 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 7.5 p -110.81 134.87 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 107.676 -1.231 . . . . 72.31 107.676 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -110.76 122.19 47.21 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.069 0.461 . . . . 71.41 110.855 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 99.3 t -102.89 131.16 51.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 114.866 -1.061 . . . . 74.22 108.249 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 421' ' ' SER . . . . . 0.434 ' HB3' ' CG2' ' A' ' 394' ' ' ILE . 8.8 m -98.7 125.04 43.89 Favored 'General case' 0 C--N 1.274 -2.7 0 CA-C-N 115.358 -0.837 . . . . 63.4 110.112 -176.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 2.5 p -111.07 149.95 30.07 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.152 -0.685 . . . . 53.22 109.152 176.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.11 0 N-CA-C 116.098 1.199 . . . . 72.22 116.098 -172.226 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 41.2 mt-30 . . . . . 0 N--CA 1.415 -2.181 0 N-CA-C 106.781 -1.563 . . . . 63.24 106.781 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -133.59 144.89 49.58 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-O 121.0 0.428 . . . . 74.33 110.497 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.45 ' H ' ' CD ' ' A' ' 428' ' ' GLU . 0.5 OUTLIER -83.74 133.34 34.79 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 107.899 -1.149 . . . . 63.41 107.899 176.406 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 63.1 mt -80.82 129.92 65.99 Favored Pre-proline 0 C--N 1.312 -1.052 0 CA-C-N 116.612 -0.267 . . . . 73.13 111.714 -172.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.93 147.13 54.66 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.206 1.937 . . . . 64.31 111.498 173.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -83.57 105.26 14.35 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.485 -0.561 . . . . 75.15 109.485 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 11.6 p -94.77 161.18 2.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 107.972 -1.122 . . . . 55.11 107.972 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.449 ' HB3' ' OG1' ' A' ' 436' ' ' THR . 29.7 t -83.86 157.52 21.97 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 108.964 -0.754 . . . . 72.13 108.964 177.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 32.0 p -70.2 -27.02 64.16 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 112.987 0.736 . . . . 74.24 112.987 -172.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.424 ' H ' HD23 ' A' ' 435' ' ' LEU . 0.6 OUTLIER -87.54 -13.77 42.05 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.313 0.577 . . . . 75.41 110.778 179.458 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.566 HG22 ' HB3' ' A' ' 439' ' ' GLU . 1.4 m -92.54 41.4 1.07 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.782 -0.645 . . . . 62.42 110.409 -175.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -53.07 -40.35 63.97 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.974 0.909 . . . . 62.23 112.273 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.14 98.73 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 120.812 0.339 . . . . 73.05 110.918 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.566 ' HB3' HG22 ' A' ' 436' ' ' THR . 31.4 tt0 -71.14 -34.92 71.48 Favored 'General case' 0 C--O 1.201 -1.489 0 C-N-CA 120.441 -0.503 . . . . 75.33 110.684 175.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.61 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -58.52 -51.34 70.3 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 122.219 0.208 . . . . 44.01 111.018 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 36.0 m -61.39 -37.78 78.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-O 121.211 0.529 . . . . 72.43 110.401 177.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -60.43 -47.46 86.02 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.641 0.776 . . . . 64.42 111.147 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -64.8 -38.31 90.55 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 123.318 0.647 . . . . 74.23 111.184 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 83.9 mt -63.76 -37.86 88.96 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.683 -0.488 . . . . 73.23 109.683 176.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.532 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 37.1 m -70.03 -42.92 72.31 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.902 -0.59 . . . . 73.23 110.32 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -65.15 -26.44 68.18 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.051 -0.522 . . . . 74.32 111.111 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -81.04 4.95 17.98 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.065 -0.516 . . . . 45.52 111.879 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 108.03 -67.94 0.22 Allowed Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.334 -0.936 . . . . 63.24 112.795 174.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 449' ' ' PHE . . . . . 0.519 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 1.8 p90 -50.54 -60.75 2.7 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.679 0.992 . . . . 73.43 113.679 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 450' ' ' GLY . . . . . 0.532 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 60.92 23.46 61.45 Favored Glycine 0 CA--C 1.499 -0.914 0 C-N-CA 121.255 -0.497 . . . . 72.03 112.203 -176.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.405 ' HB3' HG22 ' A' ' 483' ' ' VAL . 25.3 mmt180 -105.04 110.98 23.59 Favored 'General case' 0 N--CA 1.414 -2.258 0 N-CA-C 109.073 -0.714 . . . . 74.34 109.073 -178.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -131.97 143.32 50.02 Favored 'General case' 0 N--CA 1.415 -2.223 0 CA-C-N 114.608 -1.178 . . . . 74.04 110.192 -177.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -134.52 123.1 23.36 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 107.499 -1.297 . . . . 73.02 107.499 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -100.03 133.33 44.57 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.35 0.595 . . . . 73.23 111.901 -174.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -119.28 144.98 46.5 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 108.437 -0.949 . . . . 65.43 108.437 176.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -114.8 135.75 53.83 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.593 -0.892 . . . . 51.23 108.593 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 40.2 m -147.48 142.33 16.69 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 109.38 -0.6 . . . . 72.54 109.38 176.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.446 ' HA ' ' O ' ' A' ' 490' ' ' SER . 12.2 Cg_exo -70.17 131.62 21.01 Favored 'Trans proline' 0 C--O 1.247 0.948 0 C-N-CA 122.204 1.936 . . . . 50.21 111.555 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 56.4 m -149.75 -179.95 7.53 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.365 -0.976 . . . . 70.01 108.365 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 10.1 t -45.12 135.72 5.12 Favored Pre-proline 0 C--O 1.246 0.903 0 C-N-CA 124.015 0.926 . . . . 73.31 112.387 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.63 -30.39 36.4 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 124.363 3.375 . . . . 70.13 113.638 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -71.37 -23.45 61.9 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.57 0.581 . . . . 62.11 112.57 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 84.5 mt -99.74 -6.33 27.23 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.66 -0.416 . . . . 60.12 110.913 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 98.0 t -61.38 127.72 21.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 116.154 -0.475 . . . . 72.51 110.716 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 91.82 -3.59 77.92 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 115.614 -0.721 . . . . 72.02 111.661 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -118.19 166.37 12.67 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 108.278 -1.008 . . . . 35.05 108.278 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 93.8 t -76.12 145.7 10.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 108.306 -0.998 . . . . 74.5 108.306 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 68.5 mt -97.61 -35.25 5.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.262 -1.384 . . . . 64.23 107.262 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 159.68 -167.33 35.2 Favored Glycine 0 N--CA 1.423 -2.212 0 CA-C-N 115.356 -0.838 . . . . 70.33 111.012 176.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 470' ' ' THR . . . . . 0.656 HG22 HG12 ' A' ' 486' ' ' ILE . 72.8 p -116.2 144.85 43.64 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 106.969 -1.493 . . . . 73.51 106.969 178.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -67.1 -58.38 9.28 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 119.153 -1.019 . . . . 72.15 110.101 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 473' ' ' PRO . 31.3 Cg_endo -68.2 130.18 20.82 Favored 'Trans proline' 0 C--N 1.376 2.015 0 N-CA-C 106.364 -2.206 . . . . 61.14 106.364 168.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 472' ' ' PRO . 23.8 Cg_exo -61.82 138.6 75.22 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 121.55 1.5 . . . . 71.22 112.774 -172.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -75.85 11.17 1.48 Allowed 'General case' 0 C--O 1.202 -1.431 0 CA-C-N 115.324 -0.853 . . . . 53.12 111.468 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -109.56 -1.54 18.15 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.799 -0.637 . . . . 72.43 109.427 177.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 476' ' ' GLN . . . . . 0.401 ' HG2' ' HB2' ' A' ' 473' ' ' PRO . 85.7 mm-40 -94.24 172.55 8.14 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.867 -0.606 . . . . 43.41 111.778 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.438 HG22 ' HB3' ' A' ' 426' ' ' GLN . 1.9 m -99.42 108.16 20.57 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 107.994 -1.113 . . . . 71.4 107.994 -178.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 50.1 m -100.64 138.66 37.41 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 120.901 0.382 . . . . 61.41 110.815 -176.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -77.37 154.53 32.67 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.659 -0.7 . . . . 64.14 111.134 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 480' ' ' ILE . . . . . 0.519 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 1.7 mp -65.32 -24.74 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-N 115.493 -0.776 . . . . 72.44 111.555 178.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 4.4 p -93.48 6.04 49.54 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.72 0.771 . . . . 74.1 111.565 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -107.88 131.71 54.22 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.693 -0.685 . . . . 55.01 111.435 -176.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.405 HG22 ' HB3' ' A' ' 451' ' ' ARG . 55.0 t -94.65 126.9 46.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.752 -0.658 . . . . 74.54 110.095 -177.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 34.4 m -98.36 133.7 39.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-O 121.51 0.672 . . . . 44.33 111.033 178.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.9 129.02 51.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.851 -0.613 . . . . 71.31 109.794 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.656 HG12 HG22 ' A' ' 470' ' ' THR . 4.9 mt -117.12 128.74 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 C-N-CA 124.43 1.092 . . . . 72.42 110.215 -176.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 5.8 tt -108.4 126.92 65.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-N 116.447 -0.342 . . . . 73.15 110.354 -177.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 34.6 m -111.43 152.0 13.42 Favored 'Isoleucine or valine' 0 C--O 1.252 1.236 0 CA-C-N 116.229 -0.441 . . . . 72.24 110.633 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.87 123.3 6.04 Favored Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 115.928 -0.578 . . . . 45.43 113.59 -176.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.446 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 31.0 t . . . . . 0 N--CA 1.428 -1.542 0 N-CA-C 107.728 -1.212 . . . . 54.42 107.728 177.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.443 -1.487 0 CA-C-O 121.263 0.443 . . . . 61.41 111.533 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 493' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . -90.36 119.73 30.89 Favored 'General case' 0 N--CA 1.41 -2.43 0 N-CA-C 107.513 -1.291 . . . . 52.0 107.513 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 51.5 p -116.59 143.36 45.71 Favored 'General case' 0 C--N 1.27 -2.859 0 N-CA-C 109.159 -0.682 . . . . 60.11 109.159 -178.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 495' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 544' ' ' THR . 10.3 ttpp -151.44 164.46 36.71 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 108.445 -0.946 . . . . 74.54 108.445 176.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 10.7 p-10 -79.67 136.54 36.83 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.85 -0.796 . . . . 62.04 108.85 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 40.6 pt -75.45 131.41 77.62 Favored Pre-proline 0 C--N 1.305 -1.355 0 N-CA-C 109.374 -0.602 . . . . 74.44 109.374 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -56.65 118.15 4.94 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.592 2.861 . . . . 65.3 114.285 -174.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -84.42 94.53 8.53 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-N 115.824 -0.625 . . . . 74.33 109.532 177.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.7 p -159.75 93.75 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-O 122.247 1.022 . . . . 62.1 110.947 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -108.09 162.84 13.68 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 107.862 -1.162 . . . . 75.1 107.862 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 98.1 23.38 13.17 Favored Glycine 0 C--N 1.295 -1.747 0 N-CA-C 108.967 -1.653 . . . . 63.25 108.967 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -129.38 165.5 21.39 Favored 'General case' 0 CA--C 1.471 -2.068 0 CA-C-N 114.402 -0.899 . . . . 70.35 109.336 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 6.9 m -88.67 156.44 19.01 Favored 'General case' 0 C--N 1.275 -2.67 0 C-N-CA 120.118 -0.633 . . . . 52.42 110.208 -173.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 12.2 p -50.53 -41.24 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 124.521 1.129 . . . . 72.35 113.522 -174.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -67.41 -39.67 85.54 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.372 0.606 . . . . 55.33 110.549 -178.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 48.8 t -70.37 -43.78 77.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.344 -0.844 . . . . 64.54 109.529 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -61.68 -47.11 86.81 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.226 -0.897 . . . . 50.42 112.26 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -64.2 -35.92 82.36 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.137 0.273 . . . . 72.51 110.708 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 52.5 tttm -58.69 -53.8 54.28 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.032 -0.531 . . . . 73.25 109.831 175.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -62.61 -41.69 99.13 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.286 -0.87 . . . . 74.14 110.914 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 9.0 tt -61.46 -47.87 83.72 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.955 -0.566 . . . . 73.33 110.408 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 513' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 12.8 m120 -66.68 -37.81 85.5 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 111.812 0.301 . . . . 70.23 111.812 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 54.4 t -62.74 -31.69 53.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.162 -0.472 . . . . 74.43 111.052 177.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -86.15 13.25 8.14 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 114.147 1.166 . . . . 74.03 114.147 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 102.07 -11.58 57.28 Favored Glycine 0 CA--C 1.499 -0.907 0 C-N-CA 119.925 -1.131 . . . . 54.11 114.214 171.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 88.8 m-85 -91.11 120.34 31.99 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.331 -0.618 . . . . 73.33 109.331 -177.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 22.7 p -97.96 -14.84 20.38 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 113.329 0.863 . . . . 72.12 113.329 -174.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -123.22 117.58 25.64 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.092 0.473 . . . . 63.43 112.102 -172.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -131.51 147.89 52.58 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.782 -0.645 . . . . 70.44 111.694 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 521' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 51.1 m -132.69 140.16 48.0 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.161 -1.422 . . . . 70.42 107.161 173.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 522' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 4.9 pp0? -117.77 128.77 55.2 Favored 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 119.945 -0.702 . . . . 74.24 112.191 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -111.92 143.53 42.74 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.443 -0.947 . . . . 54.21 108.443 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 524' ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 57.1 m -96.52 139.35 32.75 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 113.095 0.776 . . . . 54.32 113.095 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 40.6 t -122.22 159.14 25.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 106.778 -1.564 . . . . 73.42 106.778 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 526' ' ' ASP . . . . . 0.569 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 30.9 m-20 -85.0 134.58 34.22 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 107.741 -1.207 . . . . 62.03 107.741 177.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 527' ' ' SER . . . . . 0.539 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 19.0 m -153.57 178.3 1.65 Allowed Pre-proline 0 C--N 1.313 -1.016 0 N-CA-C 109.197 -0.668 . . . . 62.33 109.197 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -89.0 -8.32 4.92 Favored 'Trans proline' 0 CA--C 1.55 1.28 0 C-N-CA 122.47 2.113 . . . . 62.02 111.114 170.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.9 142.07 48.17 Favored Pre-proline 0 C--O 1.213 -0.861 0 N-CA-C 108.675 -0.861 . . . . 64.24 108.675 176.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -63.42 160.36 35.83 Favored 'Trans proline' 0 C--O 1.247 0.972 0 C-N-CA 122.558 2.172 . . . . 64.42 113.419 -176.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -58.38 118.44 5.56 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.038 -0.983 . . . . 53.22 110.334 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 121.36 -12.46 9.62 Favored Glycine 0 C--N 1.3 -1.465 0 C-N-CA 120.45 -0.881 . . . . 42.55 112.201 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -82.71 131.46 35.2 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.927 -0.768 . . . . 72.42 108.927 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.435 HG22 HG22 ' A' ' 555' ' ' VAL . 54.3 t -90.84 112.67 25.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.676 -0.861 . . . . 72.41 108.676 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 45.8 m -111.04 14.55 21.93 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 122.661 1.22 . . . . 73.41 111.611 -175.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 161.97 -173.84 38.35 Favored Glycine 0 CA--C 1.494 -1.26 0 C-N-CA 119.903 -1.141 . . . . 75.11 112.251 173.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 31.6 p -130.43 153.86 48.32 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.856 -1.165 . . . . 71.34 107.856 176.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -67.75 -54.74 16.13 Favored Pre-proline 0 C--N 1.309 -1.163 0 CA-C-O 119.31 -0.376 . . . . 54.52 111.25 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.32 153.39 45.37 Favored 'Trans proline' 0 C--N 1.371 1.717 0 N-CA-C 108.026 -1.567 . . . . 71.22 108.026 170.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.84 137.86 46.63 Favored 'Trans proline' 0 C--O 1.249 1.055 0 CA-C-N 120.119 1.078 . . . . 60.31 110.932 -177.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -69.68 137.78 52.4 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.735 -0.666 . . . . 55.22 110.396 -178.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.73 -14.34 59.01 Favored Glycine 0 C--N 1.303 -1.286 0 C-N-CA 120.61 -0.805 . . . . 52.3 111.726 -178.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 27.0 m -72.67 137.45 46.03 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 109.407 -0.59 . . . . 70.02 109.407 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 8.9 t -87.2 127.12 35.16 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-O 121.536 0.684 . . . . 74.44 110.124 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.3 m -138.96 162.46 52.38 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 107.738 -1.208 . . . . 73.45 107.738 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 47.0 Cg_exo -60.77 134.59 54.74 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 121.734 1.623 . . . . 63.2 109.784 173.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.405 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 26.9 m -63.57 -20.25 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 113.728 1.011 . . . . 63.12 113.728 -174.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -83.65 -4.47 58.62 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.395 0.617 . . . . 74.24 111.4 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 14.6 m -74.27 160.39 31.18 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.505 -0.554 . . . . 61.34 109.505 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 38.2 t -97.44 115.39 37.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.52 -0.548 . . . . 73.21 109.52 -178.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 61.2 mt -85.01 131.74 33.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 109.108 -0.701 . . . . 65.14 109.108 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 552' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 521' ' ' SER . 34.8 tt0 -103.03 116.2 32.07 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 108.296 -1.001 . . . . 73.42 108.296 176.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 553' ' ' LEU . . . . . 0.48 ' H ' HD23 ' A' ' 553' ' ' LEU . 1.6 pt? -103.76 134.73 46.59 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.493 -0.776 . . . . 64.41 109.285 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -102.05 118.3 36.6 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-O 122.797 1.284 . . . . 74.44 111.409 -175.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 524' ' ' SER . 92.3 t -105.01 136.28 39.44 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 CA-C-N 112.914 -1.948 . . . . 73.34 110.271 -172.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.539 ' HB3' ' HB2' ' A' ' 527' ' ' SER . 75.0 m -75.47 148.94 38.64 Favored 'General case' 0 C--N 1.27 -2.86 0 N-CA-C 113.584 0.957 . . . . 61.41 113.584 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.569 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 9.8 ptpp? -108.84 156.01 20.14 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 105.12 -2.178 . . . . 71.45 105.12 165.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -71.73 -27.59 70.62 Favored Glycine 0 CA--C 1.496 -1.126 0 C-N-CA 120.797 -0.716 . . . . 71.4 111.683 -177.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 62.6 t30 57.85 28.98 16.81 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 122.879 1.324 . . . . 73.51 109.84 173.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -145.8 154.41 41.99 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 105.785 -1.932 . . . . 74.14 105.785 -175.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -143.07 156.19 44.77 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 120.354 -0.538 . . . . 70.52 110.222 175.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 78.1 t -79.15 119.66 28.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 108.519 -0.919 . . . . 75.15 108.519 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 563' ' ' MET . . . . . 0.585 ' SD ' HD12 ' A' ' 620' ' ' ILE . 52.4 ttp -90.46 129.64 44.42 Favored Pre-proline 0 C--N 1.302 -1.488 0 CA-C-N 116.588 -0.278 . . . . 73.3 111.618 -176.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 564' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 563' ' ' MET . 19.5 Cg_exo -69.2 169.85 17.26 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.166 2.578 . . . . 64.32 111.649 174.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -77.23 139.38 39.85 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.83 -0.804 . . . . 64.53 108.83 177.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 25.5 tp -137.97 12.98 2.89 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.781 0.8 . . . . 74.34 109.546 -178.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 53.3 p -79.96 147.78 31.46 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.21 -0.45 . . . . 74.11 111.393 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 77.61 7.89 87.19 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.86 -0.686 . . . . 25.23 113.2 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 8.2 mmt -87.61 143.67 27.07 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.6 -0.889 . . . . 74.5 108.6 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -89.45 176.73 6.79 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 110.071 -0.344 . . . . 72.12 110.071 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -60.93 -34.14 74.25 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.999 -1.112 . . . . 74.51 107.999 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.6 m -73.72 -7.62 10.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.469 -1.241 . . . . 62.43 111.291 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -101.55 -44.06 5.7 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 108.866 -0.791 . . . . 74.04 108.866 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -53.75 -53.68 48.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.006 -0.997 . . . . 44.41 113.481 -175.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -65.45 -53.51 37.85 Favored Pre-proline 0 CA--C 1.553 1.093 0 N-CA-C 113.493 0.923 . . . . 73.21 113.493 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -60.27 -39.34 68.78 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 121.783 1.655 . . . . 75.15 112.196 177.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.561 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 30.2 mtt180 -68.95 -33.5 73.82 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 113.683 0.994 . . . . 72.31 113.683 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 6.8 tt -58.09 -50.19 74.34 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.663 -0.865 . . . . 74.13 108.663 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -68.23 -43.88 76.97 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.207 -0.906 . . . . 72.34 113.439 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -64.17 -40.42 96.07 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 113.389 0.885 . . . . 62.33 113.389 -175.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 581' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 577' ' ' ARG 0.308 3.7 pp -93.13 0.32 57.19 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.05 -1.06 . . . . 73.14 113.655 179.37 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 71.26 43.25 55.74 Favored Glycine 0 CA--C 1.504 -0.631 0 CA-C-N 115.986 -0.552 . . . . 75.12 112.395 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 22.4 t90 -73.21 126.85 31.02 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.073 -0.714 . . . . 74.32 109.073 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 2.5 m -105.76 2.38 27.85 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.753 -0.658 . . . . 70.21 110.491 -175.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -91.72 172.32 35.57 Favored Glycine 0 N--CA 1.436 -1.347 0 C-N-CA 120.594 -0.812 . . . . 73.55 112.433 -175.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 89.4 mmm -92.79 137.18 32.59 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.246 0.546 . . . . 74.11 111.665 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -83.0 128.19 34.25 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.623 -1.172 . . . . 74.54 108.113 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -95.39 103.37 15.23 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.992 -0.549 . . . . 73.41 109.81 -177.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 589' ' ' LYS . . . . . 0.482 ' HD3' ' CE2' ' A' ' 624' ' ' PHE . 52.4 tptt -112.51 110.76 21.14 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 109.107 -0.701 . . . . 62.42 109.107 176.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -91.37 -117.05 2.09 Favored Glycine 0 N--CA 1.428 -1.863 0 C-N-CA 120.512 -0.852 . . . . 63.12 112.313 178.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -84.03 155.64 22.63 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 123.132 0.573 . . . . 64.32 111.333 -177.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -94.21 124.45 38.23 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 109.657 -0.497 . . . . 73.04 109.657 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 49.9 t -125.91 127.62 71.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 107.7 -1.222 . . . . 54.51 107.7 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -73.73 121.14 20.33 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.478 -0.889 . . . . 62.54 108.924 176.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -118.95 -39.11 2.97 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.238 -0.892 . . . . 41.04 110.658 -175.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 60.5 -157.48 29.17 Favored Glycine 0 N--CA 1.423 -2.207 0 O-C-N 123.936 0.772 . . . . 62.31 111.339 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -65.33 -40.99 96.84 Favored Glycine 0 C--N 1.28 -2.528 0 N-CA-C 112.061 -0.415 . . . . 35.21 112.061 174.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 10.2 m -58.38 -40.53 82.55 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 113.121 0.786 . . . . 60.1 113.121 -171.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -108.85 -4.5 16.8 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 111.95 0.352 . . . . 74.43 111.95 177.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 65.8 m80 56.1 102.83 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.471 1.109 . . . . 73.45 113.263 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -77.15 80.25 3.67 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 122.711 1.243 . . . . 65.04 109.812 172.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -134.49 171.16 14.69 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.271 -1.751 . . . . 73.52 106.271 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 603' ' ' VAL . . . . . 0.425 HG11 HD22 ' A' ' 622' ' ' LEU . 76.1 t -61.08 129.67 24.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 107.58 -1.267 . . . . 64.54 107.58 173.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 97.6 t -87.25 -50.31 13.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-O 121.591 0.71 . . . . 71.01 109.27 -175.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -149.44 157.58 43.42 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 106.871 -1.529 . . . . 63.43 106.871 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 606' ' ' GLN . . . . . 0.517 ' HB2' HD11 ' A' ' 620' ' ' ILE . 17.0 pt20 -110.14 123.3 49.48 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 107.948 -1.131 . . . . 72.35 107.948 173.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.507 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 25.3 t-20 -48.58 -54.5 26.05 Favored Pre-proline 0 CA--C 1.553 1.084 0 N-CA-C 113.468 0.914 . . . . 70.22 113.468 -177.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.507 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 4.1 Cg_endo -90.26 138.74 2.83 Favored 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 121.473 1.448 . . . . 73.34 109.944 173.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 609' ' ' PRO . . . . . 0.445 ' HG2' ' OG1' ' A' ' 612' ' ' THR . 29.3 Cg_endo -67.92 147.57 74.67 Favored 'Trans proline' 0 C--O 1.249 1.066 0 C-N-CA 121.985 1.79 . . . . 71.0 113.13 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.55 133.63 49.79 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.283 -0.871 . . . . 62.33 110.456 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 95.96 -8.18 67.71 Favored Glycine 0 C--N 1.305 -1.181 0 C-N-CA 120.717 -0.754 . . . . 51.25 112.113 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 612' ' ' THR . . . . . 0.445 ' OG1' ' HG2' ' A' ' 609' ' ' PRO . 15.7 m -91.28 157.91 16.87 Favored 'General case' 0 C--O 1.256 1.434 0 N-CA-C 109.052 -0.721 . . . . 73.34 109.052 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -77.01 128.63 9.15 Favored Glycine 0 N--CA 1.428 -1.861 0 N-CA-C 111.425 -0.67 . . . . 72.05 111.425 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 614' ' ' VAL . . . . . 0.413 ' CG2' ' HB2' ' A' ' 563' ' ' MET . 33.4 m -122.16 144.19 32.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 C-N-CA 123.528 0.731 . . . . 72.1 110.49 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -39.53 144.23 0.18 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 125.816 1.647 . . . . 70.45 112.115 174.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 616' ' ' ARG . . . . . 0.496 ' HG3' ' N ' ' A' ' 617' ' ' ASP . 3.2 ptp180 -54.9 -28.43 50.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 123.773 0.671 . . . . 75.01 111.021 -178.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 617' ' ' ASP . . . . . 0.496 ' N ' ' HG3' ' A' ' 616' ' ' ARG . 21.2 t70 -60.05 -42.06 93.65 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.783 -1.098 . . . . 74.5 109.652 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 87.08 12.54 67.88 Favored Glycine 0 N--CA 1.413 -2.846 0 CA-C-N 115.012 -0.995 . . . . 33.11 113.363 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 619' ' ' ILE . . . . . 0.466 ' HB ' ' OD2' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -69.4 119.76 15.89 Favored 'Isoleucine or valine' 0 C--O 1.251 1.143 0 CA-C-N 118.604 1.202 . . . . 61.45 109.631 -177.398 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.585 HD12 ' SD ' ' A' ' 563' ' ' MET . 4.1 tt -124.81 132.64 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.223 0 CA-C-N 113.287 -1.779 . . . . 73.41 107.581 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 87.6 m -96.64 122.37 39.5 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 121.814 0.816 . . . . 51.13 109.707 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 622' ' ' LEU . . . . . 0.425 HD22 HG11 ' A' ' 603' ' ' VAL . 61.2 mt -119.9 150.78 39.93 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 105.881 -1.896 . . . . 74.42 105.881 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -128.64 135.79 49.78 Favored 'General case' 0 C--N 1.27 -2.859 0 N-CA-C 106.729 -1.582 . . . . 60.44 106.729 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.482 ' CE2' ' HD3' ' A' ' 589' ' ' LYS . 26.5 p90 -143.24 164.05 31.28 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 108.557 -0.905 . . . . 70.01 108.557 176.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -77.15 -82.06 0.58 Allowed Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 120.582 -0.818 . . . . 64.45 112.932 -177.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 . . . . . 0 C--N 1.292 -1.899 0 N-CA-C 107.878 -1.156 . . . . 71.05 107.878 -177.029 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 . . . . . 0 C--O 1.254 1.332 0 N-CA-C 104.91 -2.255 . . . . 74.3 104.91 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 29.5 m -115.49 160.68 14.72 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 CA-C-O 121.303 0.573 . . . . 72.4 110.929 -170.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 361' ' ' GLN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 409' ' ' SER . 33.8 tt0 -94.35 139.64 30.82 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 115.872 -0.603 . . . . 63.25 110.063 -175.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.685 HG22 ' CZ ' ' A' ' 382' ' ' PHE . 60.5 t -94.68 141.1 22.93 Favored Pre-proline 0 C--N 1.28 -2.436 0 N-CA-C 106.232 -1.766 . . . . 71.31 106.232 -176.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -73.15 119.34 5.97 Favored 'Trans proline' 0 N--CA 1.436 -1.861 0 C-N-CA 120.824 1.016 . . . . 63.14 111.678 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 364' ' ' ASP . . . . . 0.611 ' OD2' ' HD2' ' A' ' 366' ' ' ARG . 24.8 t70 -89.98 82.51 6.14 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 105.974 -1.862 . . . . 63.31 105.974 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 3.0 m -92.46 30.35 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 113.941 -1.482 . . . . 65.31 114.017 -171.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.611 ' HD2' ' OD2' ' A' ' 364' ' ' ASP . 0.0 OUTLIER -52.66 145.26 12.33 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 124.62 1.168 . . . . 62.53 112.399 174.968 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.56 -0.84 45.98 Favored Glycine 0 CA--C 1.492 -1.36 0 CA-C-N 115.81 -0.632 . . . . 70.45 112.821 175.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -112.19 -155.84 0.57 Allowed 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.009 -1.108 . . . . 71.15 108.009 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 21.4 p -94.58 161.53 14.16 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 108.667 -0.864 . . . . 72.32 108.667 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 19.1 p -63.13 -40.01 96.34 Favored 'General case' 0 C--O 1.209 -1.033 0 C-N-CA 120.698 -0.401 . . . . 64.21 109.943 178.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.45 -46.31 89.11 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 116.201 -0.454 . . . . 65.32 111.727 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -69.06 -44.79 71.9 Favored 'General case' 0 C--O 1.253 1.255 0 CA-C-O 121.301 0.572 . . . . 74.42 110.69 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -63.83 -44.63 92.66 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.412 -0.813 . . . . 65.15 110.981 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 70.0 mt -69.31 -37.04 75.07 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.594 0 CA-C-N 116.304 -0.407 . . . . 52.22 110.966 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.78 -43.88 90.53 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.376 0.608 . . . . 32.5 109.986 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 376' ' ' THR . . . . . 0.56 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 54.6 m -65.76 -47.41 75.29 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.288 -0.869 . . . . 65.51 109.859 177.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 26.1 tp -60.98 -40.18 92.46 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 123.898 0.879 . . . . 72.01 111.602 -176.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -70.29 -37.66 74.86 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.136 0.575 . . . . 64.53 110.077 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -67.98 -19.15 64.91 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 120.833 0.349 . . . . 63.33 111.527 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 380' ' ' ARG . . . . . 0.56 ' HG2' ' O ' ' A' ' 376' ' ' THR . 16.6 mmt85 -89.42 -8.71 52.48 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.07 0.462 . . . . 73.23 110.046 177.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 84.78 16.34 65.89 Favored Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 115.826 -0.624 . . . . 73.43 113.587 175.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.685 ' CZ ' HG22 ' A' ' 362' ' ' VAL . 71.0 m-85 -86.4 161.12 18.83 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 117.607 0.703 . . . . 74.22 111.786 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.429 ' HB2' ' HA ' ' A' ' 415' ' ' GLU . 34.2 mmtp -90.4 138.34 31.62 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 107.813 -1.18 . . . . 71.13 107.813 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 384' ' ' ILE . . . . . 0.461 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -117.11 141.21 36.51 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 C-N-CA 119.864 -0.734 . . . . 63.44 109.574 -175.947 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 6.2 tpp180 -132.13 147.65 52.44 Favored 'General case' 0 N--CA 1.408 -2.547 0 N-CA-C 107.54 -1.282 . . . . 75.41 107.54 176.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 54.5 m -134.87 132.33 38.43 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 109.552 -0.536 . . . . 74.31 109.552 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -111.68 119.84 40.01 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 105.436 -2.061 . . . . 61.4 105.436 175.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 388' ' ' GLN . . . . . 0.458 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 20.0 pm0 -125.63 135.41 52.13 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.97 -0.692 . . . . 74.24 110.775 -177.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -136.75 135.04 19.73 Favored Pre-proline 0 C--N 1.297 -1.713 0 CA-C-N 115.525 -0.761 . . . . 72.13 109.102 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 390' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 422' ' ' THR . 20.7 Cg_exo -70.81 127.51 13.85 Favored 'Trans proline' 0 C--O 1.255 1.374 0 N-CA-C 106.236 -2.255 . . . . 74.23 106.236 166.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.547 ' OD1' HG22 ' A' ' 393' ' ' THR . 7.9 t0 169.15 -165.2 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 105.743 -1.947 . . . . 52.15 105.743 -169.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 10.6 t -151.93 -1.33 0.31 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 122.153 -0.342 . . . . 71.21 110.787 175.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.547 HG22 ' OD1' ' A' ' 391' ' ' ASP . 13.4 t -94.85 -7.92 38.83 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.807 -0.558 . . . . 72.24 112.331 -173.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.491 HD13 ' H ' ' A' ' 394' ' ' ILE . 0.2 OUTLIER -111.01 152.07 43.42 Favored Pre-proline 0 C--N 1.312 -1.061 0 N-CA-C 108.119 -1.067 . . . . 72.33 108.119 176.514 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_exo -29.95 133.5 0.05 OUTLIER 'Trans proline' 0 CA--C 1.553 1.459 0 C-N-CA 125.083 3.855 . . . . 74.13 117.18 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.9 163.76 27.08 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 123.908 3.072 . . . . 73.15 111.836 176.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 397' ' ' ASP . . . . . 0.584 ' HA ' HG13 ' A' ' 420' ' ' VAL . 5.4 p-10 -57.07 -7.84 0.56 Allowed 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 123.826 0.851 . . . . 73.12 112.64 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 53.9 m170 -104.88 124.02 48.74 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 105.102 -2.184 . . . . 73.44 105.102 172.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 28.5 m -72.11 118.79 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.647 0 CA-C-O 121.261 0.553 . . . . 72.4 110.938 -169.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.81 -36.98 10.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 107.274 -1.38 . . . . 75.42 107.274 177.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 401' ' ' GLY . . . . . 0.489 ' HA2' ' HB2' ' A' ' 366' ' ' ARG . . . -146.64 156.94 27.24 Favored Glycine 0 N--CA 1.412 -2.911 0 N-CA-C 109.207 -1.557 . . . . 65.2 109.207 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 402' ' ' THR . . . . . 0.476 ' OG1' ' HB3' ' A' ' 366' ' ' ARG . 2.1 p -124.46 -177.71 3.89 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 107.486 -1.302 . . . . 71.33 107.486 176.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -99.64 134.28 21.21 Favored Pre-proline 0 C--N 1.293 -1.887 0 C-N-CA 118.836 -1.146 . . . . 51.1 109.23 -174.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -49.02 -12.12 0.2 Allowed 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 124.787 3.658 . . . . 72.32 115.186 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.76 -29.89 55.13 Favored 'General case' 0 C--O 1.21 -0.986 0 C-N-CA 123.439 0.695 . . . . 72.34 110.021 172.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 406' ' ' ALA . . . . . 0.59 ' HA ' ' HB ' ' A' ' 362' ' ' VAL . . . -66.9 -50.42 62.48 Favored 'General case' 0 N--CA 1.437 -1.079 0 O-C-N 123.603 0.565 . . . . 52.55 111.079 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -72.8 -8.6 56.24 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 121.852 -0.53 . . . . 73.3 111.393 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 90.2 m -85.52 131.4 34.37 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 106.144 -1.799 . . . . 62.33 106.144 174.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 409' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 361' ' ' GLN . 47.1 p -74.5 112.95 11.19 Favored 'General case' 0 N--CA 1.417 -2.104 0 C-N-CA 118.653 -1.219 . . . . 71.44 108.859 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 23.7 m -114.56 169.51 5.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 109.911 -0.403 . . . . 44.34 109.911 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 17.1 m -65.11 136.51 56.79 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.808 -0.812 . . . . 74.43 108.808 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -58.02 109.56 0.76 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.144 0.497 . . . . 72.44 111.629 -175.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 105.89 36.65 2.71 Favored Glycine 0 N--CA 1.438 -1.23 0 CA-C-N 115.523 -0.762 . . . . 71.43 112.661 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -96.96 175.43 6.33 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 109.357 -0.609 . . . . 70.44 109.357 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 415' ' ' GLU . . . . . 0.429 ' HA ' ' HB2' ' A' ' 383' ' ' LYS . 40.9 mm-40 -86.74 120.1 27.68 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.278 0.631 . . . . 64.21 111.341 -172.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 43.0 mm -113.16 111.43 36.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 N-CA-C 108.808 -0.812 . . . . 74.31 108.808 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 30.5 p -90.85 130.48 36.8 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 112.772 0.656 . . . . 65.34 112.772 -175.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 4.1 p -121.62 135.24 62.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.957 -0.757 . . . . 74.4 108.957 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -109.18 127.4 54.18 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.588 -0.523 . . . . 73.03 109.588 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.584 HG13 ' HA ' ' A' ' 397' ' ' ASP . 44.6 t -126.54 137.72 56.95 Favored 'Isoleucine or valine' 0 C--O 1.25 1.126 0 CA-C-N 115.04 -0.982 . . . . 55.42 111.23 -174.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 10.0 t -98.03 121.4 39.91 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.557 -1.275 . . . . 72.12 107.557 176.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 422' ' ' THR . . . . . 0.523 ' O ' ' HA ' ' A' ' 390' ' ' PRO . 7.5 t -120.84 107.79 13.15 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.149 0.426 . . . . 71.23 112.149 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.022 0 C-N-CA 119.388 -1.387 . . . . 55.52 112.869 176.355 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 . . . . . 0 N--CA 1.434 -1.264 0 N-CA-C 106.468 -1.679 . . . . 61.02 106.468 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 18.0 mmm-85 -122.51 154.33 38.0 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 120.022 -0.671 . . . . 71.33 110.512 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.424 ' CD ' ' H ' ' A' ' 428' ' ' GLU . 0.0 OUTLIER -85.66 141.24 29.91 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-N 114.738 -1.119 . . . . 73.25 109.401 -177.734 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.443 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 66.2 mt -77.38 126.9 84.24 Favored Pre-proline 0 N--CA 1.426 -1.631 0 N-CA-C 105.698 -1.964 . . . . 64.02 105.698 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.27 141.26 67.98 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 121.973 1.782 . . . . 62.44 112.477 -177.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -87.63 137.02 32.7 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.968 -1.123 . . . . 62.13 107.968 177.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.589 HG11 ' HB2' ' A' ' 440' ' ' ALA . 13.3 p -152.02 159.75 3.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 109.335 -0.616 . . . . 53.53 109.335 -175.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.618 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 13.6 m -78.76 152.77 31.29 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 109.068 -0.716 . . . . 74.13 109.068 177.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 32.7 p -69.07 -25.86 64.66 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 114.037 1.125 . . . . 74.5 114.037 -173.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.5 pp -90.01 -10.23 45.71 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.679 0.752 . . . . 61.44 111.245 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.618 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 1.0 OUTLIER -100.16 41.76 1.15 Allowed 'General case' 0 CA--C 1.569 1.674 0 CA-C-N 115.186 -0.915 . . . . 65.31 110.022 -175.731 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -52.99 -38.2 62.05 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 113.559 0.948 . . . . 63.11 113.559 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.01 -35.71 77.58 Favored 'General case' 0 C--O 1.247 0.961 0 CA-C-O 122.016 0.912 . . . . 52.11 110.836 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.403 ' CB ' HG22 ' A' ' 436' ' ' THR . 35.1 tp10 -69.63 -37.55 76.84 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.401 -0.592 . . . . 70.01 109.401 176.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.589 ' HB2' HG11 ' A' ' 432' ' ' VAL . . . -60.54 -51.3 70.04 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.867 -0.606 . . . . 50.2 111.095 -178.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 35.6 m -63.39 -41.56 93.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 112.104 0.409 . . . . 71.11 112.104 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -68.23 -41.61 80.97 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 119.651 -0.82 . . . . 74.11 110.713 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -65.34 -38.26 89.59 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-N 115.901 -0.59 . . . . 75.04 111.042 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.431 ' CD2' ' HB3' ' A' ' 452' ' ' PHE . 13.5 tp -63.49 -36.46 83.82 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.081 -0.711 . . . . 73.41 109.081 178.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.42 ' HA ' ' HA3' ' A' ' 450' ' ' GLY . 40.0 m -68.98 -39.48 79.39 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.573 -0.74 . . . . 74.01 110.129 178.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.05 -15.95 62.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.937 -0.574 . . . . 43.24 111.13 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -88.74 5.07 45.11 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.873 -0.603 . . . . 64.42 110.906 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 109.03 -87.93 0.5 Allowed Glycine 0 CA--C 1.484 -1.883 0 N-CA-C 111.077 -0.809 . . . . 65.4 111.077 174.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -35.49 -63.14 0.36 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.435 1.272 . . . . 74.13 114.435 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 450' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 445' ' ' THR . . . 55.42 30.75 56.15 Favored Glycine 0 C--O 1.217 -0.909 0 N-CA-C 114.204 0.442 . . . . 72.55 114.204 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.509 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 30.3 mmm180 -105.75 111.18 23.74 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.64 -0.874 . . . . 73.05 108.64 -177.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.431 ' HB3' ' CD2' ' A' ' 444' ' ' LEU . 40.8 p90 -133.1 150.37 52.07 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 121.405 0.622 . . . . 75.43 111.869 -174.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -137.17 126.75 25.21 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.774 -1.103 . . . . 72.5 108.84 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -94.74 128.64 41.58 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 120.831 0.348 . . . . 63.01 110.593 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -128.99 157.86 40.48 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.826 -0.805 . . . . 61.21 108.826 177.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -126.19 147.94 49.55 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.95 -0.3 . . . . 73.12 110.338 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 20.9 t -152.62 147.47 19.37 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 107.631 -1.248 . . . . 63.52 107.631 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 490' ' ' SER . 35.6 Cg_endo -65.84 135.78 42.68 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.237 1.958 . . . . 61.44 111.38 178.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 34.7 m -151.94 179.09 8.76 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.658 -0.867 . . . . 61.03 108.658 -177.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.5 t -47.92 133.5 11.58 Favored Pre-proline 0 C--O 1.248 1.012 0 O-C-N 123.958 0.786 . . . . 75.24 111.02 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.69 -30.87 38.74 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 124.331 3.354 . . . . 74.13 114.003 -174.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -73.21 -27.64 61.73 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 112.345 0.498 . . . . 62.14 112.345 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -94.18 -2.23 52.9 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 120.721 0.296 . . . . 70.41 111.41 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 76.7 t -61.13 127.77 21.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.091 -0.707 . . . . 72.04 109.091 174.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.99 -4.59 75.07 Favored Glycine 0 C--N 1.304 -1.205 0 N-CA-C 111.733 -0.547 . . . . 72.31 111.733 -177.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -117.68 166.45 12.41 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.135 -0.691 . . . . 71.12 109.135 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 81.6 t -75.42 144.74 11.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 115.516 -0.766 . . . . 55.12 109.771 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 47.6 mm -97.68 -30.38 3.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 107.676 -1.231 . . . . 73.44 107.676 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 158.56 -169.51 35.02 Favored Glycine 0 N--CA 1.418 -2.548 0 CA-C-N 115.179 -0.919 . . . . 75.44 112.131 174.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 470' ' ' THR . . . . . 0.542 HG22 HG12 ' A' ' 486' ' ' ILE . 20.9 p -114.79 144.55 43.32 Favored 'General case' 0 C--N 1.28 -2.413 0 N-CA-C 106.565 -1.642 . . . . 72.43 106.565 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.499 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 22.4 t-20 -52.51 -53.41 53.86 Favored Pre-proline 0 N--CA 1.48 1.058 0 N-CA-C 112.744 0.646 . . . . 64.35 112.744 178.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 2.7 Cg_endo -85.83 147.62 9.45 Favored 'Trans proline' 0 N--CA 1.442 -1.516 0 N-CA-C 108.414 -1.418 . . . . 52.31 108.414 170.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.67 132.32 37.18 Favored 'Trans proline' 0 C--O 1.241 0.626 0 C-N-CA 121.633 1.555 . . . . 63.32 111.194 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.443 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -75.11 18.16 0.2 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.733 0.813 . . . . 72.02 112.239 -176.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -110.55 -10.3 14.53 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 123.491 0.716 . . . . 75.42 110.25 173.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -102.35 174.74 5.78 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.109 0.48 . . . . 73.21 111.995 -173.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.26 145.88 24.11 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.071 -0.968 . . . . 64.44 111.585 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 29.1 p -137.24 149.31 47.07 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.069 -0.715 . . . . 72.35 109.069 176.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.13 165.26 18.56 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.406 -0.361 . . . . 74.52 111.417 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 42.5 mm -74.88 -16.43 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-O 121.679 0.752 . . . . 72.24 110.444 -178.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 7.3 t -98.2 5.24 48.67 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.506 -0.746 . . . . 43.41 109.74 176.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -77.43 132.38 38.45 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.999 -0.546 . . . . 63.32 110.206 -175.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.509 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 43.1 t -105.04 126.17 60.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.913 -0.773 . . . . 75.32 108.913 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.449 HG12 ' HG2' ' A' ' 472' ' ' PRO . 20.2 m -108.29 126.38 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 CA-C-O 121.898 0.856 . . . . 61.12 111.048 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.425 HG23 ' HB2' ' A' ' 471' ' ' ASN . 0.0 OUTLIER -94.22 129.3 44.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 108.326 -0.99 . . . . 72.42 108.326 176.729 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.542 HG12 HG22 ' A' ' 470' ' ' THR . 18.2 mt -113.5 127.33 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 CA-C-N 115.17 -0.923 . . . . 72.2 109.808 -176.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 8.0 tt -107.18 126.79 63.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 115.429 -0.805 . . . . 74.5 110.161 -175.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 32.6 m -109.42 151.9 11.6 Favored 'Isoleucine or valine' 0 C--O 1.249 1.056 0 C-N-CA 123.209 0.603 . . . . 75.53 110.193 178.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.91 123.8 6.25 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 110.864 -0.894 . . . . 64.31 110.864 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 44.7 m . . . . . 0 C--N 1.306 -1.32 0 CA-C-N 117.221 0.51 . . . . 71.12 111.118 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo . . . . . 0 C--O 1.251 1.132 0 CA-C-O 120.982 0.326 . . . . 73.43 111.651 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -124.01 56.88 1.23 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.668 -0.864 . . . . 62.43 108.668 175.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 2.9 p -117.09 144.08 45.07 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 114.986 -1.006 . . . . 71.23 111.119 -176.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -140.61 163.81 31.86 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.588 -0.893 . . . . 72.12 108.588 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -97.25 126.66 42.6 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.822 -0.807 . . . . 70.22 108.822 -177.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.4 pt -78.55 127.06 81.73 Favored Pre-proline 0 C--N 1.313 -1.011 0 N-CA-C 113.138 0.792 . . . . 73.11 113.138 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -96.19 155.64 1.37 Allowed 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 122.97 2.447 . . . . 54.42 110.083 169.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -123.99 164.35 19.51 Favored 'General case' 0 C--N 1.314 -0.945 0 O-C-N 121.675 -0.641 . . . . 75.13 111.303 -176.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 6.4 p -151.9 96.28 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 CA-C-O 121.947 0.88 . . . . 73.32 110.179 177.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -102.85 100.67 10.67 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.468 -0.787 . . . . 74.2 110.732 -177.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 152.1 48.41 0.02 OUTLIER Glycine 0 C--N 1.302 -1.313 0 N-CA-C 110.329 -1.108 . . . . 63.45 110.329 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -156.15 -178.52 7.38 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.529 -1.656 . . . . 73.21 106.529 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 18.0 p -89.64 160.07 16.82 Favored 'General case' 0 C--N 1.286 -2.188 0 C-N-CA 120.0 -0.68 . . . . 64.25 109.424 174.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.461 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.3 p -52.51 -43.55 42.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 O-C-N 123.946 0.779 . . . . 72.12 111.745 178.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -62.67 -42.56 99.68 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.945 0.402 . . . . 75.21 111.069 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 57.6 t -73.44 -37.34 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 121.153 0.502 . . . . 64.22 110.283 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.6 -44.92 92.6 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.424 -0.353 . . . . 64.52 111.094 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 97.5 mt-30 -60.91 -40.76 94.38 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.448 0.467 . . . . 70.25 109.958 177.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.454 ' O ' HG23 ' A' ' 514' ' ' VAL . 58.8 tttp -57.9 -50.37 73.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.313 -0.858 . . . . 74.15 110.105 177.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -62.34 -40.82 97.62 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-N 115.479 -0.782 . . . . 51.44 111.421 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 512' ' ' LEU . . . . . 0.424 HD23 ' HB3' ' A' ' 520' ' ' PHE . 40.9 tp -61.1 -41.15 96.15 Favored 'General case' 0 C--O 1.238 0.485 0 O-C-N 123.369 0.418 . . . . 74.33 109.958 177.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 513' ' ' ASN . . . . . 0.432 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 12.1 m120 -65.35 -37.69 87.81 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 116.014 -0.539 . . . . 64.54 110.675 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 510' ' ' LYS . 95.5 t -66.06 -28.42 43.74 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 116.117 -0.492 . . . . 72.3 110.362 177.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -75.56 -4.29 39.06 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.814 0.34 . . . . 74.11 111.171 178.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 105.6 -10.61 45.91 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.892 -0.671 . . . . 74.15 112.854 175.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.432 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 70.6 m-85 -95.77 114.11 25.81 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.157 -0.683 . . . . 73.1 109.157 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 16.5 p -87.57 -17.95 30.83 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 113.709 1.003 . . . . 63.41 113.709 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 519' ' ' LYS . . . . . 0.454 ' HD2' ' O ' ' A' ' 548' ' ' ASP . 96.7 mttt -108.51 119.55 39.85 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.854 0.835 . . . . 71.02 113.208 -172.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 520' ' ' PHE . . . . . 0.424 ' HB3' HD23 ' A' ' 512' ' ' LEU . 15.3 p90 -130.46 152.14 50.18 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.507 -1.224 . . . . 74.33 111.195 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 63.5 m -142.03 156.54 45.43 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 107.51 -1.293 . . . . 63.2 107.51 170.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 522' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 26.8 pt20 -116.67 148.9 40.59 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-O 121.542 0.687 . . . . 71.23 111.056 -177.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 523' ' ' ALA . . . . . 0.512 ' HB3' ' HG2' ' A' ' 554' ' ' GLN . . . -120.38 119.03 31.91 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.145 -1.428 . . . . 54.33 107.145 175.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 17.0 m -86.25 123.26 31.32 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 116.243 -0.435 . . . . 42.31 110.528 -176.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 45.0 t -121.43 149.07 24.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 105.672 -1.973 . . . . 72.31 105.672 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -102.04 137.05 40.83 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.654 -0.819 . . . . 52.21 108.934 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 54.2 m -155.38 -176.83 0.65 Allowed Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 107.758 -1.201 . . . . 74.14 107.758 -176.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -87.5 3.59 6.32 Favored 'Trans proline' 0 CA--C 1.551 1.35 0 C-N-CA 121.699 1.599 . . . . 64.42 112.798 173.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.508 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 3.6 mpt_? -89.84 134.19 32.53 Favored Pre-proline 0 C--O 1.213 -0.832 0 N-CA-C 108.619 -0.882 . . . . 75.31 108.619 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -54.79 141.68 76.03 Favored 'Trans proline' 0 N--CA 1.483 0.866 0 C-N-CA 123.223 2.615 . . . . 72.14 114.315 -171.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.584 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -61.07 114.22 2.99 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 114.614 -1.176 . . . . 75.31 111.375 -175.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 132.49 -20.08 4.44 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 110.226 -1.15 . . . . 61.33 110.226 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -69.88 131.41 44.4 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 123.185 0.594 . . . . 74.44 109.895 177.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 7.6 p -86.58 106.15 15.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.13 -1.063 . . . . 62.21 108.13 174.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 12.0 t -78.56 -16.43 57.45 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.991 -0.55 . . . . 75.24 111.361 -174.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 163.25 -166.56 37.14 Favored Glycine 0 N--CA 1.429 -1.798 0 N-CA-C 111.194 -0.762 . . . . 72.12 111.194 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 42.4 p -128.71 149.19 50.79 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 107.706 -1.22 . . . . 75.21 107.706 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -71.71 -49.44 10.96 Favored Pre-proline 0 C--N 1.303 -1.423 0 C-N-CA 120.621 -0.431 . . . . 71.42 110.81 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -81.76 126.09 5.1 Favored 'Trans proline' 0 CA--C 1.555 1.531 0 N-CA-C 109.515 -0.994 . . . . 62.44 109.515 168.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.38 160.84 43.96 Favored 'Trans proline' 0 C--O 1.257 1.471 0 C-N-CA 122.716 2.278 . . . . 42.25 113.325 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.94 139.81 58.81 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.339 -0.846 . . . . 52.25 110.47 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.27 -17.79 43.25 Favored Glycine 0 C--N 1.297 -1.627 0 N-CA-C 111.343 -0.703 . . . . 35.12 111.343 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 34.9 m -67.57 123.05 19.37 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.827 -0.434 . . . . 71.0 109.827 178.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 10.8 m -82.77 123.22 29.12 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 108.075 -1.083 . . . . 34.25 108.075 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 32.0 m -136.5 155.0 77.23 Favored Pre-proline 0 C--N 1.308 -1.23 0 N-CA-C 108.786 -0.82 . . . . 75.13 108.786 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -60.59 146.89 96.24 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.182 1.921 . . . . 74.03 110.222 172.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 27.9 m -60.94 -20.53 22.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 113.58 0.955 . . . . 75.44 113.58 -176.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 548' ' ' ASP . . . . . 0.454 ' O ' ' HD2' ' A' ' 519' ' ' LYS . 11.6 t70 -97.96 4.08 49.48 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.315 0.579 . . . . 74.31 110.566 -178.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.0 t -69.7 154.48 41.92 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.12 0.486 . . . . 74.44 110.403 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 43.6 t -95.22 127.07 47.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.581 -0.896 . . . . 71.21 108.581 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 2.7 mp -103.97 136.24 38.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 109.204 -0.665 . . . . 70.54 109.204 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -102.97 119.23 38.47 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-O 121.515 0.674 . . . . 71.44 111.344 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 553' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 5.2 mp -100.23 133.87 44.0 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.64 -1.164 . . . . 70.03 108.372 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 554' ' ' GLN . . . . . 0.512 ' HG2' ' HB3' ' A' ' 523' ' ' ALA . 51.3 mt-30 -97.93 121.75 40.23 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-O 121.294 0.569 . . . . 44.23 110.283 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 60.7 t -109.94 133.41 55.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 115.194 -0.912 . . . . 73.3 108.797 -175.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.584 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 29.8 p -94.17 133.34 37.78 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-O 121.024 0.44 . . . . 61.51 111.811 -178.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -84.41 145.43 28.19 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 107.218 -1.401 . . . . 52.14 107.218 169.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 558' ' ' GLY . . . . . 0.508 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -81.6 -28.33 43.63 Favored Glycine 0 CA--C 1.478 -2.265 0 O-C-N 123.813 0.695 . . . . 72.23 113.381 -173.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 70.3 -35.19 0.31 Allowed 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 124.49 1.116 . . . . 64.25 113.946 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.44 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 48.2 mt-30 -125.65 146.16 49.84 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 121.306 0.574 . . . . 74.14 111.638 -172.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -124.72 139.76 53.56 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 115.039 -0.982 . . . . 65.05 109.184 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 91.2 t -61.46 121.71 10.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 123.393 0.677 . . . . 61.24 112.333 -175.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 563' ' ' MET . . . . . 0.428 ' HG2' ' O ' ' A' ' 564' ' ' PRO . 54.2 ttp -97.25 132.83 24.79 Favored Pre-proline 0 C--O 1.245 0.864 0 CA-C-N 115.769 -0.651 . . . . 71.31 111.103 -178.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 564' ' ' PRO . . . . . 0.428 ' O ' ' HG2' ' A' ' 563' ' ' MET . 13.6 Cg_exo -73.39 170.27 20.3 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.268 2.645 . . . . 74.02 110.646 171.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -74.98 115.57 14.75 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.834 0.826 . . . . 72.22 111.418 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 94.8 mt -113.67 7.41 17.24 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 122.666 1.222 . . . . 74.45 107.76 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 1.4 p -79.63 153.27 29.52 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-N 113.695 -1.593 . . . . 63.13 111.18 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 88.81 14.44 61.08 Favored Glycine 0 N--CA 1.436 -1.366 0 CA-C-N 115.634 -0.712 . . . . 52.54 112.908 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 89.1 mtp -108.3 156.27 19.57 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.739 -0.467 . . . . 75.21 109.739 -175.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 570' ' ' PHE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 96.2 m-85 -75.56 153.92 37.1 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 108.031 -1.1 . . . . 72.52 108.031 176.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 74.8 t-105 -68.13 -22.6 64.87 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.532 -0.544 . . . . 74.52 109.532 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 10.8 p -74.82 -16.92 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 115.229 -0.896 . . . . 74.12 109.358 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -101.3 -44.17 5.74 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.956 -0.565 . . . . 74.5 110.04 175.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -58.12 -52.28 66.22 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.281 -0.872 . . . . 72.01 112.674 -176.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.421 ' HA ' ' HG ' ' A' ' 578' ' ' LEU . 41.3 tt0 -60.7 -51.93 76.15 Favored Pre-proline 0 CA--C 1.557 1.22 0 N-CA-C 112.939 0.718 . . . . 74.34 112.939 -177.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -58.04 -37.23 96.66 Favored 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 121.132 1.221 . . . . 62.12 112.341 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -69.02 -37.74 78.83 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 112.915 0.709 . . . . 61.21 112.915 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.421 ' HG ' ' HA ' ' A' ' 575' ' ' GLU . 4.1 pp -67.0 -38.36 85.86 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.988 -0.685 . . . . 73.25 110.481 177.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 579' ' ' ARG . . . . . 0.407 ' N ' HD12 ' A' ' 578' ' ' LEU . 79.8 mtp180 -63.49 -44.52 94.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.307 -0.861 . . . . 64.22 110.136 176.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.96 -29.19 68.98 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.516 0.726 . . . . 43.02 111.873 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 64.6 tp -81.2 -7.26 59.53 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 121.381 0.61 . . . . 75.43 109.883 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 77.83 31.02 50.58 Favored Glycine 0 CA--C 1.492 -1.374 0 N-CA-C 111.305 -0.718 . . . . 54.12 111.305 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 583' ' ' TRP . . . . . 0.402 ' CE3' HD13 ' A' ' 578' ' ' LEU . 86.8 t90 -87.36 140.68 29.29 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 109.043 -0.725 . . . . 75.54 109.043 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 5.8 t -133.33 -50.15 0.86 Allowed 'General case' 0 N--CA 1.41 -2.426 0 CA-C-N 115.708 -0.678 . . . . 71.51 109.496 175.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . 29.59 -126.6 0.11 Allowed Glycine 0 C--N 1.365 2.186 0 C-N-CA 125.352 1.453 . . . . 63.15 114.16 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 586' ' ' MET . . . . . 0.438 ' O ' HG12 ' A' ' 619' ' ' ILE . 51.6 ttm -138.03 125.13 21.48 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 105.18 -2.156 . . . . 64.1 105.18 172.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -99.15 125.2 44.65 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.912 -1.144 . . . . 72.33 107.912 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -105.14 101.47 11.02 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 115.901 -0.591 . . . . 45.0 109.61 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -99.89 109.88 22.25 Favored 'General case' 0 N--CA 1.416 -2.17 0 N-CA-C 106.833 -1.543 . . . . 42.03 106.833 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -103.85 -121.6 4.95 Favored Glycine 0 N--CA 1.425 -2.086 0 N-CA-C 110.535 -1.026 . . . . 51.5 110.535 178.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -86.9 119.75 27.45 Favored 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 120.702 -0.399 . . . . 72.21 110.788 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -77.86 152.57 33.31 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 105.273 -2.121 . . . . 72.3 105.273 169.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 593' ' ' VAL . . . . . 0.409 ' O ' ' HB2' ' A' ' 626' ' ' GLN . 59.5 t -103.84 116.04 46.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 C-N-CA 118.931 -1.108 . . . . 52.23 111.94 -169.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.33 107.08 17.17 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.951 -1.129 . . . . 73.1 107.951 175.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -139.47 17.98 2.55 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.288 -1.004 . . . . 75.2 108.288 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 98.33 144.21 16.41 Favored Glycine 0 N--CA 1.414 -2.816 0 CA-C-N 114.645 -1.161 . . . . 42.31 111.089 -176.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.76 -32.3 61.69 Favored Glycine 0 C--N 1.32 -0.315 0 O-C-N 123.935 0.432 . . . . 72.23 112.503 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 10.0 m -59.06 -23.61 62.17 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.212 1.005 . . . . 72.04 112.798 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -86.71 -13.72 44.57 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 121.852 -0.53 . . . . 60.45 110.397 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 56.92 161.59 0.02 OUTLIER 'General case' 0 C--O 1.243 0.757 0 N-CA-C 115.475 1.657 . . . . 75.53 115.475 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -79.56 89.62 5.09 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 114.745 -1.116 . . . . 72.14 109.455 172.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 602' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 49.4 ttt180 -117.65 148.78 41.64 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 106.569 -1.641 . . . . 73.24 106.569 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 67.9 t -61.77 131.12 26.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.468 -0.938 . . . . 75.34 108.468 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 83.7 t -86.87 -46.56 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.008 0 N-CA-C 109.142 -0.688 . . . . 75.44 109.142 -174.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -156.1 164.17 38.74 Favored 'General case' 0 N--CA 1.415 -2.217 0 N-CA-C 107.647 -1.242 . . . . 72.34 107.647 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.04 150.84 44.46 Favored 'General case' 0 C--N 1.279 -2.458 0 N-CA-C 106.928 -1.508 . . . . 60.41 106.928 173.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.648 ' HB3' ' HD3' ' A' ' 608' ' ' PRO 0.294 48.7 t-20 -70.3 -79.36 0.05 OUTLIER Pre-proline 0 CA--C 1.563 1.445 0 CA-C-O 117.555 -1.212 . . . . 74.14 113.587 -171.946 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.648 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 14.6 Cg_exo -73.24 127.39 11.91 Favored 'Trans proline' 0 C--N 1.374 1.875 0 CA-C-N 122.729 2.01 . . . . 73.05 108.866 174.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.86 160.18 34.49 Favored 'Trans proline' 0 C--O 1.24 0.61 0 C-N-CA 122.392 2.062 . . . . 55.01 112.594 -175.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.94 127.05 29.57 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.434 -0.58 . . . . 61.41 109.434 -178.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.47 -12.48 47.36 Favored Glycine 0 N--CA 1.431 -1.651 0 C-N-CA 120.573 -0.823 . . . . 45.54 111.231 -175.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 27.8 m -97.66 164.62 12.34 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 107.936 -1.135 . . . . 53.12 107.936 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -88.81 143.41 17.59 Favored Glycine 0 N--CA 1.427 -1.95 0 C-N-CA 121.197 -0.525 . . . . 72.21 113.59 -177.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 24.3 m -107.92 142.17 21.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.989 -1.115 . . . . 64.3 107.989 173.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.571 HD21 HG22 ' A' ' 619' ' ' ILE . 31.8 p30 -62.54 164.87 6.91 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 114.282 1.216 . . . . 44.52 114.282 -175.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -55.49 -25.8 39.02 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 114.788 1.403 . . . . 75.24 114.788 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -74.73 -44.53 49.44 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 106.845 -1.539 . . . . 72.32 106.845 174.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 97.56 20.65 21.6 Favored Glycine 0 N--CA 1.418 -2.511 0 CA-C-N 114.672 -1.149 . . . . 74.12 110.53 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 619' ' ' ILE . . . . . 0.571 HG22 HD21 ' A' ' 615' ' ' ASN . 0.0 OUTLIER -69.42 122.03 20.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 122.078 0.942 . . . . 73.41 109.928 -172.257 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 9.4 tp -121.89 132.59 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.098 0 CA-C-N 114.606 -1.179 . . . . 73.12 108.929 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.464 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 7.4 m -97.62 119.72 36.69 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.178 -1.045 . . . . 61.34 108.178 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 81.6 mt -130.76 154.43 47.99 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 123.739 0.815 . . . . 74.44 109.33 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 65.2 mmt-85 -136.71 154.9 50.47 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 104.583 -2.377 . . . . 71.33 104.583 173.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 602' ' ' ARG . 30.5 p90 -141.31 160.35 40.31 Favored 'General case' 0 C--N 1.288 -2.082 0 O-C-N 123.293 0.371 . . . . 72.35 110.403 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -73.44 -151.14 1.72 Allowed Glycine 0 C--N 1.309 -0.959 0 O-C-N 124.196 0.935 . . . . 45.22 113.446 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 626' ' ' GLN . . . . . 0.409 ' HB2' ' O ' ' A' ' 593' ' ' VAL . 6.9 tp-100 . . . . . 0 C--N 1.299 -1.602 0 CA-C-O 119.31 -0.376 . . . . 70.11 110.438 -175.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 C--O 1.243 0.73 0 N-CA-C 109.725 -0.472 . . . . 72.44 109.725 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.67 163.56 34.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 109.724 -0.473 . . . . 63.04 109.724 -177.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -93.67 137.36 33.0 Favored 'General case' 0 N--CA 1.404 -2.762 0 CA-C-O 121.619 0.723 . . . . 74.44 109.245 177.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.424 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 91.4 t -98.29 134.27 22.12 Favored Pre-proline 0 C--N 1.268 -2.972 0 CA-C-N 114.337 -1.302 . . . . 72.21 110.171 -173.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 363' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 3.6 Cg_exo -71.21 128.79 15.15 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.856 1.704 . . . . 74.11 110.214 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.39 157.92 18.44 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.288 -0.565 . . . . 75.43 109.485 -177.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.502 HG23 ' HA ' ' A' ' 373' ' ' ALA . 18.8 m -131.5 26.55 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-N 115.205 -0.907 . . . . 65.33 109.085 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -66.43 148.55 51.71 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 114.749 -1.114 . . . . 73.44 109.103 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 367' ' ' GLY . . . . . 0.416 ' H ' HG23 ' A' ' 399' ' ' VAL . . . 107.01 0.7 35.95 Favored Glycine 0 C--N 1.315 -0.625 0 N-CA-C 111.349 -0.7 . . . . 75.54 111.349 -173.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -113.03 -146.83 0.41 Allowed 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.7 -0.852 . . . . 70.42 108.7 175.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 58.4 p -89.57 160.77 16.52 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 107.929 -1.137 . . . . 64.35 107.929 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 8.8 p -63.52 -34.89 78.78 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 120.078 -0.649 . . . . 73.35 110.568 177.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -65.81 -47.58 74.61 Favored 'General case' 0 C--O 1.216 -0.692 0 N-CA-C 111.902 0.334 . . . . 74.44 111.902 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -67.19 -42.85 83.5 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.716 0.77 . . . . 70.14 109.247 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 373' ' ' ALA . . . . . 0.502 ' HA ' HG23 ' A' ' 365' ' ' VAL . . . -65.35 -42.65 92.61 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 114.558 -1.201 . . . . 73.12 112.27 -177.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 58.1 mt -69.58 -45.58 77.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 116.592 -0.276 . . . . 74.23 110.55 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.81 -44.56 90.84 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 123.515 0.509 . . . . 73.35 111.647 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 376' ' ' THR . . . . . 0.508 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 23.6 m -65.2 -46.64 79.89 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 116.13 -0.486 . . . . 71.31 110.597 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.418 HD23 ' O ' ' A' ' 373' ' ' ALA . 4.6 mm? -63.17 -38.07 89.71 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 111.803 0.297 . . . . 70.43 111.803 178.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -63.65 -38.05 89.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.056 0.455 . . . . 73.4 110.068 178.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -70.07 -21.24 63.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 73.14 111.644 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 380' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 376' ' ' THR . 38.4 mmt180 -82.6 -14.11 55.36 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.61 -0.515 . . . . 73.3 109.61 176.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 97.54 6.02 57.59 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 111.385 -0.686 . . . . 45.33 111.385 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -89.4 149.01 23.17 Favored 'General case' 0 N--CA 1.406 -2.653 0 CA-C-O 121.61 0.719 . . . . 75.53 111.244 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.483 ' HB2' ' HG2' ' A' ' 415' ' ' GLU . 45.8 mmtm -96.14 155.09 16.9 Favored 'General case' 0 N--CA 1.41 -2.466 0 CA-C-N 114.548 -1.205 . . . . 72.41 107.764 -177.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 384' ' ' ILE . . . . . 0.479 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -130.42 141.94 45.01 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 N-CA-C 109.204 -0.665 . . . . 72.11 109.204 -177.837 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 28.2 ttm-85 -125.53 127.57 46.63 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 108.186 -1.042 . . . . 74.21 108.186 177.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 33.5 m -115.56 123.64 48.98 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-O 120.925 0.393 . . . . 62.2 110.691 -173.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -112.24 131.09 55.69 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.994 -1.484 . . . . 71.43 106.994 175.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 388' ' ' GLN . . . . . 0.483 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 19.1 pm0 -123.11 142.16 51.18 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 119.374 -0.931 . . . . 71.23 111.403 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 389' ' ' LYS . . . . . 0.436 ' HB2' HG13 ' A' ' 394' ' ' ILE . 75.4 mmtt -131.88 131.26 22.53 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 108.646 -0.872 . . . . 74.11 108.646 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 390' ' ' PRO . . . . . 0.449 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 60.6 Cg_endo -83.62 129.18 4.85 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 121.626 1.55 . . . . 64.21 111.538 176.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 14.8 t70 158.58 -158.06 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 104.308 -2.478 . . . . 61.34 104.308 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 19.3 m -136.36 2.37 2.74 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 119.213 0.915 . . . . 73.13 110.784 177.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 1.3 p -81.87 -27.65 33.36 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 112.792 0.664 . . . . 54.21 112.792 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.653 HD13 ' H ' ' A' ' 394' ' ' ILE . 0.2 OUTLIER -93.04 152.09 41.08 Favored Pre-proline 0 C--N 1.29 -1.997 0 CA-C-N 115.898 -0.592 . . . . 72.33 110.399 -176.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -43.01 129.46 5.65 Favored 'Trans proline' 0 C--N 1.363 1.339 0 C-N-CA 124.159 3.239 . . . . 52.03 114.528 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -61.04 161.61 21.91 Favored 'Trans proline' 0 N--CA 1.482 0.851 0 C-N-CA 124.212 3.275 . . . . 60.35 113.489 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -59.37 -8.08 1.6 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 112.975 0.732 . . . . 75.02 112.975 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -98.02 122.38 41.08 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 103.52 -2.77 . . . . 65.22 103.52 171.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.416 HG23 ' H ' ' A' ' 367' ' ' GLY . 26.8 m -77.92 117.05 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.351 0 C-N-CA 118.982 -1.087 . . . . 73.44 113.565 -162.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 43.6 pt -103.32 -27.4 3.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 114.523 -1.217 . . . . 73.34 108.548 174.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.8 157.13 27.27 Favored Glycine 1 CA--C 1.442 -4.525 0 CA-C-O 122.397 0.998 . . . . 63.12 111.647 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 402' ' ' THR . . . . . 0.484 HG22 ' H ' ' A' ' 403' ' ' ASP . 87.2 m -156.54 -177.89 6.93 Favored 'General case' 0 N--CA 1.383 -3.783 0 N-CA-C 104.592 -2.373 . . . . 63.44 104.592 -171.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 403' ' ' ASP . . . . . 0.484 ' H ' HG22 ' A' ' 402' ' ' THR . 15.0 m-20 -98.6 131.65 25.5 Favored Pre-proline 0 C--N 1.264 -3.111 0 N-CA-C 106.117 -1.808 . . . . 71.22 106.117 174.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.6 26.31 0.12 Allowed 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 124.472 3.448 . . . . 74.1 114.761 -171.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.414 ' H ' ' C ' ' A' ' 403' ' ' ASP . . . -56.92 -35.99 69.67 Favored 'General case' 0 C--O 1.209 -1.077 0 C-N-CA 123.658 0.783 . . . . 70.45 110.635 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -70.86 -33.61 70.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.33 0.586 . . . . 64.31 111.049 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -88.12 -1.34 57.95 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 122.081 0.943 . . . . 74.14 109.406 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 26.6 m -95.28 148.51 22.34 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 104.874 -2.269 . . . . 73.3 104.874 173.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 4.1 p -74.89 111.99 10.65 Favored 'General case' 0 N--CA 1.41 -2.46 0 C-N-CA 118.603 -1.239 . . . . 62.24 108.839 176.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 30.2 m -123.71 167.46 17.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.702 -0.681 . . . . 43.21 110.344 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 38.4 m -76.94 146.91 37.25 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 108.832 -0.803 . . . . 75.42 108.832 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -64.73 109.45 2.04 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.9 0.381 . . . . 72.13 111.184 -176.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 111.67 53.12 0.53 Allowed Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.819 -0.628 . . . . 64.31 112.614 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.61 -167.65 1.29 Allowed 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.46 -0.941 . . . . 71.31 108.46 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 415' ' ' GLU . . . . . 0.483 ' HG2' ' HB2' ' A' ' 383' ' ' LYS . 37.1 mt-10 -113.91 137.16 52.06 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.114 0.483 . . . . 72.13 110.305 -176.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 34.7 mm -110.28 110.73 33.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 108.712 -0.848 . . . . 44.3 108.712 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 21.0 p -84.1 131.22 34.81 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 123.098 0.559 . . . . 65.34 111.838 -177.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 10.6 p -127.25 135.2 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-N 115.673 -0.694 . . . . 73.23 111.441 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -105.27 124.61 49.83 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.992 -0.744 . . . . 73.43 108.992 172.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 16.7 m -126.04 152.7 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.545 0 CA-C-N 115.28 -0.873 . . . . 63.44 110.535 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 421' ' ' SER . . . . . 0.415 ' HB2' HG12 ' A' ' 394' ' ' ILE . 27.1 t -99.38 129.64 45.59 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-O 121.718 0.77 . . . . 54.44 110.584 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 3.0 p -93.61 158.36 15.73 Favored 'General case' 0 N--CA 1.401 -2.906 0 N-CA-C 105.008 -2.219 . . . . 53.41 105.008 166.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 2.419 0 N-CA-C 116.729 1.451 . . . . 74.25 116.729 -175.427 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 . . . . . 0 N--CA 1.422 -1.849 0 N-CA-C 106.676 -1.602 . . . . 75.34 106.676 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 -122.21 152.46 39.96 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 119.398 -0.921 . . . . 72.35 111.254 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -83.23 138.64 33.52 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 114.445 -1.252 . . . . 62.55 109.073 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 53.7 mt -84.12 122.95 75.89 Favored Pre-proline 0 N--CA 1.424 -1.733 0 N-CA-C 107.297 -1.371 . . . . 63.43 107.297 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.451 ' HG2' ' HB3' ' A' ' 443' ' ' LYS . 56.2 Cg_endo -70.74 150.42 62.2 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.802 1.668 . . . . 72.1 110.892 176.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -80.5 130.13 34.95 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.167 -1.049 . . . . 72.14 108.167 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 39.5 t -127.03 152.3 34.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 107.438 -1.319 . . . . 74.41 107.438 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 42.6 t -70.29 143.64 51.99 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.833 -0.803 . . . . 72.4 108.833 176.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 434' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 18.9 p -67.56 -28.44 67.79 Favored 'General case' 0 N--CA 1.424 -1.726 0 C-N-CA 123.658 0.783 . . . . 65.41 111.532 -175.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 2.3 pp -79.36 -12.53 59.92 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.339 0.59 . . . . 71.14 111.963 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 3.2 p -104.05 62.98 0.75 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 121.567 0.699 . . . . 74.45 112.41 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -56.95 -38.58 73.13 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.078 -0.964 . . . . 73.04 111.014 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -60.04 -42.49 94.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.424 0.63 . . . . 74.5 110.254 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.475 ' O ' ' HB3' ' A' ' 442' ' ' LYS . 25.8 tp10 -70.89 -34.95 72.1 Favored 'General case' 0 C--O 1.205 -1.237 0 CA-C-N 115.463 -0.79 . . . . 71.12 110.035 178.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.6 -51.42 69.47 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.303 0.112 . . . . 73.21 111.303 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 33.9 m -63.01 -36.57 76.39 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 CA-C-O 121.273 0.559 . . . . 75.3 110.839 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 439' ' ' GLU . 16.6 tppt? -60.04 -47.69 84.8 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.942 -1.026 . . . . 65.43 109.998 176.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 443' ' ' LYS . . . . . 0.451 ' HB3' ' HG2' ' A' ' 430' ' ' PRO . 28.5 mmtp -67.04 -38.51 86.0 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 113.067 0.765 . . . . 75.52 113.067 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 9.8 mp -63.71 -34.93 78.96 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.6 -0.44 . . . . 70.33 109.974 174.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 92.9 m -68.23 -42.2 80.09 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.884 -0.598 . . . . 74.51 110.182 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.82 -20.64 62.55 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.909 -0.587 . . . . 70.42 112.063 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -90.2 3.28 53.96 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 112.492 0.553 . . . . 65.54 112.492 -178.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 110.28 -75.28 0.21 Allowed Glycine 0 CA--C 1.497 -1.071 0 C-N-CA 119.581 -1.295 . . . . 71.55 112.98 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 449' ' ' PHE . . . . . 0.433 ' HA ' ' O ' ' A' ' 480' ' ' ILE . 0.2 OUTLIER -40.94 -62.36 0.83 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.902 1.075 . . . . 74.22 113.902 177.589 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 61.14 23.08 61.43 Favored Glycine 0 C--O 1.221 -0.701 0 C-N-CA 121.172 -0.537 . . . . 75.02 112.447 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.402 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 10.5 mmm180 -97.89 111.24 23.61 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 107.921 -1.14 . . . . 70.33 107.921 -177.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.433 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 19.7 p90 -137.6 149.49 46.69 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 121.215 0.531 . . . . 62.44 111.576 -177.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -136.19 142.48 44.12 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.446 -1.316 . . . . 62.32 107.446 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -112.7 126.03 54.96 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 120.601 0.239 . . . . 52.2 110.558 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 455' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -123.07 136.15 54.7 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.281 -1.007 . . . . 71.13 108.281 175.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -113.34 141.52 46.94 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.834 -1.173 . . . . 65.4 107.834 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 50.0 m -144.68 140.22 16.23 Favored Pre-proline 0 C--N 1.292 -1.931 0 N-CA-C 109.939 -0.393 . . . . 73.42 109.939 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.605 ' HA ' ' O ' ' A' ' 490' ' ' SER . 21.4 Cg_endo -64.93 122.6 10.45 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.625 1.55 . . . . 53.3 108.968 176.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 19.8 m -135.84 179.64 6.22 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.55 -0.75 . . . . 63.53 110.133 -171.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 460' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 464' ' ' VAL . 7.2 t -59.5 139.75 88.98 Favored Pre-proline 0 N--CA 1.42 -1.927 0 O-C-N 124.13 0.894 . . . . 71.31 109.399 174.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.37 -29.08 29.31 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.707 3.605 . . . . 70.01 113.492 -175.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -65.34 -37.18 86.29 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.541 -0.3 . . . . 63.35 111.807 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.07 -14.87 32.91 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 121.044 -0.262 . . . . 71.31 111.397 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 460' ' ' THR . 85.4 t -60.31 128.12 20.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-N 116.498 -0.319 . . . . 63.24 110.29 177.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 95.45 -12.11 68.1 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.519 -0.764 . . . . 72.14 112.229 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -122.47 167.45 13.33 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.204 -0.665 . . . . 51.43 109.204 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.456 HG13 HG23 ' A' ' 486' ' ' ILE . 62.4 t -72.63 143.89 13.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 107.567 -1.272 . . . . 73.44 107.567 171.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 55.3 mt -97.18 -34.03 4.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.372 -1.344 . . . . 23.34 107.372 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 163.06 -172.87 39.17 Favored Glycine 0 N--CA 1.409 -3.106 0 CA-C-N 114.802 -1.09 . . . . 64.32 110.508 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 24.5 p -116.1 147.83 40.91 Favored 'General case' 0 N--CA 1.404 -2.728 0 N-CA-C 105.931 -1.877 . . . . 72.41 105.931 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.432 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 20.3 t-20 -70.18 -49.99 16.83 Favored Pre-proline 0 C--N 1.313 -0.979 0 C-N-CA 118.237 -1.385 . . . . 72.22 110.756 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 19.2 Cg_exo -74.07 125.42 9.8 Favored 'Trans proline' 0 C--N 1.368 1.582 0 N-CA-C 106.837 -2.024 . . . . 64.15 106.837 165.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.438 ' HB2' ' HG2' ' A' ' 476' ' ' GLN . 21.8 Cg_exo -61.98 133.64 45.47 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 122.129 1.886 . . . . 71.24 113.562 -172.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -75.34 16.87 0.3 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.057 0.943 . . . . 64.43 112.188 -176.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -110.45 -10.93 14.54 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.887 -0.597 . . . . 64.21 109.551 177.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 476' ' ' GLN . . . . . 0.438 ' HG2' ' HB2' ' A' ' 473' ' ' PRO . 78.6 mm-40 -90.24 176.97 6.55 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.661 -0.699 . . . . 63.4 112.473 -174.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 6.1 m -107.57 114.98 29.34 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 107.412 -1.329 . . . . 74.11 107.412 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 13.4 p -112.61 147.85 35.82 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.157 0.503 . . . . 74.24 111.635 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.58 160.22 30.42 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.843 -0.617 . . . . 71.32 111.371 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 480' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 449' ' ' PHE . 1.8 mp -67.63 -15.16 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.394 0 CA-C-O 122.145 0.974 . . . . 74.2 112.059 -178.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 11.6 p -103.49 5.3 36.76 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.436 -0.79 . . . . 75.11 111.331 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -85.36 129.39 34.82 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.094 -0.706 . . . . 61.31 109.094 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.402 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 61.5 t -91.93 126.6 44.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.864 -0.607 . . . . 74.22 110.303 -177.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 30.2 t -106.38 120.05 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 N-CA-C 108.781 -0.822 . . . . 52.13 108.781 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.39 123.67 47.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-O 121.227 0.537 . . . . 63.4 110.124 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.456 HG23 HG13 ' A' ' 467' ' ' VAL . 1.7 mp -102.59 128.09 55.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 124.976 1.31 . . . . 72.41 108.795 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 8.2 tt -109.74 126.6 66.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 109.255 -0.646 . . . . 75.21 109.255 176.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 34.1 m -109.17 151.34 11.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 116.251 -0.431 . . . . 51.12 110.232 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -88.78 131.58 10.76 Favored Glycine 0 N--CA 1.439 -1.104 0 C-N-CA 120.592 -0.813 . . . . 75.01 111.851 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.605 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 19.5 m . . . . . 0 C--N 1.308 -1.229 0 N-CA-C 108.65 -0.87 . . . . 71.12 108.65 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 CA--C 1.542 0.916 0 CA-C-O 120.964 0.319 . . . . 74.1 112.603 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -84.65 67.08 9.88 Favored 'General case' 0 C--O 1.25 1.095 0 CA-C-O 122.158 0.98 . . . . 65.32 110.461 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.47 ' HB ' HG22 ' A' ' 544' ' ' THR . 11.1 p -117.64 153.67 32.9 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 114.735 -1.121 . . . . 62.43 110.559 -178.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -149.73 150.38 31.99 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.689 -0.856 . . . . 64.32 108.689 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.7 p-10 -81.74 138.95 35.13 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 123.588 0.755 . . . . 71.12 110.903 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 497' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 543' ' ' THR . 22.2 pt -92.85 117.92 67.72 Favored Pre-proline 0 C--N 1.307 -1.254 0 CA-C-N 115.954 -0.567 . . . . 72.23 110.876 176.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -92.99 146.45 2.44 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.422 2.081 . . . . 71.13 111.373 175.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -83.39 96.07 8.42 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 122.803 1.287 . . . . 72.2 110.634 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.6 p -100.44 23.26 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 123.258 1.504 . . . . 75.41 107.432 177.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -77.07 171.6 14.55 Favored 'General case' 0 N--CA 1.416 -2.149 0 CA-C-N 113.368 -1.742 . . . . 73.04 110.295 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 96.74 22.4 18.47 Favored Glycine 0 C--N 1.285 -2.278 0 N-CA-C 108.258 -1.937 . . . . 63.31 108.258 -177.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -133.68 174.73 10.13 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 108.265 -1.013 . . . . 61.23 108.265 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 41.7 p -77.91 164.32 25.24 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 117.966 0.348 . . . . 62.41 110.998 -176.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 17.4 m -51.42 -44.49 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.652 0 C-N-CA 123.79 0.836 . . . . 73.22 112.982 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -68.01 -41.78 81.68 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.215 0.531 . . . . 73.1 111.079 -178.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 62.5 t -72.55 -46.45 55.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 115.361 -0.836 . . . . 74.44 111.535 -175.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.72 -40.44 96.75 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.655 -0.248 . . . . 43.13 110.812 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -59.96 -43.55 94.98 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.387 -0.598 . . . . 75.04 109.387 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.502 ' O ' HG23 ' A' ' 514' ' ' VAL . 59.7 tttm -58.1 -50.95 71.71 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.729 -1.123 . . . . 70.02 109.801 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -62.59 -46.75 86.88 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.575 -0.739 . . . . 75.42 112.046 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.94 -40.51 89.19 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 120.878 -0.329 . . . . 64.11 110.729 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -63.97 -37.98 89.42 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.127 -0.488 . . . . 55.13 111.309 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 510' ' ' LYS . 77.3 t -62.48 -30.47 49.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 121.006 0.431 . . . . 72.11 110.785 178.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -83.07 7.96 14.28 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.161 0.505 . . . . 75.54 111.715 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 93.99 -10.47 71.95 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.988 -0.625 . . . . 72.41 111.81 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -87.56 81.45 7.74 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-O 121.882 0.849 . . . . 73.35 109.433 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 3.5 p -89.89 3.34 53.32 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.917 -1.038 . . . . 75.44 110.98 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -108.74 113.45 26.42 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.061 -1.089 . . . . 71.43 108.061 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 520' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' A' ' 551' ' ' ILE . 15.3 p90 -131.56 156.64 45.39 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.024 -0.989 . . . . 71.21 111.791 -174.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 50.3 m -137.0 145.55 44.26 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 106.041 -1.837 . . . . 73.51 106.041 171.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -117.09 132.99 56.55 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 120.856 0.36 . . . . 64.35 110.267 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -124.58 141.11 52.34 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.179 -1.045 . . . . 75.51 108.179 176.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 6.4 m -110.28 120.75 43.45 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.62 -0.881 . . . . 72.0 108.62 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 34.9 m -120.9 164.12 17.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 110.294 -0.262 . . . . 55.54 110.294 -175.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 526' ' ' ASP . . . . . 0.641 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 8.0 p-10 -90.63 135.26 33.82 Favored 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 120.274 -0.57 . . . . 74.01 111.343 -177.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 527' ' ' SER . . . . . 0.455 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 67.5 m -160.75 -179.92 1.18 Allowed Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 108.914 -0.773 . . . . 61.5 108.914 176.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -85.55 -19.15 3.62 Favored 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 121.505 1.47 . . . . 72.5 111.158 171.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -69.11 137.16 89.36 Favored Pre-proline 0 N--CA 1.437 -1.092 0 C-N-CA 124.018 0.927 . . . . 75.13 109.628 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -56.73 144.56 86.4 Favored 'Trans proline' 0 C--O 1.245 0.863 0 C-N-CA 123.624 2.883 . . . . 52.41 115.505 -170.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.634 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -67.4 115.51 7.12 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 114.258 -1.337 . . . . 75.23 109.907 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 133.93 -21.47 3.94 Favored Glycine 0 C--N 1.297 -1.61 0 N-CA-C 110.777 -0.929 . . . . 54.31 110.777 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -83.07 128.9 34.9 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 120.951 0.405 . . . . 74.43 110.596 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.46 HG22 HG22 ' A' ' 555' ' ' VAL . 84.2 t -83.22 105.74 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 N-CA-C 104.791 -2.3 . . . . 72.32 104.791 170.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 74.1 m -83.69 -16.85 43.45 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 112.312 0.486 . . . . 75.44 112.312 -173.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 173.44 -161.78 32.66 Favored Glycine 0 CA--C 1.49 -1.505 0 C-N-CA 120.099 -1.048 . . . . 61.52 111.251 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 23.7 p -127.77 160.07 32.85 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.782 -0.822 . . . . 71.05 108.782 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -73.01 -51.57 6.1 Favored Pre-proline 0 C--N 1.307 -1.243 0 CA-C-O 119.337 -0.363 . . . . 73.5 110.034 176.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 29.6 Cg_endo -66.55 130.86 24.58 Favored 'Trans proline' 0 C--N 1.378 2.103 0 N-CA-C 108.487 -1.39 . . . . 71.34 108.487 170.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 540' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 38.9 Cg_exo -61.66 142.11 93.24 Favored 'Trans proline' 0 C--O 1.241 0.673 0 C-N-CA 122.59 2.193 . . . . 74.22 114.161 -176.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.54 141.72 57.76 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.125 -0.943 . . . . 44.13 109.996 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.11 -20.65 46.61 Favored Glycine 0 C--N 1.302 -1.322 0 N-CA-C 110.545 -1.022 . . . . 72.12 110.545 -177.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.433 ' O ' HG12 ' A' ' 497' ' ' ILE . 63.5 m -76.47 137.66 39.81 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-O 121.507 0.67 . . . . 40.44 109.868 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.47 HG22 ' HB ' ' A' ' 494' ' ' THR . 18.4 m -94.14 123.92 37.82 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 115.373 -0.83 . . . . 74.51 109.749 -176.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 31.6 m -129.12 157.96 74.36 Favored Pre-proline 0 C--N 1.312 -1.044 0 N-CA-C 109.217 -0.661 . . . . 75.21 109.217 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 494' ' ' THR . 25.0 Cg_exo -66.07 143.61 72.58 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.067 1.845 . . . . 74.43 110.793 175.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 36.0 m -66.26 -19.04 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-O 121.521 0.677 . . . . 51.51 111.842 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -87.53 -2.05 58.35 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 115.297 -0.865 . . . . 73.23 110.703 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 32.3 t -89.09 157.24 18.39 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.485 -0.561 . . . . 74.24 109.485 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 25.8 t -96.33 136.65 26.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 109.24 -0.652 . . . . 71.14 109.24 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 551' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 520' ' ' PHE . 2.7 mp -113.66 138.56 42.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.379 -0.6 . . . . 73.32 109.379 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -101.98 121.13 41.56 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 121.36 0.6 . . . . 74.35 110.472 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.3 mp -95.56 132.08 41.08 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.364 -1.289 . . . . 71.25 107.859 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -106.84 120.17 41.31 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 122.013 0.911 . . . . 63.34 110.953 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.46 HG22 HG22 ' A' ' 534' ' ' VAL . 47.0 t -99.61 135.65 34.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-N 114.111 -1.404 . . . . 53.34 108.211 -178.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.634 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 68.2 m -90.73 149.2 22.13 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 116.464 -0.335 . . . . 41.23 110.455 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.641 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 15.8 ptmt -105.65 146.68 29.39 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 105.226 -2.138 . . . . 74.51 105.226 172.079 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -84.15 -24.72 47.06 Favored Glycine 0 N--CA 1.433 -1.549 0 C-N-CA 119.479 -1.343 . . . . 64.12 112.239 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 70.02 5.91 5.5 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.687 1.195 . . . . 71.34 111.004 -177.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 15.3 tp60 -148.53 141.87 25.2 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 106.891 -1.522 . . . . 75.15 106.891 -171.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -143.86 149.52 37.06 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.945 -0.761 . . . . 74.24 108.945 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.52 119.79 32.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 121.286 0.565 . . . . 51.34 111.413 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 60.4 ttp -97.75 134.0 22.84 Favored Pre-proline 0 C--N 1.316 -0.873 0 N-CA-C 108.537 -0.912 . . . . 72.11 108.537 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -64.18 169.52 10.61 Favored 'Trans proline' 0 C--O 1.245 0.872 0 C-N-CA 122.864 2.376 . . . . 75.41 112.378 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 565' ' ' ASP . . . . . 0.549 ' HA ' ' HB1' ' A' ' 610' ' ' ALA . 31.9 t70 -69.0 131.07 44.48 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 113.802 1.038 . . . . 65.11 113.802 -177.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 93.8 mt -147.12 23.19 1.19 Allowed 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 125.141 1.377 . . . . 75.35 107.942 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 2.8 m -79.25 146.28 33.1 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 116.25 -0.432 . . . . 75.43 110.824 -175.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 82.75 33.63 24.02 Favored Glycine 0 CA--C 1.496 -1.105 0 C-N-CA 120.796 -0.716 . . . . 72.02 112.137 174.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 25.0 mmt -108.04 -175.12 2.69 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.089 0.471 . . . . 72.43 110.387 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -110.25 155.9 21.41 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 108.845 -0.798 . . . . 73.3 108.845 -176.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 26.6 t90 -59.9 -30.68 69.19 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 123.217 0.323 . . . . 73.41 111.207 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 11.7 p -63.9 -21.51 28.91 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 CA-C-O 121.355 0.597 . . . . 74.23 110.791 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 573' ' ' ASP . . . . . 0.646 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 17.9 t70 -101.69 -41.74 6.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.715 -0.675 . . . . 75.53 109.703 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -62.79 -46.76 86.48 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 113.189 0.811 . . . . 51.51 113.189 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -54.33 -55.32 38.41 Favored Pre-proline 0 CA--C 1.577 2.016 0 O-C-N 123.215 0.322 . . . . 73.31 110.76 -178.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.37 -28.48 84.23 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.446 2.098 . . . . 65.24 114.24 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.646 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 29.1 mmt180 -58.15 -47.13 84.3 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.818 -0.438 . . . . 72.25 109.818 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 9.9 mp -61.11 -40.41 93.66 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.589 -0.732 . . . . 63.33 110.993 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -64.76 -46.83 80.46 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.931 -0.577 . . . . 75.41 110.206 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -67.63 -34.95 78.0 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.739 -0.664 . . . . 62.3 112.786 -177.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 581' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 92.4 mt -81.49 -7.55 59.6 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 112.61 0.596 . . . . 63.21 112.61 -176.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 74.41 40.16 40.75 Favored Glycine 0 CA--C 1.504 -0.627 0 C-N-CA 119.712 -1.232 . . . . 62.41 110.128 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 583' ' ' TRP . . . . . 0.455 ' CH2' ' HB2' ' A' ' 587' ' ' LEU . 77.0 t90 -72.51 136.09 45.82 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.59 -0.805 . . . . 70.14 111.166 -178.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 34.1 m -146.94 95.28 2.55 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.578 -0.527 . . . . 74.31 109.578 175.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -161.73 -144.98 4.17 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 108.871 -1.692 . . . . 71.2 108.871 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 87.5 mtp -111.34 133.7 53.46 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 118.085 0.943 . . . . 63.23 110.827 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 587' ' ' LEU . . . . . 0.455 ' HB2' ' CH2' ' A' ' 583' ' ' TRP . 61.6 tp -114.52 129.23 56.65 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.964 -1.124 . . . . 73.41 107.964 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -101.55 100.07 10.45 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 119.16 -1.016 . . . . 62.01 109.007 176.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -114.38 110.56 20.07 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 115.269 -0.878 . . . . 53.45 108.954 175.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 590' ' ' GLY . . . . . 0.438 ' HA3' ' NH1' ' A' ' 623' ' ' ARG . . . -90.8 -151.08 25.77 Favored Glycine 0 N--CA 1.433 -1.512 0 C-N-CA 120.991 -0.623 . . . . 62.14 113.069 -178.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -100.21 154.49 18.42 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 110.025 -0.361 . . . . 65.34 110.025 -177.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 592' ' ' ASP . . . . . 0.403 ' HB2' ' HG3' ' A' ' 626' ' ' GLN . 4.5 p30 -73.49 149.82 42.04 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 123.896 0.748 . . . . 74.11 110.634 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 94.8 t -138.45 130.2 37.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 115.476 -0.784 . . . . 62.02 109.763 -177.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -77.68 106.73 9.67 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 107.4 -1.333 . . . . 62.23 107.4 173.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -126.39 -20.16 4.48 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 116.03 -0.532 . . . . 73.33 111.132 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 128.2 157.93 9.52 Favored Glycine 0 C--N 1.302 -1.343 0 N-CA-C 110.412 -1.075 . . . . 42.03 110.412 -177.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.35 -35.67 66.64 Favored Glycine 0 N--CA 1.46 0.279 0 N-CA-C 113.992 0.357 . . . . 71.11 113.992 -173.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 19.9 m -62.61 -24.54 67.63 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.036 0.446 . . . . 70.24 111.701 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -107.05 -11.57 15.62 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 122.057 -0.402 . . . . 71.43 111.809 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 41.6 m170 -77.78 133.64 38.2 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 122.204 -0.31 . . . . 71.15 111.707 -176.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 58.9 t30 70.03 -21.73 0.17 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 125.488 1.515 . . . . 53.3 114.254 174.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 17.7 ttp85 -91.38 149.69 21.61 Favored 'General case' 0 C--N 1.312 -1.059 0 O-C-N 121.976 -0.453 . . . . 74.34 111.184 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 603' ' ' VAL . . . . . 0.495 HG23 ' HB2' ' A' ' 622' ' ' LEU . 9.0 p -62.71 133.66 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 O-C-N 123.765 0.665 . . . . 70.02 109.911 174.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 90.8 t -90.94 -48.46 14.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 108.317 -0.994 . . . . 72.03 108.317 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 605' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 622' ' ' LEU . 49.1 p90 -151.89 152.65 32.84 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 107.124 -1.435 . . . . 71.33 107.124 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -126.48 139.36 53.3 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 109.156 -0.683 . . . . 63.45 109.156 176.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.604 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 25.3 t-20 -54.91 -66.85 0.81 Allowed Pre-proline 0 C--N 1.311 -1.071 0 CA-C-N 115.407 -0.815 . . . . 72.35 112.454 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.604 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 88.2 Cg_endo -93.04 132.99 0.95 Allowed 'Trans proline' 0 N--CA 1.442 -1.55 0 CA-C-N 121.481 1.564 . . . . 73.21 110.6 173.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -70.3 134.76 27.58 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 121.102 1.201 . . . . 73.23 110.834 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 610' ' ' ALA . . . . . 0.549 ' HB1' ' HA ' ' A' ' 565' ' ' ASP . . . -69.49 129.68 40.38 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.6 -0.889 . . . . 33.11 108.6 176.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.38 -2.89 39.96 Favored Glycine 0 C--N 1.299 -1.513 0 N-CA-C 109.707 -1.357 . . . . 53.45 109.707 -172.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 30.2 m -119.11 167.54 11.7 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 107.832 -1.174 . . . . 71.04 107.832 177.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -71.34 126.17 12.76 Favored Glycine 0 N--CA 1.432 -1.588 0 CA-C-O 120.984 0.214 . . . . 72.05 112.987 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 614' ' ' VAL . . . . . 0.44 HG12 ' HB2' ' A' ' 608' ' ' PRO . 35.6 m -106.15 143.6 16.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 C-N-CA 124.606 1.162 . . . . 55.1 108.385 177.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.435 ' ND2' ' HB2' ' A' ' 617' ' ' ASP . 32.2 p-10 -67.64 161.07 26.59 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.657 0.265 . . . . 63.24 111.506 -176.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 616' ' ' ARG . . . . . 0.51 ' HD3' ' H ' ' A' ' 616' ' ' ARG . 0.0 OUTLIER -52.95 -30.71 36.28 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.812 -0.631 . . . . 65.43 111.796 178.799 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 617' ' ' ASP . . . . . 0.435 ' HB2' ' ND2' ' A' ' 615' ' ' ASN . 4.8 m-20 -71.34 -37.81 71.68 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 116.394 -0.366 . . . . 74.4 111.064 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 85.05 22.88 51.21 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 118.553 -1.784 . . . . 31.4 111.524 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.96 122.04 17.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 122.637 1.208 . . . . 72.24 109.773 -169.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 5.1 tp -126.4 123.28 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 CA-C-N 114.068 -1.423 . . . . 75.22 111.209 -174.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.557 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 55.0 m -115.0 121.87 44.47 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 107.952 -1.129 . . . . 65.02 107.952 173.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 622' ' ' LEU . . . . . 0.495 ' HB2' HG23 ' A' ' 603' ' ' VAL . 0.0 OUTLIER -138.41 159.48 41.97 Favored 'General case' 0 CA--C 1.479 -1.781 0 N-CA-C 107.044 -1.465 . . . . 74.44 107.044 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 623' ' ' ARG . . . . . 0.438 ' NH1' ' HA3' ' A' ' 590' ' ' GLY . 18.2 tpt180 -135.42 149.48 49.63 Favored 'General case' 0 C--N 1.267 -2.999 0 N-CA-C 105.686 -1.968 . . . . 73.55 105.686 178.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -141.08 162.02 36.47 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 106.569 -1.641 . . . . 65.35 106.569 177.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -78.44 -101.57 0.21 Allowed Glycine 0 N--CA 1.427 -1.912 0 N-CA-C 109.832 -1.307 . . . . 74.23 109.832 177.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 626' ' ' GLN . . . . . 0.403 ' HG3' ' HB2' ' A' ' 592' ' ' ASP . 33.3 tt0 . . . . . 0 C--N 1.282 -2.329 0 N-CA-C 108.664 -0.865 . . . . 63.13 108.664 175.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 . . . . . 0 CA--C 1.504 -0.806 0 N-CA-C 107.859 -1.163 . . . . 74.34 107.859 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 35.9 m -117.42 159.25 17.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-O 120.864 0.364 . . . . 63.54 110.145 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -95.5 122.96 38.79 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.609 -1.626 . . . . 71.43 106.609 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.583 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 60.7 t -96.46 133.17 25.13 Favored Pre-proline 0 C--N 1.294 -1.843 0 CA-C-N 116.2 -0.455 . . . . 52.22 110.627 -170.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 363' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 6.9 Cg_exo -68.9 127.63 15.57 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 121.682 1.588 . . . . 73.15 111.3 178.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -82.35 100.48 10.0 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 122.575 1.179 . . . . 74.03 110.039 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 20.0 m -74.32 9.11 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 113.587 -1.642 . . . . 63.53 114.522 -174.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -63.34 144.62 56.8 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 123.025 0.53 . . . . 55.45 111.252 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.52 0.35 43.25 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.959 -0.564 . . . . 40.45 112.395 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -112.16 -160.6 0.72 Allowed 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.538 -1.282 . . . . 61.3 107.538 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 369' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 84.0 p -91.58 166.01 13.04 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 106.696 -1.594 . . . . 43.44 106.696 177.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 40.2 t -60.63 -42.33 96.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 118.376 0.534 . . . . 62.44 109.608 177.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.19 -46.56 76.92 Favored 'General case' 0 C--O 1.214 -0.804 0 CA-C-N 115.892 -0.594 . . . . 70.22 111.727 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -65.91 -44.55 84.89 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 120.648 0.261 . . . . 75.41 111.161 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -61.86 -48.64 79.62 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.762 -0.653 . . . . 71.41 111.121 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 66.7 mt -67.21 -40.0 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 116.049 -0.523 . . . . 62.21 110.936 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.19 -39.73 91.27 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-O 120.626 0.251 . . . . 61.43 111.212 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 376' ' ' THR . . . . . 0.427 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 90.4 m -63.96 -48.52 76.17 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 116.088 -0.506 . . . . 63.54 109.953 177.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.9 -38.9 92.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.312 -0.404 . . . . 51.42 111.081 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -62.92 -43.8 97.82 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.824 -0.625 . . . . 74.03 111.113 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -67.64 -23.66 65.37 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.488 0.661 . . . . 74.32 111.569 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 380' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 376' ' ' THR . 27.9 mmt180 -84.7 -14.16 49.25 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.747 -0.66 . . . . 71.2 111.088 177.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.81 16.3 45.75 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.309 -0.948 . . . . 71.1 112.447 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.46 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 53.8 m-85 -83.99 173.73 10.92 Favored 'General case' 0 N--CA 1.421 -1.875 0 CA-C-O 120.946 0.403 . . . . 62.53 111.537 177.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -116.17 150.46 37.42 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 107.186 -1.413 . . . . 65.03 107.186 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 384' ' ' ILE . . . . . 0.42 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -126.69 140.35 49.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 CA-C-O 121.094 0.473 . . . . 75.13 110.801 -178.25 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 385' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 417' ' ' THR . 39.9 ttt180 -116.06 127.95 55.3 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 105.995 -1.854 . . . . 72.33 105.995 174.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 22.8 m -111.87 131.88 55.07 Favored 'General case' 0 C--N 1.276 -2.623 0 C-N-CA 119.988 -0.685 . . . . 70.13 110.403 -175.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -111.11 119.46 39.06 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 105.264 -2.124 . . . . 71.41 105.264 175.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 388' ' ' GLN . . . . . 0.716 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 19.3 pm0 -129.73 123.13 30.32 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.774 0.321 . . . . 64.41 111.28 -176.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -138.52 138.04 21.46 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 116.252 -0.431 . . . . 74.2 111.525 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 390' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' A' ' 422' ' ' THR . 8.4 Cg_exo -77.84 131.29 11.07 Favored 'Trans proline' 0 C--O 1.259 1.541 0 C-N-CA 122.472 2.115 . . . . 74.33 110.223 169.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.434 ' HB3' HG12 ' A' ' 394' ' ' ILE . 22.8 t70 169.01 136.87 0.02 OUTLIER 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 124.304 1.042 . . . . 65.24 108.328 -177.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 14.3 m -93.64 4.59 53.72 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 113.015 0.746 . . . . 64.22 113.015 -173.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 86.0 m -99.8 -30.15 12.22 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.578 -0.701 . . . . 71.41 110.248 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.434 HG12 ' HB3' ' A' ' 391' ' ' ASP . 16.9 pt -87.6 148.63 44.51 Favored Pre-proline 0 N--CA 1.433 -1.323 0 CA-C-N 116.097 -0.501 . . . . 75.43 110.297 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 395' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 396' ' ' PRO . 13.8 Cg_endo -55.2 138.47 79.33 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.057 3.171 . . . . 63.32 115.397 -173.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 396' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 395' ' ' PRO . 62.5 Cg_exo -55.62 164.47 4.28 Favored 'Trans proline' 0 C--N 1.361 1.192 0 C-N-CA 124.949 3.766 . . . . 45.54 112.274 175.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -55.58 -7.93 0.32 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 113.176 0.806 . . . . 74.31 113.176 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 34.2 m170 -77.72 111.56 13.64 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 104.914 -2.254 . . . . 74.21 104.914 169.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 33.3 m -77.16 122.74 32.38 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 N-CA-C 113.329 0.863 . . . . 63.23 113.329 -165.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 47.3 pt -89.8 -27.79 5.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 115.861 -0.608 . . . . 74.02 109.942 176.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.05 162.61 28.13 Favored Glycine 0 N--CA 1.419 -2.445 0 C-N-CA 119.714 -1.232 . . . . 61.42 114.035 -175.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 12.9 p -142.09 -176.84 4.96 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 126.767 2.027 . . . . 65.33 105.955 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -98.34 134.54 21.83 Favored Pre-proline 0 C--N 1.299 -1.627 0 C-N-CA 119.339 -0.944 . . . . 72.21 109.981 -175.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -59.92 -0.89 0.98 Allowed 'Trans proline' 0 C--N 1.362 1.284 0 C-N-CA 124.589 3.526 . . . . 71.53 115.205 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.0 -29.56 68.56 Favored 'General case' 0 C--O 1.203 -1.385 0 N-CA-C 108.243 -1.021 . . . . 64.34 108.243 172.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 406' ' ' ALA . . . . . 0.583 ' HA ' ' HB ' ' A' ' 362' ' ' VAL . . . -62.93 -44.04 97.16 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.236 -0.893 . . . . 60.25 109.761 175.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -80.64 -4.04 52.74 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.234 -0.894 . . . . 73.13 111.555 -175.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 23.1 m -98.74 150.45 21.81 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 105.534 -2.024 . . . . 70.45 105.534 173.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 52.2 p -75.27 111.93 11.04 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 117.695 -1.602 . . . . 73.4 107.091 175.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.5 m -125.54 169.04 17.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 120.846 0.355 . . . . 72.22 111.136 -177.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 13.7 m -64.63 134.58 54.59 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.455 -0.793 . . . . 74.34 109.686 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -64.56 128.66 36.74 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 116.057 -0.519 . . . . 73.32 110.127 -176.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 413' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 89.36 47.43 4.06 Favored Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 120.412 -0.899 . . . . 73.11 111.016 -177.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -106.83 161.31 14.8 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.794 -1.187 . . . . 72.04 107.794 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -86.27 108.9 18.6 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 121.398 0.618 . . . . 74.54 110.698 -176.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 41.9 mm -97.24 120.77 47.01 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 N-CA-C 108.217 -1.031 . . . . 63.53 108.217 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 417' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 385' ' ' ARG . 22.5 m -79.24 129.26 34.28 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.298 0.57 . . . . 65.24 111.124 -177.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 9.0 p -116.84 135.7 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-N 114.885 -1.052 . . . . 73.11 108.456 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -95.5 120.95 36.65 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 120.889 0.376 . . . . 60.11 110.718 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.716 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 99.2 t -127.25 131.68 70.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 108.488 -0.931 . . . . 70.55 108.488 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 4.1 m -131.43 143.11 50.2 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.504 -0.878 . . . . 41.14 109.568 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 422' ' ' THR . . . . . 0.524 ' O ' ' HA ' ' A' ' 390' ' ' PRO . 63.6 p -98.68 118.06 34.54 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 105.459 -2.052 . . . . 64.45 105.459 172.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.254 0 N-CA-C 116.084 1.194 . . . . 52.25 116.084 -170.876 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.422 ' HB3' HG22 ' A' ' 477' ' ' THR . 43.4 mt-30 . . . . . 0 N--CA 1.42 -1.94 0 N-CA-C 107.139 -1.43 . . . . 72.24 107.139 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.644 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 1.1 mmp_? -122.6 149.49 43.91 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-O 121.495 0.664 . . . . 70.22 112.141 -176.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' A' ' 428' ' ' GLU . 10.4 pt-20 -83.12 138.17 33.78 Favored 'General case' 0 C--N 1.276 -2.615 0 CA-C-N 113.836 -1.529 . . . . 72.44 108.566 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 58.2 mt -98.46 125.91 41.34 Favored Pre-proline 0 C--N 1.286 -2.155 0 N-CA-C 108.007 -1.109 . . . . 62.54 108.007 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -70.35 142.85 46.37 Favored 'Trans proline' 0 C--O 1.24 0.603 0 C-N-CA 122.216 1.944 . . . . 75.32 110.191 174.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -68.13 116.42 8.73 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.854 0.359 . . . . 70.2 110.369 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.05 140.25 27.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 109.216 -0.661 . . . . 73.53 109.216 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.596 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 19.6 m -68.94 158.29 34.96 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-O 120.864 0.364 . . . . 72.5 111.124 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 36.9 p -69.76 -28.87 66.13 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 114.309 1.225 . . . . 64.42 114.309 -171.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.0 pp -88.39 -11.55 45.8 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.655 0.741 . . . . 73.24 111.57 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.596 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 0.2 OUTLIER -92.53 40.87 1.06 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.663 -0.699 . . . . 65.24 110.743 -175.188 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -52.87 -38.28 61.37 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.545 0.738 . . . . 62.22 112.503 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.18 -41.82 97.48 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.979 0.418 . . . . 51.31 110.703 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -70.49 -34.66 72.61 Favored 'General case' 0 C--O 1.207 -1.137 0 CA-C-N 116.195 -0.457 . . . . 72.41 110.185 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.58 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -59.69 -51.7 68.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 119.766 -0.159 . . . . 73.02 111.119 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.6 m -62.01 -38.18 80.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-O 121.305 0.574 . . . . 73.43 110.463 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -60.63 -47.77 84.77 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.341 1.057 . . . . 53.24 110.971 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -65.75 -38.84 90.21 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 123.189 0.596 . . . . 50.3 111.428 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 85.3 mt -64.02 -36.88 85.43 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.167 -0.47 . . . . 51.11 110.176 177.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 33.1 m -70.11 -44.37 69.12 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.016 -0.538 . . . . 62.33 110.164 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.21 -18.31 65.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.854 -0.612 . . . . 71.25 111.246 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -90.04 5.48 46.48 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.129 -0.487 . . . . 72.42 111.824 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 109.71 -83.7 0.34 Allowed Glycine 0 CA--C 1.494 -1.225 0 C-N-CA 120.039 -1.077 . . . . 74.41 112.081 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -36.71 -61.85 0.51 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.734 1.383 . . . . 75.1 114.734 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 60.05 27.71 65.26 Favored Glycine 0 CA--C 1.508 -0.355 0 C-N-CA 120.842 -0.694 . . . . 63.22 111.434 -175.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -102.36 111.17 23.35 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 109.28 -0.637 . . . . 71.24 109.28 -176.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 11.5 p90 -139.64 152.03 46.44 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.653 -0.703 . . . . 75.54 110.298 -177.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -142.65 122.95 13.87 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.906 -1.146 . . . . 72.33 107.906 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -96.36 130.81 43.39 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 120.96 0.409 . . . . 75.53 111.758 -177.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 455' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -135.15 150.04 50.09 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 123.498 0.719 . . . . 55.23 109.199 175.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -123.1 149.82 44.0 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 119.915 -0.714 . . . . 73.01 110.491 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 46.1 m -151.18 151.65 29.78 Favored Pre-proline 0 C--N 1.295 -1.798 0 N-CA-C 107.184 -1.413 . . . . 71.31 107.184 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 490' ' ' SER . 19.2 Cg_exo -65.48 144.58 79.94 Favored 'Trans proline' 0 C--O 1.243 0.738 0 C-N-CA 121.747 1.631 . . . . 72.53 112.018 -177.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 14.9 t -152.55 179.37 8.65 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 106.709 -1.589 . . . . 65.23 106.709 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.5 t -56.17 142.94 65.6 Favored Pre-proline 0 C--N 1.305 -1.347 0 C-N-CA 123.947 0.899 . . . . 74.21 110.621 177.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -51.49 -29.73 32.77 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 124.464 3.443 . . . . 75.41 113.121 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.51 -19.39 60.93 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.942 0.401 . . . . 71.14 112.057 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -108.13 -1.93 19.92 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.112 0.412 . . . . 65.54 112.112 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 84.4 t -61.06 127.14 20.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.266 -0.642 . . . . 64.1 109.266 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.68 -13.09 68.26 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 116.065 -0.516 . . . . 32.13 111.812 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.419 ' O ' HG23 ' A' ' 488' ' ' VAL . 11.8 mptt -109.76 159.0 17.55 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.167 0.508 . . . . 74.53 110.12 -178.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 76.8 t -71.85 145.8 11.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 115.071 -0.968 . . . . 73.22 109.711 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 62.1 mt -98.39 -35.44 5.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 107.83 -1.174 . . . . 70.23 107.83 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 164.72 -174.52 40.71 Favored Glycine 0 N--CA 1.43 -1.757 0 CA-C-N 115.468 -0.787 . . . . 72.12 112.176 176.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 470' ' ' THR . . . . . 0.61 HG22 HG12 ' A' ' 486' ' ' ILE . 58.8 p -115.2 141.94 47.34 Favored 'General case' 0 N--CA 1.422 -1.825 0 N-CA-C 106.933 -1.506 . . . . 72.05 106.933 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.54 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 2.8 t-20 -64.46 -57.3 17.73 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 119.85 -0.74 . . . . 74.05 111.358 178.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.54 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 17.2 Cg_exo -74.19 138.53 25.31 Favored 'Trans proline' 0 C--N 1.363 1.311 0 N-CA-C 107.026 -1.951 . . . . 61.41 107.026 168.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -63.0 126.14 17.37 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 121.749 1.633 . . . . 72.21 113.669 -173.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -86.16 10.73 13.64 Favored 'General case' 0 C--O 1.205 -1.272 0 CA-C-N 115.275 -0.875 . . . . 61.04 111.047 -177.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -110.65 -0.68 17.1 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.54 -0.755 . . . . 75.02 110.455 176.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -124.46 -168.48 1.81 Allowed 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.024 -0.535 . . . . 74.24 110.548 -173.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.422 HG22 ' HB3' ' A' ' 426' ' ' GLN . 0.2 OUTLIER -89.09 131.46 35.24 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 115.54 -0.755 . . . . 42.35 110.544 -177.206 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 49.5 m -127.98 148.16 50.51 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 122.902 0.481 . . . . 63.04 110.097 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -77.87 158.77 29.3 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.932 -0.576 . . . . 71.42 110.931 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 35.0 mm -73.16 -23.06 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 121.552 0.692 . . . . 73.34 110.57 -175.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 17.0 m -95.94 1.8 53.1 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 122.081 0.943 . . . . 60.14 109.93 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -93.06 130.19 38.76 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.751 -0.659 . . . . 63.4 110.705 -175.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.2 p -100.34 126.41 53.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.25 0.548 . . . . 72.44 111.487 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 32.7 m -95.75 121.68 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-O 121.816 0.817 . . . . 42.11 110.327 178.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.61 129.28 43.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.971 -1.122 . . . . 75.14 107.971 177.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.61 HG12 HG22 ' A' ' 470' ' ' THR . 11.6 mt -113.73 124.61 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 CA-C-N 114.83 -1.077 . . . . 51.31 110.274 -175.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 8.5 tt -104.94 126.19 59.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 115.256 -0.883 . . . . 72.34 109.33 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 466' ' ' LYS . 2.3 p -111.41 145.53 17.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 C-N-CA 124.252 1.021 . . . . 64.21 109.447 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -80.14 124.41 6.48 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.991 -0.623 . . . . 72.23 111.662 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 18.3 t . . . . . 0 C--N 1.31 -1.138 0 N-CA-C 108.84 -0.8 . . . . 74.4 108.84 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo . . . . . 0 N--CA 1.456 -0.698 0 CA-C-O 120.831 0.263 . . . . 54.41 112.414 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -136.7 21.38 3.1 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 122.154 0.978 . . . . 70.12 110.521 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 27.5 p -130.19 151.69 50.43 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-N 114.334 -1.303 . . . . 74.3 110.61 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 495' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 495' ' ' LYS . 18.7 mmtt -147.82 164.33 33.97 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.679 -0.691 . . . . 74.45 110.245 175.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -95.73 136.77 35.72 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.988 -0.551 . . . . 73.35 110.428 -175.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 27.7 pt -92.08 117.78 67.86 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 109.283 -0.636 . . . . 73.15 109.283 175.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.22 -179.39 5.38 Favored 'Trans proline' 0 C--O 1.249 1.058 0 C-N-CA 121.966 1.777 . . . . 54.55 111.934 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -79.07 111.26 15.1 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.471 -0.566 . . . . 74.42 109.471 177.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 9.9 p -113.35 18.97 7.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 122.424 1.107 . . . . 75.43 109.191 -176.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 501' ' ' ALA . . . . . 0.413 ' HB2' ' HA2' ' A' ' 536' ' ' GLY . . . -83.46 119.16 24.33 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.432 -0.803 . . . . 70.34 110.783 -177.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 120.33 22.12 3.22 Favored Glycine 0 N--CA 1.436 -1.338 0 C-N-CA 121.054 -0.593 . . . . 50.14 112.888 177.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 503' ' ' GLN . . . . . 0.53 HE22 ' N ' ' A' ' 508' ' ' ALA . 0.0 OUTLIER -137.14 -172.19 3.14 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 122.591 -0.358 . . . . 74.42 110.876 178.759 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 8.6 m -91.01 154.88 19.11 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 118.483 -1.287 . . . . 64.42 110.303 -173.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 9.5 p -58.34 -41.3 80.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 123.342 0.657 . . . . 70.2 112.415 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -59.73 -39.8 85.93 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.455 0.645 . . . . 71.03 109.877 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 29.3 t -73.52 -36.7 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 CA-C-N 115.314 -0.857 . . . . 64.34 109.955 -177.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 508' ' ' ALA . . . . . 0.53 ' N ' HE22 ' A' ' 503' ' ' GLN . . . -63.39 -49.78 72.45 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.397 -0.365 . . . . 63.0 111.593 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -63.23 -35.15 79.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.012 0.434 . . . . 75.01 110.554 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.435 ' O ' HG23 ' A' ' 514' ' ' VAL . 5.0 tppp? -61.99 -53.1 60.31 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.249 -0.887 . . . . 51.34 109.893 176.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -61.59 -44.91 96.15 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-N 116.163 -0.471 . . . . 53.22 111.632 -176.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -61.0 -44.07 97.96 Favored 'General case' 0 C--O 1.247 0.924 0 O-C-N 123.236 0.335 . . . . 53.24 111.442 178.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 513' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 10.2 m120 -63.84 -38.8 92.42 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 120.317 -0.553 . . . . 63.54 111.109 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 510' ' ' LYS . 73.0 t -61.88 -35.04 65.73 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 CA-C-N 116.052 -0.522 . . . . 75.42 111.087 177.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -74.63 -13.87 60.7 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.573 -0.451 . . . . 73.43 111.017 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 115.24 -2.06 22.38 Favored Glycine 0 N--CA 1.436 -1.335 0 C-N-CA 120.437 -0.887 . . . . 72.14 112.503 178.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.462 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 65.7 m-85 -85.27 109.36 18.3 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.517 -0.919 . . . . 74.14 108.517 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 17.5 p -88.18 -14.7 37.97 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 113.674 0.99 . . . . 75.43 113.674 -173.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -117.64 122.5 43.75 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 120.952 0.406 . . . . 70.43 111.497 -175.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 520' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 551' ' ' ILE . 46.3 p90 -129.88 153.47 48.27 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 116.002 -0.545 . . . . 64.24 111.366 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 521' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 58.5 m -139.9 152.26 46.26 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.193 -1.41 . . . . 74.02 107.193 174.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.9 pm0 -123.39 135.91 54.37 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-O 121.163 0.506 . . . . 70.14 111.068 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -131.55 130.79 42.73 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.28 -1.007 . . . . 75.23 108.28 176.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 524' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 19.8 m -96.03 132.55 41.27 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 110.129 -0.323 . . . . 60.41 110.129 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 34.0 m -121.54 149.57 24.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 108.154 -1.054 . . . . 63.33 108.154 178.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -74.6 135.47 42.04 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 121.029 -0.269 . . . . 74.21 111.432 -173.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 527' ' ' SER . . . . . 0.486 ' HB2' ' OG ' ' A' ' 556' ' ' SER . 70.3 m -159.43 174.65 3.81 Favored Pre-proline 0 C--N 1.314 -0.968 0 C-N-CA 123.771 0.828 . . . . 70.22 108.789 178.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -89.44 -3.05 5.93 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.969 1.779 . . . . 70.24 111.147 174.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.503 ' HB2' ' OG ' ' A' ' 556' ' ' SER . 23.8 mmt85 -79.93 133.31 58.43 Favored Pre-proline 0 N--CA 1.444 -0.753 0 N-CA-C 107.741 -1.207 . . . . 72.32 107.741 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -56.14 144.44 80.47 Favored 'Trans proline' 0 C--O 1.254 1.314 0 C-N-CA 123.065 2.51 . . . . 64.52 113.4 -175.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -57.8 113.66 1.95 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.69 -1.141 . . . . 75.03 110.69 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 138.71 -26.79 2.74 Favored Glycine 0 C--N 1.306 -1.126 0 CA-C-N 115.785 -0.643 . . . . 40.2 111.536 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -76.49 127.86 33.65 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.166 -0.679 . . . . 71.33 109.166 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 83.6 t -79.6 117.76 25.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.041 -1.096 . . . . 70.42 108.041 176.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 13.7 t -91.92 -1.86 57.08 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.678 -0.692 . . . . 54.11 110.757 -176.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.413 ' HA2' ' HB2' ' A' ' 501' ' ' ALA . . . 149.95 -166.07 29.84 Favored Glycine 0 CA--C 1.489 -1.557 0 C-N-CA 120.685 -0.769 . . . . 61.43 111.874 177.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 13.3 p -119.0 158.7 25.25 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 109.391 -0.596 . . . . 74.54 109.391 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.503 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 5.3 t30 -65.89 -52.36 41.79 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-O 119.083 -0.484 . . . . 52.15 111.097 177.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 4.8 Cg_exo -78.96 142.6 17.52 Favored 'Trans proline' 0 C--N 1.368 1.591 0 N-CA-C 108.2 -1.5 . . . . 70.42 108.2 171.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 540' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 31.5 Cg_exo -59.79 144.65 99.41 Favored 'Trans proline' 0 C--O 1.253 1.229 0 C-N-CA 122.297 1.998 . . . . 71.42 113.107 -177.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -64.33 137.37 57.87 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 115.896 -0.593 . . . . 73.34 109.819 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 102.44 -12.44 56.86 Favored Glycine 0 C--N 1.298 -1.578 0 C-N-CA 121.018 -0.61 . . . . 71.43 111.919 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 23.9 m -75.33 130.97 39.93 Favored 'General case' 0 C--O 1.245 0.843 0 N-CA-C 109.752 -0.462 . . . . 51.44 109.752 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 14.6 m -84.4 122.9 29.6 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 107.291 -1.374 . . . . 74.04 107.291 176.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.5 m -131.51 157.32 78.49 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.907 -0.405 . . . . 73.34 109.907 -177.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -64.86 140.47 67.01 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.4 2.066 . . . . 74.43 111.607 176.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.462 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 27.0 m -63.98 -20.14 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-O 121.761 0.791 . . . . 42.53 111.834 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -87.06 -11.2 50.99 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.058 -0.973 . . . . 41.25 111.873 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 80.5 p -82.09 175.98 9.89 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 120.017 -0.673 . . . . 71.13 112.343 -176.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 27.0 t -101.72 119.17 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 116.012 -0.54 . . . . 75.35 110.737 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 551' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 520' ' ' PHE . 1.8 mp -101.17 124.6 54.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 108.842 -0.799 . . . . 74.42 108.842 177.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 552' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 521' ' ' SER . 35.0 tt0 -102.86 128.84 49.47 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-O 121.211 0.529 . . . . 73.35 110.236 -178.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -93.37 133.98 36.07 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.329 -0.989 . . . . 74.13 108.329 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -95.85 114.25 25.96 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.944 -1.502 . . . . 65.44 106.944 176.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 524' ' ' SER . 40.5 t -99.79 141.3 17.21 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 108.391 -0.966 . . . . 72.1 108.391 -177.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.638 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 36.0 t -78.84 129.71 34.88 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 121.214 0.53 . . . . 72.33 111.27 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 12.2 ttpp -93.65 121.51 35.15 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 106.747 -1.575 . . . . 74.43 106.747 169.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -81.39 -24.24 57.12 Favored Glycine 0 CA--C 1.494 -1.269 0 C-N-CA 120.48 -0.867 . . . . 52.14 112.099 -177.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 4.8 p30 58.62 6.96 0.66 Allowed 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 127.257 2.223 . . . . 71.52 114.26 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -134.21 170.91 14.99 Favored 'General case' 0 C--O 1.253 1.244 0 CA-C-O 121.688 0.756 . . . . 73.21 112.286 -173.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -145.99 148.33 32.62 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.88 -1.526 . . . . 73.15 106.88 173.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 9.4 p -71.18 127.75 33.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-O 121.176 0.512 . . . . 71.3 110.229 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 58.7 ttp -96.26 115.29 65.52 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 109.272 -0.64 . . . . 75.31 109.272 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.98 154.9 72.1 Favored 'Trans proline' 0 C--O 1.242 0.684 0 C-N-CA 122.08 1.853 . . . . 44.05 110.367 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 565' ' ' ASP . . . . . 0.489 ' HA ' ' HB1' ' A' ' 610' ' ' ALA . 4.2 p-10 -76.03 118.1 18.44 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 121.822 0.82 . . . . 74.21 111.236 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 96.2 mt -137.52 34.09 2.49 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.009 -1.45 . . . . 65.24 107.184 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 14.8 m -71.25 132.72 45.35 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.008 -0.996 . . . . 64.24 111.342 -175.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 99.86 38.8 3.53 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 121.114 -0.565 . . . . 65.53 113.312 174.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 83.6 mtp -109.69 155.26 21.75 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.435 -0.58 . . . . 73.42 109.435 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 570' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 66.2 m-85 -74.96 149.73 39.27 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 107.286 -1.375 . . . . 72.31 107.286 175.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 571' ' ' TRP . . . . . 0.505 ' O ' ' HG3' ' A' ' 575' ' ' GLU . 41.0 t90 -60.47 -29.81 69.28 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 123.274 0.359 . . . . 64.42 110.855 -177.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 33.2 m -80.16 -10.42 12.49 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.612 0 CA-C-O 121.568 0.699 . . . . 65.02 110.894 -176.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -101.78 -31.84 10.56 Favored 'General case' 0 C--O 1.266 1.927 0 CA-C-O 122.885 1.326 . . . . 63.42 107.88 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 574' ' ' ALA . . . . . 0.45 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -68.77 -36.72 78.68 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 113.885 -1.507 . . . . 73.3 110.392 176.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.588 ' HB2' ' HD3' ' A' ' 576' ' ' PRO . 43.4 mt-10 -51.75 -57.79 13.42 Favored Pre-proline 0 CA--C 1.559 1.3 0 CA-C-O 118.87 -0.586 . . . . 73.51 111.66 177.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 576' ' ' PRO . . . . . 0.588 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 64.3 Cg_exo -56.63 -39.5 90.93 Favored 'Trans proline' 0 C--N 1.387 2.598 0 C-N-CA 121.768 1.645 . . . . 74.12 112.542 175.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -59.03 -43.59 91.64 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 119.782 -0.767 . . . . 74.54 112.269 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 96.2 mt -65.97 -47.22 75.33 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.521 0.677 . . . . 73.44 110.307 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -65.03 -34.98 79.72 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.412 -0.813 . . . . 75.51 111.643 -177.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.65 -33.38 70.91 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.367 0.506 . . . . 44.11 112.367 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 4.0 pp -88.4 -3.61 58.8 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.474 0.916 . . . . 72.43 113.474 -176.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 86.12 37.77 8.93 Favored Glycine 0 C--N 1.314 -0.648 0 C-N-CA 120.183 -1.008 . . . . 73.44 112.001 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 82.3 t90 -71.87 127.94 34.17 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 123.19 0.596 . . . . 74.01 110.808 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 23.0 m -138.3 67.9 1.4 Allowed 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 122.183 0.992 . . . . 70.12 109.404 174.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -124.44 -149.88 7.75 Favored Glycine 0 N--CA 1.436 -1.313 0 N-CA-C 110.07 -1.212 . . . . 73.33 110.07 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 586' ' ' MET . . . . . 0.485 ' O ' HG12 ' A' ' 619' ' ' ILE . 8.6 mmt -122.79 139.03 54.44 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.6 -0.519 . . . . 72.21 109.6 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -101.16 127.55 47.67 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 106.524 -1.658 . . . . 75.24 106.524 174.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -97.25 99.85 11.31 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 120.19 -0.604 . . . . 72.01 110.822 -175.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -114.42 109.19 17.92 Favored 'General case' 0 N--CA 1.409 -2.51 0 N-CA-C 108.154 -1.054 . . . . 72.53 108.154 170.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -143.97 -62.36 0.02 OUTLIER Glycine 0 CA--C 1.477 -2.319 0 N-CA-C 108.849 -1.7 . . . . 40.25 108.849 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 591' ' ' ALA . . . . . 0.429 ' O ' ' HD2' ' A' ' 623' ' ' ARG . . . -89.86 136.54 32.98 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.541 -0.911 . . . . 62.15 108.541 173.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -116.72 157.08 26.05 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.608 -0.516 . . . . 75.44 109.608 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 593' ' ' VAL . . . . . 0.422 ' O ' ' HA2' ' A' ' 625' ' ' GLY . 38.5 t -107.15 132.01 55.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 120.336 -0.546 . . . . 71.44 110.232 -177.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 594' ' ' ASP . . . . . 0.603 ' HA ' ' OE1' ' A' ' 626' ' ' GLN . 5.8 p-10 -73.76 112.4 9.83 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.102 0.477 . . . . 73.54 112.255 -178.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -176.6 19.97 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 114.56 -1.2 . . . . 61.24 110.647 175.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 83.74 127.6 1.39 Allowed Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 110.326 -1.11 . . . . 61.33 110.326 -174.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.559 ' O ' ' HB2' ' A' ' 601' ' ' ASN . . . -62.12 -49.55 73.84 Favored Glycine 0 C--O 1.2 -2.0 0 C-N-CA 120.478 -0.868 . . . . 74.3 112.478 -176.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 47.0 m -71.56 -24.13 61.87 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.315 0.578 . . . . 53.15 111.689 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -89.64 -7.69 54.14 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.925 -0.58 . . . . 74.04 112.169 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -145.45 28.61 1.18 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.836 0.827 . . . . 74.54 109.547 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 601' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 597' ' ' GLY . 20.7 t-20 -86.55 62.94 7.71 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 122.425 1.107 . . . . 64.41 108.575 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 602' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 37.1 ptt85 -143.0 171.84 13.51 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 107.453 -1.314 . . . . 73.54 107.453 -176.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 11.7 p -62.84 129.87 26.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 107.388 -1.338 . . . . 70.23 107.388 174.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 87.2 t -95.98 -36.4 6.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 119.833 -0.747 . . . . 53.33 109.09 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -154.79 158.96 40.26 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 105.892 -1.892 . . . . 71.01 105.892 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -128.86 124.93 36.54 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.047 -0.723 . . . . 73.03 109.047 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.498 ' HB2' ' HB ' ' A' ' 621' ' ' THR . 21.9 t-20 -59.36 -50.66 86.26 Favored Pre-proline 0 CA--C 1.559 1.327 0 CA-C-N 115.792 -0.64 . . . . 74.22 112.453 -177.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.494 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 4.3 Cg_exo -90.09 124.89 1.21 Allowed 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 121.908 1.739 . . . . 51.12 110.764 173.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.79 139.09 66.95 Favored 'Trans proline' 0 C--O 1.252 1.189 0 C-N-CA 122.414 2.076 . . . . 64.31 111.909 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 610' ' ' ALA . . . . . 0.489 ' HB1' ' HA ' ' A' ' 565' ' ' ASP . . . -64.09 138.44 58.46 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.594 -0.73 . . . . 54.42 110.363 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 99.69 -5.86 58.59 Favored Glycine 0 N--CA 1.435 -1.425 0 N-CA-C 111.441 -0.664 . . . . 72.54 111.441 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 12.1 m -99.96 160.22 14.48 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 108.772 -0.825 . . . . 62.02 108.772 -178.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -75.08 125.3 8.15 Favored Glycine 0 N--CA 1.423 -2.199 0 N-CA-C 109.883 -1.287 . . . . 41.23 109.883 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 34.7 m -112.22 142.62 24.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 108.612 -0.884 . . . . 73.3 108.612 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.42 HD21 ' CG2' ' A' ' 619' ' ' ILE . 30.5 p30 -43.68 152.79 0.14 Allowed 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.745 1.017 . . . . 73.3 113.745 177.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -56.8 -25.72 56.35 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.345 1.058 . . . . 71.45 112.604 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -63.84 -42.9 97.5 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 108.401 -0.963 . . . . 71.0 108.401 176.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 618' ' ' GLY . . . . . 0.411 ' O ' HG12 ' A' ' 620' ' ' ILE . . . 81.97 19.25 65.64 Favored Glycine 0 N--CA 1.42 -2.386 0 N-CA-C 109.324 -1.51 . . . . 62.1 109.324 -177.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 619' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 586' ' ' MET . 0.0 OUTLIER -70.71 117.76 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-O 122.274 1.035 . . . . 72.21 108.594 -175.407 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 618' ' ' GLY . 47.7 mm -115.32 130.31 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.195 0 N-CA-C 105.941 -1.874 . . . . 74.53 105.941 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.498 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 27.7 m -96.87 114.64 26.29 Favored 'General case' 0 N--CA 1.401 -2.918 0 C-N-CA 117.175 -1.81 . . . . 75.55 106.977 175.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 4.4 pp -140.9 150.3 43.01 Favored 'General case' 0 N--CA 1.406 -2.627 0 N-CA-C 105.753 -1.943 . . . . 73.43 105.753 176.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 623' ' ' ARG . . . . . 0.429 ' HD2' ' O ' ' A' ' 591' ' ' ALA . 28.5 mtm180 -133.81 156.71 47.53 Favored 'General case' 0 C--N 1.269 -2.893 0 N-CA-C 108.502 -0.925 . . . . 55.11 108.502 175.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -133.18 166.87 21.44 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 124.444 1.09 . . . . 74.22 111.405 -173.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 625' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 593' ' ' VAL . . . -66.18 139.41 37.97 Favored Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 115.214 0.846 . . . . 53.25 115.214 -176.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 626' ' ' GLN . . . . . 0.603 ' OE1' ' HA ' ' A' ' 594' ' ' ASP . 1.3 mp0 . . . . . 0 N--CA 1.473 0.689 0 N-CA-C 116.118 1.896 . . . . 72.5 116.118 176.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 . . . . . 0 CA--C 1.491 -1.321 0 N-CA-C 106.972 -1.492 . . . . 64.32 106.972 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 360' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 409' ' ' SER . 24.0 m -121.54 163.56 19.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.354 0 N-CA-C 109.654 -0.499 . . . . 63.34 109.654 -177.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.37 129.81 39.37 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.365 -1.346 . . . . 72.02 107.365 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 55.6 t -97.16 129.85 31.18 Favored Pre-proline 0 C--N 1.282 -2.366 0 CA-C-N 115.427 -0.806 . . . . 65.41 109.494 -171.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -68.86 128.59 17.1 Favored 'Trans proline' 0 C--O 1.241 0.629 0 C-N-CA 122.124 1.883 . . . . 73.42 111.925 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -89.21 144.67 25.94 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-O 121.633 0.73 . . . . 73.13 109.291 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.05 21.69 3.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 CA-C-N 114.817 -1.083 . . . . 60.33 112.036 -174.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.414 ' HB3' HG23 ' A' ' 402' ' ' THR . 18.6 ptt180 -56.01 144.37 28.98 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.021 -0.99 . . . . 73.14 112.529 175.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.5 -0.08 46.46 Favored Glycine 0 C--N 1.311 -0.843 0 CA-C-N 115.71 -0.677 . . . . 34.42 112.486 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -111.34 -150.77 0.47 Allowed 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.11 -1.07 . . . . 73.11 108.11 176.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 80.0 p -97.77 161.53 13.71 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.36 -1.348 . . . . 74.14 107.36 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 42.3 m -63.32 -37.6 87.87 Favored 'General case' 0 C--O 1.21 -1.022 0 C-N-CA 120.838 -0.345 . . . . 74.11 110.305 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.06 -46.14 85.69 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 111.831 0.308 . . . . 73.14 111.831 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -68.92 -41.66 77.85 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 121.618 0.723 . . . . 74.31 109.24 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.81 -50.88 69.25 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.983 -1.008 . . . . 72.05 111.197 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 374' ' ' ILE . . . . . 0.404 HG23 HD13 ' A' ' 384' ' ' ILE . 78.7 mt -64.74 -40.11 87.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.904 -0.589 . . . . 71.44 110.68 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.79 -38.07 77.73 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.139 0.495 . . . . 73.13 111.054 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 27.3 m -65.64 -47.09 76.77 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.074 -0.512 . . . . 73.41 110.334 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.85 -37.57 87.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.294 -0.412 . . . . 74.32 111.873 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -62.59 -37.91 88.09 Favored 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 122.296 0.239 . . . . 74.05 110.367 176.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -68.45 -21.22 64.65 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 121.19 0.519 . . . . 65.12 111.171 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -86.96 -14.13 42.63 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.982 -0.554 . . . . 71.13 110.224 174.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 95.63 9.48 57.56 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.567 -0.825 . . . . 64.21 112.474 176.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -82.55 155.48 24.48 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-O 121.13 0.49 . . . . 74.13 111.655 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -100.77 132.52 46.13 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 106.65 -1.611 . . . . 73.42 106.65 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 384' ' ' ILE . . . . . 0.414 ' N ' HD12 ' A' ' 384' ' ' ILE . 1.8 mp -119.11 146.38 23.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 107.665 -1.235 . . . . 70.2 107.665 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 46.2 ttt180 -111.75 127.96 55.95 Favored 'General case' 0 C--N 1.259 -3.361 0 N-CA-C 106.542 -1.651 . . . . 75.04 106.542 177.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 27.4 m -113.72 117.87 32.74 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 106.998 -1.482 . . . . 60.52 106.998 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 387' ' ' LEU . . . . . 0.438 HD12 ' HG2' ' A' ' 389' ' ' LYS . 0.8 OUTLIER -112.17 119.99 40.27 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.406 -0.961 . . . . 73.21 108.406 -177.467 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -94.1 122.51 36.69 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.219 -0.66 . . . . 74.2 109.219 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 389' ' ' LYS . . . . . 0.48 ' HE2' ' HA ' ' A' ' 389' ' ' LYS . 4.5 mmpt? -125.51 119.44 24.65 Favored Pre-proline 0 C--N 1.3 -1.55 0 C-N-CA 121.141 -0.223 . . . . 72.14 111.058 176.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 390' ' ' PRO . . . . . 0.618 ' HA ' ' O ' ' A' ' 422' ' ' THR . 38.0 Cg_exo -69.23 128.32 16.34 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.93 1.753 . . . . 71.3 108.993 171.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.586 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 7.0 t70 143.04 -171.42 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 104.923 -2.251 . . . . 75.04 104.923 -175.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 23.3 t -131.31 2.91 4.25 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.338 -0.616 . . . . 64.32 109.338 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 14.7 t -77.47 -5.6 50.48 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 122.918 0.487 . . . . 73.52 112.004 -178.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.512 HD13 ' H ' ' A' ' 394' ' ' ILE . 0.2 OUTLIER -114.8 151.96 45.93 Favored Pre-proline 0 C--N 1.303 -1.427 0 CA-C-O 118.998 -0.525 . . . . 74.34 109.69 -177.223 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -44.05 138.49 6.54 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 124.025 3.15 . . . . 74.14 114.105 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.5 161.71 16.73 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.417 2.745 . . . . 75.25 112.788 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 397' ' ' ASP . . . . . 0.422 ' HA ' HG13 ' A' ' 420' ' ' VAL . 6.0 p-10 -57.15 -8.3 0.67 Allowed 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 113.434 0.901 . . . . 71.52 113.434 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -111.56 130.2 55.82 Favored 'General case' 0 CA--C 1.478 -1.821 0 N-CA-C 106.581 -1.637 . . . . 55.11 106.581 171.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 20.1 m -66.37 119.32 11.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 O-C-N 123.787 0.679 . . . . 70.24 111.293 -169.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 8.7 tp -94.51 -29.33 4.16 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 108.508 -0.923 . . . . 71.33 108.508 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.84 170.6 27.77 Favored Glycine 0 N--CA 1.411 -3.025 0 N-CA-C 110.312 -1.115 . . . . 71.21 110.312 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 402' ' ' THR . . . . . 0.414 HG23 ' HB3' ' A' ' 366' ' ' ARG . 3.3 p -121.64 -179.28 4.05 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 107.712 -1.218 . . . . 75.14 107.712 176.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -101.4 134.58 20.19 Favored Pre-proline 0 C--N 1.293 -1.87 0 N-CA-C 107.703 -1.221 . . . . 70.1 107.703 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -51.59 -13.36 1.43 Allowed 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 124.33 3.353 . . . . 62.54 115.493 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.49 -39.4 70.39 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-O 120.703 0.287 . . . . 71.24 110.285 176.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -71.17 -33.54 70.11 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.859 0.838 . . . . 74.12 110.227 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -86.15 3.97 40.45 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.927 -1.033 . . . . 60.24 111.162 -177.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 27.1 m -109.7 154.36 22.99 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 105.514 -2.032 . . . . 74.41 105.514 171.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 409' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 360' ' ' VAL . 50.5 m -74.88 112.42 11.08 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 119.737 -0.785 . . . . 60.11 109.433 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 21.7 m -124.81 164.88 22.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 116.332 -0.394 . . . . 64.22 109.972 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 15.4 m -72.41 146.25 47.1 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.958 -0.386 . . . . 75.14 109.958 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -65.58 131.82 47.32 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.997 -0.371 . . . . 74.01 109.997 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 89.57 38.89 6.44 Favored Glycine 0 C--N 1.311 -0.836 0 C-N-CA 120.752 -0.737 . . . . 33.22 111.955 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -100.51 -175.99 3.07 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.328 -1.36 . . . . 73.13 107.328 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -108.83 123.25 48.76 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.137 0.494 . . . . 72.11 110.741 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 416' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 48.4 mm -112.18 137.4 45.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 106.538 -1.652 . . . . 73.33 106.538 175.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.4 t -116.76 132.0 56.81 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.842 -0.536 . . . . 65.43 110.892 -174.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 9.9 p -116.28 134.6 59.17 Favored 'Isoleucine or valine' 0 C--O 1.253 1.249 0 N-CA-C 109.567 -0.531 . . . . 73.24 109.567 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -102.42 116.07 31.86 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.997 -0.742 . . . . 64.2 108.997 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.422 HG13 ' HA ' ' A' ' 397' ' ' ASP . 77.0 t -104.93 130.88 55.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 116.116 -0.493 . . . . 71.32 110.775 -176.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 30.6 t -85.92 123.85 31.72 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 115.593 -0.731 . . . . 74.41 110.241 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 422' ' ' THR . . . . . 0.618 ' O ' ' HA ' ' A' ' 390' ' ' PRO . 12.2 p -116.39 138.92 50.96 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 106.216 -1.772 . . . . 75.14 106.216 171.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.484 0 N-CA-C 116.598 1.399 . . . . 64.24 116.598 -172.12 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 . . . . . 0 N--CA 1.428 -1.573 0 N-CA-C 106.308 -1.738 . . . . 74.21 106.308 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.428 ' HA ' ' HE ' ' A' ' 427' ' ' ARG . 1.2 mmp_? -120.79 165.32 15.3 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 109.469 -0.567 . . . . 44.13 109.469 -178.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -115.25 142.1 47.13 Favored 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 108.229 -1.026 . . . . 54.34 108.229 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.526 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 74.0 mt -77.17 121.02 83.95 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 108.95 -0.759 . . . . 41.41 108.95 -175.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 429' ' ' ILE . 20.8 Cg_exo -68.16 160.25 49.61 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 123.499 2.799 . . . . 64.12 114.411 -177.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -77.79 155.42 31.14 Favored 'General case' 0 C--O 1.249 1.077 0 CA-C-N 115.522 -0.763 . . . . 51.33 109.765 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 13.6 p -164.43 144.41 2.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 116.267 -0.424 . . . . 74.12 110.255 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 24.3 t -77.03 150.62 35.78 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 108.651 -0.87 . . . . 63.34 108.651 178.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 434' ' ' THR . . . . . 0.516 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 25.1 p -67.09 -23.41 65.84 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 121.578 0.704 . . . . 73.21 111.807 -176.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 2.5 pp -86.69 -11.26 51.75 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 113.046 0.758 . . . . 73.11 113.046 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -113.9 69.53 0.71 Allowed 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 114.049 1.129 . . . . 73.23 114.049 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 437' ' ' TYR . . . . . 0.403 ' O ' HG23 ' A' ' 441' ' ' VAL . 64.9 t80 -61.91 -37.55 85.05 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.211 -0.45 . . . . 75.02 110.261 175.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -58.83 -37.22 75.95 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 120.707 0.289 . . . . 73.54 111.025 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -66.68 -36.78 83.35 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.712 -0.847 . . . . 72.2 108.712 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.416 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -63.55 -43.61 96.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.873 -0.603 . . . . 35.42 109.672 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 441' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 437' ' ' TYR . 86.6 t -58.73 -50.43 79.27 Favored 'Isoleucine or valine' 0 C--O 1.244 0.773 0 CA-C-N 115.532 -0.758 . . . . 63.34 110.764 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . 0.342 0.0 OUTLIER -68.63 -34.08 75.12 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 113.945 1.091 . . . . 52.33 113.945 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -62.91 -47.5 83.02 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.778 0.323 . . . . 71.52 110.898 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.416 HD13 ' O ' ' A' ' 440' ' ' ALA . 9.1 mp -65.5 -32.84 74.66 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.156 -0.475 . . . . 70.15 111.846 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.403 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 70.8 m -69.25 -46.77 66.5 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.913 0.387 . . . . 54.13 110.505 179.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.14 -15.49 62.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.146 0.498 . . . . 51.54 111.244 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.63 -1.4 37.92 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 116.007 -0.542 . . . . 43.31 111.2 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 114.58 -83.95 0.35 Allowed Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.807 -0.711 . . . . 45.15 111.584 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -40.68 -62.43 0.79 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 114.596 1.332 . . . . 75.25 114.596 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 450' ' ' GLY . . . . . 0.403 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 67.61 29.46 73.96 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.941 -0.647 . . . . 45.12 112.356 -177.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 31.7 mmm180 -105.54 111.44 24.15 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-O 121.507 0.67 . . . . 75.03 109.263 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -130.99 159.97 35.92 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 108.254 -1.017 . . . . 73.5 108.254 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -152.16 135.94 16.28 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 108.128 -1.064 . . . . 73.33 108.128 177.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -103.22 128.06 50.34 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.1 0.476 . . . . 65.51 109.964 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.37 149.08 42.9 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 107.364 -1.347 . . . . 70.34 107.364 174.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -125.53 138.8 53.98 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.142 0.496 . . . . 64.34 109.942 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 457' ' ' SER . . . . . 0.498 ' HB2' HD11 ' A' ' 487' ' ' ILE . 48.5 t -128.37 142.38 44.5 Favored Pre-proline 0 C--N 1.291 -1.943 0 N-CA-C 108.019 -1.104 . . . . 74.41 108.019 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.656 ' HA ' ' O ' ' A' ' 490' ' ' SER . 58.1 Cg_endo -76.27 122.56 6.67 Favored 'Trans proline' 0 N--CA 1.428 -2.361 0 C-N-CA 121.204 1.27 . . . . 74.33 109.691 176.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 48.8 m -144.69 179.21 7.44 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 108.887 -0.783 . . . . 55.03 108.887 -177.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 9.7 t -49.93 134.34 21.51 Favored Pre-proline 0 C--O 1.255 1.386 0 O-C-N 123.982 0.802 . . . . 71.34 111.902 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 461' ' ' PRO . . . . . 0.462 ' HA ' ' CG2' ' A' ' 464' ' ' VAL . 6.2 Cg_endo -50.93 -29.93 28.8 Favored 'Trans proline' 0 C--N 1.361 1.193 0 C-N-CA 124.187 3.258 . . . . 71.44 113.935 -175.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -66.44 -21.38 66.2 Favored 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 113.217 0.821 . . . . 42.04 113.217 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -100.24 -7.23 24.89 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 122.005 -0.435 . . . . 72.05 111.566 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.462 ' CG2' ' HA ' ' A' ' 461' ' ' PRO . 82.4 t -60.84 131.37 25.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 116.165 -0.471 . . . . 72.12 111.757 -178.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 96.26 -10.64 67.47 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.779 -0.646 . . . . 63.45 112.145 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -118.73 166.16 13.11 Favored 'General case' 0 N--CA 1.416 -2.149 0 N-CA-C 109.075 -0.713 . . . . 71.22 109.075 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.516 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 68.9 t -77.8 145.31 10.11 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 108.635 -0.876 . . . . 72.24 108.635 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 51.5 mt -97.74 -25.77 4.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 107.202 -1.407 . . . . 53.2 107.202 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 154.42 -167.73 32.51 Favored Glycine 0 N--CA 1.419 -2.444 0 CA-C-N 114.868 -1.06 . . . . 75.34 111.304 175.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.22 137.17 52.32 Favored 'General case' 0 N--CA 1.405 -2.688 0 N-CA-C 105.482 -2.044 . . . . 42.13 105.482 176.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -66.14 -53.31 33.52 Favored Pre-proline 0 C--N 1.323 -0.584 0 C-N-CA 119.388 -0.925 . . . . 72.33 110.772 -177.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -68.98 124.72 11.7 Favored 'Trans proline' 0 C--N 1.364 1.394 0 N-CA-C 107.24 -1.869 . . . . 62.52 107.24 167.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.481 ' C ' ' H ' ' A' ' 475' ' ' ASN . 19.8 Cg_exo -62.34 145.47 95.89 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.928 1.752 . . . . 75.24 113.271 -174.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.526 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -69.05 11.31 0.21 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.237 1.015 . . . . 72.43 111.28 175.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 475' ' ' ASN . . . . . 0.481 ' H ' ' C ' ' A' ' 473' ' ' PRO . 12.9 m120 -108.62 -10.87 15.17 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 124.204 1.002 . . . . 63.34 108.623 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -98.49 171.12 8.36 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 121.485 0.659 . . . . 73.34 111.36 -176.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.02 129.71 51.65 Favored 'General case' 0 N--CA 1.402 -2.846 0 CA-C-N 114.664 -1.153 . . . . 72.02 111.721 -176.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 6.2 p -108.27 148.17 30.39 Favored 'General case' 0 N--CA 1.418 -2.059 0 C-N-CA 123.903 0.881 . . . . 54.34 110.038 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.434 ' H ' ' HB2' ' A' ' 482' ' ' ASN . . . -89.28 175.25 7.42 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 116.369 -0.378 . . . . 72.4 110.148 176.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 32.9 mm -81.15 -6.67 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-O 122.197 0.999 . . . . 54.43 109.871 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 40.1 m -112.76 5.04 17.39 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 122.238 1.018 . . . . 54.21 109.061 175.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 482' ' ' ASN . . . . . 0.434 ' HB2' ' H ' ' A' ' 479' ' ' ALA . 23.3 t-20 -80.69 134.49 35.86 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.597 -0.729 . . . . 63.33 111.514 -173.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.92 126.03 53.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 116.039 -0.528 . . . . 75.15 110.362 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 65.2 t -100.66 120.61 50.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 121.014 0.435 . . . . 73.41 110.093 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.62 118.96 44.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-O 121.828 0.823 . . . . 62.22 110.022 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 42.7 mt -111.3 128.64 67.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 114.534 -1.212 . . . . 74.3 109.976 -178.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.498 HD11 ' HB2' ' A' ' 457' ' ' SER . 17.3 tt -110.84 127.08 68.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.839 -0.619 . . . . 74.25 111.96 -173.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.499 HG12 HG22 ' A' ' 467' ' ' VAL . 35.5 m -108.32 152.35 10.21 Favored 'Isoleucine or valine' 0 C--O 1.248 1.023 0 C-N-CA 123.806 0.842 . . . . 75.31 111.156 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -88.1 133.5 11.85 Favored Glycine 0 N--CA 1.434 -1.44 0 CA-C-N 115.831 -0.622 . . . . 14.52 112.223 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.656 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 44.4 m . . . . . 0 C--N 1.303 -1.454 0 N-CA-C 107.344 -1.354 . . . . 54.43 107.344 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo . . . . . 0 N--CA 1.444 -1.41 0 CA-C-O 121.981 0.742 . . . . 71.32 113.735 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -104.02 41.5 1.29 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.447 -1.316 . . . . 41.34 107.447 176.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 546' ' ' PRO . 72.7 p -117.24 153.77 32.33 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 114.34 -1.3 . . . . 64.14 108.945 -176.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 495' ' ' LYS . . . . . 0.504 ' HD3' ' H ' ' A' ' 496' ' ' ASP . 6.0 tmtt? -150.16 151.65 33.44 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 107.47 -1.307 . . . . 63.15 107.47 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.504 ' H ' ' HD3' ' A' ' 495' ' ' LYS . 9.8 p-10 -79.83 138.08 37.12 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 123.587 0.755 . . . . 62.43 109.489 177.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 36.4 pt -86.39 137.41 34.56 Favored Pre-proline 0 C--N 1.303 -1.418 0 CA-C-N 116.182 -0.463 . . . . 70.45 110.792 178.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -89.15 179.9 2.23 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.656 2.237 . . . . 75.51 112.339 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -84.38 142.05 30.43 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.832 -1.173 . . . . 73.14 107.832 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 10.6 p -139.32 19.23 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 CA-C-O 122.179 0.99 . . . . 61.15 110.052 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -72.41 114.52 10.62 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.199 -0.91 . . . . 43.14 110.893 -177.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 115.3 -8.12 20.67 Favored Glycine 0 CA--C 1.482 -1.973 0 N-CA-C 111.311 -0.716 . . . . 65.2 111.311 176.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -100.47 165.75 11.28 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 108.199 -1.037 . . . . 65.04 108.199 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 5.6 t -91.73 164.73 13.61 Favored 'General case' 0 C--N 1.285 -2.239 0 C-N-CA 120.217 -0.593 . . . . 65.1 109.889 -175.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 48.4 t -54.27 -41.26 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.606 0.762 . . . . 61.04 110.976 -177.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -57.68 -42.6 83.94 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 115.506 -0.77 . . . . 74.54 111.12 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 63.8 t -75.35 -42.54 43.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 116.028 -0.533 . . . . 73.14 109.738 -178.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -61.26 -49.69 76.05 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.71 -0.677 . . . . 62.44 111.853 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 513' ' ' ASN . 63.9 tt0 -65.35 -37.03 85.82 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.374 0.607 . . . . 63.31 110.04 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.491 ' O ' HG23 ' A' ' 514' ' ' VAL . 37.6 ttmt -65.93 -48.79 70.2 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.82 -1.082 . . . . 70.34 111.696 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -62.03 -48.58 79.66 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 121.149 0.5 . . . . 73.24 110.924 -177.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 512' ' ' LEU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 517' ' ' PHE . 4.2 mm? -64.9 -36.54 84.7 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.578 -0.737 . . . . 74.15 110.885 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 513' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 509' ' ' GLN . 0.6 OUTLIER -60.92 -39.86 90.97 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 122.564 0.346 . . . . 75.1 110.553 178.378 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 510' ' ' LYS . 78.4 t -59.37 -36.65 65.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.645 -0.707 . . . . 73.5 110.758 178.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -79.58 -21.55 44.89 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.105 0.479 . . . . 73.24 110.639 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 127.5 -2.78 7.1 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 120.524 -0.846 . . . . 63.42 113.902 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.582 ' HA ' ' O ' ' A' ' 547' ' ' VAL . 95.1 m-85 -82.8 117.25 22.56 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.738 -1.208 . . . . 72.34 107.738 -176.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.6 m -118.8 -4.24 10.72 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 118.823 -1.151 . . . . 74.15 112.375 -174.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 519' ' ' LYS . . . . . 0.423 ' HB3' HG22 ' A' ' 550' ' ' VAL . 64.3 mttp -112.26 115.21 28.42 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.637 -0.664 . . . . 65.31 110.82 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -126.25 154.37 43.45 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.256 -0.429 . . . . 73.21 110.909 -174.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 49.2 m -141.45 141.11 33.7 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.414 -1.328 . . . . 61.05 107.414 171.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -117.57 138.22 52.07 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-O 121.016 0.436 . . . . 71.35 110.94 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -124.39 116.77 23.11 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.038 -1.097 . . . . 63.52 108.038 176.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 524' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 19.7 m -97.82 136.03 38.73 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.601 0.238 . . . . 40.13 111.326 -176.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 61.5 t -129.47 148.87 33.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 107.031 -1.47 . . . . 53.22 107.031 177.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 526' ' ' ASP . . . . . 0.412 ' HB2' ' HB2' ' A' ' 559' ' ' ASN . 0.4 OUTLIER -78.38 136.63 37.71 Favored 'General case' 0 C--O 1.248 0.975 0 N-CA-C 108.727 -0.842 . . . . 72.53 108.727 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 527' ' ' SER . . . . . 0.409 ' OG ' ' HB2' ' A' ' 556' ' ' SER . 77.6 p -153.33 179.56 1.26 Allowed Pre-proline 0 C--N 1.294 -1.819 0 N-CA-C 107.871 -1.159 . . . . 74.13 107.871 -176.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -85.09 -0.7 9.19 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 121.69 1.594 . . . . 64.13 111.367 172.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.427 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 12.7 mtp180 -88.39 139.74 30.14 Favored Pre-proline 0 N--CA 1.432 -1.345 0 N-CA-C 108.096 -1.075 . . . . 72.1 108.096 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.27 153.95 31.26 Favored 'Trans proline' 0 C--O 1.254 1.309 0 C-N-CA 123.304 2.669 . . . . 70.34 113.949 -176.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.634 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -74.75 116.29 15.29 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.347 -0.842 . . . . 71.21 110.527 -176.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 118.88 -7.42 13.15 Favored Glycine 0 CA--C 1.49 -1.481 0 C-N-CA 120.049 -1.072 . . . . 45.33 111.203 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -83.67 140.46 32.14 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 108.321 -0.992 . . . . 73.33 108.321 174.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 60.9 t -88.45 118.29 33.68 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 N-CA-C 108.063 -1.088 . . . . 74.22 108.063 178.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 535' ' ' THR . . . . . 0.481 ' OG1' ' HB3' ' A' ' 556' ' ' SER . 90.5 m -78.19 -24.2 47.26 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.776 -1.102 . . . . 71.44 109.802 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 153.54 -164.75 31.22 Favored Glycine 0 N--CA 1.424 -2.132 0 N-CA-C 110.435 -1.066 . . . . 44.31 110.435 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 18.0 p -117.71 159.29 23.22 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 109.327 -0.62 . . . . 62.12 109.327 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -63.11 -57.49 20.67 Favored Pre-proline 0 C--N 1.315 -0.924 0 O-C-N 123.625 0.578 . . . . 53.24 110.328 177.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -73.23 133.01 18.73 Favored 'Trans proline' 0 C--N 1.363 1.319 0 N-CA-C 109.136 -1.14 . . . . 73.24 109.136 171.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.14 156.73 48.48 Favored 'Trans proline' 0 C--O 1.252 1.203 0 C-N-CA 122.492 2.128 . . . . 32.11 112.354 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -57.31 140.52 49.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.786 -0.643 . . . . 73.54 110.97 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.26 -16.38 56.94 Favored Glycine 0 N--CA 1.433 -1.528 0 CA-C-N 115.708 -0.678 . . . . 73.33 111.687 -178.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 99.7 m -65.28 123.93 20.86 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.071 0.462 . . . . 64.11 110.436 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 54.1 m -88.41 123.47 32.99 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 115.466 -0.788 . . . . 74.1 109.674 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 31.2 m -137.85 154.81 74.86 Favored Pre-proline 0 C--N 1.312 -1.053 0 N-CA-C 108.288 -1.004 . . . . 51.33 108.288 177.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' A' ' 494' ' ' THR . 52.6 Cg_exo -60.76 142.56 98.09 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.293 1.996 . . . . 74.23 110.863 173.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 517' ' ' PHE . 27.2 m -62.27 -20.45 24.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.799 0.809 . . . . 74.01 111.815 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 548' ' ' ASP . . . . . 0.402 ' O ' ' HD2' ' A' ' 519' ' ' LYS . 26.8 t70 -90.26 -5.59 56.15 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.38 -0.827 . . . . 64.14 111.713 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 72.1 m -83.35 166.01 18.81 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 121.751 -0.593 . . . . 74.21 111.567 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.423 HG22 ' HB3' ' A' ' 519' ' ' LYS . 21.5 t -92.67 129.54 43.08 Favored 'Isoleucine or valine' 0 C--O 1.254 1.294 0 CA-C-N 115.671 -0.695 . . . . 62.13 110.452 -176.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 551' ' ' ILE . . . . . 0.456 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -111.55 134.99 52.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.176 0.512 . . . . 74.45 110.256 174.383 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -102.98 121.11 41.86 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.566 -0.743 . . . . 74.51 109.885 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.2 mp -104.36 134.08 48.18 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.189 -0.914 . . . . 70.11 110.355 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -90.83 123.99 34.8 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.646 -0.872 . . . . 72.24 108.646 174.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 524' ' ' SER . 64.1 t -109.53 129.15 64.85 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 N-CA-C 108.509 -0.923 . . . . 70.42 108.509 -177.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.634 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 24.4 p -77.07 140.98 40.45 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-O 121.481 0.658 . . . . 75.34 112.183 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -104.3 131.92 51.11 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 107.057 -1.46 . . . . 75.12 107.057 168.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 558' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -69.5 -30.22 71.22 Favored Glycine 0 CA--C 1.489 -1.546 0 O-C-N 123.805 0.691 . . . . 65.22 111.515 -177.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 559' ' ' ASN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 526' ' ' ASP . 63.2 t30 70.28 9.43 6.99 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.581 1.152 . . . . 74.25 110.423 174.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.448 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 96.3 mt-30 -121.99 145.14 48.41 Favored 'General case' 0 N--CA 1.412 -2.375 0 CA-C-N 114.773 -1.103 . . . . 71.44 110.482 -178.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -123.27 147.96 46.41 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.371 -0.974 . . . . 74.43 108.371 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 59.0 t -69.74 121.2 18.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-O 121.08 0.467 . . . . 73.42 112.163 -173.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 563' ' ' MET . . . . . 0.421 ' HA ' ' HD3' ' A' ' 564' ' ' PRO . 53.7 ttp -97.88 132.01 25.64 Favored Pre-proline 0 C--O 1.25 1.102 0 CA-C-N 115.812 -0.631 . . . . 61.15 110.944 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 564' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 563' ' ' MET . 30.7 Cg_exo -65.52 170.63 10.73 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 123.306 2.671 . . . . 75.33 111.764 173.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -72.34 132.44 43.99 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.429 0.633 . . . . 74.35 110.823 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 94.9 mt -120.62 -4.64 9.77 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.157 -0.929 . . . . 53.1 108.597 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 38.3 t -79.11 149.39 32.08 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.783 -1.099 . . . . 74.0 109.829 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 72.88 39.97 53.39 Favored Glycine 0 C--O 1.221 -0.714 0 C-N-CA 120.894 -0.67 . . . . 73.02 111.64 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 89.3 mtp -146.06 158.11 43.87 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.337 -1.727 . . . . 74.33 106.337 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 570' ' ' PHE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 96.6 m-85 -84.48 155.95 21.94 Favored 'General case' 0 N--CA 1.424 -1.741 0 C-N-CA 120.019 -0.673 . . . . 72.32 109.506 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 55.4 t90 -65.91 -22.87 66.53 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.148 0.499 . . . . 73.33 109.735 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 33.7 m -72.75 -12.06 15.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.803 -0.635 . . . . 53.14 110.697 177.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 573' ' ' ASP . . . . . 0.477 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 41.8 m-20 -101.48 -39.72 7.4 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 108.401 -0.963 . . . . 74.15 108.401 175.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -60.31 -40.72 91.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.436 -0.802 . . . . 72.35 111.503 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.485 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 1.2 tm-20 -57.32 -59.03 14.06 Favored Pre-proline 0 CA--C 1.578 2.052 0 C-N-CA 123.308 0.643 . . . . 54.55 110.477 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.33 -29.89 86.68 Favored 'Trans proline' 0 C--N 1.373 1.86 0 CA-C-N 120.912 1.362 . . . . 74.35 113.159 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 16.3 mmt180 -65.82 -43.32 88.95 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 121.103 -0.239 . . . . 72.25 110.808 177.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.4 pp -66.1 -38.03 87.23 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.046 0.451 . . . . 42.32 110.311 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -65.33 -35.29 80.54 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 115.863 -0.608 . . . . 71.34 110.794 175.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.55 -25.52 64.96 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 122.719 0.407 . . . . 44.0 110.928 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 89.9 mt -92.29 -8.17 45.94 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.85 -0.614 . . . . 64.24 110.503 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 65.4 41.95 96.21 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 110.71 -0.956 . . . . 45.03 110.71 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 74.2 t90 -77.51 136.63 38.34 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.296 0.57 . . . . 74.4 112.083 -175.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 81.7 m -151.79 99.53 2.59 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.526 -0.916 . . . . 74.22 108.526 173.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -140.26 -119.52 1.63 Allowed Glycine 0 N--CA 1.433 -1.507 0 N-CA-C 109.939 -1.264 . . . . 73.1 109.939 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -130.62 124.52 31.9 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.054 -0.721 . . . . 75.22 109.054 176.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -108.13 128.86 55.07 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 105.97 -1.863 . . . . 73.13 105.97 177.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -104.27 115.41 30.34 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.54 -0.911 . . . . 61.33 108.54 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -87.76 125.2 34.29 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 116.168 -0.469 . . . . 52.34 110.114 -176.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -103.9 173.9 22.04 Favored Glycine 0 N--CA 1.426 -2.008 0 N-CA-C 110.186 -1.166 . . . . 72.11 110.186 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -87.38 154.78 20.4 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.804 -0.443 . . . . 61.33 109.804 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 592' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' A' ' 625' ' ' GLY . 4.3 p-10 -69.59 124.8 24.88 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.261 0.553 . . . . 64.5 109.557 178.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 95.3 t -129.04 115.73 37.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.812 -0.81 . . . . 43.33 108.812 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 594' ' ' ASP . . . . . 0.402 ' HA ' ' HB2' ' A' ' 626' ' ' GLN . 4.3 p-10 -84.48 118.82 24.54 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.349 -0.982 . . . . 52.42 108.349 178.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 595' ' ' ALA . . . . . 0.437 ' HB3' ' HG3' ' A' ' 599' ' ' GLN . . . -142.8 9.0 1.73 Allowed 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.941 -0.704 . . . . 72.51 112.004 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 125.49 -176.71 17.22 Favored Glycine 0 N--CA 1.435 -1.375 0 C-N-CA 120.152 -1.023 . . . . 74.1 111.955 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -63.44 -40.48 98.88 Favored Glycine 0 N--CA 1.45 -0.393 0 O-C-N 124.215 0.597 . . . . 63.45 113.066 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 23.8 m -63.18 -23.87 67.63 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 122.895 0.478 . . . . 74.53 111.628 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 599' ' ' GLN . . . . . 0.437 ' HG3' ' HB3' ' A' ' 595' ' ' ALA . 82.4 mm-40 -105.08 -1.64 25.35 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 111.979 0.363 . . . . 74.02 111.979 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -84.81 109.96 18.47 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 119.861 -0.736 . . . . 74.35 110.621 -176.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 57.01 0.27 0.07 Allowed 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 126.805 2.042 . . . . 73.33 114.973 176.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 602' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 8.2 ptm180 -108.08 157.22 18.45 Favored 'General case' 0 C--N 1.289 -2.036 0 O-C-N 120.812 -1.18 . . . . 74.4 113.871 -173.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 603' ' ' VAL . . . . . 0.415 HG13 ' HB2' ' A' ' 622' ' ' LEU . 66.5 t -69.11 130.77 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 113.908 -1.497 . . . . 73.45 108.502 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 604' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 623' ' ' ARG . 46.5 t -84.31 -50.09 15.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 121.49 0.662 . . . . 71.34 109.669 -176.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -154.6 164.15 39.15 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 106.129 -1.804 . . . . 70.4 106.129 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -115.05 128.6 56.35 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 107.289 -1.374 . . . . 63.54 107.289 174.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.583 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 16.6 t-20 -48.25 -58.17 8.72 Favored Pre-proline 0 N--CA 1.48 1.025 0 O-C-N 123.798 0.686 . . . . 65.31 112.475 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.583 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 2.8 Cg_endo -86.34 120.87 1.88 Allowed 'Trans proline' 0 N--CA 1.442 -1.534 0 N-CA-C 108.097 -1.54 . . . . 75.12 108.097 169.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -63.31 160.27 35.85 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.371 2.047 . . . . 74.12 113.132 -177.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -57.85 127.28 31.29 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.437 -0.801 . . . . 72.44 111.055 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 91.95 -1.29 74.11 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.321 -0.942 . . . . 74.11 112.118 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 24.7 m -99.15 160.58 14.17 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.459 -0.941 . . . . 62.32 108.459 178.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -87.64 143.17 18.3 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 121.494 -0.384 . . . . 65.3 114.047 -175.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 614' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 27.8 m -113.81 142.55 25.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 C-N-CA 124.004 0.922 . . . . 63.32 109.42 176.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.408 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 29.7 p-10 -58.89 176.26 0.22 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.731 1.011 . . . . 73.55 113.731 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -60.92 -25.86 67.06 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.96 -0.564 . . . . 73.22 112.421 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.31 -33.67 65.29 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.698 -0.853 . . . . 70.42 108.698 174.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 79.51 21.93 65.76 Favored Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 110.428 -1.069 . . . . 63.14 110.428 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.16 119.5 15.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 122.319 1.057 . . . . 72.0 111.29 -168.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 2.8 tp -116.56 126.5 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 CA-C-N 113.582 -1.645 . . . . 64.41 109.561 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.532 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 93.8 m -100.98 118.79 37.69 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 108.851 -0.796 . . . . 72.32 108.851 173.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 622' ' ' LEU . . . . . 0.415 ' HB2' HG13 ' A' ' 603' ' ' VAL . 1.6 pt? -132.74 151.85 51.89 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 107.605 -1.257 . . . . 55.3 107.605 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 623' ' ' ARG . . . . . 0.407 ' O ' HG23 ' A' ' 604' ' ' VAL . 13.6 tpt180 -131.51 141.76 49.82 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 109.1 -0.704 . . . . 72.23 109.1 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -127.97 143.4 51.09 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 106.793 -1.558 . . . . 60.33 106.793 172.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 625' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 592' ' ' ASP . . . -85.87 -89.81 0.92 Allowed Glycine 0 N--CA 1.436 -1.319 0 C-N-CA 120.639 -0.791 . . . . 70.43 112.394 -176.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 626' ' ' GLN . . . . . 0.402 ' HB2' ' HA ' ' A' ' 594' ' ' ASP . 8.5 tp-100 . . . . . 0 C--N 1.309 -1.177 0 CA-C-O 118.866 -0.588 . . . . 62.01 110.554 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 121.168 0.508 . . . . 53.03 110.39 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 30.2 m -137.56 162.98 31.85 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 107.671 -1.233 . . . . 54.42 107.671 178.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -94.09 139.37 31.06 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 106.067 -1.827 . . . . 75.23 106.067 175.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.528 HG22 ' CZ ' ' A' ' 382' ' ' PHE . 90.6 t -93.48 128.82 40.83 Favored Pre-proline 0 C--N 1.281 -2.389 0 N-CA-C 108.28 -1.007 . . . . 73.44 108.28 -168.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 363' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 13.6 Cg_exo -61.09 120.59 8.37 Favored 'Trans proline' 0 C--N 1.361 1.204 0 C-N-CA 122.468 2.112 . . . . 55.12 112.304 -174.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -87.71 84.36 7.08 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 114.571 -1.195 . . . . 75.2 108.053 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 28.2 m -92.09 16.03 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.078 -0.964 . . . . 72.33 112.707 -174.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . 0.296 0.2 OUTLIER -65.29 148.38 51.79 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.926 -0.579 . . . . 74.2 112.546 176.705 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 106.4 -1.78 37.2 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 110.125 -1.19 . . . . 63.11 110.125 -170.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -109.27 -158.93 0.66 Allowed 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 107.588 -1.264 . . . . 71.31 107.588 173.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 369' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 65.4 p -90.52 160.56 15.91 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 109.94 -0.393 . . . . 73.14 109.94 -175.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 27.1 p -56.13 -46.47 79.18 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 123.556 0.535 . . . . 63.05 110.451 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.31 -46.27 84.31 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 115.843 -0.617 . . . . 43.43 112.291 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -66.67 -44.1 82.74 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 120.153 -0.619 . . . . 65.04 110.471 -178.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -63.17 -48.6 77.72 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.519 -0.764 . . . . 73.13 111.771 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 90.1 mt -65.83 -42.23 91.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 CA-C-N 116.547 -0.297 . . . . 74.43 110.301 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.79 -43.33 94.46 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.417 -0.356 . . . . 74.31 111.189 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 33.8 m -63.0 -47.51 82.8 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.026 -0.534 . . . . 70.35 111.457 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 11.1 mp -64.59 -41.64 96.12 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.137 -0.225 . . . . 72.41 111.545 178.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -63.62 -38.72 92.19 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.301 -0.409 . . . . 74.34 110.186 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -64.97 -30.81 71.82 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.894 0.378 . . . . 62.44 111.155 176.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -81.72 -8.66 59.72 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.131 -0.486 . . . . 71.51 110.826 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 99.49 0.18 56.79 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.603 -0.808 . . . . 72.34 112.491 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.528 ' CZ ' HG22 ' A' ' 362' ' ' VAL . 62.7 m-85 -78.26 147.67 34.24 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 109.124 -0.695 . . . . 74.0 109.124 178.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.527 ' HB2' ' HG2' ' A' ' 415' ' ' GLU . 40.9 mmtm -100.35 144.53 29.24 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.497 -1.668 . . . . 75.32 106.497 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 384' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 1.5 mp -129.0 140.46 49.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 108.353 -0.981 . . . . 74.23 108.353 -179.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -109.85 128.05 55.08 Favored 'General case' 0 C--N 1.264 -3.113 0 N-CA-C 104.893 -2.262 . . . . 72.55 104.893 175.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 19.3 m -115.26 127.86 55.76 Favored 'General case' 0 C--N 1.257 -3.446 0 N-CA-C 108.095 -1.076 . . . . 71.24 108.095 -175.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.87 120.83 43.27 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.67 -1.233 . . . . 63.12 107.67 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -95.89 132.82 40.77 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.823 -0.436 . . . . 54.24 109.823 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 389' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 421' ' ' SER . 93.3 mttt -136.04 134.24 20.22 Favored Pre-proline 0 C--N 1.297 -1.703 0 N-CA-C 108.39 -0.967 . . . . 71.03 108.39 173.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 390' ' ' PRO . . . . . 0.515 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 29.5 Cg_endo -91.51 127.31 1.07 Allowed 'Trans proline' 0 C--O 1.251 1.146 0 C-N-CA 121.296 1.331 . . . . 53.34 111.259 175.065 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.515 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 12.2 t70 150.97 -164.92 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 103.203 -2.888 . . . . 74.1 103.203 -177.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 13.1 t -141.83 2.91 1.6 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 119.369 0.986 . . . . 72.23 110.539 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 11.5 t -87.74 -7.74 56.95 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.265 1.031 . . . . 63.14 109.787 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.569 HD13 ' H ' ' A' ' 394' ' ' ILE . 0.2 OUTLIER -109.25 151.81 42.25 Favored Pre-proline 0 N--CA 1.417 -2.088 0 N-CA-C 106.737 -1.579 . . . . 61.31 106.737 178.414 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 395' ' ' PRO . . . . . 0.434 ' HA ' ' HD2' ' A' ' 396' ' ' PRO . 1.1 Cg_exo -22.92 113.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.087 1 C-N-CA 125.739 4.293 . . . . 73.45 115.736 -179.064 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 396' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 395' ' ' PRO . 28.9 Cg_endo -61.63 164.09 16.71 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 124.252 3.301 . . . . 74.32 112.605 -178.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 397' ' ' ASP . . . . . 0.499 ' HA ' ' CG2' ' A' ' 420' ' ' VAL . 31.4 t70 -56.53 -9.23 0.68 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 122.504 1.145 . . . . 54.11 111.937 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 64.1 m170 -103.96 111.33 23.84 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 103.5 -2.778 . . . . 64.5 103.5 168.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 27.4 m -63.14 119.49 7.3 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 O-C-N 124.403 1.065 . . . . 72.43 112.425 -168.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 9.1 tp -91.19 -29.14 4.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-N 115.515 -0.766 . . . . 71.33 110.443 -176.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.93 162.37 28.32 Favored Glycine 0 N--CA 1.42 -2.375 0 C-N-CA 119.533 -1.318 . . . . 63.51 113.554 -174.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 10.6 p -132.36 -175.7 3.84 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 125.7 1.6 . . . . 62.21 109.116 -177.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -101.37 134.3 20.37 Favored Pre-proline 0 C--N 1.293 -1.879 0 N-CA-C 107.28 -1.378 . . . . 62.52 107.28 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -47.03 -24.95 3.62 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 124.412 3.408 . . . . 54.21 115.122 -177.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.51 -28.23 68.23 Favored 'General case' 0 C--O 1.209 -1.067 0 CA-C-N 116.27 -0.423 . . . . 54.05 111.327 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -73.99 -32.54 63.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.825 0.821 . . . . 71.02 110.014 178.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -87.27 -2.15 58.41 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.522 -0.763 . . . . 73.44 109.498 -178.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 24.9 m -102.18 151.85 21.71 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.44 -1.689 . . . . 73.42 106.44 173.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 46.2 m -79.92 112.41 17.18 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 119.125 -1.03 . . . . 54.5 109.306 176.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.8 m -121.36 168.67 13.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 116.371 -0.377 . . . . 71.11 110.124 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 57.1 m -61.88 133.17 55.11 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.245 0.545 . . . . 72.02 110.936 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -61.77 112.44 2.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.316 -0.856 . . . . 72.12 112.754 -174.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 119.55 6.5 10.46 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.602 -0.808 . . . . 65.23 113.383 177.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -69.49 179.19 2.16 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 122.442 0.297 . . . . 73.21 111.233 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 415' ' ' GLU . . . . . 0.527 ' HG2' ' HB2' ' A' ' 383' ' ' LYS . 40.2 mt-10 -106.49 122.8 47.02 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 122.848 0.459 . . . . 71.2 110.569 -174.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 416' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 49.2 mm -112.41 130.6 65.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 108.78 -0.822 . . . . 74.03 108.78 178.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 81.4 m -96.95 132.35 42.83 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.116 0.484 . . . . 52.31 111.003 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 5.6 p -122.86 134.59 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 CA-C-N 115.78 -0.646 . . . . 63.21 109.762 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -95.59 129.23 42.85 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.982 -0.747 . . . . 73.1 108.982 174.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.499 ' CG2' ' HA ' ' A' ' 397' ' ' ASP . 8.6 p -138.7 141.51 36.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 109.617 -0.512 . . . . 75.53 109.617 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 421' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 11.5 p -100.15 121.97 42.26 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-O 121.699 0.761 . . . . 65.11 112.184 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 9.3 t -121.44 121.33 37.33 Favored 'General case' 0 N--CA 1.41 -2.449 0 N-CA-C 108.001 -1.111 . . . . 72.22 108.001 170.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.588 0 C-N-CA 119.701 -1.238 . . . . 62.21 112.597 177.971 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 . . . . . 0 N--CA 1.442 -0.854 0 N-CA-C 108.727 -0.842 . . . . 73.35 108.727 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 447' ' ' ALA . 3.9 mmp_? -122.39 152.99 39.64 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.747 0.308 . . . . 74.51 111.162 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -91.02 139.04 31.14 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 115.759 -0.655 . . . . 54.15 110.642 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 50.4 mt -86.04 126.3 65.82 Favored Pre-proline 0 N--CA 1.421 -1.887 0 N-CA-C 106.914 -1.513 . . . . 71.4 106.914 176.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -73.12 141.43 32.64 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.174 1.916 . . . . 62.44 110.537 169.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -80.91 116.15 20.74 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.828 -1.175 . . . . 72.25 107.828 173.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.443 HG12 ' HB ' ' A' ' 436' ' ' THR . 61.4 t -107.34 154.17 8.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 108.035 -1.098 . . . . 74.14 108.035 -175.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.512 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 19.6 m -67.13 152.35 45.91 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 120.818 0.342 . . . . 63.33 110.805 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 35.5 p -67.28 -27.93 67.6 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 113.979 1.103 . . . . 63.34 113.979 -172.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 2.4 pp -88.38 -10.34 49.65 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.719 0.771 . . . . 73.41 111.439 176.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.512 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 1.6 m -96.84 37.0 1.33 Allowed 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.428 0.632 . . . . 74.33 110.35 -175.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -52.76 -38.78 61.5 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.705 0.802 . . . . 72.21 112.56 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.33 -40.31 93.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.932 0.396 . . . . 71.52 111.33 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.406 ' HB3' HG22 ' A' ' 436' ' ' THR . 29.3 tp10 -70.84 -34.53 71.77 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.523 -0.547 . . . . 75.15 109.523 176.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.52 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.02 -50.98 71.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.594 -0.276 . . . . 64.1 111.218 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.1 m -60.71 -37.34 75.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 121.301 0.572 . . . . 71.1 110.634 177.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -60.37 -47.66 85.1 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.257 -0.883 . . . . 62.33 110.81 175.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -65.02 -39.5 93.48 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.817 0.341 . . . . 71.54 111.609 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.52 HD13 ' O ' ' A' ' 440' ' ' ALA . 6.2 mp -65.21 -36.19 83.4 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.968 -0.56 . . . . 70.3 110.999 177.152 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 65.8 m -70.18 -42.7 72.09 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-O 120.825 0.345 . . . . 75.52 110.091 177.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -65.93 -21.87 66.46 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-O 121.438 0.637 . . . . 63.31 110.844 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 447' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 427' ' ' ARG . . . -82.65 5.42 21.18 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.451 -0.795 . . . . 72.42 111.465 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 100.69 -73.68 0.41 Allowed Glycine 0 CA--C 1.501 -0.79 0 C-N-CA 120.408 -0.901 . . . . 74.44 112.525 174.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -43.88 -59.36 2.3 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.955 1.094 . . . . 74.1 113.955 176.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 59.31 29.71 66.49 Favored Glycine 0 C--O 1.224 -0.53 0 C-N-CA 121.24 -0.505 . . . . 74.11 112.652 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -102.59 110.56 22.53 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 108.385 -0.968 . . . . 65.11 108.385 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -140.71 143.05 34.82 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.865 -0.607 . . . . 44.34 111.05 -177.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -131.22 122.95 27.42 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.592 -0.892 . . . . 74.52 108.592 178.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -91.36 128.16 37.08 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.371 -0.603 . . . . 64.31 109.371 176.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -116.74 139.44 50.57 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 106.911 -1.514 . . . . 64.43 106.911 175.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -115.32 130.87 57.03 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.374 -0.973 . . . . 64.42 108.374 -176.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 41.9 t -132.59 140.15 36.92 Favored Pre-proline 0 C--N 1.283 -2.306 0 N-CA-C 108.793 -0.817 . . . . 52.11 108.793 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.711 ' HA ' ' O ' ' A' ' 490' ' ' SER . 49.7 Cg_endo -72.52 121.76 7.7 Favored 'Trans proline' 0 N--CA 1.437 -1.805 0 C-N-CA 121.045 1.163 . . . . 71.23 109.726 174.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 48.8 m -142.69 179.38 7.02 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.661 -0.7 . . . . 71.3 110.55 -173.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 14.1 t -52.12 138.63 36.06 Favored Pre-proline 0 CA--C 1.562 1.412 0 C-N-CA 124.198 0.999 . . . . 61.32 111.274 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.77 -30.0 36.17 Favored 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 124.868 3.712 . . . . 61.22 114.058 -173.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -73.17 -19.84 61.03 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.608 0.596 . . . . 75.23 112.608 -176.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -101.79 -6.83 23.15 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.232 -0.292 . . . . 70.4 111.32 177.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 94.4 t -61.09 128.09 21.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 120.854 0.359 . . . . 63.2 110.341 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.42 -11.85 71.13 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.432 -0.804 . . . . 71.42 111.831 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -110.93 165.36 11.92 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 109.636 -0.505 . . . . 25.52 109.636 -177.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.416 HG22 HG12 ' A' ' 488' ' ' VAL . 80.6 t -76.98 145.3 10.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 107.086 -1.449 . . . . 72.34 107.086 171.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 64.8 mt -97.32 -31.96 3.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 107.031 -1.47 . . . . 71.02 107.031 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 160.39 -178.36 36.45 Favored Glycine 0 N--CA 1.417 -2.625 0 CA-C-N 114.983 -1.008 . . . . 61.43 110.858 175.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 470' ' ' THR . . . . . 0.574 HG22 HG12 ' A' ' 486' ' ' ILE . 54.3 p -114.39 146.44 40.57 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 106.117 -1.809 . . . . 43.11 106.117 175.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -67.19 -54.51 19.28 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 120.054 -0.658 . . . . 55.42 110.675 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -73.15 138.81 28.53 Favored 'Trans proline' 0 C--N 1.368 1.585 0 N-CA-C 107.797 -1.655 . . . . 64.22 107.797 169.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.428 ' HB2' ' HG2' ' A' ' 476' ' ' GLN . 23.0 Cg_exo -62.62 132.28 37.13 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.611 1.541 . . . . 65.03 111.888 -177.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -73.75 16.69 0.2 Allowed 'General case' 0 C--O 1.195 -1.768 0 C-N-CA 124.214 1.006 . . . . 43.41 112.355 -177.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -111.8 -8.87 14.12 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 122.645 0.378 . . . . 65.53 111.2 173.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 476' ' ' GLN . . . . . 0.428 ' HG2' ' HB2' ' A' ' 473' ' ' PRO . 85.2 mm-40 -77.61 171.1 15.45 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 113.606 0.965 . . . . 74.31 113.606 -172.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 1.1 m -105.37 115.53 30.42 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 107.592 -1.262 . . . . 65.41 107.592 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 22.0 m -115.1 142.62 46.4 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 120.613 0.244 . . . . 74.13 110.401 -176.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -71.72 166.57 21.69 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.813 -0.63 . . . . 72.12 110.19 176.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 29.4 mm -70.95 -3.18 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.362 0 CA-C-O 121.821 0.82 . . . . 53.14 111.797 -173.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 14.6 t -112.19 5.29 18.38 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.18 -0.95 . . . . 51.15 110.711 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -79.79 132.66 36.2 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.803 -0.56 . . . . 72.21 111.377 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 46.0 t -106.61 121.7 59.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 108.35 -0.981 . . . . 70.41 108.35 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 28.7 m -104.72 134.62 45.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-O 121.518 0.675 . . . . 73.32 111.929 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.13 125.99 50.02 Favored 'Isoleucine or valine' 0 C--O 1.252 1.195 0 N-CA-C 108.91 -0.774 . . . . 74.51 108.91 178.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.574 HG12 HG22 ' A' ' 470' ' ' THR . 7.9 mt -119.62 127.44 75.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.259 -0.882 . . . . 64.15 109.381 -178.078 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 7.1 tt -108.38 127.14 64.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.07 0.462 . . . . 62.32 111.287 -177.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.416 HG12 HG22 ' A' ' 467' ' ' VAL . 31.9 m -111.23 151.75 13.3 Favored 'Isoleucine or valine' 0 C--O 1.252 1.203 0 CA-C-N 115.849 -0.614 . . . . 72.5 109.933 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.17 133.97 12.2 Favored Glycine 0 N--CA 1.43 -1.702 0 C-N-CA 121.022 -0.609 . . . . 74.0 111.946 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.711 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 33.4 m . . . . . 0 C--N 1.29 -1.982 0 N-CA-C 105.779 -1.934 . . . . 74.42 105.779 176.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo . . . . . 0 N--CA 1.44 -1.633 0 CA-C-O 121.281 0.45 . . . . 74.33 111.63 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -110.6 35.3 3.53 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 122.404 1.097 . . . . 75.33 108.506 177.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 546' ' ' PRO . 17.2 p -117.22 150.06 39.37 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 113.758 -1.564 . . . . 72.42 110.994 -174.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 495' ' ' LYS . . . . . 0.51 ' HA ' ' HE3' ' A' ' 495' ' ' LYS . 0.0 OUTLIER -137.04 164.28 28.75 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.694 -1.224 . . . . 71.12 107.694 175.474 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.7 m-20 -90.36 138.34 31.62 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 109.531 -0.544 . . . . 74.42 109.531 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 497' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 543' ' ' THR . 35.9 pt -95.54 124.54 52.72 Favored Pre-proline 0 C--N 1.306 -1.286 0 C-N-CA 120.787 -0.365 . . . . 45.23 110.754 177.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -89.38 171.14 4.51 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.391 2.061 . . . . 72.04 110.51 174.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -87.87 154.57 20.42 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.386 -0.968 . . . . 70.41 108.386 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.5 p -145.91 104.31 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 108.954 -0.758 . . . . 71.0 108.954 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -140.68 119.85 12.89 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.732 -0.667 . . . . 74.3 110.497 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 122.97 -12.38 8.63 Favored Glycine 0 CA--C 1.486 -1.77 0 C-N-CA 120.119 -1.039 . . . . 60.43 111.779 177.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 503' ' ' GLN . . . . . 0.484 ' O ' HG12 ' A' ' 534' ' ' VAL . 81.9 mt-30 -99.0 171.09 8.26 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.438 -0.949 . . . . 65.15 108.438 176.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 14.5 t -90.15 157.78 17.57 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.358 -0.979 . . . . 72.42 108.358 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 12.4 p -52.78 -41.1 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 113.084 0.772 . . . . 64.25 113.084 -176.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -61.54 -41.87 98.0 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.125 0.488 . . . . 71.0 110.6 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 93.5 t -69.54 -43.38 80.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.441 -0.799 . . . . 73.41 110.196 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -61.31 -49.5 76.75 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.081 -0.508 . . . . 70.02 111.412 -178.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -63.07 -38.09 89.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.042 0.449 . . . . 73.23 111.285 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.462 ' O ' HG23 ' A' ' 514' ' ' VAL . 33.6 ttmt -62.54 -42.29 99.43 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.343 -0.844 . . . . 74.43 109.719 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -62.82 -48.37 79.36 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.056 -0.52 . . . . 72.12 110.79 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.93 -36.54 79.6 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.076 0.399 . . . . 71.42 112.076 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -60.36 -37.43 80.68 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 116.351 -0.386 . . . . 72.31 111.145 176.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 510' ' ' LYS . 94.2 t -61.48 -36.43 73.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.117 -0.492 . . . . 74.43 110.387 177.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -76.46 -15.03 60.0 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.573 -0.285 . . . . 74.41 111.354 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 110.91 -8.65 29.57 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.793 -0.717 . . . . 30.52 112.846 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.461 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 76.2 m-85 -80.06 113.82 18.52 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 108.085 -1.08 . . . . 75.52 108.085 -177.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.4 m -116.71 -8.95 11.37 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 118.548 -1.261 . . . . 71.14 114.113 -171.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -108.34 120.81 43.45 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.391 -0.818 . . . . 74.53 110.397 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -120.93 156.04 32.94 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 113.338 0.866 . . . . 65.43 113.338 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 46.9 m -141.85 138.52 32.2 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 106.296 -1.742 . . . . 61.51 106.296 169.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 522' ' ' GLN . . . . . 0.507 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 0.0 OUTLIER -121.63 141.35 51.2 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 119.601 -0.84 . . . . 73.22 111.094 179.523 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -119.89 122.61 41.66 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.683 -1.228 . . . . 74.41 107.683 176.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 524' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 67.1 m -88.86 128.02 35.65 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 121.214 0.531 . . . . 73.32 110.508 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 24.7 m -121.44 149.82 24.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.96 -0.756 . . . . 65.13 108.96 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 526' ' ' ASP . . . . . 0.408 ' HB3' ' HE3' ' A' ' 557' ' ' LYS . 10.0 p-10 -73.94 135.03 43.22 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 108.354 -0.98 . . . . 52.53 108.354 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 527' ' ' SER . . . . . 0.405 ' HB3' ' HD2' ' A' ' 528' ' ' PRO . 45.4 m -152.16 172.55 5.37 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 108.628 -0.879 . . . . 72.32 108.628 -176.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 528' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 527' ' ' SER . 72.6 Cg_endo -82.67 -10.31 10.77 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 121.452 1.435 . . . . 64.4 110.424 174.146 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.433 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 27.3 mmt180 -81.36 138.18 48.43 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-N 114.862 -1.063 . . . . 64.53 108.18 -178.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -62.46 149.65 90.15 Favored 'Trans proline' 0 C--O 1.249 1.03 0 C-N-CA 122.351 2.034 . . . . 64.02 112.316 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -58.57 118.26 5.44 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.224 -0.898 . . . . 72.53 110.79 -178.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 127.59 -23.73 5.33 Favored Glycine 0 N--CA 1.434 -1.442 0 N-CA-C 111.113 -0.795 . . . . 70.32 111.113 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -81.14 134.96 35.73 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.468 -0.938 . . . . 74.35 108.468 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 503' ' ' GLN . 13.4 p -80.96 135.24 25.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 CA-C-O 121.3 0.571 . . . . 64.42 110.519 -178.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 535' ' ' THR . . . . . 0.471 ' HB ' ' HG3' ' A' ' 554' ' ' GLN . 77.5 m -88.91 -32.83 17.53 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.168 -0.924 . . . . 70.42 109.889 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.38 -152.1 24.21 Favored Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 110.091 -1.203 . . . . 70.32 110.091 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 27.3 p -117.56 157.19 26.78 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.551 -0.537 . . . . 72.11 109.551 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -73.09 -50.04 6.87 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 109.59 -0.522 . . . . 74.41 109.59 175.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.12 146.92 78.29 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 121.217 1.278 . . . . 74.41 109.649 171.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.43 143.81 53.66 Favored 'Trans proline' 0 C--O 1.25 1.122 0 C-N-CA 122.181 1.921 . . . . 75.24 113.089 -176.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.86 133.51 50.2 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.815 -0.809 . . . . 74.13 108.815 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.47 -5.31 35.32 Favored Glycine 0 C--N 1.299 -1.506 0 C-N-CA 120.053 -1.07 . . . . 62.44 111.111 -176.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.47 ' O ' HG12 ' A' ' 497' ' ' ILE . 62.4 m -82.26 133.69 35.25 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.516 -0.55 . . . . 75.24 109.516 176.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 11.9 t -96.44 130.84 43.5 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 119.984 -0.686 . . . . 70.41 109.571 176.061 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.1 m -139.44 159.24 66.6 Favored Pre-proline 0 C--N 1.316 -0.891 0 N-CA-C 109.175 -0.676 . . . . 75.21 109.175 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 494' ' ' THR . 35.9 Cg_exo -63.39 142.04 83.69 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.367 2.045 . . . . 62.41 111.374 176.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.461 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 27.7 m -66.72 -23.19 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-O 121.445 0.64 . . . . 73.03 112.32 -177.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -79.68 -13.41 59.49 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.517 -0.765 . . . . 74.13 110.574 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 56.7 m -77.5 164.97 24.94 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 113.463 0.912 . . . . 72.2 113.463 -175.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 23.9 t -90.9 131.39 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-N 114.629 -1.169 . . . . 73.11 109.179 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 551' ' ' ILE . . . . . 0.47 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -116.51 142.39 30.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 109.721 -0.474 . . . . 54.2 109.721 175.317 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -103.78 116.66 32.72 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.839 -0.619 . . . . 74.22 110.713 -175.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 553' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 7.3 mp -103.27 134.4 46.74 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.238 -0.892 . . . . 75.12 109.738 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 554' ' ' GLN . . . . . 0.471 ' HG3' ' HB ' ' A' ' 535' ' ' THR . 10.2 pt20 -101.29 125.38 47.92 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 108.834 -0.802 . . . . 71.01 108.834 179.002 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 524' ' ' SER . 59.5 t -114.8 138.59 44.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-N 115.44 -0.8 . . . . 71.13 110.002 -174.051 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 63.2 m -69.35 140.57 54.28 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 113.606 0.965 . . . . 74.31 113.606 178.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' A' ' 526' ' ' ASP . 3.0 ttpt -103.26 139.76 38.29 Favored 'General case' 0 N--CA 1.422 -1.825 0 N-CA-C 104.915 -2.254 . . . . 73.1 104.915 166.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 558' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -67.68 -36.56 87.86 Favored Glycine 0 CA--C 1.484 -1.905 0 C-N-CA 120.55 -0.833 . . . . 41.44 112.395 -172.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 66.2 t30 67.33 -3.84 0.97 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.808 1.243 . . . . 64.34 112.857 171.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -151.38 142.06 22.74 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.172 -1.418 . . . . 70.11 107.172 -174.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -136.18 134.93 38.72 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 120.627 0.251 . . . . 74.43 111.092 174.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.1 p -60.27 123.23 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.737 0.815 . . . . 73.31 112.931 -175.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 563' ' ' MET . . . . . 0.444 ' HG2' ' O ' ' A' ' 612' ' ' THR . 25.5 ptm -98.11 141.19 22.55 Favored Pre-proline 0 C--O 1.253 1.259 0 CA-C-N 115.9 -0.591 . . . . 55.34 111.421 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.35 169.85 21.55 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.793 2.328 . . . . 43.53 110.555 171.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -72.52 130.45 40.65 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.163 0.506 . . . . 74.01 110.021 177.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 93.2 mt -116.6 -9.78 11.3 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.656 -0.702 . . . . 55.4 110.943 -177.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 10.5 p -70.36 129.88 40.47 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 109.952 -0.388 . . . . 75.13 109.952 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 90.3 -0.26 77.87 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.581 -0.819 . . . . 74.41 111.942 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 26.4 mmt -91.32 151.21 20.96 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 108.845 -0.798 . . . . 62.41 108.845 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -93.28 140.79 29.15 Favored 'General case' 0 N--CA 1.416 -2.165 0 N-CA-C 109.35 -0.611 . . . . 74.23 109.35 -176.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 571' ' ' TRP . . . . . 0.435 ' HA ' ' HB3' ' A' ' 574' ' ' ALA . 60.7 t-105 -71.53 -15.65 62.3 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.659 -0.701 . . . . 75.42 110.276 -174.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 14.0 p -72.31 -19.3 19.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.896 0.855 . . . . 63.12 108.908 178.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -102.27 -44.77 5.32 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 114.511 -1.222 . . . . 60.34 110.359 176.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 574' ' ' ALA . . . . . 0.435 ' HB3' ' HA ' ' A' ' 571' ' ' TRP . . . -65.42 -41.34 93.68 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 113.923 1.083 . . . . 73.44 113.923 -176.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.585 ' O ' ' HG2' ' A' ' 579' ' ' ARG . 32.0 tt0 -65.54 -53.55 36.81 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 120.176 -0.61 . . . . 73.44 111.907 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 576' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 52.4 Cg_exo -55.88 -39.26 92.21 Favored 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 121.91 1.74 . . . . 74.14 113.136 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 574' ' ' ALA . 3.2 ppt_? -67.76 -37.19 81.76 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 119.536 -0.865 . . . . 75.43 110.809 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.452 HD12 ' N ' ' A' ' 579' ' ' ARG 0.275 3.5 pp -66.55 -36.41 82.59 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 120.498 -0.481 . . . . 64.31 111.507 179.865 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 579' ' ' ARG . . . . . 0.585 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 45.8 mmm-85 -57.21 -42.75 81.92 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.169 -0.923 . . . . 75.12 108.711 176.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -67.8 -28.05 67.26 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.716 -0.675 . . . . 74.54 111.912 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 10.5 mp -80.56 -8.06 59.46 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.145 0.498 . . . . 72.53 111.164 177.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 77.77 16.28 80.25 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-N 115.759 -0.655 . . . . 64.05 111.95 179.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -70.78 140.46 51.29 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 109.523 -0.547 . . . . 74.51 109.523 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 9.6 t -137.21 -50.01 0.62 Allowed 'General case' 0 N--CA 1.406 -2.638 0 CA-C-O 118.871 -0.585 . . . . 73.23 110.238 175.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . 30.67 -126.69 0.16 Allowed Glycine 0 C--N 1.371 2.488 0 O-C-N 124.631 1.207 . . . . 43.03 113.734 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 25.7 ptm -137.93 125.54 22.21 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.881 -1.526 . . . . 74.4 106.881 170.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -87.41 123.84 32.78 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.69 -0.855 . . . . 75.33 108.69 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -95.96 107.33 19.6 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.669 -0.696 . . . . 72.31 109.277 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -112.5 113.3 25.4 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 108.582 -0.895 . . . . 71.01 108.582 176.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -83.25 -126.09 1.1 Allowed Glycine 0 N--CA 1.435 -1.367 0 N-CA-C 111.066 -0.814 . . . . 62.13 111.066 175.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -70.98 137.73 49.35 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.873 0.368 . . . . 74.24 111.124 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -97.49 126.95 43.06 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 106.903 -1.518 . . . . 72.15 106.903 176.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 48.8 t -137.27 128.95 41.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 C-N-CA 120.955 -0.298 . . . . 73.35 110.463 -172.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -77.38 108.35 10.46 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 105.173 -2.158 . . . . 60.13 105.173 170.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -105.1 0.19 27.24 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-O 121.216 0.531 . . . . 75.45 111.44 -174.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 100.82 171.47 28.93 Favored Glycine 0 N--CA 1.433 -1.56 0 N-CA-C 109.584 -1.406 . . . . 51.14 109.584 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -63.46 -48.16 80.82 Favored Glycine 0 C--N 1.306 -1.126 0 C-N-CA 120.721 -0.752 . . . . 64.01 113.382 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 42.0 p -69.25 -26.79 64.95 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.502 0.668 . . . . 65.22 112.243 -175.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -105.91 -1.64 23.88 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 118.926 -0.559 . . . . 72.52 110.992 -174.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 600' ' ' HIS . . . . . 0.491 ' CG ' ' H ' ' A' ' 601' ' ' ASN . 0.3 OUTLIER -35.32 -115.74 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.616 0 N-CA-C 117.677 2.473 . . . . 54.51 117.677 -167.866 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 601' ' ' ASN . . . . . 0.491 ' H ' ' CG ' ' A' ' 600' ' ' HIS . 4.6 p30 -92.96 83.92 4.81 Favored 'General case' 0 C--N 1.287 -2.109 0 O-C-N 120.558 -1.339 . . . . 74.12 109.92 178.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -126.11 150.85 47.93 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 115.548 -0.751 . . . . 73.12 109.678 175.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 85.7 t -67.84 130.9 33.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 O-C-N 123.875 0.734 . . . . 74.15 109.358 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 60.1 t -93.11 -52.14 10.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.363 0.601 . . . . 74.45 109.786 -176.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -136.41 158.81 43.55 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.405 -0.961 . . . . 72.11 108.405 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 606' ' ' GLN . . . . . 0.415 ' HA ' HD23 ' A' ' 622' ' ' LEU . 19.5 pt20 -125.32 122.3 36.46 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.564 -1.273 . . . . 74.14 107.564 174.081 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.613 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 41.8 t30 -51.47 -59.0 8.81 Favored Pre-proline 0 CA--C 1.555 1.17 0 CA-C-O 119.094 -0.479 . . . . 71.21 112.175 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.613 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 2.7 Cg_endo -85.03 129.65 3.94 Favored 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 121.322 1.348 . . . . 72.34 109.123 171.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.81 161.52 35.84 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 122.696 2.264 . . . . 61.5 112.905 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -59.21 129.99 44.81 Favored 'General case' 0 C--O 1.249 1.051 0 CA-C-N 115.754 -0.657 . . . . 61.22 110.959 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 95.59 -10.76 68.83 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 120.863 -0.684 . . . . 63.23 111.706 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 612' ' ' THR . . . . . 0.444 ' O ' ' HG2' ' A' ' 563' ' ' MET . 24.0 m -89.27 161.97 16.11 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.642 -1.244 . . . . 73.25 107.642 178.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -99.12 143.19 16.45 Favored Glycine 0 N--CA 1.418 -2.518 0 C-N-CA 119.985 -1.102 . . . . 52.44 113.237 -177.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 614' ' ' VAL . . . . . 0.406 HG12 ' HG2' ' A' ' 608' ' ' PRO . 13.6 m -94.12 143.42 11.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.374 -0.973 . . . . 75.4 108.374 175.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.438 HD21 HG22 ' A' ' 619' ' ' ILE . 31.1 p30 -58.24 175.41 0.23 Allowed 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 114.21 1.189 . . . . 72.53 114.21 -175.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -55.95 -38.36 70.24 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 125.458 1.503 . . . . 74.43 110.986 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.91 -33.91 68.67 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 115.607 -0.724 . . . . 63.24 109.501 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 82.5 19.74 63.48 Favored Glycine 0 N--CA 1.417 -2.618 0 N-CA-C 109.974 -1.25 . . . . 63.31 109.974 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 619' ' ' ILE . . . . . 0.438 HG22 HD21 ' A' ' 615' ' ' ASN . 0.0 OUTLIER -70.62 119.44 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 108.629 -0.878 . . . . 72.12 108.629 -174.561 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 8.5 tp -116.26 132.42 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 0 CA-C-N 114.73 -1.123 . . . . 73.52 109.678 -174.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.524 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 32.8 m -105.28 117.53 34.24 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 108.912 -0.773 . . . . 75.34 108.912 178.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 622' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 606' ' ' GLN . 72.9 mt -139.09 165.65 26.59 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 105.747 -1.946 . . . . 74.41 105.747 -177.002 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -142.94 139.54 30.75 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 106.468 -1.678 . . . . 74.21 106.468 173.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -138.77 160.89 38.57 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.145 -1.057 . . . . 63.41 108.145 -177.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -87.15 -117.46 1.14 Allowed Glycine 0 N--CA 1.43 -1.734 0 O-C-N 123.915 0.759 . . . . 54.41 113.35 -177.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 . . . . . 0 C--N 1.298 -1.666 0 N-CA-C 109.21 -0.663 . . . . 74.01 109.21 -174.682 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 . . . . . 0 CA--C 1.498 -1.03 0 N-CA-C 107.179 -1.415 . . . . 75.03 107.179 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.15 163.51 34.06 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.46 0 N-CA-C 108.226 -1.028 . . . . 70.05 108.226 -177.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -94.46 138.15 32.74 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 105.007 -2.22 . . . . 61.4 105.007 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.407 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 91.9 t -95.3 123.53 56.53 Favored Pre-proline 0 C--N 1.271 -2.825 0 N-CA-C 109.308 -0.627 . . . . 35.41 109.308 -171.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 363' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 17.9 Cg_exo -60.89 126.28 19.25 Favored 'Trans proline' 0 N--CA 1.445 -1.349 0 C-N-CA 122.316 2.011 . . . . 70.34 110.995 -178.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -84.62 114.2 21.82 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-O 122.639 1.209 . . . . 75.23 109.326 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.499 HG13 ' HB1' ' A' ' 373' ' ' ALA . 9.2 p -88.21 15.12 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 CA-C-N 113.832 -1.531 . . . . 54.54 111.554 -173.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -56.5 146.69 23.98 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.191 1.396 . . . . 74.55 111.954 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.41 0.47 43.68 Favored Glycine 0 CA--C 1.503 -0.673 0 CA-C-N 116.263 -0.426 . . . . 72.43 113.354 177.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -115.75 -159.39 0.71 Allowed 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 108.273 -1.01 . . . . 75.52 108.273 177.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 369' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 60.1 p -90.96 166.83 12.82 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 108.66 -0.867 . . . . 72.51 108.66 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 66.7 m -62.85 -41.13 99.23 Favored 'General case' 0 C--O 1.208 -1.101 0 C-N-CA 120.004 -0.678 . . . . 74.13 110.026 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.49 -46.68 81.97 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 116.728 -0.214 . . . . 71.22 111.563 -178.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -69.09 -39.83 78.77 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.475 0.655 . . . . 72.03 110.002 -176.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 373' ' ' ALA . . . . . 0.499 ' HB1' HG13 ' A' ' 365' ' ' VAL . . . -67.24 -46.47 73.66 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.582 -0.735 . . . . 74.32 111.285 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 374' ' ' ILE . . . . . 0.435 HG12 HG21 ' A' ' 384' ' ' ILE . 75.9 mt -64.44 -40.98 90.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-N 116.353 -0.385 . . . . 72.3 110.302 177.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.99 -41.85 88.61 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.378 0.608 . . . . 72.11 110.619 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 87.2 m -63.17 -47.62 81.86 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.655 -0.702 . . . . 51.11 110.756 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 97.6 mt -64.05 -37.99 89.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.337 -0.392 . . . . 65.53 110.7 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -63.67 -38.66 91.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.799 -0.637 . . . . 54.43 110.775 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -68.9 -24.63 64.33 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 120.981 0.42 . . . . 75.55 111.382 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -82.09 -14.76 55.32 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.153 -0.476 . . . . 75.35 110.757 176.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.95 16.82 43.16 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.212 -0.994 . . . . 53.13 112.257 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -88.16 159.59 18.12 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 121.395 0.617 . . . . 75.33 111.829 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -100.64 132.6 45.95 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 106.824 -1.547 . . . . 62.32 106.824 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 384' ' ' ILE . . . . . 0.435 HG21 HG12 ' A' ' 374' ' ' ILE . 0.8 OUTLIER -122.89 137.29 56.87 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 N-CA-C 106.824 -1.547 . . . . 72.14 106.824 178.759 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 385' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 417' ' ' THR . 32.5 ttt180 -116.82 138.58 51.41 Favored 'General case' 0 C--N 1.255 -3.533 0 N-CA-C 105.724 -1.954 . . . . 72.2 105.724 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 41.0 m -130.23 132.51 46.0 Favored 'General case' 0 C--N 1.272 -2.786 0 O-C-N 121.771 -0.581 . . . . 63.41 109.483 -174.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.7 121.89 42.95 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.649 -1.241 . . . . 74.31 107.649 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -89.53 122.5 32.75 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.941 -0.763 . . . . 72.01 108.941 -178.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 389' ' ' LYS . . . . . 0.621 ' O ' ' HA ' ' A' ' 421' ' ' SER . 51.8 mtmt -132.98 135.78 26.49 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 109.028 -0.73 . . . . 74.32 109.028 177.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -76.14 176.6 9.83 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.32 2.014 . . . . 61.32 112.609 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 11.2 t70 87.92 167.82 0.06 Allowed 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 126.351 1.861 . . . . 73.44 110.707 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 32.6 t -105.7 -12.7 15.81 Favored 'General case' 0 N--CA 1.439 -1.022 0 O-C-N 122.35 -0.219 . . . . 64.22 111.222 -175.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 6.0 t -82.63 -3.38 56.12 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 119.198 -1.001 . . . . 70.34 109.548 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 47.6 mm -88.14 146.15 37.65 Favored Pre-proline 0 C--N 1.302 -1.475 0 N-CA-C 106.17 -1.789 . . . . 72.42 106.17 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 395' ' ' PRO . . . . . 0.44 ' HA ' ' HD2' ' A' ' 396' ' ' PRO . 28.3 Cg_exo -37.94 116.31 0.21 Allowed 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 123.772 2.981 . . . . 74.53 113.12 177.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 396' ' ' PRO . . . . . 0.528 ' HA ' ' OG ' ' A' ' 421' ' ' SER . 12.2 Cg_endo -57.72 151.99 52.02 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.041 2.494 . . . . 72.22 112.732 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 397' ' ' ASP . . . . . 0.46 ' HA ' HG23 ' A' ' 420' ' ' VAL . 8.7 p-10 -59.19 -8.17 1.49 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.874 1.27 . . . . 74.51 113.638 -178.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 31.4 m170 -106.55 109.96 22.03 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 104.327 -2.471 . . . . 61.54 104.327 171.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 28.0 m -62.78 119.07 5.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 124.647 1.217 . . . . 74.42 112.567 -165.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 400' ' ' ILE . . . . . 0.548 ' H ' HD13 ' A' ' 400' ' ' ILE . 0.2 OUTLIER -92.25 -28.22 4.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.4 -0.818 . . . . 73.15 109.89 179.132 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.75 160.11 28.06 Favored Glycine 0 N--CA 1.399 -3.824 0 CA-C-N 115.232 -0.895 . . . . 73.13 111.054 -176.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -114.83 -175.99 2.81 Favored 'General case' 0 C--N 1.27 -2.87 0 C-N-CA 125.351 1.46 . . . . 73.4 108.339 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -99.3 137.3 20.35 Favored Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 107.095 -1.446 . . . . 62.32 107.095 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -54.91 -16.28 11.49 Favored 'Trans proline' 0 C--N 1.365 1.411 0 C-N-CA 124.313 3.342 . . . . 72.32 114.662 -174.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.65 -28.69 68.76 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 116.308 -0.406 . . . . 64.35 110.249 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -73.96 -38.27 64.26 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.507 0.67 . . . . 61.15 110.392 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -81.2 -5.18 57.45 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.499 0.666 . . . . 74.22 110.629 -177.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 30.9 m -95.29 143.56 26.58 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.307 -1.738 . . . . 65.2 106.307 173.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 47.7 m -74.51 112.48 10.73 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 118.441 -1.304 . . . . 63.44 108.666 176.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 28.7 m -127.58 169.2 19.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 115.876 -0.602 . . . . 55.4 109.862 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 29.6 t -71.85 132.62 44.67 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 106.761 -1.57 . . . . 71.32 106.761 175.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -65.46 133.4 51.2 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-O 121.22 0.533 . . . . 61.22 111.157 -175.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 104.89 54.81 0.75 Allowed Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 110.816 -0.914 . . . . 22.51 110.816 -177.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -113.32 -177.23 3.08 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.818 -1.178 . . . . 61.15 107.818 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -107.67 108.88 20.32 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.153 -0.684 . . . . 71.11 109.153 -177.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.6 mm -98.01 116.77 41.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.37 -0.974 . . . . 61.42 108.37 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 417' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 385' ' ' ARG . 58.1 m -97.74 130.82 44.68 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 120.849 0.357 . . . . 72.23 110.535 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 4.8 p -118.96 136.18 56.99 Favored 'Isoleucine or valine' 0 C--O 1.252 1.223 0 C-N-CA 123.577 0.751 . . . . 60.44 110.232 -177.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -93.96 120.07 33.72 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.013 -0.736 . . . . 63.5 109.013 176.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.46 HG23 ' HA ' ' A' ' 397' ' ' ASP . 14.7 p -113.81 132.45 62.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 109.7 -0.481 . . . . 71.13 109.7 -178.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 421' ' ' SER . . . . . 0.621 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 11.9 p -88.26 125.36 34.61 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.075 0.464 . . . . 72.25 111.301 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 5.6 t -118.36 106.52 12.83 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-O 121.191 0.519 . . . . 74.02 111.379 177.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.398 0 N-CA-C 115.226 0.85 . . . . 73.43 115.226 175.481 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 . . . . . 0 CA--C 1.52 -0.187 0 CA-C-O 120.634 0.254 . . . . 74.12 111.522 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 10.9 mmp_? -122.23 153.81 38.35 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-N 116.312 -0.404 . . . . 72.31 110.456 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 40.6 tt0 -84.83 141.47 30.45 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.418 -1.327 . . . . 72.13 107.418 174.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.423 ' HA ' ' HD3' ' A' ' 430' ' ' PRO . 68.2 mt -78.08 125.92 84.48 Favored Pre-proline 0 N--CA 1.437 -1.121 0 N-CA-C 107.212 -1.403 . . . . 70.44 107.212 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 429' ' ' ILE . 23.4 Cg_exo -67.62 145.05 68.68 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.473 2.115 . . . . 75.15 113.093 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -75.44 104.81 6.16 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 108.992 -0.744 . . . . 64.41 108.992 175.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 46.1 t -116.78 138.01 48.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 107.93 -1.137 . . . . 54.23 107.93 178.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.41 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 18.5 m -68.97 152.33 45.4 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 121.053 0.454 . . . . 74.32 111.025 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 434' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 58.3 p -63.89 -34.44 77.95 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 113.535 0.939 . . . . 44.42 113.535 -170.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.6 pp -84.22 -11.32 56.71 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 120.98 0.419 . . . . 73.24 111.842 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.41 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 0.8 OUTLIER -93.95 42.77 1.1 Allowed 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 115.687 -0.688 . . . . 54.24 109.731 -177.6 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -52.14 -39.65 60.25 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.725 1.21 . . . . 75.35 112.989 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.19 -41.79 99.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.085 0.469 . . . . 74.21 110.218 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -71.17 -33.97 70.5 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 116.19 -0.459 . . . . 71.31 110.286 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.46 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -59.43 -51.25 70.68 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.497 -0.127 . . . . 63.14 110.888 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.4 m -61.45 -37.63 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 CA-C-O 121.111 0.481 . . . . 75.43 110.458 177.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -60.52 -48.19 82.86 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.244 1.018 . . . . 65.22 110.908 176.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -66.42 -38.5 87.57 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 123.777 0.831 . . . . 72.4 111.466 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.46 HD13 ' O ' ' A' ' 440' ' ' ALA . 6.9 mp -66.15 -33.96 76.95 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.877 -0.601 . . . . 73.32 110.927 176.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.508 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 56.2 m -70.13 -45.07 67.6 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.251 0.548 . . . . 73.53 109.874 177.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.69 -16.36 64.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.541 -0.754 . . . . 74.01 110.917 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.84 5.67 20.9 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.081 -0.509 . . . . 74.12 111.74 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 100.72 -67.39 0.5 Allowed Glycine 0 CA--C 1.497 -1.088 0 C-N-CA 120.552 -0.832 . . . . 53.33 111.938 175.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -51.54 -59.39 4.31 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.264 0.839 . . . . 71.43 113.264 178.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 450' ' ' GLY . . . . . 0.508 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 60.76 19.89 55.99 Favored Glycine 0 CA--C 1.505 -0.569 0 CA-C-O 121.25 0.361 . . . . 74.34 113.059 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.498 ' NH2' ' HA ' ' A' ' 481' ' ' THR . 13.6 mtm180 -105.29 111.35 24.06 Favored 'General case' 0 N--CA 1.415 -2.209 0 CA-C-O 121.258 0.552 . . . . 74.01 110.172 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.511 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 15.0 p90 -135.3 145.34 47.4 Favored 'General case' 0 N--CA 1.412 -2.364 0 CA-C-N 114.151 -1.386 . . . . 74.34 109.55 -175.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 26.1 mmtm -136.43 127.24 27.38 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.349 -0.842 . . . . 72.31 108.877 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -90.72 127.26 36.25 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 123.644 0.59 . . . . 74.4 111.369 -174.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -126.85 147.29 50.05 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.905 -1.146 . . . . 75.51 107.905 175.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -122.06 146.5 47.13 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 120.376 -0.53 . . . . 44.55 109.937 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 23.2 t -142.79 137.53 15.21 Favored Pre-proline 0 C--N 1.297 -1.713 0 N-CA-C 107.686 -1.227 . . . . 54.55 107.686 177.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.578 ' HA ' ' O ' ' A' ' 490' ' ' SER . 23.9 Cg_exo -64.92 123.01 10.98 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.738 1.625 . . . . 62.15 110.471 176.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 54.9 m -148.94 -178.31 6.29 Favored 'General case' 0 C--N 1.287 -2.117 0 C-N-CA 124.971 1.308 . . . . 55.42 108.136 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 11.2 t -45.27 134.39 5.58 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 123.727 0.811 . . . . 71.51 112.283 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 461' ' ' PRO . . . . . 0.463 ' HA ' HG23 ' A' ' 464' ' ' VAL . 9.5 Cg_endo -51.92 -29.21 34.34 Favored 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 124.814 3.676 . . . . 74.45 114.067 -175.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.405 ' O ' ' HD2' ' A' ' 466' ' ' LYS . 11.3 pt-20 -71.77 -19.42 62.02 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 112.055 0.391 . . . . 52.43 112.055 -178.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 72.6 mt -96.09 -2.54 46.4 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 111.601 0.223 . . . . 75.3 111.601 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.463 HG23 ' HA ' ' A' ' 461' ' ' PRO . 87.9 t -60.81 127.39 20.3 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 CA-C-O 120.891 0.377 . . . . 74.52 110.315 178.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 84.7 -10.57 61.86 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.312 -0.858 . . . . 74.05 112.065 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.405 ' HD2' ' O ' ' A' ' 462' ' ' GLU . 50.2 mttp -111.98 166.23 11.41 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 108.182 -1.044 . . . . 73.52 108.182 -176.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.498 ' O ' ' HB ' ' A' ' 434' ' ' THR . 87.2 t -80.41 146.83 7.01 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.294 0 CA-C-N 116.261 -0.427 . . . . 62.53 109.957 -177.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 63.9 mt -98.57 -35.21 4.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 107.439 -1.319 . . . . 42.25 107.439 174.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 156.68 -152.1 23.48 Favored Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 110.166 -1.174 . . . . 64.25 110.166 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 3.6 p -132.15 157.15 45.02 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.547 -0.908 . . . . 73.45 108.547 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -71.82 -46.46 12.17 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 119.728 -0.789 . . . . 75.51 110.625 175.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' ' 473' ' ' PRO . 18.0 Cg_exo -71.15 141.69 40.23 Favored 'Trans proline' 0 C--N 1.374 1.89 0 N-CA-C 107.304 -1.845 . . . . 70.22 107.304 167.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 472' ' ' PRO . 27.9 Cg_exo -62.34 127.54 21.26 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 121.508 1.472 . . . . 43.42 112.063 -177.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -73.99 2.03 9.6 Favored 'General case' 0 C--O 1.201 -1.448 0 C-N-CA 123.646 0.778 . . . . 73.23 112.444 -175.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -110.4 5.4 21.45 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.603 0.716 . . . . 73.22 110.005 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -109.12 176.78 4.97 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-N 115.616 -0.72 . . . . 62.33 111.529 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 2.3 p -96.8 145.9 25.41 Favored 'General case' 0 N--CA 1.391 -3.406 0 CA-C-N 114.663 -1.153 . . . . 73.4 110.773 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 49.7 m -137.29 148.06 46.11 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 107.548 -1.279 . . . . 73.3 107.548 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -77.96 159.57 28.74 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 120.715 0.293 . . . . 73.34 110.441 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.61 -18.37 23.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.524 0.678 . . . . 71.33 111.316 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 481' ' ' THR . . . . . 0.498 ' HA ' ' NH2' ' A' ' 451' ' ' ARG . 7.7 t -87.28 1.91 51.77 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.943 -0.571 . . . . 45.32 111.065 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -93.05 148.91 21.6 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.045 0.45 . . . . 74.24 110.863 -177.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.9 p -108.6 126.34 65.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.568 -1.271 . . . . 72.31 107.568 172.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 26.9 m -105.33 134.25 47.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 121.903 0.859 . . . . 70.54 111.852 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.87 122.61 44.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 114.968 -1.015 . . . . 74.14 110.288 -178.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.416 HD11 HD21 ' A' ' 444' ' ' LEU . 36.2 mm -97.94 113.13 31.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 107.462 -1.31 . . . . 74.44 107.462 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 9.5 tt -99.08 126.24 52.38 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 108.911 -0.774 . . . . 54.24 108.911 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 27.2 m -111.25 151.92 13.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 123.345 0.658 . . . . 65.11 110.668 -178.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -77.37 132.64 12.25 Favored Glycine 0 N--CA 1.424 -2.136 0 CA-C-N 115.562 -0.744 . . . . 71.42 112.553 -178.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.578 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 31.3 t . . . . . 0 N--CA 1.419 -2.005 0 N-CA-C 104.401 -2.444 . . . . 53.51 104.401 175.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo . . . . . 0 N--CA 1.445 -1.348 0 N-CA-C 110.731 -0.527 . . . . 74.1 110.731 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 493' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . -75.14 84.85 2.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.777 0.799 . . . . 63.33 109.305 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 9.7 p -122.5 144.3 49.16 Favored 'General case' 0 N--CA 1.419 -2.014 0 CA-C-N 114.776 -1.102 . . . . 73.15 111.393 -173.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -139.96 149.48 43.33 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.713 -0.847 . . . . 75.44 108.713 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.548 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 6.5 p-10 -90.65 137.35 32.42 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 109.465 -0.568 . . . . 72.05 109.465 177.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 28.0 pt -91.01 110.45 42.22 Favored Pre-proline 0 C--N 1.304 -1.409 0 CA-C-N 115.698 -0.683 . . . . 74.01 109.856 177.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 498' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 496' ' ' ASP . 66.0 Cg_endo -90.71 150.4 4.14 Favored 'Trans proline' 0 N--CA 1.441 -1.562 0 C-N-CA 122.292 1.995 . . . . 72.12 111.97 178.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -78.88 91.5 4.78 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 122.517 1.151 . . . . 54.1 109.976 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 15.3 t -104.37 2.91 10.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.336 -1.357 . . . . 64.14 107.336 177.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -53.79 107.56 0.27 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.293 -1.321 . . . . 55.14 112.754 -175.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 177.85 27.85 0.04 OUTLIER Glycine 0 C--N 1.306 -1.117 0 N-CA-C 111.327 -0.709 . . . . 42.44 111.327 176.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.05 -170.85 3.43 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.267 -0.642 . . . . 71.4 109.267 -178.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 532' ' ' GLY . 8.8 t -84.13 157.91 21.55 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 109.076 -0.713 . . . . 55.23 109.076 -176.177 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.4 p -48.67 -41.77 12.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 124.194 0.997 . . . . 54.2 112.304 -177.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -61.53 -41.54 97.48 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.72 0.295 . . . . 74.24 111.778 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 47.3 t -76.01 -40.74 38.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-O 121.185 0.517 . . . . 74.3 110.602 -176.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.36 -46.88 84.49 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.068 -0.515 . . . . 61.02 110.224 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -61.95 -35.69 79.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.679 -0.691 . . . . 73.15 110.232 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.452 ' O ' HG23 ' A' ' 514' ' ' VAL . 0.3 OUTLIER -60.55 -43.08 97.63 Favored 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 109.016 -0.735 . . . . 75.42 109.016 177.13 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -62.57 -47.29 84.47 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.598 -0.274 . . . . 72.12 111.445 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.84 -40.07 94.03 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.733 0.301 . . . . 72.03 111.135 178.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.31 -38.16 88.37 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.055 -0.52 . . . . 73.1 110.636 178.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 510' ' ' LYS . 70.1 t -65.99 -31.16 52.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 115.886 -0.597 . . . . 74.24 110.746 176.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -78.44 -8.6 58.68 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.725 -0.39 . . . . 71.21 111.572 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 516' ' ' GLY . . . . . 0.402 ' O ' ' HB ' ' A' ' 547' ' ' VAL . . . 104.73 0.36 42.58 Favored Glycine 0 CA--C 1.504 -0.624 0 C-N-CA 120.859 -0.686 . . . . 70.31 112.557 177.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.472 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 83.8 m-85 -82.1 101.54 10.45 Favored 'General case' 0 CA--C 1.484 -1.595 0 N-CA-C 108.161 -1.051 . . . . 74.32 108.161 -178.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.5 m -100.0 -4.06 30.83 Favored 'General case' 0 N--CA 1.415 -2.205 0 CA-C-N 114.693 -1.139 . . . . 74.12 110.988 -173.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 519' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 97.0 mttt -116.61 114.25 23.84 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.589 -0.893 . . . . 65.34 108.589 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -132.16 152.11 51.44 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.483 -0.78 . . . . 74.13 112.451 -175.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 46.4 m -141.04 134.17 29.39 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.49 -1.3 . . . . 65.25 107.49 171.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 522' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 3.4 pm0 -118.82 138.84 52.43 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 117.907 0.321 . . . . 54.23 110.214 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -131.77 143.52 50.28 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.348 -1.353 . . . . 70.11 107.348 177.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 524' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 14.9 t -121.24 132.61 54.92 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.083 0.468 . . . . 73.34 110.089 -178.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 34.0 t -124.9 149.57 29.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 106.998 -1.482 . . . . 73.34 106.998 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 526' ' ' ASP . . . . . 0.605 ' HA ' ' HB3' ' A' ' 557' ' ' LYS . 4.1 p30 -66.59 134.69 52.85 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.892 0.853 . . . . 75.25 109.172 178.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 70.8 m -153.14 167.09 14.12 Favored Pre-proline 0 C--N 1.28 -2.442 0 CA-C-N 114.472 -1.24 . . . . 74.54 108.526 -173.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.86 -24.91 45.9 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.655 1.57 . . . . 54.03 113.055 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.98 142.2 79.26 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.595 -0.275 . . . . 74.33 111.183 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.61 151.78 60.41 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 123.263 2.642 . . . . 75.11 113.232 -178.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -62.47 119.66 9.57 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.366 -0.834 . . . . 74.31 111.44 -176.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 532' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 504' ' ' THR . . . 118.09 -22.19 9.85 Favored Glycine 0 N--CA 1.425 -2.049 0 C-N-CA 120.403 -0.903 . . . . 65.44 112.351 177.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -80.1 127.59 32.49 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.496 -0.927 . . . . 65.32 108.496 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 57.4 t -75.98 122.95 31.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 109.212 -0.662 . . . . 75.02 109.212 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 535' ' ' THR . . . . . 0.683 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 14.0 t -90.05 -14.86 32.96 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.186 -0.461 . . . . 53.33 110.898 -177.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 153.11 -158.01 27.67 Favored Glycine 0 N--CA 1.429 -1.819 0 N-CA-C 111.325 -0.71 . . . . 75.4 111.325 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 20.9 p -128.68 156.8 42.88 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 109.753 -0.462 . . . . 61.51 109.753 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -70.49 -50.39 14.43 Favored Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 116.298 -0.41 . . . . 72.15 110.077 176.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 18.0 Cg_endo -63.11 135.32 50.29 Favored 'Trans proline' 0 C--N 1.371 1.738 0 N-CA-C 108.368 -1.435 . . . . 71.44 108.368 168.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 540' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 31.6 Cg_exo -59.44 140.7 95.43 Favored 'Trans proline' 0 C--O 1.249 1.073 0 C-N-CA 122.656 2.237 . . . . 65.53 113.552 -176.118 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -67.83 134.66 51.3 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.646 -0.872 . . . . 73.04 108.646 176.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 103.82 -6.83 48.57 Favored Glycine 0 C--N 1.298 -1.551 0 C-N-CA 120.817 -0.706 . . . . 60.45 111.346 -176.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 23.6 m -81.57 131.6 35.28 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.891 -0.411 . . . . 74.42 109.891 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 27.9 m -90.33 122.89 33.62 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 108.087 -1.079 . . . . 70.13 108.087 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 13.0 m -134.88 157.72 76.51 Favored Pre-proline 0 C--N 1.309 -1.159 0 C-N-CA 122.659 0.384 . . . . 74.4 110.188 -177.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 22.6 Cg_exo -67.62 139.93 50.16 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.492 2.128 . . . . 74.13 111.746 177.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.472 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 33.2 m -65.87 -20.04 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 122.265 1.031 . . . . 63.03 110.819 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -78.67 -10.05 59.62 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 113.666 -1.606 . . . . 75.3 111.252 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 94.4 p -96.5 172.96 7.6 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 120.631 -0.428 . . . . 61.25 110.868 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 7.1 p -102.65 129.66 53.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-O 120.904 0.383 . . . . 70.24 111.604 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 551' ' ' ILE . . . . . 0.493 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -106.33 146.12 13.32 Favored 'Isoleucine or valine' 0 C--O 1.247 0.939 0 CA-C-O 121.181 0.515 . . . . 71.13 109.974 177.216 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -107.63 116.18 31.48 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-O 121.56 0.695 . . . . 73.25 110.861 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 553' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 51.7 mt -94.09 134.17 36.79 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 125.129 1.372 . . . . 71.32 108.864 -178.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -113.89 118.86 35.37 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 122.088 0.947 . . . . 73.24 110.921 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 524' ' ' SER . 39.7 t -101.26 139.75 21.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 CA-C-N 114.356 -1.293 . . . . 71.22 109.637 -175.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.683 ' OG ' ' HB ' ' A' ' 535' ' ' THR . 50.2 m -79.02 134.61 36.78 Favored 'General case' 0 N--CA 1.418 -2.032 0 CA-C-O 121.792 0.806 . . . . 72.32 111.172 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.605 ' HB3' ' HA ' ' A' ' 526' ' ' ASP . 11.3 tppt? -101.76 126.08 48.55 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 105.112 -2.181 . . . . 61.04 105.112 171.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -71.64 -45.29 45.85 Favored Glycine 0 CA--C 1.484 -1.906 0 C-N-CA 120.187 -1.006 . . . . 71.54 112.238 -172.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 57.1 t30 62.84 25.17 14.95 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-O 122.701 1.239 . . . . 71.01 109.042 177.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.565 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 94.4 mt-30 -129.35 156.96 43.2 Favored 'General case' 0 C--O 1.25 1.114 0 CA-C-N 114.538 -1.21 . . . . 70.43 110.733 -176.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -130.18 144.12 51.18 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.252 -0.885 . . . . 74.24 108.636 176.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 54.3 t -66.17 125.99 24.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 121.128 0.489 . . . . 64.31 112.278 -178.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 563' ' ' MET . . . . . 0.454 ' HA ' ' HD3' ' A' ' 564' ' ' PRO . 53.8 ttp -92.08 130.02 39.59 Favored Pre-proline 0 C--O 1.25 1.126 0 CA-C-N 115.501 -0.772 . . . . 62.25 110.853 -178.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 564' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 563' ' ' MET . 15.9 Cg_exo -71.85 169.9 20.09 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.087 2.524 . . . . 75.53 111.512 173.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -67.96 142.19 56.06 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 116.179 -0.464 . . . . 62.41 111.295 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.16 16.92 5.58 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.6 0.714 . . . . 62.52 111.266 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 16.9 m -64.37 130.54 44.19 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.427 -0.806 . . . . 42.32 109.74 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 568' ' ' GLY . . . . . 0.428 ' H ' ' CG1' ' A' ' 603' ' ' VAL . . . 100.15 24.23 9.85 Favored Glycine 0 C--N 1.308 -1.025 0 C-N-CA 120.655 -0.783 . . . . 64.45 112.478 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 90.6 mtp -109.54 144.51 37.73 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.274 -0.639 . . . . 72.41 109.274 177.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 570' ' ' PHE . . . . . 0.538 ' CD2' ' HB3' ' A' ' 602' ' ' ARG . 80.5 m-85 -101.34 140.08 36.12 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 107.048 -1.464 . . . . 72.51 107.048 -176.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 55.2 t90 -57.96 -28.72 64.6 Favored 'General case' 0 C--O 1.25 1.108 0 CA-C-O 121.139 0.495 . . . . 74.41 111.886 -177.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 35.8 m -73.4 -22.63 19.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.389 0.614 . . . . 74.21 111.196 -177.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 573' ' ' ASP . . . . . 0.621 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 12.4 t70 -101.53 -35.43 9.16 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.679 -0.691 . . . . 71.14 109.901 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 574' ' ' ALA . . . . . 0.42 ' O ' HD13 ' A' ' 578' ' ' LEU . . . -57.82 -50.84 71.93 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.193 0.997 . . . . 73.24 112.818 -177.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.508 ' O ' ' HG2' ' A' ' 579' ' ' ARG . 49.5 mt-10 -55.51 -56.22 31.68 Favored Pre-proline 0 N--CA 1.469 0.515 0 N-CA-C 112.9 0.704 . . . . 64.55 112.9 -178.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -53.95 -33.61 73.06 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 121.54 1.494 . . . . 73.25 113.465 176.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.621 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 35.1 mmt180 -63.81 -47.59 80.22 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.894 -0.78 . . . . 63.41 108.894 177.071 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.42 HD13 ' O ' ' A' ' 574' ' ' ALA . 9.4 mp -66.08 -39.68 90.22 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.0 -1.0 . . . . 72.1 111.308 -177.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 579' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 11.6 mmm180 -65.05 -37.14 86.61 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.376 -0.375 . . . . 70.43 110.855 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.93 -30.87 69.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.362 0.601 . . . . 73.12 110.587 178.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 581' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 95.4 mt -81.65 -8.16 59.67 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.428 -0.805 . . . . 61.42 111.085 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 70.81 28.63 70.42 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.702 -0.559 . . . . 50.42 111.702 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 73.3 t90 -62.03 127.9 33.57 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 123.224 0.61 . . . . 71.43 110.569 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 12.1 m -128.24 84.5 2.25 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-O 121.24 0.543 . . . . 62.41 109.734 177.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -135.33 -145.21 5.1 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 109.243 -1.543 . . . . 65.12 109.243 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 26.5 ttt -134.77 125.92 27.91 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 117.262 0.531 . . . . 75.14 110.17 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -115.83 123.26 47.74 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 105.629 -1.989 . . . . 52.34 105.629 173.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -107.83 106.45 16.75 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 116.303 -0.408 . . . . 74.03 111.048 -175.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.62 110.14 22.62 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 106.239 -1.763 . . . . 74.54 106.239 174.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -98.92 -87.4 1.91 Allowed Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 109.663 -1.375 . . . . 73.33 109.663 176.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -102.53 133.02 48.19 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 120.763 0.316 . . . . 70.54 110.749 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -83.86 157.38 22.02 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.9 -1.148 . . . . 61.5 107.9 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 46.4 t -117.62 125.25 73.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 119.617 -0.833 . . . . 43.33 111.503 -175.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -81.63 106.66 13.75 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 105.495 -2.039 . . . . 75.21 105.495 172.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -132.69 -6.72 3.21 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 112.171 0.434 . . . . 43.42 112.171 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 82.94 -178.95 53.1 Favored Glycine 0 N--CA 1.418 -2.527 0 C-N-CA 120.79 -0.719 . . . . 22.22 111.565 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -62.92 -33.56 87.46 Favored Glycine 0 C--N 1.303 -1.28 0 CA-C-N 115.575 -0.312 . . . . 73.13 112.769 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 22.6 m -56.57 -33.63 66.34 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.782 0.66 . . . . 60.42 112.782 -176.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -108.23 -14.59 14.67 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 119.897 -0.721 . . . . 72.21 110.162 178.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 39.89 -160.19 0.0 OUTLIER 'General case' 0 CA--C 1.587 2.368 0 C-N-CA 126.095 1.758 . . . . 71.31 113.379 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -87.55 28.33 1.0 Allowed 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.288 -0.882 . . . . 73.22 110.053 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 602' ' ' ARG . . . . . 0.538 ' HB3' ' CD2' ' A' ' 570' ' ' PHE 0.254 3.1 ppt_? -102.15 168.5 9.33 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.833 -0.747 . . . . 74.45 112.824 -176.335 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 603' ' ' VAL . . . . . 0.428 ' CG1' ' H ' ' A' ' 568' ' ' GLY . 7.6 p -56.72 134.52 20.88 Favored 'Isoleucine or valine' 0 C--O 1.25 1.094 0 O-C-N 124.55 1.156 . . . . 62.25 112.23 -176.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 10.5 p -101.64 -32.57 3.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 119.581 -0.847 . . . . 63.53 109.018 177.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -154.81 140.47 18.0 Favored 'General case' 0 C--O 1.25 1.08 0 N-CA-C 107.168 -1.419 . . . . 63.22 107.168 174.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -98.23 122.12 41.0 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.745 -0.835 . . . . 72.14 108.745 173.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.4 ' CB ' ' HB ' ' A' ' 621' ' ' THR . 15.0 t-20 -55.08 -56.15 31.27 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 114.313 1.227 . . . . 73.23 114.313 -177.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -84.09 123.0 3.02 Favored 'Trans proline' 0 N--CA 1.438 -1.755 0 CA-C-N 120.643 1.265 . . . . 64.4 109.43 176.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -64.02 144.82 88.68 Favored 'Trans proline' 0 C--O 1.246 0.912 0 C-N-CA 122.159 1.906 . . . . 64.42 111.193 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -62.69 132.33 51.93 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.121 -0.696 . . . . 74.3 109.121 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 100.1 0.67 56.0 Favored Glycine 0 N--CA 1.437 -1.289 0 C-N-CA 119.766 -1.207 . . . . 71.31 111.994 -177.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 14.2 m -100.97 154.68 18.49 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.596 -0.89 . . . . 73.42 108.596 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -80.13 132.85 11.67 Favored Glycine 0 N--CA 1.431 -1.694 0 N-CA-C 112.111 -0.396 . . . . 71.02 112.111 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 34.9 m -114.5 142.48 27.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 109.35 -0.611 . . . . 51.5 109.35 176.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.565 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 23.3 m-20 -57.75 169.6 0.7 Allowed 'General case' 0 CA--C 1.492 -1.255 0 C-N-CA 124.235 1.014 . . . . 72.53 111.803 -177.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -60.74 -24.6 65.85 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 113.774 -1.557 . . . . 73.04 110.22 172.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -77.07 -35.58 56.53 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 119.831 -0.748 . . . . 72.32 110.058 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 81.02 22.71 60.64 Favored Glycine 0 N--CA 1.426 -2.024 0 C-N-CA 118.484 -1.817 . . . . 74.12 113.409 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.73 119.66 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 122.489 1.138 . . . . 63.0 108.876 -174.156 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.72 132.93 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 N-CA-C 107.281 -1.377 . . . . 52.04 107.281 -173.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.4 ' HB ' ' CB ' ' A' ' 607' ' ' ASN . 19.0 m -111.09 134.95 52.29 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 121.786 -0.571 . . . . 72.33 111.095 -177.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 84.3 mt -137.54 154.1 49.88 Favored 'General case' 0 CA--C 1.497 -1.087 0 C-N-CA 125.106 1.363 . . . . 62.23 107.775 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 51.0 mmm-85 -128.22 137.36 51.99 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 104.431 -2.433 . . . . 72.3 104.431 169.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -141.87 165.49 27.32 Favored 'General case' 0 C--N 1.28 -2.423 0 O-C-N 124.263 0.977 . . . . 74.43 109.627 -174.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -97.02 -134.62 8.25 Favored Glycine 0 N--CA 1.417 -2.598 0 C-N-CA 120.464 -0.874 . . . . 73.21 112.034 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 . . . . . 0 C--N 1.295 -1.767 0 C-N-CA 123.991 0.916 . . . . 63.22 109.381 -177.629 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 . . . . . 0 CA--C 1.506 -0.731 0 N-CA-C 109.421 -0.585 . . . . 75.22 109.421 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.2 m -116.84 159.05 17.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 108.756 -0.831 . . . . 62.22 108.756 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -95.46 136.14 36.21 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 103.697 -2.705 . . . . 70.12 103.697 177.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.408 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 94.0 t -95.46 127.85 40.45 Favored Pre-proline 0 C--N 1.28 -2.443 0 C-N-CA 119.89 -0.724 . . . . 43.41 112.415 -163.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 363' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 13.4 Cg_exo -67.56 113.35 2.9 Favored 'Trans proline' 0 N--CA 1.441 -1.597 0 C-N-CA 122.529 2.153 . . . . 62.24 110.306 174.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 364' ' ' ASP . . . . . 0.505 ' HB2' HG21 ' A' ' 402' ' ' THR . 19.9 p-10 -101.3 111.94 24.31 Favored 'General case' 0 C--N 1.262 -3.196 0 CA-C-N 113.959 -1.473 . . . . 62.42 110.819 -176.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.557 ' HB ' ' OE1' ' A' ' 368' ' ' GLN . 7.0 m -85.73 37.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 114.132 -1.394 . . . . 61.45 113.598 -176.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.513 ' H ' ' HD2' ' A' ' 366' ' ' ARG . 0.0 OUTLIER -65.38 146.79 54.46 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.337 -0.847 . . . . 63.23 110.601 172.38 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.35 -4.53 44.18 Favored Glycine 0 C--N 1.304 -1.249 0 N-CA-C 110.781 -0.927 . . . . 53.32 110.781 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 368' ' ' GLN . . . . . 0.557 ' OE1' ' HB ' ' A' ' 365' ' ' VAL . 76.8 mt-30 -109.19 -156.8 0.59 Allowed 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 107.658 -1.238 . . . . 64.12 107.658 177.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 60.4 p -99.1 167.15 10.89 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 109.087 -0.708 . . . . 74.5 109.087 -177.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 18.2 p -57.87 -46.67 84.5 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 123.438 0.461 . . . . 72.32 110.63 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.31 -41.9 89.03 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.756 -0.656 . . . . 43.04 112.327 -177.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -69.3 -42.58 75.23 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 121.504 0.669 . . . . 73.44 109.307 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.77 -47.61 74.6 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.381 -0.827 . . . . 63.43 111.577 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 65.6 mt -62.77 -39.99 86.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 65.22 110.836 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.09 -43.86 91.87 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.125 0.488 . . . . 54.44 110.558 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 18.1 m -63.73 -47.22 81.95 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.59 -0.732 . . . . 75.02 109.963 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 98.4 mt -61.91 -41.78 98.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.833 -0.621 . . . . 64.35 110.824 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 62.0 tp60 -63.83 -41.16 97.91 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.896 -0.593 . . . . 42.41 110.51 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -63.12 -27.14 69.18 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 120.907 0.384 . . . . 75.03 111.412 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -90.79 -7.68 51.72 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 112.304 0.483 . . . . 75.31 112.304 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 95.23 7.99 59.1 Favored Glycine 0 C--N 1.307 -1.071 0 C-N-CA 120.856 -0.688 . . . . 61.31 113.055 177.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.448 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 75.0 m-85 -80.13 145.11 32.54 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-O 121.18 0.514 . . . . 74.3 111.385 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -92.07 143.41 26.49 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.603 -1.258 . . . . 62.25 107.603 -178.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 384' ' ' ILE . . . . . 0.461 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -125.82 154.75 35.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 121.274 0.559 . . . . 63.03 111.267 -178.781 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -136.35 135.2 38.64 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 107.507 -1.294 . . . . 72.13 107.507 174.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 26.4 m -103.06 120.9 41.5 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 108.279 -1.008 . . . . 72.51 108.279 178.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -111.46 119.68 39.62 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 106.786 -1.561 . . . . 73.14 106.786 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 10.9 pm0 -102.61 131.87 49.09 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.56 0.695 . . . . 73.32 111.851 -177.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 389' ' ' LYS . . . . . 0.674 ' O ' ' HA ' ' A' ' 421' ' ' SER . 99.1 mttt -128.93 150.34 74.93 Favored Pre-proline 0 C--N 1.293 -1.855 0 N-CA-C 106.703 -1.591 . . . . 70.24 106.703 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -71.84 166.29 29.98 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 121.489 1.459 . . . . 75.13 110.558 176.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -76.35 87.4 3.14 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-O 121.848 0.833 . . . . 75.44 110.526 176.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 392' ' ' SER . . . . . 0.45 ' O ' ' HB ' ' A' ' 393' ' ' THR . 19.6 m -112.38 42.5 1.8 Allowed 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 106.735 -1.579 . . . . 74.41 106.735 173.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 392' ' ' SER . 99.6 m 70.88 29.32 3.1 Favored 'General case' 0 CA--C 1.573 1.861 0 CA-C-O 123.58 1.657 . . . . 33.02 109.551 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 1.7 pt -116.43 151.25 46.73 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 113.6 0.963 . . . . 73.23 113.6 -176.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -24.46 110.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.366 1.498 1 C-N-CA 126.584 4.856 . . . . 73.45 118.258 -175.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -68.45 162.3 41.28 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.262 3.308 . . . . 74.41 110.651 172.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 397' ' ' ASP . . . . . 0.46 ' HB3' HG23 ' A' ' 420' ' ' VAL . 0.6 OUTLIER -57.21 -13.88 3.6 Favored 'General case' 0 N--CA 1.507 2.396 0 CA-C-O 121.098 0.475 . . . . 74.11 111.882 -176.301 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -84.01 111.04 18.92 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 105.295 -2.113 . . . . 75.14 105.295 178.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.418 HG23 ' HA ' ' A' ' 366' ' ' ARG . 28.0 m -63.0 118.02 4.61 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 O-C-N 124.602 1.189 . . . . 72.33 112.335 -166.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 400' ' ' ILE . . . . . 0.404 HD13 ' O ' ' A' ' 400' ' ' ILE . 0.0 OUTLIER -106.04 -28.59 2.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 114.84 -1.073 . . . . 64.41 109.727 -176.501 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -144.77 165.46 27.62 Favored Glycine 0 N--CA 1.428 -1.858 0 N-CA-C 110.289 -1.124 . . . . 73.13 110.289 -175.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 402' ' ' THR . . . . . 0.505 HG21 ' HB2' ' A' ' 364' ' ' ASP . 9.1 p -118.03 -178.85 3.6 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 113.341 0.867 . . . . 75.11 113.341 -173.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -102.32 140.42 21.12 Favored Pre-proline 0 N--CA 1.437 -1.117 0 N-CA-C 106.607 -1.627 . . . . 73.35 106.607 176.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -55.77 -24.63 47.52 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.314 2.676 . . . . 75.13 114.131 -176.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -62.38 -35.02 77.87 Favored 'General case' 0 C--O 1.209 -1.051 0 CA-C-N 116.543 -0.299 . . . . 72.43 111.368 -177.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -77.92 -35.75 50.21 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.492 0.663 . . . . 63.44 110.928 -178.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -82.02 -10.92 59.08 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.911 -0.586 . . . . 74.41 111.711 -175.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 25.0 m -103.35 160.28 14.83 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 106.428 -1.693 . . . . 72.52 106.428 177.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 5.9 p -76.68 113.0 13.84 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 118.322 0.51 . . . . 72.11 110.744 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 33.4 m -130.76 166.85 27.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.443 -0.577 . . . . 61.14 109.443 177.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 56.3 m -70.07 139.4 52.58 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.819 -0.808 . . . . 65.14 108.819 175.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 412' ' ' ALA . . . . . 0.448 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -61.7 109.79 1.32 Allowed 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 120.92 0.391 . . . . 62.21 110.5 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 128.72 38.84 0.34 Allowed Glycine 0 N--CA 1.441 -1.003 0 CA-C-N 115.525 -0.761 . . . . 53.54 112.055 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -97.33 -171.7 2.26 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 108.028 -1.101 . . . . 64.35 108.028 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -111.86 124.78 53.1 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 122.771 0.429 . . . . 60.41 111.387 -173.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 46.7 mm -119.24 117.59 54.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 120.756 0.312 . . . . 73.23 110.17 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 13.5 t -89.86 131.03 36.0 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-O 121.348 0.594 . . . . 71.44 109.679 176.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 10.8 p -105.25 135.71 42.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 C-N-CA 124.105 0.962 . . . . 62.3 108.932 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.37 128.19 42.02 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 120.822 -0.351 . . . . 75.21 110.607 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.46 HG23 ' HB3' ' A' ' 397' ' ' ASP . 3.4 p -128.04 131.33 69.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 115.877 -0.601 . . . . 73.45 109.787 173.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 421' ' ' SER . . . . . 0.674 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 3.0 p -94.72 122.77 37.67 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-O 121.051 0.453 . . . . 62.05 109.929 174.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.8 t -119.24 106.62 12.51 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-O 121.41 0.624 . . . . 73.01 111.86 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.188 0 CA-C-N 115.572 -0.74 . . . . 74.41 114.136 174.9 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.479 ' HG3' ' HB ' ' A' ' 477' ' ' THR . 16.3 tp60 . . . . . 0 N--CA 1.41 -2.468 0 N-CA-C 105.572 -2.01 . . . . 70.34 105.572 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.592 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 2.9 mmp_? -122.25 140.89 52.08 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.888 -0.725 . . . . 72.12 111.678 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.422 ' O ' ' HD3' ' A' ' 430' ' ' PRO . 9.5 pt-20 -83.74 139.06 32.97 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 114.393 -1.276 . . . . 71.23 110.186 -177.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 57.9 mt -98.41 112.61 62.71 Favored Pre-proline 0 N--CA 1.418 -2.068 0 N-CA-C 106.81 -1.552 . . . . 75.32 106.81 174.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 428' ' ' GLU . 16.3 Cg_exo -73.07 141.07 32.22 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 N-CA-C 107.885 -1.621 . . . . 72.22 107.885 165.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -84.43 132.71 34.54 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 118.205 -1.398 . . . . 34.24 108.833 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 59.4 t -105.7 151.7 7.73 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 N-CA-C 105.968 -1.864 . . . . 73.41 105.968 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 39.2 m -57.08 141.21 46.78 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.213 0.53 . . . . 72.1 111.138 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 434' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 36.5 p -64.26 -26.71 68.62 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 114.102 1.149 . . . . 44.14 114.102 -172.079 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.5 pp -82.93 -15.84 49.76 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 119.841 -0.744 . . . . 73.21 110.92 176.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.81 40.04 1.15 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.284 1.034 . . . . 73.01 109.362 -177.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -52.0 -38.76 57.93 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.522 1.129 . . . . 75.23 112.592 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -60.99 -41.8 97.15 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.037 0.446 . . . . 70.25 110.573 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -70.64 -35.97 73.19 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.963 -0.562 . . . . 61.25 109.602 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.514 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.47 -51.51 69.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.981 -0.554 . . . . 44.44 110.992 -178.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 36.0 m -63.08 -40.89 90.78 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 N-CA-C 112.279 0.474 . . . . 72.31 112.279 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . 0.267 0.1 OUTLIER -68.63 -34.54 75.91 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 113.338 0.866 . . . . 73.33 113.338 177.729 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -64.52 -41.03 96.64 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.284 -1.006 . . . . 75.52 108.284 179.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.514 HD13 ' O ' ' A' ' 440' ' ' ALA . 7.0 mp -63.49 -32.92 74.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.507 -0.77 . . . . 61.25 110.92 176.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.409 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 61.5 m -69.42 -43.02 74.25 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 116.067 -0.515 . . . . 74.03 110.354 177.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.44 -26.01 66.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.638 -0.71 . . . . 75.13 111.209 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.65 -6.15 56.55 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.072 0.463 . . . . 73.52 111.834 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 121.33 -77.1 0.33 Allowed Glycine 0 CA--C 1.495 -1.194 0 C-N-CA 120.314 -0.946 . . . . 60.23 112.227 176.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 449' ' ' PHE . . . . . 0.43 ' HA ' ' O ' ' A' ' 480' ' ' ILE . 0.5 OUTLIER -40.13 -68.51 0.17 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.134 1.161 . . . . 74.4 114.134 176.738 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 450' ' ' GLY . . . . . 0.409 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 58.93 25.68 59.7 Favored Glycine 0 C--N 1.318 -0.458 0 C-N-CA 121.589 -0.338 . . . . 34.41 112.645 -177.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.492 ' CB ' ' HA ' ' A' ' 483' ' ' VAL . 52.6 mmt-85 -101.82 111.82 24.22 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 107.258 -1.386 . . . . 73.12 107.258 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -139.14 145.77 39.81 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-O 120.973 0.416 . . . . 74.11 111.175 -176.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -131.47 123.42 28.04 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.046 -1.094 . . . . 55.43 108.046 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -99.3 121.46 41.11 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.98 0.419 . . . . 75.31 110.755 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -116.97 154.47 30.83 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.254 -1.017 . . . . 72.05 108.254 177.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -130.55 141.94 50.47 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.3 -0.63 . . . . 64.2 109.3 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 50.3 m -145.44 149.86 42.27 Favored Pre-proline 0 C--N 1.291 -1.938 0 N-CA-C 109.494 -0.558 . . . . 64.14 109.494 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.686 ' HA ' ' O ' ' A' ' 490' ' ' SER . 36.8 Cg_endo -67.49 127.38 16.35 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.321 2.014 . . . . 74.44 110.651 177.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 50.6 m -147.22 179.51 7.58 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.974 -0.38 . . . . 73.32 109.974 -177.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.8 t -54.31 135.97 60.44 Favored Pre-proline 0 N--CA 1.437 -1.079 0 C-N-CA 123.958 0.903 . . . . 61.14 110.315 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.16 -30.41 32.27 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 124.461 3.441 . . . . 63.14 115.192 -172.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -73.12 -27.83 61.91 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.829 -0.748 . . . . 71.44 112.546 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 83.5 mt -89.23 -11.86 42.44 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.217 0.532 . . . . 72.42 110.252 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.425 HG13 ' HA ' ' A' ' 490' ' ' SER . 70.6 t -60.61 128.76 22.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.447 -0.797 . . . . 74.44 110.457 177.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 96.22 -13.63 65.54 Favored Glycine 0 N--CA 1.432 -1.633 0 CA-C-N 115.058 -0.974 . . . . 73.52 111.553 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -117.27 166.65 12.02 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 109.201 -0.666 . . . . 75.23 109.201 -176.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.476 ' O ' ' HB ' ' A' ' 434' ' ' THR . 72.0 t -70.68 147.22 11.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 N-CA-C 107.993 -1.114 . . . . 75.44 107.993 173.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 64.3 mt -97.74 -35.88 5.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 107.008 -1.479 . . . . 53.13 107.008 176.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 169.3 -178.84 42.25 Favored Glycine 0 N--CA 1.416 -2.64 0 N-CA-C 109.789 -1.324 . . . . 62.43 109.789 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 470' ' ' THR . . . . . 0.555 HG22 HG12 ' A' ' 486' ' ' ILE . 41.4 p -115.65 137.95 51.56 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 107.262 -1.384 . . . . 73.41 107.262 178.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.496 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 50.8 t-20 -62.85 -47.43 87.15 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 120.726 -0.389 . . . . 63.01 110.058 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.496 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 12.9 Cg_exo -77.05 132.77 13.03 Favored 'Trans proline' 0 C--N 1.365 1.438 0 N-CA-C 106.852 -2.019 . . . . 63.52 106.852 167.274 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.88 127.04 20.29 Favored 'Trans proline' 0 C--O 1.239 0.564 0 C-N-CA 121.902 1.735 . . . . 65.14 112.739 -174.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -85.24 16.78 3.38 Favored 'General case' 0 C--O 1.203 -1.35 0 CA-C-N 114.949 -1.023 . . . . 74.43 110.89 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -112.27 -6.09 14.11 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.771 -0.65 . . . . 74.21 110.089 173.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -111.62 -175.29 2.66 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 115.598 -0.728 . . . . 71.11 110.96 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.479 ' HB ' ' HG3' ' A' ' 426' ' ' GLN . 0.6 OUTLIER -90.89 148.82 22.21 Favored 'General case' 0 N--CA 1.404 -2.774 0 CA-C-N 115.32 -0.854 . . . . 55.15 111.45 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 27.1 t -133.65 149.67 51.56 Favored 'General case' 0 C--O 1.26 1.658 0 N-CA-C 108.683 -0.858 . . . . 62.25 108.683 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -79.63 157.46 27.28 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.139 -0.482 . . . . 60.44 109.739 178.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 480' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 449' ' ' PHE . 37.6 mm -71.07 -21.03 21.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.877 0.846 . . . . 72.24 109.919 -176.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 17.4 p -100.02 5.92 45.08 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.786 -0.643 . . . . 72.33 112.045 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 482' ' ' ASN . . . . . 0.401 ' O ' ' HB2' ' A' ' 451' ' ' ARG . 54.4 t-20 -87.76 128.93 35.32 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.348 -0.612 . . . . 74.42 109.348 -176.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.492 ' HA ' ' CB ' ' A' ' 451' ' ' ARG . 40.0 t -96.81 113.47 31.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.318 -0.993 . . . . 74.34 108.318 177.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 21.2 m -91.37 129.04 42.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 121.479 0.656 . . . . 72.02 111.378 -177.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -94.27 125.43 46.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-O 121.537 0.684 . . . . 74.2 109.259 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.555 HG12 HG22 ' A' ' 470' ' ' THR . 6.0 mt -115.2 124.37 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 CA-C-N 114.658 -1.156 . . . . 73.02 109.566 -176.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 10.8 tt -104.75 126.82 59.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-O 121.021 0.439 . . . . 64.24 110.386 -176.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 32.9 m -108.22 151.77 10.27 Favored 'Isoleucine or valine' 0 C--O 1.252 1.232 0 CA-C-N 115.878 -0.601 . . . . 64.43 110.221 178.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.7 136.2 13.86 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 110.746 -0.942 . . . . 73.23 110.746 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.686 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 12.5 t . . . . . 0 C--N 1.297 -1.682 0 N-CA-C 109.041 -0.726 . . . . 74.32 109.041 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo . . . . . 0 N--CA 1.439 -1.704 0 N-CA-C 110.54 -0.6 . . . . 71.35 110.54 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 493' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . -101.09 23.95 10.09 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 122.465 1.126 . . . . 72.52 109.649 -178.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.458 ' HB ' ' OG1' ' A' ' 544' ' ' THR . 9.9 p -120.43 143.42 48.49 Favored 'General case' 0 C--N 1.273 -2.726 0 CA-C-N 113.695 -1.593 . . . . 72.04 110.267 -177.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -138.58 151.68 47.5 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.002 -1.111 . . . . 72.21 108.002 177.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.591 ' OD1' ' HB ' ' A' ' 544' ' ' THR . 69.0 m-20 -80.62 126.42 31.24 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.538 -1.282 . . . . 74.52 107.538 176.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 28.4 pt -76.06 126.54 86.66 Favored Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 123.381 0.425 . . . . 74.3 111.957 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -92.51 156.78 2.99 Favored 'Trans proline' 0 N--CA 1.445 -1.363 0 C-N-CA 122.674 2.249 . . . . 71.51 110.454 173.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -79.32 109.61 13.83 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 122.301 1.048 . . . . 61.03 109.972 178.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.2 p -95.05 17.08 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 122.871 1.32 . . . . 64.22 108.08 178.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -81.74 72.26 8.79 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 114.319 -1.309 . . . . 71.33 110.949 -177.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . -158.17 10.04 0.21 Allowed Glycine 0 C--N 1.291 -1.935 0 CA-C-N 114.793 -1.094 . . . . 42.22 110.71 177.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -139.92 176.44 8.75 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 106.378 -1.712 . . . . 73.01 106.378 -173.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 30.2 p -83.01 159.98 22.08 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 109.405 -0.591 . . . . 72.14 109.405 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.7 p -50.54 -41.11 19.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 123.84 0.856 . . . . 74.41 112.47 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -63.68 -42.41 98.03 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.344 0.593 . . . . 63.2 111.089 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 61.6 t -75.9 -38.62 36.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.806 -0.634 . . . . 71.5 110.105 -177.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.18 -48.56 77.86 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.105 -0.498 . . . . 52.35 111.442 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -61.95 -38.56 88.96 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.234 0.334 . . . . 60.35 110.541 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.487 ' O ' HG23 ' A' ' 514' ' ' VAL . 6.3 tmtm? -59.2 -48.96 79.66 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.937 -0.764 . . . . 65.31 108.937 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -62.65 -42.26 99.51 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 116.274 -0.421 . . . . 62.3 111.346 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 97.4 mt -65.26 -40.65 94.23 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.335 -0.393 . . . . 75.43 111.494 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -61.78 -37.98 86.37 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.951 -0.388 . . . . 62.02 109.951 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 510' ' ' LYS . 73.2 t -61.97 -35.75 70.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 115.633 -0.712 . . . . 54.23 110.83 176.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -78.92 -8.1 58.57 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 112.101 0.408 . . . . 73.02 112.101 -178.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 112.47 -13.44 25.48 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.439 -0.886 . . . . 74.34 112.381 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -81.43 95.75 7.16 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 106.905 -1.517 . . . . 73.22 106.905 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.8 m -98.17 -3.6 37.3 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 119.695 -0.802 . . . . 72.11 111.497 -172.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -120.54 114.56 21.92 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.457 -0.572 . . . . 71.33 109.457 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -131.35 150.76 52.02 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.903 -0.59 . . . . 71.2 110.775 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 49.7 m -127.94 143.23 51.09 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 107.445 -1.317 . . . . 73.31 107.445 174.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.31 125.6 51.34 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-O 120.906 0.384 . . . . 63.42 111.641 -178.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 523' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 554' ' ' GLN . . . -116.31 117.17 29.25 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.617 -0.883 . . . . 65.01 108.617 178.154 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 524' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 19.5 m -94.92 131.63 40.63 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.089 0.471 . . . . 71.23 112.144 -176.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 28.6 m -121.29 153.29 24.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 107.703 -1.221 . . . . 71.01 107.703 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -84.83 139.33 31.99 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.77 -0.772 . . . . 74.24 111.626 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 64.9 p -162.27 156.71 18.81 Favored Pre-proline 0 C--O 1.19 -2.066 0 N-CA-C 106.549 -1.649 . . . . 70.13 106.549 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -61.07 -12.89 24.82 Favored 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 122.005 1.803 . . . . 74.02 113.383 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -70.59 130.86 88.45 Favored Pre-proline 0 N--CA 1.45 -0.443 0 N-CA-C 108.52 -0.918 . . . . 74.4 108.52 178.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.3 147.26 78.07 Favored 'Trans proline' 0 C--O 1.253 1.25 0 C-N-CA 122.761 2.307 . . . . 74.41 113.301 -177.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.659 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -59.15 127.85 34.22 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.896 -1.047 . . . . 73.03 111.367 -175.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 119.43 -19.15 9.96 Favored Glycine 0 C--N 1.3 -1.424 0 N-CA-C 111.16 -0.776 . . . . 64.3 111.16 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -72.54 132.45 43.83 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.227 -0.657 . . . . 74.24 109.227 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 59.6 t -89.42 113.96 26.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 108.664 -0.865 . . . . 72.24 108.664 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 535' ' ' THR . . . . . 0.444 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 11.4 t -86.96 -20.49 27.22 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.695 -0.402 . . . . 72.31 111.173 -176.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 169.92 -163.4 36.82 Favored Glycine 0 CA--C 1.494 -1.239 0 C-N-CA 120.412 -0.899 . . . . 75.34 111.29 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 46.0 p -129.45 154.8 46.61 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.181 -1.414 . . . . 75.42 107.181 176.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -68.53 -54.2 14.78 Favored Pre-proline 0 C--N 1.309 -1.153 0 C-N-CA 119.959 -0.697 . . . . 63.32 110.446 177.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.32 136.91 29.94 Favored 'Trans proline' 0 C--N 1.371 1.74 0 CA-C-N 119.887 0.996 . . . . 62.51 110.009 175.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.1 145.08 65.85 Favored 'Trans proline' 0 C--O 1.254 1.284 0 C-N-CA 122.692 2.262 . . . . 74.44 113.186 -178.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.94 141.72 57.86 Favored 'General case' 0 C--O 1.247 0.952 0 CA-C-N 115.804 -0.634 . . . . 74.52 110.5 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 99.32 -12.03 61.75 Favored Glycine 0 N--CA 1.432 -1.604 0 CA-C-N 115.695 -0.684 . . . . 72.33 111.428 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 49.8 m -77.28 132.7 38.79 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 108.875 -0.787 . . . . 52.11 108.875 177.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.591 ' HB ' ' OD1' ' A' ' 496' ' ' ASP . 10.0 t -87.69 124.05 33.16 Favored 'General case' 0 N--CA 1.419 -2.006 0 CA-C-O 121.304 0.573 . . . . 72.35 109.699 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 19.6 m -125.88 154.89 73.59 Favored Pre-proline 0 C--N 1.297 -1.697 0 N-CA-C 108.15 -1.056 . . . . 73.31 108.15 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 13.1 Cg_exo -71.82 136.22 27.28 Favored 'Trans proline' 0 N--CA 1.443 -1.472 0 C-N-CA 121.842 1.694 . . . . 75.32 110.168 175.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 32.6 m -64.96 -19.89 26.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.941 0.877 . . . . 75.22 110.512 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -76.12 -14.86 60.17 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.247 -1.342 . . . . 71.13 111.027 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 67.4 m -94.51 -171.93 2.63 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.215 -0.448 . . . . 73.12 111.92 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 18.1 t -116.02 126.61 73.59 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 CA-C-N 116.262 -0.426 . . . . 63.34 110.325 -174.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 551' ' ' ILE . . . . . 0.51 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -102.49 145.91 11.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.556 -0.535 . . . . 63.15 109.556 175.697 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -108.82 121.46 45.11 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-O 121.406 0.622 . . . . 75.12 111.085 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 59.4 mt -97.99 134.5 41.02 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.389 -1.278 . . . . 74.12 108.315 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 554' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 523' ' ' ALA . 11.0 pt20 -106.33 119.5 39.41 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-O 122.158 0.98 . . . . 73.3 109.847 177.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 524' ' ' SER . 57.2 t -105.82 145.5 13.77 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 CA-C-N 113.898 -1.501 . . . . 75.42 109.977 -171.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.659 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 63.3 m -83.41 133.65 34.92 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-O 121.602 0.715 . . . . 55.45 111.613 178.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.77 137.35 42.71 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 104.829 -2.285 . . . . 75.22 104.829 169.043 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 558' ' ' GLY . . . . . 0.481 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -75.87 -47.82 11.07 Favored Glycine 0 N--CA 1.433 -1.524 0 C-N-CA 118.42 -1.847 . . . . 54.2 110.763 -175.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 5.7 t30 61.24 -7.51 0.09 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 113.458 0.91 . . . . 71.51 113.458 175.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.481 ' H ' ' C ' ' A' ' 558' ' ' GLY . 25.4 tp60 -139.32 141.23 37.7 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 103.354 -2.832 . . . . 64.43 103.354 -177.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -141.82 153.26 44.39 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 118.653 0.66 . . . . 72.24 111.067 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 70.2 t -69.58 118.19 13.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 N-CA-C 108.764 -0.828 . . . . 75.41 108.764 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 58.8 ttp -88.87 134.36 33.78 Favored Pre-proline 0 C--N 1.304 -1.395 0 C-N-CA 120.376 -0.529 . . . . 52.24 110.392 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -66.03 161.92 37.72 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.518 2.146 . . . . 75.23 109.92 171.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -80.89 132.68 35.46 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.147 -0.621 . . . . 75.11 111.793 -177.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 566' ' ' LEU . . . . . 0.466 HD12 ' SD ' ' A' ' 569' ' ' MET . 39.7 tp -138.16 19.28 2.79 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.326 -1.361 . . . . 71.22 107.326 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 11.9 m -73.72 131.37 41.53 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.25 -0.886 . . . . 43.34 110.707 -173.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 568' ' ' GLY . . . . . 0.462 ' H ' ' HB ' ' A' ' 603' ' ' VAL . . . 71.56 9.87 69.95 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 114.397 0.519 . . . . 52.54 114.397 176.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 569' ' ' MET . . . . . 0.466 ' SD ' HD12 ' A' ' 566' ' ' LEU . 86.7 mtp -90.73 153.63 20.13 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.197 -0.668 . . . . 73.54 109.197 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 570' ' ' PHE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 98.8 m-85 -73.24 140.28 46.78 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 120.721 0.296 . . . . 75.31 110.757 -175.471 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 571' ' ' TRP . . . . . 0.409 ' HA ' ' HB3' ' A' ' 574' ' ' ALA . 32.1 t90 -66.01 -17.89 64.98 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 123.859 0.864 . . . . 74.0 110.335 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 35.3 m -78.05 -24.2 13.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.244 0.545 . . . . 64.44 109.96 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 573' ' ' ASP . . . . . 0.644 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 31.4 t70 -101.43 -28.26 12.68 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.341 -0.845 . . . . 73.23 109.637 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 574' ' ' ALA . . . . . 0.409 ' HB3' ' HA ' ' A' ' 571' ' ' TRP . . . -65.92 -32.37 73.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.86 -0.609 . . . . 52.04 110.851 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.54 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 12.9 tp10 -57.79 -53.29 67.24 Favored Pre-proline 0 CA--C 1.583 2.235 0 CA-C-N 115.879 -0.6 . . . . 73.23 111.136 177.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 576' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 573' ' ' ASP . 50.6 Cg_exo -59.56 -36.64 92.29 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 121.32 1.346 . . . . 71.31 112.699 171.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.644 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 22.8 mmt180 -59.8 -44.66 93.85 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 120.75 0.309 . . . . 65.2 110.677 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.4 pp -65.44 -40.43 93.27 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.024 -0.535 . . . . 74.01 112.247 -175.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 579' ' ' ARG . . . . . 0.452 ' N ' HD12 ' A' ' 578' ' ' LEU . 73.6 mtp180 -65.72 -35.39 80.61 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.148 0.499 . . . . 73.04 110.951 176.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.33 -39.11 74.93 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.001 -0.545 . . . . 74.43 111.192 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 89.0 mt -83.03 -7.27 59.68 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.385 0.513 . . . . 74.35 112.385 -177.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 74.28 39.52 43.49 Favored Glycine 0 C--O 1.241 0.585 0 C-N-CA 120.638 -0.791 . . . . 72.24 111.533 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 33.2 t90 -67.72 127.16 31.73 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 109.579 -0.526 . . . . 65.43 109.579 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 3.7 m -116.76 10.3 14.21 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.466 -0.938 . . . . 64.12 108.466 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -77.69 177.4 53.0 Favored Glycine 0 N--CA 1.431 -1.67 0 CA-C-N 115.354 -0.839 . . . . 74.5 113.51 -173.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 52.4 tpp -104.24 140.3 38.04 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 109.235 -0.654 . . . . 72.43 109.235 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -80.58 130.23 35.0 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.071 -1.826 . . . . 74.44 106.071 176.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -95.04 102.07 13.86 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.486 0.66 . . . . 73.24 110.592 -176.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -88.38 110.17 20.58 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.914 -1.039 . . . . 74.52 109.228 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 590' ' ' GLY . . . . . 0.435 ' HA3' ' NH2' ' A' ' 623' ' ' ARG . . . -114.22 -86.73 1.46 Allowed Glycine 0 N--CA 1.43 -1.706 0 N-CA-C 109.7 -1.36 . . . . 54.02 109.7 176.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.19 147.99 42.54 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.21 -1.034 . . . . 63.35 108.21 176.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -90.74 141.39 28.85 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.214 -1.032 . . . . 64.35 108.214 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 60.8 t -107.43 121.7 60.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 110.575 -0.157 . . . . 63.35 110.575 -173.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -86.55 107.5 18.15 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.165 -1.014 . . . . 42.15 108.577 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -150.03 22.67 0.86 Allowed 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.974 -0.75 . . . . 61.43 108.974 -177.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 92.06 82.35 1.46 Allowed Glycine 0 N--CA 1.424 -2.147 0 N-CA-C 109.385 -1.486 . . . . 41.42 109.385 -176.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.18 -43.85 88.9 Favored Glycine 0 C--O 1.208 -1.49 0 O-C-N 123.93 0.429 . . . . 72.2 112.645 -175.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 25.5 m -59.23 -28.72 66.94 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 113.377 0.88 . . . . 73.04 113.377 -178.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -106.85 -12.59 15.45 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.367 0.603 . . . . 62.23 111.456 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 600' ' ' HIS . . . . . 0.5 ' C ' ' H ' ' A' ' 602' ' ' ARG . 35.6 m80 -130.62 22.22 5.07 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 113.49 0.922 . . . . 65.15 113.49 -173.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -77.41 37.57 0.22 Allowed 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 122.429 1.109 . . . . 54.31 109.761 175.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 602' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 12.1 ptt180 -125.44 166.53 16.44 Favored 'General case' 0 N--CA 1.412 -2.368 0 C-N-CA 125.703 1.601 . . . . 74.34 108.305 -176.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 603' ' ' VAL . . . . . 0.462 ' HB ' ' H ' ' A' ' 568' ' ' GLY . 55.6 t -63.46 129.84 27.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.458 -0.941 . . . . 75.34 108.458 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 35.3 m -94.66 -45.02 13.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 119.999 -0.681 . . . . 72.44 110.464 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -131.02 146.59 52.44 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 106.062 -1.829 . . . . 73.24 106.062 174.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 606' ' ' GLN . . . . . 0.41 ' OE1' ' HD2' ' A' ' 608' ' ' PRO . 0.1 OUTLIER -120.51 129.33 53.78 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 107.331 -1.359 . . . . 70.25 107.331 -175.946 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.548 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 30.5 t30 -84.9 -71.76 0.1 Allowed Pre-proline 0 CA--C 1.563 1.465 0 N-CA-C 114.687 1.366 . . . . 64.1 114.687 -173.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 6.1 Cg_exo -76.14 114.77 3.98 Favored 'Trans proline' 0 C--N 1.372 1.775 0 CA-C-N 122.05 1.768 . . . . 51.02 109.547 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -63.29 135.57 50.98 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 122.476 2.117 . . . . 55.14 114.205 -171.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.84 138.69 56.3 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.041 -0.981 . . . . 63.43 109.379 177.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 94.45 -19.54 53.02 Favored Glycine 0 C--N 1.302 -1.319 0 N-CA-C 110.662 -0.975 . . . . 63.41 110.662 -176.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 28.9 m -98.58 162.75 12.97 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 107.878 -1.156 . . . . 72.03 107.878 178.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -74.39 116.47 5.2 Favored Glycine 0 N--CA 1.424 -2.137 0 CA-C-O 121.43 0.461 . . . . 55.14 112.462 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 20.5 m -104.94 144.48 14.68 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 107.194 -1.409 . . . . 64.3 107.194 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.517 HD21 HG22 ' A' ' 619' ' ' ILE . 28.4 p30 -48.43 148.59 1.9 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 112.513 0.561 . . . . 70.24 112.513 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -55.38 -24.42 29.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.598 -0.728 . . . . 72.25 112.408 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 617' ' ' ASP . . . . . 0.467 ' OD2' ' HB ' ' A' ' 619' ' ' ILE . 19.2 t70 -61.52 -53.22 59.19 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.569 -1.271 . . . . 73.34 107.569 175.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 96.5 19.33 27.93 Favored Glycine 0 N--CA 1.419 -2.445 0 CA-C-N 114.992 -1.004 . . . . 60.31 111.416 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 619' ' ' ILE . . . . . 0.517 HG22 HD21 ' A' ' 615' ' ' ASN . 0.0 OUTLIER -69.18 119.93 15.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 122.151 0.977 . . . . 55.51 109.73 -173.433 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.27 130.37 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.602 0 CA-C-N 114.611 -1.177 . . . . 75.03 108.158 -176.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 6.5 m -98.26 118.01 33.95 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.38 -0.97 . . . . 73.43 108.38 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 622' ' ' LEU . . . . . 0.604 ' O ' ' HD2' ' A' ' 623' ' ' ARG . 2.4 pt? -138.78 157.69 45.61 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.063 -0.517 . . . . 70.25 109.814 -177.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 623' ' ' ARG . . . . . 0.604 ' HD2' ' O ' ' A' ' 622' ' ' LEU . 6.9 mpt_? -129.63 143.08 50.66 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 105.202 -2.147 . . . . 73.43 105.202 171.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -141.22 165.23 28.1 Favored 'General case' 0 C--N 1.293 -1.861 0 O-C-N 123.896 0.747 . . . . 75.34 110.51 -178.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -66.55 138.74 36.23 Favored Glycine 0 N--CA 1.426 -2.004 0 CA-C-N 114.813 -1.085 . . . . 64.33 112.726 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 . . . . . 0 C--N 1.286 -2.158 0 C-N-CA 124.736 1.214 . . . . 74.44 109.02 -178.349 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 CA--C 1.48 -1.725 0 N-CA-C 108.887 -0.783 . . . . 45.21 108.887 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 360' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 409' ' ' SER . 31.2 m -133.81 159.51 42.45 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 CA-C-N 115.332 -0.849 . . . . 43.34 108.747 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -93.99 138.26 32.3 Favored 'General case' 0 N--CA 1.39 -3.437 0 N-CA-C 107.45 -1.315 . . . . 72.43 107.45 174.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 78.1 t -95.72 129.43 34.52 Favored Pre-proline 0 C--N 1.267 -3.001 0 CA-C-N 115.297 -0.865 . . . . 63.44 109.056 -172.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -57.77 127.71 26.28 Favored 'Trans proline' 0 CA--C 1.498 -1.302 0 C-N-CA 122.233 1.955 . . . . 73.44 110.153 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -80.21 126.36 31.02 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.196 -1.039 . . . . 75.32 108.196 -174.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 10.7 m -88.88 1.24 7.15 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 N-CA-C 113.387 0.884 . . . . 71.45 113.387 -173.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -56.48 144.7 30.31 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 123.584 0.552 . . . . 73.25 111.206 176.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.69 -16.6 47.43 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.728 -0.669 . . . . 53.12 112.398 -178.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -99.27 -156.12 0.53 Allowed 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 108.368 -0.975 . . . . 73.13 108.368 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 369' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 95.8 p -98.86 175.1 6.07 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 107.375 -1.343 . . . . 53.21 107.375 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.0 p -63.17 -44.71 94.66 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 109.799 -0.445 . . . . 71.34 109.799 175.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.58 -46.27 83.44 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 116.216 -0.447 . . . . 72.03 111.299 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 372' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 369' ' ' SER . 4.1 m-20 -64.52 -38.47 91.14 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 121.0 0.429 . . . . 73.54 111.64 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -67.49 -47.88 68.72 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.98 -0.554 . . . . 64.22 110.575 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 82.1 mt -60.98 -43.72 96.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-N 115.728 -0.669 . . . . 75.52 110.411 176.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.76 -42.75 89.63 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 115.856 -0.611 . . . . 65.2 111.002 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 376' ' ' THR . . . . . 0.564 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 31.2 m -67.37 -48.01 68.7 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.738 -0.664 . . . . 74.33 110.228 -178.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 92.0 mt -64.64 -39.0 92.92 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 112.152 0.427 . . . . 75.21 112.152 -178.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 63.8 tp60 -64.43 -41.21 96.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.803 0.335 . . . . 72.22 110.176 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -70.05 -20.56 63.23 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 112.176 0.436 . . . . 70.03 112.176 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 380' ' ' ARG . . . . . 0.564 ' HG2' ' O ' ' A' ' 376' ' ' THR . 5.9 mmp_? -86.43 -12.62 48.6 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.023 0.439 . . . . 71.42 109.869 176.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.09 3.95 55.53 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 121.182 -0.532 . . . . 72.53 112.982 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -80.66 164.81 22.56 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-O 120.954 0.407 . . . . 74.4 110.301 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -108.43 141.52 40.17 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 107.531 -1.285 . . . . 71.12 107.531 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 384' ' ' ILE . . . . . 0.472 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -124.58 152.79 30.86 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.491 0 CA-C-O 121.323 0.583 . . . . 71.05 110.199 -177.039 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -133.07 127.05 33.18 Favored 'General case' 0 N--CA 1.4 -2.974 0 N-CA-C 106.644 -1.613 . . . . 65.41 106.644 175.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 21.0 m -118.36 123.27 44.89 Favored 'General case' 0 C--N 1.271 -2.821 0 N-CA-C 107.887 -1.153 . . . . 74.24 107.887 -175.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.17 121.37 44.74 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.873 -1.158 . . . . 71.35 107.873 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 388' ' ' GLN . . . . . 0.447 ' HB3' HG21 ' A' ' 422' ' ' THR . 1.4 mp0 -94.08 126.67 39.43 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.3 -0.629 . . . . 75.05 109.3 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 389' ' ' LYS . . . . . 0.409 ' HD2' HG21 ' A' ' 394' ' ' ILE . 97.3 mttt -130.87 136.57 29.11 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 110.055 -0.35 . . . . 64.03 110.055 175.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 390' ' ' PRO . . . . . 0.57 ' HA ' ' O ' ' A' ' 422' ' ' THR . 23.5 Cg_exo -68.06 166.45 24.85 Favored 'Trans proline' 0 C--O 1.248 0.984 0 C-N-CA 122.066 1.844 . . . . 62.01 110.125 172.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 2.9 m-20 85.04 170.25 0.08 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.349 1.059 . . . . 64.14 110.645 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 69.3 p -108.82 9.28 26.84 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 120.677 0.275 . . . . 70.34 111.39 -176.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 15.4 t -78.43 -7.02 56.91 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.627 0.727 . . . . 50.22 110.901 -177.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.515 HD13 ' H ' ' A' ' 394' ' ' ILE . 0.2 OUTLIER -115.87 151.5 46.47 Favored Pre-proline 0 C--N 1.298 -1.656 0 N-CA-C 107.882 -1.155 . . . . 65.53 107.882 175.798 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -32.79 131.24 0.1 Allowed 'Trans proline' 0 C--N 1.363 1.316 0 C-N-CA 124.569 3.513 . . . . 75.43 114.928 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.25 164.37 3.85 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 124.476 3.451 . . . . 72.32 113.352 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -56.43 -8.64 0.56 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.525 1.13 . . . . 74.11 112.355 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 60.3 m170 -115.79 131.61 56.89 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 104.563 -2.384 . . . . 65.43 104.563 170.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 24.7 m -71.03 117.15 13.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-O 121.978 0.894 . . . . 65.4 111.453 -169.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 50.0 mm -102.99 -26.66 3.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.078 -1.082 . . . . 54.02 108.078 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -144.31 157.53 27.2 Favored Glycine 0 N--CA 1.399 -3.807 0 N-CA-C 109.486 -1.446 . . . . 42.21 109.486 -178.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 8.0 p -146.56 -176.17 5.08 Favored 'General case' 0 C--N 1.275 -2.662 0 C-N-CA 125.111 1.364 . . . . 71.44 107.808 -172.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -100.58 139.74 20.85 Favored Pre-proline 0 C--N 1.29 -2.004 0 N-CA-C 108.272 -1.01 . . . . 72.12 108.272 -174.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.21 -12.89 6.02 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 123.951 3.101 . . . . 74.32 114.691 -176.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -50.05 -41.29 47.44 Favored 'General case' 0 C--O 1.212 -0.902 0 C-N-CA 123.742 0.817 . . . . 73.35 111.584 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -71.46 -32.77 68.68 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.291 0.567 . . . . 54.11 111.398 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -85.32 -1.17 56.68 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.709 0.766 . . . . 70.34 110.683 -177.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 19.0 m -102.19 151.01 22.71 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 107.1 -1.444 . . . . 64.54 107.1 174.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 409' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 360' ' ' VAL . 20.2 m -74.68 113.83 12.4 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 108.876 -0.787 . . . . 64.33 108.876 178.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.6 m -120.24 170.3 10.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 116.272 -0.422 . . . . 73.23 110.551 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 25.8 t -77.38 150.97 35.04 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.096 -1.076 . . . . 73.43 108.096 176.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -65.61 122.12 16.52 Favored 'General case' 0 C--O 1.245 0.836 0 N-CA-C 109.413 -0.588 . . . . 52.13 109.413 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 94.62 68.25 1.04 Allowed Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 110.25 -1.14 . . . . 42.2 110.25 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -127.96 -179.51 5.01 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.528 -1.286 . . . . 50.33 107.528 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -111.4 119.65 39.53 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.049 0.452 . . . . 74.34 110.674 -174.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 46.1 mm -106.21 120.83 57.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 109.203 -0.666 . . . . 63.52 109.203 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 22.4 p -92.55 130.88 38.07 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.016 0.436 . . . . 74.45 111.307 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 5.4 p -126.82 135.33 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 109.072 -0.714 . . . . 54.1 109.072 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 419' ' ' ASN . . . . . 0.439 ' H ' HD22 ' A' ' 419' ' ' ASN . 0.0 OUTLIER -111.81 125.76 54.35 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 109.41 -0.589 . . . . 73.31 109.41 178.705 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 11.5 p -121.51 143.93 32.32 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 115.478 -0.783 . . . . 63.1 110.727 -174.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 31.3 t -84.16 121.46 27.48 Favored 'General case' 0 C--O 1.252 1.197 0 CA-C-N 115.682 -0.69 . . . . 54.43 109.679 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 422' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 390' ' ' PRO . 14.4 t -121.08 107.73 12.97 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 115.83 -0.623 . . . . 74.04 111.759 175.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.357 0 C-N-CA 119.099 -1.524 . . . . 72.13 115.424 172.426 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.415 ' HG3' ' HB ' ' A' ' 477' ' ' THR . 18.9 tp60 . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 106.291 -1.744 . . . . 72.35 106.291 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.545 ' HG3' ' O ' ' A' ' 447' ' ' ALA . 5.0 mmp_? -127.7 148.89 50.41 Favored 'General case' 0 C--O 1.209 -1.073 0 N-CA-C 113.815 1.043 . . . . 75.23 113.815 -178.001 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -83.42 138.52 33.44 Favored 'General case' 0 C--N 1.286 -2.157 0 C-N-CA 126.237 1.815 . . . . 74.42 110.548 178.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.457 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 66.5 mt -83.59 119.28 73.5 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 108.684 -0.858 . . . . 55.5 108.684 177.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.83 152.53 63.85 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.909 2.406 . . . . 63.12 113.823 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -91.42 110.1 21.39 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 115.763 -0.653 . . . . 71.22 109.457 176.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 42.2 t -116.77 150.34 18.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.354 -0.98 . . . . 61.13 108.354 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.595 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 17.0 m -68.62 150.88 47.47 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 121.071 0.462 . . . . 64.24 110.975 -179.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 40.5 p -69.77 -27.33 64.84 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 123.75 0.82 . . . . 71.53 113.179 -172.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.9 pp -88.07 -11.13 48.06 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.46 0.647 . . . . 65.2 111.349 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.595 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 0.8 OUTLIER -99.59 45.37 0.99 Allowed 'General case' 0 CA--C 1.56 1.341 0 CA-C-N 115.464 -0.789 . . . . 74.25 109.869 -175.672 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -52.65 -38.91 61.2 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 114.198 1.184 . . . . 65.44 114.198 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.49 ' O ' ' HG3' ' A' ' 442' ' ' LYS . . . -64.69 -39.56 93.87 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 120.527 -0.469 . . . . 52.44 110.544 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -65.77 -36.17 82.78 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 108.684 -0.858 . . . . 75.11 108.684 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.535 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.91 -51.63 68.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.172 -0.467 . . . . 63.32 111.46 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 27.2 m -65.86 -39.02 83.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 112.321 0.489 . . . . 65.43 112.321 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 438' ' ' ALA 0.3 0.0 OUTLIER -68.37 -34.07 75.4 Favored 'General case' 0 C--O 1.214 -0.764 0 N-CA-C 112.985 0.735 . . . . 73.2 112.985 176.483 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -61.25 -43.38 98.98 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.047 0.451 . . . . 73.34 110.056 175.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.535 HD13 ' O ' ' A' ' 440' ' ' ALA . 7.1 mp -63.67 -35.75 81.56 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.599 -0.728 . . . . 73.44 110.706 177.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.616 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 26.9 m -71.16 -45.98 62.41 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.108 -0.496 . . . . 64.23 111.078 178.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -65.41 -20.05 66.21 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.227 0.611 . . . . 74.42 110.995 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 447' ' ' ALA . . . . . 0.545 ' O ' ' HG3' ' A' ' 427' ' ' ARG . . . -79.35 -3.92 48.5 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.853 -0.612 . . . . 61.21 111.433 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 118.05 -78.6 0.3 Allowed Glycine 0 CA--C 1.49 -1.503 0 C-N-CA 120.716 -0.754 . . . . 73.42 111.562 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 449' ' ' PHE . . . . . 0.465 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 2.8 p90 -43.48 -66.82 0.33 Allowed 'General case' 0 C--O 1.241 0.652 0 N-CA-C 113.473 0.916 . . . . 61.3 113.473 177.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 450' ' ' GLY . . . . . 0.616 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 62.19 27.63 69.4 Favored Glycine 0 CA--C 1.487 -1.671 0 N-CA-C 111.037 -0.825 . . . . 74.42 111.037 -175.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -103.91 110.11 22.11 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 106.701 -1.592 . . . . 75.43 106.701 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 27.9 p90 -135.67 154.71 51.2 Favored 'General case' 0 N--CA 1.408 -2.547 0 CA-C-N 115.66 -0.7 . . . . 74.32 109.721 -176.027 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -130.77 122.9 28.03 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 107.783 -1.191 . . . . 74.15 107.783 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -86.8 129.98 34.65 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.975 -0.75 . . . . 64.11 108.975 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -136.43 140.95 43.52 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 116.358 -0.383 . . . . 63.32 110.084 177.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -114.14 146.24 40.57 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 106.903 -1.517 . . . . 75.13 106.903 175.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 52.7 m -148.6 150.22 33.08 Favored Pre-proline 0 C--N 1.28 -2.449 0 N-CA-C 108.487 -0.931 . . . . 60.43 108.487 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.681 ' HA ' ' O ' ' A' ' 490' ' ' SER . 37.5 Cg_endo -66.69 132.77 29.69 Favored 'Trans proline' 0 N--CA 1.442 -1.536 0 C-N-CA 121.667 1.578 . . . . 63.13 110.423 177.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 21.2 m -142.38 178.12 7.8 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.042 -0.725 . . . . 72.43 109.042 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 6.9 t -62.34 137.54 96.06 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 109.691 -0.485 . . . . 63.21 109.691 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.42 -29.36 30.73 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 124.415 3.41 . . . . 73.35 113.62 -176.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -67.92 -33.36 74.54 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-O 120.943 0.401 . . . . 73.22 111.398 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.35 -20.04 23.32 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 111.904 0.335 . . . . 75.45 111.904 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 78.0 t -52.28 133.35 14.25 Favored 'Isoleucine or valine' 0 C--O 1.245 0.85 0 O-C-N 123.603 0.564 . . . . 72.34 111.016 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.88 -20.3 48.48 Favored Glycine 0 N--CA 1.438 -1.191 0 CA-C-N 115.646 -0.706 . . . . 54.05 112.292 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -113.33 166.28 11.63 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 117.103 0.451 . . . . 74.5 110.21 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.439 HG22 HG12 ' A' ' 488' ' ' VAL . 77.6 t -72.85 143.3 14.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 115.563 -0.744 . . . . 71.34 109.237 177.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 50.5 mm -96.89 -31.78 4.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 107.532 -1.285 . . . . 61.02 107.532 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 153.4 -163.96 30.87 Favored Glycine 0 N--CA 1.422 -2.287 0 CA-C-N 115.539 -0.755 . . . . 42.51 111.893 175.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.71 139.14 50.89 Favored 'General case' 0 N--CA 1.413 -2.277 0 N-CA-C 106.62 -1.622 . . . . 74.32 106.62 176.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.483 ' HB3' HG23 ' A' ' 485' ' ' ILE . 27.4 t-20 -64.96 -51.04 59.14 Favored Pre-proline 0 N--CA 1.471 0.605 0 CA-C-O 119.228 -0.415 . . . . 74.01 111.003 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.458 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 21.8 Cg_exo -70.29 130.52 18.83 Favored 'Trans proline' 0 C--N 1.371 1.761 0 N-CA-C 107.131 -1.911 . . . . 72.14 107.131 169.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.468 ' C ' ' H ' ' A' ' 475' ' ' ASN . 39.7 Cg_exo -62.06 133.51 44.5 Favored 'Trans proline' 0 C--O 1.24 0.595 0 C-N-CA 121.856 1.704 . . . . 74.13 113.212 -174.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.457 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -70.92 14.49 0.14 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.159 1.384 . . . . 15.43 111.588 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 475' ' ' ASN . . . . . 0.468 ' H ' ' C ' ' A' ' 473' ' ' PRO . 16.3 m120 -109.19 -13.72 14.61 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 108.484 -0.932 . . . . 75.54 108.484 -178.176 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -104.79 178.86 4.44 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.547 -0.751 . . . . 73.44 111.344 -175.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.415 ' HB ' ' HG3' ' A' ' 426' ' ' GLN . 0.9 OUTLIER -106.59 137.84 43.86 Favored 'General case' 0 N--CA 1.396 -3.142 0 CA-C-N 115.573 -0.74 . . . . 72.13 110.898 -179.595 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 12.3 p -117.13 149.65 40.0 Favored 'General case' 0 N--CA 1.424 -1.75 0 C-N-CA 123.97 0.908 . . . . 62.41 110.145 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -80.83 158.53 25.36 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.916 -0.584 . . . . 44.21 110.129 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 480' ' ' ILE . . . . . 0.465 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 37.0 mm -69.72 -17.53 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 122.231 1.015 . . . . 63.1 110.318 -178.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 7.4 p -100.09 2.02 42.8 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.654 -0.703 . . . . 71.44 111.403 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -95.75 134.9 38.14 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.048 -0.524 . . . . 60.45 110.846 -175.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 37.6 t -99.88 116.44 43.16 Favored 'Isoleucine or valine' 0 C--O 1.243 0.754 0 N-CA-C 109.228 -0.656 . . . . 71.22 109.228 -177.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 32.1 m -99.72 136.79 29.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 121.436 0.636 . . . . 65.52 111.384 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.483 HG23 ' HB3' ' A' ' 471' ' ' ASN . 0.0 OUTLIER -99.98 128.35 51.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 121.452 0.644 . . . . 73.55 111.742 -176.841 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 16.3 mt -112.56 128.25 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 CA-C-N 114.599 -1.182 . . . . 72.51 109.88 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 6.1 tt -111.03 126.71 68.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-N 115.151 -0.931 . . . . 63.01 110.515 -173.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.439 HG12 HG22 ' A' ' 467' ' ' VAL . 35.0 m -105.56 149.52 8.93 Favored 'Isoleucine or valine' 0 C--O 1.254 1.306 0 CA-C-N 115.933 -0.576 . . . . 72.34 110.032 177.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -84.22 125.97 7.37 Favored Glycine 0 N--CA 1.437 -1.279 0 N-CA-C 111.372 -0.691 . . . . 73.15 111.372 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.681 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 25.5 t . . . . . 0 N--CA 1.422 -1.865 0 N-CA-C 107.075 -1.454 . . . . 73.44 107.075 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo . . . . . 0 C--O 1.249 1.057 0 CA-C-O 121.052 0.355 . . . . 75.42 111.853 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -104.37 118.99 37.95 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-O 121.44 0.638 . . . . 54.12 109.677 -177.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 11.0 p -116.82 143.15 46.02 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 115.018 -0.992 . . . . 73.54 109.66 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 495' ' ' LYS . . . . . 0.43 ' HE2' ' HA ' ' A' ' 495' ' ' LYS . 3.5 mmpt? -146.86 151.67 37.45 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 123.168 0.587 . . . . 73.54 109.837 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.539 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.2 p-10 -87.24 135.38 33.33 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.84 -1.17 . . . . 73.32 107.84 174.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 26.2 pt -75.26 121.01 84.31 Favored Pre-proline 0 C--N 1.294 -1.813 0 CA-C-N 115.784 -0.644 . . . . 72.22 109.729 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -75.25 159.9 39.92 Favored 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 122.184 1.923 . . . . 61.22 111.765 -177.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -77.84 90.27 4.08 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 106.272 -1.751 . . . . 74.04 106.272 174.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 10.0 p -96.65 7.5 7.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-O 122.319 1.056 . . . . 53.24 110.427 -171.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -78.06 79.05 4.53 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.203 -0.908 . . . . 63.21 111.932 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . -178.13 31.75 0.07 OUTLIER Glycine 0 C--N 1.304 -1.197 0 N-CA-C 110.703 -0.959 . . . . 61.54 110.703 177.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -157.51 -177.37 6.54 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 107.956 -1.127 . . . . 73.3 107.956 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 5.9 t -91.23 156.81 17.56 Favored 'General case' 0 N--CA 1.426 -1.642 0 C-N-CA 119.02 -1.072 . . . . 42.22 109.738 -177.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.5 p -54.16 -40.27 46.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 C-N-CA 124.707 1.203 . . . . 71.41 111.271 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -60.9 -43.38 98.59 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.624 -0.716 . . . . 71.41 110.697 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 64.0 t -76.77 -37.13 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-N 116.042 -0.526 . . . . 72.21 110.241 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 508' ' ' ALA . . . . . 0.48 ' O ' ' HG ' ' A' ' 512' ' ' LEU . . . -62.9 -48.87 77.11 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.93 -0.577 . . . . 63.25 111.662 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -65.18 -35.66 81.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.762 0.315 . . . . 61.32 110.246 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.521 ' O ' HG23 ' A' ' 514' ' ' VAL . 26.2 tptp -64.15 -45.37 88.75 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.848 -0.797 . . . . 74.23 108.848 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -62.27 -42.69 99.56 Favored 'General case' 0 CA--C 1.505 -0.78 0 O-C-N 123.609 0.568 . . . . 71.23 110.775 177.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 512' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 508' ' ' ALA . 87.5 mt -59.93 -42.94 95.07 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 116.447 -0.342 . . . . 55.13 110.612 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -62.28 -37.86 87.09 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 116.253 -0.431 . . . . 54.34 110.586 177.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 510' ' ' LYS . 92.6 t -61.87 -35.68 69.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.898 -0.592 . . . . 63.23 110.735 177.24 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -78.26 -19.58 53.41 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.213 0.53 . . . . 75.44 110.213 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 117.93 -5.98 15.78 Favored Glycine 0 N--CA 1.436 -1.326 0 C-N-CA 120.639 -0.791 . . . . 71.53 112.678 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.607 ' HA ' ' O ' ' A' ' 547' ' ' VAL . 74.6 m-85 -68.83 122.18 18.07 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 121.214 0.53 . . . . 74.51 110.642 -178.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 518' ' ' THR . . . . . 0.419 ' OG1' ' HA ' ' A' ' 548' ' ' ASP . 10.7 p -93.64 -39.7 10.67 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.567 -0.742 . . . . 71.42 112.357 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -108.43 114.94 29.18 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 122.152 0.977 . . . . 72.44 113.139 -171.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 520' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' A' ' 551' ' ' ILE . 46.2 p90 -130.72 151.58 51.01 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.566 -1.197 . . . . 73.11 110.167 176.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 25.1 m -125.17 143.03 51.14 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.111 -1.07 . . . . 74.24 108.111 176.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -117.91 119.71 35.67 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.827 -0.434 . . . . 73.33 109.827 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 523' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 554' ' ' GLN . . . -127.39 125.94 41.56 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.72 -0.844 . . . . 74.21 108.72 178.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 524' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 20.6 m -101.65 138.5 38.56 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.878 -0.329 . . . . 52.24 111.568 -178.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 30.1 m -123.71 149.38 27.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 108.415 -0.957 . . . . 62.35 108.415 176.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 526' ' ' ASP . . . . . 0.501 ' HA ' ' HB3' ' A' ' 557' ' ' LYS . 4.7 p-10 -69.57 136.02 50.77 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 121.248 0.547 . . . . 71.53 110.717 -177.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 25.6 p -163.01 167.56 11.64 Favored Pre-proline 0 C--N 1.307 -1.257 0 CA-C-N 115.237 -0.892 . . . . 75.02 109.046 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -77.39 6.56 4.31 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 122.483 2.122 . . . . 73.12 112.839 176.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -96.52 140.51 22.22 Favored Pre-proline 0 N--CA 1.445 -0.679 0 N-CA-C 108.206 -1.035 . . . . 74.31 108.206 175.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -64.42 161.4 34.96 Favored 'Trans proline' 0 C--O 1.246 0.908 0 C-N-CA 122.996 2.464 . . . . 75.53 113.962 -174.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.588 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -66.38 120.77 13.91 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.289 -0.868 . . . . 75.21 110.078 -178.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 122.94 -27.25 5.95 Favored Glycine 0 N--CA 1.434 -1.435 0 C-N-CA 120.657 -0.782 . . . . 71.44 111.594 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -69.63 125.61 27.23 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.358 -0.608 . . . . 65.34 109.358 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 94.0 t -81.48 111.6 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 N-CA-C 107.568 -1.271 . . . . 60.11 107.568 176.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 11.7 t -95.05 -16.22 22.86 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 120.63 -0.428 . . . . 62.13 111.982 -174.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 174.68 -175.13 46.89 Favored Glycine 0 CA--C 1.489 -1.564 0 C-N-CA 120.326 -0.94 . . . . 73.3 111.33 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 23.4 p -129.33 157.18 42.61 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.414 -0.958 . . . . 73.11 108.414 176.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.435 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 26.0 t-20 -73.06 -53.16 5.14 Favored Pre-proline 0 C--N 1.309 -1.186 0 C-N-CA 120.634 -0.427 . . . . 62.14 111.283 177.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.435 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 13.8 Cg_exo -72.86 136.45 25.24 Favored 'Trans proline' 0 C--N 1.368 1.605 0 N-CA-C 108.375 -1.433 . . . . 61.13 108.375 172.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -59.45 139.92 91.75 Favored 'Trans proline' 0 C--O 1.262 1.702 0 C-N-CA 122.2 1.933 . . . . 61.42 112.258 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -67.88 141.34 56.44 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.438 -0.801 . . . . 62.55 109.276 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 102.14 -12.27 57.28 Favored Glycine 0 N--CA 1.427 -1.932 0 C-N-CA 120.976 -0.63 . . . . 55.4 111.664 -176.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 45.8 m -72.57 126.94 31.08 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 116.943 0.372 . . . . 52.12 110.327 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 10.2 t -83.73 123.17 29.58 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.455 0.645 . . . . 73.53 110.029 177.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.9 m -138.21 157.46 72.69 Favored Pre-proline 0 C--N 1.305 -1.348 0 N-CA-C 108.972 -0.751 . . . . 74.54 108.972 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -65.89 150.5 85.69 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 121.554 1.503 . . . . 62.0 110.108 173.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' A' ' 517' ' ' PHE . 26.9 m -59.97 -20.2 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 113.316 0.858 . . . . 52.41 113.316 -177.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 548' ' ' ASP . . . . . 0.419 ' HA ' ' OG1' ' A' ' 518' ' ' THR . 9.7 t70 -95.09 4.92 53.17 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.603 0.716 . . . . 64.21 111.454 -177.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.1 t -71.62 171.58 11.2 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 109.4 -0.593 . . . . 74.11 109.4 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 49.1 t -101.12 112.82 35.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 109.836 -0.431 . . . . 52.13 109.836 -177.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 551' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 520' ' ' PHE . 2.9 mp -101.14 121.85 52.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.763 -0.829 . . . . 73.23 108.763 178.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -102.69 116.41 32.53 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.17 0.509 . . . . 73.52 110.082 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 4.6 mp -97.22 134.13 40.93 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.05 -0.977 . . . . 63.32 108.682 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 554' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 523' ' ' ALA . 52.7 mt-30 -105.21 114.83 29.26 Favored 'General case' 0 N--CA 1.414 -2.26 0 CA-C-O 122.03 0.919 . . . . 73.2 108.852 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 524' ' ' SER . 22.1 t -101.85 147.6 8.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 CA-C-N 113.967 -1.469 . . . . 70.01 108.855 -172.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.588 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 23.4 m -76.43 130.84 38.6 Favored 'General case' 0 N--CA 1.412 -2.35 0 CA-C-O 121.863 0.84 . . . . 52.4 112.447 177.144 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.501 ' HB3' ' HA ' ' A' ' 526' ' ' ASP . 10.2 tppt? -90.88 123.71 34.61 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 104.096 -2.557 . . . . 74.42 104.096 167.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -66.69 -42.3 93.34 Favored Glycine 0 CA--C 1.482 -2.009 0 N-CA-C 109.98 -1.248 . . . . 73.54 109.98 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 9.5 t30 65.57 21.15 11.72 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 122.171 0.986 . . . . 70.25 110.352 172.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -134.8 156.23 49.24 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.509 -0.769 . . . . 73.25 111.537 -176.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -133.4 156.73 47.14 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.395 -0.965 . . . . 73.53 108.395 176.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 54.9 t -73.22 124.47 30.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 120.777 0.322 . . . . 64.34 110.155 -178.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 52.9 ttp -97.26 137.52 21.18 Favored Pre-proline 0 C--N 1.311 -1.109 0 CA-C-N 116.159 -0.473 . . . . 72.52 111.962 -178.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -65.49 170.99 10.09 Favored 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 124.148 3.232 . . . . 72.34 112.535 172.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -82.14 134.25 35.31 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.31 -0.626 . . . . 60.04 109.31 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -120.38 -26.04 5.5 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.614 -0.884 . . . . 60.11 108.614 171.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 12.2 p -71.67 139.23 49.13 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.48 -0.782 . . . . 61.23 110.48 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 79.58 39.33 18.3 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 110.99 -0.844 . . . . 71.34 110.99 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 89.2 mtp -144.69 170.32 16.32 Favored 'General case' 0 C--O 1.249 1.075 0 N-CA-C 108.263 -1.014 . . . . 44.54 108.263 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -95.53 148.97 21.94 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 108.559 -0.904 . . . . 71.33 108.559 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 73.8 t-105 -61.73 -28.39 69.4 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 123.406 0.682 . . . . 74.23 109.968 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 13.8 p -71.54 -21.04 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-N 115.247 -0.888 . . . . 64.13 110.667 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -101.19 -30.82 11.33 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.812 -0.81 . . . . 62.43 108.812 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -59.06 -45.94 89.52 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.199 -0.91 . . . . 63.45 112.441 -178.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 579' ' ' ARG . 31.5 mt-10 -59.51 -57.65 25.34 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 113.7 1.0 . . . . 64.43 113.7 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -58.07 -34.75 98.81 Favored 'Trans proline' 0 C--N 1.364 1.394 0 C-N-CA 121.173 1.248 . . . . 63.33 112.26 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -59.21 -48.13 82.77 Favored 'General case' 0 N--CA 1.42 -1.925 0 C-N-CA 122.506 0.322 . . . . 74.41 110.526 177.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . 0.286 4.2 pp -68.04 -38.3 82.33 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 112.813 0.672 . . . . 72.31 112.813 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 579' ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 35.3 mmt180 -65.12 -47.56 76.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.472 -0.331 . . . . 63.43 110.458 178.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.93 -17.15 62.69 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.904 -0.589 . . . . 71.54 112.365 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 60.4 tp -85.84 -9.11 57.54 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 109.603 -0.517 . . . . 51.13 109.603 178.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 73.87 38.66 48.8 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 111.219 -0.752 . . . . 61.23 111.219 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 50.5 t90 -83.36 135.08 34.85 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-O 121.266 0.555 . . . . 73.33 111.015 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 10.1 t -145.89 106.34 4.07 Favored 'General case' 0 N--CA 1.408 -2.545 0 CA-C-N 114.783 -1.099 . . . . 74.32 108.126 173.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -159.18 -154.68 7.34 Favored Glycine 0 N--CA 1.429 -1.828 0 N-CA-C 108.774 -1.73 . . . . 73.11 108.774 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 60.9 mtt -107.58 125.23 51.05 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.68 -0.808 . . . . 64.04 112.324 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 59.2 tp -93.88 130.16 40.04 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.642 -0.873 . . . . 73.31 108.642 178.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 588' ' ' ASP . . . . . 0.462 ' HB3' HG23 ' A' ' 621' ' ' THR . 23.6 t70 -99.28 113.22 25.38 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 120.972 0.415 . . . . 74.02 111.232 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -91.86 109.4 20.73 Favored 'General case' 0 N--CA 1.408 -2.554 0 N-CA-C 106.4 -1.704 . . . . 71.15 106.4 171.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -87.9 -95.25 0.96 Allowed Glycine 0 N--CA 1.424 -2.124 0 C-N-CA 120.599 -0.81 . . . . 70.14 111.399 -178.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.44 151.28 46.11 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.214 -0.662 . . . . 74.42 109.214 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -84.84 132.07 34.45 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.719 -1.215 . . . . 72.5 107.719 175.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 73.5 t -123.63 127.7 74.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 CA-C-N 116.275 -0.421 . . . . 73.52 110.539 -171.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -78.53 107.25 11.05 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.018 -1.475 . . . . 74.5 107.018 175.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -127.47 0.86 6.26 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.81 -0.632 . . . . 72.14 110.736 -176.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 104.99 141.33 10.77 Favored Glycine 0 N--CA 1.431 -1.639 0 N-CA-C 108.8 -1.72 . . . . 74.31 108.8 -177.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -55.77 -39.31 76.4 Favored Glycine 0 C--O 1.224 -0.491 0 CA-C-N 117.193 0.497 . . . . 43.45 112.793 -173.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 3.9 m -60.37 -24.63 65.25 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.995 0.918 . . . . 65.22 111.923 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -108.76 -1.57 19.23 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.137 0.421 . . . . 73.14 112.137 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 59.5 m170 -72.38 -42.28 65.41 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.463 0.542 . . . . 65.34 112.463 -176.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -92.77 32.4 1.25 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 122.04 0.924 . . . . 74.34 108.749 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 602' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 603' ' ' VAL . 29.9 ttt180 -118.7 141.8 48.27 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.609 -0.682 . . . . 62.11 109.729 -178.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 603' ' ' VAL . . . . . 0.412 ' O ' ' HG2' ' A' ' 602' ' ' ARG . 71.4 t -73.15 130.9 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 106.094 -1.817 . . . . 75.14 106.094 172.009 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 73.6 t -80.05 -53.35 13.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-O 121.71 0.767 . . . . 63.5 109.292 -172.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -156.78 164.23 38.34 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 104.67 -2.345 . . . . 65.33 104.67 177.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -115.86 142.51 46.67 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 107.571 -1.27 . . . . 64.34 107.571 174.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.513 ' HB2' ' HB ' ' A' ' 621' ' ' THR . 41.1 t30 -64.21 -52.52 54.17 Favored Pre-proline 0 C--N 1.285 -2.211 0 N-CA-C 114.441 1.275 . . . . 74.41 114.441 -176.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 609' ' ' PRO . 2.3 Cg_endo -87.38 148.99 7.72 Favored 'Trans proline' 0 CA--C 1.549 1.238 0 CA-C-N 121.444 1.551 . . . . 74.11 110.594 176.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 609' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 608' ' ' PRO . 15.8 Cg_exo -70.06 134.24 26.9 Favored 'Trans proline' 0 C--O 1.248 0.994 0 C-N-CA 121.731 1.621 . . . . 72.42 113.152 -177.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -68.56 134.32 49.83 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.678 -0.692 . . . . 75.3 110.724 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 86.48 -1.62 87.31 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.674 -0.774 . . . . 33.3 111.75 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 612' ' ' THR . . . . . 0.421 ' OG1' ' HB2' ' A' ' 609' ' ' PRO . 19.8 m -105.52 161.04 14.69 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 108.26 -1.015 . . . . 74.41 108.26 -178.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -73.17 129.99 13.24 Favored Glycine 0 N--CA 1.432 -1.575 0 N-CA-C 111.877 -0.489 . . . . 60.22 111.877 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 34.0 m -118.44 144.12 27.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.922 -0.77 . . . . 44.21 108.922 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.452 ' ND2' ' HB3' ' A' ' 617' ' ' ASP . 27.4 p-10 -43.6 155.59 0.07 Allowed 'General case' 0 C--O 1.216 -0.699 0 C-N-CA 124.73 1.212 . . . . 73.02 113.158 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -56.24 -25.92 49.45 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.048 0.758 . . . . 74.34 113.048 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 617' ' ' ASP . . . . . 0.452 ' HB3' ' ND2' ' A' ' 615' ' ' ASN . 30.8 t70 -65.83 -37.94 87.55 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.262 -0.644 . . . . 74.45 109.262 174.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 85.69 21.56 53.15 Favored Glycine 0 N--CA 1.424 -2.14 0 CA-C-N 115.681 -0.69 . . . . 61.41 112.182 176.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 619' ' ' ILE . . . . . 0.4 ' HB ' ' OD2' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -68.44 118.52 12.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 122.448 1.118 . . . . 61.02 110.404 -169.351 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.97 124.55 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.946 0 N-CA-C 106.976 -1.49 . . . . 74.3 106.976 -177.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.513 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 3.0 m -105.36 127.39 52.94 Favored 'General case' 0 N--CA 1.42 -1.944 0 C-N-CA 120.492 -0.483 . . . . 70.14 109.908 -177.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.0 mp -120.98 149.81 42.09 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 105.434 -2.062 . . . . 72.33 105.434 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -137.53 148.16 45.74 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 107.615 -1.254 . . . . 64.0 107.615 173.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -123.78 167.6 13.82 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 107.713 -1.217 . . . . 63.23 107.713 -177.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -67.0 -105.19 0.02 OUTLIER Glycine 0 CA--C 1.533 1.157 0 O-C-N 123.927 0.767 . . . . 71.45 111.824 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 . . . . . 0 C--N 1.296 -1.751 0 CA-C-O 118.575 -0.726 . . . . 72.25 109.185 177.032 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 . . . . . 0 N--CA 1.431 -1.376 0 N-CA-C 106.847 -1.538 . . . . 72.13 106.847 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 28.4 m -116.8 149.67 18.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.231 0 C-N-CA 120.538 -0.465 . . . . 53.25 110.417 -173.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 361' ' ' GLN . . . . . 0.411 ' OE1' ' HA ' ' A' ' 407' ' ' ASN . 0.5 OUTLIER -93.9 128.98 40.48 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 105.172 -2.159 . . . . 73.34 105.172 -179.072 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.438 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 92.9 t -95.43 122.37 59.52 Favored Pre-proline 0 C--N 1.28 -2.435 0 CA-C-N 115.266 -0.879 . . . . 63.54 110.864 -167.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 363' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 18.0 Cg_exo -61.94 125.61 16.93 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 122.312 2.008 . . . . 45.25 110.163 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 364' ' ' ASP . . . . . 0.475 ' HB2' ' HG3' ' A' ' 366' ' ' ARG . 3.7 p-10 -71.85 125.87 28.28 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.339 -0.846 . . . . 71.43 109.714 -176.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.418 HG11 ' HA ' ' A' ' 373' ' ' ALA . 17.9 t -98.33 0.11 10.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-O 122.085 0.945 . . . . 72.12 108.728 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.475 ' HG3' ' HB2' ' A' ' 364' ' ' ASP 0.298 0.0 OUTLIER -64.96 146.6 54.77 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.963 -1.017 . . . . 73.2 113.047 179.325 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.26 -9.34 45.81 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 109.806 -1.318 . . . . 72.15 109.806 -172.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -110.7 -163.53 0.86 Allowed 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 107.35 -1.352 . . . . 52.03 107.35 178.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 369' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 76.2 p -86.87 160.42 18.74 Favored 'General case' 0 C--N 1.286 -2.157 0 O-C-N 121.865 -0.522 . . . . 71.32 111.602 -170.348 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 34.2 p -58.95 -46.43 88.03 Favored 'General case' 0 N--CA 1.435 -1.208 0 O-C-N 123.622 0.576 . . . . 41.24 110.6 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.85 -46.79 80.41 Favored 'General case' 0 C--O 1.214 -0.797 0 CA-C-N 116.235 -0.439 . . . . 52.4 111.667 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -67.63 -37.74 82.9 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.259 0.552 . . . . 62.34 111.259 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 373' ' ' ALA . . . . . 0.418 ' HA ' HG11 ' A' ' 365' ' ' VAL . . . -69.46 -48.53 60.53 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.619 -0.719 . . . . 72.23 111.318 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 89.0 mt -64.9 -42.11 93.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 CA-C-N 116.449 -0.341 . . . . 53.11 110.922 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.95 -45.57 90.15 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 120.717 0.294 . . . . 63.01 111.348 -178.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 32.7 m -64.38 -47.57 78.75 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.998 -0.546 . . . . 73.41 111.147 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.1 -38.74 92.16 Favored 'General case' 0 C--O 1.24 0.597 0 O-C-N 122.094 -0.379 . . . . 70.42 111.709 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 -63.43 -42.12 98.69 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.986 -0.552 . . . . 72.31 110.189 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -67.89 -28.13 67.25 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 112.027 0.381 . . . . 63.31 112.027 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -79.96 -15.7 56.75 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.494 -0.482 . . . . 70.13 110.253 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 96.07 15.89 40.28 Favored Glycine 0 N--CA 1.434 -1.461 0 C-N-CA 120.289 -0.957 . . . . 61.1 113.021 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -77.75 143.06 38.3 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 108.667 -0.864 . . . . 72.22 108.667 175.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -84.64 131.86 34.55 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 105.805 -1.924 . . . . 74.21 105.805 176.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 384' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 2.4 pp -130.83 138.24 54.05 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 CA-C-O 121.85 0.833 . . . . 72.35 113.23 -175.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 385' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 385' ' ' ARG . 33.0 ttp180 -113.8 141.28 47.49 Favored 'General case' 0 C--N 1.276 -2.588 0 N-CA-C 107.053 -1.462 . . . . 63.53 107.053 175.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 20.9 m -122.37 121.16 36.02 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 108.127 -1.064 . . . . 72.11 108.127 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -111.61 127.82 55.86 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.819 -1.178 . . . . 72.5 107.819 -176.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -93.04 131.91 37.63 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.925 0.393 . . . . 73.44 111.504 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 389' ' ' LYS . . . . . 0.615 ' O ' ' HA ' ' A' ' 421' ' ' SER . 71.6 mmtt -126.36 132.91 24.49 Favored Pre-proline 0 C--N 1.304 -1.393 0 CA-C-N 115.797 -0.638 . . . . 51.52 109.465 175.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 390' ' ' PRO . . . . . 0.752 ' HA ' ' O ' ' A' ' 422' ' ' THR . 12.2 Cg_exo -72.37 140.26 33.21 Favored 'Trans proline' 0 C--O 1.247 0.95 0 C-N-CA 122.177 1.918 . . . . 74.13 109.901 175.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . 0.324 3.8 p30 -73.97 118.87 17.43 Favored 'General case' 0 CA--C 1.466 -2.26 0 C-N-CA 118.187 -1.405 . . . . 71.25 114.172 -178.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 392' ' ' SER . . . . . 0.549 ' O ' ' HB ' ' A' ' 393' ' ' THR . 50.1 m -143.94 81.69 1.69 Allowed 'General case' 0 N--CA 1.39 -3.462 0 N-CA-C 105.335 -2.098 . . . . 72.24 105.335 166.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.549 ' HB ' ' O ' ' A' ' 392' ' ' SER . 85.5 m 96.52 2.52 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 113.961 -1.472 . . . . 72.22 110.98 174.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 5.6 pt -104.92 151.58 39.44 Favored Pre-proline 0 C--N 1.291 -1.971 0 CA-C-N 114.843 -1.072 . . . . 61.23 109.341 176.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 395' ' ' PRO . . . . . 0.415 ' HB2' ' HD2' ' A' ' 396' ' ' PRO . 83.2 Cg_endo -74.56 -172.94 1.33 Allowed 'Trans proline' 0 CA--C 1.563 1.962 0 C-N-CA 123.305 2.67 . . . . 61.22 113.927 -172.023 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 396' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 395' ' ' PRO . 79.8 Cg_exo -55.17 163.16 4.76 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 123.277 2.651 . . . . 61.35 112.018 172.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -56.02 -8.5 0.46 Allowed 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 125.43 1.492 . . . . 73.43 112.929 -174.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 50.0 m170 -64.88 121.57 14.93 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 107.187 -1.412 . . . . 73.2 107.187 175.141 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 29.6 m -68.7 117.92 11.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 115.167 -0.924 . . . . 61.22 110.927 -168.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 400' ' ' ILE . . . . . 0.453 HD13 ' O ' ' A' ' 400' ' ' ILE . 0.0 OUTLIER -92.52 -29.34 4.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 115.989 -0.551 . . . . 75.31 110.265 -174.677 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.55 160.53 28.11 Favored Glycine 0 N--CA 1.417 -2.592 0 C-N-CA 119.528 -1.32 . . . . 74.04 112.409 -174.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 402' ' ' THR . . . . . 0.43 ' OG1' ' HG2' ' A' ' 366' ' ' ARG . 2.9 p -145.01 -176.83 5.24 Favored 'General case' 0 C--N 1.283 -2.321 0 C-N-CA 125.963 1.705 . . . . 64.54 107.72 -176.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -99.52 138.19 20.42 Favored Pre-proline 0 C--N 1.291 -1.977 0 N-CA-C 107.718 -1.216 . . . . 75.31 107.718 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -48.11 -15.04 0.35 Allowed 'Trans proline' 0 C--N 1.364 1.375 0 C-N-CA 124.758 3.638 . . . . 73.41 115.509 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -52.73 -43.7 65.9 Favored 'General case' 0 C--O 1.213 -0.866 0 N-CA-C 109.947 -0.39 . . . . 61.44 109.947 176.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -65.96 -35.19 79.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.622 0.725 . . . . 75.33 109.887 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 407' ' ' ASN . . . . . 0.411 ' HA ' ' OE1' ' A' ' 361' ' ' GLN . 17.0 m120 -84.64 1.69 45.07 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.209 -0.905 . . . . 72.31 111.378 -177.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 29.6 m -109.27 167.51 10.06 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.324 -1.732 . . . . 73.25 106.324 174.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 15.9 m -76.56 112.79 13.48 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 108.615 -0.883 . . . . 73.32 108.615 175.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 14.2 m -122.13 170.39 12.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 120.807 0.337 . . . . 55.54 111.703 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 2.7 m -56.1 141.61 39.73 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.144 -0.935 . . . . 62.25 110.501 -178.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -66.56 109.69 2.89 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.058 -1.089 . . . . 74.41 108.058 176.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 86.51 42.7 6.41 Favored Glycine 0 N--CA 1.433 -1.536 0 N-CA-C 110.708 -0.957 . . . . 43.34 110.708 -176.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -79.94 -171.91 3.13 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.805 -0.813 . . . . 71.32 108.805 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -108.41 112.68 25.22 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 122.882 0.473 . . . . 73.4 110.412 -176.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 416' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 49.1 mm -116.57 137.47 50.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 109.575 -0.528 . . . . 71.1 109.575 -177.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 14.0 t -111.56 131.77 55.01 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.773 -0.825 . . . . 74.4 108.773 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 5.9 p -115.75 135.26 56.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.616 -0.512 . . . . 72.51 109.616 -177.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -100.8 128.6 46.78 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.277 -0.638 . . . . 72.54 109.277 178.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 8.3 p -126.3 137.31 58.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.794 -0.639 . . . . 73.52 109.871 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 421' ' ' SER . . . . . 0.615 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 2.3 p -92.59 120.68 33.28 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-O 122.024 0.916 . . . . 64.52 112.017 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 422' ' ' THR . . . . . 0.752 ' O ' ' HA ' ' A' ' 390' ' ' PRO . 6.2 t -122.46 155.0 37.05 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 108.095 -1.076 . . . . 72.12 108.095 174.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.029 0 C-N-CA 119.984 -1.103 . . . . 25.22 113.643 174.069 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 . . . . . 0 N--CA 1.44 -0.941 0 N-CA-C 108.279 -1.008 . . . . 72.1 108.279 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.425 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 2.2 mmp_? -119.82 138.16 53.54 Favored 'General case' 0 CA--C 1.492 -1.268 0 CA-C-O 121.147 0.498 . . . . 75.41 109.938 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 13.7 pt-20 -88.16 136.28 33.04 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.493 -0.776 . . . . 63.33 109.489 178.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 59.5 mt -80.67 130.71 63.32 Favored Pre-proline 0 C--N 1.298 -1.661 0 CA-C-N 115.854 -0.612 . . . . 60.34 109.368 -177.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -71.71 141.77 38.34 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 121.877 1.718 . . . . 63.25 110.736 170.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -82.84 111.53 18.83 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.901 -1.148 . . . . 65.43 107.901 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 60.9 t -103.5 143.46 15.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.137 -1.06 . . . . 74.42 108.137 -175.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 15.8 m -60.41 155.06 18.97 Favored 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 112.632 0.604 . . . . 74.54 112.632 -176.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 21.9 p -69.14 -24.98 64.16 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 115.339 1.607 . . . . 74.24 115.339 -170.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.1 pp -90.3 -11.6 40.3 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.953 0.883 . . . . 72.24 110.414 177.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.425 HG22 ' CB ' ' A' ' 439' ' ' GLU . 0.2 OUTLIER -99.95 34.43 2.3 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 114.914 -1.039 . . . . 65.15 109.643 -175.327 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -55.84 -38.33 69.9 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.172 0.989 . . . . 71.22 113.028 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.46 -36.78 84.88 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.868 0.842 . . . . 64.24 110.102 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.505 ' OE2' ' HD2' ' A' ' 442' ' ' LYS . 24.9 tp10 -70.92 -35.4 72.23 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.121 -0.945 . . . . 65.43 109.336 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.562 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -63.63 -50.55 68.89 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.001 -0.545 . . . . 61.24 110.988 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 31.2 m -62.1 -38.67 81.45 Favored 'Isoleucine or valine' 0 C--O 1.25 1.129 0 N-CA-C 112.606 0.595 . . . . 51.03 112.606 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.505 ' HD2' ' OE2' ' A' ' 439' ' ' GLU . 17.4 ptpt -67.93 -38.44 82.88 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 120.061 -0.656 . . . . 70.4 109.973 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -62.76 -38.56 91.07 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.336 -0.393 . . . . 74.25 110.924 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 77.8 mt -63.42 -37.66 88.13 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.933 -0.576 . . . . 75.14 109.453 177.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 41.0 m -69.93 -43.2 72.12 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.278 -0.873 . . . . 53.04 110.321 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -65.72 -27.37 68.28 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.048 0.539 . . . . 71.3 111.707 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.7 -13.56 59.38 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.477 -0.329 . . . . 64.33 111.459 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 448' ' ' GLY . . . . . 0.417 ' HA3' HD12 ' A' ' 480' ' ' ILE . . . 130.05 -81.27 0.34 Allowed Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 120.868 -0.682 . . . . 74.25 111.749 178.277 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -36.64 -68.9 0.12 Allowed 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 115.003 1.483 . . . . 65.31 115.003 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 59.65 35.15 84.96 Favored Glycine 0 C--N 1.318 -0.463 0 C-N-CA 121.007 -0.616 . . . . 72.31 112.551 -177.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.494 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 36.1 mmt180 -107.2 110.95 23.14 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.516 -1.29 . . . . 75.02 107.516 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -143.97 146.57 33.01 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 121.087 0.47 . . . . 74.34 111.532 -173.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 453' ' ' LYS . . . . . 0.429 ' HB2' ' HA ' ' A' ' 485' ' ' ILE . 34.8 mmtp -131.58 148.35 52.61 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 115.421 -0.809 . . . . 71.05 109.215 178.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -113.64 125.94 54.71 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.798 -0.816 . . . . 53.42 108.798 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 455' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -126.17 137.22 53.55 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.923 -1.14 . . . . 61.23 107.923 176.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 456' ' ' ASN . . . . . 0.52 ' HB2' ' OG ' ' A' ' 490' ' ' SER . 8.3 p30 -114.25 144.64 42.9 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 109.29 -0.633 . . . . 74.14 109.29 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 50.9 m -148.69 148.59 28.44 Favored Pre-proline 0 C--N 1.296 -1.734 0 N-CA-C 108.507 -0.923 . . . . 74.54 108.507 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.69 ' HA ' ' O ' ' A' ' 490' ' ' SER . 19.6 Cg_endo -64.33 125.49 15.19 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.189 1.926 . . . . 74.13 112.238 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 49.7 m -133.49 179.53 6.16 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.187 -1.042 . . . . 71.11 108.187 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.8 t -59.1 137.38 88.06 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 109.907 -0.405 . . . . 72.53 109.907 176.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -51.27 -29.74 30.92 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 124.528 3.485 . . . . 75.42 113.228 -176.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -72.99 -23.61 60.67 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.555 0.576 . . . . 65.11 112.555 -178.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 67.0 mt -101.42 -3.3 28.93 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.669 0.248 . . . . 73.45 111.669 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.441 HG13 ' HA ' ' A' ' 490' ' ' SER . 76.9 t -60.12 128.96 21.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 116.089 -0.505 . . . . 63.51 110.489 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.48 -11.76 59.77 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 115.742 -0.663 . . . . 63.31 112.392 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -114.04 165.81 12.25 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 109.355 -0.609 . . . . 74.24 109.355 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 71.1 t -74.33 146.22 10.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 116.062 -0.517 . . . . 65.23 109.832 177.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 49.3 mm -98.18 -35.11 4.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 107.839 -1.171 . . . . 72.14 107.839 177.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 169.61 -179.49 42.05 Favored Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 110.813 -0.915 . . . . 63.53 110.813 177.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 470' ' ' THR . . . . . 0.483 HG22 HG12 ' A' ' 486' ' ' ILE . 61.4 p -115.49 141.85 47.5 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 105.171 -2.159 . . . . 42.35 105.171 176.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.446 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 25.2 t-20 -69.1 -53.78 13.21 Favored Pre-proline 0 C--N 1.319 -0.733 0 C-N-CA 118.882 -1.127 . . . . 71.34 111.692 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.466 ' HG2' ' HA ' ' A' ' 484' ' ' VAL . 8.5 Cg_exo -76.61 139.88 20.68 Favored 'Trans proline' 0 C--N 1.364 1.389 0 N-CA-C 107.621 -1.723 . . . . 73.32 107.621 170.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.93 126.76 18.75 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.043 1.829 . . . . 71.43 112.461 -175.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -86.48 19.13 2.93 Favored 'General case' 0 C--O 1.206 -1.221 0 CA-C-N 115.111 -0.95 . . . . 74.1 109.797 -177.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -110.01 -13.64 14.37 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.449 -0.796 . . . . 72.53 109.563 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -93.18 168.87 10.82 Favored 'General case' 0 C--O 1.247 0.954 0 N-CA-C 114.396 1.258 . . . . 50.2 114.396 -170.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 0.4 OUTLIER -82.79 109.5 16.99 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-N 113.6 -1.636 . . . . 73.43 108.296 -179.704 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 64.7 m -104.97 145.7 30.06 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-O 121.465 0.65 . . . . 72.11 111.5 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -84.68 169.42 14.33 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 107.566 -1.272 . . . . 72.45 107.566 175.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 480' ' ' ILE . . . . . 0.417 HD12 ' HA3' ' A' ' 448' ' ' GLY . 34.6 mm -72.46 -11.07 14.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 122.078 0.942 . . . . 54.42 110.356 -177.023 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 4.5 p -97.68 5.19 49.66 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.585 -0.734 . . . . 70.4 112.462 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -81.11 129.54 34.61 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 122.081 -0.387 . . . . 74.54 111.705 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.494 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.1 p -108.64 125.93 65.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.817 -0.628 . . . . 71.12 109.88 176.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.466 ' HA ' ' HG2' ' A' ' 472' ' ' PRO . 27.3 m -106.02 120.46 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 CA-C-O 121.941 0.877 . . . . 72.32 112.23 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.429 ' HA ' ' HB2' ' A' ' 453' ' ' LYS . 0.0 OUTLIER -92.86 121.52 43.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.415 -1.328 . . . . 62.22 107.415 175.35 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.483 HG12 HG22 ' A' ' 470' ' ' THR . 35.1 mt -114.35 128.75 71.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.044 -0.98 . . . . 73.34 111.379 -174.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 5.8 tt -101.87 126.56 55.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 116.031 -0.531 . . . . 71.33 110.649 -176.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 28.0 m -108.38 151.35 10.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 123.435 0.694 . . . . 42.11 109.893 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -84.14 128.9 8.86 Favored Glycine 0 N--CA 1.434 -1.465 0 C-N-CA 120.97 -0.633 . . . . 61.22 111.731 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.69 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 49.1 m . . . . . 0 C--N 1.301 -1.533 0 N-CA-C 108.725 -0.842 . . . . 63.52 108.725 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo . . . . . 0 N--CA 1.442 -1.53 0 CA-C-O 121.434 0.514 . . . . 75.04 112.32 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -108.56 77.06 1.06 Allowed 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.661 -0.866 . . . . 71.1 108.661 177.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 19.1 p -117.86 144.9 45.0 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 114.911 -1.04 . . . . 54.01 110.918 -176.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 495' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 495' ' ' LYS . 16.0 mmtt -150.25 165.13 33.9 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 112.124 0.416 . . . . 72.52 112.124 175.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.79 133.74 36.32 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 107.399 -1.334 . . . . 71.13 107.399 -178.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 39.5 pt -78.85 133.16 62.41 Favored Pre-proline 0 C--N 1.294 -1.841 0 C-N-CA 120.137 -0.625 . . . . 64.45 109.968 175.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.84 -179.35 5.38 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.782 2.322 . . . . 75.1 111.893 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -108.68 141.49 40.57 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.911 -0.774 . . . . 73.54 108.911 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.402 ' O ' ' HA2' ' A' ' 536' ' ' GLY . 4.8 p -143.95 103.58 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 CA-C-O 121.555 0.693 . . . . 74.32 110.137 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -141.71 106.71 4.94 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.181 -0.918 . . . . 52.22 109.219 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 123.13 -16.13 8.17 Favored Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 120.173 -1.013 . . . . 74.11 111.376 178.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -89.74 173.45 8.27 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.854 -0.424 . . . . 74.43 109.854 177.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 13.9 t -91.79 157.74 16.72 Favored 'General case' 0 N--CA 1.425 -1.707 0 C-N-CA 119.771 -0.772 . . . . 52.12 109.984 -176.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 9.5 p -53.27 -41.19 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 124.229 1.012 . . . . 74.2 112.158 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -62.57 -41.98 99.27 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.128 0.49 . . . . 60.55 111.2 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 86.3 t -71.79 -37.35 61.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-N 116.092 -0.504 . . . . 72.43 110.513 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 508' ' ' ALA . . . . . 0.465 ' O ' HD23 ' A' ' 512' ' ' LEU . . . -61.5 -49.12 78.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.835 -0.62 . . . . 72.22 111.242 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -60.23 -46.91 88.16 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.019 0.438 . . . . 71.24 110.72 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.454 ' O ' HG23 ' A' ' 514' ' ' VAL . 55.8 tptt -65.44 -49.97 67.17 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 113.027 0.751 . . . . 74.42 113.027 -174.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -63.07 -37.76 88.5 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 120.142 -0.623 . . . . 64.53 110.45 -175.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 512' ' ' LEU . . . . . 0.465 HD23 ' O ' ' A' ' 508' ' ' ALA . 4.6 mm? -62.75 -43.3 99.15 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 116.551 -0.295 . . . . 64.0 111.007 175.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -62.98 -38.25 90.41 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 120.987 0.422 . . . . 54.22 110.699 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 510' ' ' LYS . 81.2 t -62.96 -34.25 65.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.562 -0.745 . . . . 71.44 110.554 177.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -85.27 3.2 40.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.89 0.376 . . . . 64.53 111.12 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 516' ' ' GLY . . . . . 0.541 ' O ' ' HB ' ' A' ' 547' ' ' VAL . . . 109.62 -20.84 26.81 Favored Glycine 0 N--CA 1.437 -1.289 0 C-N-CA 120.827 -0.701 . . . . 43.1 113.811 174.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -77.32 98.58 5.24 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.437 -1.319 . . . . 73.54 107.437 -175.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.91 -17.11 30.27 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.592 -0.731 . . . . 71.33 112.307 -169.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 519' ' ' LYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 28.1 mtpp -112.18 122.15 46.95 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.168 0.509 . . . . 71.24 111.604 -176.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -129.77 152.44 49.26 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.496 -0.775 . . . . 73.43 110.725 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.9 m -141.39 152.68 44.53 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 108.134 -1.061 . . . . 70.24 108.134 173.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 522' ' ' GLN . . . . . 0.44 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 26.0 pt20 -117.19 151.07 37.66 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-O 121.365 0.602 . . . . 71.12 111.199 -178.153 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 523' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 554' ' ' GLN . . . -132.79 118.69 19.33 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.23 -1.396 . . . . 54.41 107.23 174.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 11.7 p -85.92 128.86 34.93 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.013 0.435 . . . . 55.42 111.341 -177.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 28.7 m -127.3 160.02 36.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 109.485 -0.561 . . . . 73.34 109.485 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -72.76 136.18 45.44 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.565 -0.531 . . . . 72.45 109.565 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 52.1 m -152.58 161.92 27.91 Favored Pre-proline 0 C--N 1.304 -1.38 0 O-C-N 121.958 -0.464 . . . . 62.21 110.58 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -84.4 -2.55 9.98 Favored 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 122.392 2.061 . . . . 75.41 110.322 173.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.454 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 23.3 mmt180 -84.73 145.67 44.77 Favored Pre-proline 0 N--CA 1.44 -0.935 0 N-CA-C 106.81 -1.552 . . . . 72.31 106.81 177.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.88 162.48 41.96 Favored 'Trans proline' 0 C--O 1.246 0.878 0 C-N-CA 122.148 1.899 . . . . 72.52 111.874 177.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -57.11 126.03 25.35 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.298 -0.864 . . . . 55.13 111.679 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 116.64 -17.45 13.66 Favored Glycine 0 C--N 1.309 -0.938 0 C-N-CA 120.917 -0.658 . . . . 70.02 111.903 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -78.18 144.77 36.05 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.346 -0.983 . . . . 53.33 108.346 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 64.0 t -95.03 121.51 45.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 O-C-N 121.675 -0.64 . . . . 74.22 110.409 176.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 36.6 m -72.59 -40.85 66.25 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 124.588 1.155 . . . . 75.41 110.85 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 500' ' ' VAL . . . 162.16 -157.31 29.13 Favored Glycine 0 N--CA 1.432 -1.577 0 N-CA-C 110.602 -0.999 . . . . 75.43 110.602 -178.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 57.7 p -118.89 151.86 37.35 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.046 -0.724 . . . . 63.43 109.046 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -73.24 -54.4 4.28 Favored Pre-proline 0 C--N 1.313 -1.0 0 CA-C-O 119.44 -0.314 . . . . 74.1 110.712 177.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -74.06 143.24 32.2 Favored 'Trans proline' 0 C--N 1.36 1.164 0 N-CA-C 109.089 -1.158 . . . . 73.3 109.089 170.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.26 149.82 85.04 Favored 'Trans proline' 0 C--O 1.253 1.241 0 C-N-CA 122.313 2.008 . . . . 73.41 112.448 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -65.89 144.31 56.88 Favored 'General case' 0 C--O 1.249 1.049 0 N-CA-C 109.574 -0.528 . . . . 55.21 109.574 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.8 -12.5 57.82 Favored Glycine 0 N--CA 1.423 -2.195 0 C-N-CA 120.23 -0.985 . . . . 74.42 111.489 -176.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 54.2 m -66.59 120.94 14.28 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.251 -0.648 . . . . 63.3 109.251 176.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 41.1 m -85.32 122.61 29.74 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 108.614 -0.884 . . . . 64.05 108.614 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.61 158.26 70.61 Favored Pre-proline 0 C--N 1.311 -1.082 0 N-CA-C 108.834 -0.802 . . . . 73.43 108.834 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -64.78 149.18 90.04 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.073 1.849 . . . . 74.31 110.921 174.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.541 ' HB ' ' O ' ' A' ' 516' ' ' GLY . 36.0 m -63.14 -20.14 25.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-O 121.952 0.882 . . . . 54.21 111.6 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -77.43 -16.16 58.95 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.416 -1.266 . . . . 71.53 110.768 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 42.3 m -81.79 158.6 24.06 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 121.273 0.559 . . . . 62.21 111.784 -176.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 92.1 t -89.03 128.74 40.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 115.073 -0.967 . . . . 64.43 110.159 -178.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 551' ' ' ILE . . . . . 0.49 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -100.05 132.77 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 108.023 -1.102 . . . . 62.53 108.023 171.472 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -103.24 115.91 31.46 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-O 121.536 0.684 . . . . 71.45 111.329 -176.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 553' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 1.9 mm? -98.3 133.79 42.21 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.275 -1.329 . . . . 73.31 109.03 -179.049 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 554' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 523' ' ' ALA . 48.7 mt-30 -97.62 121.79 39.94 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.517 -0.549 . . . . 65.45 109.517 176.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 48.3 t -103.63 137.53 31.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 115.573 -0.74 . . . . 53.32 110.373 -173.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.454 ' HB3' ' HB2' ' A' ' 529' ' ' ARG . 22.0 m -69.58 129.47 39.76 Favored 'General case' 0 N--CA 1.427 -1.612 0 C-N-CA 124.071 0.948 . . . . 72.53 112.211 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -110.57 123.02 49.18 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 106.502 -1.666 . . . . 75.4 106.502 170.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -80.23 -30.38 41.89 Favored Glycine 0 C--N 1.311 -0.841 0 C-N-CA 120.984 -0.627 . . . . 74.1 113.845 -172.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 73.52 -2.52 2.73 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.687 1.195 . . . . 73.4 112.152 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.438 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 87.5 mt-30 -113.25 141.95 46.39 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.767 0.317 . . . . 52.44 110.859 -176.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -125.41 136.51 53.49 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.026 -0.533 . . . . 74.42 109.816 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 59.1 t -68.89 116.01 8.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 120.999 0.428 . . . . 34.35 110.612 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 59.5 ttp -97.1 132.01 26.52 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 109.148 -0.686 . . . . 62.12 109.148 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.85 168.99 15.61 Favored 'Trans proline' 0 C--O 1.244 0.787 0 C-N-CA 122.255 1.97 . . . . 52.02 111.045 176.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 565' ' ' ASP . . . . . 0.404 ' HA ' ' HB1' ' A' ' 610' ' ' ALA . 9.5 p-10 -89.44 114.99 26.54 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-O 122.291 1.043 . . . . 63.44 112.395 -178.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 566' ' ' LEU . . . . . 0.487 HD23 ' HD2' ' A' ' 577' ' ' ARG . 4.5 mp -118.16 7.1 12.06 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 106.188 -1.782 . . . . 74.01 106.188 171.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 32.5 t -80.34 153.71 28.22 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 113.577 -1.647 . . . . 52.31 109.946 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 97.71 44.81 2.6 Favored Glycine 0 N--CA 1.432 -1.599 0 N-CA-C 110.293 -1.123 . . . . 60.42 110.293 -177.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 62.1 mtp -140.79 -176.79 4.79 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.41 -1.33 . . . . 74.15 107.41 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -97.03 156.41 16.37 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.072 -1.084 . . . . 71.4 108.072 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 571' ' ' TRP . . . . . 0.571 ' HA ' ' HB3' ' A' ' 574' ' ' ALA . 76.5 t-105 -59.01 -29.39 67.22 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 122.987 0.515 . . . . 74.35 111.204 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 31.4 m -62.57 -23.95 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 116.122 -0.49 . . . . 72.21 111.302 178.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 573' ' ' ASP . . . . . 0.537 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 1.3 m-20 -101.13 -25.88 13.87 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-N 115.983 -0.553 . . . . 74.41 110.524 176.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 574' ' ' ALA . . . . . 0.571 ' HB3' ' HA ' ' A' ' 571' ' ' TRP . . . -72.91 -33.35 65.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.724 -0.671 . . . . 53.43 112.26 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.444 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 32.4 tt0 -60.57 -49.6 89.24 Favored Pre-proline 0 CA--C 1.56 1.363 0 C-N-CA 120.237 -0.585 . . . . 63.13 111.05 176.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 576' ' ' PRO . . . . . 0.444 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 70.2 Cg_exo -56.22 -35.65 95.74 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 121.459 1.439 . . . . 75.43 111.999 171.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 37.0 mmt180 -59.27 -46.76 87.64 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 109.616 -0.512 . . . . 75.3 109.616 176.136 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.439 ' HB3' ' O ' ' A' ' 575' ' ' GLU . 6.6 tt -57.77 -46.62 84.31 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 125.011 1.324 . . . . 74.44 109.626 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 579' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 575' ' ' GLU . 64.8 mtt-85 -65.31 -44.33 88.21 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.072 -0.967 . . . . 73.3 111.157 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -69.78 -28.26 65.61 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.04 0.448 . . . . 62.44 112.074 -177.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 97.6 mt -84.35 -8.08 59.11 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.613 -0.267 . . . . 64.11 110.914 177.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 61.68 42.42 99.75 Favored Glycine 0 CA--C 1.505 -0.579 0 N-CA-C 110.85 -0.9 . . . . 61.35 110.85 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 83.2 t90 -71.32 135.13 47.23 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.246 0.546 . . . . 75.23 111.688 -176.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 23.3 m -147.42 102.85 3.5 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 108.365 -0.976 . . . . 51.51 108.365 174.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -161.64 -124.07 0.7 Allowed Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 111.241 -0.744 . . . . 60.52 111.241 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 586' ' ' MET . . . . . 0.49 ' HB3' HG12 ' A' ' 619' ' ' ILE . 0.1 OUTLIER -137.5 125.68 23.06 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.926 -0.768 . . . . 74.14 108.926 177.041 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 59.9 tp -97.24 117.58 31.77 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.818 -0.808 . . . . 63.02 108.818 176.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 588' ' ' ASP . . . . . 0.439 ' OD2' HD11 ' A' ' 619' ' ' ILE . 13.4 m-20 -101.24 101.94 12.73 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.157 -0.683 . . . . 75.0 109.157 174.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -88.04 126.43 35.09 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 106.352 -1.721 . . . . 74.24 106.352 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -73.67 -151.91 2.12 Favored Glycine 0 C--N 1.302 -1.336 0 CA-C-N 115.828 -0.624 . . . . 52.34 114.631 -177.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -58.82 143.65 46.74 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.371 0.605 . . . . 75.12 112.435 -177.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -94.2 124.74 38.41 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.398 -0.964 . . . . 73.24 108.398 175.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 47.5 t -123.08 117.77 52.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 109.177 -0.675 . . . . 71.42 109.177 -177.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -80.14 106.71 12.36 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.244 -0.65 . . . . 74.04 109.244 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -153.52 17.44 0.53 Allowed 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.93 -0.577 . . . . 72.25 110.584 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 99.96 101.53 2.39 Favored Glycine 0 N--CA 1.427 -1.939 0 N-CA-C 110.213 -1.155 . . . . 55.23 110.213 -175.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -60.9 -40.3 98.14 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-O 119.893 -0.393 . . . . 75.04 113.387 -176.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 15.6 m -56.99 -33.19 66.88 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.341 0.867 . . . . 73.55 113.341 -174.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -108.19 -10.59 15.38 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 112.993 0.738 . . . . 74.53 112.993 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 600' ' ' HIS . . . . . 0.415 ' C ' ' H ' ' A' ' 602' ' ' ARG . 68.9 m-70 -107.54 14.97 25.26 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.737 0.78 . . . . 73.42 110.929 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -81.47 15.35 2.09 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.762 -1.108 . . . . 74.41 108.371 175.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 602' ' ' ARG . . . . . 0.415 ' H ' ' C ' ' A' ' 600' ' ' HIS . 33.1 ttp180 -97.32 152.09 19.25 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.345 -0.843 . . . . 74.52 109.064 -175.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 10.0 p -65.26 137.16 25.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 O-C-N 123.45 0.469 . . . . 71.35 109.959 175.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 92.1 t -102.27 -52.95 7.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 120.36 -0.536 . . . . 73.53 109.561 177.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -154.07 164.32 38.67 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 107.789 -1.189 . . . . 65.32 107.789 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 606' ' ' GLN . . . . . 0.473 ' HA ' ' O ' ' A' ' 621' ' ' THR . 18.6 pt20 -143.88 155.1 43.97 Favored 'General case' 0 C--N 1.314 -0.976 0 O-C-N 124.097 0.873 . . . . 74.44 109.414 177.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . 0.278 81.8 m-20 -80.64 -55.46 0.72 Allowed Pre-proline 0 C--N 1.312 -1.062 0 N-CA-C 114.306 1.224 . . . . 74.53 114.306 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -85.85 107.83 0.94 Allowed 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.912 1.741 . . . . 41.5 109.287 173.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -70.38 144.93 52.15 Favored 'Trans proline' 0 C--O 1.243 0.756 0 C-N-CA 122.846 2.364 . . . . 72.24 113.467 -176.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 610' ' ' ALA . . . . . 0.404 ' HB1' ' HA ' ' A' ' 565' ' ' ASP . . . -68.67 137.58 54.28 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 108.562 -0.903 . . . . 64.54 108.562 175.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 99.81 -12.95 60.99 Favored Glycine 0 C--N 1.299 -1.481 0 N-CA-C 110.427 -1.069 . . . . 54.2 110.427 -175.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 25.8 m -106.78 162.82 13.45 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 107.898 -1.149 . . . . 74.54 107.898 178.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -72.19 117.18 6.21 Favored Glycine 0 N--CA 1.431 -1.635 0 N-CA-C 110.435 -1.066 . . . . 72.34 110.435 175.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.7 m -91.29 141.66 14.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.154 0.502 . . . . 63.23 110.55 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.609 HD21 HG22 ' A' ' 619' ' ' ILE . 8.9 p-10 -58.0 145.41 36.17 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 114.099 -1.409 . . . . 73.11 112.786 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -57.55 -25.25 59.65 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.483 1.113 . . . . 71.45 111.39 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -59.78 -45.26 92.84 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 115.351 -0.84 . . . . 74.2 109.261 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 79.12 12.17 84.32 Favored Glycine 0 N--CA 1.412 -2.915 0 N-CA-C 110.159 -1.176 . . . . 72.13 110.159 -175.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 619' ' ' ILE . . . . . 0.609 HG22 HD21 ' A' ' 615' ' ' ASN . 0.0 OUTLIER -70.39 126.29 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 108.335 -0.987 . . . . 25.23 108.335 -176.594 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.457 ' N ' HD13 ' A' ' 619' ' ' ILE . 7.5 tp -126.54 129.91 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.675 0 CA-C-N 115.645 -0.707 . . . . 74.23 110.991 -174.042 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 606' ' ' GLN . 39.7 m -104.66 127.19 52.34 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.27 -1.011 . . . . 74.31 108.27 175.052 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 96.0 mt -138.0 150.79 47.3 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 108.558 -0.905 . . . . 73.0 108.558 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -128.24 136.98 51.79 Favored 'General case' 0 C--N 1.278 -2.506 0 N-CA-C 107.295 -1.372 . . . . 74.03 107.295 172.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -141.9 165.61 26.99 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 104.42 -2.437 . . . . 75.04 104.42 170.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -61.26 -100.08 0.01 OUTLIER Glycine 0 C--N 1.301 -1.374 0 O-C-N 124.056 0.847 . . . . 73.11 113.683 -174.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 . . . . . 0 C--N 1.291 -1.941 0 N-CA-C 108.123 -1.066 . . . . 61.31 108.123 178.185 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 . . . . . 0 CA--C 1.49 -1.358 0 N-CA-C 108.504 -0.925 . . . . 54.42 108.504 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 34.5 m -117.24 145.92 22.39 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 108.896 -0.779 . . . . 61.04 108.896 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -95.35 121.5 37.08 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 106.01 -1.848 . . . . 75.15 106.01 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.407 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 63.7 t -97.39 121.58 58.13 Favored Pre-proline 0 C--N 1.291 -1.94 0 CA-C-N 114.942 -1.026 . . . . 72.33 110.849 -171.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 363' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 24.6 Cg_exo -63.5 158.26 46.5 Favored 'Trans proline' 0 C--O 1.242 0.688 0 C-N-CA 122.217 1.944 . . . . 71.4 110.229 177.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -103.42 168.85 8.9 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 120.355 -0.538 . . . . 73.42 109.898 -173.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 9.9 t -128.61 2.57 2.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-O 121.638 0.732 . . . . 74.41 109.15 -177.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.531 ' HD3' ' OG1' ' A' ' 402' ' ' THR . 16.8 ptt-85 -58.2 144.46 40.66 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.439 0.638 . . . . 63.31 111.723 178.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.4 -7.11 50.62 Favored Glycine 0 N--CA 1.425 -2.041 0 CA-C-N 115.004 -0.998 . . . . 72.42 111.607 -178.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -109.76 -87.89 0.51 Allowed 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 113.018 0.747 . . . . 74.44 113.018 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 369' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 81.3 p -159.44 159.51 33.7 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 109.213 -0.662 . . . . 73.51 109.213 -175.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 46.4 t -63.12 -40.5 97.78 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.788 -0.819 . . . . 73.31 108.788 175.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -63.92 -47.15 81.68 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 118.997 -0.525 . . . . 71.12 112.188 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -69.77 -35.88 75.28 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 119.721 -0.792 . . . . 75.35 110.607 -178.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -64.87 -51.26 62.99 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.789 -0.641 . . . . 44.1 109.935 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 68.5 mt -60.98 -46.27 96.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.687 -0.233 . . . . 63.55 110.591 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.83 -44.45 90.89 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 116.073 -0.512 . . . . 72.42 112.065 -176.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 28.3 m -67.67 -48.95 65.18 Favored 'General case' 0 C--O 1.249 1.067 0 CA-C-O 120.865 0.364 . . . . 41.13 111.068 -177.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.04 -40.44 94.79 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.092 0.404 . . . . 65.53 112.092 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -66.62 -36.62 83.03 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.263 -0.426 . . . . 74.0 110.484 -177.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -70.16 -24.71 63.2 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 120.721 0.296 . . . . 71.13 111.727 176.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -86.91 -8.69 57.02 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.087 0.47 . . . . 73.32 111.389 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 97.83 4.15 57.96 Favored Glycine 0 C--N 1.309 -0.922 0 C-N-CA 120.378 -0.915 . . . . 65.02 112.306 176.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -79.91 148.37 31.29 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 109.129 -0.693 . . . . 71.03 109.129 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -95.01 132.67 39.62 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 107.704 -1.221 . . . . 75.13 107.704 -177.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 1.4 pp -118.83 131.07 72.68 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 CA-C-O 121.755 0.788 . . . . 71.02 112.688 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -113.15 127.6 56.24 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 107.881 -1.155 . . . . 71.45 107.881 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 27.5 m -119.38 128.1 53.75 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 109.968 -0.382 . . . . 72.32 109.968 -177.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -111.3 119.76 39.97 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.645 -0.872 . . . . 74.12 108.645 176.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 11.4 pm0 -100.57 122.72 43.72 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.054 -0.721 . . . . 74.31 109.054 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 389' ' ' LYS . . . . . 0.409 ' HB2' HG13 ' A' ' 394' ' ' ILE . 68.2 mttm -119.63 134.36 23.86 Favored Pre-proline 0 C--N 1.293 -1.877 0 CA-C-N 115.96 -0.564 . . . . 72.43 110.004 -177.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 390' ' ' PRO . . . . . 0.49 ' O ' HD11 ' A' ' 394' ' ' ILE . 11.1 Cg_exo -72.52 157.47 52.73 Favored 'Trans proline' 0 C--O 1.248 0.979 0 C-N-CA 121.935 1.757 . . . . 73.1 110.116 175.185 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 32.7 t70 88.34 152.6 0.05 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 125.267 1.427 . . . . 73.1 111.938 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 17.9 m -101.5 13.0 36.32 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 113.262 0.838 . . . . 73.33 113.262 -174.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 26.9 m -76.03 -25.93 56.13 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.654 -1.239 . . . . 71.42 107.654 172.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.49 HD11 ' O ' ' A' ' 390' ' ' PRO . 0.0 OUTLIER -88.82 149.45 43.71 Favored Pre-proline 0 N--CA 1.433 -1.313 0 CA-C-N 114.764 -1.107 . . . . 73.31 108.67 172.524 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 395' ' ' PRO . . . . . 0.442 ' HA ' ' HD3' ' A' ' 396' ' ' PRO . 27.9 Cg_endo -63.31 133.66 41.5 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.198 2.599 . . . . 74.23 114.709 -174.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 396' ' ' PRO . . . . . 0.444 ' HA ' ' HB3' ' A' ' 421' ' ' SER . 53.8 Cg_exo -55.5 163.03 5.47 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 124.268 3.312 . . . . 72.02 111.934 175.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -56.47 -8.1 0.49 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.729 0.812 . . . . 53.51 113.165 -175.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 32.7 m170 -83.26 104.21 13.25 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 105.248 -2.13 . . . . 74.3 105.248 168.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.407 HG23 ' HA ' ' A' ' 366' ' ' ARG . 25.2 m -64.92 120.18 11.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 CA-C-N 114.798 -1.092 . . . . 72.34 111.216 -168.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 9.8 tp -98.17 -29.22 3.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 120.519 -0.472 . . . . 53.15 110.244 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.81 157.98 27.53 Favored Glycine 0 N--CA 1.428 -1.861 0 N-CA-C 110.867 -0.893 . . . . 75.4 110.867 -177.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 402' ' ' THR . . . . . 0.531 ' OG1' ' HD3' ' A' ' 366' ' ' ARG . 17.3 p -139.43 -177.69 5.05 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 124.213 1.005 . . . . 64.32 109.246 -177.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 403' ' ' ASP . . . . . 0.457 ' HA ' ' HD3' ' A' ' 404' ' ' PRO . 16.8 t70 -101.17 133.48 20.93 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 107.342 -1.355 . . . . 71.34 107.342 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 404' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 403' ' ' ASP . 17.4 Cg_exo -67.76 11.02 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 123.473 2.782 . . . . 71.41 115.147 -173.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.86 -49.12 71.92 Favored 'General case' 0 C--O 1.216 -0.686 0 N-CA-C 109.756 -0.461 . . . . 52.42 109.756 176.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -69.82 -30.96 68.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.522 0.677 . . . . 64.33 110.239 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -76.8 -6.67 53.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.741 0.781 . . . . 74.43 110.354 -176.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 31.9 m -101.73 155.97 17.79 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 106.337 -1.727 . . . . 53.54 106.337 174.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 46.0 m -74.49 112.06 10.29 Favored 'General case' 0 N--CA 1.415 -2.197 0 N-CA-C 107.485 -1.302 . . . . 61.43 107.485 177.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 24.2 m -128.33 162.13 35.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 110.274 -0.269 . . . . 73.3 110.274 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 11.4 m -67.14 131.65 46.23 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.75 -0.833 . . . . 62.23 108.75 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -59.94 136.94 58.17 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 112.719 0.637 . . . . 73.42 112.719 -174.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 88.92 49.36 3.59 Favored Glycine 0 N--CA 1.434 -1.497 0 CA-C-N 114.887 -1.051 . . . . 71.41 111.599 -178.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -103.64 -173.66 2.36 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.688 -0.856 . . . . 75.15 108.688 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -109.08 120.66 43.19 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 123.274 0.629 . . . . 74.32 110.009 -176.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 48.6 mm -110.7 122.47 65.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 109.086 -0.709 . . . . 73.14 109.086 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 41.6 m -101.46 131.15 47.73 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.86 0.362 . . . . 72.41 111.301 -178.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 4.8 p -126.58 135.94 62.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 123.829 0.852 . . . . 74.33 109.643 -179.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -113.75 125.34 54.0 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.181 0.515 . . . . 63.44 109.855 176.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 22.0 m -124.72 150.3 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.185 0 CA-C-N 115.097 -0.956 . . . . 72.22 111.483 -176.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 421' ' ' SER . . . . . 0.444 ' HB3' ' HA ' ' A' ' 396' ' ' PRO . 16.3 t -88.77 145.57 25.53 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.214 1.007 . . . . 70.13 112.473 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.3 p -117.14 157.83 25.26 Favored 'General case' 0 N--CA 1.412 -2.369 0 CA-C-N 113.207 -1.815 . . . . 72.33 106.191 171.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.667 0 N-CA-C 116.997 1.559 . . . . 40.13 116.997 -175.144 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 . . . . . 0 N--CA 1.424 -1.765 0 N-CA-C 106.924 -1.509 . . . . 64.13 106.924 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -121.13 142.15 50.13 Favored 'General case' 0 CA--C 1.486 -1.483 0 C-N-CA 119.809 -0.756 . . . . 75.32 111.992 -178.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 11.2 pt-20 -83.09 131.83 35.13 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.172 -1.377 . . . . 74.32 110.191 -176.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 60.6 mt -88.52 127.77 55.37 Favored Pre-proline 0 C--N 1.305 -1.346 0 N-CA-C 108.722 -0.844 . . . . 71.53 108.722 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -71.41 142.82 41.68 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 121.624 1.55 . . . . 54.14 110.152 174.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -77.89 115.14 17.41 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.443 -0.577 . . . . 71.34 109.443 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 48.0 t -109.85 146.17 15.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 108.237 -1.023 . . . . 62.33 108.237 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 2.5 p -67.32 153.04 44.61 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 122.915 0.486 . . . . 64.44 112.105 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 434' ' ' THR . . . . . 0.421 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 18.6 p -65.15 -31.77 73.12 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 113.302 0.853 . . . . 75.04 113.302 -173.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 2.2 pp -82.13 -10.95 59.01 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 112.272 0.471 . . . . 74.43 112.272 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.542 HG22 ' HB3' ' A' ' 439' ' ' GLU . 3.7 m -103.96 44.84 0.99 Allowed 'General case' 0 CA--C 1.563 1.463 0 CA-C-O 121.722 0.772 . . . . 73.15 110.214 -177.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -52.36 -38.22 58.21 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.153 0.981 . . . . 65.33 112.457 177.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -60.04 -42.7 95.01 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.551 0.691 . . . . 44.32 110.559 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.542 ' HB3' HG22 ' A' ' 436' ' ' THR . 36.7 tt0 -70.91 -35.64 72.37 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.724 -0.671 . . . . 65.11 110.47 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.564 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -60.18 -49.39 77.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.124 -0.489 . . . . 53.23 110.884 -178.273 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.7 m -66.05 -39.52 84.73 Favored 'Isoleucine or valine' 0 C--O 1.25 1.107 0 N-CA-C 112.292 0.478 . . . . 70.1 112.292 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.416 ' HG3' ' HA ' ' A' ' 439' ' ' GLU . 0.0 OUTLIER -68.31 -34.65 76.52 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 119.751 -0.78 . . . . 70.23 112.083 177.546 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -64.09 -38.85 92.56 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.54 -0.3 . . . . 75.23 110.738 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 92.9 mt -63.46 -39.67 95.08 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.962 -0.563 . . . . 74.02 110.219 178.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.514 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 15.7 m -70.89 -39.3 72.88 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.929 -0.578 . . . . 41.23 111.197 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.98 -20.96 64.18 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.384 0.611 . . . . 73.14 110.94 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -85.69 5.35 32.48 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 115.53 -0.759 . . . . 73.32 111.923 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 110.22 -85.13 0.39 Allowed Glycine 0 CA--C 1.491 -1.418 0 C-N-CA 120.052 -1.07 . . . . 62.33 112.054 175.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -35.3 -62.36 0.39 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.4 1.259 . . . . 73.42 114.4 176.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 450' ' ' GLY . . . . . 0.514 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 58.39 26.17 58.89 Favored Glycine 0 CA--C 1.504 -0.622 0 C-N-CA 121.343 -0.456 . . . . 74.23 113.183 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.471 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 21.9 mmt180 -105.3 110.8 23.3 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 107.892 -1.151 . . . . 72.13 107.892 -177.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 33.1 p90 -140.66 152.46 45.39 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 116.315 -0.402 . . . . 63.03 110.132 -177.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -138.0 123.01 19.05 Favored 'General case' 0 C--N 1.291 -1.943 0 O-C-N 124.002 0.813 . . . . 75.33 109.392 176.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -87.26 126.58 34.92 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.292 -1.003 . . . . 71.21 108.292 178.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.09 146.1 43.35 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 107.276 -1.379 . . . . 54.43 107.276 177.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -120.03 140.24 51.3 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 109.477 -0.564 . . . . 73.41 109.477 -175.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 457' ' ' SER . . . . . 0.419 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 49.4 m -147.69 132.59 8.98 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 109.489 -0.559 . . . . 63.45 109.489 174.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.626 ' HA ' ' O ' ' A' ' 490' ' ' SER . 38.9 Cg_exo -64.75 122.73 10.67 Favored 'Trans proline' 0 C--O 1.238 0.505 0 C-N-CA 122.225 1.95 . . . . 72.42 110.684 177.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 17.6 m -143.4 175.03 10.23 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 108.142 -1.059 . . . . 61.33 108.142 -176.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.9 t -47.6 139.36 8.56 Favored Pre-proline 0 C--O 1.249 1.076 0 C-N-CA 124.259 1.023 . . . . 52.44 112.251 178.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.13 -29.29 28.12 Favored 'Trans proline' 0 C--N 1.36 1.175 0 C-N-CA 124.74 3.626 . . . . 75.41 113.612 -177.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.25 -22.87 63.82 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 112.089 0.403 . . . . 75.54 112.089 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -104.25 -8.91 18.98 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 111.681 0.252 . . . . 61.01 111.681 178.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 98.6 t -60.84 127.25 20.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.974 0.416 . . . . 72.55 110.179 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.05 -16.18 60.19 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.934 -0.576 . . . . 73.43 112.41 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -107.63 166.04 10.97 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 108.352 -0.981 . . . . 75.51 108.352 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.421 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 75.2 t -76.72 143.08 13.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 108.571 -0.9 . . . . 75.44 108.571 176.011 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 63.8 mt -98.18 -30.9 3.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 107.961 -1.125 . . . . 75.02 107.961 177.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 167.17 179.26 40.03 Favored Glycine 0 N--CA 1.425 -2.096 0 N-CA-C 110.862 -0.895 . . . . 74.55 110.862 177.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 470' ' ' THR . . . . . 0.552 HG22 HG12 ' A' ' 486' ' ' ILE . 59.2 p -115.64 140.66 48.98 Favored 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 107.41 -1.329 . . . . 63.41 107.41 177.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.51 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 7.2 t30 -63.7 -50.31 72.31 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 120.756 -0.377 . . . . 44.21 110.471 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.51 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 1.4 Cg_endo -88.35 152.87 6.65 Favored 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 121.593 1.529 . . . . 74.41 108.94 171.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -63.74 126.76 18.1 Favored 'Trans proline' 0 C--O 1.243 0.726 0 C-N-CA 121.313 1.342 . . . . 72.42 111.681 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -93.88 14.38 19.66 Favored 'General case' 0 C--O 1.202 -1.432 0 CA-C-O 121.68 0.753 . . . . 75.43 110.12 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -110.02 -1.99 17.31 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.715 -0.675 . . . . 75.12 109.318 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -109.75 174.68 5.75 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.36 -0.836 . . . . 70.23 112.578 -173.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 2.5 m -86.33 114.32 23.02 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 114.108 -1.405 . . . . 72.02 108.776 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 15.7 m -109.42 148.08 31.72 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 109.877 -0.416 . . . . 71.34 109.877 -176.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.98 157.74 36.12 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.478 -0.328 . . . . 53.32 110.809 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 37.6 mm -72.35 -17.73 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-O 122.084 0.945 . . . . 72.45 110.518 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 2.7 p -99.52 5.47 46.08 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.898 -0.592 . . . . 73.52 111.437 177.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -84.61 129.97 34.78 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.519 -0.549 . . . . 73.11 109.519 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.471 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 42.7 t -102.43 120.59 52.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.748 -0.834 . . . . 73.55 108.748 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 28.3 m -100.66 120.92 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-O 122.022 0.915 . . . . 70.2 111.239 -178.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.403 HG23 ' HB3' ' A' ' 471' ' ' ASN . 0.0 OUTLIER -95.51 128.99 46.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 109.352 -0.61 . . . . 61.03 109.352 178.87 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.552 HG12 HG22 ' A' ' 470' ' ' THR . 9.8 mt -120.36 128.14 75.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 C-N-CA 124.393 1.077 . . . . 61.01 110.267 -174.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 6.4 tt -100.85 127.17 54.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 C-N-CA 122.587 0.355 . . . . 64.44 111.342 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 34.3 m -113.07 152.17 14.84 Favored 'Isoleucine or valine' 0 C--O 1.254 1.3 0 C-N-CA 123.347 0.659 . . . . 54.1 110.241 178.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -81.24 130.91 10.02 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 121.042 -0.599 . . . . 52.21 113.537 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.626 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 35.6 t . . . . . 0 C--N 1.309 -1.171 0 N-CA-C 106.067 -1.827 . . . . 43.24 106.067 176.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 C--O 1.249 1.026 0 N-CA-C 111.091 -0.388 . . . . 73.02 111.091 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -129.19 32.32 4.73 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-O 121.879 0.847 . . . . 75.53 110.582 -177.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 546' ' ' PRO . 19.6 p -118.12 142.13 47.75 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 114.686 -1.143 . . . . 74.33 109.885 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? -139.65 163.2 33.2 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.393 -0.595 . . . . 75.12 109.393 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.4 p-10 -85.74 138.81 31.84 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.809 -0.632 . . . . 71.04 110.001 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 38.2 pt -88.1 133.74 36.47 Favored Pre-proline 0 C--N 1.295 -1.771 0 C-N-CA 120.536 -0.465 . . . . 72.42 109.823 175.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -87.04 175.18 5.05 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.649 2.233 . . . . 74.21 111.819 177.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -92.63 157.24 16.6 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.547 -0.909 . . . . 73.01 108.547 177.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.456 HG21 ' HA ' ' A' ' 508' ' ' ALA . 9.4 p -159.97 12.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.256 0 CA-C-O 121.531 0.681 . . . . 65.34 111.587 -177.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -74.59 95.05 2.74 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 121.417 0.627 . . . . 75.33 110.947 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 159.64 -22.64 0.28 Allowed Glycine 0 N--CA 1.427 -1.914 0 CA-C-N 115.39 -0.823 . . . . 74.01 111.497 -177.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -102.11 -177.85 3.53 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.02 -0.672 . . . . 70.01 109.241 176.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 20.3 p -83.41 158.93 21.92 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 110.036 -0.357 . . . . 70.31 110.036 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.491 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 9.5 p -52.99 -41.14 39.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 O-C-N 123.703 0.627 . . . . 73.54 111.92 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 506' ' ' ASP . . . . . 0.481 ' O ' ' HD3' ' A' ' 510' ' ' LYS . 3.4 m-20 -57.57 -42.02 82.26 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.746 0.419 . . . . 74.14 111.166 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 59.4 t -68.85 -38.29 78.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.231 0.538 . . . . 72.4 109.888 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 508' ' ' ALA . . . . . 0.456 ' HA ' HG21 ' A' ' 500' ' ' VAL . . . -62.96 -44.09 97.01 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.633 -0.712 . . . . 53.3 110.821 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.491 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 26.5 mt-30 -60.18 -39.58 86.97 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.0 -0.545 . . . . 72.13 110.836 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.481 ' HD3' ' O ' ' A' ' 506' ' ' ASP . 14.4 mptt -65.88 -50.62 63.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.698 -0.683 . . . . 72.33 111.047 177.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -61.89 -40.89 97.0 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 116.394 -0.367 . . . . 75.43 111.474 -177.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 94.0 mt -62.71 -44.76 95.38 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 110.358 -0.238 . . . . 73.01 110.358 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -60.46 -41.45 94.18 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.017 -0.538 . . . . 60.13 110.88 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 510' ' ' LYS . 73.5 t -57.85 -36.46 55.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.871 -0.604 . . . . 72.02 111.71 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -87.18 0.26 55.6 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.249 -0.58 . . . . 75.14 112.365 -177.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 98.97 14.16 37.5 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.754 -0.736 . . . . 75.24 113.719 175.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -101.03 110.19 22.19 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.344 -0.984 . . . . 74.43 108.344 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.39 -14.66 22.31 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 116.011 -0.54 . . . . 54.04 111.871 -175.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 519' ' ' LYS . . . . . 0.507 ' HD2' ' O ' ' A' ' 548' ' ' ASP . 99.2 mttt -108.03 115.5 30.25 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.608 0.718 . . . . 72.32 111.871 -175.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -130.21 150.94 51.23 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.084 -0.962 . . . . 53.34 109.65 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 521' ' ' SER . . . . . 0.531 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 51.1 m -136.42 140.55 43.25 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 106.983 -1.488 . . . . 73.05 106.983 174.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -122.97 125.21 44.84 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.544 0.688 . . . . 75.01 112.35 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -116.33 116.49 27.83 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.728 -1.124 . . . . 75.24 108.047 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 524' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 12.4 p -91.8 130.18 37.62 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.148 0.499 . . . . 51.41 111.173 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 27.2 m -121.89 158.54 25.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.252 -1.018 . . . . 75.43 108.252 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -73.35 137.72 44.92 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 119.87 -0.732 . . . . 71.2 109.189 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 24.6 m -148.35 171.06 6.73 Favored Pre-proline 0 C--N 1.287 -2.142 0 N-CA-C 107.941 -1.133 . . . . 73.2 107.941 -178.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -81.61 -11.08 11.75 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 121.508 1.472 . . . . 70.14 110.783 172.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.467 ' HD3' ' OE2' ' A' ' 533' ' ' GLU . 88.4 mtt180 -80.91 145.39 57.18 Favored Pre-proline 0 N--CA 1.444 -0.735 0 CA-C-N 115.276 -0.874 . . . . 71.21 108.932 178.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.26 151.47 82.16 Favored 'Trans proline' 0 C--O 1.253 1.235 0 C-N-CA 122.787 2.325 . . . . 64.25 112.855 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.682 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -62.43 112.12 2.31 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.932 -1.031 . . . . 70.24 111.739 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 134.11 -20.88 3.96 Favored Glycine 0 C--N 1.308 -0.977 0 C-N-CA 120.829 -0.701 . . . . 64.2 112.617 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 533' ' ' GLU . . . . . 0.467 ' OE2' ' HD3' ' A' ' 529' ' ' ARG . 34.3 tt0 -83.02 142.37 31.38 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.702 -0.481 . . . . 53.11 109.702 179.054 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 63.1 t -81.92 123.41 38.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 108.666 -0.864 . . . . 72.41 108.666 178.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 535' ' ' THR . . . . . 0.69 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 10.3 t -96.44 -19.74 18.94 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.36 -0.536 . . . . 73.14 110.742 -178.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 177.48 179.13 47.58 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.244 -0.979 . . . . 73.21 111.509 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 72.1 p -124.16 149.82 45.86 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.562 -1.273 . . . . 60.52 107.562 177.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.424 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 47.6 t30 -67.75 -59.82 6.25 Favored Pre-proline 0 C--N 1.323 -0.555 0 C-N-CA 120.548 -0.461 . . . . 74.11 109.931 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 57.2 Cg_endo -76.29 130.56 12.1 Favored 'Trans proline' 0 N--CA 1.44 -1.653 0 N-CA-C 108.298 -1.462 . . . . 63.54 108.298 170.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -66.63 150.69 83.73 Favored 'Trans proline' 0 C--O 1.255 1.371 0 C-N-CA 122.01 1.807 . . . . 75.31 112.178 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -58.98 142.74 50.27 Favored 'General case' 0 C--O 1.249 1.067 0 CA-C-N 115.759 -0.655 . . . . 72.54 109.787 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 102.9 -17.33 52.9 Favored Glycine 0 C--N 1.291 -1.917 0 C-N-CA 120.508 -0.853 . . . . 55.45 111.677 -179.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 61.5 m -68.9 127.49 33.28 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 109.959 -0.385 . . . . 65.2 109.959 178.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 20.6 m -91.62 122.99 34.68 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.384 -0.969 . . . . 64.24 108.384 177.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 29.4 m -137.37 161.26 61.84 Favored Pre-proline 0 C--N 1.311 -1.102 0 N-CA-C 109.033 -0.728 . . . . 50.04 109.033 -176.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 494' ' ' THR . 13.6 Cg_endo -61.33 151.68 77.65 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 121.809 1.673 . . . . 74.34 110.821 173.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 30.5 m -63.3 -20.31 25.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.596 0.712 . . . . 42.13 112.166 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 548' ' ' ASP . . . . . 0.507 ' O ' ' HD2' ' A' ' 519' ' ' LYS . 26.8 t70 -90.42 4.25 51.5 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.628 -0.715 . . . . 73.33 110.863 178.337 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.1 t -71.15 162.61 29.14 Favored 'General case' 0 C--O 1.241 0.62 0 O-C-N 121.474 -0.766 . . . . 71.03 109.402 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 18.0 t -109.32 116.75 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 CA-C-O 121.152 0.501 . . . . 74.45 109.961 -176.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 2.5 mp -91.95 123.86 44.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 109.124 -0.695 . . . . 55.21 109.124 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 552' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 521' ' ' SER . 37.7 tt0 -102.87 120.14 40.08 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-O 121.056 0.455 . . . . 73.24 110.029 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -96.65 134.27 40.11 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.96 -1.018 . . . . 71.13 109.817 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -92.47 114.88 27.56 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.513 -1.291 . . . . 74.14 107.513 171.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 524' ' ' SER . 47.6 t -100.73 141.72 17.01 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.39 0 N-CA-C 108.684 -0.858 . . . . 72.42 108.684 -177.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.69 ' OG ' ' HB ' ' A' ' 535' ' ' THR . 71.7 m -81.45 138.76 35.5 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-O 121.124 0.488 . . . . 73.04 111.75 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.11 135.72 52.4 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 105.678 -1.971 . . . . 73.01 105.678 169.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -71.12 -41.95 59.45 Favored Glycine 0 CA--C 1.497 -1.039 0 N-CA-C 111.297 -0.721 . . . . 64.54 111.297 -175.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 65.4 t30 66.43 8.12 5.49 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.686 1.194 . . . . 75.5 111.21 175.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -113.78 162.3 16.48 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.127 -0.942 . . . . 71.21 109.152 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -137.19 144.92 43.12 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.414 -0.588 . . . . 74.43 109.414 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 96.8 t -72.83 122.61 25.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 123.528 0.517 . . . . 45.11 110.233 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 48.7 ttm -78.22 126.11 83.96 Favored Pre-proline 0 C--N 1.308 -1.231 0 CA-C-N 115.714 -0.676 . . . . 42.43 109.964 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.3 169.33 18.57 Favored 'Trans proline' 0 C--O 1.243 0.774 0 C-N-CA 122.569 2.18 . . . . 64.01 110.7 176.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -83.08 119.7 24.82 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.834 0.826 . . . . 71.22 111.338 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 95.0 mt -127.34 14.04 7.15 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.083 -1.417 . . . . 73.42 107.453 176.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 9.3 m -72.04 130.7 41.56 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.431 -1.258 . . . . 71.41 109.356 -178.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 85.02 22.91 51.24 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.345 -0.931 . . . . 64.3 112.028 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 87.9 mtp -116.14 -178.91 3.52 Favored 'General case' 0 C--O 1.25 1.105 0 N-CA-C 109.282 -0.636 . . . . 74.0 109.282 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 570' ' ' PHE . . . . . 0.409 ' HB3' ' OD1' ' A' ' 601' ' ' ASN . 97.1 m-85 -97.47 153.17 18.3 Favored 'General case' 0 N--CA 1.414 -2.226 0 N-CA-C 109.176 -0.676 . . . . 75.11 109.176 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 64.1 t90 -64.57 -27.37 68.91 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 123.441 0.697 . . . . 70.21 110.142 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 10.3 p -71.66 -16.44 18.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.779 -0.646 . . . . 73.11 109.694 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 573' ' ' ASP . . . . . 0.509 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 22.9 m-20 -101.14 -44.91 5.54 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.6 -0.519 . . . . 73.22 109.6 176.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -62.91 -52.68 62.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.596 -0.729 . . . . 72.34 112.664 -175.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.464 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 4.1 tm-20 -55.55 -52.11 74.59 Favored Pre-proline 0 CA--C 1.567 1.623 0 C-N-CA 122.784 0.434 . . . . 74.54 111.851 -176.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 576' ' ' PRO . . . . . 0.464 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 52.3 Cg_exo -61.12 -29.46 87.25 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 121.785 1.657 . . . . 44.42 113.038 174.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.542 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 20.0 mmt180 -66.43 -40.41 89.51 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 111.479 0.177 . . . . 73.54 111.479 178.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.13 -45.53 90.68 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.202 0.525 . . . . 64.54 109.952 177.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -59.68 -39.64 85.18 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.362 -0.835 . . . . 65.11 110.961 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.29 -21.39 62.95 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.341 -0.39 . . . . 44.42 111.717 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 581' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 92.3 mt -82.66 -6.8 59.57 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 120.956 0.407 . . . . 54.42 111.43 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 88.36 20.07 50.07 Favored Glycine 0 C--O 1.238 0.37 0 C-N-CA 120.135 -1.031 . . . . 60.14 111.495 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 89.9 t90 -70.92 129.84 40.07 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.006 -0.738 . . . . 72.5 109.006 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 1.2 m -127.56 13.92 7.02 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.606 -0.516 . . . . 63.34 109.606 -176.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 585' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -88.98 -156.82 32.07 Favored Glycine 0 CA--C 1.498 -1.029 0 C-N-CA 120.538 -0.839 . . . . 44.31 114.987 -173.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 50.0 ttm -108.1 131.36 54.7 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 122.873 0.469 . . . . 73.21 111.37 -178.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -101.37 128.96 47.32 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.653 -1.24 . . . . 64.13 107.653 176.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -107.0 122.36 46.28 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 116.2 -0.454 . . . . 75.41 109.837 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -90.28 132.97 35.24 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.404 -0.816 . . . . 71.33 110.158 -178.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -85.34 177.64 50.42 Favored Glycine 0 N--CA 1.431 -1.682 0 C-N-CA 120.987 -0.625 . . . . 64.11 112.227 175.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -72.53 144.74 47.85 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 123.067 0.547 . . . . 63.11 111.451 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -63.42 151.35 41.29 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.866 -0.607 . . . . 74.11 111.402 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 47.0 t -138.39 116.97 13.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 107.954 -1.128 . . . . 72.02 107.954 -178.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -74.43 124.06 25.84 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.085 -1.08 . . . . 73.13 108.085 177.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -160.19 12.9 0.12 Allowed 'General case' 0 C--O 1.244 0.801 0 N-CA-C 112.376 0.51 . . . . 74.21 112.376 -176.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 89.8 166.67 41.79 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.172 -1.013 . . . . 50.02 112.086 -178.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -59.56 -48.23 87.04 Favored Glycine 0 CA--C 1.519 0.301 0 N-CA-C 114.724 0.649 . . . . 71.52 114.724 -175.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 28.2 m -61.23 -25.22 66.92 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-O 121.224 0.535 . . . . 75.52 112.136 -176.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -108.36 -1.52 19.9 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 112.477 0.547 . . . . 75.44 112.477 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.53 -51.65 11.29 Favored 'General case' 0 C--O 1.195 -1.791 0 C-N-CA 119.624 -0.83 . . . . 74.04 111.864 -173.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 601' ' ' ASN . . . . . 0.409 ' OD1' ' HB3' ' A' ' 570' ' ' PHE . 16.7 t-20 -92.19 19.39 6.98 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 120.857 -1.152 . . . . 73.34 109.429 -177.121 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 20.0 tpp85 -91.08 139.77 30.45 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.015 -0.993 . . . . 63.3 109.936 -176.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 13.5 p -65.05 139.97 20.52 Favored 'Isoleucine or valine' 0 C--O 1.247 0.94 0 N-CA-C 108.597 -0.89 . . . . 63.44 108.597 175.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 95.5 t -100.15 -46.88 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.056 0 N-CA-C 108.427 -0.953 . . . . 64.41 108.427 -177.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -156.15 157.23 35.59 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 105.872 -1.899 . . . . 73.42 105.872 176.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -123.4 131.94 53.81 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 106.918 -1.512 . . . . 73.02 106.918 173.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.611 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 25.8 t-20 -50.8 -58.09 11.34 Favored Pre-proline 0 C--N 1.312 -1.028 0 CA-C-O 118.844 -0.598 . . . . 72.11 112.366 -177.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.611 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 11.1 Cg_endo -96.76 121.5 0.2 Allowed 'Trans proline' 0 N--CA 1.44 -1.674 0 C-N-CA 121.733 1.622 . . . . 75.45 109.716 173.45 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -66.46 158.36 55.79 Favored 'Trans proline' 0 C--O 1.25 1.077 0 C-N-CA 122.116 1.877 . . . . 72.11 112.277 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.86 130.91 47.92 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.854 -0.612 . . . . 62.31 110.679 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 104.29 -3.77 43.93 Favored Glycine 0 C--N 1.3 -1.425 0 C-N-CA 120.635 -0.793 . . . . 74.34 112.119 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 6.1 m -93.13 148.13 22.28 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.235 -0.654 . . . . 63.11 109.235 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -84.5 115.79 4.16 Favored Glycine 0 N--CA 1.425 -2.056 0 N-CA-C 109.272 -1.531 . . . . 61.4 109.272 175.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.4 m -100.98 143.7 13.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 C-N-CA 122.854 0.461 . . . . 52.01 111.067 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -44.4 166.53 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.637 1.975 . . . . 75.13 113.354 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.0 -26.08 61.93 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.943 0.401 . . . . 64.52 111.59 -176.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 617' ' ' ASP . . . . . 0.501 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 25.8 t70 -79.68 -37.23 36.27 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.592 -0.731 . . . . 75.21 109.315 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 81.42 22.76 59.83 Favored Glycine 0 N--CA 1.429 -1.789 0 C-N-CA 118.948 -1.596 . . . . 51.43 111.527 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.81 119.8 12.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 122.286 1.041 . . . . 65.42 109.165 -168.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.15 126.76 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-N 114.513 -1.221 . . . . 71.41 110.594 -172.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.527 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 32.2 m -100.9 125.8 47.48 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.128 -0.693 . . . . 74.43 109.128 175.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.5 pp -133.85 154.63 50.89 Favored 'General case' 0 CA--C 1.479 -1.759 0 N-CA-C 108.612 -0.885 . . . . 72.42 108.612 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -127.98 141.57 51.49 Favored 'General case' 0 C--N 1.257 -3.414 0 N-CA-C 105.43 -2.063 . . . . 72.24 105.43 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -137.41 166.82 22.91 Favored 'General case' 0 C--N 1.277 -2.561 0 N-CA-C 107.129 -1.434 . . . . 74.34 107.129 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -70.7 -137.34 0.14 Allowed Glycine 0 N--CA 1.427 -1.921 0 O-C-N 124.325 1.016 . . . . 65.01 115.343 -174.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 C--N 1.289 -2.05 0 CA-C-O 118.967 -0.54 . . . . 65.14 109.575 -171.159 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 . . . . . 0 CA--C 1.5 -0.949 0 N-CA-C 106.019 -1.845 . . . . 73.44 106.019 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 31.4 m -115.51 154.14 16.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-O 121.633 0.73 . . . . 71.4 111.053 -172.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 361' ' ' GLN . . . . . 0.403 ' OE1' ' HA ' ' A' ' 407' ' ' ASN . 0.3 OUTLIER -94.92 136.77 34.83 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 106.425 -1.694 . . . . 74.43 106.425 -176.16 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.574 HG22 ' CZ ' ' A' ' 382' ' ' PHE . 98.0 t -95.12 118.63 66.49 Favored Pre-proline 0 C--N 1.297 -1.68 0 CA-C-N 116.028 -0.533 . . . . 74.3 110.773 -169.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 363' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 17.1 Cg_exo -64.59 130.92 27.86 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 123.027 2.485 . . . . 61.15 112.271 -178.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -93.66 121.16 34.8 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.238 -0.892 . . . . 70.34 110.342 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 5.7 m -104.65 23.91 2.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 122.005 0.907 . . . . 64.21 110.986 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.462 ' HA ' HG23 ' A' ' 399' ' ' VAL . 4.5 ppt_? -54.85 145.54 19.61 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.551 -1.204 . . . . 72.34 110.781 172.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.15 -11.8 51.94 Favored Glycine 0 C--N 1.302 -1.344 0 N-CA-C 110.356 -1.098 . . . . 71.3 110.356 -175.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -108.18 -151.66 0.47 Allowed 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 108.464 -0.939 . . . . 71.24 108.464 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 80.6 p -98.21 157.44 16.16 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.43 -0.582 . . . . 72.13 109.43 -174.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.5 p -63.67 -41.06 98.22 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 112.306 0.484 . . . . 75.24 112.306 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -67.14 -42.83 83.74 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-O 119.462 -0.304 . . . . 50.4 111.495 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.02 -35.12 74.09 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 119.558 -0.857 . . . . 62.41 110.594 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.22 -47.95 75.04 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.788 -0.642 . . . . 60.43 110.611 177.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 374' ' ' ILE . . . . . 0.548 HG23 HG13 ' A' ' 384' ' ' ILE . 70.6 mt -61.71 -43.19 96.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-N 116.039 -0.528 . . . . 61.44 110.309 175.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.57 -44.77 89.87 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.126 -0.488 . . . . 74.43 110.112 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 87.9 m -60.74 -46.81 89.02 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.964 -0.562 . . . . 52.54 110.753 178.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 93.7 mt -62.98 -40.33 97.42 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.346 -0.388 . . . . 62.42 110.22 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 65.3 tp60 -62.12 -43.29 99.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.671 -0.695 . . . . 64.15 110.3 178.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -60.0 -31.85 70.31 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 120.982 0.42 . . . . 63.25 111.384 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -85.86 -12.24 51.23 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.957 -0.565 . . . . 75.41 111.751 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 94.49 14.57 50.08 Favored Glycine 0 C--N 1.307 -1.059 0 C-N-CA 120.761 -0.733 . . . . 61.33 112.701 177.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.574 ' CZ ' HG22 ' A' ' 362' ' ' VAL . 52.2 m-85 -81.04 150.82 28.67 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-O 121.076 0.465 . . . . 75.53 111.221 177.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.419 ' CB ' ' HG2' ' A' ' 415' ' ' GLU . 7.7 mmtp -84.49 144.78 28.49 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.854 -1.165 . . . . 75.2 107.854 175.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 384' ' ' ILE . . . . . 0.548 HG13 HG23 ' A' ' 374' ' ' ILE . 0.2 OUTLIER -129.93 133.83 63.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-O 121.495 0.664 . . . . 74.15 111.015 -177.867 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 385' ' ' ARG . . . . . 0.463 ' NE ' ' HA ' ' A' ' 385' ' ' ARG . 3.6 tpm_? -115.89 147.13 41.43 Favored 'General case' 0 N--CA 1.41 -2.437 0 N-CA-C 106.519 -1.66 . . . . 72.4 106.519 173.166 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 39.1 m -129.55 127.64 41.13 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 109.507 -0.553 . . . . 75.15 109.507 -177.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -119.12 130.52 55.61 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 105.488 -2.042 . . . . 73.35 105.488 176.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 19.4 pm0 -121.55 135.9 54.98 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 118.452 0.569 . . . . 63.43 110.062 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -134.42 115.92 12.83 Favored Pre-proline 0 C--N 1.314 -0.952 0 C-N-CA 121.335 -0.146 . . . . 55.41 111.1 177.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 390' ' ' PRO . . . . . 0.495 ' CA ' ' HB ' ' A' ' 422' ' ' THR . 64.8 Cg_endo -87.91 135.49 3.4 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.43 2.087 . . . . 74.51 111.146 174.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.537 ' HB3' HG12 ' A' ' 394' ' ' ILE . 13.1 t70 -179.82 153.65 0.54 Allowed 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 109.022 -0.733 . . . . 50.43 109.022 177.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 9.9 m -73.87 -18.53 60.91 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 123.186 0.594 . . . . 64.35 111.959 -177.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 3.1 m -87.63 -17.37 32.02 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-O 121.741 0.781 . . . . 65.31 109.975 -178.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.571 HG22 ' HB3' ' A' ' 421' ' ' SER . 45.4 mm -90.22 135.68 29.55 Favored Pre-proline 0 C--N 1.301 -1.513 0 CA-C-N 115.446 -0.797 . . . . 44.03 111.311 -171.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 395' ' ' PRO . . . . . 0.456 ' HB3' ' HD2' ' A' ' 396' ' ' PRO . 95.7 Cg_exo -50.14 179.0 0.02 OUTLIER 'Trans proline' 0 CA--C 1.585 3.072 1 C-N-CA 126.104 4.536 . . . . 71.11 116.021 179.223 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 396' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 395' ' ' PRO . 37.6 Cg_endo -67.14 160.96 44.98 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 123.191 2.594 . . . . 72.34 113.13 173.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -62.58 -6.24 3.3 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 124.591 1.156 . . . . 73.24 113.618 -177.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -65.6 158.04 28.23 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.946 -0.761 . . . . 64.4 108.946 177.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.462 HG23 ' HA ' ' A' ' 366' ' ' ARG . 6.4 m -86.36 117.77 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 C-N-CA 118.49 -1.284 . . . . 70.03 108.893 176.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 400' ' ' ILE . . . . . 0.413 HD12 ' N ' ' A' ' 401' ' ' GLY . 2.7 pp -88.96 -28.52 5.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 113.007 0.743 . . . . 53.31 113.007 -177.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 401' ' ' GLY . . . . . 0.413 ' N ' HD12 ' A' ' 400' ' ' ILE . . . -167.97 169.3 41.28 Favored Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 110.659 -0.976 . . . . 61.4 110.659 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 18.6 p -114.95 172.71 6.88 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.69 -0.856 . . . . 72.42 108.69 177.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -102.71 155.42 36.56 Favored Pre-proline 0 C--N 1.292 -1.9 0 N-CA-C 109.028 -0.73 . . . . 61.45 109.028 177.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -50.1 -20.13 4.98 Favored 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 124.043 3.162 . . . . 74.11 115.384 -175.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -62.23 -42.82 99.65 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 110.044 -0.354 . . . . 73.21 110.044 -178.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 406' ' ' ALA . . . . . 0.421 ' O ' ' HB ' ' A' ' 362' ' ' VAL . . . -71.3 -33.09 69.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.87 0.843 . . . . 60.3 109.741 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 407' ' ' ASN . . . . . 0.403 ' HA ' ' OE1' ' A' ' 361' ' ' GLN . 18.2 m120 -86.52 2.18 48.92 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.326 -0.852 . . . . 74.11 112.27 -176.051 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 36.3 m -103.21 152.16 21.8 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 105.783 -1.932 . . . . 65.31 105.783 172.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 24.6 m -74.8 112.85 11.43 Favored 'General case' 0 N--CA 1.429 -1.517 0 C-N-CA 119.56 -0.856 . . . . 52.42 109.252 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 35.1 m -113.36 169.06 5.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 121.048 0.451 . . . . 75.42 110.256 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 19.9 m -66.45 134.7 53.01 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.637 -0.875 . . . . 74.24 108.637 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -54.78 112.37 1.02 Allowed 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 122.994 0.518 . . . . 61.11 111.086 -178.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 105.49 27.74 5.68 Favored Glycine 0 N--CA 1.433 -1.552 0 C-N-CA 120.591 -0.814 . . . . 55.32 112.86 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -85.16 177.22 7.95 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.418 -0.956 . . . . 75.44 108.418 177.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 415' ' ' GLU . . . . . 0.419 ' HG2' ' CB ' ' A' ' 383' ' ' LYS . 27.5 mt-10 -97.87 110.88 23.37 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.65 0.738 . . . . 71.15 110.97 -172.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 44.9 mm -98.33 122.62 50.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 CA-C-N 115.064 -0.971 . . . . 75.24 108.977 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 417' ' ' THR . . . . . 0.423 HG22 ' HB3' ' A' ' 385' ' ' ARG . 15.6 p -89.22 130.73 35.58 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.831 -0.622 . . . . 75.4 111.419 -177.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 7.5 p -114.36 134.3 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 N-CA-C 109.118 -0.697 . . . . 73.23 109.118 175.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -106.03 115.39 30.15 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.993 -1.484 . . . . 64.41 106.993 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 48.6 t -106.93 130.64 58.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-O 122.047 0.927 . . . . 74.51 109.727 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 421' ' ' SER . . . . . 0.571 ' HB3' HG22 ' A' ' 394' ' ' ILE . 49.6 m -87.71 123.34 32.43 Favored 'General case' 0 C--N 1.273 -2.751 0 CA-C-N 114.164 -1.38 . . . . 43.15 108.746 179.038 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 422' ' ' THR . . . . . 0.495 ' HB ' ' CA ' ' A' ' 390' ' ' PRO . 6.2 m -106.08 157.6 17.42 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 108.131 -1.063 . . . . 45.25 108.131 -177.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.651 0 N-CA-C 116.645 1.418 . . . . 71.3 116.645 -173.954 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.405 ' HB3' HG22 ' A' ' 477' ' ' THR . 43.5 mt-30 . . . . . 0 N--CA 1.428 -1.555 0 N-CA-C 107.677 -1.231 . . . . 74.41 107.677 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.573 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 4.2 mmp_? -126.17 141.8 51.79 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.369 0.604 . . . . 71.4 111.152 176.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.402 ' H ' ' HG2' ' A' ' 428' ' ' GLU . 8.7 pt-20 -83.11 129.63 35.04 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 106.724 -1.584 . . . . 75.04 106.724 175.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 53.0 mt -80.42 131.22 62.37 Favored Pre-proline 0 N--CA 1.428 -1.556 0 N-CA-C 108.947 -0.76 . . . . 63.12 108.947 -174.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -69.35 140.72 44.96 Favored 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 121.468 1.446 . . . . 70.24 110.993 176.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -89.46 114.39 25.87 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.305 -1.368 . . . . 74.52 107.305 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.444 HG11 ' HB2' ' A' ' 440' ' ' ALA . 14.7 p -110.82 159.29 10.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 108.663 -0.866 . . . . 74.13 108.663 -175.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 22.6 p -68.31 137.76 54.91 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 108.141 -1.059 . . . . 63.33 108.141 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 434' ' ' THR . . . . . 0.426 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 18.3 p -63.38 -21.56 66.35 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 113.675 0.991 . . . . 74.12 113.675 -174.089 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.2 pp -78.2 -11.48 59.93 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 120.103 -0.639 . . . . 64.14 111.606 177.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.3 m -106.79 61.79 0.63 Allowed 'General case' 0 N--CA 1.432 -1.351 0 CA-C-O 121.725 0.774 . . . . 63.23 111.729 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -52.32 -38.25 58.08 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.363 1.065 . . . . 74.5 111.507 174.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -59.39 -42.53 91.9 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.34 0.591 . . . . 53.44 110.904 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -70.92 -36.89 72.86 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.574 -0.739 . . . . 74.44 109.23 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.527 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.03 -51.69 68.58 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.748 -0.66 . . . . 63.05 111.095 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 35.5 m -64.86 -40.73 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 N-CA-C 112.589 0.588 . . . . 51.41 112.589 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -68.77 -36.37 78.23 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 119.862 -0.735 . . . . 70.41 111.276 178.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -63.9 -41.86 97.59 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.27 -0.423 . . . . 74.22 110.908 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.527 HD13 ' O ' ' A' ' 440' ' ' ALA . 7.3 mp -63.75 -32.69 74.27 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.918 -0.583 . . . . 71.02 110.322 176.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 85.2 m -69.97 -44.9 68.52 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.653 -0.703 . . . . 64.31 110.293 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.22 -22.26 65.72 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.361 0.601 . . . . 71.35 110.814 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.83 5.09 14.58 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.44 -0.8 . . . . 71.31 112.321 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 104.31 -82.95 0.38 Allowed Glycine 0 CA--C 1.492 -1.366 0 C-N-CA 120.261 -0.971 . . . . 70.25 111.816 175.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -41.09 -56.16 2.4 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.012 1.116 . . . . 74.2 114.012 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 59.25 27.25 62.62 Favored Glycine 0 C--N 1.322 -0.202 0 C-N-CA 121.528 -0.368 . . . . 73.14 113.239 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -101.34 111.21 23.37 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 109.526 -0.546 . . . . 72.45 109.526 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.512 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 27.8 p90 -134.48 150.83 50.85 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 115.485 -0.78 . . . . 74.42 109.712 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 21.4 tptp -138.46 127.81 24.49 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 106.558 -1.645 . . . . 62.32 106.558 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -98.31 127.86 44.45 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.367 0.603 . . . . 74.3 111.938 -176.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 455' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -126.92 139.88 52.74 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.23 -1.026 . . . . 75.45 108.23 176.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -112.85 143.58 43.87 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.658 -0.867 . . . . 72.31 108.658 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 22.8 t -139.92 134.33 15.83 Favored Pre-proline 0 C--N 1.295 -1.779 0 N-CA-C 109.054 -0.721 . . . . 72.44 109.054 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 490' ' ' SER . 52.7 Cg_endo -74.27 128.15 11.83 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 121.859 1.706 . . . . 74.52 110.59 176.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 35.0 m -147.14 179.93 7.27 Favored 'General case' 0 C--N 1.288 -2.098 0 C-N-CA 123.247 0.619 . . . . 74.41 109.466 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.5 t -48.85 143.87 7.84 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 125.189 1.396 . . . . 74.24 112.148 178.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 461' ' ' PRO . . . . . 0.487 ' HA ' HG23 ' A' ' 464' ' ' VAL . 10.3 Cg_endo -51.68 -29.29 32.64 Favored 'Trans proline' 0 C--N 1.362 1.275 0 C-N-CA 124.761 3.64 . . . . 72.42 113.484 -178.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -74.89 -8.36 56.24 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 112.767 0.654 . . . . 65.43 112.767 -176.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -111.4 -6.93 14.41 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.969 0.359 . . . . 70.14 111.969 177.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.487 HG23 ' HA ' ' A' ' 461' ' ' PRO . 59.7 t -60.92 127.09 19.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.068 0.461 . . . . 74.01 111.736 -176.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.26 -8.12 77.74 Favored Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 115.754 -0.657 . . . . 33.24 112.49 177.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -108.06 151.68 25.53 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 109.826 -0.435 . . . . 74.43 109.826 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.44 HG22 HG12 ' A' ' 488' ' ' VAL . 67.1 t -68.68 142.92 15.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 106.41 -1.7 . . . . 73.41 106.41 170.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 60.0 mt -97.23 -35.22 5.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 108.704 -0.851 . . . . 64.22 108.704 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 164.99 -165.08 37.47 Favored Glycine 0 N--CA 1.418 -2.532 0 C-N-CA 120.43 -0.89 . . . . 33.11 111.292 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -143.37 149.92 38.4 Favored 'General case' 0 N--CA 1.408 -2.561 0 N-CA-C 107.453 -1.314 . . . . 61.44 107.453 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -67.49 -55.32 15.13 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 120.623 -0.431 . . . . 74.32 110.703 178.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -74.09 128.3 12.1 Favored 'Trans proline' 0 C--N 1.367 1.548 0 N-CA-C 108.009 -1.573 . . . . 72.22 108.009 169.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -62.54 129.85 27.92 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.248 1.966 . . . . 74.13 112.887 -176.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -81.98 13.68 3.21 Favored 'General case' 0 C--O 1.206 -1.188 0 CA-C-N 115.194 -0.912 . . . . 73.22 110.718 -178.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -110.07 0.13 18.25 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.583 0.706 . . . . 74.4 109.398 174.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -103.32 175.79 5.36 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.91 -0.587 . . . . 65.11 112.154 -176.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.405 HG22 ' HB3' ' A' ' 426' ' ' GLN . 2.3 m -98.38 114.43 26.77 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 108.056 -1.09 . . . . 53.41 108.056 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 23.0 p -110.02 147.01 34.33 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 116.283 -0.417 . . . . 62.34 110.057 -176.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -77.55 167.32 21.82 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.634 -0.257 . . . . 54.32 110.387 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 25.3 mm -71.61 -3.93 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-O 122.679 1.228 . . . . 62.42 110.398 -176.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 1.5 p -104.76 5.99 33.73 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.123 -0.944 . . . . 73.12 111.756 178.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -88.92 142.93 27.23 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.03 0.443 . . . . 72.14 111.821 -178.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.65 127.08 65.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.514 -0.767 . . . . 63.14 109.453 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 44.3 t -102.89 120.72 53.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 109.285 -0.635 . . . . 71.34 109.285 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.63 119.41 44.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 108.733 -0.84 . . . . 70.11 108.733 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 48.7 mm -104.48 109.26 26.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-N 115.599 -0.728 . . . . 72.25 109.558 -175.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 9.6 tt -99.96 121.82 51.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.719 -0.474 . . . . 34.33 109.719 178.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.44 HG12 HG22 ' A' ' 467' ' ' VAL . 35.9 m -103.61 151.13 6.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.943 -0.572 . . . . 62.12 110.817 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -92.8 127.31 8.93 Favored Glycine 0 N--CA 1.424 -2.12 0 CA-C-N 115.615 -0.721 . . . . 40.34 111.714 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 25.1 m . . . . . 0 C--N 1.29 -1.989 0 N-CA-C 106.384 -1.71 . . . . 63.11 106.384 176.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo . . . . . 0 N--CA 1.442 -1.506 0 N-CA-C 110.287 -0.697 . . . . 53.33 110.287 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 493' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . -90.47 27.49 1.7 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.925 0.869 . . . . 72.41 111.408 -177.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 16.4 p -117.51 143.13 46.37 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 114.708 -1.133 . . . . 73.21 109.806 -178.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 495' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 495' ' ' LYS . 67.5 mmtt -139.9 155.2 47.31 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 116.356 -0.384 . . . . 63.35 110.578 177.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -84.17 119.48 25.06 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.831 -1.174 . . . . 71.32 107.831 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 27.2 pt -75.64 120.26 80.87 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 112.347 0.499 . . . . 75.11 112.347 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -93.33 138.45 1.44 Allowed 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 122.672 2.248 . . . . 64.22 111.677 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -90.81 135.35 33.78 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.745 -0.835 . . . . 74.42 108.745 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 19.1 t -134.75 94.08 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 107.523 -1.288 . . . . 72.33 107.523 175.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -88.73 123.99 33.69 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.71 -0.677 . . . . 60.51 109.822 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 125.18 9.69 4.99 Favored Glycine 0 N--CA 1.425 -2.074 0 C-N-CA 119.949 -1.119 . . . . 42.01 112.843 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -106.25 168.18 9.32 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.701 -0.851 . . . . 73.44 108.701 176.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 7.0 m -83.35 157.12 22.67 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.835 -1.172 . . . . 74.23 107.835 176.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 48.8 t -51.11 -44.61 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 122.911 0.484 . . . . 64.01 111.606 -178.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -63.37 -41.91 98.83 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.718 -0.674 . . . . 61.12 111.845 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 33.1 t -72.26 -40.41 65.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 116.121 -0.49 . . . . 72.21 109.912 -176.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.73 -49.44 73.02 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.641 -0.709 . . . . 71.1 111.243 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -65.08 -35.26 80.59 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.705 -0.225 . . . . 60.44 110.663 -178.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.447 ' O ' HG23 ' A' ' 514' ' ' VAL . 47.4 tttp -57.38 -52.29 65.97 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 124.088 0.867 . . . . 74.51 110.237 -178.121 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -62.74 -44.58 95.84 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 116.099 -0.501 . . . . 71.1 110.139 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.08 -45.81 91.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.751 -0.659 . . . . 74.44 111.137 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.26 -43.18 92.46 Favored 'General case' 0 CA--C 1.5 -0.949 0 O-C-N 123.495 0.497 . . . . 65.33 110.744 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 510' ' ' LYS . 78.7 t -59.72 -38.31 75.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.53 -0.759 . . . . 73.4 111.015 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -74.87 -22.76 58.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.041 0.448 . . . . 63.22 111.239 -178.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 134.44 -16.79 4.32 Favored Glycine 0 N--CA 1.428 -1.844 0 C-N-CA 119.747 -1.216 . . . . 44.51 112.665 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.681 ' HA ' ' O ' ' A' ' 547' ' ' VAL . 91.2 m-85 -75.89 96.79 3.79 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.744 -0.465 . . . . 65.22 109.744 -177.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 3.1 p -95.73 -12.81 24.84 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 113.38 0.882 . . . . 43.42 113.38 -175.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 519' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 64.6 mttp -108.74 115.85 30.88 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.434 -0.506 . . . . 73.42 110.364 178.138 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -130.2 151.25 50.93 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 109.739 -0.467 . . . . 72.33 109.739 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 61.3 m -141.1 140.82 34.23 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 107.909 -1.145 . . . . 75.55 107.909 175.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 522' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 4.7 pm0 -117.41 137.15 52.69 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 121.326 0.584 . . . . 61.13 111.332 -176.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -111.58 116.95 31.69 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.767 -1.197 . . . . 42.42 107.767 176.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 19.3 m -96.96 124.46 40.94 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.487 -0.561 . . . . 72.02 109.487 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 28.4 m -129.13 150.02 34.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.753 -0.832 . . . . 75.04 108.753 177.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -68.74 135.64 51.59 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.937 -0.764 . . . . 72.34 108.937 178.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 50.8 m -156.54 171.95 6.72 Favored Pre-proline 0 C--N 1.297 -1.697 0 N-CA-C 108.558 -0.904 . . . . 74.5 108.558 -176.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -71.72 -19.93 27.05 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 121.835 1.69 . . . . 61.21 113.356 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.01 138.59 49.46 Favored Pre-proline 0 N--CA 1.469 0.495 0 C-N-CA 120.535 -0.466 . . . . 64.31 110.204 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.89 141.56 93.19 Favored 'Trans proline' 0 C--O 1.261 1.652 0 C-N-CA 122.726 2.284 . . . . 70.35 112.068 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.675 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -57.99 118.37 5.32 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 115.128 -0.942 . . . . 35.13 111.513 -176.128 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 135.92 -25.79 3.18 Favored Glycine 0 N--CA 1.432 -1.616 0 CA-C-N 115.59 -0.732 . . . . 32.24 111.32 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -83.73 134.47 34.75 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.104 0.478 . . . . 72.3 111.523 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 57.3 t -79.5 128.81 38.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 115.834 -0.621 . . . . 73.31 110.307 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 90.7 m -81.64 -33.8 31.17 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 124.781 1.232 . . . . 52.15 110.049 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.59 -150.82 22.79 Favored Glycine 0 N--CA 1.434 -1.452 0 N-CA-C 109.758 -1.337 . . . . 62.42 109.758 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 40.0 p -116.87 156.83 26.66 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 117.291 0.545 . . . . 64.11 110.063 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -82.11 -48.29 0.93 Allowed Pre-proline 0 C--N 1.31 -1.131 0 CA-C-N 115.496 -0.774 . . . . 73.54 110.014 173.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 26.8 Cg_endo -66.63 133.55 32.32 Favored 'Trans proline' 0 C--N 1.37 1.675 0 N-CA-C 108.923 -1.222 . . . . 72.52 108.923 169.075 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 540' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 31.9 Cg_exo -58.96 140.63 96.16 Favored 'Trans proline' 0 C--O 1.251 1.171 0 C-N-CA 122.51 2.14 . . . . 43.11 112.961 -177.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.33 140.95 58.13 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.76 -0.654 . . . . 74.04 109.671 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 98.54 -9.98 62.73 Favored Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 111.385 -0.686 . . . . 62.02 111.385 -178.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 41.9 m -75.28 126.26 30.66 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.603 -0.517 . . . . 72.22 109.603 178.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 495' ' ' LYS . 15.2 t -83.48 129.81 34.99 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 108.12 -1.067 . . . . 43.14 108.12 174.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 11.4 p -142.43 153.43 62.4 Favored Pre-proline 0 C--N 1.294 -1.835 0 N-CA-C 106.649 -1.611 . . . . 63.1 106.649 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 51.3 Cg_exo -58.5 140.27 93.98 Favored 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 121.78 1.654 . . . . 51.31 111.185 175.111 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.681 ' O ' ' HA ' ' A' ' 517' ' ' PHE . 27.1 m -65.22 -23.16 32.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 121.234 0.54 . . . . 72.01 112.33 -176.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.89 2.12 52.32 Favored 'General case' 0 N--CA 1.421 -1.896 0 O-C-N 122.028 -0.42 . . . . 64.43 111.116 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 66.2 m -84.96 170.49 13.0 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 121.16 0.505 . . . . 55.42 111.172 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 10.0 p -93.0 128.53 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-O 121.605 0.717 . . . . 65.32 111.842 -178.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 551' ' ' ILE . . . . . 0.508 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -108.52 136.11 45.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 108.572 -0.899 . . . . 61.12 108.572 172.717 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -103.53 118.44 36.74 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.445 0.641 . . . . 74.53 111.091 -176.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 553' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 2.3 mm? -95.94 134.35 39.04 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.499 -1.228 . . . . 63.52 109.525 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -98.3 124.52 42.97 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 108.77 -0.826 . . . . 74.13 108.77 175.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 57.2 t -114.43 128.64 71.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 115.899 -0.591 . . . . 75.22 110.662 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.675 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 69.4 m -69.8 131.57 44.72 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.698 -0.683 . . . . 63.1 111.565 174.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt -104.45 133.32 49.53 Favored 'General case' 0 C--O 1.202 -1.412 0 N-CA-C 107.435 -1.32 . . . . 72.23 107.435 169.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -70.16 -37.69 72.36 Favored Glycine 0 CA--C 1.503 -0.667 0 C-N-CA 120.184 -1.008 . . . . 61.31 111.279 -177.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 65.7 t30 65.35 28.56 11.76 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.603 1.161 . . . . 75.35 108.486 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -137.09 150.59 48.11 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 114.513 -1.221 . . . . 73.21 108.887 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -130.34 157.18 43.27 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.313 -0.625 . . . . 73.03 109.313 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 58.8 t -71.96 118.54 17.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 109.984 -0.376 . . . . 63.15 109.984 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 563' ' ' MET . . . . . 0.462 ' HB2' ' CG2' ' A' ' 614' ' ' VAL . 55.8 ttp -97.37 138.1 21.16 Favored Pre-proline 0 C--N 1.31 -1.145 0 CA-C-N 116.147 -0.478 . . . . 55.45 110.465 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.64 169.77 9.44 Favored 'Trans proline' 0 CA--C 1.552 1.395 0 C-N-CA 123.098 2.532 . . . . 72.34 111.422 172.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -88.37 129.78 35.32 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 113.064 0.764 . . . . 72.35 113.064 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 566' ' ' LEU . . . . . 0.421 ' O ' ' HB3' ' A' ' 569' ' ' MET . 2.8 mm? -114.25 -9.67 12.82 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.196 -1.039 . . . . 54.34 108.196 173.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 3.0 p -74.31 132.07 41.73 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 114.7 -1.136 . . . . 75.13 110.21 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 76.48 20.9 76.24 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 111.026 -0.829 . . . . 72.33 111.026 -176.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 569' ' ' MET . . . . . 0.421 ' HB3' ' O ' ' A' ' 566' ' ' LEU . 51.7 ttm -121.76 149.47 43.24 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.732 -0.84 . . . . 55.43 108.732 -178.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -82.62 142.61 31.61 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 108.655 -0.869 . . . . 71.52 108.655 177.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 72.1 t-105 -51.62 -27.22 10.66 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 124.707 1.203 . . . . 73.44 111.877 177.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 34.9 m -70.53 -20.39 22.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.58 -0.282 . . . . 61.01 111.525 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 573' ' ' ASP . . . . . 0.415 ' O ' ' HG3' ' A' ' 577' ' ' ARG . 9.6 t70 -101.57 -36.14 8.88 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.151 -1.055 . . . . 65.1 108.151 177.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.02 95.65 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 114.964 -1.016 . . . . 64.14 112.678 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.47 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 37.4 tt0 -57.63 -51.1 84.24 Favored Pre-proline 0 CA--C 1.563 1.458 0 CA-C-O 119.524 -0.274 . . . . 71.41 111.487 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 576' ' ' PRO . . . . . 0.47 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 54.1 Cg_exo -56.12 -39.69 89.6 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 121.46 1.44 . . . . 74.2 112.662 173.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 573' ' ' ASP . 51.4 mtt180 -64.25 -41.91 96.74 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.51 -0.476 . . . . 75.14 112.062 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.491 HD12 ' N ' ' A' ' 579' ' ' ARG 0.25 4.1 pp -66.28 -43.73 85.59 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 119.91 -0.716 . . . . 73.23 111.792 -177.575 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 579' ' ' ARG . . . . . 0.491 ' N ' HD12 ' A' ' 578' ' ' LEU . 15.8 ptm180 -66.43 -35.75 81.08 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 120.914 -0.314 . . . . 74.04 111.197 176.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.72 -28.29 66.69 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 122.638 0.375 . . . . 64.33 111.801 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 9.7 mp -81.52 -7.37 59.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.037 0.446 . . . . 75.02 111.217 174.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 80.36 15.16 79.0 Favored Glycine 0 N--CA 1.437 -1.244 0 C-N-CA 121.126 -0.559 . . . . 71.24 111.883 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 73.4 t90 -66.02 130.73 44.24 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.386 0.613 . . . . 73.41 110.01 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 75.5 m -143.83 93.65 2.49 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.833 -1.173 . . . . 71.3 107.833 176.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -150.6 -161.42 9.94 Favored Glycine 0 N--CA 1.419 -2.448 0 N-CA-C 109.409 -1.476 . . . . 73.43 109.409 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 55.0 ttp -91.04 124.89 35.61 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 120.832 0.349 . . . . 75.35 110.271 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -98.46 121.3 40.22 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 105.738 -1.949 . . . . 74.44 105.738 173.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -98.52 101.59 13.08 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.948 -0.76 . . . . 63.54 108.948 -177.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -99.6 130.44 45.84 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.606 -1.257 . . . . 74.11 107.606 -177.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -77.17 -97.93 0.19 Allowed Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.387 -1.085 . . . . 75.21 110.387 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.2 153.79 47.94 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.878 -0.786 . . . . 74.22 108.878 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -83.7 124.9 31.33 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.055 -1.091 . . . . 65.11 108.055 175.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 58.4 t -127.79 116.88 44.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 CA-C-N 115.881 -0.6 . . . . 42.01 109.944 -175.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -78.4 111.46 14.42 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.29 -1.374 . . . . 74.41 107.29 175.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -133.46 2.82 3.55 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.305 -0.558 . . . . 65.2 112.251 -176.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 127.85 166.06 11.98 Favored Glycine 0 N--CA 1.437 -1.29 0 N-CA-C 111.145 -0.782 . . . . 75.23 111.145 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -59.05 -35.64 84.82 Favored Glycine 0 C--O 1.227 -0.339 0 O-C-N 123.639 0.258 . . . . 15.34 113.532 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 13.4 p -65.78 -23.92 66.82 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.203 0.525 . . . . 72.21 111.722 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -102.37 -1.54 30.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.077 -0.51 . . . . 72.33 110.034 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -77.81 111.09 13.27 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.605 -0.517 . . . . 72.32 109.605 -177.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 62.9 -11.99 0.08 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.325 1.85 . . . . 73.33 115.159 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -77.51 138.68 39.34 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 118.449 0.568 . . . . 64.03 112.404 -174.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 71.7 t -72.86 131.82 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 114.835 -1.075 . . . . 41.43 108.689 176.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 604' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 623' ' ' ARG . 27.7 m -94.35 -41.14 12.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 C-N-CA 119.627 -0.829 . . . . 74.05 111.039 -176.079 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -151.4 154.69 37.14 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 106.678 -1.601 . . . . 71.1 106.678 175.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 606' ' ' GLN . . . . . 0.63 ' HA ' ' O ' ' A' ' 621' ' ' THR . 13.3 pt20 -133.82 142.43 47.85 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 106.646 -1.612 . . . . 72.25 106.646 174.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.443 ' HB2' ' OG1' ' A' ' 621' ' ' THR 0.33 91.4 m-20 -76.33 -57.39 1.37 Allowed Pre-proline 0 C--N 1.306 -1.29 0 N-CA-C 114.34 1.237 . . . . 71.31 114.34 -179.168 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' ' 609' ' ' PRO . 31.5 Cg_exo -63.66 119.53 6.62 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 121.785 1.657 . . . . 75.0 110.048 175.021 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 609' ' ' PRO . . . . . 0.42 ' HB2' ' OG1' ' A' ' 612' ' ' THR . 6.2 Cg_exo -70.97 134.52 25.61 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 121.8 1.667 . . . . 51.2 113.762 -176.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -69.33 132.17 46.0 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.082 -0.963 . . . . 52.42 110.317 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 89.34 -8.58 79.53 Favored Glycine 0 C--N 1.309 -0.923 0 N-CA-C 111.435 -0.666 . . . . 74.22 111.435 -178.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 612' ' ' THR . . . . . 0.42 ' OG1' ' HB2' ' A' ' 609' ' ' PRO . 17.9 m -104.88 160.17 15.22 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 108.048 -1.093 . . . . 70.13 108.048 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -71.68 114.26 5.01 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.944 -0.862 . . . . 45.31 110.944 176.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 614' ' ' VAL . . . . . 0.462 ' CG2' ' HB2' ' A' ' 563' ' ' MET . 20.6 m -103.31 144.99 13.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 C-N-CA 124.234 1.013 . . . . 74.02 109.929 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -38.85 134.03 1.04 Allowed 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 125.665 1.586 . . . . 65.01 110.565 177.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 616' ' ' ARG . . . . . 0.408 ' HD3' ' N ' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -51.18 -25.06 4.83 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 114.494 1.294 . . . . 71.21 114.494 -171.367 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 617' ' ' ASP . . . . . 0.408 ' N ' ' HD3' ' A' ' 616' ' ' ARG . 3.4 p30 -77.43 -26.06 51.22 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.846 -0.616 . . . . 70.14 110.716 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 78.0 20.29 73.38 Favored Glycine 0 N--CA 1.433 -1.526 0 CA-C-O 119.081 -0.844 . . . . 74.22 114.461 173.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.76 119.58 13.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 118.429 1.115 . . . . 65.1 108.755 -176.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 7.0 tp -106.77 127.39 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.027 0 CA-C-N 114.207 -1.361 . . . . 74.43 110.504 -173.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.63 ' O ' ' HA ' ' A' ' 606' ' ' GLN . 1.6 p -107.71 117.72 34.86 Favored 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 109.241 -0.652 . . . . 54.42 109.241 176.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.1 pp -138.54 150.68 46.62 Favored 'General case' 0 CA--C 1.486 -1.496 0 C-N-CA 124.4 1.08 . . . . 74.3 108.431 -177.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 623' ' ' ARG . . . . . 0.437 ' O ' HG22 ' A' ' 604' ' ' VAL . 2.7 tmt_? -132.88 137.11 46.57 Favored 'General case' 0 C--N 1.273 -2.738 0 N-CA-C 104.861 -2.274 . . . . 72.42 104.861 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -129.78 165.23 22.35 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 107.962 -1.125 . . . . 65.41 107.962 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -82.5 -88.04 0.71 Allowed Glycine 0 N--CA 1.426 -1.985 0 N-CA-C 109.851 -1.3 . . . . 65.41 109.851 178.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 . . . . . 0 C--N 1.286 -2.176 0 N-CA-C 109.087 -0.708 . . . . 72.21 109.087 178.419 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 C--O 1.245 0.853 0 CA-C-O 120.77 0.319 . . . . 64.4 111.042 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 28.0 m -127.74 156.75 39.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 C-N-CA 123.583 0.753 . . . . 75.31 109.66 -178.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -95.89 122.79 39.07 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.221 -1.77 . . . . 63.23 106.221 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.439 HG21 ' CZ ' ' A' ' 382' ' ' PHE . 48.0 t -98.81 139.15 20.87 Favored Pre-proline 0 C--N 1.283 -2.313 0 CA-C-N 115.782 -0.645 . . . . 64.12 110.761 -171.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 363' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 14.9 Cg_exo -70.61 150.07 62.46 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.25 1.967 . . . . 73.32 111.442 175.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 364' ' ' ASP . . . . . 0.45 ' OD2' ' HD2' ' A' ' 366' ' ' ARG . 27.9 t0 -102.76 152.66 20.99 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 107.247 -1.39 . . . . 62.52 107.247 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 10.2 t -122.67 11.64 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.374 0 CA-C-O 121.818 0.818 . . . . 61.13 109.675 -174.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.537 ' HB3' ' OG1' ' A' ' 402' ' ' THR . 8.8 ptm180 -52.37 144.33 13.27 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 115.606 -0.724 . . . . 74.11 111.858 177.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.5 -11.07 54.02 Favored Glycine 0 C--N 1.312 -0.771 0 CA-C-N 115.593 -0.73 . . . . 71.15 111.843 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -110.39 -151.3 0.47 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 123.074 0.55 . . . . 74.21 110.312 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 71.8 p -97.81 159.28 15.03 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.253 -0.647 . . . . 60.33 109.253 -173.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 5.6 p -63.55 -35.89 81.98 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 120.862 -0.335 . . . . 55.32 110.839 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -65.78 -46.42 78.78 Favored 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 111.733 0.271 . . . . 75.43 111.733 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -68.11 -41.31 81.96 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 121.452 0.644 . . . . 74.24 109.281 -177.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.54 -51.52 59.27 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.005 -0.998 . . . . 64.42 111.53 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 77.1 mt -63.96 -39.2 84.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 CA-C-N 116.355 -0.384 . . . . 75.11 110.854 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.05 -44.05 91.76 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 120.946 0.403 . . . . 73.44 110.495 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 44.5 m -65.48 -47.13 77.13 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.834 -0.621 . . . . 71.12 111.455 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 10.8 mp -61.76 -45.43 93.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.812 -0.177 . . . . 75.54 111.193 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -65.81 -35.42 80.64 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.178 -0.465 . . . . 74.51 110.344 -178.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -67.2 -25.24 66.02 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 120.972 0.415 . . . . 63.33 111.786 176.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -86.45 -8.07 57.91 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.945 0.402 . . . . 74.22 110.25 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 381' ' ' GLY . . . . . 0.449 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 100.42 0.69 55.62 Favored Glycine 0 CA--C 1.502 -0.748 0 CA-C-N 115.587 -0.733 . . . . 72.22 112.389 178.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.628 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 47.4 m-85 -80.0 153.97 28.51 Favored 'General case' 0 N--CA 1.418 -2.074 0 CA-C-O 121.443 0.639 . . . . 74.12 110.901 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 74.8 mmtt -113.01 161.42 17.06 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 114.916 -1.038 . . . . 75.11 108.414 -176.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 384' ' ' ILE . . . . . 0.446 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -127.31 146.0 33.85 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 CA-C-O 121.461 0.648 . . . . 43.23 111.207 -176.956 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -110.26 127.98 55.28 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 104.64 -2.356 . . . . 63.14 104.64 174.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 25.5 m -117.37 127.0 53.62 Favored 'General case' 0 C--N 1.271 -2.828 0 C-N-CA 120.185 -0.606 . . . . 73.14 110.073 -174.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -112.12 128.64 56.28 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 105.472 -2.047 . . . . 75.14 105.472 177.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 388' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 16.1 pm0 -120.65 145.5 47.37 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.815 -0.754 . . . . 63.5 111.397 -177.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 389' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 421' ' ' SER . 54.7 mttp -139.38 143.01 34.26 Favored Pre-proline 0 C--N 1.298 -1.669 0 CA-C-N 115.431 -0.804 . . . . 72.22 109.263 176.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -74.89 158.03 42.87 Favored 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 122.229 1.953 . . . . 72.45 110.452 172.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 8.5 t70 87.43 -169.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 126.468 1.907 . . . . 73.13 108.869 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 37.4 m -144.02 14.29 1.68 Allowed 'General case' 0 C--N 1.316 -0.868 0 O-C-N 121.573 -0.704 . . . . 52.42 110.835 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 12.6 t -81.67 -19.12 42.31 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.807 -1.183 . . . . 70.22 107.807 176.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.606 HD13 ' H ' ' A' ' 394' ' ' ILE . 0.2 OUTLIER -97.61 152.84 38.38 Favored Pre-proline 0 N--CA 1.431 -1.418 0 N-CA-C 106.571 -1.64 . . . . 71.5 106.571 176.32 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 395' ' ' PRO . . . . . 0.428 ' HA ' ' HD2' ' A' ' 396' ' ' PRO . 1.0 OUTLIER -27.78 111.78 0.03 OUTLIER 'Trans proline' 0 CA--C 1.553 1.449 0 C-N-CA 125.089 3.86 . . . . 73.04 114.907 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 396' ' ' PRO . . . . . 0.592 ' HA ' ' OG ' ' A' ' 421' ' ' SER . 42.2 Cg_endo -63.73 160.92 34.39 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 124.159 3.239 . . . . 52.4 115.242 -174.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -60.11 -8.6 2.5 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 125.078 1.351 . . . . 74.21 113.091 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 37.0 m170 -106.39 132.31 52.56 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 105.746 -1.946 . . . . 74.44 105.746 175.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 27.7 m -75.21 117.6 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.256 0 C-N-CA 119.381 -0.927 . . . . 75.35 111.761 -165.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 400' ' ' ILE . . . . . 0.596 ' H ' HD13 ' A' ' 400' ' ' ILE . 0.2 OUTLIER -97.24 -28.76 3.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 107.292 -1.373 . . . . 70.03 107.292 174.042 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.54 157.53 27.43 Favored Glycine 1 N--CA 1.395 -4.079 0 N-CA-C 108.938 -1.665 . . . . 73.31 108.938 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 402' ' ' THR . . . . . 0.537 ' OG1' ' HB3' ' A' ' 366' ' ' ARG . 0.8 OUTLIER -146.25 -176.25 5.09 Favored 'General case' 0 C--N 1.262 -3.207 0 N-CA-C 105.878 -1.897 . . . . 72.44 105.878 -177.726 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -100.28 126.95 34.44 Favored Pre-proline 0 C--N 1.289 -2.025 0 C-N-CA 118.208 -1.397 . . . . 53.42 109.731 -173.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.84 0.18 1.7 Allowed 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 124.067 3.178 . . . . 61.41 114.791 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.1 -34.46 68.34 Favored 'General case' 0 C--O 1.209 -1.046 0 N-CA-C 109.206 -0.664 . . . . 64.42 109.206 173.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -63.85 -40.7 97.19 Favored 'General case' 0 C--O 1.212 -0.887 0 CA-C-N 115.805 -0.634 . . . . 65.31 110.042 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -83.71 0.6 46.42 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.122 0.487 . . . . 64.14 111.513 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 34.0 m -95.21 157.41 15.91 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 104.92 -2.252 . . . . 72.23 104.92 171.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 49.0 m -74.35 112.47 10.55 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 118.55 -1.26 . . . . 71.41 108.928 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 18.6 m -128.48 169.1 20.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 C-N-CA 122.49 0.316 . . . . 44.5 110.366 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 15.6 m -79.86 145.18 32.87 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.762 -0.459 . . . . 73.04 109.762 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 412' ' ' ALA . . . . . 0.628 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -66.69 113.73 5.05 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.293 0.568 . . . . 52.4 110.56 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 413' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 110.35 44.68 0.98 Allowed Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 110.776 -0.93 . . . . 75.21 110.776 -178.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -109.21 166.29 10.97 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.198 -1.038 . . . . 75.12 108.198 -177.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 415' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 49.2 mt-10 -100.23 118.5 36.66 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 118.212 0.46 . . . . 63.22 110.837 -177.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 44.4 mm -103.61 133.18 48.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 109.188 -0.671 . . . . 73.33 109.188 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 11.5 t -85.18 130.46 34.6 Favored 'General case' 0 C--O 1.252 1.217 0 CA-C-O 121.303 0.573 . . . . 74.32 112.306 -176.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 5.3 p -127.3 135.78 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 C-N-CA 124.052 0.941 . . . . 72.21 109.544 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -101.99 129.18 48.22 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.77 -0.456 . . . . 71.21 109.77 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 8.9 p -123.1 133.1 70.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 109.356 -0.609 . . . . 73.01 109.356 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 421' ' ' SER . . . . . 0.592 ' OG ' ' HA ' ' A' ' 396' ' ' PRO . 74.6 p -103.61 130.9 51.12 Favored 'General case' 0 N--CA 1.428 -1.541 0 O-C-N 122.086 -0.384 . . . . 62.32 110.55 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 41.0 p -97.02 107.97 20.61 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.987 -1.486 . . . . 72.05 106.987 173.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.708 0 N-CA-C 116.653 1.421 . . . . 62.42 116.653 -170.089 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 . . . . . 0 N--CA 1.434 -1.269 0 N-CA-C 107.09 -1.448 . . . . 62.12 107.09 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.458 ' HA ' ' HE ' ' A' ' 427' ' ' ARG . 8.5 mmp_? -121.98 150.17 42.43 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-O 121.017 0.437 . . . . 72.2 111.217 -176.232 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -85.8 138.51 32.02 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.427 -0.806 . . . . 72.21 109.729 -177.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 56.9 mt -87.55 131.57 43.42 Favored Pre-proline 0 C--N 1.295 -1.769 0 N-CA-C 108.733 -0.839 . . . . 64.24 108.733 178.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -70.76 141.45 41.21 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.715 1.61 . . . . 64.11 110.634 172.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -84.61 99.86 11.05 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.801 -1.185 . . . . 63.43 107.801 178.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 60.9 t -101.9 136.94 31.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 108.597 -0.89 . . . . 71.23 108.597 -174.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.408 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 18.9 m -57.22 149.8 19.11 Favored 'General case' 0 N--CA 1.435 -1.209 0 O-C-N 124.252 0.97 . . . . 73.4 112.517 -177.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 434' ' ' THR . . . . . 0.424 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 24.8 p -69.45 -25.06 63.91 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 115.283 1.586 . . . . 52.32 115.283 -170.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.7 pp -85.97 -11.67 52.42 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.628 -0.829 . . . . 72.53 110.768 176.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.408 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 0.2 OUTLIER -98.68 42.53 1.09 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.183 -0.917 . . . . 63.01 110.152 -175.123 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -52.56 -38.71 60.43 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.396 1.079 . . . . 62.55 112.749 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -62.27 -39.57 93.35 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.559 0.695 . . . . 42.41 110.681 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -70.53 -37.39 74.08 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.266 -0.879 . . . . 65.31 109.158 177.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -62.66 -51.82 65.74 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.936 -0.575 . . . . 72.14 111.078 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 28.8 m -61.88 -38.89 81.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 112.476 0.547 . . . . 65.44 112.476 -177.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -68.28 -38.08 81.35 Favored 'General case' 0 C--N 1.35 0.623 0 C-N-CA 119.255 -0.978 . . . . 62.41 110.908 177.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -66.35 -38.66 88.11 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.462 0.542 . . . . 75.12 112.462 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -63.38 -35.8 81.6 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.881 -0.414 . . . . 71.13 109.881 174.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.492 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 47.0 m -70.49 -48.3 56.37 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.918 -0.583 . . . . 74.52 110.804 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.5 -16.65 63.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.949 -0.569 . . . . 64.4 111.91 -177.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.05 -13.14 59.95 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.279 -0.419 . . . . 64.43 111.751 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 124.98 -69.88 0.48 Allowed Glycine 0 CA--C 1.492 -1.348 0 C-N-CA 120.068 -1.063 . . . . 53.23 111.932 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 449' ' ' PHE . . . . . 0.419 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 0.1 OUTLIER -48.52 -65.81 0.51 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.542 0.571 . . . . 74.23 112.542 177.108 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 450' ' ' GLY . . . . . 0.492 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 64.28 21.93 66.79 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 116.123 -0.49 . . . . 61.31 113.287 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.506 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 28.5 mmm180 -104.27 110.49 22.73 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 107.466 -1.309 . . . . 75.11 107.466 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -137.13 147.01 45.72 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 115.662 -0.699 . . . . 75.52 109.875 -177.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -132.77 148.95 52.33 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 108.264 -1.013 . . . . 65.02 108.264 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -117.67 125.75 51.27 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 110.212 -0.292 . . . . 65.43 110.212 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.19 148.13 41.88 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.293 -1.002 . . . . 73.31 108.293 176.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -114.17 140.85 48.19 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.141 -0.689 . . . . 74.53 109.141 -177.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 68.4 m -148.41 137.93 12.38 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 110.46 -0.2 . . . . 64.33 110.46 173.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.741 ' HA ' ' O ' ' A' ' 490' ' ' SER . 29.6 Cg_endo -65.75 128.09 19.24 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.348 2.032 . . . . 75.01 110.426 175.025 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 48.5 m -140.57 -179.83 6.25 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 116.489 -0.323 . . . . 64.33 110.589 -176.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 460' ' ' THR . . . . . 0.406 ' O ' HG13 ' A' ' 464' ' ' VAL . 9.9 t -45.58 130.99 6.44 Favored Pre-proline 0 CA--C 1.556 1.192 0 C-N-CA 124.53 1.132 . . . . 72.34 111.934 178.333 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 461' ' ' PRO . . . . . 0.565 ' O ' HG22 ' A' ' 464' ' ' VAL . 11.3 Cg_endo -51.72 -28.24 29.28 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 125.18 3.92 . . . . 73.45 114.466 -174.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.74 -32.08 67.35 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.147 0.498 . . . . 72.25 111.83 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 463' ' ' LEU . . . . . 0.535 HD13 ' O ' ' A' ' 463' ' ' LEU . 3.3 tm? -97.2 -13.46 22.05 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.984 -0.553 . . . . 70.34 110.66 -171.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' ' 461' ' ' PRO . 19.4 m -60.09 131.09 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 CA-C-O 121.47 0.652 . . . . 70.52 111.174 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.65 2.18 55.34 Favored Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 115.294 -0.866 . . . . 55.25 111.655 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -128.28 166.46 18.56 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.978 -0.749 . . . . 75.1 108.978 176.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.437 HG22 HG12 ' A' ' 488' ' ' VAL . 70.8 t -72.41 148.8 9.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.354 -0.98 . . . . 74.22 108.354 175.014 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 47.5 mt -97.36 -35.25 5.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 106.61 -1.626 . . . . 71.0 106.61 174.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 153.6 -168.67 32.22 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 110.377 -1.089 . . . . 73.15 110.377 176.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 470' ' ' THR . . . . . 0.524 ' HB ' HG12 ' A' ' 486' ' ' ILE . 0.6 OUTLIER -115.83 141.11 48.53 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 107.929 -1.137 . . . . 60.54 107.929 176.266 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.497 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 46.2 t-20 -63.36 -51.4 68.42 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 123.529 0.518 . . . . 74.43 110.512 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.497 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 27.3 Cg_exo -70.55 124.09 10.44 Favored 'Trans proline' 0 C--N 1.373 1.856 0 N-CA-C 107.0 -1.961 . . . . 72.35 107.0 166.059 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.421 ' C ' ' H ' ' A' ' 475' ' ' ASN . 18.2 Cg_endo -61.94 127.78 22.37 Favored 'Trans proline' 0 C--O 1.241 0.673 0 C-N-CA 122.467 2.112 . . . . 61.34 114.248 -172.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -77.68 16.53 0.66 Allowed 'General case' 0 C--O 1.198 -1.642 0 CA-C-N 114.676 -1.147 . . . . 63.21 110.475 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 475' ' ' ASN . . . . . 0.421 ' H ' ' C ' ' A' ' 473' ' ' PRO . 7.3 m-20 -109.14 -9.19 15.05 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.601 -0.727 . . . . 72.02 109.618 178.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -107.07 175.47 5.49 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-O 121.722 0.773 . . . . 74.0 112.902 -174.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 4.1 m -92.38 106.14 18.2 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 114.421 -1.263 . . . . 65.04 108.842 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 68.2 m -100.87 149.32 23.99 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 123.263 0.625 . . . . 72.24 111.119 -176.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -78.3 154.43 30.91 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.328 -0.396 . . . . 64.14 111.448 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 480' ' ' ILE . . . . . 0.419 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 1.7 mp -68.56 -23.06 27.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 C-N-CA 123.61 0.764 . . . . 63.1 111.622 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 17.7 p -94.42 5.55 51.44 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.365 0.602 . . . . 75.22 111.16 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -98.83 140.71 32.61 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.17 -0.468 . . . . 75.55 111.113 -175.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.506 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.5 p -107.34 127.11 63.42 Favored 'Isoleucine or valine' 0 C--O 1.245 0.824 0 CA-C-N 115.977 -0.556 . . . . 73.34 111.803 -178.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.413 ' HA ' ' HG2' ' A' ' 472' ' ' PRO . 32.5 m -97.05 140.97 16.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.34 0.59 . . . . 63.43 110.392 177.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.95 114.0 45.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.893 -0.78 . . . . 73.02 108.893 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.524 HG12 ' HB ' ' A' ' 470' ' ' THR . 61.4 mt -98.69 124.84 52.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 114.618 -1.174 . . . . 72.54 109.707 -178.207 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 5.2 tt -109.43 126.72 66.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 109.458 -0.571 . . . . 63.13 109.458 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.437 HG12 HG22 ' A' ' 467' ' ' VAL . 32.6 m -105.34 151.13 7.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 115.871 -0.604 . . . . 62.24 110.758 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -90.16 122.89 6.76 Favored Glycine 0 N--CA 1.416 -2.635 0 N-CA-C 109.33 -1.508 . . . . 21.23 109.33 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.741 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 8.5 t . . . . . 0 C--N 1.279 -2.471 0 N-CA-C 107.575 -1.269 . . . . 53.23 107.575 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 N--CA 1.446 -1.288 0 CA-C-O 121.409 0.504 . . . . 74.31 113.129 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -81.07 92.61 6.27 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 108.929 -0.767 . . . . 60.35 108.929 177.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 9.4 p -117.22 143.82 45.46 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.0 -1.0 . . . . 54.41 109.727 -177.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -150.99 157.46 42.91 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.46 -0.941 . . . . 63.2 108.46 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.511 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.5 m-20 -80.37 128.23 33.32 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 107.544 -1.28 . . . . 63.22 107.544 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 497' ' ' ILE . . . . . 0.458 HD11 ' HB2' ' A' ' 539' ' ' PRO . 40.7 pt -76.11 136.49 69.3 Favored Pre-proline 0 C--N 1.299 -1.611 0 O-C-N 123.121 0.263 . . . . 73.34 111.42 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 498' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 497' ' ' ILE . 1.5 Cg_endo -88.55 155.59 6.42 Favored 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 122.265 1.977 . . . . 32.5 108.938 168.073 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.92 165.44 11.71 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.664 -1.236 . . . . 74.42 107.664 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.77 117.14 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.354 0 CA-C-O 121.989 0.9 . . . . 70.2 111.279 -174.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -131.32 110.33 11.0 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 114.423 -1.262 . . . . 72.24 107.968 174.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 135.89 -14.58 4.1 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 119.768 -1.206 . . . . 71.33 112.553 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -98.02 172.59 7.53 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.324 -0.551 . . . . 63.42 110.074 177.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 11.4 t -90.3 157.28 17.74 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 107.959 -1.126 . . . . 72.42 107.959 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.453 ' HA ' ' CG2' ' A' ' 534' ' ' VAL . 7.6 p -50.05 -46.92 24.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 O-C-N 124.26 0.975 . . . . 55.24 112.594 -175.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.24 -42.08 80.24 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.389 -0.524 . . . . 72.45 111.923 -177.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 95.6 t -72.42 -36.24 54.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.091 -0.504 . . . . 65.15 111.255 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.65 -49.02 74.86 Favored 'General case' 0 C--N 1.31 -1.111 0 O-C-N 122.21 -0.306 . . . . 73.35 110.859 178.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -60.22 -36.4 77.61 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.8 0.81 . . . . 73.4 109.823 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.401 ' O ' HG23 ' A' ' 514' ' ' VAL . 80.4 tttt -65.23 -46.54 80.2 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 114.401 -1.272 . . . . 73.12 109.666 -177.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -61.77 -47.97 82.77 Favored 'General case' 0 CA--C 1.495 -1.172 0 O-C-N 124.188 0.93 . . . . 74.2 111.263 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.75 -41.84 91.88 Favored 'General case' 0 CA--C 1.513 -0.468 0 O-C-N 123.159 0.287 . . . . 72.01 111.053 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 513' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 10.3 m-20 -62.68 -38.19 89.4 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.341 -0.391 . . . . 71.14 111.215 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 510' ' ' LYS . 73.9 t -70.13 -29.18 38.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.962 -0.563 . . . . 61.34 110.866 178.31 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -76.74 -12.13 59.94 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.191 0.519 . . . . 72.04 110.001 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 516' ' ' GLY . . . . . 0.489 ' O ' ' HB ' ' A' ' 547' ' ' VAL . . . 121.48 -25.52 6.92 Favored Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 120.837 -0.696 . . . . 71.31 111.974 177.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.591 ' HA ' ' O ' ' A' ' 547' ' ' VAL . 66.1 m-85 -76.22 103.81 6.43 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.529 0.68 . . . . 61.35 109.685 -176.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 3.3 p -86.17 -28.41 23.94 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 113.896 1.073 . . . . 72.52 113.896 -170.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 519' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 67.9 mttm -109.07 126.24 52.96 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.443 0.639 . . . . 70.53 112.34 -174.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -129.82 157.49 42.06 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 123.756 0.822 . . . . 72.43 110.398 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 71.1 m -137.44 143.55 41.87 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 107.022 -1.473 . . . . 73.44 107.022 170.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -125.06 147.68 48.86 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 120.75 0.309 . . . . 74.51 110.357 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -141.08 129.5 22.48 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 107.817 -1.179 . . . . 75.11 107.817 174.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 524' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 52.4 m -89.2 139.46 30.46 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 109.865 -0.42 . . . . 54.52 109.865 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 26.8 m -120.98 164.73 17.23 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 107.631 -1.248 . . . . 43.01 107.631 178.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 526' ' ' ASP . . . . . 0.627 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 2.2 p-10 -82.62 134.69 35.17 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 118.963 -1.095 . . . . 73.31 108.671 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 527' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 48.3 m -155.29 168.06 12.88 Favored Pre-proline 0 N--CA 1.441 -0.877 0 C-N-CA 120.482 -0.487 . . . . 73.2 110.554 -176.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -83.24 -10.7 9.99 Favored 'Trans proline' 0 CA--C 1.546 1.113 0 C-N-CA 122.014 1.809 . . . . 64.43 111.23 171.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.35 135.16 50.6 Favored Pre-proline 0 CA--C 1.506 -0.73 0 N-CA-C 107.695 -1.224 . . . . 75.23 107.695 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.95 150.88 52.73 Favored 'Trans proline' 0 C--O 1.256 1.417 0 C-N-CA 122.686 2.257 . . . . 73.43 113.446 -176.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -64.41 121.77 15.15 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.856 -1.066 . . . . 71.41 110.966 -175.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 126.7 -16.29 6.56 Favored Glycine 0 N--CA 1.424 -2.123 0 C-N-CA 120.455 -0.878 . . . . 63.45 111.864 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -83.19 128.43 34.48 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 120.448 -0.501 . . . . 71.03 110.143 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.453 ' CG2' ' HA ' ' A' ' 505' ' ' VAL . 59.9 t -84.66 114.19 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.337 0 N-CA-C 106.08 -1.822 . . . . 53.53 106.08 174.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 9.1 m -113.73 9.86 17.79 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 119.526 -0.87 . . . . 74.43 111.918 -173.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 179.02 168.51 38.24 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 119.284 -1.436 . . . . 71.42 112.821 176.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 45.4 p -132.1 155.08 48.74 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.789 -1.189 . . . . 74.31 107.789 176.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.487 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 23.3 t-20 -73.37 -57.46 2.73 Favored Pre-proline 0 C--N 1.314 -0.952 0 C-N-CA 120.189 -0.604 . . . . 72.24 111.477 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.487 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 1.1 Cg_endo -84.0 140.9 9.16 Favored 'Trans proline' 0 N--CA 1.436 -1.909 0 CA-C-N 120.053 1.055 . . . . 72.41 109.509 175.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 540' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 3.4 Cg_exo -73.45 158.42 48.03 Favored 'Trans proline' 0 C--O 1.267 1.97 0 C-N-CA 121.977 1.785 . . . . 62.32 112.528 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.17 139.88 58.82 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 115.113 -0.948 . . . . 72.2 109.81 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 104.21 -8.75 49.33 Favored Glycine 0 N--CA 1.422 -2.28 0 C-N-CA 120.347 -0.93 . . . . 43.34 111.625 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 26.4 m -75.76 120.45 21.15 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.732 -0.84 . . . . 63.45 108.732 175.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 10.9 t -88.16 124.88 34.26 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-O 121.366 0.603 . . . . 45.44 110.864 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 33.8 m -141.95 165.3 28.71 Favored Pre-proline 0 C--N 1.315 -0.895 0 N-CA-C 108.164 -1.05 . . . . 65.22 108.164 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.61 144.44 94.25 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 121.92 1.747 . . . . 72.12 110.399 172.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 517' ' ' PHE . 34.8 m -64.71 -20.29 27.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 121.942 0.877 . . . . 74.12 112.166 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -92.78 4.8 53.13 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 115.773 -0.649 . . . . 62.2 111.65 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 12.8 t -86.6 170.72 11.6 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.424 -0.954 . . . . 64.24 108.424 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 99.7 t -95.92 131.98 41.3 Favored 'Isoleucine or valine' 0 C--O 1.247 0.925 0 N-CA-C 112.586 0.587 . . . . 51.45 112.586 -175.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 551' ' ' ILE . . . . . 0.529 HD13 ' O ' ' A' ' 519' ' ' LYS . 0.2 OUTLIER -105.34 134.22 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 108.574 -0.899 . . . . 70.05 108.574 169.13 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -102.97 117.08 33.8 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 116.446 -0.343 . . . . 64.51 110.167 -176.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 5.3 mp -103.9 134.43 47.21 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.07 0.948 . . . . 63.01 111.239 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -96.89 121.84 39.21 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.66 -0.867 . . . . 72.21 108.66 174.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 524' ' ' SER . 24.5 t -107.9 139.6 29.35 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 N-CA-C 108.612 -0.885 . . . . 61.22 108.612 -178.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.585 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 69.1 m -81.42 143.79 31.88 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 111.88 0.326 . . . . 50.42 111.88 178.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.627 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 12.2 ptmt -105.47 156.43 18.22 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 104.591 -2.374 . . . . 74.3 104.591 167.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -83.5 -24.31 50.99 Favored Glycine 0 CA--C 1.498 -1.03 0 C-N-CA 119.864 -1.16 . . . . 55.33 115.446 -168.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 559' ' ' ASN . . . . . 0.492 ' HB3' ' HD2' ' A' ' 616' ' ' ARG . 85.6 m-20 62.67 27.62 16.22 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.112 0.482 . . . . 71.33 110.586 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -128.58 149.28 50.7 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.231 -1.026 . . . . 53.42 108.231 -172.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -140.89 149.2 41.61 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.167 -1.049 . . . . 51.43 108.167 173.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.4 p -83.67 116.86 28.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 121.849 0.833 . . . . 71.3 112.081 -176.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 60.0 ttp -89.5 127.05 56.21 Favored Pre-proline 0 C--N 1.312 -1.033 0 CA-C-N 115.283 -0.871 . . . . 52.05 108.689 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.62 154.8 66.83 Favored 'Trans proline' 0 C--O 1.239 0.555 0 C-N-CA 122.261 1.974 . . . . 72.44 111.811 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -83.13 115.5 21.93 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.351 0.596 . . . . 71.04 111.782 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 566' ' ' LEU . . . . . 0.581 ' O ' ' HG3' ' A' ' 569' ' ' MET . 95.2 mt -136.87 18.33 3.04 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.536 -1.211 . . . . 70.35 109.001 178.071 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 24.0 t -52.69 131.07 34.26 Favored 'General case' 0 CA--C 1.553 1.093 0 O-C-N 123.384 0.427 . . . . 73.22 110.748 -175.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 107.37 41.54 1.61 Allowed Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 109.382 -1.487 . . . . 74.54 109.382 -174.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 569' ' ' MET . . . . . 0.581 ' HG3' ' O ' ' A' ' 566' ' ' LEU . 79.0 mtp -101.02 158.11 16.25 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.167 -0.517 . . . . 75.01 110.518 -177.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 570' ' ' PHE . . . . . 0.431 ' HB3' ' OD1' ' A' ' 601' ' ' ASN . 98.7 m-85 -102.69 168.13 9.45 Favored 'General case' 0 N--CA 1.416 -2.13 0 N-CA-C 106.886 -1.524 . . . . 75.32 106.886 170.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 79.9 t90 -64.23 -32.37 73.92 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.902 -0.777 . . . . 74.3 108.902 174.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.1 p -67.94 -20.19 25.66 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 CA-C-N 115.511 -0.768 . . . . 73.24 110.612 177.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -85.43 -38.06 19.08 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 108.444 -0.946 . . . . 71.54 108.444 175.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -57.66 -41.38 81.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.043 -0.981 . . . . 73.53 112.185 -177.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -55.59 -59.82 10.23 Favored Pre-proline 0 CA--C 1.591 2.529 0 N-CA-C 112.795 0.665 . . . . 71.34 112.795 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.1 -43.02 26.2 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 121.622 1.548 . . . . 62.44 112.88 175.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -59.79 -33.81 72.2 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 111.772 0.286 . . . . 72.11 111.772 -177.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 6.9 tt -57.4 -46.65 83.25 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.622 0.769 . . . . 52.13 109.422 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -65.38 -47.42 76.4 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.86 -0.609 . . . . 72.01 111.634 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.64 -39.16 88.12 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.605 -0.725 . . . . 53.43 112.598 -175.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 88.9 mt -84.49 -8.01 59.08 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 111.677 0.251 . . . . 62.32 111.677 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 66.76 41.57 93.61 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 111.481 -0.647 . . . . 73.14 111.481 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 90.9 t90 -83.61 134.77 34.78 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.039 0.447 . . . . 70.44 111.798 -176.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 91.4 m -154.13 96.38 1.94 Allowed 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 124.561 1.144 . . . . 72.43 108.314 170.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -147.19 -147.16 4.49 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 108.569 -1.812 . . . . 74.42 108.569 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 586' ' ' MET . . . . . 0.571 ' HB3' HG12 ' A' ' 619' ' ' ILE . 23.2 ttt -98.28 124.23 42.78 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 117.888 0.844 . . . . 74.04 109.028 178.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 57.4 tp -94.92 115.53 27.57 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 107.361 -1.348 . . . . 74.33 107.361 177.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -95.67 104.5 16.42 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.639 -0.825 . . . . 74.24 109.697 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -110.6 134.25 52.58 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.996 -0.547 . . . . 73.33 109.686 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -102.8 -173.4 26.71 Favored Glycine 0 N--CA 1.432 -1.577 0 N-CA-C 110.072 -1.211 . . . . 73.11 110.072 174.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -65.85 148.74 51.29 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 122.449 0.3 . . . . 34.0 110.799 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 592' ' ' ASP . . . . . 0.413 ' HA ' ' O ' ' A' ' 625' ' ' GLY . 3.7 m-20 -78.98 123.61 27.45 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.688 -1.227 . . . . 44.1 107.688 177.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 88.6 t -137.54 120.3 20.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 116.291 -0.413 . . . . 62.11 110.538 -173.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -80.53 106.86 12.87 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.001 -1.111 . . . . 63.44 108.001 174.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -126.37 2.05 7.01 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.84 -0.618 . . . . 44.23 111.361 -176.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 123.2 163.58 11.83 Favored Glycine 0 N--CA 1.43 -1.704 0 C-N-CA 119.815 -1.183 . . . . 75.23 111.084 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.24 -36.6 69.38 Favored Glycine 0 C--O 1.223 -0.573 0 N-CA-C 114.151 0.421 . . . . 43.13 114.151 -173.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 25.8 m -64.59 -24.5 67.61 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 117.176 0.488 . . . . 73.45 111.939 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -107.05 -8.32 16.58 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 122.044 -0.41 . . . . 73.23 110.876 -178.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 59.3 m170 -74.38 103.48 4.77 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 112.901 0.704 . . . . 71.44 112.901 -175.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 601' ' ' ASN . . . . . 0.431 ' OD1' ' HB3' ' A' ' 570' ' ' PHE . 4.5 t-20 69.04 -4.27 1.29 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.14 1.776 . . . . 75.22 112.695 172.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -86.78 140.65 29.51 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.31 1.044 . . . . 71.22 108.254 -177.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 603' ' ' VAL . . . . . 0.403 HG13 ' HB2' ' A' ' 622' ' ' LEU . 96.8 t -69.82 130.79 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 107.444 -1.317 . . . . 73.43 107.444 176.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 604' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 623' ' ' ARG . 9.0 p -99.42 -32.89 3.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 119.204 -0.998 . . . . 65.01 110.899 -174.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -147.62 153.47 39.44 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 106.356 -1.72 . . . . 72.42 106.356 176.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -123.42 -172.09 2.44 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 108.557 -0.905 . . . . 63.02 108.557 177.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.509 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 55.2 t30 -113.36 -65.02 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.534 0 C-N-CA 119.152 -1.019 . . . . 64.5 112.277 -177.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.509 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 59.1 Cg_endo -88.99 157.96 5.87 Favored 'Trans proline' 0 CA--C 1.552 1.404 0 CA-C-N 120.835 1.334 . . . . 60.12 110.65 174.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -70.73 135.0 27.13 Favored 'Trans proline' 0 C--O 1.249 1.026 0 C-N-CA 122.304 2.002 . . . . 54.1 112.623 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -68.89 132.62 47.02 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.642 -0.708 . . . . 60.22 109.665 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 93.07 -0.48 69.2 Favored Glycine 0 C--N 1.316 -0.548 0 N-CA-C 111.153 -0.779 . . . . 65.1 111.153 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 43.2 m -110.98 164.36 12.88 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 108.429 -0.952 . . . . 63.4 108.429 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -70.4 122.66 11.09 Favored Glycine 0 N--CA 1.416 -2.683 0 N-CA-C 111.371 -0.692 . . . . 71.24 111.371 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 33.1 m -105.82 144.51 15.16 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 108.074 -1.084 . . . . 63.45 108.074 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.441 ' ND2' ' HB3' ' A' ' 617' ' ' ASP . 29.5 p-10 -53.85 149.21 9.06 Favored 'General case' 0 C--O 1.22 -0.482 0 O-C-N 123.309 0.38 . . . . 74.41 110.536 -178.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 616' ' ' ARG . . . . . 0.492 ' HD2' ' HB3' ' A' ' 559' ' ' ASN . 0.1 OUTLIER -54.71 -25.44 27.35 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 112.696 0.628 . . . . 74.22 112.696 -178.388 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 617' ' ' ASP . . . . . 0.441 ' HB3' ' ND2' ' A' ' 615' ' ' ASN . 31.5 t70 -67.73 -37.07 81.7 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.724 -0.671 . . . . 63.34 109.486 177.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 85.53 21.39 54.15 Favored Glycine 0 C--O 1.202 -1.876 0 C-N-CA 120.655 -0.784 . . . . 65.3 112.627 176.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 619' ' ' ILE . . . . . 0.571 HG12 ' HB3' ' A' ' 586' ' ' MET . 0.1 OUTLIER -68.69 119.72 14.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 122.563 1.173 . . . . 75.31 111.333 -170.548 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 40.2 mm -121.04 119.76 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-N 114.027 -1.442 . . . . 62.42 107.747 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 51.8 m -98.87 118.64 36.09 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.354 -1.351 . . . . 72.24 107.354 174.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 622' ' ' LEU . . . . . 0.403 ' HB2' HG13 ' A' ' 603' ' ' VAL . 2.2 pt? -138.04 165.39 26.7 Favored 'General case' 0 CA--C 1.484 -1.558 0 N-CA-C 108.162 -1.051 . . . . 74.32 108.162 -174.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 623' ' ' ARG . . . . . 0.445 ' O ' HG12 ' A' ' 604' ' ' VAL . 14.2 tpt180 -148.14 141.63 25.38 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 106.617 -1.623 . . . . 74.32 106.617 176.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -136.52 158.89 43.38 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 105.818 -1.919 . . . . 73.34 105.818 173.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 625' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 592' ' ' ASP . . . -77.8 -90.96 0.31 Allowed Glycine 0 N--CA 1.426 -1.99 0 N-CA-C 110.355 -1.098 . . . . 61.55 110.355 178.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 . . . . . 0 C--N 1.288 -2.098 0 CA-C-O 118.132 -0.937 . . . . 72.44 109.143 176.417 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 . . . . . 0 CA--C 1.505 -0.785 0 CA-C-O 121.011 0.434 . . . . 74.22 110.89 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 28.5 m -116.89 147.93 19.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 109.209 -0.663 . . . . 74.42 109.209 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 361' ' ' GLN . . . . . 0.424 ' NE2' ' HA ' ' A' ' 407' ' ' ASN . 0.8 OUTLIER -94.09 130.07 40.4 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 105.18 -2.156 . . . . 74.43 105.18 -178.759 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.461 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 79.8 t -95.8 132.13 27.84 Favored Pre-proline 0 C--N 1.288 -2.093 0 CA-C-N 115.46 -0.791 . . . . 71.53 111.025 -166.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 363' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 17.2 Cg_exo -61.5 122.43 11.06 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.531 2.154 . . . . 61.42 111.938 -178.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -89.08 111.42 22.16 Favored 'General case' 0 C--N 1.272 -2.779 0 CA-C-N 114.072 -1.422 . . . . 63.34 110.465 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 7.1 t -86.72 24.0 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.558 0 CA-C-O 122.807 1.289 . . . . 75.45 111.24 -174.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.531 ' O ' ' HD2' ' A' ' 366' ' ' ARG . 1.9 ppt_? -52.86 144.63 14.16 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.691 -1.14 . . . . 74.2 112.225 172.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 98.51 -14.47 62.03 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 120.82 -0.705 . . . . 64.35 112.54 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -102.07 -89.38 0.37 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 120.222 -0.591 . . . . 72.12 111.104 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 369' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 81.0 p -164.74 168.79 17.54 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.138 -1.06 . . . . 44.45 108.138 177.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 28.7 m -63.37 -40.82 98.3 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 109.053 -0.721 . . . . 63.12 109.053 176.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.79 -45.83 90.84 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.835 -0.621 . . . . 72.23 110.983 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -64.05 -42.38 97.05 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.355 0.41 . . . . 75.24 111.043 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 373' ' ' ALA . . . . . 0.402 ' O ' ' HG ' ' A' ' 377' ' ' LEU . . . -66.74 -50.11 63.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.14 -0.482 . . . . 62.21 111.06 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 78.4 mt -61.98 -40.23 86.54 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 CA-C-N 116.228 -0.442 . . . . 74.03 110.996 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.8 -47.2 85.6 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.195 0.522 . . . . 62.2 110.363 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 376' ' ' THR . . . . . 0.668 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 27.9 m -66.04 -47.96 72.65 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 115.104 -0.953 . . . . 64.25 110.024 -179.052 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 373' ' ' ALA . 97.5 mt -61.89 -44.68 96.3 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.604 -0.271 . . . . 63.53 111.694 -177.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -63.37 -42.81 98.88 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.267 -0.424 . . . . 64.15 110.6 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -70.42 -17.5 63.01 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.102 0.477 . . . . 73.35 112.237 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 380' ' ' ARG . . . . . 0.668 ' HG2' ' O ' ' A' ' 376' ' ' THR . 17.5 mmm180 -89.56 -13.75 36.6 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 120.882 -0.327 . . . . 64.4 110.665 176.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.08 13.49 36.45 Favored Glycine 0 C--N 1.309 -0.968 0 C-N-CA 120.315 -0.945 . . . . 42.43 112.301 177.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -87.84 156.61 19.3 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 121.003 0.43 . . . . 61.53 110.725 175.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -105.6 154.27 20.64 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.946 -1.131 . . . . 73.33 107.946 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 384' ' ' ILE . . . . . 0.418 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -127.68 149.09 32.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 119.65 -0.82 . . . . 72.13 112.406 -176.338 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 385' ' ' ARG . . . . . 0.431 ' HD2' ' OG1' ' A' ' 417' ' ' THR . 41.6 ttm180 -116.92 128.12 54.91 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 105.283 -2.117 . . . . 75.13 105.283 173.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 31.1 m -122.8 124.67 43.85 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 109.123 -0.695 . . . . 72.42 109.123 -175.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -111.76 119.8 39.85 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.141 -1.799 . . . . 64.33 106.141 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 388' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 19.2 pm0 -116.9 134.85 54.25 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.455 -0.498 . . . . 53.35 110.891 -177.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 389' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 390' ' ' PRO . 28.3 mtpp -135.86 145.0 50.95 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-N 115.787 -0.642 . . . . 63.25 110.658 178.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 390' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 389' ' ' LYS . 33.9 Cg_exo -68.5 153.62 73.43 Favored 'Trans proline' 0 C--O 1.252 1.188 0 C-N-CA 122.628 2.219 . . . . 74.43 108.85 169.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -62.64 124.94 22.3 Favored 'General case' 0 CA--C 1.487 -1.453 0 CA-C-O 122.519 1.152 . . . . 70.14 112.739 -175.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 49.5 m -154.37 34.19 0.42 Allowed 'General case' 0 C--N 1.279 -2.5 0 CA-C-N 112.525 -2.125 . . . . 70.14 106.134 178.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 23.2 m 81.38 46.1 0.03 OUTLIER 'General case' 0 CA--C 1.57 1.736 0 C-N-CA 125.862 1.665 . . . . 72.15 111.515 -178.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.25 151.59 46.94 Favored Pre-proline 0 C--N 1.313 -1.009 0 CA-C-N 115.431 -0.804 . . . . 71.1 110.68 174.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 395' ' ' PRO . . . . . 0.412 ' HB3' HD13 ' A' ' 400' ' ' ILE . 81.9 Cg_exo -50.8 136.54 43.01 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 C-N-CA 124.007 3.138 . . . . 75.05 114.654 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.99 163.02 17.39 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.733 2.955 . . . . 75.14 111.841 176.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -56.86 -8.41 0.6 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 112.885 0.698 . . . . 63.43 112.885 -179.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 33.8 m170 -85.51 114.47 22.56 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 106.959 -1.497 . . . . 73.21 106.959 173.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 15.5 m -68.3 119.53 14.21 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-N 116.067 -0.515 . . . . 64.23 112.005 -174.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 400' ' ' ILE . . . . . 0.412 HD13 ' HB3' ' A' ' 395' ' ' PRO . 3.9 mp -87.25 -30.55 5.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 108.083 -1.08 . . . . 61.22 108.083 176.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.39 171.02 27.35 Favored Glycine 0 N--CA 1.422 -2.239 0 N-CA-C 110.774 -0.93 . . . . 34.14 110.774 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 4.1 p -114.6 -178.06 3.28 Favored 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 123.059 0.544 . . . . 74.03 110.75 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -100.62 136.93 19.79 Favored Pre-proline 0 C--N 1.293 -1.881 0 N-CA-C 107.862 -1.162 . . . . 64.32 107.862 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -47.51 -22.64 2.92 Favored 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 124.503 3.468 . . . . 61.43 115.275 -176.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -64.74 -29.29 70.27 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 120.729 0.3 . . . . 55.12 110.961 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -85.28 -40.78 16.2 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.571 0.7 . . . . 63.44 110.327 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 407' ' ' ASN . . . . . 0.424 ' HA ' ' NE2' ' A' ' 361' ' ' GLN . 13.0 m120 -77.14 -11.18 59.78 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.421 -0.809 . . . . 71.04 112.126 -173.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 57.2 m -100.94 157.51 16.69 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 107.558 -1.275 . . . . 70.11 107.558 177.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 44.1 m -74.53 112.77 11.04 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 108.066 -1.086 . . . . 72.33 108.066 177.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.5 169.33 20.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 120.972 0.415 . . . . 70.01 111.202 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 22.8 t -73.64 133.05 43.37 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 107.096 -1.446 . . . . 73.41 107.096 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -61.88 138.5 58.36 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.134 0.492 . . . . 72.22 111.56 -176.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 93.1 39.48 5.13 Favored Glycine 0 N--CA 1.437 -1.286 0 CA-C-N 115.704 -0.68 . . . . 53.53 111.943 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -102.49 -174.33 2.54 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.191 -1.411 . . . . 62.14 107.191 177.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -109.83 116.27 31.34 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 118.374 0.534 . . . . 74.31 109.897 -177.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 32.2 mm -99.37 129.19 50.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 109.154 -0.684 . . . . 71.32 109.154 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 417' ' ' THR . . . . . 0.431 ' OG1' ' HD2' ' A' ' 385' ' ' ARG . 44.7 m -91.74 131.13 37.33 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 112.38 0.511 . . . . 71.32 112.38 -177.126 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 3.5 p -123.33 134.96 64.78 Favored 'Isoleucine or valine' 0 C--O 1.252 1.226 0 N-CA-C 108.351 -0.981 . . . . 75.51 108.351 176.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -107.24 124.99 50.56 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.244 -0.65 . . . . 65.33 109.244 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 2.7 p -125.79 131.46 71.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-N 115.49 -0.777 . . . . 73.24 111.176 -177.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 29.3 t -107.61 131.34 54.47 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-O 121.941 0.877 . . . . 45.01 110.23 176.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 24.2 p -87.15 158.48 19.15 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 105.363 -2.088 . . . . 42.41 105.363 170.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 2.191 0 CA-C-N 118.679 0.672 . . . . 72.14 114.092 -179.035 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.588 ' HG2' HG22 ' A' ' 477' ' ' THR . 45.9 tt0 . . . . . 0 N--CA 1.408 -2.572 0 N-CA-C 104.23 -2.507 . . . . 71.34 104.23 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.46 ' HA ' ' HE ' ' A' ' 427' ' ' ARG . 3.2 mmp_? -122.53 156.68 33.68 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 120.492 -0.483 . . . . 74.32 111.847 -173.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -83.22 139.98 32.81 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.788 -1.19 . . . . 72.34 107.788 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 73.3 mt -78.96 122.5 84.62 Favored Pre-proline 0 N--CA 1.425 -1.693 0 N-CA-C 108.298 -1.001 . . . . 51.33 108.298 -178.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -69.97 140.82 42.79 Favored 'Trans proline' 0 N--CA 1.429 -2.323 0 C-N-CA 121.256 1.304 . . . . 60.42 110.05 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -100.85 155.95 17.64 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 115.677 -0.692 . . . . 73.22 109.479 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.588 HG11 ' HB2' ' A' ' 440' ' ' ALA . 8.5 p -153.2 170.94 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 N-CA-C 107.452 -1.314 . . . . 71.35 107.452 -174.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.459 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 14.5 m -73.09 146.36 45.84 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 108.713 -0.847 . . . . 63.32 108.713 176.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 15.7 p -68.4 -23.92 64.7 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 113.59 0.959 . . . . 72.34 113.59 -174.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.5 pp -80.39 -11.87 59.64 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 120.113 -0.635 . . . . 61.52 110.383 177.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.466 HG22 ' HB3' ' A' ' 439' ' ' GLU . 1.3 m -101.84 44.15 1.03 Allowed 'General case' 0 CA--C 1.555 1.135 0 CA-C-N 115.592 -0.731 . . . . 61.43 110.902 -175.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -52.42 -38.18 58.49 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.387 0.675 . . . . 71.33 112.389 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.0 -45.03 83.31 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.209 0.528 . . . . 65.54 111.025 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.466 ' HB3' HG22 ' A' ' 436' ' ' THR . 33.7 tt0 -70.7 -33.26 70.69 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.68 -0.691 . . . . 73.44 110.51 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.588 ' HB2' HG11 ' A' ' 432' ' ' VAL . . . -58.95 -51.27 70.78 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.088 0.155 . . . . 44.33 110.658 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 33.6 m -62.52 -37.12 78.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-O 121.201 0.524 . . . . 70.44 110.849 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -60.39 -47.99 83.71 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.312 -0.858 . . . . 64.34 110.437 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -66.03 -38.75 89.18 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.904 -0.589 . . . . 73.01 111.725 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 93.1 mt -63.66 -33.66 76.13 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.791 0.329 . . . . 74.32 110.383 176.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 66.3 m -70.28 -44.9 67.45 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 115.912 -0.586 . . . . 74.35 110.1 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.75 -21.69 65.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.597 -0.729 . . . . 63.13 110.907 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.22 5.09 21.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.622 -0.717 . . . . 74.41 112.436 -179.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 105.18 -79.47 0.28 Allowed Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.11 -1.043 . . . . 72.24 111.998 175.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -39.62 -61.07 0.87 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.358 1.244 . . . . 73.32 114.358 176.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 62.15 18.45 57.73 Favored Glycine 0 C--N 1.321 -0.293 0 C-N-CA 121.634 -0.317 . . . . 71.42 113.186 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 14.3 mmt180 -95.15 111.29 23.14 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.356 -0.979 . . . . 74.33 108.356 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -136.49 153.88 50.9 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 120.689 0.281 . . . . 72.44 110.795 -178.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -142.37 133.16 25.56 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.545 -1.28 . . . . 73.22 107.545 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -101.5 134.52 44.48 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.832 -0.433 . . . . 74.51 109.832 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -124.37 138.83 54.33 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.036 -1.468 . . . . 22.41 107.036 173.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -121.07 136.67 54.93 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 109.479 -0.563 . . . . 62.04 109.479 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 32.5 t -135.72 141.2 36.13 Favored Pre-proline 0 C--N 1.296 -1.746 0 N-CA-C 108.708 -0.849 . . . . 61.13 108.708 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.693 ' HA ' ' O ' ' A' ' 490' ' ' SER . 37.6 Cg_endo -69.43 131.16 21.11 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.18 1.92 . . . . 73.03 110.521 175.144 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 61.1 m -151.22 -179.38 7.29 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.638 -0.875 . . . . 60.32 108.638 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 11.9 t -48.22 138.81 10.62 Favored Pre-proline 0 C--O 1.25 1.104 0 C-N-CA 123.941 0.897 . . . . 51.43 111.11 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -51.39 -29.39 30.59 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 124.401 3.401 . . . . 72.21 113.817 -175.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -75.27 -26.57 58.9 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.026 -0.67 . . . . 53.01 111.939 -177.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -88.58 -14.96 36.33 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 120.689 0.28 . . . . 71.0 111.07 178.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 86.5 t -60.87 127.56 20.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 109.385 -0.598 . . . . 75.15 109.385 176.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 96.92 -5.81 63.94 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 115.799 -0.637 . . . . 72.02 112.945 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.411 ' HD2' ' N ' ' A' ' 466' ' ' LYS . 8.2 mptt -124.46 160.18 28.82 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 108.393 -0.965 . . . . 73.23 108.393 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.415 HG22 HG12 ' A' ' 488' ' ' VAL . 77.7 t -70.95 142.62 15.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 107.612 -1.255 . . . . 72.33 107.612 173.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 59.0 mt -97.57 -35.65 5.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 107.566 -1.272 . . . . 75.3 107.566 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 173.24 -172.43 45.15 Favored Glycine 0 N--CA 1.412 -2.931 0 N-CA-C 109.707 -1.357 . . . . 73.14 109.707 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 30.2 p -121.18 146.24 46.99 Favored 'General case' 0 C--N 1.271 -2.832 0 N-CA-C 107.216 -1.401 . . . . 74.05 107.216 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.453 ' HB3' HG23 ' A' ' 485' ' ' ILE . 58.0 t30 -72.07 -46.2 11.35 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 119.096 -1.042 . . . . 74.12 110.153 176.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -82.61 146.44 13.47 Favored 'Trans proline' 0 C--N 1.374 1.906 0 N-CA-C 108.517 -1.378 . . . . 73.44 108.517 169.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.478 ' HB2' ' HG2' ' A' ' 476' ' ' GLN . 19.5 Cg_exo -65.36 127.29 17.88 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 121.778 1.652 . . . . 73.44 111.691 -178.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -86.3 8.95 19.35 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.643 0.735 . . . . 70.54 111.299 -175.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -109.4 -6.73 15.36 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 116.039 -0.528 . . . . 72.51 110.364 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 476' ' ' GLN . . . . . 0.478 ' HG2' ' HB2' ' A' ' 473' ' ' PRO . 81.2 mm-40 -97.24 172.2 7.95 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 116.01 -0.541 . . . . 62.41 111.791 -174.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.588 HG22 ' HG2' ' A' ' 426' ' ' GLN . 1.3 m -92.91 119.01 31.77 Favored 'General case' 0 N--CA 1.418 -2.032 0 CA-C-N 115.272 -0.876 . . . . 51.13 108.688 -177.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 54.9 m -115.49 148.04 39.94 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 123.171 0.588 . . . . 74.01 110.719 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -73.26 159.07 33.97 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.767 -0.651 . . . . 50.55 111.066 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 43.7 mm -69.09 -21.09 25.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.748 0.785 . . . . 63.23 110.295 -177.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 3.7 p -100.15 5.33 44.82 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.734 -0.604 . . . . 73.3 111.87 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -94.1 133.9 37.1 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.216 -0.447 . . . . 75.11 109.926 -177.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 33.0 t -100.64 126.77 54.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.082 -0.508 . . . . 72.32 110.621 -174.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 35.0 m -103.0 137.47 31.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.429 0.633 . . . . 72.33 111.143 178.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.453 HG23 ' HB3' ' A' ' 471' ' ' ASN . 0.0 OUTLIER -107.16 128.45 62.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.495 0.664 . . . . 73.31 110.096 -178.957 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 38.5 mm -109.21 128.23 65.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 C-N-CA 125.046 1.338 . . . . 75.54 108.858 -174.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 13.4 tt -112.07 126.47 69.47 Favored 'Isoleucine or valine' 0 C--O 1.246 0.887 0 CA-C-O 121.453 0.644 . . . . 71.13 110.977 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.415 HG12 HG22 ' A' ' 467' ' ' VAL . 34.5 m -113.29 151.64 15.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 0 CA-C-N 115.448 -0.796 . . . . 61.4 111.495 -177.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.0 132.53 11.22 Favored Glycine 0 N--CA 1.433 -1.548 0 N-CA-C 109.534 -1.426 . . . . 24.23 109.534 177.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.693 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 21.5 p . . . . . 0 C--N 1.294 -1.815 0 CA-C-N 116.958 0.379 . . . . 74.12 110.48 -176.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo . . . . . 0 C--O 1.252 1.205 0 N-CA-C 110.891 -0.465 . . . . 75.42 110.891 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -91.32 78.09 5.79 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.718 0.771 . . . . 73.33 110.043 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 546' ' ' PRO . 18.2 p -117.79 142.94 46.72 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.98 -1.009 . . . . 72.41 110.697 -178.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 4.8 mmmp? -141.15 152.62 44.84 Favored 'General case' 0 CA--C 1.494 -1.183 0 CA-C-O 121.524 0.678 . . . . 74.14 110.792 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 12.4 p-10 -80.62 134.41 35.89 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 114.265 -1.334 . . . . 73.4 108.518 175.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 31.8 pt -83.35 125.28 74.6 Favored Pre-proline 0 C--N 1.3 -1.55 0 C-N-CA 120.527 -0.469 . . . . 74.44 109.834 177.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -79.8 -175.81 2.91 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.279 1.986 . . . . 64.44 111.107 178.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -84.22 90.17 7.46 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.678 0.752 . . . . 73.33 110.675 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 12.8 p -104.96 3.17 10.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 123.353 1.549 . . . . 53.22 106.985 175.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 501' ' ' ALA . . . . . 0.568 ' HB1' ' HA2' ' A' ' 536' ' ' GLY . . . -83.6 63.59 7.48 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 113.161 -1.836 . . . . 75.31 111.446 -174.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 165.95 28.65 0.02 OUTLIER Glycine 0 C--N 1.309 -0.962 0 C-N-CA 119.253 -1.451 . . . . 72.12 113.244 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -118.74 -169.13 1.66 Allowed 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 106.753 -1.573 . . . . 73.43 106.753 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 11.4 m -81.96 155.45 25.22 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.038 -1.467 . . . . 75.44 107.038 175.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.621 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 6.0 p -55.1 -46.36 77.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.231 0.456 . . . . 65.04 112.231 -176.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -66.51 -41.63 88.58 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 116.475 -0.329 . . . . 62.32 111.326 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 60.0 t -66.43 -42.04 89.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.694 -0.685 . . . . 71.41 109.817 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -61.86 -44.91 95.86 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 115.424 -0.807 . . . . 71.2 111.253 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.621 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 89.4 mt-30 -60.29 -40.41 90.38 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 121.191 0.519 . . . . 72.14 110.887 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.449 ' O ' HG23 ' A' ' 514' ' ' VAL . 64.0 mttm -64.47 -53.6 45.74 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.417 -0.81 . . . . 74.1 109.626 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -62.77 -37.8 88.08 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 115.514 -0.766 . . . . 75.14 111.288 -177.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 8.4 tt -59.04 -44.79 91.83 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 109.108 -0.701 . . . . 72.42 109.108 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 513' ' ' ASN . . . . . 0.546 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 6.8 m-20 -64.62 -37.64 88.28 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.173 -0.467 . . . . 72.04 111.426 177.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 510' ' ' LYS . 92.7 t -63.71 -30.25 49.42 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 CA-C-N 116.028 -0.533 . . . . 63.44 111.088 177.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -77.15 -4.53 45.01 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.82 0.343 . . . . 75.33 111.353 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 106.42 -10.69 42.81 Favored Glycine 0 CA--C 1.496 -1.122 0 C-N-CA 120.664 -0.779 . . . . 52.42 112.226 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 82.4 m-85 -88.52 114.42 25.12 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 107.377 -1.342 . . . . 63.32 107.377 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 5.0 p -89.56 -19.4 25.04 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 112.983 0.735 . . . . 70.41 112.983 -175.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -107.93 119.51 39.67 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.404 0.621 . . . . 63.4 111.924 -172.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -129.8 156.4 44.39 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.346 -0.843 . . . . 73.31 110.524 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 10.1 p -141.64 147.05 36.94 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.381 -1.34 . . . . 71.11 107.381 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -124.51 133.48 53.31 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 121.169 0.509 . . . . 60.15 111.427 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -132.97 126.39 31.88 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.436 -0.95 . . . . 71.15 108.436 178.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 11.0 m -98.1 134.64 40.9 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-O 120.828 0.347 . . . . 74.01 110.423 -177.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 525' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 557' ' ' LYS . 30.5 m -123.01 149.96 26.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.083 -1.081 . . . . 63.31 108.083 176.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -66.33 135.67 54.71 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.998 -0.741 . . . . 75.3 108.998 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 74.2 m -149.91 166.99 13.9 Favored Pre-proline 0 C--N 1.293 -1.863 0 CA-C-N 115.754 -0.657 . . . . 64.24 111.162 -173.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -79.48 -23.36 7.32 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 121.805 1.67 . . . . 54.52 110.658 170.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -70.79 147.28 94.2 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 108.607 -0.886 . . . . 73.11 108.607 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -61.77 158.95 35.13 Favored 'Trans proline' 0 C--O 1.251 1.13 0 C-N-CA 122.835 2.357 . . . . 72.35 113.129 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -67.24 120.46 13.83 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.581 -0.736 . . . . 31.3 110.783 -179.012 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 118.52 -17.21 11.28 Favored Glycine 0 C--N 1.309 -0.924 0 C-N-CA 120.651 -0.785 . . . . 54.4 111.646 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -77.42 133.1 38.74 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.095 -1.076 . . . . 71.3 108.095 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 77.3 t -82.41 117.58 28.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 108.216 -1.031 . . . . 63.23 108.216 177.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 535' ' ' THR . . . . . 0.52 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 13.7 t -82.07 -17.66 45.83 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.781 0.8 . . . . 72.33 109.727 -177.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.568 ' HA2' ' HB1' ' A' ' 501' ' ' ALA . . . 162.35 -163.31 34.95 Favored Glycine 0 N--CA 1.411 -3.021 0 N-CA-C 110.618 -0.993 . . . . 31.44 110.618 177.159 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 537' ' ' THR . . . . . 0.433 HG22 HD23 ' A' ' 553' ' ' LEU . 22.8 p -124.98 154.88 40.53 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 107.749 -1.204 . . . . 63.1 107.749 176.04 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -66.31 -55.88 18.29 Favored Pre-proline 0 C--N 1.306 -1.306 0 N-CA-C 109.606 -0.516 . . . . 64.2 109.606 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.46 127.06 10.09 Favored 'Trans proline' 0 C--N 1.368 1.561 0 N-CA-C 109.128 -1.143 . . . . 53.44 109.128 169.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.6 152.99 64.7 Favored 'Trans proline' 0 C--O 1.245 0.873 0 C-N-CA 123.14 2.56 . . . . 75.23 112.944 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -67.12 138.26 56.94 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.118 -0.492 . . . . 62.33 110.096 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 104.41 -20.82 38.83 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 111.469 -0.652 . . . . 64.25 111.469 -177.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 32.8 m -65.41 135.61 55.46 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.5 -0.556 . . . . 71.05 109.5 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 17.2 m -97.7 123.18 41.52 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 109.333 -0.617 . . . . 73.13 109.333 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.0 m -136.53 159.81 69.08 Favored Pre-proline 0 C--N 1.31 -1.141 0 N-CA-C 109.161 -0.681 . . . . 73.43 109.161 -178.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 494' ' ' THR . 41.7 Cg_exo -63.88 147.6 92.08 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.221 1.947 . . . . 74.54 111.435 174.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 29.5 m -64.97 -19.62 25.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.703 0.763 . . . . 61.51 111.557 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -93.55 3.64 55.21 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.169 -0.923 . . . . 64.11 110.256 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 11.7 t -85.71 162.19 18.86 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.546 -0.909 . . . . 44.3 108.546 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 21.6 t -97.36 128.06 49.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 109.604 -0.517 . . . . 42.31 109.604 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 2.3 mp -101.68 131.58 49.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 108.863 -0.791 . . . . 75.32 108.863 176.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -102.67 116.69 33.09 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 121.489 0.661 . . . . 71.45 110.669 -178.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 553' ' ' LEU . . . . . 0.433 HD23 HG22 ' A' ' 537' ' ' THR . 84.4 mt -90.31 128.84 36.55 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.768 -1.197 . . . . 34.42 107.768 177.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -103.82 113.76 27.53 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 122.379 1.085 . . . . 71.1 109.379 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 23.0 t -94.38 147.13 5.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-N 114.02 -1.446 . . . . 62.34 110.019 -172.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.52 ' OG ' ' HB ' ' A' ' 535' ' ' THR . 7.5 m -86.31 131.58 34.18 Favored 'General case' 0 N--CA 1.414 -2.268 0 CA-C-N 115.636 -0.711 . . . . 73.22 109.769 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 525' ' ' VAL . 9.4 ttmm -99.12 119.44 37.85 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 107.107 -1.442 . . . . 73.24 107.107 171.023 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -67.69 -37.48 89.06 Favored Glycine 0 CA--C 1.495 -1.203 0 N-CA-C 110.955 -0.858 . . . . 72.15 110.955 -177.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 559' ' ' ASN . . . . . 0.488 ' OD1' ' HD2' ' A' ' 616' ' ' ARG . 52.3 t30 65.8 4.47 2.94 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.964 1.706 . . . . 73.04 111.284 175.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 -142.89 141.24 31.48 Favored 'General case' 0 N--CA 1.415 -2.177 0 N-CA-C 104.702 -2.333 . . . . 74.25 104.702 -173.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -142.25 135.93 29.32 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 118.663 0.665 . . . . 75.11 111.027 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 6.6 p -70.14 116.42 11.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.732 0.777 . . . . 63.25 112.206 -176.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 61.4 ttp -98.2 139.77 21.44 Favored Pre-proline 0 C--N 1.309 -1.178 0 CA-C-N 115.222 -0.899 . . . . 63.53 108.774 177.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -60.68 161.86 20.01 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.764 2.309 . . . . 64.34 111.798 176.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 565' ' ' ASP . . . . . 0.658 ' HA ' ' HB1' ' A' ' 610' ' ' ALA . 0.5 OUTLIER -68.16 128.53 36.9 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.797 0.808 . . . . 51.03 112.761 -175.051 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 57.1 tp -131.13 4.29 4.41 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 107.509 -1.293 . . . . 65.24 107.509 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 7.7 m -77.34 134.68 38.42 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 113.983 -1.462 . . . . 42.53 109.842 -176.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 88.0 16.89 58.79 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.643 -0.789 . . . . 72.11 112.119 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 85.7 mtp -114.96 178.15 4.39 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.452 -0.944 . . . . 72.55 108.452 -178.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 570' ' ' PHE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 66.7 m-85 -89.61 155.52 19.2 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 121.27 0.557 . . . . 74.13 111.492 -176.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -62.35 -29.18 70.27 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 124.909 1.283 . . . . 75.42 109.602 175.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 10.1 p -73.13 -12.51 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 CA-C-N 115.385 -0.825 . . . . 73.52 109.864 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -101.21 -37.23 8.63 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.737 -0.665 . . . . 74.02 109.653 175.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 574' ' ' ALA . . . . . 0.526 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -63.47 -54.76 31.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.114 -0.948 . . . . 75.35 113.343 -174.001 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' A' ' 579' ' ' ARG . 30.3 mt-10 -62.13 -50.2 81.32 Favored Pre-proline 0 N--CA 1.466 0.366 0 N-CA-C 113.921 1.082 . . . . 72.21 113.921 -179.01 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -52.77 -42.98 59.49 Favored 'Trans proline' 0 C--N 1.366 1.461 0 C-N-CA 122.082 1.855 . . . . 72.43 113.096 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -67.96 -37.62 81.79 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 119.948 -0.701 . . . . 71.23 111.012 179.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 94.5 mt -63.42 -47.16 83.09 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 121.427 0.632 . . . . 74.03 110.156 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 579' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' A' ' 575' ' ' GLU . 97.7 mtt180 -62.68 -38.05 88.85 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.271 -0.877 . . . . 75.32 110.26 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.2 -33.14 71.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.968 -0.56 . . . . 64.32 112.151 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 4.3 pp -82.64 -8.31 59.61 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 120.562 -0.455 . . . . 53.32 111.777 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 90.47 33.93 8.29 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.779 -0.724 . . . . 61.34 112.488 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 65.9 t90 -66.29 137.18 56.76 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 122.542 0.337 . . . . 74.2 110.153 176.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 49.9 m -145.04 102.0 3.7 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.573 -0.899 . . . . 75.13 108.573 176.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -172.5 -156.34 12.41 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 110.102 -1.199 . . . . 65.03 110.102 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 586' ' ' MET . . . . . 0.508 ' HB3' HG12 ' A' ' 619' ' ' ILE . 14.4 tpt -102.71 127.93 49.65 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.082 0.467 . . . . 72.02 111.138 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -97.7 126.04 42.81 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.065 -1.458 . . . . 74.5 107.065 176.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -123.28 110.33 15.07 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.374 0.607 . . . . 74.25 110.196 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -99.96 135.41 41.43 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.094 -0.957 . . . . 62.23 111.399 -174.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -68.76 143.31 39.91 Favored Glycine 0 C--N 1.306 -1.089 0 N-CA-C 109.165 -1.574 . . . . 64.23 109.165 169.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -61.22 130.5 46.55 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 122.878 0.471 . . . . 62.41 111.001 -176.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -55.23 135.16 49.91 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.541 0.941 . . . . 65.14 113.541 -172.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 85.8 t -137.99 115.9 12.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 114.814 -1.084 . . . . 75.11 109.013 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -90.78 111.88 23.45 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.742 -1.183 . . . . 70.3 108.612 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -148.56 20.75 1.04 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.938 0.718 . . . . 71.0 112.938 -174.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 140.31 155.65 6.62 Favored Glycine 0 CA--C 1.498 -0.994 0 C-N-CA 118.482 -1.818 . . . . 62.34 112.936 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.465 ' HA2' ' CD2' ' A' ' 600' ' ' HIS . . . -62.96 -49.77 69.42 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 114.262 0.465 . . . . 31.12 114.262 -175.362 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 25.4 m -71.98 -24.6 61.61 Favored 'General case' 0 C--N 1.312 -1.063 0 O-C-N 122.118 -0.636 . . . . 60.02 111.535 -176.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -93.12 -11.39 33.01 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 115.955 -0.566 . . . . 75.33 112.4 -177.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 600' ' ' HIS . . . . . 0.63 ' HB2' ' H ' ' A' ' 626' ' ' GLN . 0.5 OUTLIER -101.04 143.37 31.25 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 118.073 -1.451 . . . . 72.45 110.544 -176.866 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 69.98 -30.9 0.2 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.573 1.549 . . . . 71.52 112.005 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 602' ' ' ARG . . . . . 0.561 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 46.4 ttt180 -72.88 139.54 46.95 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.598 -0.689 . . . . 61.05 110.74 -177.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 603' ' ' VAL . . . . . 0.419 HG13 ' HB2' ' A' ' 622' ' ' LEU . 94.2 t -77.99 130.79 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 107.604 -1.258 . . . . 72.23 107.604 177.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 58.8 t -98.23 -55.73 5.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 108.562 -0.903 . . . . 74.42 108.562 -177.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 605' ' ' TYR . . . . . 0.424 ' O ' ' HA ' ' A' ' 622' ' ' LEU . 49.7 p90 -129.9 151.84 50.03 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 108.294 -1.002 . . . . 71.41 108.294 175.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 606' ' ' GLN . . . . . 0.534 ' HA ' ' O ' ' A' ' 621' ' ' THR . 17.7 pt20 -127.71 139.3 52.78 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 107.138 -1.43 . . . . 72.51 107.138 175.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.603 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 24.5 t-20 -46.43 -66.9 0.44 Allowed Pre-proline 0 CA--C 1.55 0.964 0 O-C-N 124.167 0.917 . . . . 63.14 112.607 -176.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.603 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 84.2 Cg_endo -91.22 124.1 0.86 Allowed 'Trans proline' 0 N--CA 1.436 -1.887 0 CA-C-N 121.233 1.476 . . . . 72.24 108.822 169.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.5 134.9 32.04 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.934 1.756 . . . . 73.4 112.399 -175.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 610' ' ' ALA . . . . . 0.658 ' HB1' ' HA ' ' A' ' 565' ' ' ASP . . . -68.79 138.93 55.21 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 115.537 -0.756 . . . . 54.21 110.024 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 101.57 -12.82 58.2 Favored Glycine 0 C--N 1.302 -1.317 0 N-CA-C 108.963 -1.655 . . . . 70.24 108.963 -173.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 16.5 m -118.06 168.76 10.25 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 107.143 -1.428 . . . . 60.43 107.143 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -71.22 126.5 13.32 Favored Glycine 0 N--CA 1.423 -2.222 0 N-CA-C 111.756 -0.538 . . . . 74.43 111.756 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 614' ' ' VAL . . . . . 0.414 HG12 ' HB2' ' A' ' 608' ' ' PRO . 31.4 m -94.27 141.69 14.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 109.271 -0.64 . . . . 74.53 109.271 177.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.15 144.03 36.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.888 -0.596 . . . . 72.33 111.753 177.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 616' ' ' ARG . . . . . 0.488 ' HD2' ' OD1' ' A' ' 559' ' ' ASN . 0.9 OUTLIER -54.03 -25.74 22.92 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.066 0.946 . . . . 73.43 112.26 179.771 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -61.13 -32.1 71.8 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 123.738 0.815 . . . . 74.3 109.879 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 73.08 8.43 74.03 Favored Glycine 0 N--CA 1.418 -2.506 0 N-CA-C 110.805 -0.918 . . . . 71.53 110.805 -176.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 619' ' ' ILE . . . . . 0.508 HG12 ' HB3' ' A' ' 586' ' ' MET . 0.0 OUTLIER -68.99 121.08 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 CA-C-O 122.068 0.937 . . . . 73.32 108.516 -174.461 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.18 119.57 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.549 0 CA-C-N 114.183 -1.372 . . . . 60.43 109.591 -176.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 606' ' ' GLN . 55.8 m -101.68 128.86 47.8 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.027 -1.471 . . . . 73.54 107.027 175.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 622' ' ' LEU . . . . . 0.438 HD23 ' H ' ' A' ' 622' ' ' LEU . 2.3 pt? -132.06 154.46 49.39 Favored 'General case' 0 CA--C 1.475 -1.926 0 N-CA-C 108.829 -0.804 . . . . 74.14 108.829 -176.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.94 135.19 49.61 Favored 'General case' 0 N--CA 1.398 -3.067 0 N-CA-C 105.672 -1.973 . . . . 64.4 105.672 177.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -142.79 165.67 26.75 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 106.128 -1.804 . . . . 73.2 106.128 177.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -77.43 -102.72 0.17 Allowed Glycine 0 N--CA 1.428 -1.863 0 C-N-CA 119.705 -1.236 . . . . 54.22 110.214 172.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 626' ' ' GLN . . . . . 0.63 ' H ' ' HB2' ' A' ' 600' ' ' HIS . 49.4 tt0 . . . . . 0 C--N 1.298 -1.642 0 N-CA-C 108.7 -0.852 . . . . 75.11 108.7 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 . . . . . 0 CA--C 1.494 -1.183 0 CA-C-O 120.832 0.349 . . . . 52.12 110.159 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 360' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 409' ' ' SER . 21.5 m -141.51 164.51 19.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 107.852 -1.166 . . . . 63.34 107.852 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -92.59 138.07 31.82 Favored 'General case' 0 N--CA 1.397 -3.085 0 N-CA-C 107.076 -1.453 . . . . 54.34 107.076 174.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.465 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 76.0 t -94.91 125.05 52.44 Favored Pre-proline 0 C--N 1.266 -3.045 0 N-CA-C 107.218 -1.401 . . . . 72.54 107.218 -173.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 363' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 28.0 Cg_exo -57.35 136.82 78.5 Favored 'Trans proline' 0 CA--C 1.499 -1.234 0 C-N-CA 123.252 2.635 . . . . 71.34 113.185 -169.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -75.49 101.53 4.89 Favored 'General case' 0 N--CA 1.421 -1.915 0 CA-C-O 122.742 1.258 . . . . 73.41 109.699 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 365' ' ' VAL . 5.8 m -81.86 7.08 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-N 114.112 -1.404 . . . . 74.22 112.643 -178.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.527 ' HA ' HG23 ' A' ' 399' ' ' VAL . 36.4 ptt180 -58.66 146.01 37.83 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 125.132 1.373 . . . . 74.31 111.667 175.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.97 -10.46 51.9 Favored Glycine 0 N--CA 1.436 -1.345 0 N-CA-C 111.11 -0.796 . . . . 62.11 111.11 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -110.46 -161.62 0.76 Allowed 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.988 -1.115 . . . . 75.23 107.988 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 75.8 p -94.11 158.69 15.49 Favored 'General case' 0 C--N 1.276 -2.623 0 N-CA-C 108.24 -1.022 . . . . 74.32 108.24 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.439 ' O ' ' HB ' ' A' ' 374' ' ' ILE . 46.8 t -60.32 -36.06 77.06 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 109.722 -0.473 . . . . 72.34 109.722 176.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.56 -47.78 71.72 Favored 'General case' 0 C--O 1.213 -0.841 0 CA-C-O 119.24 -0.409 . . . . 74.41 111.763 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -70.09 -40.62 74.87 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 119.722 -0.791 . . . . 71.12 110.901 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -61.54 -47.31 86.11 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.257 -0.883 . . . . 64.33 110.599 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 374' ' ' ILE . . . . . 0.439 ' HB ' ' O ' ' A' ' 370' ' ' SER . 1.6 mp -69.07 -38.3 78.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.926 -0.579 . . . . 72.11 111.209 177.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -60.14 -38.35 82.84 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.535 0.683 . . . . 63.13 110.353 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 86.1 m -63.76 -45.48 89.61 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.443 -0.799 . . . . 62.0 110.167 177.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 85.4 mt -64.24 -38.83 92.46 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.13 -0.486 . . . . 62.32 110.629 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -62.1 -40.41 95.77 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.56 -0.533 . . . . 74.12 109.56 177.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -63.13 -30.05 71.28 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.131 0.572 . . . . 64.41 111.585 176.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -84.48 -14.07 50.19 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.097 -0.502 . . . . 74.22 110.885 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 94.94 12.91 54.81 Favored Glycine 0 C--N 1.311 -0.836 0 C-N-CA 120.779 -0.724 . . . . 73.34 112.702 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -80.56 157.77 25.96 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-O 121.195 0.522 . . . . 75.22 111.395 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 74.9 mmtt -98.86 132.78 43.95 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 106.698 -1.593 . . . . 73.21 106.698 177.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 384' ' ' ILE . . . . . 0.464 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -123.09 154.93 28.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 CA-C-O 121.822 0.82 . . . . 72.21 110.861 -177.124 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -135.58 134.04 38.93 Favored 'General case' 0 N--CA 1.399 -2.997 0 CA-C-N 114.235 -1.348 . . . . 71.31 107.432 173.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 52.2 m -125.0 121.98 35.97 Favored 'General case' 0 C--N 1.271 -2.838 0 N-CA-C 106.631 -1.618 . . . . 74.24 106.631 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.21 119.23 38.23 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 105.854 -1.906 . . . . 74.43 105.854 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 388' ' ' GLN . . . . . 0.58 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 19.5 pm0 -123.0 129.1 51.09 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 119.964 -0.694 . . . . 73.52 111.384 -176.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 389' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 421' ' ' SER . 96.1 mttt -134.7 148.68 68.24 Favored Pre-proline 0 C--N 1.308 -1.207 0 N-CA-C 107.61 -1.255 . . . . 74.03 107.61 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -69.28 127.47 15.02 Favored 'Trans proline' 0 C--O 1.249 1.027 0 N-CA-C 105.909 -2.381 . . . . 52.13 105.909 168.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -177.41 157.4 1.3 Allowed 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 118.993 -1.083 . . . . 64.32 110.962 -169.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 10.9 m -112.08 -4.95 14.32 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.776 0.322 . . . . 64.42 110.93 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 42.4 m -92.45 -42.2 9.87 Favored 'General case' 0 N--CA 1.435 -1.184 0 O-C-N 122.118 -0.364 . . . . 75.14 111.101 -175.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.434 HG13 ' HB3' ' A' ' 421' ' ' SER . 21.1 pt -88.02 148.36 42.98 Favored Pre-proline 0 C--N 1.31 -1.123 0 C-N-CA 120.47 -0.492 . . . . 72.34 110.623 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 395' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 396' ' ' PRO . 87.1 Cg_exo -49.04 147.08 11.21 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 124.493 3.462 . . . . 70.13 115.443 -177.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 396' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 395' ' ' PRO . 51.8 Cg_exo -56.5 165.64 4.3 Favored 'Trans proline' 0 C--O 1.22 -0.418 0 C-N-CA 124.593 3.529 . . . . 75.23 110.813 170.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 397' ' ' ASP . . . . . 0.666 ' HA ' HG13 ' A' ' 420' ' ' VAL . 6.1 p-10 -55.17 -7.84 0.24 Allowed 'General case' 0 N--CA 1.505 2.308 0 C-N-CA 123.468 0.707 . . . . 74.04 112.538 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -91.87 117.3 29.67 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 106.118 -1.808 . . . . 61.31 106.118 172.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.527 HG23 ' HA ' ' A' ' 366' ' ' ARG . 16.2 m -73.62 118.65 19.36 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-O 120.9 0.381 . . . . 72.14 110.827 -173.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 9.2 tp -89.78 -28.7 5.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-O 121.396 0.617 . . . . 71.03 110.51 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.43 169.59 27.65 Favored Glycine 0 N--CA 1.425 -2.068 0 N-CA-C 110.234 -1.147 . . . . 64.15 110.234 -177.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 10.5 p -114.15 -178.66 3.43 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 123.545 0.203 . . . . 64.13 110.59 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -100.74 139.79 20.85 Favored Pre-proline 0 C--N 1.307 -1.247 0 N-CA-C 107.777 -1.194 . . . . 63.45 107.777 -177.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -43.18 -30.25 2.06 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 124.391 3.394 . . . . 72.54 114.313 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.28 -31.53 70.32 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 123.309 0.381 . . . . 72.24 111.459 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 406' ' ' ALA . . . . . 0.401 ' HB2' HD12 ' A' ' 416' ' ' ILE . . . -86.14 -34.39 20.59 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.701 0.762 . . . . 70.24 110.188 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -82.8 -1.99 53.25 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.259 -0.882 . . . . 74.32 111.426 -175.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 26.8 m -110.76 153.54 25.18 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 106.194 -1.78 . . . . 74.55 106.194 175.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 409' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 360' ' ' VAL . 39.3 m -73.87 112.73 10.27 Favored 'General case' 0 N--CA 1.425 -1.686 0 C-N-CA 120.205 -0.598 . . . . 20.34 109.749 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 23.9 m -122.54 166.71 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 115.403 -0.817 . . . . 74.22 109.719 178.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 42.7 m -75.74 138.77 41.47 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 109.228 -0.656 . . . . 63.42 109.228 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -61.31 109.43 1.14 Allowed 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.184 0.516 . . . . 33.52 110.55 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 116.79 67.26 0.38 Allowed Glycine 0 N--CA 1.428 -1.873 0 N-CA-C 110.203 -1.159 . . . . 61.21 110.203 -178.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -135.5 -168.58 2.22 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.888 -1.152 . . . . 74.22 107.888 -177.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 415' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 40.1 mt-10 -106.99 131.09 54.44 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 123.622 0.769 . . . . 71.13 110.518 -176.125 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 416' ' ' ILE . . . . . 0.401 HD12 ' HB2' ' A' ' 406' ' ' ALA . 42.4 mm -119.37 115.86 49.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.928 -0.767 . . . . 63.52 108.928 176.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 13.7 p -98.82 130.94 45.27 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 123.929 0.891 . . . . 73.3 111.127 -177.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 8.7 p -126.96 135.06 64.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 120.905 0.384 . . . . 64.25 111.496 178.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -101.15 120.83 40.81 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.099 0.476 . . . . 75.04 110.059 176.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.666 HG13 ' HA ' ' A' ' 397' ' ' ASP . 44.8 t -126.49 144.36 36.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 C-N-CA 123.939 0.896 . . . . 72.01 111.252 -174.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 421' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 27.3 p -101.25 127.13 47.98 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.384 0.611 . . . . 60.22 110.832 176.176 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.1 t -117.69 106.05 12.67 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 115.888 -0.597 . . . . 75.12 109.42 177.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.888 0 C-N-CA 119.589 -1.291 . . . . 43.24 112.344 179.943 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 . . . . . 0 N--CA 1.446 -0.67 0 CA-C-O 120.881 0.372 . . . . 55.23 110.51 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -121.03 152.92 38.05 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-O 121.803 0.811 . . . . 70.14 111.041 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.59 ' CD ' ' H ' ' A' ' 428' ' ' GLU . 0.3 OUTLIER -86.81 140.34 29.79 Favored 'General case' 0 C--N 1.268 -2.942 0 CA-C-N 114.05 -1.432 . . . . 65.51 111.764 -174.552 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.508 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 65.7 mt -79.79 116.6 62.2 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 109.239 -0.652 . . . . 64.24 109.239 -177.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.51 147.26 51.62 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.851 2.368 . . . . 72.52 113.081 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -92.32 131.89 37.15 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 106.553 -1.647 . . . . 75.35 106.553 175.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.6 HG11 ' HB2' ' A' ' 440' ' ' ALA . 11.4 p -132.33 159.68 42.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 C-N-CA 120.855 -0.338 . . . . 71.33 110.852 -171.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.606 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 15.3 m -68.6 152.93 44.68 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 108.772 -0.825 . . . . 63.14 108.772 175.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 81.8 p -69.13 -33.5 73.56 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 114.413 1.264 . . . . 74.14 114.413 -167.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.8 pp -90.65 -11.67 39.12 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.629 -1.228 . . . . 53.21 111.553 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.606 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 1.2 m -86.83 42.05 1.0 Allowed 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.472 -0.786 . . . . 73.04 111.081 -174.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -56.58 -37.05 70.07 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.953 0.901 . . . . 74.51 110.632 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -54.97 -41.42 71.15 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.158 -0.474 . . . . 72.32 111.254 175.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -70.4 -35.65 73.58 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.777 -0.453 . . . . 72.1 109.777 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.623 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -60.9 -51.41 69.4 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.543 -0.753 . . . . 53.52 110.477 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 33.8 m -65.53 -39.7 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 112.482 0.549 . . . . 63.44 112.482 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.422 ' HD3' ' N ' ' A' ' 443' ' ' LYS . 0.1 OUTLIER -67.89 -34.92 77.59 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 120.131 -0.628 . . . . 70.21 111.971 178.096 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 443' ' ' LYS . . . . . 0.422 ' N ' ' HD3' ' A' ' 442' ' ' LYS . 0.9 OUTLIER -66.14 -40.63 90.75 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.084 -0.507 . . . . 74.24 109.747 177.875 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 76.8 mt -67.45 -32.86 74.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.597 -0.729 . . . . 70.13 110.18 177.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 90.5 m -69.89 -42.55 73.27 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.128 0.49 . . . . 63.33 109.975 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.46 -15.75 62.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.434 0.635 . . . . 71.43 110.767 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -85.49 5.25 32.11 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.422 -0.808 . . . . 32.52 111.459 178.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 104.92 -74.48 0.24 Allowed Glycine 0 CA--C 1.495 -1.176 0 C-N-CA 120.747 -0.739 . . . . 51.44 111.874 176.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 449' ' ' PHE . . . . . 0.541 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 3.6 p90 -49.19 -59.57 3.55 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 113.975 1.102 . . . . 71.23 113.975 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 60.59 29.32 69.41 Favored Glycine 0 C--O 1.217 -0.912 0 N-CA-C 111.028 -0.829 . . . . 72.42 111.028 -174.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.411 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 27.9 mmt180 -103.55 111.42 23.87 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.965 -1.124 . . . . 70.2 107.965 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -141.54 150.11 41.69 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 120.84 0.352 . . . . 71.31 111.326 -176.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 453' ' ' LYS . . . . . 0.451 ' HE3' ' HB ' ' A' ' 485' ' ' ILE . 52.8 mtmt -136.79 146.83 46.18 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.768 -1.197 . . . . 72.14 107.768 178.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 454' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' ' 486' ' ' ILE . 53.4 tt0 -117.31 128.52 55.13 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 109.931 -0.396 . . . . 71.12 109.931 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -116.89 154.82 30.12 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.027 -1.101 . . . . 75.11 108.027 177.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -125.1 137.74 54.18 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 108.935 -0.765 . . . . 74.01 108.935 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 26.6 t -137.97 141.79 33.73 Favored Pre-proline 0 C--N 1.292 -1.929 0 N-CA-C 109.538 -0.541 . . . . 71.45 109.538 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.696 ' HA ' ' O ' ' A' ' 490' ' ' SER . 44.4 Cg_endo -70.32 124.28 10.7 Favored 'Trans proline' 0 C--O 1.25 1.079 0 C-N-CA 122.417 2.078 . . . . 64.53 111.679 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 50.3 m -152.04 179.85 8.12 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.51 -0.552 . . . . 64.04 109.51 -177.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.6 t -49.17 139.46 13.16 Favored Pre-proline 0 CA--C 1.56 1.333 0 C-N-CA 123.702 0.801 . . . . 62.35 112.126 176.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.57 -28.5 29.01 Favored 'Trans proline' 0 C--N 1.365 1.419 0 C-N-CA 125.112 3.875 . . . . 65.14 113.966 -177.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -68.63 -21.24 64.49 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 116.162 -0.472 . . . . 60.31 111.635 -178.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 91.6 mt -103.61 -13.18 16.63 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 120.859 0.361 . . . . 74.51 110.913 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 70.0 t -60.97 127.62 20.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.001 -0.545 . . . . 64.2 110.954 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 95.64 -15.82 62.41 Favored Glycine 0 N--CA 1.441 -1.031 0 CA-C-N 115.639 -0.71 . . . . 73.55 112.114 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.65 166.83 12.27 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 110.211 -0.292 . . . . 61.04 110.211 -178.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 73.2 t -72.19 143.39 14.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 115.826 -0.625 . . . . 64.42 109.643 179.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 70.0 mt -97.38 -31.04 3.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 107.244 -1.391 . . . . 75.3 107.244 176.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 159.74 -159.22 30.42 Favored Glycine 0 N--CA 1.425 -2.086 0 N-CA-C 109.977 -1.249 . . . . 54.5 109.977 177.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 470' ' ' THR . . . . . 0.519 HG22 HG12 ' A' ' 486' ' ' ILE . 61.9 p -114.7 146.67 40.65 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 105.608 -1.997 . . . . 62.11 105.608 178.118 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.489 ' HB3' HG23 ' A' ' 485' ' ' ILE . 28.5 t-20 -72.85 -53.86 5.05 Favored Pre-proline 0 C--N 1.314 -0.947 0 C-N-CA 118.871 -1.132 . . . . 71.31 110.236 178.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -67.75 134.54 32.85 Favored 'Trans proline' 0 C--N 1.368 1.604 0 N-CA-C 107.904 -1.614 . . . . 75.33 107.904 168.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' A' ' 475' ' ' ASN . 24.7 Cg_exo -62.12 139.21 77.21 Favored 'Trans proline' 0 C--O 1.242 0.702 0 C-N-CA 122.216 1.944 . . . . 74.33 112.632 -175.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.508 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -75.84 19.91 0.2 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 122.163 0.983 . . . . 75.04 110.979 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 475' ' ' ASN . . . . . 0.438 ' H ' ' C ' ' A' ' 473' ' ' PRO . 10.1 m120 -109.21 -17.65 13.79 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.412 -0.959 . . . . 75.33 108.412 178.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -87.33 170.43 11.42 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.696 -0.683 . . . . 65.15 111.733 -174.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 4.5 m -106.3 127.02 52.94 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 108.304 -0.998 . . . . 72.42 108.304 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 9.8 p -105.95 146.06 30.52 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 123.031 0.533 . . . . 71.23 111.236 -177.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -90.26 162.75 15.05 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.452 -0.34 . . . . 74.14 110.815 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 480' ' ' ILE . . . . . 0.541 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 1.7 mp -70.93 -20.58 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.966 0.889 . . . . 71.31 111.187 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 12.2 p -93.39 1.17 56.99 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.988 0.899 . . . . 54.31 111.029 178.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -104.93 138.17 41.57 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.004 -0.998 . . . . 75.12 111.649 -173.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.411 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.4 p -108.06 127.03 64.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.809 -0.632 . . . . 63.13 111.027 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 35.8 m -95.45 141.57 14.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-O 121.299 0.571 . . . . 74.3 111.294 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.489 HG23 ' HB3' ' A' ' 471' ' ' ASN . 0.0 OUTLIER -109.43 125.91 66.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.196 0 CA-C-O 121.485 0.66 . . . . 74.33 110.251 -178.441 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.519 HG12 HG22 ' A' ' 470' ' ' THR . 8.9 mt -112.62 128.61 69.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 115.067 -0.97 . . . . 74.41 110.919 -178.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 8.8 tt -105.17 127.21 59.99 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 123.41 0.684 . . . . 64.52 111.905 -174.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 28.6 m -111.61 152.07 13.57 Favored 'Isoleucine or valine' 0 C--O 1.25 1.097 0 C-N-CA 124.017 0.927 . . . . 54.33 110.241 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -81.9 140.76 21.15 Favored Glycine 0 C--O 1.246 0.854 0 C-N-CA 120.99 -0.624 . . . . 71.21 111.979 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.696 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 13.2 t . . . . . 0 C--N 1.308 -1.212 0 N-CA-C 109.017 -0.735 . . . . 74.22 109.017 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo . . . . . 0 CA--C 1.544 0.996 0 CA-C-O 121.035 0.348 . . . . 73.24 112.194 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -84.99 65.73 9.39 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-O 122.083 0.944 . . . . 72.04 111.875 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 1.3 p -118.03 143.42 46.43 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 114.899 -1.046 . . . . 65.01 109.673 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -146.34 148.83 32.78 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.84 -1.17 . . . . 63.44 107.84 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.562 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 9.5 p-10 -87.54 130.07 34.86 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.475 0.655 . . . . 73.12 110.985 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 38.3 pt -75.92 137.82 69.46 Favored Pre-proline 0 C--N 1.307 -1.28 0 CA-C-N 114.862 -1.063 . . . . 74.34 110.418 -178.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -93.86 -170.72 0.24 Allowed 'Trans proline' 0 N--CA 1.443 -1.482 0 C-N-CA 122.269 1.979 . . . . 61.44 111.211 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -83.9 145.91 28.34 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.666 -1.235 . . . . 72.45 107.666 174.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 9.2 p -136.22 8.58 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.455 0 CA-C-O 122.616 1.198 . . . . 65.23 108.469 177.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -71.17 121.43 18.32 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 114.019 -1.446 . . . . 62.1 109.628 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 108.73 30.57 3.7 Favored Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 110.789 -0.924 . . . . 74.14 110.789 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -142.03 176.09 9.22 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.907 -0.775 . . . . 74.0 108.907 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 29.6 p -91.67 160.02 15.58 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 110.021 -0.362 . . . . 74.21 110.021 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 30.7 m -53.73 -40.24 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 C-N-CA 124.181 0.993 . . . . 71.04 112.255 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -66.72 -42.44 86.35 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.655 -0.702 . . . . 64.22 110.791 -178.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 64.8 t -74.77 -35.06 35.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 116.432 -0.349 . . . . 73.33 110.253 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -59.61 -49.74 76.6 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.134 -0.485 . . . . 72.01 111.573 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -65.58 -35.89 82.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 74.03 110.725 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.416 ' O ' HG23 ' A' ' 514' ' ' VAL . 58.6 tptt -61.47 -47.35 86.06 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.706 -0.679 . . . . 64.45 109.647 178.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -62.08 -44.83 95.81 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 116.382 -0.372 . . . . 71.3 110.165 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.73 -47.52 85.31 Favored 'General case' 0 C--O 1.242 0.664 0 O-C-N 123.422 0.451 . . . . 73.54 110.376 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.92 -38.15 87.32 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 116.182 -0.463 . . . . 74.4 111.105 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 510' ' ' LYS . 55.2 t -64.01 -35.6 74.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 122.828 0.451 . . . . 74.23 111.366 177.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -79.29 -12.77 59.94 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.374 -0.53 . . . . 74.21 110.695 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 516' ' ' GLY . . . . . 0.439 ' O ' ' HB ' ' A' ' 547' ' ' VAL . . . 113.11 -0.14 25.41 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.69 -0.767 . . . . 62.23 113.154 177.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.457 ' HA ' ' O ' ' A' ' 547' ' ' VAL . 79.2 m-85 -82.82 115.77 21.86 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.454 -0.572 . . . . 71.45 109.454 -178.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.7 p -88.69 -26.04 22.04 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 113.643 0.979 . . . . 73.45 113.643 -176.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 519' ' ' LYS . . . . . 0.51 ' HE2' ' HA ' ' A' ' 519' ' ' LYS . 6.4 mmpt? -110.13 120.66 43.15 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 113.613 0.968 . . . . 74.45 113.613 -176.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -131.82 140.2 49.08 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 113.809 -1.541 . . . . 73.12 111.242 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 54.0 m -134.47 144.42 48.08 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.627 -0.879 . . . . 65.03 108.627 176.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -117.35 122.57 44.24 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.721 0.772 . . . . 63.25 110.807 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -100.89 140.29 35.38 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.685 -0.688 . . . . 71.21 109.663 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 15.9 m -88.79 116.01 26.75 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.982 -0.554 . . . . 73.32 109.646 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 35.7 m -121.98 158.56 25.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.935 -0.765 . . . . 73.24 108.935 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 526' ' ' ASP . . . . . 0.524 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 5.2 p-10 -94.71 136.83 34.55 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.838 -0.745 . . . . 62.24 109.89 179.051 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 527' ' ' SER . . . . . 0.456 ' HB2' ' HB2' ' A' ' 556' ' ' SER . 38.6 m -153.81 173.57 4.56 Favored Pre-proline 0 C--N 1.305 -1.331 0 N-CA-C 106.442 -1.688 . . . . 35.33 106.442 174.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -81.88 -8.3 12.2 Favored 'Trans proline' 0 CA--C 1.547 1.16 0 CA-C-N 120.642 1.265 . . . . 44.13 111.6 173.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.435 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 4.1 mpt_? -76.39 134.61 69.94 Favored Pre-proline 0 C--O 1.223 -0.328 0 CA-C-N 116.046 -0.524 . . . . 71.32 109.813 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -57.08 154.93 30.89 Favored 'Trans proline' 0 C--O 1.255 1.368 0 C-N-CA 123.225 2.616 . . . . 75.3 114.032 -177.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.5 117.02 4.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.87 -1.059 . . . . 72.12 111.892 -178.311 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 132.21 -20.02 4.52 Favored Glycine 0 CA--C 1.49 -1.497 0 N-CA-C 110.797 -0.921 . . . . 42.01 110.797 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -74.27 125.25 28.02 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.922 -0.639 . . . . 74.23 110.04 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 85.9 t -84.34 107.39 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 N-CA-C 106.36 -1.718 . . . . 74.52 106.36 172.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 26.8 m -75.01 -25.96 59.19 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.632 -1.167 . . . . 61.11 111.002 -174.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 162.03 -163.78 35.02 Favored Glycine 0 N--CA 1.427 -1.963 0 N-CA-C 110.311 -1.115 . . . . 14.11 110.311 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 19.5 p -117.73 155.3 30.22 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.987 -0.746 . . . . 73.55 108.987 178.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -75.52 -52.97 2.73 Favored Pre-proline 0 C--N 1.305 -1.34 0 N-CA-C 109.614 -0.513 . . . . 70.34 109.614 176.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -64.32 130.33 26.64 Favored 'Trans proline' 0 C--N 1.365 1.405 0 N-CA-C 107.951 -1.596 . . . . 73.23 107.951 167.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -63.21 143.67 90.22 Favored 'Trans proline' 0 C--O 1.246 0.879 0 C-N-CA 122.226 1.951 . . . . 74.14 112.479 -177.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -65.14 136.1 56.29 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.604 -0.517 . . . . 63.02 109.604 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.95 -19.46 32.74 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 111.446 -0.662 . . . . 65.13 111.446 -176.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 35.2 m -68.51 134.48 50.13 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.699 0.285 . . . . 73.14 110.329 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 28.2 m -85.41 122.8 30.08 Favored 'General case' 0 N--CA 1.416 -2.138 0 N-CA-C 107.741 -1.207 . . . . 71.12 107.741 177.046 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 52.9 t -127.72 152.27 76.68 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 107.147 -1.427 . . . . 71.43 107.147 -176.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -66.2 139.52 55.6 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 121.512 1.475 . . . . 74.51 109.701 171.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 517' ' ' PHE . 28.7 m -63.28 -20.12 25.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.665 0.745 . . . . 71.35 112.548 -177.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -93.45 3.48 55.5 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.465 -0.788 . . . . 65.24 110.727 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 8.6 t -92.4 -178.43 4.92 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.761 -0.587 . . . . 72.24 109.916 -178.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 45.5 t -102.1 122.74 54.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 122.948 0.499 . . . . 65.42 111.181 -174.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 1.9 mp -103.58 126.77 58.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.158 -1.053 . . . . 54.55 108.158 175.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -103.56 120.48 40.96 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-O 121.488 0.661 . . . . 73.24 111.989 -176.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 69.2 mt -94.75 134.3 37.51 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 125.569 1.547 . . . . 72.21 108.249 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -104.02 118.66 37.19 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 109.15 -0.685 . . . . 73.44 109.15 176.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 43.4 t -109.79 129.5 64.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 CA-C-N 115.17 -0.923 . . . . 71.04 109.191 -175.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.456 ' HB2' ' HB2' ' A' ' 527' ' ' SER . 32.0 p -80.07 143.5 33.95 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 113.494 0.924 . . . . 62.22 113.494 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.524 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 45.1 pttt -92.41 152.42 19.73 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 102.863 -3.014 . . . . 74.53 102.863 165.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 558' ' ' GLY . . . . . 0.486 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -75.53 -32.14 55.28 Favored Glycine 0 CA--C 1.479 -2.17 0 C-N-CA 119.079 -1.534 . . . . 73.14 111.166 -176.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 64.3 t30 71.98 -28.99 0.19 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.516 1.526 . . . . 74.34 111.839 173.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.486 ' H ' ' C ' ' A' ' 558' ' ' GLY . 92.8 mt-30 -135.23 145.88 48.06 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 106.75 -1.574 . . . . 61.25 106.75 174.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -123.07 138.09 54.76 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 109.383 -0.599 . . . . 52.53 109.383 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 90.2 t -59.94 116.88 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 O-C-N 123.933 0.771 . . . . 64.14 110.321 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 563' ' ' MET . . . . . 0.424 ' HA ' ' HD3' ' A' ' 564' ' ' PRO . 25.7 ptm -80.62 146.74 61.45 Favored Pre-proline 0 C--O 1.249 1.031 0 CA-C-N 116.103 -0.498 . . . . 75.32 110.475 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 564' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 563' ' ' MET . 15.5 Cg_exo -71.39 169.76 20.04 Favored 'Trans proline' 0 C--O 1.243 0.77 0 C-N-CA 122.862 2.374 . . . . 65.23 111.592 174.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -74.34 125.66 28.97 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 112.776 0.658 . . . . 45.05 112.776 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 96.1 mt -142.03 18.91 2.12 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.595 -1.184 . . . . 70.33 108.125 177.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 60.2 p -79.84 139.13 37.3 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 112.455 0.539 . . . . 55.34 112.455 -175.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 83.83 25.36 45.97 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 121.137 -0.554 . . . . 75.5 112.707 176.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 84.4 mtp -108.23 174.92 5.66 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.839 -0.43 . . . . 61.24 109.839 -178.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -102.5 136.96 41.4 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 106.922 -1.51 . . . . 75.13 106.922 177.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 81.8 t90 -54.66 -29.58 53.0 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 124.021 0.929 . . . . 63.23 112.356 -176.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 16.7 m -74.57 -19.16 16.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.342 0.592 . . . . 64.3 111.347 -177.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -102.29 -36.54 8.44 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.862 0.839 . . . . 72.43 109.644 178.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -67.46 -43.21 81.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.83 -1.077 . . . . 73.11 112.54 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.403 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 41.4 tt0 -57.15 -50.56 87.47 Favored Pre-proline 0 CA--C 1.558 1.283 0 CA-C-O 119.44 -0.314 . . . . 75.2 111.481 178.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 576' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 83.5 Cg_exo -53.53 -37.96 83.12 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.095 1.863 . . . . 65.54 112.617 172.235 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.527 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 45.4 mmt-85 -64.96 -39.14 93.04 Favored 'General case' 0 C--O 1.214 -0.799 0 C-N-CA 120.242 -0.583 . . . . 75.12 110.586 177.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 96.3 mt -62.24 -43.12 99.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.336 0.589 . . . . 71.51 109.452 177.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -61.85 -38.81 89.62 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.375 -0.83 . . . . 75.53 110.317 178.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.21 -30.0 66.98 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.063 -0.517 . . . . 52.25 111.415 177.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 581' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 93.0 mt -81.97 -7.19 59.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.826 0.346 . . . . 62.34 111.332 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 82.7 35.64 18.71 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 120.974 -0.632 . . . . 63.13 111.914 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 83.5 t90 -77.51 130.44 36.97 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.129 0.49 . . . . 74.51 110.177 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 50.4 m -145.05 89.43 1.96 Allowed 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.158 -1.052 . . . . 74.15 108.158 175.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -153.58 -146.84 4.48 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 110.208 -1.157 . . . . 65.52 110.208 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 586' ' ' MET . . . . . 0.49 ' HB3' HG12 ' A' ' 619' ' ' ILE . 23.8 ttt -115.93 135.33 54.08 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 117.182 0.491 . . . . 74.34 110.894 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -100.47 130.78 46.59 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.05 -1.834 . . . . 70.34 106.05 175.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -102.36 118.67 37.38 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.867 -0.733 . . . . 64.12 110.637 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 4.0 mmmp? -87.76 111.94 21.88 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-O 121.5 0.666 . . . . 71.45 112.15 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -81.23 -173.41 47.75 Favored Glycine 0 N--CA 1.427 -1.907 0 N-CA-C 109.676 -1.37 . . . . 41.31 109.676 171.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -70.51 145.02 51.16 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.998 0.399 . . . . 64.31 110.977 -175.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -85.59 124.67 32.4 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.925 -1.139 . . . . 72.23 107.925 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.92 124.85 68.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 C-N-CA 122.903 0.481 . . . . 74.14 110.863 -174.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -75.67 111.8 11.38 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.489 -0.93 . . . . 74.12 108.489 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -114.19 -19.78 11.18 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 112.081 0.4 . . . . 53.23 112.081 -176.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 126.96 145.83 6.34 Favored Glycine 0 CA--C 1.492 -1.391 0 N-CA-C 108.663 -1.775 . . . . 74.14 108.663 -176.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.17 -40.1 82.86 Favored Glycine 0 N--CA 1.47 0.912 0 CA-C-N 117.512 0.656 . . . . 42.11 113.955 -173.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 15.8 m -66.38 -24.31 66.47 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 122.951 0.501 . . . . 65.23 111.46 -178.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -108.7 -1.11 19.69 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.269 0.841 . . . . 74.32 113.269 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -68.07 150.64 48.17 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.943 -0.392 . . . . 65.42 109.943 177.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 63.42 -6.31 0.21 Allowed 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 124.878 1.271 . . . . 54.2 114.122 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 602' ' ' ARG . . . . . 0.524 ' HD2' ' O ' ' A' ' 603' ' ' VAL . 5.5 tmm_? -79.15 138.62 37.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 118.459 0.572 . . . . 72.31 109.883 -178.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 603' ' ' VAL . . . . . 0.524 ' O ' ' HD2' ' A' ' 602' ' ' ARG . 13.9 p -64.0 142.2 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.85 0.86 . . . . 61.3 111.171 -177.078 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 604' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 623' ' ' ARG . 7.5 p -96.13 -47.79 12.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 118.687 -1.205 . . . . 64.4 109.216 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -156.99 155.82 31.91 Favored 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 105.337 -2.097 . . . . 65.53 105.337 173.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -115.75 128.78 56.12 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 107.356 -1.349 . . . . 73.04 107.356 173.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.595 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 25.2 t-20 -48.77 -52.55 44.71 Favored Pre-proline 0 CA--C 1.545 0.779 0 O-C-N 123.99 0.806 . . . . 65.11 111.634 -177.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 13.7 Cg_endo -100.86 110.19 0.05 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.054 0 C-N-CA 121.659 1.573 . . . . 50.22 109.441 169.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.95 160.37 34.01 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.494 2.13 . . . . 73.25 111.485 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -57.32 126.96 29.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.576 0.227 . . . . 65.22 110.46 -177.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 102.03 -5.43 53.15 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.227 -0.987 . . . . 22.54 112.329 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 23.7 m -92.24 155.33 18.05 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.946 -0.761 . . . . 63.34 108.946 177.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -82.98 126.05 7.28 Favored Glycine 0 N--CA 1.426 -1.988 0 N-CA-C 111.368 -0.693 . . . . 71.42 111.368 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.3 m -103.81 142.18 17.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-O 120.598 0.237 . . . . 74.21 110.419 178.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.05 146.12 11.83 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 123.822 0.849 . . . . 72.12 112.267 177.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.02 -35.97 16.71 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 125.976 1.71 . . . . 72.32 112.874 -175.138 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -73.94 -30.26 62.45 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.883 -1.053 . . . . 71.21 111.484 -175.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 93.29 12.13 57.69 Favored Glycine 0 N--CA 1.414 -2.776 0 CA-C-O 119.211 -0.772 . . . . 62.1 114.078 174.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 619' ' ' ILE . . . . . 0.49 HG12 ' HB3' ' A' ' 586' ' ' MET . 0.0 OUTLIER -69.67 119.78 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 C-N-CA 117.715 -1.594 . . . . 64.22 107.736 178.629 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.84 132.14 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 114.793 -1.094 . . . . 74.02 108.349 -175.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 90.2 m -106.23 116.89 32.71 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 121.221 0.534 . . . . 63.14 110.507 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 622' ' ' LEU . . . . . 0.489 ' HB2' HG23 ' A' ' 603' ' ' VAL . 0.0 OUTLIER -139.92 149.97 43.98 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 104.558 -2.386 . . . . 72.04 104.558 173.04 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 623' ' ' ARG . . . . . 0.4 ' O ' HG12 ' A' ' 604' ' ' VAL . 44.5 ttp180 -128.78 156.13 44.05 Favored 'General case' 0 C--N 1.254 -3.578 0 N-CA-C 105.987 -1.857 . . . . 73.52 105.987 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -125.2 166.08 17.11 Favored 'General case' 0 C--N 1.26 -3.292 0 N-CA-C 105.367 -2.086 . . . . 72.23 105.367 175.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -61.28 -89.25 0.02 OUTLIER Glycine 0 C--N 1.314 -0.687 0 C-N-CA 120.104 -1.046 . . . . 64.03 110.708 176.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 . . . . . 0 C--N 1.289 -2.054 0 N-CA-C 107.03 -1.47 . . . . 53.0 107.03 175.047 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 C--O 1.241 0.643 0 N-CA-C 108.477 -0.934 . . . . 74.32 108.477 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 31.5 m -121.49 163.67 19.17 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-O 120.76 0.314 . . . . 41.04 110.74 -175.031 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -94.41 136.59 34.54 Favored 'General case' 0 N--CA 1.383 -3.793 0 N-CA-C 107.439 -1.319 . . . . 60.42 107.439 175.569 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 72.1 t -97.42 135.06 21.93 Favored Pre-proline 0 C--N 1.265 -3.093 0 CA-C-N 114.624 -1.171 . . . . 74.15 109.911 -171.17 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -65.99 121.9 9.33 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 121.65 1.566 . . . . 72.34 110.948 179.244 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -88.77 147.48 24.42 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.749 -1.575 . . . . 74.24 106.749 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 4.8 t -120.84 11.54 6.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 CA-C-N 116.052 -0.522 . . . . 71.41 109.947 -172.511 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.5 ' HA ' HG23 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -60.69 143.11 54.9 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 119.158 -1.017 . . . . 74.11 110.03 176.535 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.94 -9.28 46.93 Favored Glycine 0 C--N 1.301 -1.395 0 N-CA-C 111.233 -0.747 . . . . 54.0 111.233 -172.498 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -109.03 -145.86 0.4 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.483 -0.932 . . . . 73.15 108.483 174.386 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 369' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 96.4 p -107.13 167.04 10.18 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.426 -0.909 . . . . 71.02 108.899 -176.781 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 25.2 t -59.69 -39.55 84.9 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 109.167 -0.679 . . . . 52.02 109.167 176.756 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.37 -46.66 75.95 Favored 'General case' 0 C--O 1.213 -0.843 0 CA-C-N 116.102 -0.499 . . . . 60.03 111.357 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -64.11 -41.42 97.25 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.359 0.599 . . . . 72.42 110.924 -179.251 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.06 -51.34 62.03 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.389 -0.823 . . . . 61.31 111.073 -178.539 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 39.8 mm -66.08 -39.98 85.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.042 -0.526 . . . . 73.51 110.955 -179.303 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.24 -38.82 88.01 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 120.937 0.399 . . . . 74.31 111.15 -179.111 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 376' ' ' THR . . . . . 0.546 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 79.5 m -66.41 -47.28 73.78 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.845 -0.616 . . . . 74.04 111.177 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.75 -37.99 89.44 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.557 0.218 . . . . 63.2 111.159 178.83 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 65.4 tp60 -59.9 -48.03 83.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.95 -0.568 . . . . 54.11 109.747 177.096 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -61.03 -30.88 70.57 Favored 'General case' 0 CA--C 1.495 -1.17 0 N-CA-C 113.096 0.776 . . . . 72.41 113.096 177.231 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 380' ' ' ARG . . . . . 0.546 ' HG2' ' O ' ' A' ' 376' ' ' THR . 13.3 mmt180 -78.44 -14.08 59.54 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.272 -0.422 . . . . 70.2 110.735 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 91.14 16.11 54.49 Favored Glycine 0 CA--C 1.501 -0.842 0 C-N-CA 119.772 -1.204 . . . . 53.42 111.506 177.412 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -88.92 162.89 15.85 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-O 121.385 0.612 . . . . 74.31 110.518 178.877 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.54 ' HB2' ' HG2' ' A' ' 415' ' ' GLU . 75.2 mmtt -94.43 148.87 21.8 Favored 'General case' 0 N--CA 1.411 -2.375 0 N-CA-C 106.862 -1.533 . . . . 62.33 106.862 178.848 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 384' ' ' ILE . . . . . 0.481 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -123.28 141.3 44.11 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-O 121.622 0.725 . . . . 74.53 110.968 -175.546 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 385' ' ' ARG . . . . . 0.425 ' HB3' ' HA ' ' A' ' 417' ' ' THR . 44.3 ttt180 -125.08 127.53 47.05 Favored 'General case' 0 N--CA 1.406 -2.632 0 N-CA-C 106.384 -1.709 . . . . 75.14 106.384 174.362 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 26.8 m -129.95 127.86 40.93 Favored 'General case' 0 C--N 1.276 -2.589 0 N-CA-C 108.97 -0.752 . . . . 62.22 108.97 -177.949 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -112.05 120.34 41.53 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.565 -0.531 . . . . 72.1 109.565 176.757 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -100.66 121.97 42.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.703 -0.851 . . . . 74.03 108.703 -179.007 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 389' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 421' ' ' SER . 44.5 mtmt -137.24 138.25 24.74 Favored Pre-proline 0 C--N 1.301 -1.509 0 C-N-CA 120.398 -0.521 . . . . 72.2 109.717 175.983 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -75.42 128.78 11.42 Favored 'Trans proline' 0 C--O 1.257 1.454 0 N-CA-C 107.972 -1.588 . . . . 63.43 107.972 172.54 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.446 ' OD1' HG22 ' A' ' 393' ' ' THR . 7.3 t70 -174.62 -172.67 0.67 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.086 -1.82 . . . . 73.41 106.086 -172.745 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 41.4 m -150.97 -2.6 0.34 Allowed 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 122.545 0.338 . . . . 73.52 111.605 175.832 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.446 HG22 ' OD1' ' A' ' 391' ' ' ASP . 10.7 t -105.91 -24.87 12.34 Favored 'General case' 0 C--O 1.244 0.764 0 O-C-N 121.696 -0.627 . . . . 65.5 109.898 -178.677 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.459 HG13 ' HB2' ' A' ' 421' ' ' SER . 49.1 pt -88.66 152.54 49.34 Favored Pre-proline 0 N--CA 1.439 -1.021 0 N-CA-C 107.805 -1.183 . . . . 63.5 107.805 176.525 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 395' ' ' PRO . . . . . 0.484 ' HB3' ' H ' ' A' ' 400' ' ' ILE . 21.7 Cg_exo -32.9 111.58 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 124.634 3.556 . . . . 73.44 116.398 179.616 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -56.48 166.86 3.14 Favored 'Trans proline' 0 C--O 1.221 -0.343 0 C-N-CA 124.943 3.762 . . . . 72.15 110.676 170.062 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 397' ' ' ASP . . . . . 0.485 ' HA ' ' CG2' ' A' ' 420' ' ' VAL . 4.6 p-10 -54.94 -8.58 0.27 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 112.684 0.624 . . . . 73.43 112.684 -178.947 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 63.1 m170 -98.01 106.16 18.41 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 103.319 -2.845 . . . . 70.44 103.319 166.59 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.5 HG23 ' HA ' ' A' ' 366' ' ' ARG . 18.6 m -63.08 118.43 5.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 O-C-N 124.185 0.928 . . . . 51.42 113.209 -166.608 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 400' ' ' ILE . . . . . 0.484 ' H ' ' HB3' ' A' ' 395' ' ' PRO . 41.7 mm -98.2 -27.47 3.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 114.575 -1.193 . . . . 73.2 109.881 179.837 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.42 157.14 27.25 Favored Glycine 0 N--CA 1.414 -2.777 0 C-N-CA 119.901 -1.142 . . . . 71.12 112.026 -176.683 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 4.7 p -148.08 -176.15 5.17 Favored 'General case' 0 C--N 1.284 -2.242 0 C-N-CA 126.253 1.821 . . . . 72.13 107.412 -175.36 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -99.82 137.26 20.14 Favored Pre-proline 0 C--N 1.299 -1.602 0 N-CA-C 107.894 -1.15 . . . . 64.01 107.894 176.337 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.27 -2.86 3.46 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.824 3.016 . . . . 72.32 113.36 -177.085 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -52.61 -35.28 54.17 Favored 'General case' 0 C--O 1.21 -1.013 0 C-N-CA 124.656 1.183 . . . . 62.2 111.165 176.964 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -68.35 -37.47 80.53 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 121.533 0.682 . . . . 74.32 110.211 178.157 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -82.69 -3.91 57.06 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.579 0.704 . . . . 75.02 109.452 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 32.0 m -93.55 152.5 18.99 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.398 -1.705 . . . . 42.31 106.398 176.506 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 13.2 p -77.37 111.57 13.18 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 108.554 -0.906 . . . . 74.24 108.554 176.907 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 28.8 m -127.51 169.16 19.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-O 121.095 0.474 . . . . 74.11 110.876 -179.524 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 3.4 m -78.69 146.74 33.82 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.961 -0.755 . . . . 61.14 108.961 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -71.51 109.91 5.77 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.015 0.435 . . . . 73.51 110.529 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 122.8 23.23 2.31 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 120.852 -0.69 . . . . 72.11 112.749 178.754 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -86.68 -173.77 4.65 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.642 -0.873 . . . . 70.04 108.642 177.639 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 415' ' ' GLU . . . . . 0.54 ' HG2' ' HB2' ' A' ' 383' ' ' LYS . 32.9 mt-10 -111.21 119.19 38.11 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.263 -0.643 . . . . 73.02 109.263 -175.896 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.1 mm -98.17 120.25 47.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-O 120.837 0.351 . . . . 72.31 110.091 -178.771 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 417' ' ' THR . . . . . 0.425 ' HA ' ' HB3' ' A' ' 385' ' ' ARG . 36.4 m -90.7 125.88 35.81 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.972 -0.558 . . . . 73.23 111.726 -178.599 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 4.3 p -116.55 134.82 58.8 Favored 'Isoleucine or valine' 0 C--O 1.255 1.384 0 N-CA-C 109.261 -0.644 . . . . 71.53 109.261 174.533 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -99.29 116.89 32.52 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.515 -1.661 . . . . 75.34 106.515 177.028 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.485 ' CG2' ' HA ' ' A' ' 397' ' ' ASP . 10.7 p -127.61 136.0 61.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 121.32 0.581 . . . . 73.04 110.608 -175.531 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 421' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 14.1 t -102.39 122.58 44.56 Favored 'General case' 0 N--CA 1.415 -2.223 0 C-N-CA 119.839 -0.744 . . . . 64.14 110.031 178.295 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 8.9 t -118.94 107.53 13.68 Favored 'General case' 0 N--CA 1.411 -2.377 0 CA-C-N 115.175 -0.92 . . . . 61.23 108.753 176.387 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.4 0 C-N-CA 120.871 -0.68 . . . . 43.42 111.923 -178.514 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 . . . . . 0 N--CA 1.424 -1.728 0 N-CA-C 109.674 -0.491 . . . . 61.51 109.674 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.509 ' HG3' ' O ' ' A' ' 447' ' ' ALA . 4.3 mmp_? -120.33 155.6 33.01 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 109.653 -0.499 . . . . 75.52 109.653 -178.574 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -91.66 137.37 32.42 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 115.086 -0.961 . . . . 61.5 110.101 -176.153 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 59.7 mt -96.12 118.67 65.48 Favored Pre-proline 0 N--CA 1.421 -1.88 0 N-CA-C 107.519 -1.289 . . . . 70.2 107.519 177.017 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -71.6 141.48 38.14 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 N-CA-C 108.125 -1.529 . . . . 75.34 108.125 171.08 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -80.13 134.46 36.17 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 118.229 -1.389 . . . . 72.21 108.592 178.575 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.439 HG11 ' HB2' ' A' ' 440' ' ' ALA . 8.9 p -101.23 161.99 3.49 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.374 0 N-CA-C 108.39 -0.967 . . . . 61.2 108.39 -172.332 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 26.7 m -75.68 158.02 32.88 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 107.33 -1.359 . . . . 75.33 107.33 174.64 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 434' ' ' THR . . . . . 0.448 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 74.3 p -67.99 -40.34 83.09 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.943 0.878 . . . . 75.21 111.32 -173.458 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.507 ' H ' HD23 ' A' ' 435' ' ' LEU . 0.6 OUTLIER -67.5 -28.78 68.12 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 113.784 1.031 . . . . 74.25 113.784 178.946 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.6 p -89.9 59.2 4.49 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 114.511 1.3 . . . . 62.13 114.511 -172.912 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -64.26 -37.86 88.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.115 -0.493 . . . . 74.24 111.364 177.294 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -62.43 -36.3 81.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.899 0.38 . . . . 72.24 110.457 178.795 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -67.51 -39.35 85.14 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.64 -0.504 . . . . 65.23 109.64 175.22 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.467 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.19 -50.38 73.89 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.969 -0.56 . . . . 74.14 110.924 -178.489 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.0 m -62.14 -40.77 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 111.935 0.346 . . . . 72.13 111.935 -179.178 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -36.41 80.03 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 120.366 -0.534 . . . . 71.51 112.3 178.455 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -63.22 -47.1 83.92 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 120.931 0.396 . . . . 72.11 110.384 177.008 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.467 HD13 ' O ' ' A' ' 440' ' ' ALA . 2.6 mp -63.68 -35.54 80.88 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.361 -0.836 . . . . 52.33 110.601 179.866 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 89.4 m -69.33 -45.8 68.61 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 116.172 -0.467 . . . . 61.44 110.488 177.162 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.13 -16.49 62.56 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 120.848 0.356 . . . . 74.31 111.88 -178.424 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 447' ' ' ALA . . . . . 0.509 ' O ' ' HG3' ' A' ' 427' ' ' ARG . . . -84.6 -4.66 59.11 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.177 -0.465 . . . . 62.21 111.488 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 117.66 -83.48 0.35 Allowed Glycine 0 CA--C 1.498 -1.017 0 C-N-CA 120.121 -1.038 . . . . 63.14 111.963 177.085 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -36.99 -63.52 0.42 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.374 1.249 . . . . 74.13 114.374 177.865 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 62.71 20.2 61.51 Favored Glycine 0 C--O 1.221 -0.668 0 CA-C-N 116.384 -0.371 . . . . 35.53 113.322 -178.776 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -96.97 110.43 22.97 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.079 -1.082 . . . . 65.54 108.079 -178.996 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.442 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 21.2 p90 -138.91 158.95 43.28 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 115.972 -0.558 . . . . 70.04 110.437 -177.453 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -144.98 148.23 33.54 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.447 -1.316 . . . . 75.41 107.447 179.177 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -119.05 127.36 53.34 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 117.877 0.308 . . . . 74.41 110.323 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -124.52 150.58 45.67 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.395 -0.965 . . . . 64.04 108.395 175.929 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -114.03 141.53 47.32 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.922 -0.399 . . . . 74.12 109.922 -177.201 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 23.2 t -138.37 137.59 20.9 Favored Pre-proline 0 C--N 1.307 -1.242 0 N-CA-C 108.898 -0.778 . . . . 74.12 108.898 176.285 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 490' ' ' SER . 8.0 Cg_exo -71.05 122.78 9.09 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 121.819 1.679 . . . . 62.12 111.36 177.19 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 49.5 m -147.09 179.88 7.31 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.09 -1.078 . . . . 74.52 108.09 -178.704 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.8 t -43.74 137.78 3.23 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 124.333 1.053 . . . . 52.2 113.193 179.64 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 461' ' ' PRO . . . . . 0.504 ' O ' HG12 ' A' ' 464' ' ' VAL . 9.3 Cg_endo -51.58 -28.84 30.25 Favored 'Trans proline' 0 C--N 1.363 1.298 0 C-N-CA 124.815 3.676 . . . . 65.33 113.963 -177.419 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.73 -18.6 63.53 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.315 0.579 . . . . 65.12 111.406 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 82.7 mt -102.73 6.62 39.55 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 116.176 -0.465 . . . . 63.22 112.02 -179.353 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 461' ' ' PRO . 14.8 p -61.54 127.35 21.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 119.491 -0.883 . . . . 65.22 109.406 176.716 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 78.85 -1.24 74.65 Favored Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 121.171 -0.538 . . . . 62.01 112.204 179.064 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -101.35 159.29 15.39 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 108.265 -1.013 . . . . 71.42 108.265 -178.552 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.448 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 75.1 t -80.54 140.9 15.99 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 CA-C-N 115.426 -0.806 . . . . 65.45 109.569 176.468 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 63.2 mt -98.28 -35.25 5.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 108.249 -1.019 . . . . 74.42 108.249 176.645 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 168.86 -177.4 42.71 Favored Glycine 0 N--CA 1.425 -2.064 0 C-N-CA 120.526 -0.845 . . . . 61.41 112.215 178.063 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 470' ' ' THR . . . . . 0.524 HG22 HG12 ' A' ' 486' ' ' ILE . 72.3 p -116.14 144.24 44.43 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.432 -1.692 . . . . 73.1 106.432 179.081 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.512 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 22.3 t-20 -64.31 -57.68 16.74 Favored Pre-proline 0 C--N 1.319 -0.724 0 C-N-CA 120.064 -0.654 . . . . 71.11 112.051 177.781 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 24.4 Cg_exo -73.25 139.92 29.95 Favored 'Trans proline' 0 C--N 1.361 1.188 0 N-CA-C 108.041 -1.561 . . . . 54.41 108.041 170.152 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.418 ' C ' ' H ' ' A' ' 475' ' ' ASN . 23.8 Cg_exo -62.59 128.1 22.55 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.373 2.048 . . . . 75.04 114.234 -173.474 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -83.84 18.58 1.95 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 122.431 1.11 . . . . 52.2 109.375 179.383 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 475' ' ' ASN . . . . . 0.418 ' H ' ' C ' ' A' ' 473' ' ' PRO . 15.5 m120 -111.88 -9.96 14.02 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.038 -1.437 . . . . 74.42 109.427 -179.427 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -119.75 -179.35 3.87 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-O 121.454 0.645 . . . . 75.41 112.564 -170.144 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.97 134.38 34.52 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.621 -1.251 . . . . 71.13 107.621 178.136 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 24.4 m -128.96 145.56 51.2 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.151 -0.685 . . . . 63.53 109.151 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -78.44 167.48 21.24 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 120.861 0.362 . . . . 61.12 111.862 -178.098 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 40.0 mm -71.43 -17.17 19.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.633 0.73 . . . . 75.01 110.272 -178.217 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 15.9 p -94.88 5.24 52.46 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.658 -0.651 . . . . 54.54 112.14 179.254 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -83.69 139.54 32.71 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.273 0.559 . . . . 65.03 112.194 -177.713 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 60.2 t -108.3 126.52 64.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 107.842 -1.17 . . . . 74.54 107.842 176.27 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.45 HG12 ' HG2' ' A' ' 472' ' ' PRO . 34.1 m -110.11 120.57 61.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-O 121.426 0.631 . . . . 74.0 111.158 178.823 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.75 129.1 44.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.219 -1.03 . . . . 74.13 108.219 174.187 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.524 HG12 HG22 ' A' ' 470' ' ' THR . 18.4 mt -113.06 128.26 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 CA-C-N 115.117 -0.947 . . . . 73.2 110.366 -177.438 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 4.9 tt -104.48 126.6 59.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-N 115.566 -0.743 . . . . 71.13 109.695 -178.984 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 34.2 m -111.96 151.74 13.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 115.523 -0.762 . . . . 32.01 109.571 179.275 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -90.23 144.53 17.59 Favored Glycine 0 N--CA 1.424 -2.131 0 C-N-CA 121.167 -0.539 . . . . 62.23 112.959 -176.961 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.541 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 23.2 t . . . . . 0 N--CA 1.42 -1.957 0 N-CA-C 106.192 -1.781 . . . . 53.11 106.192 174.176 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo . . . . . 0 C--O 1.248 0.983 0 N-CA-C 110.476 -0.625 . . . . 72.11 110.476 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -88.57 72.41 8.77 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.749 0.785 . . . . 55.52 111.371 -177.098 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 22.1 p -126.0 146.46 49.87 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.361 -0.836 . . . . 73.44 110.823 -178.671 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -138.14 146.35 42.69 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.498 -0.927 . . . . 73.54 108.498 178.84 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 13.7 t70 -99.59 111.66 23.97 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.424 -0.954 . . . . 72.44 108.424 -178.975 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 497' ' ' ILE . . . . . 0.569 HD13 ' O ' ' A' ' 543' ' ' THR . 0.2 OUTLIER -75.79 127.1 86.27 Favored Pre-proline 0 C--O 1.236 0.357 0 N-CA-C 113.797 1.036 . . . . 71.23 113.797 -174.114 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -94.98 151.23 1.71 Allowed 'Trans proline' 0 CA--C 1.55 1.314 0 C-N-CA 123.111 2.54 . . . . 64.43 110.84 171.178 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 499' ' ' ASP . . . . . 0.441 ' HB3' ' HB2' ' A' ' 541' ' ' ALA . 7.3 p-10 -89.94 129.94 36.22 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.382 0.611 . . . . 53.14 110.323 -179.088 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.79 81.7 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-O 122.806 1.289 . . . . 73.1 109.533 177.268 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -97.44 145.78 25.85 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 113.814 -1.539 . . . . 64.13 108.885 -177.656 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 111.47 44.39 0.91 Allowed Glycine 0 CA--C 1.476 -2.378 0 N-CA-C 109.27 -1.532 . . . . 44.34 109.27 -177.082 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -141.22 167.05 23.11 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 108.826 -0.805 . . . . 65.33 108.826 -177.161 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 13.2 t -91.41 161.84 14.83 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 108.061 -1.088 . . . . 70.24 108.061 176.694 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 31.2 m -51.44 -42.07 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.668 0 C-N-CA 124.49 1.116 . . . . 72.24 113.396 -174.943 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -68.16 -41.8 81.02 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.253 0.549 . . . . 64.04 111.04 -177.444 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 51.7 t -72.66 -36.53 53.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.365 -0.834 . . . . 62.43 110.46 -176.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -62.51 -48.48 79.37 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.611 -0.268 . . . . 72.01 110.696 178.403 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -60.18 -41.77 93.61 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.298 0.571 . . . . 75.13 109.758 178.746 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.407 ' O ' HG23 ' A' ' 514' ' ' VAL . 0.6 OUTLIER -61.5 -43.19 99.3 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.546 -1.206 . . . . 70.23 110.173 -177.852 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -62.4 -42.91 99.79 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 116.438 -0.347 . . . . 74.1 111.281 179.416 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.31 -40.9 97.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.54 -0.3 . . . . 73.4 110.504 177.805 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -61.83 -43.02 99.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.965 0.412 . . . . 75.15 110.161 178.173 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 510' ' ' LYS . 93.7 t -67.1 -26.34 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-N 115.656 -0.702 . . . . 74.33 111.583 178.575 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -76.17 -25.38 55.18 Favored 'General case' 0 CA--C 1.514 -0.416 0 O-C-N 121.666 -0.646 . . . . 71.22 109.908 177.547 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 111.87 36.35 1.7 Allowed Glycine 0 N--CA 1.436 -1.359 0 C-N-CA 120.822 -0.704 . . . . 73.25 111.944 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -120.34 122.82 41.66 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 107.484 -1.302 . . . . 73.33 107.484 178.441 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.6 m -101.81 -18.17 15.89 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 115.831 -0.622 . . . . 73.53 110.628 -175.629 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -113.61 113.22 24.75 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.82 0.819 . . . . 70.11 110.907 -179.394 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -132.28 155.94 47.43 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.379 -1.282 . . . . 64.04 110.155 -177.611 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 48.8 m -141.34 138.84 33.37 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 108.122 -1.066 . . . . 72.45 108.122 173.246 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.09 119.57 35.16 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.644 0.735 . . . . 63.21 112.15 179.733 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -107.15 118.86 37.83 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.258 -0.883 . . . . 71.24 109.726 -178.255 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 67.4 m -84.54 123.01 29.82 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.087 -0.709 . . . . 53.24 109.087 176.023 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 32.7 m -121.4 150.98 24.55 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 N-CA-C 107.554 -1.276 . . . . 72.1 107.554 -179.663 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 526' ' ' ASP . . . . . 0.408 ' HB2' HD21 ' A' ' 559' ' ' ASN . 0.2 OUTLIER -90.53 137.54 32.27 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.58 -1.248 . . . . 61.21 109.981 -177.374 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 69.0 m -155.96 -176.12 0.58 Allowed Pre-proline 0 C--N 1.304 -1.413 0 N-CA-C 107.445 -1.317 . . . . 74.41 107.445 -176.934 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -73.45 -28.21 12.39 Favored 'Trans proline' 0 C--N 1.36 1.148 0 CA-C-N 120.941 1.372 . . . . 74.12 111.739 173.396 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -64.84 137.14 97.05 Favored Pre-proline 0 N--CA 1.475 0.812 0 CA-C-N 116.405 -0.362 . . . . 64.11 111.813 -178.834 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.58 151.9 43.91 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 124.032 3.155 . . . . 72.04 114.965 -173.318 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.59 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -69.35 107.97 3.52 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 115.047 -0.978 . . . . 35.24 110.875 -178.496 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 128.69 -10.87 6.35 Favored Glycine 0 C--N 1.292 -1.899 0 N-CA-C 110.393 -1.083 . . . . 63.24 110.393 -178.714 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -82.52 125.02 30.65 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 109.238 -0.653 . . . . 75.32 109.238 176.891 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 62.0 t -87.8 107.53 17.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 106.788 -1.56 . . . . 62.44 106.788 175.499 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 6.1 t -83.87 -8.7 59.13 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.631 -0.713 . . . . 74.22 111.336 -172.056 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.16 -155.5 26.46 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 120.693 -0.765 . . . . 64.53 111.299 177.448 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 537' ' ' THR . . . . . 0.458 HG22 HD23 ' A' ' 553' ' ' LEU . 24.6 p -122.99 159.43 28.37 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 109.348 -0.612 . . . . 63.35 109.348 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -72.97 -53.05 5.33 Favored Pre-proline 0 C--N 1.306 -1.292 0 CA-C-O 118.876 -0.583 . . . . 64.54 110.578 174.062 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -61.57 128.09 23.68 Favored 'Trans proline' 0 C--N 1.378 2.084 0 N-CA-C 109.008 -1.189 . . . . 71.33 109.008 170.578 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -64.65 141.44 72.8 Favored 'Trans proline' 0 C--O 1.253 1.259 0 C-N-CA 122.177 1.918 . . . . 74.1 112.599 -177.656 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 541' ' ' ALA . . . . . 0.441 ' HB2' ' HB3' ' A' ' 499' ' ' ASP . . . -67.65 139.74 56.82 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 108.13 -1.063 . . . . 73.3 108.13 175.639 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.82 -5.0 39.54 Favored Glycine 0 N--CA 1.416 -2.668 0 N-CA-C 110.313 -1.115 . . . . 23.23 110.313 -175.513 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.569 ' O ' HD13 ' A' ' 497' ' ' ILE . 27.2 m -88.85 136.61 32.92 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 120.49 -0.484 . . . . 63.25 109.767 177.275 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 28.9 m -89.82 122.84 33.26 Favored 'General case' 0 N--CA 1.416 -2.147 0 N-CA-C 107.148 -1.427 . . . . 63.45 107.148 172.276 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.4 m -127.01 154.54 76.5 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 110.222 -0.288 . . . . 54.32 110.222 -177.453 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -68.84 151.88 73.98 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.305 2.003 . . . . 64.12 110.113 173.136 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 26.3 m -67.32 -20.28 26.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.724 0.773 . . . . 53.22 110.063 177.836 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -77.56 -11.4 59.85 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 114.94 -1.027 . . . . 72.22 112.258 -179.454 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 49.0 m -78.72 154.65 29.89 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 121.863 -0.523 . . . . 51.31 111.021 178.908 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 41.7 t -97.72 116.04 39.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 108.679 -0.859 . . . . 72.33 108.679 179.434 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.42 126.61 40.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.171 -0.677 . . . . 74.41 109.171 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -102.43 115.78 31.27 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-O 121.775 0.798 . . . . 62.11 109.636 -178.585 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 553' ' ' LEU . . . . . 0.458 HD23 HG22 ' A' ' 537' ' ' THR . 67.3 mt -87.65 134.25 33.68 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 113.856 -1.52 . . . . 75.51 107.551 178.096 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -112.32 115.36 28.63 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 122.257 1.027 . . . . 73.04 110.137 178.569 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 41.7 t -101.15 139.45 22.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 CA-C-N 114.441 -1.254 . . . . 75.02 108.446 -176.16 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.59 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 50.6 m -92.46 147.29 23.02 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-O 121.413 0.625 . . . . 54.11 112.093 179.786 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 0.2 OUTLIER -118.58 132.49 56.2 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 105.247 -2.131 . . . . 75.0 105.247 170.772 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -82.47 -24.1 54.78 Favored Glycine 0 CA--C 1.492 -1.371 0 N-CA-C 114.638 0.615 . . . . 72.12 114.638 -169.017 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 559' ' ' ASN . . . . . 0.408 HD21 ' HB2' ' A' ' 526' ' ' ASP . 43.8 m-80 68.13 31.81 5.19 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 107.548 -1.278 . . . . 60.45 107.548 -174.362 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 -135.11 141.72 46.08 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 106.281 -1.748 . . . . 73.34 106.281 -175.803 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -143.09 147.66 35.38 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 109.731 -0.47 . . . . 72.41 109.731 176.785 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 562' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 612' ' ' THR . 63.1 t -67.99 118.37 11.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-O 121.149 0.5 . . . . 75.15 110.303 -179.34 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 563' ' ' MET . . . . . 0.408 ' HG2' ' O ' ' A' ' 564' ' ' PRO . 53.7 ttp -83.15 132.96 48.85 Favored Pre-proline 0 C--N 1.306 -1.293 0 CA-C-N 115.759 -0.655 . . . . 74.42 111.251 -177.553 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 564' ' ' PRO . . . . . 0.408 ' O ' ' HG2' ' A' ' 563' ' ' MET . 61.1 Cg_endo -74.29 170.14 20.87 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.048 2.498 . . . . 73.12 110.597 172.69 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -67.17 142.44 57.02 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.913 0.387 . . . . 74.43 110.905 179.529 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 94.0 mt -121.56 17.56 11.25 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.745 -0.661 . . . . 74.31 109.593 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 11.3 m -63.04 130.5 44.98 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.314 -0.857 . . . . 74.35 109.851 -179.785 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 88.43 46.2 4.72 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 119.916 -1.135 . . . . 54.04 112.197 177.427 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 26.8 ptm -118.71 157.72 26.92 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.162 -1.051 . . . . 71.22 108.162 176.401 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 570' ' ' PHE . . . . . 0.477 ' H ' ' HB3' ' A' ' 573' ' ' ASP . 91.9 m-85 -130.81 163.68 26.82 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.608 -1.256 . . . . 73.25 107.608 -176.502 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 35.8 t90 -65.44 -36.54 84.22 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.41 0.624 . . . . 74.12 109.612 176.803 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.7 m -75.58 -8.88 12.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.363 -0.835 . . . . 74.0 110.433 -178.811 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 573' ' ' ASP . . . . . 0.498 ' O ' ' HB2' ' A' ' 577' ' ' ARG . 13.7 t70 -101.21 -37.32 8.59 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.97 -1.013 . . . . 75.42 109.287 178.217 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -61.47 -34.71 75.92 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 124.314 1.046 . . . . 60.41 111.892 -179.404 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.476 ' HB2' ' HD3' ' A' ' 576' ' ' PRO . 9.3 mm-40 -60.1 -58.83 16.53 Favored Pre-proline 0 CA--C 1.559 1.291 0 N-CA-C 112.672 0.619 . . . . 34.34 112.672 177.241 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 576' ' ' PRO . . . . . 0.476 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 51.0 Cg_exo -61.59 -35.1 83.04 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 121.57 1.513 . . . . 64.24 111.782 171.887 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 573' ' ' ASP . 0.4 OUTLIER -59.54 -40.59 87.72 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.039 0.535 . . . . 73.42 110.394 -178.106 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 7.1 tt -57.63 -47.37 82.41 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.702 0.801 . . . . 75.13 109.237 179.666 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -66.63 -46.93 74.23 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.563 -0.744 . . . . 74.25 110.248 -178.65 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -62.79 -39.03 92.97 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.749 0.82 . . . . 75.01 112.803 -177.517 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 96.4 mt -89.45 -8.57 52.69 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 120.719 -0.392 . . . . 73.21 111.457 -179.029 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 63.52 43.38 98.19 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 109.679 -1.369 . . . . 50.44 109.679 -175.503 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 22.1 t90 -73.75 126.63 30.79 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 114.845 -0.677 . . . . 72.34 111.14 -172.389 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 24.0 m -99.86 -8.07 24.54 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.575 0.702 . . . . 63.33 109.749 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 585' ' ' GLY . . . . . 0.43 ' HA2' ' OD1' ' A' ' 617' ' ' ASP . . . -69.14 170.35 41.52 Favored Glycine 0 N--CA 1.428 -1.874 0 CA-C-N 115.127 -0.942 . . . . 74.45 113.804 -177.129 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 36.1 ttm -105.48 135.14 47.42 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.101 -1.05 . . . . 71.43 109.997 -177.12 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 56.7 tp -88.59 131.13 35.09 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.51 -0.922 . . . . 73.1 108.51 175.974 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -94.37 104.78 16.76 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.002 0.429 . . . . 72.3 110.797 -176.302 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -114.24 112.41 23.09 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 109.415 -0.587 . . . . 74.41 109.415 174.182 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -127.48 -40.76 0.31 Allowed Glycine 0 C--N 1.309 -0.97 0 C-N-CA 119.435 -1.364 . . . . 63.3 112.943 177.711 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 591' ' ' ALA . . . . . 0.484 ' HB3' ' NH2' ' A' ' 623' ' ' ARG . . . -139.58 157.5 45.7 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 122.577 0.351 . . . . 53.21 110.643 -177.788 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -110.39 124.26 51.39 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.457 -1.312 . . . . 71.34 107.457 176.422 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 35.9 t -109.02 115.89 50.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 C-N-CA 120.063 -0.655 . . . . 65.11 110.365 -176.85 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -100.03 116.78 32.86 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.995 -0.682 . . . . 64.03 110.425 179.658 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -132.69 -27.94 1.66 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 116.092 -0.504 . . . . 64.4 110.898 179.494 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 141.24 -169.41 25.05 Favored Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 110.494 -1.042 . . . . 53.33 110.494 -177.865 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.53 -35.18 65.58 Favored Glycine 0 CA--C 1.509 -0.307 0 O-C-N 123.877 0.398 . . . . 61.34 113.851 -175.877 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 42.6 m -58.68 -32.3 68.99 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.102 0.408 . . . . 63.13 112.102 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -108.61 -1.59 19.46 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.071 0.462 . . . . 75.44 110.651 -178.095 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -67.1 99.72 0.7 Allowed 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.211 -0.45 . . . . 75.44 112.051 -175.611 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 601' ' ' ASN . . . . . 0.458 ' OD1' ' HB3' ' A' ' 570' ' ' PHE . 11.7 t-20 67.15 -3.25 1.02 Allowed 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 125.251 1.42 . . . . 62.31 112.367 174.384 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -93.18 152.93 18.93 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 123.963 0.905 . . . . 75.15 111.326 -175.186 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 603' ' ' VAL . . . . . 0.477 HG23 ' HB2' ' A' ' 622' ' ' LEU . 12.9 p -57.06 138.76 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 124.554 1.142 . . . . 70.3 110.697 178.631 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 61.0 t -93.97 -56.12 5.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 108.118 -1.068 . . . . 74.43 108.118 179.119 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -151.42 154.62 36.98 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 107.78 -1.193 . . . . 62.0 107.78 -179.59 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 606' ' ' GLN . . . . . 0.413 ' HB2' HD11 ' A' ' 620' ' ' ILE . 16.7 pt20 -109.06 122.1 46.55 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.038 -1.467 . . . . 73.44 107.038 172.744 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.557 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 42.7 t-20 -53.21 -57.95 14.52 Favored Pre-proline 0 N--CA 1.483 1.189 0 CA-C-O 119.31 -0.376 . . . . 61.11 111.926 -178.659 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.557 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 1.2 Cg_endo -85.7 131.33 3.9 Favored 'Trans proline' 0 N--CA 1.44 -1.635 0 C-N-CA 121.262 1.308 . . . . 71.1 109.947 174.999 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 609' ' ' PRO . . . . . 0.493 ' O ' HG22 ' A' ' 612' ' ' THR . 53.2 Cg_endo -70.38 156.22 62.2 Favored 'Trans proline' 0 C--O 1.243 0.739 0 C-N-CA 122.069 1.846 . . . . 72.41 111.541 178.625 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -64.41 128.33 35.33 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.371 -0.603 . . . . 74.11 109.371 178.98 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 106.02 -3.57 38.38 Favored Glycine 0 C--N 1.3 -1.432 0 C-N-CA 120.394 -0.908 . . . . 22.23 112.92 -177.983 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 612' ' ' THR . . . . . 0.493 HG22 ' O ' ' A' ' 609' ' ' PRO . 9.1 t -96.17 176.88 5.91 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-N 117.858 0.829 . . . . 73.15 109.111 175.504 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -97.87 119.47 6.44 Favored Glycine 0 N--CA 1.425 -2.082 0 CA-C-N 116.194 -0.457 . . . . 62.14 112.041 -177.075 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 26.8 m -104.95 144.3 14.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 C-N-CA 123.479 0.712 . . . . 73.55 109.523 177.86 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.557 ' ND2' ' HB3' ' A' ' 617' ' ' ASP . 36.6 p-10 -57.8 161.13 4.0 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 123.684 0.794 . . . . 74.32 111.968 -178.074 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -63.21 -25.9 68.55 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 120.82 0.343 . . . . 63.54 111.218 -178.015 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 617' ' ' ASP . . . . . 0.557 ' HB3' ' ND2' ' A' ' 615' ' ' ASN . 13.9 t70 -60.08 -40.05 88.21 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.667 -0.864 . . . . 74.44 108.667 174.308 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 87.96 20.98 48.14 Favored Glycine 0 N--CA 1.428 -1.885 0 CA-C-N 115.408 -0.814 . . . . 70.33 112.115 176.87 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 619' ' ' ILE . . . . . 0.425 ' HB ' ' OD1' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -69.24 119.28 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-O 122.762 1.268 . . . . 72.03 109.883 -173.523 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.413 HD11 ' HB2' ' A' ' 606' ' ' GLN . 3.2 tp -117.55 125.69 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.939 0 CA-C-N 113.422 -1.717 . . . . 74.22 107.714 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 17.5 m -98.26 116.39 30.39 Favored 'General case' 0 N--CA 1.412 -2.367 0 C-N-CA 118.877 -1.129 . . . . 74.51 108.097 178.436 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 622' ' ' LEU . . . . . 0.477 ' HB2' HG23 ' A' ' 603' ' ' VAL . 0.0 OUTLIER -139.64 155.4 47.43 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 106.961 -1.496 . . . . 62.35 106.961 179.653 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 623' ' ' ARG . . . . . 0.484 ' NH2' ' HB3' ' A' ' 591' ' ' ALA . 57.2 mtp180 -128.74 156.63 43.21 Favored 'General case' 0 C--N 1.272 -2.782 0 N-CA-C 105.271 -2.122 . . . . 70.24 105.271 175.186 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -131.14 158.05 41.5 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 106.637 -1.616 . . . . 73.33 106.637 175.184 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -81.88 -117.32 0.47 Allowed Glycine 0 N--CA 1.423 -2.181 0 C-N-CA 120.073 -1.06 . . . . 74.53 113.414 -177.252 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 . . . . . 0 C--N 1.297 -1.709 0 N-CA-C 108.886 -0.783 . . . . 73.15 108.886 -174.134 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 . . . . . 0 CA--C 1.502 -0.886 0 N-CA-C 109.412 -0.588 . . . . 71.12 109.412 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 34.6 m -121.22 153.93 24.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 N-CA-C 107.019 -1.474 . . . . 40.22 107.019 177.869 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -94.56 136.2 35.13 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 117.578 -1.649 . . . . 74.23 107.284 179.274 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 98.1 t -96.8 124.24 50.91 Favored Pre-proline 0 C--N 1.274 -2.704 0 N-CA-C 109.666 -0.494 . . . . 73.42 109.666 -172.912 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -64.12 125.87 16.06 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.935 1.757 . . . . 74.21 110.058 178.802 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 364' ' ' ASP . . . . . 0.571 ' OD1' ' HG2' ' A' ' 366' ' ' ARG . 16.5 t70 -85.69 138.36 32.18 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-O 121.726 0.774 . . . . 73.34 112.044 -176.608 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 18.5 m -108.22 4.93 9.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 113.981 -1.463 . . . . 60.05 111.777 -175.421 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.571 ' HG2' ' OD1' ' A' ' 364' ' ' ASP . 25.7 mmt-85 -62.54 147.48 48.87 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 112.624 0.602 . . . . 64.22 112.624 178.568 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.64 -9.59 44.7 Favored Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 110.709 -0.957 . . . . 74.34 110.709 -174.624 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -103.75 -150.68 0.42 Allowed 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.481 -0.933 . . . . 71.02 108.481 178.767 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 60.3 p -98.05 155.04 17.31 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.464 -0.939 . . . . 73.21 108.464 -178.162 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 23.0 t -61.42 -33.79 74.3 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.587 -0.523 . . . . 70.24 109.587 179.104 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -65.59 -46.46 79.3 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 116.24 -0.436 . . . . 73.35 111.138 178.76 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.54 -44.87 73.6 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-O 121.426 0.632 . . . . 61.1 110.376 -179.505 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -60.21 -48.11 83.13 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.582 -1.19 . . . . 40.43 111.567 -178.23 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.53 -39.31 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 116.644 -0.253 . . . . 52.11 111.27 177.721 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.9 -44.48 91.24 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-O 121.302 0.572 . . . . 74.3 111.112 -178.994 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 376' ' ' THR . . . . . 0.443 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 70.9 m -64.18 -47.34 80.19 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.438 -0.801 . . . . 64.25 110.648 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 95.5 mt -64.16 -38.79 92.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.474 -0.33 . . . . 74.14 111.169 -179.265 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 63.6 tp60 -62.29 -43.02 99.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.981 -0.554 . . . . 73.54 110.787 179.053 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -64.19 -31.86 73.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.274 0.559 . . . . 74.25 111.279 176.97 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 380' ' ' ARG . . . . . 0.443 ' HG2' ' O ' ' A' ' 376' ' ' THR . 29.8 mmm180 -80.11 -13.55 59.19 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.989 -0.55 . . . . 65.33 111.388 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 94.06 15.65 47.55 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.65 -0.786 . . . . 52.12 112.578 177.335 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -80.39 156.54 26.62 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 122.451 -0.441 . . . . 74.21 111.266 177.248 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -99.76 133.81 43.57 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 107.129 -1.434 . . . . 34.22 107.129 177.924 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 384' ' ' ILE . . . . . 0.491 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -127.33 155.1 38.32 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 C-N-CA 120.1 -0.64 . . . . 72.11 111.124 -175.404 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 385' ' ' ARG . . . . . 0.412 ' HB3' HG22 ' A' ' 417' ' ' THR . 7.7 tpt180 -136.08 141.28 44.22 Favored 'General case' 0 N--CA 1.403 -2.817 0 CA-C-N 114.571 -1.195 . . . . 74.31 108.011 169.763 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.2 m -127.22 134.9 50.04 Favored 'General case' 0 C--N 1.271 -2.846 0 N-CA-C 104.55 -2.389 . . . . 61.11 104.55 179.634 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.57 124.34 45.09 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 119.317 -0.953 . . . . 62.25 109.201 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -91.34 121.79 33.39 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.086 -0.709 . . . . 74.1 109.086 -177.306 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 389' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 421' ' ' SER . 55.0 mtpt -136.79 130.32 17.68 Favored Pre-proline 0 C--N 1.308 -1.22 0 N-CA-C 110.215 -0.291 . . . . 73.41 110.215 176.352 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 390' ' ' PRO . . . . . 0.528 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 54.0 Cg_endo -79.4 127.95 7.69 Favored 'Trans proline' 0 C--O 1.254 1.324 0 C-N-CA 120.956 1.104 . . . . 53.31 109.836 173.823 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.528 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 8.6 t70 154.33 -164.92 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 103.802 -2.666 . . . . 71.33 103.802 -177.649 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 26.7 t -142.7 4.7 1.53 Allowed 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 118.098 0.408 . . . . 60.21 110.187 176.512 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 15.3 t -79.62 -18.13 52.24 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-O 121.338 0.589 . . . . 54.24 109.781 179.661 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.616 HD13 ' H ' ' A' ' 394' ' ' ILE . 0.2 OUTLIER -99.58 150.43 36.78 Favored Pre-proline 0 N--CA 1.424 -1.743 0 N-CA-C 107.012 -1.477 . . . . 74.32 107.012 176.704 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 395' ' ' PRO . . . . . 0.427 ' HA ' ' HD2' ' A' ' 396' ' ' PRO . 77.8 Cg_exo -49.72 132.89 32.08 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.139 2.559 . . . . 65.53 114.228 -177.556 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 396' ' ' PRO . . . . . 0.574 ' HA ' ' OG ' ' A' ' 421' ' ' SER . 17.5 Cg_endo -60.75 164.03 14.58 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.595 2.863 . . . . 72.45 110.832 174.302 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 397' ' ' ASP . . . . . 0.425 ' HA ' HG13 ' A' ' 420' ' ' VAL . 0.9 OUTLIER -57.51 -8.91 0.93 Allowed 'General case' 0 N--CA 1.511 2.583 0 CA-C-O 121.915 0.864 . . . . 72.31 111.012 179.023 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -93.57 101.23 13.4 Favored 'General case' 0 CA--C 1.477 -1.841 0 N-CA-C 102.398 -3.186 . . . . 74.42 102.398 170.205 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 16.5 m -63.32 118.19 5.15 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.488 0 O-C-N 124.197 0.936 . . . . 64.52 112.491 -166.662 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 49.3 mm -103.61 -39.3 5.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 115.259 -0.882 . . . . 73.03 111.08 -177.34 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.41 157.32 27.35 Favored Glycine 0 N--CA 1.433 -1.54 0 C-N-CA 119.739 -1.219 . . . . 35.55 112.627 -175.51 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -156.31 -174.98 5.19 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 126.062 1.745 . . . . 73.52 109.797 -176.261 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 403' ' ' ASP . . . . . 0.424 ' C ' ' H ' ' A' ' 405' ' ' ALA . 10.7 t70 -96.96 136.15 21.7 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 105.942 -1.873 . . . . 74.42 105.942 176.252 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 404' ' ' PRO . . . . . 0.507 ' HA ' ' OD1' ' A' ' 407' ' ' ASN . 38.0 Cg_endo -63.01 23.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 124.823 3.682 . . . . 74.12 115.622 -173.092 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.424 ' H ' ' C ' ' A' ' 403' ' ' ASP . . . -54.01 -42.16 68.79 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 124.075 0.95 . . . . 72.1 110.92 177.569 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -79.24 -31.1 43.46 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.593 0.711 . . . . 73.5 110.516 -179.666 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 407' ' ' ASN . . . . . 0.507 ' OD1' ' HA ' ' A' ' 404' ' ' PRO . 8.9 m120 -79.68 -7.75 58.78 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.354 -0.839 . . . . 73.32 110.194 -175.782 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 89.9 m -99.42 148.71 23.93 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.564 -1.643 . . . . 74.25 106.564 176.623 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 17.3 m -74.45 111.89 10.09 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 107.814 -1.18 . . . . 62.32 107.814 177.445 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.36 169.86 20.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 C-N-CA 123.089 0.556 . . . . 61.42 110.262 -177.773 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 49.7 m -68.49 131.9 46.07 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.447 -0.946 . . . . 73.41 108.447 174.303 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -58.51 111.07 1.11 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.334 0.588 . . . . 64.02 110.683 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 111.1 73.81 0.72 Allowed Glycine 0 N--CA 1.432 -1.577 0 N-CA-C 110.58 -1.008 . . . . 65.21 110.58 -179.526 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -129.44 -175.0 3.44 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 105.853 -1.906 . . . . 34.3 105.853 179.935 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -102.76 123.45 46.45 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 118.401 0.546 . . . . 73.51 110.545 -177.02 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 27.1 mm -113.12 120.69 63.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 109.043 -0.725 . . . . 53.14 109.043 -179.746 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 417' ' ' THR . . . . . 0.412 HG22 ' HB3' ' A' ' 385' ' ' ARG . 17.1 p -100.62 131.44 46.53 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 112.006 0.373 . . . . 72.31 112.006 -178.488 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 7.7 p -126.81 134.91 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-O 120.892 0.377 . . . . 65.43 110.846 176.279 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -101.6 128.46 47.87 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.816 -1.179 . . . . 73.41 107.816 175.201 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.425 HG13 ' HA ' ' A' ' 397' ' ' ASP . 54.0 t -124.55 135.92 62.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 C-N-CA 122.999 0.52 . . . . 73.01 110.352 -175.491 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 421' ' ' SER . . . . . 0.574 ' OG ' ' HA ' ' A' ' 396' ' ' PRO . 77.7 p -84.9 121.12 27.29 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 109.086 -0.709 . . . . 61.13 109.086 177.897 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 33.8 m -118.69 106.2 12.35 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 109.07 -0.715 . . . . 60.32 109.07 177.95 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.045 0 C-N-CA 120.6 -0.81 . . . . 72.15 111.687 -178.514 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 . . . . . 0 N--CA 1.431 -1.386 0 N-CA-C 108.036 -1.098 . . . . 72.22 108.036 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -121.08 143.03 49.29 Favored 'General case' 0 CA--C 1.479 -1.779 0 CA-C-O 121.367 0.603 . . . . 71.13 112.145 -173.694 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -82.96 134.71 35.05 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.271 -1.331 . . . . 75.45 108.755 178.999 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 474' ' ' ALA . 50.2 mt -83.02 125.96 73.67 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 109.144 -0.688 . . . . 71.23 109.144 -179.45 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -71.03 154.68 62.57 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.426 2.084 . . . . 74.24 110.905 173.077 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -74.07 158.86 33.51 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 108.986 -0.746 . . . . 74.42 108.986 178.068 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 12.2 p -142.4 147.05 21.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 109.949 -0.389 . . . . 64.03 109.949 -178.447 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 19.5 m -72.84 137.01 45.45 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 108.65 -0.87 . . . . 65.33 108.65 175.806 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 54.4 p -62.44 -31.19 71.86 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 113.822 1.045 . . . . 72.41 113.822 -171.349 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.4 pp -81.67 -11.5 59.05 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.224 -0.99 . . . . 63.13 111.382 179.11 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 5.5 m -105.41 62.68 0.68 Allowed 'General case' 0 N--CA 1.432 -1.341 0 CA-C-O 122.191 0.996 . . . . 70.43 112.0 -176.21 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -56.12 -37.1 68.99 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.593 1.157 . . . . 73.54 111.397 176.25 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.33 -40.61 78.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.124 0.488 . . . . 64.32 111.016 178.077 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -70.28 -34.97 73.4 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.308 -0.627 . . . . 73.44 109.308 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.555 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -60.8 -51.39 69.52 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.74 -0.664 . . . . 62.31 111.345 179.15 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 35.4 m -65.47 -39.11 84.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 112.31 0.485 . . . . 74.0 112.31 -177.802 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -34.76 77.41 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 120.607 -0.437 . . . . 72.21 111.572 178.111 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 27.3 mmtm -61.76 -39.81 92.95 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-N 116.4 -0.363 . . . . 75.42 110.452 177.427 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 75.5 mt -63.88 -43.25 96.6 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.369 -0.832 . . . . 52.31 110.073 179.252 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 61.1 m -65.35 -42.68 92.57 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.362 -0.381 . . . . 74.22 111.646 177.946 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -63.35 -29.25 70.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.708 0.766 . . . . 71.23 110.611 178.455 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -85.02 5.22 30.28 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.454 -0.794 . . . . 42.02 111.889 179.194 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 105.48 -66.5 0.27 Allowed Glycine 0 CA--C 1.496 -1.142 0 C-N-CA 120.374 -0.917 . . . . 42.2 112.96 172.749 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -46.65 -65.88 0.49 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 114.353 1.242 . . . . 73.05 114.353 177.767 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 59.09 26.22 60.83 Favored Glycine 0 N--CA 1.469 0.887 0 C-N-CA 120.948 -0.644 . . . . 73.32 112.65 -176.005 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.581 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 16.3 mmt85 -100.73 111.37 23.59 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 107.148 -1.427 . . . . 75.41 107.148 -177.221 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -140.2 153.44 46.59 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 112.487 0.551 . . . . 70.21 112.487 -174.247 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 453' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' A' ' 453' ' ' LYS . 72.0 mmtt -138.81 148.53 43.9 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 124.77 1.228 . . . . 51.14 108.996 176.814 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -121.1 124.94 45.99 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 122.967 0.507 . . . . 74.22 110.609 -176.808 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -128.19 162.79 26.13 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.016 -0.735 . . . . 71.25 109.016 178.05 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -129.11 146.76 50.98 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 120.969 0.414 . . . . 33.24 110.072 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 36.8 t -143.47 149.14 46.52 Favored Pre-proline 0 C--N 1.29 -1.985 0 N-CA-C 107.453 -1.314 . . . . 34.22 107.453 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.716 ' HA ' ' O ' ' A' ' 490' ' ' SER . 24.3 Cg_exo -64.83 134.77 41.74 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.874 1.716 . . . . 61.54 109.722 176.545 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 62.6 m -152.07 172.17 16.73 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 116.181 -0.463 . . . . 63.02 109.855 -178.191 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 7.0 t -53.78 141.46 46.79 Favored Pre-proline 0 N--CA 1.438 -1.043 0 C-N-CA 124.487 1.115 . . . . 70.54 111.072 177.22 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -52.72 -30.67 47.34 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 124.698 3.598 . . . . 74.5 113.342 -176.302 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -72.97 -28.63 62.51 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.958 -0.565 . . . . 50.43 111.791 -178.812 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 11.2 mp -98.57 -0.61 42.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.592 0.234 . . . . 63.32 111.555 178.736 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 53.3 t -61.69 126.65 20.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-O 121.035 0.445 . . . . 75.03 109.92 175.229 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 87.58 0.21 84.44 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.711 -0.677 . . . . 64.34 111.75 -178.738 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.32 158.95 17.87 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.861 -0.792 . . . . 72.23 108.861 179.363 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 70.2 t -75.19 138.78 20.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 N-CA-C 108.728 -0.842 . . . . 53.42 108.728 176.382 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 48.9 mm -97.26 -27.86 3.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.395 -1.335 . . . . 73.21 107.395 179.062 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 156.57 -168.79 33.82 Favored Glycine 0 N--CA 1.422 -2.272 0 CA-C-N 115.209 -0.905 . . . . 62.34 112.052 175.472 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 470' ' ' THR . . . . . 0.701 HG22 HG12 ' A' ' 486' ' ' ILE . 39.7 p -115.64 147.2 41.08 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 104.905 -2.258 . . . . 73.21 104.905 177.375 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.429 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 9.8 t30 -68.38 -55.13 12.84 Favored Pre-proline 0 C--N 1.31 -1.12 0 C-N-CA 118.542 -1.263 . . . . 54.53 111.815 176.394 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.429 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 23.9 Cg_exo -70.01 155.42 65.16 Favored 'Trans proline' 0 C--N 1.371 1.725 0 N-CA-C 108.769 -1.281 . . . . 71.13 108.769 172.428 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -62.27 126.66 19.07 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 121.82 1.68 . . . . 73.11 112.123 -176.687 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.421 ' O ' ' HB ' ' A' ' 429' ' ' ILE . . . -84.7 -2.08 57.06 Favored 'General case' 0 C--O 1.204 -1.322 0 CA-C-N 115.437 -0.801 . . . . 73.22 112.068 -174.491 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -110.71 6.37 21.55 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 120.108 -0.637 . . . . 71.15 111.874 175.613 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -110.23 173.75 6.18 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.517 0.932 . . . . 72.3 113.517 -174.014 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.11 117.11 21.4 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.803 -1.09 . . . . 71.12 110.969 -177.368 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 49.0 m -117.12 148.26 41.71 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.709 -0.849 . . . . 73.23 108.709 177.449 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -81.32 161.11 23.98 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.601 -0.518 . . . . 65.15 109.601 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.01 -17.82 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 CA-C-O 121.732 0.777 . . . . 71.42 112.353 -178.179 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.1 t -95.96 4.79 52.41 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.583 -0.698 . . . . 52.52 111.772 179.093 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -86.92 129.49 34.86 Favored 'General case' 0 CA--C 1.508 -0.638 0 O-C-N 121.961 -0.462 . . . . 72.14 111.091 -177.782 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.581 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.1 p -104.79 123.51 58.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.459 0.647 . . . . 65.51 110.509 178.687 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 34.7 m -101.28 126.91 55.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 121.787 0.803 . . . . 72.1 111.122 -179.1 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.71 125.22 45.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 108.213 -1.032 . . . . 74.43 108.213 176.36 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.701 HG12 HG22 ' A' ' 470' ' ' THR . 37.1 mt -109.53 126.3 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 CA-C-N 115.076 -0.965 . . . . 54.32 110.809 -178.003 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 4.4 tt -104.64 127.0 59.41 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 CA-C-N 114.887 -1.051 . . . . 72.11 110.011 -177.213 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 33.1 m -110.18 151.57 12.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 C-N-CA 122.786 0.434 . . . . 72.52 110.012 177.726 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -84.62 135.48 13.64 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.674 -0.57 . . . . 63.52 111.674 -179.226 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.716 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 46.4 m . . . . . 0 C--N 1.306 -1.285 0 CA-C-N 117.155 0.477 . . . . 73.54 110.176 178.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo . . . . . 0 N--CA 1.445 -1.367 0 N-CA-C 111.122 -0.376 . . . . 72.1 111.122 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -85.02 45.87 1.22 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.682 0.754 . . . . 62.53 110.151 178.879 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 10.8 p -122.58 145.95 47.87 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.511 -0.768 . . . . 51.22 110.485 -178.29 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -143.39 150.04 38.53 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 123.104 0.561 . . . . 62.22 111.32 178.464 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 11.1 p-10 -86.85 127.83 35.03 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.164 -0.926 . . . . 65.4 110.319 178.911 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 31.1 pt -81.17 134.1 52.89 Favored Pre-proline 0 C--N 1.304 -1.396 0 CA-C-N 115.658 -0.701 . . . . 74.32 110.426 179.029 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -82.43 175.99 8.39 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.658 2.239 . . . . 75.23 112.978 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -83.08 142.13 31.51 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.365 -0.834 . . . . 71.12 108.765 177.048 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 51.3 t -138.57 91.11 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 N-CA-C 107.74 -1.207 . . . . 74.41 107.74 -179.556 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -151.1 121.08 7.13 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.775 -0.454 . . . . 70.55 109.775 178.455 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 102.69 25.63 7.56 Favored Glycine 0 CA--C 1.489 -1.557 0 C-N-CA 120.164 -1.017 . . . . 42.14 111.243 176.447 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -131.95 170.3 15.1 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 109.118 -0.697 . . . . 65.04 109.118 178.829 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 15.1 t -91.57 160.63 15.31 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.284 -1.006 . . . . 71.03 108.284 178.359 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 47.5 t -51.88 -42.5 33.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 C-N-CA 123.709 0.803 . . . . 73.03 111.788 -175.779 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -67.86 -42.34 81.46 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.25 0.463 . . . . 63.04 112.25 -177.879 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 66.3 t -75.2 -34.68 31.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-O 121.281 0.562 . . . . 64.23 110.172 -177.769 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -61.95 -50.0 73.89 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.911 -0.586 . . . . 63.15 110.661 178.526 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -65.89 -34.91 79.22 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 120.819 -0.352 . . . . 75.31 110.95 178.498 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.402 ' O ' HG23 ' A' ' 514' ' ' VAL . 78.7 tttt -55.84 -48.25 75.81 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.5 0.72 . . . . 72.21 110.166 178.437 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -62.31 -45.93 91.02 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-N 116.091 -0.504 . . . . 62.24 110.436 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 90.1 mt -61.76 -38.25 87.29 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.823 -0.626 . . . . 73.51 111.335 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -61.42 -42.48 98.8 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.954 0.407 . . . . 65.13 110.124 177.799 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 510' ' ' LYS . 85.8 t -66.61 -29.55 46.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-N 115.601 -0.727 . . . . 62.13 110.666 178.774 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -84.23 3.02 37.2 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 121.872 -0.518 . . . . 73.33 112.066 179.402 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 82.54 39.41 10.85 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 121.006 -0.616 . . . . 70.12 112.791 177.251 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -124.77 138.59 54.27 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.994 -1.113 . . . . 74.42 107.994 176.947 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 3.6 m -131.84 -11.58 3.4 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.708 -0.797 . . . . 72.41 111.677 -176.212 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -107.64 115.01 29.39 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.25 -0.648 . . . . 73.25 109.25 -174.394 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -130.01 155.94 45.29 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.565 -0.743 . . . . 73.23 110.005 -175.069 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 521' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 66.9 m -141.83 127.85 19.56 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 106.999 -1.482 . . . . 75.05 106.999 170.625 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 522' ' ' GLN . . . . . 0.503 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 0.0 OUTLIER -117.3 133.35 56.08 Favored 'General case' 0 N--CA 1.418 -2.053 0 CA-C-O 121.23 0.538 . . . . 54.35 111.129 -179.3 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -113.87 143.13 45.19 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.442 -0.948 . . . . 72.11 108.442 178.866 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 61.0 m -102.71 126.98 50.02 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.0 0.428 . . . . 73.12 110.833 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 26.7 m -121.3 168.3 13.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.68 -1.23 . . . . 62.12 107.68 177.594 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 526' ' ' ASP . . . . . 0.608 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 5.4 p-10 -102.65 136.42 42.52 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.31 -0.956 . . . . 51.13 111.178 -179.476 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 527' ' ' SER . . . . . 0.419 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 18.7 m -152.85 178.15 1.68 Allowed Pre-proline 0 C--N 1.308 -1.219 0 N-CA-C 108.343 -0.984 . . . . 73.41 108.343 178.368 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -83.8 -0.37 9.65 Favored 'Trans proline' 0 C--N 1.361 1.216 0 C-N-CA 121.848 1.699 . . . . 51.41 111.135 173.435 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.51 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 8.1 mmm180 -76.73 138.84 66.28 Favored Pre-proline 0 C--O 1.211 -0.943 0 N-CA-C 106.826 -1.546 . . . . 70.5 106.826 178.532 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.08 150.41 86.66 Favored 'Trans proline' 0 C--O 1.246 0.879 0 C-N-CA 122.387 2.058 . . . . 75.12 112.074 -177.651 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.67 107.9 0.76 Allowed 'General case' 0 C--O 1.239 0.534 0 CA-C-N 116.21 -0.45 . . . . 45.03 110.439 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 133.51 -17.77 4.44 Favored Glycine 0 C--N 1.298 -1.562 0 N-CA-C 110.602 -0.999 . . . . 73.32 110.602 -177.612 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -75.58 124.73 27.7 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.272 -1.011 . . . . 73.25 108.272 177.292 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 47.1 t -82.92 115.61 25.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 106.711 -1.588 . . . . 62.12 106.711 175.172 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 535' ' ' THR . . . . . 0.424 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 10.6 t -83.48 -20.44 33.99 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.055 0.455 . . . . 62.22 110.5 -175.997 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 166.12 -159.37 32.62 Favored Glycine 0 N--CA 1.428 -1.849 0 C-N-CA 120.638 -0.791 . . . . 33.11 111.169 178.573 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 21.7 p -132.77 158.74 41.66 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.668 -0.864 . . . . 74.43 108.668 178.653 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -74.84 -53.35 3.11 Favored Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 109.886 -0.412 . . . . 70.13 109.886 176.34 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.458 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 45.8 Cg_endo -70.42 140.22 39.72 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 120.906 1.071 . . . . 65.21 110.176 173.476 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 540' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 17.2 Cg_exo -68.23 142.01 53.97 Favored 'Trans proline' 0 C--O 1.247 0.938 0 C-N-CA 122.592 2.195 . . . . 45.12 112.731 -179.123 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -65.76 135.58 55.09 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.746 -0.661 . . . . 72.32 109.683 178.605 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 103.67 -14.34 53.52 Favored Glycine 0 C--N 1.304 -1.199 0 C-N-CA 120.78 -0.724 . . . . 64.31 112.31 -179.853 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 27.6 m -67.2 129.77 40.98 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 110.349 -0.241 . . . . 72.23 110.349 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 56.7 m -92.11 122.69 34.84 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 108.223 -1.029 . . . . 71.32 108.223 177.265 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 26.0 m -132.4 164.72 41.43 Favored Pre-proline 0 C--N 1.307 -1.271 0 N-CA-C 109.404 -0.591 . . . . 74.54 109.404 -176.901 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -62.61 150.86 86.36 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.194 1.929 . . . . 72.01 110.18 174.787 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 27.4 m -64.21 -20.53 27.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 112.661 0.615 . . . . 72.12 112.661 -177.742 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -83.14 3.43 30.81 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 123.841 0.856 . . . . 51.44 111.805 178.764 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 11.7 t -80.46 158.67 25.84 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.111 0.482 . . . . 61.3 111.041 -176.481 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 70.0 t -101.37 135.12 39.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.842 -0.617 . . . . 51.42 110.19 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 551' ' ' ILE . . . . . 0.428 ' N ' HD12 ' A' ' 551' ' ' ILE . 2.6 mp -97.15 126.13 50.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 107.462 -1.31 . . . . 52.24 107.462 176.282 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 552' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 521' ' ' SER . 36.6 tt0 -103.53 116.29 32.1 Favored 'General case' 0 N--CA 1.428 -1.56 0 C-N-CA 120.602 -0.439 . . . . 72.24 109.978 -179.237 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 553' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 4.6 mp -101.5 134.48 44.53 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.154 -0.93 . . . . 74.32 109.032 -178.652 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -110.01 114.14 27.42 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 122.11 0.957 . . . . 60.52 109.553 177.86 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 48.6 t -103.0 141.44 18.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-N 114.342 -1.299 . . . . 72.22 109.087 -174.464 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 67.9 m -96.65 147.6 23.73 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.205 0.526 . . . . 64.14 112.212 -179.161 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.608 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 15.1 ptpt -96.78 150.72 20.38 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 105.282 -2.118 . . . . 72.34 105.282 170.692 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 558' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -73.39 -37.55 53.76 Favored Glycine 0 CA--C 1.485 -1.842 0 N-CA-C 110.931 -0.868 . . . . 34.22 110.931 -178.832 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 63.2 t30 69.79 -0.86 2.52 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 122.54 1.162 . . . . 73.13 110.609 175.722 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 77.9 mt-30 -142.57 144.42 32.88 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 106.509 -1.663 . . . . 75.42 106.509 179.565 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -123.71 140.94 52.49 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 120.75 -0.38 . . . . 73.32 110.402 179.33 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.99 123.16 11.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.575 0.702 . . . . 31.03 112.037 -178.122 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 59.6 ttp -97.28 134.66 22.45 Favored Pre-proline 0 C--N 1.305 -1.352 0 CA-C-N 115.43 -0.805 . . . . 70.34 109.874 178.463 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.15 169.62 13.34 Favored 'Trans proline' 0 C--O 1.244 0.821 0 C-N-CA 122.805 2.336 . . . . 72.22 111.197 175.496 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 565' ' ' ASP . . . . . 0.537 ' HA ' ' HB1' ' A' ' 610' ' ' ALA . 28.1 t70 -66.83 114.69 5.88 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.401 0.62 . . . . 71.31 112.085 -178.274 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 93.2 mt -133.87 10.0 3.91 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.208 -1.034 . . . . 72.43 108.208 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 14.6 m -79.17 134.08 36.7 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.935 -1.03 . . . . 63.42 110.575 -175.238 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 77.19 33.98 42.91 Favored Glycine 0 C--O 1.221 -0.66 0 C-N-CA 120.724 -0.751 . . . . 71.54 111.94 -179.708 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 569' ' ' MET . . . . . 0.544 ' SD ' ' HD3' ' A' ' 577' ' ' ARG . 36.0 ttp -100.27 146.37 26.99 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.814 -0.439 . . . . 73.43 109.814 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 570' ' ' PHE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 93.4 m-85 -76.59 147.87 37.36 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.279 -1.008 . . . . 63.15 108.279 178.92 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 571' ' ' TRP . . . . . 0.497 ' HA ' ' HB3' ' A' ' 574' ' ' ALA . 72.4 t-105 -59.67 -22.84 62.5 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 112.057 0.392 . . . . 75.34 112.057 -178.231 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 29.5 m -70.52 -23.14 24.14 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.438 0 CA-C-N 115.951 -0.568 . . . . 64.34 111.335 -178.582 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -101.06 -33.37 10.18 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.939 -0.763 . . . . 74.14 108.939 175.974 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 574' ' ' ALA . . . . . 0.497 ' HB3' ' HA ' ' A' ' 571' ' ' TRP . . . -58.23 -53.48 57.8 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.469 0.914 . . . . 62.33 113.469 -176.03 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.449 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 34.7 tt0 -58.5 -51.9 78.49 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 120.51 -0.476 . . . . 71.5 112.021 -178.253 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 576' ' ' PRO . . . . . 0.449 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 51.2 Cg_exo -57.8 -40.76 76.26 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 121.918 1.745 . . . . 52.51 112.789 176.58 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.544 ' HD3' ' SD ' ' A' ' 569' ' ' MET . 80.9 mtp180 -69.09 -33.94 74.32 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 120.326 -0.55 . . . . 72.21 112.139 -179.249 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 92.8 mt -65.36 -47.55 76.04 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.008 0.433 . . . . 72.53 110.454 178.706 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -65.31 -34.81 79.22 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.964 -0.562 . . . . 74.34 111.176 177.918 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -65.4 -32.43 74.05 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.924 0.393 . . . . 41.24 111.093 178.417 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 581' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 577' ' ' ARG . 4.1 mm? -81.46 -5.2 57.69 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.251 -0.431 . . . . 73.41 111.179 177.42 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 72.78 31.71 62.12 Favored Glycine 0 N--CA 1.431 -1.649 0 C-N-CA 121.018 -0.61 . . . . 63.24 111.6 -179.783 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 78.6 t90 -65.1 139.05 58.67 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.678 0.275 . . . . 73.51 110.286 177.093 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 29.2 m -151.62 103.03 2.92 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.361 -0.607 . . . . 75.04 109.361 175.357 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -161.39 -138.26 2.38 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 109.497 -1.441 . . . . 22.15 109.497 177.814 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 16.4 mmt -117.71 132.09 56.53 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.214 0.53 . . . . 25.34 110.766 175.589 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 24.8 tp -98.91 118.18 35.09 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 106.347 -1.723 . . . . 55.11 106.347 178.375 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -120.35 100.45 7.17 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 118.112 -1.435 . . . . 52.32 111.962 178.447 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 589' ' ' LYS . . . . . 0.419 ' O ' ' HD2' ' A' ' 589' ' ' LYS . 0.1 OUTLIER -113.79 133.8 55.16 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.143 -1.389 . . . . 63.31 108.391 171.476 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -73.2 -102.33 0.07 OUTLIER Glycine 0 C--N 1.301 -1.361 0 C-N-CA 120.745 -0.741 . . . . 64.31 113.842 -176.31 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -91.81 135.8 33.64 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 120.591 0.234 . . . . 73.03 111.489 -177.612 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -89.3 125.97 35.33 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 106.915 -1.513 . . . . 41.04 106.915 177.995 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 78.4 t -124.67 115.63 45.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 110.158 -0.312 . . . . 70.03 110.158 -175.127 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -74.49 113.42 11.71 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.683 -0.858 . . . . 74.14 108.683 177.06 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -125.32 -28.98 3.3 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 115.648 -0.705 . . . . 75.42 110.373 177.593 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 107.74 147.97 13.78 Favored Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 110.015 -1.234 . . . . 74.23 110.015 -176.351 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -62.5 -33.57 86.83 Favored Glycine 0 C--N 1.32 -0.348 0 CA-C-N 116.915 0.357 . . . . 42.12 112.776 -177.602 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 27.4 m -65.89 -23.97 66.75 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-O 121.144 0.497 . . . . 75.14 111.206 178.333 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -87.11 0.47 55.22 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.54 0.736 . . . . 63.34 110.765 -179.573 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . 0.4 10.3 p-80 69.65 92.0 0.09 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 126.545 1.938 . . . . 75.44 116.123 176.671 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -90.66 69.35 6.66 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 123.033 1.397 . . . . 54.12 107.999 171.917 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 602' ' ' ARG . . . . . 0.441 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 37.2 ptt85 -106.82 162.44 13.8 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.227 -1.351 . . . . 72.14 110.178 -176.574 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 603' ' ' VAL . . . . . 0.413 HG13 ' HB2' ' A' ' 622' ' ' LEU . 75.9 t -68.98 130.86 34.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 106.133 -1.803 . . . . 62.33 106.133 172.72 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 28.3 m -107.48 -31.18 2.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 119.494 -0.882 . . . . 54.31 111.937 -176.332 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -145.05 157.13 44.21 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 106.942 -1.503 . . . . 73.04 106.942 176.058 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 606' ' ' GLN . . . . . 0.416 ' HB2' HD11 ' A' ' 620' ' ' ILE . 10.7 pt20 -148.98 160.2 43.52 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 106.872 -1.529 . . . . 65.43 106.872 -179.321 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.527 ' HB2' ' HD3' ' A' ' 608' ' ' PRO . 88.6 m-20 -68.56 -57.85 7.85 Favored Pre-proline 0 C--N 1.315 -0.893 0 C-N-CA 120.185 -0.606 . . . . 72.33 112.022 -179.492 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.527 ' HD3' ' HB2' ' A' ' 607' ' ' ASN . 10.1 Cg_endo -99.07 127.02 0.17 Allowed 'Trans proline' 0 N--CA 1.44 -1.674 0 C-N-CA 122.123 1.882 . . . . 53.14 112.245 178.877 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.45 158.67 54.21 Favored 'Trans proline' 0 C--O 1.246 0.891 0 C-N-CA 121.927 1.751 . . . . 64.11 111.432 176.545 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 610' ' ' ALA . . . . . 0.537 ' HB1' ' HA ' ' A' ' 565' ' ' ASP . . . -68.02 137.39 55.03 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.776 -0.824 . . . . 74.34 108.776 177.337 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 90.04 -0.05 78.35 Favored Glycine 0 C--N 1.309 -0.932 0 C-N-CA 120.337 -0.935 . . . . 62.43 111.144 -177.469 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 27.6 m -111.48 159.62 17.91 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 107.514 -1.291 . . . . 73.35 107.514 177.5 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -77.92 133.62 13.26 Favored Glycine 0 N--CA 1.427 -1.944 0 N-CA-C 111.743 -0.543 . . . . 50.23 111.743 177.689 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 614' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 21.6 m -96.72 141.18 15.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 109.032 -0.729 . . . . 75.25 109.032 177.336 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -55.77 148.85 15.68 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.91 0.884 . . . . 71.53 110.358 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -52.63 -30.68 32.84 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 112.962 0.727 . . . . 74.03 112.962 -174.143 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 617' ' ' ASP . . . . . 0.574 ' OD2' ' HB ' ' A' ' 619' ' ' ILE . 32.7 t70 -79.78 -31.42 40.82 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.951 0.405 . . . . 75.12 110.739 -178.535 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 77.74 20.71 73.35 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.902 -0.666 . . . . 54.51 112.789 179.013 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 619' ' ' ILE . . . . . 0.574 ' HB ' ' OD2' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -68.3 121.01 16.69 Favored 'Isoleucine or valine' 0 C--O 1.246 0.872 0 CA-C-O 122.536 1.16 . . . . 72.3 109.209 -173.796 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.416 HD11 ' HB2' ' A' ' 606' ' ' GLN . 6.3 tp -115.08 120.09 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.093 0 CA-C-N 113.957 -1.474 . . . . 75.33 112.379 -171.763 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 14.5 m -99.4 117.25 33.4 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 105.565 -2.013 . . . . 73.55 105.565 170.834 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 622' ' ' LEU . . . . . 0.43 HD23 ' H ' ' A' ' 622' ' ' LEU . 2.2 pt? -140.09 162.69 34.63 Favored 'General case' 0 CA--C 1.483 -1.631 0 N-CA-C 108.987 -0.746 . . . . 73.0 108.987 -175.429 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -134.79 137.23 43.19 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 107.442 -1.318 . . . . 75.41 107.442 172.866 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -142.02 166.06 25.74 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 105.281 -2.118 . . . . 75.44 105.281 173.389 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -66.4 -86.74 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.426 -1.07 . . . . 45.43 110.426 175.616 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 . . . . . 0 C--N 1.299 -1.624 0 N-CA-C 105.95 -1.87 . . . . 74.52 105.95 175.763 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 N--CA 1.44 -0.943 0 N-CA-C 108.241 -1.022 . . . . 74.53 108.241 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.9 m -134.52 163.27 37.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.494 -0.928 . . . . 63.51 108.494 178.027 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -94.23 140.59 29.58 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 106.455 -1.683 . . . . 70.34 106.455 175.782 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.517 HG22 ' CZ ' ' A' ' 382' ' ' PHE . 75.7 t -93.92 134.48 26.07 Favored Pre-proline 0 C--N 1.277 -2.565 0 N-CA-C 107.559 -1.274 . . . . 73.5 107.559 -174.719 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.84 149.48 66.46 Favored 'Trans proline' 0 C--O 1.253 1.259 0 C-N-CA 123.042 2.495 . . . . 63.15 113.308 -171.279 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -87.24 75.15 9.39 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 115.076 -0.966 . . . . 35.11 111.258 -177.409 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 27.7 m -91.54 -5.25 10.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 122.917 1.341 . . . . 72.03 108.005 173.988 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -66.39 146.43 54.57 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 112.329 -2.214 . . . . 72.21 108.21 177.05 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 367' ' ' GLY . . . . . 0.508 ' H ' HG23 ' A' ' 399' ' ' VAL . . . 104.53 1.23 43.51 Favored Glycine 0 C--N 1.304 -1.237 0 C-N-CA 119.475 -1.345 . . . . 41.33 114.042 178.674 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -110.29 -77.39 0.59 Allowed 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.094 -0.706 . . . . 73.44 109.094 -177.65 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 78.7 p -149.78 153.13 36.34 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 106.767 -1.568 . . . . 65.32 106.767 178.248 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.409 ' O ' ' HB ' ' A' ' 374' ' ' ILE . 22.6 t -62.64 -33.72 75.61 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.964 -0.754 . . . . 63.41 108.964 177.278 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -68.69 -47.83 65.43 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 112.53 0.567 . . . . 51.43 112.53 -178.9 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -69.69 -45.27 68.66 Favored 'General case' 0 CA--C 1.503 -0.859 0 C-N-CA 119.482 -0.887 . . . . 75.01 110.631 -178.097 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 373' ' ' ALA . . . . . 0.467 ' O ' ' HG ' ' A' ' 377' ' ' LEU . . . -61.17 -50.57 72.61 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.407 -0.815 . . . . 73.22 110.96 -178.361 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 374' ' ' ILE . . . . . 0.409 ' HB ' ' O ' ' A' ' 370' ' ' SER . 1.7 mp -69.28 -38.97 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 120.727 -0.389 . . . . 73.12 111.778 -177.862 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.71 -44.02 93.88 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.226 0.536 . . . . 64.1 110.884 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 376' ' ' THR . . . . . 0.406 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 21.0 m -66.52 -47.1 74.03 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.572 -0.74 . . . . 73.34 110.104 -179.171 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 373' ' ' ALA . 94.0 mt -61.49 -42.45 98.8 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.271 -0.422 . . . . 74.44 110.629 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 62.5 tp60 -61.21 -42.46 98.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.129 -0.487 . . . . 75.32 111.157 -179.532 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -67.57 -24.52 65.52 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 112.072 0.397 . . . . 75.24 112.072 179.31 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 380' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 376' ' ' THR . 37.8 mmt180 -81.42 -13.76 57.88 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.106 0.479 . . . . 73.42 110.123 176.518 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.67 7.43 51.06 Favored Glycine 0 N--CA 1.437 -1.297 0 CA-C-N 115.701 -0.681 . . . . 74.53 112.337 178.381 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.517 ' CZ ' HG22 ' A' ' 362' ' ' VAL . 57.4 m-85 -74.36 148.72 41.03 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-O 121.431 0.634 . . . . 74.42 110.322 178.159 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.653 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 47.0 mmtm -98.61 146.24 26.02 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 106.548 -1.649 . . . . 72.4 106.548 178.293 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.71 150.68 27.16 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.302 0 C-N-CA 119.735 -0.786 . . . . 73.45 110.095 -179.14 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -117.06 146.15 43.28 Favored 'General case' 0 N--CA 1.404 -2.769 0 N-CA-C 106.372 -1.714 . . . . 73.44 106.372 171.796 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 89.0 m -135.02 117.85 16.18 Favored 'General case' 0 C--N 1.256 -3.496 0 N-CA-C 106.371 -1.714 . . . . 73.24 106.371 -179.342 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 20.8 tp -117.83 130.89 56.54 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 108.967 -0.753 . . . . 65.52 108.967 -176.107 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -91.12 131.0 36.96 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-O 121.099 0.476 . . . . 74.41 110.311 -178.867 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 389' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 421' ' ' SER . 76.0 mmtt -125.85 143.31 44.86 Favored Pre-proline 0 C--N 1.297 -1.69 0 N-CA-C 107.396 -1.335 . . . . 75.21 107.396 177.643 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 390' ' ' PRO . . . . . 0.419 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 13.7 Cg_endo -98.14 127.25 0.22 Allowed 'Trans proline' 0 N--CA 1.449 -1.137 0 N-CA-C 108.867 -1.243 . . . . 74.51 108.867 166.563 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 6.7 t70 168.09 -170.04 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.286 -1.375 . . . . 74.15 107.286 -174.899 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 31.7 t -136.74 -11.36 1.79 Allowed 'General case' 0 N--CA 1.428 -1.573 0 C-N-CA 123.22 0.608 . . . . 71.24 110.376 178.136 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 14.6 t -71.42 -28.85 64.28 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 108.089 -1.078 . . . . 74.23 108.089 176.604 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.467 HD13 ' H ' ' A' ' 394' ' ' ILE . 0.2 OUTLIER -110.1 129.97 23.36 Favored Pre-proline 0 N--CA 1.41 -2.426 0 N-CA-C 104.278 -2.49 . . . . 74.54 104.278 167.051 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -92.91 -175.49 0.54 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.698 2.265 . . . . 73.24 113.798 -172.897 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -53.16 167.25 0.78 Allowed 'Trans proline' 0 C--N 1.365 1.419 0 C-N-CA 124.25 3.3 . . . . 74.02 111.351 169.816 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -53.08 -6.22 0.06 Allowed 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 126.427 1.891 . . . . 73.24 113.667 -170.573 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 27.9 m170 -77.21 93.1 3.9 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 105.453 -2.055 . . . . 75.33 105.453 170.984 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.508 HG23 ' H ' ' A' ' 367' ' ' GLY . 16.6 m -67.54 119.57 13.41 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 113.546 -1.661 . . . . 62.14 112.534 -166.911 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.88 -35.81 8.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 108.763 -0.828 . . . . 71.34 108.763 178.756 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.84 163.53 28.58 Favored Glycine 0 N--CA 1.414 -2.77 0 CA-C-N 115.513 -0.767 . . . . 34.03 111.198 -177.391 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.3 p -150.06 -176.4 5.43 Favored 'General case' 0 C--N 1.288 -2.109 0 C-N-CA 126.207 1.803 . . . . 52.5 107.558 -178.358 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 403' ' ' ASP . . . . . 0.433 ' HA ' ' HD3' ' A' ' 404' ' ' PRO . 17.3 t70 -98.88 139.72 21.25 Favored Pre-proline 0 C--N 1.3 -1.563 0 C-N-CA 120.157 -0.617 . . . . 64.21 109.476 -174.16 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 404' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 403' ' ' ASP . 50.3 Cg_exo -57.86 1.61 0.21 Allowed 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 124.93 3.753 . . . . 64.31 115.624 -179.569 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.08 -33.82 63.09 Favored 'General case' 0 C--O 1.213 -0.854 0 CA-C-O 120.968 0.413 . . . . 63.23 110.084 175.56 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -70.49 -30.84 67.73 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-N 115.515 -0.766 . . . . 44.52 111.06 178.455 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -87.74 -5.02 58.86 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.841 0.829 . . . . 72.32 109.286 -178.271 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 31.0 m -91.8 149.13 21.75 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 105.821 -1.918 . . . . 63.44 105.821 175.159 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 12.6 p -78.73 112.25 15.66 Favored 'General case' 0 N--CA 1.418 -2.049 0 C-N-CA 119.23 -0.988 . . . . 64.34 109.624 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 35.2 m -119.57 159.92 20.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 115.971 -0.559 . . . . 73.54 109.714 178.623 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 56.0 m -67.0 134.86 52.79 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.347 -0.612 . . . . 74.2 109.347 178.102 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -53.71 114.5 1.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.125 0.57 . . . . 74.2 111.62 -178.046 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 112.42 14.05 11.07 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.663 -0.698 . . . . 55.33 112.042 -178.706 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -75.27 -174.56 2.4 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 109.907 -0.405 . . . . 73.11 109.907 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 415' ' ' GLU . . . . . 0.653 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 9.7 pt-20 -119.38 130.93 55.57 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 113.275 0.843 . . . . 75.22 113.275 -171.101 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.4 mm -116.89 127.49 74.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.916 -0.584 . . . . 64.21 110.551 -179.314 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 35.3 m -93.06 130.72 38.57 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 120.733 0.302 . . . . 52.53 111.307 178.663 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 5.2 p -120.41 135.35 60.94 Favored 'Isoleucine or valine' 0 C--O 1.248 0.994 0 N-CA-C 109.565 -0.532 . . . . 62.55 109.565 178.003 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -100.39 124.83 46.39 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.121 -0.696 . . . . 70.05 109.121 177.137 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 70.8 t -118.54 131.79 70.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 107.717 -1.216 . . . . 71.52 107.717 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 421' ' ' SER . . . . . 0.568 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 32.6 t -101.74 120.89 41.08 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 117.635 -1.626 . . . . 62.41 110.497 179.777 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 4.1 t -121.67 107.29 12.19 Favored 'General case' 0 N--CA 1.403 -2.781 0 CA-C-N 114.492 -1.231 . . . . 75.44 108.624 171.677 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -2.004 0 C-N-CA 119.695 -1.241 . . . . 63.21 112.274 179.532 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 . . . . . 0 N--CA 1.437 -1.092 0 N-CA-C 106.891 -1.522 . . . . 71.05 106.891 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.529 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 5.0 mmp_? -121.49 151.96 39.69 Favored 'General case' 0 CA--C 1.485 -1.534 0 CA-C-O 121.594 0.711 . . . . 53.35 111.527 -177.241 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.85 140.42 32.92 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 114.355 -1.293 . . . . 75.42 108.109 -176.218 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.47 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 78.2 mt -78.86 113.43 35.28 Favored Pre-proline 0 C--N 1.299 -1.588 0 N-CA-C 108.215 -1.031 . . . . 64.43 108.215 -179.641 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.77 141.06 40.24 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 121.849 1.7 . . . . 63.22 110.936 178.876 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -92.0 127.09 37.33 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.935 -1.135 . . . . 70.32 107.935 176.315 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 90.6 t -121.73 150.03 24.99 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 N-CA-C 108.104 -1.072 . . . . 73.23 108.104 -176.054 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.512 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 19.4 m -55.3 144.84 23.56 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 123.818 0.699 . . . . 34.31 110.579 -179.811 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 434' ' ' THR . . . . . 0.481 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 41.8 p -69.16 -25.77 64.53 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 113.341 0.867 . . . . 62.41 113.341 -169.386 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.435 ' H ' HD23 ' A' ' 435' ' ' LEU . 0.6 OUTLIER -90.16 -12.07 39.28 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 116.05 -0.523 . . . . 71.23 110.744 178.084 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.512 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 2.6 m -98.06 43.42 1.06 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.956 0.884 . . . . 74.13 109.176 -176.691 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -53.48 -38.93 64.12 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.351 1.061 . . . . 74.13 112.954 179.736 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -62.07 -40.51 96.04 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 121.537 0.684 . . . . 65.11 109.992 179.543 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.499 ' HB3' HG22 ' A' ' 436' ' ' THR . 40.9 tt0 -71.47 -34.06 69.87 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.862 -0.608 . . . . 64.41 111.199 177.154 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.477 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -59.35 -47.02 87.0 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.389 0.137 . . . . 71.14 110.833 -178.726 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 21.5 m -65.53 -36.98 78.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-O 121.337 0.589 . . . . 71.13 110.189 177.189 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -60.23 -47.25 86.79 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.803 0.841 . . . . 73.44 110.952 176.295 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -64.17 -38.79 92.33 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 123.663 0.785 . . . . 71.05 111.6 179.726 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 93.8 mt -63.93 -34.7 78.55 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.0 0.428 . . . . 60.42 109.988 175.619 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.451 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 43.8 m -70.16 -42.76 72.09 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.884 -0.598 . . . . 65.11 110.625 178.618 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.49 -23.09 65.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.364 0.602 . . . . 74.01 111.064 179.123 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.95 5.21 22.74 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.016 -0.538 . . . . 53.01 111.495 178.967 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 108.61 -84.15 0.36 Allowed Glycine 0 N--CA 1.435 -1.42 0 C-N-CA 120.429 -0.891 . . . . 61.34 112.072 175.552 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -37.08 -57.3 0.86 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.133 1.16 . . . . 73.11 114.133 179.536 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 450' ' ' GLY . . . . . 0.451 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 56.15 30.89 58.49 Favored Glycine 0 CA--C 1.505 -0.559 0 O-C-N 123.362 0.414 . . . . 64.11 113.347 179.44 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 61.3 mmt-85 -112.73 122.86 48.91 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 108.096 -1.076 . . . . 74.42 108.096 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 18.0 p90 -144.28 152.11 40.34 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.98 -0.554 . . . . 73.4 111.448 -174.632 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -131.72 138.58 48.71 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.565 -0.902 . . . . 63.44 108.565 175.81 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -98.08 121.08 39.56 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.628 -0.879 . . . . 63.41 108.628 176.598 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -116.98 148.55 41.34 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 107.881 -1.155 . . . . 72.33 107.881 178.011 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 -113.86 146.19 40.37 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 108.481 -0.933 . . . . 74.22 108.481 -176.477 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 26.9 t -143.92 134.46 12.17 Favored Pre-proline 0 C--N 1.294 -1.813 0 N-CA-C 108.645 -0.872 . . . . 72.0 108.645 175.296 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.64 ' HA ' ' O ' ' A' ' 490' ' ' SER . 68.1 Cg_endo -76.78 124.13 7.3 Favored 'Trans proline' 0 N--CA 1.439 -1.691 0 C-N-CA 121.898 1.732 . . . . 74.4 111.134 178.253 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 69.6 m -151.17 179.87 7.92 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.779 -0.646 . . . . 70.31 109.416 -178.738 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.9 t -46.77 139.22 6.67 Favored Pre-proline 0 C--O 1.25 1.114 0 C-N-CA 125.061 1.344 . . . . 72.23 112.684 178.919 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 461' ' ' PRO . . . . . 0.415 ' HA ' ' CG2' ' A' ' 464' ' ' VAL . 10.2 Cg_endo -51.61 -29.55 33.08 Favored 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 124.609 3.54 . . . . 63.43 113.567 -177.734 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -66.95 -24.51 66.07 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 120.959 0.409 . . . . 41.34 111.582 -178.603 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 91.1 mt -99.27 -13.47 19.66 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 120.707 0.289 . . . . 51.43 111.289 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.415 ' CG2' ' HA ' ' A' ' 461' ' ' PRO . 88.8 t -60.73 127.61 20.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.154 -0.475 . . . . 44.04 110.481 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.57 -11.7 71.5 Favored Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 116.083 -0.508 . . . . 73.54 112.175 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.97 159.42 16.56 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 107.577 -1.268 . . . . 74.11 107.577 179.37 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 76.1 t -75.45 146.97 8.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 106.998 -1.482 . . . . 71.42 106.998 173.571 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 61.3 mt -97.53 -29.82 3.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 107.557 -1.275 . . . . 64.31 107.557 177.33 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 158.8 -160.65 31.27 Favored Glycine 0 N--CA 1.423 -2.178 0 N-CA-C 111.014 -0.834 . . . . 43.14 111.014 176.163 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 470' ' ' THR . . . . . 0.562 HG22 HG12 ' A' ' 486' ' ' ILE . 52.8 p -115.04 140.88 48.69 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 105.016 -2.216 . . . . 35.32 105.016 177.96 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -65.11 -54.6 32.42 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 119.135 -1.026 . . . . 73.34 110.03 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.84 135.03 29.24 Favored 'Trans proline' 0 C--N 1.368 1.594 0 N-CA-C 108.42 -1.416 . . . . 72.22 108.42 170.756 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.513 ' C ' ' H ' ' A' ' 475' ' ' ASN . 35.5 Cg_exo -62.3 141.82 88.97 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 122.177 1.918 . . . . 64.34 112.482 -177.054 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.47 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -75.16 22.86 0.11 Allowed 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 122.441 1.115 . . . . 72.35 110.792 178.812 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 475' ' ' ASN . . . . . 0.513 ' H ' ' C ' ' A' ' 473' ' ' PRO . 10.2 m120 -109.36 -17.65 13.75 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 114.293 -1.321 . . . . 61.33 108.25 179.342 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -95.78 165.6 12.22 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 113.226 0.824 . . . . 63.23 113.226 -172.603 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.7 113.46 26.97 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 113.944 -1.48 . . . . 71.31 108.203 -179.735 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 18.5 p -102.67 145.55 29.51 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 110.132 -0.321 . . . . 70.34 110.132 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -71.73 164.36 26.1 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.284 -0.416 . . . . 63.01 110.519 179.234 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 37.6 mm -74.78 -8.67 11.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 122.122 0.963 . . . . 50.31 110.745 -174.564 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.0 t -100.1 5.16 44.92 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.844 -0.616 . . . . 75.15 110.53 177.4 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -87.12 147.45 25.64 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 112.628 0.603 . . . . 44.15 112.628 -176.198 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 44.2 t -107.38 117.49 53.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 108.737 -0.838 . . . . 75.33 108.737 177.606 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 58.8 t -89.55 120.08 37.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-O 121.289 0.566 . . . . 63.24 109.772 -179.119 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.93 123.76 46.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 121.491 0.662 . . . . 73.3 110.006 179.104 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.562 HG12 HG22 ' A' ' 470' ' ' THR . 14.1 mt -113.59 128.28 70.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 114.766 -1.106 . . . . 72.1 110.547 -178.072 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 5.1 tt -103.89 126.41 58.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 115.386 -0.825 . . . . 64.22 110.816 -175.481 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 33.5 m -110.1 151.35 12.35 Favored 'Isoleucine or valine' 0 C--O 1.251 1.152 0 CA-C-N 115.824 -0.625 . . . . 73.41 109.714 178.658 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.78 132.19 10.92 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 120.65 -0.786 . . . . 71.12 112.156 -179.268 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.64 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 49.0 m . . . . . 0 C--N 1.3 -1.568 0 N-CA-C 107.267 -1.383 . . . . 54.34 107.267 176.392 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo . . . . . 0 C--O 1.244 0.778 0 N-CA-C 110.822 -0.491 . . . . 74.53 110.822 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -81.89 55.47 2.76 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.931 0.872 . . . . 73.33 110.963 -178.215 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 58.0 p -120.23 142.93 48.58 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.29 -1.004 . . . . 70.45 108.29 -179.066 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -130.48 152.78 49.5 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.798 0.332 . . . . 74.05 110.872 -179.873 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -83.88 115.9 22.5 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 124.007 0.923 . . . . 75.4 109.905 -176.485 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 497' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 543' ' ' THR . 38.0 pt -83.82 130.09 56.69 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 116.396 -0.365 . . . . 75.22 111.156 -178.696 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -83.26 -169.27 0.69 Allowed 'Trans proline' 0 C--O 1.239 0.534 0 C-N-CA 122.969 2.446 . . . . 65.52 112.165 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -78.49 138.59 38.51 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.804 -0.813 . . . . 72.44 108.804 177.301 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 14.7 p -126.92 -15.0 3.49 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-O 121.448 0.642 . . . . 74.14 110.737 -177.338 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -66.73 112.18 4.08 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.082 -0.71 . . . . 51.42 109.082 178.823 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 136.81 -25.54 3.07 Favored Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.901 -0.666 . . . . 62.35 111.715 -178.374 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -103.01 172.33 6.88 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 122.47 -0.429 . . . . 54.25 111.068 178.336 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 21.8 p -89.77 160.97 16.26 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 116.495 -0.32 . . . . 74.5 111.069 -176.654 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 532' ' ' GLY . 25.0 t -54.1 -42.08 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 123.645 0.59 . . . . 54.05 111.403 -177.13 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.67 -42.13 95.6 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.075 -0.511 . . . . 55.54 112.007 -178.946 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 67.2 t -71.35 -41.76 73.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 109.657 -0.498 . . . . 73.24 109.657 179.852 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -60.38 -49.64 76.78 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.254 -0.885 . . . . 72.34 111.645 -179.393 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -64.96 -35.66 81.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.712 0.292 . . . . 70.33 110.691 -178.387 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.478 ' O ' HG23 ' A' ' 514' ' ' VAL . 4.6 tppp? -64.84 -47.13 79.07 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.846 -0.615 . . . . 73.34 109.364 179.192 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -63.38 -48.15 79.12 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.882 -0.599 . . . . 73.12 111.952 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -61.77 -39.75 92.74 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 116.658 -0.246 . . . . 75.25 111.467 178.8 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -61.79 -37.79 85.65 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 120.682 0.277 . . . . 72.3 111.011 177.933 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 510' ' ' LYS . 73.3 t -62.34 -37.14 77.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.011 -0.541 . . . . 74.44 110.416 176.885 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -71.91 -23.57 61.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.906 0.384 . . . . 74.41 111.553 178.357 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 124.59 -12.69 7.84 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 120.394 -0.908 . . . . 74.33 112.317 178.747 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.46 ' HA ' ' O ' ' A' ' 547' ' ' VAL . 90.5 m-85 -80.44 101.17 8.88 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 107.591 -1.263 . . . . 74.2 107.591 -177.349 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.87 -8.89 27.33 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 120.058 -0.657 . . . . 73.21 112.413 -171.736 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 519' ' ' LYS . . . . . 0.501 ' O ' HD13 ' A' ' 551' ' ' ILE . 63.6 mttp -108.21 114.59 28.59 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.037 -0.665 . . . . 60.42 109.984 -178.037 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -131.01 140.34 50.11 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 116.01 -0.541 . . . . 73.23 111.218 -177.752 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 521' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 33.0 m -128.43 142.29 51.14 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.277 -1.379 . . . . 71.54 107.277 175.866 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -117.94 141.04 48.88 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.043 0.449 . . . . 63.13 111.091 179.778 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -135.43 128.51 31.65 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.894 -1.15 . . . . 45.23 107.894 178.045 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 70.2 m -93.74 134.07 36.46 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.096 0.475 . . . . 70.1 111.818 -177.463 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 525' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 557' ' ' LYS . 35.2 m -121.98 150.11 25.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 107.972 -1.121 . . . . 72.32 107.972 177.795 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -66.75 136.74 55.93 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.525 -0.47 . . . . 63.55 110.547 -179.226 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 20.2 m -149.93 169.1 9.71 Favored Pre-proline 0 C--N 1.307 -1.278 0 CA-C-N 116.049 -0.523 . . . . 42.35 109.985 -177.937 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -84.41 -25.46 2.08 Favored 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 121.892 1.728 . . . . 54.1 111.5 173.508 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.427 ' HD3' ' OE2' ' A' ' 533' ' ' GLU . 15.2 ptp180 -81.06 150.03 67.67 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 109.7 -0.481 . . . . 74.24 109.7 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.78 149.0 62.68 Favored 'Trans proline' 0 C--O 1.26 1.601 0 C-N-CA 123.82 3.014 . . . . 72.43 115.909 -175.206 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.666 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -62.87 121.2 12.91 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 113.914 -1.494 . . . . 74.11 110.701 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 532' ' ' GLY . . . . . 0.456 ' O ' HG23 ' A' ' 505' ' ' VAL . . . 130.69 -23.46 4.47 Favored Glycine 0 C--N 1.303 -1.25 0 C-N-CA 120.763 -0.732 . . . . 72.52 111.462 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 533' ' ' GLU . . . . . 0.427 ' OE2' ' HD3' ' A' ' 529' ' ' ARG . 29.2 tt0 -83.48 144.29 29.65 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.422 -0.584 . . . . 75.14 109.422 177.614 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 67.0 t -89.54 125.75 42.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 109.275 -0.639 . . . . 73.21 109.275 179.395 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 535' ' ' THR . . . . . 0.586 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 14.4 t -100.84 -10.57 20.58 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-O 120.66 0.267 . . . . 52.41 111.611 -178.261 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 171.46 -175.41 44.98 Favored Glycine 0 CA--C 1.498 -0.984 0 C-N-CA 119.912 -1.137 . . . . 63.12 111.411 179.156 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 537' ' ' THR . . . . . 0.401 HG22 HD23 ' A' ' 553' ' ' LEU . 8.1 p -139.29 157.97 44.98 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 117.168 0.484 . . . . 75.01 111.314 179.495 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.438 ' HB3' ' HB3' ' A' ' 552' ' ' GLU . 21.2 t-20 -64.01 -54.87 36.8 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-N 115.27 -0.877 . . . . 73.45 109.72 176.906 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -73.53 122.59 7.98 Favored 'Trans proline' 0 C--N 1.373 1.867 0 N-CA-C 108.014 -1.571 . . . . 70.2 108.014 169.127 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.17 141.13 61.92 Favored 'Trans proline' 0 C--O 1.254 1.317 0 C-N-CA 122.01 1.807 . . . . 53.24 112.519 -176.733 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -58.78 134.26 56.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.498 -0.774 . . . . 41.22 109.963 -179.191 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 102.73 -5.93 51.57 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 120.544 -0.836 . . . . 54.33 111.973 -177.639 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.501 ' O ' HG12 ' A' ' 497' ' ' ILE . 79.3 m -88.94 137.74 32.04 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.852 0.326 . . . . 64.44 110.794 177.134 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 17.9 m -89.27 122.73 32.81 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.03 -1.47 . . . . 64.15 107.03 173.461 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 16.1 m -131.73 156.15 80.48 Favored Pre-proline 0 C--N 1.313 -0.981 0 CA-C-O 119.423 -0.323 . . . . 73.5 110.56 -177.278 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -59.54 139.55 89.75 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 123.043 2.495 . . . . 75.23 111.774 178.645 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 517' ' ' PHE . 27.3 m -65.41 -21.31 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 113.487 0.921 . . . . 73.34 113.487 -175.873 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -87.15 -11.96 48.44 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.045 0.45 . . . . 74.11 111.108 178.93 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 73.7 m -69.88 155.11 41.04 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.61 0.719 . . . . 71.33 112.719 -177.375 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 27.3 t -88.79 125.97 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-N 114.884 -1.053 . . . . 44.22 110.065 -176.282 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 551' ' ' ILE . . . . . 0.501 HD13 ' O ' ' A' ' 519' ' ' LYS . 0.2 OUTLIER -102.39 129.03 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 119.684 -0.807 . . . . 74.25 109.228 174.228 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 552' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 521' ' ' SER . 38.1 tt0 -102.73 119.27 38.54 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 108.899 -0.778 . . . . 73.24 108.899 -179.427 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 553' ' ' LEU . . . . . 0.401 HD23 HG22 ' A' ' 537' ' ' THR . 47.6 mt -92.19 122.88 35.09 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.117 -0.947 . . . . 65.33 109.443 -179.107 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -85.93 112.71 21.43 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.782 -1.192 . . . . 73.24 107.782 171.78 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 42.8 t -95.64 140.16 17.56 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 CA-C-N 115.207 -0.906 . . . . 63.53 109.283 -176.505 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.666 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 66.5 m -76.17 141.33 41.89 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-O 121.448 0.642 . . . . 73.22 111.533 177.45 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 525' ' ' VAL . 16.7 ttmt -114.66 119.64 37.41 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 125.613 1.565 . . . . 71.1 107.003 173.724 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -74.74 -24.31 72.66 Favored Glycine 0 C--N 1.314 -0.662 0 C-N-CA 120.574 -0.822 . . . . 75.21 113.831 -174.072 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 559' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' A' ' 615' ' ' ASN . 24.9 m120 74.53 18.14 2.92 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.069 1.348 . . . . 74.14 110.658 -178.539 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -131.89 141.19 49.3 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.566 -0.531 . . . . 71.0 109.566 -173.462 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -137.74 139.24 40.01 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 108.342 -0.984 . . . . 72.34 108.342 173.137 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 11.4 p -62.77 129.27 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 N-CA-C 113.3 0.852 . . . . 73.32 113.3 -173.816 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 57.2 ttp -97.56 128.94 32.88 Favored Pre-proline 0 C--O 1.254 1.328 0 CA-C-N 115.649 -0.705 . . . . 75.41 110.006 177.11 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.35 170.23 19.72 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.072 2.514 . . . . 62.22 112.048 176.224 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 565' ' ' ASP . . . . . 0.416 ' HB3' ' CB ' ' A' ' 610' ' ' ALA . 6.4 p-10 -86.34 122.37 30.21 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.424 0.63 . . . . 65.53 112.368 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.08 13.2 1.11 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 122.24 1.019 . . . . 71.12 109.423 174.102 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 1.8 m -72.57 153.19 41.41 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 114.588 -1.187 . . . . 62.32 111.355 -175.834 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 77.14 36.24 35.85 Favored Glycine 0 CA--C 1.519 0.297 0 N-CA-C 114.637 0.615 . . . . 74.14 114.637 174.667 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 25.1 ptm -129.12 174.67 9.35 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.421 -0.585 . . . . 73.4 109.421 -179.627 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 570' ' ' PHE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 90.6 m-85 -79.63 144.34 33.88 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-O 120.881 0.372 . . . . 75.2 110.527 -174.856 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 571' ' ' TRP . . . . . 0.564 ' HA ' ' HB3' ' A' ' 574' ' ' ALA . 74.9 t-105 -67.76 -17.83 64.67 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.729 -0.668 . . . . 62.12 111.292 -174.574 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 30.1 m -68.24 -28.24 40.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.755 -0.657 . . . . 71.32 110.444 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 573' ' ' ASP . . . . . 0.596 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 26.0 m-20 -101.77 -34.21 9.53 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 115.904 -0.589 . . . . 63.33 109.966 176.33 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 574' ' ' ALA . . . . . 0.564 ' HB3' ' HA ' ' A' ' 571' ' ' TRP . . . -57.27 -46.8 82.74 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.942 1.09 . . . . 64.14 113.942 -175.663 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.543 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 5.9 tm-20 -59.14 -53.11 69.58 Favored Pre-proline 0 CA--C 1.566 1.566 0 N-CA-C 109.438 -0.579 . . . . 74.43 109.438 179.063 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 576' ' ' PRO . . . . . 0.543 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 79.6 Cg_exo -53.95 -38.06 86.18 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.329 2.019 . . . . 62.05 113.27 171.587 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.596 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 69.0 mmt-85 -58.92 -43.17 91.08 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 110.344 -0.243 . . . . 60.44 110.344 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.09 -42.31 99.58 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.959 -0.564 . . . . 63.4 109.938 -179.076 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -64.36 -41.12 96.89 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.753 -0.658 . . . . 74.14 110.554 178.178 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.18 -24.1 64.93 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.803 -0.635 . . . . 71.33 111.636 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 581' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 89.0 mt -83.82 -8.0 59.32 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.006 0.431 . . . . 61.41 110.16 176.789 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 86.02 20.74 54.8 Favored Glycine 0 N--CA 1.438 -1.23 0 C-N-CA 120.622 -0.799 . . . . 75.42 111.476 -179.244 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 86.9 t90 -88.09 127.88 35.41 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 121.077 0.465 . . . . 74.11 109.829 178.133 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 36.4 m -149.92 66.24 0.98 Allowed 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.608 -1.256 . . . . 61.21 107.608 170.777 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -103.44 -129.75 6.72 Favored Glycine 0 N--CA 1.434 -1.498 0 CA-C-N 114.627 -1.169 . . . . 53.41 110.189 179.414 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 24.5 ttt -121.03 126.8 50.82 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.49 -0.559 . . . . 63.43 109.49 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -103.58 131.14 50.97 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.16 -1.422 . . . . 74.22 107.16 177.86 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -94.56 108.46 20.41 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.82 -0.807 . . . . 64.11 108.82 177.321 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -89.61 113.16 24.56 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.594 -1.262 . . . . 72.45 107.594 179.509 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -83.23 -105.3 0.51 Allowed Glycine 0 N--CA 1.432 -1.595 0 C-N-CA 120.464 -0.874 . . . . 60.42 110.968 178.846 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.99 146.72 39.45 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.121 -1.437 . . . . 61.42 107.121 176.277 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -75.44 129.07 36.71 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.293 0.568 . . . . 63.23 109.816 -178.926 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 26.0 t -112.16 132.53 60.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 116.253 -0.43 . . . . 74.41 111.616 -172.985 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -76.13 107.21 8.2 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 106.734 -1.58 . . . . 72.3 106.734 171.291 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -111.82 -10.49 14.01 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 112.673 0.62 . . . . 74.45 112.673 -172.926 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 596' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 600' ' ' HIS . . . 127.16 170.67 12.91 Favored Glycine 0 CA--C 1.49 -1.516 0 N-CA-C 109.653 -1.379 . . . . 61.31 109.653 179.472 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -64.59 -50.5 58.7 Favored Glycine 0 C--N 1.316 -0.567 0 C-N-CA 119.478 -1.344 . . . . 63.34 112.531 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 10.4 p -70.44 -23.71 62.77 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 112.485 0.55 . . . . 55.13 112.485 -176.822 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -108.01 -0.72 21.11 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 118.709 -0.662 . . . . 73.33 112.619 -175.767 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 600' ' ' HIS . . . . . 0.482 ' HB3' ' O ' ' A' ' 596' ' ' GLY 0.289 25.1 p-80 -55.39 -74.69 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 114.675 1.361 . . . . 71.33 114.675 -169.473 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 601' ' ' ASN . . . . . 0.438 ' OD1' ' HB3' ' A' ' 571' ' ' TRP . 13.5 t-20 -97.13 71.14 2.41 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.247 -0.908 . . . . 75.3 108.965 -175.636 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 602' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 44.1 ttt180 -143.15 150.97 40.15 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.552 -0.749 . . . . 74.55 110.558 -173.62 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 93.0 t -66.78 132.46 32.13 Favored 'Isoleucine or valine' 0 C--O 1.246 0.921 0 N-CA-C 107.3 -1.37 . . . . 73.03 107.3 174.611 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 54.9 t -92.25 -52.96 9.32 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 N-CA-C 108.307 -0.997 . . . . 54.24 108.307 -172.408 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 605' ' ' TYR . . . . . 0.416 ' O ' ' HA ' ' A' ' 622' ' ' LEU . 45.1 p90 -156.08 160.39 39.92 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 107.297 -1.372 . . . . 71.02 107.297 177.422 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.54 140.18 52.29 Favored 'General case' 0 C--N 1.283 -2.296 0 O-C-N 124.364 1.04 . . . . 72.13 110.047 176.012 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.555 ' HB2' ' HB ' ' A' ' 621' ' ' THR . 25.6 t-20 -52.22 -55.27 32.92 Favored Pre-proline 0 CA--C 1.558 1.272 0 C-N-CA 124.611 1.165 . . . . 71.03 113.822 -177.721 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.554 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 9.4 Cg_endo -97.42 128.69 0.27 Allowed 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 122.176 1.918 . . . . 74.05 111.572 177.785 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.87 154.71 66.98 Favored 'Trans proline' 0 C--O 1.247 0.945 0 C-N-CA 121.661 1.574 . . . . 63.34 110.59 176.554 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 610' ' ' ALA . . . . . 0.416 ' CB ' ' HB3' ' A' ' 565' ' ' ASP . . . -53.44 130.29 35.03 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 123.184 0.594 . . . . 60.54 111.774 -178.379 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 97.79 -0.0 59.17 Favored Glycine 0 N--CA 1.432 -1.569 0 C-N-CA 119.875 -1.155 . . . . 72.41 112.379 -179.142 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 22.5 m -98.36 155.64 17.12 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.882 -1.155 . . . . 71.44 107.882 176.388 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -88.15 138.3 14.96 Favored Glycine 0 N--CA 1.412 -2.963 0 C-N-CA 120.871 -0.68 . . . . 43.51 111.956 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 18.7 m -104.09 143.59 15.6 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 C-N-CA 123.637 0.775 . . . . 63.22 109.918 176.937 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.635 HD21 HG22 ' A' ' 619' ' ' ILE . 1.9 p-10 -55.96 140.78 41.98 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 125.336 1.454 . . . . 75.21 111.347 178.976 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -50.63 -31.59 16.52 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 113.939 1.088 . . . . 75.13 113.939 -174.048 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -71.77 -23.86 61.66 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 120.829 0.347 . . . . 75.23 110.696 -177.417 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 86.09 19.52 57.25 Favored Glycine 0 N--CA 1.41 -3.079 0 C-N-CA 120.465 -0.874 . . . . 74.52 114.155 172.975 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 619' ' ' ILE . . . . . 0.635 HG22 HD21 ' A' ' 615' ' ' ASN . 0.2 OUTLIER -73.51 124.43 30.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 C-N-CA 116.823 -1.951 . . . . 73.22 108.94 176.198 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.447 ' N ' HD13 ' A' ' 619' ' ' ILE . 6.6 tp -120.05 128.87 75.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.5 -0.773 . . . . 53.12 109.423 -178.956 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.555 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 35.9 m -102.68 116.8 33.31 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 108.925 -0.768 . . . . 33.41 108.925 178.978 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 622' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 605' ' ' TYR . 3.9 pp -139.89 160.3 40.22 Favored 'General case' 0 CA--C 1.478 -1.814 0 N-CA-C 106.41 -1.7 . . . . 72.21 106.41 178.646 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -128.7 147.14 50.73 Favored 'General case' 0 C--N 1.259 -3.353 0 N-CA-C 106.394 -1.706 . . . . 74.3 106.394 179.598 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -128.62 165.25 21.17 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.347 -0.983 . . . . 74.51 108.347 176.119 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -92.95 -114.37 2.25 Favored Glycine 0 N--CA 1.413 -2.884 0 O-C-N 123.889 0.743 . . . . 72.33 112.748 -179.383 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 . . . . . 0 C--N 1.302 -1.46 0 CA-C-O 118.876 -0.583 . . . . 74.12 110.822 -173.865 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 . . . . . 0 C--O 1.246 0.871 0 N-CA-C 108.54 -0.911 . . . . 52.23 108.54 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 30.3 m -119.56 151.83 22.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.517 -0.92 . . . . 63.34 108.517 -178.986 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -95.08 135.84 36.13 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 106.169 -1.789 . . . . 72.45 106.169 176.589 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.468 HG22 ' CZ ' ' A' ' 382' ' ' PHE . 59.4 t -97.39 132.06 26.1 Favored Pre-proline 0 C--N 1.286 -2.178 0 CA-C-N 115.987 -0.551 . . . . 65.13 110.826 -169.249 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 363' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 13.3 Cg_exo -66.56 134.03 34.11 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.17 1.913 . . . . 72.51 112.389 -179.301 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 364' ' ' ASP . . . . . 0.402 ' OD1' ' HG2' ' A' ' 366' ' ' ARG . 3.5 p30 -100.5 144.15 29.84 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.705 -1.22 . . . . 63.32 107.705 176.774 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 4.3 t -123.09 28.2 2.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 107.544 -1.28 . . . . 75.32 107.544 -179.724 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.52 ' HB3' HG23 ' A' ' 402' ' ' THR . 14.1 ptt180 -61.07 143.91 54.49 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.597 -1.183 . . . . 72.53 110.61 178.723 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.06 -13.89 55.74 Favored Glycine 0 N--CA 1.429 -1.779 0 CA-C-N 116.063 -0.517 . . . . 74.4 112.294 178.92 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -105.16 -87.29 0.45 Allowed 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 121.173 -0.211 . . . . 70.32 111.323 -178.722 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 89.5 p -156.32 160.67 39.93 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 108.227 -1.027 . . . . 63.05 108.227 179.557 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 1.4 p -63.49 -34.68 78.31 Favored 'General case' 0 N--CA 1.422 -1.847 0 O-C-N 123.498 0.499 . . . . 65.51 109.716 174.882 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.07 -46.37 89.4 Favored 'General case' 0 C--O 1.214 -0.771 0 CA-C-N 116.044 -0.525 . . . . 72.13 110.487 178.22 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -63.91 -41.91 97.56 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 120.826 0.346 . . . . 54.21 111.206 178.157 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -68.33 -45.6 72.48 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.237 -0.438 . . . . 64.31 111.356 -178.39 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 73.6 mt -65.9 -44.43 92.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.408 -0.36 . . . . 71.43 110.818 178.881 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.9 -43.89 91.1 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 120.922 0.392 . . . . 64.15 111.607 -177.985 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 38.9 m -64.29 -48.46 75.57 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.006 -0.543 . . . . 74.24 110.435 -178.937 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 10.8 mp -65.19 -37.92 88.84 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.163 -0.471 . . . . 61.4 111.862 178.914 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -61.11 -42.35 98.37 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.795 0.838 . . . . 75.12 109.867 178.541 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -66.2 -28.53 68.83 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.988 -0.551 . . . . 70.43 111.333 177.745 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -86.18 -14.41 44.1 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.907 0.384 . . . . 64.12 111.416 178.419 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 90.57 16.21 55.47 Favored Glycine 0 C--N 1.307 -1.076 0 C-N-CA 120.444 -0.884 . . . . 71.25 112.633 177.892 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.468 ' CZ ' HG22 ' A' ' 362' ' ' VAL . 26.1 m-85 -78.23 161.24 27.44 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-O 121.374 0.606 . . . . 52.23 111.542 178.02 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 48.5 mmtm -100.73 132.43 46.13 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 108.946 -0.761 . . . . 73.44 108.946 178.164 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 384' ' ' ILE . . . . . 0.423 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -118.0 154.8 19.98 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.721 0 N-CA-C 108.615 -0.883 . . . . 74.35 108.615 175.998 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -124.99 135.22 52.58 Favored 'General case' 0 C--N 1.265 -3.069 0 N-CA-C 106.182 -1.785 . . . . 73.24 106.182 177.508 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 31.1 m -119.04 117.58 29.14 Favored 'General case' 0 C--N 1.271 -2.841 0 N-CA-C 109.157 -0.683 . . . . 70.21 109.157 -177.383 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 387' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' A' ' 419' ' ' ASN . 2.9 tm? -116.07 127.58 54.99 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 106.292 -1.744 . . . . 74.14 106.292 179.479 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 388' ' ' GLN . . . . . 0.441 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 16.5 pm0 -114.22 147.5 38.84 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.997 -0.681 . . . . 74.42 111.439 -177.979 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -136.39 137.52 24.49 Favored Pre-proline 0 C--N 1.308 -1.234 0 N-CA-C 107.849 -1.167 . . . . 74.42 107.849 175.193 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -72.64 148.73 47.79 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 121.425 1.417 . . . . 74.0 109.505 172.982 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . 0.279 27.8 t70 -61.55 115.37 3.86 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 116.934 2.198 . . . . 45.53 116.934 -171.916 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 392' ' ' SER . . . . . 0.453 ' O ' ' HB ' ' A' ' 393' ' ' THR . 3.2 p -143.75 65.89 1.3 Allowed 'General case' 0 N--CA 1.383 -3.778 0 CA-C-N 111.822 -2.444 . . . . 64.0 106.744 166.622 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.497 HG22 ' O ' ' A' ' 393' ' ' THR . 63.4 m 87.38 39.08 0.02 OUTLIER 'General case' 0 CA--C 1.571 1.771 0 CA-C-O 123.703 1.716 . . . . 64.42 111.471 176.545 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -117.14 149.51 44.48 Favored Pre-proline 0 C--N 1.291 -1.967 0 O-C-N 121.032 -1.042 . . . . 73.23 112.125 175.917 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.02 178.49 6.44 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.911 2.407 . . . . 71.13 111.131 -179.051 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -55.91 161.11 8.86 Favored 'Trans proline' 0 C--N 1.362 1.252 0 C-N-CA 122.765 2.31 . . . . 71.41 112.328 176.034 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 397' ' ' ASP . . . . . 0.433 ' HB2' HG13 ' A' ' 420' ' ' VAL . 5.4 p-10 -58.09 -8.35 1.04 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.953 1.301 . . . . 71.51 113.142 -178.815 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -74.25 172.05 12.52 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.285 -0.635 . . . . 74.14 109.285 -179.468 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 13.9 m -97.32 118.7 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.999 0 N-CA-C 108.417 -0.957 . . . . 71.34 108.417 176.677 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 2.2 mp -94.88 -32.05 4.46 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 107.592 -1.262 . . . . 70.02 107.592 178.345 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.88 170.85 27.75 Favored Glycine 0 N--CA 1.418 -2.536 0 N-CA-C 109.101 -1.599 . . . . 35.02 109.101 179.307 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 402' ' ' THR . . . . . 0.52 HG23 ' HB3' ' A' ' 366' ' ' ARG . 2.5 p -129.34 -177.87 4.42 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 122.572 0.349 . . . . 75.34 110.443 -179.262 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -100.14 135.96 20.22 Favored Pre-proline 0 C--N 1.293 -1.866 0 N-CA-C 106.626 -1.62 . . . . 63.45 106.626 178.771 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -55.52 -12.18 5.77 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 124.034 3.156 . . . . 72.52 114.836 -175.469 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -53.88 -35.61 61.76 Favored 'General case' 0 C--O 1.212 -0.874 0 C-N-CA 122.899 0.48 . . . . 75.44 110.548 176.641 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.11 -39.51 68.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.338 0.589 . . . . 71.34 110.879 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -83.61 2.28 38.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.365 0.602 . . . . 72.3 110.639 -179.048 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 27.1 m -102.17 145.89 28.74 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 106.326 -1.731 . . . . 52.54 106.326 172.686 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 48.8 m -75.01 113.03 11.85 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 119.039 -1.064 . . . . 74.51 108.822 175.255 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.5 m -118.95 170.24 8.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.889 -0.596 . . . . 74.04 110.037 179.766 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 22.8 t -69.19 152.08 45.54 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.797 -0.445 . . . . 74.33 109.797 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -63.91 109.4 1.76 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.362 0.601 . . . . 74.41 111.185 -178.649 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 100.56 44.64 2.1 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 115.185 -0.916 . . . . 73.51 113.05 178.074 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -92.03 -174.21 3.71 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.984 -1.117 . . . . 62.44 107.984 178.456 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 415' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 44.8 mt-10 -109.16 133.0 53.58 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 121.53 0.681 . . . . 72.15 112.582 -177.624 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 44.6 mm -118.76 113.82 42.9 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 107.697 -1.223 . . . . 64.41 107.697 174.087 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 14.8 t -89.63 131.16 35.76 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.441 0.638 . . . . 73.14 111.274 -179.541 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 9.2 p -115.49 135.1 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 CA-C-N 115.329 -0.85 . . . . 42.33 109.562 -177.88 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 419' ' ' ASN . . . . . 0.493 ' HA ' ' O ' ' A' ' 387' ' ' LEU . 2.8 t-20 -97.74 116.0 29.09 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.887 -0.725 . . . . 63.34 109.339 176.236 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 98.4 t -102.44 136.0 36.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.109 -1.071 . . . . 60.05 108.109 179.232 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 15.8 m -99.09 135.05 41.05 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-O 121.543 0.687 . . . . 63.55 111.418 -178.847 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 17.6 p -105.95 160.06 15.56 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.492 -1.299 . . . . 71.52 107.492 172.409 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 1.999 0 N-CA-C 114.789 0.675 . . . . 45.35 114.789 -178.063 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 . . . . . 0 N--CA 1.423 -1.815 0 N-CA-C 106.975 -1.491 . . . . 74.41 106.975 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.5 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 4.2 mmp_? -122.35 147.37 46.34 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-O 120.797 0.332 . . . . 74.44 110.472 177.802 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -88.71 139.1 30.81 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 107.496 -1.298 . . . . 74.15 107.496 178.624 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 63.4 mt -80.43 118.99 75.01 Favored Pre-proline 0 N--CA 1.428 -1.536 0 N-CA-C 108.241 -1.022 . . . . 64.4 108.241 179.569 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -71.08 154.12 62.56 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 121.872 1.715 . . . . 75.2 110.549 177.409 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -77.4 89.43 3.79 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.53 0.681 . . . . 64.43 110.079 177.667 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 42.0 t -93.18 131.19 40.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 105.765 -1.939 . . . . 73.24 105.765 175.572 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.484 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 15.7 m -64.44 151.89 43.01 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 120.929 0.395 . . . . 52.35 111.197 -176.726 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 26.9 p -59.76 -33.41 71.64 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 123.427 0.691 . . . . 63.24 112.275 -176.621 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.496 ' HB3' ' HG3' ' A' ' 466' ' ' LYS . 1.9 pp -81.56 -11.23 59.23 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.465 0.65 . . . . 72.41 112.601 178.336 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.547 HG22 ' HB3' ' A' ' 439' ' ' GLU . 3.5 m -97.9 34.27 1.94 Allowed 'General case' 0 CA--C 1.564 1.509 0 N-CA-C 108.971 -0.752 . . . . 52.33 108.971 -178.703 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -51.41 -39.27 56.92 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.495 1.118 . . . . 71.4 113.391 179.745 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.1 -42.27 99.54 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-O 121.866 0.841 . . . . 72.33 110.268 -179.676 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.547 ' HB3' HG22 ' A' ' 436' ' ' THR . 26.8 tt0 -70.56 -33.96 71.69 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.451 -0.795 . . . . 71.21 109.468 178.691 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.621 ' O ' HD22 ' A' ' 444' ' ' LEU . . . -59.51 -50.19 74.89 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.378 -0.374 . . . . 72.01 110.961 -179.35 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.4 m -62.53 -38.61 81.88 Favored 'Isoleucine or valine' 0 C--O 1.257 1.46 0 N-CA-C 112.058 0.392 . . . . 74.44 112.058 179.637 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 442' ' ' LYS . 0.0 OUTLIER -68.0 -33.51 74.75 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 119.33 -0.948 . . . . 42.32 111.329 175.321 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -61.61 -42.96 99.61 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.368 -0.378 . . . . 62.32 111.262 175.559 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.621 HD22 ' O ' ' A' ' 440' ' ' ALA . 0.9 OUTLIER -63.79 -33.14 75.01 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 119.714 -0.794 . . . . 63.03 110.395 177.147 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 91.3 m -65.42 -44.02 88.69 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 116.174 -0.466 . . . . 74.43 110.456 177.797 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.76 -22.28 63.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.465 0.65 . . . . 44.31 110.979 179.225 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.69 5.46 13.26 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.64 -0.709 . . . . 61.5 112.182 -178.972 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 101.53 -73.79 0.36 Allowed Glycine 0 CA--C 1.493 -1.338 0 C-N-CA 119.977 -1.106 . . . . 61.4 112.232 174.837 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -47.83 -56.81 6.63 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 113.255 0.835 . . . . 73.44 113.255 178.041 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 61.97 25.43 66.04 Favored Glycine 0 CA--C 1.507 -0.418 0 C-N-CA 121.27 -0.49 . . . . 60.35 112.664 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -100.98 110.86 22.94 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.596 -1.261 . . . . 71.44 107.596 -177.628 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.612 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 32.3 p90 -139.12 151.33 46.58 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 120.731 0.301 . . . . 72.31 110.826 -179.194 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -131.25 130.2 42.56 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.435 -0.95 . . . . 71.41 108.435 177.878 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -97.62 123.16 41.42 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 123.649 0.593 . . . . 61.33 110.039 179.204 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.22 135.47 53.77 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 107.043 -1.466 . . . . 31.54 107.043 173.191 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -112.67 139.42 48.29 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.771 -0.825 . . . . 74.2 108.771 179.703 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 457' ' ' SER . . . . . 0.488 ' O ' ' HA2' ' A' ' 489' ' ' GLY . 23.2 t -141.94 136.34 15.1 Favored Pre-proline 0 C--N 1.287 -2.118 0 N-CA-C 108.898 -0.778 . . . . 74.25 108.898 179.708 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.687 ' HA ' ' O ' ' A' ' 490' ' ' SER . 30.4 Cg_endo -65.8 131.35 27.18 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.169 1.913 . . . . 72.12 110.54 175.994 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 46.1 m -147.34 174.88 11.24 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 122.259 -0.276 . . . . 61.43 110.402 -177.491 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 3.9 t -50.66 142.98 15.16 Favored Pre-proline 0 N--CA 1.446 -0.658 0 C-N-CA 124.973 1.309 . . . . 74.42 111.716 176.689 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.54 -29.73 33.13 Favored 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 124.653 3.569 . . . . 74.51 113.153 -177.481 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -68.53 -35.06 76.94 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.379 -0.373 . . . . 72.52 111.197 179.29 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -96.18 -9.11 31.32 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 113.057 0.762 . . . . 51.33 113.057 -178.345 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 92.9 t -60.5 127.11 19.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.795 -0.817 . . . . 74.42 108.795 175.975 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.98 -1.43 67.92 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 111.788 -0.525 . . . . 65.52 111.788 -178.567 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.496 ' HG3' ' HB3' ' A' ' 435' ' ' LEU . 10.0 mptt -122.89 155.18 37.2 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-O 121.595 0.712 . . . . 74.02 111.336 -178.884 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 73.4 t -68.45 137.77 23.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 114.115 -1.402 . . . . 75.02 109.718 175.861 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 40.3 mm -97.95 -28.02 3.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 108.386 -0.968 . . . . 72.42 108.386 -179.811 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 168.36 164.43 24.04 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.238 -0.982 . . . . 60.34 113.088 177.556 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 1.1 t -116.96 142.8 46.47 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 107.468 -1.308 . . . . 75.13 107.468 176.369 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.423 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 47.4 t30 -70.65 -53.14 9.81 Favored Pre-proline 0 C--N 1.321 -0.642 0 C-N-CA 119.493 -0.883 . . . . 73.2 111.242 177.457 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.465 ' HG2' ' HA ' ' A' ' 484' ' ' VAL . 27.6 Cg_exo -65.95 134.79 38.52 Favored 'Trans proline' 0 C--N 1.368 1.589 0 N-CA-C 108.269 -1.473 . . . . 74.31 108.269 171.58 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 472' ' ' PRO . 21.0 Cg_exo -62.48 127.6 21.29 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.213 1.942 . . . . 72.42 111.791 -176.823 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -71.43 2.17 5.33 Favored 'General case' 0 C--O 1.209 -1.058 0 CA-C-N 115.816 -0.629 . . . . 72.43 112.578 -177.401 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -108.89 -12.96 14.83 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.164 0.507 . . . . 75.14 111.402 179.283 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -102.26 173.05 6.54 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.235 0.54 . . . . 74.2 112.02 -172.757 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 1.3 m -91.69 119.92 31.98 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 115.277 -0.874 . . . . 62.33 108.902 -177.646 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 13.1 p -102.46 145.96 28.8 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.148 0.499 . . . . 63.43 110.925 -177.935 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -80.38 154.16 27.89 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.909 -0.587 . . . . 73.13 111.376 -176.252 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 23.1 mm -74.02 -6.19 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 CA-C-O 122.154 0.978 . . . . 72.12 110.498 -177.793 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 6.4 p -108.48 5.42 25.22 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.488 0.661 . . . . 51.3 111.156 177.927 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -97.36 150.59 20.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.52 -0.764 . . . . 71.41 111.251 -173.772 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 59.8 t -108.14 126.4 64.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 123.667 0.787 . . . . 63.33 110.452 -177.054 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.612 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 61.0 t -101.03 120.03 49.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 120.892 0.377 . . . . 74.44 110.361 -179.985 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.98 126.03 59.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 109.022 -0.732 . . . . 72.31 109.022 177.525 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 16.8 mt -120.55 128.35 76.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 114.749 -1.114 . . . . 64.15 111.506 -177.132 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 6.9 tt -103.62 126.95 58.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 115.481 -0.781 . . . . 73.12 109.849 177.795 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 2.4 p -119.02 139.04 47.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 123.39 0.676 . . . . 74.11 110.076 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 457' ' ' SER . . . -77.08 127.64 8.55 Favored Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 111.034 -0.827 . . . . 72.42 111.034 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.687 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 23.0 t . . . . . 0 C--N 1.301 -1.513 0 N-CA-C 108.05 -1.093 . . . . 71.35 108.05 -178.289 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo . . . . . 0 N--CA 1.444 -1.403 0 CA-C-O 121.283 0.451 . . . . 43.21 112.312 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -96.7 24.28 6.19 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 122.655 1.217 . . . . 65.11 108.601 178.012 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 546' ' ' PRO . 18.7 p -117.07 149.25 40.6 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 112.615 -2.084 . . . . 72.24 109.296 -175.805 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 495' ' ' LYS . . . . . 0.4 ' HD2' ' O ' ' A' ' 515' ' ' TYR . 64.9 mttm -137.01 147.71 46.41 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.263 -0.643 . . . . 61.25 109.263 174.873 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 6.3 p-10 -80.7 129.92 34.8 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 124.014 0.821 . . . . 72.54 109.418 179.071 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 497' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 543' ' ' THR . 36.3 pt -87.19 131.31 44.87 Favored Pre-proline 0 C--N 1.295 -1.762 0 CA-C-N 115.825 -0.625 . . . . 75.3 110.506 179.391 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.56 -172.34 1.46 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.216 1.944 . . . . 73.15 109.377 173.302 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -82.01 149.47 28.11 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.4 -1.334 . . . . 71.51 107.4 176.937 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.56 85.98 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 CA-C-O 122.59 1.186 . . . . 73.15 108.94 177.111 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -149.86 128.54 12.4 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 114.218 -1.355 . . . . 72.14 108.876 -178.038 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 122.77 -20.8 7.66 Favored Glycine 0 N--CA 1.435 -1.429 0 C-N-CA 120.246 -0.978 . . . . 73.21 111.673 177.354 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.87 177.39 4.86 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 120.952 0.406 . . . . 63.25 110.843 178.619 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 9.4 t -87.95 157.88 18.82 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.102 -0.703 . . . . 61.14 109.102 -178.912 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.3 p -50.6 -41.63 20.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 124.317 1.047 . . . . 73.11 112.043 -179.181 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -61.74 -41.53 97.79 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.043 0.386 . . . . 74.41 112.043 179.129 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 89.6 t -71.21 -42.43 75.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-O 121.243 0.544 . . . . 65.55 109.891 179.084 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -60.41 -42.45 96.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.489 -0.778 . . . . 53.12 110.633 179.143 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -59.41 -46.22 89.33 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.27 -0.877 . . . . 54.33 109.953 179.673 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.425 ' O ' HG23 ' A' ' 514' ' ' VAL . 2.8 tmmm? -60.49 -44.3 96.09 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.163 -0.926 . . . . 71.43 108.904 -179.09 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -61.97 -48.09 81.91 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 116.117 -0.492 . . . . 70.3 111.035 -179.407 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.93 -38.89 92.76 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 111.804 0.298 . . . . 75.35 111.804 179.402 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -63.14 -38.17 90.12 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 121.232 -0.187 . . . . 73.33 110.939 179.014 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 510' ' ' LYS . 72.2 t -61.17 -35.46 65.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.027 0.441 . . . . 72.5 110.648 176.605 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 515' ' ' TYR . . . . . 0.4 ' O ' ' HD2' ' A' ' 495' ' ' LYS . 22.8 m-85 -79.06 -4.53 50.67 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 120.886 0.374 . . . . 75.52 110.99 -178.631 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 97.62 3.12 58.48 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 120.653 -0.784 . . . . 35.13 112.685 177.021 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.497 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 85.2 m-85 -86.44 115.24 23.82 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 108.032 -1.099 . . . . 73.53 108.032 -178.881 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.4 m -114.77 11.26 16.74 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 119.489 -0.884 . . . . 72.0 111.166 -176.27 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 519' ' ' LYS . . . . . 0.409 ' HB3' HG22 ' A' ' 550' ' ' VAL . 67.7 mttm -129.41 114.23 15.9 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.279 -0.637 . . . . 72.41 109.279 176.249 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -130.86 150.54 51.97 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 115.645 -0.707 . . . . 74.34 110.075 178.743 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 68.9 m -126.73 146.76 50.1 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 107.174 -1.417 . . . . 74.22 107.174 172.82 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -117.94 129.37 55.57 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 120.251 -0.58 . . . . 73.24 109.956 -179.392 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -105.33 115.99 31.19 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 106.867 -1.531 . . . . 71.35 106.867 175.576 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 19.4 m -88.89 114.74 25.84 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 121.676 0.751 . . . . 61.21 110.602 -176.509 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 28.1 m -121.47 168.83 13.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-N 114.464 -1.244 . . . . 75.33 108.232 -178.014 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 526' ' ' ASP . . . . . 0.544 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 7.0 p-10 -103.74 149.65 24.8 Favored 'General case' 0 C--N 1.282 -2.336 0 C-N-CA 120.049 -0.66 . . . . 73.11 111.748 -177.778 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 19.8 m -149.44 178.13 1.58 Allowed Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 105.286 -2.116 . . . . 72.44 105.286 177.012 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -87.65 -12.44 4.46 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 121.29 1.327 . . . . 73.53 111.523 172.168 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.4 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 35.5 mtp85 -87.01 148.42 45.25 Favored Pre-proline 0 N--CA 1.428 -1.546 0 C-N-CA 123.484 0.714 . . . . 72.41 109.332 179.033 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -56.14 148.47 59.28 Favored 'Trans proline' 0 C--O 1.259 1.556 0 C-N-CA 124.019 3.146 . . . . 74.34 117.13 -170.598 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.56 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -61.2 137.39 58.24 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 113.367 -1.742 . . . . 73.43 111.054 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 108.9 -17.95 32.0 Favored Glycine 0 N--CA 1.429 -1.828 0 N-CA-C 110.895 -0.882 . . . . 53.35 110.895 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -80.38 136.63 36.41 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 109.731 -0.47 . . . . 74.21 109.731 178.314 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 60.0 t -86.14 120.74 36.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.037 -1.097 . . . . 53.3 108.037 178.329 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 535' ' ' THR . . . . . 0.509 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 9.7 t -92.91 -1.97 56.25 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.946 -0.57 . . . . 73.45 110.78 -176.882 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 144.27 -167.19 26.99 Favored Glycine 0 CA--C 1.496 -1.095 0 N-CA-C 111.216 -0.754 . . . . 73.33 111.216 176.238 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 12.6 p -118.55 160.1 22.37 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 117.398 0.599 . . . . 61.05 110.288 176.036 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.454 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 35.4 t30 -71.2 -51.64 10.05 Favored Pre-proline 0 C--N 1.31 -1.144 0 CA-C-N 116.244 -0.434 . . . . 71.12 110.104 175.81 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.454 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 14.0 Cg_exo -72.59 135.87 24.84 Favored 'Trans proline' 0 C--N 1.38 2.208 0 N-CA-C 109.134 -1.141 . . . . 75.0 109.134 171.287 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.69 154.51 67.92 Favored 'Trans proline' 0 C--O 1.254 1.285 0 C-N-CA 122.364 2.042 . . . . 74.23 113.415 -177.094 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.06 138.11 58.21 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.429 -0.805 . . . . 73.22 110.163 178.747 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.56 -20.4 34.63 Favored Glycine 0 C--N 1.305 -1.174 0 N-CA-C 111.755 -0.538 . . . . 75.53 111.755 -179.362 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.428 ' O ' HG12 ' A' ' 497' ' ' ILE . 25.6 m -70.63 133.39 46.64 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.34 -0.245 . . . . 75.31 110.34 -178.443 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 15.0 t -98.12 129.58 44.92 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 109.083 -0.71 . . . . 72.22 109.083 177.037 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 7.1 m -136.43 154.4 76.91 Favored Pre-proline 0 C--N 1.297 -1.675 0 CA-C-N 115.668 -0.696 . . . . 63.21 109.218 179.732 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 494' ' ' THR . 26.9 Cg_exo -64.57 139.01 62.02 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.435 2.09 . . . . 64.23 111.244 178.414 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.497 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 35.3 m -63.85 -20.87 27.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 113.313 0.857 . . . . 74.22 113.313 -175.643 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -94.43 4.03 54.39 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.848 0.832 . . . . 44.44 110.508 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 39.4 m -93.54 179.49 5.37 Favored 'General case' 0 N--CA 1.437 -1.101 0 O-C-N 121.911 -0.493 . . . . 74.53 110.524 178.606 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.409 HG22 ' HB3' ' A' ' 519' ' ' LYS . 19.8 t -106.83 131.6 56.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 116.468 -0.333 . . . . 74.42 111.078 -174.117 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 551' ' ' ILE . . . . . 0.503 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -114.44 136.69 50.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 108.396 -0.964 . . . . 54.11 108.396 172.164 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -103.68 124.14 48.3 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 121.421 0.629 . . . . 53.23 111.726 -178.622 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.3 mp -97.37 134.77 40.2 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.681 -1.145 . . . . 70.33 110.014 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -86.97 119.06 26.78 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.505 -1.665 . . . . 73.23 106.505 177.313 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 59.6 t -114.41 131.07 67.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.793 -0.567 . . . . 53.0 109.866 -178.13 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.56 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 69.8 m -81.35 157.89 24.88 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 113.407 0.892 . . . . 73.02 113.407 -178.242 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.544 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 14.2 ptpt -119.08 158.34 26.06 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 105.326 -2.102 . . . . 74.5 105.326 167.519 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 558' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -75.03 -42.65 29.01 Favored Glycine 0 CA--C 1.485 -1.808 0 C-N-CA 119.949 -1.12 . . . . 63.23 112.432 -174.597 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 55.7 t30 67.35 -12.4 0.26 Allowed 'General case' 0 CA--C 1.569 1.696 0 C-N-CA 124.186 0.994 . . . . 74.43 112.759 173.48 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.477 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 71.3 mt-30 -136.63 160.73 37.92 Favored 'General case' 0 C--O 1.253 1.289 0 C-N-CA 125.859 1.663 . . . . 72.24 107.505 176.373 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -138.92 136.6 35.65 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 110.117 -0.327 . . . . 65.02 110.117 176.708 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 8.3 p -59.89 121.68 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 121.599 0.714 . . . . 74.43 112.176 -178.013 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 21.4 ptm -87.6 147.05 40.72 Favored Pre-proline 0 C--O 1.252 1.211 0 CA-C-N 115.654 -0.703 . . . . 73.05 112.803 -175.085 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.69 170.78 19.56 Favored 'Trans proline' 0 CA--C 1.551 1.329 0 C-N-CA 124.566 3.511 . . . . 64.42 112.902 175.457 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.5 124.07 28.62 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.995 -0.548 . . . . 75.21 112.15 177.883 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -112.61 -3.31 14.35 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 122.045 0.926 . . . . 71.24 108.815 174.398 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 11.1 m -68.24 137.53 54.83 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.103 -1.408 . . . . 72.12 111.455 -177.587 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 80.4 30.92 39.15 Favored Glycine 0 N--CA 1.438 -1.203 0 C-N-CA 121.103 -0.57 . . . . 62.11 112.019 176.338 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 64.6 mtt -137.3 173.23 11.9 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.899 -0.778 . . . . 74.21 108.899 -178.677 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 570' ' ' PHE . . . . . 0.495 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 89.0 m-85 -100.28 166.26 11.07 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 109.29 -0.633 . . . . 75.12 109.29 179.252 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 69.9 t90 -67.73 -28.47 67.67 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.327 -0.619 . . . . 71.11 109.327 178.059 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 10.2 p -68.56 -10.02 12.41 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 CA-C-N 115.63 -0.713 . . . . 72.45 110.409 176.739 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 573' ' ' ASP . . . . . 0.454 ' O ' ' HG3' ' A' ' 577' ' ' ARG . 38.0 m-20 -100.59 -44.51 5.82 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 108.163 -1.051 . . . . 73.23 108.163 173.611 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 574' ' ' ALA . . . . . 0.461 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -59.35 -51.74 68.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.112 -0.949 . . . . 65.11 112.564 -177.33 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.573 ' OE2' ' HD3' ' A' ' 579' ' ' ARG . 21.0 tp10 -52.95 -56.77 20.27 Favored Pre-proline 0 CA--C 1.562 1.431 0 CA-C-O 119.02 -0.514 . . . . 73.34 112.09 -179.666 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 576' ' ' PRO . . . . . 0.446 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 53.5 Cg_exo -57.77 -38.16 93.91 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.126 1.884 . . . . 74.23 112.595 176.332 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 573' ' ' ASP . 80.8 mtp180 -65.79 -36.85 84.69 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 120.864 -0.335 . . . . 74.34 111.332 -179.558 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 96.1 mt -63.36 -38.77 92.45 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.128 0.49 . . . . 73.51 109.797 178.192 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 579' ' ' ARG . . . . . 0.573 ' HD3' ' OE2' ' A' ' 575' ' ' GLU . 7.0 mmm180 -65.3 -45.79 82.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.509 -0.769 . . . . 74.13 108.941 179.562 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.22 -29.81 70.14 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.369 -0.832 . . . . 70.41 112.213 -178.318 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 95.5 mt -81.59 -6.3 58.86 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.843 0.354 . . . . 74.02 110.833 178.53 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 72.87 35.77 58.08 Favored Glycine 0 N--CA 1.439 -1.114 0 N-CA-C 111.456 -0.657 . . . . 54.3 111.456 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 583' ' ' TRP . . . . . 0.405 ' CH2' ' HB2' ' A' ' 587' ' ' LEU . 79.1 t90 -76.22 128.65 35.35 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.782 -0.451 . . . . 74.12 109.782 -179.79 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 17.6 m -150.54 86.56 1.4 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.899 -0.778 . . . . 62.24 108.899 174.106 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -147.73 -142.92 3.74 Favored Glycine 0 C--N 1.309 -0.943 0 N-CA-C 110.244 -1.142 . . . . 63.24 110.244 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 47.7 tpp -96.51 125.21 40.84 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 117.538 0.669 . . . . 70.45 110.964 177.409 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 587' ' ' LEU . . . . . 0.405 ' HB2' ' CH2' ' A' ' 583' ' ' TRP . 3.4 tm? -96.23 128.96 43.62 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.54 -1.652 . . . . 71.05 106.54 175.434 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -94.99 123.26 38.37 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 105.241 -2.133 . . . . 65.11 105.241 178.439 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -85.52 121.42 28.2 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 113.251 0.834 . . . . 73.23 113.251 -162.483 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -105.47 144.0 15.74 Favored Glycine 0 N--CA 1.407 -3.237 0 N-CA-C 107.875 -2.09 . . . . 63.44 107.875 171.3 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -94.21 150.93 19.85 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 117.072 0.436 . . . . 75.33 110.018 -179.251 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -73.44 124.8 26.51 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.314 -1.365 . . . . 75.24 107.314 173.271 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 41.1 t -105.94 123.35 60.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 CA-C-N 116.188 -0.46 . . . . 73.51 111.367 -175.235 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 594' ' ' ASP . . . . . 0.446 ' HA ' ' HB2' ' A' ' 626' ' ' GLN . 6.3 p-10 -81.32 107.8 14.41 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.477 -1.305 . . . . 75.42 107.477 173.938 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -136.08 21.1 3.24 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.615 -0.72 . . . . 73.24 109.725 -177.844 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 101.18 173.46 28.75 Favored Glycine 0 N--CA 1.427 -1.914 0 C-N-CA 120.267 -0.968 . . . . 33.04 110.812 -177.505 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -62.18 -33.42 85.84 Favored Glycine 0 C--O 1.218 -0.865 0 N-CA-C 114.188 0.435 . . . . 53.33 114.188 -175.093 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 13.7 m -58.31 -24.44 59.64 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 113.806 1.039 . . . . 52.0 113.806 -175.828 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -98.49 -0.31 43.63 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 113.343 0.868 . . . . 74.45 113.343 -175.339 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 600' ' ' HIS . . . . . 0.476 ' HA ' ' OXT' ' A' ' 626' ' ' GLN . 5.7 p80 -35.46 98.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 115.682 1.734 . . . . 65.44 115.682 -174.264 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 52.95 10.29 0.15 Allowed 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 126.075 1.75 . . . . 63.22 115.381 172.09 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 602' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 38.4 ttt180 -79.83 143.34 34.46 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.945 -1.097 . . . . 71.35 110.945 -175.408 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 87.9 t -74.58 131.0 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 108.224 -1.028 . . . . 71.03 108.224 179.818 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 46.5 t -94.04 -48.09 13.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.332 0.587 . . . . 74.34 110.248 -175.345 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -148.34 151.19 34.93 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.635 -0.711 . . . . 63.41 110.049 179.099 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 606' ' ' GLN . . . . . 0.461 ' HA ' ' O ' ' A' ' 621' ' ' THR . 14.4 pt20 -115.57 141.7 47.71 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.869 -1.16 . . . . 71.14 107.869 174.372 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.612 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 3.9 t30 -51.35 -57.16 15.16 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 123.66 0.6 . . . . 74.31 112.274 -175.915 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.612 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 9.6 Cg_endo -100.01 138.66 0.27 Allowed 'Trans proline' 0 N--CA 1.433 -2.069 0 C-N-CA 121.742 1.628 . . . . 73.14 110.096 172.271 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -70.13 147.14 59.82 Favored 'Trans proline' 0 C--O 1.252 1.177 0 C-N-CA 121.313 1.342 . . . . 53.05 109.918 175.753 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -62.37 138.98 58.55 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.886 0.375 . . . . 52.54 110.551 -178.874 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.16 -8.21 44.84 Favored Glycine 0 N--CA 1.431 -1.649 0 N-CA-C 110.598 -1.001 . . . . 61.15 110.598 -175.032 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 6.1 m -100.83 157.29 16.83 Favored 'General case' 0 C--O 1.249 1.066 0 N-CA-C 108.384 -0.969 . . . . 63.23 108.384 178.174 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -85.69 132.18 10.95 Favored Glycine 0 N--CA 1.428 -1.867 0 N-CA-C 111.227 -0.749 . . . . 55.31 111.227 178.35 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 21.8 m -97.43 142.47 14.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 110.055 -0.35 . . . . 70.43 110.055 178.166 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.477 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 30.1 p-10 -57.05 167.13 0.88 Allowed 'General case' 0 N--CA 1.436 -1.164 0 O-C-N 124.476 1.11 . . . . 74.04 112.478 -178.821 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -61.02 -25.33 66.83 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.832 -1.077 . . . . 63.04 111.847 -178.035 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -78.44 -37.04 44.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.445 -0.343 . . . . 65.24 110.536 176.298 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 90.5 22.4 34.45 Favored Glycine 0 C--O 1.211 -1.307 0 C-N-CA 119.254 -1.451 . . . . 31.42 112.444 179.153 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.82 123.14 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 CA-C-O 122.63 1.205 . . . . 62.41 110.819 -168.754 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 6.3 tp -129.34 132.37 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 113.839 -1.528 . . . . 71.44 111.256 -174.085 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 606' ' ' GLN . 44.2 m -104.45 137.27 42.57 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 107.971 -1.122 . . . . 71.02 107.971 174.629 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 88.7 mt -138.15 157.01 47.16 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.243 -1.391 . . . . 63.42 107.243 178.638 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -144.25 136.6 26.59 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 104.178 -2.527 . . . . 64.34 104.178 177.063 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 602' ' ' ARG . 6.8 p90 -143.06 161.65 37.6 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 123.658 0.599 . . . . 71.4 111.526 -177.463 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -88.18 -163.62 39.4 Favored Glycine 0 N--CA 1.426 -2.004 0 C-N-CA 120.836 -0.697 . . . . 41.13 111.797 177.648 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 626' ' ' GLN . . . . . 0.476 ' OXT' ' HA ' ' A' ' 600' ' ' HIS . 56.5 tp60 . . . . . 0 C--N 1.303 -1.444 0 C-N-CA 123.166 0.586 . . . . 72.34 110.352 -177.72 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 CA--C 1.506 -0.736 0 CA-C-O 121.07 0.462 . . . . 72.44 109.944 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 360' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 409' ' ' SER . 35.9 m -120.73 163.06 18.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 115.724 -0.671 . . . . 64.32 109.411 -175.475 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -94.05 136.94 33.8 Favored 'General case' 0 N--CA 1.39 -3.45 0 N-CA-C 108.733 -0.84 . . . . 52.31 108.733 176.103 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 94.7 t -97.8 129.28 31.67 Favored Pre-proline 0 C--N 1.269 -2.908 0 CA-C-N 114.289 -1.323 . . . . 62.43 109.566 -173.521 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -65.33 120.3 7.48 Favored 'Trans proline' 0 N--CA 1.443 -1.489 0 C-N-CA 121.769 1.646 . . . . 73.33 110.37 176.905 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -97.03 83.17 3.31 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 106.981 -1.488 . . . . 73.42 106.981 -175.473 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 30.2 m -71.65 34.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 125.997 1.719 . . . . 73.34 115.053 -171.748 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.431 ' HG3' ' OG1' ' A' ' 402' ' ' THR . 21.0 mmt180 -65.41 148.38 51.81 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 125.315 1.446 . . . . 71.34 111.795 177.377 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 106.47 0.67 37.52 Favored Glycine 0 CA--C 1.501 -0.791 0 N-CA-C 111.028 -0.829 . . . . 65.32 111.028 -175.704 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -111.03 -154.53 0.54 Allowed 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 108.392 -0.966 . . . . 70.41 108.392 175.025 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 61.8 p -96.26 168.24 10.7 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 109.765 -0.457 . . . . 74.54 109.765 -176.701 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.88 -46.99 85.25 Favored 'General case' 0 N--CA 1.421 -1.918 0 CA-C-N 115.339 -0.846 . . . . 54.04 109.329 179.706 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.38 -44.83 82.04 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.701 -0.681 . . . . 71.2 112.411 -176.858 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -66.94 -47.2 72.39 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.885 0.374 . . . . 61.54 110.097 -177.144 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -67.35 -41.12 85.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.87 -0.604 . . . . 73.02 111.873 -177.99 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 66.5 mt -68.09 -39.8 81.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 116.692 -0.231 . . . . 71.33 110.399 177.809 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.16 -38.65 89.85 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 120.799 0.333 . . . . 50.13 110.34 179.61 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 376' ' ' THR . . . . . 0.608 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 52.0 m -63.14 -47.9 80.75 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.725 -0.67 . . . . 71.54 110.199 179.307 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 98.2 mt -64.01 -42.33 97.18 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 116.33 -0.396 . . . . 74.22 110.506 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -64.21 -41.67 96.95 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.967 -0.561 . . . . 72.1 109.758 179.826 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -69.82 -17.64 63.41 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 112.969 0.729 . . . . 75.1 112.969 177.404 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 380' ' ' ARG . . . . . 0.608 ' HG2' ' O ' ' A' ' 376' ' ' THR . 6.9 mmp_? -88.78 -10.8 46.89 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.653 -0.499 . . . . 73.11 109.653 175.468 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.48 2.9 55.51 Favored Glycine 0 C--N 1.32 -0.36 0 CA-C-N 115.948 -0.569 . . . . 65.3 112.786 178.157 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -82.62 154.23 25.04 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-O 121.254 0.55 . . . . 33.44 111.895 -177.864 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -101.26 145.8 28.38 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.224 -1.399 . . . . 75.14 107.224 179.8 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 384' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 1.1 mp -129.38 144.01 39.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.171 -1.048 . . . . 71.31 108.171 179.252 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 385' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 385' ' ' ARG . 13.9 ttm180 -110.56 127.87 55.4 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 105.714 -1.958 . . . . 72.32 105.714 174.203 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 23.7 m -114.04 117.41 31.22 Favored 'General case' 0 C--N 1.271 -2.827 0 N-CA-C 108.074 -1.084 . . . . 74.4 108.074 -178.828 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.55 128.77 56.56 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.361 -0.977 . . . . 53.32 108.361 -177.96 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 388' ' ' GLN . . . . . 0.405 ' HB3' ' OG1' ' A' ' 422' ' ' THR . 1.8 mp0 -99.78 127.94 45.9 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.666 -0.494 . . . . 73.11 109.666 -178.507 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 389' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 421' ' ' SER . 98.0 mttt -132.74 123.35 18.23 Favored Pre-proline 0 C--N 1.313 -1.017 0 N-CA-C 111.781 0.289 . . . . 73.34 111.781 178.61 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 390' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 389' ' ' LYS . 4.2 Cg_exo -82.69 128.09 5.16 Favored 'Trans proline' 0 C--O 1.254 1.288 0 C-N-CA 121.865 1.71 . . . . 72.21 109.032 171.779 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.563 ' HB3' ' CD1' ' A' ' 394' ' ' ILE . 10.2 t70 171.95 -162.17 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 105.174 -2.158 . . . . 63.5 105.174 -174.956 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 36.1 p -141.57 2.3 1.61 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.171 0.51 . . . . 61.5 111.186 178.157 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 25.6 m -98.92 -25.99 14.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.395 0.617 . . . . 75.52 111.381 -175.011 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.563 ' CD1' ' HB3' ' A' ' 391' ' ' ASP . 0.2 OUTLIER -88.53 152.29 49.31 Favored Pre-proline 0 C--N 1.298 -1.636 0 CA-C-N 116.075 -0.511 . . . . 72.34 109.911 -178.167 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 395' ' ' PRO . . . . . 0.428 ' HB3' HG22 ' A' ' 400' ' ' ILE . 7.6 Cg_exo -35.59 150.71 0.03 OUTLIER 'Trans proline' 0 CA--C 1.553 1.453 1 C-N-CA 125.468 4.112 . . . . 74.15 116.924 177.631 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.72 162.58 10.46 Favored 'Trans proline' 0 C--N 1.364 1.388 0 C-N-CA 124.147 3.231 . . . . 64.22 110.619 172.088 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 397' ' ' ASP . . . . . 0.548 ' HA ' HG13 ' A' ' 420' ' ' VAL . 0.9 OUTLIER -59.12 -9.69 2.22 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 113.181 0.808 . . . . 72.43 113.181 -176.232 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -95.06 -178.82 4.61 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 108.77 -0.826 . . . . 72.32 108.77 178.923 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 27.6 m -97.73 117.46 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.825 0 C-N-CA 117.065 -1.854 . . . . 72.01 110.575 179.597 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 400' ' ' ILE . . . . . 0.428 HG22 ' HB3' ' A' ' 395' ' ' PRO . 0.0 OUTLIER -107.89 -47.4 7.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 109.44 -0.578 . . . . 71.23 109.44 175.337 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.75 169.19 27.94 Favored Glycine 0 N--CA 1.427 -1.947 0 N-CA-C 111.141 -0.784 . . . . 60.01 111.141 -177.5 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 402' ' ' THR . . . . . 0.431 ' OG1' ' HG3' ' A' ' 366' ' ' ARG . 0.6 OUTLIER -155.67 -176.08 5.77 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 125.479 1.511 . . . . 54.23 109.935 -176.911 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -99.0 155.41 36.6 Favored Pre-proline 0 C--N 1.299 -1.61 0 N-CA-C 106.605 -1.628 . . . . 54.34 106.605 -178.962 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -59.93 10.56 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 124.575 3.517 . . . . 73.21 116.156 -172.842 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -53.45 -43.94 68.47 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 122.868 0.467 . . . . 60.44 111.855 -179.355 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -79.53 -32.33 42.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.251 0.548 . . . . 61.51 111.019 -179.177 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -79.74 1.57 26.1 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.108 0.48 . . . . 72.12 111.211 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 51.0 m -105.47 149.56 26.07 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.676 -1.601 . . . . 75.1 106.676 172.382 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 409' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 360' ' ' VAL . 15.0 p -76.0 113.48 13.56 Favored 'General case' 0 N--CA 1.422 -1.826 0 C-N-CA 119.806 -0.758 . . . . 63.21 110.975 178.77 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.4 m -121.93 170.0 12.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.377 -0.829 . . . . 44.44 109.482 178.869 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 33.3 t -76.52 157.15 32.34 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.145 -0.687 . . . . 63.11 109.145 179.759 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -69.24 109.87 4.32 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-O 121.289 0.566 . . . . 52.2 110.079 179.754 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 108.38 55.61 0.59 Allowed Glycine 0 N--CA 1.433 -1.514 0 CA-C-N 115.095 -0.957 . . . . 71.13 111.413 179.152 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -100.32 -173.18 2.35 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.739 -1.208 . . . . 74.44 107.739 178.057 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -120.08 113.86 21.12 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.414 -0.587 . . . . 74.15 109.414 -177.34 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 416' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 44.9 mm -104.32 133.71 47.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 108.822 -0.807 . . . . 74.3 108.822 -179.058 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 80.3 m -101.82 132.24 47.68 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 122.022 -0.424 . . . . 62.21 110.192 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 9.7 p -115.44 134.36 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 108.888 -0.782 . . . . 70.11 108.888 176.622 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -105.26 114.2 28.24 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.812 0.815 . . . . 75.43 109.286 177.805 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.548 HG13 ' HA ' ' A' ' 397' ' ' ASP . 96.3 t -111.22 131.39 62.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 114.569 -1.196 . . . . 71.13 108.846 -174.209 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 421' ' ' SER . . . . . 0.465 ' HB2' HG12 ' A' ' 394' ' ' ILE . 17.3 t -92.67 121.82 34.47 Favored 'General case' 0 N--CA 1.428 -1.553 0 C-N-CA 119.53 -0.868 . . . . 74.32 110.0 179.265 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 422' ' ' THR . . . . . 0.405 ' OG1' ' HB3' ' A' ' 388' ' ' GLN . 33.9 p -120.09 107.28 12.85 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 116.152 -0.476 . . . . 73.14 110.225 174.244 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.193 0 C-N-CA 119.94 -1.124 . . . . 63.31 113.438 176.255 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 . . . . . 0 N--CA 1.43 -1.47 0 N-CA-C 107.334 -1.358 . . . . 63.35 107.334 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -121.22 151.79 39.58 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 119.585 -0.846 . . . . 74.55 112.428 -169.817 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 34.9 tt0 -83.63 138.77 33.19 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.299 -1.319 . . . . 75.44 109.009 -176.488 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 70.7 mt -80.59 116.65 63.44 Favored Pre-proline 0 C--N 1.306 -1.305 0 N-CA-C 108.082 -1.081 . . . . 70.2 108.082 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -71.29 140.62 37.42 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.476 1.451 . . . . 75.13 110.201 176.398 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.28 128.62 35.48 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.413 -1.328 . . . . 74.22 107.413 175.603 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 42.9 t -118.28 157.45 19.72 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 107.514 -1.291 . . . . 73.43 107.514 -177.889 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.524 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 15.4 m -63.74 146.64 53.49 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-O 120.961 0.41 . . . . 71.45 110.985 -179.511 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 34.8 p -69.14 -25.91 64.62 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 124.66 1.184 . . . . 71.45 112.574 -170.511 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.493 ' H ' HD23 ' A' ' 435' ' ' LEU . 0.6 OUTLIER -90.61 -10.94 41.47 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 115.431 -0.804 . . . . 72.31 111.109 179.334 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.617 HG22 ' HB3' ' A' ' 439' ' ' GLU . 2.4 m -100.66 46.14 0.96 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.424 0.63 . . . . 74.44 109.729 -176.197 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -52.24 -42.79 63.92 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 113.892 1.071 . . . . 73.55 113.892 -178.944 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.52 -44.48 94.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.633 0.254 . . . . 45.34 110.996 -176.978 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.617 ' HB3' HG22 ' A' ' 436' ' ' THR . 28.1 tt0 -70.62 -33.11 70.66 Favored 'General case' 0 C--O 1.195 -1.775 0 CA-C-N 116.474 -0.33 . . . . 73.11 110.777 174.484 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.417 ' O ' HD23 ' A' ' 444' ' ' LEU . . . -59.66 -52.28 66.18 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.988 -0.285 . . . . 54.44 110.75 179.127 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 33.7 m -62.48 -36.33 74.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.614 0.721 . . . . 71.11 110.398 177.437 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.532 ' HB3' ' HA ' ' A' ' 439' ' ' GLU . 20.7 ttmm -59.46 -46.79 87.76 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 124.97 1.308 . . . . 60.23 110.229 176.019 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -65.9 -38.76 89.59 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 123.282 0.633 . . . . 73.31 111.727 -179.64 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 440' ' ' ALA . 4.6 mm? -63.32 -34.64 78.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.054 -0.35 . . . . 71.43 110.054 174.859 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.527 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 32.4 m -69.66 -45.67 67.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.25 0.548 . . . . 71.33 110.221 178.129 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.63 -24.95 64.62 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.635 -0.711 . . . . 52.33 112.455 -178.118 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.57 -4.77 53.01 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.326 0.491 . . . . 73.22 112.326 -177.651 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 125.88 -79.59 0.37 Allowed Glycine 0 CA--C 1.497 -1.074 0 C-N-CA 119.96 -1.114 . . . . 71.11 111.98 177.447 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -42.65 -66.87 0.32 Allowed 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.372 1.069 . . . . 54.23 113.858 178.354 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 450' ' ' GLY . . . . . 0.527 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 63.1 25.54 68.24 Favored Glycine 0 CA--C 1.502 -0.766 0 O-C-N 123.362 0.414 . . . . 65.43 112.626 -178.338 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.504 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 8.6 mmt180 -105.31 110.61 23.03 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.432 -1.692 . . . . 72.31 106.432 -179.711 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.415 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 30.5 p90 -141.03 154.42 45.99 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-O 121.228 0.537 . . . . 64.03 112.091 -176.177 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 5.4 tppp? -137.11 135.0 37.04 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.477 -1.305 . . . . 63.44 107.477 177.681 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -100.03 133.08 44.93 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.312 -0.625 . . . . 74.4 109.312 176.915 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -126.67 151.73 47.69 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.724 -0.473 . . . . 71.14 109.724 177.878 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -113.9 141.3 47.53 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.589 -1.263 . . . . 74.42 107.589 179.245 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 37.3 t -138.1 135.34 18.48 Favored Pre-proline 0 C--N 1.283 -2.323 0 N-CA-C 109.122 -0.695 . . . . 41.4 109.122 178.394 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.642 ' HA ' ' O ' ' A' ' 490' ' ' SER . 51.0 Cg_endo -73.07 122.9 8.45 Favored 'Trans proline' 0 N--CA 1.439 -1.679 0 C-N-CA 121.521 1.481 . . . . 72.13 109.403 174.608 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 51.0 m -148.44 -179.79 7.22 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 109.685 -0.487 . . . . 64.24 109.685 -175.852 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.1 t -47.69 137.86 9.6 Favored Pre-proline 0 C--O 1.251 1.158 0 C-N-CA 124.556 1.143 . . . . 73.24 112.03 178.371 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -52.73 -29.31 41.49 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 124.642 3.562 . . . . 63.35 113.668 -175.958 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.403 ' HG2' ' H ' ' A' ' 462' ' ' GLU . 8.8 pt-20 -71.33 -26.61 62.91 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 112.718 0.636 . . . . 74.1 112.718 -178.53 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -93.89 -4.52 49.81 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.806 -0.559 . . . . 55.0 111.624 179.566 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 85.3 t -60.68 127.79 20.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-N 116.006 -0.543 . . . . 71.31 110.524 178.224 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 95.88 -7.27 67.5 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 115.613 -0.721 . . . . 61.35 113.862 176.456 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.443 ' O ' HG23 ' A' ' 488' ' ' VAL . 6.8 mptt -122.35 158.96 28.47 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.586 -0.894 . . . . 65.41 108.586 -179.707 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 488' ' ' VAL . 66.2 t -72.13 143.81 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.739 0 N-CA-C 107.999 -1.112 . . . . 61.31 107.999 176.624 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 58.3 mt -97.26 -27.73 3.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 107.492 -1.299 . . . . 70.3 107.492 179.409 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 153.18 -165.83 31.38 Favored Glycine 0 N--CA 1.419 -2.457 0 C-N-CA 120.541 -0.837 . . . . 61.14 111.956 175.558 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.13 142.69 46.48 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 106.991 -1.485 . . . . 72.01 106.991 176.979 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -67.68 -55.72 13.64 Favored Pre-proline 0 CA--C 1.548 0.879 0 N-CA-C 109.712 -0.477 . . . . 53.51 109.712 179.064 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.461 ' HA ' ' HD3' ' A' ' 473' ' ' PRO . 12.2 Cg_endo -61.15 133.84 49.16 Favored 'Trans proline' 0 C--N 1.37 1.659 0 N-CA-C 108.276 -1.471 . . . . 72.25 108.276 168.917 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 472' ' ' PRO . 32.5 Cg_exo -62.14 127.96 22.65 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.742 2.295 . . . . 72.42 113.821 -173.862 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -74.03 12.8 0.63 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.968 0.907 . . . . 63.22 111.234 178.59 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -111.03 -7.65 14.51 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.852 -0.613 . . . . 74.5 109.846 176.188 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -116.25 174.7 5.91 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 113.542 0.942 . . . . 60.44 113.542 -170.809 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 0.9 OUTLIER -99.09 141.12 32.27 Favored 'General case' 0 N--CA 1.411 -2.414 0 C-N-CA 124.513 1.125 . . . . 70.11 112.6 -179.173 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 28.3 p -137.82 149.17 46.12 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.11 -0.95 . . . . 64.25 109.362 177.765 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.93 162.11 27.37 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 120.846 0.355 . . . . 63.04 110.948 178.477 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.9 mp -67.57 -15.19 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-O 122.133 0.968 . . . . 74.41 110.976 -178.543 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.2 p -94.41 0.75 55.66 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 115.953 -0.567 . . . . 71.3 112.067 177.437 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -83.69 133.88 34.79 Favored 'General case' 0 CA--C 1.503 -0.855 0 O-C-N 122.005 -0.434 . . . . 73.44 111.414 -178.581 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.504 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.3 p -96.53 126.71 49.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.658 -0.701 . . . . 63.4 109.728 178.089 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 22.3 m -101.48 136.75 31.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-O 121.313 0.578 . . . . 64.33 110.346 178.703 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.79 120.24 58.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 109.005 -0.739 . . . . 52.32 109.005 178.98 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 37.2 mt -109.49 122.91 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 114.663 -1.153 . . . . 73.3 109.9 -177.249 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.4 tt -106.61 127.0 62.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 115.062 -0.972 . . . . 74.52 111.631 -173.533 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 466' ' ' LYS . 2.5 p -111.34 142.78 22.72 Favored 'Isoleucine or valine' 0 C--O 1.247 0.967 0 N-CA-C 109.088 -0.708 . . . . 64.11 109.088 176.411 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -88.17 141.11 16.69 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.88 -0.676 . . . . 25.14 113.468 -176.059 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.642 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 11.1 t . . . . . 0 N--CA 1.431 -1.414 0 N-CA-C 106.804 -1.554 . . . . 63.22 106.804 176.131 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo . . . . . 0 C--O 1.244 0.805 0 CA-C-O 120.987 0.328 . . . . 74.14 112.535 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -118.19 53.46 0.96 Allowed 'General case' 0 C--O 1.244 0.805 0 CA-C-O 122.302 1.048 . . . . 74.42 108.239 177.446 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 22.8 p -117.78 147.95 42.52 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.762 -1.108 . . . . 75.21 111.233 -176.022 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -141.47 161.79 37.05 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.139 -1.06 . . . . 62.12 108.139 177.495 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.3 p-10 -100.4 138.25 37.72 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.267 0.556 . . . . 74.33 110.754 178.951 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 30.9 pt -77.04 137.51 65.46 Favored Pre-proline 0 C--N 1.308 -1.234 0 CA-C-N 115.293 -0.867 . . . . 73.12 111.967 -178.56 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -81.79 176.32 8.51 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.692 2.261 . . . . 73.41 111.22 176.636 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -86.7 118.88 26.39 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 108.843 -0.799 . . . . 75.45 108.843 178.82 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.09 8.78 7.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-O 122.107 0.956 . . . . 65.4 109.967 -177.426 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -68.19 108.02 3.0 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.93 -1.032 . . . . 55.35 109.719 -179.343 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 132.13 -19.11 4.66 Favored Glycine 0 N--CA 1.432 -1.621 0 C-N-CA 120.689 -0.767 . . . . 53.02 111.36 -177.892 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -99.58 172.94 6.98 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.045 -0.662 . . . . 63.11 109.344 177.542 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 533' ' ' GLU . 40.2 p -90.81 157.69 17.23 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.105 -0.638 . . . . 64.55 110.866 -176.078 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 10.0 p -53.7 -40.75 44.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.848 0.685 . . . . 65.11 112.848 -175.982 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -62.76 -42.93 99.91 Favored 'General case' 0 C--O 1.249 1.064 0 CA-C-O 121.236 0.541 . . . . 73.4 110.387 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 87.8 t -74.66 -37.05 42.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.631 -0.713 . . . . 74.31 110.065 -178.936 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 508' ' ' ALA . . . . . 0.461 ' HA ' ' ND2' ' A' ' 511' ' ' ASN . . . -63.29 -50.24 70.87 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.261 -0.882 . . . . 71.33 111.957 -179.015 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -64.82 -35.53 81.41 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.853 0.359 . . . . 72.03 110.712 -178.965 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.447 ' O ' HG23 ' A' ' 514' ' ' VAL . 3.6 tppp? -65.63 -52.97 47.78 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.672 -0.695 . . . . 74.14 111.627 179.756 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 511' ' ' ASN . . . . . 0.461 ' ND2' ' HA ' ' A' ' 508' ' ' ALA . 8.0 p30 -66.02 -37.82 86.85 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 120.342 -0.543 . . . . 75.04 111.539 -176.452 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 512' ' ' LEU . . . . . 0.427 HD23 ' O ' ' A' ' 508' ' ' ALA . 4.6 mm? -60.08 -41.32 92.18 Favored 'General case' 0 C--O 1.246 0.904 0 C-N-CA 121.032 -0.267 . . . . 75.03 110.617 176.052 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -63.11 -38.22 90.31 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 116.414 -0.357 . . . . 64.14 111.158 178.336 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 510' ' ' LYS . 96.9 t -63.77 -30.98 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 CA-C-N 115.889 -0.596 . . . . 73.54 111.223 179.198 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -80.26 -13.22 59.39 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 120.502 -0.479 . . . . 72.24 111.647 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 119.0 -14.7 11.16 Favored Glycine 0 N--CA 1.434 -1.445 0 C-N-CA 119.955 -1.117 . . . . 64.4 112.504 178.716 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -77.44 102.56 6.91 Favored 'General case' 0 CA--C 1.481 -1.692 0 N-CA-C 106.182 -1.784 . . . . 71.45 106.182 -178.678 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.5 m -88.91 -28.86 20.03 Favored 'General case' 0 N--CA 1.407 -2.58 0 C-N-CA 119.479 -0.888 . . . . 74.25 113.03 -167.152 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 519' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 61.7 mttp -108.32 125.36 51.62 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.736 -0.785 . . . . 71.41 111.659 -174.508 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -130.64 149.49 52.27 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.727 -0.669 . . . . 75.44 110.851 -178.38 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 46.9 m -132.29 143.71 50.08 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.33 -1.359 . . . . 72.45 107.33 173.786 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -117.04 144.32 44.74 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 109.381 -0.6 . . . . 72.44 109.381 179.327 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -130.64 129.99 43.37 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.3 -0.63 . . . . 54.14 109.3 178.814 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 50.8 m -84.11 120.97 26.8 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.542 -0.54 . . . . 51.12 109.542 179.529 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 32.3 m -121.4 162.71 20.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 108.149 -1.056 . . . . 33.42 108.149 179.229 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 526' ' ' ASP . . . . . 0.622 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 6.9 p-10 -82.52 134.38 35.2 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 119.26 -0.976 . . . . 73.53 109.378 -178.57 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 527' ' ' SER . . . . . 0.506 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 51.1 m -152.73 167.99 12.28 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 110.231 -0.285 . . . . 72.41 110.231 177.13 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -85.7 -8.05 8.35 Favored 'Trans proline' 0 C--N 1.36 1.148 0 C-N-CA 122.284 1.99 . . . . 63.13 111.295 174.555 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.523 ' HD3' ' OE2' ' A' ' 533' ' ' GLU . 50.4 mtt180 -80.07 145.53 61.18 Favored Pre-proline 0 N--CA 1.445 -0.71 0 N-CA-C 107.589 -1.263 . . . . 73.21 107.589 178.467 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -61.31 152.29 73.42 Favored 'Trans proline' 0 C--O 1.256 1.422 0 C-N-CA 122.364 2.043 . . . . 44.31 112.585 -179.327 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.658 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -62.93 115.58 4.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.132 -0.94 . . . . 74.13 111.352 -176.238 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 134.3 -24.64 3.55 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 120.564 -0.827 . . . . 35.15 112.224 178.756 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 533' ' ' GLU . . . . . 0.523 ' OE2' ' HD3' ' A' ' 529' ' ' ARG . 32.0 tt0 -82.99 137.85 33.99 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.349 -0.541 . . . . 73.32 109.797 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 88.2 t -81.83 120.2 32.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.86 -0.793 . . . . 74.31 108.86 178.413 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 535' ' ' THR . . . . . 0.463 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 9.3 t -80.94 -13.27 59.05 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.314 -0.403 . . . . 61.43 110.154 -179.075 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.91 -170.76 29.29 Favored Glycine 0 N--CA 1.426 -2.005 0 N-CA-C 109.987 -1.245 . . . . 50.22 109.987 178.222 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 14.1 p -116.88 160.4 20.93 Favored 'General case' 0 C--N 1.273 -2.729 0 N-CA-C 108.384 -0.969 . . . . 74.14 108.384 178.959 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.504 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 38.1 t30 -67.02 -51.75 35.03 Favored Pre-proline 0 C--N 1.317 -0.841 0 C-N-CA 120.443 -0.503 . . . . 64.42 110.762 178.305 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.504 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 3.9 Cg_exo -77.45 131.13 11.35 Favored 'Trans proline' 0 C--N 1.367 1.538 0 N-CA-C 107.601 -1.73 . . . . 74.43 107.601 170.576 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.93 162.15 39.23 Favored 'Trans proline' 0 C--O 1.25 1.117 0 C-N-CA 122.142 1.895 . . . . 53.15 112.555 -177.215 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -56.99 131.33 49.52 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 109.415 -0.587 . . . . 35.12 109.415 175.783 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.9 -12.06 38.04 Favored Glycine 0 C--N 1.301 -1.399 0 C-N-CA 120.928 -0.654 . . . . 42.34 111.929 -177.656 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 56.5 m -68.16 120.68 14.74 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.222 -0.659 . . . . 75.53 109.222 177.111 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 31.8 m -90.77 122.18 33.28 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 109.266 -0.642 . . . . 63.33 109.266 -179.464 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 28.7 m -136.88 158.68 72.47 Favored Pre-proline 0 C--N 1.311 -1.087 0 N-CA-C 108.96 -0.756 . . . . 75.3 108.96 -177.57 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -62.5 148.02 93.95 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 122.28 1.986 . . . . 73.2 110.723 175.527 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 27.0 m -64.13 -27.52 42.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 121.482 0.658 . . . . 75.53 111.882 -178.946 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -88.85 2.91 52.88 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 116.159 -0.473 . . . . 63.53 110.755 -179.25 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 9.7 t -82.14 172.16 13.5 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 120.862 0.363 . . . . 65.21 110.243 -176.88 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 7.8 t -110.58 124.01 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 CA-C-N 115.883 -0.599 . . . . 75.43 109.618 -176.653 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 551' ' ' ILE . . . . . 0.504 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -107.39 145.87 14.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 120.313 -0.555 . . . . 71.04 110.297 176.567 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -103.3 117.25 34.07 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.209 0.528 . . . . 73.31 111.037 -176.624 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 5.5 mp -98.77 130.7 45.23 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.562 -1.199 . . . . 75.23 108.6 178.641 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -102.08 120.03 39.76 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 121.489 0.661 . . . . 65.11 109.651 179.759 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 40.0 t -100.37 137.35 28.17 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 CA-C-N 115.191 -0.913 . . . . 73.41 109.413 -175.629 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.658 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 6.2 m -79.64 123.23 27.44 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.99 -1.004 . . . . 70.34 109.239 -179.015 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.622 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 17.6 ptmt -92.17 145.7 24.3 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 104.313 -2.477 . . . . 51.54 104.313 169.351 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 558' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -79.14 -30.42 46.54 Favored Glycine 0 CA--C 1.486 -1.775 0 C-N-CA 118.964 -1.589 . . . . 51.24 113.486 -172.344 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 70.34 -29.15 0.18 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.663 1.185 . . . . 71.23 113.008 179.491 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.498 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 76.6 mt-30 -128.14 154.4 45.8 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 123.839 0.856 . . . . 74.45 112.015 -176.099 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -138.96 151.09 46.6 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.76 -0.83 . . . . 70.34 108.76 176.528 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 8.5 p -65.78 122.71 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 CA-C-O 121.262 0.554 . . . . 73.44 111.745 -178.912 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 563' ' ' MET . . . . . 0.484 ' HG2' ' O ' ' A' ' 564' ' ' PRO . 57.6 ttp -97.82 137.56 20.96 Favored Pre-proline 0 C--O 1.249 1.046 0 CA-C-N 116.182 -0.463 . . . . 45.52 111.311 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 564' ' ' PRO . . . . . 0.484 ' O ' ' HG2' ' A' ' 563' ' ' MET . 12.6 Cg_exo -73.4 169.39 22.4 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.633 2.222 . . . . 54.23 109.829 169.674 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -83.04 141.13 32.28 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.165 0.507 . . . . 62.42 110.722 -179.25 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 89.4 mt -122.99 15.32 9.96 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.96 -1.126 . . . . 72.32 107.96 177.034 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 7.7 m -72.17 141.21 49.07 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 114.437 -1.256 . . . . 72.4 109.837 -178.046 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 80.37 13.99 80.91 Favored Glycine 0 C--O 1.217 -0.945 0 C-N-CA 120.523 -0.846 . . . . 61.42 113.185 178.271 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 26.2 mmt -105.13 165.14 11.3 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 122.295 -0.532 . . . . 75.54 110.485 178.788 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -86.42 161.21 18.77 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.858 -1.164 . . . . 63.13 107.858 -179.658 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 30.8 t90 -71.22 -25.93 62.72 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.946 -0.761 . . . . 72.22 108.946 177.667 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.0 p -73.78 -17.72 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 115.27 -0.877 . . . . 62.35 109.407 179.475 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 573' ' ' ASP . . . . . 0.625 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 25.0 t70 -97.26 -34.97 10.89 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.362 -0.607 . . . . 74.44 109.362 178.5 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -64.03 -33.62 76.17 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.736 -0.665 . . . . 71.01 111.436 178.607 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.519 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 40.0 tt0 -55.99 -57.11 23.94 Favored Pre-proline 0 CA--C 1.576 1.953 0 CA-C-N 115.923 -0.58 . . . . 61.31 111.973 177.472 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 576' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 38.9 Cg_exo -61.05 -31.46 90.99 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 121.59 1.527 . . . . 74.34 112.835 173.656 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.625 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 24.2 mmt180 -58.9 -47.82 83.63 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 110.123 -0.325 . . . . 75.51 110.123 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.513 HD12 ' N ' ' A' ' 579' ' ' ARG . 4.4 pp -64.09 -45.98 86.29 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 112.372 0.508 . . . . 60.15 112.372 -174.595 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 579' ' ' ARG . . . . . 0.513 ' N ' HD12 ' A' ' 578' ' ' LEU . 4.1 ptp180 -66.02 -35.23 80.0 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.682 -0.407 . . . . 73.23 112.074 178.618 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.85 -36.42 72.86 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.23 0.538 . . . . 23.11 111.605 178.44 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 581' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 86.8 mt -81.84 -3.3 53.7 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 112.418 0.525 . . . . 55.42 112.418 -177.42 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 73.39 40.68 47.68 Favored Glycine 0 CA--C 1.506 -0.528 0 C-N-CA 120.581 -0.818 . . . . 61.2 111.178 -179.632 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 75.6 t90 -70.04 137.64 51.46 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.999 -0.6 . . . . 72.02 110.739 -179.614 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 5.9 t -156.49 75.23 0.85 Allowed 'General case' 0 N--CA 1.424 -1.748 0 CA-C-O 122.283 1.04 . . . . 75.3 109.399 178.432 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -141.38 -137.71 3.44 Favored Glycine 0 N--CA 1.434 -1.457 0 N-CA-C 110.923 -0.871 . . . . 70.42 110.923 -178.587 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 65.7 mtt -126.8 136.87 52.96 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.057 -1.09 . . . . 53.35 108.057 177.622 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -97.38 128.51 44.25 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.796 -1.187 . . . . 72.44 107.796 -176.837 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -105.01 101.86 11.4 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.949 -0.7 . . . . 74.44 110.346 179.453 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -102.45 133.57 47.19 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 107.746 -1.205 . . . . 73.41 107.746 175.597 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -90.99 -154.44 30.52 Favored Glycine 0 N--CA 1.418 -2.558 0 N-CA-C 110.312 -1.115 . . . . 60.02 110.312 177.107 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -71.0 133.6 46.48 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 110.153 -0.314 . . . . 73.21 110.153 179.048 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -77.23 123.24 26.18 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 105.469 -2.048 . . . . 72.34 105.469 177.282 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 94.5 t -136.03 135.68 50.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-O 120.971 0.415 . . . . 74.24 111.895 -171.315 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 594' ' ' ASP . . . . . 0.425 ' HB2' HE21 ' A' ' 626' ' ' GLN . 17.7 t70 -97.58 106.54 18.87 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 105.86 -1.904 . . . . 71.11 105.86 173.16 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -145.15 9.54 1.26 Allowed 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 112.777 0.658 . . . . 71.35 112.777 -175.561 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 122.91 167.04 12.82 Favored Glycine 0 C--N 1.302 -1.327 0 C-N-CA 119.84 -1.171 . . . . 72.21 111.583 179.836 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.75 -43.13 91.93 Favored Glycine 0 C--O 1.239 0.433 0 O-C-N 123.864 0.391 . . . . 45.11 114.052 -172.565 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 15.8 m -65.65 -34.11 77.46 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.181 0.515 . . . . 71.02 111.231 -179.112 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 599' ' ' GLN . . . . . 0.427 ' O ' ' HA3' ' A' ' 625' ' ' GLY . 80.9 mm-40 -92.49 -0.97 57.28 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 112.511 0.56 . . . . 54.22 112.511 -178.644 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -89.86 -106.56 0.09 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.424 0.898 . . . . 73.0 113.424 -178.515 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -92.46 54.86 2.38 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.185 0.517 . . . . 74.4 110.005 -173.227 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -144.12 140.85 29.65 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.891 -0.781 . . . . 71.01 108.891 176.802 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 95.8 t -64.34 130.15 29.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 107.509 -1.293 . . . . 72.32 107.509 173.322 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 58.0 t -89.2 -52.32 11.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.046 0.45 . . . . 61.34 110.429 -177.335 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -135.52 155.85 49.83 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.134 -1.061 . . . . 74.43 108.134 179.391 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -118.9 100.29 7.28 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 107.194 -1.41 . . . . 72.04 107.194 178.956 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.499 ' CB ' ' HB ' ' A' ' 621' ' ' THR . 26.7 t-20 -54.75 -51.58 77.7 Favored Pre-proline 0 CA--C 1.554 1.111 0 N-CA-C 113.772 1.027 . . . . 63.04 113.772 -177.72 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 609' ' ' PRO . 7.8 Cg_exo -75.84 128.95 11.2 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 121.094 1.196 . . . . 51.03 109.229 173.072 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 609' ' ' PRO . . . . . 0.521 ' HB2' ' OG1' ' A' ' 612' ' ' THR . 12.6 Cg_exo -70.31 135.8 30.02 Favored 'Trans proline' 0 C--O 1.242 0.7 0 C-N-CA 122.395 2.064 . . . . 51.34 113.196 -177.533 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -68.35 134.47 50.32 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.216 -0.661 . . . . 60.21 109.216 176.125 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 88.27 0.39 82.73 Favored Glycine 0 C--N 1.305 -1.182 0 C-N-CA 120.136 -1.031 . . . . 73.13 111.108 -178.614 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 612' ' ' THR . . . . . 0.521 ' OG1' ' HB2' ' A' ' 609' ' ' PRO . 39.7 m -111.8 160.6 17.18 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.631 -1.248 . . . . 72.11 107.631 178.321 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -75.89 135.68 18.35 Favored Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 111.223 -0.751 . . . . 74.35 111.223 178.697 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.18 142.18 37.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 108.113 -1.069 . . . . 62.41 108.113 176.894 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.498 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 34.9 p-10 -50.61 153.09 1.75 Allowed 'General case' 0 C--O 1.217 -0.648 0 N-CA-C 113.169 0.803 . . . . 72.23 113.169 179.174 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 616' ' ' ARG . . . . . 0.509 ' HD3' ' H ' ' A' ' 616' ' ' ARG . 0.0 OUTLIER -48.65 -30.82 5.86 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.952 1.301 . . . . 73.43 112.196 177.624 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 617' ' ' ASP . . . . . 0.491 ' HB2' ' ND2' ' A' ' 615' ' ' ASN . 1.0 OUTLIER -66.04 -44.41 84.69 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.578 -0.737 . . . . 71.43 110.325 176.736 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 87.45 23.1 41.19 Favored Glycine 0 N--CA 1.426 -1.986 0 C-N-CA 118.65 -1.738 . . . . 64.32 111.34 -178.266 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.84 119.2 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 123.238 1.494 . . . . 62.13 109.359 -167.972 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 4.2 tp -115.19 119.94 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.118 0 CA-C-N 113.215 -1.811 . . . . 73.32 110.528 -172.596 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.499 ' HB ' ' CB ' ' A' ' 607' ' ' ASN . 24.9 m -98.98 117.13 32.8 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 106.181 -1.785 . . . . 73.4 106.181 171.912 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -138.93 165.37 27.26 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 107.536 -1.283 . . . . 54.32 107.536 -175.835 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -134.11 135.77 43.42 Favored 'General case' 0 C--N 1.272 -2.786 0 N-CA-C 107.623 -1.251 . . . . 71.35 107.623 178.614 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -143.68 165.41 27.7 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 124.857 1.348 . . . . 72.23 107.578 172.709 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 625' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' A' ' 599' ' ' GLN . . . -113.37 -110.87 2.99 Favored Glycine 0 C--N 1.279 -2.623 0 N-CA-C 111.586 -0.606 . . . . 63.12 111.586 -179.092 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 626' ' ' GLN . . . . . 0.425 HE21 ' HB2' ' A' ' 594' ' ' ASP . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.17 0 C-N-CA 121.034 -0.266 . . . . 74.42 111.03 179.02 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--O 1.239 0.513 0 N-CA-C 105.424 -2.065 . . . . 72.52 105.424 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 31.5 m -116.12 157.79 16.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-O 121.488 0.661 . . . . 73.01 111.63 -169.822 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -94.76 124.3 38.72 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 106.606 -1.627 . . . . 71.25 106.606 -176.196 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 406' ' ' ALA . 89.7 t -101.35 129.53 26.76 Favored Pre-proline 0 C--N 1.287 -2.109 0 CA-C-N 114.993 -1.003 . . . . 73.41 111.335 -172.58 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -73.41 132.75 18.11 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.138 1.892 . . . . 73.01 109.42 174.637 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -91.76 158.89 16.1 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 120.291 -0.564 . . . . 74.33 109.648 -175.551 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.522 HG21 ' HA ' ' A' ' 373' ' ' ALA . 4.0 m -114.17 6.34 7.71 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 C-N-CA 124.203 1.001 . . . . 72.03 111.673 -176.026 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.77 145.38 12.39 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 112.757 0.651 . . . . 72.0 112.757 172.725 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 367' ' ' GLY . . . . . 0.404 ' H ' HG23 ' A' ' 399' ' ' VAL . . . 104.85 -6.02 43.54 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.254 -0.884 . . . . 54.33 112.307 -176.478 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -104.97 -92.44 0.37 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.73 0.3 . . . . 44.41 111.075 179.608 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 64.9 p -156.31 157.11 35.15 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 107.619 -1.252 . . . . 74.34 107.619 -179.133 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 7.9 p -64.1 -37.52 87.75 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 118.307 0.503 . . . . 64.11 111.221 179.702 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.21 -45.45 94.5 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 116.07 -0.514 . . . . 61.52 111.206 178.789 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -69.12 -39.24 79.03 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.609 -0.515 . . . . 65.11 109.609 179.692 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 373' ' ' ALA . . . . . 0.522 ' HA ' HG21 ' A' ' 365' ' ' VAL . . . -61.91 -51.36 68.45 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.679 -0.692 . . . . 71.44 111.403 -178.964 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 78.5 mt -65.56 -39.97 86.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.188 -0.46 . . . . 60.31 110.124 179.122 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.26 -47.35 85.7 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.063 -0.517 . . . . 63.1 110.907 -179.496 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 376' ' ' THR . . . . . 0.527 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 51.3 m -64.97 -47.46 77.51 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.953 -0.567 . . . . 71.52 110.982 -179.085 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 10.8 mp -62.9 -39.02 93.23 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 112.145 0.424 . . . . 71.41 112.145 -179.248 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -64.99 -38.81 92.2 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.764 0.316 . . . . 53.41 110.205 179.349 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -68.37 -26.59 65.65 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.142 0.496 . . . . 51.41 111.355 176.744 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 380' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 376' ' ' THR . 9.7 mmm180 -82.15 -14.26 55.94 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.284 -0.416 . . . . 55.41 110.846 178.71 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 92.88 16.37 48.43 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.475 -0.869 . . . . 63.14 111.157 179.639 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.455 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 29.3 m-85 -93.16 154.77 17.87 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-O 121.454 0.645 . . . . 70.32 110.427 179.396 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.428 ' HB2' ' HG2' ' A' ' 415' ' ' GLU . 32.6 mmtp -103.75 145.01 30.72 Favored 'General case' 0 N--CA 1.409 -2.508 0 N-CA-C 107.184 -1.413 . . . . 75.54 107.184 -176.626 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 384' ' ' ILE . . . . . 0.524 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -118.86 142.45 33.8 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 C-N-CA 119.868 -0.733 . . . . 74.2 110.545 -176.726 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 23.7 tpt180 -111.75 147.32 35.89 Favored 'General case' 0 N--CA 1.408 -2.527 0 N-CA-C 105.172 -2.158 . . . . 72.35 105.172 171.829 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 42.9 m -132.77 121.67 23.37 Favored 'General case' 0 C--N 1.269 -2.925 0 C-N-CA 120.229 -0.588 . . . . 71.24 109.56 -175.782 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 66.0 tp -111.22 119.1 37.81 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 107.406 -1.331 . . . . 62.02 107.406 -179.783 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 388' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 12.4 pm0 -102.96 131.7 49.74 Favored 'General case' 0 N--CA 1.425 -1.702 0 C-N-CA 119.845 -0.742 . . . . 42.42 110.408 177.966 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 389' ' ' LYS . . . . . 0.548 ' O ' ' HA ' ' A' ' 421' ' ' SER . 13.2 mmmm -126.01 148.32 62.49 Favored Pre-proline 0 C--N 1.282 -2.367 0 N-CA-C 106.152 -1.796 . . . . 73.24 106.152 -178.264 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -69.35 158.04 58.97 Favored 'Trans proline' 0 C--O 1.243 0.765 0 N-CA-C 108.751 -1.288 . . . . 73.24 108.751 173.135 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -74.82 82.88 2.14 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-O 121.818 0.818 . . . . 72.02 109.688 178.019 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 392' ' ' SER . . . . . 0.467 ' O ' ' HB ' ' A' ' 393' ' ' THR . 17.1 m -103.29 49.3 0.83 Allowed 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 114.593 -1.185 . . . . 74.41 108.843 178.709 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 392' ' ' SER . 99.2 m 69.54 20.28 7.17 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-O 123.206 1.479 . . . . 71.31 110.02 -179.715 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 5.4 pt -115.75 152.3 47.22 Favored Pre-proline 0 C--N 1.301 -1.536 0 CA-C-N 114.85 -1.068 . . . . 63.23 111.155 -174.357 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 395' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 396' ' ' PRO . 0.6 OUTLIER -21.5 116.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.364 1.388 1 C-N-CA 126.48 4.786 . . . . 45.43 116.831 -177.82 . . . . . . . . 4 4 . 1 . 026 nuclear build core ' A' A ' 396' ' ' PRO . . . . . 0.52 ' HA ' ' OG ' ' A' ' 421' ' ' SER . 41.9 Cg_exo -59.02 161.86 14.89 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 124.267 3.311 . . . . 52.11 114.52 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -57.89 -8.46 0.99 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.996 1.318 . . . . 74.44 113.438 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -98.72 137.14 37.76 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.016 -1.846 . . . . 73.31 106.016 176.21 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 367' ' ' GLY . 18.8 m -72.34 118.2 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 C-N-CA 119.039 -1.064 . . . . 74.31 112.514 -167.86 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.4 -30.6 2.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 105.843 -1.91 . . . . 74.23 105.843 171.386 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.7 157.89 27.55 Favored Glycine 0 N--CA 1.416 -2.673 0 CA-C-N 114.618 -1.174 . . . . 64.03 111.099 -178.399 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 9.3 p -144.83 -175.71 4.78 Favored 'General case' 0 C--N 1.278 -2.523 0 C-N-CA 127.314 2.246 . . . . 51.24 105.369 -177.119 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -98.92 125.95 40.22 Favored Pre-proline 0 C--N 1.295 -1.789 0 C-N-CA 118.118 -1.433 . . . . 72.12 107.673 178.895 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -59.29 6.25 0.09 OUTLIER 'Trans proline' 0 C--N 1.365 1.397 0 C-N-CA 124.691 3.594 . . . . 71.44 115.91 -176.585 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.26 -33.58 67.74 Favored 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 109.467 -0.568 . . . . 73.04 109.467 174.907 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 406' ' ' ALA . . . . . 0.402 ' O ' ' HB ' ' A' ' 362' ' ' VAL . . . -67.04 -36.32 81.82 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-O 121.512 0.672 . . . . 61.34 110.319 177.275 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -85.77 0.72 52.12 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.914 0.864 . . . . 63.44 110.16 -179.147 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 28.5 m -97.33 158.39 15.48 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 104.896 -2.261 . . . . 74.22 104.896 171.588 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 33.7 p -74.32 112.08 10.13 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 118.649 -1.22 . . . . 72.15 108.712 179.236 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 17.1 m -129.53 159.11 41.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 121.296 0.569 . . . . 61.32 112.037 -179.456 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 3.0 p -60.94 140.82 57.66 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.083 -0.962 . . . . 62.32 110.869 177.944 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -65.0 111.01 2.67 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 121.477 0.656 . . . . 64.11 110.372 -177.538 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 413' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 107.07 39.92 1.9 Allowed Glycine 0 N--CA 1.423 -2.21 0 CA-C-N 115.05 -0.977 . . . . 73.52 112.001 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -92.18 -179.31 5.21 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.931 -0.766 . . . . 55.23 108.931 -178.319 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 415' ' ' GLU . . . . . 0.428 ' HG2' ' HB2' ' A' ' 383' ' ' LYS . 43.9 mt-10 -104.69 114.91 29.43 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 110.005 -0.368 . . . . 75.13 110.005 -176.855 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 45.4 mm -107.41 128.78 62.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 109.188 -0.671 . . . . 63.32 109.188 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 25.5 m -85.2 130.29 34.63 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.307 0.575 . . . . 65.41 111.782 -178.023 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 9.4 p -114.68 135.49 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 CA-C-N 115.041 -0.981 . . . . 61.43 108.902 177.861 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -97.67 128.71 44.56 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 110.153 -0.314 . . . . 75.04 110.153 179.27 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 94.6 t -123.72 131.11 73.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 109.235 -0.654 . . . . 63.54 109.235 176.667 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 421' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 95.8 p -99.49 123.66 43.96 Favored 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 120.403 -0.519 . . . . 63.44 109.912 177.152 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 5.5 t -119.7 108.68 14.73 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 112.735 0.642 . . . . 71.43 112.735 -179.712 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.332 0 N-CA-C 115.373 0.909 . . . . 74.43 115.373 171.871 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 . . . . . 0 N--CA 1.423 -1.787 0 N-CA-C 104.775 -2.306 . . . . 54.32 104.775 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 477' ' ' THR . 20.5 mmm180 -121.66 147.16 46.23 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 119.593 -0.843 . . . . 73.15 111.679 -173.54 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 15.6 pt-20 -82.05 139.19 34.62 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.184 -0.916 . . . . 74.54 108.635 -178.963 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 65.1 mt -78.93 125.79 83.31 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 107.806 -1.183 . . . . 74.33 107.806 -178.878 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -70.51 141.49 42.31 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 121.848 1.699 . . . . 71.33 110.693 175.612 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -80.63 112.55 18.1 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.603 -0.517 . . . . 63.13 109.603 177.981 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 28.2 t -115.78 147.16 19.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 107.528 -1.286 . . . . 61.1 107.528 -179.045 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 1.6 p -58.01 138.17 56.18 Favored 'General case' 0 N--CA 1.432 -1.355 0 O-C-N 123.638 0.586 . . . . 74.32 111.463 179.961 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 31.7 p -64.57 -34.88 79.28 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 123.931 0.893 . . . . 74.14 112.05 -171.047 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.57 ' H ' HD23 ' A' ' 435' ' ' LEU . 0.7 OUTLIER -75.02 -16.88 60.59 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-N 115.198 -0.91 . . . . 61.53 111.464 -179.775 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.427 HG22 ' HB2' ' A' ' 439' ' ' GLU . 2.1 m -105.03 50.6 0.78 Allowed 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.517 0.675 . . . . 73.13 109.26 -175.075 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 437' ' ' TYR . . . . . 0.421 ' O ' HG23 ' A' ' 441' ' ' VAL . 38.9 t80 -52.61 -38.82 60.88 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.893 0.877 . . . . 73.44 112.913 -179.683 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -59.44 -40.6 87.35 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-O 121.066 0.46 . . . . 62.12 110.918 179.444 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.427 ' HB2' HG22 ' A' ' 436' ' ' THR . 42.9 tp10 -70.04 -35.63 74.43 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.968 -0.753 . . . . 61.41 108.968 179.621 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.96 -43.62 98.48 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.893 -0.594 . . . . 71.53 110.054 178.732 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 441' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 437' ' ' TYR . 84.9 t -58.48 -47.85 87.04 Favored 'Isoleucine or valine' 0 C--O 1.246 0.9 0 CA-C-N 115.232 -0.894 . . . . 74.02 110.911 178.669 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -67.38 -34.53 77.47 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 119.789 -0.765 . . . . 74.0 110.708 -179.376 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -62.53 -42.63 99.65 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 116.826 -0.17 . . . . 75.24 111.291 178.515 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 10.2 mp -63.76 -35.09 79.43 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 120.871 0.367 . . . . 61.3 110.389 176.277 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.46 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 22.2 m -68.19 -46.23 71.23 Favored 'General case' 0 C--O 1.249 1.033 0 CA-C-N 115.936 -0.574 . . . . 42.12 110.557 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.36 -17.39 62.42 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-O 121.105 0.479 . . . . 64.43 111.401 179.53 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.34 5.26 24.0 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.888 -0.596 . . . . 64.01 112.272 -179.871 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 110.48 -82.08 0.3 Allowed Glycine 0 CA--C 1.488 -1.615 0 C-N-CA 119.514 -1.327 . . . . 42.5 112.034 175.778 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 449' ' ' PHE . . . . . 0.415 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 0.6 OUTLIER -39.91 -65.22 0.41 Allowed 'General case' 0 C--O 1.248 0.995 0 N-CA-C 113.917 1.08 . . . . 71.03 113.917 175.573 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 450' ' ' GLY . . . . . 0.46 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 59.35 29.69 66.59 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.859 -0.496 . . . . 74.34 111.859 -175.232 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.453 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 16.1 mmm180 -105.06 111.23 23.93 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.472 -1.677 . . . . 62.41 106.472 -179.291 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 35.5 p90 -134.17 153.4 51.86 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 120.871 0.367 . . . . 71.43 110.939 -175.422 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -148.32 122.9 9.79 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.944 -0.761 . . . . 70.41 108.944 177.825 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -83.83 129.39 34.94 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 123.359 0.664 . . . . 73.03 111.458 179.752 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.08 144.66 47.47 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.274 -1.38 . . . . 64.3 107.274 173.342 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -122.29 136.83 54.97 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.521 -0.918 . . . . 71.34 108.521 -177.635 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 457' ' ' SER . . . . . 0.427 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 49.4 m -149.45 138.31 12.39 Favored Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 122.356 -0.215 . . . . 70.04 110.595 176.785 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.73 ' HA ' ' O ' ' A' ' 490' ' ' SER . 22.5 Cg_exo -65.82 129.39 22.02 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.404 2.07 . . . . 74.24 111.014 176.358 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 60.6 m -152.21 -179.28 7.39 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.951 -0.568 . . . . 42.43 109.884 -178.042 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 9.7 t -45.0 136.71 4.74 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.952 1.301 . . . . 64.02 112.432 178.643 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.76 -29.48 34.12 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 124.752 3.635 . . . . 73.44 113.933 -175.954 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -70.38 -30.7 67.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.571 -0.286 . . . . 51.31 111.722 -178.932 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -95.75 -8.81 33.44 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 111.66 0.244 . . . . 63.35 111.66 179.738 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 80.5 t -60.57 127.66 20.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.473 -0.566 . . . . 74.23 109.473 176.696 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 91.06 -15.07 61.82 Favored Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 116.002 -0.544 . . . . 43.31 112.107 -179.529 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -108.69 166.55 10.71 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 109.424 -0.584 . . . . 63.43 109.424 -177.852 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 79.4 t -73.51 140.82 17.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 108.182 -1.044 . . . . 63.15 108.182 173.572 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 65.5 mt -97.33 -35.28 5.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.56 -1.274 . . . . 55.34 107.56 177.253 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 172.76 -179.06 44.49 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 120.297 -0.954 . . . . 74.1 112.031 177.741 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 470' ' ' THR . . . . . 0.506 HG22 HG12 ' A' ' 486' ' ' ILE . 33.1 p -115.17 143.93 44.46 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 105.929 -1.878 . . . . 65.52 105.929 178.805 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -60.32 -57.19 28.45 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 119.888 -0.725 . . . . 72.52 112.146 178.607 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -71.94 152.57 57.7 Favored 'Trans proline' 0 C--N 1.361 1.196 0 N-CA-C 108.001 -1.577 . . . . 72.54 108.001 170.58 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.31 127.82 22.09 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 121.601 1.534 . . . . 75.44 111.44 -179.035 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -76.63 6.45 5.89 Favored 'General case' 0 C--O 1.211 -0.928 0 C-N-CA 124.239 1.016 . . . . 64.24 111.932 -175.981 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -109.78 -4.97 15.73 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 116.106 -0.497 . . . . 73.23 109.808 172.625 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -117.26 176.0 5.35 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 112.981 0.734 . . . . 71.44 112.981 -171.421 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 3.7 p -83.41 131.14 35.05 Favored 'General case' 0 N--CA 1.413 -2.295 0 C-N-CA 124.633 1.173 . . . . 74.42 113.145 -177.782 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 43.8 m -121.23 148.64 43.99 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 106.971 -1.492 . . . . 73.22 106.971 175.611 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.457 ' HB3' ' HB2' ' A' ' 482' ' ' ASN . . . -74.48 156.44 36.93 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.725 -0.39 . . . . 73.25 111.442 -176.585 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 480' ' ' ILE . . . . . 0.415 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 43.5 mm -69.36 -26.8 32.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.823 0.82 . . . . 73.34 110.25 -177.006 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.4 t -97.9 5.07 49.39 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.69 0.757 . . . . 75.44 109.904 179.021 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 482' ' ' ASN . . . . . 0.457 ' HB2' ' HB3' ' A' ' 479' ' ' ALA . 21.1 t-20 -94.63 135.63 35.87 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.54 -0.755 . . . . 62.35 110.301 -176.597 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.453 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.3 p -89.86 126.75 42.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-O 121.283 0.564 . . . . 72.12 111.444 -177.043 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 60.6 t -96.77 118.53 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.91 0 N-CA-C 107.844 -1.169 . . . . 72.53 107.844 176.207 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.27 129.08 50.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 108.063 -1.088 . . . . 70.42 108.063 177.606 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.506 HG12 HG22 ' A' ' 470' ' ' THR . 15.2 mt -118.54 128.23 75.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-N 115.158 -0.928 . . . . 73.21 110.635 -174.758 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 6.2 tt -103.19 126.17 57.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 115.69 -0.687 . . . . 73.32 110.428 -179.452 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 33.8 m -109.26 151.2 11.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 115.692 -0.685 . . . . 72.14 109.547 178.387 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.42 135.55 14.29 Favored Glycine 0 N--CA 1.423 -2.179 0 C-N-CA 121.125 -0.56 . . . . 70.15 111.744 -178.482 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.73 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 12.8 t . . . . . 0 C--N 1.283 -2.326 0 N-CA-C 105.825 -1.917 . . . . 55.23 105.825 177.234 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo . . . . . 0 C--O 1.251 1.129 0 CA-C-O 120.797 0.249 . . . . 64.44 111.736 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -91.25 81.17 5.52 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.532 -0.914 . . . . 62.1 108.532 175.982 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 5.9 p -117.81 153.56 33.26 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.263 -0.88 . . . . 72.42 112.209 -175.193 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 8.0 mmtm -137.24 136.85 38.47 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.242 -0.89 . . . . 72.44 109.746 179.986 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -82.27 121.61 26.87 Favored 'General case' 0 CA--C 1.485 -1.527 0 N-CA-C 105.508 -2.034 . . . . 62.41 105.508 168.876 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 497' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 543' ' ' THR . 44.1 pt -75.38 123.69 88.75 Favored Pre-proline 0 C--N 1.292 -1.905 0 N-CA-C 113.348 0.87 . . . . 64.13 113.348 -172.6 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -86.58 164.6 9.31 Favored 'Trans proline' 0 N--CA 1.429 -2.301 0 C-N-CA 122.472 2.114 . . . . 60.14 108.871 171.784 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -82.35 147.26 28.93 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 120.383 -0.527 . . . . 52.24 109.99 -178.487 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.1 p -130.35 8.29 2.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-O 122.045 0.926 . . . . 75.43 109.832 -176.824 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -81.23 157.11 25.31 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 115.43 -0.805 . . . . 72.52 110.185 -175.994 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 108.55 1.51 32.77 Favored Glycine 0 C--N 1.287 -2.145 0 N-CA-C 109.573 -1.411 . . . . 61.52 109.573 -178.49 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -120.62 175.43 6.01 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.414 -0.958 . . . . 65.53 108.414 -179.267 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 15.0 t -83.89 159.83 21.24 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.82 -1.178 . . . . 74.1 107.82 178.544 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 532' ' ' GLY . 48.2 t -46.84 -48.94 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 123.905 0.882 . . . . 73.42 111.239 -176.54 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -63.46 -41.85 98.62 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.188 -0.915 . . . . 72.44 111.571 -175.158 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 88.2 t -76.35 -40.61 35.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.908 -0.587 . . . . 54.1 110.857 -177.695 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.26 -45.8 89.8 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.378 -0.374 . . . . 72.2 110.881 -179.307 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -65.21 -35.45 81.11 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.402 -0.363 . . . . 74.32 110.893 178.573 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.429 ' O ' HG23 ' A' ' 514' ' ' VAL . 51.1 tptt -62.79 -45.88 90.6 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.37 -0.604 . . . . 73.02 109.37 178.204 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -63.62 -37.42 87.28 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 115.951 -0.568 . . . . 74.54 111.08 177.37 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 512' ' ' LEU . . . . . 0.455 HD11 HD12 ' A' ' 551' ' ' ILE . 59.4 tp -59.8 -43.18 94.6 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.826 -0.625 . . . . 44.33 109.457 177.122 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 513' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 13.5 m120 -63.25 -38.03 89.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.611 -0.722 . . . . 71.53 110.192 177.711 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 510' ' ' LYS . 94.9 t -63.69 -33.37 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 115.564 -0.743 . . . . 51.04 110.651 176.829 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -68.01 -27.49 66.6 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.85 0.357 . . . . 64.41 110.138 178.568 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 131.57 -18.31 4.91 Favored Glycine 0 CA--C 1.506 -0.499 0 C-N-CA 121.006 -0.616 . . . . 64.1 112.267 178.721 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.46 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 85.9 m-85 -78.63 115.15 18.14 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.347 0.594 . . . . 71.55 110.001 -177.025 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 12.5 p -86.87 -16.69 35.28 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.796 -0.638 . . . . 72.13 112.71 -176.83 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 519' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 36.2 mtmm -117.29 130.87 56.83 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.232 0.539 . . . . 64.2 112.001 -174.612 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 520' ' ' PHE . . . . . 0.444 ' HB3' HD23 ' A' ' 512' ' ' LEU . 12.2 p90 -130.07 156.81 43.9 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.346 -0.843 . . . . 73.05 112.398 -177.852 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 49.2 m -140.17 158.36 44.16 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 106.831 -1.544 . . . . 55.25 106.831 173.174 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 522' ' ' GLN . . . . . 0.524 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 0.0 OUTLIER -135.37 145.24 47.16 Favored 'General case' 0 N--CA 1.413 -2.312 0 CA-C-N 118.293 0.497 . . . . 62.51 109.986 179.395 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -129.82 116.13 18.25 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.239 -1.022 . . . . 41.25 108.239 176.072 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 18.4 m -88.12 120.89 29.9 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.726 -0.472 . . . . 61.31 109.726 178.91 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 47.5 t -120.8 148.12 24.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 107.258 -1.386 . . . . 75.5 107.258 -179.616 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 526' ' ' ASP . . . . . 0.453 ' HB2' HD21 ' A' ' 559' ' ' ASN . 9.5 p-10 -68.86 136.41 52.63 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.185 0.517 . . . . 44.42 111.55 -175.978 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 69.6 m -156.78 176.36 2.65 Favored Pre-proline 0 C--N 1.3 -1.549 0 N-CA-C 108.709 -0.849 . . . . 54.33 108.709 -179.285 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -83.32 -14.48 8.2 Favored 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 121.947 1.764 . . . . 62.21 111.598 171.349 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.588 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 0.0 OUTLIER -76.04 140.75 70.35 Favored Pre-proline 0 C--O 1.215 -0.716 0 CA-C-N 115.925 -0.579 . . . . 74.01 109.542 -179.743 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -56.61 144.82 84.22 Favored 'Trans proline' 0 C--O 1.249 1.026 0 C-N-CA 123.399 2.733 . . . . 74.25 113.432 -176.962 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.64 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -62.7 117.51 6.39 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 114.498 -1.228 . . . . 73.14 110.472 -178.329 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 532' ' ' GLY . . . . . 0.438 ' O ' HG23 ' A' ' 505' ' ' VAL . . . 126.82 -19.3 6.18 Favored Glycine 0 C--N 1.3 -1.431 0 C-N-CA 120.48 -0.867 . . . . 74.12 111.48 179.828 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -83.58 125.81 32.18 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 120.735 0.302 . . . . 74.25 110.548 177.752 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 62.0 t -81.92 118.84 30.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.093 -1.077 . . . . 64.24 108.093 178.357 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 99.2 m -104.66 -21.54 13.38 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 120.295 -0.562 . . . . 71.04 112.46 -177.013 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -159.16 -178.4 33.13 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 119.433 -1.365 . . . . 42.11 112.12 178.964 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 25.5 p -124.84 156.6 37.58 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.409 -1.33 . . . . 73.14 107.409 175.982 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.526 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 23.0 t-20 -60.03 -56.99 30.05 Favored Pre-proline 0 CA--C 1.55 0.965 0 CA-C-O 119.307 -0.377 . . . . 44.3 110.777 179.617 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.526 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 98.1 Cg_endo -84.09 143.65 10.37 Favored 'Trans proline' 0 C--N 1.367 1.51 0 CA-C-N 120.307 1.146 . . . . 74.51 110.095 172.849 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.97 148.98 58.42 Favored 'Trans proline' 0 C--O 1.258 1.506 0 C-N-CA 122.164 1.909 . . . . 62.04 112.026 179.642 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.06 134.53 57.07 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 115.908 -0.587 . . . . 75.5 109.681 178.179 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.83 -5.8 34.88 Favored Glycine 0 C--N 1.304 -1.235 0 C-N-CA 120.058 -1.068 . . . . 55.25 111.365 -175.266 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.477 ' O ' HG12 ' A' ' 497' ' ' ILE . 88.5 m -82.65 131.08 35.21 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.266 -1.013 . . . . 74.21 108.266 173.636 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 9.7 t -101.03 127.5 47.52 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-O 121.172 0.511 . . . . 52.31 109.891 178.669 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 31.0 m -138.55 165.12 35.16 Favored Pre-proline 0 C--N 1.313 -1.015 0 N-CA-C 108.547 -0.909 . . . . 65.54 108.547 -178.244 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -62.49 143.28 92.9 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.214 1.943 . . . . 51.43 111.547 175.094 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 32.4 m -62.38 -19.78 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.606 0.762 . . . . 73.45 113.016 -176.848 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -87.96 -14.88 38.03 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.251 -0.431 . . . . 73.13 111.246 -175.595 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 51.8 m -62.71 161.87 11.69 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 114.677 1.362 . . . . 65.42 114.677 -173.397 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 7.7 p -93.95 123.89 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-N 115.193 -0.912 . . . . 65.55 110.269 -179.507 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 551' ' ' ILE . . . . . 0.455 HD12 HD11 ' A' ' 512' ' ' LEU . 52.3 mt -108.17 138.85 32.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 120.379 -0.528 . . . . 74.23 111.094 179.472 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -101.77 120.93 41.14 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 115.617 -0.719 . . . . 72.03 109.782 -179.077 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 553' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 1.5 mm? -95.73 126.34 40.93 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.153 -1.425 . . . . 75.32 107.153 176.671 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . 0.29 10.9 pt20 -102.19 120.5 40.57 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 122.698 1.237 . . . . 74.0 111.091 179.716 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 42.7 t -101.38 145.04 12.16 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-N 112.83 -1.986 . . . . 71.41 109.986 -169.076 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.64 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 73.9 m -82.07 133.06 35.26 Favored 'General case' 0 N--CA 1.41 -2.452 0 CA-C-O 121.552 0.691 . . . . 61.11 111.529 175.631 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -88.26 137.95 31.87 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 104.966 -2.235 . . . . 61.41 104.966 168.577 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 558' ' ' GLY . . . . . 0.588 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -81.69 -43.15 8.55 Favored Glycine 0 CA--C 1.475 -2.446 0 C-N-CA 120.252 -0.975 . . . . 54.1 113.786 -170.434 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 559' ' ' ASN . . . . . 0.453 HD21 ' HB2' ' A' ' 526' ' ' ASP . 78.5 m-20 67.83 -31.77 0.19 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.043 0.937 . . . . 74.44 113.286 -176.785 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.457 ' H ' ' C ' ' A' ' 558' ' ' GLY . 3.0 tp60 -126.57 140.48 52.41 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 108.903 -0.777 . . . . 72.31 108.903 -175.047 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -143.45 139.09 29.73 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.765 -0.828 . . . . 61.23 108.765 174.741 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 9.6 p -59.81 124.11 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-O 121.647 0.737 . . . . 72.43 112.709 -176.252 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 57.9 ttp -95.34 137.76 22.03 Favored Pre-proline 0 C--O 1.249 1.039 0 CA-C-N 115.886 -0.597 . . . . 74.41 110.512 -179.93 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -64.22 170.01 9.91 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 123.246 2.631 . . . . 44.33 111.311 172.165 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 565' ' ' ASP . . . . . 0.455 ' HA ' ' HB2' ' A' ' 610' ' ' ALA . 3.5 p-10 -70.92 138.26 49.96 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.723 0.773 . . . . 63.1 112.51 -176.554 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 94.5 mt -136.15 15.53 3.26 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.287 -1.324 . . . . 75.01 107.938 174.844 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 27.7 t -67.37 134.2 51.05 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 115.302 -0.863 . . . . 72.44 109.885 -177.407 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 86.07 40.11 7.68 Favored Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 110.41 -1.076 . . . . 42.05 110.41 179.953 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 21.5 ptm -109.29 158.0 18.3 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.979 -0.749 . . . . 44.52 108.979 -179.831 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 570' ' ' PHE . . . . . 0.493 ' H ' ' HB3' ' A' ' 573' ' ' ASP . 77.3 m-85 -108.75 165.16 11.76 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 106.739 -1.578 . . . . 73.2 106.739 175.603 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 24.6 t90 -71.59 -30.31 65.68 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 108.979 -0.749 . . . . 75.33 108.979 177.101 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 30.0 m -80.08 -6.06 9.07 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 CA-C-O 121.793 0.806 . . . . 64.52 109.798 176.677 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 573' ' ' ASP . . . . . 0.493 ' HB3' ' H ' ' A' ' 570' ' ' PHE . 14.1 t70 -99.38 -30.03 12.43 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.905 -1.146 . . . . 73.52 107.905 177.199 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -62.86 -42.01 99.59 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 114.496 -1.229 . . . . 35.11 110.735 177.476 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 578' ' ' LEU . 44.2 tt0 -57.4 -52.25 75.62 Favored Pre-proline 0 CA--C 1.577 1.982 0 N-CA-C 113.014 0.746 . . . . 73.13 113.014 179.261 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 576' ' ' PRO . . . . . 0.42 ' HD2' ' C ' ' A' ' 573' ' ' ASP . 75.0 Cg_exo -55.38 -40.03 87.77 Favored 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 121.963 1.776 . . . . 65.44 112.172 173.114 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -68.3 -34.1 75.54 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.43 -0.508 . . . . 64.44 112.078 177.853 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.427 ' HB3' ' O ' ' A' ' 575' ' ' GLU . 5.9 tt -58.77 -49.47 77.54 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.268 0.627 . . . . 62.22 109.724 178.848 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -67.37 -40.96 85.78 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.286 0.847 . . . . 74.13 113.286 177.138 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.57 -39.86 88.69 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.186 0.439 . . . . 62.4 112.186 -177.666 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 10.4 mp -86.3 -8.97 57.31 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 111.971 0.36 . . . . 75.34 111.971 -179.276 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 68.34 21.81 74.35 Favored Glycine 0 C--O 1.241 0.559 0 N-CA-C 111.317 -0.713 . . . . 62.41 111.317 -177.54 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 583' ' ' TRP . . . . . 0.402 ' CZ2' HG22 ' A' ' 620' ' ' ILE . 42.9 t90 -60.61 126.96 29.37 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 123.198 0.599 . . . . 73.44 111.031 -177.359 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 8.8 m -130.41 89.44 2.78 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 115.517 -0.765 . . . . 71.51 109.122 178.153 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -144.14 -142.67 3.94 Favored Glycine 0 N--CA 1.426 -2.023 0 N-CA-C 109.479 -1.448 . . . . 65.13 109.479 177.43 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 14.4 tpt -129.0 131.41 47.42 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.768 -0.827 . . . . 71.31 108.768 179.099 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -98.03 123.1 41.89 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.07 -1.456 . . . . 73.32 107.07 177.066 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -98.11 107.38 19.85 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.995 -0.548 . . . . 72.43 109.994 -178.422 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.49 133.26 36.97 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.98 -0.554 . . . . 53.55 110.954 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -97.95 -164.83 31.38 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.737 -0.665 . . . . 62.33 113.406 -175.086 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -74.84 141.3 44.26 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 123.178 0.591 . . . . 53.43 110.834 -178.266 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -85.64 133.26 34.04 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.622 -0.717 . . . . 73.43 109.646 -177.096 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 73.4 t -125.34 115.41 43.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 107.206 -1.405 . . . . 75.42 107.206 175.337 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -86.02 107.64 17.88 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.221 -0.992 . . . . 51.32 110.213 -179.736 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -124.05 -11.17 7.59 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.212 -0.904 . . . . 74.25 111.495 -178.788 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 119.18 -172.67 14.7 Favored Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 121.099 -0.572 . . . . 73.32 111.673 177.779 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.87 -34.03 64.56 Favored Glycine 0 C--O 1.222 -0.623 0 N-CA-C 114.514 0.566 . . . . 40.43 114.514 -175.53 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 19.0 m -66.14 -24.72 66.72 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 117.344 0.572 . . . . 72.53 111.997 -178.445 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -109.66 -0.83 18.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.282 0.563 . . . . 74.1 111.286 178.616 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -67.62 105.42 1.87 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.195 -0.911 . . . . 62.51 113.099 -175.261 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 62.87 0.94 0.75 Allowed 'General case' 0 CA--C 1.56 1.352 0 C-N-CA 125.773 1.629 . . . . 70.52 114.081 171.713 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 602' ' ' ARG . . . . . 0.431 ' HD2' ' O ' ' A' ' 603' ' ' VAL . 8.7 tmm_? -90.93 148.47 22.42 Favored 'General case' 0 C--N 1.313 -0.995 0 O-C-N 121.911 -0.493 . . . . 71.32 110.607 -178.174 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 603' ' ' VAL . . . . . 0.469 HG23 ' HB2' ' A' ' 622' ' ' LEU . 7.1 p -56.11 131.76 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.01 0.924 . . . . 51.15 111.465 -177.634 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 14.7 p -106.91 -34.89 2.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 C-N-CA 119.9 -0.72 . . . . 60.14 109.385 -178.728 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -154.12 148.43 26.0 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 105.114 -2.18 . . . . 70.13 105.114 171.559 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -122.39 136.56 54.92 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 108.713 -0.847 . . . . 74.01 108.713 176.627 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.575 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 24.5 t-20 -59.37 -52.39 74.65 Favored Pre-proline 0 C--N 1.309 -1.164 0 CA-C-N 115.443 -0.799 . . . . 65.52 111.298 -178.436 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.575 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 29.6 Cg_endo -105.27 110.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.962 0 C-N-CA 121.883 1.722 . . . . 40.22 111.389 173.341 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -67.76 156.86 64.33 Favored 'Trans proline' 0 C--O 1.239 0.545 0 C-N-CA 122.139 1.893 . . . . 54.21 110.705 176.408 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 610' ' ' ALA . . . . . 0.455 ' HB2' ' HA ' ' A' ' 565' ' ' ASP . . . -60.07 137.35 58.11 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 110.009 -0.367 . . . . 72.01 110.009 178.975 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 90.05 0.96 76.83 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 119.44 -1.362 . . . . 63.24 111.564 -178.355 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 9.8 m -107.95 155.62 20.11 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.999 -1.111 . . . . 75.14 107.999 178.182 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -81.64 132.16 10.96 Favored Glycine 0 N--CA 1.418 -2.515 0 CA-C-N 116.352 -0.386 . . . . 74.2 112.525 -179.433 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 22.2 m -101.14 142.55 15.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 123.222 0.609 . . . . 73.44 110.375 177.008 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.516 ' OD1' HG22 ' A' ' 619' ' ' ILE . 0.0 OUTLIER -54.55 149.39 10.69 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.234 0.959 . . . . 74.44 111.96 178.171 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . 0.255 0.0 OUTLIER -61.0 -24.38 66.1 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.752 1.019 . . . . 75.51 113.752 179.929 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -68.62 -31.3 70.36 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 109.159 -0.682 . . . . 74.54 109.159 176.062 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 88.91 9.52 67.93 Favored Glycine 0 N--CA 1.418 -2.525 0 CA-C-N 115.006 -0.997 . . . . 75.52 113.264 176.855 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 619' ' ' ILE . . . . . 0.516 HG22 ' OD1' ' A' ' 615' ' ' ASN . 0.0 OUTLIER -69.59 119.57 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 CA-C-N 118.547 1.174 . . . . 54.5 109.103 -175.675 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.402 HG22 ' CZ2' ' A' ' 583' ' ' TRP . 0.0 OUTLIER -118.51 131.93 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 N-CA-C 108.836 -0.801 . . . . 63.2 108.836 -176.881 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.501 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 60.1 m -118.08 127.84 54.18 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 120.867 0.365 . . . . 63.12 111.627 -178.585 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 622' ' ' LEU . . . . . 0.469 ' HB2' HG23 ' A' ' 603' ' ' VAL . 0.0 OUTLIER -138.5 150.91 46.89 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 105.455 -2.054 . . . . 74.51 105.455 174.048 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -127.74 156.17 42.85 Favored 'General case' 0 C--N 1.266 -3.044 0 N-CA-C 106.079 -1.823 . . . . 70.33 106.079 179.248 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -131.13 165.63 22.86 Favored 'General case' 0 C--N 1.275 -2.634 0 N-CA-C 106.847 -1.538 . . . . 71.45 106.847 179.644 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -71.72 -84.96 0.2 Allowed Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 109.224 -1.551 . . . . 71.53 109.224 175.408 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 . . . . . 0 C--N 1.299 -1.594 0 N-CA-C 108.697 -0.853 . . . . 74.14 108.697 174.346 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 . . . . . 0 C--O 1.244 0.79 0 N-CA-C 109.012 -0.736 . . . . 74.14 109.012 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.76 142.93 27.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 109.725 -0.472 . . . . 63.13 109.725 -176.978 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -95.41 118.63 32.5 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.934 -1.506 . . . . 70.03 106.934 -176.853 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.44 ' HB ' ' O ' ' A' ' 406' ' ' ALA . 65.3 t -97.09 141.07 22.5 Favored Pre-proline 0 C--N 1.288 -2.093 0 CA-C-N 115.181 -0.918 . . . . 62.34 110.927 -170.284 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -66.49 142.87 66.97 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 121.84 1.693 . . . . 75.5 109.741 174.859 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 364' ' ' ASP . . . . . 0.465 ' HB2' ' ND2' ' A' ' 407' ' ' ASN . 35.1 t0 -95.83 142.61 27.89 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.915 -1.143 . . . . 72.33 107.915 -177.931 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.521 ' CG2' ' HA ' ' A' ' 373' ' ' ALA . 11.4 p -106.2 -7.47 10.22 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.676 0 CA-C-N 115.253 -0.885 . . . . 62.32 112.45 -168.472 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . 0.254 2.2 ppt_? -54.39 146.56 15.51 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.834 1.42 . . . . 74.22 114.834 175.884 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.44 0.79 40.55 Favored Glycine 0 C--O 1.24 0.482 0 CA-C-N 115.333 -0.848 . . . . 62.31 111.698 -177.219 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -119.33 -153.48 0.54 Allowed 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.545 -0.909 . . . . 75.2 108.545 177.672 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 51.5 p -96.35 153.47 17.8 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.503 -0.925 . . . . 74.23 108.503 -178.215 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 32.1 t -57.39 -37.34 72.52 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 123.322 0.389 . . . . 71.14 110.14 178.503 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.09 -47.04 75.51 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 119.287 -0.387 . . . . 70.33 111.412 179.78 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -70.05 -34.72 73.58 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 119.734 -0.786 . . . . 60.3 109.999 179.685 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 373' ' ' ALA . . . . . 0.521 ' HA ' ' CG2' ' A' ' 365' ' ' VAL . . . -63.39 -51.47 65.7 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.107 -0.951 . . . . 51.32 111.162 179.801 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 374' ' ' ILE . . . . . 0.41 HG23 HG13 ' A' ' 384' ' ' ILE . 82.3 mt -64.05 -40.26 88.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.957 -0.565 . . . . 74.41 109.908 176.654 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.71 -47.35 84.88 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.107 -0.497 . . . . 52.05 111.007 -178.12 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 376' ' ' THR . . . . . 0.466 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 37.3 m -63.14 -47.27 83.44 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.794 -0.639 . . . . 72.12 110.16 -178.901 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 95.4 mt -64.04 -41.4 97.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.006 -0.543 . . . . 45.21 111.11 -178.842 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 64.4 tp60 -63.12 -42.43 99.53 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.284 -0.416 . . . . 64.31 110.662 179.375 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -68.52 -20.33 64.56 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 111.915 0.339 . . . . 74.23 111.915 179.323 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 380' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 376' ' ' THR . 34.0 mmt180 -88.05 -14.18 39.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.345 -0.389 . . . . 72.33 110.335 176.164 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.46 16.72 45.13 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 120.655 -0.783 . . . . 74.51 112.463 179.231 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -88.85 156.21 19.07 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-O 121.327 0.584 . . . . 75.43 112.062 179.597 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -93.16 143.78 25.92 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 115.014 -0.993 . . . . 72.14 108.741 -177.712 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 384' ' ' ILE . . . . . 0.446 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -130.37 146.04 34.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-O 121.172 0.51 . . . . 74.52 110.223 -178.356 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -128.02 126.85 42.1 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 105.971 -1.863 . . . . 74.44 105.971 171.233 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 8.0 m -115.06 123.62 49.49 Favored 'General case' 0 C--N 1.274 -2.713 0 N-CA-C 107.212 -1.403 . . . . 64.41 107.212 -178.137 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -110.87 121.47 45.42 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.527 -0.916 . . . . 73.43 108.527 -177.774 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -90.55 133.79 34.83 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.678 -0.692 . . . . 72.13 110.441 -176.626 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 389' ' ' LYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 421' ' ' SER . 98.1 mttt -136.93 145.34 50.28 Favored Pre-proline 0 C--N 1.312 -1.044 0 N-CA-C 108.896 -0.779 . . . . 74.34 108.896 172.918 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 390' ' ' PRO . . . . . 0.503 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 56.7 Cg_endo -101.28 135.78 0.16 Allowed 'Trans proline' 0 CA--C 1.554 1.498 0 C-N-CA 122.0 1.8 . . . . 64.43 111.5 169.569 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.571 ' OD2' HG22 ' A' ' 393' ' ' THR . 12.9 t70 161.64 -168.03 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 126.073 1.749 . . . . 72.13 107.339 174.911 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 392' ' ' SER . . . . . 0.413 ' H ' ' CG ' ' A' ' 391' ' ' ASP . 32.3 t -128.17 -15.6 4.67 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 118.03 0.377 . . . . 61.4 110.558 179.421 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.571 HG22 ' OD2' ' A' ' 391' ' ' ASP . 13.1 t -79.75 -29.97 40.64 Favored 'General case' 0 C--O 1.252 1.209 0 N-CA-C 108.836 -0.802 . . . . 73.15 108.836 177.125 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.88 126.02 55.06 Favored Pre-proline 0 N--CA 1.417 -2.101 0 N-CA-C 105.22 -2.141 . . . . 70.52 105.22 165.519 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 395' ' ' PRO . . . . . 0.498 ' HG3' HD12 ' A' ' 400' ' ' ILE . 95.1 Cg_endo -78.51 155.06 27.93 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 N-CA-C 117.343 2.017 . . . . 64.23 117.343 -167.23 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 396' ' ' PRO . . . . . 0.518 ' HA ' ' O ' ' A' ' 421' ' ' SER . 74.0 Cg_exo -53.9 167.73 1.02 Allowed 'Trans proline' 0 CA--C 1.492 -1.585 1 C-N-CA 126.081 4.52 . . . . 62.14 111.709 170.888 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 397' ' ' ASP . . . . . 0.514 ' HA ' HG23 ' A' ' 420' ' ' VAL . 4.5 p-10 -51.57 -5.93 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 127.149 2.18 . . . . 74.21 115.836 -164.523 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -80.42 109.06 14.56 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.069 -1.456 . . . . 63.23 107.069 170.104 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 24.7 m -83.94 120.99 35.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 115.14 -0.937 . . . . 63.54 113.418 -168.558 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 400' ' ' ILE . . . . . 0.498 HD12 ' HG3' ' A' ' 395' ' ' PRO . 0.2 OUTLIER -84.92 -27.71 6.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.611 -0.722 . . . . 73.34 109.822 177.18 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.9 157.53 27.4 Favored Glycine 0 N--CA 1.42 -2.427 0 C-N-CA 119.389 -1.386 . . . . 73.23 113.988 -176.597 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 11.7 p -136.29 -173.83 3.51 Favored 'General case' 0 C--N 1.273 -2.721 0 C-N-CA 128.701 2.8 . . . . 45.23 104.825 -177.588 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -97.8 129.34 31.52 Favored Pre-proline 0 C--N 1.286 -2.154 0 N-CA-C 106.633 -1.617 . . . . 62.43 106.633 179.688 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.18 -1.26 0.17 Allowed 'Trans proline' 0 C--N 1.367 1.548 0 C-N-CA 124.731 3.621 . . . . 61.43 115.512 -176.368 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -50.45 -36.88 35.31 Favored 'General case' 0 C--O 1.209 -1.074 0 C-N-CA 124.15 0.98 . . . . 33.13 109.484 173.511 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 406' ' ' ALA . . . . . 0.44 ' O ' ' HB ' ' A' ' 362' ' ' VAL . . . -59.31 -50.05 75.47 Favored 'General case' 0 C--O 1.217 -0.651 0 O-C-N 123.54 0.525 . . . . 33.41 110.902 178.678 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 407' ' ' ASN . . . . . 0.465 ' ND2' ' HB2' ' A' ' 364' ' ' ASP . 13.3 m120 -82.56 0.16 44.05 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 120.448 -0.501 . . . . 73.15 111.991 -178.989 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 30.2 m -86.31 150.07 24.6 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 105.134 -2.173 . . . . 64.35 105.134 173.104 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 19.4 m -75.79 112.34 12.07 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 106.372 -1.714 . . . . 42.31 106.372 175.862 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 31.0 m -125.92 169.52 17.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-O 121.009 0.433 . . . . 65.22 111.192 -174.941 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 21.4 t -77.46 140.79 39.89 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 107.353 -1.351 . . . . 71.41 107.353 176.896 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -57.86 109.71 0.78 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.026 0.441 . . . . 72.4 111.277 -178.652 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 105.32 61.64 0.64 Allowed Glycine 0 N--CA 1.436 -1.358 0 N-CA-C 111.183 -0.767 . . . . 53.51 111.183 -179.99 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -111.01 177.18 4.74 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.163 -0.68 . . . . 31.1 109.163 179.92 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -90.06 112.67 24.18 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 124.296 1.038 . . . . 62.42 111.345 -174.38 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 39.5 mm -107.11 109.23 27.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 109.71 -0.478 . . . . 73.4 109.71 177.657 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 40.9 p -88.38 131.18 34.95 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 122.705 0.402 . . . . 60.32 110.308 179.765 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 6.1 p -127.19 133.29 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 109.448 -0.575 . . . . 63.11 109.448 176.736 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -97.41 128.94 44.63 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.736 -0.839 . . . . 64.44 108.736 174.552 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.514 HG23 ' HA ' ' A' ' 397' ' ' ASP . 7.0 p -129.57 143.89 39.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.886 -0.783 . . . . 72.34 108.886 -176.509 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 421' ' ' SER . . . . . 0.557 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 14.5 m -119.58 130.01 54.92 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 119.156 -1.017 . . . . 54.2 111.359 -178.821 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 5.3 t -119.09 107.06 13.02 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.483 -0.78 . . . . 71.2 111.285 -179.504 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.903 0 CA-C-N 116.276 -0.42 . . . . 71.42 113.63 177.159 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.416 ' CB ' HG22 ' A' ' 477' ' ' THR . 62.0 mt-30 . . . . . 0 N--CA 1.428 -1.561 0 N-CA-C 106.434 -1.691 . . . . 73.31 106.434 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.479 ' HG2' HD11 ' A' ' 480' ' ' ILE . 57.4 mmm-85 -126.61 163.73 22.79 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.594 -0.691 . . . . 74.4 111.977 -178.891 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.1 138.74 33.57 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 114.535 -1.211 . . . . 62.01 108.832 -179.084 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 62.4 mt -91.27 123.72 63.41 Favored Pre-proline 0 N--CA 1.425 -1.701 0 N-CA-C 108.515 -0.921 . . . . 74.11 108.515 177.103 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -71.4 141.01 37.85 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 121.617 1.545 . . . . 63.52 109.733 171.588 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -87.75 168.34 13.05 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.261 -1.014 . . . . 72.03 108.261 177.372 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.681 HG11 ' HB2' ' A' ' 440' ' ' ALA . 13.8 p -153.98 164.94 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.266 -1.013 . . . . 75.14 108.266 -175.546 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 37.6 m -75.95 147.9 38.57 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.435 -0.95 . . . . 62.15 108.435 174.139 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 47.0 p -66.45 -27.99 68.24 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 114.486 1.291 . . . . 51.44 114.486 -170.877 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.1 pp -79.49 -15.83 57.08 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.295 -0.878 . . . . 54.11 112.35 176.522 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.01 47.91 1.16 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.09 0.471 . . . . 72.02 111.34 -174.568 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 437' ' ' TYR . . . . . 0.479 ' OH ' ' HB2' ' A' ' 454' ' ' GLN . 71.2 t80 -52.95 -38.65 62.23 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.27 0.628 . . . . 74.2 112.634 178.629 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.36 -39.61 91.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.427 0.632 . . . . 73.23 110.731 179.79 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -70.3 -35.37 73.64 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.509 -0.769 . . . . 64.34 109.879 178.857 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.681 ' HB2' HG11 ' A' ' 432' ' ' VAL . . . -59.64 -51.23 70.69 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.839 -0.619 . . . . 63.13 111.092 -178.892 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.1 m -65.44 -39.09 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 112.275 0.472 . . . . 64.24 112.275 -178.28 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . 0.273 0.1 OUTLIER -68.17 -34.43 76.29 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 119.556 -0.858 . . . . 74.53 112.1 176.602 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -63.35 -42.01 98.9 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 116.565 -0.289 . . . . 61.34 110.584 174.885 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 93.3 mt -63.57 -33.15 74.96 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.11 -0.495 . . . . 73.3 110.551 178.916 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 48.2 m -70.08 -43.84 70.29 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.13 -0.486 . . . . 63.41 110.065 179.493 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.23 -15.36 62.45 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.675 0.75 . . . . 63.43 110.706 178.801 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -87.01 -0.9 57.38 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.451 -0.795 . . . . 74.43 111.659 179.531 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 112.79 -77.56 0.24 Allowed Glycine 0 CA--C 1.499 -0.963 0 C-N-CA 120.201 -1.0 . . . . 74.44 112.28 176.77 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 449' ' ' PHE . . . . . 0.431 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 0.1 OUTLIER -43.55 -65.55 0.48 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.521 0.934 . . . . 74.41 113.521 177.318 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 62.11 21.64 61.85 Favored Glycine 0 C--O 1.226 -0.354 0 C-N-CA 121.077 -0.582 . . . . 74.34 111.704 -175.421 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -102.91 110.78 22.83 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 108.213 -1.032 . . . . 70.14 108.213 -178.004 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.452 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 27.8 p90 -142.68 163.93 31.49 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 115.59 -0.732 . . . . 73.34 109.665 -175.95 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -151.89 124.14 8.22 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.862 -0.792 . . . . 72.33 108.862 176.356 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 454' ' ' GLN . . . . . 0.479 ' HB2' ' OH ' ' A' ' 437' ' ' TYR . 57.3 tt0 -87.22 128.4 35.15 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 123.454 0.471 . . . . 74.34 109.959 179.897 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -122.17 138.03 54.62 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.23 -1.026 . . . . 73.33 108.23 175.025 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -114.44 133.16 55.95 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.84 -1.171 . . . . 75.52 107.84 -179.13 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 49.1 m -151.73 145.35 17.69 Favored Pre-proline 0 C--N 1.298 -1.638 0 N-CA-C 109.676 -0.49 . . . . 63.33 109.676 176.846 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.684 ' HA ' ' O ' ' A' ' 490' ' ' SER . 29.2 Cg_endo -65.3 122.54 10.29 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.147 1.898 . . . . 63.12 109.264 177.398 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 35.2 m -134.04 179.88 5.98 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 115.634 -0.712 . . . . 35.22 109.734 -173.276 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 6.0 t -54.16 135.84 59.12 Favored Pre-proline 0 N--CA 1.436 -1.166 0 O-C-N 124.26 0.975 . . . . 71.44 109.552 178.77 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -50.97 -29.76 28.47 Favored 'Trans proline' 0 N--CA 1.477 0.512 0 C-N-CA 124.689 3.592 . . . . 55.31 115.085 -171.679 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -75.58 -22.38 57.01 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.973 0.416 . . . . 64.13 112.018 179.272 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -98.37 -5.91 31.8 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.842 0.353 . . . . 64.22 110.692 177.389 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 62.3 t -61.42 127.72 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 109.163 -0.681 . . . . 74.32 109.163 174.233 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 85.93 -4.02 86.41 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 111.415 -0.674 . . . . 63.32 111.415 -179.162 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -122.46 156.82 33.28 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 121.558 0.695 . . . . 55.43 109.433 -177.064 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 47.4 t -71.09 142.59 15.38 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.503 0 CA-C-N 114.599 -1.182 . . . . 73.51 108.128 173.089 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 52.1 mt -97.59 -28.99 3.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 108.809 -0.811 . . . . 73.45 108.809 179.71 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 154.74 -170.11 33.01 Favored Glycine 0 N--CA 1.427 -1.957 0 C-N-CA 120.337 -0.935 . . . . 64.41 112.16 177.042 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 470' ' ' THR . . . . . 0.565 HG22 HG12 ' A' ' 486' ' ' ILE . 36.1 p -115.45 139.9 49.62 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.803 -1.555 . . . . 72.42 106.803 -179.824 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.435 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 9.0 t30 -63.43 -50.9 71.36 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 119.361 -0.935 . . . . 74.13 112.037 177.481 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.435 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 22.0 Cg_exo -75.06 151.11 38.84 Favored 'Trans proline' 0 C--N 1.36 1.157 0 N-CA-C 108.5 -1.385 . . . . 62.33 108.5 170.456 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.24 127.07 20.06 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.004 1.802 . . . . 73.15 112.173 -178.508 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -89.06 3.86 50.32 Favored 'General case' 0 C--O 1.207 -1.175 0 CA-C-N 115.511 -0.768 . . . . 75.21 110.732 -177.928 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -111.08 8.14 21.7 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.524 -0.762 . . . . 72.3 109.933 179.499 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -125.69 179.59 5.09 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 116.198 -0.455 . . . . 74.21 111.043 -174.247 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.416 HG22 ' CB ' ' A' ' 426' ' ' GLN . 3.6 m -89.84 117.57 28.78 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 115.516 -0.766 . . . . 42.11 109.481 179.917 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 50.1 m -118.94 148.68 42.69 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.471 -0.566 . . . . 53.11 109.471 -179.172 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -73.16 153.38 40.75 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.67 0.619 . . . . 70.1 112.67 -174.503 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 480' ' ' ILE . . . . . 0.479 HD11 ' HG2' ' A' ' 427' ' ' ARG . 2.2 mp -65.03 -26.82 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-O 121.756 0.788 . . . . 70.43 110.695 178.75 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 12.2 p -90.85 5.38 48.7 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.477 -0.783 . . . . 62.04 111.502 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -103.33 129.6 50.41 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.084 -0.507 . . . . 61.24 109.958 -176.55 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.2 p -98.58 127.19 51.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.706 -0.679 . . . . 70.05 111.408 -176.086 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 33.5 m -96.67 123.45 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-O 121.403 0.62 . . . . 71.54 110.618 178.121 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.95 128.99 43.27 Favored 'Isoleucine or valine' 0 C--O 1.256 1.435 0 N-CA-C 107.994 -1.113 . . . . 70.11 107.994 176.844 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.565 HG12 HG22 ' A' ' 470' ' ' THR . 42.2 mt -119.72 119.59 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 CA-C-N 114.996 -1.002 . . . . 60.13 110.269 -175.692 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 5.8 tt -103.03 127.12 57.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 115.295 -0.866 . . . . 73.53 111.176 -178.513 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 1.9 p -107.93 136.21 44.09 Favored 'Isoleucine or valine' 0 C--O 1.256 1.403 0 CA-C-N 115.361 -0.836 . . . . 64.12 108.973 176.05 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -73.53 127.95 11.0 Favored Glycine 0 N--CA 1.419 -2.483 0 N-CA-C 110.619 -0.993 . . . . 71.21 110.619 179.328 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.684 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 14.4 t . . . . . 0 C--N 1.28 -2.455 0 N-CA-C 106.907 -1.516 . . . . 71.45 106.907 178.345 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo . . . . . 0 N--CA 1.448 -1.178 0 N-CA-C 110.897 -0.463 . . . . 73.23 110.897 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 493' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . -84.86 52.78 2.51 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.997 -0.742 . . . . 54.4 108.997 179.888 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 546' ' ' PRO . 24.3 p -116.5 148.14 41.08 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 115.231 -0.895 . . . . 63.24 110.423 -174.234 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -145.45 155.06 42.89 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 108.138 -1.06 . . . . 65.43 108.138 178.353 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -89.82 122.9 33.32 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.638 -0.505 . . . . 60.35 109.638 -177.565 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 37.0 pt -79.55 136.29 55.95 Favored Pre-proline 0 C--N 1.307 -1.264 0 O-C-N 123.271 0.357 . . . . 73.54 111.341 -179.433 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -85.18 -174.32 1.66 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.643 2.229 . . . . 75.24 110.266 174.719 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -92.59 147.17 23.1 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.376 -0.601 . . . . 64.12 109.376 179.83 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 41.2 t -129.28 93.86 2.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 107.314 -1.365 . . . . 70.3 107.314 178.6 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -148.22 112.9 5.37 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 107.223 -1.399 . . . . 63.45 107.223 179.566 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 110.24 36.35 1.97 Allowed Glycine 0 N--CA 1.421 -2.314 0 N-CA-C 110.172 -1.171 . . . . 74.11 110.172 -178.016 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -143.1 166.79 23.7 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 108.33 -0.989 . . . . 75.3 108.33 178.651 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 532' ' ' GLY . 11.8 t -93.32 157.43 16.25 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.043 -1.465 . . . . 62.31 107.043 173.869 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 10.5 p -55.37 -40.43 57.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 112.235 0.457 . . . . 55.0 112.235 -178.599 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -58.32 -42.82 87.59 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.496 0.665 . . . . 52.32 110.949 179.503 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 99.6 t -76.37 -36.73 29.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.641 -0.708 . . . . 74.45 110.107 -179.219 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -61.35 -49.21 77.86 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.762 -0.654 . . . . 73.42 111.229 178.856 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -63.21 -37.19 86.26 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 120.485 -0.486 . . . . 71.52 110.32 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -62.64 -45.7 91.61 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.11 -0.7 . . . . 75.32 109.11 179.442 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -62.16 -48.66 79.07 Favored 'General case' 0 CA--C 1.494 -1.197 0 O-C-N 123.107 0.254 . . . . 62.5 111.291 179.953 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.77 -40.5 97.49 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 112.261 0.467 . . . . 64.32 112.261 -179.073 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -65.48 -37.98 88.42 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 120.718 -0.393 . . . . 63.23 110.99 179.146 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 68.7 t -68.92 -26.87 33.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.07 0.462 . . . . 63.1 110.741 176.755 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 17.4 m-30 -81.33 -1.78 46.59 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.262 -0.575 . . . . 75.25 110.14 178.951 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 516' ' ' GLY . . . . . 0.543 ' O ' ' HB ' ' A' ' 547' ' ' VAL . . . 101.78 -4.92 53.57 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.925 -0.655 . . . . 52.31 113.318 176.08 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -83.85 112.81 20.46 Favored 'General case' 0 CA--C 1.476 -1.899 0 N-CA-C 106.548 -1.649 . . . . 70.42 106.548 -177.541 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.3 m -89.19 -25.42 21.79 Favored 'General case' 0 N--CA 1.406 -2.656 0 CA-C-N 115.033 -0.985 . . . . 61.2 112.651 -167.66 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 519' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 96.8 mttt -116.15 125.06 51.82 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 120.117 -0.633 . . . . 52.32 111.035 -177.207 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -129.73 153.14 48.48 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 123.37 0.668 . . . . 74.42 109.909 -179.437 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 50.5 m -141.09 147.25 38.24 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 108.253 -1.017 . . . . 45.33 108.253 174.978 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -116.76 130.9 57.0 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-O 121.229 0.537 . . . . 74.15 110.417 179.81 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -105.34 119.79 39.95 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 107.68 -1.23 . . . . 71.32 107.68 176.149 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 42.3 m -90.0 121.27 31.93 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.271 0.558 . . . . 74.25 110.31 -178.423 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 26.9 m -121.77 153.64 25.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.427 -0.953 . . . . 55.34 108.427 178.345 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 526' ' ' ASP . . . . . 0.504 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 1.1 p-10 -89.04 136.44 33.01 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.036 -1.098 . . . . 54.41 108.036 178.135 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 527' ' ' SER . . . . . 0.428 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 19.7 m -153.48 166.97 14.47 Favored Pre-proline 0 C--N 1.292 -1.912 0 N-CA-C 108.575 -0.898 . . . . 73.31 108.575 179.618 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -73.6 -3.71 14.19 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 121.775 1.65 . . . . 64.22 112.132 175.602 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.46 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 2.1 mpt_? -85.21 134.57 40.51 Favored Pre-proline 0 CA--C 1.515 -0.396 0 N-CA-C 108.093 -1.077 . . . . 72.22 108.093 179.476 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -56.23 143.95 83.2 Favored 'Trans proline' 0 C--O 1.242 0.724 0 C-N-CA 123.064 2.51 . . . . 34.43 113.723 -175.512 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -53.18 125.6 18.05 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 114.615 -1.175 . . . . 72.3 112.629 -174.801 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 532' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 504' ' ' THR . . . 114.41 -16.31 19.63 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.482 -0.781 . . . . 51.43 111.294 178.124 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -74.33 125.73 29.13 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.674 -0.491 . . . . 64.52 109.674 179.494 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 53.3 t -82.78 112.01 19.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.1 -1.444 . . . . 73.24 107.1 176.222 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 15.0 t -80.5 -18.51 48.37 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.755 -0.657 . . . . 75.43 111.114 -175.778 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 163.81 -170.0 38.96 Favored Glycine 0 CA--C 1.495 -1.182 0 C-N-CA 119.94 -1.124 . . . . 43.13 111.828 178.514 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 65.0 p -117.31 153.86 32.24 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.183 -1.043 . . . . 71.42 108.183 -179.95 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.422 ' HB2' HE22 ' A' ' 554' ' ' GLN . 34.5 t30 -77.25 -53.87 1.59 Allowed Pre-proline 0 C--N 1.314 -0.948 0 C-N-CA 120.116 -0.633 . . . . 73.21 110.565 177.813 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -70.63 126.94 13.25 Favored 'Trans proline' 0 C--N 1.357 0.993 0 N-CA-C 107.739 -1.677 . . . . 70.32 107.739 167.707 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.88 156.57 63.62 Favored 'Trans proline' 0 C--O 1.247 0.974 0 C-N-CA 122.499 2.132 . . . . 74.51 113.358 -175.348 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.09 138.71 58.43 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.661 -0.7 . . . . 55.21 109.914 178.423 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 98.12 -6.34 61.76 Favored Glycine 0 N--CA 1.433 -1.554 0 C-N-CA 120.261 -0.971 . . . . 42.02 112.088 -178.778 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 59.0 m -76.23 132.96 40.21 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 109.392 -0.595 . . . . 62.1 109.392 176.803 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 5.0 m -95.11 122.02 37.34 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 107.745 -1.205 . . . . 71.42 107.745 179.294 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 24.3 m -138.16 156.23 73.95 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 109.895 -0.409 . . . . 73.25 109.895 -178.971 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.52 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 37.5 Cg_exo -63.6 139.94 72.54 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.114 1.876 . . . . 64.01 111.375 175.417 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.543 ' HB ' ' O ' ' A' ' 516' ' ' GLY . 30.8 m -64.57 -20.31 26.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 121.841 0.829 . . . . 72.12 111.912 -179.746 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -77.88 -18.0 56.7 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.04 -0.982 . . . . 71.43 110.628 178.816 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 24.6 m -77.76 179.06 6.88 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 112.841 0.682 . . . . 75.21 112.841 -174.977 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 39.1 t -105.78 124.91 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 CA-C-N 115.108 -0.951 . . . . 74.42 109.644 -176.666 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 551' ' ' ILE . . . . . 0.488 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -104.87 135.87 40.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.96 -0.756 . . . . 72.23 108.96 173.43 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -106.85 119.71 40.08 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 116.02 -0.536 . . . . 62.23 111.21 -176.103 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -101.77 134.12 45.44 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.664 -1.153 . . . . 72.13 109.444 179.814 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 554' ' ' GLN . . . . . 0.422 HE22 ' HB2' ' A' ' 538' ' ' ASN . 1.9 mp0 -93.74 122.44 36.21 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.074 0.464 . . . . 75.12 109.844 175.659 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 50.3 t -112.58 130.37 66.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 107.95 -1.13 . . . . 73.42 107.95 -178.981 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 74.6 m -88.15 137.28 32.47 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-O 121.667 0.746 . . . . 63.33 112.318 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.504 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 4.1 ptpt -90.75 147.7 23.06 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 103.986 -2.598 . . . . 71.22 103.986 169.925 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 558' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -83.25 -24.9 50.15 Favored Glycine 0 CA--C 1.479 -2.158 0 C-N-CA 120.318 -0.944 . . . . 64.52 113.57 -171.08 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 559' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 615' ' ' ASN . 88.0 m-20 72.06 -44.03 0.58 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.578 1.151 . . . . 73.35 111.183 -177.283 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.465 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 97.5 mt-30 -119.81 141.73 49.24 Favored 'General case' 0 N--CA 1.424 -1.766 0 C-N-CA 123.548 0.739 . . . . 54.1 111.432 -175.767 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 561' ' ' PHE . . . . . 0.444 ' O ' ' HA2' ' A' ' 613' ' ' GLY . 45.4 p90 -126.99 149.74 49.74 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.489 -0.56 . . . . 74.31 109.489 178.46 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 99.8 t -59.49 120.3 5.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.06 0.457 . . . . 52.21 111.881 -177.945 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 563' ' ' MET . . . . . 0.433 ' HA ' ' HD3' ' A' ' 564' ' ' PRO . 57.1 ttp -97.09 137.09 21.25 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 116.031 -0.532 . . . . 54.22 111.19 179.995 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 564' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 563' ' ' MET . 17.4 Cg_exo -68.68 170.28 15.59 Favored 'Trans proline' 0 CA--C 1.551 1.332 0 C-N-CA 123.5 2.8 . . . . 74.22 112.684 174.162 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.18 129.47 40.0 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 112.669 0.618 . . . . 53.53 112.669 179.385 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 566' ' ' LEU . . . . . 0.453 ' O ' ' HG2' ' A' ' 569' ' ' MET . 95.3 mt -114.74 12.38 17.04 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 122.271 1.034 . . . . 75.42 108.409 175.865 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 20.3 m -79.58 144.52 33.79 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.847 -1.069 . . . . 72.45 110.886 -178.863 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 80.62 9.62 86.19 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 114.616 0.606 . . . . 63.44 114.616 175.285 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 569' ' ' MET . . . . . 0.453 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 26.5 ptm -112.44 164.05 13.73 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 117.427 0.614 . . . . 74.05 109.502 -179.006 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -103.98 163.97 12.02 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.487 0.661 . . . . 54.31 111.291 -177.281 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 19.6 t90 -62.07 -29.66 70.46 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 125.073 1.349 . . . . 72.11 109.488 176.422 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 34.3 m -71.29 -15.12 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 115.845 -0.616 . . . . 62.14 110.771 177.531 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -96.9 -34.84 11.1 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.336 -0.987 . . . . 72.31 108.336 175.904 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -60.86 -41.53 96.08 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.8 -1.091 . . . . 52.42 112.188 -178.259 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.492 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 38.7 mt-10 -59.73 -54.54 54.67 Favored Pre-proline 0 CA--C 1.554 1.127 0 N-CA-C 112.928 0.714 . . . . 73.34 112.928 -179.705 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 576' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 52.2 Cg_exo -59.58 -37.04 90.93 Favored 'Trans proline' 0 C--N 1.369 1.615 0 C-N-CA 121.388 1.392 . . . . 74.44 112.249 174.781 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -59.11 -47.88 83.65 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.347 0.659 . . . . 74.24 110.451 177.894 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.6 pp -67.16 -41.01 86.72 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.151 0.426 . . . . 73.04 112.151 -175.853 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -65.35 -40.03 93.1 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.571 -0.74 . . . . 75.42 110.968 -179.744 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.19 -38.34 87.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.611 -0.722 . . . . 64.24 112.025 -178.201 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.26 -8.51 48.17 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.676 0.621 . . . . 53.15 112.676 -178.851 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 68.09 40.37 88.36 Favored Glycine 0 C--N 1.311 -0.822 0 C-N-CA 119.927 -1.13 . . . . 74.42 110.567 -175.669 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 583' ' ' TRP . . . . . 0.426 ' HE3' ' HB2' ' A' ' 578' ' ' LEU . 83.2 t90 -82.25 135.33 35.25 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.469 -0.567 . . . . 62.2 109.469 179.113 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 9.0 t -148.06 87.58 1.62 Allowed 'General case' 0 N--CA 1.418 -2.042 0 CA-C-O 122.754 1.264 . . . . 54.04 111.045 175.762 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -123.76 -109.74 1.9 Allowed Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 109.094 -1.602 . . . . 72.33 109.094 177.867 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 69.7 mtp -137.27 124.15 21.33 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 120.714 -0.394 . . . . 74.32 111.99 176.78 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -87.39 121.58 30.02 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 103.073 -2.936 . . . . 71.11 103.073 166.251 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -122.3 111.54 17.03 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 119.362 -0.935 . . . . 74.11 113.15 -168.709 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 589' ' ' LYS . . . . . 0.483 ' HD3' ' O ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -113.33 110.24 20.02 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 109.412 -0.588 . . . . 75.14 109.412 170.853 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -90.48 -55.65 1.9 Allowed Glycine 0 CA--C 1.492 -1.352 0 C-N-CA 120.628 -0.796 . . . . 71.43 111.867 -178.214 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -127.42 134.62 49.87 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 109.817 -0.438 . . . . 74.22 109.817 -179.277 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -86.8 123.01 31.48 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 105.683 -1.969 . . . . 55.32 105.683 174.731 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 88.0 t -132.72 126.32 54.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.066 0.46 . . . . 71.33 111.343 -174.388 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 594' ' ' ASP . . . . . 0.548 ' HA ' ' NE2' ' A' ' 600' ' ' HIS . 21.5 t70 -83.14 110.68 18.24 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 109.067 -0.716 . . . . 64.24 109.067 175.628 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -131.32 2.14 4.2 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 120.988 0.423 . . . . 70.22 111.897 -179.608 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 111.81 155.99 13.3 Favored Glycine 0 CA--C 1.499 -0.954 0 N-CA-C 110.798 -0.921 . . . . 44.2 110.798 179.574 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -55.56 -37.06 65.99 Favored Glycine 0 N--CA 1.464 0.541 0 N-CA-C 114.418 0.527 . . . . 73.44 114.418 -171.614 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 23.6 m -64.81 -23.55 67.27 Favored 'General case' 0 CA--C 1.552 1.058 0 CA-C-O 120.943 0.402 . . . . 61.13 111.956 178.832 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -99.43 -13.07 19.7 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 121.968 -0.458 . . . . 73.23 111.308 -179.118 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 600' ' ' HIS . . . . . 0.548 ' NE2' ' HA ' ' A' ' 594' ' ' ASP . 12.0 m170 -85.66 137.21 32.99 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 109.518 -0.549 . . . . 65.23 109.518 -178.164 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 65.82 -11.11 0.2 Allowed 'General case' 0 C--O 1.206 -1.214 0 C-N-CA 124.505 1.122 . . . . 71.55 113.374 -175.776 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 602' ' ' ARG . . . . . 0.472 ' HD2' ' O ' ' A' ' 603' ' ' VAL . 3.3 tmm_? -86.68 138.37 31.71 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.417 -0.957 . . . . 74.4 108.417 -175.78 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 603' ' ' VAL . . . . . 0.472 ' O ' ' HD2' ' A' ' 602' ' ' ARG . 97.7 t -74.73 129.29 36.8 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 108.164 -1.05 . . . . 71.32 108.164 -179.889 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 68.9 t -84.97 -51.57 13.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 109.717 -0.475 . . . . 65.24 109.717 -172.991 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -147.09 157.96 43.78 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 107.647 -1.242 . . . . 52.54 107.647 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -113.43 120.88 42.56 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 106.407 -1.701 . . . . 63.14 106.407 174.077 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.484 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 51.2 t30 -52.75 -52.91 60.01 Favored Pre-proline 0 N--CA 1.477 0.876 0 N-CA-C 112.979 0.733 . . . . 63.14 112.979 -177.141 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 3.0 Cg_exo -83.69 119.26 2.57 Favored 'Trans proline' 0 C--O 1.253 1.245 0 C-N-CA 121.118 1.212 . . . . 73.22 109.425 171.073 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 609' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 608' ' ' PRO . 24.1 Cg_exo -63.97 145.46 89.99 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 122.609 2.206 . . . . 72.05 112.219 -178.443 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.68 131.41 45.53 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.695 -0.684 . . . . 75.14 109.219 178.216 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.67 -19.61 38.55 Favored Glycine 0 C--N 1.296 -1.674 0 N-CA-C 110.082 -1.207 . . . . 73.0 110.082 -173.416 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 27.8 m -91.06 158.53 16.62 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.911 -1.144 . . . . 72.41 107.911 176.562 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 613' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 561' ' ' PHE . . . -84.3 132.78 11.31 Favored Glycine 0 N--CA 1.419 -2.458 0 C-N-CA 121.527 -0.368 . . . . 75.22 112.238 -179.879 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 614' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 34.2 m -113.98 142.42 26.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 C-N-CA 123.67 0.788 . . . . 51.51 109.541 177.007 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.524 ' ND2' ' HB2' ' A' ' 617' ' ' ASP . 26.5 p-10 -52.66 162.02 0.64 Allowed 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 124.078 0.951 . . . . 72.34 112.98 177.65 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -58.41 -25.13 61.78 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 112.702 0.63 . . . . 73.32 112.702 177.406 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 617' ' ' ASP . . . . . 0.524 ' HB2' ' ND2' ' A' ' 615' ' ' ASN . 19.6 m-20 -70.53 -28.51 64.99 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.98 -0.554 . . . . 75.24 109.745 177.108 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 74.22 21.01 79.55 Favored Glycine 0 N--CA 1.432 -1.608 0 CA-C-N 115.689 -0.687 . . . . 15.01 112.488 177.401 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.83 118.83 13.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 122.322 1.058 . . . . 75.2 109.994 -169.963 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.476 HG22 ' HG2' ' A' ' 608' ' ' PRO . 2.8 pp -125.94 133.4 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.385 0 CA-C-N 114.218 -1.355 . . . . 71.35 109.702 -178.038 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.475 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 83.4 m -98.38 120.39 38.71 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 109.087 -0.709 . . . . 61.14 109.087 176.464 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 622' ' ' LEU . . . . . 0.411 ' HB2' HG13 ' A' ' 603' ' ' VAL . 2.7 pp -119.82 165.94 13.93 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.669 -1.151 . . . . 71.31 109.065 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -146.55 146.95 30.65 Favored 'General case' 0 C--N 1.269 -2.9 0 N-CA-C 106.364 -1.717 . . . . 73.3 106.364 177.912 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -138.79 165.53 26.77 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 105.691 -1.966 . . . . 74.2 105.691 175.581 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -66.12 -95.35 0.03 OUTLIER Glycine 0 C--N 1.313 -0.701 0 C-N-CA 120.112 -1.042 . . . . 63.21 111.372 178.865 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 626' ' ' GLN . . . . . 0.429 ' HB3' ' CE1' ' A' ' 600' ' ' HIS . 52.9 tt0 . . . . . 0 C--N 1.292 -1.897 0 N-CA-C 108.447 -0.945 . . . . 73.34 108.447 173.223 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 . . . . . 0 N--CA 1.421 -1.911 0 N-CA-C 105.848 -1.908 . . . . 50.33 105.848 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.7 m -125.83 161.44 30.98 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.48 0 N-CA-C 109.422 -0.584 . . . . 62.31 109.422 -177.19 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 361' ' ' GLN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 409' ' ' SER . 42.4 tt0 -94.12 137.95 32.73 Favored 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 105.489 -2.041 . . . . 73.12 105.489 176.534 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.494 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 91.0 t -95.12 126.14 47.66 Favored Pre-proline 0 C--N 1.278 -2.542 0 N-CA-C 109.711 -0.477 . . . . 63.1 109.711 -166.34 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -62.22 123.49 12.6 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 122.095 1.864 . . . . 65.14 111.232 -178.495 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -81.64 143.2 32.08 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 107.713 -1.217 . . . . 72.21 107.713 179.974 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.537 HG13 ' HB1' ' A' ' 373' ' ' ALA . 7.1 p -126.93 18.02 3.51 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.699 0 CA-C-O 122.605 1.193 . . . . 62.35 110.595 -170.129 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.16 146.83 53.59 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.309 -1.314 . . . . 63.51 113.132 -179.289 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.02 0.5 41.67 Favored Glycine 0 CA--C 1.502 -0.744 0 CA-C-N 115.943 -0.571 . . . . 74.43 112.794 179.094 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -115.0 -158.48 0.67 Allowed 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 107.966 -1.124 . . . . 75.31 107.966 175.705 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 70.6 p -91.35 155.77 18.25 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 108.135 -1.061 . . . . 72.03 108.135 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 23.2 m -63.0 -33.99 76.6 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 120.688 0.28 . . . . 52.35 110.674 -179.029 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.9 -46.54 74.56 Favored 'General case' 0 C--O 1.212 -0.892 0 CA-C-O 119.435 -0.317 . . . . 74.35 111.051 178.807 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -69.12 -43.1 75.11 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-O 121.164 0.507 . . . . 75.22 110.579 179.659 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 373' ' ' ALA . . . . . 0.537 ' HB1' HG13 ' A' ' 365' ' ' VAL . . . -63.32 -49.11 75.27 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.371 -0.831 . . . . 64.32 111.728 -178.108 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.15 -38.1 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-N 116.52 -0.309 . . . . 73.24 110.834 179.322 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -60.64 -47.08 87.82 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.828 0.347 . . . . 64.55 110.885 178.839 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 60.0 m -60.91 -46.88 88.88 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.258 0.551 . . . . 75.35 110.215 179.678 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.503 HD22 HG23 ' A' ' 384' ' ' ILE . 7.6 tt -63.4 -38.87 92.83 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 115.546 -0.752 . . . . 54.54 110.752 -179.265 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -63.88 -40.37 96.38 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.135 0.574 . . . . 71.33 109.826 177.624 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -70.25 -17.61 63.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.166 0.508 . . . . 75.44 112.024 178.181 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -84.33 -14.72 48.86 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.077 0.465 . . . . 73.34 110.18 174.397 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 96.37 8.13 57.74 Favored Glycine 0 N--CA 1.435 -1.426 0 C-N-CA 120.586 -0.816 . . . . 71.12 112.728 175.822 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.482 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 66.4 m-85 -80.69 169.13 18.03 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-O 120.768 0.318 . . . . 62.22 110.688 178.996 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -112.44 150.24 31.46 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.17 -1.048 . . . . 74.01 108.17 -179.099 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 384' ' ' ILE . . . . . 0.503 HG23 HD22 ' A' ' 377' ' ' LEU . 0.1 OUTLIER -130.76 149.13 33.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 CA-C-O 121.572 0.701 . . . . 62.23 112.035 177.181 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.72 139.7 45.77 Favored 'General case' 0 N--CA 1.4 -2.954 0 N-CA-C 103.444 -2.798 . . . . 63.14 103.444 169.797 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 52.0 m -133.76 119.14 18.89 Favored 'General case' 0 C--N 1.252 -3.649 0 N-CA-C 108.468 -0.938 . . . . 63.34 108.468 -175.011 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -110.95 119.36 38.82 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.159 -0.682 . . . . 73.21 109.159 -179.664 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 12.7 pm0 -102.08 120.78 40.99 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 107.054 -1.461 . . . . 74.44 107.054 176.485 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 389' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 421' ' ' SER . 55.8 mtmt -139.29 140.96 27.6 Favored Pre-proline 0 C--N 1.285 -2.198 0 CA-C-N 115.834 -0.621 . . . . 73.25 109.789 -175.755 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 390' ' ' PRO . . . . . 0.463 ' HA ' ' O ' ' A' ' 422' ' ' THR . 24.1 Cg_exo -69.14 174.31 9.15 Favored 'Trans proline' 0 C--O 1.246 0.911 0 C-N-CA 121.972 1.781 . . . . 74.11 110.016 169.286 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 90.15 173.74 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.768 1.627 . . . . 72.52 111.471 -179.2 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 38.6 m -119.53 13.48 12.58 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.642 0.734 . . . . 75.53 109.384 -176.818 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 10.7 m -78.02 -15.73 58.68 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 122.297 1.046 . . . . 70.53 109.45 -179.726 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.605 HG12 ' OG ' ' A' ' 421' ' ' SER . 0.1 OUTLIER -113.69 151.82 44.96 Favored Pre-proline 0 N--CA 1.42 -1.938 0 CA-C-N 114.54 -1.209 . . . . 65.03 108.975 179.339 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.31 158.0 2.79 Favored 'Trans proline' 0 CA--C 1.554 1.483 0 C-N-CA 124.756 3.637 . . . . 74.35 115.854 -175.487 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.13 161.41 8.89 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 123.967 3.111 . . . . 71.3 112.716 178.339 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 397' ' ' ASP . . . . . 0.516 ' HA ' HG23 ' A' ' 420' ' ' VAL . 6.6 p-10 -58.99 -9.42 1.88 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.889 0.876 . . . . 74.03 113.324 -176.867 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 59.6 m170 -114.51 145.99 41.25 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.265 -1.384 . . . . 70.45 107.265 177.016 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 30.6 m -72.28 118.95 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 N-CA-C 112.9 0.704 . . . . 73.44 112.9 -167.817 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 400' ' ' ILE . . . . . 0.446 HD13 ' O ' ' A' ' 400' ' ' ILE . 0.0 OUTLIER -97.97 -29.02 3.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 106.613 -1.625 . . . . 75.01 106.613 176.275 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.7 163.16 28.56 Favored Glycine 0 N--CA 1.409 -3.13 0 CA-C-N 114.808 -1.087 . . . . 63.43 110.446 -178.055 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.8 p -119.55 -176.56 3.18 Favored 'General case' 0 C--N 1.282 -2.331 0 C-N-CA 124.832 1.253 . . . . 71.54 109.265 179.101 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 403' ' ' ASP . . . . . 0.496 ' HB2' ' O ' ' A' ' 417' ' ' THR . 20.2 t70 -99.4 134.78 20.97 Favored Pre-proline 0 C--N 1.299 -1.612 0 N-CA-C 108.814 -0.81 . . . . 74.15 108.814 -174.581 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 404' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 403' ' ' ASP . 74.2 Cg_exo -53.24 -17.1 7.92 Favored 'Trans proline' 0 C--N 1.363 1.318 0 C-N-CA 124.335 3.357 . . . . 74.13 115.134 -176.389 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -61.0 -32.99 72.56 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.967 -0.383 . . . . 71.32 109.967 177.062 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 406' ' ' ALA . . . . . 0.494 ' HA ' ' HB ' ' A' ' 362' ' ' VAL . . . -72.75 -30.91 64.53 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.663 0.744 . . . . 54.02 110.052 179.256 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -81.0 -10.79 59.67 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.345 -0.843 . . . . 73.44 109.843 -178.722 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 40.0 m -96.5 150.09 21.01 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.928 -1.508 . . . . 60.21 106.928 175.727 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 409' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 361' ' ' GLN . 23.2 m -81.28 111.99 18.18 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 107.964 -1.125 . . . . 42.32 107.964 176.795 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.3 m -123.75 169.29 15.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-O 120.967 0.413 . . . . 65.51 110.587 -178.544 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 15.7 m -65.88 136.9 56.76 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.966 -0.753 . . . . 73.25 108.966 178.133 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -67.07 114.23 5.68 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.556 0.693 . . . . 72.32 111.223 -174.799 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 413' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 110.06 40.3 1.43 Allowed Glycine 0 N--CA 1.423 -2.193 0 CA-C-N 115.032 -0.985 . . . . 72.12 111.667 -179.798 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -114.53 -176.62 2.94 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.538 -0.465 . . . . 65.2 109.856 -179.015 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -87.21 119.51 27.52 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 123.842 0.857 . . . . 52.34 111.651 -167.619 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 38.8 mm -112.28 121.49 64.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 107.902 -1.147 . . . . 54.03 107.902 174.994 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 417' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 403' ' ' ASP . 35.5 m -93.05 129.32 39.03 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 113.348 0.87 . . . . 64.44 113.348 -173.98 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 4.2 p -124.42 135.84 62.47 Favored 'Isoleucine or valine' 0 C--O 1.247 0.934 0 CA-C-N 116.237 -0.438 . . . . 73.53 110.34 179.773 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -107.35 128.57 54.57 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.503 -0.317 . . . . 62.5 110.168 178.321 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.516 HG23 ' HA ' ' A' ' 397' ' ' ASP . 7.5 p -123.81 131.49 72.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 109.285 -0.635 . . . . 62.44 109.285 177.382 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 421' ' ' SER . . . . . 0.605 ' OG ' HG12 ' A' ' 394' ' ' ILE . 43.4 m -95.83 122.9 39.11 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.544 0.687 . . . . 62.32 112.12 -177.208 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 422' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 390' ' ' PRO . 6.0 t -119.49 106.99 12.77 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.392 -0.822 . . . . 61.22 109.993 175.525 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.203 0 C-N-CA 120.318 -0.944 . . . . 74.0 113.134 179.041 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 . . . . . 0 N--CA 1.427 -1.61 0 N-CA-C 106.965 -1.494 . . . . 74.14 106.965 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.535 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 5.4 mmp_? -122.71 154.81 37.61 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 120.982 0.42 . . . . 65.24 110.847 176.337 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -83.57 138.99 33.13 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 115.292 -0.867 . . . . 51.11 110.117 -175.829 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.49 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 60.4 mt -86.39 127.49 60.85 Favored Pre-proline 0 N--CA 1.425 -1.695 0 N-CA-C 107.085 -1.45 . . . . 73.15 107.085 176.048 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.483 ' HG2' ' HB3' ' A' ' 443' ' ' LYS . 12.1 Cg_exo -70.19 151.16 66.49 Favored 'Trans proline' 0 C--O 1.239 0.527 0 C-N-CA 122.08 1.853 . . . . 74.15 110.918 176.157 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -69.19 137.73 53.51 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 107.868 -1.16 . . . . 71.54 107.868 178.226 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 2.4 p -116.97 111.27 34.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 C-N-CA 120.306 -0.557 . . . . 73.2 112.206 -176.462 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 1.8 p -65.63 139.52 58.43 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 107.265 -1.383 . . . . 75.13 107.265 171.622 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 434' ' ' THR . . . . . 0.59 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 62.7 p -63.28 -30.87 71.93 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 113.767 1.025 . . . . 73.33 113.767 -164.117 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.458 ' H ' HD23 ' A' ' 435' ' ' LEU . 0.5 OUTLIER -90.42 -11.1 41.46 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 115.867 -0.606 . . . . 65.05 111.767 -179.947 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.456 HG22 ' CB ' ' A' ' 439' ' ' GLU . 1.4 m -105.66 45.75 0.95 Allowed 'General case' 0 CA--C 1.573 1.841 0 CA-C-O 122.462 1.125 . . . . 75.01 110.788 -173.158 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 437' ' ' TYR . . . . . 0.4 ' O ' HG23 ' A' ' 441' ' ' VAL . 49.5 t80 -58.58 -38.2 77.39 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.955 -1.021 . . . . 75.41 113.27 177.037 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -62.52 -36.52 82.85 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 118.508 0.595 . . . . 53.4 110.657 179.397 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.456 ' CB ' HG22 ' A' ' 436' ' ' THR . 9.6 tp10 -62.66 -39.41 93.83 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.729 -0.841 . . . . 74.53 108.729 175.645 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.42 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -63.82 -42.97 97.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.04 -0.527 . . . . 55.41 110.343 178.038 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 441' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 437' ' ' TYR . 78.5 t -58.28 -48.95 83.48 Favored 'Isoleucine or valine' 0 C--O 1.256 1.443 0 CA-C-N 115.998 -0.547 . . . . 64.03 111.034 -179.114 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -67.67 -40.85 84.42 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.134 -0.626 . . . . 71.33 110.804 -177.858 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 443' ' ' LYS . . . . . 0.483 ' HB3' ' HG2' ' A' ' 430' ' ' PRO . 27.5 mmtp -66.45 -40.87 89.66 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.622 -0.717 . . . . 55.34 112.032 -177.517 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.42 HD13 ' O ' ' A' ' 440' ' ' ALA . 8.2 mp -63.67 -38.46 91.19 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.25 0.344 . . . . 70.41 110.159 175.879 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.42 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 98.3 m -64.08 -47.49 79.9 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 120.984 0.421 . . . . 71.44 110.972 179.225 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.49 -15.65 62.32 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.167 -0.469 . . . . 72.14 112.11 -179.598 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -85.54 5.34 31.89 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.035 0.445 . . . . 64.41 111.724 179.699 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 104.56 -66.97 0.29 Allowed Glycine 0 CA--C 1.497 -1.045 0 C-N-CA 120.139 -1.029 . . . . 54.11 112.406 175.212 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 449' ' ' PHE . . . . . 0.424 ' HA ' ' O ' ' A' ' 480' ' ' ILE . 1.3 p90 -49.65 -61.44 2.11 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 113.193 0.812 . . . . 74.24 113.193 177.627 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 450' ' ' GLY . . . . . 0.42 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 57.94 25.12 55.92 Favored Glycine 0 CA--C 1.504 -0.611 0 O-C-N 123.056 0.222 . . . . 64.34 113.301 -179.923 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.404 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 62.7 mtt180 -106.63 113.72 27.39 Favored 'General case' 0 N--CA 1.419 -2.017 0 N-CA-C 108.989 -0.745 . . . . 75.01 108.989 -178.042 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 43.2 p90 -137.8 151.8 48.49 Favored 'General case' 0 C--N 1.279 -2.459 0 CA-C-N 115.192 -0.913 . . . . 72.51 110.012 -175.756 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -142.39 122.85 14.03 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.124 -0.944 . . . . 72.32 110.189 176.663 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -93.95 125.57 38.65 Favored 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 123.778 0.831 . . . . 52.4 109.654 178.626 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -119.18 147.15 44.54 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.99 -1.115 . . . . 72.54 107.99 175.314 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 456' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 488' ' ' VAL . 87.7 m-20 -120.61 133.49 55.37 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 120.855 0.359 . . . . 72.33 111.365 -179.869 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 27.3 t -135.79 139.45 30.72 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 108.979 -0.749 . . . . 72.31 108.979 179.704 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.662 ' HA ' ' O ' ' A' ' 490' ' ' SER . 32.9 Cg_endo -65.94 127.39 17.63 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.292 1.994 . . . . 72.52 110.977 177.495 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 69.5 m -147.76 179.47 7.68 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 122.912 0.485 . . . . 75.52 109.945 -179.7 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 460' ' ' THR . . . . . 0.477 ' O ' HG23 ' A' ' 464' ' ' VAL . 5.2 t -50.23 139.29 19.09 Favored Pre-proline 0 C--O 1.248 0.986 0 C-N-CA 125.125 1.37 . . . . 52.33 111.753 178.223 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.33 -29.8 31.62 Favored 'Trans proline' 0 C--N 1.36 1.132 0 C-N-CA 124.644 3.563 . . . . 73.04 113.45 -177.439 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -72.92 -25.12 60.93 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.293 0.479 . . . . 75.12 112.293 -178.992 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -104.13 -5.38 22.07 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.879 0.371 . . . . 65.23 111.488 177.427 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 460' ' ' THR . 54.0 t -60.36 127.75 20.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.19 -0.459 . . . . 74.34 110.025 177.117 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 90.02 0.5 77.61 Favored Glycine 0 N--CA 1.422 -2.236 0 C-N-CA 121.037 -0.602 . . . . 61.52 112.534 179.001 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.402 ' C ' HG13 ' A' ' 488' ' ' VAL . 0.0 OUTLIER -131.12 163.18 28.23 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 119.604 -0.838 . . . . 63.33 111.213 -179.813 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.59 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 67.7 t -67.01 133.42 31.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 114.711 -1.131 . . . . 54.55 111.216 -177.088 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 53.8 mt -98.3 -24.28 4.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.226 -1.027 . . . . 75.14 108.226 179.15 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 165.33 169.62 29.19 Favored Glycine 0 N--CA 1.427 -1.907 0 CA-C-N 115.471 -0.786 . . . . 73.42 112.65 177.317 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 1.7 t -116.89 137.94 51.87 Favored 'General case' 0 N--CA 1.406 -2.66 0 N-CA-C 106.341 -1.726 . . . . 62.13 106.341 174.783 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.503 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 49.0 t30 -65.52 -53.44 37.73 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 119.822 -0.751 . . . . 64.14 111.055 179.523 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 9.7 Cg_exo -74.84 122.43 7.27 Favored 'Trans proline' 0 C--N 1.366 1.497 0 N-CA-C 107.195 -1.887 . . . . 42.22 107.195 170.811 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.462 ' C ' ' H ' ' A' ' 475' ' ' ASN . 26.9 Cg_exo -62.61 139.26 74.69 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 121.743 1.629 . . . . 72.04 112.565 -176.142 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.49 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -74.67 11.6 1.0 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 122.611 1.196 . . . . 64.35 110.843 -179.632 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 475' ' ' ASN . . . . . 0.462 ' H ' ' C ' ' A' ' 473' ' ' PRO . 78.9 m-20 -110.4 -4.8 15.4 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-N 114.385 -1.279 . . . . 53.34 108.852 -178.854 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -115.83 170.93 8.1 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 121.512 0.672 . . . . 70.34 111.808 -175.243 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.32 137.62 37.56 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.518 -1.219 . . . . 75.24 108.713 -178.378 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 21.1 p -126.27 149.2 49.27 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 120.999 0.428 . . . . 74.21 111.049 -179.146 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -72.97 160.72 31.66 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.431 -0.804 . . . . 70.24 110.537 178.213 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 480' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 449' ' ' PHE . 1.9 mp -72.65 -16.81 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-O 121.947 0.88 . . . . 74.44 111.014 -179.867 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 15.3 t -96.05 5.16 51.79 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-O 121.772 0.796 . . . . 51.13 109.853 177.48 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -89.55 137.61 32.18 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.993 -0.549 . . . . 75.35 109.941 -175.633 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.404 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.2 p -104.37 126.05 59.12 Favored 'Isoleucine or valine' 0 C--O 1.245 0.841 0 CA-C-O 121.336 0.588 . . . . 70.0 110.849 179.705 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 61.8 t -95.83 119.99 44.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.981 -0.554 . . . . 65.33 109.859 -179.271 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.18 123.98 55.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 108.863 -0.792 . . . . 71.1 108.863 178.598 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 39.5 mt -120.15 128.11 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 CA-C-N 114.723 -1.126 . . . . 61.23 110.184 -176.774 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 9.3 tt -101.9 125.15 56.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 115.891 -0.595 . . . . 75.3 110.074 -179.148 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 456' ' ' ASN . 10.6 t -113.18 139.03 40.53 Favored 'Isoleucine or valine' 0 C--O 1.251 1.14 0 N-CA-C 106.569 -1.641 . . . . 40.52 106.569 179.236 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -75.53 153.76 44.79 Favored Glycine 0 C--N 1.299 -1.522 0 CA-C-O 121.346 0.414 . . . . 75.12 113.275 -176.665 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.662 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 48.6 m . . . . . 0 C--N 1.285 -2.201 0 N-CA-C 106.6 -1.63 . . . . 64.03 106.6 176.012 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo . . . . . 0 N--CA 1.446 -1.312 0 CA-C-O 121.563 0.568 . . . . 60.31 112.69 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -95.6 99.94 11.74 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 109.219 -0.66 . . . . 54.15 109.219 176.705 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 13.7 p -117.83 143.0 46.68 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.35 -0.841 . . . . 64.05 109.595 179.208 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -144.76 154.23 42.5 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.674 -0.862 . . . . 70.42 108.674 176.939 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 11.9 p-10 -94.63 136.66 34.68 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.757 -0.831 . . . . 75.33 108.757 176.038 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 30.1 pt -75.62 137.38 70.58 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-N 115.369 -0.832 . . . . 75.35 112.038 -176.314 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -87.34 -170.18 0.57 Allowed 'Trans proline' 0 C--O 1.248 1.023 0 C-N-CA 122.995 2.464 . . . . 70.42 110.947 175.414 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -94.8 122.98 37.99 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.615 0.721 . . . . 62.04 109.687 177.985 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.6 p -113.42 7.57 7.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-O 122.374 1.083 . . . . 72.04 109.993 -177.62 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -73.72 121.22 20.44 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.204 -0.907 . . . . 31.11 109.788 -179.251 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 124.28 -17.75 7.44 Favored Glycine 0 C--N 1.289 -2.057 0 N-CA-C 110.105 -1.198 . . . . 63.34 110.105 -179.866 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -94.11 171.98 8.51 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 109.654 -0.498 . . . . 71.5 109.654 178.148 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 61.1 m -87.69 155.65 19.83 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.145 -1.057 . . . . 71.23 108.145 -179.302 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.6 p -54.17 -41.96 53.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 123.522 0.729 . . . . 74.53 112.316 -178.693 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -60.77 -42.24 97.1 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 123.368 0.667 . . . . 75.32 111.324 178.963 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.27 -40.75 50.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 115.419 -0.81 . . . . 60.34 109.769 -179.202 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -60.69 -49.51 77.23 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.464 -0.789 . . . . 41.23 111.339 -178.481 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -64.6 -36.05 82.98 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.596 -0.274 . . . . 71.15 110.264 -178.614 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.422 ' O ' HG23 ' A' ' 514' ' ' VAL . 87.7 tttt -61.47 -47.19 86.83 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.786 -0.643 . . . . 72.44 109.95 179.457 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -61.92 -48.17 81.63 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 116.192 -0.458 . . . . 74.4 110.818 -178.735 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.7 -45.65 93.4 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.4 -0.364 . . . . 55.35 111.182 178.793 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -63.18 -37.96 89.3 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 120.727 0.299 . . . . 74.25 111.711 -178.681 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 510' ' ' LYS . 79.4 t -65.1 -33.73 65.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-N 116.266 -0.425 . . . . 54.0 110.967 177.392 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -79.63 -9.38 59.62 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.399 0.518 . . . . 55.12 112.399 179.953 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 115.53 -20.43 13.64 Favored Glycine 0 CA--C 1.495 -1.159 0 C-N-CA 120.454 -0.879 . . . . 52.44 111.747 179.109 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 517' ' ' PHE . . . . . 0.453 ' CE1' ' HA ' ' A' ' 547' ' ' VAL . 74.9 m-85 -78.25 81.74 4.6 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.41 -0.959 . . . . 74.32 108.41 179.625 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.6 p -87.91 -8.99 54.99 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 114.96 -1.018 . . . . 45.13 113.355 -173.102 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -108.01 115.52 30.28 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-O 121.407 0.622 . . . . 75.02 109.725 -177.563 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -130.48 156.37 44.89 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.454 -0.794 . . . . 71.44 111.253 -178.847 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 38.4 m -132.45 140.79 48.55 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 106.301 -1.74 . . . . 70.35 106.301 173.423 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -117.54 139.43 50.96 Favored 'General case' 0 N--CA 1.422 -1.869 0 C-N-CA 120.018 -0.673 . . . . 72.3 110.312 179.634 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -115.94 124.38 50.43 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 107.349 -1.352 . . . . 75.32 107.349 175.269 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 39.5 m -89.33 114.54 25.96 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.403 -0.962 . . . . 71.43 108.403 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 33.4 m -121.32 165.99 16.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 N-CA-C 109.309 -0.626 . . . . 54.14 109.309 -177.454 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 526' ' ' ASP . . . . . 0.4 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 3.5 p-10 -104.43 137.48 42.24 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.607 -0.886 . . . . 72.12 108.607 177.367 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 17.3 m -151.27 179.95 1.14 Allowed Pre-proline 0 C--N 1.295 -1.801 0 N-CA-C 109.292 -0.633 . . . . 64.44 109.292 -177.77 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -80.42 -7.04 13.83 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 121.695 1.597 . . . . 74.2 110.49 170.05 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.42 ' HA ' ' HD3' ' A' ' 530' ' ' PRO . 15.7 mmm180 -82.72 137.43 44.22 Favored Pre-proline 0 N--CA 1.447 -0.611 0 N-CA-C 107.892 -1.151 . . . . 45.23 107.892 177.995 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 530' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 529' ' ' ARG . 36.8 Cg_exo -58.8 160.23 18.53 Favored 'Trans proline' 0 N--CA 1.484 0.946 0 C-N-CA 123.566 2.844 . . . . 74.11 115.267 -175.04 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -66.71 113.6 4.96 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.686 -1.143 . . . . 62.05 111.435 -178.977 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 117.25 -19.56 11.7 Favored Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 110.856 -0.898 . . . . 32.15 110.856 178.867 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -83.11 134.62 35.0 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.533 -0.914 . . . . 72.34 108.533 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 58.8 t -80.42 126.36 39.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 109.321 -0.622 . . . . 72.12 109.321 -179.609 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 535' ' ' THR . . . . . 0.655 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 15.1 t -81.13 -18.03 47.85 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 121.506 0.669 . . . . 74.11 109.602 179.131 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.24 -161.44 28.61 Favored Glycine 0 N--CA 1.439 -1.148 0 C-N-CA 120.989 -0.624 . . . . 65.21 112.153 176.293 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 537' ' ' THR . . . . . 0.469 HG22 HD13 ' A' ' 553' ' ' LEU . 15.4 p -117.2 160.26 21.33 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.543 -0.54 . . . . 75.44 109.543 179.226 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.458 ' HB2' HE22 ' A' ' 554' ' ' GLN . 50.7 t30 -68.99 -55.34 10.62 Favored Pre-proline 0 C--N 1.325 -0.491 0 C-N-CA 120.514 -0.475 . . . . 74.3 110.241 177.441 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.82 134.2 25.23 Favored 'Trans proline' 0 C--N 1.366 1.463 0 N-CA-C 109.191 -1.119 . . . . 62.12 109.191 171.447 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.59 157.52 58.02 Favored 'Trans proline' 0 C--O 1.253 1.245 0 C-N-CA 122.578 2.185 . . . . 74.1 112.724 179.971 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.88 134.96 57.34 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.044 -0.525 . . . . 64.23 109.812 178.315 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.57 -13.34 39.16 Favored Glycine 0 C--N 1.307 -1.048 0 C-N-CA 120.844 -0.693 . . . . 71.13 111.739 -177.731 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 496' ' ' ASP . 81.7 m -70.92 120.89 17.15 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 109.072 -0.714 . . . . 22.01 109.072 178.359 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 31.9 m -86.62 122.88 31.16 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.026 -0.731 . . . . 54.3 109.026 -179.661 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 12.2 m -135.1 154.93 79.32 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 109.686 -0.487 . . . . 64.23 109.686 -179.327 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.43 149.77 45.22 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.964 1.776 . . . . 64.31 110.029 175.805 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.453 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 25.8 m -59.54 -19.58 16.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 112.673 0.62 . . . . 74.44 112.673 178.961 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -81.21 3.55 23.38 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.24 1.016 . . . . 72.51 112.64 179.479 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 77.5 p -88.16 175.16 7.83 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 121.996 -0.44 . . . . 73.42 112.17 -176.869 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 39.0 t -112.58 119.24 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 108.79 -0.818 . . . . 43.52 108.79 179.086 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 1.8 mp -98.13 131.21 45.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-O 121.113 0.483 . . . . 75.13 110.223 -179.179 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -103.23 117.82 35.38 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-O 121.258 0.551 . . . . 75.2 110.9 179.822 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 553' ' ' LEU . . . . . 0.469 HD13 HG22 ' A' ' 537' ' ' THR . 2.4 mm? -98.89 132.89 43.88 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.311 -1.313 . . . . 64.14 108.746 179.002 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 554' ' ' GLN . . . . . 0.458 HE22 ' HB2' ' A' ' 538' ' ' ASN . 26.0 mp0 -100.48 118.59 37.0 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.849 -1.167 . . . . 71.13 107.849 172.157 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 46.0 t -104.42 131.18 53.93 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 107.385 -1.339 . . . . 62.54 107.385 -178.22 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.655 ' OG ' ' HB ' ' A' ' 535' ' ' THR . 50.2 m -95.92 158.13 15.59 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 114.044 1.127 . . . . 74.55 114.044 -175.131 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 19.0 ptpt -113.68 148.2 36.78 Favored 'General case' 0 N--CA 1.414 -2.272 0 N-CA-C 105.888 -1.894 . . . . 64.21 105.888 164.092 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -75.08 -22.26 76.87 Favored Glycine 0 C--N 1.292 -1.874 0 O-C-N 124.103 0.877 . . . . 74.44 111.929 -178.586 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 73.67 10.38 4.8 Favored 'General case' 0 CA--C 1.485 -1.524 0 C-N-CA 124.654 1.181 . . . . 64.45 109.284 -171.786 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 33.3 tt0 -128.39 141.26 51.47 Favored 'General case' 0 N--CA 1.408 -2.537 0 CA-C-N 115.525 -0.761 . . . . 73.33 109.42 -176.857 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -138.82 155.1 48.42 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.564 -0.743 . . . . 71.21 109.394 -179.33 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.4 p -63.64 130.58 28.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 O-C-N 123.614 0.571 . . . . 73.22 111.081 -179.157 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 56.4 ttp -94.78 126.41 47.38 Favored Pre-proline 0 C--O 1.253 1.263 0 CA-C-N 115.886 -0.597 . . . . 73.34 109.543 178.36 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -63.43 169.78 9.11 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.068 2.512 . . . . 61.22 112.551 175.941 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -75.19 133.61 41.39 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.871 -0.604 . . . . 73.45 111.29 -179.526 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 566' ' ' LEU . . . . . 0.436 ' HB3' ' SD ' ' A' ' 569' ' ' MET . 92.8 mt -137.66 27.97 2.72 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.828 -0.804 . . . . 75.01 108.828 -177.674 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 17.7 m -77.86 130.31 36.48 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.907 -0.588 . . . . 53.21 111.228 -174.705 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 67.48 38.05 90.46 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.957 -0.565 . . . . 61.11 112.937 176.447 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 569' ' ' MET . . . . . 0.436 ' SD ' ' HB3' ' A' ' 566' ' ' LEU . 23.6 ptm -99.46 168.77 9.77 Favored 'General case' 0 C--O 1.255 1.363 0 N-CA-C 108.839 -0.8 . . . . 61.52 108.839 -179.413 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -106.76 148.98 27.81 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 109.471 -0.566 . . . . 62.05 109.471 -178.077 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 571' ' ' TRP . . . . . 0.449 ' HA ' ' HB3' ' A' ' 574' ' ' ALA . 61.2 t-105 -62.31 -25.01 67.64 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 124.129 0.972 . . . . 71.01 110.269 -178.976 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 13.7 p -68.82 -21.72 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 115.548 -0.751 . . . . 50.32 110.386 179.498 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -101.28 -29.76 11.89 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 109.501 -0.555 . . . . 70.25 109.501 176.103 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 574' ' ' ALA . . . . . 0.449 ' HB3' ' HA ' ' A' ' 571' ' ' TRP . . . -61.7 -49.96 74.39 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.164 -0.925 . . . . 65.54 111.92 -179.385 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.451 ' HB2' ' HD3' ' A' ' 576' ' ' PRO . 38.0 mt-10 -54.21 -53.85 54.37 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 113.283 0.846 . . . . 70.11 113.283 -179.267 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 576' ' ' PRO . . . . . 0.451 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 50.7 Cg_exo -53.87 -45.03 44.02 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 121.887 1.725 . . . . 63.4 112.337 176.825 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.556 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 20.6 mmm180 -64.0 -41.43 97.48 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.512 -0.313 . . . . 64.32 111.174 -179.961 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 7.1 tt -63.64 -49.27 73.89 Favored 'General case' 0 C--O 1.247 0.926 0 C-N-CA 123.403 0.681 . . . . 52.52 109.858 -176.094 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 579' ' ' ARG . . . . . 0.433 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 4.6 ptp180 -67.27 -37.9 84.21 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.616 -0.72 . . . . 74.25 112.595 179.03 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.22 -39.16 75.26 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 112.575 0.583 . . . . 73.43 112.575 -178.148 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 581' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 4.0 pp -84.62 -1.23 55.71 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.66 -0.816 . . . . 62.31 112.437 -179.117 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 67.03 47.46 65.17 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 115.366 -0.834 . . . . 43.4 112.093 177.351 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 22.5 t90 -63.67 127.15 30.06 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.923 -0.399 . . . . 74.14 109.923 179.039 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 3.6 m -125.23 24.22 7.46 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.122 -0.696 . . . . 72.0 109.122 -176.726 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -92.43 -170.2 40.7 Favored Glycine 0 CA--C 1.508 -0.406 0 C-N-CA 120.71 -0.757 . . . . 71.23 113.904 -175.438 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 64.7 mtt -98.7 126.39 44.29 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.87 0.367 . . . . 74.5 110.474 -179.311 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 55.0 tp -96.84 102.25 14.0 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.12 -1.067 . . . . 71.05 108.12 177.504 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -96.43 101.46 13.09 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.268 0.556 . . . . 71.4 110.463 -178.851 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.32 114.22 28.31 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.547 -1.279 . . . . 73.31 107.547 178.631 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -75.97 -88.45 0.27 Allowed Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 120.622 -0.799 . . . . 73.5 111.206 177.45 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -125.58 154.66 41.89 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 122.436 -0.449 . . . . 63.11 110.48 -178.898 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -82.15 141.47 33.05 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.346 -0.983 . . . . 75.32 108.346 173.933 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 42.5 t -124.24 116.53 48.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 108.935 -0.765 . . . . 73.31 108.935 -177.473 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -89.2 107.81 19.26 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 107.778 -1.193 . . . . 72.05 107.778 177.573 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -127.18 9.54 6.76 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.887 -0.597 . . . . 74.11 111.197 -178.814 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 128.65 169.73 12.66 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.302 -0.951 . . . . 62.44 111.701 178.175 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -57.11 -46.46 91.51 Favored Glycine 0 C--O 1.237 0.329 0 O-C-N 123.933 0.431 . . . . 71.12 113.034 -177.112 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 30.9 t -65.87 -29.69 70.18 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.313 0.578 . . . . 73.41 110.514 -178.722 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 599' ' ' GLN . . . . . 0.596 ' O ' ' HA3' ' A' ' 625' ' ' GLY . 87.4 mm-40 -87.31 -1.02 57.62 Favored 'General case' 0 C--O 1.211 -0.97 0 CA-C-N 115.65 -0.705 . . . . 74.31 112.788 -174.114 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 600' ' ' HIS . . . . . 0.522 ' HA ' ' H ' ' A' ' 626' ' ' GLN . 19.8 m80 -63.52 -71.77 0.16 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.952 0.882 . . . . 72.05 110.921 176.919 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -95.62 31.13 2.1 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.798 -0.637 . . . . 63.5 111.023 -173.575 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 1.3 mmm-85 -105.15 140.23 38.63 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 116.064 -0.516 . . . . 71.32 110.233 -177.904 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 97.3 t -73.7 138.18 21.78 Favored 'Isoleucine or valine' 0 C--O 1.252 1.218 0 N-CA-C 107.306 -1.368 . . . . 73.35 107.306 174.819 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 57.8 t -94.43 -50.55 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.973 0 CA-C-O 121.743 0.782 . . . . 62.13 109.421 -174.084 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -146.9 155.88 42.65 Favored 'General case' 0 N--CA 1.415 -2.219 0 N-CA-C 107.701 -1.222 . . . . 63.11 107.701 -178.537 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -120.84 121.88 39.08 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 106.465 -1.68 . . . . 71.2 106.465 171.123 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.563 ' HB2' ' HB ' ' A' ' 621' ' ' THR . 26.3 t-20 -59.03 -52.79 72.27 Favored Pre-proline 0 C--N 1.299 -1.623 0 CA-C-N 115.539 -0.755 . . . . 55.32 112.67 -177.893 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 1.0 OUTLIER -87.8 123.28 1.74 Allowed 'Trans proline' 0 N--CA 1.442 -1.544 0 C-N-CA 121.275 1.317 . . . . 74.23 109.668 173.546 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.06 156.15 60.53 Favored 'Trans proline' 0 C--O 1.244 0.793 0 C-N-CA 122.287 1.992 . . . . 65.21 111.36 177.978 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -59.09 127.96 34.79 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.828 -0.434 . . . . 72.33 109.828 178.559 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.18 -7.81 44.3 Favored Glycine 0 C--N 1.31 -0.891 0 C-N-CA 120.343 -0.932 . . . . 73.31 111.755 -177.613 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 26.9 m -89.13 157.26 18.36 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 107.988 -1.116 . . . . 70.33 107.988 178.247 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -90.98 143.52 16.68 Favored Glycine 0 N--CA 1.422 -2.238 0 C-N-CA 120.787 -0.721 . . . . 75.51 113.092 -177.42 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 614' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 19.0 m -115.71 141.65 32.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 109.376 -0.601 . . . . 62.44 109.376 174.388 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -70.82 -179.71 2.33 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 123.852 0.861 . . . . 72.15 113.066 -177.386 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -61.95 -36.03 80.21 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.072 0.949 . . . . 71.04 109.718 -179.728 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 617' ' ' ASP . . . . . 0.417 ' OD2' ' HB ' ' A' ' 619' ' ' ILE . 21.2 t70 -63.28 -40.33 97.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.008 -0.997 . . . . 52.53 108.656 174.588 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 87.97 22.03 43.83 Favored Glycine 0 N--CA 1.425 -2.09 0 C-N-CA 120.14 -1.029 . . . . 60.4 111.919 176.385 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 619' ' ' ILE . . . . . 0.417 ' HB ' ' OD2' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -68.76 118.46 12.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 122.422 1.106 . . . . 40.33 110.19 -170.398 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.34 130.38 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.743 0 N-CA-C 106.336 -1.727 . . . . 70.42 106.336 -179.923 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.563 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 6.4 m -100.77 117.19 34.36 Favored 'General case' 0 N--CA 1.421 -1.908 0 C-N-CA 119.455 -0.898 . . . . 73.31 109.428 -178.533 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -139.26 150.78 45.87 Favored 'General case' 0 CA--C 1.48 -1.736 0 N-CA-C 106.054 -1.832 . . . . 64.0 106.054 178.976 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -134.36 151.54 51.28 Favored 'General case' 0 C--N 1.266 -3.057 0 N-CA-C 105.132 -2.173 . . . . 75.43 105.132 176.523 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -120.4 165.55 14.76 Favored 'General case' 0 C--N 1.274 -2.705 0 N-CA-C 107.266 -1.383 . . . . 74.01 107.266 177.461 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 625' ' ' GLY . . . . . 0.596 ' HA3' ' O ' ' A' ' 599' ' ' GLN . . . -70.46 -108.29 0.04 OUTLIER Glycine 0 C--N 1.302 -1.344 0 O-C-N 123.915 0.759 . . . . 71.13 114.317 -174.409 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 626' ' ' GLN . . . . . 0.522 ' H ' ' HA ' ' A' ' 600' ' ' HIS . 8.6 tp-100 . . . . . 0 C--N 1.296 -1.746 0 CA-C-O 118.998 -0.525 . . . . 64.45 110.0 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.148 0 N-CA-C 110.827 -0.909 . . . . 65.33 110.827 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 49.9 mm -75.99 130.05 36.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-O 120.903 0.383 . . . . 73.42 109.98 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.81 133.75 47.76 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.531 -0.759 . . . . 62.21 110.839 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.21 -10.28 57.84 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 122.006 0.907 . . . . 73.41 108.682 175.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.66 150.56 44.47 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 106.196 -1.779 . . . . 71.04 106.196 172.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 24.4 m -113.85 142.35 26.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-O 121.779 0.799 . . . . 74.43 110.3 -170.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -95.01 126.64 40.49 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 106.291 -1.744 . . . . 75.41 106.291 -176.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.454 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 64.0 t -97.35 121.25 59.11 Favored Pre-proline 0 C--N 1.286 -2.18 0 CA-C-N 114.616 -1.174 . . . . 75.33 111.577 -169.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 363' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 24.5 Cg_exo -62.29 135.8 56.19 Favored 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 123.026 2.484 . . . . 74.32 111.658 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -105.14 149.81 25.57 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.917 -1.142 . . . . 72.53 107.917 -176.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.518 ' CG2' ' HA ' ' A' ' 373' ' ' ALA . 26.1 m -134.63 20.06 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 C-N-CA 122.415 0.286 . . . . 71.13 111.032 -177.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.54 146.5 9.83 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 112.797 0.666 . . . . 65.32 112.797 177.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 367' ' ' GLY . . . . . 0.435 ' H ' HG23 ' A' ' 399' ' ' VAL . . . 105.07 0.83 41.65 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 115.83 -0.623 . . . . 32.43 112.357 -178.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -111.1 -89.35 0.5 Allowed 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 120.299 -0.561 . . . . 62.14 111.081 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 59.9 p -152.57 165.53 34.89 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.018 -0.734 . . . . 63.14 109.018 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.41 -46.14 87.76 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.721 -0.844 . . . . 73.14 108.721 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -59.53 -45.51 91.56 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 115.305 -0.861 . . . . 74.13 112.05 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -67.3 -41.38 85.46 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.087 0.47 . . . . 51.43 110.328 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 373' ' ' ALA . . . . . 0.518 ' HA ' ' CG2' ' A' ' 365' ' ' VAL . . . -65.79 -48.97 69.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.106 -0.497 . . . . 73.14 111.261 -179.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.17 -38.2 81.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.01 -0.541 . . . . 73.4 110.511 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.65 -42.03 87.41 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.259 0.623 . . . . 71.44 111.11 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.3 m -65.69 -49.02 70.05 Favored 'General case' 0 C--O 1.248 1.014 0 CA-C-O 121.58 0.705 . . . . 75.04 110.206 -178.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 9.9 mp -65.51 -42.63 91.84 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.572 -0.74 . . . . 73.41 111.74 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -64.46 -38.44 91.05 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.006 -0.543 . . . . 70.23 110.314 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -59.89 -39.08 84.15 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 116.023 -0.535 . . . . 62.12 110.687 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' ARG . . . . . 0.428 ' HA ' ' HD3' ' A' ' 380' ' ' ARG . 25.2 mmt180 -81.37 -12.35 59.01 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.613 -0.721 . . . . 74.0 112.193 -177.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.32 7.27 52.23 Favored Glycine 0 C--N 1.303 -1.27 0 C-N-CA 120.636 -0.792 . . . . 61.2 112.694 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.523 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 47.7 m-85 -81.66 159.46 23.97 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-O 121.355 0.598 . . . . 73.12 111.621 177.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.505 ' HB2' ' HG2' ' A' ' 415' ' ' GLU . 46.4 mtmt -115.23 161.8 17.95 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 115.005 -0.998 . . . . 43.12 108.826 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.21 157.38 41.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-O 120.862 0.363 . . . . 60.11 110.698 -177.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 61.6 ttp85 -120.16 126.84 51.66 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 107.138 -1.43 . . . . 72.44 107.138 170.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 17.6 m -108.27 125.13 51.33 Favored 'General case' 0 C--N 1.281 -2.408 0 N-CA-C 108.694 -0.854 . . . . 62.11 108.694 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -111.71 119.74 39.68 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.663 -0.866 . . . . 74.42 108.663 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -96.61 139.26 32.96 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 110.138 -0.319 . . . . 72.11 110.138 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -131.31 127.53 21.78 Favored Pre-proline 0 C--N 1.307 -1.247 0 N-CA-C 108.278 -1.008 . . . . 75.54 108.278 174.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -63.3 142.95 88.02 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.245 1.963 . . . . 74.23 111.794 177.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 7.3 t70 87.03 148.04 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 126.864 2.065 . . . . 65.23 110.368 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 13.0 t -103.12 11.96 36.44 Favored 'General case' 0 CA--C 1.552 1.058 0 CA-C-O 120.991 0.424 . . . . 64.41 110.546 -175.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 8.4 t -73.44 -18.08 61.17 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.97 0.891 . . . . 75.44 109.016 175.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.46 HD13 ' H ' ' A' ' 394' ' ' ILE . 0.1 OUTLIER -104.48 151.24 39.15 Favored Pre-proline 0 N--CA 1.427 -1.576 0 N-CA-C 107.459 -1.311 . . . . 61.31 107.459 173.098 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -23.33 114.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.678 1 C-N-CA 126.205 4.603 . . . . 64.52 115.7 -175.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.06 160.29 10.69 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 123.922 3.081 . . . . 64.2 112.833 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -57.97 -12.88 3.66 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 113.545 0.942 . . . . 75.5 113.545 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 28.7 m170 -91.89 148.46 22.2 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 108.257 -1.016 . . . . 71.32 108.257 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.435 HG23 ' H ' ' A' ' 367' ' ' GLY . 30.0 m -77.75 117.17 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.255 0 C-N-CA 118.687 -1.205 . . . . 70.34 111.089 -171.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 35.6 pt -106.68 -28.8 2.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 115.198 -0.91 . . . . 75.55 108.729 173.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.72 158.0 27.58 Favored Glycine 0 N--CA 1.417 -2.607 0 N-CA-C 109.489 -1.444 . . . . 31.53 109.489 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 3.9 p -137.93 -178.58 5.32 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 123.623 0.769 . . . . 73.04 109.476 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -102.1 132.16 21.85 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 108.154 -1.054 . . . . 61.42 108.154 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.34 3.09 0.89 Allowed 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.307 2.671 . . . . 72.41 115.632 -176.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -52.87 -47.59 67.72 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 109.673 -0.492 . . . . 65.33 109.673 175.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -69.95 -28.97 66.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.639 -0.71 . . . . 64.02 110.464 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -81.35 -6.14 58.6 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 122.014 0.911 . . . . 75.32 109.753 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 28.3 m -101.92 160.66 14.3 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.538 -1.653 . . . . 54.11 106.538 175.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 20.2 m -76.48 113.11 13.72 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 119.55 -0.86 . . . . 73.44 109.067 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.3 m -123.66 170.02 14.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 122.86 0.464 . . . . 65.24 111.018 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 19.2 m -74.25 141.05 45.39 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.887 -0.783 . . . . 54.32 108.887 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 412' ' ' ALA . . . . . 0.523 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -69.08 108.94 3.77 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.072 0.463 . . . . 73.31 110.468 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 121.38 37.76 0.67 Allowed Glycine 0 C--N 1.311 -0.819 0 CA-C-N 115.194 -0.912 . . . . 41.3 111.744 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -100.02 179.07 4.61 Favored 'General case' 0 C--O 1.245 0.861 0 N-CA-C 107.7 -1.222 . . . . 70.43 107.7 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 415' ' ' GLU . . . . . 0.505 ' HG2' ' HB2' ' A' ' 383' ' ' LYS . 44.8 mt-10 -116.41 115.0 25.05 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 118.249 0.477 . . . . 74.21 109.957 -178.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 42.6 mm -97.94 129.47 48.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 121.062 0.458 . . . . 75.14 110.072 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 2.2 p -79.81 131.21 35.84 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 123.866 0.866 . . . . 72.41 111.776 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 10.7 p -119.13 134.35 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.872 0 N-CA-C 109.01 -0.737 . . . . 61.51 109.01 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -95.4 120.77 36.21 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.546 -0.909 . . . . 74.45 108.546 -176.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 50.5 t -128.45 149.1 32.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 122.869 0.468 . . . . 72.4 109.885 -176.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 44.2 m -126.24 148.98 49.37 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.573 -0.529 . . . . 51.01 109.573 173.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 1.5 m -103.65 157.94 16.72 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 106.897 -1.52 . . . . 71.14 106.897 -175.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -53.9 179.76 0.15 Allowed Glycine 0 CA--C 1.542 1.73 0 N-CA-C 115.626 1.011 . . . . 74.55 115.626 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.7 142.8 91.27 Favored 'Trans proline' 0 C--O 1.246 0.888 0 C-N-CA 123.818 3.012 . . . . 75.25 113.213 -175.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -81.14 126.01 30.94 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.286 -0.87 . . . . 74.41 110.929 -175.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -136.14 155.5 50.08 Favored 'General case' 0 C--N 1.266 -3.057 0 N-CA-C 107.404 -1.332 . . . . 71.34 107.404 173.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 447' ' ' ALA . 2.4 mmp_? -122.78 143.74 49.63 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-O 120.717 0.294 . . . . 72.1 110.655 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -86.27 138.98 31.43 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 107.079 -1.452 . . . . 54.41 107.079 173.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 67.6 mt -78.78 121.97 84.14 Favored Pre-proline 0 C--N 1.3 -1.545 0 CA-C-O 121.115 0.483 . . . . 74.24 110.825 -172.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.91 148.62 58.0 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.636 2.224 . . . . 74.41 111.434 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -87.48 145.15 26.38 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.666 -0.494 . . . . 74.42 109.666 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.28 153.05 16.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.839 -0.8 . . . . 75.11 108.839 -175.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 2.7 p -64.47 137.0 57.63 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 121.399 0.618 . . . . 62.35 110.294 175.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 434' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 23.6 p -69.1 -21.21 64.07 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 125.053 1.341 . . . . 75.14 112.128 -171.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.511 ' H ' HD23 ' A' ' 435' ' ' LEU . 0.6 OUTLIER -88.56 -11.02 46.83 Favored 'General case' 0 C--N 1.275 -2.632 0 CA-C-N 115.668 -0.696 . . . . 63.01 110.502 179.422 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.8 m -108.61 66.4 0.64 Allowed 'General case' 0 N--CA 1.426 -1.637 0 CA-C-O 121.835 0.826 . . . . 60.31 111.125 -175.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -53.38 -38.52 63.43 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 124.462 1.105 . . . . 71.44 111.859 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -58.89 -42.65 90.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.89 0.376 . . . . 74.43 110.85 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -70.96 -36.21 72.47 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.925 -0.58 . . . . 74.24 109.988 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.623 ' O ' HD22 ' A' ' 444' ' ' LEU . . . -60.39 -52.58 64.65 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 116.686 -0.234 . . . . 72.44 111.551 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 26.9 m -63.63 -36.5 76.67 Favored 'Isoleucine or valine' 0 C--O 1.245 0.828 0 CA-C-O 121.402 0.62 . . . . 55.04 110.773 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 41.5 tptt -59.18 -45.79 90.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.911 -1.041 . . . . 63.33 109.464 175.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -64.21 -39.76 94.65 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 113.381 0.882 . . . . 72.23 113.381 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.623 HD22 ' O ' ' A' ' 440' ' ' ALA . 1.4 mm? -68.01 -33.03 73.83 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 119.056 -1.057 . . . . 74.31 110.762 175.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 45.5 m -70.12 -42.69 72.29 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.293 0.568 . . . . 70.13 110.074 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.98 -15.49 62.58 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.845 -0.616 . . . . 75.41 110.651 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 447' ' ' ALA . . . . . 0.465 ' O ' ' HG3' ' A' ' 427' ' ' ARG . . . -86.92 2.87 47.86 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.061 -0.518 . . . . 44.45 111.454 177.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 106.35 -76.59 0.23 Allowed Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.172 -1.013 . . . . 42.43 112.127 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -46.28 -57.3 4.7 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 114.377 1.251 . . . . 72.14 114.377 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 59.41 28.41 64.7 Favored Glycine 0 CA--C 1.508 -0.382 0 O-C-N 123.5 0.5 . . . . 61.45 112.271 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.485 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 16.1 mmt180 -105.04 111.0 23.62 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 107.385 -1.339 . . . . 73.42 107.385 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.516 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 18.1 p90 -144.89 157.38 44.17 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-O 120.81 0.338 . . . . 72.14 111.451 -175.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -131.1 149.08 52.76 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 124.483 1.113 . . . . 73.3 108.22 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -116.86 119.42 35.32 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.937 -0.764 . . . . 75.13 108.937 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.6 143.01 48.87 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.001 -0.741 . . . . 73.2 109.001 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -112.98 135.02 54.22 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 107.269 -1.382 . . . . 73.33 107.269 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 38.2 t -137.44 134.81 18.75 Favored Pre-proline 0 C--N 1.289 -2.032 0 N-CA-C 109.118 -0.697 . . . . 51.11 109.118 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.617 ' HA ' ' O ' ' A' ' 490' ' ' SER . 37.1 Cg_endo -65.89 122.45 10.03 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 121.715 1.61 . . . . 71.53 108.549 175.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 15.3 m -131.82 179.34 6.13 Favored 'General case' 0 C--N 1.286 -2.157 0 C-N-CA 120.06 -0.656 . . . . 71.33 110.893 -173.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.7 t -55.78 141.49 65.77 Favored Pre-proline 0 N--CA 1.422 -1.853 0 C-N-CA 125.008 1.323 . . . . 75.21 108.458 173.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 461' ' ' PRO . . . . . 0.417 ' HB3' ' OG1' ' A' ' 494' ' ' THR . 9.6 Cg_endo -50.58 -30.11 27.16 Favored 'Trans proline' 0 N--CA 1.481 0.777 0 C-N-CA 124.766 3.644 . . . . 71.45 114.781 -171.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -75.89 -27.2 57.61 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 113.103 0.779 . . . . 72.4 113.103 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -92.95 -19.88 21.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.939 0.4 . . . . 75.11 111.688 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 90.5 t -60.78 134.89 26.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 109.423 -0.584 . . . . 73.22 109.423 175.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 101.35 -15.74 57.33 Favored Glycine 0 N--CA 1.431 -1.647 0 C-N-CA 121.085 -0.579 . . . . 65.33 113.248 177.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.2 166.59 24.27 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 117.521 0.661 . . . . 53.21 110.751 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.479 ' O ' ' HB ' ' A' ' 434' ' ' THR . 54.6 t -67.12 142.5 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.336 0 N-CA-C 108.478 -0.934 . . . . 61.4 108.478 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 42.5 mt -97.59 -28.22 3.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 107.689 -1.226 . . . . 64.21 107.689 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 150.23 -150.99 23.12 Favored Glycine 0 N--CA 1.411 -2.997 0 CA-C-N 114.646 -1.161 . . . . 71.11 110.661 176.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 470' ' ' THR . . . . . 0.706 HG22 HG12 ' A' ' 486' ' ' ILE . 43.7 p -115.26 151.62 34.17 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 105.352 -2.092 . . . . 62.24 105.352 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.41 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 8.8 t30 -69.91 -50.67 16.58 Favored Pre-proline 0 C--N 1.304 -1.378 0 C-N-CA 118.698 -1.201 . . . . 63.11 111.055 176.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.41 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 23.5 Cg_exo -68.46 162.07 42.31 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 121.289 1.326 . . . . 54.02 109.36 172.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.494 ' HB2' ' OE1' ' A' ' 476' ' ' GLN . 20.7 Cg_endo -61.64 127.73 22.52 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.294 1.996 . . . . 72.52 111.988 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.481 ' HB2' ' OG1' ' A' ' 470' ' ' THR . . . -91.27 0.39 57.53 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 113.556 0.947 . . . . 60.44 113.556 -170.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -108.96 -12.99 14.81 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 119.677 -0.809 . . . . 74.04 109.672 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 476' ' ' GLN . . . . . 0.494 ' OE1' ' HB2' ' A' ' 473' ' ' PRO . 20.1 mp0 -92.35 -175.28 3.97 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 114.143 -1.39 . . . . 63.22 111.474 -172.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 1.4 p -93.79 141.13 28.84 Favored 'General case' 0 N--CA 1.404 -2.746 0 N-CA-C 113.387 0.884 . . . . 71.33 113.387 -176.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 12.7 p -127.08 148.05 50.15 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-N 114.618 -1.174 . . . . 73.5 108.269 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -75.58 163.72 27.06 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 116.845 -0.161 . . . . 43.12 110.857 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 22.6 mm -80.04 -5.15 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.019 0 CA-C-O 122.264 1.03 . . . . 75.34 109.552 -176.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.5 t -110.64 5.13 20.77 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.726 0.774 . . . . 75.54 109.259 175.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -93.01 143.05 26.62 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.835 -0.621 . . . . 75.24 110.686 -175.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.485 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.1 p -108.25 127.1 64.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 C-N-CA 123.11 0.564 . . . . 53.13 111.475 -177.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 27.8 m -105.12 125.46 60.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-O 121.864 0.84 . . . . 73.11 111.788 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.66 125.19 45.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.813 -0.81 . . . . 62.44 108.813 177.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.706 HG12 HG22 ' A' ' 470' ' ' THR . 42.5 mt -110.28 128.65 66.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 C-N-CA 124.465 1.106 . . . . 75.25 110.999 -176.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 4.8 tt -111.15 127.13 68.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 115.357 -0.838 . . . . 70.12 111.122 -174.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 467' ' ' VAL . 2.5 p -115.19 135.47 55.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 115.218 -0.901 . . . . 71.51 109.92 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -72.66 125.87 10.5 Favored Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 110.517 -1.033 . . . . 64.53 110.517 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.617 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 8.6 t -142.52 148.36 37.51 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 108.268 -1.012 . . . . 60.24 108.268 -176.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 85.32 87.26 0.94 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.238 -0.982 . . . . 71.55 113.162 177.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -92.23 146.13 2.89 Favored 'Trans proline' 0 N--CA 1.44 -1.618 0 C-N-CA 122.391 2.061 . . . . 73.05 111.655 176.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -128.99 23.9 5.65 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 122.748 1.261 . . . . 60.11 108.261 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.417 ' OG1' ' HB3' ' A' ' 461' ' ' PRO . 14.6 p -127.22 143.54 51.23 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 112.909 -1.95 . . . . 70.15 109.309 -176.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -147.03 161.85 39.98 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.042 -1.096 . . . . 64.53 108.042 176.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.2 p-10 -93.87 135.24 35.4 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 109.517 -0.549 . . . . 73.35 109.517 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 40.3 pt -80.18 137.77 52.8 Favored Pre-proline 0 C--N 1.302 -1.467 0 CA-C-N 115.952 -0.567 . . . . 72.32 111.37 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.63 168.31 19.74 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.653 2.236 . . . . 72.41 112.859 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -70.87 121.73 18.62 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.642 -0.873 . . . . 70.32 108.642 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.01 87.89 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.178 0 CA-C-O 122.475 1.131 . . . . 71.35 110.845 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -146.97 122.5 10.42 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 113.703 -1.59 . . . . 71.04 108.08 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 112.43 -11.98 25.94 Favored Glycine 0 CA--C 1.493 -1.282 0 N-CA-C 109.888 -1.285 . . . . 73.45 109.888 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -94.71 169.32 10.25 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 114.888 -0.656 . . . . 71.02 109.677 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 5.5 m -84.39 157.16 21.51 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.458 -0.941 . . . . 72.31 108.458 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 17.5 t -55.65 -41.96 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.227 0.611 . . . . 63.23 110.933 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -62.1 -40.58 96.33 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.669 -0.696 . . . . 71.42 110.836 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 48.8 t -73.94 -38.9 50.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.839 -0.619 . . . . 71.44 109.558 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -62.81 -49.43 74.97 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.566 -0.743 . . . . 64.35 111.356 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -63.15 -35.71 81.21 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 109.629 -0.508 . . . . 74.12 109.629 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.468 ' O ' HG23 ' A' ' 514' ' ' VAL . 48.4 tttp -64.79 -45.33 86.74 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.674 -0.694 . . . . 62.02 109.976 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 511' ' ' ASN . . . . . 0.403 ' O ' ' HD1' ' A' ' 515' ' ' TYR . 92.1 m-20 -62.34 -42.39 99.35 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 120.6 0.238 . . . . 73.44 110.734 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.33 -42.83 96.07 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 116.596 -0.274 . . . . 74.43 111.381 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -63.23 -37.69 88.23 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.785 -0.189 . . . . 61.51 111.041 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 510' ' ' LYS . 56.9 t -59.88 -35.03 58.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.085 0.469 . . . . 65.33 110.844 176.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 515' ' ' TYR . . . . . 0.403 ' HD1' ' O ' ' A' ' 511' ' ' ASN . 31.3 m-85 -79.45 -8.21 58.96 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.881 0.372 . . . . 72.31 111.936 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 103.23 -0.4 47.24 Favored Glycine 0 C--N 1.303 -1.279 0 C-N-CA 120.075 -1.06 . . . . 62.23 112.55 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.601 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 79.2 m-85 -84.59 96.33 9.14 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.451 -1.314 . . . . 74.03 107.451 177.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 6.3 p -87.19 -13.89 42.71 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 113.234 0.827 . . . . 74.14 113.234 -174.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -108.83 114.73 28.75 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.166 0.508 . . . . 72.2 109.676 -178.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -131.42 154.44 48.67 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.755 -0.657 . . . . 75.42 110.619 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 43.8 m -141.54 140.94 33.54 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 107.772 -1.196 . . . . 43.32 107.772 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 522' ' ' GLN . . . . . 0.502 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 4.8 pm0 -117.56 128.46 54.97 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 118.468 0.576 . . . . 52.51 111.551 -177.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -111.66 116.22 30.41 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.039 -0.726 . . . . 53.11 109.039 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 35.4 m -95.08 124.72 39.28 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 120.743 0.306 . . . . 50.42 111.03 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 18.7 m -122.8 151.29 26.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 108.539 -0.912 . . . . 62.21 108.539 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 526' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 557' ' ' LYS . 3.8 p30 -66.59 136.13 55.15 Favored 'General case' 0 CA--C 1.495 -1.169 0 CA-C-O 121.681 0.753 . . . . 73.04 110.423 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 20.0 m -146.43 158.34 47.23 Favored Pre-proline 0 C--N 1.281 -2.404 0 CA-C-N 114.737 -1.119 . . . . 24.21 108.596 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -69.68 -21.76 33.43 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 121.551 1.501 . . . . 70.31 108.802 170.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.512 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 60.0 mtm-85 -69.71 135.12 88.05 Favored Pre-proline 0 N--CA 1.436 -1.152 0 CA-C-N 114.188 -1.369 . . . . 72.55 108.4 176.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.8 149.12 79.85 Favored 'Trans proline' 0 C--O 1.251 1.154 0 C-N-CA 123.26 2.64 . . . . 74.43 113.491 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -64.39 117.4 7.23 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.613 -0.721 . . . . 62.04 110.917 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 129.81 -23.41 4.73 Favored Glycine 0 C--N 1.302 -1.311 0 C-N-CA 120.212 -0.994 . . . . 71.13 111.99 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -79.4 125.74 29.92 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.235 -0.654 . . . . 74.34 109.235 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 88.8 t -73.19 119.41 20.08 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 109.774 -0.454 . . . . 72.3 109.774 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 57.6 m -66.36 -40.31 89.7 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 124.687 1.195 . . . . 71.42 109.436 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 162.86 -159.81 32.22 Favored Glycine 0 N--CA 1.424 -2.113 0 N-CA-C 109.392 -1.483 . . . . 34.12 109.392 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 7.1 p -126.57 161.07 28.86 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 117.056 0.428 . . . . 72.15 110.317 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.497 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 24.8 t-20 -59.63 -51.99 77.19 Favored Pre-proline 0 CA--C 1.545 0.78 0 O-C-N 123.537 0.523 . . . . 74.4 111.198 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.497 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 1.2 Cg_endo -87.37 143.08 6.36 Favored 'Trans proline' 0 N--CA 1.441 -1.595 0 CA-C-N 120.257 1.128 . . . . 53.04 109.301 170.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -70.16 163.6 37.98 Favored 'Trans proline' 0 C--O 1.249 1.065 0 C-N-CA 122.428 2.085 . . . . 73.23 112.556 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.8 142.49 57.27 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.777 -0.647 . . . . 64.14 110.61 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 88.94 -5.95 84.1 Favored Glycine 0 N--CA 1.431 -1.666 0 C-N-CA 120.844 -0.693 . . . . 71.22 112.212 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 30.8 m -77.91 123.28 26.59 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.646 -0.501 . . . . 73.24 109.646 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 33.3 m -80.56 122.44 27.05 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 108.697 -0.853 . . . . 62.12 108.697 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 19.7 m -136.71 160.38 66.68 Favored Pre-proline 0 C--N 1.311 -1.108 0 N-CA-C 109.179 -0.674 . . . . 73.51 109.179 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -68.35 141.13 50.49 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.25 1.966 . . . . 62.32 111.458 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.601 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 26.9 m -66.79 -20.52 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 121.749 0.785 . . . . 64.33 111.927 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -90.59 3.68 53.42 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.137 -0.938 . . . . 63.33 111.13 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.0 t -83.77 164.23 19.69 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.291 -0.633 . . . . 73.05 109.291 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 41.3 t -98.18 112.71 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 N-CA-C 107.998 -1.112 . . . . 72.25 107.998 178.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 1.8 mp -91.74 135.64 26.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-O 120.938 0.399 . . . . 74.44 110.272 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -101.9 122.26 43.68 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-O 121.473 0.654 . . . . 74.5 110.777 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 553' ' ' LEU . . . . . 0.502 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 65.3 mt -97.8 116.16 29.47 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 106.562 -1.644 . . . . 70.03 106.562 176.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -91.83 121.98 33.94 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 108.489 -0.93 . . . . 72.44 108.489 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 60.3 t -111.12 133.74 55.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-N 115.82 -0.627 . . . . 73.24 112.149 -170.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.578 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 9.6 m -71.69 128.66 36.51 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 114.925 -1.034 . . . . 63.22 109.065 174.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 526' ' ' ASP . 0.8 OUTLIER -116.97 110.74 18.66 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 109.317 -0.623 . . . . 64.11 109.317 175.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -72.49 -33.38 61.17 Favored Glycine 0 CA--C 1.49 -1.526 0 CA-C-N 115.707 -0.678 . . . . 71.42 111.448 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 44.32 36.34 1.56 Allowed 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 126.345 1.858 . . . . 73.23 113.007 178.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 12.1 tp60 -140.05 146.22 38.71 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.488 -1.301 . . . . 65.51 107.488 -174.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -147.16 142.62 27.51 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.604 -0.887 . . . . 74.1 108.604 174.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 54.2 t -76.62 128.38 37.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-O 120.911 0.386 . . . . 75.42 111.76 -174.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 58.7 ttp -97.7 132.4 25.11 Favored Pre-proline 0 C--O 1.247 0.951 0 CA-C-N 115.99 -0.55 . . . . 75.34 110.198 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -66.57 169.67 13.87 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 123.051 2.501 . . . . 55.41 112.932 176.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -72.16 132.27 43.92 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 113.299 0.851 . . . . 70.33 113.299 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 96.5 mt -136.22 21.85 3.22 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.566 0.746 . . . . 72.53 109.003 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 10.3 m -75.4 130.29 38.74 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 116.147 -0.479 . . . . 35.14 112.224 -173.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 65.65 29.22 74.66 Favored Glycine 0 C--O 1.212 -1.247 0 CA-C-N 115.498 -0.774 . . . . 74.23 114.873 173.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 18.1 ptp -112.61 178.85 4.15 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 117.798 0.799 . . . . 74.25 109.136 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 570' ' ' PHE . . . . . 0.402 ' HB3' ' OD1' ' A' ' 601' ' ' ASN . 89.7 m-85 -84.87 154.27 22.38 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 120.302 -0.559 . . . . 71.51 109.67 178.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 28.0 t90 -68.47 -20.15 64.59 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.387 -0.597 . . . . 74.22 109.387 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 33.8 m -71.28 -13.31 16.87 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.355 0 CA-C-N 115.936 -0.575 . . . . 45.34 110.985 176.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -101.06 -44.13 5.81 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 109.417 -0.586 . . . . 70.42 109.417 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -59.57 -46.27 89.4 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.817 -1.083 . . . . 71.13 112.214 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.488 ' O ' ' HG3' ' A' ' 579' ' ' ARG . 55.8 tt0 -57.92 -59.87 11.81 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 113.323 0.861 . . . . 55.42 113.323 -178.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.54 -35.59 89.55 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 121.183 1.255 . . . . 61.0 112.406 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.42 ' HD3' ' HA ' ' A' ' 577' ' ' ARG . 7.8 mmt85 -65.0 -43.38 92.76 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.031 0.382 . . . . 74.54 112.031 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.404 HD12 ' N ' ' A' ' 579' ' ' ARG . 4.4 pp -67.58 -40.71 84.85 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 119.607 -0.837 . . . . 44.4 111.259 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 579' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 575' ' ' GLU . 20.1 mtp180 -65.14 -40.32 94.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.085 -0.507 . . . . 75.52 110.094 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -63.96 -35.73 81.64 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.982 -0.554 . . . . 74.43 112.468 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 4.2 pp -81.66 2.03 31.43 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.988 0.736 . . . . 62.42 112.988 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 82.97 39.67 9.99 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.484 -0.865 . . . . 72.1 112.227 176.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 89.6 t90 -79.57 133.91 36.46 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.939 -0.393 . . . . 71.01 109.939 176.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 61.5 m -147.86 90.85 1.87 Allowed 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.375 -0.602 . . . . 73.21 109.375 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -147.01 -131.52 2.19 Favored Glycine 0 N--CA 1.433 -1.549 0 N-CA-C 111.088 -0.805 . . . . 74.2 111.088 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 586' ' ' MET . . . . . 0.461 ' HB2' HG12 ' A' ' 619' ' ' ILE . 59.7 mtt -119.67 125.65 49.22 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.763 -0.829 . . . . 73.1 108.763 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -105.17 130.94 53.22 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 107.799 -1.185 . . . . 73.11 107.799 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -100.71 101.89 12.87 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 120.601 -0.439 . . . . 70.52 110.698 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 589' ' ' LYS . . . . . 0.408 ' C ' ' HD3' ' A' ' 589' ' ' LYS . 11.8 tmtt? -113.02 111.7 22.61 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 107.252 -1.388 . . . . 74.21 107.252 174.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -93.97 -149.52 25.48 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.958 -0.639 . . . . 74.32 113.197 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -76.16 146.23 39.33 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 120.776 0.322 . . . . 34.23 111.083 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -84.97 125.32 32.59 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 106.405 -1.702 . . . . 75.22 106.405 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 57.5 t -128.73 116.58 41.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 N-CA-C 109.956 -0.387 . . . . 70.02 109.956 -171.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -77.59 108.11 10.54 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.24 -1.393 . . . . 54.13 107.24 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -121.42 -5.12 9.33 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.717 -0.674 . . . . 64.21 111.744 -176.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 119.69 -177.97 16.46 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 120.507 -0.854 . . . . 44.51 112.341 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -58.71 -37.01 88.89 Favored Glycine 0 C--N 1.319 -0.365 0 O-C-N 124.084 0.52 . . . . 64.42 114.381 -175.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 14.4 m -64.89 -24.29 67.49 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 117.264 0.532 . . . . 64.44 111.365 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -108.11 -0.56 21.03 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 113.096 0.776 . . . . 72.43 113.096 -173.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 600' ' ' HIS . . . . . 0.503 ' HA ' ' O ' ' A' ' 626' ' ' GLN . 14.9 p-80 -70.39 103.22 2.36 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 119.194 -1.002 . . . . 74.35 111.644 -174.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 601' ' ' ASN . . . . . 0.402 ' OD1' ' HB3' ' A' ' 570' ' ' PHE . 18.9 t-20 58.37 5.32 0.42 Allowed 'General case' 0 CA--C 1.569 1.7 0 C-N-CA 125.924 1.69 . . . . 74.13 113.59 178.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 602' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 624' ' ' PHE . 13.6 mmt180 -78.98 140.22 38.05 Favored 'General case' 0 C--N 1.317 -0.804 0 O-C-N 121.66 -0.65 . . . . 75.1 110.455 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 97.6 t -69.48 131.63 33.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 107.911 -1.144 . . . . 74.45 107.911 174.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 56.9 t -87.71 -46.05 16.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-O 121.263 0.554 . . . . 64.31 109.649 -175.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -156.24 152.4 27.71 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 107.684 -1.228 . . . . 72.33 107.684 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -116.68 112.39 21.16 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.356 -1.35 . . . . 70.42 107.356 171.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.475 ' HB2' ' HB ' ' A' ' 621' ' ' THR . 38.7 t30 -48.45 -52.13 45.86 Favored Pre-proline 0 CA--C 1.556 1.204 0 N-CA-C 113.622 0.971 . . . . 73.12 113.622 -177.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 5.4 Cg_exo -82.29 124.64 4.3 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.121 1.214 . . . . 64.25 109.562 172.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 609' ' ' PRO . . . . . 0.49 ' O ' HG22 ' A' ' 612' ' ' THR . 13.4 Cg_endo -65.0 135.84 45.77 Favored 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 122.045 1.83 . . . . 60.01 113.144 -177.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -65.75 130.69 44.18 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.248 -0.887 . . . . 75.21 110.025 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.09 -8.44 45.37 Favored Glycine 0 N--CA 1.433 -1.537 0 C-N-CA 120.132 -1.032 . . . . 61.22 113.066 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 612' ' ' THR . . . . . 0.49 HG22 ' O ' ' A' ' 609' ' ' PRO . 10.1 t -113.75 175.93 5.25 Favored 'General case' 0 C--O 1.258 1.514 0 C-N-CA 118.919 -1.112 . . . . 74.32 109.541 177.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -79.77 128.3 8.44 Favored Glycine 0 N--CA 1.416 -2.684 0 CA-C-N 115.448 -0.796 . . . . 33.54 111.546 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 23.4 m -102.2 144.49 13.33 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 C-N-CA 124.031 0.932 . . . . 75.2 108.709 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.48 HD21 HG22 ' A' ' 619' ' ' ILE . 24.8 p-10 -50.01 152.59 1.59 Allowed 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 124.452 1.101 . . . . 71.0 111.857 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -26.25 13.59 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.123 0.969 . . . . 61.41 113.061 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.34 -38.53 74.88 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.662 -0.866 . . . . 74.11 108.662 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 82.33 22.12 59.33 Favored Glycine 0 N--CA 1.424 -2.159 0 C-N-CA 120.923 -0.656 . . . . 34.43 111.886 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 619' ' ' ILE . . . . . 0.48 HG22 HD21 ' A' ' 615' ' ' ASN . 0.0 OUTLIER -68.16 119.19 13.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-O 122.621 1.2 . . . . 73.35 110.459 -168.833 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 4.4 tp -115.67 119.17 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.876 0 CA-C-N 113.899 -1.5 . . . . 75.14 109.614 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.475 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 25.7 m -105.4 117.45 34.06 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 106.543 -1.651 . . . . 72.45 106.543 174.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 622' ' ' LEU . . . . . 0.413 HD23 ' H ' ' A' ' 622' ' ' LEU . 2.1 pt? -138.96 153.77 48.23 Favored 'General case' 0 CA--C 1.479 -1.758 0 N-CA-C 106.447 -1.686 . . . . 54.25 106.447 -177.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -136.45 153.67 50.99 Favored 'General case' 0 C--N 1.268 -2.974 0 N-CA-C 107.464 -1.31 . . . . 74.33 107.464 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.415 ' HA ' ' O ' ' A' ' 602' ' ' ARG . 51.1 p90 -140.62 163.01 34.01 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 105.383 -2.081 . . . . 74.21 105.383 172.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -82.46 -86.52 0.76 Allowed Glycine 0 N--CA 1.424 -2.155 0 C-N-CA 119.677 -1.249 . . . . 63.35 110.282 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 626' ' ' GLN . . . . . 0.503 ' O ' ' HA ' ' A' ' 600' ' ' HIS . 35.6 tt0 . . . . . 0 C--N 1.29 -1.991 0 CA-C-O 117.7 -1.143 . . . . 53.14 108.428 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.918 0 N-CA-C 110.145 -1.182 . . . . 43.05 110.145 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 9.0 tp -75.46 124.07 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.559 0 CA-C-N 117.824 0.812 . . . . 71.14 110.047 177.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.82 137.95 31.99 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 109.031 -0.729 . . . . 53.31 109.031 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -90.76 -19.06 23.92 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.459 -0.941 . . . . 75.34 108.459 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -76.7 139.19 40.42 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 103.728 -2.693 . . . . 40.33 103.728 169.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 35.7 m -116.08 151.3 17.88 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.664 0 C-N-CA 120.074 -0.65 . . . . 72.23 109.805 -172.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -95.05 136.04 35.85 Favored 'General case' 0 N--CA 1.411 -2.406 0 N-CA-C 106.579 -1.637 . . . . 53.45 106.579 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 89.8 t -111.07 118.19 48.47 Favored Pre-proline 0 C--N 1.275 -2.632 0 CA-C-O 121.141 0.496 . . . . 65.32 111.198 -173.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -81.38 123.54 4.43 Favored 'Trans proline' 0 N--CA 1.44 -1.674 0 C-N-CA 121.814 1.676 . . . . 74.21 109.717 172.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' ASP . . . . . 0.569 ' OD2' ' HB3' ' A' ' 366' ' ' ARG . 7.5 p-10 -101.43 137.91 39.13 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 122.237 1.017 . . . . 64.45 110.646 -176.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 27.7 m -82.93 36.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 114.381 -1.281 . . . . 71.43 112.471 -174.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.569 ' HB3' ' OD2' ' A' ' 364' ' ' ASP . 0.0 OUTLIER -56.04 146.72 21.85 Favored 'General case' 0 C--O 1.247 0.934 0 C-N-CA 124.452 1.101 . . . . 71.22 110.97 176.314 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.28 1.21 41.13 Favored Glycine 0 C--N 1.309 -0.944 0 N-CA-C 111.927 -0.469 . . . . 71.32 111.927 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -110.87 -153.2 0.51 Allowed 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 108.076 -1.083 . . . . 74.41 108.076 176.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 54.9 p -93.32 168.68 10.92 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.215 -0.661 . . . . 42.43 109.215 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 20.6 p -63.28 -46.36 87.12 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 109.828 -0.434 . . . . 74.53 109.828 176.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -63.36 -46.43 86.6 Favored 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 112.851 0.686 . . . . 73.52 112.851 -177.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -67.03 -45.23 78.12 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 120.546 -0.462 . . . . 70.41 110.095 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -66.59 -46.62 75.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.868 -0.606 . . . . 64.55 111.514 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 67.7 mt -64.73 -37.91 81.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.616 -0.266 . . . . 73.43 110.806 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.88 -43.29 99.14 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 110.273 -0.269 . . . . 73.32 110.273 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 33.3 m -63.45 -48.33 78.15 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.866 -0.606 . . . . 73.43 110.313 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.45 -41.6 96.44 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 112.353 0.501 . . . . 74.23 112.353 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -67.01 -38.79 86.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.666 -0.243 . . . . 64.12 110.515 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -70.19 -21.01 63.09 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.027 0.442 . . . . 63.22 111.601 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' ARG . . . . . 0.466 ' NE ' ' HA ' ' A' ' 380' ' ' ARG . 3.3 mmp_? -81.06 -15.09 57.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.027 0.441 . . . . 61.13 109.919 174.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.26 5.58 54.33 Favored Glycine 0 C--N 1.306 -1.114 0 CA-C-N 115.789 -0.641 . . . . 61.55 112.548 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -85.42 148.65 25.9 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-O 121.117 0.484 . . . . 62.11 110.73 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -101.13 149.39 24.02 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 107.741 -1.207 . . . . 75.21 107.741 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.415 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -134.62 157.19 41.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.891 0 C-N-CA 120.717 -0.393 . . . . 64.21 110.009 -178.549 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -132.46 126.86 34.01 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.165 -1.42 . . . . 63.02 107.165 173.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 28.8 m -109.12 126.53 53.31 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 108.367 -0.975 . . . . 74.3 108.367 -177.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 51.2 tp -111.46 120.09 41.0 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.57 -0.53 . . . . 75.02 109.57 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -89.83 122.09 32.57 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.148 -0.686 . . . . 64.31 109.148 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 389' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 421' ' ' SER . 56.9 mtpt -135.4 125.5 16.73 Favored Pre-proline 0 C--N 1.311 -1.069 0 N-CA-C 109.937 -0.394 . . . . 74.44 109.937 177.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -80.39 128.37 7.04 Favored 'Trans proline' 0 C--O 1.253 1.252 0 C-N-CA 121.39 1.393 . . . . 64.13 109.238 173.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.467 ' HA ' ' CG ' ' A' ' 425' ' ' GLU . 13.5 t70 174.99 158.46 0.18 Allowed 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.195 -1.409 . . . . 72.33 107.195 -174.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 13.5 m -100.72 -11.98 19.5 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 120.86 0.362 . . . . 54.22 111.697 -177.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 11.1 m -109.11 2.1 20.88 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 122.121 0.963 . . . . 70.41 110.343 -176.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 34.6 mm -88.86 140.52 29.37 Favored Pre-proline 0 C--N 1.306 -1.297 0 CA-C-N 115.769 -0.651 . . . . 65.52 109.33 178.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 395' ' ' PRO . . . . . 0.451 ' HA ' ' HD3' ' A' ' 396' ' ' PRO . 20.1 Cg_exo -39.97 129.92 2.11 Favored 'Trans proline' 0 C--N 1.365 1.401 0 C-N-CA 124.4 3.4 . . . . 62.32 113.719 176.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 396' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 395' ' ' PRO . 50.1 Cg_exo -57.8 161.24 13.07 Favored 'Trans proline' 0 N--CA 1.483 0.855 0 C-N-CA 123.535 2.824 . . . . 71.3 112.699 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 397' ' ' ASP . . . . . 0.589 ' HA ' HG13 ' A' ' 420' ' ' VAL . 2.5 p30 -59.78 -8.47 2.14 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 122.022 0.915 . . . . 62.21 112.853 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 43.8 m170 -102.42 123.71 46.68 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 105.188 -2.153 . . . . 72.2 105.188 173.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 32.4 m -68.08 119.54 13.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 112.98 0.733 . . . . 74.43 112.98 -165.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 400' ' ' ILE . . . . . 0.436 HD13 ' O ' ' A' ' 400' ' ' ILE . 0.0 OUTLIER -102.99 -28.12 3.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 106.767 -1.568 . . . . 72.4 106.767 175.361 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.52 166.3 27.76 Favored Glycine 0 N--CA 1.414 -2.793 0 N-CA-C 110.546 -1.022 . . . . 51.5 110.546 -177.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 40.5 p -146.8 -173.91 4.34 Favored 'General case' 0 C--N 1.286 -2.178 0 C-N-CA 126.078 1.751 . . . . 73.42 106.331 -174.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 403' ' ' ASP . . . . . 0.424 ' HA ' ' HD3' ' A' ' 404' ' ' PRO . 21.6 t70 -98.43 126.52 39.17 Favored Pre-proline 0 C--N 1.296 -1.756 0 N-CA-C 107.699 -1.223 . . . . 71.05 107.699 -177.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 404' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 403' ' ' ASP . 52.8 Cg_exo -56.31 -4.65 0.79 Allowed 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 124.864 3.709 . . . . 73.24 116.324 -174.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.67 -39.81 71.45 Favored 'General case' 0 C--O 1.204 -1.294 0 N-CA-C 109.767 -0.457 . . . . 70.12 109.767 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -63.53 -40.05 96.01 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-O 121.365 0.603 . . . . 72.31 110.77 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -80.61 -4.58 54.67 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.389 0.614 . . . . 71.0 110.456 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 27.8 m -98.23 160.61 14.18 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 105.423 -2.066 . . . . 55.13 105.423 173.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 13.4 m -76.52 112.6 13.22 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 118.829 -1.148 . . . . 75.54 108.871 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 23.0 m -128.33 170.05 18.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.077 0.465 . . . . 73.11 111.198 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 36.7 t -74.35 143.3 44.94 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 108.782 -0.822 . . . . 62.34 108.782 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -63.09 131.14 47.55 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.065 -0.516 . . . . 31.2 111.293 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 90.89 29.71 12.6 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.714 -0.676 . . . . 72.21 112.655 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -83.07 -175.7 5.97 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 109.52 -0.548 . . . . 72.31 109.52 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -110.72 117.47 33.54 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 123.358 0.663 . . . . 62.3 111.291 -174.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.0 mm -105.77 115.08 46.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.405 0.622 . . . . 51.43 110.358 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 40.6 p -87.05 130.8 34.33 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 123.655 0.782 . . . . 73.42 110.691 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 8.2 p -124.19 134.55 66.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 109.736 -0.468 . . . . 73.1 109.736 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -104.66 122.81 46.43 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.851 -0.739 . . . . 65.3 110.357 176.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.589 HG13 ' HA ' ' A' ' 397' ' ' ASP . 34.7 t -111.75 131.87 61.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 114.705 -1.134 . . . . 72.4 110.588 -175.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 421' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 34.2 p -85.93 125.97 33.75 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 120.285 -0.566 . . . . 45.41 109.577 176.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.1 t -117.49 105.47 12.13 Favored 'General case' 0 N--CA 1.407 -2.621 0 C-N-CA 119.509 -0.876 . . . . 53.43 109.221 175.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 79.04 120.37 0.28 Allowed Glycine 0 N--CA 1.436 -1.303 0 CA-C-N 115.494 -0.776 . . . . 53.21 113.318 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -63.78 154.23 70.75 Favored 'Trans proline' 0 C--O 1.251 1.133 0 C-N-CA 121.776 1.651 . . . . 71.42 109.112 171.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.467 ' CG ' ' HA ' ' A' ' 391' ' ' ASP . 28.8 mt-10 -75.55 140.58 42.81 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 109.496 -0.557 . . . . 54.31 109.496 -177.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.504 ' OE1' ' HB ' ' A' ' 477' ' ' THR . 34.0 tt0 -102.58 144.86 30.45 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 107.387 -1.338 . . . . 73.01 107.387 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.618 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 1.6 mmp_? -122.32 139.87 53.31 Favored 'General case' 0 CA--C 1.479 -1.769 0 N-CA-C 112.795 0.665 . . . . 74.04 112.795 -174.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 42.2 tt0 -85.26 132.99 34.18 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.627 -1.17 . . . . 65.15 108.256 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 57.8 mt -80.92 124.43 81.47 Favored Pre-proline 0 C--N 1.307 -1.259 0 N-CA-C 109.812 -0.44 . . . . 72.14 109.812 -178.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -70.77 147.0 55.43 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.332 2.021 . . . . 72.15 110.397 175.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -81.21 102.19 10.17 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.494 0.664 . . . . 73.24 110.243 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 61.0 t -96.93 140.42 17.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 106.882 -1.525 . . . . 72.41 106.882 177.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 2.4 p -63.97 146.96 53.16 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 112.619 0.6 . . . . 71.01 112.619 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 25.7 p -60.63 -32.71 71.86 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 124.811 1.245 . . . . 72.41 113.774 -173.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.9 pp -81.04 -10.74 59.65 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.48 0.657 . . . . 74.24 111.588 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.3 m -106.61 40.95 1.52 Allowed 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.627 -0.879 . . . . 65.1 108.627 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -51.69 -37.98 53.07 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.943 1.297 . . . . 75.31 112.401 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -59.82 -38.85 83.18 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.046 0.45 . . . . 51.21 111.26 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.483 ' CD ' ' HE3' ' A' ' 442' ' ' LYS . 16.2 tp10 -70.4 -37.15 74.44 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.881 -0.785 . . . . 70.01 108.881 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.582 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -60.7 -51.24 70.19 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.518 -0.764 . . . . 75.1 111.162 -178.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 27.5 m -63.97 -40.55 89.48 Favored 'Isoleucine or valine' 0 C--O 1.249 1.029 0 N-CA-C 112.627 0.603 . . . . 73.31 112.627 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.483 ' HE3' ' CD ' ' A' ' 439' ' ' GLU . 41.9 pttt -68.61 -35.1 76.88 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 119.134 -1.026 . . . . 74.41 112.104 177.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -65.09 -38.31 90.33 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.347 -0.388 . . . . 75.33 110.882 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 94.3 mt -63.2 -38.59 91.78 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.332 -0.618 . . . . 74.31 109.332 177.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.446 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 86.4 m -66.14 -45.23 81.75 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.718 -0.674 . . . . 75.44 111.129 178.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.62 -15.87 63.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.038 0.447 . . . . 64.3 111.632 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -88.62 4.0 48.58 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.997 0.427 . . . . 51.44 111.396 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 112.47 -73.35 0.22 Allowed Glycine 0 CA--C 1.496 -1.152 0 C-N-CA 120.351 -0.928 . . . . 72.53 111.829 175.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 449' ' ' PHE . . . . . 0.56 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 0.4 OUTLIER -45.57 -68.27 0.21 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 114.021 1.119 . . . . 75.43 114.021 177.945 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 450' ' ' GLY . . . . . 0.446 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 60.36 27.33 65.41 Favored Glycine 0 C--N 1.315 -0.605 0 N-CA-C 111.38 -0.688 . . . . 62.44 111.38 -173.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.523 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 32.3 mmt180 -100.16 110.4 22.67 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 106.424 -1.695 . . . . 73.13 106.424 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.405 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 17.3 p90 -143.6 147.0 33.73 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 109.592 -0.521 . . . . 73.35 109.592 -177.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -137.75 123.1 19.46 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 108.43 -0.952 . . . . 65.3 108.43 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -87.38 124.71 33.68 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 123.598 0.561 . . . . 73.33 109.933 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 455' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -121.61 142.26 50.29 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 107.343 -1.354 . . . . 74.32 107.343 176.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -125.14 143.06 51.12 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 119.536 -0.865 . . . . 64.41 109.955 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 48.9 m -141.55 139.28 18.44 Favored Pre-proline 0 C--N 1.285 -2.197 0 N-CA-C 107.911 -1.144 . . . . 73.4 107.911 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.715 ' HA ' ' O ' ' A' ' 490' ' ' SER . 34.1 Cg_endo -65.44 122.56 10.28 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 121.746 1.631 . . . . 75.52 111.116 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 47.2 m -135.46 179.64 6.21 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.794 -1.094 . . . . 74.5 109.692 -174.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.9 t -49.3 133.71 17.07 Favored Pre-proline 0 C--O 1.251 1.179 0 O-C-N 124.103 0.877 . . . . 72.41 112.392 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.92 -29.62 35.95 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 124.566 3.51 . . . . 53.22 113.913 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -74.79 -23.8 58.56 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.652 0.612 . . . . 64.22 112.652 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -100.23 -6.05 26.64 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.975 0.416 . . . . 62.32 111.488 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 86.6 t -60.58 128.6 21.98 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 CA-C-N 116.192 -0.458 . . . . 62.33 109.841 176.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 97.07 -3.14 61.93 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.969 -0.634 . . . . 54.03 112.148 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -122.53 165.85 15.75 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 108.322 -0.992 . . . . 74.3 108.322 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 70.9 t -73.97 146.54 10.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.792 -1.188 . . . . 75.44 107.792 173.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 45.5 mt -98.08 -35.64 5.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 107.747 -1.205 . . . . 73.24 107.747 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 161.86 -162.24 33.93 Favored Glycine 0 N--CA 1.417 -2.631 0 N-CA-C 109.851 -1.3 . . . . 63.3 109.851 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 470' ' ' THR . . . . . 0.433 HG22 HD13 ' A' ' 486' ' ' ILE . 28.5 p -130.52 153.86 48.4 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 109.869 -0.419 . . . . 70.02 109.869 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -75.03 -56.31 2.06 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 109.017 -0.734 . . . . 72.2 109.017 172.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.28 163.9 35.37 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 121.405 1.403 . . . . 51.3 108.927 172.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -71.88 126.98 12.44 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.168 1.245 . . . . 54.13 112.241 -177.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -99.93 2.04 43.27 Favored 'General case' 0 C--O 1.212 -0.893 0 CA-C-O 121.532 0.682 . . . . 62.41 110.55 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -110.7 5.49 20.93 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 120.202 -0.599 . . . . 73.34 110.48 175.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -122.92 -177.57 3.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.896 0.379 . . . . 74.01 110.507 -175.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 1.0 OUTLIER -71.37 132.12 44.39 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 124.987 1.315 . . . . 70.51 113.471 179.296 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 69.6 m -130.55 144.28 51.31 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 115.517 -0.765 . . . . 73.35 109.578 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -79.34 161.53 26.17 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.342 -0.845 . . . . 74.42 110.893 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.56 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 1.8 mp -70.08 -25.23 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.834 0.826 . . . . 74.55 111.265 -177.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 17.2 m -93.28 -9.28 39.55 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.543 0.687 . . . . 72.3 110.401 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -85.76 129.33 34.86 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.44 -0.8 . . . . 75.01 110.49 -175.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.523 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 10.7 p -97.52 126.81 50.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.176 0.512 . . . . 71.41 111.742 -178.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 35.9 m -100.2 127.31 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-O 121.711 0.767 . . . . 63.32 110.915 177.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.57 124.55 45.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.667 -0.697 . . . . 73.25 109.544 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.433 HD13 HG22 ' A' ' 470' ' ' THR . 34.3 mm -107.5 116.7 51.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.482 -1.303 . . . . 62.21 107.482 -177.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 11.7 tt -100.19 125.97 53.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 121.556 0.694 . . . . 50.35 110.025 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 33.6 m -110.3 151.13 12.59 Favored 'Isoleucine or valine' 0 C--O 1.258 1.536 0 CA-C-N 115.375 -0.829 . . . . 73.45 111.097 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -80.9 128.64 8.56 Favored Glycine 0 N--CA 1.419 -2.45 0 CA-C-N 115.307 -0.861 . . . . 64.14 111.158 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.715 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 31.3 t -130.59 160.64 33.58 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 104.113 -2.551 . . . . 65.14 104.113 177.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 156.07 107.25 0.26 Allowed Glycine 0 N--CA 1.423 -2.185 0 C-N-CA 117.604 -2.236 . . . . 70.02 114.329 177.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -85.74 101.76 0.68 Allowed 'Trans proline' 0 N--CA 1.416 -3.06 0 C-N-CA 121.959 1.772 . . . . 70.31 109.265 169.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 493' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . -88.99 65.45 7.52 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.442 -0.947 . . . . 65.41 108.442 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 2.6 p -117.44 143.31 46.15 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 114.464 -1.244 . . . . 73.43 111.579 -175.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -135.95 151.23 49.73 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.499 -0.926 . . . . 72.54 108.499 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.5 p-10 -85.41 130.49 34.58 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.469 -0.938 . . . . 75.13 108.469 176.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 497' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 543' ' ' THR . 28.8 pt -92.11 121.91 65.9 Favored Pre-proline 0 C--N 1.29 -2.01 0 CA-C-N 116.109 -0.496 . . . . 60.02 111.038 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -85.73 -164.08 0.21 Allowed 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.552 2.168 . . . . 74.33 110.24 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -94.35 145.93 24.41 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 118.722 -1.191 . . . . 63.11 108.449 177.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 10.2 p -137.58 16.84 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 122.826 1.298 . . . . 72.5 107.505 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 501' ' ' ALA . . . . . 0.526 ' HB2' ' HA2' ' A' ' 536' ' ' GLY . . . -87.75 145.65 26.03 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 113.706 -1.588 . . . . 61.12 110.363 -174.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 107.02 -10.33 40.29 Favored Glycine 0 C--N 1.293 -1.845 0 N-CA-C 108.922 -1.671 . . . . 52.52 108.922 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -103.84 175.42 5.49 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 114.351 -0.925 . . . . 74.23 108.836 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 20.7 p -85.75 163.97 17.88 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-O 120.584 0.231 . . . . 63.5 111.069 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.1 p -54.96 -41.44 58.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.73 -0.668 . . . . 75.23 112.331 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -66.27 -41.7 89.52 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 120.521 -0.471 . . . . 72.2 110.864 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 90.5 t -67.89 -41.27 84.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.223 -0.444 . . . . 72.02 110.184 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.3 -46.64 85.77 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.31 -0.404 . . . . 53.14 110.629 178.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -59.56 -43.32 93.6 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.313 0.645 . . . . 73.03 109.761 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.432 ' O ' HG23 ' A' ' 514' ' ' VAL . 17.9 ttmm -59.51 -46.98 87.27 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.804 -1.089 . . . . 73.23 109.776 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -62.48 -46.02 90.37 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.257 -0.429 . . . . 74.51 111.032 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 10.3 mp -60.15 -43.48 95.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.396 -0.365 . . . . 72.41 111.297 178.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -61.71 -39.84 92.92 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.336 0.397 . . . . 71.21 110.91 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 510' ' ' LYS . 70.3 t -64.86 -32.41 58.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 116.019 -0.537 . . . . 73.41 111.053 177.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -85.74 2.51 45.21 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.346 -0.542 . . . . 73.24 111.785 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 98.86 -18.07 57.35 Favored Glycine 0 C--O 1.243 0.696 0 C-N-CA 120.847 -0.692 . . . . 73.24 112.797 176.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.486 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 83.4 m-85 -68.7 98.89 0.94 Allowed 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.955 0.883 . . . . 65.31 109.706 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.54 9.99 29.37 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.797 -1.092 . . . . 74.1 112.674 -174.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 519' ' ' LYS . . . . . 0.443 ' HD2' ' O ' ' A' ' 548' ' ' ASP . 63.6 mttp -122.72 113.46 19.24 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.536 -0.913 . . . . 65.01 108.536 173.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -132.2 156.57 46.22 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.581 -0.736 . . . . 74.54 111.653 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 521' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 52.6 m -135.64 136.53 41.06 Favored 'General case' 0 C--N 1.276 -2.605 0 N-CA-C 106.987 -1.486 . . . . 70.51 106.987 173.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -117.08 124.27 48.83 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.418 0.628 . . . . 65.25 109.913 -177.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -110.81 125.54 53.68 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 115.682 -0.69 . . . . 53.42 109.189 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 2.9 p -92.01 120.73 32.92 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 109.085 -0.709 . . . . 64.33 109.085 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 525' ' ' VAL . . . . . 0.508 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 26.9 m -121.24 152.22 24.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 116.548 -0.296 . . . . 73.03 110.465 -175.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -66.94 135.23 53.48 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 108.796 -0.816 . . . . 65.02 108.796 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 66.3 m -152.98 166.54 15.23 Favored Pre-proline 0 C--N 1.307 -1.278 0 C-N-CA 120.912 -0.315 . . . . 75.54 111.24 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -91.13 -7.16 3.73 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.099 1.866 . . . . 71.01 109.859 168.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.419 ' HA ' ' HD3' ' A' ' 530' ' ' PRO . 29.0 mmm180 -81.98 136.43 47.36 Favored Pre-proline 0 N--CA 1.42 -1.932 0 C-N-CA 124.924 1.29 . . . . 74.53 108.143 177.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 530' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 529' ' ' ARG . 33.8 Cg_exo -59.23 149.38 80.99 Favored 'Trans proline' 0 C--O 1.259 1.563 0 C-N-CA 122.61 2.207 . . . . 74.51 113.74 -177.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.641 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -61.61 126.16 26.35 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 114.114 -1.403 . . . . 42.32 111.59 -176.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 120.94 -24.23 7.52 Favored Glycine 0 C--N 1.305 -1.161 0 CA-C-N 115.646 -0.706 . . . . 61.13 111.973 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -82.67 125.79 31.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.801 0.334 . . . . 63.44 110.282 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 85.9 t -75.39 113.27 14.01 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 107.921 -1.14 . . . . 63.4 107.921 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 535' ' ' THR . . . . . 0.621 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 12.6 t -78.35 -18.84 54.58 Favored 'General case' 0 C--N 1.314 -0.941 0 O-C-N 123.593 0.558 . . . . 72.43 110.998 -176.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.526 ' HA2' ' HB2' ' A' ' 501' ' ' ALA . . . 160.08 -174.27 36.83 Favored Glycine 0 N--CA 1.422 -2.25 0 C-N-CA 120.499 -0.858 . . . . 64.15 111.213 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 19.4 p -117.42 157.47 26.15 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 108.607 -0.886 . . . . 52.44 108.607 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.452 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 19.4 t30 -71.17 -52.3 9.39 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 109.987 -0.375 . . . . 55.11 109.987 176.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.457 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 38.1 Cg_exo -66.13 131.92 28.34 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 120.914 1.076 . . . . 75.24 109.563 171.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 540' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 23.6 Cg_exo -66.23 147.94 84.17 Favored 'Trans proline' 0 C--O 1.243 0.767 0 C-N-CA 122.84 2.36 . . . . 73.1 113.24 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.21 134.42 55.9 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.672 -0.695 . . . . 64.13 109.583 176.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.47 -20.51 32.24 Favored Glycine 0 C--N 1.301 -1.395 0 N-CA-C 111.191 -0.764 . . . . 41.53 111.191 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.428 ' O ' HG12 ' A' ' 497' ' ' ILE . 44.9 m -67.43 134.8 52.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.98 0.419 . . . . 75.32 110.655 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 30.6 m -96.4 122.59 39.45 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 108.924 -0.769 . . . . 71.02 108.924 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 22.1 m -136.45 155.21 77.18 Favored Pre-proline 0 C--N 1.312 -1.022 0 CA-C-N 116.158 -0.474 . . . . 62.33 109.963 -177.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 37.5 Cg_exo -62.72 148.11 93.83 Favored 'Trans proline' 0 C--O 1.221 -0.363 0 C-N-CA 122.411 2.074 . . . . 64.35 111.929 176.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.486 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 35.5 m -65.81 -19.92 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-O 121.864 0.84 . . . . 43.24 111.005 177.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 548' ' ' ASP . . . . . 0.443 ' O ' ' HD2' ' A' ' 519' ' ' LYS . 37.6 t70 -92.79 3.43 55.67 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.581 -1.19 . . . . 72.41 110.058 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 30.2 t -84.06 159.48 21.15 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.562 -0.903 . . . . 62.12 108.562 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 18.1 t -96.38 122.55 48.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 109.01 -0.737 . . . . 71.21 109.01 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 61.5 mt -100.56 131.72 47.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 109.585 -0.524 . . . . 75.12 109.585 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 552' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 521' ' ' SER . 35.6 tt0 -102.46 115.81 31.33 Favored 'General case' 0 N--CA 1.418 -2.03 0 N-CA-C 109.395 -0.595 . . . . 54.44 109.395 178.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 553' ' ' LEU . . . . . 0.503 HD13 ' H ' ' A' ' 553' ' ' LEU . 0.0 OUTLIER -105.01 134.04 48.78 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.023 -0.99 . . . . 70.11 110.238 175.884 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -102.81 119.72 39.34 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.471 0.653 . . . . 55.12 110.639 -175.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 41.7 t -100.06 138.94 22.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-N 115.138 -0.937 . . . . 42.32 108.627 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.641 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 5.0 m -85.52 141.5 29.84 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.929 -0.578 . . . . 70.22 110.41 -178.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 525' ' ' VAL . 23.0 ptmt -110.28 147.55 33.64 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 105.485 -2.042 . . . . 74.14 105.485 167.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -79.29 -23.7 62.64 Favored Glycine 0 C--N 1.3 -1.472 0 C-N-CA 119.881 -1.152 . . . . 61.01 112.126 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 17.2 m120 59.34 37.65 23.32 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.09 -0.707 . . . . 73.05 109.09 -174.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -112.16 141.91 45.27 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.806 -0.633 . . . . 54.43 110.286 -172.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -123.77 146.76 48.08 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.708 -0.849 . . . . 71.32 108.708 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 56.9 t -72.55 117.52 16.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 121.086 0.47 . . . . 64.33 110.024 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 55.9 ttp -97.23 126.15 43.04 Favored Pre-proline 0 C--N 1.309 -1.18 0 CA-C-N 115.473 -0.785 . . . . 72.41 110.352 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -61.27 170.53 5.05 Favored 'Trans proline' 0 CA--C 1.548 1.22 0 C-N-CA 123.143 2.562 . . . . 63.12 111.804 171.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -60.69 143.6 53.87 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 123.663 0.785 . . . . 73.51 111.466 -178.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -123.94 -42.53 2.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.051 0.453 . . . . 73.21 110.315 -176.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 22.7 t -76.37 144.73 39.9 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.473 -0.936 . . . . 61.44 108.473 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 110.7 -7.1 29.76 Favored Glycine 0 C--N 1.31 -0.915 0 N-CA-C 110.636 -0.986 . . . . 70.51 110.636 -176.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 14.8 mtm -114.69 156.39 24.87 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 122.886 0.475 . . . . 74.23 110.739 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -87.38 143.55 27.19 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 106.196 -1.779 . . . . 71.54 106.196 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 33.3 t90 -51.24 -31.73 21.84 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 113.195 0.813 . . . . 72.44 113.195 -175.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 29.7 m -78.27 -19.38 13.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-O 121.398 0.618 . . . . 70.43 110.909 -176.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -100.99 -35.54 9.34 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.991 0.9 . . . . 73.2 108.86 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -67.98 -40.19 83.15 Favored 'General case' 0 C--O 1.205 -1.257 0 CA-C-N 114.264 -1.335 . . . . 71.14 111.623 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.503 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 36.0 tt0 -54.08 -57.57 17.47 Favored Pre-proline 0 CA--C 1.563 1.48 0 N-CA-C 112.595 0.591 . . . . 71.15 112.595 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 576' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 44.8 Cg_exo -59.79 -39.66 70.69 Favored 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 121.514 1.476 . . . . 65.11 111.619 177.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -39.1 90.95 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-O 120.955 0.407 . . . . 65.15 109.921 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.535 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 58.3 tp -66.82 -48.15 69.84 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 123.482 0.713 . . . . 65.53 110.914 -178.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -66.34 -35.09 79.46 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.033 -0.667 . . . . 61.5 111.11 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -65.68 -29.58 70.15 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.962 -0.563 . . . . 73.24 111.735 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 581' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 578' ' ' LEU . 4.3 pp -81.62 1.39 34.15 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.066 0.46 . . . . 72.3 111.588 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 92.67 22.91 27.35 Favored Glycine 0 CA--C 1.496 -1.144 0 C-N-CA 120.809 -0.71 . . . . 33.13 113.509 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 84.0 t90 -80.92 136.94 36.12 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 120.352 -0.539 . . . . 64.12 111.128 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 10.8 m -154.24 101.68 2.4 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 106.933 -1.506 . . . . 63.35 106.933 172.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -158.24 -149.65 5.53 Favored Glycine 0 CA--C 1.491 -1.453 0 N-CA-C 109.714 -1.354 . . . . 55.44 109.714 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 58.5 ttp -94.75 127.13 40.53 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 117.68 0.74 . . . . 70.42 110.203 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -102.3 130.01 48.89 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.534 -1.654 . . . . 73.02 106.534 176.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -95.87 105.23 17.22 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.276 0.56 . . . . 73.24 110.517 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -94.42 126.52 39.75 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 106.709 -1.589 . . . . 61.1 106.709 177.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 590' ' ' GLY . . . . . 0.509 ' HA3' ' NH1' ' A' ' 623' ' ' ARG . . . -120.8 -116.32 2.48 Favored Glycine 0 N--CA 1.423 -2.184 0 C-N-CA 120.596 -0.812 . . . . 64.2 112.257 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -137.13 144.72 43.15 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.682 -0.488 . . . . 61.13 109.682 -177.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -80.47 140.46 35.92 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.114 -1.069 . . . . 73.42 108.114 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 57.3 t -137.2 120.74 21.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 109.517 -0.549 . . . . 72.11 109.517 -172.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.28 106.96 5.33 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.54 -1.281 . . . . 73.33 107.54 173.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -138.64 8.25 2.59 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.899 0.703 . . . . 72.04 112.899 -174.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 117.96 139.83 6.34 Favored Glycine 0 C--N 1.299 -1.503 0 C-N-CA 120.088 -1.053 . . . . 43.43 110.92 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -55.39 -33.73 58.84 Favored Glycine 0 C--O 1.223 -0.558 0 N-CA-C 114.845 0.698 . . . . 71.44 114.845 -173.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 18.5 m -65.63 -24.59 67.08 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 117.503 0.651 . . . . 74.5 111.727 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -98.58 -12.46 21.14 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.212 0.53 . . . . 64.44 109.759 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 67.1 m170 -76.67 137.27 39.31 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.981 -0.554 . . . . 75.54 111.183 -176.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 9.5 p30 46.34 12.8 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 126.929 2.092 . . . . 70.23 115.964 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -126.61 146.72 50.05 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.598 -0.89 . . . . 63.44 108.598 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.31 131.33 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.268 0.627 . . . . 73.01 111.392 -177.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 60.2 t -90.49 -38.85 11.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 120.992 0.425 . . . . 63.34 111.159 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -151.83 162.4 41.11 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.992 -0.373 . . . . 75.34 109.992 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -131.85 127.62 36.94 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 123.845 0.715 . . . . 75.42 109.669 -176.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.572 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 50.7 t-20 -71.86 -62.11 1.75 Allowed Pre-proline 0 CA--C 1.562 1.422 0 N-CA-C 112.744 0.646 . . . . 73.45 112.744 -178.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 3.3 Cg_endo -87.41 134.14 3.38 Favored 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 121.38 1.387 . . . . 71.01 110.7 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.49 137.39 59.62 Favored 'Trans proline' 0 C--O 1.252 1.213 0 C-N-CA 122.853 2.369 . . . . 40.44 114.042 -177.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.9 131.12 44.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.984 -1.007 . . . . 65.43 110.319 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 89.58 0.19 79.46 Favored Glycine 0 C--N 1.312 -0.779 0 C-N-CA 120.694 -0.765 . . . . 64.33 112.271 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 22.5 m -101.31 157.92 16.43 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.919 -0.771 . . . . 71.24 108.919 178.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -73.1 113.83 4.49 Favored Glycine 0 N--CA 1.429 -1.816 0 N-CA-C 108.767 -1.733 . . . . 55.24 108.767 174.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 24.4 m -96.01 141.94 14.57 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-O 121.24 0.543 . . . . 75.24 112.03 -176.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.412 HD22 ' CG ' ' A' ' 617' ' ' ASP . 1.3 p-10 -47.64 140.63 6.01 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 126.322 1.849 . . . . 74.02 111.518 175.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -54.06 -25.93 24.17 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 114.326 1.232 . . . . 62.21 114.326 -175.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 617' ' ' ASP . . . . . 0.412 ' CG ' HD22 ' A' ' 615' ' ' ASN . 9.3 p-10 -75.37 -25.49 57.74 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.165 -0.679 . . . . 72.14 109.165 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 67.79 21.36 73.06 Favored Glycine 0 N--CA 1.428 -1.897 0 CA-C-O 119.296 -0.725 . . . . 71.34 113.744 172.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.87 118.31 11.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-O 123.312 1.53 . . . . 71.14 111.138 -168.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 3.2 tp -112.12 119.13 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.958 0 CA-C-N 112.96 -1.927 . . . . 75.11 108.649 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 7.0 m -98.6 117.49 33.18 Favored 'General case' 0 N--CA 1.406 -2.665 0 N-CA-C 105.958 -1.867 . . . . 60.4 105.958 175.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -139.28 160.7 39.2 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.23 -1.396 . . . . 75.12 107.23 -178.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 623' ' ' ARG . . . . . 0.509 ' NH1' ' HA3' ' A' ' 590' ' ' GLY . 13.0 tpt180 -151.16 150.96 31.26 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 105.755 -1.943 . . . . 73.44 105.755 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -138.84 160.98 38.38 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 106.0 -1.852 . . . . 65.14 106.0 173.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -78.2 -96.02 0.24 Allowed Glycine 0 N--CA 1.421 -2.331 0 N-CA-C 110.987 -0.845 . . . . 54.14 110.987 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 . . . . . 0 C--N 1.283 -2.295 0 N-CA-C 108.159 -1.052 . . . . 75.12 108.159 179.277 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.752 0 N-CA-C 110.783 -0.927 . . . . 51.34 110.783 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 11.2 tp -90.98 152.5 3.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 109.529 -0.545 . . . . 74.13 109.529 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 23.7 m -92.85 161.32 14.54 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 108.392 -0.966 . . . . 54.44 108.392 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.24 81.24 1.45 Allowed 'General case' 0 N--CA 1.428 -1.55 0 CA-C-O 122.315 1.055 . . . . 73.35 110.376 -177.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.4 128.96 38.48 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 113.568 -1.651 . . . . 70.11 108.484 175.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 409' ' ' SER . 35.8 m -117.45 163.92 14.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 109.393 -0.595 . . . . 73.1 109.393 -174.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -93.19 138.0 32.0 Favored 'General case' 0 N--CA 1.421 -1.875 0 N-CA-C 106.378 -1.712 . . . . 72.44 106.378 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 60.5 t -95.24 120.04 64.66 Favored Pre-proline 0 C--N 1.28 -2.425 0 CA-C-N 115.744 -0.662 . . . . 61.14 110.005 -167.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -65.7 122.82 10.54 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.54 2.16 . . . . 61.13 112.225 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -108.59 153.72 22.98 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 114.523 -1.217 . . . . 62.43 108.894 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.451 ' CG2' ' HA ' ' A' ' 373' ' ' ALA . 15.9 m -134.84 28.52 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 115.361 -0.836 . . . . 64.44 109.852 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.47 148.0 24.84 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 115.221 -0.899 . . . . 73.54 112.304 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 367' ' ' GLY . . . . . 0.425 ' H ' HG23 ' A' ' 399' ' ' VAL . . . 105.95 -5.25 39.39 Favored Glycine 0 C--N 1.321 -0.285 0 CA-C-N 116.332 -0.395 . . . . 75.14 112.251 -176.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -106.48 -85.08 0.51 Allowed 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 120.868 0.365 . . . . 65.2 110.831 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 41.9 p -153.46 157.82 40.45 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 108.449 -0.945 . . . . 64.2 108.449 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 49.0 m -63.95 -35.67 81.44 Favored 'General case' 0 C--O 1.203 -1.359 0 N-CA-C 109.692 -0.484 . . . . 72.22 109.692 175.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.81 -46.77 88.09 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 116.348 -0.387 . . . . 73.0 111.973 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -68.1 -38.78 82.7 Favored 'General case' 0 C--O 1.245 0.828 0 C-N-CA 120.289 -0.564 . . . . 54.41 110.163 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 373' ' ' ALA . . . . . 0.451 ' HA ' ' CG2' ' A' ' 365' ' ' VAL . . . -66.59 -51.09 60.23 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.66 -0.7 . . . . 51.31 111.092 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.434 HG23 HG12 ' A' ' 384' ' ' ILE . 60.1 mt -60.08 -43.52 92.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 123.167 0.587 . . . . 60.33 110.517 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -60.47 -47.22 87.07 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.101 0.477 . . . . 45.32 110.59 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 376' ' ' THR . . . . . 0.526 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 58.9 m -66.61 -47.79 71.57 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.811 -0.631 . . . . 72.15 111.402 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 9.8 mp -64.24 -37.69 88.39 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 112.001 0.371 . . . . 75.03 112.001 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -64.02 -41.5 97.43 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 109.518 -0.549 . . . . 55.32 109.518 176.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -67.31 -22.38 65.63 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 116.24 -0.436 . . . . 64.34 111.452 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 376' ' ' THR . 13.7 mmm180 -80.94 -14.54 57.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.983 0.421 . . . . 73.52 109.963 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 96.8 14.9 41.56 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.904 -0.665 . . . . 13.42 112.244 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.504 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 55.1 m-85 -93.22 167.72 11.57 Favored 'General case' 0 N--CA 1.427 -1.621 0 O-C-N 122.488 -0.419 . . . . 70.32 110.969 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -105.51 143.83 33.13 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 106.528 -1.656 . . . . 73.44 106.528 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.434 HG12 HG23 ' A' ' 374' ' ' ILE . 1.2 pp -125.6 131.94 71.48 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 CA-C-O 121.593 0.711 . . . . 74.51 111.939 -177.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -111.04 129.34 55.94 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 114.707 -1.133 . . . . 71.51 108.035 -176.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 10.5 m -121.66 123.98 43.19 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 110.101 -0.333 . . . . 62.44 110.101 -176.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -111.57 122.82 48.83 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.536 -0.542 . . . . 64.22 109.536 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 7.6 pm0 -102.93 126.97 50.31 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.962 0.41 . . . . 73.4 110.536 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -135.14 136.27 24.42 Favored Pre-proline 0 C--N 1.297 -1.696 0 CA-C-N 115.994 -0.548 . . . . 64.41 110.394 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.07 147.24 93.85 Favored 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 123.055 2.503 . . . . 73.24 111.846 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 6.4 t70 86.41 178.59 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.515 1.926 . . . . 72.02 108.949 -178.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 25.7 m -132.41 14.66 4.55 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 121.692 0.758 . . . . 72.4 110.366 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 10.1 t -69.08 -28.05 66.17 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 107.889 -1.152 . . . . 73.31 107.889 172.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.67 HD13 ' H ' ' A' ' 394' ' ' ILE . 0.2 OUTLIER -88.55 151.73 48.5 Favored Pre-proline 0 N--CA 1.433 -1.308 0 N-CA-C 107.59 -1.263 . . . . 74.21 107.59 174.003 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -28.97 116.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.306 0 C-N-CA 125.148 3.899 . . . . 71.23 115.034 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' PRO . . . . . 0.602 ' HA ' ' OG ' ' A' ' 421' ' ' SER . 48.5 Cg_exo -58.55 161.03 15.45 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 123.805 3.003 . . . . 61.44 113.626 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -57.63 -9.24 1.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.13 0.972 . . . . 63.31 113.077 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' HIS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 32.6 m170 -107.37 119.86 40.55 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 104.504 -2.406 . . . . 64.52 104.504 171.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.425 HG23 ' H ' ' A' ' 367' ' ' GLY . 11.0 m -62.84 118.24 4.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.196 0 O-C-N 123.681 0.613 . . . . 51.23 111.574 -168.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.38 -34.96 8.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 108.029 -1.1 . . . . 65.35 108.029 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -152.73 157.92 27.58 Favored Glycine 0 N--CA 1.409 -3.153 0 N-CA-C 109.369 -1.492 . . . . 71.3 109.369 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.2 p -117.89 -178.82 3.58 Favored 'General case' 0 C--N 1.277 -2.58 0 N-CA-C 108.435 -0.95 . . . . 72.3 108.435 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -100.74 146.28 31.81 Favored Pre-proline 0 C--N 1.295 -1.795 0 C-N-CA 119.306 -0.958 . . . . 63.03 111.006 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.12 -16.36 1.78 Allowed 'Trans proline' 0 C--N 1.364 1.347 0 C-N-CA 125.221 3.947 . . . . 60.32 114.868 -176.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.43 -33.86 63.93 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.365 0.666 . . . . 72.03 111.042 176.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -82.34 -30.69 30.27 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.434 0.635 . . . . 71.35 111.135 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -86.56 -1.84 57.98 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.335 0.588 . . . . 64.33 110.573 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 47.2 m -107.54 148.38 29.32 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.094 -1.447 . . . . 75.44 107.094 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 409' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 360' ' ' VAL . 65.3 m -74.5 113.34 11.64 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 120.055 -0.658 . . . . 25.4 110.319 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 33.4 m -129.31 169.49 20.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.774 -0.648 . . . . 63.52 109.467 177.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 22.6 t -79.84 156.39 27.39 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.094 -0.706 . . . . 60.55 109.094 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 412' ' ' ALA . . . . . 0.504 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -70.87 143.13 51.13 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 116.101 -0.499 . . . . 21.43 110.703 -178.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 103.02 10.6 36.54 Favored Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 120.398 -0.906 . . . . 44.52 112.98 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -80.53 174.51 11.54 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.244 -1.021 . . . . 72.22 108.244 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -110.01 114.69 28.42 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.945 -0.761 . . . . 74.31 108.945 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 46.6 mm -97.7 127.37 50.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 109.179 -0.674 . . . . 61.34 109.179 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 1.7 p -86.66 130.67 34.39 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 114.028 1.121 . . . . 73.45 114.028 -176.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 2.1 t -123.34 134.89 64.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 C-N-CA 125.126 1.37 . . . . 75.43 110.007 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -106.49 129.12 54.5 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 115.457 -0.792 . . . . 53.04 109.871 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 5.3 p -118.76 131.22 72.17 Favored 'Isoleucine or valine' 0 C--O 1.256 1.408 0 N-CA-C 109.707 -0.479 . . . . 64.15 109.707 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 421' ' ' SER . . . . . 0.602 ' OG ' ' HA ' ' A' ' 396' ' ' PRO . 54.6 p -84.75 125.54 32.64 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 115.904 -0.589 . . . . 75.14 110.43 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.8 m -97.82 156.9 16.37 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 107.132 -1.433 . . . . 62.14 107.132 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -44.08 148.78 0.96 Allowed Glycine 0 C--O 1.255 1.411 0 N-CA-C 114.815 0.686 . . . . 64.11 114.815 -177.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.07 152.12 19.3 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 123.788 2.992 . . . . 62.41 112.638 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.42 ' O ' HD13 ' A' ' 480' ' ' ILE . 31.6 mt-10 -72.36 145.76 47.53 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.276 -0.875 . . . . 64.55 109.593 -174.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -122.29 157.38 31.85 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.284 -1.006 . . . . 74.14 108.284 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.551 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 1.5 mmp_? -123.56 159.57 28.9 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 112.698 0.629 . . . . 62.34 112.698 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -82.66 141.18 32.68 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.534 -1.212 . . . . 72.44 108.169 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.443 HD12 ' O ' ' A' ' 473' ' ' PRO . 63.9 mt -77.84 125.98 84.77 Favored Pre-proline 0 N--CA 1.43 -1.449 0 N-CA-C 107.685 -1.228 . . . . 61.52 107.685 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 429' ' ' ILE . 16.9 Cg_exo -69.7 140.85 43.92 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.639 1.559 . . . . 73.1 111.35 178.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -95.4 130.2 42.28 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.302 -1.74 . . . . 71.01 106.302 175.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.541 HG11 ' HB2' ' A' ' 440' ' ' ALA . 13.2 p -129.59 150.51 34.69 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.259 0 C-N-CA 120.346 -0.542 . . . . 73.12 110.515 -172.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 5.7 m -63.23 137.89 58.36 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 107.657 -1.238 . . . . 52.44 107.657 173.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 434' ' ' THR . . . . . 0.457 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 52.9 p -60.16 -28.77 68.19 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 123.989 0.916 . . . . 74.13 113.293 -171.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.403 ' HB3' ' HG3' ' A' ' 466' ' ' LYS . 1.1 pp -88.15 -10.73 49.04 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 113.558 0.947 . . . . 74.41 113.558 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 3.6 m -102.65 49.96 0.83 Allowed 'General case' 0 CA--C 1.563 1.459 0 CA-C-O 121.62 0.724 . . . . 75.52 111.056 -175.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -52.72 -37.63 59.51 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.93 0.892 . . . . 72.43 112.58 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' A' ' 442' ' ' LYS . . . -58.82 -40.1 83.18 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.101 0.477 . . . . 61.42 111.367 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -69.42 -35.47 75.74 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.604 -0.887 . . . . 61.51 108.604 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.541 ' HB2' HG11 ' A' ' 432' ' ' VAL . . . -60.78 -51.67 68.35 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.591 -0.732 . . . . 25.0 111.036 -178.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 33.5 m -62.31 -44.61 99.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 120.829 -0.348 . . . . 73.45 111.829 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 438' ' ' ALA 0.339 0.0 OUTLIER -68.66 -33.7 74.44 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 113.432 0.901 . . . . 71.42 113.432 178.881 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -65.01 -43.05 93.79 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 122.197 -0.314 . . . . 71.24 111.108 174.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.492 HD13 ' O ' ' A' ' 440' ' ' ALA . 8.9 mp -63.37 -35.24 79.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.347 -0.388 . . . . 75.12 110.325 177.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.461 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 38.6 m -67.28 -44.29 79.66 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 116.11 -0.495 . . . . 74.14 110.671 178.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.71 -22.94 65.24 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.22 -0.446 . . . . 72.14 111.435 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -80.09 5.16 15.02 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 116.061 -0.518 . . . . 53.11 111.737 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 102.23 -61.21 0.53 Allowed Glycine 0 CA--C 1.492 -1.374 0 C-N-CA 120.739 -0.743 . . . . 70.31 112.348 173.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 449' ' ' PHE . . . . . 0.44 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 0.9 OUTLIER -53.28 -63.4 1.16 Allowed 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 112.885 0.698 . . . . 70.1 112.885 178.224 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 450' ' ' GLY . . . . . 0.461 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 60.01 23.22 59.07 Favored Glycine 0 C--N 1.316 -0.572 0 O-C-N 123.199 0.312 . . . . 63.11 113.15 -178.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.446 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 35.6 mmt180 -108.2 110.82 22.54 Favored 'General case' 0 N--CA 1.422 -1.856 0 N-CA-C 107.337 -1.357 . . . . 74.31 107.337 -178.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -131.29 146.02 52.12 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.651 -0.704 . . . . 63.34 110.499 -175.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -131.58 132.79 44.39 Favored 'General case' 0 C--N 1.286 -2.196 0 N-CA-C 108.397 -0.964 . . . . 62.42 108.397 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -101.05 126.98 47.77 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 120.956 0.408 . . . . 75.13 110.244 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.27 153.31 36.55 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.539 -1.282 . . . . 70.22 107.539 175.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -127.36 144.84 50.98 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.602 -0.518 . . . . 74.42 109.602 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 28.2 t -141.81 142.99 27.1 Favored Pre-proline 0 C--N 1.291 -1.963 0 N-CA-C 107.932 -1.136 . . . . 60.34 107.932 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.659 ' HA ' ' O ' ' A' ' 490' ' ' SER . 19.3 Cg_exo -65.83 138.73 54.4 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.872 1.715 . . . . 63.22 110.251 176.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 65.9 m -150.82 174.42 13.09 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 109.522 -0.547 . . . . 73.41 109.522 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.0 t -52.83 136.91 45.52 Favored Pre-proline 0 N--CA 1.437 -1.112 0 C-N-CA 123.739 0.816 . . . . 52.45 110.571 174.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.89 -30.24 38.12 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 124.624 3.549 . . . . 63.04 113.478 -175.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -67.43 -27.83 67.39 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.184 -0.462 . . . . 74.13 111.624 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -99.23 -13.38 19.73 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 111.717 0.266 . . . . 64.43 111.717 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 56.9 t -59.25 130.56 22.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.268 -0.424 . . . . 73.13 110.79 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.08 -10.26 60.05 Favored Glycine 0 N--CA 1.435 -1.399 0 CA-C-N 115.92 -0.582 . . . . 65.34 111.84 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.403 ' HG3' ' HB3' ' A' ' 435' ' ' LEU . 3.8 mppt? -118.03 166.57 12.38 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-O 120.886 0.375 . . . . 53.42 110.899 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.457 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 74.4 t -73.35 143.07 14.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 108.167 -1.049 . . . . 71.24 108.167 176.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 48.9 mm -98.02 -27.07 3.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.313 -0.995 . . . . 74.12 108.313 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 157.94 -161.48 31.52 Favored Glycine 0 N--CA 1.428 -1.894 0 CA-C-N 115.643 -0.708 . . . . 52.14 111.572 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 470' ' ' THR . . . . . 0.465 HG22 HG12 ' A' ' 486' ' ' ILE . 40.0 p -115.21 141.29 48.22 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.593 -1.262 . . . . 62.42 107.593 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.492 ' HB3' HG23 ' A' ' 485' ' ' ILE . 6.7 t30 -64.73 -50.42 64.28 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 109.791 -0.448 . . . . 63.12 109.791 176.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -75.29 155.44 41.62 Favored 'Trans proline' 0 C--N 1.377 2.035 0 N-CA-C 108.951 -1.211 . . . . 74.33 108.951 173.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.443 ' O ' HD12 ' A' ' 429' ' ' ILE . 37.3 Cg_exo -62.96 126.19 17.5 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.173 1.248 . . . . 52.4 109.819 177.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -74.4 -0.7 18.16 Favored 'General case' 0 C--O 1.194 -1.838 0 N-CA-C 112.984 0.735 . . . . 63.52 112.984 -173.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -108.96 3.86 22.68 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 121.78 -0.575 . . . . 50.24 110.071 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 476' ' ' GLN . . . . . 0.417 ' HG2' ' HB2' ' A' ' 473' ' ' PRO . 84.3 mm-40 -98.17 175.71 5.99 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 112.269 0.47 . . . . 74.24 112.269 -177.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 1.3 m -105.87 112.29 25.29 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.464 -0.789 . . . . 50.13 109.455 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 12.7 p -101.12 145.98 28.07 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.038 0.447 . . . . 65.45 110.858 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -75.33 150.57 38.42 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.547 -0.751 . . . . 61.45 110.739 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.44 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 1.7 mp -67.85 -26.05 33.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 123.519 0.728 . . . . 74.15 111.59 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 12.5 t -89.46 2.58 54.33 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.822 0.82 . . . . 74.22 110.342 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -102.82 144.14 31.54 Favored 'General case' 0 C--N 1.318 -0.802 0 O-C-N 121.936 -0.478 . . . . 62.15 110.78 -175.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.446 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 6.4 p -108.15 127.21 64.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 C-N-CA 123.067 0.547 . . . . 73.14 111.566 -177.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 35.7 m -104.73 141.86 19.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.771 -0.65 . . . . 33.34 111.391 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.492 HG23 ' HB3' ' A' ' 471' ' ' ASN . 0.0 OUTLIER -108.93 130.13 62.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.401 0.62 . . . . 64.41 111.795 -178.513 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.465 HG12 HG22 ' A' ' 470' ' ' THR . 13.1 mt -113.81 129.72 69.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 C-N-CA 125.084 1.354 . . . . 70.51 111.206 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 9.9 tt -105.33 126.96 60.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.586 -0.734 . . . . 73.31 111.388 -174.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.411 HG12 HG22 ' A' ' 467' ' ' VAL . 35.7 m -109.68 151.65 11.9 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 C-N-CA 123.519 0.728 . . . . 75.2 110.326 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -92.28 132.51 11.3 Favored Glycine 0 C--N 1.311 -0.809 0 N-CA-C 111.053 -0.819 . . . . 74.31 111.053 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.659 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 23.3 t -134.51 160.41 38.11 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 109.642 -0.503 . . . . 65.24 109.642 -177.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 108.5 80.51 1.24 Allowed Glycine 0 N--CA 1.443 -0.837 0 CA-C-O 119.704 -0.498 . . . . 74.43 112.725 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -68.42 146.27 67.94 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.346 2.031 . . . . 72.34 110.798 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 493' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . -112.19 25.9 11.1 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.582 0.706 . . . . 51.12 111.101 -176.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 6.6 p -116.94 143.47 45.67 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 114.93 -1.032 . . . . 72.31 110.659 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -151.2 147.09 26.59 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 108.419 -0.956 . . . . 72.25 108.419 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.524 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 7.6 p-10 -85.71 132.5 34.13 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.699 0.761 . . . . 75.23 112.543 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 33.7 pt -77.18 137.45 64.91 Favored Pre-proline 0 C--N 1.308 -1.22 0 CA-C-N 114.461 -1.245 . . . . 75.23 111.247 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -85.7 175.02 6.3 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.417 2.078 . . . . 60.35 112.528 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -97.21 132.46 42.94 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.59 -0.732 . . . . 60.52 109.654 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.2 104.11 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.626 0 CA-C-O 122.017 0.913 . . . . 61.23 110.598 -177.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -146.55 139.91 25.74 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.958 -1.019 . . . . 51.43 108.725 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 113.9 -18.48 19.24 Favored Glycine 0 CA--C 1.485 -1.837 0 N-CA-C 110.412 -1.075 . . . . 72.11 110.412 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 503' ' ' GLN . . . . . 0.432 ' O ' HG12 ' A' ' 534' ' ' VAL . 50.8 mt-30 -95.87 -179.52 4.73 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 109.22 -0.659 . . . . 70.51 109.22 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 15.0 t -91.87 157.16 17.01 Favored 'General case' 0 N--CA 1.421 -1.896 0 C-N-CA 118.184 -1.406 . . . . 64.12 107.885 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 6.0 p -53.77 -42.5 52.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 O-C-N 123.742 0.651 . . . . 64.4 112.344 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -65.48 -41.52 93.19 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.265 0.353 . . . . 72.03 110.976 -176.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 81.8 t -70.59 -44.49 76.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.878 0.371 . . . . 71.25 110.798 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 508' ' ' ALA . . . . . 0.415 ' O ' ' HG ' ' A' ' 512' ' ' LEU . . . -61.44 -48.49 80.94 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.01 -0.541 . . . . 73.31 111.147 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -60.4 -43.11 96.98 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.249 -0.887 . . . . 75.32 109.939 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.483 ' O ' HG23 ' A' ' 514' ' ' VAL . 35.4 ttmt -63.21 -42.37 99.29 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.967 -1.015 . . . . 53.42 110.127 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -62.33 -41.7 98.77 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.057 0.456 . . . . 72.23 110.136 178.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 512' ' ' LEU . . . . . 0.442 HD13 HG13 ' A' ' 551' ' ' ILE . 89.4 mt -65.73 -37.1 85.47 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.717 -0.674 . . . . 72.13 110.923 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -64.23 -37.76 88.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.253 -0.431 . . . . 75.43 110.051 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 510' ' ' LYS . 93.3 t -62.55 -31.17 51.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 115.889 -0.596 . . . . 71.12 110.673 177.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -77.24 -6.75 54.25 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 120.818 0.342 . . . . 74.14 111.062 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 106.96 -0.06 35.9 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.401 -0.904 . . . . 51.35 113.239 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -90.86 99.37 12.42 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 107.56 -1.274 . . . . 75.3 107.56 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.1 m -91.0 -11.35 39.16 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.972 -1.013 . . . . 75.15 112.076 -172.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 519' ' ' LYS . . . . . 0.517 ' HD2' ' O ' ' A' ' 548' ' ' ASP . 95.7 mttt -108.62 118.18 36.12 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.239 -0.652 . . . . 74.42 109.239 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -129.63 155.0 46.55 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.147 0.498 . . . . 70.51 111.01 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 4.8 p -141.11 148.17 39.69 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 107.457 -1.312 . . . . 65.12 107.457 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 522' ' ' GLN . . . . . 0.459 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 10.7 pt20 -132.64 132.61 42.63 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-O 121.235 0.54 . . . . 71.44 111.062 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -113.56 141.51 47.08 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.457 -1.682 . . . . 61.43 106.457 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 45.3 p -121.22 129.16 53.06 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 120.397 -0.521 . . . . 64.54 111.459 -177.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 525' ' ' VAL . . . . . 0.57 ' O ' ' HB3' ' A' ' 557' ' ' LYS . 19.5 m -121.82 166.67 16.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 109.267 -0.642 . . . . 65.52 109.267 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -92.38 137.85 32.01 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.997 -1.483 . . . . 75.1 106.997 174.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 10.3 m -141.65 173.22 4.99 Favored Pre-proline 0 C--N 1.276 -2.625 0 N-CA-C 108.477 -0.934 . . . . 54.24 108.477 -172.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -79.22 -17.52 11.67 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 121.651 1.567 . . . . 64.32 109.19 168.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.603 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 18.0 mmm180 -67.38 152.19 96.41 Favored Pre-proline 0 N--CA 1.441 -0.905 0 C-N-CA 125.752 1.621 . . . . 65.31 108.581 177.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.44 156.32 61.82 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.335 2.023 . . . . 62.54 112.791 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 557' ' ' LYS . . . -70.93 124.92 25.48 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.937 -0.574 . . . . 73.22 111.038 -178.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 107.82 -10.95 38.14 Favored Glycine 0 C--N 1.305 -1.182 0 C-N-CA 120.589 -0.815 . . . . 42.1 111.395 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -82.46 138.64 34.31 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.469 -1.678 . . . . 70.32 106.469 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.432 HG12 ' O ' ' A' ' 503' ' ' GLN . 11.6 p -95.22 118.29 41.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 119.896 -0.722 . . . . 75.52 110.163 -178.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 535' ' ' THR . . . . . 0.582 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 13.2 t -84.05 0.09 49.64 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.364 -0.38 . . . . 44.11 111.614 -175.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.424 ' H ' HG22 ' A' ' 534' ' ' VAL . . . 135.49 -160.94 24.63 Favored Glycine 0 CA--C 1.495 -1.204 0 C-N-CA 120.887 -0.673 . . . . 75.21 111.921 175.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 37.2 p -117.77 155.3 30.26 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.794 -0.817 . . . . 73.12 108.794 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -76.16 -50.34 2.98 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-O 119.437 -0.316 . . . . 64.21 110.507 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -66.95 135.95 39.6 Favored 'Trans proline' 0 C--N 1.369 1.609 0 N-CA-C 108.991 -1.196 . . . . 73.02 108.991 169.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.56 150.56 86.49 Favored 'Trans proline' 0 C--O 1.244 0.784 0 C-N-CA 122.378 2.052 . . . . 63.53 112.799 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.22 138.02 57.39 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.924 -0.769 . . . . 73.23 108.924 176.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.47 -11.34 58.13 Favored Glycine 0 C--N 1.294 -1.789 0 C-N-CA 120.606 -0.807 . . . . 53.21 111.767 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 59.5 m -69.87 120.86 16.24 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.595 -0.521 . . . . 72.3 109.595 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 11.5 t -85.89 123.16 30.92 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 109.079 -0.711 . . . . 71.41 109.079 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 29.1 m -135.88 159.96 69.22 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 108.349 -0.982 . . . . 72.04 108.349 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 32.3 Cg_exo -61.54 141.1 90.48 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 121.711 1.608 . . . . 74.0 110.8 174.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 35.2 m -61.05 -19.65 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-O 121.811 0.815 . . . . 74.52 111.978 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 548' ' ' ASP . . . . . 0.517 ' O ' ' HD2' ' A' ' 519' ' ' LYS . 25.1 t70 -90.12 -1.23 57.92 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.242 -0.89 . . . . 74.14 110.897 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 67.2 m -86.29 172.95 10.07 Favored 'General case' 0 C--N 1.313 -1.018 0 O-C-N 121.697 -0.627 . . . . 73.41 112.547 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 14.3 p -100.14 136.49 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 115.255 -0.884 . . . . 62.11 110.886 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 551' ' ' ILE . . . . . 0.502 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -108.97 145.67 15.51 Favored 'Isoleucine or valine' 0 C--O 1.252 1.228 0 N-CA-C 109.245 -0.65 . . . . 71.24 109.245 174.782 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -109.13 115.15 29.5 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 121.303 0.573 . . . . 74.23 111.035 -176.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 553' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 5.1 mp -95.5 135.2 37.45 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.612 -1.177 . . . . 55.04 109.425 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -110.43 118.12 35.41 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.68 0.752 . . . . 73.41 110.318 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.88 141.1 16.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 114.731 -1.122 . . . . 72.54 110.288 -174.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.603 ' HB3' ' HB2' ' A' ' 529' ' ' ARG . 7.8 m -86.29 147.95 25.84 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 115.35 -0.841 . . . . 63.11 110.653 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.57 ' HB3' ' O ' ' A' ' 525' ' ' VAL . 0.5 OUTLIER -123.58 130.12 52.19 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.111 -0.95 . . . . 73.54 109.691 173.69 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 558' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -66.25 -43.46 92.9 Favored Glycine 0 CA--C 1.486 -1.769 0 N-CA-C 111.36 -0.696 . . . . 31.14 111.36 -176.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 64.3 t30 72.53 -8.74 1.16 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.968 1.307 . . . . 74.23 110.56 176.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.463 ' H ' ' C ' ' A' ' 558' ' ' GLY . 97.0 mt-30 -127.21 155.34 43.58 Favored 'General case' 0 N--CA 1.423 -1.81 0 C-N-CA 125.567 1.547 . . . . 70.33 107.375 177.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -126.48 147.65 49.79 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.844 -0.798 . . . . 74.04 108.844 177.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 62.8 t -63.43 116.98 3.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 O-C-N 123.408 0.442 . . . . 74.33 110.079 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 58.3 ttp -75.49 124.77 89.12 Favored Pre-proline 0 C--N 1.306 -1.314 0 CA-C-N 115.979 -0.555 . . . . 73.25 110.788 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -65.89 169.41 13.32 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.095 2.53 . . . . 44.35 110.32 174.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -89.19 114.17 25.46 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 118.72 -1.192 . . . . 53.2 111.688 -177.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -125.81 0.18 7.37 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.567 -1.271 . . . . 64.25 107.567 173.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 23.9 m -65.07 151.2 46.63 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 113.777 -1.556 . . . . 54.31 112.238 -174.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 90.79 35.97 7.01 Favored Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 110.213 -1.155 . . . . 50.42 110.213 -175.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 15.9 ptm -117.53 157.5 26.21 Favored 'General case' 0 C--O 1.25 1.089 0 N-CA-C 109.529 -0.545 . . . . 73.15 109.529 -174.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 570' ' ' PHE . . . . . 0.59 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 86.3 m-85 -84.53 171.52 12.43 Favored 'General case' 0 CA--C 1.502 -0.9 0 O-C-N 123.322 0.389 . . . . 70.4 110.821 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 29.4 t90 -62.6 -34.0 76.12 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.941 -0.762 . . . . 72.45 108.941 172.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 29.1 m -72.33 -7.96 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.318 -0.855 . . . . 73.44 110.97 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 573' ' ' ASP . . . . . 0.584 ' O ' ' HD3' ' A' ' 577' ' ' ARG . 31.6 m-20 -100.92 -44.83 5.63 Favored 'General case' 0 CA--C 1.492 -1.276 0 N-CA-C 109.407 -0.59 . . . . 74.04 109.407 174.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 574' ' ' ALA . . . . . 0.646 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -61.04 -53.2 60.07 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.081 -0.963 . . . . 72.43 112.539 -175.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.417 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 1.0 OUTLIER -57.95 -50.69 86.67 Favored Pre-proline 0 CA--C 1.574 1.892 0 O-C-N 123.547 0.529 . . . . 70.41 112.005 -174.659 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 576' ' ' PRO . . . . . 0.417 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 67.1 Cg_exo -58.25 -38.42 91.04 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 121.847 1.698 . . . . 63.23 112.268 174.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.584 ' HD3' ' O ' ' A' ' 573' ' ' ASP . 5.7 mpt_? -67.67 -34.26 76.57 Favored 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 121.111 -0.236 . . . . 74.53 111.555 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 76.2 mt -60.7 -43.11 98.17 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.976 -0.75 . . . . 73.1 108.976 177.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -64.28 -45.9 85.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.147 -0.933 . . . . 72.3 109.302 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.11 92.27 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.854 -1.066 . . . . 64.51 113.44 -176.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 11.1 mp -82.22 -9.09 59.62 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 113.127 0.788 . . . . 72.5 113.127 -177.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 68.78 32.36 74.01 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 109.255 -1.538 . . . . 44.25 109.255 -174.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 44.8 t90 -60.61 134.07 56.72 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.021 0.928 . . . . 61.04 110.284 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 8.9 t -126.61 19.33 7.34 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.858 -0.61 . . . . 73.55 109.917 -176.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -79.97 -155.22 10.27 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 115.808 -0.633 . . . . 34.34 113.511 -176.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 586' ' ' MET . . . . . 0.44 ' H ' HG12 ' A' ' 619' ' ' ILE . 86.1 mtp -124.94 132.62 53.26 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.551 -0.907 . . . . 54.22 108.551 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 61.9 tp -106.8 130.69 54.46 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.328 -0.619 . . . . 74.44 109.328 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -114.2 121.92 45.2 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 120.898 0.38 . . . . 72.15 110.206 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -105.5 118.38 36.42 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 116.153 -0.476 . . . . 72.13 110.216 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -88.19 -163.09 38.85 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.691 -0.964 . . . . 72.2 110.691 177.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -67.19 147.8 52.6 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 120.742 0.306 . . . . 72.33 110.699 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -93.72 124.51 37.76 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.138 0.494 . . . . 54.21 111.448 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 91.2 t -114.73 126.39 72.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 106.664 -1.606 . . . . 62.13 106.664 175.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 594' ' ' ASP . . . . . 0.535 ' HA ' ' HB2' ' A' ' 626' ' ' GLN . 6.2 p-10 -102.44 125.35 49.13 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 120.445 -0.502 . . . . 65.02 109.877 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -133.04 -28.68 1.51 Allowed 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.464 -0.789 . . . . 74.32 110.428 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 130.37 125.29 2.69 Favored Glycine 0 CA--C 1.486 -1.752 0 N-CA-C 109.979 -1.248 . . . . 62.52 109.979 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.29 -36.07 67.81 Favored Glycine 0 C--O 1.21 -1.363 0 N-CA-C 114.641 0.617 . . . . 63.14 114.641 -172.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 18.6 m -62.67 -32.06 73.06 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 117.58 0.69 . . . . 75.54 112.194 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -109.37 -1.92 18.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.62 -0.264 . . . . 54.01 111.525 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 600' ' ' HIS . . . . . 0.502 ' CE1' ' HA3' ' A' ' 625' ' ' GLY . 5.9 t-160 -150.49 -148.92 0.28 Allowed 'General case' 0 C--O 1.204 -1.328 0 N-CA-C 108.78 -0.822 . . . . 65.43 108.78 -170.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 601' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 626' ' ' GLN . 3.1 t-20 62.22 2.87 0.9 Allowed 'General case' 0 N--CA 1.516 2.828 0 C-N-CA 125.1 1.36 . . . . 75.3 112.282 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 602' ' ' ARG . . . . . 0.59 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 9.2 ptp85 -110.64 171.58 7.38 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.036 -0.984 . . . . 73.43 109.355 -177.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 603' ' ' VAL . . . . . 0.422 HG23 ' HB2' ' A' ' 622' ' ' LEU . 7.6 p -57.03 130.78 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 O-C-N 124.469 1.105 . . . . 51.34 109.039 176.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 29.2 m -101.22 -37.17 5.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 121.504 0.669 . . . . 64.23 109.561 -175.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 605' ' ' TYR . . . . . 0.469 ' CE2' ' HD3' ' A' ' 623' ' ' ARG . 35.4 p90 -151.28 152.86 33.8 Favored 'General case' 0 N--CA 1.409 -2.524 0 N-CA-C 105.768 -1.938 . . . . 72.31 105.768 172.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -128.49 144.45 51.15 Favored 'General case' 0 C--N 1.27 -2.865 0 N-CA-C 107.972 -1.121 . . . . 73.12 107.972 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.501 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 42.8 t30 -72.44 -51.92 7.11 Favored Pre-proline 0 C--N 1.286 -2.162 0 CA-C-N 115.652 -0.704 . . . . 65.04 111.054 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.501 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 10.3 Cg_endo -97.78 111.48 0.1 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.582 0 C-N-CA 121.594 1.529 . . . . 74.41 110.309 170.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -68.25 159.07 54.81 Favored 'Trans proline' 0 C--O 1.248 0.978 0 C-N-CA 121.974 1.783 . . . . 64.4 110.465 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -60.11 132.91 55.4 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.789 -0.448 . . . . 61.03 109.789 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.25 -11.06 47.67 Favored Glycine 0 C--N 1.308 -0.997 0 C-N-CA 120.532 -0.842 . . . . 45.51 111.585 -176.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 22.7 m -89.95 156.34 18.5 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.775 -0.824 . . . . 71.41 108.775 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -80.84 125.17 6.75 Favored Glycine 0 N--CA 1.419 -2.454 0 N-CA-C 111.704 -0.558 . . . . 61.12 111.704 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 29.1 m -107.64 141.48 22.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 108.177 -1.045 . . . . 71.14 108.177 175.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.61 ' ND2' ' HB3' ' A' ' 617' ' ' ASP . 31.4 p-10 -63.22 164.52 8.62 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 122.903 0.481 . . . . 74.35 111.873 -177.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -61.84 -25.6 67.62 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.213 0.53 . . . . 62.45 111.242 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 617' ' ' ASP . . . . . 0.61 ' HB3' ' ND2' ' A' ' 615' ' ' ASN . 16.0 t70 -68.11 -37.44 81.16 Favored 'General case' 0 C--O 1.245 0.856 0 CA-C-N 115.535 -0.757 . . . . 63.44 109.321 176.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 89.65 19.71 47.23 Favored Glycine 0 N--CA 1.429 -1.79 0 CA-C-N 115.283 -0.872 . . . . 74.42 113.147 174.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 619' ' ' ILE . . . . . 0.44 HG12 ' H ' ' A' ' 586' ' ' MET . 0.0 OUTLIER -70.09 118.13 14.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 122.457 1.122 . . . . 63.01 109.192 -174.375 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.09 129.4 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 N-CA-C 107.691 -1.226 . . . . 71.02 107.691 -175.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.442 ' HB ' ' CB ' ' A' ' 607' ' ' ASN . 32.8 m -99.71 118.31 35.94 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 109.473 -0.566 . . . . 61.33 109.473 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 622' ' ' LEU . . . . . 0.422 ' HB2' HG23 ' A' ' 603' ' ' VAL . 2.2 pt? -133.86 150.47 51.37 Favored 'General case' 0 CA--C 1.477 -1.852 0 N-CA-C 105.089 -2.189 . . . . 61.12 105.089 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 623' ' ' ARG . . . . . 0.469 ' HD3' ' CE2' ' A' ' 605' ' ' TYR . 79.7 ttt180 -132.94 139.41 47.31 Favored 'General case' 0 C--N 1.262 -3.208 0 N-CA-C 107.17 -1.418 . . . . 75.12 107.17 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -140.16 163.8 31.76 Favored 'General case' 0 C--N 1.289 -2.052 0 O-C-N 124.048 0.842 . . . . 63.51 109.439 -175.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 625' ' ' GLY . . . . . 0.502 ' HA3' ' CE1' ' A' ' 600' ' ' HIS . . . -123.64 -141.67 5.88 Favored Glycine 0 N--CA 1.416 -2.685 0 N-CA-C 109.992 -1.243 . . . . 44.15 109.992 174.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 626' ' ' GLN . . . . . 0.535 ' HB2' ' HA ' ' A' ' 594' ' ' ASP . 47.5 mt-30 . . . . . 0 C--N 1.297 -1.681 0 N-CA-C 108.314 -0.995 . . . . 64.13 108.314 177.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.92 0 N-CA-C 110.668 -0.973 . . . . 45.13 110.668 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 8.6 tp -78.63 125.56 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.921 0 CA-C-O 121.364 0.602 . . . . 63.01 110.651 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.45 140.59 29.38 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.218 -0.66 . . . . 74.35 109.218 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -87.83 -12.5 44.78 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 122.219 1.009 . . . . 51.01 108.358 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -92.81 149.52 21.23 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.142 -1.39 . . . . 70.42 107.289 178.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.8 m -116.93 161.15 15.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 108.905 -0.776 . . . . 71.41 108.905 -177.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -95.04 136.84 34.87 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.008 -1.077 . . . . 61.02 108.142 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.413 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 95.6 t -97.58 127.81 36.55 Favored Pre-proline 0 C--N 1.285 -2.227 0 CA-C-N 115.798 -0.637 . . . . 74.34 110.281 -173.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 363' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 23.9 Cg_exo -64.17 137.66 57.7 Favored 'Trans proline' 0 C--O 1.242 0.695 0 C-N-CA 122.66 2.24 . . . . 53.4 111.015 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -79.1 130.36 35.42 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 122.055 0.931 . . . . 70.3 109.706 -178.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 7.9 p -107.94 5.25 9.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-O 122.656 1.217 . . . . 73.42 110.622 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.13 145.01 52.51 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.952 -1.022 . . . . 72.12 110.66 173.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 91.68 0.51 72.3 Favored Glycine 0 N--CA 1.434 -1.439 0 CA-C-N 116.216 -0.447 . . . . 70.53 112.303 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -107.82 -82.06 0.56 Allowed 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.263 0.468 . . . . 73.24 112.263 -176.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 11.8 t -154.29 150.88 28.47 Favored 'General case' 0 CA--C 1.503 -0.861 0 O-C-N 121.644 -0.66 . . . . 62.11 110.501 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.616 ' HB3' ' O ' ' A' ' 397' ' ' ASP . 1.4 p -63.68 -47.22 82.08 Favored 'General case' 0 N--CA 1.435 -1.181 0 O-C-N 123.799 0.687 . . . . 74.01 109.896 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -68.8 -45.59 70.86 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 115.158 -0.928 . . . . 61.32 110.691 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -68.88 -34.66 75.79 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 119.458 -0.897 . . . . 75.33 111.783 -176.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 373' ' ' ALA . . . . . 0.407 ' O ' HD13 ' A' ' 377' ' ' LEU . . . -67.93 -51.11 51.46 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.662 0.267 . . . . 61.54 110.834 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.37 -37.36 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 116.239 -0.437 . . . . 74.34 110.697 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.58 -47.08 85.5 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 120.893 0.378 . . . . 71.01 111.062 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 42.2 m -62.53 -47.77 82.43 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-O 121.576 0.703 . . . . 73.24 110.081 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.407 HD13 ' O ' ' A' ' 373' ' ' ALA . 9.6 mp -64.33 -39.1 93.22 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.495 -0.775 . . . . 73.21 112.096 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 62.0 tp60 -61.79 -44.45 96.85 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.131 0.572 . . . . 44.23 110.373 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -68.35 -19.38 64.64 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.29 0.567 . . . . 71.51 112.07 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' ARG . . . . . 0.486 ' NE ' ' HA ' ' A' ' 380' ' ' ARG . 3.9 mmp_? -96.45 -13.95 22.74 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 112.515 0.561 . . . . 72.03 112.515 177.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.13 14.51 54.32 Favored Glycine 0 C--O 1.25 1.12 0 C-N-CA 120.87 -0.681 . . . . 63.52 112.367 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.406 ' CZ ' HG21 ' A' ' 362' ' ' VAL . 26.7 m-85 -76.62 140.05 40.84 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-O 121.141 0.496 . . . . 65.14 110.121 177.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -85.08 134.77 34.19 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 107.628 -1.249 . . . . 73.0 107.628 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.451 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -128.13 157.15 40.46 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 CA-C-O 120.999 0.428 . . . . 64.13 110.338 -175.873 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -134.99 137.36 42.95 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 106.636 -1.616 . . . . 61.42 106.636 172.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 13.1 m -135.09 116.76 14.94 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.802 -0.814 . . . . 62.13 108.802 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -113.78 123.43 49.83 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.491 -0.929 . . . . 62.03 108.491 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -89.79 125.22 35.22 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.54 -0.541 . . . . 75.43 109.54 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 389' ' ' LYS . . . . . 0.763 ' HZ2' ' HB2' ' A' ' 389' ' ' LYS . 7.2 mtmp? -114.84 133.31 22.62 Favored Pre-proline 0 C--N 1.307 -1.26 0 N-CA-C 108.159 -1.052 . . . . 73.33 108.159 176.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.425 ' O ' ' HB3' ' A' ' 391' ' ' ASP . 3.3 Cg_exo -85.76 128.47 3.35 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.769 1.646 . . . . 64.22 109.517 172.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.425 ' HB3' ' O ' ' A' ' 390' ' ' PRO . 2.0 p30 158.43 159.25 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.055 -1.461 . . . . 74.15 107.055 -175.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 20.3 p -126.68 23.9 6.67 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.456 0.646 . . . . 62.14 110.165 177.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 39.5 m -90.85 -37.72 13.41 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 108.624 -0.88 . . . . 70.44 108.624 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 37.6 mm -89.71 141.89 28.81 Favored Pre-proline 0 N--CA 1.432 -1.332 0 N-CA-C 106.666 -1.605 . . . . 73.4 106.666 178.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -51.39 161.04 2.0 Favored 'Trans proline' 0 CA--C 1.56 1.782 0 C-N-CA 123.267 2.645 . . . . 64.24 113.606 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -54.65 162.89 4.31 Favored 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 124.675 3.584 . . . . 72.05 114.155 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' ASP . . . . . 0.616 ' O ' ' HB3' ' A' ' 370' ' ' SER . 5.9 p-10 -56.38 -9.88 0.8 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.381 1.473 . . . . 62.02 113.973 -172.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -67.62 145.89 54.4 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.185 -1.413 . . . . 73.21 107.185 176.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.43 HG13 ' HA ' ' A' ' 370' ' ' SER . 10.3 m -63.29 118.43 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 C-N-CA 119.298 -0.961 . . . . 75.11 112.324 -171.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.29 -34.75 7.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.226 -1.027 . . . . 64.14 108.226 178.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -156.59 157.62 28.09 Favored Glycine 0 N--CA 1.423 -2.174 0 N-CA-C 110.731 -0.948 . . . . 72.2 110.731 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 11.5 p -126.77 -178.21 4.3 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.811 -1.181 . . . . 63.12 107.811 175.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -100.5 139.44 20.63 Favored Pre-proline 0 C--N 1.296 -1.731 0 C-N-CA 119.596 -0.842 . . . . 61.44 109.364 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -52.8 -3.09 0.11 Allowed 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 124.599 3.533 . . . . 41.5 115.765 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.7 -37.19 65.52 Favored 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 122.947 0.499 . . . . 20.42 109.673 173.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -69.11 -41.06 77.93 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-O 121.666 0.746 . . . . 52.14 109.988 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -77.65 -1.24 30.02 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.261 -0.881 . . . . 60.11 110.563 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 75.2 m -98.68 147.07 25.22 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.345 -1.724 . . . . 74.13 106.345 172.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 34.8 m -74.23 112.05 10.0 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 107.385 -1.339 . . . . 52.42 107.385 175.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 23.1 m -133.27 169.64 21.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 121.28 0.562 . . . . 65.41 110.772 -176.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 10.1 t -84.29 154.98 22.63 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 106.557 -1.646 . . . . 75.41 106.557 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -67.91 108.13 2.91 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 121.369 0.604 . . . . 44.33 110.411 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 133.06 54.4 0.08 OUTLIER Glycine 0 N--CA 1.427 -1.952 0 CA-C-N 115.262 -0.881 . . . . 73.34 112.005 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -104.28 -173.2 2.25 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.035 -1.468 . . . . 51.22 107.035 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -115.42 125.63 53.38 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 118.97 0.805 . . . . 64.04 111.085 -176.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.6 mm -122.56 117.99 53.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 121.158 0.504 . . . . 55.13 110.03 177.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 23.8 p -95.26 127.83 41.62 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 123.108 0.563 . . . . 73.2 110.392 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 18.5 t -120.77 134.91 62.68 Favored 'Isoleucine or valine' 0 C--O 1.25 1.131 0 C-N-CA 123.786 0.834 . . . . 64.13 111.843 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -108.78 128.59 55.02 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-O 121.47 0.652 . . . . 74.25 111.008 174.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.506 HG13 ' CB ' ' A' ' 397' ' ' ASP . 2.9 t -106.52 144.2 16.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 C-N-CA 125.075 1.35 . . . . 64.34 110.843 -175.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 10.4 m -118.66 123.36 44.76 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 109.556 -0.535 . . . . 64.02 109.556 176.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 20.6 p -107.78 107.93 18.91 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 105.879 -1.897 . . . . 74.54 105.879 173.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -44.21 -88.12 0.01 OUTLIER Glycine 0 C--O 1.252 1.27 0 N-CA-C 116.858 1.503 . . . . 44.02 116.858 -170.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.5 128.84 16.85 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.65 2.233 . . . . 63.11 114.551 -172.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.424 ' HB2' HG12 ' A' ' 480' ' ' ILE . 14.0 mt-10 -102.4 136.42 42.26 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.44 -1.689 . . . . 64.53 106.44 174.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 33.8 tt0 -133.5 137.52 45.67 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 120.673 -0.411 . . . . 74.54 110.758 -178.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -127.89 159.61 34.38 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 121.097 0.475 . . . . 75.13 111.322 -178.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -103.59 139.0 39.48 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.067 -0.969 . . . . 72.51 109.027 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.74 ' HB ' ' O ' ' A' ' 474' ' ' ALA . 2.7 mp -90.11 124.04 64.33 Favored Pre-proline 0 C--N 1.319 -0.753 0 C-N-CA 119.578 -0.849 . . . . 64.44 109.123 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -66.69 148.37 82.89 Favored 'Trans proline' 0 C--O 1.24 0.604 0 C-N-CA 122.32 2.013 . . . . 75.31 111.393 177.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -76.37 103.89 6.61 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-O 121.491 0.663 . . . . 71.42 110.926 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 60.9 t -98.24 150.01 5.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 107.222 -1.399 . . . . 70.11 107.222 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 35.6 m -73.43 154.88 39.8 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 121.07 0.462 . . . . 54.13 111.055 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 434' ' ' THR . . . . . 0.564 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 33.5 p -68.3 -30.14 69.07 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 123.692 0.797 . . . . 74.02 112.403 -174.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 1.6 pp -80.09 -11.46 59.76 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 113.007 0.743 . . . . 73.54 113.007 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.414 ' HB ' ' HB3' ' A' ' 439' ' ' GLU . 0.9 OUTLIER -109.42 65.15 0.61 Allowed 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 113.582 0.956 . . . . 75.12 113.582 -178.595 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -59.01 -38.58 79.57 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.52 0.728 . . . . 74.24 111.908 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -62.48 -36.83 83.72 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.397 0.618 . . . . 74.42 110.548 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.414 ' HB3' ' HB ' ' A' ' 436' ' ' THR . 7.0 tp10 -70.12 -40.53 74.82 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.781 -0.822 . . . . 75.13 108.781 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.564 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -60.86 -51.13 70.61 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.8 -0.637 . . . . 41.44 111.269 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 32.5 m -64.26 -39.73 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 112.78 0.659 . . . . 73.1 112.78 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -68.43 -36.89 79.71 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 119.488 -0.885 . . . . 75.32 110.34 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -66.14 -38.29 87.75 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.96 -0.563 . . . . 61.31 110.936 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 93.7 mt -63.42 -36.3 83.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.157 0.504 . . . . 74.4 109.647 175.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.434 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 33.2 m -70.09 -43.81 70.33 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.579 -0.737 . . . . 70.01 110.444 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -66.96 -21.62 65.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.033 -0.53 . . . . 74.25 111.386 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.7 4.93 26.58 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.018 0.437 . . . . 53.4 111.418 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 448' ' ' GLY . . . . . 0.46 ' HA3' HD12 ' A' ' 480' ' ' ILE . . . 111.2 -84.94 0.38 Allowed Glycine 0 CA--C 1.484 -1.845 0 C-N-CA 120.525 -0.845 . . . . 64.11 111.793 175.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 449' ' ' PHE . . . . . 0.4 ' N ' HG23 ' A' ' 480' ' ' ILE . 2.0 p90 -38.53 -60.28 0.82 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.432 1.271 . . . . 74.02 114.432 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 450' ' ' GLY . . . . . 0.434 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 61.3 30.13 73.22 Favored Glycine 0 CA--C 1.501 -0.799 0 C-N-CA 121.22 -0.514 . . . . 74.33 112.047 -177.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.485 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 40.9 mmm-85 -104.37 110.92 23.35 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 108.477 -0.934 . . . . 74.5 108.477 -177.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -136.09 140.31 43.64 Favored 'General case' 0 N--CA 1.423 -1.778 0 CA-C-N 115.818 -0.628 . . . . 64.22 111.585 -176.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -131.67 140.04 49.23 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.936 -1.029 . . . . 54.42 108.238 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -109.33 129.28 55.53 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.128 0.49 . . . . 74.13 111.531 -176.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.88 150.67 40.7 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.112 -1.07 . . . . 51.33 108.112 176.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -121.97 140.68 52.16 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.762 -0.829 . . . . 71.1 108.762 -177.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 24.3 t -144.7 137.34 13.55 Favored Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 109.338 -0.616 . . . . 63.35 109.338 176.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 490' ' ' SER . 47.3 Cg_endo -71.03 134.56 25.55 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.939 1.759 . . . . 74.04 110.538 175.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 70.2 m -152.76 -179.42 7.61 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 122.801 0.44 . . . . 75.41 110.155 -177.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.2 t -47.64 137.28 9.75 Favored Pre-proline 0 C--O 1.254 1.316 0 C-N-CA 124.276 1.03 . . . . 71.23 110.899 173.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -52.81 -30.94 49.34 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 124.375 3.383 . . . . 51.33 113.451 -175.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -68.5 -26.79 65.64 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.712 0.634 . . . . 75.34 112.712 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -95.33 -15.78 22.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.935 0.398 . . . . 74.54 111.135 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 83.4 t -60.7 128.73 22.36 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 115.996 -0.547 . . . . 63.44 110.304 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.06 -11.23 60.42 Favored Glycine 0 N--CA 1.433 -1.531 0 CA-C-N 115.495 -0.775 . . . . 73.23 111.757 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -119.1 167.18 12.04 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.033 -0.729 . . . . 74.24 109.033 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.564 ' O ' ' HB ' ' A' ' 434' ' ' THR . 79.3 t -75.68 147.11 8.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.114 -1.439 . . . . 72.45 107.114 173.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 65.2 mt -97.88 -35.15 5.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 107.296 -1.372 . . . . 45.43 107.296 176.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 160.06 -160.38 31.57 Favored Glycine 0 N--CA 1.416 -2.682 0 N-CA-C 109.729 -1.348 . . . . 73.42 109.729 177.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 26.3 p -115.98 145.73 42.71 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 107.335 -1.357 . . . . 42.45 107.335 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -64.3 -56.15 25.61 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 119.968 -0.693 . . . . 61.34 110.401 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -80.69 149.49 18.42 Favored 'Trans proline' 0 C--N 1.37 1.699 0 N-CA-C 107.842 -1.638 . . . . 42.31 107.842 169.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -64.81 126.93 17.56 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.588 1.525 . . . . 63.41 113.039 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.74 ' O ' ' HB ' ' A' ' 429' ' ' ILE . . . -86.11 -34.67 20.56 Favored 'General case' 0 C--O 1.198 -1.631 0 CA-C-O 122.224 1.011 . . . . 63.34 108.383 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -72.21 12.37 0.44 Allowed 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.528 -1.215 . . . . 64.5 111.717 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -119.81 -165.49 1.18 Allowed 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 107.978 -1.119 . . . . 75.11 107.978 175.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.44 140.1 37.93 Favored 'General case' 0 N--CA 1.402 -2.874 0 CA-C-O 121.44 0.638 . . . . 62.33 111.883 -178.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 39.5 m -136.99 139.05 41.17 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.852 -0.613 . . . . 52.45 109.473 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -67.85 165.09 18.28 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.869 -0.605 . . . . 72.32 110.776 177.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.46 HD12 ' HA3' ' A' ' 448' ' ' GLY . 29.0 mm -70.57 -15.38 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 121.914 0.864 . . . . 70.12 110.616 -176.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.2 t -92.41 2.9 56.39 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.996 -0.547 . . . . 75.43 110.801 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -92.36 140.95 29.08 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.178 0.513 . . . . 73.14 111.798 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.485 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.3 p -108.31 127.07 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 CA-C-N 115.23 -0.895 . . . . 73.35 109.946 177.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 29.9 m -104.09 132.74 49.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-O 121.779 0.799 . . . . 72.01 111.029 178.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.72 124.25 55.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 115.258 -0.883 . . . . 75.2 110.552 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.443 HG23 HG13 ' A' ' 467' ' ' VAL . 1.7 mp -100.84 125.52 54.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 125.542 1.537 . . . . 61.23 108.671 -178.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 8.8 tt -107.03 126.41 63.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 109.479 -0.563 . . . . 65.42 109.479 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.447 HG12 HG22 ' A' ' 467' ' ' VAL . 33.6 m -110.29 151.21 12.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 116.18 -0.464 . . . . 61.3 110.7 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -83.58 121.58 5.53 Favored Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 109.43 -1.468 . . . . 61.13 109.43 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 23.3 t -141.07 128.99 21.82 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 108.28 -1.008 . . . . 42.45 108.28 -176.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 83.36 98.62 0.56 Allowed Glycine 0 N--CA 1.434 -1.454 0 C-N-CA 120.819 -0.705 . . . . 63.04 113.064 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -77.86 140.87 18.68 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.499 2.132 . . . . 70.35 110.923 177.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -94.77 26.58 3.47 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 122.422 1.106 . . . . 61.23 110.491 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 12.8 p -118.07 147.54 43.16 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 114.134 -1.394 . . . . 54.14 110.295 -178.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 495' ' ' LYS . . . . . 0.485 ' HD3' ' N ' ' A' ' 496' ' ' ASP . 6.8 tmtm? -150.6 140.2 21.6 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 105.559 -2.015 . . . . 73.1 105.559 175.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 11.4 p-10 -89.07 127.1 35.68 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.526 0.679 . . . . 72.32 111.179 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 28.3 pt -75.89 130.15 79.24 Favored Pre-proline 0 C--N 1.306 -1.321 0 CA-C-N 114.865 -1.061 . . . . 70.31 110.878 -177.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -85.61 -174.72 1.69 Allowed 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.342 2.028 . . . . 73.32 110.737 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -80.04 133.14 36.11 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.033 -1.099 . . . . 71.21 108.033 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 13.0 p -133.09 -7.25 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-O 121.551 0.691 . . . . 70.23 111.187 -174.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.97 114.8 9.39 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.273 0.559 . . . . 62.0 110.338 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 130.84 -21.94 4.63 Favored Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 109.685 -1.366 . . . . 44.14 109.685 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -87.08 168.9 12.86 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 109.285 -0.635 . . . . 74.24 109.285 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 47.5 p -85.59 162.32 18.91 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 109.817 -0.438 . . . . 52.41 109.817 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 18.8 m -54.24 -42.23 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.045 0 C-N-CA 123.667 0.787 . . . . 73.14 113.004 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -67.35 -42.27 83.78 Favored 'General case' 0 CA--C 1.507 -0.683 0 C-N-CA 120.643 -0.423 . . . . 73.31 110.856 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 97.7 t -69.74 -40.16 78.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.808 -0.633 . . . . 74.55 110.369 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.24 -49.4 74.32 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.55 -0.295 . . . . 52.12 111.026 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -63.11 -35.42 80.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.068 0.461 . . . . 63.24 110.121 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -62.47 -44.03 97.39 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.171 -0.922 . . . . 75.25 109.037 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -61.56 -49.0 78.4 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 109.723 -0.473 . . . . 71.12 109.723 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.89 -47.66 83.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.182 -0.463 . . . . 72.25 111.494 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -66.41 -39.19 88.83 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 112.231 0.456 . . . . 74.5 112.231 -176.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.43 -29.14 45.61 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 CA-C-O 121.164 0.507 . . . . 54.32 110.837 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 -87.11 -5.39 59.04 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.154 -0.618 . . . . 75.34 111.525 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 516' ' ' GLY . . . . . 0.444 ' O ' ' HB ' ' A' ' 547' ' ' VAL . . . 110.21 -4.7 30.05 Favored Glycine 0 CA--C 1.492 -1.369 0 C-N-CA 120.525 -0.845 . . . . 71.41 114.246 175.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.527 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 88.9 m-85 -77.8 119.0 20.68 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.849 -0.797 . . . . 64.45 108.849 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 17.0 p -89.9 -31.67 17.19 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 115.384 -0.826 . . . . 62.4 112.933 -174.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -108.59 119.23 38.92 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.681 0.753 . . . . 74.01 112.457 -172.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -130.32 145.82 51.83 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.071 -0.968 . . . . 73.31 109.442 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 61.2 m -141.23 142.89 33.92 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 108.319 -0.993 . . . . 53.12 108.319 175.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -117.55 135.3 54.04 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.501 -0.555 . . . . 71.14 109.501 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -124.05 119.44 29.51 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.973 -0.751 . . . . 74.43 108.973 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 524' ' ' SER . . . . . 0.549 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 55.1 m -84.77 130.85 34.62 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.512 0.672 . . . . 71.12 112.545 -177.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 28.0 m -121.86 150.63 25.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 106.648 -1.612 . . . . 65.01 106.648 173.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 526' ' ' ASP . . . . . 0.548 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 1.4 p-10 -92.71 137.14 32.62 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 117.839 -1.545 . . . . 64.3 110.483 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 49.0 m -150.28 -179.02 0.91 Allowed Pre-proline 0 C--N 1.293 -1.867 0 N-CA-C 106.111 -1.811 . . . . 72.43 106.111 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -87.04 -11.34 5.43 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 121.549 1.499 . . . . 41.43 111.033 171.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -69.15 127.75 92.88 Favored Pre-proline 0 N--CA 1.441 -0.919 0 N-CA-C 108.344 -0.984 . . . . 71.52 108.344 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -55.7 141.51 84.07 Favored 'Trans proline' 0 C--O 1.255 1.373 0 C-N-CA 122.982 2.454 . . . . 75.23 114.371 -171.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -59.67 125.94 25.64 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 114.313 -1.312 . . . . 72.5 110.949 -176.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 123.83 -19.26 7.44 Favored Glycine 0 N--CA 1.427 -1.962 0 C-N-CA 120.732 -0.747 . . . . 52.32 111.244 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -82.78 129.61 35.01 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.801 -0.444 . . . . 74.53 109.801 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 91.0 t -78.6 110.3 14.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 107.909 -1.145 . . . . 74.31 107.909 174.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 18.3 m -75.89 -34.62 59.97 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 123.892 0.877 . . . . 72.23 111.232 -176.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -173.65 179.91 44.73 Favored Glycine 0 CA--C 1.496 -1.143 0 N-CA-C 110.79 -0.924 . . . . 65.35 110.79 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 35.7 p -128.66 152.7 48.08 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.434 -0.58 . . . . 75.54 109.434 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -62.88 -57.47 21.39 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-O 119.174 -0.441 . . . . 70.33 110.99 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -75.5 139.39 22.97 Favored 'Trans proline' 0 C--N 1.369 1.618 0 CA-C-N 120.135 1.084 . . . . 73.12 109.858 171.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -71.35 142.79 41.87 Favored 'Trans proline' 0 C--O 1.251 1.141 0 C-N-CA 122.531 2.154 . . . . 70.23 112.963 -178.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -65.11 135.32 55.38 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.514 -0.766 . . . . 63.21 110.92 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.61 -18.91 34.46 Favored Glycine 0 N--CA 1.433 -1.5 0 CA-C-N 115.709 -0.678 . . . . 72.24 111.421 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 25.9 m -77.77 132.26 38.0 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.767 0.318 . . . . 75.44 111.094 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 36.0 m -81.92 122.56 27.91 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 107.645 -1.242 . . . . 73.04 107.645 176.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.5 m -134.81 159.5 71.92 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 109.601 -0.518 . . . . 64.35 109.601 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -67.29 137.55 43.92 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.334 2.023 . . . . 75.22 111.545 176.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.527 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 34.1 m -63.04 -19.97 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-O 121.863 0.84 . . . . 54.44 112.044 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -80.83 -12.24 59.47 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.072 -0.967 . . . . 65.22 111.856 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 8.5 t -81.78 171.94 13.94 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 120.33 -0.548 . . . . 73.21 111.653 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 44.4 t -99.0 122.38 50.65 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 CA-C-N 115.636 -0.711 . . . . 73.23 110.107 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 2.5 mp -102.6 124.06 56.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.175 -1.046 . . . . 64.33 108.175 175.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -102.02 123.47 45.97 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-O 121.167 0.508 . . . . 74.35 109.897 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 53.3 mt -98.26 120.99 39.62 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 114.534 -1.212 . . . . 72.44 108.872 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -83.23 119.73 24.93 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 106.69 -1.596 . . . . 70.03 106.69 173.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 524' ' ' SER . 45.0 t -113.06 129.32 68.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 N-CA-C 109.252 -0.647 . . . . 61.52 109.252 -177.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.563 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 23.8 p -82.55 146.87 28.95 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-O 120.884 0.373 . . . . 65.32 111.457 178.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.548 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 14.5 ptpt -97.18 152.52 18.74 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 103.732 -2.692 . . . . 74.51 103.732 167.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -80.18 -32.82 34.24 Favored Glycine 0 CA--C 1.491 -1.437 0 C-N-CA 119.408 -1.377 . . . . 73.45 111.186 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 64.2 t30 61.9 17.02 8.54 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.614 1.166 . . . . 62.41 110.575 176.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -144.76 158.96 43.58 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 107.969 -1.123 . . . . 64.33 107.969 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -143.53 148.59 36.21 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.838 -1.171 . . . . 73.05 107.838 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 61.1 t -76.13 116.06 18.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.741 -0.837 . . . . 55.41 108.741 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 563' ' ' MET . . . . . 0.406 ' HA ' ' HD3' ' A' ' 564' ' ' PRO . 54.0 ttp -89.96 138.21 27.79 Favored Pre-proline 0 C--N 1.298 -1.651 0 CA-C-N 115.761 -0.654 . . . . 73.11 111.156 -176.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 564' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 563' ' ' MET . 33.8 Cg_exo -63.51 170.47 8.19 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.321 2.681 . . . . 72.13 111.414 172.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 565' ' ' ASP . . . . . 0.481 ' HA ' ' HB1' ' A' ' 610' ' ' ALA . 25.1 t70 -84.33 115.14 22.34 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.04 0.448 . . . . 63.02 111.503 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 5.5 mp -125.89 -4.8 6.93 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.785 -0.643 . . . . 74.02 109.93 175.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 16.4 t -79.45 146.89 32.5 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 109.582 -0.525 . . . . 72.13 109.582 -176.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 91.14 3.53 69.82 Favored Glycine 0 C--N 1.312 -0.788 0 C-N-CA 120.83 -0.7 . . . . 51.32 112.231 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 85.8 mtp -100.72 177.64 4.93 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 107.332 -1.359 . . . . 75.21 107.332 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 570' ' ' PHE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 63.2 m-85 -80.47 160.16 25.35 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 119.675 -0.81 . . . . 72.5 110.124 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 78.0 t90 -62.89 -28.76 70.27 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.821 -0.807 . . . . 71.4 108.821 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 21.8 m -76.42 -10.01 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.1 -0.954 . . . . 74.41 111.049 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 573' ' ' ASP . . . . . 0.431 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 20.6 m-20 -96.04 -44.45 7.33 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 107.567 -1.272 . . . . 74.2 107.567 173.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -56.51 -48.69 76.67 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 114.613 -1.176 . . . . 64.23 111.783 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -50.88 -59.61 7.16 Favored Pre-proline 0 CA--C 1.555 1.162 0 N-CA-C 114.045 1.128 . . . . 75.35 114.045 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 576' ' ' PRO . . . . . 0.414 ' HD2' ' O ' ' A' ' 573' ' ' ASP . 39.9 Cg_exo -61.99 -41.5 36.19 Favored 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 121.5 1.467 . . . . 71.21 113.115 176.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.431 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 11.9 mmt180 -61.29 -41.01 96.25 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 120.575 0.226 . . . . 73.2 111.016 -177.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 8.8 mp -65.79 -47.17 76.03 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 120.95 0.405 . . . . 75.23 110.987 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -65.14 -34.98 79.68 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.279 -0.419 . . . . 65.22 111.151 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -67.74 -38.27 83.29 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.344 -0.389 . . . . 74.51 111.75 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 4.2 pp -83.4 2.23 37.51 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.564 0.697 . . . . 72.44 111.639 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 83.92 29.46 31.6 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.391 -0.822 . . . . 34.32 113.718 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -81.09 127.49 32.69 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 117.14 0.47 . . . . 72.31 110.399 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 57.0 m -142.87 90.89 2.24 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.393 -1.336 . . . . 73.21 107.393 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -142.21 -133.73 2.87 Favored Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 110.86 -0.896 . . . . 72.41 110.86 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 51.5 ttm -126.6 128.56 46.99 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.445 -0.576 . . . . 65.44 109.445 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 7.3 tt -100.92 114.99 29.36 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.374 -1.343 . . . . 72.01 107.374 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 588' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 621' ' ' THR . 28.6 t70 -119.33 112.39 19.37 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.711 0.767 . . . . 54.24 111.954 -178.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 589' ' ' LYS . . . . . 0.536 ' HE3' ' H ' ' A' ' 624' ' ' PHE . 1.5 tmtp? -87.92 112.84 22.98 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.241 -1.762 . . . . 75.54 106.241 176.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -80.72 -111.67 0.3 Allowed Glycine 0 C--O 1.25 1.095 0 C-N-CA 121.308 -0.473 . . . . 33.32 113.682 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -65.74 144.76 56.68 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 110.032 -0.358 . . . . 74.52 110.032 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 592' ' ' ASP . . . . . 0.502 ' OD1' ' HB2' ' A' ' 626' ' ' GLN . 4.5 t0 -116.25 152.14 34.4 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 120.088 -0.645 . . . . 73.41 110.029 -177.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 96.1 t -137.4 116.32 14.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 108.593 -0.892 . . . . 64.53 108.593 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 594' ' ' ASP . . . . . 0.479 ' HA ' ' HB3' ' A' ' 626' ' ' GLN . 7.2 p-10 -78.15 124.53 28.16 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.211 -0.449 . . . . 65.22 109.854 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -156.33 -9.56 0.1 Allowed 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 113.11 0.782 . . . . 72.13 113.11 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 104.92 41.5 1.96 Allowed Glycine 0 CA--C 1.505 -0.568 0 N-CA-C 109.069 -1.613 . . . . 45.35 109.069 -174.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 626' ' ' GLN . . . -56.95 -31.04 60.92 Favored Glycine 0 C--O 1.203 -1.789 0 C-N-CA 125.78 1.657 . . . . 74.14 115.004 -174.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 2.4 p -55.2 -24.82 29.08 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 113.148 0.796 . . . . 74.43 113.148 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -102.31 -12.52 17.88 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 111.975 0.361 . . . . 73.44 111.975 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -145.09 37.29 1.14 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.081 0.771 . . . . 74.25 113.081 -173.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -68.7 90.37 0.41 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 122.222 1.01 . . . . 42.33 111.15 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 602' ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 32.6 ttp85 -115.63 143.56 45.18 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.173 -1.376 . . . . 71.14 109.391 -176.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.48 130.02 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 106.757 -1.572 . . . . 73.34 106.757 176.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 94.6 t -96.46 -51.99 9.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 121.619 0.723 . . . . 70.22 109.065 -175.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -145.08 160.02 42.06 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 104.441 -2.429 . . . . 62.51 104.441 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 606' ' ' GLN . . . . . 0.53 ' HA ' ' O ' ' A' ' 621' ' ' THR . 13.8 pt20 -147.19 139.29 24.46 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 106.98 -1.489 . . . . 73.2 106.98 173.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . 0.255 93.9 m-20 -61.06 -42.67 87.66 Favored Pre-proline 0 C--N 1.306 -1.286 0 N-CA-C 114.668 1.359 . . . . 65.02 114.668 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -69.39 108.67 2.06 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 121.192 1.262 . . . . 74.31 109.946 171.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -70.74 135.23 27.64 Favored 'Trans proline' 0 C--O 1.25 1.113 0 C-N-CA 121.981 1.787 . . . . 54.11 112.403 -175.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 610' ' ' ALA . . . . . 0.481 ' HB1' ' HA ' ' A' ' 565' ' ' ASP . . . -67.69 134.76 51.65 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.573 -0.739 . . . . 54.43 109.538 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 86.67 -2.38 87.26 Favored Glycine 0 N--CA 1.434 -1.444 0 C-N-CA 120.707 -0.759 . . . . 52.23 112.466 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 9.6 m -111.54 161.72 15.89 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.488 -0.56 . . . . 63.21 109.488 -176.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -71.68 113.19 4.47 Favored Glycine 0 N--CA 1.435 -1.407 0 N-CA-C 110.084 -1.206 . . . . 65.43 110.084 174.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 32.3 m -107.74 143.05 18.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 123.065 0.546 . . . . 64.12 110.544 -177.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.474 HD21 HG22 ' A' ' 619' ' ' ILE . 23.8 p-10 -42.53 136.72 2.35 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 124.867 1.355 . . . . 73.44 112.079 176.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -58.71 -24.95 62.38 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 124.854 1.261 . . . . 73.41 110.014 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -55.67 -45.21 77.77 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.588 -0.733 . . . . 74.41 109.797 173.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 71.48 19.41 77.7 Favored Glycine 0 N--CA 1.423 -2.186 0 CA-C-N 115.649 -0.705 . . . . 71.44 112.396 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 619' ' ' ILE . . . . . 0.474 HG22 HD21 ' A' ' 615' ' ' ASN . 0.0 OUTLIER -69.7 119.78 16.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 107.879 -1.156 . . . . 73.32 107.879 -176.839 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.92 119.66 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.575 0 CA-C-O 122.345 1.069 . . . . 74.01 111.352 -170.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' A' ' 606' ' ' GLN . 0.2 OUTLIER -104.38 121.68 43.89 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-N 114.073 -1.421 . . . . 53.11 109.542 175.723 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 622' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 2.3 pt? -138.4 165.35 27.01 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 123.851 0.86 . . . . 73.05 110.345 -174.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 21.6 ttp85 -134.54 137.51 43.88 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 107.716 -1.216 . . . . 70.31 107.716 174.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.536 ' H ' ' HE3' ' A' ' 589' ' ' LYS . 35.3 p90 -141.52 157.76 44.72 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.862 -1.162 . . . . 73.52 107.862 176.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -56.9 150.94 27.01 Favored Glycine 0 C--N 1.314 -0.68 0 O-C-N 124.597 1.186 . . . . 33.42 114.711 -177.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 626' ' ' GLN . . . . . 0.502 ' HB2' ' OD1' ' A' ' 592' ' ' ASP . 60.7 tt0 . . . . . 0 C--N 1.302 -1.468 0 C-N-CA 124.741 1.216 . . . . 73.2 108.472 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.615 0 N-CA-C 110.537 -1.025 . . . . 63.11 110.537 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 9.2 tp -74.25 126.88 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.558 0 CA-C-O 121.668 0.747 . . . . 74.45 108.993 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 2.7 m -99.84 145.07 28.17 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 115.654 -0.703 . . . . 73.13 109.231 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.95 -33.29 0.93 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.174 0.512 . . . . 75.4 109.721 176.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -107.34 122.47 46.65 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 105.54 -2.022 . . . . 73.2 105.54 170.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 31.8 m -117.56 164.34 13.94 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 N-CA-C 109.836 -0.431 . . . . 63.34 109.836 -172.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -92.43 136.36 33.27 Favored 'General case' 1 N--CA 1.378 -4.037 0 N-CA-C 106.458 -1.682 . . . . 74.33 106.458 175.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 72.2 t -96.96 121.22 59.84 Favored Pre-proline 0 C--N 1.255 -3.517 0 CA-C-N 114.576 -1.193 . . . . 64.45 109.899 -171.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.48 114.81 3.78 Favored 'Trans proline' 0 N--CA 1.43 -2.231 0 C-N-CA 121.165 1.243 . . . . 71.34 109.877 174.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' ASP . . . . . 0.436 ' OD2' ' HB ' ' A' ' 402' ' ' THR . 8.1 p-10 -100.83 141.21 34.03 Favored 'General case' 0 C--N 1.272 -2.8 0 CA-C-N 115.18 -0.918 . . . . 71.0 109.728 -177.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.475 ' H ' HD21 ' A' ' 377' ' ' LEU . 38.2 t -89.23 15.69 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 CA-C-N 114.326 -1.307 . . . . 64.54 111.12 -171.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.467 ' HB2' HG22 ' A' ' 402' ' ' THR . 30.1 mtp180 -65.33 147.21 53.84 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.075 -0.966 . . . . 50.42 110.966 175.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 367' ' ' GLY . . . . . 0.576 ' H ' ' HB ' ' A' ' 399' ' ' VAL . . . 107.7 -6.14 35.39 Favored Glycine 0 C--N 1.307 -1.049 0 N-CA-C 110.956 -0.858 . . . . 63.44 110.956 -171.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -110.58 -154.0 0.53 Allowed 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 107.215 -1.402 . . . . 75.52 107.215 170.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 78.4 p -82.77 162.45 21.7 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 118.872 0.76 . . . . 74.1 109.305 -176.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 54.6 p -57.18 -46.67 82.61 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 123.265 0.353 . . . . 73.12 110.528 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.82 -46.24 82.8 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 116.086 -0.506 . . . . 52.01 112.226 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -67.07 -42.61 84.39 Favored 'General case' 0 C--O 1.255 1.349 0 CA-C-O 121.663 0.744 . . . . 72.15 109.673 -176.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.05 -51.14 63.18 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.751 -1.113 . . . . 75.34 110.795 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 74.6 mt -60.13 -43.29 92.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 CA-C-N 116.284 -0.417 . . . . 62.1 111.137 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.51 -44.38 89.44 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 123.63 0.581 . . . . 71.35 110.849 -177.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 376' ' ' THR . . . . . 0.52 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 12.9 m -69.1 -46.81 66.8 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 116.013 -0.54 . . . . 75.12 111.359 -178.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.475 HD21 ' H ' ' A' ' 365' ' ' VAL . 4.5 mm? -59.66 -43.03 94.1 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 120.647 0.261 . . . . 74.15 111.486 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -64.42 -42.29 96.12 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.11 -0.495 . . . . 73.5 110.516 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -69.07 -17.82 63.92 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 111.941 0.348 . . . . 74.03 111.941 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 376' ' ' THR . 22.1 mmm180 -90.0 -11.76 40.64 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.183 0.516 . . . . 64.53 110.826 176.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.17 9.18 48.89 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.178 -1.01 . . . . 72.31 112.546 177.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -90.68 159.36 16.42 Favored 'General case' 0 N--CA 1.415 -2.223 0 N-CA-C 109.514 -0.551 . . . . 72.23 109.514 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.411 ' HB2' ' HG2' ' A' ' 415' ' ' GLU . 92.0 mttt -105.91 158.11 17.01 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 109.065 -0.717 . . . . 75.32 109.065 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.466 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -132.64 150.97 33.74 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.523 0 N-CA-C 108.19 -1.041 . . . . 71.33 108.19 177.946 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -118.28 126.88 53.05 Favored 'General case' 0 C--N 1.273 -2.741 0 N-CA-C 105.421 -2.066 . . . . 64.15 105.421 173.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 28.0 m -118.79 119.97 35.98 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 109.527 -0.546 . . . . 54.12 109.527 -173.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -112.15 125.59 54.29 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.369 -0.604 . . . . 64.32 109.369 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 13.1 pm0 -100.31 121.92 42.26 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.175 -0.676 . . . . 74.0 109.175 177.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -120.86 117.52 30.97 Favored Pre-proline 0 C--N 1.304 -1.41 0 CA-C-N 115.674 -0.694 . . . . 71.44 110.222 -172.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -87.68 129.87 2.64 Favored 'Trans proline' 0 C--O 1.254 1.282 0 C-N-CA 122.27 1.98 . . . . 74.41 111.291 176.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.503 ' HB3' HG12 ' A' ' 394' ' ' ILE . 27.1 t70 176.85 162.47 0.43 Allowed 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.483 -0.562 . . . . 73.04 109.483 -177.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 7.7 m -89.64 -14.61 34.5 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 113.047 0.758 . . . . 73.31 113.047 -175.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 10.1 t -123.04 8.52 9.26 Favored 'General case' 0 C--O 1.249 1.079 0 C-N-CA 118.519 -1.272 . . . . 72.21 113.06 -175.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.503 HG12 ' HB3' ' A' ' 391' ' ' ASP . 33.6 mm -88.36 133.76 35.95 Favored Pre-proline 0 C--N 1.31 -1.151 0 N-CA-C 107.214 -1.402 . . . . 45.54 107.214 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 395' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 396' ' ' PRO . 11.0 Cg_endo -53.58 145.56 47.3 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.483 2.789 . . . . 73.21 114.429 -178.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 396' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 395' ' ' PRO . 81.1 Cg_exo -55.32 162.08 6.36 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 123.758 2.972 . . . . 63.21 111.804 175.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 397' ' ' ASP . . . . . 0.409 ' CB ' HG13 ' A' ' 420' ' ' VAL . 2.9 p-10 -57.21 -8.69 0.76 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.476 1.11 . . . . 71.42 113.311 -175.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 398' ' ' HIS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 46.1 m170 -76.62 124.85 28.25 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.825 -1.176 . . . . 75.21 107.825 175.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.576 ' HB ' ' H ' ' A' ' 367' ' ' GLY . 8.9 t -76.48 132.43 33.01 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.577 0 CA-C-N 115.508 -0.769 . . . . 74.41 111.041 -167.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 28.9 pt -98.58 -27.97 3.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 114.959 -1.019 . . . . 64.14 113.504 -175.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.52 174.2 25.62 Favored Glycine 0 CA--C 1.503 -0.711 0 N-CA-C 110.439 -1.064 . . . . 73.32 110.439 -173.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.467 HG22 ' HB2' ' A' ' 366' ' ' ARG . 60.2 p -111.14 -178.67 3.52 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 118.164 0.982 . . . . 72.24 111.391 -174.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 403' ' ' ASP . . . . . 0.459 ' CB ' HG23 ' A' ' 416' ' ' ILE . 7.6 t70 -110.72 129.03 24.39 Favored Pre-proline 0 C--N 1.314 -0.96 0 N-CA-C 109.231 -0.655 . . . . 41.23 109.231 -176.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.67 -26.63 66.27 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 123.358 2.705 . . . . 53.23 113.804 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.95 -42.22 75.88 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.942 -0.572 . . . . 61.05 110.347 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -79.97 -31.84 39.86 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 121.688 0.756 . . . . 64.42 110.485 -178.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -84.74 2.39 42.25 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.721 -0.672 . . . . 71.21 111.099 -173.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 25.4 m -109.82 154.23 23.29 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.293 -1.743 . . . . 75.11 106.293 172.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 26.7 m -74.91 113.01 11.72 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 119.58 -0.848 . . . . 60.04 109.295 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 30.9 m -129.99 169.2 21.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-O 120.815 0.341 . . . . 61.5 110.283 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 33.5 m -69.75 143.45 53.02 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.17 -1.048 . . . . 40.41 108.17 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -68.04 109.03 3.31 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.174 0.512 . . . . 74.24 110.505 -177.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 129.97 69.1 0.11 Allowed Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 110.367 -1.093 . . . . 72.05 110.367 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -130.16 -175.38 3.61 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.227 -1.397 . . . . 73.52 107.227 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 415' ' ' GLU . . . . . 0.411 ' HG2' ' HB2' ' A' ' 383' ' ' LYS . 43.8 mt-10 -114.49 132.62 56.22 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.355 0.598 . . . . 75.43 111.342 -176.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 416' ' ' ILE . . . . . 0.459 HG23 ' CB ' ' A' ' 403' ' ' ASP . 36.4 mm -112.14 115.4 49.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 106.707 -1.59 . . . . 71.4 106.707 177.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 54.5 m -91.61 118.6 30.76 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.157 0.503 . . . . 54.15 111.987 -172.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 14.1 p -110.71 135.06 50.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 C-N-CA 124.294 1.038 . . . . 61.13 111.32 -175.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -102.53 116.1 31.91 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.05 -0.722 . . . . 74.22 109.05 176.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 72.6 t -108.54 131.63 58.61 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 106.66 -1.607 . . . . 72.14 106.66 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 421' ' ' SER . . . . . 0.413 ' OG ' ' HB ' ' A' ' 394' ' ' ILE . 33.0 t -119.79 137.12 54.16 Favored 'General case' 0 C--N 1.288 -2.096 0 C-N-CA 119.276 -0.969 . . . . 65.11 111.93 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.1 p -96.1 156.33 16.38 Favored 'General case' 0 N--CA 1.408 -2.564 0 N-CA-C 106.148 -1.797 . . . . 70.03 106.148 170.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -66.42 -162.71 1.31 Allowed Glycine 0 C--O 1.262 1.886 0 N-CA-C 116.073 1.189 . . . . 75.34 116.073 -172.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.41 137.39 80.12 Favored 'Trans proline' 0 CA--C 1.503 -1.028 0 C-N-CA 123.626 2.884 . . . . 71.21 111.459 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.467 ' O ' HG12 ' A' ' 480' ' ' ILE . 28.7 mt-10 -74.87 145.5 42.7 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-O 121.897 0.856 . . . . 75.44 111.524 -177.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.441 ' HG2' ' HA ' ' A' ' 479' ' ' ALA . 45.9 mt-30 -134.06 142.63 47.63 Favored 'General case' 0 N--CA 1.409 -2.52 0 N-CA-C 107.277 -1.379 . . . . 72.52 107.277 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.559 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 3.4 mmp_? -122.91 147.63 46.38 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-O 121.217 0.532 . . . . 74.04 110.881 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.423 ' HG2' ' H ' ' A' ' 428' ' ' GLU . 8.9 pt-20 -83.36 133.68 34.94 Favored 'General case' 0 C--N 1.272 -2.792 0 CA-C-N 114.61 -1.177 . . . . 71.21 107.98 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.52 ' HB ' ' O ' ' A' ' 474' ' ' ALA . 63.5 mt -80.51 125.57 80.5 Favored Pre-proline 0 N--CA 1.429 -1.5 0 C-N-CA 120.121 -0.631 . . . . 72.34 109.461 -175.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.88 146.11 52.38 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 122.28 1.987 . . . . 54.42 111.014 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -78.9 144.56 34.79 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.718 -0.845 . . . . 74.41 108.718 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.473 HG11 ' HB2' ' A' ' 440' ' ' ALA . 13.1 p -143.25 160.87 17.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 108.379 -0.971 . . . . 72.41 108.379 -175.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 19.2 m -68.89 138.0 54.31 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 108.486 -0.931 . . . . 75.25 108.486 174.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 35.2 p -69.21 -29.57 67.55 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 123.088 0.555 . . . . 53.34 111.612 -175.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.2 pp -80.32 -10.47 59.75 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.103 0.477 . . . . 73.23 111.611 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 5.1 m -105.95 57.41 0.66 Allowed 'General case' 0 CA--C 1.566 1.562 0 CA-C-O 121.669 0.747 . . . . 64.2 110.609 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.26 -38.42 58.13 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.465 1.106 . . . . 73.23 112.0 175.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.82 -42.81 85.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.189 0.519 . . . . 70.41 110.764 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -71.59 -35.44 70.53 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 116.02 -0.536 . . . . 75.3 110.517 178.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.509 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -59.5 -51.31 70.41 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.548 -0.296 . . . . 61.44 111.016 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 22.2 m -64.65 -36.96 78.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 CA-C-O 120.648 0.261 . . . . 74.22 111.441 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 37.9 tptt -59.39 -47.54 85.05 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.815 -0.63 . . . . 73.11 109.507 175.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -64.97 -37.92 89.26 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.762 -0.654 . . . . 74.32 112.258 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 90.1 mt -63.39 -37.23 86.49 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.883 -0.414 . . . . 72.41 109.883 175.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.428 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 28.5 m -67.77 -44.55 77.16 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.958 -0.564 . . . . 60.23 109.972 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.13 -16.09 62.53 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.445 -0.798 . . . . 74.22 112.14 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 447' ' ' ALA . . . . . 0.482 ' O ' ' HG3' ' A' ' 427' ' ' ARG . . . -87.87 5.82 38.5 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.005 0.431 . . . . 75.2 111.666 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 448' ' ' GLY . . . . . 0.436 ' HA3' HD12 ' A' ' 480' ' ' ILE . . . 107.14 -73.57 0.21 Allowed Glycine 0 CA--C 1.491 -1.457 0 C-N-CA 120.006 -1.092 . . . . 23.01 111.883 175.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 449' ' ' PHE . . . . . 0.436 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 1.3 p90 -42.43 -65.97 0.41 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.806 1.039 . . . . 71.4 113.806 176.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 450' ' ' GLY . . . . . 0.428 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 62.9 17.34 58.27 Favored Glycine 0 C--N 1.317 -0.479 0 C-N-CA 121.447 -0.406 . . . . 64.34 112.545 -176.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 16.4 mmm-85 -93.07 110.73 22.21 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 106.416 -1.698 . . . . 71.24 106.416 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.526 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 15.4 p90 -141.03 150.12 42.6 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-O 121.066 0.46 . . . . 75.43 111.69 -177.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -132.22 123.33 26.77 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.147 -1.057 . . . . 74.21 108.147 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -90.46 132.56 35.58 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.037 -0.727 . . . . 71.53 109.037 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 455' ' ' ALA . . . . . 0.433 ' O ' HD12 ' A' ' 487' ' ' ILE . . . -132.72 134.62 45.01 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 109.175 -0.676 . . . . 70.41 109.175 176.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 456' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 488' ' ' VAL . 34.7 p30 -118.98 139.54 51.51 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 120.961 0.41 . . . . 74.14 110.397 174.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 34.2 t -135.44 143.01 43.43 Favored Pre-proline 0 C--N 1.288 -2.084 0 N-CA-C 108.299 -1.0 . . . . 70.14 108.299 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 490' ' ' SER . 24.5 Cg_exo -65.56 132.31 30.61 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 121.728 1.619 . . . . 65.41 109.519 174.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 28.5 p -152.19 179.68 8.3 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 108.32 -0.993 . . . . 32.33 108.32 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.8 t -47.18 137.25 8.45 Favored Pre-proline 0 C--O 1.247 0.949 0 C-N-CA 123.732 0.813 . . . . 74.41 111.959 176.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.81 -29.38 34.14 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 124.533 3.488 . . . . 73.33 113.842 -176.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -64.17 -29.28 70.41 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 120.955 0.407 . . . . 64.43 111.403 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 79.7 mt -94.87 11.79 30.44 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 112.334 0.494 . . . . 62.31 112.334 -176.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 13.0 p -60.71 127.18 19.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 C-N-CA 120.156 -0.617 . . . . 73.25 110.022 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 76.38 2.29 73.45 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.347 -0.842 . . . . 72.33 113.308 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -107.83 139.74 41.97 Favored 'General case' 0 N--CA 1.413 -2.303 0 CA-C-O 121.39 0.614 . . . . 65.11 110.908 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 79.0 t -67.2 134.22 30.44 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 CA-C-N 114.005 -1.452 . . . . 65.2 107.6 173.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 55.6 mt -96.64 -28.32 3.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 108.278 -1.008 . . . . 61.31 108.278 -176.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 159.72 -164.01 33.91 Favored Glycine 0 N--CA 1.416 -2.695 0 N-CA-C 110.659 -0.977 . . . . 54.54 110.659 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 12.1 p -135.66 145.4 46.75 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 107.218 -1.401 . . . . 75.21 107.218 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -62.89 -52.74 61.53 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 119.799 -0.761 . . . . 64.43 110.495 177.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 473' ' ' PRO . 29.9 Cg_endo -69.45 134.82 29.59 Favored 'Trans proline' 0 C--N 1.366 1.497 0 N-CA-C 107.408 -1.804 . . . . 72.14 107.408 168.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.488 ' HB2' ' CG ' ' A' ' 476' ' ' GLN . 28.7 Cg_exo -61.84 127.75 22.37 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 121.623 1.549 . . . . 71.14 112.231 -175.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.52 ' O ' ' HB ' ' A' ' 429' ' ' ILE . . . -77.89 -3.68 42.92 Favored 'General case' 0 C--O 1.204 -1.338 0 CA-C-N 115.073 -0.967 . . . . 72.13 113.514 -171.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -110.25 0.56 18.17 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.244 -0.91 . . . . 72.43 111.174 174.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 476' ' ' GLN . . . . . 0.488 ' CG ' ' HB2' ' A' ' 473' ' ' PRO . 15.5 mm100 -100.22 -177.35 3.5 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.671 -0.695 . . . . 73.32 110.613 -176.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.38 130.26 35.78 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 115.979 -0.555 . . . . 63.24 109.906 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 41.3 t -124.56 142.19 51.54 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.698 -0.853 . . . . 43.31 108.698 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.441 ' HA ' ' HG2' ' A' ' 426' ' ' GLN . . . -72.7 152.87 41.45 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 112.586 0.587 . . . . 62.21 112.586 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 425' ' ' GLU . 43.2 mm -64.68 -24.97 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-O 121.835 0.826 . . . . 70.12 110.874 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 7.8 p -96.9 5.7 50.03 Favored 'General case' 0 C--N 1.291 -1.977 0 O-C-N 121.839 -0.538 . . . . 74.22 111.589 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -100.15 144.91 28.62 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.018 -0.537 . . . . 72.12 110.641 -174.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.8 p -94.48 127.38 46.52 Favored 'Isoleucine or valine' 0 C--O 1.249 1.039 0 CA-C-O 121.531 0.681 . . . . 62.0 112.367 -177.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 56.4 t -101.34 120.59 51.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 108.838 -0.801 . . . . 60.12 108.838 177.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.73 123.37 50.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-O 121.128 0.489 . . . . 54.13 109.747 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 29.2 mm -100.83 110.11 27.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 C-N-CA 124.789 1.236 . . . . 71.41 109.293 -177.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.433 HD12 ' O ' ' A' ' 455' ' ' ALA . 5.9 tp -99.44 126.9 52.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 109.349 -0.611 . . . . 72.33 109.349 177.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 456' ' ' ASN . 2.4 p -120.53 142.06 38.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 C-N-CA 123.946 0.898 . . . . 75.35 108.882 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -90.01 142.48 16.53 Favored Glycine 0 N--CA 1.431 -1.681 0 C-N-CA 120.666 -0.778 . . . . 63.12 113.567 -176.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 22.8 t -114.36 129.74 56.66 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.152 -1.795 . . . . 70.45 106.152 174.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -156.64 90.85 0.12 Allowed Glycine 0 C--N 1.304 -1.247 0 C-N-CA 119.183 -1.484 . . . . 54.22 112.846 -177.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -64.85 148.63 90.02 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 122.998 2.465 . . . . 60.33 113.395 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -147.43 37.5 0.92 Allowed 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 106.869 -1.53 . . . . 71.5 106.869 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.521 ' HB ' HG22 ' A' ' 544' ' ' THR . 1.0 OUTLIER -116.45 146.17 42.74 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 113.493 -1.685 . . . . 62.23 113.055 -169.902 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 495' ' ' LYS . . . . . 0.454 ' HA ' ' HE3' ' A' ' 495' ' ' LYS . 1.0 OUTLIER -142.26 146.68 35.38 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 124.468 1.107 . . . . 73.23 108.395 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 7.3 m-20 -80.42 131.15 35.55 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 109.134 -0.691 . . . . 55.04 109.134 176.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 35.1 pt -77.09 130.45 75.29 Favored Pre-proline 0 C--N 1.3 -1.552 0 C-N-CA 120.532 -0.467 . . . . 65.13 111.55 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 498' ' ' PRO . . . . . 0.457 ' HD2' HD13 ' A' ' 512' ' ' LEU . 41.7 Cg_endo -69.02 165.97 28.28 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.615 2.21 . . . . 71.52 111.029 175.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -92.8 147.33 22.94 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.832 -0.622 . . . . 62.43 110.695 -177.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.3 p -162.54 89.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 122.401 1.096 . . . . 45.11 110.829 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -137.53 114.48 10.67 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.14 -0.936 . . . . 71.3 108.743 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 101.11 17.51 22.41 Favored Glycine 0 N--CA 1.429 -1.791 0 N-CA-C 109.899 -1.281 . . . . 43.33 109.899 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 503' ' ' GLN . . . . . 0.477 ' OE1' HG11 ' A' ' 507' ' ' VAL . 44.7 mt-30 -124.65 174.23 8.0 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 108.044 -1.095 . . . . 63.43 108.044 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 9.4 t -92.2 168.16 11.54 Favored 'General case' 0 C--O 1.256 1.397 0 C-N-CA 119.694 -0.803 . . . . 63.14 110.791 -175.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 89.7 t -49.87 -41.38 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.832 1.253 . . . . 62.3 111.603 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -57.67 -39.25 76.64 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.556 -0.747 . . . . 62.55 111.381 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 507' ' ' VAL . . . . . 0.477 HG11 ' OE1' ' A' ' 503' ' ' GLN . 23.0 t -75.48 -38.54 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-N 115.686 -0.688 . . . . 71.22 110.107 -175.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 508' ' ' ALA . . . . . 0.436 ' O ' HD23 ' A' ' 512' ' ' LEU . . . -62.6 -49.76 73.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.624 -0.716 . . . . 63.35 110.998 -177.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.413 ' O ' ' HB2' ' A' ' 513' ' ' ASN . 17.7 pt20 -65.43 -35.83 82.11 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.318 -0.401 . . . . 73.2 110.862 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -50.7 67.92 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.734 -0.666 . . . . 63.42 109.837 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -62.01 -47.24 85.65 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 120.662 0.268 . . . . 75.04 111.125 -177.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 512' ' ' LEU . . . . . 0.457 HD13 ' HD2' ' A' ' 498' ' ' PRO . 4.3 mm? -63.93 -43.16 96.73 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.458 -0.337 . . . . 73.51 111.788 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 513' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 509' ' ' GLN . 36.9 t30 -60.07 -42.75 95.23 Favored 'General case' 0 N--CA 1.423 -1.816 0 C-N-CA 122.859 0.464 . . . . 42.11 111.384 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 48.9 t -59.5 -31.98 47.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 123.322 0.649 . . . . 72.24 111.653 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -85.59 -5.0 59.32 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 112.045 0.387 . . . . 71.44 112.045 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 116.87 -10.94 15.45 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 119.826 -1.178 . . . . 61.43 113.742 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -74.01 125.69 28.83 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 117.335 0.567 . . . . 75.21 111.589 -176.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 11.7 p -104.54 -23.98 13.07 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.479 -0.782 . . . . 74.54 112.0 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 519' ' ' LYS . . . . . 0.432 ' O ' HD13 ' A' ' 551' ' ' ILE . 10.0 mtmp? -111.46 114.69 27.97 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 120.322 -0.551 . . . . 74.31 110.757 -176.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -114.59 132.63 56.28 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.135 -1.061 . . . . 74.42 108.135 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 25.4 p -115.52 134.21 55.29 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 107.305 -1.369 . . . . 72.33 107.305 173.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -117.27 120.37 38.04 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 109.156 -0.683 . . . . 73.24 109.156 -175.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -106.68 138.52 42.69 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.802 -0.635 . . . . 41.54 109.845 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 57.2 m -92.52 123.9 36.17 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.513 -0.551 . . . . 70.2 109.513 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 60.6 t -120.88 148.43 24.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 106.845 -1.539 . . . . 73.51 106.845 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.53 135.96 38.26 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-O 120.965 0.412 . . . . 74.4 111.607 -178.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 527' ' ' SER . . . . . 0.429 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 38.7 m -154.13 172.5 5.72 Favored Pre-proline 0 N--CA 1.429 -1.521 0 N-CA-C 106.162 -1.792 . . . . 54.11 106.162 175.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -90.93 -0.91 4.98 Favored 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 121.938 1.759 . . . . 73.52 109.842 167.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.558 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 0.0 OUTLIER -78.31 132.6 65.8 Favored Pre-proline 0 C--O 1.216 -0.681 0 CA-C-N 114.912 -1.04 . . . . 64.13 109.229 178.406 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 530' ' ' PRO . . . . . 0.432 ' O ' ' HB2' ' A' ' 533' ' ' GLU . 31.2 Cg_exo -56.03 143.68 82.28 Favored 'Trans proline' 0 C--O 1.246 0.88 0 C-N-CA 123.1 2.534 . . . . 72.33 113.692 -175.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.61 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -56.7 132.01 50.76 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.287 -0.87 . . . . 72.31 111.045 -178.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 110.9 -8.91 29.64 Favored Glycine 0 C--N 1.306 -1.127 0 N-CA-C 110.357 -1.097 . . . . 72.34 110.357 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 533' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 530' ' ' PRO . 7.5 tp10 -82.62 125.55 31.32 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 106.811 -1.551 . . . . 71.24 106.811 178.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 91.2 t -89.1 110.03 20.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 107.564 -1.273 . . . . 73.03 107.564 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 535' ' ' THR . . . . . 0.485 HG23 ' HG3' ' A' ' 554' ' ' GLN . 11.4 t -78.32 -12.48 60.01 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.884 -0.598 . . . . 72.24 110.683 -176.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.98 -159.45 28.33 Favored Glycine 0 N--CA 1.428 -1.844 0 C-N-CA 120.952 -0.642 . . . . 72.01 111.743 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 40.7 p -117.67 148.52 41.89 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 107.323 -1.362 . . . . 73.41 107.323 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.455 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 51.0 t30 -66.07 -50.57 50.88 Favored Pre-proline 0 C--N 1.315 -0.908 0 C-N-CA 120.603 -0.439 . . . . 75.54 111.543 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.455 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 11.2 Cg_exo -75.8 141.55 24.53 Favored 'Trans proline' 0 C--N 1.367 1.525 0 N-CA-C 108.304 -1.46 . . . . 71.42 108.304 170.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.51 143.35 97.16 Favored 'Trans proline' 0 C--O 1.249 1.063 0 C-N-CA 122.068 1.845 . . . . 63.55 111.756 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.02 138.15 58.34 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.289 0.566 . . . . 30.44 111.818 -177.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 96.1 -10.35 67.78 Favored Glycine 0 C--N 1.308 -0.977 0 CA-C-N 115.942 -0.572 . . . . 74.34 112.439 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 42.8 m -70.77 134.4 47.38 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.506 -0.553 . . . . 61.22 109.506 178.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.521 HG22 ' HB ' ' A' ' 494' ' ' THR . 24.8 m -84.06 123.08 29.65 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 109.177 -0.675 . . . . 70.43 109.177 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.68 157.47 78.08 Favored Pre-proline 0 C--N 1.313 -0.982 0 N-CA-C 108.444 -0.947 . . . . 50.14 108.444 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -68.19 141.68 53.07 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.804 1.67 . . . . 74.24 111.045 176.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 35.0 m -65.14 -20.2 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-O 121.842 0.829 . . . . 52.32 110.443 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -74.37 -18.63 60.65 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.607 -1.178 . . . . 74.41 110.493 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.1 t -87.37 150.96 23.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.113 -1.069 . . . . 64.42 108.113 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 12.5 p -88.82 135.84 24.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.003 -1.11 . . . . 74.01 108.003 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 551' ' ' ILE . . . . . 0.571 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -96.33 145.9 8.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 C-N-CA 118.738 -1.185 . . . . 72.11 109.701 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -109.74 115.83 30.57 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-O 121.579 0.704 . . . . 74.33 110.857 -175.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -94.94 133.88 38.21 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 106.169 -1.789 . . . . 65.23 106.169 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 554' ' ' GLN . . . . . 0.485 ' HG3' HG23 ' A' ' 535' ' ' THR . 13.8 pt20 -108.48 116.45 32.0 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 122.099 0.952 . . . . 72.2 110.143 -177.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 54.6 t -103.7 139.68 23.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 CA-C-N 114.403 -1.271 . . . . 74.34 108.573 -175.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.61 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 73.5 m -82.4 136.52 34.94 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-O 122.068 0.937 . . . . 64.5 113.006 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -85.18 139.45 31.67 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 104.5 -2.408 . . . . 74.13 104.5 167.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 558' ' ' GLY . . . . . 0.558 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -83.18 -43.87 7.3 Favored Glycine 0 CA--C 1.484 -1.845 0 C-N-CA 119.768 -1.206 . . . . 61.42 113.547 -174.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 64.46 18.72 11.5 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 112.69 0.626 . . . . 71.44 112.69 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -124.21 145.75 49.14 Favored 'General case' 0 N--CA 1.417 -2.111 0 C-N-CA 120.283 -0.567 . . . . 72.25 110.547 -169.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -139.54 153.06 47.36 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.883 -0.784 . . . . 65.43 108.883 174.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 8.9 p -78.17 125.4 37.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.448 0.642 . . . . 74.03 112.446 -173.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 52.8 ttp -97.34 130.81 28.63 Favored Pre-proline 0 C--O 1.248 1.009 0 CA-C-N 115.92 -0.582 . . . . 73.44 111.065 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -74.22 170.49 20.05 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.939 2.426 . . . . 64.1 111.298 174.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -69.36 120.07 14.61 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.51 0.671 . . . . 71.11 110.902 177.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 87.2 mt -104.05 -7.04 20.57 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.647 -0.706 . . . . 75.12 110.102 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 47.4 m -66.65 132.01 47.22 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.598 -0.728 . . . . 72.14 109.875 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 93.91 -11.51 70.8 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.716 -0.754 . . . . 64.53 112.327 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 89.4 mtp -83.84 146.17 28.25 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.493 -0.558 . . . . 75.52 109.493 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -92.21 137.95 31.94 Favored 'General case' 0 N--CA 1.414 -2.247 0 N-CA-C 107.027 -1.471 . . . . 75.11 107.027 177.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 571' ' ' TRP . . . . . 0.453 ' HA ' ' HB3' ' A' ' 574' ' ' ALA . 41.1 t90 -57.84 -25.82 61.18 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 123.399 0.437 . . . . 63.44 111.916 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 14.3 p -64.16 -29.95 48.73 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-O 120.996 0.427 . . . . 74.21 110.831 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -101.3 -34.3 9.69 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-O 121.687 0.756 . . . . 72.23 109.452 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 574' ' ' ALA . . . . . 0.46 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -63.6 -40.31 96.61 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-N 115.168 -0.924 . . . . 70.13 111.875 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.458 ' O ' ' HG2' ' A' ' 579' ' ' ARG . 17.4 tp10 -51.4 -59.34 8.06 Favored Pre-proline 0 CA--C 1.562 1.421 0 C-N-CA 123.074 0.55 . . . . 73.31 112.047 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.46 -35.26 83.64 Favored 'Trans proline' 0 C--N 1.375 1.929 0 CA-C-N 120.684 1.28 . . . . 60.54 112.6 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.513 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 83.2 mmt-85 -66.51 -39.77 88.84 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 120.469 -0.492 . . . . 74.41 111.817 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 93.8 mt -65.89 -43.71 87.48 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.459 -0.337 . . . . 75.44 111.134 -177.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 579' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 29.5 mmt180 -65.04 -37.41 87.48 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.731 -0.47 . . . . 74.12 109.731 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.13 -31.16 71.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.441 -0.799 . . . . 73.31 111.422 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 581' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 99.1 mt -81.88 -7.81 59.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.399 -0.364 . . . . 54.43 111.531 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 87.13 34.47 10.71 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.698 -0.763 . . . . 53.45 111.855 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 44.4 t90 -86.67 127.67 34.96 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.574 -0.528 . . . . 72.43 109.574 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 13.9 m -133.16 28.28 4.12 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 122.618 1.199 . . . . 75.41 108.117 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -82.97 -164.78 36.37 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 114.883 -1.053 . . . . 74.24 112.065 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 55.0 ttp -108.93 130.98 55.46 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 122.615 -0.344 . . . . 73.44 110.463 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 41.7 tp -90.56 116.28 28.34 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.401 -1.333 . . . . 74.1 107.401 175.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -107.26 107.73 18.8 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.408 0.623 . . . . 74.24 111.574 -177.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -112.77 124.7 53.17 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.675 -1.232 . . . . 74.34 107.675 174.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -88.54 -120.56 1.7 Allowed Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 109.944 -1.262 . . . . 61.5 109.944 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -82.09 133.6 35.29 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.524 -0.917 . . . . 73.42 108.524 176.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -78.82 124.9 28.68 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.262 -1.014 . . . . 74.14 108.262 177.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 44.0 t -121.85 116.2 48.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 116.064 -0.516 . . . . 63.21 110.555 -174.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -90.46 107.64 19.29 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.495 -1.298 . . . . 73.31 107.495 176.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -132.01 4.46 4.13 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.763 -0.775 . . . . 54.43 111.603 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 116.11 -175.75 16.01 Favored Glycine 0 N--CA 1.424 -2.12 0 C-N-CA 120.403 -0.903 . . . . 74.05 111.051 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -58.69 -33.32 72.11 Favored Glycine 0 C--N 1.322 -0.196 0 C-N-CA 123.455 0.55 . . . . 41.32 114.18 -175.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 19.9 m -64.41 -27.56 69.09 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 120.9 0.381 . . . . 64.13 111.433 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -109.13 -1.44 18.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.981 0.419 . . . . 73.22 111.329 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -81.73 113.01 19.42 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 112.241 0.46 . . . . 62.31 112.241 -173.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 57.48 -2.11 0.06 Allowed 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 126.506 1.922 . . . . 62.3 115.46 172.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -96.54 145.98 25.22 Favored 'General case' 0 CA--C 1.501 -0.91 0 O-C-N 121.015 -1.053 . . . . 74.11 111.722 -174.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 97.8 t -65.43 130.04 30.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 107.045 -1.465 . . . . 71.42 107.045 173.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 87.9 t -89.02 -41.81 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-O 121.311 0.577 . . . . 62.43 110.061 -175.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -151.03 158.15 43.75 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.823 -1.177 . . . . 72.22 107.823 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -119.19 127.24 53.12 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 107.517 -1.29 . . . . 71.21 107.517 175.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.549 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 27.0 t-20 -54.53 -58.07 15.85 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-O 118.785 -0.626 . . . . 64.4 112.623 -179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.549 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 2.9 Cg_endo -84.44 136.49 6.53 Favored 'Trans proline' 0 C--N 1.363 1.305 0 CA-C-N 120.926 1.366 . . . . 74.21 109.921 174.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 609' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 608' ' ' PRO . 22.9 Cg_exo -63.94 158.62 46.36 Favored 'Trans proline' 0 C--O 1.243 0.755 0 C-N-CA 122.37 2.047 . . . . 75.21 111.882 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.59 130.42 42.98 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 116.305 -0.407 . . . . 72.12 109.94 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 98.16 -2.27 59.52 Favored Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 120.532 -0.842 . . . . 75.31 111.663 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 15.0 m -92.76 155.87 17.39 Favored 'General case' 0 C--O 1.253 1.25 0 N-CA-C 108.484 -0.932 . . . . 74.32 108.484 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -80.8 134.08 12.92 Favored Glycine 0 N--CA 1.415 -2.725 0 C-N-CA 120.883 -0.675 . . . . 42.21 112.211 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 28.8 m -110.61 142.95 21.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 C-N-CA 123.0 0.52 . . . . 64.13 109.715 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.419 HD21 HG22 ' A' ' 619' ' ' ILE . 5.2 p-10 -54.99 172.57 0.11 Allowed 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 125.545 1.538 . . . . 63.45 113.256 -178.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 616' ' ' ARG . . . . . 0.531 ' H ' ' HD2' ' A' ' 616' ' ' ARG . 1.5 mpt_? -48.22 -43.44 32.11 Favored 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 124.279 1.032 . . . . 73.14 112.462 -174.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -85.99 -19.22 30.7 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.966 -0.561 . . . . 72.44 111.43 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 81.31 21.98 61.49 Favored Glycine 0 CA--C 1.494 -1.227 0 C-N-CA 120.233 -0.984 . . . . 63.4 113.722 173.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 619' ' ' ILE . . . . . 0.419 HG22 HD21 ' A' ' 615' ' ' ASN . 0.0 OUTLIER -67.95 119.26 13.36 Favored 'Isoleucine or valine' 0 C--O 1.252 1.218 0 CA-C-O 123.549 1.642 . . . . 75.55 110.545 -171.472 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.41 HG12 ' HD2' ' A' ' 608' ' ' PRO . 0.0 OUTLIER -117.76 132.34 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.521 0 CA-C-N 112.257 -2.247 . . . . 75.45 106.036 -178.911 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 31.5 m -96.41 118.88 33.84 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.789 -0.819 . . . . 72.45 108.789 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 1.6 pp -130.34 165.5 22.39 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 113.518 -1.674 . . . . 63.21 109.178 -176.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 7.7 tpp180 -142.45 139.06 31.46 Favored 'General case' 0 C--N 1.269 -2.918 0 N-CA-C 105.86 -1.904 . . . . 54.35 105.86 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -139.67 149.45 43.71 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.332 -0.988 . . . . 60.33 108.332 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -75.14 -98.44 0.11 Allowed Glycine 0 N--CA 1.438 -1.182 0 O-C-N 123.764 0.665 . . . . 64.43 113.628 -173.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 . . . . . 0 N--CA 1.429 -1.512 0 N-CA-C 108.991 -0.744 . . . . 74.54 108.991 179.84 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.646 0 N-CA-C 110.596 -1.002 . . . . 62.13 110.596 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 11.2 tp -87.06 143.67 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-N 117.187 0.493 . . . . 72.51 109.889 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 20.2 m -110.11 152.16 26.35 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.497 -1.668 . . . . 61.13 106.497 174.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.496 ' HD2' ' H ' ' A' ' 358' ' ' ARG 0.304 0.0 OUTLIER -100.38 72.44 1.61 Allowed 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 122.389 1.09 . . . . 74.24 112.497 -176.96 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -96.97 143.74 27.55 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 106.112 -1.81 . . . . 72.42 106.112 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 32.3 m -117.75 136.74 53.94 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.525 0 N-CA-C 108.908 -0.775 . . . . 63.4 108.908 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -97.94 122.26 40.84 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 105.262 -2.125 . . . . 71.21 105.262 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.412 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 59.1 t -96.82 122.86 55.65 Favored Pre-proline 0 C--N 1.285 -2.207 0 CA-C-N 115.723 -0.671 . . . . 73.41 111.844 -166.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 363' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 23.6 Cg_exo -65.14 140.91 67.23 Favored 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 122.857 2.371 . . . . 51.31 112.001 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -91.63 141.99 28.1 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 115.636 -0.711 . . . . 75.54 109.94 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 12.1 t -119.97 25.96 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.459 0 CA-C-O 122.74 1.257 . . . . 73.51 108.884 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? -63.38 144.62 56.81 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.175 -0.92 . . . . 63.12 113.181 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 91.29 0.38 73.72 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.968 -0.635 . . . . 74.43 112.847 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -104.08 -81.86 0.51 Allowed 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 120.543 -0.463 . . . . 63.51 110.46 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 87.8 p -169.1 163.34 11.14 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 107.512 -1.292 . . . . 73.41 107.512 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 12.0 m -63.77 -41.0 98.05 Favored 'General case' 0 N--CA 1.422 -1.873 0 O-C-N 123.987 0.804 . . . . 64.15 109.15 176.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.25 -46.69 87.71 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 115.871 -0.604 . . . . 75.11 111.484 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -64.97 -43.66 91.91 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 120.972 0.415 . . . . 64.55 110.978 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 373' ' ' ALA . . . . . 0.404 ' O ' HD13 ' A' ' 377' ' ' LEU . . . -66.53 -47.6 72.39 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.841 -0.618 . . . . 45.31 110.622 -178.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 80.5 mt -67.15 -40.32 84.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.933 -0.122 . . . . 71.34 111.296 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.91 -41.72 98.25 Favored 'General case' 0 C--O 1.246 0.877 0 N-CA-C 112.399 0.518 . . . . 25.01 112.399 -177.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 376' ' ' THR . . . . . 0.408 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 21.2 m -67.19 -47.46 70.84 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.87 -0.605 . . . . 64.33 109.959 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.404 HD13 ' O ' ' A' ' 373' ' ' ALA . 10.8 mp -64.28 -38.21 90.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.918 -0.583 . . . . 74.13 111.508 178.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -60.29 -44.33 95.48 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 123.356 0.662 . . . . 73.24 109.722 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -70.26 -20.58 63.05 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 112.352 0.501 . . . . 72.54 112.352 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 376' ' ' THR . 35.2 mmt180 -85.52 -14.03 47.16 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.706 -0.398 . . . . 71.53 110.056 174.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 96.09 8.29 57.95 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.074 -0.584 . . . . 62.35 112.743 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -77.75 157.37 30.07 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 112.941 0.719 . . . . 74.33 112.941 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.444 ' HB2' ' HG2' ' A' ' 415' ' ' GLU . 27.4 mmtp -96.84 151.22 19.87 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.795 -1.093 . . . . 72.21 108.947 176.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.509 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 0.2 OUTLIER -129.94 136.39 59.01 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 CA-C-N 115.87 -0.604 . . . . 60.13 109.496 178.569 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -108.97 126.52 53.18 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 105.359 -2.089 . . . . 70.02 105.359 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 20.9 m -106.48 118.39 36.54 Favored 'General case' 0 C--N 1.282 -2.34 0 C-N-CA 120.351 -0.539 . . . . 74.41 110.429 -170.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -120.46 129.32 53.82 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.242 -1.021 . . . . 60.32 108.242 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -103.92 143.05 33.37 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.976 -0.379 . . . . 74.5 109.976 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -126.57 115.76 22.89 Favored Pre-proline 0 C--N 1.306 -1.289 0 N-CA-C 109.521 -0.548 . . . . 74.51 109.521 174.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.416 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 56.7 Cg_endo -98.46 129.76 0.23 Allowed 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.38 2.053 . . . . 75.52 112.526 175.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.591 ' HB3' HG12 ' A' ' 394' ' ' ILE . 9.7 t70 173.71 160.49 0.15 Allowed 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 109.302 -0.629 . . . . 75.21 109.302 174.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 35.3 t -75.57 -24.32 56.63 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.317 0.579 . . . . 75.34 110.084 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 3.3 m -83.42 -4.7 58.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.239 1.019 . . . . 64.31 108.986 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.591 HG12 ' HB3' ' A' ' 391' ' ' ASP . 15.1 mm -88.53 134.55 33.99 Favored Pre-proline 0 N--CA 1.427 -1.578 0 CA-C-N 114.568 -1.197 . . . . 53.45 110.367 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 395' ' ' PRO . . . . . 0.545 ' HG3' HD13 ' A' ' 400' ' ' ILE . 60.6 Cg_endo -66.14 -173.6 0.35 Allowed 'Trans proline' 0 CA--C 1.573 2.468 0 C-N-CA 125.003 3.802 . . . . 53.0 114.698 -176.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -58.47 159.41 19.9 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 122.872 2.381 . . . . 75.14 113.761 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -57.88 -9.81 1.47 Allowed 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 126.885 2.074 . . . . 74.33 113.362 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -90.18 177.38 6.45 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 116.112 -0.494 . . . . 63.14 111.56 -176.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 19.2 m -83.12 119.23 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 C-N-CA 120.51 -0.476 . . . . 62.54 110.912 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 400' ' ' ILE . . . . . 0.545 HD13 ' HG3' ' A' ' 395' ' ' PRO . 30.0 pt -86.77 -32.24 6.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.277 0.56 . . . . 73.42 109.707 177.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -147.99 170.36 28.64 Favored Glycine 0 N--CA 1.413 -2.845 0 N-CA-C 110.348 -1.101 . . . . 41.21 110.348 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.24 -179.42 3.63 Favored 'General case' 0 C--N 1.278 -2.54 0 CA-C-O 120.744 0.307 . . . . 64.5 110.678 178.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -102.1 129.74 25.73 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 107.974 -1.121 . . . . 72.01 107.974 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.94 -17.67 24.98 Favored 'Trans proline' 0 C--O 1.25 1.094 0 C-N-CA 124.01 3.14 . . . . 53.23 114.972 -173.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.5 -35.42 75.9 Favored 'General case' 0 C--O 1.21 -1.0 0 N-CA-C 109.657 -0.497 . . . . 51.11 109.657 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -69.33 -39.51 78.13 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.375 0.607 . . . . 33.1 110.265 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -75.65 -7.28 53.9 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.434 0.635 . . . . 72.23 110.987 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 29.6 m -98.67 153.91 18.35 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 106.998 -1.482 . . . . 74.21 106.998 174.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 61.0 m -75.07 113.04 11.94 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 118.974 -1.09 . . . . 53.25 109.104 176.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 18.7 m -121.24 169.81 12.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 122.867 0.467 . . . . 73.52 109.744 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 3.4 p -76.75 147.87 37.06 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 120.567 -0.453 . . . . 73.21 110.479 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -62.34 126.83 28.7 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 116.119 -0.492 . . . . 75.02 110.186 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 96.81 28.35 8.89 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 120.884 -0.674 . . . . 72.15 111.692 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -83.34 177.52 8.47 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.246 -1.02 . . . . 51.14 108.246 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 415' ' ' GLU . . . . . 0.444 ' HG2' ' HB2' ' A' ' 383' ' ' LYS . 39.0 mt-10 -111.3 108.94 18.72 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.216 0.531 . . . . 62.52 109.974 -174.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 416' ' ' ILE . . . . . 0.509 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 46.2 mm -102.22 129.13 54.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 115.215 -0.902 . . . . 74.2 108.83 -178.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 30.1 m -85.86 130.58 34.51 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.083 0.468 . . . . 72.11 111.205 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 7.5 p -110.81 134.87 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 107.676 -1.231 . . . . 72.31 107.676 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -110.76 122.19 47.21 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.069 0.461 . . . . 71.41 110.855 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 99.3 t -102.89 131.16 51.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 114.866 -1.061 . . . . 74.22 108.249 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 421' ' ' SER . . . . . 0.434 ' HB3' ' CG2' ' A' ' 394' ' ' ILE . 8.8 m -98.7 125.04 43.89 Favored 'General case' 0 C--N 1.274 -2.7 0 CA-C-N 115.358 -0.837 . . . . 63.4 110.112 -176.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 2.5 p -111.07 149.95 30.07 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.152 -0.685 . . . . 53.22 109.152 176.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -64.81 -162.46 0.68 Allowed Glycine 0 C--O 1.25 1.11 0 N-CA-C 116.098 1.199 . . . . 72.22 116.098 -172.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.56 139.97 83.02 Favored 'Trans proline' 0 C--N 1.362 1.271 0 C-N-CA 123.342 2.695 . . . . 60.32 111.365 -178.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.443 ' HG3' ' HA ' ' A' ' 391' ' ' ASP . 33.7 mt-10 -73.29 146.85 45.05 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 113.773 1.027 . . . . 72.52 113.773 -172.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 41.2 mt-30 -131.84 151.16 51.87 Favored 'General case' 0 N--CA 1.415 -2.181 0 CA-C-N 113.273 -1.785 . . . . 63.24 106.781 172.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -133.59 144.89 49.58 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-O 121.0 0.428 . . . . 74.33 110.497 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.45 ' H ' ' CD ' ' A' ' 428' ' ' GLU . 0.5 OUTLIER -83.74 133.34 34.79 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 107.899 -1.149 . . . . 63.41 107.899 176.406 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 63.1 mt -80.82 129.92 65.99 Favored Pre-proline 0 C--N 1.312 -1.052 0 CA-C-N 116.612 -0.267 . . . . 73.13 111.714 -172.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.93 147.13 54.66 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.206 1.937 . . . . 64.31 111.498 173.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -83.57 105.26 14.35 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.485 -0.561 . . . . 75.15 109.485 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 11.6 p -94.77 161.18 2.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 107.972 -1.122 . . . . 55.11 107.972 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.449 ' HB3' ' OG1' ' A' ' 436' ' ' THR . 29.7 t -83.86 157.52 21.97 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 108.964 -0.754 . . . . 72.13 108.964 177.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 32.0 p -70.2 -27.02 64.16 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 112.987 0.736 . . . . 74.24 112.987 -172.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.424 ' H ' HD23 ' A' ' 435' ' ' LEU . 0.6 OUTLIER -87.54 -13.77 42.05 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.313 0.577 . . . . 75.41 110.778 179.458 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.566 HG22 ' HB3' ' A' ' 439' ' ' GLU . 1.4 m -92.54 41.4 1.07 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.782 -0.645 . . . . 62.42 110.409 -175.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -53.07 -40.35 63.97 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.974 0.909 . . . . 62.23 112.273 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.14 98.73 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 120.812 0.339 . . . . 73.05 110.918 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.566 ' HB3' HG22 ' A' ' 436' ' ' THR . 31.4 tt0 -71.14 -34.92 71.48 Favored 'General case' 0 C--O 1.201 -1.489 0 C-N-CA 120.441 -0.503 . . . . 75.33 110.684 175.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.61 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -58.52 -51.34 70.3 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 122.219 0.208 . . . . 44.01 111.018 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 36.0 m -61.39 -37.78 78.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-O 121.211 0.529 . . . . 72.43 110.401 177.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -60.43 -47.46 86.02 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.641 0.776 . . . . 64.42 111.147 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -64.8 -38.31 90.55 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 123.318 0.647 . . . . 74.23 111.184 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 83.9 mt -63.76 -37.86 88.96 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.683 -0.488 . . . . 73.23 109.683 176.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.532 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 37.1 m -70.03 -42.92 72.31 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.902 -0.59 . . . . 73.23 110.32 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -65.15 -26.44 68.18 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.051 -0.522 . . . . 74.32 111.111 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -81.04 4.95 17.98 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.065 -0.516 . . . . 45.52 111.879 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 108.03 -67.94 0.22 Allowed Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.334 -0.936 . . . . 63.24 112.795 174.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 449' ' ' PHE . . . . . 0.519 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 1.8 p90 -50.54 -60.75 2.7 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.679 0.992 . . . . 73.43 113.679 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 450' ' ' GLY . . . . . 0.532 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 60.92 23.46 61.45 Favored Glycine 0 CA--C 1.499 -0.914 0 C-N-CA 121.255 -0.497 . . . . 72.03 112.203 -176.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.405 ' HB3' HG22 ' A' ' 483' ' ' VAL . 25.3 mmt180 -105.04 110.98 23.59 Favored 'General case' 0 N--CA 1.414 -2.258 0 N-CA-C 109.073 -0.714 . . . . 74.34 109.073 -178.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -131.97 143.32 50.02 Favored 'General case' 0 N--CA 1.415 -2.223 0 CA-C-N 114.608 -1.178 . . . . 74.04 110.192 -177.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -134.52 123.1 23.36 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 107.499 -1.297 . . . . 73.02 107.499 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -100.03 133.33 44.57 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.35 0.595 . . . . 73.23 111.901 -174.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -119.28 144.98 46.5 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 108.437 -0.949 . . . . 65.43 108.437 176.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -114.8 135.75 53.83 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.593 -0.892 . . . . 51.23 108.593 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 40.2 m -147.48 142.33 16.69 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 109.38 -0.6 . . . . 72.54 109.38 176.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.446 ' HA ' ' O ' ' A' ' 490' ' ' SER . 12.2 Cg_exo -70.17 131.62 21.01 Favored 'Trans proline' 0 C--O 1.247 0.948 0 C-N-CA 122.204 1.936 . . . . 50.21 111.555 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 56.4 m -149.75 -179.95 7.53 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.365 -0.976 . . . . 70.01 108.365 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 10.1 t -45.12 135.72 5.12 Favored Pre-proline 0 C--O 1.246 0.903 0 C-N-CA 124.015 0.926 . . . . 73.31 112.387 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.63 -30.39 36.4 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 124.363 3.375 . . . . 70.13 113.638 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -71.37 -23.45 61.9 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.57 0.581 . . . . 62.11 112.57 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 84.5 mt -99.74 -6.33 27.23 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.66 -0.416 . . . . 60.12 110.913 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 98.0 t -61.38 127.72 21.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 116.154 -0.475 . . . . 72.51 110.716 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 91.82 -3.59 77.92 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 115.614 -0.721 . . . . 72.02 111.661 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -118.19 166.37 12.67 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 108.278 -1.008 . . . . 35.05 108.278 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 93.8 t -76.12 145.7 10.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 108.306 -0.998 . . . . 74.5 108.306 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 68.5 mt -97.61 -35.25 5.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.262 -1.384 . . . . 64.23 107.262 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 159.68 -167.33 35.2 Favored Glycine 0 N--CA 1.423 -2.212 0 CA-C-N 115.356 -0.838 . . . . 70.33 111.012 176.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 470' ' ' THR . . . . . 0.656 HG22 HG12 ' A' ' 486' ' ' ILE . 72.8 p -116.2 144.85 43.64 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 106.969 -1.493 . . . . 73.51 106.969 178.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -67.1 -58.38 9.28 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 119.153 -1.019 . . . . 72.15 110.101 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 473' ' ' PRO . 31.3 Cg_endo -68.2 130.18 20.82 Favored 'Trans proline' 0 C--N 1.376 2.015 0 N-CA-C 106.364 -2.206 . . . . 61.14 106.364 168.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 472' ' ' PRO . 23.8 Cg_exo -61.82 138.6 75.22 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 121.55 1.5 . . . . 71.22 112.774 -172.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -75.85 11.17 1.48 Allowed 'General case' 0 C--O 1.202 -1.431 0 CA-C-N 115.324 -0.853 . . . . 53.12 111.468 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -109.56 -1.54 18.15 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.799 -0.637 . . . . 72.43 109.427 177.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 476' ' ' GLN . . . . . 0.401 ' HG2' ' HB2' ' A' ' 473' ' ' PRO . 85.7 mm-40 -94.24 172.55 8.14 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.867 -0.606 . . . . 43.41 111.778 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.438 HG22 ' HB3' ' A' ' 426' ' ' GLN . 1.9 m -99.42 108.16 20.57 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 107.994 -1.113 . . . . 71.4 107.994 -178.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 50.1 m -100.64 138.66 37.41 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 120.901 0.382 . . . . 61.41 110.815 -176.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -77.37 154.53 32.67 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.659 -0.7 . . . . 64.14 111.134 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.519 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 1.7 mp -65.32 -24.74 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-N 115.493 -0.776 . . . . 72.44 111.555 178.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 4.4 p -93.48 6.04 49.54 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.72 0.771 . . . . 74.1 111.565 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -107.88 131.71 54.22 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.693 -0.685 . . . . 55.01 111.435 -176.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.405 HG22 ' HB3' ' A' ' 451' ' ' ARG . 55.0 t -94.65 126.9 46.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.752 -0.658 . . . . 74.54 110.095 -177.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 34.4 m -98.36 133.7 39.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-O 121.51 0.672 . . . . 44.33 111.033 178.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.9 129.02 51.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.851 -0.613 . . . . 71.31 109.794 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.656 HG12 HG22 ' A' ' 470' ' ' THR . 4.9 mt -117.12 128.74 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 C-N-CA 124.43 1.092 . . . . 72.42 110.215 -176.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 5.8 tt -108.4 126.92 65.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-N 116.447 -0.342 . . . . 73.15 110.354 -177.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 34.6 m -111.43 152.0 13.42 Favored 'Isoleucine or valine' 0 C--O 1.252 1.236 0 CA-C-N 116.229 -0.441 . . . . 72.24 110.633 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.87 123.3 6.04 Favored Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 115.928 -0.578 . . . . 45.43 113.59 -176.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.446 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 31.0 t -101.89 153.72 19.59 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 107.728 -1.212 . . . . 54.42 107.728 177.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -92.62 179.19 40.06 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 120.914 -0.66 . . . . 63.41 113.751 -175.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.33 166.0 22.84 Favored 'Trans proline' 0 N--CA 1.443 -1.487 0 C-N-CA 122.644 2.229 . . . . 61.41 111.533 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 493' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . -90.36 119.73 30.89 Favored 'General case' 0 N--CA 1.41 -2.43 0 N-CA-C 107.513 -1.291 . . . . 52.0 107.513 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 51.5 p -116.59 143.36 45.71 Favored 'General case' 0 C--N 1.27 -2.859 0 N-CA-C 109.159 -0.682 . . . . 60.11 109.159 -178.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 495' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 544' ' ' THR . 10.3 ttpp -151.44 164.46 36.71 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 108.445 -0.946 . . . . 74.54 108.445 176.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 10.7 p-10 -79.67 136.54 36.83 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.85 -0.796 . . . . 62.04 108.85 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 40.6 pt -75.45 131.41 77.62 Favored Pre-proline 0 C--N 1.305 -1.355 0 N-CA-C 109.374 -0.602 . . . . 74.44 109.374 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -56.65 118.15 4.94 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.592 2.861 . . . . 65.3 114.285 -174.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -84.42 94.53 8.53 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-N 115.824 -0.625 . . . . 74.33 109.532 177.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.7 p -159.75 93.75 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-O 122.247 1.022 . . . . 62.1 110.947 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -108.09 162.84 13.68 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 107.862 -1.162 . . . . 75.1 107.862 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 98.1 23.38 13.17 Favored Glycine 0 C--N 1.295 -1.747 0 N-CA-C 108.967 -1.653 . . . . 63.25 108.967 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -129.38 165.5 21.39 Favored 'General case' 0 CA--C 1.471 -2.068 0 CA-C-N 114.402 -0.899 . . . . 70.35 109.336 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 6.9 m -88.67 156.44 19.01 Favored 'General case' 0 C--N 1.275 -2.67 0 C-N-CA 120.118 -0.633 . . . . 52.42 110.208 -173.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 12.2 p -50.53 -41.24 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 124.521 1.129 . . . . 72.35 113.522 -174.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -67.41 -39.67 85.54 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.372 0.606 . . . . 55.33 110.549 -178.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 48.8 t -70.37 -43.78 77.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.344 -0.844 . . . . 64.54 109.529 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -61.68 -47.11 86.81 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.226 -0.897 . . . . 50.42 112.26 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -64.2 -35.92 82.36 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.137 0.273 . . . . 72.51 110.708 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 52.5 tttm -58.69 -53.8 54.28 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.032 -0.531 . . . . 73.25 109.831 175.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -62.61 -41.69 99.13 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.286 -0.87 . . . . 74.14 110.914 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 9.0 tt -61.46 -47.87 83.72 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.955 -0.566 . . . . 73.33 110.408 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 513' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 12.8 m120 -66.68 -37.81 85.5 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 111.812 0.301 . . . . 70.23 111.812 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 54.4 t -62.74 -31.69 53.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.162 -0.472 . . . . 74.43 111.052 177.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -86.15 13.25 8.14 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 114.147 1.166 . . . . 74.03 114.147 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 102.07 -11.58 57.28 Favored Glycine 0 CA--C 1.499 -0.907 0 C-N-CA 119.925 -1.131 . . . . 54.11 114.214 171.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 88.8 m-85 -91.11 120.34 31.99 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.331 -0.618 . . . . 73.33 109.331 -177.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 22.7 p -97.96 -14.84 20.38 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 113.329 0.863 . . . . 72.12 113.329 -174.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -123.22 117.58 25.64 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.092 0.473 . . . . 63.43 112.102 -172.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -131.51 147.89 52.58 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.782 -0.645 . . . . 70.44 111.694 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 521' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 51.1 m -132.69 140.16 48.0 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.161 -1.422 . . . . 70.42 107.161 173.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 522' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 4.9 pp0? -117.77 128.77 55.2 Favored 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 119.945 -0.702 . . . . 74.24 112.191 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -111.92 143.53 42.74 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.443 -0.947 . . . . 54.21 108.443 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 524' ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 57.1 m -96.52 139.35 32.75 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 113.095 0.776 . . . . 54.32 113.095 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 40.6 t -122.22 159.14 25.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 106.778 -1.564 . . . . 73.42 106.778 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 526' ' ' ASP . . . . . 0.569 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 30.9 m-20 -85.0 134.58 34.22 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 107.741 -1.207 . . . . 62.03 107.741 177.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 527' ' ' SER . . . . . 0.539 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 19.0 m -153.57 178.3 1.65 Allowed Pre-proline 0 C--N 1.313 -1.016 0 N-CA-C 109.197 -0.668 . . . . 62.33 109.197 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -89.0 -8.32 4.92 Favored 'Trans proline' 0 CA--C 1.55 1.28 0 C-N-CA 122.47 2.113 . . . . 62.02 111.114 170.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.9 142.07 48.17 Favored Pre-proline 0 C--O 1.213 -0.861 0 N-CA-C 108.675 -0.861 . . . . 64.24 108.675 176.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -63.42 160.36 35.83 Favored 'Trans proline' 0 C--O 1.247 0.972 0 C-N-CA 122.558 2.172 . . . . 64.42 113.419 -176.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -58.38 118.44 5.56 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.038 -0.983 . . . . 53.22 110.334 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 121.36 -12.46 9.62 Favored Glycine 0 C--N 1.3 -1.465 0 C-N-CA 120.45 -0.881 . . . . 42.55 112.201 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -82.71 131.46 35.2 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.927 -0.768 . . . . 72.42 108.927 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.435 HG22 HG22 ' A' ' 555' ' ' VAL . 54.3 t -90.84 112.67 25.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.676 -0.861 . . . . 72.41 108.676 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 45.8 m -111.04 14.55 21.93 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 122.661 1.22 . . . . 73.41 111.611 -175.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 161.97 -173.84 38.35 Favored Glycine 0 CA--C 1.494 -1.26 0 C-N-CA 119.903 -1.141 . . . . 75.11 112.251 173.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 31.6 p -130.43 153.86 48.32 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.856 -1.165 . . . . 71.34 107.856 176.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -67.75 -54.74 16.13 Favored Pre-proline 0 C--N 1.309 -1.163 0 CA-C-O 119.31 -0.376 . . . . 54.52 111.25 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.32 153.39 45.37 Favored 'Trans proline' 0 C--N 1.371 1.717 0 N-CA-C 108.026 -1.567 . . . . 71.22 108.026 170.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.84 137.86 46.63 Favored 'Trans proline' 0 C--O 1.249 1.055 0 CA-C-N 120.119 1.078 . . . . 60.31 110.932 -177.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -69.68 137.78 52.4 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.735 -0.666 . . . . 55.22 110.396 -178.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.73 -14.34 59.01 Favored Glycine 0 C--N 1.303 -1.286 0 C-N-CA 120.61 -0.805 . . . . 52.3 111.726 -178.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 27.0 m -72.67 137.45 46.03 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 109.407 -0.59 . . . . 70.02 109.407 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 8.9 t -87.2 127.12 35.16 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-O 121.536 0.684 . . . . 74.44 110.124 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.3 m -138.96 162.46 52.38 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 107.738 -1.208 . . . . 73.45 107.738 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 47.0 Cg_exo -60.77 134.59 54.74 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 121.734 1.623 . . . . 63.2 109.784 173.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.405 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 26.9 m -63.57 -20.25 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 113.728 1.011 . . . . 63.12 113.728 -174.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -83.65 -4.47 58.62 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.395 0.617 . . . . 74.24 111.4 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 14.6 m -74.27 160.39 31.18 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.505 -0.554 . . . . 61.34 109.505 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 38.2 t -97.44 115.39 37.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.52 -0.548 . . . . 73.21 109.52 -178.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 61.2 mt -85.01 131.74 33.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 109.108 -0.701 . . . . 65.14 109.108 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 552' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 521' ' ' SER . 34.8 tt0 -103.03 116.2 32.07 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 108.296 -1.001 . . . . 73.42 108.296 176.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 553' ' ' LEU . . . . . 0.48 ' H ' HD23 ' A' ' 553' ' ' LEU . 1.6 pt? -103.76 134.73 46.59 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.493 -0.776 . . . . 64.41 109.285 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -102.05 118.3 36.6 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-O 122.797 1.284 . . . . 74.44 111.409 -175.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 524' ' ' SER . 92.3 t -105.01 136.28 39.44 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 CA-C-N 112.914 -1.948 . . . . 73.34 110.271 -172.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.539 ' HB3' ' HB2' ' A' ' 527' ' ' SER . 75.0 m -75.47 148.94 38.64 Favored 'General case' 0 C--N 1.27 -2.86 0 N-CA-C 113.584 0.957 . . . . 61.41 113.584 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.569 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 9.8 ptpp? -108.84 156.01 20.14 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 105.12 -2.178 . . . . 71.45 105.12 165.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -71.73 -27.59 70.62 Favored Glycine 0 CA--C 1.496 -1.126 0 C-N-CA 120.797 -0.716 . . . . 71.4 111.683 -177.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 62.6 t30 57.85 28.98 16.81 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 122.879 1.324 . . . . 73.51 109.84 173.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -145.8 154.41 41.99 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 105.785 -1.932 . . . . 74.14 105.785 -175.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -143.07 156.19 44.77 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 120.354 -0.538 . . . . 70.52 110.222 175.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 78.1 t -79.15 119.66 28.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 108.519 -0.919 . . . . 75.15 108.519 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 563' ' ' MET . . . . . 0.585 ' SD ' HD12 ' A' ' 620' ' ' ILE . 52.4 ttp -90.46 129.64 44.42 Favored Pre-proline 0 C--N 1.302 -1.488 0 CA-C-N 116.588 -0.278 . . . . 73.3 111.618 -176.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 564' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 563' ' ' MET . 19.5 Cg_exo -69.2 169.85 17.26 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.166 2.578 . . . . 64.32 111.649 174.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -77.23 139.38 39.85 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.83 -0.804 . . . . 64.53 108.83 177.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 25.5 tp -137.97 12.98 2.89 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.781 0.8 . . . . 74.34 109.546 -178.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 53.3 p -79.96 147.78 31.46 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.21 -0.45 . . . . 74.11 111.393 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 77.61 7.89 87.19 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.86 -0.686 . . . . 25.23 113.2 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 8.2 mmt -87.61 143.67 27.07 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.6 -0.889 . . . . 74.5 108.6 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -89.45 176.73 6.79 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 110.071 -0.344 . . . . 72.12 110.071 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -60.93 -34.14 74.25 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.999 -1.112 . . . . 74.51 107.999 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.6 m -73.72 -7.62 10.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.469 -1.241 . . . . 62.43 111.291 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -101.55 -44.06 5.7 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 108.866 -0.791 . . . . 74.04 108.866 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -53.75 -53.68 48.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.006 -0.997 . . . . 44.41 113.481 -175.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -65.45 -53.51 37.85 Favored Pre-proline 0 CA--C 1.553 1.093 0 N-CA-C 113.493 0.923 . . . . 73.21 113.493 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -60.27 -39.34 68.78 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 121.783 1.655 . . . . 75.15 112.196 177.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.561 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 30.2 mtt180 -68.95 -33.5 73.82 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 113.683 0.994 . . . . 72.31 113.683 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 6.8 tt -58.09 -50.19 74.34 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.663 -0.865 . . . . 74.13 108.663 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -68.23 -43.88 76.97 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.207 -0.906 . . . . 72.34 113.439 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -64.17 -40.42 96.07 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 113.389 0.885 . . . . 62.33 113.389 -175.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 581' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 577' ' ' ARG 0.308 3.7 pp -93.13 0.32 57.19 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.05 -1.06 . . . . 73.14 113.655 179.37 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 71.26 43.25 55.74 Favored Glycine 0 CA--C 1.504 -0.631 0 CA-C-N 115.986 -0.552 . . . . 75.12 112.395 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 22.4 t90 -73.21 126.85 31.02 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.073 -0.714 . . . . 74.32 109.073 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 2.5 m -105.76 2.38 27.85 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.753 -0.658 . . . . 70.21 110.491 -175.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -91.72 172.32 35.57 Favored Glycine 0 N--CA 1.436 -1.347 0 C-N-CA 120.594 -0.812 . . . . 73.55 112.433 -175.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 89.4 mmm -92.79 137.18 32.59 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.246 0.546 . . . . 74.11 111.665 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -83.0 128.19 34.25 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.623 -1.172 . . . . 74.54 108.113 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -95.39 103.37 15.23 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.992 -0.549 . . . . 73.41 109.81 -177.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 589' ' ' LYS . . . . . 0.482 ' HD3' ' CE2' ' A' ' 624' ' ' PHE . 52.4 tptt -112.51 110.76 21.14 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 109.107 -0.701 . . . . 62.42 109.107 176.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -91.37 -117.05 2.09 Favored Glycine 0 N--CA 1.428 -1.863 0 C-N-CA 120.512 -0.852 . . . . 63.12 112.313 178.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -84.03 155.64 22.63 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 123.132 0.573 . . . . 64.32 111.333 -177.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -94.21 124.45 38.23 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 109.657 -0.497 . . . . 73.04 109.657 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 49.9 t -125.91 127.62 71.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 107.7 -1.222 . . . . 54.51 107.7 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -73.73 121.14 20.33 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.478 -0.889 . . . . 62.54 108.924 176.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -118.95 -39.11 2.97 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.238 -0.892 . . . . 41.04 110.658 -175.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 60.5 -157.48 29.17 Favored Glycine 0 N--CA 1.423 -2.207 0 O-C-N 123.936 0.772 . . . . 62.31 111.339 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -65.33 -40.99 96.84 Favored Glycine 0 C--N 1.28 -2.528 0 N-CA-C 112.061 -0.415 . . . . 35.21 112.061 174.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 10.2 m -58.38 -40.53 82.55 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 113.121 0.786 . . . . 60.1 113.121 -171.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -108.85 -4.5 16.8 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 111.95 0.352 . . . . 74.43 111.95 177.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 65.8 m80 56.1 102.83 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.471 1.109 . . . . 73.45 113.263 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -77.15 80.25 3.67 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 122.711 1.243 . . . . 65.04 109.812 172.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -134.49 171.16 14.69 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.271 -1.751 . . . . 73.52 106.271 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 603' ' ' VAL . . . . . 0.425 HG11 HD22 ' A' ' 622' ' ' LEU . 76.1 t -61.08 129.67 24.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 107.58 -1.267 . . . . 64.54 107.58 173.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 97.6 t -87.25 -50.31 13.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-O 121.591 0.71 . . . . 71.01 109.27 -175.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -149.44 157.58 43.42 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 106.871 -1.529 . . . . 63.43 106.871 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 606' ' ' GLN . . . . . 0.517 ' HB2' HD11 ' A' ' 620' ' ' ILE . 17.0 pt20 -110.14 123.3 49.48 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 107.948 -1.131 . . . . 72.35 107.948 173.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.507 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 25.3 t-20 -48.58 -54.5 26.05 Favored Pre-proline 0 CA--C 1.553 1.084 0 N-CA-C 113.468 0.914 . . . . 70.22 113.468 -177.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.507 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 4.1 Cg_endo -90.26 138.74 2.83 Favored 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 121.473 1.448 . . . . 73.34 109.944 173.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 609' ' ' PRO . . . . . 0.445 ' HG2' ' OG1' ' A' ' 612' ' ' THR . 29.3 Cg_endo -67.92 147.57 74.67 Favored 'Trans proline' 0 C--O 1.249 1.066 0 C-N-CA 121.985 1.79 . . . . 71.0 113.13 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.55 133.63 49.79 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.283 -0.871 . . . . 62.33 110.456 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 95.96 -8.18 67.71 Favored Glycine 0 C--N 1.305 -1.181 0 C-N-CA 120.717 -0.754 . . . . 51.25 112.113 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 612' ' ' THR . . . . . 0.445 ' OG1' ' HG2' ' A' ' 609' ' ' PRO . 15.7 m -91.28 157.91 16.87 Favored 'General case' 0 C--O 1.256 1.434 0 N-CA-C 109.052 -0.721 . . . . 73.34 109.052 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -77.01 128.63 9.15 Favored Glycine 0 N--CA 1.428 -1.861 0 N-CA-C 111.425 -0.67 . . . . 72.05 111.425 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 614' ' ' VAL . . . . . 0.413 ' CG2' ' HB2' ' A' ' 563' ' ' MET . 33.4 m -122.16 144.19 32.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 C-N-CA 123.528 0.731 . . . . 72.1 110.49 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -39.53 144.23 0.18 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 125.816 1.647 . . . . 70.45 112.115 174.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 616' ' ' ARG . . . . . 0.496 ' HG3' ' N ' ' A' ' 617' ' ' ASP . 3.2 ptp180 -54.9 -28.43 50.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 123.773 0.671 . . . . 75.01 111.021 -178.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 617' ' ' ASP . . . . . 0.496 ' N ' ' HG3' ' A' ' 616' ' ' ARG . 21.2 t70 -60.05 -42.06 93.65 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.783 -1.098 . . . . 74.5 109.652 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 87.08 12.54 67.88 Favored Glycine 0 N--CA 1.413 -2.846 0 CA-C-N 115.012 -0.995 . . . . 33.11 113.363 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 619' ' ' ILE . . . . . 0.466 ' HB ' ' OD2' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -69.4 119.76 15.89 Favored 'Isoleucine or valine' 0 C--O 1.251 1.143 0 CA-C-N 118.604 1.202 . . . . 61.45 109.631 -177.398 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.585 HD12 ' SD ' ' A' ' 563' ' ' MET . 4.1 tt -124.81 132.64 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.223 0 CA-C-N 113.287 -1.779 . . . . 73.41 107.581 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 87.6 m -96.64 122.37 39.5 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 121.814 0.816 . . . . 51.13 109.707 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 622' ' ' LEU . . . . . 0.425 HD22 HG11 ' A' ' 603' ' ' VAL . 61.2 mt -119.9 150.78 39.93 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 105.881 -1.896 . . . . 74.42 105.881 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -128.64 135.79 49.78 Favored 'General case' 0 C--N 1.27 -2.859 0 N-CA-C 106.729 -1.582 . . . . 60.44 106.729 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.482 ' CE2' ' HD3' ' A' ' 589' ' ' LYS . 26.5 p90 -143.24 164.05 31.28 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 108.557 -0.905 . . . . 70.01 108.557 176.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -77.15 -82.06 0.58 Allowed Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 120.582 -0.818 . . . . 64.45 112.932 -177.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 . . . . . 0 C--N 1.292 -1.899 0 N-CA-C 107.878 -1.156 . . . . 71.05 107.878 -177.029 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.488 0 N-CA-C 109.647 -1.381 . . . . 43.05 109.647 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 11.2 tp -78.42 137.16 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 CA-C-N 117.608 0.704 . . . . 75.21 111.568 -176.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 17.9 m -120.23 147.83 44.45 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 104.536 -2.394 . . . . 71.11 104.536 170.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 23.6 mtt85 -93.11 77.41 4.63 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 114.506 1.298 . . . . 75.22 114.506 -171.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -71.47 148.57 46.68 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 104.91 -2.255 . . . . 74.3 104.91 166.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 29.5 m -115.49 160.68 14.72 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 CA-C-O 121.303 0.573 . . . . 72.4 110.929 -170.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' GLN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 409' ' ' SER . 33.8 tt0 -94.35 139.64 30.82 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 115.872 -0.603 . . . . 63.25 110.063 -175.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.685 HG22 ' CZ ' ' A' ' 382' ' ' PHE . 60.5 t -94.68 141.1 22.93 Favored Pre-proline 0 C--N 1.28 -2.436 0 N-CA-C 106.232 -1.766 . . . . 71.31 106.232 -176.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -73.15 119.34 5.97 Favored 'Trans proline' 0 N--CA 1.436 -1.861 0 C-N-CA 120.824 1.016 . . . . 63.14 111.678 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' ASP . . . . . 0.611 ' OD2' ' HD2' ' A' ' 366' ' ' ARG . 24.8 t70 -89.98 82.51 6.14 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 105.974 -1.862 . . . . 63.31 105.974 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 3.0 m -92.46 30.35 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 113.941 -1.482 . . . . 65.31 114.017 -171.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.611 ' HD2' ' OD2' ' A' ' 364' ' ' ASP . 0.0 OUTLIER -52.66 145.26 12.33 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 124.62 1.168 . . . . 62.53 112.399 174.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.56 -0.84 45.98 Favored Glycine 0 CA--C 1.492 -1.36 0 CA-C-N 115.81 -0.632 . . . . 70.45 112.821 175.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -112.19 -155.84 0.57 Allowed 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.009 -1.108 . . . . 71.15 108.009 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 21.4 p -94.58 161.53 14.16 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 108.667 -0.864 . . . . 72.32 108.667 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 19.1 p -63.13 -40.01 96.34 Favored 'General case' 0 C--O 1.209 -1.033 0 C-N-CA 120.698 -0.401 . . . . 64.21 109.943 178.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.45 -46.31 89.11 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 116.201 -0.454 . . . . 65.32 111.727 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -69.06 -44.79 71.9 Favored 'General case' 0 C--O 1.253 1.255 0 CA-C-O 121.301 0.572 . . . . 74.42 110.69 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -63.83 -44.63 92.66 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.412 -0.813 . . . . 65.15 110.981 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 70.0 mt -69.31 -37.04 75.07 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.594 0 CA-C-N 116.304 -0.407 . . . . 52.22 110.966 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.78 -43.88 90.53 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.376 0.608 . . . . 32.5 109.986 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 376' ' ' THR . . . . . 0.56 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 54.6 m -65.76 -47.41 75.29 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.288 -0.869 . . . . 65.51 109.859 177.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 26.1 tp -60.98 -40.18 92.46 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 123.898 0.879 . . . . 72.01 111.602 -176.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -70.29 -37.66 74.86 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.136 0.575 . . . . 64.53 110.077 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -67.98 -19.15 64.91 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 120.833 0.349 . . . . 63.33 111.527 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' ARG . . . . . 0.56 ' HG2' ' O ' ' A' ' 376' ' ' THR . 16.6 mmt85 -89.42 -8.71 52.48 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.07 0.462 . . . . 73.23 110.046 177.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 84.78 16.34 65.89 Favored Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 115.826 -0.624 . . . . 73.43 113.587 175.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.685 ' CZ ' HG22 ' A' ' 362' ' ' VAL . 71.0 m-85 -86.4 161.12 18.83 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 117.607 0.703 . . . . 74.22 111.786 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.429 ' HB2' ' HA ' ' A' ' 415' ' ' GLU . 34.2 mmtp -90.4 138.34 31.62 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 107.813 -1.18 . . . . 71.13 107.813 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.461 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -117.11 141.21 36.51 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 C-N-CA 119.864 -0.734 . . . . 63.44 109.574 -175.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 6.2 tpp180 -132.13 147.65 52.44 Favored 'General case' 0 N--CA 1.408 -2.547 0 N-CA-C 107.54 -1.282 . . . . 75.41 107.54 176.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 54.5 m -134.87 132.33 38.43 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 109.552 -0.536 . . . . 74.31 109.552 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -111.68 119.84 40.01 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 105.436 -2.061 . . . . 61.4 105.436 175.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.458 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 20.0 pm0 -125.63 135.41 52.13 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.97 -0.692 . . . . 74.24 110.775 -177.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -136.75 135.04 19.73 Favored Pre-proline 0 C--N 1.297 -1.713 0 CA-C-N 115.525 -0.761 . . . . 72.13 109.102 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 422' ' ' THR . 20.7 Cg_exo -70.81 127.51 13.85 Favored 'Trans proline' 0 C--O 1.255 1.374 0 N-CA-C 106.236 -2.255 . . . . 74.23 106.236 166.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.547 ' OD1' HG22 ' A' ' 393' ' ' THR . 7.9 t0 169.15 -165.2 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 105.743 -1.947 . . . . 52.15 105.743 -169.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 10.6 t -151.93 -1.33 0.31 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 122.153 -0.342 . . . . 71.21 110.787 175.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.547 HG22 ' OD1' ' A' ' 391' ' ' ASP . 13.4 t -94.85 -7.92 38.83 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.807 -0.558 . . . . 72.24 112.331 -173.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.491 HD13 ' H ' ' A' ' 394' ' ' ILE . 0.2 OUTLIER -111.01 152.07 43.42 Favored Pre-proline 0 C--N 1.312 -1.061 0 N-CA-C 108.119 -1.067 . . . . 72.33 108.119 176.514 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_exo -29.95 133.5 0.05 OUTLIER 'Trans proline' 0 CA--C 1.553 1.459 0 C-N-CA 125.083 3.855 . . . . 74.13 117.18 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.9 163.76 27.08 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 123.908 3.072 . . . . 73.15 111.836 176.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' ASP . . . . . 0.584 ' HA ' HG13 ' A' ' 420' ' ' VAL . 5.4 p-10 -57.07 -7.84 0.56 Allowed 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 123.826 0.851 . . . . 73.12 112.64 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 53.9 m170 -104.88 124.02 48.74 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 105.102 -2.184 . . . . 73.44 105.102 172.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 28.5 m -72.11 118.79 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.647 0 CA-C-O 121.261 0.553 . . . . 72.4 110.938 -169.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.81 -36.98 10.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 107.274 -1.38 . . . . 75.42 107.274 177.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 401' ' ' GLY . . . . . 0.489 ' HA2' ' HB2' ' A' ' 366' ' ' ARG . . . -146.64 156.94 27.24 Favored Glycine 0 N--CA 1.412 -2.911 0 N-CA-C 109.207 -1.557 . . . . 65.2 109.207 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.476 ' OG1' ' HB3' ' A' ' 366' ' ' ARG . 2.1 p -124.46 -177.71 3.89 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 107.486 -1.302 . . . . 71.33 107.486 176.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -99.64 134.28 21.21 Favored Pre-proline 0 C--N 1.293 -1.887 0 C-N-CA 118.836 -1.146 . . . . 51.1 109.23 -174.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -49.02 -12.12 0.2 Allowed 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 124.787 3.658 . . . . 72.32 115.186 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.76 -29.89 55.13 Favored 'General case' 0 C--O 1.21 -0.986 0 C-N-CA 123.439 0.695 . . . . 72.34 110.021 172.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 406' ' ' ALA . . . . . 0.59 ' HA ' ' HB ' ' A' ' 362' ' ' VAL . . . -66.9 -50.42 62.48 Favored 'General case' 0 N--CA 1.437 -1.079 0 O-C-N 123.603 0.565 . . . . 52.55 111.079 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -72.8 -8.6 56.24 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 121.852 -0.53 . . . . 73.3 111.393 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 90.2 m -85.52 131.4 34.37 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 106.144 -1.799 . . . . 62.33 106.144 174.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 409' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 361' ' ' GLN . 47.1 p -74.5 112.95 11.19 Favored 'General case' 0 N--CA 1.417 -2.104 0 C-N-CA 118.653 -1.219 . . . . 71.44 108.859 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 23.7 m -114.56 169.51 5.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 109.911 -0.403 . . . . 44.34 109.911 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 17.1 m -65.11 136.51 56.79 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.808 -0.812 . . . . 74.43 108.808 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -58.02 109.56 0.76 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.144 0.497 . . . . 72.44 111.629 -175.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 105.89 36.65 2.71 Favored Glycine 0 N--CA 1.438 -1.23 0 CA-C-N 115.523 -0.762 . . . . 71.43 112.661 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -96.96 175.43 6.33 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 109.357 -0.609 . . . . 70.44 109.357 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 415' ' ' GLU . . . . . 0.429 ' HA ' ' HB2' ' A' ' 383' ' ' LYS . 40.9 mm-40 -86.74 120.1 27.68 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.278 0.631 . . . . 64.21 111.341 -172.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 43.0 mm -113.16 111.43 36.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 N-CA-C 108.808 -0.812 . . . . 74.31 108.808 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 30.5 p -90.85 130.48 36.8 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 112.772 0.656 . . . . 65.34 112.772 -175.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 4.1 p -121.62 135.24 62.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.957 -0.757 . . . . 74.4 108.957 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -109.18 127.4 54.18 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.588 -0.523 . . . . 73.03 109.588 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.584 HG13 ' HA ' ' A' ' 397' ' ' ASP . 44.6 t -126.54 137.72 56.95 Favored 'Isoleucine or valine' 0 C--O 1.25 1.126 0 CA-C-N 115.04 -0.982 . . . . 55.42 111.23 -174.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 10.0 t -98.03 121.4 39.91 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.557 -1.275 . . . . 72.12 107.557 176.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.523 ' O ' ' HA ' ' A' ' 390' ' ' PRO . 7.5 t -120.84 107.79 13.15 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.149 0.426 . . . . 71.23 112.149 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 103.46 128.88 6.45 Favored Glycine 0 C--N 1.308 -1.022 0 C-N-CA 119.388 -1.387 . . . . 55.52 112.869 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -64.05 157.83 51.03 Favored 'Trans proline' 0 C--O 1.245 0.866 0 C-N-CA 123.273 2.649 . . . . 73.5 112.395 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.453 ' HG2' ' HA ' ' A' ' 391' ' ' ASP . 38.4 mt-10 -74.73 156.05 37.02 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.836 -1.074 . . . . 71.01 111.184 -178.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -89.09 147.34 24.28 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 106.468 -1.679 . . . . 61.02 106.468 173.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 18.0 mmm-85 -122.51 154.33 38.0 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 120.022 -0.671 . . . . 71.33 110.512 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.424 ' CD ' ' H ' ' A' ' 428' ' ' GLU . 0.0 OUTLIER -85.66 141.24 29.91 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-N 114.738 -1.119 . . . . 73.25 109.401 -177.734 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.443 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 66.2 mt -77.38 126.9 84.24 Favored Pre-proline 0 N--CA 1.426 -1.631 0 N-CA-C 105.698 -1.964 . . . . 64.02 105.698 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.27 141.26 67.98 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 121.973 1.782 . . . . 62.44 112.477 -177.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -87.63 137.02 32.7 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.968 -1.123 . . . . 62.13 107.968 177.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.589 HG11 ' HB2' ' A' ' 440' ' ' ALA . 13.3 p -152.02 159.75 3.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 109.335 -0.616 . . . . 53.53 109.335 -175.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.618 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 13.6 m -78.76 152.77 31.29 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 109.068 -0.716 . . . . 74.13 109.068 177.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 32.7 p -69.07 -25.86 64.66 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 114.037 1.125 . . . . 74.5 114.037 -173.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.5 pp -90.01 -10.23 45.71 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.679 0.752 . . . . 61.44 111.245 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.618 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 1.0 OUTLIER -100.16 41.76 1.15 Allowed 'General case' 0 CA--C 1.569 1.674 0 CA-C-N 115.186 -0.915 . . . . 65.31 110.022 -175.731 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -52.99 -38.2 62.05 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 113.559 0.948 . . . . 63.11 113.559 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.01 -35.71 77.58 Favored 'General case' 0 C--O 1.247 0.961 0 CA-C-O 122.016 0.912 . . . . 52.11 110.836 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.403 ' CB ' HG22 ' A' ' 436' ' ' THR . 35.1 tp10 -69.63 -37.55 76.84 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.401 -0.592 . . . . 70.01 109.401 176.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.589 ' HB2' HG11 ' A' ' 432' ' ' VAL . . . -60.54 -51.3 70.04 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.867 -0.606 . . . . 50.2 111.095 -178.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 35.6 m -63.39 -41.56 93.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 112.104 0.409 . . . . 71.11 112.104 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -68.23 -41.61 80.97 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 119.651 -0.82 . . . . 74.11 110.713 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -65.34 -38.26 89.59 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-N 115.901 -0.59 . . . . 75.04 111.042 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.431 ' CD2' ' HB3' ' A' ' 452' ' ' PHE . 13.5 tp -63.49 -36.46 83.82 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.081 -0.711 . . . . 73.41 109.081 178.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.42 ' HA ' ' HA3' ' A' ' 450' ' ' GLY . 40.0 m -68.98 -39.48 79.39 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.573 -0.74 . . . . 74.01 110.129 178.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.05 -15.95 62.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.937 -0.574 . . . . 43.24 111.13 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -88.74 5.07 45.11 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.873 -0.603 . . . . 64.42 110.906 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 109.03 -87.93 0.5 Allowed Glycine 0 CA--C 1.484 -1.883 0 N-CA-C 111.077 -0.809 . . . . 65.4 111.077 174.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -35.49 -63.14 0.36 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.435 1.272 . . . . 74.13 114.435 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 450' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 445' ' ' THR . . . 55.42 30.75 56.15 Favored Glycine 0 C--O 1.217 -0.909 0 N-CA-C 114.204 0.442 . . . . 72.55 114.204 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.509 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 30.3 mmm180 -105.75 111.18 23.74 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.64 -0.874 . . . . 73.05 108.64 -177.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.431 ' HB3' ' CD2' ' A' ' 444' ' ' LEU . 40.8 p90 -133.1 150.37 52.07 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 121.405 0.622 . . . . 75.43 111.869 -174.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -137.17 126.75 25.21 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.774 -1.103 . . . . 72.5 108.84 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -94.74 128.64 41.58 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 120.831 0.348 . . . . 63.01 110.593 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -128.99 157.86 40.48 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.826 -0.805 . . . . 61.21 108.826 177.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -126.19 147.94 49.55 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.95 -0.3 . . . . 73.12 110.338 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 20.9 t -152.62 147.47 19.37 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 107.631 -1.248 . . . . 63.52 107.631 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 490' ' ' SER . 35.6 Cg_endo -65.84 135.78 42.68 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.237 1.958 . . . . 61.44 111.38 178.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 34.7 m -151.94 179.09 8.76 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.658 -0.867 . . . . 61.03 108.658 -177.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.5 t -47.92 133.5 11.58 Favored Pre-proline 0 C--O 1.248 1.012 0 O-C-N 123.958 0.786 . . . . 75.24 111.02 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.69 -30.87 38.74 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 124.331 3.354 . . . . 74.13 114.003 -174.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -73.21 -27.64 61.73 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 112.345 0.498 . . . . 62.14 112.345 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -94.18 -2.23 52.9 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 120.721 0.296 . . . . 70.41 111.41 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 76.7 t -61.13 127.77 21.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.091 -0.707 . . . . 72.04 109.091 174.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.99 -4.59 75.07 Favored Glycine 0 C--N 1.304 -1.205 0 N-CA-C 111.733 -0.547 . . . . 72.31 111.733 -177.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -117.68 166.45 12.41 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.135 -0.691 . . . . 71.12 109.135 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 81.6 t -75.42 144.74 11.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 115.516 -0.766 . . . . 55.12 109.771 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 47.6 mm -97.68 -30.38 3.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 107.676 -1.231 . . . . 73.44 107.676 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 158.56 -169.51 35.02 Favored Glycine 0 N--CA 1.418 -2.548 0 CA-C-N 115.179 -0.919 . . . . 75.44 112.131 174.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 470' ' ' THR . . . . . 0.542 HG22 HG12 ' A' ' 486' ' ' ILE . 20.9 p -114.79 144.55 43.32 Favored 'General case' 0 C--N 1.28 -2.413 0 N-CA-C 106.565 -1.642 . . . . 72.43 106.565 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.499 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 22.4 t-20 -52.51 -53.41 53.86 Favored Pre-proline 0 N--CA 1.48 1.058 0 N-CA-C 112.744 0.646 . . . . 64.35 112.744 178.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 2.7 Cg_endo -85.83 147.62 9.45 Favored 'Trans proline' 0 N--CA 1.442 -1.516 0 N-CA-C 108.414 -1.418 . . . . 52.31 108.414 170.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.67 132.32 37.18 Favored 'Trans proline' 0 C--O 1.241 0.626 0 C-N-CA 121.633 1.555 . . . . 63.32 111.194 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.443 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -75.11 18.16 0.2 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.733 0.813 . . . . 72.02 112.239 -176.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -110.55 -10.3 14.53 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 123.491 0.716 . . . . 75.42 110.25 173.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -102.35 174.74 5.78 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.109 0.48 . . . . 73.21 111.995 -173.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.26 145.88 24.11 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.071 -0.968 . . . . 64.44 111.585 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 29.1 p -137.24 149.31 47.07 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.069 -0.715 . . . . 72.35 109.069 176.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.13 165.26 18.56 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.406 -0.361 . . . . 74.52 111.417 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 42.5 mm -74.88 -16.43 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-O 121.679 0.752 . . . . 72.24 110.444 -178.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 7.3 t -98.2 5.24 48.67 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.506 -0.746 . . . . 43.41 109.74 176.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -77.43 132.38 38.45 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.999 -0.546 . . . . 63.32 110.206 -175.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.509 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 43.1 t -105.04 126.17 60.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.913 -0.773 . . . . 75.32 108.913 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.449 HG12 ' HG2' ' A' ' 472' ' ' PRO . 20.2 m -108.29 126.38 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 CA-C-O 121.898 0.856 . . . . 61.12 111.048 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.425 HG23 ' HB2' ' A' ' 471' ' ' ASN . 0.0 OUTLIER -94.22 129.3 44.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 108.326 -0.99 . . . . 72.42 108.326 176.729 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.542 HG12 HG22 ' A' ' 470' ' ' THR . 18.2 mt -113.5 127.33 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 CA-C-N 115.17 -0.923 . . . . 72.2 109.808 -176.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 8.0 tt -107.18 126.79 63.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 115.429 -0.805 . . . . 74.5 110.161 -175.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 32.6 m -109.42 151.9 11.6 Favored 'Isoleucine or valine' 0 C--O 1.249 1.056 0 C-N-CA 123.209 0.603 . . . . 75.53 110.193 178.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.91 123.8 6.25 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 110.864 -0.894 . . . . 64.31 110.864 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 44.7 m -142.73 129.87 20.86 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 117.221 0.51 . . . . 71.12 111.118 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 107.77 82.47 1.46 Allowed Glycine 0 C--N 1.31 -0.897 0 C-N-CA 120.732 -0.747 . . . . 51.23 113.548 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -92.17 160.76 3.18 Favored 'Trans proline' 0 C--O 1.251 1.132 0 C-N-CA 122.299 1.999 . . . . 73.43 111.651 174.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -124.01 56.88 1.23 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.668 -0.864 . . . . 62.43 108.668 175.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 2.9 p -117.09 144.08 45.07 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 114.986 -1.006 . . . . 71.23 111.119 -176.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -140.61 163.81 31.86 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.588 -0.893 . . . . 72.12 108.588 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -97.25 126.66 42.6 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.822 -0.807 . . . . 70.22 108.822 -177.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.4 pt -78.55 127.06 81.73 Favored Pre-proline 0 C--N 1.313 -1.011 0 N-CA-C 113.138 0.792 . . . . 73.11 113.138 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -96.19 155.64 1.37 Allowed 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 122.97 2.447 . . . . 54.42 110.083 169.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -123.99 164.35 19.51 Favored 'General case' 0 C--N 1.314 -0.945 0 O-C-N 121.675 -0.641 . . . . 75.13 111.303 -176.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 6.4 p -151.9 96.28 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 CA-C-O 121.947 0.88 . . . . 73.32 110.179 177.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -102.85 100.67 10.67 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.468 -0.787 . . . . 74.2 110.732 -177.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 152.1 48.41 0.02 OUTLIER Glycine 0 C--N 1.302 -1.313 0 N-CA-C 110.329 -1.108 . . . . 63.45 110.329 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -156.15 -178.52 7.38 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.529 -1.656 . . . . 73.21 106.529 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 18.0 p -89.64 160.07 16.82 Favored 'General case' 0 C--N 1.286 -2.188 0 C-N-CA 120.0 -0.68 . . . . 64.25 109.424 174.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.461 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.3 p -52.51 -43.55 42.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 O-C-N 123.946 0.779 . . . . 72.12 111.745 178.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -62.67 -42.56 99.68 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.945 0.402 . . . . 75.21 111.069 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 57.6 t -73.44 -37.34 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 121.153 0.502 . . . . 64.22 110.283 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.6 -44.92 92.6 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.424 -0.353 . . . . 64.52 111.094 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 97.5 mt-30 -60.91 -40.76 94.38 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.448 0.467 . . . . 70.25 109.958 177.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.454 ' O ' HG23 ' A' ' 514' ' ' VAL . 58.8 tttp -57.9 -50.37 73.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.313 -0.858 . . . . 74.15 110.105 177.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -62.34 -40.82 97.62 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-N 115.479 -0.782 . . . . 51.44 111.421 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 512' ' ' LEU . . . . . 0.424 HD23 ' HB3' ' A' ' 520' ' ' PHE . 40.9 tp -61.1 -41.15 96.15 Favored 'General case' 0 C--O 1.238 0.485 0 O-C-N 123.369 0.418 . . . . 74.33 109.958 177.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 513' ' ' ASN . . . . . 0.432 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 12.1 m120 -65.35 -37.69 87.81 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 116.014 -0.539 . . . . 64.54 110.675 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 510' ' ' LYS . 95.5 t -66.06 -28.42 43.74 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 116.117 -0.492 . . . . 72.3 110.362 177.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -75.56 -4.29 39.06 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.814 0.34 . . . . 74.11 111.171 178.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 105.6 -10.61 45.91 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.892 -0.671 . . . . 74.15 112.854 175.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.432 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 70.6 m-85 -95.77 114.11 25.81 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.157 -0.683 . . . . 73.1 109.157 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 16.5 p -87.57 -17.95 30.83 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 113.709 1.003 . . . . 63.41 113.709 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 519' ' ' LYS . . . . . 0.454 ' HD2' ' O ' ' A' ' 548' ' ' ASP . 96.7 mttt -108.51 119.55 39.85 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.854 0.835 . . . . 71.02 113.208 -172.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 520' ' ' PHE . . . . . 0.424 ' HB3' HD23 ' A' ' 512' ' ' LEU . 15.3 p90 -130.46 152.14 50.18 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.507 -1.224 . . . . 74.33 111.195 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 63.5 m -142.03 156.54 45.43 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 107.51 -1.293 . . . . 63.2 107.51 170.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 522' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 26.8 pt20 -116.67 148.9 40.59 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-O 121.542 0.687 . . . . 71.23 111.056 -177.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 523' ' ' ALA . . . . . 0.512 ' HB3' ' HG2' ' A' ' 554' ' ' GLN . . . -120.38 119.03 31.91 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.145 -1.428 . . . . 54.33 107.145 175.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 17.0 m -86.25 123.26 31.32 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 116.243 -0.435 . . . . 42.31 110.528 -176.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 45.0 t -121.43 149.07 24.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 105.672 -1.973 . . . . 72.31 105.672 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -102.04 137.05 40.83 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.654 -0.819 . . . . 52.21 108.934 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 54.2 m -155.38 -176.83 0.65 Allowed Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 107.758 -1.201 . . . . 74.14 107.758 -176.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -87.5 3.59 6.32 Favored 'Trans proline' 0 CA--C 1.551 1.35 0 C-N-CA 121.699 1.599 . . . . 64.42 112.798 173.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.508 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 3.6 mpt_? -89.84 134.19 32.53 Favored Pre-proline 0 C--O 1.213 -0.832 0 N-CA-C 108.619 -0.882 . . . . 75.31 108.619 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -54.79 141.68 76.03 Favored 'Trans proline' 0 N--CA 1.483 0.866 0 C-N-CA 123.223 2.615 . . . . 72.14 114.315 -171.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.584 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -61.07 114.22 2.99 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 114.614 -1.176 . . . . 75.31 111.375 -175.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 132.49 -20.08 4.44 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 110.226 -1.15 . . . . 61.33 110.226 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -69.88 131.41 44.4 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 123.185 0.594 . . . . 74.44 109.895 177.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 7.6 p -86.58 106.15 15.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.13 -1.063 . . . . 62.21 108.13 174.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 12.0 t -78.56 -16.43 57.45 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.991 -0.55 . . . . 75.24 111.361 -174.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 163.25 -166.56 37.14 Favored Glycine 0 N--CA 1.429 -1.798 0 N-CA-C 111.194 -0.762 . . . . 72.12 111.194 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 42.4 p -128.71 149.19 50.79 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 107.706 -1.22 . . . . 75.21 107.706 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -71.71 -49.44 10.96 Favored Pre-proline 0 C--N 1.303 -1.423 0 C-N-CA 120.621 -0.431 . . . . 71.42 110.81 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -81.76 126.09 5.1 Favored 'Trans proline' 0 CA--C 1.555 1.531 0 N-CA-C 109.515 -0.994 . . . . 62.44 109.515 168.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.38 160.84 43.96 Favored 'Trans proline' 0 C--O 1.257 1.471 0 C-N-CA 122.716 2.278 . . . . 42.25 113.325 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.94 139.81 58.81 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.339 -0.846 . . . . 52.25 110.47 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.27 -17.79 43.25 Favored Glycine 0 C--N 1.297 -1.627 0 N-CA-C 111.343 -0.703 . . . . 35.12 111.343 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 34.9 m -67.57 123.05 19.37 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.827 -0.434 . . . . 71.0 109.827 178.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 10.8 m -82.77 123.22 29.12 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 108.075 -1.083 . . . . 34.25 108.075 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 32.0 m -136.5 155.0 77.23 Favored Pre-proline 0 C--N 1.308 -1.23 0 N-CA-C 108.786 -0.82 . . . . 75.13 108.786 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -60.59 146.89 96.24 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.182 1.921 . . . . 74.03 110.222 172.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 27.9 m -60.94 -20.53 22.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 113.58 0.955 . . . . 75.44 113.58 -176.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 548' ' ' ASP . . . . . 0.454 ' O ' ' HD2' ' A' ' 519' ' ' LYS . 11.6 t70 -97.96 4.08 49.48 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.315 0.579 . . . . 74.31 110.566 -178.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.0 t -69.7 154.48 41.92 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.12 0.486 . . . . 74.44 110.403 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 43.6 t -95.22 127.07 47.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.581 -0.896 . . . . 71.21 108.581 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 2.7 mp -103.97 136.24 38.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 109.204 -0.665 . . . . 70.54 109.204 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -102.97 119.23 38.47 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-O 121.515 0.674 . . . . 71.44 111.344 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 553' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 5.2 mp -100.23 133.87 44.0 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.64 -1.164 . . . . 70.03 108.372 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 554' ' ' GLN . . . . . 0.512 ' HG2' ' HB3' ' A' ' 523' ' ' ALA . 51.3 mt-30 -97.93 121.75 40.23 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-O 121.294 0.569 . . . . 44.23 110.283 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 60.7 t -109.94 133.41 55.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 115.194 -0.912 . . . . 73.3 108.797 -175.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.584 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 29.8 p -94.17 133.34 37.78 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-O 121.024 0.44 . . . . 61.51 111.811 -178.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -84.41 145.43 28.19 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 107.218 -1.401 . . . . 52.14 107.218 169.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 558' ' ' GLY . . . . . 0.508 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -81.6 -28.33 43.63 Favored Glycine 0 CA--C 1.478 -2.265 0 O-C-N 123.813 0.695 . . . . 72.23 113.381 -173.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 70.3 -35.19 0.31 Allowed 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 124.49 1.116 . . . . 64.25 113.946 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.44 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 48.2 mt-30 -125.65 146.16 49.84 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 121.306 0.574 . . . . 74.14 111.638 -172.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -124.72 139.76 53.56 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 115.039 -0.982 . . . . 65.05 109.184 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 91.2 t -61.46 121.71 10.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 123.393 0.677 . . . . 61.24 112.333 -175.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 563' ' ' MET . . . . . 0.428 ' HG2' ' O ' ' A' ' 564' ' ' PRO . 54.2 ttp -97.25 132.83 24.79 Favored Pre-proline 0 C--O 1.245 0.864 0 CA-C-N 115.769 -0.651 . . . . 71.31 111.103 -178.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 564' ' ' PRO . . . . . 0.428 ' O ' ' HG2' ' A' ' 563' ' ' MET . 13.6 Cg_exo -73.39 170.27 20.3 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.268 2.645 . . . . 74.02 110.646 171.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -74.98 115.57 14.75 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.834 0.826 . . . . 72.22 111.418 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 94.8 mt -113.67 7.41 17.24 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 122.666 1.222 . . . . 74.45 107.76 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 1.4 p -79.63 153.27 29.52 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-N 113.695 -1.593 . . . . 63.13 111.18 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 88.81 14.44 61.08 Favored Glycine 0 N--CA 1.436 -1.366 0 CA-C-N 115.634 -0.712 . . . . 52.54 112.908 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 89.1 mtp -108.3 156.27 19.57 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.739 -0.467 . . . . 75.21 109.739 -175.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 570' ' ' PHE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 96.2 m-85 -75.56 153.92 37.1 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 108.031 -1.1 . . . . 72.52 108.031 176.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 74.8 t-105 -68.13 -22.6 64.87 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.532 -0.544 . . . . 74.52 109.532 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 10.8 p -74.82 -16.92 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 115.229 -0.896 . . . . 74.12 109.358 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -101.3 -44.17 5.74 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.956 -0.565 . . . . 74.5 110.04 175.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -58.12 -52.28 66.22 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.281 -0.872 . . . . 72.01 112.674 -176.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.421 ' HA ' ' HG ' ' A' ' 578' ' ' LEU . 41.3 tt0 -60.7 -51.93 76.15 Favored Pre-proline 0 CA--C 1.557 1.22 0 N-CA-C 112.939 0.718 . . . . 74.34 112.939 -177.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -58.04 -37.23 96.66 Favored 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 121.132 1.221 . . . . 62.12 112.341 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -69.02 -37.74 78.83 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 112.915 0.709 . . . . 61.21 112.915 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.421 ' HG ' ' HA ' ' A' ' 575' ' ' GLU . 4.1 pp -67.0 -38.36 85.86 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.988 -0.685 . . . . 73.25 110.481 177.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 579' ' ' ARG . . . . . 0.407 ' N ' HD12 ' A' ' 578' ' ' LEU . 79.8 mtp180 -63.49 -44.52 94.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.307 -0.861 . . . . 64.22 110.136 176.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.96 -29.19 68.98 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.516 0.726 . . . . 43.02 111.873 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 64.6 tp -81.2 -7.26 59.53 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 121.381 0.61 . . . . 75.43 109.883 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 77.83 31.02 50.58 Favored Glycine 0 CA--C 1.492 -1.374 0 N-CA-C 111.305 -0.718 . . . . 54.12 111.305 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 583' ' ' TRP . . . . . 0.402 ' CE3' HD13 ' A' ' 578' ' ' LEU . 86.8 t90 -87.36 140.68 29.29 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 109.043 -0.725 . . . . 75.54 109.043 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 5.8 t -133.33 -50.15 0.86 Allowed 'General case' 0 N--CA 1.41 -2.426 0 CA-C-N 115.708 -0.678 . . . . 71.51 109.496 175.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . 29.59 -126.6 0.11 Allowed Glycine 0 C--N 1.365 2.186 0 C-N-CA 125.352 1.453 . . . . 63.15 114.16 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 586' ' ' MET . . . . . 0.438 ' O ' HG12 ' A' ' 619' ' ' ILE . 51.6 ttm -138.03 125.13 21.48 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 105.18 -2.156 . . . . 64.1 105.18 172.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -99.15 125.2 44.65 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.912 -1.144 . . . . 72.33 107.912 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -105.14 101.47 11.02 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 115.901 -0.591 . . . . 45.0 109.61 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -99.89 109.88 22.25 Favored 'General case' 0 N--CA 1.416 -2.17 0 N-CA-C 106.833 -1.543 . . . . 42.03 106.833 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -103.85 -121.6 4.95 Favored Glycine 0 N--CA 1.425 -2.086 0 N-CA-C 110.535 -1.026 . . . . 51.5 110.535 178.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -86.9 119.75 27.45 Favored 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 120.702 -0.399 . . . . 72.21 110.788 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -77.86 152.57 33.31 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 105.273 -2.121 . . . . 72.3 105.273 169.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 593' ' ' VAL . . . . . 0.409 ' O ' ' HB2' ' A' ' 626' ' ' GLN . 59.5 t -103.84 116.04 46.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 C-N-CA 118.931 -1.108 . . . . 52.23 111.94 -169.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.33 107.08 17.17 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.951 -1.129 . . . . 73.1 107.951 175.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -139.47 17.98 2.55 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.288 -1.004 . . . . 75.2 108.288 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 98.33 144.21 16.41 Favored Glycine 0 N--CA 1.414 -2.816 0 CA-C-N 114.645 -1.161 . . . . 42.31 111.089 -176.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.76 -32.3 61.69 Favored Glycine 0 C--N 1.32 -0.315 0 O-C-N 123.935 0.432 . . . . 72.23 112.503 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 10.0 m -59.06 -23.61 62.17 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.212 1.005 . . . . 72.04 112.798 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -86.71 -13.72 44.57 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 121.852 -0.53 . . . . 60.45 110.397 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 56.92 161.59 0.02 OUTLIER 'General case' 0 C--O 1.243 0.757 0 N-CA-C 115.475 1.657 . . . . 75.53 115.475 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -79.56 89.62 5.09 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 114.745 -1.116 . . . . 72.14 109.455 172.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 602' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 49.4 ttt180 -117.65 148.78 41.64 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 106.569 -1.641 . . . . 73.24 106.569 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 67.9 t -61.77 131.12 26.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.468 -0.938 . . . . 75.34 108.468 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 83.7 t -86.87 -46.56 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.008 0 N-CA-C 109.142 -0.688 . . . . 75.44 109.142 -174.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -156.1 164.17 38.74 Favored 'General case' 0 N--CA 1.415 -2.217 0 N-CA-C 107.647 -1.242 . . . . 72.34 107.647 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.04 150.84 44.46 Favored 'General case' 0 C--N 1.279 -2.458 0 N-CA-C 106.928 -1.508 . . . . 60.41 106.928 173.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.648 ' HB3' ' HD3' ' A' ' 608' ' ' PRO 0.294 48.7 t-20 -70.3 -79.36 0.05 OUTLIER Pre-proline 0 CA--C 1.563 1.445 0 CA-C-O 117.555 -1.212 . . . . 74.14 113.587 -171.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.648 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 14.6 Cg_exo -73.24 127.39 11.91 Favored 'Trans proline' 0 C--N 1.374 1.875 0 CA-C-N 122.729 2.01 . . . . 73.05 108.866 174.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.86 160.18 34.49 Favored 'Trans proline' 0 C--O 1.24 0.61 0 C-N-CA 122.392 2.062 . . . . 55.01 112.594 -175.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.94 127.05 29.57 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.434 -0.58 . . . . 61.41 109.434 -178.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.47 -12.48 47.36 Favored Glycine 0 N--CA 1.431 -1.651 0 C-N-CA 120.573 -0.823 . . . . 45.54 111.231 -175.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 27.8 m -97.66 164.62 12.34 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 107.936 -1.135 . . . . 53.12 107.936 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -88.81 143.41 17.59 Favored Glycine 0 N--CA 1.427 -1.95 0 C-N-CA 121.197 -0.525 . . . . 72.21 113.59 -177.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 24.3 m -107.92 142.17 21.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.989 -1.115 . . . . 64.3 107.989 173.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.571 HD21 HG22 ' A' ' 619' ' ' ILE . 31.8 p30 -62.54 164.87 6.91 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 114.282 1.216 . . . . 44.52 114.282 -175.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -55.49 -25.8 39.02 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 114.788 1.403 . . . . 75.24 114.788 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -74.73 -44.53 49.44 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 106.845 -1.539 . . . . 72.32 106.845 174.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 97.56 20.65 21.6 Favored Glycine 0 N--CA 1.418 -2.511 0 CA-C-N 114.672 -1.149 . . . . 74.12 110.53 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 619' ' ' ILE . . . . . 0.571 HG22 HD21 ' A' ' 615' ' ' ASN . 0.0 OUTLIER -69.42 122.03 20.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 122.078 0.942 . . . . 73.41 109.928 -172.257 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 9.4 tp -121.89 132.59 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.098 0 CA-C-N 114.606 -1.179 . . . . 73.12 108.929 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.464 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 7.4 m -97.62 119.72 36.69 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.178 -1.045 . . . . 61.34 108.178 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 81.6 mt -130.76 154.43 47.99 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 123.739 0.815 . . . . 74.44 109.33 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 65.2 mmt-85 -136.71 154.9 50.47 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 104.583 -2.377 . . . . 71.33 104.583 173.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 602' ' ' ARG . 30.5 p90 -141.31 160.35 40.31 Favored 'General case' 0 C--N 1.288 -2.082 0 O-C-N 123.293 0.371 . . . . 72.35 110.403 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -73.44 -151.14 1.72 Allowed Glycine 0 C--N 1.309 -0.959 0 O-C-N 124.196 0.935 . . . . 45.22 113.446 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 626' ' ' GLN . . . . . 0.409 ' HB2' ' O ' ' A' ' 593' ' ' VAL . 6.9 tp-100 . . . . . 0 C--N 1.299 -1.602 0 CA-C-O 119.31 -0.376 . . . . 70.11 110.438 -175.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.592 0 N-CA-C 111.045 -0.822 . . . . 74.45 111.045 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 8.2 tp -75.48 126.28 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 CA-C-O 121.515 0.674 . . . . 63.32 109.391 177.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.61 140.94 51.76 Favored 'General case' 0 N--CA 1.389 -3.479 0 CA-C-N 115.384 -0.826 . . . . 61.23 112.12 -177.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 2.1 ppt_? -145.99 86.2 1.71 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 122.614 1.197 . . . . 72.53 110.8 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -107.56 148.08 29.73 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.063 -1.426 . . . . 72.44 109.725 -176.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.67 163.56 34.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 109.724 -0.473 . . . . 63.04 109.724 -177.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -93.67 137.36 33.0 Favored 'General case' 0 N--CA 1.404 -2.762 0 CA-C-O 121.619 0.723 . . . . 74.44 109.245 177.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.424 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 91.4 t -98.29 134.27 22.12 Favored Pre-proline 0 C--N 1.268 -2.972 0 CA-C-N 114.337 -1.302 . . . . 72.21 110.171 -173.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 363' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 3.6 Cg_exo -71.21 128.79 15.15 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.856 1.704 . . . . 74.11 110.214 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.39 157.92 18.44 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.288 -0.565 . . . . 75.43 109.485 -177.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.502 HG23 ' HA ' ' A' ' 373' ' ' ALA . 18.8 m -131.5 26.55 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-N 115.205 -0.907 . . . . 65.33 109.085 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -66.43 148.55 51.71 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 114.749 -1.114 . . . . 73.44 109.103 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 367' ' ' GLY . . . . . 0.416 ' H ' HG23 ' A' ' 399' ' ' VAL . . . 107.01 0.7 35.95 Favored Glycine 0 C--N 1.315 -0.625 0 N-CA-C 111.349 -0.7 . . . . 75.54 111.349 -173.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -113.03 -146.83 0.41 Allowed 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.7 -0.852 . . . . 70.42 108.7 175.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 58.4 p -89.57 160.77 16.52 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 107.929 -1.137 . . . . 64.35 107.929 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 8.8 p -63.52 -34.89 78.78 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 120.078 -0.649 . . . . 73.35 110.568 177.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -65.81 -47.58 74.61 Favored 'General case' 0 C--O 1.216 -0.692 0 N-CA-C 111.902 0.334 . . . . 74.44 111.902 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -67.19 -42.85 83.5 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.716 0.77 . . . . 70.14 109.247 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 373' ' ' ALA . . . . . 0.502 ' HA ' HG23 ' A' ' 365' ' ' VAL . . . -65.35 -42.65 92.61 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 114.558 -1.201 . . . . 73.12 112.27 -177.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 58.1 mt -69.58 -45.58 77.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 116.592 -0.276 . . . . 74.23 110.55 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.81 -44.56 90.84 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 123.515 0.509 . . . . 73.35 111.647 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 376' ' ' THR . . . . . 0.508 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 23.6 m -65.2 -46.64 79.89 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 116.13 -0.486 . . . . 71.31 110.597 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.418 HD23 ' O ' ' A' ' 373' ' ' ALA . 4.6 mm? -63.17 -38.07 89.71 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 111.803 0.297 . . . . 70.43 111.803 178.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -63.65 -38.05 89.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.056 0.455 . . . . 73.4 110.068 178.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -70.07 -21.24 63.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 73.14 111.644 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 376' ' ' THR . 38.4 mmt180 -82.6 -14.11 55.36 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.61 -0.515 . . . . 73.3 109.61 176.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 97.54 6.02 57.59 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 111.385 -0.686 . . . . 45.33 111.385 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -89.4 149.01 23.17 Favored 'General case' 0 N--CA 1.406 -2.653 0 CA-C-O 121.61 0.719 . . . . 75.53 111.244 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.483 ' HB2' ' HG2' ' A' ' 415' ' ' GLU . 45.8 mmtm -96.14 155.09 16.9 Favored 'General case' 0 N--CA 1.41 -2.466 0 CA-C-N 114.548 -1.205 . . . . 72.41 107.764 -177.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.479 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -130.42 141.94 45.01 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 N-CA-C 109.204 -0.665 . . . . 72.11 109.204 -177.837 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 28.2 ttm-85 -125.53 127.57 46.63 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 108.186 -1.042 . . . . 74.21 108.186 177.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 33.5 m -115.56 123.64 48.98 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-O 120.925 0.393 . . . . 62.2 110.691 -173.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -112.24 131.09 55.69 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.994 -1.484 . . . . 71.43 106.994 175.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.483 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 19.1 pm0 -123.11 142.16 51.18 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 119.374 -0.931 . . . . 71.23 111.403 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 389' ' ' LYS . . . . . 0.436 ' HB2' HG13 ' A' ' 394' ' ' ILE . 75.4 mmtt -131.88 131.26 22.53 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 108.646 -0.872 . . . . 74.11 108.646 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.449 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 60.6 Cg_endo -83.62 129.18 4.85 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 121.626 1.55 . . . . 64.21 111.538 176.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 14.8 t70 158.58 -158.06 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 104.308 -2.478 . . . . 61.34 104.308 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 19.3 m -136.36 2.37 2.74 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 119.213 0.915 . . . . 73.13 110.784 177.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 1.3 p -81.87 -27.65 33.36 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 112.792 0.664 . . . . 54.21 112.792 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.653 HD13 ' H ' ' A' ' 394' ' ' ILE . 0.2 OUTLIER -93.04 152.09 41.08 Favored Pre-proline 0 C--N 1.29 -1.997 0 CA-C-N 115.898 -0.592 . . . . 72.33 110.399 -176.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -43.01 129.46 5.65 Favored 'Trans proline' 0 C--N 1.363 1.339 0 C-N-CA 124.159 3.239 . . . . 52.03 114.528 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -61.04 161.61 21.91 Favored 'Trans proline' 0 N--CA 1.482 0.851 0 C-N-CA 124.212 3.275 . . . . 60.35 113.489 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -59.37 -8.08 1.6 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 112.975 0.732 . . . . 75.02 112.975 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -98.02 122.38 41.08 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 103.52 -2.77 . . . . 65.22 103.52 171.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.416 HG23 ' H ' ' A' ' 367' ' ' GLY . 26.8 m -77.92 117.05 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.351 0 C-N-CA 118.982 -1.087 . . . . 73.44 113.565 -162.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 43.6 pt -103.32 -27.4 3.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 114.523 -1.217 . . . . 73.34 108.548 174.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.8 157.13 27.27 Favored Glycine 1 CA--C 1.442 -4.525 0 CA-C-O 122.397 0.998 . . . . 63.12 111.647 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.484 HG22 ' H ' ' A' ' 403' ' ' ASP . 87.2 m -156.54 -177.89 6.93 Favored 'General case' 0 N--CA 1.383 -3.783 0 N-CA-C 104.592 -2.373 . . . . 63.44 104.592 -171.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 403' ' ' ASP . . . . . 0.484 ' H ' HG22 ' A' ' 402' ' ' THR . 15.0 m-20 -98.6 131.65 25.5 Favored Pre-proline 0 C--N 1.264 -3.111 0 N-CA-C 106.117 -1.808 . . . . 71.22 106.117 174.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.6 26.31 0.12 Allowed 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 124.472 3.448 . . . . 74.1 114.761 -171.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.414 ' H ' ' C ' ' A' ' 403' ' ' ASP . . . -56.92 -35.99 69.67 Favored 'General case' 0 C--O 1.209 -1.077 0 C-N-CA 123.658 0.783 . . . . 70.45 110.635 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -70.86 -33.61 70.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.33 0.586 . . . . 64.31 111.049 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -88.12 -1.34 57.95 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 122.081 0.943 . . . . 74.14 109.406 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 26.6 m -95.28 148.51 22.34 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 104.874 -2.269 . . . . 73.3 104.874 173.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 4.1 p -74.89 111.99 10.65 Favored 'General case' 0 N--CA 1.41 -2.46 0 C-N-CA 118.603 -1.239 . . . . 62.24 108.839 176.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 30.2 m -123.71 167.46 17.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.702 -0.681 . . . . 43.21 110.344 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 38.4 m -76.94 146.91 37.25 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 108.832 -0.803 . . . . 75.42 108.832 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -64.73 109.45 2.04 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.9 0.381 . . . . 72.13 111.184 -176.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 111.67 53.12 0.53 Allowed Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.819 -0.628 . . . . 64.31 112.614 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.61 -167.65 1.29 Allowed 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.46 -0.941 . . . . 71.31 108.46 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 415' ' ' GLU . . . . . 0.483 ' HG2' ' HB2' ' A' ' 383' ' ' LYS . 37.1 mt-10 -113.91 137.16 52.06 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.114 0.483 . . . . 72.13 110.305 -176.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 34.7 mm -110.28 110.73 33.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 108.712 -0.848 . . . . 44.3 108.712 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 21.0 p -84.1 131.22 34.81 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 123.098 0.559 . . . . 65.34 111.838 -177.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 10.6 p -127.25 135.2 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-N 115.673 -0.694 . . . . 73.23 111.441 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -105.27 124.61 49.83 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.992 -0.744 . . . . 73.43 108.992 172.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 16.7 m -126.04 152.7 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.545 0 CA-C-N 115.28 -0.873 . . . . 63.44 110.535 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 421' ' ' SER . . . . . 0.415 ' HB2' HG12 ' A' ' 394' ' ' ILE . 27.1 t -99.38 129.64 45.59 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-O 121.718 0.77 . . . . 54.44 110.584 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 3.0 p -93.61 158.36 15.73 Favored 'General case' 0 N--CA 1.401 -2.906 0 N-CA-C 105.008 -2.219 . . . . 53.41 105.008 166.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -56.83 -141.85 0.01 OUTLIER Glycine 0 CA--C 1.553 2.419 0 N-CA-C 116.729 1.451 . . . . 74.25 116.729 -175.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -70.86 154.61 63.29 Favored 'Trans proline' 0 C--O 1.263 1.763 0 C-N-CA 121.782 1.655 . . . . 71.12 113.355 -173.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -74.79 166.57 23.39 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 114.561 -1.2 . . . . 71.24 110.015 177.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -113.23 157.58 21.55 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 106.676 -1.602 . . . . 75.34 106.676 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 -122.21 152.46 39.96 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 119.398 -0.921 . . . . 72.35 111.254 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -83.23 138.64 33.52 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 114.445 -1.252 . . . . 62.55 109.073 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 53.7 mt -84.12 122.95 75.89 Favored Pre-proline 0 N--CA 1.424 -1.733 0 N-CA-C 107.297 -1.371 . . . . 63.43 107.297 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.451 ' HG2' ' HB3' ' A' ' 443' ' ' LYS . 56.2 Cg_endo -70.74 150.42 62.2 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.802 1.668 . . . . 72.1 110.892 176.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -80.5 130.13 34.95 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.167 -1.049 . . . . 72.14 108.167 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 39.5 t -127.03 152.3 34.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 107.438 -1.319 . . . . 74.41 107.438 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 42.6 t -70.29 143.64 51.99 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.833 -0.803 . . . . 72.4 108.833 176.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 434' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 18.9 p -67.56 -28.44 67.79 Favored 'General case' 0 N--CA 1.424 -1.726 0 C-N-CA 123.658 0.783 . . . . 65.41 111.532 -175.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 2.3 pp -79.36 -12.53 59.92 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.339 0.59 . . . . 71.14 111.963 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 3.2 p -104.05 62.98 0.75 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 121.567 0.699 . . . . 74.45 112.41 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -56.95 -38.58 73.13 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.078 -0.964 . . . . 73.04 111.014 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -60.04 -42.49 94.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.424 0.63 . . . . 74.5 110.254 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.475 ' O ' ' HB3' ' A' ' 442' ' ' LYS . 25.8 tp10 -70.89 -34.95 72.1 Favored 'General case' 0 C--O 1.205 -1.237 0 CA-C-N 115.463 -0.79 . . . . 71.12 110.035 178.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.6 -51.42 69.47 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.303 0.112 . . . . 73.21 111.303 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 33.9 m -63.01 -36.57 76.39 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 CA-C-O 121.273 0.559 . . . . 75.3 110.839 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 439' ' ' GLU . 16.6 tppt? -60.04 -47.69 84.8 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.942 -1.026 . . . . 65.43 109.998 176.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 443' ' ' LYS . . . . . 0.451 ' HB3' ' HG2' ' A' ' 430' ' ' PRO . 28.5 mmtp -67.04 -38.51 86.0 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 113.067 0.765 . . . . 75.52 113.067 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 9.8 mp -63.71 -34.93 78.96 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.6 -0.44 . . . . 70.33 109.974 174.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 92.9 m -68.23 -42.2 80.09 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.884 -0.598 . . . . 74.51 110.182 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.82 -20.64 62.55 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.909 -0.587 . . . . 70.42 112.063 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -90.2 3.28 53.96 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 112.492 0.553 . . . . 65.54 112.492 -178.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 110.28 -75.28 0.21 Allowed Glycine 0 CA--C 1.497 -1.071 0 C-N-CA 119.581 -1.295 . . . . 71.55 112.98 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 449' ' ' PHE . . . . . 0.433 ' HA ' ' O ' ' A' ' 480' ' ' ILE . 0.2 OUTLIER -40.94 -62.36 0.83 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.902 1.075 . . . . 74.22 113.902 177.589 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 61.14 23.08 61.43 Favored Glycine 0 C--O 1.221 -0.701 0 C-N-CA 121.172 -0.537 . . . . 75.02 112.447 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.402 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 10.5 mmm180 -97.89 111.24 23.61 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 107.921 -1.14 . . . . 70.33 107.921 -177.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.433 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 19.7 p90 -137.6 149.49 46.69 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 121.215 0.531 . . . . 62.44 111.576 -177.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -136.19 142.48 44.12 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.446 -1.316 . . . . 62.32 107.446 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -112.7 126.03 54.96 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 120.601 0.239 . . . . 52.2 110.558 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 455' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -123.07 136.15 54.7 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.281 -1.007 . . . . 71.13 108.281 175.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -113.34 141.52 46.94 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.834 -1.173 . . . . 65.4 107.834 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 50.0 m -144.68 140.22 16.23 Favored Pre-proline 0 C--N 1.292 -1.931 0 N-CA-C 109.939 -0.393 . . . . 73.42 109.939 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.605 ' HA ' ' O ' ' A' ' 490' ' ' SER . 21.4 Cg_endo -64.93 122.6 10.45 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.625 1.55 . . . . 53.3 108.968 176.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 19.8 m -135.84 179.64 6.22 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.55 -0.75 . . . . 63.53 110.133 -171.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 460' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 464' ' ' VAL . 7.2 t -59.5 139.75 88.98 Favored Pre-proline 0 N--CA 1.42 -1.927 0 O-C-N 124.13 0.894 . . . . 71.31 109.399 174.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.37 -29.08 29.31 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.707 3.605 . . . . 70.01 113.492 -175.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -65.34 -37.18 86.29 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.541 -0.3 . . . . 63.35 111.807 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.07 -14.87 32.91 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 121.044 -0.262 . . . . 71.31 111.397 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 460' ' ' THR . 85.4 t -60.31 128.12 20.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-N 116.498 -0.319 . . . . 63.24 110.29 177.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 95.45 -12.11 68.1 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.519 -0.764 . . . . 72.14 112.229 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -122.47 167.45 13.33 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.204 -0.665 . . . . 51.43 109.204 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.456 HG13 HG23 ' A' ' 486' ' ' ILE . 62.4 t -72.63 143.89 13.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 107.567 -1.272 . . . . 73.44 107.567 171.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 55.3 mt -97.18 -34.03 4.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.372 -1.344 . . . . 23.34 107.372 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 163.06 -172.87 39.17 Favored Glycine 0 N--CA 1.409 -3.106 0 CA-C-N 114.802 -1.09 . . . . 64.32 110.508 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 24.5 p -116.1 147.83 40.91 Favored 'General case' 0 N--CA 1.404 -2.728 0 N-CA-C 105.931 -1.877 . . . . 72.41 105.931 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.432 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 20.3 t-20 -70.18 -49.99 16.83 Favored Pre-proline 0 C--N 1.313 -0.979 0 C-N-CA 118.237 -1.385 . . . . 72.22 110.756 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 19.2 Cg_exo -74.07 125.42 9.8 Favored 'Trans proline' 0 C--N 1.368 1.582 0 N-CA-C 106.837 -2.024 . . . . 64.15 106.837 165.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.438 ' HB2' ' HG2' ' A' ' 476' ' ' GLN . 21.8 Cg_exo -61.98 133.64 45.47 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 122.129 1.886 . . . . 71.24 113.562 -172.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -75.34 16.87 0.3 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.057 0.943 . . . . 64.43 112.188 -176.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -110.45 -10.93 14.54 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.887 -0.597 . . . . 64.21 109.551 177.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 476' ' ' GLN . . . . . 0.438 ' HG2' ' HB2' ' A' ' 473' ' ' PRO . 78.6 mm-40 -90.24 176.97 6.55 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.661 -0.699 . . . . 63.4 112.473 -174.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 6.1 m -107.57 114.98 29.34 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 107.412 -1.329 . . . . 74.11 107.412 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 13.4 p -112.61 147.85 35.82 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.157 0.503 . . . . 74.24 111.635 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.58 160.22 30.42 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.843 -0.617 . . . . 71.32 111.371 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 449' ' ' PHE . 1.8 mp -67.63 -15.16 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.394 0 CA-C-O 122.145 0.974 . . . . 74.2 112.059 -178.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 11.6 p -103.49 5.3 36.76 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.436 -0.79 . . . . 75.11 111.331 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -85.36 129.39 34.82 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.094 -0.706 . . . . 61.31 109.094 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.402 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 61.5 t -91.93 126.6 44.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.864 -0.607 . . . . 74.22 110.303 -177.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 30.2 t -106.38 120.05 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 N-CA-C 108.781 -0.822 . . . . 52.13 108.781 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.39 123.67 47.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-O 121.227 0.537 . . . . 63.4 110.124 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.456 HG23 HG13 ' A' ' 467' ' ' VAL . 1.7 mp -102.59 128.09 55.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 124.976 1.31 . . . . 72.41 108.795 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 8.2 tt -109.74 126.6 66.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 109.255 -0.646 . . . . 75.21 109.255 176.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 34.1 m -109.17 151.34 11.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 116.251 -0.431 . . . . 51.12 110.232 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -88.78 131.58 10.76 Favored Glycine 0 N--CA 1.439 -1.104 0 C-N-CA 120.592 -0.813 . . . . 75.01 111.851 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.605 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 19.5 m -123.64 155.78 37.09 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.65 -0.87 . . . . 71.12 108.65 177.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 135.08 90.88 0.35 Allowed Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.51 -0.852 . . . . 73.32 112.009 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.96 151.45 24.11 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.202 1.935 . . . . 74.1 112.603 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -84.65 67.08 9.88 Favored 'General case' 0 C--O 1.25 1.095 0 CA-C-O 122.158 0.98 . . . . 65.32 110.461 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.47 ' HB ' HG22 ' A' ' 544' ' ' THR . 11.1 p -117.64 153.67 32.9 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 114.735 -1.121 . . . . 62.43 110.559 -178.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -149.73 150.38 31.99 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.689 -0.856 . . . . 64.32 108.689 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.7 p-10 -81.74 138.95 35.13 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 123.588 0.755 . . . . 71.12 110.903 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 497' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 543' ' ' THR . 22.2 pt -92.85 117.92 67.72 Favored Pre-proline 0 C--N 1.307 -1.254 0 CA-C-N 115.954 -0.567 . . . . 72.23 110.876 176.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -92.99 146.45 2.44 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.422 2.081 . . . . 71.13 111.373 175.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -83.39 96.07 8.42 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 122.803 1.287 . . . . 72.2 110.634 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.6 p -100.44 23.26 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 123.258 1.504 . . . . 75.41 107.432 177.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -77.07 171.6 14.55 Favored 'General case' 0 N--CA 1.416 -2.149 0 CA-C-N 113.368 -1.742 . . . . 73.04 110.295 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 96.74 22.4 18.47 Favored Glycine 0 C--N 1.285 -2.278 0 N-CA-C 108.258 -1.937 . . . . 63.31 108.258 -177.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -133.68 174.73 10.13 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 108.265 -1.013 . . . . 61.23 108.265 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 41.7 p -77.91 164.32 25.24 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 117.966 0.348 . . . . 62.41 110.998 -176.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 17.4 m -51.42 -44.49 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.652 0 C-N-CA 123.79 0.836 . . . . 73.22 112.982 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -68.01 -41.78 81.68 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.215 0.531 . . . . 73.1 111.079 -178.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 62.5 t -72.55 -46.45 55.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 115.361 -0.836 . . . . 74.44 111.535 -175.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.72 -40.44 96.75 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.655 -0.248 . . . . 43.13 110.812 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -59.96 -43.55 94.98 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.387 -0.598 . . . . 75.04 109.387 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.502 ' O ' HG23 ' A' ' 514' ' ' VAL . 59.7 tttm -58.1 -50.95 71.71 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.729 -1.123 . . . . 70.02 109.801 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -62.59 -46.75 86.88 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.575 -0.739 . . . . 75.42 112.046 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.94 -40.51 89.19 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 120.878 -0.329 . . . . 64.11 110.729 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -63.97 -37.98 89.42 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.127 -0.488 . . . . 55.13 111.309 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 510' ' ' LYS . 77.3 t -62.48 -30.47 49.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 121.006 0.431 . . . . 72.11 110.785 178.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -83.07 7.96 14.28 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.161 0.505 . . . . 75.54 111.715 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 93.99 -10.47 71.95 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.988 -0.625 . . . . 72.41 111.81 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -87.56 81.45 7.74 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-O 121.882 0.849 . . . . 73.35 109.433 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 3.5 p -89.89 3.34 53.32 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.917 -1.038 . . . . 75.44 110.98 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -108.74 113.45 26.42 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.061 -1.089 . . . . 71.43 108.061 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 520' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' A' ' 551' ' ' ILE . 15.3 p90 -131.56 156.64 45.39 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.024 -0.989 . . . . 71.21 111.791 -174.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 50.3 m -137.0 145.55 44.26 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 106.041 -1.837 . . . . 73.51 106.041 171.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -117.09 132.99 56.55 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 120.856 0.36 . . . . 64.35 110.267 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -124.58 141.11 52.34 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.179 -1.045 . . . . 75.51 108.179 176.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 6.4 m -110.28 120.75 43.45 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.62 -0.881 . . . . 72.0 108.62 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 34.9 m -120.9 164.12 17.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 110.294 -0.262 . . . . 55.54 110.294 -175.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 526' ' ' ASP . . . . . 0.641 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 8.0 p-10 -90.63 135.26 33.82 Favored 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 120.274 -0.57 . . . . 74.01 111.343 -177.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 527' ' ' SER . . . . . 0.455 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 67.5 m -160.75 -179.92 1.18 Allowed Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 108.914 -0.773 . . . . 61.5 108.914 176.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -85.55 -19.15 3.62 Favored 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 121.505 1.47 . . . . 72.5 111.158 171.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -69.11 137.16 89.36 Favored Pre-proline 0 N--CA 1.437 -1.092 0 C-N-CA 124.018 0.927 . . . . 75.13 109.628 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -56.73 144.56 86.4 Favored 'Trans proline' 0 C--O 1.245 0.863 0 C-N-CA 123.624 2.883 . . . . 52.41 115.505 -170.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.634 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -67.4 115.51 7.12 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 114.258 -1.337 . . . . 75.23 109.907 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 133.93 -21.47 3.94 Favored Glycine 0 C--N 1.297 -1.61 0 N-CA-C 110.777 -0.929 . . . . 54.31 110.777 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -83.07 128.9 34.9 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 120.951 0.405 . . . . 74.43 110.596 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.46 HG22 HG22 ' A' ' 555' ' ' VAL . 84.2 t -83.22 105.74 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 N-CA-C 104.791 -2.3 . . . . 72.32 104.791 170.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 74.1 m -83.69 -16.85 43.45 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 112.312 0.486 . . . . 75.44 112.312 -173.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 173.44 -161.78 32.66 Favored Glycine 0 CA--C 1.49 -1.505 0 C-N-CA 120.099 -1.048 . . . . 61.52 111.251 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 23.7 p -127.77 160.07 32.85 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.782 -0.822 . . . . 71.05 108.782 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -73.01 -51.57 6.1 Favored Pre-proline 0 C--N 1.307 -1.243 0 CA-C-O 119.337 -0.363 . . . . 73.5 110.034 176.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 29.6 Cg_endo -66.55 130.86 24.58 Favored 'Trans proline' 0 C--N 1.378 2.103 0 N-CA-C 108.487 -1.39 . . . . 71.34 108.487 170.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 540' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 38.9 Cg_exo -61.66 142.11 93.24 Favored 'Trans proline' 0 C--O 1.241 0.673 0 C-N-CA 122.59 2.193 . . . . 74.22 114.161 -176.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.54 141.72 57.76 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.125 -0.943 . . . . 44.13 109.996 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.11 -20.65 46.61 Favored Glycine 0 C--N 1.302 -1.322 0 N-CA-C 110.545 -1.022 . . . . 72.12 110.545 -177.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.433 ' O ' HG12 ' A' ' 497' ' ' ILE . 63.5 m -76.47 137.66 39.81 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-O 121.507 0.67 . . . . 40.44 109.868 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.47 HG22 ' HB ' ' A' ' 494' ' ' THR . 18.4 m -94.14 123.92 37.82 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 115.373 -0.83 . . . . 74.51 109.749 -176.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 31.6 m -129.12 157.96 74.36 Favored Pre-proline 0 C--N 1.312 -1.044 0 N-CA-C 109.217 -0.661 . . . . 75.21 109.217 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 494' ' ' THR . 25.0 Cg_exo -66.07 143.61 72.58 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.067 1.845 . . . . 74.43 110.793 175.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 36.0 m -66.26 -19.04 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-O 121.521 0.677 . . . . 51.51 111.842 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -87.53 -2.05 58.35 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 115.297 -0.865 . . . . 73.23 110.703 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 32.3 t -89.09 157.24 18.39 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.485 -0.561 . . . . 74.24 109.485 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 25.8 t -96.33 136.65 26.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 109.24 -0.652 . . . . 71.14 109.24 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 551' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 520' ' ' PHE . 2.7 mp -113.66 138.56 42.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.379 -0.6 . . . . 73.32 109.379 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -101.98 121.13 41.56 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 121.36 0.6 . . . . 74.35 110.472 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.3 mp -95.56 132.08 41.08 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.364 -1.289 . . . . 71.25 107.859 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -106.84 120.17 41.31 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 122.013 0.911 . . . . 63.34 110.953 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.46 HG22 HG22 ' A' ' 534' ' ' VAL . 47.0 t -99.61 135.65 34.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-N 114.111 -1.404 . . . . 53.34 108.211 -178.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.634 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 68.2 m -90.73 149.2 22.13 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 116.464 -0.335 . . . . 41.23 110.455 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.641 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 15.8 ptmt -105.65 146.68 29.39 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 105.226 -2.138 . . . . 74.51 105.226 172.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -84.15 -24.72 47.06 Favored Glycine 0 N--CA 1.433 -1.549 0 C-N-CA 119.479 -1.343 . . . . 64.12 112.239 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 70.02 5.91 5.5 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.687 1.195 . . . . 71.34 111.004 -177.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 15.3 tp60 -148.53 141.87 25.2 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 106.891 -1.522 . . . . 75.15 106.891 -171.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -143.86 149.52 37.06 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.945 -0.761 . . . . 74.24 108.945 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.52 119.79 32.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 121.286 0.565 . . . . 51.34 111.413 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 60.4 ttp -97.75 134.0 22.84 Favored Pre-proline 0 C--N 1.316 -0.873 0 N-CA-C 108.537 -0.912 . . . . 72.11 108.537 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -64.18 169.52 10.61 Favored 'Trans proline' 0 C--O 1.245 0.872 0 C-N-CA 122.864 2.376 . . . . 75.41 112.378 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 565' ' ' ASP . . . . . 0.549 ' HA ' ' HB1' ' A' ' 610' ' ' ALA . 31.9 t70 -69.0 131.07 44.48 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 113.802 1.038 . . . . 65.11 113.802 -177.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 93.8 mt -147.12 23.19 1.19 Allowed 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 125.141 1.377 . . . . 75.35 107.942 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 2.8 m -79.25 146.28 33.1 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 116.25 -0.432 . . . . 75.43 110.824 -175.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 82.75 33.63 24.02 Favored Glycine 0 CA--C 1.496 -1.105 0 C-N-CA 120.796 -0.716 . . . . 72.02 112.137 174.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 25.0 mmt -108.04 -175.12 2.69 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.089 0.471 . . . . 72.43 110.387 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -110.25 155.9 21.41 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 108.845 -0.798 . . . . 73.3 108.845 -176.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 26.6 t90 -59.9 -30.68 69.19 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 123.217 0.323 . . . . 73.41 111.207 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 11.7 p -63.9 -21.51 28.91 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 CA-C-O 121.355 0.597 . . . . 74.23 110.791 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 573' ' ' ASP . . . . . 0.646 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 17.9 t70 -101.69 -41.74 6.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.715 -0.675 . . . . 75.53 109.703 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -62.79 -46.76 86.48 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 113.189 0.811 . . . . 51.51 113.189 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -54.33 -55.32 38.41 Favored Pre-proline 0 CA--C 1.577 2.016 0 O-C-N 123.215 0.322 . . . . 73.31 110.76 -178.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.37 -28.48 84.23 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.446 2.098 . . . . 65.24 114.24 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.646 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 29.1 mmt180 -58.15 -47.13 84.3 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.818 -0.438 . . . . 72.25 109.818 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 9.9 mp -61.11 -40.41 93.66 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.589 -0.732 . . . . 63.33 110.993 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -64.76 -46.83 80.46 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.931 -0.577 . . . . 75.41 110.206 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -67.63 -34.95 78.0 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.739 -0.664 . . . . 62.3 112.786 -177.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 581' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 92.4 mt -81.49 -7.55 59.6 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 112.61 0.596 . . . . 63.21 112.61 -176.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 74.41 40.16 40.75 Favored Glycine 0 CA--C 1.504 -0.627 0 C-N-CA 119.712 -1.232 . . . . 62.41 110.128 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 583' ' ' TRP . . . . . 0.455 ' CH2' ' HB2' ' A' ' 587' ' ' LEU . 77.0 t90 -72.51 136.09 45.82 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.59 -0.805 . . . . 70.14 111.166 -178.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 34.1 m -146.94 95.28 2.55 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.578 -0.527 . . . . 74.31 109.578 175.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -161.73 -144.98 4.17 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 108.871 -1.692 . . . . 71.2 108.871 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 87.5 mtp -111.34 133.7 53.46 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 118.085 0.943 . . . . 63.23 110.827 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 587' ' ' LEU . . . . . 0.455 ' HB2' ' CH2' ' A' ' 583' ' ' TRP . 61.6 tp -114.52 129.23 56.65 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.964 -1.124 . . . . 73.41 107.964 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -101.55 100.07 10.45 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 119.16 -1.016 . . . . 62.01 109.007 176.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -114.38 110.56 20.07 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 115.269 -0.878 . . . . 53.45 108.954 175.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 590' ' ' GLY . . . . . 0.438 ' HA3' ' NH1' ' A' ' 623' ' ' ARG . . . -90.8 -151.08 25.77 Favored Glycine 0 N--CA 1.433 -1.512 0 C-N-CA 120.991 -0.623 . . . . 62.14 113.069 -178.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -100.21 154.49 18.42 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 110.025 -0.361 . . . . 65.34 110.025 -177.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 592' ' ' ASP . . . . . 0.403 ' HB2' ' HG3' ' A' ' 626' ' ' GLN . 4.5 p30 -73.49 149.82 42.04 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 123.896 0.748 . . . . 74.11 110.634 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 94.8 t -138.45 130.2 37.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 115.476 -0.784 . . . . 62.02 109.763 -177.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -77.68 106.73 9.67 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 107.4 -1.333 . . . . 62.23 107.4 173.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -126.39 -20.16 4.48 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 116.03 -0.532 . . . . 73.33 111.132 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 128.2 157.93 9.52 Favored Glycine 0 C--N 1.302 -1.343 0 N-CA-C 110.412 -1.075 . . . . 42.03 110.412 -177.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.35 -35.67 66.64 Favored Glycine 0 N--CA 1.46 0.279 0 N-CA-C 113.992 0.357 . . . . 71.11 113.992 -173.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 19.9 m -62.61 -24.54 67.63 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.036 0.446 . . . . 70.24 111.701 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -107.05 -11.57 15.62 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 122.057 -0.402 . . . . 71.43 111.809 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 41.6 m170 -77.78 133.64 38.2 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 122.204 -0.31 . . . . 71.15 111.707 -176.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 58.9 t30 70.03 -21.73 0.17 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 125.488 1.515 . . . . 53.3 114.254 174.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 17.7 ttp85 -91.38 149.69 21.61 Favored 'General case' 0 C--N 1.312 -1.059 0 O-C-N 121.976 -0.453 . . . . 74.34 111.184 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 603' ' ' VAL . . . . . 0.495 HG23 ' HB2' ' A' ' 622' ' ' LEU . 9.0 p -62.71 133.66 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 O-C-N 123.765 0.665 . . . . 70.02 109.911 174.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 90.8 t -90.94 -48.46 14.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 108.317 -0.994 . . . . 72.03 108.317 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 605' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 622' ' ' LEU . 49.1 p90 -151.89 152.65 32.84 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 107.124 -1.435 . . . . 71.33 107.124 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -126.48 139.36 53.3 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 109.156 -0.683 . . . . 63.45 109.156 176.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.604 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 25.3 t-20 -54.91 -66.85 0.81 Allowed Pre-proline 0 C--N 1.311 -1.071 0 CA-C-N 115.407 -0.815 . . . . 72.35 112.454 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.604 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 88.2 Cg_endo -93.04 132.99 0.95 Allowed 'Trans proline' 0 N--CA 1.442 -1.55 0 CA-C-N 121.481 1.564 . . . . 73.21 110.6 173.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -70.3 134.76 27.58 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 121.102 1.201 . . . . 73.23 110.834 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 610' ' ' ALA . . . . . 0.549 ' HB1' ' HA ' ' A' ' 565' ' ' ASP . . . -69.49 129.68 40.38 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.6 -0.889 . . . . 33.11 108.6 176.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.38 -2.89 39.96 Favored Glycine 0 C--N 1.299 -1.513 0 N-CA-C 109.707 -1.357 . . . . 53.45 109.707 -172.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 30.2 m -119.11 167.54 11.7 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 107.832 -1.174 . . . . 71.04 107.832 177.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -71.34 126.17 12.76 Favored Glycine 0 N--CA 1.432 -1.588 0 CA-C-O 120.984 0.214 . . . . 72.05 112.987 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 614' ' ' VAL . . . . . 0.44 HG12 ' HB2' ' A' ' 608' ' ' PRO . 35.6 m -106.15 143.6 16.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 C-N-CA 124.606 1.162 . . . . 55.1 108.385 177.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.435 ' ND2' ' HB2' ' A' ' 617' ' ' ASP . 32.2 p-10 -67.64 161.07 26.59 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.657 0.265 . . . . 63.24 111.506 -176.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 616' ' ' ARG . . . . . 0.51 ' HD3' ' H ' ' A' ' 616' ' ' ARG . 0.0 OUTLIER -52.95 -30.71 36.28 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.812 -0.631 . . . . 65.43 111.796 178.799 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 617' ' ' ASP . . . . . 0.435 ' HB2' ' ND2' ' A' ' 615' ' ' ASN . 4.8 m-20 -71.34 -37.81 71.68 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 116.394 -0.366 . . . . 74.4 111.064 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 85.05 22.88 51.21 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 118.553 -1.784 . . . . 31.4 111.524 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.96 122.04 17.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 122.637 1.208 . . . . 72.24 109.773 -169.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 5.1 tp -126.4 123.28 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 CA-C-N 114.068 -1.423 . . . . 75.22 111.209 -174.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.557 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 55.0 m -115.0 121.87 44.47 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 107.952 -1.129 . . . . 65.02 107.952 173.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 622' ' ' LEU . . . . . 0.495 ' HB2' HG23 ' A' ' 603' ' ' VAL . 0.0 OUTLIER -138.41 159.48 41.97 Favored 'General case' 0 CA--C 1.479 -1.781 0 N-CA-C 107.044 -1.465 . . . . 74.44 107.044 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 623' ' ' ARG . . . . . 0.438 ' NH1' ' HA3' ' A' ' 590' ' ' GLY . 18.2 tpt180 -135.42 149.48 49.63 Favored 'General case' 0 C--N 1.267 -2.999 0 N-CA-C 105.686 -1.968 . . . . 73.55 105.686 178.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -141.08 162.02 36.47 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 106.569 -1.641 . . . . 65.35 106.569 177.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -78.44 -101.57 0.21 Allowed Glycine 0 N--CA 1.427 -1.912 0 N-CA-C 109.832 -1.307 . . . . 74.23 109.832 177.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 626' ' ' GLN . . . . . 0.403 ' HG3' ' HB2' ' A' ' 592' ' ' ASP . 33.3 tt0 . . . . . 0 C--N 1.282 -2.329 0 N-CA-C 108.664 -0.865 . . . . 63.13 108.664 175.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.265 0 N-CA-C 110.105 -1.198 . . . . 60.14 110.105 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 9.9 tp -75.75 134.34 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 N-CA-C 109.062 -0.718 . . . . 74.13 109.062 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.04 128.85 36.6 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 108.415 -0.957 . . . . 64.13 108.415 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -92.82 -11.49 33.55 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.348 -0.842 . . . . 72.12 109.262 -176.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -112.26 149.12 32.79 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.859 -1.163 . . . . 74.34 107.859 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 35.9 m -117.42 159.25 17.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-O 120.864 0.364 . . . . 63.54 110.145 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -95.5 122.96 38.79 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.609 -1.626 . . . . 71.43 106.609 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.583 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 60.7 t -96.46 133.17 25.13 Favored Pre-proline 0 C--N 1.294 -1.843 0 CA-C-N 116.2 -0.455 . . . . 52.22 110.627 -170.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 363' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 6.9 Cg_exo -68.9 127.63 15.57 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 121.682 1.588 . . . . 73.15 111.3 178.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -82.35 100.48 10.0 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 122.575 1.179 . . . . 74.03 110.039 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 20.0 m -74.32 9.11 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 113.587 -1.642 . . . . 63.53 114.522 -174.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -63.34 144.62 56.8 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 123.025 0.53 . . . . 55.45 111.252 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.52 0.35 43.25 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.959 -0.564 . . . . 40.45 112.395 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -112.16 -160.6 0.72 Allowed 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.538 -1.282 . . . . 61.3 107.538 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 84.0 p -91.58 166.01 13.04 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 106.696 -1.594 . . . . 43.44 106.696 177.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 40.2 t -60.63 -42.33 96.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 118.376 0.534 . . . . 62.44 109.608 177.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.19 -46.56 76.92 Favored 'General case' 0 C--O 1.214 -0.804 0 CA-C-N 115.892 -0.594 . . . . 70.22 111.727 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -65.91 -44.55 84.89 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 120.648 0.261 . . . . 75.41 111.161 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -61.86 -48.64 79.62 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.762 -0.653 . . . . 71.41 111.121 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 66.7 mt -67.21 -40.0 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 116.049 -0.523 . . . . 62.21 110.936 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.19 -39.73 91.27 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-O 120.626 0.251 . . . . 61.43 111.212 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 376' ' ' THR . . . . . 0.427 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 90.4 m -63.96 -48.52 76.17 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 116.088 -0.506 . . . . 63.54 109.953 177.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.9 -38.9 92.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.312 -0.404 . . . . 51.42 111.081 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -62.92 -43.8 97.82 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.824 -0.625 . . . . 74.03 111.113 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -67.64 -23.66 65.37 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.488 0.661 . . . . 74.32 111.569 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 376' ' ' THR . 27.9 mmt180 -84.7 -14.16 49.25 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.747 -0.66 . . . . 71.2 111.088 177.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.81 16.3 45.75 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.309 -0.948 . . . . 71.1 112.447 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.46 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 53.8 m-85 -83.99 173.73 10.92 Favored 'General case' 0 N--CA 1.421 -1.875 0 CA-C-O 120.946 0.403 . . . . 62.53 111.537 177.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -116.17 150.46 37.42 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 107.186 -1.413 . . . . 65.03 107.186 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.42 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -126.69 140.35 49.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 CA-C-O 121.094 0.473 . . . . 75.13 110.801 -178.25 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 385' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 417' ' ' THR . 39.9 ttt180 -116.06 127.95 55.3 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 105.995 -1.854 . . . . 72.33 105.995 174.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 22.8 m -111.87 131.88 55.07 Favored 'General case' 0 C--N 1.276 -2.623 0 C-N-CA 119.988 -0.685 . . . . 70.13 110.403 -175.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -111.11 119.46 39.06 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 105.264 -2.124 . . . . 71.41 105.264 175.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.716 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 19.3 pm0 -129.73 123.13 30.32 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.774 0.321 . . . . 64.41 111.28 -176.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -138.52 138.04 21.46 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 116.252 -0.431 . . . . 74.2 111.525 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' A' ' 422' ' ' THR . 8.4 Cg_exo -77.84 131.29 11.07 Favored 'Trans proline' 0 C--O 1.259 1.541 0 C-N-CA 122.472 2.115 . . . . 74.33 110.223 169.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.434 ' HB3' HG12 ' A' ' 394' ' ' ILE . 22.8 t70 169.01 136.87 0.02 OUTLIER 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 124.304 1.042 . . . . 65.24 108.328 -177.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 14.3 m -93.64 4.59 53.72 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 113.015 0.746 . . . . 64.22 113.015 -173.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 86.0 m -99.8 -30.15 12.22 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.578 -0.701 . . . . 71.41 110.248 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.434 HG12 ' HB3' ' A' ' 391' ' ' ASP . 16.9 pt -87.6 148.63 44.51 Favored Pre-proline 0 N--CA 1.433 -1.323 0 CA-C-N 116.097 -0.501 . . . . 75.43 110.297 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 395' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 396' ' ' PRO . 13.8 Cg_endo -55.2 138.47 79.33 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.057 3.171 . . . . 63.32 115.397 -173.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 396' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 395' ' ' PRO . 62.5 Cg_exo -55.62 164.47 4.28 Favored 'Trans proline' 0 C--N 1.361 1.192 0 C-N-CA 124.949 3.766 . . . . 45.54 112.274 175.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -55.58 -7.93 0.32 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 113.176 0.806 . . . . 74.31 113.176 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' HIS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 34.2 m170 -77.72 111.56 13.64 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 104.914 -2.254 . . . . 74.21 104.914 169.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 33.3 m -77.16 122.74 32.38 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 N-CA-C 113.329 0.863 . . . . 63.23 113.329 -165.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 47.3 pt -89.8 -27.79 5.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 115.861 -0.608 . . . . 74.02 109.942 176.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.05 162.61 28.13 Favored Glycine 0 N--CA 1.419 -2.445 0 C-N-CA 119.714 -1.232 . . . . 61.42 114.035 -175.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 12.9 p -142.09 -176.84 4.96 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 126.767 2.027 . . . . 65.33 105.955 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -98.34 134.54 21.83 Favored Pre-proline 0 C--N 1.299 -1.627 0 C-N-CA 119.339 -0.944 . . . . 72.21 109.981 -175.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -59.92 -0.89 0.98 Allowed 'Trans proline' 0 C--N 1.362 1.284 0 C-N-CA 124.589 3.526 . . . . 71.53 115.205 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.0 -29.56 68.56 Favored 'General case' 0 C--O 1.203 -1.385 0 N-CA-C 108.243 -1.021 . . . . 64.34 108.243 172.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 406' ' ' ALA . . . . . 0.583 ' HA ' ' HB ' ' A' ' 362' ' ' VAL . . . -62.93 -44.04 97.16 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.236 -0.893 . . . . 60.25 109.761 175.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -80.64 -4.04 52.74 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.234 -0.894 . . . . 73.13 111.555 -175.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 23.1 m -98.74 150.45 21.81 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 105.534 -2.024 . . . . 70.45 105.534 173.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 52.2 p -75.27 111.93 11.04 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 117.695 -1.602 . . . . 73.4 107.091 175.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.5 m -125.54 169.04 17.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 120.846 0.355 . . . . 72.22 111.136 -177.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 13.7 m -64.63 134.58 54.59 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.455 -0.793 . . . . 74.34 109.686 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -64.56 128.66 36.74 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 116.057 -0.519 . . . . 73.32 110.127 -176.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 413' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 89.36 47.43 4.06 Favored Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 120.412 -0.899 . . . . 73.11 111.016 -177.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -106.83 161.31 14.8 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.794 -1.187 . . . . 72.04 107.794 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -86.27 108.9 18.6 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 121.398 0.618 . . . . 74.54 110.698 -176.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 41.9 mm -97.24 120.77 47.01 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 N-CA-C 108.217 -1.031 . . . . 63.53 108.217 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 417' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 385' ' ' ARG . 22.5 m -79.24 129.26 34.28 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.298 0.57 . . . . 65.24 111.124 -177.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 9.0 p -116.84 135.7 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-N 114.885 -1.052 . . . . 73.11 108.456 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -95.5 120.95 36.65 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 120.889 0.376 . . . . 60.11 110.718 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.716 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 99.2 t -127.25 131.68 70.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 108.488 -0.931 . . . . 70.55 108.488 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 4.1 m -131.43 143.11 50.2 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.504 -0.878 . . . . 41.14 109.568 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.524 ' O ' ' HA ' ' A' ' 390' ' ' PRO . 63.6 p -98.68 118.06 34.54 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 105.459 -2.052 . . . . 64.45 105.459 172.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -51.04 -87.81 0.01 OUTLIER Glycine 0 C--O 1.252 1.254 0 N-CA-C 116.084 1.194 . . . . 52.25 116.084 -170.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -69.44 131.77 22.4 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.148 1.899 . . . . 54.23 113.366 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -94.51 123.18 37.78 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 107.824 -1.176 . . . . 53.02 107.824 177.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.422 ' HB3' HG22 ' A' ' 477' ' ' THR . 43.4 mt-30 -128.81 142.6 50.93 Favored 'General case' 0 C--N 1.253 -3.623 0 N-CA-C 107.139 -1.43 . . . . 72.24 107.139 174.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.644 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 1.1 mmp_? -122.6 149.49 43.91 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-O 121.495 0.664 . . . . 70.22 112.141 -176.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' A' ' 428' ' ' GLU . 10.4 pt-20 -83.12 138.17 33.78 Favored 'General case' 0 C--N 1.276 -2.615 0 CA-C-N 113.836 -1.529 . . . . 72.44 108.566 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 58.2 mt -98.46 125.91 41.34 Favored Pre-proline 0 C--N 1.286 -2.155 0 N-CA-C 108.007 -1.109 . . . . 62.54 108.007 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -70.35 142.85 46.37 Favored 'Trans proline' 0 C--O 1.24 0.603 0 C-N-CA 122.216 1.944 . . . . 75.32 110.191 174.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -68.13 116.42 8.73 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.854 0.359 . . . . 70.2 110.369 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.05 140.25 27.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 109.216 -0.661 . . . . 73.53 109.216 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.596 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 19.6 m -68.94 158.29 34.96 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-O 120.864 0.364 . . . . 72.5 111.124 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 36.9 p -69.76 -28.87 66.13 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 114.309 1.225 . . . . 64.42 114.309 -171.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.0 pp -88.39 -11.55 45.8 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.655 0.741 . . . . 73.24 111.57 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.596 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 0.2 OUTLIER -92.53 40.87 1.06 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.663 -0.699 . . . . 65.24 110.743 -175.188 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -52.87 -38.28 61.37 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.545 0.738 . . . . 62.22 112.503 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.18 -41.82 97.48 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.979 0.418 . . . . 51.31 110.703 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -70.49 -34.66 72.61 Favored 'General case' 0 C--O 1.207 -1.137 0 CA-C-N 116.195 -0.457 . . . . 72.41 110.185 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.58 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -59.69 -51.7 68.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 119.766 -0.159 . . . . 73.02 111.119 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.6 m -62.01 -38.18 80.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-O 121.305 0.574 . . . . 73.43 110.463 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -60.63 -47.77 84.77 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.341 1.057 . . . . 53.24 110.971 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -65.75 -38.84 90.21 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 123.189 0.596 . . . . 50.3 111.428 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 85.3 mt -64.02 -36.88 85.43 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.167 -0.47 . . . . 51.11 110.176 177.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 33.1 m -70.11 -44.37 69.12 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.016 -0.538 . . . . 62.33 110.164 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.21 -18.31 65.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.854 -0.612 . . . . 71.25 111.246 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -90.04 5.48 46.48 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.129 -0.487 . . . . 72.42 111.824 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 109.71 -83.7 0.34 Allowed Glycine 0 CA--C 1.494 -1.225 0 C-N-CA 120.039 -1.077 . . . . 74.41 112.081 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -36.71 -61.85 0.51 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.734 1.383 . . . . 75.1 114.734 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 60.05 27.71 65.26 Favored Glycine 0 CA--C 1.508 -0.355 0 C-N-CA 120.842 -0.694 . . . . 63.22 111.434 -175.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -102.36 111.17 23.35 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 109.28 -0.637 . . . . 71.24 109.28 -176.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 11.5 p90 -139.64 152.03 46.44 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.653 -0.703 . . . . 75.54 110.298 -177.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -142.65 122.95 13.87 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.906 -1.146 . . . . 72.33 107.906 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -96.36 130.81 43.39 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 120.96 0.409 . . . . 75.53 111.758 -177.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 455' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -135.15 150.04 50.09 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 123.498 0.719 . . . . 55.23 109.199 175.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -123.1 149.82 44.0 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 119.915 -0.714 . . . . 73.01 110.491 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 46.1 m -151.18 151.65 29.78 Favored Pre-proline 0 C--N 1.295 -1.798 0 N-CA-C 107.184 -1.413 . . . . 71.31 107.184 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 490' ' ' SER . 19.2 Cg_exo -65.48 144.58 79.94 Favored 'Trans proline' 0 C--O 1.243 0.738 0 C-N-CA 121.747 1.631 . . . . 72.53 112.018 -177.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 14.9 t -152.55 179.37 8.65 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 106.709 -1.589 . . . . 65.23 106.709 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.5 t -56.17 142.94 65.6 Favored Pre-proline 0 C--N 1.305 -1.347 0 C-N-CA 123.947 0.899 . . . . 74.21 110.621 177.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -51.49 -29.73 32.77 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 124.464 3.443 . . . . 75.41 113.121 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.51 -19.39 60.93 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.942 0.401 . . . . 71.14 112.057 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -108.13 -1.93 19.92 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.112 0.412 . . . . 65.54 112.112 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 84.4 t -61.06 127.14 20.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.266 -0.642 . . . . 64.1 109.266 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.68 -13.09 68.26 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 116.065 -0.516 . . . . 32.13 111.812 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.419 ' O ' HG23 ' A' ' 488' ' ' VAL . 11.8 mptt -109.76 159.0 17.55 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.167 0.508 . . . . 74.53 110.12 -178.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 76.8 t -71.85 145.8 11.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 115.071 -0.968 . . . . 73.22 109.711 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 62.1 mt -98.39 -35.44 5.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 107.83 -1.174 . . . . 70.23 107.83 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 164.72 -174.52 40.71 Favored Glycine 0 N--CA 1.43 -1.757 0 CA-C-N 115.468 -0.787 . . . . 72.12 112.176 176.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 470' ' ' THR . . . . . 0.61 HG22 HG12 ' A' ' 486' ' ' ILE . 58.8 p -115.2 141.94 47.34 Favored 'General case' 0 N--CA 1.422 -1.825 0 N-CA-C 106.933 -1.506 . . . . 72.05 106.933 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.54 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 2.8 t-20 -64.46 -57.3 17.73 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 119.85 -0.74 . . . . 74.05 111.358 178.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.54 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 17.2 Cg_exo -74.19 138.53 25.31 Favored 'Trans proline' 0 C--N 1.363 1.311 0 N-CA-C 107.026 -1.951 . . . . 61.41 107.026 168.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -63.0 126.14 17.37 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 121.749 1.633 . . . . 72.21 113.669 -173.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -86.16 10.73 13.64 Favored 'General case' 0 C--O 1.205 -1.272 0 CA-C-N 115.275 -0.875 . . . . 61.04 111.047 -177.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -110.65 -0.68 17.1 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.54 -0.755 . . . . 75.02 110.455 176.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -124.46 -168.48 1.81 Allowed 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.024 -0.535 . . . . 74.24 110.548 -173.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.422 HG22 ' HB3' ' A' ' 426' ' ' GLN . 0.2 OUTLIER -89.09 131.46 35.24 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 115.54 -0.755 . . . . 42.35 110.544 -177.206 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 49.5 m -127.98 148.16 50.51 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 122.902 0.481 . . . . 63.04 110.097 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -77.87 158.77 29.3 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.932 -0.576 . . . . 71.42 110.931 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 35.0 mm -73.16 -23.06 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 121.552 0.692 . . . . 73.34 110.57 -175.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 17.0 m -95.94 1.8 53.1 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 122.081 0.943 . . . . 60.14 109.93 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -93.06 130.19 38.76 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.751 -0.659 . . . . 63.4 110.705 -175.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.2 p -100.34 126.41 53.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.25 0.548 . . . . 72.44 111.487 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 32.7 m -95.75 121.68 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-O 121.816 0.817 . . . . 42.11 110.327 178.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.61 129.28 43.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.971 -1.122 . . . . 75.14 107.971 177.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.61 HG12 HG22 ' A' ' 470' ' ' THR . 11.6 mt -113.73 124.61 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 CA-C-N 114.83 -1.077 . . . . 51.31 110.274 -175.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 8.5 tt -104.94 126.19 59.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 115.256 -0.883 . . . . 72.34 109.33 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 466' ' ' LYS . 2.3 p -111.41 145.53 17.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 C-N-CA 124.252 1.021 . . . . 64.21 109.447 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -80.14 124.41 6.48 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.991 -0.623 . . . . 72.23 111.662 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 18.3 t -142.78 132.15 23.5 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.84 -0.8 . . . . 74.4 108.84 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 138.52 107.07 0.75 Allowed Glycine 0 N--CA 1.437 -1.295 0 N-CA-C 109.89 -1.284 . . . . 74.45 109.89 -177.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -71.31 142.76 41.93 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.296 1.997 . . . . 54.41 112.414 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -136.7 21.38 3.1 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 122.154 0.978 . . . . 70.12 110.521 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 27.5 p -130.19 151.69 50.43 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-N 114.334 -1.303 . . . . 74.3 110.61 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 495' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 495' ' ' LYS . 18.7 mmtt -147.82 164.33 33.97 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.679 -0.691 . . . . 74.45 110.245 175.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -95.73 136.77 35.72 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.988 -0.551 . . . . 73.35 110.428 -175.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 27.7 pt -92.08 117.78 67.86 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 109.283 -0.636 . . . . 73.15 109.283 175.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.22 -179.39 5.38 Favored 'Trans proline' 0 C--O 1.249 1.058 0 C-N-CA 121.966 1.777 . . . . 54.55 111.934 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -79.07 111.26 15.1 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.471 -0.566 . . . . 74.42 109.471 177.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 9.9 p -113.35 18.97 7.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 122.424 1.107 . . . . 75.43 109.191 -176.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 501' ' ' ALA . . . . . 0.413 ' HB2' ' HA2' ' A' ' 536' ' ' GLY . . . -83.46 119.16 24.33 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.432 -0.803 . . . . 70.34 110.783 -177.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 120.33 22.12 3.22 Favored Glycine 0 N--CA 1.436 -1.338 0 C-N-CA 121.054 -0.593 . . . . 50.14 112.888 177.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 503' ' ' GLN . . . . . 0.53 HE22 ' N ' ' A' ' 508' ' ' ALA . 0.0 OUTLIER -137.14 -172.19 3.14 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 122.591 -0.358 . . . . 74.42 110.876 178.759 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 8.6 m -91.01 154.88 19.11 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 118.483 -1.287 . . . . 64.42 110.303 -173.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 9.5 p -58.34 -41.3 80.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 123.342 0.657 . . . . 70.2 112.415 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -59.73 -39.8 85.93 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.455 0.645 . . . . 71.03 109.877 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 29.3 t -73.52 -36.7 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 CA-C-N 115.314 -0.857 . . . . 64.34 109.955 -177.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 508' ' ' ALA . . . . . 0.53 ' N ' HE22 ' A' ' 503' ' ' GLN . . . -63.39 -49.78 72.45 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.397 -0.365 . . . . 63.0 111.593 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -63.23 -35.15 79.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.012 0.434 . . . . 75.01 110.554 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.435 ' O ' HG23 ' A' ' 514' ' ' VAL . 5.0 tppp? -61.99 -53.1 60.31 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.249 -0.887 . . . . 51.34 109.893 176.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -61.59 -44.91 96.15 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-N 116.163 -0.471 . . . . 53.22 111.632 -176.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -61.0 -44.07 97.96 Favored 'General case' 0 C--O 1.247 0.924 0 O-C-N 123.236 0.335 . . . . 53.24 111.442 178.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 513' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 10.2 m120 -63.84 -38.8 92.42 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 120.317 -0.553 . . . . 63.54 111.109 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 510' ' ' LYS . 73.0 t -61.88 -35.04 65.73 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 CA-C-N 116.052 -0.522 . . . . 75.42 111.087 177.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -74.63 -13.87 60.7 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.573 -0.451 . . . . 73.43 111.017 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 115.24 -2.06 22.38 Favored Glycine 0 N--CA 1.436 -1.335 0 C-N-CA 120.437 -0.887 . . . . 72.14 112.503 178.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.462 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 65.7 m-85 -85.27 109.36 18.3 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.517 -0.919 . . . . 74.14 108.517 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 17.5 p -88.18 -14.7 37.97 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 113.674 0.99 . . . . 75.43 113.674 -173.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -117.64 122.5 43.75 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 120.952 0.406 . . . . 70.43 111.497 -175.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 520' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 551' ' ' ILE . 46.3 p90 -129.88 153.47 48.27 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 116.002 -0.545 . . . . 64.24 111.366 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 521' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 58.5 m -139.9 152.26 46.26 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.193 -1.41 . . . . 74.02 107.193 174.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.9 pm0 -123.39 135.91 54.37 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-O 121.163 0.506 . . . . 70.14 111.068 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -131.55 130.79 42.73 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.28 -1.007 . . . . 75.23 108.28 176.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 524' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 19.8 m -96.03 132.55 41.27 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 110.129 -0.323 . . . . 60.41 110.129 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 34.0 m -121.54 149.57 24.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 108.154 -1.054 . . . . 63.33 108.154 178.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -74.6 135.47 42.04 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 121.029 -0.269 . . . . 74.21 111.432 -173.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 527' ' ' SER . . . . . 0.486 ' HB2' ' OG ' ' A' ' 556' ' ' SER . 70.3 m -159.43 174.65 3.81 Favored Pre-proline 0 C--N 1.314 -0.968 0 C-N-CA 123.771 0.828 . . . . 70.22 108.789 178.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -89.44 -3.05 5.93 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.969 1.779 . . . . 70.24 111.147 174.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.503 ' HB2' ' OG ' ' A' ' 556' ' ' SER . 23.8 mmt85 -79.93 133.31 58.43 Favored Pre-proline 0 N--CA 1.444 -0.753 0 N-CA-C 107.741 -1.207 . . . . 72.32 107.741 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -56.14 144.44 80.47 Favored 'Trans proline' 0 C--O 1.254 1.314 0 C-N-CA 123.065 2.51 . . . . 64.52 113.4 -175.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -57.8 113.66 1.95 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.69 -1.141 . . . . 75.03 110.69 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 138.71 -26.79 2.74 Favored Glycine 0 C--N 1.306 -1.126 0 CA-C-N 115.785 -0.643 . . . . 40.2 111.536 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -76.49 127.86 33.65 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.166 -0.679 . . . . 71.33 109.166 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 83.6 t -79.6 117.76 25.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.041 -1.096 . . . . 70.42 108.041 176.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 13.7 t -91.92 -1.86 57.08 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.678 -0.692 . . . . 54.11 110.757 -176.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.413 ' HA2' ' HB2' ' A' ' 501' ' ' ALA . . . 149.95 -166.07 29.84 Favored Glycine 0 CA--C 1.489 -1.557 0 C-N-CA 120.685 -0.769 . . . . 61.43 111.874 177.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 13.3 p -119.0 158.7 25.25 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 109.391 -0.596 . . . . 74.54 109.391 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.503 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 5.3 t30 -65.89 -52.36 41.79 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-O 119.083 -0.484 . . . . 52.15 111.097 177.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 4.8 Cg_exo -78.96 142.6 17.52 Favored 'Trans proline' 0 C--N 1.368 1.591 0 N-CA-C 108.2 -1.5 . . . . 70.42 108.2 171.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 540' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 31.5 Cg_exo -59.79 144.65 99.41 Favored 'Trans proline' 0 C--O 1.253 1.229 0 C-N-CA 122.297 1.998 . . . . 71.42 113.107 -177.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -64.33 137.37 57.87 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 115.896 -0.593 . . . . 73.34 109.819 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 102.44 -12.44 56.86 Favored Glycine 0 C--N 1.298 -1.578 0 C-N-CA 121.018 -0.61 . . . . 71.43 111.919 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 23.9 m -75.33 130.97 39.93 Favored 'General case' 0 C--O 1.245 0.843 0 N-CA-C 109.752 -0.462 . . . . 51.44 109.752 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 14.6 m -84.4 122.9 29.6 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 107.291 -1.374 . . . . 74.04 107.291 176.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.5 m -131.51 157.32 78.49 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.907 -0.405 . . . . 73.34 109.907 -177.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -64.86 140.47 67.01 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.4 2.066 . . . . 74.43 111.607 176.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.462 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 27.0 m -63.98 -20.14 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-O 121.761 0.791 . . . . 42.53 111.834 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -87.06 -11.2 50.99 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.058 -0.973 . . . . 41.25 111.873 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 80.5 p -82.09 175.98 9.89 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 120.017 -0.673 . . . . 71.13 112.343 -176.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 27.0 t -101.72 119.17 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 116.012 -0.54 . . . . 75.35 110.737 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 551' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 520' ' ' PHE . 1.8 mp -101.17 124.6 54.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 108.842 -0.799 . . . . 74.42 108.842 177.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 552' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 521' ' ' SER . 35.0 tt0 -102.86 128.84 49.47 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-O 121.211 0.529 . . . . 73.35 110.236 -178.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -93.37 133.98 36.07 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.329 -0.989 . . . . 74.13 108.329 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -95.85 114.25 25.96 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.944 -1.502 . . . . 65.44 106.944 176.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 524' ' ' SER . 40.5 t -99.79 141.3 17.21 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 108.391 -0.966 . . . . 72.1 108.391 -177.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.638 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 36.0 t -78.84 129.71 34.88 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 121.214 0.53 . . . . 72.33 111.27 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 12.2 ttpp -93.65 121.51 35.15 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 106.747 -1.575 . . . . 74.43 106.747 169.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -81.39 -24.24 57.12 Favored Glycine 0 CA--C 1.494 -1.269 0 C-N-CA 120.48 -0.867 . . . . 52.14 112.099 -177.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 4.8 p30 58.62 6.96 0.66 Allowed 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 127.257 2.223 . . . . 71.52 114.26 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -134.21 170.91 14.99 Favored 'General case' 0 C--O 1.253 1.244 0 CA-C-O 121.688 0.756 . . . . 73.21 112.286 -173.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -145.99 148.33 32.62 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.88 -1.526 . . . . 73.15 106.88 173.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 9.4 p -71.18 127.75 33.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-O 121.176 0.512 . . . . 71.3 110.229 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 58.7 ttp -96.26 115.29 65.52 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 109.272 -0.64 . . . . 75.31 109.272 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.98 154.9 72.1 Favored 'Trans proline' 0 C--O 1.242 0.684 0 C-N-CA 122.08 1.853 . . . . 44.05 110.367 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 565' ' ' ASP . . . . . 0.489 ' HA ' ' HB1' ' A' ' 610' ' ' ALA . 4.2 p-10 -76.03 118.1 18.44 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 121.822 0.82 . . . . 74.21 111.236 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 96.2 mt -137.52 34.09 2.49 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.009 -1.45 . . . . 65.24 107.184 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 14.8 m -71.25 132.72 45.35 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.008 -0.996 . . . . 64.24 111.342 -175.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 99.86 38.8 3.53 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 121.114 -0.565 . . . . 65.53 113.312 174.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 83.6 mtp -109.69 155.26 21.75 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.435 -0.58 . . . . 73.42 109.435 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 570' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 66.2 m-85 -74.96 149.73 39.27 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 107.286 -1.375 . . . . 72.31 107.286 175.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 571' ' ' TRP . . . . . 0.505 ' O ' ' HG3' ' A' ' 575' ' ' GLU . 41.0 t90 -60.47 -29.81 69.28 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 123.274 0.359 . . . . 64.42 110.855 -177.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 33.2 m -80.16 -10.42 12.49 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.612 0 CA-C-O 121.568 0.699 . . . . 65.02 110.894 -176.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -101.78 -31.84 10.56 Favored 'General case' 0 C--O 1.266 1.927 0 CA-C-O 122.885 1.326 . . . . 63.42 107.88 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 574' ' ' ALA . . . . . 0.45 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -68.77 -36.72 78.68 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 113.885 -1.507 . . . . 73.3 110.392 176.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.588 ' HB2' ' HD3' ' A' ' 576' ' ' PRO . 43.4 mt-10 -51.75 -57.79 13.42 Favored Pre-proline 0 CA--C 1.559 1.3 0 CA-C-O 118.87 -0.586 . . . . 73.51 111.66 177.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 576' ' ' PRO . . . . . 0.588 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 64.3 Cg_exo -56.63 -39.5 90.93 Favored 'Trans proline' 0 C--N 1.387 2.598 0 C-N-CA 121.768 1.645 . . . . 74.12 112.542 175.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -59.03 -43.59 91.64 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 119.782 -0.767 . . . . 74.54 112.269 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 96.2 mt -65.97 -47.22 75.33 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.521 0.677 . . . . 73.44 110.307 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -65.03 -34.98 79.72 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.412 -0.813 . . . . 75.51 111.643 -177.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.65 -33.38 70.91 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.367 0.506 . . . . 44.11 112.367 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 4.0 pp -88.4 -3.61 58.8 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.474 0.916 . . . . 72.43 113.474 -176.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 86.12 37.77 8.93 Favored Glycine 0 C--N 1.314 -0.648 0 C-N-CA 120.183 -1.008 . . . . 73.44 112.001 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 82.3 t90 -71.87 127.94 34.17 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 123.19 0.596 . . . . 74.01 110.808 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 23.0 m -138.3 67.9 1.4 Allowed 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 122.183 0.992 . . . . 70.12 109.404 174.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -124.44 -149.88 7.75 Favored Glycine 0 N--CA 1.436 -1.313 0 N-CA-C 110.07 -1.212 . . . . 73.33 110.07 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 586' ' ' MET . . . . . 0.485 ' O ' HG12 ' A' ' 619' ' ' ILE . 8.6 mmt -122.79 139.03 54.44 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.6 -0.519 . . . . 72.21 109.6 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -101.16 127.55 47.67 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 106.524 -1.658 . . . . 75.24 106.524 174.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -97.25 99.85 11.31 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 120.19 -0.604 . . . . 72.01 110.822 -175.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -114.42 109.19 17.92 Favored 'General case' 0 N--CA 1.409 -2.51 0 N-CA-C 108.154 -1.054 . . . . 72.53 108.154 170.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -143.97 -62.36 0.02 OUTLIER Glycine 0 CA--C 1.477 -2.319 0 N-CA-C 108.849 -1.7 . . . . 40.25 108.849 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 591' ' ' ALA . . . . . 0.429 ' O ' ' HD2' ' A' ' 623' ' ' ARG . . . -89.86 136.54 32.98 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.541 -0.911 . . . . 62.15 108.541 173.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -116.72 157.08 26.05 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.608 -0.516 . . . . 75.44 109.608 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 593' ' ' VAL . . . . . 0.422 ' O ' ' HA2' ' A' ' 625' ' ' GLY . 38.5 t -107.15 132.01 55.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 120.336 -0.546 . . . . 71.44 110.232 -177.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 594' ' ' ASP . . . . . 0.603 ' HA ' ' OE1' ' A' ' 626' ' ' GLN . 5.8 p-10 -73.76 112.4 9.83 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.102 0.477 . . . . 73.54 112.255 -178.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -176.6 19.97 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 114.56 -1.2 . . . . 61.24 110.647 175.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 83.74 127.6 1.39 Allowed Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 110.326 -1.11 . . . . 61.33 110.326 -174.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.559 ' O ' ' HB2' ' A' ' 601' ' ' ASN . . . -62.12 -49.55 73.84 Favored Glycine 0 C--O 1.2 -2.0 0 C-N-CA 120.478 -0.868 . . . . 74.3 112.478 -176.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 47.0 m -71.56 -24.13 61.87 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.315 0.578 . . . . 53.15 111.689 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -89.64 -7.69 54.14 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.925 -0.58 . . . . 74.04 112.169 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -145.45 28.61 1.18 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.836 0.827 . . . . 74.54 109.547 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 601' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 597' ' ' GLY . 20.7 t-20 -86.55 62.94 7.71 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 122.425 1.107 . . . . 64.41 108.575 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 602' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 37.1 ptt85 -143.0 171.84 13.51 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 107.453 -1.314 . . . . 73.54 107.453 -176.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 11.7 p -62.84 129.87 26.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 107.388 -1.338 . . . . 70.23 107.388 174.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 87.2 t -95.98 -36.4 6.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 119.833 -0.747 . . . . 53.33 109.09 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -154.79 158.96 40.26 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 105.892 -1.892 . . . . 71.01 105.892 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -128.86 124.93 36.54 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.047 -0.723 . . . . 73.03 109.047 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.498 ' HB2' ' HB ' ' A' ' 621' ' ' THR . 21.9 t-20 -59.36 -50.66 86.26 Favored Pre-proline 0 CA--C 1.559 1.327 0 CA-C-N 115.792 -0.64 . . . . 74.22 112.453 -177.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.494 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 4.3 Cg_exo -90.09 124.89 1.21 Allowed 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 121.908 1.739 . . . . 51.12 110.764 173.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.79 139.09 66.95 Favored 'Trans proline' 0 C--O 1.252 1.189 0 C-N-CA 122.414 2.076 . . . . 64.31 111.909 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 610' ' ' ALA . . . . . 0.489 ' HB1' ' HA ' ' A' ' 565' ' ' ASP . . . -64.09 138.44 58.46 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.594 -0.73 . . . . 54.42 110.363 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 99.69 -5.86 58.59 Favored Glycine 0 N--CA 1.435 -1.425 0 N-CA-C 111.441 -0.664 . . . . 72.54 111.441 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 12.1 m -99.96 160.22 14.48 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 108.772 -0.825 . . . . 62.02 108.772 -178.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -75.08 125.3 8.15 Favored Glycine 0 N--CA 1.423 -2.199 0 N-CA-C 109.883 -1.287 . . . . 41.23 109.883 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 34.7 m -112.22 142.62 24.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 108.612 -0.884 . . . . 73.3 108.612 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.42 HD21 ' CG2' ' A' ' 619' ' ' ILE . 30.5 p30 -43.68 152.79 0.14 Allowed 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.745 1.017 . . . . 73.3 113.745 177.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -56.8 -25.72 56.35 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.345 1.058 . . . . 71.45 112.604 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -63.84 -42.9 97.5 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 108.401 -0.963 . . . . 71.0 108.401 176.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 618' ' ' GLY . . . . . 0.411 ' O ' HG12 ' A' ' 620' ' ' ILE . . . 81.97 19.25 65.64 Favored Glycine 0 N--CA 1.42 -2.386 0 N-CA-C 109.324 -1.51 . . . . 62.1 109.324 -177.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 619' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 586' ' ' MET . 0.0 OUTLIER -70.71 117.76 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-O 122.274 1.035 . . . . 72.21 108.594 -175.407 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 618' ' ' GLY . 47.7 mm -115.32 130.31 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.195 0 N-CA-C 105.941 -1.874 . . . . 74.53 105.941 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.498 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 27.7 m -96.87 114.64 26.29 Favored 'General case' 0 N--CA 1.401 -2.918 0 C-N-CA 117.175 -1.81 . . . . 75.55 106.977 175.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 4.4 pp -140.9 150.3 43.01 Favored 'General case' 0 N--CA 1.406 -2.627 0 N-CA-C 105.753 -1.943 . . . . 73.43 105.753 176.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 623' ' ' ARG . . . . . 0.429 ' HD2' ' O ' ' A' ' 591' ' ' ALA . 28.5 mtm180 -133.81 156.71 47.53 Favored 'General case' 0 C--N 1.269 -2.893 0 N-CA-C 108.502 -0.925 . . . . 55.11 108.502 175.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -133.18 166.87 21.44 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 124.444 1.09 . . . . 74.22 111.405 -173.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 625' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 593' ' ' VAL . . . -66.18 139.41 37.97 Favored Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 115.214 0.846 . . . . 53.25 115.214 -176.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 626' ' ' GLN . . . . . 0.603 ' OE1' ' HA ' ' A' ' 594' ' ' ASP . 1.3 mp0 . . . . . 0 N--CA 1.473 0.689 0 N-CA-C 116.118 1.896 . . . . 72.5 116.118 176.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.076 0 N-CA-C 111.267 -0.733 . . . . 43.05 111.267 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 11.3 tp -85.14 146.6 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 N-CA-C 108.534 -0.913 . . . . 73.42 108.534 177.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 4.6 m -88.71 155.81 19.37 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 106.716 -1.587 . . . . 60.51 106.716 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -72.14 -24.56 61.48 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 120.045 -0.662 . . . . 75.04 110.035 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -83.24 126.76 33.0 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 106.972 -1.492 . . . . 64.32 106.972 170.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 360' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 409' ' ' SER . 24.0 m -121.54 163.56 19.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.354 0 N-CA-C 109.654 -0.499 . . . . 63.34 109.654 -177.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.37 129.81 39.37 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.365 -1.346 . . . . 72.02 107.365 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 55.6 t -97.16 129.85 31.18 Favored Pre-proline 0 C--N 1.282 -2.366 0 CA-C-N 115.427 -0.806 . . . . 65.41 109.494 -171.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -68.86 128.59 17.1 Favored 'Trans proline' 0 C--O 1.241 0.629 0 C-N-CA 122.124 1.883 . . . . 73.42 111.925 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -89.21 144.67 25.94 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-O 121.633 0.73 . . . . 73.13 109.291 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.05 21.69 3.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 CA-C-N 114.817 -1.083 . . . . 60.33 112.036 -174.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.414 ' HB3' HG23 ' A' ' 402' ' ' THR . 18.6 ptt180 -56.01 144.37 28.98 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.021 -0.99 . . . . 73.14 112.529 175.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.5 -0.08 46.46 Favored Glycine 0 C--N 1.311 -0.843 0 CA-C-N 115.71 -0.677 . . . . 34.42 112.486 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -111.34 -150.77 0.47 Allowed 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.11 -1.07 . . . . 73.11 108.11 176.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 80.0 p -97.77 161.53 13.71 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.36 -1.348 . . . . 74.14 107.36 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 42.3 m -63.32 -37.6 87.87 Favored 'General case' 0 C--O 1.21 -1.022 0 C-N-CA 120.838 -0.345 . . . . 74.11 110.305 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.06 -46.14 85.69 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 111.831 0.308 . . . . 73.14 111.831 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -68.92 -41.66 77.85 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 121.618 0.723 . . . . 74.31 109.24 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.81 -50.88 69.25 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.983 -1.008 . . . . 72.05 111.197 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.404 HG23 HD13 ' A' ' 384' ' ' ILE . 78.7 mt -64.74 -40.11 87.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.904 -0.589 . . . . 71.44 110.68 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.79 -38.07 77.73 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.139 0.495 . . . . 73.13 111.054 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 27.3 m -65.64 -47.09 76.77 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.074 -0.512 . . . . 73.41 110.334 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.85 -37.57 87.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.294 -0.412 . . . . 74.32 111.873 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -62.59 -37.91 88.09 Favored 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 122.296 0.239 . . . . 74.05 110.367 176.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -68.45 -21.22 64.65 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 121.19 0.519 . . . . 65.12 111.171 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -86.96 -14.13 42.63 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.982 -0.554 . . . . 71.13 110.224 174.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 95.63 9.48 57.56 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.567 -0.825 . . . . 64.21 112.474 176.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -82.55 155.48 24.48 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-O 121.13 0.49 . . . . 74.13 111.655 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -100.77 132.52 46.13 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 106.65 -1.611 . . . . 73.42 106.65 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.414 ' N ' HD12 ' A' ' 384' ' ' ILE . 1.8 mp -119.11 146.38 23.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 107.665 -1.235 . . . . 70.2 107.665 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 46.2 ttt180 -111.75 127.96 55.95 Favored 'General case' 0 C--N 1.259 -3.361 0 N-CA-C 106.542 -1.651 . . . . 75.04 106.542 177.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 27.4 m -113.72 117.87 32.74 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 106.998 -1.482 . . . . 60.52 106.998 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' LEU . . . . . 0.438 HD12 ' HG2' ' A' ' 389' ' ' LYS . 0.8 OUTLIER -112.17 119.99 40.27 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.406 -0.961 . . . . 73.21 108.406 -177.467 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -94.1 122.51 36.69 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.219 -0.66 . . . . 74.2 109.219 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 389' ' ' LYS . . . . . 0.48 ' HE2' ' HA ' ' A' ' 389' ' ' LYS . 4.5 mmpt? -125.51 119.44 24.65 Favored Pre-proline 0 C--N 1.3 -1.55 0 C-N-CA 121.141 -0.223 . . . . 72.14 111.058 176.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.618 ' HA ' ' O ' ' A' ' 422' ' ' THR . 38.0 Cg_exo -69.23 128.32 16.34 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.93 1.753 . . . . 71.3 108.993 171.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.586 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 7.0 t70 143.04 -171.42 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 104.923 -2.251 . . . . 75.04 104.923 -175.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 23.3 t -131.31 2.91 4.25 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.338 -0.616 . . . . 64.32 109.338 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 14.7 t -77.47 -5.6 50.48 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 122.918 0.487 . . . . 73.52 112.004 -178.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.512 HD13 ' H ' ' A' ' 394' ' ' ILE . 0.2 OUTLIER -114.8 151.96 45.93 Favored Pre-proline 0 C--N 1.303 -1.427 0 CA-C-O 118.998 -0.525 . . . . 74.34 109.69 -177.223 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -44.05 138.49 6.54 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 124.025 3.15 . . . . 74.14 114.105 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.5 161.71 16.73 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.417 2.745 . . . . 75.25 112.788 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' ASP . . . . . 0.422 ' HA ' HG13 ' A' ' 420' ' ' VAL . 6.0 p-10 -57.15 -8.3 0.67 Allowed 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 113.434 0.901 . . . . 71.52 113.434 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -111.56 130.2 55.82 Favored 'General case' 0 CA--C 1.478 -1.821 0 N-CA-C 106.581 -1.637 . . . . 55.11 106.581 171.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 20.1 m -66.37 119.32 11.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 O-C-N 123.787 0.679 . . . . 70.24 111.293 -169.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 8.7 tp -94.51 -29.33 4.16 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 108.508 -0.923 . . . . 71.33 108.508 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.84 170.6 27.77 Favored Glycine 0 N--CA 1.411 -3.025 0 N-CA-C 110.312 -1.115 . . . . 71.21 110.312 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.414 HG23 ' HB3' ' A' ' 366' ' ' ARG . 3.3 p -121.64 -179.28 4.05 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 107.712 -1.218 . . . . 75.14 107.712 176.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -101.4 134.58 20.19 Favored Pre-proline 0 C--N 1.293 -1.87 0 N-CA-C 107.703 -1.221 . . . . 70.1 107.703 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -51.59 -13.36 1.43 Allowed 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 124.33 3.353 . . . . 62.54 115.493 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.49 -39.4 70.39 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-O 120.703 0.287 . . . . 71.24 110.285 176.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -71.17 -33.54 70.11 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.859 0.838 . . . . 74.12 110.227 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -86.15 3.97 40.45 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.927 -1.033 . . . . 60.24 111.162 -177.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 27.1 m -109.7 154.36 22.99 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 105.514 -2.032 . . . . 74.41 105.514 171.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 409' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 360' ' ' VAL . 50.5 m -74.88 112.42 11.08 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 119.737 -0.785 . . . . 60.11 109.433 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 21.7 m -124.81 164.88 22.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 116.332 -0.394 . . . . 64.22 109.972 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 15.4 m -72.41 146.25 47.1 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.958 -0.386 . . . . 75.14 109.958 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -65.58 131.82 47.32 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.997 -0.371 . . . . 74.01 109.997 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 89.57 38.89 6.44 Favored Glycine 0 C--N 1.311 -0.836 0 C-N-CA 120.752 -0.737 . . . . 33.22 111.955 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -100.51 -175.99 3.07 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.328 -1.36 . . . . 73.13 107.328 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -108.83 123.25 48.76 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.137 0.494 . . . . 72.11 110.741 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 416' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 48.4 mm -112.18 137.4 45.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 106.538 -1.652 . . . . 73.33 106.538 175.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.4 t -116.76 132.0 56.81 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.842 -0.536 . . . . 65.43 110.892 -174.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 9.9 p -116.28 134.6 59.17 Favored 'Isoleucine or valine' 0 C--O 1.253 1.249 0 N-CA-C 109.567 -0.531 . . . . 73.24 109.567 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -102.42 116.07 31.86 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.997 -0.742 . . . . 64.2 108.997 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.422 HG13 ' HA ' ' A' ' 397' ' ' ASP . 77.0 t -104.93 130.88 55.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 116.116 -0.493 . . . . 71.32 110.775 -176.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 30.6 t -85.92 123.85 31.72 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 115.593 -0.731 . . . . 74.41 110.241 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.618 ' O ' ' HA ' ' A' ' 390' ' ' PRO . 12.2 p -116.39 138.92 50.96 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 106.216 -1.772 . . . . 75.14 106.216 171.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -55.22 -92.98 0.01 OUTLIER Glycine 0 CA--C 1.538 1.484 0 N-CA-C 116.598 1.399 . . . . 64.24 116.598 -172.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 424' ' ' PRO . . . . . 0.406 ' O ' ' HB3' ' A' ' 390' ' ' PRO . 57.1 Cg_endo -65.43 130.34 24.96 Favored 'Trans proline' 0 C--O 1.248 0.988 0 C-N-CA 123.296 2.664 . . . . 65.1 115.106 -171.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.554 ' HA ' ' CB ' ' A' ' 390' ' ' PRO . 35.3 mt-10 -72.77 158.15 36.13 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 113.597 -1.638 . . . . 73.14 111.882 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -92.71 133.87 35.59 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 106.308 -1.738 . . . . 74.21 106.308 177.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.428 ' HA ' ' HE ' ' A' ' 427' ' ' ARG . 1.2 mmp_? -120.79 165.32 15.3 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 109.469 -0.567 . . . . 44.13 109.469 -178.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -115.25 142.1 47.13 Favored 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 108.229 -1.026 . . . . 54.34 108.229 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.526 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 74.0 mt -77.17 121.02 83.95 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 108.95 -0.759 . . . . 41.41 108.95 -175.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 429' ' ' ILE . 20.8 Cg_exo -68.16 160.25 49.61 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 123.499 2.799 . . . . 64.12 114.411 -177.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -77.79 155.42 31.14 Favored 'General case' 0 C--O 1.249 1.077 0 CA-C-N 115.522 -0.763 . . . . 51.33 109.765 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 13.6 p -164.43 144.41 2.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 116.267 -0.424 . . . . 74.12 110.255 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 24.3 t -77.03 150.62 35.78 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 108.651 -0.87 . . . . 63.34 108.651 178.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 434' ' ' THR . . . . . 0.516 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 25.1 p -67.09 -23.41 65.84 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 121.578 0.704 . . . . 73.21 111.807 -176.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 2.5 pp -86.69 -11.26 51.75 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 113.046 0.758 . . . . 73.11 113.046 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -113.9 69.53 0.71 Allowed 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 114.049 1.129 . . . . 73.23 114.049 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 437' ' ' TYR . . . . . 0.403 ' O ' HG23 ' A' ' 441' ' ' VAL . 64.9 t80 -61.91 -37.55 85.05 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.211 -0.45 . . . . 75.02 110.261 175.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -58.83 -37.22 75.95 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 120.707 0.289 . . . . 73.54 111.025 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -66.68 -36.78 83.35 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.712 -0.847 . . . . 72.2 108.712 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.416 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -63.55 -43.61 96.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.873 -0.603 . . . . 35.42 109.672 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 441' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 437' ' ' TYR . 86.6 t -58.73 -50.43 79.27 Favored 'Isoleucine or valine' 0 C--O 1.244 0.773 0 CA-C-N 115.532 -0.758 . . . . 63.34 110.764 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . 0.342 0.0 OUTLIER -68.63 -34.08 75.12 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 113.945 1.091 . . . . 52.33 113.945 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -62.91 -47.5 83.02 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.778 0.323 . . . . 71.52 110.898 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.416 HD13 ' O ' ' A' ' 440' ' ' ALA . 9.1 mp -65.5 -32.84 74.66 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.156 -0.475 . . . . 70.15 111.846 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.403 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 70.8 m -69.25 -46.77 66.5 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.913 0.387 . . . . 54.13 110.505 179.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.14 -15.49 62.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.146 0.498 . . . . 51.54 111.244 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.63 -1.4 37.92 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 116.007 -0.542 . . . . 43.31 111.2 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 114.58 -83.95 0.35 Allowed Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.807 -0.711 . . . . 45.15 111.584 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -40.68 -62.43 0.79 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 114.596 1.332 . . . . 75.25 114.596 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 450' ' ' GLY . . . . . 0.403 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 67.61 29.46 73.96 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.941 -0.647 . . . . 45.12 112.356 -177.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 31.7 mmm180 -105.54 111.44 24.15 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-O 121.507 0.67 . . . . 75.03 109.263 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -130.99 159.97 35.92 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 108.254 -1.017 . . . . 73.5 108.254 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -152.16 135.94 16.28 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 108.128 -1.064 . . . . 73.33 108.128 177.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -103.22 128.06 50.34 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.1 0.476 . . . . 65.51 109.964 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.37 149.08 42.9 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 107.364 -1.347 . . . . 70.34 107.364 174.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -125.53 138.8 53.98 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.142 0.496 . . . . 64.34 109.942 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 457' ' ' SER . . . . . 0.498 ' HB2' HD11 ' A' ' 487' ' ' ILE . 48.5 t -128.37 142.38 44.5 Favored Pre-proline 0 C--N 1.291 -1.943 0 N-CA-C 108.019 -1.104 . . . . 74.41 108.019 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.656 ' HA ' ' O ' ' A' ' 490' ' ' SER . 58.1 Cg_endo -76.27 122.56 6.67 Favored 'Trans proline' 0 N--CA 1.428 -2.361 0 C-N-CA 121.204 1.27 . . . . 74.33 109.691 176.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 48.8 m -144.69 179.21 7.44 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 108.887 -0.783 . . . . 55.03 108.887 -177.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 9.7 t -49.93 134.34 21.51 Favored Pre-proline 0 C--O 1.255 1.386 0 O-C-N 123.982 0.802 . . . . 71.34 111.902 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 461' ' ' PRO . . . . . 0.462 ' HA ' ' CG2' ' A' ' 464' ' ' VAL . 6.2 Cg_endo -50.93 -29.93 28.8 Favored 'Trans proline' 0 C--N 1.361 1.193 0 C-N-CA 124.187 3.258 . . . . 71.44 113.935 -175.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -66.44 -21.38 66.2 Favored 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 113.217 0.821 . . . . 42.04 113.217 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -100.24 -7.23 24.89 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 122.005 -0.435 . . . . 72.05 111.566 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.462 ' CG2' ' HA ' ' A' ' 461' ' ' PRO . 82.4 t -60.84 131.37 25.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 116.165 -0.471 . . . . 72.12 111.757 -178.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 96.26 -10.64 67.47 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.779 -0.646 . . . . 63.45 112.145 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -118.73 166.16 13.11 Favored 'General case' 0 N--CA 1.416 -2.149 0 N-CA-C 109.075 -0.713 . . . . 71.22 109.075 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.516 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 68.9 t -77.8 145.31 10.11 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 108.635 -0.876 . . . . 72.24 108.635 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 51.5 mt -97.74 -25.77 4.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 107.202 -1.407 . . . . 53.2 107.202 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 154.42 -167.73 32.51 Favored Glycine 0 N--CA 1.419 -2.444 0 CA-C-N 114.868 -1.06 . . . . 75.34 111.304 175.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.22 137.17 52.32 Favored 'General case' 0 N--CA 1.405 -2.688 0 N-CA-C 105.482 -2.044 . . . . 42.13 105.482 176.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -66.14 -53.31 33.52 Favored Pre-proline 0 C--N 1.323 -0.584 0 C-N-CA 119.388 -0.925 . . . . 72.33 110.772 -177.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -68.98 124.72 11.7 Favored 'Trans proline' 0 C--N 1.364 1.394 0 N-CA-C 107.24 -1.869 . . . . 62.52 107.24 167.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.481 ' C ' ' H ' ' A' ' 475' ' ' ASN . 19.8 Cg_exo -62.34 145.47 95.89 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.928 1.752 . . . . 75.24 113.271 -174.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.526 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -69.05 11.31 0.21 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.237 1.015 . . . . 72.43 111.28 175.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 475' ' ' ASN . . . . . 0.481 ' H ' ' C ' ' A' ' 473' ' ' PRO . 12.9 m120 -108.62 -10.87 15.17 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 124.204 1.002 . . . . 63.34 108.623 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -98.49 171.12 8.36 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 121.485 0.659 . . . . 73.34 111.36 -176.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.02 129.71 51.65 Favored 'General case' 0 N--CA 1.402 -2.846 0 CA-C-N 114.664 -1.153 . . . . 72.02 111.721 -176.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 6.2 p -108.27 148.17 30.39 Favored 'General case' 0 N--CA 1.418 -2.059 0 C-N-CA 123.903 0.881 . . . . 54.34 110.038 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.434 ' H ' ' HB2' ' A' ' 482' ' ' ASN . . . -89.28 175.25 7.42 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 116.369 -0.378 . . . . 72.4 110.148 176.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 32.9 mm -81.15 -6.67 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-O 122.197 0.999 . . . . 54.43 109.871 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 40.1 m -112.76 5.04 17.39 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 122.238 1.018 . . . . 54.21 109.061 175.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 482' ' ' ASN . . . . . 0.434 ' HB2' ' H ' ' A' ' 479' ' ' ALA . 23.3 t-20 -80.69 134.49 35.86 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.597 -0.729 . . . . 63.33 111.514 -173.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.92 126.03 53.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 116.039 -0.528 . . . . 75.15 110.362 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 65.2 t -100.66 120.61 50.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 121.014 0.435 . . . . 73.41 110.093 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.62 118.96 44.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-O 121.828 0.823 . . . . 62.22 110.022 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 42.7 mt -111.3 128.64 67.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 114.534 -1.212 . . . . 74.3 109.976 -178.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.498 HD11 ' HB2' ' A' ' 457' ' ' SER . 17.3 tt -110.84 127.08 68.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.839 -0.619 . . . . 74.25 111.96 -173.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.499 HG12 HG22 ' A' ' 467' ' ' VAL . 35.5 m -108.32 152.35 10.21 Favored 'Isoleucine or valine' 0 C--O 1.248 1.023 0 C-N-CA 123.806 0.842 . . . . 75.31 111.156 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -88.1 133.5 11.85 Favored Glycine 0 N--CA 1.434 -1.44 0 CA-C-N 115.831 -0.622 . . . . 14.52 112.223 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.656 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 44.4 m -132.98 160.66 36.48 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.344 -1.354 . . . . 54.43 107.344 177.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 151.11 149.58 5.09 Favored Glycine 0 C--N 1.296 -1.684 0 C-N-CA 120.262 -0.97 . . . . 62.24 110.711 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -91.94 162.55 3.3 Favored 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 122.478 2.119 . . . . 71.32 113.735 -177.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -104.02 41.5 1.29 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.447 -1.316 . . . . 41.34 107.447 176.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 546' ' ' PRO . 72.7 p -117.24 153.77 32.33 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 114.34 -1.3 . . . . 64.14 108.945 -176.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 495' ' ' LYS . . . . . 0.504 ' HD3' ' H ' ' A' ' 496' ' ' ASP . 6.0 tmtt? -150.16 151.65 33.44 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 107.47 -1.307 . . . . 63.15 107.47 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.504 ' H ' ' HD3' ' A' ' 495' ' ' LYS . 9.8 p-10 -79.83 138.08 37.12 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 123.587 0.755 . . . . 62.43 109.489 177.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 36.4 pt -86.39 137.41 34.56 Favored Pre-proline 0 C--N 1.303 -1.418 0 CA-C-N 116.182 -0.463 . . . . 70.45 110.792 178.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -89.15 179.9 2.23 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.656 2.237 . . . . 75.51 112.339 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -84.38 142.05 30.43 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.832 -1.173 . . . . 73.14 107.832 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 10.6 p -139.32 19.23 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 CA-C-O 122.179 0.99 . . . . 61.15 110.052 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -72.41 114.52 10.62 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.199 -0.91 . . . . 43.14 110.893 -177.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 115.3 -8.12 20.67 Favored Glycine 0 CA--C 1.482 -1.973 0 N-CA-C 111.311 -0.716 . . . . 65.2 111.311 176.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -100.47 165.75 11.28 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 108.199 -1.037 . . . . 65.04 108.199 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 5.6 t -91.73 164.73 13.61 Favored 'General case' 0 C--N 1.285 -2.239 0 C-N-CA 120.217 -0.593 . . . . 65.1 109.889 -175.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 48.4 t -54.27 -41.26 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.606 0.762 . . . . 61.04 110.976 -177.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -57.68 -42.6 83.94 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 115.506 -0.77 . . . . 74.54 111.12 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 63.8 t -75.35 -42.54 43.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 116.028 -0.533 . . . . 73.14 109.738 -178.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -61.26 -49.69 76.05 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.71 -0.677 . . . . 62.44 111.853 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 513' ' ' ASN . 63.9 tt0 -65.35 -37.03 85.82 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.374 0.607 . . . . 63.31 110.04 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.491 ' O ' HG23 ' A' ' 514' ' ' VAL . 37.6 ttmt -65.93 -48.79 70.2 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.82 -1.082 . . . . 70.34 111.696 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -62.03 -48.58 79.66 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 121.149 0.5 . . . . 73.24 110.924 -177.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 512' ' ' LEU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 517' ' ' PHE . 4.2 mm? -64.9 -36.54 84.7 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.578 -0.737 . . . . 74.15 110.885 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 513' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 509' ' ' GLN . 0.6 OUTLIER -60.92 -39.86 90.97 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 122.564 0.346 . . . . 75.1 110.553 178.378 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 510' ' ' LYS . 78.4 t -59.37 -36.65 65.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.645 -0.707 . . . . 73.5 110.758 178.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -79.58 -21.55 44.89 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.105 0.479 . . . . 73.24 110.639 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 127.5 -2.78 7.1 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 120.524 -0.846 . . . . 63.42 113.902 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.582 ' HA ' ' O ' ' A' ' 547' ' ' VAL . 95.1 m-85 -82.8 117.25 22.56 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.738 -1.208 . . . . 72.34 107.738 -176.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.6 m -118.8 -4.24 10.72 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 118.823 -1.151 . . . . 74.15 112.375 -174.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 519' ' ' LYS . . . . . 0.423 ' HB3' HG22 ' A' ' 550' ' ' VAL . 64.3 mttp -112.26 115.21 28.42 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.637 -0.664 . . . . 65.31 110.82 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -126.25 154.37 43.45 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.256 -0.429 . . . . 73.21 110.909 -174.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 49.2 m -141.45 141.11 33.7 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.414 -1.328 . . . . 61.05 107.414 171.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -117.57 138.22 52.07 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-O 121.016 0.436 . . . . 71.35 110.94 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -124.39 116.77 23.11 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.038 -1.097 . . . . 63.52 108.038 176.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 524' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 19.7 m -97.82 136.03 38.73 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.601 0.238 . . . . 40.13 111.326 -176.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 61.5 t -129.47 148.87 33.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 107.031 -1.47 . . . . 53.22 107.031 177.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 526' ' ' ASP . . . . . 0.412 ' HB2' ' HB2' ' A' ' 559' ' ' ASN . 0.4 OUTLIER -78.38 136.63 37.71 Favored 'General case' 0 C--O 1.248 0.975 0 N-CA-C 108.727 -0.842 . . . . 72.53 108.727 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 527' ' ' SER . . . . . 0.409 ' OG ' ' HB2' ' A' ' 556' ' ' SER . 77.6 p -153.33 179.56 1.26 Allowed Pre-proline 0 C--N 1.294 -1.819 0 N-CA-C 107.871 -1.159 . . . . 74.13 107.871 -176.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -85.09 -0.7 9.19 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 121.69 1.594 . . . . 64.13 111.367 172.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.427 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 12.7 mtp180 -88.39 139.74 30.14 Favored Pre-proline 0 N--CA 1.432 -1.345 0 N-CA-C 108.096 -1.075 . . . . 72.1 108.096 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.27 153.95 31.26 Favored 'Trans proline' 0 C--O 1.254 1.309 0 C-N-CA 123.304 2.669 . . . . 70.34 113.949 -176.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.634 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -74.75 116.29 15.29 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.347 -0.842 . . . . 71.21 110.527 -176.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 118.88 -7.42 13.15 Favored Glycine 0 CA--C 1.49 -1.481 0 C-N-CA 120.049 -1.072 . . . . 45.33 111.203 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -83.67 140.46 32.14 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 108.321 -0.992 . . . . 73.33 108.321 174.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 60.9 t -88.45 118.29 33.68 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 N-CA-C 108.063 -1.088 . . . . 74.22 108.063 178.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 535' ' ' THR . . . . . 0.481 ' OG1' ' HB3' ' A' ' 556' ' ' SER . 90.5 m -78.19 -24.2 47.26 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.776 -1.102 . . . . 71.44 109.802 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 153.54 -164.75 31.22 Favored Glycine 0 N--CA 1.424 -2.132 0 N-CA-C 110.435 -1.066 . . . . 44.31 110.435 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 18.0 p -117.71 159.29 23.22 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 109.327 -0.62 . . . . 62.12 109.327 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -63.11 -57.49 20.67 Favored Pre-proline 0 C--N 1.315 -0.924 0 O-C-N 123.625 0.578 . . . . 53.24 110.328 177.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -73.23 133.01 18.73 Favored 'Trans proline' 0 C--N 1.363 1.319 0 N-CA-C 109.136 -1.14 . . . . 73.24 109.136 171.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.14 156.73 48.48 Favored 'Trans proline' 0 C--O 1.252 1.203 0 C-N-CA 122.492 2.128 . . . . 32.11 112.354 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -57.31 140.52 49.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.786 -0.643 . . . . 73.54 110.97 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.26 -16.38 56.94 Favored Glycine 0 N--CA 1.433 -1.528 0 CA-C-N 115.708 -0.678 . . . . 73.33 111.687 -178.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 99.7 m -65.28 123.93 20.86 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.071 0.462 . . . . 64.11 110.436 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 54.1 m -88.41 123.47 32.99 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 115.466 -0.788 . . . . 74.1 109.674 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 31.2 m -137.85 154.81 74.86 Favored Pre-proline 0 C--N 1.312 -1.053 0 N-CA-C 108.288 -1.004 . . . . 51.33 108.288 177.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' A' ' 494' ' ' THR . 52.6 Cg_exo -60.76 142.56 98.09 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.293 1.996 . . . . 74.23 110.863 173.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 517' ' ' PHE . 27.2 m -62.27 -20.45 24.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.799 0.809 . . . . 74.01 111.815 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 548' ' ' ASP . . . . . 0.402 ' O ' ' HD2' ' A' ' 519' ' ' LYS . 26.8 t70 -90.26 -5.59 56.15 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.38 -0.827 . . . . 64.14 111.713 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 72.1 m -83.35 166.01 18.81 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 121.751 -0.593 . . . . 74.21 111.567 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.423 HG22 ' HB3' ' A' ' 519' ' ' LYS . 21.5 t -92.67 129.54 43.08 Favored 'Isoleucine or valine' 0 C--O 1.254 1.294 0 CA-C-N 115.671 -0.695 . . . . 62.13 110.452 -176.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 551' ' ' ILE . . . . . 0.456 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -111.55 134.99 52.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.176 0.512 . . . . 74.45 110.256 174.383 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -102.98 121.11 41.86 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.566 -0.743 . . . . 74.51 109.885 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.2 mp -104.36 134.08 48.18 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.189 -0.914 . . . . 70.11 110.355 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -90.83 123.99 34.8 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.646 -0.872 . . . . 72.24 108.646 174.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 524' ' ' SER . 64.1 t -109.53 129.15 64.85 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 N-CA-C 108.509 -0.923 . . . . 70.42 108.509 -177.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.634 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 24.4 p -77.07 140.98 40.45 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-O 121.481 0.658 . . . . 75.34 112.183 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -104.3 131.92 51.11 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 107.057 -1.46 . . . . 75.12 107.057 168.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 558' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -69.5 -30.22 71.22 Favored Glycine 0 CA--C 1.489 -1.546 0 O-C-N 123.805 0.691 . . . . 65.22 111.515 -177.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 559' ' ' ASN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 526' ' ' ASP . 63.2 t30 70.28 9.43 6.99 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.581 1.152 . . . . 74.25 110.423 174.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.448 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 96.3 mt-30 -121.99 145.14 48.41 Favored 'General case' 0 N--CA 1.412 -2.375 0 CA-C-N 114.773 -1.103 . . . . 71.44 110.482 -178.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -123.27 147.96 46.41 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.371 -0.974 . . . . 74.43 108.371 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 59.0 t -69.74 121.2 18.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-O 121.08 0.467 . . . . 73.42 112.163 -173.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 563' ' ' MET . . . . . 0.421 ' HA ' ' HD3' ' A' ' 564' ' ' PRO . 53.7 ttp -97.88 132.01 25.64 Favored Pre-proline 0 C--O 1.25 1.102 0 CA-C-N 115.812 -0.631 . . . . 61.15 110.944 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 564' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 563' ' ' MET . 30.7 Cg_exo -65.52 170.63 10.73 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 123.306 2.671 . . . . 75.33 111.764 173.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -72.34 132.44 43.99 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.429 0.633 . . . . 74.35 110.823 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 94.9 mt -120.62 -4.64 9.77 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.157 -0.929 . . . . 53.1 108.597 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 38.3 t -79.11 149.39 32.08 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.783 -1.099 . . . . 74.0 109.829 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 72.88 39.97 53.39 Favored Glycine 0 C--O 1.221 -0.714 0 C-N-CA 120.894 -0.67 . . . . 73.02 111.64 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 89.3 mtp -146.06 158.11 43.87 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.337 -1.727 . . . . 74.33 106.337 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 570' ' ' PHE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 96.6 m-85 -84.48 155.95 21.94 Favored 'General case' 0 N--CA 1.424 -1.741 0 C-N-CA 120.019 -0.673 . . . . 72.32 109.506 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 55.4 t90 -65.91 -22.87 66.53 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.148 0.499 . . . . 73.33 109.735 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 33.7 m -72.75 -12.06 15.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.803 -0.635 . . . . 53.14 110.697 177.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 573' ' ' ASP . . . . . 0.477 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 41.8 m-20 -101.48 -39.72 7.4 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 108.401 -0.963 . . . . 74.15 108.401 175.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -60.31 -40.72 91.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.436 -0.802 . . . . 72.35 111.503 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.485 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 1.2 tm-20 -57.32 -59.03 14.06 Favored Pre-proline 0 CA--C 1.578 2.052 0 C-N-CA 123.308 0.643 . . . . 54.55 110.477 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.33 -29.89 86.68 Favored 'Trans proline' 0 C--N 1.373 1.86 0 CA-C-N 120.912 1.362 . . . . 74.35 113.159 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 16.3 mmt180 -65.82 -43.32 88.95 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 121.103 -0.239 . . . . 72.25 110.808 177.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.4 pp -66.1 -38.03 87.23 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.046 0.451 . . . . 42.32 110.311 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -65.33 -35.29 80.54 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 115.863 -0.608 . . . . 71.34 110.794 175.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.55 -25.52 64.96 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 122.719 0.407 . . . . 44.0 110.928 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 89.9 mt -92.29 -8.17 45.94 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.85 -0.614 . . . . 64.24 110.503 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 65.4 41.95 96.21 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 110.71 -0.956 . . . . 45.03 110.71 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 74.2 t90 -77.51 136.63 38.34 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.296 0.57 . . . . 74.4 112.083 -175.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 81.7 m -151.79 99.53 2.59 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.526 -0.916 . . . . 74.22 108.526 173.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -140.26 -119.52 1.63 Allowed Glycine 0 N--CA 1.433 -1.507 0 N-CA-C 109.939 -1.264 . . . . 73.1 109.939 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -130.62 124.52 31.9 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.054 -0.721 . . . . 75.22 109.054 176.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -108.13 128.86 55.07 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 105.97 -1.863 . . . . 73.13 105.97 177.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -104.27 115.41 30.34 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.54 -0.911 . . . . 61.33 108.54 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -87.76 125.2 34.29 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 116.168 -0.469 . . . . 52.34 110.114 -176.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -103.9 173.9 22.04 Favored Glycine 0 N--CA 1.426 -2.008 0 N-CA-C 110.186 -1.166 . . . . 72.11 110.186 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -87.38 154.78 20.4 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.804 -0.443 . . . . 61.33 109.804 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 592' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' A' ' 625' ' ' GLY . 4.3 p-10 -69.59 124.8 24.88 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.261 0.553 . . . . 64.5 109.557 178.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 95.3 t -129.04 115.73 37.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.812 -0.81 . . . . 43.33 108.812 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 594' ' ' ASP . . . . . 0.402 ' HA ' ' HB2' ' A' ' 626' ' ' GLN . 4.3 p-10 -84.48 118.82 24.54 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.349 -0.982 . . . . 52.42 108.349 178.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 595' ' ' ALA . . . . . 0.437 ' HB3' ' HG3' ' A' ' 599' ' ' GLN . . . -142.8 9.0 1.73 Allowed 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.941 -0.704 . . . . 72.51 112.004 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 125.49 -176.71 17.22 Favored Glycine 0 N--CA 1.435 -1.375 0 C-N-CA 120.152 -1.023 . . . . 74.1 111.955 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -63.44 -40.48 98.88 Favored Glycine 0 N--CA 1.45 -0.393 0 O-C-N 124.215 0.597 . . . . 63.45 113.066 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 23.8 m -63.18 -23.87 67.63 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 122.895 0.478 . . . . 74.53 111.628 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 599' ' ' GLN . . . . . 0.437 ' HG3' ' HB3' ' A' ' 595' ' ' ALA . 82.4 mm-40 -105.08 -1.64 25.35 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 111.979 0.363 . . . . 74.02 111.979 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -84.81 109.96 18.47 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 119.861 -0.736 . . . . 74.35 110.621 -176.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 57.01 0.27 0.07 Allowed 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 126.805 2.042 . . . . 73.33 114.973 176.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 602' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 8.2 ptm180 -108.08 157.22 18.45 Favored 'General case' 0 C--N 1.289 -2.036 0 O-C-N 120.812 -1.18 . . . . 74.4 113.871 -173.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 603' ' ' VAL . . . . . 0.415 HG13 ' HB2' ' A' ' 622' ' ' LEU . 66.5 t -69.11 130.77 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 113.908 -1.497 . . . . 73.45 108.502 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 604' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 623' ' ' ARG . 46.5 t -84.31 -50.09 15.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 121.49 0.662 . . . . 71.34 109.669 -176.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -154.6 164.15 39.15 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 106.129 -1.804 . . . . 70.4 106.129 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -115.05 128.6 56.35 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 107.289 -1.374 . . . . 63.54 107.289 174.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.583 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 16.6 t-20 -48.25 -58.17 8.72 Favored Pre-proline 0 N--CA 1.48 1.025 0 O-C-N 123.798 0.686 . . . . 65.31 112.475 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.583 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 2.8 Cg_endo -86.34 120.87 1.88 Allowed 'Trans proline' 0 N--CA 1.442 -1.534 0 N-CA-C 108.097 -1.54 . . . . 75.12 108.097 169.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -63.31 160.27 35.85 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.371 2.047 . . . . 74.12 113.132 -177.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -57.85 127.28 31.29 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.437 -0.801 . . . . 72.44 111.055 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 91.95 -1.29 74.11 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.321 -0.942 . . . . 74.11 112.118 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 24.7 m -99.15 160.58 14.17 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.459 -0.941 . . . . 62.32 108.459 178.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -87.64 143.17 18.3 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 121.494 -0.384 . . . . 65.3 114.047 -175.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 614' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 27.8 m -113.81 142.55 25.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 C-N-CA 124.004 0.922 . . . . 63.32 109.42 176.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.408 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 29.7 p-10 -58.89 176.26 0.22 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.731 1.011 . . . . 73.55 113.731 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -60.92 -25.86 67.06 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.96 -0.564 . . . . 73.22 112.421 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.31 -33.67 65.29 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.698 -0.853 . . . . 70.42 108.698 174.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 79.51 21.93 65.76 Favored Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 110.428 -1.069 . . . . 63.14 110.428 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.16 119.5 15.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 122.319 1.057 . . . . 72.0 111.29 -168.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 2.8 tp -116.56 126.5 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 CA-C-N 113.582 -1.645 . . . . 64.41 109.561 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.532 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 93.8 m -100.98 118.79 37.69 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 108.851 -0.796 . . . . 72.32 108.851 173.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 622' ' ' LEU . . . . . 0.415 ' HB2' HG13 ' A' ' 603' ' ' VAL . 1.6 pt? -132.74 151.85 51.89 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 107.605 -1.257 . . . . 55.3 107.605 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 623' ' ' ARG . . . . . 0.407 ' O ' HG23 ' A' ' 604' ' ' VAL . 13.6 tpt180 -131.51 141.76 49.82 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 109.1 -0.704 . . . . 72.23 109.1 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -127.97 143.4 51.09 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 106.793 -1.558 . . . . 60.33 106.793 172.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 625' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 592' ' ' ASP . . . -85.87 -89.81 0.92 Allowed Glycine 0 N--CA 1.436 -1.319 0 C-N-CA 120.639 -0.791 . . . . 70.43 112.394 -176.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 626' ' ' GLN . . . . . 0.402 ' HB2' ' HA ' ' A' ' 594' ' ' ASP . 8.5 tp-100 . . . . . 0 C--N 1.309 -1.177 0 CA-C-O 118.866 -0.588 . . . . 62.01 110.554 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.79 0 N-CA-C 111.108 -0.797 . . . . 52.14 111.108 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 10.6 tp -76.46 134.48 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 N-CA-C 108.992 -0.744 . . . . 63.21 108.992 175.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 1.3 p -83.21 155.78 23.53 Favored 'General case' 0 N--CA 1.394 -3.227 0 C-N-CA 123.22 0.608 . . . . 64.01 110.677 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -98.03 72.17 2.18 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.665 -1.235 . . . . 73.44 107.665 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -82.05 148.52 28.55 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.224 -1.353 . . . . 53.03 110.39 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 30.2 m -137.56 162.98 31.85 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 107.671 -1.233 . . . . 54.42 107.671 178.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -94.09 139.37 31.06 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 106.067 -1.827 . . . . 75.23 106.067 175.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.528 HG22 ' CZ ' ' A' ' 382' ' ' PHE . 90.6 t -93.48 128.82 40.83 Favored Pre-proline 0 C--N 1.281 -2.389 0 N-CA-C 108.28 -1.007 . . . . 73.44 108.28 -168.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 363' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 13.6 Cg_exo -61.09 120.59 8.37 Favored 'Trans proline' 0 C--N 1.361 1.204 0 C-N-CA 122.468 2.112 . . . . 55.12 112.304 -174.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -87.71 84.36 7.08 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 114.571 -1.195 . . . . 75.2 108.053 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 28.2 m -92.09 16.03 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.078 -0.964 . . . . 72.33 112.707 -174.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . 0.296 0.2 OUTLIER -65.29 148.38 51.79 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.926 -0.579 . . . . 74.2 112.546 176.705 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 106.4 -1.78 37.2 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 110.125 -1.19 . . . . 63.11 110.125 -170.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -109.27 -158.93 0.66 Allowed 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 107.588 -1.264 . . . . 71.31 107.588 173.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 65.4 p -90.52 160.56 15.91 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 109.94 -0.393 . . . . 73.14 109.94 -175.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 27.1 p -56.13 -46.47 79.18 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 123.556 0.535 . . . . 63.05 110.451 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.31 -46.27 84.31 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 115.843 -0.617 . . . . 43.43 112.291 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -66.67 -44.1 82.74 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 120.153 -0.619 . . . . 65.04 110.471 -178.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -63.17 -48.6 77.72 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.519 -0.764 . . . . 73.13 111.771 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 90.1 mt -65.83 -42.23 91.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 CA-C-N 116.547 -0.297 . . . . 74.43 110.301 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.79 -43.33 94.46 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.417 -0.356 . . . . 74.31 111.189 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 33.8 m -63.0 -47.51 82.8 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.026 -0.534 . . . . 70.35 111.457 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 11.1 mp -64.59 -41.64 96.12 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.137 -0.225 . . . . 72.41 111.545 178.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -63.62 -38.72 92.19 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.301 -0.409 . . . . 74.34 110.186 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -64.97 -30.81 71.82 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.894 0.378 . . . . 62.44 111.155 176.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -81.72 -8.66 59.72 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.131 -0.486 . . . . 71.51 110.826 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 99.49 0.18 56.79 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.603 -0.808 . . . . 72.34 112.491 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.528 ' CZ ' HG22 ' A' ' 362' ' ' VAL . 62.7 m-85 -78.26 147.67 34.24 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 109.124 -0.695 . . . . 74.0 109.124 178.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.527 ' HB2' ' HG2' ' A' ' 415' ' ' GLU . 40.9 mmtm -100.35 144.53 29.24 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.497 -1.668 . . . . 75.32 106.497 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 1.5 mp -129.0 140.46 49.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 108.353 -0.981 . . . . 74.23 108.353 -179.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -109.85 128.05 55.08 Favored 'General case' 0 C--N 1.264 -3.113 0 N-CA-C 104.893 -2.262 . . . . 72.55 104.893 175.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 19.3 m -115.26 127.86 55.76 Favored 'General case' 0 C--N 1.257 -3.446 0 N-CA-C 108.095 -1.076 . . . . 71.24 108.095 -175.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.87 120.83 43.27 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.67 -1.233 . . . . 63.12 107.67 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -95.89 132.82 40.77 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.823 -0.436 . . . . 54.24 109.823 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 389' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 421' ' ' SER . 93.3 mttt -136.04 134.24 20.22 Favored Pre-proline 0 C--N 1.297 -1.703 0 N-CA-C 108.39 -0.967 . . . . 71.03 108.39 173.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.515 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 29.5 Cg_endo -91.51 127.31 1.07 Allowed 'Trans proline' 0 C--O 1.251 1.146 0 C-N-CA 121.296 1.331 . . . . 53.34 111.259 175.065 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.515 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 12.2 t70 150.97 -164.92 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 103.203 -2.888 . . . . 74.1 103.203 -177.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 13.1 t -141.83 2.91 1.6 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 119.369 0.986 . . . . 72.23 110.539 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 11.5 t -87.74 -7.74 56.95 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.265 1.031 . . . . 63.14 109.787 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.569 HD13 ' H ' ' A' ' 394' ' ' ILE . 0.2 OUTLIER -109.25 151.81 42.25 Favored Pre-proline 0 N--CA 1.417 -2.088 0 N-CA-C 106.737 -1.579 . . . . 61.31 106.737 178.414 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 395' ' ' PRO . . . . . 0.434 ' HA ' ' HD2' ' A' ' 396' ' ' PRO . 1.1 Cg_exo -22.92 113.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.087 1 C-N-CA 125.739 4.293 . . . . 73.45 115.736 -179.064 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 396' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 395' ' ' PRO . 28.9 Cg_endo -61.63 164.09 16.71 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 124.252 3.301 . . . . 74.32 112.605 -178.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 397' ' ' ASP . . . . . 0.499 ' HA ' ' CG2' ' A' ' 420' ' ' VAL . 31.4 t70 -56.53 -9.23 0.68 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 122.504 1.145 . . . . 54.11 111.937 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 398' ' ' HIS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 64.1 m170 -103.96 111.33 23.84 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 103.5 -2.778 . . . . 64.5 103.5 168.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 27.4 m -63.14 119.49 7.3 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 O-C-N 124.403 1.065 . . . . 72.43 112.425 -168.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 9.1 tp -91.19 -29.14 4.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-N 115.515 -0.766 . . . . 71.33 110.443 -176.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.93 162.37 28.32 Favored Glycine 0 N--CA 1.42 -2.375 0 C-N-CA 119.533 -1.318 . . . . 63.51 113.554 -174.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 10.6 p -132.36 -175.7 3.84 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 125.7 1.6 . . . . 62.21 109.116 -177.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -101.37 134.3 20.37 Favored Pre-proline 0 C--N 1.293 -1.879 0 N-CA-C 107.28 -1.378 . . . . 62.52 107.28 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -47.03 -24.95 3.62 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 124.412 3.408 . . . . 54.21 115.122 -177.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.51 -28.23 68.23 Favored 'General case' 0 C--O 1.209 -1.067 0 CA-C-N 116.27 -0.423 . . . . 54.05 111.327 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -73.99 -32.54 63.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.825 0.821 . . . . 71.02 110.014 178.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -87.27 -2.15 58.41 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.522 -0.763 . . . . 73.44 109.498 -178.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 24.9 m -102.18 151.85 21.71 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.44 -1.689 . . . . 73.42 106.44 173.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 46.2 m -79.92 112.41 17.18 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 119.125 -1.03 . . . . 54.5 109.306 176.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.8 m -121.36 168.67 13.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 116.371 -0.377 . . . . 71.11 110.124 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 57.1 m -61.88 133.17 55.11 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.245 0.545 . . . . 72.02 110.936 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -61.77 112.44 2.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.316 -0.856 . . . . 72.12 112.754 -174.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 119.55 6.5 10.46 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.602 -0.808 . . . . 65.23 113.383 177.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -69.49 179.19 2.16 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 122.442 0.297 . . . . 73.21 111.233 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 415' ' ' GLU . . . . . 0.527 ' HG2' ' HB2' ' A' ' 383' ' ' LYS . 40.2 mt-10 -106.49 122.8 47.02 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 122.848 0.459 . . . . 71.2 110.569 -174.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 416' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 49.2 mm -112.41 130.6 65.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 108.78 -0.822 . . . . 74.03 108.78 178.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 81.4 m -96.95 132.35 42.83 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.116 0.484 . . . . 52.31 111.003 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 5.6 p -122.86 134.59 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 CA-C-N 115.78 -0.646 . . . . 63.21 109.762 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -95.59 129.23 42.85 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.982 -0.747 . . . . 73.1 108.982 174.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.499 ' CG2' ' HA ' ' A' ' 397' ' ' ASP . 8.6 p -138.7 141.51 36.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 109.617 -0.512 . . . . 75.53 109.617 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 421' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 11.5 p -100.15 121.97 42.26 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-O 121.699 0.761 . . . . 65.11 112.184 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 9.3 t -121.44 121.33 37.33 Favored 'General case' 0 N--CA 1.41 -2.449 0 N-CA-C 108.001 -1.111 . . . . 72.22 108.001 170.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 121.08 137.36 5.27 Favored Glycine 0 C--N 1.297 -1.588 0 C-N-CA 119.701 -1.238 . . . . 62.21 112.597 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -74.69 157.87 43.77 Favored 'Trans proline' 0 C--O 1.251 1.142 0 C-N-CA 122.949 2.433 . . . . 74.44 113.272 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -74.75 164.79 26.18 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.042 -1.436 . . . . 75.31 110.13 178.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -92.94 156.72 16.74 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.727 -0.842 . . . . 73.35 108.727 175.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 447' ' ' ALA . 3.9 mmp_? -122.39 152.99 39.64 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.747 0.308 . . . . 74.51 111.162 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -91.02 139.04 31.14 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 115.759 -0.655 . . . . 54.15 110.642 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 50.4 mt -86.04 126.3 65.82 Favored Pre-proline 0 N--CA 1.421 -1.887 0 N-CA-C 106.914 -1.513 . . . . 71.4 106.914 176.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -73.12 141.43 32.64 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.174 1.916 . . . . 62.44 110.537 169.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -80.91 116.15 20.74 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.828 -1.175 . . . . 72.25 107.828 173.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.443 HG12 ' HB ' ' A' ' 436' ' ' THR . 61.4 t -107.34 154.17 8.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 108.035 -1.098 . . . . 74.14 108.035 -175.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.512 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 19.6 m -67.13 152.35 45.91 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 120.818 0.342 . . . . 63.33 110.805 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 35.5 p -67.28 -27.93 67.6 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 113.979 1.103 . . . . 63.34 113.979 -172.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 2.4 pp -88.38 -10.34 49.65 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.719 0.771 . . . . 73.41 111.439 176.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.512 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 1.6 m -96.84 37.0 1.33 Allowed 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.428 0.632 . . . . 74.33 110.35 -175.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -52.76 -38.78 61.5 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.705 0.802 . . . . 72.21 112.56 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.33 -40.31 93.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.932 0.396 . . . . 71.52 111.33 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.406 ' HB3' HG22 ' A' ' 436' ' ' THR . 29.3 tp10 -70.84 -34.53 71.77 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.523 -0.547 . . . . 75.15 109.523 176.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.52 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.02 -50.98 71.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.594 -0.276 . . . . 64.1 111.218 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.1 m -60.71 -37.34 75.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 121.301 0.572 . . . . 71.1 110.634 177.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -60.37 -47.66 85.1 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.257 -0.883 . . . . 62.33 110.81 175.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -65.02 -39.5 93.48 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.817 0.341 . . . . 71.54 111.609 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.52 HD13 ' O ' ' A' ' 440' ' ' ALA . 6.2 mp -65.21 -36.19 83.4 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.968 -0.56 . . . . 70.3 110.999 177.152 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 65.8 m -70.18 -42.7 72.09 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-O 120.825 0.345 . . . . 75.52 110.091 177.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -65.93 -21.87 66.46 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-O 121.438 0.637 . . . . 63.31 110.844 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 447' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 427' ' ' ARG . . . -82.65 5.42 21.18 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.451 -0.795 . . . . 72.42 111.465 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 100.69 -73.68 0.41 Allowed Glycine 0 CA--C 1.501 -0.79 0 C-N-CA 120.408 -0.901 . . . . 74.44 112.525 174.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -43.88 -59.36 2.3 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.955 1.094 . . . . 74.1 113.955 176.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 59.31 29.71 66.49 Favored Glycine 0 C--O 1.224 -0.53 0 C-N-CA 121.24 -0.505 . . . . 74.11 112.652 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -102.59 110.56 22.53 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 108.385 -0.968 . . . . 65.11 108.385 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -140.71 143.05 34.82 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.865 -0.607 . . . . 44.34 111.05 -177.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -131.22 122.95 27.42 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.592 -0.892 . . . . 74.52 108.592 178.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -91.36 128.16 37.08 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.371 -0.603 . . . . 64.31 109.371 176.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -116.74 139.44 50.57 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 106.911 -1.514 . . . . 64.43 106.911 175.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -115.32 130.87 57.03 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.374 -0.973 . . . . 64.42 108.374 -176.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 41.9 t -132.59 140.15 36.92 Favored Pre-proline 0 C--N 1.283 -2.306 0 N-CA-C 108.793 -0.817 . . . . 52.11 108.793 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.711 ' HA ' ' O ' ' A' ' 490' ' ' SER . 49.7 Cg_endo -72.52 121.76 7.7 Favored 'Trans proline' 0 N--CA 1.437 -1.805 0 C-N-CA 121.045 1.163 . . . . 71.23 109.726 174.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 48.8 m -142.69 179.38 7.02 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.661 -0.7 . . . . 71.3 110.55 -173.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 14.1 t -52.12 138.63 36.06 Favored Pre-proline 0 CA--C 1.562 1.412 0 C-N-CA 124.198 0.999 . . . . 61.32 111.274 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.77 -30.0 36.17 Favored 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 124.868 3.712 . . . . 61.22 114.058 -173.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -73.17 -19.84 61.03 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.608 0.596 . . . . 75.23 112.608 -176.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -101.79 -6.83 23.15 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.232 -0.292 . . . . 70.4 111.32 177.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 94.4 t -61.09 128.09 21.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 120.854 0.359 . . . . 63.2 110.341 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.42 -11.85 71.13 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.432 -0.804 . . . . 71.42 111.831 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -110.93 165.36 11.92 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 109.636 -0.505 . . . . 25.52 109.636 -177.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.416 HG22 HG12 ' A' ' 488' ' ' VAL . 80.6 t -76.98 145.3 10.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 107.086 -1.449 . . . . 72.34 107.086 171.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 64.8 mt -97.32 -31.96 3.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 107.031 -1.47 . . . . 71.02 107.031 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 160.39 -178.36 36.45 Favored Glycine 0 N--CA 1.417 -2.625 0 CA-C-N 114.983 -1.008 . . . . 61.43 110.858 175.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 470' ' ' THR . . . . . 0.574 HG22 HG12 ' A' ' 486' ' ' ILE . 54.3 p -114.39 146.44 40.57 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 106.117 -1.809 . . . . 43.11 106.117 175.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -67.19 -54.51 19.28 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 120.054 -0.658 . . . . 55.42 110.675 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -73.15 138.81 28.53 Favored 'Trans proline' 0 C--N 1.368 1.585 0 N-CA-C 107.797 -1.655 . . . . 64.22 107.797 169.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.428 ' HB2' ' HG2' ' A' ' 476' ' ' GLN . 23.0 Cg_exo -62.62 132.28 37.13 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.611 1.541 . . . . 65.03 111.888 -177.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -73.75 16.69 0.2 Allowed 'General case' 0 C--O 1.195 -1.768 0 C-N-CA 124.214 1.006 . . . . 43.41 112.355 -177.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -111.8 -8.87 14.12 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 122.645 0.378 . . . . 65.53 111.2 173.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 476' ' ' GLN . . . . . 0.428 ' HG2' ' HB2' ' A' ' 473' ' ' PRO . 85.2 mm-40 -77.61 171.1 15.45 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 113.606 0.965 . . . . 74.31 113.606 -172.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 1.1 m -105.37 115.53 30.42 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 107.592 -1.262 . . . . 65.41 107.592 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 22.0 m -115.1 142.62 46.4 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 120.613 0.244 . . . . 74.13 110.401 -176.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -71.72 166.57 21.69 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.813 -0.63 . . . . 72.12 110.19 176.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 29.4 mm -70.95 -3.18 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.362 0 CA-C-O 121.821 0.82 . . . . 53.14 111.797 -173.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 14.6 t -112.19 5.29 18.38 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.18 -0.95 . . . . 51.15 110.711 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -79.79 132.66 36.2 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.803 -0.56 . . . . 72.21 111.377 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 46.0 t -106.61 121.7 59.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 108.35 -0.981 . . . . 70.41 108.35 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 28.7 m -104.72 134.62 45.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-O 121.518 0.675 . . . . 73.32 111.929 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.13 125.99 50.02 Favored 'Isoleucine or valine' 0 C--O 1.252 1.195 0 N-CA-C 108.91 -0.774 . . . . 74.51 108.91 178.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.574 HG12 HG22 ' A' ' 470' ' ' THR . 7.9 mt -119.62 127.44 75.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.259 -0.882 . . . . 64.15 109.381 -178.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 7.1 tt -108.38 127.14 64.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.07 0.462 . . . . 62.32 111.287 -177.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.416 HG12 HG22 ' A' ' 467' ' ' VAL . 31.9 m -111.23 151.75 13.3 Favored 'Isoleucine or valine' 0 C--O 1.252 1.203 0 CA-C-N 115.849 -0.614 . . . . 72.5 109.933 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.17 133.97 12.2 Favored Glycine 0 N--CA 1.43 -1.702 0 C-N-CA 121.022 -0.609 . . . . 74.0 111.946 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.711 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 33.4 m -135.01 161.02 36.48 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 105.779 -1.934 . . . . 74.42 105.779 176.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 151.29 134.02 2.11 Favored Glycine 0 C--N 1.295 -1.695 0 C-N-CA 118.468 -1.825 . . . . 45.13 113.925 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -97.97 152.7 0.85 Allowed 'Trans proline' 0 N--CA 1.44 -1.633 0 C-N-CA 122.756 2.304 . . . . 74.33 111.63 172.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -110.6 35.3 3.53 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 122.404 1.097 . . . . 75.33 108.506 177.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 546' ' ' PRO . 17.2 p -117.22 150.06 39.37 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 113.758 -1.564 . . . . 72.42 110.994 -174.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 495' ' ' LYS . . . . . 0.51 ' HA ' ' HE3' ' A' ' 495' ' ' LYS . 0.0 OUTLIER -137.04 164.28 28.75 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.694 -1.224 . . . . 71.12 107.694 175.474 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.7 m-20 -90.36 138.34 31.62 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 109.531 -0.544 . . . . 74.42 109.531 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 497' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 543' ' ' THR . 35.9 pt -95.54 124.54 52.72 Favored Pre-proline 0 C--N 1.306 -1.286 0 C-N-CA 120.787 -0.365 . . . . 45.23 110.754 177.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -89.38 171.14 4.51 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.391 2.061 . . . . 72.04 110.51 174.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -87.87 154.57 20.42 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.386 -0.968 . . . . 70.41 108.386 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.5 p -145.91 104.31 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 108.954 -0.758 . . . . 71.0 108.954 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -140.68 119.85 12.89 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.732 -0.667 . . . . 74.3 110.497 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 122.97 -12.38 8.63 Favored Glycine 0 CA--C 1.486 -1.77 0 C-N-CA 120.119 -1.039 . . . . 60.43 111.779 177.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 503' ' ' GLN . . . . . 0.484 ' O ' HG12 ' A' ' 534' ' ' VAL . 81.9 mt-30 -99.0 171.09 8.26 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.438 -0.949 . . . . 65.15 108.438 176.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 14.5 t -90.15 157.78 17.57 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.358 -0.979 . . . . 72.42 108.358 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 12.4 p -52.78 -41.1 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 113.084 0.772 . . . . 64.25 113.084 -176.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -61.54 -41.87 98.0 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.125 0.488 . . . . 71.0 110.6 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 93.5 t -69.54 -43.38 80.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.441 -0.799 . . . . 73.41 110.196 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -61.31 -49.5 76.75 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.081 -0.508 . . . . 70.02 111.412 -178.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -63.07 -38.09 89.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.042 0.449 . . . . 73.23 111.285 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.462 ' O ' HG23 ' A' ' 514' ' ' VAL . 33.6 ttmt -62.54 -42.29 99.43 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.343 -0.844 . . . . 74.43 109.719 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -62.82 -48.37 79.36 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.056 -0.52 . . . . 72.12 110.79 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.93 -36.54 79.6 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.076 0.399 . . . . 71.42 112.076 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -60.36 -37.43 80.68 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 116.351 -0.386 . . . . 72.31 111.145 176.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 510' ' ' LYS . 94.2 t -61.48 -36.43 73.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.117 -0.492 . . . . 74.43 110.387 177.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -76.46 -15.03 60.0 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.573 -0.285 . . . . 74.41 111.354 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 110.91 -8.65 29.57 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.793 -0.717 . . . . 30.52 112.846 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.461 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 76.2 m-85 -80.06 113.82 18.52 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 108.085 -1.08 . . . . 75.52 108.085 -177.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.4 m -116.71 -8.95 11.37 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 118.548 -1.261 . . . . 71.14 114.113 -171.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -108.34 120.81 43.45 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.391 -0.818 . . . . 74.53 110.397 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -120.93 156.04 32.94 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 113.338 0.866 . . . . 65.43 113.338 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 46.9 m -141.85 138.52 32.2 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 106.296 -1.742 . . . . 61.51 106.296 169.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 522' ' ' GLN . . . . . 0.507 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 0.0 OUTLIER -121.63 141.35 51.2 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 119.601 -0.84 . . . . 73.22 111.094 179.523 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -119.89 122.61 41.66 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.683 -1.228 . . . . 74.41 107.683 176.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 524' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 67.1 m -88.86 128.02 35.65 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 121.214 0.531 . . . . 73.32 110.508 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 24.7 m -121.44 149.82 24.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.96 -0.756 . . . . 65.13 108.96 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 526' ' ' ASP . . . . . 0.408 ' HB3' ' HE3' ' A' ' 557' ' ' LYS . 10.0 p-10 -73.94 135.03 43.22 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 108.354 -0.98 . . . . 52.53 108.354 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 527' ' ' SER . . . . . 0.405 ' HB3' ' HD2' ' A' ' 528' ' ' PRO . 45.4 m -152.16 172.55 5.37 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 108.628 -0.879 . . . . 72.32 108.628 -176.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 528' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 527' ' ' SER . 72.6 Cg_endo -82.67 -10.31 10.77 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 121.452 1.435 . . . . 64.4 110.424 174.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.433 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 27.3 mmt180 -81.36 138.18 48.43 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-N 114.862 -1.063 . . . . 64.53 108.18 -178.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -62.46 149.65 90.15 Favored 'Trans proline' 0 C--O 1.249 1.03 0 C-N-CA 122.351 2.034 . . . . 64.02 112.316 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -58.57 118.26 5.44 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.224 -0.898 . . . . 72.53 110.79 -178.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 127.59 -23.73 5.33 Favored Glycine 0 N--CA 1.434 -1.442 0 N-CA-C 111.113 -0.795 . . . . 70.32 111.113 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -81.14 134.96 35.73 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.468 -0.938 . . . . 74.35 108.468 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 503' ' ' GLN . 13.4 p -80.96 135.24 25.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 CA-C-O 121.3 0.571 . . . . 64.42 110.519 -178.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 535' ' ' THR . . . . . 0.471 ' HB ' ' HG3' ' A' ' 554' ' ' GLN . 77.5 m -88.91 -32.83 17.53 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.168 -0.924 . . . . 70.42 109.889 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.38 -152.1 24.21 Favored Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 110.091 -1.203 . . . . 70.32 110.091 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 27.3 p -117.56 157.19 26.78 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.551 -0.537 . . . . 72.11 109.551 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -73.09 -50.04 6.87 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 109.59 -0.522 . . . . 74.41 109.59 175.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.12 146.92 78.29 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 121.217 1.278 . . . . 74.41 109.649 171.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.43 143.81 53.66 Favored 'Trans proline' 0 C--O 1.25 1.122 0 C-N-CA 122.181 1.921 . . . . 75.24 113.089 -176.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.86 133.51 50.2 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.815 -0.809 . . . . 74.13 108.815 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.47 -5.31 35.32 Favored Glycine 0 C--N 1.299 -1.506 0 C-N-CA 120.053 -1.07 . . . . 62.44 111.111 -176.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.47 ' O ' HG12 ' A' ' 497' ' ' ILE . 62.4 m -82.26 133.69 35.25 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.516 -0.55 . . . . 75.24 109.516 176.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 11.9 t -96.44 130.84 43.5 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 119.984 -0.686 . . . . 70.41 109.571 176.061 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.1 m -139.44 159.24 66.6 Favored Pre-proline 0 C--N 1.316 -0.891 0 N-CA-C 109.175 -0.676 . . . . 75.21 109.175 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 494' ' ' THR . 35.9 Cg_exo -63.39 142.04 83.69 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.367 2.045 . . . . 62.41 111.374 176.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.461 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 27.7 m -66.72 -23.19 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-O 121.445 0.64 . . . . 73.03 112.32 -177.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -79.68 -13.41 59.49 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.517 -0.765 . . . . 74.13 110.574 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 56.7 m -77.5 164.97 24.94 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 113.463 0.912 . . . . 72.2 113.463 -175.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 23.9 t -90.9 131.39 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-N 114.629 -1.169 . . . . 73.11 109.179 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 551' ' ' ILE . . . . . 0.47 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -116.51 142.39 30.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 109.721 -0.474 . . . . 54.2 109.721 175.317 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -103.78 116.66 32.72 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.839 -0.619 . . . . 74.22 110.713 -175.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 553' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 7.3 mp -103.27 134.4 46.74 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.238 -0.892 . . . . 75.12 109.738 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 554' ' ' GLN . . . . . 0.471 ' HG3' ' HB ' ' A' ' 535' ' ' THR . 10.2 pt20 -101.29 125.38 47.92 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 108.834 -0.802 . . . . 71.01 108.834 179.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 524' ' ' SER . 59.5 t -114.8 138.59 44.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-N 115.44 -0.8 . . . . 71.13 110.002 -174.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 63.2 m -69.35 140.57 54.28 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 113.606 0.965 . . . . 74.31 113.606 178.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' A' ' 526' ' ' ASP . 3.0 ttpt -103.26 139.76 38.29 Favored 'General case' 0 N--CA 1.422 -1.825 0 N-CA-C 104.915 -2.254 . . . . 73.1 104.915 166.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 558' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -67.68 -36.56 87.86 Favored Glycine 0 CA--C 1.484 -1.905 0 C-N-CA 120.55 -0.833 . . . . 41.44 112.395 -172.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 66.2 t30 67.33 -3.84 0.97 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.808 1.243 . . . . 64.34 112.857 171.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -151.38 142.06 22.74 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.172 -1.418 . . . . 70.11 107.172 -174.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -136.18 134.93 38.72 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 120.627 0.251 . . . . 74.43 111.092 174.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.1 p -60.27 123.23 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.737 0.815 . . . . 73.31 112.931 -175.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 563' ' ' MET . . . . . 0.444 ' HG2' ' O ' ' A' ' 612' ' ' THR . 25.5 ptm -98.11 141.19 22.55 Favored Pre-proline 0 C--O 1.253 1.259 0 CA-C-N 115.9 -0.591 . . . . 55.34 111.421 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.35 169.85 21.55 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.793 2.328 . . . . 43.53 110.555 171.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -72.52 130.45 40.65 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.163 0.506 . . . . 74.01 110.021 177.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 93.2 mt -116.6 -9.78 11.3 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.656 -0.702 . . . . 55.4 110.943 -177.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 10.5 p -70.36 129.88 40.47 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 109.952 -0.388 . . . . 75.13 109.952 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 90.3 -0.26 77.87 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.581 -0.819 . . . . 74.41 111.942 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 26.4 mmt -91.32 151.21 20.96 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 108.845 -0.798 . . . . 62.41 108.845 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -93.28 140.79 29.15 Favored 'General case' 0 N--CA 1.416 -2.165 0 N-CA-C 109.35 -0.611 . . . . 74.23 109.35 -176.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 571' ' ' TRP . . . . . 0.435 ' HA ' ' HB3' ' A' ' 574' ' ' ALA . 60.7 t-105 -71.53 -15.65 62.3 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.659 -0.701 . . . . 75.42 110.276 -174.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 14.0 p -72.31 -19.3 19.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.896 0.855 . . . . 63.12 108.908 178.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -102.27 -44.77 5.32 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 114.511 -1.222 . . . . 60.34 110.359 176.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 574' ' ' ALA . . . . . 0.435 ' HB3' ' HA ' ' A' ' 571' ' ' TRP . . . -65.42 -41.34 93.68 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 113.923 1.083 . . . . 73.44 113.923 -176.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.585 ' O ' ' HG2' ' A' ' 579' ' ' ARG . 32.0 tt0 -65.54 -53.55 36.81 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 120.176 -0.61 . . . . 73.44 111.907 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 576' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 52.4 Cg_exo -55.88 -39.26 92.21 Favored 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 121.91 1.74 . . . . 74.14 113.136 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 574' ' ' ALA . 3.2 ppt_? -67.76 -37.19 81.76 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 119.536 -0.865 . . . . 75.43 110.809 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.452 HD12 ' N ' ' A' ' 579' ' ' ARG 0.275 3.5 pp -66.55 -36.41 82.59 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 120.498 -0.481 . . . . 64.31 111.507 179.865 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 579' ' ' ARG . . . . . 0.585 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 45.8 mmm-85 -57.21 -42.75 81.92 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.169 -0.923 . . . . 75.12 108.711 176.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -67.8 -28.05 67.26 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.716 -0.675 . . . . 74.54 111.912 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 10.5 mp -80.56 -8.06 59.46 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.145 0.498 . . . . 72.53 111.164 177.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 77.77 16.28 80.25 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-N 115.759 -0.655 . . . . 64.05 111.95 179.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -70.78 140.46 51.29 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 109.523 -0.547 . . . . 74.51 109.523 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 9.6 t -137.21 -50.01 0.62 Allowed 'General case' 0 N--CA 1.406 -2.638 0 CA-C-O 118.871 -0.585 . . . . 73.23 110.238 175.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . 30.67 -126.69 0.16 Allowed Glycine 0 C--N 1.371 2.488 0 O-C-N 124.631 1.207 . . . . 43.03 113.734 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 25.7 ptm -137.93 125.54 22.21 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.881 -1.526 . . . . 74.4 106.881 170.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -87.41 123.84 32.78 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.69 -0.855 . . . . 75.33 108.69 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -95.96 107.33 19.6 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.669 -0.696 . . . . 72.31 109.277 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -112.5 113.3 25.4 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 108.582 -0.895 . . . . 71.01 108.582 176.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -83.25 -126.09 1.1 Allowed Glycine 0 N--CA 1.435 -1.367 0 N-CA-C 111.066 -0.814 . . . . 62.13 111.066 175.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -70.98 137.73 49.35 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.873 0.368 . . . . 74.24 111.124 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -97.49 126.95 43.06 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 106.903 -1.518 . . . . 72.15 106.903 176.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 48.8 t -137.27 128.95 41.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 C-N-CA 120.955 -0.298 . . . . 73.35 110.463 -172.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -77.38 108.35 10.46 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 105.173 -2.158 . . . . 60.13 105.173 170.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -105.1 0.19 27.24 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-O 121.216 0.531 . . . . 75.45 111.44 -174.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 100.82 171.47 28.93 Favored Glycine 0 N--CA 1.433 -1.56 0 N-CA-C 109.584 -1.406 . . . . 51.14 109.584 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -63.46 -48.16 80.82 Favored Glycine 0 C--N 1.306 -1.126 0 C-N-CA 120.721 -0.752 . . . . 64.01 113.382 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 42.0 p -69.25 -26.79 64.95 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.502 0.668 . . . . 65.22 112.243 -175.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -105.91 -1.64 23.88 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 118.926 -0.559 . . . . 72.52 110.992 -174.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 600' ' ' HIS . . . . . 0.491 ' CG ' ' H ' ' A' ' 601' ' ' ASN . 0.3 OUTLIER -35.32 -115.74 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.616 0 N-CA-C 117.677 2.473 . . . . 54.51 117.677 -167.866 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 601' ' ' ASN . . . . . 0.491 ' H ' ' CG ' ' A' ' 600' ' ' HIS . 4.6 p30 -92.96 83.92 4.81 Favored 'General case' 0 C--N 1.287 -2.109 0 O-C-N 120.558 -1.339 . . . . 74.12 109.92 178.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -126.11 150.85 47.93 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 115.548 -0.751 . . . . 73.12 109.678 175.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 85.7 t -67.84 130.9 33.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 O-C-N 123.875 0.734 . . . . 74.15 109.358 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 60.1 t -93.11 -52.14 10.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.363 0.601 . . . . 74.45 109.786 -176.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -136.41 158.81 43.55 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.405 -0.961 . . . . 72.11 108.405 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 606' ' ' GLN . . . . . 0.415 ' HA ' HD23 ' A' ' 622' ' ' LEU . 19.5 pt20 -125.32 122.3 36.46 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.564 -1.273 . . . . 74.14 107.564 174.081 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.613 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 41.8 t30 -51.47 -59.0 8.81 Favored Pre-proline 0 CA--C 1.555 1.17 0 CA-C-O 119.094 -0.479 . . . . 71.21 112.175 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.613 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 2.7 Cg_endo -85.03 129.65 3.94 Favored 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 121.322 1.348 . . . . 72.34 109.123 171.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.81 161.52 35.84 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 122.696 2.264 . . . . 61.5 112.905 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -59.21 129.99 44.81 Favored 'General case' 0 C--O 1.249 1.051 0 CA-C-N 115.754 -0.657 . . . . 61.22 110.959 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 95.59 -10.76 68.83 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 120.863 -0.684 . . . . 63.23 111.706 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 612' ' ' THR . . . . . 0.444 ' O ' ' HG2' ' A' ' 563' ' ' MET . 24.0 m -89.27 161.97 16.11 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.642 -1.244 . . . . 73.25 107.642 178.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -99.12 143.19 16.45 Favored Glycine 0 N--CA 1.418 -2.518 0 C-N-CA 119.985 -1.102 . . . . 52.44 113.237 -177.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 614' ' ' VAL . . . . . 0.406 HG12 ' HG2' ' A' ' 608' ' ' PRO . 13.6 m -94.12 143.42 11.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.374 -0.973 . . . . 75.4 108.374 175.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.438 HD21 HG22 ' A' ' 619' ' ' ILE . 31.1 p30 -58.24 175.41 0.23 Allowed 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 114.21 1.189 . . . . 72.53 114.21 -175.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -55.95 -38.36 70.24 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 125.458 1.503 . . . . 74.43 110.986 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.91 -33.91 68.67 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 115.607 -0.724 . . . . 63.24 109.501 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 82.5 19.74 63.48 Favored Glycine 0 N--CA 1.417 -2.618 0 N-CA-C 109.974 -1.25 . . . . 63.31 109.974 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 619' ' ' ILE . . . . . 0.438 HG22 HD21 ' A' ' 615' ' ' ASN . 0.0 OUTLIER -70.62 119.44 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 108.629 -0.878 . . . . 72.12 108.629 -174.561 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 8.5 tp -116.26 132.42 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 0 CA-C-N 114.73 -1.123 . . . . 73.52 109.678 -174.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.524 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 32.8 m -105.28 117.53 34.24 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 108.912 -0.773 . . . . 75.34 108.912 178.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 622' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 606' ' ' GLN . 72.9 mt -139.09 165.65 26.59 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 105.747 -1.946 . . . . 74.41 105.747 -177.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -142.94 139.54 30.75 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 106.468 -1.678 . . . . 74.21 106.468 173.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -138.77 160.89 38.57 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.145 -1.057 . . . . 63.41 108.145 -177.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -87.15 -117.46 1.14 Allowed Glycine 0 N--CA 1.43 -1.734 0 O-C-N 123.915 0.759 . . . . 54.41 113.35 -177.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 . . . . . 0 C--N 1.298 -1.666 0 N-CA-C 109.21 -0.663 . . . . 74.01 109.21 -174.682 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.822 0 N-CA-C 112.045 -0.422 . . . . 43.05 112.045 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 9.7 tp -75.41 122.3 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 CA-C-O 121.666 0.746 . . . . 75.1 109.224 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 1.5 m -76.47 151.81 36.34 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.342 -0.845 . . . . 61.32 110.166 -176.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -88.1 -28.39 21.33 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.636 -1.246 . . . . 54.51 107.636 176.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -73.41 141.48 46.95 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 107.179 -1.415 . . . . 75.03 107.179 175.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.15 163.51 34.06 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.46 0 N-CA-C 108.226 -1.028 . . . . 70.05 108.226 -177.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -94.46 138.15 32.74 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 105.007 -2.22 . . . . 61.4 105.007 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.407 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 91.9 t -95.3 123.53 56.53 Favored Pre-proline 0 C--N 1.271 -2.825 0 N-CA-C 109.308 -0.627 . . . . 35.41 109.308 -171.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 363' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 17.9 Cg_exo -60.89 126.28 19.25 Favored 'Trans proline' 0 N--CA 1.445 -1.349 0 C-N-CA 122.316 2.011 . . . . 70.34 110.995 -178.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -84.62 114.2 21.82 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-O 122.639 1.209 . . . . 75.23 109.326 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.499 HG13 ' HB1' ' A' ' 373' ' ' ALA . 9.2 p -88.21 15.12 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 CA-C-N 113.832 -1.531 . . . . 54.54 111.554 -173.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -56.5 146.69 23.98 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.191 1.396 . . . . 74.55 111.954 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.41 0.47 43.68 Favored Glycine 0 CA--C 1.503 -0.673 0 CA-C-N 116.263 -0.426 . . . . 72.43 113.354 177.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -115.75 -159.39 0.71 Allowed 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 108.273 -1.01 . . . . 75.52 108.273 177.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 60.1 p -90.96 166.83 12.82 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 108.66 -0.867 . . . . 72.51 108.66 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 66.7 m -62.85 -41.13 99.23 Favored 'General case' 0 C--O 1.208 -1.101 0 C-N-CA 120.004 -0.678 . . . . 74.13 110.026 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.49 -46.68 81.97 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 116.728 -0.214 . . . . 71.22 111.563 -178.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -69.09 -39.83 78.77 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.475 0.655 . . . . 72.03 110.002 -176.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 373' ' ' ALA . . . . . 0.499 ' HB1' HG13 ' A' ' 365' ' ' VAL . . . -67.24 -46.47 73.66 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.582 -0.735 . . . . 74.32 111.285 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.435 HG12 HG21 ' A' ' 384' ' ' ILE . 75.9 mt -64.44 -40.98 90.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-N 116.353 -0.385 . . . . 72.3 110.302 177.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.99 -41.85 88.61 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.378 0.608 . . . . 72.11 110.619 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 87.2 m -63.17 -47.62 81.86 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.655 -0.702 . . . . 51.11 110.756 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 97.6 mt -64.05 -37.99 89.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.337 -0.392 . . . . 65.53 110.7 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -63.67 -38.66 91.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.799 -0.637 . . . . 54.43 110.775 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -68.9 -24.63 64.33 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 120.981 0.42 . . . . 75.55 111.382 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -82.09 -14.76 55.32 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.153 -0.476 . . . . 75.35 110.757 176.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.95 16.82 43.16 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.212 -0.994 . . . . 53.13 112.257 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -88.16 159.59 18.12 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 121.395 0.617 . . . . 75.33 111.829 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -100.64 132.6 45.95 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 106.824 -1.547 . . . . 62.32 106.824 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.435 HG21 HG12 ' A' ' 374' ' ' ILE . 0.8 OUTLIER -122.89 137.29 56.87 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 N-CA-C 106.824 -1.547 . . . . 72.14 106.824 178.759 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 385' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 417' ' ' THR . 32.5 ttt180 -116.82 138.58 51.41 Favored 'General case' 0 C--N 1.255 -3.533 0 N-CA-C 105.724 -1.954 . . . . 72.2 105.724 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 41.0 m -130.23 132.51 46.0 Favored 'General case' 0 C--N 1.272 -2.786 0 O-C-N 121.771 -0.581 . . . . 63.41 109.483 -174.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.7 121.89 42.95 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.649 -1.241 . . . . 74.31 107.649 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -89.53 122.5 32.75 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.941 -0.763 . . . . 72.01 108.941 -178.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 389' ' ' LYS . . . . . 0.621 ' O ' ' HA ' ' A' ' 421' ' ' SER . 51.8 mtmt -132.98 135.78 26.49 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 109.028 -0.73 . . . . 74.32 109.028 177.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -76.14 176.6 9.83 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.32 2.014 . . . . 61.32 112.609 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 11.2 t70 87.92 167.82 0.06 Allowed 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 126.351 1.861 . . . . 73.44 110.707 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 32.6 t -105.7 -12.7 15.81 Favored 'General case' 0 N--CA 1.439 -1.022 0 O-C-N 122.35 -0.219 . . . . 64.22 111.222 -175.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 6.0 t -82.63 -3.38 56.12 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 119.198 -1.001 . . . . 70.34 109.548 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 47.6 mm -88.14 146.15 37.65 Favored Pre-proline 0 C--N 1.302 -1.475 0 N-CA-C 106.17 -1.789 . . . . 72.42 106.17 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 395' ' ' PRO . . . . . 0.44 ' HA ' ' HD2' ' A' ' 396' ' ' PRO . 28.3 Cg_exo -37.94 116.31 0.21 Allowed 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 123.772 2.981 . . . . 74.53 113.12 177.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 396' ' ' PRO . . . . . 0.528 ' HA ' ' OG ' ' A' ' 421' ' ' SER . 12.2 Cg_endo -57.72 151.99 52.02 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.041 2.494 . . . . 72.22 112.732 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 397' ' ' ASP . . . . . 0.46 ' HA ' HG23 ' A' ' 420' ' ' VAL . 8.7 p-10 -59.19 -8.17 1.49 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.874 1.27 . . . . 74.51 113.638 -178.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 398' ' ' HIS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 31.4 m170 -106.55 109.96 22.03 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 104.327 -2.471 . . . . 61.54 104.327 171.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 28.0 m -62.78 119.07 5.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 124.647 1.217 . . . . 74.42 112.567 -165.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 400' ' ' ILE . . . . . 0.548 ' H ' HD13 ' A' ' 400' ' ' ILE . 0.2 OUTLIER -92.25 -28.22 4.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.4 -0.818 . . . . 73.15 109.89 179.132 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.75 160.11 28.06 Favored Glycine 0 N--CA 1.399 -3.824 0 CA-C-N 115.232 -0.895 . . . . 73.13 111.054 -176.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -114.83 -175.99 2.81 Favored 'General case' 0 C--N 1.27 -2.87 0 C-N-CA 125.351 1.46 . . . . 73.4 108.339 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -99.3 137.3 20.35 Favored Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 107.095 -1.446 . . . . 62.32 107.095 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -54.91 -16.28 11.49 Favored 'Trans proline' 0 C--N 1.365 1.411 0 C-N-CA 124.313 3.342 . . . . 72.32 114.662 -174.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.65 -28.69 68.76 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 116.308 -0.406 . . . . 64.35 110.249 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -73.96 -38.27 64.26 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.507 0.67 . . . . 61.15 110.392 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -81.2 -5.18 57.45 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.499 0.666 . . . . 74.22 110.629 -177.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 30.9 m -95.29 143.56 26.58 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.307 -1.738 . . . . 65.2 106.307 173.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 47.7 m -74.51 112.48 10.73 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 118.441 -1.304 . . . . 63.44 108.666 176.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 28.7 m -127.58 169.2 19.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 115.876 -0.602 . . . . 55.4 109.862 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 29.6 t -71.85 132.62 44.67 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 106.761 -1.57 . . . . 71.32 106.761 175.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -65.46 133.4 51.2 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-O 121.22 0.533 . . . . 61.22 111.157 -175.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 104.89 54.81 0.75 Allowed Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 110.816 -0.914 . . . . 22.51 110.816 -177.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -113.32 -177.23 3.08 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.818 -1.178 . . . . 61.15 107.818 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -107.67 108.88 20.32 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.153 -0.684 . . . . 71.11 109.153 -177.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.6 mm -98.01 116.77 41.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.37 -0.974 . . . . 61.42 108.37 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 417' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 385' ' ' ARG . 58.1 m -97.74 130.82 44.68 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 120.849 0.357 . . . . 72.23 110.535 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 4.8 p -118.96 136.18 56.99 Favored 'Isoleucine or valine' 0 C--O 1.252 1.223 0 C-N-CA 123.577 0.751 . . . . 60.44 110.232 -177.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -93.96 120.07 33.72 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.013 -0.736 . . . . 63.5 109.013 176.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.46 HG23 ' HA ' ' A' ' 397' ' ' ASP . 14.7 p -113.81 132.45 62.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 109.7 -0.481 . . . . 71.13 109.7 -178.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 421' ' ' SER . . . . . 0.621 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 11.9 p -88.26 125.36 34.61 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.075 0.464 . . . . 72.25 111.301 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 5.6 t -118.36 106.52 12.83 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-O 121.191 0.519 . . . . 74.02 111.379 177.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 70.63 114.1 0.04 OUTLIER Glycine 0 CA--C 1.536 1.398 0 N-CA-C 115.226 0.85 . . . . 73.43 115.226 175.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.53 144.5 97.88 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 122.467 2.111 . . . . 63.01 111.104 174.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.437 ' O ' HD13 ' A' ' 480' ' ' ILE . 33.6 mt-10 -101.05 166.55 10.75 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 109.679 -0.489 . . . . 64.21 109.679 -177.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -88.32 157.58 18.69 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.634 0.254 . . . . 74.12 111.522 -176.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 10.9 mmp_? -122.23 153.81 38.35 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-N 116.312 -0.404 . . . . 72.31 110.456 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 40.6 tt0 -84.83 141.47 30.45 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.418 -1.327 . . . . 72.13 107.418 174.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.423 ' HA ' ' HD3' ' A' ' 430' ' ' PRO . 68.2 mt -78.08 125.92 84.48 Favored Pre-proline 0 N--CA 1.437 -1.121 0 N-CA-C 107.212 -1.403 . . . . 70.44 107.212 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 429' ' ' ILE . 23.4 Cg_exo -67.62 145.05 68.68 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.473 2.115 . . . . 75.15 113.093 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -75.44 104.81 6.16 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 108.992 -0.744 . . . . 64.41 108.992 175.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 46.1 t -116.78 138.01 48.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 107.93 -1.137 . . . . 54.23 107.93 178.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.41 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 18.5 m -68.97 152.33 45.4 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 121.053 0.454 . . . . 74.32 111.025 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 434' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 58.3 p -63.89 -34.44 77.95 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 113.535 0.939 . . . . 44.42 113.535 -170.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.6 pp -84.22 -11.32 56.71 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 120.98 0.419 . . . . 73.24 111.842 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.41 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 0.8 OUTLIER -93.95 42.77 1.1 Allowed 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 115.687 -0.688 . . . . 54.24 109.731 -177.6 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -52.14 -39.65 60.25 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.725 1.21 . . . . 75.35 112.989 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.19 -41.79 99.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.085 0.469 . . . . 74.21 110.218 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -71.17 -33.97 70.5 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 116.19 -0.459 . . . . 71.31 110.286 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.46 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -59.43 -51.25 70.68 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.497 -0.127 . . . . 63.14 110.888 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.4 m -61.45 -37.63 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 CA-C-O 121.111 0.481 . . . . 75.43 110.458 177.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -60.52 -48.19 82.86 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.244 1.018 . . . . 65.22 110.908 176.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -66.42 -38.5 87.57 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 123.777 0.831 . . . . 72.4 111.466 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.46 HD13 ' O ' ' A' ' 440' ' ' ALA . 6.9 mp -66.15 -33.96 76.95 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.877 -0.601 . . . . 73.32 110.927 176.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.508 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 56.2 m -70.13 -45.07 67.6 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.251 0.548 . . . . 73.53 109.874 177.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.69 -16.36 64.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.541 -0.754 . . . . 74.01 110.917 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.84 5.67 20.9 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.081 -0.509 . . . . 74.12 111.74 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 100.72 -67.39 0.5 Allowed Glycine 0 CA--C 1.497 -1.088 0 C-N-CA 120.552 -0.832 . . . . 53.33 111.938 175.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -51.54 -59.39 4.31 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.264 0.839 . . . . 71.43 113.264 178.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 450' ' ' GLY . . . . . 0.508 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 60.76 19.89 55.99 Favored Glycine 0 CA--C 1.505 -0.569 0 CA-C-O 121.25 0.361 . . . . 74.34 113.059 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.498 ' NH2' ' HA ' ' A' ' 481' ' ' THR . 13.6 mtm180 -105.29 111.35 24.06 Favored 'General case' 0 N--CA 1.415 -2.209 0 CA-C-O 121.258 0.552 . . . . 74.01 110.172 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.511 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 15.0 p90 -135.3 145.34 47.4 Favored 'General case' 0 N--CA 1.412 -2.364 0 CA-C-N 114.151 -1.386 . . . . 74.34 109.55 -175.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 26.1 mmtm -136.43 127.24 27.38 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.349 -0.842 . . . . 72.31 108.877 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -90.72 127.26 36.25 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 123.644 0.59 . . . . 74.4 111.369 -174.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -126.85 147.29 50.05 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.905 -1.146 . . . . 75.51 107.905 175.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -122.06 146.5 47.13 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 120.376 -0.53 . . . . 44.55 109.937 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 23.2 t -142.79 137.53 15.21 Favored Pre-proline 0 C--N 1.297 -1.713 0 N-CA-C 107.686 -1.227 . . . . 54.55 107.686 177.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.578 ' HA ' ' O ' ' A' ' 490' ' ' SER . 23.9 Cg_exo -64.92 123.01 10.98 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.738 1.625 . . . . 62.15 110.471 176.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 54.9 m -148.94 -178.31 6.29 Favored 'General case' 0 C--N 1.287 -2.117 0 C-N-CA 124.971 1.308 . . . . 55.42 108.136 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 11.2 t -45.27 134.39 5.58 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 123.727 0.811 . . . . 71.51 112.283 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 461' ' ' PRO . . . . . 0.463 ' HA ' HG23 ' A' ' 464' ' ' VAL . 9.5 Cg_endo -51.92 -29.21 34.34 Favored 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 124.814 3.676 . . . . 74.45 114.067 -175.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.405 ' O ' ' HD2' ' A' ' 466' ' ' LYS . 11.3 pt-20 -71.77 -19.42 62.02 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 112.055 0.391 . . . . 52.43 112.055 -178.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 72.6 mt -96.09 -2.54 46.4 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 111.601 0.223 . . . . 75.3 111.601 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.463 HG23 ' HA ' ' A' ' 461' ' ' PRO . 87.9 t -60.81 127.39 20.3 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 CA-C-O 120.891 0.377 . . . . 74.52 110.315 178.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 84.7 -10.57 61.86 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.312 -0.858 . . . . 74.05 112.065 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.405 ' HD2' ' O ' ' A' ' 462' ' ' GLU . 50.2 mttp -111.98 166.23 11.41 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 108.182 -1.044 . . . . 73.52 108.182 -176.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.498 ' O ' ' HB ' ' A' ' 434' ' ' THR . 87.2 t -80.41 146.83 7.01 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.294 0 CA-C-N 116.261 -0.427 . . . . 62.53 109.957 -177.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 63.9 mt -98.57 -35.21 4.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 107.439 -1.319 . . . . 42.25 107.439 174.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 156.68 -152.1 23.48 Favored Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 110.166 -1.174 . . . . 64.25 110.166 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 3.6 p -132.15 157.15 45.02 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.547 -0.908 . . . . 73.45 108.547 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -71.82 -46.46 12.17 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 119.728 -0.789 . . . . 75.51 110.625 175.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' ' 473' ' ' PRO . 18.0 Cg_exo -71.15 141.69 40.23 Favored 'Trans proline' 0 C--N 1.374 1.89 0 N-CA-C 107.304 -1.845 . . . . 70.22 107.304 167.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 472' ' ' PRO . 27.9 Cg_exo -62.34 127.54 21.26 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 121.508 1.472 . . . . 43.42 112.063 -177.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -73.99 2.03 9.6 Favored 'General case' 0 C--O 1.201 -1.448 0 C-N-CA 123.646 0.778 . . . . 73.23 112.444 -175.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -110.4 5.4 21.45 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.603 0.716 . . . . 73.22 110.005 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -109.12 176.78 4.97 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-N 115.616 -0.72 . . . . 62.33 111.529 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 2.3 p -96.8 145.9 25.41 Favored 'General case' 0 N--CA 1.391 -3.406 0 CA-C-N 114.663 -1.153 . . . . 73.4 110.773 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 49.7 m -137.29 148.06 46.11 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 107.548 -1.279 . . . . 73.3 107.548 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -77.96 159.57 28.74 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 120.715 0.293 . . . . 73.34 110.441 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.437 HD13 ' O ' ' A' ' 425' ' ' GLU . 1.7 mp -65.61 -18.37 23.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.524 0.678 . . . . 71.33 111.316 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 481' ' ' THR . . . . . 0.498 ' HA ' ' NH2' ' A' ' 451' ' ' ARG . 7.7 t -87.28 1.91 51.77 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.943 -0.571 . . . . 45.32 111.065 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -93.05 148.91 21.6 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.045 0.45 . . . . 74.24 110.863 -177.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.9 p -108.6 126.34 65.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.568 -1.271 . . . . 72.31 107.568 172.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 26.9 m -105.33 134.25 47.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 121.903 0.859 . . . . 70.54 111.852 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.87 122.61 44.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 114.968 -1.015 . . . . 74.14 110.288 -178.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.416 HD11 HD21 ' A' ' 444' ' ' LEU . 36.2 mm -97.94 113.13 31.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 107.462 -1.31 . . . . 74.44 107.462 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 9.5 tt -99.08 126.24 52.38 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 108.911 -0.774 . . . . 54.24 108.911 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 27.2 m -111.25 151.92 13.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 123.345 0.658 . . . . 65.11 110.668 -178.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -77.37 132.64 12.25 Favored Glycine 0 N--CA 1.424 -2.136 0 CA-C-N 115.562 -0.744 . . . . 71.42 112.553 -178.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.578 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 31.3 t -122.64 160.69 25.25 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 104.401 -2.444 . . . . 53.51 104.401 175.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 169.45 128.49 1.01 Allowed Glycine 0 C--N 1.291 -1.94 0 C-N-CA 118.083 -2.008 . . . . 63.55 112.805 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -84.01 149.46 12.25 Favored 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 122.499 2.133 . . . . 74.1 110.731 176.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 493' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . -75.14 84.85 2.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.777 0.799 . . . . 63.33 109.305 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 9.7 p -122.5 144.3 49.16 Favored 'General case' 0 N--CA 1.419 -2.014 0 CA-C-N 114.776 -1.102 . . . . 73.15 111.393 -173.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -139.96 149.48 43.33 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.713 -0.847 . . . . 75.44 108.713 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.548 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 6.5 p-10 -90.65 137.35 32.42 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 109.465 -0.568 . . . . 72.05 109.465 177.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 28.0 pt -91.01 110.45 42.22 Favored Pre-proline 0 C--N 1.304 -1.409 0 CA-C-N 115.698 -0.683 . . . . 74.01 109.856 177.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 498' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 496' ' ' ASP . 66.0 Cg_endo -90.71 150.4 4.14 Favored 'Trans proline' 0 N--CA 1.441 -1.562 0 C-N-CA 122.292 1.995 . . . . 72.12 111.97 178.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -78.88 91.5 4.78 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 122.517 1.151 . . . . 54.1 109.976 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 15.3 t -104.37 2.91 10.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.336 -1.357 . . . . 64.14 107.336 177.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -53.79 107.56 0.27 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.293 -1.321 . . . . 55.14 112.754 -175.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 177.85 27.85 0.04 OUTLIER Glycine 0 C--N 1.306 -1.117 0 N-CA-C 111.327 -0.709 . . . . 42.44 111.327 176.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.05 -170.85 3.43 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.267 -0.642 . . . . 71.4 109.267 -178.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 532' ' ' GLY . 8.8 t -84.13 157.91 21.55 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 109.076 -0.713 . . . . 55.23 109.076 -176.177 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.4 p -48.67 -41.77 12.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 124.194 0.997 . . . . 54.2 112.304 -177.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -61.53 -41.54 97.48 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.72 0.295 . . . . 74.24 111.778 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 47.3 t -76.01 -40.74 38.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-O 121.185 0.517 . . . . 74.3 110.602 -176.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.36 -46.88 84.49 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.068 -0.515 . . . . 61.02 110.224 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -61.95 -35.69 79.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.679 -0.691 . . . . 73.15 110.232 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.452 ' O ' HG23 ' A' ' 514' ' ' VAL . 0.3 OUTLIER -60.55 -43.08 97.63 Favored 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 109.016 -0.735 . . . . 75.42 109.016 177.13 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -62.57 -47.29 84.47 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.598 -0.274 . . . . 72.12 111.445 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.84 -40.07 94.03 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.733 0.301 . . . . 72.03 111.135 178.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.31 -38.16 88.37 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.055 -0.52 . . . . 73.1 110.636 178.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 510' ' ' LYS . 70.1 t -65.99 -31.16 52.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 115.886 -0.597 . . . . 74.24 110.746 176.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -78.44 -8.6 58.68 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.725 -0.39 . . . . 71.21 111.572 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 516' ' ' GLY . . . . . 0.402 ' O ' ' HB ' ' A' ' 547' ' ' VAL . . . 104.73 0.36 42.58 Favored Glycine 0 CA--C 1.504 -0.624 0 C-N-CA 120.859 -0.686 . . . . 70.31 112.557 177.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.472 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 83.8 m-85 -82.1 101.54 10.45 Favored 'General case' 0 CA--C 1.484 -1.595 0 N-CA-C 108.161 -1.051 . . . . 74.32 108.161 -178.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.5 m -100.0 -4.06 30.83 Favored 'General case' 0 N--CA 1.415 -2.205 0 CA-C-N 114.693 -1.139 . . . . 74.12 110.988 -173.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 519' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 97.0 mttt -116.61 114.25 23.84 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.589 -0.893 . . . . 65.34 108.589 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -132.16 152.11 51.44 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.483 -0.78 . . . . 74.13 112.451 -175.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 46.4 m -141.04 134.17 29.39 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.49 -1.3 . . . . 65.25 107.49 171.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 522' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 3.4 pm0 -118.82 138.84 52.43 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 117.907 0.321 . . . . 54.23 110.214 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -131.77 143.52 50.28 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.348 -1.353 . . . . 70.11 107.348 177.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 524' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 14.9 t -121.24 132.61 54.92 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.083 0.468 . . . . 73.34 110.089 -178.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 34.0 t -124.9 149.57 29.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 106.998 -1.482 . . . . 73.34 106.998 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 526' ' ' ASP . . . . . 0.605 ' HA ' ' HB3' ' A' ' 557' ' ' LYS . 4.1 p30 -66.59 134.69 52.85 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.892 0.853 . . . . 75.25 109.172 178.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 70.8 m -153.14 167.09 14.12 Favored Pre-proline 0 C--N 1.28 -2.442 0 CA-C-N 114.472 -1.24 . . . . 74.54 108.526 -173.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.86 -24.91 45.9 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.655 1.57 . . . . 54.03 113.055 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.98 142.2 79.26 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.595 -0.275 . . . . 74.33 111.183 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.61 151.78 60.41 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 123.263 2.642 . . . . 75.11 113.232 -178.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -62.47 119.66 9.57 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.366 -0.834 . . . . 74.31 111.44 -176.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 532' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 504' ' ' THR . . . 118.09 -22.19 9.85 Favored Glycine 0 N--CA 1.425 -2.049 0 C-N-CA 120.403 -0.903 . . . . 65.44 112.351 177.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -80.1 127.59 32.49 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.496 -0.927 . . . . 65.32 108.496 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 57.4 t -75.98 122.95 31.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 109.212 -0.662 . . . . 75.02 109.212 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 535' ' ' THR . . . . . 0.683 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 14.0 t -90.05 -14.86 32.96 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.186 -0.461 . . . . 53.33 110.898 -177.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 153.11 -158.01 27.67 Favored Glycine 0 N--CA 1.429 -1.819 0 N-CA-C 111.325 -0.71 . . . . 75.4 111.325 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 20.9 p -128.68 156.8 42.88 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 109.753 -0.462 . . . . 61.51 109.753 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -70.49 -50.39 14.43 Favored Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 116.298 -0.41 . . . . 72.15 110.077 176.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 18.0 Cg_endo -63.11 135.32 50.29 Favored 'Trans proline' 0 C--N 1.371 1.738 0 N-CA-C 108.368 -1.435 . . . . 71.44 108.368 168.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 540' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 31.6 Cg_exo -59.44 140.7 95.43 Favored 'Trans proline' 0 C--O 1.249 1.073 0 C-N-CA 122.656 2.237 . . . . 65.53 113.552 -176.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -67.83 134.66 51.3 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.646 -0.872 . . . . 73.04 108.646 176.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 103.82 -6.83 48.57 Favored Glycine 0 C--N 1.298 -1.551 0 C-N-CA 120.817 -0.706 . . . . 60.45 111.346 -176.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 23.6 m -81.57 131.6 35.28 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.891 -0.411 . . . . 74.42 109.891 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 27.9 m -90.33 122.89 33.62 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 108.087 -1.079 . . . . 70.13 108.087 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 13.0 m -134.88 157.72 76.51 Favored Pre-proline 0 C--N 1.309 -1.159 0 C-N-CA 122.659 0.384 . . . . 74.4 110.188 -177.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 22.6 Cg_exo -67.62 139.93 50.16 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.492 2.128 . . . . 74.13 111.746 177.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.472 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 33.2 m -65.87 -20.04 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 122.265 1.031 . . . . 63.03 110.819 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -78.67 -10.05 59.62 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 113.666 -1.606 . . . . 75.3 111.252 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 94.4 p -96.5 172.96 7.6 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 120.631 -0.428 . . . . 61.25 110.868 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 7.1 p -102.65 129.66 53.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-O 120.904 0.383 . . . . 70.24 111.604 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 551' ' ' ILE . . . . . 0.493 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -106.33 146.12 13.32 Favored 'Isoleucine or valine' 0 C--O 1.247 0.939 0 CA-C-O 121.181 0.515 . . . . 71.13 109.974 177.216 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -107.63 116.18 31.48 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-O 121.56 0.695 . . . . 73.25 110.861 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 553' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 51.7 mt -94.09 134.17 36.79 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 125.129 1.372 . . . . 71.32 108.864 -178.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -113.89 118.86 35.37 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 122.088 0.947 . . . . 73.24 110.921 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 524' ' ' SER . 39.7 t -101.26 139.75 21.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 CA-C-N 114.356 -1.293 . . . . 71.22 109.637 -175.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.683 ' OG ' ' HB ' ' A' ' 535' ' ' THR . 50.2 m -79.02 134.61 36.78 Favored 'General case' 0 N--CA 1.418 -2.032 0 CA-C-O 121.792 0.806 . . . . 72.32 111.172 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.605 ' HB3' ' HA ' ' A' ' 526' ' ' ASP . 11.3 tppt? -101.76 126.08 48.55 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 105.112 -2.181 . . . . 61.04 105.112 171.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -71.64 -45.29 45.85 Favored Glycine 0 CA--C 1.484 -1.906 0 C-N-CA 120.187 -1.006 . . . . 71.54 112.238 -172.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 57.1 t30 62.84 25.17 14.95 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-O 122.701 1.239 . . . . 71.01 109.042 177.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.565 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 94.4 mt-30 -129.35 156.96 43.2 Favored 'General case' 0 C--O 1.25 1.114 0 CA-C-N 114.538 -1.21 . . . . 70.43 110.733 -176.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -130.18 144.12 51.18 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.252 -0.885 . . . . 74.24 108.636 176.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 54.3 t -66.17 125.99 24.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 121.128 0.489 . . . . 64.31 112.278 -178.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 563' ' ' MET . . . . . 0.454 ' HA ' ' HD3' ' A' ' 564' ' ' PRO . 53.8 ttp -92.08 130.02 39.59 Favored Pre-proline 0 C--O 1.25 1.126 0 CA-C-N 115.501 -0.772 . . . . 62.25 110.853 -178.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 564' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 563' ' ' MET . 15.9 Cg_exo -71.85 169.9 20.09 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.087 2.524 . . . . 75.53 111.512 173.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -67.96 142.19 56.06 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 116.179 -0.464 . . . . 62.41 111.295 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.16 16.92 5.58 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.6 0.714 . . . . 62.52 111.266 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 16.9 m -64.37 130.54 44.19 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.427 -0.806 . . . . 42.32 109.74 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 568' ' ' GLY . . . . . 0.428 ' H ' ' CG1' ' A' ' 603' ' ' VAL . . . 100.15 24.23 9.85 Favored Glycine 0 C--N 1.308 -1.025 0 C-N-CA 120.655 -0.783 . . . . 64.45 112.478 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 90.6 mtp -109.54 144.51 37.73 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.274 -0.639 . . . . 72.41 109.274 177.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 570' ' ' PHE . . . . . 0.538 ' CD2' ' HB3' ' A' ' 602' ' ' ARG . 80.5 m-85 -101.34 140.08 36.12 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 107.048 -1.464 . . . . 72.51 107.048 -176.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 55.2 t90 -57.96 -28.72 64.6 Favored 'General case' 0 C--O 1.25 1.108 0 CA-C-O 121.139 0.495 . . . . 74.41 111.886 -177.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 35.8 m -73.4 -22.63 19.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.389 0.614 . . . . 74.21 111.196 -177.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 573' ' ' ASP . . . . . 0.621 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 12.4 t70 -101.53 -35.43 9.16 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.679 -0.691 . . . . 71.14 109.901 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 574' ' ' ALA . . . . . 0.42 ' O ' HD13 ' A' ' 578' ' ' LEU . . . -57.82 -50.84 71.93 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.193 0.997 . . . . 73.24 112.818 -177.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.508 ' O ' ' HG2' ' A' ' 579' ' ' ARG . 49.5 mt-10 -55.51 -56.22 31.68 Favored Pre-proline 0 N--CA 1.469 0.515 0 N-CA-C 112.9 0.704 . . . . 64.55 112.9 -178.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -53.95 -33.61 73.06 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 121.54 1.494 . . . . 73.25 113.465 176.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.621 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 35.1 mmt180 -63.81 -47.59 80.22 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.894 -0.78 . . . . 63.41 108.894 177.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.42 HD13 ' O ' ' A' ' 574' ' ' ALA . 9.4 mp -66.08 -39.68 90.22 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.0 -1.0 . . . . 72.1 111.308 -177.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 579' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 11.6 mmm180 -65.05 -37.14 86.61 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.376 -0.375 . . . . 70.43 110.855 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.93 -30.87 69.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.362 0.601 . . . . 73.12 110.587 178.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 581' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 95.4 mt -81.65 -8.16 59.67 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.428 -0.805 . . . . 61.42 111.085 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 70.81 28.63 70.42 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.702 -0.559 . . . . 50.42 111.702 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 73.3 t90 -62.03 127.9 33.57 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 123.224 0.61 . . . . 71.43 110.569 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 12.1 m -128.24 84.5 2.25 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-O 121.24 0.543 . . . . 62.41 109.734 177.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -135.33 -145.21 5.1 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 109.243 -1.543 . . . . 65.12 109.243 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 26.5 ttt -134.77 125.92 27.91 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 117.262 0.531 . . . . 75.14 110.17 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -115.83 123.26 47.74 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 105.629 -1.989 . . . . 52.34 105.629 173.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -107.83 106.45 16.75 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 116.303 -0.408 . . . . 74.03 111.048 -175.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.62 110.14 22.62 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 106.239 -1.763 . . . . 74.54 106.239 174.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -98.92 -87.4 1.91 Allowed Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 109.663 -1.375 . . . . 73.33 109.663 176.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -102.53 133.02 48.19 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 120.763 0.316 . . . . 70.54 110.749 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -83.86 157.38 22.02 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.9 -1.148 . . . . 61.5 107.9 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 46.4 t -117.62 125.25 73.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 119.617 -0.833 . . . . 43.33 111.503 -175.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -81.63 106.66 13.75 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 105.495 -2.039 . . . . 75.21 105.495 172.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -132.69 -6.72 3.21 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 112.171 0.434 . . . . 43.42 112.171 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 82.94 -178.95 53.1 Favored Glycine 0 N--CA 1.418 -2.527 0 C-N-CA 120.79 -0.719 . . . . 22.22 111.565 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -62.92 -33.56 87.46 Favored Glycine 0 C--N 1.303 -1.28 0 CA-C-N 115.575 -0.312 . . . . 73.13 112.769 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 22.6 m -56.57 -33.63 66.34 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.782 0.66 . . . . 60.42 112.782 -176.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -108.23 -14.59 14.67 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 119.897 -0.721 . . . . 72.21 110.162 178.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 39.89 -160.19 0.0 OUTLIER 'General case' 0 CA--C 1.587 2.368 0 C-N-CA 126.095 1.758 . . . . 71.31 113.379 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -87.55 28.33 1.0 Allowed 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.288 -0.882 . . . . 73.22 110.053 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 602' ' ' ARG . . . . . 0.538 ' HB3' ' CD2' ' A' ' 570' ' ' PHE 0.254 3.1 ppt_? -102.15 168.5 9.33 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.833 -0.747 . . . . 74.45 112.824 -176.335 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 603' ' ' VAL . . . . . 0.428 ' CG1' ' H ' ' A' ' 568' ' ' GLY . 7.6 p -56.72 134.52 20.88 Favored 'Isoleucine or valine' 0 C--O 1.25 1.094 0 O-C-N 124.55 1.156 . . . . 62.25 112.23 -176.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 10.5 p -101.64 -32.57 3.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 119.581 -0.847 . . . . 63.53 109.018 177.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -154.81 140.47 18.0 Favored 'General case' 0 C--O 1.25 1.08 0 N-CA-C 107.168 -1.419 . . . . 63.22 107.168 174.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -98.23 122.12 41.0 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.745 -0.835 . . . . 72.14 108.745 173.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.4 ' CB ' ' HB ' ' A' ' 621' ' ' THR . 15.0 t-20 -55.08 -56.15 31.27 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 114.313 1.227 . . . . 73.23 114.313 -177.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -84.09 123.0 3.02 Favored 'Trans proline' 0 N--CA 1.438 -1.755 0 CA-C-N 120.643 1.265 . . . . 64.4 109.43 176.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -64.02 144.82 88.68 Favored 'Trans proline' 0 C--O 1.246 0.912 0 C-N-CA 122.159 1.906 . . . . 64.42 111.193 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -62.69 132.33 51.93 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.121 -0.696 . . . . 74.3 109.121 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 100.1 0.67 56.0 Favored Glycine 0 N--CA 1.437 -1.289 0 C-N-CA 119.766 -1.207 . . . . 71.31 111.994 -177.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 14.2 m -100.97 154.68 18.49 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.596 -0.89 . . . . 73.42 108.596 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -80.13 132.85 11.67 Favored Glycine 0 N--CA 1.431 -1.694 0 N-CA-C 112.111 -0.396 . . . . 71.02 112.111 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 34.9 m -114.5 142.48 27.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 109.35 -0.611 . . . . 51.5 109.35 176.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.565 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 23.3 m-20 -57.75 169.6 0.7 Allowed 'General case' 0 CA--C 1.492 -1.255 0 C-N-CA 124.235 1.014 . . . . 72.53 111.803 -177.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -60.74 -24.6 65.85 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 113.774 -1.557 . . . . 73.04 110.22 172.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -77.07 -35.58 56.53 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 119.831 -0.748 . . . . 72.32 110.058 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 81.02 22.71 60.64 Favored Glycine 0 N--CA 1.426 -2.024 0 C-N-CA 118.484 -1.817 . . . . 74.12 113.409 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.73 119.66 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 122.489 1.138 . . . . 63.0 108.876 -174.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.72 132.93 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 N-CA-C 107.281 -1.377 . . . . 52.04 107.281 -173.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.4 ' HB ' ' CB ' ' A' ' 607' ' ' ASN . 19.0 m -111.09 134.95 52.29 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 121.786 -0.571 . . . . 72.33 111.095 -177.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 84.3 mt -137.54 154.1 49.88 Favored 'General case' 0 CA--C 1.497 -1.087 0 C-N-CA 125.106 1.363 . . . . 62.23 107.775 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 51.0 mmm-85 -128.22 137.36 51.99 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 104.431 -2.433 . . . . 72.3 104.431 169.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -141.87 165.49 27.32 Favored 'General case' 0 C--N 1.28 -2.423 0 O-C-N 124.263 0.977 . . . . 74.43 109.627 -174.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -97.02 -134.62 8.25 Favored Glycine 0 N--CA 1.417 -2.598 0 C-N-CA 120.464 -0.874 . . . . 73.21 112.034 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 . . . . . 0 C--N 1.295 -1.767 0 C-N-CA 123.991 0.916 . . . . 63.22 109.381 -177.629 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.095 0 N-CA-C 110.521 -1.032 . . . . 43.05 110.521 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 9.6 tp -75.86 104.67 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 CA-C-O 122.728 1.251 . . . . 63.21 112.651 -178.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.71 -155.89 0.25 Allowed 'General case' 0 C--N 1.281 -2.377 0 CA-C-N 114.277 -1.329 . . . . 70.32 108.087 174.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -71.66 3.15 4.28 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 122.064 0.935 . . . . 71.3 111.132 174.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -70.06 151.21 45.76 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 125.396 1.479 . . . . 75.22 109.421 175.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.2 m -116.84 159.05 17.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 108.756 -0.831 . . . . 62.22 108.756 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -95.46 136.14 36.21 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 103.697 -2.705 . . . . 70.12 103.697 177.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.408 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 94.0 t -95.46 127.85 40.45 Favored Pre-proline 0 C--N 1.28 -2.443 0 C-N-CA 119.89 -0.724 . . . . 43.41 112.415 -163.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 363' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 13.4 Cg_exo -67.56 113.35 2.9 Favored 'Trans proline' 0 N--CA 1.441 -1.597 0 C-N-CA 122.529 2.153 . . . . 62.24 110.306 174.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 364' ' ' ASP . . . . . 0.505 ' HB2' HG21 ' A' ' 402' ' ' THR . 19.9 p-10 -101.3 111.94 24.31 Favored 'General case' 0 C--N 1.262 -3.196 0 CA-C-N 113.959 -1.473 . . . . 62.42 110.819 -176.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.557 ' HB ' ' OE1' ' A' ' 368' ' ' GLN . 7.0 m -85.73 37.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 114.132 -1.394 . . . . 61.45 113.598 -176.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.513 ' H ' ' HD2' ' A' ' 366' ' ' ARG . 0.0 OUTLIER -65.38 146.79 54.46 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.337 -0.847 . . . . 63.23 110.601 172.38 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.35 -4.53 44.18 Favored Glycine 0 C--N 1.304 -1.249 0 N-CA-C 110.781 -0.927 . . . . 53.32 110.781 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 368' ' ' GLN . . . . . 0.557 ' OE1' ' HB ' ' A' ' 365' ' ' VAL . 76.8 mt-30 -109.19 -156.8 0.59 Allowed 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 107.658 -1.238 . . . . 64.12 107.658 177.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 60.4 p -99.1 167.15 10.89 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 109.087 -0.708 . . . . 74.5 109.087 -177.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 18.2 p -57.87 -46.67 84.5 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 123.438 0.461 . . . . 72.32 110.63 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.31 -41.9 89.03 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.756 -0.656 . . . . 43.04 112.327 -177.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -69.3 -42.58 75.23 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 121.504 0.669 . . . . 73.44 109.307 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.77 -47.61 74.6 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.381 -0.827 . . . . 63.43 111.577 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 65.6 mt -62.77 -39.99 86.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 65.22 110.836 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.09 -43.86 91.87 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.125 0.488 . . . . 54.44 110.558 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 18.1 m -63.73 -47.22 81.95 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.59 -0.732 . . . . 75.02 109.963 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 98.4 mt -61.91 -41.78 98.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.833 -0.621 . . . . 64.35 110.824 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 62.0 tp60 -63.83 -41.16 97.91 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.896 -0.593 . . . . 42.41 110.51 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -63.12 -27.14 69.18 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 120.907 0.384 . . . . 75.03 111.412 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -90.79 -7.68 51.72 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 112.304 0.483 . . . . 75.31 112.304 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 95.23 7.99 59.1 Favored Glycine 0 C--N 1.307 -1.071 0 C-N-CA 120.856 -0.688 . . . . 61.31 113.055 177.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.448 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 75.0 m-85 -80.13 145.11 32.54 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-O 121.18 0.514 . . . . 74.3 111.385 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -92.07 143.41 26.49 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.603 -1.258 . . . . 62.25 107.603 -178.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.461 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -125.82 154.75 35.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 121.274 0.559 . . . . 63.03 111.267 -178.781 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -136.35 135.2 38.64 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 107.507 -1.294 . . . . 72.13 107.507 174.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 26.4 m -103.06 120.9 41.5 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 108.279 -1.008 . . . . 72.51 108.279 178.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -111.46 119.68 39.62 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 106.786 -1.561 . . . . 73.14 106.786 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 10.9 pm0 -102.61 131.87 49.09 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.56 0.695 . . . . 73.32 111.851 -177.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 389' ' ' LYS . . . . . 0.674 ' O ' ' HA ' ' A' ' 421' ' ' SER . 99.1 mttt -128.93 150.34 74.93 Favored Pre-proline 0 C--N 1.293 -1.855 0 N-CA-C 106.703 -1.591 . . . . 70.24 106.703 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -71.84 166.29 29.98 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 121.489 1.459 . . . . 75.13 110.558 176.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.463 ' HB2' ' HA ' ' A' ' 424' ' ' PRO . 3.4 m-20 -76.35 87.4 3.14 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-O 121.848 0.833 . . . . 75.44 110.526 176.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 392' ' ' SER . . . . . 0.45 ' O ' ' HB ' ' A' ' 393' ' ' THR . 19.6 m -112.38 42.5 1.8 Allowed 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 106.735 -1.579 . . . . 74.41 106.735 173.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 392' ' ' SER . 99.6 m 70.88 29.32 3.1 Favored 'General case' 0 CA--C 1.573 1.861 0 CA-C-O 123.58 1.657 . . . . 33.02 109.551 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 1.7 pt -116.43 151.25 46.73 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 113.6 0.963 . . . . 73.23 113.6 -176.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -24.46 110.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.366 1.498 1 C-N-CA 126.584 4.856 . . . . 73.45 118.258 -175.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -68.45 162.3 41.28 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.262 3.308 . . . . 74.41 110.651 172.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 397' ' ' ASP . . . . . 0.46 ' HB3' HG23 ' A' ' 420' ' ' VAL . 0.6 OUTLIER -57.21 -13.88 3.6 Favored 'General case' 0 N--CA 1.507 2.396 0 CA-C-O 121.098 0.475 . . . . 74.11 111.882 -176.301 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -84.01 111.04 18.92 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 105.295 -2.113 . . . . 75.14 105.295 178.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.418 HG23 ' HA ' ' A' ' 366' ' ' ARG . 28.0 m -63.0 118.02 4.61 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 O-C-N 124.602 1.189 . . . . 72.33 112.335 -166.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 400' ' ' ILE . . . . . 0.404 HD13 ' O ' ' A' ' 400' ' ' ILE . 0.0 OUTLIER -106.04 -28.59 2.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 114.84 -1.073 . . . . 64.41 109.727 -176.501 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -144.77 165.46 27.62 Favored Glycine 0 N--CA 1.428 -1.858 0 N-CA-C 110.289 -1.124 . . . . 73.13 110.289 -175.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.505 HG21 ' HB2' ' A' ' 364' ' ' ASP . 9.1 p -118.03 -178.85 3.6 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 113.341 0.867 . . . . 75.11 113.341 -173.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -102.32 140.42 21.12 Favored Pre-proline 0 N--CA 1.437 -1.117 0 N-CA-C 106.607 -1.627 . . . . 73.35 106.607 176.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -55.77 -24.63 47.52 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.314 2.676 . . . . 75.13 114.131 -176.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -62.38 -35.02 77.87 Favored 'General case' 0 C--O 1.209 -1.051 0 CA-C-N 116.543 -0.299 . . . . 72.43 111.368 -177.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -77.92 -35.75 50.21 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.492 0.663 . . . . 63.44 110.928 -178.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -82.02 -10.92 59.08 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.911 -0.586 . . . . 74.41 111.711 -175.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 25.0 m -103.35 160.28 14.83 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 106.428 -1.693 . . . . 72.52 106.428 177.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 5.9 p -76.68 113.0 13.84 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 118.322 0.51 . . . . 72.11 110.744 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 33.4 m -130.76 166.85 27.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.443 -0.577 . . . . 61.14 109.443 177.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 56.3 m -70.07 139.4 52.58 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.819 -0.808 . . . . 65.14 108.819 175.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 412' ' ' ALA . . . . . 0.448 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -61.7 109.79 1.32 Allowed 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 120.92 0.391 . . . . 62.21 110.5 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 128.72 38.84 0.34 Allowed Glycine 0 N--CA 1.441 -1.003 0 CA-C-N 115.525 -0.761 . . . . 53.54 112.055 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -97.33 -171.7 2.26 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 108.028 -1.101 . . . . 64.35 108.028 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -111.86 124.78 53.1 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 122.771 0.429 . . . . 60.41 111.387 -173.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 46.7 mm -119.24 117.59 54.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 120.756 0.312 . . . . 73.23 110.17 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 13.5 t -89.86 131.03 36.0 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-O 121.348 0.594 . . . . 71.44 109.679 176.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 10.8 p -105.25 135.71 42.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 C-N-CA 124.105 0.962 . . . . 62.3 108.932 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.37 128.19 42.02 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 120.822 -0.351 . . . . 75.21 110.607 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.46 HG23 ' HB3' ' A' ' 397' ' ' ASP . 3.4 p -128.04 131.33 69.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 115.877 -0.601 . . . . 73.45 109.787 173.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 421' ' ' SER . . . . . 0.674 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 3.0 p -94.72 122.77 37.67 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-O 121.051 0.453 . . . . 62.05 109.929 174.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.8 t -119.24 106.62 12.51 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-O 121.41 0.624 . . . . 73.01 111.86 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 77.1 124.38 0.24 Allowed Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 115.572 -0.74 . . . . 74.41 114.136 174.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 424' ' ' PRO . . . . . 0.463 ' HA ' ' HB2' ' A' ' 391' ' ' ASP . 38.2 Cg_exo -64.66 155.4 67.14 Favored 'Trans proline' 0 C--O 1.249 1.063 0 C-N-CA 122.264 1.976 . . . . 65.42 110.207 173.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -72.73 150.22 43.07 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 121.978 0.894 . . . . 73.42 112.414 -174.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.479 ' HG3' ' HB ' ' A' ' 477' ' ' THR . 16.3 tp60 -88.35 139.49 30.43 Favored 'General case' 0 N--CA 1.41 -2.468 0 N-CA-C 105.572 -2.01 . . . . 70.34 105.572 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.592 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 2.9 mmp_? -122.25 140.89 52.08 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.888 -0.725 . . . . 72.12 111.678 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.422 ' O ' ' HD3' ' A' ' 430' ' ' PRO . 9.5 pt-20 -83.74 139.06 32.97 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 114.393 -1.276 . . . . 71.23 110.186 -177.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 57.9 mt -98.41 112.61 62.71 Favored Pre-proline 0 N--CA 1.418 -2.068 0 N-CA-C 106.81 -1.552 . . . . 75.32 106.81 174.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 428' ' ' GLU . 16.3 Cg_exo -73.07 141.07 32.22 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 N-CA-C 107.885 -1.621 . . . . 72.22 107.885 165.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -84.43 132.71 34.54 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 118.205 -1.398 . . . . 34.24 108.833 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 59.4 t -105.7 151.7 7.73 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 N-CA-C 105.968 -1.864 . . . . 73.41 105.968 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 39.2 m -57.08 141.21 46.78 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.213 0.53 . . . . 72.1 111.138 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 434' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 36.5 p -64.26 -26.71 68.62 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 114.102 1.149 . . . . 44.14 114.102 -172.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.5 pp -82.93 -15.84 49.76 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 119.841 -0.744 . . . . 73.21 110.92 176.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.81 40.04 1.15 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.284 1.034 . . . . 73.01 109.362 -177.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -52.0 -38.76 57.93 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.522 1.129 . . . . 75.23 112.592 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -60.99 -41.8 97.15 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.037 0.446 . . . . 70.25 110.573 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -70.64 -35.97 73.19 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.963 -0.562 . . . . 61.25 109.602 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.514 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.47 -51.51 69.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.981 -0.554 . . . . 44.44 110.992 -178.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 36.0 m -63.08 -40.89 90.78 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 N-CA-C 112.279 0.474 . . . . 72.31 112.279 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . 0.267 0.1 OUTLIER -68.63 -34.54 75.91 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 113.338 0.866 . . . . 73.33 113.338 177.729 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -64.52 -41.03 96.64 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.284 -1.006 . . . . 75.52 108.284 179.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.514 HD13 ' O ' ' A' ' 440' ' ' ALA . 7.0 mp -63.49 -32.92 74.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.507 -0.77 . . . . 61.25 110.92 176.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.409 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 61.5 m -69.42 -43.02 74.25 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 116.067 -0.515 . . . . 74.03 110.354 177.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.44 -26.01 66.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.638 -0.71 . . . . 75.13 111.209 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.65 -6.15 56.55 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.072 0.463 . . . . 73.52 111.834 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 121.33 -77.1 0.33 Allowed Glycine 0 CA--C 1.495 -1.194 0 C-N-CA 120.314 -0.946 . . . . 60.23 112.227 176.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 449' ' ' PHE . . . . . 0.43 ' HA ' ' O ' ' A' ' 480' ' ' ILE . 0.5 OUTLIER -40.13 -68.51 0.17 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.134 1.161 . . . . 74.4 114.134 176.738 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 450' ' ' GLY . . . . . 0.409 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 58.93 25.68 59.7 Favored Glycine 0 C--N 1.318 -0.458 0 C-N-CA 121.589 -0.338 . . . . 34.41 112.645 -177.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.492 ' CB ' ' HA ' ' A' ' 483' ' ' VAL . 52.6 mmt-85 -101.82 111.82 24.22 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 107.258 -1.386 . . . . 73.12 107.258 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -139.14 145.77 39.81 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-O 120.973 0.416 . . . . 74.11 111.175 -176.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -131.47 123.42 28.04 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.046 -1.094 . . . . 55.43 108.046 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -99.3 121.46 41.11 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.98 0.419 . . . . 75.31 110.755 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -116.97 154.47 30.83 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.254 -1.017 . . . . 72.05 108.254 177.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -130.55 141.94 50.47 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.3 -0.63 . . . . 64.2 109.3 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 50.3 m -145.44 149.86 42.27 Favored Pre-proline 0 C--N 1.291 -1.938 0 N-CA-C 109.494 -0.558 . . . . 64.14 109.494 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.686 ' HA ' ' O ' ' A' ' 490' ' ' SER . 36.8 Cg_endo -67.49 127.38 16.35 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.321 2.014 . . . . 74.44 110.651 177.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 50.6 m -147.22 179.51 7.58 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.974 -0.38 . . . . 73.32 109.974 -177.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.8 t -54.31 135.97 60.44 Favored Pre-proline 0 N--CA 1.437 -1.079 0 C-N-CA 123.958 0.903 . . . . 61.14 110.315 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.16 -30.41 32.27 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 124.461 3.441 . . . . 63.14 115.192 -172.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -73.12 -27.83 61.91 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.829 -0.748 . . . . 71.44 112.546 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 83.5 mt -89.23 -11.86 42.44 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.217 0.532 . . . . 72.42 110.252 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.425 HG13 ' HA ' ' A' ' 490' ' ' SER . 70.6 t -60.61 128.76 22.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.447 -0.797 . . . . 74.44 110.457 177.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 96.22 -13.63 65.54 Favored Glycine 0 N--CA 1.432 -1.633 0 CA-C-N 115.058 -0.974 . . . . 73.52 111.553 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -117.27 166.65 12.02 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 109.201 -0.666 . . . . 75.23 109.201 -176.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.476 ' O ' ' HB ' ' A' ' 434' ' ' THR . 72.0 t -70.68 147.22 11.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 N-CA-C 107.993 -1.114 . . . . 75.44 107.993 173.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 64.3 mt -97.74 -35.88 5.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 107.008 -1.479 . . . . 53.13 107.008 176.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 169.3 -178.84 42.25 Favored Glycine 0 N--CA 1.416 -2.64 0 N-CA-C 109.789 -1.324 . . . . 62.43 109.789 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 470' ' ' THR . . . . . 0.555 HG22 HG12 ' A' ' 486' ' ' ILE . 41.4 p -115.65 137.95 51.56 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 107.262 -1.384 . . . . 73.41 107.262 178.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.496 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 50.8 t-20 -62.85 -47.43 87.15 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 120.726 -0.389 . . . . 63.01 110.058 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.496 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 12.9 Cg_exo -77.05 132.77 13.03 Favored 'Trans proline' 0 C--N 1.365 1.438 0 N-CA-C 106.852 -2.019 . . . . 63.52 106.852 167.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.88 127.04 20.29 Favored 'Trans proline' 0 C--O 1.239 0.564 0 C-N-CA 121.902 1.735 . . . . 65.14 112.739 -174.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -85.24 16.78 3.38 Favored 'General case' 0 C--O 1.203 -1.35 0 CA-C-N 114.949 -1.023 . . . . 74.43 110.89 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -112.27 -6.09 14.11 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.771 -0.65 . . . . 74.21 110.089 173.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -111.62 -175.29 2.66 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 115.598 -0.728 . . . . 71.11 110.96 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.479 ' HB ' ' HG3' ' A' ' 426' ' ' GLN . 0.6 OUTLIER -90.89 148.82 22.21 Favored 'General case' 0 N--CA 1.404 -2.774 0 CA-C-N 115.32 -0.854 . . . . 55.15 111.45 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 27.1 t -133.65 149.67 51.56 Favored 'General case' 0 C--O 1.26 1.658 0 N-CA-C 108.683 -0.858 . . . . 62.25 108.683 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -79.63 157.46 27.28 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.139 -0.482 . . . . 60.44 109.739 178.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 449' ' ' PHE . 37.6 mm -71.07 -21.03 21.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.877 0.846 . . . . 72.24 109.919 -176.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 17.4 p -100.02 5.92 45.08 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.786 -0.643 . . . . 72.33 112.045 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 482' ' ' ASN . . . . . 0.401 ' O ' ' HB2' ' A' ' 451' ' ' ARG . 54.4 t-20 -87.76 128.93 35.32 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.348 -0.612 . . . . 74.42 109.348 -176.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.492 ' HA ' ' CB ' ' A' ' 451' ' ' ARG . 40.0 t -96.81 113.47 31.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.318 -0.993 . . . . 74.34 108.318 177.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 21.2 m -91.37 129.04 42.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 121.479 0.656 . . . . 72.02 111.378 -177.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -94.27 125.43 46.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-O 121.537 0.684 . . . . 74.2 109.259 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.555 HG12 HG22 ' A' ' 470' ' ' THR . 6.0 mt -115.2 124.37 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 CA-C-N 114.658 -1.156 . . . . 73.02 109.566 -176.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 10.8 tt -104.75 126.82 59.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-O 121.021 0.439 . . . . 64.24 110.386 -176.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 32.9 m -108.22 151.77 10.27 Favored 'Isoleucine or valine' 0 C--O 1.252 1.232 0 CA-C-N 115.878 -0.601 . . . . 64.43 110.221 178.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.7 136.2 13.86 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 110.746 -0.942 . . . . 73.23 110.746 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.686 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 12.5 t -139.15 160.37 39.95 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.041 -0.726 . . . . 74.32 109.041 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 86.92 76.97 1.25 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 114.963 0.745 . . . . 74.43 114.963 176.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -87.26 122.23 1.77 Allowed 'Trans proline' 0 N--CA 1.439 -1.704 0 C-N-CA 121.892 1.728 . . . . 71.35 110.54 175.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 493' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . -101.09 23.95 10.09 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 122.465 1.126 . . . . 72.52 109.649 -178.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.458 ' HB ' ' OG1' ' A' ' 544' ' ' THR . 9.9 p -120.43 143.42 48.49 Favored 'General case' 0 C--N 1.273 -2.726 0 CA-C-N 113.695 -1.593 . . . . 72.04 110.267 -177.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -138.58 151.68 47.5 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.002 -1.111 . . . . 72.21 108.002 177.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.591 ' OD1' ' HB ' ' A' ' 544' ' ' THR . 69.0 m-20 -80.62 126.42 31.24 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.538 -1.282 . . . . 74.52 107.538 176.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 28.4 pt -76.06 126.54 86.66 Favored Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 123.381 0.425 . . . . 74.3 111.957 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -92.51 156.78 2.99 Favored 'Trans proline' 0 N--CA 1.445 -1.363 0 C-N-CA 122.674 2.249 . . . . 71.51 110.454 173.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -79.32 109.61 13.83 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 122.301 1.048 . . . . 61.03 109.972 178.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.2 p -95.05 17.08 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 122.871 1.32 . . . . 64.22 108.08 178.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -81.74 72.26 8.79 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 114.319 -1.309 . . . . 71.33 110.949 -177.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . -158.17 10.04 0.21 Allowed Glycine 0 C--N 1.291 -1.935 0 CA-C-N 114.793 -1.094 . . . . 42.22 110.71 177.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -139.92 176.44 8.75 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 106.378 -1.712 . . . . 73.01 106.378 -173.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 30.2 p -83.01 159.98 22.08 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 109.405 -0.591 . . . . 72.14 109.405 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.7 p -50.54 -41.11 19.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 123.84 0.856 . . . . 74.41 112.47 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -63.68 -42.41 98.03 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.344 0.593 . . . . 63.2 111.089 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 61.6 t -75.9 -38.62 36.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.806 -0.634 . . . . 71.5 110.105 -177.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.18 -48.56 77.86 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.105 -0.498 . . . . 52.35 111.442 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -61.95 -38.56 88.96 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.234 0.334 . . . . 60.35 110.541 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.487 ' O ' HG23 ' A' ' 514' ' ' VAL . 6.3 tmtm? -59.2 -48.96 79.66 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.937 -0.764 . . . . 65.31 108.937 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -62.65 -42.26 99.51 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 116.274 -0.421 . . . . 62.3 111.346 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 97.4 mt -65.26 -40.65 94.23 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.335 -0.393 . . . . 75.43 111.494 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -61.78 -37.98 86.37 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.951 -0.388 . . . . 62.02 109.951 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 510' ' ' LYS . 73.2 t -61.97 -35.75 70.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 115.633 -0.712 . . . . 54.23 110.83 176.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -78.92 -8.1 58.57 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 112.101 0.408 . . . . 73.02 112.101 -178.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 112.47 -13.44 25.48 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.439 -0.886 . . . . 74.34 112.381 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -81.43 95.75 7.16 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 106.905 -1.517 . . . . 73.22 106.905 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.8 m -98.17 -3.6 37.3 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 119.695 -0.802 . . . . 72.11 111.497 -172.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -120.54 114.56 21.92 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.457 -0.572 . . . . 71.33 109.457 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -131.35 150.76 52.02 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.903 -0.59 . . . . 71.2 110.775 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 49.7 m -127.94 143.23 51.09 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 107.445 -1.317 . . . . 73.31 107.445 174.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.31 125.6 51.34 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-O 120.906 0.384 . . . . 63.42 111.641 -178.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 523' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 554' ' ' GLN . . . -116.31 117.17 29.25 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.617 -0.883 . . . . 65.01 108.617 178.154 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 524' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 19.5 m -94.92 131.63 40.63 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.089 0.471 . . . . 71.23 112.144 -176.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 28.6 m -121.29 153.29 24.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 107.703 -1.221 . . . . 71.01 107.703 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -84.83 139.33 31.99 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.77 -0.772 . . . . 74.24 111.626 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 64.9 p -162.27 156.71 18.81 Favored Pre-proline 0 C--O 1.19 -2.066 0 N-CA-C 106.549 -1.649 . . . . 70.13 106.549 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -61.07 -12.89 24.82 Favored 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 122.005 1.803 . . . . 74.02 113.383 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -70.59 130.86 88.45 Favored Pre-proline 0 N--CA 1.45 -0.443 0 N-CA-C 108.52 -0.918 . . . . 74.4 108.52 178.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.3 147.26 78.07 Favored 'Trans proline' 0 C--O 1.253 1.25 0 C-N-CA 122.761 2.307 . . . . 74.41 113.301 -177.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.659 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -59.15 127.85 34.22 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.896 -1.047 . . . . 73.03 111.367 -175.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 119.43 -19.15 9.96 Favored Glycine 0 C--N 1.3 -1.424 0 N-CA-C 111.16 -0.776 . . . . 64.3 111.16 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -72.54 132.45 43.83 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.227 -0.657 . . . . 74.24 109.227 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 59.6 t -89.42 113.96 26.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 108.664 -0.865 . . . . 72.24 108.664 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 535' ' ' THR . . . . . 0.444 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 11.4 t -86.96 -20.49 27.22 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.695 -0.402 . . . . 72.31 111.173 -176.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 169.92 -163.4 36.82 Favored Glycine 0 CA--C 1.494 -1.239 0 C-N-CA 120.412 -0.899 . . . . 75.34 111.29 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 46.0 p -129.45 154.8 46.61 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.181 -1.414 . . . . 75.42 107.181 176.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -68.53 -54.2 14.78 Favored Pre-proline 0 C--N 1.309 -1.153 0 C-N-CA 119.959 -0.697 . . . . 63.32 110.446 177.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.32 136.91 29.94 Favored 'Trans proline' 0 C--N 1.371 1.74 0 CA-C-N 119.887 0.996 . . . . 62.51 110.009 175.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.1 145.08 65.85 Favored 'Trans proline' 0 C--O 1.254 1.284 0 C-N-CA 122.692 2.262 . . . . 74.44 113.186 -178.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.94 141.72 57.86 Favored 'General case' 0 C--O 1.247 0.952 0 CA-C-N 115.804 -0.634 . . . . 74.52 110.5 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 99.32 -12.03 61.75 Favored Glycine 0 N--CA 1.432 -1.604 0 CA-C-N 115.695 -0.684 . . . . 72.33 111.428 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 49.8 m -77.28 132.7 38.79 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 108.875 -0.787 . . . . 52.11 108.875 177.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.591 ' HB ' ' OD1' ' A' ' 496' ' ' ASP . 10.0 t -87.69 124.05 33.16 Favored 'General case' 0 N--CA 1.419 -2.006 0 CA-C-O 121.304 0.573 . . . . 72.35 109.699 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 19.6 m -125.88 154.89 73.59 Favored Pre-proline 0 C--N 1.297 -1.697 0 N-CA-C 108.15 -1.056 . . . . 73.31 108.15 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 13.1 Cg_exo -71.82 136.22 27.28 Favored 'Trans proline' 0 N--CA 1.443 -1.472 0 C-N-CA 121.842 1.694 . . . . 75.32 110.168 175.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 32.6 m -64.96 -19.89 26.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.941 0.877 . . . . 75.22 110.512 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -76.12 -14.86 60.17 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.247 -1.342 . . . . 71.13 111.027 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 67.4 m -94.51 -171.93 2.63 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.215 -0.448 . . . . 73.12 111.92 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 18.1 t -116.02 126.61 73.59 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 CA-C-N 116.262 -0.426 . . . . 63.34 110.325 -174.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 551' ' ' ILE . . . . . 0.51 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -102.49 145.91 11.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.556 -0.535 . . . . 63.15 109.556 175.697 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -108.82 121.46 45.11 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-O 121.406 0.622 . . . . 75.12 111.085 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 59.4 mt -97.99 134.5 41.02 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.389 -1.278 . . . . 74.12 108.315 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 554' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 523' ' ' ALA . 11.0 pt20 -106.33 119.5 39.41 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-O 122.158 0.98 . . . . 73.3 109.847 177.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 524' ' ' SER . 57.2 t -105.82 145.5 13.77 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 CA-C-N 113.898 -1.501 . . . . 75.42 109.977 -171.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.659 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 63.3 m -83.41 133.65 34.92 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-O 121.602 0.715 . . . . 55.45 111.613 178.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.77 137.35 42.71 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 104.829 -2.285 . . . . 75.22 104.829 169.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 558' ' ' GLY . . . . . 0.481 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -75.87 -47.82 11.07 Favored Glycine 0 N--CA 1.433 -1.524 0 C-N-CA 118.42 -1.847 . . . . 54.2 110.763 -175.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 5.7 t30 61.24 -7.51 0.09 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 113.458 0.91 . . . . 71.51 113.458 175.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.481 ' H ' ' C ' ' A' ' 558' ' ' GLY . 25.4 tp60 -139.32 141.23 37.7 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 103.354 -2.832 . . . . 64.43 103.354 -177.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -141.82 153.26 44.39 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 118.653 0.66 . . . . 72.24 111.067 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 70.2 t -69.58 118.19 13.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 N-CA-C 108.764 -0.828 . . . . 75.41 108.764 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 58.8 ttp -88.87 134.36 33.78 Favored Pre-proline 0 C--N 1.304 -1.395 0 C-N-CA 120.376 -0.529 . . . . 52.24 110.392 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -66.03 161.92 37.72 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.518 2.146 . . . . 75.23 109.92 171.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -80.89 132.68 35.46 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.147 -0.621 . . . . 75.11 111.793 -177.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 566' ' ' LEU . . . . . 0.466 HD12 ' SD ' ' A' ' 569' ' ' MET . 39.7 tp -138.16 19.28 2.79 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.326 -1.361 . . . . 71.22 107.326 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 11.9 m -73.72 131.37 41.53 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.25 -0.886 . . . . 43.34 110.707 -173.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 568' ' ' GLY . . . . . 0.462 ' H ' ' HB ' ' A' ' 603' ' ' VAL . . . 71.56 9.87 69.95 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 114.397 0.519 . . . . 52.54 114.397 176.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 569' ' ' MET . . . . . 0.466 ' SD ' HD12 ' A' ' 566' ' ' LEU . 86.7 mtp -90.73 153.63 20.13 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.197 -0.668 . . . . 73.54 109.197 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 570' ' ' PHE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 98.8 m-85 -73.24 140.28 46.78 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 120.721 0.296 . . . . 75.31 110.757 -175.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 571' ' ' TRP . . . . . 0.409 ' HA ' ' HB3' ' A' ' 574' ' ' ALA . 32.1 t90 -66.01 -17.89 64.98 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 123.859 0.864 . . . . 74.0 110.335 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 35.3 m -78.05 -24.2 13.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.244 0.545 . . . . 64.44 109.96 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 573' ' ' ASP . . . . . 0.644 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 31.4 t70 -101.43 -28.26 12.68 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.341 -0.845 . . . . 73.23 109.637 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 574' ' ' ALA . . . . . 0.409 ' HB3' ' HA ' ' A' ' 571' ' ' TRP . . . -65.92 -32.37 73.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.86 -0.609 . . . . 52.04 110.851 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.54 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 12.9 tp10 -57.79 -53.29 67.24 Favored Pre-proline 0 CA--C 1.583 2.235 0 CA-C-N 115.879 -0.6 . . . . 73.23 111.136 177.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 576' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 573' ' ' ASP . 50.6 Cg_exo -59.56 -36.64 92.29 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 121.32 1.346 . . . . 71.31 112.699 171.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.644 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 22.8 mmt180 -59.8 -44.66 93.85 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 120.75 0.309 . . . . 65.2 110.677 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.4 pp -65.44 -40.43 93.27 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.024 -0.535 . . . . 74.01 112.247 -175.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 579' ' ' ARG . . . . . 0.452 ' N ' HD12 ' A' ' 578' ' ' LEU . 73.6 mtp180 -65.72 -35.39 80.61 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.148 0.499 . . . . 73.04 110.951 176.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.33 -39.11 74.93 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.001 -0.545 . . . . 74.43 111.192 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 89.0 mt -83.03 -7.27 59.68 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.385 0.513 . . . . 74.35 112.385 -177.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 74.28 39.52 43.49 Favored Glycine 0 C--O 1.241 0.585 0 C-N-CA 120.638 -0.791 . . . . 72.24 111.533 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 33.2 t90 -67.72 127.16 31.73 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 109.579 -0.526 . . . . 65.43 109.579 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 3.7 m -116.76 10.3 14.21 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.466 -0.938 . . . . 64.12 108.466 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -77.69 177.4 53.0 Favored Glycine 0 N--CA 1.431 -1.67 0 CA-C-N 115.354 -0.839 . . . . 74.5 113.51 -173.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 52.4 tpp -104.24 140.3 38.04 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 109.235 -0.654 . . . . 72.43 109.235 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -80.58 130.23 35.0 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.071 -1.826 . . . . 74.44 106.071 176.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -95.04 102.07 13.86 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.486 0.66 . . . . 73.24 110.592 -176.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -88.38 110.17 20.58 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.914 -1.039 . . . . 74.52 109.228 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 590' ' ' GLY . . . . . 0.435 ' HA3' ' NH2' ' A' ' 623' ' ' ARG . . . -114.22 -86.73 1.46 Allowed Glycine 0 N--CA 1.43 -1.706 0 N-CA-C 109.7 -1.36 . . . . 54.02 109.7 176.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.19 147.99 42.54 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.21 -1.034 . . . . 63.35 108.21 176.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -90.74 141.39 28.85 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.214 -1.032 . . . . 64.35 108.214 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 60.8 t -107.43 121.7 60.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 110.575 -0.157 . . . . 63.35 110.575 -173.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -86.55 107.5 18.15 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.165 -1.014 . . . . 42.15 108.577 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -150.03 22.67 0.86 Allowed 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.974 -0.75 . . . . 61.43 108.974 -177.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 92.06 82.35 1.46 Allowed Glycine 0 N--CA 1.424 -2.147 0 N-CA-C 109.385 -1.486 . . . . 41.42 109.385 -176.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.18 -43.85 88.9 Favored Glycine 0 C--O 1.208 -1.49 0 O-C-N 123.93 0.429 . . . . 72.2 112.645 -175.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 25.5 m -59.23 -28.72 66.94 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 113.377 0.88 . . . . 73.04 113.377 -178.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -106.85 -12.59 15.45 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.367 0.603 . . . . 62.23 111.456 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 600' ' ' HIS . . . . . 0.5 ' C ' ' H ' ' A' ' 602' ' ' ARG . 35.6 m80 -130.62 22.22 5.07 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 113.49 0.922 . . . . 65.15 113.49 -173.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -77.41 37.57 0.22 Allowed 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 122.429 1.109 . . . . 54.31 109.761 175.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 602' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 12.1 ptt180 -125.44 166.53 16.44 Favored 'General case' 0 N--CA 1.412 -2.368 0 C-N-CA 125.703 1.601 . . . . 74.34 108.305 -176.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 603' ' ' VAL . . . . . 0.462 ' HB ' ' H ' ' A' ' 568' ' ' GLY . 55.6 t -63.46 129.84 27.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.458 -0.941 . . . . 75.34 108.458 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 35.3 m -94.66 -45.02 13.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 119.999 -0.681 . . . . 72.44 110.464 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -131.02 146.59 52.44 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 106.062 -1.829 . . . . 73.24 106.062 174.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 606' ' ' GLN . . . . . 0.41 ' OE1' ' HD2' ' A' ' 608' ' ' PRO . 0.1 OUTLIER -120.51 129.33 53.78 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 107.331 -1.359 . . . . 70.25 107.331 -175.946 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.548 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 30.5 t30 -84.9 -71.76 0.1 Allowed Pre-proline 0 CA--C 1.563 1.465 0 N-CA-C 114.687 1.366 . . . . 64.1 114.687 -173.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 6.1 Cg_exo -76.14 114.77 3.98 Favored 'Trans proline' 0 C--N 1.372 1.775 0 CA-C-N 122.05 1.768 . . . . 51.02 109.547 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -63.29 135.57 50.98 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 122.476 2.117 . . . . 55.14 114.205 -171.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.84 138.69 56.3 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.041 -0.981 . . . . 63.43 109.379 177.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 94.45 -19.54 53.02 Favored Glycine 0 C--N 1.302 -1.319 0 N-CA-C 110.662 -0.975 . . . . 63.41 110.662 -176.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 28.9 m -98.58 162.75 12.97 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 107.878 -1.156 . . . . 72.03 107.878 178.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -74.39 116.47 5.2 Favored Glycine 0 N--CA 1.424 -2.137 0 CA-C-O 121.43 0.461 . . . . 55.14 112.462 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 20.5 m -104.94 144.48 14.68 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 107.194 -1.409 . . . . 64.3 107.194 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.517 HD21 HG22 ' A' ' 619' ' ' ILE . 28.4 p30 -48.43 148.59 1.9 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 112.513 0.561 . . . . 70.24 112.513 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -55.38 -24.42 29.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.598 -0.728 . . . . 72.25 112.408 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 617' ' ' ASP . . . . . 0.467 ' OD2' ' HB ' ' A' ' 619' ' ' ILE . 19.2 t70 -61.52 -53.22 59.19 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.569 -1.271 . . . . 73.34 107.569 175.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 96.5 19.33 27.93 Favored Glycine 0 N--CA 1.419 -2.445 0 CA-C-N 114.992 -1.004 . . . . 60.31 111.416 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 619' ' ' ILE . . . . . 0.517 HG22 HD21 ' A' ' 615' ' ' ASN . 0.0 OUTLIER -69.18 119.93 15.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 122.151 0.977 . . . . 55.51 109.73 -173.433 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.27 130.37 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.602 0 CA-C-N 114.611 -1.177 . . . . 75.03 108.158 -176.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 6.5 m -98.26 118.01 33.95 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.38 -0.97 . . . . 73.43 108.38 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 622' ' ' LEU . . . . . 0.604 ' O ' ' HD2' ' A' ' 623' ' ' ARG . 2.4 pt? -138.78 157.69 45.61 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.063 -0.517 . . . . 70.25 109.814 -177.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 623' ' ' ARG . . . . . 0.604 ' HD2' ' O ' ' A' ' 622' ' ' LEU . 6.9 mpt_? -129.63 143.08 50.66 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 105.202 -2.147 . . . . 73.43 105.202 171.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -141.22 165.23 28.1 Favored 'General case' 0 C--N 1.293 -1.861 0 O-C-N 123.896 0.747 . . . . 75.34 110.51 -178.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -66.55 138.74 36.23 Favored Glycine 0 N--CA 1.426 -2.004 0 CA-C-N 114.813 -1.085 . . . . 64.33 112.726 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 . . . . . 0 C--N 1.286 -2.158 0 C-N-CA 124.736 1.214 . . . . 74.44 109.02 -178.349 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.967 0 N-CA-C 110.188 -1.165 . . . . 43.05 110.188 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 10.3 tp -74.69 139.68 18.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.923 -0.769 . . . . 74.22 108.923 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 19.2 m -105.03 150.79 24.67 Favored 'General case' 0 N--CA 1.416 -2.138 0 N-CA-C 109.171 -0.678 . . . . 75.32 109.171 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.458 ' HD2' ' H ' ' A' ' 358' ' ' ARG . 0.1 OUTLIER -116.08 86.38 2.47 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 106.126 -1.805 . . . . 73.32 106.126 174.614 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.49 130.63 43.85 Favored 'General case' 0 CA--C 1.48 -1.725 0 CA-C-N 112.999 -1.91 . . . . 45.21 108.887 -176.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 360' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 409' ' ' SER . 31.2 m -133.81 159.51 42.45 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 CA-C-N 115.332 -0.849 . . . . 43.34 108.747 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -93.99 138.26 32.3 Favored 'General case' 0 N--CA 1.39 -3.437 0 N-CA-C 107.45 -1.315 . . . . 72.43 107.45 174.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 78.1 t -95.72 129.43 34.52 Favored Pre-proline 0 C--N 1.267 -3.001 0 CA-C-N 115.297 -0.865 . . . . 63.44 109.056 -172.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -57.77 127.71 26.28 Favored 'Trans proline' 0 CA--C 1.498 -1.302 0 C-N-CA 122.233 1.955 . . . . 73.44 110.153 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -80.21 126.36 31.02 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.196 -1.039 . . . . 75.32 108.196 -174.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 10.7 m -88.88 1.24 7.15 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 N-CA-C 113.387 0.884 . . . . 71.45 113.387 -173.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -56.48 144.7 30.31 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 123.584 0.552 . . . . 73.25 111.206 176.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.69 -16.6 47.43 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.728 -0.669 . . . . 53.12 112.398 -178.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -99.27 -156.12 0.53 Allowed 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 108.368 -0.975 . . . . 73.13 108.368 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 95.8 p -98.86 175.1 6.07 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 107.375 -1.343 . . . . 53.21 107.375 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.0 p -63.17 -44.71 94.66 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 109.799 -0.445 . . . . 71.34 109.799 175.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.58 -46.27 83.44 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 116.216 -0.447 . . . . 72.03 111.299 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 372' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 369' ' ' SER . 4.1 m-20 -64.52 -38.47 91.14 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 121.0 0.429 . . . . 73.54 111.64 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -67.49 -47.88 68.72 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.98 -0.554 . . . . 64.22 110.575 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 82.1 mt -60.98 -43.72 96.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-N 115.728 -0.669 . . . . 75.52 110.411 176.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.76 -42.75 89.63 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 115.856 -0.611 . . . . 65.2 111.002 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 376' ' ' THR . . . . . 0.564 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 31.2 m -67.37 -48.01 68.7 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.738 -0.664 . . . . 74.33 110.228 -178.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 92.0 mt -64.64 -39.0 92.92 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 112.152 0.427 . . . . 75.21 112.152 -178.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 63.8 tp60 -64.43 -41.21 96.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.803 0.335 . . . . 72.22 110.176 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -70.05 -20.56 63.23 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 112.176 0.436 . . . . 70.03 112.176 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 380' ' ' ARG . . . . . 0.564 ' HG2' ' O ' ' A' ' 376' ' ' THR . 5.9 mmp_? -86.43 -12.62 48.6 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.023 0.439 . . . . 71.42 109.869 176.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.09 3.95 55.53 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 121.182 -0.532 . . . . 72.53 112.982 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -80.66 164.81 22.56 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-O 120.954 0.407 . . . . 74.4 110.301 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -108.43 141.52 40.17 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 107.531 -1.285 . . . . 71.12 107.531 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.472 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -124.58 152.79 30.86 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.491 0 CA-C-O 121.323 0.583 . . . . 71.05 110.199 -177.039 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -133.07 127.05 33.18 Favored 'General case' 0 N--CA 1.4 -2.974 0 N-CA-C 106.644 -1.613 . . . . 65.41 106.644 175.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 21.0 m -118.36 123.27 44.89 Favored 'General case' 0 C--N 1.271 -2.821 0 N-CA-C 107.887 -1.153 . . . . 74.24 107.887 -175.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.17 121.37 44.74 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.873 -1.158 . . . . 71.35 107.873 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.447 ' HB3' HG21 ' A' ' 422' ' ' THR . 1.4 mp0 -94.08 126.67 39.43 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.3 -0.629 . . . . 75.05 109.3 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 389' ' ' LYS . . . . . 0.409 ' HD2' HG21 ' A' ' 394' ' ' ILE . 97.3 mttt -130.87 136.57 29.11 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 110.055 -0.35 . . . . 64.03 110.055 175.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.57 ' HA ' ' O ' ' A' ' 422' ' ' THR . 23.5 Cg_exo -68.06 166.45 24.85 Favored 'Trans proline' 0 C--O 1.248 0.984 0 C-N-CA 122.066 1.844 . . . . 62.01 110.125 172.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 2.9 m-20 85.04 170.25 0.08 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.349 1.059 . . . . 64.14 110.645 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 69.3 p -108.82 9.28 26.84 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 120.677 0.275 . . . . 70.34 111.39 -176.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 15.4 t -78.43 -7.02 56.91 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.627 0.727 . . . . 50.22 110.901 -177.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.515 HD13 ' H ' ' A' ' 394' ' ' ILE . 0.2 OUTLIER -115.87 151.5 46.47 Favored Pre-proline 0 C--N 1.298 -1.656 0 N-CA-C 107.882 -1.155 . . . . 65.53 107.882 175.798 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -32.79 131.24 0.1 Allowed 'Trans proline' 0 C--N 1.363 1.316 0 C-N-CA 124.569 3.513 . . . . 75.43 114.928 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.25 164.37 3.85 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 124.476 3.451 . . . . 72.32 113.352 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -56.43 -8.64 0.56 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.525 1.13 . . . . 74.11 112.355 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 398' ' ' HIS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 60.3 m170 -115.79 131.61 56.89 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 104.563 -2.384 . . . . 65.43 104.563 170.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 24.7 m -71.03 117.15 13.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-O 121.978 0.894 . . . . 65.4 111.453 -169.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 50.0 mm -102.99 -26.66 3.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.078 -1.082 . . . . 54.02 108.078 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -144.31 157.53 27.2 Favored Glycine 0 N--CA 1.399 -3.807 0 N-CA-C 109.486 -1.446 . . . . 42.21 109.486 -178.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 8.0 p -146.56 -176.17 5.08 Favored 'General case' 0 C--N 1.275 -2.662 0 C-N-CA 125.111 1.364 . . . . 71.44 107.808 -172.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -100.58 139.74 20.85 Favored Pre-proline 0 C--N 1.29 -2.004 0 N-CA-C 108.272 -1.01 . . . . 72.12 108.272 -174.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.21 -12.89 6.02 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 123.951 3.101 . . . . 74.32 114.691 -176.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -50.05 -41.29 47.44 Favored 'General case' 0 C--O 1.212 -0.902 0 C-N-CA 123.742 0.817 . . . . 73.35 111.584 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -71.46 -32.77 68.68 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.291 0.567 . . . . 54.11 111.398 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -85.32 -1.17 56.68 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.709 0.766 . . . . 70.34 110.683 -177.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 19.0 m -102.19 151.01 22.71 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 107.1 -1.444 . . . . 64.54 107.1 174.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 409' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 360' ' ' VAL . 20.2 m -74.68 113.83 12.4 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 108.876 -0.787 . . . . 64.33 108.876 178.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.6 m -120.24 170.3 10.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 116.272 -0.422 . . . . 73.23 110.551 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 25.8 t -77.38 150.97 35.04 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.096 -1.076 . . . . 73.43 108.096 176.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -65.61 122.12 16.52 Favored 'General case' 0 C--O 1.245 0.836 0 N-CA-C 109.413 -0.588 . . . . 52.13 109.413 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 94.62 68.25 1.04 Allowed Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 110.25 -1.14 . . . . 42.2 110.25 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -127.96 -179.51 5.01 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.528 -1.286 . . . . 50.33 107.528 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -111.4 119.65 39.53 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.049 0.452 . . . . 74.34 110.674 -174.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 46.1 mm -106.21 120.83 57.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 109.203 -0.666 . . . . 63.52 109.203 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 22.4 p -92.55 130.88 38.07 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.016 0.436 . . . . 74.45 111.307 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 5.4 p -126.82 135.33 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 109.072 -0.714 . . . . 54.1 109.072 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 419' ' ' ASN . . . . . 0.439 ' H ' HD22 ' A' ' 419' ' ' ASN . 0.0 OUTLIER -111.81 125.76 54.35 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 109.41 -0.589 . . . . 73.31 109.41 178.705 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 11.5 p -121.51 143.93 32.32 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 115.478 -0.783 . . . . 63.1 110.727 -174.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 31.3 t -84.16 121.46 27.48 Favored 'General case' 0 C--O 1.252 1.197 0 CA-C-N 115.682 -0.69 . . . . 54.43 109.679 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 390' ' ' PRO . 14.4 t -121.08 107.73 12.97 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 115.83 -0.623 . . . . 74.04 111.759 175.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 97.78 152.18 28.07 Favored Glycine 0 C--N 1.302 -1.357 0 C-N-CA 119.099 -1.524 . . . . 72.13 115.424 172.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -72.52 158.7 50.59 Favored 'Trans proline' 0 C--O 1.243 0.744 0 C-N-CA 124.205 3.27 . . . . 72.13 113.74 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.436 ' HG2' ' HA ' ' A' ' 391' ' ' ASP . 35.4 mt-10 -76.85 163.95 26.28 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.155 -1.384 . . . . 74.25 111.637 -175.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.415 ' HG3' ' HB ' ' A' ' 477' ' ' THR . 18.9 tp60 -88.73 138.99 30.92 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 106.291 -1.744 . . . . 72.35 106.291 178.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.545 ' HG3' ' O ' ' A' ' 447' ' ' ALA . 5.0 mmp_? -127.7 148.89 50.41 Favored 'General case' 0 C--O 1.209 -1.073 0 N-CA-C 113.815 1.043 . . . . 75.23 113.815 -178.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -83.42 138.52 33.44 Favored 'General case' 0 C--N 1.286 -2.157 0 C-N-CA 126.237 1.815 . . . . 74.42 110.548 178.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.457 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 66.5 mt -83.59 119.28 73.5 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 108.684 -0.858 . . . . 55.5 108.684 177.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.83 152.53 63.85 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.909 2.406 . . . . 63.12 113.823 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -91.42 110.1 21.39 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 115.763 -0.653 . . . . 71.22 109.457 176.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 42.2 t -116.77 150.34 18.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.354 -0.98 . . . . 61.13 108.354 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.595 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 17.0 m -68.62 150.88 47.47 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 121.071 0.462 . . . . 64.24 110.975 -179.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 40.5 p -69.77 -27.33 64.84 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 123.75 0.82 . . . . 71.53 113.179 -172.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.9 pp -88.07 -11.13 48.06 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.46 0.647 . . . . 65.2 111.349 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.595 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 0.8 OUTLIER -99.59 45.37 0.99 Allowed 'General case' 0 CA--C 1.56 1.341 0 CA-C-N 115.464 -0.789 . . . . 74.25 109.869 -175.672 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -52.65 -38.91 61.2 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 114.198 1.184 . . . . 65.44 114.198 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.49 ' O ' ' HG3' ' A' ' 442' ' ' LYS . . . -64.69 -39.56 93.87 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 120.527 -0.469 . . . . 52.44 110.544 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -65.77 -36.17 82.78 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 108.684 -0.858 . . . . 75.11 108.684 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.535 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.91 -51.63 68.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.172 -0.467 . . . . 63.32 111.46 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 27.2 m -65.86 -39.02 83.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 112.321 0.489 . . . . 65.43 112.321 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 438' ' ' ALA 0.3 0.0 OUTLIER -68.37 -34.07 75.4 Favored 'General case' 0 C--O 1.214 -0.764 0 N-CA-C 112.985 0.735 . . . . 73.2 112.985 176.483 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -61.25 -43.38 98.98 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.047 0.451 . . . . 73.34 110.056 175.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.535 HD13 ' O ' ' A' ' 440' ' ' ALA . 7.1 mp -63.67 -35.75 81.56 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.599 -0.728 . . . . 73.44 110.706 177.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.616 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 26.9 m -71.16 -45.98 62.41 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.108 -0.496 . . . . 64.23 111.078 178.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -65.41 -20.05 66.21 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.227 0.611 . . . . 74.42 110.995 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 447' ' ' ALA . . . . . 0.545 ' O ' ' HG3' ' A' ' 427' ' ' ARG . . . -79.35 -3.92 48.5 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.853 -0.612 . . . . 61.21 111.433 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 118.05 -78.6 0.3 Allowed Glycine 0 CA--C 1.49 -1.503 0 C-N-CA 120.716 -0.754 . . . . 73.42 111.562 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 449' ' ' PHE . . . . . 0.465 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 2.8 p90 -43.48 -66.82 0.33 Allowed 'General case' 0 C--O 1.241 0.652 0 N-CA-C 113.473 0.916 . . . . 61.3 113.473 177.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 450' ' ' GLY . . . . . 0.616 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 62.19 27.63 69.4 Favored Glycine 0 CA--C 1.487 -1.671 0 N-CA-C 111.037 -0.825 . . . . 74.42 111.037 -175.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -103.91 110.11 22.11 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 106.701 -1.592 . . . . 75.43 106.701 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 27.9 p90 -135.67 154.71 51.2 Favored 'General case' 0 N--CA 1.408 -2.547 0 CA-C-N 115.66 -0.7 . . . . 74.32 109.721 -176.027 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -130.77 122.9 28.03 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 107.783 -1.191 . . . . 74.15 107.783 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -86.8 129.98 34.65 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.975 -0.75 . . . . 64.11 108.975 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -136.43 140.95 43.52 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 116.358 -0.383 . . . . 63.32 110.084 177.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -114.14 146.24 40.57 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 106.903 -1.517 . . . . 75.13 106.903 175.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 52.7 m -148.6 150.22 33.08 Favored Pre-proline 0 C--N 1.28 -2.449 0 N-CA-C 108.487 -0.931 . . . . 60.43 108.487 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.681 ' HA ' ' O ' ' A' ' 490' ' ' SER . 37.5 Cg_endo -66.69 132.77 29.69 Favored 'Trans proline' 0 N--CA 1.442 -1.536 0 C-N-CA 121.667 1.578 . . . . 63.13 110.423 177.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 21.2 m -142.38 178.12 7.8 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.042 -0.725 . . . . 72.43 109.042 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 6.9 t -62.34 137.54 96.06 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 109.691 -0.485 . . . . 63.21 109.691 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.42 -29.36 30.73 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 124.415 3.41 . . . . 73.35 113.62 -176.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -67.92 -33.36 74.54 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-O 120.943 0.401 . . . . 73.22 111.398 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.35 -20.04 23.32 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 111.904 0.335 . . . . 75.45 111.904 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 78.0 t -52.28 133.35 14.25 Favored 'Isoleucine or valine' 0 C--O 1.245 0.85 0 O-C-N 123.603 0.564 . . . . 72.34 111.016 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.88 -20.3 48.48 Favored Glycine 0 N--CA 1.438 -1.191 0 CA-C-N 115.646 -0.706 . . . . 54.05 112.292 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -113.33 166.28 11.63 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 117.103 0.451 . . . . 74.5 110.21 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.439 HG22 HG12 ' A' ' 488' ' ' VAL . 77.6 t -72.85 143.3 14.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 115.563 -0.744 . . . . 71.34 109.237 177.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 50.5 mm -96.89 -31.78 4.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 107.532 -1.285 . . . . 61.02 107.532 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 153.4 -163.96 30.87 Favored Glycine 0 N--CA 1.422 -2.287 0 CA-C-N 115.539 -0.755 . . . . 42.51 111.893 175.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.71 139.14 50.89 Favored 'General case' 0 N--CA 1.413 -2.277 0 N-CA-C 106.62 -1.622 . . . . 74.32 106.62 176.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.483 ' HB3' HG23 ' A' ' 485' ' ' ILE . 27.4 t-20 -64.96 -51.04 59.14 Favored Pre-proline 0 N--CA 1.471 0.605 0 CA-C-O 119.228 -0.415 . . . . 74.01 111.003 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.458 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 21.8 Cg_exo -70.29 130.52 18.83 Favored 'Trans proline' 0 C--N 1.371 1.761 0 N-CA-C 107.131 -1.911 . . . . 72.14 107.131 169.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.468 ' C ' ' H ' ' A' ' 475' ' ' ASN . 39.7 Cg_exo -62.06 133.51 44.5 Favored 'Trans proline' 0 C--O 1.24 0.595 0 C-N-CA 121.856 1.704 . . . . 74.13 113.212 -174.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.457 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -70.92 14.49 0.14 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.159 1.384 . . . . 15.43 111.588 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 475' ' ' ASN . . . . . 0.468 ' H ' ' C ' ' A' ' 473' ' ' PRO . 16.3 m120 -109.19 -13.72 14.61 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 108.484 -0.932 . . . . 75.54 108.484 -178.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -104.79 178.86 4.44 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.547 -0.751 . . . . 73.44 111.344 -175.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.415 ' HB ' ' HG3' ' A' ' 426' ' ' GLN . 0.9 OUTLIER -106.59 137.84 43.86 Favored 'General case' 0 N--CA 1.396 -3.142 0 CA-C-N 115.573 -0.74 . . . . 72.13 110.898 -179.595 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 12.3 p -117.13 149.65 40.0 Favored 'General case' 0 N--CA 1.424 -1.75 0 C-N-CA 123.97 0.908 . . . . 62.41 110.145 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -80.83 158.53 25.36 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.916 -0.584 . . . . 44.21 110.129 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.465 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 37.0 mm -69.72 -17.53 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 122.231 1.015 . . . . 63.1 110.318 -178.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 7.4 p -100.09 2.02 42.8 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.654 -0.703 . . . . 71.44 111.403 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -95.75 134.9 38.14 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.048 -0.524 . . . . 60.45 110.846 -175.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 37.6 t -99.88 116.44 43.16 Favored 'Isoleucine or valine' 0 C--O 1.243 0.754 0 N-CA-C 109.228 -0.656 . . . . 71.22 109.228 -177.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 32.1 m -99.72 136.79 29.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 121.436 0.636 . . . . 65.52 111.384 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.483 HG23 ' HB3' ' A' ' 471' ' ' ASN . 0.0 OUTLIER -99.98 128.35 51.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 121.452 0.644 . . . . 73.55 111.742 -176.841 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 16.3 mt -112.56 128.25 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 CA-C-N 114.599 -1.182 . . . . 72.51 109.88 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 6.1 tt -111.03 126.71 68.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-N 115.151 -0.931 . . . . 63.01 110.515 -173.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.439 HG12 HG22 ' A' ' 467' ' ' VAL . 35.0 m -105.56 149.52 8.93 Favored 'Isoleucine or valine' 0 C--O 1.254 1.306 0 CA-C-N 115.933 -0.576 . . . . 72.34 110.032 177.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -84.22 125.97 7.37 Favored Glycine 0 N--CA 1.437 -1.279 0 N-CA-C 111.372 -0.691 . . . . 73.15 111.372 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.681 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 25.5 t -135.99 160.65 37.97 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 107.075 -1.454 . . . . 73.44 107.075 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 146.99 166.32 12.29 Favored Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 119.637 -1.268 . . . . 74.42 111.399 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -71.69 156.16 57.72 Favored 'Trans proline' 0 C--O 1.249 1.057 0 C-N-CA 123.254 2.636 . . . . 75.42 111.853 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -104.37 118.99 37.95 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-O 121.44 0.638 . . . . 54.12 109.677 -177.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 11.0 p -116.82 143.15 46.02 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 115.018 -0.992 . . . . 73.54 109.66 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 495' ' ' LYS . . . . . 0.43 ' HE2' ' HA ' ' A' ' 495' ' ' LYS . 3.5 mmpt? -146.86 151.67 37.45 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 123.168 0.587 . . . . 73.54 109.837 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.539 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.2 p-10 -87.24 135.38 33.33 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.84 -1.17 . . . . 73.32 107.84 174.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 26.2 pt -75.26 121.01 84.31 Favored Pre-proline 0 C--N 1.294 -1.813 0 CA-C-N 115.784 -0.644 . . . . 72.22 109.729 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -75.25 159.9 39.92 Favored 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 122.184 1.923 . . . . 61.22 111.765 -177.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -77.84 90.27 4.08 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 106.272 -1.751 . . . . 74.04 106.272 174.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 10.0 p -96.65 7.5 7.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-O 122.319 1.056 . . . . 53.24 110.427 -171.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -78.06 79.05 4.53 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.203 -0.908 . . . . 63.21 111.932 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . -178.13 31.75 0.07 OUTLIER Glycine 0 C--N 1.304 -1.197 0 N-CA-C 110.703 -0.959 . . . . 61.54 110.703 177.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -157.51 -177.37 6.54 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 107.956 -1.127 . . . . 73.3 107.956 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 5.9 t -91.23 156.81 17.56 Favored 'General case' 0 N--CA 1.426 -1.642 0 C-N-CA 119.02 -1.072 . . . . 42.22 109.738 -177.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.5 p -54.16 -40.27 46.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 C-N-CA 124.707 1.203 . . . . 71.41 111.271 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -60.9 -43.38 98.59 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.624 -0.716 . . . . 71.41 110.697 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 64.0 t -76.77 -37.13 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-N 116.042 -0.526 . . . . 72.21 110.241 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 508' ' ' ALA . . . . . 0.48 ' O ' ' HG ' ' A' ' 512' ' ' LEU . . . -62.9 -48.87 77.11 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.93 -0.577 . . . . 63.25 111.662 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -65.18 -35.66 81.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.762 0.315 . . . . 61.32 110.246 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.521 ' O ' HG23 ' A' ' 514' ' ' VAL . 26.2 tptp -64.15 -45.37 88.75 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.848 -0.797 . . . . 74.23 108.848 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -62.27 -42.69 99.56 Favored 'General case' 0 CA--C 1.505 -0.78 0 O-C-N 123.609 0.568 . . . . 71.23 110.775 177.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 512' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 508' ' ' ALA . 87.5 mt -59.93 -42.94 95.07 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 116.447 -0.342 . . . . 55.13 110.612 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -62.28 -37.86 87.09 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 116.253 -0.431 . . . . 54.34 110.586 177.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 510' ' ' LYS . 92.6 t -61.87 -35.68 69.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.898 -0.592 . . . . 63.23 110.735 177.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -78.26 -19.58 53.41 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.213 0.53 . . . . 75.44 110.213 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 117.93 -5.98 15.78 Favored Glycine 0 N--CA 1.436 -1.326 0 C-N-CA 120.639 -0.791 . . . . 71.53 112.678 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.607 ' HA ' ' O ' ' A' ' 547' ' ' VAL . 74.6 m-85 -68.83 122.18 18.07 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 121.214 0.53 . . . . 74.51 110.642 -178.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 518' ' ' THR . . . . . 0.419 ' OG1' ' HA ' ' A' ' 548' ' ' ASP . 10.7 p -93.64 -39.7 10.67 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.567 -0.742 . . . . 71.42 112.357 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -108.43 114.94 29.18 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 122.152 0.977 . . . . 72.44 113.139 -171.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 520' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' A' ' 551' ' ' ILE . 46.2 p90 -130.72 151.58 51.01 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.566 -1.197 . . . . 73.11 110.167 176.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 25.1 m -125.17 143.03 51.14 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.111 -1.07 . . . . 74.24 108.111 176.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -117.91 119.71 35.67 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.827 -0.434 . . . . 73.33 109.827 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 523' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 554' ' ' GLN . . . -127.39 125.94 41.56 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.72 -0.844 . . . . 74.21 108.72 178.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 524' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 20.6 m -101.65 138.5 38.56 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.878 -0.329 . . . . 52.24 111.568 -178.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 30.1 m -123.71 149.38 27.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 108.415 -0.957 . . . . 62.35 108.415 176.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 526' ' ' ASP . . . . . 0.501 ' HA ' ' HB3' ' A' ' 557' ' ' LYS . 4.7 p-10 -69.57 136.02 50.77 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 121.248 0.547 . . . . 71.53 110.717 -177.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 25.6 p -163.01 167.56 11.64 Favored Pre-proline 0 C--N 1.307 -1.257 0 CA-C-N 115.237 -0.892 . . . . 75.02 109.046 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -77.39 6.56 4.31 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 122.483 2.122 . . . . 73.12 112.839 176.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -96.52 140.51 22.22 Favored Pre-proline 0 N--CA 1.445 -0.679 0 N-CA-C 108.206 -1.035 . . . . 74.31 108.206 175.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -64.42 161.4 34.96 Favored 'Trans proline' 0 C--O 1.246 0.908 0 C-N-CA 122.996 2.464 . . . . 75.53 113.962 -174.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.588 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -66.38 120.77 13.91 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.289 -0.868 . . . . 75.21 110.078 -178.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 122.94 -27.25 5.95 Favored Glycine 0 N--CA 1.434 -1.435 0 C-N-CA 120.657 -0.782 . . . . 71.44 111.594 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -69.63 125.61 27.23 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.358 -0.608 . . . . 65.34 109.358 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 94.0 t -81.48 111.6 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 N-CA-C 107.568 -1.271 . . . . 60.11 107.568 176.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 11.7 t -95.05 -16.22 22.86 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 120.63 -0.428 . . . . 62.13 111.982 -174.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 174.68 -175.13 46.89 Favored Glycine 0 CA--C 1.489 -1.564 0 C-N-CA 120.326 -0.94 . . . . 73.3 111.33 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 23.4 p -129.33 157.18 42.61 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.414 -0.958 . . . . 73.11 108.414 176.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.435 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 26.0 t-20 -73.06 -53.16 5.14 Favored Pre-proline 0 C--N 1.309 -1.186 0 C-N-CA 120.634 -0.427 . . . . 62.14 111.283 177.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.435 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 13.8 Cg_exo -72.86 136.45 25.24 Favored 'Trans proline' 0 C--N 1.368 1.605 0 N-CA-C 108.375 -1.433 . . . . 61.13 108.375 172.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -59.45 139.92 91.75 Favored 'Trans proline' 0 C--O 1.262 1.702 0 C-N-CA 122.2 1.933 . . . . 61.42 112.258 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -67.88 141.34 56.44 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.438 -0.801 . . . . 62.55 109.276 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 102.14 -12.27 57.28 Favored Glycine 0 N--CA 1.427 -1.932 0 C-N-CA 120.976 -0.63 . . . . 55.4 111.664 -176.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 45.8 m -72.57 126.94 31.08 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 116.943 0.372 . . . . 52.12 110.327 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 10.2 t -83.73 123.17 29.58 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.455 0.645 . . . . 73.53 110.029 177.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.9 m -138.21 157.46 72.69 Favored Pre-proline 0 C--N 1.305 -1.348 0 N-CA-C 108.972 -0.751 . . . . 74.54 108.972 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -65.89 150.5 85.69 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 121.554 1.503 . . . . 62.0 110.108 173.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' A' ' 517' ' ' PHE . 26.9 m -59.97 -20.2 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 113.316 0.858 . . . . 52.41 113.316 -177.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 548' ' ' ASP . . . . . 0.419 ' HA ' ' OG1' ' A' ' 518' ' ' THR . 9.7 t70 -95.09 4.92 53.17 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.603 0.716 . . . . 64.21 111.454 -177.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.1 t -71.62 171.58 11.2 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 109.4 -0.593 . . . . 74.11 109.4 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 49.1 t -101.12 112.82 35.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 109.836 -0.431 . . . . 52.13 109.836 -177.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 551' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 520' ' ' PHE . 2.9 mp -101.14 121.85 52.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.763 -0.829 . . . . 73.23 108.763 178.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -102.69 116.41 32.53 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.17 0.509 . . . . 73.52 110.082 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 4.6 mp -97.22 134.13 40.93 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.05 -0.977 . . . . 63.32 108.682 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 554' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 523' ' ' ALA . 52.7 mt-30 -105.21 114.83 29.26 Favored 'General case' 0 N--CA 1.414 -2.26 0 CA-C-O 122.03 0.919 . . . . 73.2 108.852 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 524' ' ' SER . 22.1 t -101.85 147.6 8.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 CA-C-N 113.967 -1.469 . . . . 70.01 108.855 -172.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.588 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 23.4 m -76.43 130.84 38.6 Favored 'General case' 0 N--CA 1.412 -2.35 0 CA-C-O 121.863 0.84 . . . . 52.4 112.447 177.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.501 ' HB3' ' HA ' ' A' ' 526' ' ' ASP . 10.2 tppt? -90.88 123.71 34.61 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 104.096 -2.557 . . . . 74.42 104.096 167.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -66.69 -42.3 93.34 Favored Glycine 0 CA--C 1.482 -2.009 0 N-CA-C 109.98 -1.248 . . . . 73.54 109.98 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 9.5 t30 65.57 21.15 11.72 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 122.171 0.986 . . . . 70.25 110.352 172.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -134.8 156.23 49.24 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.509 -0.769 . . . . 73.25 111.537 -176.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -133.4 156.73 47.14 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.395 -0.965 . . . . 73.53 108.395 176.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 54.9 t -73.22 124.47 30.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 120.777 0.322 . . . . 64.34 110.155 -178.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 52.9 ttp -97.26 137.52 21.18 Favored Pre-proline 0 C--N 1.311 -1.109 0 CA-C-N 116.159 -0.473 . . . . 72.52 111.962 -178.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -65.49 170.99 10.09 Favored 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 124.148 3.232 . . . . 72.34 112.535 172.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -82.14 134.25 35.31 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.31 -0.626 . . . . 60.04 109.31 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -120.38 -26.04 5.5 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.614 -0.884 . . . . 60.11 108.614 171.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 12.2 p -71.67 139.23 49.13 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.48 -0.782 . . . . 61.23 110.48 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 79.58 39.33 18.3 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 110.99 -0.844 . . . . 71.34 110.99 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 89.2 mtp -144.69 170.32 16.32 Favored 'General case' 0 C--O 1.249 1.075 0 N-CA-C 108.263 -1.014 . . . . 44.54 108.263 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -95.53 148.97 21.94 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 108.559 -0.904 . . . . 71.33 108.559 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 73.8 t-105 -61.73 -28.39 69.4 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 123.406 0.682 . . . . 74.23 109.968 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 13.8 p -71.54 -21.04 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-N 115.247 -0.888 . . . . 64.13 110.667 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -101.19 -30.82 11.33 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.812 -0.81 . . . . 62.43 108.812 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -59.06 -45.94 89.52 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.199 -0.91 . . . . 63.45 112.441 -178.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 579' ' ' ARG . 31.5 mt-10 -59.51 -57.65 25.34 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 113.7 1.0 . . . . 64.43 113.7 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -58.07 -34.75 98.81 Favored 'Trans proline' 0 C--N 1.364 1.394 0 C-N-CA 121.173 1.248 . . . . 63.33 112.26 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -59.21 -48.13 82.77 Favored 'General case' 0 N--CA 1.42 -1.925 0 C-N-CA 122.506 0.322 . . . . 74.41 110.526 177.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . 0.286 4.2 pp -68.04 -38.3 82.33 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 112.813 0.672 . . . . 72.31 112.813 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 579' ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 35.3 mmt180 -65.12 -47.56 76.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.472 -0.331 . . . . 63.43 110.458 178.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.93 -17.15 62.69 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.904 -0.589 . . . . 71.54 112.365 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 60.4 tp -85.84 -9.11 57.54 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 109.603 -0.517 . . . . 51.13 109.603 178.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 73.87 38.66 48.8 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 111.219 -0.752 . . . . 61.23 111.219 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 50.5 t90 -83.36 135.08 34.85 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-O 121.266 0.555 . . . . 73.33 111.015 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 10.1 t -145.89 106.34 4.07 Favored 'General case' 0 N--CA 1.408 -2.545 0 CA-C-N 114.783 -1.099 . . . . 74.32 108.126 173.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -159.18 -154.68 7.34 Favored Glycine 0 N--CA 1.429 -1.828 0 N-CA-C 108.774 -1.73 . . . . 73.11 108.774 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 60.9 mtt -107.58 125.23 51.05 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.68 -0.808 . . . . 64.04 112.324 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 59.2 tp -93.88 130.16 40.04 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.642 -0.873 . . . . 73.31 108.642 178.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 588' ' ' ASP . . . . . 0.462 ' HB3' HG23 ' A' ' 621' ' ' THR . 23.6 t70 -99.28 113.22 25.38 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 120.972 0.415 . . . . 74.02 111.232 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -91.86 109.4 20.73 Favored 'General case' 0 N--CA 1.408 -2.554 0 N-CA-C 106.4 -1.704 . . . . 71.15 106.4 171.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -87.9 -95.25 0.96 Allowed Glycine 0 N--CA 1.424 -2.124 0 C-N-CA 120.599 -0.81 . . . . 70.14 111.399 -178.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.44 151.28 46.11 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.214 -0.662 . . . . 74.42 109.214 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -84.84 132.07 34.45 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.719 -1.215 . . . . 72.5 107.719 175.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 73.5 t -123.63 127.7 74.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 CA-C-N 116.275 -0.421 . . . . 73.52 110.539 -171.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -78.53 107.25 11.05 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.018 -1.475 . . . . 74.5 107.018 175.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -127.47 0.86 6.26 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.81 -0.632 . . . . 72.14 110.736 -176.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 104.99 141.33 10.77 Favored Glycine 0 N--CA 1.431 -1.639 0 N-CA-C 108.8 -1.72 . . . . 74.31 108.8 -177.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -55.77 -39.31 76.4 Favored Glycine 0 C--O 1.224 -0.491 0 CA-C-N 117.193 0.497 . . . . 43.45 112.793 -173.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 3.9 m -60.37 -24.63 65.25 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.995 0.918 . . . . 65.22 111.923 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -108.76 -1.57 19.23 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.137 0.421 . . . . 73.14 112.137 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 59.5 m170 -72.38 -42.28 65.41 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.463 0.542 . . . . 65.34 112.463 -176.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -92.77 32.4 1.25 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 122.04 0.924 . . . . 74.34 108.749 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 602' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 603' ' ' VAL . 29.9 ttt180 -118.7 141.8 48.27 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.609 -0.682 . . . . 62.11 109.729 -178.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 603' ' ' VAL . . . . . 0.412 ' O ' ' HG2' ' A' ' 602' ' ' ARG . 71.4 t -73.15 130.9 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 106.094 -1.817 . . . . 75.14 106.094 172.009 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 73.6 t -80.05 -53.35 13.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-O 121.71 0.767 . . . . 63.5 109.292 -172.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -156.78 164.23 38.34 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 104.67 -2.345 . . . . 65.33 104.67 177.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -115.86 142.51 46.67 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 107.571 -1.27 . . . . 64.34 107.571 174.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.513 ' HB2' ' HB ' ' A' ' 621' ' ' THR . 41.1 t30 -64.21 -52.52 54.17 Favored Pre-proline 0 C--N 1.285 -2.211 0 N-CA-C 114.441 1.275 . . . . 74.41 114.441 -176.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 609' ' ' PRO . 2.3 Cg_endo -87.38 148.99 7.72 Favored 'Trans proline' 0 CA--C 1.549 1.238 0 CA-C-N 121.444 1.551 . . . . 74.11 110.594 176.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 609' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 608' ' ' PRO . 15.8 Cg_exo -70.06 134.24 26.9 Favored 'Trans proline' 0 C--O 1.248 0.994 0 C-N-CA 121.731 1.621 . . . . 72.42 113.152 -177.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -68.56 134.32 49.83 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.678 -0.692 . . . . 75.3 110.724 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 86.48 -1.62 87.31 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.674 -0.774 . . . . 33.3 111.75 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 612' ' ' THR . . . . . 0.421 ' OG1' ' HB2' ' A' ' 609' ' ' PRO . 19.8 m -105.52 161.04 14.69 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 108.26 -1.015 . . . . 74.41 108.26 -178.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -73.17 129.99 13.24 Favored Glycine 0 N--CA 1.432 -1.575 0 N-CA-C 111.877 -0.489 . . . . 60.22 111.877 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 34.0 m -118.44 144.12 27.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.922 -0.77 . . . . 44.21 108.922 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.452 ' ND2' ' HB3' ' A' ' 617' ' ' ASP . 27.4 p-10 -43.6 155.59 0.07 Allowed 'General case' 0 C--O 1.216 -0.699 0 C-N-CA 124.73 1.212 . . . . 73.02 113.158 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -56.24 -25.92 49.45 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.048 0.758 . . . . 74.34 113.048 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 617' ' ' ASP . . . . . 0.452 ' HB3' ' ND2' ' A' ' 615' ' ' ASN . 30.8 t70 -65.83 -37.94 87.55 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.262 -0.644 . . . . 74.45 109.262 174.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 85.69 21.56 53.15 Favored Glycine 0 N--CA 1.424 -2.14 0 CA-C-N 115.681 -0.69 . . . . 61.41 112.182 176.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 619' ' ' ILE . . . . . 0.4 ' HB ' ' OD2' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -68.44 118.52 12.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 122.448 1.118 . . . . 61.02 110.404 -169.351 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.97 124.55 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.946 0 N-CA-C 106.976 -1.49 . . . . 74.3 106.976 -177.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.513 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 3.0 m -105.36 127.39 52.94 Favored 'General case' 0 N--CA 1.42 -1.944 0 C-N-CA 120.492 -0.483 . . . . 70.14 109.908 -177.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.0 mp -120.98 149.81 42.09 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 105.434 -2.062 . . . . 72.33 105.434 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -137.53 148.16 45.74 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 107.615 -1.254 . . . . 64.0 107.615 173.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -123.78 167.6 13.82 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 107.713 -1.217 . . . . 63.23 107.713 -177.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -67.0 -105.19 0.02 OUTLIER Glycine 0 CA--C 1.533 1.157 0 O-C-N 123.927 0.767 . . . . 71.45 111.824 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 . . . . . 0 C--N 1.296 -1.751 0 CA-C-O 118.575 -0.726 . . . . 72.25 109.185 177.032 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.486 0 N-CA-C 110.061 -1.216 . . . . 51.14 110.061 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 10.1 tp -77.35 125.03 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.785 0 CA-C-O 121.869 0.842 . . . . 71.05 111.627 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 24.3 m -144.66 152.39 40.39 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 104.797 -2.297 . . . . 73.42 104.797 177.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . 0.338 0.0 OUTLIER -87.78 72.69 9.4 Favored 'General case' 0 CA--C 1.492 -1.253 0 CA-C-O 122.763 1.268 . . . . 73.35 112.445 -178.278 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -92.33 148.57 22.03 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 113.123 -1.853 . . . . 72.13 106.847 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 28.4 m -116.8 149.67 18.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.231 0 C-N-CA 120.538 -0.465 . . . . 53.25 110.417 -173.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 361' ' ' GLN . . . . . 0.411 ' OE1' ' HA ' ' A' ' 407' ' ' ASN . 0.5 OUTLIER -93.9 128.98 40.48 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 105.172 -2.159 . . . . 73.34 105.172 -179.072 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.438 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 92.9 t -95.43 122.37 59.52 Favored Pre-proline 0 C--N 1.28 -2.435 0 CA-C-N 115.266 -0.879 . . . . 63.54 110.864 -167.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 363' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 18.0 Cg_exo -61.94 125.61 16.93 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 122.312 2.008 . . . . 45.25 110.163 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 364' ' ' ASP . . . . . 0.475 ' HB2' ' HG3' ' A' ' 366' ' ' ARG . 3.7 p-10 -71.85 125.87 28.28 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.339 -0.846 . . . . 71.43 109.714 -176.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.418 HG11 ' HA ' ' A' ' 373' ' ' ALA . 17.9 t -98.33 0.11 10.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-O 122.085 0.945 . . . . 72.12 108.728 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.475 ' HG3' ' HB2' ' A' ' 364' ' ' ASP 0.298 0.0 OUTLIER -64.96 146.6 54.77 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.963 -1.017 . . . . 73.2 113.047 179.325 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.26 -9.34 45.81 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 109.806 -1.318 . . . . 72.15 109.806 -172.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -110.7 -163.53 0.86 Allowed 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 107.35 -1.352 . . . . 52.03 107.35 178.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 76.2 p -86.87 160.42 18.74 Favored 'General case' 0 C--N 1.286 -2.157 0 O-C-N 121.865 -0.522 . . . . 71.32 111.602 -170.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 34.2 p -58.95 -46.43 88.03 Favored 'General case' 0 N--CA 1.435 -1.208 0 O-C-N 123.622 0.576 . . . . 41.24 110.6 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.85 -46.79 80.41 Favored 'General case' 0 C--O 1.214 -0.797 0 CA-C-N 116.235 -0.439 . . . . 52.4 111.667 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -67.63 -37.74 82.9 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.259 0.552 . . . . 62.34 111.259 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 373' ' ' ALA . . . . . 0.418 ' HA ' HG11 ' A' ' 365' ' ' VAL . . . -69.46 -48.53 60.53 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.619 -0.719 . . . . 72.23 111.318 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 89.0 mt -64.9 -42.11 93.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 CA-C-N 116.449 -0.341 . . . . 53.11 110.922 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.95 -45.57 90.15 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 120.717 0.294 . . . . 63.01 111.348 -178.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 32.7 m -64.38 -47.57 78.75 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.998 -0.546 . . . . 73.41 111.147 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.1 -38.74 92.16 Favored 'General case' 0 C--O 1.24 0.597 0 O-C-N 122.094 -0.379 . . . . 70.42 111.709 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 -63.43 -42.12 98.69 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.986 -0.552 . . . . 72.31 110.189 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -67.89 -28.13 67.25 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 112.027 0.381 . . . . 63.31 112.027 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -79.96 -15.7 56.75 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.494 -0.482 . . . . 70.13 110.253 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 96.07 15.89 40.28 Favored Glycine 0 N--CA 1.434 -1.461 0 C-N-CA 120.289 -0.957 . . . . 61.1 113.021 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -77.75 143.06 38.3 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 108.667 -0.864 . . . . 72.22 108.667 175.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -84.64 131.86 34.55 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 105.805 -1.924 . . . . 74.21 105.805 176.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 2.4 pp -130.83 138.24 54.05 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 CA-C-O 121.85 0.833 . . . . 72.35 113.23 -175.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 385' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 385' ' ' ARG . 33.0 ttp180 -113.8 141.28 47.49 Favored 'General case' 0 C--N 1.276 -2.588 0 N-CA-C 107.053 -1.462 . . . . 63.53 107.053 175.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 20.9 m -122.37 121.16 36.02 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 108.127 -1.064 . . . . 72.11 108.127 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -111.61 127.82 55.86 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.819 -1.178 . . . . 72.5 107.819 -176.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -93.04 131.91 37.63 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.925 0.393 . . . . 73.44 111.504 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 389' ' ' LYS . . . . . 0.615 ' O ' ' HA ' ' A' ' 421' ' ' SER . 71.6 mmtt -126.36 132.91 24.49 Favored Pre-proline 0 C--N 1.304 -1.393 0 CA-C-N 115.797 -0.638 . . . . 51.52 109.465 175.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.752 ' HA ' ' O ' ' A' ' 422' ' ' THR . 12.2 Cg_exo -72.37 140.26 33.21 Favored 'Trans proline' 0 C--O 1.247 0.95 0 C-N-CA 122.177 1.918 . . . . 74.13 109.901 175.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . 0.324 3.8 p30 -73.97 118.87 17.43 Favored 'General case' 0 CA--C 1.466 -2.26 0 C-N-CA 118.187 -1.405 . . . . 71.25 114.172 -178.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 392' ' ' SER . . . . . 0.549 ' O ' ' HB ' ' A' ' 393' ' ' THR . 50.1 m -143.94 81.69 1.69 Allowed 'General case' 0 N--CA 1.39 -3.462 0 N-CA-C 105.335 -2.098 . . . . 72.24 105.335 166.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.549 ' HB ' ' O ' ' A' ' 392' ' ' SER . 85.5 m 96.52 2.52 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 113.961 -1.472 . . . . 72.22 110.98 174.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 5.6 pt -104.92 151.58 39.44 Favored Pre-proline 0 C--N 1.291 -1.971 0 CA-C-N 114.843 -1.072 . . . . 61.23 109.341 176.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 395' ' ' PRO . . . . . 0.415 ' HB2' ' HD2' ' A' ' 396' ' ' PRO . 83.2 Cg_endo -74.56 -172.94 1.33 Allowed 'Trans proline' 0 CA--C 1.563 1.962 0 C-N-CA 123.305 2.67 . . . . 61.22 113.927 -172.023 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 396' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 395' ' ' PRO . 79.8 Cg_exo -55.17 163.16 4.76 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 123.277 2.651 . . . . 61.35 112.018 172.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -56.02 -8.5 0.46 Allowed 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 125.43 1.492 . . . . 73.43 112.929 -174.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 398' ' ' HIS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 50.0 m170 -64.88 121.57 14.93 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 107.187 -1.412 . . . . 73.2 107.187 175.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 29.6 m -68.7 117.92 11.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 115.167 -0.924 . . . . 61.22 110.927 -168.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 400' ' ' ILE . . . . . 0.453 HD13 ' O ' ' A' ' 400' ' ' ILE . 0.0 OUTLIER -92.52 -29.34 4.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 115.989 -0.551 . . . . 75.31 110.265 -174.677 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.55 160.53 28.11 Favored Glycine 0 N--CA 1.417 -2.592 0 C-N-CA 119.528 -1.32 . . . . 74.04 112.409 -174.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.43 ' OG1' ' HG2' ' A' ' 366' ' ' ARG . 2.9 p -145.01 -176.83 5.24 Favored 'General case' 0 C--N 1.283 -2.321 0 C-N-CA 125.963 1.705 . . . . 64.54 107.72 -176.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -99.52 138.19 20.42 Favored Pre-proline 0 C--N 1.291 -1.977 0 N-CA-C 107.718 -1.216 . . . . 75.31 107.718 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -48.11 -15.04 0.35 Allowed 'Trans proline' 0 C--N 1.364 1.375 0 C-N-CA 124.758 3.638 . . . . 73.41 115.509 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -52.73 -43.7 65.9 Favored 'General case' 0 C--O 1.213 -0.866 0 N-CA-C 109.947 -0.39 . . . . 61.44 109.947 176.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -65.96 -35.19 79.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.622 0.725 . . . . 75.33 109.887 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 407' ' ' ASN . . . . . 0.411 ' HA ' ' OE1' ' A' ' 361' ' ' GLN . 17.0 m120 -84.64 1.69 45.07 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.209 -0.905 . . . . 72.31 111.378 -177.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 29.6 m -109.27 167.51 10.06 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.324 -1.732 . . . . 73.25 106.324 174.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 15.9 m -76.56 112.79 13.48 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 108.615 -0.883 . . . . 73.32 108.615 175.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 14.2 m -122.13 170.39 12.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 120.807 0.337 . . . . 55.54 111.703 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 2.7 m -56.1 141.61 39.73 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.144 -0.935 . . . . 62.25 110.501 -178.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -66.56 109.69 2.89 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.058 -1.089 . . . . 74.41 108.058 176.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 86.51 42.7 6.41 Favored Glycine 0 N--CA 1.433 -1.536 0 N-CA-C 110.708 -0.957 . . . . 43.34 110.708 -176.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -79.94 -171.91 3.13 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.805 -0.813 . . . . 71.32 108.805 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -108.41 112.68 25.22 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 122.882 0.473 . . . . 73.4 110.412 -176.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 416' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 49.1 mm -116.57 137.47 50.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 109.575 -0.528 . . . . 71.1 109.575 -177.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 14.0 t -111.56 131.77 55.01 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.773 -0.825 . . . . 74.4 108.773 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 5.9 p -115.75 135.26 56.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.616 -0.512 . . . . 72.51 109.616 -177.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -100.8 128.6 46.78 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.277 -0.638 . . . . 72.54 109.277 178.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 8.3 p -126.3 137.31 58.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.794 -0.639 . . . . 73.52 109.871 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 421' ' ' SER . . . . . 0.615 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 2.3 p -92.59 120.68 33.28 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-O 122.024 0.916 . . . . 64.52 112.017 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.752 ' O ' ' HA ' ' A' ' 390' ' ' PRO . 6.2 t -122.46 155.0 37.05 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 108.095 -1.076 . . . . 72.12 108.095 174.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 79.59 99.37 0.27 Allowed Glycine 0 C--N 1.307 -1.029 0 C-N-CA 119.984 -1.103 . . . . 25.22 113.643 174.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.38 152.8 75.19 Favored 'Trans proline' 0 C--O 1.253 1.235 0 C-N-CA 122.868 2.379 . . . . 75.21 112.517 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -72.46 164.41 26.43 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.24 -0.891 . . . . 72.34 112.537 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -135.2 160.61 37.82 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 114.529 -1.214 . . . . 72.1 108.279 -175.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.425 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 2.2 mmp_? -119.82 138.16 53.54 Favored 'General case' 0 CA--C 1.492 -1.268 0 CA-C-O 121.147 0.498 . . . . 75.41 109.938 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 13.7 pt-20 -88.16 136.28 33.04 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.493 -0.776 . . . . 63.33 109.489 178.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 59.5 mt -80.67 130.71 63.32 Favored Pre-proline 0 C--N 1.298 -1.661 0 CA-C-N 115.854 -0.612 . . . . 60.34 109.368 -177.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -71.71 141.77 38.34 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 121.877 1.718 . . . . 63.25 110.736 170.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -82.84 111.53 18.83 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.901 -1.148 . . . . 65.43 107.901 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 60.9 t -103.5 143.46 15.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.137 -1.06 . . . . 74.42 108.137 -175.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 15.8 m -60.41 155.06 18.97 Favored 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 112.632 0.604 . . . . 74.54 112.632 -176.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 21.9 p -69.14 -24.98 64.16 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 115.339 1.607 . . . . 74.24 115.339 -170.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.1 pp -90.3 -11.6 40.3 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.953 0.883 . . . . 72.24 110.414 177.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.425 HG22 ' CB ' ' A' ' 439' ' ' GLU . 0.2 OUTLIER -99.95 34.43 2.3 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 114.914 -1.039 . . . . 65.15 109.643 -175.327 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -55.84 -38.33 69.9 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.172 0.989 . . . . 71.22 113.028 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.46 -36.78 84.88 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.868 0.842 . . . . 64.24 110.102 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.505 ' OE2' ' HD2' ' A' ' 442' ' ' LYS . 24.9 tp10 -70.92 -35.4 72.23 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.121 -0.945 . . . . 65.43 109.336 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.562 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -63.63 -50.55 68.89 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.001 -0.545 . . . . 61.24 110.988 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 31.2 m -62.1 -38.67 81.45 Favored 'Isoleucine or valine' 0 C--O 1.25 1.129 0 N-CA-C 112.606 0.595 . . . . 51.03 112.606 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.505 ' HD2' ' OE2' ' A' ' 439' ' ' GLU . 17.4 ptpt -67.93 -38.44 82.88 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 120.061 -0.656 . . . . 70.4 109.973 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -62.76 -38.56 91.07 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.336 -0.393 . . . . 74.25 110.924 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 77.8 mt -63.42 -37.66 88.13 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.933 -0.576 . . . . 75.14 109.453 177.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 41.0 m -69.93 -43.2 72.12 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.278 -0.873 . . . . 53.04 110.321 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -65.72 -27.37 68.28 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.048 0.539 . . . . 71.3 111.707 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.7 -13.56 59.38 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.477 -0.329 . . . . 64.33 111.459 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 448' ' ' GLY . . . . . 0.417 ' HA3' HD12 ' A' ' 480' ' ' ILE . . . 130.05 -81.27 0.34 Allowed Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 120.868 -0.682 . . . . 74.25 111.749 178.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -36.64 -68.9 0.12 Allowed 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 115.003 1.483 . . . . 65.31 115.003 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 59.65 35.15 84.96 Favored Glycine 0 C--N 1.318 -0.463 0 C-N-CA 121.007 -0.616 . . . . 72.31 112.551 -177.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.494 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 36.1 mmt180 -107.2 110.95 23.14 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.516 -1.29 . . . . 75.02 107.516 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -143.97 146.57 33.01 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 121.087 0.47 . . . . 74.34 111.532 -173.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 453' ' ' LYS . . . . . 0.429 ' HB2' ' HA ' ' A' ' 485' ' ' ILE . 34.8 mmtp -131.58 148.35 52.61 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 115.421 -0.809 . . . . 71.05 109.215 178.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -113.64 125.94 54.71 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.798 -0.816 . . . . 53.42 108.798 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 455' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -126.17 137.22 53.55 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.923 -1.14 . . . . 61.23 107.923 176.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 456' ' ' ASN . . . . . 0.52 ' HB2' ' OG ' ' A' ' 490' ' ' SER . 8.3 p30 -114.25 144.64 42.9 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 109.29 -0.633 . . . . 74.14 109.29 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 50.9 m -148.69 148.59 28.44 Favored Pre-proline 0 C--N 1.296 -1.734 0 N-CA-C 108.507 -0.923 . . . . 74.54 108.507 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.69 ' HA ' ' O ' ' A' ' 490' ' ' SER . 19.6 Cg_endo -64.33 125.49 15.19 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.189 1.926 . . . . 74.13 112.238 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 49.7 m -133.49 179.53 6.16 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.187 -1.042 . . . . 71.11 108.187 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.8 t -59.1 137.38 88.06 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 109.907 -0.405 . . . . 72.53 109.907 176.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -51.27 -29.74 30.92 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 124.528 3.485 . . . . 75.42 113.228 -176.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -72.99 -23.61 60.67 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.555 0.576 . . . . 65.11 112.555 -178.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 67.0 mt -101.42 -3.3 28.93 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.669 0.248 . . . . 73.45 111.669 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.441 HG13 ' HA ' ' A' ' 490' ' ' SER . 76.9 t -60.12 128.96 21.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 116.089 -0.505 . . . . 63.51 110.489 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.48 -11.76 59.77 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 115.742 -0.663 . . . . 63.31 112.392 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -114.04 165.81 12.25 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 109.355 -0.609 . . . . 74.24 109.355 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 71.1 t -74.33 146.22 10.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 116.062 -0.517 . . . . 65.23 109.832 177.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 49.3 mm -98.18 -35.11 4.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 107.839 -1.171 . . . . 72.14 107.839 177.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 169.61 -179.49 42.05 Favored Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 110.813 -0.915 . . . . 63.53 110.813 177.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 470' ' ' THR . . . . . 0.483 HG22 HG12 ' A' ' 486' ' ' ILE . 61.4 p -115.49 141.85 47.5 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 105.171 -2.159 . . . . 42.35 105.171 176.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.446 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 25.2 t-20 -69.1 -53.78 13.21 Favored Pre-proline 0 C--N 1.319 -0.733 0 C-N-CA 118.882 -1.127 . . . . 71.34 111.692 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.466 ' HG2' ' HA ' ' A' ' 484' ' ' VAL . 8.5 Cg_exo -76.61 139.88 20.68 Favored 'Trans proline' 0 C--N 1.364 1.389 0 N-CA-C 107.621 -1.723 . . . . 73.32 107.621 170.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.93 126.76 18.75 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.043 1.829 . . . . 71.43 112.461 -175.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -86.48 19.13 2.93 Favored 'General case' 0 C--O 1.206 -1.221 0 CA-C-N 115.111 -0.95 . . . . 74.1 109.797 -177.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -110.01 -13.64 14.37 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.449 -0.796 . . . . 72.53 109.563 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -93.18 168.87 10.82 Favored 'General case' 0 C--O 1.247 0.954 0 N-CA-C 114.396 1.258 . . . . 50.2 114.396 -170.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 0.4 OUTLIER -82.79 109.5 16.99 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-N 113.6 -1.636 . . . . 73.43 108.296 -179.704 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 64.7 m -104.97 145.7 30.06 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-O 121.465 0.65 . . . . 72.11 111.5 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -84.68 169.42 14.33 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 107.566 -1.272 . . . . 72.45 107.566 175.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.417 HD12 ' HA3' ' A' ' 448' ' ' GLY . 34.6 mm -72.46 -11.07 14.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 122.078 0.942 . . . . 54.42 110.356 -177.023 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 4.5 p -97.68 5.19 49.66 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.585 -0.734 . . . . 70.4 112.462 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -81.11 129.54 34.61 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 122.081 -0.387 . . . . 74.54 111.705 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.494 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.1 p -108.64 125.93 65.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.817 -0.628 . . . . 71.12 109.88 176.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.466 ' HA ' ' HG2' ' A' ' 472' ' ' PRO . 27.3 m -106.02 120.46 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 CA-C-O 121.941 0.877 . . . . 72.32 112.23 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.429 ' HA ' ' HB2' ' A' ' 453' ' ' LYS . 0.0 OUTLIER -92.86 121.52 43.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.415 -1.328 . . . . 62.22 107.415 175.35 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.483 HG12 HG22 ' A' ' 470' ' ' THR . 35.1 mt -114.35 128.75 71.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.044 -0.98 . . . . 73.34 111.379 -174.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 5.8 tt -101.87 126.56 55.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 116.031 -0.531 . . . . 71.33 110.649 -176.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 28.0 m -108.38 151.35 10.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 123.435 0.694 . . . . 42.11 109.893 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -84.14 128.9 8.86 Favored Glycine 0 N--CA 1.434 -1.465 0 C-N-CA 120.97 -0.633 . . . . 61.22 111.731 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.69 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 49.1 m -129.8 160.74 32.55 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.725 -0.842 . . . . 63.52 108.725 178.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 152.79 173.49 22.25 Favored Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 110.186 -1.166 . . . . 64.42 110.186 179.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -93.2 155.6 2.59 Favored 'Trans proline' 0 N--CA 1.442 -1.53 0 C-N-CA 122.661 2.241 . . . . 75.04 112.32 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -108.56 77.06 1.06 Allowed 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.661 -0.866 . . . . 71.1 108.661 177.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 19.1 p -117.86 144.9 45.0 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 114.911 -1.04 . . . . 54.01 110.918 -176.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 495' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 495' ' ' LYS . 16.0 mmtt -150.25 165.13 33.9 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 112.124 0.416 . . . . 72.52 112.124 175.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.79 133.74 36.32 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 107.399 -1.334 . . . . 71.13 107.399 -178.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 39.5 pt -78.85 133.16 62.41 Favored Pre-proline 0 C--N 1.294 -1.841 0 C-N-CA 120.137 -0.625 . . . . 64.45 109.968 175.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.84 -179.35 5.38 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.782 2.322 . . . . 75.1 111.893 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -108.68 141.49 40.57 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.911 -0.774 . . . . 73.54 108.911 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.402 ' O ' ' HA2' ' A' ' 536' ' ' GLY . 4.8 p -143.95 103.58 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 CA-C-O 121.555 0.693 . . . . 74.32 110.137 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -141.71 106.71 4.94 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.181 -0.918 . . . . 52.22 109.219 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 123.13 -16.13 8.17 Favored Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 120.173 -1.013 . . . . 74.11 111.376 178.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -89.74 173.45 8.27 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.854 -0.424 . . . . 74.43 109.854 177.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 13.9 t -91.79 157.74 16.72 Favored 'General case' 0 N--CA 1.425 -1.707 0 C-N-CA 119.771 -0.772 . . . . 52.12 109.984 -176.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 9.5 p -53.27 -41.19 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 124.229 1.012 . . . . 74.2 112.158 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -62.57 -41.98 99.27 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.128 0.49 . . . . 60.55 111.2 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 86.3 t -71.79 -37.35 61.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-N 116.092 -0.504 . . . . 72.43 110.513 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 508' ' ' ALA . . . . . 0.465 ' O ' HD23 ' A' ' 512' ' ' LEU . . . -61.5 -49.12 78.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.835 -0.62 . . . . 72.22 111.242 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -60.23 -46.91 88.16 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.019 0.438 . . . . 71.24 110.72 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.454 ' O ' HG23 ' A' ' 514' ' ' VAL . 55.8 tptt -65.44 -49.97 67.17 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 113.027 0.751 . . . . 74.42 113.027 -174.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -63.07 -37.76 88.5 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 120.142 -0.623 . . . . 64.53 110.45 -175.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 512' ' ' LEU . . . . . 0.465 HD23 ' O ' ' A' ' 508' ' ' ALA . 4.6 mm? -62.75 -43.3 99.15 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 116.551 -0.295 . . . . 64.0 111.007 175.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -62.98 -38.25 90.41 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 120.987 0.422 . . . . 54.22 110.699 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 510' ' ' LYS . 81.2 t -62.96 -34.25 65.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.562 -0.745 . . . . 71.44 110.554 177.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -85.27 3.2 40.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.89 0.376 . . . . 64.53 111.12 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 516' ' ' GLY . . . . . 0.541 ' O ' ' HB ' ' A' ' 547' ' ' VAL . . . 109.62 -20.84 26.81 Favored Glycine 0 N--CA 1.437 -1.289 0 C-N-CA 120.827 -0.701 . . . . 43.1 113.811 174.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -77.32 98.58 5.24 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.437 -1.319 . . . . 73.54 107.437 -175.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.91 -17.11 30.27 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.592 -0.731 . . . . 71.33 112.307 -169.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 519' ' ' LYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 28.1 mtpp -112.18 122.15 46.95 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.168 0.509 . . . . 71.24 111.604 -176.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -129.77 152.44 49.26 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.496 -0.775 . . . . 73.43 110.725 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.9 m -141.39 152.68 44.53 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 108.134 -1.061 . . . . 70.24 108.134 173.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 522' ' ' GLN . . . . . 0.44 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 26.0 pt20 -117.19 151.07 37.66 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-O 121.365 0.602 . . . . 71.12 111.199 -178.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 523' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 554' ' ' GLN . . . -132.79 118.69 19.33 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.23 -1.396 . . . . 54.41 107.23 174.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 11.7 p -85.92 128.86 34.93 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.013 0.435 . . . . 55.42 111.341 -177.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 28.7 m -127.3 160.02 36.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 109.485 -0.561 . . . . 73.34 109.485 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -72.76 136.18 45.44 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.565 -0.531 . . . . 72.45 109.565 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 52.1 m -152.58 161.92 27.91 Favored Pre-proline 0 C--N 1.304 -1.38 0 O-C-N 121.958 -0.464 . . . . 62.21 110.58 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -84.4 -2.55 9.98 Favored 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 122.392 2.061 . . . . 75.41 110.322 173.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.454 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 23.3 mmt180 -84.73 145.67 44.77 Favored Pre-proline 0 N--CA 1.44 -0.935 0 N-CA-C 106.81 -1.552 . . . . 72.31 106.81 177.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.88 162.48 41.96 Favored 'Trans proline' 0 C--O 1.246 0.878 0 C-N-CA 122.148 1.899 . . . . 72.52 111.874 177.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -57.11 126.03 25.35 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.298 -0.864 . . . . 55.13 111.679 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 116.64 -17.45 13.66 Favored Glycine 0 C--N 1.309 -0.938 0 C-N-CA 120.917 -0.658 . . . . 70.02 111.903 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -78.18 144.77 36.05 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.346 -0.983 . . . . 53.33 108.346 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 64.0 t -95.03 121.51 45.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 O-C-N 121.675 -0.64 . . . . 74.22 110.409 176.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 36.6 m -72.59 -40.85 66.25 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 124.588 1.155 . . . . 75.41 110.85 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 500' ' ' VAL . . . 162.16 -157.31 29.13 Favored Glycine 0 N--CA 1.432 -1.577 0 N-CA-C 110.602 -0.999 . . . . 75.43 110.602 -178.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 57.7 p -118.89 151.86 37.35 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.046 -0.724 . . . . 63.43 109.046 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -73.24 -54.4 4.28 Favored Pre-proline 0 C--N 1.313 -1.0 0 CA-C-O 119.44 -0.314 . . . . 74.1 110.712 177.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -74.06 143.24 32.2 Favored 'Trans proline' 0 C--N 1.36 1.164 0 N-CA-C 109.089 -1.158 . . . . 73.3 109.089 170.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.26 149.82 85.04 Favored 'Trans proline' 0 C--O 1.253 1.241 0 C-N-CA 122.313 2.008 . . . . 73.41 112.448 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -65.89 144.31 56.88 Favored 'General case' 0 C--O 1.249 1.049 0 N-CA-C 109.574 -0.528 . . . . 55.21 109.574 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.8 -12.5 57.82 Favored Glycine 0 N--CA 1.423 -2.195 0 C-N-CA 120.23 -0.985 . . . . 74.42 111.489 -176.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 54.2 m -66.59 120.94 14.28 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.251 -0.648 . . . . 63.3 109.251 176.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 41.1 m -85.32 122.61 29.74 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 108.614 -0.884 . . . . 64.05 108.614 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.61 158.26 70.61 Favored Pre-proline 0 C--N 1.311 -1.082 0 N-CA-C 108.834 -0.802 . . . . 73.43 108.834 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -64.78 149.18 90.04 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.073 1.849 . . . . 74.31 110.921 174.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.541 ' HB ' ' O ' ' A' ' 516' ' ' GLY . 36.0 m -63.14 -20.14 25.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-O 121.952 0.882 . . . . 54.21 111.6 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -77.43 -16.16 58.95 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.416 -1.266 . . . . 71.53 110.768 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 42.3 m -81.79 158.6 24.06 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 121.273 0.559 . . . . 62.21 111.784 -176.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 92.1 t -89.03 128.74 40.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 115.073 -0.967 . . . . 64.43 110.159 -178.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 551' ' ' ILE . . . . . 0.49 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -100.05 132.77 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 108.023 -1.102 . . . . 62.53 108.023 171.472 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -103.24 115.91 31.46 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-O 121.536 0.684 . . . . 71.45 111.329 -176.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 553' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 1.9 mm? -98.3 133.79 42.21 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.275 -1.329 . . . . 73.31 109.03 -179.049 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 554' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 523' ' ' ALA . 48.7 mt-30 -97.62 121.79 39.94 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.517 -0.549 . . . . 65.45 109.517 176.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 48.3 t -103.63 137.53 31.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 115.573 -0.74 . . . . 53.32 110.373 -173.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.454 ' HB3' ' HB2' ' A' ' 529' ' ' ARG . 22.0 m -69.58 129.47 39.76 Favored 'General case' 0 N--CA 1.427 -1.612 0 C-N-CA 124.071 0.948 . . . . 72.53 112.211 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -110.57 123.02 49.18 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 106.502 -1.666 . . . . 75.4 106.502 170.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -80.23 -30.38 41.89 Favored Glycine 0 C--N 1.311 -0.841 0 C-N-CA 120.984 -0.627 . . . . 74.1 113.845 -172.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 73.52 -2.52 2.73 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.687 1.195 . . . . 73.4 112.152 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.438 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 87.5 mt-30 -113.25 141.95 46.39 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.767 0.317 . . . . 52.44 110.859 -176.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -125.41 136.51 53.49 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.026 -0.533 . . . . 74.42 109.816 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 59.1 t -68.89 116.01 8.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 120.999 0.428 . . . . 34.35 110.612 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 59.5 ttp -97.1 132.01 26.52 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 109.148 -0.686 . . . . 62.12 109.148 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.85 168.99 15.61 Favored 'Trans proline' 0 C--O 1.244 0.787 0 C-N-CA 122.255 1.97 . . . . 52.02 111.045 176.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 565' ' ' ASP . . . . . 0.404 ' HA ' ' HB1' ' A' ' 610' ' ' ALA . 9.5 p-10 -89.44 114.99 26.54 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-O 122.291 1.043 . . . . 63.44 112.395 -178.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 566' ' ' LEU . . . . . 0.487 HD23 ' HD2' ' A' ' 577' ' ' ARG . 4.5 mp -118.16 7.1 12.06 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 106.188 -1.782 . . . . 74.01 106.188 171.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 32.5 t -80.34 153.71 28.22 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 113.577 -1.647 . . . . 52.31 109.946 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 97.71 44.81 2.6 Favored Glycine 0 N--CA 1.432 -1.599 0 N-CA-C 110.293 -1.123 . . . . 60.42 110.293 -177.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 62.1 mtp -140.79 -176.79 4.79 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.41 -1.33 . . . . 74.15 107.41 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -97.03 156.41 16.37 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.072 -1.084 . . . . 71.4 108.072 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 571' ' ' TRP . . . . . 0.571 ' HA ' ' HB3' ' A' ' 574' ' ' ALA . 76.5 t-105 -59.01 -29.39 67.22 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 122.987 0.515 . . . . 74.35 111.204 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 31.4 m -62.57 -23.95 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 116.122 -0.49 . . . . 72.21 111.302 178.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 573' ' ' ASP . . . . . 0.537 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 1.3 m-20 -101.13 -25.88 13.87 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-N 115.983 -0.553 . . . . 74.41 110.524 176.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 574' ' ' ALA . . . . . 0.571 ' HB3' ' HA ' ' A' ' 571' ' ' TRP . . . -72.91 -33.35 65.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.724 -0.671 . . . . 53.43 112.26 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.444 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 32.4 tt0 -60.57 -49.6 89.24 Favored Pre-proline 0 CA--C 1.56 1.363 0 C-N-CA 120.237 -0.585 . . . . 63.13 111.05 176.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 576' ' ' PRO . . . . . 0.444 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 70.2 Cg_exo -56.22 -35.65 95.74 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 121.459 1.439 . . . . 75.43 111.999 171.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 37.0 mmt180 -59.27 -46.76 87.64 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 109.616 -0.512 . . . . 75.3 109.616 176.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.439 ' HB3' ' O ' ' A' ' 575' ' ' GLU . 6.6 tt -57.77 -46.62 84.31 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 125.011 1.324 . . . . 74.44 109.626 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 579' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 575' ' ' GLU . 64.8 mtt-85 -65.31 -44.33 88.21 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.072 -0.967 . . . . 73.3 111.157 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -69.78 -28.26 65.61 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.04 0.448 . . . . 62.44 112.074 -177.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 97.6 mt -84.35 -8.08 59.11 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.613 -0.267 . . . . 64.11 110.914 177.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 61.68 42.42 99.75 Favored Glycine 0 CA--C 1.505 -0.579 0 N-CA-C 110.85 -0.9 . . . . 61.35 110.85 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 83.2 t90 -71.32 135.13 47.23 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.246 0.546 . . . . 75.23 111.688 -176.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 23.3 m -147.42 102.85 3.5 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 108.365 -0.976 . . . . 51.51 108.365 174.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -161.64 -124.07 0.7 Allowed Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 111.241 -0.744 . . . . 60.52 111.241 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 586' ' ' MET . . . . . 0.49 ' HB3' HG12 ' A' ' 619' ' ' ILE . 0.1 OUTLIER -137.5 125.68 23.06 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.926 -0.768 . . . . 74.14 108.926 177.041 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 59.9 tp -97.24 117.58 31.77 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.818 -0.808 . . . . 63.02 108.818 176.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 588' ' ' ASP . . . . . 0.439 ' OD2' HD11 ' A' ' 619' ' ' ILE . 13.4 m-20 -101.24 101.94 12.73 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.157 -0.683 . . . . 75.0 109.157 174.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -88.04 126.43 35.09 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 106.352 -1.721 . . . . 74.24 106.352 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -73.67 -151.91 2.12 Favored Glycine 0 C--N 1.302 -1.336 0 CA-C-N 115.828 -0.624 . . . . 52.34 114.631 -177.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -58.82 143.65 46.74 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.371 0.605 . . . . 75.12 112.435 -177.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -94.2 124.74 38.41 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.398 -0.964 . . . . 73.24 108.398 175.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 47.5 t -123.08 117.77 52.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 109.177 -0.675 . . . . 71.42 109.177 -177.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -80.14 106.71 12.36 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.244 -0.65 . . . . 74.04 109.244 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -153.52 17.44 0.53 Allowed 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.93 -0.577 . . . . 72.25 110.584 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 99.96 101.53 2.39 Favored Glycine 0 N--CA 1.427 -1.939 0 N-CA-C 110.213 -1.155 . . . . 55.23 110.213 -175.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -60.9 -40.3 98.14 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-O 119.893 -0.393 . . . . 75.04 113.387 -176.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 15.6 m -56.99 -33.19 66.88 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.341 0.867 . . . . 73.55 113.341 -174.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -108.19 -10.59 15.38 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 112.993 0.738 . . . . 74.53 112.993 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 600' ' ' HIS . . . . . 0.415 ' C ' ' H ' ' A' ' 602' ' ' ARG . 68.9 m-70 -107.54 14.97 25.26 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.737 0.78 . . . . 73.42 110.929 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -81.47 15.35 2.09 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.762 -1.108 . . . . 74.41 108.371 175.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 602' ' ' ARG . . . . . 0.415 ' H ' ' C ' ' A' ' 600' ' ' HIS . 33.1 ttp180 -97.32 152.09 19.25 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.345 -0.843 . . . . 74.52 109.064 -175.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 10.0 p -65.26 137.16 25.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 O-C-N 123.45 0.469 . . . . 71.35 109.959 175.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 92.1 t -102.27 -52.95 7.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 120.36 -0.536 . . . . 73.53 109.561 177.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -154.07 164.32 38.67 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 107.789 -1.189 . . . . 65.32 107.789 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 606' ' ' GLN . . . . . 0.473 ' HA ' ' O ' ' A' ' 621' ' ' THR . 18.6 pt20 -143.88 155.1 43.97 Favored 'General case' 0 C--N 1.314 -0.976 0 O-C-N 124.097 0.873 . . . . 74.44 109.414 177.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . 0.278 81.8 m-20 -80.64 -55.46 0.72 Allowed Pre-proline 0 C--N 1.312 -1.062 0 N-CA-C 114.306 1.224 . . . . 74.53 114.306 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -85.85 107.83 0.94 Allowed 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.912 1.741 . . . . 41.5 109.287 173.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -70.38 144.93 52.15 Favored 'Trans proline' 0 C--O 1.243 0.756 0 C-N-CA 122.846 2.364 . . . . 72.24 113.467 -176.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 610' ' ' ALA . . . . . 0.404 ' HB1' ' HA ' ' A' ' 565' ' ' ASP . . . -68.67 137.58 54.28 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 108.562 -0.903 . . . . 64.54 108.562 175.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 99.81 -12.95 60.99 Favored Glycine 0 C--N 1.299 -1.481 0 N-CA-C 110.427 -1.069 . . . . 54.2 110.427 -175.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 25.8 m -106.78 162.82 13.45 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 107.898 -1.149 . . . . 74.54 107.898 178.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -72.19 117.18 6.21 Favored Glycine 0 N--CA 1.431 -1.635 0 N-CA-C 110.435 -1.066 . . . . 72.34 110.435 175.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.7 m -91.29 141.66 14.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.154 0.502 . . . . 63.23 110.55 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.609 HD21 HG22 ' A' ' 619' ' ' ILE . 8.9 p-10 -58.0 145.41 36.17 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 114.099 -1.409 . . . . 73.11 112.786 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -57.55 -25.25 59.65 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.483 1.113 . . . . 71.45 111.39 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -59.78 -45.26 92.84 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 115.351 -0.84 . . . . 74.2 109.261 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 79.12 12.17 84.32 Favored Glycine 0 N--CA 1.412 -2.915 0 N-CA-C 110.159 -1.176 . . . . 72.13 110.159 -175.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 619' ' ' ILE . . . . . 0.609 HG22 HD21 ' A' ' 615' ' ' ASN . 0.0 OUTLIER -70.39 126.29 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 108.335 -0.987 . . . . 25.23 108.335 -176.594 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.457 ' N ' HD13 ' A' ' 619' ' ' ILE . 7.5 tp -126.54 129.91 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.675 0 CA-C-N 115.645 -0.707 . . . . 74.23 110.991 -174.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 606' ' ' GLN . 39.7 m -104.66 127.19 52.34 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.27 -1.011 . . . . 74.31 108.27 175.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 96.0 mt -138.0 150.79 47.3 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 108.558 -0.905 . . . . 73.0 108.558 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -128.24 136.98 51.79 Favored 'General case' 0 C--N 1.278 -2.506 0 N-CA-C 107.295 -1.372 . . . . 74.03 107.295 172.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -141.9 165.61 26.99 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 104.42 -2.437 . . . . 75.04 104.42 170.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -61.26 -100.08 0.01 OUTLIER Glycine 0 C--N 1.301 -1.374 0 O-C-N 124.056 0.847 . . . . 73.11 113.683 -174.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 . . . . . 0 C--N 1.291 -1.941 0 N-CA-C 108.123 -1.066 . . . . 61.31 108.123 178.185 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.823 0 N-CA-C 110.939 -0.864 . . . . 61.25 110.939 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 8.9 tp -74.73 151.61 6.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 C-N-CA 123.146 0.578 . . . . 52.54 110.181 -177.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 1.6 m -61.33 148.65 40.61 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.745 -0.835 . . . . 70.11 108.745 178.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.433 ' HD2' ' N ' ' A' ' 358' ' ' ARG . 3.3 mpt_? -100.11 70.81 1.58 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.316 -0.624 . . . . 74.2 109.316 -176.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -98.7 146.4 25.91 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 108.504 -0.925 . . . . 54.42 108.504 178.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 34.5 m -117.24 145.92 22.39 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 108.896 -0.779 . . . . 61.04 108.896 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -95.35 121.5 37.08 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 106.01 -1.848 . . . . 75.15 106.01 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.407 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 63.7 t -97.39 121.58 58.13 Favored Pre-proline 0 C--N 1.291 -1.94 0 CA-C-N 114.942 -1.026 . . . . 72.33 110.849 -171.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 363' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 24.6 Cg_exo -63.5 158.26 46.5 Favored 'Trans proline' 0 C--O 1.242 0.688 0 C-N-CA 122.217 1.944 . . . . 71.4 110.229 177.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -103.42 168.85 8.9 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 120.355 -0.538 . . . . 73.42 109.898 -173.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 9.9 t -128.61 2.57 2.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-O 121.638 0.732 . . . . 74.41 109.15 -177.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.531 ' HD3' ' OG1' ' A' ' 402' ' ' THR . 16.8 ptt-85 -58.2 144.46 40.66 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.439 0.638 . . . . 63.31 111.723 178.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.4 -7.11 50.62 Favored Glycine 0 N--CA 1.425 -2.041 0 CA-C-N 115.004 -0.998 . . . . 72.42 111.607 -178.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -109.76 -87.89 0.51 Allowed 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 113.018 0.747 . . . . 74.44 113.018 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 81.3 p -159.44 159.51 33.7 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 109.213 -0.662 . . . . 73.51 109.213 -175.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 46.4 t -63.12 -40.5 97.78 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.788 -0.819 . . . . 73.31 108.788 175.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -63.92 -47.15 81.68 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 118.997 -0.525 . . . . 71.12 112.188 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -69.77 -35.88 75.28 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 119.721 -0.792 . . . . 75.35 110.607 -178.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -64.87 -51.26 62.99 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.789 -0.641 . . . . 44.1 109.935 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 68.5 mt -60.98 -46.27 96.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.687 -0.233 . . . . 63.55 110.591 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.83 -44.45 90.89 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 116.073 -0.512 . . . . 72.42 112.065 -176.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 28.3 m -67.67 -48.95 65.18 Favored 'General case' 0 C--O 1.249 1.067 0 CA-C-O 120.865 0.364 . . . . 41.13 111.068 -177.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.04 -40.44 94.79 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.092 0.404 . . . . 65.53 112.092 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -66.62 -36.62 83.03 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.263 -0.426 . . . . 74.0 110.484 -177.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -70.16 -24.71 63.2 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 120.721 0.296 . . . . 71.13 111.727 176.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -86.91 -8.69 57.02 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.087 0.47 . . . . 73.32 111.389 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 97.83 4.15 57.96 Favored Glycine 0 C--N 1.309 -0.922 0 C-N-CA 120.378 -0.915 . . . . 65.02 112.306 176.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -79.91 148.37 31.29 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 109.129 -0.693 . . . . 71.03 109.129 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -95.01 132.67 39.62 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 107.704 -1.221 . . . . 75.13 107.704 -177.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 1.4 pp -118.83 131.07 72.68 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 CA-C-O 121.755 0.788 . . . . 71.02 112.688 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -113.15 127.6 56.24 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 107.881 -1.155 . . . . 71.45 107.881 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 27.5 m -119.38 128.1 53.75 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 109.968 -0.382 . . . . 72.32 109.968 -177.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -111.3 119.76 39.97 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.645 -0.872 . . . . 74.12 108.645 176.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 11.4 pm0 -100.57 122.72 43.72 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.054 -0.721 . . . . 74.31 109.054 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 389' ' ' LYS . . . . . 0.409 ' HB2' HG13 ' A' ' 394' ' ' ILE . 68.2 mttm -119.63 134.36 23.86 Favored Pre-proline 0 C--N 1.293 -1.877 0 CA-C-N 115.96 -0.564 . . . . 72.43 110.004 -177.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.49 ' O ' HD11 ' A' ' 394' ' ' ILE . 11.1 Cg_exo -72.52 157.47 52.73 Favored 'Trans proline' 0 C--O 1.248 0.979 0 C-N-CA 121.935 1.757 . . . . 73.1 110.116 175.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 32.7 t70 88.34 152.6 0.05 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 125.267 1.427 . . . . 73.1 111.938 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 17.9 m -101.5 13.0 36.32 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 113.262 0.838 . . . . 73.33 113.262 -174.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 26.9 m -76.03 -25.93 56.13 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.654 -1.239 . . . . 71.42 107.654 172.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.49 HD11 ' O ' ' A' ' 390' ' ' PRO . 0.0 OUTLIER -88.82 149.45 43.71 Favored Pre-proline 0 N--CA 1.433 -1.313 0 CA-C-N 114.764 -1.107 . . . . 73.31 108.67 172.524 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 395' ' ' PRO . . . . . 0.442 ' HA ' ' HD3' ' A' ' 396' ' ' PRO . 27.9 Cg_endo -63.31 133.66 41.5 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.198 2.599 . . . . 74.23 114.709 -174.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 396' ' ' PRO . . . . . 0.444 ' HA ' ' HB3' ' A' ' 421' ' ' SER . 53.8 Cg_exo -55.5 163.03 5.47 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 124.268 3.312 . . . . 72.02 111.934 175.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -56.47 -8.1 0.49 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.729 0.812 . . . . 53.51 113.165 -175.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 398' ' ' HIS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 32.7 m170 -83.26 104.21 13.25 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 105.248 -2.13 . . . . 74.3 105.248 168.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.407 HG23 ' HA ' ' A' ' 366' ' ' ARG . 25.2 m -64.92 120.18 11.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 CA-C-N 114.798 -1.092 . . . . 72.34 111.216 -168.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 9.8 tp -98.17 -29.22 3.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 120.519 -0.472 . . . . 53.15 110.244 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.81 157.98 27.53 Favored Glycine 0 N--CA 1.428 -1.861 0 N-CA-C 110.867 -0.893 . . . . 75.4 110.867 -177.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.531 ' OG1' ' HD3' ' A' ' 366' ' ' ARG . 17.3 p -139.43 -177.69 5.05 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 124.213 1.005 . . . . 64.32 109.246 -177.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 403' ' ' ASP . . . . . 0.457 ' HA ' ' HD3' ' A' ' 404' ' ' PRO . 16.8 t70 -101.17 133.48 20.93 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 107.342 -1.355 . . . . 71.34 107.342 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 404' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 403' ' ' ASP . 17.4 Cg_exo -67.76 11.02 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 123.473 2.782 . . . . 71.41 115.147 -173.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.86 -49.12 71.92 Favored 'General case' 0 C--O 1.216 -0.686 0 N-CA-C 109.756 -0.461 . . . . 52.42 109.756 176.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -69.82 -30.96 68.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.522 0.677 . . . . 64.33 110.239 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -76.8 -6.67 53.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.741 0.781 . . . . 74.43 110.354 -176.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 31.9 m -101.73 155.97 17.79 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 106.337 -1.727 . . . . 53.54 106.337 174.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 46.0 m -74.49 112.06 10.29 Favored 'General case' 0 N--CA 1.415 -2.197 0 N-CA-C 107.485 -1.302 . . . . 61.43 107.485 177.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 24.2 m -128.33 162.13 35.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 110.274 -0.269 . . . . 73.3 110.274 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 11.4 m -67.14 131.65 46.23 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.75 -0.833 . . . . 62.23 108.75 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -59.94 136.94 58.17 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 112.719 0.637 . . . . 73.42 112.719 -174.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 88.92 49.36 3.59 Favored Glycine 0 N--CA 1.434 -1.497 0 CA-C-N 114.887 -1.051 . . . . 71.41 111.599 -178.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -103.64 -173.66 2.36 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.688 -0.856 . . . . 75.15 108.688 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -109.08 120.66 43.19 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 123.274 0.629 . . . . 74.32 110.009 -176.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 48.6 mm -110.7 122.47 65.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 109.086 -0.709 . . . . 73.14 109.086 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 41.6 m -101.46 131.15 47.73 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.86 0.362 . . . . 72.41 111.301 -178.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 4.8 p -126.58 135.94 62.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 123.829 0.852 . . . . 74.33 109.643 -179.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -113.75 125.34 54.0 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.181 0.515 . . . . 63.44 109.855 176.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 22.0 m -124.72 150.3 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.185 0 CA-C-N 115.097 -0.956 . . . . 72.22 111.483 -176.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 421' ' ' SER . . . . . 0.444 ' HB3' ' HA ' ' A' ' 396' ' ' PRO . 16.3 t -88.77 145.57 25.53 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.214 1.007 . . . . 70.13 112.473 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.3 p -117.14 157.83 25.26 Favored 'General case' 0 N--CA 1.412 -2.369 0 CA-C-N 113.207 -1.815 . . . . 72.33 106.191 171.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -41.7 162.07 0.02 OUTLIER Glycine 0 C--O 1.259 1.667 0 N-CA-C 116.997 1.559 . . . . 40.13 116.997 -175.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.15 156.68 28.58 Favored 'Trans proline' 0 C--O 1.253 1.268 0 C-N-CA 123.864 3.043 . . . . 73.15 112.841 -176.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -87.6 165.65 15.29 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.435 -0.802 . . . . 65.54 111.347 -176.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -89.44 159.25 17.38 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 106.924 -1.509 . . . . 64.13 106.924 175.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -121.13 142.15 50.13 Favored 'General case' 0 CA--C 1.486 -1.483 0 C-N-CA 119.809 -0.756 . . . . 75.32 111.992 -178.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 11.2 pt-20 -83.09 131.83 35.13 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.172 -1.377 . . . . 74.32 110.191 -176.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 60.6 mt -88.52 127.77 55.37 Favored Pre-proline 0 C--N 1.305 -1.346 0 N-CA-C 108.722 -0.844 . . . . 71.53 108.722 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -71.41 142.82 41.68 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 121.624 1.55 . . . . 54.14 110.152 174.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -77.89 115.14 17.41 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.443 -0.577 . . . . 71.34 109.443 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 48.0 t -109.85 146.17 15.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 108.237 -1.023 . . . . 62.33 108.237 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 2.5 p -67.32 153.04 44.61 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 122.915 0.486 . . . . 64.44 112.105 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 434' ' ' THR . . . . . 0.421 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 18.6 p -65.15 -31.77 73.12 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 113.302 0.853 . . . . 75.04 113.302 -173.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 2.2 pp -82.13 -10.95 59.01 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 112.272 0.471 . . . . 74.43 112.272 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.542 HG22 ' HB3' ' A' ' 439' ' ' GLU . 3.7 m -103.96 44.84 0.99 Allowed 'General case' 0 CA--C 1.563 1.463 0 CA-C-O 121.722 0.772 . . . . 73.15 110.214 -177.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -52.36 -38.22 58.21 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.153 0.981 . . . . 65.33 112.457 177.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -60.04 -42.7 95.01 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.551 0.691 . . . . 44.32 110.559 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.542 ' HB3' HG22 ' A' ' 436' ' ' THR . 36.7 tt0 -70.91 -35.64 72.37 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.724 -0.671 . . . . 65.11 110.47 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.564 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -60.18 -49.39 77.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.124 -0.489 . . . . 53.23 110.884 -178.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.7 m -66.05 -39.52 84.73 Favored 'Isoleucine or valine' 0 C--O 1.25 1.107 0 N-CA-C 112.292 0.478 . . . . 70.1 112.292 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.416 ' HG3' ' HA ' ' A' ' 439' ' ' GLU . 0.0 OUTLIER -68.31 -34.65 76.52 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 119.751 -0.78 . . . . 70.23 112.083 177.546 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -64.09 -38.85 92.56 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.54 -0.3 . . . . 75.23 110.738 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 92.9 mt -63.46 -39.67 95.08 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.962 -0.563 . . . . 74.02 110.219 178.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.514 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 15.7 m -70.89 -39.3 72.88 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.929 -0.578 . . . . 41.23 111.197 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.98 -20.96 64.18 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.384 0.611 . . . . 73.14 110.94 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -85.69 5.35 32.48 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 115.53 -0.759 . . . . 73.32 111.923 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 110.22 -85.13 0.39 Allowed Glycine 0 CA--C 1.491 -1.418 0 C-N-CA 120.052 -1.07 . . . . 62.33 112.054 175.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -35.3 -62.36 0.39 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.4 1.259 . . . . 73.42 114.4 176.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 450' ' ' GLY . . . . . 0.514 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 58.39 26.17 58.89 Favored Glycine 0 CA--C 1.504 -0.622 0 C-N-CA 121.343 -0.456 . . . . 74.23 113.183 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.471 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 21.9 mmt180 -105.3 110.8 23.3 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 107.892 -1.151 . . . . 72.13 107.892 -177.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 33.1 p90 -140.66 152.46 45.39 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 116.315 -0.402 . . . . 63.03 110.132 -177.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -138.0 123.01 19.05 Favored 'General case' 0 C--N 1.291 -1.943 0 O-C-N 124.002 0.813 . . . . 75.33 109.392 176.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -87.26 126.58 34.92 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.292 -1.003 . . . . 71.21 108.292 178.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.09 146.1 43.35 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 107.276 -1.379 . . . . 54.43 107.276 177.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -120.03 140.24 51.3 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 109.477 -0.564 . . . . 73.41 109.477 -175.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 457' ' ' SER . . . . . 0.419 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 49.4 m -147.69 132.59 8.98 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 109.489 -0.559 . . . . 63.45 109.489 174.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.626 ' HA ' ' O ' ' A' ' 490' ' ' SER . 38.9 Cg_exo -64.75 122.73 10.67 Favored 'Trans proline' 0 C--O 1.238 0.505 0 C-N-CA 122.225 1.95 . . . . 72.42 110.684 177.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 17.6 m -143.4 175.03 10.23 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 108.142 -1.059 . . . . 61.33 108.142 -176.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.9 t -47.6 139.36 8.56 Favored Pre-proline 0 C--O 1.249 1.076 0 C-N-CA 124.259 1.023 . . . . 52.44 112.251 178.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.13 -29.29 28.12 Favored 'Trans proline' 0 C--N 1.36 1.175 0 C-N-CA 124.74 3.626 . . . . 75.41 113.612 -177.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.25 -22.87 63.82 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 112.089 0.403 . . . . 75.54 112.089 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -104.25 -8.91 18.98 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 111.681 0.252 . . . . 61.01 111.681 178.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 98.6 t -60.84 127.25 20.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.974 0.416 . . . . 72.55 110.179 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.05 -16.18 60.19 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.934 -0.576 . . . . 73.43 112.41 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -107.63 166.04 10.97 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 108.352 -0.981 . . . . 75.51 108.352 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.421 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 75.2 t -76.72 143.08 13.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 108.571 -0.9 . . . . 75.44 108.571 176.011 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 63.8 mt -98.18 -30.9 3.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 107.961 -1.125 . . . . 75.02 107.961 177.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 167.17 179.26 40.03 Favored Glycine 0 N--CA 1.425 -2.096 0 N-CA-C 110.862 -0.895 . . . . 74.55 110.862 177.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 470' ' ' THR . . . . . 0.552 HG22 HG12 ' A' ' 486' ' ' ILE . 59.2 p -115.64 140.66 48.98 Favored 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 107.41 -1.329 . . . . 63.41 107.41 177.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.51 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 7.2 t30 -63.7 -50.31 72.31 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 120.756 -0.377 . . . . 44.21 110.471 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.51 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 1.4 Cg_endo -88.35 152.87 6.65 Favored 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 121.593 1.529 . . . . 74.41 108.94 171.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -63.74 126.76 18.1 Favored 'Trans proline' 0 C--O 1.243 0.726 0 C-N-CA 121.313 1.342 . . . . 72.42 111.681 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -93.88 14.38 19.66 Favored 'General case' 0 C--O 1.202 -1.432 0 CA-C-O 121.68 0.753 . . . . 75.43 110.12 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -110.02 -1.99 17.31 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.715 -0.675 . . . . 75.12 109.318 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -109.75 174.68 5.75 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.36 -0.836 . . . . 70.23 112.578 -173.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 2.5 m -86.33 114.32 23.02 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 114.108 -1.405 . . . . 72.02 108.776 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 15.7 m -109.42 148.08 31.72 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 109.877 -0.416 . . . . 71.34 109.877 -176.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.98 157.74 36.12 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.478 -0.328 . . . . 53.32 110.809 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 37.6 mm -72.35 -17.73 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-O 122.084 0.945 . . . . 72.45 110.518 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 2.7 p -99.52 5.47 46.08 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.898 -0.592 . . . . 73.52 111.437 177.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -84.61 129.97 34.78 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.519 -0.549 . . . . 73.11 109.519 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.471 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 42.7 t -102.43 120.59 52.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.748 -0.834 . . . . 73.55 108.748 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 28.3 m -100.66 120.92 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-O 122.022 0.915 . . . . 70.2 111.239 -178.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.403 HG23 ' HB3' ' A' ' 471' ' ' ASN . 0.0 OUTLIER -95.51 128.99 46.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 109.352 -0.61 . . . . 61.03 109.352 178.87 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.552 HG12 HG22 ' A' ' 470' ' ' THR . 9.8 mt -120.36 128.14 75.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 C-N-CA 124.393 1.077 . . . . 61.01 110.267 -174.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 6.4 tt -100.85 127.17 54.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 C-N-CA 122.587 0.355 . . . . 64.44 111.342 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 34.3 m -113.07 152.17 14.84 Favored 'Isoleucine or valine' 0 C--O 1.254 1.3 0 C-N-CA 123.347 0.659 . . . . 54.1 110.241 178.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -81.24 130.91 10.02 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 121.042 -0.599 . . . . 52.21 113.537 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.626 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 35.6 t -114.82 160.02 19.95 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 106.067 -1.827 . . . . 43.24 106.067 176.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -172.84 95.37 0.1 Allowed Glycine 0 C--N 1.316 -0.571 0 C-N-CA 120.078 -1.058 . . . . 73.34 112.712 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.58 134.26 9.81 Favored 'Trans proline' 0 C--O 1.249 1.026 0 C-N-CA 122.831 2.354 . . . . 73.02 111.091 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -129.19 32.32 4.73 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-O 121.879 0.847 . . . . 75.53 110.582 -177.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 546' ' ' PRO . 19.6 p -118.12 142.13 47.75 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 114.686 -1.143 . . . . 74.33 109.885 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? -139.65 163.2 33.2 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.393 -0.595 . . . . 75.12 109.393 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.4 p-10 -85.74 138.81 31.84 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.809 -0.632 . . . . 71.04 110.001 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 38.2 pt -88.1 133.74 36.47 Favored Pre-proline 0 C--N 1.295 -1.771 0 C-N-CA 120.536 -0.465 . . . . 72.42 109.823 175.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -87.04 175.18 5.05 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.649 2.233 . . . . 74.21 111.819 177.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -92.63 157.24 16.6 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.547 -0.909 . . . . 73.01 108.547 177.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.456 HG21 ' HA ' ' A' ' 508' ' ' ALA . 9.4 p -159.97 12.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.256 0 CA-C-O 121.531 0.681 . . . . 65.34 111.587 -177.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -74.59 95.05 2.74 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 121.417 0.627 . . . . 75.33 110.947 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 159.64 -22.64 0.28 Allowed Glycine 0 N--CA 1.427 -1.914 0 CA-C-N 115.39 -0.823 . . . . 74.01 111.497 -177.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -102.11 -177.85 3.53 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.02 -0.672 . . . . 70.01 109.241 176.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 20.3 p -83.41 158.93 21.92 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 110.036 -0.357 . . . . 70.31 110.036 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.491 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 9.5 p -52.99 -41.14 39.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 O-C-N 123.703 0.627 . . . . 73.54 111.92 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 506' ' ' ASP . . . . . 0.481 ' O ' ' HD3' ' A' ' 510' ' ' LYS . 3.4 m-20 -57.57 -42.02 82.26 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.746 0.419 . . . . 74.14 111.166 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 59.4 t -68.85 -38.29 78.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.231 0.538 . . . . 72.4 109.888 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 508' ' ' ALA . . . . . 0.456 ' HA ' HG21 ' A' ' 500' ' ' VAL . . . -62.96 -44.09 97.01 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.633 -0.712 . . . . 53.3 110.821 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.491 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 26.5 mt-30 -60.18 -39.58 86.97 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.0 -0.545 . . . . 72.13 110.836 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.481 ' HD3' ' O ' ' A' ' 506' ' ' ASP . 14.4 mptt -65.88 -50.62 63.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.698 -0.683 . . . . 72.33 111.047 177.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -61.89 -40.89 97.0 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 116.394 -0.367 . . . . 75.43 111.474 -177.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 94.0 mt -62.71 -44.76 95.38 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 110.358 -0.238 . . . . 73.01 110.358 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -60.46 -41.45 94.18 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.017 -0.538 . . . . 60.13 110.88 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 510' ' ' LYS . 73.5 t -57.85 -36.46 55.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.871 -0.604 . . . . 72.02 111.71 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -87.18 0.26 55.6 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.249 -0.58 . . . . 75.14 112.365 -177.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 98.97 14.16 37.5 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.754 -0.736 . . . . 75.24 113.719 175.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -101.03 110.19 22.19 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.344 -0.984 . . . . 74.43 108.344 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.39 -14.66 22.31 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 116.011 -0.54 . . . . 54.04 111.871 -175.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 519' ' ' LYS . . . . . 0.507 ' HD2' ' O ' ' A' ' 548' ' ' ASP . 99.2 mttt -108.03 115.5 30.25 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.608 0.718 . . . . 72.32 111.871 -175.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -130.21 150.94 51.23 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.084 -0.962 . . . . 53.34 109.65 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 521' ' ' SER . . . . . 0.531 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 51.1 m -136.42 140.55 43.25 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 106.983 -1.488 . . . . 73.05 106.983 174.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -122.97 125.21 44.84 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.544 0.688 . . . . 75.01 112.35 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -116.33 116.49 27.83 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.728 -1.124 . . . . 75.24 108.047 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 524' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 12.4 p -91.8 130.18 37.62 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.148 0.499 . . . . 51.41 111.173 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 27.2 m -121.89 158.54 25.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.252 -1.018 . . . . 75.43 108.252 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -73.35 137.72 44.92 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 119.87 -0.732 . . . . 71.2 109.189 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 24.6 m -148.35 171.06 6.73 Favored Pre-proline 0 C--N 1.287 -2.142 0 N-CA-C 107.941 -1.133 . . . . 73.2 107.941 -178.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -81.61 -11.08 11.75 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 121.508 1.472 . . . . 70.14 110.783 172.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.467 ' HD3' ' OE2' ' A' ' 533' ' ' GLU . 88.4 mtt180 -80.91 145.39 57.18 Favored Pre-proline 0 N--CA 1.444 -0.735 0 CA-C-N 115.276 -0.874 . . . . 71.21 108.932 178.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.26 151.47 82.16 Favored 'Trans proline' 0 C--O 1.253 1.235 0 C-N-CA 122.787 2.325 . . . . 64.25 112.855 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.682 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -62.43 112.12 2.31 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.932 -1.031 . . . . 70.24 111.739 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 134.11 -20.88 3.96 Favored Glycine 0 C--N 1.308 -0.977 0 C-N-CA 120.829 -0.701 . . . . 64.2 112.617 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 533' ' ' GLU . . . . . 0.467 ' OE2' ' HD3' ' A' ' 529' ' ' ARG . 34.3 tt0 -83.02 142.37 31.38 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.702 -0.481 . . . . 53.11 109.702 179.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 63.1 t -81.92 123.41 38.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 108.666 -0.864 . . . . 72.41 108.666 178.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 535' ' ' THR . . . . . 0.69 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 10.3 t -96.44 -19.74 18.94 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.36 -0.536 . . . . 73.14 110.742 -178.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 177.48 179.13 47.58 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.244 -0.979 . . . . 73.21 111.509 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 72.1 p -124.16 149.82 45.86 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.562 -1.273 . . . . 60.52 107.562 177.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.424 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 47.6 t30 -67.75 -59.82 6.25 Favored Pre-proline 0 C--N 1.323 -0.555 0 C-N-CA 120.548 -0.461 . . . . 74.11 109.931 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 57.2 Cg_endo -76.29 130.56 12.1 Favored 'Trans proline' 0 N--CA 1.44 -1.653 0 N-CA-C 108.298 -1.462 . . . . 63.54 108.298 170.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -66.63 150.69 83.73 Favored 'Trans proline' 0 C--O 1.255 1.371 0 C-N-CA 122.01 1.807 . . . . 75.31 112.178 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -58.98 142.74 50.27 Favored 'General case' 0 C--O 1.249 1.067 0 CA-C-N 115.759 -0.655 . . . . 72.54 109.787 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 102.9 -17.33 52.9 Favored Glycine 0 C--N 1.291 -1.917 0 C-N-CA 120.508 -0.853 . . . . 55.45 111.677 -179.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 61.5 m -68.9 127.49 33.28 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 109.959 -0.385 . . . . 65.2 109.959 178.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 20.6 m -91.62 122.99 34.68 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.384 -0.969 . . . . 64.24 108.384 177.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 29.4 m -137.37 161.26 61.84 Favored Pre-proline 0 C--N 1.311 -1.102 0 N-CA-C 109.033 -0.728 . . . . 50.04 109.033 -176.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 494' ' ' THR . 13.6 Cg_endo -61.33 151.68 77.65 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 121.809 1.673 . . . . 74.34 110.821 173.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 30.5 m -63.3 -20.31 25.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.596 0.712 . . . . 42.13 112.166 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 548' ' ' ASP . . . . . 0.507 ' O ' ' HD2' ' A' ' 519' ' ' LYS . 26.8 t70 -90.42 4.25 51.5 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.628 -0.715 . . . . 73.33 110.863 178.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.1 t -71.15 162.61 29.14 Favored 'General case' 0 C--O 1.241 0.62 0 O-C-N 121.474 -0.766 . . . . 71.03 109.402 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 18.0 t -109.32 116.75 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 CA-C-O 121.152 0.501 . . . . 74.45 109.961 -176.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 2.5 mp -91.95 123.86 44.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 109.124 -0.695 . . . . 55.21 109.124 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 552' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 521' ' ' SER . 37.7 tt0 -102.87 120.14 40.08 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-O 121.056 0.455 . . . . 73.24 110.029 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -96.65 134.27 40.11 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.96 -1.018 . . . . 71.13 109.817 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -92.47 114.88 27.56 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.513 -1.291 . . . . 74.14 107.513 171.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 524' ' ' SER . 47.6 t -100.73 141.72 17.01 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.39 0 N-CA-C 108.684 -0.858 . . . . 72.42 108.684 -177.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.69 ' OG ' ' HB ' ' A' ' 535' ' ' THR . 71.7 m -81.45 138.76 35.5 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-O 121.124 0.488 . . . . 73.04 111.75 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.11 135.72 52.4 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 105.678 -1.971 . . . . 73.01 105.678 169.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -71.12 -41.95 59.45 Favored Glycine 0 CA--C 1.497 -1.039 0 N-CA-C 111.297 -0.721 . . . . 64.54 111.297 -175.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 65.4 t30 66.43 8.12 5.49 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.686 1.194 . . . . 75.5 111.21 175.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -113.78 162.3 16.48 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.127 -0.942 . . . . 71.21 109.152 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -137.19 144.92 43.12 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.414 -0.588 . . . . 74.43 109.414 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 96.8 t -72.83 122.61 25.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 123.528 0.517 . . . . 45.11 110.233 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 48.7 ttm -78.22 126.11 83.96 Favored Pre-proline 0 C--N 1.308 -1.231 0 CA-C-N 115.714 -0.676 . . . . 42.43 109.964 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.3 169.33 18.57 Favored 'Trans proline' 0 C--O 1.243 0.774 0 C-N-CA 122.569 2.18 . . . . 64.01 110.7 176.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -83.08 119.7 24.82 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.834 0.826 . . . . 71.22 111.338 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 95.0 mt -127.34 14.04 7.15 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.083 -1.417 . . . . 73.42 107.453 176.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 9.3 m -72.04 130.7 41.56 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.431 -1.258 . . . . 71.41 109.356 -178.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 85.02 22.91 51.24 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.345 -0.931 . . . . 64.3 112.028 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 87.9 mtp -116.14 -178.91 3.52 Favored 'General case' 0 C--O 1.25 1.105 0 N-CA-C 109.282 -0.636 . . . . 74.0 109.282 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 570' ' ' PHE . . . . . 0.409 ' HB3' ' OD1' ' A' ' 601' ' ' ASN . 97.1 m-85 -97.47 153.17 18.3 Favored 'General case' 0 N--CA 1.414 -2.226 0 N-CA-C 109.176 -0.676 . . . . 75.11 109.176 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 64.1 t90 -64.57 -27.37 68.91 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 123.441 0.697 . . . . 70.21 110.142 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 10.3 p -71.66 -16.44 18.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.779 -0.646 . . . . 73.11 109.694 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 573' ' ' ASP . . . . . 0.509 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 22.9 m-20 -101.14 -44.91 5.54 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.6 -0.519 . . . . 73.22 109.6 176.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -62.91 -52.68 62.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.596 -0.729 . . . . 72.34 112.664 -175.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.464 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 4.1 tm-20 -55.55 -52.11 74.59 Favored Pre-proline 0 CA--C 1.567 1.623 0 C-N-CA 122.784 0.434 . . . . 74.54 111.851 -176.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 576' ' ' PRO . . . . . 0.464 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 52.3 Cg_exo -61.12 -29.46 87.25 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 121.785 1.657 . . . . 44.42 113.038 174.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.542 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 20.0 mmt180 -66.43 -40.41 89.51 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 111.479 0.177 . . . . 73.54 111.479 178.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.13 -45.53 90.68 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.202 0.525 . . . . 64.54 109.952 177.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -59.68 -39.64 85.18 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.362 -0.835 . . . . 65.11 110.961 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.29 -21.39 62.95 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.341 -0.39 . . . . 44.42 111.717 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 581' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 92.3 mt -82.66 -6.8 59.57 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 120.956 0.407 . . . . 54.42 111.43 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 88.36 20.07 50.07 Favored Glycine 0 C--O 1.238 0.37 0 C-N-CA 120.135 -1.031 . . . . 60.14 111.495 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 89.9 t90 -70.92 129.84 40.07 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.006 -0.738 . . . . 72.5 109.006 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 1.2 m -127.56 13.92 7.02 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.606 -0.516 . . . . 63.34 109.606 -176.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 585' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -88.98 -156.82 32.07 Favored Glycine 0 CA--C 1.498 -1.029 0 C-N-CA 120.538 -0.839 . . . . 44.31 114.987 -173.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 50.0 ttm -108.1 131.36 54.7 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 122.873 0.469 . . . . 73.21 111.37 -178.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -101.37 128.96 47.32 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.653 -1.24 . . . . 64.13 107.653 176.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -107.0 122.36 46.28 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 116.2 -0.454 . . . . 75.41 109.837 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -90.28 132.97 35.24 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.404 -0.816 . . . . 71.33 110.158 -178.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -85.34 177.64 50.42 Favored Glycine 0 N--CA 1.431 -1.682 0 C-N-CA 120.987 -0.625 . . . . 64.11 112.227 175.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -72.53 144.74 47.85 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 123.067 0.547 . . . . 63.11 111.451 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -63.42 151.35 41.29 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.866 -0.607 . . . . 74.11 111.402 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 47.0 t -138.39 116.97 13.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 107.954 -1.128 . . . . 72.02 107.954 -178.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -74.43 124.06 25.84 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.085 -1.08 . . . . 73.13 108.085 177.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -160.19 12.9 0.12 Allowed 'General case' 0 C--O 1.244 0.801 0 N-CA-C 112.376 0.51 . . . . 74.21 112.376 -176.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 89.8 166.67 41.79 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.172 -1.013 . . . . 50.02 112.086 -178.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -59.56 -48.23 87.04 Favored Glycine 0 CA--C 1.519 0.301 0 N-CA-C 114.724 0.649 . . . . 71.52 114.724 -175.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 28.2 m -61.23 -25.22 66.92 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-O 121.224 0.535 . . . . 75.52 112.136 -176.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -108.36 -1.52 19.9 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 112.477 0.547 . . . . 75.44 112.477 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.53 -51.65 11.29 Favored 'General case' 0 C--O 1.195 -1.791 0 C-N-CA 119.624 -0.83 . . . . 74.04 111.864 -173.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 601' ' ' ASN . . . . . 0.409 ' OD1' ' HB3' ' A' ' 570' ' ' PHE . 16.7 t-20 -92.19 19.39 6.98 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 120.857 -1.152 . . . . 73.34 109.429 -177.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 20.0 tpp85 -91.08 139.77 30.45 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.015 -0.993 . . . . 63.3 109.936 -176.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 13.5 p -65.05 139.97 20.52 Favored 'Isoleucine or valine' 0 C--O 1.247 0.94 0 N-CA-C 108.597 -0.89 . . . . 63.44 108.597 175.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 95.5 t -100.15 -46.88 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.056 0 N-CA-C 108.427 -0.953 . . . . 64.41 108.427 -177.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -156.15 157.23 35.59 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 105.872 -1.899 . . . . 73.42 105.872 176.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -123.4 131.94 53.81 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 106.918 -1.512 . . . . 73.02 106.918 173.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.611 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 25.8 t-20 -50.8 -58.09 11.34 Favored Pre-proline 0 C--N 1.312 -1.028 0 CA-C-O 118.844 -0.598 . . . . 72.11 112.366 -177.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.611 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 11.1 Cg_endo -96.76 121.5 0.2 Allowed 'Trans proline' 0 N--CA 1.44 -1.674 0 C-N-CA 121.733 1.622 . . . . 75.45 109.716 173.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -66.46 158.36 55.79 Favored 'Trans proline' 0 C--O 1.25 1.077 0 C-N-CA 122.116 1.877 . . . . 72.11 112.277 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.86 130.91 47.92 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.854 -0.612 . . . . 62.31 110.679 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 104.29 -3.77 43.93 Favored Glycine 0 C--N 1.3 -1.425 0 C-N-CA 120.635 -0.793 . . . . 74.34 112.119 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 6.1 m -93.13 148.13 22.28 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.235 -0.654 . . . . 63.11 109.235 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -84.5 115.79 4.16 Favored Glycine 0 N--CA 1.425 -2.056 0 N-CA-C 109.272 -1.531 . . . . 61.4 109.272 175.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.4 m -100.98 143.7 13.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 C-N-CA 122.854 0.461 . . . . 52.01 111.067 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -44.4 166.53 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.637 1.975 . . . . 75.13 113.354 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.0 -26.08 61.93 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.943 0.401 . . . . 64.52 111.59 -176.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 617' ' ' ASP . . . . . 0.501 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 25.8 t70 -79.68 -37.23 36.27 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.592 -0.731 . . . . 75.21 109.315 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 81.42 22.76 59.83 Favored Glycine 0 N--CA 1.429 -1.789 0 C-N-CA 118.948 -1.596 . . . . 51.43 111.527 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.81 119.8 12.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 122.286 1.041 . . . . 65.42 109.165 -168.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.15 126.76 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-N 114.513 -1.221 . . . . 71.41 110.594 -172.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.527 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 32.2 m -100.9 125.8 47.48 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.128 -0.693 . . . . 74.43 109.128 175.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.5 pp -133.85 154.63 50.89 Favored 'General case' 0 CA--C 1.479 -1.759 0 N-CA-C 108.612 -0.885 . . . . 72.42 108.612 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -127.98 141.57 51.49 Favored 'General case' 0 C--N 1.257 -3.414 0 N-CA-C 105.43 -2.063 . . . . 72.24 105.43 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -137.41 166.82 22.91 Favored 'General case' 0 C--N 1.277 -2.561 0 N-CA-C 107.129 -1.434 . . . . 74.34 107.129 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -70.7 -137.34 0.14 Allowed Glycine 0 N--CA 1.427 -1.921 0 O-C-N 124.325 1.016 . . . . 65.01 115.343 -174.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 C--N 1.289 -2.05 0 CA-C-O 118.967 -0.54 . . . . 65.14 109.575 -171.159 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.818 0 N-CA-C 110.525 -1.03 . . . . 43.05 110.525 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 10.5 tp -76.03 145.93 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 N-CA-C 109.199 -0.667 . . . . 51.14 109.199 177.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.9 134.64 44.88 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 109.587 -0.523 . . . . 71.32 109.587 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -88.97 -21.22 23.64 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.786 -1.561 . . . . 53.33 106.786 176.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -86.36 150.62 24.2 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 106.019 -1.845 . . . . 73.44 106.019 174.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 31.4 m -115.51 154.14 16.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-O 121.633 0.73 . . . . 71.4 111.053 -172.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 361' ' ' GLN . . . . . 0.403 ' OE1' ' HA ' ' A' ' 407' ' ' ASN . 0.3 OUTLIER -94.92 136.77 34.83 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 106.425 -1.694 . . . . 74.43 106.425 -176.16 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.574 HG22 ' CZ ' ' A' ' 382' ' ' PHE . 98.0 t -95.12 118.63 66.49 Favored Pre-proline 0 C--N 1.297 -1.68 0 CA-C-N 116.028 -0.533 . . . . 74.3 110.773 -169.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 363' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 17.1 Cg_exo -64.59 130.92 27.86 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 123.027 2.485 . . . . 61.15 112.271 -178.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -93.66 121.16 34.8 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.238 -0.892 . . . . 70.34 110.342 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 5.7 m -104.65 23.91 2.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 122.005 0.907 . . . . 64.21 110.986 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.462 ' HA ' HG23 ' A' ' 399' ' ' VAL . 4.5 ppt_? -54.85 145.54 19.61 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.551 -1.204 . . . . 72.34 110.781 172.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.15 -11.8 51.94 Favored Glycine 0 C--N 1.302 -1.344 0 N-CA-C 110.356 -1.098 . . . . 71.3 110.356 -175.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -108.18 -151.66 0.47 Allowed 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 108.464 -0.939 . . . . 71.24 108.464 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 80.6 p -98.21 157.44 16.16 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.43 -0.582 . . . . 72.13 109.43 -174.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.5 p -63.67 -41.06 98.22 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 112.306 0.484 . . . . 75.24 112.306 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -67.14 -42.83 83.74 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-O 119.462 -0.304 . . . . 50.4 111.495 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.02 -35.12 74.09 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 119.558 -0.857 . . . . 62.41 110.594 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.22 -47.95 75.04 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.788 -0.642 . . . . 60.43 110.611 177.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.548 HG23 HG13 ' A' ' 384' ' ' ILE . 70.6 mt -61.71 -43.19 96.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-N 116.039 -0.528 . . . . 61.44 110.309 175.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.57 -44.77 89.87 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.126 -0.488 . . . . 74.43 110.112 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 87.9 m -60.74 -46.81 89.02 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.964 -0.562 . . . . 52.54 110.753 178.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 93.7 mt -62.98 -40.33 97.42 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.346 -0.388 . . . . 62.42 110.22 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 65.3 tp60 -62.12 -43.29 99.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.671 -0.695 . . . . 64.15 110.3 178.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -60.0 -31.85 70.31 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 120.982 0.42 . . . . 63.25 111.384 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -85.86 -12.24 51.23 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.957 -0.565 . . . . 75.41 111.751 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 94.49 14.57 50.08 Favored Glycine 0 C--N 1.307 -1.059 0 C-N-CA 120.761 -0.733 . . . . 61.33 112.701 177.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.574 ' CZ ' HG22 ' A' ' 362' ' ' VAL . 52.2 m-85 -81.04 150.82 28.67 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-O 121.076 0.465 . . . . 75.53 111.221 177.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.419 ' CB ' ' HG2' ' A' ' 415' ' ' GLU . 7.7 mmtp -84.49 144.78 28.49 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.854 -1.165 . . . . 75.2 107.854 175.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.548 HG13 HG23 ' A' ' 374' ' ' ILE . 0.2 OUTLIER -129.93 133.83 63.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-O 121.495 0.664 . . . . 74.15 111.015 -177.867 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 385' ' ' ARG . . . . . 0.463 ' NE ' ' HA ' ' A' ' 385' ' ' ARG . 3.6 tpm_? -115.89 147.13 41.43 Favored 'General case' 0 N--CA 1.41 -2.437 0 N-CA-C 106.519 -1.66 . . . . 72.4 106.519 173.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 39.1 m -129.55 127.64 41.13 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 109.507 -0.553 . . . . 75.15 109.507 -177.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -119.12 130.52 55.61 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 105.488 -2.042 . . . . 73.35 105.488 176.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 19.4 pm0 -121.55 135.9 54.98 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 118.452 0.569 . . . . 63.43 110.062 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -134.42 115.92 12.83 Favored Pre-proline 0 C--N 1.314 -0.952 0 C-N-CA 121.335 -0.146 . . . . 55.41 111.1 177.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.495 ' CA ' ' HB ' ' A' ' 422' ' ' THR . 64.8 Cg_endo -87.91 135.49 3.4 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.43 2.087 . . . . 74.51 111.146 174.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.537 ' HB3' HG12 ' A' ' 394' ' ' ILE . 13.1 t70 -179.82 153.65 0.54 Allowed 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 109.022 -0.733 . . . . 50.43 109.022 177.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 9.9 m -73.87 -18.53 60.91 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 123.186 0.594 . . . . 64.35 111.959 -177.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 3.1 m -87.63 -17.37 32.02 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-O 121.741 0.781 . . . . 65.31 109.975 -178.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.571 HG22 ' HB3' ' A' ' 421' ' ' SER . 45.4 mm -90.22 135.68 29.55 Favored Pre-proline 0 C--N 1.301 -1.513 0 CA-C-N 115.446 -0.797 . . . . 44.03 111.311 -171.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 395' ' ' PRO . . . . . 0.456 ' HB3' ' HD2' ' A' ' 396' ' ' PRO . 95.7 Cg_exo -50.14 179.0 0.02 OUTLIER 'Trans proline' 0 CA--C 1.585 3.072 1 C-N-CA 126.104 4.536 . . . . 71.11 116.021 179.223 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 396' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 395' ' ' PRO . 37.6 Cg_endo -67.14 160.96 44.98 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 123.191 2.594 . . . . 72.34 113.13 173.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -62.58 -6.24 3.3 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 124.591 1.156 . . . . 73.24 113.618 -177.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -65.6 158.04 28.23 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.946 -0.761 . . . . 64.4 108.946 177.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.462 HG23 ' HA ' ' A' ' 366' ' ' ARG . 6.4 m -86.36 117.77 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 C-N-CA 118.49 -1.284 . . . . 70.03 108.893 176.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 400' ' ' ILE . . . . . 0.413 HD12 ' N ' ' A' ' 401' ' ' GLY . 2.7 pp -88.96 -28.52 5.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 113.007 0.743 . . . . 53.31 113.007 -177.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 401' ' ' GLY . . . . . 0.413 ' N ' HD12 ' A' ' 400' ' ' ILE . . . -167.97 169.3 41.28 Favored Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 110.659 -0.976 . . . . 61.4 110.659 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 18.6 p -114.95 172.71 6.88 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.69 -0.856 . . . . 72.42 108.69 177.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -102.71 155.42 36.56 Favored Pre-proline 0 C--N 1.292 -1.9 0 N-CA-C 109.028 -0.73 . . . . 61.45 109.028 177.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -50.1 -20.13 4.98 Favored 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 124.043 3.162 . . . . 74.11 115.384 -175.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -62.23 -42.82 99.65 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 110.044 -0.354 . . . . 73.21 110.044 -178.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 406' ' ' ALA . . . . . 0.421 ' O ' ' HB ' ' A' ' 362' ' ' VAL . . . -71.3 -33.09 69.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.87 0.843 . . . . 60.3 109.741 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 407' ' ' ASN . . . . . 0.403 ' HA ' ' OE1' ' A' ' 361' ' ' GLN . 18.2 m120 -86.52 2.18 48.92 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.326 -0.852 . . . . 74.11 112.27 -176.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 36.3 m -103.21 152.16 21.8 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 105.783 -1.932 . . . . 65.31 105.783 172.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 24.6 m -74.8 112.85 11.43 Favored 'General case' 0 N--CA 1.429 -1.517 0 C-N-CA 119.56 -0.856 . . . . 52.42 109.252 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 35.1 m -113.36 169.06 5.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 121.048 0.451 . . . . 75.42 110.256 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 19.9 m -66.45 134.7 53.01 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.637 -0.875 . . . . 74.24 108.637 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -54.78 112.37 1.02 Allowed 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 122.994 0.518 . . . . 61.11 111.086 -178.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 105.49 27.74 5.68 Favored Glycine 0 N--CA 1.433 -1.552 0 C-N-CA 120.591 -0.814 . . . . 55.32 112.86 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -85.16 177.22 7.95 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.418 -0.956 . . . . 75.44 108.418 177.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 415' ' ' GLU . . . . . 0.419 ' HG2' ' CB ' ' A' ' 383' ' ' LYS . 27.5 mt-10 -97.87 110.88 23.37 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.65 0.738 . . . . 71.15 110.97 -172.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 44.9 mm -98.33 122.62 50.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 CA-C-N 115.064 -0.971 . . . . 75.24 108.977 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 417' ' ' THR . . . . . 0.423 HG22 ' HB3' ' A' ' 385' ' ' ARG . 15.6 p -89.22 130.73 35.58 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.831 -0.622 . . . . 75.4 111.419 -177.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 7.5 p -114.36 134.3 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 N-CA-C 109.118 -0.697 . . . . 73.23 109.118 175.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -106.03 115.39 30.15 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.993 -1.484 . . . . 64.41 106.993 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 48.6 t -106.93 130.64 58.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-O 122.047 0.927 . . . . 74.51 109.727 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 421' ' ' SER . . . . . 0.571 ' HB3' HG22 ' A' ' 394' ' ' ILE . 49.6 m -87.71 123.34 32.43 Favored 'General case' 0 C--N 1.273 -2.751 0 CA-C-N 114.164 -1.38 . . . . 43.15 108.746 179.038 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.495 ' HB ' ' CA ' ' A' ' 390' ' ' PRO . 6.2 m -106.08 157.6 17.42 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 108.131 -1.063 . . . . 45.25 108.131 -177.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -52.79 168.96 0.8 Allowed Glycine 0 CA--C 1.54 1.651 0 N-CA-C 116.645 1.418 . . . . 71.3 116.645 -173.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.93 144.0 86.89 Favored 'Trans proline' 0 C--O 1.247 0.944 0 C-N-CA 123.372 2.715 . . . . 73.14 110.573 178.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -88.24 145.55 25.82 Favored 'General case' 0 N--CA 1.42 -1.949 0 CA-C-O 121.575 0.702 . . . . 72.22 111.758 -175.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.405 ' HB3' HG22 ' A' ' 477' ' ' THR . 43.5 mt-30 -135.43 157.26 47.34 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 107.677 -1.231 . . . . 74.41 107.677 176.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.573 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 4.2 mmp_? -126.17 141.8 51.79 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.369 0.604 . . . . 71.4 111.152 176.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.402 ' H ' ' HG2' ' A' ' 428' ' ' GLU . 8.7 pt-20 -83.11 129.63 35.04 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 106.724 -1.584 . . . . 75.04 106.724 175.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 53.0 mt -80.42 131.22 62.37 Favored Pre-proline 0 N--CA 1.428 -1.556 0 N-CA-C 108.947 -0.76 . . . . 63.12 108.947 -174.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -69.35 140.72 44.96 Favored 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 121.468 1.446 . . . . 70.24 110.993 176.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -89.46 114.39 25.87 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.305 -1.368 . . . . 74.52 107.305 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.444 HG11 ' HB2' ' A' ' 440' ' ' ALA . 14.7 p -110.82 159.29 10.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 108.663 -0.866 . . . . 74.13 108.663 -175.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 22.6 p -68.31 137.76 54.91 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 108.141 -1.059 . . . . 63.33 108.141 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 434' ' ' THR . . . . . 0.426 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 18.3 p -63.38 -21.56 66.35 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 113.675 0.991 . . . . 74.12 113.675 -174.089 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.2 pp -78.2 -11.48 59.93 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 120.103 -0.639 . . . . 64.14 111.606 177.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.3 m -106.79 61.79 0.63 Allowed 'General case' 0 N--CA 1.432 -1.351 0 CA-C-O 121.725 0.774 . . . . 63.23 111.729 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -52.32 -38.25 58.08 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.363 1.065 . . . . 74.5 111.507 174.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -59.39 -42.53 91.9 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.34 0.591 . . . . 53.44 110.904 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -70.92 -36.89 72.86 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.574 -0.739 . . . . 74.44 109.23 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.527 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.03 -51.69 68.58 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.748 -0.66 . . . . 63.05 111.095 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 35.5 m -64.86 -40.73 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 N-CA-C 112.589 0.588 . . . . 51.41 112.589 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -68.77 -36.37 78.23 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 119.862 -0.735 . . . . 70.41 111.276 178.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -63.9 -41.86 97.59 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.27 -0.423 . . . . 74.22 110.908 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.527 HD13 ' O ' ' A' ' 440' ' ' ALA . 7.3 mp -63.75 -32.69 74.27 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.918 -0.583 . . . . 71.02 110.322 176.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 85.2 m -69.97 -44.9 68.52 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.653 -0.703 . . . . 64.31 110.293 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.22 -22.26 65.72 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.361 0.601 . . . . 71.35 110.814 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.83 5.09 14.58 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.44 -0.8 . . . . 71.31 112.321 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 104.31 -82.95 0.38 Allowed Glycine 0 CA--C 1.492 -1.366 0 C-N-CA 120.261 -0.971 . . . . 70.25 111.816 175.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -41.09 -56.16 2.4 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.012 1.116 . . . . 74.2 114.012 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 59.25 27.25 62.62 Favored Glycine 0 C--N 1.322 -0.202 0 C-N-CA 121.528 -0.368 . . . . 73.14 113.239 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -101.34 111.21 23.37 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 109.526 -0.546 . . . . 72.45 109.526 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.512 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 27.8 p90 -134.48 150.83 50.85 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 115.485 -0.78 . . . . 74.42 109.712 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 21.4 tptp -138.46 127.81 24.49 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 106.558 -1.645 . . . . 62.32 106.558 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -98.31 127.86 44.45 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.367 0.603 . . . . 74.3 111.938 -176.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 455' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -126.92 139.88 52.74 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.23 -1.026 . . . . 75.45 108.23 176.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -112.85 143.58 43.87 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.658 -0.867 . . . . 72.31 108.658 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 22.8 t -139.92 134.33 15.83 Favored Pre-proline 0 C--N 1.295 -1.779 0 N-CA-C 109.054 -0.721 . . . . 72.44 109.054 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 490' ' ' SER . 52.7 Cg_endo -74.27 128.15 11.83 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 121.859 1.706 . . . . 74.52 110.59 176.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 35.0 m -147.14 179.93 7.27 Favored 'General case' 0 C--N 1.288 -2.098 0 C-N-CA 123.247 0.619 . . . . 74.41 109.466 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.5 t -48.85 143.87 7.84 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 125.189 1.396 . . . . 74.24 112.148 178.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 461' ' ' PRO . . . . . 0.487 ' HA ' HG23 ' A' ' 464' ' ' VAL . 10.3 Cg_endo -51.68 -29.29 32.64 Favored 'Trans proline' 0 C--N 1.362 1.275 0 C-N-CA 124.761 3.64 . . . . 72.42 113.484 -178.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -74.89 -8.36 56.24 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 112.767 0.654 . . . . 65.43 112.767 -176.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -111.4 -6.93 14.41 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.969 0.359 . . . . 70.14 111.969 177.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.487 HG23 ' HA ' ' A' ' 461' ' ' PRO . 59.7 t -60.92 127.09 19.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.068 0.461 . . . . 74.01 111.736 -176.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.26 -8.12 77.74 Favored Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 115.754 -0.657 . . . . 33.24 112.49 177.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -108.06 151.68 25.53 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 109.826 -0.435 . . . . 74.43 109.826 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.44 HG22 HG12 ' A' ' 488' ' ' VAL . 67.1 t -68.68 142.92 15.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 106.41 -1.7 . . . . 73.41 106.41 170.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 60.0 mt -97.23 -35.22 5.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 108.704 -0.851 . . . . 64.22 108.704 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 164.99 -165.08 37.47 Favored Glycine 0 N--CA 1.418 -2.532 0 C-N-CA 120.43 -0.89 . . . . 33.11 111.292 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -143.37 149.92 38.4 Favored 'General case' 0 N--CA 1.408 -2.561 0 N-CA-C 107.453 -1.314 . . . . 61.44 107.453 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -67.49 -55.32 15.13 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 120.623 -0.431 . . . . 74.32 110.703 178.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -74.09 128.3 12.1 Favored 'Trans proline' 0 C--N 1.367 1.548 0 N-CA-C 108.009 -1.573 . . . . 72.22 108.009 169.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -62.54 129.85 27.92 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.248 1.966 . . . . 74.13 112.887 -176.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -81.98 13.68 3.21 Favored 'General case' 0 C--O 1.206 -1.188 0 CA-C-N 115.194 -0.912 . . . . 73.22 110.718 -178.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -110.07 0.13 18.25 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.583 0.706 . . . . 74.4 109.398 174.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -103.32 175.79 5.36 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.91 -0.587 . . . . 65.11 112.154 -176.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.405 HG22 ' HB3' ' A' ' 426' ' ' GLN . 2.3 m -98.38 114.43 26.77 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 108.056 -1.09 . . . . 53.41 108.056 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 23.0 p -110.02 147.01 34.33 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 116.283 -0.417 . . . . 62.34 110.057 -176.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -77.55 167.32 21.82 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.634 -0.257 . . . . 54.32 110.387 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 25.3 mm -71.61 -3.93 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-O 122.679 1.228 . . . . 62.42 110.398 -176.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 1.5 p -104.76 5.99 33.73 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.123 -0.944 . . . . 73.12 111.756 178.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -88.92 142.93 27.23 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.03 0.443 . . . . 72.14 111.821 -178.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.65 127.08 65.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.514 -0.767 . . . . 63.14 109.453 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 44.3 t -102.89 120.72 53.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 109.285 -0.635 . . . . 71.34 109.285 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.63 119.41 44.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 108.733 -0.84 . . . . 70.11 108.733 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 48.7 mm -104.48 109.26 26.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-N 115.599 -0.728 . . . . 72.25 109.558 -175.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 9.6 tt -99.96 121.82 51.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.719 -0.474 . . . . 34.33 109.719 178.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.44 HG12 HG22 ' A' ' 467' ' ' VAL . 35.9 m -103.61 151.13 6.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.943 -0.572 . . . . 62.12 110.817 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -92.8 127.31 8.93 Favored Glycine 0 N--CA 1.424 -2.12 0 CA-C-N 115.615 -0.721 . . . . 40.34 111.714 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 25.1 m -119.99 160.27 23.09 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 106.384 -1.71 . . . . 63.11 106.384 176.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -134.65 162.29 24.63 Favored Glycine 0 C--N 1.298 -1.576 0 C-N-CA 118.541 -1.79 . . . . 15.14 112.836 -176.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -75.51 109.72 2.96 Favored 'Trans proline' 0 N--CA 1.442 -1.506 0 C-N-CA 122.39 2.06 . . . . 53.33 110.287 178.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 493' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . -90.47 27.49 1.7 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.925 0.869 . . . . 72.41 111.408 -177.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 16.4 p -117.51 143.13 46.37 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 114.708 -1.133 . . . . 73.21 109.806 -178.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 495' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 495' ' ' LYS . 67.5 mmtt -139.9 155.2 47.31 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 116.356 -0.384 . . . . 63.35 110.578 177.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -84.17 119.48 25.06 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.831 -1.174 . . . . 71.32 107.831 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 27.2 pt -75.64 120.26 80.87 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 112.347 0.499 . . . . 75.11 112.347 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -93.33 138.45 1.44 Allowed 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 122.672 2.248 . . . . 64.22 111.677 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -90.81 135.35 33.78 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.745 -0.835 . . . . 74.42 108.745 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 19.1 t -134.75 94.08 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 107.523 -1.288 . . . . 72.33 107.523 175.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -88.73 123.99 33.69 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.71 -0.677 . . . . 60.51 109.822 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 125.18 9.69 4.99 Favored Glycine 0 N--CA 1.425 -2.074 0 C-N-CA 119.949 -1.119 . . . . 42.01 112.843 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -106.25 168.18 9.32 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.701 -0.851 . . . . 73.44 108.701 176.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 7.0 m -83.35 157.12 22.67 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.835 -1.172 . . . . 74.23 107.835 176.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 48.8 t -51.11 -44.61 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 122.911 0.484 . . . . 64.01 111.606 -178.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -63.37 -41.91 98.83 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.718 -0.674 . . . . 61.12 111.845 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 33.1 t -72.26 -40.41 65.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 116.121 -0.49 . . . . 72.21 109.912 -176.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.73 -49.44 73.02 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.641 -0.709 . . . . 71.1 111.243 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -65.08 -35.26 80.59 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.705 -0.225 . . . . 60.44 110.663 -178.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.447 ' O ' HG23 ' A' ' 514' ' ' VAL . 47.4 tttp -57.38 -52.29 65.97 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 124.088 0.867 . . . . 74.51 110.237 -178.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -62.74 -44.58 95.84 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 116.099 -0.501 . . . . 71.1 110.139 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.08 -45.81 91.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.751 -0.659 . . . . 74.44 111.137 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.26 -43.18 92.46 Favored 'General case' 0 CA--C 1.5 -0.949 0 O-C-N 123.495 0.497 . . . . 65.33 110.744 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 510' ' ' LYS . 78.7 t -59.72 -38.31 75.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.53 -0.759 . . . . 73.4 111.015 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -74.87 -22.76 58.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.041 0.448 . . . . 63.22 111.239 -178.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 134.44 -16.79 4.32 Favored Glycine 0 N--CA 1.428 -1.844 0 C-N-CA 119.747 -1.216 . . . . 44.51 112.665 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.681 ' HA ' ' O ' ' A' ' 547' ' ' VAL . 91.2 m-85 -75.89 96.79 3.79 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.744 -0.465 . . . . 65.22 109.744 -177.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 3.1 p -95.73 -12.81 24.84 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 113.38 0.882 . . . . 43.42 113.38 -175.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 519' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 64.6 mttp -108.74 115.85 30.88 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.434 -0.506 . . . . 73.42 110.364 178.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -130.2 151.25 50.93 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 109.739 -0.467 . . . . 72.33 109.739 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 61.3 m -141.1 140.82 34.23 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 107.909 -1.145 . . . . 75.55 107.909 175.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 522' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 4.7 pm0 -117.41 137.15 52.69 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 121.326 0.584 . . . . 61.13 111.332 -176.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -111.58 116.95 31.69 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.767 -1.197 . . . . 42.42 107.767 176.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 19.3 m -96.96 124.46 40.94 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.487 -0.561 . . . . 72.02 109.487 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 28.4 m -129.13 150.02 34.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.753 -0.832 . . . . 75.04 108.753 177.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -68.74 135.64 51.59 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.937 -0.764 . . . . 72.34 108.937 178.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 50.8 m -156.54 171.95 6.72 Favored Pre-proline 0 C--N 1.297 -1.697 0 N-CA-C 108.558 -0.904 . . . . 74.5 108.558 -176.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -71.72 -19.93 27.05 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 121.835 1.69 . . . . 61.21 113.356 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.01 138.59 49.46 Favored Pre-proline 0 N--CA 1.469 0.495 0 C-N-CA 120.535 -0.466 . . . . 64.31 110.204 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.89 141.56 93.19 Favored 'Trans proline' 0 C--O 1.261 1.652 0 C-N-CA 122.726 2.284 . . . . 70.35 112.068 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.675 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -57.99 118.37 5.32 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 115.128 -0.942 . . . . 35.13 111.513 -176.128 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 135.92 -25.79 3.18 Favored Glycine 0 N--CA 1.432 -1.616 0 CA-C-N 115.59 -0.732 . . . . 32.24 111.32 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -83.73 134.47 34.75 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.104 0.478 . . . . 72.3 111.523 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 57.3 t -79.5 128.81 38.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 115.834 -0.621 . . . . 73.31 110.307 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 90.7 m -81.64 -33.8 31.17 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 124.781 1.232 . . . . 52.15 110.049 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.59 -150.82 22.79 Favored Glycine 0 N--CA 1.434 -1.452 0 N-CA-C 109.758 -1.337 . . . . 62.42 109.758 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 40.0 p -116.87 156.83 26.66 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 117.291 0.545 . . . . 64.11 110.063 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -82.11 -48.29 0.93 Allowed Pre-proline 0 C--N 1.31 -1.131 0 CA-C-N 115.496 -0.774 . . . . 73.54 110.014 173.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 26.8 Cg_endo -66.63 133.55 32.32 Favored 'Trans proline' 0 C--N 1.37 1.675 0 N-CA-C 108.923 -1.222 . . . . 72.52 108.923 169.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 540' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 31.9 Cg_exo -58.96 140.63 96.16 Favored 'Trans proline' 0 C--O 1.251 1.171 0 C-N-CA 122.51 2.14 . . . . 43.11 112.961 -177.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.33 140.95 58.13 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.76 -0.654 . . . . 74.04 109.671 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 98.54 -9.98 62.73 Favored Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 111.385 -0.686 . . . . 62.02 111.385 -178.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 41.9 m -75.28 126.26 30.66 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.603 -0.517 . . . . 72.22 109.603 178.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 495' ' ' LYS . 15.2 t -83.48 129.81 34.99 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 108.12 -1.067 . . . . 43.14 108.12 174.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 11.4 p -142.43 153.43 62.4 Favored Pre-proline 0 C--N 1.294 -1.835 0 N-CA-C 106.649 -1.611 . . . . 63.1 106.649 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 51.3 Cg_exo -58.5 140.27 93.98 Favored 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 121.78 1.654 . . . . 51.31 111.185 175.111 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.681 ' O ' ' HA ' ' A' ' 517' ' ' PHE . 27.1 m -65.22 -23.16 32.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 121.234 0.54 . . . . 72.01 112.33 -176.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.89 2.12 52.32 Favored 'General case' 0 N--CA 1.421 -1.896 0 O-C-N 122.028 -0.42 . . . . 64.43 111.116 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 66.2 m -84.96 170.49 13.0 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 121.16 0.505 . . . . 55.42 111.172 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 10.0 p -93.0 128.53 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-O 121.605 0.717 . . . . 65.32 111.842 -178.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 551' ' ' ILE . . . . . 0.508 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -108.52 136.11 45.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 108.572 -0.899 . . . . 61.12 108.572 172.717 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -103.53 118.44 36.74 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.445 0.641 . . . . 74.53 111.091 -176.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 553' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 2.3 mm? -95.94 134.35 39.04 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.499 -1.228 . . . . 63.52 109.525 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -98.3 124.52 42.97 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 108.77 -0.826 . . . . 74.13 108.77 175.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 57.2 t -114.43 128.64 71.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 115.899 -0.591 . . . . 75.22 110.662 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.675 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 69.4 m -69.8 131.57 44.72 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.698 -0.683 . . . . 63.1 111.565 174.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt -104.45 133.32 49.53 Favored 'General case' 0 C--O 1.202 -1.412 0 N-CA-C 107.435 -1.32 . . . . 72.23 107.435 169.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -70.16 -37.69 72.36 Favored Glycine 0 CA--C 1.503 -0.667 0 C-N-CA 120.184 -1.008 . . . . 61.31 111.279 -177.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 65.7 t30 65.35 28.56 11.76 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.603 1.161 . . . . 75.35 108.486 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -137.09 150.59 48.11 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 114.513 -1.221 . . . . 73.21 108.887 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -130.34 157.18 43.27 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.313 -0.625 . . . . 73.03 109.313 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 58.8 t -71.96 118.54 17.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 109.984 -0.376 . . . . 63.15 109.984 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 563' ' ' MET . . . . . 0.462 ' HB2' ' CG2' ' A' ' 614' ' ' VAL . 55.8 ttp -97.37 138.1 21.16 Favored Pre-proline 0 C--N 1.31 -1.145 0 CA-C-N 116.147 -0.478 . . . . 55.45 110.465 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.64 169.77 9.44 Favored 'Trans proline' 0 CA--C 1.552 1.395 0 C-N-CA 123.098 2.532 . . . . 72.34 111.422 172.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -88.37 129.78 35.32 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 113.064 0.764 . . . . 72.35 113.064 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 566' ' ' LEU . . . . . 0.421 ' O ' ' HB3' ' A' ' 569' ' ' MET . 2.8 mm? -114.25 -9.67 12.82 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.196 -1.039 . . . . 54.34 108.196 173.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 3.0 p -74.31 132.07 41.73 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 114.7 -1.136 . . . . 75.13 110.21 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 76.48 20.9 76.24 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 111.026 -0.829 . . . . 72.33 111.026 -176.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 569' ' ' MET . . . . . 0.421 ' HB3' ' O ' ' A' ' 566' ' ' LEU . 51.7 ttm -121.76 149.47 43.24 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.732 -0.84 . . . . 55.43 108.732 -178.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -82.62 142.61 31.61 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 108.655 -0.869 . . . . 71.52 108.655 177.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 72.1 t-105 -51.62 -27.22 10.66 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 124.707 1.203 . . . . 73.44 111.877 177.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 34.9 m -70.53 -20.39 22.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.58 -0.282 . . . . 61.01 111.525 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 573' ' ' ASP . . . . . 0.415 ' O ' ' HG3' ' A' ' 577' ' ' ARG . 9.6 t70 -101.57 -36.14 8.88 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.151 -1.055 . . . . 65.1 108.151 177.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.02 95.65 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 114.964 -1.016 . . . . 64.14 112.678 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.47 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 37.4 tt0 -57.63 -51.1 84.24 Favored Pre-proline 0 CA--C 1.563 1.458 0 CA-C-O 119.524 -0.274 . . . . 71.41 111.487 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 576' ' ' PRO . . . . . 0.47 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 54.1 Cg_exo -56.12 -39.69 89.6 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 121.46 1.44 . . . . 74.2 112.662 173.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 573' ' ' ASP . 51.4 mtt180 -64.25 -41.91 96.74 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.51 -0.476 . . . . 75.14 112.062 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.491 HD12 ' N ' ' A' ' 579' ' ' ARG 0.25 4.1 pp -66.28 -43.73 85.59 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 119.91 -0.716 . . . . 73.23 111.792 -177.575 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 579' ' ' ARG . . . . . 0.491 ' N ' HD12 ' A' ' 578' ' ' LEU . 15.8 ptm180 -66.43 -35.75 81.08 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 120.914 -0.314 . . . . 74.04 111.197 176.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.72 -28.29 66.69 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 122.638 0.375 . . . . 64.33 111.801 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 9.7 mp -81.52 -7.37 59.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.037 0.446 . . . . 75.02 111.217 174.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 80.36 15.16 79.0 Favored Glycine 0 N--CA 1.437 -1.244 0 C-N-CA 121.126 -0.559 . . . . 71.24 111.883 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 73.4 t90 -66.02 130.73 44.24 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.386 0.613 . . . . 73.41 110.01 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 75.5 m -143.83 93.65 2.49 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.833 -1.173 . . . . 71.3 107.833 176.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -150.6 -161.42 9.94 Favored Glycine 0 N--CA 1.419 -2.448 0 N-CA-C 109.409 -1.476 . . . . 73.43 109.409 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 55.0 ttp -91.04 124.89 35.61 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 120.832 0.349 . . . . 75.35 110.271 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -98.46 121.3 40.22 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 105.738 -1.949 . . . . 74.44 105.738 173.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -98.52 101.59 13.08 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.948 -0.76 . . . . 63.54 108.948 -177.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -99.6 130.44 45.84 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.606 -1.257 . . . . 74.11 107.606 -177.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -77.17 -97.93 0.19 Allowed Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.387 -1.085 . . . . 75.21 110.387 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.2 153.79 47.94 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.878 -0.786 . . . . 74.22 108.878 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -83.7 124.9 31.33 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.055 -1.091 . . . . 65.11 108.055 175.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 58.4 t -127.79 116.88 44.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 CA-C-N 115.881 -0.6 . . . . 42.01 109.944 -175.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -78.4 111.46 14.42 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.29 -1.374 . . . . 74.41 107.29 175.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -133.46 2.82 3.55 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.305 -0.558 . . . . 65.2 112.251 -176.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 127.85 166.06 11.98 Favored Glycine 0 N--CA 1.437 -1.29 0 N-CA-C 111.145 -0.782 . . . . 75.23 111.145 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -59.05 -35.64 84.82 Favored Glycine 0 C--O 1.227 -0.339 0 O-C-N 123.639 0.258 . . . . 15.34 113.532 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 13.4 p -65.78 -23.92 66.82 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.203 0.525 . . . . 72.21 111.722 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -102.37 -1.54 30.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.077 -0.51 . . . . 72.33 110.034 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -77.81 111.09 13.27 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.605 -0.517 . . . . 72.32 109.605 -177.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 62.9 -11.99 0.08 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.325 1.85 . . . . 73.33 115.159 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -77.51 138.68 39.34 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 118.449 0.568 . . . . 64.03 112.404 -174.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 71.7 t -72.86 131.82 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 114.835 -1.075 . . . . 41.43 108.689 176.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 604' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 623' ' ' ARG . 27.7 m -94.35 -41.14 12.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 C-N-CA 119.627 -0.829 . . . . 74.05 111.039 -176.079 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -151.4 154.69 37.14 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 106.678 -1.601 . . . . 71.1 106.678 175.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 606' ' ' GLN . . . . . 0.63 ' HA ' ' O ' ' A' ' 621' ' ' THR . 13.3 pt20 -133.82 142.43 47.85 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 106.646 -1.612 . . . . 72.25 106.646 174.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.443 ' HB2' ' OG1' ' A' ' 621' ' ' THR 0.33 91.4 m-20 -76.33 -57.39 1.37 Allowed Pre-proline 0 C--N 1.306 -1.29 0 N-CA-C 114.34 1.237 . . . . 71.31 114.34 -179.168 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' ' 609' ' ' PRO . 31.5 Cg_exo -63.66 119.53 6.62 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 121.785 1.657 . . . . 75.0 110.048 175.021 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 609' ' ' PRO . . . . . 0.42 ' HB2' ' OG1' ' A' ' 612' ' ' THR . 6.2 Cg_exo -70.97 134.52 25.61 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 121.8 1.667 . . . . 51.2 113.762 -176.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -69.33 132.17 46.0 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.082 -0.963 . . . . 52.42 110.317 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 89.34 -8.58 79.53 Favored Glycine 0 C--N 1.309 -0.923 0 N-CA-C 111.435 -0.666 . . . . 74.22 111.435 -178.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 612' ' ' THR . . . . . 0.42 ' OG1' ' HB2' ' A' ' 609' ' ' PRO . 17.9 m -104.88 160.17 15.22 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 108.048 -1.093 . . . . 70.13 108.048 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -71.68 114.26 5.01 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.944 -0.862 . . . . 45.31 110.944 176.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 614' ' ' VAL . . . . . 0.462 ' CG2' ' HB2' ' A' ' 563' ' ' MET . 20.6 m -103.31 144.99 13.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 C-N-CA 124.234 1.013 . . . . 74.02 109.929 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -38.85 134.03 1.04 Allowed 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 125.665 1.586 . . . . 65.01 110.565 177.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 616' ' ' ARG . . . . . 0.408 ' HD3' ' N ' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -51.18 -25.06 4.83 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 114.494 1.294 . . . . 71.21 114.494 -171.367 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 617' ' ' ASP . . . . . 0.408 ' N ' ' HD3' ' A' ' 616' ' ' ARG . 3.4 p30 -77.43 -26.06 51.22 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.846 -0.616 . . . . 70.14 110.716 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 78.0 20.29 73.38 Favored Glycine 0 N--CA 1.433 -1.526 0 CA-C-O 119.081 -0.844 . . . . 74.22 114.461 173.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.76 119.58 13.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 118.429 1.115 . . . . 65.1 108.755 -176.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 7.0 tp -106.77 127.39 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.027 0 CA-C-N 114.207 -1.361 . . . . 74.43 110.504 -173.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.63 ' O ' ' HA ' ' A' ' 606' ' ' GLN . 1.6 p -107.71 117.72 34.86 Favored 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 109.241 -0.652 . . . . 54.42 109.241 176.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.1 pp -138.54 150.68 46.62 Favored 'General case' 0 CA--C 1.486 -1.496 0 C-N-CA 124.4 1.08 . . . . 74.3 108.431 -177.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 623' ' ' ARG . . . . . 0.437 ' O ' HG22 ' A' ' 604' ' ' VAL . 2.7 tmt_? -132.88 137.11 46.57 Favored 'General case' 0 C--N 1.273 -2.738 0 N-CA-C 104.861 -2.274 . . . . 72.42 104.861 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -129.78 165.23 22.35 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 107.962 -1.125 . . . . 65.41 107.962 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -82.5 -88.04 0.71 Allowed Glycine 0 N--CA 1.426 -1.985 0 N-CA-C 109.851 -1.3 . . . . 65.41 109.851 178.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 . . . . . 0 C--N 1.286 -2.176 0 N-CA-C 109.087 -0.708 . . . . 72.21 109.087 178.419 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.12 0 N-CA-C 110.969 -0.852 . . . . 75.02 110.969 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 9.3 tp -75.4 137.93 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 109.615 -0.513 . . . . 72.25 109.615 178.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 5.7 m -77.39 154.72 32.44 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.566 -0.902 . . . . 74.23 108.566 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.17 84.92 2.31 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 122.208 1.004 . . . . 75.35 110.66 178.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -76.88 148.22 36.6 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 113.739 -1.573 . . . . 64.4 111.042 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 28.0 m -127.74 156.75 39.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 C-N-CA 123.583 0.753 . . . . 75.31 109.66 -178.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -95.89 122.79 39.07 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.221 -1.77 . . . . 63.23 106.221 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.439 HG21 ' CZ ' ' A' ' 382' ' ' PHE . 48.0 t -98.81 139.15 20.87 Favored Pre-proline 0 C--N 1.283 -2.313 0 CA-C-N 115.782 -0.645 . . . . 64.12 110.761 -171.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 363' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 14.9 Cg_exo -70.61 150.07 62.46 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.25 1.967 . . . . 73.32 111.442 175.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 364' ' ' ASP . . . . . 0.45 ' OD2' ' HD2' ' A' ' 366' ' ' ARG . 27.9 t0 -102.76 152.66 20.99 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 107.247 -1.39 . . . . 62.52 107.247 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 10.2 t -122.67 11.64 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.374 0 CA-C-O 121.818 0.818 . . . . 61.13 109.675 -174.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.537 ' HB3' ' OG1' ' A' ' 402' ' ' THR . 8.8 ptm180 -52.37 144.33 13.27 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 115.606 -0.724 . . . . 74.11 111.858 177.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.5 -11.07 54.02 Favored Glycine 0 C--N 1.312 -0.771 0 CA-C-N 115.593 -0.73 . . . . 71.15 111.843 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -110.39 -151.3 0.47 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 123.074 0.55 . . . . 74.21 110.312 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 71.8 p -97.81 159.28 15.03 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.253 -0.647 . . . . 60.33 109.253 -173.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 5.6 p -63.55 -35.89 81.98 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 120.862 -0.335 . . . . 55.32 110.839 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -65.78 -46.42 78.78 Favored 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 111.733 0.271 . . . . 75.43 111.733 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -68.11 -41.31 81.96 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 121.452 0.644 . . . . 74.24 109.281 -177.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.54 -51.52 59.27 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.005 -0.998 . . . . 64.42 111.53 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 77.1 mt -63.96 -39.2 84.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 CA-C-N 116.355 -0.384 . . . . 75.11 110.854 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.05 -44.05 91.76 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 120.946 0.403 . . . . 73.44 110.495 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 44.5 m -65.48 -47.13 77.13 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.834 -0.621 . . . . 71.12 111.455 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 10.8 mp -61.76 -45.43 93.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.812 -0.177 . . . . 75.54 111.193 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -65.81 -35.42 80.64 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.178 -0.465 . . . . 74.51 110.344 -178.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -67.2 -25.24 66.02 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 120.972 0.415 . . . . 63.33 111.786 176.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -86.45 -8.07 57.91 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.945 0.402 . . . . 74.22 110.25 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 381' ' ' GLY . . . . . 0.449 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 100.42 0.69 55.62 Favored Glycine 0 CA--C 1.502 -0.748 0 CA-C-N 115.587 -0.733 . . . . 72.22 112.389 178.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.628 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 47.4 m-85 -80.0 153.97 28.51 Favored 'General case' 0 N--CA 1.418 -2.074 0 CA-C-O 121.443 0.639 . . . . 74.12 110.901 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 74.8 mmtt -113.01 161.42 17.06 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 114.916 -1.038 . . . . 75.11 108.414 -176.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.446 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -127.31 146.0 33.85 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 CA-C-O 121.461 0.648 . . . . 43.23 111.207 -176.956 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -110.26 127.98 55.28 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 104.64 -2.356 . . . . 63.14 104.64 174.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 25.5 m -117.37 127.0 53.62 Favored 'General case' 0 C--N 1.271 -2.828 0 C-N-CA 120.185 -0.606 . . . . 73.14 110.073 -174.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -112.12 128.64 56.28 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 105.472 -2.047 . . . . 75.14 105.472 177.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 16.1 pm0 -120.65 145.5 47.37 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.815 -0.754 . . . . 63.5 111.397 -177.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 389' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 421' ' ' SER . 54.7 mttp -139.38 143.01 34.26 Favored Pre-proline 0 C--N 1.298 -1.669 0 CA-C-N 115.431 -0.804 . . . . 72.22 109.263 176.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -74.89 158.03 42.87 Favored 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 122.229 1.953 . . . . 72.45 110.452 172.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 8.5 t70 87.43 -169.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 126.468 1.907 . . . . 73.13 108.869 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 37.4 m -144.02 14.29 1.68 Allowed 'General case' 0 C--N 1.316 -0.868 0 O-C-N 121.573 -0.704 . . . . 52.42 110.835 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 12.6 t -81.67 -19.12 42.31 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.807 -1.183 . . . . 70.22 107.807 176.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.606 HD13 ' H ' ' A' ' 394' ' ' ILE . 0.2 OUTLIER -97.61 152.84 38.38 Favored Pre-proline 0 N--CA 1.431 -1.418 0 N-CA-C 106.571 -1.64 . . . . 71.5 106.571 176.32 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 395' ' ' PRO . . . . . 0.428 ' HA ' ' HD2' ' A' ' 396' ' ' PRO . 1.0 OUTLIER -27.78 111.78 0.03 OUTLIER 'Trans proline' 0 CA--C 1.553 1.449 0 C-N-CA 125.089 3.86 . . . . 73.04 114.907 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 396' ' ' PRO . . . . . 0.592 ' HA ' ' OG ' ' A' ' 421' ' ' SER . 42.2 Cg_endo -63.73 160.92 34.39 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 124.159 3.239 . . . . 52.4 115.242 -174.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -60.11 -8.6 2.5 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 125.078 1.351 . . . . 74.21 113.091 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 37.0 m170 -106.39 132.31 52.56 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 105.746 -1.946 . . . . 74.44 105.746 175.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 27.7 m -75.21 117.6 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.256 0 C-N-CA 119.381 -0.927 . . . . 75.35 111.761 -165.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 400' ' ' ILE . . . . . 0.596 ' H ' HD13 ' A' ' 400' ' ' ILE . 0.2 OUTLIER -97.24 -28.76 3.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 107.292 -1.373 . . . . 70.03 107.292 174.042 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.54 157.53 27.43 Favored Glycine 1 N--CA 1.395 -4.079 0 N-CA-C 108.938 -1.665 . . . . 73.31 108.938 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.537 ' OG1' ' HB3' ' A' ' 366' ' ' ARG . 0.8 OUTLIER -146.25 -176.25 5.09 Favored 'General case' 0 C--N 1.262 -3.207 0 N-CA-C 105.878 -1.897 . . . . 72.44 105.878 -177.726 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -100.28 126.95 34.44 Favored Pre-proline 0 C--N 1.289 -2.025 0 C-N-CA 118.208 -1.397 . . . . 53.42 109.731 -173.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.84 0.18 1.7 Allowed 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 124.067 3.178 . . . . 61.41 114.791 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.1 -34.46 68.34 Favored 'General case' 0 C--O 1.209 -1.046 0 N-CA-C 109.206 -0.664 . . . . 64.42 109.206 173.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -63.85 -40.7 97.19 Favored 'General case' 0 C--O 1.212 -0.887 0 CA-C-N 115.805 -0.634 . . . . 65.31 110.042 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -83.71 0.6 46.42 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.122 0.487 . . . . 64.14 111.513 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 34.0 m -95.21 157.41 15.91 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 104.92 -2.252 . . . . 72.23 104.92 171.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 49.0 m -74.35 112.47 10.55 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 118.55 -1.26 . . . . 71.41 108.928 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 18.6 m -128.48 169.1 20.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 C-N-CA 122.49 0.316 . . . . 44.5 110.366 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 15.6 m -79.86 145.18 32.87 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.762 -0.459 . . . . 73.04 109.762 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 412' ' ' ALA . . . . . 0.628 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -66.69 113.73 5.05 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.293 0.568 . . . . 52.4 110.56 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 413' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 110.35 44.68 0.98 Allowed Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 110.776 -0.93 . . . . 75.21 110.776 -178.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -109.21 166.29 10.97 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.198 -1.038 . . . . 75.12 108.198 -177.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 415' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 49.2 mt-10 -100.23 118.5 36.66 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 118.212 0.46 . . . . 63.22 110.837 -177.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 44.4 mm -103.61 133.18 48.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 109.188 -0.671 . . . . 73.33 109.188 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 11.5 t -85.18 130.46 34.6 Favored 'General case' 0 C--O 1.252 1.217 0 CA-C-O 121.303 0.573 . . . . 74.32 112.306 -176.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 5.3 p -127.3 135.78 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 C-N-CA 124.052 0.941 . . . . 72.21 109.544 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -101.99 129.18 48.22 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.77 -0.456 . . . . 71.21 109.77 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 8.9 p -123.1 133.1 70.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 109.356 -0.609 . . . . 73.01 109.356 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 421' ' ' SER . . . . . 0.592 ' OG ' ' HA ' ' A' ' 396' ' ' PRO . 74.6 p -103.61 130.9 51.12 Favored 'General case' 0 N--CA 1.428 -1.541 0 O-C-N 122.086 -0.384 . . . . 62.32 110.55 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 41.0 p -97.02 107.97 20.61 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.987 -1.486 . . . . 72.05 106.987 173.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -44.82 -86.49 0.01 OUTLIER Glycine 0 N--CA 1.467 0.708 0 N-CA-C 116.653 1.421 . . . . 62.42 116.653 -170.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -71.95 128.46 14.08 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.697 1.598 . . . . 75.2 112.741 -175.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -92.02 153.4 19.45 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 107.737 -1.208 . . . . 75.3 107.737 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -88.47 156.23 19.22 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.09 -1.448 . . . . 62.12 107.09 174.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.458 ' HA ' ' HE ' ' A' ' 427' ' ' ARG . 8.5 mmp_? -121.98 150.17 42.43 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-O 121.017 0.437 . . . . 72.2 111.217 -176.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -85.8 138.51 32.02 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.427 -0.806 . . . . 72.21 109.729 -177.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 56.9 mt -87.55 131.57 43.42 Favored Pre-proline 0 C--N 1.295 -1.769 0 N-CA-C 108.733 -0.839 . . . . 64.24 108.733 178.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -70.76 141.45 41.21 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.715 1.61 . . . . 64.11 110.634 172.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -84.61 99.86 11.05 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.801 -1.185 . . . . 63.43 107.801 178.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 60.9 t -101.9 136.94 31.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 108.597 -0.89 . . . . 71.23 108.597 -174.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.408 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 18.9 m -57.22 149.8 19.11 Favored 'General case' 0 N--CA 1.435 -1.209 0 O-C-N 124.252 0.97 . . . . 73.4 112.517 -177.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 434' ' ' THR . . . . . 0.424 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 24.8 p -69.45 -25.06 63.91 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 115.283 1.586 . . . . 52.32 115.283 -170.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.7 pp -85.97 -11.67 52.42 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.628 -0.829 . . . . 72.53 110.768 176.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.408 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 0.2 OUTLIER -98.68 42.53 1.09 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.183 -0.917 . . . . 63.01 110.152 -175.123 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -52.56 -38.71 60.43 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.396 1.079 . . . . 62.55 112.749 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -62.27 -39.57 93.35 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.559 0.695 . . . . 42.41 110.681 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -70.53 -37.39 74.08 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.266 -0.879 . . . . 65.31 109.158 177.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -62.66 -51.82 65.74 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.936 -0.575 . . . . 72.14 111.078 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 28.8 m -61.88 -38.89 81.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 112.476 0.547 . . . . 65.44 112.476 -177.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -68.28 -38.08 81.35 Favored 'General case' 0 C--N 1.35 0.623 0 C-N-CA 119.255 -0.978 . . . . 62.41 110.908 177.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -66.35 -38.66 88.11 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.462 0.542 . . . . 75.12 112.462 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -63.38 -35.8 81.6 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.881 -0.414 . . . . 71.13 109.881 174.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.492 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 47.0 m -70.49 -48.3 56.37 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.918 -0.583 . . . . 74.52 110.804 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.5 -16.65 63.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.949 -0.569 . . . . 64.4 111.91 -177.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.05 -13.14 59.95 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.279 -0.419 . . . . 64.43 111.751 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 124.98 -69.88 0.48 Allowed Glycine 0 CA--C 1.492 -1.348 0 C-N-CA 120.068 -1.063 . . . . 53.23 111.932 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 449' ' ' PHE . . . . . 0.419 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 0.1 OUTLIER -48.52 -65.81 0.51 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.542 0.571 . . . . 74.23 112.542 177.108 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 450' ' ' GLY . . . . . 0.492 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 64.28 21.93 66.79 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 116.123 -0.49 . . . . 61.31 113.287 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.506 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 28.5 mmm180 -104.27 110.49 22.73 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 107.466 -1.309 . . . . 75.11 107.466 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -137.13 147.01 45.72 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 115.662 -0.699 . . . . 75.52 109.875 -177.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -132.77 148.95 52.33 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 108.264 -1.013 . . . . 65.02 108.264 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -117.67 125.75 51.27 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 110.212 -0.292 . . . . 65.43 110.212 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.19 148.13 41.88 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.293 -1.002 . . . . 73.31 108.293 176.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -114.17 140.85 48.19 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.141 -0.689 . . . . 74.53 109.141 -177.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 68.4 m -148.41 137.93 12.38 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 110.46 -0.2 . . . . 64.33 110.46 173.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.741 ' HA ' ' O ' ' A' ' 490' ' ' SER . 29.6 Cg_endo -65.75 128.09 19.24 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.348 2.032 . . . . 75.01 110.426 175.025 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 48.5 m -140.57 -179.83 6.25 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 116.489 -0.323 . . . . 64.33 110.589 -176.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 460' ' ' THR . . . . . 0.406 ' O ' HG13 ' A' ' 464' ' ' VAL . 9.9 t -45.58 130.99 6.44 Favored Pre-proline 0 CA--C 1.556 1.192 0 C-N-CA 124.53 1.132 . . . . 72.34 111.934 178.333 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 461' ' ' PRO . . . . . 0.565 ' O ' HG22 ' A' ' 464' ' ' VAL . 11.3 Cg_endo -51.72 -28.24 29.28 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 125.18 3.92 . . . . 73.45 114.466 -174.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.74 -32.08 67.35 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.147 0.498 . . . . 72.25 111.83 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 463' ' ' LEU . . . . . 0.535 HD13 ' O ' ' A' ' 463' ' ' LEU . 3.3 tm? -97.2 -13.46 22.05 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.984 -0.553 . . . . 70.34 110.66 -171.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' ' 461' ' ' PRO . 19.4 m -60.09 131.09 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 CA-C-O 121.47 0.652 . . . . 70.52 111.174 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.65 2.18 55.34 Favored Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 115.294 -0.866 . . . . 55.25 111.655 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -128.28 166.46 18.56 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.978 -0.749 . . . . 75.1 108.978 176.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.437 HG22 HG12 ' A' ' 488' ' ' VAL . 70.8 t -72.41 148.8 9.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.354 -0.98 . . . . 74.22 108.354 175.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 47.5 mt -97.36 -35.25 5.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 106.61 -1.626 . . . . 71.0 106.61 174.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 153.6 -168.67 32.22 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 110.377 -1.089 . . . . 73.15 110.377 176.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 470' ' ' THR . . . . . 0.524 ' HB ' HG12 ' A' ' 486' ' ' ILE . 0.6 OUTLIER -115.83 141.11 48.53 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 107.929 -1.137 . . . . 60.54 107.929 176.266 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.497 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 46.2 t-20 -63.36 -51.4 68.42 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 123.529 0.518 . . . . 74.43 110.512 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.497 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 27.3 Cg_exo -70.55 124.09 10.44 Favored 'Trans proline' 0 C--N 1.373 1.856 0 N-CA-C 107.0 -1.961 . . . . 72.35 107.0 166.059 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.421 ' C ' ' H ' ' A' ' 475' ' ' ASN . 18.2 Cg_endo -61.94 127.78 22.37 Favored 'Trans proline' 0 C--O 1.241 0.673 0 C-N-CA 122.467 2.112 . . . . 61.34 114.248 -172.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -77.68 16.53 0.66 Allowed 'General case' 0 C--O 1.198 -1.642 0 CA-C-N 114.676 -1.147 . . . . 63.21 110.475 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 475' ' ' ASN . . . . . 0.421 ' H ' ' C ' ' A' ' 473' ' ' PRO . 7.3 m-20 -109.14 -9.19 15.05 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.601 -0.727 . . . . 72.02 109.618 178.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -107.07 175.47 5.49 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-O 121.722 0.773 . . . . 74.0 112.902 -174.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 4.1 m -92.38 106.14 18.2 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 114.421 -1.263 . . . . 65.04 108.842 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 68.2 m -100.87 149.32 23.99 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 123.263 0.625 . . . . 72.24 111.119 -176.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -78.3 154.43 30.91 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.328 -0.396 . . . . 64.14 111.448 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.419 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 1.7 mp -68.56 -23.06 27.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 C-N-CA 123.61 0.764 . . . . 63.1 111.622 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 17.7 p -94.42 5.55 51.44 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.365 0.602 . . . . 75.22 111.16 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -98.83 140.71 32.61 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.17 -0.468 . . . . 75.55 111.113 -175.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.506 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.5 p -107.34 127.11 63.42 Favored 'Isoleucine or valine' 0 C--O 1.245 0.824 0 CA-C-N 115.977 -0.556 . . . . 73.34 111.803 -178.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.413 ' HA ' ' HG2' ' A' ' 472' ' ' PRO . 32.5 m -97.05 140.97 16.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.34 0.59 . . . . 63.43 110.392 177.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.95 114.0 45.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.893 -0.78 . . . . 73.02 108.893 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.524 HG12 ' HB ' ' A' ' 470' ' ' THR . 61.4 mt -98.69 124.84 52.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 114.618 -1.174 . . . . 72.54 109.707 -178.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 5.2 tt -109.43 126.72 66.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 109.458 -0.571 . . . . 63.13 109.458 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.437 HG12 HG22 ' A' ' 467' ' ' VAL . 32.6 m -105.34 151.13 7.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 115.871 -0.604 . . . . 62.24 110.758 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -90.16 122.89 6.76 Favored Glycine 0 N--CA 1.416 -2.635 0 N-CA-C 109.33 -1.508 . . . . 21.23 109.33 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.741 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 8.5 t -125.22 160.34 29.45 Favored 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 107.575 -1.269 . . . . 53.23 107.575 -178.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 161.5 174.52 31.47 Favored Glycine 0 N--CA 1.435 -1.372 0 C-N-CA 119.983 -1.103 . . . . 51.34 112.112 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -93.31 152.74 2.5 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 123.084 2.523 . . . . 74.31 113.129 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -81.07 92.61 6.27 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 108.929 -0.767 . . . . 60.35 108.929 177.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 9.4 p -117.22 143.82 45.46 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.0 -1.0 . . . . 54.41 109.727 -177.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -150.99 157.46 42.91 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.46 -0.941 . . . . 63.2 108.46 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.511 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.5 m-20 -80.37 128.23 33.32 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 107.544 -1.28 . . . . 63.22 107.544 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 497' ' ' ILE . . . . . 0.458 HD11 ' HB2' ' A' ' 539' ' ' PRO . 40.7 pt -76.11 136.49 69.3 Favored Pre-proline 0 C--N 1.299 -1.611 0 O-C-N 123.121 0.263 . . . . 73.34 111.42 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 498' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 497' ' ' ILE . 1.5 Cg_endo -88.55 155.59 6.42 Favored 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 122.265 1.977 . . . . 32.5 108.938 168.073 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.92 165.44 11.71 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.664 -1.236 . . . . 74.42 107.664 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.77 117.14 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.354 0 CA-C-O 121.989 0.9 . . . . 70.2 111.279 -174.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -131.32 110.33 11.0 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 114.423 -1.262 . . . . 72.24 107.968 174.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 135.89 -14.58 4.1 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 119.768 -1.206 . . . . 71.33 112.553 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -98.02 172.59 7.53 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.324 -0.551 . . . . 63.42 110.074 177.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 11.4 t -90.3 157.28 17.74 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 107.959 -1.126 . . . . 72.42 107.959 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.453 ' HA ' ' CG2' ' A' ' 534' ' ' VAL . 7.6 p -50.05 -46.92 24.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 O-C-N 124.26 0.975 . . . . 55.24 112.594 -175.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.24 -42.08 80.24 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.389 -0.524 . . . . 72.45 111.923 -177.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 95.6 t -72.42 -36.24 54.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.091 -0.504 . . . . 65.15 111.255 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.65 -49.02 74.86 Favored 'General case' 0 C--N 1.31 -1.111 0 O-C-N 122.21 -0.306 . . . . 73.35 110.859 178.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -60.22 -36.4 77.61 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.8 0.81 . . . . 73.4 109.823 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.401 ' O ' HG23 ' A' ' 514' ' ' VAL . 80.4 tttt -65.23 -46.54 80.2 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 114.401 -1.272 . . . . 73.12 109.666 -177.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -61.77 -47.97 82.77 Favored 'General case' 0 CA--C 1.495 -1.172 0 O-C-N 124.188 0.93 . . . . 74.2 111.263 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.75 -41.84 91.88 Favored 'General case' 0 CA--C 1.513 -0.468 0 O-C-N 123.159 0.287 . . . . 72.01 111.053 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 513' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 10.3 m-20 -62.68 -38.19 89.4 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.341 -0.391 . . . . 71.14 111.215 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 510' ' ' LYS . 73.9 t -70.13 -29.18 38.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.962 -0.563 . . . . 61.34 110.866 178.31 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -76.74 -12.13 59.94 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.191 0.519 . . . . 72.04 110.001 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 516' ' ' GLY . . . . . 0.489 ' O ' ' HB ' ' A' ' 547' ' ' VAL . . . 121.48 -25.52 6.92 Favored Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 120.837 -0.696 . . . . 71.31 111.974 177.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.591 ' HA ' ' O ' ' A' ' 547' ' ' VAL . 66.1 m-85 -76.22 103.81 6.43 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.529 0.68 . . . . 61.35 109.685 -176.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 3.3 p -86.17 -28.41 23.94 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 113.896 1.073 . . . . 72.52 113.896 -170.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 519' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 67.9 mttm -109.07 126.24 52.96 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.443 0.639 . . . . 70.53 112.34 -174.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -129.82 157.49 42.06 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 123.756 0.822 . . . . 72.43 110.398 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 71.1 m -137.44 143.55 41.87 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 107.022 -1.473 . . . . 73.44 107.022 170.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -125.06 147.68 48.86 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 120.75 0.309 . . . . 74.51 110.357 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -141.08 129.5 22.48 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 107.817 -1.179 . . . . 75.11 107.817 174.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 524' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 52.4 m -89.2 139.46 30.46 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 109.865 -0.42 . . . . 54.52 109.865 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 26.8 m -120.98 164.73 17.23 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 107.631 -1.248 . . . . 43.01 107.631 178.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 526' ' ' ASP . . . . . 0.627 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 2.2 p-10 -82.62 134.69 35.17 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 118.963 -1.095 . . . . 73.31 108.671 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 527' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 48.3 m -155.29 168.06 12.88 Favored Pre-proline 0 N--CA 1.441 -0.877 0 C-N-CA 120.482 -0.487 . . . . 73.2 110.554 -176.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -83.24 -10.7 9.99 Favored 'Trans proline' 0 CA--C 1.546 1.113 0 C-N-CA 122.014 1.809 . . . . 64.43 111.23 171.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.35 135.16 50.6 Favored Pre-proline 0 CA--C 1.506 -0.73 0 N-CA-C 107.695 -1.224 . . . . 75.23 107.695 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.95 150.88 52.73 Favored 'Trans proline' 0 C--O 1.256 1.417 0 C-N-CA 122.686 2.257 . . . . 73.43 113.446 -176.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -64.41 121.77 15.15 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.856 -1.066 . . . . 71.41 110.966 -175.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 126.7 -16.29 6.56 Favored Glycine 0 N--CA 1.424 -2.123 0 C-N-CA 120.455 -0.878 . . . . 63.45 111.864 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -83.19 128.43 34.48 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 120.448 -0.501 . . . . 71.03 110.143 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.453 ' CG2' ' HA ' ' A' ' 505' ' ' VAL . 59.9 t -84.66 114.19 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.337 0 N-CA-C 106.08 -1.822 . . . . 53.53 106.08 174.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 9.1 m -113.73 9.86 17.79 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 119.526 -0.87 . . . . 74.43 111.918 -173.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 179.02 168.51 38.24 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 119.284 -1.436 . . . . 71.42 112.821 176.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 45.4 p -132.1 155.08 48.74 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.789 -1.189 . . . . 74.31 107.789 176.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.487 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 23.3 t-20 -73.37 -57.46 2.73 Favored Pre-proline 0 C--N 1.314 -0.952 0 C-N-CA 120.189 -0.604 . . . . 72.24 111.477 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.487 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 1.1 Cg_endo -84.0 140.9 9.16 Favored 'Trans proline' 0 N--CA 1.436 -1.909 0 CA-C-N 120.053 1.055 . . . . 72.41 109.509 175.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 540' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 3.4 Cg_exo -73.45 158.42 48.03 Favored 'Trans proline' 0 C--O 1.267 1.97 0 C-N-CA 121.977 1.785 . . . . 62.32 112.528 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.17 139.88 58.82 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 115.113 -0.948 . . . . 72.2 109.81 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 104.21 -8.75 49.33 Favored Glycine 0 N--CA 1.422 -2.28 0 C-N-CA 120.347 -0.93 . . . . 43.34 111.625 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 26.4 m -75.76 120.45 21.15 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.732 -0.84 . . . . 63.45 108.732 175.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 10.9 t -88.16 124.88 34.26 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-O 121.366 0.603 . . . . 45.44 110.864 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 33.8 m -141.95 165.3 28.71 Favored Pre-proline 0 C--N 1.315 -0.895 0 N-CA-C 108.164 -1.05 . . . . 65.22 108.164 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.61 144.44 94.25 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 121.92 1.747 . . . . 72.12 110.399 172.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 517' ' ' PHE . 34.8 m -64.71 -20.29 27.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 121.942 0.877 . . . . 74.12 112.166 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -92.78 4.8 53.13 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 115.773 -0.649 . . . . 62.2 111.65 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 12.8 t -86.6 170.72 11.6 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.424 -0.954 . . . . 64.24 108.424 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 99.7 t -95.92 131.98 41.3 Favored 'Isoleucine or valine' 0 C--O 1.247 0.925 0 N-CA-C 112.586 0.587 . . . . 51.45 112.586 -175.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 551' ' ' ILE . . . . . 0.529 HD13 ' O ' ' A' ' 519' ' ' LYS . 0.2 OUTLIER -105.34 134.22 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 108.574 -0.899 . . . . 70.05 108.574 169.13 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -102.97 117.08 33.8 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 116.446 -0.343 . . . . 64.51 110.167 -176.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 5.3 mp -103.9 134.43 47.21 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.07 0.948 . . . . 63.01 111.239 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -96.89 121.84 39.21 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.66 -0.867 . . . . 72.21 108.66 174.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 524' ' ' SER . 24.5 t -107.9 139.6 29.35 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 N-CA-C 108.612 -0.885 . . . . 61.22 108.612 -178.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.585 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 69.1 m -81.42 143.79 31.88 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 111.88 0.326 . . . . 50.42 111.88 178.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.627 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 12.2 ptmt -105.47 156.43 18.22 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 104.591 -2.374 . . . . 74.3 104.591 167.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -83.5 -24.31 50.99 Favored Glycine 0 CA--C 1.498 -1.03 0 C-N-CA 119.864 -1.16 . . . . 55.33 115.446 -168.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 559' ' ' ASN . . . . . 0.492 ' HB3' ' HD2' ' A' ' 616' ' ' ARG . 85.6 m-20 62.67 27.62 16.22 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.112 0.482 . . . . 71.33 110.586 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -128.58 149.28 50.7 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.231 -1.026 . . . . 53.42 108.231 -172.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -140.89 149.2 41.61 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.167 -1.049 . . . . 51.43 108.167 173.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.4 p -83.67 116.86 28.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 121.849 0.833 . . . . 71.3 112.081 -176.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 60.0 ttp -89.5 127.05 56.21 Favored Pre-proline 0 C--N 1.312 -1.033 0 CA-C-N 115.283 -0.871 . . . . 52.05 108.689 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.62 154.8 66.83 Favored 'Trans proline' 0 C--O 1.239 0.555 0 C-N-CA 122.261 1.974 . . . . 72.44 111.811 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -83.13 115.5 21.93 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.351 0.596 . . . . 71.04 111.782 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 566' ' ' LEU . . . . . 0.581 ' O ' ' HG3' ' A' ' 569' ' ' MET . 95.2 mt -136.87 18.33 3.04 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.536 -1.211 . . . . 70.35 109.001 178.071 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 24.0 t -52.69 131.07 34.26 Favored 'General case' 0 CA--C 1.553 1.093 0 O-C-N 123.384 0.427 . . . . 73.22 110.748 -175.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 107.37 41.54 1.61 Allowed Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 109.382 -1.487 . . . . 74.54 109.382 -174.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 569' ' ' MET . . . . . 0.581 ' HG3' ' O ' ' A' ' 566' ' ' LEU . 79.0 mtp -101.02 158.11 16.25 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.167 -0.517 . . . . 75.01 110.518 -177.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 570' ' ' PHE . . . . . 0.431 ' HB3' ' OD1' ' A' ' 601' ' ' ASN . 98.7 m-85 -102.69 168.13 9.45 Favored 'General case' 0 N--CA 1.416 -2.13 0 N-CA-C 106.886 -1.524 . . . . 75.32 106.886 170.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 79.9 t90 -64.23 -32.37 73.92 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.902 -0.777 . . . . 74.3 108.902 174.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.1 p -67.94 -20.19 25.66 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 CA-C-N 115.511 -0.768 . . . . 73.24 110.612 177.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -85.43 -38.06 19.08 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 108.444 -0.946 . . . . 71.54 108.444 175.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -57.66 -41.38 81.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.043 -0.981 . . . . 73.53 112.185 -177.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -55.59 -59.82 10.23 Favored Pre-proline 0 CA--C 1.591 2.529 0 N-CA-C 112.795 0.665 . . . . 71.34 112.795 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.1 -43.02 26.2 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 121.622 1.548 . . . . 62.44 112.88 175.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -59.79 -33.81 72.2 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 111.772 0.286 . . . . 72.11 111.772 -177.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 6.9 tt -57.4 -46.65 83.25 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.622 0.769 . . . . 52.13 109.422 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -65.38 -47.42 76.4 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.86 -0.609 . . . . 72.01 111.634 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.64 -39.16 88.12 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.605 -0.725 . . . . 53.43 112.598 -175.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 88.9 mt -84.49 -8.01 59.08 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 111.677 0.251 . . . . 62.32 111.677 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 66.76 41.57 93.61 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 111.481 -0.647 . . . . 73.14 111.481 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 90.9 t90 -83.61 134.77 34.78 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.039 0.447 . . . . 70.44 111.798 -176.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 91.4 m -154.13 96.38 1.94 Allowed 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 124.561 1.144 . . . . 72.43 108.314 170.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -147.19 -147.16 4.49 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 108.569 -1.812 . . . . 74.42 108.569 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 586' ' ' MET . . . . . 0.571 ' HB3' HG12 ' A' ' 619' ' ' ILE . 23.2 ttt -98.28 124.23 42.78 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 117.888 0.844 . . . . 74.04 109.028 178.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 57.4 tp -94.92 115.53 27.57 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 107.361 -1.348 . . . . 74.33 107.361 177.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -95.67 104.5 16.42 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.639 -0.825 . . . . 74.24 109.697 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -110.6 134.25 52.58 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.996 -0.547 . . . . 73.33 109.686 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -102.8 -173.4 26.71 Favored Glycine 0 N--CA 1.432 -1.577 0 N-CA-C 110.072 -1.211 . . . . 73.11 110.072 174.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -65.85 148.74 51.29 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 122.449 0.3 . . . . 34.0 110.799 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 592' ' ' ASP . . . . . 0.413 ' HA ' ' O ' ' A' ' 625' ' ' GLY . 3.7 m-20 -78.98 123.61 27.45 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.688 -1.227 . . . . 44.1 107.688 177.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 88.6 t -137.54 120.3 20.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 116.291 -0.413 . . . . 62.11 110.538 -173.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -80.53 106.86 12.87 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.001 -1.111 . . . . 63.44 108.001 174.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -126.37 2.05 7.01 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.84 -0.618 . . . . 44.23 111.361 -176.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 123.2 163.58 11.83 Favored Glycine 0 N--CA 1.43 -1.704 0 C-N-CA 119.815 -1.183 . . . . 75.23 111.084 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.24 -36.6 69.38 Favored Glycine 0 C--O 1.223 -0.573 0 N-CA-C 114.151 0.421 . . . . 43.13 114.151 -173.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 25.8 m -64.59 -24.5 67.61 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 117.176 0.488 . . . . 73.45 111.939 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -107.05 -8.32 16.58 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 122.044 -0.41 . . . . 73.23 110.876 -178.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 59.3 m170 -74.38 103.48 4.77 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 112.901 0.704 . . . . 71.44 112.901 -175.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 601' ' ' ASN . . . . . 0.431 ' OD1' ' HB3' ' A' ' 570' ' ' PHE . 4.5 t-20 69.04 -4.27 1.29 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.14 1.776 . . . . 75.22 112.695 172.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -86.78 140.65 29.51 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.31 1.044 . . . . 71.22 108.254 -177.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 603' ' ' VAL . . . . . 0.403 HG13 ' HB2' ' A' ' 622' ' ' LEU . 96.8 t -69.82 130.79 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 107.444 -1.317 . . . . 73.43 107.444 176.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 604' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 623' ' ' ARG . 9.0 p -99.42 -32.89 3.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 119.204 -0.998 . . . . 65.01 110.899 -174.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -147.62 153.47 39.44 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 106.356 -1.72 . . . . 72.42 106.356 176.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -123.42 -172.09 2.44 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 108.557 -0.905 . . . . 63.02 108.557 177.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.509 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 55.2 t30 -113.36 -65.02 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.534 0 C-N-CA 119.152 -1.019 . . . . 64.5 112.277 -177.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.509 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 59.1 Cg_endo -88.99 157.96 5.87 Favored 'Trans proline' 0 CA--C 1.552 1.404 0 CA-C-N 120.835 1.334 . . . . 60.12 110.65 174.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -70.73 135.0 27.13 Favored 'Trans proline' 0 C--O 1.249 1.026 0 C-N-CA 122.304 2.002 . . . . 54.1 112.623 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -68.89 132.62 47.02 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.642 -0.708 . . . . 60.22 109.665 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 93.07 -0.48 69.2 Favored Glycine 0 C--N 1.316 -0.548 0 N-CA-C 111.153 -0.779 . . . . 65.1 111.153 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 43.2 m -110.98 164.36 12.88 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 108.429 -0.952 . . . . 63.4 108.429 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -70.4 122.66 11.09 Favored Glycine 0 N--CA 1.416 -2.683 0 N-CA-C 111.371 -0.692 . . . . 71.24 111.371 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 33.1 m -105.82 144.51 15.16 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 108.074 -1.084 . . . . 63.45 108.074 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.441 ' ND2' ' HB3' ' A' ' 617' ' ' ASP . 29.5 p-10 -53.85 149.21 9.06 Favored 'General case' 0 C--O 1.22 -0.482 0 O-C-N 123.309 0.38 . . . . 74.41 110.536 -178.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 616' ' ' ARG . . . . . 0.492 ' HD2' ' HB3' ' A' ' 559' ' ' ASN . 0.1 OUTLIER -54.71 -25.44 27.35 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 112.696 0.628 . . . . 74.22 112.696 -178.388 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 617' ' ' ASP . . . . . 0.441 ' HB3' ' ND2' ' A' ' 615' ' ' ASN . 31.5 t70 -67.73 -37.07 81.7 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.724 -0.671 . . . . 63.34 109.486 177.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 85.53 21.39 54.15 Favored Glycine 0 C--O 1.202 -1.876 0 C-N-CA 120.655 -0.784 . . . . 65.3 112.627 176.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 619' ' ' ILE . . . . . 0.571 HG12 ' HB3' ' A' ' 586' ' ' MET . 0.1 OUTLIER -68.69 119.72 14.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 122.563 1.173 . . . . 75.31 111.333 -170.548 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 40.2 mm -121.04 119.76 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-N 114.027 -1.442 . . . . 62.42 107.747 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 51.8 m -98.87 118.64 36.09 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.354 -1.351 . . . . 72.24 107.354 174.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 622' ' ' LEU . . . . . 0.403 ' HB2' HG13 ' A' ' 603' ' ' VAL . 2.2 pt? -138.04 165.39 26.7 Favored 'General case' 0 CA--C 1.484 -1.558 0 N-CA-C 108.162 -1.051 . . . . 74.32 108.162 -174.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 623' ' ' ARG . . . . . 0.445 ' O ' HG12 ' A' ' 604' ' ' VAL . 14.2 tpt180 -148.14 141.63 25.38 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 106.617 -1.623 . . . . 74.32 106.617 176.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -136.52 158.89 43.38 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 105.818 -1.919 . . . . 73.34 105.818 173.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 625' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 592' ' ' ASP . . . -77.8 -90.96 0.31 Allowed Glycine 0 N--CA 1.426 -1.99 0 N-CA-C 110.355 -1.098 . . . . 61.55 110.355 178.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 . . . . . 0 C--N 1.288 -2.098 0 CA-C-O 118.132 -0.937 . . . . 72.44 109.143 176.417 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.247 0 N-CA-C 109.745 -1.342 . . . . 43.05 109.745 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 9.8 tp -74.72 120.58 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.857 0 CA-C-O 122.29 1.043 . . . . 72.45 110.302 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 23.2 m -110.43 161.45 15.65 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 114.946 -1.024 . . . . 73.33 109.004 -177.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.09 83.76 2.06 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 107.579 -1.267 . . . . 61.43 107.579 175.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -66.5 149.35 50.58 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 113.058 -1.883 . . . . 74.22 110.89 -173.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 28.5 m -116.89 147.93 19.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 109.209 -0.663 . . . . 74.42 109.209 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 361' ' ' GLN . . . . . 0.424 ' NE2' ' HA ' ' A' ' 407' ' ' ASN . 0.8 OUTLIER -94.09 130.07 40.4 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 105.18 -2.156 . . . . 74.43 105.18 -178.759 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.461 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 79.8 t -95.8 132.13 27.84 Favored Pre-proline 0 C--N 1.288 -2.093 0 CA-C-N 115.46 -0.791 . . . . 71.53 111.025 -166.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 363' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 17.2 Cg_exo -61.5 122.43 11.06 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.531 2.154 . . . . 61.42 111.938 -178.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -89.08 111.42 22.16 Favored 'General case' 0 C--N 1.272 -2.779 0 CA-C-N 114.072 -1.422 . . . . 63.34 110.465 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 7.1 t -86.72 24.0 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.558 0 CA-C-O 122.807 1.289 . . . . 75.45 111.24 -174.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.531 ' O ' ' HD2' ' A' ' 366' ' ' ARG . 1.9 ppt_? -52.86 144.63 14.16 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.691 -1.14 . . . . 74.2 112.225 172.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 98.51 -14.47 62.03 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 120.82 -0.705 . . . . 64.35 112.54 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -102.07 -89.38 0.37 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 120.222 -0.591 . . . . 72.12 111.104 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 81.0 p -164.74 168.79 17.54 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.138 -1.06 . . . . 44.45 108.138 177.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 28.7 m -63.37 -40.82 98.3 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 109.053 -0.721 . . . . 63.12 109.053 176.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.79 -45.83 90.84 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.835 -0.621 . . . . 72.23 110.983 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -64.05 -42.38 97.05 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.355 0.41 . . . . 75.24 111.043 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 373' ' ' ALA . . . . . 0.402 ' O ' ' HG ' ' A' ' 377' ' ' LEU . . . -66.74 -50.11 63.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.14 -0.482 . . . . 62.21 111.06 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 78.4 mt -61.98 -40.23 86.54 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 CA-C-N 116.228 -0.442 . . . . 74.03 110.996 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.8 -47.2 85.6 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.195 0.522 . . . . 62.2 110.363 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 376' ' ' THR . . . . . 0.668 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 27.9 m -66.04 -47.96 72.65 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 115.104 -0.953 . . . . 64.25 110.024 -179.052 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 373' ' ' ALA . 97.5 mt -61.89 -44.68 96.3 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.604 -0.271 . . . . 63.53 111.694 -177.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -63.37 -42.81 98.88 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.267 -0.424 . . . . 64.15 110.6 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -70.42 -17.5 63.01 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.102 0.477 . . . . 73.35 112.237 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 380' ' ' ARG . . . . . 0.668 ' HG2' ' O ' ' A' ' 376' ' ' THR . 17.5 mmm180 -89.56 -13.75 36.6 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 120.882 -0.327 . . . . 64.4 110.665 176.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.08 13.49 36.45 Favored Glycine 0 C--N 1.309 -0.968 0 C-N-CA 120.315 -0.945 . . . . 42.43 112.301 177.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -87.84 156.61 19.3 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 121.003 0.43 . . . . 61.53 110.725 175.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -105.6 154.27 20.64 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.946 -1.131 . . . . 73.33 107.946 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.418 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -127.68 149.09 32.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 119.65 -0.82 . . . . 72.13 112.406 -176.338 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 385' ' ' ARG . . . . . 0.431 ' HD2' ' OG1' ' A' ' 417' ' ' THR . 41.6 ttm180 -116.92 128.12 54.91 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 105.283 -2.117 . . . . 75.13 105.283 173.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 31.1 m -122.8 124.67 43.85 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 109.123 -0.695 . . . . 72.42 109.123 -175.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -111.76 119.8 39.85 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.141 -1.799 . . . . 64.33 106.141 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 19.2 pm0 -116.9 134.85 54.25 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.455 -0.498 . . . . 53.35 110.891 -177.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 389' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 390' ' ' PRO . 28.3 mtpp -135.86 145.0 50.95 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-N 115.787 -0.642 . . . . 63.25 110.658 178.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 389' ' ' LYS . 33.9 Cg_exo -68.5 153.62 73.43 Favored 'Trans proline' 0 C--O 1.252 1.188 0 C-N-CA 122.628 2.219 . . . . 74.43 108.85 169.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -62.64 124.94 22.3 Favored 'General case' 0 CA--C 1.487 -1.453 0 CA-C-O 122.519 1.152 . . . . 70.14 112.739 -175.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 49.5 m -154.37 34.19 0.42 Allowed 'General case' 0 C--N 1.279 -2.5 0 CA-C-N 112.525 -2.125 . . . . 70.14 106.134 178.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 23.2 m 81.38 46.1 0.03 OUTLIER 'General case' 0 CA--C 1.57 1.736 0 C-N-CA 125.862 1.665 . . . . 72.15 111.515 -178.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.25 151.59 46.94 Favored Pre-proline 0 C--N 1.313 -1.009 0 CA-C-N 115.431 -0.804 . . . . 71.1 110.68 174.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 395' ' ' PRO . . . . . 0.412 ' HB3' HD13 ' A' ' 400' ' ' ILE . 81.9 Cg_exo -50.8 136.54 43.01 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 C-N-CA 124.007 3.138 . . . . 75.05 114.654 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.99 163.02 17.39 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.733 2.955 . . . . 75.14 111.841 176.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -56.86 -8.41 0.6 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 112.885 0.698 . . . . 63.43 112.885 -179.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 398' ' ' HIS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 33.8 m170 -85.51 114.47 22.56 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 106.959 -1.497 . . . . 73.21 106.959 173.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 15.5 m -68.3 119.53 14.21 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-N 116.067 -0.515 . . . . 64.23 112.005 -174.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 400' ' ' ILE . . . . . 0.412 HD13 ' HB3' ' A' ' 395' ' ' PRO . 3.9 mp -87.25 -30.55 5.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 108.083 -1.08 . . . . 61.22 108.083 176.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.39 171.02 27.35 Favored Glycine 0 N--CA 1.422 -2.239 0 N-CA-C 110.774 -0.93 . . . . 34.14 110.774 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 4.1 p -114.6 -178.06 3.28 Favored 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 123.059 0.544 . . . . 74.03 110.75 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -100.62 136.93 19.79 Favored Pre-proline 0 C--N 1.293 -1.881 0 N-CA-C 107.862 -1.162 . . . . 64.32 107.862 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -47.51 -22.64 2.92 Favored 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 124.503 3.468 . . . . 61.43 115.275 -176.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -64.74 -29.29 70.27 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 120.729 0.3 . . . . 55.12 110.961 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -85.28 -40.78 16.2 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.571 0.7 . . . . 63.44 110.327 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 407' ' ' ASN . . . . . 0.424 ' HA ' ' NE2' ' A' ' 361' ' ' GLN . 13.0 m120 -77.14 -11.18 59.78 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.421 -0.809 . . . . 71.04 112.126 -173.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 57.2 m -100.94 157.51 16.69 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 107.558 -1.275 . . . . 70.11 107.558 177.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 44.1 m -74.53 112.77 11.04 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 108.066 -1.086 . . . . 72.33 108.066 177.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.5 169.33 20.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 120.972 0.415 . . . . 70.01 111.202 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 22.8 t -73.64 133.05 43.37 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 107.096 -1.446 . . . . 73.41 107.096 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -61.88 138.5 58.36 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.134 0.492 . . . . 72.22 111.56 -176.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 93.1 39.48 5.13 Favored Glycine 0 N--CA 1.437 -1.286 0 CA-C-N 115.704 -0.68 . . . . 53.53 111.943 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -102.49 -174.33 2.54 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.191 -1.411 . . . . 62.14 107.191 177.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -109.83 116.27 31.34 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 118.374 0.534 . . . . 74.31 109.897 -177.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 32.2 mm -99.37 129.19 50.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 109.154 -0.684 . . . . 71.32 109.154 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 417' ' ' THR . . . . . 0.431 ' OG1' ' HD2' ' A' ' 385' ' ' ARG . 44.7 m -91.74 131.13 37.33 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 112.38 0.511 . . . . 71.32 112.38 -177.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 3.5 p -123.33 134.96 64.78 Favored 'Isoleucine or valine' 0 C--O 1.252 1.226 0 N-CA-C 108.351 -0.981 . . . . 75.51 108.351 176.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -107.24 124.99 50.56 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.244 -0.65 . . . . 65.33 109.244 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 2.7 p -125.79 131.46 71.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-N 115.49 -0.777 . . . . 73.24 111.176 -177.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 29.3 t -107.61 131.34 54.47 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-O 121.941 0.877 . . . . 45.01 110.23 176.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 24.2 p -87.15 158.48 19.15 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 105.363 -2.088 . . . . 42.41 105.363 170.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -65.46 -159.08 0.49 Allowed Glycine 0 CA--C 1.549 2.191 0 CA-C-N 118.679 0.672 . . . . 72.14 114.092 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.91 153.41 75.48 Favored 'Trans proline' 0 C--O 1.243 0.731 0 C-N-CA 122.283 1.989 . . . . 70.31 111.675 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.448 ' O ' HG12 ' A' ' 480' ' ' ILE . 36.1 mt-10 -86.95 166.12 15.34 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 122.118 0.961 . . . . 71.14 113.17 -175.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.588 ' HG2' HG22 ' A' ' 477' ' ' THR . 45.9 tt0 -132.51 131.87 42.06 Favored 'General case' 0 N--CA 1.408 -2.572 0 N-CA-C 104.23 -2.507 . . . . 71.34 104.23 171.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.46 ' HA ' ' HE ' ' A' ' 427' ' ' ARG . 3.2 mmp_? -122.53 156.68 33.68 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 120.492 -0.483 . . . . 74.32 111.847 -173.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -83.22 139.98 32.81 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.788 -1.19 . . . . 72.34 107.788 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 73.3 mt -78.96 122.5 84.62 Favored Pre-proline 0 N--CA 1.425 -1.693 0 N-CA-C 108.298 -1.001 . . . . 51.33 108.298 -178.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -69.97 140.82 42.79 Favored 'Trans proline' 0 N--CA 1.429 -2.323 0 C-N-CA 121.256 1.304 . . . . 60.42 110.05 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -100.85 155.95 17.64 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 115.677 -0.692 . . . . 73.22 109.479 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.588 HG11 ' HB2' ' A' ' 440' ' ' ALA . 8.5 p -153.2 170.94 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 N-CA-C 107.452 -1.314 . . . . 71.35 107.452 -174.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.459 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 14.5 m -73.09 146.36 45.84 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 108.713 -0.847 . . . . 63.32 108.713 176.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 15.7 p -68.4 -23.92 64.7 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 113.59 0.959 . . . . 72.34 113.59 -174.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.5 pp -80.39 -11.87 59.64 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 120.113 -0.635 . . . . 61.52 110.383 177.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.466 HG22 ' HB3' ' A' ' 439' ' ' GLU . 1.3 m -101.84 44.15 1.03 Allowed 'General case' 0 CA--C 1.555 1.135 0 CA-C-N 115.592 -0.731 . . . . 61.43 110.902 -175.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -52.42 -38.18 58.49 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.387 0.675 . . . . 71.33 112.389 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.0 -45.03 83.31 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.209 0.528 . . . . 65.54 111.025 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.466 ' HB3' HG22 ' A' ' 436' ' ' THR . 33.7 tt0 -70.7 -33.26 70.69 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.68 -0.691 . . . . 73.44 110.51 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.588 ' HB2' HG11 ' A' ' 432' ' ' VAL . . . -58.95 -51.27 70.78 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.088 0.155 . . . . 44.33 110.658 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 33.6 m -62.52 -37.12 78.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-O 121.201 0.524 . . . . 70.44 110.849 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -60.39 -47.99 83.71 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.312 -0.858 . . . . 64.34 110.437 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -66.03 -38.75 89.18 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.904 -0.589 . . . . 73.01 111.725 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 93.1 mt -63.66 -33.66 76.13 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.791 0.329 . . . . 74.32 110.383 176.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 66.3 m -70.28 -44.9 67.45 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 115.912 -0.586 . . . . 74.35 110.1 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.75 -21.69 65.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.597 -0.729 . . . . 63.13 110.907 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.22 5.09 21.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.622 -0.717 . . . . 74.41 112.436 -179.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 105.18 -79.47 0.28 Allowed Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.11 -1.043 . . . . 72.24 111.998 175.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -39.62 -61.07 0.87 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.358 1.244 . . . . 73.32 114.358 176.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 62.15 18.45 57.73 Favored Glycine 0 C--N 1.321 -0.293 0 C-N-CA 121.634 -0.317 . . . . 71.42 113.186 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 14.3 mmt180 -95.15 111.29 23.14 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.356 -0.979 . . . . 74.33 108.356 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -136.49 153.88 50.9 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 120.689 0.281 . . . . 72.44 110.795 -178.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -142.37 133.16 25.56 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.545 -1.28 . . . . 73.22 107.545 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -101.5 134.52 44.48 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.832 -0.433 . . . . 74.51 109.832 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -124.37 138.83 54.33 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.036 -1.468 . . . . 22.41 107.036 173.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -121.07 136.67 54.93 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 109.479 -0.563 . . . . 62.04 109.479 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 32.5 t -135.72 141.2 36.13 Favored Pre-proline 0 C--N 1.296 -1.746 0 N-CA-C 108.708 -0.849 . . . . 61.13 108.708 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.693 ' HA ' ' O ' ' A' ' 490' ' ' SER . 37.6 Cg_endo -69.43 131.16 21.11 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.18 1.92 . . . . 73.03 110.521 175.144 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 61.1 m -151.22 -179.38 7.29 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.638 -0.875 . . . . 60.32 108.638 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 11.9 t -48.22 138.81 10.62 Favored Pre-proline 0 C--O 1.25 1.104 0 C-N-CA 123.941 0.897 . . . . 51.43 111.11 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -51.39 -29.39 30.59 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 124.401 3.401 . . . . 72.21 113.817 -175.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -75.27 -26.57 58.9 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.026 -0.67 . . . . 53.01 111.939 -177.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -88.58 -14.96 36.33 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 120.689 0.28 . . . . 71.0 111.07 178.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 86.5 t -60.87 127.56 20.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 109.385 -0.598 . . . . 75.15 109.385 176.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 96.92 -5.81 63.94 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 115.799 -0.637 . . . . 72.02 112.945 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.411 ' HD2' ' N ' ' A' ' 466' ' ' LYS . 8.2 mptt -124.46 160.18 28.82 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 108.393 -0.965 . . . . 73.23 108.393 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.415 HG22 HG12 ' A' ' 488' ' ' VAL . 77.7 t -70.95 142.62 15.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 107.612 -1.255 . . . . 72.33 107.612 173.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 59.0 mt -97.57 -35.65 5.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 107.566 -1.272 . . . . 75.3 107.566 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 173.24 -172.43 45.15 Favored Glycine 0 N--CA 1.412 -2.931 0 N-CA-C 109.707 -1.357 . . . . 73.14 109.707 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 30.2 p -121.18 146.24 46.99 Favored 'General case' 0 C--N 1.271 -2.832 0 N-CA-C 107.216 -1.401 . . . . 74.05 107.216 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.453 ' HB3' HG23 ' A' ' 485' ' ' ILE . 58.0 t30 -72.07 -46.2 11.35 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 119.096 -1.042 . . . . 74.12 110.153 176.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -82.61 146.44 13.47 Favored 'Trans proline' 0 C--N 1.374 1.906 0 N-CA-C 108.517 -1.378 . . . . 73.44 108.517 169.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.478 ' HB2' ' HG2' ' A' ' 476' ' ' GLN . 19.5 Cg_exo -65.36 127.29 17.88 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 121.778 1.652 . . . . 73.44 111.691 -178.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -86.3 8.95 19.35 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.643 0.735 . . . . 70.54 111.299 -175.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -109.4 -6.73 15.36 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 116.039 -0.528 . . . . 72.51 110.364 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 476' ' ' GLN . . . . . 0.478 ' HG2' ' HB2' ' A' ' 473' ' ' PRO . 81.2 mm-40 -97.24 172.2 7.95 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 116.01 -0.541 . . . . 62.41 111.791 -174.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.588 HG22 ' HG2' ' A' ' 426' ' ' GLN . 1.3 m -92.91 119.01 31.77 Favored 'General case' 0 N--CA 1.418 -2.032 0 CA-C-N 115.272 -0.876 . . . . 51.13 108.688 -177.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 54.9 m -115.49 148.04 39.94 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 123.171 0.588 . . . . 74.01 110.719 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -73.26 159.07 33.97 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.767 -0.651 . . . . 50.55 111.066 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 425' ' ' GLU . 43.7 mm -69.09 -21.09 25.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.748 0.785 . . . . 63.23 110.295 -177.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 3.7 p -100.15 5.33 44.82 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.734 -0.604 . . . . 73.3 111.87 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -94.1 133.9 37.1 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.216 -0.447 . . . . 75.11 109.926 -177.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 33.0 t -100.64 126.77 54.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.082 -0.508 . . . . 72.32 110.621 -174.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 35.0 m -103.0 137.47 31.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.429 0.633 . . . . 72.33 111.143 178.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.453 HG23 ' HB3' ' A' ' 471' ' ' ASN . 0.0 OUTLIER -107.16 128.45 62.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.495 0.664 . . . . 73.31 110.096 -178.957 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 38.5 mm -109.21 128.23 65.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 C-N-CA 125.046 1.338 . . . . 75.54 108.858 -174.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 13.4 tt -112.07 126.47 69.47 Favored 'Isoleucine or valine' 0 C--O 1.246 0.887 0 CA-C-O 121.453 0.644 . . . . 71.13 110.977 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.415 HG12 HG22 ' A' ' 467' ' ' VAL . 34.5 m -113.29 151.64 15.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 0 CA-C-N 115.448 -0.796 . . . . 61.4 111.495 -177.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.0 132.53 11.22 Favored Glycine 0 N--CA 1.433 -1.548 0 N-CA-C 109.534 -1.426 . . . . 24.23 109.534 177.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.693 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 21.5 p -141.79 160.98 39.08 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 116.958 0.379 . . . . 74.12 110.48 -176.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 127.07 88.32 0.64 Allowed Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 120.138 -1.029 . . . . 65.5 113.013 175.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -73.94 143.37 32.8 Favored 'Trans proline' 0 C--O 1.252 1.205 0 C-N-CA 122.403 2.069 . . . . 75.42 110.891 177.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -91.32 78.09 5.79 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.718 0.771 . . . . 73.33 110.043 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 546' ' ' PRO . 18.2 p -117.79 142.94 46.72 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.98 -1.009 . . . . 72.41 110.697 -178.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 4.8 mmmp? -141.15 152.62 44.84 Favored 'General case' 0 CA--C 1.494 -1.183 0 CA-C-O 121.524 0.678 . . . . 74.14 110.792 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 12.4 p-10 -80.62 134.41 35.89 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 114.265 -1.334 . . . . 73.4 108.518 175.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 31.8 pt -83.35 125.28 74.6 Favored Pre-proline 0 C--N 1.3 -1.55 0 C-N-CA 120.527 -0.469 . . . . 74.44 109.834 177.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -79.8 -175.81 2.91 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.279 1.986 . . . . 64.44 111.107 178.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -84.22 90.17 7.46 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.678 0.752 . . . . 73.33 110.675 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 12.8 p -104.96 3.17 10.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 123.353 1.549 . . . . 53.22 106.985 175.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 501' ' ' ALA . . . . . 0.568 ' HB1' ' HA2' ' A' ' 536' ' ' GLY . . . -83.6 63.59 7.48 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 113.161 -1.836 . . . . 75.31 111.446 -174.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 165.95 28.65 0.02 OUTLIER Glycine 0 C--N 1.309 -0.962 0 C-N-CA 119.253 -1.451 . . . . 72.12 113.244 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -118.74 -169.13 1.66 Allowed 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 106.753 -1.573 . . . . 73.43 106.753 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 11.4 m -81.96 155.45 25.22 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.038 -1.467 . . . . 75.44 107.038 175.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.621 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 6.0 p -55.1 -46.36 77.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.231 0.456 . . . . 65.04 112.231 -176.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -66.51 -41.63 88.58 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 116.475 -0.329 . . . . 62.32 111.326 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 60.0 t -66.43 -42.04 89.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.694 -0.685 . . . . 71.41 109.817 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -61.86 -44.91 95.86 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 115.424 -0.807 . . . . 71.2 111.253 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.621 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 89.4 mt-30 -60.29 -40.41 90.38 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 121.191 0.519 . . . . 72.14 110.887 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.449 ' O ' HG23 ' A' ' 514' ' ' VAL . 64.0 mttm -64.47 -53.6 45.74 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.417 -0.81 . . . . 74.1 109.626 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -62.77 -37.8 88.08 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 115.514 -0.766 . . . . 75.14 111.288 -177.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 8.4 tt -59.04 -44.79 91.83 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 109.108 -0.701 . . . . 72.42 109.108 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 513' ' ' ASN . . . . . 0.546 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 6.8 m-20 -64.62 -37.64 88.28 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.173 -0.467 . . . . 72.04 111.426 177.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 510' ' ' LYS . 92.7 t -63.71 -30.25 49.42 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 CA-C-N 116.028 -0.533 . . . . 63.44 111.088 177.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -77.15 -4.53 45.01 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.82 0.343 . . . . 75.33 111.353 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 106.42 -10.69 42.81 Favored Glycine 0 CA--C 1.496 -1.122 0 C-N-CA 120.664 -0.779 . . . . 52.42 112.226 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 82.4 m-85 -88.52 114.42 25.12 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 107.377 -1.342 . . . . 63.32 107.377 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 5.0 p -89.56 -19.4 25.04 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 112.983 0.735 . . . . 70.41 112.983 -175.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -107.93 119.51 39.67 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.404 0.621 . . . . 63.4 111.924 -172.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -129.8 156.4 44.39 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.346 -0.843 . . . . 73.31 110.524 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 10.1 p -141.64 147.05 36.94 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.381 -1.34 . . . . 71.11 107.381 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -124.51 133.48 53.31 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 121.169 0.509 . . . . 60.15 111.427 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -132.97 126.39 31.88 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.436 -0.95 . . . . 71.15 108.436 178.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 11.0 m -98.1 134.64 40.9 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-O 120.828 0.347 . . . . 74.01 110.423 -177.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 525' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 557' ' ' LYS . 30.5 m -123.01 149.96 26.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.083 -1.081 . . . . 63.31 108.083 176.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -66.33 135.67 54.71 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.998 -0.741 . . . . 75.3 108.998 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 74.2 m -149.91 166.99 13.9 Favored Pre-proline 0 C--N 1.293 -1.863 0 CA-C-N 115.754 -0.657 . . . . 64.24 111.162 -173.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -79.48 -23.36 7.32 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 121.805 1.67 . . . . 54.52 110.658 170.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -70.79 147.28 94.2 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 108.607 -0.886 . . . . 73.11 108.607 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -61.77 158.95 35.13 Favored 'Trans proline' 0 C--O 1.251 1.13 0 C-N-CA 122.835 2.357 . . . . 72.35 113.129 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -67.24 120.46 13.83 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.581 -0.736 . . . . 31.3 110.783 -179.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 118.52 -17.21 11.28 Favored Glycine 0 C--N 1.309 -0.924 0 C-N-CA 120.651 -0.785 . . . . 54.4 111.646 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -77.42 133.1 38.74 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.095 -1.076 . . . . 71.3 108.095 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 77.3 t -82.41 117.58 28.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 108.216 -1.031 . . . . 63.23 108.216 177.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 535' ' ' THR . . . . . 0.52 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 13.7 t -82.07 -17.66 45.83 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.781 0.8 . . . . 72.33 109.727 -177.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.568 ' HA2' ' HB1' ' A' ' 501' ' ' ALA . . . 162.35 -163.31 34.95 Favored Glycine 0 N--CA 1.411 -3.021 0 N-CA-C 110.618 -0.993 . . . . 31.44 110.618 177.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 537' ' ' THR . . . . . 0.433 HG22 HD23 ' A' ' 553' ' ' LEU . 22.8 p -124.98 154.88 40.53 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 107.749 -1.204 . . . . 63.1 107.749 176.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -66.31 -55.88 18.29 Favored Pre-proline 0 C--N 1.306 -1.306 0 N-CA-C 109.606 -0.516 . . . . 64.2 109.606 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.46 127.06 10.09 Favored 'Trans proline' 0 C--N 1.368 1.561 0 N-CA-C 109.128 -1.143 . . . . 53.44 109.128 169.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.6 152.99 64.7 Favored 'Trans proline' 0 C--O 1.245 0.873 0 C-N-CA 123.14 2.56 . . . . 75.23 112.944 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -67.12 138.26 56.94 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.118 -0.492 . . . . 62.33 110.096 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 104.41 -20.82 38.83 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 111.469 -0.652 . . . . 64.25 111.469 -177.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 32.8 m -65.41 135.61 55.46 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.5 -0.556 . . . . 71.05 109.5 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 17.2 m -97.7 123.18 41.52 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 109.333 -0.617 . . . . 73.13 109.333 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.0 m -136.53 159.81 69.08 Favored Pre-proline 0 C--N 1.31 -1.141 0 N-CA-C 109.161 -0.681 . . . . 73.43 109.161 -178.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 494' ' ' THR . 41.7 Cg_exo -63.88 147.6 92.08 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.221 1.947 . . . . 74.54 111.435 174.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 29.5 m -64.97 -19.62 25.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.703 0.763 . . . . 61.51 111.557 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -93.55 3.64 55.21 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.169 -0.923 . . . . 64.11 110.256 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 11.7 t -85.71 162.19 18.86 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.546 -0.909 . . . . 44.3 108.546 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 21.6 t -97.36 128.06 49.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 109.604 -0.517 . . . . 42.31 109.604 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 2.3 mp -101.68 131.58 49.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 108.863 -0.791 . . . . 75.32 108.863 176.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -102.67 116.69 33.09 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 121.489 0.661 . . . . 71.45 110.669 -178.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 553' ' ' LEU . . . . . 0.433 HD23 HG22 ' A' ' 537' ' ' THR . 84.4 mt -90.31 128.84 36.55 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.768 -1.197 . . . . 34.42 107.768 177.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -103.82 113.76 27.53 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 122.379 1.085 . . . . 71.1 109.379 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 23.0 t -94.38 147.13 5.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-N 114.02 -1.446 . . . . 62.34 110.019 -172.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.52 ' OG ' ' HB ' ' A' ' 535' ' ' THR . 7.5 m -86.31 131.58 34.18 Favored 'General case' 0 N--CA 1.414 -2.268 0 CA-C-N 115.636 -0.711 . . . . 73.22 109.769 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 525' ' ' VAL . 9.4 ttmm -99.12 119.44 37.85 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 107.107 -1.442 . . . . 73.24 107.107 171.023 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -67.69 -37.48 89.06 Favored Glycine 0 CA--C 1.495 -1.203 0 N-CA-C 110.955 -0.858 . . . . 72.15 110.955 -177.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 559' ' ' ASN . . . . . 0.488 ' OD1' ' HD2' ' A' ' 616' ' ' ARG . 52.3 t30 65.8 4.47 2.94 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.964 1.706 . . . . 73.04 111.284 175.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 -142.89 141.24 31.48 Favored 'General case' 0 N--CA 1.415 -2.177 0 N-CA-C 104.702 -2.333 . . . . 74.25 104.702 -173.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -142.25 135.93 29.32 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 118.663 0.665 . . . . 75.11 111.027 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 6.6 p -70.14 116.42 11.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.732 0.777 . . . . 63.25 112.206 -176.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 61.4 ttp -98.2 139.77 21.44 Favored Pre-proline 0 C--N 1.309 -1.178 0 CA-C-N 115.222 -0.899 . . . . 63.53 108.774 177.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -60.68 161.86 20.01 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.764 2.309 . . . . 64.34 111.798 176.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 565' ' ' ASP . . . . . 0.658 ' HA ' ' HB1' ' A' ' 610' ' ' ALA . 0.5 OUTLIER -68.16 128.53 36.9 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.797 0.808 . . . . 51.03 112.761 -175.051 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 57.1 tp -131.13 4.29 4.41 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 107.509 -1.293 . . . . 65.24 107.509 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 7.7 m -77.34 134.68 38.42 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 113.983 -1.462 . . . . 42.53 109.842 -176.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 88.0 16.89 58.79 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.643 -0.789 . . . . 72.11 112.119 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 85.7 mtp -114.96 178.15 4.39 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.452 -0.944 . . . . 72.55 108.452 -178.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 570' ' ' PHE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 66.7 m-85 -89.61 155.52 19.2 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 121.27 0.557 . . . . 74.13 111.492 -176.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -62.35 -29.18 70.27 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 124.909 1.283 . . . . 75.42 109.602 175.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 10.1 p -73.13 -12.51 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 CA-C-N 115.385 -0.825 . . . . 73.52 109.864 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -101.21 -37.23 8.63 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.737 -0.665 . . . . 74.02 109.653 175.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 574' ' ' ALA . . . . . 0.526 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -63.47 -54.76 31.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.114 -0.948 . . . . 75.35 113.343 -174.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' A' ' 579' ' ' ARG . 30.3 mt-10 -62.13 -50.2 81.32 Favored Pre-proline 0 N--CA 1.466 0.366 0 N-CA-C 113.921 1.082 . . . . 72.21 113.921 -179.01 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -52.77 -42.98 59.49 Favored 'Trans proline' 0 C--N 1.366 1.461 0 C-N-CA 122.082 1.855 . . . . 72.43 113.096 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -67.96 -37.62 81.79 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 119.948 -0.701 . . . . 71.23 111.012 179.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 94.5 mt -63.42 -47.16 83.09 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 121.427 0.632 . . . . 74.03 110.156 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 579' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' A' ' 575' ' ' GLU . 97.7 mtt180 -62.68 -38.05 88.85 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.271 -0.877 . . . . 75.32 110.26 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.2 -33.14 71.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.968 -0.56 . . . . 64.32 112.151 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 4.3 pp -82.64 -8.31 59.61 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 120.562 -0.455 . . . . 53.32 111.777 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 90.47 33.93 8.29 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.779 -0.724 . . . . 61.34 112.488 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 65.9 t90 -66.29 137.18 56.76 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 122.542 0.337 . . . . 74.2 110.153 176.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 49.9 m -145.04 102.0 3.7 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.573 -0.899 . . . . 75.13 108.573 176.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -172.5 -156.34 12.41 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 110.102 -1.199 . . . . 65.03 110.102 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 586' ' ' MET . . . . . 0.508 ' HB3' HG12 ' A' ' 619' ' ' ILE . 14.4 tpt -102.71 127.93 49.65 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.082 0.467 . . . . 72.02 111.138 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -97.7 126.04 42.81 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.065 -1.458 . . . . 74.5 107.065 176.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -123.28 110.33 15.07 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.374 0.607 . . . . 74.25 110.196 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -99.96 135.41 41.43 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.094 -0.957 . . . . 62.23 111.399 -174.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -68.76 143.31 39.91 Favored Glycine 0 C--N 1.306 -1.089 0 N-CA-C 109.165 -1.574 . . . . 64.23 109.165 169.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -61.22 130.5 46.55 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 122.878 0.471 . . . . 62.41 111.001 -176.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -55.23 135.16 49.91 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.541 0.941 . . . . 65.14 113.541 -172.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 85.8 t -137.99 115.9 12.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 114.814 -1.084 . . . . 75.11 109.013 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -90.78 111.88 23.45 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.742 -1.183 . . . . 70.3 108.612 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -148.56 20.75 1.04 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.938 0.718 . . . . 71.0 112.938 -174.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 140.31 155.65 6.62 Favored Glycine 0 CA--C 1.498 -0.994 0 C-N-CA 118.482 -1.818 . . . . 62.34 112.936 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.465 ' HA2' ' CD2' ' A' ' 600' ' ' HIS . . . -62.96 -49.77 69.42 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 114.262 0.465 . . . . 31.12 114.262 -175.362 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 25.4 m -71.98 -24.6 61.61 Favored 'General case' 0 C--N 1.312 -1.063 0 O-C-N 122.118 -0.636 . . . . 60.02 111.535 -176.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -93.12 -11.39 33.01 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 115.955 -0.566 . . . . 75.33 112.4 -177.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 600' ' ' HIS . . . . . 0.63 ' HB2' ' H ' ' A' ' 626' ' ' GLN . 0.5 OUTLIER -101.04 143.37 31.25 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 118.073 -1.451 . . . . 72.45 110.544 -176.866 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 69.98 -30.9 0.2 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.573 1.549 . . . . 71.52 112.005 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 602' ' ' ARG . . . . . 0.561 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 46.4 ttt180 -72.88 139.54 46.95 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.598 -0.689 . . . . 61.05 110.74 -177.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 603' ' ' VAL . . . . . 0.419 HG13 ' HB2' ' A' ' 622' ' ' LEU . 94.2 t -77.99 130.79 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 107.604 -1.258 . . . . 72.23 107.604 177.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 58.8 t -98.23 -55.73 5.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 108.562 -0.903 . . . . 74.42 108.562 -177.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 605' ' ' TYR . . . . . 0.424 ' O ' ' HA ' ' A' ' 622' ' ' LEU . 49.7 p90 -129.9 151.84 50.03 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 108.294 -1.002 . . . . 71.41 108.294 175.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 606' ' ' GLN . . . . . 0.534 ' HA ' ' O ' ' A' ' 621' ' ' THR . 17.7 pt20 -127.71 139.3 52.78 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 107.138 -1.43 . . . . 72.51 107.138 175.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.603 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 24.5 t-20 -46.43 -66.9 0.44 Allowed Pre-proline 0 CA--C 1.55 0.964 0 O-C-N 124.167 0.917 . . . . 63.14 112.607 -176.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.603 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 84.2 Cg_endo -91.22 124.1 0.86 Allowed 'Trans proline' 0 N--CA 1.436 -1.887 0 CA-C-N 121.233 1.476 . . . . 72.24 108.822 169.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.5 134.9 32.04 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.934 1.756 . . . . 73.4 112.399 -175.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 610' ' ' ALA . . . . . 0.658 ' HB1' ' HA ' ' A' ' 565' ' ' ASP . . . -68.79 138.93 55.21 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 115.537 -0.756 . . . . 54.21 110.024 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 101.57 -12.82 58.2 Favored Glycine 0 C--N 1.302 -1.317 0 N-CA-C 108.963 -1.655 . . . . 70.24 108.963 -173.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 16.5 m -118.06 168.76 10.25 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 107.143 -1.428 . . . . 60.43 107.143 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -71.22 126.5 13.32 Favored Glycine 0 N--CA 1.423 -2.222 0 N-CA-C 111.756 -0.538 . . . . 74.43 111.756 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 614' ' ' VAL . . . . . 0.414 HG12 ' HB2' ' A' ' 608' ' ' PRO . 31.4 m -94.27 141.69 14.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 109.271 -0.64 . . . . 74.53 109.271 177.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.15 144.03 36.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.888 -0.596 . . . . 72.33 111.753 177.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 616' ' ' ARG . . . . . 0.488 ' HD2' ' OD1' ' A' ' 559' ' ' ASN . 0.9 OUTLIER -54.03 -25.74 22.92 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.066 0.946 . . . . 73.43 112.26 179.771 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -61.13 -32.1 71.8 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 123.738 0.815 . . . . 74.3 109.879 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 73.08 8.43 74.03 Favored Glycine 0 N--CA 1.418 -2.506 0 N-CA-C 110.805 -0.918 . . . . 71.53 110.805 -176.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 619' ' ' ILE . . . . . 0.508 HG12 ' HB3' ' A' ' 586' ' ' MET . 0.0 OUTLIER -68.99 121.08 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 CA-C-O 122.068 0.937 . . . . 73.32 108.516 -174.461 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.18 119.57 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.549 0 CA-C-N 114.183 -1.372 . . . . 60.43 109.591 -176.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 606' ' ' GLN . 55.8 m -101.68 128.86 47.8 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.027 -1.471 . . . . 73.54 107.027 175.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 622' ' ' LEU . . . . . 0.438 HD23 ' H ' ' A' ' 622' ' ' LEU . 2.3 pt? -132.06 154.46 49.39 Favored 'General case' 0 CA--C 1.475 -1.926 0 N-CA-C 108.829 -0.804 . . . . 74.14 108.829 -176.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.94 135.19 49.61 Favored 'General case' 0 N--CA 1.398 -3.067 0 N-CA-C 105.672 -1.973 . . . . 64.4 105.672 177.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -142.79 165.67 26.75 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 106.128 -1.804 . . . . 73.2 106.128 177.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -77.43 -102.72 0.17 Allowed Glycine 0 N--CA 1.428 -1.863 0 C-N-CA 119.705 -1.236 . . . . 54.22 110.214 172.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 626' ' ' GLN . . . . . 0.63 ' H ' ' HB2' ' A' ' 600' ' ' HIS . 49.4 tt0 . . . . . 0 C--N 1.298 -1.642 0 N-CA-C 108.7 -0.852 . . . . 75.11 108.7 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.409 0 N-CA-C 110.608 -0.997 . . . . 43.05 110.608 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 6.6 tp -81.06 116.07 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.041 0 CA-C-O 121.514 0.673 . . . . 62.0 111.012 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 2.0 m -76.08 137.33 40.09 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.754 -1.573 . . . . 63.21 106.754 175.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 411' ' ' SER . 13.6 mmm-85 -99.55 -145.39 0.33 Allowed 'General case' 0 N--CA 1.383 -3.809 0 N-CA-C 107.69 -1.226 . . . . 74.32 107.69 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -126.2 142.25 51.6 Favored 'General case' 0 C--N 1.267 -2.987 0 CA-C-N 115.542 -0.753 . . . . 52.12 110.159 -171.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 360' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 409' ' ' SER . 21.5 m -141.51 164.51 19.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 107.852 -1.166 . . . . 63.34 107.852 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -92.59 138.07 31.82 Favored 'General case' 0 N--CA 1.397 -3.085 0 N-CA-C 107.076 -1.453 . . . . 54.34 107.076 174.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.465 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 76.0 t -94.91 125.05 52.44 Favored Pre-proline 0 C--N 1.266 -3.045 0 N-CA-C 107.218 -1.401 . . . . 72.54 107.218 -173.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 363' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 28.0 Cg_exo -57.35 136.82 78.5 Favored 'Trans proline' 0 CA--C 1.499 -1.234 0 C-N-CA 123.252 2.635 . . . . 71.34 113.185 -169.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -75.49 101.53 4.89 Favored 'General case' 0 N--CA 1.421 -1.915 0 CA-C-O 122.742 1.258 . . . . 73.41 109.699 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 365' ' ' VAL . 5.8 m -81.86 7.08 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-N 114.112 -1.404 . . . . 74.22 112.643 -178.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.527 ' HA ' HG23 ' A' ' 399' ' ' VAL . 36.4 ptt180 -58.66 146.01 37.83 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 125.132 1.373 . . . . 74.31 111.667 175.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.97 -10.46 51.9 Favored Glycine 0 N--CA 1.436 -1.345 0 N-CA-C 111.11 -0.796 . . . . 62.11 111.11 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -110.46 -161.62 0.76 Allowed 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.988 -1.115 . . . . 75.23 107.988 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 75.8 p -94.11 158.69 15.49 Favored 'General case' 0 C--N 1.276 -2.623 0 N-CA-C 108.24 -1.022 . . . . 74.32 108.24 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.439 ' O ' ' HB ' ' A' ' 374' ' ' ILE . 46.8 t -60.32 -36.06 77.06 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 109.722 -0.473 . . . . 72.34 109.722 176.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.56 -47.78 71.72 Favored 'General case' 0 C--O 1.213 -0.841 0 CA-C-O 119.24 -0.409 . . . . 74.41 111.763 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -70.09 -40.62 74.87 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 119.722 -0.791 . . . . 71.12 110.901 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -61.54 -47.31 86.11 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.257 -0.883 . . . . 64.33 110.599 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.439 ' HB ' ' O ' ' A' ' 370' ' ' SER . 1.6 mp -69.07 -38.3 78.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.926 -0.579 . . . . 72.11 111.209 177.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -60.14 -38.35 82.84 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.535 0.683 . . . . 63.13 110.353 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 86.1 m -63.76 -45.48 89.61 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.443 -0.799 . . . . 62.0 110.167 177.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 85.4 mt -64.24 -38.83 92.46 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.13 -0.486 . . . . 62.32 110.629 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -62.1 -40.41 95.77 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.56 -0.533 . . . . 74.12 109.56 177.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -63.13 -30.05 71.28 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.131 0.572 . . . . 64.41 111.585 176.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -84.48 -14.07 50.19 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.097 -0.502 . . . . 74.22 110.885 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 94.94 12.91 54.81 Favored Glycine 0 C--N 1.311 -0.836 0 C-N-CA 120.779 -0.724 . . . . 73.34 112.702 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -80.56 157.77 25.96 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-O 121.195 0.522 . . . . 75.22 111.395 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 74.9 mmtt -98.86 132.78 43.95 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 106.698 -1.593 . . . . 73.21 106.698 177.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.464 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -123.09 154.93 28.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 CA-C-O 121.822 0.82 . . . . 72.21 110.861 -177.124 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -135.58 134.04 38.93 Favored 'General case' 0 N--CA 1.399 -2.997 0 CA-C-N 114.235 -1.348 . . . . 71.31 107.432 173.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 52.2 m -125.0 121.98 35.97 Favored 'General case' 0 C--N 1.271 -2.838 0 N-CA-C 106.631 -1.618 . . . . 74.24 106.631 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.21 119.23 38.23 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 105.854 -1.906 . . . . 74.43 105.854 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.58 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 19.5 pm0 -123.0 129.1 51.09 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 119.964 -0.694 . . . . 73.52 111.384 -176.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 389' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 421' ' ' SER . 96.1 mttt -134.7 148.68 68.24 Favored Pre-proline 0 C--N 1.308 -1.207 0 N-CA-C 107.61 -1.255 . . . . 74.03 107.61 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -69.28 127.47 15.02 Favored 'Trans proline' 0 C--O 1.249 1.027 0 N-CA-C 105.909 -2.381 . . . . 52.13 105.909 168.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -177.41 157.4 1.3 Allowed 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 118.993 -1.083 . . . . 64.32 110.962 -169.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 10.9 m -112.08 -4.95 14.32 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.776 0.322 . . . . 64.42 110.93 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 42.4 m -92.45 -42.2 9.87 Favored 'General case' 0 N--CA 1.435 -1.184 0 O-C-N 122.118 -0.364 . . . . 75.14 111.101 -175.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.434 HG13 ' HB3' ' A' ' 421' ' ' SER . 21.1 pt -88.02 148.36 42.98 Favored Pre-proline 0 C--N 1.31 -1.123 0 C-N-CA 120.47 -0.492 . . . . 72.34 110.623 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 395' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 396' ' ' PRO . 87.1 Cg_exo -49.04 147.08 11.21 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 124.493 3.462 . . . . 70.13 115.443 -177.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 396' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 395' ' ' PRO . 51.8 Cg_exo -56.5 165.64 4.3 Favored 'Trans proline' 0 C--O 1.22 -0.418 0 C-N-CA 124.593 3.529 . . . . 75.23 110.813 170.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 397' ' ' ASP . . . . . 0.666 ' HA ' HG13 ' A' ' 420' ' ' VAL . 6.1 p-10 -55.17 -7.84 0.24 Allowed 'General case' 0 N--CA 1.505 2.308 0 C-N-CA 123.468 0.707 . . . . 74.04 112.538 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -91.87 117.3 29.67 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 106.118 -1.808 . . . . 61.31 106.118 172.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.527 HG23 ' HA ' ' A' ' 366' ' ' ARG . 16.2 m -73.62 118.65 19.36 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-O 120.9 0.381 . . . . 72.14 110.827 -173.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 9.2 tp -89.78 -28.7 5.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-O 121.396 0.617 . . . . 71.03 110.51 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.43 169.59 27.65 Favored Glycine 0 N--CA 1.425 -2.068 0 N-CA-C 110.234 -1.147 . . . . 64.15 110.234 -177.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 10.5 p -114.15 -178.66 3.43 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 123.545 0.203 . . . . 64.13 110.59 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -100.74 139.79 20.85 Favored Pre-proline 0 C--N 1.307 -1.247 0 N-CA-C 107.777 -1.194 . . . . 63.45 107.777 -177.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -43.18 -30.25 2.06 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 124.391 3.394 . . . . 72.54 114.313 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.28 -31.53 70.32 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 123.309 0.381 . . . . 72.24 111.459 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 406' ' ' ALA . . . . . 0.401 ' HB2' HD12 ' A' ' 416' ' ' ILE . . . -86.14 -34.39 20.59 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.701 0.762 . . . . 70.24 110.188 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -82.8 -1.99 53.25 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.259 -0.882 . . . . 74.32 111.426 -175.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 26.8 m -110.76 153.54 25.18 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 106.194 -1.78 . . . . 74.55 106.194 175.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 409' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 360' ' ' VAL . 39.3 m -73.87 112.73 10.27 Favored 'General case' 0 N--CA 1.425 -1.686 0 C-N-CA 120.205 -0.598 . . . . 20.34 109.749 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 23.9 m -122.54 166.71 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 115.403 -0.817 . . . . 74.22 109.719 178.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 411' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 358' ' ' ARG . 42.7 m -75.74 138.77 41.47 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 109.228 -0.656 . . . . 63.42 109.228 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -61.31 109.43 1.14 Allowed 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.184 0.516 . . . . 33.52 110.55 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 116.79 67.26 0.38 Allowed Glycine 0 N--CA 1.428 -1.873 0 N-CA-C 110.203 -1.159 . . . . 61.21 110.203 -178.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -135.5 -168.58 2.22 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.888 -1.152 . . . . 74.22 107.888 -177.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 415' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 40.1 mt-10 -106.99 131.09 54.44 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 123.622 0.769 . . . . 71.13 110.518 -176.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 416' ' ' ILE . . . . . 0.401 HD12 ' HB2' ' A' ' 406' ' ' ALA . 42.4 mm -119.37 115.86 49.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.928 -0.767 . . . . 63.52 108.928 176.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 13.7 p -98.82 130.94 45.27 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 123.929 0.891 . . . . 73.3 111.127 -177.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 8.7 p -126.96 135.06 64.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 120.905 0.384 . . . . 64.25 111.496 178.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -101.15 120.83 40.81 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.099 0.476 . . . . 75.04 110.059 176.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.666 HG13 ' HA ' ' A' ' 397' ' ' ASP . 44.8 t -126.49 144.36 36.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 C-N-CA 123.939 0.896 . . . . 72.01 111.252 -174.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 421' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 27.3 p -101.25 127.13 47.98 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.384 0.611 . . . . 60.22 110.832 176.176 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.1 t -117.69 106.05 12.67 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 115.888 -0.597 . . . . 75.12 109.42 177.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.416 ' HA2' ' HD3' ' A' ' 424' ' ' PRO . . . 95.72 126.45 4.99 Favored Glycine 0 N--CA 1.428 -1.888 0 C-N-CA 119.589 -1.291 . . . . 43.24 112.344 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 424' ' ' PRO . . . . . 0.416 ' HD3' ' HA2' ' A' ' 423' ' ' GLY . 11.1 Cg_exo -73.34 157.68 49.38 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 122.851 2.367 . . . . 73.22 110.625 174.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -83.62 166.16 18.4 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.88 -0.6 . . . . 70.43 111.024 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -88.08 159.17 18.35 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.63 -0.714 . . . . 55.23 110.51 -176.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -121.03 152.92 38.05 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-O 121.803 0.811 . . . . 70.14 111.041 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.59 ' CD ' ' H ' ' A' ' 428' ' ' GLU . 0.3 OUTLIER -86.81 140.34 29.79 Favored 'General case' 0 C--N 1.268 -2.942 0 CA-C-N 114.05 -1.432 . . . . 65.51 111.764 -174.552 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.508 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 65.7 mt -79.79 116.6 62.2 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 109.239 -0.652 . . . . 64.24 109.239 -177.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.51 147.26 51.62 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.851 2.368 . . . . 72.52 113.081 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -92.32 131.89 37.15 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 106.553 -1.647 . . . . 75.35 106.553 175.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.6 HG11 ' HB2' ' A' ' 440' ' ' ALA . 11.4 p -132.33 159.68 42.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 C-N-CA 120.855 -0.338 . . . . 71.33 110.852 -171.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.606 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 15.3 m -68.6 152.93 44.68 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 108.772 -0.825 . . . . 63.14 108.772 175.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 81.8 p -69.13 -33.5 73.56 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 114.413 1.264 . . . . 74.14 114.413 -167.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.8 pp -90.65 -11.67 39.12 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.629 -1.228 . . . . 53.21 111.553 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.606 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 1.2 m -86.83 42.05 1.0 Allowed 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.472 -0.786 . . . . 73.04 111.081 -174.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -56.58 -37.05 70.07 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.953 0.901 . . . . 74.51 110.632 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -54.97 -41.42 71.15 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.158 -0.474 . . . . 72.32 111.254 175.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -70.4 -35.65 73.58 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.777 -0.453 . . . . 72.1 109.777 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.623 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -60.9 -51.41 69.4 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.543 -0.753 . . . . 53.52 110.477 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 33.8 m -65.53 -39.7 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 112.482 0.549 . . . . 63.44 112.482 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.422 ' HD3' ' N ' ' A' ' 443' ' ' LYS . 0.1 OUTLIER -67.89 -34.92 77.59 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 120.131 -0.628 . . . . 70.21 111.971 178.096 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 443' ' ' LYS . . . . . 0.422 ' N ' ' HD3' ' A' ' 442' ' ' LYS . 0.9 OUTLIER -66.14 -40.63 90.75 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.084 -0.507 . . . . 74.24 109.747 177.875 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 76.8 mt -67.45 -32.86 74.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.597 -0.729 . . . . 70.13 110.18 177.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 90.5 m -69.89 -42.55 73.27 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.128 0.49 . . . . 63.33 109.975 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.46 -15.75 62.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.434 0.635 . . . . 71.43 110.767 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -85.49 5.25 32.11 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.422 -0.808 . . . . 32.52 111.459 178.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 104.92 -74.48 0.24 Allowed Glycine 0 CA--C 1.495 -1.176 0 C-N-CA 120.747 -0.739 . . . . 51.44 111.874 176.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 449' ' ' PHE . . . . . 0.541 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 3.6 p90 -49.19 -59.57 3.55 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 113.975 1.102 . . . . 71.23 113.975 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 60.59 29.32 69.41 Favored Glycine 0 C--O 1.217 -0.912 0 N-CA-C 111.028 -0.829 . . . . 72.42 111.028 -174.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.411 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 27.9 mmt180 -103.55 111.42 23.87 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.965 -1.124 . . . . 70.2 107.965 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -141.54 150.11 41.69 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 120.84 0.352 . . . . 71.31 111.326 -176.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 453' ' ' LYS . . . . . 0.451 ' HE3' ' HB ' ' A' ' 485' ' ' ILE . 52.8 mtmt -136.79 146.83 46.18 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.768 -1.197 . . . . 72.14 107.768 178.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 454' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' ' 486' ' ' ILE . 53.4 tt0 -117.31 128.52 55.13 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 109.931 -0.396 . . . . 71.12 109.931 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -116.89 154.82 30.12 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.027 -1.101 . . . . 75.11 108.027 177.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -125.1 137.74 54.18 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 108.935 -0.765 . . . . 74.01 108.935 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 26.6 t -137.97 141.79 33.73 Favored Pre-proline 0 C--N 1.292 -1.929 0 N-CA-C 109.538 -0.541 . . . . 71.45 109.538 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.696 ' HA ' ' O ' ' A' ' 490' ' ' SER . 44.4 Cg_endo -70.32 124.28 10.7 Favored 'Trans proline' 0 C--O 1.25 1.079 0 C-N-CA 122.417 2.078 . . . . 64.53 111.679 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 50.3 m -152.04 179.85 8.12 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.51 -0.552 . . . . 64.04 109.51 -177.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.6 t -49.17 139.46 13.16 Favored Pre-proline 0 CA--C 1.56 1.333 0 C-N-CA 123.702 0.801 . . . . 62.35 112.126 176.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.57 -28.5 29.01 Favored 'Trans proline' 0 C--N 1.365 1.419 0 C-N-CA 125.112 3.875 . . . . 65.14 113.966 -177.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -68.63 -21.24 64.49 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 116.162 -0.472 . . . . 60.31 111.635 -178.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 91.6 mt -103.61 -13.18 16.63 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 120.859 0.361 . . . . 74.51 110.913 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 70.0 t -60.97 127.62 20.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.001 -0.545 . . . . 64.2 110.954 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 95.64 -15.82 62.41 Favored Glycine 0 N--CA 1.441 -1.031 0 CA-C-N 115.639 -0.71 . . . . 73.55 112.114 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.65 166.83 12.27 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 110.211 -0.292 . . . . 61.04 110.211 -178.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 73.2 t -72.19 143.39 14.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 115.826 -0.625 . . . . 64.42 109.643 179.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 70.0 mt -97.38 -31.04 3.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 107.244 -1.391 . . . . 75.3 107.244 176.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 159.74 -159.22 30.42 Favored Glycine 0 N--CA 1.425 -2.086 0 N-CA-C 109.977 -1.249 . . . . 54.5 109.977 177.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 470' ' ' THR . . . . . 0.519 HG22 HG12 ' A' ' 486' ' ' ILE . 61.9 p -114.7 146.67 40.65 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 105.608 -1.997 . . . . 62.11 105.608 178.118 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.489 ' HB3' HG23 ' A' ' 485' ' ' ILE . 28.5 t-20 -72.85 -53.86 5.05 Favored Pre-proline 0 C--N 1.314 -0.947 0 C-N-CA 118.871 -1.132 . . . . 71.31 110.236 178.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -67.75 134.54 32.85 Favored 'Trans proline' 0 C--N 1.368 1.604 0 N-CA-C 107.904 -1.614 . . . . 75.33 107.904 168.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' A' ' 475' ' ' ASN . 24.7 Cg_exo -62.12 139.21 77.21 Favored 'Trans proline' 0 C--O 1.242 0.702 0 C-N-CA 122.216 1.944 . . . . 74.33 112.632 -175.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.508 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -75.84 19.91 0.2 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 122.163 0.983 . . . . 75.04 110.979 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 475' ' ' ASN . . . . . 0.438 ' H ' ' C ' ' A' ' 473' ' ' PRO . 10.1 m120 -109.21 -17.65 13.79 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.412 -0.959 . . . . 75.33 108.412 178.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -87.33 170.43 11.42 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.696 -0.683 . . . . 65.15 111.733 -174.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 4.5 m -106.3 127.02 52.94 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 108.304 -0.998 . . . . 72.42 108.304 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 9.8 p -105.95 146.06 30.52 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 123.031 0.533 . . . . 71.23 111.236 -177.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -90.26 162.75 15.05 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.452 -0.34 . . . . 74.14 110.815 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.541 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 1.7 mp -70.93 -20.58 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.966 0.889 . . . . 71.31 111.187 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 12.2 p -93.39 1.17 56.99 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.988 0.899 . . . . 54.31 111.029 178.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -104.93 138.17 41.57 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.004 -0.998 . . . . 75.12 111.649 -173.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.411 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.4 p -108.06 127.03 64.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.809 -0.632 . . . . 63.13 111.027 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 35.8 m -95.45 141.57 14.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-O 121.299 0.571 . . . . 74.3 111.294 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.489 HG23 ' HB3' ' A' ' 471' ' ' ASN . 0.0 OUTLIER -109.43 125.91 66.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.196 0 CA-C-O 121.485 0.66 . . . . 74.33 110.251 -178.441 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.519 HG12 HG22 ' A' ' 470' ' ' THR . 8.9 mt -112.62 128.61 69.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 115.067 -0.97 . . . . 74.41 110.919 -178.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 8.8 tt -105.17 127.21 59.99 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 123.41 0.684 . . . . 64.52 111.905 -174.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 28.6 m -111.61 152.07 13.57 Favored 'Isoleucine or valine' 0 C--O 1.25 1.097 0 C-N-CA 124.017 0.927 . . . . 54.33 110.241 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -81.9 140.76 21.15 Favored Glycine 0 C--O 1.246 0.854 0 C-N-CA 120.99 -0.624 . . . . 71.21 111.979 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.696 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 13.2 t -142.36 160.49 40.15 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.017 -0.735 . . . . 74.22 109.017 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 81.71 78.0 1.01 Allowed Glycine 0 CA--C 1.534 1.274 0 N-CA-C 115.693 1.037 . . . . 74.21 115.693 173.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -89.51 129.73 1.87 Allowed 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 122.703 2.269 . . . . 73.24 112.194 177.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -84.99 65.73 9.39 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-O 122.083 0.944 . . . . 72.04 111.875 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 1.3 p -118.03 143.42 46.43 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 114.899 -1.046 . . . . 65.01 109.673 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -146.34 148.83 32.78 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.84 -1.17 . . . . 63.44 107.84 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.562 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 9.5 p-10 -87.54 130.07 34.86 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.475 0.655 . . . . 73.12 110.985 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 38.3 pt -75.92 137.82 69.46 Favored Pre-proline 0 C--N 1.307 -1.28 0 CA-C-N 114.862 -1.063 . . . . 74.34 110.418 -178.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -93.86 -170.72 0.24 Allowed 'Trans proline' 0 N--CA 1.443 -1.482 0 C-N-CA 122.269 1.979 . . . . 61.44 111.211 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -83.9 145.91 28.34 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.666 -1.235 . . . . 72.45 107.666 174.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 9.2 p -136.22 8.58 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.455 0 CA-C-O 122.616 1.198 . . . . 65.23 108.469 177.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -71.17 121.43 18.32 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 114.019 -1.446 . . . . 62.1 109.628 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 108.73 30.57 3.7 Favored Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 110.789 -0.924 . . . . 74.14 110.789 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -142.03 176.09 9.22 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.907 -0.775 . . . . 74.0 108.907 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 29.6 p -91.67 160.02 15.58 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 110.021 -0.362 . . . . 74.21 110.021 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 30.7 m -53.73 -40.24 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 C-N-CA 124.181 0.993 . . . . 71.04 112.255 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -66.72 -42.44 86.35 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.655 -0.702 . . . . 64.22 110.791 -178.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 64.8 t -74.77 -35.06 35.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 116.432 -0.349 . . . . 73.33 110.253 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -59.61 -49.74 76.6 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.134 -0.485 . . . . 72.01 111.573 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -65.58 -35.89 82.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 74.03 110.725 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.416 ' O ' HG23 ' A' ' 514' ' ' VAL . 58.6 tptt -61.47 -47.35 86.06 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.706 -0.679 . . . . 64.45 109.647 178.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -62.08 -44.83 95.81 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 116.382 -0.372 . . . . 71.3 110.165 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.73 -47.52 85.31 Favored 'General case' 0 C--O 1.242 0.664 0 O-C-N 123.422 0.451 . . . . 73.54 110.376 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.92 -38.15 87.32 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 116.182 -0.463 . . . . 74.4 111.105 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 510' ' ' LYS . 55.2 t -64.01 -35.6 74.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 122.828 0.451 . . . . 74.23 111.366 177.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -79.29 -12.77 59.94 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.374 -0.53 . . . . 74.21 110.695 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 516' ' ' GLY . . . . . 0.439 ' O ' ' HB ' ' A' ' 547' ' ' VAL . . . 113.11 -0.14 25.41 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.69 -0.767 . . . . 62.23 113.154 177.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.457 ' HA ' ' O ' ' A' ' 547' ' ' VAL . 79.2 m-85 -82.82 115.77 21.86 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.454 -0.572 . . . . 71.45 109.454 -178.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.7 p -88.69 -26.04 22.04 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 113.643 0.979 . . . . 73.45 113.643 -176.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 519' ' ' LYS . . . . . 0.51 ' HE2' ' HA ' ' A' ' 519' ' ' LYS . 6.4 mmpt? -110.13 120.66 43.15 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 113.613 0.968 . . . . 74.45 113.613 -176.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -131.82 140.2 49.08 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 113.809 -1.541 . . . . 73.12 111.242 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 54.0 m -134.47 144.42 48.08 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.627 -0.879 . . . . 65.03 108.627 176.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -117.35 122.57 44.24 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.721 0.772 . . . . 63.25 110.807 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -100.89 140.29 35.38 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.685 -0.688 . . . . 71.21 109.663 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 15.9 m -88.79 116.01 26.75 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.982 -0.554 . . . . 73.32 109.646 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 35.7 m -121.98 158.56 25.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.935 -0.765 . . . . 73.24 108.935 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 526' ' ' ASP . . . . . 0.524 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 5.2 p-10 -94.71 136.83 34.55 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.838 -0.745 . . . . 62.24 109.89 179.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 527' ' ' SER . . . . . 0.456 ' HB2' ' HB2' ' A' ' 556' ' ' SER . 38.6 m -153.81 173.57 4.56 Favored Pre-proline 0 C--N 1.305 -1.331 0 N-CA-C 106.442 -1.688 . . . . 35.33 106.442 174.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -81.88 -8.3 12.2 Favored 'Trans proline' 0 CA--C 1.547 1.16 0 CA-C-N 120.642 1.265 . . . . 44.13 111.6 173.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.435 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 4.1 mpt_? -76.39 134.61 69.94 Favored Pre-proline 0 C--O 1.223 -0.328 0 CA-C-N 116.046 -0.524 . . . . 71.32 109.813 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -57.08 154.93 30.89 Favored 'Trans proline' 0 C--O 1.255 1.368 0 C-N-CA 123.225 2.616 . . . . 75.3 114.032 -177.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.5 117.02 4.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.87 -1.059 . . . . 72.12 111.892 -178.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 132.21 -20.02 4.52 Favored Glycine 0 CA--C 1.49 -1.497 0 N-CA-C 110.797 -0.921 . . . . 42.01 110.797 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -74.27 125.25 28.02 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.922 -0.639 . . . . 74.23 110.04 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 85.9 t -84.34 107.39 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 N-CA-C 106.36 -1.718 . . . . 74.52 106.36 172.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 26.8 m -75.01 -25.96 59.19 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.632 -1.167 . . . . 61.11 111.002 -174.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 162.03 -163.78 35.02 Favored Glycine 0 N--CA 1.427 -1.963 0 N-CA-C 110.311 -1.115 . . . . 14.11 110.311 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 19.5 p -117.73 155.3 30.22 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.987 -0.746 . . . . 73.55 108.987 178.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -75.52 -52.97 2.73 Favored Pre-proline 0 C--N 1.305 -1.34 0 N-CA-C 109.614 -0.513 . . . . 70.34 109.614 176.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -64.32 130.33 26.64 Favored 'Trans proline' 0 C--N 1.365 1.405 0 N-CA-C 107.951 -1.596 . . . . 73.23 107.951 167.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -63.21 143.67 90.22 Favored 'Trans proline' 0 C--O 1.246 0.879 0 C-N-CA 122.226 1.951 . . . . 74.14 112.479 -177.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -65.14 136.1 56.29 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.604 -0.517 . . . . 63.02 109.604 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.95 -19.46 32.74 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 111.446 -0.662 . . . . 65.13 111.446 -176.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 35.2 m -68.51 134.48 50.13 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.699 0.285 . . . . 73.14 110.329 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 28.2 m -85.41 122.8 30.08 Favored 'General case' 0 N--CA 1.416 -2.138 0 N-CA-C 107.741 -1.207 . . . . 71.12 107.741 177.046 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 52.9 t -127.72 152.27 76.68 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 107.147 -1.427 . . . . 71.43 107.147 -176.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -66.2 139.52 55.6 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 121.512 1.475 . . . . 74.51 109.701 171.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 517' ' ' PHE . 28.7 m -63.28 -20.12 25.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.665 0.745 . . . . 71.35 112.548 -177.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -93.45 3.48 55.5 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.465 -0.788 . . . . 65.24 110.727 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 8.6 t -92.4 -178.43 4.92 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.761 -0.587 . . . . 72.24 109.916 -178.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 45.5 t -102.1 122.74 54.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 122.948 0.499 . . . . 65.42 111.181 -174.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 1.9 mp -103.58 126.77 58.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.158 -1.053 . . . . 54.55 108.158 175.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -103.56 120.48 40.96 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-O 121.488 0.661 . . . . 73.24 111.989 -176.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 69.2 mt -94.75 134.3 37.51 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 125.569 1.547 . . . . 72.21 108.249 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -104.02 118.66 37.19 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 109.15 -0.685 . . . . 73.44 109.15 176.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 43.4 t -109.79 129.5 64.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 CA-C-N 115.17 -0.923 . . . . 71.04 109.191 -175.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.456 ' HB2' ' HB2' ' A' ' 527' ' ' SER . 32.0 p -80.07 143.5 33.95 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 113.494 0.924 . . . . 62.22 113.494 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.524 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 45.1 pttt -92.41 152.42 19.73 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 102.863 -3.014 . . . . 74.53 102.863 165.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 558' ' ' GLY . . . . . 0.486 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -75.53 -32.14 55.28 Favored Glycine 0 CA--C 1.479 -2.17 0 C-N-CA 119.079 -1.534 . . . . 73.14 111.166 -176.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 64.3 t30 71.98 -28.99 0.19 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.516 1.526 . . . . 74.34 111.839 173.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.486 ' H ' ' C ' ' A' ' 558' ' ' GLY . 92.8 mt-30 -135.23 145.88 48.06 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 106.75 -1.574 . . . . 61.25 106.75 174.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -123.07 138.09 54.76 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 109.383 -0.599 . . . . 52.53 109.383 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 90.2 t -59.94 116.88 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 O-C-N 123.933 0.771 . . . . 64.14 110.321 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 563' ' ' MET . . . . . 0.424 ' HA ' ' HD3' ' A' ' 564' ' ' PRO . 25.7 ptm -80.62 146.74 61.45 Favored Pre-proline 0 C--O 1.249 1.031 0 CA-C-N 116.103 -0.498 . . . . 75.32 110.475 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 564' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 563' ' ' MET . 15.5 Cg_exo -71.39 169.76 20.04 Favored 'Trans proline' 0 C--O 1.243 0.77 0 C-N-CA 122.862 2.374 . . . . 65.23 111.592 174.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -74.34 125.66 28.97 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 112.776 0.658 . . . . 45.05 112.776 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 96.1 mt -142.03 18.91 2.12 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.595 -1.184 . . . . 70.33 108.125 177.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 60.2 p -79.84 139.13 37.3 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 112.455 0.539 . . . . 55.34 112.455 -175.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 83.83 25.36 45.97 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 121.137 -0.554 . . . . 75.5 112.707 176.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 84.4 mtp -108.23 174.92 5.66 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.839 -0.43 . . . . 61.24 109.839 -178.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -102.5 136.96 41.4 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 106.922 -1.51 . . . . 75.13 106.922 177.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 81.8 t90 -54.66 -29.58 53.0 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 124.021 0.929 . . . . 63.23 112.356 -176.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 16.7 m -74.57 -19.16 16.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.342 0.592 . . . . 64.3 111.347 -177.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -102.29 -36.54 8.44 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.862 0.839 . . . . 72.43 109.644 178.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -67.46 -43.21 81.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.83 -1.077 . . . . 73.11 112.54 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.403 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 41.4 tt0 -57.15 -50.56 87.47 Favored Pre-proline 0 CA--C 1.558 1.283 0 CA-C-O 119.44 -0.314 . . . . 75.2 111.481 178.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 576' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 83.5 Cg_exo -53.53 -37.96 83.12 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.095 1.863 . . . . 65.54 112.617 172.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.527 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 45.4 mmt-85 -64.96 -39.14 93.04 Favored 'General case' 0 C--O 1.214 -0.799 0 C-N-CA 120.242 -0.583 . . . . 75.12 110.586 177.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 96.3 mt -62.24 -43.12 99.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.336 0.589 . . . . 71.51 109.452 177.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -61.85 -38.81 89.62 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.375 -0.83 . . . . 75.53 110.317 178.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.21 -30.0 66.98 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.063 -0.517 . . . . 52.25 111.415 177.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 581' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 93.0 mt -81.97 -7.19 59.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.826 0.346 . . . . 62.34 111.332 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 82.7 35.64 18.71 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 120.974 -0.632 . . . . 63.13 111.914 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 83.5 t90 -77.51 130.44 36.97 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.129 0.49 . . . . 74.51 110.177 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 50.4 m -145.05 89.43 1.96 Allowed 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.158 -1.052 . . . . 74.15 108.158 175.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -153.58 -146.84 4.48 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 110.208 -1.157 . . . . 65.52 110.208 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 586' ' ' MET . . . . . 0.49 ' HB3' HG12 ' A' ' 619' ' ' ILE . 23.8 ttt -115.93 135.33 54.08 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 117.182 0.491 . . . . 74.34 110.894 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -100.47 130.78 46.59 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.05 -1.834 . . . . 70.34 106.05 175.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -102.36 118.67 37.38 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.867 -0.733 . . . . 64.12 110.637 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 4.0 mmmp? -87.76 111.94 21.88 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-O 121.5 0.666 . . . . 71.45 112.15 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -81.23 -173.41 47.75 Favored Glycine 0 N--CA 1.427 -1.907 0 N-CA-C 109.676 -1.37 . . . . 41.31 109.676 171.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -70.51 145.02 51.16 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.998 0.399 . . . . 64.31 110.977 -175.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -85.59 124.67 32.4 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.925 -1.139 . . . . 72.23 107.925 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.92 124.85 68.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 C-N-CA 122.903 0.481 . . . . 74.14 110.863 -174.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -75.67 111.8 11.38 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.489 -0.93 . . . . 74.12 108.489 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -114.19 -19.78 11.18 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 112.081 0.4 . . . . 53.23 112.081 -176.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 126.96 145.83 6.34 Favored Glycine 0 CA--C 1.492 -1.391 0 N-CA-C 108.663 -1.775 . . . . 74.14 108.663 -176.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.17 -40.1 82.86 Favored Glycine 0 N--CA 1.47 0.912 0 CA-C-N 117.512 0.656 . . . . 42.11 113.955 -173.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 15.8 m -66.38 -24.31 66.47 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 122.951 0.501 . . . . 65.23 111.46 -178.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -108.7 -1.11 19.69 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.269 0.841 . . . . 74.32 113.269 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -68.07 150.64 48.17 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.943 -0.392 . . . . 65.42 109.943 177.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 63.42 -6.31 0.21 Allowed 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 124.878 1.271 . . . . 54.2 114.122 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 602' ' ' ARG . . . . . 0.524 ' HD2' ' O ' ' A' ' 603' ' ' VAL . 5.5 tmm_? -79.15 138.62 37.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 118.459 0.572 . . . . 72.31 109.883 -178.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 603' ' ' VAL . . . . . 0.524 ' O ' ' HD2' ' A' ' 602' ' ' ARG . 13.9 p -64.0 142.2 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.85 0.86 . . . . 61.3 111.171 -177.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 604' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 623' ' ' ARG . 7.5 p -96.13 -47.79 12.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 118.687 -1.205 . . . . 64.4 109.216 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -156.99 155.82 31.91 Favored 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 105.337 -2.097 . . . . 65.53 105.337 173.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -115.75 128.78 56.12 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 107.356 -1.349 . . . . 73.04 107.356 173.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.595 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 25.2 t-20 -48.77 -52.55 44.71 Favored Pre-proline 0 CA--C 1.545 0.779 0 O-C-N 123.99 0.806 . . . . 65.11 111.634 -177.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 13.7 Cg_endo -100.86 110.19 0.05 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.054 0 C-N-CA 121.659 1.573 . . . . 50.22 109.441 169.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.95 160.37 34.01 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.494 2.13 . . . . 73.25 111.485 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -57.32 126.96 29.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.576 0.227 . . . . 65.22 110.46 -177.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 102.03 -5.43 53.15 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.227 -0.987 . . . . 22.54 112.329 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 23.7 m -92.24 155.33 18.05 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.946 -0.761 . . . . 63.34 108.946 177.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -82.98 126.05 7.28 Favored Glycine 0 N--CA 1.426 -1.988 0 N-CA-C 111.368 -0.693 . . . . 71.42 111.368 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.3 m -103.81 142.18 17.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-O 120.598 0.237 . . . . 74.21 110.419 178.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.05 146.12 11.83 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 123.822 0.849 . . . . 72.12 112.267 177.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.02 -35.97 16.71 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 125.976 1.71 . . . . 72.32 112.874 -175.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -73.94 -30.26 62.45 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.883 -1.053 . . . . 71.21 111.484 -175.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 93.29 12.13 57.69 Favored Glycine 0 N--CA 1.414 -2.776 0 CA-C-O 119.211 -0.772 . . . . 62.1 114.078 174.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 619' ' ' ILE . . . . . 0.49 HG12 ' HB3' ' A' ' 586' ' ' MET . 0.0 OUTLIER -69.67 119.78 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 C-N-CA 117.715 -1.594 . . . . 64.22 107.736 178.629 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.84 132.14 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 114.793 -1.094 . . . . 74.02 108.349 -175.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 90.2 m -106.23 116.89 32.71 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 121.221 0.534 . . . . 63.14 110.507 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 622' ' ' LEU . . . . . 0.489 ' HB2' HG23 ' A' ' 603' ' ' VAL . 0.0 OUTLIER -139.92 149.97 43.98 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 104.558 -2.386 . . . . 72.04 104.558 173.04 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 623' ' ' ARG . . . . . 0.4 ' O ' HG12 ' A' ' 604' ' ' VAL . 44.5 ttp180 -128.78 156.13 44.05 Favored 'General case' 0 C--N 1.254 -3.578 0 N-CA-C 105.987 -1.857 . . . . 73.52 105.987 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -125.2 166.08 17.11 Favored 'General case' 0 C--N 1.26 -3.292 0 N-CA-C 105.367 -2.086 . . . . 72.23 105.367 175.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -61.28 -89.25 0.02 OUTLIER Glycine 0 C--N 1.314 -0.687 0 C-N-CA 120.104 -1.046 . . . . 64.03 110.708 176.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 . . . . . 0 C--N 1.289 -2.054 0 N-CA-C 107.03 -1.47 . . . . 53.0 107.03 175.047 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.14 0 N-CA-C 110.039 -1.224 . . . . 43.05 110.039 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 9.4 tp -74.22 127.26 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-O 121.946 0.879 . . . . 74.31 110.485 -178.456 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.75 152.3 23.36 Favored 'General case' 0 N--CA 1.387 -3.585 0 CA-C-N 114.814 -1.085 . . . . 53.53 110.665 -179.277 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.15 14.11 21.82 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.606 0.717 . . . . 74.44 109.148 -179.122 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -67.48 148.14 51.91 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.717 -1.129 . . . . 74.32 108.477 178.426 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 31.5 m -121.49 163.67 19.17 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-O 120.76 0.314 . . . . 41.04 110.74 -175.031 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -94.41 136.59 34.54 Favored 'General case' 0 N--CA 1.383 -3.793 0 N-CA-C 107.439 -1.319 . . . . 60.42 107.439 175.569 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 72.1 t -97.42 135.06 21.93 Favored Pre-proline 0 C--N 1.265 -3.093 0 CA-C-N 114.624 -1.171 . . . . 74.15 109.911 -171.17 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -65.99 121.9 9.33 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 121.65 1.566 . . . . 72.34 110.948 179.244 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -88.77 147.48 24.42 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.749 -1.575 . . . . 74.24 106.749 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 4.8 t -120.84 11.54 6.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 CA-C-N 116.052 -0.522 . . . . 71.41 109.947 -172.511 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.5 ' HA ' HG23 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -60.69 143.11 54.9 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 119.158 -1.017 . . . . 74.11 110.03 176.535 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.94 -9.28 46.93 Favored Glycine 0 C--N 1.301 -1.395 0 N-CA-C 111.233 -0.747 . . . . 54.0 111.233 -172.498 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -109.03 -145.86 0.4 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.483 -0.932 . . . . 73.15 108.483 174.386 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 96.4 p -107.13 167.04 10.18 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.426 -0.909 . . . . 71.02 108.899 -176.781 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 25.2 t -59.69 -39.55 84.9 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 109.167 -0.679 . . . . 52.02 109.167 176.756 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.37 -46.66 75.95 Favored 'General case' 0 C--O 1.213 -0.843 0 CA-C-N 116.102 -0.499 . . . . 60.03 111.357 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -64.11 -41.42 97.25 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.359 0.599 . . . . 72.42 110.924 -179.251 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.06 -51.34 62.03 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.389 -0.823 . . . . 61.31 111.073 -178.539 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 39.8 mm -66.08 -39.98 85.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.042 -0.526 . . . . 73.51 110.955 -179.303 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.24 -38.82 88.01 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 120.937 0.399 . . . . 74.31 111.15 -179.111 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 376' ' ' THR . . . . . 0.546 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 79.5 m -66.41 -47.28 73.78 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.845 -0.616 . . . . 74.04 111.177 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.75 -37.99 89.44 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.557 0.218 . . . . 63.2 111.159 178.83 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 65.4 tp60 -59.9 -48.03 83.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.95 -0.568 . . . . 54.11 109.747 177.096 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -61.03 -30.88 70.57 Favored 'General case' 0 CA--C 1.495 -1.17 0 N-CA-C 113.096 0.776 . . . . 72.41 113.096 177.231 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 380' ' ' ARG . . . . . 0.546 ' HG2' ' O ' ' A' ' 376' ' ' THR . 13.3 mmt180 -78.44 -14.08 59.54 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.272 -0.422 . . . . 70.2 110.735 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 91.14 16.11 54.49 Favored Glycine 0 CA--C 1.501 -0.842 0 C-N-CA 119.772 -1.204 . . . . 53.42 111.506 177.412 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -88.92 162.89 15.85 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-O 121.385 0.612 . . . . 74.31 110.518 178.877 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.54 ' HB2' ' HG2' ' A' ' 415' ' ' GLU . 75.2 mmtt -94.43 148.87 21.8 Favored 'General case' 0 N--CA 1.411 -2.375 0 N-CA-C 106.862 -1.533 . . . . 62.33 106.862 178.848 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.481 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -123.28 141.3 44.11 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-O 121.622 0.725 . . . . 74.53 110.968 -175.546 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 385' ' ' ARG . . . . . 0.425 ' HB3' ' HA ' ' A' ' 417' ' ' THR . 44.3 ttt180 -125.08 127.53 47.05 Favored 'General case' 0 N--CA 1.406 -2.632 0 N-CA-C 106.384 -1.709 . . . . 75.14 106.384 174.362 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 26.8 m -129.95 127.86 40.93 Favored 'General case' 0 C--N 1.276 -2.589 0 N-CA-C 108.97 -0.752 . . . . 62.22 108.97 -177.949 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -112.05 120.34 41.53 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.565 -0.531 . . . . 72.1 109.565 176.757 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -100.66 121.97 42.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.703 -0.851 . . . . 74.03 108.703 -179.007 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 389' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 421' ' ' SER . 44.5 mtmt -137.24 138.25 24.74 Favored Pre-proline 0 C--N 1.301 -1.509 0 C-N-CA 120.398 -0.521 . . . . 72.2 109.717 175.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -75.42 128.78 11.42 Favored 'Trans proline' 0 C--O 1.257 1.454 0 N-CA-C 107.972 -1.588 . . . . 63.43 107.972 172.54 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.446 ' OD1' HG22 ' A' ' 393' ' ' THR . 7.3 t70 -174.62 -172.67 0.67 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.086 -1.82 . . . . 73.41 106.086 -172.745 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 41.4 m -150.97 -2.6 0.34 Allowed 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 122.545 0.338 . . . . 73.52 111.605 175.832 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.446 HG22 ' OD1' ' A' ' 391' ' ' ASP . 10.7 t -105.91 -24.87 12.34 Favored 'General case' 0 C--O 1.244 0.764 0 O-C-N 121.696 -0.627 . . . . 65.5 109.898 -178.677 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.459 HG13 ' HB2' ' A' ' 421' ' ' SER . 49.1 pt -88.66 152.54 49.34 Favored Pre-proline 0 N--CA 1.439 -1.021 0 N-CA-C 107.805 -1.183 . . . . 63.5 107.805 176.525 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 395' ' ' PRO . . . . . 0.484 ' HB3' ' H ' ' A' ' 400' ' ' ILE . 21.7 Cg_exo -32.9 111.58 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 124.634 3.556 . . . . 73.44 116.398 179.616 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -56.48 166.86 3.14 Favored 'Trans proline' 0 C--O 1.221 -0.343 0 C-N-CA 124.943 3.762 . . . . 72.15 110.676 170.062 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 397' ' ' ASP . . . . . 0.485 ' HA ' ' CG2' ' A' ' 420' ' ' VAL . 4.6 p-10 -54.94 -8.58 0.27 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 112.684 0.624 . . . . 73.43 112.684 -178.947 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 398' ' ' HIS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 63.1 m170 -98.01 106.16 18.41 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 103.319 -2.845 . . . . 70.44 103.319 166.59 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.5 HG23 ' HA ' ' A' ' 366' ' ' ARG . 18.6 m -63.08 118.43 5.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 O-C-N 124.185 0.928 . . . . 51.42 113.209 -166.608 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 400' ' ' ILE . . . . . 0.484 ' H ' ' HB3' ' A' ' 395' ' ' PRO . 41.7 mm -98.2 -27.47 3.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 114.575 -1.193 . . . . 73.2 109.881 179.837 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.42 157.14 27.25 Favored Glycine 0 N--CA 1.414 -2.777 0 C-N-CA 119.901 -1.142 . . . . 71.12 112.026 -176.683 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 4.7 p -148.08 -176.15 5.17 Favored 'General case' 0 C--N 1.284 -2.242 0 C-N-CA 126.253 1.821 . . . . 72.13 107.412 -175.36 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -99.82 137.26 20.14 Favored Pre-proline 0 C--N 1.299 -1.602 0 N-CA-C 107.894 -1.15 . . . . 64.01 107.894 176.337 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.27 -2.86 3.46 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.824 3.016 . . . . 72.32 113.36 -177.085 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -52.61 -35.28 54.17 Favored 'General case' 0 C--O 1.21 -1.013 0 C-N-CA 124.656 1.183 . . . . 62.2 111.165 176.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -68.35 -37.47 80.53 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 121.533 0.682 . . . . 74.32 110.211 178.157 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -82.69 -3.91 57.06 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.579 0.704 . . . . 75.02 109.452 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 32.0 m -93.55 152.5 18.99 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.398 -1.705 . . . . 42.31 106.398 176.506 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 13.2 p -77.37 111.57 13.18 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 108.554 -0.906 . . . . 74.24 108.554 176.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 28.8 m -127.51 169.16 19.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-O 121.095 0.474 . . . . 74.11 110.876 -179.524 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 3.4 m -78.69 146.74 33.82 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.961 -0.755 . . . . 61.14 108.961 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -71.51 109.91 5.77 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.015 0.435 . . . . 73.51 110.529 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 122.8 23.23 2.31 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 120.852 -0.69 . . . . 72.11 112.749 178.754 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -86.68 -173.77 4.65 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.642 -0.873 . . . . 70.04 108.642 177.639 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 415' ' ' GLU . . . . . 0.54 ' HG2' ' HB2' ' A' ' 383' ' ' LYS . 32.9 mt-10 -111.21 119.19 38.11 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.263 -0.643 . . . . 73.02 109.263 -175.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.1 mm -98.17 120.25 47.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-O 120.837 0.351 . . . . 72.31 110.091 -178.771 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 417' ' ' THR . . . . . 0.425 ' HA ' ' HB3' ' A' ' 385' ' ' ARG . 36.4 m -90.7 125.88 35.81 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.972 -0.558 . . . . 73.23 111.726 -178.599 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 4.3 p -116.55 134.82 58.8 Favored 'Isoleucine or valine' 0 C--O 1.255 1.384 0 N-CA-C 109.261 -0.644 . . . . 71.53 109.261 174.533 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -99.29 116.89 32.52 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.515 -1.661 . . . . 75.34 106.515 177.028 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.485 ' CG2' ' HA ' ' A' ' 397' ' ' ASP . 10.7 p -127.61 136.0 61.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 121.32 0.581 . . . . 73.04 110.608 -175.531 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 421' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 14.1 t -102.39 122.58 44.56 Favored 'General case' 0 N--CA 1.415 -2.223 0 C-N-CA 119.839 -0.744 . . . . 64.14 110.031 178.295 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 8.9 t -118.94 107.53 13.68 Favored 'General case' 0 N--CA 1.411 -2.377 0 CA-C-N 115.175 -0.92 . . . . 61.23 108.753 176.387 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 106.82 103.33 2.87 Favored Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 120.871 -0.68 . . . . 43.42 111.923 -178.514 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -69.91 154.62 66.97 Favored 'Trans proline' 0 C--O 1.246 0.909 0 C-N-CA 122.223 1.949 . . . . 54.1 110.668 177.29 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -81.71 166.41 20.12 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.571 0.701 . . . . 73.31 112.509 -174.931 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -97.82 158.79 15.32 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 114.617 -1.174 . . . . 61.51 109.674 179.551 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.509 ' HG3' ' O ' ' A' ' 447' ' ' ALA . 4.3 mmp_? -120.33 155.6 33.01 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 109.653 -0.499 . . . . 75.52 109.653 -178.574 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -91.66 137.37 32.42 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 115.086 -0.961 . . . . 61.5 110.101 -176.153 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 59.7 mt -96.12 118.67 65.48 Favored Pre-proline 0 N--CA 1.421 -1.88 0 N-CA-C 107.519 -1.289 . . . . 70.2 107.519 177.017 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -71.6 141.48 38.14 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 N-CA-C 108.125 -1.529 . . . . 75.34 108.125 171.08 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -80.13 134.46 36.17 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 118.229 -1.389 . . . . 72.21 108.592 178.575 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.439 HG11 ' HB2' ' A' ' 440' ' ' ALA . 8.9 p -101.23 161.99 3.49 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.374 0 N-CA-C 108.39 -0.967 . . . . 61.2 108.39 -172.332 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 26.7 m -75.68 158.02 32.88 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 107.33 -1.359 . . . . 75.33 107.33 174.64 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 434' ' ' THR . . . . . 0.448 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 74.3 p -67.99 -40.34 83.09 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.943 0.878 . . . . 75.21 111.32 -173.458 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.507 ' H ' HD23 ' A' ' 435' ' ' LEU . 0.6 OUTLIER -67.5 -28.78 68.12 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 113.784 1.031 . . . . 74.25 113.784 178.946 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.6 p -89.9 59.2 4.49 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 114.511 1.3 . . . . 62.13 114.511 -172.912 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -64.26 -37.86 88.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.115 -0.493 . . . . 74.24 111.364 177.294 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -62.43 -36.3 81.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.899 0.38 . . . . 72.24 110.457 178.795 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -67.51 -39.35 85.14 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.64 -0.504 . . . . 65.23 109.64 175.22 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.467 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.19 -50.38 73.89 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.969 -0.56 . . . . 74.14 110.924 -178.489 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.0 m -62.14 -40.77 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 111.935 0.346 . . . . 72.13 111.935 -179.178 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -36.41 80.03 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 120.366 -0.534 . . . . 71.51 112.3 178.455 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -63.22 -47.1 83.92 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 120.931 0.396 . . . . 72.11 110.384 177.008 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.467 HD13 ' O ' ' A' ' 440' ' ' ALA . 2.6 mp -63.68 -35.54 80.88 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.361 -0.836 . . . . 52.33 110.601 179.866 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 89.4 m -69.33 -45.8 68.61 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 116.172 -0.467 . . . . 61.44 110.488 177.162 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.13 -16.49 62.56 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 120.848 0.356 . . . . 74.31 111.88 -178.424 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 447' ' ' ALA . . . . . 0.509 ' O ' ' HG3' ' A' ' 427' ' ' ARG . . . -84.6 -4.66 59.11 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.177 -0.465 . . . . 62.21 111.488 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 117.66 -83.48 0.35 Allowed Glycine 0 CA--C 1.498 -1.017 0 C-N-CA 120.121 -1.038 . . . . 63.14 111.963 177.085 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -36.99 -63.52 0.42 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.374 1.249 . . . . 74.13 114.374 177.865 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 62.71 20.2 61.51 Favored Glycine 0 C--O 1.221 -0.668 0 CA-C-N 116.384 -0.371 . . . . 35.53 113.322 -178.776 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -96.97 110.43 22.97 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.079 -1.082 . . . . 65.54 108.079 -178.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.442 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 21.2 p90 -138.91 158.95 43.28 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 115.972 -0.558 . . . . 70.04 110.437 -177.453 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -144.98 148.23 33.54 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.447 -1.316 . . . . 75.41 107.447 179.177 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -119.05 127.36 53.34 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 117.877 0.308 . . . . 74.41 110.323 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -124.52 150.58 45.67 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.395 -0.965 . . . . 64.04 108.395 175.929 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -114.03 141.53 47.32 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.922 -0.399 . . . . 74.12 109.922 -177.201 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 23.2 t -138.37 137.59 20.9 Favored Pre-proline 0 C--N 1.307 -1.242 0 N-CA-C 108.898 -0.778 . . . . 74.12 108.898 176.285 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 490' ' ' SER . 8.0 Cg_exo -71.05 122.78 9.09 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 121.819 1.679 . . . . 62.12 111.36 177.19 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 49.5 m -147.09 179.88 7.31 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.09 -1.078 . . . . 74.52 108.09 -178.704 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.8 t -43.74 137.78 3.23 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 124.333 1.053 . . . . 52.2 113.193 179.64 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 461' ' ' PRO . . . . . 0.504 ' O ' HG12 ' A' ' 464' ' ' VAL . 9.3 Cg_endo -51.58 -28.84 30.25 Favored 'Trans proline' 0 C--N 1.363 1.298 0 C-N-CA 124.815 3.676 . . . . 65.33 113.963 -177.419 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.73 -18.6 63.53 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.315 0.579 . . . . 65.12 111.406 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 82.7 mt -102.73 6.62 39.55 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 116.176 -0.465 . . . . 63.22 112.02 -179.353 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 461' ' ' PRO . 14.8 p -61.54 127.35 21.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 119.491 -0.883 . . . . 65.22 109.406 176.716 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 78.85 -1.24 74.65 Favored Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 121.171 -0.538 . . . . 62.01 112.204 179.064 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -101.35 159.29 15.39 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 108.265 -1.013 . . . . 71.42 108.265 -178.552 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.448 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 75.1 t -80.54 140.9 15.99 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 CA-C-N 115.426 -0.806 . . . . 65.45 109.569 176.468 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 63.2 mt -98.28 -35.25 5.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 108.249 -1.019 . . . . 74.42 108.249 176.645 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 168.86 -177.4 42.71 Favored Glycine 0 N--CA 1.425 -2.064 0 C-N-CA 120.526 -0.845 . . . . 61.41 112.215 178.063 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 470' ' ' THR . . . . . 0.524 HG22 HG12 ' A' ' 486' ' ' ILE . 72.3 p -116.14 144.24 44.43 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.432 -1.692 . . . . 73.1 106.432 179.081 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.512 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 22.3 t-20 -64.31 -57.68 16.74 Favored Pre-proline 0 C--N 1.319 -0.724 0 C-N-CA 120.064 -0.654 . . . . 71.11 112.051 177.781 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 24.4 Cg_exo -73.25 139.92 29.95 Favored 'Trans proline' 0 C--N 1.361 1.188 0 N-CA-C 108.041 -1.561 . . . . 54.41 108.041 170.152 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.418 ' C ' ' H ' ' A' ' 475' ' ' ASN . 23.8 Cg_exo -62.59 128.1 22.55 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.373 2.048 . . . . 75.04 114.234 -173.474 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -83.84 18.58 1.95 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 122.431 1.11 . . . . 52.2 109.375 179.383 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 475' ' ' ASN . . . . . 0.418 ' H ' ' C ' ' A' ' 473' ' ' PRO . 15.5 m120 -111.88 -9.96 14.02 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.038 -1.437 . . . . 74.42 109.427 -179.427 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -119.75 -179.35 3.87 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-O 121.454 0.645 . . . . 75.41 112.564 -170.144 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.97 134.38 34.52 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.621 -1.251 . . . . 71.13 107.621 178.136 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 24.4 m -128.96 145.56 51.2 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.151 -0.685 . . . . 63.53 109.151 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -78.44 167.48 21.24 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 120.861 0.362 . . . . 61.12 111.862 -178.098 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 40.0 mm -71.43 -17.17 19.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.633 0.73 . . . . 75.01 110.272 -178.217 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 15.9 p -94.88 5.24 52.46 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.658 -0.651 . . . . 54.54 112.14 179.254 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -83.69 139.54 32.71 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.273 0.559 . . . . 65.03 112.194 -177.713 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 60.2 t -108.3 126.52 64.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 107.842 -1.17 . . . . 74.54 107.842 176.27 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.45 HG12 ' HG2' ' A' ' 472' ' ' PRO . 34.1 m -110.11 120.57 61.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-O 121.426 0.631 . . . . 74.0 111.158 178.823 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.75 129.1 44.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.219 -1.03 . . . . 74.13 108.219 174.187 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.524 HG12 HG22 ' A' ' 470' ' ' THR . 18.4 mt -113.06 128.26 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 CA-C-N 115.117 -0.947 . . . . 73.2 110.366 -177.438 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 4.9 tt -104.48 126.6 59.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-N 115.566 -0.743 . . . . 71.13 109.695 -178.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 34.2 m -111.96 151.74 13.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 115.523 -0.762 . . . . 32.01 109.571 179.275 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -90.23 144.53 17.59 Favored Glycine 0 N--CA 1.424 -2.131 0 C-N-CA 121.167 -0.539 . . . . 62.23 112.959 -176.961 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.541 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 23.2 t -124.38 142.91 50.92 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 106.192 -1.781 . . . . 53.11 106.192 174.176 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -130.81 105.59 0.65 Allowed Glycine 0 N--CA 1.433 -1.529 0 C-N-CA 119.639 -1.267 . . . . 63.43 112.96 -175.455 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -66.09 147.7 84.48 Favored 'Trans proline' 0 C--O 1.248 0.983 0 C-N-CA 122.939 2.426 . . . . 72.11 110.476 174.326 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -88.57 72.41 8.77 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.749 0.785 . . . . 55.52 111.371 -177.098 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 22.1 p -126.0 146.46 49.87 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.361 -0.836 . . . . 73.44 110.823 -178.671 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -138.14 146.35 42.69 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.498 -0.927 . . . . 73.54 108.498 178.84 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 13.7 t70 -99.59 111.66 23.97 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.424 -0.954 . . . . 72.44 108.424 -178.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 497' ' ' ILE . . . . . 0.569 HD13 ' O ' ' A' ' 543' ' ' THR . 0.2 OUTLIER -75.79 127.1 86.27 Favored Pre-proline 0 C--O 1.236 0.357 0 N-CA-C 113.797 1.036 . . . . 71.23 113.797 -174.114 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -94.98 151.23 1.71 Allowed 'Trans proline' 0 CA--C 1.55 1.314 0 C-N-CA 123.111 2.54 . . . . 64.43 110.84 171.178 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 499' ' ' ASP . . . . . 0.441 ' HB3' ' HB2' ' A' ' 541' ' ' ALA . 7.3 p-10 -89.94 129.94 36.22 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.382 0.611 . . . . 53.14 110.323 -179.088 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.79 81.7 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-O 122.806 1.289 . . . . 73.1 109.533 177.268 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -97.44 145.78 25.85 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 113.814 -1.539 . . . . 64.13 108.885 -177.656 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 111.47 44.39 0.91 Allowed Glycine 0 CA--C 1.476 -2.378 0 N-CA-C 109.27 -1.532 . . . . 44.34 109.27 -177.082 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -141.22 167.05 23.11 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 108.826 -0.805 . . . . 65.33 108.826 -177.161 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 13.2 t -91.41 161.84 14.83 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 108.061 -1.088 . . . . 70.24 108.061 176.694 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 31.2 m -51.44 -42.07 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.668 0 C-N-CA 124.49 1.116 . . . . 72.24 113.396 -174.943 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -68.16 -41.8 81.02 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.253 0.549 . . . . 64.04 111.04 -177.444 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 51.7 t -72.66 -36.53 53.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.365 -0.834 . . . . 62.43 110.46 -176.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -62.51 -48.48 79.37 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.611 -0.268 . . . . 72.01 110.696 178.403 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -60.18 -41.77 93.61 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.298 0.571 . . . . 75.13 109.758 178.746 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.407 ' O ' HG23 ' A' ' 514' ' ' VAL . 0.6 OUTLIER -61.5 -43.19 99.3 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.546 -1.206 . . . . 70.23 110.173 -177.852 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -62.4 -42.91 99.79 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 116.438 -0.347 . . . . 74.1 111.281 179.416 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.31 -40.9 97.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.54 -0.3 . . . . 73.4 110.504 177.805 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -61.83 -43.02 99.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.965 0.412 . . . . 75.15 110.161 178.173 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 510' ' ' LYS . 93.7 t -67.1 -26.34 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-N 115.656 -0.702 . . . . 74.33 111.583 178.575 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -76.17 -25.38 55.18 Favored 'General case' 0 CA--C 1.514 -0.416 0 O-C-N 121.666 -0.646 . . . . 71.22 109.908 177.547 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 111.87 36.35 1.7 Allowed Glycine 0 N--CA 1.436 -1.359 0 C-N-CA 120.822 -0.704 . . . . 73.25 111.944 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -120.34 122.82 41.66 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 107.484 -1.302 . . . . 73.33 107.484 178.441 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.6 m -101.81 -18.17 15.89 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 115.831 -0.622 . . . . 73.53 110.628 -175.629 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -113.61 113.22 24.75 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.82 0.819 . . . . 70.11 110.907 -179.394 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -132.28 155.94 47.43 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.379 -1.282 . . . . 64.04 110.155 -177.611 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 48.8 m -141.34 138.84 33.37 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 108.122 -1.066 . . . . 72.45 108.122 173.246 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.09 119.57 35.16 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.644 0.735 . . . . 63.21 112.15 179.733 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -107.15 118.86 37.83 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.258 -0.883 . . . . 71.24 109.726 -178.255 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 67.4 m -84.54 123.01 29.82 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.087 -0.709 . . . . 53.24 109.087 176.023 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 32.7 m -121.4 150.98 24.55 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 N-CA-C 107.554 -1.276 . . . . 72.1 107.554 -179.663 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 526' ' ' ASP . . . . . 0.408 ' HB2' HD21 ' A' ' 559' ' ' ASN . 0.2 OUTLIER -90.53 137.54 32.27 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.58 -1.248 . . . . 61.21 109.981 -177.374 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 69.0 m -155.96 -176.12 0.58 Allowed Pre-proline 0 C--N 1.304 -1.413 0 N-CA-C 107.445 -1.317 . . . . 74.41 107.445 -176.934 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -73.45 -28.21 12.39 Favored 'Trans proline' 0 C--N 1.36 1.148 0 CA-C-N 120.941 1.372 . . . . 74.12 111.739 173.396 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -64.84 137.14 97.05 Favored Pre-proline 0 N--CA 1.475 0.812 0 CA-C-N 116.405 -0.362 . . . . 64.11 111.813 -178.834 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.58 151.9 43.91 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 124.032 3.155 . . . . 72.04 114.965 -173.318 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.59 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -69.35 107.97 3.52 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 115.047 -0.978 . . . . 35.24 110.875 -178.496 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 128.69 -10.87 6.35 Favored Glycine 0 C--N 1.292 -1.899 0 N-CA-C 110.393 -1.083 . . . . 63.24 110.393 -178.714 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -82.52 125.02 30.65 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 109.238 -0.653 . . . . 75.32 109.238 176.891 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 62.0 t -87.8 107.53 17.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 106.788 -1.56 . . . . 62.44 106.788 175.499 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 6.1 t -83.87 -8.7 59.13 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.631 -0.713 . . . . 74.22 111.336 -172.056 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.16 -155.5 26.46 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 120.693 -0.765 . . . . 64.53 111.299 177.448 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 537' ' ' THR . . . . . 0.458 HG22 HD23 ' A' ' 553' ' ' LEU . 24.6 p -122.99 159.43 28.37 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 109.348 -0.612 . . . . 63.35 109.348 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -72.97 -53.05 5.33 Favored Pre-proline 0 C--N 1.306 -1.292 0 CA-C-O 118.876 -0.583 . . . . 64.54 110.578 174.062 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -61.57 128.09 23.68 Favored 'Trans proline' 0 C--N 1.378 2.084 0 N-CA-C 109.008 -1.189 . . . . 71.33 109.008 170.578 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -64.65 141.44 72.8 Favored 'Trans proline' 0 C--O 1.253 1.259 0 C-N-CA 122.177 1.918 . . . . 74.1 112.599 -177.656 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 541' ' ' ALA . . . . . 0.441 ' HB2' ' HB3' ' A' ' 499' ' ' ASP . . . -67.65 139.74 56.82 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 108.13 -1.063 . . . . 73.3 108.13 175.639 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.82 -5.0 39.54 Favored Glycine 0 N--CA 1.416 -2.668 0 N-CA-C 110.313 -1.115 . . . . 23.23 110.313 -175.513 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.569 ' O ' HD13 ' A' ' 497' ' ' ILE . 27.2 m -88.85 136.61 32.92 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 120.49 -0.484 . . . . 63.25 109.767 177.275 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 28.9 m -89.82 122.84 33.26 Favored 'General case' 0 N--CA 1.416 -2.147 0 N-CA-C 107.148 -1.427 . . . . 63.45 107.148 172.276 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.4 m -127.01 154.54 76.5 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 110.222 -0.288 . . . . 54.32 110.222 -177.453 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -68.84 151.88 73.98 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.305 2.003 . . . . 64.12 110.113 173.136 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 26.3 m -67.32 -20.28 26.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.724 0.773 . . . . 53.22 110.063 177.836 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -77.56 -11.4 59.85 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 114.94 -1.027 . . . . 72.22 112.258 -179.454 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 49.0 m -78.72 154.65 29.89 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 121.863 -0.523 . . . . 51.31 111.021 178.908 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 41.7 t -97.72 116.04 39.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 108.679 -0.859 . . . . 72.33 108.679 179.434 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.42 126.61 40.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.171 -0.677 . . . . 74.41 109.171 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -102.43 115.78 31.27 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-O 121.775 0.798 . . . . 62.11 109.636 -178.585 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 553' ' ' LEU . . . . . 0.458 HD23 HG22 ' A' ' 537' ' ' THR . 67.3 mt -87.65 134.25 33.68 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 113.856 -1.52 . . . . 75.51 107.551 178.096 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -112.32 115.36 28.63 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 122.257 1.027 . . . . 73.04 110.137 178.569 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 41.7 t -101.15 139.45 22.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 CA-C-N 114.441 -1.254 . . . . 75.02 108.446 -176.16 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.59 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 50.6 m -92.46 147.29 23.02 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-O 121.413 0.625 . . . . 54.11 112.093 179.786 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 0.2 OUTLIER -118.58 132.49 56.2 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 105.247 -2.131 . . . . 75.0 105.247 170.772 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -82.47 -24.1 54.78 Favored Glycine 0 CA--C 1.492 -1.371 0 N-CA-C 114.638 0.615 . . . . 72.12 114.638 -169.017 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 559' ' ' ASN . . . . . 0.408 HD21 ' HB2' ' A' ' 526' ' ' ASP . 43.8 m-80 68.13 31.81 5.19 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 107.548 -1.278 . . . . 60.45 107.548 -174.362 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 -135.11 141.72 46.08 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 106.281 -1.748 . . . . 73.34 106.281 -175.803 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -143.09 147.66 35.38 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 109.731 -0.47 . . . . 72.41 109.731 176.785 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 562' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 612' ' ' THR . 63.1 t -67.99 118.37 11.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-O 121.149 0.5 . . . . 75.15 110.303 -179.34 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 563' ' ' MET . . . . . 0.408 ' HG2' ' O ' ' A' ' 564' ' ' PRO . 53.7 ttp -83.15 132.96 48.85 Favored Pre-proline 0 C--N 1.306 -1.293 0 CA-C-N 115.759 -0.655 . . . . 74.42 111.251 -177.553 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 564' ' ' PRO . . . . . 0.408 ' O ' ' HG2' ' A' ' 563' ' ' MET . 61.1 Cg_endo -74.29 170.14 20.87 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.048 2.498 . . . . 73.12 110.597 172.69 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -67.17 142.44 57.02 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.913 0.387 . . . . 74.43 110.905 179.529 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 94.0 mt -121.56 17.56 11.25 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.745 -0.661 . . . . 74.31 109.593 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 11.3 m -63.04 130.5 44.98 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.314 -0.857 . . . . 74.35 109.851 -179.785 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 88.43 46.2 4.72 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 119.916 -1.135 . . . . 54.04 112.197 177.427 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 26.8 ptm -118.71 157.72 26.92 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.162 -1.051 . . . . 71.22 108.162 176.401 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 570' ' ' PHE . . . . . 0.477 ' H ' ' HB3' ' A' ' 573' ' ' ASP . 91.9 m-85 -130.81 163.68 26.82 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.608 -1.256 . . . . 73.25 107.608 -176.502 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 35.8 t90 -65.44 -36.54 84.22 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.41 0.624 . . . . 74.12 109.612 176.803 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.7 m -75.58 -8.88 12.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.363 -0.835 . . . . 74.0 110.433 -178.811 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 573' ' ' ASP . . . . . 0.498 ' O ' ' HB2' ' A' ' 577' ' ' ARG . 13.7 t70 -101.21 -37.32 8.59 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.97 -1.013 . . . . 75.42 109.287 178.217 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -61.47 -34.71 75.92 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 124.314 1.046 . . . . 60.41 111.892 -179.404 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.476 ' HB2' ' HD3' ' A' ' 576' ' ' PRO . 9.3 mm-40 -60.1 -58.83 16.53 Favored Pre-proline 0 CA--C 1.559 1.291 0 N-CA-C 112.672 0.619 . . . . 34.34 112.672 177.241 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 576' ' ' PRO . . . . . 0.476 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 51.0 Cg_exo -61.59 -35.1 83.04 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 121.57 1.513 . . . . 64.24 111.782 171.887 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 573' ' ' ASP . 0.4 OUTLIER -59.54 -40.59 87.72 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.039 0.535 . . . . 73.42 110.394 -178.106 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 7.1 tt -57.63 -47.37 82.41 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.702 0.801 . . . . 75.13 109.237 179.666 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -66.63 -46.93 74.23 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.563 -0.744 . . . . 74.25 110.248 -178.65 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -62.79 -39.03 92.97 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.749 0.82 . . . . 75.01 112.803 -177.517 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 96.4 mt -89.45 -8.57 52.69 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 120.719 -0.392 . . . . 73.21 111.457 -179.029 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 63.52 43.38 98.19 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 109.679 -1.369 . . . . 50.44 109.679 -175.503 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 22.1 t90 -73.75 126.63 30.79 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 114.845 -0.677 . . . . 72.34 111.14 -172.389 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 24.0 m -99.86 -8.07 24.54 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.575 0.702 . . . . 63.33 109.749 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 585' ' ' GLY . . . . . 0.43 ' HA2' ' OD1' ' A' ' 617' ' ' ASP . . . -69.14 170.35 41.52 Favored Glycine 0 N--CA 1.428 -1.874 0 CA-C-N 115.127 -0.942 . . . . 74.45 113.804 -177.129 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 36.1 ttm -105.48 135.14 47.42 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.101 -1.05 . . . . 71.43 109.997 -177.12 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 56.7 tp -88.59 131.13 35.09 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.51 -0.922 . . . . 73.1 108.51 175.974 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -94.37 104.78 16.76 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.002 0.429 . . . . 72.3 110.797 -176.302 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -114.24 112.41 23.09 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 109.415 -0.587 . . . . 74.41 109.415 174.182 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -127.48 -40.76 0.31 Allowed Glycine 0 C--N 1.309 -0.97 0 C-N-CA 119.435 -1.364 . . . . 63.3 112.943 177.711 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 591' ' ' ALA . . . . . 0.484 ' HB3' ' NH2' ' A' ' 623' ' ' ARG . . . -139.58 157.5 45.7 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 122.577 0.351 . . . . 53.21 110.643 -177.788 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -110.39 124.26 51.39 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.457 -1.312 . . . . 71.34 107.457 176.422 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 35.9 t -109.02 115.89 50.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 C-N-CA 120.063 -0.655 . . . . 65.11 110.365 -176.85 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -100.03 116.78 32.86 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.995 -0.682 . . . . 64.03 110.425 179.658 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -132.69 -27.94 1.66 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 116.092 -0.504 . . . . 64.4 110.898 179.494 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 141.24 -169.41 25.05 Favored Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 110.494 -1.042 . . . . 53.33 110.494 -177.865 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.53 -35.18 65.58 Favored Glycine 0 CA--C 1.509 -0.307 0 O-C-N 123.877 0.398 . . . . 61.34 113.851 -175.877 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 42.6 m -58.68 -32.3 68.99 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.102 0.408 . . . . 63.13 112.102 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -108.61 -1.59 19.46 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.071 0.462 . . . . 75.44 110.651 -178.095 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -67.1 99.72 0.7 Allowed 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.211 -0.45 . . . . 75.44 112.051 -175.611 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 601' ' ' ASN . . . . . 0.458 ' OD1' ' HB3' ' A' ' 570' ' ' PHE . 11.7 t-20 67.15 -3.25 1.02 Allowed 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 125.251 1.42 . . . . 62.31 112.367 174.384 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -93.18 152.93 18.93 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 123.963 0.905 . . . . 75.15 111.326 -175.186 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 603' ' ' VAL . . . . . 0.477 HG23 ' HB2' ' A' ' 622' ' ' LEU . 12.9 p -57.06 138.76 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 124.554 1.142 . . . . 70.3 110.697 178.631 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 61.0 t -93.97 -56.12 5.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 108.118 -1.068 . . . . 74.43 108.118 179.119 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -151.42 154.62 36.98 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 107.78 -1.193 . . . . 62.0 107.78 -179.59 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 606' ' ' GLN . . . . . 0.413 ' HB2' HD11 ' A' ' 620' ' ' ILE . 16.7 pt20 -109.06 122.1 46.55 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.038 -1.467 . . . . 73.44 107.038 172.744 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.557 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 42.7 t-20 -53.21 -57.95 14.52 Favored Pre-proline 0 N--CA 1.483 1.189 0 CA-C-O 119.31 -0.376 . . . . 61.11 111.926 -178.659 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.557 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 1.2 Cg_endo -85.7 131.33 3.9 Favored 'Trans proline' 0 N--CA 1.44 -1.635 0 C-N-CA 121.262 1.308 . . . . 71.1 109.947 174.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 609' ' ' PRO . . . . . 0.493 ' O ' HG22 ' A' ' 612' ' ' THR . 53.2 Cg_endo -70.38 156.22 62.2 Favored 'Trans proline' 0 C--O 1.243 0.739 0 C-N-CA 122.069 1.846 . . . . 72.41 111.541 178.625 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -64.41 128.33 35.33 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.371 -0.603 . . . . 74.11 109.371 178.98 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 106.02 -3.57 38.38 Favored Glycine 0 C--N 1.3 -1.432 0 C-N-CA 120.394 -0.908 . . . . 22.23 112.92 -177.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 612' ' ' THR . . . . . 0.493 HG22 ' O ' ' A' ' 609' ' ' PRO . 9.1 t -96.17 176.88 5.91 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-N 117.858 0.829 . . . . 73.15 109.111 175.504 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -97.87 119.47 6.44 Favored Glycine 0 N--CA 1.425 -2.082 0 CA-C-N 116.194 -0.457 . . . . 62.14 112.041 -177.075 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 26.8 m -104.95 144.3 14.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 C-N-CA 123.479 0.712 . . . . 73.55 109.523 177.86 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.557 ' ND2' ' HB3' ' A' ' 617' ' ' ASP . 36.6 p-10 -57.8 161.13 4.0 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 123.684 0.794 . . . . 74.32 111.968 -178.074 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -63.21 -25.9 68.55 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 120.82 0.343 . . . . 63.54 111.218 -178.015 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 617' ' ' ASP . . . . . 0.557 ' HB3' ' ND2' ' A' ' 615' ' ' ASN . 13.9 t70 -60.08 -40.05 88.21 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.667 -0.864 . . . . 74.44 108.667 174.308 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 87.96 20.98 48.14 Favored Glycine 0 N--CA 1.428 -1.885 0 CA-C-N 115.408 -0.814 . . . . 70.33 112.115 176.87 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 619' ' ' ILE . . . . . 0.425 ' HB ' ' OD1' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -69.24 119.28 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-O 122.762 1.268 . . . . 72.03 109.883 -173.523 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.413 HD11 ' HB2' ' A' ' 606' ' ' GLN . 3.2 tp -117.55 125.69 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.939 0 CA-C-N 113.422 -1.717 . . . . 74.22 107.714 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 17.5 m -98.26 116.39 30.39 Favored 'General case' 0 N--CA 1.412 -2.367 0 C-N-CA 118.877 -1.129 . . . . 74.51 108.097 178.436 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 622' ' ' LEU . . . . . 0.477 ' HB2' HG23 ' A' ' 603' ' ' VAL . 0.0 OUTLIER -139.64 155.4 47.43 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 106.961 -1.496 . . . . 62.35 106.961 179.653 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 623' ' ' ARG . . . . . 0.484 ' NH2' ' HB3' ' A' ' 591' ' ' ALA . 57.2 mtp180 -128.74 156.63 43.21 Favored 'General case' 0 C--N 1.272 -2.782 0 N-CA-C 105.271 -2.122 . . . . 70.24 105.271 175.186 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -131.14 158.05 41.5 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 106.637 -1.616 . . . . 73.33 106.637 175.184 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -81.88 -117.32 0.47 Allowed Glycine 0 N--CA 1.423 -2.181 0 C-N-CA 120.073 -1.06 . . . . 74.53 113.414 -177.252 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 . . . . . 0 C--N 1.297 -1.709 0 N-CA-C 108.886 -0.783 . . . . 73.15 108.886 -174.134 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.38 0 N-CA-C 109.715 -1.354 . . . . 43.05 109.715 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 10.7 tp -75.08 141.79 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 108.436 -0.95 . . . . 73.11 108.436 177.693 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 1.4 m -73.15 134.7 44.52 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 109.189 -0.671 . . . . 64.12 109.189 178.556 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -92.21 -37.29 12.78 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 108.494 -0.928 . . . . 64.32 108.494 -179.583 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -89.07 117.89 28.39 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.073 -0.967 . . . . 71.12 109.412 -176.986 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 34.6 m -121.22 153.93 24.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 N-CA-C 107.019 -1.474 . . . . 40.22 107.019 177.869 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -94.56 136.2 35.13 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 117.578 -1.649 . . . . 74.23 107.284 179.274 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 98.1 t -96.8 124.24 50.91 Favored Pre-proline 0 C--N 1.274 -2.704 0 N-CA-C 109.666 -0.494 . . . . 73.42 109.666 -172.912 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -64.12 125.87 16.06 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.935 1.757 . . . . 74.21 110.058 178.802 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 364' ' ' ASP . . . . . 0.571 ' OD1' ' HG2' ' A' ' 366' ' ' ARG . 16.5 t70 -85.69 138.36 32.18 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-O 121.726 0.774 . . . . 73.34 112.044 -176.608 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 18.5 m -108.22 4.93 9.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 113.981 -1.463 . . . . 60.05 111.777 -175.421 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.571 ' HG2' ' OD1' ' A' ' 364' ' ' ASP . 25.7 mmt-85 -62.54 147.48 48.87 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 112.624 0.602 . . . . 64.22 112.624 178.568 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.64 -9.59 44.7 Favored Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 110.709 -0.957 . . . . 74.34 110.709 -174.624 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -103.75 -150.68 0.42 Allowed 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.481 -0.933 . . . . 71.02 108.481 178.767 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 60.3 p -98.05 155.04 17.31 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.464 -0.939 . . . . 73.21 108.464 -178.162 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 23.0 t -61.42 -33.79 74.3 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.587 -0.523 . . . . 70.24 109.587 179.104 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -65.59 -46.46 79.3 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 116.24 -0.436 . . . . 73.35 111.138 178.76 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.54 -44.87 73.6 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-O 121.426 0.632 . . . . 61.1 110.376 -179.505 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -60.21 -48.11 83.13 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.582 -1.19 . . . . 40.43 111.567 -178.23 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.53 -39.31 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 116.644 -0.253 . . . . 52.11 111.27 177.721 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.9 -44.48 91.24 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-O 121.302 0.572 . . . . 74.3 111.112 -178.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 376' ' ' THR . . . . . 0.443 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 70.9 m -64.18 -47.34 80.19 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.438 -0.801 . . . . 64.25 110.648 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 95.5 mt -64.16 -38.79 92.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.474 -0.33 . . . . 74.14 111.169 -179.265 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 63.6 tp60 -62.29 -43.02 99.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.981 -0.554 . . . . 73.54 110.787 179.053 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -64.19 -31.86 73.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.274 0.559 . . . . 74.25 111.279 176.97 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 380' ' ' ARG . . . . . 0.443 ' HG2' ' O ' ' A' ' 376' ' ' THR . 29.8 mmm180 -80.11 -13.55 59.19 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.989 -0.55 . . . . 65.33 111.388 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 94.06 15.65 47.55 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.65 -0.786 . . . . 52.12 112.578 177.335 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -80.39 156.54 26.62 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 122.451 -0.441 . . . . 74.21 111.266 177.248 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -99.76 133.81 43.57 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 107.129 -1.434 . . . . 34.22 107.129 177.924 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.491 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -127.33 155.1 38.32 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 C-N-CA 120.1 -0.64 . . . . 72.11 111.124 -175.404 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 385' ' ' ARG . . . . . 0.412 ' HB3' HG22 ' A' ' 417' ' ' THR . 7.7 tpt180 -136.08 141.28 44.22 Favored 'General case' 0 N--CA 1.403 -2.817 0 CA-C-N 114.571 -1.195 . . . . 74.31 108.011 169.763 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.2 m -127.22 134.9 50.04 Favored 'General case' 0 C--N 1.271 -2.846 0 N-CA-C 104.55 -2.389 . . . . 61.11 104.55 179.634 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.57 124.34 45.09 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 119.317 -0.953 . . . . 62.25 109.201 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -91.34 121.79 33.39 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.086 -0.709 . . . . 74.1 109.086 -177.306 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 389' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 421' ' ' SER . 55.0 mtpt -136.79 130.32 17.68 Favored Pre-proline 0 C--N 1.308 -1.22 0 N-CA-C 110.215 -0.291 . . . . 73.41 110.215 176.352 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.528 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 54.0 Cg_endo -79.4 127.95 7.69 Favored 'Trans proline' 0 C--O 1.254 1.324 0 C-N-CA 120.956 1.104 . . . . 53.31 109.836 173.823 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.528 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 8.6 t70 154.33 -164.92 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 103.802 -2.666 . . . . 71.33 103.802 -177.649 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 26.7 t -142.7 4.7 1.53 Allowed 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 118.098 0.408 . . . . 60.21 110.187 176.512 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 15.3 t -79.62 -18.13 52.24 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-O 121.338 0.589 . . . . 54.24 109.781 179.661 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.616 HD13 ' H ' ' A' ' 394' ' ' ILE . 0.2 OUTLIER -99.58 150.43 36.78 Favored Pre-proline 0 N--CA 1.424 -1.743 0 N-CA-C 107.012 -1.477 . . . . 74.32 107.012 176.704 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 395' ' ' PRO . . . . . 0.427 ' HA ' ' HD2' ' A' ' 396' ' ' PRO . 77.8 Cg_exo -49.72 132.89 32.08 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.139 2.559 . . . . 65.53 114.228 -177.556 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 396' ' ' PRO . . . . . 0.574 ' HA ' ' OG ' ' A' ' 421' ' ' SER . 17.5 Cg_endo -60.75 164.03 14.58 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.595 2.863 . . . . 72.45 110.832 174.302 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 397' ' ' ASP . . . . . 0.425 ' HA ' HG13 ' A' ' 420' ' ' VAL . 0.9 OUTLIER -57.51 -8.91 0.93 Allowed 'General case' 0 N--CA 1.511 2.583 0 CA-C-O 121.915 0.864 . . . . 72.31 111.012 179.023 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -93.57 101.23 13.4 Favored 'General case' 0 CA--C 1.477 -1.841 0 N-CA-C 102.398 -3.186 . . . . 74.42 102.398 170.205 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 16.5 m -63.32 118.19 5.15 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.488 0 O-C-N 124.197 0.936 . . . . 64.52 112.491 -166.662 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 49.3 mm -103.61 -39.3 5.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 115.259 -0.882 . . . . 73.03 111.08 -177.34 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.41 157.32 27.35 Favored Glycine 0 N--CA 1.433 -1.54 0 C-N-CA 119.739 -1.219 . . . . 35.55 112.627 -175.51 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -156.31 -174.98 5.19 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 126.062 1.745 . . . . 73.52 109.797 -176.261 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 403' ' ' ASP . . . . . 0.424 ' C ' ' H ' ' A' ' 405' ' ' ALA . 10.7 t70 -96.96 136.15 21.7 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 105.942 -1.873 . . . . 74.42 105.942 176.252 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 404' ' ' PRO . . . . . 0.507 ' HA ' ' OD1' ' A' ' 407' ' ' ASN . 38.0 Cg_endo -63.01 23.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 124.823 3.682 . . . . 74.12 115.622 -173.092 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.424 ' H ' ' C ' ' A' ' 403' ' ' ASP . . . -54.01 -42.16 68.79 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 124.075 0.95 . . . . 72.1 110.92 177.569 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -79.24 -31.1 43.46 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.593 0.711 . . . . 73.5 110.516 -179.666 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 407' ' ' ASN . . . . . 0.507 ' OD1' ' HA ' ' A' ' 404' ' ' PRO . 8.9 m120 -79.68 -7.75 58.78 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.354 -0.839 . . . . 73.32 110.194 -175.782 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 89.9 m -99.42 148.71 23.93 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.564 -1.643 . . . . 74.25 106.564 176.623 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 17.3 m -74.45 111.89 10.09 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 107.814 -1.18 . . . . 62.32 107.814 177.445 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.36 169.86 20.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 C-N-CA 123.089 0.556 . . . . 61.42 110.262 -177.773 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 49.7 m -68.49 131.9 46.07 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.447 -0.946 . . . . 73.41 108.447 174.303 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -58.51 111.07 1.11 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.334 0.588 . . . . 64.02 110.683 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 111.1 73.81 0.72 Allowed Glycine 0 N--CA 1.432 -1.577 0 N-CA-C 110.58 -1.008 . . . . 65.21 110.58 -179.526 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -129.44 -175.0 3.44 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 105.853 -1.906 . . . . 34.3 105.853 179.935 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -102.76 123.45 46.45 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 118.401 0.546 . . . . 73.51 110.545 -177.02 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 27.1 mm -113.12 120.69 63.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 109.043 -0.725 . . . . 53.14 109.043 -179.746 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 417' ' ' THR . . . . . 0.412 HG22 ' HB3' ' A' ' 385' ' ' ARG . 17.1 p -100.62 131.44 46.53 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 112.006 0.373 . . . . 72.31 112.006 -178.488 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 7.7 p -126.81 134.91 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-O 120.892 0.377 . . . . 65.43 110.846 176.279 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -101.6 128.46 47.87 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.816 -1.179 . . . . 73.41 107.816 175.201 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.425 HG13 ' HA ' ' A' ' 397' ' ' ASP . 54.0 t -124.55 135.92 62.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 C-N-CA 122.999 0.52 . . . . 73.01 110.352 -175.491 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 421' ' ' SER . . . . . 0.574 ' OG ' ' HA ' ' A' ' 396' ' ' PRO . 77.7 p -84.9 121.12 27.29 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 109.086 -0.709 . . . . 61.13 109.086 177.897 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 33.8 m -118.69 106.2 12.35 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 109.07 -0.715 . . . . 60.32 109.07 177.95 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 92.21 118.52 2.45 Favored Glycine 0 N--CA 1.425 -2.045 0 C-N-CA 120.6 -0.81 . . . . 72.15 111.687 -178.514 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -77.96 158.12 30.87 Favored 'Trans proline' 0 C--O 1.243 0.747 0 C-N-CA 122.565 2.177 . . . . 70.22 109.692 174.9 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -71.72 166.1 22.65 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.726 0.774 . . . . 74.14 111.897 -175.371 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -87.63 158.32 18.89 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.502 -1.226 . . . . 72.22 108.036 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -121.08 143.03 49.29 Favored 'General case' 0 CA--C 1.479 -1.779 0 CA-C-O 121.367 0.603 . . . . 71.13 112.145 -173.694 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -82.96 134.71 35.05 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.271 -1.331 . . . . 75.45 108.755 178.999 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 474' ' ' ALA . 50.2 mt -83.02 125.96 73.67 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 109.144 -0.688 . . . . 71.23 109.144 -179.45 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -71.03 154.68 62.57 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.426 2.084 . . . . 74.24 110.905 173.077 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -74.07 158.86 33.51 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 108.986 -0.746 . . . . 74.42 108.986 178.068 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 12.2 p -142.4 147.05 21.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 109.949 -0.389 . . . . 64.03 109.949 -178.447 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 19.5 m -72.84 137.01 45.45 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 108.65 -0.87 . . . . 65.33 108.65 175.806 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 54.4 p -62.44 -31.19 71.86 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 113.822 1.045 . . . . 72.41 113.822 -171.349 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.4 pp -81.67 -11.5 59.05 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.224 -0.99 . . . . 63.13 111.382 179.11 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 5.5 m -105.41 62.68 0.68 Allowed 'General case' 0 N--CA 1.432 -1.341 0 CA-C-O 122.191 0.996 . . . . 70.43 112.0 -176.21 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -56.12 -37.1 68.99 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.593 1.157 . . . . 73.54 111.397 176.25 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.33 -40.61 78.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.124 0.488 . . . . 64.32 111.016 178.077 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -70.28 -34.97 73.4 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.308 -0.627 . . . . 73.44 109.308 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.555 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -60.8 -51.39 69.52 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.74 -0.664 . . . . 62.31 111.345 179.15 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 35.4 m -65.47 -39.11 84.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 112.31 0.485 . . . . 74.0 112.31 -177.802 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -34.76 77.41 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 120.607 -0.437 . . . . 72.21 111.572 178.111 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 27.3 mmtm -61.76 -39.81 92.95 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-N 116.4 -0.363 . . . . 75.42 110.452 177.427 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 75.5 mt -63.88 -43.25 96.6 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.369 -0.832 . . . . 52.31 110.073 179.252 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 61.1 m -65.35 -42.68 92.57 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.362 -0.381 . . . . 74.22 111.646 177.946 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -63.35 -29.25 70.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.708 0.766 . . . . 71.23 110.611 178.455 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -85.02 5.22 30.28 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.454 -0.794 . . . . 42.02 111.889 179.194 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 105.48 -66.5 0.27 Allowed Glycine 0 CA--C 1.496 -1.142 0 C-N-CA 120.374 -0.917 . . . . 42.2 112.96 172.749 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -46.65 -65.88 0.49 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 114.353 1.242 . . . . 73.05 114.353 177.767 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 59.09 26.22 60.83 Favored Glycine 0 N--CA 1.469 0.887 0 C-N-CA 120.948 -0.644 . . . . 73.32 112.65 -176.005 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.581 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 16.3 mmt85 -100.73 111.37 23.59 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 107.148 -1.427 . . . . 75.41 107.148 -177.221 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -140.2 153.44 46.59 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 112.487 0.551 . . . . 70.21 112.487 -174.247 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 453' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' A' ' 453' ' ' LYS . 72.0 mmtt -138.81 148.53 43.9 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 124.77 1.228 . . . . 51.14 108.996 176.814 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -121.1 124.94 45.99 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 122.967 0.507 . . . . 74.22 110.609 -176.808 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -128.19 162.79 26.13 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.016 -0.735 . . . . 71.25 109.016 178.05 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -129.11 146.76 50.98 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 120.969 0.414 . . . . 33.24 110.072 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 36.8 t -143.47 149.14 46.52 Favored Pre-proline 0 C--N 1.29 -1.985 0 N-CA-C 107.453 -1.314 . . . . 34.22 107.453 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.716 ' HA ' ' O ' ' A' ' 490' ' ' SER . 24.3 Cg_exo -64.83 134.77 41.74 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.874 1.716 . . . . 61.54 109.722 176.545 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 62.6 m -152.07 172.17 16.73 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 116.181 -0.463 . . . . 63.02 109.855 -178.191 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 7.0 t -53.78 141.46 46.79 Favored Pre-proline 0 N--CA 1.438 -1.043 0 C-N-CA 124.487 1.115 . . . . 70.54 111.072 177.22 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -52.72 -30.67 47.34 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 124.698 3.598 . . . . 74.5 113.342 -176.302 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -72.97 -28.63 62.51 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.958 -0.565 . . . . 50.43 111.791 -178.812 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 11.2 mp -98.57 -0.61 42.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.592 0.234 . . . . 63.32 111.555 178.736 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 53.3 t -61.69 126.65 20.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-O 121.035 0.445 . . . . 75.03 109.92 175.229 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 87.58 0.21 84.44 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.711 -0.677 . . . . 64.34 111.75 -178.738 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.32 158.95 17.87 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.861 -0.792 . . . . 72.23 108.861 179.363 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 70.2 t -75.19 138.78 20.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 N-CA-C 108.728 -0.842 . . . . 53.42 108.728 176.382 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 48.9 mm -97.26 -27.86 3.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.395 -1.335 . . . . 73.21 107.395 179.062 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 156.57 -168.79 33.82 Favored Glycine 0 N--CA 1.422 -2.272 0 CA-C-N 115.209 -0.905 . . . . 62.34 112.052 175.472 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 470' ' ' THR . . . . . 0.701 HG22 HG12 ' A' ' 486' ' ' ILE . 39.7 p -115.64 147.2 41.08 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 104.905 -2.258 . . . . 73.21 104.905 177.375 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.429 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 9.8 t30 -68.38 -55.13 12.84 Favored Pre-proline 0 C--N 1.31 -1.12 0 C-N-CA 118.542 -1.263 . . . . 54.53 111.815 176.394 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.429 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 23.9 Cg_exo -70.01 155.42 65.16 Favored 'Trans proline' 0 C--N 1.371 1.725 0 N-CA-C 108.769 -1.281 . . . . 71.13 108.769 172.428 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -62.27 126.66 19.07 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 121.82 1.68 . . . . 73.11 112.123 -176.687 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.421 ' O ' ' HB ' ' A' ' 429' ' ' ILE . . . -84.7 -2.08 57.06 Favored 'General case' 0 C--O 1.204 -1.322 0 CA-C-N 115.437 -0.801 . . . . 73.22 112.068 -174.491 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -110.71 6.37 21.55 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 120.108 -0.637 . . . . 71.15 111.874 175.613 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -110.23 173.75 6.18 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.517 0.932 . . . . 72.3 113.517 -174.014 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.11 117.11 21.4 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.803 -1.09 . . . . 71.12 110.969 -177.368 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 49.0 m -117.12 148.26 41.71 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.709 -0.849 . . . . 73.23 108.709 177.449 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -81.32 161.11 23.98 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.601 -0.518 . . . . 65.15 109.601 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.01 -17.82 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 CA-C-O 121.732 0.777 . . . . 71.42 112.353 -178.179 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.1 t -95.96 4.79 52.41 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.583 -0.698 . . . . 52.52 111.772 179.093 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -86.92 129.49 34.86 Favored 'General case' 0 CA--C 1.508 -0.638 0 O-C-N 121.961 -0.462 . . . . 72.14 111.091 -177.782 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.581 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.1 p -104.79 123.51 58.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.459 0.647 . . . . 65.51 110.509 178.687 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 34.7 m -101.28 126.91 55.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 121.787 0.803 . . . . 72.1 111.122 -179.1 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.71 125.22 45.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 108.213 -1.032 . . . . 74.43 108.213 176.36 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.701 HG12 HG22 ' A' ' 470' ' ' THR . 37.1 mt -109.53 126.3 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 CA-C-N 115.076 -0.965 . . . . 54.32 110.809 -178.003 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 4.4 tt -104.64 127.0 59.41 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 CA-C-N 114.887 -1.051 . . . . 72.11 110.011 -177.213 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 33.1 m -110.18 151.57 12.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 C-N-CA 122.786 0.434 . . . . 72.52 110.012 177.726 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -84.62 135.48 13.64 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.674 -0.57 . . . . 63.52 111.674 -179.226 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.716 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 46.4 m -142.89 160.53 40.16 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 117.155 0.477 . . . . 73.54 110.176 178.993 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 81.17 86.9 0.65 Allowed Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 121.359 -0.448 . . . . 43.14 112.936 176.175 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -85.46 127.11 3.22 Favored 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 122.392 2.061 . . . . 72.1 111.122 178.155 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -85.02 45.87 1.22 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.682 0.754 . . . . 62.53 110.151 178.879 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 10.8 p -122.58 145.95 47.87 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.511 -0.768 . . . . 51.22 110.485 -178.29 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -143.39 150.04 38.53 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 123.104 0.561 . . . . 62.22 111.32 178.464 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 11.1 p-10 -86.85 127.83 35.03 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.164 -0.926 . . . . 65.4 110.319 178.911 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 31.1 pt -81.17 134.1 52.89 Favored Pre-proline 0 C--N 1.304 -1.396 0 CA-C-N 115.658 -0.701 . . . . 74.32 110.426 179.029 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -82.43 175.99 8.39 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.658 2.239 . . . . 75.23 112.978 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -83.08 142.13 31.51 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.365 -0.834 . . . . 71.12 108.765 177.048 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 51.3 t -138.57 91.11 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 N-CA-C 107.74 -1.207 . . . . 74.41 107.74 -179.556 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -151.1 121.08 7.13 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.775 -0.454 . . . . 70.55 109.775 178.455 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 102.69 25.63 7.56 Favored Glycine 0 CA--C 1.489 -1.557 0 C-N-CA 120.164 -1.017 . . . . 42.14 111.243 176.447 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -131.95 170.3 15.1 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 109.118 -0.697 . . . . 65.04 109.118 178.829 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 15.1 t -91.57 160.63 15.31 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.284 -1.006 . . . . 71.03 108.284 178.359 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 47.5 t -51.88 -42.5 33.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 C-N-CA 123.709 0.803 . . . . 73.03 111.788 -175.779 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -67.86 -42.34 81.46 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.25 0.463 . . . . 63.04 112.25 -177.879 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 66.3 t -75.2 -34.68 31.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-O 121.281 0.562 . . . . 64.23 110.172 -177.769 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -61.95 -50.0 73.89 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.911 -0.586 . . . . 63.15 110.661 178.526 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -65.89 -34.91 79.22 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 120.819 -0.352 . . . . 75.31 110.95 178.498 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.402 ' O ' HG23 ' A' ' 514' ' ' VAL . 78.7 tttt -55.84 -48.25 75.81 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.5 0.72 . . . . 72.21 110.166 178.437 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -62.31 -45.93 91.02 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-N 116.091 -0.504 . . . . 62.24 110.436 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 90.1 mt -61.76 -38.25 87.29 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.823 -0.626 . . . . 73.51 111.335 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -61.42 -42.48 98.8 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.954 0.407 . . . . 65.13 110.124 177.799 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 510' ' ' LYS . 85.8 t -66.61 -29.55 46.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-N 115.601 -0.727 . . . . 62.13 110.666 178.774 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -84.23 3.02 37.2 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 121.872 -0.518 . . . . 73.33 112.066 179.402 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 82.54 39.41 10.85 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 121.006 -0.616 . . . . 70.12 112.791 177.251 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -124.77 138.59 54.27 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.994 -1.113 . . . . 74.42 107.994 176.947 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 3.6 m -131.84 -11.58 3.4 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.708 -0.797 . . . . 72.41 111.677 -176.212 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -107.64 115.01 29.39 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.25 -0.648 . . . . 73.25 109.25 -174.394 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -130.01 155.94 45.29 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.565 -0.743 . . . . 73.23 110.005 -175.069 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 521' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 66.9 m -141.83 127.85 19.56 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 106.999 -1.482 . . . . 75.05 106.999 170.625 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 522' ' ' GLN . . . . . 0.503 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 0.0 OUTLIER -117.3 133.35 56.08 Favored 'General case' 0 N--CA 1.418 -2.053 0 CA-C-O 121.23 0.538 . . . . 54.35 111.129 -179.3 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -113.87 143.13 45.19 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.442 -0.948 . . . . 72.11 108.442 178.866 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 61.0 m -102.71 126.98 50.02 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.0 0.428 . . . . 73.12 110.833 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 26.7 m -121.3 168.3 13.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.68 -1.23 . . . . 62.12 107.68 177.594 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 526' ' ' ASP . . . . . 0.608 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 5.4 p-10 -102.65 136.42 42.52 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.31 -0.956 . . . . 51.13 111.178 -179.476 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 527' ' ' SER . . . . . 0.419 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 18.7 m -152.85 178.15 1.68 Allowed Pre-proline 0 C--N 1.308 -1.219 0 N-CA-C 108.343 -0.984 . . . . 73.41 108.343 178.368 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -83.8 -0.37 9.65 Favored 'Trans proline' 0 C--N 1.361 1.216 0 C-N-CA 121.848 1.699 . . . . 51.41 111.135 173.435 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.51 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 8.1 mmm180 -76.73 138.84 66.28 Favored Pre-proline 0 C--O 1.211 -0.943 0 N-CA-C 106.826 -1.546 . . . . 70.5 106.826 178.532 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.08 150.41 86.66 Favored 'Trans proline' 0 C--O 1.246 0.879 0 C-N-CA 122.387 2.058 . . . . 75.12 112.074 -177.651 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.67 107.9 0.76 Allowed 'General case' 0 C--O 1.239 0.534 0 CA-C-N 116.21 -0.45 . . . . 45.03 110.439 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 133.51 -17.77 4.44 Favored Glycine 0 C--N 1.298 -1.562 0 N-CA-C 110.602 -0.999 . . . . 73.32 110.602 -177.612 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -75.58 124.73 27.7 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.272 -1.011 . . . . 73.25 108.272 177.292 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 47.1 t -82.92 115.61 25.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 106.711 -1.588 . . . . 62.12 106.711 175.172 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 535' ' ' THR . . . . . 0.424 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 10.6 t -83.48 -20.44 33.99 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.055 0.455 . . . . 62.22 110.5 -175.997 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 166.12 -159.37 32.62 Favored Glycine 0 N--CA 1.428 -1.849 0 C-N-CA 120.638 -0.791 . . . . 33.11 111.169 178.573 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 21.7 p -132.77 158.74 41.66 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.668 -0.864 . . . . 74.43 108.668 178.653 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -74.84 -53.35 3.11 Favored Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 109.886 -0.412 . . . . 70.13 109.886 176.34 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.458 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 45.8 Cg_endo -70.42 140.22 39.72 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 120.906 1.071 . . . . 65.21 110.176 173.476 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 540' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 17.2 Cg_exo -68.23 142.01 53.97 Favored 'Trans proline' 0 C--O 1.247 0.938 0 C-N-CA 122.592 2.195 . . . . 45.12 112.731 -179.123 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -65.76 135.58 55.09 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.746 -0.661 . . . . 72.32 109.683 178.605 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 103.67 -14.34 53.52 Favored Glycine 0 C--N 1.304 -1.199 0 C-N-CA 120.78 -0.724 . . . . 64.31 112.31 -179.853 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 27.6 m -67.2 129.77 40.98 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 110.349 -0.241 . . . . 72.23 110.349 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 56.7 m -92.11 122.69 34.84 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 108.223 -1.029 . . . . 71.32 108.223 177.265 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 26.0 m -132.4 164.72 41.43 Favored Pre-proline 0 C--N 1.307 -1.271 0 N-CA-C 109.404 -0.591 . . . . 74.54 109.404 -176.901 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -62.61 150.86 86.36 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.194 1.929 . . . . 72.01 110.18 174.787 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 27.4 m -64.21 -20.53 27.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 112.661 0.615 . . . . 72.12 112.661 -177.742 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -83.14 3.43 30.81 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 123.841 0.856 . . . . 51.44 111.805 178.764 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 11.7 t -80.46 158.67 25.84 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.111 0.482 . . . . 61.3 111.041 -176.481 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 70.0 t -101.37 135.12 39.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.842 -0.617 . . . . 51.42 110.19 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 551' ' ' ILE . . . . . 0.428 ' N ' HD12 ' A' ' 551' ' ' ILE . 2.6 mp -97.15 126.13 50.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 107.462 -1.31 . . . . 52.24 107.462 176.282 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 552' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 521' ' ' SER . 36.6 tt0 -103.53 116.29 32.1 Favored 'General case' 0 N--CA 1.428 -1.56 0 C-N-CA 120.602 -0.439 . . . . 72.24 109.978 -179.237 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 553' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 4.6 mp -101.5 134.48 44.53 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.154 -0.93 . . . . 74.32 109.032 -178.652 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -110.01 114.14 27.42 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 122.11 0.957 . . . . 60.52 109.553 177.86 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 48.6 t -103.0 141.44 18.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-N 114.342 -1.299 . . . . 72.22 109.087 -174.464 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 67.9 m -96.65 147.6 23.73 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.205 0.526 . . . . 64.14 112.212 -179.161 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.608 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 15.1 ptpt -96.78 150.72 20.38 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 105.282 -2.118 . . . . 72.34 105.282 170.692 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 558' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -73.39 -37.55 53.76 Favored Glycine 0 CA--C 1.485 -1.842 0 N-CA-C 110.931 -0.868 . . . . 34.22 110.931 -178.832 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 63.2 t30 69.79 -0.86 2.52 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 122.54 1.162 . . . . 73.13 110.609 175.722 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 77.9 mt-30 -142.57 144.42 32.88 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 106.509 -1.663 . . . . 75.42 106.509 179.565 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -123.71 140.94 52.49 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 120.75 -0.38 . . . . 73.32 110.402 179.33 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.99 123.16 11.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.575 0.702 . . . . 31.03 112.037 -178.122 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 59.6 ttp -97.28 134.66 22.45 Favored Pre-proline 0 C--N 1.305 -1.352 0 CA-C-N 115.43 -0.805 . . . . 70.34 109.874 178.463 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.15 169.62 13.34 Favored 'Trans proline' 0 C--O 1.244 0.821 0 C-N-CA 122.805 2.336 . . . . 72.22 111.197 175.496 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 565' ' ' ASP . . . . . 0.537 ' HA ' ' HB1' ' A' ' 610' ' ' ALA . 28.1 t70 -66.83 114.69 5.88 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.401 0.62 . . . . 71.31 112.085 -178.274 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 93.2 mt -133.87 10.0 3.91 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.208 -1.034 . . . . 72.43 108.208 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 14.6 m -79.17 134.08 36.7 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.935 -1.03 . . . . 63.42 110.575 -175.238 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 77.19 33.98 42.91 Favored Glycine 0 C--O 1.221 -0.66 0 C-N-CA 120.724 -0.751 . . . . 71.54 111.94 -179.708 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 569' ' ' MET . . . . . 0.544 ' SD ' ' HD3' ' A' ' 577' ' ' ARG . 36.0 ttp -100.27 146.37 26.99 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.814 -0.439 . . . . 73.43 109.814 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 570' ' ' PHE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 93.4 m-85 -76.59 147.87 37.36 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.279 -1.008 . . . . 63.15 108.279 178.92 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 571' ' ' TRP . . . . . 0.497 ' HA ' ' HB3' ' A' ' 574' ' ' ALA . 72.4 t-105 -59.67 -22.84 62.5 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 112.057 0.392 . . . . 75.34 112.057 -178.231 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 29.5 m -70.52 -23.14 24.14 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.438 0 CA-C-N 115.951 -0.568 . . . . 64.34 111.335 -178.582 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -101.06 -33.37 10.18 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.939 -0.763 . . . . 74.14 108.939 175.974 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 574' ' ' ALA . . . . . 0.497 ' HB3' ' HA ' ' A' ' 571' ' ' TRP . . . -58.23 -53.48 57.8 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.469 0.914 . . . . 62.33 113.469 -176.03 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.449 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 34.7 tt0 -58.5 -51.9 78.49 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 120.51 -0.476 . . . . 71.5 112.021 -178.253 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 576' ' ' PRO . . . . . 0.449 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 51.2 Cg_exo -57.8 -40.76 76.26 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 121.918 1.745 . . . . 52.51 112.789 176.58 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.544 ' HD3' ' SD ' ' A' ' 569' ' ' MET . 80.9 mtp180 -69.09 -33.94 74.32 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 120.326 -0.55 . . . . 72.21 112.139 -179.249 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 92.8 mt -65.36 -47.55 76.04 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.008 0.433 . . . . 72.53 110.454 178.706 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -65.31 -34.81 79.22 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.964 -0.562 . . . . 74.34 111.176 177.918 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -65.4 -32.43 74.05 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.924 0.393 . . . . 41.24 111.093 178.417 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 581' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 577' ' ' ARG . 4.1 mm? -81.46 -5.2 57.69 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.251 -0.431 . . . . 73.41 111.179 177.42 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 72.78 31.71 62.12 Favored Glycine 0 N--CA 1.431 -1.649 0 C-N-CA 121.018 -0.61 . . . . 63.24 111.6 -179.783 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 78.6 t90 -65.1 139.05 58.67 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.678 0.275 . . . . 73.51 110.286 177.093 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 29.2 m -151.62 103.03 2.92 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.361 -0.607 . . . . 75.04 109.361 175.357 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -161.39 -138.26 2.38 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 109.497 -1.441 . . . . 22.15 109.497 177.814 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 16.4 mmt -117.71 132.09 56.53 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.214 0.53 . . . . 25.34 110.766 175.589 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 24.8 tp -98.91 118.18 35.09 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 106.347 -1.723 . . . . 55.11 106.347 178.375 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -120.35 100.45 7.17 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 118.112 -1.435 . . . . 52.32 111.962 178.447 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 589' ' ' LYS . . . . . 0.419 ' O ' ' HD2' ' A' ' 589' ' ' LYS . 0.1 OUTLIER -113.79 133.8 55.16 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.143 -1.389 . . . . 63.31 108.391 171.476 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -73.2 -102.33 0.07 OUTLIER Glycine 0 C--N 1.301 -1.361 0 C-N-CA 120.745 -0.741 . . . . 64.31 113.842 -176.31 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -91.81 135.8 33.64 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 120.591 0.234 . . . . 73.03 111.489 -177.612 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -89.3 125.97 35.33 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 106.915 -1.513 . . . . 41.04 106.915 177.995 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 78.4 t -124.67 115.63 45.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 110.158 -0.312 . . . . 70.03 110.158 -175.127 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -74.49 113.42 11.71 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.683 -0.858 . . . . 74.14 108.683 177.06 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -125.32 -28.98 3.3 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 115.648 -0.705 . . . . 75.42 110.373 177.593 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 107.74 147.97 13.78 Favored Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 110.015 -1.234 . . . . 74.23 110.015 -176.351 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -62.5 -33.57 86.83 Favored Glycine 0 C--N 1.32 -0.348 0 CA-C-N 116.915 0.357 . . . . 42.12 112.776 -177.602 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 27.4 m -65.89 -23.97 66.75 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-O 121.144 0.497 . . . . 75.14 111.206 178.333 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -87.11 0.47 55.22 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.54 0.736 . . . . 63.34 110.765 -179.573 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . 0.4 10.3 p-80 69.65 92.0 0.09 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 126.545 1.938 . . . . 75.44 116.123 176.671 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -90.66 69.35 6.66 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 123.033 1.397 . . . . 54.12 107.999 171.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 602' ' ' ARG . . . . . 0.441 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 37.2 ptt85 -106.82 162.44 13.8 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.227 -1.351 . . . . 72.14 110.178 -176.574 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 603' ' ' VAL . . . . . 0.413 HG13 ' HB2' ' A' ' 622' ' ' LEU . 75.9 t -68.98 130.86 34.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 106.133 -1.803 . . . . 62.33 106.133 172.72 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 28.3 m -107.48 -31.18 2.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 119.494 -0.882 . . . . 54.31 111.937 -176.332 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -145.05 157.13 44.21 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 106.942 -1.503 . . . . 73.04 106.942 176.058 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 606' ' ' GLN . . . . . 0.416 ' HB2' HD11 ' A' ' 620' ' ' ILE . 10.7 pt20 -148.98 160.2 43.52 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 106.872 -1.529 . . . . 65.43 106.872 -179.321 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.527 ' HB2' ' HD3' ' A' ' 608' ' ' PRO . 88.6 m-20 -68.56 -57.85 7.85 Favored Pre-proline 0 C--N 1.315 -0.893 0 C-N-CA 120.185 -0.606 . . . . 72.33 112.022 -179.492 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.527 ' HD3' ' HB2' ' A' ' 607' ' ' ASN . 10.1 Cg_endo -99.07 127.02 0.17 Allowed 'Trans proline' 0 N--CA 1.44 -1.674 0 C-N-CA 122.123 1.882 . . . . 53.14 112.245 178.877 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.45 158.67 54.21 Favored 'Trans proline' 0 C--O 1.246 0.891 0 C-N-CA 121.927 1.751 . . . . 64.11 111.432 176.545 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 610' ' ' ALA . . . . . 0.537 ' HB1' ' HA ' ' A' ' 565' ' ' ASP . . . -68.02 137.39 55.03 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.776 -0.824 . . . . 74.34 108.776 177.337 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 90.04 -0.05 78.35 Favored Glycine 0 C--N 1.309 -0.932 0 C-N-CA 120.337 -0.935 . . . . 62.43 111.144 -177.469 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 27.6 m -111.48 159.62 17.91 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 107.514 -1.291 . . . . 73.35 107.514 177.5 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -77.92 133.62 13.26 Favored Glycine 0 N--CA 1.427 -1.944 0 N-CA-C 111.743 -0.543 . . . . 50.23 111.743 177.689 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 614' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 21.6 m -96.72 141.18 15.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 109.032 -0.729 . . . . 75.25 109.032 177.336 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -55.77 148.85 15.68 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.91 0.884 . . . . 71.53 110.358 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -52.63 -30.68 32.84 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 112.962 0.727 . . . . 74.03 112.962 -174.143 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 617' ' ' ASP . . . . . 0.574 ' OD2' ' HB ' ' A' ' 619' ' ' ILE . 32.7 t70 -79.78 -31.42 40.82 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.951 0.405 . . . . 75.12 110.739 -178.535 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 77.74 20.71 73.35 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.902 -0.666 . . . . 54.51 112.789 179.013 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 619' ' ' ILE . . . . . 0.574 ' HB ' ' OD2' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -68.3 121.01 16.69 Favored 'Isoleucine or valine' 0 C--O 1.246 0.872 0 CA-C-O 122.536 1.16 . . . . 72.3 109.209 -173.796 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.416 HD11 ' HB2' ' A' ' 606' ' ' GLN . 6.3 tp -115.08 120.09 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.093 0 CA-C-N 113.957 -1.474 . . . . 75.33 112.379 -171.763 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 14.5 m -99.4 117.25 33.4 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 105.565 -2.013 . . . . 73.55 105.565 170.834 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 622' ' ' LEU . . . . . 0.43 HD23 ' H ' ' A' ' 622' ' ' LEU . 2.2 pt? -140.09 162.69 34.63 Favored 'General case' 0 CA--C 1.483 -1.631 0 N-CA-C 108.987 -0.746 . . . . 73.0 108.987 -175.429 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -134.79 137.23 43.19 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 107.442 -1.318 . . . . 75.41 107.442 172.866 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -142.02 166.06 25.74 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 105.281 -2.118 . . . . 75.44 105.281 173.389 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -66.4 -86.74 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.426 -1.07 . . . . 45.43 110.426 175.616 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 . . . . . 0 C--N 1.299 -1.624 0 N-CA-C 105.95 -1.87 . . . . 74.52 105.95 175.763 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.986 0 N-CA-C 109.968 -1.253 . . . . 61.51 109.968 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 10.3 tp -75.77 131.96 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 CA-C-N 117.566 0.683 . . . . 70.11 109.77 177.075 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.4 -175.15 4.99 Favored 'General case' 0 N--CA 1.409 -2.51 0 C-N-CA 124.282 1.033 . . . . 74.42 112.288 -177.642 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -72.6 20.23 0.07 Allowed 'General case' 0 C--O 1.242 0.66 0 C-N-CA 124.496 1.119 . . . . 74.32 113.521 -177.868 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -74.74 127.55 33.41 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.241 -1.022 . . . . 74.53 108.241 176.892 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.9 m -134.52 163.27 37.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.494 -0.928 . . . . 63.51 108.494 178.027 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -94.23 140.59 29.58 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 106.455 -1.683 . . . . 70.34 106.455 175.782 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.517 HG22 ' CZ ' ' A' ' 382' ' ' PHE . 75.7 t -93.92 134.48 26.07 Favored Pre-proline 0 C--N 1.277 -2.565 0 N-CA-C 107.559 -1.274 . . . . 73.5 107.559 -174.719 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.84 149.48 66.46 Favored 'Trans proline' 0 C--O 1.253 1.259 0 C-N-CA 123.042 2.495 . . . . 63.15 113.308 -171.279 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -87.24 75.15 9.39 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 115.076 -0.966 . . . . 35.11 111.258 -177.409 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 27.7 m -91.54 -5.25 10.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 122.917 1.341 . . . . 72.03 108.005 173.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -66.39 146.43 54.57 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 112.329 -2.214 . . . . 72.21 108.21 177.05 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 367' ' ' GLY . . . . . 0.508 ' H ' HG23 ' A' ' 399' ' ' VAL . . . 104.53 1.23 43.51 Favored Glycine 0 C--N 1.304 -1.237 0 C-N-CA 119.475 -1.345 . . . . 41.33 114.042 178.674 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -110.29 -77.39 0.59 Allowed 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.094 -0.706 . . . . 73.44 109.094 -177.65 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 78.7 p -149.78 153.13 36.34 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 106.767 -1.568 . . . . 65.32 106.767 178.248 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.409 ' O ' ' HB ' ' A' ' 374' ' ' ILE . 22.6 t -62.64 -33.72 75.61 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.964 -0.754 . . . . 63.41 108.964 177.278 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -68.69 -47.83 65.43 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 112.53 0.567 . . . . 51.43 112.53 -178.9 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -69.69 -45.27 68.66 Favored 'General case' 0 CA--C 1.503 -0.859 0 C-N-CA 119.482 -0.887 . . . . 75.01 110.631 -178.097 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 373' ' ' ALA . . . . . 0.467 ' O ' ' HG ' ' A' ' 377' ' ' LEU . . . -61.17 -50.57 72.61 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.407 -0.815 . . . . 73.22 110.96 -178.361 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.409 ' HB ' ' O ' ' A' ' 370' ' ' SER . 1.7 mp -69.28 -38.97 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 120.727 -0.389 . . . . 73.12 111.778 -177.862 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.71 -44.02 93.88 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.226 0.536 . . . . 64.1 110.884 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 376' ' ' THR . . . . . 0.406 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 21.0 m -66.52 -47.1 74.03 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.572 -0.74 . . . . 73.34 110.104 -179.171 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 373' ' ' ALA . 94.0 mt -61.49 -42.45 98.8 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.271 -0.422 . . . . 74.44 110.629 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 62.5 tp60 -61.21 -42.46 98.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.129 -0.487 . . . . 75.32 111.157 -179.532 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -67.57 -24.52 65.52 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 112.072 0.397 . . . . 75.24 112.072 179.31 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 380' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 376' ' ' THR . 37.8 mmt180 -81.42 -13.76 57.88 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.106 0.479 . . . . 73.42 110.123 176.518 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.67 7.43 51.06 Favored Glycine 0 N--CA 1.437 -1.297 0 CA-C-N 115.701 -0.681 . . . . 74.53 112.337 178.381 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.517 ' CZ ' HG22 ' A' ' 362' ' ' VAL . 57.4 m-85 -74.36 148.72 41.03 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-O 121.431 0.634 . . . . 74.42 110.322 178.159 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.653 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 47.0 mmtm -98.61 146.24 26.02 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 106.548 -1.649 . . . . 72.4 106.548 178.293 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.71 150.68 27.16 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.302 0 C-N-CA 119.735 -0.786 . . . . 73.45 110.095 -179.14 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -117.06 146.15 43.28 Favored 'General case' 0 N--CA 1.404 -2.769 0 N-CA-C 106.372 -1.714 . . . . 73.44 106.372 171.796 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 89.0 m -135.02 117.85 16.18 Favored 'General case' 0 C--N 1.256 -3.496 0 N-CA-C 106.371 -1.714 . . . . 73.24 106.371 -179.342 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 20.8 tp -117.83 130.89 56.54 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 108.967 -0.753 . . . . 65.52 108.967 -176.107 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -91.12 131.0 36.96 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-O 121.099 0.476 . . . . 74.41 110.311 -178.867 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 389' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 421' ' ' SER . 76.0 mmtt -125.85 143.31 44.86 Favored Pre-proline 0 C--N 1.297 -1.69 0 N-CA-C 107.396 -1.335 . . . . 75.21 107.396 177.643 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.419 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 13.7 Cg_endo -98.14 127.25 0.22 Allowed 'Trans proline' 0 N--CA 1.449 -1.137 0 N-CA-C 108.867 -1.243 . . . . 74.51 108.867 166.563 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 6.7 t70 168.09 -170.04 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.286 -1.375 . . . . 74.15 107.286 -174.899 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 31.7 t -136.74 -11.36 1.79 Allowed 'General case' 0 N--CA 1.428 -1.573 0 C-N-CA 123.22 0.608 . . . . 71.24 110.376 178.136 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 14.6 t -71.42 -28.85 64.28 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 108.089 -1.078 . . . . 74.23 108.089 176.604 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.467 HD13 ' H ' ' A' ' 394' ' ' ILE . 0.2 OUTLIER -110.1 129.97 23.36 Favored Pre-proline 0 N--CA 1.41 -2.426 0 N-CA-C 104.278 -2.49 . . . . 74.54 104.278 167.051 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -92.91 -175.49 0.54 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.698 2.265 . . . . 73.24 113.798 -172.897 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -53.16 167.25 0.78 Allowed 'Trans proline' 0 C--N 1.365 1.419 0 C-N-CA 124.25 3.3 . . . . 74.02 111.351 169.816 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -53.08 -6.22 0.06 Allowed 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 126.427 1.891 . . . . 73.24 113.667 -170.573 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 27.9 m170 -77.21 93.1 3.9 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 105.453 -2.055 . . . . 75.33 105.453 170.984 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.508 HG23 ' H ' ' A' ' 367' ' ' GLY . 16.6 m -67.54 119.57 13.41 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 113.546 -1.661 . . . . 62.14 112.534 -166.911 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.88 -35.81 8.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 108.763 -0.828 . . . . 71.34 108.763 178.756 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.84 163.53 28.58 Favored Glycine 0 N--CA 1.414 -2.77 0 CA-C-N 115.513 -0.767 . . . . 34.03 111.198 -177.391 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.3 p -150.06 -176.4 5.43 Favored 'General case' 0 C--N 1.288 -2.109 0 C-N-CA 126.207 1.803 . . . . 52.5 107.558 -178.358 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 403' ' ' ASP . . . . . 0.433 ' HA ' ' HD3' ' A' ' 404' ' ' PRO . 17.3 t70 -98.88 139.72 21.25 Favored Pre-proline 0 C--N 1.3 -1.563 0 C-N-CA 120.157 -0.617 . . . . 64.21 109.476 -174.16 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 404' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 403' ' ' ASP . 50.3 Cg_exo -57.86 1.61 0.21 Allowed 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 124.93 3.753 . . . . 64.31 115.624 -179.569 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.08 -33.82 63.09 Favored 'General case' 0 C--O 1.213 -0.854 0 CA-C-O 120.968 0.413 . . . . 63.23 110.084 175.56 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -70.49 -30.84 67.73 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-N 115.515 -0.766 . . . . 44.52 111.06 178.455 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -87.74 -5.02 58.86 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.841 0.829 . . . . 72.32 109.286 -178.271 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 31.0 m -91.8 149.13 21.75 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 105.821 -1.918 . . . . 63.44 105.821 175.159 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 12.6 p -78.73 112.25 15.66 Favored 'General case' 0 N--CA 1.418 -2.049 0 C-N-CA 119.23 -0.988 . . . . 64.34 109.624 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 35.2 m -119.57 159.92 20.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 115.971 -0.559 . . . . 73.54 109.714 178.623 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 56.0 m -67.0 134.86 52.79 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.347 -0.612 . . . . 74.2 109.347 178.102 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -53.71 114.5 1.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.125 0.57 . . . . 74.2 111.62 -178.046 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 112.42 14.05 11.07 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.663 -0.698 . . . . 55.33 112.042 -178.706 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -75.27 -174.56 2.4 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 109.907 -0.405 . . . . 73.11 109.907 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 415' ' ' GLU . . . . . 0.653 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 9.7 pt-20 -119.38 130.93 55.57 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 113.275 0.843 . . . . 75.22 113.275 -171.101 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.4 mm -116.89 127.49 74.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.916 -0.584 . . . . 64.21 110.551 -179.314 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 35.3 m -93.06 130.72 38.57 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 120.733 0.302 . . . . 52.53 111.307 178.663 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 5.2 p -120.41 135.35 60.94 Favored 'Isoleucine or valine' 0 C--O 1.248 0.994 0 N-CA-C 109.565 -0.532 . . . . 62.55 109.565 178.003 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -100.39 124.83 46.39 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.121 -0.696 . . . . 70.05 109.121 177.137 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 70.8 t -118.54 131.79 70.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 107.717 -1.216 . . . . 71.52 107.717 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 421' ' ' SER . . . . . 0.568 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 32.6 t -101.74 120.89 41.08 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 117.635 -1.626 . . . . 62.41 110.497 179.777 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 4.1 t -121.67 107.29 12.19 Favored 'General case' 0 N--CA 1.403 -2.781 0 CA-C-N 114.492 -1.231 . . . . 75.44 108.624 171.677 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 120.58 106.44 2.07 Favored Glycine 0 N--CA 1.426 -2.004 0 C-N-CA 119.695 -1.241 . . . . 63.21 112.274 179.532 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -70.22 157.94 57.91 Favored 'Trans proline' 0 C--O 1.247 0.965 0 C-N-CA 122.996 2.464 . . . . 74.02 110.613 174.712 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -72.15 167.43 20.3 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.883 0.849 . . . . 73.34 112.565 -174.377 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -87.13 158.08 19.24 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 106.891 -1.522 . . . . 71.05 106.891 178.147 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.529 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 5.0 mmp_? -121.49 151.96 39.69 Favored 'General case' 0 CA--C 1.485 -1.534 0 CA-C-O 121.594 0.711 . . . . 53.35 111.527 -177.241 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.85 140.42 32.92 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 114.355 -1.293 . . . . 75.42 108.109 -176.218 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.47 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 78.2 mt -78.86 113.43 35.28 Favored Pre-proline 0 C--N 1.299 -1.588 0 N-CA-C 108.215 -1.031 . . . . 64.43 108.215 -179.641 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.77 141.06 40.24 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 121.849 1.7 . . . . 63.22 110.936 178.876 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -92.0 127.09 37.33 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.935 -1.135 . . . . 70.32 107.935 176.315 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 90.6 t -121.73 150.03 24.99 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 N-CA-C 108.104 -1.072 . . . . 73.23 108.104 -176.054 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.512 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 19.4 m -55.3 144.84 23.56 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 123.818 0.699 . . . . 34.31 110.579 -179.811 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 434' ' ' THR . . . . . 0.481 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 41.8 p -69.16 -25.77 64.53 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 113.341 0.867 . . . . 62.41 113.341 -169.386 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.435 ' H ' HD23 ' A' ' 435' ' ' LEU . 0.6 OUTLIER -90.16 -12.07 39.28 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 116.05 -0.523 . . . . 71.23 110.744 178.084 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.512 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 2.6 m -98.06 43.42 1.06 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.956 0.884 . . . . 74.13 109.176 -176.691 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -53.48 -38.93 64.12 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.351 1.061 . . . . 74.13 112.954 179.736 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -62.07 -40.51 96.04 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 121.537 0.684 . . . . 65.11 109.992 179.543 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.499 ' HB3' HG22 ' A' ' 436' ' ' THR . 40.9 tt0 -71.47 -34.06 69.87 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.862 -0.608 . . . . 64.41 111.199 177.154 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.477 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -59.35 -47.02 87.0 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.389 0.137 . . . . 71.14 110.833 -178.726 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 21.5 m -65.53 -36.98 78.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-O 121.337 0.589 . . . . 71.13 110.189 177.189 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -60.23 -47.25 86.79 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.803 0.841 . . . . 73.44 110.952 176.295 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -64.17 -38.79 92.33 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 123.663 0.785 . . . . 71.05 111.6 179.726 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 93.8 mt -63.93 -34.7 78.55 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.0 0.428 . . . . 60.42 109.988 175.619 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.451 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 43.8 m -70.16 -42.76 72.09 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.884 -0.598 . . . . 65.11 110.625 178.618 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.49 -23.09 65.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.364 0.602 . . . . 74.01 111.064 179.123 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.95 5.21 22.74 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.016 -0.538 . . . . 53.01 111.495 178.967 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 108.61 -84.15 0.36 Allowed Glycine 0 N--CA 1.435 -1.42 0 C-N-CA 120.429 -0.891 . . . . 61.34 112.072 175.552 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -37.08 -57.3 0.86 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.133 1.16 . . . . 73.11 114.133 179.536 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 450' ' ' GLY . . . . . 0.451 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 56.15 30.89 58.49 Favored Glycine 0 CA--C 1.505 -0.559 0 O-C-N 123.362 0.414 . . . . 64.11 113.347 179.44 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 61.3 mmt-85 -112.73 122.86 48.91 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 108.096 -1.076 . . . . 74.42 108.096 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 18.0 p90 -144.28 152.11 40.34 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.98 -0.554 . . . . 73.4 111.448 -174.632 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -131.72 138.58 48.71 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.565 -0.902 . . . . 63.44 108.565 175.81 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -98.08 121.08 39.56 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.628 -0.879 . . . . 63.41 108.628 176.598 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -116.98 148.55 41.34 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 107.881 -1.155 . . . . 72.33 107.881 178.011 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 -113.86 146.19 40.37 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 108.481 -0.933 . . . . 74.22 108.481 -176.477 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 26.9 t -143.92 134.46 12.17 Favored Pre-proline 0 C--N 1.294 -1.813 0 N-CA-C 108.645 -0.872 . . . . 72.0 108.645 175.296 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.64 ' HA ' ' O ' ' A' ' 490' ' ' SER . 68.1 Cg_endo -76.78 124.13 7.3 Favored 'Trans proline' 0 N--CA 1.439 -1.691 0 C-N-CA 121.898 1.732 . . . . 74.4 111.134 178.253 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 69.6 m -151.17 179.87 7.92 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.779 -0.646 . . . . 70.31 109.416 -178.738 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.9 t -46.77 139.22 6.67 Favored Pre-proline 0 C--O 1.25 1.114 0 C-N-CA 125.061 1.344 . . . . 72.23 112.684 178.919 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 461' ' ' PRO . . . . . 0.415 ' HA ' ' CG2' ' A' ' 464' ' ' VAL . 10.2 Cg_endo -51.61 -29.55 33.08 Favored 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 124.609 3.54 . . . . 63.43 113.567 -177.734 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -66.95 -24.51 66.07 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 120.959 0.409 . . . . 41.34 111.582 -178.603 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 91.1 mt -99.27 -13.47 19.66 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 120.707 0.289 . . . . 51.43 111.289 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.415 ' CG2' ' HA ' ' A' ' 461' ' ' PRO . 88.8 t -60.73 127.61 20.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.154 -0.475 . . . . 44.04 110.481 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.57 -11.7 71.5 Favored Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 116.083 -0.508 . . . . 73.54 112.175 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.97 159.42 16.56 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 107.577 -1.268 . . . . 74.11 107.577 179.37 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 76.1 t -75.45 146.97 8.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 106.998 -1.482 . . . . 71.42 106.998 173.571 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 61.3 mt -97.53 -29.82 3.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 107.557 -1.275 . . . . 64.31 107.557 177.33 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 158.8 -160.65 31.27 Favored Glycine 0 N--CA 1.423 -2.178 0 N-CA-C 111.014 -0.834 . . . . 43.14 111.014 176.163 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 470' ' ' THR . . . . . 0.562 HG22 HG12 ' A' ' 486' ' ' ILE . 52.8 p -115.04 140.88 48.69 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 105.016 -2.216 . . . . 35.32 105.016 177.96 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -65.11 -54.6 32.42 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 119.135 -1.026 . . . . 73.34 110.03 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.84 135.03 29.24 Favored 'Trans proline' 0 C--N 1.368 1.594 0 N-CA-C 108.42 -1.416 . . . . 72.22 108.42 170.756 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.513 ' C ' ' H ' ' A' ' 475' ' ' ASN . 35.5 Cg_exo -62.3 141.82 88.97 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 122.177 1.918 . . . . 64.34 112.482 -177.054 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.47 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -75.16 22.86 0.11 Allowed 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 122.441 1.115 . . . . 72.35 110.792 178.812 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 475' ' ' ASN . . . . . 0.513 ' H ' ' C ' ' A' ' 473' ' ' PRO . 10.2 m120 -109.36 -17.65 13.75 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 114.293 -1.321 . . . . 61.33 108.25 179.342 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -95.78 165.6 12.22 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 113.226 0.824 . . . . 63.23 113.226 -172.603 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.7 113.46 26.97 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 113.944 -1.48 . . . . 71.31 108.203 -179.735 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 18.5 p -102.67 145.55 29.51 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 110.132 -0.321 . . . . 70.34 110.132 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -71.73 164.36 26.1 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.284 -0.416 . . . . 63.01 110.519 179.234 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 37.6 mm -74.78 -8.67 11.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 122.122 0.963 . . . . 50.31 110.745 -174.564 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.0 t -100.1 5.16 44.92 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.844 -0.616 . . . . 75.15 110.53 177.4 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -87.12 147.45 25.64 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 112.628 0.603 . . . . 44.15 112.628 -176.198 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 44.2 t -107.38 117.49 53.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 108.737 -0.838 . . . . 75.33 108.737 177.606 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 58.8 t -89.55 120.08 37.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-O 121.289 0.566 . . . . 63.24 109.772 -179.119 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.93 123.76 46.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 121.491 0.662 . . . . 73.3 110.006 179.104 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.562 HG12 HG22 ' A' ' 470' ' ' THR . 14.1 mt -113.59 128.28 70.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 114.766 -1.106 . . . . 72.1 110.547 -178.072 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 5.1 tt -103.89 126.41 58.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 115.386 -0.825 . . . . 64.22 110.816 -175.481 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 33.5 m -110.1 151.35 12.35 Favored 'Isoleucine or valine' 0 C--O 1.251 1.152 0 CA-C-N 115.824 -0.625 . . . . 73.41 109.714 178.658 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.78 132.19 10.92 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 120.65 -0.786 . . . . 71.12 112.156 -179.268 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.64 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 49.0 m -126.32 156.93 39.65 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.267 -1.383 . . . . 54.34 107.267 176.392 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -144.64 129.56 3.6 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 118.976 -1.583 . . . . 70.0 113.275 -176.853 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -75.61 166.57 28.21 Favored 'Trans proline' 0 C--O 1.244 0.778 0 C-N-CA 122.839 2.36 . . . . 74.53 110.822 176.562 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -81.89 55.47 2.76 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.931 0.872 . . . . 73.33 110.963 -178.215 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 58.0 p -120.23 142.93 48.58 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.29 -1.004 . . . . 70.45 108.29 -179.066 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -130.48 152.78 49.5 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.798 0.332 . . . . 74.05 110.872 -179.873 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -83.88 115.9 22.5 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 124.007 0.923 . . . . 75.4 109.905 -176.485 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 497' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 543' ' ' THR . 38.0 pt -83.82 130.09 56.69 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 116.396 -0.365 . . . . 75.22 111.156 -178.696 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -83.26 -169.27 0.69 Allowed 'Trans proline' 0 C--O 1.239 0.534 0 C-N-CA 122.969 2.446 . . . . 65.52 112.165 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -78.49 138.59 38.51 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.804 -0.813 . . . . 72.44 108.804 177.301 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 14.7 p -126.92 -15.0 3.49 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-O 121.448 0.642 . . . . 74.14 110.737 -177.338 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -66.73 112.18 4.08 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.082 -0.71 . . . . 51.42 109.082 178.823 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 136.81 -25.54 3.07 Favored Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.901 -0.666 . . . . 62.35 111.715 -178.374 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -103.01 172.33 6.88 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 122.47 -0.429 . . . . 54.25 111.068 178.336 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 21.8 p -89.77 160.97 16.26 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 116.495 -0.32 . . . . 74.5 111.069 -176.654 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 532' ' ' GLY . 25.0 t -54.1 -42.08 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 123.645 0.59 . . . . 54.05 111.403 -177.13 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.67 -42.13 95.6 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.075 -0.511 . . . . 55.54 112.007 -178.946 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 67.2 t -71.35 -41.76 73.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 109.657 -0.498 . . . . 73.24 109.657 179.852 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -60.38 -49.64 76.78 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.254 -0.885 . . . . 72.34 111.645 -179.393 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -64.96 -35.66 81.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.712 0.292 . . . . 70.33 110.691 -178.387 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.478 ' O ' HG23 ' A' ' 514' ' ' VAL . 4.6 tppp? -64.84 -47.13 79.07 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.846 -0.615 . . . . 73.34 109.364 179.192 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -63.38 -48.15 79.12 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.882 -0.599 . . . . 73.12 111.952 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -61.77 -39.75 92.74 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 116.658 -0.246 . . . . 75.25 111.467 178.8 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -61.79 -37.79 85.65 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 120.682 0.277 . . . . 72.3 111.011 177.933 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 510' ' ' LYS . 73.3 t -62.34 -37.14 77.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.011 -0.541 . . . . 74.44 110.416 176.885 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -71.91 -23.57 61.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.906 0.384 . . . . 74.41 111.553 178.357 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 124.59 -12.69 7.84 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 120.394 -0.908 . . . . 74.33 112.317 178.747 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.46 ' HA ' ' O ' ' A' ' 547' ' ' VAL . 90.5 m-85 -80.44 101.17 8.88 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 107.591 -1.263 . . . . 74.2 107.591 -177.349 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.87 -8.89 27.33 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 120.058 -0.657 . . . . 73.21 112.413 -171.736 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 519' ' ' LYS . . . . . 0.501 ' O ' HD13 ' A' ' 551' ' ' ILE . 63.6 mttp -108.21 114.59 28.59 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.037 -0.665 . . . . 60.42 109.984 -178.037 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -131.01 140.34 50.11 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 116.01 -0.541 . . . . 73.23 111.218 -177.752 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 521' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 33.0 m -128.43 142.29 51.14 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.277 -1.379 . . . . 71.54 107.277 175.866 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -117.94 141.04 48.88 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.043 0.449 . . . . 63.13 111.091 179.778 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -135.43 128.51 31.65 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.894 -1.15 . . . . 45.23 107.894 178.045 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 70.2 m -93.74 134.07 36.46 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.096 0.475 . . . . 70.1 111.818 -177.463 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 525' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 557' ' ' LYS . 35.2 m -121.98 150.11 25.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 107.972 -1.121 . . . . 72.32 107.972 177.795 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -66.75 136.74 55.93 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.525 -0.47 . . . . 63.55 110.547 -179.226 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 20.2 m -149.93 169.1 9.71 Favored Pre-proline 0 C--N 1.307 -1.278 0 CA-C-N 116.049 -0.523 . . . . 42.35 109.985 -177.937 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -84.41 -25.46 2.08 Favored 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 121.892 1.728 . . . . 54.1 111.5 173.508 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.427 ' HD3' ' OE2' ' A' ' 533' ' ' GLU . 15.2 ptp180 -81.06 150.03 67.67 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 109.7 -0.481 . . . . 74.24 109.7 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.78 149.0 62.68 Favored 'Trans proline' 0 C--O 1.26 1.601 0 C-N-CA 123.82 3.014 . . . . 72.43 115.909 -175.206 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.666 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -62.87 121.2 12.91 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 113.914 -1.494 . . . . 74.11 110.701 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 532' ' ' GLY . . . . . 0.456 ' O ' HG23 ' A' ' 505' ' ' VAL . . . 130.69 -23.46 4.47 Favored Glycine 0 C--N 1.303 -1.25 0 C-N-CA 120.763 -0.732 . . . . 72.52 111.462 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 533' ' ' GLU . . . . . 0.427 ' OE2' ' HD3' ' A' ' 529' ' ' ARG . 29.2 tt0 -83.48 144.29 29.65 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.422 -0.584 . . . . 75.14 109.422 177.614 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 67.0 t -89.54 125.75 42.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 109.275 -0.639 . . . . 73.21 109.275 179.395 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 535' ' ' THR . . . . . 0.586 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 14.4 t -100.84 -10.57 20.58 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-O 120.66 0.267 . . . . 52.41 111.611 -178.261 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 171.46 -175.41 44.98 Favored Glycine 0 CA--C 1.498 -0.984 0 C-N-CA 119.912 -1.137 . . . . 63.12 111.411 179.156 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 537' ' ' THR . . . . . 0.401 HG22 HD23 ' A' ' 553' ' ' LEU . 8.1 p -139.29 157.97 44.98 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 117.168 0.484 . . . . 75.01 111.314 179.495 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.438 ' HB3' ' HB3' ' A' ' 552' ' ' GLU . 21.2 t-20 -64.01 -54.87 36.8 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-N 115.27 -0.877 . . . . 73.45 109.72 176.906 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -73.53 122.59 7.98 Favored 'Trans proline' 0 C--N 1.373 1.867 0 N-CA-C 108.014 -1.571 . . . . 70.2 108.014 169.127 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.17 141.13 61.92 Favored 'Trans proline' 0 C--O 1.254 1.317 0 C-N-CA 122.01 1.807 . . . . 53.24 112.519 -176.733 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -58.78 134.26 56.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.498 -0.774 . . . . 41.22 109.963 -179.191 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 102.73 -5.93 51.57 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 120.544 -0.836 . . . . 54.33 111.973 -177.639 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.501 ' O ' HG12 ' A' ' 497' ' ' ILE . 79.3 m -88.94 137.74 32.04 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.852 0.326 . . . . 64.44 110.794 177.134 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 17.9 m -89.27 122.73 32.81 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.03 -1.47 . . . . 64.15 107.03 173.461 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 16.1 m -131.73 156.15 80.48 Favored Pre-proline 0 C--N 1.313 -0.981 0 CA-C-O 119.423 -0.323 . . . . 73.5 110.56 -177.278 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -59.54 139.55 89.75 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 123.043 2.495 . . . . 75.23 111.774 178.645 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 517' ' ' PHE . 27.3 m -65.41 -21.31 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 113.487 0.921 . . . . 73.34 113.487 -175.873 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -87.15 -11.96 48.44 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.045 0.45 . . . . 74.11 111.108 178.93 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 73.7 m -69.88 155.11 41.04 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.61 0.719 . . . . 71.33 112.719 -177.375 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 27.3 t -88.79 125.97 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-N 114.884 -1.053 . . . . 44.22 110.065 -176.282 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 551' ' ' ILE . . . . . 0.501 HD13 ' O ' ' A' ' 519' ' ' LYS . 0.2 OUTLIER -102.39 129.03 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 119.684 -0.807 . . . . 74.25 109.228 174.228 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 552' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 521' ' ' SER . 38.1 tt0 -102.73 119.27 38.54 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 108.899 -0.778 . . . . 73.24 108.899 -179.427 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 553' ' ' LEU . . . . . 0.401 HD23 HG22 ' A' ' 537' ' ' THR . 47.6 mt -92.19 122.88 35.09 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.117 -0.947 . . . . 65.33 109.443 -179.107 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -85.93 112.71 21.43 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.782 -1.192 . . . . 73.24 107.782 171.78 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 42.8 t -95.64 140.16 17.56 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 CA-C-N 115.207 -0.906 . . . . 63.53 109.283 -176.505 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.666 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 66.5 m -76.17 141.33 41.89 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-O 121.448 0.642 . . . . 73.22 111.533 177.45 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 525' ' ' VAL . 16.7 ttmt -114.66 119.64 37.41 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 125.613 1.565 . . . . 71.1 107.003 173.724 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -74.74 -24.31 72.66 Favored Glycine 0 C--N 1.314 -0.662 0 C-N-CA 120.574 -0.822 . . . . 75.21 113.831 -174.072 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 559' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' A' ' 615' ' ' ASN . 24.9 m120 74.53 18.14 2.92 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.069 1.348 . . . . 74.14 110.658 -178.539 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -131.89 141.19 49.3 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.566 -0.531 . . . . 71.0 109.566 -173.462 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -137.74 139.24 40.01 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 108.342 -0.984 . . . . 72.34 108.342 173.137 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 11.4 p -62.77 129.27 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 N-CA-C 113.3 0.852 . . . . 73.32 113.3 -173.816 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 57.2 ttp -97.56 128.94 32.88 Favored Pre-proline 0 C--O 1.254 1.328 0 CA-C-N 115.649 -0.705 . . . . 75.41 110.006 177.11 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.35 170.23 19.72 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.072 2.514 . . . . 62.22 112.048 176.224 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 565' ' ' ASP . . . . . 0.416 ' HB3' ' CB ' ' A' ' 610' ' ' ALA . 6.4 p-10 -86.34 122.37 30.21 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.424 0.63 . . . . 65.53 112.368 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.08 13.2 1.11 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 122.24 1.019 . . . . 71.12 109.423 174.102 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 1.8 m -72.57 153.19 41.41 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 114.588 -1.187 . . . . 62.32 111.355 -175.834 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 77.14 36.24 35.85 Favored Glycine 0 CA--C 1.519 0.297 0 N-CA-C 114.637 0.615 . . . . 74.14 114.637 174.667 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 25.1 ptm -129.12 174.67 9.35 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.421 -0.585 . . . . 73.4 109.421 -179.627 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 570' ' ' PHE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 90.6 m-85 -79.63 144.34 33.88 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-O 120.881 0.372 . . . . 75.2 110.527 -174.856 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 571' ' ' TRP . . . . . 0.564 ' HA ' ' HB3' ' A' ' 574' ' ' ALA . 74.9 t-105 -67.76 -17.83 64.67 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.729 -0.668 . . . . 62.12 111.292 -174.574 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 30.1 m -68.24 -28.24 40.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.755 -0.657 . . . . 71.32 110.444 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 573' ' ' ASP . . . . . 0.596 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 26.0 m-20 -101.77 -34.21 9.53 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 115.904 -0.589 . . . . 63.33 109.966 176.33 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 574' ' ' ALA . . . . . 0.564 ' HB3' ' HA ' ' A' ' 571' ' ' TRP . . . -57.27 -46.8 82.74 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.942 1.09 . . . . 64.14 113.942 -175.663 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.543 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 5.9 tm-20 -59.14 -53.11 69.58 Favored Pre-proline 0 CA--C 1.566 1.566 0 N-CA-C 109.438 -0.579 . . . . 74.43 109.438 179.063 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 576' ' ' PRO . . . . . 0.543 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 79.6 Cg_exo -53.95 -38.06 86.18 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.329 2.019 . . . . 62.05 113.27 171.587 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.596 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 69.0 mmt-85 -58.92 -43.17 91.08 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 110.344 -0.243 . . . . 60.44 110.344 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.09 -42.31 99.58 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.959 -0.564 . . . . 63.4 109.938 -179.076 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -64.36 -41.12 96.89 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.753 -0.658 . . . . 74.14 110.554 178.178 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.18 -24.1 64.93 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.803 -0.635 . . . . 71.33 111.636 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 581' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 89.0 mt -83.82 -8.0 59.32 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.006 0.431 . . . . 61.41 110.16 176.789 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 86.02 20.74 54.8 Favored Glycine 0 N--CA 1.438 -1.23 0 C-N-CA 120.622 -0.799 . . . . 75.42 111.476 -179.244 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 86.9 t90 -88.09 127.88 35.41 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 121.077 0.465 . . . . 74.11 109.829 178.133 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 36.4 m -149.92 66.24 0.98 Allowed 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.608 -1.256 . . . . 61.21 107.608 170.777 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -103.44 -129.75 6.72 Favored Glycine 0 N--CA 1.434 -1.498 0 CA-C-N 114.627 -1.169 . . . . 53.41 110.189 179.414 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 24.5 ttt -121.03 126.8 50.82 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.49 -0.559 . . . . 63.43 109.49 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -103.58 131.14 50.97 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.16 -1.422 . . . . 74.22 107.16 177.86 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -94.56 108.46 20.41 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.82 -0.807 . . . . 64.11 108.82 177.321 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -89.61 113.16 24.56 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.594 -1.262 . . . . 72.45 107.594 179.509 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -83.23 -105.3 0.51 Allowed Glycine 0 N--CA 1.432 -1.595 0 C-N-CA 120.464 -0.874 . . . . 60.42 110.968 178.846 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.99 146.72 39.45 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.121 -1.437 . . . . 61.42 107.121 176.277 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -75.44 129.07 36.71 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.293 0.568 . . . . 63.23 109.816 -178.926 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 26.0 t -112.16 132.53 60.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 116.253 -0.43 . . . . 74.41 111.616 -172.985 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -76.13 107.21 8.2 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 106.734 -1.58 . . . . 72.3 106.734 171.291 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -111.82 -10.49 14.01 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 112.673 0.62 . . . . 74.45 112.673 -172.926 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 596' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 600' ' ' HIS . . . 127.16 170.67 12.91 Favored Glycine 0 CA--C 1.49 -1.516 0 N-CA-C 109.653 -1.379 . . . . 61.31 109.653 179.472 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -64.59 -50.5 58.7 Favored Glycine 0 C--N 1.316 -0.567 0 C-N-CA 119.478 -1.344 . . . . 63.34 112.531 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 10.4 p -70.44 -23.71 62.77 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 112.485 0.55 . . . . 55.13 112.485 -176.822 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -108.01 -0.72 21.11 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 118.709 -0.662 . . . . 73.33 112.619 -175.767 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 600' ' ' HIS . . . . . 0.482 ' HB3' ' O ' ' A' ' 596' ' ' GLY 0.289 25.1 p-80 -55.39 -74.69 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 114.675 1.361 . . . . 71.33 114.675 -169.473 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 601' ' ' ASN . . . . . 0.438 ' OD1' ' HB3' ' A' ' 571' ' ' TRP . 13.5 t-20 -97.13 71.14 2.41 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.247 -0.908 . . . . 75.3 108.965 -175.636 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 602' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 44.1 ttt180 -143.15 150.97 40.15 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.552 -0.749 . . . . 74.55 110.558 -173.62 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 93.0 t -66.78 132.46 32.13 Favored 'Isoleucine or valine' 0 C--O 1.246 0.921 0 N-CA-C 107.3 -1.37 . . . . 73.03 107.3 174.611 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 54.9 t -92.25 -52.96 9.32 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 N-CA-C 108.307 -0.997 . . . . 54.24 108.307 -172.408 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 605' ' ' TYR . . . . . 0.416 ' O ' ' HA ' ' A' ' 622' ' ' LEU . 45.1 p90 -156.08 160.39 39.92 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 107.297 -1.372 . . . . 71.02 107.297 177.422 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.54 140.18 52.29 Favored 'General case' 0 C--N 1.283 -2.296 0 O-C-N 124.364 1.04 . . . . 72.13 110.047 176.012 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.555 ' HB2' ' HB ' ' A' ' 621' ' ' THR . 25.6 t-20 -52.22 -55.27 32.92 Favored Pre-proline 0 CA--C 1.558 1.272 0 C-N-CA 124.611 1.165 . . . . 71.03 113.822 -177.721 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.554 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 9.4 Cg_endo -97.42 128.69 0.27 Allowed 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 122.176 1.918 . . . . 74.05 111.572 177.785 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.87 154.71 66.98 Favored 'Trans proline' 0 C--O 1.247 0.945 0 C-N-CA 121.661 1.574 . . . . 63.34 110.59 176.554 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 610' ' ' ALA . . . . . 0.416 ' CB ' ' HB3' ' A' ' 565' ' ' ASP . . . -53.44 130.29 35.03 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 123.184 0.594 . . . . 60.54 111.774 -178.379 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 97.79 -0.0 59.17 Favored Glycine 0 N--CA 1.432 -1.569 0 C-N-CA 119.875 -1.155 . . . . 72.41 112.379 -179.142 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 22.5 m -98.36 155.64 17.12 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.882 -1.155 . . . . 71.44 107.882 176.388 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -88.15 138.3 14.96 Favored Glycine 0 N--CA 1.412 -2.963 0 C-N-CA 120.871 -0.68 . . . . 43.51 111.956 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 18.7 m -104.09 143.59 15.6 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 C-N-CA 123.637 0.775 . . . . 63.22 109.918 176.937 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.635 HD21 HG22 ' A' ' 619' ' ' ILE . 1.9 p-10 -55.96 140.78 41.98 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 125.336 1.454 . . . . 75.21 111.347 178.976 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -50.63 -31.59 16.52 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 113.939 1.088 . . . . 75.13 113.939 -174.048 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -71.77 -23.86 61.66 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 120.829 0.347 . . . . 75.23 110.696 -177.417 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 86.09 19.52 57.25 Favored Glycine 0 N--CA 1.41 -3.079 0 C-N-CA 120.465 -0.874 . . . . 74.52 114.155 172.975 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 619' ' ' ILE . . . . . 0.635 HG22 HD21 ' A' ' 615' ' ' ASN . 0.2 OUTLIER -73.51 124.43 30.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 C-N-CA 116.823 -1.951 . . . . 73.22 108.94 176.198 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.447 ' N ' HD13 ' A' ' 619' ' ' ILE . 6.6 tp -120.05 128.87 75.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.5 -0.773 . . . . 53.12 109.423 -178.956 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.555 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 35.9 m -102.68 116.8 33.31 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 108.925 -0.768 . . . . 33.41 108.925 178.978 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 622' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 605' ' ' TYR . 3.9 pp -139.89 160.3 40.22 Favored 'General case' 0 CA--C 1.478 -1.814 0 N-CA-C 106.41 -1.7 . . . . 72.21 106.41 178.646 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -128.7 147.14 50.73 Favored 'General case' 0 C--N 1.259 -3.353 0 N-CA-C 106.394 -1.706 . . . . 74.3 106.394 179.598 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -128.62 165.25 21.17 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.347 -0.983 . . . . 74.51 108.347 176.119 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -92.95 -114.37 2.25 Favored Glycine 0 N--CA 1.413 -2.884 0 O-C-N 123.889 0.743 . . . . 72.33 112.748 -179.383 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 . . . . . 0 C--N 1.302 -1.46 0 CA-C-O 118.876 -0.583 . . . . 74.12 110.822 -173.865 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.285 0 N-CA-C 110.363 -1.095 . . . . 70.02 110.363 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 9.3 tp -75.45 119.66 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-O 121.543 0.687 . . . . 62.22 111.392 -179.836 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 3.7 m -86.3 150.68 24.18 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 105.788 -1.93 . . . . 64.4 105.788 173.974 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 358' ' ' ARG . 5.2 mmm180 -92.52 42.81 1.11 Allowed 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.928 -0.709 . . . . 73.41 111.454 -171.505 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -75.96 148.26 38.28 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.54 -0.911 . . . . 52.23 108.54 177.158 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 30.3 m -119.56 151.83 22.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.517 -0.92 . . . . 63.34 108.517 -178.986 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -95.08 135.84 36.13 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 106.169 -1.789 . . . . 72.45 106.169 176.589 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.468 HG22 ' CZ ' ' A' ' 382' ' ' PHE . 59.4 t -97.39 132.06 26.1 Favored Pre-proline 0 C--N 1.286 -2.178 0 CA-C-N 115.987 -0.551 . . . . 65.13 110.826 -169.249 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 363' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 13.3 Cg_exo -66.56 134.03 34.11 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.17 1.913 . . . . 72.51 112.389 -179.301 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 364' ' ' ASP . . . . . 0.402 ' OD1' ' HG2' ' A' ' 366' ' ' ARG . 3.5 p30 -100.5 144.15 29.84 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.705 -1.22 . . . . 63.32 107.705 176.774 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 4.3 t -123.09 28.2 2.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 107.544 -1.28 . . . . 75.32 107.544 -179.724 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.52 ' HB3' HG23 ' A' ' 402' ' ' THR . 14.1 ptt180 -61.07 143.91 54.49 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.597 -1.183 . . . . 72.53 110.61 178.723 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.06 -13.89 55.74 Favored Glycine 0 N--CA 1.429 -1.779 0 CA-C-N 116.063 -0.517 . . . . 74.4 112.294 178.92 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -105.16 -87.29 0.45 Allowed 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 121.173 -0.211 . . . . 70.32 111.323 -178.722 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 89.5 p -156.32 160.67 39.93 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 108.227 -1.027 . . . . 63.05 108.227 179.557 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 1.4 p -63.49 -34.68 78.31 Favored 'General case' 0 N--CA 1.422 -1.847 0 O-C-N 123.498 0.499 . . . . 65.51 109.716 174.882 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.07 -46.37 89.4 Favored 'General case' 0 C--O 1.214 -0.771 0 CA-C-N 116.044 -0.525 . . . . 72.13 110.487 178.22 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -63.91 -41.91 97.56 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 120.826 0.346 . . . . 54.21 111.206 178.157 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -68.33 -45.6 72.48 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.237 -0.438 . . . . 64.31 111.356 -178.39 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 73.6 mt -65.9 -44.43 92.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.408 -0.36 . . . . 71.43 110.818 178.881 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.9 -43.89 91.1 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 120.922 0.392 . . . . 64.15 111.607 -177.985 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 38.9 m -64.29 -48.46 75.57 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.006 -0.543 . . . . 74.24 110.435 -178.937 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 10.8 mp -65.19 -37.92 88.84 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.163 -0.471 . . . . 61.4 111.862 178.914 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -61.11 -42.35 98.37 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.795 0.838 . . . . 75.12 109.867 178.541 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -66.2 -28.53 68.83 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.988 -0.551 . . . . 70.43 111.333 177.745 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -86.18 -14.41 44.1 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.907 0.384 . . . . 64.12 111.416 178.419 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 90.57 16.21 55.47 Favored Glycine 0 C--N 1.307 -1.076 0 C-N-CA 120.444 -0.884 . . . . 71.25 112.633 177.892 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.468 ' CZ ' HG22 ' A' ' 362' ' ' VAL . 26.1 m-85 -78.23 161.24 27.44 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-O 121.374 0.606 . . . . 52.23 111.542 178.02 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 48.5 mmtm -100.73 132.43 46.13 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 108.946 -0.761 . . . . 73.44 108.946 178.164 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.423 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -118.0 154.8 19.98 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.721 0 N-CA-C 108.615 -0.883 . . . . 74.35 108.615 175.998 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -124.99 135.22 52.58 Favored 'General case' 0 C--N 1.265 -3.069 0 N-CA-C 106.182 -1.785 . . . . 73.24 106.182 177.508 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 31.1 m -119.04 117.58 29.14 Favored 'General case' 0 C--N 1.271 -2.841 0 N-CA-C 109.157 -0.683 . . . . 70.21 109.157 -177.383 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 387' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' A' ' 419' ' ' ASN . 2.9 tm? -116.07 127.58 54.99 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 106.292 -1.744 . . . . 74.14 106.292 179.479 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.441 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 16.5 pm0 -114.22 147.5 38.84 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.997 -0.681 . . . . 74.42 111.439 -177.979 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -136.39 137.52 24.49 Favored Pre-proline 0 C--N 1.308 -1.234 0 N-CA-C 107.849 -1.167 . . . . 74.42 107.849 175.193 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.481 ' HB2' ' HG2' ' A' ' 425' ' ' GLU . 53.9 Cg_endo -72.64 148.73 47.79 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 121.425 1.417 . . . . 74.0 109.505 172.982 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . 0.279 27.8 t70 -61.55 115.37 3.86 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 116.934 2.198 . . . . 45.53 116.934 -171.916 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 392' ' ' SER . . . . . 0.453 ' O ' ' HB ' ' A' ' 393' ' ' THR . 3.2 p -143.75 65.89 1.3 Allowed 'General case' 0 N--CA 1.383 -3.778 0 CA-C-N 111.822 -2.444 . . . . 64.0 106.744 166.622 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.497 HG22 ' O ' ' A' ' 393' ' ' THR . 63.4 m 87.38 39.08 0.02 OUTLIER 'General case' 0 CA--C 1.571 1.771 0 CA-C-O 123.703 1.716 . . . . 64.42 111.471 176.545 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -117.14 149.51 44.48 Favored Pre-proline 0 C--N 1.291 -1.967 0 O-C-N 121.032 -1.042 . . . . 73.23 112.125 175.917 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.02 178.49 6.44 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.911 2.407 . . . . 71.13 111.131 -179.051 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -55.91 161.11 8.86 Favored 'Trans proline' 0 C--N 1.362 1.252 0 C-N-CA 122.765 2.31 . . . . 71.41 112.328 176.034 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 397' ' ' ASP . . . . . 0.433 ' HB2' HG13 ' A' ' 420' ' ' VAL . 5.4 p-10 -58.09 -8.35 1.04 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.953 1.301 . . . . 71.51 113.142 -178.815 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -74.25 172.05 12.52 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.285 -0.635 . . . . 74.14 109.285 -179.468 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 13.9 m -97.32 118.7 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.999 0 N-CA-C 108.417 -0.957 . . . . 71.34 108.417 176.677 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 2.2 mp -94.88 -32.05 4.46 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 107.592 -1.262 . . . . 70.02 107.592 178.345 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.88 170.85 27.75 Favored Glycine 0 N--CA 1.418 -2.536 0 N-CA-C 109.101 -1.599 . . . . 35.02 109.101 179.307 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.52 HG23 ' HB3' ' A' ' 366' ' ' ARG . 2.5 p -129.34 -177.87 4.42 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 122.572 0.349 . . . . 75.34 110.443 -179.262 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -100.14 135.96 20.22 Favored Pre-proline 0 C--N 1.293 -1.866 0 N-CA-C 106.626 -1.62 . . . . 63.45 106.626 178.771 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -55.52 -12.18 5.77 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 124.034 3.156 . . . . 72.52 114.836 -175.469 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -53.88 -35.61 61.76 Favored 'General case' 0 C--O 1.212 -0.874 0 C-N-CA 122.899 0.48 . . . . 75.44 110.548 176.641 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.11 -39.51 68.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.338 0.589 . . . . 71.34 110.879 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -83.61 2.28 38.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.365 0.602 . . . . 72.3 110.639 -179.048 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 27.1 m -102.17 145.89 28.74 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 106.326 -1.731 . . . . 52.54 106.326 172.686 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 48.8 m -75.01 113.03 11.85 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 119.039 -1.064 . . . . 74.51 108.822 175.255 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.5 m -118.95 170.24 8.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.889 -0.596 . . . . 74.04 110.037 179.766 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 22.8 t -69.19 152.08 45.54 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.797 -0.445 . . . . 74.33 109.797 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -63.91 109.4 1.76 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.362 0.601 . . . . 74.41 111.185 -178.649 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 100.56 44.64 2.1 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 115.185 -0.916 . . . . 73.51 113.05 178.074 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -92.03 -174.21 3.71 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.984 -1.117 . . . . 62.44 107.984 178.456 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 415' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 44.8 mt-10 -109.16 133.0 53.58 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 121.53 0.681 . . . . 72.15 112.582 -177.624 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 44.6 mm -118.76 113.82 42.9 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 107.697 -1.223 . . . . 64.41 107.697 174.087 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 14.8 t -89.63 131.16 35.76 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.441 0.638 . . . . 73.14 111.274 -179.541 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 9.2 p -115.49 135.1 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 CA-C-N 115.329 -0.85 . . . . 42.33 109.562 -177.88 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 419' ' ' ASN . . . . . 0.493 ' HA ' ' O ' ' A' ' 387' ' ' LEU . 2.8 t-20 -97.74 116.0 29.09 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.887 -0.725 . . . . 63.34 109.339 176.236 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 98.4 t -102.44 136.0 36.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.109 -1.071 . . . . 60.05 108.109 179.232 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 15.8 m -99.09 135.05 41.05 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-O 121.543 0.687 . . . . 63.55 111.418 -178.847 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 17.6 p -105.95 160.06 15.56 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.492 -1.299 . . . . 71.52 107.492 172.409 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -44.04 159.94 0.1 Allowed Glycine 0 CA--C 1.546 1.999 0 N-CA-C 114.789 0.675 . . . . 45.35 114.789 -178.063 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -52.5 149.9 22.53 Favored 'Trans proline' 0 C--O 1.248 0.987 0 C-N-CA 124.085 3.19 . . . . 64.51 113.163 -176.688 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.481 ' HG2' ' HB2' ' A' ' 390' ' ' PRO . 33.3 mt-10 -71.71 127.77 33.63 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-O 122.602 1.192 . . . . 55.43 111.906 -175.285 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -136.8 158.49 44.33 Favored 'General case' 0 C--N 1.27 -2.862 0 CA-C-N 112.877 -1.965 . . . . 74.41 106.975 177.54 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.5 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 4.2 mmp_? -122.35 147.37 46.34 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-O 120.797 0.332 . . . . 74.44 110.472 177.802 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -88.71 139.1 30.81 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 107.496 -1.298 . . . . 74.15 107.496 178.624 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 63.4 mt -80.43 118.99 75.01 Favored Pre-proline 0 N--CA 1.428 -1.536 0 N-CA-C 108.241 -1.022 . . . . 64.4 108.241 179.569 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -71.08 154.12 62.56 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 121.872 1.715 . . . . 75.2 110.549 177.409 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -77.4 89.43 3.79 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.53 0.681 . . . . 64.43 110.079 177.667 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 42.0 t -93.18 131.19 40.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 105.765 -1.939 . . . . 73.24 105.765 175.572 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.484 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 15.7 m -64.44 151.89 43.01 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 120.929 0.395 . . . . 52.35 111.197 -176.726 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 26.9 p -59.76 -33.41 71.64 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 123.427 0.691 . . . . 63.24 112.275 -176.621 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.496 ' HB3' ' HG3' ' A' ' 466' ' ' LYS . 1.9 pp -81.56 -11.23 59.23 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.465 0.65 . . . . 72.41 112.601 178.336 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.547 HG22 ' HB3' ' A' ' 439' ' ' GLU . 3.5 m -97.9 34.27 1.94 Allowed 'General case' 0 CA--C 1.564 1.509 0 N-CA-C 108.971 -0.752 . . . . 52.33 108.971 -178.703 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -51.41 -39.27 56.92 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.495 1.118 . . . . 71.4 113.391 179.745 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.1 -42.27 99.54 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-O 121.866 0.841 . . . . 72.33 110.268 -179.676 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.547 ' HB3' HG22 ' A' ' 436' ' ' THR . 26.8 tt0 -70.56 -33.96 71.69 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.451 -0.795 . . . . 71.21 109.468 178.691 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.621 ' O ' HD22 ' A' ' 444' ' ' LEU . . . -59.51 -50.19 74.89 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.378 -0.374 . . . . 72.01 110.961 -179.35 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.4 m -62.53 -38.61 81.88 Favored 'Isoleucine or valine' 0 C--O 1.257 1.46 0 N-CA-C 112.058 0.392 . . . . 74.44 112.058 179.637 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 442' ' ' LYS . 0.0 OUTLIER -68.0 -33.51 74.75 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 119.33 -0.948 . . . . 42.32 111.329 175.321 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -61.61 -42.96 99.61 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.368 -0.378 . . . . 62.32 111.262 175.559 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.621 HD22 ' O ' ' A' ' 440' ' ' ALA . 0.9 OUTLIER -63.79 -33.14 75.01 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 119.714 -0.794 . . . . 63.03 110.395 177.147 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 91.3 m -65.42 -44.02 88.69 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 116.174 -0.466 . . . . 74.43 110.456 177.797 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.76 -22.28 63.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.465 0.65 . . . . 44.31 110.979 179.225 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.69 5.46 13.26 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.64 -0.709 . . . . 61.5 112.182 -178.972 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 101.53 -73.79 0.36 Allowed Glycine 0 CA--C 1.493 -1.338 0 C-N-CA 119.977 -1.106 . . . . 61.4 112.232 174.837 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -47.83 -56.81 6.63 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 113.255 0.835 . . . . 73.44 113.255 178.041 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 61.97 25.43 66.04 Favored Glycine 0 CA--C 1.507 -0.418 0 C-N-CA 121.27 -0.49 . . . . 60.35 112.664 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -100.98 110.86 22.94 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.596 -1.261 . . . . 71.44 107.596 -177.628 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.612 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 32.3 p90 -139.12 151.33 46.58 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 120.731 0.301 . . . . 72.31 110.826 -179.194 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -131.25 130.2 42.56 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.435 -0.95 . . . . 71.41 108.435 177.878 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -97.62 123.16 41.42 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 123.649 0.593 . . . . 61.33 110.039 179.204 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.22 135.47 53.77 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 107.043 -1.466 . . . . 31.54 107.043 173.191 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -112.67 139.42 48.29 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.771 -0.825 . . . . 74.2 108.771 179.703 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 457' ' ' SER . . . . . 0.488 ' O ' ' HA2' ' A' ' 489' ' ' GLY . 23.2 t -141.94 136.34 15.1 Favored Pre-proline 0 C--N 1.287 -2.118 0 N-CA-C 108.898 -0.778 . . . . 74.25 108.898 179.708 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.687 ' HA ' ' O ' ' A' ' 490' ' ' SER . 30.4 Cg_endo -65.8 131.35 27.18 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.169 1.913 . . . . 72.12 110.54 175.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 46.1 m -147.34 174.88 11.24 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 122.259 -0.276 . . . . 61.43 110.402 -177.491 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 3.9 t -50.66 142.98 15.16 Favored Pre-proline 0 N--CA 1.446 -0.658 0 C-N-CA 124.973 1.309 . . . . 74.42 111.716 176.689 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.54 -29.73 33.13 Favored 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 124.653 3.569 . . . . 74.51 113.153 -177.481 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -68.53 -35.06 76.94 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.379 -0.373 . . . . 72.52 111.197 179.29 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -96.18 -9.11 31.32 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 113.057 0.762 . . . . 51.33 113.057 -178.345 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 92.9 t -60.5 127.11 19.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.795 -0.817 . . . . 74.42 108.795 175.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.98 -1.43 67.92 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 111.788 -0.525 . . . . 65.52 111.788 -178.567 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.496 ' HG3' ' HB3' ' A' ' 435' ' ' LEU . 10.0 mptt -122.89 155.18 37.2 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-O 121.595 0.712 . . . . 74.02 111.336 -178.884 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 73.4 t -68.45 137.77 23.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 114.115 -1.402 . . . . 75.02 109.718 175.861 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 40.3 mm -97.95 -28.02 3.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 108.386 -0.968 . . . . 72.42 108.386 -179.811 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 168.36 164.43 24.04 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.238 -0.982 . . . . 60.34 113.088 177.556 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 1.1 t -116.96 142.8 46.47 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 107.468 -1.308 . . . . 75.13 107.468 176.369 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.423 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 47.4 t30 -70.65 -53.14 9.81 Favored Pre-proline 0 C--N 1.321 -0.642 0 C-N-CA 119.493 -0.883 . . . . 73.2 111.242 177.457 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.465 ' HG2' ' HA ' ' A' ' 484' ' ' VAL . 27.6 Cg_exo -65.95 134.79 38.52 Favored 'Trans proline' 0 C--N 1.368 1.589 0 N-CA-C 108.269 -1.473 . . . . 74.31 108.269 171.58 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 472' ' ' PRO . 21.0 Cg_exo -62.48 127.6 21.29 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.213 1.942 . . . . 72.42 111.791 -176.823 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -71.43 2.17 5.33 Favored 'General case' 0 C--O 1.209 -1.058 0 CA-C-N 115.816 -0.629 . . . . 72.43 112.578 -177.401 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -108.89 -12.96 14.83 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.164 0.507 . . . . 75.14 111.402 179.283 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -102.26 173.05 6.54 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.235 0.54 . . . . 74.2 112.02 -172.757 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 1.3 m -91.69 119.92 31.98 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 115.277 -0.874 . . . . 62.33 108.902 -177.646 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 13.1 p -102.46 145.96 28.8 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.148 0.499 . . . . 63.43 110.925 -177.935 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -80.38 154.16 27.89 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.909 -0.587 . . . . 73.13 111.376 -176.252 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 425' ' ' GLU . 23.1 mm -74.02 -6.19 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 CA-C-O 122.154 0.978 . . . . 72.12 110.498 -177.793 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 6.4 p -108.48 5.42 25.22 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.488 0.661 . . . . 51.3 111.156 177.927 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -97.36 150.59 20.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.52 -0.764 . . . . 71.41 111.251 -173.772 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 59.8 t -108.14 126.4 64.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 123.667 0.787 . . . . 63.33 110.452 -177.054 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.612 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 61.0 t -101.03 120.03 49.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 120.892 0.377 . . . . 74.44 110.361 -179.985 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.98 126.03 59.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 109.022 -0.732 . . . . 72.31 109.022 177.525 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 16.8 mt -120.55 128.35 76.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 114.749 -1.114 . . . . 64.15 111.506 -177.132 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 6.9 tt -103.62 126.95 58.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 115.481 -0.781 . . . . 73.12 109.849 177.795 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 2.4 p -119.02 139.04 47.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 123.39 0.676 . . . . 74.11 110.076 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 457' ' ' SER . . . -77.08 127.64 8.55 Favored Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 111.034 -0.827 . . . . 72.42 111.034 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.687 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 23.0 t -143.44 160.62 40.23 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.05 -1.093 . . . . 71.35 108.05 -178.289 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 150.0 83.66 0.04 OUTLIER Glycine 0 C--N 1.31 -0.904 0 C-N-CA 120.21 -0.995 . . . . 60.32 111.731 179.344 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -79.03 112.87 3.14 Favored 'Trans proline' 0 N--CA 1.444 -1.403 0 C-N-CA 122.505 2.137 . . . . 43.21 112.312 -178.459 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -96.7 24.28 6.19 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 122.655 1.217 . . . . 65.11 108.601 178.012 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 546' ' ' PRO . 18.7 p -117.07 149.25 40.6 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 112.615 -2.084 . . . . 72.24 109.296 -175.805 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 495' ' ' LYS . . . . . 0.4 ' HD2' ' O ' ' A' ' 515' ' ' TYR . 64.9 mttm -137.01 147.71 46.41 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.263 -0.643 . . . . 61.25 109.263 174.873 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 6.3 p-10 -80.7 129.92 34.8 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 124.014 0.821 . . . . 72.54 109.418 179.071 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 497' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 543' ' ' THR . 36.3 pt -87.19 131.31 44.87 Favored Pre-proline 0 C--N 1.295 -1.762 0 CA-C-N 115.825 -0.625 . . . . 75.3 110.506 179.391 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.56 -172.34 1.46 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.216 1.944 . . . . 73.15 109.377 173.302 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -82.01 149.47 28.11 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.4 -1.334 . . . . 71.51 107.4 176.937 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.56 85.98 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 CA-C-O 122.59 1.186 . . . . 73.15 108.94 177.111 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -149.86 128.54 12.4 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 114.218 -1.355 . . . . 72.14 108.876 -178.038 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 122.77 -20.8 7.66 Favored Glycine 0 N--CA 1.435 -1.429 0 C-N-CA 120.246 -0.978 . . . . 73.21 111.673 177.354 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.87 177.39 4.86 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 120.952 0.406 . . . . 63.25 110.843 178.619 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 9.4 t -87.95 157.88 18.82 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.102 -0.703 . . . . 61.14 109.102 -178.912 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.3 p -50.6 -41.63 20.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 124.317 1.047 . . . . 73.11 112.043 -179.181 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -61.74 -41.53 97.79 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.043 0.386 . . . . 74.41 112.043 179.129 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 89.6 t -71.21 -42.43 75.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-O 121.243 0.544 . . . . 65.55 109.891 179.084 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -60.41 -42.45 96.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.489 -0.778 . . . . 53.12 110.633 179.143 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -59.41 -46.22 89.33 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.27 -0.877 . . . . 54.33 109.953 179.673 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.425 ' O ' HG23 ' A' ' 514' ' ' VAL . 2.8 tmmm? -60.49 -44.3 96.09 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.163 -0.926 . . . . 71.43 108.904 -179.09 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -61.97 -48.09 81.91 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 116.117 -0.492 . . . . 70.3 111.035 -179.407 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.93 -38.89 92.76 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 111.804 0.298 . . . . 75.35 111.804 179.402 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -63.14 -38.17 90.12 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 121.232 -0.187 . . . . 73.33 110.939 179.014 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 510' ' ' LYS . 72.2 t -61.17 -35.46 65.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.027 0.441 . . . . 72.5 110.648 176.605 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 515' ' ' TYR . . . . . 0.4 ' O ' ' HD2' ' A' ' 495' ' ' LYS . 22.8 m-85 -79.06 -4.53 50.67 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 120.886 0.374 . . . . 75.52 110.99 -178.631 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 97.62 3.12 58.48 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 120.653 -0.784 . . . . 35.13 112.685 177.021 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.497 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 85.2 m-85 -86.44 115.24 23.82 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 108.032 -1.099 . . . . 73.53 108.032 -178.881 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.4 m -114.77 11.26 16.74 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 119.489 -0.884 . . . . 72.0 111.166 -176.27 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 519' ' ' LYS . . . . . 0.409 ' HB3' HG22 ' A' ' 550' ' ' VAL . 67.7 mttm -129.41 114.23 15.9 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.279 -0.637 . . . . 72.41 109.279 176.249 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -130.86 150.54 51.97 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 115.645 -0.707 . . . . 74.34 110.075 178.743 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 68.9 m -126.73 146.76 50.1 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 107.174 -1.417 . . . . 74.22 107.174 172.82 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -117.94 129.37 55.57 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 120.251 -0.58 . . . . 73.24 109.956 -179.392 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -105.33 115.99 31.19 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 106.867 -1.531 . . . . 71.35 106.867 175.576 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 19.4 m -88.89 114.74 25.84 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 121.676 0.751 . . . . 61.21 110.602 -176.509 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 28.1 m -121.47 168.83 13.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-N 114.464 -1.244 . . . . 75.33 108.232 -178.014 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 526' ' ' ASP . . . . . 0.544 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 7.0 p-10 -103.74 149.65 24.8 Favored 'General case' 0 C--N 1.282 -2.336 0 C-N-CA 120.049 -0.66 . . . . 73.11 111.748 -177.778 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 19.8 m -149.44 178.13 1.58 Allowed Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 105.286 -2.116 . . . . 72.44 105.286 177.012 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -87.65 -12.44 4.46 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 121.29 1.327 . . . . 73.53 111.523 172.168 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.4 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 35.5 mtp85 -87.01 148.42 45.25 Favored Pre-proline 0 N--CA 1.428 -1.546 0 C-N-CA 123.484 0.714 . . . . 72.41 109.332 179.033 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -56.14 148.47 59.28 Favored 'Trans proline' 0 C--O 1.259 1.556 0 C-N-CA 124.019 3.146 . . . . 74.34 117.13 -170.598 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.56 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -61.2 137.39 58.24 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 113.367 -1.742 . . . . 73.43 111.054 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 108.9 -17.95 32.0 Favored Glycine 0 N--CA 1.429 -1.828 0 N-CA-C 110.895 -0.882 . . . . 53.35 110.895 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -80.38 136.63 36.41 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 109.731 -0.47 . . . . 74.21 109.731 178.314 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 60.0 t -86.14 120.74 36.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.037 -1.097 . . . . 53.3 108.037 178.329 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 535' ' ' THR . . . . . 0.509 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 9.7 t -92.91 -1.97 56.25 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.946 -0.57 . . . . 73.45 110.78 -176.882 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 144.27 -167.19 26.99 Favored Glycine 0 CA--C 1.496 -1.095 0 N-CA-C 111.216 -0.754 . . . . 73.33 111.216 176.238 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 12.6 p -118.55 160.1 22.37 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 117.398 0.599 . . . . 61.05 110.288 176.036 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.454 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 35.4 t30 -71.2 -51.64 10.05 Favored Pre-proline 0 C--N 1.31 -1.144 0 CA-C-N 116.244 -0.434 . . . . 71.12 110.104 175.81 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.454 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 14.0 Cg_exo -72.59 135.87 24.84 Favored 'Trans proline' 0 C--N 1.38 2.208 0 N-CA-C 109.134 -1.141 . . . . 75.0 109.134 171.287 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.69 154.51 67.92 Favored 'Trans proline' 0 C--O 1.254 1.285 0 C-N-CA 122.364 2.042 . . . . 74.23 113.415 -177.094 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.06 138.11 58.21 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.429 -0.805 . . . . 73.22 110.163 178.747 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.56 -20.4 34.63 Favored Glycine 0 C--N 1.305 -1.174 0 N-CA-C 111.755 -0.538 . . . . 75.53 111.755 -179.362 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.428 ' O ' HG12 ' A' ' 497' ' ' ILE . 25.6 m -70.63 133.39 46.64 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.34 -0.245 . . . . 75.31 110.34 -178.443 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 15.0 t -98.12 129.58 44.92 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 109.083 -0.71 . . . . 72.22 109.083 177.037 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 7.1 m -136.43 154.4 76.91 Favored Pre-proline 0 C--N 1.297 -1.675 0 CA-C-N 115.668 -0.696 . . . . 63.21 109.218 179.732 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 494' ' ' THR . 26.9 Cg_exo -64.57 139.01 62.02 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.435 2.09 . . . . 64.23 111.244 178.414 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.497 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 35.3 m -63.85 -20.87 27.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 113.313 0.857 . . . . 74.22 113.313 -175.643 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -94.43 4.03 54.39 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.848 0.832 . . . . 44.44 110.508 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 39.4 m -93.54 179.49 5.37 Favored 'General case' 0 N--CA 1.437 -1.101 0 O-C-N 121.911 -0.493 . . . . 74.53 110.524 178.606 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.409 HG22 ' HB3' ' A' ' 519' ' ' LYS . 19.8 t -106.83 131.6 56.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 116.468 -0.333 . . . . 74.42 111.078 -174.117 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 551' ' ' ILE . . . . . 0.503 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -114.44 136.69 50.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 108.396 -0.964 . . . . 54.11 108.396 172.164 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -103.68 124.14 48.3 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 121.421 0.629 . . . . 53.23 111.726 -178.622 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.3 mp -97.37 134.77 40.2 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.681 -1.145 . . . . 70.33 110.014 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -86.97 119.06 26.78 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.505 -1.665 . . . . 73.23 106.505 177.313 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 59.6 t -114.41 131.07 67.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.793 -0.567 . . . . 53.0 109.866 -178.13 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.56 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 69.8 m -81.35 157.89 24.88 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 113.407 0.892 . . . . 73.02 113.407 -178.242 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.544 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 14.2 ptpt -119.08 158.34 26.06 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 105.326 -2.102 . . . . 74.5 105.326 167.519 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 558' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -75.03 -42.65 29.01 Favored Glycine 0 CA--C 1.485 -1.808 0 C-N-CA 119.949 -1.12 . . . . 63.23 112.432 -174.597 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 55.7 t30 67.35 -12.4 0.26 Allowed 'General case' 0 CA--C 1.569 1.696 0 C-N-CA 124.186 0.994 . . . . 74.43 112.759 173.48 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.477 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 71.3 mt-30 -136.63 160.73 37.92 Favored 'General case' 0 C--O 1.253 1.289 0 C-N-CA 125.859 1.663 . . . . 72.24 107.505 176.373 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -138.92 136.6 35.65 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 110.117 -0.327 . . . . 65.02 110.117 176.708 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 8.3 p -59.89 121.68 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 121.599 0.714 . . . . 74.43 112.176 -178.013 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 21.4 ptm -87.6 147.05 40.72 Favored Pre-proline 0 C--O 1.252 1.211 0 CA-C-N 115.654 -0.703 . . . . 73.05 112.803 -175.085 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.69 170.78 19.56 Favored 'Trans proline' 0 CA--C 1.551 1.329 0 C-N-CA 124.566 3.511 . . . . 64.42 112.902 175.457 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.5 124.07 28.62 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.995 -0.548 . . . . 75.21 112.15 177.883 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -112.61 -3.31 14.35 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 122.045 0.926 . . . . 71.24 108.815 174.398 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 11.1 m -68.24 137.53 54.83 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.103 -1.408 . . . . 72.12 111.455 -177.587 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 80.4 30.92 39.15 Favored Glycine 0 N--CA 1.438 -1.203 0 C-N-CA 121.103 -0.57 . . . . 62.11 112.019 176.338 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 64.6 mtt -137.3 173.23 11.9 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.899 -0.778 . . . . 74.21 108.899 -178.677 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 570' ' ' PHE . . . . . 0.495 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 89.0 m-85 -100.28 166.26 11.07 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 109.29 -0.633 . . . . 75.12 109.29 179.252 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 69.9 t90 -67.73 -28.47 67.67 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.327 -0.619 . . . . 71.11 109.327 178.059 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 10.2 p -68.56 -10.02 12.41 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 CA-C-N 115.63 -0.713 . . . . 72.45 110.409 176.739 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 573' ' ' ASP . . . . . 0.454 ' O ' ' HG3' ' A' ' 577' ' ' ARG . 38.0 m-20 -100.59 -44.51 5.82 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 108.163 -1.051 . . . . 73.23 108.163 173.611 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 574' ' ' ALA . . . . . 0.461 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -59.35 -51.74 68.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.112 -0.949 . . . . 65.11 112.564 -177.33 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.573 ' OE2' ' HD3' ' A' ' 579' ' ' ARG . 21.0 tp10 -52.95 -56.77 20.27 Favored Pre-proline 0 CA--C 1.562 1.431 0 CA-C-O 119.02 -0.514 . . . . 73.34 112.09 -179.666 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 576' ' ' PRO . . . . . 0.446 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 53.5 Cg_exo -57.77 -38.16 93.91 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.126 1.884 . . . . 74.23 112.595 176.332 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 573' ' ' ASP . 80.8 mtp180 -65.79 -36.85 84.69 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 120.864 -0.335 . . . . 74.34 111.332 -179.558 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 96.1 mt -63.36 -38.77 92.45 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.128 0.49 . . . . 73.51 109.797 178.192 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 579' ' ' ARG . . . . . 0.573 ' HD3' ' OE2' ' A' ' 575' ' ' GLU . 7.0 mmm180 -65.3 -45.79 82.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.509 -0.769 . . . . 74.13 108.941 179.562 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.22 -29.81 70.14 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.369 -0.832 . . . . 70.41 112.213 -178.318 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 95.5 mt -81.59 -6.3 58.86 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.843 0.354 . . . . 74.02 110.833 178.53 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 72.87 35.77 58.08 Favored Glycine 0 N--CA 1.439 -1.114 0 N-CA-C 111.456 -0.657 . . . . 54.3 111.456 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 583' ' ' TRP . . . . . 0.405 ' CH2' ' HB2' ' A' ' 587' ' ' LEU . 79.1 t90 -76.22 128.65 35.35 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.782 -0.451 . . . . 74.12 109.782 -179.79 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 17.6 m -150.54 86.56 1.4 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.899 -0.778 . . . . 62.24 108.899 174.106 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -147.73 -142.92 3.74 Favored Glycine 0 C--N 1.309 -0.943 0 N-CA-C 110.244 -1.142 . . . . 63.24 110.244 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 47.7 tpp -96.51 125.21 40.84 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 117.538 0.669 . . . . 70.45 110.964 177.409 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 587' ' ' LEU . . . . . 0.405 ' HB2' ' CH2' ' A' ' 583' ' ' TRP . 3.4 tm? -96.23 128.96 43.62 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.54 -1.652 . . . . 71.05 106.54 175.434 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -94.99 123.26 38.37 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 105.241 -2.133 . . . . 65.11 105.241 178.439 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -85.52 121.42 28.2 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 113.251 0.834 . . . . 73.23 113.251 -162.483 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -105.47 144.0 15.74 Favored Glycine 0 N--CA 1.407 -3.237 0 N-CA-C 107.875 -2.09 . . . . 63.44 107.875 171.3 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -94.21 150.93 19.85 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 117.072 0.436 . . . . 75.33 110.018 -179.251 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -73.44 124.8 26.51 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.314 -1.365 . . . . 75.24 107.314 173.271 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 41.1 t -105.94 123.35 60.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 CA-C-N 116.188 -0.46 . . . . 73.51 111.367 -175.235 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 594' ' ' ASP . . . . . 0.446 ' HA ' ' HB2' ' A' ' 626' ' ' GLN . 6.3 p-10 -81.32 107.8 14.41 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.477 -1.305 . . . . 75.42 107.477 173.938 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -136.08 21.1 3.24 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.615 -0.72 . . . . 73.24 109.725 -177.844 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 101.18 173.46 28.75 Favored Glycine 0 N--CA 1.427 -1.914 0 C-N-CA 120.267 -0.968 . . . . 33.04 110.812 -177.505 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -62.18 -33.42 85.84 Favored Glycine 0 C--O 1.218 -0.865 0 N-CA-C 114.188 0.435 . . . . 53.33 114.188 -175.093 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 13.7 m -58.31 -24.44 59.64 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 113.806 1.039 . . . . 52.0 113.806 -175.828 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -98.49 -0.31 43.63 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 113.343 0.868 . . . . 74.45 113.343 -175.339 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 600' ' ' HIS . . . . . 0.476 ' HA ' ' OXT' ' A' ' 626' ' ' GLN . 5.7 p80 -35.46 98.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 115.682 1.734 . . . . 65.44 115.682 -174.264 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 52.95 10.29 0.15 Allowed 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 126.075 1.75 . . . . 63.22 115.381 172.09 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 602' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 38.4 ttt180 -79.83 143.34 34.46 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.945 -1.097 . . . . 71.35 110.945 -175.408 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 87.9 t -74.58 131.0 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 108.224 -1.028 . . . . 71.03 108.224 179.818 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 46.5 t -94.04 -48.09 13.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.332 0.587 . . . . 74.34 110.248 -175.345 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -148.34 151.19 34.93 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.635 -0.711 . . . . 63.41 110.049 179.099 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 606' ' ' GLN . . . . . 0.461 ' HA ' ' O ' ' A' ' 621' ' ' THR . 14.4 pt20 -115.57 141.7 47.71 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.869 -1.16 . . . . 71.14 107.869 174.372 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.612 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 3.9 t30 -51.35 -57.16 15.16 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 123.66 0.6 . . . . 74.31 112.274 -175.915 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.612 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 9.6 Cg_endo -100.01 138.66 0.27 Allowed 'Trans proline' 0 N--CA 1.433 -2.069 0 C-N-CA 121.742 1.628 . . . . 73.14 110.096 172.271 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -70.13 147.14 59.82 Favored 'Trans proline' 0 C--O 1.252 1.177 0 C-N-CA 121.313 1.342 . . . . 53.05 109.918 175.753 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -62.37 138.98 58.55 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.886 0.375 . . . . 52.54 110.551 -178.874 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.16 -8.21 44.84 Favored Glycine 0 N--CA 1.431 -1.649 0 N-CA-C 110.598 -1.001 . . . . 61.15 110.598 -175.032 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 6.1 m -100.83 157.29 16.83 Favored 'General case' 0 C--O 1.249 1.066 0 N-CA-C 108.384 -0.969 . . . . 63.23 108.384 178.174 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -85.69 132.18 10.95 Favored Glycine 0 N--CA 1.428 -1.867 0 N-CA-C 111.227 -0.749 . . . . 55.31 111.227 178.35 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 21.8 m -97.43 142.47 14.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 110.055 -0.35 . . . . 70.43 110.055 178.166 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.477 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 30.1 p-10 -57.05 167.13 0.88 Allowed 'General case' 0 N--CA 1.436 -1.164 0 O-C-N 124.476 1.11 . . . . 74.04 112.478 -178.821 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -61.02 -25.33 66.83 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.832 -1.077 . . . . 63.04 111.847 -178.035 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -78.44 -37.04 44.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.445 -0.343 . . . . 65.24 110.536 176.298 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 90.5 22.4 34.45 Favored Glycine 0 C--O 1.211 -1.307 0 C-N-CA 119.254 -1.451 . . . . 31.42 112.444 179.153 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.82 123.14 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 CA-C-O 122.63 1.205 . . . . 62.41 110.819 -168.754 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 6.3 tp -129.34 132.37 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 113.839 -1.528 . . . . 71.44 111.256 -174.085 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 606' ' ' GLN . 44.2 m -104.45 137.27 42.57 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 107.971 -1.122 . . . . 71.02 107.971 174.629 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 88.7 mt -138.15 157.01 47.16 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.243 -1.391 . . . . 63.42 107.243 178.638 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -144.25 136.6 26.59 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 104.178 -2.527 . . . . 64.34 104.178 177.063 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 602' ' ' ARG . 6.8 p90 -143.06 161.65 37.6 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 123.658 0.599 . . . . 71.4 111.526 -177.463 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -88.18 -163.62 39.4 Favored Glycine 0 N--CA 1.426 -2.004 0 C-N-CA 120.836 -0.697 . . . . 41.13 111.797 177.648 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 626' ' ' GLN . . . . . 0.476 ' OXT' ' HA ' ' A' ' 600' ' ' HIS . 56.5 tp60 . . . . . 0 C--N 1.303 -1.444 0 C-N-CA 123.166 0.586 . . . . 72.34 110.352 -177.72 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.646 0 N-CA-C 110.855 -0.898 . . . . 64.52 110.855 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 10.0 tp -74.78 117.7 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-O 121.986 0.898 . . . . 72.32 109.808 179.636 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 10.5 m -122.54 158.78 29.13 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.353 -0.839 . . . . 62.13 109.87 -174.793 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.5 96.78 4.65 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 124.326 1.05 . . . . 74.44 108.313 179.782 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.7 133.81 49.97 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 113.143 -1.844 . . . . 72.44 109.944 -179.664 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 360' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 409' ' ' SER . 35.9 m -120.73 163.06 18.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 115.724 -0.671 . . . . 64.32 109.411 -175.475 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -94.05 136.94 33.8 Favored 'General case' 0 N--CA 1.39 -3.45 0 N-CA-C 108.733 -0.84 . . . . 52.31 108.733 176.103 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 94.7 t -97.8 129.28 31.67 Favored Pre-proline 0 C--N 1.269 -2.908 0 CA-C-N 114.289 -1.323 . . . . 62.43 109.566 -173.521 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -65.33 120.3 7.48 Favored 'Trans proline' 0 N--CA 1.443 -1.489 0 C-N-CA 121.769 1.646 . . . . 73.33 110.37 176.905 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -97.03 83.17 3.31 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 106.981 -1.488 . . . . 73.42 106.981 -175.473 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 30.2 m -71.65 34.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 125.997 1.719 . . . . 73.34 115.053 -171.748 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.431 ' HG3' ' OG1' ' A' ' 402' ' ' THR . 21.0 mmt180 -65.41 148.38 51.81 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 125.315 1.446 . . . . 71.34 111.795 177.377 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 106.47 0.67 37.52 Favored Glycine 0 CA--C 1.501 -0.791 0 N-CA-C 111.028 -0.829 . . . . 65.32 111.028 -175.704 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -111.03 -154.53 0.54 Allowed 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 108.392 -0.966 . . . . 70.41 108.392 175.025 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 61.8 p -96.26 168.24 10.7 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 109.765 -0.457 . . . . 74.54 109.765 -176.701 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.88 -46.99 85.25 Favored 'General case' 0 N--CA 1.421 -1.918 0 CA-C-N 115.339 -0.846 . . . . 54.04 109.329 179.706 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.38 -44.83 82.04 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.701 -0.681 . . . . 71.2 112.411 -176.858 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -66.94 -47.2 72.39 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.885 0.374 . . . . 61.54 110.097 -177.144 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -67.35 -41.12 85.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.87 -0.604 . . . . 73.02 111.873 -177.99 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 66.5 mt -68.09 -39.8 81.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 116.692 -0.231 . . . . 71.33 110.399 177.809 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.16 -38.65 89.85 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 120.799 0.333 . . . . 50.13 110.34 179.61 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 376' ' ' THR . . . . . 0.608 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 52.0 m -63.14 -47.9 80.75 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.725 -0.67 . . . . 71.54 110.199 179.307 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 98.2 mt -64.01 -42.33 97.18 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 116.33 -0.396 . . . . 74.22 110.506 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -64.21 -41.67 96.95 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.967 -0.561 . . . . 72.1 109.758 179.826 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -69.82 -17.64 63.41 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 112.969 0.729 . . . . 75.1 112.969 177.404 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 380' ' ' ARG . . . . . 0.608 ' HG2' ' O ' ' A' ' 376' ' ' THR . 6.9 mmp_? -88.78 -10.8 46.89 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.653 -0.499 . . . . 73.11 109.653 175.468 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.48 2.9 55.51 Favored Glycine 0 C--N 1.32 -0.36 0 CA-C-N 115.948 -0.569 . . . . 65.3 112.786 178.157 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -82.62 154.23 25.04 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-O 121.254 0.55 . . . . 33.44 111.895 -177.864 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -101.26 145.8 28.38 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.224 -1.399 . . . . 75.14 107.224 179.8 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 1.1 mp -129.38 144.01 39.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.171 -1.048 . . . . 71.31 108.171 179.252 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 385' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 385' ' ' ARG . 13.9 ttm180 -110.56 127.87 55.4 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 105.714 -1.958 . . . . 72.32 105.714 174.203 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 23.7 m -114.04 117.41 31.22 Favored 'General case' 0 C--N 1.271 -2.827 0 N-CA-C 108.074 -1.084 . . . . 74.4 108.074 -178.828 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.55 128.77 56.56 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.361 -0.977 . . . . 53.32 108.361 -177.96 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.405 ' HB3' ' OG1' ' A' ' 422' ' ' THR . 1.8 mp0 -99.78 127.94 45.9 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.666 -0.494 . . . . 73.11 109.666 -178.507 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 389' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 421' ' ' SER . 98.0 mttt -132.74 123.35 18.23 Favored Pre-proline 0 C--N 1.313 -1.017 0 N-CA-C 111.781 0.289 . . . . 73.34 111.781 178.61 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 389' ' ' LYS . 4.2 Cg_exo -82.69 128.09 5.16 Favored 'Trans proline' 0 C--O 1.254 1.288 0 C-N-CA 121.865 1.71 . . . . 72.21 109.032 171.779 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.563 ' HB3' ' CD1' ' A' ' 394' ' ' ILE . 10.2 t70 171.95 -162.17 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 105.174 -2.158 . . . . 63.5 105.174 -174.956 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 36.1 p -141.57 2.3 1.61 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.171 0.51 . . . . 61.5 111.186 178.157 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 25.6 m -98.92 -25.99 14.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.395 0.617 . . . . 75.52 111.381 -175.011 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.563 ' CD1' ' HB3' ' A' ' 391' ' ' ASP . 0.2 OUTLIER -88.53 152.29 49.31 Favored Pre-proline 0 C--N 1.298 -1.636 0 CA-C-N 116.075 -0.511 . . . . 72.34 109.911 -178.167 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 395' ' ' PRO . . . . . 0.428 ' HB3' HG22 ' A' ' 400' ' ' ILE . 7.6 Cg_exo -35.59 150.71 0.03 OUTLIER 'Trans proline' 0 CA--C 1.553 1.453 1 C-N-CA 125.468 4.112 . . . . 74.15 116.924 177.631 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.72 162.58 10.46 Favored 'Trans proline' 0 C--N 1.364 1.388 0 C-N-CA 124.147 3.231 . . . . 64.22 110.619 172.088 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 397' ' ' ASP . . . . . 0.548 ' HA ' HG13 ' A' ' 420' ' ' VAL . 0.9 OUTLIER -59.12 -9.69 2.22 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 113.181 0.808 . . . . 72.43 113.181 -176.232 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -95.06 -178.82 4.61 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 108.77 -0.826 . . . . 72.32 108.77 178.923 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 27.6 m -97.73 117.46 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.825 0 C-N-CA 117.065 -1.854 . . . . 72.01 110.575 179.597 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 400' ' ' ILE . . . . . 0.428 HG22 ' HB3' ' A' ' 395' ' ' PRO . 0.0 OUTLIER -107.89 -47.4 7.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 109.44 -0.578 . . . . 71.23 109.44 175.337 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.75 169.19 27.94 Favored Glycine 0 N--CA 1.427 -1.947 0 N-CA-C 111.141 -0.784 . . . . 60.01 111.141 -177.5 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.431 ' OG1' ' HG3' ' A' ' 366' ' ' ARG . 0.6 OUTLIER -155.67 -176.08 5.77 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 125.479 1.511 . . . . 54.23 109.935 -176.911 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -99.0 155.41 36.6 Favored Pre-proline 0 C--N 1.299 -1.61 0 N-CA-C 106.605 -1.628 . . . . 54.34 106.605 -178.962 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -59.93 10.56 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 124.575 3.517 . . . . 73.21 116.156 -172.842 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -53.45 -43.94 68.47 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 122.868 0.467 . . . . 60.44 111.855 -179.355 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -79.53 -32.33 42.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.251 0.548 . . . . 61.51 111.019 -179.177 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -79.74 1.57 26.1 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.108 0.48 . . . . 72.12 111.211 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 51.0 m -105.47 149.56 26.07 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.676 -1.601 . . . . 75.1 106.676 172.382 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 409' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 360' ' ' VAL . 15.0 p -76.0 113.48 13.56 Favored 'General case' 0 N--CA 1.422 -1.826 0 C-N-CA 119.806 -0.758 . . . . 63.21 110.975 178.77 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.4 m -121.93 170.0 12.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.377 -0.829 . . . . 44.44 109.482 178.869 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 33.3 t -76.52 157.15 32.34 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.145 -0.687 . . . . 63.11 109.145 179.759 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -69.24 109.87 4.32 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-O 121.289 0.566 . . . . 52.2 110.079 179.754 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 108.38 55.61 0.59 Allowed Glycine 0 N--CA 1.433 -1.514 0 CA-C-N 115.095 -0.957 . . . . 71.13 111.413 179.152 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -100.32 -173.18 2.35 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.739 -1.208 . . . . 74.44 107.739 178.057 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -120.08 113.86 21.12 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.414 -0.587 . . . . 74.15 109.414 -177.34 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 416' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 44.9 mm -104.32 133.71 47.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 108.822 -0.807 . . . . 74.3 108.822 -179.058 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 80.3 m -101.82 132.24 47.68 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 122.022 -0.424 . . . . 62.21 110.192 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 9.7 p -115.44 134.36 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 108.888 -0.782 . . . . 70.11 108.888 176.622 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -105.26 114.2 28.24 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.812 0.815 . . . . 75.43 109.286 177.805 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.548 HG13 ' HA ' ' A' ' 397' ' ' ASP . 96.3 t -111.22 131.39 62.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 114.569 -1.196 . . . . 71.13 108.846 -174.209 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 421' ' ' SER . . . . . 0.465 ' HB2' HG12 ' A' ' 394' ' ' ILE . 17.3 t -92.67 121.82 34.47 Favored 'General case' 0 N--CA 1.428 -1.553 0 C-N-CA 119.53 -0.868 . . . . 74.32 110.0 179.265 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.405 ' OG1' ' HB3' ' A' ' 388' ' ' GLN . 33.9 p -120.09 107.28 12.85 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 116.152 -0.476 . . . . 73.14 110.225 174.244 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 101.7 124.03 5.33 Favored Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 119.94 -1.124 . . . . 63.31 113.438 176.255 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -83.31 158.95 15.01 Favored 'Trans proline' 0 C--O 1.254 1.295 0 C-N-CA 123.2 2.6 . . . . 70.35 111.227 176.149 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -72.37 166.27 22.87 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.563 -0.744 . . . . 61.32 110.798 -178.201 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -87.07 157.88 19.32 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 107.334 -1.358 . . . . 63.35 107.334 179.725 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -121.22 151.79 39.58 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 119.585 -0.846 . . . . 74.55 112.428 -169.817 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 34.9 tt0 -83.63 138.77 33.19 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.299 -1.319 . . . . 75.44 109.009 -176.488 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 70.7 mt -80.59 116.65 63.44 Favored Pre-proline 0 C--N 1.306 -1.305 0 N-CA-C 108.082 -1.081 . . . . 70.2 108.082 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -71.29 140.62 37.42 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.476 1.451 . . . . 75.13 110.201 176.398 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.28 128.62 35.48 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.413 -1.328 . . . . 74.22 107.413 175.603 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 42.9 t -118.28 157.45 19.72 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 107.514 -1.291 . . . . 73.43 107.514 -177.889 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.524 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 15.4 m -63.74 146.64 53.49 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-O 120.961 0.41 . . . . 71.45 110.985 -179.511 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 34.8 p -69.14 -25.91 64.62 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 124.66 1.184 . . . . 71.45 112.574 -170.511 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.493 ' H ' HD23 ' A' ' 435' ' ' LEU . 0.6 OUTLIER -90.61 -10.94 41.47 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 115.431 -0.804 . . . . 72.31 111.109 179.334 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.617 HG22 ' HB3' ' A' ' 439' ' ' GLU . 2.4 m -100.66 46.14 0.96 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.424 0.63 . . . . 74.44 109.729 -176.197 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -52.24 -42.79 63.92 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 113.892 1.071 . . . . 73.55 113.892 -178.944 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.52 -44.48 94.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.633 0.254 . . . . 45.34 110.996 -176.978 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.617 ' HB3' HG22 ' A' ' 436' ' ' THR . 28.1 tt0 -70.62 -33.11 70.66 Favored 'General case' 0 C--O 1.195 -1.775 0 CA-C-N 116.474 -0.33 . . . . 73.11 110.777 174.484 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.417 ' O ' HD23 ' A' ' 444' ' ' LEU . . . -59.66 -52.28 66.18 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.988 -0.285 . . . . 54.44 110.75 179.127 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 33.7 m -62.48 -36.33 74.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.614 0.721 . . . . 71.11 110.398 177.437 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.532 ' HB3' ' HA ' ' A' ' 439' ' ' GLU . 20.7 ttmm -59.46 -46.79 87.76 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 124.97 1.308 . . . . 60.23 110.229 176.019 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -65.9 -38.76 89.59 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 123.282 0.633 . . . . 73.31 111.727 -179.64 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 440' ' ' ALA . 4.6 mm? -63.32 -34.64 78.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.054 -0.35 . . . . 71.43 110.054 174.859 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.527 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 32.4 m -69.66 -45.67 67.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.25 0.548 . . . . 71.33 110.221 178.129 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.63 -24.95 64.62 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.635 -0.711 . . . . 52.33 112.455 -178.118 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.57 -4.77 53.01 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.326 0.491 . . . . 73.22 112.326 -177.651 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 125.88 -79.59 0.37 Allowed Glycine 0 CA--C 1.497 -1.074 0 C-N-CA 119.96 -1.114 . . . . 71.11 111.98 177.447 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -42.65 -66.87 0.32 Allowed 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.372 1.069 . . . . 54.23 113.858 178.354 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 450' ' ' GLY . . . . . 0.527 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 63.1 25.54 68.24 Favored Glycine 0 CA--C 1.502 -0.766 0 O-C-N 123.362 0.414 . . . . 65.43 112.626 -178.338 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.504 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 8.6 mmt180 -105.31 110.61 23.03 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.432 -1.692 . . . . 72.31 106.432 -179.711 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.415 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 30.5 p90 -141.03 154.42 45.99 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-O 121.228 0.537 . . . . 64.03 112.091 -176.177 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 5.4 tppp? -137.11 135.0 37.04 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.477 -1.305 . . . . 63.44 107.477 177.681 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -100.03 133.08 44.93 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.312 -0.625 . . . . 74.4 109.312 176.915 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -126.67 151.73 47.69 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.724 -0.473 . . . . 71.14 109.724 177.878 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -113.9 141.3 47.53 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.589 -1.263 . . . . 74.42 107.589 179.245 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 37.3 t -138.1 135.34 18.48 Favored Pre-proline 0 C--N 1.283 -2.323 0 N-CA-C 109.122 -0.695 . . . . 41.4 109.122 178.394 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.642 ' HA ' ' O ' ' A' ' 490' ' ' SER . 51.0 Cg_endo -73.07 122.9 8.45 Favored 'Trans proline' 0 N--CA 1.439 -1.679 0 C-N-CA 121.521 1.481 . . . . 72.13 109.403 174.608 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 51.0 m -148.44 -179.79 7.22 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 109.685 -0.487 . . . . 64.24 109.685 -175.852 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.1 t -47.69 137.86 9.6 Favored Pre-proline 0 C--O 1.251 1.158 0 C-N-CA 124.556 1.143 . . . . 73.24 112.03 178.371 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -52.73 -29.31 41.49 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 124.642 3.562 . . . . 63.35 113.668 -175.958 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.403 ' HG2' ' H ' ' A' ' 462' ' ' GLU . 8.8 pt-20 -71.33 -26.61 62.91 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 112.718 0.636 . . . . 74.1 112.718 -178.53 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -93.89 -4.52 49.81 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.806 -0.559 . . . . 55.0 111.624 179.566 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 85.3 t -60.68 127.79 20.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-N 116.006 -0.543 . . . . 71.31 110.524 178.224 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 95.88 -7.27 67.5 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 115.613 -0.721 . . . . 61.35 113.862 176.456 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.443 ' O ' HG23 ' A' ' 488' ' ' VAL . 6.8 mptt -122.35 158.96 28.47 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.586 -0.894 . . . . 65.41 108.586 -179.707 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 488' ' ' VAL . 66.2 t -72.13 143.81 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.739 0 N-CA-C 107.999 -1.112 . . . . 61.31 107.999 176.624 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 58.3 mt -97.26 -27.73 3.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 107.492 -1.299 . . . . 70.3 107.492 179.409 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 153.18 -165.83 31.38 Favored Glycine 0 N--CA 1.419 -2.457 0 C-N-CA 120.541 -0.837 . . . . 61.14 111.956 175.558 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.13 142.69 46.48 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 106.991 -1.485 . . . . 72.01 106.991 176.979 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -67.68 -55.72 13.64 Favored Pre-proline 0 CA--C 1.548 0.879 0 N-CA-C 109.712 -0.477 . . . . 53.51 109.712 179.064 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.461 ' HA ' ' HD3' ' A' ' 473' ' ' PRO . 12.2 Cg_endo -61.15 133.84 49.16 Favored 'Trans proline' 0 C--N 1.37 1.659 0 N-CA-C 108.276 -1.471 . . . . 72.25 108.276 168.917 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 472' ' ' PRO . 32.5 Cg_exo -62.14 127.96 22.65 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.742 2.295 . . . . 72.42 113.821 -173.862 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -74.03 12.8 0.63 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.968 0.907 . . . . 63.22 111.234 178.59 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -111.03 -7.65 14.51 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.852 -0.613 . . . . 74.5 109.846 176.188 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -116.25 174.7 5.91 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 113.542 0.942 . . . . 60.44 113.542 -170.809 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 0.9 OUTLIER -99.09 141.12 32.27 Favored 'General case' 0 N--CA 1.411 -2.414 0 C-N-CA 124.513 1.125 . . . . 70.11 112.6 -179.173 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 28.3 p -137.82 149.17 46.12 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.11 -0.95 . . . . 64.25 109.362 177.765 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.93 162.11 27.37 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 120.846 0.355 . . . . 63.04 110.948 178.477 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.9 mp -67.57 -15.19 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-O 122.133 0.968 . . . . 74.41 110.976 -178.543 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.2 p -94.41 0.75 55.66 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 115.953 -0.567 . . . . 71.3 112.067 177.437 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -83.69 133.88 34.79 Favored 'General case' 0 CA--C 1.503 -0.855 0 O-C-N 122.005 -0.434 . . . . 73.44 111.414 -178.581 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.504 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.3 p -96.53 126.71 49.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.658 -0.701 . . . . 63.4 109.728 178.089 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 22.3 m -101.48 136.75 31.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-O 121.313 0.578 . . . . 64.33 110.346 178.703 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.79 120.24 58.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 109.005 -0.739 . . . . 52.32 109.005 178.98 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 37.2 mt -109.49 122.91 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 114.663 -1.153 . . . . 73.3 109.9 -177.249 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.4 tt -106.61 127.0 62.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 115.062 -0.972 . . . . 74.52 111.631 -173.533 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 466' ' ' LYS . 2.5 p -111.34 142.78 22.72 Favored 'Isoleucine or valine' 0 C--O 1.247 0.967 0 N-CA-C 109.088 -0.708 . . . . 64.11 109.088 176.411 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -88.17 141.11 16.69 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.88 -0.676 . . . . 25.14 113.468 -176.059 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.642 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 11.1 t -138.8 160.73 38.97 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.804 -1.554 . . . . 63.22 106.804 176.131 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 167.52 156.95 10.32 Favored Glycine 0 N--CA 1.44 -1.068 0 C-N-CA 119.174 -1.488 . . . . 61.31 113.062 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -89.6 167.15 5.07 Favored 'Trans proline' 0 C--O 1.244 0.805 0 C-N-CA 123.705 2.937 . . . . 74.14 112.535 179.38 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -118.19 53.46 0.96 Allowed 'General case' 0 C--O 1.244 0.805 0 CA-C-O 122.302 1.048 . . . . 74.42 108.239 177.446 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 22.8 p -117.78 147.95 42.52 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.762 -1.108 . . . . 75.21 111.233 -176.022 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -141.47 161.79 37.05 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.139 -1.06 . . . . 62.12 108.139 177.495 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.3 p-10 -100.4 138.25 37.72 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.267 0.556 . . . . 74.33 110.754 178.951 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 30.9 pt -77.04 137.51 65.46 Favored Pre-proline 0 C--N 1.308 -1.234 0 CA-C-N 115.293 -0.867 . . . . 73.12 111.967 -178.56 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -81.79 176.32 8.51 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.692 2.261 . . . . 73.41 111.22 176.636 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -86.7 118.88 26.39 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 108.843 -0.799 . . . . 75.45 108.843 178.82 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.09 8.78 7.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-O 122.107 0.956 . . . . 65.4 109.967 -177.426 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -68.19 108.02 3.0 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.93 -1.032 . . . . 55.35 109.719 -179.343 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 132.13 -19.11 4.66 Favored Glycine 0 N--CA 1.432 -1.621 0 C-N-CA 120.689 -0.767 . . . . 53.02 111.36 -177.892 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -99.58 172.94 6.98 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.045 -0.662 . . . . 63.11 109.344 177.542 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 533' ' ' GLU . 40.2 p -90.81 157.69 17.23 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.105 -0.638 . . . . 64.55 110.866 -176.078 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 10.0 p -53.7 -40.75 44.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.848 0.685 . . . . 65.11 112.848 -175.982 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -62.76 -42.93 99.91 Favored 'General case' 0 C--O 1.249 1.064 0 CA-C-O 121.236 0.541 . . . . 73.4 110.387 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 87.8 t -74.66 -37.05 42.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.631 -0.713 . . . . 74.31 110.065 -178.936 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 508' ' ' ALA . . . . . 0.461 ' HA ' ' ND2' ' A' ' 511' ' ' ASN . . . -63.29 -50.24 70.87 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.261 -0.882 . . . . 71.33 111.957 -179.015 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -64.82 -35.53 81.41 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.853 0.359 . . . . 72.03 110.712 -178.965 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.447 ' O ' HG23 ' A' ' 514' ' ' VAL . 3.6 tppp? -65.63 -52.97 47.78 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.672 -0.695 . . . . 74.14 111.627 179.756 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 511' ' ' ASN . . . . . 0.461 ' ND2' ' HA ' ' A' ' 508' ' ' ALA . 8.0 p30 -66.02 -37.82 86.85 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 120.342 -0.543 . . . . 75.04 111.539 -176.452 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 512' ' ' LEU . . . . . 0.427 HD23 ' O ' ' A' ' 508' ' ' ALA . 4.6 mm? -60.08 -41.32 92.18 Favored 'General case' 0 C--O 1.246 0.904 0 C-N-CA 121.032 -0.267 . . . . 75.03 110.617 176.052 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -63.11 -38.22 90.31 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 116.414 -0.357 . . . . 64.14 111.158 178.336 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 510' ' ' LYS . 96.9 t -63.77 -30.98 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 CA-C-N 115.889 -0.596 . . . . 73.54 111.223 179.198 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -80.26 -13.22 59.39 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 120.502 -0.479 . . . . 72.24 111.647 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 119.0 -14.7 11.16 Favored Glycine 0 N--CA 1.434 -1.445 0 C-N-CA 119.955 -1.117 . . . . 64.4 112.504 178.716 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -77.44 102.56 6.91 Favored 'General case' 0 CA--C 1.481 -1.692 0 N-CA-C 106.182 -1.784 . . . . 71.45 106.182 -178.678 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.5 m -88.91 -28.86 20.03 Favored 'General case' 0 N--CA 1.407 -2.58 0 C-N-CA 119.479 -0.888 . . . . 74.25 113.03 -167.152 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 519' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 61.7 mttp -108.32 125.36 51.62 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.736 -0.785 . . . . 71.41 111.659 -174.508 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -130.64 149.49 52.27 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.727 -0.669 . . . . 75.44 110.851 -178.38 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 46.9 m -132.29 143.71 50.08 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.33 -1.359 . . . . 72.45 107.33 173.786 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -117.04 144.32 44.74 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 109.381 -0.6 . . . . 72.44 109.381 179.327 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -130.64 129.99 43.37 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.3 -0.63 . . . . 54.14 109.3 178.814 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 50.8 m -84.11 120.97 26.8 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.542 -0.54 . . . . 51.12 109.542 179.529 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 32.3 m -121.4 162.71 20.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 108.149 -1.056 . . . . 33.42 108.149 179.229 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 526' ' ' ASP . . . . . 0.622 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 6.9 p-10 -82.52 134.38 35.2 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 119.26 -0.976 . . . . 73.53 109.378 -178.57 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 527' ' ' SER . . . . . 0.506 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 51.1 m -152.73 167.99 12.28 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 110.231 -0.285 . . . . 72.41 110.231 177.13 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -85.7 -8.05 8.35 Favored 'Trans proline' 0 C--N 1.36 1.148 0 C-N-CA 122.284 1.99 . . . . 63.13 111.295 174.555 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.523 ' HD3' ' OE2' ' A' ' 533' ' ' GLU . 50.4 mtt180 -80.07 145.53 61.18 Favored Pre-proline 0 N--CA 1.445 -0.71 0 N-CA-C 107.589 -1.263 . . . . 73.21 107.589 178.467 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -61.31 152.29 73.42 Favored 'Trans proline' 0 C--O 1.256 1.422 0 C-N-CA 122.364 2.043 . . . . 44.31 112.585 -179.327 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.658 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -62.93 115.58 4.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.132 -0.94 . . . . 74.13 111.352 -176.238 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 134.3 -24.64 3.55 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 120.564 -0.827 . . . . 35.15 112.224 178.756 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 533' ' ' GLU . . . . . 0.523 ' OE2' ' HD3' ' A' ' 529' ' ' ARG . 32.0 tt0 -82.99 137.85 33.99 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.349 -0.541 . . . . 73.32 109.797 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 88.2 t -81.83 120.2 32.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.86 -0.793 . . . . 74.31 108.86 178.413 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 535' ' ' THR . . . . . 0.463 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 9.3 t -80.94 -13.27 59.05 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.314 -0.403 . . . . 61.43 110.154 -179.075 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.91 -170.76 29.29 Favored Glycine 0 N--CA 1.426 -2.005 0 N-CA-C 109.987 -1.245 . . . . 50.22 109.987 178.222 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 14.1 p -116.88 160.4 20.93 Favored 'General case' 0 C--N 1.273 -2.729 0 N-CA-C 108.384 -0.969 . . . . 74.14 108.384 178.959 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.504 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 38.1 t30 -67.02 -51.75 35.03 Favored Pre-proline 0 C--N 1.317 -0.841 0 C-N-CA 120.443 -0.503 . . . . 64.42 110.762 178.305 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.504 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 3.9 Cg_exo -77.45 131.13 11.35 Favored 'Trans proline' 0 C--N 1.367 1.538 0 N-CA-C 107.601 -1.73 . . . . 74.43 107.601 170.576 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.93 162.15 39.23 Favored 'Trans proline' 0 C--O 1.25 1.117 0 C-N-CA 122.142 1.895 . . . . 53.15 112.555 -177.215 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -56.99 131.33 49.52 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 109.415 -0.587 . . . . 35.12 109.415 175.783 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.9 -12.06 38.04 Favored Glycine 0 C--N 1.301 -1.399 0 C-N-CA 120.928 -0.654 . . . . 42.34 111.929 -177.656 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 56.5 m -68.16 120.68 14.74 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.222 -0.659 . . . . 75.53 109.222 177.111 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 31.8 m -90.77 122.18 33.28 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 109.266 -0.642 . . . . 63.33 109.266 -179.464 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 28.7 m -136.88 158.68 72.47 Favored Pre-proline 0 C--N 1.311 -1.087 0 N-CA-C 108.96 -0.756 . . . . 75.3 108.96 -177.57 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -62.5 148.02 93.95 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 122.28 1.986 . . . . 73.2 110.723 175.527 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 27.0 m -64.13 -27.52 42.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 121.482 0.658 . . . . 75.53 111.882 -178.946 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -88.85 2.91 52.88 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 116.159 -0.473 . . . . 63.53 110.755 -179.25 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 9.7 t -82.14 172.16 13.5 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 120.862 0.363 . . . . 65.21 110.243 -176.88 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 7.8 t -110.58 124.01 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 CA-C-N 115.883 -0.599 . . . . 75.43 109.618 -176.653 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 551' ' ' ILE . . . . . 0.504 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -107.39 145.87 14.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 120.313 -0.555 . . . . 71.04 110.297 176.567 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -103.3 117.25 34.07 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.209 0.528 . . . . 73.31 111.037 -176.624 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 5.5 mp -98.77 130.7 45.23 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.562 -1.199 . . . . 75.23 108.6 178.641 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -102.08 120.03 39.76 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 121.489 0.661 . . . . 65.11 109.651 179.759 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 40.0 t -100.37 137.35 28.17 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 CA-C-N 115.191 -0.913 . . . . 73.41 109.413 -175.629 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.658 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 6.2 m -79.64 123.23 27.44 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.99 -1.004 . . . . 70.34 109.239 -179.015 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.622 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 17.6 ptmt -92.17 145.7 24.3 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 104.313 -2.477 . . . . 51.54 104.313 169.351 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 558' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -79.14 -30.42 46.54 Favored Glycine 0 CA--C 1.486 -1.775 0 C-N-CA 118.964 -1.589 . . . . 51.24 113.486 -172.344 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 70.34 -29.15 0.18 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.663 1.185 . . . . 71.23 113.008 179.491 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.498 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 76.6 mt-30 -128.14 154.4 45.8 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 123.839 0.856 . . . . 74.45 112.015 -176.099 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -138.96 151.09 46.6 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.76 -0.83 . . . . 70.34 108.76 176.528 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 8.5 p -65.78 122.71 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 CA-C-O 121.262 0.554 . . . . 73.44 111.745 -178.912 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 563' ' ' MET . . . . . 0.484 ' HG2' ' O ' ' A' ' 564' ' ' PRO . 57.6 ttp -97.82 137.56 20.96 Favored Pre-proline 0 C--O 1.249 1.046 0 CA-C-N 116.182 -0.463 . . . . 45.52 111.311 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 564' ' ' PRO . . . . . 0.484 ' O ' ' HG2' ' A' ' 563' ' ' MET . 12.6 Cg_exo -73.4 169.39 22.4 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.633 2.222 . . . . 54.23 109.829 169.674 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -83.04 141.13 32.28 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.165 0.507 . . . . 62.42 110.722 -179.25 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 89.4 mt -122.99 15.32 9.96 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.96 -1.126 . . . . 72.32 107.96 177.034 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 7.7 m -72.17 141.21 49.07 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 114.437 -1.256 . . . . 72.4 109.837 -178.046 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 80.37 13.99 80.91 Favored Glycine 0 C--O 1.217 -0.945 0 C-N-CA 120.523 -0.846 . . . . 61.42 113.185 178.271 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 26.2 mmt -105.13 165.14 11.3 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 122.295 -0.532 . . . . 75.54 110.485 178.788 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -86.42 161.21 18.77 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.858 -1.164 . . . . 63.13 107.858 -179.658 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 30.8 t90 -71.22 -25.93 62.72 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.946 -0.761 . . . . 72.22 108.946 177.667 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.0 p -73.78 -17.72 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 115.27 -0.877 . . . . 62.35 109.407 179.475 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 573' ' ' ASP . . . . . 0.625 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 25.0 t70 -97.26 -34.97 10.89 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.362 -0.607 . . . . 74.44 109.362 178.5 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -64.03 -33.62 76.17 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.736 -0.665 . . . . 71.01 111.436 178.607 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.519 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 40.0 tt0 -55.99 -57.11 23.94 Favored Pre-proline 0 CA--C 1.576 1.953 0 CA-C-N 115.923 -0.58 . . . . 61.31 111.973 177.472 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 576' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 38.9 Cg_exo -61.05 -31.46 90.99 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 121.59 1.527 . . . . 74.34 112.835 173.656 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.625 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 24.2 mmt180 -58.9 -47.82 83.63 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 110.123 -0.325 . . . . 75.51 110.123 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.513 HD12 ' N ' ' A' ' 579' ' ' ARG . 4.4 pp -64.09 -45.98 86.29 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 112.372 0.508 . . . . 60.15 112.372 -174.595 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 579' ' ' ARG . . . . . 0.513 ' N ' HD12 ' A' ' 578' ' ' LEU . 4.1 ptp180 -66.02 -35.23 80.0 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.682 -0.407 . . . . 73.23 112.074 178.618 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.85 -36.42 72.86 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.23 0.538 . . . . 23.11 111.605 178.44 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 581' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 86.8 mt -81.84 -3.3 53.7 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 112.418 0.525 . . . . 55.42 112.418 -177.42 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 73.39 40.68 47.68 Favored Glycine 0 CA--C 1.506 -0.528 0 C-N-CA 120.581 -0.818 . . . . 61.2 111.178 -179.632 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 75.6 t90 -70.04 137.64 51.46 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.999 -0.6 . . . . 72.02 110.739 -179.614 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 5.9 t -156.49 75.23 0.85 Allowed 'General case' 0 N--CA 1.424 -1.748 0 CA-C-O 122.283 1.04 . . . . 75.3 109.399 178.432 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -141.38 -137.71 3.44 Favored Glycine 0 N--CA 1.434 -1.457 0 N-CA-C 110.923 -0.871 . . . . 70.42 110.923 -178.587 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 65.7 mtt -126.8 136.87 52.96 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.057 -1.09 . . . . 53.35 108.057 177.622 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -97.38 128.51 44.25 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.796 -1.187 . . . . 72.44 107.796 -176.837 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -105.01 101.86 11.4 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.949 -0.7 . . . . 74.44 110.346 179.453 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -102.45 133.57 47.19 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 107.746 -1.205 . . . . 73.41 107.746 175.597 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -90.99 -154.44 30.52 Favored Glycine 0 N--CA 1.418 -2.558 0 N-CA-C 110.312 -1.115 . . . . 60.02 110.312 177.107 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -71.0 133.6 46.48 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 110.153 -0.314 . . . . 73.21 110.153 179.048 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -77.23 123.24 26.18 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 105.469 -2.048 . . . . 72.34 105.469 177.282 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 94.5 t -136.03 135.68 50.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-O 120.971 0.415 . . . . 74.24 111.895 -171.315 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 594' ' ' ASP . . . . . 0.425 ' HB2' HE21 ' A' ' 626' ' ' GLN . 17.7 t70 -97.58 106.54 18.87 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 105.86 -1.904 . . . . 71.11 105.86 173.16 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -145.15 9.54 1.26 Allowed 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 112.777 0.658 . . . . 71.35 112.777 -175.561 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 122.91 167.04 12.82 Favored Glycine 0 C--N 1.302 -1.327 0 C-N-CA 119.84 -1.171 . . . . 72.21 111.583 179.836 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.75 -43.13 91.93 Favored Glycine 0 C--O 1.239 0.433 0 O-C-N 123.864 0.391 . . . . 45.11 114.052 -172.565 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 15.8 m -65.65 -34.11 77.46 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.181 0.515 . . . . 71.02 111.231 -179.112 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 599' ' ' GLN . . . . . 0.427 ' O ' ' HA3' ' A' ' 625' ' ' GLY . 80.9 mm-40 -92.49 -0.97 57.28 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 112.511 0.56 . . . . 54.22 112.511 -178.644 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -89.86 -106.56 0.09 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.424 0.898 . . . . 73.0 113.424 -178.515 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -92.46 54.86 2.38 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.185 0.517 . . . . 74.4 110.005 -173.227 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -144.12 140.85 29.65 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.891 -0.781 . . . . 71.01 108.891 176.802 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 95.8 t -64.34 130.15 29.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 107.509 -1.293 . . . . 72.32 107.509 173.322 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 58.0 t -89.2 -52.32 11.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.046 0.45 . . . . 61.34 110.429 -177.335 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -135.52 155.85 49.83 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.134 -1.061 . . . . 74.43 108.134 179.391 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -118.9 100.29 7.28 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 107.194 -1.41 . . . . 72.04 107.194 178.956 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.499 ' CB ' ' HB ' ' A' ' 621' ' ' THR . 26.7 t-20 -54.75 -51.58 77.7 Favored Pre-proline 0 CA--C 1.554 1.111 0 N-CA-C 113.772 1.027 . . . . 63.04 113.772 -177.72 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 609' ' ' PRO . 7.8 Cg_exo -75.84 128.95 11.2 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 121.094 1.196 . . . . 51.03 109.229 173.072 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 609' ' ' PRO . . . . . 0.521 ' HB2' ' OG1' ' A' ' 612' ' ' THR . 12.6 Cg_exo -70.31 135.8 30.02 Favored 'Trans proline' 0 C--O 1.242 0.7 0 C-N-CA 122.395 2.064 . . . . 51.34 113.196 -177.533 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -68.35 134.47 50.32 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.216 -0.661 . . . . 60.21 109.216 176.125 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 88.27 0.39 82.73 Favored Glycine 0 C--N 1.305 -1.182 0 C-N-CA 120.136 -1.031 . . . . 73.13 111.108 -178.614 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 612' ' ' THR . . . . . 0.521 ' OG1' ' HB2' ' A' ' 609' ' ' PRO . 39.7 m -111.8 160.6 17.18 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.631 -1.248 . . . . 72.11 107.631 178.321 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -75.89 135.68 18.35 Favored Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 111.223 -0.751 . . . . 74.35 111.223 178.697 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.18 142.18 37.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 108.113 -1.069 . . . . 62.41 108.113 176.894 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.498 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 34.9 p-10 -50.61 153.09 1.75 Allowed 'General case' 0 C--O 1.217 -0.648 0 N-CA-C 113.169 0.803 . . . . 72.23 113.169 179.174 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 616' ' ' ARG . . . . . 0.509 ' HD3' ' H ' ' A' ' 616' ' ' ARG . 0.0 OUTLIER -48.65 -30.82 5.86 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.952 1.301 . . . . 73.43 112.196 177.624 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 617' ' ' ASP . . . . . 0.491 ' HB2' ' ND2' ' A' ' 615' ' ' ASN . 1.0 OUTLIER -66.04 -44.41 84.69 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.578 -0.737 . . . . 71.43 110.325 176.736 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 87.45 23.1 41.19 Favored Glycine 0 N--CA 1.426 -1.986 0 C-N-CA 118.65 -1.738 . . . . 64.32 111.34 -178.266 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.84 119.2 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 123.238 1.494 . . . . 62.13 109.359 -167.972 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 4.2 tp -115.19 119.94 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.118 0 CA-C-N 113.215 -1.811 . . . . 73.32 110.528 -172.596 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.499 ' HB ' ' CB ' ' A' ' 607' ' ' ASN . 24.9 m -98.98 117.13 32.8 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 106.181 -1.785 . . . . 73.4 106.181 171.912 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -138.93 165.37 27.26 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 107.536 -1.283 . . . . 54.32 107.536 -175.835 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -134.11 135.77 43.42 Favored 'General case' 0 C--N 1.272 -2.786 0 N-CA-C 107.623 -1.251 . . . . 71.35 107.623 178.614 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -143.68 165.41 27.7 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 124.857 1.348 . . . . 72.23 107.578 172.709 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 625' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' A' ' 599' ' ' GLN . . . -113.37 -110.87 2.99 Favored Glycine 0 C--N 1.279 -2.623 0 N-CA-C 111.586 -0.606 . . . . 63.12 111.586 -179.092 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 626' ' ' GLN . . . . . 0.425 HE21 ' HB2' ' A' ' 594' ' ' ASP . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.17 0 C-N-CA 121.034 -0.266 . . . . 74.42 111.03 179.02 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.049 0 N-CA-C 110.6 -1.0 . . . . 70.03 110.6 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 8.4 tp -74.36 109.71 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 CA-C-O 122.268 1.032 . . . . 73.41 111.068 -176.594 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 3.1 m -77.17 151.16 35.41 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.636 -1.166 . . . . 72.23 108.869 -179.814 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 21.3 mtp180 -79.32 -20.18 48.56 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.16 0.505 . . . . 71.32 110.422 -179.468 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.65 129.96 41.52 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 105.424 -2.065 . . . . 72.52 105.424 167.312 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 31.5 m -116.12 157.79 16.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-O 121.488 0.661 . . . . 73.01 111.63 -169.822 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -94.76 124.3 38.72 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 106.606 -1.627 . . . . 71.25 106.606 -176.196 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 406' ' ' ALA . 89.7 t -101.35 129.53 26.76 Favored Pre-proline 0 C--N 1.287 -2.109 0 CA-C-N 114.993 -1.003 . . . . 73.41 111.335 -172.58 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -73.41 132.75 18.11 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.138 1.892 . . . . 73.01 109.42 174.637 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -91.76 158.89 16.1 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 120.291 -0.564 . . . . 74.33 109.648 -175.551 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.522 HG21 ' HA ' ' A' ' 373' ' ' ALA . 4.0 m -114.17 6.34 7.71 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 C-N-CA 124.203 1.001 . . . . 72.03 111.673 -176.026 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.77 145.38 12.39 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 112.757 0.651 . . . . 72.0 112.757 172.725 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 367' ' ' GLY . . . . . 0.404 ' H ' HG23 ' A' ' 399' ' ' VAL . . . 104.85 -6.02 43.54 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.254 -0.884 . . . . 54.33 112.307 -176.478 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -104.97 -92.44 0.37 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.73 0.3 . . . . 44.41 111.075 179.608 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 64.9 p -156.31 157.11 35.15 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 107.619 -1.252 . . . . 74.34 107.619 -179.133 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 7.9 p -64.1 -37.52 87.75 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 118.307 0.503 . . . . 64.11 111.221 179.702 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.21 -45.45 94.5 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 116.07 -0.514 . . . . 61.52 111.206 178.789 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -69.12 -39.24 79.03 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.609 -0.515 . . . . 65.11 109.609 179.692 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 373' ' ' ALA . . . . . 0.522 ' HA ' HG21 ' A' ' 365' ' ' VAL . . . -61.91 -51.36 68.45 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.679 -0.692 . . . . 71.44 111.403 -178.964 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 78.5 mt -65.56 -39.97 86.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.188 -0.46 . . . . 60.31 110.124 179.122 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.26 -47.35 85.7 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.063 -0.517 . . . . 63.1 110.907 -179.496 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 376' ' ' THR . . . . . 0.527 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 51.3 m -64.97 -47.46 77.51 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.953 -0.567 . . . . 71.52 110.982 -179.085 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 10.8 mp -62.9 -39.02 93.23 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 112.145 0.424 . . . . 71.41 112.145 -179.248 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -64.99 -38.81 92.2 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.764 0.316 . . . . 53.41 110.205 179.349 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -68.37 -26.59 65.65 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.142 0.496 . . . . 51.41 111.355 176.744 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 380' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 376' ' ' THR . 9.7 mmm180 -82.15 -14.26 55.94 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.284 -0.416 . . . . 55.41 110.846 178.71 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 92.88 16.37 48.43 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.475 -0.869 . . . . 63.14 111.157 179.639 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.455 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 29.3 m-85 -93.16 154.77 17.87 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-O 121.454 0.645 . . . . 70.32 110.427 179.396 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.428 ' HB2' ' HG2' ' A' ' 415' ' ' GLU . 32.6 mmtp -103.75 145.01 30.72 Favored 'General case' 0 N--CA 1.409 -2.508 0 N-CA-C 107.184 -1.413 . . . . 75.54 107.184 -176.626 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.524 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -118.86 142.45 33.8 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 C-N-CA 119.868 -0.733 . . . . 74.2 110.545 -176.726 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 23.7 tpt180 -111.75 147.32 35.89 Favored 'General case' 0 N--CA 1.408 -2.527 0 N-CA-C 105.172 -2.158 . . . . 72.35 105.172 171.829 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 42.9 m -132.77 121.67 23.37 Favored 'General case' 0 C--N 1.269 -2.925 0 C-N-CA 120.229 -0.588 . . . . 71.24 109.56 -175.782 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 66.0 tp -111.22 119.1 37.81 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 107.406 -1.331 . . . . 62.02 107.406 -179.783 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 12.4 pm0 -102.96 131.7 49.74 Favored 'General case' 0 N--CA 1.425 -1.702 0 C-N-CA 119.845 -0.742 . . . . 42.42 110.408 177.966 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 389' ' ' LYS . . . . . 0.548 ' O ' ' HA ' ' A' ' 421' ' ' SER . 13.2 mmmm -126.01 148.32 62.49 Favored Pre-proline 0 C--N 1.282 -2.367 0 N-CA-C 106.152 -1.796 . . . . 73.24 106.152 -178.264 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -69.35 158.04 58.97 Favored 'Trans proline' 0 C--O 1.243 0.765 0 N-CA-C 108.751 -1.288 . . . . 73.24 108.751 173.135 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.439 ' HB2' ' HA ' ' A' ' 424' ' ' PRO . 6.1 m-20 -74.82 82.88 2.14 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-O 121.818 0.818 . . . . 72.02 109.688 178.019 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 392' ' ' SER . . . . . 0.467 ' O ' ' HB ' ' A' ' 393' ' ' THR . 17.1 m -103.29 49.3 0.83 Allowed 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 114.593 -1.185 . . . . 74.41 108.843 178.709 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 392' ' ' SER . 99.2 m 69.54 20.28 7.17 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-O 123.206 1.479 . . . . 71.31 110.02 -179.715 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 5.4 pt -115.75 152.3 47.22 Favored Pre-proline 0 C--N 1.301 -1.536 0 CA-C-N 114.85 -1.068 . . . . 63.23 111.155 -174.357 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 395' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 396' ' ' PRO . 0.6 OUTLIER -21.5 116.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.364 1.388 1 C-N-CA 126.48 4.786 . . . . 45.43 116.831 -177.82 . . . . . . . . 4 4 . 1 . 026 nuclear build full ' A' A ' 396' ' ' PRO . . . . . 0.52 ' HA ' ' OG ' ' A' ' 421' ' ' SER . 41.9 Cg_exo -59.02 161.86 14.89 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 124.267 3.311 . . . . 52.11 114.52 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -57.89 -8.46 0.99 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.996 1.318 . . . . 74.44 113.438 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -98.72 137.14 37.76 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.016 -1.846 . . . . 73.31 106.016 176.21 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 367' ' ' GLY . 18.8 m -72.34 118.2 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 C-N-CA 119.039 -1.064 . . . . 74.31 112.514 -167.86 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.4 -30.6 2.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 105.843 -1.91 . . . . 74.23 105.843 171.386 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.7 157.89 27.55 Favored Glycine 0 N--CA 1.416 -2.673 0 CA-C-N 114.618 -1.174 . . . . 64.03 111.099 -178.399 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 9.3 p -144.83 -175.71 4.78 Favored 'General case' 0 C--N 1.278 -2.523 0 C-N-CA 127.314 2.246 . . . . 51.24 105.369 -177.119 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -98.92 125.95 40.22 Favored Pre-proline 0 C--N 1.295 -1.789 0 C-N-CA 118.118 -1.433 . . . . 72.12 107.673 178.895 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -59.29 6.25 0.09 OUTLIER 'Trans proline' 0 C--N 1.365 1.397 0 C-N-CA 124.691 3.594 . . . . 71.44 115.91 -176.585 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.26 -33.58 67.74 Favored 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 109.467 -0.568 . . . . 73.04 109.467 174.907 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 406' ' ' ALA . . . . . 0.402 ' O ' ' HB ' ' A' ' 362' ' ' VAL . . . -67.04 -36.32 81.82 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-O 121.512 0.672 . . . . 61.34 110.319 177.275 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -85.77 0.72 52.12 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.914 0.864 . . . . 63.44 110.16 -179.147 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 28.5 m -97.33 158.39 15.48 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 104.896 -2.261 . . . . 74.22 104.896 171.588 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 33.7 p -74.32 112.08 10.13 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 118.649 -1.22 . . . . 72.15 108.712 179.236 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 17.1 m -129.53 159.11 41.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 121.296 0.569 . . . . 61.32 112.037 -179.456 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 3.0 p -60.94 140.82 57.66 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.083 -0.962 . . . . 62.32 110.869 177.944 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -65.0 111.01 2.67 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 121.477 0.656 . . . . 64.11 110.372 -177.538 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 413' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 107.07 39.92 1.9 Allowed Glycine 0 N--CA 1.423 -2.21 0 CA-C-N 115.05 -0.977 . . . . 73.52 112.001 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -92.18 -179.31 5.21 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.931 -0.766 . . . . 55.23 108.931 -178.319 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 415' ' ' GLU . . . . . 0.428 ' HG2' ' HB2' ' A' ' 383' ' ' LYS . 43.9 mt-10 -104.69 114.91 29.43 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 110.005 -0.368 . . . . 75.13 110.005 -176.855 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 45.4 mm -107.41 128.78 62.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 109.188 -0.671 . . . . 63.32 109.188 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 25.5 m -85.2 130.29 34.63 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.307 0.575 . . . . 65.41 111.782 -178.023 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 9.4 p -114.68 135.49 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 CA-C-N 115.041 -0.981 . . . . 61.43 108.902 177.861 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -97.67 128.71 44.56 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 110.153 -0.314 . . . . 75.04 110.153 179.27 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 94.6 t -123.72 131.11 73.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 109.235 -0.654 . . . . 63.54 109.235 176.667 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 421' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 95.8 p -99.49 123.66 43.96 Favored 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 120.403 -0.519 . . . . 63.44 109.912 177.152 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 5.5 t -119.7 108.68 14.73 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 112.735 0.642 . . . . 71.43 112.735 -179.712 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 81.99 120.54 0.58 Allowed Glycine 0 CA--C 1.535 1.332 0 N-CA-C 115.373 0.909 . . . . 74.43 115.373 171.871 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 424' ' ' PRO . . . . . 0.439 ' HA ' ' HB2' ' A' ' 391' ' ' ASP . 34.8 Cg_exo -61.89 158.54 37.75 Favored 'Trans proline' 0 C--O 1.251 1.152 0 C-N-CA 123.814 3.009 . . . . 73.41 112.144 174.77 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -71.53 155.94 40.0 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.283 -0.871 . . . . 53.4 111.76 -174.721 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -127.38 150.14 49.75 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 104.775 -2.306 . . . . 54.32 104.775 172.809 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 477' ' ' THR . 20.5 mmm180 -121.66 147.16 46.23 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 119.593 -0.843 . . . . 73.15 111.679 -173.54 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 15.6 pt-20 -82.05 139.19 34.62 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.184 -0.916 . . . . 74.54 108.635 -178.963 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 65.1 mt -78.93 125.79 83.31 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 107.806 -1.183 . . . . 74.33 107.806 -178.878 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -70.51 141.49 42.31 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 121.848 1.699 . . . . 71.33 110.693 175.612 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -80.63 112.55 18.1 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.603 -0.517 . . . . 63.13 109.603 177.981 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 28.2 t -115.78 147.16 19.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 107.528 -1.286 . . . . 61.1 107.528 -179.045 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 1.6 p -58.01 138.17 56.18 Favored 'General case' 0 N--CA 1.432 -1.355 0 O-C-N 123.638 0.586 . . . . 74.32 111.463 179.961 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 31.7 p -64.57 -34.88 79.28 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 123.931 0.893 . . . . 74.14 112.05 -171.047 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.57 ' H ' HD23 ' A' ' 435' ' ' LEU . 0.7 OUTLIER -75.02 -16.88 60.59 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-N 115.198 -0.91 . . . . 61.53 111.464 -179.775 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.427 HG22 ' HB2' ' A' ' 439' ' ' GLU . 2.1 m -105.03 50.6 0.78 Allowed 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.517 0.675 . . . . 73.13 109.26 -175.075 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 437' ' ' TYR . . . . . 0.421 ' O ' HG23 ' A' ' 441' ' ' VAL . 38.9 t80 -52.61 -38.82 60.88 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.893 0.877 . . . . 73.44 112.913 -179.683 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -59.44 -40.6 87.35 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-O 121.066 0.46 . . . . 62.12 110.918 179.444 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.427 ' HB2' HG22 ' A' ' 436' ' ' THR . 42.9 tp10 -70.04 -35.63 74.43 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.968 -0.753 . . . . 61.41 108.968 179.621 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.96 -43.62 98.48 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.893 -0.594 . . . . 71.53 110.054 178.732 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 441' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 437' ' ' TYR . 84.9 t -58.48 -47.85 87.04 Favored 'Isoleucine or valine' 0 C--O 1.246 0.9 0 CA-C-N 115.232 -0.894 . . . . 74.02 110.911 178.669 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -67.38 -34.53 77.47 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 119.789 -0.765 . . . . 74.0 110.708 -179.376 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -62.53 -42.63 99.65 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 116.826 -0.17 . . . . 75.24 111.291 178.515 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 10.2 mp -63.76 -35.09 79.43 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 120.871 0.367 . . . . 61.3 110.389 176.277 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.46 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 22.2 m -68.19 -46.23 71.23 Favored 'General case' 0 C--O 1.249 1.033 0 CA-C-N 115.936 -0.574 . . . . 42.12 110.557 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.36 -17.39 62.42 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-O 121.105 0.479 . . . . 64.43 111.401 179.53 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.34 5.26 24.0 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.888 -0.596 . . . . 64.01 112.272 -179.871 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 110.48 -82.08 0.3 Allowed Glycine 0 CA--C 1.488 -1.615 0 C-N-CA 119.514 -1.327 . . . . 42.5 112.034 175.778 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 449' ' ' PHE . . . . . 0.415 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 0.6 OUTLIER -39.91 -65.22 0.41 Allowed 'General case' 0 C--O 1.248 0.995 0 N-CA-C 113.917 1.08 . . . . 71.03 113.917 175.573 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 450' ' ' GLY . . . . . 0.46 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 59.35 29.69 66.59 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.859 -0.496 . . . . 74.34 111.859 -175.232 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.453 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 16.1 mmm180 -105.06 111.23 23.93 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.472 -1.677 . . . . 62.41 106.472 -179.291 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 35.5 p90 -134.17 153.4 51.86 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 120.871 0.367 . . . . 71.43 110.939 -175.422 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -148.32 122.9 9.79 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.944 -0.761 . . . . 70.41 108.944 177.825 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -83.83 129.39 34.94 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 123.359 0.664 . . . . 73.03 111.458 179.752 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.08 144.66 47.47 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.274 -1.38 . . . . 64.3 107.274 173.342 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -122.29 136.83 54.97 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.521 -0.918 . . . . 71.34 108.521 -177.635 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 457' ' ' SER . . . . . 0.427 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 49.4 m -149.45 138.31 12.39 Favored Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 122.356 -0.215 . . . . 70.04 110.595 176.785 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.73 ' HA ' ' O ' ' A' ' 490' ' ' SER . 22.5 Cg_exo -65.82 129.39 22.02 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.404 2.07 . . . . 74.24 111.014 176.358 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 60.6 m -152.21 -179.28 7.39 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.951 -0.568 . . . . 42.43 109.884 -178.042 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 9.7 t -45.0 136.71 4.74 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.952 1.301 . . . . 64.02 112.432 178.643 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.76 -29.48 34.12 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 124.752 3.635 . . . . 73.44 113.933 -175.954 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -70.38 -30.7 67.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.571 -0.286 . . . . 51.31 111.722 -178.932 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -95.75 -8.81 33.44 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 111.66 0.244 . . . . 63.35 111.66 179.738 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 80.5 t -60.57 127.66 20.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.473 -0.566 . . . . 74.23 109.473 176.696 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 91.06 -15.07 61.82 Favored Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 116.002 -0.544 . . . . 43.31 112.107 -179.529 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -108.69 166.55 10.71 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 109.424 -0.584 . . . . 63.43 109.424 -177.852 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 79.4 t -73.51 140.82 17.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 108.182 -1.044 . . . . 63.15 108.182 173.572 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 65.5 mt -97.33 -35.28 5.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.56 -1.274 . . . . 55.34 107.56 177.253 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 172.76 -179.06 44.49 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 120.297 -0.954 . . . . 74.1 112.031 177.741 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 470' ' ' THR . . . . . 0.506 HG22 HG12 ' A' ' 486' ' ' ILE . 33.1 p -115.17 143.93 44.46 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 105.929 -1.878 . . . . 65.52 105.929 178.805 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -60.32 -57.19 28.45 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 119.888 -0.725 . . . . 72.52 112.146 178.607 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -71.94 152.57 57.7 Favored 'Trans proline' 0 C--N 1.361 1.196 0 N-CA-C 108.001 -1.577 . . . . 72.54 108.001 170.58 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.31 127.82 22.09 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 121.601 1.534 . . . . 75.44 111.44 -179.035 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -76.63 6.45 5.89 Favored 'General case' 0 C--O 1.211 -0.928 0 C-N-CA 124.239 1.016 . . . . 64.24 111.932 -175.981 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -109.78 -4.97 15.73 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 116.106 -0.497 . . . . 73.23 109.808 172.625 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -117.26 176.0 5.35 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 112.981 0.734 . . . . 71.44 112.981 -171.421 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 3.7 p -83.41 131.14 35.05 Favored 'General case' 0 N--CA 1.413 -2.295 0 C-N-CA 124.633 1.173 . . . . 74.42 113.145 -177.782 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 43.8 m -121.23 148.64 43.99 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 106.971 -1.492 . . . . 73.22 106.971 175.611 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.457 ' HB3' ' HB2' ' A' ' 482' ' ' ASN . . . -74.48 156.44 36.93 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.725 -0.39 . . . . 73.25 111.442 -176.585 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.415 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 43.5 mm -69.36 -26.8 32.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.823 0.82 . . . . 73.34 110.25 -177.006 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.4 t -97.9 5.07 49.39 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.69 0.757 . . . . 75.44 109.904 179.021 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 482' ' ' ASN . . . . . 0.457 ' HB2' ' HB3' ' A' ' 479' ' ' ALA . 21.1 t-20 -94.63 135.63 35.87 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.54 -0.755 . . . . 62.35 110.301 -176.597 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.453 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.3 p -89.86 126.75 42.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-O 121.283 0.564 . . . . 72.12 111.444 -177.043 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 60.6 t -96.77 118.53 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.91 0 N-CA-C 107.844 -1.169 . . . . 72.53 107.844 176.207 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.27 129.08 50.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 108.063 -1.088 . . . . 70.42 108.063 177.606 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.506 HG12 HG22 ' A' ' 470' ' ' THR . 15.2 mt -118.54 128.23 75.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-N 115.158 -0.928 . . . . 73.21 110.635 -174.758 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 6.2 tt -103.19 126.17 57.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 115.69 -0.687 . . . . 73.32 110.428 -179.452 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 33.8 m -109.26 151.2 11.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 115.692 -0.685 . . . . 72.14 109.547 178.387 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.42 135.55 14.29 Favored Glycine 0 N--CA 1.423 -2.179 0 C-N-CA 121.125 -0.56 . . . . 70.15 111.744 -178.482 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.73 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 12.8 t -126.05 160.19 30.76 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 105.825 -1.917 . . . . 55.23 105.825 177.234 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 153.77 100.78 0.19 Allowed Glycine 0 C--N 1.297 -1.618 0 C-N-CA 119.048 -1.548 . . . . 73.24 112.157 178.864 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -72.5 150.0 50.88 Favored 'Trans proline' 0 C--O 1.251 1.129 0 C-N-CA 122.45 2.1 . . . . 64.44 111.736 179.06 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -91.25 81.17 5.52 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.532 -0.914 . . . . 62.1 108.532 175.982 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 5.9 p -117.81 153.56 33.26 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.263 -0.88 . . . . 72.42 112.209 -175.193 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 8.0 mmtm -137.24 136.85 38.47 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.242 -0.89 . . . . 72.44 109.746 179.986 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -82.27 121.61 26.87 Favored 'General case' 0 CA--C 1.485 -1.527 0 N-CA-C 105.508 -2.034 . . . . 62.41 105.508 168.876 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 497' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 543' ' ' THR . 44.1 pt -75.38 123.69 88.75 Favored Pre-proline 0 C--N 1.292 -1.905 0 N-CA-C 113.348 0.87 . . . . 64.13 113.348 -172.6 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -86.58 164.6 9.31 Favored 'Trans proline' 0 N--CA 1.429 -2.301 0 C-N-CA 122.472 2.114 . . . . 60.14 108.871 171.784 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -82.35 147.26 28.93 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 120.383 -0.527 . . . . 52.24 109.99 -178.487 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.1 p -130.35 8.29 2.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-O 122.045 0.926 . . . . 75.43 109.832 -176.824 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -81.23 157.11 25.31 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 115.43 -0.805 . . . . 72.52 110.185 -175.994 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 108.55 1.51 32.77 Favored Glycine 0 C--N 1.287 -2.145 0 N-CA-C 109.573 -1.411 . . . . 61.52 109.573 -178.49 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -120.62 175.43 6.01 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.414 -0.958 . . . . 65.53 108.414 -179.267 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 15.0 t -83.89 159.83 21.24 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.82 -1.178 . . . . 74.1 107.82 178.544 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 532' ' ' GLY . 48.2 t -46.84 -48.94 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 123.905 0.882 . . . . 73.42 111.239 -176.54 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -63.46 -41.85 98.62 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.188 -0.915 . . . . 72.44 111.571 -175.158 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 88.2 t -76.35 -40.61 35.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.908 -0.587 . . . . 54.1 110.857 -177.695 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.26 -45.8 89.8 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.378 -0.374 . . . . 72.2 110.881 -179.307 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -65.21 -35.45 81.11 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.402 -0.363 . . . . 74.32 110.893 178.573 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.429 ' O ' HG23 ' A' ' 514' ' ' VAL . 51.1 tptt -62.79 -45.88 90.6 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.37 -0.604 . . . . 73.02 109.37 178.204 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -63.62 -37.42 87.28 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 115.951 -0.568 . . . . 74.54 111.08 177.37 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 512' ' ' LEU . . . . . 0.455 HD11 HD12 ' A' ' 551' ' ' ILE . 59.4 tp -59.8 -43.18 94.6 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.826 -0.625 . . . . 44.33 109.457 177.122 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 513' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 13.5 m120 -63.25 -38.03 89.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.611 -0.722 . . . . 71.53 110.192 177.711 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 510' ' ' LYS . 94.9 t -63.69 -33.37 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 115.564 -0.743 . . . . 51.04 110.651 176.829 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -68.01 -27.49 66.6 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.85 0.357 . . . . 64.41 110.138 178.568 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 131.57 -18.31 4.91 Favored Glycine 0 CA--C 1.506 -0.499 0 C-N-CA 121.006 -0.616 . . . . 64.1 112.267 178.721 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.46 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 85.9 m-85 -78.63 115.15 18.14 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.347 0.594 . . . . 71.55 110.001 -177.025 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 12.5 p -86.87 -16.69 35.28 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.796 -0.638 . . . . 72.13 112.71 -176.83 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 519' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 36.2 mtmm -117.29 130.87 56.83 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.232 0.539 . . . . 64.2 112.001 -174.612 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 520' ' ' PHE . . . . . 0.444 ' HB3' HD23 ' A' ' 512' ' ' LEU . 12.2 p90 -130.07 156.81 43.9 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.346 -0.843 . . . . 73.05 112.398 -177.852 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 49.2 m -140.17 158.36 44.16 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 106.831 -1.544 . . . . 55.25 106.831 173.174 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 522' ' ' GLN . . . . . 0.524 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 0.0 OUTLIER -135.37 145.24 47.16 Favored 'General case' 0 N--CA 1.413 -2.312 0 CA-C-N 118.293 0.497 . . . . 62.51 109.986 179.395 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -129.82 116.13 18.25 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.239 -1.022 . . . . 41.25 108.239 176.072 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 18.4 m -88.12 120.89 29.9 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.726 -0.472 . . . . 61.31 109.726 178.91 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 47.5 t -120.8 148.12 24.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 107.258 -1.386 . . . . 75.5 107.258 -179.616 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 526' ' ' ASP . . . . . 0.453 ' HB2' HD21 ' A' ' 559' ' ' ASN . 9.5 p-10 -68.86 136.41 52.63 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.185 0.517 . . . . 44.42 111.55 -175.978 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 69.6 m -156.78 176.36 2.65 Favored Pre-proline 0 C--N 1.3 -1.549 0 N-CA-C 108.709 -0.849 . . . . 54.33 108.709 -179.285 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -83.32 -14.48 8.2 Favored 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 121.947 1.764 . . . . 62.21 111.598 171.349 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.588 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 0.0 OUTLIER -76.04 140.75 70.35 Favored Pre-proline 0 C--O 1.215 -0.716 0 CA-C-N 115.925 -0.579 . . . . 74.01 109.542 -179.743 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -56.61 144.82 84.22 Favored 'Trans proline' 0 C--O 1.249 1.026 0 C-N-CA 123.399 2.733 . . . . 74.25 113.432 -176.962 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.64 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -62.7 117.51 6.39 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 114.498 -1.228 . . . . 73.14 110.472 -178.329 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 532' ' ' GLY . . . . . 0.438 ' O ' HG23 ' A' ' 505' ' ' VAL . . . 126.82 -19.3 6.18 Favored Glycine 0 C--N 1.3 -1.431 0 C-N-CA 120.48 -0.867 . . . . 74.12 111.48 179.828 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -83.58 125.81 32.18 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 120.735 0.302 . . . . 74.25 110.548 177.752 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 62.0 t -81.92 118.84 30.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.093 -1.077 . . . . 64.24 108.093 178.357 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 99.2 m -104.66 -21.54 13.38 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 120.295 -0.562 . . . . 71.04 112.46 -177.013 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -159.16 -178.4 33.13 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 119.433 -1.365 . . . . 42.11 112.12 178.964 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 25.5 p -124.84 156.6 37.58 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.409 -1.33 . . . . 73.14 107.409 175.982 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.526 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 23.0 t-20 -60.03 -56.99 30.05 Favored Pre-proline 0 CA--C 1.55 0.965 0 CA-C-O 119.307 -0.377 . . . . 44.3 110.777 179.617 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.526 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 98.1 Cg_endo -84.09 143.65 10.37 Favored 'Trans proline' 0 C--N 1.367 1.51 0 CA-C-N 120.307 1.146 . . . . 74.51 110.095 172.849 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.97 148.98 58.42 Favored 'Trans proline' 0 C--O 1.258 1.506 0 C-N-CA 122.164 1.909 . . . . 62.04 112.026 179.642 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.06 134.53 57.07 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 115.908 -0.587 . . . . 75.5 109.681 178.179 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.83 -5.8 34.88 Favored Glycine 0 C--N 1.304 -1.235 0 C-N-CA 120.058 -1.068 . . . . 55.25 111.365 -175.266 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.477 ' O ' HG12 ' A' ' 497' ' ' ILE . 88.5 m -82.65 131.08 35.21 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.266 -1.013 . . . . 74.21 108.266 173.636 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 9.7 t -101.03 127.5 47.52 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-O 121.172 0.511 . . . . 52.31 109.891 178.669 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 31.0 m -138.55 165.12 35.16 Favored Pre-proline 0 C--N 1.313 -1.015 0 N-CA-C 108.547 -0.909 . . . . 65.54 108.547 -178.244 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -62.49 143.28 92.9 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.214 1.943 . . . . 51.43 111.547 175.094 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 32.4 m -62.38 -19.78 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.606 0.762 . . . . 73.45 113.016 -176.848 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -87.96 -14.88 38.03 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.251 -0.431 . . . . 73.13 111.246 -175.595 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 51.8 m -62.71 161.87 11.69 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 114.677 1.362 . . . . 65.42 114.677 -173.397 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 7.7 p -93.95 123.89 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-N 115.193 -0.912 . . . . 65.55 110.269 -179.507 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 551' ' ' ILE . . . . . 0.455 HD12 HD11 ' A' ' 512' ' ' LEU . 52.3 mt -108.17 138.85 32.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 120.379 -0.528 . . . . 74.23 111.094 179.472 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -101.77 120.93 41.14 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 115.617 -0.719 . . . . 72.03 109.782 -179.077 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 553' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 1.5 mm? -95.73 126.34 40.93 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.153 -1.425 . . . . 75.32 107.153 176.671 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . 0.29 10.9 pt20 -102.19 120.5 40.57 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 122.698 1.237 . . . . 74.0 111.091 179.716 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 42.7 t -101.38 145.04 12.16 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-N 112.83 -1.986 . . . . 71.41 109.986 -169.076 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.64 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 73.9 m -82.07 133.06 35.26 Favored 'General case' 0 N--CA 1.41 -2.452 0 CA-C-O 121.552 0.691 . . . . 61.11 111.529 175.631 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -88.26 137.95 31.87 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 104.966 -2.235 . . . . 61.41 104.966 168.577 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 558' ' ' GLY . . . . . 0.588 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -81.69 -43.15 8.55 Favored Glycine 0 CA--C 1.475 -2.446 0 C-N-CA 120.252 -0.975 . . . . 54.1 113.786 -170.434 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 559' ' ' ASN . . . . . 0.453 HD21 ' HB2' ' A' ' 526' ' ' ASP . 78.5 m-20 67.83 -31.77 0.19 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.043 0.937 . . . . 74.44 113.286 -176.785 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.457 ' H ' ' C ' ' A' ' 558' ' ' GLY . 3.0 tp60 -126.57 140.48 52.41 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 108.903 -0.777 . . . . 72.31 108.903 -175.047 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -143.45 139.09 29.73 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.765 -0.828 . . . . 61.23 108.765 174.741 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 9.6 p -59.81 124.11 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-O 121.647 0.737 . . . . 72.43 112.709 -176.252 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 57.9 ttp -95.34 137.76 22.03 Favored Pre-proline 0 C--O 1.249 1.039 0 CA-C-N 115.886 -0.597 . . . . 74.41 110.512 -179.93 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -64.22 170.01 9.91 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 123.246 2.631 . . . . 44.33 111.311 172.165 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 565' ' ' ASP . . . . . 0.455 ' HA ' ' HB2' ' A' ' 610' ' ' ALA . 3.5 p-10 -70.92 138.26 49.96 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.723 0.773 . . . . 63.1 112.51 -176.554 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 94.5 mt -136.15 15.53 3.26 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.287 -1.324 . . . . 75.01 107.938 174.844 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 27.7 t -67.37 134.2 51.05 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 115.302 -0.863 . . . . 72.44 109.885 -177.407 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 86.07 40.11 7.68 Favored Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 110.41 -1.076 . . . . 42.05 110.41 179.953 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 21.5 ptm -109.29 158.0 18.3 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.979 -0.749 . . . . 44.52 108.979 -179.831 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 570' ' ' PHE . . . . . 0.493 ' H ' ' HB3' ' A' ' 573' ' ' ASP . 77.3 m-85 -108.75 165.16 11.76 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 106.739 -1.578 . . . . 73.2 106.739 175.603 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 24.6 t90 -71.59 -30.31 65.68 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 108.979 -0.749 . . . . 75.33 108.979 177.101 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 30.0 m -80.08 -6.06 9.07 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 CA-C-O 121.793 0.806 . . . . 64.52 109.798 176.677 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 573' ' ' ASP . . . . . 0.493 ' HB3' ' H ' ' A' ' 570' ' ' PHE . 14.1 t70 -99.38 -30.03 12.43 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.905 -1.146 . . . . 73.52 107.905 177.199 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -62.86 -42.01 99.59 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 114.496 -1.229 . . . . 35.11 110.735 177.476 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 578' ' ' LEU . 44.2 tt0 -57.4 -52.25 75.62 Favored Pre-proline 0 CA--C 1.577 1.982 0 N-CA-C 113.014 0.746 . . . . 73.13 113.014 179.261 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 576' ' ' PRO . . . . . 0.42 ' HD2' ' C ' ' A' ' 573' ' ' ASP . 75.0 Cg_exo -55.38 -40.03 87.77 Favored 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 121.963 1.776 . . . . 65.44 112.172 173.114 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -68.3 -34.1 75.54 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.43 -0.508 . . . . 64.44 112.078 177.853 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.427 ' HB3' ' O ' ' A' ' 575' ' ' GLU . 5.9 tt -58.77 -49.47 77.54 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.268 0.627 . . . . 62.22 109.724 178.848 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -67.37 -40.96 85.78 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.286 0.847 . . . . 74.13 113.286 177.138 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.57 -39.86 88.69 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.186 0.439 . . . . 62.4 112.186 -177.666 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 10.4 mp -86.3 -8.97 57.31 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 111.971 0.36 . . . . 75.34 111.971 -179.276 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 68.34 21.81 74.35 Favored Glycine 0 C--O 1.241 0.559 0 N-CA-C 111.317 -0.713 . . . . 62.41 111.317 -177.54 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 583' ' ' TRP . . . . . 0.402 ' CZ2' HG22 ' A' ' 620' ' ' ILE . 42.9 t90 -60.61 126.96 29.37 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 123.198 0.599 . . . . 73.44 111.031 -177.359 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 8.8 m -130.41 89.44 2.78 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 115.517 -0.765 . . . . 71.51 109.122 178.153 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -144.14 -142.67 3.94 Favored Glycine 0 N--CA 1.426 -2.023 0 N-CA-C 109.479 -1.448 . . . . 65.13 109.479 177.43 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 14.4 tpt -129.0 131.41 47.42 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.768 -0.827 . . . . 71.31 108.768 179.099 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -98.03 123.1 41.89 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.07 -1.456 . . . . 73.32 107.07 177.066 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -98.11 107.38 19.85 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.995 -0.548 . . . . 72.43 109.994 -178.422 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.49 133.26 36.97 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.98 -0.554 . . . . 53.55 110.954 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -97.95 -164.83 31.38 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.737 -0.665 . . . . 62.33 113.406 -175.086 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -74.84 141.3 44.26 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 123.178 0.591 . . . . 53.43 110.834 -178.266 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -85.64 133.26 34.04 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.622 -0.717 . . . . 73.43 109.646 -177.096 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 73.4 t -125.34 115.41 43.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 107.206 -1.405 . . . . 75.42 107.206 175.337 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -86.02 107.64 17.88 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.221 -0.992 . . . . 51.32 110.213 -179.736 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -124.05 -11.17 7.59 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.212 -0.904 . . . . 74.25 111.495 -178.788 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 119.18 -172.67 14.7 Favored Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 121.099 -0.572 . . . . 73.32 111.673 177.779 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.87 -34.03 64.56 Favored Glycine 0 C--O 1.222 -0.623 0 N-CA-C 114.514 0.566 . . . . 40.43 114.514 -175.53 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 19.0 m -66.14 -24.72 66.72 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 117.344 0.572 . . . . 72.53 111.997 -178.445 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -109.66 -0.83 18.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.282 0.563 . . . . 74.1 111.286 178.616 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -67.62 105.42 1.87 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.195 -0.911 . . . . 62.51 113.099 -175.261 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 62.87 0.94 0.75 Allowed 'General case' 0 CA--C 1.56 1.352 0 C-N-CA 125.773 1.629 . . . . 70.52 114.081 171.713 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 602' ' ' ARG . . . . . 0.431 ' HD2' ' O ' ' A' ' 603' ' ' VAL . 8.7 tmm_? -90.93 148.47 22.42 Favored 'General case' 0 C--N 1.313 -0.995 0 O-C-N 121.911 -0.493 . . . . 71.32 110.607 -178.174 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 603' ' ' VAL . . . . . 0.469 HG23 ' HB2' ' A' ' 622' ' ' LEU . 7.1 p -56.11 131.76 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.01 0.924 . . . . 51.15 111.465 -177.634 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 14.7 p -106.91 -34.89 2.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 C-N-CA 119.9 -0.72 . . . . 60.14 109.385 -178.728 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -154.12 148.43 26.0 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 105.114 -2.18 . . . . 70.13 105.114 171.559 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -122.39 136.56 54.92 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 108.713 -0.847 . . . . 74.01 108.713 176.627 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.575 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 24.5 t-20 -59.37 -52.39 74.65 Favored Pre-proline 0 C--N 1.309 -1.164 0 CA-C-N 115.443 -0.799 . . . . 65.52 111.298 -178.436 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.575 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 29.6 Cg_endo -105.27 110.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.962 0 C-N-CA 121.883 1.722 . . . . 40.22 111.389 173.341 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -67.76 156.86 64.33 Favored 'Trans proline' 0 C--O 1.239 0.545 0 C-N-CA 122.139 1.893 . . . . 54.21 110.705 176.408 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 610' ' ' ALA . . . . . 0.455 ' HB2' ' HA ' ' A' ' 565' ' ' ASP . . . -60.07 137.35 58.11 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 110.009 -0.367 . . . . 72.01 110.009 178.975 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 90.05 0.96 76.83 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 119.44 -1.362 . . . . 63.24 111.564 -178.355 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 9.8 m -107.95 155.62 20.11 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.999 -1.111 . . . . 75.14 107.999 178.182 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -81.64 132.16 10.96 Favored Glycine 0 N--CA 1.418 -2.515 0 CA-C-N 116.352 -0.386 . . . . 74.2 112.525 -179.433 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 22.2 m -101.14 142.55 15.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 123.222 0.609 . . . . 73.44 110.375 177.008 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.516 ' OD1' HG22 ' A' ' 619' ' ' ILE . 0.0 OUTLIER -54.55 149.39 10.69 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.234 0.959 . . . . 74.44 111.96 178.171 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . 0.255 0.0 OUTLIER -61.0 -24.38 66.1 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.752 1.019 . . . . 75.51 113.752 179.929 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -68.62 -31.3 70.36 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 109.159 -0.682 . . . . 74.54 109.159 176.062 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 88.91 9.52 67.93 Favored Glycine 0 N--CA 1.418 -2.525 0 CA-C-N 115.006 -0.997 . . . . 75.52 113.264 176.855 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 619' ' ' ILE . . . . . 0.516 HG22 ' OD1' ' A' ' 615' ' ' ASN . 0.0 OUTLIER -69.59 119.57 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 CA-C-N 118.547 1.174 . . . . 54.5 109.103 -175.675 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.402 HG22 ' CZ2' ' A' ' 583' ' ' TRP . 0.0 OUTLIER -118.51 131.93 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 N-CA-C 108.836 -0.801 . . . . 63.2 108.836 -176.881 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.501 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 60.1 m -118.08 127.84 54.18 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 120.867 0.365 . . . . 63.12 111.627 -178.585 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 622' ' ' LEU . . . . . 0.469 ' HB2' HG23 ' A' ' 603' ' ' VAL . 0.0 OUTLIER -138.5 150.91 46.89 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 105.455 -2.054 . . . . 74.51 105.455 174.048 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -127.74 156.17 42.85 Favored 'General case' 0 C--N 1.266 -3.044 0 N-CA-C 106.079 -1.823 . . . . 70.33 106.079 179.248 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -131.13 165.63 22.86 Favored 'General case' 0 C--N 1.275 -2.634 0 N-CA-C 106.847 -1.538 . . . . 71.45 106.847 179.644 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -71.72 -84.96 0.2 Allowed Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 109.224 -1.551 . . . . 71.53 109.224 175.408 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 . . . . . 0 C--N 1.299 -1.594 0 N-CA-C 108.697 -0.853 . . . . 74.14 108.697 174.346 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.162 0 N-CA-C 110.1 -1.2 . . . . 74.53 110.1 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 9.2 tp -74.81 122.7 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 CA-C-N 117.787 0.794 . . . . 72.12 110.474 -179.93 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 1.3 m -70.57 150.7 45.82 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 108.367 -0.975 . . . . 64.25 108.367 179.411 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -84.79 -28.87 25.87 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.732 -1.21 . . . . 74.51 107.732 179.316 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -97.56 150.46 21.09 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.837 -1.528 . . . . 74.14 109.012 179.815 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.76 142.93 27.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 109.725 -0.472 . . . . 63.13 109.725 -176.978 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -95.41 118.63 32.5 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.934 -1.506 . . . . 70.03 106.934 -176.853 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.44 ' HB ' ' O ' ' A' ' 406' ' ' ALA . 65.3 t -97.09 141.07 22.5 Favored Pre-proline 0 C--N 1.288 -2.093 0 CA-C-N 115.181 -0.918 . . . . 62.34 110.927 -170.284 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -66.49 142.87 66.97 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 121.84 1.693 . . . . 75.5 109.741 174.859 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 364' ' ' ASP . . . . . 0.465 ' HB2' ' ND2' ' A' ' 407' ' ' ASN . 35.1 t0 -95.83 142.61 27.89 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.915 -1.143 . . . . 72.33 107.915 -177.931 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.521 ' CG2' ' HA ' ' A' ' 373' ' ' ALA . 11.4 p -106.2 -7.47 10.22 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.676 0 CA-C-N 115.253 -0.885 . . . . 62.32 112.45 -168.472 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . 0.254 2.2 ppt_? -54.39 146.56 15.51 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.834 1.42 . . . . 74.22 114.834 175.884 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.44 0.79 40.55 Favored Glycine 0 C--O 1.24 0.482 0 CA-C-N 115.333 -0.848 . . . . 62.31 111.698 -177.219 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -119.33 -153.48 0.54 Allowed 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.545 -0.909 . . . . 75.2 108.545 177.672 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 51.5 p -96.35 153.47 17.8 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.503 -0.925 . . . . 74.23 108.503 -178.215 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 32.1 t -57.39 -37.34 72.52 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 123.322 0.389 . . . . 71.14 110.14 178.503 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.09 -47.04 75.51 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 119.287 -0.387 . . . . 70.33 111.412 179.78 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -70.05 -34.72 73.58 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 119.734 -0.786 . . . . 60.3 109.999 179.685 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 373' ' ' ALA . . . . . 0.521 ' HA ' ' CG2' ' A' ' 365' ' ' VAL . . . -63.39 -51.47 65.7 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.107 -0.951 . . . . 51.32 111.162 179.801 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.41 HG23 HG13 ' A' ' 384' ' ' ILE . 82.3 mt -64.05 -40.26 88.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.957 -0.565 . . . . 74.41 109.908 176.654 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.71 -47.35 84.88 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.107 -0.497 . . . . 52.05 111.007 -178.12 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 376' ' ' THR . . . . . 0.466 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 37.3 m -63.14 -47.27 83.44 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.794 -0.639 . . . . 72.12 110.16 -178.901 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 95.4 mt -64.04 -41.4 97.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.006 -0.543 . . . . 45.21 111.11 -178.842 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 64.4 tp60 -63.12 -42.43 99.53 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.284 -0.416 . . . . 64.31 110.662 179.375 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -68.52 -20.33 64.56 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 111.915 0.339 . . . . 74.23 111.915 179.323 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 380' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 376' ' ' THR . 34.0 mmt180 -88.05 -14.18 39.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.345 -0.389 . . . . 72.33 110.335 176.164 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.46 16.72 45.13 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 120.655 -0.783 . . . . 74.51 112.463 179.231 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -88.85 156.21 19.07 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-O 121.327 0.584 . . . . 75.43 112.062 179.597 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -93.16 143.78 25.92 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 115.014 -0.993 . . . . 72.14 108.741 -177.712 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.446 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -130.37 146.04 34.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-O 121.172 0.51 . . . . 74.52 110.223 -178.356 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -128.02 126.85 42.1 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 105.971 -1.863 . . . . 74.44 105.971 171.233 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 8.0 m -115.06 123.62 49.49 Favored 'General case' 0 C--N 1.274 -2.713 0 N-CA-C 107.212 -1.403 . . . . 64.41 107.212 -178.137 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -110.87 121.47 45.42 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.527 -0.916 . . . . 73.43 108.527 -177.774 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -90.55 133.79 34.83 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.678 -0.692 . . . . 72.13 110.441 -176.626 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 389' ' ' LYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 421' ' ' SER . 98.1 mttt -136.93 145.34 50.28 Favored Pre-proline 0 C--N 1.312 -1.044 0 N-CA-C 108.896 -0.779 . . . . 74.34 108.896 172.918 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.503 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 56.7 Cg_endo -101.28 135.78 0.16 Allowed 'Trans proline' 0 CA--C 1.554 1.498 0 C-N-CA 122.0 1.8 . . . . 64.43 111.5 169.569 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.571 ' OD2' HG22 ' A' ' 393' ' ' THR . 12.9 t70 161.64 -168.03 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 126.073 1.749 . . . . 72.13 107.339 174.911 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 392' ' ' SER . . . . . 0.413 ' H ' ' CG ' ' A' ' 391' ' ' ASP . 32.3 t -128.17 -15.6 4.67 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 118.03 0.377 . . . . 61.4 110.558 179.421 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.571 HG22 ' OD2' ' A' ' 391' ' ' ASP . 13.1 t -79.75 -29.97 40.64 Favored 'General case' 0 C--O 1.252 1.209 0 N-CA-C 108.836 -0.802 . . . . 73.15 108.836 177.125 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.88 126.02 55.06 Favored Pre-proline 0 N--CA 1.417 -2.101 0 N-CA-C 105.22 -2.141 . . . . 70.52 105.22 165.519 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 395' ' ' PRO . . . . . 0.498 ' HG3' HD12 ' A' ' 400' ' ' ILE . 95.1 Cg_endo -78.51 155.06 27.93 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 N-CA-C 117.343 2.017 . . . . 64.23 117.343 -167.23 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 396' ' ' PRO . . . . . 0.518 ' HA ' ' O ' ' A' ' 421' ' ' SER . 74.0 Cg_exo -53.9 167.73 1.02 Allowed 'Trans proline' 0 CA--C 1.492 -1.585 1 C-N-CA 126.081 4.52 . . . . 62.14 111.709 170.888 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 397' ' ' ASP . . . . . 0.514 ' HA ' HG23 ' A' ' 420' ' ' VAL . 4.5 p-10 -51.57 -5.93 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 127.149 2.18 . . . . 74.21 115.836 -164.523 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -80.42 109.06 14.56 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.069 -1.456 . . . . 63.23 107.069 170.104 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 24.7 m -83.94 120.99 35.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 115.14 -0.937 . . . . 63.54 113.418 -168.558 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 400' ' ' ILE . . . . . 0.498 HD12 ' HG3' ' A' ' 395' ' ' PRO . 0.2 OUTLIER -84.92 -27.71 6.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.611 -0.722 . . . . 73.34 109.822 177.18 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.9 157.53 27.4 Favored Glycine 0 N--CA 1.42 -2.427 0 C-N-CA 119.389 -1.386 . . . . 73.23 113.988 -176.597 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 11.7 p -136.29 -173.83 3.51 Favored 'General case' 0 C--N 1.273 -2.721 0 C-N-CA 128.701 2.8 . . . . 45.23 104.825 -177.588 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -97.8 129.34 31.52 Favored Pre-proline 0 C--N 1.286 -2.154 0 N-CA-C 106.633 -1.617 . . . . 62.43 106.633 179.688 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.18 -1.26 0.17 Allowed 'Trans proline' 0 C--N 1.367 1.548 0 C-N-CA 124.731 3.621 . . . . 61.43 115.512 -176.368 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -50.45 -36.88 35.31 Favored 'General case' 0 C--O 1.209 -1.074 0 C-N-CA 124.15 0.98 . . . . 33.13 109.484 173.511 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 406' ' ' ALA . . . . . 0.44 ' O ' ' HB ' ' A' ' 362' ' ' VAL . . . -59.31 -50.05 75.47 Favored 'General case' 0 C--O 1.217 -0.651 0 O-C-N 123.54 0.525 . . . . 33.41 110.902 178.678 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 407' ' ' ASN . . . . . 0.465 ' ND2' ' HB2' ' A' ' 364' ' ' ASP . 13.3 m120 -82.56 0.16 44.05 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 120.448 -0.501 . . . . 73.15 111.991 -178.989 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 30.2 m -86.31 150.07 24.6 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 105.134 -2.173 . . . . 64.35 105.134 173.104 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 19.4 m -75.79 112.34 12.07 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 106.372 -1.714 . . . . 42.31 106.372 175.862 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 31.0 m -125.92 169.52 17.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-O 121.009 0.433 . . . . 65.22 111.192 -174.941 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 21.4 t -77.46 140.79 39.89 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 107.353 -1.351 . . . . 71.41 107.353 176.896 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -57.86 109.71 0.78 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.026 0.441 . . . . 72.4 111.277 -178.652 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 105.32 61.64 0.64 Allowed Glycine 0 N--CA 1.436 -1.358 0 N-CA-C 111.183 -0.767 . . . . 53.51 111.183 -179.99 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -111.01 177.18 4.74 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.163 -0.68 . . . . 31.1 109.163 179.92 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -90.06 112.67 24.18 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 124.296 1.038 . . . . 62.42 111.345 -174.38 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 39.5 mm -107.11 109.23 27.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 109.71 -0.478 . . . . 73.4 109.71 177.657 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 40.9 p -88.38 131.18 34.95 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 122.705 0.402 . . . . 60.32 110.308 179.765 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 6.1 p -127.19 133.29 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 109.448 -0.575 . . . . 63.11 109.448 176.736 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -97.41 128.94 44.63 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.736 -0.839 . . . . 64.44 108.736 174.552 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.514 HG23 ' HA ' ' A' ' 397' ' ' ASP . 7.0 p -129.57 143.89 39.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.886 -0.783 . . . . 72.34 108.886 -176.509 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 421' ' ' SER . . . . . 0.557 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 14.5 m -119.58 130.01 54.92 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 119.156 -1.017 . . . . 54.2 111.359 -178.821 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 5.3 t -119.09 107.06 13.02 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.483 -0.78 . . . . 71.2 111.285 -179.504 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 78.55 141.61 1.94 Allowed Glycine 0 CA--C 1.528 0.903 0 CA-C-N 116.276 -0.42 . . . . 71.42 113.63 177.159 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -83.77 156.66 13.75 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.368 2.046 . . . . 53.05 111.922 178.565 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -88.8 166.72 13.83 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 121.565 0.698 . . . . 73.41 110.867 -179.146 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.416 ' CB ' HG22 ' A' ' 477' ' ' THR . 62.0 mt-30 -125.29 157.15 37.38 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.434 -1.691 . . . . 73.31 106.434 178.087 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.479 ' HG2' HD11 ' A' ' 480' ' ' ILE . 57.4 mmm-85 -126.61 163.73 22.79 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.594 -0.691 . . . . 74.4 111.977 -178.891 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.1 138.74 33.57 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 114.535 -1.211 . . . . 62.01 108.832 -179.084 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 62.4 mt -91.27 123.72 63.41 Favored Pre-proline 0 N--CA 1.425 -1.701 0 N-CA-C 108.515 -0.921 . . . . 74.11 108.515 177.103 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -71.4 141.01 37.85 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 121.617 1.545 . . . . 63.52 109.733 171.588 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -87.75 168.34 13.05 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.261 -1.014 . . . . 72.03 108.261 177.372 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.681 HG11 ' HB2' ' A' ' 440' ' ' ALA . 13.8 p -153.98 164.94 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.266 -1.013 . . . . 75.14 108.266 -175.546 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 37.6 m -75.95 147.9 38.57 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.435 -0.95 . . . . 62.15 108.435 174.139 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 47.0 p -66.45 -27.99 68.24 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 114.486 1.291 . . . . 51.44 114.486 -170.877 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.1 pp -79.49 -15.83 57.08 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.295 -0.878 . . . . 54.11 112.35 176.522 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.01 47.91 1.16 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.09 0.471 . . . . 72.02 111.34 -174.568 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 437' ' ' TYR . . . . . 0.479 ' OH ' ' HB2' ' A' ' 454' ' ' GLN . 71.2 t80 -52.95 -38.65 62.23 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.27 0.628 . . . . 74.2 112.634 178.629 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.36 -39.61 91.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.427 0.632 . . . . 73.23 110.731 179.79 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -70.3 -35.37 73.64 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.509 -0.769 . . . . 64.34 109.879 178.857 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.681 ' HB2' HG11 ' A' ' 432' ' ' VAL . . . -59.64 -51.23 70.69 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.839 -0.619 . . . . 63.13 111.092 -178.892 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.1 m -65.44 -39.09 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 112.275 0.472 . . . . 64.24 112.275 -178.28 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . 0.273 0.1 OUTLIER -68.17 -34.43 76.29 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 119.556 -0.858 . . . . 74.53 112.1 176.602 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -63.35 -42.01 98.9 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 116.565 -0.289 . . . . 61.34 110.584 174.885 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 93.3 mt -63.57 -33.15 74.96 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.11 -0.495 . . . . 73.3 110.551 178.916 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 48.2 m -70.08 -43.84 70.29 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.13 -0.486 . . . . 63.41 110.065 179.493 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.23 -15.36 62.45 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.675 0.75 . . . . 63.43 110.706 178.801 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -87.01 -0.9 57.38 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.451 -0.795 . . . . 74.43 111.659 179.531 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 112.79 -77.56 0.24 Allowed Glycine 0 CA--C 1.499 -0.963 0 C-N-CA 120.201 -1.0 . . . . 74.44 112.28 176.77 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 449' ' ' PHE . . . . . 0.431 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 0.1 OUTLIER -43.55 -65.55 0.48 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.521 0.934 . . . . 74.41 113.521 177.318 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 62.11 21.64 61.85 Favored Glycine 0 C--O 1.226 -0.354 0 C-N-CA 121.077 -0.582 . . . . 74.34 111.704 -175.421 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -102.91 110.78 22.83 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 108.213 -1.032 . . . . 70.14 108.213 -178.004 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.452 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 27.8 p90 -142.68 163.93 31.49 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 115.59 -0.732 . . . . 73.34 109.665 -175.95 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -151.89 124.14 8.22 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.862 -0.792 . . . . 72.33 108.862 176.356 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 454' ' ' GLN . . . . . 0.479 ' HB2' ' OH ' ' A' ' 437' ' ' TYR . 57.3 tt0 -87.22 128.4 35.15 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 123.454 0.471 . . . . 74.34 109.959 179.897 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -122.17 138.03 54.62 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.23 -1.026 . . . . 73.33 108.23 175.025 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -114.44 133.16 55.95 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.84 -1.171 . . . . 75.52 107.84 -179.13 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 49.1 m -151.73 145.35 17.69 Favored Pre-proline 0 C--N 1.298 -1.638 0 N-CA-C 109.676 -0.49 . . . . 63.33 109.676 176.846 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.684 ' HA ' ' O ' ' A' ' 490' ' ' SER . 29.2 Cg_endo -65.3 122.54 10.29 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.147 1.898 . . . . 63.12 109.264 177.398 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 35.2 m -134.04 179.88 5.98 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 115.634 -0.712 . . . . 35.22 109.734 -173.276 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 6.0 t -54.16 135.84 59.12 Favored Pre-proline 0 N--CA 1.436 -1.166 0 O-C-N 124.26 0.975 . . . . 71.44 109.552 178.77 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -50.97 -29.76 28.47 Favored 'Trans proline' 0 N--CA 1.477 0.512 0 C-N-CA 124.689 3.592 . . . . 55.31 115.085 -171.679 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -75.58 -22.38 57.01 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.973 0.416 . . . . 64.13 112.018 179.272 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -98.37 -5.91 31.8 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.842 0.353 . . . . 64.22 110.692 177.389 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 62.3 t -61.42 127.72 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 109.163 -0.681 . . . . 74.32 109.163 174.233 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 85.93 -4.02 86.41 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 111.415 -0.674 . . . . 63.32 111.415 -179.162 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -122.46 156.82 33.28 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 121.558 0.695 . . . . 55.43 109.433 -177.064 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 47.4 t -71.09 142.59 15.38 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.503 0 CA-C-N 114.599 -1.182 . . . . 73.51 108.128 173.089 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 52.1 mt -97.59 -28.99 3.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 108.809 -0.811 . . . . 73.45 108.809 179.71 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 154.74 -170.11 33.01 Favored Glycine 0 N--CA 1.427 -1.957 0 C-N-CA 120.337 -0.935 . . . . 64.41 112.16 177.042 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 470' ' ' THR . . . . . 0.565 HG22 HG12 ' A' ' 486' ' ' ILE . 36.1 p -115.45 139.9 49.62 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.803 -1.555 . . . . 72.42 106.803 -179.824 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.435 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 9.0 t30 -63.43 -50.9 71.36 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 119.361 -0.935 . . . . 74.13 112.037 177.481 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.435 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 22.0 Cg_exo -75.06 151.11 38.84 Favored 'Trans proline' 0 C--N 1.36 1.157 0 N-CA-C 108.5 -1.385 . . . . 62.33 108.5 170.456 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.24 127.07 20.06 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.004 1.802 . . . . 73.15 112.173 -178.508 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -89.06 3.86 50.32 Favored 'General case' 0 C--O 1.207 -1.175 0 CA-C-N 115.511 -0.768 . . . . 75.21 110.732 -177.928 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -111.08 8.14 21.7 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.524 -0.762 . . . . 72.3 109.933 179.499 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -125.69 179.59 5.09 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 116.198 -0.455 . . . . 74.21 111.043 -174.247 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.416 HG22 ' CB ' ' A' ' 426' ' ' GLN . 3.6 m -89.84 117.57 28.78 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 115.516 -0.766 . . . . 42.11 109.481 179.917 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 50.1 m -118.94 148.68 42.69 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.471 -0.566 . . . . 53.11 109.471 -179.172 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -73.16 153.38 40.75 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.67 0.619 . . . . 70.1 112.67 -174.503 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.479 HD11 ' HG2' ' A' ' 427' ' ' ARG . 2.2 mp -65.03 -26.82 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-O 121.756 0.788 . . . . 70.43 110.695 178.75 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 12.2 p -90.85 5.38 48.7 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.477 -0.783 . . . . 62.04 111.502 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -103.33 129.6 50.41 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.084 -0.507 . . . . 61.24 109.958 -176.55 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.2 p -98.58 127.19 51.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.706 -0.679 . . . . 70.05 111.408 -176.086 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 33.5 m -96.67 123.45 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-O 121.403 0.62 . . . . 71.54 110.618 178.121 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.95 128.99 43.27 Favored 'Isoleucine or valine' 0 C--O 1.256 1.435 0 N-CA-C 107.994 -1.113 . . . . 70.11 107.994 176.844 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.565 HG12 HG22 ' A' ' 470' ' ' THR . 42.2 mt -119.72 119.59 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 CA-C-N 114.996 -1.002 . . . . 60.13 110.269 -175.692 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 5.8 tt -103.03 127.12 57.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 115.295 -0.866 . . . . 73.53 111.176 -178.513 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 1.9 p -107.93 136.21 44.09 Favored 'Isoleucine or valine' 0 C--O 1.256 1.403 0 CA-C-N 115.361 -0.836 . . . . 64.12 108.973 176.05 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -73.53 127.95 11.0 Favored Glycine 0 N--CA 1.419 -2.483 0 N-CA-C 110.619 -0.993 . . . . 71.21 110.619 179.328 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.684 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 14.4 t -115.88 158.56 22.79 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 106.907 -1.516 . . . . 71.45 106.907 178.345 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -171.57 84.25 0.08 OUTLIER Glycine 0 N--CA 1.431 -1.649 0 N-CA-C 110.417 -1.073 . . . . 72.35 110.417 -179.806 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -69.89 113.04 3.26 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.059 1.839 . . . . 73.23 110.897 -178.128 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 493' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . -84.86 52.78 2.51 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.997 -0.742 . . . . 54.4 108.997 179.888 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 546' ' ' PRO . 24.3 p -116.5 148.14 41.08 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 115.231 -0.895 . . . . 63.24 110.423 -174.234 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -145.45 155.06 42.89 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 108.138 -1.06 . . . . 65.43 108.138 178.353 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -89.82 122.9 33.32 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.638 -0.505 . . . . 60.35 109.638 -177.565 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 37.0 pt -79.55 136.29 55.95 Favored Pre-proline 0 C--N 1.307 -1.264 0 O-C-N 123.271 0.357 . . . . 73.54 111.341 -179.433 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -85.18 -174.32 1.66 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.643 2.229 . . . . 75.24 110.266 174.719 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -92.59 147.17 23.1 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.376 -0.601 . . . . 64.12 109.376 179.83 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 41.2 t -129.28 93.86 2.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 107.314 -1.365 . . . . 70.3 107.314 178.6 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -148.22 112.9 5.37 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 107.223 -1.399 . . . . 63.45 107.223 179.566 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 110.24 36.35 1.97 Allowed Glycine 0 N--CA 1.421 -2.314 0 N-CA-C 110.172 -1.171 . . . . 74.11 110.172 -178.016 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -143.1 166.79 23.7 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 108.33 -0.989 . . . . 75.3 108.33 178.651 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 532' ' ' GLY . 11.8 t -93.32 157.43 16.25 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.043 -1.465 . . . . 62.31 107.043 173.869 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 10.5 p -55.37 -40.43 57.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 112.235 0.457 . . . . 55.0 112.235 -178.599 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -58.32 -42.82 87.59 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.496 0.665 . . . . 52.32 110.949 179.503 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 99.6 t -76.37 -36.73 29.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.641 -0.708 . . . . 74.45 110.107 -179.219 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -61.35 -49.21 77.86 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.762 -0.654 . . . . 73.42 111.229 178.856 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -63.21 -37.19 86.26 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 120.485 -0.486 . . . . 71.52 110.32 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -62.64 -45.7 91.61 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.11 -0.7 . . . . 75.32 109.11 179.442 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -62.16 -48.66 79.07 Favored 'General case' 0 CA--C 1.494 -1.197 0 O-C-N 123.107 0.254 . . . . 62.5 111.291 179.953 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.77 -40.5 97.49 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 112.261 0.467 . . . . 64.32 112.261 -179.073 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -65.48 -37.98 88.42 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 120.718 -0.393 . . . . 63.23 110.99 179.146 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 68.7 t -68.92 -26.87 33.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.07 0.462 . . . . 63.1 110.741 176.755 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 17.4 m-30 -81.33 -1.78 46.59 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.262 -0.575 . . . . 75.25 110.14 178.951 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 516' ' ' GLY . . . . . 0.543 ' O ' ' HB ' ' A' ' 547' ' ' VAL . . . 101.78 -4.92 53.57 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.925 -0.655 . . . . 52.31 113.318 176.08 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -83.85 112.81 20.46 Favored 'General case' 0 CA--C 1.476 -1.899 0 N-CA-C 106.548 -1.649 . . . . 70.42 106.548 -177.541 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.3 m -89.19 -25.42 21.79 Favored 'General case' 0 N--CA 1.406 -2.656 0 CA-C-N 115.033 -0.985 . . . . 61.2 112.651 -167.66 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 519' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 96.8 mttt -116.15 125.06 51.82 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 120.117 -0.633 . . . . 52.32 111.035 -177.207 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -129.73 153.14 48.48 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 123.37 0.668 . . . . 74.42 109.909 -179.437 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 50.5 m -141.09 147.25 38.24 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 108.253 -1.017 . . . . 45.33 108.253 174.978 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -116.76 130.9 57.0 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-O 121.229 0.537 . . . . 74.15 110.417 179.81 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -105.34 119.79 39.95 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 107.68 -1.23 . . . . 71.32 107.68 176.149 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 42.3 m -90.0 121.27 31.93 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.271 0.558 . . . . 74.25 110.31 -178.423 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 26.9 m -121.77 153.64 25.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.427 -0.953 . . . . 55.34 108.427 178.345 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 526' ' ' ASP . . . . . 0.504 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 1.1 p-10 -89.04 136.44 33.01 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.036 -1.098 . . . . 54.41 108.036 178.135 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 527' ' ' SER . . . . . 0.428 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 19.7 m -153.48 166.97 14.47 Favored Pre-proline 0 C--N 1.292 -1.912 0 N-CA-C 108.575 -0.898 . . . . 73.31 108.575 179.618 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -73.6 -3.71 14.19 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 121.775 1.65 . . . . 64.22 112.132 175.602 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.46 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 2.1 mpt_? -85.21 134.57 40.51 Favored Pre-proline 0 CA--C 1.515 -0.396 0 N-CA-C 108.093 -1.077 . . . . 72.22 108.093 179.476 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -56.23 143.95 83.2 Favored 'Trans proline' 0 C--O 1.242 0.724 0 C-N-CA 123.064 2.51 . . . . 34.43 113.723 -175.512 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -53.18 125.6 18.05 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 114.615 -1.175 . . . . 72.3 112.629 -174.801 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 532' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 504' ' ' THR . . . 114.41 -16.31 19.63 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.482 -0.781 . . . . 51.43 111.294 178.124 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -74.33 125.73 29.13 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.674 -0.491 . . . . 64.52 109.674 179.494 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 53.3 t -82.78 112.01 19.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.1 -1.444 . . . . 73.24 107.1 176.222 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 15.0 t -80.5 -18.51 48.37 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.755 -0.657 . . . . 75.43 111.114 -175.778 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 163.81 -170.0 38.96 Favored Glycine 0 CA--C 1.495 -1.182 0 C-N-CA 119.94 -1.124 . . . . 43.13 111.828 178.514 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 65.0 p -117.31 153.86 32.24 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.183 -1.043 . . . . 71.42 108.183 -179.95 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.422 ' HB2' HE22 ' A' ' 554' ' ' GLN . 34.5 t30 -77.25 -53.87 1.59 Allowed Pre-proline 0 C--N 1.314 -0.948 0 C-N-CA 120.116 -0.633 . . . . 73.21 110.565 177.813 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -70.63 126.94 13.25 Favored 'Trans proline' 0 C--N 1.357 0.993 0 N-CA-C 107.739 -1.677 . . . . 70.32 107.739 167.707 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.88 156.57 63.62 Favored 'Trans proline' 0 C--O 1.247 0.974 0 C-N-CA 122.499 2.132 . . . . 74.51 113.358 -175.348 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.09 138.71 58.43 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.661 -0.7 . . . . 55.21 109.914 178.423 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 98.12 -6.34 61.76 Favored Glycine 0 N--CA 1.433 -1.554 0 C-N-CA 120.261 -0.971 . . . . 42.02 112.088 -178.778 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 59.0 m -76.23 132.96 40.21 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 109.392 -0.595 . . . . 62.1 109.392 176.803 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 5.0 m -95.11 122.02 37.34 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 107.745 -1.205 . . . . 71.42 107.745 179.294 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 24.3 m -138.16 156.23 73.95 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 109.895 -0.409 . . . . 73.25 109.895 -178.971 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.52 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 37.5 Cg_exo -63.6 139.94 72.54 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.114 1.876 . . . . 64.01 111.375 175.417 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.543 ' HB ' ' O ' ' A' ' 516' ' ' GLY . 30.8 m -64.57 -20.31 26.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 121.841 0.829 . . . . 72.12 111.912 -179.746 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -77.88 -18.0 56.7 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.04 -0.982 . . . . 71.43 110.628 178.816 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 24.6 m -77.76 179.06 6.88 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 112.841 0.682 . . . . 75.21 112.841 -174.977 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 39.1 t -105.78 124.91 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 CA-C-N 115.108 -0.951 . . . . 74.42 109.644 -176.666 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 551' ' ' ILE . . . . . 0.488 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -104.87 135.87 40.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.96 -0.756 . . . . 72.23 108.96 173.43 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -106.85 119.71 40.08 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 116.02 -0.536 . . . . 62.23 111.21 -176.103 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -101.77 134.12 45.44 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.664 -1.153 . . . . 72.13 109.444 179.814 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 554' ' ' GLN . . . . . 0.422 HE22 ' HB2' ' A' ' 538' ' ' ASN . 1.9 mp0 -93.74 122.44 36.21 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.074 0.464 . . . . 75.12 109.844 175.659 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 50.3 t -112.58 130.37 66.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 107.95 -1.13 . . . . 73.42 107.95 -178.981 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 74.6 m -88.15 137.28 32.47 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-O 121.667 0.746 . . . . 63.33 112.318 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.504 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 4.1 ptpt -90.75 147.7 23.06 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 103.986 -2.598 . . . . 71.22 103.986 169.925 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 558' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -83.25 -24.9 50.15 Favored Glycine 0 CA--C 1.479 -2.158 0 C-N-CA 120.318 -0.944 . . . . 64.52 113.57 -171.08 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 559' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 615' ' ' ASN . 88.0 m-20 72.06 -44.03 0.58 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.578 1.151 . . . . 73.35 111.183 -177.283 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.465 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 97.5 mt-30 -119.81 141.73 49.24 Favored 'General case' 0 N--CA 1.424 -1.766 0 C-N-CA 123.548 0.739 . . . . 54.1 111.432 -175.767 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 561' ' ' PHE . . . . . 0.444 ' O ' ' HA2' ' A' ' 613' ' ' GLY . 45.4 p90 -126.99 149.74 49.74 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.489 -0.56 . . . . 74.31 109.489 178.46 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 99.8 t -59.49 120.3 5.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.06 0.457 . . . . 52.21 111.881 -177.945 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 563' ' ' MET . . . . . 0.433 ' HA ' ' HD3' ' A' ' 564' ' ' PRO . 57.1 ttp -97.09 137.09 21.25 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 116.031 -0.532 . . . . 54.22 111.19 179.995 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 564' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 563' ' ' MET . 17.4 Cg_exo -68.68 170.28 15.59 Favored 'Trans proline' 0 CA--C 1.551 1.332 0 C-N-CA 123.5 2.8 . . . . 74.22 112.684 174.162 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.18 129.47 40.0 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 112.669 0.618 . . . . 53.53 112.669 179.385 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 566' ' ' LEU . . . . . 0.453 ' O ' ' HG2' ' A' ' 569' ' ' MET . 95.3 mt -114.74 12.38 17.04 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 122.271 1.034 . . . . 75.42 108.409 175.865 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 20.3 m -79.58 144.52 33.79 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.847 -1.069 . . . . 72.45 110.886 -178.863 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 80.62 9.62 86.19 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 114.616 0.606 . . . . 63.44 114.616 175.285 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 569' ' ' MET . . . . . 0.453 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 26.5 ptm -112.44 164.05 13.73 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 117.427 0.614 . . . . 74.05 109.502 -179.006 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -103.98 163.97 12.02 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.487 0.661 . . . . 54.31 111.291 -177.281 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 19.6 t90 -62.07 -29.66 70.46 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 125.073 1.349 . . . . 72.11 109.488 176.422 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 34.3 m -71.29 -15.12 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 115.845 -0.616 . . . . 62.14 110.771 177.531 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -96.9 -34.84 11.1 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.336 -0.987 . . . . 72.31 108.336 175.904 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -60.86 -41.53 96.08 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.8 -1.091 . . . . 52.42 112.188 -178.259 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.492 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 38.7 mt-10 -59.73 -54.54 54.67 Favored Pre-proline 0 CA--C 1.554 1.127 0 N-CA-C 112.928 0.714 . . . . 73.34 112.928 -179.705 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 576' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 52.2 Cg_exo -59.58 -37.04 90.93 Favored 'Trans proline' 0 C--N 1.369 1.615 0 C-N-CA 121.388 1.392 . . . . 74.44 112.249 174.781 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -59.11 -47.88 83.65 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.347 0.659 . . . . 74.24 110.451 177.894 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.6 pp -67.16 -41.01 86.72 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.151 0.426 . . . . 73.04 112.151 -175.853 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -65.35 -40.03 93.1 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.571 -0.74 . . . . 75.42 110.968 -179.744 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.19 -38.34 87.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.611 -0.722 . . . . 64.24 112.025 -178.201 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.26 -8.51 48.17 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.676 0.621 . . . . 53.15 112.676 -178.851 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 68.09 40.37 88.36 Favored Glycine 0 C--N 1.311 -0.822 0 C-N-CA 119.927 -1.13 . . . . 74.42 110.567 -175.669 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 583' ' ' TRP . . . . . 0.426 ' HE3' ' HB2' ' A' ' 578' ' ' LEU . 83.2 t90 -82.25 135.33 35.25 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.469 -0.567 . . . . 62.2 109.469 179.113 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 9.0 t -148.06 87.58 1.62 Allowed 'General case' 0 N--CA 1.418 -2.042 0 CA-C-O 122.754 1.264 . . . . 54.04 111.045 175.762 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -123.76 -109.74 1.9 Allowed Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 109.094 -1.602 . . . . 72.33 109.094 177.867 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 69.7 mtp -137.27 124.15 21.33 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 120.714 -0.394 . . . . 74.32 111.99 176.78 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -87.39 121.58 30.02 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 103.073 -2.936 . . . . 71.11 103.073 166.251 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -122.3 111.54 17.03 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 119.362 -0.935 . . . . 74.11 113.15 -168.709 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 589' ' ' LYS . . . . . 0.483 ' HD3' ' O ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -113.33 110.24 20.02 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 109.412 -0.588 . . . . 75.14 109.412 170.853 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -90.48 -55.65 1.9 Allowed Glycine 0 CA--C 1.492 -1.352 0 C-N-CA 120.628 -0.796 . . . . 71.43 111.867 -178.214 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -127.42 134.62 49.87 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 109.817 -0.438 . . . . 74.22 109.817 -179.277 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -86.8 123.01 31.48 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 105.683 -1.969 . . . . 55.32 105.683 174.731 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 88.0 t -132.72 126.32 54.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.066 0.46 . . . . 71.33 111.343 -174.388 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 594' ' ' ASP . . . . . 0.548 ' HA ' ' NE2' ' A' ' 600' ' ' HIS . 21.5 t70 -83.14 110.68 18.24 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 109.067 -0.716 . . . . 64.24 109.067 175.628 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -131.32 2.14 4.2 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 120.988 0.423 . . . . 70.22 111.897 -179.608 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 111.81 155.99 13.3 Favored Glycine 0 CA--C 1.499 -0.954 0 N-CA-C 110.798 -0.921 . . . . 44.2 110.798 179.574 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -55.56 -37.06 65.99 Favored Glycine 0 N--CA 1.464 0.541 0 N-CA-C 114.418 0.527 . . . . 73.44 114.418 -171.614 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 23.6 m -64.81 -23.55 67.27 Favored 'General case' 0 CA--C 1.552 1.058 0 CA-C-O 120.943 0.402 . . . . 61.13 111.956 178.832 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -99.43 -13.07 19.7 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 121.968 -0.458 . . . . 73.23 111.308 -179.118 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 600' ' ' HIS . . . . . 0.548 ' NE2' ' HA ' ' A' ' 594' ' ' ASP . 12.0 m170 -85.66 137.21 32.99 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 109.518 -0.549 . . . . 65.23 109.518 -178.164 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 65.82 -11.11 0.2 Allowed 'General case' 0 C--O 1.206 -1.214 0 C-N-CA 124.505 1.122 . . . . 71.55 113.374 -175.776 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 602' ' ' ARG . . . . . 0.472 ' HD2' ' O ' ' A' ' 603' ' ' VAL . 3.3 tmm_? -86.68 138.37 31.71 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.417 -0.957 . . . . 74.4 108.417 -175.78 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 603' ' ' VAL . . . . . 0.472 ' O ' ' HD2' ' A' ' 602' ' ' ARG . 97.7 t -74.73 129.29 36.8 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 108.164 -1.05 . . . . 71.32 108.164 -179.889 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 68.9 t -84.97 -51.57 13.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 109.717 -0.475 . . . . 65.24 109.717 -172.991 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -147.09 157.96 43.78 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 107.647 -1.242 . . . . 52.54 107.647 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -113.43 120.88 42.56 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 106.407 -1.701 . . . . 63.14 106.407 174.077 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.484 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 51.2 t30 -52.75 -52.91 60.01 Favored Pre-proline 0 N--CA 1.477 0.876 0 N-CA-C 112.979 0.733 . . . . 63.14 112.979 -177.141 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 3.0 Cg_exo -83.69 119.26 2.57 Favored 'Trans proline' 0 C--O 1.253 1.245 0 C-N-CA 121.118 1.212 . . . . 73.22 109.425 171.073 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 609' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 608' ' ' PRO . 24.1 Cg_exo -63.97 145.46 89.99 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 122.609 2.206 . . . . 72.05 112.219 -178.443 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.68 131.41 45.53 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.695 -0.684 . . . . 75.14 109.219 178.216 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.67 -19.61 38.55 Favored Glycine 0 C--N 1.296 -1.674 0 N-CA-C 110.082 -1.207 . . . . 73.0 110.082 -173.416 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 27.8 m -91.06 158.53 16.62 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.911 -1.144 . . . . 72.41 107.911 176.562 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 613' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 561' ' ' PHE . . . -84.3 132.78 11.31 Favored Glycine 0 N--CA 1.419 -2.458 0 C-N-CA 121.527 -0.368 . . . . 75.22 112.238 -179.879 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 614' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 34.2 m -113.98 142.42 26.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 C-N-CA 123.67 0.788 . . . . 51.51 109.541 177.007 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.524 ' ND2' ' HB2' ' A' ' 617' ' ' ASP . 26.5 p-10 -52.66 162.02 0.64 Allowed 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 124.078 0.951 . . . . 72.34 112.98 177.65 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -58.41 -25.13 61.78 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 112.702 0.63 . . . . 73.32 112.702 177.406 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 617' ' ' ASP . . . . . 0.524 ' HB2' ' ND2' ' A' ' 615' ' ' ASN . 19.6 m-20 -70.53 -28.51 64.99 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.98 -0.554 . . . . 75.24 109.745 177.108 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 74.22 21.01 79.55 Favored Glycine 0 N--CA 1.432 -1.608 0 CA-C-N 115.689 -0.687 . . . . 15.01 112.488 177.401 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.83 118.83 13.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 122.322 1.058 . . . . 75.2 109.994 -169.963 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.476 HG22 ' HG2' ' A' ' 608' ' ' PRO . 2.8 pp -125.94 133.4 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.385 0 CA-C-N 114.218 -1.355 . . . . 71.35 109.702 -178.038 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.475 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 83.4 m -98.38 120.39 38.71 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 109.087 -0.709 . . . . 61.14 109.087 176.464 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 622' ' ' LEU . . . . . 0.411 ' HB2' HG13 ' A' ' 603' ' ' VAL . 2.7 pp -119.82 165.94 13.93 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.669 -1.151 . . . . 71.31 109.065 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -146.55 146.95 30.65 Favored 'General case' 0 C--N 1.269 -2.9 0 N-CA-C 106.364 -1.717 . . . . 73.3 106.364 177.912 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -138.79 165.53 26.77 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 105.691 -1.966 . . . . 74.2 105.691 175.581 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -66.12 -95.35 0.03 OUTLIER Glycine 0 C--N 1.313 -0.701 0 C-N-CA 120.112 -1.042 . . . . 63.21 111.372 178.865 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 626' ' ' GLN . . . . . 0.429 ' HB3' ' CE1' ' A' ' 600' ' ' HIS . 52.9 tt0 . . . . . 0 C--N 1.292 -1.897 0 N-CA-C 108.447 -0.945 . . . . 73.34 108.447 173.223 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.937 0 N-CA-C 110.077 -1.209 . . . . 71.41 110.077 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 7.0 tp -75.03 115.27 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.943 0 CA-C-O 122.375 1.083 . . . . 70.31 112.61 -179.125 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 7.4 m -116.89 151.91 35.61 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 103.933 -2.617 . . . . 73.02 103.933 173.605 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 64.9 mtp180 -80.84 48.79 1.12 Allowed 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 119.089 0.859 . . . . 64.13 112.432 -176.357 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -105.11 148.53 26.74 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 105.848 -1.908 . . . . 50.33 105.848 175.536 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.7 m -125.83 161.44 30.98 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.48 0 N-CA-C 109.422 -0.584 . . . . 62.31 109.422 -177.19 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 361' ' ' GLN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 409' ' ' SER . 42.4 tt0 -94.12 137.95 32.73 Favored 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 105.489 -2.041 . . . . 73.12 105.489 176.534 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.494 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 91.0 t -95.12 126.14 47.66 Favored Pre-proline 0 C--N 1.278 -2.542 0 N-CA-C 109.711 -0.477 . . . . 63.1 109.711 -166.34 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -62.22 123.49 12.6 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 122.095 1.864 . . . . 65.14 111.232 -178.495 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -81.64 143.2 32.08 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 107.713 -1.217 . . . . 72.21 107.713 179.974 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.537 HG13 ' HB1' ' A' ' 373' ' ' ALA . 7.1 p -126.93 18.02 3.51 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.699 0 CA-C-O 122.605 1.193 . . . . 62.35 110.595 -170.129 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.16 146.83 53.59 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.309 -1.314 . . . . 63.51 113.132 -179.289 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.02 0.5 41.67 Favored Glycine 0 CA--C 1.502 -0.744 0 CA-C-N 115.943 -0.571 . . . . 74.43 112.794 179.094 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -115.0 -158.48 0.67 Allowed 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 107.966 -1.124 . . . . 75.31 107.966 175.705 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 70.6 p -91.35 155.77 18.25 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 108.135 -1.061 . . . . 72.03 108.135 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 23.2 m -63.0 -33.99 76.6 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 120.688 0.28 . . . . 52.35 110.674 -179.029 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.9 -46.54 74.56 Favored 'General case' 0 C--O 1.212 -0.892 0 CA-C-O 119.435 -0.317 . . . . 74.35 111.051 178.807 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -69.12 -43.1 75.11 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-O 121.164 0.507 . . . . 75.22 110.579 179.659 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 373' ' ' ALA . . . . . 0.537 ' HB1' HG13 ' A' ' 365' ' ' VAL . . . -63.32 -49.11 75.27 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.371 -0.831 . . . . 64.32 111.728 -178.108 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.15 -38.1 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-N 116.52 -0.309 . . . . 73.24 110.834 179.322 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -60.64 -47.08 87.82 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.828 0.347 . . . . 64.55 110.885 178.839 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 60.0 m -60.91 -46.88 88.88 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.258 0.551 . . . . 75.35 110.215 179.678 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.503 HD22 HG23 ' A' ' 384' ' ' ILE . 7.6 tt -63.4 -38.87 92.83 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 115.546 -0.752 . . . . 54.54 110.752 -179.265 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -63.88 -40.37 96.38 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.135 0.574 . . . . 71.33 109.826 177.624 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -70.25 -17.61 63.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.166 0.508 . . . . 75.44 112.024 178.181 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -84.33 -14.72 48.86 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.077 0.465 . . . . 73.34 110.18 174.397 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 96.37 8.13 57.74 Favored Glycine 0 N--CA 1.435 -1.426 0 C-N-CA 120.586 -0.816 . . . . 71.12 112.728 175.822 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.482 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 66.4 m-85 -80.69 169.13 18.03 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-O 120.768 0.318 . . . . 62.22 110.688 178.996 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -112.44 150.24 31.46 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.17 -1.048 . . . . 74.01 108.17 -179.099 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.503 HG23 HD22 ' A' ' 377' ' ' LEU . 0.1 OUTLIER -130.76 149.13 33.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 CA-C-O 121.572 0.701 . . . . 62.23 112.035 177.181 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.72 139.7 45.77 Favored 'General case' 0 N--CA 1.4 -2.954 0 N-CA-C 103.444 -2.798 . . . . 63.14 103.444 169.797 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 52.0 m -133.76 119.14 18.89 Favored 'General case' 0 C--N 1.252 -3.649 0 N-CA-C 108.468 -0.938 . . . . 63.34 108.468 -175.011 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -110.95 119.36 38.82 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.159 -0.682 . . . . 73.21 109.159 -179.664 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 12.7 pm0 -102.08 120.78 40.99 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 107.054 -1.461 . . . . 74.44 107.054 176.485 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 389' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 421' ' ' SER . 55.8 mtmt -139.29 140.96 27.6 Favored Pre-proline 0 C--N 1.285 -2.198 0 CA-C-N 115.834 -0.621 . . . . 73.25 109.789 -175.755 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.463 ' HA ' ' O ' ' A' ' 422' ' ' THR . 24.1 Cg_exo -69.14 174.31 9.15 Favored 'Trans proline' 0 C--O 1.246 0.911 0 C-N-CA 121.972 1.781 . . . . 74.11 110.016 169.286 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 90.15 173.74 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.768 1.627 . . . . 72.52 111.471 -179.2 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 392' ' ' SER . . . . . 0.437 ' N ' ' HG3' ' A' ' 425' ' ' GLU . 38.6 m -119.53 13.48 12.58 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.642 0.734 . . . . 75.53 109.384 -176.818 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 10.7 m -78.02 -15.73 58.68 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 122.297 1.046 . . . . 70.53 109.45 -179.726 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.605 HG12 ' OG ' ' A' ' 421' ' ' SER . 0.1 OUTLIER -113.69 151.82 44.96 Favored Pre-proline 0 N--CA 1.42 -1.938 0 CA-C-N 114.54 -1.209 . . . . 65.03 108.975 179.339 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.31 158.0 2.79 Favored 'Trans proline' 0 CA--C 1.554 1.483 0 C-N-CA 124.756 3.637 . . . . 74.35 115.854 -175.487 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.13 161.41 8.89 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 123.967 3.111 . . . . 71.3 112.716 178.339 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 397' ' ' ASP . . . . . 0.516 ' HA ' HG23 ' A' ' 420' ' ' VAL . 6.6 p-10 -58.99 -9.42 1.88 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.889 0.876 . . . . 74.03 113.324 -176.867 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 59.6 m170 -114.51 145.99 41.25 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.265 -1.384 . . . . 70.45 107.265 177.016 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 30.6 m -72.28 118.95 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 N-CA-C 112.9 0.704 . . . . 73.44 112.9 -167.817 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 400' ' ' ILE . . . . . 0.446 HD13 ' O ' ' A' ' 400' ' ' ILE . 0.0 OUTLIER -97.97 -29.02 3.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 106.613 -1.625 . . . . 75.01 106.613 176.275 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.7 163.16 28.56 Favored Glycine 0 N--CA 1.409 -3.13 0 CA-C-N 114.808 -1.087 . . . . 63.43 110.446 -178.055 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.8 p -119.55 -176.56 3.18 Favored 'General case' 0 C--N 1.282 -2.331 0 C-N-CA 124.832 1.253 . . . . 71.54 109.265 179.101 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 403' ' ' ASP . . . . . 0.496 ' HB2' ' O ' ' A' ' 417' ' ' THR . 20.2 t70 -99.4 134.78 20.97 Favored Pre-proline 0 C--N 1.299 -1.612 0 N-CA-C 108.814 -0.81 . . . . 74.15 108.814 -174.581 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 404' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 403' ' ' ASP . 74.2 Cg_exo -53.24 -17.1 7.92 Favored 'Trans proline' 0 C--N 1.363 1.318 0 C-N-CA 124.335 3.357 . . . . 74.13 115.134 -176.389 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -61.0 -32.99 72.56 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.967 -0.383 . . . . 71.32 109.967 177.062 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 406' ' ' ALA . . . . . 0.494 ' HA ' ' HB ' ' A' ' 362' ' ' VAL . . . -72.75 -30.91 64.53 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.663 0.744 . . . . 54.02 110.052 179.256 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -81.0 -10.79 59.67 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.345 -0.843 . . . . 73.44 109.843 -178.722 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 40.0 m -96.5 150.09 21.01 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.928 -1.508 . . . . 60.21 106.928 175.727 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 409' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 361' ' ' GLN . 23.2 m -81.28 111.99 18.18 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 107.964 -1.125 . . . . 42.32 107.964 176.795 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.3 m -123.75 169.29 15.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-O 120.967 0.413 . . . . 65.51 110.587 -178.544 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 15.7 m -65.88 136.9 56.76 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.966 -0.753 . . . . 73.25 108.966 178.133 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -67.07 114.23 5.68 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.556 0.693 . . . . 72.32 111.223 -174.799 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 413' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 110.06 40.3 1.43 Allowed Glycine 0 N--CA 1.423 -2.193 0 CA-C-N 115.032 -0.985 . . . . 72.12 111.667 -179.798 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -114.53 -176.62 2.94 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.538 -0.465 . . . . 65.2 109.856 -179.015 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -87.21 119.51 27.52 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 123.842 0.857 . . . . 52.34 111.651 -167.619 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 38.8 mm -112.28 121.49 64.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 107.902 -1.147 . . . . 54.03 107.902 174.994 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 417' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 403' ' ' ASP . 35.5 m -93.05 129.32 39.03 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 113.348 0.87 . . . . 64.44 113.348 -173.98 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 4.2 p -124.42 135.84 62.47 Favored 'Isoleucine or valine' 0 C--O 1.247 0.934 0 CA-C-N 116.237 -0.438 . . . . 73.53 110.34 179.773 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -107.35 128.57 54.57 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.503 -0.317 . . . . 62.5 110.168 178.321 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.516 HG23 ' HA ' ' A' ' 397' ' ' ASP . 7.5 p -123.81 131.49 72.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 109.285 -0.635 . . . . 62.44 109.285 177.382 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 421' ' ' SER . . . . . 0.605 ' OG ' HG12 ' A' ' 394' ' ' ILE . 43.4 m -95.83 122.9 39.11 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.544 0.687 . . . . 62.32 112.12 -177.208 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 390' ' ' PRO . 6.0 t -119.49 106.99 12.77 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.392 -0.822 . . . . 61.22 109.993 175.525 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 103.22 90.98 2.18 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 120.318 -0.944 . . . . 74.0 113.134 179.041 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.02 158.08 26.75 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 123.831 3.02 . . . . 43.43 113.075 179.463 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 392' ' ' SER . 46.0 mt-10 -72.02 144.16 48.9 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 122.126 0.965 . . . . 74.33 113.063 -175.939 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -116.79 151.82 35.69 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 113.382 -1.735 . . . . 74.14 106.965 179.584 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.535 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 5.4 mmp_? -122.71 154.81 37.61 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 120.982 0.42 . . . . 65.24 110.847 176.337 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -83.57 138.99 33.13 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 115.292 -0.867 . . . . 51.11 110.117 -175.829 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.49 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 60.4 mt -86.39 127.49 60.85 Favored Pre-proline 0 N--CA 1.425 -1.695 0 N-CA-C 107.085 -1.45 . . . . 73.15 107.085 176.048 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.483 ' HG2' ' HB3' ' A' ' 443' ' ' LYS . 12.1 Cg_exo -70.19 151.16 66.49 Favored 'Trans proline' 0 C--O 1.239 0.527 0 C-N-CA 122.08 1.853 . . . . 74.15 110.918 176.157 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -69.19 137.73 53.51 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 107.868 -1.16 . . . . 71.54 107.868 178.226 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 2.4 p -116.97 111.27 34.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 C-N-CA 120.306 -0.557 . . . . 73.2 112.206 -176.462 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 1.8 p -65.63 139.52 58.43 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 107.265 -1.383 . . . . 75.13 107.265 171.622 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 434' ' ' THR . . . . . 0.59 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 62.7 p -63.28 -30.87 71.93 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 113.767 1.025 . . . . 73.33 113.767 -164.117 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.458 ' H ' HD23 ' A' ' 435' ' ' LEU . 0.5 OUTLIER -90.42 -11.1 41.46 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 115.867 -0.606 . . . . 65.05 111.767 -179.947 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.456 HG22 ' CB ' ' A' ' 439' ' ' GLU . 1.4 m -105.66 45.75 0.95 Allowed 'General case' 0 CA--C 1.573 1.841 0 CA-C-O 122.462 1.125 . . . . 75.01 110.788 -173.158 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 437' ' ' TYR . . . . . 0.4 ' O ' HG23 ' A' ' 441' ' ' VAL . 49.5 t80 -58.58 -38.2 77.39 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.955 -1.021 . . . . 75.41 113.27 177.037 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -62.52 -36.52 82.85 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 118.508 0.595 . . . . 53.4 110.657 179.397 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.456 ' CB ' HG22 ' A' ' 436' ' ' THR . 9.6 tp10 -62.66 -39.41 93.83 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.729 -0.841 . . . . 74.53 108.729 175.645 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.42 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -63.82 -42.97 97.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.04 -0.527 . . . . 55.41 110.343 178.038 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 441' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 437' ' ' TYR . 78.5 t -58.28 -48.95 83.48 Favored 'Isoleucine or valine' 0 C--O 1.256 1.443 0 CA-C-N 115.998 -0.547 . . . . 64.03 111.034 -179.114 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -67.67 -40.85 84.42 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.134 -0.626 . . . . 71.33 110.804 -177.858 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 443' ' ' LYS . . . . . 0.483 ' HB3' ' HG2' ' A' ' 430' ' ' PRO . 27.5 mmtp -66.45 -40.87 89.66 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.622 -0.717 . . . . 55.34 112.032 -177.517 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.42 HD13 ' O ' ' A' ' 440' ' ' ALA . 8.2 mp -63.67 -38.46 91.19 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.25 0.344 . . . . 70.41 110.159 175.879 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.42 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 98.3 m -64.08 -47.49 79.9 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 120.984 0.421 . . . . 71.44 110.972 179.225 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.49 -15.65 62.32 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.167 -0.469 . . . . 72.14 112.11 -179.598 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -85.54 5.34 31.89 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.035 0.445 . . . . 64.41 111.724 179.699 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 104.56 -66.97 0.29 Allowed Glycine 0 CA--C 1.497 -1.045 0 C-N-CA 120.139 -1.029 . . . . 54.11 112.406 175.212 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 449' ' ' PHE . . . . . 0.424 ' HA ' ' O ' ' A' ' 480' ' ' ILE . 1.3 p90 -49.65 -61.44 2.11 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 113.193 0.812 . . . . 74.24 113.193 177.627 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 450' ' ' GLY . . . . . 0.42 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 57.94 25.12 55.92 Favored Glycine 0 CA--C 1.504 -0.611 0 O-C-N 123.056 0.222 . . . . 64.34 113.301 -179.923 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.404 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 62.7 mtt180 -106.63 113.72 27.39 Favored 'General case' 0 N--CA 1.419 -2.017 0 N-CA-C 108.989 -0.745 . . . . 75.01 108.989 -178.042 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 43.2 p90 -137.8 151.8 48.49 Favored 'General case' 0 C--N 1.279 -2.459 0 CA-C-N 115.192 -0.913 . . . . 72.51 110.012 -175.756 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -142.39 122.85 14.03 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.124 -0.944 . . . . 72.32 110.189 176.663 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -93.95 125.57 38.65 Favored 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 123.778 0.831 . . . . 52.4 109.654 178.626 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -119.18 147.15 44.54 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.99 -1.115 . . . . 72.54 107.99 175.314 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 456' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 488' ' ' VAL . 87.7 m-20 -120.61 133.49 55.37 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 120.855 0.359 . . . . 72.33 111.365 -179.869 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 27.3 t -135.79 139.45 30.72 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 108.979 -0.749 . . . . 72.31 108.979 179.704 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.662 ' HA ' ' O ' ' A' ' 490' ' ' SER . 32.9 Cg_endo -65.94 127.39 17.63 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.292 1.994 . . . . 72.52 110.977 177.495 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 69.5 m -147.76 179.47 7.68 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 122.912 0.485 . . . . 75.52 109.945 -179.7 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 460' ' ' THR . . . . . 0.477 ' O ' HG23 ' A' ' 464' ' ' VAL . 5.2 t -50.23 139.29 19.09 Favored Pre-proline 0 C--O 1.248 0.986 0 C-N-CA 125.125 1.37 . . . . 52.33 111.753 178.223 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.33 -29.8 31.62 Favored 'Trans proline' 0 C--N 1.36 1.132 0 C-N-CA 124.644 3.563 . . . . 73.04 113.45 -177.439 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -72.92 -25.12 60.93 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.293 0.479 . . . . 75.12 112.293 -178.992 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -104.13 -5.38 22.07 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.879 0.371 . . . . 65.23 111.488 177.427 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 460' ' ' THR . 54.0 t -60.36 127.75 20.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.19 -0.459 . . . . 74.34 110.025 177.117 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 90.02 0.5 77.61 Favored Glycine 0 N--CA 1.422 -2.236 0 C-N-CA 121.037 -0.602 . . . . 61.52 112.534 179.001 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.402 ' C ' HG13 ' A' ' 488' ' ' VAL . 0.0 OUTLIER -131.12 163.18 28.23 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 119.604 -0.838 . . . . 63.33 111.213 -179.813 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.59 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 67.7 t -67.01 133.42 31.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 114.711 -1.131 . . . . 54.55 111.216 -177.088 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 53.8 mt -98.3 -24.28 4.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.226 -1.027 . . . . 75.14 108.226 179.15 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 165.33 169.62 29.19 Favored Glycine 0 N--CA 1.427 -1.907 0 CA-C-N 115.471 -0.786 . . . . 73.42 112.65 177.317 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 1.7 t -116.89 137.94 51.87 Favored 'General case' 0 N--CA 1.406 -2.66 0 N-CA-C 106.341 -1.726 . . . . 62.13 106.341 174.783 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.503 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 49.0 t30 -65.52 -53.44 37.73 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 119.822 -0.751 . . . . 64.14 111.055 179.523 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 9.7 Cg_exo -74.84 122.43 7.27 Favored 'Trans proline' 0 C--N 1.366 1.497 0 N-CA-C 107.195 -1.887 . . . . 42.22 107.195 170.811 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.462 ' C ' ' H ' ' A' ' 475' ' ' ASN . 26.9 Cg_exo -62.61 139.26 74.69 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 121.743 1.629 . . . . 72.04 112.565 -176.142 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.49 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -74.67 11.6 1.0 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 122.611 1.196 . . . . 64.35 110.843 -179.632 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 475' ' ' ASN . . . . . 0.462 ' H ' ' C ' ' A' ' 473' ' ' PRO . 78.9 m-20 -110.4 -4.8 15.4 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-N 114.385 -1.279 . . . . 53.34 108.852 -178.854 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -115.83 170.93 8.1 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 121.512 0.672 . . . . 70.34 111.808 -175.243 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.32 137.62 37.56 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.518 -1.219 . . . . 75.24 108.713 -178.378 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 21.1 p -126.27 149.2 49.27 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 120.999 0.428 . . . . 74.21 111.049 -179.146 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -72.97 160.72 31.66 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.431 -0.804 . . . . 70.24 110.537 178.213 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 449' ' ' PHE . 1.9 mp -72.65 -16.81 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-O 121.947 0.88 . . . . 74.44 111.014 -179.867 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 15.3 t -96.05 5.16 51.79 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-O 121.772 0.796 . . . . 51.13 109.853 177.48 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -89.55 137.61 32.18 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.993 -0.549 . . . . 75.35 109.941 -175.633 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.404 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.2 p -104.37 126.05 59.12 Favored 'Isoleucine or valine' 0 C--O 1.245 0.841 0 CA-C-O 121.336 0.588 . . . . 70.0 110.849 179.705 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 61.8 t -95.83 119.99 44.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.981 -0.554 . . . . 65.33 109.859 -179.271 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.18 123.98 55.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 108.863 -0.792 . . . . 71.1 108.863 178.598 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 39.5 mt -120.15 128.11 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 CA-C-N 114.723 -1.126 . . . . 61.23 110.184 -176.774 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 9.3 tt -101.9 125.15 56.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 115.891 -0.595 . . . . 75.3 110.074 -179.148 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 456' ' ' ASN . 10.6 t -113.18 139.03 40.53 Favored 'Isoleucine or valine' 0 C--O 1.251 1.14 0 N-CA-C 106.569 -1.641 . . . . 40.52 106.569 179.236 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -75.53 153.76 44.79 Favored Glycine 0 C--N 1.299 -1.522 0 CA-C-O 121.346 0.414 . . . . 75.12 113.275 -176.665 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.662 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 48.6 m -141.22 160.69 39.58 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 106.6 -1.63 . . . . 64.03 106.6 176.012 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -178.0 -156.84 17.49 Favored Glycine 0 N--CA 1.435 -1.396 0 C-N-CA 119.384 -1.388 . . . . 72.44 112.081 -178.775 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -92.56 166.18 2.8 Favored 'Trans proline' 0 N--CA 1.446 -1.312 0 C-N-CA 122.857 2.372 . . . . 60.31 112.69 -179.381 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -95.6 99.94 11.74 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 109.219 -0.66 . . . . 54.15 109.219 176.705 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 13.7 p -117.83 143.0 46.68 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.35 -0.841 . . . . 64.05 109.595 179.208 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -144.76 154.23 42.5 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.674 -0.862 . . . . 70.42 108.674 176.939 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 11.9 p-10 -94.63 136.66 34.68 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.757 -0.831 . . . . 75.33 108.757 176.038 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 30.1 pt -75.62 137.38 70.58 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-N 115.369 -0.832 . . . . 75.35 112.038 -176.314 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -87.34 -170.18 0.57 Allowed 'Trans proline' 0 C--O 1.248 1.023 0 C-N-CA 122.995 2.464 . . . . 70.42 110.947 175.414 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -94.8 122.98 37.99 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.615 0.721 . . . . 62.04 109.687 177.985 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.6 p -113.42 7.57 7.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-O 122.374 1.083 . . . . 72.04 109.993 -177.62 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -73.72 121.22 20.44 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.204 -0.907 . . . . 31.11 109.788 -179.251 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 124.28 -17.75 7.44 Favored Glycine 0 C--N 1.289 -2.057 0 N-CA-C 110.105 -1.198 . . . . 63.34 110.105 -179.866 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -94.11 171.98 8.51 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 109.654 -0.498 . . . . 71.5 109.654 178.148 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 61.1 m -87.69 155.65 19.83 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.145 -1.057 . . . . 71.23 108.145 -179.302 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.6 p -54.17 -41.96 53.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 123.522 0.729 . . . . 74.53 112.316 -178.693 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -60.77 -42.24 97.1 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 123.368 0.667 . . . . 75.32 111.324 178.963 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.27 -40.75 50.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 115.419 -0.81 . . . . 60.34 109.769 -179.202 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -60.69 -49.51 77.23 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.464 -0.789 . . . . 41.23 111.339 -178.481 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -64.6 -36.05 82.98 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.596 -0.274 . . . . 71.15 110.264 -178.614 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.422 ' O ' HG23 ' A' ' 514' ' ' VAL . 87.7 tttt -61.47 -47.19 86.83 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.786 -0.643 . . . . 72.44 109.95 179.457 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -61.92 -48.17 81.63 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 116.192 -0.458 . . . . 74.4 110.818 -178.735 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.7 -45.65 93.4 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.4 -0.364 . . . . 55.35 111.182 178.793 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -63.18 -37.96 89.3 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 120.727 0.299 . . . . 74.25 111.711 -178.681 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 510' ' ' LYS . 79.4 t -65.1 -33.73 65.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-N 116.266 -0.425 . . . . 54.0 110.967 177.392 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -79.63 -9.38 59.62 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.399 0.518 . . . . 55.12 112.399 179.953 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 115.53 -20.43 13.64 Favored Glycine 0 CA--C 1.495 -1.159 0 C-N-CA 120.454 -0.879 . . . . 52.44 111.747 179.109 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 517' ' ' PHE . . . . . 0.453 ' CE1' ' HA ' ' A' ' 547' ' ' VAL . 74.9 m-85 -78.25 81.74 4.6 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.41 -0.959 . . . . 74.32 108.41 179.625 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.6 p -87.91 -8.99 54.99 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 114.96 -1.018 . . . . 45.13 113.355 -173.102 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -108.01 115.52 30.28 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-O 121.407 0.622 . . . . 75.02 109.725 -177.563 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -130.48 156.37 44.89 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.454 -0.794 . . . . 71.44 111.253 -178.847 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 38.4 m -132.45 140.79 48.55 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 106.301 -1.74 . . . . 70.35 106.301 173.423 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -117.54 139.43 50.96 Favored 'General case' 0 N--CA 1.422 -1.869 0 C-N-CA 120.018 -0.673 . . . . 72.3 110.312 179.634 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -115.94 124.38 50.43 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 107.349 -1.352 . . . . 75.32 107.349 175.269 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 39.5 m -89.33 114.54 25.96 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.403 -0.962 . . . . 71.43 108.403 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 33.4 m -121.32 165.99 16.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 N-CA-C 109.309 -0.626 . . . . 54.14 109.309 -177.454 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 526' ' ' ASP . . . . . 0.4 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 3.5 p-10 -104.43 137.48 42.24 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.607 -0.886 . . . . 72.12 108.607 177.367 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 17.3 m -151.27 179.95 1.14 Allowed Pre-proline 0 C--N 1.295 -1.801 0 N-CA-C 109.292 -0.633 . . . . 64.44 109.292 -177.77 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -80.42 -7.04 13.83 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 121.695 1.597 . . . . 74.2 110.49 170.05 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.42 ' HA ' ' HD3' ' A' ' 530' ' ' PRO . 15.7 mmm180 -82.72 137.43 44.22 Favored Pre-proline 0 N--CA 1.447 -0.611 0 N-CA-C 107.892 -1.151 . . . . 45.23 107.892 177.995 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 530' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 529' ' ' ARG . 36.8 Cg_exo -58.8 160.23 18.53 Favored 'Trans proline' 0 N--CA 1.484 0.946 0 C-N-CA 123.566 2.844 . . . . 74.11 115.267 -175.04 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -66.71 113.6 4.96 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.686 -1.143 . . . . 62.05 111.435 -178.977 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 117.25 -19.56 11.7 Favored Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 110.856 -0.898 . . . . 32.15 110.856 178.867 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -83.11 134.62 35.0 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.533 -0.914 . . . . 72.34 108.533 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 58.8 t -80.42 126.36 39.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 109.321 -0.622 . . . . 72.12 109.321 -179.609 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 535' ' ' THR . . . . . 0.655 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 15.1 t -81.13 -18.03 47.85 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 121.506 0.669 . . . . 74.11 109.602 179.131 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.24 -161.44 28.61 Favored Glycine 0 N--CA 1.439 -1.148 0 C-N-CA 120.989 -0.624 . . . . 65.21 112.153 176.293 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 537' ' ' THR . . . . . 0.469 HG22 HD13 ' A' ' 553' ' ' LEU . 15.4 p -117.2 160.26 21.33 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.543 -0.54 . . . . 75.44 109.543 179.226 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.458 ' HB2' HE22 ' A' ' 554' ' ' GLN . 50.7 t30 -68.99 -55.34 10.62 Favored Pre-proline 0 C--N 1.325 -0.491 0 C-N-CA 120.514 -0.475 . . . . 74.3 110.241 177.441 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.82 134.2 25.23 Favored 'Trans proline' 0 C--N 1.366 1.463 0 N-CA-C 109.191 -1.119 . . . . 62.12 109.191 171.447 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.59 157.52 58.02 Favored 'Trans proline' 0 C--O 1.253 1.245 0 C-N-CA 122.578 2.185 . . . . 74.1 112.724 179.971 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.88 134.96 57.34 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.044 -0.525 . . . . 64.23 109.812 178.315 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.57 -13.34 39.16 Favored Glycine 0 C--N 1.307 -1.048 0 C-N-CA 120.844 -0.693 . . . . 71.13 111.739 -177.731 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 496' ' ' ASP . 81.7 m -70.92 120.89 17.15 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 109.072 -0.714 . . . . 22.01 109.072 178.359 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 31.9 m -86.62 122.88 31.16 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.026 -0.731 . . . . 54.3 109.026 -179.661 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 12.2 m -135.1 154.93 79.32 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 109.686 -0.487 . . . . 64.23 109.686 -179.327 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.43 149.77 45.22 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.964 1.776 . . . . 64.31 110.029 175.805 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.453 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 25.8 m -59.54 -19.58 16.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 112.673 0.62 . . . . 74.44 112.673 178.961 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -81.21 3.55 23.38 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.24 1.016 . . . . 72.51 112.64 179.479 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 77.5 p -88.16 175.16 7.83 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 121.996 -0.44 . . . . 73.42 112.17 -176.869 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 39.0 t -112.58 119.24 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 108.79 -0.818 . . . . 43.52 108.79 179.086 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 1.8 mp -98.13 131.21 45.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-O 121.113 0.483 . . . . 75.13 110.223 -179.179 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -103.23 117.82 35.38 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-O 121.258 0.551 . . . . 75.2 110.9 179.822 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 553' ' ' LEU . . . . . 0.469 HD13 HG22 ' A' ' 537' ' ' THR . 2.4 mm? -98.89 132.89 43.88 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.311 -1.313 . . . . 64.14 108.746 179.002 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 554' ' ' GLN . . . . . 0.458 HE22 ' HB2' ' A' ' 538' ' ' ASN . 26.0 mp0 -100.48 118.59 37.0 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.849 -1.167 . . . . 71.13 107.849 172.157 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 46.0 t -104.42 131.18 53.93 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 107.385 -1.339 . . . . 62.54 107.385 -178.22 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.655 ' OG ' ' HB ' ' A' ' 535' ' ' THR . 50.2 m -95.92 158.13 15.59 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 114.044 1.127 . . . . 74.55 114.044 -175.131 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 19.0 ptpt -113.68 148.2 36.78 Favored 'General case' 0 N--CA 1.414 -2.272 0 N-CA-C 105.888 -1.894 . . . . 64.21 105.888 164.092 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -75.08 -22.26 76.87 Favored Glycine 0 C--N 1.292 -1.874 0 O-C-N 124.103 0.877 . . . . 74.44 111.929 -178.586 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 73.67 10.38 4.8 Favored 'General case' 0 CA--C 1.485 -1.524 0 C-N-CA 124.654 1.181 . . . . 64.45 109.284 -171.786 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 33.3 tt0 -128.39 141.26 51.47 Favored 'General case' 0 N--CA 1.408 -2.537 0 CA-C-N 115.525 -0.761 . . . . 73.33 109.42 -176.857 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -138.82 155.1 48.42 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.564 -0.743 . . . . 71.21 109.394 -179.33 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.4 p -63.64 130.58 28.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 O-C-N 123.614 0.571 . . . . 73.22 111.081 -179.157 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 56.4 ttp -94.78 126.41 47.38 Favored Pre-proline 0 C--O 1.253 1.263 0 CA-C-N 115.886 -0.597 . . . . 73.34 109.543 178.36 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -63.43 169.78 9.11 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.068 2.512 . . . . 61.22 112.551 175.941 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -75.19 133.61 41.39 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.871 -0.604 . . . . 73.45 111.29 -179.526 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 566' ' ' LEU . . . . . 0.436 ' HB3' ' SD ' ' A' ' 569' ' ' MET . 92.8 mt -137.66 27.97 2.72 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.828 -0.804 . . . . 75.01 108.828 -177.674 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 17.7 m -77.86 130.31 36.48 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.907 -0.588 . . . . 53.21 111.228 -174.705 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 67.48 38.05 90.46 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.957 -0.565 . . . . 61.11 112.937 176.447 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 569' ' ' MET . . . . . 0.436 ' SD ' ' HB3' ' A' ' 566' ' ' LEU . 23.6 ptm -99.46 168.77 9.77 Favored 'General case' 0 C--O 1.255 1.363 0 N-CA-C 108.839 -0.8 . . . . 61.52 108.839 -179.413 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -106.76 148.98 27.81 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 109.471 -0.566 . . . . 62.05 109.471 -178.077 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 571' ' ' TRP . . . . . 0.449 ' HA ' ' HB3' ' A' ' 574' ' ' ALA . 61.2 t-105 -62.31 -25.01 67.64 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 124.129 0.972 . . . . 71.01 110.269 -178.976 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 13.7 p -68.82 -21.72 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 115.548 -0.751 . . . . 50.32 110.386 179.498 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -101.28 -29.76 11.89 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 109.501 -0.555 . . . . 70.25 109.501 176.103 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 574' ' ' ALA . . . . . 0.449 ' HB3' ' HA ' ' A' ' 571' ' ' TRP . . . -61.7 -49.96 74.39 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.164 -0.925 . . . . 65.54 111.92 -179.385 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.451 ' HB2' ' HD3' ' A' ' 576' ' ' PRO . 38.0 mt-10 -54.21 -53.85 54.37 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 113.283 0.846 . . . . 70.11 113.283 -179.267 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 576' ' ' PRO . . . . . 0.451 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 50.7 Cg_exo -53.87 -45.03 44.02 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 121.887 1.725 . . . . 63.4 112.337 176.825 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.556 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 20.6 mmm180 -64.0 -41.43 97.48 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.512 -0.313 . . . . 64.32 111.174 -179.961 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 7.1 tt -63.64 -49.27 73.89 Favored 'General case' 0 C--O 1.247 0.926 0 C-N-CA 123.403 0.681 . . . . 52.52 109.858 -176.094 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 579' ' ' ARG . . . . . 0.433 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 4.6 ptp180 -67.27 -37.9 84.21 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.616 -0.72 . . . . 74.25 112.595 179.03 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.22 -39.16 75.26 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 112.575 0.583 . . . . 73.43 112.575 -178.148 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 581' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 4.0 pp -84.62 -1.23 55.71 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.66 -0.816 . . . . 62.31 112.437 -179.117 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 67.03 47.46 65.17 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 115.366 -0.834 . . . . 43.4 112.093 177.351 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 22.5 t90 -63.67 127.15 30.06 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.923 -0.399 . . . . 74.14 109.923 179.039 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 3.6 m -125.23 24.22 7.46 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.122 -0.696 . . . . 72.0 109.122 -176.726 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -92.43 -170.2 40.7 Favored Glycine 0 CA--C 1.508 -0.406 0 C-N-CA 120.71 -0.757 . . . . 71.23 113.904 -175.438 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 64.7 mtt -98.7 126.39 44.29 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.87 0.367 . . . . 74.5 110.474 -179.311 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 55.0 tp -96.84 102.25 14.0 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.12 -1.067 . . . . 71.05 108.12 177.504 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -96.43 101.46 13.09 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.268 0.556 . . . . 71.4 110.463 -178.851 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.32 114.22 28.31 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.547 -1.279 . . . . 73.31 107.547 178.631 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -75.97 -88.45 0.27 Allowed Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 120.622 -0.799 . . . . 73.5 111.206 177.45 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -125.58 154.66 41.89 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 122.436 -0.449 . . . . 63.11 110.48 -178.898 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -82.15 141.47 33.05 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.346 -0.983 . . . . 75.32 108.346 173.933 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 42.5 t -124.24 116.53 48.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 108.935 -0.765 . . . . 73.31 108.935 -177.473 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -89.2 107.81 19.26 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 107.778 -1.193 . . . . 72.05 107.778 177.573 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -127.18 9.54 6.76 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.887 -0.597 . . . . 74.11 111.197 -178.814 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 128.65 169.73 12.66 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.302 -0.951 . . . . 62.44 111.701 178.175 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -57.11 -46.46 91.51 Favored Glycine 0 C--O 1.237 0.329 0 O-C-N 123.933 0.431 . . . . 71.12 113.034 -177.112 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 30.9 t -65.87 -29.69 70.18 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.313 0.578 . . . . 73.41 110.514 -178.722 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 599' ' ' GLN . . . . . 0.596 ' O ' ' HA3' ' A' ' 625' ' ' GLY . 87.4 mm-40 -87.31 -1.02 57.62 Favored 'General case' 0 C--O 1.211 -0.97 0 CA-C-N 115.65 -0.705 . . . . 74.31 112.788 -174.114 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 600' ' ' HIS . . . . . 0.522 ' HA ' ' H ' ' A' ' 626' ' ' GLN . 19.8 m80 -63.52 -71.77 0.16 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.952 0.882 . . . . 72.05 110.921 176.919 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -95.62 31.13 2.1 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.798 -0.637 . . . . 63.5 111.023 -173.575 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 1.3 mmm-85 -105.15 140.23 38.63 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 116.064 -0.516 . . . . 71.32 110.233 -177.904 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 97.3 t -73.7 138.18 21.78 Favored 'Isoleucine or valine' 0 C--O 1.252 1.218 0 N-CA-C 107.306 -1.368 . . . . 73.35 107.306 174.819 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 57.8 t -94.43 -50.55 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.973 0 CA-C-O 121.743 0.782 . . . . 62.13 109.421 -174.084 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -146.9 155.88 42.65 Favored 'General case' 0 N--CA 1.415 -2.219 0 N-CA-C 107.701 -1.222 . . . . 63.11 107.701 -178.537 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -120.84 121.88 39.08 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 106.465 -1.68 . . . . 71.2 106.465 171.123 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.563 ' HB2' ' HB ' ' A' ' 621' ' ' THR . 26.3 t-20 -59.03 -52.79 72.27 Favored Pre-proline 0 C--N 1.299 -1.623 0 CA-C-N 115.539 -0.755 . . . . 55.32 112.67 -177.893 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 1.0 OUTLIER -87.8 123.28 1.74 Allowed 'Trans proline' 0 N--CA 1.442 -1.544 0 C-N-CA 121.275 1.317 . . . . 74.23 109.668 173.546 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.06 156.15 60.53 Favored 'Trans proline' 0 C--O 1.244 0.793 0 C-N-CA 122.287 1.992 . . . . 65.21 111.36 177.978 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -59.09 127.96 34.79 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.828 -0.434 . . . . 72.33 109.828 178.559 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.18 -7.81 44.3 Favored Glycine 0 C--N 1.31 -0.891 0 C-N-CA 120.343 -0.932 . . . . 73.31 111.755 -177.613 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 26.9 m -89.13 157.26 18.36 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 107.988 -1.116 . . . . 70.33 107.988 178.247 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -90.98 143.52 16.68 Favored Glycine 0 N--CA 1.422 -2.238 0 C-N-CA 120.787 -0.721 . . . . 75.51 113.092 -177.42 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 614' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 19.0 m -115.71 141.65 32.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 109.376 -0.601 . . . . 62.44 109.376 174.388 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -70.82 -179.71 2.33 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 123.852 0.861 . . . . 72.15 113.066 -177.386 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -61.95 -36.03 80.21 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.072 0.949 . . . . 71.04 109.718 -179.728 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 617' ' ' ASP . . . . . 0.417 ' OD2' ' HB ' ' A' ' 619' ' ' ILE . 21.2 t70 -63.28 -40.33 97.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.008 -0.997 . . . . 52.53 108.656 174.588 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 87.97 22.03 43.83 Favored Glycine 0 N--CA 1.425 -2.09 0 C-N-CA 120.14 -1.029 . . . . 60.4 111.919 176.385 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 619' ' ' ILE . . . . . 0.417 ' HB ' ' OD2' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -68.76 118.46 12.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 122.422 1.106 . . . . 40.33 110.19 -170.398 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.34 130.38 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.743 0 N-CA-C 106.336 -1.727 . . . . 70.42 106.336 -179.923 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.563 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 6.4 m -100.77 117.19 34.36 Favored 'General case' 0 N--CA 1.421 -1.908 0 C-N-CA 119.455 -0.898 . . . . 73.31 109.428 -178.533 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -139.26 150.78 45.87 Favored 'General case' 0 CA--C 1.48 -1.736 0 N-CA-C 106.054 -1.832 . . . . 64.0 106.054 178.976 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -134.36 151.54 51.28 Favored 'General case' 0 C--N 1.266 -3.057 0 N-CA-C 105.132 -2.173 . . . . 75.43 105.132 176.523 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -120.4 165.55 14.76 Favored 'General case' 0 C--N 1.274 -2.705 0 N-CA-C 107.266 -1.383 . . . . 74.01 107.266 177.461 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 625' ' ' GLY . . . . . 0.596 ' HA3' ' O ' ' A' ' 599' ' ' GLN . . . -70.46 -108.29 0.04 OUTLIER Glycine 0 C--N 1.302 -1.344 0 O-C-N 123.915 0.759 . . . . 71.13 114.317 -174.409 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 626' ' ' GLN . . . . . 0.522 ' H ' ' HA ' ' A' ' 600' ' ' HIS . 8.6 tp-100 . . . . . 0 C--N 1.296 -1.746 0 CA-C-O 118.998 -0.525 . . . . 64.45 110.0 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 . . . . . 0 C--O 1.246 0.887 0 N-CA-C 106.196 -1.779 . . . . 71.04 106.196 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 24.4 m -113.85 142.35 26.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-O 121.779 0.799 . . . . 74.43 110.3 -170.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . 0.504 ' NE2' ' HA ' ' A' ' 407' ' ' ASN . 0.8 OUTLIER -95.01 126.64 40.49 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 106.291 -1.744 . . . . 75.41 106.291 -176.62 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.454 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 64.0 t -97.35 121.25 59.11 Favored Pre-proline 0 C--N 1.286 -2.18 0 CA-C-N 114.616 -1.174 . . . . 75.33 111.577 -169.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 24.5 Cg_exo -62.29 135.8 56.19 Favored 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 123.026 2.484 . . . . 74.32 111.658 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -105.14 149.81 25.57 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.917 -1.142 . . . . 72.53 107.917 -176.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.518 ' CG2' ' HA ' ' A' ' 373' ' ' ALA . 26.1 m -134.63 20.06 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 C-N-CA 122.415 0.286 . . . . 71.13 111.032 -177.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.54 146.5 9.83 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 112.797 0.666 . . . . 65.32 112.797 177.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . 0.435 ' H ' HG23 ' A' ' 399' ' ' VAL . . . 105.07 0.83 41.65 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 115.83 -0.623 . . . . 32.43 112.357 -178.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . 0.478 HE21 ' HB ' ' A' ' 365' ' ' VAL . 32.7 mt-30 -111.1 -89.35 0.5 Allowed 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 120.299 -0.561 . . . . 62.14 111.081 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 59.9 p -152.57 165.53 34.89 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.018 -0.734 . . . . 63.14 109.018 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.41 -46.14 87.76 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.721 -0.844 . . . . 73.14 108.721 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -59.53 -45.51 91.56 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 115.305 -0.861 . . . . 74.13 112.05 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -67.3 -41.38 85.46 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.087 0.47 . . . . 51.43 110.328 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . 0.518 ' HA ' ' CG2' ' A' ' 365' ' ' VAL . . . -65.79 -48.97 69.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.106 -0.497 . . . . 73.14 111.261 -179.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.17 -38.2 81.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.01 -0.541 . . . . 73.4 110.511 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.65 -42.03 87.41 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.259 0.623 . . . . 71.44 111.11 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.3 m -65.69 -49.02 70.05 Favored 'General case' 0 C--O 1.248 1.014 0 CA-C-O 121.58 0.705 . . . . 75.04 110.206 -178.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 9.9 mp -65.51 -42.63 91.84 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.572 -0.74 . . . . 73.41 111.74 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -64.46 -38.44 91.05 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.006 -0.543 . . . . 70.23 110.314 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -59.89 -39.08 84.15 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 116.023 -0.535 . . . . 62.12 110.687 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . 0.428 ' HA ' ' HD3' ' A' ' 380' ' ' ARG . 25.2 mmt180 -81.37 -12.35 59.01 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.613 -0.721 . . . . 74.0 112.193 -177.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.32 7.27 52.23 Favored Glycine 0 C--N 1.303 -1.27 0 C-N-CA 120.636 -0.792 . . . . 61.2 112.694 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.523 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 47.7 m-85 -81.66 159.46 23.97 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-O 121.355 0.598 . . . . 73.12 111.621 177.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.505 ' HB2' ' HG2' ' A' ' 415' ' ' GLU . 46.4 mtmt -115.23 161.8 17.95 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 115.005 -0.998 . . . . 43.12 108.826 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.21 157.38 41.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-O 120.862 0.363 . . . . 60.11 110.698 -177.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 61.6 ttp85 -120.16 126.84 51.66 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 107.138 -1.43 . . . . 72.44 107.138 170.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 17.6 m -108.27 125.13 51.33 Favored 'General case' 0 C--N 1.281 -2.408 0 N-CA-C 108.694 -0.854 . . . . 62.11 108.694 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -111.71 119.74 39.68 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.663 -0.866 . . . . 74.42 108.663 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -96.61 139.26 32.96 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 110.138 -0.319 . . . . 72.11 110.138 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -131.31 127.53 21.78 Favored Pre-proline 0 C--N 1.307 -1.247 0 N-CA-C 108.278 -1.008 . . . . 75.54 108.278 174.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -63.3 142.95 88.02 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.245 1.963 . . . . 74.23 111.794 177.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 7.3 t70 87.03 148.04 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 126.864 2.065 . . . . 65.23 110.368 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 13.0 t -103.12 11.96 36.44 Favored 'General case' 0 CA--C 1.552 1.058 0 CA-C-O 120.991 0.424 . . . . 64.41 110.546 -175.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 8.4 t -73.44 -18.08 61.17 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.97 0.891 . . . . 75.44 109.016 175.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.46 HD13 ' H ' ' A' ' 394' ' ' ILE . 0.1 OUTLIER -104.48 151.24 39.15 Favored Pre-proline 0 N--CA 1.427 -1.576 0 N-CA-C 107.459 -1.311 . . . . 61.31 107.459 173.098 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -23.33 114.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.678 1 C-N-CA 126.205 4.603 . . . . 64.52 115.7 -175.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.06 160.29 10.69 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 123.922 3.081 . . . . 64.2 112.833 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -57.97 -12.88 3.66 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 113.545 0.942 . . . . 75.5 113.545 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 28.7 m170 -91.89 148.46 22.2 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 108.257 -1.016 . . . . 71.32 108.257 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.435 HG23 ' H ' ' A' ' 367' ' ' GLY . 30.0 m -77.75 117.17 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.255 0 C-N-CA 118.687 -1.205 . . . . 70.34 111.089 -171.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 35.6 pt -106.68 -28.8 2.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 115.198 -0.91 . . . . 75.55 108.729 173.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.72 158.0 27.58 Favored Glycine 0 N--CA 1.417 -2.607 0 N-CA-C 109.489 -1.444 . . . . 31.53 109.489 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 3.9 p -137.93 -178.58 5.32 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 123.623 0.769 . . . . 73.04 109.476 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -102.1 132.16 21.85 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 108.154 -1.054 . . . . 61.42 108.154 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.34 3.09 0.89 Allowed 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.307 2.671 . . . . 72.41 115.632 -176.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -52.87 -47.59 67.72 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 109.673 -0.492 . . . . 65.33 109.673 175.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -69.95 -28.97 66.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.639 -0.71 . . . . 64.02 110.464 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . 0.504 ' HA ' ' NE2' ' A' ' 361' ' ' GLN . 5.9 m120 -81.35 -6.14 58.6 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 122.014 0.911 . . . . 75.32 109.753 -176.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 28.3 m -101.92 160.66 14.3 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.538 -1.653 . . . . 54.11 106.538 175.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 20.2 m -76.48 113.11 13.72 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 119.55 -0.86 . . . . 73.44 109.067 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.3 m -123.66 170.02 14.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 122.86 0.464 . . . . 65.24 111.018 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 19.2 m -74.25 141.05 45.39 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.887 -0.783 . . . . 54.32 108.887 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . 0.523 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -69.08 108.94 3.77 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.072 0.463 . . . . 73.31 110.468 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 121.38 37.76 0.67 Allowed Glycine 0 C--N 1.311 -0.819 0 CA-C-N 115.194 -0.912 . . . . 41.3 111.744 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -100.02 179.07 4.61 Favored 'General case' 0 C--O 1.245 0.861 0 N-CA-C 107.7 -1.222 . . . . 70.43 107.7 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . 0.505 ' HG2' ' HB2' ' A' ' 383' ' ' LYS . 44.8 mt-10 -116.41 115.0 25.05 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 118.249 0.477 . . . . 74.21 109.957 -178.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 42.6 mm -97.94 129.47 48.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 121.062 0.458 . . . . 75.14 110.072 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 2.2 p -79.81 131.21 35.84 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 123.866 0.866 . . . . 72.41 111.776 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 10.7 p -119.13 134.35 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.872 0 N-CA-C 109.01 -0.737 . . . . 61.51 109.01 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -95.4 120.77 36.21 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.546 -0.909 . . . . 74.45 108.546 -176.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 50.5 t -128.45 149.1 32.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 122.869 0.468 . . . . 72.4 109.885 -176.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 44.2 m -126.24 148.98 49.37 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.573 -0.529 . . . . 51.01 109.573 173.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 1.5 m -103.65 157.94 16.72 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 106.897 -1.52 . . . . 71.14 106.897 -175.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.73 0 N-CA-C 115.626 1.011 . . . . 74.55 115.626 -178.563 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 . . . . . 0 N--CA 1.429 -1.504 0 N-CA-C 107.404 -1.332 . . . . 71.34 107.404 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 447' ' ' ALA . 2.4 mmp_? -122.78 143.74 49.63 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-O 120.717 0.294 . . . . 72.1 110.655 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -86.27 138.98 31.43 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 107.079 -1.452 . . . . 54.41 107.079 173.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 67.6 mt -78.78 121.97 84.14 Favored Pre-proline 0 C--N 1.3 -1.545 0 CA-C-O 121.115 0.483 . . . . 74.24 110.825 -172.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.91 148.62 58.0 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.636 2.224 . . . . 74.41 111.434 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -87.48 145.15 26.38 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.666 -0.494 . . . . 74.42 109.666 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.28 153.05 16.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.839 -0.8 . . . . 75.11 108.839 -175.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 2.7 p -64.47 137.0 57.63 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 121.399 0.618 . . . . 62.35 110.294 175.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 23.6 p -69.1 -21.21 64.07 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 125.053 1.341 . . . . 75.14 112.128 -171.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.511 ' H ' HD23 ' A' ' 435' ' ' LEU . 0.6 OUTLIER -88.56 -11.02 46.83 Favored 'General case' 0 C--N 1.275 -2.632 0 CA-C-N 115.668 -0.696 . . . . 63.01 110.502 179.422 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.8 m -108.61 66.4 0.64 Allowed 'General case' 0 N--CA 1.426 -1.637 0 CA-C-O 121.835 0.826 . . . . 60.31 111.125 -175.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -53.38 -38.52 63.43 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 124.462 1.105 . . . . 71.44 111.859 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -58.89 -42.65 90.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.89 0.376 . . . . 74.43 110.85 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -70.96 -36.21 72.47 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.925 -0.58 . . . . 74.24 109.988 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.623 ' O ' HD22 ' A' ' 444' ' ' LEU . . . -60.39 -52.58 64.65 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 116.686 -0.234 . . . . 72.44 111.551 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 26.9 m -63.63 -36.5 76.67 Favored 'Isoleucine or valine' 0 C--O 1.245 0.828 0 CA-C-O 121.402 0.62 . . . . 55.04 110.773 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 41.5 tptt -59.18 -45.79 90.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.911 -1.041 . . . . 63.33 109.464 175.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -64.21 -39.76 94.65 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 113.381 0.882 . . . . 72.23 113.381 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.623 HD22 ' O ' ' A' ' 440' ' ' ALA . 1.4 mm? -68.01 -33.03 73.83 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 119.056 -1.057 . . . . 74.31 110.762 175.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 45.5 m -70.12 -42.69 72.29 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.293 0.568 . . . . 70.13 110.074 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.98 -15.49 62.58 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.845 -0.616 . . . . 75.41 110.651 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . 0.465 ' O ' ' HG3' ' A' ' 427' ' ' ARG . . . -86.92 2.87 47.86 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.061 -0.518 . . . . 44.45 111.454 177.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 106.35 -76.59 0.23 Allowed Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.172 -1.013 . . . . 42.43 112.127 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -46.28 -57.3 4.7 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 114.377 1.251 . . . . 72.14 114.377 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 59.41 28.41 64.7 Favored Glycine 0 CA--C 1.508 -0.382 0 O-C-N 123.5 0.5 . . . . 61.45 112.271 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.485 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 16.1 mmt180 -105.04 111.0 23.62 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 107.385 -1.339 . . . . 73.42 107.385 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.516 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 18.1 p90 -144.89 157.38 44.17 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-O 120.81 0.338 . . . . 72.14 111.451 -175.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -131.1 149.08 52.76 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 124.483 1.113 . . . . 73.3 108.22 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -116.86 119.42 35.32 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.937 -0.764 . . . . 75.13 108.937 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.6 143.01 48.87 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.001 -0.741 . . . . 73.2 109.001 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -112.98 135.02 54.22 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 107.269 -1.382 . . . . 73.33 107.269 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 38.2 t -137.44 134.81 18.75 Favored Pre-proline 0 C--N 1.289 -2.032 0 N-CA-C 109.118 -0.697 . . . . 51.11 109.118 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.617 ' HA ' ' O ' ' A' ' 490' ' ' SER . 37.1 Cg_endo -65.89 122.45 10.03 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 121.715 1.61 . . . . 71.53 108.549 175.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 15.3 m -131.82 179.34 6.13 Favored 'General case' 0 C--N 1.286 -2.157 0 C-N-CA 120.06 -0.656 . . . . 71.33 110.893 -173.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.7 t -55.78 141.49 65.77 Favored Pre-proline 0 N--CA 1.422 -1.853 0 C-N-CA 125.008 1.323 . . . . 75.21 108.458 173.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . 0.417 ' HB3' ' OG1' ' A' ' 494' ' ' THR . 9.6 Cg_endo -50.58 -30.11 27.16 Favored 'Trans proline' 0 N--CA 1.481 0.777 0 C-N-CA 124.766 3.644 . . . . 71.45 114.781 -171.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -75.89 -27.2 57.61 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 113.103 0.779 . . . . 72.4 113.103 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -92.95 -19.88 21.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.939 0.4 . . . . 75.11 111.688 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 90.5 t -60.78 134.89 26.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 109.423 -0.584 . . . . 73.22 109.423 175.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 101.35 -15.74 57.33 Favored Glycine 0 N--CA 1.431 -1.647 0 C-N-CA 121.085 -0.579 . . . . 65.33 113.248 177.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.2 166.59 24.27 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 117.521 0.661 . . . . 53.21 110.751 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.479 ' O ' ' HB ' ' A' ' 434' ' ' THR . 54.6 t -67.12 142.5 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.336 0 N-CA-C 108.478 -0.934 . . . . 61.4 108.478 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 42.5 mt -97.59 -28.22 3.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 107.689 -1.226 . . . . 64.21 107.689 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 150.23 -150.99 23.12 Favored Glycine 0 N--CA 1.411 -2.997 0 CA-C-N 114.646 -1.161 . . . . 71.11 110.661 176.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . 0.706 HG22 HG12 ' A' ' 486' ' ' ILE . 43.7 p -115.26 151.62 34.17 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 105.352 -2.092 . . . . 62.24 105.352 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.41 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 8.8 t30 -69.91 -50.67 16.58 Favored Pre-proline 0 C--N 1.304 -1.378 0 C-N-CA 118.698 -1.201 . . . . 63.11 111.055 176.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.41 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 23.5 Cg_exo -68.46 162.07 42.31 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 121.289 1.326 . . . . 54.02 109.36 172.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.494 ' HB2' ' OE1' ' A' ' 476' ' ' GLN . 20.7 Cg_endo -61.64 127.73 22.52 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.294 1.996 . . . . 72.52 111.988 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.481 ' HB2' ' OG1' ' A' ' 470' ' ' THR . . . -91.27 0.39 57.53 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 113.556 0.947 . . . . 60.44 113.556 -170.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -108.96 -12.99 14.81 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 119.677 -0.809 . . . . 74.04 109.672 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . 0.494 ' OE1' ' HB2' ' A' ' 473' ' ' PRO . 20.1 mp0 -92.35 -175.28 3.97 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 114.143 -1.39 . . . . 63.22 111.474 -172.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 1.4 p -93.79 141.13 28.84 Favored 'General case' 0 N--CA 1.404 -2.746 0 N-CA-C 113.387 0.884 . . . . 71.33 113.387 -176.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 12.7 p -127.08 148.05 50.15 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-N 114.618 -1.174 . . . . 73.5 108.269 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -75.58 163.72 27.06 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 116.845 -0.161 . . . . 43.12 110.857 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 22.6 mm -80.04 -5.15 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.019 0 CA-C-O 122.264 1.03 . . . . 75.34 109.552 -176.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.5 t -110.64 5.13 20.77 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.726 0.774 . . . . 75.54 109.259 175.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -93.01 143.05 26.62 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.835 -0.621 . . . . 75.24 110.686 -175.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.485 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.1 p -108.25 127.1 64.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 C-N-CA 123.11 0.564 . . . . 53.13 111.475 -177.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 27.8 m -105.12 125.46 60.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-O 121.864 0.84 . . . . 73.11 111.788 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.66 125.19 45.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.813 -0.81 . . . . 62.44 108.813 177.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.706 HG12 HG22 ' A' ' 470' ' ' THR . 42.5 mt -110.28 128.65 66.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 C-N-CA 124.465 1.106 . . . . 75.25 110.999 -176.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 4.8 tt -111.15 127.13 68.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 115.357 -0.838 . . . . 70.12 111.122 -174.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 467' ' ' VAL . 2.5 p -115.19 135.47 55.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 115.218 -0.901 . . . . 71.51 109.92 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -72.66 125.87 10.5 Favored Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 110.517 -1.033 . . . . 64.53 110.517 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.617 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 8.6 t . . . . . 0 N--CA 1.424 -1.77 0 N-CA-C 108.268 -1.012 . . . . 60.24 108.268 -176.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo . . . . . 0 N--CA 1.44 -1.618 0 CA-C-O 121.01 0.338 . . . . 73.05 111.655 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -128.99 23.9 5.65 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 122.748 1.261 . . . . 60.11 108.261 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.417 ' OG1' ' HB3' ' A' ' 461' ' ' PRO . 14.6 p -127.22 143.54 51.23 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 112.909 -1.95 . . . . 70.15 109.309 -176.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -147.03 161.85 39.98 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.042 -1.096 . . . . 64.53 108.042 176.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.2 p-10 -93.87 135.24 35.4 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 109.517 -0.549 . . . . 73.35 109.517 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 40.3 pt -80.18 137.77 52.8 Favored Pre-proline 0 C--N 1.302 -1.467 0 CA-C-N 115.952 -0.567 . . . . 72.32 111.37 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.63 168.31 19.74 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.653 2.236 . . . . 72.41 112.859 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -70.87 121.73 18.62 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.642 -0.873 . . . . 70.32 108.642 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.01 87.89 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.178 0 CA-C-O 122.475 1.131 . . . . 71.35 110.845 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -146.97 122.5 10.42 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 113.703 -1.59 . . . . 71.04 108.08 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 112.43 -11.98 25.94 Favored Glycine 0 CA--C 1.493 -1.282 0 N-CA-C 109.888 -1.285 . . . . 73.45 109.888 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -94.71 169.32 10.25 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 114.888 -0.656 . . . . 71.02 109.677 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 5.5 m -84.39 157.16 21.51 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.458 -0.941 . . . . 72.31 108.458 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 17.5 t -55.65 -41.96 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.227 0.611 . . . . 63.23 110.933 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -62.1 -40.58 96.33 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.669 -0.696 . . . . 71.42 110.836 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 48.8 t -73.94 -38.9 50.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.839 -0.619 . . . . 71.44 109.558 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -62.81 -49.43 74.97 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.566 -0.743 . . . . 64.35 111.356 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -63.15 -35.71 81.21 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 109.629 -0.508 . . . . 74.12 109.629 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.468 ' O ' HG23 ' A' ' 514' ' ' VAL . 48.4 tttp -64.79 -45.33 86.74 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.674 -0.694 . . . . 62.02 109.976 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . 0.403 ' O ' ' HD1' ' A' ' 515' ' ' TYR . 92.1 m-20 -62.34 -42.39 99.35 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 120.6 0.238 . . . . 73.44 110.734 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.33 -42.83 96.07 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 116.596 -0.274 . . . . 74.43 111.381 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -63.23 -37.69 88.23 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.785 -0.189 . . . . 61.51 111.041 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 510' ' ' LYS . 56.9 t -59.88 -35.03 58.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.085 0.469 . . . . 65.33 110.844 176.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . 0.403 ' HD1' ' O ' ' A' ' 511' ' ' ASN . 31.3 m-85 -79.45 -8.21 58.96 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.881 0.372 . . . . 72.31 111.936 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 103.23 -0.4 47.24 Favored Glycine 0 C--N 1.303 -1.279 0 C-N-CA 120.075 -1.06 . . . . 62.23 112.55 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.601 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 79.2 m-85 -84.59 96.33 9.14 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.451 -1.314 . . . . 74.03 107.451 177.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 6.3 p -87.19 -13.89 42.71 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 113.234 0.827 . . . . 74.14 113.234 -174.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -108.83 114.73 28.75 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.166 0.508 . . . . 72.2 109.676 -178.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -131.42 154.44 48.67 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.755 -0.657 . . . . 75.42 110.619 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 43.8 m -141.54 140.94 33.54 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 107.772 -1.196 . . . . 43.32 107.772 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . 0.502 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 0.0 OUTLIER -117.56 128.46 54.97 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 118.468 0.576 . . . . 52.51 111.551 -177.273 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -111.66 116.22 30.41 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.039 -0.726 . . . . 53.11 109.039 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 35.4 m -95.08 124.72 39.28 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 120.743 0.306 . . . . 50.42 111.03 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 18.7 m -122.8 151.29 26.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 108.539 -0.912 . . . . 62.21 108.539 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 557' ' ' LYS . 3.8 p30 -66.59 136.13 55.15 Favored 'General case' 0 CA--C 1.495 -1.169 0 CA-C-O 121.681 0.753 . . . . 73.04 110.423 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 20.0 m -146.43 158.34 47.23 Favored Pre-proline 0 C--N 1.281 -2.404 0 CA-C-N 114.737 -1.119 . . . . 24.21 108.596 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -69.68 -21.76 33.43 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 121.551 1.501 . . . . 70.31 108.802 170.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.512 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 60.0 mtm-85 -69.71 135.12 88.05 Favored Pre-proline 0 N--CA 1.436 -1.152 0 CA-C-N 114.188 -1.369 . . . . 72.55 108.4 176.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.8 149.12 79.85 Favored 'Trans proline' 0 C--O 1.251 1.154 0 C-N-CA 123.26 2.64 . . . . 74.43 113.491 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -64.39 117.4 7.23 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.613 -0.721 . . . . 62.04 110.917 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 129.81 -23.41 4.73 Favored Glycine 0 C--N 1.302 -1.311 0 C-N-CA 120.212 -0.994 . . . . 71.13 111.99 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -79.4 125.74 29.92 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.235 -0.654 . . . . 74.34 109.235 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 88.8 t -73.19 119.41 20.08 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 109.774 -0.454 . . . . 72.3 109.774 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 57.6 m -66.36 -40.31 89.7 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 124.687 1.195 . . . . 71.42 109.436 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 162.86 -159.81 32.22 Favored Glycine 0 N--CA 1.424 -2.113 0 N-CA-C 109.392 -1.483 . . . . 34.12 109.392 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 7.1 p -126.57 161.07 28.86 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 117.056 0.428 . . . . 72.15 110.317 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.497 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 24.8 t-20 -59.63 -51.99 77.19 Favored Pre-proline 0 CA--C 1.545 0.78 0 O-C-N 123.537 0.523 . . . . 74.4 111.198 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.497 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 1.2 Cg_endo -87.37 143.08 6.36 Favored 'Trans proline' 0 N--CA 1.441 -1.595 0 CA-C-N 120.257 1.128 . . . . 53.04 109.301 170.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -70.16 163.6 37.98 Favored 'Trans proline' 0 C--O 1.249 1.065 0 C-N-CA 122.428 2.085 . . . . 73.23 112.556 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.8 142.49 57.27 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.777 -0.647 . . . . 64.14 110.61 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 88.94 -5.95 84.1 Favored Glycine 0 N--CA 1.431 -1.666 0 C-N-CA 120.844 -0.693 . . . . 71.22 112.212 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 30.8 m -77.91 123.28 26.59 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.646 -0.501 . . . . 73.24 109.646 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 33.3 m -80.56 122.44 27.05 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 108.697 -0.853 . . . . 62.12 108.697 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 19.7 m -136.71 160.38 66.68 Favored Pre-proline 0 C--N 1.311 -1.108 0 N-CA-C 109.179 -0.674 . . . . 73.51 109.179 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -68.35 141.13 50.49 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.25 1.966 . . . . 62.32 111.458 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.601 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 26.9 m -66.79 -20.52 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 121.749 0.785 . . . . 64.33 111.927 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -90.59 3.68 53.42 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.137 -0.938 . . . . 63.33 111.13 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.0 t -83.77 164.23 19.69 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.291 -0.633 . . . . 73.05 109.291 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 41.3 t -98.18 112.71 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 N-CA-C 107.998 -1.112 . . . . 72.25 107.998 178.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 1.8 mp -91.74 135.64 26.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-O 120.938 0.399 . . . . 74.44 110.272 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -101.9 122.26 43.68 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-O 121.473 0.654 . . . . 74.5 110.777 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . 0.502 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 65.3 mt -97.8 116.16 29.47 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 106.562 -1.644 . . . . 70.03 106.562 176.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -91.83 121.98 33.94 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 108.489 -0.93 . . . . 72.44 108.489 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 60.3 t -111.12 133.74 55.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-N 115.82 -0.627 . . . . 73.24 112.149 -170.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.578 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 9.6 m -71.69 128.66 36.51 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 114.925 -1.034 . . . . 63.22 109.065 174.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 526' ' ' ASP . 0.8 OUTLIER -116.97 110.74 18.66 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 109.317 -0.623 . . . . 64.11 109.317 175.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -72.49 -33.38 61.17 Favored Glycine 0 CA--C 1.49 -1.526 0 CA-C-N 115.707 -0.678 . . . . 71.42 111.448 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 44.32 36.34 1.56 Allowed 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 126.345 1.858 . . . . 73.23 113.007 178.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 12.1 tp60 -140.05 146.22 38.71 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.488 -1.301 . . . . 65.51 107.488 -174.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -147.16 142.62 27.51 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.604 -0.887 . . . . 74.1 108.604 174.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 54.2 t -76.62 128.38 37.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-O 120.911 0.386 . . . . 75.42 111.76 -174.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 58.7 ttp -97.7 132.4 25.11 Favored Pre-proline 0 C--O 1.247 0.951 0 CA-C-N 115.99 -0.55 . . . . 75.34 110.198 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -66.57 169.67 13.87 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 123.051 2.501 . . . . 55.41 112.932 176.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -72.16 132.27 43.92 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 113.299 0.851 . . . . 70.33 113.299 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 96.5 mt -136.22 21.85 3.22 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.566 0.746 . . . . 72.53 109.003 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 10.3 m -75.4 130.29 38.74 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 116.147 -0.479 . . . . 35.14 112.224 -173.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 65.65 29.22 74.66 Favored Glycine 0 C--O 1.212 -1.247 0 CA-C-N 115.498 -0.774 . . . . 74.23 114.873 173.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 18.1 ptp -112.61 178.85 4.15 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 117.798 0.799 . . . . 74.25 109.136 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . 0.402 ' HB3' ' OD1' ' A' ' 601' ' ' ASN . 89.7 m-85 -84.87 154.27 22.38 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 120.302 -0.559 . . . . 71.51 109.67 178.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 28.0 t90 -68.47 -20.15 64.59 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.387 -0.597 . . . . 74.22 109.387 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 33.8 m -71.28 -13.31 16.87 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.355 0 CA-C-N 115.936 -0.575 . . . . 45.34 110.985 176.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -101.06 -44.13 5.81 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 109.417 -0.586 . . . . 70.42 109.417 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -59.57 -46.27 89.4 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.817 -1.083 . . . . 71.13 112.214 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.488 ' O ' ' HG3' ' A' ' 579' ' ' ARG . 55.8 tt0 -57.92 -59.87 11.81 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 113.323 0.861 . . . . 55.42 113.323 -178.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.54 -35.59 89.55 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 121.183 1.255 . . . . 61.0 112.406 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.42 ' HD3' ' HA ' ' A' ' 577' ' ' ARG . 7.8 mmt85 -65.0 -43.38 92.76 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.031 0.382 . . . . 74.54 112.031 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.404 HD12 ' N ' ' A' ' 579' ' ' ARG . 4.4 pp -67.58 -40.71 84.85 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 119.607 -0.837 . . . . 44.4 111.259 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 575' ' ' GLU . 20.1 mtp180 -65.14 -40.32 94.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.085 -0.507 . . . . 75.52 110.094 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -63.96 -35.73 81.64 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.982 -0.554 . . . . 74.43 112.468 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 4.2 pp -81.66 2.03 31.43 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.988 0.736 . . . . 62.42 112.988 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 82.97 39.67 9.99 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.484 -0.865 . . . . 72.1 112.227 176.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 89.6 t90 -79.57 133.91 36.46 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.939 -0.393 . . . . 71.01 109.939 176.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 61.5 m -147.86 90.85 1.87 Allowed 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.375 -0.602 . . . . 73.21 109.375 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -147.01 -131.52 2.19 Favored Glycine 0 N--CA 1.433 -1.549 0 N-CA-C 111.088 -0.805 . . . . 74.2 111.088 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . 0.461 ' HB2' HG12 ' A' ' 619' ' ' ILE . 59.7 mtt -119.67 125.65 49.22 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.763 -0.829 . . . . 73.1 108.763 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -105.17 130.94 53.22 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 107.799 -1.185 . . . . 73.11 107.799 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -100.71 101.89 12.87 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 120.601 -0.439 . . . . 70.52 110.698 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . 0.408 ' C ' ' HD3' ' A' ' 589' ' ' LYS . 11.8 tmtt? -113.02 111.7 22.61 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 107.252 -1.388 . . . . 74.21 107.252 174.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -93.97 -149.52 25.48 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.958 -0.639 . . . . 74.32 113.197 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -76.16 146.23 39.33 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 120.776 0.322 . . . . 34.23 111.083 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -84.97 125.32 32.59 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 106.405 -1.702 . . . . 75.22 106.405 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 57.5 t -128.73 116.58 41.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 N-CA-C 109.956 -0.387 . . . . 70.02 109.956 -171.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -77.59 108.11 10.54 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.24 -1.393 . . . . 54.13 107.24 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -121.42 -5.12 9.33 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.717 -0.674 . . . . 64.21 111.744 -176.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 119.69 -177.97 16.46 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 120.507 -0.854 . . . . 44.51 112.341 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -58.71 -37.01 88.89 Favored Glycine 0 C--N 1.319 -0.365 0 O-C-N 124.084 0.52 . . . . 64.42 114.381 -175.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 14.4 m -64.89 -24.29 67.49 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 117.264 0.532 . . . . 64.44 111.365 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -108.11 -0.56 21.03 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 113.096 0.776 . . . . 72.43 113.096 -173.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . 0.503 ' HA ' ' O ' ' A' ' 626' ' ' GLN . 14.9 p-80 -70.39 103.22 2.36 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 119.194 -1.002 . . . . 74.35 111.644 -174.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . 0.402 ' OD1' ' HB3' ' A' ' 570' ' ' PHE . 18.9 t-20 58.37 5.32 0.42 Allowed 'General case' 0 CA--C 1.569 1.7 0 C-N-CA 125.924 1.69 . . . . 74.13 113.59 178.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 624' ' ' PHE . 13.6 mmt180 -78.98 140.22 38.05 Favored 'General case' 0 C--N 1.317 -0.804 0 O-C-N 121.66 -0.65 . . . . 75.1 110.455 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 97.6 t -69.48 131.63 33.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 107.911 -1.144 . . . . 74.45 107.911 174.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 56.9 t -87.71 -46.05 16.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-O 121.263 0.554 . . . . 64.31 109.649 -175.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -156.24 152.4 27.71 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 107.684 -1.228 . . . . 72.33 107.684 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -116.68 112.39 21.16 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.356 -1.35 . . . . 70.42 107.356 171.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.475 ' HB2' ' HB ' ' A' ' 621' ' ' THR . 38.7 t30 -48.45 -52.13 45.86 Favored Pre-proline 0 CA--C 1.556 1.204 0 N-CA-C 113.622 0.971 . . . . 73.12 113.622 -177.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 5.4 Cg_exo -82.29 124.64 4.3 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.121 1.214 . . . . 64.25 109.562 172.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . 0.49 ' O ' HG22 ' A' ' 612' ' ' THR . 13.4 Cg_endo -65.0 135.84 45.77 Favored 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 122.045 1.83 . . . . 60.01 113.144 -177.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -65.75 130.69 44.18 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.248 -0.887 . . . . 75.21 110.025 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.09 -8.44 45.37 Favored Glycine 0 N--CA 1.433 -1.537 0 C-N-CA 120.132 -1.032 . . . . 61.22 113.066 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . 0.49 HG22 ' O ' ' A' ' 609' ' ' PRO . 10.1 t -113.75 175.93 5.25 Favored 'General case' 0 C--O 1.258 1.514 0 C-N-CA 118.919 -1.112 . . . . 74.32 109.541 177.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -79.77 128.3 8.44 Favored Glycine 0 N--CA 1.416 -2.684 0 CA-C-N 115.448 -0.796 . . . . 33.54 111.546 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 23.4 m -102.2 144.49 13.33 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 C-N-CA 124.031 0.932 . . . . 75.2 108.709 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.48 HD21 HG22 ' A' ' 619' ' ' ILE . 24.8 p-10 -50.01 152.59 1.59 Allowed 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 124.452 1.101 . . . . 71.0 111.857 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -26.25 13.59 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.123 0.969 . . . . 61.41 113.061 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.34 -38.53 74.88 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.662 -0.866 . . . . 74.11 108.662 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 82.33 22.12 59.33 Favored Glycine 0 N--CA 1.424 -2.159 0 C-N-CA 120.923 -0.656 . . . . 34.43 111.886 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . 0.48 HG22 HD21 ' A' ' 615' ' ' ASN . 0.0 OUTLIER -68.16 119.19 13.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-O 122.621 1.2 . . . . 73.35 110.459 -168.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 4.4 tp -115.67 119.17 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.876 0 CA-C-N 113.899 -1.5 . . . . 75.14 109.614 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.475 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 25.7 m -105.4 117.45 34.06 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 106.543 -1.651 . . . . 72.45 106.543 174.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . 0.413 HD23 ' H ' ' A' ' 622' ' ' LEU . 2.1 pt? -138.96 153.77 48.23 Favored 'General case' 0 CA--C 1.479 -1.758 0 N-CA-C 106.447 -1.686 . . . . 54.25 106.447 -177.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -136.45 153.67 50.99 Favored 'General case' 0 C--N 1.268 -2.974 0 N-CA-C 107.464 -1.31 . . . . 74.33 107.464 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.415 ' HA ' ' O ' ' A' ' 602' ' ' ARG . 51.1 p90 -140.62 163.01 34.01 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 105.383 -2.081 . . . . 74.21 105.383 172.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -82.46 -86.52 0.76 Allowed Glycine 0 N--CA 1.424 -2.155 0 C-N-CA 119.677 -1.249 . . . . 63.35 110.282 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . 0.503 ' O ' ' HA ' ' A' ' 600' ' ' HIS . 35.6 tt0 . . . . . 0 C--N 1.29 -1.991 0 CA-C-O 117.7 -1.143 . . . . 53.14 108.428 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 . . . . . 0 N--CA 1.435 -1.193 0 N-CA-C 103.728 -2.693 . . . . 40.33 103.728 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 35.7 m -116.08 151.3 17.88 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.664 0 C-N-CA 120.074 -0.65 . . . . 72.23 109.805 -172.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -95.05 136.04 35.85 Favored 'General case' 0 N--CA 1.411 -2.406 0 N-CA-C 106.579 -1.637 . . . . 53.45 106.579 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 89.8 t -111.07 118.19 48.47 Favored Pre-proline 0 C--N 1.275 -2.632 0 CA-C-O 121.141 0.496 . . . . 65.32 111.198 -173.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -81.38 123.54 4.43 Favored 'Trans proline' 0 N--CA 1.44 -1.674 0 C-N-CA 121.814 1.676 . . . . 74.21 109.717 172.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . 0.569 ' OD2' ' HB3' ' A' ' 366' ' ' ARG . 7.5 p-10 -101.43 137.91 39.13 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 122.237 1.017 . . . . 64.45 110.646 -176.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.536 ' HB ' ' NE2' ' A' ' 368' ' ' GLN . 27.7 m -82.93 36.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 114.381 -1.281 . . . . 71.43 112.471 -174.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.569 ' HB3' ' OD2' ' A' ' 364' ' ' ASP . 0.0 OUTLIER -56.04 146.72 21.85 Favored 'General case' 0 C--O 1.247 0.934 0 C-N-CA 124.452 1.101 . . . . 71.22 110.97 176.314 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.28 1.21 41.13 Favored Glycine 0 C--N 1.309 -0.944 0 N-CA-C 111.927 -0.469 . . . . 71.32 111.927 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . 0.536 ' NE2' ' HB ' ' A' ' 365' ' ' VAL . 36.1 mt-30 -110.87 -153.2 0.51 Allowed 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 108.076 -1.083 . . . . 74.41 108.076 176.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 54.9 p -93.32 168.68 10.92 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.215 -0.661 . . . . 42.43 109.215 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 20.6 p -63.28 -46.36 87.12 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 109.828 -0.434 . . . . 74.53 109.828 176.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -63.36 -46.43 86.6 Favored 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 112.851 0.686 . . . . 73.52 112.851 -177.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -67.03 -45.23 78.12 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 120.546 -0.462 . . . . 70.41 110.095 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -66.59 -46.62 75.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.868 -0.606 . . . . 64.55 111.514 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 67.7 mt -64.73 -37.91 81.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.616 -0.266 . . . . 73.43 110.806 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.88 -43.29 99.14 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 110.273 -0.269 . . . . 73.32 110.273 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 33.3 m -63.45 -48.33 78.15 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.866 -0.606 . . . . 73.43 110.313 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.45 -41.6 96.44 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 112.353 0.501 . . . . 74.23 112.353 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -67.01 -38.79 86.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.666 -0.243 . . . . 64.12 110.515 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -70.19 -21.01 63.09 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.027 0.442 . . . . 63.22 111.601 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . 0.466 ' NE ' ' HA ' ' A' ' 380' ' ' ARG . 3.3 mmp_? -81.06 -15.09 57.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.027 0.441 . . . . 61.13 109.919 174.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.26 5.58 54.33 Favored Glycine 0 C--N 1.306 -1.114 0 CA-C-N 115.789 -0.641 . . . . 61.55 112.548 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -85.42 148.65 25.9 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-O 121.117 0.484 . . . . 62.11 110.73 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -101.13 149.39 24.02 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 107.741 -1.207 . . . . 75.21 107.741 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . 0.415 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -134.62 157.19 41.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.891 0 C-N-CA 120.717 -0.393 . . . . 64.21 110.009 -178.549 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -132.46 126.86 34.01 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.165 -1.42 . . . . 63.02 107.165 173.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 28.8 m -109.12 126.53 53.31 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 108.367 -0.975 . . . . 74.3 108.367 -177.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 51.2 tp -111.46 120.09 41.0 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.57 -0.53 . . . . 75.02 109.57 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -89.83 122.09 32.57 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.148 -0.686 . . . . 64.31 109.148 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 421' ' ' SER . 56.9 mtpt -135.4 125.5 16.73 Favored Pre-proline 0 C--N 1.311 -1.069 0 N-CA-C 109.937 -0.394 . . . . 74.44 109.937 177.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -80.39 128.37 7.04 Favored 'Trans proline' 0 C--O 1.253 1.252 0 C-N-CA 121.39 1.393 . . . . 64.13 109.238 173.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 13.5 t70 174.99 158.46 0.18 Allowed 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.195 -1.409 . . . . 72.33 107.195 -174.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 13.5 m -100.72 -11.98 19.5 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 120.86 0.362 . . . . 54.22 111.697 -177.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 11.1 m -109.11 2.1 20.88 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 122.121 0.963 . . . . 70.41 110.343 -176.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 34.6 mm -88.86 140.52 29.37 Favored Pre-proline 0 C--N 1.306 -1.297 0 CA-C-N 115.769 -0.651 . . . . 65.52 109.33 178.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . 0.451 ' HA ' ' HD3' ' A' ' 396' ' ' PRO . 20.1 Cg_exo -39.97 129.92 2.11 Favored 'Trans proline' 0 C--N 1.365 1.401 0 C-N-CA 124.4 3.4 . . . . 62.32 113.719 176.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 395' ' ' PRO . 50.1 Cg_exo -57.8 161.24 13.07 Favored 'Trans proline' 0 N--CA 1.483 0.855 0 C-N-CA 123.535 2.824 . . . . 71.3 112.699 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . 0.589 ' HA ' HG13 ' A' ' 420' ' ' VAL . 2.5 p30 -59.78 -8.47 2.14 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 122.022 0.915 . . . . 62.21 112.853 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 43.8 m170 -102.42 123.71 46.68 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 105.188 -2.153 . . . . 72.2 105.188 173.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 32.4 m -68.08 119.54 13.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 112.98 0.733 . . . . 74.43 112.98 -165.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . 0.436 HD13 ' O ' ' A' ' 400' ' ' ILE . 0.0 OUTLIER -102.99 -28.12 3.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 106.767 -1.568 . . . . 72.4 106.767 175.361 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.52 166.3 27.76 Favored Glycine 0 N--CA 1.414 -2.793 0 N-CA-C 110.546 -1.022 . . . . 51.5 110.546 -177.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 40.5 p -146.8 -173.91 4.34 Favored 'General case' 0 C--N 1.286 -2.178 0 C-N-CA 126.078 1.751 . . . . 73.42 106.331 -174.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . 0.424 ' HA ' ' HD3' ' A' ' 404' ' ' PRO . 21.6 t70 -98.43 126.52 39.17 Favored Pre-proline 0 C--N 1.296 -1.756 0 N-CA-C 107.699 -1.223 . . . . 71.05 107.699 -177.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 403' ' ' ASP . 52.8 Cg_exo -56.31 -4.65 0.79 Allowed 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 124.864 3.709 . . . . 73.24 116.324 -174.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.67 -39.81 71.45 Favored 'General case' 0 C--O 1.204 -1.294 0 N-CA-C 109.767 -0.457 . . . . 70.12 109.767 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -63.53 -40.05 96.01 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-O 121.365 0.603 . . . . 72.31 110.77 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -80.61 -4.58 54.67 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.389 0.614 . . . . 71.0 110.456 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 27.8 m -98.23 160.61 14.18 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 105.423 -2.066 . . . . 55.13 105.423 173.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 13.4 m -76.52 112.6 13.22 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 118.829 -1.148 . . . . 75.54 108.871 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 23.0 m -128.33 170.05 18.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.077 0.465 . . . . 73.11 111.198 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 36.7 t -74.35 143.3 44.94 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 108.782 -0.822 . . . . 62.34 108.782 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -63.09 131.14 47.55 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.065 -0.516 . . . . 31.2 111.293 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 90.89 29.71 12.6 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.714 -0.676 . . . . 72.21 112.655 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -83.07 -175.7 5.97 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 109.52 -0.548 . . . . 72.31 109.52 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -110.72 117.47 33.54 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 123.358 0.663 . . . . 62.3 111.291 -174.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.0 mm -105.77 115.08 46.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.405 0.622 . . . . 51.43 110.358 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 40.6 p -87.05 130.8 34.33 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 123.655 0.782 . . . . 73.42 110.691 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 8.2 p -124.19 134.55 66.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 109.736 -0.468 . . . . 73.1 109.736 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . 0.411 ' H ' HD22 ' A' ' 419' ' ' ASN . 0.1 OUTLIER -104.66 122.81 46.43 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.851 -0.739 . . . . 65.3 110.357 176.715 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.589 HG13 ' HA ' ' A' ' 397' ' ' ASP . 34.7 t -111.75 131.87 61.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 114.705 -1.134 . . . . 72.4 110.588 -175.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 34.2 p -85.93 125.97 33.75 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 120.285 -0.566 . . . . 45.41 109.577 176.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.1 t -117.49 105.47 12.13 Favored 'General case' 0 N--CA 1.407 -2.621 0 C-N-CA 119.509 -0.876 . . . . 53.43 109.221 175.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.303 0 CA-C-N 115.494 -0.776 . . . . 53.21 113.318 179.469 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.504 ' OE1' ' HB ' ' A' ' 477' ' ' THR . 34.0 tt0 . . . . . 0 N--CA 1.42 -1.933 0 N-CA-C 107.387 -1.338 . . . . 73.01 107.387 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.618 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 1.6 mmp_? -122.32 139.87 53.31 Favored 'General case' 0 CA--C 1.479 -1.769 0 N-CA-C 112.795 0.665 . . . . 74.04 112.795 -174.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 42.2 tt0 -85.26 132.99 34.18 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.627 -1.17 . . . . 65.15 108.256 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 57.8 mt -80.92 124.43 81.47 Favored Pre-proline 0 C--N 1.307 -1.259 0 N-CA-C 109.812 -0.44 . . . . 72.14 109.812 -178.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -70.77 147.0 55.43 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.332 2.021 . . . . 72.15 110.397 175.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -81.21 102.19 10.17 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.494 0.664 . . . . 73.24 110.243 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 61.0 t -96.93 140.42 17.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 106.882 -1.525 . . . . 72.41 106.882 177.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 2.4 p -63.97 146.96 53.16 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 112.619 0.6 . . . . 71.01 112.619 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 25.7 p -60.63 -32.71 71.86 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 124.811 1.245 . . . . 72.41 113.774 -173.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.9 pp -81.04 -10.74 59.65 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.48 0.657 . . . . 74.24 111.588 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.3 m -106.61 40.95 1.52 Allowed 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.627 -0.879 . . . . 65.1 108.627 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -51.69 -37.98 53.07 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.943 1.297 . . . . 75.31 112.401 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -59.82 -38.85 83.18 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.046 0.45 . . . . 51.21 111.26 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.483 ' CD ' ' HE3' ' A' ' 442' ' ' LYS . 16.2 tp10 -70.4 -37.15 74.44 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.881 -0.785 . . . . 70.01 108.881 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.582 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -60.7 -51.24 70.19 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.518 -0.764 . . . . 75.1 111.162 -178.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 27.5 m -63.97 -40.55 89.48 Favored 'Isoleucine or valine' 0 C--O 1.249 1.029 0 N-CA-C 112.627 0.603 . . . . 73.31 112.627 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.483 ' HE3' ' CD ' ' A' ' 439' ' ' GLU . 41.9 pttt -68.61 -35.1 76.88 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 119.134 -1.026 . . . . 74.41 112.104 177.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -65.09 -38.31 90.33 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.347 -0.388 . . . . 75.33 110.882 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 94.3 mt -63.2 -38.59 91.78 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.332 -0.618 . . . . 74.31 109.332 177.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.446 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 86.4 m -66.14 -45.23 81.75 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.718 -0.674 . . . . 75.44 111.129 178.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.62 -15.87 63.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.038 0.447 . . . . 64.3 111.632 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -88.62 4.0 48.58 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.997 0.427 . . . . 51.44 111.396 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 112.47 -73.35 0.22 Allowed Glycine 0 CA--C 1.496 -1.152 0 C-N-CA 120.351 -0.928 . . . . 72.53 111.829 175.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . 0.56 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 0.4 OUTLIER -45.57 -68.27 0.21 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 114.021 1.119 . . . . 75.43 114.021 177.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . 0.446 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 60.36 27.33 65.41 Favored Glycine 0 C--N 1.315 -0.605 0 N-CA-C 111.38 -0.688 . . . . 62.44 111.38 -173.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.523 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 32.3 mmt180 -100.16 110.4 22.67 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 106.424 -1.695 . . . . 73.13 106.424 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.405 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 17.3 p90 -143.6 147.0 33.73 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 109.592 -0.521 . . . . 73.35 109.592 -177.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -137.75 123.1 19.46 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 108.43 -0.952 . . . . 65.3 108.43 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -87.38 124.71 33.68 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 123.598 0.561 . . . . 73.33 109.933 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -121.61 142.26 50.29 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 107.343 -1.354 . . . . 74.32 107.343 176.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -125.14 143.06 51.12 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 119.536 -0.865 . . . . 64.41 109.955 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 48.9 m -141.55 139.28 18.44 Favored Pre-proline 0 C--N 1.285 -2.197 0 N-CA-C 107.911 -1.144 . . . . 73.4 107.911 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.715 ' HA ' ' O ' ' A' ' 490' ' ' SER . 34.1 Cg_endo -65.44 122.56 10.28 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 121.746 1.631 . . . . 75.52 111.116 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 47.2 m -135.46 179.64 6.21 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.794 -1.094 . . . . 74.5 109.692 -174.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.9 t -49.3 133.71 17.07 Favored Pre-proline 0 C--O 1.251 1.179 0 O-C-N 124.103 0.877 . . . . 72.41 112.392 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.92 -29.62 35.95 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 124.566 3.51 . . . . 53.22 113.913 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -74.79 -23.8 58.56 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.652 0.612 . . . . 64.22 112.652 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -100.23 -6.05 26.64 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.975 0.416 . . . . 62.32 111.488 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 86.6 t -60.58 128.6 21.98 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 CA-C-N 116.192 -0.458 . . . . 62.33 109.841 176.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 97.07 -3.14 61.93 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.969 -0.634 . . . . 54.03 112.148 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -122.53 165.85 15.75 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 108.322 -0.992 . . . . 74.3 108.322 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 70.9 t -73.97 146.54 10.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.792 -1.188 . . . . 75.44 107.792 173.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 45.5 mt -98.08 -35.64 5.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 107.747 -1.205 . . . . 73.24 107.747 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 161.86 -162.24 33.93 Favored Glycine 0 N--CA 1.417 -2.631 0 N-CA-C 109.851 -1.3 . . . . 63.3 109.851 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . 0.433 HG22 HD13 ' A' ' 486' ' ' ILE . 28.5 p -130.52 153.86 48.4 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 109.869 -0.419 . . . . 70.02 109.869 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -75.03 -56.31 2.06 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 109.017 -0.734 . . . . 72.2 109.017 172.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.28 163.9 35.37 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 121.405 1.403 . . . . 51.3 108.927 172.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -71.88 126.98 12.44 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.168 1.245 . . . . 54.13 112.241 -177.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -99.93 2.04 43.27 Favored 'General case' 0 C--O 1.212 -0.893 0 CA-C-O 121.532 0.682 . . . . 62.41 110.55 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -110.7 5.49 20.93 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 120.202 -0.599 . . . . 73.34 110.48 175.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -122.92 -177.57 3.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.896 0.379 . . . . 74.01 110.507 -175.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 1.0 OUTLIER -71.37 132.12 44.39 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 124.987 1.315 . . . . 70.51 113.471 179.296 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 69.6 m -130.55 144.28 51.31 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 115.517 -0.765 . . . . 73.35 109.578 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -79.34 161.53 26.17 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.342 -0.845 . . . . 74.42 110.893 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . 0.56 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 1.8 mp -70.08 -25.23 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.834 0.826 . . . . 74.55 111.265 -177.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 17.2 m -93.28 -9.28 39.55 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.543 0.687 . . . . 72.3 110.401 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -85.76 129.33 34.86 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.44 -0.8 . . . . 75.01 110.49 -175.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.523 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 10.7 p -97.52 126.81 50.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.176 0.512 . . . . 71.41 111.742 -178.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 35.9 m -100.2 127.31 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-O 121.711 0.767 . . . . 63.32 110.915 177.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.57 124.55 45.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.667 -0.697 . . . . 73.25 109.544 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.433 HD13 HG22 ' A' ' 470' ' ' THR . 34.3 mm -107.5 116.7 51.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.482 -1.303 . . . . 62.21 107.482 -177.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 11.7 tt -100.19 125.97 53.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 121.556 0.694 . . . . 50.35 110.025 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 33.6 m -110.3 151.13 12.59 Favored 'Isoleucine or valine' 0 C--O 1.258 1.536 0 CA-C-N 115.375 -0.829 . . . . 73.45 111.097 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -80.9 128.64 8.56 Favored Glycine 0 N--CA 1.419 -2.45 0 CA-C-N 115.307 -0.861 . . . . 64.14 111.158 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.715 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 31.3 t . . . . . 0 C--N 1.291 -1.939 0 N-CA-C 104.113 -2.551 . . . . 65.14 104.113 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo . . . . . 0 N--CA 1.416 -3.06 0 N-CA-C 109.265 -1.091 . . . . 70.31 109.265 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . -88.99 65.45 7.52 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.442 -0.947 . . . . 65.41 108.442 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 2.6 p -117.44 143.31 46.15 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 114.464 -1.244 . . . . 73.43 111.579 -175.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -135.95 151.23 49.73 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.499 -0.926 . . . . 72.54 108.499 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.5 p-10 -85.41 130.49 34.58 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.469 -0.938 . . . . 75.13 108.469 176.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 543' ' ' THR . 28.8 pt -92.11 121.91 65.9 Favored Pre-proline 0 C--N 1.29 -2.01 0 CA-C-N 116.109 -0.496 . . . . 60.02 111.038 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -85.73 -164.08 0.21 Allowed 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.552 2.168 . . . . 74.33 110.24 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -94.35 145.93 24.41 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 118.722 -1.191 . . . . 63.11 108.449 177.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 10.2 p -137.58 16.84 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 122.826 1.298 . . . . 72.5 107.505 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . 0.526 ' HB2' ' HA2' ' A' ' 536' ' ' GLY . . . -87.75 145.65 26.03 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 113.706 -1.588 . . . . 61.12 110.363 -174.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 107.02 -10.33 40.29 Favored Glycine 0 C--N 1.293 -1.845 0 N-CA-C 108.922 -1.671 . . . . 52.52 108.922 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -103.84 175.42 5.49 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 114.351 -0.925 . . . . 74.23 108.836 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 20.7 p -85.75 163.97 17.88 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-O 120.584 0.231 . . . . 63.5 111.069 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.1 p -54.96 -41.44 58.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.73 -0.668 . . . . 75.23 112.331 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -66.27 -41.7 89.52 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 120.521 -0.471 . . . . 72.2 110.864 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 90.5 t -67.89 -41.27 84.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.223 -0.444 . . . . 72.02 110.184 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.3 -46.64 85.77 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.31 -0.404 . . . . 53.14 110.629 178.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -59.56 -43.32 93.6 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.313 0.645 . . . . 73.03 109.761 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.432 ' O ' HG23 ' A' ' 514' ' ' VAL . 17.9 ttmm -59.51 -46.98 87.27 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.804 -1.089 . . . . 73.23 109.776 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -62.48 -46.02 90.37 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.257 -0.429 . . . . 74.51 111.032 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 10.3 mp -60.15 -43.48 95.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.396 -0.365 . . . . 72.41 111.297 178.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.71 -39.84 92.92 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.336 0.397 . . . . 71.21 110.91 178.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 510' ' ' LYS . 70.3 t -64.86 -32.41 58.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 116.019 -0.537 . . . . 73.41 111.053 177.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -85.74 2.51 45.21 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.346 -0.542 . . . . 73.24 111.785 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 98.86 -18.07 57.35 Favored Glycine 0 C--O 1.243 0.696 0 C-N-CA 120.847 -0.692 . . . . 73.24 112.797 176.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.486 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 83.4 m-85 -68.7 98.89 0.94 Allowed 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.955 0.883 . . . . 65.31 109.706 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.54 9.99 29.37 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.797 -1.092 . . . . 74.1 112.674 -174.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . 0.443 ' HD2' ' O ' ' A' ' 548' ' ' ASP . 63.6 mttp -122.72 113.46 19.24 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.536 -0.913 . . . . 65.01 108.536 173.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -132.2 156.57 46.22 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.581 -0.736 . . . . 74.54 111.653 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 52.6 m -135.64 136.53 41.06 Favored 'General case' 0 C--N 1.276 -2.605 0 N-CA-C 106.987 -1.486 . . . . 70.51 106.987 173.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -117.08 124.27 48.83 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.418 0.628 . . . . 65.25 109.913 -177.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -110.81 125.54 53.68 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 115.682 -0.69 . . . . 53.42 109.189 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 2.9 p -92.01 120.73 32.92 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 109.085 -0.709 . . . . 64.33 109.085 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . 0.508 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 26.9 m -121.24 152.22 24.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 116.548 -0.296 . . . . 73.03 110.465 -175.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -66.94 135.23 53.48 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 108.796 -0.816 . . . . 65.02 108.796 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 66.3 m -152.98 166.54 15.23 Favored Pre-proline 0 C--N 1.307 -1.278 0 C-N-CA 120.912 -0.315 . . . . 75.54 111.24 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -91.13 -7.16 3.73 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.099 1.866 . . . . 71.01 109.859 168.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.419 ' HA ' ' HD3' ' A' ' 530' ' ' PRO . 29.0 mmm180 -81.98 136.43 47.36 Favored Pre-proline 0 N--CA 1.42 -1.932 0 C-N-CA 124.924 1.29 . . . . 74.53 108.143 177.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 529' ' ' ARG . 33.8 Cg_exo -59.23 149.38 80.99 Favored 'Trans proline' 0 C--O 1.259 1.563 0 C-N-CA 122.61 2.207 . . . . 74.51 113.74 -177.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.641 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -61.61 126.16 26.35 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 114.114 -1.403 . . . . 42.32 111.59 -176.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 120.94 -24.23 7.52 Favored Glycine 0 C--N 1.305 -1.161 0 CA-C-N 115.646 -0.706 . . . . 61.13 111.973 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -82.67 125.79 31.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.801 0.334 . . . . 63.44 110.282 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 85.9 t -75.39 113.27 14.01 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 107.921 -1.14 . . . . 63.4 107.921 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . 0.621 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 12.6 t -78.35 -18.84 54.58 Favored 'General case' 0 C--N 1.314 -0.941 0 O-C-N 123.593 0.558 . . . . 72.43 110.998 -176.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.526 ' HA2' ' HB2' ' A' ' 501' ' ' ALA . . . 160.08 -174.27 36.83 Favored Glycine 0 N--CA 1.422 -2.25 0 C-N-CA 120.499 -0.858 . . . . 64.15 111.213 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 19.4 p -117.42 157.47 26.15 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 108.607 -0.886 . . . . 52.44 108.607 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.452 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 19.4 t30 -71.17 -52.3 9.39 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 109.987 -0.375 . . . . 55.11 109.987 176.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.457 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 38.1 Cg_exo -66.13 131.92 28.34 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 120.914 1.076 . . . . 75.24 109.563 171.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 23.6 Cg_exo -66.23 147.94 84.17 Favored 'Trans proline' 0 C--O 1.243 0.767 0 C-N-CA 122.84 2.36 . . . . 73.1 113.24 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.21 134.42 55.9 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.672 -0.695 . . . . 64.13 109.583 176.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.47 -20.51 32.24 Favored Glycine 0 C--N 1.301 -1.395 0 N-CA-C 111.191 -0.764 . . . . 41.53 111.191 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.428 ' O ' HG12 ' A' ' 497' ' ' ILE . 44.9 m -67.43 134.8 52.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.98 0.419 . . . . 75.32 110.655 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 30.6 m -96.4 122.59 39.45 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 108.924 -0.769 . . . . 71.02 108.924 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 22.1 m -136.45 155.21 77.18 Favored Pre-proline 0 C--N 1.312 -1.022 0 CA-C-N 116.158 -0.474 . . . . 62.33 109.963 -177.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 37.5 Cg_exo -62.72 148.11 93.83 Favored 'Trans proline' 0 C--O 1.221 -0.363 0 C-N-CA 122.411 2.074 . . . . 64.35 111.929 176.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.486 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 35.5 m -65.81 -19.92 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-O 121.864 0.84 . . . . 43.24 111.005 177.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . 0.443 ' O ' ' HD2' ' A' ' 519' ' ' LYS . 37.6 t70 -92.79 3.43 55.67 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.581 -1.19 . . . . 72.41 110.058 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 30.2 t -84.06 159.48 21.15 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.562 -0.903 . . . . 62.12 108.562 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 18.1 t -96.38 122.55 48.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 109.01 -0.737 . . . . 71.21 109.01 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 61.5 mt -100.56 131.72 47.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 109.585 -0.524 . . . . 75.12 109.585 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 521' ' ' SER . 35.6 tt0 -102.46 115.81 31.33 Favored 'General case' 0 N--CA 1.418 -2.03 0 N-CA-C 109.395 -0.595 . . . . 54.44 109.395 178.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . 0.503 HD13 ' H ' ' A' ' 553' ' ' LEU . 0.0 OUTLIER -105.01 134.04 48.78 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.023 -0.99 . . . . 70.11 110.238 175.884 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -102.81 119.72 39.34 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.471 0.653 . . . . 55.12 110.639 -175.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 41.7 t -100.06 138.94 22.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-N 115.138 -0.937 . . . . 42.32 108.627 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.641 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 5.0 m -85.52 141.5 29.84 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.929 -0.578 . . . . 70.22 110.41 -178.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 525' ' ' VAL . 23.0 ptmt -110.28 147.55 33.64 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 105.485 -2.042 . . . . 74.14 105.485 167.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -79.29 -23.7 62.64 Favored Glycine 0 C--N 1.3 -1.472 0 C-N-CA 119.881 -1.152 . . . . 61.01 112.126 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 17.2 m120 59.34 37.65 23.32 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.09 -0.707 . . . . 73.05 109.09 -174.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -112.16 141.91 45.27 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.806 -0.633 . . . . 54.43 110.286 -172.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -123.77 146.76 48.08 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.708 -0.849 . . . . 71.32 108.708 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 56.9 t -72.55 117.52 16.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 121.086 0.47 . . . . 64.33 110.024 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 55.9 ttp -97.23 126.15 43.04 Favored Pre-proline 0 C--N 1.309 -1.18 0 CA-C-N 115.473 -0.785 . . . . 72.41 110.352 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -61.27 170.53 5.05 Favored 'Trans proline' 0 CA--C 1.548 1.22 0 C-N-CA 123.143 2.562 . . . . 63.12 111.804 171.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -60.69 143.6 53.87 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 123.663 0.785 . . . . 73.51 111.466 -178.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -123.94 -42.53 2.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.051 0.453 . . . . 73.21 110.315 -176.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 22.7 t -76.37 144.73 39.9 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.473 -0.936 . . . . 61.44 108.473 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 110.7 -7.1 29.76 Favored Glycine 0 C--N 1.31 -0.915 0 N-CA-C 110.636 -0.986 . . . . 70.51 110.636 -176.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 14.8 mtm -114.69 156.39 24.87 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 122.886 0.475 . . . . 74.23 110.739 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -87.38 143.55 27.19 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 106.196 -1.779 . . . . 71.54 106.196 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 33.3 t90 -51.24 -31.73 21.84 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 113.195 0.813 . . . . 72.44 113.195 -175.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 29.7 m -78.27 -19.38 13.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-O 121.398 0.618 . . . . 70.43 110.909 -176.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -100.99 -35.54 9.34 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.991 0.9 . . . . 73.2 108.86 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -67.98 -40.19 83.15 Favored 'General case' 0 C--O 1.205 -1.257 0 CA-C-N 114.264 -1.335 . . . . 71.14 111.623 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.503 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 36.0 tt0 -54.08 -57.57 17.47 Favored Pre-proline 0 CA--C 1.563 1.48 0 N-CA-C 112.595 0.591 . . . . 71.15 112.595 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 44.8 Cg_exo -59.79 -39.66 70.69 Favored 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 121.514 1.476 . . . . 65.11 111.619 177.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -39.1 90.95 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-O 120.955 0.407 . . . . 65.15 109.921 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.535 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 58.3 tp -66.82 -48.15 69.84 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 123.482 0.713 . . . . 65.53 110.914 -178.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -66.34 -35.09 79.46 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.033 -0.667 . . . . 61.5 111.11 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -65.68 -29.58 70.15 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.962 -0.563 . . . . 73.24 111.735 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 578' ' ' LEU . 4.3 pp -81.62 1.39 34.15 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.066 0.46 . . . . 72.3 111.588 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 92.67 22.91 27.35 Favored Glycine 0 CA--C 1.496 -1.144 0 C-N-CA 120.809 -0.71 . . . . 33.13 113.509 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 84.0 t90 -80.92 136.94 36.12 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 120.352 -0.539 . . . . 64.12 111.128 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 10.8 m -154.24 101.68 2.4 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 106.933 -1.506 . . . . 63.35 106.933 172.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -158.24 -149.65 5.53 Favored Glycine 0 CA--C 1.491 -1.453 0 N-CA-C 109.714 -1.354 . . . . 55.44 109.714 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 58.5 ttp -94.75 127.13 40.53 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 117.68 0.74 . . . . 70.42 110.203 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -102.3 130.01 48.89 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.534 -1.654 . . . . 73.02 106.534 176.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -95.87 105.23 17.22 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.276 0.56 . . . . 73.24 110.517 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -94.42 126.52 39.75 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 106.709 -1.589 . . . . 61.1 106.709 177.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . 0.509 ' HA3' ' NH1' ' A' ' 623' ' ' ARG . . . -120.8 -116.32 2.48 Favored Glycine 0 N--CA 1.423 -2.184 0 C-N-CA 120.596 -0.812 . . . . 64.2 112.257 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -137.13 144.72 43.15 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.682 -0.488 . . . . 61.13 109.682 -177.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -80.47 140.46 35.92 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.114 -1.069 . . . . 73.42 108.114 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 57.3 t -137.2 120.74 21.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 109.517 -0.549 . . . . 72.11 109.517 -172.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.28 106.96 5.33 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.54 -1.281 . . . . 73.33 107.54 173.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -138.64 8.25 2.59 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.899 0.703 . . . . 72.04 112.899 -174.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 117.96 139.83 6.34 Favored Glycine 0 C--N 1.299 -1.503 0 C-N-CA 120.088 -1.053 . . . . 43.43 110.92 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -55.39 -33.73 58.84 Favored Glycine 0 C--O 1.223 -0.558 0 N-CA-C 114.845 0.698 . . . . 71.44 114.845 -173.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 18.5 m -65.63 -24.59 67.08 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 117.503 0.651 . . . . 74.5 111.727 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -98.58 -12.46 21.14 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.212 0.53 . . . . 64.44 109.759 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 67.1 m170 -76.67 137.27 39.31 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.981 -0.554 . . . . 75.54 111.183 -176.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 9.5 p30 46.34 12.8 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 126.929 2.092 . . . . 70.23 115.964 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -126.61 146.72 50.05 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.598 -0.89 . . . . 63.44 108.598 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.31 131.33 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.268 0.627 . . . . 73.01 111.392 -177.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 60.2 t -90.49 -38.85 11.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 120.992 0.425 . . . . 63.34 111.159 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -151.83 162.4 41.11 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.992 -0.373 . . . . 75.34 109.992 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -131.85 127.62 36.94 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 123.845 0.715 . . . . 75.42 109.669 -176.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.572 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 50.7 t-20 -71.86 -62.11 1.75 Allowed Pre-proline 0 CA--C 1.562 1.422 0 N-CA-C 112.744 0.646 . . . . 73.45 112.744 -178.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 3.3 Cg_endo -87.41 134.14 3.38 Favored 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 121.38 1.387 . . . . 71.01 110.7 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.49 137.39 59.62 Favored 'Trans proline' 0 C--O 1.252 1.213 0 C-N-CA 122.853 2.369 . . . . 40.44 114.042 -177.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.9 131.12 44.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.984 -1.007 . . . . 65.43 110.319 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 89.58 0.19 79.46 Favored Glycine 0 C--N 1.312 -0.779 0 C-N-CA 120.694 -0.765 . . . . 64.33 112.271 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 22.5 m -101.31 157.92 16.43 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.919 -0.771 . . . . 71.24 108.919 178.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -73.1 113.83 4.49 Favored Glycine 0 N--CA 1.429 -1.816 0 N-CA-C 108.767 -1.733 . . . . 55.24 108.767 174.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 24.4 m -96.01 141.94 14.57 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-O 121.24 0.543 . . . . 75.24 112.03 -176.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.412 HD22 ' CG ' ' A' ' 617' ' ' ASP . 1.3 p-10 -47.64 140.63 6.01 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 126.322 1.849 . . . . 74.02 111.518 175.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -54.06 -25.93 24.17 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 114.326 1.232 . . . . 62.21 114.326 -175.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . 0.412 ' CG ' HD22 ' A' ' 615' ' ' ASN . 9.3 p-10 -75.37 -25.49 57.74 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.165 -0.679 . . . . 72.14 109.165 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 67.79 21.36 73.06 Favored Glycine 0 N--CA 1.428 -1.897 0 CA-C-O 119.296 -0.725 . . . . 71.34 113.744 172.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.87 118.31 11.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-O 123.312 1.53 . . . . 71.14 111.138 -168.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 3.2 tp -112.12 119.13 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.958 0 CA-C-N 112.96 -1.927 . . . . 75.11 108.649 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 7.0 m -98.6 117.49 33.18 Favored 'General case' 0 N--CA 1.406 -2.665 0 N-CA-C 105.958 -1.867 . . . . 60.4 105.958 175.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -139.28 160.7 39.2 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.23 -1.396 . . . . 75.12 107.23 -178.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . 0.509 ' NH1' ' HA3' ' A' ' 590' ' ' GLY . 13.0 tpt180 -151.16 150.96 31.26 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 105.755 -1.943 . . . . 73.44 105.755 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -138.84 160.98 38.38 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 106.0 -1.852 . . . . 65.14 106.0 173.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -78.2 -96.02 0.24 Allowed Glycine 0 N--CA 1.421 -2.331 0 N-CA-C 110.987 -0.845 . . . . 54.14 110.987 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 . . . . . 0 C--N 1.283 -2.295 0 N-CA-C 108.159 -1.052 . . . . 75.12 108.159 179.277 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 CA--C 1.509 -0.61 0 N-CA-C 108.484 -0.932 . . . . 70.11 108.484 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 409' ' ' SER . 35.8 m -117.45 163.92 14.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 109.393 -0.595 . . . . 73.1 109.393 -174.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -93.19 138.0 32.0 Favored 'General case' 0 N--CA 1.421 -1.875 0 N-CA-C 106.378 -1.712 . . . . 72.44 106.378 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 60.5 t -95.24 120.04 64.66 Favored Pre-proline 0 C--N 1.28 -2.425 0 CA-C-N 115.744 -0.662 . . . . 61.14 110.005 -167.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -65.7 122.82 10.54 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.54 2.16 . . . . 61.13 112.225 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -108.59 153.72 22.98 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 114.523 -1.217 . . . . 62.43 108.894 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.523 ' HB ' HE21 ' A' ' 368' ' ' GLN . 15.9 m -134.84 28.52 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 115.361 -0.836 . . . . 64.44 109.852 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.47 148.0 24.84 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 115.221 -0.899 . . . . 73.54 112.304 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . 0.425 ' H ' HG23 ' A' ' 399' ' ' VAL . . . 105.95 -5.25 39.39 Favored Glycine 0 C--N 1.321 -0.285 0 CA-C-N 116.332 -0.395 . . . . 75.14 112.251 -176.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . 0.523 HE21 ' HB ' ' A' ' 365' ' ' VAL . 40.6 mt-30 -106.48 -85.08 0.51 Allowed 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 120.868 0.365 . . . . 65.2 110.831 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 41.9 p -153.46 157.82 40.45 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 108.449 -0.945 . . . . 64.2 108.449 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 49.0 m -63.95 -35.67 81.44 Favored 'General case' 0 C--O 1.203 -1.359 0 N-CA-C 109.692 -0.484 . . . . 72.22 109.692 175.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.81 -46.77 88.09 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 116.348 -0.387 . . . . 73.0 111.973 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -68.1 -38.78 82.7 Favored 'General case' 0 C--O 1.245 0.828 0 C-N-CA 120.289 -0.564 . . . . 54.41 110.163 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . 0.451 ' HA ' ' CG2' ' A' ' 365' ' ' VAL . . . -66.59 -51.09 60.23 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.66 -0.7 . . . . 51.31 111.092 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . 0.434 HG23 HG12 ' A' ' 384' ' ' ILE . 60.1 mt -60.08 -43.52 92.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 123.167 0.587 . . . . 60.33 110.517 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -60.47 -47.22 87.07 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.101 0.477 . . . . 45.32 110.59 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . 0.526 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 58.9 m -66.61 -47.79 71.57 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.811 -0.631 . . . . 72.15 111.402 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 9.8 mp -64.24 -37.69 88.39 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 112.001 0.371 . . . . 75.03 112.001 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -64.02 -41.5 97.43 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 109.518 -0.549 . . . . 55.32 109.518 176.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -67.31 -22.38 65.63 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 116.24 -0.436 . . . . 64.34 111.452 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 376' ' ' THR . 13.7 mmm180 -80.94 -14.54 57.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.983 0.421 . . . . 73.52 109.963 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 96.8 14.9 41.56 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.904 -0.665 . . . . 13.42 112.244 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.504 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 55.1 m-85 -93.22 167.72 11.57 Favored 'General case' 0 N--CA 1.427 -1.621 0 O-C-N 122.488 -0.419 . . . . 70.32 110.969 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -105.51 143.83 33.13 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 106.528 -1.656 . . . . 73.44 106.528 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . 0.434 HG12 HG23 ' A' ' 374' ' ' ILE . 1.2 pp -125.6 131.94 71.48 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 CA-C-O 121.593 0.711 . . . . 74.51 111.939 -177.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -111.04 129.34 55.94 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 114.707 -1.133 . . . . 71.51 108.035 -176.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 10.5 m -121.66 123.98 43.19 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 110.101 -0.333 . . . . 62.44 110.101 -176.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -111.57 122.82 48.83 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.536 -0.542 . . . . 64.22 109.536 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.93 126.97 50.31 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.962 0.41 . . . . 73.4 110.536 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -135.14 136.27 24.42 Favored Pre-proline 0 C--N 1.297 -1.696 0 CA-C-N 115.994 -0.548 . . . . 64.41 110.394 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.07 147.24 93.85 Favored 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 123.055 2.503 . . . . 73.24 111.846 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 6.4 t70 86.41 178.59 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.515 1.926 . . . . 72.02 108.949 -178.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 25.7 m -132.41 14.66 4.55 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 121.692 0.758 . . . . 72.4 110.366 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 10.1 t -69.08 -28.05 66.17 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 107.889 -1.152 . . . . 73.31 107.889 172.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.67 HD13 ' H ' ' A' ' 394' ' ' ILE . 0.2 OUTLIER -88.55 151.73 48.5 Favored Pre-proline 0 N--CA 1.433 -1.308 0 N-CA-C 107.59 -1.263 . . . . 74.21 107.59 174.003 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -28.97 116.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.306 0 C-N-CA 125.148 3.899 . . . . 71.23 115.034 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . 0.602 ' HA ' ' OG ' ' A' ' 421' ' ' SER . 48.5 Cg_exo -58.55 161.03 15.45 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 123.805 3.003 . . . . 61.44 113.626 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -57.63 -9.24 1.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.13 0.972 . . . . 63.31 113.077 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 32.6 m170 -107.37 119.86 40.55 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 104.504 -2.406 . . . . 64.52 104.504 171.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.425 HG23 ' H ' ' A' ' 367' ' ' GLY . 11.0 m -62.84 118.24 4.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.196 0 O-C-N 123.681 0.613 . . . . 51.23 111.574 -168.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.38 -34.96 8.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 108.029 -1.1 . . . . 65.35 108.029 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -152.73 157.92 27.58 Favored Glycine 0 N--CA 1.409 -3.153 0 N-CA-C 109.369 -1.492 . . . . 71.3 109.369 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.2 p -117.89 -178.82 3.58 Favored 'General case' 0 C--N 1.277 -2.58 0 N-CA-C 108.435 -0.95 . . . . 72.3 108.435 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -100.74 146.28 31.81 Favored Pre-proline 0 C--N 1.295 -1.795 0 C-N-CA 119.306 -0.958 . . . . 63.03 111.006 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.12 -16.36 1.78 Allowed 'Trans proline' 0 C--N 1.364 1.347 0 C-N-CA 125.221 3.947 . . . . 60.32 114.868 -176.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.43 -33.86 63.93 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.365 0.666 . . . . 72.03 111.042 176.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -82.34 -30.69 30.27 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.434 0.635 . . . . 71.35 111.135 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -86.56 -1.84 57.98 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.335 0.588 . . . . 64.33 110.573 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 47.2 m -107.54 148.38 29.32 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.094 -1.447 . . . . 75.44 107.094 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 360' ' ' VAL . 65.3 m -74.5 113.34 11.64 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 120.055 -0.658 . . . . 25.4 110.319 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 33.4 m -129.31 169.49 20.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.774 -0.648 . . . . 63.52 109.467 177.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 22.6 t -79.84 156.39 27.39 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.094 -0.706 . . . . 60.55 109.094 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . 0.504 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -70.87 143.13 51.13 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 116.101 -0.499 . . . . 21.43 110.703 -178.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 103.02 10.6 36.54 Favored Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 120.398 -0.906 . . . . 44.52 112.98 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -80.53 174.51 11.54 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.244 -1.021 . . . . 72.22 108.244 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -110.01 114.69 28.42 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.945 -0.761 . . . . 74.31 108.945 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 46.6 mm -97.7 127.37 50.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 109.179 -0.674 . . . . 61.34 109.179 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 1.7 p -86.66 130.67 34.39 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 114.028 1.121 . . . . 73.45 114.028 -176.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 2.1 t -123.34 134.89 64.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 C-N-CA 125.126 1.37 . . . . 75.43 110.007 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -106.49 129.12 54.5 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 115.457 -0.792 . . . . 53.04 109.871 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 5.3 p -118.76 131.22 72.17 Favored 'Isoleucine or valine' 0 C--O 1.256 1.408 0 N-CA-C 109.707 -0.479 . . . . 64.15 109.707 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . 0.602 ' OG ' ' HA ' ' A' ' 396' ' ' PRO . 54.6 p -84.75 125.54 32.64 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 115.904 -0.589 . . . . 75.14 110.43 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.8 m -97.82 156.9 16.37 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 107.132 -1.433 . . . . 62.14 107.132 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.411 0 N-CA-C 114.815 0.686 . . . . 64.11 114.815 -177.101 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 . . . . . 0 N--CA 1.436 -1.134 0 N-CA-C 108.284 -1.006 . . . . 74.14 108.284 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.551 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 1.5 mmp_? -123.56 159.57 28.9 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 112.698 0.629 . . . . 62.34 112.698 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -82.66 141.18 32.68 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.534 -1.212 . . . . 72.44 108.169 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.443 HD12 ' O ' ' A' ' 473' ' ' PRO . 63.9 mt -77.84 125.98 84.77 Favored Pre-proline 0 N--CA 1.43 -1.449 0 N-CA-C 107.685 -1.228 . . . . 61.52 107.685 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 429' ' ' ILE . 16.9 Cg_exo -69.7 140.85 43.92 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.639 1.559 . . . . 73.1 111.35 178.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -95.4 130.2 42.28 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.302 -1.74 . . . . 71.01 106.302 175.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.541 HG11 ' HB2' ' A' ' 440' ' ' ALA . 13.2 p -129.59 150.51 34.69 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.259 0 C-N-CA 120.346 -0.542 . . . . 73.12 110.515 -172.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 5.7 m -63.23 137.89 58.36 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 107.657 -1.238 . . . . 52.44 107.657 173.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . 0.457 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 52.9 p -60.16 -28.77 68.19 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 123.989 0.916 . . . . 74.13 113.293 -171.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.403 ' HB3' ' HG3' ' A' ' 466' ' ' LYS . 1.1 pp -88.15 -10.73 49.04 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 113.558 0.947 . . . . 74.41 113.558 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 3.6 m -102.65 49.96 0.83 Allowed 'General case' 0 CA--C 1.563 1.459 0 CA-C-O 121.62 0.724 . . . . 75.52 111.056 -175.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -52.72 -37.63 59.51 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.93 0.892 . . . . 72.43 112.58 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' A' ' 442' ' ' LYS . . . -58.82 -40.1 83.18 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.101 0.477 . . . . 61.42 111.367 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -69.42 -35.47 75.74 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.604 -0.887 . . . . 61.51 108.604 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.541 ' HB2' HG11 ' A' ' 432' ' ' VAL . . . -60.78 -51.67 68.35 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.591 -0.732 . . . . 25.0 111.036 -178.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 33.5 m -62.31 -44.61 99.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 120.829 -0.348 . . . . 73.45 111.829 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 438' ' ' ALA 0.339 0.0 OUTLIER -68.66 -33.7 74.44 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 113.432 0.901 . . . . 71.42 113.432 178.881 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -65.01 -43.05 93.79 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 122.197 -0.314 . . . . 71.24 111.108 174.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.492 HD13 ' O ' ' A' ' 440' ' ' ALA . 8.9 mp -63.37 -35.24 79.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.347 -0.388 . . . . 75.12 110.325 177.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.461 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 38.6 m -67.28 -44.29 79.66 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 116.11 -0.495 . . . . 74.14 110.671 178.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.71 -22.94 65.24 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.22 -0.446 . . . . 72.14 111.435 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -80.09 5.16 15.02 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 116.061 -0.518 . . . . 53.11 111.737 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 102.23 -61.21 0.53 Allowed Glycine 0 CA--C 1.492 -1.374 0 C-N-CA 120.739 -0.743 . . . . 70.31 112.348 173.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . 0.44 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 0.9 OUTLIER -53.28 -63.4 1.16 Allowed 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 112.885 0.698 . . . . 70.1 112.885 178.224 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . 0.461 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 60.01 23.22 59.07 Favored Glycine 0 C--N 1.316 -0.572 0 O-C-N 123.199 0.312 . . . . 63.11 113.15 -178.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.446 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 35.6 mmt180 -108.2 110.82 22.54 Favored 'General case' 0 N--CA 1.422 -1.856 0 N-CA-C 107.337 -1.357 . . . . 74.31 107.337 -178.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -131.29 146.02 52.12 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.651 -0.704 . . . . 63.34 110.499 -175.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -131.58 132.79 44.39 Favored 'General case' 0 C--N 1.286 -2.196 0 N-CA-C 108.397 -0.964 . . . . 62.42 108.397 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -101.05 126.98 47.77 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 120.956 0.408 . . . . 75.13 110.244 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.27 153.31 36.55 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.539 -1.282 . . . . 70.22 107.539 175.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -127.36 144.84 50.98 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.602 -0.518 . . . . 74.42 109.602 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 28.2 t -141.81 142.99 27.1 Favored Pre-proline 0 C--N 1.291 -1.963 0 N-CA-C 107.932 -1.136 . . . . 60.34 107.932 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.659 ' HA ' ' O ' ' A' ' 490' ' ' SER . 19.3 Cg_exo -65.83 138.73 54.4 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.872 1.715 . . . . 63.22 110.251 176.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 65.9 m -150.82 174.42 13.09 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 109.522 -0.547 . . . . 73.41 109.522 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.0 t -52.83 136.91 45.52 Favored Pre-proline 0 N--CA 1.437 -1.112 0 C-N-CA 123.739 0.816 . . . . 52.45 110.571 174.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.89 -30.24 38.12 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 124.624 3.549 . . . . 63.04 113.478 -175.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -67.43 -27.83 67.39 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.184 -0.462 . . . . 74.13 111.624 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -99.23 -13.38 19.73 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 111.717 0.266 . . . . 64.43 111.717 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 56.9 t -59.25 130.56 22.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.268 -0.424 . . . . 73.13 110.79 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.08 -10.26 60.05 Favored Glycine 0 N--CA 1.435 -1.399 0 CA-C-N 115.92 -0.582 . . . . 65.34 111.84 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.403 ' HG3' ' HB3' ' A' ' 435' ' ' LEU . 3.8 mppt? -118.03 166.57 12.38 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-O 120.886 0.375 . . . . 53.42 110.899 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.457 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 74.4 t -73.35 143.07 14.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 108.167 -1.049 . . . . 71.24 108.167 176.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 48.9 mm -98.02 -27.07 3.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.313 -0.995 . . . . 74.12 108.313 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 157.94 -161.48 31.52 Favored Glycine 0 N--CA 1.428 -1.894 0 CA-C-N 115.643 -0.708 . . . . 52.14 111.572 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . 0.465 HG22 HG12 ' A' ' 486' ' ' ILE . 40.0 p -115.21 141.29 48.22 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.593 -1.262 . . . . 62.42 107.593 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.492 ' HB3' HG23 ' A' ' 485' ' ' ILE . 6.7 t30 -64.73 -50.42 64.28 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 109.791 -0.448 . . . . 63.12 109.791 176.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -75.29 155.44 41.62 Favored 'Trans proline' 0 C--N 1.377 2.035 0 N-CA-C 108.951 -1.211 . . . . 74.33 108.951 173.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.443 ' O ' HD12 ' A' ' 429' ' ' ILE . 37.3 Cg_exo -62.96 126.19 17.5 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.173 1.248 . . . . 52.4 109.819 177.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -74.4 -0.7 18.16 Favored 'General case' 0 C--O 1.194 -1.838 0 N-CA-C 112.984 0.735 . . . . 63.52 112.984 -173.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . 0.457 ' N ' HD22 ' A' ' 475' ' ' ASN . 0.7 OUTLIER -108.96 3.86 22.68 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 121.78 -0.575 . . . . 50.24 110.071 -179.374 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . 0.417 ' HG2' ' HB2' ' A' ' 473' ' ' PRO . 84.3 mm-40 -98.17 175.71 5.99 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 112.269 0.47 . . . . 74.24 112.269 -177.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 1.3 m -105.87 112.29 25.29 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.464 -0.789 . . . . 50.13 109.455 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 12.7 p -101.12 145.98 28.07 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.038 0.447 . . . . 65.45 110.858 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -75.33 150.57 38.42 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.547 -0.751 . . . . 61.45 110.739 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . 0.44 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 1.7 mp -67.85 -26.05 33.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 123.519 0.728 . . . . 74.15 111.59 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 12.5 t -89.46 2.58 54.33 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.822 0.82 . . . . 74.22 110.342 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -102.82 144.14 31.54 Favored 'General case' 0 C--N 1.318 -0.802 0 O-C-N 121.936 -0.478 . . . . 62.15 110.78 -175.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.446 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 6.4 p -108.15 127.21 64.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 C-N-CA 123.067 0.547 . . . . 73.14 111.566 -177.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 35.7 m -104.73 141.86 19.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.771 -0.65 . . . . 33.34 111.391 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.492 HG23 ' HB3' ' A' ' 471' ' ' ASN . 0.0 OUTLIER -108.93 130.13 62.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.401 0.62 . . . . 64.41 111.795 -178.513 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.465 HG12 HG22 ' A' ' 470' ' ' THR . 13.1 mt -113.81 129.72 69.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 C-N-CA 125.084 1.354 . . . . 70.51 111.206 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 9.9 tt -105.33 126.96 60.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.586 -0.734 . . . . 73.31 111.388 -174.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.411 HG12 HG22 ' A' ' 467' ' ' VAL . 35.7 m -109.68 151.65 11.9 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 C-N-CA 123.519 0.728 . . . . 75.2 110.326 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -92.28 132.51 11.3 Favored Glycine 0 C--N 1.311 -0.809 0 N-CA-C 111.053 -0.819 . . . . 74.31 111.053 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.659 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 23.3 t . . . . . 0 N--CA 1.43 -1.428 0 N-CA-C 109.642 -0.503 . . . . 65.24 109.642 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo . . . . . 0 CA--C 1.531 0.347 0 N-CA-C 110.798 -0.501 . . . . 72.34 110.798 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . -112.19 25.9 11.1 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.582 0.706 . . . . 51.12 111.101 -176.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 6.6 p -116.94 143.47 45.67 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 114.93 -1.032 . . . . 72.31 110.659 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -151.2 147.09 26.59 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 108.419 -0.956 . . . . 72.25 108.419 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.524 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 7.6 p-10 -85.71 132.5 34.13 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.699 0.761 . . . . 75.23 112.543 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 33.7 pt -77.18 137.45 64.91 Favored Pre-proline 0 C--N 1.308 -1.22 0 CA-C-N 114.461 -1.245 . . . . 75.23 111.247 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -85.7 175.02 6.3 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.417 2.078 . . . . 60.35 112.528 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -97.21 132.46 42.94 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.59 -0.732 . . . . 60.52 109.654 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.2 104.11 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.626 0 CA-C-O 122.017 0.913 . . . . 61.23 110.598 -177.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -146.55 139.91 25.74 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.958 -1.019 . . . . 51.43 108.725 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 113.9 -18.48 19.24 Favored Glycine 0 CA--C 1.485 -1.837 0 N-CA-C 110.412 -1.075 . . . . 72.11 110.412 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.432 ' O ' HG12 ' A' ' 534' ' ' VAL . 50.6 mt-30 -95.87 -179.52 4.73 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 109.22 -0.659 . . . . 70.51 109.22 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 15.0 t -91.87 157.16 17.01 Favored 'General case' 0 N--CA 1.421 -1.896 0 C-N-CA 118.184 -1.406 . . . . 64.12 107.885 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 6.0 p -53.77 -42.5 52.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 O-C-N 123.742 0.651 . . . . 64.4 112.344 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -65.48 -41.52 93.19 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.265 0.353 . . . . 72.03 110.976 -176.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 81.8 t -70.59 -44.49 76.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.878 0.371 . . . . 71.25 110.798 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . 0.415 ' O ' ' HG ' ' A' ' 512' ' ' LEU . . . -61.44 -48.49 80.94 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.01 -0.541 . . . . 73.31 111.147 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -60.4 -43.11 96.98 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.249 -0.887 . . . . 75.32 109.939 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.483 ' O ' HG23 ' A' ' 514' ' ' VAL . 35.4 ttmt -63.21 -42.37 99.29 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.967 -1.015 . . . . 53.42 110.127 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -62.33 -41.7 98.77 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.057 0.456 . . . . 72.23 110.136 178.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . 0.442 HD13 HG13 ' A' ' 551' ' ' ILE . 89.4 mt -65.73 -37.1 85.47 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.717 -0.674 . . . . 72.13 110.923 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -64.23 -37.76 88.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.253 -0.431 . . . . 75.43 110.051 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 510' ' ' LYS . 93.3 t -62.55 -31.17 51.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 115.889 -0.596 . . . . 71.12 110.673 177.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -77.24 -6.75 54.25 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 120.818 0.342 . . . . 74.14 111.062 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 106.96 -0.06 35.9 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.401 -0.904 . . . . 51.35 113.239 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -90.86 99.37 12.42 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 107.56 -1.274 . . . . 75.3 107.56 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.1 m -91.0 -11.35 39.16 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.972 -1.013 . . . . 75.15 112.076 -172.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . 0.517 ' HD2' ' O ' ' A' ' 548' ' ' ASP . 95.7 mttt -108.62 118.18 36.12 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.239 -0.652 . . . . 74.42 109.239 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -129.63 155.0 46.55 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.147 0.498 . . . . 70.51 111.01 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 4.8 p -141.11 148.17 39.69 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 107.457 -1.312 . . . . 65.12 107.457 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . 0.459 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 4.0 pt20 -132.64 132.61 42.63 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-O 121.235 0.54 . . . . 71.44 111.062 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -113.56 141.51 47.08 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.457 -1.682 . . . . 61.43 106.457 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 45.3 p -121.22 129.16 53.06 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 120.397 -0.521 . . . . 64.54 111.459 -177.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . 0.57 ' O ' ' HB3' ' A' ' 557' ' ' LYS . 19.5 m -121.82 166.67 16.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 109.267 -0.642 . . . . 65.52 109.267 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -92.38 137.85 32.01 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.997 -1.483 . . . . 75.1 106.997 174.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 10.3 m -141.65 173.22 4.99 Favored Pre-proline 0 C--N 1.276 -2.625 0 N-CA-C 108.477 -0.934 . . . . 54.24 108.477 -172.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -79.22 -17.52 11.67 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 121.651 1.567 . . . . 64.32 109.19 168.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.603 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 18.0 mmm180 -67.38 152.19 96.41 Favored Pre-proline 0 N--CA 1.441 -0.905 0 C-N-CA 125.752 1.621 . . . . 65.31 108.581 177.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.44 156.32 61.82 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.335 2.023 . . . . 62.54 112.791 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 557' ' ' LYS . . . -70.93 124.92 25.48 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.937 -0.574 . . . . 73.22 111.038 -178.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 107.82 -10.95 38.14 Favored Glycine 0 C--N 1.305 -1.182 0 C-N-CA 120.589 -0.815 . . . . 42.1 111.395 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -82.46 138.64 34.31 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.469 -1.678 . . . . 70.32 106.469 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.432 HG12 ' O ' ' A' ' 503' ' ' GLN . 11.6 p -95.22 118.29 41.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 119.896 -0.722 . . . . 75.52 110.163 -178.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . 0.582 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 13.2 t -84.05 0.09 49.64 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.364 -0.38 . . . . 44.11 111.614 -175.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.424 ' H ' HG22 ' A' ' 534' ' ' VAL . . . 135.49 -160.94 24.63 Favored Glycine 0 CA--C 1.495 -1.204 0 C-N-CA 120.887 -0.673 . . . . 75.21 111.921 175.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 37.2 p -117.77 155.3 30.26 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.794 -0.817 . . . . 73.12 108.794 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -76.16 -50.34 2.98 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-O 119.437 -0.316 . . . . 64.21 110.507 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -66.95 135.95 39.6 Favored 'Trans proline' 0 C--N 1.369 1.609 0 N-CA-C 108.991 -1.196 . . . . 73.02 108.991 169.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.56 150.56 86.49 Favored 'Trans proline' 0 C--O 1.244 0.784 0 C-N-CA 122.378 2.052 . . . . 63.53 112.799 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.22 138.02 57.39 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.924 -0.769 . . . . 73.23 108.924 176.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.47 -11.34 58.13 Favored Glycine 0 C--N 1.294 -1.789 0 C-N-CA 120.606 -0.807 . . . . 53.21 111.767 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 59.5 m -69.87 120.86 16.24 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.595 -0.521 . . . . 72.3 109.595 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 11.5 t -85.89 123.16 30.92 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 109.079 -0.711 . . . . 71.41 109.079 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 29.1 m -135.88 159.96 69.22 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 108.349 -0.982 . . . . 72.04 108.349 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 32.3 Cg_exo -61.54 141.1 90.48 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 121.711 1.608 . . . . 74.0 110.8 174.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 35.2 m -61.05 -19.65 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-O 121.811 0.815 . . . . 74.52 111.978 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . 0.517 ' O ' ' HD2' ' A' ' 519' ' ' LYS . 25.1 t70 -90.12 -1.23 57.92 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.242 -0.89 . . . . 74.14 110.897 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 67.2 m -86.29 172.95 10.07 Favored 'General case' 0 C--N 1.313 -1.018 0 O-C-N 121.697 -0.627 . . . . 73.41 112.547 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 14.3 p -100.14 136.49 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 115.255 -0.884 . . . . 62.11 110.886 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . 0.502 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -108.97 145.67 15.51 Favored 'Isoleucine or valine' 0 C--O 1.252 1.228 0 N-CA-C 109.245 -0.65 . . . . 71.24 109.245 174.782 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -109.13 115.15 29.5 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 121.303 0.573 . . . . 74.23 111.035 -176.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 5.1 mp -95.5 135.2 37.45 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.612 -1.177 . . . . 55.04 109.425 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -110.43 118.12 35.41 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.68 0.752 . . . . 73.41 110.318 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.88 141.1 16.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 114.731 -1.122 . . . . 72.54 110.288 -174.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.603 ' HB3' ' HB2' ' A' ' 529' ' ' ARG . 7.8 m -86.29 147.95 25.84 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 115.35 -0.841 . . . . 63.11 110.653 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.57 ' HB3' ' O ' ' A' ' 525' ' ' VAL . 0.5 OUTLIER -123.58 130.12 52.19 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.111 -0.95 . . . . 73.54 109.691 173.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -66.25 -43.46 92.9 Favored Glycine 0 CA--C 1.486 -1.769 0 N-CA-C 111.36 -0.696 . . . . 31.14 111.36 -176.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 64.3 t30 72.53 -8.74 1.16 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.968 1.307 . . . . 74.23 110.56 176.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.463 ' H ' ' C ' ' A' ' 558' ' ' GLY . 97.0 mt-30 -127.21 155.34 43.58 Favored 'General case' 0 N--CA 1.423 -1.81 0 C-N-CA 125.567 1.547 . . . . 70.33 107.375 177.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -126.48 147.65 49.79 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.844 -0.798 . . . . 74.04 108.844 177.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 62.8 t -63.43 116.98 3.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 O-C-N 123.408 0.442 . . . . 74.33 110.079 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 58.3 ttp -75.49 124.77 89.12 Favored Pre-proline 0 C--N 1.306 -1.314 0 CA-C-N 115.979 -0.555 . . . . 73.25 110.788 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -65.89 169.41 13.32 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.095 2.53 . . . . 44.35 110.32 174.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -89.19 114.17 25.46 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 118.72 -1.192 . . . . 53.2 111.688 -177.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -125.81 0.18 7.37 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.567 -1.271 . . . . 64.25 107.567 173.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 23.9 m -65.07 151.2 46.63 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 113.777 -1.556 . . . . 54.31 112.238 -174.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 90.79 35.97 7.01 Favored Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 110.213 -1.155 . . . . 50.42 110.213 -175.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 15.9 ptm -117.53 157.5 26.21 Favored 'General case' 0 C--O 1.25 1.089 0 N-CA-C 109.529 -0.545 . . . . 73.15 109.529 -174.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . 0.59 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 86.3 m-85 -84.53 171.52 12.43 Favored 'General case' 0 CA--C 1.502 -0.9 0 O-C-N 123.322 0.389 . . . . 70.4 110.821 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 29.4 t90 -62.6 -34.0 76.12 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.941 -0.762 . . . . 72.45 108.941 172.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 29.1 m -72.33 -7.96 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.318 -0.855 . . . . 73.44 110.97 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . 0.584 ' O ' ' HD3' ' A' ' 577' ' ' ARG . 31.6 m-20 -100.92 -44.83 5.63 Favored 'General case' 0 CA--C 1.492 -1.276 0 N-CA-C 109.407 -0.59 . . . . 74.04 109.407 174.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . 0.646 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -61.04 -53.2 60.07 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.081 -0.963 . . . . 72.43 112.539 -175.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.417 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 1.0 OUTLIER -57.95 -50.69 86.67 Favored Pre-proline 0 CA--C 1.574 1.892 0 O-C-N 123.547 0.529 . . . . 70.41 112.005 -174.659 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . 0.417 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 67.1 Cg_exo -58.25 -38.42 91.04 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 121.847 1.698 . . . . 63.23 112.268 174.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.584 ' HD3' ' O ' ' A' ' 573' ' ' ASP . 5.7 mpt_? -67.67 -34.26 76.57 Favored 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 121.111 -0.236 . . . . 74.53 111.555 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 76.2 mt -60.7 -43.11 98.17 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.976 -0.75 . . . . 73.1 108.976 177.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -64.28 -45.9 85.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.147 -0.933 . . . . 72.3 109.302 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.11 92.27 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.854 -1.066 . . . . 64.51 113.44 -176.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 11.1 mp -82.22 -9.09 59.62 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 113.127 0.788 . . . . 72.5 113.127 -177.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 68.78 32.36 74.01 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 109.255 -1.538 . . . . 44.25 109.255 -174.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 44.8 t90 -60.61 134.07 56.72 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.021 0.928 . . . . 61.04 110.284 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 8.9 t -126.61 19.33 7.34 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.858 -0.61 . . . . 73.55 109.917 -176.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -79.97 -155.22 10.27 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 115.808 -0.633 . . . . 34.34 113.511 -176.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . 0.44 ' H ' HG12 ' A' ' 619' ' ' ILE . 86.1 mtp -124.94 132.62 53.26 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.551 -0.907 . . . . 54.22 108.551 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 61.9 tp -106.8 130.69 54.46 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.328 -0.619 . . . . 74.44 109.328 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -114.2 121.92 45.2 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 120.898 0.38 . . . . 72.15 110.206 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -105.5 118.38 36.42 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 116.153 -0.476 . . . . 72.13 110.216 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -88.19 -163.09 38.85 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.691 -0.964 . . . . 72.2 110.691 177.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -67.19 147.8 52.6 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 120.742 0.306 . . . . 72.33 110.699 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . 0.423 ' HB3' ' NE2' ' A' ' 626' ' ' GLN . 21.6 m-20 -93.72 124.51 37.76 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.138 0.494 . . . . 54.21 111.448 -178.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 91.2 t -114.73 126.39 72.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 106.664 -1.606 . . . . 62.13 106.664 175.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . 0.535 ' HA ' ' HB2' ' A' ' 626' ' ' GLN . 6.2 p-10 -102.44 125.35 49.13 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 120.445 -0.502 . . . . 65.02 109.877 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -133.04 -28.68 1.51 Allowed 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.464 -0.789 . . . . 74.32 110.428 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 130.37 125.29 2.69 Favored Glycine 0 CA--C 1.486 -1.752 0 N-CA-C 109.979 -1.248 . . . . 62.52 109.979 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.29 -36.07 67.81 Favored Glycine 0 C--O 1.21 -1.363 0 N-CA-C 114.641 0.617 . . . . 63.14 114.641 -172.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 18.6 m -62.67 -32.06 73.06 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 117.58 0.69 . . . . 75.54 112.194 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -109.37 -1.92 18.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.62 -0.264 . . . . 54.01 111.525 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . 0.502 ' CE1' ' HA3' ' A' ' 625' ' ' GLY . 5.9 t-160 -150.49 -148.92 0.28 Allowed 'General case' 0 C--O 1.204 -1.328 0 N-CA-C 108.78 -0.822 . . . . 65.43 108.78 -170.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 626' ' ' GLN . 3.1 t-20 62.22 2.87 0.9 Allowed 'General case' 0 N--CA 1.516 2.828 0 C-N-CA 125.1 1.36 . . . . 75.3 112.282 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . 0.59 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 9.2 ptp85 -110.64 171.58 7.38 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.036 -0.984 . . . . 73.43 109.355 -177.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . 0.422 HG23 ' HB2' ' A' ' 622' ' ' LEU . 7.6 p -57.03 130.78 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 O-C-N 124.469 1.105 . . . . 51.34 109.039 176.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 29.2 m -101.22 -37.17 5.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 121.504 0.669 . . . . 64.23 109.561 -175.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . 0.469 ' CE2' ' HD3' ' A' ' 623' ' ' ARG . 35.4 p90 -151.28 152.86 33.8 Favored 'General case' 0 N--CA 1.409 -2.524 0 N-CA-C 105.768 -1.938 . . . . 72.31 105.768 172.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -128.49 144.45 51.15 Favored 'General case' 0 C--N 1.27 -2.865 0 N-CA-C 107.972 -1.121 . . . . 73.12 107.972 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.501 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 42.8 t30 -72.44 -51.92 7.11 Favored Pre-proline 0 C--N 1.286 -2.162 0 CA-C-N 115.652 -0.704 . . . . 65.04 111.054 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.501 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 10.3 Cg_endo -97.78 111.48 0.1 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.582 0 C-N-CA 121.594 1.529 . . . . 74.41 110.309 170.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -68.25 159.07 54.81 Favored 'Trans proline' 0 C--O 1.248 0.978 0 C-N-CA 121.974 1.783 . . . . 64.4 110.465 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -60.11 132.91 55.4 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.789 -0.448 . . . . 61.03 109.789 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.25 -11.06 47.67 Favored Glycine 0 C--N 1.308 -0.997 0 C-N-CA 120.532 -0.842 . . . . 45.51 111.585 -176.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 22.7 m -89.95 156.34 18.5 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.775 -0.824 . . . . 71.41 108.775 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -80.84 125.17 6.75 Favored Glycine 0 N--CA 1.419 -2.454 0 N-CA-C 111.704 -0.558 . . . . 61.12 111.704 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 29.1 m -107.64 141.48 22.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 108.177 -1.045 . . . . 71.14 108.177 175.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.61 ' ND2' ' HB3' ' A' ' 617' ' ' ASP . 31.4 p-10 -63.22 164.52 8.62 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 122.903 0.481 . . . . 74.35 111.873 -177.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -61.84 -25.6 67.62 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.213 0.53 . . . . 62.45 111.242 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . 0.61 ' HB3' ' ND2' ' A' ' 615' ' ' ASN . 16.0 t70 -68.11 -37.44 81.16 Favored 'General case' 0 C--O 1.245 0.856 0 CA-C-N 115.535 -0.757 . . . . 63.44 109.321 176.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 89.65 19.71 47.23 Favored Glycine 0 N--CA 1.429 -1.79 0 CA-C-N 115.283 -0.872 . . . . 74.42 113.147 174.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . 0.44 HG12 ' H ' ' A' ' 586' ' ' MET . 0.0 OUTLIER -70.09 118.13 14.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 122.457 1.122 . . . . 63.01 109.192 -174.375 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.09 129.4 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 N-CA-C 107.691 -1.226 . . . . 71.02 107.691 -175.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.442 ' HB ' ' CB ' ' A' ' 607' ' ' ASN . 32.8 m -99.71 118.31 35.94 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 109.473 -0.566 . . . . 61.33 109.473 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . 0.422 ' HB2' HG23 ' A' ' 603' ' ' VAL . 2.2 pt? -133.86 150.47 51.37 Favored 'General case' 0 CA--C 1.477 -1.852 0 N-CA-C 105.089 -2.189 . . . . 61.12 105.089 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . 0.469 ' HD3' ' CE2' ' A' ' 605' ' ' TYR . 79.7 ttt180 -132.94 139.41 47.31 Favored 'General case' 0 C--N 1.262 -3.208 0 N-CA-C 107.17 -1.418 . . . . 75.12 107.17 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -140.16 163.8 31.76 Favored 'General case' 0 C--N 1.289 -2.052 0 O-C-N 124.048 0.842 . . . . 63.51 109.439 -175.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . 0.502 ' HA3' ' CE1' ' A' ' 600' ' ' HIS . . . -123.64 -141.67 5.88 Favored Glycine 0 N--CA 1.416 -2.685 0 N-CA-C 109.992 -1.243 . . . . 44.15 109.992 174.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . 0.535 ' HB2' ' HA ' ' A' ' 594' ' ' ASP . 38.6 mt-30 . . . . . 0 C--N 1.297 -1.681 0 N-CA-C 108.314 -0.995 . . . . 64.13 108.314 177.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 . . . . . 0 N--CA 1.436 -1.154 0 N-CA-C 107.289 -1.374 . . . . 70.42 107.289 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.8 m -116.93 161.15 15.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 108.905 -0.776 . . . . 71.41 108.905 -177.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -95.04 136.84 34.87 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.008 -1.077 . . . . 61.02 108.142 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.413 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 95.6 t -97.58 127.81 36.55 Favored Pre-proline 0 C--N 1.285 -2.227 0 CA-C-N 115.798 -0.637 . . . . 74.34 110.281 -173.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 23.9 Cg_exo -64.17 137.66 57.7 Favored 'Trans proline' 0 C--O 1.242 0.695 0 C-N-CA 122.66 2.24 . . . . 53.4 111.015 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -79.1 130.36 35.42 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 122.055 0.931 . . . . 70.3 109.706 -178.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 7.9 p -107.94 5.25 9.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-O 122.656 1.217 . . . . 73.42 110.622 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.13 145.01 52.51 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.952 -1.022 . . . . 72.12 110.66 173.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 91.68 0.51 72.3 Favored Glycine 0 N--CA 1.434 -1.439 0 CA-C-N 116.216 -0.447 . . . . 70.53 112.303 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -107.82 -82.06 0.56 Allowed 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.263 0.468 . . . . 73.24 112.263 -176.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 11.8 t -154.29 150.88 28.47 Favored 'General case' 0 CA--C 1.503 -0.861 0 O-C-N 121.644 -0.66 . . . . 62.11 110.501 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.616 ' HB3' ' O ' ' A' ' 397' ' ' ASP . 1.4 p -63.68 -47.22 82.08 Favored 'General case' 0 N--CA 1.435 -1.181 0 O-C-N 123.799 0.687 . . . . 74.01 109.896 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -68.8 -45.59 70.86 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 115.158 -0.928 . . . . 61.32 110.691 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -68.88 -34.66 75.79 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 119.458 -0.897 . . . . 75.33 111.783 -176.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . 0.407 ' O ' HD13 ' A' ' 377' ' ' LEU . . . -67.93 -51.11 51.46 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.662 0.267 . . . . 61.54 110.834 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.37 -37.36 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 116.239 -0.437 . . . . 74.34 110.697 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.58 -47.08 85.5 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 120.893 0.378 . . . . 71.01 111.062 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 42.2 m -62.53 -47.77 82.43 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-O 121.576 0.703 . . . . 73.24 110.081 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.407 HD13 ' O ' ' A' ' 373' ' ' ALA . 9.6 mp -64.33 -39.1 93.22 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.495 -0.775 . . . . 73.21 112.096 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -61.79 -44.45 96.85 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.131 0.572 . . . . 44.23 110.373 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -68.35 -19.38 64.64 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.29 0.567 . . . . 71.51 112.07 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . 0.486 ' NE ' ' HA ' ' A' ' 380' ' ' ARG . 3.9 mmp_? -96.45 -13.95 22.74 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 112.515 0.561 . . . . 72.03 112.515 177.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.13 14.51 54.32 Favored Glycine 0 C--O 1.25 1.12 0 C-N-CA 120.87 -0.681 . . . . 63.52 112.367 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.406 ' CZ ' HG21 ' A' ' 362' ' ' VAL . 26.7 m-85 -76.62 140.05 40.84 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-O 121.141 0.496 . . . . 65.14 110.121 177.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -85.08 134.77 34.19 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 107.628 -1.249 . . . . 73.0 107.628 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . 0.451 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -128.13 157.15 40.46 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 CA-C-O 120.999 0.428 . . . . 64.13 110.338 -175.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -134.99 137.36 42.95 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 106.636 -1.616 . . . . 61.42 106.636 172.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 13.1 m -135.09 116.76 14.94 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.802 -0.814 . . . . 62.13 108.802 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -113.78 123.43 49.83 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.491 -0.929 . . . . 62.03 108.491 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -89.79 125.22 35.22 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.54 -0.541 . . . . 75.43 109.54 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . 0.763 ' HZ2' ' HB2' ' A' ' 389' ' ' LYS . 7.2 mtmp? -114.84 133.31 22.62 Favored Pre-proline 0 C--N 1.307 -1.26 0 N-CA-C 108.159 -1.052 . . . . 73.33 108.159 176.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . 0.425 ' O ' ' HB3' ' A' ' 391' ' ' ASP . 3.3 Cg_exo -85.76 128.47 3.35 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.769 1.646 . . . . 64.22 109.517 172.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.425 ' HB3' ' O ' ' A' ' 390' ' ' PRO . 2.0 p30 158.43 159.25 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.055 -1.461 . . . . 74.15 107.055 -175.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 20.3 p -126.68 23.9 6.67 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.456 0.646 . . . . 62.14 110.165 177.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 39.5 m -90.85 -37.72 13.41 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 108.624 -0.88 . . . . 70.44 108.624 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 37.6 mm -89.71 141.89 28.81 Favored Pre-proline 0 N--CA 1.432 -1.332 0 N-CA-C 106.666 -1.605 . . . . 73.4 106.666 178.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -51.39 161.04 2.0 Favored 'Trans proline' 0 CA--C 1.56 1.782 0 C-N-CA 123.267 2.645 . . . . 64.24 113.606 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -54.65 162.89 4.31 Favored 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 124.675 3.584 . . . . 72.05 114.155 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . 0.616 ' O ' ' HB3' ' A' ' 370' ' ' SER . 5.9 p-10 -56.38 -9.88 0.8 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.381 1.473 . . . . 62.02 113.973 -172.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -67.62 145.89 54.4 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.185 -1.413 . . . . 73.21 107.185 176.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.43 HG13 ' HA ' ' A' ' 370' ' ' SER . 10.3 m -63.29 118.43 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 C-N-CA 119.298 -0.961 . . . . 75.11 112.324 -171.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.29 -34.75 7.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.226 -1.027 . . . . 64.14 108.226 178.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -156.59 157.62 28.09 Favored Glycine 0 N--CA 1.423 -2.174 0 N-CA-C 110.731 -0.948 . . . . 72.2 110.731 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 11.5 p -126.77 -178.21 4.3 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.811 -1.181 . . . . 63.12 107.811 175.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -100.5 139.44 20.63 Favored Pre-proline 0 C--N 1.296 -1.731 0 C-N-CA 119.596 -0.842 . . . . 61.44 109.364 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -52.8 -3.09 0.11 Allowed 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 124.599 3.533 . . . . 41.5 115.765 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.7 -37.19 65.52 Favored 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 122.947 0.499 . . . . 20.42 109.673 173.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -69.11 -41.06 77.93 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-O 121.666 0.746 . . . . 52.14 109.988 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -77.65 -1.24 30.02 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.261 -0.881 . . . . 60.11 110.563 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 75.2 m -98.68 147.07 25.22 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.345 -1.724 . . . . 74.13 106.345 172.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 34.8 m -74.23 112.05 10.0 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 107.385 -1.339 . . . . 52.42 107.385 175.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 23.1 m -133.27 169.64 21.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 121.28 0.562 . . . . 65.41 110.772 -176.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 10.1 t -84.29 154.98 22.63 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 106.557 -1.646 . . . . 75.41 106.557 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -67.91 108.13 2.91 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 121.369 0.604 . . . . 44.33 110.411 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 133.06 54.4 0.08 OUTLIER Glycine 0 N--CA 1.427 -1.952 0 CA-C-N 115.262 -0.881 . . . . 73.34 112.005 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -104.28 -173.2 2.25 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.035 -1.468 . . . . 51.22 107.035 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -115.42 125.63 53.38 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 118.97 0.805 . . . . 64.04 111.085 -176.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.6 mm -122.56 117.99 53.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 121.158 0.504 . . . . 55.13 110.03 177.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 23.8 p -95.26 127.83 41.62 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 123.108 0.563 . . . . 73.2 110.392 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 18.5 t -120.77 134.91 62.68 Favored 'Isoleucine or valine' 0 C--O 1.25 1.131 0 C-N-CA 123.786 0.834 . . . . 64.13 111.843 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -108.78 128.59 55.02 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-O 121.47 0.652 . . . . 74.25 111.008 174.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.506 HG13 ' CB ' ' A' ' 397' ' ' ASP . 2.9 t -106.52 144.2 16.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 C-N-CA 125.075 1.35 . . . . 64.34 110.843 -175.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 10.4 m -118.66 123.36 44.76 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 109.556 -0.535 . . . . 64.02 109.556 176.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 20.6 p -107.78 107.93 18.91 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 105.879 -1.897 . . . . 74.54 105.879 173.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.27 0 N-CA-C 116.858 1.503 . . . . 44.02 116.858 -170.501 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 33.8 tt0 . . . . . 0 N--CA 1.43 -1.46 0 CA-C-O 120.536 0.207 . . . . 74.54 110.758 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -127.89 159.61 34.38 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 121.097 0.475 . . . . 75.13 111.322 -178.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -103.59 139.0 39.48 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.067 -0.969 . . . . 72.51 109.027 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.74 ' HB ' ' O ' ' A' ' 474' ' ' ALA . 2.7 mp -90.11 124.04 64.33 Favored Pre-proline 0 C--N 1.319 -0.753 0 C-N-CA 119.578 -0.849 . . . . 64.44 109.123 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -66.69 148.37 82.89 Favored 'Trans proline' 0 C--O 1.24 0.604 0 C-N-CA 122.32 2.013 . . . . 75.31 111.393 177.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -76.37 103.89 6.61 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-O 121.491 0.663 . . . . 71.42 110.926 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 60.9 t -98.24 150.01 5.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 107.222 -1.399 . . . . 70.11 107.222 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 35.6 m -73.43 154.88 39.8 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 121.07 0.462 . . . . 54.13 111.055 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . 0.564 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 33.5 p -68.3 -30.14 69.07 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 123.692 0.797 . . . . 74.02 112.403 -174.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 1.6 pp -80.09 -11.46 59.76 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 113.007 0.743 . . . . 73.54 113.007 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.414 ' HB ' ' HB3' ' A' ' 439' ' ' GLU . 0.9 OUTLIER -109.42 65.15 0.61 Allowed 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 113.582 0.956 . . . . 75.12 113.582 -178.595 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -59.01 -38.58 79.57 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.52 0.728 . . . . 74.24 111.908 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -62.48 -36.83 83.72 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.397 0.618 . . . . 74.42 110.548 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.414 ' HB3' ' HB ' ' A' ' 436' ' ' THR . 7.0 tp10 -70.12 -40.53 74.82 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.781 -0.822 . . . . 75.13 108.781 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.564 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -60.86 -51.13 70.61 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.8 -0.637 . . . . 41.44 111.269 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 32.5 m -64.26 -39.73 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 112.78 0.659 . . . . 73.1 112.78 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -68.43 -36.89 79.71 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 119.488 -0.885 . . . . 75.32 110.34 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -66.14 -38.29 87.75 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.96 -0.563 . . . . 61.31 110.936 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 93.7 mt -63.42 -36.3 83.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.157 0.504 . . . . 74.4 109.647 175.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.434 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 33.2 m -70.09 -43.81 70.33 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.579 -0.737 . . . . 70.01 110.444 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -66.96 -21.62 65.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.033 -0.53 . . . . 74.25 111.386 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.7 4.93 26.58 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.018 0.437 . . . . 53.4 111.418 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . 0.46 ' HA3' HD12 ' A' ' 480' ' ' ILE . . . 111.2 -84.94 0.38 Allowed Glycine 0 CA--C 1.484 -1.845 0 C-N-CA 120.525 -0.845 . . . . 64.11 111.793 175.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . 0.4 ' N ' HG23 ' A' ' 480' ' ' ILE . 2.0 p90 -38.53 -60.28 0.82 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.432 1.271 . . . . 74.02 114.432 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . 0.434 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 61.3 30.13 73.22 Favored Glycine 0 CA--C 1.501 -0.799 0 C-N-CA 121.22 -0.514 . . . . 74.33 112.047 -177.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.485 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 40.9 mmm-85 -104.37 110.92 23.35 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 108.477 -0.934 . . . . 74.5 108.477 -177.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -136.09 140.31 43.64 Favored 'General case' 0 N--CA 1.423 -1.778 0 CA-C-N 115.818 -0.628 . . . . 64.22 111.585 -176.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -131.67 140.04 49.23 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.936 -1.029 . . . . 54.42 108.238 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -109.33 129.28 55.53 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.128 0.49 . . . . 74.13 111.531 -176.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.88 150.67 40.7 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.112 -1.07 . . . . 51.33 108.112 176.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -121.97 140.68 52.16 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.762 -0.829 . . . . 71.1 108.762 -177.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 24.3 t -144.7 137.34 13.55 Favored Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 109.338 -0.616 . . . . 63.35 109.338 176.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 490' ' ' SER . 47.3 Cg_endo -71.03 134.56 25.55 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.939 1.759 . . . . 74.04 110.538 175.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 70.2 m -152.76 -179.42 7.61 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 122.801 0.44 . . . . 75.41 110.155 -177.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.2 t -47.64 137.28 9.75 Favored Pre-proline 0 C--O 1.254 1.316 0 C-N-CA 124.276 1.03 . . . . 71.23 110.899 173.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -52.81 -30.94 49.34 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 124.375 3.383 . . . . 51.33 113.451 -175.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -68.5 -26.79 65.64 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.712 0.634 . . . . 75.34 112.712 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -95.33 -15.78 22.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.935 0.398 . . . . 74.54 111.135 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 83.4 t -60.7 128.73 22.36 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 115.996 -0.547 . . . . 63.44 110.304 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.06 -11.23 60.42 Favored Glycine 0 N--CA 1.433 -1.531 0 CA-C-N 115.495 -0.775 . . . . 73.23 111.757 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -119.1 167.18 12.04 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.033 -0.729 . . . . 74.24 109.033 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.564 ' O ' ' HB ' ' A' ' 434' ' ' THR . 79.3 t -75.68 147.11 8.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.114 -1.439 . . . . 72.45 107.114 173.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 65.2 mt -97.88 -35.15 5.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 107.296 -1.372 . . . . 45.43 107.296 176.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 160.06 -160.38 31.57 Favored Glycine 0 N--CA 1.416 -2.682 0 N-CA-C 109.729 -1.348 . . . . 73.42 109.729 177.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 26.3 p -115.98 145.73 42.71 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 107.335 -1.357 . . . . 42.45 107.335 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -64.3 -56.15 25.61 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 119.968 -0.693 . . . . 61.34 110.401 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -80.69 149.49 18.42 Favored 'Trans proline' 0 C--N 1.37 1.699 0 N-CA-C 107.842 -1.638 . . . . 42.31 107.842 169.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -64.81 126.93 17.56 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.588 1.525 . . . . 63.41 113.039 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.74 ' O ' ' HB ' ' A' ' 429' ' ' ILE . . . -86.11 -34.67 20.56 Favored 'General case' 0 C--O 1.198 -1.631 0 CA-C-O 122.224 1.011 . . . . 63.34 108.383 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -72.21 12.37 0.44 Allowed 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.528 -1.215 . . . . 64.5 111.717 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -119.81 -165.49 1.18 Allowed 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 107.978 -1.119 . . . . 75.11 107.978 175.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.44 140.1 37.93 Favored 'General case' 0 N--CA 1.402 -2.874 0 CA-C-O 121.44 0.638 . . . . 62.33 111.883 -178.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 39.5 m -136.99 139.05 41.17 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.852 -0.613 . . . . 52.45 109.473 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -67.85 165.09 18.28 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.869 -0.605 . . . . 72.32 110.776 177.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . 0.46 HD12 ' HA3' ' A' ' 448' ' ' GLY . 29.0 mm -70.57 -15.38 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 121.914 0.864 . . . . 70.12 110.616 -176.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.2 t -92.41 2.9 56.39 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.996 -0.547 . . . . 75.43 110.801 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -92.36 140.95 29.08 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.178 0.513 . . . . 73.14 111.798 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.485 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.3 p -108.31 127.07 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 CA-C-N 115.23 -0.895 . . . . 73.35 109.946 177.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 29.9 m -104.09 132.74 49.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-O 121.779 0.799 . . . . 72.01 111.029 178.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.72 124.25 55.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 115.258 -0.883 . . . . 75.2 110.552 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.443 HG23 HG13 ' A' ' 467' ' ' VAL . 1.7 mp -100.84 125.52 54.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 125.542 1.537 . . . . 61.23 108.671 -178.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 8.8 tt -107.03 126.41 63.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 109.479 -0.563 . . . . 65.42 109.479 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.447 HG12 HG22 ' A' ' 467' ' ' VAL . 33.6 m -110.29 151.21 12.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 116.18 -0.464 . . . . 61.3 110.7 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -83.58 121.58 5.53 Favored Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 109.43 -1.468 . . . . 61.13 109.43 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 23.3 t . . . . . 0 N--CA 1.426 -1.632 0 N-CA-C 108.28 -1.008 . . . . 42.45 108.28 -176.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.451 -1.022 0 N-CA-C 110.923 -0.453 . . . . 70.35 110.923 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -94.77 26.58 3.47 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 122.422 1.106 . . . . 61.23 110.491 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 12.8 p -118.07 147.54 43.16 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 114.134 -1.394 . . . . 54.14 110.295 -178.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . 0.485 ' HD3' ' N ' ' A' ' 496' ' ' ASP . 6.8 tmtm? -150.6 140.2 21.6 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 105.559 -2.015 . . . . 73.1 105.559 175.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 11.4 p-10 -89.07 127.1 35.68 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.526 0.679 . . . . 72.32 111.179 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 28.3 pt -75.89 130.15 79.24 Favored Pre-proline 0 C--N 1.306 -1.321 0 CA-C-N 114.865 -1.061 . . . . 70.31 110.878 -177.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -85.61 -174.72 1.69 Allowed 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.342 2.028 . . . . 73.32 110.737 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -80.04 133.14 36.11 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.033 -1.099 . . . . 71.21 108.033 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.435 HG23 ' NE2' ' A' ' 503' ' ' GLN . 13.0 p -133.09 -7.25 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-O 121.551 0.691 . . . . 70.23 111.187 -174.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.97 114.8 9.39 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.273 0.559 . . . . 62.0 110.338 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 130.84 -21.94 4.63 Favored Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 109.685 -1.366 . . . . 44.14 109.685 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.435 ' NE2' HG23 ' A' ' 500' ' ' VAL . 21.3 mt-30 -87.08 168.9 12.86 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 109.285 -0.635 . . . . 74.24 109.285 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 47.5 p -85.59 162.32 18.91 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 109.817 -0.438 . . . . 52.41 109.817 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 18.8 m -54.24 -42.23 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.045 0 C-N-CA 123.667 0.787 . . . . 73.14 113.004 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -67.35 -42.27 83.78 Favored 'General case' 0 CA--C 1.507 -0.683 0 C-N-CA 120.643 -0.423 . . . . 73.31 110.856 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 97.7 t -69.74 -40.16 78.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.808 -0.633 . . . . 74.55 110.369 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.24 -49.4 74.32 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.55 -0.295 . . . . 52.12 111.026 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -63.11 -35.42 80.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.068 0.461 . . . . 63.24 110.121 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -62.47 -44.03 97.39 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.171 -0.922 . . . . 75.25 109.037 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.56 -49.0 78.4 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 109.723 -0.473 . . . . 71.12 109.723 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.89 -47.66 83.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.182 -0.463 . . . . 72.25 111.494 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -66.41 -39.19 88.83 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 112.231 0.456 . . . . 74.5 112.231 -176.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.43 -29.14 45.61 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 CA-C-O 121.164 0.507 . . . . 54.32 110.837 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 -87.11 -5.39 59.04 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.154 -0.618 . . . . 75.34 111.525 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . 0.444 ' O ' ' HB ' ' A' ' 547' ' ' VAL . . . 110.21 -4.7 30.05 Favored Glycine 0 CA--C 1.492 -1.369 0 C-N-CA 120.525 -0.845 . . . . 71.41 114.246 175.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.527 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 88.9 m-85 -77.8 119.0 20.68 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.849 -0.797 . . . . 64.45 108.849 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 17.0 p -89.9 -31.67 17.19 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 115.384 -0.826 . . . . 62.4 112.933 -174.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -108.59 119.23 38.92 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.681 0.753 . . . . 74.01 112.457 -172.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -130.32 145.82 51.83 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.071 -0.968 . . . . 73.31 109.442 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 61.2 m -141.23 142.89 33.92 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 108.319 -0.993 . . . . 53.12 108.319 175.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -117.55 135.3 54.04 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.501 -0.555 . . . . 71.14 109.501 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -124.05 119.44 29.51 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.973 -0.751 . . . . 74.43 108.973 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . 0.549 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 55.1 m -84.77 130.85 34.62 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.512 0.672 . . . . 71.12 112.545 -177.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 28.0 m -121.86 150.63 25.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 106.648 -1.612 . . . . 65.01 106.648 173.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . 0.548 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 1.4 p-10 -92.71 137.14 32.62 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 117.839 -1.545 . . . . 64.3 110.483 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 49.0 m -150.28 -179.02 0.91 Allowed Pre-proline 0 C--N 1.293 -1.867 0 N-CA-C 106.111 -1.811 . . . . 72.43 106.111 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -87.04 -11.34 5.43 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 121.549 1.499 . . . . 41.43 111.033 171.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -69.15 127.75 92.88 Favored Pre-proline 0 N--CA 1.441 -0.919 0 N-CA-C 108.344 -0.984 . . . . 71.52 108.344 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -55.7 141.51 84.07 Favored 'Trans proline' 0 C--O 1.255 1.373 0 C-N-CA 122.982 2.454 . . . . 75.23 114.371 -171.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -59.67 125.94 25.64 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 114.313 -1.312 . . . . 72.5 110.949 -176.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 123.83 -19.26 7.44 Favored Glycine 0 N--CA 1.427 -1.962 0 C-N-CA 120.732 -0.747 . . . . 52.32 111.244 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -82.78 129.61 35.01 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.801 -0.444 . . . . 74.53 109.801 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 91.0 t -78.6 110.3 14.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 107.909 -1.145 . . . . 74.31 107.909 174.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 18.3 m -75.89 -34.62 59.97 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 123.892 0.877 . . . . 72.23 111.232 -176.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -173.65 179.91 44.73 Favored Glycine 0 CA--C 1.496 -1.143 0 N-CA-C 110.79 -0.924 . . . . 65.35 110.79 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 35.7 p -128.66 152.7 48.08 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.434 -0.58 . . . . 75.54 109.434 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -62.88 -57.47 21.39 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-O 119.174 -0.441 . . . . 70.33 110.99 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -75.5 139.39 22.97 Favored 'Trans proline' 0 C--N 1.369 1.618 0 CA-C-N 120.135 1.084 . . . . 73.12 109.858 171.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -71.35 142.79 41.87 Favored 'Trans proline' 0 C--O 1.251 1.141 0 C-N-CA 122.531 2.154 . . . . 70.23 112.963 -178.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -65.11 135.32 55.38 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.514 -0.766 . . . . 63.21 110.92 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.61 -18.91 34.46 Favored Glycine 0 N--CA 1.433 -1.5 0 CA-C-N 115.709 -0.678 . . . . 72.24 111.421 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 25.9 m -77.77 132.26 38.0 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.767 0.318 . . . . 75.44 111.094 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 36.0 m -81.92 122.56 27.91 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 107.645 -1.242 . . . . 73.04 107.645 176.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.5 m -134.81 159.5 71.92 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 109.601 -0.518 . . . . 64.35 109.601 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -67.29 137.55 43.92 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.334 2.023 . . . . 75.22 111.545 176.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.527 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 34.1 m -63.04 -19.97 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-O 121.863 0.84 . . . . 54.44 112.044 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -80.83 -12.24 59.47 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.072 -0.967 . . . . 65.22 111.856 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 8.5 t -81.78 171.94 13.94 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 120.33 -0.548 . . . . 73.21 111.653 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 44.4 t -99.0 122.38 50.65 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 CA-C-N 115.636 -0.711 . . . . 73.23 110.107 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 2.5 mp -102.6 124.06 56.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.175 -1.046 . . . . 64.33 108.175 175.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -102.02 123.47 45.97 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-O 121.167 0.508 . . . . 74.35 109.897 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 53.3 mt -98.26 120.99 39.62 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 114.534 -1.212 . . . . 72.44 108.872 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -83.23 119.73 24.93 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 106.69 -1.596 . . . . 70.03 106.69 173.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 524' ' ' SER . 45.0 t -113.06 129.32 68.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 N-CA-C 109.252 -0.647 . . . . 61.52 109.252 -177.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.563 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 23.8 p -82.55 146.87 28.95 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-O 120.884 0.373 . . . . 65.32 111.457 178.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.548 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 14.5 ptpt -97.18 152.52 18.74 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 103.732 -2.692 . . . . 74.51 103.732 167.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -80.18 -32.82 34.24 Favored Glycine 0 CA--C 1.491 -1.437 0 C-N-CA 119.408 -1.377 . . . . 73.45 111.186 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 64.2 t30 61.9 17.02 8.54 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.614 1.166 . . . . 62.41 110.575 176.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -144.76 158.96 43.58 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 107.969 -1.123 . . . . 64.33 107.969 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -143.53 148.59 36.21 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.838 -1.171 . . . . 73.05 107.838 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 61.1 t -76.13 116.06 18.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.741 -0.837 . . . . 55.41 108.741 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . 0.406 ' HA ' ' HD3' ' A' ' 564' ' ' PRO . 54.0 ttp -89.96 138.21 27.79 Favored Pre-proline 0 C--N 1.298 -1.651 0 CA-C-N 115.761 -0.654 . . . . 73.11 111.156 -176.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 563' ' ' MET . 33.8 Cg_exo -63.51 170.47 8.19 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.321 2.681 . . . . 72.13 111.414 172.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . 0.481 ' HA ' ' HB1' ' A' ' 610' ' ' ALA . 25.1 t70 -84.33 115.14 22.34 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.04 0.448 . . . . 63.02 111.503 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 5.5 mp -125.89 -4.8 6.93 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.785 -0.643 . . . . 74.02 109.93 175.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 16.4 t -79.45 146.89 32.5 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 109.582 -0.525 . . . . 72.13 109.582 -176.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 91.14 3.53 69.82 Favored Glycine 0 C--N 1.312 -0.788 0 C-N-CA 120.83 -0.7 . . . . 51.32 112.231 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 85.8 mtp -100.72 177.64 4.93 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 107.332 -1.359 . . . . 75.21 107.332 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 63.2 m-85 -80.47 160.16 25.35 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 119.675 -0.81 . . . . 72.5 110.124 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 78.0 t90 -62.89 -28.76 70.27 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.821 -0.807 . . . . 71.4 108.821 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 21.8 m -76.42 -10.01 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.1 -0.954 . . . . 74.41 111.049 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . 0.431 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 20.6 m-20 -96.04 -44.45 7.33 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 107.567 -1.272 . . . . 74.2 107.567 173.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -56.51 -48.69 76.67 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 114.613 -1.176 . . . . 64.23 111.783 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -50.88 -59.61 7.16 Favored Pre-proline 0 CA--C 1.555 1.162 0 N-CA-C 114.045 1.128 . . . . 75.35 114.045 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . 0.414 ' HD2' ' O ' ' A' ' 573' ' ' ASP . 39.9 Cg_exo -61.99 -41.5 36.19 Favored 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 121.5 1.467 . . . . 71.21 113.115 176.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.431 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 11.9 mmt180 -61.29 -41.01 96.25 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 120.575 0.226 . . . . 73.2 111.016 -177.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 8.8 mp -65.79 -47.17 76.03 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 120.95 0.405 . . . . 75.23 110.987 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -65.14 -34.98 79.68 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.279 -0.419 . . . . 65.22 111.151 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -67.74 -38.27 83.29 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.344 -0.389 . . . . 74.51 111.75 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 4.2 pp -83.4 2.23 37.51 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.564 0.697 . . . . 72.44 111.639 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 83.92 29.46 31.6 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.391 -0.822 . . . . 34.32 113.718 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -81.09 127.49 32.69 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 117.14 0.47 . . . . 72.31 110.399 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 57.0 m -142.87 90.89 2.24 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.393 -1.336 . . . . 73.21 107.393 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -142.21 -133.73 2.87 Favored Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 110.86 -0.896 . . . . 72.41 110.86 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 51.5 ttm -126.6 128.56 46.99 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.445 -0.576 . . . . 65.44 109.445 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 7.3 tt -100.92 114.99 29.36 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.374 -1.343 . . . . 72.01 107.374 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 621' ' ' THR . 28.6 t70 -119.33 112.39 19.37 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.711 0.767 . . . . 54.24 111.954 -178.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . 0.536 ' HE3' ' H ' ' A' ' 624' ' ' PHE . 1.5 tmtp? -87.92 112.84 22.98 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.241 -1.762 . . . . 75.54 106.241 176.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -80.72 -111.67 0.3 Allowed Glycine 0 C--O 1.25 1.095 0 C-N-CA 121.308 -0.473 . . . . 33.32 113.682 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -65.74 144.76 56.68 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 110.032 -0.358 . . . . 74.52 110.032 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . 0.502 ' OD1' ' HB2' ' A' ' 626' ' ' GLN . 4.5 t0 -116.25 152.14 34.4 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 120.088 -0.645 . . . . 73.41 110.029 -177.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 96.1 t -137.4 116.32 14.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 108.593 -0.892 . . . . 64.53 108.593 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . 0.479 ' HA ' ' HB3' ' A' ' 626' ' ' GLN . 7.2 p-10 -78.15 124.53 28.16 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.211 -0.449 . . . . 65.22 109.854 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -156.33 -9.56 0.1 Allowed 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 113.11 0.782 . . . . 72.13 113.11 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 104.92 41.5 1.96 Allowed Glycine 0 CA--C 1.505 -0.568 0 N-CA-C 109.069 -1.613 . . . . 45.35 109.069 -174.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 626' ' ' GLN . . . -56.95 -31.04 60.92 Favored Glycine 0 C--O 1.203 -1.789 0 C-N-CA 125.78 1.657 . . . . 74.14 115.004 -174.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 2.4 p -55.2 -24.82 29.08 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 113.148 0.796 . . . . 74.43 113.148 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -102.31 -12.52 17.88 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 111.975 0.361 . . . . 73.44 111.975 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -145.09 37.29 1.14 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.081 0.771 . . . . 74.25 113.081 -173.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -68.7 90.37 0.41 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 122.222 1.01 . . . . 42.33 111.15 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 32.6 ttp85 -115.63 143.56 45.18 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.173 -1.376 . . . . 71.14 109.391 -176.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.48 130.02 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 106.757 -1.572 . . . . 73.34 106.757 176.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 94.6 t -96.46 -51.99 9.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 121.619 0.723 . . . . 70.22 109.065 -175.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -145.08 160.02 42.06 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 104.441 -2.429 . . . . 62.51 104.441 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . 0.53 ' HA ' ' O ' ' A' ' 621' ' ' THR . 13.8 pt20 -147.19 139.29 24.46 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 106.98 -1.489 . . . . 73.2 106.98 173.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . 0.255 93.9 m-20 -61.06 -42.67 87.66 Favored Pre-proline 0 C--N 1.306 -1.286 0 N-CA-C 114.668 1.359 . . . . 65.02 114.668 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -69.39 108.67 2.06 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 121.192 1.262 . . . . 74.31 109.946 171.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -70.74 135.23 27.64 Favored 'Trans proline' 0 C--O 1.25 1.113 0 C-N-CA 121.981 1.787 . . . . 54.11 112.403 -175.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . 0.481 ' HB1' ' HA ' ' A' ' 565' ' ' ASP . . . -67.69 134.76 51.65 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.573 -0.739 . . . . 54.43 109.538 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 86.67 -2.38 87.26 Favored Glycine 0 N--CA 1.434 -1.444 0 C-N-CA 120.707 -0.759 . . . . 52.23 112.466 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 9.6 m -111.54 161.72 15.89 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.488 -0.56 . . . . 63.21 109.488 -176.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -71.68 113.19 4.47 Favored Glycine 0 N--CA 1.435 -1.407 0 N-CA-C 110.084 -1.206 . . . . 65.43 110.084 174.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 32.3 m -107.74 143.05 18.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 123.065 0.546 . . . . 64.12 110.544 -177.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.474 HD21 HG22 ' A' ' 619' ' ' ILE . 23.8 p-10 -42.53 136.72 2.35 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 124.867 1.355 . . . . 73.44 112.079 176.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -58.71 -24.95 62.38 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 124.854 1.261 . . . . 73.41 110.014 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -55.67 -45.21 77.77 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.588 -0.733 . . . . 74.41 109.797 173.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 71.48 19.41 77.7 Favored Glycine 0 N--CA 1.423 -2.186 0 CA-C-N 115.649 -0.705 . . . . 71.44 112.396 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . 0.474 HG22 HD21 ' A' ' 615' ' ' ASN . 0.0 OUTLIER -69.7 119.78 16.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 107.879 -1.156 . . . . 73.32 107.879 -176.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.92 119.66 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.575 0 CA-C-O 122.345 1.069 . . . . 74.01 111.352 -170.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' A' ' 606' ' ' GLN . 0.2 OUTLIER -104.38 121.68 43.89 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-N 114.073 -1.421 . . . . 53.11 109.542 175.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 2.3 pt? -138.4 165.35 27.01 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 123.851 0.86 . . . . 73.05 110.345 -174.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 21.6 ttp85 -134.54 137.51 43.88 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 107.716 -1.216 . . . . 70.31 107.716 174.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.536 ' H ' ' HE3' ' A' ' 589' ' ' LYS . 35.3 p90 -141.52 157.76 44.72 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.862 -1.162 . . . . 73.52 107.862 176.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -56.9 150.94 27.01 Favored Glycine 0 C--N 1.314 -0.68 0 O-C-N 124.597 1.186 . . . . 33.42 114.711 -177.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . 0.502 ' HB2' ' OD1' ' A' ' 592' ' ' ASP . 8.9 tt0 . . . . . 0 C--N 1.302 -1.468 0 C-N-CA 124.741 1.216 . . . . 73.2 108.472 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 . . . . . 0 CA--C 1.493 -1.247 0 N-CA-C 105.54 -2.022 . . . . 73.2 105.54 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 31.8 m -117.56 164.34 13.94 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 N-CA-C 109.836 -0.431 . . . . 63.34 109.836 -172.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -92.43 136.36 33.27 Favored 'General case' 1 N--CA 1.378 -4.037 0 N-CA-C 106.458 -1.682 . . . . 74.33 106.458 175.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 72.2 t -96.96 121.22 59.84 Favored Pre-proline 0 C--N 1.255 -3.517 0 CA-C-N 114.576 -1.193 . . . . 64.45 109.899 -171.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.48 114.81 3.78 Favored 'Trans proline' 0 N--CA 1.43 -2.231 0 C-N-CA 121.165 1.243 . . . . 71.34 109.877 174.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . 0.436 ' OD2' ' HB ' ' A' ' 402' ' ' THR . 8.1 p-10 -100.83 141.21 34.03 Favored 'General case' 0 C--N 1.272 -2.8 0 CA-C-N 115.18 -0.918 . . . . 71.0 109.728 -177.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.475 ' H ' HD21 ' A' ' 377' ' ' LEU . 38.2 t -89.23 15.69 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 CA-C-N 114.326 -1.307 . . . . 64.54 111.12 -171.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.467 ' HB2' HG22 ' A' ' 402' ' ' THR . 30.1 mtp180 -65.33 147.21 53.84 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.075 -0.966 . . . . 50.42 110.966 175.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . 0.576 ' H ' ' HB ' ' A' ' 399' ' ' VAL . . . 107.7 -6.14 35.39 Favored Glycine 0 C--N 1.307 -1.049 0 N-CA-C 110.956 -0.858 . . . . 63.44 110.956 -171.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -110.58 -154.0 0.53 Allowed 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 107.215 -1.402 . . . . 75.52 107.215 170.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 78.4 p -82.77 162.45 21.7 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 118.872 0.76 . . . . 74.1 109.305 -176.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 54.6 p -57.18 -46.67 82.61 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 123.265 0.353 . . . . 73.12 110.528 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.82 -46.24 82.8 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 116.086 -0.506 . . . . 52.01 112.226 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -67.07 -42.61 84.39 Favored 'General case' 0 C--O 1.255 1.349 0 CA-C-O 121.663 0.744 . . . . 72.15 109.673 -176.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.05 -51.14 63.18 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.751 -1.113 . . . . 75.34 110.795 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 74.6 mt -60.13 -43.29 92.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 CA-C-N 116.284 -0.417 . . . . 62.1 111.137 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.51 -44.38 89.44 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 123.63 0.581 . . . . 71.35 110.849 -177.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . 0.52 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 12.9 m -69.1 -46.81 66.8 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 116.013 -0.54 . . . . 75.12 111.359 -178.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.475 HD21 ' H ' ' A' ' 365' ' ' VAL . 4.5 mm? -59.66 -43.03 94.1 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 120.647 0.261 . . . . 74.15 111.486 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -64.42 -42.29 96.12 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.11 -0.495 . . . . 73.5 110.516 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -69.07 -17.82 63.92 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 111.941 0.348 . . . . 74.03 111.941 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 376' ' ' THR . 22.1 mmm180 -90.0 -11.76 40.64 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.183 0.516 . . . . 64.53 110.826 176.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.17 9.18 48.89 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.178 -1.01 . . . . 72.31 112.546 177.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -90.68 159.36 16.42 Favored 'General case' 0 N--CA 1.415 -2.223 0 N-CA-C 109.514 -0.551 . . . . 72.23 109.514 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.411 ' HB2' ' HG2' ' A' ' 415' ' ' GLU . 92.0 mttt -105.91 158.11 17.01 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 109.065 -0.717 . . . . 75.32 109.065 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . 0.466 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -132.64 150.97 33.74 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.523 0 N-CA-C 108.19 -1.041 . . . . 71.33 108.19 177.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -118.28 126.88 53.05 Favored 'General case' 0 C--N 1.273 -2.741 0 N-CA-C 105.421 -2.066 . . . . 64.15 105.421 173.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 28.0 m -118.79 119.97 35.98 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 109.527 -0.546 . . . . 54.12 109.527 -173.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -112.15 125.59 54.29 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.369 -0.604 . . . . 64.32 109.369 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -100.31 121.92 42.26 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.175 -0.676 . . . . 74.0 109.175 177.067 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -120.86 117.52 30.97 Favored Pre-proline 0 C--N 1.304 -1.41 0 CA-C-N 115.674 -0.694 . . . . 71.44 110.222 -172.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -87.68 129.87 2.64 Favored 'Trans proline' 0 C--O 1.254 1.282 0 C-N-CA 122.27 1.98 . . . . 74.41 111.291 176.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.503 ' HB3' HG12 ' A' ' 394' ' ' ILE . 27.1 t70 176.85 162.47 0.43 Allowed 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.483 -0.562 . . . . 73.04 109.483 -177.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 7.7 m -89.64 -14.61 34.5 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 113.047 0.758 . . . . 73.31 113.047 -175.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 10.1 t -123.04 8.52 9.26 Favored 'General case' 0 C--O 1.249 1.079 0 C-N-CA 118.519 -1.272 . . . . 72.21 113.06 -175.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.503 HG12 ' HB3' ' A' ' 391' ' ' ASP . 33.6 mm -88.36 133.76 35.95 Favored Pre-proline 0 C--N 1.31 -1.151 0 N-CA-C 107.214 -1.402 . . . . 45.54 107.214 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 396' ' ' PRO . 11.0 Cg_endo -53.58 145.56 47.3 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.483 2.789 . . . . 73.21 114.429 -178.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 395' ' ' PRO . 81.1 Cg_exo -55.32 162.08 6.36 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 123.758 2.972 . . . . 63.21 111.804 175.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . 0.409 ' CB ' HG13 ' A' ' 420' ' ' VAL . 2.9 p-10 -57.21 -8.69 0.76 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.476 1.11 . . . . 71.42 113.311 -175.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 46.1 m170 -76.62 124.85 28.25 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.825 -1.176 . . . . 75.21 107.825 175.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.576 ' HB ' ' H ' ' A' ' 367' ' ' GLY . 8.9 t -76.48 132.43 33.01 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.577 0 CA-C-N 115.508 -0.769 . . . . 74.41 111.041 -167.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 28.9 pt -98.58 -27.97 3.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 114.959 -1.019 . . . . 64.14 113.504 -175.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.52 174.2 25.62 Favored Glycine 0 CA--C 1.503 -0.711 0 N-CA-C 110.439 -1.064 . . . . 73.32 110.439 -173.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . 0.467 HG22 ' HB2' ' A' ' 366' ' ' ARG . 60.2 p -111.14 -178.67 3.52 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 118.164 0.982 . . . . 72.24 111.391 -174.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . 0.459 ' CB ' HG23 ' A' ' 416' ' ' ILE . 7.6 t70 -110.72 129.03 24.39 Favored Pre-proline 0 C--N 1.314 -0.96 0 N-CA-C 109.231 -0.655 . . . . 41.23 109.231 -176.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.67 -26.63 66.27 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 123.358 2.705 . . . . 53.23 113.804 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.95 -42.22 75.88 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.942 -0.572 . . . . 61.05 110.347 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -79.97 -31.84 39.86 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 121.688 0.756 . . . . 64.42 110.485 -178.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -84.74 2.39 42.25 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.721 -0.672 . . . . 71.21 111.099 -173.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 25.4 m -109.82 154.23 23.29 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.293 -1.743 . . . . 75.11 106.293 172.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 26.7 m -74.91 113.01 11.72 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 119.58 -0.848 . . . . 60.04 109.295 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 30.9 m -129.99 169.2 21.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-O 120.815 0.341 . . . . 61.5 110.283 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 33.5 m -69.75 143.45 53.02 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.17 -1.048 . . . . 40.41 108.17 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -68.04 109.03 3.31 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.174 0.512 . . . . 74.24 110.505 -177.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 129.97 69.1 0.11 Allowed Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 110.367 -1.093 . . . . 72.05 110.367 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -130.16 -175.38 3.61 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.227 -1.397 . . . . 73.52 107.227 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . 0.411 ' HG2' ' HB2' ' A' ' 383' ' ' LYS . 43.8 mt-10 -114.49 132.62 56.22 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.355 0.598 . . . . 75.43 111.342 -176.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . 0.459 HG23 ' CB ' ' A' ' 403' ' ' ASP . 36.4 mm -112.14 115.4 49.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 106.707 -1.59 . . . . 71.4 106.707 177.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 54.5 m -91.61 118.6 30.76 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.157 0.503 . . . . 54.15 111.987 -172.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 14.1 p -110.71 135.06 50.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 C-N-CA 124.294 1.038 . . . . 61.13 111.32 -175.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -102.53 116.1 31.91 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.05 -0.722 . . . . 74.22 109.05 176.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 72.6 t -108.54 131.63 58.61 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 106.66 -1.607 . . . . 72.14 106.66 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . 0.413 ' OG ' ' HB ' ' A' ' 394' ' ' ILE . 33.0 t -119.79 137.12 54.16 Favored 'General case' 0 C--N 1.288 -2.096 0 C-N-CA 119.276 -0.969 . . . . 65.11 111.93 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.1 p -96.1 156.33 16.38 Favored 'General case' 0 N--CA 1.408 -2.564 0 N-CA-C 106.148 -1.797 . . . . 70.03 106.148 170.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.262 1.886 0 N-CA-C 116.073 1.189 . . . . 75.34 116.073 -172.58 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.441 ' HG2' ' HA ' ' A' ' 479' ' ' ALA . 45.9 mt-30 . . . . . 0 N--CA 1.409 -2.52 0 N-CA-C 107.277 -1.379 . . . . 72.52 107.277 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.559 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 3.4 mmp_? -122.91 147.63 46.38 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-O 121.217 0.532 . . . . 74.04 110.881 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.423 ' HG2' ' H ' ' A' ' 428' ' ' GLU . 8.9 pt-20 -83.36 133.68 34.94 Favored 'General case' 0 C--N 1.272 -2.792 0 CA-C-N 114.61 -1.177 . . . . 71.21 107.98 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.52 ' HB ' ' O ' ' A' ' 474' ' ' ALA . 63.5 mt -80.51 125.57 80.5 Favored Pre-proline 0 N--CA 1.429 -1.5 0 C-N-CA 120.121 -0.631 . . . . 72.34 109.461 -175.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.88 146.11 52.38 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 122.28 1.987 . . . . 54.42 111.014 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -78.9 144.56 34.79 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.718 -0.845 . . . . 74.41 108.718 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.473 HG11 ' HB2' ' A' ' 440' ' ' ALA . 13.1 p -143.25 160.87 17.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 108.379 -0.971 . . . . 72.41 108.379 -175.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 19.2 m -68.89 138.0 54.31 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 108.486 -0.931 . . . . 75.25 108.486 174.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 35.2 p -69.21 -29.57 67.55 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 123.088 0.555 . . . . 53.34 111.612 -175.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.2 pp -80.32 -10.47 59.75 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.103 0.477 . . . . 73.23 111.611 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 5.1 m -105.95 57.41 0.66 Allowed 'General case' 0 CA--C 1.566 1.562 0 CA-C-O 121.669 0.747 . . . . 64.2 110.609 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.26 -38.42 58.13 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.465 1.106 . . . . 73.23 112.0 175.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.82 -42.81 85.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.189 0.519 . . . . 70.41 110.764 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -71.59 -35.44 70.53 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 116.02 -0.536 . . . . 75.3 110.517 178.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.509 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -59.5 -51.31 70.41 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.548 -0.296 . . . . 61.44 111.016 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 22.2 m -64.65 -36.96 78.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 CA-C-O 120.648 0.261 . . . . 74.22 111.441 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 37.9 tptt -59.39 -47.54 85.05 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.815 -0.63 . . . . 73.11 109.507 175.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -64.97 -37.92 89.26 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.762 -0.654 . . . . 74.32 112.258 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 90.1 mt -63.39 -37.23 86.49 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.883 -0.414 . . . . 72.41 109.883 175.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.428 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 28.5 m -67.77 -44.55 77.16 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.958 -0.564 . . . . 60.23 109.972 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.13 -16.09 62.53 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.445 -0.798 . . . . 74.22 112.14 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . 0.482 ' O ' ' HG3' ' A' ' 427' ' ' ARG . . . -87.87 5.82 38.5 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.005 0.431 . . . . 75.2 111.666 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . 0.436 ' HA3' HD12 ' A' ' 480' ' ' ILE . . . 107.14 -73.57 0.21 Allowed Glycine 0 CA--C 1.491 -1.457 0 C-N-CA 120.006 -1.092 . . . . 23.01 111.883 175.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . 0.436 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 1.3 p90 -42.43 -65.97 0.41 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.806 1.039 . . . . 71.4 113.806 176.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . 0.428 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 62.9 17.34 58.27 Favored Glycine 0 C--N 1.317 -0.479 0 C-N-CA 121.447 -0.406 . . . . 64.34 112.545 -176.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 16.4 mmm-85 -93.07 110.73 22.21 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 106.416 -1.698 . . . . 71.24 106.416 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.526 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 15.4 p90 -141.03 150.12 42.6 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-O 121.066 0.46 . . . . 75.43 111.69 -177.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -132.22 123.33 26.77 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.147 -1.057 . . . . 74.21 108.147 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -90.46 132.56 35.58 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.037 -0.727 . . . . 71.53 109.037 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . 0.433 ' O ' HD12 ' A' ' 487' ' ' ILE . . . -132.72 134.62 45.01 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 109.175 -0.676 . . . . 70.41 109.175 176.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 488' ' ' VAL . 34.7 p30 -118.98 139.54 51.51 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 120.961 0.41 . . . . 74.14 110.397 174.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 34.2 t -135.44 143.01 43.43 Favored Pre-proline 0 C--N 1.288 -2.084 0 N-CA-C 108.299 -1.0 . . . . 70.14 108.299 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 490' ' ' SER . 24.5 Cg_exo -65.56 132.31 30.61 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 121.728 1.619 . . . . 65.41 109.519 174.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 28.5 p -152.19 179.68 8.3 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 108.32 -0.993 . . . . 32.33 108.32 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.8 t -47.18 137.25 8.45 Favored Pre-proline 0 C--O 1.247 0.949 0 C-N-CA 123.732 0.813 . . . . 74.41 111.959 176.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.81 -29.38 34.14 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 124.533 3.488 . . . . 73.33 113.842 -176.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -64.17 -29.28 70.41 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 120.955 0.407 . . . . 64.43 111.403 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 79.7 mt -94.87 11.79 30.44 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 112.334 0.494 . . . . 62.31 112.334 -176.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 13.0 p -60.71 127.18 19.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 C-N-CA 120.156 -0.617 . . . . 73.25 110.022 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 76.38 2.29 73.45 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.347 -0.842 . . . . 72.33 113.308 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -107.83 139.74 41.97 Favored 'General case' 0 N--CA 1.413 -2.303 0 CA-C-O 121.39 0.614 . . . . 65.11 110.908 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 79.0 t -67.2 134.22 30.44 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 CA-C-N 114.005 -1.452 . . . . 65.2 107.6 173.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 55.6 mt -96.64 -28.32 3.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 108.278 -1.008 . . . . 61.31 108.278 -176.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 159.72 -164.01 33.91 Favored Glycine 0 N--CA 1.416 -2.695 0 N-CA-C 110.659 -0.977 . . . . 54.54 110.659 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 12.1 p -135.66 145.4 46.75 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 107.218 -1.401 . . . . 75.21 107.218 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -62.89 -52.74 61.53 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 119.799 -0.761 . . . . 64.43 110.495 177.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 473' ' ' PRO . 29.9 Cg_endo -69.45 134.82 29.59 Favored 'Trans proline' 0 C--N 1.366 1.497 0 N-CA-C 107.408 -1.804 . . . . 72.14 107.408 168.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.488 ' HB2' ' CG ' ' A' ' 476' ' ' GLN . 28.7 Cg_exo -61.84 127.75 22.37 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 121.623 1.549 . . . . 71.14 112.231 -175.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.52 ' O ' ' HB ' ' A' ' 429' ' ' ILE . . . -77.89 -3.68 42.92 Favored 'General case' 0 C--O 1.204 -1.338 0 CA-C-N 115.073 -0.967 . . . . 72.13 113.514 -171.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -110.25 0.56 18.17 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.244 -0.91 . . . . 72.43 111.174 174.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . 0.488 ' CG ' ' HB2' ' A' ' 473' ' ' PRO . 15.5 mm100 -100.22 -177.35 3.5 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.671 -0.695 . . . . 73.32 110.613 -176.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.38 130.26 35.78 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 115.979 -0.555 . . . . 63.24 109.906 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 41.3 t -124.56 142.19 51.54 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.698 -0.853 . . . . 43.31 108.698 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.441 ' HA ' ' HG2' ' A' ' 426' ' ' GLN . . . -72.7 152.87 41.45 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 112.586 0.587 . . . . 62.21 112.586 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . 0.436 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 43.2 mm -64.68 -24.97 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-O 121.835 0.826 . . . . 70.12 110.874 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 7.8 p -96.9 5.7 50.03 Favored 'General case' 0 C--N 1.291 -1.977 0 O-C-N 121.839 -0.538 . . . . 74.22 111.589 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -100.15 144.91 28.62 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.018 -0.537 . . . . 72.12 110.641 -174.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.8 p -94.48 127.38 46.52 Favored 'Isoleucine or valine' 0 C--O 1.249 1.039 0 CA-C-O 121.531 0.681 . . . . 62.0 112.367 -177.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 56.4 t -101.34 120.59 51.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 108.838 -0.801 . . . . 60.12 108.838 177.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.73 123.37 50.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-O 121.128 0.489 . . . . 54.13 109.747 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 29.2 mm -100.83 110.11 27.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 C-N-CA 124.789 1.236 . . . . 71.41 109.293 -177.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.433 HD12 ' O ' ' A' ' 455' ' ' ALA . 5.9 tp -99.44 126.9 52.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 109.349 -0.611 . . . . 72.33 109.349 177.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 456' ' ' ASN . 2.4 p -120.53 142.06 38.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 C-N-CA 123.946 0.898 . . . . 75.35 108.882 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -90.01 142.48 16.53 Favored Glycine 0 N--CA 1.431 -1.681 0 C-N-CA 120.666 -0.778 . . . . 63.12 113.567 -176.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 22.8 t . . . . . 0 C--N 1.299 -1.607 0 N-CA-C 106.152 -1.795 . . . . 70.45 106.152 174.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo . . . . . 0 CA--C 1.546 1.087 0 CA-C-O 121.41 0.504 . . . . 60.33 113.395 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -147.43 37.5 0.92 Allowed 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 106.869 -1.53 . . . . 71.5 106.869 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.521 ' HB ' HG22 ' A' ' 544' ' ' THR . 1.0 OUTLIER -116.45 146.17 42.74 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 113.493 -1.685 . . . . 62.23 113.055 -169.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . 0.454 ' HA ' ' HE3' ' A' ' 495' ' ' LYS . 1.0 OUTLIER -142.26 146.68 35.38 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 124.468 1.107 . . . . 73.23 108.395 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 7.3 m-20 -80.42 131.15 35.55 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 109.134 -0.691 . . . . 55.04 109.134 176.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 35.1 pt -77.09 130.45 75.29 Favored Pre-proline 0 C--N 1.3 -1.552 0 C-N-CA 120.532 -0.467 . . . . 65.13 111.55 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . 0.457 ' HD2' HD13 ' A' ' 512' ' ' LEU . 41.7 Cg_endo -69.02 165.97 28.28 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.615 2.21 . . . . 71.52 111.029 175.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -92.8 147.33 22.94 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.832 -0.622 . . . . 62.43 110.695 -177.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.3 p -162.54 89.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 122.401 1.096 . . . . 45.11 110.829 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -137.53 114.48 10.67 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.14 -0.936 . . . . 71.3 108.743 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 101.11 17.51 22.41 Favored Glycine 0 N--CA 1.429 -1.791 0 N-CA-C 109.899 -1.281 . . . . 43.33 109.899 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.477 ' OE1' HG11 ' A' ' 507' ' ' VAL . 44.7 mt-30 -124.65 174.23 8.0 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 108.044 -1.095 . . . . 63.43 108.044 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 9.4 t -92.2 168.16 11.54 Favored 'General case' 0 C--O 1.256 1.397 0 C-N-CA 119.694 -0.803 . . . . 63.14 110.791 -175.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 89.7 t -49.87 -41.38 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.832 1.253 . . . . 62.3 111.603 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -57.67 -39.25 76.64 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.556 -0.747 . . . . 62.55 111.381 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . 0.477 HG11 ' OE1' ' A' ' 503' ' ' GLN . 23.0 t -75.48 -38.54 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-N 115.686 -0.688 . . . . 71.22 110.107 -175.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . 0.436 ' O ' HD23 ' A' ' 512' ' ' LEU . . . -62.6 -49.76 73.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.624 -0.716 . . . . 63.35 110.998 -177.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.413 ' O ' ' HB2' ' A' ' 513' ' ' ASN . 10.3 pt20 -65.43 -35.83 82.11 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.318 -0.401 . . . . 73.2 110.862 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -50.7 67.92 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.734 -0.666 . . . . 63.42 109.837 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -62.01 -47.24 85.65 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 120.662 0.268 . . . . 75.04 111.125 -177.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . 0.457 HD13 ' HD2' ' A' ' 498' ' ' PRO . 4.3 mm? -63.93 -43.16 96.73 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.458 -0.337 . . . . 73.51 111.788 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 509' ' ' GLN . 1.8 t-20 -60.07 -42.75 95.23 Favored 'General case' 0 N--CA 1.423 -1.816 0 C-N-CA 122.859 0.464 . . . . 42.11 111.384 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 48.9 t -59.5 -31.98 47.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 123.322 0.649 . . . . 72.24 111.653 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -85.59 -5.0 59.32 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 112.045 0.387 . . . . 71.44 112.045 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 116.87 -10.94 15.45 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 119.826 -1.178 . . . . 61.43 113.742 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -74.01 125.69 28.83 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 117.335 0.567 . . . . 75.21 111.589 -176.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 11.7 p -104.54 -23.98 13.07 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.479 -0.782 . . . . 74.54 112.0 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . 0.432 ' O ' HD13 ' A' ' 551' ' ' ILE . 10.0 mtmp? -111.46 114.69 27.97 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 120.322 -0.551 . . . . 74.31 110.757 -176.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -114.59 132.63 56.28 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.135 -1.061 . . . . 74.42 108.135 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 25.4 p -115.52 134.21 55.29 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 107.305 -1.369 . . . . 72.33 107.305 173.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -117.27 120.37 38.04 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 109.156 -0.683 . . . . 73.24 109.156 -175.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -106.68 138.52 42.69 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.802 -0.635 . . . . 41.54 109.845 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 57.2 m -92.52 123.9 36.17 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.513 -0.551 . . . . 70.2 109.513 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 60.6 t -120.88 148.43 24.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 106.845 -1.539 . . . . 73.51 106.845 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.53 135.96 38.26 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-O 120.965 0.412 . . . . 74.4 111.607 -178.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . 0.429 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 38.7 m -154.13 172.5 5.72 Favored Pre-proline 0 N--CA 1.429 -1.521 0 N-CA-C 106.162 -1.792 . . . . 54.11 106.162 175.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -90.93 -0.91 4.98 Favored 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 121.938 1.759 . . . . 73.52 109.842 167.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.558 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 0.0 OUTLIER -78.31 132.6 65.8 Favored Pre-proline 0 C--O 1.216 -0.681 0 CA-C-N 114.912 -1.04 . . . . 64.13 109.229 178.406 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . 0.432 ' O ' ' HB2' ' A' ' 533' ' ' GLU . 31.2 Cg_exo -56.03 143.68 82.28 Favored 'Trans proline' 0 C--O 1.246 0.88 0 C-N-CA 123.1 2.534 . . . . 72.33 113.692 -175.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.61 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -56.7 132.01 50.76 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.287 -0.87 . . . . 72.31 111.045 -178.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 110.9 -8.91 29.64 Favored Glycine 0 C--N 1.306 -1.127 0 N-CA-C 110.357 -1.097 . . . . 72.34 110.357 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 530' ' ' PRO . 7.5 tp10 -82.62 125.55 31.32 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 106.811 -1.551 . . . . 71.24 106.811 178.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 91.2 t -89.1 110.03 20.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 107.564 -1.273 . . . . 73.03 107.564 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . 0.485 HG23 ' HG3' ' A' ' 554' ' ' GLN . 11.4 t -78.32 -12.48 60.01 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.884 -0.598 . . . . 72.24 110.683 -176.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.98 -159.45 28.33 Favored Glycine 0 N--CA 1.428 -1.844 0 C-N-CA 120.952 -0.642 . . . . 72.01 111.743 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 40.7 p -117.67 148.52 41.89 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 107.323 -1.362 . . . . 73.41 107.323 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.455 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 51.0 t30 -66.07 -50.57 50.88 Favored Pre-proline 0 C--N 1.315 -0.908 0 C-N-CA 120.603 -0.439 . . . . 75.54 111.543 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.455 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 11.2 Cg_exo -75.8 141.55 24.53 Favored 'Trans proline' 0 C--N 1.367 1.525 0 N-CA-C 108.304 -1.46 . . . . 71.42 108.304 170.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.51 143.35 97.16 Favored 'Trans proline' 0 C--O 1.249 1.063 0 C-N-CA 122.068 1.845 . . . . 63.55 111.756 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.02 138.15 58.34 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.289 0.566 . . . . 30.44 111.818 -177.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 96.1 -10.35 67.78 Favored Glycine 0 C--N 1.308 -0.977 0 CA-C-N 115.942 -0.572 . . . . 74.34 112.439 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 42.8 m -70.77 134.4 47.38 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.506 -0.553 . . . . 61.22 109.506 178.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.521 HG22 ' HB ' ' A' ' 494' ' ' THR . 24.8 m -84.06 123.08 29.65 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 109.177 -0.675 . . . . 70.43 109.177 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.68 157.47 78.08 Favored Pre-proline 0 C--N 1.313 -0.982 0 N-CA-C 108.444 -0.947 . . . . 50.14 108.444 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -68.19 141.68 53.07 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.804 1.67 . . . . 74.24 111.045 176.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 35.0 m -65.14 -20.2 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-O 121.842 0.829 . . . . 52.32 110.443 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -74.37 -18.63 60.65 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.607 -1.178 . . . . 74.41 110.493 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.1 t -87.37 150.96 23.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.113 -1.069 . . . . 64.42 108.113 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 12.5 p -88.82 135.84 24.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.003 -1.11 . . . . 74.01 108.003 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . 0.571 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -96.33 145.9 8.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 C-N-CA 118.738 -1.185 . . . . 72.11 109.701 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -109.74 115.83 30.57 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-O 121.579 0.704 . . . . 74.33 110.857 -175.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -94.94 133.88 38.21 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 106.169 -1.789 . . . . 65.23 106.169 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . 0.485 ' HG3' HG23 ' A' ' 535' ' ' THR . 3.1 pt20 -108.48 116.45 32.0 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 122.099 0.952 . . . . 72.2 110.143 -177.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 54.6 t -103.7 139.68 23.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 CA-C-N 114.403 -1.271 . . . . 74.34 108.573 -175.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.61 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 73.5 m -82.4 136.52 34.94 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-O 122.068 0.937 . . . . 64.5 113.006 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -85.18 139.45 31.67 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 104.5 -2.408 . . . . 74.13 104.5 167.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . 0.558 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -83.18 -43.87 7.3 Favored Glycine 0 CA--C 1.484 -1.845 0 C-N-CA 119.768 -1.206 . . . . 61.42 113.547 -174.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 64.46 18.72 11.5 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 112.69 0.626 . . . . 71.44 112.69 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -124.21 145.75 49.14 Favored 'General case' 0 N--CA 1.417 -2.111 0 C-N-CA 120.283 -0.567 . . . . 72.25 110.547 -169.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -139.54 153.06 47.36 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.883 -0.784 . . . . 65.43 108.883 174.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 8.9 p -78.17 125.4 37.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.448 0.642 . . . . 74.03 112.446 -173.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 52.8 ttp -97.34 130.81 28.63 Favored Pre-proline 0 C--O 1.248 1.009 0 CA-C-N 115.92 -0.582 . . . . 73.44 111.065 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -74.22 170.49 20.05 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.939 2.426 . . . . 64.1 111.298 174.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -69.36 120.07 14.61 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.51 0.671 . . . . 71.11 110.902 177.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 87.2 mt -104.05 -7.04 20.57 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.647 -0.706 . . . . 75.12 110.102 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 47.4 m -66.65 132.01 47.22 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.598 -0.728 . . . . 72.14 109.875 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 93.91 -11.51 70.8 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.716 -0.754 . . . . 64.53 112.327 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 89.4 mtp -83.84 146.17 28.25 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.493 -0.558 . . . . 75.52 109.493 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -92.21 137.95 31.94 Favored 'General case' 0 N--CA 1.414 -2.247 0 N-CA-C 107.027 -1.471 . . . . 75.11 107.027 177.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . 0.453 ' HA ' ' HB3' ' A' ' 574' ' ' ALA . 41.1 t90 -57.84 -25.82 61.18 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 123.399 0.437 . . . . 63.44 111.916 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 14.3 p -64.16 -29.95 48.73 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-O 120.996 0.427 . . . . 74.21 110.831 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -101.3 -34.3 9.69 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-O 121.687 0.756 . . . . 72.23 109.452 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . 0.46 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -63.6 -40.31 96.61 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-N 115.168 -0.924 . . . . 70.13 111.875 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.458 ' O ' ' HG2' ' A' ' 579' ' ' ARG . 17.4 tp10 -51.4 -59.34 8.06 Favored Pre-proline 0 CA--C 1.562 1.421 0 C-N-CA 123.074 0.55 . . . . 73.31 112.047 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.46 -35.26 83.64 Favored 'Trans proline' 0 C--N 1.375 1.929 0 CA-C-N 120.684 1.28 . . . . 60.54 112.6 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.513 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 83.2 mmt-85 -66.51 -39.77 88.84 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 120.469 -0.492 . . . . 74.41 111.817 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 93.8 mt -65.89 -43.71 87.48 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.459 -0.337 . . . . 75.44 111.134 -177.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 29.5 mmt180 -65.04 -37.41 87.48 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.731 -0.47 . . . . 74.12 109.731 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.13 -31.16 71.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.441 -0.799 . . . . 73.31 111.422 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 99.1 mt -81.88 -7.81 59.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.399 -0.364 . . . . 54.43 111.531 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 87.13 34.47 10.71 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.698 -0.763 . . . . 53.45 111.855 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 44.4 t90 -86.67 127.67 34.96 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.574 -0.528 . . . . 72.43 109.574 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 13.9 m -133.16 28.28 4.12 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 122.618 1.199 . . . . 75.41 108.117 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -82.97 -164.78 36.37 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 114.883 -1.053 . . . . 74.24 112.065 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 55.0 ttp -108.93 130.98 55.46 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 122.615 -0.344 . . . . 73.44 110.463 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 41.7 tp -90.56 116.28 28.34 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.401 -1.333 . . . . 74.1 107.401 175.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -107.26 107.73 18.8 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.408 0.623 . . . . 74.24 111.574 -177.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -112.77 124.7 53.17 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.675 -1.232 . . . . 74.34 107.675 174.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -88.54 -120.56 1.7 Allowed Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 109.944 -1.262 . . . . 61.5 109.944 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -82.09 133.6 35.29 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.524 -0.917 . . . . 73.42 108.524 176.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -78.82 124.9 28.68 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.262 -1.014 . . . . 74.14 108.262 177.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 44.0 t -121.85 116.2 48.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 116.064 -0.516 . . . . 63.21 110.555 -174.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -90.46 107.64 19.29 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.495 -1.298 . . . . 73.31 107.495 176.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -132.01 4.46 4.13 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.763 -0.775 . . . . 54.43 111.603 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 116.11 -175.75 16.01 Favored Glycine 0 N--CA 1.424 -2.12 0 C-N-CA 120.403 -0.903 . . . . 74.05 111.051 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -58.69 -33.32 72.11 Favored Glycine 0 C--N 1.322 -0.196 0 C-N-CA 123.455 0.55 . . . . 41.32 114.18 -175.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 19.9 m -64.41 -27.56 69.09 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 120.9 0.381 . . . . 64.13 111.433 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -109.13 -1.44 18.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.981 0.419 . . . . 73.22 111.329 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -81.73 113.01 19.42 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 112.241 0.46 . . . . 62.31 112.241 -173.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 57.48 -2.11 0.06 Allowed 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 126.506 1.922 . . . . 62.3 115.46 172.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -96.54 145.98 25.22 Favored 'General case' 0 CA--C 1.501 -0.91 0 O-C-N 121.015 -1.053 . . . . 74.11 111.722 -174.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 97.8 t -65.43 130.04 30.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 107.045 -1.465 . . . . 71.42 107.045 173.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 87.9 t -89.02 -41.81 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-O 121.311 0.577 . . . . 62.43 110.061 -175.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -151.03 158.15 43.75 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.823 -1.177 . . . . 72.22 107.823 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -119.19 127.24 53.12 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 107.517 -1.29 . . . . 71.21 107.517 175.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.549 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 27.0 t-20 -54.53 -58.07 15.85 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-O 118.785 -0.626 . . . . 64.4 112.623 -179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.549 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 2.9 Cg_endo -84.44 136.49 6.53 Favored 'Trans proline' 0 C--N 1.363 1.305 0 CA-C-N 120.926 1.366 . . . . 74.21 109.921 174.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 608' ' ' PRO . 22.9 Cg_exo -63.94 158.62 46.36 Favored 'Trans proline' 0 C--O 1.243 0.755 0 C-N-CA 122.37 2.047 . . . . 75.21 111.882 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.59 130.42 42.98 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 116.305 -0.407 . . . . 72.12 109.94 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 98.16 -2.27 59.52 Favored Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 120.532 -0.842 . . . . 75.31 111.663 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 15.0 m -92.76 155.87 17.39 Favored 'General case' 0 C--O 1.253 1.25 0 N-CA-C 108.484 -0.932 . . . . 74.32 108.484 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -80.8 134.08 12.92 Favored Glycine 0 N--CA 1.415 -2.725 0 C-N-CA 120.883 -0.675 . . . . 42.21 112.211 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 28.8 m -110.61 142.95 21.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 C-N-CA 123.0 0.52 . . . . 64.13 109.715 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.419 HD21 HG22 ' A' ' 619' ' ' ILE . 5.2 p-10 -54.99 172.57 0.11 Allowed 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 125.545 1.538 . . . . 63.45 113.256 -178.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . 0.531 ' H ' ' HD2' ' A' ' 616' ' ' ARG . 1.5 mpt_? -48.22 -43.44 32.11 Favored 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 124.279 1.032 . . . . 73.14 112.462 -174.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -85.99 -19.22 30.7 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.966 -0.561 . . . . 72.44 111.43 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 81.31 21.98 61.49 Favored Glycine 0 CA--C 1.494 -1.227 0 C-N-CA 120.233 -0.984 . . . . 63.4 113.722 173.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . 0.419 HG22 HD21 ' A' ' 615' ' ' ASN . 0.0 OUTLIER -67.95 119.26 13.36 Favored 'Isoleucine or valine' 0 C--O 1.252 1.218 0 CA-C-O 123.549 1.642 . . . . 75.55 110.545 -171.472 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.41 HG12 ' HD2' ' A' ' 608' ' ' PRO . 0.0 OUTLIER -117.76 132.34 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.521 0 CA-C-N 112.257 -2.247 . . . . 75.45 106.036 -178.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 31.5 m -96.41 118.88 33.84 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.789 -0.819 . . . . 72.45 108.789 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 1.6 pp -130.34 165.5 22.39 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 113.518 -1.674 . . . . 63.21 109.178 -176.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 7.7 tpp180 -142.45 139.06 31.46 Favored 'General case' 0 C--N 1.269 -2.918 0 N-CA-C 105.86 -1.904 . . . . 54.35 105.86 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -139.67 149.45 43.71 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.332 -0.988 . . . . 60.33 108.332 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -75.14 -98.44 0.11 Allowed Glycine 0 N--CA 1.438 -1.182 0 O-C-N 123.764 0.665 . . . . 64.43 113.628 -173.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 . . . . . 0 N--CA 1.429 -1.512 0 N-CA-C 108.991 -0.744 . . . . 74.54 108.991 179.84 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 CA--C 1.486 -1.511 0 N-CA-C 106.112 -1.81 . . . . 72.42 106.112 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 32.3 m -117.75 136.74 53.94 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.525 0 N-CA-C 108.908 -0.775 . . . . 63.4 108.908 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . 0.498 ' NE2' ' HA ' ' A' ' 407' ' ' ASN . 0.8 OUTLIER -97.94 122.26 40.84 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 105.262 -2.125 . . . . 71.21 105.262 178.452 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.412 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 59.1 t -96.82 122.86 55.65 Favored Pre-proline 0 C--N 1.285 -2.207 0 CA-C-N 115.723 -0.671 . . . . 73.41 111.844 -166.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 23.6 Cg_exo -65.14 140.91 67.23 Favored 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 122.857 2.371 . . . . 51.31 112.001 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -91.63 141.99 28.1 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 115.636 -0.711 . . . . 75.54 109.94 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 12.1 t -119.97 25.96 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.459 0 CA-C-O 122.74 1.257 . . . . 73.51 108.884 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? -63.38 144.62 56.81 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.175 -0.92 . . . . 63.12 113.181 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 91.29 0.38 73.72 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.968 -0.635 . . . . 74.43 112.847 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -104.08 -81.86 0.51 Allowed 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 120.543 -0.463 . . . . 63.51 110.46 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 87.8 p -169.1 163.34 11.14 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 107.512 -1.292 . . . . 73.41 107.512 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 12.0 m -63.77 -41.0 98.05 Favored 'General case' 0 N--CA 1.422 -1.873 0 O-C-N 123.987 0.804 . . . . 64.15 109.15 176.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.25 -46.69 87.71 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 115.871 -0.604 . . . . 75.11 111.484 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -64.97 -43.66 91.91 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 120.972 0.415 . . . . 64.55 110.978 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . 0.404 ' O ' HD13 ' A' ' 377' ' ' LEU . . . -66.53 -47.6 72.39 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.841 -0.618 . . . . 45.31 110.622 -178.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 80.5 mt -67.15 -40.32 84.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.933 -0.122 . . . . 71.34 111.296 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.91 -41.72 98.25 Favored 'General case' 0 C--O 1.246 0.877 0 N-CA-C 112.399 0.518 . . . . 25.01 112.399 -177.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . 0.408 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 21.2 m -67.19 -47.46 70.84 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.87 -0.605 . . . . 64.33 109.959 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.404 HD13 ' O ' ' A' ' 373' ' ' ALA . 10.8 mp -64.28 -38.21 90.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.918 -0.583 . . . . 74.13 111.508 178.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -60.29 -44.33 95.48 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 123.356 0.662 . . . . 73.24 109.722 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -70.26 -20.58 63.05 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 112.352 0.501 . . . . 72.54 112.352 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 376' ' ' THR . 35.2 mmt180 -85.52 -14.03 47.16 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.706 -0.398 . . . . 71.53 110.056 174.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 96.09 8.29 57.95 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.074 -0.584 . . . . 62.35 112.743 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -77.75 157.37 30.07 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 112.941 0.719 . . . . 74.33 112.941 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.444 ' HB2' ' HG2' ' A' ' 415' ' ' GLU . 27.4 mmtp -96.84 151.22 19.87 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.795 -1.093 . . . . 72.21 108.947 176.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . 0.509 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 0.2 OUTLIER -129.94 136.39 59.01 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 CA-C-N 115.87 -0.604 . . . . 60.13 109.496 178.569 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -108.97 126.52 53.18 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 105.359 -2.089 . . . . 70.02 105.359 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 20.9 m -106.48 118.39 36.54 Favored 'General case' 0 C--N 1.282 -2.34 0 C-N-CA 120.351 -0.539 . . . . 74.41 110.429 -170.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -120.46 129.32 53.82 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.242 -1.021 . . . . 60.32 108.242 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -103.92 143.05 33.37 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.976 -0.379 . . . . 74.5 109.976 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -126.57 115.76 22.89 Favored Pre-proline 0 C--N 1.306 -1.289 0 N-CA-C 109.521 -0.548 . . . . 74.51 109.521 174.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . 0.416 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 56.7 Cg_endo -98.46 129.76 0.23 Allowed 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.38 2.053 . . . . 75.52 112.526 175.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.591 ' HB3' HG12 ' A' ' 394' ' ' ILE . 9.7 t70 173.71 160.49 0.15 Allowed 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 109.302 -0.629 . . . . 75.21 109.302 174.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 35.3 t -75.57 -24.32 56.63 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.317 0.579 . . . . 75.34 110.084 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 3.3 m -83.42 -4.7 58.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.239 1.019 . . . . 64.31 108.986 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.591 HG12 ' HB3' ' A' ' 391' ' ' ASP . 15.1 mm -88.53 134.55 33.99 Favored Pre-proline 0 N--CA 1.427 -1.578 0 CA-C-N 114.568 -1.197 . . . . 53.45 110.367 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . 0.545 ' HG3' HD13 ' A' ' 400' ' ' ILE . 60.6 Cg_endo -66.14 -173.6 0.35 Allowed 'Trans proline' 0 CA--C 1.573 2.468 0 C-N-CA 125.003 3.802 . . . . 53.0 114.698 -176.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -58.47 159.41 19.9 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 122.872 2.381 . . . . 75.14 113.761 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -57.88 -9.81 1.47 Allowed 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 126.885 2.074 . . . . 74.33 113.362 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -90.18 177.38 6.45 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 116.112 -0.494 . . . . 63.14 111.56 -176.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 19.2 m -83.12 119.23 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 C-N-CA 120.51 -0.476 . . . . 62.54 110.912 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . 0.545 HD13 ' HG3' ' A' ' 395' ' ' PRO . 30.0 pt -86.77 -32.24 6.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.277 0.56 . . . . 73.42 109.707 177.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -147.99 170.36 28.64 Favored Glycine 0 N--CA 1.413 -2.845 0 N-CA-C 110.348 -1.101 . . . . 41.21 110.348 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.24 -179.42 3.63 Favored 'General case' 0 C--N 1.278 -2.54 0 CA-C-O 120.744 0.307 . . . . 64.5 110.678 178.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -102.1 129.74 25.73 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 107.974 -1.121 . . . . 72.01 107.974 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.94 -17.67 24.98 Favored 'Trans proline' 0 C--O 1.25 1.094 0 C-N-CA 124.01 3.14 . . . . 53.23 114.972 -173.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.5 -35.42 75.9 Favored 'General case' 0 C--O 1.21 -1.0 0 N-CA-C 109.657 -0.497 . . . . 51.11 109.657 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -69.33 -39.51 78.13 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.375 0.607 . . . . 33.1 110.265 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . 0.498 ' HA ' ' NE2' ' A' ' 361' ' ' GLN . 17.4 m120 -75.65 -7.28 53.9 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.434 0.635 . . . . 72.23 110.987 -178.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 29.6 m -98.67 153.91 18.35 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 106.998 -1.482 . . . . 74.21 106.998 174.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 61.0 m -75.07 113.04 11.94 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 118.974 -1.09 . . . . 53.25 109.104 176.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 18.7 m -121.24 169.81 12.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 122.867 0.467 . . . . 73.52 109.744 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 3.4 p -76.75 147.87 37.06 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 120.567 -0.453 . . . . 73.21 110.479 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -62.34 126.83 28.7 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 116.119 -0.492 . . . . 75.02 110.186 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 96.81 28.35 8.89 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 120.884 -0.674 . . . . 72.15 111.692 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -83.34 177.52 8.47 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.246 -1.02 . . . . 51.14 108.246 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . 0.444 ' HG2' ' HB2' ' A' ' 383' ' ' LYS . 39.0 mt-10 -111.3 108.94 18.72 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.216 0.531 . . . . 62.52 109.974 -174.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . 0.509 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 46.2 mm -102.22 129.13 54.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 115.215 -0.902 . . . . 74.2 108.83 -178.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 30.1 m -85.86 130.58 34.51 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.083 0.468 . . . . 72.11 111.205 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 7.5 p -110.81 134.87 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 107.676 -1.231 . . . . 72.31 107.676 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -110.76 122.19 47.21 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.069 0.461 . . . . 71.41 110.855 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 99.3 t -102.89 131.16 51.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 114.866 -1.061 . . . . 74.22 108.249 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . 0.434 ' HB3' ' CG2' ' A' ' 394' ' ' ILE . 8.8 m -98.7 125.04 43.89 Favored 'General case' 0 C--N 1.274 -2.7 0 CA-C-N 115.358 -0.837 . . . . 63.4 110.112 -176.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 2.5 p -111.07 149.95 30.07 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.152 -0.685 . . . . 53.22 109.152 176.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.11 0 N-CA-C 116.098 1.199 . . . . 72.22 116.098 -172.226 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 41.2 mt-30 . . . . . 0 N--CA 1.415 -2.181 0 N-CA-C 106.781 -1.563 . . . . 63.24 106.781 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -133.59 144.89 49.58 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-O 121.0 0.428 . . . . 74.33 110.497 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.45 ' H ' ' CD ' ' A' ' 428' ' ' GLU . 0.5 OUTLIER -83.74 133.34 34.79 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 107.899 -1.149 . . . . 63.41 107.899 176.406 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 63.1 mt -80.82 129.92 65.99 Favored Pre-proline 0 C--N 1.312 -1.052 0 CA-C-N 116.612 -0.267 . . . . 73.13 111.714 -172.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.93 147.13 54.66 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.206 1.937 . . . . 64.31 111.498 173.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -83.57 105.26 14.35 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.485 -0.561 . . . . 75.15 109.485 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 11.6 p -94.77 161.18 2.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 107.972 -1.122 . . . . 55.11 107.972 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.449 ' HB3' ' OG1' ' A' ' 436' ' ' THR . 29.7 t -83.86 157.52 21.97 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 108.964 -0.754 . . . . 72.13 108.964 177.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 32.0 p -70.2 -27.02 64.16 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 112.987 0.736 . . . . 74.24 112.987 -172.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.424 ' H ' HD23 ' A' ' 435' ' ' LEU . 0.6 OUTLIER -87.54 -13.77 42.05 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.313 0.577 . . . . 75.41 110.778 179.458 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.566 HG22 ' HB3' ' A' ' 439' ' ' GLU . 1.4 m -92.54 41.4 1.07 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.782 -0.645 . . . . 62.42 110.409 -175.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -53.07 -40.35 63.97 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.974 0.909 . . . . 62.23 112.273 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.14 98.73 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 120.812 0.339 . . . . 73.05 110.918 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.566 ' HB3' HG22 ' A' ' 436' ' ' THR . 31.4 tt0 -71.14 -34.92 71.48 Favored 'General case' 0 C--O 1.201 -1.489 0 C-N-CA 120.441 -0.503 . . . . 75.33 110.684 175.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.61 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -58.52 -51.34 70.3 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 122.219 0.208 . . . . 44.01 111.018 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 36.0 m -61.39 -37.78 78.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-O 121.211 0.529 . . . . 72.43 110.401 177.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -60.43 -47.46 86.02 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.641 0.776 . . . . 64.42 111.147 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -64.8 -38.31 90.55 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 123.318 0.647 . . . . 74.23 111.184 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 83.9 mt -63.76 -37.86 88.96 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.683 -0.488 . . . . 73.23 109.683 176.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.532 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 37.1 m -70.03 -42.92 72.31 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.902 -0.59 . . . . 73.23 110.32 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -65.15 -26.44 68.18 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.051 -0.522 . . . . 74.32 111.111 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -81.04 4.95 17.98 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.065 -0.516 . . . . 45.52 111.879 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 108.03 -67.94 0.22 Allowed Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.334 -0.936 . . . . 63.24 112.795 174.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . 0.519 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 1.8 p90 -50.54 -60.75 2.7 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.679 0.992 . . . . 73.43 113.679 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . 0.532 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 60.92 23.46 61.45 Favored Glycine 0 CA--C 1.499 -0.914 0 C-N-CA 121.255 -0.497 . . . . 72.03 112.203 -176.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.405 ' HB3' HG22 ' A' ' 483' ' ' VAL . 25.3 mmt180 -105.04 110.98 23.59 Favored 'General case' 0 N--CA 1.414 -2.258 0 N-CA-C 109.073 -0.714 . . . . 74.34 109.073 -178.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -131.97 143.32 50.02 Favored 'General case' 0 N--CA 1.415 -2.223 0 CA-C-N 114.608 -1.178 . . . . 74.04 110.192 -177.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -134.52 123.1 23.36 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 107.499 -1.297 . . . . 73.02 107.499 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -100.03 133.33 44.57 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.35 0.595 . . . . 73.23 111.901 -174.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -119.28 144.98 46.5 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 108.437 -0.949 . . . . 65.43 108.437 176.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -114.8 135.75 53.83 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.593 -0.892 . . . . 51.23 108.593 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 40.2 m -147.48 142.33 16.69 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 109.38 -0.6 . . . . 72.54 109.38 176.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.446 ' HA ' ' O ' ' A' ' 490' ' ' SER . 12.2 Cg_exo -70.17 131.62 21.01 Favored 'Trans proline' 0 C--O 1.247 0.948 0 C-N-CA 122.204 1.936 . . . . 50.21 111.555 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 56.4 m -149.75 -179.95 7.53 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.365 -0.976 . . . . 70.01 108.365 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 10.1 t -45.12 135.72 5.12 Favored Pre-proline 0 C--O 1.246 0.903 0 C-N-CA 124.015 0.926 . . . . 73.31 112.387 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.63 -30.39 36.4 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 124.363 3.375 . . . . 70.13 113.638 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -71.37 -23.45 61.9 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.57 0.581 . . . . 62.11 112.57 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 84.5 mt -99.74 -6.33 27.23 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.66 -0.416 . . . . 60.12 110.913 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 98.0 t -61.38 127.72 21.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 116.154 -0.475 . . . . 72.51 110.716 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 91.82 -3.59 77.92 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 115.614 -0.721 . . . . 72.02 111.661 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -118.19 166.37 12.67 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 108.278 -1.008 . . . . 35.05 108.278 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 93.8 t -76.12 145.7 10.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 108.306 -0.998 . . . . 74.5 108.306 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 68.5 mt -97.61 -35.25 5.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.262 -1.384 . . . . 64.23 107.262 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 159.68 -167.33 35.2 Favored Glycine 0 N--CA 1.423 -2.212 0 CA-C-N 115.356 -0.838 . . . . 70.33 111.012 176.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . 0.656 HG22 HG12 ' A' ' 486' ' ' ILE . 72.8 p -116.2 144.85 43.64 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 106.969 -1.493 . . . . 73.51 106.969 178.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -67.1 -58.38 9.28 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 119.153 -1.019 . . . . 72.15 110.101 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 473' ' ' PRO . 31.3 Cg_endo -68.2 130.18 20.82 Favored 'Trans proline' 0 C--N 1.376 2.015 0 N-CA-C 106.364 -2.206 . . . . 61.14 106.364 168.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 472' ' ' PRO . 23.8 Cg_exo -61.82 138.6 75.22 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 121.55 1.5 . . . . 71.22 112.774 -172.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -75.85 11.17 1.48 Allowed 'General case' 0 C--O 1.202 -1.431 0 CA-C-N 115.324 -0.853 . . . . 53.12 111.468 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -109.56 -1.54 18.15 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.799 -0.637 . . . . 72.43 109.427 177.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . 0.401 ' HG2' ' HB2' ' A' ' 473' ' ' PRO . 85.7 mm-40 -94.24 172.55 8.14 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.867 -0.606 . . . . 43.41 111.778 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.438 HG22 ' HB3' ' A' ' 426' ' ' GLN . 1.9 m -99.42 108.16 20.57 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 107.994 -1.113 . . . . 71.4 107.994 -178.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 50.1 m -100.64 138.66 37.41 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 120.901 0.382 . . . . 61.41 110.815 -176.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -77.37 154.53 32.67 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.659 -0.7 . . . . 64.14 111.134 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . 0.519 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 1.7 mp -65.32 -24.74 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-N 115.493 -0.776 . . . . 72.44 111.555 178.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 4.4 p -93.48 6.04 49.54 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.72 0.771 . . . . 74.1 111.565 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -107.88 131.71 54.22 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.693 -0.685 . . . . 55.01 111.435 -176.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.405 HG22 ' HB3' ' A' ' 451' ' ' ARG . 55.0 t -94.65 126.9 46.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.752 -0.658 . . . . 74.54 110.095 -177.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 34.4 m -98.36 133.7 39.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-O 121.51 0.672 . . . . 44.33 111.033 178.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.9 129.02 51.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.851 -0.613 . . . . 71.31 109.794 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.656 HG12 HG22 ' A' ' 470' ' ' THR . 4.9 mt -117.12 128.74 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 C-N-CA 124.43 1.092 . . . . 72.42 110.215 -176.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 5.8 tt -108.4 126.92 65.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-N 116.447 -0.342 . . . . 73.15 110.354 -177.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 34.6 m -111.43 152.0 13.42 Favored 'Isoleucine or valine' 0 C--O 1.252 1.236 0 CA-C-N 116.229 -0.441 . . . . 72.24 110.633 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.87 123.3 6.04 Favored Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 115.928 -0.578 . . . . 45.43 113.59 -176.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.446 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 31.0 t . . . . . 0 N--CA 1.428 -1.542 0 N-CA-C 107.728 -1.212 . . . . 54.42 107.728 177.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.443 -1.487 0 CA-C-O 121.263 0.443 . . . . 61.41 111.533 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . -90.36 119.73 30.89 Favored 'General case' 0 N--CA 1.41 -2.43 0 N-CA-C 107.513 -1.291 . . . . 52.0 107.513 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 51.5 p -116.59 143.36 45.71 Favored 'General case' 0 C--N 1.27 -2.859 0 N-CA-C 109.159 -0.682 . . . . 60.11 109.159 -178.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 544' ' ' THR . 10.3 ttpp -151.44 164.46 36.71 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 108.445 -0.946 . . . . 74.54 108.445 176.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 10.7 p-10 -79.67 136.54 36.83 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.85 -0.796 . . . . 62.04 108.85 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 40.6 pt -75.45 131.41 77.62 Favored Pre-proline 0 C--N 1.305 -1.355 0 N-CA-C 109.374 -0.602 . . . . 74.44 109.374 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -56.65 118.15 4.94 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.592 2.861 . . . . 65.3 114.285 -174.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -84.42 94.53 8.53 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-N 115.824 -0.625 . . . . 74.33 109.532 177.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.7 p -159.75 93.75 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-O 122.247 1.022 . . . . 62.1 110.947 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -108.09 162.84 13.68 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 107.862 -1.162 . . . . 75.1 107.862 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 98.1 23.38 13.17 Favored Glycine 0 C--N 1.295 -1.747 0 N-CA-C 108.967 -1.653 . . . . 63.25 108.967 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -129.38 165.5 21.39 Favored 'General case' 0 CA--C 1.471 -2.068 0 CA-C-N 114.402 -0.899 . . . . 70.35 109.336 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 6.9 m -88.67 156.44 19.01 Favored 'General case' 0 C--N 1.275 -2.67 0 C-N-CA 120.118 -0.633 . . . . 52.42 110.208 -173.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 12.2 p -50.53 -41.24 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 124.521 1.129 . . . . 72.35 113.522 -174.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -67.41 -39.67 85.54 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.372 0.606 . . . . 55.33 110.549 -178.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 48.8 t -70.37 -43.78 77.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.344 -0.844 . . . . 64.54 109.529 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -61.68 -47.11 86.81 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.226 -0.897 . . . . 50.42 112.26 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -64.2 -35.92 82.36 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.137 0.273 . . . . 72.51 110.708 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 52.5 tttm -58.69 -53.8 54.28 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.032 -0.531 . . . . 73.25 109.831 175.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -62.61 -41.69 99.13 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.286 -0.87 . . . . 74.14 110.914 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 9.0 tt -61.46 -47.87 83.72 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.955 -0.566 . . . . 73.33 110.408 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 12.8 m120 -66.68 -37.81 85.5 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 111.812 0.301 . . . . 70.23 111.812 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 54.4 t -62.74 -31.69 53.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.162 -0.472 . . . . 74.43 111.052 177.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -86.15 13.25 8.14 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 114.147 1.166 . . . . 74.03 114.147 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 102.07 -11.58 57.28 Favored Glycine 0 CA--C 1.499 -0.907 0 C-N-CA 119.925 -1.131 . . . . 54.11 114.214 171.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 88.8 m-85 -91.11 120.34 31.99 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.331 -0.618 . . . . 73.33 109.331 -177.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 22.7 p -97.96 -14.84 20.38 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 113.329 0.863 . . . . 72.12 113.329 -174.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -123.22 117.58 25.64 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.092 0.473 . . . . 63.43 112.102 -172.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -131.51 147.89 52.58 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.782 -0.645 . . . . 70.44 111.694 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 51.1 m -132.69 140.16 48.0 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.161 -1.422 . . . . 70.42 107.161 173.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 0.0 OUTLIER -117.77 128.77 55.2 Favored 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 119.945 -0.702 . . . . 74.24 112.191 -178.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -111.92 143.53 42.74 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.443 -0.947 . . . . 54.21 108.443 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 57.1 m -96.52 139.35 32.75 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 113.095 0.776 . . . . 54.32 113.095 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 40.6 t -122.22 159.14 25.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 106.778 -1.564 . . . . 73.42 106.778 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . 0.569 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 30.9 m-20 -85.0 134.58 34.22 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 107.741 -1.207 . . . . 62.03 107.741 177.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . 0.539 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 19.0 m -153.57 178.3 1.65 Allowed Pre-proline 0 C--N 1.313 -1.016 0 N-CA-C 109.197 -0.668 . . . . 62.33 109.197 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -89.0 -8.32 4.92 Favored 'Trans proline' 0 CA--C 1.55 1.28 0 C-N-CA 122.47 2.113 . . . . 62.02 111.114 170.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.9 142.07 48.17 Favored Pre-proline 0 C--O 1.213 -0.861 0 N-CA-C 108.675 -0.861 . . . . 64.24 108.675 176.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -63.42 160.36 35.83 Favored 'Trans proline' 0 C--O 1.247 0.972 0 C-N-CA 122.558 2.172 . . . . 64.42 113.419 -176.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -58.38 118.44 5.56 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.038 -0.983 . . . . 53.22 110.334 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 121.36 -12.46 9.62 Favored Glycine 0 C--N 1.3 -1.465 0 C-N-CA 120.45 -0.881 . . . . 42.55 112.201 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -82.71 131.46 35.2 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.927 -0.768 . . . . 72.42 108.927 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.435 HG22 HG22 ' A' ' 555' ' ' VAL . 54.3 t -90.84 112.67 25.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.676 -0.861 . . . . 72.41 108.676 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 45.8 m -111.04 14.55 21.93 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 122.661 1.22 . . . . 73.41 111.611 -175.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 161.97 -173.84 38.35 Favored Glycine 0 CA--C 1.494 -1.26 0 C-N-CA 119.903 -1.141 . . . . 75.11 112.251 173.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 31.6 p -130.43 153.86 48.32 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.856 -1.165 . . . . 71.34 107.856 176.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -67.75 -54.74 16.13 Favored Pre-proline 0 C--N 1.309 -1.163 0 CA-C-O 119.31 -0.376 . . . . 54.52 111.25 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.32 153.39 45.37 Favored 'Trans proline' 0 C--N 1.371 1.717 0 N-CA-C 108.026 -1.567 . . . . 71.22 108.026 170.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.84 137.86 46.63 Favored 'Trans proline' 0 C--O 1.249 1.055 0 CA-C-N 120.119 1.078 . . . . 60.31 110.932 -177.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -69.68 137.78 52.4 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.735 -0.666 . . . . 55.22 110.396 -178.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.73 -14.34 59.01 Favored Glycine 0 C--N 1.303 -1.286 0 C-N-CA 120.61 -0.805 . . . . 52.3 111.726 -178.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 27.0 m -72.67 137.45 46.03 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 109.407 -0.59 . . . . 70.02 109.407 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 8.9 t -87.2 127.12 35.16 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-O 121.536 0.684 . . . . 74.44 110.124 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.3 m -138.96 162.46 52.38 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 107.738 -1.208 . . . . 73.45 107.738 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 47.0 Cg_exo -60.77 134.59 54.74 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 121.734 1.623 . . . . 63.2 109.784 173.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.405 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 26.9 m -63.57 -20.25 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 113.728 1.011 . . . . 63.12 113.728 -174.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -83.65 -4.47 58.62 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.395 0.617 . . . . 74.24 111.4 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 14.6 m -74.27 160.39 31.18 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.505 -0.554 . . . . 61.34 109.505 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 38.2 t -97.44 115.39 37.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.52 -0.548 . . . . 73.21 109.52 -178.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 61.2 mt -85.01 131.74 33.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 109.108 -0.701 . . . . 65.14 109.108 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 521' ' ' SER . 34.8 tt0 -103.03 116.2 32.07 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 108.296 -1.001 . . . . 73.42 108.296 176.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . 0.48 ' H ' HD23 ' A' ' 553' ' ' LEU . 1.6 pt? -103.76 134.73 46.59 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.493 -0.776 . . . . 64.41 109.285 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -102.05 118.3 36.6 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-O 122.797 1.284 . . . . 74.44 111.409 -175.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 524' ' ' SER . 92.3 t -105.01 136.28 39.44 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 CA-C-N 112.914 -1.948 . . . . 73.34 110.271 -172.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.539 ' HB3' ' HB2' ' A' ' 527' ' ' SER . 75.0 m -75.47 148.94 38.64 Favored 'General case' 0 C--N 1.27 -2.86 0 N-CA-C 113.584 0.957 . . . . 61.41 113.584 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.569 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 9.8 ptpp? -108.84 156.01 20.14 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 105.12 -2.178 . . . . 71.45 105.12 165.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -71.73 -27.59 70.62 Favored Glycine 0 CA--C 1.496 -1.126 0 C-N-CA 120.797 -0.716 . . . . 71.4 111.683 -177.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 62.6 t30 57.85 28.98 16.81 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 122.879 1.324 . . . . 73.51 109.84 173.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.8 154.41 41.99 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 105.785 -1.932 . . . . 74.14 105.785 -175.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -143.07 156.19 44.77 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 120.354 -0.538 . . . . 70.52 110.222 175.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 78.1 t -79.15 119.66 28.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 108.519 -0.919 . . . . 75.15 108.519 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . 0.585 ' SD ' HD12 ' A' ' 620' ' ' ILE . 52.4 ttp -90.46 129.64 44.42 Favored Pre-proline 0 C--N 1.302 -1.488 0 CA-C-N 116.588 -0.278 . . . . 73.3 111.618 -176.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 563' ' ' MET . 19.5 Cg_exo -69.2 169.85 17.26 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.166 2.578 . . . . 64.32 111.649 174.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -77.23 139.38 39.85 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.83 -0.804 . . . . 64.53 108.83 177.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 25.5 tp -137.97 12.98 2.89 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.781 0.8 . . . . 74.34 109.546 -178.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 53.3 p -79.96 147.78 31.46 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.21 -0.45 . . . . 74.11 111.393 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 77.61 7.89 87.19 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.86 -0.686 . . . . 25.23 113.2 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 8.2 mmt -87.61 143.67 27.07 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.6 -0.889 . . . . 74.5 108.6 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -89.45 176.73 6.79 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 110.071 -0.344 . . . . 72.12 110.071 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -60.93 -34.14 74.25 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.999 -1.112 . . . . 74.51 107.999 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.6 m -73.72 -7.62 10.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.469 -1.241 . . . . 62.43 111.291 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -101.55 -44.06 5.7 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 108.866 -0.791 . . . . 74.04 108.866 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -53.75 -53.68 48.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.006 -0.997 . . . . 44.41 113.481 -175.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -65.45 -53.51 37.85 Favored Pre-proline 0 CA--C 1.553 1.093 0 N-CA-C 113.493 0.923 . . . . 73.21 113.493 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -60.27 -39.34 68.78 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 121.783 1.655 . . . . 75.15 112.196 177.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.561 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 30.2 mtt180 -68.95 -33.5 73.82 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 113.683 0.994 . . . . 72.31 113.683 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 6.8 tt -58.09 -50.19 74.34 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.663 -0.865 . . . . 74.13 108.663 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -68.23 -43.88 76.97 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.207 -0.906 . . . . 72.34 113.439 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -64.17 -40.42 96.07 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 113.389 0.885 . . . . 62.33 113.389 -175.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 577' ' ' ARG 0.308 3.7 pp -93.13 0.32 57.19 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.05 -1.06 . . . . 73.14 113.655 179.37 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 71.26 43.25 55.74 Favored Glycine 0 CA--C 1.504 -0.631 0 CA-C-N 115.986 -0.552 . . . . 75.12 112.395 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 22.4 t90 -73.21 126.85 31.02 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.073 -0.714 . . . . 74.32 109.073 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 2.5 m -105.76 2.38 27.85 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.753 -0.658 . . . . 70.21 110.491 -175.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -91.72 172.32 35.57 Favored Glycine 0 N--CA 1.436 -1.347 0 C-N-CA 120.594 -0.812 . . . . 73.55 112.433 -175.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 89.4 mmm -92.79 137.18 32.59 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.246 0.546 . . . . 74.11 111.665 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -83.0 128.19 34.25 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.623 -1.172 . . . . 74.54 108.113 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -95.39 103.37 15.23 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.992 -0.549 . . . . 73.41 109.81 -177.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . 0.482 ' HD3' ' CE2' ' A' ' 624' ' ' PHE . 52.4 tptt -112.51 110.76 21.14 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 109.107 -0.701 . . . . 62.42 109.107 176.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -91.37 -117.05 2.09 Favored Glycine 0 N--CA 1.428 -1.863 0 C-N-CA 120.512 -0.852 . . . . 63.12 112.313 178.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -84.03 155.64 22.63 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 123.132 0.573 . . . . 64.32 111.333 -177.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -94.21 124.45 38.23 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 109.657 -0.497 . . . . 73.04 109.657 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 49.9 t -125.91 127.62 71.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 107.7 -1.222 . . . . 54.51 107.7 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -73.73 121.14 20.33 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.478 -0.889 . . . . 62.54 108.924 176.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -118.95 -39.11 2.97 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.238 -0.892 . . . . 41.04 110.658 -175.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 60.5 -157.48 29.17 Favored Glycine 0 N--CA 1.423 -2.207 0 O-C-N 123.936 0.772 . . . . 62.31 111.339 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -65.33 -40.99 96.84 Favored Glycine 0 C--N 1.28 -2.528 0 N-CA-C 112.061 -0.415 . . . . 35.21 112.061 174.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 10.2 m -58.38 -40.53 82.55 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 113.121 0.786 . . . . 60.1 113.121 -171.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -108.85 -4.5 16.8 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 111.95 0.352 . . . . 74.43 111.95 177.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 65.8 m80 56.1 102.83 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.471 1.109 . . . . 73.45 113.263 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -77.15 80.25 3.67 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 122.711 1.243 . . . . 65.04 109.812 172.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -134.49 171.16 14.69 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.271 -1.751 . . . . 73.52 106.271 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . 0.425 HG11 HD22 ' A' ' 622' ' ' LEU . 76.1 t -61.08 129.67 24.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 107.58 -1.267 . . . . 64.54 107.58 173.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 97.6 t -87.25 -50.31 13.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-O 121.591 0.71 . . . . 71.01 109.27 -175.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -149.44 157.58 43.42 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 106.871 -1.529 . . . . 63.43 106.871 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . 0.517 ' HB2' HD11 ' A' ' 620' ' ' ILE . 17.0 pt20 -110.14 123.3 49.48 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 107.948 -1.131 . . . . 72.35 107.948 173.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.507 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 25.3 t-20 -48.58 -54.5 26.05 Favored Pre-proline 0 CA--C 1.553 1.084 0 N-CA-C 113.468 0.914 . . . . 70.22 113.468 -177.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.507 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 4.1 Cg_endo -90.26 138.74 2.83 Favored 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 121.473 1.448 . . . . 73.34 109.944 173.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . 0.445 ' HG2' ' OG1' ' A' ' 612' ' ' THR . 29.3 Cg_endo -67.92 147.57 74.67 Favored 'Trans proline' 0 C--O 1.249 1.066 0 C-N-CA 121.985 1.79 . . . . 71.0 113.13 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.55 133.63 49.79 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.283 -0.871 . . . . 62.33 110.456 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 95.96 -8.18 67.71 Favored Glycine 0 C--N 1.305 -1.181 0 C-N-CA 120.717 -0.754 . . . . 51.25 112.113 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . 0.445 ' OG1' ' HG2' ' A' ' 609' ' ' PRO . 15.7 m -91.28 157.91 16.87 Favored 'General case' 0 C--O 1.256 1.434 0 N-CA-C 109.052 -0.721 . . . . 73.34 109.052 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -77.01 128.63 9.15 Favored Glycine 0 N--CA 1.428 -1.861 0 N-CA-C 111.425 -0.67 . . . . 72.05 111.425 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . 0.413 ' CG2' ' HB2' ' A' ' 563' ' ' MET . 33.4 m -122.16 144.19 32.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 C-N-CA 123.528 0.731 . . . . 72.1 110.49 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -39.53 144.23 0.18 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 125.816 1.647 . . . . 70.45 112.115 174.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . 0.496 ' HG3' ' N ' ' A' ' 617' ' ' ASP . 3.2 ptp180 -54.9 -28.43 50.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 123.773 0.671 . . . . 75.01 111.021 -178.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . 0.496 ' N ' ' HG3' ' A' ' 616' ' ' ARG . 21.2 t70 -60.05 -42.06 93.65 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.783 -1.098 . . . . 74.5 109.652 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 87.08 12.54 67.88 Favored Glycine 0 N--CA 1.413 -2.846 0 CA-C-N 115.012 -0.995 . . . . 33.11 113.363 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . 0.466 ' HB ' ' OD2' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -69.4 119.76 15.89 Favored 'Isoleucine or valine' 0 C--O 1.251 1.143 0 CA-C-N 118.604 1.202 . . . . 61.45 109.631 -177.398 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.585 HD12 ' SD ' ' A' ' 563' ' ' MET . 4.1 tt -124.81 132.64 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.223 0 CA-C-N 113.287 -1.779 . . . . 73.41 107.581 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 87.6 m -96.64 122.37 39.5 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 121.814 0.816 . . . . 51.13 109.707 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . 0.425 HD22 HG11 ' A' ' 603' ' ' VAL . 61.2 mt -119.9 150.78 39.93 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 105.881 -1.896 . . . . 74.42 105.881 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -128.64 135.79 49.78 Favored 'General case' 0 C--N 1.27 -2.859 0 N-CA-C 106.729 -1.582 . . . . 60.44 106.729 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.482 ' CE2' ' HD3' ' A' ' 589' ' ' LYS . 26.5 p90 -143.24 164.05 31.28 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 108.557 -0.905 . . . . 70.01 108.557 176.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -77.15 -82.06 0.58 Allowed Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 120.582 -0.818 . . . . 64.45 112.932 -177.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 . . . . . 0 C--N 1.292 -1.899 0 N-CA-C 107.878 -1.156 . . . . 71.05 107.878 -177.029 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 . . . . . 0 C--O 1.254 1.332 0 N-CA-C 104.91 -2.255 . . . . 74.3 104.91 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 29.5 m -115.49 160.68 14.72 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 CA-C-O 121.303 0.573 . . . . 72.4 110.929 -170.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 409' ' ' SER . 33.8 tt0 -94.35 139.64 30.82 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 115.872 -0.603 . . . . 63.25 110.063 -175.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.685 HG22 ' CZ ' ' A' ' 382' ' ' PHE . 60.5 t -94.68 141.1 22.93 Favored Pre-proline 0 C--N 1.28 -2.436 0 N-CA-C 106.232 -1.766 . . . . 71.31 106.232 -176.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -73.15 119.34 5.97 Favored 'Trans proline' 0 N--CA 1.436 -1.861 0 C-N-CA 120.824 1.016 . . . . 63.14 111.678 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . 0.611 ' OD2' ' HD2' ' A' ' 366' ' ' ARG . 24.8 t70 -89.98 82.51 6.14 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 105.974 -1.862 . . . . 63.31 105.974 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.522 ' HB ' HE21 ' A' ' 368' ' ' GLN . 3.0 m -92.46 30.35 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 113.941 -1.482 . . . . 65.31 114.017 -171.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.611 ' HD2' ' OD2' ' A' ' 364' ' ' ASP . 0.0 OUTLIER -52.66 145.26 12.33 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 124.62 1.168 . . . . 62.53 112.399 174.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.56 -0.84 45.98 Favored Glycine 0 CA--C 1.492 -1.36 0 CA-C-N 115.81 -0.632 . . . . 70.45 112.821 175.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . 0.522 HE21 ' HB ' ' A' ' 365' ' ' VAL . 36.4 mt-30 -112.19 -155.84 0.57 Allowed 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.009 -1.108 . . . . 71.15 108.009 178.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 21.4 p -94.58 161.53 14.16 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 108.667 -0.864 . . . . 72.32 108.667 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 19.1 p -63.13 -40.01 96.34 Favored 'General case' 0 C--O 1.209 -1.033 0 C-N-CA 120.698 -0.401 . . . . 64.21 109.943 178.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.45 -46.31 89.11 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 116.201 -0.454 . . . . 65.32 111.727 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -69.06 -44.79 71.9 Favored 'General case' 0 C--O 1.253 1.255 0 CA-C-O 121.301 0.572 . . . . 74.42 110.69 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -63.83 -44.63 92.66 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.412 -0.813 . . . . 65.15 110.981 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 70.0 mt -69.31 -37.04 75.07 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.594 0 CA-C-N 116.304 -0.407 . . . . 52.22 110.966 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.78 -43.88 90.53 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.376 0.608 . . . . 32.5 109.986 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . 0.56 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 54.6 m -65.76 -47.41 75.29 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.288 -0.869 . . . . 65.51 109.859 177.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 26.1 tp -60.98 -40.18 92.46 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 123.898 0.879 . . . . 72.01 111.602 -176.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -70.29 -37.66 74.86 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.136 0.575 . . . . 64.53 110.077 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -67.98 -19.15 64.91 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 120.833 0.349 . . . . 63.33 111.527 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . 0.56 ' HG2' ' O ' ' A' ' 376' ' ' THR . 16.6 mmt85 -89.42 -8.71 52.48 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.07 0.462 . . . . 73.23 110.046 177.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 84.78 16.34 65.89 Favored Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 115.826 -0.624 . . . . 73.43 113.587 175.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.685 ' CZ ' HG22 ' A' ' 362' ' ' VAL . 71.0 m-85 -86.4 161.12 18.83 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 117.607 0.703 . . . . 74.22 111.786 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.429 ' HB2' ' HA ' ' A' ' 415' ' ' GLU . 34.2 mmtp -90.4 138.34 31.62 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 107.813 -1.18 . . . . 71.13 107.813 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . 0.461 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -117.11 141.21 36.51 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 C-N-CA 119.864 -0.734 . . . . 63.44 109.574 -175.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 6.2 tpp180 -132.13 147.65 52.44 Favored 'General case' 0 N--CA 1.408 -2.547 0 N-CA-C 107.54 -1.282 . . . . 75.41 107.54 176.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 54.5 m -134.87 132.33 38.43 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 109.552 -0.536 . . . . 74.31 109.552 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -111.68 119.84 40.01 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 105.436 -2.061 . . . . 61.4 105.436 175.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.593 HE21 ' N ' ' A' ' 388' ' ' GLN . 0.0 OUTLIER -125.63 135.41 52.13 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.97 -0.692 . . . . 74.24 110.775 -177.041 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -136.75 135.04 19.73 Favored Pre-proline 0 C--N 1.297 -1.713 0 CA-C-N 115.525 -0.761 . . . . 72.13 109.102 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 422' ' ' THR . 20.7 Cg_exo -70.81 127.51 13.85 Favored 'Trans proline' 0 C--O 1.255 1.374 0 N-CA-C 106.236 -2.255 . . . . 74.23 106.236 166.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.547 ' OD1' HG22 ' A' ' 393' ' ' THR . 7.9 t0 169.15 -165.2 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 105.743 -1.947 . . . . 52.15 105.743 -169.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 10.6 t -151.93 -1.33 0.31 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 122.153 -0.342 . . . . 71.21 110.787 175.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.547 HG22 ' OD1' ' A' ' 391' ' ' ASP . 13.4 t -94.85 -7.92 38.83 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.807 -0.558 . . . . 72.24 112.331 -173.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.491 HD13 ' H ' ' A' ' 394' ' ' ILE . 0.2 OUTLIER -111.01 152.07 43.42 Favored Pre-proline 0 C--N 1.312 -1.061 0 N-CA-C 108.119 -1.067 . . . . 72.33 108.119 176.514 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_exo -29.95 133.5 0.05 OUTLIER 'Trans proline' 0 CA--C 1.553 1.459 0 C-N-CA 125.083 3.855 . . . . 74.13 117.18 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.9 163.76 27.08 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 123.908 3.072 . . . . 73.15 111.836 176.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . 0.584 ' HA ' HG13 ' A' ' 420' ' ' VAL . 5.4 p-10 -57.07 -7.84 0.56 Allowed 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 123.826 0.851 . . . . 73.12 112.64 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 53.9 m170 -104.88 124.02 48.74 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 105.102 -2.184 . . . . 73.44 105.102 172.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 28.5 m -72.11 118.79 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.647 0 CA-C-O 121.261 0.553 . . . . 72.4 110.938 -169.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.81 -36.98 10.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 107.274 -1.38 . . . . 75.42 107.274 177.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . 0.489 ' HA2' ' HB2' ' A' ' 366' ' ' ARG . . . -146.64 156.94 27.24 Favored Glycine 0 N--CA 1.412 -2.911 0 N-CA-C 109.207 -1.557 . . . . 65.2 109.207 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . 0.476 ' OG1' ' HB3' ' A' ' 366' ' ' ARG . 2.1 p -124.46 -177.71 3.89 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 107.486 -1.302 . . . . 71.33 107.486 176.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -99.64 134.28 21.21 Favored Pre-proline 0 C--N 1.293 -1.887 0 C-N-CA 118.836 -1.146 . . . . 51.1 109.23 -174.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -49.02 -12.12 0.2 Allowed 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 124.787 3.658 . . . . 72.32 115.186 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.76 -29.89 55.13 Favored 'General case' 0 C--O 1.21 -0.986 0 C-N-CA 123.439 0.695 . . . . 72.34 110.021 172.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . 0.59 ' HA ' ' HB ' ' A' ' 362' ' ' VAL . . . -66.9 -50.42 62.48 Favored 'General case' 0 N--CA 1.437 -1.079 0 O-C-N 123.603 0.565 . . . . 52.55 111.079 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -72.8 -8.6 56.24 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 121.852 -0.53 . . . . 73.3 111.393 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 90.2 m -85.52 131.4 34.37 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 106.144 -1.799 . . . . 62.33 106.144 174.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 361' ' ' GLN . 47.1 p -74.5 112.95 11.19 Favored 'General case' 0 N--CA 1.417 -2.104 0 C-N-CA 118.653 -1.219 . . . . 71.44 108.859 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 23.7 m -114.56 169.51 5.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 109.911 -0.403 . . . . 44.34 109.911 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 17.1 m -65.11 136.51 56.79 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.808 -0.812 . . . . 74.43 108.808 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -58.02 109.56 0.76 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.144 0.497 . . . . 72.44 111.629 -175.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 105.89 36.65 2.71 Favored Glycine 0 N--CA 1.438 -1.23 0 CA-C-N 115.523 -0.762 . . . . 71.43 112.661 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -96.96 175.43 6.33 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 109.357 -0.609 . . . . 70.44 109.357 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . 0.429 ' HA ' ' HB2' ' A' ' 383' ' ' LYS . 40.9 mm-40 -86.74 120.1 27.68 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.278 0.631 . . . . 64.21 111.341 -172.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 43.0 mm -113.16 111.43 36.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 N-CA-C 108.808 -0.812 . . . . 74.31 108.808 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 30.5 p -90.85 130.48 36.8 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 112.772 0.656 . . . . 65.34 112.772 -175.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 4.1 p -121.62 135.24 62.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.957 -0.757 . . . . 74.4 108.957 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -109.18 127.4 54.18 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.588 -0.523 . . . . 73.03 109.588 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.584 HG13 ' HA ' ' A' ' 397' ' ' ASP . 44.6 t -126.54 137.72 56.95 Favored 'Isoleucine or valine' 0 C--O 1.25 1.126 0 CA-C-N 115.04 -0.982 . . . . 55.42 111.23 -174.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 10.0 t -98.03 121.4 39.91 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.557 -1.275 . . . . 72.12 107.557 176.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . 0.523 ' O ' ' HA ' ' A' ' 390' ' ' PRO . 7.5 t -120.84 107.79 13.15 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.149 0.426 . . . . 71.23 112.149 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.022 0 C-N-CA 119.388 -1.387 . . . . 55.52 112.869 176.355 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 . . . . . 0 N--CA 1.434 -1.264 0 N-CA-C 106.468 -1.679 . . . . 61.02 106.468 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 18.0 mmm-85 -122.51 154.33 38.0 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 120.022 -0.671 . . . . 71.33 110.512 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.424 ' CD ' ' H ' ' A' ' 428' ' ' GLU . 0.0 OUTLIER -85.66 141.24 29.91 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-N 114.738 -1.119 . . . . 73.25 109.401 -177.734 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.443 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 66.2 mt -77.38 126.9 84.24 Favored Pre-proline 0 N--CA 1.426 -1.631 0 N-CA-C 105.698 -1.964 . . . . 64.02 105.698 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.27 141.26 67.98 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 121.973 1.782 . . . . 62.44 112.477 -177.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -87.63 137.02 32.7 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.968 -1.123 . . . . 62.13 107.968 177.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.589 HG11 ' HB2' ' A' ' 440' ' ' ALA . 13.3 p -152.02 159.75 3.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 109.335 -0.616 . . . . 53.53 109.335 -175.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.618 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 13.6 m -78.76 152.77 31.29 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 109.068 -0.716 . . . . 74.13 109.068 177.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 32.7 p -69.07 -25.86 64.66 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 114.037 1.125 . . . . 74.5 114.037 -173.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.5 pp -90.01 -10.23 45.71 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.679 0.752 . . . . 61.44 111.245 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.618 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 1.0 OUTLIER -100.16 41.76 1.15 Allowed 'General case' 0 CA--C 1.569 1.674 0 CA-C-N 115.186 -0.915 . . . . 65.31 110.022 -175.731 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -52.99 -38.2 62.05 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 113.559 0.948 . . . . 63.11 113.559 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.01 -35.71 77.58 Favored 'General case' 0 C--O 1.247 0.961 0 CA-C-O 122.016 0.912 . . . . 52.11 110.836 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.403 ' CB ' HG22 ' A' ' 436' ' ' THR . 35.1 tp10 -69.63 -37.55 76.84 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.401 -0.592 . . . . 70.01 109.401 176.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.589 ' HB2' HG11 ' A' ' 432' ' ' VAL . . . -60.54 -51.3 70.04 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.867 -0.606 . . . . 50.2 111.095 -178.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 35.6 m -63.39 -41.56 93.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 112.104 0.409 . . . . 71.11 112.104 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -68.23 -41.61 80.97 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 119.651 -0.82 . . . . 74.11 110.713 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -65.34 -38.26 89.59 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-N 115.901 -0.59 . . . . 75.04 111.042 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.431 ' CD2' ' HB3' ' A' ' 452' ' ' PHE . 13.5 tp -63.49 -36.46 83.82 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.081 -0.711 . . . . 73.41 109.081 178.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.42 ' HA ' ' HA3' ' A' ' 450' ' ' GLY . 40.0 m -68.98 -39.48 79.39 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.573 -0.74 . . . . 74.01 110.129 178.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.05 -15.95 62.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.937 -0.574 . . . . 43.24 111.13 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -88.74 5.07 45.11 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.873 -0.603 . . . . 64.42 110.906 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 109.03 -87.93 0.5 Allowed Glycine 0 CA--C 1.484 -1.883 0 N-CA-C 111.077 -0.809 . . . . 65.4 111.077 174.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -35.49 -63.14 0.36 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.435 1.272 . . . . 74.13 114.435 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 445' ' ' THR . . . 55.42 30.75 56.15 Favored Glycine 0 C--O 1.217 -0.909 0 N-CA-C 114.204 0.442 . . . . 72.55 114.204 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.509 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 30.3 mmm180 -105.75 111.18 23.74 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.64 -0.874 . . . . 73.05 108.64 -177.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.431 ' HB3' ' CD2' ' A' ' 444' ' ' LEU . 40.8 p90 -133.1 150.37 52.07 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 121.405 0.622 . . . . 75.43 111.869 -174.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -137.17 126.75 25.21 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.774 -1.103 . . . . 72.5 108.84 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -94.74 128.64 41.58 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 120.831 0.348 . . . . 63.01 110.593 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -128.99 157.86 40.48 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.826 -0.805 . . . . 61.21 108.826 177.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -126.19 147.94 49.55 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.95 -0.3 . . . . 73.12 110.338 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 20.9 t -152.62 147.47 19.37 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 107.631 -1.248 . . . . 63.52 107.631 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 490' ' ' SER . 35.6 Cg_endo -65.84 135.78 42.68 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.237 1.958 . . . . 61.44 111.38 178.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 34.7 m -151.94 179.09 8.76 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.658 -0.867 . . . . 61.03 108.658 -177.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.5 t -47.92 133.5 11.58 Favored Pre-proline 0 C--O 1.248 1.012 0 O-C-N 123.958 0.786 . . . . 75.24 111.02 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.69 -30.87 38.74 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 124.331 3.354 . . . . 74.13 114.003 -174.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -73.21 -27.64 61.73 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 112.345 0.498 . . . . 62.14 112.345 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -94.18 -2.23 52.9 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 120.721 0.296 . . . . 70.41 111.41 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 76.7 t -61.13 127.77 21.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.091 -0.707 . . . . 72.04 109.091 174.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.99 -4.59 75.07 Favored Glycine 0 C--N 1.304 -1.205 0 N-CA-C 111.733 -0.547 . . . . 72.31 111.733 -177.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -117.68 166.45 12.41 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.135 -0.691 . . . . 71.12 109.135 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 81.6 t -75.42 144.74 11.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 115.516 -0.766 . . . . 55.12 109.771 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 47.6 mm -97.68 -30.38 3.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 107.676 -1.231 . . . . 73.44 107.676 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 158.56 -169.51 35.02 Favored Glycine 0 N--CA 1.418 -2.548 0 CA-C-N 115.179 -0.919 . . . . 75.44 112.131 174.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . 0.542 HG22 HG12 ' A' ' 486' ' ' ILE . 20.9 p -114.79 144.55 43.32 Favored 'General case' 0 C--N 1.28 -2.413 0 N-CA-C 106.565 -1.642 . . . . 72.43 106.565 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.499 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 22.4 t-20 -52.51 -53.41 53.86 Favored Pre-proline 0 N--CA 1.48 1.058 0 N-CA-C 112.744 0.646 . . . . 64.35 112.744 178.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 2.7 Cg_endo -85.83 147.62 9.45 Favored 'Trans proline' 0 N--CA 1.442 -1.516 0 N-CA-C 108.414 -1.418 . . . . 52.31 108.414 170.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.67 132.32 37.18 Favored 'Trans proline' 0 C--O 1.241 0.626 0 C-N-CA 121.633 1.555 . . . . 63.32 111.194 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.443 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -75.11 18.16 0.2 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.733 0.813 . . . . 72.02 112.239 -176.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -110.55 -10.3 14.53 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 123.491 0.716 . . . . 75.42 110.25 173.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -102.35 174.74 5.78 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.109 0.48 . . . . 73.21 111.995 -173.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.26 145.88 24.11 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.071 -0.968 . . . . 64.44 111.585 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 29.1 p -137.24 149.31 47.07 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.069 -0.715 . . . . 72.35 109.069 176.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.13 165.26 18.56 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.406 -0.361 . . . . 74.52 111.417 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 42.5 mm -74.88 -16.43 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-O 121.679 0.752 . . . . 72.24 110.444 -178.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 7.3 t -98.2 5.24 48.67 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.506 -0.746 . . . . 43.41 109.74 176.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -77.43 132.38 38.45 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.999 -0.546 . . . . 63.32 110.206 -175.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.509 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 43.1 t -105.04 126.17 60.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.913 -0.773 . . . . 75.32 108.913 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.449 HG12 ' HG2' ' A' ' 472' ' ' PRO . 20.2 m -108.29 126.38 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 CA-C-O 121.898 0.856 . . . . 61.12 111.048 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.425 HG23 ' HB2' ' A' ' 471' ' ' ASN . 0.0 OUTLIER -94.22 129.3 44.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 108.326 -0.99 . . . . 72.42 108.326 176.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.542 HG12 HG22 ' A' ' 470' ' ' THR . 18.2 mt -113.5 127.33 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 CA-C-N 115.17 -0.923 . . . . 72.2 109.808 -176.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 8.0 tt -107.18 126.79 63.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 115.429 -0.805 . . . . 74.5 110.161 -175.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 32.6 m -109.42 151.9 11.6 Favored 'Isoleucine or valine' 0 C--O 1.249 1.056 0 C-N-CA 123.209 0.603 . . . . 75.53 110.193 178.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.91 123.8 6.25 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 110.864 -0.894 . . . . 64.31 110.864 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 44.7 m . . . . . 0 C--N 1.306 -1.32 0 CA-C-N 117.221 0.51 . . . . 71.12 111.118 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo . . . . . 0 C--O 1.251 1.132 0 CA-C-O 120.982 0.326 . . . . 73.43 111.651 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -124.01 56.88 1.23 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.668 -0.864 . . . . 62.43 108.668 175.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 2.9 p -117.09 144.08 45.07 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 114.986 -1.006 . . . . 71.23 111.119 -176.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -140.61 163.81 31.86 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.588 -0.893 . . . . 72.12 108.588 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -97.25 126.66 42.6 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.822 -0.807 . . . . 70.22 108.822 -177.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.4 pt -78.55 127.06 81.73 Favored Pre-proline 0 C--N 1.313 -1.011 0 N-CA-C 113.138 0.792 . . . . 73.11 113.138 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -96.19 155.64 1.37 Allowed 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 122.97 2.447 . . . . 54.42 110.083 169.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -123.99 164.35 19.51 Favored 'General case' 0 C--N 1.314 -0.945 0 O-C-N 121.675 -0.641 . . . . 75.13 111.303 -176.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 6.4 p -151.9 96.28 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 CA-C-O 121.947 0.88 . . . . 73.32 110.179 177.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -102.85 100.67 10.67 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.468 -0.787 . . . . 74.2 110.732 -177.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 152.1 48.41 0.02 OUTLIER Glycine 0 C--N 1.302 -1.313 0 N-CA-C 110.329 -1.108 . . . . 63.45 110.329 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -156.15 -178.52 7.38 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.529 -1.656 . . . . 73.21 106.529 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 18.0 p -89.64 160.07 16.82 Favored 'General case' 0 C--N 1.286 -2.188 0 C-N-CA 120.0 -0.68 . . . . 64.25 109.424 174.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.461 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.3 p -52.51 -43.55 42.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 O-C-N 123.946 0.779 . . . . 72.12 111.745 178.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -62.67 -42.56 99.68 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.945 0.402 . . . . 75.21 111.069 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 57.6 t -73.44 -37.34 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 121.153 0.502 . . . . 64.22 110.283 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.6 -44.92 92.6 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.424 -0.353 . . . . 64.52 111.094 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 23.6 mt-30 -60.91 -40.76 94.38 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.448 0.467 . . . . 70.25 109.958 177.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.454 ' O ' HG23 ' A' ' 514' ' ' VAL . 58.8 tttp -57.9 -50.37 73.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.313 -0.858 . . . . 74.15 110.105 177.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -62.34 -40.82 97.62 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-N 115.479 -0.782 . . . . 51.44 111.421 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . 0.424 HD23 ' HB3' ' A' ' 520' ' ' PHE . 40.9 tp -61.1 -41.15 96.15 Favored 'General case' 0 C--O 1.238 0.485 0 O-C-N 123.369 0.418 . . . . 74.33 109.958 177.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . 0.432 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 12.1 m120 -65.35 -37.69 87.81 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 116.014 -0.539 . . . . 64.54 110.675 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 510' ' ' LYS . 95.5 t -66.06 -28.42 43.74 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 116.117 -0.492 . . . . 72.3 110.362 177.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -75.56 -4.29 39.06 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.814 0.34 . . . . 74.11 111.171 178.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 105.6 -10.61 45.91 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.892 -0.671 . . . . 74.15 112.854 175.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.432 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 70.6 m-85 -95.77 114.11 25.81 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.157 -0.683 . . . . 73.1 109.157 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 16.5 p -87.57 -17.95 30.83 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 113.709 1.003 . . . . 63.41 113.709 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . 0.454 ' HD2' ' O ' ' A' ' 548' ' ' ASP . 96.7 mttt -108.51 119.55 39.85 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.854 0.835 . . . . 71.02 113.208 -172.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . 0.424 ' HB3' HD23 ' A' ' 512' ' ' LEU . 15.3 p90 -130.46 152.14 50.18 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.507 -1.224 . . . . 74.33 111.195 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 63.5 m -142.03 156.54 45.43 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 107.51 -1.293 . . . . 63.2 107.51 170.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 3.9 pt20 -116.67 148.9 40.59 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-O 121.542 0.687 . . . . 71.23 111.056 -177.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . 0.512 ' HB3' ' HG2' ' A' ' 554' ' ' GLN . . . -120.38 119.03 31.91 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.145 -1.428 . . . . 54.33 107.145 175.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 17.0 m -86.25 123.26 31.32 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 116.243 -0.435 . . . . 42.31 110.528 -176.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 45.0 t -121.43 149.07 24.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 105.672 -1.973 . . . . 72.31 105.672 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -102.04 137.05 40.83 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.654 -0.819 . . . . 52.21 108.934 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 54.2 m -155.38 -176.83 0.65 Allowed Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 107.758 -1.201 . . . . 74.14 107.758 -176.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -87.5 3.59 6.32 Favored 'Trans proline' 0 CA--C 1.551 1.35 0 C-N-CA 121.699 1.599 . . . . 64.42 112.798 173.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.508 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 3.6 mpt_? -89.84 134.19 32.53 Favored Pre-proline 0 C--O 1.213 -0.832 0 N-CA-C 108.619 -0.882 . . . . 75.31 108.619 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -54.79 141.68 76.03 Favored 'Trans proline' 0 N--CA 1.483 0.866 0 C-N-CA 123.223 2.615 . . . . 72.14 114.315 -171.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.584 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -61.07 114.22 2.99 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 114.614 -1.176 . . . . 75.31 111.375 -175.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 132.49 -20.08 4.44 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 110.226 -1.15 . . . . 61.33 110.226 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -69.88 131.41 44.4 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 123.185 0.594 . . . . 74.44 109.895 177.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 7.6 p -86.58 106.15 15.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.13 -1.063 . . . . 62.21 108.13 174.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 12.0 t -78.56 -16.43 57.45 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.991 -0.55 . . . . 75.24 111.361 -174.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 163.25 -166.56 37.14 Favored Glycine 0 N--CA 1.429 -1.798 0 N-CA-C 111.194 -0.762 . . . . 72.12 111.194 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 42.4 p -128.71 149.19 50.79 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 107.706 -1.22 . . . . 75.21 107.706 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -71.71 -49.44 10.96 Favored Pre-proline 0 C--N 1.303 -1.423 0 C-N-CA 120.621 -0.431 . . . . 71.42 110.81 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -81.76 126.09 5.1 Favored 'Trans proline' 0 CA--C 1.555 1.531 0 N-CA-C 109.515 -0.994 . . . . 62.44 109.515 168.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.38 160.84 43.96 Favored 'Trans proline' 0 C--O 1.257 1.471 0 C-N-CA 122.716 2.278 . . . . 42.25 113.325 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.94 139.81 58.81 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.339 -0.846 . . . . 52.25 110.47 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.27 -17.79 43.25 Favored Glycine 0 C--N 1.297 -1.627 0 N-CA-C 111.343 -0.703 . . . . 35.12 111.343 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 34.9 m -67.57 123.05 19.37 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.827 -0.434 . . . . 71.0 109.827 178.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 10.8 m -82.77 123.22 29.12 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 108.075 -1.083 . . . . 34.25 108.075 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 32.0 m -136.5 155.0 77.23 Favored Pre-proline 0 C--N 1.308 -1.23 0 N-CA-C 108.786 -0.82 . . . . 75.13 108.786 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -60.59 146.89 96.24 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.182 1.921 . . . . 74.03 110.222 172.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 27.9 m -60.94 -20.53 22.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 113.58 0.955 . . . . 75.44 113.58 -176.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . 0.454 ' O ' ' HD2' ' A' ' 519' ' ' LYS . 11.6 t70 -97.96 4.08 49.48 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.315 0.579 . . . . 74.31 110.566 -178.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.0 t -69.7 154.48 41.92 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.12 0.486 . . . . 74.44 110.403 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 43.6 t -95.22 127.07 47.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.581 -0.896 . . . . 71.21 108.581 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 2.7 mp -103.97 136.24 38.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 109.204 -0.665 . . . . 70.54 109.204 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -102.97 119.23 38.47 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-O 121.515 0.674 . . . . 71.44 111.344 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 5.2 mp -100.23 133.87 44.0 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.64 -1.164 . . . . 70.03 108.372 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . 0.512 ' HG2' ' HB3' ' A' ' 523' ' ' ALA . 48.6 mt-30 -97.93 121.75 40.23 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-O 121.294 0.569 . . . . 44.23 110.283 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 60.7 t -109.94 133.41 55.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 115.194 -0.912 . . . . 73.3 108.797 -175.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.584 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 29.8 p -94.17 133.34 37.78 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-O 121.024 0.44 . . . . 61.51 111.811 -178.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -84.41 145.43 28.19 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 107.218 -1.401 . . . . 52.14 107.218 169.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . 0.508 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -81.6 -28.33 43.63 Favored Glycine 0 CA--C 1.478 -2.265 0 O-C-N 123.813 0.695 . . . . 72.23 113.381 -173.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 70.3 -35.19 0.31 Allowed 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 124.49 1.116 . . . . 64.25 113.946 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.44 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 48.2 mt-30 -125.65 146.16 49.84 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 121.306 0.574 . . . . 74.14 111.638 -172.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -124.72 139.76 53.56 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 115.039 -0.982 . . . . 65.05 109.184 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 91.2 t -61.46 121.71 10.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 123.393 0.677 . . . . 61.24 112.333 -175.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . 0.428 ' HG2' ' O ' ' A' ' 564' ' ' PRO . 54.2 ttp -97.25 132.83 24.79 Favored Pre-proline 0 C--O 1.245 0.864 0 CA-C-N 115.769 -0.651 . . . . 71.31 111.103 -178.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . 0.428 ' O ' ' HG2' ' A' ' 563' ' ' MET . 13.6 Cg_exo -73.39 170.27 20.3 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.268 2.645 . . . . 74.02 110.646 171.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -74.98 115.57 14.75 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.834 0.826 . . . . 72.22 111.418 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 94.8 mt -113.67 7.41 17.24 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 122.666 1.222 . . . . 74.45 107.76 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 1.4 p -79.63 153.27 29.52 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-N 113.695 -1.593 . . . . 63.13 111.18 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 88.81 14.44 61.08 Favored Glycine 0 N--CA 1.436 -1.366 0 CA-C-N 115.634 -0.712 . . . . 52.54 112.908 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 89.1 mtp -108.3 156.27 19.57 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.739 -0.467 . . . . 75.21 109.739 -175.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 96.2 m-85 -75.56 153.92 37.1 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 108.031 -1.1 . . . . 72.52 108.031 176.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 74.8 t-105 -68.13 -22.6 64.87 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.532 -0.544 . . . . 74.52 109.532 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 10.8 p -74.82 -16.92 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 115.229 -0.896 . . . . 74.12 109.358 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -101.3 -44.17 5.74 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.956 -0.565 . . . . 74.5 110.04 175.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -58.12 -52.28 66.22 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.281 -0.872 . . . . 72.01 112.674 -176.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.421 ' HA ' ' HG ' ' A' ' 578' ' ' LEU . 41.3 tt0 -60.7 -51.93 76.15 Favored Pre-proline 0 CA--C 1.557 1.22 0 N-CA-C 112.939 0.718 . . . . 74.34 112.939 -177.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -58.04 -37.23 96.66 Favored 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 121.132 1.221 . . . . 62.12 112.341 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -69.02 -37.74 78.83 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 112.915 0.709 . . . . 61.21 112.915 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.421 ' HG ' ' HA ' ' A' ' 575' ' ' GLU . 4.1 pp -67.0 -38.36 85.86 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.988 -0.685 . . . . 73.25 110.481 177.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . 0.407 ' N ' HD12 ' A' ' 578' ' ' LEU . 79.8 mtp180 -63.49 -44.52 94.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.307 -0.861 . . . . 64.22 110.136 176.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.96 -29.19 68.98 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.516 0.726 . . . . 43.02 111.873 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 64.6 tp -81.2 -7.26 59.53 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 121.381 0.61 . . . . 75.43 109.883 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 77.83 31.02 50.58 Favored Glycine 0 CA--C 1.492 -1.374 0 N-CA-C 111.305 -0.718 . . . . 54.12 111.305 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . 0.402 ' CE3' HD13 ' A' ' 578' ' ' LEU . 86.8 t90 -87.36 140.68 29.29 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 109.043 -0.725 . . . . 75.54 109.043 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 5.8 t -133.33 -50.15 0.86 Allowed 'General case' 0 N--CA 1.41 -2.426 0 CA-C-N 115.708 -0.678 . . . . 71.51 109.496 175.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . 29.59 -126.6 0.11 Allowed Glycine 0 C--N 1.365 2.186 0 C-N-CA 125.352 1.453 . . . . 63.15 114.16 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . 0.438 ' O ' HG12 ' A' ' 619' ' ' ILE . 51.6 ttm -138.03 125.13 21.48 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 105.18 -2.156 . . . . 64.1 105.18 172.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -99.15 125.2 44.65 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.912 -1.144 . . . . 72.33 107.912 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -105.14 101.47 11.02 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 115.901 -0.591 . . . . 45.0 109.61 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -99.89 109.88 22.25 Favored 'General case' 0 N--CA 1.416 -2.17 0 N-CA-C 106.833 -1.543 . . . . 42.03 106.833 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -103.85 -121.6 4.95 Favored Glycine 0 N--CA 1.425 -2.086 0 N-CA-C 110.535 -1.026 . . . . 51.5 110.535 178.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -86.9 119.75 27.45 Favored 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 120.702 -0.399 . . . . 72.21 110.788 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -77.86 152.57 33.31 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 105.273 -2.121 . . . . 72.3 105.273 169.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . 0.409 ' O ' ' HB2' ' A' ' 626' ' ' GLN . 59.5 t -103.84 116.04 46.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 C-N-CA 118.931 -1.108 . . . . 52.23 111.94 -169.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.33 107.08 17.17 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.951 -1.129 . . . . 73.1 107.951 175.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -139.47 17.98 2.55 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.288 -1.004 . . . . 75.2 108.288 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 98.33 144.21 16.41 Favored Glycine 0 N--CA 1.414 -2.816 0 CA-C-N 114.645 -1.161 . . . . 42.31 111.089 -176.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.76 -32.3 61.69 Favored Glycine 0 C--N 1.32 -0.315 0 O-C-N 123.935 0.432 . . . . 72.23 112.503 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 10.0 m -59.06 -23.61 62.17 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.212 1.005 . . . . 72.04 112.798 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -86.71 -13.72 44.57 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 121.852 -0.53 . . . . 60.45 110.397 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 56.92 161.59 0.02 OUTLIER 'General case' 0 C--O 1.243 0.757 0 N-CA-C 115.475 1.657 . . . . 75.53 115.475 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -79.56 89.62 5.09 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 114.745 -1.116 . . . . 72.14 109.455 172.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 49.4 ttt180 -117.65 148.78 41.64 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 106.569 -1.641 . . . . 73.24 106.569 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 67.9 t -61.77 131.12 26.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.468 -0.938 . . . . 75.34 108.468 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 83.7 t -86.87 -46.56 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.008 0 N-CA-C 109.142 -0.688 . . . . 75.44 109.142 -174.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -156.1 164.17 38.74 Favored 'General case' 0 N--CA 1.415 -2.217 0 N-CA-C 107.647 -1.242 . . . . 72.34 107.647 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.04 150.84 44.46 Favored 'General case' 0 C--N 1.279 -2.458 0 N-CA-C 106.928 -1.508 . . . . 60.41 106.928 173.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.648 ' HB3' ' HD3' ' A' ' 608' ' ' PRO 0.294 48.7 t-20 -70.3 -79.36 0.05 OUTLIER Pre-proline 0 CA--C 1.563 1.445 0 CA-C-O 117.555 -1.212 . . . . 74.14 113.587 -171.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.648 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 14.6 Cg_exo -73.24 127.39 11.91 Favored 'Trans proline' 0 C--N 1.374 1.875 0 CA-C-N 122.729 2.01 . . . . 73.05 108.866 174.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.86 160.18 34.49 Favored 'Trans proline' 0 C--O 1.24 0.61 0 C-N-CA 122.392 2.062 . . . . 55.01 112.594 -175.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.94 127.05 29.57 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.434 -0.58 . . . . 61.41 109.434 -178.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.47 -12.48 47.36 Favored Glycine 0 N--CA 1.431 -1.651 0 C-N-CA 120.573 -0.823 . . . . 45.54 111.231 -175.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 27.8 m -97.66 164.62 12.34 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 107.936 -1.135 . . . . 53.12 107.936 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -88.81 143.41 17.59 Favored Glycine 0 N--CA 1.427 -1.95 0 C-N-CA 121.197 -0.525 . . . . 72.21 113.59 -177.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 24.3 m -107.92 142.17 21.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.989 -1.115 . . . . 64.3 107.989 173.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.571 HD21 HG22 ' A' ' 619' ' ' ILE . 31.8 p30 -62.54 164.87 6.91 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 114.282 1.216 . . . . 44.52 114.282 -175.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -55.49 -25.8 39.02 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 114.788 1.403 . . . . 75.24 114.788 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -74.73 -44.53 49.44 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 106.845 -1.539 . . . . 72.32 106.845 174.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 97.56 20.65 21.6 Favored Glycine 0 N--CA 1.418 -2.511 0 CA-C-N 114.672 -1.149 . . . . 74.12 110.53 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . 0.571 HG22 HD21 ' A' ' 615' ' ' ASN . 0.0 OUTLIER -69.42 122.03 20.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 122.078 0.942 . . . . 73.41 109.928 -172.257 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 9.4 tp -121.89 132.59 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.098 0 CA-C-N 114.606 -1.179 . . . . 73.12 108.929 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.464 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 7.4 m -97.62 119.72 36.69 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.178 -1.045 . . . . 61.34 108.178 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 81.6 mt -130.76 154.43 47.99 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 123.739 0.815 . . . . 74.44 109.33 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 65.2 mmt-85 -136.71 154.9 50.47 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 104.583 -2.377 . . . . 71.33 104.583 173.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 602' ' ' ARG . 30.5 p90 -141.31 160.35 40.31 Favored 'General case' 0 C--N 1.288 -2.082 0 O-C-N 123.293 0.371 . . . . 72.35 110.403 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -73.44 -151.14 1.72 Allowed Glycine 0 C--N 1.309 -0.959 0 O-C-N 124.196 0.935 . . . . 45.22 113.446 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . 0.409 ' HB2' ' O ' ' A' ' 593' ' ' VAL . 6.9 tp-100 . . . . . 0 C--N 1.299 -1.602 0 CA-C-O 119.31 -0.376 . . . . 70.11 110.438 -175.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 C--O 1.243 0.73 0 N-CA-C 109.725 -0.472 . . . . 72.44 109.725 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.67 163.56 34.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 109.724 -0.473 . . . . 63.04 109.724 -177.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -93.67 137.36 33.0 Favored 'General case' 0 N--CA 1.404 -2.762 0 CA-C-O 121.619 0.723 . . . . 74.44 109.245 177.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.424 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 91.4 t -98.29 134.27 22.12 Favored Pre-proline 0 C--N 1.268 -2.972 0 CA-C-N 114.337 -1.302 . . . . 72.21 110.171 -173.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 3.6 Cg_exo -71.21 128.79 15.15 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.856 1.704 . . . . 74.11 110.214 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.39 157.92 18.44 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.288 -0.565 . . . . 75.43 109.485 -177.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.502 HG23 ' HA ' ' A' ' 373' ' ' ALA . 18.8 m -131.5 26.55 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-N 115.205 -0.907 . . . . 65.33 109.085 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -66.43 148.55 51.71 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 114.749 -1.114 . . . . 73.44 109.103 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . 0.416 ' H ' HG23 ' A' ' 399' ' ' VAL . . . 107.01 0.7 35.95 Favored Glycine 0 C--N 1.315 -0.625 0 N-CA-C 111.349 -0.7 . . . . 75.54 111.349 -173.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . 0.468 HE21 ' HB ' ' A' ' 365' ' ' VAL . 39.1 mt-30 -113.03 -146.83 0.41 Allowed 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.7 -0.852 . . . . 70.42 108.7 175.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 58.4 p -89.57 160.77 16.52 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 107.929 -1.137 . . . . 64.35 107.929 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 8.8 p -63.52 -34.89 78.78 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 120.078 -0.649 . . . . 73.35 110.568 177.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -65.81 -47.58 74.61 Favored 'General case' 0 C--O 1.216 -0.692 0 N-CA-C 111.902 0.334 . . . . 74.44 111.902 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -67.19 -42.85 83.5 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.716 0.77 . . . . 70.14 109.247 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . 0.502 ' HA ' HG23 ' A' ' 365' ' ' VAL . . . -65.35 -42.65 92.61 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 114.558 -1.201 . . . . 73.12 112.27 -177.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 58.1 mt -69.58 -45.58 77.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 116.592 -0.276 . . . . 74.23 110.55 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.81 -44.56 90.84 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 123.515 0.509 . . . . 73.35 111.647 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . 0.508 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 23.6 m -65.2 -46.64 79.89 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 116.13 -0.486 . . . . 71.31 110.597 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.418 HD23 ' O ' ' A' ' 373' ' ' ALA . 4.6 mm? -63.17 -38.07 89.71 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 111.803 0.297 . . . . 70.43 111.803 178.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -63.65 -38.05 89.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.056 0.455 . . . . 73.4 110.068 178.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -70.07 -21.24 63.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 73.14 111.644 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 376' ' ' THR . 38.4 mmt180 -82.6 -14.11 55.36 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.61 -0.515 . . . . 73.3 109.61 176.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 97.54 6.02 57.59 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 111.385 -0.686 . . . . 45.33 111.385 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -89.4 149.01 23.17 Favored 'General case' 0 N--CA 1.406 -2.653 0 CA-C-O 121.61 0.719 . . . . 75.53 111.244 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.483 ' HB2' ' HG2' ' A' ' 415' ' ' GLU . 45.8 mmtm -96.14 155.09 16.9 Favored 'General case' 0 N--CA 1.41 -2.466 0 CA-C-N 114.548 -1.205 . . . . 72.41 107.764 -177.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . 0.479 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -130.42 141.94 45.01 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 N-CA-C 109.204 -0.665 . . . . 72.11 109.204 -177.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 28.2 ttm-85 -125.53 127.57 46.63 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 108.186 -1.042 . . . . 74.21 108.186 177.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 33.5 m -115.56 123.64 48.98 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-O 120.925 0.393 . . . . 62.2 110.691 -173.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -112.24 131.09 55.69 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.994 -1.484 . . . . 71.43 106.994 175.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.528 HE21 ' N ' ' A' ' 388' ' ' GLN . 0.0 OUTLIER -123.11 142.16 51.18 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 119.374 -0.931 . . . . 71.23 111.403 -179.079 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . 0.436 ' HB2' HG13 ' A' ' 394' ' ' ILE . 75.4 mmtt -131.88 131.26 22.53 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 108.646 -0.872 . . . . 74.11 108.646 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . 0.449 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 60.6 Cg_endo -83.62 129.18 4.85 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 121.626 1.55 . . . . 64.21 111.538 176.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 14.8 t70 158.58 -158.06 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 104.308 -2.478 . . . . 61.34 104.308 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 19.3 m -136.36 2.37 2.74 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 119.213 0.915 . . . . 73.13 110.784 177.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 1.3 p -81.87 -27.65 33.36 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 112.792 0.664 . . . . 54.21 112.792 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.653 HD13 ' H ' ' A' ' 394' ' ' ILE . 0.2 OUTLIER -93.04 152.09 41.08 Favored Pre-proline 0 C--N 1.29 -1.997 0 CA-C-N 115.898 -0.592 . . . . 72.33 110.399 -176.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -43.01 129.46 5.65 Favored 'Trans proline' 0 C--N 1.363 1.339 0 C-N-CA 124.159 3.239 . . . . 52.03 114.528 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -61.04 161.61 21.91 Favored 'Trans proline' 0 N--CA 1.482 0.851 0 C-N-CA 124.212 3.275 . . . . 60.35 113.489 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -59.37 -8.08 1.6 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 112.975 0.732 . . . . 75.02 112.975 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -98.02 122.38 41.08 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 103.52 -2.77 . . . . 65.22 103.52 171.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.416 HG23 ' H ' ' A' ' 367' ' ' GLY . 26.8 m -77.92 117.05 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.351 0 C-N-CA 118.982 -1.087 . . . . 73.44 113.565 -162.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 43.6 pt -103.32 -27.4 3.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 114.523 -1.217 . . . . 73.34 108.548 174.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.8 157.13 27.27 Favored Glycine 1 CA--C 1.442 -4.525 0 CA-C-O 122.397 0.998 . . . . 63.12 111.647 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . 0.484 HG22 ' H ' ' A' ' 403' ' ' ASP . 87.2 m -156.54 -177.89 6.93 Favored 'General case' 0 N--CA 1.383 -3.783 0 N-CA-C 104.592 -2.373 . . . . 63.44 104.592 -171.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . 0.484 ' H ' HG22 ' A' ' 402' ' ' THR . 15.0 m-20 -98.6 131.65 25.5 Favored Pre-proline 0 C--N 1.264 -3.111 0 N-CA-C 106.117 -1.808 . . . . 71.22 106.117 174.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.6 26.31 0.12 Allowed 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 124.472 3.448 . . . . 74.1 114.761 -171.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.414 ' H ' ' C ' ' A' ' 403' ' ' ASP . . . -56.92 -35.99 69.67 Favored 'General case' 0 C--O 1.209 -1.077 0 C-N-CA 123.658 0.783 . . . . 70.45 110.635 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -70.86 -33.61 70.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.33 0.586 . . . . 64.31 111.049 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -88.12 -1.34 57.95 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 122.081 0.943 . . . . 74.14 109.406 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 26.6 m -95.28 148.51 22.34 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 104.874 -2.269 . . . . 73.3 104.874 173.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 4.1 p -74.89 111.99 10.65 Favored 'General case' 0 N--CA 1.41 -2.46 0 C-N-CA 118.603 -1.239 . . . . 62.24 108.839 176.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 30.2 m -123.71 167.46 17.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.702 -0.681 . . . . 43.21 110.344 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 38.4 m -76.94 146.91 37.25 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 108.832 -0.803 . . . . 75.42 108.832 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -64.73 109.45 2.04 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.9 0.381 . . . . 72.13 111.184 -176.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 111.67 53.12 0.53 Allowed Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.819 -0.628 . . . . 64.31 112.614 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.61 -167.65 1.29 Allowed 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.46 -0.941 . . . . 71.31 108.46 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . 0.483 ' HG2' ' HB2' ' A' ' 383' ' ' LYS . 37.1 mt-10 -113.91 137.16 52.06 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.114 0.483 . . . . 72.13 110.305 -176.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 34.7 mm -110.28 110.73 33.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 108.712 -0.848 . . . . 44.3 108.712 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 21.0 p -84.1 131.22 34.81 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 123.098 0.559 . . . . 65.34 111.838 -177.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 10.6 p -127.25 135.2 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-N 115.673 -0.694 . . . . 73.23 111.441 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -105.27 124.61 49.83 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.992 -0.744 . . . . 73.43 108.992 172.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 16.7 m -126.04 152.7 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.545 0 CA-C-N 115.28 -0.873 . . . . 63.44 110.535 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . 0.415 ' HB2' HG12 ' A' ' 394' ' ' ILE . 27.1 t -99.38 129.64 45.59 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-O 121.718 0.77 . . . . 54.44 110.584 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 3.0 p -93.61 158.36 15.73 Favored 'General case' 0 N--CA 1.401 -2.906 0 N-CA-C 105.008 -2.219 . . . . 53.41 105.008 166.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 2.419 0 N-CA-C 116.729 1.451 . . . . 74.25 116.729 -175.427 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 . . . . . 0 N--CA 1.422 -1.849 0 N-CA-C 106.676 -1.602 . . . . 75.34 106.676 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 -122.21 152.46 39.96 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 119.398 -0.921 . . . . 72.35 111.254 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -83.23 138.64 33.52 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 114.445 -1.252 . . . . 62.55 109.073 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 53.7 mt -84.12 122.95 75.89 Favored Pre-proline 0 N--CA 1.424 -1.733 0 N-CA-C 107.297 -1.371 . . . . 63.43 107.297 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.451 ' HG2' ' HB3' ' A' ' 443' ' ' LYS . 56.2 Cg_endo -70.74 150.42 62.2 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.802 1.668 . . . . 72.1 110.892 176.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -80.5 130.13 34.95 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.167 -1.049 . . . . 72.14 108.167 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 39.5 t -127.03 152.3 34.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 107.438 -1.319 . . . . 74.41 107.438 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 42.6 t -70.29 143.64 51.99 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.833 -0.803 . . . . 72.4 108.833 176.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 18.9 p -67.56 -28.44 67.79 Favored 'General case' 0 N--CA 1.424 -1.726 0 C-N-CA 123.658 0.783 . . . . 65.41 111.532 -175.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 2.3 pp -79.36 -12.53 59.92 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.339 0.59 . . . . 71.14 111.963 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 3.2 p -104.05 62.98 0.75 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 121.567 0.699 . . . . 74.45 112.41 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -56.95 -38.58 73.13 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.078 -0.964 . . . . 73.04 111.014 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -60.04 -42.49 94.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.424 0.63 . . . . 74.5 110.254 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.475 ' O ' ' HB3' ' A' ' 442' ' ' LYS . 25.8 tp10 -70.89 -34.95 72.1 Favored 'General case' 0 C--O 1.205 -1.237 0 CA-C-N 115.463 -0.79 . . . . 71.12 110.035 178.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.6 -51.42 69.47 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.303 0.112 . . . . 73.21 111.303 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 33.9 m -63.01 -36.57 76.39 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 CA-C-O 121.273 0.559 . . . . 75.3 110.839 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 439' ' ' GLU . 16.6 tppt? -60.04 -47.69 84.8 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.942 -1.026 . . . . 65.43 109.998 176.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . 0.451 ' HB3' ' HG2' ' A' ' 430' ' ' PRO . 28.5 mmtp -67.04 -38.51 86.0 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 113.067 0.765 . . . . 75.52 113.067 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 9.8 mp -63.71 -34.93 78.96 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.6 -0.44 . . . . 70.33 109.974 174.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 92.9 m -68.23 -42.2 80.09 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.884 -0.598 . . . . 74.51 110.182 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.82 -20.64 62.55 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.909 -0.587 . . . . 70.42 112.063 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -90.2 3.28 53.96 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 112.492 0.553 . . . . 65.54 112.492 -178.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 110.28 -75.28 0.21 Allowed Glycine 0 CA--C 1.497 -1.071 0 C-N-CA 119.581 -1.295 . . . . 71.55 112.98 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . 0.433 ' HA ' ' O ' ' A' ' 480' ' ' ILE . 0.2 OUTLIER -40.94 -62.36 0.83 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.902 1.075 . . . . 74.22 113.902 177.589 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 61.14 23.08 61.43 Favored Glycine 0 C--O 1.221 -0.701 0 C-N-CA 121.172 -0.537 . . . . 75.02 112.447 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.402 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 10.5 mmm180 -97.89 111.24 23.61 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 107.921 -1.14 . . . . 70.33 107.921 -177.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.433 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 19.7 p90 -137.6 149.49 46.69 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 121.215 0.531 . . . . 62.44 111.576 -177.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -136.19 142.48 44.12 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.446 -1.316 . . . . 62.32 107.446 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -112.7 126.03 54.96 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 120.601 0.239 . . . . 52.2 110.558 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -123.07 136.15 54.7 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.281 -1.007 . . . . 71.13 108.281 175.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -113.34 141.52 46.94 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.834 -1.173 . . . . 65.4 107.834 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 50.0 m -144.68 140.22 16.23 Favored Pre-proline 0 C--N 1.292 -1.931 0 N-CA-C 109.939 -0.393 . . . . 73.42 109.939 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.605 ' HA ' ' O ' ' A' ' 490' ' ' SER . 21.4 Cg_endo -64.93 122.6 10.45 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.625 1.55 . . . . 53.3 108.968 176.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 19.8 m -135.84 179.64 6.22 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.55 -0.75 . . . . 63.53 110.133 -171.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 464' ' ' VAL . 7.2 t -59.5 139.75 88.98 Favored Pre-proline 0 N--CA 1.42 -1.927 0 O-C-N 124.13 0.894 . . . . 71.31 109.399 174.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.37 -29.08 29.31 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.707 3.605 . . . . 70.01 113.492 -175.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -65.34 -37.18 86.29 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.541 -0.3 . . . . 63.35 111.807 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.07 -14.87 32.91 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 121.044 -0.262 . . . . 71.31 111.397 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 460' ' ' THR . 85.4 t -60.31 128.12 20.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-N 116.498 -0.319 . . . . 63.24 110.29 177.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 95.45 -12.11 68.1 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.519 -0.764 . . . . 72.14 112.229 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -122.47 167.45 13.33 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.204 -0.665 . . . . 51.43 109.204 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.456 HG13 HG23 ' A' ' 486' ' ' ILE . 62.4 t -72.63 143.89 13.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 107.567 -1.272 . . . . 73.44 107.567 171.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 55.3 mt -97.18 -34.03 4.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.372 -1.344 . . . . 23.34 107.372 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 163.06 -172.87 39.17 Favored Glycine 0 N--CA 1.409 -3.106 0 CA-C-N 114.802 -1.09 . . . . 64.32 110.508 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 24.5 p -116.1 147.83 40.91 Favored 'General case' 0 N--CA 1.404 -2.728 0 N-CA-C 105.931 -1.877 . . . . 72.41 105.931 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.432 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 20.3 t-20 -70.18 -49.99 16.83 Favored Pre-proline 0 C--N 1.313 -0.979 0 C-N-CA 118.237 -1.385 . . . . 72.22 110.756 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 19.2 Cg_exo -74.07 125.42 9.8 Favored 'Trans proline' 0 C--N 1.368 1.582 0 N-CA-C 106.837 -2.024 . . . . 64.15 106.837 165.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.438 ' HB2' ' HG2' ' A' ' 476' ' ' GLN . 21.8 Cg_exo -61.98 133.64 45.47 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 122.129 1.886 . . . . 71.24 113.562 -172.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -75.34 16.87 0.3 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.057 0.943 . . . . 64.43 112.188 -176.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -110.45 -10.93 14.54 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.887 -0.597 . . . . 64.21 109.551 177.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . 0.438 ' HG2' ' HB2' ' A' ' 473' ' ' PRO . 78.6 mm-40 -90.24 176.97 6.55 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.661 -0.699 . . . . 63.4 112.473 -174.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 6.1 m -107.57 114.98 29.34 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 107.412 -1.329 . . . . 74.11 107.412 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 13.4 p -112.61 147.85 35.82 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.157 0.503 . . . . 74.24 111.635 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.58 160.22 30.42 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.843 -0.617 . . . . 71.32 111.371 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 449' ' ' PHE . 1.8 mp -67.63 -15.16 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.394 0 CA-C-O 122.145 0.974 . . . . 74.2 112.059 -178.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 11.6 p -103.49 5.3 36.76 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.436 -0.79 . . . . 75.11 111.331 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -85.36 129.39 34.82 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.094 -0.706 . . . . 61.31 109.094 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.402 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 61.5 t -91.93 126.6 44.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.864 -0.607 . . . . 74.22 110.303 -177.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 30.2 t -106.38 120.05 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 N-CA-C 108.781 -0.822 . . . . 52.13 108.781 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.39 123.67 47.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-O 121.227 0.537 . . . . 63.4 110.124 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.456 HG23 HG13 ' A' ' 467' ' ' VAL . 1.7 mp -102.59 128.09 55.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 124.976 1.31 . . . . 72.41 108.795 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 8.2 tt -109.74 126.6 66.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 109.255 -0.646 . . . . 75.21 109.255 176.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 34.1 m -109.17 151.34 11.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 116.251 -0.431 . . . . 51.12 110.232 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -88.78 131.58 10.76 Favored Glycine 0 N--CA 1.439 -1.104 0 C-N-CA 120.592 -0.813 . . . . 75.01 111.851 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.605 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 19.5 m . . . . . 0 C--N 1.308 -1.229 0 N-CA-C 108.65 -0.87 . . . . 71.12 108.65 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 CA--C 1.542 0.916 0 CA-C-O 120.964 0.319 . . . . 74.1 112.603 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -84.65 67.08 9.88 Favored 'General case' 0 C--O 1.25 1.095 0 CA-C-O 122.158 0.98 . . . . 65.32 110.461 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.47 ' HB ' HG22 ' A' ' 544' ' ' THR . 11.1 p -117.64 153.67 32.9 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 114.735 -1.121 . . . . 62.43 110.559 -178.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -149.73 150.38 31.99 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.689 -0.856 . . . . 64.32 108.689 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.7 p-10 -81.74 138.95 35.13 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 123.588 0.755 . . . . 71.12 110.903 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 543' ' ' THR . 22.2 pt -92.85 117.92 67.72 Favored Pre-proline 0 C--N 1.307 -1.254 0 CA-C-N 115.954 -0.567 . . . . 72.23 110.876 176.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -92.99 146.45 2.44 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.422 2.081 . . . . 71.13 111.373 175.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -83.39 96.07 8.42 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 122.803 1.287 . . . . 72.2 110.634 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.6 p -100.44 23.26 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 123.258 1.504 . . . . 75.41 107.432 177.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -77.07 171.6 14.55 Favored 'General case' 0 N--CA 1.416 -2.149 0 CA-C-N 113.368 -1.742 . . . . 73.04 110.295 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 96.74 22.4 18.47 Favored Glycine 0 C--N 1.285 -2.278 0 N-CA-C 108.258 -1.937 . . . . 63.31 108.258 -177.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -133.68 174.73 10.13 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 108.265 -1.013 . . . . 61.23 108.265 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 41.7 p -77.91 164.32 25.24 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 117.966 0.348 . . . . 62.41 110.998 -176.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 17.4 m -51.42 -44.49 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.652 0 C-N-CA 123.79 0.836 . . . . 73.22 112.982 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -68.01 -41.78 81.68 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.215 0.531 . . . . 73.1 111.079 -178.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 62.5 t -72.55 -46.45 55.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 115.361 -0.836 . . . . 74.44 111.535 -175.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.72 -40.44 96.75 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.655 -0.248 . . . . 43.13 110.812 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -59.96 -43.55 94.98 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.387 -0.598 . . . . 75.04 109.387 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.502 ' O ' HG23 ' A' ' 514' ' ' VAL . 59.7 tttm -58.1 -50.95 71.71 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.729 -1.123 . . . . 70.02 109.801 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -62.59 -46.75 86.88 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.575 -0.739 . . . . 75.42 112.046 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.94 -40.51 89.19 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 120.878 -0.329 . . . . 64.11 110.729 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.97 -37.98 89.42 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.127 -0.488 . . . . 55.13 111.309 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 510' ' ' LYS . 77.3 t -62.48 -30.47 49.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 121.006 0.431 . . . . 72.11 110.785 178.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -83.07 7.96 14.28 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.161 0.505 . . . . 75.54 111.715 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 93.99 -10.47 71.95 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.988 -0.625 . . . . 72.41 111.81 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -87.56 81.45 7.74 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-O 121.882 0.849 . . . . 73.35 109.433 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 3.5 p -89.89 3.34 53.32 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.917 -1.038 . . . . 75.44 110.98 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -108.74 113.45 26.42 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.061 -1.089 . . . . 71.43 108.061 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' A' ' 551' ' ' ILE . 15.3 p90 -131.56 156.64 45.39 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.024 -0.989 . . . . 71.21 111.791 -174.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 50.3 m -137.0 145.55 44.26 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 106.041 -1.837 . . . . 73.51 106.041 171.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -117.09 132.99 56.55 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 120.856 0.36 . . . . 64.35 110.267 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -124.58 141.11 52.34 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.179 -1.045 . . . . 75.51 108.179 176.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 6.4 m -110.28 120.75 43.45 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.62 -0.881 . . . . 72.0 108.62 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 34.9 m -120.9 164.12 17.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 110.294 -0.262 . . . . 55.54 110.294 -175.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . 0.641 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 8.0 p-10 -90.63 135.26 33.82 Favored 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 120.274 -0.57 . . . . 74.01 111.343 -177.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . 0.455 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 67.5 m -160.75 -179.92 1.18 Allowed Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 108.914 -0.773 . . . . 61.5 108.914 176.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -85.55 -19.15 3.62 Favored 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 121.505 1.47 . . . . 72.5 111.158 171.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -69.11 137.16 89.36 Favored Pre-proline 0 N--CA 1.437 -1.092 0 C-N-CA 124.018 0.927 . . . . 75.13 109.628 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -56.73 144.56 86.4 Favored 'Trans proline' 0 C--O 1.245 0.863 0 C-N-CA 123.624 2.883 . . . . 52.41 115.505 -170.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.634 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -67.4 115.51 7.12 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 114.258 -1.337 . . . . 75.23 109.907 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 133.93 -21.47 3.94 Favored Glycine 0 C--N 1.297 -1.61 0 N-CA-C 110.777 -0.929 . . . . 54.31 110.777 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -83.07 128.9 34.9 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 120.951 0.405 . . . . 74.43 110.596 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.46 HG22 HG22 ' A' ' 555' ' ' VAL . 84.2 t -83.22 105.74 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 N-CA-C 104.791 -2.3 . . . . 72.32 104.791 170.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 74.1 m -83.69 -16.85 43.45 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 112.312 0.486 . . . . 75.44 112.312 -173.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 173.44 -161.78 32.66 Favored Glycine 0 CA--C 1.49 -1.505 0 C-N-CA 120.099 -1.048 . . . . 61.52 111.251 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 23.7 p -127.77 160.07 32.85 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.782 -0.822 . . . . 71.05 108.782 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -73.01 -51.57 6.1 Favored Pre-proline 0 C--N 1.307 -1.243 0 CA-C-O 119.337 -0.363 . . . . 73.5 110.034 176.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 29.6 Cg_endo -66.55 130.86 24.58 Favored 'Trans proline' 0 C--N 1.378 2.103 0 N-CA-C 108.487 -1.39 . . . . 71.34 108.487 170.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 38.9 Cg_exo -61.66 142.11 93.24 Favored 'Trans proline' 0 C--O 1.241 0.673 0 C-N-CA 122.59 2.193 . . . . 74.22 114.161 -176.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.54 141.72 57.76 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.125 -0.943 . . . . 44.13 109.996 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.11 -20.65 46.61 Favored Glycine 0 C--N 1.302 -1.322 0 N-CA-C 110.545 -1.022 . . . . 72.12 110.545 -177.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.433 ' O ' HG12 ' A' ' 497' ' ' ILE . 63.5 m -76.47 137.66 39.81 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-O 121.507 0.67 . . . . 40.44 109.868 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.47 HG22 ' HB ' ' A' ' 494' ' ' THR . 18.4 m -94.14 123.92 37.82 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 115.373 -0.83 . . . . 74.51 109.749 -176.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 31.6 m -129.12 157.96 74.36 Favored Pre-proline 0 C--N 1.312 -1.044 0 N-CA-C 109.217 -0.661 . . . . 75.21 109.217 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 494' ' ' THR . 25.0 Cg_exo -66.07 143.61 72.58 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.067 1.845 . . . . 74.43 110.793 175.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 36.0 m -66.26 -19.04 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-O 121.521 0.677 . . . . 51.51 111.842 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -87.53 -2.05 58.35 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 115.297 -0.865 . . . . 73.23 110.703 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 32.3 t -89.09 157.24 18.39 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.485 -0.561 . . . . 74.24 109.485 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 25.8 t -96.33 136.65 26.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 109.24 -0.652 . . . . 71.14 109.24 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 520' ' ' PHE . 2.7 mp -113.66 138.56 42.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.379 -0.6 . . . . 73.32 109.379 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -101.98 121.13 41.56 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 121.36 0.6 . . . . 74.35 110.472 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.3 mp -95.56 132.08 41.08 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.364 -1.289 . . . . 71.25 107.859 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -106.84 120.17 41.31 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 122.013 0.911 . . . . 63.34 110.953 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.46 HG22 HG22 ' A' ' 534' ' ' VAL . 47.0 t -99.61 135.65 34.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-N 114.111 -1.404 . . . . 53.34 108.211 -178.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.634 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 68.2 m -90.73 149.2 22.13 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 116.464 -0.335 . . . . 41.23 110.455 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.641 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 15.8 ptmt -105.65 146.68 29.39 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 105.226 -2.138 . . . . 74.51 105.226 172.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -84.15 -24.72 47.06 Favored Glycine 0 N--CA 1.433 -1.549 0 C-N-CA 119.479 -1.343 . . . . 64.12 112.239 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 70.02 5.91 5.5 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.687 1.195 . . . . 71.34 111.004 -177.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 15.3 tp60 -148.53 141.87 25.2 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 106.891 -1.522 . . . . 75.15 106.891 -171.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -143.86 149.52 37.06 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.945 -0.761 . . . . 74.24 108.945 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.52 119.79 32.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 121.286 0.565 . . . . 51.34 111.413 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 60.4 ttp -97.75 134.0 22.84 Favored Pre-proline 0 C--N 1.316 -0.873 0 N-CA-C 108.537 -0.912 . . . . 72.11 108.537 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -64.18 169.52 10.61 Favored 'Trans proline' 0 C--O 1.245 0.872 0 C-N-CA 122.864 2.376 . . . . 75.41 112.378 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . 0.549 ' HA ' ' HB1' ' A' ' 610' ' ' ALA . 31.9 t70 -69.0 131.07 44.48 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 113.802 1.038 . . . . 65.11 113.802 -177.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 93.8 mt -147.12 23.19 1.19 Allowed 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 125.141 1.377 . . . . 75.35 107.942 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 2.8 m -79.25 146.28 33.1 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 116.25 -0.432 . . . . 75.43 110.824 -175.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 82.75 33.63 24.02 Favored Glycine 0 CA--C 1.496 -1.105 0 C-N-CA 120.796 -0.716 . . . . 72.02 112.137 174.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 25.0 mmt -108.04 -175.12 2.69 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.089 0.471 . . . . 72.43 110.387 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -110.25 155.9 21.41 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 108.845 -0.798 . . . . 73.3 108.845 -176.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 26.6 t90 -59.9 -30.68 69.19 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 123.217 0.323 . . . . 73.41 111.207 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 11.7 p -63.9 -21.51 28.91 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 CA-C-O 121.355 0.597 . . . . 74.23 110.791 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . 0.646 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 17.9 t70 -101.69 -41.74 6.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.715 -0.675 . . . . 75.53 109.703 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -62.79 -46.76 86.48 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 113.189 0.811 . . . . 51.51 113.189 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -54.33 -55.32 38.41 Favored Pre-proline 0 CA--C 1.577 2.016 0 O-C-N 123.215 0.322 . . . . 73.31 110.76 -178.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.37 -28.48 84.23 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.446 2.098 . . . . 65.24 114.24 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.646 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 29.1 mmt180 -58.15 -47.13 84.3 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.818 -0.438 . . . . 72.25 109.818 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 9.9 mp -61.11 -40.41 93.66 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.589 -0.732 . . . . 63.33 110.993 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -64.76 -46.83 80.46 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.931 -0.577 . . . . 75.41 110.206 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -67.63 -34.95 78.0 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.739 -0.664 . . . . 62.3 112.786 -177.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 92.4 mt -81.49 -7.55 59.6 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 112.61 0.596 . . . . 63.21 112.61 -176.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 74.41 40.16 40.75 Favored Glycine 0 CA--C 1.504 -0.627 0 C-N-CA 119.712 -1.232 . . . . 62.41 110.128 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . 0.455 ' CH2' ' HB2' ' A' ' 587' ' ' LEU . 77.0 t90 -72.51 136.09 45.82 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.59 -0.805 . . . . 70.14 111.166 -178.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 34.1 m -146.94 95.28 2.55 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.578 -0.527 . . . . 74.31 109.578 175.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -161.73 -144.98 4.17 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 108.871 -1.692 . . . . 71.2 108.871 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 87.5 mtp -111.34 133.7 53.46 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 118.085 0.943 . . . . 63.23 110.827 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . 0.455 ' HB2' ' CH2' ' A' ' 583' ' ' TRP . 61.6 tp -114.52 129.23 56.65 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.964 -1.124 . . . . 73.41 107.964 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -101.55 100.07 10.45 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 119.16 -1.016 . . . . 62.01 109.007 176.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -114.38 110.56 20.07 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 115.269 -0.878 . . . . 53.45 108.954 175.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . 0.438 ' HA3' ' NH1' ' A' ' 623' ' ' ARG . . . -90.8 -151.08 25.77 Favored Glycine 0 N--CA 1.433 -1.512 0 C-N-CA 120.991 -0.623 . . . . 62.14 113.069 -178.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -100.21 154.49 18.42 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 110.025 -0.361 . . . . 65.34 110.025 -177.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . 0.403 ' HB2' ' HG3' ' A' ' 626' ' ' GLN . 4.5 p30 -73.49 149.82 42.04 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 123.896 0.748 . . . . 74.11 110.634 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 94.8 t -138.45 130.2 37.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 115.476 -0.784 . . . . 62.02 109.763 -177.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -77.68 106.73 9.67 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 107.4 -1.333 . . . . 62.23 107.4 173.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -126.39 -20.16 4.48 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 116.03 -0.532 . . . . 73.33 111.132 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 128.2 157.93 9.52 Favored Glycine 0 C--N 1.302 -1.343 0 N-CA-C 110.412 -1.075 . . . . 42.03 110.412 -177.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.35 -35.67 66.64 Favored Glycine 0 N--CA 1.46 0.279 0 N-CA-C 113.992 0.357 . . . . 71.11 113.992 -173.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 19.9 m -62.61 -24.54 67.63 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.036 0.446 . . . . 70.24 111.701 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -107.05 -11.57 15.62 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 122.057 -0.402 . . . . 71.43 111.809 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 41.6 m170 -77.78 133.64 38.2 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 122.204 -0.31 . . . . 71.15 111.707 -176.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 58.9 t30 70.03 -21.73 0.17 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 125.488 1.515 . . . . 53.3 114.254 174.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 17.7 ttp85 -91.38 149.69 21.61 Favored 'General case' 0 C--N 1.312 -1.059 0 O-C-N 121.976 -0.453 . . . . 74.34 111.184 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . 0.495 HG23 ' HB2' ' A' ' 622' ' ' LEU . 9.0 p -62.71 133.66 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 O-C-N 123.765 0.665 . . . . 70.02 109.911 174.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 90.8 t -90.94 -48.46 14.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 108.317 -0.994 . . . . 72.03 108.317 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 622' ' ' LEU . 49.1 p90 -151.89 152.65 32.84 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 107.124 -1.435 . . . . 71.33 107.124 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -126.48 139.36 53.3 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 109.156 -0.683 . . . . 63.45 109.156 176.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.604 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 25.3 t-20 -54.91 -66.85 0.81 Allowed Pre-proline 0 C--N 1.311 -1.071 0 CA-C-N 115.407 -0.815 . . . . 72.35 112.454 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.604 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 88.2 Cg_endo -93.04 132.99 0.95 Allowed 'Trans proline' 0 N--CA 1.442 -1.55 0 CA-C-N 121.481 1.564 . . . . 73.21 110.6 173.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -70.3 134.76 27.58 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 121.102 1.201 . . . . 73.23 110.834 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . 0.549 ' HB1' ' HA ' ' A' ' 565' ' ' ASP . . . -69.49 129.68 40.38 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.6 -0.889 . . . . 33.11 108.6 176.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.38 -2.89 39.96 Favored Glycine 0 C--N 1.299 -1.513 0 N-CA-C 109.707 -1.357 . . . . 53.45 109.707 -172.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 30.2 m -119.11 167.54 11.7 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 107.832 -1.174 . . . . 71.04 107.832 177.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -71.34 126.17 12.76 Favored Glycine 0 N--CA 1.432 -1.588 0 CA-C-O 120.984 0.214 . . . . 72.05 112.987 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . 0.44 HG12 ' HB2' ' A' ' 608' ' ' PRO . 35.6 m -106.15 143.6 16.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 C-N-CA 124.606 1.162 . . . . 55.1 108.385 177.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.435 ' ND2' ' HB2' ' A' ' 617' ' ' ASP . 32.2 p-10 -67.64 161.07 26.59 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.657 0.265 . . . . 63.24 111.506 -176.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . 0.51 ' HD3' ' H ' ' A' ' 616' ' ' ARG . 0.0 OUTLIER -52.95 -30.71 36.28 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.812 -0.631 . . . . 65.43 111.796 178.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . 0.435 ' HB2' ' ND2' ' A' ' 615' ' ' ASN . 4.8 m-20 -71.34 -37.81 71.68 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 116.394 -0.366 . . . . 74.4 111.064 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 85.05 22.88 51.21 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 118.553 -1.784 . . . . 31.4 111.524 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.96 122.04 17.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 122.637 1.208 . . . . 72.24 109.773 -169.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 5.1 tp -126.4 123.28 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 CA-C-N 114.068 -1.423 . . . . 75.22 111.209 -174.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.557 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 55.0 m -115.0 121.87 44.47 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 107.952 -1.129 . . . . 65.02 107.952 173.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . 0.495 ' HB2' HG23 ' A' ' 603' ' ' VAL . 0.0 OUTLIER -138.41 159.48 41.97 Favored 'General case' 0 CA--C 1.479 -1.781 0 N-CA-C 107.044 -1.465 . . . . 74.44 107.044 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . 0.438 ' NH1' ' HA3' ' A' ' 590' ' ' GLY . 18.2 tpt180 -135.42 149.48 49.63 Favored 'General case' 0 C--N 1.267 -2.999 0 N-CA-C 105.686 -1.968 . . . . 73.55 105.686 178.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -141.08 162.02 36.47 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 106.569 -1.641 . . . . 65.35 106.569 177.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -78.44 -101.57 0.21 Allowed Glycine 0 N--CA 1.427 -1.912 0 N-CA-C 109.832 -1.307 . . . . 74.23 109.832 177.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . 0.403 ' HG3' ' HB2' ' A' ' 592' ' ' ASP . 33.3 tt0 . . . . . 0 C--N 1.282 -2.329 0 N-CA-C 108.664 -0.865 . . . . 63.13 108.664 175.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 . . . . . 0 CA--C 1.504 -0.806 0 N-CA-C 107.859 -1.163 . . . . 74.34 107.859 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 35.9 m -117.42 159.25 17.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-O 120.864 0.364 . . . . 63.54 110.145 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.5 122.96 38.79 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.609 -1.626 . . . . 71.43 106.609 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.583 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 60.7 t -96.46 133.17 25.13 Favored Pre-proline 0 C--N 1.294 -1.843 0 CA-C-N 116.2 -0.455 . . . . 52.22 110.627 -170.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 6.9 Cg_exo -68.9 127.63 15.57 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 121.682 1.588 . . . . 73.15 111.3 178.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -82.35 100.48 10.0 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 122.575 1.179 . . . . 74.03 110.039 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 20.0 m -74.32 9.11 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 113.587 -1.642 . . . . 63.53 114.522 -174.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -63.34 144.62 56.8 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 123.025 0.53 . . . . 55.45 111.252 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.52 0.35 43.25 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.959 -0.564 . . . . 40.45 112.395 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -112.16 -160.6 0.72 Allowed 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.538 -1.282 . . . . 61.3 107.538 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 84.0 p -91.58 166.01 13.04 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 106.696 -1.594 . . . . 43.44 106.696 177.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 40.2 t -60.63 -42.33 96.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 118.376 0.534 . . . . 62.44 109.608 177.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.19 -46.56 76.92 Favored 'General case' 0 C--O 1.214 -0.804 0 CA-C-N 115.892 -0.594 . . . . 70.22 111.727 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -65.91 -44.55 84.89 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 120.648 0.261 . . . . 75.41 111.161 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -61.86 -48.64 79.62 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.762 -0.653 . . . . 71.41 111.121 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 66.7 mt -67.21 -40.0 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 116.049 -0.523 . . . . 62.21 110.936 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.19 -39.73 91.27 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-O 120.626 0.251 . . . . 61.43 111.212 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . 0.427 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 90.4 m -63.96 -48.52 76.17 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 116.088 -0.506 . . . . 63.54 109.953 177.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.9 -38.9 92.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.312 -0.404 . . . . 51.42 111.081 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -62.92 -43.8 97.82 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.824 -0.625 . . . . 74.03 111.113 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -67.64 -23.66 65.37 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.488 0.661 . . . . 74.32 111.569 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 376' ' ' THR . 27.9 mmt180 -84.7 -14.16 49.25 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.747 -0.66 . . . . 71.2 111.088 177.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.81 16.3 45.75 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.309 -0.948 . . . . 71.1 112.447 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.46 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 53.8 m-85 -83.99 173.73 10.92 Favored 'General case' 0 N--CA 1.421 -1.875 0 CA-C-O 120.946 0.403 . . . . 62.53 111.537 177.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -116.17 150.46 37.42 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 107.186 -1.413 . . . . 65.03 107.186 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . 0.42 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -126.69 140.35 49.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 CA-C-O 121.094 0.473 . . . . 75.13 110.801 -178.25 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 417' ' ' THR . 39.9 ttt180 -116.06 127.95 55.3 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 105.995 -1.854 . . . . 72.33 105.995 174.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 22.8 m -111.87 131.88 55.07 Favored 'General case' 0 C--N 1.276 -2.623 0 C-N-CA 119.988 -0.685 . . . . 70.13 110.403 -175.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -111.11 119.46 39.06 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 105.264 -2.124 . . . . 71.41 105.264 175.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.716 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -129.73 123.13 30.32 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.774 0.321 . . . . 64.41 111.28 -176.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -138.52 138.04 21.46 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 116.252 -0.431 . . . . 74.2 111.525 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' A' ' 422' ' ' THR . 8.4 Cg_exo -77.84 131.29 11.07 Favored 'Trans proline' 0 C--O 1.259 1.541 0 C-N-CA 122.472 2.115 . . . . 74.33 110.223 169.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.434 ' HB3' HG12 ' A' ' 394' ' ' ILE . 22.8 t70 169.01 136.87 0.02 OUTLIER 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 124.304 1.042 . . . . 65.24 108.328 -177.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 14.3 m -93.64 4.59 53.72 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 113.015 0.746 . . . . 64.22 113.015 -173.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 86.0 m -99.8 -30.15 12.22 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.578 -0.701 . . . . 71.41 110.248 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.434 HG12 ' HB3' ' A' ' 391' ' ' ASP . 16.9 pt -87.6 148.63 44.51 Favored Pre-proline 0 N--CA 1.433 -1.323 0 CA-C-N 116.097 -0.501 . . . . 75.43 110.297 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 396' ' ' PRO . 13.8 Cg_endo -55.2 138.47 79.33 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.057 3.171 . . . . 63.32 115.397 -173.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 395' ' ' PRO . 62.5 Cg_exo -55.62 164.47 4.28 Favored 'Trans proline' 0 C--N 1.361 1.192 0 C-N-CA 124.949 3.766 . . . . 45.54 112.274 175.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -55.58 -7.93 0.32 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 113.176 0.806 . . . . 74.31 113.176 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 34.2 m170 -77.72 111.56 13.64 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 104.914 -2.254 . . . . 74.21 104.914 169.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 33.3 m -77.16 122.74 32.38 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 N-CA-C 113.329 0.863 . . . . 63.23 113.329 -165.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 47.3 pt -89.8 -27.79 5.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 115.861 -0.608 . . . . 74.02 109.942 176.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.05 162.61 28.13 Favored Glycine 0 N--CA 1.419 -2.445 0 C-N-CA 119.714 -1.232 . . . . 61.42 114.035 -175.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 12.9 p -142.09 -176.84 4.96 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 126.767 2.027 . . . . 65.33 105.955 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -98.34 134.54 21.83 Favored Pre-proline 0 C--N 1.299 -1.627 0 C-N-CA 119.339 -0.944 . . . . 72.21 109.981 -175.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -59.92 -0.89 0.98 Allowed 'Trans proline' 0 C--N 1.362 1.284 0 C-N-CA 124.589 3.526 . . . . 71.53 115.205 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.0 -29.56 68.56 Favored 'General case' 0 C--O 1.203 -1.385 0 N-CA-C 108.243 -1.021 . . . . 64.34 108.243 172.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . 0.583 ' HA ' ' HB ' ' A' ' 362' ' ' VAL . . . -62.93 -44.04 97.16 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.236 -0.893 . . . . 60.25 109.761 175.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -80.64 -4.04 52.74 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.234 -0.894 . . . . 73.13 111.555 -175.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 23.1 m -98.74 150.45 21.81 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 105.534 -2.024 . . . . 70.45 105.534 173.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 52.2 p -75.27 111.93 11.04 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 117.695 -1.602 . . . . 73.4 107.091 175.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.5 m -125.54 169.04 17.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 120.846 0.355 . . . . 72.22 111.136 -177.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 13.7 m -64.63 134.58 54.59 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.455 -0.793 . . . . 74.34 109.686 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -64.56 128.66 36.74 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 116.057 -0.519 . . . . 73.32 110.127 -176.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 89.36 47.43 4.06 Favored Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 120.412 -0.899 . . . . 73.11 111.016 -177.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -106.83 161.31 14.8 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.794 -1.187 . . . . 72.04 107.794 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -86.27 108.9 18.6 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 121.398 0.618 . . . . 74.54 110.698 -176.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 41.9 mm -97.24 120.77 47.01 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 N-CA-C 108.217 -1.031 . . . . 63.53 108.217 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 385' ' ' ARG . 22.5 m -79.24 129.26 34.28 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.298 0.57 . . . . 65.24 111.124 -177.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 9.0 p -116.84 135.7 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-N 114.885 -1.052 . . . . 73.11 108.456 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.5 120.95 36.65 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 120.889 0.376 . . . . 60.11 110.718 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.716 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 99.2 t -127.25 131.68 70.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 108.488 -0.931 . . . . 70.55 108.488 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 4.1 m -131.43 143.11 50.2 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.504 -0.878 . . . . 41.14 109.568 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . 0.524 ' O ' ' HA ' ' A' ' 390' ' ' PRO . 63.6 p -98.68 118.06 34.54 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 105.459 -2.052 . . . . 64.45 105.459 172.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.254 0 N-CA-C 116.084 1.194 . . . . 52.25 116.084 -170.876 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.422 ' HB3' HG22 ' A' ' 477' ' ' THR . 43.4 mt-30 . . . . . 0 N--CA 1.42 -1.94 0 N-CA-C 107.139 -1.43 . . . . 72.24 107.139 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.644 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 1.1 mmp_? -122.6 149.49 43.91 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-O 121.495 0.664 . . . . 70.22 112.141 -176.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' A' ' 428' ' ' GLU . 10.4 pt-20 -83.12 138.17 33.78 Favored 'General case' 0 C--N 1.276 -2.615 0 CA-C-N 113.836 -1.529 . . . . 72.44 108.566 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 58.2 mt -98.46 125.91 41.34 Favored Pre-proline 0 C--N 1.286 -2.155 0 N-CA-C 108.007 -1.109 . . . . 62.54 108.007 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -70.35 142.85 46.37 Favored 'Trans proline' 0 C--O 1.24 0.603 0 C-N-CA 122.216 1.944 . . . . 75.32 110.191 174.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -68.13 116.42 8.73 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.854 0.359 . . . . 70.2 110.369 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.05 140.25 27.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 109.216 -0.661 . . . . 73.53 109.216 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.596 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 19.6 m -68.94 158.29 34.96 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-O 120.864 0.364 . . . . 72.5 111.124 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 36.9 p -69.76 -28.87 66.13 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 114.309 1.225 . . . . 64.42 114.309 -171.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.0 pp -88.39 -11.55 45.8 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.655 0.741 . . . . 73.24 111.57 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.596 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 0.2 OUTLIER -92.53 40.87 1.06 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.663 -0.699 . . . . 65.24 110.743 -175.188 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -52.87 -38.28 61.37 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.545 0.738 . . . . 62.22 112.503 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.18 -41.82 97.48 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.979 0.418 . . . . 51.31 110.703 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -70.49 -34.66 72.61 Favored 'General case' 0 C--O 1.207 -1.137 0 CA-C-N 116.195 -0.457 . . . . 72.41 110.185 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.58 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -59.69 -51.7 68.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 119.766 -0.159 . . . . 73.02 111.119 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.6 m -62.01 -38.18 80.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-O 121.305 0.574 . . . . 73.43 110.463 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -60.63 -47.77 84.77 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.341 1.057 . . . . 53.24 110.971 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -65.75 -38.84 90.21 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 123.189 0.596 . . . . 50.3 111.428 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 85.3 mt -64.02 -36.88 85.43 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.167 -0.47 . . . . 51.11 110.176 177.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 33.1 m -70.11 -44.37 69.12 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.016 -0.538 . . . . 62.33 110.164 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.21 -18.31 65.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.854 -0.612 . . . . 71.25 111.246 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -90.04 5.48 46.48 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.129 -0.487 . . . . 72.42 111.824 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 109.71 -83.7 0.34 Allowed Glycine 0 CA--C 1.494 -1.225 0 C-N-CA 120.039 -1.077 . . . . 74.41 112.081 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -36.71 -61.85 0.51 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.734 1.383 . . . . 75.1 114.734 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 60.05 27.71 65.26 Favored Glycine 0 CA--C 1.508 -0.355 0 C-N-CA 120.842 -0.694 . . . . 63.22 111.434 -175.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -102.36 111.17 23.35 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 109.28 -0.637 . . . . 71.24 109.28 -176.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 11.5 p90 -139.64 152.03 46.44 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.653 -0.703 . . . . 75.54 110.298 -177.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -142.65 122.95 13.87 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.906 -1.146 . . . . 72.33 107.906 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -96.36 130.81 43.39 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 120.96 0.409 . . . . 75.53 111.758 -177.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -135.15 150.04 50.09 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 123.498 0.719 . . . . 55.23 109.199 175.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -123.1 149.82 44.0 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 119.915 -0.714 . . . . 73.01 110.491 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 46.1 m -151.18 151.65 29.78 Favored Pre-proline 0 C--N 1.295 -1.798 0 N-CA-C 107.184 -1.413 . . . . 71.31 107.184 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 490' ' ' SER . 19.2 Cg_exo -65.48 144.58 79.94 Favored 'Trans proline' 0 C--O 1.243 0.738 0 C-N-CA 121.747 1.631 . . . . 72.53 112.018 -177.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 14.9 t -152.55 179.37 8.65 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 106.709 -1.589 . . . . 65.23 106.709 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.5 t -56.17 142.94 65.6 Favored Pre-proline 0 C--N 1.305 -1.347 0 C-N-CA 123.947 0.899 . . . . 74.21 110.621 177.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -51.49 -29.73 32.77 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 124.464 3.443 . . . . 75.41 113.121 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.51 -19.39 60.93 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.942 0.401 . . . . 71.14 112.057 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -108.13 -1.93 19.92 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.112 0.412 . . . . 65.54 112.112 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 84.4 t -61.06 127.14 20.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.266 -0.642 . . . . 64.1 109.266 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.68 -13.09 68.26 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 116.065 -0.516 . . . . 32.13 111.812 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.419 ' O ' HG23 ' A' ' 488' ' ' VAL . 11.8 mptt -109.76 159.0 17.55 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.167 0.508 . . . . 74.53 110.12 -178.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 76.8 t -71.85 145.8 11.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 115.071 -0.968 . . . . 73.22 109.711 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 62.1 mt -98.39 -35.44 5.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 107.83 -1.174 . . . . 70.23 107.83 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 164.72 -174.52 40.71 Favored Glycine 0 N--CA 1.43 -1.757 0 CA-C-N 115.468 -0.787 . . . . 72.12 112.176 176.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . 0.61 HG22 HG12 ' A' ' 486' ' ' ILE . 58.8 p -115.2 141.94 47.34 Favored 'General case' 0 N--CA 1.422 -1.825 0 N-CA-C 106.933 -1.506 . . . . 72.05 106.933 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.54 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 2.8 t-20 -64.46 -57.3 17.73 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 119.85 -0.74 . . . . 74.05 111.358 178.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.54 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 17.2 Cg_exo -74.19 138.53 25.31 Favored 'Trans proline' 0 C--N 1.363 1.311 0 N-CA-C 107.026 -1.951 . . . . 61.41 107.026 168.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -63.0 126.14 17.37 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 121.749 1.633 . . . . 72.21 113.669 -173.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -86.16 10.73 13.64 Favored 'General case' 0 C--O 1.205 -1.272 0 CA-C-N 115.275 -0.875 . . . . 61.04 111.047 -177.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -110.65 -0.68 17.1 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.54 -0.755 . . . . 75.02 110.455 176.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -124.46 -168.48 1.81 Allowed 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.024 -0.535 . . . . 74.24 110.548 -173.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.422 HG22 ' HB3' ' A' ' 426' ' ' GLN . 0.2 OUTLIER -89.09 131.46 35.24 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 115.54 -0.755 . . . . 42.35 110.544 -177.206 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 49.5 m -127.98 148.16 50.51 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 122.902 0.481 . . . . 63.04 110.097 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -77.87 158.77 29.3 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.932 -0.576 . . . . 71.42 110.931 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 35.0 mm -73.16 -23.06 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 121.552 0.692 . . . . 73.34 110.57 -175.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 17.0 m -95.94 1.8 53.1 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 122.081 0.943 . . . . 60.14 109.93 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -93.06 130.19 38.76 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.751 -0.659 . . . . 63.4 110.705 -175.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.2 p -100.34 126.41 53.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.25 0.548 . . . . 72.44 111.487 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 32.7 m -95.75 121.68 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-O 121.816 0.817 . . . . 42.11 110.327 178.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.61 129.28 43.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.971 -1.122 . . . . 75.14 107.971 177.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.61 HG12 HG22 ' A' ' 470' ' ' THR . 11.6 mt -113.73 124.61 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 CA-C-N 114.83 -1.077 . . . . 51.31 110.274 -175.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 8.5 tt -104.94 126.19 59.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 115.256 -0.883 . . . . 72.34 109.33 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 466' ' ' LYS . 2.3 p -111.41 145.53 17.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 C-N-CA 124.252 1.021 . . . . 64.21 109.447 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -80.14 124.41 6.48 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.991 -0.623 . . . . 72.23 111.662 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 18.3 t . . . . . 0 C--N 1.31 -1.138 0 N-CA-C 108.84 -0.8 . . . . 74.4 108.84 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo . . . . . 0 N--CA 1.456 -0.698 0 CA-C-O 120.831 0.263 . . . . 54.41 112.414 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -136.7 21.38 3.1 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 122.154 0.978 . . . . 70.12 110.521 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 27.5 p -130.19 151.69 50.43 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-N 114.334 -1.303 . . . . 74.3 110.61 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 495' ' ' LYS . 18.7 mmtt -147.82 164.33 33.97 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.679 -0.691 . . . . 74.45 110.245 175.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -95.73 136.77 35.72 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.988 -0.551 . . . . 73.35 110.428 -175.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 27.7 pt -92.08 117.78 67.86 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 109.283 -0.636 . . . . 73.15 109.283 175.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.22 -179.39 5.38 Favored 'Trans proline' 0 C--O 1.249 1.058 0 C-N-CA 121.966 1.777 . . . . 54.55 111.934 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -79.07 111.26 15.1 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.471 -0.566 . . . . 74.42 109.471 177.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 9.9 p -113.35 18.97 7.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 122.424 1.107 . . . . 75.43 109.191 -176.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . 0.413 ' HB2' ' HA2' ' A' ' 536' ' ' GLY . . . -83.46 119.16 24.33 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.432 -0.803 . . . . 70.34 110.783 -177.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 120.33 22.12 3.22 Favored Glycine 0 N--CA 1.436 -1.338 0 C-N-CA 121.054 -0.593 . . . . 50.14 112.888 177.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.53 HE22 ' N ' ' A' ' 508' ' ' ALA . 0.0 OUTLIER -137.14 -172.19 3.14 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 122.591 -0.358 . . . . 74.42 110.876 178.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 8.6 m -91.01 154.88 19.11 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 118.483 -1.287 . . . . 64.42 110.303 -173.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 9.5 p -58.34 -41.3 80.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 123.342 0.657 . . . . 70.2 112.415 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -59.73 -39.8 85.93 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.455 0.645 . . . . 71.03 109.877 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 29.3 t -73.52 -36.7 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 CA-C-N 115.314 -0.857 . . . . 64.34 109.955 -177.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . 0.53 ' N ' HE22 ' A' ' 503' ' ' GLN . . . -63.39 -49.78 72.45 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.397 -0.365 . . . . 63.0 111.593 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -63.23 -35.15 79.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.012 0.434 . . . . 75.01 110.554 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.435 ' O ' HG23 ' A' ' 514' ' ' VAL . 5.0 tppp? -61.99 -53.1 60.31 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.249 -0.887 . . . . 51.34 109.893 176.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -61.59 -44.91 96.15 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-N 116.163 -0.471 . . . . 53.22 111.632 -176.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -61.0 -44.07 97.96 Favored 'General case' 0 C--O 1.247 0.924 0 O-C-N 123.236 0.335 . . . . 53.24 111.442 178.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 10.2 m120 -63.84 -38.8 92.42 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 120.317 -0.553 . . . . 63.54 111.109 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 510' ' ' LYS . 73.0 t -61.88 -35.04 65.73 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 CA-C-N 116.052 -0.522 . . . . 75.42 111.087 177.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -74.63 -13.87 60.7 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.573 -0.451 . . . . 73.43 111.017 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 115.24 -2.06 22.38 Favored Glycine 0 N--CA 1.436 -1.335 0 C-N-CA 120.437 -0.887 . . . . 72.14 112.503 178.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.462 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 65.7 m-85 -85.27 109.36 18.3 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.517 -0.919 . . . . 74.14 108.517 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 17.5 p -88.18 -14.7 37.97 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 113.674 0.99 . . . . 75.43 113.674 -173.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -117.64 122.5 43.75 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 120.952 0.406 . . . . 70.43 111.497 -175.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 551' ' ' ILE . 46.3 p90 -129.88 153.47 48.27 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 116.002 -0.545 . . . . 64.24 111.366 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 58.5 m -139.9 152.26 46.26 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.193 -1.41 . . . . 74.02 107.193 174.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.39 135.91 54.37 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-O 121.163 0.506 . . . . 70.14 111.068 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -131.55 130.79 42.73 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.28 -1.007 . . . . 75.23 108.28 176.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 19.8 m -96.03 132.55 41.27 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 110.129 -0.323 . . . . 60.41 110.129 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 34.0 m -121.54 149.57 24.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 108.154 -1.054 . . . . 63.33 108.154 178.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -74.6 135.47 42.04 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 121.029 -0.269 . . . . 74.21 111.432 -173.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . 0.486 ' HB2' ' OG ' ' A' ' 556' ' ' SER . 70.3 m -159.43 174.65 3.81 Favored Pre-proline 0 C--N 1.314 -0.968 0 C-N-CA 123.771 0.828 . . . . 70.22 108.789 178.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -89.44 -3.05 5.93 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.969 1.779 . . . . 70.24 111.147 174.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.503 ' HB2' ' OG ' ' A' ' 556' ' ' SER . 23.8 mmt85 -79.93 133.31 58.43 Favored Pre-proline 0 N--CA 1.444 -0.753 0 N-CA-C 107.741 -1.207 . . . . 72.32 107.741 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -56.14 144.44 80.47 Favored 'Trans proline' 0 C--O 1.254 1.314 0 C-N-CA 123.065 2.51 . . . . 64.52 113.4 -175.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -57.8 113.66 1.95 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.69 -1.141 . . . . 75.03 110.69 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 138.71 -26.79 2.74 Favored Glycine 0 C--N 1.306 -1.126 0 CA-C-N 115.785 -0.643 . . . . 40.2 111.536 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -76.49 127.86 33.65 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.166 -0.679 . . . . 71.33 109.166 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 83.6 t -79.6 117.76 25.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.041 -1.096 . . . . 70.42 108.041 176.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 13.7 t -91.92 -1.86 57.08 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.678 -0.692 . . . . 54.11 110.757 -176.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.413 ' HA2' ' HB2' ' A' ' 501' ' ' ALA . . . 149.95 -166.07 29.84 Favored Glycine 0 CA--C 1.489 -1.557 0 C-N-CA 120.685 -0.769 . . . . 61.43 111.874 177.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 13.3 p -119.0 158.7 25.25 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 109.391 -0.596 . . . . 74.54 109.391 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.503 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 27.3 t-20 -65.89 -52.36 41.79 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-O 119.083 -0.484 . . . . 52.15 111.097 177.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 4.8 Cg_exo -78.96 142.6 17.52 Favored 'Trans proline' 0 C--N 1.368 1.591 0 N-CA-C 108.2 -1.5 . . . . 70.42 108.2 171.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 31.5 Cg_exo -59.79 144.65 99.41 Favored 'Trans proline' 0 C--O 1.253 1.229 0 C-N-CA 122.297 1.998 . . . . 71.42 113.107 -177.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -64.33 137.37 57.87 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 115.896 -0.593 . . . . 73.34 109.819 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 102.44 -12.44 56.86 Favored Glycine 0 C--N 1.298 -1.578 0 C-N-CA 121.018 -0.61 . . . . 71.43 111.919 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 23.9 m -75.33 130.97 39.93 Favored 'General case' 0 C--O 1.245 0.843 0 N-CA-C 109.752 -0.462 . . . . 51.44 109.752 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 14.6 m -84.4 122.9 29.6 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 107.291 -1.374 . . . . 74.04 107.291 176.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.5 m -131.51 157.32 78.49 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.907 -0.405 . . . . 73.34 109.907 -177.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -64.86 140.47 67.01 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.4 2.066 . . . . 74.43 111.607 176.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.462 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 27.0 m -63.98 -20.14 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-O 121.761 0.791 . . . . 42.53 111.834 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -87.06 -11.2 50.99 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.058 -0.973 . . . . 41.25 111.873 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 80.5 p -82.09 175.98 9.89 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 120.017 -0.673 . . . . 71.13 112.343 -176.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 27.0 t -101.72 119.17 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 116.012 -0.54 . . . . 75.35 110.737 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 520' ' ' PHE . 1.8 mp -101.17 124.6 54.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 108.842 -0.799 . . . . 74.42 108.842 177.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 521' ' ' SER . 35.0 tt0 -102.86 128.84 49.47 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-O 121.211 0.529 . . . . 73.35 110.236 -178.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -93.37 133.98 36.07 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.329 -0.989 . . . . 74.13 108.329 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . 0.507 ' HA ' HE21 ' A' ' 554' ' ' GLN . 0.0 OUTLIER -95.85 114.25 25.96 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.944 -1.502 . . . . 65.44 106.944 176.037 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 524' ' ' SER . 40.5 t -99.79 141.3 17.21 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 108.391 -0.966 . . . . 72.1 108.391 -177.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.638 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 36.0 t -78.84 129.71 34.88 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 121.214 0.53 . . . . 72.33 111.27 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 12.2 ttpp -93.65 121.51 35.15 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 106.747 -1.575 . . . . 74.43 106.747 169.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -81.39 -24.24 57.12 Favored Glycine 0 CA--C 1.494 -1.269 0 C-N-CA 120.48 -0.867 . . . . 52.14 112.099 -177.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 4.8 p30 58.62 6.96 0.66 Allowed 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 127.257 2.223 . . . . 71.52 114.26 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -134.21 170.91 14.99 Favored 'General case' 0 C--O 1.253 1.244 0 CA-C-O 121.688 0.756 . . . . 73.21 112.286 -173.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -145.99 148.33 32.62 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.88 -1.526 . . . . 73.15 106.88 173.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 9.4 p -71.18 127.75 33.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-O 121.176 0.512 . . . . 71.3 110.229 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 58.7 ttp -96.26 115.29 65.52 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 109.272 -0.64 . . . . 75.31 109.272 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.98 154.9 72.1 Favored 'Trans proline' 0 C--O 1.242 0.684 0 C-N-CA 122.08 1.853 . . . . 44.05 110.367 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . 0.489 ' HA ' ' HB1' ' A' ' 610' ' ' ALA . 4.2 p-10 -76.03 118.1 18.44 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 121.822 0.82 . . . . 74.21 111.236 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 96.2 mt -137.52 34.09 2.49 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.009 -1.45 . . . . 65.24 107.184 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 14.8 m -71.25 132.72 45.35 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.008 -0.996 . . . . 64.24 111.342 -175.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 99.86 38.8 3.53 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 121.114 -0.565 . . . . 65.53 113.312 174.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 83.6 mtp -109.69 155.26 21.75 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.435 -0.58 . . . . 73.42 109.435 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 66.2 m-85 -74.96 149.73 39.27 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 107.286 -1.375 . . . . 72.31 107.286 175.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . 0.505 ' O ' ' HG3' ' A' ' 575' ' ' GLU . 41.0 t90 -60.47 -29.81 69.28 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 123.274 0.359 . . . . 64.42 110.855 -177.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 33.2 m -80.16 -10.42 12.49 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.612 0 CA-C-O 121.568 0.699 . . . . 65.02 110.894 -176.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -101.78 -31.84 10.56 Favored 'General case' 0 C--O 1.266 1.927 0 CA-C-O 122.885 1.326 . . . . 63.42 107.88 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . 0.45 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -68.77 -36.72 78.68 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 113.885 -1.507 . . . . 73.3 110.392 176.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.588 ' HB2' ' HD3' ' A' ' 576' ' ' PRO . 43.4 mt-10 -51.75 -57.79 13.42 Favored Pre-proline 0 CA--C 1.559 1.3 0 CA-C-O 118.87 -0.586 . . . . 73.51 111.66 177.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . 0.588 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 64.3 Cg_exo -56.63 -39.5 90.93 Favored 'Trans proline' 0 C--N 1.387 2.598 0 C-N-CA 121.768 1.645 . . . . 74.12 112.542 175.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -59.03 -43.59 91.64 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 119.782 -0.767 . . . . 74.54 112.269 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 96.2 mt -65.97 -47.22 75.33 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.521 0.677 . . . . 73.44 110.307 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -65.03 -34.98 79.72 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.412 -0.813 . . . . 75.51 111.643 -177.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.65 -33.38 70.91 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.367 0.506 . . . . 44.11 112.367 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 4.0 pp -88.4 -3.61 58.8 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.474 0.916 . . . . 72.43 113.474 -176.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 86.12 37.77 8.93 Favored Glycine 0 C--N 1.314 -0.648 0 C-N-CA 120.183 -1.008 . . . . 73.44 112.001 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 82.3 t90 -71.87 127.94 34.17 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 123.19 0.596 . . . . 74.01 110.808 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 23.0 m -138.3 67.9 1.4 Allowed 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 122.183 0.992 . . . . 70.12 109.404 174.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -124.44 -149.88 7.75 Favored Glycine 0 N--CA 1.436 -1.313 0 N-CA-C 110.07 -1.212 . . . . 73.33 110.07 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . 0.485 ' O ' HG12 ' A' ' 619' ' ' ILE . 8.6 mmt -122.79 139.03 54.44 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.6 -0.519 . . . . 72.21 109.6 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -101.16 127.55 47.67 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 106.524 -1.658 . . . . 75.24 106.524 174.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -97.25 99.85 11.31 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 120.19 -0.604 . . . . 72.01 110.822 -175.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -114.42 109.19 17.92 Favored 'General case' 0 N--CA 1.409 -2.51 0 N-CA-C 108.154 -1.054 . . . . 72.53 108.154 170.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -143.97 -62.36 0.02 OUTLIER Glycine 0 CA--C 1.477 -2.319 0 N-CA-C 108.849 -1.7 . . . . 40.25 108.849 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . 0.429 ' O ' ' HD2' ' A' ' 623' ' ' ARG . . . -89.86 136.54 32.98 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.541 -0.911 . . . . 62.15 108.541 173.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -116.72 157.08 26.05 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.608 -0.516 . . . . 75.44 109.608 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . 0.422 ' O ' ' HA2' ' A' ' 625' ' ' GLY . 38.5 t -107.15 132.01 55.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 120.336 -0.546 . . . . 71.44 110.232 -177.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . 0.603 ' HA ' ' OE1' ' A' ' 626' ' ' GLN . 5.8 p-10 -73.76 112.4 9.83 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.102 0.477 . . . . 73.54 112.255 -178.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -176.6 19.97 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 114.56 -1.2 . . . . 61.24 110.647 175.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 83.74 127.6 1.39 Allowed Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 110.326 -1.11 . . . . 61.33 110.326 -174.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.559 ' O ' ' HB2' ' A' ' 601' ' ' ASN . . . -62.12 -49.55 73.84 Favored Glycine 0 C--O 1.2 -2.0 0 C-N-CA 120.478 -0.868 . . . . 74.3 112.478 -176.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 47.0 m -71.56 -24.13 61.87 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.315 0.578 . . . . 53.15 111.689 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -89.64 -7.69 54.14 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.925 -0.58 . . . . 74.04 112.169 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -145.45 28.61 1.18 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.836 0.827 . . . . 74.54 109.547 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 597' ' ' GLY . 8.5 t30 -86.55 62.94 7.71 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 122.425 1.107 . . . . 64.41 108.575 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 37.1 ptt85 -143.0 171.84 13.51 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 107.453 -1.314 . . . . 73.54 107.453 -176.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 11.7 p -62.84 129.87 26.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 107.388 -1.338 . . . . 70.23 107.388 174.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 87.2 t -95.98 -36.4 6.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 119.833 -0.747 . . . . 53.33 109.09 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -154.79 158.96 40.26 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 105.892 -1.892 . . . . 71.01 105.892 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -128.86 124.93 36.54 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.047 -0.723 . . . . 73.03 109.047 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.498 ' HB2' ' HB ' ' A' ' 621' ' ' THR . 21.9 t-20 -59.36 -50.66 86.26 Favored Pre-proline 0 CA--C 1.559 1.327 0 CA-C-N 115.792 -0.64 . . . . 74.22 112.453 -177.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.494 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 4.3 Cg_exo -90.09 124.89 1.21 Allowed 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 121.908 1.739 . . . . 51.12 110.764 173.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.79 139.09 66.95 Favored 'Trans proline' 0 C--O 1.252 1.189 0 C-N-CA 122.414 2.076 . . . . 64.31 111.909 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . 0.489 ' HB1' ' HA ' ' A' ' 565' ' ' ASP . . . -64.09 138.44 58.46 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.594 -0.73 . . . . 54.42 110.363 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 99.69 -5.86 58.59 Favored Glycine 0 N--CA 1.435 -1.425 0 N-CA-C 111.441 -0.664 . . . . 72.54 111.441 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 12.1 m -99.96 160.22 14.48 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 108.772 -0.825 . . . . 62.02 108.772 -178.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -75.08 125.3 8.15 Favored Glycine 0 N--CA 1.423 -2.199 0 N-CA-C 109.883 -1.287 . . . . 41.23 109.883 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 34.7 m -112.22 142.62 24.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 108.612 -0.884 . . . . 73.3 108.612 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.42 HD21 ' CG2' ' A' ' 619' ' ' ILE . 30.5 p30 -43.68 152.79 0.14 Allowed 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.745 1.017 . . . . 73.3 113.745 177.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -56.8 -25.72 56.35 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.345 1.058 . . . . 71.45 112.604 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -63.84 -42.9 97.5 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 108.401 -0.963 . . . . 71.0 108.401 176.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . 0.411 ' O ' HG12 ' A' ' 620' ' ' ILE . . . 81.97 19.25 65.64 Favored Glycine 0 N--CA 1.42 -2.386 0 N-CA-C 109.324 -1.51 . . . . 62.1 109.324 -177.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 586' ' ' MET . 0.0 OUTLIER -70.71 117.76 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-O 122.274 1.035 . . . . 72.21 108.594 -175.407 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 618' ' ' GLY . 47.7 mm -115.32 130.31 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.195 0 N-CA-C 105.941 -1.874 . . . . 74.53 105.941 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.498 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 27.7 m -96.87 114.64 26.29 Favored 'General case' 0 N--CA 1.401 -2.918 0 C-N-CA 117.175 -1.81 . . . . 75.55 106.977 175.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 4.4 pp -140.9 150.3 43.01 Favored 'General case' 0 N--CA 1.406 -2.627 0 N-CA-C 105.753 -1.943 . . . . 73.43 105.753 176.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . 0.429 ' HD2' ' O ' ' A' ' 591' ' ' ALA . 28.5 mtm180 -133.81 156.71 47.53 Favored 'General case' 0 C--N 1.269 -2.893 0 N-CA-C 108.502 -0.925 . . . . 55.11 108.502 175.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -133.18 166.87 21.44 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 124.444 1.09 . . . . 74.22 111.405 -173.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 593' ' ' VAL . . . -66.18 139.41 37.97 Favored Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 115.214 0.846 . . . . 53.25 115.214 -176.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . 0.603 ' OE1' ' HA ' ' A' ' 594' ' ' ASP . 1.3 mp0 . . . . . 0 N--CA 1.473 0.689 0 N-CA-C 116.118 1.896 . . . . 72.5 116.118 176.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 . . . . . 0 CA--C 1.491 -1.321 0 N-CA-C 106.972 -1.492 . . . . 64.32 106.972 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 409' ' ' SER . 24.0 m -121.54 163.56 19.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.354 0 N-CA-C 109.654 -0.499 . . . . 63.34 109.654 -177.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.37 129.81 39.37 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.365 -1.346 . . . . 72.02 107.365 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 55.6 t -97.16 129.85 31.18 Favored Pre-proline 0 C--N 1.282 -2.366 0 CA-C-N 115.427 -0.806 . . . . 65.41 109.494 -171.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -68.86 128.59 17.1 Favored 'Trans proline' 0 C--O 1.241 0.629 0 C-N-CA 122.124 1.883 . . . . 73.42 111.925 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -89.21 144.67 25.94 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-O 121.633 0.73 . . . . 73.13 109.291 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.418 ' HB ' HE21 ' A' ' 368' ' ' GLN . 2.8 m -126.05 21.69 3.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 CA-C-N 114.817 -1.083 . . . . 60.33 112.036 -174.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.414 ' HB3' HG23 ' A' ' 402' ' ' THR . 18.6 ptt180 -56.01 144.37 28.98 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.021 -0.99 . . . . 73.14 112.529 175.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.5 -0.08 46.46 Favored Glycine 0 C--N 1.311 -0.843 0 CA-C-N 115.71 -0.677 . . . . 34.42 112.486 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . 0.418 HE21 ' HB ' ' A' ' 365' ' ' VAL . 39.4 mt-30 -111.34 -150.77 0.47 Allowed 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.11 -1.07 . . . . 73.11 108.11 176.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 80.0 p -97.77 161.53 13.71 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.36 -1.348 . . . . 74.14 107.36 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 42.3 m -63.32 -37.6 87.87 Favored 'General case' 0 C--O 1.21 -1.022 0 C-N-CA 120.838 -0.345 . . . . 74.11 110.305 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.06 -46.14 85.69 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 111.831 0.308 . . . . 73.14 111.831 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -68.92 -41.66 77.85 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 121.618 0.723 . . . . 74.31 109.24 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.81 -50.88 69.25 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.983 -1.008 . . . . 72.05 111.197 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . 0.404 HG23 HD13 ' A' ' 384' ' ' ILE . 78.7 mt -64.74 -40.11 87.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.904 -0.589 . . . . 71.44 110.68 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.79 -38.07 77.73 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.139 0.495 . . . . 73.13 111.054 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 27.3 m -65.64 -47.09 76.77 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.074 -0.512 . . . . 73.41 110.334 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.85 -37.57 87.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.294 -0.412 . . . . 74.32 111.873 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . 0.465 HE21 ' HA ' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -62.59 -37.91 88.09 Favored 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 122.296 0.239 . . . . 74.05 110.367 176.476 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -68.45 -21.22 64.65 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 121.19 0.519 . . . . 65.12 111.171 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -86.96 -14.13 42.63 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.982 -0.554 . . . . 71.13 110.224 174.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 95.63 9.48 57.56 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.567 -0.825 . . . . 64.21 112.474 176.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -82.55 155.48 24.48 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-O 121.13 0.49 . . . . 74.13 111.655 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -100.77 132.52 46.13 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 106.65 -1.611 . . . . 73.42 106.65 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . 0.414 ' N ' HD12 ' A' ' 384' ' ' ILE . 1.8 mp -119.11 146.38 23.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 107.665 -1.235 . . . . 70.2 107.665 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 46.2 ttt180 -111.75 127.96 55.95 Favored 'General case' 0 C--N 1.259 -3.361 0 N-CA-C 106.542 -1.651 . . . . 75.04 106.542 177.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 27.4 m -113.72 117.87 32.74 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 106.998 -1.482 . . . . 60.52 106.998 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . 0.438 HD12 ' HG2' ' A' ' 389' ' ' LYS . 0.8 OUTLIER -112.17 119.99 40.27 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.406 -0.961 . . . . 73.21 108.406 -177.467 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -94.1 122.51 36.69 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.219 -0.66 . . . . 74.2 109.219 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . 0.48 ' HE2' ' HA ' ' A' ' 389' ' ' LYS . 4.5 mmpt? -125.51 119.44 24.65 Favored Pre-proline 0 C--N 1.3 -1.55 0 C-N-CA 121.141 -0.223 . . . . 72.14 111.058 176.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . 0.618 ' HA ' ' O ' ' A' ' 422' ' ' THR . 38.0 Cg_exo -69.23 128.32 16.34 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.93 1.753 . . . . 71.3 108.993 171.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.586 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 7.0 t70 143.04 -171.42 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 104.923 -2.251 . . . . 75.04 104.923 -175.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 23.3 t -131.31 2.91 4.25 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.338 -0.616 . . . . 64.32 109.338 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 14.7 t -77.47 -5.6 50.48 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 122.918 0.487 . . . . 73.52 112.004 -178.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.512 HD13 ' H ' ' A' ' 394' ' ' ILE . 0.2 OUTLIER -114.8 151.96 45.93 Favored Pre-proline 0 C--N 1.303 -1.427 0 CA-C-O 118.998 -0.525 . . . . 74.34 109.69 -177.223 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -44.05 138.49 6.54 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 124.025 3.15 . . . . 74.14 114.105 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.5 161.71 16.73 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.417 2.745 . . . . 75.25 112.788 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . 0.422 ' HA ' HG13 ' A' ' 420' ' ' VAL . 6.0 p-10 -57.15 -8.3 0.67 Allowed 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 113.434 0.901 . . . . 71.52 113.434 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -111.56 130.2 55.82 Favored 'General case' 0 CA--C 1.478 -1.821 0 N-CA-C 106.581 -1.637 . . . . 55.11 106.581 171.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 20.1 m -66.37 119.32 11.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 O-C-N 123.787 0.679 . . . . 70.24 111.293 -169.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 8.7 tp -94.51 -29.33 4.16 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 108.508 -0.923 . . . . 71.33 108.508 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.84 170.6 27.77 Favored Glycine 0 N--CA 1.411 -3.025 0 N-CA-C 110.312 -1.115 . . . . 71.21 110.312 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . 0.414 HG23 ' HB3' ' A' ' 366' ' ' ARG . 3.3 p -121.64 -179.28 4.05 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 107.712 -1.218 . . . . 75.14 107.712 176.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -101.4 134.58 20.19 Favored Pre-proline 0 C--N 1.293 -1.87 0 N-CA-C 107.703 -1.221 . . . . 70.1 107.703 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -51.59 -13.36 1.43 Allowed 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 124.33 3.353 . . . . 62.54 115.493 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.49 -39.4 70.39 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-O 120.703 0.287 . . . . 71.24 110.285 176.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -71.17 -33.54 70.11 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.859 0.838 . . . . 74.12 110.227 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -86.15 3.97 40.45 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.927 -1.033 . . . . 60.24 111.162 -177.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 27.1 m -109.7 154.36 22.99 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 105.514 -2.032 . . . . 74.41 105.514 171.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 360' ' ' VAL . 50.5 m -74.88 112.42 11.08 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 119.737 -0.785 . . . . 60.11 109.433 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 21.7 m -124.81 164.88 22.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 116.332 -0.394 . . . . 64.22 109.972 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 15.4 m -72.41 146.25 47.1 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.958 -0.386 . . . . 75.14 109.958 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -65.58 131.82 47.32 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.997 -0.371 . . . . 74.01 109.997 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 89.57 38.89 6.44 Favored Glycine 0 C--N 1.311 -0.836 0 C-N-CA 120.752 -0.737 . . . . 33.22 111.955 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -100.51 -175.99 3.07 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.328 -1.36 . . . . 73.13 107.328 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -108.83 123.25 48.76 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.137 0.494 . . . . 72.11 110.741 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 48.4 mm -112.18 137.4 45.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 106.538 -1.652 . . . . 73.33 106.538 175.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.4 t -116.76 132.0 56.81 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.842 -0.536 . . . . 65.43 110.892 -174.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 9.9 p -116.28 134.6 59.17 Favored 'Isoleucine or valine' 0 C--O 1.253 1.249 0 N-CA-C 109.567 -0.531 . . . . 73.24 109.567 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -102.42 116.07 31.86 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.997 -0.742 . . . . 64.2 108.997 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.422 HG13 ' HA ' ' A' ' 397' ' ' ASP . 77.0 t -104.93 130.88 55.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 116.116 -0.493 . . . . 71.32 110.775 -176.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 30.6 t -85.92 123.85 31.72 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 115.593 -0.731 . . . . 74.41 110.241 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . 0.618 ' O ' ' HA ' ' A' ' 390' ' ' PRO . 12.2 p -116.39 138.92 50.96 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 106.216 -1.772 . . . . 75.14 106.216 171.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.484 0 N-CA-C 116.598 1.399 . . . . 64.24 116.598 -172.12 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 . . . . . 0 N--CA 1.428 -1.573 0 N-CA-C 106.308 -1.738 . . . . 74.21 106.308 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.428 ' HA ' ' HE ' ' A' ' 427' ' ' ARG . 1.2 mmp_? -120.79 165.32 15.3 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 109.469 -0.567 . . . . 44.13 109.469 -178.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -115.25 142.1 47.13 Favored 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 108.229 -1.026 . . . . 54.34 108.229 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.526 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 74.0 mt -77.17 121.02 83.95 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 108.95 -0.759 . . . . 41.41 108.95 -175.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 429' ' ' ILE . 20.8 Cg_exo -68.16 160.25 49.61 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 123.499 2.799 . . . . 64.12 114.411 -177.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -77.79 155.42 31.14 Favored 'General case' 0 C--O 1.249 1.077 0 CA-C-N 115.522 -0.763 . . . . 51.33 109.765 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 13.6 p -164.43 144.41 2.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 116.267 -0.424 . . . . 74.12 110.255 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 24.3 t -77.03 150.62 35.78 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 108.651 -0.87 . . . . 63.34 108.651 178.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . 0.516 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 25.1 p -67.09 -23.41 65.84 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 121.578 0.704 . . . . 73.21 111.807 -176.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 2.5 pp -86.69 -11.26 51.75 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 113.046 0.758 . . . . 73.11 113.046 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -113.9 69.53 0.71 Allowed 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 114.049 1.129 . . . . 73.23 114.049 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . 0.403 ' O ' HG23 ' A' ' 441' ' ' VAL . 64.9 t80 -61.91 -37.55 85.05 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.211 -0.45 . . . . 75.02 110.261 175.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -58.83 -37.22 75.95 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 120.707 0.289 . . . . 73.54 111.025 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -66.68 -36.78 83.35 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.712 -0.847 . . . . 72.2 108.712 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.416 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -63.55 -43.61 96.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.873 -0.603 . . . . 35.42 109.672 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 437' ' ' TYR . 86.6 t -58.73 -50.43 79.27 Favored 'Isoleucine or valine' 0 C--O 1.244 0.773 0 CA-C-N 115.532 -0.758 . . . . 63.34 110.764 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . 0.342 0.0 OUTLIER -68.63 -34.08 75.12 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 113.945 1.091 . . . . 52.33 113.945 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -62.91 -47.5 83.02 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.778 0.323 . . . . 71.52 110.898 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.416 HD13 ' O ' ' A' ' 440' ' ' ALA . 9.1 mp -65.5 -32.84 74.66 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.156 -0.475 . . . . 70.15 111.846 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.403 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 70.8 m -69.25 -46.77 66.5 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.913 0.387 . . . . 54.13 110.505 179.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.14 -15.49 62.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.146 0.498 . . . . 51.54 111.244 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.63 -1.4 37.92 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 116.007 -0.542 . . . . 43.31 111.2 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 114.58 -83.95 0.35 Allowed Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.807 -0.711 . . . . 45.15 111.584 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -40.68 -62.43 0.79 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 114.596 1.332 . . . . 75.25 114.596 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . 0.403 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 67.61 29.46 73.96 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.941 -0.647 . . . . 45.12 112.356 -177.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 31.7 mmm180 -105.54 111.44 24.15 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-O 121.507 0.67 . . . . 75.03 109.263 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -130.99 159.97 35.92 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 108.254 -1.017 . . . . 73.5 108.254 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -152.16 135.94 16.28 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 108.128 -1.064 . . . . 73.33 108.128 177.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -103.22 128.06 50.34 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.1 0.476 . . . . 65.51 109.964 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.37 149.08 42.9 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 107.364 -1.347 . . . . 70.34 107.364 174.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -125.53 138.8 53.98 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.142 0.496 . . . . 64.34 109.942 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . 0.498 ' HB2' HD11 ' A' ' 487' ' ' ILE . 48.5 t -128.37 142.38 44.5 Favored Pre-proline 0 C--N 1.291 -1.943 0 N-CA-C 108.019 -1.104 . . . . 74.41 108.019 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.656 ' HA ' ' O ' ' A' ' 490' ' ' SER . 58.1 Cg_endo -76.27 122.56 6.67 Favored 'Trans proline' 0 N--CA 1.428 -2.361 0 C-N-CA 121.204 1.27 . . . . 74.33 109.691 176.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 48.8 m -144.69 179.21 7.44 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 108.887 -0.783 . . . . 55.03 108.887 -177.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 9.7 t -49.93 134.34 21.51 Favored Pre-proline 0 C--O 1.255 1.386 0 O-C-N 123.982 0.802 . . . . 71.34 111.902 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . 0.462 ' HA ' ' CG2' ' A' ' 464' ' ' VAL . 6.2 Cg_endo -50.93 -29.93 28.8 Favored 'Trans proline' 0 C--N 1.361 1.193 0 C-N-CA 124.187 3.258 . . . . 71.44 113.935 -175.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -66.44 -21.38 66.2 Favored 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 113.217 0.821 . . . . 42.04 113.217 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -100.24 -7.23 24.89 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 122.005 -0.435 . . . . 72.05 111.566 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.462 ' CG2' ' HA ' ' A' ' 461' ' ' PRO . 82.4 t -60.84 131.37 25.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 116.165 -0.471 . . . . 72.12 111.757 -178.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 96.26 -10.64 67.47 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.779 -0.646 . . . . 63.45 112.145 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -118.73 166.16 13.11 Favored 'General case' 0 N--CA 1.416 -2.149 0 N-CA-C 109.075 -0.713 . . . . 71.22 109.075 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.516 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 68.9 t -77.8 145.31 10.11 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 108.635 -0.876 . . . . 72.24 108.635 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 51.5 mt -97.74 -25.77 4.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 107.202 -1.407 . . . . 53.2 107.202 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 154.42 -167.73 32.51 Favored Glycine 0 N--CA 1.419 -2.444 0 CA-C-N 114.868 -1.06 . . . . 75.34 111.304 175.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.22 137.17 52.32 Favored 'General case' 0 N--CA 1.405 -2.688 0 N-CA-C 105.482 -2.044 . . . . 42.13 105.482 176.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -66.14 -53.31 33.52 Favored Pre-proline 0 C--N 1.323 -0.584 0 C-N-CA 119.388 -0.925 . . . . 72.33 110.772 -177.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -68.98 124.72 11.7 Favored 'Trans proline' 0 C--N 1.364 1.394 0 N-CA-C 107.24 -1.869 . . . . 62.52 107.24 167.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.481 ' C ' ' H ' ' A' ' 475' ' ' ASN . 19.8 Cg_exo -62.34 145.47 95.89 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.928 1.752 . . . . 75.24 113.271 -174.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.526 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -69.05 11.31 0.21 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.237 1.015 . . . . 72.43 111.28 175.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . 0.481 ' H ' ' C ' ' A' ' 473' ' ' PRO . 12.9 m120 -108.62 -10.87 15.17 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 124.204 1.002 . . . . 63.34 108.623 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -98.49 171.12 8.36 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 121.485 0.659 . . . . 73.34 111.36 -176.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.02 129.71 51.65 Favored 'General case' 0 N--CA 1.402 -2.846 0 CA-C-N 114.664 -1.153 . . . . 72.02 111.721 -176.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 6.2 p -108.27 148.17 30.39 Favored 'General case' 0 N--CA 1.418 -2.059 0 C-N-CA 123.903 0.881 . . . . 54.34 110.038 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.434 ' H ' ' HB2' ' A' ' 482' ' ' ASN . . . -89.28 175.25 7.42 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 116.369 -0.378 . . . . 72.4 110.148 176.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 32.9 mm -81.15 -6.67 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-O 122.197 0.999 . . . . 54.43 109.871 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 40.1 m -112.76 5.04 17.39 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 122.238 1.018 . . . . 54.21 109.061 175.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . 0.434 ' HB2' ' H ' ' A' ' 479' ' ' ALA . 23.3 t-20 -80.69 134.49 35.86 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.597 -0.729 . . . . 63.33 111.514 -173.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.92 126.03 53.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 116.039 -0.528 . . . . 75.15 110.362 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 65.2 t -100.66 120.61 50.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 121.014 0.435 . . . . 73.41 110.093 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.62 118.96 44.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-O 121.828 0.823 . . . . 62.22 110.022 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 42.7 mt -111.3 128.64 67.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 114.534 -1.212 . . . . 74.3 109.976 -178.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.498 HD11 ' HB2' ' A' ' 457' ' ' SER . 17.3 tt -110.84 127.08 68.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.839 -0.619 . . . . 74.25 111.96 -173.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.499 HG12 HG22 ' A' ' 467' ' ' VAL . 35.5 m -108.32 152.35 10.21 Favored 'Isoleucine or valine' 0 C--O 1.248 1.023 0 C-N-CA 123.806 0.842 . . . . 75.31 111.156 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -88.1 133.5 11.85 Favored Glycine 0 N--CA 1.434 -1.44 0 CA-C-N 115.831 -0.622 . . . . 14.52 112.223 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.656 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 44.4 m . . . . . 0 C--N 1.303 -1.454 0 N-CA-C 107.344 -1.354 . . . . 54.43 107.344 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo . . . . . 0 N--CA 1.444 -1.41 0 CA-C-O 121.981 0.742 . . . . 71.32 113.735 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -104.02 41.5 1.29 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.447 -1.316 . . . . 41.34 107.447 176.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 546' ' ' PRO . 72.7 p -117.24 153.77 32.33 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 114.34 -1.3 . . . . 64.14 108.945 -176.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . 0.504 ' HD3' ' H ' ' A' ' 496' ' ' ASP . 6.0 tmtt? -150.16 151.65 33.44 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 107.47 -1.307 . . . . 63.15 107.47 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.504 ' H ' ' HD3' ' A' ' 495' ' ' LYS . 9.8 p-10 -79.83 138.08 37.12 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 123.587 0.755 . . . . 62.43 109.489 177.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 36.4 pt -86.39 137.41 34.56 Favored Pre-proline 0 C--N 1.303 -1.418 0 CA-C-N 116.182 -0.463 . . . . 70.45 110.792 178.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -89.15 179.9 2.23 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.656 2.237 . . . . 75.51 112.339 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -84.38 142.05 30.43 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.832 -1.173 . . . . 73.14 107.832 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.416 ' HA ' HE21 ' A' ' 503' ' ' GLN . 10.6 p -139.32 19.23 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 CA-C-O 122.179 0.99 . . . . 61.15 110.052 -178.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -72.41 114.52 10.62 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.199 -0.91 . . . . 43.14 110.893 -177.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 115.3 -8.12 20.67 Favored Glycine 0 CA--C 1.482 -1.973 0 N-CA-C 111.311 -0.716 . . . . 65.2 111.311 176.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.416 HE21 ' HA ' ' A' ' 500' ' ' VAL . 45.8 mt-30 -100.47 165.75 11.28 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 108.199 -1.037 . . . . 65.04 108.199 177.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 5.6 t -91.73 164.73 13.61 Favored 'General case' 0 C--N 1.285 -2.239 0 C-N-CA 120.217 -0.593 . . . . 65.1 109.889 -175.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 48.4 t -54.27 -41.26 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.606 0.762 . . . . 61.04 110.976 -177.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -57.68 -42.6 83.94 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 115.506 -0.77 . . . . 74.54 111.12 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 63.8 t -75.35 -42.54 43.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 116.028 -0.533 . . . . 73.14 109.738 -178.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -61.26 -49.69 76.05 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.71 -0.677 . . . . 62.44 111.853 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 513' ' ' ASN . 10.2 tt0 -65.35 -37.03 85.82 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.374 0.607 . . . . 63.31 110.04 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.491 ' O ' HG23 ' A' ' 514' ' ' VAL . 37.6 ttmt -65.93 -48.79 70.2 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.82 -1.082 . . . . 70.34 111.696 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -62.03 -48.58 79.66 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 121.149 0.5 . . . . 73.24 110.924 -177.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 517' ' ' PHE . 4.2 mm? -64.9 -36.54 84.7 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.578 -0.737 . . . . 74.15 110.885 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 509' ' ' GLN . 0.6 OUTLIER -60.92 -39.86 90.97 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 122.564 0.346 . . . . 75.1 110.553 178.378 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 510' ' ' LYS . 78.4 t -59.37 -36.65 65.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.645 -0.707 . . . . 73.5 110.758 178.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -79.58 -21.55 44.89 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.105 0.479 . . . . 73.24 110.639 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 127.5 -2.78 7.1 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 120.524 -0.846 . . . . 63.42 113.902 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.582 ' HA ' ' O ' ' A' ' 547' ' ' VAL . 95.1 m-85 -82.8 117.25 22.56 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.738 -1.208 . . . . 72.34 107.738 -176.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.6 m -118.8 -4.24 10.72 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 118.823 -1.151 . . . . 74.15 112.375 -174.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . 0.423 ' HB3' HG22 ' A' ' 550' ' ' VAL . 64.3 mttp -112.26 115.21 28.42 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.637 -0.664 . . . . 65.31 110.82 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -126.25 154.37 43.45 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.256 -0.429 . . . . 73.21 110.909 -174.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 49.2 m -141.45 141.11 33.7 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.414 -1.328 . . . . 61.05 107.414 171.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -117.57 138.22 52.07 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-O 121.016 0.436 . . . . 71.35 110.94 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -124.39 116.77 23.11 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.038 -1.097 . . . . 63.52 108.038 176.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 19.7 m -97.82 136.03 38.73 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.601 0.238 . . . . 40.13 111.326 -176.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 61.5 t -129.47 148.87 33.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 107.031 -1.47 . . . . 53.22 107.031 177.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . 0.412 ' HB2' ' HB2' ' A' ' 559' ' ' ASN . 0.4 OUTLIER -78.38 136.63 37.71 Favored 'General case' 0 C--O 1.248 0.975 0 N-CA-C 108.727 -0.842 . . . . 72.53 108.727 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . 0.409 ' OG ' ' HB2' ' A' ' 556' ' ' SER . 77.6 p -153.33 179.56 1.26 Allowed Pre-proline 0 C--N 1.294 -1.819 0 N-CA-C 107.871 -1.159 . . . . 74.13 107.871 -176.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -85.09 -0.7 9.19 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 121.69 1.594 . . . . 64.13 111.367 172.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.427 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 12.7 mtp180 -88.39 139.74 30.14 Favored Pre-proline 0 N--CA 1.432 -1.345 0 N-CA-C 108.096 -1.075 . . . . 72.1 108.096 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.27 153.95 31.26 Favored 'Trans proline' 0 C--O 1.254 1.309 0 C-N-CA 123.304 2.669 . . . . 70.34 113.949 -176.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.634 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -74.75 116.29 15.29 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.347 -0.842 . . . . 71.21 110.527 -176.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 118.88 -7.42 13.15 Favored Glycine 0 CA--C 1.49 -1.481 0 C-N-CA 120.049 -1.072 . . . . 45.33 111.203 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -83.67 140.46 32.14 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 108.321 -0.992 . . . . 73.33 108.321 174.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 60.9 t -88.45 118.29 33.68 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 N-CA-C 108.063 -1.088 . . . . 74.22 108.063 178.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . 0.481 ' OG1' ' HB3' ' A' ' 556' ' ' SER . 90.5 m -78.19 -24.2 47.26 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.776 -1.102 . . . . 71.44 109.802 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 153.54 -164.75 31.22 Favored Glycine 0 N--CA 1.424 -2.132 0 N-CA-C 110.435 -1.066 . . . . 44.31 110.435 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 18.0 p -117.71 159.29 23.22 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 109.327 -0.62 . . . . 62.12 109.327 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -63.11 -57.49 20.67 Favored Pre-proline 0 C--N 1.315 -0.924 0 O-C-N 123.625 0.578 . . . . 53.24 110.328 177.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -73.23 133.01 18.73 Favored 'Trans proline' 0 C--N 1.363 1.319 0 N-CA-C 109.136 -1.14 . . . . 73.24 109.136 171.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.14 156.73 48.48 Favored 'Trans proline' 0 C--O 1.252 1.203 0 C-N-CA 122.492 2.128 . . . . 32.11 112.354 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -57.31 140.52 49.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.786 -0.643 . . . . 73.54 110.97 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.26 -16.38 56.94 Favored Glycine 0 N--CA 1.433 -1.528 0 CA-C-N 115.708 -0.678 . . . . 73.33 111.687 -178.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 99.7 m -65.28 123.93 20.86 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.071 0.462 . . . . 64.11 110.436 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 54.1 m -88.41 123.47 32.99 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 115.466 -0.788 . . . . 74.1 109.674 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 31.2 m -137.85 154.81 74.86 Favored Pre-proline 0 C--N 1.312 -1.053 0 N-CA-C 108.288 -1.004 . . . . 51.33 108.288 177.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' A' ' 494' ' ' THR . 52.6 Cg_exo -60.76 142.56 98.09 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.293 1.996 . . . . 74.23 110.863 173.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 517' ' ' PHE . 27.2 m -62.27 -20.45 24.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.799 0.809 . . . . 74.01 111.815 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . 0.402 ' O ' ' HD2' ' A' ' 519' ' ' LYS . 26.8 t70 -90.26 -5.59 56.15 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.38 -0.827 . . . . 64.14 111.713 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 72.1 m -83.35 166.01 18.81 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 121.751 -0.593 . . . . 74.21 111.567 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.423 HG22 ' HB3' ' A' ' 519' ' ' LYS . 21.5 t -92.67 129.54 43.08 Favored 'Isoleucine or valine' 0 C--O 1.254 1.294 0 CA-C-N 115.671 -0.695 . . . . 62.13 110.452 -176.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . 0.456 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -111.55 134.99 52.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.176 0.512 . . . . 74.45 110.256 174.383 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -102.98 121.11 41.86 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.566 -0.743 . . . . 74.51 109.885 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.2 mp -104.36 134.08 48.18 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.189 -0.914 . . . . 70.11 110.355 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -90.83 123.99 34.8 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.646 -0.872 . . . . 72.24 108.646 174.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 524' ' ' SER . 64.1 t -109.53 129.15 64.85 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 N-CA-C 108.509 -0.923 . . . . 70.42 108.509 -177.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.634 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 24.4 p -77.07 140.98 40.45 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-O 121.481 0.658 . . . . 75.34 112.183 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -104.3 131.92 51.11 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 107.057 -1.46 . . . . 75.12 107.057 168.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -69.5 -30.22 71.22 Favored Glycine 0 CA--C 1.489 -1.546 0 O-C-N 123.805 0.691 . . . . 65.22 111.515 -177.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 526' ' ' ASP . 63.2 t30 70.28 9.43 6.99 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.581 1.152 . . . . 74.25 110.423 174.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.448 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 96.3 mt-30 -121.99 145.14 48.41 Favored 'General case' 0 N--CA 1.412 -2.375 0 CA-C-N 114.773 -1.103 . . . . 71.44 110.482 -178.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -123.27 147.96 46.41 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.371 -0.974 . . . . 74.43 108.371 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 59.0 t -69.74 121.2 18.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-O 121.08 0.467 . . . . 73.42 112.163 -173.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . 0.421 ' HA ' ' HD3' ' A' ' 564' ' ' PRO . 53.7 ttp -97.88 132.01 25.64 Favored Pre-proline 0 C--O 1.25 1.102 0 CA-C-N 115.812 -0.631 . . . . 61.15 110.944 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 563' ' ' MET . 30.7 Cg_exo -65.52 170.63 10.73 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 123.306 2.671 . . . . 75.33 111.764 173.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -72.34 132.44 43.99 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.429 0.633 . . . . 74.35 110.823 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 94.9 mt -120.62 -4.64 9.77 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.157 -0.929 . . . . 53.1 108.597 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 38.3 t -79.11 149.39 32.08 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.783 -1.099 . . . . 74.0 109.829 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 72.88 39.97 53.39 Favored Glycine 0 C--O 1.221 -0.714 0 C-N-CA 120.894 -0.67 . . . . 73.02 111.64 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 89.3 mtp -146.06 158.11 43.87 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.337 -1.727 . . . . 74.33 106.337 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 96.6 m-85 -84.48 155.95 21.94 Favored 'General case' 0 N--CA 1.424 -1.741 0 C-N-CA 120.019 -0.673 . . . . 72.32 109.506 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 55.4 t90 -65.91 -22.87 66.53 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.148 0.499 . . . . 73.33 109.735 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 33.7 m -72.75 -12.06 15.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.803 -0.635 . . . . 53.14 110.697 177.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . 0.477 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 41.8 m-20 -101.48 -39.72 7.4 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 108.401 -0.963 . . . . 74.15 108.401 175.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -60.31 -40.72 91.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.436 -0.802 . . . . 72.35 111.503 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.485 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 1.2 tm-20 -57.32 -59.03 14.06 Favored Pre-proline 0 CA--C 1.578 2.052 0 C-N-CA 123.308 0.643 . . . . 54.55 110.477 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.33 -29.89 86.68 Favored 'Trans proline' 0 C--N 1.373 1.86 0 CA-C-N 120.912 1.362 . . . . 74.35 113.159 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 16.3 mmt180 -65.82 -43.32 88.95 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 121.103 -0.239 . . . . 72.25 110.808 177.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.4 pp -66.1 -38.03 87.23 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.046 0.451 . . . . 42.32 110.311 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -65.33 -35.29 80.54 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 115.863 -0.608 . . . . 71.34 110.794 175.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.55 -25.52 64.96 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 122.719 0.407 . . . . 44.0 110.928 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 89.9 mt -92.29 -8.17 45.94 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.85 -0.614 . . . . 64.24 110.503 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 65.4 41.95 96.21 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 110.71 -0.956 . . . . 45.03 110.71 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 74.2 t90 -77.51 136.63 38.34 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.296 0.57 . . . . 74.4 112.083 -175.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 81.7 m -151.79 99.53 2.59 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.526 -0.916 . . . . 74.22 108.526 173.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -140.26 -119.52 1.63 Allowed Glycine 0 N--CA 1.433 -1.507 0 N-CA-C 109.939 -1.264 . . . . 73.1 109.939 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -130.62 124.52 31.9 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.054 -0.721 . . . . 75.22 109.054 176.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -108.13 128.86 55.07 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 105.97 -1.863 . . . . 73.13 105.97 177.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -104.27 115.41 30.34 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.54 -0.911 . . . . 61.33 108.54 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -87.76 125.2 34.29 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 116.168 -0.469 . . . . 52.34 110.114 -176.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -103.9 173.9 22.04 Favored Glycine 0 N--CA 1.426 -2.008 0 N-CA-C 110.186 -1.166 . . . . 72.11 110.186 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -87.38 154.78 20.4 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.804 -0.443 . . . . 61.33 109.804 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' A' ' 625' ' ' GLY . 4.3 p-10 -69.59 124.8 24.88 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.261 0.553 . . . . 64.5 109.557 178.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 95.3 t -129.04 115.73 37.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.812 -0.81 . . . . 43.33 108.812 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . 0.402 ' HA ' ' HB2' ' A' ' 626' ' ' GLN . 4.3 p-10 -84.48 118.82 24.54 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.349 -0.982 . . . . 52.42 108.349 178.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . 0.437 ' HB3' ' HG3' ' A' ' 599' ' ' GLN . . . -142.8 9.0 1.73 Allowed 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.941 -0.704 . . . . 72.51 112.004 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 125.49 -176.71 17.22 Favored Glycine 0 N--CA 1.435 -1.375 0 C-N-CA 120.152 -1.023 . . . . 74.1 111.955 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -63.44 -40.48 98.88 Favored Glycine 0 N--CA 1.45 -0.393 0 O-C-N 124.215 0.597 . . . . 63.45 113.066 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 23.8 m -63.18 -23.87 67.63 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 122.895 0.478 . . . . 74.53 111.628 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . 0.437 ' HG3' ' HB3' ' A' ' 595' ' ' ALA . 82.4 mm-40 -105.08 -1.64 25.35 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 111.979 0.363 . . . . 74.02 111.979 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -84.81 109.96 18.47 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 119.861 -0.736 . . . . 74.35 110.621 -176.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 57.01 0.27 0.07 Allowed 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 126.805 2.042 . . . . 73.33 114.973 176.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 8.2 ptm180 -108.08 157.22 18.45 Favored 'General case' 0 C--N 1.289 -2.036 0 O-C-N 120.812 -1.18 . . . . 74.4 113.871 -173.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . 0.415 HG13 ' HB2' ' A' ' 622' ' ' LEU . 66.5 t -69.11 130.77 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 113.908 -1.497 . . . . 73.45 108.502 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 623' ' ' ARG . 46.5 t -84.31 -50.09 15.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 121.49 0.662 . . . . 71.34 109.669 -176.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -154.6 164.15 39.15 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 106.129 -1.804 . . . . 70.4 106.129 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -115.05 128.6 56.35 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 107.289 -1.374 . . . . 63.54 107.289 174.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.583 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 16.6 t-20 -48.25 -58.17 8.72 Favored Pre-proline 0 N--CA 1.48 1.025 0 O-C-N 123.798 0.686 . . . . 65.31 112.475 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.583 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 2.8 Cg_endo -86.34 120.87 1.88 Allowed 'Trans proline' 0 N--CA 1.442 -1.534 0 N-CA-C 108.097 -1.54 . . . . 75.12 108.097 169.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -63.31 160.27 35.85 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.371 2.047 . . . . 74.12 113.132 -177.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -57.85 127.28 31.29 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.437 -0.801 . . . . 72.44 111.055 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 91.95 -1.29 74.11 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.321 -0.942 . . . . 74.11 112.118 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 24.7 m -99.15 160.58 14.17 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.459 -0.941 . . . . 62.32 108.459 178.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -87.64 143.17 18.3 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 121.494 -0.384 . . . . 65.3 114.047 -175.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 27.8 m -113.81 142.55 25.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 C-N-CA 124.004 0.922 . . . . 63.32 109.42 176.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.408 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 29.7 p-10 -58.89 176.26 0.22 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.731 1.011 . . . . 73.55 113.731 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -60.92 -25.86 67.06 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.96 -0.564 . . . . 73.22 112.421 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.31 -33.67 65.29 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.698 -0.853 . . . . 70.42 108.698 174.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 79.51 21.93 65.76 Favored Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 110.428 -1.069 . . . . 63.14 110.428 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.16 119.5 15.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 122.319 1.057 . . . . 72.0 111.29 -168.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 2.8 tp -116.56 126.5 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 CA-C-N 113.582 -1.645 . . . . 64.41 109.561 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.532 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 93.8 m -100.98 118.79 37.69 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 108.851 -0.796 . . . . 72.32 108.851 173.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . 0.415 ' HB2' HG13 ' A' ' 603' ' ' VAL . 1.6 pt? -132.74 151.85 51.89 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 107.605 -1.257 . . . . 55.3 107.605 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . 0.407 ' O ' HG23 ' A' ' 604' ' ' VAL . 13.6 tpt180 -131.51 141.76 49.82 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 109.1 -0.704 . . . . 72.23 109.1 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -127.97 143.4 51.09 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 106.793 -1.558 . . . . 60.33 106.793 172.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 592' ' ' ASP . . . -85.87 -89.81 0.92 Allowed Glycine 0 N--CA 1.436 -1.319 0 C-N-CA 120.639 -0.791 . . . . 70.43 112.394 -176.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . 0.402 ' HB2' ' HA ' ' A' ' 594' ' ' ASP . 8.5 tp-100 . . . . . 0 C--N 1.309 -1.177 0 CA-C-O 118.866 -0.588 . . . . 62.01 110.554 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 121.168 0.508 . . . . 53.03 110.39 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 30.2 m -137.56 162.98 31.85 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 107.671 -1.233 . . . . 54.42 107.671 178.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -94.09 139.37 31.06 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 106.067 -1.827 . . . . 75.23 106.067 175.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.528 HG22 ' CZ ' ' A' ' 382' ' ' PHE . 90.6 t -93.48 128.82 40.83 Favored Pre-proline 0 C--N 1.281 -2.389 0 N-CA-C 108.28 -1.007 . . . . 73.44 108.28 -168.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 13.6 Cg_exo -61.09 120.59 8.37 Favored 'Trans proline' 0 C--N 1.361 1.204 0 C-N-CA 122.468 2.112 . . . . 55.12 112.304 -174.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -87.71 84.36 7.08 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 114.571 -1.195 . . . . 75.2 108.053 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.509 ' HB ' HE21 ' A' ' 368' ' ' GLN . 28.2 m -92.09 16.03 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.078 -0.964 . . . . 72.33 112.707 -174.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . 0.296 0.2 OUTLIER -65.29 148.38 51.79 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.926 -0.579 . . . . 74.2 112.546 176.705 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 106.4 -1.78 37.2 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 110.125 -1.19 . . . . 63.11 110.125 -170.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . 0.509 HE21 ' HB ' ' A' ' 365' ' ' VAL . 39.5 mt-30 -109.27 -158.93 0.66 Allowed 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 107.588 -1.264 . . . . 71.31 107.588 173.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 65.4 p -90.52 160.56 15.91 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 109.94 -0.393 . . . . 73.14 109.94 -175.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 27.1 p -56.13 -46.47 79.18 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 123.556 0.535 . . . . 63.05 110.451 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.31 -46.27 84.31 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 115.843 -0.617 . . . . 43.43 112.291 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -66.67 -44.1 82.74 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 120.153 -0.619 . . . . 65.04 110.471 -178.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -63.17 -48.6 77.72 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.519 -0.764 . . . . 73.13 111.771 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 90.1 mt -65.83 -42.23 91.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 CA-C-N 116.547 -0.297 . . . . 74.43 110.301 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.79 -43.33 94.46 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.417 -0.356 . . . . 74.31 111.189 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 33.8 m -63.0 -47.51 82.8 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.026 -0.534 . . . . 70.35 111.457 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 11.1 mp -64.59 -41.64 96.12 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.137 -0.225 . . . . 72.41 111.545 178.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . 0.447 HE21 ' HA ' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -63.62 -38.72 92.19 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.301 -0.409 . . . . 74.34 110.186 -179.095 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -64.97 -30.81 71.82 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.894 0.378 . . . . 62.44 111.155 176.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -81.72 -8.66 59.72 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.131 -0.486 . . . . 71.51 110.826 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 99.49 0.18 56.79 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.603 -0.808 . . . . 72.34 112.491 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.528 ' CZ ' HG22 ' A' ' 362' ' ' VAL . 62.7 m-85 -78.26 147.67 34.24 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 109.124 -0.695 . . . . 74.0 109.124 178.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.527 ' HB2' ' HG2' ' A' ' 415' ' ' GLU . 40.9 mmtm -100.35 144.53 29.24 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.497 -1.668 . . . . 75.32 106.497 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 1.5 mp -129.0 140.46 49.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 108.353 -0.981 . . . . 74.23 108.353 -179.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -109.85 128.05 55.08 Favored 'General case' 0 C--N 1.264 -3.113 0 N-CA-C 104.893 -2.262 . . . . 72.55 104.893 175.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 19.3 m -115.26 127.86 55.76 Favored 'General case' 0 C--N 1.257 -3.446 0 N-CA-C 108.095 -1.076 . . . . 71.24 108.095 -175.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.87 120.83 43.27 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.67 -1.233 . . . . 63.12 107.67 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -95.89 132.82 40.77 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.823 -0.436 . . . . 54.24 109.823 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 421' ' ' SER . 93.3 mttt -136.04 134.24 20.22 Favored Pre-proline 0 C--N 1.297 -1.703 0 N-CA-C 108.39 -0.967 . . . . 71.03 108.39 173.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . 0.515 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 29.5 Cg_endo -91.51 127.31 1.07 Allowed 'Trans proline' 0 C--O 1.251 1.146 0 C-N-CA 121.296 1.331 . . . . 53.34 111.259 175.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.515 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 12.2 t70 150.97 -164.92 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 103.203 -2.888 . . . . 74.1 103.203 -177.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 13.1 t -141.83 2.91 1.6 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 119.369 0.986 . . . . 72.23 110.539 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 11.5 t -87.74 -7.74 56.95 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.265 1.031 . . . . 63.14 109.787 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.569 HD13 ' H ' ' A' ' 394' ' ' ILE . 0.2 OUTLIER -109.25 151.81 42.25 Favored Pre-proline 0 N--CA 1.417 -2.088 0 N-CA-C 106.737 -1.579 . . . . 61.31 106.737 178.414 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . 0.434 ' HA ' ' HD2' ' A' ' 396' ' ' PRO . 1.1 Cg_exo -22.92 113.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.087 1 C-N-CA 125.739 4.293 . . . . 73.45 115.736 -179.064 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 395' ' ' PRO . 28.9 Cg_endo -61.63 164.09 16.71 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 124.252 3.301 . . . . 74.32 112.605 -178.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . 0.499 ' HA ' ' CG2' ' A' ' 420' ' ' VAL . 31.4 t70 -56.53 -9.23 0.68 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 122.504 1.145 . . . . 54.11 111.937 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 64.1 m170 -103.96 111.33 23.84 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 103.5 -2.778 . . . . 64.5 103.5 168.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 27.4 m -63.14 119.49 7.3 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 O-C-N 124.403 1.065 . . . . 72.43 112.425 -168.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 9.1 tp -91.19 -29.14 4.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-N 115.515 -0.766 . . . . 71.33 110.443 -176.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.93 162.37 28.32 Favored Glycine 0 N--CA 1.42 -2.375 0 C-N-CA 119.533 -1.318 . . . . 63.51 113.554 -174.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 10.6 p -132.36 -175.7 3.84 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 125.7 1.6 . . . . 62.21 109.116 -177.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -101.37 134.3 20.37 Favored Pre-proline 0 C--N 1.293 -1.879 0 N-CA-C 107.28 -1.378 . . . . 62.52 107.28 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -47.03 -24.95 3.62 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 124.412 3.408 . . . . 54.21 115.122 -177.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.51 -28.23 68.23 Favored 'General case' 0 C--O 1.209 -1.067 0 CA-C-N 116.27 -0.423 . . . . 54.05 111.327 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -73.99 -32.54 63.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.825 0.821 . . . . 71.02 110.014 178.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -87.27 -2.15 58.41 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.522 -0.763 . . . . 73.44 109.498 -178.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 24.9 m -102.18 151.85 21.71 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.44 -1.689 . . . . 73.42 106.44 173.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 46.2 m -79.92 112.41 17.18 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 119.125 -1.03 . . . . 54.5 109.306 176.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.8 m -121.36 168.67 13.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 116.371 -0.377 . . . . 71.11 110.124 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 57.1 m -61.88 133.17 55.11 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.245 0.545 . . . . 72.02 110.936 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -61.77 112.44 2.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.316 -0.856 . . . . 72.12 112.754 -174.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 119.55 6.5 10.46 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.602 -0.808 . . . . 65.23 113.383 177.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -69.49 179.19 2.16 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 122.442 0.297 . . . . 73.21 111.233 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . 0.527 ' HG2' ' HB2' ' A' ' 383' ' ' LYS . 40.2 mt-10 -106.49 122.8 47.02 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 122.848 0.459 . . . . 71.2 110.569 -174.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 49.2 mm -112.41 130.6 65.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 108.78 -0.822 . . . . 74.03 108.78 178.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 81.4 m -96.95 132.35 42.83 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.116 0.484 . . . . 52.31 111.003 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 5.6 p -122.86 134.59 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 CA-C-N 115.78 -0.646 . . . . 63.21 109.762 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -95.59 129.23 42.85 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.982 -0.747 . . . . 73.1 108.982 174.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.499 ' CG2' ' HA ' ' A' ' 397' ' ' ASP . 8.6 p -138.7 141.51 36.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 109.617 -0.512 . . . . 75.53 109.617 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 11.5 p -100.15 121.97 42.26 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-O 121.699 0.761 . . . . 65.11 112.184 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 9.3 t -121.44 121.33 37.33 Favored 'General case' 0 N--CA 1.41 -2.449 0 N-CA-C 108.001 -1.111 . . . . 72.22 108.001 170.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.588 0 C-N-CA 119.701 -1.238 . . . . 62.21 112.597 177.971 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 . . . . . 0 N--CA 1.442 -0.854 0 N-CA-C 108.727 -0.842 . . . . 73.35 108.727 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 447' ' ' ALA . 3.9 mmp_? -122.39 152.99 39.64 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.747 0.308 . . . . 74.51 111.162 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -91.02 139.04 31.14 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 115.759 -0.655 . . . . 54.15 110.642 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 50.4 mt -86.04 126.3 65.82 Favored Pre-proline 0 N--CA 1.421 -1.887 0 N-CA-C 106.914 -1.513 . . . . 71.4 106.914 176.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -73.12 141.43 32.64 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.174 1.916 . . . . 62.44 110.537 169.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -80.91 116.15 20.74 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.828 -1.175 . . . . 72.25 107.828 173.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.443 HG12 ' HB ' ' A' ' 436' ' ' THR . 61.4 t -107.34 154.17 8.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 108.035 -1.098 . . . . 74.14 108.035 -175.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.512 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 19.6 m -67.13 152.35 45.91 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 120.818 0.342 . . . . 63.33 110.805 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 35.5 p -67.28 -27.93 67.6 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 113.979 1.103 . . . . 63.34 113.979 -172.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 2.4 pp -88.38 -10.34 49.65 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.719 0.771 . . . . 73.41 111.439 176.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.512 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 1.6 m -96.84 37.0 1.33 Allowed 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.428 0.632 . . . . 74.33 110.35 -175.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -52.76 -38.78 61.5 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.705 0.802 . . . . 72.21 112.56 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.33 -40.31 93.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.932 0.396 . . . . 71.52 111.33 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.406 ' HB3' HG22 ' A' ' 436' ' ' THR . 29.3 tp10 -70.84 -34.53 71.77 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.523 -0.547 . . . . 75.15 109.523 176.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.52 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.02 -50.98 71.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.594 -0.276 . . . . 64.1 111.218 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.1 m -60.71 -37.34 75.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 121.301 0.572 . . . . 71.1 110.634 177.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -60.37 -47.66 85.1 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.257 -0.883 . . . . 62.33 110.81 175.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -65.02 -39.5 93.48 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.817 0.341 . . . . 71.54 111.609 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.52 HD13 ' O ' ' A' ' 440' ' ' ALA . 6.2 mp -65.21 -36.19 83.4 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.968 -0.56 . . . . 70.3 110.999 177.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 65.8 m -70.18 -42.7 72.09 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-O 120.825 0.345 . . . . 75.52 110.091 177.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -65.93 -21.87 66.46 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-O 121.438 0.637 . . . . 63.31 110.844 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 427' ' ' ARG . . . -82.65 5.42 21.18 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.451 -0.795 . . . . 72.42 111.465 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 100.69 -73.68 0.41 Allowed Glycine 0 CA--C 1.501 -0.79 0 C-N-CA 120.408 -0.901 . . . . 74.44 112.525 174.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -43.88 -59.36 2.3 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.955 1.094 . . . . 74.1 113.955 176.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 59.31 29.71 66.49 Favored Glycine 0 C--O 1.224 -0.53 0 C-N-CA 121.24 -0.505 . . . . 74.11 112.652 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -102.59 110.56 22.53 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 108.385 -0.968 . . . . 65.11 108.385 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -140.71 143.05 34.82 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.865 -0.607 . . . . 44.34 111.05 -177.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -131.22 122.95 27.42 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.592 -0.892 . . . . 74.52 108.592 178.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -91.36 128.16 37.08 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.371 -0.603 . . . . 64.31 109.371 176.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -116.74 139.44 50.57 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 106.911 -1.514 . . . . 64.43 106.911 175.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -115.32 130.87 57.03 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.374 -0.973 . . . . 64.42 108.374 -176.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 41.9 t -132.59 140.15 36.92 Favored Pre-proline 0 C--N 1.283 -2.306 0 N-CA-C 108.793 -0.817 . . . . 52.11 108.793 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.711 ' HA ' ' O ' ' A' ' 490' ' ' SER . 49.7 Cg_endo -72.52 121.76 7.7 Favored 'Trans proline' 0 N--CA 1.437 -1.805 0 C-N-CA 121.045 1.163 . . . . 71.23 109.726 174.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 48.8 m -142.69 179.38 7.02 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.661 -0.7 . . . . 71.3 110.55 -173.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 14.1 t -52.12 138.63 36.06 Favored Pre-proline 0 CA--C 1.562 1.412 0 C-N-CA 124.198 0.999 . . . . 61.32 111.274 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.77 -30.0 36.17 Favored 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 124.868 3.712 . . . . 61.22 114.058 -173.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -73.17 -19.84 61.03 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.608 0.596 . . . . 75.23 112.608 -176.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -101.79 -6.83 23.15 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.232 -0.292 . . . . 70.4 111.32 177.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 94.4 t -61.09 128.09 21.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 120.854 0.359 . . . . 63.2 110.341 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.42 -11.85 71.13 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.432 -0.804 . . . . 71.42 111.831 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -110.93 165.36 11.92 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 109.636 -0.505 . . . . 25.52 109.636 -177.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.416 HG22 HG12 ' A' ' 488' ' ' VAL . 80.6 t -76.98 145.3 10.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 107.086 -1.449 . . . . 72.34 107.086 171.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 64.8 mt -97.32 -31.96 3.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 107.031 -1.47 . . . . 71.02 107.031 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 160.39 -178.36 36.45 Favored Glycine 0 N--CA 1.417 -2.625 0 CA-C-N 114.983 -1.008 . . . . 61.43 110.858 175.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . 0.574 HG22 HG12 ' A' ' 486' ' ' ILE . 54.3 p -114.39 146.44 40.57 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 106.117 -1.809 . . . . 43.11 106.117 175.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -67.19 -54.51 19.28 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 120.054 -0.658 . . . . 55.42 110.675 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -73.15 138.81 28.53 Favored 'Trans proline' 0 C--N 1.368 1.585 0 N-CA-C 107.797 -1.655 . . . . 64.22 107.797 169.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.428 ' HB2' ' HG2' ' A' ' 476' ' ' GLN . 23.0 Cg_exo -62.62 132.28 37.13 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.611 1.541 . . . . 65.03 111.888 -177.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -73.75 16.69 0.2 Allowed 'General case' 0 C--O 1.195 -1.768 0 C-N-CA 124.214 1.006 . . . . 43.41 112.355 -177.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -111.8 -8.87 14.12 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 122.645 0.378 . . . . 65.53 111.2 173.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . 0.428 ' HG2' ' HB2' ' A' ' 473' ' ' PRO . 85.2 mm-40 -77.61 171.1 15.45 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 113.606 0.965 . . . . 74.31 113.606 -172.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 1.1 m -105.37 115.53 30.42 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 107.592 -1.262 . . . . 65.41 107.592 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 22.0 m -115.1 142.62 46.4 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 120.613 0.244 . . . . 74.13 110.401 -176.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -71.72 166.57 21.69 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.813 -0.63 . . . . 72.12 110.19 176.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 29.4 mm -70.95 -3.18 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.362 0 CA-C-O 121.821 0.82 . . . . 53.14 111.797 -173.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 14.6 t -112.19 5.29 18.38 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.18 -0.95 . . . . 51.15 110.711 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -79.79 132.66 36.2 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.803 -0.56 . . . . 72.21 111.377 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 46.0 t -106.61 121.7 59.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 108.35 -0.981 . . . . 70.41 108.35 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 28.7 m -104.72 134.62 45.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-O 121.518 0.675 . . . . 73.32 111.929 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.13 125.99 50.02 Favored 'Isoleucine or valine' 0 C--O 1.252 1.195 0 N-CA-C 108.91 -0.774 . . . . 74.51 108.91 178.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.574 HG12 HG22 ' A' ' 470' ' ' THR . 7.9 mt -119.62 127.44 75.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.259 -0.882 . . . . 64.15 109.381 -178.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 7.1 tt -108.38 127.14 64.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.07 0.462 . . . . 62.32 111.287 -177.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.416 HG12 HG22 ' A' ' 467' ' ' VAL . 31.9 m -111.23 151.75 13.3 Favored 'Isoleucine or valine' 0 C--O 1.252 1.203 0 CA-C-N 115.849 -0.614 . . . . 72.5 109.933 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.17 133.97 12.2 Favored Glycine 0 N--CA 1.43 -1.702 0 C-N-CA 121.022 -0.609 . . . . 74.0 111.946 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.711 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 33.4 m . . . . . 0 C--N 1.29 -1.982 0 N-CA-C 105.779 -1.934 . . . . 74.42 105.779 176.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo . . . . . 0 N--CA 1.44 -1.633 0 CA-C-O 121.281 0.45 . . . . 74.33 111.63 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -110.6 35.3 3.53 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 122.404 1.097 . . . . 75.33 108.506 177.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 546' ' ' PRO . 17.2 p -117.22 150.06 39.37 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 113.758 -1.564 . . . . 72.42 110.994 -174.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . 0.51 ' HA ' ' HE3' ' A' ' 495' ' ' LYS . 0.0 OUTLIER -137.04 164.28 28.75 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.694 -1.224 . . . . 71.12 107.694 175.474 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.7 m-20 -90.36 138.34 31.62 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 109.531 -0.544 . . . . 74.42 109.531 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 543' ' ' THR . 35.9 pt -95.54 124.54 52.72 Favored Pre-proline 0 C--N 1.306 -1.286 0 C-N-CA 120.787 -0.365 . . . . 45.23 110.754 177.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -89.38 171.14 4.51 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.391 2.061 . . . . 72.04 110.51 174.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -87.87 154.57 20.42 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.386 -0.968 . . . . 70.41 108.386 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.5 p -145.91 104.31 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 108.954 -0.758 . . . . 71.0 108.954 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -140.68 119.85 12.89 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.732 -0.667 . . . . 74.3 110.497 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 122.97 -12.38 8.63 Favored Glycine 0 CA--C 1.486 -1.77 0 C-N-CA 120.119 -1.039 . . . . 60.43 111.779 177.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.484 ' O ' HG12 ' A' ' 534' ' ' VAL . 20.2 mt-30 -99.0 171.09 8.26 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.438 -0.949 . . . . 65.15 108.438 176.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 14.5 t -90.15 157.78 17.57 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.358 -0.979 . . . . 72.42 108.358 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 12.4 p -52.78 -41.1 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 113.084 0.772 . . . . 64.25 113.084 -176.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -61.54 -41.87 98.0 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.125 0.488 . . . . 71.0 110.6 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 93.5 t -69.54 -43.38 80.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.441 -0.799 . . . . 73.41 110.196 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -61.31 -49.5 76.75 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.081 -0.508 . . . . 70.02 111.412 -178.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -63.07 -38.09 89.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.042 0.449 . . . . 73.23 111.285 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.462 ' O ' HG23 ' A' ' 514' ' ' VAL . 33.6 ttmt -62.54 -42.29 99.43 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.343 -0.844 . . . . 74.43 109.719 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -62.82 -48.37 79.36 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.056 -0.52 . . . . 72.12 110.79 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.93 -36.54 79.6 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.076 0.399 . . . . 71.42 112.076 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.36 -37.43 80.68 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 116.351 -0.386 . . . . 72.31 111.145 176.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 510' ' ' LYS . 94.2 t -61.48 -36.43 73.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.117 -0.492 . . . . 74.43 110.387 177.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -76.46 -15.03 60.0 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.573 -0.285 . . . . 74.41 111.354 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 110.91 -8.65 29.57 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.793 -0.717 . . . . 30.52 112.846 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.461 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 76.2 m-85 -80.06 113.82 18.52 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 108.085 -1.08 . . . . 75.52 108.085 -177.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.4 m -116.71 -8.95 11.37 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 118.548 -1.261 . . . . 71.14 114.113 -171.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -108.34 120.81 43.45 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.391 -0.818 . . . . 74.53 110.397 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -120.93 156.04 32.94 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 113.338 0.866 . . . . 65.43 113.338 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 46.9 m -141.85 138.52 32.2 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 106.296 -1.742 . . . . 61.51 106.296 169.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . 0.507 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 0.0 OUTLIER -121.63 141.35 51.2 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 119.601 -0.84 . . . . 73.22 111.094 179.523 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -119.89 122.61 41.66 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.683 -1.228 . . . . 74.41 107.683 176.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 67.1 m -88.86 128.02 35.65 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 121.214 0.531 . . . . 73.32 110.508 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 24.7 m -121.44 149.82 24.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.96 -0.756 . . . . 65.13 108.96 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . 0.408 ' HB3' ' HE3' ' A' ' 557' ' ' LYS . 10.0 p-10 -73.94 135.03 43.22 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 108.354 -0.98 . . . . 52.53 108.354 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . 0.405 ' HB3' ' HD2' ' A' ' 528' ' ' PRO . 45.4 m -152.16 172.55 5.37 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 108.628 -0.879 . . . . 72.32 108.628 -176.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 527' ' ' SER . 72.6 Cg_endo -82.67 -10.31 10.77 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 121.452 1.435 . . . . 64.4 110.424 174.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.433 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 27.3 mmt180 -81.36 138.18 48.43 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-N 114.862 -1.063 . . . . 64.53 108.18 -178.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -62.46 149.65 90.15 Favored 'Trans proline' 0 C--O 1.249 1.03 0 C-N-CA 122.351 2.034 . . . . 64.02 112.316 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -58.57 118.26 5.44 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.224 -0.898 . . . . 72.53 110.79 -178.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 127.59 -23.73 5.33 Favored Glycine 0 N--CA 1.434 -1.442 0 N-CA-C 111.113 -0.795 . . . . 70.32 111.113 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -81.14 134.96 35.73 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.468 -0.938 . . . . 74.35 108.468 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 503' ' ' GLN . 13.4 p -80.96 135.24 25.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 CA-C-O 121.3 0.571 . . . . 64.42 110.519 -178.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . 0.471 ' HB ' ' HG3' ' A' ' 554' ' ' GLN . 77.5 m -88.91 -32.83 17.53 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.168 -0.924 . . . . 70.42 109.889 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.38 -152.1 24.21 Favored Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 110.091 -1.203 . . . . 70.32 110.091 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 27.3 p -117.56 157.19 26.78 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.551 -0.537 . . . . 72.11 109.551 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -73.09 -50.04 6.87 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 109.59 -0.522 . . . . 74.41 109.59 175.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.12 146.92 78.29 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 121.217 1.278 . . . . 74.41 109.649 171.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.43 143.81 53.66 Favored 'Trans proline' 0 C--O 1.25 1.122 0 C-N-CA 122.181 1.921 . . . . 75.24 113.089 -176.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.86 133.51 50.2 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.815 -0.809 . . . . 74.13 108.815 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.47 -5.31 35.32 Favored Glycine 0 C--N 1.299 -1.506 0 C-N-CA 120.053 -1.07 . . . . 62.44 111.111 -176.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.47 ' O ' HG12 ' A' ' 497' ' ' ILE . 62.4 m -82.26 133.69 35.25 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.516 -0.55 . . . . 75.24 109.516 176.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 11.9 t -96.44 130.84 43.5 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 119.984 -0.686 . . . . 70.41 109.571 176.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.1 m -139.44 159.24 66.6 Favored Pre-proline 0 C--N 1.316 -0.891 0 N-CA-C 109.175 -0.676 . . . . 75.21 109.175 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 494' ' ' THR . 35.9 Cg_exo -63.39 142.04 83.69 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.367 2.045 . . . . 62.41 111.374 176.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.461 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 27.7 m -66.72 -23.19 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-O 121.445 0.64 . . . . 73.03 112.32 -177.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -79.68 -13.41 59.49 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.517 -0.765 . . . . 74.13 110.574 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 56.7 m -77.5 164.97 24.94 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 113.463 0.912 . . . . 72.2 113.463 -175.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 23.9 t -90.9 131.39 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-N 114.629 -1.169 . . . . 73.11 109.179 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . 0.47 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -116.51 142.39 30.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 109.721 -0.474 . . . . 54.2 109.721 175.317 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -103.78 116.66 32.72 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.839 -0.619 . . . . 74.22 110.713 -175.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 7.3 mp -103.27 134.4 46.74 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.238 -0.892 . . . . 75.12 109.738 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . 0.471 ' HG3' ' HB ' ' A' ' 535' ' ' THR . 1.6 pt20 -101.29 125.38 47.92 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 108.834 -0.802 . . . . 71.01 108.834 179.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 524' ' ' SER . 59.5 t -114.8 138.59 44.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-N 115.44 -0.8 . . . . 71.13 110.002 -174.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 63.2 m -69.35 140.57 54.28 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 113.606 0.965 . . . . 74.31 113.606 178.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' A' ' 526' ' ' ASP . 3.0 ttpt -103.26 139.76 38.29 Favored 'General case' 0 N--CA 1.422 -1.825 0 N-CA-C 104.915 -2.254 . . . . 73.1 104.915 166.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -67.68 -36.56 87.86 Favored Glycine 0 CA--C 1.484 -1.905 0 C-N-CA 120.55 -0.833 . . . . 41.44 112.395 -172.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 66.2 t30 67.33 -3.84 0.97 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.808 1.243 . . . . 64.34 112.857 171.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -151.38 142.06 22.74 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.172 -1.418 . . . . 70.11 107.172 -174.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -136.18 134.93 38.72 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 120.627 0.251 . . . . 74.43 111.092 174.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.1 p -60.27 123.23 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.737 0.815 . . . . 73.31 112.931 -175.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . 0.444 ' HG2' ' O ' ' A' ' 612' ' ' THR . 25.5 ptm -98.11 141.19 22.55 Favored Pre-proline 0 C--O 1.253 1.259 0 CA-C-N 115.9 -0.591 . . . . 55.34 111.421 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.35 169.85 21.55 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.793 2.328 . . . . 43.53 110.555 171.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -72.52 130.45 40.65 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.163 0.506 . . . . 74.01 110.021 177.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 93.2 mt -116.6 -9.78 11.3 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.656 -0.702 . . . . 55.4 110.943 -177.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 10.5 p -70.36 129.88 40.47 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 109.952 -0.388 . . . . 75.13 109.952 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 90.3 -0.26 77.87 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.581 -0.819 . . . . 74.41 111.942 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 26.4 mmt -91.32 151.21 20.96 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 108.845 -0.798 . . . . 62.41 108.845 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -93.28 140.79 29.15 Favored 'General case' 0 N--CA 1.416 -2.165 0 N-CA-C 109.35 -0.611 . . . . 74.23 109.35 -176.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . 0.435 ' HA ' ' HB3' ' A' ' 574' ' ' ALA . 60.7 t-105 -71.53 -15.65 62.3 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.659 -0.701 . . . . 75.42 110.276 -174.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 14.0 p -72.31 -19.3 19.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.896 0.855 . . . . 63.12 108.908 178.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -102.27 -44.77 5.32 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 114.511 -1.222 . . . . 60.34 110.359 176.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . 0.435 ' HB3' ' HA ' ' A' ' 571' ' ' TRP . . . -65.42 -41.34 93.68 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 113.923 1.083 . . . . 73.44 113.923 -176.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.585 ' O ' ' HG2' ' A' ' 579' ' ' ARG . 32.0 tt0 -65.54 -53.55 36.81 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 120.176 -0.61 . . . . 73.44 111.907 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 52.4 Cg_exo -55.88 -39.26 92.21 Favored 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 121.91 1.74 . . . . 74.14 113.136 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 574' ' ' ALA . 3.2 ppt_? -67.76 -37.19 81.76 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 119.536 -0.865 . . . . 75.43 110.809 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.452 HD12 ' N ' ' A' ' 579' ' ' ARG 0.275 3.5 pp -66.55 -36.41 82.59 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 120.498 -0.481 . . . . 64.31 111.507 179.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . 0.585 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 45.8 mmm-85 -57.21 -42.75 81.92 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.169 -0.923 . . . . 75.12 108.711 176.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -67.8 -28.05 67.26 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.716 -0.675 . . . . 74.54 111.912 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 10.5 mp -80.56 -8.06 59.46 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.145 0.498 . . . . 72.53 111.164 177.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 77.77 16.28 80.25 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-N 115.759 -0.655 . . . . 64.05 111.95 179.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -70.78 140.46 51.29 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 109.523 -0.547 . . . . 74.51 109.523 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 9.6 t -137.21 -50.01 0.62 Allowed 'General case' 0 N--CA 1.406 -2.638 0 CA-C-O 118.871 -0.585 . . . . 73.23 110.238 175.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . 30.67 -126.69 0.16 Allowed Glycine 0 C--N 1.371 2.488 0 O-C-N 124.631 1.207 . . . . 43.03 113.734 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 25.7 ptm -137.93 125.54 22.21 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.881 -1.526 . . . . 74.4 106.881 170.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -87.41 123.84 32.78 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.69 -0.855 . . . . 75.33 108.69 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -95.96 107.33 19.6 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.669 -0.696 . . . . 72.31 109.277 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -112.5 113.3 25.4 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 108.582 -0.895 . . . . 71.01 108.582 176.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -83.25 -126.09 1.1 Allowed Glycine 0 N--CA 1.435 -1.367 0 N-CA-C 111.066 -0.814 . . . . 62.13 111.066 175.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -70.98 137.73 49.35 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.873 0.368 . . . . 74.24 111.124 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -97.49 126.95 43.06 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 106.903 -1.518 . . . . 72.15 106.903 176.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 48.8 t -137.27 128.95 41.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 C-N-CA 120.955 -0.298 . . . . 73.35 110.463 -172.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -77.38 108.35 10.46 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 105.173 -2.158 . . . . 60.13 105.173 170.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -105.1 0.19 27.24 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-O 121.216 0.531 . . . . 75.45 111.44 -174.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 100.82 171.47 28.93 Favored Glycine 0 N--CA 1.433 -1.56 0 N-CA-C 109.584 -1.406 . . . . 51.14 109.584 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -63.46 -48.16 80.82 Favored Glycine 0 C--N 1.306 -1.126 0 C-N-CA 120.721 -0.752 . . . . 64.01 113.382 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 42.0 p -69.25 -26.79 64.95 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.502 0.668 . . . . 65.22 112.243 -175.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -105.91 -1.64 23.88 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 118.926 -0.559 . . . . 72.52 110.992 -174.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . 0.491 ' CG ' ' H ' ' A' ' 601' ' ' ASN . 0.3 OUTLIER -35.32 -115.74 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.616 0 N-CA-C 117.677 2.473 . . . . 54.51 117.677 -167.866 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . 0.491 ' H ' ' CG ' ' A' ' 600' ' ' HIS . 4.6 p30 -92.96 83.92 4.81 Favored 'General case' 0 C--N 1.287 -2.109 0 O-C-N 120.558 -1.339 . . . . 74.12 109.92 178.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -126.11 150.85 47.93 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 115.548 -0.751 . . . . 73.12 109.678 175.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 85.7 t -67.84 130.9 33.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 O-C-N 123.875 0.734 . . . . 74.15 109.358 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 60.1 t -93.11 -52.14 10.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.363 0.601 . . . . 74.45 109.786 -176.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -136.41 158.81 43.55 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.405 -0.961 . . . . 72.11 108.405 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . 0.415 ' HA ' HD23 ' A' ' 622' ' ' LEU . 19.5 pt20 -125.32 122.3 36.46 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.564 -1.273 . . . . 74.14 107.564 174.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.613 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 41.8 t30 -51.47 -59.0 8.81 Favored Pre-proline 0 CA--C 1.555 1.17 0 CA-C-O 119.094 -0.479 . . . . 71.21 112.175 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.613 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 2.7 Cg_endo -85.03 129.65 3.94 Favored 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 121.322 1.348 . . . . 72.34 109.123 171.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.81 161.52 35.84 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 122.696 2.264 . . . . 61.5 112.905 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -59.21 129.99 44.81 Favored 'General case' 0 C--O 1.249 1.051 0 CA-C-N 115.754 -0.657 . . . . 61.22 110.959 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 95.59 -10.76 68.83 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 120.863 -0.684 . . . . 63.23 111.706 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . 0.444 ' O ' ' HG2' ' A' ' 563' ' ' MET . 24.0 m -89.27 161.97 16.11 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.642 -1.244 . . . . 73.25 107.642 178.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -99.12 143.19 16.45 Favored Glycine 0 N--CA 1.418 -2.518 0 C-N-CA 119.985 -1.102 . . . . 52.44 113.237 -177.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . 0.406 HG12 ' HG2' ' A' ' 608' ' ' PRO . 13.6 m -94.12 143.42 11.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.374 -0.973 . . . . 75.4 108.374 175.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.438 HD21 HG22 ' A' ' 619' ' ' ILE . 31.1 p30 -58.24 175.41 0.23 Allowed 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 114.21 1.189 . . . . 72.53 114.21 -175.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -55.95 -38.36 70.24 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 125.458 1.503 . . . . 74.43 110.986 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.91 -33.91 68.67 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 115.607 -0.724 . . . . 63.24 109.501 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 82.5 19.74 63.48 Favored Glycine 0 N--CA 1.417 -2.618 0 N-CA-C 109.974 -1.25 . . . . 63.31 109.974 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . 0.438 HG22 HD21 ' A' ' 615' ' ' ASN . 0.0 OUTLIER -70.62 119.44 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 108.629 -0.878 . . . . 72.12 108.629 -174.561 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 8.5 tp -116.26 132.42 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 0 CA-C-N 114.73 -1.123 . . . . 73.52 109.678 -174.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.524 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 32.8 m -105.28 117.53 34.24 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 108.912 -0.773 . . . . 75.34 108.912 178.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 606' ' ' GLN . 72.9 mt -139.09 165.65 26.59 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 105.747 -1.946 . . . . 74.41 105.747 -177.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -142.94 139.54 30.75 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 106.468 -1.678 . . . . 74.21 106.468 173.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -138.77 160.89 38.57 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.145 -1.057 . . . . 63.41 108.145 -177.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -87.15 -117.46 1.14 Allowed Glycine 0 N--CA 1.43 -1.734 0 O-C-N 123.915 0.759 . . . . 54.41 113.35 -177.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 . . . . . 0 C--N 1.298 -1.666 0 N-CA-C 109.21 -0.663 . . . . 74.01 109.21 -174.682 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 . . . . . 0 CA--C 1.498 -1.03 0 N-CA-C 107.179 -1.415 . . . . 75.03 107.179 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.15 163.51 34.06 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.46 0 N-CA-C 108.226 -1.028 . . . . 70.05 108.226 -177.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -94.46 138.15 32.74 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 105.007 -2.22 . . . . 61.4 105.007 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.407 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 91.9 t -95.3 123.53 56.53 Favored Pre-proline 0 C--N 1.271 -2.825 0 N-CA-C 109.308 -0.627 . . . . 35.41 109.308 -171.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 17.9 Cg_exo -60.89 126.28 19.25 Favored 'Trans proline' 0 N--CA 1.445 -1.349 0 C-N-CA 122.316 2.011 . . . . 70.34 110.995 -178.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -84.62 114.2 21.82 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-O 122.639 1.209 . . . . 75.23 109.326 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.499 HG13 ' HB1' ' A' ' 373' ' ' ALA . 9.2 p -88.21 15.12 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 CA-C-N 113.832 -1.531 . . . . 54.54 111.554 -173.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -56.5 146.69 23.98 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.191 1.396 . . . . 74.55 111.954 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.41 0.47 43.68 Favored Glycine 0 CA--C 1.503 -0.673 0 CA-C-N 116.263 -0.426 . . . . 72.43 113.354 177.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -115.75 -159.39 0.71 Allowed 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 108.273 -1.01 . . . . 75.52 108.273 177.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 60.1 p -90.96 166.83 12.82 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 108.66 -0.867 . . . . 72.51 108.66 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 66.7 m -62.85 -41.13 99.23 Favored 'General case' 0 C--O 1.208 -1.101 0 C-N-CA 120.004 -0.678 . . . . 74.13 110.026 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.49 -46.68 81.97 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 116.728 -0.214 . . . . 71.22 111.563 -178.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -69.09 -39.83 78.77 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.475 0.655 . . . . 72.03 110.002 -176.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . 0.499 ' HB1' HG13 ' A' ' 365' ' ' VAL . . . -67.24 -46.47 73.66 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.582 -0.735 . . . . 74.32 111.285 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . 0.435 HG12 HG21 ' A' ' 384' ' ' ILE . 75.9 mt -64.44 -40.98 90.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-N 116.353 -0.385 . . . . 72.3 110.302 177.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.99 -41.85 88.61 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.378 0.608 . . . . 72.11 110.619 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 87.2 m -63.17 -47.62 81.86 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.655 -0.702 . . . . 51.11 110.756 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 97.6 mt -64.05 -37.99 89.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.337 -0.392 . . . . 65.53 110.7 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . 0.405 HE21 ' HB2' ' A' ' 378' ' ' GLN . 0.1 OUTLIER -63.67 -38.66 91.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.799 -0.637 . . . . 54.43 110.775 178.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -68.9 -24.63 64.33 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 120.981 0.42 . . . . 75.55 111.382 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -82.09 -14.76 55.32 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.153 -0.476 . . . . 75.35 110.757 176.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.95 16.82 43.16 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.212 -0.994 . . . . 53.13 112.257 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -88.16 159.59 18.12 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 121.395 0.617 . . . . 75.33 111.829 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -100.64 132.6 45.95 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 106.824 -1.547 . . . . 62.32 106.824 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . 0.435 HG21 HG12 ' A' ' 374' ' ' ILE . 0.8 OUTLIER -122.89 137.29 56.87 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 N-CA-C 106.824 -1.547 . . . . 72.14 106.824 178.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 417' ' ' THR . 32.5 ttt180 -116.82 138.58 51.41 Favored 'General case' 0 C--N 1.255 -3.533 0 N-CA-C 105.724 -1.954 . . . . 72.2 105.724 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 41.0 m -130.23 132.51 46.0 Favored 'General case' 0 C--N 1.272 -2.786 0 O-C-N 121.771 -0.581 . . . . 63.41 109.483 -174.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.7 121.89 42.95 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.649 -1.241 . . . . 74.31 107.649 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -89.53 122.5 32.75 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.941 -0.763 . . . . 72.01 108.941 -178.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . 0.621 ' O ' ' HA ' ' A' ' 421' ' ' SER . 51.8 mtmt -132.98 135.78 26.49 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 109.028 -0.73 . . . . 74.32 109.028 177.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -76.14 176.6 9.83 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.32 2.014 . . . . 61.32 112.609 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 11.2 t70 87.92 167.82 0.06 Allowed 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 126.351 1.861 . . . . 73.44 110.707 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 32.6 t -105.7 -12.7 15.81 Favored 'General case' 0 N--CA 1.439 -1.022 0 O-C-N 122.35 -0.219 . . . . 64.22 111.222 -175.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 6.0 t -82.63 -3.38 56.12 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 119.198 -1.001 . . . . 70.34 109.548 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 47.6 mm -88.14 146.15 37.65 Favored Pre-proline 0 C--N 1.302 -1.475 0 N-CA-C 106.17 -1.789 . . . . 72.42 106.17 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . 0.44 ' HA ' ' HD2' ' A' ' 396' ' ' PRO . 28.3 Cg_exo -37.94 116.31 0.21 Allowed 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 123.772 2.981 . . . . 74.53 113.12 177.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . 0.528 ' HA ' ' OG ' ' A' ' 421' ' ' SER . 12.2 Cg_endo -57.72 151.99 52.02 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.041 2.494 . . . . 72.22 112.732 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . 0.46 ' HA ' HG23 ' A' ' 420' ' ' VAL . 8.7 p-10 -59.19 -8.17 1.49 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.874 1.27 . . . . 74.51 113.638 -178.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 31.4 m170 -106.55 109.96 22.03 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 104.327 -2.471 . . . . 61.54 104.327 171.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 28.0 m -62.78 119.07 5.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 124.647 1.217 . . . . 74.42 112.567 -165.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . 0.548 ' H ' HD13 ' A' ' 400' ' ' ILE . 0.2 OUTLIER -92.25 -28.22 4.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.4 -0.818 . . . . 73.15 109.89 179.132 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.75 160.11 28.06 Favored Glycine 0 N--CA 1.399 -3.824 0 CA-C-N 115.232 -0.895 . . . . 73.13 111.054 -176.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -114.83 -175.99 2.81 Favored 'General case' 0 C--N 1.27 -2.87 0 C-N-CA 125.351 1.46 . . . . 73.4 108.339 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -99.3 137.3 20.35 Favored Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 107.095 -1.446 . . . . 62.32 107.095 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -54.91 -16.28 11.49 Favored 'Trans proline' 0 C--N 1.365 1.411 0 C-N-CA 124.313 3.342 . . . . 72.32 114.662 -174.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.65 -28.69 68.76 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 116.308 -0.406 . . . . 64.35 110.249 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -73.96 -38.27 64.26 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.507 0.67 . . . . 61.15 110.392 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -81.2 -5.18 57.45 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.499 0.666 . . . . 74.22 110.629 -177.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 30.9 m -95.29 143.56 26.58 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.307 -1.738 . . . . 65.2 106.307 173.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 47.7 m -74.51 112.48 10.73 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 118.441 -1.304 . . . . 63.44 108.666 176.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 28.7 m -127.58 169.2 19.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 115.876 -0.602 . . . . 55.4 109.862 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 29.6 t -71.85 132.62 44.67 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 106.761 -1.57 . . . . 71.32 106.761 175.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -65.46 133.4 51.2 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-O 121.22 0.533 . . . . 61.22 111.157 -175.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 104.89 54.81 0.75 Allowed Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 110.816 -0.914 . . . . 22.51 110.816 -177.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -113.32 -177.23 3.08 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.818 -1.178 . . . . 61.15 107.818 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -107.67 108.88 20.32 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.153 -0.684 . . . . 71.11 109.153 -177.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.6 mm -98.01 116.77 41.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.37 -0.974 . . . . 61.42 108.37 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 385' ' ' ARG . 58.1 m -97.74 130.82 44.68 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 120.849 0.357 . . . . 72.23 110.535 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 4.8 p -118.96 136.18 56.99 Favored 'Isoleucine or valine' 0 C--O 1.252 1.223 0 C-N-CA 123.577 0.751 . . . . 60.44 110.232 -177.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -93.96 120.07 33.72 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.013 -0.736 . . . . 63.5 109.013 176.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.46 HG23 ' HA ' ' A' ' 397' ' ' ASP . 14.7 p -113.81 132.45 62.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 109.7 -0.481 . . . . 71.13 109.7 -178.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . 0.621 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 11.9 p -88.26 125.36 34.61 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.075 0.464 . . . . 72.25 111.301 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 5.6 t -118.36 106.52 12.83 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-O 121.191 0.519 . . . . 74.02 111.379 177.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.398 0 N-CA-C 115.226 0.85 . . . . 73.43 115.226 175.481 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 . . . . . 0 CA--C 1.52 -0.187 0 CA-C-O 120.634 0.254 . . . . 74.12 111.522 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 10.9 mmp_? -122.23 153.81 38.35 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-N 116.312 -0.404 . . . . 72.31 110.456 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 40.6 tt0 -84.83 141.47 30.45 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.418 -1.327 . . . . 72.13 107.418 174.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.423 ' HA ' ' HD3' ' A' ' 430' ' ' PRO . 68.2 mt -78.08 125.92 84.48 Favored Pre-proline 0 N--CA 1.437 -1.121 0 N-CA-C 107.212 -1.403 . . . . 70.44 107.212 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 429' ' ' ILE . 23.4 Cg_exo -67.62 145.05 68.68 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.473 2.115 . . . . 75.15 113.093 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -75.44 104.81 6.16 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 108.992 -0.744 . . . . 64.41 108.992 175.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 46.1 t -116.78 138.01 48.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 107.93 -1.137 . . . . 54.23 107.93 178.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.41 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 18.5 m -68.97 152.33 45.4 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 121.053 0.454 . . . . 74.32 111.025 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 58.3 p -63.89 -34.44 77.95 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 113.535 0.939 . . . . 44.42 113.535 -170.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.6 pp -84.22 -11.32 56.71 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 120.98 0.419 . . . . 73.24 111.842 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.41 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 0.8 OUTLIER -93.95 42.77 1.1 Allowed 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 115.687 -0.688 . . . . 54.24 109.731 -177.6 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -52.14 -39.65 60.25 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.725 1.21 . . . . 75.35 112.989 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.19 -41.79 99.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.085 0.469 . . . . 74.21 110.218 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -71.17 -33.97 70.5 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 116.19 -0.459 . . . . 71.31 110.286 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.46 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -59.43 -51.25 70.68 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.497 -0.127 . . . . 63.14 110.888 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.4 m -61.45 -37.63 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 CA-C-O 121.111 0.481 . . . . 75.43 110.458 177.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -60.52 -48.19 82.86 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.244 1.018 . . . . 65.22 110.908 176.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -66.42 -38.5 87.57 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 123.777 0.831 . . . . 72.4 111.466 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.46 HD13 ' O ' ' A' ' 440' ' ' ALA . 6.9 mp -66.15 -33.96 76.95 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.877 -0.601 . . . . 73.32 110.927 176.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.508 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 56.2 m -70.13 -45.07 67.6 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.251 0.548 . . . . 73.53 109.874 177.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.69 -16.36 64.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.541 -0.754 . . . . 74.01 110.917 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.84 5.67 20.9 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.081 -0.509 . . . . 74.12 111.74 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 100.72 -67.39 0.5 Allowed Glycine 0 CA--C 1.497 -1.088 0 C-N-CA 120.552 -0.832 . . . . 53.33 111.938 175.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -51.54 -59.39 4.31 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.264 0.839 . . . . 71.43 113.264 178.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . 0.508 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 60.76 19.89 55.99 Favored Glycine 0 CA--C 1.505 -0.569 0 CA-C-O 121.25 0.361 . . . . 74.34 113.059 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.498 ' NH2' ' HA ' ' A' ' 481' ' ' THR . 13.6 mtm180 -105.29 111.35 24.06 Favored 'General case' 0 N--CA 1.415 -2.209 0 CA-C-O 121.258 0.552 . . . . 74.01 110.172 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.511 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 15.0 p90 -135.3 145.34 47.4 Favored 'General case' 0 N--CA 1.412 -2.364 0 CA-C-N 114.151 -1.386 . . . . 74.34 109.55 -175.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 26.1 mmtm -136.43 127.24 27.38 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.349 -0.842 . . . . 72.31 108.877 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -90.72 127.26 36.25 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 123.644 0.59 . . . . 74.4 111.369 -174.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -126.85 147.29 50.05 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.905 -1.146 . . . . 75.51 107.905 175.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -122.06 146.5 47.13 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 120.376 -0.53 . . . . 44.55 109.937 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 23.2 t -142.79 137.53 15.21 Favored Pre-proline 0 C--N 1.297 -1.713 0 N-CA-C 107.686 -1.227 . . . . 54.55 107.686 177.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.578 ' HA ' ' O ' ' A' ' 490' ' ' SER . 23.9 Cg_exo -64.92 123.01 10.98 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.738 1.625 . . . . 62.15 110.471 176.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 54.9 m -148.94 -178.31 6.29 Favored 'General case' 0 C--N 1.287 -2.117 0 C-N-CA 124.971 1.308 . . . . 55.42 108.136 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 11.2 t -45.27 134.39 5.58 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 123.727 0.811 . . . . 71.51 112.283 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . 0.463 ' HA ' HG23 ' A' ' 464' ' ' VAL . 9.5 Cg_endo -51.92 -29.21 34.34 Favored 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 124.814 3.676 . . . . 74.45 114.067 -175.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.405 ' O ' ' HD2' ' A' ' 466' ' ' LYS . 11.3 pt-20 -71.77 -19.42 62.02 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 112.055 0.391 . . . . 52.43 112.055 -178.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 72.6 mt -96.09 -2.54 46.4 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 111.601 0.223 . . . . 75.3 111.601 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.463 HG23 ' HA ' ' A' ' 461' ' ' PRO . 87.9 t -60.81 127.39 20.3 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 CA-C-O 120.891 0.377 . . . . 74.52 110.315 178.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 84.7 -10.57 61.86 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.312 -0.858 . . . . 74.05 112.065 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.405 ' HD2' ' O ' ' A' ' 462' ' ' GLU . 50.2 mttp -111.98 166.23 11.41 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 108.182 -1.044 . . . . 73.52 108.182 -176.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.498 ' O ' ' HB ' ' A' ' 434' ' ' THR . 87.2 t -80.41 146.83 7.01 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.294 0 CA-C-N 116.261 -0.427 . . . . 62.53 109.957 -177.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 63.9 mt -98.57 -35.21 4.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 107.439 -1.319 . . . . 42.25 107.439 174.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 156.68 -152.1 23.48 Favored Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 110.166 -1.174 . . . . 64.25 110.166 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 3.6 p -132.15 157.15 45.02 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.547 -0.908 . . . . 73.45 108.547 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -71.82 -46.46 12.17 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 119.728 -0.789 . . . . 75.51 110.625 175.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' ' 473' ' ' PRO . 18.0 Cg_exo -71.15 141.69 40.23 Favored 'Trans proline' 0 C--N 1.374 1.89 0 N-CA-C 107.304 -1.845 . . . . 70.22 107.304 167.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 472' ' ' PRO . 27.9 Cg_exo -62.34 127.54 21.26 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 121.508 1.472 . . . . 43.42 112.063 -177.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -73.99 2.03 9.6 Favored 'General case' 0 C--O 1.201 -1.448 0 C-N-CA 123.646 0.778 . . . . 73.23 112.444 -175.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -110.4 5.4 21.45 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.603 0.716 . . . . 73.22 110.005 175.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -109.12 176.78 4.97 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-N 115.616 -0.72 . . . . 62.33 111.529 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 2.3 p -96.8 145.9 25.41 Favored 'General case' 0 N--CA 1.391 -3.406 0 CA-C-N 114.663 -1.153 . . . . 73.4 110.773 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 49.7 m -137.29 148.06 46.11 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 107.548 -1.279 . . . . 73.3 107.548 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -77.96 159.57 28.74 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 120.715 0.293 . . . . 73.34 110.441 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.61 -18.37 23.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.524 0.678 . . . . 71.33 111.316 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . 0.498 ' HA ' ' NH2' ' A' ' 451' ' ' ARG . 7.7 t -87.28 1.91 51.77 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.943 -0.571 . . . . 45.32 111.065 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -93.05 148.91 21.6 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.045 0.45 . . . . 74.24 110.863 -177.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.9 p -108.6 126.34 65.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.568 -1.271 . . . . 72.31 107.568 172.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 26.9 m -105.33 134.25 47.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 121.903 0.859 . . . . 70.54 111.852 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.87 122.61 44.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 114.968 -1.015 . . . . 74.14 110.288 -178.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.416 HD11 HD21 ' A' ' 444' ' ' LEU . 36.2 mm -97.94 113.13 31.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 107.462 -1.31 . . . . 74.44 107.462 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 9.5 tt -99.08 126.24 52.38 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 108.911 -0.774 . . . . 54.24 108.911 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 27.2 m -111.25 151.92 13.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 123.345 0.658 . . . . 65.11 110.668 -178.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -77.37 132.64 12.25 Favored Glycine 0 N--CA 1.424 -2.136 0 CA-C-N 115.562 -0.744 . . . . 71.42 112.553 -178.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.578 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 31.3 t . . . . . 0 N--CA 1.419 -2.005 0 N-CA-C 104.401 -2.444 . . . . 53.51 104.401 175.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo . . . . . 0 N--CA 1.445 -1.348 0 N-CA-C 110.731 -0.527 . . . . 74.1 110.731 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . -75.14 84.85 2.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.777 0.799 . . . . 63.33 109.305 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 9.7 p -122.5 144.3 49.16 Favored 'General case' 0 N--CA 1.419 -2.014 0 CA-C-N 114.776 -1.102 . . . . 73.15 111.393 -173.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -139.96 149.48 43.33 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.713 -0.847 . . . . 75.44 108.713 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.548 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 6.5 p-10 -90.65 137.35 32.42 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 109.465 -0.568 . . . . 72.05 109.465 177.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 28.0 pt -91.01 110.45 42.22 Favored Pre-proline 0 C--N 1.304 -1.409 0 CA-C-N 115.698 -0.683 . . . . 74.01 109.856 177.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 496' ' ' ASP . 66.0 Cg_endo -90.71 150.4 4.14 Favored 'Trans proline' 0 N--CA 1.441 -1.562 0 C-N-CA 122.292 1.995 . . . . 72.12 111.97 178.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -78.88 91.5 4.78 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 122.517 1.151 . . . . 54.1 109.976 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 15.3 t -104.37 2.91 10.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.336 -1.357 . . . . 64.14 107.336 177.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -53.79 107.56 0.27 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.293 -1.321 . . . . 55.14 112.754 -175.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 177.85 27.85 0.04 OUTLIER Glycine 0 C--N 1.306 -1.117 0 N-CA-C 111.327 -0.709 . . . . 42.44 111.327 176.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.05 -170.85 3.43 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.267 -0.642 . . . . 71.4 109.267 -178.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 532' ' ' GLY . 8.8 t -84.13 157.91 21.55 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 109.076 -0.713 . . . . 55.23 109.076 -176.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.4 p -48.67 -41.77 12.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 124.194 0.997 . . . . 54.2 112.304 -177.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -61.53 -41.54 97.48 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.72 0.295 . . . . 74.24 111.778 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 47.3 t -76.01 -40.74 38.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-O 121.185 0.517 . . . . 74.3 110.602 -176.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.36 -46.88 84.49 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.068 -0.515 . . . . 61.02 110.224 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -61.95 -35.69 79.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.679 -0.691 . . . . 73.15 110.232 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.452 ' O ' HG23 ' A' ' 514' ' ' VAL . 0.3 OUTLIER -60.55 -43.08 97.63 Favored 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 109.016 -0.735 . . . . 75.42 109.016 177.13 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -62.57 -47.29 84.47 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.598 -0.274 . . . . 72.12 111.445 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.84 -40.07 94.03 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.733 0.301 . . . . 72.03 111.135 178.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.31 -38.16 88.37 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.055 -0.52 . . . . 73.1 110.636 178.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 510' ' ' LYS . 70.1 t -65.99 -31.16 52.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 115.886 -0.597 . . . . 74.24 110.746 176.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -78.44 -8.6 58.68 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.725 -0.39 . . . . 71.21 111.572 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . 0.402 ' O ' ' HB ' ' A' ' 547' ' ' VAL . . . 104.73 0.36 42.58 Favored Glycine 0 CA--C 1.504 -0.624 0 C-N-CA 120.859 -0.686 . . . . 70.31 112.557 177.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.472 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 83.8 m-85 -82.1 101.54 10.45 Favored 'General case' 0 CA--C 1.484 -1.595 0 N-CA-C 108.161 -1.051 . . . . 74.32 108.161 -178.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.5 m -100.0 -4.06 30.83 Favored 'General case' 0 N--CA 1.415 -2.205 0 CA-C-N 114.693 -1.139 . . . . 74.12 110.988 -173.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 97.0 mttt -116.61 114.25 23.84 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.589 -0.893 . . . . 65.34 108.589 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -132.16 152.11 51.44 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.483 -0.78 . . . . 74.13 112.451 -175.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 46.4 m -141.04 134.17 29.39 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.49 -1.3 . . . . 65.25 107.49 171.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 0.0 OUTLIER -118.82 138.84 52.43 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 117.907 0.321 . . . . 54.23 110.214 179.631 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -131.77 143.52 50.28 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.348 -1.353 . . . . 70.11 107.348 177.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 14.9 t -121.24 132.61 54.92 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.083 0.468 . . . . 73.34 110.089 -178.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 34.0 t -124.9 149.57 29.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 106.998 -1.482 . . . . 73.34 106.998 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . 0.605 ' HA ' ' HB3' ' A' ' 557' ' ' LYS . 4.1 p30 -66.59 134.69 52.85 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.892 0.853 . . . . 75.25 109.172 178.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 70.8 m -153.14 167.09 14.12 Favored Pre-proline 0 C--N 1.28 -2.442 0 CA-C-N 114.472 -1.24 . . . . 74.54 108.526 -173.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.86 -24.91 45.9 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.655 1.57 . . . . 54.03 113.055 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.98 142.2 79.26 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.595 -0.275 . . . . 74.33 111.183 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.61 151.78 60.41 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 123.263 2.642 . . . . 75.11 113.232 -178.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -62.47 119.66 9.57 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.366 -0.834 . . . . 74.31 111.44 -176.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 504' ' ' THR . . . 118.09 -22.19 9.85 Favored Glycine 0 N--CA 1.425 -2.049 0 C-N-CA 120.403 -0.903 . . . . 65.44 112.351 177.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -80.1 127.59 32.49 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.496 -0.927 . . . . 65.32 108.496 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 57.4 t -75.98 122.95 31.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 109.212 -0.662 . . . . 75.02 109.212 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . 0.683 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 14.0 t -90.05 -14.86 32.96 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.186 -0.461 . . . . 53.33 110.898 -177.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 153.11 -158.01 27.67 Favored Glycine 0 N--CA 1.429 -1.819 0 N-CA-C 111.325 -0.71 . . . . 75.4 111.325 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 20.9 p -128.68 156.8 42.88 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 109.753 -0.462 . . . . 61.51 109.753 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -70.49 -50.39 14.43 Favored Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 116.298 -0.41 . . . . 72.15 110.077 176.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 18.0 Cg_endo -63.11 135.32 50.29 Favored 'Trans proline' 0 C--N 1.371 1.738 0 N-CA-C 108.368 -1.435 . . . . 71.44 108.368 168.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 31.6 Cg_exo -59.44 140.7 95.43 Favored 'Trans proline' 0 C--O 1.249 1.073 0 C-N-CA 122.656 2.237 . . . . 65.53 113.552 -176.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -67.83 134.66 51.3 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.646 -0.872 . . . . 73.04 108.646 176.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 103.82 -6.83 48.57 Favored Glycine 0 C--N 1.298 -1.551 0 C-N-CA 120.817 -0.706 . . . . 60.45 111.346 -176.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 23.6 m -81.57 131.6 35.28 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.891 -0.411 . . . . 74.42 109.891 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 27.9 m -90.33 122.89 33.62 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 108.087 -1.079 . . . . 70.13 108.087 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 13.0 m -134.88 157.72 76.51 Favored Pre-proline 0 C--N 1.309 -1.159 0 C-N-CA 122.659 0.384 . . . . 74.4 110.188 -177.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 22.6 Cg_exo -67.62 139.93 50.16 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.492 2.128 . . . . 74.13 111.746 177.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.472 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 33.2 m -65.87 -20.04 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 122.265 1.031 . . . . 63.03 110.819 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -78.67 -10.05 59.62 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 113.666 -1.606 . . . . 75.3 111.252 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 94.4 p -96.5 172.96 7.6 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 120.631 -0.428 . . . . 61.25 110.868 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 7.1 p -102.65 129.66 53.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-O 120.904 0.383 . . . . 70.24 111.604 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . 0.493 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -106.33 146.12 13.32 Favored 'Isoleucine or valine' 0 C--O 1.247 0.939 0 CA-C-O 121.181 0.515 . . . . 71.13 109.974 177.216 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -107.63 116.18 31.48 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-O 121.56 0.695 . . . . 73.25 110.861 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 51.7 mt -94.09 134.17 36.79 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 125.129 1.372 . . . . 71.32 108.864 -178.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -113.89 118.86 35.37 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 122.088 0.947 . . . . 73.24 110.921 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 524' ' ' SER . 39.7 t -101.26 139.75 21.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 CA-C-N 114.356 -1.293 . . . . 71.22 109.637 -175.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.683 ' OG ' ' HB ' ' A' ' 535' ' ' THR . 50.2 m -79.02 134.61 36.78 Favored 'General case' 0 N--CA 1.418 -2.032 0 CA-C-O 121.792 0.806 . . . . 72.32 111.172 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.605 ' HB3' ' HA ' ' A' ' 526' ' ' ASP . 11.3 tppt? -101.76 126.08 48.55 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 105.112 -2.181 . . . . 61.04 105.112 171.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -71.64 -45.29 45.85 Favored Glycine 0 CA--C 1.484 -1.906 0 C-N-CA 120.187 -1.006 . . . . 71.54 112.238 -172.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 57.1 t30 62.84 25.17 14.95 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-O 122.701 1.239 . . . . 71.01 109.042 177.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.565 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 94.4 mt-30 -129.35 156.96 43.2 Favored 'General case' 0 C--O 1.25 1.114 0 CA-C-N 114.538 -1.21 . . . . 70.43 110.733 -176.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -130.18 144.12 51.18 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.252 -0.885 . . . . 74.24 108.636 176.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 54.3 t -66.17 125.99 24.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 121.128 0.489 . . . . 64.31 112.278 -178.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . 0.454 ' HA ' ' HD3' ' A' ' 564' ' ' PRO . 53.8 ttp -92.08 130.02 39.59 Favored Pre-proline 0 C--O 1.25 1.126 0 CA-C-N 115.501 -0.772 . . . . 62.25 110.853 -178.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 563' ' ' MET . 15.9 Cg_exo -71.85 169.9 20.09 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.087 2.524 . . . . 75.53 111.512 173.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -67.96 142.19 56.06 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 116.179 -0.464 . . . . 62.41 111.295 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.16 16.92 5.58 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.6 0.714 . . . . 62.52 111.266 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 16.9 m -64.37 130.54 44.19 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.427 -0.806 . . . . 42.32 109.74 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . 0.428 ' H ' ' CG1' ' A' ' 603' ' ' VAL . . . 100.15 24.23 9.85 Favored Glycine 0 C--N 1.308 -1.025 0 C-N-CA 120.655 -0.783 . . . . 64.45 112.478 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 90.6 mtp -109.54 144.51 37.73 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.274 -0.639 . . . . 72.41 109.274 177.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . 0.538 ' CD2' ' HB3' ' A' ' 602' ' ' ARG . 80.5 m-85 -101.34 140.08 36.12 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 107.048 -1.464 . . . . 72.51 107.048 -176.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 55.2 t90 -57.96 -28.72 64.6 Favored 'General case' 0 C--O 1.25 1.108 0 CA-C-O 121.139 0.495 . . . . 74.41 111.886 -177.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 35.8 m -73.4 -22.63 19.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.389 0.614 . . . . 74.21 111.196 -177.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . 0.621 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 12.4 t70 -101.53 -35.43 9.16 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.679 -0.691 . . . . 71.14 109.901 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . 0.42 ' O ' HD13 ' A' ' 578' ' ' LEU . . . -57.82 -50.84 71.93 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.193 0.997 . . . . 73.24 112.818 -177.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.508 ' O ' ' HG2' ' A' ' 579' ' ' ARG . 49.5 mt-10 -55.51 -56.22 31.68 Favored Pre-proline 0 N--CA 1.469 0.515 0 N-CA-C 112.9 0.704 . . . . 64.55 112.9 -178.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -53.95 -33.61 73.06 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 121.54 1.494 . . . . 73.25 113.465 176.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.621 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 35.1 mmt180 -63.81 -47.59 80.22 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.894 -0.78 . . . . 63.41 108.894 177.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.42 HD13 ' O ' ' A' ' 574' ' ' ALA . 9.4 mp -66.08 -39.68 90.22 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.0 -1.0 . . . . 72.1 111.308 -177.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 11.6 mmm180 -65.05 -37.14 86.61 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.376 -0.375 . . . . 70.43 110.855 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.93 -30.87 69.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.362 0.601 . . . . 73.12 110.587 178.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 95.4 mt -81.65 -8.16 59.67 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.428 -0.805 . . . . 61.42 111.085 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 70.81 28.63 70.42 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.702 -0.559 . . . . 50.42 111.702 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 73.3 t90 -62.03 127.9 33.57 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 123.224 0.61 . . . . 71.43 110.569 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 12.1 m -128.24 84.5 2.25 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-O 121.24 0.543 . . . . 62.41 109.734 177.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -135.33 -145.21 5.1 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 109.243 -1.543 . . . . 65.12 109.243 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 26.5 ttt -134.77 125.92 27.91 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 117.262 0.531 . . . . 75.14 110.17 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -115.83 123.26 47.74 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 105.629 -1.989 . . . . 52.34 105.629 173.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -107.83 106.45 16.75 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 116.303 -0.408 . . . . 74.03 111.048 -175.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.62 110.14 22.62 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 106.239 -1.763 . . . . 74.54 106.239 174.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -98.92 -87.4 1.91 Allowed Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 109.663 -1.375 . . . . 73.33 109.663 176.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -102.53 133.02 48.19 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 120.763 0.316 . . . . 70.54 110.749 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -83.86 157.38 22.02 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.9 -1.148 . . . . 61.5 107.9 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 46.4 t -117.62 125.25 73.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 119.617 -0.833 . . . . 43.33 111.503 -175.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -81.63 106.66 13.75 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 105.495 -2.039 . . . . 75.21 105.495 172.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -132.69 -6.72 3.21 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 112.171 0.434 . . . . 43.42 112.171 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 82.94 -178.95 53.1 Favored Glycine 0 N--CA 1.418 -2.527 0 C-N-CA 120.79 -0.719 . . . . 22.22 111.565 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -62.92 -33.56 87.46 Favored Glycine 0 C--N 1.303 -1.28 0 CA-C-N 115.575 -0.312 . . . . 73.13 112.769 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 22.6 m -56.57 -33.63 66.34 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.782 0.66 . . . . 60.42 112.782 -176.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -108.23 -14.59 14.67 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 119.897 -0.721 . . . . 72.21 110.162 178.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 39.89 -160.19 0.0 OUTLIER 'General case' 0 CA--C 1.587 2.368 0 C-N-CA 126.095 1.758 . . . . 71.31 113.379 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -87.55 28.33 1.0 Allowed 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.288 -0.882 . . . . 73.22 110.053 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . 0.538 ' HB3' ' CD2' ' A' ' 570' ' ' PHE 0.254 3.1 ppt_? -102.15 168.5 9.33 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.833 -0.747 . . . . 74.45 112.824 -176.335 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . 0.428 ' CG1' ' H ' ' A' ' 568' ' ' GLY . 7.6 p -56.72 134.52 20.88 Favored 'Isoleucine or valine' 0 C--O 1.25 1.094 0 O-C-N 124.55 1.156 . . . . 62.25 112.23 -176.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 10.5 p -101.64 -32.57 3.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 119.581 -0.847 . . . . 63.53 109.018 177.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -154.81 140.47 18.0 Favored 'General case' 0 C--O 1.25 1.08 0 N-CA-C 107.168 -1.419 . . . . 63.22 107.168 174.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -98.23 122.12 41.0 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.745 -0.835 . . . . 72.14 108.745 173.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.4 ' CB ' ' HB ' ' A' ' 621' ' ' THR . 15.0 t-20 -55.08 -56.15 31.27 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 114.313 1.227 . . . . 73.23 114.313 -177.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -84.09 123.0 3.02 Favored 'Trans proline' 0 N--CA 1.438 -1.755 0 CA-C-N 120.643 1.265 . . . . 64.4 109.43 176.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -64.02 144.82 88.68 Favored 'Trans proline' 0 C--O 1.246 0.912 0 C-N-CA 122.159 1.906 . . . . 64.42 111.193 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -62.69 132.33 51.93 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.121 -0.696 . . . . 74.3 109.121 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 100.1 0.67 56.0 Favored Glycine 0 N--CA 1.437 -1.289 0 C-N-CA 119.766 -1.207 . . . . 71.31 111.994 -177.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 14.2 m -100.97 154.68 18.49 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.596 -0.89 . . . . 73.42 108.596 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -80.13 132.85 11.67 Favored Glycine 0 N--CA 1.431 -1.694 0 N-CA-C 112.111 -0.396 . . . . 71.02 112.111 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 34.9 m -114.5 142.48 27.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 109.35 -0.611 . . . . 51.5 109.35 176.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.565 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 23.3 m-20 -57.75 169.6 0.7 Allowed 'General case' 0 CA--C 1.492 -1.255 0 C-N-CA 124.235 1.014 . . . . 72.53 111.803 -177.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -60.74 -24.6 65.85 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 113.774 -1.557 . . . . 73.04 110.22 172.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -77.07 -35.58 56.53 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 119.831 -0.748 . . . . 72.32 110.058 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 81.02 22.71 60.64 Favored Glycine 0 N--CA 1.426 -2.024 0 C-N-CA 118.484 -1.817 . . . . 74.12 113.409 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.73 119.66 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 122.489 1.138 . . . . 63.0 108.876 -174.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.72 132.93 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 N-CA-C 107.281 -1.377 . . . . 52.04 107.281 -173.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.4 ' HB ' ' CB ' ' A' ' 607' ' ' ASN . 19.0 m -111.09 134.95 52.29 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 121.786 -0.571 . . . . 72.33 111.095 -177.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 84.3 mt -137.54 154.1 49.88 Favored 'General case' 0 CA--C 1.497 -1.087 0 C-N-CA 125.106 1.363 . . . . 62.23 107.775 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 51.0 mmm-85 -128.22 137.36 51.99 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 104.431 -2.433 . . . . 72.3 104.431 169.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -141.87 165.49 27.32 Favored 'General case' 0 C--N 1.28 -2.423 0 O-C-N 124.263 0.977 . . . . 74.43 109.627 -174.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -97.02 -134.62 8.25 Favored Glycine 0 N--CA 1.417 -2.598 0 C-N-CA 120.464 -0.874 . . . . 73.21 112.034 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 . . . . . 0 C--N 1.295 -1.767 0 C-N-CA 123.991 0.916 . . . . 63.22 109.381 -177.629 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 . . . . . 0 CA--C 1.506 -0.731 0 N-CA-C 109.421 -0.585 . . . . 75.22 109.421 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.2 m -116.84 159.05 17.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 108.756 -0.831 . . . . 62.22 108.756 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -95.46 136.14 36.21 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 103.697 -2.705 . . . . 70.12 103.697 177.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.408 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 94.0 t -95.46 127.85 40.45 Favored Pre-proline 0 C--N 1.28 -2.443 0 C-N-CA 119.89 -0.724 . . . . 43.41 112.415 -163.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 13.4 Cg_exo -67.56 113.35 2.9 Favored 'Trans proline' 0 N--CA 1.441 -1.597 0 C-N-CA 122.529 2.153 . . . . 62.24 110.306 174.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . 0.505 ' HB2' HG21 ' A' ' 402' ' ' THR . 19.9 p-10 -101.3 111.94 24.31 Favored 'General case' 0 C--N 1.262 -3.196 0 CA-C-N 113.959 -1.473 . . . . 62.42 110.819 -176.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.707 ' HB ' ' NE2' ' A' ' 368' ' ' GLN . 7.0 m -85.73 37.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 114.132 -1.394 . . . . 61.45 113.598 -176.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.513 ' H ' ' HD2' ' A' ' 366' ' ' ARG . 0.0 OUTLIER -65.38 146.79 54.46 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.337 -0.847 . . . . 63.23 110.601 172.38 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.35 -4.53 44.18 Favored Glycine 0 C--N 1.304 -1.249 0 N-CA-C 110.781 -0.927 . . . . 53.32 110.781 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . 0.707 ' NE2' ' HB ' ' A' ' 365' ' ' VAL . 16.4 mt-30 -109.19 -156.8 0.59 Allowed 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 107.658 -1.238 . . . . 64.12 107.658 177.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 60.4 p -99.1 167.15 10.89 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 109.087 -0.708 . . . . 74.5 109.087 -177.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 18.2 p -57.87 -46.67 84.5 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 123.438 0.461 . . . . 72.32 110.63 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.31 -41.9 89.03 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.756 -0.656 . . . . 43.04 112.327 -177.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -69.3 -42.58 75.23 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 121.504 0.669 . . . . 73.44 109.307 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.77 -47.61 74.6 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.381 -0.827 . . . . 63.43 111.577 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 65.6 mt -62.77 -39.99 86.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 65.22 110.836 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.09 -43.86 91.87 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.125 0.488 . . . . 54.44 110.558 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 18.1 m -63.73 -47.22 81.95 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.59 -0.732 . . . . 75.02 109.963 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 98.4 mt -61.91 -41.78 98.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.833 -0.621 . . . . 64.35 110.824 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -63.83 -41.16 97.91 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.896 -0.593 . . . . 42.41 110.51 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -63.12 -27.14 69.18 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 120.907 0.384 . . . . 75.03 111.412 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -90.79 -7.68 51.72 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 112.304 0.483 . . . . 75.31 112.304 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 95.23 7.99 59.1 Favored Glycine 0 C--N 1.307 -1.071 0 C-N-CA 120.856 -0.688 . . . . 61.31 113.055 177.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.448 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 75.0 m-85 -80.13 145.11 32.54 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-O 121.18 0.514 . . . . 74.3 111.385 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -92.07 143.41 26.49 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.603 -1.258 . . . . 62.25 107.603 -178.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . 0.461 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -125.82 154.75 35.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 121.274 0.559 . . . . 63.03 111.267 -178.781 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -136.35 135.2 38.64 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 107.507 -1.294 . . . . 72.13 107.507 174.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 26.4 m -103.06 120.9 41.5 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 108.279 -1.008 . . . . 72.51 108.279 178.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -111.46 119.68 39.62 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 106.786 -1.561 . . . . 73.14 106.786 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.522 HE21 ' N ' ' A' ' 388' ' ' GLN . 0.0 OUTLIER -102.61 131.87 49.09 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.56 0.695 . . . . 73.32 111.851 -177.218 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . 0.674 ' O ' ' HA ' ' A' ' 421' ' ' SER . 99.1 mttt -128.93 150.34 74.93 Favored Pre-proline 0 C--N 1.293 -1.855 0 N-CA-C 106.703 -1.591 . . . . 70.24 106.703 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -71.84 166.29 29.98 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 121.489 1.459 . . . . 75.13 110.558 176.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -76.35 87.4 3.14 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-O 121.848 0.833 . . . . 75.44 110.526 176.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . 0.45 ' O ' ' HB ' ' A' ' 393' ' ' THR . 19.6 m -112.38 42.5 1.8 Allowed 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 106.735 -1.579 . . . . 74.41 106.735 173.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 392' ' ' SER . 99.6 m 70.88 29.32 3.1 Favored 'General case' 0 CA--C 1.573 1.861 0 CA-C-O 123.58 1.657 . . . . 33.02 109.551 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 1.7 pt -116.43 151.25 46.73 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 113.6 0.963 . . . . 73.23 113.6 -176.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -24.46 110.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.366 1.498 1 C-N-CA 126.584 4.856 . . . . 73.45 118.258 -175.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -68.45 162.3 41.28 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.262 3.308 . . . . 74.41 110.651 172.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . 0.46 ' HB3' HG23 ' A' ' 420' ' ' VAL . 0.6 OUTLIER -57.21 -13.88 3.6 Favored 'General case' 0 N--CA 1.507 2.396 0 CA-C-O 121.098 0.475 . . . . 74.11 111.882 -176.301 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -84.01 111.04 18.92 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 105.295 -2.113 . . . . 75.14 105.295 178.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.418 HG23 ' HA ' ' A' ' 366' ' ' ARG . 28.0 m -63.0 118.02 4.61 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 O-C-N 124.602 1.189 . . . . 72.33 112.335 -166.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . 0.404 HD13 ' O ' ' A' ' 400' ' ' ILE . 0.0 OUTLIER -106.04 -28.59 2.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 114.84 -1.073 . . . . 64.41 109.727 -176.501 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -144.77 165.46 27.62 Favored Glycine 0 N--CA 1.428 -1.858 0 N-CA-C 110.289 -1.124 . . . . 73.13 110.289 -175.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . 0.505 HG21 ' HB2' ' A' ' 364' ' ' ASP . 9.1 p -118.03 -178.85 3.6 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 113.341 0.867 . . . . 75.11 113.341 -173.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -102.32 140.42 21.12 Favored Pre-proline 0 N--CA 1.437 -1.117 0 N-CA-C 106.607 -1.627 . . . . 73.35 106.607 176.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -55.77 -24.63 47.52 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.314 2.676 . . . . 75.13 114.131 -176.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -62.38 -35.02 77.87 Favored 'General case' 0 C--O 1.209 -1.051 0 CA-C-N 116.543 -0.299 . . . . 72.43 111.368 -177.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -77.92 -35.75 50.21 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.492 0.663 . . . . 63.44 110.928 -178.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -82.02 -10.92 59.08 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.911 -0.586 . . . . 74.41 111.711 -175.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 25.0 m -103.35 160.28 14.83 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 106.428 -1.693 . . . . 72.52 106.428 177.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 5.9 p -76.68 113.0 13.84 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 118.322 0.51 . . . . 72.11 110.744 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 33.4 m -130.76 166.85 27.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.443 -0.577 . . . . 61.14 109.443 177.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 56.3 m -70.07 139.4 52.58 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.819 -0.808 . . . . 65.14 108.819 175.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . 0.448 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -61.7 109.79 1.32 Allowed 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 120.92 0.391 . . . . 62.21 110.5 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 128.72 38.84 0.34 Allowed Glycine 0 N--CA 1.441 -1.003 0 CA-C-N 115.525 -0.761 . . . . 53.54 112.055 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -97.33 -171.7 2.26 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 108.028 -1.101 . . . . 64.35 108.028 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -111.86 124.78 53.1 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 122.771 0.429 . . . . 60.41 111.387 -173.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 46.7 mm -119.24 117.59 54.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 120.756 0.312 . . . . 73.23 110.17 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 13.5 t -89.86 131.03 36.0 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-O 121.348 0.594 . . . . 71.44 109.679 176.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 10.8 p -105.25 135.71 42.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 C-N-CA 124.105 0.962 . . . . 62.3 108.932 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.37 128.19 42.02 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 120.822 -0.351 . . . . 75.21 110.607 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.46 HG23 ' HB3' ' A' ' 397' ' ' ASP . 3.4 p -128.04 131.33 69.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 115.877 -0.601 . . . . 73.45 109.787 173.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . 0.674 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 3.0 p -94.72 122.77 37.67 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-O 121.051 0.453 . . . . 62.05 109.929 174.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.8 t -119.24 106.62 12.51 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-O 121.41 0.624 . . . . 73.01 111.86 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.188 0 CA-C-N 115.572 -0.74 . . . . 74.41 114.136 174.9 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.479 ' HG3' ' HB ' ' A' ' 477' ' ' THR . 16.3 tp60 . . . . . 0 N--CA 1.41 -2.468 0 N-CA-C 105.572 -2.01 . . . . 70.34 105.572 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.592 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 2.9 mmp_? -122.25 140.89 52.08 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.888 -0.725 . . . . 72.12 111.678 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.422 ' O ' ' HD3' ' A' ' 430' ' ' PRO . 9.5 pt-20 -83.74 139.06 32.97 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 114.393 -1.276 . . . . 71.23 110.186 -177.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 57.9 mt -98.41 112.61 62.71 Favored Pre-proline 0 N--CA 1.418 -2.068 0 N-CA-C 106.81 -1.552 . . . . 75.32 106.81 174.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 428' ' ' GLU . 16.3 Cg_exo -73.07 141.07 32.22 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 N-CA-C 107.885 -1.621 . . . . 72.22 107.885 165.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -84.43 132.71 34.54 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 118.205 -1.398 . . . . 34.24 108.833 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 59.4 t -105.7 151.7 7.73 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 N-CA-C 105.968 -1.864 . . . . 73.41 105.968 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 39.2 m -57.08 141.21 46.78 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.213 0.53 . . . . 72.1 111.138 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 36.5 p -64.26 -26.71 68.62 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 114.102 1.149 . . . . 44.14 114.102 -172.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.5 pp -82.93 -15.84 49.76 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 119.841 -0.744 . . . . 73.21 110.92 176.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.81 40.04 1.15 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.284 1.034 . . . . 73.01 109.362 -177.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -52.0 -38.76 57.93 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.522 1.129 . . . . 75.23 112.592 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -60.99 -41.8 97.15 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.037 0.446 . . . . 70.25 110.573 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -70.64 -35.97 73.19 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.963 -0.562 . . . . 61.25 109.602 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.514 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.47 -51.51 69.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.981 -0.554 . . . . 44.44 110.992 -178.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 36.0 m -63.08 -40.89 90.78 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 N-CA-C 112.279 0.474 . . . . 72.31 112.279 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . 0.267 0.1 OUTLIER -68.63 -34.54 75.91 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 113.338 0.866 . . . . 73.33 113.338 177.729 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -64.52 -41.03 96.64 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.284 -1.006 . . . . 75.52 108.284 179.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.514 HD13 ' O ' ' A' ' 440' ' ' ALA . 7.0 mp -63.49 -32.92 74.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.507 -0.77 . . . . 61.25 110.92 176.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.409 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 61.5 m -69.42 -43.02 74.25 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 116.067 -0.515 . . . . 74.03 110.354 177.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.44 -26.01 66.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.638 -0.71 . . . . 75.13 111.209 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.65 -6.15 56.55 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.072 0.463 . . . . 73.52 111.834 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 121.33 -77.1 0.33 Allowed Glycine 0 CA--C 1.495 -1.194 0 C-N-CA 120.314 -0.946 . . . . 60.23 112.227 176.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . 0.43 ' HA ' ' O ' ' A' ' 480' ' ' ILE . 0.5 OUTLIER -40.13 -68.51 0.17 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.134 1.161 . . . . 74.4 114.134 176.738 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . 0.409 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 58.93 25.68 59.7 Favored Glycine 0 C--N 1.318 -0.458 0 C-N-CA 121.589 -0.338 . . . . 34.41 112.645 -177.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.492 ' CB ' ' HA ' ' A' ' 483' ' ' VAL . 52.6 mmt-85 -101.82 111.82 24.22 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 107.258 -1.386 . . . . 73.12 107.258 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -139.14 145.77 39.81 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-O 120.973 0.416 . . . . 74.11 111.175 -176.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -131.47 123.42 28.04 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.046 -1.094 . . . . 55.43 108.046 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -99.3 121.46 41.11 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.98 0.419 . . . . 75.31 110.755 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -116.97 154.47 30.83 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.254 -1.017 . . . . 72.05 108.254 177.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -130.55 141.94 50.47 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.3 -0.63 . . . . 64.2 109.3 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 50.3 m -145.44 149.86 42.27 Favored Pre-proline 0 C--N 1.291 -1.938 0 N-CA-C 109.494 -0.558 . . . . 64.14 109.494 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.686 ' HA ' ' O ' ' A' ' 490' ' ' SER . 36.8 Cg_endo -67.49 127.38 16.35 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.321 2.014 . . . . 74.44 110.651 177.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 50.6 m -147.22 179.51 7.58 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.974 -0.38 . . . . 73.32 109.974 -177.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.8 t -54.31 135.97 60.44 Favored Pre-proline 0 N--CA 1.437 -1.079 0 C-N-CA 123.958 0.903 . . . . 61.14 110.315 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.16 -30.41 32.27 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 124.461 3.441 . . . . 63.14 115.192 -172.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -73.12 -27.83 61.91 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.829 -0.748 . . . . 71.44 112.546 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 83.5 mt -89.23 -11.86 42.44 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.217 0.532 . . . . 72.42 110.252 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.425 HG13 ' HA ' ' A' ' 490' ' ' SER . 70.6 t -60.61 128.76 22.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.447 -0.797 . . . . 74.44 110.457 177.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 96.22 -13.63 65.54 Favored Glycine 0 N--CA 1.432 -1.633 0 CA-C-N 115.058 -0.974 . . . . 73.52 111.553 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -117.27 166.65 12.02 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 109.201 -0.666 . . . . 75.23 109.201 -176.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.476 ' O ' ' HB ' ' A' ' 434' ' ' THR . 72.0 t -70.68 147.22 11.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 N-CA-C 107.993 -1.114 . . . . 75.44 107.993 173.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 64.3 mt -97.74 -35.88 5.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 107.008 -1.479 . . . . 53.13 107.008 176.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 169.3 -178.84 42.25 Favored Glycine 0 N--CA 1.416 -2.64 0 N-CA-C 109.789 -1.324 . . . . 62.43 109.789 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . 0.555 HG22 HG12 ' A' ' 486' ' ' ILE . 41.4 p -115.65 137.95 51.56 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 107.262 -1.384 . . . . 73.41 107.262 178.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.496 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 0.2 OUTLIER -62.85 -47.43 87.15 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 120.726 -0.389 . . . . 63.01 110.058 -179.494 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.496 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 12.9 Cg_exo -77.05 132.77 13.03 Favored 'Trans proline' 0 C--N 1.365 1.438 0 N-CA-C 106.852 -2.019 . . . . 63.52 106.852 167.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.88 127.04 20.29 Favored 'Trans proline' 0 C--O 1.239 0.564 0 C-N-CA 121.902 1.735 . . . . 65.14 112.739 -174.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -85.24 16.78 3.38 Favored 'General case' 0 C--O 1.203 -1.35 0 CA-C-N 114.949 -1.023 . . . . 74.43 110.89 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -112.27 -6.09 14.11 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.771 -0.65 . . . . 74.21 110.089 173.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -111.62 -175.29 2.66 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 115.598 -0.728 . . . . 71.11 110.96 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.479 ' HB ' ' HG3' ' A' ' 426' ' ' GLN . 0.6 OUTLIER -90.89 148.82 22.21 Favored 'General case' 0 N--CA 1.404 -2.774 0 CA-C-N 115.32 -0.854 . . . . 55.15 111.45 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 27.1 t -133.65 149.67 51.56 Favored 'General case' 0 C--O 1.26 1.658 0 N-CA-C 108.683 -0.858 . . . . 62.25 108.683 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -79.63 157.46 27.28 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.139 -0.482 . . . . 60.44 109.739 178.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 449' ' ' PHE . 37.6 mm -71.07 -21.03 21.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.877 0.846 . . . . 72.24 109.919 -176.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 17.4 p -100.02 5.92 45.08 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.786 -0.643 . . . . 72.33 112.045 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . 0.401 ' O ' ' HB2' ' A' ' 451' ' ' ARG . 54.4 t-20 -87.76 128.93 35.32 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.348 -0.612 . . . . 74.42 109.348 -176.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.492 ' HA ' ' CB ' ' A' ' 451' ' ' ARG . 40.0 t -96.81 113.47 31.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.318 -0.993 . . . . 74.34 108.318 177.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 21.2 m -91.37 129.04 42.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 121.479 0.656 . . . . 72.02 111.378 -177.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -94.27 125.43 46.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-O 121.537 0.684 . . . . 74.2 109.259 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.555 HG12 HG22 ' A' ' 470' ' ' THR . 6.0 mt -115.2 124.37 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 CA-C-N 114.658 -1.156 . . . . 73.02 109.566 -176.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 10.8 tt -104.75 126.82 59.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-O 121.021 0.439 . . . . 64.24 110.386 -176.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 32.9 m -108.22 151.77 10.27 Favored 'Isoleucine or valine' 0 C--O 1.252 1.232 0 CA-C-N 115.878 -0.601 . . . . 64.43 110.221 178.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.7 136.2 13.86 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 110.746 -0.942 . . . . 73.23 110.746 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.686 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 12.5 t . . . . . 0 C--N 1.297 -1.682 0 N-CA-C 109.041 -0.726 . . . . 74.32 109.041 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo . . . . . 0 N--CA 1.439 -1.704 0 N-CA-C 110.54 -0.6 . . . . 71.35 110.54 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . -101.09 23.95 10.09 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 122.465 1.126 . . . . 72.52 109.649 -178.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.458 ' HB ' ' OG1' ' A' ' 544' ' ' THR . 9.9 p -120.43 143.42 48.49 Favored 'General case' 0 C--N 1.273 -2.726 0 CA-C-N 113.695 -1.593 . . . . 72.04 110.267 -177.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -138.58 151.68 47.5 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.002 -1.111 . . . . 72.21 108.002 177.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.591 ' OD1' ' HB ' ' A' ' 544' ' ' THR . 69.0 m-20 -80.62 126.42 31.24 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.538 -1.282 . . . . 74.52 107.538 176.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 28.4 pt -76.06 126.54 86.66 Favored Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 123.381 0.425 . . . . 74.3 111.957 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -92.51 156.78 2.99 Favored 'Trans proline' 0 N--CA 1.445 -1.363 0 C-N-CA 122.674 2.249 . . . . 71.51 110.454 173.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -79.32 109.61 13.83 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 122.301 1.048 . . . . 61.03 109.972 178.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.2 p -95.05 17.08 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 122.871 1.32 . . . . 64.22 108.08 178.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -81.74 72.26 8.79 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 114.319 -1.309 . . . . 71.33 110.949 -177.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . -158.17 10.04 0.21 Allowed Glycine 0 C--N 1.291 -1.935 0 CA-C-N 114.793 -1.094 . . . . 42.22 110.71 177.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -139.92 176.44 8.75 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 106.378 -1.712 . . . . 73.01 106.378 -173.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 30.2 p -83.01 159.98 22.08 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 109.405 -0.591 . . . . 72.14 109.405 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.7 p -50.54 -41.11 19.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 123.84 0.856 . . . . 74.41 112.47 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -63.68 -42.41 98.03 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.344 0.593 . . . . 63.2 111.089 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 61.6 t -75.9 -38.62 36.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.806 -0.634 . . . . 71.5 110.105 -177.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.18 -48.56 77.86 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.105 -0.498 . . . . 52.35 111.442 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -61.95 -38.56 88.96 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.234 0.334 . . . . 60.35 110.541 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.487 ' O ' HG23 ' A' ' 514' ' ' VAL . 6.3 tmtm? -59.2 -48.96 79.66 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.937 -0.764 . . . . 65.31 108.937 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -62.65 -42.26 99.51 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 116.274 -0.421 . . . . 62.3 111.346 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 97.4 mt -65.26 -40.65 94.23 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.335 -0.393 . . . . 75.43 111.494 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -61.78 -37.98 86.37 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.951 -0.388 . . . . 62.02 109.951 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 510' ' ' LYS . 73.2 t -61.97 -35.75 70.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 115.633 -0.712 . . . . 54.23 110.83 176.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -78.92 -8.1 58.57 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 112.101 0.408 . . . . 73.02 112.101 -178.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 112.47 -13.44 25.48 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.439 -0.886 . . . . 74.34 112.381 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -81.43 95.75 7.16 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 106.905 -1.517 . . . . 73.22 106.905 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.8 m -98.17 -3.6 37.3 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 119.695 -0.802 . . . . 72.11 111.497 -172.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -120.54 114.56 21.92 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.457 -0.572 . . . . 71.33 109.457 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -131.35 150.76 52.02 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.903 -0.59 . . . . 71.2 110.775 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 49.7 m -127.94 143.23 51.09 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 107.445 -1.317 . . . . 73.31 107.445 174.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.31 125.6 51.34 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-O 120.906 0.384 . . . . 63.42 111.641 -178.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 554' ' ' GLN . . . -116.31 117.17 29.25 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.617 -0.883 . . . . 65.01 108.617 178.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 19.5 m -94.92 131.63 40.63 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.089 0.471 . . . . 71.23 112.144 -176.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 28.6 m -121.29 153.29 24.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 107.703 -1.221 . . . . 71.01 107.703 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -84.83 139.33 31.99 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.77 -0.772 . . . . 74.24 111.626 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 64.9 p -162.27 156.71 18.81 Favored Pre-proline 0 C--O 1.19 -2.066 0 N-CA-C 106.549 -1.649 . . . . 70.13 106.549 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -61.07 -12.89 24.82 Favored 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 122.005 1.803 . . . . 74.02 113.383 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -70.59 130.86 88.45 Favored Pre-proline 0 N--CA 1.45 -0.443 0 N-CA-C 108.52 -0.918 . . . . 74.4 108.52 178.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.3 147.26 78.07 Favored 'Trans proline' 0 C--O 1.253 1.25 0 C-N-CA 122.761 2.307 . . . . 74.41 113.301 -177.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.659 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -59.15 127.85 34.22 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.896 -1.047 . . . . 73.03 111.367 -175.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 119.43 -19.15 9.96 Favored Glycine 0 C--N 1.3 -1.424 0 N-CA-C 111.16 -0.776 . . . . 64.3 111.16 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -72.54 132.45 43.83 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.227 -0.657 . . . . 74.24 109.227 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 59.6 t -89.42 113.96 26.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 108.664 -0.865 . . . . 72.24 108.664 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . 0.444 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 11.4 t -86.96 -20.49 27.22 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.695 -0.402 . . . . 72.31 111.173 -176.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 169.92 -163.4 36.82 Favored Glycine 0 CA--C 1.494 -1.239 0 C-N-CA 120.412 -0.899 . . . . 75.34 111.29 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 46.0 p -129.45 154.8 46.61 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.181 -1.414 . . . . 75.42 107.181 176.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -68.53 -54.2 14.78 Favored Pre-proline 0 C--N 1.309 -1.153 0 C-N-CA 119.959 -0.697 . . . . 63.32 110.446 177.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.32 136.91 29.94 Favored 'Trans proline' 0 C--N 1.371 1.74 0 CA-C-N 119.887 0.996 . . . . 62.51 110.009 175.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.1 145.08 65.85 Favored 'Trans proline' 0 C--O 1.254 1.284 0 C-N-CA 122.692 2.262 . . . . 74.44 113.186 -178.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.94 141.72 57.86 Favored 'General case' 0 C--O 1.247 0.952 0 CA-C-N 115.804 -0.634 . . . . 74.52 110.5 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 99.32 -12.03 61.75 Favored Glycine 0 N--CA 1.432 -1.604 0 CA-C-N 115.695 -0.684 . . . . 72.33 111.428 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 49.8 m -77.28 132.7 38.79 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 108.875 -0.787 . . . . 52.11 108.875 177.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.591 ' HB ' ' OD1' ' A' ' 496' ' ' ASP . 10.0 t -87.69 124.05 33.16 Favored 'General case' 0 N--CA 1.419 -2.006 0 CA-C-O 121.304 0.573 . . . . 72.35 109.699 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 19.6 m -125.88 154.89 73.59 Favored Pre-proline 0 C--N 1.297 -1.697 0 N-CA-C 108.15 -1.056 . . . . 73.31 108.15 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 13.1 Cg_exo -71.82 136.22 27.28 Favored 'Trans proline' 0 N--CA 1.443 -1.472 0 C-N-CA 121.842 1.694 . . . . 75.32 110.168 175.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 32.6 m -64.96 -19.89 26.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.941 0.877 . . . . 75.22 110.512 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -76.12 -14.86 60.17 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.247 -1.342 . . . . 71.13 111.027 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 67.4 m -94.51 -171.93 2.63 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.215 -0.448 . . . . 73.12 111.92 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 18.1 t -116.02 126.61 73.59 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 CA-C-N 116.262 -0.426 . . . . 63.34 110.325 -174.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . 0.51 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -102.49 145.91 11.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.556 -0.535 . . . . 63.15 109.556 175.697 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -108.82 121.46 45.11 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-O 121.406 0.622 . . . . 75.12 111.085 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 59.4 mt -97.99 134.5 41.02 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.389 -1.278 . . . . 74.12 108.315 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 523' ' ' ALA . 2.0 pt20 -106.33 119.5 39.41 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-O 122.158 0.98 . . . . 73.3 109.847 177.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 524' ' ' SER . 57.2 t -105.82 145.5 13.77 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 CA-C-N 113.898 -1.501 . . . . 75.42 109.977 -171.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.659 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 63.3 m -83.41 133.65 34.92 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-O 121.602 0.715 . . . . 55.45 111.613 178.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.77 137.35 42.71 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 104.829 -2.285 . . . . 75.22 104.829 169.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . 0.481 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -75.87 -47.82 11.07 Favored Glycine 0 N--CA 1.433 -1.524 0 C-N-CA 118.42 -1.847 . . . . 54.2 110.763 -175.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 5.7 t30 61.24 -7.51 0.09 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 113.458 0.91 . . . . 71.51 113.458 175.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.481 ' H ' ' C ' ' A' ' 558' ' ' GLY . 25.4 tp60 -139.32 141.23 37.7 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 103.354 -2.832 . . . . 64.43 103.354 -177.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -141.82 153.26 44.39 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 118.653 0.66 . . . . 72.24 111.067 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 70.2 t -69.58 118.19 13.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 N-CA-C 108.764 -0.828 . . . . 75.41 108.764 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 58.8 ttp -88.87 134.36 33.78 Favored Pre-proline 0 C--N 1.304 -1.395 0 C-N-CA 120.376 -0.529 . . . . 52.24 110.392 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -66.03 161.92 37.72 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.518 2.146 . . . . 75.23 109.92 171.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -80.89 132.68 35.46 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.147 -0.621 . . . . 75.11 111.793 -177.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . 0.466 HD12 ' SD ' ' A' ' 569' ' ' MET . 39.7 tp -138.16 19.28 2.79 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.326 -1.361 . . . . 71.22 107.326 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 11.9 m -73.72 131.37 41.53 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.25 -0.886 . . . . 43.34 110.707 -173.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . 0.462 ' H ' ' HB ' ' A' ' 603' ' ' VAL . . . 71.56 9.87 69.95 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 114.397 0.519 . . . . 52.54 114.397 176.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . 0.466 ' SD ' HD12 ' A' ' 566' ' ' LEU . 86.7 mtp -90.73 153.63 20.13 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.197 -0.668 . . . . 73.54 109.197 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 98.8 m-85 -73.24 140.28 46.78 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 120.721 0.296 . . . . 75.31 110.757 -175.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . 0.409 ' HA ' ' HB3' ' A' ' 574' ' ' ALA . 32.1 t90 -66.01 -17.89 64.98 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 123.859 0.864 . . . . 74.0 110.335 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 35.3 m -78.05 -24.2 13.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.244 0.545 . . . . 64.44 109.96 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . 0.644 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 31.4 t70 -101.43 -28.26 12.68 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.341 -0.845 . . . . 73.23 109.637 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . 0.409 ' HB3' ' HA ' ' A' ' 571' ' ' TRP . . . -65.92 -32.37 73.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.86 -0.609 . . . . 52.04 110.851 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.54 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 12.9 tp10 -57.79 -53.29 67.24 Favored Pre-proline 0 CA--C 1.583 2.235 0 CA-C-N 115.879 -0.6 . . . . 73.23 111.136 177.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 573' ' ' ASP . 50.6 Cg_exo -59.56 -36.64 92.29 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 121.32 1.346 . . . . 71.31 112.699 171.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.644 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 22.8 mmt180 -59.8 -44.66 93.85 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 120.75 0.309 . . . . 65.2 110.677 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.4 pp -65.44 -40.43 93.27 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.024 -0.535 . . . . 74.01 112.247 -175.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . 0.452 ' N ' HD12 ' A' ' 578' ' ' LEU . 73.6 mtp180 -65.72 -35.39 80.61 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.148 0.499 . . . . 73.04 110.951 176.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.33 -39.11 74.93 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.001 -0.545 . . . . 74.43 111.192 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 89.0 mt -83.03 -7.27 59.68 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.385 0.513 . . . . 74.35 112.385 -177.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 74.28 39.52 43.49 Favored Glycine 0 C--O 1.241 0.585 0 C-N-CA 120.638 -0.791 . . . . 72.24 111.533 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 33.2 t90 -67.72 127.16 31.73 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 109.579 -0.526 . . . . 65.43 109.579 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 3.7 m -116.76 10.3 14.21 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.466 -0.938 . . . . 64.12 108.466 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -77.69 177.4 53.0 Favored Glycine 0 N--CA 1.431 -1.67 0 CA-C-N 115.354 -0.839 . . . . 74.5 113.51 -173.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 52.4 tpp -104.24 140.3 38.04 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 109.235 -0.654 . . . . 72.43 109.235 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -80.58 130.23 35.0 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.071 -1.826 . . . . 74.44 106.071 176.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -95.04 102.07 13.86 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.486 0.66 . . . . 73.24 110.592 -176.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -88.38 110.17 20.58 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.914 -1.039 . . . . 74.52 109.228 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . 0.435 ' HA3' ' NH2' ' A' ' 623' ' ' ARG . . . -114.22 -86.73 1.46 Allowed Glycine 0 N--CA 1.43 -1.706 0 N-CA-C 109.7 -1.36 . . . . 54.02 109.7 176.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.19 147.99 42.54 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.21 -1.034 . . . . 63.35 108.21 176.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -90.74 141.39 28.85 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.214 -1.032 . . . . 64.35 108.214 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 60.8 t -107.43 121.7 60.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 110.575 -0.157 . . . . 63.35 110.575 -173.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -86.55 107.5 18.15 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.165 -1.014 . . . . 42.15 108.577 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -150.03 22.67 0.86 Allowed 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.974 -0.75 . . . . 61.43 108.974 -177.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 92.06 82.35 1.46 Allowed Glycine 0 N--CA 1.424 -2.147 0 N-CA-C 109.385 -1.486 . . . . 41.42 109.385 -176.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.18 -43.85 88.9 Favored Glycine 0 C--O 1.208 -1.49 0 O-C-N 123.93 0.429 . . . . 72.2 112.645 -175.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 25.5 m -59.23 -28.72 66.94 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 113.377 0.88 . . . . 73.04 113.377 -178.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -106.85 -12.59 15.45 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.367 0.603 . . . . 62.23 111.456 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . 0.5 ' C ' ' H ' ' A' ' 602' ' ' ARG . 35.6 m80 -130.62 22.22 5.07 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 113.49 0.922 . . . . 65.15 113.49 -173.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -77.41 37.57 0.22 Allowed 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 122.429 1.109 . . . . 54.31 109.761 175.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 12.1 ptt180 -125.44 166.53 16.44 Favored 'General case' 0 N--CA 1.412 -2.368 0 C-N-CA 125.703 1.601 . . . . 74.34 108.305 -176.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . 0.462 ' HB ' ' H ' ' A' ' 568' ' ' GLY . 55.6 t -63.46 129.84 27.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.458 -0.941 . . . . 75.34 108.458 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 35.3 m -94.66 -45.02 13.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 119.999 -0.681 . . . . 72.44 110.464 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -131.02 146.59 52.44 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 106.062 -1.829 . . . . 73.24 106.062 174.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . 0.41 ' OE1' ' HD2' ' A' ' 608' ' ' PRO . 0.1 OUTLIER -120.51 129.33 53.78 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 107.331 -1.359 . . . . 70.25 107.331 -175.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.548 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 30.5 t30 -84.9 -71.76 0.1 Allowed Pre-proline 0 CA--C 1.563 1.465 0 N-CA-C 114.687 1.366 . . . . 64.1 114.687 -173.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 6.1 Cg_exo -76.14 114.77 3.98 Favored 'Trans proline' 0 C--N 1.372 1.775 0 CA-C-N 122.05 1.768 . . . . 51.02 109.547 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -63.29 135.57 50.98 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 122.476 2.117 . . . . 55.14 114.205 -171.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.84 138.69 56.3 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.041 -0.981 . . . . 63.43 109.379 177.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 94.45 -19.54 53.02 Favored Glycine 0 C--N 1.302 -1.319 0 N-CA-C 110.662 -0.975 . . . . 63.41 110.662 -176.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 28.9 m -98.58 162.75 12.97 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 107.878 -1.156 . . . . 72.03 107.878 178.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -74.39 116.47 5.2 Favored Glycine 0 N--CA 1.424 -2.137 0 CA-C-O 121.43 0.461 . . . . 55.14 112.462 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 20.5 m -104.94 144.48 14.68 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 107.194 -1.409 . . . . 64.3 107.194 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.517 HD21 HG22 ' A' ' 619' ' ' ILE . 28.4 p30 -48.43 148.59 1.9 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 112.513 0.561 . . . . 70.24 112.513 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -55.38 -24.42 29.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.598 -0.728 . . . . 72.25 112.408 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . 0.467 ' OD2' ' HB ' ' A' ' 619' ' ' ILE . 19.2 t70 -61.52 -53.22 59.19 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.569 -1.271 . . . . 73.34 107.569 175.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 96.5 19.33 27.93 Favored Glycine 0 N--CA 1.419 -2.445 0 CA-C-N 114.992 -1.004 . . . . 60.31 111.416 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . 0.517 HG22 HD21 ' A' ' 615' ' ' ASN . 0.0 OUTLIER -69.18 119.93 15.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 122.151 0.977 . . . . 55.51 109.73 -173.433 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.27 130.37 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.602 0 CA-C-N 114.611 -1.177 . . . . 75.03 108.158 -176.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 6.5 m -98.26 118.01 33.95 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.38 -0.97 . . . . 73.43 108.38 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . 0.604 ' O ' ' HD2' ' A' ' 623' ' ' ARG . 2.4 pt? -138.78 157.69 45.61 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.063 -0.517 . . . . 70.25 109.814 -177.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . 0.604 ' HD2' ' O ' ' A' ' 622' ' ' LEU . 6.9 mpt_? -129.63 143.08 50.66 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 105.202 -2.147 . . . . 73.43 105.202 171.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -141.22 165.23 28.1 Favored 'General case' 0 C--N 1.293 -1.861 0 O-C-N 123.896 0.747 . . . . 75.34 110.51 -178.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -66.55 138.74 36.23 Favored Glycine 0 N--CA 1.426 -2.004 0 CA-C-N 114.813 -1.085 . . . . 64.33 112.726 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 C--N 1.286 -2.158 0 C-N-CA 124.736 1.214 . . . . 74.44 109.02 -178.349 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 CA--C 1.48 -1.725 0 N-CA-C 108.887 -0.783 . . . . 45.21 108.887 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 409' ' ' SER . 31.2 m -133.81 159.51 42.45 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 CA-C-N 115.332 -0.849 . . . . 43.34 108.747 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . 0.408 HE21 ' HB3' ' A' ' 361' ' ' GLN . 9.6 mt-30 -93.99 138.26 32.3 Favored 'General case' 0 N--CA 1.39 -3.437 0 N-CA-C 107.45 -1.315 . . . . 72.43 107.45 174.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 78.1 t -95.72 129.43 34.52 Favored Pre-proline 0 C--N 1.267 -3.001 0 CA-C-N 115.297 -0.865 . . . . 63.44 109.056 -172.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -57.77 127.71 26.28 Favored 'Trans proline' 0 CA--C 1.498 -1.302 0 C-N-CA 122.233 1.955 . . . . 73.44 110.153 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -80.21 126.36 31.02 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.196 -1.039 . . . . 75.32 108.196 -174.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 10.7 m -88.88 1.24 7.15 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 N-CA-C 113.387 0.884 . . . . 71.45 113.387 -173.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -56.48 144.7 30.31 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 123.584 0.552 . . . . 73.25 111.206 176.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.69 -16.6 47.43 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.728 -0.669 . . . . 53.12 112.398 -178.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -99.27 -156.12 0.53 Allowed 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 108.368 -0.975 . . . . 73.13 108.368 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 95.8 p -98.86 175.1 6.07 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 107.375 -1.343 . . . . 53.21 107.375 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.0 p -63.17 -44.71 94.66 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 109.799 -0.445 . . . . 71.34 109.799 175.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.58 -46.27 83.44 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 116.216 -0.447 . . . . 72.03 111.299 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 369' ' ' SER . 4.1 m-20 -64.52 -38.47 91.14 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 121.0 0.429 . . . . 73.54 111.64 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -67.49 -47.88 68.72 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.98 -0.554 . . . . 64.22 110.575 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 82.1 mt -60.98 -43.72 96.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-N 115.728 -0.669 . . . . 75.52 110.411 176.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.76 -42.75 89.63 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 115.856 -0.611 . . . . 65.2 111.002 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . 0.564 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 31.2 m -67.37 -48.01 68.7 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.738 -0.664 . . . . 74.33 110.228 -178.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 92.0 mt -64.64 -39.0 92.92 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 112.152 0.427 . . . . 75.21 112.152 -178.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -64.43 -41.21 96.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.803 0.335 . . . . 72.22 110.176 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -70.05 -20.56 63.23 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 112.176 0.436 . . . . 70.03 112.176 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . 0.564 ' HG2' ' O ' ' A' ' 376' ' ' THR . 5.9 mmp_? -86.43 -12.62 48.6 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.023 0.439 . . . . 71.42 109.869 176.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.09 3.95 55.53 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 121.182 -0.532 . . . . 72.53 112.982 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -80.66 164.81 22.56 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-O 120.954 0.407 . . . . 74.4 110.301 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -108.43 141.52 40.17 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 107.531 -1.285 . . . . 71.12 107.531 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . 0.472 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -124.58 152.79 30.86 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.491 0 CA-C-O 121.323 0.583 . . . . 71.05 110.199 -177.039 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -133.07 127.05 33.18 Favored 'General case' 0 N--CA 1.4 -2.974 0 N-CA-C 106.644 -1.613 . . . . 65.41 106.644 175.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 21.0 m -118.36 123.27 44.89 Favored 'General case' 0 C--N 1.271 -2.821 0 N-CA-C 107.887 -1.153 . . . . 74.24 107.887 -175.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.17 121.37 44.74 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.873 -1.158 . . . . 71.35 107.873 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.447 ' HB3' HG21 ' A' ' 422' ' ' THR . 1.4 mp0 -94.08 126.67 39.43 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.3 -0.629 . . . . 75.05 109.3 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . 0.409 ' HD2' HG21 ' A' ' 394' ' ' ILE . 97.3 mttt -130.87 136.57 29.11 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 110.055 -0.35 . . . . 64.03 110.055 175.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . 0.57 ' HA ' ' O ' ' A' ' 422' ' ' THR . 23.5 Cg_exo -68.06 166.45 24.85 Favored 'Trans proline' 0 C--O 1.248 0.984 0 C-N-CA 122.066 1.844 . . . . 62.01 110.125 172.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 2.9 m-20 85.04 170.25 0.08 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.349 1.059 . . . . 64.14 110.645 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 69.3 p -108.82 9.28 26.84 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 120.677 0.275 . . . . 70.34 111.39 -176.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 15.4 t -78.43 -7.02 56.91 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.627 0.727 . . . . 50.22 110.901 -177.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.515 HD13 ' H ' ' A' ' 394' ' ' ILE . 0.2 OUTLIER -115.87 151.5 46.47 Favored Pre-proline 0 C--N 1.298 -1.656 0 N-CA-C 107.882 -1.155 . . . . 65.53 107.882 175.798 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -32.79 131.24 0.1 Allowed 'Trans proline' 0 C--N 1.363 1.316 0 C-N-CA 124.569 3.513 . . . . 75.43 114.928 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.25 164.37 3.85 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 124.476 3.451 . . . . 72.32 113.352 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -56.43 -8.64 0.56 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.525 1.13 . . . . 74.11 112.355 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 60.3 m170 -115.79 131.61 56.89 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 104.563 -2.384 . . . . 65.43 104.563 170.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 24.7 m -71.03 117.15 13.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-O 121.978 0.894 . . . . 65.4 111.453 -169.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 50.0 mm -102.99 -26.66 3.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.078 -1.082 . . . . 54.02 108.078 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -144.31 157.53 27.2 Favored Glycine 0 N--CA 1.399 -3.807 0 N-CA-C 109.486 -1.446 . . . . 42.21 109.486 -178.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 8.0 p -146.56 -176.17 5.08 Favored 'General case' 0 C--N 1.275 -2.662 0 C-N-CA 125.111 1.364 . . . . 71.44 107.808 -172.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -100.58 139.74 20.85 Favored Pre-proline 0 C--N 1.29 -2.004 0 N-CA-C 108.272 -1.01 . . . . 72.12 108.272 -174.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.21 -12.89 6.02 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 123.951 3.101 . . . . 74.32 114.691 -176.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -50.05 -41.29 47.44 Favored 'General case' 0 C--O 1.212 -0.902 0 C-N-CA 123.742 0.817 . . . . 73.35 111.584 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -71.46 -32.77 68.68 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.291 0.567 . . . . 54.11 111.398 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -85.32 -1.17 56.68 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.709 0.766 . . . . 70.34 110.683 -177.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 19.0 m -102.19 151.01 22.71 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 107.1 -1.444 . . . . 64.54 107.1 174.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 360' ' ' VAL . 20.2 m -74.68 113.83 12.4 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 108.876 -0.787 . . . . 64.33 108.876 178.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.6 m -120.24 170.3 10.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 116.272 -0.422 . . . . 73.23 110.551 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 25.8 t -77.38 150.97 35.04 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.096 -1.076 . . . . 73.43 108.096 176.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -65.61 122.12 16.52 Favored 'General case' 0 C--O 1.245 0.836 0 N-CA-C 109.413 -0.588 . . . . 52.13 109.413 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 94.62 68.25 1.04 Allowed Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 110.25 -1.14 . . . . 42.2 110.25 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -127.96 -179.51 5.01 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.528 -1.286 . . . . 50.33 107.528 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -111.4 119.65 39.53 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.049 0.452 . . . . 74.34 110.674 -174.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 46.1 mm -106.21 120.83 57.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 109.203 -0.666 . . . . 63.52 109.203 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 22.4 p -92.55 130.88 38.07 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.016 0.436 . . . . 74.45 111.307 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 5.4 p -126.82 135.33 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 109.072 -0.714 . . . . 54.1 109.072 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . 0.439 ' H ' HD22 ' A' ' 419' ' ' ASN . 0.0 OUTLIER -111.81 125.76 54.35 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 109.41 -0.589 . . . . 73.31 109.41 178.705 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 11.5 p -121.51 143.93 32.32 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 115.478 -0.783 . . . . 63.1 110.727 -174.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 31.3 t -84.16 121.46 27.48 Favored 'General case' 0 C--O 1.252 1.197 0 CA-C-N 115.682 -0.69 . . . . 54.43 109.679 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 390' ' ' PRO . 14.4 t -121.08 107.73 12.97 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 115.83 -0.623 . . . . 74.04 111.759 175.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.357 0 C-N-CA 119.099 -1.524 . . . . 72.13 115.424 172.426 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.415 ' HG3' ' HB ' ' A' ' 477' ' ' THR . 18.9 tp60 . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 106.291 -1.744 . . . . 72.35 106.291 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.545 ' HG3' ' O ' ' A' ' 447' ' ' ALA . 5.0 mmp_? -127.7 148.89 50.41 Favored 'General case' 0 C--O 1.209 -1.073 0 N-CA-C 113.815 1.043 . . . . 75.23 113.815 -178.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -83.42 138.52 33.44 Favored 'General case' 0 C--N 1.286 -2.157 0 C-N-CA 126.237 1.815 . . . . 74.42 110.548 178.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.457 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 66.5 mt -83.59 119.28 73.5 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 108.684 -0.858 . . . . 55.5 108.684 177.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.83 152.53 63.85 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.909 2.406 . . . . 63.12 113.823 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -91.42 110.1 21.39 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 115.763 -0.653 . . . . 71.22 109.457 176.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 42.2 t -116.77 150.34 18.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.354 -0.98 . . . . 61.13 108.354 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.595 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 17.0 m -68.62 150.88 47.47 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 121.071 0.462 . . . . 64.24 110.975 -179.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 40.5 p -69.77 -27.33 64.84 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 123.75 0.82 . . . . 71.53 113.179 -172.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.9 pp -88.07 -11.13 48.06 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.46 0.647 . . . . 65.2 111.349 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.595 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 0.8 OUTLIER -99.59 45.37 0.99 Allowed 'General case' 0 CA--C 1.56 1.341 0 CA-C-N 115.464 -0.789 . . . . 74.25 109.869 -175.672 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -52.65 -38.91 61.2 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 114.198 1.184 . . . . 65.44 114.198 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.49 ' O ' ' HG3' ' A' ' 442' ' ' LYS . . . -64.69 -39.56 93.87 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 120.527 -0.469 . . . . 52.44 110.544 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -65.77 -36.17 82.78 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 108.684 -0.858 . . . . 75.11 108.684 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.535 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.91 -51.63 68.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.172 -0.467 . . . . 63.32 111.46 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 27.2 m -65.86 -39.02 83.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 112.321 0.489 . . . . 65.43 112.321 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 438' ' ' ALA 0.3 0.0 OUTLIER -68.37 -34.07 75.4 Favored 'General case' 0 C--O 1.214 -0.764 0 N-CA-C 112.985 0.735 . . . . 73.2 112.985 176.483 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -61.25 -43.38 98.98 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.047 0.451 . . . . 73.34 110.056 175.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.535 HD13 ' O ' ' A' ' 440' ' ' ALA . 7.1 mp -63.67 -35.75 81.56 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.599 -0.728 . . . . 73.44 110.706 177.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.616 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 26.9 m -71.16 -45.98 62.41 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.108 -0.496 . . . . 64.23 111.078 178.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -65.41 -20.05 66.21 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.227 0.611 . . . . 74.42 110.995 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . 0.545 ' O ' ' HG3' ' A' ' 427' ' ' ARG . . . -79.35 -3.92 48.5 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.853 -0.612 . . . . 61.21 111.433 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 118.05 -78.6 0.3 Allowed Glycine 0 CA--C 1.49 -1.503 0 C-N-CA 120.716 -0.754 . . . . 73.42 111.562 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . 0.465 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 2.8 p90 -43.48 -66.82 0.33 Allowed 'General case' 0 C--O 1.241 0.652 0 N-CA-C 113.473 0.916 . . . . 61.3 113.473 177.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . 0.616 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 62.19 27.63 69.4 Favored Glycine 0 CA--C 1.487 -1.671 0 N-CA-C 111.037 -0.825 . . . . 74.42 111.037 -175.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -103.91 110.11 22.11 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 106.701 -1.592 . . . . 75.43 106.701 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 27.9 p90 -135.67 154.71 51.2 Favored 'General case' 0 N--CA 1.408 -2.547 0 CA-C-N 115.66 -0.7 . . . . 74.32 109.721 -176.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -130.77 122.9 28.03 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 107.783 -1.191 . . . . 74.15 107.783 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -86.8 129.98 34.65 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.975 -0.75 . . . . 64.11 108.975 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -136.43 140.95 43.52 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 116.358 -0.383 . . . . 63.32 110.084 177.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -114.14 146.24 40.57 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 106.903 -1.517 . . . . 75.13 106.903 175.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 52.7 m -148.6 150.22 33.08 Favored Pre-proline 0 C--N 1.28 -2.449 0 N-CA-C 108.487 -0.931 . . . . 60.43 108.487 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.681 ' HA ' ' O ' ' A' ' 490' ' ' SER . 37.5 Cg_endo -66.69 132.77 29.69 Favored 'Trans proline' 0 N--CA 1.442 -1.536 0 C-N-CA 121.667 1.578 . . . . 63.13 110.423 177.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 21.2 m -142.38 178.12 7.8 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.042 -0.725 . . . . 72.43 109.042 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 6.9 t -62.34 137.54 96.06 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 109.691 -0.485 . . . . 63.21 109.691 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.42 -29.36 30.73 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 124.415 3.41 . . . . 73.35 113.62 -176.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -67.92 -33.36 74.54 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-O 120.943 0.401 . . . . 73.22 111.398 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.35 -20.04 23.32 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 111.904 0.335 . . . . 75.45 111.904 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 78.0 t -52.28 133.35 14.25 Favored 'Isoleucine or valine' 0 C--O 1.245 0.85 0 O-C-N 123.603 0.564 . . . . 72.34 111.016 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.88 -20.3 48.48 Favored Glycine 0 N--CA 1.438 -1.191 0 CA-C-N 115.646 -0.706 . . . . 54.05 112.292 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -113.33 166.28 11.63 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 117.103 0.451 . . . . 74.5 110.21 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.439 HG22 HG12 ' A' ' 488' ' ' VAL . 77.6 t -72.85 143.3 14.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 115.563 -0.744 . . . . 71.34 109.237 177.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 50.5 mm -96.89 -31.78 4.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 107.532 -1.285 . . . . 61.02 107.532 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 153.4 -163.96 30.87 Favored Glycine 0 N--CA 1.422 -2.287 0 CA-C-N 115.539 -0.755 . . . . 42.51 111.893 175.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.71 139.14 50.89 Favored 'General case' 0 N--CA 1.413 -2.277 0 N-CA-C 106.62 -1.622 . . . . 74.32 106.62 176.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.483 ' HB3' HG23 ' A' ' 485' ' ' ILE . 27.4 t-20 -64.96 -51.04 59.14 Favored Pre-proline 0 N--CA 1.471 0.605 0 CA-C-O 119.228 -0.415 . . . . 74.01 111.003 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.458 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 21.8 Cg_exo -70.29 130.52 18.83 Favored 'Trans proline' 0 C--N 1.371 1.761 0 N-CA-C 107.131 -1.911 . . . . 72.14 107.131 169.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.468 ' C ' ' H ' ' A' ' 475' ' ' ASN . 39.7 Cg_exo -62.06 133.51 44.5 Favored 'Trans proline' 0 C--O 1.24 0.595 0 C-N-CA 121.856 1.704 . . . . 74.13 113.212 -174.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.457 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -70.92 14.49 0.14 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.159 1.384 . . . . 15.43 111.588 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . 0.468 ' H ' ' C ' ' A' ' 473' ' ' PRO . 16.3 m120 -109.19 -13.72 14.61 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 108.484 -0.932 . . . . 75.54 108.484 -178.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -104.79 178.86 4.44 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.547 -0.751 . . . . 73.44 111.344 -175.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.415 ' HB ' ' HG3' ' A' ' 426' ' ' GLN . 0.9 OUTLIER -106.59 137.84 43.86 Favored 'General case' 0 N--CA 1.396 -3.142 0 CA-C-N 115.573 -0.74 . . . . 72.13 110.898 -179.595 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 12.3 p -117.13 149.65 40.0 Favored 'General case' 0 N--CA 1.424 -1.75 0 C-N-CA 123.97 0.908 . . . . 62.41 110.145 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -80.83 158.53 25.36 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.916 -0.584 . . . . 44.21 110.129 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . 0.465 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 37.0 mm -69.72 -17.53 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 122.231 1.015 . . . . 63.1 110.318 -178.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 7.4 p -100.09 2.02 42.8 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.654 -0.703 . . . . 71.44 111.403 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -95.75 134.9 38.14 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.048 -0.524 . . . . 60.45 110.846 -175.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 37.6 t -99.88 116.44 43.16 Favored 'Isoleucine or valine' 0 C--O 1.243 0.754 0 N-CA-C 109.228 -0.656 . . . . 71.22 109.228 -177.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 32.1 m -99.72 136.79 29.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 121.436 0.636 . . . . 65.52 111.384 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.483 HG23 ' HB3' ' A' ' 471' ' ' ASN . 0.0 OUTLIER -99.98 128.35 51.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 121.452 0.644 . . . . 73.55 111.742 -176.841 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 16.3 mt -112.56 128.25 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 CA-C-N 114.599 -1.182 . . . . 72.51 109.88 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 6.1 tt -111.03 126.71 68.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-N 115.151 -0.931 . . . . 63.01 110.515 -173.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.439 HG12 HG22 ' A' ' 467' ' ' VAL . 35.0 m -105.56 149.52 8.93 Favored 'Isoleucine or valine' 0 C--O 1.254 1.306 0 CA-C-N 115.933 -0.576 . . . . 72.34 110.032 177.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -84.22 125.97 7.37 Favored Glycine 0 N--CA 1.437 -1.279 0 N-CA-C 111.372 -0.691 . . . . 73.15 111.372 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.681 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 25.5 t . . . . . 0 N--CA 1.422 -1.865 0 N-CA-C 107.075 -1.454 . . . . 73.44 107.075 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo . . . . . 0 C--O 1.249 1.057 0 CA-C-O 121.052 0.355 . . . . 75.42 111.853 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -104.37 118.99 37.95 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-O 121.44 0.638 . . . . 54.12 109.677 -177.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 11.0 p -116.82 143.15 46.02 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 115.018 -0.992 . . . . 73.54 109.66 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . 0.43 ' HE2' ' HA ' ' A' ' 495' ' ' LYS . 3.5 mmpt? -146.86 151.67 37.45 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 123.168 0.587 . . . . 73.54 109.837 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.539 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.2 p-10 -87.24 135.38 33.33 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.84 -1.17 . . . . 73.32 107.84 174.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 26.2 pt -75.26 121.01 84.31 Favored Pre-proline 0 C--N 1.294 -1.813 0 CA-C-N 115.784 -0.644 . . . . 72.22 109.729 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -75.25 159.9 39.92 Favored 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 122.184 1.923 . . . . 61.22 111.765 -177.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -77.84 90.27 4.08 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 106.272 -1.751 . . . . 74.04 106.272 174.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 10.0 p -96.65 7.5 7.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-O 122.319 1.056 . . . . 53.24 110.427 -171.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -78.06 79.05 4.53 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.203 -0.908 . . . . 63.21 111.932 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . -178.13 31.75 0.07 OUTLIER Glycine 0 C--N 1.304 -1.197 0 N-CA-C 110.703 -0.959 . . . . 61.54 110.703 177.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -157.51 -177.37 6.54 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 107.956 -1.127 . . . . 73.3 107.956 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 5.9 t -91.23 156.81 17.56 Favored 'General case' 0 N--CA 1.426 -1.642 0 C-N-CA 119.02 -1.072 . . . . 42.22 109.738 -177.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.5 p -54.16 -40.27 46.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 C-N-CA 124.707 1.203 . . . . 71.41 111.271 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -60.9 -43.38 98.59 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.624 -0.716 . . . . 71.41 110.697 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 64.0 t -76.77 -37.13 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-N 116.042 -0.526 . . . . 72.21 110.241 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . 0.48 ' O ' ' HG ' ' A' ' 512' ' ' LEU . . . -62.9 -48.87 77.11 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.93 -0.577 . . . . 63.25 111.662 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -65.18 -35.66 81.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.762 0.315 . . . . 61.32 110.246 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.521 ' O ' HG23 ' A' ' 514' ' ' VAL . 26.2 tptp -64.15 -45.37 88.75 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.848 -0.797 . . . . 74.23 108.848 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -62.27 -42.69 99.56 Favored 'General case' 0 CA--C 1.505 -0.78 0 O-C-N 123.609 0.568 . . . . 71.23 110.775 177.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 508' ' ' ALA . 87.5 mt -59.93 -42.94 95.07 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 116.447 -0.342 . . . . 55.13 110.612 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -62.28 -37.86 87.09 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 116.253 -0.431 . . . . 54.34 110.586 177.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 510' ' ' LYS . 92.6 t -61.87 -35.68 69.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.898 -0.592 . . . . 63.23 110.735 177.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -78.26 -19.58 53.41 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.213 0.53 . . . . 75.44 110.213 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 117.93 -5.98 15.78 Favored Glycine 0 N--CA 1.436 -1.326 0 C-N-CA 120.639 -0.791 . . . . 71.53 112.678 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.607 ' HA ' ' O ' ' A' ' 547' ' ' VAL . 74.6 m-85 -68.83 122.18 18.07 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 121.214 0.53 . . . . 74.51 110.642 -178.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . 0.419 ' OG1' ' HA ' ' A' ' 548' ' ' ASP . 10.7 p -93.64 -39.7 10.67 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.567 -0.742 . . . . 71.42 112.357 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -108.43 114.94 29.18 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 122.152 0.977 . . . . 72.44 113.139 -171.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' A' ' 551' ' ' ILE . 46.2 p90 -130.72 151.58 51.01 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.566 -1.197 . . . . 73.11 110.167 176.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 25.1 m -125.17 143.03 51.14 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.111 -1.07 . . . . 74.24 108.111 176.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -117.91 119.71 35.67 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.827 -0.434 . . . . 73.33 109.827 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 554' ' ' GLN . . . -127.39 125.94 41.56 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.72 -0.844 . . . . 74.21 108.72 178.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 20.6 m -101.65 138.5 38.56 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.878 -0.329 . . . . 52.24 111.568 -178.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 30.1 m -123.71 149.38 27.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 108.415 -0.957 . . . . 62.35 108.415 176.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . 0.501 ' HA ' ' HB3' ' A' ' 557' ' ' LYS . 4.7 p-10 -69.57 136.02 50.77 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 121.248 0.547 . . . . 71.53 110.717 -177.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 25.6 p -163.01 167.56 11.64 Favored Pre-proline 0 C--N 1.307 -1.257 0 CA-C-N 115.237 -0.892 . . . . 75.02 109.046 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -77.39 6.56 4.31 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 122.483 2.122 . . . . 73.12 112.839 176.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -96.52 140.51 22.22 Favored Pre-proline 0 N--CA 1.445 -0.679 0 N-CA-C 108.206 -1.035 . . . . 74.31 108.206 175.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -64.42 161.4 34.96 Favored 'Trans proline' 0 C--O 1.246 0.908 0 C-N-CA 122.996 2.464 . . . . 75.53 113.962 -174.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.588 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -66.38 120.77 13.91 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.289 -0.868 . . . . 75.21 110.078 -178.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 122.94 -27.25 5.95 Favored Glycine 0 N--CA 1.434 -1.435 0 C-N-CA 120.657 -0.782 . . . . 71.44 111.594 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -69.63 125.61 27.23 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.358 -0.608 . . . . 65.34 109.358 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 94.0 t -81.48 111.6 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 N-CA-C 107.568 -1.271 . . . . 60.11 107.568 176.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 11.7 t -95.05 -16.22 22.86 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 120.63 -0.428 . . . . 62.13 111.982 -174.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 174.68 -175.13 46.89 Favored Glycine 0 CA--C 1.489 -1.564 0 C-N-CA 120.326 -0.94 . . . . 73.3 111.33 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 23.4 p -129.33 157.18 42.61 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.414 -0.958 . . . . 73.11 108.414 176.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.435 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 26.0 t-20 -73.06 -53.16 5.14 Favored Pre-proline 0 C--N 1.309 -1.186 0 C-N-CA 120.634 -0.427 . . . . 62.14 111.283 177.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.435 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 13.8 Cg_exo -72.86 136.45 25.24 Favored 'Trans proline' 0 C--N 1.368 1.605 0 N-CA-C 108.375 -1.433 . . . . 61.13 108.375 172.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -59.45 139.92 91.75 Favored 'Trans proline' 0 C--O 1.262 1.702 0 C-N-CA 122.2 1.933 . . . . 61.42 112.258 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -67.88 141.34 56.44 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.438 -0.801 . . . . 62.55 109.276 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 102.14 -12.27 57.28 Favored Glycine 0 N--CA 1.427 -1.932 0 C-N-CA 120.976 -0.63 . . . . 55.4 111.664 -176.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 45.8 m -72.57 126.94 31.08 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 116.943 0.372 . . . . 52.12 110.327 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 10.2 t -83.73 123.17 29.58 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.455 0.645 . . . . 73.53 110.029 177.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.9 m -138.21 157.46 72.69 Favored Pre-proline 0 C--N 1.305 -1.348 0 N-CA-C 108.972 -0.751 . . . . 74.54 108.972 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -65.89 150.5 85.69 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 121.554 1.503 . . . . 62.0 110.108 173.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' A' ' 517' ' ' PHE . 26.9 m -59.97 -20.2 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 113.316 0.858 . . . . 52.41 113.316 -177.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . 0.419 ' HA ' ' OG1' ' A' ' 518' ' ' THR . 9.7 t70 -95.09 4.92 53.17 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.603 0.716 . . . . 64.21 111.454 -177.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.1 t -71.62 171.58 11.2 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 109.4 -0.593 . . . . 74.11 109.4 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 49.1 t -101.12 112.82 35.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 109.836 -0.431 . . . . 52.13 109.836 -177.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 520' ' ' PHE . 2.9 mp -101.14 121.85 52.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.763 -0.829 . . . . 73.23 108.763 178.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -102.69 116.41 32.53 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.17 0.509 . . . . 73.52 110.082 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 4.6 mp -97.22 134.13 40.93 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.05 -0.977 . . . . 63.32 108.682 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 523' ' ' ALA . 49.6 mt-30 -105.21 114.83 29.26 Favored 'General case' 0 N--CA 1.414 -2.26 0 CA-C-O 122.03 0.919 . . . . 73.2 108.852 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 524' ' ' SER . 22.1 t -101.85 147.6 8.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 CA-C-N 113.967 -1.469 . . . . 70.01 108.855 -172.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.588 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 23.4 m -76.43 130.84 38.6 Favored 'General case' 0 N--CA 1.412 -2.35 0 CA-C-O 121.863 0.84 . . . . 52.4 112.447 177.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.501 ' HB3' ' HA ' ' A' ' 526' ' ' ASP . 10.2 tppt? -90.88 123.71 34.61 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 104.096 -2.557 . . . . 74.42 104.096 167.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -66.69 -42.3 93.34 Favored Glycine 0 CA--C 1.482 -2.009 0 N-CA-C 109.98 -1.248 . . . . 73.54 109.98 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 9.5 t30 65.57 21.15 11.72 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 122.171 0.986 . . . . 70.25 110.352 172.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -134.8 156.23 49.24 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.509 -0.769 . . . . 73.25 111.537 -176.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -133.4 156.73 47.14 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.395 -0.965 . . . . 73.53 108.395 176.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 54.9 t -73.22 124.47 30.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 120.777 0.322 . . . . 64.34 110.155 -178.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 52.9 ttp -97.26 137.52 21.18 Favored Pre-proline 0 C--N 1.311 -1.109 0 CA-C-N 116.159 -0.473 . . . . 72.52 111.962 -178.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -65.49 170.99 10.09 Favored 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 124.148 3.232 . . . . 72.34 112.535 172.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -82.14 134.25 35.31 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.31 -0.626 . . . . 60.04 109.31 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -120.38 -26.04 5.5 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.614 -0.884 . . . . 60.11 108.614 171.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 12.2 p -71.67 139.23 49.13 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.48 -0.782 . . . . 61.23 110.48 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 79.58 39.33 18.3 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 110.99 -0.844 . . . . 71.34 110.99 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 89.2 mtp -144.69 170.32 16.32 Favored 'General case' 0 C--O 1.249 1.075 0 N-CA-C 108.263 -1.014 . . . . 44.54 108.263 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -95.53 148.97 21.94 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 108.559 -0.904 . . . . 71.33 108.559 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 73.8 t-105 -61.73 -28.39 69.4 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 123.406 0.682 . . . . 74.23 109.968 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 13.8 p -71.54 -21.04 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-N 115.247 -0.888 . . . . 64.13 110.667 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -101.19 -30.82 11.33 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.812 -0.81 . . . . 62.43 108.812 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -59.06 -45.94 89.52 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.199 -0.91 . . . . 63.45 112.441 -178.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 579' ' ' ARG . 31.5 mt-10 -59.51 -57.65 25.34 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 113.7 1.0 . . . . 64.43 113.7 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -58.07 -34.75 98.81 Favored 'Trans proline' 0 C--N 1.364 1.394 0 C-N-CA 121.173 1.248 . . . . 63.33 112.26 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -59.21 -48.13 82.77 Favored 'General case' 0 N--CA 1.42 -1.925 0 C-N-CA 122.506 0.322 . . . . 74.41 110.526 177.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . 0.286 4.2 pp -68.04 -38.3 82.33 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 112.813 0.672 . . . . 72.31 112.813 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 35.3 mmt180 -65.12 -47.56 76.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.472 -0.331 . . . . 63.43 110.458 178.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.93 -17.15 62.69 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.904 -0.589 . . . . 71.54 112.365 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 60.4 tp -85.84 -9.11 57.54 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 109.603 -0.517 . . . . 51.13 109.603 178.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 73.87 38.66 48.8 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 111.219 -0.752 . . . . 61.23 111.219 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 50.5 t90 -83.36 135.08 34.85 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-O 121.266 0.555 . . . . 73.33 111.015 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 10.1 t -145.89 106.34 4.07 Favored 'General case' 0 N--CA 1.408 -2.545 0 CA-C-N 114.783 -1.099 . . . . 74.32 108.126 173.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -159.18 -154.68 7.34 Favored Glycine 0 N--CA 1.429 -1.828 0 N-CA-C 108.774 -1.73 . . . . 73.11 108.774 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 60.9 mtt -107.58 125.23 51.05 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.68 -0.808 . . . . 64.04 112.324 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 59.2 tp -93.88 130.16 40.04 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.642 -0.873 . . . . 73.31 108.642 178.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . 0.462 ' HB3' HG23 ' A' ' 621' ' ' THR . 23.6 t70 -99.28 113.22 25.38 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 120.972 0.415 . . . . 74.02 111.232 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -91.86 109.4 20.73 Favored 'General case' 0 N--CA 1.408 -2.554 0 N-CA-C 106.4 -1.704 . . . . 71.15 106.4 171.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -87.9 -95.25 0.96 Allowed Glycine 0 N--CA 1.424 -2.124 0 C-N-CA 120.599 -0.81 . . . . 70.14 111.399 -178.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.44 151.28 46.11 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.214 -0.662 . . . . 74.42 109.214 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -84.84 132.07 34.45 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.719 -1.215 . . . . 72.5 107.719 175.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 73.5 t -123.63 127.7 74.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 CA-C-N 116.275 -0.421 . . . . 73.52 110.539 -171.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -78.53 107.25 11.05 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.018 -1.475 . . . . 74.5 107.018 175.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -127.47 0.86 6.26 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.81 -0.632 . . . . 72.14 110.736 -176.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 104.99 141.33 10.77 Favored Glycine 0 N--CA 1.431 -1.639 0 N-CA-C 108.8 -1.72 . . . . 74.31 108.8 -177.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -55.77 -39.31 76.4 Favored Glycine 0 C--O 1.224 -0.491 0 CA-C-N 117.193 0.497 . . . . 43.45 112.793 -173.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 3.9 m -60.37 -24.63 65.25 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.995 0.918 . . . . 65.22 111.923 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -108.76 -1.57 19.23 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.137 0.421 . . . . 73.14 112.137 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 59.5 m170 -72.38 -42.28 65.41 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.463 0.542 . . . . 65.34 112.463 -176.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -92.77 32.4 1.25 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 122.04 0.924 . . . . 74.34 108.749 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 603' ' ' VAL . 29.9 ttt180 -118.7 141.8 48.27 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.609 -0.682 . . . . 62.11 109.729 -178.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . 0.412 ' O ' ' HG2' ' A' ' 602' ' ' ARG . 71.4 t -73.15 130.9 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 106.094 -1.817 . . . . 75.14 106.094 172.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 73.6 t -80.05 -53.35 13.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-O 121.71 0.767 . . . . 63.5 109.292 -172.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -156.78 164.23 38.34 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 104.67 -2.345 . . . . 65.33 104.67 177.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -115.86 142.51 46.67 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 107.571 -1.27 . . . . 64.34 107.571 174.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.513 ' HB2' ' HB ' ' A' ' 621' ' ' THR . 41.1 t30 -64.21 -52.52 54.17 Favored Pre-proline 0 C--N 1.285 -2.211 0 N-CA-C 114.441 1.275 . . . . 74.41 114.441 -176.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 609' ' ' PRO . 2.3 Cg_endo -87.38 148.99 7.72 Favored 'Trans proline' 0 CA--C 1.549 1.238 0 CA-C-N 121.444 1.551 . . . . 74.11 110.594 176.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 608' ' ' PRO . 15.8 Cg_exo -70.06 134.24 26.9 Favored 'Trans proline' 0 C--O 1.248 0.994 0 C-N-CA 121.731 1.621 . . . . 72.42 113.152 -177.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -68.56 134.32 49.83 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.678 -0.692 . . . . 75.3 110.724 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 86.48 -1.62 87.31 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.674 -0.774 . . . . 33.3 111.75 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . 0.421 ' OG1' ' HB2' ' A' ' 609' ' ' PRO . 19.8 m -105.52 161.04 14.69 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 108.26 -1.015 . . . . 74.41 108.26 -178.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -73.17 129.99 13.24 Favored Glycine 0 N--CA 1.432 -1.575 0 N-CA-C 111.877 -0.489 . . . . 60.22 111.877 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 34.0 m -118.44 144.12 27.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.922 -0.77 . . . . 44.21 108.922 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.452 ' ND2' ' HB3' ' A' ' 617' ' ' ASP . 27.4 p-10 -43.6 155.59 0.07 Allowed 'General case' 0 C--O 1.216 -0.699 0 C-N-CA 124.73 1.212 . . . . 73.02 113.158 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -56.24 -25.92 49.45 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.048 0.758 . . . . 74.34 113.048 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . 0.452 ' HB3' ' ND2' ' A' ' 615' ' ' ASN . 30.8 t70 -65.83 -37.94 87.55 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.262 -0.644 . . . . 74.45 109.262 174.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 85.69 21.56 53.15 Favored Glycine 0 N--CA 1.424 -2.14 0 CA-C-N 115.681 -0.69 . . . . 61.41 112.182 176.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . 0.4 ' HB ' ' OD2' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -68.44 118.52 12.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 122.448 1.118 . . . . 61.02 110.404 -169.351 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.97 124.55 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.946 0 N-CA-C 106.976 -1.49 . . . . 74.3 106.976 -177.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.513 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 3.0 m -105.36 127.39 52.94 Favored 'General case' 0 N--CA 1.42 -1.944 0 C-N-CA 120.492 -0.483 . . . . 70.14 109.908 -177.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.0 mp -120.98 149.81 42.09 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 105.434 -2.062 . . . . 72.33 105.434 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -137.53 148.16 45.74 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 107.615 -1.254 . . . . 64.0 107.615 173.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -123.78 167.6 13.82 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 107.713 -1.217 . . . . 63.23 107.713 -177.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -67.0 -105.19 0.02 OUTLIER Glycine 0 CA--C 1.533 1.157 0 O-C-N 123.927 0.767 . . . . 71.45 111.824 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 . . . . . 0 C--N 1.296 -1.751 0 CA-C-O 118.575 -0.726 . . . . 72.25 109.185 177.032 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 . . . . . 0 N--CA 1.431 -1.376 0 N-CA-C 106.847 -1.538 . . . . 72.13 106.847 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 28.4 m -116.8 149.67 18.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.231 0 C-N-CA 120.538 -0.465 . . . . 53.25 110.417 -173.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . 0.552 ' NE2' ' HA ' ' A' ' 407' ' ' ASN . 0.8 OUTLIER -93.9 128.98 40.48 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 105.172 -2.159 . . . . 73.34 105.172 -179.072 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.438 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 92.9 t -95.43 122.37 59.52 Favored Pre-proline 0 C--N 1.28 -2.435 0 CA-C-N 115.266 -0.879 . . . . 63.54 110.864 -167.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 18.0 Cg_exo -61.94 125.61 16.93 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 122.312 2.008 . . . . 45.25 110.163 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . 0.475 ' HB2' ' HG3' ' A' ' 366' ' ' ARG . 3.7 p-10 -71.85 125.87 28.28 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.339 -0.846 . . . . 71.43 109.714 -176.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.418 HG11 ' HA ' ' A' ' 373' ' ' ALA . 17.9 t -98.33 0.11 10.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-O 122.085 0.945 . . . . 72.12 108.728 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.475 ' HG3' ' HB2' ' A' ' 364' ' ' ASP 0.298 0.0 OUTLIER -64.96 146.6 54.77 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.963 -1.017 . . . . 73.2 113.047 179.325 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.26 -9.34 45.81 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 109.806 -1.318 . . . . 72.15 109.806 -172.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -110.7 -163.53 0.86 Allowed 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 107.35 -1.352 . . . . 52.03 107.35 178.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 76.2 p -86.87 160.42 18.74 Favored 'General case' 0 C--N 1.286 -2.157 0 O-C-N 121.865 -0.522 . . . . 71.32 111.602 -170.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 34.2 p -58.95 -46.43 88.03 Favored 'General case' 0 N--CA 1.435 -1.208 0 O-C-N 123.622 0.576 . . . . 41.24 110.6 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.85 -46.79 80.41 Favored 'General case' 0 C--O 1.214 -0.797 0 CA-C-N 116.235 -0.439 . . . . 52.4 111.667 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -67.63 -37.74 82.9 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.259 0.552 . . . . 62.34 111.259 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . 0.418 ' HA ' HG11 ' A' ' 365' ' ' VAL . . . -69.46 -48.53 60.53 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.619 -0.719 . . . . 72.23 111.318 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 89.0 mt -64.9 -42.11 93.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 CA-C-N 116.449 -0.341 . . . . 53.11 110.922 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.95 -45.57 90.15 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 120.717 0.294 . . . . 63.01 111.348 -178.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 32.7 m -64.38 -47.57 78.75 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.998 -0.546 . . . . 73.41 111.147 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.1 -38.74 92.16 Favored 'General case' 0 C--O 1.24 0.597 0 O-C-N 122.094 -0.379 . . . . 70.42 111.709 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -63.43 -42.12 98.69 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.986 -0.552 . . . . 72.31 110.189 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -67.89 -28.13 67.25 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 112.027 0.381 . . . . 63.31 112.027 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -79.96 -15.7 56.75 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.494 -0.482 . . . . 70.13 110.253 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 96.07 15.89 40.28 Favored Glycine 0 N--CA 1.434 -1.461 0 C-N-CA 120.289 -0.957 . . . . 61.1 113.021 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -77.75 143.06 38.3 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 108.667 -0.864 . . . . 72.22 108.667 175.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -84.64 131.86 34.55 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 105.805 -1.924 . . . . 74.21 105.805 176.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 2.4 pp -130.83 138.24 54.05 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 CA-C-O 121.85 0.833 . . . . 72.35 113.23 -175.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 385' ' ' ARG . 33.0 ttp180 -113.8 141.28 47.49 Favored 'General case' 0 C--N 1.276 -2.588 0 N-CA-C 107.053 -1.462 . . . . 63.53 107.053 175.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 20.9 m -122.37 121.16 36.02 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 108.127 -1.064 . . . . 72.11 108.127 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -111.61 127.82 55.86 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.819 -1.178 . . . . 72.5 107.819 -176.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -93.04 131.91 37.63 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.925 0.393 . . . . 73.44 111.504 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . 0.615 ' O ' ' HA ' ' A' ' 421' ' ' SER . 71.6 mmtt -126.36 132.91 24.49 Favored Pre-proline 0 C--N 1.304 -1.393 0 CA-C-N 115.797 -0.638 . . . . 51.52 109.465 175.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . 0.752 ' HA ' ' O ' ' A' ' 422' ' ' THR . 12.2 Cg_exo -72.37 140.26 33.21 Favored 'Trans proline' 0 C--O 1.247 0.95 0 C-N-CA 122.177 1.918 . . . . 74.13 109.901 175.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . 0.324 3.8 p30 -73.97 118.87 17.43 Favored 'General case' 0 CA--C 1.466 -2.26 0 C-N-CA 118.187 -1.405 . . . . 71.25 114.172 -178.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . 0.549 ' O ' ' HB ' ' A' ' 393' ' ' THR . 50.1 m -143.94 81.69 1.69 Allowed 'General case' 0 N--CA 1.39 -3.462 0 N-CA-C 105.335 -2.098 . . . . 72.24 105.335 166.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.549 ' HB ' ' O ' ' A' ' 392' ' ' SER . 85.5 m 96.52 2.52 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 113.961 -1.472 . . . . 72.22 110.98 174.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 5.6 pt -104.92 151.58 39.44 Favored Pre-proline 0 C--N 1.291 -1.971 0 CA-C-N 114.843 -1.072 . . . . 61.23 109.341 176.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . 0.415 ' HB2' ' HD2' ' A' ' 396' ' ' PRO . 83.2 Cg_endo -74.56 -172.94 1.33 Allowed 'Trans proline' 0 CA--C 1.563 1.962 0 C-N-CA 123.305 2.67 . . . . 61.22 113.927 -172.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 395' ' ' PRO . 79.8 Cg_exo -55.17 163.16 4.76 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 123.277 2.651 . . . . 61.35 112.018 172.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -56.02 -8.5 0.46 Allowed 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 125.43 1.492 . . . . 73.43 112.929 -174.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 50.0 m170 -64.88 121.57 14.93 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 107.187 -1.412 . . . . 73.2 107.187 175.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 29.6 m -68.7 117.92 11.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 115.167 -0.924 . . . . 61.22 110.927 -168.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . 0.453 HD13 ' O ' ' A' ' 400' ' ' ILE . 0.0 OUTLIER -92.52 -29.34 4.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 115.989 -0.551 . . . . 75.31 110.265 -174.677 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.55 160.53 28.11 Favored Glycine 0 N--CA 1.417 -2.592 0 C-N-CA 119.528 -1.32 . . . . 74.04 112.409 -174.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . 0.43 ' OG1' ' HG2' ' A' ' 366' ' ' ARG . 2.9 p -145.01 -176.83 5.24 Favored 'General case' 0 C--N 1.283 -2.321 0 C-N-CA 125.963 1.705 . . . . 64.54 107.72 -176.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -99.52 138.19 20.42 Favored Pre-proline 0 C--N 1.291 -1.977 0 N-CA-C 107.718 -1.216 . . . . 75.31 107.718 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -48.11 -15.04 0.35 Allowed 'Trans proline' 0 C--N 1.364 1.375 0 C-N-CA 124.758 3.638 . . . . 73.41 115.509 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -52.73 -43.7 65.9 Favored 'General case' 0 C--O 1.213 -0.866 0 N-CA-C 109.947 -0.39 . . . . 61.44 109.947 176.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -65.96 -35.19 79.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.622 0.725 . . . . 75.33 109.887 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . 0.552 ' HA ' ' NE2' ' A' ' 361' ' ' GLN . 17.0 m120 -84.64 1.69 45.07 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.209 -0.905 . . . . 72.31 111.378 -177.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 29.6 m -109.27 167.51 10.06 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.324 -1.732 . . . . 73.25 106.324 174.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 15.9 m -76.56 112.79 13.48 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 108.615 -0.883 . . . . 73.32 108.615 175.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 14.2 m -122.13 170.39 12.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 120.807 0.337 . . . . 55.54 111.703 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 2.7 m -56.1 141.61 39.73 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.144 -0.935 . . . . 62.25 110.501 -178.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -66.56 109.69 2.89 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.058 -1.089 . . . . 74.41 108.058 176.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 86.51 42.7 6.41 Favored Glycine 0 N--CA 1.433 -1.536 0 N-CA-C 110.708 -0.957 . . . . 43.34 110.708 -176.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -79.94 -171.91 3.13 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.805 -0.813 . . . . 71.32 108.805 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -108.41 112.68 25.22 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 122.882 0.473 . . . . 73.4 110.412 -176.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 49.1 mm -116.57 137.47 50.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 109.575 -0.528 . . . . 71.1 109.575 -177.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 14.0 t -111.56 131.77 55.01 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.773 -0.825 . . . . 74.4 108.773 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 5.9 p -115.75 135.26 56.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.616 -0.512 . . . . 72.51 109.616 -177.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -100.8 128.6 46.78 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.277 -0.638 . . . . 72.54 109.277 178.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 8.3 p -126.3 137.31 58.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.794 -0.639 . . . . 73.52 109.871 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . 0.615 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 2.3 p -92.59 120.68 33.28 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-O 122.024 0.916 . . . . 64.52 112.017 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . 0.752 ' O ' ' HA ' ' A' ' 390' ' ' PRO . 6.2 t -122.46 155.0 37.05 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 108.095 -1.076 . . . . 72.12 108.095 174.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.029 0 C-N-CA 119.984 -1.103 . . . . 25.22 113.643 174.069 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 . . . . . 0 N--CA 1.44 -0.941 0 N-CA-C 108.279 -1.008 . . . . 72.1 108.279 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.425 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 2.2 mmp_? -119.82 138.16 53.54 Favored 'General case' 0 CA--C 1.492 -1.268 0 CA-C-O 121.147 0.498 . . . . 75.41 109.938 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 13.7 pt-20 -88.16 136.28 33.04 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.493 -0.776 . . . . 63.33 109.489 178.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 59.5 mt -80.67 130.71 63.32 Favored Pre-proline 0 C--N 1.298 -1.661 0 CA-C-N 115.854 -0.612 . . . . 60.34 109.368 -177.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -71.71 141.77 38.34 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 121.877 1.718 . . . . 63.25 110.736 170.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -82.84 111.53 18.83 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.901 -1.148 . . . . 65.43 107.901 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 60.9 t -103.5 143.46 15.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.137 -1.06 . . . . 74.42 108.137 -175.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 15.8 m -60.41 155.06 18.97 Favored 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 112.632 0.604 . . . . 74.54 112.632 -176.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 21.9 p -69.14 -24.98 64.16 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 115.339 1.607 . . . . 74.24 115.339 -170.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.1 pp -90.3 -11.6 40.3 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.953 0.883 . . . . 72.24 110.414 177.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.425 HG22 ' CB ' ' A' ' 439' ' ' GLU . 0.2 OUTLIER -99.95 34.43 2.3 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 114.914 -1.039 . . . . 65.15 109.643 -175.327 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -55.84 -38.33 69.9 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.172 0.989 . . . . 71.22 113.028 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.46 -36.78 84.88 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.868 0.842 . . . . 64.24 110.102 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.505 ' OE2' ' HD2' ' A' ' 442' ' ' LYS . 24.9 tp10 -70.92 -35.4 72.23 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.121 -0.945 . . . . 65.43 109.336 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.562 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -63.63 -50.55 68.89 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.001 -0.545 . . . . 61.24 110.988 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 31.2 m -62.1 -38.67 81.45 Favored 'Isoleucine or valine' 0 C--O 1.25 1.129 0 N-CA-C 112.606 0.595 . . . . 51.03 112.606 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.505 ' HD2' ' OE2' ' A' ' 439' ' ' GLU . 17.4 ptpt -67.93 -38.44 82.88 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 120.061 -0.656 . . . . 70.4 109.973 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -62.76 -38.56 91.07 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.336 -0.393 . . . . 74.25 110.924 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 77.8 mt -63.42 -37.66 88.13 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.933 -0.576 . . . . 75.14 109.453 177.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 41.0 m -69.93 -43.2 72.12 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.278 -0.873 . . . . 53.04 110.321 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -65.72 -27.37 68.28 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.048 0.539 . . . . 71.3 111.707 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.7 -13.56 59.38 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.477 -0.329 . . . . 64.33 111.459 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . 0.417 ' HA3' HD12 ' A' ' 480' ' ' ILE . . . 130.05 -81.27 0.34 Allowed Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 120.868 -0.682 . . . . 74.25 111.749 178.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -36.64 -68.9 0.12 Allowed 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 115.003 1.483 . . . . 65.31 115.003 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 59.65 35.15 84.96 Favored Glycine 0 C--N 1.318 -0.463 0 C-N-CA 121.007 -0.616 . . . . 72.31 112.551 -177.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.494 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 36.1 mmt180 -107.2 110.95 23.14 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.516 -1.29 . . . . 75.02 107.516 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -143.97 146.57 33.01 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 121.087 0.47 . . . . 74.34 111.532 -173.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . 0.429 ' HB2' ' HA ' ' A' ' 485' ' ' ILE . 34.8 mmtp -131.58 148.35 52.61 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 115.421 -0.809 . . . . 71.05 109.215 178.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -113.64 125.94 54.71 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.798 -0.816 . . . . 53.42 108.798 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -126.17 137.22 53.55 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.923 -1.14 . . . . 61.23 107.923 176.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . 0.52 ' HB2' ' OG ' ' A' ' 490' ' ' SER . 8.3 p30 -114.25 144.64 42.9 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 109.29 -0.633 . . . . 74.14 109.29 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 50.9 m -148.69 148.59 28.44 Favored Pre-proline 0 C--N 1.296 -1.734 0 N-CA-C 108.507 -0.923 . . . . 74.54 108.507 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.69 ' HA ' ' O ' ' A' ' 490' ' ' SER . 19.6 Cg_endo -64.33 125.49 15.19 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.189 1.926 . . . . 74.13 112.238 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 49.7 m -133.49 179.53 6.16 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.187 -1.042 . . . . 71.11 108.187 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.8 t -59.1 137.38 88.06 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 109.907 -0.405 . . . . 72.53 109.907 176.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -51.27 -29.74 30.92 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 124.528 3.485 . . . . 75.42 113.228 -176.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -72.99 -23.61 60.67 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.555 0.576 . . . . 65.11 112.555 -178.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 67.0 mt -101.42 -3.3 28.93 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.669 0.248 . . . . 73.45 111.669 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.441 HG13 ' HA ' ' A' ' 490' ' ' SER . 76.9 t -60.12 128.96 21.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 116.089 -0.505 . . . . 63.51 110.489 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.48 -11.76 59.77 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 115.742 -0.663 . . . . 63.31 112.392 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -114.04 165.81 12.25 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 109.355 -0.609 . . . . 74.24 109.355 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 71.1 t -74.33 146.22 10.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 116.062 -0.517 . . . . 65.23 109.832 177.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 49.3 mm -98.18 -35.11 4.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 107.839 -1.171 . . . . 72.14 107.839 177.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 169.61 -179.49 42.05 Favored Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 110.813 -0.915 . . . . 63.53 110.813 177.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . 0.483 HG22 HG12 ' A' ' 486' ' ' ILE . 61.4 p -115.49 141.85 47.5 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 105.171 -2.159 . . . . 42.35 105.171 176.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.446 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 25.2 t-20 -69.1 -53.78 13.21 Favored Pre-proline 0 C--N 1.319 -0.733 0 C-N-CA 118.882 -1.127 . . . . 71.34 111.692 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.466 ' HG2' ' HA ' ' A' ' 484' ' ' VAL . 8.5 Cg_exo -76.61 139.88 20.68 Favored 'Trans proline' 0 C--N 1.364 1.389 0 N-CA-C 107.621 -1.723 . . . . 73.32 107.621 170.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.93 126.76 18.75 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.043 1.829 . . . . 71.43 112.461 -175.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -86.48 19.13 2.93 Favored 'General case' 0 C--O 1.206 -1.221 0 CA-C-N 115.111 -0.95 . . . . 74.1 109.797 -177.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -110.01 -13.64 14.37 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.449 -0.796 . . . . 72.53 109.563 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -93.18 168.87 10.82 Favored 'General case' 0 C--O 1.247 0.954 0 N-CA-C 114.396 1.258 . . . . 50.2 114.396 -170.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 0.4 OUTLIER -82.79 109.5 16.99 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-N 113.6 -1.636 . . . . 73.43 108.296 -179.704 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 64.7 m -104.97 145.7 30.06 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-O 121.465 0.65 . . . . 72.11 111.5 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -84.68 169.42 14.33 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 107.566 -1.272 . . . . 72.45 107.566 175.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . 0.417 HD12 ' HA3' ' A' ' 448' ' ' GLY . 34.6 mm -72.46 -11.07 14.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 122.078 0.942 . . . . 54.42 110.356 -177.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 4.5 p -97.68 5.19 49.66 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.585 -0.734 . . . . 70.4 112.462 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -81.11 129.54 34.61 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 122.081 -0.387 . . . . 74.54 111.705 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.494 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.1 p -108.64 125.93 65.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.817 -0.628 . . . . 71.12 109.88 176.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.466 ' HA ' ' HG2' ' A' ' 472' ' ' PRO . 27.3 m -106.02 120.46 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 CA-C-O 121.941 0.877 . . . . 72.32 112.23 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.429 ' HA ' ' HB2' ' A' ' 453' ' ' LYS . 0.0 OUTLIER -92.86 121.52 43.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.415 -1.328 . . . . 62.22 107.415 175.35 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.483 HG12 HG22 ' A' ' 470' ' ' THR . 35.1 mt -114.35 128.75 71.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.044 -0.98 . . . . 73.34 111.379 -174.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 5.8 tt -101.87 126.56 55.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 116.031 -0.531 . . . . 71.33 110.649 -176.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 28.0 m -108.38 151.35 10.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 123.435 0.694 . . . . 42.11 109.893 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -84.14 128.9 8.86 Favored Glycine 0 N--CA 1.434 -1.465 0 C-N-CA 120.97 -0.633 . . . . 61.22 111.731 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.69 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 49.1 m . . . . . 0 C--N 1.301 -1.533 0 N-CA-C 108.725 -0.842 . . . . 63.52 108.725 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo . . . . . 0 N--CA 1.442 -1.53 0 CA-C-O 121.434 0.514 . . . . 75.04 112.32 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -108.56 77.06 1.06 Allowed 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.661 -0.866 . . . . 71.1 108.661 177.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 19.1 p -117.86 144.9 45.0 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 114.911 -1.04 . . . . 54.01 110.918 -176.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 495' ' ' LYS . 16.0 mmtt -150.25 165.13 33.9 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 112.124 0.416 . . . . 72.52 112.124 175.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.79 133.74 36.32 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 107.399 -1.334 . . . . 71.13 107.399 -178.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 39.5 pt -78.85 133.16 62.41 Favored Pre-proline 0 C--N 1.294 -1.841 0 C-N-CA 120.137 -0.625 . . . . 64.45 109.968 175.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.84 -179.35 5.38 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.782 2.322 . . . . 75.1 111.893 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -108.68 141.49 40.57 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.911 -0.774 . . . . 73.54 108.911 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.402 ' O ' ' HA2' ' A' ' 536' ' ' GLY . 4.8 p -143.95 103.58 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 CA-C-O 121.555 0.693 . . . . 74.32 110.137 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -141.71 106.71 4.94 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.181 -0.918 . . . . 52.22 109.219 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 123.13 -16.13 8.17 Favored Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 120.173 -1.013 . . . . 74.11 111.376 178.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -89.74 173.45 8.27 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.854 -0.424 . . . . 74.43 109.854 177.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 13.9 t -91.79 157.74 16.72 Favored 'General case' 0 N--CA 1.425 -1.707 0 C-N-CA 119.771 -0.772 . . . . 52.12 109.984 -176.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.428 HG22 HE21 ' A' ' 509' ' ' GLN . 9.5 p -53.27 -41.19 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 124.229 1.012 . . . . 74.2 112.158 -178.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -62.57 -41.98 99.27 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.128 0.49 . . . . 60.55 111.2 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 86.3 t -71.79 -37.35 61.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-N 116.092 -0.504 . . . . 72.43 110.513 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . 0.465 ' O ' HD23 ' A' ' 512' ' ' LEU . . . -61.5 -49.12 78.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.835 -0.62 . . . . 72.22 111.242 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.428 HE21 HG22 ' A' ' 505' ' ' VAL . 79.3 mt-30 -60.23 -46.91 88.16 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.019 0.438 . . . . 71.24 110.72 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.454 ' O ' HG23 ' A' ' 514' ' ' VAL . 55.8 tptt -65.44 -49.97 67.17 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 113.027 0.751 . . . . 74.42 113.027 -174.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -63.07 -37.76 88.5 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 120.142 -0.623 . . . . 64.53 110.45 -175.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . 0.465 HD23 ' O ' ' A' ' 508' ' ' ALA . 4.6 mm? -62.75 -43.3 99.15 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 116.551 -0.295 . . . . 64.0 111.007 175.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -62.98 -38.25 90.41 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 120.987 0.422 . . . . 54.22 110.699 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 510' ' ' LYS . 81.2 t -62.96 -34.25 65.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.562 -0.745 . . . . 71.44 110.554 177.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -85.27 3.2 40.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.89 0.376 . . . . 64.53 111.12 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . 0.541 ' O ' ' HB ' ' A' ' 547' ' ' VAL . . . 109.62 -20.84 26.81 Favored Glycine 0 N--CA 1.437 -1.289 0 C-N-CA 120.827 -0.701 . . . . 43.1 113.811 174.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -77.32 98.58 5.24 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.437 -1.319 . . . . 73.54 107.437 -175.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.91 -17.11 30.27 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.592 -0.731 . . . . 71.33 112.307 -169.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 28.1 mtpp -112.18 122.15 46.95 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.168 0.509 . . . . 71.24 111.604 -176.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -129.77 152.44 49.26 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.496 -0.775 . . . . 73.43 110.725 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.9 m -141.39 152.68 44.53 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 108.134 -1.061 . . . . 70.24 108.134 173.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . 0.44 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 4.1 pt20 -117.19 151.07 37.66 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-O 121.365 0.602 . . . . 71.12 111.199 -178.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 554' ' ' GLN . . . -132.79 118.69 19.33 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.23 -1.396 . . . . 54.41 107.23 174.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 11.7 p -85.92 128.86 34.93 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.013 0.435 . . . . 55.42 111.341 -177.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 28.7 m -127.3 160.02 36.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 109.485 -0.561 . . . . 73.34 109.485 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -72.76 136.18 45.44 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.565 -0.531 . . . . 72.45 109.565 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 52.1 m -152.58 161.92 27.91 Favored Pre-proline 0 C--N 1.304 -1.38 0 O-C-N 121.958 -0.464 . . . . 62.21 110.58 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -84.4 -2.55 9.98 Favored 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 122.392 2.061 . . . . 75.41 110.322 173.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.454 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 23.3 mmt180 -84.73 145.67 44.77 Favored Pre-proline 0 N--CA 1.44 -0.935 0 N-CA-C 106.81 -1.552 . . . . 72.31 106.81 177.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.88 162.48 41.96 Favored 'Trans proline' 0 C--O 1.246 0.878 0 C-N-CA 122.148 1.899 . . . . 72.52 111.874 177.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -57.11 126.03 25.35 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.298 -0.864 . . . . 55.13 111.679 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 116.64 -17.45 13.66 Favored Glycine 0 C--N 1.309 -0.938 0 C-N-CA 120.917 -0.658 . . . . 70.02 111.903 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -78.18 144.77 36.05 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.346 -0.983 . . . . 53.33 108.346 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 64.0 t -95.03 121.51 45.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 O-C-N 121.675 -0.64 . . . . 74.22 110.409 176.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 36.6 m -72.59 -40.85 66.25 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 124.588 1.155 . . . . 75.41 110.85 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 500' ' ' VAL . . . 162.16 -157.31 29.13 Favored Glycine 0 N--CA 1.432 -1.577 0 N-CA-C 110.602 -0.999 . . . . 75.43 110.602 -178.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 57.7 p -118.89 151.86 37.35 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.046 -0.724 . . . . 63.43 109.046 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -73.24 -54.4 4.28 Favored Pre-proline 0 C--N 1.313 -1.0 0 CA-C-O 119.44 -0.314 . . . . 74.1 110.712 177.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -74.06 143.24 32.2 Favored 'Trans proline' 0 C--N 1.36 1.164 0 N-CA-C 109.089 -1.158 . . . . 73.3 109.089 170.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.26 149.82 85.04 Favored 'Trans proline' 0 C--O 1.253 1.241 0 C-N-CA 122.313 2.008 . . . . 73.41 112.448 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -65.89 144.31 56.88 Favored 'General case' 0 C--O 1.249 1.049 0 N-CA-C 109.574 -0.528 . . . . 55.21 109.574 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.8 -12.5 57.82 Favored Glycine 0 N--CA 1.423 -2.195 0 C-N-CA 120.23 -0.985 . . . . 74.42 111.489 -176.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 54.2 m -66.59 120.94 14.28 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.251 -0.648 . . . . 63.3 109.251 176.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 41.1 m -85.32 122.61 29.74 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 108.614 -0.884 . . . . 64.05 108.614 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.61 158.26 70.61 Favored Pre-proline 0 C--N 1.311 -1.082 0 N-CA-C 108.834 -0.802 . . . . 73.43 108.834 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -64.78 149.18 90.04 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.073 1.849 . . . . 74.31 110.921 174.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.541 ' HB ' ' O ' ' A' ' 516' ' ' GLY . 36.0 m -63.14 -20.14 25.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-O 121.952 0.882 . . . . 54.21 111.6 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -77.43 -16.16 58.95 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.416 -1.266 . . . . 71.53 110.768 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 42.3 m -81.79 158.6 24.06 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 121.273 0.559 . . . . 62.21 111.784 -176.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 92.1 t -89.03 128.74 40.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 115.073 -0.967 . . . . 64.43 110.159 -178.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . 0.49 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -100.05 132.77 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 108.023 -1.102 . . . . 62.53 108.023 171.472 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -103.24 115.91 31.46 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-O 121.536 0.684 . . . . 71.45 111.329 -176.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 1.9 mm? -98.3 133.79 42.21 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.275 -1.329 . . . . 73.31 109.03 -179.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 523' ' ' ALA . 45.2 mt-30 -97.62 121.79 39.94 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.517 -0.549 . . . . 65.45 109.517 176.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 48.3 t -103.63 137.53 31.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 115.573 -0.74 . . . . 53.32 110.373 -173.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.454 ' HB3' ' HB2' ' A' ' 529' ' ' ARG . 22.0 m -69.58 129.47 39.76 Favored 'General case' 0 N--CA 1.427 -1.612 0 C-N-CA 124.071 0.948 . . . . 72.53 112.211 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -110.57 123.02 49.18 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 106.502 -1.666 . . . . 75.4 106.502 170.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -80.23 -30.38 41.89 Favored Glycine 0 C--N 1.311 -0.841 0 C-N-CA 120.984 -0.627 . . . . 74.1 113.845 -172.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 73.52 -2.52 2.73 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.687 1.195 . . . . 73.4 112.152 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.438 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 87.5 mt-30 -113.25 141.95 46.39 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.767 0.317 . . . . 52.44 110.859 -176.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -125.41 136.51 53.49 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.026 -0.533 . . . . 74.42 109.816 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 59.1 t -68.89 116.01 8.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 120.999 0.428 . . . . 34.35 110.612 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 59.5 ttp -97.1 132.01 26.52 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 109.148 -0.686 . . . . 62.12 109.148 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.85 168.99 15.61 Favored 'Trans proline' 0 C--O 1.244 0.787 0 C-N-CA 122.255 1.97 . . . . 52.02 111.045 176.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . 0.404 ' HA ' ' HB1' ' A' ' 610' ' ' ALA . 9.5 p-10 -89.44 114.99 26.54 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-O 122.291 1.043 . . . . 63.44 112.395 -178.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . 0.487 HD23 ' HD2' ' A' ' 577' ' ' ARG . 4.5 mp -118.16 7.1 12.06 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 106.188 -1.782 . . . . 74.01 106.188 171.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 32.5 t -80.34 153.71 28.22 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 113.577 -1.647 . . . . 52.31 109.946 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 97.71 44.81 2.6 Favored Glycine 0 N--CA 1.432 -1.599 0 N-CA-C 110.293 -1.123 . . . . 60.42 110.293 -177.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 62.1 mtp -140.79 -176.79 4.79 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.41 -1.33 . . . . 74.15 107.41 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -97.03 156.41 16.37 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.072 -1.084 . . . . 71.4 108.072 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . 0.571 ' HA ' ' HB3' ' A' ' 574' ' ' ALA . 76.5 t-105 -59.01 -29.39 67.22 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 122.987 0.515 . . . . 74.35 111.204 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 31.4 m -62.57 -23.95 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 116.122 -0.49 . . . . 72.21 111.302 178.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . 0.537 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 1.3 m-20 -101.13 -25.88 13.87 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-N 115.983 -0.553 . . . . 74.41 110.524 176.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . 0.571 ' HB3' ' HA ' ' A' ' 571' ' ' TRP . . . -72.91 -33.35 65.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.724 -0.671 . . . . 53.43 112.26 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.444 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 32.4 tt0 -60.57 -49.6 89.24 Favored Pre-proline 0 CA--C 1.56 1.363 0 C-N-CA 120.237 -0.585 . . . . 63.13 111.05 176.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . 0.444 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 70.2 Cg_exo -56.22 -35.65 95.74 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 121.459 1.439 . . . . 75.43 111.999 171.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 37.0 mmt180 -59.27 -46.76 87.64 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 109.616 -0.512 . . . . 75.3 109.616 176.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.439 ' HB3' ' O ' ' A' ' 575' ' ' GLU . 6.6 tt -57.77 -46.62 84.31 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 125.011 1.324 . . . . 74.44 109.626 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 575' ' ' GLU . 64.8 mtt-85 -65.31 -44.33 88.21 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.072 -0.967 . . . . 73.3 111.157 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -69.78 -28.26 65.61 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.04 0.448 . . . . 62.44 112.074 -177.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 97.6 mt -84.35 -8.08 59.11 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.613 -0.267 . . . . 64.11 110.914 177.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 61.68 42.42 99.75 Favored Glycine 0 CA--C 1.505 -0.579 0 N-CA-C 110.85 -0.9 . . . . 61.35 110.85 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 83.2 t90 -71.32 135.13 47.23 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.246 0.546 . . . . 75.23 111.688 -176.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 23.3 m -147.42 102.85 3.5 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 108.365 -0.976 . . . . 51.51 108.365 174.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -161.64 -124.07 0.7 Allowed Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 111.241 -0.744 . . . . 60.52 111.241 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . 0.49 ' HB3' HG12 ' A' ' 619' ' ' ILE . 0.1 OUTLIER -137.5 125.68 23.06 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.926 -0.768 . . . . 74.14 108.926 177.041 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 59.9 tp -97.24 117.58 31.77 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.818 -0.808 . . . . 63.02 108.818 176.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . 0.439 ' OD2' HD11 ' A' ' 619' ' ' ILE . 13.4 m-20 -101.24 101.94 12.73 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.157 -0.683 . . . . 75.0 109.157 174.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -88.04 126.43 35.09 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 106.352 -1.721 . . . . 74.24 106.352 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -73.67 -151.91 2.12 Favored Glycine 0 C--N 1.302 -1.336 0 CA-C-N 115.828 -0.624 . . . . 52.34 114.631 -177.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -58.82 143.65 46.74 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.371 0.605 . . . . 75.12 112.435 -177.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -94.2 124.74 38.41 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.398 -0.964 . . . . 73.24 108.398 175.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 47.5 t -123.08 117.77 52.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 109.177 -0.675 . . . . 71.42 109.177 -177.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -80.14 106.71 12.36 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.244 -0.65 . . . . 74.04 109.244 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -153.52 17.44 0.53 Allowed 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.93 -0.577 . . . . 72.25 110.584 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 99.96 101.53 2.39 Favored Glycine 0 N--CA 1.427 -1.939 0 N-CA-C 110.213 -1.155 . . . . 55.23 110.213 -175.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -60.9 -40.3 98.14 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-O 119.893 -0.393 . . . . 75.04 113.387 -176.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 15.6 m -56.99 -33.19 66.88 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.341 0.867 . . . . 73.55 113.341 -174.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -108.19 -10.59 15.38 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 112.993 0.738 . . . . 74.53 112.993 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . 0.415 ' C ' ' H ' ' A' ' 602' ' ' ARG . 68.9 m-70 -107.54 14.97 25.26 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.737 0.78 . . . . 73.42 110.929 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -81.47 15.35 2.09 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.762 -1.108 . . . . 74.41 108.371 175.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . 0.415 ' H ' ' C ' ' A' ' 600' ' ' HIS . 33.1 ttp180 -97.32 152.09 19.25 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.345 -0.843 . . . . 74.52 109.064 -175.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 10.0 p -65.26 137.16 25.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 O-C-N 123.45 0.469 . . . . 71.35 109.959 175.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 92.1 t -102.27 -52.95 7.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 120.36 -0.536 . . . . 73.53 109.561 177.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -154.07 164.32 38.67 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 107.789 -1.189 . . . . 65.32 107.789 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . 0.473 ' HA ' ' O ' ' A' ' 621' ' ' THR . 18.6 pt20 -143.88 155.1 43.97 Favored 'General case' 0 C--N 1.314 -0.976 0 O-C-N 124.097 0.873 . . . . 74.44 109.414 177.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . 0.278 81.8 m-20 -80.64 -55.46 0.72 Allowed Pre-proline 0 C--N 1.312 -1.062 0 N-CA-C 114.306 1.224 . . . . 74.53 114.306 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -85.85 107.83 0.94 Allowed 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.912 1.741 . . . . 41.5 109.287 173.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -70.38 144.93 52.15 Favored 'Trans proline' 0 C--O 1.243 0.756 0 C-N-CA 122.846 2.364 . . . . 72.24 113.467 -176.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . 0.404 ' HB1' ' HA ' ' A' ' 565' ' ' ASP . . . -68.67 137.58 54.28 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 108.562 -0.903 . . . . 64.54 108.562 175.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 99.81 -12.95 60.99 Favored Glycine 0 C--N 1.299 -1.481 0 N-CA-C 110.427 -1.069 . . . . 54.2 110.427 -175.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 25.8 m -106.78 162.82 13.45 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 107.898 -1.149 . . . . 74.54 107.898 178.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -72.19 117.18 6.21 Favored Glycine 0 N--CA 1.431 -1.635 0 N-CA-C 110.435 -1.066 . . . . 72.34 110.435 175.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.7 m -91.29 141.66 14.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.154 0.502 . . . . 63.23 110.55 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.609 HD21 HG22 ' A' ' 619' ' ' ILE . 8.9 p-10 -58.0 145.41 36.17 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 114.099 -1.409 . . . . 73.11 112.786 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -57.55 -25.25 59.65 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.483 1.113 . . . . 71.45 111.39 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -59.78 -45.26 92.84 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 115.351 -0.84 . . . . 74.2 109.261 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 79.12 12.17 84.32 Favored Glycine 0 N--CA 1.412 -2.915 0 N-CA-C 110.159 -1.176 . . . . 72.13 110.159 -175.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . 0.609 HG22 HD21 ' A' ' 615' ' ' ASN . 0.0 OUTLIER -70.39 126.29 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 108.335 -0.987 . . . . 25.23 108.335 -176.594 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.457 ' N ' HD13 ' A' ' 619' ' ' ILE . 7.5 tp -126.54 129.91 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.675 0 CA-C-N 115.645 -0.707 . . . . 74.23 110.991 -174.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 606' ' ' GLN . 39.7 m -104.66 127.19 52.34 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.27 -1.011 . . . . 74.31 108.27 175.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 96.0 mt -138.0 150.79 47.3 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 108.558 -0.905 . . . . 73.0 108.558 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -128.24 136.98 51.79 Favored 'General case' 0 C--N 1.278 -2.506 0 N-CA-C 107.295 -1.372 . . . . 74.03 107.295 172.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -141.9 165.61 26.99 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 104.42 -2.437 . . . . 75.04 104.42 170.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -61.26 -100.08 0.01 OUTLIER Glycine 0 C--N 1.301 -1.374 0 O-C-N 124.056 0.847 . . . . 73.11 113.683 -174.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . 0.501 HE21 ' HA ' ' A' ' 626' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.291 -1.941 0 N-CA-C 108.123 -1.066 . . . . 61.31 108.123 178.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 . . . . . 0 CA--C 1.49 -1.358 0 N-CA-C 108.504 -0.925 . . . . 54.42 108.504 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 34.5 m -117.24 145.92 22.39 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 108.896 -0.779 . . . . 61.04 108.896 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -95.35 121.5 37.08 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 106.01 -1.848 . . . . 75.15 106.01 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.407 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 63.7 t -97.39 121.58 58.13 Favored Pre-proline 0 C--N 1.291 -1.94 0 CA-C-N 114.942 -1.026 . . . . 72.33 110.849 -171.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 24.6 Cg_exo -63.5 158.26 46.5 Favored 'Trans proline' 0 C--O 1.242 0.688 0 C-N-CA 122.217 1.944 . . . . 71.4 110.229 177.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -103.42 168.85 8.9 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 120.355 -0.538 . . . . 73.42 109.898 -173.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 9.9 t -128.61 2.57 2.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-O 121.638 0.732 . . . . 74.41 109.15 -177.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.531 ' HD3' ' OG1' ' A' ' 402' ' ' THR . 16.8 ptt-85 -58.2 144.46 40.66 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.439 0.638 . . . . 63.31 111.723 178.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.4 -7.11 50.62 Favored Glycine 0 N--CA 1.425 -2.041 0 CA-C-N 115.004 -0.998 . . . . 72.42 111.607 -178.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -109.76 -87.89 0.51 Allowed 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 113.018 0.747 . . . . 74.44 113.018 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 81.3 p -159.44 159.51 33.7 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 109.213 -0.662 . . . . 73.51 109.213 -175.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 46.4 t -63.12 -40.5 97.78 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.788 -0.819 . . . . 73.31 108.788 175.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -63.92 -47.15 81.68 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 118.997 -0.525 . . . . 71.12 112.188 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -69.77 -35.88 75.28 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 119.721 -0.792 . . . . 75.35 110.607 -178.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -64.87 -51.26 62.99 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.789 -0.641 . . . . 44.1 109.935 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 68.5 mt -60.98 -46.27 96.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.687 -0.233 . . . . 63.55 110.591 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.83 -44.45 90.89 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 116.073 -0.512 . . . . 72.42 112.065 -176.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 28.3 m -67.67 -48.95 65.18 Favored 'General case' 0 C--O 1.249 1.067 0 CA-C-O 120.865 0.364 . . . . 41.13 111.068 -177.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.04 -40.44 94.79 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.092 0.404 . . . . 65.53 112.092 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . 0.497 HE21 ' HA ' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -66.62 -36.62 83.03 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.263 -0.426 . . . . 74.0 110.484 -177.742 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -70.16 -24.71 63.2 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 120.721 0.296 . . . . 71.13 111.727 176.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -86.91 -8.69 57.02 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.087 0.47 . . . . 73.32 111.389 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 97.83 4.15 57.96 Favored Glycine 0 C--N 1.309 -0.922 0 C-N-CA 120.378 -0.915 . . . . 65.02 112.306 176.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -79.91 148.37 31.29 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 109.129 -0.693 . . . . 71.03 109.129 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -95.01 132.67 39.62 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 107.704 -1.221 . . . . 75.13 107.704 -177.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 1.4 pp -118.83 131.07 72.68 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 CA-C-O 121.755 0.788 . . . . 71.02 112.688 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -113.15 127.6 56.24 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 107.881 -1.155 . . . . 71.45 107.881 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 27.5 m -119.38 128.1 53.75 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 109.968 -0.382 . . . . 72.32 109.968 -177.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -111.3 119.76 39.97 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.645 -0.872 . . . . 74.12 108.645 176.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.518 HE21 ' N ' ' A' ' 388' ' ' GLN . 0.0 OUTLIER -100.57 122.72 43.72 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.054 -0.721 . . . . 74.31 109.054 179.502 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . 0.409 ' HB2' HG13 ' A' ' 394' ' ' ILE . 68.2 mttm -119.63 134.36 23.86 Favored Pre-proline 0 C--N 1.293 -1.877 0 CA-C-N 115.96 -0.564 . . . . 72.43 110.004 -177.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . 0.49 ' O ' HD11 ' A' ' 394' ' ' ILE . 11.1 Cg_exo -72.52 157.47 52.73 Favored 'Trans proline' 0 C--O 1.248 0.979 0 C-N-CA 121.935 1.757 . . . . 73.1 110.116 175.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 32.7 t70 88.34 152.6 0.05 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 125.267 1.427 . . . . 73.1 111.938 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 17.9 m -101.5 13.0 36.32 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 113.262 0.838 . . . . 73.33 113.262 -174.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 26.9 m -76.03 -25.93 56.13 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.654 -1.239 . . . . 71.42 107.654 172.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.49 HD11 ' O ' ' A' ' 390' ' ' PRO . 0.0 OUTLIER -88.82 149.45 43.71 Favored Pre-proline 0 N--CA 1.433 -1.313 0 CA-C-N 114.764 -1.107 . . . . 73.31 108.67 172.524 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . 0.442 ' HA ' ' HD3' ' A' ' 396' ' ' PRO . 27.9 Cg_endo -63.31 133.66 41.5 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.198 2.599 . . . . 74.23 114.709 -174.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . 0.444 ' HA ' ' HB3' ' A' ' 421' ' ' SER . 53.8 Cg_exo -55.5 163.03 5.47 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 124.268 3.312 . . . . 72.02 111.934 175.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -56.47 -8.1 0.49 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.729 0.812 . . . . 53.51 113.165 -175.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 32.7 m170 -83.26 104.21 13.25 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 105.248 -2.13 . . . . 74.3 105.248 168.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.407 HG23 ' HA ' ' A' ' 366' ' ' ARG . 25.2 m -64.92 120.18 11.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 CA-C-N 114.798 -1.092 . . . . 72.34 111.216 -168.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 9.8 tp -98.17 -29.22 3.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 120.519 -0.472 . . . . 53.15 110.244 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.81 157.98 27.53 Favored Glycine 0 N--CA 1.428 -1.861 0 N-CA-C 110.867 -0.893 . . . . 75.4 110.867 -177.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . 0.531 ' OG1' ' HD3' ' A' ' 366' ' ' ARG . 17.3 p -139.43 -177.69 5.05 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 124.213 1.005 . . . . 64.32 109.246 -177.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . 0.457 ' HA ' ' HD3' ' A' ' 404' ' ' PRO . 16.8 t70 -101.17 133.48 20.93 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 107.342 -1.355 . . . . 71.34 107.342 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 403' ' ' ASP . 17.4 Cg_exo -67.76 11.02 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 123.473 2.782 . . . . 71.41 115.147 -173.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.86 -49.12 71.92 Favored 'General case' 0 C--O 1.216 -0.686 0 N-CA-C 109.756 -0.461 . . . . 52.42 109.756 176.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -69.82 -30.96 68.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.522 0.677 . . . . 64.33 110.239 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -76.8 -6.67 53.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.741 0.781 . . . . 74.43 110.354 -176.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 31.9 m -101.73 155.97 17.79 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 106.337 -1.727 . . . . 53.54 106.337 174.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 46.0 m -74.49 112.06 10.29 Favored 'General case' 0 N--CA 1.415 -2.197 0 N-CA-C 107.485 -1.302 . . . . 61.43 107.485 177.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 24.2 m -128.33 162.13 35.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 110.274 -0.269 . . . . 73.3 110.274 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 11.4 m -67.14 131.65 46.23 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.75 -0.833 . . . . 62.23 108.75 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -59.94 136.94 58.17 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 112.719 0.637 . . . . 73.42 112.719 -174.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 88.92 49.36 3.59 Favored Glycine 0 N--CA 1.434 -1.497 0 CA-C-N 114.887 -1.051 . . . . 71.41 111.599 -178.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -103.64 -173.66 2.36 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.688 -0.856 . . . . 75.15 108.688 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -109.08 120.66 43.19 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 123.274 0.629 . . . . 74.32 110.009 -176.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 48.6 mm -110.7 122.47 65.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 109.086 -0.709 . . . . 73.14 109.086 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 41.6 m -101.46 131.15 47.73 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.86 0.362 . . . . 72.41 111.301 -178.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 4.8 p -126.58 135.94 62.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 123.829 0.852 . . . . 74.33 109.643 -179.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -113.75 125.34 54.0 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.181 0.515 . . . . 63.44 109.855 176.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 22.0 m -124.72 150.3 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.185 0 CA-C-N 115.097 -0.956 . . . . 72.22 111.483 -176.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . 0.444 ' HB3' ' HA ' ' A' ' 396' ' ' PRO . 16.3 t -88.77 145.57 25.53 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.214 1.007 . . . . 70.13 112.473 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.3 p -117.14 157.83 25.26 Favored 'General case' 0 N--CA 1.412 -2.369 0 CA-C-N 113.207 -1.815 . . . . 72.33 106.191 171.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.667 0 N-CA-C 116.997 1.559 . . . . 40.13 116.997 -175.144 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 . . . . . 0 N--CA 1.424 -1.765 0 N-CA-C 106.924 -1.509 . . . . 64.13 106.924 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -121.13 142.15 50.13 Favored 'General case' 0 CA--C 1.486 -1.483 0 C-N-CA 119.809 -0.756 . . . . 75.32 111.992 -178.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 11.2 pt-20 -83.09 131.83 35.13 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.172 -1.377 . . . . 74.32 110.191 -176.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 60.6 mt -88.52 127.77 55.37 Favored Pre-proline 0 C--N 1.305 -1.346 0 N-CA-C 108.722 -0.844 . . . . 71.53 108.722 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -71.41 142.82 41.68 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 121.624 1.55 . . . . 54.14 110.152 174.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -77.89 115.14 17.41 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.443 -0.577 . . . . 71.34 109.443 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 48.0 t -109.85 146.17 15.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 108.237 -1.023 . . . . 62.33 108.237 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 2.5 p -67.32 153.04 44.61 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 122.915 0.486 . . . . 64.44 112.105 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . 0.421 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 18.6 p -65.15 -31.77 73.12 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 113.302 0.853 . . . . 75.04 113.302 -173.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 2.2 pp -82.13 -10.95 59.01 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 112.272 0.471 . . . . 74.43 112.272 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.542 HG22 ' HB3' ' A' ' 439' ' ' GLU . 3.7 m -103.96 44.84 0.99 Allowed 'General case' 0 CA--C 1.563 1.463 0 CA-C-O 121.722 0.772 . . . . 73.15 110.214 -177.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -52.36 -38.22 58.21 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.153 0.981 . . . . 65.33 112.457 177.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -60.04 -42.7 95.01 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.551 0.691 . . . . 44.32 110.559 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.542 ' HB3' HG22 ' A' ' 436' ' ' THR . 36.7 tt0 -70.91 -35.64 72.37 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.724 -0.671 . . . . 65.11 110.47 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.564 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -60.18 -49.39 77.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.124 -0.489 . . . . 53.23 110.884 -178.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.7 m -66.05 -39.52 84.73 Favored 'Isoleucine or valine' 0 C--O 1.25 1.107 0 N-CA-C 112.292 0.478 . . . . 70.1 112.292 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.416 ' HG3' ' HA ' ' A' ' 439' ' ' GLU . 0.0 OUTLIER -68.31 -34.65 76.52 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 119.751 -0.78 . . . . 70.23 112.083 177.546 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -64.09 -38.85 92.56 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.54 -0.3 . . . . 75.23 110.738 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 92.9 mt -63.46 -39.67 95.08 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.962 -0.563 . . . . 74.02 110.219 178.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.514 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 15.7 m -70.89 -39.3 72.88 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.929 -0.578 . . . . 41.23 111.197 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.98 -20.96 64.18 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.384 0.611 . . . . 73.14 110.94 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -85.69 5.35 32.48 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 115.53 -0.759 . . . . 73.32 111.923 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 110.22 -85.13 0.39 Allowed Glycine 0 CA--C 1.491 -1.418 0 C-N-CA 120.052 -1.07 . . . . 62.33 112.054 175.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -35.3 -62.36 0.39 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.4 1.259 . . . . 73.42 114.4 176.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . 0.514 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 58.39 26.17 58.89 Favored Glycine 0 CA--C 1.504 -0.622 0 C-N-CA 121.343 -0.456 . . . . 74.23 113.183 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.471 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 21.9 mmt180 -105.3 110.8 23.3 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 107.892 -1.151 . . . . 72.13 107.892 -177.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 33.1 p90 -140.66 152.46 45.39 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 116.315 -0.402 . . . . 63.03 110.132 -177.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -138.0 123.01 19.05 Favored 'General case' 0 C--N 1.291 -1.943 0 O-C-N 124.002 0.813 . . . . 75.33 109.392 176.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -87.26 126.58 34.92 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.292 -1.003 . . . . 71.21 108.292 178.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.09 146.1 43.35 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 107.276 -1.379 . . . . 54.43 107.276 177.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -120.03 140.24 51.3 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 109.477 -0.564 . . . . 73.41 109.477 -175.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . 0.419 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 49.4 m -147.69 132.59 8.98 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 109.489 -0.559 . . . . 63.45 109.489 174.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.626 ' HA ' ' O ' ' A' ' 490' ' ' SER . 38.9 Cg_exo -64.75 122.73 10.67 Favored 'Trans proline' 0 C--O 1.238 0.505 0 C-N-CA 122.225 1.95 . . . . 72.42 110.684 177.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 17.6 m -143.4 175.03 10.23 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 108.142 -1.059 . . . . 61.33 108.142 -176.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.9 t -47.6 139.36 8.56 Favored Pre-proline 0 C--O 1.249 1.076 0 C-N-CA 124.259 1.023 . . . . 52.44 112.251 178.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.13 -29.29 28.12 Favored 'Trans proline' 0 C--N 1.36 1.175 0 C-N-CA 124.74 3.626 . . . . 75.41 113.612 -177.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.25 -22.87 63.82 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 112.089 0.403 . . . . 75.54 112.089 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -104.25 -8.91 18.98 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 111.681 0.252 . . . . 61.01 111.681 178.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 98.6 t -60.84 127.25 20.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.974 0.416 . . . . 72.55 110.179 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.05 -16.18 60.19 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.934 -0.576 . . . . 73.43 112.41 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -107.63 166.04 10.97 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 108.352 -0.981 . . . . 75.51 108.352 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.421 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 75.2 t -76.72 143.08 13.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 108.571 -0.9 . . . . 75.44 108.571 176.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 63.8 mt -98.18 -30.9 3.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 107.961 -1.125 . . . . 75.02 107.961 177.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 167.17 179.26 40.03 Favored Glycine 0 N--CA 1.425 -2.096 0 N-CA-C 110.862 -0.895 . . . . 74.55 110.862 177.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . 0.552 HG22 HG12 ' A' ' 486' ' ' ILE . 59.2 p -115.64 140.66 48.98 Favored 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 107.41 -1.329 . . . . 63.41 107.41 177.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.51 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 7.2 t30 -63.7 -50.31 72.31 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 120.756 -0.377 . . . . 44.21 110.471 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.51 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 1.4 Cg_endo -88.35 152.87 6.65 Favored 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 121.593 1.529 . . . . 74.41 108.94 171.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -63.74 126.76 18.1 Favored 'Trans proline' 0 C--O 1.243 0.726 0 C-N-CA 121.313 1.342 . . . . 72.42 111.681 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -93.88 14.38 19.66 Favored 'General case' 0 C--O 1.202 -1.432 0 CA-C-O 121.68 0.753 . . . . 75.43 110.12 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -110.02 -1.99 17.31 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.715 -0.675 . . . . 75.12 109.318 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -109.75 174.68 5.75 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.36 -0.836 . . . . 70.23 112.578 -173.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 2.5 m -86.33 114.32 23.02 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 114.108 -1.405 . . . . 72.02 108.776 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 15.7 m -109.42 148.08 31.72 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 109.877 -0.416 . . . . 71.34 109.877 -176.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.98 157.74 36.12 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.478 -0.328 . . . . 53.32 110.809 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 37.6 mm -72.35 -17.73 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-O 122.084 0.945 . . . . 72.45 110.518 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 2.7 p -99.52 5.47 46.08 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.898 -0.592 . . . . 73.52 111.437 177.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -84.61 129.97 34.78 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.519 -0.549 . . . . 73.11 109.519 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.471 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 42.7 t -102.43 120.59 52.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.748 -0.834 . . . . 73.55 108.748 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 28.3 m -100.66 120.92 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-O 122.022 0.915 . . . . 70.2 111.239 -178.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.403 HG23 ' HB3' ' A' ' 471' ' ' ASN . 0.0 OUTLIER -95.51 128.99 46.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 109.352 -0.61 . . . . 61.03 109.352 178.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.552 HG12 HG22 ' A' ' 470' ' ' THR . 9.8 mt -120.36 128.14 75.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 C-N-CA 124.393 1.077 . . . . 61.01 110.267 -174.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 6.4 tt -100.85 127.17 54.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 C-N-CA 122.587 0.355 . . . . 64.44 111.342 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 34.3 m -113.07 152.17 14.84 Favored 'Isoleucine or valine' 0 C--O 1.254 1.3 0 C-N-CA 123.347 0.659 . . . . 54.1 110.241 178.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -81.24 130.91 10.02 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 121.042 -0.599 . . . . 52.21 113.537 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.626 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 35.6 t . . . . . 0 C--N 1.309 -1.171 0 N-CA-C 106.067 -1.827 . . . . 43.24 106.067 176.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 C--O 1.249 1.026 0 N-CA-C 111.091 -0.388 . . . . 73.02 111.091 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -129.19 32.32 4.73 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-O 121.879 0.847 . . . . 75.53 110.582 -177.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 546' ' ' PRO . 19.6 p -118.12 142.13 47.75 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 114.686 -1.143 . . . . 74.33 109.885 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? -139.65 163.2 33.2 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.393 -0.595 . . . . 75.12 109.393 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.4 p-10 -85.74 138.81 31.84 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.809 -0.632 . . . . 71.04 110.001 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 38.2 pt -88.1 133.74 36.47 Favored Pre-proline 0 C--N 1.295 -1.771 0 C-N-CA 120.536 -0.465 . . . . 72.42 109.823 175.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -87.04 175.18 5.05 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.649 2.233 . . . . 74.21 111.819 177.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -92.63 157.24 16.6 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.547 -0.909 . . . . 73.01 108.547 177.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.456 HG21 ' HA ' ' A' ' 508' ' ' ALA . 9.4 p -159.97 12.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.256 0 CA-C-O 121.531 0.681 . . . . 65.34 111.587 -177.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -74.59 95.05 2.74 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 121.417 0.627 . . . . 75.33 110.947 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 159.64 -22.64 0.28 Allowed Glycine 0 N--CA 1.427 -1.914 0 CA-C-N 115.39 -0.823 . . . . 74.01 111.497 -177.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -102.11 -177.85 3.53 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.02 -0.672 . . . . 70.01 109.241 176.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 20.3 p -83.41 158.93 21.92 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 110.036 -0.357 . . . . 70.31 110.036 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.491 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 9.5 p -52.99 -41.14 39.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 O-C-N 123.703 0.627 . . . . 73.54 111.92 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . 0.481 ' O ' ' HD3' ' A' ' 510' ' ' LYS . 3.4 m-20 -57.57 -42.02 82.26 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.746 0.419 . . . . 74.14 111.166 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 59.4 t -68.85 -38.29 78.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.231 0.538 . . . . 72.4 109.888 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . 0.456 ' HA ' HG21 ' A' ' 500' ' ' VAL . . . -62.96 -44.09 97.01 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.633 -0.712 . . . . 53.3 110.821 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.491 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 26.5 mt-30 -60.18 -39.58 86.97 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.0 -0.545 . . . . 72.13 110.836 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.481 ' HD3' ' O ' ' A' ' 506' ' ' ASP . 14.4 mptt -65.88 -50.62 63.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.698 -0.683 . . . . 72.33 111.047 177.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -61.89 -40.89 97.0 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 116.394 -0.367 . . . . 75.43 111.474 -177.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 94.0 mt -62.71 -44.76 95.38 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 110.358 -0.238 . . . . 73.01 110.358 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.46 -41.45 94.18 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.017 -0.538 . . . . 60.13 110.88 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 510' ' ' LYS . 73.5 t -57.85 -36.46 55.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.871 -0.604 . . . . 72.02 111.71 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -87.18 0.26 55.6 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.249 -0.58 . . . . 75.14 112.365 -177.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 98.97 14.16 37.5 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.754 -0.736 . . . . 75.24 113.719 175.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -101.03 110.19 22.19 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.344 -0.984 . . . . 74.43 108.344 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.39 -14.66 22.31 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 116.011 -0.54 . . . . 54.04 111.871 -175.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . 0.507 ' HD2' ' O ' ' A' ' 548' ' ' ASP . 99.2 mttt -108.03 115.5 30.25 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.608 0.718 . . . . 72.32 111.871 -175.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -130.21 150.94 51.23 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.084 -0.962 . . . . 53.34 109.65 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . 0.531 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 51.1 m -136.42 140.55 43.25 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 106.983 -1.488 . . . . 73.05 106.983 174.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . 0.472 ' NE2' HG21 ' A' ' 505' ' ' VAL . 3.6 pt20 -122.97 125.21 44.84 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.544 0.688 . . . . 75.01 112.35 -175.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -116.33 116.49 27.83 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.728 -1.124 . . . . 75.24 108.047 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 12.4 p -91.8 130.18 37.62 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.148 0.499 . . . . 51.41 111.173 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 27.2 m -121.89 158.54 25.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.252 -1.018 . . . . 75.43 108.252 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -73.35 137.72 44.92 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 119.87 -0.732 . . . . 71.2 109.189 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 24.6 m -148.35 171.06 6.73 Favored Pre-proline 0 C--N 1.287 -2.142 0 N-CA-C 107.941 -1.133 . . . . 73.2 107.941 -178.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -81.61 -11.08 11.75 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 121.508 1.472 . . . . 70.14 110.783 172.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.467 ' HD3' ' OE2' ' A' ' 533' ' ' GLU . 88.4 mtt180 -80.91 145.39 57.18 Favored Pre-proline 0 N--CA 1.444 -0.735 0 CA-C-N 115.276 -0.874 . . . . 71.21 108.932 178.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.26 151.47 82.16 Favored 'Trans proline' 0 C--O 1.253 1.235 0 C-N-CA 122.787 2.325 . . . . 64.25 112.855 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.682 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -62.43 112.12 2.31 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.932 -1.031 . . . . 70.24 111.739 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 134.11 -20.88 3.96 Favored Glycine 0 C--N 1.308 -0.977 0 C-N-CA 120.829 -0.701 . . . . 64.2 112.617 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . 0.467 ' OE2' ' HD3' ' A' ' 529' ' ' ARG . 34.3 tt0 -83.02 142.37 31.38 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.702 -0.481 . . . . 53.11 109.702 179.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 63.1 t -81.92 123.41 38.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 108.666 -0.864 . . . . 72.41 108.666 178.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . 0.69 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 10.3 t -96.44 -19.74 18.94 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.36 -0.536 . . . . 73.14 110.742 -178.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 177.48 179.13 47.58 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.244 -0.979 . . . . 73.21 111.509 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 72.1 p -124.16 149.82 45.86 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.562 -1.273 . . . . 60.52 107.562 177.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.424 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 47.6 t30 -67.75 -59.82 6.25 Favored Pre-proline 0 C--N 1.323 -0.555 0 C-N-CA 120.548 -0.461 . . . . 74.11 109.931 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 57.2 Cg_endo -76.29 130.56 12.1 Favored 'Trans proline' 0 N--CA 1.44 -1.653 0 N-CA-C 108.298 -1.462 . . . . 63.54 108.298 170.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -66.63 150.69 83.73 Favored 'Trans proline' 0 C--O 1.255 1.371 0 C-N-CA 122.01 1.807 . . . . 75.31 112.178 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -58.98 142.74 50.27 Favored 'General case' 0 C--O 1.249 1.067 0 CA-C-N 115.759 -0.655 . . . . 72.54 109.787 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 102.9 -17.33 52.9 Favored Glycine 0 C--N 1.291 -1.917 0 C-N-CA 120.508 -0.853 . . . . 55.45 111.677 -179.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 61.5 m -68.9 127.49 33.28 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 109.959 -0.385 . . . . 65.2 109.959 178.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 20.6 m -91.62 122.99 34.68 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.384 -0.969 . . . . 64.24 108.384 177.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 29.4 m -137.37 161.26 61.84 Favored Pre-proline 0 C--N 1.311 -1.102 0 N-CA-C 109.033 -0.728 . . . . 50.04 109.033 -176.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 494' ' ' THR . 13.6 Cg_endo -61.33 151.68 77.65 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 121.809 1.673 . . . . 74.34 110.821 173.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 30.5 m -63.3 -20.31 25.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.596 0.712 . . . . 42.13 112.166 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . 0.507 ' O ' ' HD2' ' A' ' 519' ' ' LYS . 26.8 t70 -90.42 4.25 51.5 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.628 -0.715 . . . . 73.33 110.863 178.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.1 t -71.15 162.61 29.14 Favored 'General case' 0 C--O 1.241 0.62 0 O-C-N 121.474 -0.766 . . . . 71.03 109.402 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 18.0 t -109.32 116.75 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 CA-C-O 121.152 0.501 . . . . 74.45 109.961 -176.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 2.5 mp -91.95 123.86 44.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 109.124 -0.695 . . . . 55.21 109.124 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 521' ' ' SER . 37.7 tt0 -102.87 120.14 40.08 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-O 121.056 0.455 . . . . 73.24 110.029 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -96.65 134.27 40.11 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.96 -1.018 . . . . 71.13 109.817 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -92.47 114.88 27.56 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.513 -1.291 . . . . 74.14 107.513 171.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 524' ' ' SER . 47.6 t -100.73 141.72 17.01 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.39 0 N-CA-C 108.684 -0.858 . . . . 72.42 108.684 -177.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.69 ' OG ' ' HB ' ' A' ' 535' ' ' THR . 71.7 m -81.45 138.76 35.5 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-O 121.124 0.488 . . . . 73.04 111.75 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.11 135.72 52.4 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 105.678 -1.971 . . . . 73.01 105.678 169.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -71.12 -41.95 59.45 Favored Glycine 0 CA--C 1.497 -1.039 0 N-CA-C 111.297 -0.721 . . . . 64.54 111.297 -175.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 65.4 t30 66.43 8.12 5.49 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.686 1.194 . . . . 75.5 111.21 175.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -113.78 162.3 16.48 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.127 -0.942 . . . . 71.21 109.152 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -137.19 144.92 43.12 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.414 -0.588 . . . . 74.43 109.414 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 96.8 t -72.83 122.61 25.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 123.528 0.517 . . . . 45.11 110.233 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 48.7 ttm -78.22 126.11 83.96 Favored Pre-proline 0 C--N 1.308 -1.231 0 CA-C-N 115.714 -0.676 . . . . 42.43 109.964 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.3 169.33 18.57 Favored 'Trans proline' 0 C--O 1.243 0.774 0 C-N-CA 122.569 2.18 . . . . 64.01 110.7 176.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -83.08 119.7 24.82 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.834 0.826 . . . . 71.22 111.338 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 95.0 mt -127.34 14.04 7.15 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.083 -1.417 . . . . 73.42 107.453 176.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 9.3 m -72.04 130.7 41.56 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.431 -1.258 . . . . 71.41 109.356 -178.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 85.02 22.91 51.24 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.345 -0.931 . . . . 64.3 112.028 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 87.9 mtp -116.14 -178.91 3.52 Favored 'General case' 0 C--O 1.25 1.105 0 N-CA-C 109.282 -0.636 . . . . 74.0 109.282 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . 0.409 ' HB3' ' OD1' ' A' ' 601' ' ' ASN . 97.1 m-85 -97.47 153.17 18.3 Favored 'General case' 0 N--CA 1.414 -2.226 0 N-CA-C 109.176 -0.676 . . . . 75.11 109.176 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 64.1 t90 -64.57 -27.37 68.91 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 123.441 0.697 . . . . 70.21 110.142 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 10.3 p -71.66 -16.44 18.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.779 -0.646 . . . . 73.11 109.694 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . 0.509 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 22.9 m-20 -101.14 -44.91 5.54 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.6 -0.519 . . . . 73.22 109.6 176.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -62.91 -52.68 62.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.596 -0.729 . . . . 72.34 112.664 -175.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.464 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 4.1 tm-20 -55.55 -52.11 74.59 Favored Pre-proline 0 CA--C 1.567 1.623 0 C-N-CA 122.784 0.434 . . . . 74.54 111.851 -176.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . 0.464 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 52.3 Cg_exo -61.12 -29.46 87.25 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 121.785 1.657 . . . . 44.42 113.038 174.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.542 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 20.0 mmt180 -66.43 -40.41 89.51 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 111.479 0.177 . . . . 73.54 111.479 178.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.13 -45.53 90.68 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.202 0.525 . . . . 64.54 109.952 177.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -59.68 -39.64 85.18 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.362 -0.835 . . . . 65.11 110.961 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.29 -21.39 62.95 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.341 -0.39 . . . . 44.42 111.717 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 92.3 mt -82.66 -6.8 59.57 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 120.956 0.407 . . . . 54.42 111.43 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 88.36 20.07 50.07 Favored Glycine 0 C--O 1.238 0.37 0 C-N-CA 120.135 -1.031 . . . . 60.14 111.495 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 89.9 t90 -70.92 129.84 40.07 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.006 -0.738 . . . . 72.5 109.006 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 1.2 m -127.56 13.92 7.02 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.606 -0.516 . . . . 63.34 109.606 -176.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -88.98 -156.82 32.07 Favored Glycine 0 CA--C 1.498 -1.029 0 C-N-CA 120.538 -0.839 . . . . 44.31 114.987 -173.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 50.0 ttm -108.1 131.36 54.7 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 122.873 0.469 . . . . 73.21 111.37 -178.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -101.37 128.96 47.32 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.653 -1.24 . . . . 64.13 107.653 176.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -107.0 122.36 46.28 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 116.2 -0.454 . . . . 75.41 109.837 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -90.28 132.97 35.24 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.404 -0.816 . . . . 71.33 110.158 -178.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -85.34 177.64 50.42 Favored Glycine 0 N--CA 1.431 -1.682 0 C-N-CA 120.987 -0.625 . . . . 64.11 112.227 175.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -72.53 144.74 47.85 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 123.067 0.547 . . . . 63.11 111.451 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -63.42 151.35 41.29 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.866 -0.607 . . . . 74.11 111.402 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 47.0 t -138.39 116.97 13.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 107.954 -1.128 . . . . 72.02 107.954 -178.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -74.43 124.06 25.84 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.085 -1.08 . . . . 73.13 108.085 177.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -160.19 12.9 0.12 Allowed 'General case' 0 C--O 1.244 0.801 0 N-CA-C 112.376 0.51 . . . . 74.21 112.376 -176.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 89.8 166.67 41.79 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.172 -1.013 . . . . 50.02 112.086 -178.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -59.56 -48.23 87.04 Favored Glycine 0 CA--C 1.519 0.301 0 N-CA-C 114.724 0.649 . . . . 71.52 114.724 -175.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 28.2 m -61.23 -25.22 66.92 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-O 121.224 0.535 . . . . 75.52 112.136 -176.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -108.36 -1.52 19.9 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 112.477 0.547 . . . . 75.44 112.477 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.53 -51.65 11.29 Favored 'General case' 0 C--O 1.195 -1.791 0 C-N-CA 119.624 -0.83 . . . . 74.04 111.864 -173.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . 0.409 ' OD1' ' HB3' ' A' ' 570' ' ' PHE . 16.7 t-20 -92.19 19.39 6.98 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 120.857 -1.152 . . . . 73.34 109.429 -177.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 20.0 tpp85 -91.08 139.77 30.45 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.015 -0.993 . . . . 63.3 109.936 -176.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 13.5 p -65.05 139.97 20.52 Favored 'Isoleucine or valine' 0 C--O 1.247 0.94 0 N-CA-C 108.597 -0.89 . . . . 63.44 108.597 175.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 95.5 t -100.15 -46.88 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.056 0 N-CA-C 108.427 -0.953 . . . . 64.41 108.427 -177.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -156.15 157.23 35.59 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 105.872 -1.899 . . . . 73.42 105.872 176.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -123.4 131.94 53.81 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 106.918 -1.512 . . . . 73.02 106.918 173.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.611 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 25.8 t-20 -50.8 -58.09 11.34 Favored Pre-proline 0 C--N 1.312 -1.028 0 CA-C-O 118.844 -0.598 . . . . 72.11 112.366 -177.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.611 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 11.1 Cg_endo -96.76 121.5 0.2 Allowed 'Trans proline' 0 N--CA 1.44 -1.674 0 C-N-CA 121.733 1.622 . . . . 75.45 109.716 173.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -66.46 158.36 55.79 Favored 'Trans proline' 0 C--O 1.25 1.077 0 C-N-CA 122.116 1.877 . . . . 72.11 112.277 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.86 130.91 47.92 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.854 -0.612 . . . . 62.31 110.679 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 104.29 -3.77 43.93 Favored Glycine 0 C--N 1.3 -1.425 0 C-N-CA 120.635 -0.793 . . . . 74.34 112.119 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 6.1 m -93.13 148.13 22.28 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.235 -0.654 . . . . 63.11 109.235 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -84.5 115.79 4.16 Favored Glycine 0 N--CA 1.425 -2.056 0 N-CA-C 109.272 -1.531 . . . . 61.4 109.272 175.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.4 m -100.98 143.7 13.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 C-N-CA 122.854 0.461 . . . . 52.01 111.067 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -44.4 166.53 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.637 1.975 . . . . 75.13 113.354 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.0 -26.08 61.93 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.943 0.401 . . . . 64.52 111.59 -176.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . 0.501 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 25.8 t70 -79.68 -37.23 36.27 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.592 -0.731 . . . . 75.21 109.315 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 81.42 22.76 59.83 Favored Glycine 0 N--CA 1.429 -1.789 0 C-N-CA 118.948 -1.596 . . . . 51.43 111.527 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.81 119.8 12.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 122.286 1.041 . . . . 65.42 109.165 -168.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.15 126.76 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-N 114.513 -1.221 . . . . 71.41 110.594 -172.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.527 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 32.2 m -100.9 125.8 47.48 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.128 -0.693 . . . . 74.43 109.128 175.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.5 pp -133.85 154.63 50.89 Favored 'General case' 0 CA--C 1.479 -1.759 0 N-CA-C 108.612 -0.885 . . . . 72.42 108.612 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -127.98 141.57 51.49 Favored 'General case' 0 C--N 1.257 -3.414 0 N-CA-C 105.43 -2.063 . . . . 72.24 105.43 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -137.41 166.82 22.91 Favored 'General case' 0 C--N 1.277 -2.561 0 N-CA-C 107.129 -1.434 . . . . 74.34 107.129 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -70.7 -137.34 0.14 Allowed Glycine 0 N--CA 1.427 -1.921 0 O-C-N 124.325 1.016 . . . . 65.01 115.343 -174.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 C--N 1.289 -2.05 0 CA-C-O 118.967 -0.54 . . . . 65.14 109.575 -171.159 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 . . . . . 0 CA--C 1.5 -0.949 0 N-CA-C 106.019 -1.845 . . . . 73.44 106.019 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 31.4 m -115.51 154.14 16.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-O 121.633 0.73 . . . . 71.4 111.053 -172.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . 0.546 ' NE2' ' HA ' ' A' ' 407' ' ' ASN . 0.9 OUTLIER -94.92 136.77 34.83 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 106.425 -1.694 . . . . 74.43 106.425 -176.16 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.574 HG22 ' CZ ' ' A' ' 382' ' ' PHE . 98.0 t -95.12 118.63 66.49 Favored Pre-proline 0 C--N 1.297 -1.68 0 CA-C-N 116.028 -0.533 . . . . 74.3 110.773 -169.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 17.1 Cg_exo -64.59 130.92 27.86 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 123.027 2.485 . . . . 61.15 112.271 -178.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -93.66 121.16 34.8 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.238 -0.892 . . . . 70.34 110.342 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 5.7 m -104.65 23.91 2.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 122.005 0.907 . . . . 64.21 110.986 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.462 ' HA ' HG23 ' A' ' 399' ' ' VAL . 4.5 ppt_? -54.85 145.54 19.61 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.551 -1.204 . . . . 72.34 110.781 172.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.15 -11.8 51.94 Favored Glycine 0 C--N 1.302 -1.344 0 N-CA-C 110.356 -1.098 . . . . 71.3 110.356 -175.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -108.18 -151.66 0.47 Allowed 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 108.464 -0.939 . . . . 71.24 108.464 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 80.6 p -98.21 157.44 16.16 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.43 -0.582 . . . . 72.13 109.43 -174.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.5 p -63.67 -41.06 98.22 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 112.306 0.484 . . . . 75.24 112.306 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -67.14 -42.83 83.74 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-O 119.462 -0.304 . . . . 50.4 111.495 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.02 -35.12 74.09 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 119.558 -0.857 . . . . 62.41 110.594 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.22 -47.95 75.04 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.788 -0.642 . . . . 60.43 110.611 177.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . 0.548 HG23 HG13 ' A' ' 384' ' ' ILE . 70.6 mt -61.71 -43.19 96.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-N 116.039 -0.528 . . . . 61.44 110.309 175.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.57 -44.77 89.87 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.126 -0.488 . . . . 74.43 110.112 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 87.9 m -60.74 -46.81 89.02 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.964 -0.562 . . . . 52.54 110.753 178.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 93.7 mt -62.98 -40.33 97.42 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.346 -0.388 . . . . 62.42 110.22 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -62.12 -43.29 99.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.671 -0.695 . . . . 64.15 110.3 178.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.0 -31.85 70.31 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 120.982 0.42 . . . . 63.25 111.384 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -85.86 -12.24 51.23 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.957 -0.565 . . . . 75.41 111.751 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 94.49 14.57 50.08 Favored Glycine 0 C--N 1.307 -1.059 0 C-N-CA 120.761 -0.733 . . . . 61.33 112.701 177.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.574 ' CZ ' HG22 ' A' ' 362' ' ' VAL . 52.2 m-85 -81.04 150.82 28.67 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-O 121.076 0.465 . . . . 75.53 111.221 177.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.419 ' CB ' ' HG2' ' A' ' 415' ' ' GLU . 7.7 mmtp -84.49 144.78 28.49 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.854 -1.165 . . . . 75.2 107.854 175.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . 0.548 HG13 HG23 ' A' ' 374' ' ' ILE . 0.2 OUTLIER -129.93 133.83 63.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-O 121.495 0.664 . . . . 74.15 111.015 -177.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . 0.463 ' NE ' ' HA ' ' A' ' 385' ' ' ARG . 3.6 tpm_? -115.89 147.13 41.43 Favored 'General case' 0 N--CA 1.41 -2.437 0 N-CA-C 106.519 -1.66 . . . . 72.4 106.519 173.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 39.1 m -129.55 127.64 41.13 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 109.507 -0.553 . . . . 75.15 109.507 -177.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -119.12 130.52 55.61 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 105.488 -2.042 . . . . 73.35 105.488 176.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.506 HE21 ' N ' ' A' ' 388' ' ' GLN . 0.0 OUTLIER -121.55 135.9 54.98 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 118.452 0.569 . . . . 63.43 110.062 -178.716 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -134.42 115.92 12.83 Favored Pre-proline 0 C--N 1.314 -0.952 0 C-N-CA 121.335 -0.146 . . . . 55.41 111.1 177.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . 0.495 ' CA ' ' HB ' ' A' ' 422' ' ' THR . 64.8 Cg_endo -87.91 135.49 3.4 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.43 2.087 . . . . 74.51 111.146 174.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.537 ' HB3' HG12 ' A' ' 394' ' ' ILE . 13.1 t70 -179.82 153.65 0.54 Allowed 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 109.022 -0.733 . . . . 50.43 109.022 177.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 9.9 m -73.87 -18.53 60.91 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 123.186 0.594 . . . . 64.35 111.959 -177.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 3.1 m -87.63 -17.37 32.02 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-O 121.741 0.781 . . . . 65.31 109.975 -178.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.571 HG22 ' HB3' ' A' ' 421' ' ' SER . 45.4 mm -90.22 135.68 29.55 Favored Pre-proline 0 C--N 1.301 -1.513 0 CA-C-N 115.446 -0.797 . . . . 44.03 111.311 -171.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . 0.456 ' HB3' ' HD2' ' A' ' 396' ' ' PRO . 95.7 Cg_exo -50.14 179.0 0.02 OUTLIER 'Trans proline' 0 CA--C 1.585 3.072 1 C-N-CA 126.104 4.536 . . . . 71.11 116.021 179.223 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 395' ' ' PRO . 37.6 Cg_endo -67.14 160.96 44.98 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 123.191 2.594 . . . . 72.34 113.13 173.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -62.58 -6.24 3.3 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 124.591 1.156 . . . . 73.24 113.618 -177.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -65.6 158.04 28.23 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.946 -0.761 . . . . 64.4 108.946 177.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.462 HG23 ' HA ' ' A' ' 366' ' ' ARG . 6.4 m -86.36 117.77 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 C-N-CA 118.49 -1.284 . . . . 70.03 108.893 176.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . 0.413 HD12 ' N ' ' A' ' 401' ' ' GLY . 2.7 pp -88.96 -28.52 5.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 113.007 0.743 . . . . 53.31 113.007 -177.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . 0.413 ' N ' HD12 ' A' ' 400' ' ' ILE . . . -167.97 169.3 41.28 Favored Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 110.659 -0.976 . . . . 61.4 110.659 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 18.6 p -114.95 172.71 6.88 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.69 -0.856 . . . . 72.42 108.69 177.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -102.71 155.42 36.56 Favored Pre-proline 0 C--N 1.292 -1.9 0 N-CA-C 109.028 -0.73 . . . . 61.45 109.028 177.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -50.1 -20.13 4.98 Favored 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 124.043 3.162 . . . . 74.11 115.384 -175.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -62.23 -42.82 99.65 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 110.044 -0.354 . . . . 73.21 110.044 -178.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . 0.421 ' O ' ' HB ' ' A' ' 362' ' ' VAL . . . -71.3 -33.09 69.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.87 0.843 . . . . 60.3 109.741 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . 0.546 ' HA ' ' NE2' ' A' ' 361' ' ' GLN . 18.2 m120 -86.52 2.18 48.92 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.326 -0.852 . . . . 74.11 112.27 -176.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 36.3 m -103.21 152.16 21.8 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 105.783 -1.932 . . . . 65.31 105.783 172.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 24.6 m -74.8 112.85 11.43 Favored 'General case' 0 N--CA 1.429 -1.517 0 C-N-CA 119.56 -0.856 . . . . 52.42 109.252 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 35.1 m -113.36 169.06 5.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 121.048 0.451 . . . . 75.42 110.256 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 19.9 m -66.45 134.7 53.01 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.637 -0.875 . . . . 74.24 108.637 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -54.78 112.37 1.02 Allowed 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 122.994 0.518 . . . . 61.11 111.086 -178.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 105.49 27.74 5.68 Favored Glycine 0 N--CA 1.433 -1.552 0 C-N-CA 120.591 -0.814 . . . . 55.32 112.86 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -85.16 177.22 7.95 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.418 -0.956 . . . . 75.44 108.418 177.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . 0.419 ' HG2' ' CB ' ' A' ' 383' ' ' LYS . 27.5 mt-10 -97.87 110.88 23.37 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.65 0.738 . . . . 71.15 110.97 -172.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 44.9 mm -98.33 122.62 50.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 CA-C-N 115.064 -0.971 . . . . 75.24 108.977 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . 0.423 HG22 ' HB3' ' A' ' 385' ' ' ARG . 15.6 p -89.22 130.73 35.58 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.831 -0.622 . . . . 75.4 111.419 -177.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 7.5 p -114.36 134.3 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 N-CA-C 109.118 -0.697 . . . . 73.23 109.118 175.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -106.03 115.39 30.15 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.993 -1.484 . . . . 64.41 106.993 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 48.6 t -106.93 130.64 58.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-O 122.047 0.927 . . . . 74.51 109.727 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . 0.571 ' HB3' HG22 ' A' ' 394' ' ' ILE . 49.6 m -87.71 123.34 32.43 Favored 'General case' 0 C--N 1.273 -2.751 0 CA-C-N 114.164 -1.38 . . . . 43.15 108.746 179.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . 0.495 ' HB ' ' CA ' ' A' ' 390' ' ' PRO . 6.2 m -106.08 157.6 17.42 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 108.131 -1.063 . . . . 45.25 108.131 -177.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.651 0 N-CA-C 116.645 1.418 . . . . 71.3 116.645 -173.954 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.405 ' HB3' HG22 ' A' ' 477' ' ' THR . 43.5 mt-30 . . . . . 0 N--CA 1.428 -1.555 0 N-CA-C 107.677 -1.231 . . . . 74.41 107.677 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.573 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 4.2 mmp_? -126.17 141.8 51.79 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.369 0.604 . . . . 71.4 111.152 176.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.402 ' H ' ' HG2' ' A' ' 428' ' ' GLU . 8.7 pt-20 -83.11 129.63 35.04 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 106.724 -1.584 . . . . 75.04 106.724 175.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 53.0 mt -80.42 131.22 62.37 Favored Pre-proline 0 N--CA 1.428 -1.556 0 N-CA-C 108.947 -0.76 . . . . 63.12 108.947 -174.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -69.35 140.72 44.96 Favored 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 121.468 1.446 . . . . 70.24 110.993 176.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -89.46 114.39 25.87 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.305 -1.368 . . . . 74.52 107.305 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.444 HG11 ' HB2' ' A' ' 440' ' ' ALA . 14.7 p -110.82 159.29 10.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 108.663 -0.866 . . . . 74.13 108.663 -175.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 22.6 p -68.31 137.76 54.91 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 108.141 -1.059 . . . . 63.33 108.141 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . 0.426 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 18.3 p -63.38 -21.56 66.35 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 113.675 0.991 . . . . 74.12 113.675 -174.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.2 pp -78.2 -11.48 59.93 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 120.103 -0.639 . . . . 64.14 111.606 177.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.3 m -106.79 61.79 0.63 Allowed 'General case' 0 N--CA 1.432 -1.351 0 CA-C-O 121.725 0.774 . . . . 63.23 111.729 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -52.32 -38.25 58.08 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.363 1.065 . . . . 74.5 111.507 174.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -59.39 -42.53 91.9 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.34 0.591 . . . . 53.44 110.904 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -70.92 -36.89 72.86 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.574 -0.739 . . . . 74.44 109.23 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.527 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.03 -51.69 68.58 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.748 -0.66 . . . . 63.05 111.095 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 35.5 m -64.86 -40.73 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 N-CA-C 112.589 0.588 . . . . 51.41 112.589 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -68.77 -36.37 78.23 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 119.862 -0.735 . . . . 70.41 111.276 178.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -63.9 -41.86 97.59 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.27 -0.423 . . . . 74.22 110.908 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.527 HD13 ' O ' ' A' ' 440' ' ' ALA . 7.3 mp -63.75 -32.69 74.27 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.918 -0.583 . . . . 71.02 110.322 176.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 85.2 m -69.97 -44.9 68.52 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.653 -0.703 . . . . 64.31 110.293 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.22 -22.26 65.72 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.361 0.601 . . . . 71.35 110.814 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.83 5.09 14.58 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.44 -0.8 . . . . 71.31 112.321 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 104.31 -82.95 0.38 Allowed Glycine 0 CA--C 1.492 -1.366 0 C-N-CA 120.261 -0.971 . . . . 70.25 111.816 175.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -41.09 -56.16 2.4 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.012 1.116 . . . . 74.2 114.012 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 59.25 27.25 62.62 Favored Glycine 0 C--N 1.322 -0.202 0 C-N-CA 121.528 -0.368 . . . . 73.14 113.239 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -101.34 111.21 23.37 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 109.526 -0.546 . . . . 72.45 109.526 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.512 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 27.8 p90 -134.48 150.83 50.85 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 115.485 -0.78 . . . . 74.42 109.712 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 21.4 tptp -138.46 127.81 24.49 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 106.558 -1.645 . . . . 62.32 106.558 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -98.31 127.86 44.45 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.367 0.603 . . . . 74.3 111.938 -176.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -126.92 139.88 52.74 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.23 -1.026 . . . . 75.45 108.23 176.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -112.85 143.58 43.87 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.658 -0.867 . . . . 72.31 108.658 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 22.8 t -139.92 134.33 15.83 Favored Pre-proline 0 C--N 1.295 -1.779 0 N-CA-C 109.054 -0.721 . . . . 72.44 109.054 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 490' ' ' SER . 52.7 Cg_endo -74.27 128.15 11.83 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 121.859 1.706 . . . . 74.52 110.59 176.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 35.0 m -147.14 179.93 7.27 Favored 'General case' 0 C--N 1.288 -2.098 0 C-N-CA 123.247 0.619 . . . . 74.41 109.466 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.5 t -48.85 143.87 7.84 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 125.189 1.396 . . . . 74.24 112.148 178.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . 0.487 ' HA ' HG23 ' A' ' 464' ' ' VAL . 10.3 Cg_endo -51.68 -29.29 32.64 Favored 'Trans proline' 0 C--N 1.362 1.275 0 C-N-CA 124.761 3.64 . . . . 72.42 113.484 -178.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -74.89 -8.36 56.24 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 112.767 0.654 . . . . 65.43 112.767 -176.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -111.4 -6.93 14.41 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.969 0.359 . . . . 70.14 111.969 177.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.487 HG23 ' HA ' ' A' ' 461' ' ' PRO . 59.7 t -60.92 127.09 19.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.068 0.461 . . . . 74.01 111.736 -176.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.26 -8.12 77.74 Favored Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 115.754 -0.657 . . . . 33.24 112.49 177.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -108.06 151.68 25.53 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 109.826 -0.435 . . . . 74.43 109.826 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.44 HG22 HG12 ' A' ' 488' ' ' VAL . 67.1 t -68.68 142.92 15.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 106.41 -1.7 . . . . 73.41 106.41 170.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 60.0 mt -97.23 -35.22 5.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 108.704 -0.851 . . . . 64.22 108.704 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 164.99 -165.08 37.47 Favored Glycine 0 N--CA 1.418 -2.532 0 C-N-CA 120.43 -0.89 . . . . 33.11 111.292 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -143.37 149.92 38.4 Favored 'General case' 0 N--CA 1.408 -2.561 0 N-CA-C 107.453 -1.314 . . . . 61.44 107.453 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -67.49 -55.32 15.13 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 120.623 -0.431 . . . . 74.32 110.703 178.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -74.09 128.3 12.1 Favored 'Trans proline' 0 C--N 1.367 1.548 0 N-CA-C 108.009 -1.573 . . . . 72.22 108.009 169.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -62.54 129.85 27.92 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.248 1.966 . . . . 74.13 112.887 -176.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -81.98 13.68 3.21 Favored 'General case' 0 C--O 1.206 -1.188 0 CA-C-N 115.194 -0.912 . . . . 73.22 110.718 -178.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -110.07 0.13 18.25 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.583 0.706 . . . . 74.4 109.398 174.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -103.32 175.79 5.36 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.91 -0.587 . . . . 65.11 112.154 -176.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.405 HG22 ' HB3' ' A' ' 426' ' ' GLN . 2.3 m -98.38 114.43 26.77 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 108.056 -1.09 . . . . 53.41 108.056 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 23.0 p -110.02 147.01 34.33 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 116.283 -0.417 . . . . 62.34 110.057 -176.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -77.55 167.32 21.82 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.634 -0.257 . . . . 54.32 110.387 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 25.3 mm -71.61 -3.93 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-O 122.679 1.228 . . . . 62.42 110.398 -176.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 1.5 p -104.76 5.99 33.73 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.123 -0.944 . . . . 73.12 111.756 178.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -88.92 142.93 27.23 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.03 0.443 . . . . 72.14 111.821 -178.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.65 127.08 65.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.514 -0.767 . . . . 63.14 109.453 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 44.3 t -102.89 120.72 53.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 109.285 -0.635 . . . . 71.34 109.285 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.63 119.41 44.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 108.733 -0.84 . . . . 70.11 108.733 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 48.7 mm -104.48 109.26 26.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-N 115.599 -0.728 . . . . 72.25 109.558 -175.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 9.6 tt -99.96 121.82 51.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.719 -0.474 . . . . 34.33 109.719 178.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.44 HG12 HG22 ' A' ' 467' ' ' VAL . 35.9 m -103.61 151.13 6.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.943 -0.572 . . . . 62.12 110.817 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -92.8 127.31 8.93 Favored Glycine 0 N--CA 1.424 -2.12 0 CA-C-N 115.615 -0.721 . . . . 40.34 111.714 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 25.1 m . . . . . 0 C--N 1.29 -1.989 0 N-CA-C 106.384 -1.71 . . . . 63.11 106.384 176.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo . . . . . 0 N--CA 1.442 -1.506 0 N-CA-C 110.287 -0.697 . . . . 53.33 110.287 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . -90.47 27.49 1.7 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.925 0.869 . . . . 72.41 111.408 -177.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 16.4 p -117.51 143.13 46.37 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 114.708 -1.133 . . . . 73.21 109.806 -178.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 495' ' ' LYS . 67.5 mmtt -139.9 155.2 47.31 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 116.356 -0.384 . . . . 63.35 110.578 177.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -84.17 119.48 25.06 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.831 -1.174 . . . . 71.32 107.831 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 27.2 pt -75.64 120.26 80.87 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 112.347 0.499 . . . . 75.11 112.347 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -93.33 138.45 1.44 Allowed 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 122.672 2.248 . . . . 64.22 111.677 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -90.81 135.35 33.78 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.745 -0.835 . . . . 74.42 108.745 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 19.1 t -134.75 94.08 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 107.523 -1.288 . . . . 72.33 107.523 175.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -88.73 123.99 33.69 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.71 -0.677 . . . . 60.51 109.822 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 125.18 9.69 4.99 Favored Glycine 0 N--CA 1.425 -2.074 0 C-N-CA 119.949 -1.119 . . . . 42.01 112.843 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -106.25 168.18 9.32 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.701 -0.851 . . . . 73.44 108.701 176.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 7.0 m -83.35 157.12 22.67 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.835 -1.172 . . . . 74.23 107.835 176.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 48.8 t -51.11 -44.61 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 122.911 0.484 . . . . 64.01 111.606 -178.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -63.37 -41.91 98.83 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.718 -0.674 . . . . 61.12 111.845 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 33.1 t -72.26 -40.41 65.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 116.121 -0.49 . . . . 72.21 109.912 -176.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.73 -49.44 73.02 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.641 -0.709 . . . . 71.1 111.243 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -65.08 -35.26 80.59 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.705 -0.225 . . . . 60.44 110.663 -178.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.447 ' O ' HG23 ' A' ' 514' ' ' VAL . 47.4 tttp -57.38 -52.29 65.97 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 124.088 0.867 . . . . 74.51 110.237 -178.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -62.74 -44.58 95.84 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 116.099 -0.501 . . . . 71.1 110.139 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.08 -45.81 91.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.751 -0.659 . . . . 74.44 111.137 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.26 -43.18 92.46 Favored 'General case' 0 CA--C 1.5 -0.949 0 O-C-N 123.495 0.497 . . . . 65.33 110.744 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 510' ' ' LYS . 78.7 t -59.72 -38.31 75.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.53 -0.759 . . . . 73.4 111.015 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -74.87 -22.76 58.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.041 0.448 . . . . 63.22 111.239 -178.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 134.44 -16.79 4.32 Favored Glycine 0 N--CA 1.428 -1.844 0 C-N-CA 119.747 -1.216 . . . . 44.51 112.665 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.681 ' HA ' ' O ' ' A' ' 547' ' ' VAL . 91.2 m-85 -75.89 96.79 3.79 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.744 -0.465 . . . . 65.22 109.744 -177.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 3.1 p -95.73 -12.81 24.84 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 113.38 0.882 . . . . 43.42 113.38 -175.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 64.6 mttp -108.74 115.85 30.88 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.434 -0.506 . . . . 73.42 110.364 178.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -130.2 151.25 50.93 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 109.739 -0.467 . . . . 72.33 109.739 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 61.3 m -141.1 140.82 34.23 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 107.909 -1.145 . . . . 75.55 107.909 175.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 0.0 OUTLIER -117.41 137.15 52.69 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 121.326 0.584 . . . . 61.13 111.332 -176.648 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -111.58 116.95 31.69 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.767 -1.197 . . . . 42.42 107.767 176.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 19.3 m -96.96 124.46 40.94 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.487 -0.561 . . . . 72.02 109.487 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 28.4 m -129.13 150.02 34.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.753 -0.832 . . . . 75.04 108.753 177.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -68.74 135.64 51.59 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.937 -0.764 . . . . 72.34 108.937 178.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 50.8 m -156.54 171.95 6.72 Favored Pre-proline 0 C--N 1.297 -1.697 0 N-CA-C 108.558 -0.904 . . . . 74.5 108.558 -176.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -71.72 -19.93 27.05 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 121.835 1.69 . . . . 61.21 113.356 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.01 138.59 49.46 Favored Pre-proline 0 N--CA 1.469 0.495 0 C-N-CA 120.535 -0.466 . . . . 64.31 110.204 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.89 141.56 93.19 Favored 'Trans proline' 0 C--O 1.261 1.652 0 C-N-CA 122.726 2.284 . . . . 70.35 112.068 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.675 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -57.99 118.37 5.32 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 115.128 -0.942 . . . . 35.13 111.513 -176.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 135.92 -25.79 3.18 Favored Glycine 0 N--CA 1.432 -1.616 0 CA-C-N 115.59 -0.732 . . . . 32.24 111.32 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -83.73 134.47 34.75 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.104 0.478 . . . . 72.3 111.523 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 57.3 t -79.5 128.81 38.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 115.834 -0.621 . . . . 73.31 110.307 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 90.7 m -81.64 -33.8 31.17 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 124.781 1.232 . . . . 52.15 110.049 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.59 -150.82 22.79 Favored Glycine 0 N--CA 1.434 -1.452 0 N-CA-C 109.758 -1.337 . . . . 62.42 109.758 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 40.0 p -116.87 156.83 26.66 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 117.291 0.545 . . . . 64.11 110.063 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -82.11 -48.29 0.93 Allowed Pre-proline 0 C--N 1.31 -1.131 0 CA-C-N 115.496 -0.774 . . . . 73.54 110.014 173.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 26.8 Cg_endo -66.63 133.55 32.32 Favored 'Trans proline' 0 C--N 1.37 1.675 0 N-CA-C 108.923 -1.222 . . . . 72.52 108.923 169.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 31.9 Cg_exo -58.96 140.63 96.16 Favored 'Trans proline' 0 C--O 1.251 1.171 0 C-N-CA 122.51 2.14 . . . . 43.11 112.961 -177.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.33 140.95 58.13 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.76 -0.654 . . . . 74.04 109.671 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 98.54 -9.98 62.73 Favored Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 111.385 -0.686 . . . . 62.02 111.385 -178.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 41.9 m -75.28 126.26 30.66 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.603 -0.517 . . . . 72.22 109.603 178.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 495' ' ' LYS . 15.2 t -83.48 129.81 34.99 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 108.12 -1.067 . . . . 43.14 108.12 174.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 11.4 p -142.43 153.43 62.4 Favored Pre-proline 0 C--N 1.294 -1.835 0 N-CA-C 106.649 -1.611 . . . . 63.1 106.649 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 51.3 Cg_exo -58.5 140.27 93.98 Favored 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 121.78 1.654 . . . . 51.31 111.185 175.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.681 ' O ' ' HA ' ' A' ' 517' ' ' PHE . 27.1 m -65.22 -23.16 32.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 121.234 0.54 . . . . 72.01 112.33 -176.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.89 2.12 52.32 Favored 'General case' 0 N--CA 1.421 -1.896 0 O-C-N 122.028 -0.42 . . . . 64.43 111.116 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 66.2 m -84.96 170.49 13.0 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 121.16 0.505 . . . . 55.42 111.172 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 10.0 p -93.0 128.53 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-O 121.605 0.717 . . . . 65.32 111.842 -178.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . 0.508 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -108.52 136.11 45.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 108.572 -0.899 . . . . 61.12 108.572 172.717 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -103.53 118.44 36.74 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.445 0.641 . . . . 74.53 111.091 -176.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 2.3 mm? -95.94 134.35 39.04 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.499 -1.228 . . . . 63.52 109.525 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -98.3 124.52 42.97 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 108.77 -0.826 . . . . 74.13 108.77 175.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 57.2 t -114.43 128.64 71.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 115.899 -0.591 . . . . 75.22 110.662 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.675 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 69.4 m -69.8 131.57 44.72 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.698 -0.683 . . . . 63.1 111.565 174.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt -104.45 133.32 49.53 Favored 'General case' 0 C--O 1.202 -1.412 0 N-CA-C 107.435 -1.32 . . . . 72.23 107.435 169.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -70.16 -37.69 72.36 Favored Glycine 0 CA--C 1.503 -0.667 0 C-N-CA 120.184 -1.008 . . . . 61.31 111.279 -177.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 65.7 t30 65.35 28.56 11.76 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.603 1.161 . . . . 75.35 108.486 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -137.09 150.59 48.11 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 114.513 -1.221 . . . . 73.21 108.887 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -130.34 157.18 43.27 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.313 -0.625 . . . . 73.03 109.313 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 58.8 t -71.96 118.54 17.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 109.984 -0.376 . . . . 63.15 109.984 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . 0.462 ' HB2' ' CG2' ' A' ' 614' ' ' VAL . 55.8 ttp -97.37 138.1 21.16 Favored Pre-proline 0 C--N 1.31 -1.145 0 CA-C-N 116.147 -0.478 . . . . 55.45 110.465 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.64 169.77 9.44 Favored 'Trans proline' 0 CA--C 1.552 1.395 0 C-N-CA 123.098 2.532 . . . . 72.34 111.422 172.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -88.37 129.78 35.32 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 113.064 0.764 . . . . 72.35 113.064 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . 0.421 ' O ' ' HB3' ' A' ' 569' ' ' MET . 2.8 mm? -114.25 -9.67 12.82 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.196 -1.039 . . . . 54.34 108.196 173.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 3.0 p -74.31 132.07 41.73 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 114.7 -1.136 . . . . 75.13 110.21 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 76.48 20.9 76.24 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 111.026 -0.829 . . . . 72.33 111.026 -176.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . 0.421 ' HB3' ' O ' ' A' ' 566' ' ' LEU . 51.7 ttm -121.76 149.47 43.24 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.732 -0.84 . . . . 55.43 108.732 -178.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -82.62 142.61 31.61 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 108.655 -0.869 . . . . 71.52 108.655 177.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 72.1 t-105 -51.62 -27.22 10.66 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 124.707 1.203 . . . . 73.44 111.877 177.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 34.9 m -70.53 -20.39 22.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.58 -0.282 . . . . 61.01 111.525 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . 0.415 ' O ' ' HG3' ' A' ' 577' ' ' ARG . 9.6 t70 -101.57 -36.14 8.88 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.151 -1.055 . . . . 65.1 108.151 177.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.02 95.65 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 114.964 -1.016 . . . . 64.14 112.678 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.47 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 37.4 tt0 -57.63 -51.1 84.24 Favored Pre-proline 0 CA--C 1.563 1.458 0 CA-C-O 119.524 -0.274 . . . . 71.41 111.487 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . 0.47 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 54.1 Cg_exo -56.12 -39.69 89.6 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 121.46 1.44 . . . . 74.2 112.662 173.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 573' ' ' ASP . 51.4 mtt180 -64.25 -41.91 96.74 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.51 -0.476 . . . . 75.14 112.062 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.491 HD12 ' N ' ' A' ' 579' ' ' ARG 0.25 4.1 pp -66.28 -43.73 85.59 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 119.91 -0.716 . . . . 73.23 111.792 -177.575 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . 0.491 ' N ' HD12 ' A' ' 578' ' ' LEU . 15.8 ptm180 -66.43 -35.75 81.08 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 120.914 -0.314 . . . . 74.04 111.197 176.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.72 -28.29 66.69 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 122.638 0.375 . . . . 64.33 111.801 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 9.7 mp -81.52 -7.37 59.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.037 0.446 . . . . 75.02 111.217 174.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 80.36 15.16 79.0 Favored Glycine 0 N--CA 1.437 -1.244 0 C-N-CA 121.126 -0.559 . . . . 71.24 111.883 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 73.4 t90 -66.02 130.73 44.24 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.386 0.613 . . . . 73.41 110.01 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 75.5 m -143.83 93.65 2.49 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.833 -1.173 . . . . 71.3 107.833 176.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -150.6 -161.42 9.94 Favored Glycine 0 N--CA 1.419 -2.448 0 N-CA-C 109.409 -1.476 . . . . 73.43 109.409 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 55.0 ttp -91.04 124.89 35.61 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 120.832 0.349 . . . . 75.35 110.271 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -98.46 121.3 40.22 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 105.738 -1.949 . . . . 74.44 105.738 173.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -98.52 101.59 13.08 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.948 -0.76 . . . . 63.54 108.948 -177.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -99.6 130.44 45.84 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.606 -1.257 . . . . 74.11 107.606 -177.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -77.17 -97.93 0.19 Allowed Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.387 -1.085 . . . . 75.21 110.387 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.2 153.79 47.94 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.878 -0.786 . . . . 74.22 108.878 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -83.7 124.9 31.33 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.055 -1.091 . . . . 65.11 108.055 175.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 58.4 t -127.79 116.88 44.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 CA-C-N 115.881 -0.6 . . . . 42.01 109.944 -175.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -78.4 111.46 14.42 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.29 -1.374 . . . . 74.41 107.29 175.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -133.46 2.82 3.55 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.305 -0.558 . . . . 65.2 112.251 -176.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 127.85 166.06 11.98 Favored Glycine 0 N--CA 1.437 -1.29 0 N-CA-C 111.145 -0.782 . . . . 75.23 111.145 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -59.05 -35.64 84.82 Favored Glycine 0 C--O 1.227 -0.339 0 O-C-N 123.639 0.258 . . . . 15.34 113.532 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 13.4 p -65.78 -23.92 66.82 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.203 0.525 . . . . 72.21 111.722 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -102.37 -1.54 30.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.077 -0.51 . . . . 72.33 110.034 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -77.81 111.09 13.27 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.605 -0.517 . . . . 72.32 109.605 -177.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 12.6 m120 62.9 -11.99 0.08 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.325 1.85 . . . . 73.33 115.159 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -77.51 138.68 39.34 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 118.449 0.568 . . . . 64.03 112.404 -174.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 71.7 t -72.86 131.82 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 114.835 -1.075 . . . . 41.43 108.689 176.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 623' ' ' ARG . 27.7 m -94.35 -41.14 12.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 C-N-CA 119.627 -0.829 . . . . 74.05 111.039 -176.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -151.4 154.69 37.14 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 106.678 -1.601 . . . . 71.1 106.678 175.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . 0.63 ' HA ' ' O ' ' A' ' 621' ' ' THR . 13.3 pt20 -133.82 142.43 47.85 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 106.646 -1.612 . . . . 72.25 106.646 174.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.443 ' HB2' ' OG1' ' A' ' 621' ' ' THR 0.33 91.4 m-20 -76.33 -57.39 1.37 Allowed Pre-proline 0 C--N 1.306 -1.29 0 N-CA-C 114.34 1.237 . . . . 71.31 114.34 -179.168 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' ' 609' ' ' PRO . 31.5 Cg_exo -63.66 119.53 6.62 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 121.785 1.657 . . . . 75.0 110.048 175.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . 0.42 ' HB2' ' OG1' ' A' ' 612' ' ' THR . 6.2 Cg_exo -70.97 134.52 25.61 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 121.8 1.667 . . . . 51.2 113.762 -176.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -69.33 132.17 46.0 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.082 -0.963 . . . . 52.42 110.317 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 89.34 -8.58 79.53 Favored Glycine 0 C--N 1.309 -0.923 0 N-CA-C 111.435 -0.666 . . . . 74.22 111.435 -178.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . 0.42 ' OG1' ' HB2' ' A' ' 609' ' ' PRO . 17.9 m -104.88 160.17 15.22 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 108.048 -1.093 . . . . 70.13 108.048 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -71.68 114.26 5.01 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.944 -0.862 . . . . 45.31 110.944 176.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . 0.462 ' CG2' ' HB2' ' A' ' 563' ' ' MET . 20.6 m -103.31 144.99 13.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 C-N-CA 124.234 1.013 . . . . 74.02 109.929 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -38.85 134.03 1.04 Allowed 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 125.665 1.586 . . . . 65.01 110.565 177.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . 0.408 ' HD3' ' N ' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -51.18 -25.06 4.83 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 114.494 1.294 . . . . 71.21 114.494 -171.367 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . 0.408 ' N ' ' HD3' ' A' ' 616' ' ' ARG . 3.4 p30 -77.43 -26.06 51.22 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.846 -0.616 . . . . 70.14 110.716 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 78.0 20.29 73.38 Favored Glycine 0 N--CA 1.433 -1.526 0 CA-C-O 119.081 -0.844 . . . . 74.22 114.461 173.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.76 119.58 13.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 118.429 1.115 . . . . 65.1 108.755 -176.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 7.0 tp -106.77 127.39 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.027 0 CA-C-N 114.207 -1.361 . . . . 74.43 110.504 -173.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.63 ' O ' ' HA ' ' A' ' 606' ' ' GLN . 1.6 p -107.71 117.72 34.86 Favored 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 109.241 -0.652 . . . . 54.42 109.241 176.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.1 pp -138.54 150.68 46.62 Favored 'General case' 0 CA--C 1.486 -1.496 0 C-N-CA 124.4 1.08 . . . . 74.3 108.431 -177.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . 0.437 ' O ' HG22 ' A' ' 604' ' ' VAL . 2.7 tmt_? -132.88 137.11 46.57 Favored 'General case' 0 C--N 1.273 -2.738 0 N-CA-C 104.861 -2.274 . . . . 72.42 104.861 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -129.78 165.23 22.35 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 107.962 -1.125 . . . . 65.41 107.962 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -82.5 -88.04 0.71 Allowed Glycine 0 N--CA 1.426 -1.985 0 N-CA-C 109.851 -1.3 . . . . 65.41 109.851 178.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 . . . . . 0 C--N 1.286 -2.176 0 N-CA-C 109.087 -0.708 . . . . 72.21 109.087 178.419 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 C--O 1.245 0.853 0 CA-C-O 120.77 0.319 . . . . 64.4 111.042 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 28.0 m -127.74 156.75 39.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 C-N-CA 123.583 0.753 . . . . 75.31 109.66 -178.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . 0.489 HE21 ' C ' ' A' ' 361' ' ' GLN . 0.0 OUTLIER -95.89 122.79 39.07 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.221 -1.77 . . . . 63.23 106.221 179.328 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.439 HG21 ' CZ ' ' A' ' 382' ' ' PHE . 48.0 t -98.81 139.15 20.87 Favored Pre-proline 0 C--N 1.283 -2.313 0 CA-C-N 115.782 -0.645 . . . . 64.12 110.761 -171.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 14.9 Cg_exo -70.61 150.07 62.46 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.25 1.967 . . . . 73.32 111.442 175.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . 0.45 ' OD2' ' HD2' ' A' ' 366' ' ' ARG . 27.9 t0 -102.76 152.66 20.99 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 107.247 -1.39 . . . . 62.52 107.247 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 10.2 t -122.67 11.64 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.374 0 CA-C-O 121.818 0.818 . . . . 61.13 109.675 -174.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.537 ' HB3' ' OG1' ' A' ' 402' ' ' THR . 8.8 ptm180 -52.37 144.33 13.27 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 115.606 -0.724 . . . . 74.11 111.858 177.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.5 -11.07 54.02 Favored Glycine 0 C--N 1.312 -0.771 0 CA-C-N 115.593 -0.73 . . . . 71.15 111.843 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -110.39 -151.3 0.47 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 123.074 0.55 . . . . 74.21 110.312 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 71.8 p -97.81 159.28 15.03 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.253 -0.647 . . . . 60.33 109.253 -173.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 5.6 p -63.55 -35.89 81.98 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 120.862 -0.335 . . . . 55.32 110.839 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -65.78 -46.42 78.78 Favored 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 111.733 0.271 . . . . 75.43 111.733 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -68.11 -41.31 81.96 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 121.452 0.644 . . . . 74.24 109.281 -177.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.54 -51.52 59.27 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.005 -0.998 . . . . 64.42 111.53 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 77.1 mt -63.96 -39.2 84.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 CA-C-N 116.355 -0.384 . . . . 75.11 110.854 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.05 -44.05 91.76 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 120.946 0.403 . . . . 73.44 110.495 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 44.5 m -65.48 -47.13 77.13 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.834 -0.621 . . . . 71.12 111.455 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 10.8 mp -61.76 -45.43 93.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.812 -0.177 . . . . 75.54 111.193 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -65.81 -35.42 80.64 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.178 -0.465 . . . . 74.51 110.344 -178.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -67.2 -25.24 66.02 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 120.972 0.415 . . . . 63.33 111.786 176.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -86.45 -8.07 57.91 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.945 0.402 . . . . 74.22 110.25 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . 0.449 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 100.42 0.69 55.62 Favored Glycine 0 CA--C 1.502 -0.748 0 CA-C-N 115.587 -0.733 . . . . 72.22 112.389 178.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.628 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 47.4 m-85 -80.0 153.97 28.51 Favored 'General case' 0 N--CA 1.418 -2.074 0 CA-C-O 121.443 0.639 . . . . 74.12 110.901 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 74.8 mmtt -113.01 161.42 17.06 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 114.916 -1.038 . . . . 75.11 108.414 -176.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . 0.446 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -127.31 146.0 33.85 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 CA-C-O 121.461 0.648 . . . . 43.23 111.207 -176.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -110.26 127.98 55.28 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 104.64 -2.356 . . . . 63.14 104.64 174.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 25.5 m -117.37 127.0 53.62 Favored 'General case' 0 C--N 1.271 -2.828 0 C-N-CA 120.185 -0.606 . . . . 73.14 110.073 -174.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -112.12 128.64 56.28 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 105.472 -2.047 . . . . 75.14 105.472 177.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.495 HE21 ' N ' ' A' ' 388' ' ' GLN . 0.0 OUTLIER -120.65 145.5 47.37 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.815 -0.754 . . . . 63.5 111.397 -177.661 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 421' ' ' SER . 54.7 mttp -139.38 143.01 34.26 Favored Pre-proline 0 C--N 1.298 -1.669 0 CA-C-N 115.431 -0.804 . . . . 72.22 109.263 176.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -74.89 158.03 42.87 Favored 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 122.229 1.953 . . . . 72.45 110.452 172.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 8.5 t70 87.43 -169.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 126.468 1.907 . . . . 73.13 108.869 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 37.4 m -144.02 14.29 1.68 Allowed 'General case' 0 C--N 1.316 -0.868 0 O-C-N 121.573 -0.704 . . . . 52.42 110.835 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 12.6 t -81.67 -19.12 42.31 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.807 -1.183 . . . . 70.22 107.807 176.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.606 HD13 ' H ' ' A' ' 394' ' ' ILE . 0.2 OUTLIER -97.61 152.84 38.38 Favored Pre-proline 0 N--CA 1.431 -1.418 0 N-CA-C 106.571 -1.64 . . . . 71.5 106.571 176.32 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . 0.428 ' HA ' ' HD2' ' A' ' 396' ' ' PRO . 1.0 OUTLIER -27.78 111.78 0.03 OUTLIER 'Trans proline' 0 CA--C 1.553 1.449 0 C-N-CA 125.089 3.86 . . . . 73.04 114.907 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . 0.592 ' HA ' ' OG ' ' A' ' 421' ' ' SER . 42.2 Cg_endo -63.73 160.92 34.39 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 124.159 3.239 . . . . 52.4 115.242 -174.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -60.11 -8.6 2.5 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 125.078 1.351 . . . . 74.21 113.091 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 37.0 m170 -106.39 132.31 52.56 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 105.746 -1.946 . . . . 74.44 105.746 175.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 27.7 m -75.21 117.6 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.256 0 C-N-CA 119.381 -0.927 . . . . 75.35 111.761 -165.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . 0.596 ' H ' HD13 ' A' ' 400' ' ' ILE . 0.2 OUTLIER -97.24 -28.76 3.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 107.292 -1.373 . . . . 70.03 107.292 174.042 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.54 157.53 27.43 Favored Glycine 1 N--CA 1.395 -4.079 0 N-CA-C 108.938 -1.665 . . . . 73.31 108.938 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . 0.537 ' OG1' ' HB3' ' A' ' 366' ' ' ARG . 0.8 OUTLIER -146.25 -176.25 5.09 Favored 'General case' 0 C--N 1.262 -3.207 0 N-CA-C 105.878 -1.897 . . . . 72.44 105.878 -177.726 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -100.28 126.95 34.44 Favored Pre-proline 0 C--N 1.289 -2.025 0 C-N-CA 118.208 -1.397 . . . . 53.42 109.731 -173.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.84 0.18 1.7 Allowed 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 124.067 3.178 . . . . 61.41 114.791 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.1 -34.46 68.34 Favored 'General case' 0 C--O 1.209 -1.046 0 N-CA-C 109.206 -0.664 . . . . 64.42 109.206 173.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -63.85 -40.7 97.19 Favored 'General case' 0 C--O 1.212 -0.887 0 CA-C-N 115.805 -0.634 . . . . 65.31 110.042 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . 0.441 HD21 ' HB2' ' A' ' 364' ' ' ASP . 12.2 m120 -83.71 0.6 46.42 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.122 0.487 . . . . 64.14 111.513 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 34.0 m -95.21 157.41 15.91 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 104.92 -2.252 . . . . 72.23 104.92 171.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 49.0 m -74.35 112.47 10.55 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 118.55 -1.26 . . . . 71.41 108.928 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 18.6 m -128.48 169.1 20.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 C-N-CA 122.49 0.316 . . . . 44.5 110.366 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 15.6 m -79.86 145.18 32.87 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.762 -0.459 . . . . 73.04 109.762 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . 0.628 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -66.69 113.73 5.05 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.293 0.568 . . . . 52.4 110.56 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 110.35 44.68 0.98 Allowed Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 110.776 -0.93 . . . . 75.21 110.776 -178.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -109.21 166.29 10.97 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.198 -1.038 . . . . 75.12 108.198 -177.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 49.2 mt-10 -100.23 118.5 36.66 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 118.212 0.46 . . . . 63.22 110.837 -177.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 44.4 mm -103.61 133.18 48.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 109.188 -0.671 . . . . 73.33 109.188 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 11.5 t -85.18 130.46 34.6 Favored 'General case' 0 C--O 1.252 1.217 0 CA-C-O 121.303 0.573 . . . . 74.32 112.306 -176.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 5.3 p -127.3 135.78 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 C-N-CA 124.052 0.941 . . . . 72.21 109.544 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -101.99 129.18 48.22 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.77 -0.456 . . . . 71.21 109.77 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 8.9 p -123.1 133.1 70.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 109.356 -0.609 . . . . 73.01 109.356 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . 0.592 ' OG ' ' HA ' ' A' ' 396' ' ' PRO . 74.6 p -103.61 130.9 51.12 Favored 'General case' 0 N--CA 1.428 -1.541 0 O-C-N 122.086 -0.384 . . . . 62.32 110.55 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 41.0 p -97.02 107.97 20.61 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.987 -1.486 . . . . 72.05 106.987 173.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.708 0 N-CA-C 116.653 1.421 . . . . 62.42 116.653 -170.089 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 . . . . . 0 N--CA 1.434 -1.269 0 N-CA-C 107.09 -1.448 . . . . 62.12 107.09 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.458 ' HA ' ' HE ' ' A' ' 427' ' ' ARG . 8.5 mmp_? -121.98 150.17 42.43 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-O 121.017 0.437 . . . . 72.2 111.217 -176.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -85.8 138.51 32.02 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.427 -0.806 . . . . 72.21 109.729 -177.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 56.9 mt -87.55 131.57 43.42 Favored Pre-proline 0 C--N 1.295 -1.769 0 N-CA-C 108.733 -0.839 . . . . 64.24 108.733 178.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -70.76 141.45 41.21 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.715 1.61 . . . . 64.11 110.634 172.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -84.61 99.86 11.05 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.801 -1.185 . . . . 63.43 107.801 178.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 60.9 t -101.9 136.94 31.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 108.597 -0.89 . . . . 71.23 108.597 -174.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.408 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 18.9 m -57.22 149.8 19.11 Favored 'General case' 0 N--CA 1.435 -1.209 0 O-C-N 124.252 0.97 . . . . 73.4 112.517 -177.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . 0.424 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 24.8 p -69.45 -25.06 63.91 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 115.283 1.586 . . . . 52.32 115.283 -170.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.7 pp -85.97 -11.67 52.42 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.628 -0.829 . . . . 72.53 110.768 176.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.408 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 0.2 OUTLIER -98.68 42.53 1.09 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.183 -0.917 . . . . 63.01 110.152 -175.123 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -52.56 -38.71 60.43 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.396 1.079 . . . . 62.55 112.749 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -62.27 -39.57 93.35 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.559 0.695 . . . . 42.41 110.681 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -70.53 -37.39 74.08 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.266 -0.879 . . . . 65.31 109.158 177.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -62.66 -51.82 65.74 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.936 -0.575 . . . . 72.14 111.078 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 28.8 m -61.88 -38.89 81.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 112.476 0.547 . . . . 65.44 112.476 -177.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -68.28 -38.08 81.35 Favored 'General case' 0 C--N 1.35 0.623 0 C-N-CA 119.255 -0.978 . . . . 62.41 110.908 177.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -66.35 -38.66 88.11 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.462 0.542 . . . . 75.12 112.462 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -63.38 -35.8 81.6 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.881 -0.414 . . . . 71.13 109.881 174.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.492 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 47.0 m -70.49 -48.3 56.37 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.918 -0.583 . . . . 74.52 110.804 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.5 -16.65 63.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.949 -0.569 . . . . 64.4 111.91 -177.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.05 -13.14 59.95 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.279 -0.419 . . . . 64.43 111.751 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 124.98 -69.88 0.48 Allowed Glycine 0 CA--C 1.492 -1.348 0 C-N-CA 120.068 -1.063 . . . . 53.23 111.932 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . 0.419 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 0.1 OUTLIER -48.52 -65.81 0.51 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.542 0.571 . . . . 74.23 112.542 177.108 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . 0.492 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 64.28 21.93 66.79 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 116.123 -0.49 . . . . 61.31 113.287 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.506 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 28.5 mmm180 -104.27 110.49 22.73 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 107.466 -1.309 . . . . 75.11 107.466 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -137.13 147.01 45.72 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 115.662 -0.699 . . . . 75.52 109.875 -177.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -132.77 148.95 52.33 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 108.264 -1.013 . . . . 65.02 108.264 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -117.67 125.75 51.27 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 110.212 -0.292 . . . . 65.43 110.212 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.19 148.13 41.88 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.293 -1.002 . . . . 73.31 108.293 176.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -114.17 140.85 48.19 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.141 -0.689 . . . . 74.53 109.141 -177.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 68.4 m -148.41 137.93 12.38 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 110.46 -0.2 . . . . 64.33 110.46 173.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.741 ' HA ' ' O ' ' A' ' 490' ' ' SER . 29.6 Cg_endo -65.75 128.09 19.24 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.348 2.032 . . . . 75.01 110.426 175.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 48.5 m -140.57 -179.83 6.25 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 116.489 -0.323 . . . . 64.33 110.589 -176.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . 0.406 ' O ' HG13 ' A' ' 464' ' ' VAL . 9.9 t -45.58 130.99 6.44 Favored Pre-proline 0 CA--C 1.556 1.192 0 C-N-CA 124.53 1.132 . . . . 72.34 111.934 178.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . 0.565 ' O ' HG22 ' A' ' 464' ' ' VAL . 11.3 Cg_endo -51.72 -28.24 29.28 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 125.18 3.92 . . . . 73.45 114.466 -174.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.74 -32.08 67.35 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.147 0.498 . . . . 72.25 111.83 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . 0.535 HD13 ' O ' ' A' ' 463' ' ' LEU . 3.3 tm? -97.2 -13.46 22.05 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.984 -0.553 . . . . 70.34 110.66 -171.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' ' 461' ' ' PRO . 19.4 m -60.09 131.09 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 CA-C-O 121.47 0.652 . . . . 70.52 111.174 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.65 2.18 55.34 Favored Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 115.294 -0.866 . . . . 55.25 111.655 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -128.28 166.46 18.56 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.978 -0.749 . . . . 75.1 108.978 176.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.437 HG22 HG12 ' A' ' 488' ' ' VAL . 70.8 t -72.41 148.8 9.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.354 -0.98 . . . . 74.22 108.354 175.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 47.5 mt -97.36 -35.25 5.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 106.61 -1.626 . . . . 71.0 106.61 174.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 153.6 -168.67 32.22 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 110.377 -1.089 . . . . 73.15 110.377 176.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . 0.524 ' HB ' HG12 ' A' ' 486' ' ' ILE . 0.6 OUTLIER -115.83 141.11 48.53 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 107.929 -1.137 . . . . 60.54 107.929 176.266 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.497 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 46.2 t-20 -63.36 -51.4 68.42 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 123.529 0.518 . . . . 74.43 110.512 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.497 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 27.3 Cg_exo -70.55 124.09 10.44 Favored 'Trans proline' 0 C--N 1.373 1.856 0 N-CA-C 107.0 -1.961 . . . . 72.35 107.0 166.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.421 ' C ' ' H ' ' A' ' 475' ' ' ASN . 18.2 Cg_endo -61.94 127.78 22.37 Favored 'Trans proline' 0 C--O 1.241 0.673 0 C-N-CA 122.467 2.112 . . . . 61.34 114.248 -172.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -77.68 16.53 0.66 Allowed 'General case' 0 C--O 1.198 -1.642 0 CA-C-N 114.676 -1.147 . . . . 63.21 110.475 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . 0.421 ' H ' ' C ' ' A' ' 473' ' ' PRO . 0.9 OUTLIER -109.14 -9.19 15.05 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.601 -0.727 . . . . 72.02 109.618 178.414 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -107.07 175.47 5.49 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-O 121.722 0.773 . . . . 74.0 112.902 -174.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 4.1 m -92.38 106.14 18.2 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 114.421 -1.263 . . . . 65.04 108.842 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 68.2 m -100.87 149.32 23.99 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 123.263 0.625 . . . . 72.24 111.119 -176.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -78.3 154.43 30.91 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.328 -0.396 . . . . 64.14 111.448 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . 0.419 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 1.7 mp -68.56 -23.06 27.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 C-N-CA 123.61 0.764 . . . . 63.1 111.622 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 17.7 p -94.42 5.55 51.44 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.365 0.602 . . . . 75.22 111.16 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -98.83 140.71 32.61 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.17 -0.468 . . . . 75.55 111.113 -175.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.506 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.5 p -107.34 127.11 63.42 Favored 'Isoleucine or valine' 0 C--O 1.245 0.824 0 CA-C-N 115.977 -0.556 . . . . 73.34 111.803 -178.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.413 ' HA ' ' HG2' ' A' ' 472' ' ' PRO . 32.5 m -97.05 140.97 16.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.34 0.59 . . . . 63.43 110.392 177.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.95 114.0 45.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.893 -0.78 . . . . 73.02 108.893 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.524 HG12 ' HB ' ' A' ' 470' ' ' THR . 61.4 mt -98.69 124.84 52.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 114.618 -1.174 . . . . 72.54 109.707 -178.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 5.2 tt -109.43 126.72 66.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 109.458 -0.571 . . . . 63.13 109.458 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.437 HG12 HG22 ' A' ' 467' ' ' VAL . 32.6 m -105.34 151.13 7.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 115.871 -0.604 . . . . 62.24 110.758 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -90.16 122.89 6.76 Favored Glycine 0 N--CA 1.416 -2.635 0 N-CA-C 109.33 -1.508 . . . . 21.23 109.33 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.741 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 8.5 t . . . . . 0 C--N 1.279 -2.471 0 N-CA-C 107.575 -1.269 . . . . 53.23 107.575 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 N--CA 1.446 -1.288 0 CA-C-O 121.409 0.504 . . . . 74.31 113.129 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -81.07 92.61 6.27 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 108.929 -0.767 . . . . 60.35 108.929 177.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 9.4 p -117.22 143.82 45.46 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.0 -1.0 . . . . 54.41 109.727 -177.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -150.99 157.46 42.91 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.46 -0.941 . . . . 63.2 108.46 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.511 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.5 m-20 -80.37 128.23 33.32 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 107.544 -1.28 . . . . 63.22 107.544 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . 0.458 HD11 ' HB2' ' A' ' 539' ' ' PRO . 40.7 pt -76.11 136.49 69.3 Favored Pre-proline 0 C--N 1.299 -1.611 0 O-C-N 123.121 0.263 . . . . 73.34 111.42 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 497' ' ' ILE . 1.5 Cg_endo -88.55 155.59 6.42 Favored 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 122.265 1.977 . . . . 32.5 108.938 168.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.92 165.44 11.71 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.664 -1.236 . . . . 74.42 107.664 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.77 117.14 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.354 0 CA-C-O 121.989 0.9 . . . . 70.2 111.279 -174.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -131.32 110.33 11.0 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 114.423 -1.262 . . . . 72.24 107.968 174.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 135.89 -14.58 4.1 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 119.768 -1.206 . . . . 71.33 112.553 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -98.02 172.59 7.53 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.324 -0.551 . . . . 63.42 110.074 177.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 11.4 t -90.3 157.28 17.74 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 107.959 -1.126 . . . . 72.42 107.959 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.453 ' HA ' ' CG2' ' A' ' 534' ' ' VAL . 7.6 p -50.05 -46.92 24.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 O-C-N 124.26 0.975 . . . . 55.24 112.594 -175.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.24 -42.08 80.24 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.389 -0.524 . . . . 72.45 111.923 -177.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 95.6 t -72.42 -36.24 54.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.091 -0.504 . . . . 65.15 111.255 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.65 -49.02 74.86 Favored 'General case' 0 C--N 1.31 -1.111 0 O-C-N 122.21 -0.306 . . . . 73.35 110.859 178.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -60.22 -36.4 77.61 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.8 0.81 . . . . 73.4 109.823 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.401 ' O ' HG23 ' A' ' 514' ' ' VAL . 80.4 tttt -65.23 -46.54 80.2 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 114.401 -1.272 . . . . 73.12 109.666 -177.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -61.77 -47.97 82.77 Favored 'General case' 0 CA--C 1.495 -1.172 0 O-C-N 124.188 0.93 . . . . 74.2 111.263 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.75 -41.84 91.88 Favored 'General case' 0 CA--C 1.513 -0.468 0 O-C-N 123.159 0.287 . . . . 72.01 111.053 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 1.0 OUTLIER -62.68 -38.19 89.4 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.341 -0.391 . . . . 71.14 111.215 178.739 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 510' ' ' LYS . 73.9 t -70.13 -29.18 38.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.962 -0.563 . . . . 61.34 110.866 178.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -76.74 -12.13 59.94 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.191 0.519 . . . . 72.04 110.001 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . 0.489 ' O ' ' HB ' ' A' ' 547' ' ' VAL . . . 121.48 -25.52 6.92 Favored Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 120.837 -0.696 . . . . 71.31 111.974 177.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.591 ' HA ' ' O ' ' A' ' 547' ' ' VAL . 66.1 m-85 -76.22 103.81 6.43 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.529 0.68 . . . . 61.35 109.685 -176.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 3.3 p -86.17 -28.41 23.94 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 113.896 1.073 . . . . 72.52 113.896 -170.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 67.9 mttm -109.07 126.24 52.96 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.443 0.639 . . . . 70.53 112.34 -174.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -129.82 157.49 42.06 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 123.756 0.822 . . . . 72.43 110.398 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 71.1 m -137.44 143.55 41.87 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 107.022 -1.473 . . . . 73.44 107.022 170.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -125.06 147.68 48.86 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 120.75 0.309 . . . . 74.51 110.357 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -141.08 129.5 22.48 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 107.817 -1.179 . . . . 75.11 107.817 174.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 52.4 m -89.2 139.46 30.46 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 109.865 -0.42 . . . . 54.52 109.865 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 26.8 m -120.98 164.73 17.23 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 107.631 -1.248 . . . . 43.01 107.631 178.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . 0.627 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 2.2 p-10 -82.62 134.69 35.17 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 118.963 -1.095 . . . . 73.31 108.671 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 48.3 m -155.29 168.06 12.88 Favored Pre-proline 0 N--CA 1.441 -0.877 0 C-N-CA 120.482 -0.487 . . . . 73.2 110.554 -176.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -83.24 -10.7 9.99 Favored 'Trans proline' 0 CA--C 1.546 1.113 0 C-N-CA 122.014 1.809 . . . . 64.43 111.23 171.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.35 135.16 50.6 Favored Pre-proline 0 CA--C 1.506 -0.73 0 N-CA-C 107.695 -1.224 . . . . 75.23 107.695 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.95 150.88 52.73 Favored 'Trans proline' 0 C--O 1.256 1.417 0 C-N-CA 122.686 2.257 . . . . 73.43 113.446 -176.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -64.41 121.77 15.15 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.856 -1.066 . . . . 71.41 110.966 -175.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 126.7 -16.29 6.56 Favored Glycine 0 N--CA 1.424 -2.123 0 C-N-CA 120.455 -0.878 . . . . 63.45 111.864 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -83.19 128.43 34.48 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 120.448 -0.501 . . . . 71.03 110.143 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.453 ' CG2' ' HA ' ' A' ' 505' ' ' VAL . 59.9 t -84.66 114.19 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.337 0 N-CA-C 106.08 -1.822 . . . . 53.53 106.08 174.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 9.1 m -113.73 9.86 17.79 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 119.526 -0.87 . . . . 74.43 111.918 -173.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 179.02 168.51 38.24 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 119.284 -1.436 . . . . 71.42 112.821 176.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 45.4 p -132.1 155.08 48.74 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.789 -1.189 . . . . 74.31 107.789 176.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.487 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 23.3 t-20 -73.37 -57.46 2.73 Favored Pre-proline 0 C--N 1.314 -0.952 0 C-N-CA 120.189 -0.604 . . . . 72.24 111.477 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.487 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 1.1 Cg_endo -84.0 140.9 9.16 Favored 'Trans proline' 0 N--CA 1.436 -1.909 0 CA-C-N 120.053 1.055 . . . . 72.41 109.509 175.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 3.4 Cg_exo -73.45 158.42 48.03 Favored 'Trans proline' 0 C--O 1.267 1.97 0 C-N-CA 121.977 1.785 . . . . 62.32 112.528 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.17 139.88 58.82 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 115.113 -0.948 . . . . 72.2 109.81 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 104.21 -8.75 49.33 Favored Glycine 0 N--CA 1.422 -2.28 0 C-N-CA 120.347 -0.93 . . . . 43.34 111.625 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 26.4 m -75.76 120.45 21.15 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.732 -0.84 . . . . 63.45 108.732 175.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 10.9 t -88.16 124.88 34.26 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-O 121.366 0.603 . . . . 45.44 110.864 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 33.8 m -141.95 165.3 28.71 Favored Pre-proline 0 C--N 1.315 -0.895 0 N-CA-C 108.164 -1.05 . . . . 65.22 108.164 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.61 144.44 94.25 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 121.92 1.747 . . . . 72.12 110.399 172.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 517' ' ' PHE . 34.8 m -64.71 -20.29 27.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 121.942 0.877 . . . . 74.12 112.166 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -92.78 4.8 53.13 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 115.773 -0.649 . . . . 62.2 111.65 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 12.8 t -86.6 170.72 11.6 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.424 -0.954 . . . . 64.24 108.424 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 99.7 t -95.92 131.98 41.3 Favored 'Isoleucine or valine' 0 C--O 1.247 0.925 0 N-CA-C 112.586 0.587 . . . . 51.45 112.586 -175.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . 0.529 HD13 ' O ' ' A' ' 519' ' ' LYS . 0.2 OUTLIER -105.34 134.22 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 108.574 -0.899 . . . . 70.05 108.574 169.13 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -102.97 117.08 33.8 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 116.446 -0.343 . . . . 64.51 110.167 -176.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 5.3 mp -103.9 134.43 47.21 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.07 0.948 . . . . 63.01 111.239 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -96.89 121.84 39.21 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.66 -0.867 . . . . 72.21 108.66 174.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 524' ' ' SER . 24.5 t -107.9 139.6 29.35 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 N-CA-C 108.612 -0.885 . . . . 61.22 108.612 -178.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.585 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 69.1 m -81.42 143.79 31.88 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 111.88 0.326 . . . . 50.42 111.88 178.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.627 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 12.2 ptmt -105.47 156.43 18.22 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 104.591 -2.374 . . . . 74.3 104.591 167.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -83.5 -24.31 50.99 Favored Glycine 0 CA--C 1.498 -1.03 0 C-N-CA 119.864 -1.16 . . . . 55.33 115.446 -168.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . 0.492 ' HB3' ' HD2' ' A' ' 616' ' ' ARG . 85.6 m-20 62.67 27.62 16.22 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.112 0.482 . . . . 71.33 110.586 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -128.58 149.28 50.7 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.231 -1.026 . . . . 53.42 108.231 -172.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -140.89 149.2 41.61 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.167 -1.049 . . . . 51.43 108.167 173.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.4 p -83.67 116.86 28.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 121.849 0.833 . . . . 71.3 112.081 -176.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 60.0 ttp -89.5 127.05 56.21 Favored Pre-proline 0 C--N 1.312 -1.033 0 CA-C-N 115.283 -0.871 . . . . 52.05 108.689 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.62 154.8 66.83 Favored 'Trans proline' 0 C--O 1.239 0.555 0 C-N-CA 122.261 1.974 . . . . 72.44 111.811 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -83.13 115.5 21.93 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.351 0.596 . . . . 71.04 111.782 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . 0.581 ' O ' ' HG3' ' A' ' 569' ' ' MET . 95.2 mt -136.87 18.33 3.04 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.536 -1.211 . . . . 70.35 109.001 178.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 24.0 t -52.69 131.07 34.26 Favored 'General case' 0 CA--C 1.553 1.093 0 O-C-N 123.384 0.427 . . . . 73.22 110.748 -175.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 107.37 41.54 1.61 Allowed Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 109.382 -1.487 . . . . 74.54 109.382 -174.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . 0.581 ' HG3' ' O ' ' A' ' 566' ' ' LEU . 79.0 mtp -101.02 158.11 16.25 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.167 -0.517 . . . . 75.01 110.518 -177.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . 0.431 ' HB3' ' OD1' ' A' ' 601' ' ' ASN . 98.7 m-85 -102.69 168.13 9.45 Favored 'General case' 0 N--CA 1.416 -2.13 0 N-CA-C 106.886 -1.524 . . . . 75.32 106.886 170.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 79.9 t90 -64.23 -32.37 73.92 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.902 -0.777 . . . . 74.3 108.902 174.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.1 p -67.94 -20.19 25.66 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 CA-C-N 115.511 -0.768 . . . . 73.24 110.612 177.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -85.43 -38.06 19.08 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 108.444 -0.946 . . . . 71.54 108.444 175.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -57.66 -41.38 81.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.043 -0.981 . . . . 73.53 112.185 -177.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -55.59 -59.82 10.23 Favored Pre-proline 0 CA--C 1.591 2.529 0 N-CA-C 112.795 0.665 . . . . 71.34 112.795 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.1 -43.02 26.2 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 121.622 1.548 . . . . 62.44 112.88 175.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -59.79 -33.81 72.2 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 111.772 0.286 . . . . 72.11 111.772 -177.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 6.9 tt -57.4 -46.65 83.25 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.622 0.769 . . . . 52.13 109.422 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -65.38 -47.42 76.4 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.86 -0.609 . . . . 72.01 111.634 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.64 -39.16 88.12 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.605 -0.725 . . . . 53.43 112.598 -175.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 88.9 mt -84.49 -8.01 59.08 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 111.677 0.251 . . . . 62.32 111.677 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 66.76 41.57 93.61 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 111.481 -0.647 . . . . 73.14 111.481 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 90.9 t90 -83.61 134.77 34.78 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.039 0.447 . . . . 70.44 111.798 -176.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 91.4 m -154.13 96.38 1.94 Allowed 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 124.561 1.144 . . . . 72.43 108.314 170.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -147.19 -147.16 4.49 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 108.569 -1.812 . . . . 74.42 108.569 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . 0.571 ' HB3' HG12 ' A' ' 619' ' ' ILE . 23.2 ttt -98.28 124.23 42.78 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 117.888 0.844 . . . . 74.04 109.028 178.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 57.4 tp -94.92 115.53 27.57 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 107.361 -1.348 . . . . 74.33 107.361 177.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -95.67 104.5 16.42 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.639 -0.825 . . . . 74.24 109.697 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -110.6 134.25 52.58 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.996 -0.547 . . . . 73.33 109.686 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -102.8 -173.4 26.71 Favored Glycine 0 N--CA 1.432 -1.577 0 N-CA-C 110.072 -1.211 . . . . 73.11 110.072 174.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -65.85 148.74 51.29 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 122.449 0.3 . . . . 34.0 110.799 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . 0.413 ' HA ' ' O ' ' A' ' 625' ' ' GLY . 3.7 m-20 -78.98 123.61 27.45 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.688 -1.227 . . . . 44.1 107.688 177.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 88.6 t -137.54 120.3 20.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 116.291 -0.413 . . . . 62.11 110.538 -173.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -80.53 106.86 12.87 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.001 -1.111 . . . . 63.44 108.001 174.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -126.37 2.05 7.01 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.84 -0.618 . . . . 44.23 111.361 -176.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 123.2 163.58 11.83 Favored Glycine 0 N--CA 1.43 -1.704 0 C-N-CA 119.815 -1.183 . . . . 75.23 111.084 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.24 -36.6 69.38 Favored Glycine 0 C--O 1.223 -0.573 0 N-CA-C 114.151 0.421 . . . . 43.13 114.151 -173.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 25.8 m -64.59 -24.5 67.61 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 117.176 0.488 . . . . 73.45 111.939 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -107.05 -8.32 16.58 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 122.044 -0.41 . . . . 73.23 110.876 -178.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 59.3 m170 -74.38 103.48 4.77 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 112.901 0.704 . . . . 71.44 112.901 -175.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . 0.431 ' OD1' ' HB3' ' A' ' 570' ' ' PHE . 4.5 t-20 69.04 -4.27 1.29 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.14 1.776 . . . . 75.22 112.695 172.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -86.78 140.65 29.51 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.31 1.044 . . . . 71.22 108.254 -177.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . 0.403 HG13 ' HB2' ' A' ' 622' ' ' LEU . 96.8 t -69.82 130.79 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 107.444 -1.317 . . . . 73.43 107.444 176.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 623' ' ' ARG . 9.0 p -99.42 -32.89 3.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 119.204 -0.998 . . . . 65.01 110.899 -174.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -147.62 153.47 39.44 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 106.356 -1.72 . . . . 72.42 106.356 176.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -123.42 -172.09 2.44 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 108.557 -0.905 . . . . 63.02 108.557 177.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.509 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 55.2 t30 -113.36 -65.02 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.534 0 C-N-CA 119.152 -1.019 . . . . 64.5 112.277 -177.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.509 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 59.1 Cg_endo -88.99 157.96 5.87 Favored 'Trans proline' 0 CA--C 1.552 1.404 0 CA-C-N 120.835 1.334 . . . . 60.12 110.65 174.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -70.73 135.0 27.13 Favored 'Trans proline' 0 C--O 1.249 1.026 0 C-N-CA 122.304 2.002 . . . . 54.1 112.623 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -68.89 132.62 47.02 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.642 -0.708 . . . . 60.22 109.665 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 93.07 -0.48 69.2 Favored Glycine 0 C--N 1.316 -0.548 0 N-CA-C 111.153 -0.779 . . . . 65.1 111.153 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 43.2 m -110.98 164.36 12.88 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 108.429 -0.952 . . . . 63.4 108.429 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -70.4 122.66 11.09 Favored Glycine 0 N--CA 1.416 -2.683 0 N-CA-C 111.371 -0.692 . . . . 71.24 111.371 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 33.1 m -105.82 144.51 15.16 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 108.074 -1.084 . . . . 63.45 108.074 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.441 ' ND2' ' HB3' ' A' ' 617' ' ' ASP . 29.5 p-10 -53.85 149.21 9.06 Favored 'General case' 0 C--O 1.22 -0.482 0 O-C-N 123.309 0.38 . . . . 74.41 110.536 -178.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . 0.492 ' HD2' ' HB3' ' A' ' 559' ' ' ASN . 0.1 OUTLIER -54.71 -25.44 27.35 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 112.696 0.628 . . . . 74.22 112.696 -178.388 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . 0.441 ' HB3' ' ND2' ' A' ' 615' ' ' ASN . 31.5 t70 -67.73 -37.07 81.7 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.724 -0.671 . . . . 63.34 109.486 177.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 85.53 21.39 54.15 Favored Glycine 0 C--O 1.202 -1.876 0 C-N-CA 120.655 -0.784 . . . . 65.3 112.627 176.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . 0.571 HG12 ' HB3' ' A' ' 586' ' ' MET . 0.1 OUTLIER -68.69 119.72 14.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 122.563 1.173 . . . . 75.31 111.333 -170.548 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 40.2 mm -121.04 119.76 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-N 114.027 -1.442 . . . . 62.42 107.747 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 51.8 m -98.87 118.64 36.09 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.354 -1.351 . . . . 72.24 107.354 174.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . 0.403 ' HB2' HG13 ' A' ' 603' ' ' VAL . 2.2 pt? -138.04 165.39 26.7 Favored 'General case' 0 CA--C 1.484 -1.558 0 N-CA-C 108.162 -1.051 . . . . 74.32 108.162 -174.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . 0.445 ' O ' HG12 ' A' ' 604' ' ' VAL . 14.2 tpt180 -148.14 141.63 25.38 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 106.617 -1.623 . . . . 74.32 106.617 176.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -136.52 158.89 43.38 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 105.818 -1.919 . . . . 73.34 105.818 173.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 592' ' ' ASP . . . -77.8 -90.96 0.31 Allowed Glycine 0 N--CA 1.426 -1.99 0 N-CA-C 110.355 -1.098 . . . . 61.55 110.355 178.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 . . . . . 0 C--N 1.288 -2.098 0 CA-C-O 118.132 -0.937 . . . . 72.44 109.143 176.417 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 . . . . . 0 CA--C 1.505 -0.785 0 CA-C-O 121.011 0.434 . . . . 74.22 110.89 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 28.5 m -116.89 147.93 19.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 109.209 -0.663 . . . . 74.42 109.209 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . 0.424 ' NE2' ' HA ' ' A' ' 407' ' ' ASN . 0.8 OUTLIER -94.09 130.07 40.4 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 105.18 -2.156 . . . . 74.43 105.18 -178.759 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.461 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 79.8 t -95.8 132.13 27.84 Favored Pre-proline 0 C--N 1.288 -2.093 0 CA-C-N 115.46 -0.791 . . . . 71.53 111.025 -166.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 17.2 Cg_exo -61.5 122.43 11.06 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.531 2.154 . . . . 61.42 111.938 -178.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -89.08 111.42 22.16 Favored 'General case' 0 C--N 1.272 -2.779 0 CA-C-N 114.072 -1.422 . . . . 63.34 110.465 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 7.1 t -86.72 24.0 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.558 0 CA-C-O 122.807 1.289 . . . . 75.45 111.24 -174.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.531 ' O ' ' HD2' ' A' ' 366' ' ' ARG . 1.9 ppt_? -52.86 144.63 14.16 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.691 -1.14 . . . . 74.2 112.225 172.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 98.51 -14.47 62.03 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 120.82 -0.705 . . . . 64.35 112.54 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -102.07 -89.38 0.37 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 120.222 -0.591 . . . . 72.12 111.104 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 81.0 p -164.74 168.79 17.54 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.138 -1.06 . . . . 44.45 108.138 177.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 28.7 m -63.37 -40.82 98.3 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 109.053 -0.721 . . . . 63.12 109.053 176.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.79 -45.83 90.84 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.835 -0.621 . . . . 72.23 110.983 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -64.05 -42.38 97.05 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.355 0.41 . . . . 75.24 111.043 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . 0.402 ' O ' ' HG ' ' A' ' 377' ' ' LEU . . . -66.74 -50.11 63.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.14 -0.482 . . . . 62.21 111.06 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 78.4 mt -61.98 -40.23 86.54 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 CA-C-N 116.228 -0.442 . . . . 74.03 110.996 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.8 -47.2 85.6 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.195 0.522 . . . . 62.2 110.363 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . 0.668 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 27.9 m -66.04 -47.96 72.65 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 115.104 -0.953 . . . . 64.25 110.024 -179.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 373' ' ' ALA . 97.5 mt -61.89 -44.68 96.3 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.604 -0.271 . . . . 63.53 111.694 -177.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -63.37 -42.81 98.88 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.267 -0.424 . . . . 64.15 110.6 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -70.42 -17.5 63.01 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.102 0.477 . . . . 73.35 112.237 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . 0.668 ' HG2' ' O ' ' A' ' 376' ' ' THR . 17.5 mmm180 -89.56 -13.75 36.6 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 120.882 -0.327 . . . . 64.4 110.665 176.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.08 13.49 36.45 Favored Glycine 0 C--N 1.309 -0.968 0 C-N-CA 120.315 -0.945 . . . . 42.43 112.301 177.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -87.84 156.61 19.3 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 121.003 0.43 . . . . 61.53 110.725 175.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -105.6 154.27 20.64 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.946 -1.131 . . . . 73.33 107.946 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . 0.418 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -127.68 149.09 32.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 119.65 -0.82 . . . . 72.13 112.406 -176.338 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . 0.431 ' HD2' ' OG1' ' A' ' 417' ' ' THR . 41.6 ttm180 -116.92 128.12 54.91 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 105.283 -2.117 . . . . 75.13 105.283 173.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 31.1 m -122.8 124.67 43.85 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 109.123 -0.695 . . . . 72.42 109.123 -175.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -111.76 119.8 39.85 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.141 -1.799 . . . . 64.33 106.141 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.549 HE21 ' N ' ' A' ' 388' ' ' GLN . 0.0 OUTLIER -116.9 134.85 54.25 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.455 -0.498 . . . . 53.35 110.891 -177.541 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 390' ' ' PRO . 28.3 mtpp -135.86 145.0 50.95 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-N 115.787 -0.642 . . . . 63.25 110.658 178.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 389' ' ' LYS . 33.9 Cg_exo -68.5 153.62 73.43 Favored 'Trans proline' 0 C--O 1.252 1.188 0 C-N-CA 122.628 2.219 . . . . 74.43 108.85 169.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -62.64 124.94 22.3 Favored 'General case' 0 CA--C 1.487 -1.453 0 CA-C-O 122.519 1.152 . . . . 70.14 112.739 -175.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 49.5 m -154.37 34.19 0.42 Allowed 'General case' 0 C--N 1.279 -2.5 0 CA-C-N 112.525 -2.125 . . . . 70.14 106.134 178.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 23.2 m 81.38 46.1 0.03 OUTLIER 'General case' 0 CA--C 1.57 1.736 0 C-N-CA 125.862 1.665 . . . . 72.15 111.515 -178.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.25 151.59 46.94 Favored Pre-proline 0 C--N 1.313 -1.009 0 CA-C-N 115.431 -0.804 . . . . 71.1 110.68 174.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . 0.412 ' HB3' HD13 ' A' ' 400' ' ' ILE . 81.9 Cg_exo -50.8 136.54 43.01 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 C-N-CA 124.007 3.138 . . . . 75.05 114.654 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.99 163.02 17.39 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.733 2.955 . . . . 75.14 111.841 176.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -56.86 -8.41 0.6 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 112.885 0.698 . . . . 63.43 112.885 -179.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 33.8 m170 -85.51 114.47 22.56 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 106.959 -1.497 . . . . 73.21 106.959 173.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 15.5 m -68.3 119.53 14.21 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-N 116.067 -0.515 . . . . 64.23 112.005 -174.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . 0.412 HD13 ' HB3' ' A' ' 395' ' ' PRO . 3.9 mp -87.25 -30.55 5.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 108.083 -1.08 . . . . 61.22 108.083 176.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.39 171.02 27.35 Favored Glycine 0 N--CA 1.422 -2.239 0 N-CA-C 110.774 -0.93 . . . . 34.14 110.774 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 4.1 p -114.6 -178.06 3.28 Favored 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 123.059 0.544 . . . . 74.03 110.75 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -100.62 136.93 19.79 Favored Pre-proline 0 C--N 1.293 -1.881 0 N-CA-C 107.862 -1.162 . . . . 64.32 107.862 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -47.51 -22.64 2.92 Favored 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 124.503 3.468 . . . . 61.43 115.275 -176.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -64.74 -29.29 70.27 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 120.729 0.3 . . . . 55.12 110.961 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -85.28 -40.78 16.2 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.571 0.7 . . . . 63.44 110.327 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . 0.424 ' HA ' ' NE2' ' A' ' 361' ' ' GLN . 13.0 m120 -77.14 -11.18 59.78 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.421 -0.809 . . . . 71.04 112.126 -173.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 57.2 m -100.94 157.51 16.69 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 107.558 -1.275 . . . . 70.11 107.558 177.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 44.1 m -74.53 112.77 11.04 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 108.066 -1.086 . . . . 72.33 108.066 177.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.5 169.33 20.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 120.972 0.415 . . . . 70.01 111.202 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 22.8 t -73.64 133.05 43.37 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 107.096 -1.446 . . . . 73.41 107.096 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -61.88 138.5 58.36 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.134 0.492 . . . . 72.22 111.56 -176.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 93.1 39.48 5.13 Favored Glycine 0 N--CA 1.437 -1.286 0 CA-C-N 115.704 -0.68 . . . . 53.53 111.943 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -102.49 -174.33 2.54 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.191 -1.411 . . . . 62.14 107.191 177.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -109.83 116.27 31.34 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 118.374 0.534 . . . . 74.31 109.897 -177.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 32.2 mm -99.37 129.19 50.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 109.154 -0.684 . . . . 71.32 109.154 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . 0.431 ' OG1' ' HD2' ' A' ' 385' ' ' ARG . 44.7 m -91.74 131.13 37.33 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 112.38 0.511 . . . . 71.32 112.38 -177.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 3.5 p -123.33 134.96 64.78 Favored 'Isoleucine or valine' 0 C--O 1.252 1.226 0 N-CA-C 108.351 -0.981 . . . . 75.51 108.351 176.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -107.24 124.99 50.56 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.244 -0.65 . . . . 65.33 109.244 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 2.7 p -125.79 131.46 71.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-N 115.49 -0.777 . . . . 73.24 111.176 -177.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 29.3 t -107.61 131.34 54.47 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-O 121.941 0.877 . . . . 45.01 110.23 176.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 24.2 p -87.15 158.48 19.15 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 105.363 -2.088 . . . . 42.41 105.363 170.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 2.191 0 CA-C-N 118.679 0.672 . . . . 72.14 114.092 -179.035 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.588 ' HG2' HG22 ' A' ' 477' ' ' THR . 45.9 tt0 . . . . . 0 N--CA 1.408 -2.572 0 N-CA-C 104.23 -2.507 . . . . 71.34 104.23 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.46 ' HA ' ' HE ' ' A' ' 427' ' ' ARG . 3.2 mmp_? -122.53 156.68 33.68 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 120.492 -0.483 . . . . 74.32 111.847 -173.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -83.22 139.98 32.81 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.788 -1.19 . . . . 72.34 107.788 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 73.3 mt -78.96 122.5 84.62 Favored Pre-proline 0 N--CA 1.425 -1.693 0 N-CA-C 108.298 -1.001 . . . . 51.33 108.298 -178.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -69.97 140.82 42.79 Favored 'Trans proline' 0 N--CA 1.429 -2.323 0 C-N-CA 121.256 1.304 . . . . 60.42 110.05 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -100.85 155.95 17.64 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 115.677 -0.692 . . . . 73.22 109.479 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.588 HG11 ' HB2' ' A' ' 440' ' ' ALA . 8.5 p -153.2 170.94 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 N-CA-C 107.452 -1.314 . . . . 71.35 107.452 -174.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.459 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 14.5 m -73.09 146.36 45.84 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 108.713 -0.847 . . . . 63.32 108.713 176.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 15.7 p -68.4 -23.92 64.7 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 113.59 0.959 . . . . 72.34 113.59 -174.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.5 pp -80.39 -11.87 59.64 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 120.113 -0.635 . . . . 61.52 110.383 177.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.466 HG22 ' HB3' ' A' ' 439' ' ' GLU . 1.3 m -101.84 44.15 1.03 Allowed 'General case' 0 CA--C 1.555 1.135 0 CA-C-N 115.592 -0.731 . . . . 61.43 110.902 -175.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -52.42 -38.18 58.49 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.387 0.675 . . . . 71.33 112.389 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.0 -45.03 83.31 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.209 0.528 . . . . 65.54 111.025 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.466 ' HB3' HG22 ' A' ' 436' ' ' THR . 33.7 tt0 -70.7 -33.26 70.69 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.68 -0.691 . . . . 73.44 110.51 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.588 ' HB2' HG11 ' A' ' 432' ' ' VAL . . . -58.95 -51.27 70.78 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.088 0.155 . . . . 44.33 110.658 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 33.6 m -62.52 -37.12 78.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-O 121.201 0.524 . . . . 70.44 110.849 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -60.39 -47.99 83.71 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.312 -0.858 . . . . 64.34 110.437 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -66.03 -38.75 89.18 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.904 -0.589 . . . . 73.01 111.725 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 93.1 mt -63.66 -33.66 76.13 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.791 0.329 . . . . 74.32 110.383 176.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 66.3 m -70.28 -44.9 67.45 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 115.912 -0.586 . . . . 74.35 110.1 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.75 -21.69 65.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.597 -0.729 . . . . 63.13 110.907 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.22 5.09 21.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.622 -0.717 . . . . 74.41 112.436 -179.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 105.18 -79.47 0.28 Allowed Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.11 -1.043 . . . . 72.24 111.998 175.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -39.62 -61.07 0.87 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.358 1.244 . . . . 73.32 114.358 176.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 62.15 18.45 57.73 Favored Glycine 0 C--N 1.321 -0.293 0 C-N-CA 121.634 -0.317 . . . . 71.42 113.186 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 14.3 mmt180 -95.15 111.29 23.14 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.356 -0.979 . . . . 74.33 108.356 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -136.49 153.88 50.9 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 120.689 0.281 . . . . 72.44 110.795 -178.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -142.37 133.16 25.56 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.545 -1.28 . . . . 73.22 107.545 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -101.5 134.52 44.48 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.832 -0.433 . . . . 74.51 109.832 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -124.37 138.83 54.33 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.036 -1.468 . . . . 22.41 107.036 173.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -121.07 136.67 54.93 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 109.479 -0.563 . . . . 62.04 109.479 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 32.5 t -135.72 141.2 36.13 Favored Pre-proline 0 C--N 1.296 -1.746 0 N-CA-C 108.708 -0.849 . . . . 61.13 108.708 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.693 ' HA ' ' O ' ' A' ' 490' ' ' SER . 37.6 Cg_endo -69.43 131.16 21.11 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.18 1.92 . . . . 73.03 110.521 175.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 61.1 m -151.22 -179.38 7.29 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.638 -0.875 . . . . 60.32 108.638 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 11.9 t -48.22 138.81 10.62 Favored Pre-proline 0 C--O 1.25 1.104 0 C-N-CA 123.941 0.897 . . . . 51.43 111.11 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -51.39 -29.39 30.59 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 124.401 3.401 . . . . 72.21 113.817 -175.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -75.27 -26.57 58.9 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.026 -0.67 . . . . 53.01 111.939 -177.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -88.58 -14.96 36.33 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 120.689 0.28 . . . . 71.0 111.07 178.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 86.5 t -60.87 127.56 20.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 109.385 -0.598 . . . . 75.15 109.385 176.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 96.92 -5.81 63.94 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 115.799 -0.637 . . . . 72.02 112.945 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.411 ' HD2' ' N ' ' A' ' 466' ' ' LYS . 8.2 mptt -124.46 160.18 28.82 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 108.393 -0.965 . . . . 73.23 108.393 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.415 HG22 HG12 ' A' ' 488' ' ' VAL . 77.7 t -70.95 142.62 15.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 107.612 -1.255 . . . . 72.33 107.612 173.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 59.0 mt -97.57 -35.65 5.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 107.566 -1.272 . . . . 75.3 107.566 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 173.24 -172.43 45.15 Favored Glycine 0 N--CA 1.412 -2.931 0 N-CA-C 109.707 -1.357 . . . . 73.14 109.707 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 30.2 p -121.18 146.24 46.99 Favored 'General case' 0 C--N 1.271 -2.832 0 N-CA-C 107.216 -1.401 . . . . 74.05 107.216 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.453 ' HB3' HG23 ' A' ' 485' ' ' ILE . 58.0 t30 -72.07 -46.2 11.35 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 119.096 -1.042 . . . . 74.12 110.153 176.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -82.61 146.44 13.47 Favored 'Trans proline' 0 C--N 1.374 1.906 0 N-CA-C 108.517 -1.378 . . . . 73.44 108.517 169.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.478 ' HB2' ' HG2' ' A' ' 476' ' ' GLN . 19.5 Cg_exo -65.36 127.29 17.88 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 121.778 1.652 . . . . 73.44 111.691 -178.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -86.3 8.95 19.35 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.643 0.735 . . . . 70.54 111.299 -175.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -109.4 -6.73 15.36 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 116.039 -0.528 . . . . 72.51 110.364 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . 0.478 ' HG2' ' HB2' ' A' ' 473' ' ' PRO . 81.2 mm-40 -97.24 172.2 7.95 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 116.01 -0.541 . . . . 62.41 111.791 -174.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.588 HG22 ' HG2' ' A' ' 426' ' ' GLN . 1.3 m -92.91 119.01 31.77 Favored 'General case' 0 N--CA 1.418 -2.032 0 CA-C-N 115.272 -0.876 . . . . 51.13 108.688 -177.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 54.9 m -115.49 148.04 39.94 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 123.171 0.588 . . . . 74.01 110.719 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -73.26 159.07 33.97 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.767 -0.651 . . . . 50.55 111.066 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 43.7 mm -69.09 -21.09 25.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.748 0.785 . . . . 63.23 110.295 -177.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 3.7 p -100.15 5.33 44.82 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.734 -0.604 . . . . 73.3 111.87 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -94.1 133.9 37.1 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.216 -0.447 . . . . 75.11 109.926 -177.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 33.0 t -100.64 126.77 54.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.082 -0.508 . . . . 72.32 110.621 -174.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 35.0 m -103.0 137.47 31.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.429 0.633 . . . . 72.33 111.143 178.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.453 HG23 ' HB3' ' A' ' 471' ' ' ASN . 0.0 OUTLIER -107.16 128.45 62.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.495 0.664 . . . . 73.31 110.096 -178.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 38.5 mm -109.21 128.23 65.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 C-N-CA 125.046 1.338 . . . . 75.54 108.858 -174.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 13.4 tt -112.07 126.47 69.47 Favored 'Isoleucine or valine' 0 C--O 1.246 0.887 0 CA-C-O 121.453 0.644 . . . . 71.13 110.977 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.415 HG12 HG22 ' A' ' 467' ' ' VAL . 34.5 m -113.29 151.64 15.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 0 CA-C-N 115.448 -0.796 . . . . 61.4 111.495 -177.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.0 132.53 11.22 Favored Glycine 0 N--CA 1.433 -1.548 0 N-CA-C 109.534 -1.426 . . . . 24.23 109.534 177.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.693 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 21.5 p . . . . . 0 C--N 1.294 -1.815 0 CA-C-N 116.958 0.379 . . . . 74.12 110.48 -176.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo . . . . . 0 C--O 1.252 1.205 0 N-CA-C 110.891 -0.465 . . . . 75.42 110.891 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -91.32 78.09 5.79 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.718 0.771 . . . . 73.33 110.043 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 546' ' ' PRO . 18.2 p -117.79 142.94 46.72 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.98 -1.009 . . . . 72.41 110.697 -178.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 4.8 mmmp? -141.15 152.62 44.84 Favored 'General case' 0 CA--C 1.494 -1.183 0 CA-C-O 121.524 0.678 . . . . 74.14 110.792 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 12.4 p-10 -80.62 134.41 35.89 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 114.265 -1.334 . . . . 73.4 108.518 175.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 31.8 pt -83.35 125.28 74.6 Favored Pre-proline 0 C--N 1.3 -1.55 0 C-N-CA 120.527 -0.469 . . . . 74.44 109.834 177.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -79.8 -175.81 2.91 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.279 1.986 . . . . 64.44 111.107 178.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -84.22 90.17 7.46 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.678 0.752 . . . . 73.33 110.675 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 12.8 p -104.96 3.17 10.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 123.353 1.549 . . . . 53.22 106.985 175.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . 0.568 ' HB1' ' HA2' ' A' ' 536' ' ' GLY . . . -83.6 63.59 7.48 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 113.161 -1.836 . . . . 75.31 111.446 -174.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 165.95 28.65 0.02 OUTLIER Glycine 0 C--N 1.309 -0.962 0 C-N-CA 119.253 -1.451 . . . . 72.12 113.244 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -118.74 -169.13 1.66 Allowed 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 106.753 -1.573 . . . . 73.43 106.753 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 11.4 m -81.96 155.45 25.22 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.038 -1.467 . . . . 75.44 107.038 175.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.621 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 6.0 p -55.1 -46.36 77.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.231 0.456 . . . . 65.04 112.231 -176.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -66.51 -41.63 88.58 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 116.475 -0.329 . . . . 62.32 111.326 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 60.0 t -66.43 -42.04 89.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.694 -0.685 . . . . 71.41 109.817 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -61.86 -44.91 95.86 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 115.424 -0.807 . . . . 71.2 111.253 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.621 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 21.2 mt-30 -60.29 -40.41 90.38 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 121.191 0.519 . . . . 72.14 110.887 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.449 ' O ' HG23 ' A' ' 514' ' ' VAL . 64.0 mttm -64.47 -53.6 45.74 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.417 -0.81 . . . . 74.1 109.626 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -62.77 -37.8 88.08 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 115.514 -0.766 . . . . 75.14 111.288 -177.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 8.4 tt -59.04 -44.79 91.83 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 109.108 -0.701 . . . . 72.42 109.108 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . 0.546 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 0.8 OUTLIER -64.62 -37.64 88.28 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.173 -0.467 . . . . 72.04 111.426 177.292 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 510' ' ' LYS . 92.7 t -63.71 -30.25 49.42 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 CA-C-N 116.028 -0.533 . . . . 63.44 111.088 177.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -77.15 -4.53 45.01 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.82 0.343 . . . . 75.33 111.353 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 106.42 -10.69 42.81 Favored Glycine 0 CA--C 1.496 -1.122 0 C-N-CA 120.664 -0.779 . . . . 52.42 112.226 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 82.4 m-85 -88.52 114.42 25.12 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 107.377 -1.342 . . . . 63.32 107.377 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 5.0 p -89.56 -19.4 25.04 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 112.983 0.735 . . . . 70.41 112.983 -175.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -107.93 119.51 39.67 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.404 0.621 . . . . 63.4 111.924 -172.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -129.8 156.4 44.39 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.346 -0.843 . . . . 73.31 110.524 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 10.1 p -141.64 147.05 36.94 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.381 -1.34 . . . . 71.11 107.381 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.51 133.48 53.31 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 121.169 0.509 . . . . 60.15 111.427 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -132.97 126.39 31.88 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.436 -0.95 . . . . 71.15 108.436 178.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 11.0 m -98.1 134.64 40.9 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-O 120.828 0.347 . . . . 74.01 110.423 -177.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 557' ' ' LYS . 30.5 m -123.01 149.96 26.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.083 -1.081 . . . . 63.31 108.083 176.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -66.33 135.67 54.71 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.998 -0.741 . . . . 75.3 108.998 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 74.2 m -149.91 166.99 13.9 Favored Pre-proline 0 C--N 1.293 -1.863 0 CA-C-N 115.754 -0.657 . . . . 64.24 111.162 -173.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -79.48 -23.36 7.32 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 121.805 1.67 . . . . 54.52 110.658 170.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -70.79 147.28 94.2 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 108.607 -0.886 . . . . 73.11 108.607 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -61.77 158.95 35.13 Favored 'Trans proline' 0 C--O 1.251 1.13 0 C-N-CA 122.835 2.357 . . . . 72.35 113.129 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -67.24 120.46 13.83 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.581 -0.736 . . . . 31.3 110.783 -179.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 118.52 -17.21 11.28 Favored Glycine 0 C--N 1.309 -0.924 0 C-N-CA 120.651 -0.785 . . . . 54.4 111.646 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -77.42 133.1 38.74 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.095 -1.076 . . . . 71.3 108.095 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 77.3 t -82.41 117.58 28.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 108.216 -1.031 . . . . 63.23 108.216 177.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . 0.52 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 13.7 t -82.07 -17.66 45.83 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.781 0.8 . . . . 72.33 109.727 -177.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.568 ' HA2' ' HB1' ' A' ' 501' ' ' ALA . . . 162.35 -163.31 34.95 Favored Glycine 0 N--CA 1.411 -3.021 0 N-CA-C 110.618 -0.993 . . . . 31.44 110.618 177.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . 0.433 HG22 HD23 ' A' ' 553' ' ' LEU . 22.8 p -124.98 154.88 40.53 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 107.749 -1.204 . . . . 63.1 107.749 176.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -66.31 -55.88 18.29 Favored Pre-proline 0 C--N 1.306 -1.306 0 N-CA-C 109.606 -0.516 . . . . 64.2 109.606 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.46 127.06 10.09 Favored 'Trans proline' 0 C--N 1.368 1.561 0 N-CA-C 109.128 -1.143 . . . . 53.44 109.128 169.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.6 152.99 64.7 Favored 'Trans proline' 0 C--O 1.245 0.873 0 C-N-CA 123.14 2.56 . . . . 75.23 112.944 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -67.12 138.26 56.94 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.118 -0.492 . . . . 62.33 110.096 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 104.41 -20.82 38.83 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 111.469 -0.652 . . . . 64.25 111.469 -177.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 32.8 m -65.41 135.61 55.46 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.5 -0.556 . . . . 71.05 109.5 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 17.2 m -97.7 123.18 41.52 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 109.333 -0.617 . . . . 73.13 109.333 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.0 m -136.53 159.81 69.08 Favored Pre-proline 0 C--N 1.31 -1.141 0 N-CA-C 109.161 -0.681 . . . . 73.43 109.161 -178.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 494' ' ' THR . 41.7 Cg_exo -63.88 147.6 92.08 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.221 1.947 . . . . 74.54 111.435 174.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 29.5 m -64.97 -19.62 25.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.703 0.763 . . . . 61.51 111.557 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -93.55 3.64 55.21 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.169 -0.923 . . . . 64.11 110.256 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 11.7 t -85.71 162.19 18.86 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.546 -0.909 . . . . 44.3 108.546 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 21.6 t -97.36 128.06 49.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 109.604 -0.517 . . . . 42.31 109.604 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 2.3 mp -101.68 131.58 49.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 108.863 -0.791 . . . . 75.32 108.863 176.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -102.67 116.69 33.09 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 121.489 0.661 . . . . 71.45 110.669 -178.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . 0.433 HD23 HG22 ' A' ' 537' ' ' THR . 84.4 mt -90.31 128.84 36.55 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.768 -1.197 . . . . 34.42 107.768 177.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -103.82 113.76 27.53 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 122.379 1.085 . . . . 71.1 109.379 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 23.0 t -94.38 147.13 5.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-N 114.02 -1.446 . . . . 62.34 110.019 -172.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.52 ' OG ' ' HB ' ' A' ' 535' ' ' THR . 7.5 m -86.31 131.58 34.18 Favored 'General case' 0 N--CA 1.414 -2.268 0 CA-C-N 115.636 -0.711 . . . . 73.22 109.769 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 525' ' ' VAL . 9.4 ttmm -99.12 119.44 37.85 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 107.107 -1.442 . . . . 73.24 107.107 171.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -67.69 -37.48 89.06 Favored Glycine 0 CA--C 1.495 -1.203 0 N-CA-C 110.955 -0.858 . . . . 72.15 110.955 -177.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . 0.488 ' OD1' ' HD2' ' A' ' 616' ' ' ARG . 52.3 t30 65.8 4.47 2.94 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.964 1.706 . . . . 73.04 111.284 175.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 -142.89 141.24 31.48 Favored 'General case' 0 N--CA 1.415 -2.177 0 N-CA-C 104.702 -2.333 . . . . 74.25 104.702 -173.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -142.25 135.93 29.32 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 118.663 0.665 . . . . 75.11 111.027 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 6.6 p -70.14 116.42 11.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.732 0.777 . . . . 63.25 112.206 -176.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 61.4 ttp -98.2 139.77 21.44 Favored Pre-proline 0 C--N 1.309 -1.178 0 CA-C-N 115.222 -0.899 . . . . 63.53 108.774 177.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -60.68 161.86 20.01 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.764 2.309 . . . . 64.34 111.798 176.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . 0.658 ' HA ' ' HB1' ' A' ' 610' ' ' ALA . 0.5 OUTLIER -68.16 128.53 36.9 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.797 0.808 . . . . 51.03 112.761 -175.051 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 57.1 tp -131.13 4.29 4.41 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 107.509 -1.293 . . . . 65.24 107.509 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 7.7 m -77.34 134.68 38.42 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 113.983 -1.462 . . . . 42.53 109.842 -176.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 88.0 16.89 58.79 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.643 -0.789 . . . . 72.11 112.119 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 85.7 mtp -114.96 178.15 4.39 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.452 -0.944 . . . . 72.55 108.452 -178.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 66.7 m-85 -89.61 155.52 19.2 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 121.27 0.557 . . . . 74.13 111.492 -176.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -62.35 -29.18 70.27 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 124.909 1.283 . . . . 75.42 109.602 175.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 10.1 p -73.13 -12.51 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 CA-C-N 115.385 -0.825 . . . . 73.52 109.864 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -101.21 -37.23 8.63 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.737 -0.665 . . . . 74.02 109.653 175.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . 0.526 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -63.47 -54.76 31.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.114 -0.948 . . . . 75.35 113.343 -174.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' A' ' 579' ' ' ARG . 30.3 mt-10 -62.13 -50.2 81.32 Favored Pre-proline 0 N--CA 1.466 0.366 0 N-CA-C 113.921 1.082 . . . . 72.21 113.921 -179.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -52.77 -42.98 59.49 Favored 'Trans proline' 0 C--N 1.366 1.461 0 C-N-CA 122.082 1.855 . . . . 72.43 113.096 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -67.96 -37.62 81.79 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 119.948 -0.701 . . . . 71.23 111.012 179.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 94.5 mt -63.42 -47.16 83.09 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 121.427 0.632 . . . . 74.03 110.156 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' A' ' 575' ' ' GLU . 97.7 mtt180 -62.68 -38.05 88.85 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.271 -0.877 . . . . 75.32 110.26 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.2 -33.14 71.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.968 -0.56 . . . . 64.32 112.151 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 4.3 pp -82.64 -8.31 59.61 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 120.562 -0.455 . . . . 53.32 111.777 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 90.47 33.93 8.29 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.779 -0.724 . . . . 61.34 112.488 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 65.9 t90 -66.29 137.18 56.76 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 122.542 0.337 . . . . 74.2 110.153 176.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 49.9 m -145.04 102.0 3.7 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.573 -0.899 . . . . 75.13 108.573 176.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -172.5 -156.34 12.41 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 110.102 -1.199 . . . . 65.03 110.102 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . 0.508 ' HB3' HG12 ' A' ' 619' ' ' ILE . 14.4 tpt -102.71 127.93 49.65 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.082 0.467 . . . . 72.02 111.138 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -97.7 126.04 42.81 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.065 -1.458 . . . . 74.5 107.065 176.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -123.28 110.33 15.07 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.374 0.607 . . . . 74.25 110.196 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -99.96 135.41 41.43 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.094 -0.957 . . . . 62.23 111.399 -174.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -68.76 143.31 39.91 Favored Glycine 0 C--N 1.306 -1.089 0 N-CA-C 109.165 -1.574 . . . . 64.23 109.165 169.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -61.22 130.5 46.55 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 122.878 0.471 . . . . 62.41 111.001 -176.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -55.23 135.16 49.91 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.541 0.941 . . . . 65.14 113.541 -172.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 85.8 t -137.99 115.9 12.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 114.814 -1.084 . . . . 75.11 109.013 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -90.78 111.88 23.45 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.742 -1.183 . . . . 70.3 108.612 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -148.56 20.75 1.04 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.938 0.718 . . . . 71.0 112.938 -174.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 140.31 155.65 6.62 Favored Glycine 0 CA--C 1.498 -0.994 0 C-N-CA 118.482 -1.818 . . . . 62.34 112.936 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.465 ' HA2' ' CD2' ' A' ' 600' ' ' HIS . . . -62.96 -49.77 69.42 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 114.262 0.465 . . . . 31.12 114.262 -175.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 25.4 m -71.98 -24.6 61.61 Favored 'General case' 0 C--N 1.312 -1.063 0 O-C-N 122.118 -0.636 . . . . 60.02 111.535 -176.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -93.12 -11.39 33.01 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 115.955 -0.566 . . . . 75.33 112.4 -177.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . 0.63 ' HB2' ' H ' ' A' ' 626' ' ' GLN . 0.5 OUTLIER -101.04 143.37 31.25 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 118.073 -1.451 . . . . 72.45 110.544 -176.866 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 69.98 -30.9 0.2 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.573 1.549 . . . . 71.52 112.005 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . 0.561 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 46.4 ttt180 -72.88 139.54 46.95 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.598 -0.689 . . . . 61.05 110.74 -177.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . 0.419 HG13 ' HB2' ' A' ' 622' ' ' LEU . 94.2 t -77.99 130.79 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 107.604 -1.258 . . . . 72.23 107.604 177.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 58.8 t -98.23 -55.73 5.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 108.562 -0.903 . . . . 74.42 108.562 -177.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . 0.424 ' O ' ' HA ' ' A' ' 622' ' ' LEU . 49.7 p90 -129.9 151.84 50.03 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 108.294 -1.002 . . . . 71.41 108.294 175.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . 0.534 ' HA ' ' O ' ' A' ' 621' ' ' THR . 17.7 pt20 -127.71 139.3 52.78 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 107.138 -1.43 . . . . 72.51 107.138 175.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.603 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 24.5 t-20 -46.43 -66.9 0.44 Allowed Pre-proline 0 CA--C 1.55 0.964 0 O-C-N 124.167 0.917 . . . . 63.14 112.607 -176.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.603 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 84.2 Cg_endo -91.22 124.1 0.86 Allowed 'Trans proline' 0 N--CA 1.436 -1.887 0 CA-C-N 121.233 1.476 . . . . 72.24 108.822 169.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.5 134.9 32.04 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.934 1.756 . . . . 73.4 112.399 -175.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . 0.658 ' HB1' ' HA ' ' A' ' 565' ' ' ASP . . . -68.79 138.93 55.21 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 115.537 -0.756 . . . . 54.21 110.024 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 101.57 -12.82 58.2 Favored Glycine 0 C--N 1.302 -1.317 0 N-CA-C 108.963 -1.655 . . . . 70.24 108.963 -173.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 16.5 m -118.06 168.76 10.25 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 107.143 -1.428 . . . . 60.43 107.143 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -71.22 126.5 13.32 Favored Glycine 0 N--CA 1.423 -2.222 0 N-CA-C 111.756 -0.538 . . . . 74.43 111.756 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . 0.414 HG12 ' HB2' ' A' ' 608' ' ' PRO . 31.4 m -94.27 141.69 14.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 109.271 -0.64 . . . . 74.53 109.271 177.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.15 144.03 36.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.888 -0.596 . . . . 72.33 111.753 177.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . 0.488 ' HD2' ' OD1' ' A' ' 559' ' ' ASN . 0.9 OUTLIER -54.03 -25.74 22.92 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.066 0.946 . . . . 73.43 112.26 179.771 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -61.13 -32.1 71.8 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 123.738 0.815 . . . . 74.3 109.879 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 73.08 8.43 74.03 Favored Glycine 0 N--CA 1.418 -2.506 0 N-CA-C 110.805 -0.918 . . . . 71.53 110.805 -176.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . 0.508 HG12 ' HB3' ' A' ' 586' ' ' MET . 0.0 OUTLIER -68.99 121.08 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 CA-C-O 122.068 0.937 . . . . 73.32 108.516 -174.461 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.18 119.57 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.549 0 CA-C-N 114.183 -1.372 . . . . 60.43 109.591 -176.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 606' ' ' GLN . 55.8 m -101.68 128.86 47.8 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.027 -1.471 . . . . 73.54 107.027 175.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . 0.438 HD23 ' H ' ' A' ' 622' ' ' LEU . 2.3 pt? -132.06 154.46 49.39 Favored 'General case' 0 CA--C 1.475 -1.926 0 N-CA-C 108.829 -0.804 . . . . 74.14 108.829 -176.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.94 135.19 49.61 Favored 'General case' 0 N--CA 1.398 -3.067 0 N-CA-C 105.672 -1.973 . . . . 64.4 105.672 177.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -142.79 165.67 26.75 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 106.128 -1.804 . . . . 73.2 106.128 177.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -77.43 -102.72 0.17 Allowed Glycine 0 N--CA 1.428 -1.863 0 C-N-CA 119.705 -1.236 . . . . 54.22 110.214 172.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . 0.63 ' H ' ' HB2' ' A' ' 600' ' ' HIS . 8.4 tt0 . . . . . 0 C--N 1.298 -1.642 0 N-CA-C 108.7 -0.852 . . . . 75.11 108.7 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 . . . . . 0 CA--C 1.494 -1.183 0 CA-C-O 120.832 0.349 . . . . 52.12 110.159 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 409' ' ' SER . 21.5 m -141.51 164.51 19.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 107.852 -1.166 . . . . 63.34 107.852 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . 0.405 HE21 ' HB3' ' A' ' 361' ' ' GLN . 8.3 mt-30 -92.59 138.07 31.82 Favored 'General case' 0 N--CA 1.397 -3.085 0 N-CA-C 107.076 -1.453 . . . . 54.34 107.076 174.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.465 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 76.0 t -94.91 125.05 52.44 Favored Pre-proline 0 C--N 1.266 -3.045 0 N-CA-C 107.218 -1.401 . . . . 72.54 107.218 -173.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 28.0 Cg_exo -57.35 136.82 78.5 Favored 'Trans proline' 0 CA--C 1.499 -1.234 0 C-N-CA 123.252 2.635 . . . . 71.34 113.185 -169.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -75.49 101.53 4.89 Favored 'General case' 0 N--CA 1.421 -1.915 0 CA-C-O 122.742 1.258 . . . . 73.41 109.699 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 365' ' ' VAL . 5.8 m -81.86 7.08 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-N 114.112 -1.404 . . . . 74.22 112.643 -178.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.527 ' HA ' HG23 ' A' ' 399' ' ' VAL . 36.4 ptt180 -58.66 146.01 37.83 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 125.132 1.373 . . . . 74.31 111.667 175.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.97 -10.46 51.9 Favored Glycine 0 N--CA 1.436 -1.345 0 N-CA-C 111.11 -0.796 . . . . 62.11 111.11 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -110.46 -161.62 0.76 Allowed 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.988 -1.115 . . . . 75.23 107.988 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 75.8 p -94.11 158.69 15.49 Favored 'General case' 0 C--N 1.276 -2.623 0 N-CA-C 108.24 -1.022 . . . . 74.32 108.24 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.439 ' O ' ' HB ' ' A' ' 374' ' ' ILE . 46.8 t -60.32 -36.06 77.06 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 109.722 -0.473 . . . . 72.34 109.722 176.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.56 -47.78 71.72 Favored 'General case' 0 C--O 1.213 -0.841 0 CA-C-O 119.24 -0.409 . . . . 74.41 111.763 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -70.09 -40.62 74.87 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 119.722 -0.791 . . . . 71.12 110.901 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -61.54 -47.31 86.11 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.257 -0.883 . . . . 64.33 110.599 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . 0.439 ' HB ' ' O ' ' A' ' 370' ' ' SER . 1.6 mp -69.07 -38.3 78.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.926 -0.579 . . . . 72.11 111.209 177.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -60.14 -38.35 82.84 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.535 0.683 . . . . 63.13 110.353 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 86.1 m -63.76 -45.48 89.61 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.443 -0.799 . . . . 62.0 110.167 177.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 85.4 mt -64.24 -38.83 92.46 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.13 -0.486 . . . . 62.32 110.629 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -62.1 -40.41 95.77 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.56 -0.533 . . . . 74.12 109.56 177.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -63.13 -30.05 71.28 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.131 0.572 . . . . 64.41 111.585 176.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -84.48 -14.07 50.19 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.097 -0.502 . . . . 74.22 110.885 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 94.94 12.91 54.81 Favored Glycine 0 C--N 1.311 -0.836 0 C-N-CA 120.779 -0.724 . . . . 73.34 112.702 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -80.56 157.77 25.96 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-O 121.195 0.522 . . . . 75.22 111.395 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 74.9 mmtt -98.86 132.78 43.95 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 106.698 -1.593 . . . . 73.21 106.698 177.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . 0.464 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -123.09 154.93 28.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 CA-C-O 121.822 0.82 . . . . 72.21 110.861 -177.124 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -135.58 134.04 38.93 Favored 'General case' 0 N--CA 1.399 -2.997 0 CA-C-N 114.235 -1.348 . . . . 71.31 107.432 173.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 52.2 m -125.0 121.98 35.97 Favored 'General case' 0 C--N 1.271 -2.838 0 N-CA-C 106.631 -1.618 . . . . 74.24 106.631 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.21 119.23 38.23 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 105.854 -1.906 . . . . 74.43 105.854 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.58 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -123.0 129.1 51.09 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 119.964 -0.694 . . . . 73.52 111.384 -176.395 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 421' ' ' SER . 96.1 mttt -134.7 148.68 68.24 Favored Pre-proline 0 C--N 1.308 -1.207 0 N-CA-C 107.61 -1.255 . . . . 74.03 107.61 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -69.28 127.47 15.02 Favored 'Trans proline' 0 C--O 1.249 1.027 0 N-CA-C 105.909 -2.381 . . . . 52.13 105.909 168.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -177.41 157.4 1.3 Allowed 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 118.993 -1.083 . . . . 64.32 110.962 -169.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 10.9 m -112.08 -4.95 14.32 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.776 0.322 . . . . 64.42 110.93 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 42.4 m -92.45 -42.2 9.87 Favored 'General case' 0 N--CA 1.435 -1.184 0 O-C-N 122.118 -0.364 . . . . 75.14 111.101 -175.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.434 HG13 ' HB3' ' A' ' 421' ' ' SER . 21.1 pt -88.02 148.36 42.98 Favored Pre-proline 0 C--N 1.31 -1.123 0 C-N-CA 120.47 -0.492 . . . . 72.34 110.623 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 396' ' ' PRO . 87.1 Cg_exo -49.04 147.08 11.21 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 124.493 3.462 . . . . 70.13 115.443 -177.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 395' ' ' PRO . 51.8 Cg_exo -56.5 165.64 4.3 Favored 'Trans proline' 0 C--O 1.22 -0.418 0 C-N-CA 124.593 3.529 . . . . 75.23 110.813 170.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . 0.666 ' HA ' HG13 ' A' ' 420' ' ' VAL . 6.1 p-10 -55.17 -7.84 0.24 Allowed 'General case' 0 N--CA 1.505 2.308 0 C-N-CA 123.468 0.707 . . . . 74.04 112.538 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -91.87 117.3 29.67 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 106.118 -1.808 . . . . 61.31 106.118 172.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.527 HG23 ' HA ' ' A' ' 366' ' ' ARG . 16.2 m -73.62 118.65 19.36 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-O 120.9 0.381 . . . . 72.14 110.827 -173.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 9.2 tp -89.78 -28.7 5.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-O 121.396 0.617 . . . . 71.03 110.51 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.43 169.59 27.65 Favored Glycine 0 N--CA 1.425 -2.068 0 N-CA-C 110.234 -1.147 . . . . 64.15 110.234 -177.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 10.5 p -114.15 -178.66 3.43 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 123.545 0.203 . . . . 64.13 110.59 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -100.74 139.79 20.85 Favored Pre-proline 0 C--N 1.307 -1.247 0 N-CA-C 107.777 -1.194 . . . . 63.45 107.777 -177.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -43.18 -30.25 2.06 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 124.391 3.394 . . . . 72.54 114.313 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.28 -31.53 70.32 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 123.309 0.381 . . . . 72.24 111.459 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . 0.401 ' HB2' HD12 ' A' ' 416' ' ' ILE . . . -86.14 -34.39 20.59 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.701 0.762 . . . . 70.24 110.188 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -82.8 -1.99 53.25 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.259 -0.882 . . . . 74.32 111.426 -175.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 26.8 m -110.76 153.54 25.18 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 106.194 -1.78 . . . . 74.55 106.194 175.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 360' ' ' VAL . 39.3 m -73.87 112.73 10.27 Favored 'General case' 0 N--CA 1.425 -1.686 0 C-N-CA 120.205 -0.598 . . . . 20.34 109.749 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 23.9 m -122.54 166.71 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 115.403 -0.817 . . . . 74.22 109.719 178.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 42.7 m -75.74 138.77 41.47 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 109.228 -0.656 . . . . 63.42 109.228 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -61.31 109.43 1.14 Allowed 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.184 0.516 . . . . 33.52 110.55 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 116.79 67.26 0.38 Allowed Glycine 0 N--CA 1.428 -1.873 0 N-CA-C 110.203 -1.159 . . . . 61.21 110.203 -178.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -135.5 -168.58 2.22 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.888 -1.152 . . . . 74.22 107.888 -177.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 40.1 mt-10 -106.99 131.09 54.44 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 123.622 0.769 . . . . 71.13 110.518 -176.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . 0.401 HD12 ' HB2' ' A' ' 406' ' ' ALA . 42.4 mm -119.37 115.86 49.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.928 -0.767 . . . . 63.52 108.928 176.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 13.7 p -98.82 130.94 45.27 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 123.929 0.891 . . . . 73.3 111.127 -177.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 8.7 p -126.96 135.06 64.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 120.905 0.384 . . . . 64.25 111.496 178.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -101.15 120.83 40.81 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.099 0.476 . . . . 75.04 110.059 176.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.666 HG13 ' HA ' ' A' ' 397' ' ' ASP . 44.8 t -126.49 144.36 36.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 C-N-CA 123.939 0.896 . . . . 72.01 111.252 -174.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 27.3 p -101.25 127.13 47.98 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.384 0.611 . . . . 60.22 110.832 176.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.1 t -117.69 106.05 12.67 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 115.888 -0.597 . . . . 75.12 109.42 177.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.888 0 C-N-CA 119.589 -1.291 . . . . 43.24 112.344 179.943 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 . . . . . 0 N--CA 1.446 -0.67 0 CA-C-O 120.881 0.372 . . . . 55.23 110.51 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -121.03 152.92 38.05 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-O 121.803 0.811 . . . . 70.14 111.041 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.59 ' CD ' ' H ' ' A' ' 428' ' ' GLU . 0.3 OUTLIER -86.81 140.34 29.79 Favored 'General case' 0 C--N 1.268 -2.942 0 CA-C-N 114.05 -1.432 . . . . 65.51 111.764 -174.552 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.508 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 65.7 mt -79.79 116.6 62.2 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 109.239 -0.652 . . . . 64.24 109.239 -177.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.51 147.26 51.62 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.851 2.368 . . . . 72.52 113.081 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -92.32 131.89 37.15 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 106.553 -1.647 . . . . 75.35 106.553 175.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.6 HG11 ' HB2' ' A' ' 440' ' ' ALA . 11.4 p -132.33 159.68 42.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 C-N-CA 120.855 -0.338 . . . . 71.33 110.852 -171.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.606 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 15.3 m -68.6 152.93 44.68 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 108.772 -0.825 . . . . 63.14 108.772 175.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 81.8 p -69.13 -33.5 73.56 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 114.413 1.264 . . . . 74.14 114.413 -167.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.8 pp -90.65 -11.67 39.12 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.629 -1.228 . . . . 53.21 111.553 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.606 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 1.2 m -86.83 42.05 1.0 Allowed 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.472 -0.786 . . . . 73.04 111.081 -174.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -56.58 -37.05 70.07 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.953 0.901 . . . . 74.51 110.632 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -54.97 -41.42 71.15 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.158 -0.474 . . . . 72.32 111.254 175.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -70.4 -35.65 73.58 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.777 -0.453 . . . . 72.1 109.777 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.623 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -60.9 -51.41 69.4 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.543 -0.753 . . . . 53.52 110.477 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 33.8 m -65.53 -39.7 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 112.482 0.549 . . . . 63.44 112.482 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.422 ' HD3' ' N ' ' A' ' 443' ' ' LYS . 0.1 OUTLIER -67.89 -34.92 77.59 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 120.131 -0.628 . . . . 70.21 111.971 178.096 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . 0.422 ' N ' ' HD3' ' A' ' 442' ' ' LYS . 0.9 OUTLIER -66.14 -40.63 90.75 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.084 -0.507 . . . . 74.24 109.747 177.875 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 76.8 mt -67.45 -32.86 74.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.597 -0.729 . . . . 70.13 110.18 177.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 90.5 m -69.89 -42.55 73.27 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.128 0.49 . . . . 63.33 109.975 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.46 -15.75 62.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.434 0.635 . . . . 71.43 110.767 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -85.49 5.25 32.11 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.422 -0.808 . . . . 32.52 111.459 178.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 104.92 -74.48 0.24 Allowed Glycine 0 CA--C 1.495 -1.176 0 C-N-CA 120.747 -0.739 . . . . 51.44 111.874 176.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . 0.541 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 3.6 p90 -49.19 -59.57 3.55 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 113.975 1.102 . . . . 71.23 113.975 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 60.59 29.32 69.41 Favored Glycine 0 C--O 1.217 -0.912 0 N-CA-C 111.028 -0.829 . . . . 72.42 111.028 -174.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.411 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 27.9 mmt180 -103.55 111.42 23.87 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.965 -1.124 . . . . 70.2 107.965 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -141.54 150.11 41.69 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 120.84 0.352 . . . . 71.31 111.326 -176.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . 0.451 ' HE3' ' HB ' ' A' ' 485' ' ' ILE . 52.8 mtmt -136.79 146.83 46.18 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.768 -1.197 . . . . 72.14 107.768 178.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' ' 486' ' ' ILE . 53.4 tt0 -117.31 128.52 55.13 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 109.931 -0.396 . . . . 71.12 109.931 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -116.89 154.82 30.12 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.027 -1.101 . . . . 75.11 108.027 177.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -125.1 137.74 54.18 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 108.935 -0.765 . . . . 74.01 108.935 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 26.6 t -137.97 141.79 33.73 Favored Pre-proline 0 C--N 1.292 -1.929 0 N-CA-C 109.538 -0.541 . . . . 71.45 109.538 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.696 ' HA ' ' O ' ' A' ' 490' ' ' SER . 44.4 Cg_endo -70.32 124.28 10.7 Favored 'Trans proline' 0 C--O 1.25 1.079 0 C-N-CA 122.417 2.078 . . . . 64.53 111.679 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 50.3 m -152.04 179.85 8.12 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.51 -0.552 . . . . 64.04 109.51 -177.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.6 t -49.17 139.46 13.16 Favored Pre-proline 0 CA--C 1.56 1.333 0 C-N-CA 123.702 0.801 . . . . 62.35 112.126 176.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.57 -28.5 29.01 Favored 'Trans proline' 0 C--N 1.365 1.419 0 C-N-CA 125.112 3.875 . . . . 65.14 113.966 -177.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -68.63 -21.24 64.49 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 116.162 -0.472 . . . . 60.31 111.635 -178.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 91.6 mt -103.61 -13.18 16.63 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 120.859 0.361 . . . . 74.51 110.913 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 70.0 t -60.97 127.62 20.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.001 -0.545 . . . . 64.2 110.954 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 95.64 -15.82 62.41 Favored Glycine 0 N--CA 1.441 -1.031 0 CA-C-N 115.639 -0.71 . . . . 73.55 112.114 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.65 166.83 12.27 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 110.211 -0.292 . . . . 61.04 110.211 -178.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 73.2 t -72.19 143.39 14.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 115.826 -0.625 . . . . 64.42 109.643 179.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 70.0 mt -97.38 -31.04 3.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 107.244 -1.391 . . . . 75.3 107.244 176.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 159.74 -159.22 30.42 Favored Glycine 0 N--CA 1.425 -2.086 0 N-CA-C 109.977 -1.249 . . . . 54.5 109.977 177.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . 0.519 HG22 HG12 ' A' ' 486' ' ' ILE . 61.9 p -114.7 146.67 40.65 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 105.608 -1.997 . . . . 62.11 105.608 178.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.489 ' HB3' HG23 ' A' ' 485' ' ' ILE . 28.5 t-20 -72.85 -53.86 5.05 Favored Pre-proline 0 C--N 1.314 -0.947 0 C-N-CA 118.871 -1.132 . . . . 71.31 110.236 178.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -67.75 134.54 32.85 Favored 'Trans proline' 0 C--N 1.368 1.604 0 N-CA-C 107.904 -1.614 . . . . 75.33 107.904 168.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' A' ' 475' ' ' ASN . 24.7 Cg_exo -62.12 139.21 77.21 Favored 'Trans proline' 0 C--O 1.242 0.702 0 C-N-CA 122.216 1.944 . . . . 74.33 112.632 -175.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.508 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -75.84 19.91 0.2 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 122.163 0.983 . . . . 75.04 110.979 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . 0.438 ' H ' ' C ' ' A' ' 473' ' ' PRO . 10.1 m120 -109.21 -17.65 13.79 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.412 -0.959 . . . . 75.33 108.412 178.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -87.33 170.43 11.42 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.696 -0.683 . . . . 65.15 111.733 -174.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 4.5 m -106.3 127.02 52.94 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 108.304 -0.998 . . . . 72.42 108.304 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 9.8 p -105.95 146.06 30.52 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 123.031 0.533 . . . . 71.23 111.236 -177.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -90.26 162.75 15.05 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.452 -0.34 . . . . 74.14 110.815 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . 0.541 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 1.7 mp -70.93 -20.58 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.966 0.889 . . . . 71.31 111.187 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 12.2 p -93.39 1.17 56.99 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.988 0.899 . . . . 54.31 111.029 178.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -104.93 138.17 41.57 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.004 -0.998 . . . . 75.12 111.649 -173.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.411 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.4 p -108.06 127.03 64.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.809 -0.632 . . . . 63.13 111.027 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 35.8 m -95.45 141.57 14.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-O 121.299 0.571 . . . . 74.3 111.294 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.489 HG23 ' HB3' ' A' ' 471' ' ' ASN . 0.0 OUTLIER -109.43 125.91 66.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.196 0 CA-C-O 121.485 0.66 . . . . 74.33 110.251 -178.441 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.519 HG12 HG22 ' A' ' 470' ' ' THR . 8.9 mt -112.62 128.61 69.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 115.067 -0.97 . . . . 74.41 110.919 -178.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 8.8 tt -105.17 127.21 59.99 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 123.41 0.684 . . . . 64.52 111.905 -174.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 28.6 m -111.61 152.07 13.57 Favored 'Isoleucine or valine' 0 C--O 1.25 1.097 0 C-N-CA 124.017 0.927 . . . . 54.33 110.241 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -81.9 140.76 21.15 Favored Glycine 0 C--O 1.246 0.854 0 C-N-CA 120.99 -0.624 . . . . 71.21 111.979 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.696 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 13.2 t . . . . . 0 C--N 1.308 -1.212 0 N-CA-C 109.017 -0.735 . . . . 74.22 109.017 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo . . . . . 0 CA--C 1.544 0.996 0 CA-C-O 121.035 0.348 . . . . 73.24 112.194 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -84.99 65.73 9.39 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-O 122.083 0.944 . . . . 72.04 111.875 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 1.3 p -118.03 143.42 46.43 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 114.899 -1.046 . . . . 65.01 109.673 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -146.34 148.83 32.78 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.84 -1.17 . . . . 63.44 107.84 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.562 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 9.5 p-10 -87.54 130.07 34.86 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.475 0.655 . . . . 73.12 110.985 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 38.3 pt -75.92 137.82 69.46 Favored Pre-proline 0 C--N 1.307 -1.28 0 CA-C-N 114.862 -1.063 . . . . 74.34 110.418 -178.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -93.86 -170.72 0.24 Allowed 'Trans proline' 0 N--CA 1.443 -1.482 0 C-N-CA 122.269 1.979 . . . . 61.44 111.211 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -83.9 145.91 28.34 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.666 -1.235 . . . . 72.45 107.666 174.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 9.2 p -136.22 8.58 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.455 0 CA-C-O 122.616 1.198 . . . . 65.23 108.469 177.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -71.17 121.43 18.32 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 114.019 -1.446 . . . . 62.1 109.628 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 108.73 30.57 3.7 Favored Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 110.789 -0.924 . . . . 74.14 110.789 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -142.03 176.09 9.22 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.907 -0.775 . . . . 74.0 108.907 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 29.6 p -91.67 160.02 15.58 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 110.021 -0.362 . . . . 74.21 110.021 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 30.7 m -53.73 -40.24 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 C-N-CA 124.181 0.993 . . . . 71.04 112.255 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -66.72 -42.44 86.35 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.655 -0.702 . . . . 64.22 110.791 -178.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 64.8 t -74.77 -35.06 35.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 116.432 -0.349 . . . . 73.33 110.253 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -59.61 -49.74 76.6 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.134 -0.485 . . . . 72.01 111.573 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -65.58 -35.89 82.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 74.03 110.725 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.416 ' O ' HG23 ' A' ' 514' ' ' VAL . 58.6 tptt -61.47 -47.35 86.06 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.706 -0.679 . . . . 64.45 109.647 178.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -62.08 -44.83 95.81 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 116.382 -0.372 . . . . 71.3 110.165 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.73 -47.52 85.31 Favored 'General case' 0 C--O 1.242 0.664 0 O-C-N 123.422 0.451 . . . . 73.54 110.376 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.92 -38.15 87.32 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 116.182 -0.463 . . . . 74.4 111.105 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 510' ' ' LYS . 55.2 t -64.01 -35.6 74.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 122.828 0.451 . . . . 74.23 111.366 177.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -79.29 -12.77 59.94 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.374 -0.53 . . . . 74.21 110.695 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . 0.439 ' O ' ' HB ' ' A' ' 547' ' ' VAL . . . 113.11 -0.14 25.41 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.69 -0.767 . . . . 62.23 113.154 177.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.457 ' HA ' ' O ' ' A' ' 547' ' ' VAL . 79.2 m-85 -82.82 115.77 21.86 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.454 -0.572 . . . . 71.45 109.454 -178.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.7 p -88.69 -26.04 22.04 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 113.643 0.979 . . . . 73.45 113.643 -176.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . 0.51 ' HE2' ' HA ' ' A' ' 519' ' ' LYS . 6.4 mmpt? -110.13 120.66 43.15 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 113.613 0.968 . . . . 74.45 113.613 -176.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -131.82 140.2 49.08 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 113.809 -1.541 . . . . 73.12 111.242 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 54.0 m -134.47 144.42 48.08 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.627 -0.879 . . . . 65.03 108.627 176.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -117.35 122.57 44.24 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.721 0.772 . . . . 63.25 110.807 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -100.89 140.29 35.38 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.685 -0.688 . . . . 71.21 109.663 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 15.9 m -88.79 116.01 26.75 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.982 -0.554 . . . . 73.32 109.646 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 35.7 m -121.98 158.56 25.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.935 -0.765 . . . . 73.24 108.935 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . 0.524 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 5.2 p-10 -94.71 136.83 34.55 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.838 -0.745 . . . . 62.24 109.89 179.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . 0.456 ' HB2' ' HB2' ' A' ' 556' ' ' SER . 38.6 m -153.81 173.57 4.56 Favored Pre-proline 0 C--N 1.305 -1.331 0 N-CA-C 106.442 -1.688 . . . . 35.33 106.442 174.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -81.88 -8.3 12.2 Favored 'Trans proline' 0 CA--C 1.547 1.16 0 CA-C-N 120.642 1.265 . . . . 44.13 111.6 173.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.435 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 4.1 mpt_? -76.39 134.61 69.94 Favored Pre-proline 0 C--O 1.223 -0.328 0 CA-C-N 116.046 -0.524 . . . . 71.32 109.813 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -57.08 154.93 30.89 Favored 'Trans proline' 0 C--O 1.255 1.368 0 C-N-CA 123.225 2.616 . . . . 75.3 114.032 -177.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.5 117.02 4.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.87 -1.059 . . . . 72.12 111.892 -178.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 132.21 -20.02 4.52 Favored Glycine 0 CA--C 1.49 -1.497 0 N-CA-C 110.797 -0.921 . . . . 42.01 110.797 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -74.27 125.25 28.02 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.922 -0.639 . . . . 74.23 110.04 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 85.9 t -84.34 107.39 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 N-CA-C 106.36 -1.718 . . . . 74.52 106.36 172.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 26.8 m -75.01 -25.96 59.19 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.632 -1.167 . . . . 61.11 111.002 -174.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 162.03 -163.78 35.02 Favored Glycine 0 N--CA 1.427 -1.963 0 N-CA-C 110.311 -1.115 . . . . 14.11 110.311 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 19.5 p -117.73 155.3 30.22 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.987 -0.746 . . . . 73.55 108.987 178.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -75.52 -52.97 2.73 Favored Pre-proline 0 C--N 1.305 -1.34 0 N-CA-C 109.614 -0.513 . . . . 70.34 109.614 176.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -64.32 130.33 26.64 Favored 'Trans proline' 0 C--N 1.365 1.405 0 N-CA-C 107.951 -1.596 . . . . 73.23 107.951 167.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -63.21 143.67 90.22 Favored 'Trans proline' 0 C--O 1.246 0.879 0 C-N-CA 122.226 1.951 . . . . 74.14 112.479 -177.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -65.14 136.1 56.29 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.604 -0.517 . . . . 63.02 109.604 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.95 -19.46 32.74 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 111.446 -0.662 . . . . 65.13 111.446 -176.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 35.2 m -68.51 134.48 50.13 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.699 0.285 . . . . 73.14 110.329 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 28.2 m -85.41 122.8 30.08 Favored 'General case' 0 N--CA 1.416 -2.138 0 N-CA-C 107.741 -1.207 . . . . 71.12 107.741 177.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 52.9 t -127.72 152.27 76.68 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 107.147 -1.427 . . . . 71.43 107.147 -176.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -66.2 139.52 55.6 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 121.512 1.475 . . . . 74.51 109.701 171.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 517' ' ' PHE . 28.7 m -63.28 -20.12 25.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.665 0.745 . . . . 71.35 112.548 -177.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -93.45 3.48 55.5 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.465 -0.788 . . . . 65.24 110.727 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 8.6 t -92.4 -178.43 4.92 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.761 -0.587 . . . . 72.24 109.916 -178.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 45.5 t -102.1 122.74 54.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 122.948 0.499 . . . . 65.42 111.181 -174.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 1.9 mp -103.58 126.77 58.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.158 -1.053 . . . . 54.55 108.158 175.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -103.56 120.48 40.96 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-O 121.488 0.661 . . . . 73.24 111.989 -176.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 69.2 mt -94.75 134.3 37.51 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 125.569 1.547 . . . . 72.21 108.249 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -104.02 118.66 37.19 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 109.15 -0.685 . . . . 73.44 109.15 176.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 43.4 t -109.79 129.5 64.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 CA-C-N 115.17 -0.923 . . . . 71.04 109.191 -175.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.456 ' HB2' ' HB2' ' A' ' 527' ' ' SER . 32.0 p -80.07 143.5 33.95 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 113.494 0.924 . . . . 62.22 113.494 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.524 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 45.1 pttt -92.41 152.42 19.73 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 102.863 -3.014 . . . . 74.53 102.863 165.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . 0.486 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -75.53 -32.14 55.28 Favored Glycine 0 CA--C 1.479 -2.17 0 C-N-CA 119.079 -1.534 . . . . 73.14 111.166 -176.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 64.3 t30 71.98 -28.99 0.19 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.516 1.526 . . . . 74.34 111.839 173.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.486 ' H ' ' C ' ' A' ' 558' ' ' GLY . 92.8 mt-30 -135.23 145.88 48.06 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 106.75 -1.574 . . . . 61.25 106.75 174.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -123.07 138.09 54.76 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 109.383 -0.599 . . . . 52.53 109.383 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 90.2 t -59.94 116.88 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 O-C-N 123.933 0.771 . . . . 64.14 110.321 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . 0.424 ' HA ' ' HD3' ' A' ' 564' ' ' PRO . 25.7 ptm -80.62 146.74 61.45 Favored Pre-proline 0 C--O 1.249 1.031 0 CA-C-N 116.103 -0.498 . . . . 75.32 110.475 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 563' ' ' MET . 15.5 Cg_exo -71.39 169.76 20.04 Favored 'Trans proline' 0 C--O 1.243 0.77 0 C-N-CA 122.862 2.374 . . . . 65.23 111.592 174.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -74.34 125.66 28.97 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 112.776 0.658 . . . . 45.05 112.776 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 96.1 mt -142.03 18.91 2.12 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.595 -1.184 . . . . 70.33 108.125 177.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 60.2 p -79.84 139.13 37.3 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 112.455 0.539 . . . . 55.34 112.455 -175.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 83.83 25.36 45.97 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 121.137 -0.554 . . . . 75.5 112.707 176.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 84.4 mtp -108.23 174.92 5.66 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.839 -0.43 . . . . 61.24 109.839 -178.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -102.5 136.96 41.4 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 106.922 -1.51 . . . . 75.13 106.922 177.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 81.8 t90 -54.66 -29.58 53.0 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 124.021 0.929 . . . . 63.23 112.356 -176.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 16.7 m -74.57 -19.16 16.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.342 0.592 . . . . 64.3 111.347 -177.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -102.29 -36.54 8.44 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.862 0.839 . . . . 72.43 109.644 178.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -67.46 -43.21 81.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.83 -1.077 . . . . 73.11 112.54 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.403 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 41.4 tt0 -57.15 -50.56 87.47 Favored Pre-proline 0 CA--C 1.558 1.283 0 CA-C-O 119.44 -0.314 . . . . 75.2 111.481 178.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 83.5 Cg_exo -53.53 -37.96 83.12 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.095 1.863 . . . . 65.54 112.617 172.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.527 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 45.4 mmt-85 -64.96 -39.14 93.04 Favored 'General case' 0 C--O 1.214 -0.799 0 C-N-CA 120.242 -0.583 . . . . 75.12 110.586 177.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 96.3 mt -62.24 -43.12 99.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.336 0.589 . . . . 71.51 109.452 177.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -61.85 -38.81 89.62 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.375 -0.83 . . . . 75.53 110.317 178.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.21 -30.0 66.98 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.063 -0.517 . . . . 52.25 111.415 177.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 93.0 mt -81.97 -7.19 59.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.826 0.346 . . . . 62.34 111.332 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 82.7 35.64 18.71 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 120.974 -0.632 . . . . 63.13 111.914 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 83.5 t90 -77.51 130.44 36.97 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.129 0.49 . . . . 74.51 110.177 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 50.4 m -145.05 89.43 1.96 Allowed 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.158 -1.052 . . . . 74.15 108.158 175.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -153.58 -146.84 4.48 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 110.208 -1.157 . . . . 65.52 110.208 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . 0.49 ' HB3' HG12 ' A' ' 619' ' ' ILE . 23.8 ttt -115.93 135.33 54.08 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 117.182 0.491 . . . . 74.34 110.894 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -100.47 130.78 46.59 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.05 -1.834 . . . . 70.34 106.05 175.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -102.36 118.67 37.38 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.867 -0.733 . . . . 64.12 110.637 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 4.0 mmmp? -87.76 111.94 21.88 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-O 121.5 0.666 . . . . 71.45 112.15 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -81.23 -173.41 47.75 Favored Glycine 0 N--CA 1.427 -1.907 0 N-CA-C 109.676 -1.37 . . . . 41.31 109.676 171.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -70.51 145.02 51.16 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.998 0.399 . . . . 64.31 110.977 -175.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -85.59 124.67 32.4 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.925 -1.139 . . . . 72.23 107.925 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.92 124.85 68.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 C-N-CA 122.903 0.481 . . . . 74.14 110.863 -174.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -75.67 111.8 11.38 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.489 -0.93 . . . . 74.12 108.489 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -114.19 -19.78 11.18 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 112.081 0.4 . . . . 53.23 112.081 -176.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 126.96 145.83 6.34 Favored Glycine 0 CA--C 1.492 -1.391 0 N-CA-C 108.663 -1.775 . . . . 74.14 108.663 -176.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.17 -40.1 82.86 Favored Glycine 0 N--CA 1.47 0.912 0 CA-C-N 117.512 0.656 . . . . 42.11 113.955 -173.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 15.8 m -66.38 -24.31 66.47 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 122.951 0.501 . . . . 65.23 111.46 -178.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -108.7 -1.11 19.69 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.269 0.841 . . . . 74.32 113.269 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -68.07 150.64 48.17 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.943 -0.392 . . . . 65.42 109.943 177.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 63.42 -6.31 0.21 Allowed 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 124.878 1.271 . . . . 54.2 114.122 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . 0.524 ' HD2' ' O ' ' A' ' 603' ' ' VAL . 5.5 tmm_? -79.15 138.62 37.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 118.459 0.572 . . . . 72.31 109.883 -178.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . 0.524 ' O ' ' HD2' ' A' ' 602' ' ' ARG . 13.9 p -64.0 142.2 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.85 0.86 . . . . 61.3 111.171 -177.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 623' ' ' ARG . 7.5 p -96.13 -47.79 12.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 118.687 -1.205 . . . . 64.4 109.216 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -156.99 155.82 31.91 Favored 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 105.337 -2.097 . . . . 65.53 105.337 173.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -115.75 128.78 56.12 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 107.356 -1.349 . . . . 73.04 107.356 173.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.595 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 25.2 t-20 -48.77 -52.55 44.71 Favored Pre-proline 0 CA--C 1.545 0.779 0 O-C-N 123.99 0.806 . . . . 65.11 111.634 -177.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 13.7 Cg_endo -100.86 110.19 0.05 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.054 0 C-N-CA 121.659 1.573 . . . . 50.22 109.441 169.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.95 160.37 34.01 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.494 2.13 . . . . 73.25 111.485 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -57.32 126.96 29.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.576 0.227 . . . . 65.22 110.46 -177.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 102.03 -5.43 53.15 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.227 -0.987 . . . . 22.54 112.329 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 23.7 m -92.24 155.33 18.05 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.946 -0.761 . . . . 63.34 108.946 177.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -82.98 126.05 7.28 Favored Glycine 0 N--CA 1.426 -1.988 0 N-CA-C 111.368 -0.693 . . . . 71.42 111.368 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.3 m -103.81 142.18 17.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-O 120.598 0.237 . . . . 74.21 110.419 178.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.05 146.12 11.83 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 123.822 0.849 . . . . 72.12 112.267 177.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.02 -35.97 16.71 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 125.976 1.71 . . . . 72.32 112.874 -175.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -73.94 -30.26 62.45 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.883 -1.053 . . . . 71.21 111.484 -175.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 93.29 12.13 57.69 Favored Glycine 0 N--CA 1.414 -2.776 0 CA-C-O 119.211 -0.772 . . . . 62.1 114.078 174.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . 0.49 HG12 ' HB3' ' A' ' 586' ' ' MET . 0.0 OUTLIER -69.67 119.78 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 C-N-CA 117.715 -1.594 . . . . 64.22 107.736 178.629 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.84 132.14 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 114.793 -1.094 . . . . 74.02 108.349 -175.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 90.2 m -106.23 116.89 32.71 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 121.221 0.534 . . . . 63.14 110.507 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . 0.489 ' HB2' HG23 ' A' ' 603' ' ' VAL . 0.0 OUTLIER -139.92 149.97 43.98 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 104.558 -2.386 . . . . 72.04 104.558 173.04 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . 0.4 ' O ' HG12 ' A' ' 604' ' ' VAL . 44.5 ttp180 -128.78 156.13 44.05 Favored 'General case' 0 C--N 1.254 -3.578 0 N-CA-C 105.987 -1.857 . . . . 73.52 105.987 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -125.2 166.08 17.11 Favored 'General case' 0 C--N 1.26 -3.292 0 N-CA-C 105.367 -2.086 . . . . 72.23 105.367 175.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -61.28 -89.25 0.02 OUTLIER Glycine 0 C--N 1.314 -0.687 0 C-N-CA 120.104 -1.046 . . . . 64.03 110.708 176.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 . . . . . 0 C--N 1.289 -2.054 0 N-CA-C 107.03 -1.47 . . . . 53.0 107.03 175.047 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 C--O 1.241 0.643 0 N-CA-C 108.477 -0.934 . . . . 74.32 108.477 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 31.5 m -121.49 163.67 19.17 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-O 120.76 0.314 . . . . 41.04 110.74 -175.031 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -94.41 136.59 34.54 Favored 'General case' 0 N--CA 1.383 -3.793 0 N-CA-C 107.439 -1.319 . . . . 60.42 107.439 175.569 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 72.1 t -97.42 135.06 21.93 Favored Pre-proline 0 C--N 1.265 -3.093 0 CA-C-N 114.624 -1.171 . . . . 74.15 109.911 -171.17 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -65.99 121.9 9.33 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 121.65 1.566 . . . . 72.34 110.948 179.244 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -88.77 147.48 24.42 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.749 -1.575 . . . . 74.24 106.749 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 4.8 t -120.84 11.54 6.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 CA-C-N 116.052 -0.522 . . . . 71.41 109.947 -172.511 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.5 ' HA ' HG23 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -60.69 143.11 54.9 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 119.158 -1.017 . . . . 74.11 110.03 176.535 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.94 -9.28 46.93 Favored Glycine 0 C--N 1.301 -1.395 0 N-CA-C 111.233 -0.747 . . . . 54.0 111.233 -172.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -109.03 -145.86 0.4 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.483 -0.932 . . . . 73.15 108.483 174.386 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 96.4 p -107.13 167.04 10.18 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.426 -0.909 . . . . 71.02 108.899 -176.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 25.2 t -59.69 -39.55 84.9 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 109.167 -0.679 . . . . 52.02 109.167 176.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.37 -46.66 75.95 Favored 'General case' 0 C--O 1.213 -0.843 0 CA-C-N 116.102 -0.499 . . . . 60.03 111.357 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -64.11 -41.42 97.25 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.359 0.599 . . . . 72.42 110.924 -179.251 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.06 -51.34 62.03 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.389 -0.823 . . . . 61.31 111.073 -178.539 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 39.8 mm -66.08 -39.98 85.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.042 -0.526 . . . . 73.51 110.955 -179.303 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.24 -38.82 88.01 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 120.937 0.399 . . . . 74.31 111.15 -179.111 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . 0.546 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 79.5 m -66.41 -47.28 73.78 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.845 -0.616 . . . . 74.04 111.177 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.75 -37.99 89.44 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.557 0.218 . . . . 63.2 111.159 178.83 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -59.9 -48.03 83.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.95 -0.568 . . . . 54.11 109.747 177.096 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -61.03 -30.88 70.57 Favored 'General case' 0 CA--C 1.495 -1.17 0 N-CA-C 113.096 0.776 . . . . 72.41 113.096 177.231 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . 0.546 ' HG2' ' O ' ' A' ' 376' ' ' THR . 13.3 mmt180 -78.44 -14.08 59.54 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.272 -0.422 . . . . 70.2 110.735 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 91.14 16.11 54.49 Favored Glycine 0 CA--C 1.501 -0.842 0 C-N-CA 119.772 -1.204 . . . . 53.42 111.506 177.412 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -88.92 162.89 15.85 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-O 121.385 0.612 . . . . 74.31 110.518 178.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.54 ' HB2' ' HG2' ' A' ' 415' ' ' GLU . 75.2 mmtt -94.43 148.87 21.8 Favored 'General case' 0 N--CA 1.411 -2.375 0 N-CA-C 106.862 -1.533 . . . . 62.33 106.862 178.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . 0.481 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -123.28 141.3 44.11 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-O 121.622 0.725 . . . . 74.53 110.968 -175.546 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . 0.425 ' HB3' ' HA ' ' A' ' 417' ' ' THR . 44.3 ttt180 -125.08 127.53 47.05 Favored 'General case' 0 N--CA 1.406 -2.632 0 N-CA-C 106.384 -1.709 . . . . 75.14 106.384 174.362 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . 0.426 HG22 HE21 ' A' ' 388' ' ' GLN . 26.8 m -129.95 127.86 40.93 Favored 'General case' 0 C--N 1.276 -2.589 0 N-CA-C 108.97 -0.752 . . . . 62.22 108.97 -177.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -112.05 120.34 41.53 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.565 -0.531 . . . . 72.1 109.565 176.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.426 HE21 HG22 ' A' ' 386' ' ' THR . 0.9 OUTLIER -100.66 121.97 42.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.703 -0.851 . . . . 74.03 108.703 -179.007 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 421' ' ' SER . 44.5 mtmt -137.24 138.25 24.74 Favored Pre-proline 0 C--N 1.301 -1.509 0 C-N-CA 120.398 -0.521 . . . . 72.2 109.717 175.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -75.42 128.78 11.42 Favored 'Trans proline' 0 C--O 1.257 1.454 0 N-CA-C 107.972 -1.588 . . . . 63.43 107.972 172.54 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.446 ' OD1' HG22 ' A' ' 393' ' ' THR . 7.3 t70 -174.62 -172.67 0.67 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.086 -1.82 . . . . 73.41 106.086 -172.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 41.4 m -150.97 -2.6 0.34 Allowed 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 122.545 0.338 . . . . 73.52 111.605 175.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.446 HG22 ' OD1' ' A' ' 391' ' ' ASP . 10.7 t -105.91 -24.87 12.34 Favored 'General case' 0 C--O 1.244 0.764 0 O-C-N 121.696 -0.627 . . . . 65.5 109.898 -178.677 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.459 HG13 ' HB2' ' A' ' 421' ' ' SER . 49.1 pt -88.66 152.54 49.34 Favored Pre-proline 0 N--CA 1.439 -1.021 0 N-CA-C 107.805 -1.183 . . . . 63.5 107.805 176.525 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . 0.484 ' HB3' ' H ' ' A' ' 400' ' ' ILE . 21.7 Cg_exo -32.9 111.58 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 124.634 3.556 . . . . 73.44 116.398 179.616 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -56.48 166.86 3.14 Favored 'Trans proline' 0 C--O 1.221 -0.343 0 C-N-CA 124.943 3.762 . . . . 72.15 110.676 170.062 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . 0.485 ' HA ' ' CG2' ' A' ' 420' ' ' VAL . 4.6 p-10 -54.94 -8.58 0.27 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 112.684 0.624 . . . . 73.43 112.684 -178.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 63.1 m170 -98.01 106.16 18.41 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 103.319 -2.845 . . . . 70.44 103.319 166.59 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.5 HG23 ' HA ' ' A' ' 366' ' ' ARG . 18.6 m -63.08 118.43 5.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 O-C-N 124.185 0.928 . . . . 51.42 113.209 -166.608 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . 0.484 ' H ' ' HB3' ' A' ' 395' ' ' PRO . 41.7 mm -98.2 -27.47 3.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 114.575 -1.193 . . . . 73.2 109.881 179.837 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.42 157.14 27.25 Favored Glycine 0 N--CA 1.414 -2.777 0 C-N-CA 119.901 -1.142 . . . . 71.12 112.026 -176.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 4.7 p -148.08 -176.15 5.17 Favored 'General case' 0 C--N 1.284 -2.242 0 C-N-CA 126.253 1.821 . . . . 72.13 107.412 -175.36 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -99.82 137.26 20.14 Favored Pre-proline 0 C--N 1.299 -1.602 0 N-CA-C 107.894 -1.15 . . . . 64.01 107.894 176.337 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.27 -2.86 3.46 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.824 3.016 . . . . 72.32 113.36 -177.085 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -52.61 -35.28 54.17 Favored 'General case' 0 C--O 1.21 -1.013 0 C-N-CA 124.656 1.183 . . . . 62.2 111.165 176.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -68.35 -37.47 80.53 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 121.533 0.682 . . . . 74.32 110.211 178.157 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -82.69 -3.91 57.06 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.579 0.704 . . . . 75.02 109.452 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 32.0 m -93.55 152.5 18.99 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.398 -1.705 . . . . 42.31 106.398 176.506 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 13.2 p -77.37 111.57 13.18 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 108.554 -0.906 . . . . 74.24 108.554 176.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 28.8 m -127.51 169.16 19.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-O 121.095 0.474 . . . . 74.11 110.876 -179.524 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 3.4 m -78.69 146.74 33.82 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.961 -0.755 . . . . 61.14 108.961 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -71.51 109.91 5.77 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.015 0.435 . . . . 73.51 110.529 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 122.8 23.23 2.31 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 120.852 -0.69 . . . . 72.11 112.749 178.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -86.68 -173.77 4.65 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.642 -0.873 . . . . 70.04 108.642 177.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . 0.54 ' HG2' ' HB2' ' A' ' 383' ' ' LYS . 32.9 mt-10 -111.21 119.19 38.11 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.263 -0.643 . . . . 73.02 109.263 -175.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.1 mm -98.17 120.25 47.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-O 120.837 0.351 . . . . 72.31 110.091 -178.771 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . 0.425 ' HA ' ' HB3' ' A' ' 385' ' ' ARG . 36.4 m -90.7 125.88 35.81 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.972 -0.558 . . . . 73.23 111.726 -178.599 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 4.3 p -116.55 134.82 58.8 Favored 'Isoleucine or valine' 0 C--O 1.255 1.384 0 N-CA-C 109.261 -0.644 . . . . 71.53 109.261 174.533 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -99.29 116.89 32.52 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.515 -1.661 . . . . 75.34 106.515 177.028 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.485 ' CG2' ' HA ' ' A' ' 397' ' ' ASP . 10.7 p -127.61 136.0 61.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 121.32 0.581 . . . . 73.04 110.608 -175.531 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 14.1 t -102.39 122.58 44.56 Favored 'General case' 0 N--CA 1.415 -2.223 0 C-N-CA 119.839 -0.744 . . . . 64.14 110.031 178.295 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 8.9 t -118.94 107.53 13.68 Favored 'General case' 0 N--CA 1.411 -2.377 0 CA-C-N 115.175 -0.92 . . . . 61.23 108.753 176.387 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.4 0 C-N-CA 120.871 -0.68 . . . . 43.42 111.923 -178.514 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 . . . . . 0 N--CA 1.424 -1.728 0 N-CA-C 109.674 -0.491 . . . . 61.51 109.674 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.509 ' HG3' ' O ' ' A' ' 447' ' ' ALA . 4.3 mmp_? -120.33 155.6 33.01 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 109.653 -0.499 . . . . 75.52 109.653 -178.574 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -91.66 137.37 32.42 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 115.086 -0.961 . . . . 61.5 110.101 -176.153 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 59.7 mt -96.12 118.67 65.48 Favored Pre-proline 0 N--CA 1.421 -1.88 0 N-CA-C 107.519 -1.289 . . . . 70.2 107.519 177.017 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -71.6 141.48 38.14 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 N-CA-C 108.125 -1.529 . . . . 75.34 108.125 171.08 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -80.13 134.46 36.17 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 118.229 -1.389 . . . . 72.21 108.592 178.575 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.439 HG11 ' HB2' ' A' ' 440' ' ' ALA . 8.9 p -101.23 161.99 3.49 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.374 0 N-CA-C 108.39 -0.967 . . . . 61.2 108.39 -172.332 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 26.7 m -75.68 158.02 32.88 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 107.33 -1.359 . . . . 75.33 107.33 174.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . 0.448 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 74.3 p -67.99 -40.34 83.09 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.943 0.878 . . . . 75.21 111.32 -173.458 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.507 ' H ' HD23 ' A' ' 435' ' ' LEU . 0.6 OUTLIER -67.5 -28.78 68.12 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 113.784 1.031 . . . . 74.25 113.784 178.946 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.6 p -89.9 59.2 4.49 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 114.511 1.3 . . . . 62.13 114.511 -172.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -64.26 -37.86 88.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.115 -0.493 . . . . 74.24 111.364 177.294 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -62.43 -36.3 81.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.899 0.38 . . . . 72.24 110.457 178.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -67.51 -39.35 85.14 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.64 -0.504 . . . . 65.23 109.64 175.22 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.467 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.19 -50.38 73.89 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.969 -0.56 . . . . 74.14 110.924 -178.489 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.0 m -62.14 -40.77 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 111.935 0.346 . . . . 72.13 111.935 -179.178 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -36.41 80.03 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 120.366 -0.534 . . . . 71.51 112.3 178.455 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -63.22 -47.1 83.92 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 120.931 0.396 . . . . 72.11 110.384 177.008 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.467 HD13 ' O ' ' A' ' 440' ' ' ALA . 2.6 mp -63.68 -35.54 80.88 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.361 -0.836 . . . . 52.33 110.601 179.866 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 89.4 m -69.33 -45.8 68.61 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 116.172 -0.467 . . . . 61.44 110.488 177.162 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.13 -16.49 62.56 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 120.848 0.356 . . . . 74.31 111.88 -178.424 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . 0.509 ' O ' ' HG3' ' A' ' 427' ' ' ARG . . . -84.6 -4.66 59.11 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.177 -0.465 . . . . 62.21 111.488 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 117.66 -83.48 0.35 Allowed Glycine 0 CA--C 1.498 -1.017 0 C-N-CA 120.121 -1.038 . . . . 63.14 111.963 177.085 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -36.99 -63.52 0.42 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.374 1.249 . . . . 74.13 114.374 177.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 62.71 20.2 61.51 Favored Glycine 0 C--O 1.221 -0.668 0 CA-C-N 116.384 -0.371 . . . . 35.53 113.322 -178.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -96.97 110.43 22.97 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.079 -1.082 . . . . 65.54 108.079 -178.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.442 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 21.2 p90 -138.91 158.95 43.28 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 115.972 -0.558 . . . . 70.04 110.437 -177.453 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -144.98 148.23 33.54 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.447 -1.316 . . . . 75.41 107.447 179.177 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -119.05 127.36 53.34 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 117.877 0.308 . . . . 74.41 110.323 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -124.52 150.58 45.67 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.395 -0.965 . . . . 64.04 108.395 175.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -114.03 141.53 47.32 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.922 -0.399 . . . . 74.12 109.922 -177.201 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 23.2 t -138.37 137.59 20.9 Favored Pre-proline 0 C--N 1.307 -1.242 0 N-CA-C 108.898 -0.778 . . . . 74.12 108.898 176.285 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 490' ' ' SER . 8.0 Cg_exo -71.05 122.78 9.09 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 121.819 1.679 . . . . 62.12 111.36 177.19 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 49.5 m -147.09 179.88 7.31 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.09 -1.078 . . . . 74.52 108.09 -178.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.8 t -43.74 137.78 3.23 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 124.333 1.053 . . . . 52.2 113.193 179.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . 0.504 ' O ' HG12 ' A' ' 464' ' ' VAL . 9.3 Cg_endo -51.58 -28.84 30.25 Favored 'Trans proline' 0 C--N 1.363 1.298 0 C-N-CA 124.815 3.676 . . . . 65.33 113.963 -177.419 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.73 -18.6 63.53 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.315 0.579 . . . . 65.12 111.406 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 82.7 mt -102.73 6.62 39.55 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 116.176 -0.465 . . . . 63.22 112.02 -179.353 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 461' ' ' PRO . 14.8 p -61.54 127.35 21.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 119.491 -0.883 . . . . 65.22 109.406 176.716 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 78.85 -1.24 74.65 Favored Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 121.171 -0.538 . . . . 62.01 112.204 179.064 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -101.35 159.29 15.39 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 108.265 -1.013 . . . . 71.42 108.265 -178.552 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.448 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 75.1 t -80.54 140.9 15.99 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 CA-C-N 115.426 -0.806 . . . . 65.45 109.569 176.468 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 63.2 mt -98.28 -35.25 5.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 108.249 -1.019 . . . . 74.42 108.249 176.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 168.86 -177.4 42.71 Favored Glycine 0 N--CA 1.425 -2.064 0 C-N-CA 120.526 -0.845 . . . . 61.41 112.215 178.063 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . 0.524 HG22 HG12 ' A' ' 486' ' ' ILE . 72.3 p -116.14 144.24 44.43 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.432 -1.692 . . . . 73.1 106.432 179.081 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.512 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 22.3 t-20 -64.31 -57.68 16.74 Favored Pre-proline 0 C--N 1.319 -0.724 0 C-N-CA 120.064 -0.654 . . . . 71.11 112.051 177.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 24.4 Cg_exo -73.25 139.92 29.95 Favored 'Trans proline' 0 C--N 1.361 1.188 0 N-CA-C 108.041 -1.561 . . . . 54.41 108.041 170.152 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.418 ' C ' ' H ' ' A' ' 475' ' ' ASN . 23.8 Cg_exo -62.59 128.1 22.55 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.373 2.048 . . . . 75.04 114.234 -173.474 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -83.84 18.58 1.95 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 122.431 1.11 . . . . 52.2 109.375 179.383 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . 0.418 ' H ' ' C ' ' A' ' 473' ' ' PRO . 15.5 m120 -111.88 -9.96 14.02 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.038 -1.437 . . . . 74.42 109.427 -179.427 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -119.75 -179.35 3.87 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-O 121.454 0.645 . . . . 75.41 112.564 -170.144 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.97 134.38 34.52 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.621 -1.251 . . . . 71.13 107.621 178.136 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 24.4 m -128.96 145.56 51.2 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.151 -0.685 . . . . 63.53 109.151 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -78.44 167.48 21.24 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 120.861 0.362 . . . . 61.12 111.862 -178.098 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 40.0 mm -71.43 -17.17 19.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.633 0.73 . . . . 75.01 110.272 -178.217 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 15.9 p -94.88 5.24 52.46 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.658 -0.651 . . . . 54.54 112.14 179.254 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -83.69 139.54 32.71 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.273 0.559 . . . . 65.03 112.194 -177.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 60.2 t -108.3 126.52 64.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 107.842 -1.17 . . . . 74.54 107.842 176.27 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.45 HG12 ' HG2' ' A' ' 472' ' ' PRO . 34.1 m -110.11 120.57 61.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-O 121.426 0.631 . . . . 74.0 111.158 178.823 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.75 129.1 44.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.219 -1.03 . . . . 74.13 108.219 174.187 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.524 HG12 HG22 ' A' ' 470' ' ' THR . 18.4 mt -113.06 128.26 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 CA-C-N 115.117 -0.947 . . . . 73.2 110.366 -177.438 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 4.9 tt -104.48 126.6 59.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-N 115.566 -0.743 . . . . 71.13 109.695 -178.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 34.2 m -111.96 151.74 13.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 115.523 -0.762 . . . . 32.01 109.571 179.275 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -90.23 144.53 17.59 Favored Glycine 0 N--CA 1.424 -2.131 0 C-N-CA 121.167 -0.539 . . . . 62.23 112.959 -176.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.541 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 23.2 t . . . . . 0 N--CA 1.42 -1.957 0 N-CA-C 106.192 -1.781 . . . . 53.11 106.192 174.176 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo . . . . . 0 C--O 1.248 0.983 0 N-CA-C 110.476 -0.625 . . . . 72.11 110.476 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -88.57 72.41 8.77 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.749 0.785 . . . . 55.52 111.371 -177.098 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 22.1 p -126.0 146.46 49.87 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.361 -0.836 . . . . 73.44 110.823 -178.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -138.14 146.35 42.69 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.498 -0.927 . . . . 73.54 108.498 178.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 13.7 t70 -99.59 111.66 23.97 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.424 -0.954 . . . . 72.44 108.424 -178.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . 0.569 HD13 ' O ' ' A' ' 543' ' ' THR . 0.2 OUTLIER -75.79 127.1 86.27 Favored Pre-proline 0 C--O 1.236 0.357 0 N-CA-C 113.797 1.036 . . . . 71.23 113.797 -174.114 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -94.98 151.23 1.71 Allowed 'Trans proline' 0 CA--C 1.55 1.314 0 C-N-CA 123.111 2.54 . . . . 64.43 110.84 171.178 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . 0.441 ' HB3' ' HB2' ' A' ' 541' ' ' ALA . 7.3 p-10 -89.94 129.94 36.22 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.382 0.611 . . . . 53.14 110.323 -179.088 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.79 81.7 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-O 122.806 1.289 . . . . 73.1 109.533 177.268 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -97.44 145.78 25.85 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 113.814 -1.539 . . . . 64.13 108.885 -177.656 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 111.47 44.39 0.91 Allowed Glycine 0 CA--C 1.476 -2.378 0 N-CA-C 109.27 -1.532 . . . . 44.34 109.27 -177.082 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -141.22 167.05 23.11 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 108.826 -0.805 . . . . 65.33 108.826 -177.161 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 13.2 t -91.41 161.84 14.83 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 108.061 -1.088 . . . . 70.24 108.061 176.694 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 31.2 m -51.44 -42.07 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.668 0 C-N-CA 124.49 1.116 . . . . 72.24 113.396 -174.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -68.16 -41.8 81.02 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.253 0.549 . . . . 64.04 111.04 -177.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 51.7 t -72.66 -36.53 53.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.365 -0.834 . . . . 62.43 110.46 -176.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -62.51 -48.48 79.37 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.611 -0.268 . . . . 72.01 110.696 178.403 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -60.18 -41.77 93.61 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.298 0.571 . . . . 75.13 109.758 178.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.407 ' O ' HG23 ' A' ' 514' ' ' VAL . 0.6 OUTLIER -61.5 -43.19 99.3 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.546 -1.206 . . . . 70.23 110.173 -177.852 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -62.4 -42.91 99.79 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 116.438 -0.347 . . . . 74.1 111.281 179.416 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.31 -40.9 97.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.54 -0.3 . . . . 73.4 110.504 177.805 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -61.83 -43.02 99.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.965 0.412 . . . . 75.15 110.161 178.173 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 510' ' ' LYS . 93.7 t -67.1 -26.34 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-N 115.656 -0.702 . . . . 74.33 111.583 178.575 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -76.17 -25.38 55.18 Favored 'General case' 0 CA--C 1.514 -0.416 0 O-C-N 121.666 -0.646 . . . . 71.22 109.908 177.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 111.87 36.35 1.7 Allowed Glycine 0 N--CA 1.436 -1.359 0 C-N-CA 120.822 -0.704 . . . . 73.25 111.944 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -120.34 122.82 41.66 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 107.484 -1.302 . . . . 73.33 107.484 178.441 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.6 m -101.81 -18.17 15.89 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 115.831 -0.622 . . . . 73.53 110.628 -175.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -113.61 113.22 24.75 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.82 0.819 . . . . 70.11 110.907 -179.394 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -132.28 155.94 47.43 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.379 -1.282 . . . . 64.04 110.155 -177.611 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 48.8 m -141.34 138.84 33.37 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 108.122 -1.066 . . . . 72.45 108.122 173.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.09 119.57 35.16 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.644 0.735 . . . . 63.21 112.15 179.733 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -107.15 118.86 37.83 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.258 -0.883 . . . . 71.24 109.726 -178.255 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 67.4 m -84.54 123.01 29.82 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.087 -0.709 . . . . 53.24 109.087 176.023 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 32.7 m -121.4 150.98 24.55 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 N-CA-C 107.554 -1.276 . . . . 72.1 107.554 -179.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . 0.408 ' HB2' HD21 ' A' ' 559' ' ' ASN . 0.2 OUTLIER -90.53 137.54 32.27 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.58 -1.248 . . . . 61.21 109.981 -177.374 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 69.0 m -155.96 -176.12 0.58 Allowed Pre-proline 0 C--N 1.304 -1.413 0 N-CA-C 107.445 -1.317 . . . . 74.41 107.445 -176.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -73.45 -28.21 12.39 Favored 'Trans proline' 0 C--N 1.36 1.148 0 CA-C-N 120.941 1.372 . . . . 74.12 111.739 173.396 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -64.84 137.14 97.05 Favored Pre-proline 0 N--CA 1.475 0.812 0 CA-C-N 116.405 -0.362 . . . . 64.11 111.813 -178.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.58 151.9 43.91 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 124.032 3.155 . . . . 72.04 114.965 -173.318 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.59 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -69.35 107.97 3.52 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 115.047 -0.978 . . . . 35.24 110.875 -178.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 128.69 -10.87 6.35 Favored Glycine 0 C--N 1.292 -1.899 0 N-CA-C 110.393 -1.083 . . . . 63.24 110.393 -178.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -82.52 125.02 30.65 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 109.238 -0.653 . . . . 75.32 109.238 176.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 62.0 t -87.8 107.53 17.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 106.788 -1.56 . . . . 62.44 106.788 175.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 6.1 t -83.87 -8.7 59.13 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.631 -0.713 . . . . 74.22 111.336 -172.056 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.16 -155.5 26.46 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 120.693 -0.765 . . . . 64.53 111.299 177.448 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . 0.458 HG22 HD23 ' A' ' 553' ' ' LEU . 24.6 p -122.99 159.43 28.37 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 109.348 -0.612 . . . . 63.35 109.348 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -72.97 -53.05 5.33 Favored Pre-proline 0 C--N 1.306 -1.292 0 CA-C-O 118.876 -0.583 . . . . 64.54 110.578 174.062 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -61.57 128.09 23.68 Favored 'Trans proline' 0 C--N 1.378 2.084 0 N-CA-C 109.008 -1.189 . . . . 71.33 109.008 170.578 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -64.65 141.44 72.8 Favored 'Trans proline' 0 C--O 1.253 1.259 0 C-N-CA 122.177 1.918 . . . . 74.1 112.599 -177.656 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . 0.441 ' HB2' ' HB3' ' A' ' 499' ' ' ASP . . . -67.65 139.74 56.82 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 108.13 -1.063 . . . . 73.3 108.13 175.639 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.82 -5.0 39.54 Favored Glycine 0 N--CA 1.416 -2.668 0 N-CA-C 110.313 -1.115 . . . . 23.23 110.313 -175.513 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.569 ' O ' HD13 ' A' ' 497' ' ' ILE . 27.2 m -88.85 136.61 32.92 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 120.49 -0.484 . . . . 63.25 109.767 177.275 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 28.9 m -89.82 122.84 33.26 Favored 'General case' 0 N--CA 1.416 -2.147 0 N-CA-C 107.148 -1.427 . . . . 63.45 107.148 172.276 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.4 m -127.01 154.54 76.5 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 110.222 -0.288 . . . . 54.32 110.222 -177.453 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -68.84 151.88 73.98 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.305 2.003 . . . . 64.12 110.113 173.136 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 26.3 m -67.32 -20.28 26.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.724 0.773 . . . . 53.22 110.063 177.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -77.56 -11.4 59.85 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 114.94 -1.027 . . . . 72.22 112.258 -179.454 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 49.0 m -78.72 154.65 29.89 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 121.863 -0.523 . . . . 51.31 111.021 178.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 41.7 t -97.72 116.04 39.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 108.679 -0.859 . . . . 72.33 108.679 179.434 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.42 126.61 40.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.171 -0.677 . . . . 74.41 109.171 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -102.43 115.78 31.27 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-O 121.775 0.798 . . . . 62.11 109.636 -178.585 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . 0.458 HD23 HG22 ' A' ' 537' ' ' THR . 67.3 mt -87.65 134.25 33.68 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 113.856 -1.52 . . . . 75.51 107.551 178.096 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -112.32 115.36 28.63 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 122.257 1.027 . . . . 73.04 110.137 178.569 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 41.7 t -101.15 139.45 22.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 CA-C-N 114.441 -1.254 . . . . 75.02 108.446 -176.16 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.59 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 50.6 m -92.46 147.29 23.02 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-O 121.413 0.625 . . . . 54.11 112.093 179.786 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 0.2 OUTLIER -118.58 132.49 56.2 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 105.247 -2.131 . . . . 75.0 105.247 170.772 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -82.47 -24.1 54.78 Favored Glycine 0 CA--C 1.492 -1.371 0 N-CA-C 114.638 0.615 . . . . 72.12 114.638 -169.017 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . 0.408 HD21 ' HB2' ' A' ' 526' ' ' ASP . 43.8 m-80 68.13 31.81 5.19 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 107.548 -1.278 . . . . 60.45 107.548 -174.362 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 -135.11 141.72 46.08 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 106.281 -1.748 . . . . 73.34 106.281 -175.803 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -143.09 147.66 35.38 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 109.731 -0.47 . . . . 72.41 109.731 176.785 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 612' ' ' THR . 63.1 t -67.99 118.37 11.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-O 121.149 0.5 . . . . 75.15 110.303 -179.34 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . 0.408 ' HG2' ' O ' ' A' ' 564' ' ' PRO . 53.7 ttp -83.15 132.96 48.85 Favored Pre-proline 0 C--N 1.306 -1.293 0 CA-C-N 115.759 -0.655 . . . . 74.42 111.251 -177.553 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . 0.408 ' O ' ' HG2' ' A' ' 563' ' ' MET . 61.1 Cg_endo -74.29 170.14 20.87 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.048 2.498 . . . . 73.12 110.597 172.69 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -67.17 142.44 57.02 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.913 0.387 . . . . 74.43 110.905 179.529 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 94.0 mt -121.56 17.56 11.25 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.745 -0.661 . . . . 74.31 109.593 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 11.3 m -63.04 130.5 44.98 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.314 -0.857 . . . . 74.35 109.851 -179.785 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 88.43 46.2 4.72 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 119.916 -1.135 . . . . 54.04 112.197 177.427 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 26.8 ptm -118.71 157.72 26.92 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.162 -1.051 . . . . 71.22 108.162 176.401 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . 0.477 ' H ' ' HB3' ' A' ' 573' ' ' ASP . 91.9 m-85 -130.81 163.68 26.82 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.608 -1.256 . . . . 73.25 107.608 -176.502 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 35.8 t90 -65.44 -36.54 84.22 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.41 0.624 . . . . 74.12 109.612 176.803 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.7 m -75.58 -8.88 12.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.363 -0.835 . . . . 74.0 110.433 -178.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . 0.498 ' O ' ' HB2' ' A' ' 577' ' ' ARG . 13.7 t70 -101.21 -37.32 8.59 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.97 -1.013 . . . . 75.42 109.287 178.217 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -61.47 -34.71 75.92 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 124.314 1.046 . . . . 60.41 111.892 -179.404 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.476 ' HB2' ' HD3' ' A' ' 576' ' ' PRO . 9.3 mm-40 -60.1 -58.83 16.53 Favored Pre-proline 0 CA--C 1.559 1.291 0 N-CA-C 112.672 0.619 . . . . 34.34 112.672 177.241 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . 0.476 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 51.0 Cg_exo -61.59 -35.1 83.04 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 121.57 1.513 . . . . 64.24 111.782 171.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 573' ' ' ASP . 0.4 OUTLIER -59.54 -40.59 87.72 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.039 0.535 . . . . 73.42 110.394 -178.106 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 7.1 tt -57.63 -47.37 82.41 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.702 0.801 . . . . 75.13 109.237 179.666 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -66.63 -46.93 74.23 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.563 -0.744 . . . . 74.25 110.248 -178.65 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -62.79 -39.03 92.97 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.749 0.82 . . . . 75.01 112.803 -177.517 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 96.4 mt -89.45 -8.57 52.69 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 120.719 -0.392 . . . . 73.21 111.457 -179.029 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 63.52 43.38 98.19 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 109.679 -1.369 . . . . 50.44 109.679 -175.503 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 22.1 t90 -73.75 126.63 30.79 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 114.845 -0.677 . . . . 72.34 111.14 -172.389 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 24.0 m -99.86 -8.07 24.54 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.575 0.702 . . . . 63.33 109.749 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . 0.43 ' HA2' ' OD1' ' A' ' 617' ' ' ASP . . . -69.14 170.35 41.52 Favored Glycine 0 N--CA 1.428 -1.874 0 CA-C-N 115.127 -0.942 . . . . 74.45 113.804 -177.129 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 36.1 ttm -105.48 135.14 47.42 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.101 -1.05 . . . . 71.43 109.997 -177.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 56.7 tp -88.59 131.13 35.09 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.51 -0.922 . . . . 73.1 108.51 175.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -94.37 104.78 16.76 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.002 0.429 . . . . 72.3 110.797 -176.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -114.24 112.41 23.09 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 109.415 -0.587 . . . . 74.41 109.415 174.182 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -127.48 -40.76 0.31 Allowed Glycine 0 C--N 1.309 -0.97 0 C-N-CA 119.435 -1.364 . . . . 63.3 112.943 177.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . 0.484 ' HB3' ' NH2' ' A' ' 623' ' ' ARG . . . -139.58 157.5 45.7 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 122.577 0.351 . . . . 53.21 110.643 -177.788 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -110.39 124.26 51.39 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.457 -1.312 . . . . 71.34 107.457 176.422 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 35.9 t -109.02 115.89 50.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 C-N-CA 120.063 -0.655 . . . . 65.11 110.365 -176.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -100.03 116.78 32.86 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.995 -0.682 . . . . 64.03 110.425 179.658 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -132.69 -27.94 1.66 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 116.092 -0.504 . . . . 64.4 110.898 179.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 141.24 -169.41 25.05 Favored Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 110.494 -1.042 . . . . 53.33 110.494 -177.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.53 -35.18 65.58 Favored Glycine 0 CA--C 1.509 -0.307 0 O-C-N 123.877 0.398 . . . . 61.34 113.851 -175.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 42.6 m -58.68 -32.3 68.99 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.102 0.408 . . . . 63.13 112.102 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -108.61 -1.59 19.46 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.071 0.462 . . . . 75.44 110.651 -178.095 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -67.1 99.72 0.7 Allowed 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.211 -0.45 . . . . 75.44 112.051 -175.611 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . 0.458 ' OD1' ' HB3' ' A' ' 570' ' ' PHE . 11.7 t-20 67.15 -3.25 1.02 Allowed 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 125.251 1.42 . . . . 62.31 112.367 174.384 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -93.18 152.93 18.93 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 123.963 0.905 . . . . 75.15 111.326 -175.186 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . 0.477 HG23 ' HB2' ' A' ' 622' ' ' LEU . 12.9 p -57.06 138.76 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 124.554 1.142 . . . . 70.3 110.697 178.631 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 61.0 t -93.97 -56.12 5.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 108.118 -1.068 . . . . 74.43 108.118 179.119 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -151.42 154.62 36.98 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 107.78 -1.193 . . . . 62.0 107.78 -179.59 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . 0.413 ' HB2' HD11 ' A' ' 620' ' ' ILE . 16.7 pt20 -109.06 122.1 46.55 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.038 -1.467 . . . . 73.44 107.038 172.744 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.557 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 42.7 t-20 -53.21 -57.95 14.52 Favored Pre-proline 0 N--CA 1.483 1.189 0 CA-C-O 119.31 -0.376 . . . . 61.11 111.926 -178.659 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.557 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 1.2 Cg_endo -85.7 131.33 3.9 Favored 'Trans proline' 0 N--CA 1.44 -1.635 0 C-N-CA 121.262 1.308 . . . . 71.1 109.947 174.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . 0.493 ' O ' HG22 ' A' ' 612' ' ' THR . 53.2 Cg_endo -70.38 156.22 62.2 Favored 'Trans proline' 0 C--O 1.243 0.739 0 C-N-CA 122.069 1.846 . . . . 72.41 111.541 178.625 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -64.41 128.33 35.33 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.371 -0.603 . . . . 74.11 109.371 178.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 106.02 -3.57 38.38 Favored Glycine 0 C--N 1.3 -1.432 0 C-N-CA 120.394 -0.908 . . . . 22.23 112.92 -177.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . 0.493 HG22 ' O ' ' A' ' 609' ' ' PRO . 9.1 t -96.17 176.88 5.91 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-N 117.858 0.829 . . . . 73.15 109.111 175.504 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -97.87 119.47 6.44 Favored Glycine 0 N--CA 1.425 -2.082 0 CA-C-N 116.194 -0.457 . . . . 62.14 112.041 -177.075 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 26.8 m -104.95 144.3 14.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 C-N-CA 123.479 0.712 . . . . 73.55 109.523 177.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.557 ' ND2' ' HB3' ' A' ' 617' ' ' ASP . 36.6 p-10 -57.8 161.13 4.0 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 123.684 0.794 . . . . 74.32 111.968 -178.074 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -63.21 -25.9 68.55 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 120.82 0.343 . . . . 63.54 111.218 -178.015 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . 0.557 ' HB3' ' ND2' ' A' ' 615' ' ' ASN . 13.9 t70 -60.08 -40.05 88.21 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.667 -0.864 . . . . 74.44 108.667 174.308 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 87.96 20.98 48.14 Favored Glycine 0 N--CA 1.428 -1.885 0 CA-C-N 115.408 -0.814 . . . . 70.33 112.115 176.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . 0.425 ' HB ' ' OD1' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -69.24 119.28 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-O 122.762 1.268 . . . . 72.03 109.883 -173.523 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.413 HD11 ' HB2' ' A' ' 606' ' ' GLN . 3.2 tp -117.55 125.69 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.939 0 CA-C-N 113.422 -1.717 . . . . 74.22 107.714 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 17.5 m -98.26 116.39 30.39 Favored 'General case' 0 N--CA 1.412 -2.367 0 C-N-CA 118.877 -1.129 . . . . 74.51 108.097 178.436 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . 0.477 ' HB2' HG23 ' A' ' 603' ' ' VAL . 0.0 OUTLIER -139.64 155.4 47.43 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 106.961 -1.496 . . . . 62.35 106.961 179.653 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . 0.484 ' NH2' ' HB3' ' A' ' 591' ' ' ALA . 57.2 mtp180 -128.74 156.63 43.21 Favored 'General case' 0 C--N 1.272 -2.782 0 N-CA-C 105.271 -2.122 . . . . 70.24 105.271 175.186 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -131.14 158.05 41.5 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 106.637 -1.616 . . . . 73.33 106.637 175.184 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -81.88 -117.32 0.47 Allowed Glycine 0 N--CA 1.423 -2.181 0 C-N-CA 120.073 -1.06 . . . . 74.53 113.414 -177.252 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 . . . . . 0 C--N 1.297 -1.709 0 N-CA-C 108.886 -0.783 . . . . 73.15 108.886 -174.134 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 . . . . . 0 CA--C 1.502 -0.886 0 N-CA-C 109.412 -0.588 . . . . 71.12 109.412 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 34.6 m -121.22 153.93 24.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 N-CA-C 107.019 -1.474 . . . . 40.22 107.019 177.869 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -94.56 136.2 35.13 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 117.578 -1.649 . . . . 74.23 107.284 179.274 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 98.1 t -96.8 124.24 50.91 Favored Pre-proline 0 C--N 1.274 -2.704 0 N-CA-C 109.666 -0.494 . . . . 73.42 109.666 -172.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -64.12 125.87 16.06 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.935 1.757 . . . . 74.21 110.058 178.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . 0.571 ' OD1' ' HG2' ' A' ' 366' ' ' ARG . 16.5 t70 -85.69 138.36 32.18 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-O 121.726 0.774 . . . . 73.34 112.044 -176.608 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 18.5 m -108.22 4.93 9.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 113.981 -1.463 . . . . 60.05 111.777 -175.421 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.571 ' HG2' ' OD1' ' A' ' 364' ' ' ASP . 25.7 mmt-85 -62.54 147.48 48.87 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 112.624 0.602 . . . . 64.22 112.624 178.568 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.64 -9.59 44.7 Favored Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 110.709 -0.957 . . . . 74.34 110.709 -174.624 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -103.75 -150.68 0.42 Allowed 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.481 -0.933 . . . . 71.02 108.481 178.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 60.3 p -98.05 155.04 17.31 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.464 -0.939 . . . . 73.21 108.464 -178.162 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 23.0 t -61.42 -33.79 74.3 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.587 -0.523 . . . . 70.24 109.587 179.104 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -65.59 -46.46 79.3 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 116.24 -0.436 . . . . 73.35 111.138 178.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.54 -44.87 73.6 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-O 121.426 0.632 . . . . 61.1 110.376 -179.505 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -60.21 -48.11 83.13 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.582 -1.19 . . . . 40.43 111.567 -178.23 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.53 -39.31 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 116.644 -0.253 . . . . 52.11 111.27 177.721 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.9 -44.48 91.24 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-O 121.302 0.572 . . . . 74.3 111.112 -178.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . 0.443 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 70.9 m -64.18 -47.34 80.19 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.438 -0.801 . . . . 64.25 110.648 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 95.5 mt -64.16 -38.79 92.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.474 -0.33 . . . . 74.14 111.169 -179.265 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -62.29 -43.02 99.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.981 -0.554 . . . . 73.54 110.787 179.053 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -64.19 -31.86 73.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.274 0.559 . . . . 74.25 111.279 176.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . 0.443 ' HG2' ' O ' ' A' ' 376' ' ' THR . 29.8 mmm180 -80.11 -13.55 59.19 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.989 -0.55 . . . . 65.33 111.388 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 94.06 15.65 47.55 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.65 -0.786 . . . . 52.12 112.578 177.335 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -80.39 156.54 26.62 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 122.451 -0.441 . . . . 74.21 111.266 177.248 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -99.76 133.81 43.57 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 107.129 -1.434 . . . . 34.22 107.129 177.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . 0.491 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -127.33 155.1 38.32 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 C-N-CA 120.1 -0.64 . . . . 72.11 111.124 -175.404 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . 0.412 ' HB3' HG22 ' A' ' 417' ' ' THR . 7.7 tpt180 -136.08 141.28 44.22 Favored 'General case' 0 N--CA 1.403 -2.817 0 CA-C-N 114.571 -1.195 . . . . 74.31 108.011 169.763 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . 0.474 HG22 HE22 ' A' ' 388' ' ' GLN . 6.2 m -127.22 134.9 50.04 Favored 'General case' 0 C--N 1.271 -2.846 0 N-CA-C 104.55 -2.389 . . . . 61.11 104.55 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.57 124.34 45.09 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 119.317 -0.953 . . . . 62.25 109.201 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.474 HE22 HG22 ' A' ' 386' ' ' THR . 14.1 mm-40 -91.34 121.79 33.39 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.086 -0.709 . . . . 74.1 109.086 -177.306 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 421' ' ' SER . 55.0 mtpt -136.79 130.32 17.68 Favored Pre-proline 0 C--N 1.308 -1.22 0 N-CA-C 110.215 -0.291 . . . . 73.41 110.215 176.352 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . 0.528 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 54.0 Cg_endo -79.4 127.95 7.69 Favored 'Trans proline' 0 C--O 1.254 1.324 0 C-N-CA 120.956 1.104 . . . . 53.31 109.836 173.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.528 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 8.6 t70 154.33 -164.92 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 103.802 -2.666 . . . . 71.33 103.802 -177.649 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 26.7 t -142.7 4.7 1.53 Allowed 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 118.098 0.408 . . . . 60.21 110.187 176.512 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 15.3 t -79.62 -18.13 52.24 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-O 121.338 0.589 . . . . 54.24 109.781 179.661 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.616 HD13 ' H ' ' A' ' 394' ' ' ILE . 0.2 OUTLIER -99.58 150.43 36.78 Favored Pre-proline 0 N--CA 1.424 -1.743 0 N-CA-C 107.012 -1.477 . . . . 74.32 107.012 176.704 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . 0.427 ' HA ' ' HD2' ' A' ' 396' ' ' PRO . 77.8 Cg_exo -49.72 132.89 32.08 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.139 2.559 . . . . 65.53 114.228 -177.556 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . 0.574 ' HA ' ' OG ' ' A' ' 421' ' ' SER . 17.5 Cg_endo -60.75 164.03 14.58 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.595 2.863 . . . . 72.45 110.832 174.302 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . 0.425 ' HA ' HG13 ' A' ' 420' ' ' VAL . 0.9 OUTLIER -57.51 -8.91 0.93 Allowed 'General case' 0 N--CA 1.511 2.583 0 CA-C-O 121.915 0.864 . . . . 72.31 111.012 179.023 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -93.57 101.23 13.4 Favored 'General case' 0 CA--C 1.477 -1.841 0 N-CA-C 102.398 -3.186 . . . . 74.42 102.398 170.205 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 16.5 m -63.32 118.19 5.15 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.488 0 O-C-N 124.197 0.936 . . . . 64.52 112.491 -166.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 49.3 mm -103.61 -39.3 5.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 115.259 -0.882 . . . . 73.03 111.08 -177.34 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.41 157.32 27.35 Favored Glycine 0 N--CA 1.433 -1.54 0 C-N-CA 119.739 -1.219 . . . . 35.55 112.627 -175.51 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -156.31 -174.98 5.19 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 126.062 1.745 . . . . 73.52 109.797 -176.261 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . 0.424 ' C ' ' H ' ' A' ' 405' ' ' ALA . 10.7 t70 -96.96 136.15 21.7 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 105.942 -1.873 . . . . 74.42 105.942 176.252 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . 0.507 ' HA ' ' OD1' ' A' ' 407' ' ' ASN . 38.0 Cg_endo -63.01 23.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 124.823 3.682 . . . . 74.12 115.622 -173.092 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.424 ' H ' ' C ' ' A' ' 403' ' ' ASP . . . -54.01 -42.16 68.79 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 124.075 0.95 . . . . 72.1 110.92 177.569 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -79.24 -31.1 43.46 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.593 0.711 . . . . 73.5 110.516 -179.666 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . 0.507 ' OD1' ' HA ' ' A' ' 404' ' ' PRO . 8.9 m120 -79.68 -7.75 58.78 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.354 -0.839 . . . . 73.32 110.194 -175.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 89.9 m -99.42 148.71 23.93 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.564 -1.643 . . . . 74.25 106.564 176.623 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 17.3 m -74.45 111.89 10.09 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 107.814 -1.18 . . . . 62.32 107.814 177.445 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.36 169.86 20.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 C-N-CA 123.089 0.556 . . . . 61.42 110.262 -177.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 49.7 m -68.49 131.9 46.07 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.447 -0.946 . . . . 73.41 108.447 174.303 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -58.51 111.07 1.11 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.334 0.588 . . . . 64.02 110.683 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 111.1 73.81 0.72 Allowed Glycine 0 N--CA 1.432 -1.577 0 N-CA-C 110.58 -1.008 . . . . 65.21 110.58 -179.526 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -129.44 -175.0 3.44 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 105.853 -1.906 . . . . 34.3 105.853 179.935 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -102.76 123.45 46.45 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 118.401 0.546 . . . . 73.51 110.545 -177.02 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 27.1 mm -113.12 120.69 63.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 109.043 -0.725 . . . . 53.14 109.043 -179.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . 0.412 HG22 ' HB3' ' A' ' 385' ' ' ARG . 17.1 p -100.62 131.44 46.53 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 112.006 0.373 . . . . 72.31 112.006 -178.488 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 7.7 p -126.81 134.91 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-O 120.892 0.377 . . . . 65.43 110.846 176.279 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -101.6 128.46 47.87 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.816 -1.179 . . . . 73.41 107.816 175.201 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.425 HG13 ' HA ' ' A' ' 397' ' ' ASP . 54.0 t -124.55 135.92 62.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 C-N-CA 122.999 0.52 . . . . 73.01 110.352 -175.491 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . 0.574 ' OG ' ' HA ' ' A' ' 396' ' ' PRO . 77.7 p -84.9 121.12 27.29 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 109.086 -0.709 . . . . 61.13 109.086 177.897 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 33.8 m -118.69 106.2 12.35 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 109.07 -0.715 . . . . 60.32 109.07 177.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.045 0 C-N-CA 120.6 -0.81 . . . . 72.15 111.687 -178.514 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 . . . . . 0 N--CA 1.431 -1.386 0 N-CA-C 108.036 -1.098 . . . . 72.22 108.036 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -121.08 143.03 49.29 Favored 'General case' 0 CA--C 1.479 -1.779 0 CA-C-O 121.367 0.603 . . . . 71.13 112.145 -173.694 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -82.96 134.71 35.05 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.271 -1.331 . . . . 75.45 108.755 178.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 474' ' ' ALA . 50.2 mt -83.02 125.96 73.67 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 109.144 -0.688 . . . . 71.23 109.144 -179.45 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -71.03 154.68 62.57 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.426 2.084 . . . . 74.24 110.905 173.077 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -74.07 158.86 33.51 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 108.986 -0.746 . . . . 74.42 108.986 178.068 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 12.2 p -142.4 147.05 21.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 109.949 -0.389 . . . . 64.03 109.949 -178.447 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 19.5 m -72.84 137.01 45.45 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 108.65 -0.87 . . . . 65.33 108.65 175.806 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 54.4 p -62.44 -31.19 71.86 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 113.822 1.045 . . . . 72.41 113.822 -171.349 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.4 pp -81.67 -11.5 59.05 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.224 -0.99 . . . . 63.13 111.382 179.11 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 5.5 m -105.41 62.68 0.68 Allowed 'General case' 0 N--CA 1.432 -1.341 0 CA-C-O 122.191 0.996 . . . . 70.43 112.0 -176.21 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -56.12 -37.1 68.99 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.593 1.157 . . . . 73.54 111.397 176.25 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.33 -40.61 78.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.124 0.488 . . . . 64.32 111.016 178.077 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -70.28 -34.97 73.4 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.308 -0.627 . . . . 73.44 109.308 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.555 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -60.8 -51.39 69.52 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.74 -0.664 . . . . 62.31 111.345 179.15 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 35.4 m -65.47 -39.11 84.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 112.31 0.485 . . . . 74.0 112.31 -177.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -34.76 77.41 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 120.607 -0.437 . . . . 72.21 111.572 178.111 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 27.3 mmtm -61.76 -39.81 92.95 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-N 116.4 -0.363 . . . . 75.42 110.452 177.427 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 75.5 mt -63.88 -43.25 96.6 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.369 -0.832 . . . . 52.31 110.073 179.252 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 61.1 m -65.35 -42.68 92.57 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.362 -0.381 . . . . 74.22 111.646 177.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -63.35 -29.25 70.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.708 0.766 . . . . 71.23 110.611 178.455 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -85.02 5.22 30.28 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.454 -0.794 . . . . 42.02 111.889 179.194 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 105.48 -66.5 0.27 Allowed Glycine 0 CA--C 1.496 -1.142 0 C-N-CA 120.374 -0.917 . . . . 42.2 112.96 172.749 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -46.65 -65.88 0.49 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 114.353 1.242 . . . . 73.05 114.353 177.767 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 59.09 26.22 60.83 Favored Glycine 0 N--CA 1.469 0.887 0 C-N-CA 120.948 -0.644 . . . . 73.32 112.65 -176.005 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.581 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 16.3 mmt85 -100.73 111.37 23.59 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 107.148 -1.427 . . . . 75.41 107.148 -177.221 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -140.2 153.44 46.59 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 112.487 0.551 . . . . 70.21 112.487 -174.247 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' A' ' 453' ' ' LYS . 72.0 mmtt -138.81 148.53 43.9 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 124.77 1.228 . . . . 51.14 108.996 176.814 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -121.1 124.94 45.99 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 122.967 0.507 . . . . 74.22 110.609 -176.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -128.19 162.79 26.13 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.016 -0.735 . . . . 71.25 109.016 178.05 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -129.11 146.76 50.98 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 120.969 0.414 . . . . 33.24 110.072 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 36.8 t -143.47 149.14 46.52 Favored Pre-proline 0 C--N 1.29 -1.985 0 N-CA-C 107.453 -1.314 . . . . 34.22 107.453 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.716 ' HA ' ' O ' ' A' ' 490' ' ' SER . 24.3 Cg_exo -64.83 134.77 41.74 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.874 1.716 . . . . 61.54 109.722 176.545 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 62.6 m -152.07 172.17 16.73 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 116.181 -0.463 . . . . 63.02 109.855 -178.191 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 7.0 t -53.78 141.46 46.79 Favored Pre-proline 0 N--CA 1.438 -1.043 0 C-N-CA 124.487 1.115 . . . . 70.54 111.072 177.22 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -52.72 -30.67 47.34 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 124.698 3.598 . . . . 74.5 113.342 -176.302 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -72.97 -28.63 62.51 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.958 -0.565 . . . . 50.43 111.791 -178.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 11.2 mp -98.57 -0.61 42.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.592 0.234 . . . . 63.32 111.555 178.736 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 53.3 t -61.69 126.65 20.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-O 121.035 0.445 . . . . 75.03 109.92 175.229 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 87.58 0.21 84.44 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.711 -0.677 . . . . 64.34 111.75 -178.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.32 158.95 17.87 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.861 -0.792 . . . . 72.23 108.861 179.363 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 70.2 t -75.19 138.78 20.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 N-CA-C 108.728 -0.842 . . . . 53.42 108.728 176.382 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 48.9 mm -97.26 -27.86 3.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.395 -1.335 . . . . 73.21 107.395 179.062 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 156.57 -168.79 33.82 Favored Glycine 0 N--CA 1.422 -2.272 0 CA-C-N 115.209 -0.905 . . . . 62.34 112.052 175.472 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . 0.701 HG22 HG12 ' A' ' 486' ' ' ILE . 39.7 p -115.64 147.2 41.08 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 104.905 -2.258 . . . . 73.21 104.905 177.375 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.429 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 9.8 t30 -68.38 -55.13 12.84 Favored Pre-proline 0 C--N 1.31 -1.12 0 C-N-CA 118.542 -1.263 . . . . 54.53 111.815 176.394 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.429 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 23.9 Cg_exo -70.01 155.42 65.16 Favored 'Trans proline' 0 C--N 1.371 1.725 0 N-CA-C 108.769 -1.281 . . . . 71.13 108.769 172.428 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -62.27 126.66 19.07 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 121.82 1.68 . . . . 73.11 112.123 -176.687 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.421 ' O ' ' HB ' ' A' ' 429' ' ' ILE . . . -84.7 -2.08 57.06 Favored 'General case' 0 C--O 1.204 -1.322 0 CA-C-N 115.437 -0.801 . . . . 73.22 112.068 -174.491 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -110.71 6.37 21.55 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 120.108 -0.637 . . . . 71.15 111.874 175.613 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -110.23 173.75 6.18 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.517 0.932 . . . . 72.3 113.517 -174.014 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.11 117.11 21.4 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.803 -1.09 . . . . 71.12 110.969 -177.368 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 49.0 m -117.12 148.26 41.71 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.709 -0.849 . . . . 73.23 108.709 177.449 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -81.32 161.11 23.98 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.601 -0.518 . . . . 65.15 109.601 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.01 -17.82 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 CA-C-O 121.732 0.777 . . . . 71.42 112.353 -178.179 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.1 t -95.96 4.79 52.41 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.583 -0.698 . . . . 52.52 111.772 179.093 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -86.92 129.49 34.86 Favored 'General case' 0 CA--C 1.508 -0.638 0 O-C-N 121.961 -0.462 . . . . 72.14 111.091 -177.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.581 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.1 p -104.79 123.51 58.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.459 0.647 . . . . 65.51 110.509 178.687 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 34.7 m -101.28 126.91 55.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 121.787 0.803 . . . . 72.1 111.122 -179.1 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.71 125.22 45.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 108.213 -1.032 . . . . 74.43 108.213 176.36 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.701 HG12 HG22 ' A' ' 470' ' ' THR . 37.1 mt -109.53 126.3 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 CA-C-N 115.076 -0.965 . . . . 54.32 110.809 -178.003 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 4.4 tt -104.64 127.0 59.41 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 CA-C-N 114.887 -1.051 . . . . 72.11 110.011 -177.213 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 33.1 m -110.18 151.57 12.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 C-N-CA 122.786 0.434 . . . . 72.52 110.012 177.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -84.62 135.48 13.64 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.674 -0.57 . . . . 63.52 111.674 -179.226 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.716 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 46.4 m . . . . . 0 C--N 1.306 -1.285 0 CA-C-N 117.155 0.477 . . . . 73.54 110.176 178.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo . . . . . 0 N--CA 1.445 -1.367 0 N-CA-C 111.122 -0.376 . . . . 72.1 111.122 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -85.02 45.87 1.22 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.682 0.754 . . . . 62.53 110.151 178.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 10.8 p -122.58 145.95 47.87 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.511 -0.768 . . . . 51.22 110.485 -178.29 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -143.39 150.04 38.53 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 123.104 0.561 . . . . 62.22 111.32 178.464 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 11.1 p-10 -86.85 127.83 35.03 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.164 -0.926 . . . . 65.4 110.319 178.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 31.1 pt -81.17 134.1 52.89 Favored Pre-proline 0 C--N 1.304 -1.396 0 CA-C-N 115.658 -0.701 . . . . 74.32 110.426 179.029 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -82.43 175.99 8.39 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.658 2.239 . . . . 75.23 112.978 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -83.08 142.13 31.51 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.365 -0.834 . . . . 71.12 108.765 177.048 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 51.3 t -138.57 91.11 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 N-CA-C 107.74 -1.207 . . . . 74.41 107.74 -179.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -151.1 121.08 7.13 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.775 -0.454 . . . . 70.55 109.775 178.455 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 102.69 25.63 7.56 Favored Glycine 0 CA--C 1.489 -1.557 0 C-N-CA 120.164 -1.017 . . . . 42.14 111.243 176.447 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -131.95 170.3 15.1 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 109.118 -0.697 . . . . 65.04 109.118 178.829 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 15.1 t -91.57 160.63 15.31 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.284 -1.006 . . . . 71.03 108.284 178.359 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 47.5 t -51.88 -42.5 33.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 C-N-CA 123.709 0.803 . . . . 73.03 111.788 -175.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -67.86 -42.34 81.46 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.25 0.463 . . . . 63.04 112.25 -177.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 66.3 t -75.2 -34.68 31.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-O 121.281 0.562 . . . . 64.23 110.172 -177.769 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -61.95 -50.0 73.89 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.911 -0.586 . . . . 63.15 110.661 178.526 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -65.89 -34.91 79.22 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 120.819 -0.352 . . . . 75.31 110.95 178.498 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.402 ' O ' HG23 ' A' ' 514' ' ' VAL . 78.7 tttt -55.84 -48.25 75.81 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.5 0.72 . . . . 72.21 110.166 178.437 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -62.31 -45.93 91.02 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-N 116.091 -0.504 . . . . 62.24 110.436 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 90.1 mt -61.76 -38.25 87.29 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.823 -0.626 . . . . 73.51 111.335 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -61.42 -42.48 98.8 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.954 0.407 . . . . 65.13 110.124 177.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 510' ' ' LYS . 85.8 t -66.61 -29.55 46.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-N 115.601 -0.727 . . . . 62.13 110.666 178.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -84.23 3.02 37.2 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 121.872 -0.518 . . . . 73.33 112.066 179.402 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 82.54 39.41 10.85 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 121.006 -0.616 . . . . 70.12 112.791 177.251 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -124.77 138.59 54.27 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.994 -1.113 . . . . 74.42 107.994 176.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 3.6 m -131.84 -11.58 3.4 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.708 -0.797 . . . . 72.41 111.677 -176.212 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -107.64 115.01 29.39 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.25 -0.648 . . . . 73.25 109.25 -174.394 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -130.01 155.94 45.29 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.565 -0.743 . . . . 73.23 110.005 -175.069 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 66.9 m -141.83 127.85 19.56 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 106.999 -1.482 . . . . 75.05 106.999 170.625 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . 0.503 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 0.0 OUTLIER -117.3 133.35 56.08 Favored 'General case' 0 N--CA 1.418 -2.053 0 CA-C-O 121.23 0.538 . . . . 54.35 111.129 -179.3 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -113.87 143.13 45.19 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.442 -0.948 . . . . 72.11 108.442 178.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 61.0 m -102.71 126.98 50.02 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.0 0.428 . . . . 73.12 110.833 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 26.7 m -121.3 168.3 13.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.68 -1.23 . . . . 62.12 107.68 177.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . 0.608 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 5.4 p-10 -102.65 136.42 42.52 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.31 -0.956 . . . . 51.13 111.178 -179.476 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . 0.419 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 18.7 m -152.85 178.15 1.68 Allowed Pre-proline 0 C--N 1.308 -1.219 0 N-CA-C 108.343 -0.984 . . . . 73.41 108.343 178.368 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -83.8 -0.37 9.65 Favored 'Trans proline' 0 C--N 1.361 1.216 0 C-N-CA 121.848 1.699 . . . . 51.41 111.135 173.435 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.51 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 8.1 mmm180 -76.73 138.84 66.28 Favored Pre-proline 0 C--O 1.211 -0.943 0 N-CA-C 106.826 -1.546 . . . . 70.5 106.826 178.532 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.08 150.41 86.66 Favored 'Trans proline' 0 C--O 1.246 0.879 0 C-N-CA 122.387 2.058 . . . . 75.12 112.074 -177.651 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.67 107.9 0.76 Allowed 'General case' 0 C--O 1.239 0.534 0 CA-C-N 116.21 -0.45 . . . . 45.03 110.439 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 133.51 -17.77 4.44 Favored Glycine 0 C--N 1.298 -1.562 0 N-CA-C 110.602 -0.999 . . . . 73.32 110.602 -177.612 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -75.58 124.73 27.7 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.272 -1.011 . . . . 73.25 108.272 177.292 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 47.1 t -82.92 115.61 25.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 106.711 -1.588 . . . . 62.12 106.711 175.172 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . 0.424 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 10.6 t -83.48 -20.44 33.99 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.055 0.455 . . . . 62.22 110.5 -175.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 166.12 -159.37 32.62 Favored Glycine 0 N--CA 1.428 -1.849 0 C-N-CA 120.638 -0.791 . . . . 33.11 111.169 178.573 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 21.7 p -132.77 158.74 41.66 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.668 -0.864 . . . . 74.43 108.668 178.653 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -74.84 -53.35 3.11 Favored Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 109.886 -0.412 . . . . 70.13 109.886 176.34 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.458 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 45.8 Cg_endo -70.42 140.22 39.72 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 120.906 1.071 . . . . 65.21 110.176 173.476 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 17.2 Cg_exo -68.23 142.01 53.97 Favored 'Trans proline' 0 C--O 1.247 0.938 0 C-N-CA 122.592 2.195 . . . . 45.12 112.731 -179.123 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -65.76 135.58 55.09 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.746 -0.661 . . . . 72.32 109.683 178.605 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 103.67 -14.34 53.52 Favored Glycine 0 C--N 1.304 -1.199 0 C-N-CA 120.78 -0.724 . . . . 64.31 112.31 -179.853 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 27.6 m -67.2 129.77 40.98 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 110.349 -0.241 . . . . 72.23 110.349 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 56.7 m -92.11 122.69 34.84 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 108.223 -1.029 . . . . 71.32 108.223 177.265 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 26.0 m -132.4 164.72 41.43 Favored Pre-proline 0 C--N 1.307 -1.271 0 N-CA-C 109.404 -0.591 . . . . 74.54 109.404 -176.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -62.61 150.86 86.36 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.194 1.929 . . . . 72.01 110.18 174.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 27.4 m -64.21 -20.53 27.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 112.661 0.615 . . . . 72.12 112.661 -177.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -83.14 3.43 30.81 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 123.841 0.856 . . . . 51.44 111.805 178.764 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 11.7 t -80.46 158.67 25.84 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.111 0.482 . . . . 61.3 111.041 -176.481 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 70.0 t -101.37 135.12 39.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.842 -0.617 . . . . 51.42 110.19 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . 0.428 ' N ' HD12 ' A' ' 551' ' ' ILE . 2.6 mp -97.15 126.13 50.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 107.462 -1.31 . . . . 52.24 107.462 176.282 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 521' ' ' SER . 36.6 tt0 -103.53 116.29 32.1 Favored 'General case' 0 N--CA 1.428 -1.56 0 C-N-CA 120.602 -0.439 . . . . 72.24 109.978 -179.237 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 4.6 mp -101.5 134.48 44.53 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.154 -0.93 . . . . 74.32 109.032 -178.652 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -110.01 114.14 27.42 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 122.11 0.957 . . . . 60.52 109.553 177.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 48.6 t -103.0 141.44 18.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-N 114.342 -1.299 . . . . 72.22 109.087 -174.464 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 67.9 m -96.65 147.6 23.73 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.205 0.526 . . . . 64.14 112.212 -179.161 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.608 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 15.1 ptpt -96.78 150.72 20.38 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 105.282 -2.118 . . . . 72.34 105.282 170.692 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -73.39 -37.55 53.76 Favored Glycine 0 CA--C 1.485 -1.842 0 N-CA-C 110.931 -0.868 . . . . 34.22 110.931 -178.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 63.2 t30 69.79 -0.86 2.52 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 122.54 1.162 . . . . 73.13 110.609 175.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 77.9 mt-30 -142.57 144.42 32.88 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 106.509 -1.663 . . . . 75.42 106.509 179.565 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -123.71 140.94 52.49 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 120.75 -0.38 . . . . 73.32 110.402 179.33 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.99 123.16 11.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.575 0.702 . . . . 31.03 112.037 -178.122 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 59.6 ttp -97.28 134.66 22.45 Favored Pre-proline 0 C--N 1.305 -1.352 0 CA-C-N 115.43 -0.805 . . . . 70.34 109.874 178.463 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.15 169.62 13.34 Favored 'Trans proline' 0 C--O 1.244 0.821 0 C-N-CA 122.805 2.336 . . . . 72.22 111.197 175.496 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . 0.537 ' HA ' ' HB1' ' A' ' 610' ' ' ALA . 28.1 t70 -66.83 114.69 5.88 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.401 0.62 . . . . 71.31 112.085 -178.274 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 93.2 mt -133.87 10.0 3.91 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.208 -1.034 . . . . 72.43 108.208 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 14.6 m -79.17 134.08 36.7 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.935 -1.03 . . . . 63.42 110.575 -175.238 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 77.19 33.98 42.91 Favored Glycine 0 C--O 1.221 -0.66 0 C-N-CA 120.724 -0.751 . . . . 71.54 111.94 -179.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . 0.544 ' SD ' ' HD3' ' A' ' 577' ' ' ARG . 36.0 ttp -100.27 146.37 26.99 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.814 -0.439 . . . . 73.43 109.814 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 93.4 m-85 -76.59 147.87 37.36 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.279 -1.008 . . . . 63.15 108.279 178.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . 0.497 ' HA ' ' HB3' ' A' ' 574' ' ' ALA . 72.4 t-105 -59.67 -22.84 62.5 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 112.057 0.392 . . . . 75.34 112.057 -178.231 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 29.5 m -70.52 -23.14 24.14 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.438 0 CA-C-N 115.951 -0.568 . . . . 64.34 111.335 -178.582 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -101.06 -33.37 10.18 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.939 -0.763 . . . . 74.14 108.939 175.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . 0.497 ' HB3' ' HA ' ' A' ' 571' ' ' TRP . . . -58.23 -53.48 57.8 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.469 0.914 . . . . 62.33 113.469 -176.03 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.449 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 34.7 tt0 -58.5 -51.9 78.49 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 120.51 -0.476 . . . . 71.5 112.021 -178.253 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . 0.449 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 51.2 Cg_exo -57.8 -40.76 76.26 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 121.918 1.745 . . . . 52.51 112.789 176.58 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.544 ' HD3' ' SD ' ' A' ' 569' ' ' MET . 80.9 mtp180 -69.09 -33.94 74.32 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 120.326 -0.55 . . . . 72.21 112.139 -179.249 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 92.8 mt -65.36 -47.55 76.04 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.008 0.433 . . . . 72.53 110.454 178.706 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -65.31 -34.81 79.22 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.964 -0.562 . . . . 74.34 111.176 177.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -65.4 -32.43 74.05 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.924 0.393 . . . . 41.24 111.093 178.417 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 577' ' ' ARG . 4.1 mm? -81.46 -5.2 57.69 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.251 -0.431 . . . . 73.41 111.179 177.42 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 72.78 31.71 62.12 Favored Glycine 0 N--CA 1.431 -1.649 0 C-N-CA 121.018 -0.61 . . . . 63.24 111.6 -179.783 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 78.6 t90 -65.1 139.05 58.67 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.678 0.275 . . . . 73.51 110.286 177.093 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 29.2 m -151.62 103.03 2.92 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.361 -0.607 . . . . 75.04 109.361 175.357 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -161.39 -138.26 2.38 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 109.497 -1.441 . . . . 22.15 109.497 177.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 16.4 mmt -117.71 132.09 56.53 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.214 0.53 . . . . 25.34 110.766 175.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 24.8 tp -98.91 118.18 35.09 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 106.347 -1.723 . . . . 55.11 106.347 178.375 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -120.35 100.45 7.17 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 118.112 -1.435 . . . . 52.32 111.962 178.447 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . 0.419 ' O ' ' HD2' ' A' ' 589' ' ' LYS . 0.1 OUTLIER -113.79 133.8 55.16 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.143 -1.389 . . . . 63.31 108.391 171.476 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -73.2 -102.33 0.07 OUTLIER Glycine 0 C--N 1.301 -1.361 0 C-N-CA 120.745 -0.741 . . . . 64.31 113.842 -176.31 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -91.81 135.8 33.64 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 120.591 0.234 . . . . 73.03 111.489 -177.612 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -89.3 125.97 35.33 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 106.915 -1.513 . . . . 41.04 106.915 177.995 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 78.4 t -124.67 115.63 45.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 110.158 -0.312 . . . . 70.03 110.158 -175.127 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -74.49 113.42 11.71 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.683 -0.858 . . . . 74.14 108.683 177.06 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -125.32 -28.98 3.3 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 115.648 -0.705 . . . . 75.42 110.373 177.593 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 107.74 147.97 13.78 Favored Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 110.015 -1.234 . . . . 74.23 110.015 -176.351 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -62.5 -33.57 86.83 Favored Glycine 0 C--N 1.32 -0.348 0 CA-C-N 116.915 0.357 . . . . 42.12 112.776 -177.602 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 27.4 m -65.89 -23.97 66.75 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-O 121.144 0.497 . . . . 75.14 111.206 178.333 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -87.11 0.47 55.22 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.54 0.736 . . . . 63.34 110.765 -179.573 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . 0.4 10.3 p-80 69.65 92.0 0.09 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 126.545 1.938 . . . . 75.44 116.123 176.671 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -90.66 69.35 6.66 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 123.033 1.397 . . . . 54.12 107.999 171.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . 0.441 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 37.2 ptt85 -106.82 162.44 13.8 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.227 -1.351 . . . . 72.14 110.178 -176.574 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . 0.413 HG13 ' HB2' ' A' ' 622' ' ' LEU . 75.9 t -68.98 130.86 34.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 106.133 -1.803 . . . . 62.33 106.133 172.72 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 28.3 m -107.48 -31.18 2.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 119.494 -0.882 . . . . 54.31 111.937 -176.332 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -145.05 157.13 44.21 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 106.942 -1.503 . . . . 73.04 106.942 176.058 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . 0.416 ' HB2' HD11 ' A' ' 620' ' ' ILE . 10.7 pt20 -148.98 160.2 43.52 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 106.872 -1.529 . . . . 65.43 106.872 -179.321 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.527 ' HB2' ' HD3' ' A' ' 608' ' ' PRO . 88.6 m-20 -68.56 -57.85 7.85 Favored Pre-proline 0 C--N 1.315 -0.893 0 C-N-CA 120.185 -0.606 . . . . 72.33 112.022 -179.492 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.527 ' HD3' ' HB2' ' A' ' 607' ' ' ASN . 10.1 Cg_endo -99.07 127.02 0.17 Allowed 'Trans proline' 0 N--CA 1.44 -1.674 0 C-N-CA 122.123 1.882 . . . . 53.14 112.245 178.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.45 158.67 54.21 Favored 'Trans proline' 0 C--O 1.246 0.891 0 C-N-CA 121.927 1.751 . . . . 64.11 111.432 176.545 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . 0.537 ' HB1' ' HA ' ' A' ' 565' ' ' ASP . . . -68.02 137.39 55.03 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.776 -0.824 . . . . 74.34 108.776 177.337 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 90.04 -0.05 78.35 Favored Glycine 0 C--N 1.309 -0.932 0 C-N-CA 120.337 -0.935 . . . . 62.43 111.144 -177.469 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 27.6 m -111.48 159.62 17.91 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 107.514 -1.291 . . . . 73.35 107.514 177.5 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -77.92 133.62 13.26 Favored Glycine 0 N--CA 1.427 -1.944 0 N-CA-C 111.743 -0.543 . . . . 50.23 111.743 177.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 21.6 m -96.72 141.18 15.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 109.032 -0.729 . . . . 75.25 109.032 177.336 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.499 HD21 HG22 ' A' ' 619' ' ' ILE . 6.5 p-10 -55.77 148.85 15.68 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.91 0.884 . . . . 71.53 110.358 179.86 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -52.63 -30.68 32.84 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 112.962 0.727 . . . . 74.03 112.962 -174.143 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . 0.574 ' OD2' ' HB ' ' A' ' 619' ' ' ILE . 32.7 t70 -79.78 -31.42 40.82 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.951 0.405 . . . . 75.12 110.739 -178.535 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 77.74 20.71 73.35 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.902 -0.666 . . . . 54.51 112.789 179.013 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . 0.574 ' HB ' ' OD2' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -68.3 121.01 16.69 Favored 'Isoleucine or valine' 0 C--O 1.246 0.872 0 CA-C-O 122.536 1.16 . . . . 72.3 109.209 -173.796 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.416 HD11 ' HB2' ' A' ' 606' ' ' GLN . 6.3 tp -115.08 120.09 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.093 0 CA-C-N 113.957 -1.474 . . . . 75.33 112.379 -171.763 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 14.5 m -99.4 117.25 33.4 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 105.565 -2.013 . . . . 73.55 105.565 170.834 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . 0.43 HD23 ' H ' ' A' ' 622' ' ' LEU . 2.2 pt? -140.09 162.69 34.63 Favored 'General case' 0 CA--C 1.483 -1.631 0 N-CA-C 108.987 -0.746 . . . . 73.0 108.987 -175.429 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -134.79 137.23 43.19 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 107.442 -1.318 . . . . 75.41 107.442 172.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -142.02 166.06 25.74 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 105.281 -2.118 . . . . 75.44 105.281 173.389 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -66.4 -86.74 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.426 -1.07 . . . . 45.43 110.426 175.616 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 . . . . . 0 C--N 1.299 -1.624 0 N-CA-C 105.95 -1.87 . . . . 74.52 105.95 175.763 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 N--CA 1.44 -0.943 0 N-CA-C 108.241 -1.022 . . . . 74.53 108.241 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.9 m -134.52 163.27 37.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.494 -0.928 . . . . 63.51 108.494 178.027 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -94.23 140.59 29.58 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 106.455 -1.683 . . . . 70.34 106.455 175.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.517 HG22 ' CZ ' ' A' ' 382' ' ' PHE . 75.7 t -93.92 134.48 26.07 Favored Pre-proline 0 C--N 1.277 -2.565 0 N-CA-C 107.559 -1.274 . . . . 73.5 107.559 -174.719 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.84 149.48 66.46 Favored 'Trans proline' 0 C--O 1.253 1.259 0 C-N-CA 123.042 2.495 . . . . 63.15 113.308 -171.279 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -87.24 75.15 9.39 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 115.076 -0.966 . . . . 35.11 111.258 -177.409 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 27.7 m -91.54 -5.25 10.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 122.917 1.341 . . . . 72.03 108.005 173.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -66.39 146.43 54.57 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 112.329 -2.214 . . . . 72.21 108.21 177.05 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . 0.508 ' H ' HG23 ' A' ' 399' ' ' VAL . . . 104.53 1.23 43.51 Favored Glycine 0 C--N 1.304 -1.237 0 C-N-CA 119.475 -1.345 . . . . 41.33 114.042 178.674 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -110.29 -77.39 0.59 Allowed 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.094 -0.706 . . . . 73.44 109.094 -177.65 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 78.7 p -149.78 153.13 36.34 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 106.767 -1.568 . . . . 65.32 106.767 178.248 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.409 ' O ' ' HB ' ' A' ' 374' ' ' ILE . 22.6 t -62.64 -33.72 75.61 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.964 -0.754 . . . . 63.41 108.964 177.278 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -68.69 -47.83 65.43 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 112.53 0.567 . . . . 51.43 112.53 -178.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -69.69 -45.27 68.66 Favored 'General case' 0 CA--C 1.503 -0.859 0 C-N-CA 119.482 -0.887 . . . . 75.01 110.631 -178.097 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . 0.467 ' O ' ' HG ' ' A' ' 377' ' ' LEU . . . -61.17 -50.57 72.61 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.407 -0.815 . . . . 73.22 110.96 -178.361 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . 0.409 ' HB ' ' O ' ' A' ' 370' ' ' SER . 1.7 mp -69.28 -38.97 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 120.727 -0.389 . . . . 73.12 111.778 -177.862 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.71 -44.02 93.88 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.226 0.536 . . . . 64.1 110.884 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . 0.406 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 21.0 m -66.52 -47.1 74.03 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.572 -0.74 . . . . 73.34 110.104 -179.171 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 373' ' ' ALA . 94.0 mt -61.49 -42.45 98.8 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.271 -0.422 . . . . 74.44 110.629 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -61.21 -42.46 98.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.129 -0.487 . . . . 75.32 111.157 -179.532 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -67.57 -24.52 65.52 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 112.072 0.397 . . . . 75.24 112.072 179.31 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 376' ' ' THR . 37.8 mmt180 -81.42 -13.76 57.88 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.106 0.479 . . . . 73.42 110.123 176.518 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.67 7.43 51.06 Favored Glycine 0 N--CA 1.437 -1.297 0 CA-C-N 115.701 -0.681 . . . . 74.53 112.337 178.381 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.517 ' CZ ' HG22 ' A' ' 362' ' ' VAL . 57.4 m-85 -74.36 148.72 41.03 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-O 121.431 0.634 . . . . 74.42 110.322 178.159 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.653 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 47.0 mmtm -98.61 146.24 26.02 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 106.548 -1.649 . . . . 72.4 106.548 178.293 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.71 150.68 27.16 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.302 0 C-N-CA 119.735 -0.786 . . . . 73.45 110.095 -179.14 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -117.06 146.15 43.28 Favored 'General case' 0 N--CA 1.404 -2.769 0 N-CA-C 106.372 -1.714 . . . . 73.44 106.372 171.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 89.0 m -135.02 117.85 16.18 Favored 'General case' 0 C--N 1.256 -3.496 0 N-CA-C 106.371 -1.714 . . . . 73.24 106.371 -179.342 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 20.8 tp -117.83 130.89 56.54 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 108.967 -0.753 . . . . 65.52 108.967 -176.107 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -91.12 131.0 36.96 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-O 121.099 0.476 . . . . 74.41 110.311 -178.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 421' ' ' SER . 76.0 mmtt -125.85 143.31 44.86 Favored Pre-proline 0 C--N 1.297 -1.69 0 N-CA-C 107.396 -1.335 . . . . 75.21 107.396 177.643 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . 0.419 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 13.7 Cg_endo -98.14 127.25 0.22 Allowed 'Trans proline' 0 N--CA 1.449 -1.137 0 N-CA-C 108.867 -1.243 . . . . 74.51 108.867 166.563 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 6.7 t70 168.09 -170.04 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.286 -1.375 . . . . 74.15 107.286 -174.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 31.7 t -136.74 -11.36 1.79 Allowed 'General case' 0 N--CA 1.428 -1.573 0 C-N-CA 123.22 0.608 . . . . 71.24 110.376 178.136 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 14.6 t -71.42 -28.85 64.28 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 108.089 -1.078 . . . . 74.23 108.089 176.604 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.467 HD13 ' H ' ' A' ' 394' ' ' ILE . 0.2 OUTLIER -110.1 129.97 23.36 Favored Pre-proline 0 N--CA 1.41 -2.426 0 N-CA-C 104.278 -2.49 . . . . 74.54 104.278 167.051 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -92.91 -175.49 0.54 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.698 2.265 . . . . 73.24 113.798 -172.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -53.16 167.25 0.78 Allowed 'Trans proline' 0 C--N 1.365 1.419 0 C-N-CA 124.25 3.3 . . . . 74.02 111.351 169.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -53.08 -6.22 0.06 Allowed 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 126.427 1.891 . . . . 73.24 113.667 -170.573 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 27.9 m170 -77.21 93.1 3.9 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 105.453 -2.055 . . . . 75.33 105.453 170.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.508 HG23 ' H ' ' A' ' 367' ' ' GLY . 16.6 m -67.54 119.57 13.41 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 113.546 -1.661 . . . . 62.14 112.534 -166.911 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.88 -35.81 8.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 108.763 -0.828 . . . . 71.34 108.763 178.756 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.84 163.53 28.58 Favored Glycine 0 N--CA 1.414 -2.77 0 CA-C-N 115.513 -0.767 . . . . 34.03 111.198 -177.391 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.3 p -150.06 -176.4 5.43 Favored 'General case' 0 C--N 1.288 -2.109 0 C-N-CA 126.207 1.803 . . . . 52.5 107.558 -178.358 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . 0.433 ' HA ' ' HD3' ' A' ' 404' ' ' PRO . 17.3 t70 -98.88 139.72 21.25 Favored Pre-proline 0 C--N 1.3 -1.563 0 C-N-CA 120.157 -0.617 . . . . 64.21 109.476 -174.16 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 403' ' ' ASP . 50.3 Cg_exo -57.86 1.61 0.21 Allowed 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 124.93 3.753 . . . . 64.31 115.624 -179.569 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.08 -33.82 63.09 Favored 'General case' 0 C--O 1.213 -0.854 0 CA-C-O 120.968 0.413 . . . . 63.23 110.084 175.56 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -70.49 -30.84 67.73 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-N 115.515 -0.766 . . . . 44.52 111.06 178.455 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -87.74 -5.02 58.86 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.841 0.829 . . . . 72.32 109.286 -178.271 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 31.0 m -91.8 149.13 21.75 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 105.821 -1.918 . . . . 63.44 105.821 175.159 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 12.6 p -78.73 112.25 15.66 Favored 'General case' 0 N--CA 1.418 -2.049 0 C-N-CA 119.23 -0.988 . . . . 64.34 109.624 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 35.2 m -119.57 159.92 20.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 115.971 -0.559 . . . . 73.54 109.714 178.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 56.0 m -67.0 134.86 52.79 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.347 -0.612 . . . . 74.2 109.347 178.102 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -53.71 114.5 1.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.125 0.57 . . . . 74.2 111.62 -178.046 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 112.42 14.05 11.07 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.663 -0.698 . . . . 55.33 112.042 -178.706 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -75.27 -174.56 2.4 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 109.907 -0.405 . . . . 73.11 109.907 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . 0.653 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 9.7 pt-20 -119.38 130.93 55.57 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 113.275 0.843 . . . . 75.22 113.275 -171.101 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.4 mm -116.89 127.49 74.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.916 -0.584 . . . . 64.21 110.551 -179.314 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 35.3 m -93.06 130.72 38.57 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 120.733 0.302 . . . . 52.53 111.307 178.663 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 5.2 p -120.41 135.35 60.94 Favored 'Isoleucine or valine' 0 C--O 1.248 0.994 0 N-CA-C 109.565 -0.532 . . . . 62.55 109.565 178.003 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -100.39 124.83 46.39 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.121 -0.696 . . . . 70.05 109.121 177.137 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 70.8 t -118.54 131.79 70.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 107.717 -1.216 . . . . 71.52 107.717 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . 0.568 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 32.6 t -101.74 120.89 41.08 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 117.635 -1.626 . . . . 62.41 110.497 179.777 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 4.1 t -121.67 107.29 12.19 Favored 'General case' 0 N--CA 1.403 -2.781 0 CA-C-N 114.492 -1.231 . . . . 75.44 108.624 171.677 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -2.004 0 C-N-CA 119.695 -1.241 . . . . 63.21 112.274 179.532 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 . . . . . 0 N--CA 1.437 -1.092 0 N-CA-C 106.891 -1.522 . . . . 71.05 106.891 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.529 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 5.0 mmp_? -121.49 151.96 39.69 Favored 'General case' 0 CA--C 1.485 -1.534 0 CA-C-O 121.594 0.711 . . . . 53.35 111.527 -177.241 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.85 140.42 32.92 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 114.355 -1.293 . . . . 75.42 108.109 -176.218 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.47 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 78.2 mt -78.86 113.43 35.28 Favored Pre-proline 0 C--N 1.299 -1.588 0 N-CA-C 108.215 -1.031 . . . . 64.43 108.215 -179.641 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.77 141.06 40.24 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 121.849 1.7 . . . . 63.22 110.936 178.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -92.0 127.09 37.33 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.935 -1.135 . . . . 70.32 107.935 176.315 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 90.6 t -121.73 150.03 24.99 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 N-CA-C 108.104 -1.072 . . . . 73.23 108.104 -176.054 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.512 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 19.4 m -55.3 144.84 23.56 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 123.818 0.699 . . . . 34.31 110.579 -179.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . 0.481 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 41.8 p -69.16 -25.77 64.53 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 113.341 0.867 . . . . 62.41 113.341 -169.386 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.435 ' H ' HD23 ' A' ' 435' ' ' LEU . 0.6 OUTLIER -90.16 -12.07 39.28 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 116.05 -0.523 . . . . 71.23 110.744 178.084 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.512 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 2.6 m -98.06 43.42 1.06 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.956 0.884 . . . . 74.13 109.176 -176.691 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -53.48 -38.93 64.12 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.351 1.061 . . . . 74.13 112.954 179.736 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -62.07 -40.51 96.04 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 121.537 0.684 . . . . 65.11 109.992 179.543 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.499 ' HB3' HG22 ' A' ' 436' ' ' THR . 40.9 tt0 -71.47 -34.06 69.87 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.862 -0.608 . . . . 64.41 111.199 177.154 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.477 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -59.35 -47.02 87.0 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.389 0.137 . . . . 71.14 110.833 -178.726 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 21.5 m -65.53 -36.98 78.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-O 121.337 0.589 . . . . 71.13 110.189 177.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -60.23 -47.25 86.79 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.803 0.841 . . . . 73.44 110.952 176.295 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -64.17 -38.79 92.33 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 123.663 0.785 . . . . 71.05 111.6 179.726 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 93.8 mt -63.93 -34.7 78.55 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.0 0.428 . . . . 60.42 109.988 175.619 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.451 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 43.8 m -70.16 -42.76 72.09 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.884 -0.598 . . . . 65.11 110.625 178.618 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.49 -23.09 65.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.364 0.602 . . . . 74.01 111.064 179.123 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.95 5.21 22.74 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.016 -0.538 . . . . 53.01 111.495 178.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 108.61 -84.15 0.36 Allowed Glycine 0 N--CA 1.435 -1.42 0 C-N-CA 120.429 -0.891 . . . . 61.34 112.072 175.552 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -37.08 -57.3 0.86 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.133 1.16 . . . . 73.11 114.133 179.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . 0.451 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 56.15 30.89 58.49 Favored Glycine 0 CA--C 1.505 -0.559 0 O-C-N 123.362 0.414 . . . . 64.11 113.347 179.44 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 61.3 mmt-85 -112.73 122.86 48.91 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 108.096 -1.076 . . . . 74.42 108.096 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 18.0 p90 -144.28 152.11 40.34 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.98 -0.554 . . . . 73.4 111.448 -174.632 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -131.72 138.58 48.71 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.565 -0.902 . . . . 63.44 108.565 175.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -98.08 121.08 39.56 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.628 -0.879 . . . . 63.41 108.628 176.598 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -116.98 148.55 41.34 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 107.881 -1.155 . . . . 72.33 107.881 178.011 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 -113.86 146.19 40.37 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 108.481 -0.933 . . . . 74.22 108.481 -176.477 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 26.9 t -143.92 134.46 12.17 Favored Pre-proline 0 C--N 1.294 -1.813 0 N-CA-C 108.645 -0.872 . . . . 72.0 108.645 175.296 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.64 ' HA ' ' O ' ' A' ' 490' ' ' SER . 68.1 Cg_endo -76.78 124.13 7.3 Favored 'Trans proline' 0 N--CA 1.439 -1.691 0 C-N-CA 121.898 1.732 . . . . 74.4 111.134 178.253 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 69.6 m -151.17 179.87 7.92 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.779 -0.646 . . . . 70.31 109.416 -178.738 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.9 t -46.77 139.22 6.67 Favored Pre-proline 0 C--O 1.25 1.114 0 C-N-CA 125.061 1.344 . . . . 72.23 112.684 178.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . 0.415 ' HA ' ' CG2' ' A' ' 464' ' ' VAL . 10.2 Cg_endo -51.61 -29.55 33.08 Favored 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 124.609 3.54 . . . . 63.43 113.567 -177.734 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -66.95 -24.51 66.07 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 120.959 0.409 . . . . 41.34 111.582 -178.603 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 91.1 mt -99.27 -13.47 19.66 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 120.707 0.289 . . . . 51.43 111.289 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.415 ' CG2' ' HA ' ' A' ' 461' ' ' PRO . 88.8 t -60.73 127.61 20.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.154 -0.475 . . . . 44.04 110.481 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.57 -11.7 71.5 Favored Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 116.083 -0.508 . . . . 73.54 112.175 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.97 159.42 16.56 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 107.577 -1.268 . . . . 74.11 107.577 179.37 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 76.1 t -75.45 146.97 8.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 106.998 -1.482 . . . . 71.42 106.998 173.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 61.3 mt -97.53 -29.82 3.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 107.557 -1.275 . . . . 64.31 107.557 177.33 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 158.8 -160.65 31.27 Favored Glycine 0 N--CA 1.423 -2.178 0 N-CA-C 111.014 -0.834 . . . . 43.14 111.014 176.163 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . 0.562 HG22 HG12 ' A' ' 486' ' ' ILE . 52.8 p -115.04 140.88 48.69 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 105.016 -2.216 . . . . 35.32 105.016 177.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -65.11 -54.6 32.42 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 119.135 -1.026 . . . . 73.34 110.03 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.84 135.03 29.24 Favored 'Trans proline' 0 C--N 1.368 1.594 0 N-CA-C 108.42 -1.416 . . . . 72.22 108.42 170.756 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.513 ' C ' ' H ' ' A' ' 475' ' ' ASN . 35.5 Cg_exo -62.3 141.82 88.97 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 122.177 1.918 . . . . 64.34 112.482 -177.054 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.47 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -75.16 22.86 0.11 Allowed 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 122.441 1.115 . . . . 72.35 110.792 178.812 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . 0.513 ' H ' ' C ' ' A' ' 473' ' ' PRO . 10.2 m120 -109.36 -17.65 13.75 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 114.293 -1.321 . . . . 61.33 108.25 179.342 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -95.78 165.6 12.22 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 113.226 0.824 . . . . 63.23 113.226 -172.603 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.7 113.46 26.97 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 113.944 -1.48 . . . . 71.31 108.203 -179.735 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 18.5 p -102.67 145.55 29.51 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 110.132 -0.321 . . . . 70.34 110.132 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -71.73 164.36 26.1 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.284 -0.416 . . . . 63.01 110.519 179.234 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 37.6 mm -74.78 -8.67 11.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 122.122 0.963 . . . . 50.31 110.745 -174.564 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.0 t -100.1 5.16 44.92 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.844 -0.616 . . . . 75.15 110.53 177.4 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -87.12 147.45 25.64 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 112.628 0.603 . . . . 44.15 112.628 -176.198 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 44.2 t -107.38 117.49 53.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 108.737 -0.838 . . . . 75.33 108.737 177.606 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 58.8 t -89.55 120.08 37.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-O 121.289 0.566 . . . . 63.24 109.772 -179.119 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.93 123.76 46.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 121.491 0.662 . . . . 73.3 110.006 179.104 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.562 HG12 HG22 ' A' ' 470' ' ' THR . 14.1 mt -113.59 128.28 70.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 114.766 -1.106 . . . . 72.1 110.547 -178.072 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 5.1 tt -103.89 126.41 58.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 115.386 -0.825 . . . . 64.22 110.816 -175.481 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 33.5 m -110.1 151.35 12.35 Favored 'Isoleucine or valine' 0 C--O 1.251 1.152 0 CA-C-N 115.824 -0.625 . . . . 73.41 109.714 178.658 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.78 132.19 10.92 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 120.65 -0.786 . . . . 71.12 112.156 -179.268 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.64 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 49.0 m . . . . . 0 C--N 1.3 -1.568 0 N-CA-C 107.267 -1.383 . . . . 54.34 107.267 176.392 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo . . . . . 0 C--O 1.244 0.778 0 N-CA-C 110.822 -0.491 . . . . 74.53 110.822 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -81.89 55.47 2.76 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.931 0.872 . . . . 73.33 110.963 -178.215 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 58.0 p -120.23 142.93 48.58 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.29 -1.004 . . . . 70.45 108.29 -179.066 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -130.48 152.78 49.5 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.798 0.332 . . . . 74.05 110.872 -179.873 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -83.88 115.9 22.5 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 124.007 0.923 . . . . 75.4 109.905 -176.485 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 543' ' ' THR . 38.0 pt -83.82 130.09 56.69 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 116.396 -0.365 . . . . 75.22 111.156 -178.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -83.26 -169.27 0.69 Allowed 'Trans proline' 0 C--O 1.239 0.534 0 C-N-CA 122.969 2.446 . . . . 65.52 112.165 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -78.49 138.59 38.51 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.804 -0.813 . . . . 72.44 108.804 177.301 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 14.7 p -126.92 -15.0 3.49 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-O 121.448 0.642 . . . . 74.14 110.737 -177.338 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -66.73 112.18 4.08 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.082 -0.71 . . . . 51.42 109.082 178.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 136.81 -25.54 3.07 Favored Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.901 -0.666 . . . . 62.35 111.715 -178.374 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -103.01 172.33 6.88 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 122.47 -0.429 . . . . 54.25 111.068 178.336 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 21.8 p -89.77 160.97 16.26 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 116.495 -0.32 . . . . 74.5 111.069 -176.654 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 532' ' ' GLY . 25.0 t -54.1 -42.08 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 123.645 0.59 . . . . 54.05 111.403 -177.13 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.67 -42.13 95.6 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.075 -0.511 . . . . 55.54 112.007 -178.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 67.2 t -71.35 -41.76 73.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 109.657 -0.498 . . . . 73.24 109.657 179.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -60.38 -49.64 76.78 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.254 -0.885 . . . . 72.34 111.645 -179.393 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -64.96 -35.66 81.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.712 0.292 . . . . 70.33 110.691 -178.387 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.478 ' O ' HG23 ' A' ' 514' ' ' VAL . 4.6 tppp? -64.84 -47.13 79.07 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.846 -0.615 . . . . 73.34 109.364 179.192 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -63.38 -48.15 79.12 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.882 -0.599 . . . . 73.12 111.952 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -61.77 -39.75 92.74 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 116.658 -0.246 . . . . 75.25 111.467 178.8 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.79 -37.79 85.65 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 120.682 0.277 . . . . 72.3 111.011 177.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 510' ' ' LYS . 73.3 t -62.34 -37.14 77.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.011 -0.541 . . . . 74.44 110.416 176.885 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -71.91 -23.57 61.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.906 0.384 . . . . 74.41 111.553 178.357 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 124.59 -12.69 7.84 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 120.394 -0.908 . . . . 74.33 112.317 178.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.46 ' HA ' ' O ' ' A' ' 547' ' ' VAL . 90.5 m-85 -80.44 101.17 8.88 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 107.591 -1.263 . . . . 74.2 107.591 -177.349 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.87 -8.89 27.33 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 120.058 -0.657 . . . . 73.21 112.413 -171.736 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . 0.501 ' O ' HD13 ' A' ' 551' ' ' ILE . 63.6 mttp -108.21 114.59 28.59 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.037 -0.665 . . . . 60.42 109.984 -178.037 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -131.01 140.34 50.11 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 116.01 -0.541 . . . . 73.23 111.218 -177.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 33.0 m -128.43 142.29 51.14 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.277 -1.379 . . . . 71.54 107.277 175.866 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.94 141.04 48.88 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.043 0.449 . . . . 63.13 111.091 179.778 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -135.43 128.51 31.65 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.894 -1.15 . . . . 45.23 107.894 178.045 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 70.2 m -93.74 134.07 36.46 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.096 0.475 . . . . 70.1 111.818 -177.463 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 557' ' ' LYS . 35.2 m -121.98 150.11 25.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 107.972 -1.121 . . . . 72.32 107.972 177.795 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . 0.414 ' HB2' HD21 ' A' ' 559' ' ' ASN . 4.8 p-10 -66.75 136.74 55.93 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.525 -0.47 . . . . 63.55 110.547 -179.226 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 20.2 m -149.93 169.1 9.71 Favored Pre-proline 0 C--N 1.307 -1.278 0 CA-C-N 116.049 -0.523 . . . . 42.35 109.985 -177.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -84.41 -25.46 2.08 Favored 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 121.892 1.728 . . . . 54.1 111.5 173.508 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.427 ' HD3' ' OE2' ' A' ' 533' ' ' GLU . 15.2 ptp180 -81.06 150.03 67.67 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 109.7 -0.481 . . . . 74.24 109.7 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.78 149.0 62.68 Favored 'Trans proline' 0 C--O 1.26 1.601 0 C-N-CA 123.82 3.014 . . . . 72.43 115.909 -175.206 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.666 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -62.87 121.2 12.91 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 113.914 -1.494 . . . . 74.11 110.701 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . 0.456 ' O ' HG23 ' A' ' 505' ' ' VAL . . . 130.69 -23.46 4.47 Favored Glycine 0 C--N 1.303 -1.25 0 C-N-CA 120.763 -0.732 . . . . 72.52 111.462 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . 0.427 ' OE2' ' HD3' ' A' ' 529' ' ' ARG . 29.2 tt0 -83.48 144.29 29.65 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.422 -0.584 . . . . 75.14 109.422 177.614 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 67.0 t -89.54 125.75 42.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 109.275 -0.639 . . . . 73.21 109.275 179.395 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . 0.586 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 14.4 t -100.84 -10.57 20.58 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-O 120.66 0.267 . . . . 52.41 111.611 -178.261 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 171.46 -175.41 44.98 Favored Glycine 0 CA--C 1.498 -0.984 0 C-N-CA 119.912 -1.137 . . . . 63.12 111.411 179.156 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . 0.401 HG22 HD23 ' A' ' 553' ' ' LEU . 8.1 p -139.29 157.97 44.98 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 117.168 0.484 . . . . 75.01 111.314 179.495 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.438 ' HB3' ' HB3' ' A' ' 552' ' ' GLU . 21.2 t-20 -64.01 -54.87 36.8 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-N 115.27 -0.877 . . . . 73.45 109.72 176.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -73.53 122.59 7.98 Favored 'Trans proline' 0 C--N 1.373 1.867 0 N-CA-C 108.014 -1.571 . . . . 70.2 108.014 169.127 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.17 141.13 61.92 Favored 'Trans proline' 0 C--O 1.254 1.317 0 C-N-CA 122.01 1.807 . . . . 53.24 112.519 -176.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -58.78 134.26 56.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.498 -0.774 . . . . 41.22 109.963 -179.191 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 102.73 -5.93 51.57 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 120.544 -0.836 . . . . 54.33 111.973 -177.639 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.501 ' O ' HG12 ' A' ' 497' ' ' ILE . 79.3 m -88.94 137.74 32.04 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.852 0.326 . . . . 64.44 110.794 177.134 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 17.9 m -89.27 122.73 32.81 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.03 -1.47 . . . . 64.15 107.03 173.461 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 16.1 m -131.73 156.15 80.48 Favored Pre-proline 0 C--N 1.313 -0.981 0 CA-C-O 119.423 -0.323 . . . . 73.5 110.56 -177.278 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -59.54 139.55 89.75 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 123.043 2.495 . . . . 75.23 111.774 178.645 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 517' ' ' PHE . 27.3 m -65.41 -21.31 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 113.487 0.921 . . . . 73.34 113.487 -175.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -87.15 -11.96 48.44 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.045 0.45 . . . . 74.11 111.108 178.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 73.7 m -69.88 155.11 41.04 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.61 0.719 . . . . 71.33 112.719 -177.375 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 27.3 t -88.79 125.97 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-N 114.884 -1.053 . . . . 44.22 110.065 -176.282 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . 0.501 HD13 ' O ' ' A' ' 519' ' ' LYS . 0.2 OUTLIER -102.39 129.03 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 119.684 -0.807 . . . . 74.25 109.228 174.228 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 521' ' ' SER . 38.1 tt0 -102.73 119.27 38.54 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 108.899 -0.778 . . . . 73.24 108.899 -179.427 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . 0.401 HD23 HG22 ' A' ' 537' ' ' THR . 47.6 mt -92.19 122.88 35.09 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.117 -0.947 . . . . 65.33 109.443 -179.107 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -85.93 112.71 21.43 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.782 -1.192 . . . . 73.24 107.782 171.78 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 42.8 t -95.64 140.16 17.56 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 CA-C-N 115.207 -0.906 . . . . 63.53 109.283 -176.505 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.666 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 66.5 m -76.17 141.33 41.89 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-O 121.448 0.642 . . . . 73.22 111.533 177.45 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 525' ' ' VAL . 16.7 ttmt -114.66 119.64 37.41 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 125.613 1.565 . . . . 71.1 107.003 173.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -74.74 -24.31 72.66 Favored Glycine 0 C--N 1.314 -0.662 0 C-N-CA 120.574 -0.822 . . . . 75.21 113.831 -174.072 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' A' ' 615' ' ' ASN . 48.5 m-80 74.53 18.14 2.92 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.069 1.348 . . . . 74.14 110.658 -178.539 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -131.89 141.19 49.3 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.566 -0.531 . . . . 71.0 109.566 -173.462 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -137.74 139.24 40.01 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 108.342 -0.984 . . . . 72.34 108.342 173.137 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 11.4 p -62.77 129.27 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 N-CA-C 113.3 0.852 . . . . 73.32 113.3 -173.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 57.2 ttp -97.56 128.94 32.88 Favored Pre-proline 0 C--O 1.254 1.328 0 CA-C-N 115.649 -0.705 . . . . 75.41 110.006 177.11 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.35 170.23 19.72 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.072 2.514 . . . . 62.22 112.048 176.224 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . 0.416 ' HB3' ' CB ' ' A' ' 610' ' ' ALA . 6.4 p-10 -86.34 122.37 30.21 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.424 0.63 . . . . 65.53 112.368 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.08 13.2 1.11 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 122.24 1.019 . . . . 71.12 109.423 174.102 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 1.8 m -72.57 153.19 41.41 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 114.588 -1.187 . . . . 62.32 111.355 -175.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 77.14 36.24 35.85 Favored Glycine 0 CA--C 1.519 0.297 0 N-CA-C 114.637 0.615 . . . . 74.14 114.637 174.667 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 25.1 ptm -129.12 174.67 9.35 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.421 -0.585 . . . . 73.4 109.421 -179.627 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 90.6 m-85 -79.63 144.34 33.88 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-O 120.881 0.372 . . . . 75.2 110.527 -174.856 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . 0.564 ' HA ' ' HB3' ' A' ' 574' ' ' ALA . 74.9 t-105 -67.76 -17.83 64.67 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.729 -0.668 . . . . 62.12 111.292 -174.574 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 30.1 m -68.24 -28.24 40.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.755 -0.657 . . . . 71.32 110.444 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . 0.596 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 26.0 m-20 -101.77 -34.21 9.53 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 115.904 -0.589 . . . . 63.33 109.966 176.33 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . 0.564 ' HB3' ' HA ' ' A' ' 571' ' ' TRP . . . -57.27 -46.8 82.74 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.942 1.09 . . . . 64.14 113.942 -175.663 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.543 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 5.9 tm-20 -59.14 -53.11 69.58 Favored Pre-proline 0 CA--C 1.566 1.566 0 N-CA-C 109.438 -0.579 . . . . 74.43 109.438 179.063 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . 0.543 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 79.6 Cg_exo -53.95 -38.06 86.18 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.329 2.019 . . . . 62.05 113.27 171.587 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.596 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 69.0 mmt-85 -58.92 -43.17 91.08 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 110.344 -0.243 . . . . 60.44 110.344 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.09 -42.31 99.58 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.959 -0.564 . . . . 63.4 109.938 -179.076 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -64.36 -41.12 96.89 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.753 -0.658 . . . . 74.14 110.554 178.178 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.18 -24.1 64.93 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.803 -0.635 . . . . 71.33 111.636 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 89.0 mt -83.82 -8.0 59.32 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.006 0.431 . . . . 61.41 110.16 176.789 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 86.02 20.74 54.8 Favored Glycine 0 N--CA 1.438 -1.23 0 C-N-CA 120.622 -0.799 . . . . 75.42 111.476 -179.244 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 86.9 t90 -88.09 127.88 35.41 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 121.077 0.465 . . . . 74.11 109.829 178.133 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 36.4 m -149.92 66.24 0.98 Allowed 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.608 -1.256 . . . . 61.21 107.608 170.777 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -103.44 -129.75 6.72 Favored Glycine 0 N--CA 1.434 -1.498 0 CA-C-N 114.627 -1.169 . . . . 53.41 110.189 179.414 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 24.5 ttt -121.03 126.8 50.82 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.49 -0.559 . . . . 63.43 109.49 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -103.58 131.14 50.97 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.16 -1.422 . . . . 74.22 107.16 177.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -94.56 108.46 20.41 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.82 -0.807 . . . . 64.11 108.82 177.321 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -89.61 113.16 24.56 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.594 -1.262 . . . . 72.45 107.594 179.509 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -83.23 -105.3 0.51 Allowed Glycine 0 N--CA 1.432 -1.595 0 C-N-CA 120.464 -0.874 . . . . 60.42 110.968 178.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.99 146.72 39.45 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.121 -1.437 . . . . 61.42 107.121 176.277 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -75.44 129.07 36.71 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.293 0.568 . . . . 63.23 109.816 -178.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 26.0 t -112.16 132.53 60.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 116.253 -0.43 . . . . 74.41 111.616 -172.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -76.13 107.21 8.2 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 106.734 -1.58 . . . . 72.3 106.734 171.291 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -111.82 -10.49 14.01 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 112.673 0.62 . . . . 74.45 112.673 -172.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 600' ' ' HIS . . . 127.16 170.67 12.91 Favored Glycine 0 CA--C 1.49 -1.516 0 N-CA-C 109.653 -1.379 . . . . 61.31 109.653 179.472 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -64.59 -50.5 58.7 Favored Glycine 0 C--N 1.316 -0.567 0 C-N-CA 119.478 -1.344 . . . . 63.34 112.531 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 10.4 p -70.44 -23.71 62.77 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 112.485 0.55 . . . . 55.13 112.485 -176.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -108.01 -0.72 21.11 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 118.709 -0.662 . . . . 73.33 112.619 -175.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . 0.482 ' HB3' ' O ' ' A' ' 596' ' ' GLY 0.289 25.1 p-80 -55.39 -74.69 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 114.675 1.361 . . . . 71.33 114.675 -169.473 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . 0.438 ' OD1' ' HB3' ' A' ' 571' ' ' TRP . 13.5 t-20 -97.13 71.14 2.41 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.247 -0.908 . . . . 75.3 108.965 -175.636 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 44.1 ttt180 -143.15 150.97 40.15 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.552 -0.749 . . . . 74.55 110.558 -173.62 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 93.0 t -66.78 132.46 32.13 Favored 'Isoleucine or valine' 0 C--O 1.246 0.921 0 N-CA-C 107.3 -1.37 . . . . 73.03 107.3 174.611 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 54.9 t -92.25 -52.96 9.32 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 N-CA-C 108.307 -0.997 . . . . 54.24 108.307 -172.408 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . 0.416 ' O ' ' HA ' ' A' ' 622' ' ' LEU . 45.1 p90 -156.08 160.39 39.92 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 107.297 -1.372 . . . . 71.02 107.297 177.422 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.54 140.18 52.29 Favored 'General case' 0 C--N 1.283 -2.296 0 O-C-N 124.364 1.04 . . . . 72.13 110.047 176.012 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.555 ' HB2' ' HB ' ' A' ' 621' ' ' THR . 25.6 t-20 -52.22 -55.27 32.92 Favored Pre-proline 0 CA--C 1.558 1.272 0 C-N-CA 124.611 1.165 . . . . 71.03 113.822 -177.721 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.554 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 9.4 Cg_endo -97.42 128.69 0.27 Allowed 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 122.176 1.918 . . . . 74.05 111.572 177.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.87 154.71 66.98 Favored 'Trans proline' 0 C--O 1.247 0.945 0 C-N-CA 121.661 1.574 . . . . 63.34 110.59 176.554 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . 0.416 ' CB ' ' HB3' ' A' ' 565' ' ' ASP . . . -53.44 130.29 35.03 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 123.184 0.594 . . . . 60.54 111.774 -178.379 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 97.79 -0.0 59.17 Favored Glycine 0 N--CA 1.432 -1.569 0 C-N-CA 119.875 -1.155 . . . . 72.41 112.379 -179.142 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 22.5 m -98.36 155.64 17.12 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.882 -1.155 . . . . 71.44 107.882 176.388 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -88.15 138.3 14.96 Favored Glycine 0 N--CA 1.412 -2.963 0 C-N-CA 120.871 -0.68 . . . . 43.51 111.956 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 18.7 m -104.09 143.59 15.6 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 C-N-CA 123.637 0.775 . . . . 63.22 109.918 176.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.635 HD21 HG22 ' A' ' 619' ' ' ILE . 1.9 p-10 -55.96 140.78 41.98 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 125.336 1.454 . . . . 75.21 111.347 178.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -50.63 -31.59 16.52 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 113.939 1.088 . . . . 75.13 113.939 -174.048 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -71.77 -23.86 61.66 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 120.829 0.347 . . . . 75.23 110.696 -177.417 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 86.09 19.52 57.25 Favored Glycine 0 N--CA 1.41 -3.079 0 C-N-CA 120.465 -0.874 . . . . 74.52 114.155 172.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . 0.635 HG22 HD21 ' A' ' 615' ' ' ASN . 0.2 OUTLIER -73.51 124.43 30.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 C-N-CA 116.823 -1.951 . . . . 73.22 108.94 176.198 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.447 ' N ' HD13 ' A' ' 619' ' ' ILE . 6.6 tp -120.05 128.87 75.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.5 -0.773 . . . . 53.12 109.423 -178.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.555 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 35.9 m -102.68 116.8 33.31 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 108.925 -0.768 . . . . 33.41 108.925 178.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 605' ' ' TYR . 3.9 pp -139.89 160.3 40.22 Favored 'General case' 0 CA--C 1.478 -1.814 0 N-CA-C 106.41 -1.7 . . . . 72.21 106.41 178.646 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -128.7 147.14 50.73 Favored 'General case' 0 C--N 1.259 -3.353 0 N-CA-C 106.394 -1.706 . . . . 74.3 106.394 179.598 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -128.62 165.25 21.17 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.347 -0.983 . . . . 74.51 108.347 176.119 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -92.95 -114.37 2.25 Favored Glycine 0 N--CA 1.413 -2.884 0 O-C-N 123.889 0.743 . . . . 72.33 112.748 -179.383 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . 0.469 HE21 ' HA ' ' A' ' 626' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.46 0 CA-C-O 118.876 -0.583 . . . . 74.12 110.822 -173.865 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 . . . . . 0 C--O 1.246 0.871 0 N-CA-C 108.54 -0.911 . . . . 52.23 108.54 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 30.3 m -119.56 151.83 22.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.517 -0.92 . . . . 63.34 108.517 -178.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -95.08 135.84 36.13 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 106.169 -1.789 . . . . 72.45 106.169 176.589 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.468 HG22 ' CZ ' ' A' ' 382' ' ' PHE . 59.4 t -97.39 132.06 26.1 Favored Pre-proline 0 C--N 1.286 -2.178 0 CA-C-N 115.987 -0.551 . . . . 65.13 110.826 -169.249 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 13.3 Cg_exo -66.56 134.03 34.11 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.17 1.913 . . . . 72.51 112.389 -179.301 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . 0.402 ' OD1' ' HG2' ' A' ' 366' ' ' ARG . 3.5 p30 -100.5 144.15 29.84 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.705 -1.22 . . . . 63.32 107.705 176.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 4.3 t -123.09 28.2 2.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 107.544 -1.28 . . . . 75.32 107.544 -179.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.52 ' HB3' HG23 ' A' ' 402' ' ' THR . 14.1 ptt180 -61.07 143.91 54.49 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.597 -1.183 . . . . 72.53 110.61 178.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.06 -13.89 55.74 Favored Glycine 0 N--CA 1.429 -1.779 0 CA-C-N 116.063 -0.517 . . . . 74.4 112.294 178.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -105.16 -87.29 0.45 Allowed 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 121.173 -0.211 . . . . 70.32 111.323 -178.722 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 89.5 p -156.32 160.67 39.93 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 108.227 -1.027 . . . . 63.05 108.227 179.557 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 1.4 p -63.49 -34.68 78.31 Favored 'General case' 0 N--CA 1.422 -1.847 0 O-C-N 123.498 0.499 . . . . 65.51 109.716 174.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.07 -46.37 89.4 Favored 'General case' 0 C--O 1.214 -0.771 0 CA-C-N 116.044 -0.525 . . . . 72.13 110.487 178.22 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -63.91 -41.91 97.56 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 120.826 0.346 . . . . 54.21 111.206 178.157 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -68.33 -45.6 72.48 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.237 -0.438 . . . . 64.31 111.356 -178.39 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 73.6 mt -65.9 -44.43 92.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.408 -0.36 . . . . 71.43 110.818 178.881 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.9 -43.89 91.1 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 120.922 0.392 . . . . 64.15 111.607 -177.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 38.9 m -64.29 -48.46 75.57 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.006 -0.543 . . . . 74.24 110.435 -178.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 10.8 mp -65.19 -37.92 88.84 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.163 -0.471 . . . . 61.4 111.862 178.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -61.11 -42.35 98.37 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.795 0.838 . . . . 75.12 109.867 178.541 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -66.2 -28.53 68.83 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.988 -0.551 . . . . 70.43 111.333 177.745 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -86.18 -14.41 44.1 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.907 0.384 . . . . 64.12 111.416 178.419 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 90.57 16.21 55.47 Favored Glycine 0 C--N 1.307 -1.076 0 C-N-CA 120.444 -0.884 . . . . 71.25 112.633 177.892 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.468 ' CZ ' HG22 ' A' ' 362' ' ' VAL . 26.1 m-85 -78.23 161.24 27.44 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-O 121.374 0.606 . . . . 52.23 111.542 178.02 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 48.5 mmtm -100.73 132.43 46.13 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 108.946 -0.761 . . . . 73.44 108.946 178.164 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . 0.423 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -118.0 154.8 19.98 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.721 0 N-CA-C 108.615 -0.883 . . . . 74.35 108.615 175.998 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -124.99 135.22 52.58 Favored 'General case' 0 C--N 1.265 -3.069 0 N-CA-C 106.182 -1.785 . . . . 73.24 106.182 177.508 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 31.1 m -119.04 117.58 29.14 Favored 'General case' 0 C--N 1.271 -2.841 0 N-CA-C 109.157 -0.683 . . . . 70.21 109.157 -177.383 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' A' ' 419' ' ' ASN . 2.9 tm? -116.07 127.58 54.99 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 106.292 -1.744 . . . . 74.14 106.292 179.479 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.488 HE21 ' N ' ' A' ' 388' ' ' GLN . 0.0 OUTLIER -114.22 147.5 38.84 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.997 -0.681 . . . . 74.42 111.439 -177.979 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -136.39 137.52 24.49 Favored Pre-proline 0 C--N 1.308 -1.234 0 N-CA-C 107.849 -1.167 . . . . 74.42 107.849 175.193 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -72.64 148.73 47.79 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 121.425 1.417 . . . . 74.0 109.505 172.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . 0.279 27.8 t70 -61.55 115.37 3.86 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 116.934 2.198 . . . . 45.53 116.934 -171.916 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . 0.453 ' O ' ' HB ' ' A' ' 393' ' ' THR . 3.2 p -143.75 65.89 1.3 Allowed 'General case' 0 N--CA 1.383 -3.778 0 CA-C-N 111.822 -2.444 . . . . 64.0 106.744 166.622 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.497 HG22 ' O ' ' A' ' 393' ' ' THR . 63.4 m 87.38 39.08 0.02 OUTLIER 'General case' 0 CA--C 1.571 1.771 0 CA-C-O 123.703 1.716 . . . . 64.42 111.471 176.545 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -117.14 149.51 44.48 Favored Pre-proline 0 C--N 1.291 -1.967 0 O-C-N 121.032 -1.042 . . . . 73.23 112.125 175.917 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.02 178.49 6.44 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.911 2.407 . . . . 71.13 111.131 -179.051 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -55.91 161.11 8.86 Favored 'Trans proline' 0 C--N 1.362 1.252 0 C-N-CA 122.765 2.31 . . . . 71.41 112.328 176.034 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . 0.433 ' HB2' HG13 ' A' ' 420' ' ' VAL . 5.4 p-10 -58.09 -8.35 1.04 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.953 1.301 . . . . 71.51 113.142 -178.815 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -74.25 172.05 12.52 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.285 -0.635 . . . . 74.14 109.285 -179.468 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 13.9 m -97.32 118.7 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.999 0 N-CA-C 108.417 -0.957 . . . . 71.34 108.417 176.677 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 2.2 mp -94.88 -32.05 4.46 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 107.592 -1.262 . . . . 70.02 107.592 178.345 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.88 170.85 27.75 Favored Glycine 0 N--CA 1.418 -2.536 0 N-CA-C 109.101 -1.599 . . . . 35.02 109.101 179.307 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . 0.52 HG23 ' HB3' ' A' ' 366' ' ' ARG . 2.5 p -129.34 -177.87 4.42 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 122.572 0.349 . . . . 75.34 110.443 -179.262 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -100.14 135.96 20.22 Favored Pre-proline 0 C--N 1.293 -1.866 0 N-CA-C 106.626 -1.62 . . . . 63.45 106.626 178.771 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -55.52 -12.18 5.77 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 124.034 3.156 . . . . 72.52 114.836 -175.469 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -53.88 -35.61 61.76 Favored 'General case' 0 C--O 1.212 -0.874 0 C-N-CA 122.899 0.48 . . . . 75.44 110.548 176.641 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.11 -39.51 68.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.338 0.589 . . . . 71.34 110.879 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -83.61 2.28 38.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.365 0.602 . . . . 72.3 110.639 -179.048 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 27.1 m -102.17 145.89 28.74 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 106.326 -1.731 . . . . 52.54 106.326 172.686 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 48.8 m -75.01 113.03 11.85 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 119.039 -1.064 . . . . 74.51 108.822 175.255 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.5 m -118.95 170.24 8.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.889 -0.596 . . . . 74.04 110.037 179.766 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 22.8 t -69.19 152.08 45.54 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.797 -0.445 . . . . 74.33 109.797 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -63.91 109.4 1.76 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.362 0.601 . . . . 74.41 111.185 -178.649 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 100.56 44.64 2.1 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 115.185 -0.916 . . . . 73.51 113.05 178.074 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -92.03 -174.21 3.71 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.984 -1.117 . . . . 62.44 107.984 178.456 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 44.8 mt-10 -109.16 133.0 53.58 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 121.53 0.681 . . . . 72.15 112.582 -177.624 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 44.6 mm -118.76 113.82 42.9 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 107.697 -1.223 . . . . 64.41 107.697 174.087 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 14.8 t -89.63 131.16 35.76 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.441 0.638 . . . . 73.14 111.274 -179.541 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 9.2 p -115.49 135.1 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 CA-C-N 115.329 -0.85 . . . . 42.33 109.562 -177.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . 0.493 ' HA ' ' O ' ' A' ' 387' ' ' LEU . 2.8 t-20 -97.74 116.0 29.09 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.887 -0.725 . . . . 63.34 109.339 176.236 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 98.4 t -102.44 136.0 36.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.109 -1.071 . . . . 60.05 108.109 179.232 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 15.8 m -99.09 135.05 41.05 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-O 121.543 0.687 . . . . 63.55 111.418 -178.847 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 17.6 p -105.95 160.06 15.56 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.492 -1.299 . . . . 71.52 107.492 172.409 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 1.999 0 N-CA-C 114.789 0.675 . . . . 45.35 114.789 -178.063 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 . . . . . 0 N--CA 1.423 -1.815 0 N-CA-C 106.975 -1.491 . . . . 74.41 106.975 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.5 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 4.2 mmp_? -122.35 147.37 46.34 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-O 120.797 0.332 . . . . 74.44 110.472 177.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -88.71 139.1 30.81 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 107.496 -1.298 . . . . 74.15 107.496 178.624 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 63.4 mt -80.43 118.99 75.01 Favored Pre-proline 0 N--CA 1.428 -1.536 0 N-CA-C 108.241 -1.022 . . . . 64.4 108.241 179.569 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -71.08 154.12 62.56 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 121.872 1.715 . . . . 75.2 110.549 177.409 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -77.4 89.43 3.79 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.53 0.681 . . . . 64.43 110.079 177.667 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 42.0 t -93.18 131.19 40.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 105.765 -1.939 . . . . 73.24 105.765 175.572 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.484 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 15.7 m -64.44 151.89 43.01 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 120.929 0.395 . . . . 52.35 111.197 -176.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 26.9 p -59.76 -33.41 71.64 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 123.427 0.691 . . . . 63.24 112.275 -176.621 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.496 ' HB3' ' HG3' ' A' ' 466' ' ' LYS . 1.9 pp -81.56 -11.23 59.23 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.465 0.65 . . . . 72.41 112.601 178.336 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.547 HG22 ' HB3' ' A' ' 439' ' ' GLU . 3.5 m -97.9 34.27 1.94 Allowed 'General case' 0 CA--C 1.564 1.509 0 N-CA-C 108.971 -0.752 . . . . 52.33 108.971 -178.703 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -51.41 -39.27 56.92 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.495 1.118 . . . . 71.4 113.391 179.745 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.1 -42.27 99.54 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-O 121.866 0.841 . . . . 72.33 110.268 -179.676 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.547 ' HB3' HG22 ' A' ' 436' ' ' THR . 26.8 tt0 -70.56 -33.96 71.69 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.451 -0.795 . . . . 71.21 109.468 178.691 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.621 ' O ' HD22 ' A' ' 444' ' ' LEU . . . -59.51 -50.19 74.89 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.378 -0.374 . . . . 72.01 110.961 -179.35 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.4 m -62.53 -38.61 81.88 Favored 'Isoleucine or valine' 0 C--O 1.257 1.46 0 N-CA-C 112.058 0.392 . . . . 74.44 112.058 179.637 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 442' ' ' LYS . 0.0 OUTLIER -68.0 -33.51 74.75 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 119.33 -0.948 . . . . 42.32 111.329 175.321 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -61.61 -42.96 99.61 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.368 -0.378 . . . . 62.32 111.262 175.559 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.621 HD22 ' O ' ' A' ' 440' ' ' ALA . 0.9 OUTLIER -63.79 -33.14 75.01 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 119.714 -0.794 . . . . 63.03 110.395 177.147 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 91.3 m -65.42 -44.02 88.69 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 116.174 -0.466 . . . . 74.43 110.456 177.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.76 -22.28 63.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.465 0.65 . . . . 44.31 110.979 179.225 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.69 5.46 13.26 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.64 -0.709 . . . . 61.5 112.182 -178.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 101.53 -73.79 0.36 Allowed Glycine 0 CA--C 1.493 -1.338 0 C-N-CA 119.977 -1.106 . . . . 61.4 112.232 174.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -47.83 -56.81 6.63 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 113.255 0.835 . . . . 73.44 113.255 178.041 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 61.97 25.43 66.04 Favored Glycine 0 CA--C 1.507 -0.418 0 C-N-CA 121.27 -0.49 . . . . 60.35 112.664 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -100.98 110.86 22.94 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.596 -1.261 . . . . 71.44 107.596 -177.628 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.612 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 32.3 p90 -139.12 151.33 46.58 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 120.731 0.301 . . . . 72.31 110.826 -179.194 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -131.25 130.2 42.56 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.435 -0.95 . . . . 71.41 108.435 177.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -97.62 123.16 41.42 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 123.649 0.593 . . . . 61.33 110.039 179.204 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.22 135.47 53.77 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 107.043 -1.466 . . . . 31.54 107.043 173.191 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -112.67 139.42 48.29 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.771 -0.825 . . . . 74.2 108.771 179.703 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . 0.488 ' O ' ' HA2' ' A' ' 489' ' ' GLY . 23.2 t -141.94 136.34 15.1 Favored Pre-proline 0 C--N 1.287 -2.118 0 N-CA-C 108.898 -0.778 . . . . 74.25 108.898 179.708 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.687 ' HA ' ' O ' ' A' ' 490' ' ' SER . 30.4 Cg_endo -65.8 131.35 27.18 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.169 1.913 . . . . 72.12 110.54 175.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 46.1 m -147.34 174.88 11.24 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 122.259 -0.276 . . . . 61.43 110.402 -177.491 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 3.9 t -50.66 142.98 15.16 Favored Pre-proline 0 N--CA 1.446 -0.658 0 C-N-CA 124.973 1.309 . . . . 74.42 111.716 176.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.54 -29.73 33.13 Favored 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 124.653 3.569 . . . . 74.51 113.153 -177.481 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -68.53 -35.06 76.94 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.379 -0.373 . . . . 72.52 111.197 179.29 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -96.18 -9.11 31.32 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 113.057 0.762 . . . . 51.33 113.057 -178.345 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 92.9 t -60.5 127.11 19.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.795 -0.817 . . . . 74.42 108.795 175.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.98 -1.43 67.92 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 111.788 -0.525 . . . . 65.52 111.788 -178.567 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.496 ' HG3' ' HB3' ' A' ' 435' ' ' LEU . 10.0 mptt -122.89 155.18 37.2 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-O 121.595 0.712 . . . . 74.02 111.336 -178.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 73.4 t -68.45 137.77 23.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 114.115 -1.402 . . . . 75.02 109.718 175.861 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 40.3 mm -97.95 -28.02 3.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 108.386 -0.968 . . . . 72.42 108.386 -179.811 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 168.36 164.43 24.04 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.238 -0.982 . . . . 60.34 113.088 177.556 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 1.1 t -116.96 142.8 46.47 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 107.468 -1.308 . . . . 75.13 107.468 176.369 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.423 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 3.3 t-20 -70.65 -53.14 9.81 Favored Pre-proline 0 C--N 1.321 -0.642 0 C-N-CA 119.493 -0.883 . . . . 73.2 111.242 177.457 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.465 ' HG2' ' HA ' ' A' ' 484' ' ' VAL . 27.6 Cg_exo -65.95 134.79 38.52 Favored 'Trans proline' 0 C--N 1.368 1.589 0 N-CA-C 108.269 -1.473 . . . . 74.31 108.269 171.58 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 472' ' ' PRO . 21.0 Cg_exo -62.48 127.6 21.29 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.213 1.942 . . . . 72.42 111.791 -176.823 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -71.43 2.17 5.33 Favored 'General case' 0 C--O 1.209 -1.058 0 CA-C-N 115.816 -0.629 . . . . 72.43 112.578 -177.401 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -108.89 -12.96 14.83 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.164 0.507 . . . . 75.14 111.402 179.283 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -102.26 173.05 6.54 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.235 0.54 . . . . 74.2 112.02 -172.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 1.3 m -91.69 119.92 31.98 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 115.277 -0.874 . . . . 62.33 108.902 -177.646 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 13.1 p -102.46 145.96 28.8 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.148 0.499 . . . . 63.43 110.925 -177.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -80.38 154.16 27.89 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.909 -0.587 . . . . 73.13 111.376 -176.252 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 23.1 mm -74.02 -6.19 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 CA-C-O 122.154 0.978 . . . . 72.12 110.498 -177.793 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 6.4 p -108.48 5.42 25.22 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.488 0.661 . . . . 51.3 111.156 177.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -97.36 150.59 20.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.52 -0.764 . . . . 71.41 111.251 -173.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 59.8 t -108.14 126.4 64.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 123.667 0.787 . . . . 63.33 110.452 -177.054 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.612 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 61.0 t -101.03 120.03 49.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 120.892 0.377 . . . . 74.44 110.361 -179.985 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.98 126.03 59.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 109.022 -0.732 . . . . 72.31 109.022 177.525 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 16.8 mt -120.55 128.35 76.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 114.749 -1.114 . . . . 64.15 111.506 -177.132 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 6.9 tt -103.62 126.95 58.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 115.481 -0.781 . . . . 73.12 109.849 177.795 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 2.4 p -119.02 139.04 47.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 123.39 0.676 . . . . 74.11 110.076 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 457' ' ' SER . . . -77.08 127.64 8.55 Favored Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 111.034 -0.827 . . . . 72.42 111.034 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.687 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 23.0 t . . . . . 0 C--N 1.301 -1.513 0 N-CA-C 108.05 -1.093 . . . . 71.35 108.05 -178.289 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo . . . . . 0 N--CA 1.444 -1.403 0 CA-C-O 121.283 0.451 . . . . 43.21 112.312 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -96.7 24.28 6.19 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 122.655 1.217 . . . . 65.11 108.601 178.012 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 546' ' ' PRO . 18.7 p -117.07 149.25 40.6 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 112.615 -2.084 . . . . 72.24 109.296 -175.805 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . 0.4 ' HD2' ' O ' ' A' ' 515' ' ' TYR . 64.9 mttm -137.01 147.71 46.41 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.263 -0.643 . . . . 61.25 109.263 174.873 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 6.3 p-10 -80.7 129.92 34.8 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 124.014 0.821 . . . . 72.54 109.418 179.071 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 543' ' ' THR . 36.3 pt -87.19 131.31 44.87 Favored Pre-proline 0 C--N 1.295 -1.762 0 CA-C-N 115.825 -0.625 . . . . 75.3 110.506 179.391 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.56 -172.34 1.46 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.216 1.944 . . . . 73.15 109.377 173.302 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -82.01 149.47 28.11 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.4 -1.334 . . . . 71.51 107.4 176.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.56 85.98 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 CA-C-O 122.59 1.186 . . . . 73.15 108.94 177.111 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -149.86 128.54 12.4 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 114.218 -1.355 . . . . 72.14 108.876 -178.038 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 122.77 -20.8 7.66 Favored Glycine 0 N--CA 1.435 -1.429 0 C-N-CA 120.246 -0.978 . . . . 73.21 111.673 177.354 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.87 177.39 4.86 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 120.952 0.406 . . . . 63.25 110.843 178.619 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 9.4 t -87.95 157.88 18.82 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.102 -0.703 . . . . 61.14 109.102 -178.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.3 p -50.6 -41.63 20.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 124.317 1.047 . . . . 73.11 112.043 -179.181 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -61.74 -41.53 97.79 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.043 0.386 . . . . 74.41 112.043 179.129 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 89.6 t -71.21 -42.43 75.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-O 121.243 0.544 . . . . 65.55 109.891 179.084 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -60.41 -42.45 96.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.489 -0.778 . . . . 53.12 110.633 179.143 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -59.41 -46.22 89.33 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.27 -0.877 . . . . 54.33 109.953 179.673 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.425 ' O ' HG23 ' A' ' 514' ' ' VAL . 2.8 tmmm? -60.49 -44.3 96.09 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.163 -0.926 . . . . 71.43 108.904 -179.09 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -61.97 -48.09 81.91 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 116.117 -0.492 . . . . 70.3 111.035 -179.407 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.93 -38.89 92.76 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 111.804 0.298 . . . . 75.35 111.804 179.402 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . 0.406 HD22 ' HA ' ' A' ' 513' ' ' ASN . 10.7 m120 -63.14 -38.17 90.12 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 121.232 -0.187 . . . . 73.33 110.939 179.014 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 510' ' ' LYS . 72.2 t -61.17 -35.46 65.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.027 0.441 . . . . 72.5 110.648 176.605 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . 0.4 ' O ' ' HD2' ' A' ' 495' ' ' LYS . 22.8 m-85 -79.06 -4.53 50.67 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 120.886 0.374 . . . . 75.52 110.99 -178.631 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 97.62 3.12 58.48 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 120.653 -0.784 . . . . 35.13 112.685 177.021 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.497 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 85.2 m-85 -86.44 115.24 23.82 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 108.032 -1.099 . . . . 73.53 108.032 -178.881 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.4 m -114.77 11.26 16.74 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 119.489 -0.884 . . . . 72.0 111.166 -176.27 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . 0.409 ' HB3' HG22 ' A' ' 550' ' ' VAL . 67.7 mttm -129.41 114.23 15.9 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.279 -0.637 . . . . 72.41 109.279 176.249 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -130.86 150.54 51.97 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 115.645 -0.707 . . . . 74.34 110.075 178.743 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 68.9 m -126.73 146.76 50.1 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 107.174 -1.417 . . . . 74.22 107.174 172.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -117.94 129.37 55.57 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 120.251 -0.58 . . . . 73.24 109.956 -179.392 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -105.33 115.99 31.19 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 106.867 -1.531 . . . . 71.35 106.867 175.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 19.4 m -88.89 114.74 25.84 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 121.676 0.751 . . . . 61.21 110.602 -176.509 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 28.1 m -121.47 168.83 13.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-N 114.464 -1.244 . . . . 75.33 108.232 -178.014 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . 0.544 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 7.0 p-10 -103.74 149.65 24.8 Favored 'General case' 0 C--N 1.282 -2.336 0 C-N-CA 120.049 -0.66 . . . . 73.11 111.748 -177.778 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 19.8 m -149.44 178.13 1.58 Allowed Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 105.286 -2.116 . . . . 72.44 105.286 177.012 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -87.65 -12.44 4.46 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 121.29 1.327 . . . . 73.53 111.523 172.168 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.4 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 35.5 mtp85 -87.01 148.42 45.25 Favored Pre-proline 0 N--CA 1.428 -1.546 0 C-N-CA 123.484 0.714 . . . . 72.41 109.332 179.033 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -56.14 148.47 59.28 Favored 'Trans proline' 0 C--O 1.259 1.556 0 C-N-CA 124.019 3.146 . . . . 74.34 117.13 -170.598 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.56 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -61.2 137.39 58.24 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 113.367 -1.742 . . . . 73.43 111.054 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 108.9 -17.95 32.0 Favored Glycine 0 N--CA 1.429 -1.828 0 N-CA-C 110.895 -0.882 . . . . 53.35 110.895 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -80.38 136.63 36.41 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 109.731 -0.47 . . . . 74.21 109.731 178.314 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 60.0 t -86.14 120.74 36.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.037 -1.097 . . . . 53.3 108.037 178.329 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . 0.509 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 9.7 t -92.91 -1.97 56.25 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.946 -0.57 . . . . 73.45 110.78 -176.882 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 144.27 -167.19 26.99 Favored Glycine 0 CA--C 1.496 -1.095 0 N-CA-C 111.216 -0.754 . . . . 73.33 111.216 176.238 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 12.6 p -118.55 160.1 22.37 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 117.398 0.599 . . . . 61.05 110.288 176.036 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.454 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 35.4 t30 -71.2 -51.64 10.05 Favored Pre-proline 0 C--N 1.31 -1.144 0 CA-C-N 116.244 -0.434 . . . . 71.12 110.104 175.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.454 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 14.0 Cg_exo -72.59 135.87 24.84 Favored 'Trans proline' 0 C--N 1.38 2.208 0 N-CA-C 109.134 -1.141 . . . . 75.0 109.134 171.287 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.69 154.51 67.92 Favored 'Trans proline' 0 C--O 1.254 1.285 0 C-N-CA 122.364 2.042 . . . . 74.23 113.415 -177.094 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.06 138.11 58.21 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.429 -0.805 . . . . 73.22 110.163 178.747 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.56 -20.4 34.63 Favored Glycine 0 C--N 1.305 -1.174 0 N-CA-C 111.755 -0.538 . . . . 75.53 111.755 -179.362 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.428 ' O ' HG12 ' A' ' 497' ' ' ILE . 25.6 m -70.63 133.39 46.64 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.34 -0.245 . . . . 75.31 110.34 -178.443 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 15.0 t -98.12 129.58 44.92 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 109.083 -0.71 . . . . 72.22 109.083 177.037 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 7.1 m -136.43 154.4 76.91 Favored Pre-proline 0 C--N 1.297 -1.675 0 CA-C-N 115.668 -0.696 . . . . 63.21 109.218 179.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 494' ' ' THR . 26.9 Cg_exo -64.57 139.01 62.02 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.435 2.09 . . . . 64.23 111.244 178.414 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.497 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 35.3 m -63.85 -20.87 27.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 113.313 0.857 . . . . 74.22 113.313 -175.643 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -94.43 4.03 54.39 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.848 0.832 . . . . 44.44 110.508 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 39.4 m -93.54 179.49 5.37 Favored 'General case' 0 N--CA 1.437 -1.101 0 O-C-N 121.911 -0.493 . . . . 74.53 110.524 178.606 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.409 HG22 ' HB3' ' A' ' 519' ' ' LYS . 19.8 t -106.83 131.6 56.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 116.468 -0.333 . . . . 74.42 111.078 -174.117 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . 0.503 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -114.44 136.69 50.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 108.396 -0.964 . . . . 54.11 108.396 172.164 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -103.68 124.14 48.3 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 121.421 0.629 . . . . 53.23 111.726 -178.622 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.3 mp -97.37 134.77 40.2 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.681 -1.145 . . . . 70.33 110.014 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . 0.474 ' HA ' HE21 ' A' ' 554' ' ' GLN . 0.0 OUTLIER -86.97 119.06 26.78 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.505 -1.665 . . . . 73.23 106.505 177.313 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 59.6 t -114.41 131.07 67.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.793 -0.567 . . . . 53.0 109.866 -178.13 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.56 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 69.8 m -81.35 157.89 24.88 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 113.407 0.892 . . . . 73.02 113.407 -178.242 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.544 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 14.2 ptpt -119.08 158.34 26.06 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 105.326 -2.102 . . . . 74.5 105.326 167.519 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -75.03 -42.65 29.01 Favored Glycine 0 CA--C 1.485 -1.808 0 C-N-CA 119.949 -1.12 . . . . 63.23 112.432 -174.597 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 55.7 t30 67.35 -12.4 0.26 Allowed 'General case' 0 CA--C 1.569 1.696 0 C-N-CA 124.186 0.994 . . . . 74.43 112.759 173.48 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.477 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 71.3 mt-30 -136.63 160.73 37.92 Favored 'General case' 0 C--O 1.253 1.289 0 C-N-CA 125.859 1.663 . . . . 72.24 107.505 176.373 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -138.92 136.6 35.65 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 110.117 -0.327 . . . . 65.02 110.117 176.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 8.3 p -59.89 121.68 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 121.599 0.714 . . . . 74.43 112.176 -178.013 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 21.4 ptm -87.6 147.05 40.72 Favored Pre-proline 0 C--O 1.252 1.211 0 CA-C-N 115.654 -0.703 . . . . 73.05 112.803 -175.085 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.69 170.78 19.56 Favored 'Trans proline' 0 CA--C 1.551 1.329 0 C-N-CA 124.566 3.511 . . . . 64.42 112.902 175.457 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.5 124.07 28.62 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.995 -0.548 . . . . 75.21 112.15 177.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -112.61 -3.31 14.35 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 122.045 0.926 . . . . 71.24 108.815 174.398 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 11.1 m -68.24 137.53 54.83 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.103 -1.408 . . . . 72.12 111.455 -177.587 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 80.4 30.92 39.15 Favored Glycine 0 N--CA 1.438 -1.203 0 C-N-CA 121.103 -0.57 . . . . 62.11 112.019 176.338 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 64.6 mtt -137.3 173.23 11.9 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.899 -0.778 . . . . 74.21 108.899 -178.677 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . 0.495 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 89.0 m-85 -100.28 166.26 11.07 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 109.29 -0.633 . . . . 75.12 109.29 179.252 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 69.9 t90 -67.73 -28.47 67.67 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.327 -0.619 . . . . 71.11 109.327 178.059 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 10.2 p -68.56 -10.02 12.41 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 CA-C-N 115.63 -0.713 . . . . 72.45 110.409 176.739 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . 0.454 ' O ' ' HG3' ' A' ' 577' ' ' ARG . 38.0 m-20 -100.59 -44.51 5.82 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 108.163 -1.051 . . . . 73.23 108.163 173.611 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . 0.461 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -59.35 -51.74 68.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.112 -0.949 . . . . 65.11 112.564 -177.33 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.573 ' OE2' ' HD3' ' A' ' 579' ' ' ARG . 21.0 tp10 -52.95 -56.77 20.27 Favored Pre-proline 0 CA--C 1.562 1.431 0 CA-C-O 119.02 -0.514 . . . . 73.34 112.09 -179.666 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . 0.446 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 53.5 Cg_exo -57.77 -38.16 93.91 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.126 1.884 . . . . 74.23 112.595 176.332 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 573' ' ' ASP . 80.8 mtp180 -65.79 -36.85 84.69 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 120.864 -0.335 . . . . 74.34 111.332 -179.558 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 96.1 mt -63.36 -38.77 92.45 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.128 0.49 . . . . 73.51 109.797 178.192 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . 0.573 ' HD3' ' OE2' ' A' ' 575' ' ' GLU . 7.0 mmm180 -65.3 -45.79 82.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.509 -0.769 . . . . 74.13 108.941 179.562 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.22 -29.81 70.14 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.369 -0.832 . . . . 70.41 112.213 -178.318 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 95.5 mt -81.59 -6.3 58.86 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.843 0.354 . . . . 74.02 110.833 178.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 72.87 35.77 58.08 Favored Glycine 0 N--CA 1.439 -1.114 0 N-CA-C 111.456 -0.657 . . . . 54.3 111.456 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . 0.405 ' CH2' ' HB2' ' A' ' 587' ' ' LEU . 79.1 t90 -76.22 128.65 35.35 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.782 -0.451 . . . . 74.12 109.782 -179.79 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 17.6 m -150.54 86.56 1.4 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.899 -0.778 . . . . 62.24 108.899 174.106 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -147.73 -142.92 3.74 Favored Glycine 0 C--N 1.309 -0.943 0 N-CA-C 110.244 -1.142 . . . . 63.24 110.244 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 47.7 tpp -96.51 125.21 40.84 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 117.538 0.669 . . . . 70.45 110.964 177.409 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . 0.405 ' HB2' ' CH2' ' A' ' 583' ' ' TRP . 3.4 tm? -96.23 128.96 43.62 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.54 -1.652 . . . . 71.05 106.54 175.434 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -94.99 123.26 38.37 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 105.241 -2.133 . . . . 65.11 105.241 178.439 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -85.52 121.42 28.2 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 113.251 0.834 . . . . 73.23 113.251 -162.483 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -105.47 144.0 15.74 Favored Glycine 0 N--CA 1.407 -3.237 0 N-CA-C 107.875 -2.09 . . . . 63.44 107.875 171.3 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -94.21 150.93 19.85 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 117.072 0.436 . . . . 75.33 110.018 -179.251 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -73.44 124.8 26.51 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.314 -1.365 . . . . 75.24 107.314 173.271 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 41.1 t -105.94 123.35 60.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 CA-C-N 116.188 -0.46 . . . . 73.51 111.367 -175.235 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . 0.446 ' HA ' ' HB2' ' A' ' 626' ' ' GLN . 6.3 p-10 -81.32 107.8 14.41 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.477 -1.305 . . . . 75.42 107.477 173.938 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -136.08 21.1 3.24 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.615 -0.72 . . . . 73.24 109.725 -177.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 101.18 173.46 28.75 Favored Glycine 0 N--CA 1.427 -1.914 0 C-N-CA 120.267 -0.968 . . . . 33.04 110.812 -177.505 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -62.18 -33.42 85.84 Favored Glycine 0 C--O 1.218 -0.865 0 N-CA-C 114.188 0.435 . . . . 53.33 114.188 -175.093 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 13.7 m -58.31 -24.44 59.64 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 113.806 1.039 . . . . 52.0 113.806 -175.828 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -98.49 -0.31 43.63 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 113.343 0.868 . . . . 74.45 113.343 -175.339 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . 0.476 ' HA ' ' OXT' ' A' ' 626' ' ' GLN . 5.7 p80 -35.46 98.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 115.682 1.734 . . . . 65.44 115.682 -174.264 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 52.95 10.29 0.15 Allowed 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 126.075 1.75 . . . . 63.22 115.381 172.09 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 38.4 ttt180 -79.83 143.34 34.46 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.945 -1.097 . . . . 71.35 110.945 -175.408 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 87.9 t -74.58 131.0 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 108.224 -1.028 . . . . 71.03 108.224 179.818 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 46.5 t -94.04 -48.09 13.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.332 0.587 . . . . 74.34 110.248 -175.345 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -148.34 151.19 34.93 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.635 -0.711 . . . . 63.41 110.049 179.099 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . 0.461 ' HA ' ' O ' ' A' ' 621' ' ' THR . 14.4 pt20 -115.57 141.7 47.71 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.869 -1.16 . . . . 71.14 107.869 174.372 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.612 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 17.0 t-20 -51.35 -57.16 15.16 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 123.66 0.6 . . . . 74.31 112.274 -175.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.612 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 9.6 Cg_endo -100.01 138.66 0.27 Allowed 'Trans proline' 0 N--CA 1.433 -2.069 0 C-N-CA 121.742 1.628 . . . . 73.14 110.096 172.271 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -70.13 147.14 59.82 Favored 'Trans proline' 0 C--O 1.252 1.177 0 C-N-CA 121.313 1.342 . . . . 53.05 109.918 175.753 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -62.37 138.98 58.55 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.886 0.375 . . . . 52.54 110.551 -178.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.16 -8.21 44.84 Favored Glycine 0 N--CA 1.431 -1.649 0 N-CA-C 110.598 -1.001 . . . . 61.15 110.598 -175.032 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 6.1 m -100.83 157.29 16.83 Favored 'General case' 0 C--O 1.249 1.066 0 N-CA-C 108.384 -0.969 . . . . 63.23 108.384 178.174 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -85.69 132.18 10.95 Favored Glycine 0 N--CA 1.428 -1.867 0 N-CA-C 111.227 -0.749 . . . . 55.31 111.227 178.35 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 21.8 m -97.43 142.47 14.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 110.055 -0.35 . . . . 70.43 110.055 178.166 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.477 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 30.1 p-10 -57.05 167.13 0.88 Allowed 'General case' 0 N--CA 1.436 -1.164 0 O-C-N 124.476 1.11 . . . . 74.04 112.478 -178.821 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -61.02 -25.33 66.83 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.832 -1.077 . . . . 63.04 111.847 -178.035 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -78.44 -37.04 44.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.445 -0.343 . . . . 65.24 110.536 176.298 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 90.5 22.4 34.45 Favored Glycine 0 C--O 1.211 -1.307 0 C-N-CA 119.254 -1.451 . . . . 31.42 112.444 179.153 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.82 123.14 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 CA-C-O 122.63 1.205 . . . . 62.41 110.819 -168.754 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 6.3 tp -129.34 132.37 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 113.839 -1.528 . . . . 71.44 111.256 -174.085 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 606' ' ' GLN . 44.2 m -104.45 137.27 42.57 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 107.971 -1.122 . . . . 71.02 107.971 174.629 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 88.7 mt -138.15 157.01 47.16 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.243 -1.391 . . . . 63.42 107.243 178.638 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -144.25 136.6 26.59 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 104.178 -2.527 . . . . 64.34 104.178 177.063 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 602' ' ' ARG . 6.8 p90 -143.06 161.65 37.6 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 123.658 0.599 . . . . 71.4 111.526 -177.463 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -88.18 -163.62 39.4 Favored Glycine 0 N--CA 1.426 -2.004 0 C-N-CA 120.836 -0.697 . . . . 41.13 111.797 177.648 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . 0.476 ' OXT' ' HA ' ' A' ' 600' ' ' HIS . 8.7 tp-100 . . . . . 0 C--N 1.303 -1.444 0 C-N-CA 123.166 0.586 . . . . 72.34 110.352 -177.72 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 CA--C 1.506 -0.736 0 CA-C-O 121.07 0.462 . . . . 72.44 109.944 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 409' ' ' SER . 35.9 m -120.73 163.06 18.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 115.724 -0.671 . . . . 64.32 109.411 -175.475 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -94.05 136.94 33.8 Favored 'General case' 0 N--CA 1.39 -3.45 0 N-CA-C 108.733 -0.84 . . . . 52.31 108.733 176.103 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 94.7 t -97.8 129.28 31.67 Favored Pre-proline 0 C--N 1.269 -2.908 0 CA-C-N 114.289 -1.323 . . . . 62.43 109.566 -173.521 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -65.33 120.3 7.48 Favored 'Trans proline' 0 N--CA 1.443 -1.489 0 C-N-CA 121.769 1.646 . . . . 73.33 110.37 176.905 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -97.03 83.17 3.31 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 106.981 -1.488 . . . . 73.42 106.981 -175.473 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.487 ' HB ' ' NE2' ' A' ' 368' ' ' GLN . 30.2 m -71.65 34.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 125.997 1.719 . . . . 73.34 115.053 -171.748 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.431 ' HG3' ' OG1' ' A' ' 402' ' ' THR . 21.0 mmt180 -65.41 148.38 51.81 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 125.315 1.446 . . . . 71.34 111.795 177.377 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 106.47 0.67 37.52 Favored Glycine 0 CA--C 1.501 -0.791 0 N-CA-C 111.028 -0.829 . . . . 65.32 111.028 -175.704 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . 0.487 ' NE2' ' HB ' ' A' ' 365' ' ' VAL . 41.8 mt-30 -111.03 -154.53 0.54 Allowed 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 108.392 -0.966 . . . . 70.41 108.392 175.025 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 61.8 p -96.26 168.24 10.7 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 109.765 -0.457 . . . . 74.54 109.765 -176.701 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.88 -46.99 85.25 Favored 'General case' 0 N--CA 1.421 -1.918 0 CA-C-N 115.339 -0.846 . . . . 54.04 109.329 179.706 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.38 -44.83 82.04 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.701 -0.681 . . . . 71.2 112.411 -176.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -66.94 -47.2 72.39 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.885 0.374 . . . . 61.54 110.097 -177.144 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -67.35 -41.12 85.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.87 -0.604 . . . . 73.02 111.873 -177.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 66.5 mt -68.09 -39.8 81.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 116.692 -0.231 . . . . 71.33 110.399 177.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.16 -38.65 89.85 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 120.799 0.333 . . . . 50.13 110.34 179.61 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . 0.608 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 52.0 m -63.14 -47.9 80.75 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.725 -0.67 . . . . 71.54 110.199 179.307 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 98.2 mt -64.01 -42.33 97.18 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 116.33 -0.396 . . . . 74.22 110.506 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . 0.475 HE21 ' HA ' ' A' ' 378' ' ' GLN . 0.1 OUTLIER -64.21 -41.67 96.95 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.967 -0.561 . . . . 72.1 109.758 179.826 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -69.82 -17.64 63.41 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 112.969 0.729 . . . . 75.1 112.969 177.404 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . 0.608 ' HG2' ' O ' ' A' ' 376' ' ' THR . 6.9 mmp_? -88.78 -10.8 46.89 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.653 -0.499 . . . . 73.11 109.653 175.468 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.48 2.9 55.51 Favored Glycine 0 C--N 1.32 -0.36 0 CA-C-N 115.948 -0.569 . . . . 65.3 112.786 178.157 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -82.62 154.23 25.04 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-O 121.254 0.55 . . . . 33.44 111.895 -177.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -101.26 145.8 28.38 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.224 -1.399 . . . . 75.14 107.224 179.8 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 1.1 mp -129.38 144.01 39.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.171 -1.048 . . . . 71.31 108.171 179.252 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 385' ' ' ARG . 13.9 ttm180 -110.56 127.87 55.4 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 105.714 -1.958 . . . . 72.32 105.714 174.203 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 23.7 m -114.04 117.41 31.22 Favored 'General case' 0 C--N 1.271 -2.827 0 N-CA-C 108.074 -1.084 . . . . 74.4 108.074 -178.828 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.55 128.77 56.56 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.361 -0.977 . . . . 53.32 108.361 -177.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.405 ' HB3' ' OG1' ' A' ' 422' ' ' THR . 1.7 mp0 -99.78 127.94 45.9 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.666 -0.494 . . . . 73.11 109.666 -178.507 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 421' ' ' SER . 98.0 mttt -132.74 123.35 18.23 Favored Pre-proline 0 C--N 1.313 -1.017 0 N-CA-C 111.781 0.289 . . . . 73.34 111.781 178.61 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 389' ' ' LYS . 4.2 Cg_exo -82.69 128.09 5.16 Favored 'Trans proline' 0 C--O 1.254 1.288 0 C-N-CA 121.865 1.71 . . . . 72.21 109.032 171.779 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.563 ' HB3' ' CD1' ' A' ' 394' ' ' ILE . 10.2 t70 171.95 -162.17 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 105.174 -2.158 . . . . 63.5 105.174 -174.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 36.1 p -141.57 2.3 1.61 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.171 0.51 . . . . 61.5 111.186 178.157 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 25.6 m -98.92 -25.99 14.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.395 0.617 . . . . 75.52 111.381 -175.011 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.563 ' CD1' ' HB3' ' A' ' 391' ' ' ASP . 0.2 OUTLIER -88.53 152.29 49.31 Favored Pre-proline 0 C--N 1.298 -1.636 0 CA-C-N 116.075 -0.511 . . . . 72.34 109.911 -178.167 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . 0.428 ' HB3' HG22 ' A' ' 400' ' ' ILE . 7.6 Cg_exo -35.59 150.71 0.03 OUTLIER 'Trans proline' 0 CA--C 1.553 1.453 1 C-N-CA 125.468 4.112 . . . . 74.15 116.924 177.631 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.72 162.58 10.46 Favored 'Trans proline' 0 C--N 1.364 1.388 0 C-N-CA 124.147 3.231 . . . . 64.22 110.619 172.088 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . 0.548 ' HA ' HG13 ' A' ' 420' ' ' VAL . 0.9 OUTLIER -59.12 -9.69 2.22 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 113.181 0.808 . . . . 72.43 113.181 -176.232 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -95.06 -178.82 4.61 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 108.77 -0.826 . . . . 72.32 108.77 178.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 27.6 m -97.73 117.46 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.825 0 C-N-CA 117.065 -1.854 . . . . 72.01 110.575 179.597 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . 0.428 HG22 ' HB3' ' A' ' 395' ' ' PRO . 0.0 OUTLIER -107.89 -47.4 7.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 109.44 -0.578 . . . . 71.23 109.44 175.337 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.75 169.19 27.94 Favored Glycine 0 N--CA 1.427 -1.947 0 N-CA-C 111.141 -0.784 . . . . 60.01 111.141 -177.5 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . 0.431 ' OG1' ' HG3' ' A' ' 366' ' ' ARG . 0.6 OUTLIER -155.67 -176.08 5.77 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 125.479 1.511 . . . . 54.23 109.935 -176.911 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -99.0 155.41 36.6 Favored Pre-proline 0 C--N 1.299 -1.61 0 N-CA-C 106.605 -1.628 . . . . 54.34 106.605 -178.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -59.93 10.56 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 124.575 3.517 . . . . 73.21 116.156 -172.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -53.45 -43.94 68.47 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 122.868 0.467 . . . . 60.44 111.855 -179.355 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -79.53 -32.33 42.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.251 0.548 . . . . 61.51 111.019 -179.177 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -79.74 1.57 26.1 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.108 0.48 . . . . 72.12 111.211 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 51.0 m -105.47 149.56 26.07 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.676 -1.601 . . . . 75.1 106.676 172.382 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 360' ' ' VAL . 15.0 p -76.0 113.48 13.56 Favored 'General case' 0 N--CA 1.422 -1.826 0 C-N-CA 119.806 -0.758 . . . . 63.21 110.975 178.77 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.4 m -121.93 170.0 12.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.377 -0.829 . . . . 44.44 109.482 178.869 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 33.3 t -76.52 157.15 32.34 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.145 -0.687 . . . . 63.11 109.145 179.759 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -69.24 109.87 4.32 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-O 121.289 0.566 . . . . 52.2 110.079 179.754 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 108.38 55.61 0.59 Allowed Glycine 0 N--CA 1.433 -1.514 0 CA-C-N 115.095 -0.957 . . . . 71.13 111.413 179.152 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -100.32 -173.18 2.35 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.739 -1.208 . . . . 74.44 107.739 178.057 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -120.08 113.86 21.12 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.414 -0.587 . . . . 74.15 109.414 -177.34 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 44.9 mm -104.32 133.71 47.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 108.822 -0.807 . . . . 74.3 108.822 -179.058 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 80.3 m -101.82 132.24 47.68 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 122.022 -0.424 . . . . 62.21 110.192 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 9.7 p -115.44 134.36 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 108.888 -0.782 . . . . 70.11 108.888 176.622 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -105.26 114.2 28.24 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.812 0.815 . . . . 75.43 109.286 177.805 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.548 HG13 ' HA ' ' A' ' 397' ' ' ASP . 96.3 t -111.22 131.39 62.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 114.569 -1.196 . . . . 71.13 108.846 -174.209 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . 0.465 ' HB2' HG12 ' A' ' 394' ' ' ILE . 17.3 t -92.67 121.82 34.47 Favored 'General case' 0 N--CA 1.428 -1.553 0 C-N-CA 119.53 -0.868 . . . . 74.32 110.0 179.265 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . 0.405 ' OG1' ' HB3' ' A' ' 388' ' ' GLN . 33.9 p -120.09 107.28 12.85 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 116.152 -0.476 . . . . 73.14 110.225 174.244 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.193 0 C-N-CA 119.94 -1.124 . . . . 63.31 113.438 176.255 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 . . . . . 0 N--CA 1.43 -1.47 0 N-CA-C 107.334 -1.358 . . . . 63.35 107.334 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -121.22 151.79 39.58 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 119.585 -0.846 . . . . 74.55 112.428 -169.817 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 34.9 tt0 -83.63 138.77 33.19 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.299 -1.319 . . . . 75.44 109.009 -176.488 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 70.7 mt -80.59 116.65 63.44 Favored Pre-proline 0 C--N 1.306 -1.305 0 N-CA-C 108.082 -1.081 . . . . 70.2 108.082 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -71.29 140.62 37.42 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.476 1.451 . . . . 75.13 110.201 176.398 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.28 128.62 35.48 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.413 -1.328 . . . . 74.22 107.413 175.603 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 42.9 t -118.28 157.45 19.72 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 107.514 -1.291 . . . . 73.43 107.514 -177.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.524 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 15.4 m -63.74 146.64 53.49 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-O 120.961 0.41 . . . . 71.45 110.985 -179.511 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 34.8 p -69.14 -25.91 64.62 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 124.66 1.184 . . . . 71.45 112.574 -170.511 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.493 ' H ' HD23 ' A' ' 435' ' ' LEU . 0.6 OUTLIER -90.61 -10.94 41.47 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 115.431 -0.804 . . . . 72.31 111.109 179.334 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.617 HG22 ' HB3' ' A' ' 439' ' ' GLU . 2.4 m -100.66 46.14 0.96 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.424 0.63 . . . . 74.44 109.729 -176.197 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -52.24 -42.79 63.92 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 113.892 1.071 . . . . 73.55 113.892 -178.944 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.52 -44.48 94.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.633 0.254 . . . . 45.34 110.996 -176.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.617 ' HB3' HG22 ' A' ' 436' ' ' THR . 28.1 tt0 -70.62 -33.11 70.66 Favored 'General case' 0 C--O 1.195 -1.775 0 CA-C-N 116.474 -0.33 . . . . 73.11 110.777 174.484 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.417 ' O ' HD23 ' A' ' 444' ' ' LEU . . . -59.66 -52.28 66.18 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.988 -0.285 . . . . 54.44 110.75 179.127 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 33.7 m -62.48 -36.33 74.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.614 0.721 . . . . 71.11 110.398 177.437 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.532 ' HB3' ' HA ' ' A' ' 439' ' ' GLU . 20.7 ttmm -59.46 -46.79 87.76 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 124.97 1.308 . . . . 60.23 110.229 176.019 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -65.9 -38.76 89.59 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 123.282 0.633 . . . . 73.31 111.727 -179.64 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 440' ' ' ALA . 4.6 mm? -63.32 -34.64 78.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.054 -0.35 . . . . 71.43 110.054 174.859 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.527 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 32.4 m -69.66 -45.67 67.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.25 0.548 . . . . 71.33 110.221 178.129 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.63 -24.95 64.62 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.635 -0.711 . . . . 52.33 112.455 -178.118 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.57 -4.77 53.01 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.326 0.491 . . . . 73.22 112.326 -177.651 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 125.88 -79.59 0.37 Allowed Glycine 0 CA--C 1.497 -1.074 0 C-N-CA 119.96 -1.114 . . . . 71.11 111.98 177.447 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -42.65 -66.87 0.32 Allowed 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.372 1.069 . . . . 54.23 113.858 178.354 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . 0.527 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 63.1 25.54 68.24 Favored Glycine 0 CA--C 1.502 -0.766 0 O-C-N 123.362 0.414 . . . . 65.43 112.626 -178.338 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.504 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 8.6 mmt180 -105.31 110.61 23.03 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.432 -1.692 . . . . 72.31 106.432 -179.711 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.415 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 30.5 p90 -141.03 154.42 45.99 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-O 121.228 0.537 . . . . 64.03 112.091 -176.177 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 5.4 tppp? -137.11 135.0 37.04 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.477 -1.305 . . . . 63.44 107.477 177.681 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -100.03 133.08 44.93 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.312 -0.625 . . . . 74.4 109.312 176.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -126.67 151.73 47.69 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.724 -0.473 . . . . 71.14 109.724 177.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -113.9 141.3 47.53 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.589 -1.263 . . . . 74.42 107.589 179.245 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 37.3 t -138.1 135.34 18.48 Favored Pre-proline 0 C--N 1.283 -2.323 0 N-CA-C 109.122 -0.695 . . . . 41.4 109.122 178.394 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.642 ' HA ' ' O ' ' A' ' 490' ' ' SER . 51.0 Cg_endo -73.07 122.9 8.45 Favored 'Trans proline' 0 N--CA 1.439 -1.679 0 C-N-CA 121.521 1.481 . . . . 72.13 109.403 174.608 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 51.0 m -148.44 -179.79 7.22 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 109.685 -0.487 . . . . 64.24 109.685 -175.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.1 t -47.69 137.86 9.6 Favored Pre-proline 0 C--O 1.251 1.158 0 C-N-CA 124.556 1.143 . . . . 73.24 112.03 178.371 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -52.73 -29.31 41.49 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 124.642 3.562 . . . . 63.35 113.668 -175.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.403 ' HG2' ' H ' ' A' ' 462' ' ' GLU . 8.8 pt-20 -71.33 -26.61 62.91 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 112.718 0.636 . . . . 74.1 112.718 -178.53 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -93.89 -4.52 49.81 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.806 -0.559 . . . . 55.0 111.624 179.566 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 85.3 t -60.68 127.79 20.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-N 116.006 -0.543 . . . . 71.31 110.524 178.224 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 95.88 -7.27 67.5 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 115.613 -0.721 . . . . 61.35 113.862 176.456 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.443 ' O ' HG23 ' A' ' 488' ' ' VAL . 6.8 mptt -122.35 158.96 28.47 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.586 -0.894 . . . . 65.41 108.586 -179.707 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 488' ' ' VAL . 66.2 t -72.13 143.81 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.739 0 N-CA-C 107.999 -1.112 . . . . 61.31 107.999 176.624 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 58.3 mt -97.26 -27.73 3.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 107.492 -1.299 . . . . 70.3 107.492 179.409 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 153.18 -165.83 31.38 Favored Glycine 0 N--CA 1.419 -2.457 0 C-N-CA 120.541 -0.837 . . . . 61.14 111.956 175.558 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.13 142.69 46.48 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 106.991 -1.485 . . . . 72.01 106.991 176.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -67.68 -55.72 13.64 Favored Pre-proline 0 CA--C 1.548 0.879 0 N-CA-C 109.712 -0.477 . . . . 53.51 109.712 179.064 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.461 ' HA ' ' HD3' ' A' ' 473' ' ' PRO . 12.2 Cg_endo -61.15 133.84 49.16 Favored 'Trans proline' 0 C--N 1.37 1.659 0 N-CA-C 108.276 -1.471 . . . . 72.25 108.276 168.917 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 472' ' ' PRO . 32.5 Cg_exo -62.14 127.96 22.65 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.742 2.295 . . . . 72.42 113.821 -173.862 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -74.03 12.8 0.63 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.968 0.907 . . . . 63.22 111.234 178.59 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -111.03 -7.65 14.51 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.852 -0.613 . . . . 74.5 109.846 176.188 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -116.25 174.7 5.91 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 113.542 0.942 . . . . 60.44 113.542 -170.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 0.9 OUTLIER -99.09 141.12 32.27 Favored 'General case' 0 N--CA 1.411 -2.414 0 C-N-CA 124.513 1.125 . . . . 70.11 112.6 -179.173 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 28.3 p -137.82 149.17 46.12 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.11 -0.95 . . . . 64.25 109.362 177.765 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.93 162.11 27.37 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 120.846 0.355 . . . . 63.04 110.948 178.477 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.9 mp -67.57 -15.19 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-O 122.133 0.968 . . . . 74.41 110.976 -178.543 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.2 p -94.41 0.75 55.66 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 115.953 -0.567 . . . . 71.3 112.067 177.437 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -83.69 133.88 34.79 Favored 'General case' 0 CA--C 1.503 -0.855 0 O-C-N 122.005 -0.434 . . . . 73.44 111.414 -178.581 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.504 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.3 p -96.53 126.71 49.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.658 -0.701 . . . . 63.4 109.728 178.089 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 22.3 m -101.48 136.75 31.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-O 121.313 0.578 . . . . 64.33 110.346 178.703 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.79 120.24 58.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 109.005 -0.739 . . . . 52.32 109.005 178.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 37.2 mt -109.49 122.91 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 114.663 -1.153 . . . . 73.3 109.9 -177.249 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.4 tt -106.61 127.0 62.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 115.062 -0.972 . . . . 74.52 111.631 -173.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 466' ' ' LYS . 2.5 p -111.34 142.78 22.72 Favored 'Isoleucine or valine' 0 C--O 1.247 0.967 0 N-CA-C 109.088 -0.708 . . . . 64.11 109.088 176.411 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -88.17 141.11 16.69 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.88 -0.676 . . . . 25.14 113.468 -176.059 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.642 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 11.1 t . . . . . 0 N--CA 1.431 -1.414 0 N-CA-C 106.804 -1.554 . . . . 63.22 106.804 176.131 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo . . . . . 0 C--O 1.244 0.805 0 CA-C-O 120.987 0.328 . . . . 74.14 112.535 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -118.19 53.46 0.96 Allowed 'General case' 0 C--O 1.244 0.805 0 CA-C-O 122.302 1.048 . . . . 74.42 108.239 177.446 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 22.8 p -117.78 147.95 42.52 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.762 -1.108 . . . . 75.21 111.233 -176.022 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -141.47 161.79 37.05 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.139 -1.06 . . . . 62.12 108.139 177.495 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.3 p-10 -100.4 138.25 37.72 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.267 0.556 . . . . 74.33 110.754 178.951 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 30.9 pt -77.04 137.51 65.46 Favored Pre-proline 0 C--N 1.308 -1.234 0 CA-C-N 115.293 -0.867 . . . . 73.12 111.967 -178.56 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -81.79 176.32 8.51 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.692 2.261 . . . . 73.41 111.22 176.636 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -86.7 118.88 26.39 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 108.843 -0.799 . . . . 75.45 108.843 178.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.09 8.78 7.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-O 122.107 0.956 . . . . 65.4 109.967 -177.426 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -68.19 108.02 3.0 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.93 -1.032 . . . . 55.35 109.719 -179.343 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 132.13 -19.11 4.66 Favored Glycine 0 N--CA 1.432 -1.621 0 C-N-CA 120.689 -0.767 . . . . 53.02 111.36 -177.892 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -99.58 172.94 6.98 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.045 -0.662 . . . . 63.11 109.344 177.542 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 533' ' ' GLU . 40.2 p -90.81 157.69 17.23 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.105 -0.638 . . . . 64.55 110.866 -176.078 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 10.0 p -53.7 -40.75 44.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.848 0.685 . . . . 65.11 112.848 -175.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -62.76 -42.93 99.91 Favored 'General case' 0 C--O 1.249 1.064 0 CA-C-O 121.236 0.541 . . . . 73.4 110.387 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 87.8 t -74.66 -37.05 42.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.631 -0.713 . . . . 74.31 110.065 -178.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . 0.461 ' HA ' ' ND2' ' A' ' 511' ' ' ASN . . . -63.29 -50.24 70.87 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.261 -0.882 . . . . 71.33 111.957 -179.015 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -64.82 -35.53 81.41 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.853 0.359 . . . . 72.03 110.712 -178.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.447 ' O ' HG23 ' A' ' 514' ' ' VAL . 3.6 tppp? -65.63 -52.97 47.78 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.672 -0.695 . . . . 74.14 111.627 179.756 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . 0.461 ' ND2' ' HA ' ' A' ' 508' ' ' ALA . 8.0 p30 -66.02 -37.82 86.85 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 120.342 -0.543 . . . . 75.04 111.539 -176.452 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . 0.427 HD23 ' O ' ' A' ' 508' ' ' ALA . 4.6 mm? -60.08 -41.32 92.18 Favored 'General case' 0 C--O 1.246 0.904 0 C-N-CA 121.032 -0.267 . . . . 75.03 110.617 176.052 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.11 -38.22 90.31 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 116.414 -0.357 . . . . 64.14 111.158 178.336 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 510' ' ' LYS . 96.9 t -63.77 -30.98 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 CA-C-N 115.889 -0.596 . . . . 73.54 111.223 179.198 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -80.26 -13.22 59.39 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 120.502 -0.479 . . . . 72.24 111.647 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 119.0 -14.7 11.16 Favored Glycine 0 N--CA 1.434 -1.445 0 C-N-CA 119.955 -1.117 . . . . 64.4 112.504 178.716 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -77.44 102.56 6.91 Favored 'General case' 0 CA--C 1.481 -1.692 0 N-CA-C 106.182 -1.784 . . . . 71.45 106.182 -178.678 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.5 m -88.91 -28.86 20.03 Favored 'General case' 0 N--CA 1.407 -2.58 0 C-N-CA 119.479 -0.888 . . . . 74.25 113.03 -167.152 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 61.7 mttp -108.32 125.36 51.62 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.736 -0.785 . . . . 71.41 111.659 -174.508 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -130.64 149.49 52.27 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.727 -0.669 . . . . 75.44 110.851 -178.38 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 46.9 m -132.29 143.71 50.08 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.33 -1.359 . . . . 72.45 107.33 173.786 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.04 144.32 44.74 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 109.381 -0.6 . . . . 72.44 109.381 179.327 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -130.64 129.99 43.37 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.3 -0.63 . . . . 54.14 109.3 178.814 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 50.8 m -84.11 120.97 26.8 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.542 -0.54 . . . . 51.12 109.542 179.529 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 32.3 m -121.4 162.71 20.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 108.149 -1.056 . . . . 33.42 108.149 179.229 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . 0.622 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 6.9 p-10 -82.52 134.38 35.2 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 119.26 -0.976 . . . . 73.53 109.378 -178.57 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . 0.506 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 51.1 m -152.73 167.99 12.28 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 110.231 -0.285 . . . . 72.41 110.231 177.13 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -85.7 -8.05 8.35 Favored 'Trans proline' 0 C--N 1.36 1.148 0 C-N-CA 122.284 1.99 . . . . 63.13 111.295 174.555 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.523 ' HD3' ' OE2' ' A' ' 533' ' ' GLU . 50.4 mtt180 -80.07 145.53 61.18 Favored Pre-proline 0 N--CA 1.445 -0.71 0 N-CA-C 107.589 -1.263 . . . . 73.21 107.589 178.467 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -61.31 152.29 73.42 Favored 'Trans proline' 0 C--O 1.256 1.422 0 C-N-CA 122.364 2.043 . . . . 44.31 112.585 -179.327 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.658 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -62.93 115.58 4.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.132 -0.94 . . . . 74.13 111.352 -176.238 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 134.3 -24.64 3.55 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 120.564 -0.827 . . . . 35.15 112.224 178.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . 0.523 ' OE2' ' HD3' ' A' ' 529' ' ' ARG . 32.0 tt0 -82.99 137.85 33.99 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.349 -0.541 . . . . 73.32 109.797 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 88.2 t -81.83 120.2 32.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.86 -0.793 . . . . 74.31 108.86 178.413 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . 0.463 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 9.3 t -80.94 -13.27 59.05 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.314 -0.403 . . . . 61.43 110.154 -179.075 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.91 -170.76 29.29 Favored Glycine 0 N--CA 1.426 -2.005 0 N-CA-C 109.987 -1.245 . . . . 50.22 109.987 178.222 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 14.1 p -116.88 160.4 20.93 Favored 'General case' 0 C--N 1.273 -2.729 0 N-CA-C 108.384 -0.969 . . . . 74.14 108.384 178.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.504 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 38.1 t30 -67.02 -51.75 35.03 Favored Pre-proline 0 C--N 1.317 -0.841 0 C-N-CA 120.443 -0.503 . . . . 64.42 110.762 178.305 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.504 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 3.9 Cg_exo -77.45 131.13 11.35 Favored 'Trans proline' 0 C--N 1.367 1.538 0 N-CA-C 107.601 -1.73 . . . . 74.43 107.601 170.576 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.93 162.15 39.23 Favored 'Trans proline' 0 C--O 1.25 1.117 0 C-N-CA 122.142 1.895 . . . . 53.15 112.555 -177.215 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -56.99 131.33 49.52 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 109.415 -0.587 . . . . 35.12 109.415 175.783 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.9 -12.06 38.04 Favored Glycine 0 C--N 1.301 -1.399 0 C-N-CA 120.928 -0.654 . . . . 42.34 111.929 -177.656 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 56.5 m -68.16 120.68 14.74 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.222 -0.659 . . . . 75.53 109.222 177.111 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 31.8 m -90.77 122.18 33.28 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 109.266 -0.642 . . . . 63.33 109.266 -179.464 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 28.7 m -136.88 158.68 72.47 Favored Pre-proline 0 C--N 1.311 -1.087 0 N-CA-C 108.96 -0.756 . . . . 75.3 108.96 -177.57 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -62.5 148.02 93.95 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 122.28 1.986 . . . . 73.2 110.723 175.527 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 27.0 m -64.13 -27.52 42.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 121.482 0.658 . . . . 75.53 111.882 -178.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -88.85 2.91 52.88 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 116.159 -0.473 . . . . 63.53 110.755 -179.25 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 9.7 t -82.14 172.16 13.5 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 120.862 0.363 . . . . 65.21 110.243 -176.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 7.8 t -110.58 124.01 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 CA-C-N 115.883 -0.599 . . . . 75.43 109.618 -176.653 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . 0.504 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -107.39 145.87 14.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 120.313 -0.555 . . . . 71.04 110.297 176.567 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -103.3 117.25 34.07 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.209 0.528 . . . . 73.31 111.037 -176.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 5.5 mp -98.77 130.7 45.23 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.562 -1.199 . . . . 75.23 108.6 178.641 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -102.08 120.03 39.76 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 121.489 0.661 . . . . 65.11 109.651 179.759 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 40.0 t -100.37 137.35 28.17 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 CA-C-N 115.191 -0.913 . . . . 73.41 109.413 -175.629 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.658 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 6.2 m -79.64 123.23 27.44 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.99 -1.004 . . . . 70.34 109.239 -179.015 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.622 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 17.6 ptmt -92.17 145.7 24.3 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 104.313 -2.477 . . . . 51.54 104.313 169.351 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -79.14 -30.42 46.54 Favored Glycine 0 CA--C 1.486 -1.775 0 C-N-CA 118.964 -1.589 . . . . 51.24 113.486 -172.344 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 70.34 -29.15 0.18 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.663 1.185 . . . . 71.23 113.008 179.491 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.498 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 76.6 mt-30 -128.14 154.4 45.8 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 123.839 0.856 . . . . 74.45 112.015 -176.099 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -138.96 151.09 46.6 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.76 -0.83 . . . . 70.34 108.76 176.528 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 8.5 p -65.78 122.71 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 CA-C-O 121.262 0.554 . . . . 73.44 111.745 -178.912 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . 0.484 ' HG2' ' O ' ' A' ' 564' ' ' PRO . 57.6 ttp -97.82 137.56 20.96 Favored Pre-proline 0 C--O 1.249 1.046 0 CA-C-N 116.182 -0.463 . . . . 45.52 111.311 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . 0.484 ' O ' ' HG2' ' A' ' 563' ' ' MET . 12.6 Cg_exo -73.4 169.39 22.4 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.633 2.222 . . . . 54.23 109.829 169.674 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -83.04 141.13 32.28 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.165 0.507 . . . . 62.42 110.722 -179.25 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 89.4 mt -122.99 15.32 9.96 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.96 -1.126 . . . . 72.32 107.96 177.034 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 7.7 m -72.17 141.21 49.07 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 114.437 -1.256 . . . . 72.4 109.837 -178.046 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 80.37 13.99 80.91 Favored Glycine 0 C--O 1.217 -0.945 0 C-N-CA 120.523 -0.846 . . . . 61.42 113.185 178.271 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 26.2 mmt -105.13 165.14 11.3 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 122.295 -0.532 . . . . 75.54 110.485 178.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -86.42 161.21 18.77 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.858 -1.164 . . . . 63.13 107.858 -179.658 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 30.8 t90 -71.22 -25.93 62.72 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.946 -0.761 . . . . 72.22 108.946 177.667 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.0 p -73.78 -17.72 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 115.27 -0.877 . . . . 62.35 109.407 179.475 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . 0.625 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 25.0 t70 -97.26 -34.97 10.89 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.362 -0.607 . . . . 74.44 109.362 178.5 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -64.03 -33.62 76.17 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.736 -0.665 . . . . 71.01 111.436 178.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.519 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 40.0 tt0 -55.99 -57.11 23.94 Favored Pre-proline 0 CA--C 1.576 1.953 0 CA-C-N 115.923 -0.58 . . . . 61.31 111.973 177.472 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 38.9 Cg_exo -61.05 -31.46 90.99 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 121.59 1.527 . . . . 74.34 112.835 173.656 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.625 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 24.2 mmt180 -58.9 -47.82 83.63 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 110.123 -0.325 . . . . 75.51 110.123 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.513 HD12 ' N ' ' A' ' 579' ' ' ARG . 4.4 pp -64.09 -45.98 86.29 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 112.372 0.508 . . . . 60.15 112.372 -174.595 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . 0.513 ' N ' HD12 ' A' ' 578' ' ' LEU . 4.1 ptp180 -66.02 -35.23 80.0 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.682 -0.407 . . . . 73.23 112.074 178.618 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.85 -36.42 72.86 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.23 0.538 . . . . 23.11 111.605 178.44 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 86.8 mt -81.84 -3.3 53.7 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 112.418 0.525 . . . . 55.42 112.418 -177.42 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 73.39 40.68 47.68 Favored Glycine 0 CA--C 1.506 -0.528 0 C-N-CA 120.581 -0.818 . . . . 61.2 111.178 -179.632 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 75.6 t90 -70.04 137.64 51.46 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.999 -0.6 . . . . 72.02 110.739 -179.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 5.9 t -156.49 75.23 0.85 Allowed 'General case' 0 N--CA 1.424 -1.748 0 CA-C-O 122.283 1.04 . . . . 75.3 109.399 178.432 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -141.38 -137.71 3.44 Favored Glycine 0 N--CA 1.434 -1.457 0 N-CA-C 110.923 -0.871 . . . . 70.42 110.923 -178.587 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 65.7 mtt -126.8 136.87 52.96 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.057 -1.09 . . . . 53.35 108.057 177.622 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -97.38 128.51 44.25 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.796 -1.187 . . . . 72.44 107.796 -176.837 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -105.01 101.86 11.4 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.949 -0.7 . . . . 74.44 110.346 179.453 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -102.45 133.57 47.19 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 107.746 -1.205 . . . . 73.41 107.746 175.597 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -90.99 -154.44 30.52 Favored Glycine 0 N--CA 1.418 -2.558 0 N-CA-C 110.312 -1.115 . . . . 60.02 110.312 177.107 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -71.0 133.6 46.48 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 110.153 -0.314 . . . . 73.21 110.153 179.048 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -77.23 123.24 26.18 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 105.469 -2.048 . . . . 72.34 105.469 177.282 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 94.5 t -136.03 135.68 50.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-O 120.971 0.415 . . . . 74.24 111.895 -171.315 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . 0.425 ' HB2' HE21 ' A' ' 626' ' ' GLN . 17.7 t70 -97.58 106.54 18.87 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 105.86 -1.904 . . . . 71.11 105.86 173.16 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -145.15 9.54 1.26 Allowed 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 112.777 0.658 . . . . 71.35 112.777 -175.561 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 122.91 167.04 12.82 Favored Glycine 0 C--N 1.302 -1.327 0 C-N-CA 119.84 -1.171 . . . . 72.21 111.583 179.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.75 -43.13 91.93 Favored Glycine 0 C--O 1.239 0.433 0 O-C-N 123.864 0.391 . . . . 45.11 114.052 -172.565 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 15.8 m -65.65 -34.11 77.46 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.181 0.515 . . . . 71.02 111.231 -179.112 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . 0.427 ' O ' ' HA3' ' A' ' 625' ' ' GLY . 80.9 mm-40 -92.49 -0.97 57.28 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 112.511 0.56 . . . . 54.22 112.511 -178.644 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -89.86 -106.56 0.09 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.424 0.898 . . . . 73.0 113.424 -178.515 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -92.46 54.86 2.38 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.185 0.517 . . . . 74.4 110.005 -173.227 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -144.12 140.85 29.65 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.891 -0.781 . . . . 71.01 108.891 176.802 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 95.8 t -64.34 130.15 29.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 107.509 -1.293 . . . . 72.32 107.509 173.322 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 58.0 t -89.2 -52.32 11.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.046 0.45 . . . . 61.34 110.429 -177.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -135.52 155.85 49.83 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.134 -1.061 . . . . 74.43 108.134 179.391 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -118.9 100.29 7.28 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 107.194 -1.41 . . . . 72.04 107.194 178.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.499 ' CB ' ' HB ' ' A' ' 621' ' ' THR . 26.7 t-20 -54.75 -51.58 77.7 Favored Pre-proline 0 CA--C 1.554 1.111 0 N-CA-C 113.772 1.027 . . . . 63.04 113.772 -177.72 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 609' ' ' PRO . 7.8 Cg_exo -75.84 128.95 11.2 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 121.094 1.196 . . . . 51.03 109.229 173.072 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . 0.521 ' HB2' ' OG1' ' A' ' 612' ' ' THR . 12.6 Cg_exo -70.31 135.8 30.02 Favored 'Trans proline' 0 C--O 1.242 0.7 0 C-N-CA 122.395 2.064 . . . . 51.34 113.196 -177.533 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -68.35 134.47 50.32 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.216 -0.661 . . . . 60.21 109.216 176.125 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 88.27 0.39 82.73 Favored Glycine 0 C--N 1.305 -1.182 0 C-N-CA 120.136 -1.031 . . . . 73.13 111.108 -178.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . 0.521 ' OG1' ' HB2' ' A' ' 609' ' ' PRO . 39.7 m -111.8 160.6 17.18 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.631 -1.248 . . . . 72.11 107.631 178.321 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -75.89 135.68 18.35 Favored Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 111.223 -0.751 . . . . 74.35 111.223 178.697 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.18 142.18 37.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 108.113 -1.069 . . . . 62.41 108.113 176.894 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.498 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 34.9 p-10 -50.61 153.09 1.75 Allowed 'General case' 0 C--O 1.217 -0.648 0 N-CA-C 113.169 0.803 . . . . 72.23 113.169 179.174 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . 0.509 ' HD3' ' H ' ' A' ' 616' ' ' ARG . 0.0 OUTLIER -48.65 -30.82 5.86 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.952 1.301 . . . . 73.43 112.196 177.624 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . 0.491 ' HB2' ' ND2' ' A' ' 615' ' ' ASN . 1.0 OUTLIER -66.04 -44.41 84.69 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.578 -0.737 . . . . 71.43 110.325 176.736 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 87.45 23.1 41.19 Favored Glycine 0 N--CA 1.426 -1.986 0 C-N-CA 118.65 -1.738 . . . . 64.32 111.34 -178.266 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.84 119.2 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 123.238 1.494 . . . . 62.13 109.359 -167.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 4.2 tp -115.19 119.94 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.118 0 CA-C-N 113.215 -1.811 . . . . 73.32 110.528 -172.596 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.499 ' HB ' ' CB ' ' A' ' 607' ' ' ASN . 24.9 m -98.98 117.13 32.8 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 106.181 -1.785 . . . . 73.4 106.181 171.912 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -138.93 165.37 27.26 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 107.536 -1.283 . . . . 54.32 107.536 -175.835 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -134.11 135.77 43.42 Favored 'General case' 0 C--N 1.272 -2.786 0 N-CA-C 107.623 -1.251 . . . . 71.35 107.623 178.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -143.68 165.41 27.7 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 124.857 1.348 . . . . 72.23 107.578 172.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' A' ' 599' ' ' GLN . . . -113.37 -110.87 2.99 Favored Glycine 0 C--N 1.279 -2.623 0 N-CA-C 111.586 -0.606 . . . . 63.12 111.586 -179.092 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . 0.425 HE21 ' HB2' ' A' ' 594' ' ' ASP . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.17 0 C-N-CA 121.034 -0.266 . . . . 74.42 111.03 179.02 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--O 1.239 0.513 0 N-CA-C 105.424 -2.065 . . . . 72.52 105.424 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 31.5 m -116.12 157.79 16.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-O 121.488 0.661 . . . . 73.01 111.63 -169.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . 0.473 HE21 ' C ' ' A' ' 361' ' ' GLN . 0.0 OUTLIER -94.76 124.3 38.72 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 106.606 -1.627 . . . . 71.25 106.606 -176.196 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 406' ' ' ALA . 89.7 t -101.35 129.53 26.76 Favored Pre-proline 0 C--N 1.287 -2.109 0 CA-C-N 114.993 -1.003 . . . . 73.41 111.335 -172.58 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -73.41 132.75 18.11 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.138 1.892 . . . . 73.01 109.42 174.637 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . 0.43 ' HB2' HD21 ' A' ' 407' ' ' ASN . 6.5 t0 -91.76 158.89 16.1 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 120.291 -0.564 . . . . 74.33 109.648 -175.551 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.522 HG21 ' HA ' ' A' ' 373' ' ' ALA . 4.0 m -114.17 6.34 7.71 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 C-N-CA 124.203 1.001 . . . . 72.03 111.673 -176.026 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.77 145.38 12.39 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 112.757 0.651 . . . . 72.0 112.757 172.725 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . 0.404 ' H ' HG23 ' A' ' 399' ' ' VAL . . . 104.85 -6.02 43.54 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.254 -0.884 . . . . 54.33 112.307 -176.478 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -104.97 -92.44 0.37 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.73 0.3 . . . . 44.41 111.075 179.608 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 64.9 p -156.31 157.11 35.15 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 107.619 -1.252 . . . . 74.34 107.619 -179.133 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 7.9 p -64.1 -37.52 87.75 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 118.307 0.503 . . . . 64.11 111.221 179.702 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.21 -45.45 94.5 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 116.07 -0.514 . . . . 61.52 111.206 178.789 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -69.12 -39.24 79.03 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.609 -0.515 . . . . 65.11 109.609 179.692 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . 0.522 ' HA ' HG21 ' A' ' 365' ' ' VAL . . . -61.91 -51.36 68.45 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.679 -0.692 . . . . 71.44 111.403 -178.964 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 78.5 mt -65.56 -39.97 86.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.188 -0.46 . . . . 60.31 110.124 179.122 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.26 -47.35 85.7 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.063 -0.517 . . . . 63.1 110.907 -179.496 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . 0.527 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 51.3 m -64.97 -47.46 77.51 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.953 -0.567 . . . . 71.52 110.982 -179.085 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 10.8 mp -62.9 -39.02 93.23 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 112.145 0.424 . . . . 71.41 112.145 -179.248 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -64.99 -38.81 92.2 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.764 0.316 . . . . 53.41 110.205 179.349 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -68.37 -26.59 65.65 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.142 0.496 . . . . 51.41 111.355 176.744 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 376' ' ' THR . 9.7 mmm180 -82.15 -14.26 55.94 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.284 -0.416 . . . . 55.41 110.846 178.71 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 92.88 16.37 48.43 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.475 -0.869 . . . . 63.14 111.157 179.639 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.455 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 29.3 m-85 -93.16 154.77 17.87 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-O 121.454 0.645 . . . . 70.32 110.427 179.396 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.428 ' HB2' ' HG2' ' A' ' 415' ' ' GLU . 32.6 mmtp -103.75 145.01 30.72 Favored 'General case' 0 N--CA 1.409 -2.508 0 N-CA-C 107.184 -1.413 . . . . 75.54 107.184 -176.626 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . 0.524 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -118.86 142.45 33.8 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 C-N-CA 119.868 -0.733 . . . . 74.2 110.545 -176.726 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 23.7 tpt180 -111.75 147.32 35.89 Favored 'General case' 0 N--CA 1.408 -2.527 0 N-CA-C 105.172 -2.158 . . . . 72.35 105.172 171.829 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 42.9 m -132.77 121.67 23.37 Favored 'General case' 0 C--N 1.269 -2.925 0 C-N-CA 120.229 -0.588 . . . . 71.24 109.56 -175.782 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 66.0 tp -111.22 119.1 37.81 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 107.406 -1.331 . . . . 62.02 107.406 -179.783 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -102.96 131.7 49.74 Favored 'General case' 0 N--CA 1.425 -1.702 0 C-N-CA 119.845 -0.742 . . . . 42.42 110.408 177.966 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . 0.548 ' O ' ' HA ' ' A' ' 421' ' ' SER . 13.2 mmmm -126.01 148.32 62.49 Favored Pre-proline 0 C--N 1.282 -2.367 0 N-CA-C 106.152 -1.796 . . . . 73.24 106.152 -178.264 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -69.35 158.04 58.97 Favored 'Trans proline' 0 C--O 1.243 0.765 0 N-CA-C 108.751 -1.288 . . . . 73.24 108.751 173.135 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -74.82 82.88 2.14 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-O 121.818 0.818 . . . . 72.02 109.688 178.019 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . 0.467 ' O ' ' HB ' ' A' ' 393' ' ' THR . 17.1 m -103.29 49.3 0.83 Allowed 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 114.593 -1.185 . . . . 74.41 108.843 178.709 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 392' ' ' SER . 99.2 m 69.54 20.28 7.17 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-O 123.206 1.479 . . . . 71.31 110.02 -179.715 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 5.4 pt -115.75 152.3 47.22 Favored Pre-proline 0 C--N 1.301 -1.536 0 CA-C-N 114.85 -1.068 . . . . 63.23 111.155 -174.357 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 396' ' ' PRO . 0.6 OUTLIER -21.5 116.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.364 1.388 1 C-N-CA 126.48 4.786 . . . . 45.43 116.831 -177.82 . . . . . . . . 4 4 . 1 . 026 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . 0.52 ' HA ' ' OG ' ' A' ' 421' ' ' SER . 41.9 Cg_exo -59.02 161.86 14.89 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 124.267 3.311 . . . . 52.11 114.52 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -57.89 -8.46 0.99 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.996 1.318 . . . . 74.44 113.438 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -98.72 137.14 37.76 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.016 -1.846 . . . . 73.31 106.016 176.21 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 367' ' ' GLY . 18.8 m -72.34 118.2 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 C-N-CA 119.039 -1.064 . . . . 74.31 112.514 -167.86 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.4 -30.6 2.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 105.843 -1.91 . . . . 74.23 105.843 171.386 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.7 157.89 27.55 Favored Glycine 0 N--CA 1.416 -2.673 0 CA-C-N 114.618 -1.174 . . . . 64.03 111.099 -178.399 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 9.3 p -144.83 -175.71 4.78 Favored 'General case' 0 C--N 1.278 -2.523 0 C-N-CA 127.314 2.246 . . . . 51.24 105.369 -177.119 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -98.92 125.95 40.22 Favored Pre-proline 0 C--N 1.295 -1.789 0 C-N-CA 118.118 -1.433 . . . . 72.12 107.673 178.895 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -59.29 6.25 0.09 OUTLIER 'Trans proline' 0 C--N 1.365 1.397 0 C-N-CA 124.691 3.594 . . . . 71.44 115.91 -176.585 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.26 -33.58 67.74 Favored 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 109.467 -0.568 . . . . 73.04 109.467 174.907 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . 0.402 ' O ' ' HB ' ' A' ' 362' ' ' VAL . . . -67.04 -36.32 81.82 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-O 121.512 0.672 . . . . 61.34 110.319 177.275 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . 0.43 HD21 ' HB2' ' A' ' 364' ' ' ASP . 13.0 m120 -85.77 0.72 52.12 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.914 0.864 . . . . 63.44 110.16 -179.147 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 28.5 m -97.33 158.39 15.48 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 104.896 -2.261 . . . . 74.22 104.896 171.588 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 33.7 p -74.32 112.08 10.13 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 118.649 -1.22 . . . . 72.15 108.712 179.236 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 17.1 m -129.53 159.11 41.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 121.296 0.569 . . . . 61.32 112.037 -179.456 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 3.0 p -60.94 140.82 57.66 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.083 -0.962 . . . . 62.32 110.869 177.944 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -65.0 111.01 2.67 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 121.477 0.656 . . . . 64.11 110.372 -177.538 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 107.07 39.92 1.9 Allowed Glycine 0 N--CA 1.423 -2.21 0 CA-C-N 115.05 -0.977 . . . . 73.52 112.001 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -92.18 -179.31 5.21 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.931 -0.766 . . . . 55.23 108.931 -178.319 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . 0.428 ' HG2' ' HB2' ' A' ' 383' ' ' LYS . 43.9 mt-10 -104.69 114.91 29.43 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 110.005 -0.368 . . . . 75.13 110.005 -176.855 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 45.4 mm -107.41 128.78 62.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 109.188 -0.671 . . . . 63.32 109.188 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 25.5 m -85.2 130.29 34.63 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.307 0.575 . . . . 65.41 111.782 -178.023 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 9.4 p -114.68 135.49 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 CA-C-N 115.041 -0.981 . . . . 61.43 108.902 177.861 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -97.67 128.71 44.56 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 110.153 -0.314 . . . . 75.04 110.153 179.27 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 94.6 t -123.72 131.11 73.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 109.235 -0.654 . . . . 63.54 109.235 176.667 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 95.8 p -99.49 123.66 43.96 Favored 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 120.403 -0.519 . . . . 63.44 109.912 177.152 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 5.5 t -119.7 108.68 14.73 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 112.735 0.642 . . . . 71.43 112.735 -179.712 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.332 0 N-CA-C 115.373 0.909 . . . . 74.43 115.373 171.871 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 . . . . . 0 N--CA 1.423 -1.787 0 N-CA-C 104.775 -2.306 . . . . 54.32 104.775 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 477' ' ' THR . 20.5 mmm180 -121.66 147.16 46.23 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 119.593 -0.843 . . . . 73.15 111.679 -173.54 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 15.6 pt-20 -82.05 139.19 34.62 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.184 -0.916 . . . . 74.54 108.635 -178.963 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 65.1 mt -78.93 125.79 83.31 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 107.806 -1.183 . . . . 74.33 107.806 -178.878 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -70.51 141.49 42.31 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 121.848 1.699 . . . . 71.33 110.693 175.612 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -80.63 112.55 18.1 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.603 -0.517 . . . . 63.13 109.603 177.981 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 28.2 t -115.78 147.16 19.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 107.528 -1.286 . . . . 61.1 107.528 -179.045 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 1.6 p -58.01 138.17 56.18 Favored 'General case' 0 N--CA 1.432 -1.355 0 O-C-N 123.638 0.586 . . . . 74.32 111.463 179.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 31.7 p -64.57 -34.88 79.28 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 123.931 0.893 . . . . 74.14 112.05 -171.047 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.57 ' H ' HD23 ' A' ' 435' ' ' LEU . 0.7 OUTLIER -75.02 -16.88 60.59 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-N 115.198 -0.91 . . . . 61.53 111.464 -179.775 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.427 HG22 ' HB2' ' A' ' 439' ' ' GLU . 2.1 m -105.03 50.6 0.78 Allowed 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.517 0.675 . . . . 73.13 109.26 -175.075 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . 0.421 ' O ' HG23 ' A' ' 441' ' ' VAL . 38.9 t80 -52.61 -38.82 60.88 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.893 0.877 . . . . 73.44 112.913 -179.683 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -59.44 -40.6 87.35 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-O 121.066 0.46 . . . . 62.12 110.918 179.444 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.427 ' HB2' HG22 ' A' ' 436' ' ' THR . 42.9 tp10 -70.04 -35.63 74.43 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.968 -0.753 . . . . 61.41 108.968 179.621 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.96 -43.62 98.48 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.893 -0.594 . . . . 71.53 110.054 178.732 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 437' ' ' TYR . 84.9 t -58.48 -47.85 87.04 Favored 'Isoleucine or valine' 0 C--O 1.246 0.9 0 CA-C-N 115.232 -0.894 . . . . 74.02 110.911 178.669 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -67.38 -34.53 77.47 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 119.789 -0.765 . . . . 74.0 110.708 -179.376 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -62.53 -42.63 99.65 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 116.826 -0.17 . . . . 75.24 111.291 178.515 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 10.2 mp -63.76 -35.09 79.43 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 120.871 0.367 . . . . 61.3 110.389 176.277 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.46 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 22.2 m -68.19 -46.23 71.23 Favored 'General case' 0 C--O 1.249 1.033 0 CA-C-N 115.936 -0.574 . . . . 42.12 110.557 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.36 -17.39 62.42 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-O 121.105 0.479 . . . . 64.43 111.401 179.53 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.34 5.26 24.0 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.888 -0.596 . . . . 64.01 112.272 -179.871 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 110.48 -82.08 0.3 Allowed Glycine 0 CA--C 1.488 -1.615 0 C-N-CA 119.514 -1.327 . . . . 42.5 112.034 175.778 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . 0.415 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 0.6 OUTLIER -39.91 -65.22 0.41 Allowed 'General case' 0 C--O 1.248 0.995 0 N-CA-C 113.917 1.08 . . . . 71.03 113.917 175.573 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . 0.46 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 59.35 29.69 66.59 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.859 -0.496 . . . . 74.34 111.859 -175.232 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.453 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 16.1 mmm180 -105.06 111.23 23.93 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.472 -1.677 . . . . 62.41 106.472 -179.291 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 35.5 p90 -134.17 153.4 51.86 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 120.871 0.367 . . . . 71.43 110.939 -175.422 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -148.32 122.9 9.79 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.944 -0.761 . . . . 70.41 108.944 177.825 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -83.83 129.39 34.94 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 123.359 0.664 . . . . 73.03 111.458 179.752 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.08 144.66 47.47 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.274 -1.38 . . . . 64.3 107.274 173.342 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -122.29 136.83 54.97 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.521 -0.918 . . . . 71.34 108.521 -177.635 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . 0.427 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 49.4 m -149.45 138.31 12.39 Favored Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 122.356 -0.215 . . . . 70.04 110.595 176.785 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.73 ' HA ' ' O ' ' A' ' 490' ' ' SER . 22.5 Cg_exo -65.82 129.39 22.02 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.404 2.07 . . . . 74.24 111.014 176.358 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 60.6 m -152.21 -179.28 7.39 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.951 -0.568 . . . . 42.43 109.884 -178.042 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 9.7 t -45.0 136.71 4.74 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.952 1.301 . . . . 64.02 112.432 178.643 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.76 -29.48 34.12 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 124.752 3.635 . . . . 73.44 113.933 -175.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -70.38 -30.7 67.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.571 -0.286 . . . . 51.31 111.722 -178.932 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -95.75 -8.81 33.44 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 111.66 0.244 . . . . 63.35 111.66 179.738 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 80.5 t -60.57 127.66 20.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.473 -0.566 . . . . 74.23 109.473 176.696 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 91.06 -15.07 61.82 Favored Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 116.002 -0.544 . . . . 43.31 112.107 -179.529 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -108.69 166.55 10.71 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 109.424 -0.584 . . . . 63.43 109.424 -177.852 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 79.4 t -73.51 140.82 17.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 108.182 -1.044 . . . . 63.15 108.182 173.572 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 65.5 mt -97.33 -35.28 5.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.56 -1.274 . . . . 55.34 107.56 177.253 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 172.76 -179.06 44.49 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 120.297 -0.954 . . . . 74.1 112.031 177.741 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . 0.506 HG22 HG12 ' A' ' 486' ' ' ILE . 33.1 p -115.17 143.93 44.46 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 105.929 -1.878 . . . . 65.52 105.929 178.805 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -60.32 -57.19 28.45 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 119.888 -0.725 . . . . 72.52 112.146 178.607 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -71.94 152.57 57.7 Favored 'Trans proline' 0 C--N 1.361 1.196 0 N-CA-C 108.001 -1.577 . . . . 72.54 108.001 170.58 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.31 127.82 22.09 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 121.601 1.534 . . . . 75.44 111.44 -179.035 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -76.63 6.45 5.89 Favored 'General case' 0 C--O 1.211 -0.928 0 C-N-CA 124.239 1.016 . . . . 64.24 111.932 -175.981 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -109.78 -4.97 15.73 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 116.106 -0.497 . . . . 73.23 109.808 172.625 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -117.26 176.0 5.35 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 112.981 0.734 . . . . 71.44 112.981 -171.421 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 3.7 p -83.41 131.14 35.05 Favored 'General case' 0 N--CA 1.413 -2.295 0 C-N-CA 124.633 1.173 . . . . 74.42 113.145 -177.782 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 43.8 m -121.23 148.64 43.99 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 106.971 -1.492 . . . . 73.22 106.971 175.611 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.457 ' HB3' ' HB2' ' A' ' 482' ' ' ASN . . . -74.48 156.44 36.93 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.725 -0.39 . . . . 73.25 111.442 -176.585 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . 0.415 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 43.5 mm -69.36 -26.8 32.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.823 0.82 . . . . 73.34 110.25 -177.006 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.4 t -97.9 5.07 49.39 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.69 0.757 . . . . 75.44 109.904 179.021 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . 0.457 ' HB2' ' HB3' ' A' ' 479' ' ' ALA . 5.8 t30 -94.63 135.63 35.87 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.54 -0.755 . . . . 62.35 110.301 -176.597 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.453 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.3 p -89.86 126.75 42.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-O 121.283 0.564 . . . . 72.12 111.444 -177.043 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 60.6 t -96.77 118.53 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.91 0 N-CA-C 107.844 -1.169 . . . . 72.53 107.844 176.207 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.27 129.08 50.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 108.063 -1.088 . . . . 70.42 108.063 177.606 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.506 HG12 HG22 ' A' ' 470' ' ' THR . 15.2 mt -118.54 128.23 75.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-N 115.158 -0.928 . . . . 73.21 110.635 -174.758 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 6.2 tt -103.19 126.17 57.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 115.69 -0.687 . . . . 73.32 110.428 -179.452 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 33.8 m -109.26 151.2 11.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 115.692 -0.685 . . . . 72.14 109.547 178.387 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.42 135.55 14.29 Favored Glycine 0 N--CA 1.423 -2.179 0 C-N-CA 121.125 -0.56 . . . . 70.15 111.744 -178.482 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.73 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 12.8 t . . . . . 0 C--N 1.283 -2.326 0 N-CA-C 105.825 -1.917 . . . . 55.23 105.825 177.234 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo . . . . . 0 C--O 1.251 1.129 0 CA-C-O 120.797 0.249 . . . . 64.44 111.736 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -91.25 81.17 5.52 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.532 -0.914 . . . . 62.1 108.532 175.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 5.9 p -117.81 153.56 33.26 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.263 -0.88 . . . . 72.42 112.209 -175.193 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 8.0 mmtm -137.24 136.85 38.47 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.242 -0.89 . . . . 72.44 109.746 179.986 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -82.27 121.61 26.87 Favored 'General case' 0 CA--C 1.485 -1.527 0 N-CA-C 105.508 -2.034 . . . . 62.41 105.508 168.876 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 543' ' ' THR . 44.1 pt -75.38 123.69 88.75 Favored Pre-proline 0 C--N 1.292 -1.905 0 N-CA-C 113.348 0.87 . . . . 64.13 113.348 -172.6 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -86.58 164.6 9.31 Favored 'Trans proline' 0 N--CA 1.429 -2.301 0 C-N-CA 122.472 2.114 . . . . 60.14 108.871 171.784 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -82.35 147.26 28.93 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 120.383 -0.527 . . . . 52.24 109.99 -178.487 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.1 p -130.35 8.29 2.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-O 122.045 0.926 . . . . 75.43 109.832 -176.824 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -81.23 157.11 25.31 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 115.43 -0.805 . . . . 72.52 110.185 -175.994 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 108.55 1.51 32.77 Favored Glycine 0 C--N 1.287 -2.145 0 N-CA-C 109.573 -1.411 . . . . 61.52 109.573 -178.49 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -120.62 175.43 6.01 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.414 -0.958 . . . . 65.53 108.414 -179.267 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 15.0 t -83.89 159.83 21.24 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.82 -1.178 . . . . 74.1 107.82 178.544 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 532' ' ' GLY . 48.2 t -46.84 -48.94 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 123.905 0.882 . . . . 73.42 111.239 -176.54 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -63.46 -41.85 98.62 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.188 -0.915 . . . . 72.44 111.571 -175.158 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 88.2 t -76.35 -40.61 35.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.908 -0.587 . . . . 54.1 110.857 -177.695 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.26 -45.8 89.8 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.378 -0.374 . . . . 72.2 110.881 -179.307 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -65.21 -35.45 81.11 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.402 -0.363 . . . . 74.32 110.893 178.573 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.429 ' O ' HG23 ' A' ' 514' ' ' VAL . 51.1 tptt -62.79 -45.88 90.6 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.37 -0.604 . . . . 73.02 109.37 178.204 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -63.62 -37.42 87.28 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 115.951 -0.568 . . . . 74.54 111.08 177.37 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . 0.455 HD11 HD12 ' A' ' 551' ' ' ILE . 59.4 tp -59.8 -43.18 94.6 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.826 -0.625 . . . . 44.33 109.457 177.122 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 13.5 m120 -63.25 -38.03 89.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.611 -0.722 . . . . 71.53 110.192 177.711 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 510' ' ' LYS . 94.9 t -63.69 -33.37 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 115.564 -0.743 . . . . 51.04 110.651 176.829 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -68.01 -27.49 66.6 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.85 0.357 . . . . 64.41 110.138 178.568 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 131.57 -18.31 4.91 Favored Glycine 0 CA--C 1.506 -0.499 0 C-N-CA 121.006 -0.616 . . . . 64.1 112.267 178.721 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.46 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 85.9 m-85 -78.63 115.15 18.14 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.347 0.594 . . . . 71.55 110.001 -177.025 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 12.5 p -86.87 -16.69 35.28 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.796 -0.638 . . . . 72.13 112.71 -176.83 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 36.2 mtmm -117.29 130.87 56.83 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.232 0.539 . . . . 64.2 112.001 -174.612 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . 0.444 ' HB3' HD23 ' A' ' 512' ' ' LEU . 12.2 p90 -130.07 156.81 43.9 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.346 -0.843 . . . . 73.05 112.398 -177.852 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 49.2 m -140.17 158.36 44.16 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 106.831 -1.544 . . . . 55.25 106.831 173.174 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . 0.524 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 0.0 OUTLIER -135.37 145.24 47.16 Favored 'General case' 0 N--CA 1.413 -2.312 0 CA-C-N 118.293 0.497 . . . . 62.51 109.986 179.395 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -129.82 116.13 18.25 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.239 -1.022 . . . . 41.25 108.239 176.072 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 18.4 m -88.12 120.89 29.9 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.726 -0.472 . . . . 61.31 109.726 178.91 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 47.5 t -120.8 148.12 24.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 107.258 -1.386 . . . . 75.5 107.258 -179.616 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . 0.453 ' HB2' HD21 ' A' ' 559' ' ' ASN . 9.5 p-10 -68.86 136.41 52.63 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.185 0.517 . . . . 44.42 111.55 -175.978 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 69.6 m -156.78 176.36 2.65 Favored Pre-proline 0 C--N 1.3 -1.549 0 N-CA-C 108.709 -0.849 . . . . 54.33 108.709 -179.285 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -83.32 -14.48 8.2 Favored 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 121.947 1.764 . . . . 62.21 111.598 171.349 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.588 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 0.0 OUTLIER -76.04 140.75 70.35 Favored Pre-proline 0 C--O 1.215 -0.716 0 CA-C-N 115.925 -0.579 . . . . 74.01 109.542 -179.743 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -56.61 144.82 84.22 Favored 'Trans proline' 0 C--O 1.249 1.026 0 C-N-CA 123.399 2.733 . . . . 74.25 113.432 -176.962 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.64 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -62.7 117.51 6.39 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 114.498 -1.228 . . . . 73.14 110.472 -178.329 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . 0.438 ' O ' HG23 ' A' ' 505' ' ' VAL . . . 126.82 -19.3 6.18 Favored Glycine 0 C--N 1.3 -1.431 0 C-N-CA 120.48 -0.867 . . . . 74.12 111.48 179.828 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -83.58 125.81 32.18 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 120.735 0.302 . . . . 74.25 110.548 177.752 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 62.0 t -81.92 118.84 30.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.093 -1.077 . . . . 64.24 108.093 178.357 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 99.2 m -104.66 -21.54 13.38 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 120.295 -0.562 . . . . 71.04 112.46 -177.013 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -159.16 -178.4 33.13 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 119.433 -1.365 . . . . 42.11 112.12 178.964 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 25.5 p -124.84 156.6 37.58 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.409 -1.33 . . . . 73.14 107.409 175.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.526 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 23.0 t-20 -60.03 -56.99 30.05 Favored Pre-proline 0 CA--C 1.55 0.965 0 CA-C-O 119.307 -0.377 . . . . 44.3 110.777 179.617 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.526 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 98.1 Cg_endo -84.09 143.65 10.37 Favored 'Trans proline' 0 C--N 1.367 1.51 0 CA-C-N 120.307 1.146 . . . . 74.51 110.095 172.849 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.97 148.98 58.42 Favored 'Trans proline' 0 C--O 1.258 1.506 0 C-N-CA 122.164 1.909 . . . . 62.04 112.026 179.642 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.06 134.53 57.07 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 115.908 -0.587 . . . . 75.5 109.681 178.179 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.83 -5.8 34.88 Favored Glycine 0 C--N 1.304 -1.235 0 C-N-CA 120.058 -1.068 . . . . 55.25 111.365 -175.266 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.477 ' O ' HG12 ' A' ' 497' ' ' ILE . 88.5 m -82.65 131.08 35.21 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.266 -1.013 . . . . 74.21 108.266 173.636 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 9.7 t -101.03 127.5 47.52 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-O 121.172 0.511 . . . . 52.31 109.891 178.669 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 31.0 m -138.55 165.12 35.16 Favored Pre-proline 0 C--N 1.313 -1.015 0 N-CA-C 108.547 -0.909 . . . . 65.54 108.547 -178.244 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -62.49 143.28 92.9 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.214 1.943 . . . . 51.43 111.547 175.094 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 32.4 m -62.38 -19.78 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.606 0.762 . . . . 73.45 113.016 -176.848 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -87.96 -14.88 38.03 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.251 -0.431 . . . . 73.13 111.246 -175.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 51.8 m -62.71 161.87 11.69 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 114.677 1.362 . . . . 65.42 114.677 -173.397 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 7.7 p -93.95 123.89 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-N 115.193 -0.912 . . . . 65.55 110.269 -179.507 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . 0.455 HD12 HD11 ' A' ' 512' ' ' LEU . 52.3 mt -108.17 138.85 32.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 120.379 -0.528 . . . . 74.23 111.094 179.472 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -101.77 120.93 41.14 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 115.617 -0.719 . . . . 72.03 109.782 -179.077 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 1.5 mm? -95.73 126.34 40.93 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.153 -1.425 . . . . 75.32 107.153 176.671 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . 0.29 1.7 pt20 -102.19 120.5 40.57 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 122.698 1.237 . . . . 74.0 111.091 179.716 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 42.7 t -101.38 145.04 12.16 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-N 112.83 -1.986 . . . . 71.41 109.986 -169.076 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.64 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 73.9 m -82.07 133.06 35.26 Favored 'General case' 0 N--CA 1.41 -2.452 0 CA-C-O 121.552 0.691 . . . . 61.11 111.529 175.631 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -88.26 137.95 31.87 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 104.966 -2.235 . . . . 61.41 104.966 168.577 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . 0.588 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -81.69 -43.15 8.55 Favored Glycine 0 CA--C 1.475 -2.446 0 C-N-CA 120.252 -0.975 . . . . 54.1 113.786 -170.434 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . 0.453 HD21 ' HB2' ' A' ' 526' ' ' ASP . 78.5 m-20 67.83 -31.77 0.19 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.043 0.937 . . . . 74.44 113.286 -176.785 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.457 ' H ' ' C ' ' A' ' 558' ' ' GLY . 3.0 tp60 -126.57 140.48 52.41 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 108.903 -0.777 . . . . 72.31 108.903 -175.047 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -143.45 139.09 29.73 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.765 -0.828 . . . . 61.23 108.765 174.741 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 9.6 p -59.81 124.11 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-O 121.647 0.737 . . . . 72.43 112.709 -176.252 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 57.9 ttp -95.34 137.76 22.03 Favored Pre-proline 0 C--O 1.249 1.039 0 CA-C-N 115.886 -0.597 . . . . 74.41 110.512 -179.93 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -64.22 170.01 9.91 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 123.246 2.631 . . . . 44.33 111.311 172.165 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . 0.455 ' HA ' ' HB2' ' A' ' 610' ' ' ALA . 3.5 p-10 -70.92 138.26 49.96 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.723 0.773 . . . . 63.1 112.51 -176.554 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 94.5 mt -136.15 15.53 3.26 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.287 -1.324 . . . . 75.01 107.938 174.844 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 27.7 t -67.37 134.2 51.05 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 115.302 -0.863 . . . . 72.44 109.885 -177.407 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 86.07 40.11 7.68 Favored Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 110.41 -1.076 . . . . 42.05 110.41 179.953 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 21.5 ptm -109.29 158.0 18.3 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.979 -0.749 . . . . 44.52 108.979 -179.831 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . 0.493 ' H ' ' HB3' ' A' ' 573' ' ' ASP . 77.3 m-85 -108.75 165.16 11.76 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 106.739 -1.578 . . . . 73.2 106.739 175.603 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 24.6 t90 -71.59 -30.31 65.68 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 108.979 -0.749 . . . . 75.33 108.979 177.101 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 30.0 m -80.08 -6.06 9.07 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 CA-C-O 121.793 0.806 . . . . 64.52 109.798 176.677 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . 0.493 ' HB3' ' H ' ' A' ' 570' ' ' PHE . 14.1 t70 -99.38 -30.03 12.43 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.905 -1.146 . . . . 73.52 107.905 177.199 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -62.86 -42.01 99.59 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 114.496 -1.229 . . . . 35.11 110.735 177.476 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 578' ' ' LEU . 44.2 tt0 -57.4 -52.25 75.62 Favored Pre-proline 0 CA--C 1.577 1.982 0 N-CA-C 113.014 0.746 . . . . 73.13 113.014 179.261 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . 0.42 ' HD2' ' C ' ' A' ' 573' ' ' ASP . 75.0 Cg_exo -55.38 -40.03 87.77 Favored 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 121.963 1.776 . . . . 65.44 112.172 173.114 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -68.3 -34.1 75.54 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.43 -0.508 . . . . 64.44 112.078 177.853 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.427 ' HB3' ' O ' ' A' ' 575' ' ' GLU . 5.9 tt -58.77 -49.47 77.54 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.268 0.627 . . . . 62.22 109.724 178.848 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -67.37 -40.96 85.78 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.286 0.847 . . . . 74.13 113.286 177.138 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.57 -39.86 88.69 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.186 0.439 . . . . 62.4 112.186 -177.666 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 10.4 mp -86.3 -8.97 57.31 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 111.971 0.36 . . . . 75.34 111.971 -179.276 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 68.34 21.81 74.35 Favored Glycine 0 C--O 1.241 0.559 0 N-CA-C 111.317 -0.713 . . . . 62.41 111.317 -177.54 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . 0.402 ' CZ2' HG22 ' A' ' 620' ' ' ILE . 42.9 t90 -60.61 126.96 29.37 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 123.198 0.599 . . . . 73.44 111.031 -177.359 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 8.8 m -130.41 89.44 2.78 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 115.517 -0.765 . . . . 71.51 109.122 178.153 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -144.14 -142.67 3.94 Favored Glycine 0 N--CA 1.426 -2.023 0 N-CA-C 109.479 -1.448 . . . . 65.13 109.479 177.43 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 14.4 tpt -129.0 131.41 47.42 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.768 -0.827 . . . . 71.31 108.768 179.099 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -98.03 123.1 41.89 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.07 -1.456 . . . . 73.32 107.07 177.066 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -98.11 107.38 19.85 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.995 -0.548 . . . . 72.43 109.994 -178.422 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.49 133.26 36.97 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.98 -0.554 . . . . 53.55 110.954 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -97.95 -164.83 31.38 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.737 -0.665 . . . . 62.33 113.406 -175.086 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -74.84 141.3 44.26 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 123.178 0.591 . . . . 53.43 110.834 -178.266 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -85.64 133.26 34.04 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.622 -0.717 . . . . 73.43 109.646 -177.096 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 73.4 t -125.34 115.41 43.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 107.206 -1.405 . . . . 75.42 107.206 175.337 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -86.02 107.64 17.88 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.221 -0.992 . . . . 51.32 110.213 -179.736 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -124.05 -11.17 7.59 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.212 -0.904 . . . . 74.25 111.495 -178.788 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 119.18 -172.67 14.7 Favored Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 121.099 -0.572 . . . . 73.32 111.673 177.779 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.87 -34.03 64.56 Favored Glycine 0 C--O 1.222 -0.623 0 N-CA-C 114.514 0.566 . . . . 40.43 114.514 -175.53 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 19.0 m -66.14 -24.72 66.72 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 117.344 0.572 . . . . 72.53 111.997 -178.445 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -109.66 -0.83 18.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.282 0.563 . . . . 74.1 111.286 178.616 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -67.62 105.42 1.87 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.195 -0.911 . . . . 62.51 113.099 -175.261 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 62.87 0.94 0.75 Allowed 'General case' 0 CA--C 1.56 1.352 0 C-N-CA 125.773 1.629 . . . . 70.52 114.081 171.713 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . 0.431 ' HD2' ' O ' ' A' ' 603' ' ' VAL . 8.7 tmm_? -90.93 148.47 22.42 Favored 'General case' 0 C--N 1.313 -0.995 0 O-C-N 121.911 -0.493 . . . . 71.32 110.607 -178.174 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . 0.469 HG23 ' HB2' ' A' ' 622' ' ' LEU . 7.1 p -56.11 131.76 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.01 0.924 . . . . 51.15 111.465 -177.634 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 14.7 p -106.91 -34.89 2.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 C-N-CA 119.9 -0.72 . . . . 60.14 109.385 -178.728 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -154.12 148.43 26.0 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 105.114 -2.18 . . . . 70.13 105.114 171.559 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -122.39 136.56 54.92 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 108.713 -0.847 . . . . 74.01 108.713 176.627 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.575 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 24.5 t-20 -59.37 -52.39 74.65 Favored Pre-proline 0 C--N 1.309 -1.164 0 CA-C-N 115.443 -0.799 . . . . 65.52 111.298 -178.436 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.575 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 29.6 Cg_endo -105.27 110.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.962 0 C-N-CA 121.883 1.722 . . . . 40.22 111.389 173.341 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -67.76 156.86 64.33 Favored 'Trans proline' 0 C--O 1.239 0.545 0 C-N-CA 122.139 1.893 . . . . 54.21 110.705 176.408 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . 0.455 ' HB2' ' HA ' ' A' ' 565' ' ' ASP . . . -60.07 137.35 58.11 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 110.009 -0.367 . . . . 72.01 110.009 178.975 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 90.05 0.96 76.83 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 119.44 -1.362 . . . . 63.24 111.564 -178.355 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 9.8 m -107.95 155.62 20.11 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.999 -1.111 . . . . 75.14 107.999 178.182 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -81.64 132.16 10.96 Favored Glycine 0 N--CA 1.418 -2.515 0 CA-C-N 116.352 -0.386 . . . . 74.2 112.525 -179.433 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 22.2 m -101.14 142.55 15.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 123.222 0.609 . . . . 73.44 110.375 177.008 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.516 ' OD1' HG22 ' A' ' 619' ' ' ILE . 0.0 OUTLIER -54.55 149.39 10.69 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.234 0.959 . . . . 74.44 111.96 178.171 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . 0.255 0.0 OUTLIER -61.0 -24.38 66.1 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.752 1.019 . . . . 75.51 113.752 179.929 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -68.62 -31.3 70.36 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 109.159 -0.682 . . . . 74.54 109.159 176.062 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 88.91 9.52 67.93 Favored Glycine 0 N--CA 1.418 -2.525 0 CA-C-N 115.006 -0.997 . . . . 75.52 113.264 176.855 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . 0.516 HG22 ' OD1' ' A' ' 615' ' ' ASN . 0.0 OUTLIER -69.59 119.57 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 CA-C-N 118.547 1.174 . . . . 54.5 109.103 -175.675 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.402 HG22 ' CZ2' ' A' ' 583' ' ' TRP . 0.0 OUTLIER -118.51 131.93 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 N-CA-C 108.836 -0.801 . . . . 63.2 108.836 -176.881 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.501 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 60.1 m -118.08 127.84 54.18 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 120.867 0.365 . . . . 63.12 111.627 -178.585 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . 0.469 ' HB2' HG23 ' A' ' 603' ' ' VAL . 0.0 OUTLIER -138.5 150.91 46.89 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 105.455 -2.054 . . . . 74.51 105.455 174.048 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -127.74 156.17 42.85 Favored 'General case' 0 C--N 1.266 -3.044 0 N-CA-C 106.079 -1.823 . . . . 70.33 106.079 179.248 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -131.13 165.63 22.86 Favored 'General case' 0 C--N 1.275 -2.634 0 N-CA-C 106.847 -1.538 . . . . 71.45 106.847 179.644 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -71.72 -84.96 0.2 Allowed Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 109.224 -1.551 . . . . 71.53 109.224 175.408 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 . . . . . 0 C--N 1.299 -1.594 0 N-CA-C 108.697 -0.853 . . . . 74.14 108.697 174.346 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 . . . . . 0 C--O 1.244 0.79 0 N-CA-C 109.012 -0.736 . . . . 74.14 109.012 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.76 142.93 27.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 109.725 -0.472 . . . . 63.13 109.725 -176.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . 0.495 HE21 ' C ' ' A' ' 361' ' ' GLN . 0.0 OUTLIER -95.41 118.63 32.5 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.934 -1.506 . . . . 70.03 106.934 -176.853 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.44 ' HB ' ' O ' ' A' ' 406' ' ' ALA . 65.3 t -97.09 141.07 22.5 Favored Pre-proline 0 C--N 1.288 -2.093 0 CA-C-N 115.181 -0.918 . . . . 62.34 110.927 -170.284 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -66.49 142.87 66.97 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 121.84 1.693 . . . . 75.5 109.741 174.859 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . 0.465 ' HB2' ' ND2' ' A' ' 407' ' ' ASN . 35.1 t0 -95.83 142.61 27.89 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.915 -1.143 . . . . 72.33 107.915 -177.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.521 ' CG2' ' HA ' ' A' ' 373' ' ' ALA . 11.4 p -106.2 -7.47 10.22 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.676 0 CA-C-N 115.253 -0.885 . . . . 62.32 112.45 -168.472 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . 0.254 2.2 ppt_? -54.39 146.56 15.51 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.834 1.42 . . . . 74.22 114.834 175.884 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.44 0.79 40.55 Favored Glycine 0 C--O 1.24 0.482 0 CA-C-N 115.333 -0.848 . . . . 62.31 111.698 -177.219 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -119.33 -153.48 0.54 Allowed 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.545 -0.909 . . . . 75.2 108.545 177.672 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 51.5 p -96.35 153.47 17.8 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.503 -0.925 . . . . 74.23 108.503 -178.215 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 32.1 t -57.39 -37.34 72.52 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 123.322 0.389 . . . . 71.14 110.14 178.503 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.09 -47.04 75.51 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 119.287 -0.387 . . . . 70.33 111.412 179.78 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -70.05 -34.72 73.58 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 119.734 -0.786 . . . . 60.3 109.999 179.685 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . 0.521 ' HA ' ' CG2' ' A' ' 365' ' ' VAL . . . -63.39 -51.47 65.7 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.107 -0.951 . . . . 51.32 111.162 179.801 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . 0.41 HG23 HG13 ' A' ' 384' ' ' ILE . 82.3 mt -64.05 -40.26 88.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.957 -0.565 . . . . 74.41 109.908 176.654 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.71 -47.35 84.88 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.107 -0.497 . . . . 52.05 111.007 -178.12 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . 0.466 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 37.3 m -63.14 -47.27 83.44 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.794 -0.639 . . . . 72.12 110.16 -178.901 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 95.4 mt -64.04 -41.4 97.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.006 -0.543 . . . . 45.21 111.11 -178.842 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -63.12 -42.43 99.53 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.284 -0.416 . . . . 64.31 110.662 179.375 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -68.52 -20.33 64.56 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 111.915 0.339 . . . . 74.23 111.915 179.323 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 376' ' ' THR . 34.0 mmt180 -88.05 -14.18 39.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.345 -0.389 . . . . 72.33 110.335 176.164 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.46 16.72 45.13 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 120.655 -0.783 . . . . 74.51 112.463 179.231 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -88.85 156.21 19.07 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-O 121.327 0.584 . . . . 75.43 112.062 179.597 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -93.16 143.78 25.92 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 115.014 -0.993 . . . . 72.14 108.741 -177.712 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . 0.446 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -130.37 146.04 34.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-O 121.172 0.51 . . . . 74.52 110.223 -178.356 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -128.02 126.85 42.1 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 105.971 -1.863 . . . . 74.44 105.971 171.233 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 8.0 m -115.06 123.62 49.49 Favored 'General case' 0 C--N 1.274 -2.713 0 N-CA-C 107.212 -1.403 . . . . 64.41 107.212 -178.137 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -110.87 121.47 45.42 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.527 -0.916 . . . . 73.43 108.527 -177.774 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -90.55 133.79 34.83 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.678 -0.692 . . . . 72.13 110.441 -176.626 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 421' ' ' SER . 98.1 mttt -136.93 145.34 50.28 Favored Pre-proline 0 C--N 1.312 -1.044 0 N-CA-C 108.896 -0.779 . . . . 74.34 108.896 172.918 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . 0.503 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 56.7 Cg_endo -101.28 135.78 0.16 Allowed 'Trans proline' 0 CA--C 1.554 1.498 0 C-N-CA 122.0 1.8 . . . . 64.43 111.5 169.569 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.571 ' OD2' HG22 ' A' ' 393' ' ' THR . 12.9 t70 161.64 -168.03 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 126.073 1.749 . . . . 72.13 107.339 174.911 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . 0.413 ' H ' ' CG ' ' A' ' 391' ' ' ASP . 32.3 t -128.17 -15.6 4.67 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 118.03 0.377 . . . . 61.4 110.558 179.421 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.571 HG22 ' OD2' ' A' ' 391' ' ' ASP . 13.1 t -79.75 -29.97 40.64 Favored 'General case' 0 C--O 1.252 1.209 0 N-CA-C 108.836 -0.802 . . . . 73.15 108.836 177.125 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.88 126.02 55.06 Favored Pre-proline 0 N--CA 1.417 -2.101 0 N-CA-C 105.22 -2.141 . . . . 70.52 105.22 165.519 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . 0.498 ' HG3' HD12 ' A' ' 400' ' ' ILE . 95.1 Cg_endo -78.51 155.06 27.93 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 N-CA-C 117.343 2.017 . . . . 64.23 117.343 -167.23 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . 0.518 ' HA ' ' O ' ' A' ' 421' ' ' SER . 74.0 Cg_exo -53.9 167.73 1.02 Allowed 'Trans proline' 0 CA--C 1.492 -1.585 1 C-N-CA 126.081 4.52 . . . . 62.14 111.709 170.888 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . 0.514 ' HA ' HG23 ' A' ' 420' ' ' VAL . 4.5 p-10 -51.57 -5.93 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 127.149 2.18 . . . . 74.21 115.836 -164.523 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -80.42 109.06 14.56 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.069 -1.456 . . . . 63.23 107.069 170.104 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 24.7 m -83.94 120.99 35.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 115.14 -0.937 . . . . 63.54 113.418 -168.558 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . 0.498 HD12 ' HG3' ' A' ' 395' ' ' PRO . 0.2 OUTLIER -84.92 -27.71 6.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.611 -0.722 . . . . 73.34 109.822 177.18 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.9 157.53 27.4 Favored Glycine 0 N--CA 1.42 -2.427 0 C-N-CA 119.389 -1.386 . . . . 73.23 113.988 -176.597 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 11.7 p -136.29 -173.83 3.51 Favored 'General case' 0 C--N 1.273 -2.721 0 C-N-CA 128.701 2.8 . . . . 45.23 104.825 -177.588 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -97.8 129.34 31.52 Favored Pre-proline 0 C--N 1.286 -2.154 0 N-CA-C 106.633 -1.617 . . . . 62.43 106.633 179.688 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.18 -1.26 0.17 Allowed 'Trans proline' 0 C--N 1.367 1.548 0 C-N-CA 124.731 3.621 . . . . 61.43 115.512 -176.368 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -50.45 -36.88 35.31 Favored 'General case' 0 C--O 1.209 -1.074 0 C-N-CA 124.15 0.98 . . . . 33.13 109.484 173.511 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . 0.44 ' O ' ' HB ' ' A' ' 362' ' ' VAL . . . -59.31 -50.05 75.47 Favored 'General case' 0 C--O 1.217 -0.651 0 O-C-N 123.54 0.525 . . . . 33.41 110.902 178.678 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . 0.465 ' ND2' ' HB2' ' A' ' 364' ' ' ASP . 13.3 m120 -82.56 0.16 44.05 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 120.448 -0.501 . . . . 73.15 111.991 -178.989 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 30.2 m -86.31 150.07 24.6 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 105.134 -2.173 . . . . 64.35 105.134 173.104 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 19.4 m -75.79 112.34 12.07 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 106.372 -1.714 . . . . 42.31 106.372 175.862 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 31.0 m -125.92 169.52 17.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-O 121.009 0.433 . . . . 65.22 111.192 -174.941 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 21.4 t -77.46 140.79 39.89 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 107.353 -1.351 . . . . 71.41 107.353 176.896 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -57.86 109.71 0.78 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.026 0.441 . . . . 72.4 111.277 -178.652 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 105.32 61.64 0.64 Allowed Glycine 0 N--CA 1.436 -1.358 0 N-CA-C 111.183 -0.767 . . . . 53.51 111.183 -179.99 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -111.01 177.18 4.74 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.163 -0.68 . . . . 31.1 109.163 179.92 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -90.06 112.67 24.18 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 124.296 1.038 . . . . 62.42 111.345 -174.38 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 39.5 mm -107.11 109.23 27.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 109.71 -0.478 . . . . 73.4 109.71 177.657 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 40.9 p -88.38 131.18 34.95 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 122.705 0.402 . . . . 60.32 110.308 179.765 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 6.1 p -127.19 133.29 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 109.448 -0.575 . . . . 63.11 109.448 176.736 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -97.41 128.94 44.63 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.736 -0.839 . . . . 64.44 108.736 174.552 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.514 HG23 ' HA ' ' A' ' 397' ' ' ASP . 7.0 p -129.57 143.89 39.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.886 -0.783 . . . . 72.34 108.886 -176.509 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . 0.557 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 14.5 m -119.58 130.01 54.92 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 119.156 -1.017 . . . . 54.2 111.359 -178.821 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 5.3 t -119.09 107.06 13.02 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.483 -0.78 . . . . 71.2 111.285 -179.504 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.903 0 CA-C-N 116.276 -0.42 . . . . 71.42 113.63 177.159 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.416 ' CB ' HG22 ' A' ' 477' ' ' THR . 15.6 mt-30 . . . . . 0 N--CA 1.428 -1.561 0 N-CA-C 106.434 -1.691 . . . . 73.31 106.434 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.479 ' HG2' HD11 ' A' ' 480' ' ' ILE . 57.4 mmm-85 -126.61 163.73 22.79 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.594 -0.691 . . . . 74.4 111.977 -178.891 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.1 138.74 33.57 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 114.535 -1.211 . . . . 62.01 108.832 -179.084 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 62.4 mt -91.27 123.72 63.41 Favored Pre-proline 0 N--CA 1.425 -1.701 0 N-CA-C 108.515 -0.921 . . . . 74.11 108.515 177.103 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -71.4 141.01 37.85 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 121.617 1.545 . . . . 63.52 109.733 171.588 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -87.75 168.34 13.05 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.261 -1.014 . . . . 72.03 108.261 177.372 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.681 HG11 ' HB2' ' A' ' 440' ' ' ALA . 13.8 p -153.98 164.94 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.266 -1.013 . . . . 75.14 108.266 -175.546 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 37.6 m -75.95 147.9 38.57 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.435 -0.95 . . . . 62.15 108.435 174.139 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 47.0 p -66.45 -27.99 68.24 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 114.486 1.291 . . . . 51.44 114.486 -170.877 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.1 pp -79.49 -15.83 57.08 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.295 -0.878 . . . . 54.11 112.35 176.522 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.01 47.91 1.16 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.09 0.471 . . . . 72.02 111.34 -174.568 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . 0.479 ' OH ' ' HB2' ' A' ' 454' ' ' GLN . 71.2 t80 -52.95 -38.65 62.23 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.27 0.628 . . . . 74.2 112.634 178.629 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.36 -39.61 91.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.427 0.632 . . . . 73.23 110.731 179.79 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -70.3 -35.37 73.64 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.509 -0.769 . . . . 64.34 109.879 178.857 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.681 ' HB2' HG11 ' A' ' 432' ' ' VAL . . . -59.64 -51.23 70.69 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.839 -0.619 . . . . 63.13 111.092 -178.892 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.1 m -65.44 -39.09 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 112.275 0.472 . . . . 64.24 112.275 -178.28 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . 0.273 0.1 OUTLIER -68.17 -34.43 76.29 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 119.556 -0.858 . . . . 74.53 112.1 176.602 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -63.35 -42.01 98.9 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 116.565 -0.289 . . . . 61.34 110.584 174.885 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 93.3 mt -63.57 -33.15 74.96 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.11 -0.495 . . . . 73.3 110.551 178.916 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 48.2 m -70.08 -43.84 70.29 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.13 -0.486 . . . . 63.41 110.065 179.493 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.23 -15.36 62.45 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.675 0.75 . . . . 63.43 110.706 178.801 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -87.01 -0.9 57.38 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.451 -0.795 . . . . 74.43 111.659 179.531 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 112.79 -77.56 0.24 Allowed Glycine 0 CA--C 1.499 -0.963 0 C-N-CA 120.201 -1.0 . . . . 74.44 112.28 176.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . 0.431 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 0.1 OUTLIER -43.55 -65.55 0.48 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.521 0.934 . . . . 74.41 113.521 177.318 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 62.11 21.64 61.85 Favored Glycine 0 C--O 1.226 -0.354 0 C-N-CA 121.077 -0.582 . . . . 74.34 111.704 -175.421 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -102.91 110.78 22.83 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 108.213 -1.032 . . . . 70.14 108.213 -178.004 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.452 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 27.8 p90 -142.68 163.93 31.49 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 115.59 -0.732 . . . . 73.34 109.665 -175.95 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -151.89 124.14 8.22 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.862 -0.792 . . . . 72.33 108.862 176.356 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . 0.479 ' HB2' ' OH ' ' A' ' 437' ' ' TYR . 57.3 tt0 -87.22 128.4 35.15 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 123.454 0.471 . . . . 74.34 109.959 179.897 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -122.17 138.03 54.62 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.23 -1.026 . . . . 73.33 108.23 175.025 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -114.44 133.16 55.95 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.84 -1.171 . . . . 75.52 107.84 -179.13 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 49.1 m -151.73 145.35 17.69 Favored Pre-proline 0 C--N 1.298 -1.638 0 N-CA-C 109.676 -0.49 . . . . 63.33 109.676 176.846 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.684 ' HA ' ' O ' ' A' ' 490' ' ' SER . 29.2 Cg_endo -65.3 122.54 10.29 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.147 1.898 . . . . 63.12 109.264 177.398 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 35.2 m -134.04 179.88 5.98 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 115.634 -0.712 . . . . 35.22 109.734 -173.276 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 6.0 t -54.16 135.84 59.12 Favored Pre-proline 0 N--CA 1.436 -1.166 0 O-C-N 124.26 0.975 . . . . 71.44 109.552 178.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -50.97 -29.76 28.47 Favored 'Trans proline' 0 N--CA 1.477 0.512 0 C-N-CA 124.689 3.592 . . . . 55.31 115.085 -171.679 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -75.58 -22.38 57.01 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.973 0.416 . . . . 64.13 112.018 179.272 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -98.37 -5.91 31.8 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.842 0.353 . . . . 64.22 110.692 177.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 62.3 t -61.42 127.72 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 109.163 -0.681 . . . . 74.32 109.163 174.233 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 85.93 -4.02 86.41 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 111.415 -0.674 . . . . 63.32 111.415 -179.162 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -122.46 156.82 33.28 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 121.558 0.695 . . . . 55.43 109.433 -177.064 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 47.4 t -71.09 142.59 15.38 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.503 0 CA-C-N 114.599 -1.182 . . . . 73.51 108.128 173.089 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 52.1 mt -97.59 -28.99 3.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 108.809 -0.811 . . . . 73.45 108.809 179.71 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 154.74 -170.11 33.01 Favored Glycine 0 N--CA 1.427 -1.957 0 C-N-CA 120.337 -0.935 . . . . 64.41 112.16 177.042 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . 0.565 HG22 HG12 ' A' ' 486' ' ' ILE . 36.1 p -115.45 139.9 49.62 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.803 -1.555 . . . . 72.42 106.803 -179.824 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.435 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 9.0 t30 -63.43 -50.9 71.36 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 119.361 -0.935 . . . . 74.13 112.037 177.481 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.435 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 22.0 Cg_exo -75.06 151.11 38.84 Favored 'Trans proline' 0 C--N 1.36 1.157 0 N-CA-C 108.5 -1.385 . . . . 62.33 108.5 170.456 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.24 127.07 20.06 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.004 1.802 . . . . 73.15 112.173 -178.508 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -89.06 3.86 50.32 Favored 'General case' 0 C--O 1.207 -1.175 0 CA-C-N 115.511 -0.768 . . . . 75.21 110.732 -177.928 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -111.08 8.14 21.7 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.524 -0.762 . . . . 72.3 109.933 179.499 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -125.69 179.59 5.09 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 116.198 -0.455 . . . . 74.21 111.043 -174.247 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.416 HG22 ' CB ' ' A' ' 426' ' ' GLN . 3.6 m -89.84 117.57 28.78 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 115.516 -0.766 . . . . 42.11 109.481 179.917 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 50.1 m -118.94 148.68 42.69 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.471 -0.566 . . . . 53.11 109.471 -179.172 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -73.16 153.38 40.75 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.67 0.619 . . . . 70.1 112.67 -174.503 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . 0.479 HD11 ' HG2' ' A' ' 427' ' ' ARG . 2.2 mp -65.03 -26.82 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-O 121.756 0.788 . . . . 70.43 110.695 178.75 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 12.2 p -90.85 5.38 48.7 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.477 -0.783 . . . . 62.04 111.502 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -103.33 129.6 50.41 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.084 -0.507 . . . . 61.24 109.958 -176.55 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.2 p -98.58 127.19 51.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.706 -0.679 . . . . 70.05 111.408 -176.086 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 33.5 m -96.67 123.45 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-O 121.403 0.62 . . . . 71.54 110.618 178.121 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.95 128.99 43.27 Favored 'Isoleucine or valine' 0 C--O 1.256 1.435 0 N-CA-C 107.994 -1.113 . . . . 70.11 107.994 176.844 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.565 HG12 HG22 ' A' ' 470' ' ' THR . 42.2 mt -119.72 119.59 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 CA-C-N 114.996 -1.002 . . . . 60.13 110.269 -175.692 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 5.8 tt -103.03 127.12 57.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 115.295 -0.866 . . . . 73.53 111.176 -178.513 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 1.9 p -107.93 136.21 44.09 Favored 'Isoleucine or valine' 0 C--O 1.256 1.403 0 CA-C-N 115.361 -0.836 . . . . 64.12 108.973 176.05 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -73.53 127.95 11.0 Favored Glycine 0 N--CA 1.419 -2.483 0 N-CA-C 110.619 -0.993 . . . . 71.21 110.619 179.328 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.684 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 14.4 t . . . . . 0 C--N 1.28 -2.455 0 N-CA-C 106.907 -1.516 . . . . 71.45 106.907 178.345 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo . . . . . 0 N--CA 1.448 -1.178 0 N-CA-C 110.897 -0.463 . . . . 73.23 110.897 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . -84.86 52.78 2.51 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.997 -0.742 . . . . 54.4 108.997 179.888 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 546' ' ' PRO . 24.3 p -116.5 148.14 41.08 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 115.231 -0.895 . . . . 63.24 110.423 -174.234 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -145.45 155.06 42.89 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 108.138 -1.06 . . . . 65.43 108.138 178.353 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -89.82 122.9 33.32 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.638 -0.505 . . . . 60.35 109.638 -177.565 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 37.0 pt -79.55 136.29 55.95 Favored Pre-proline 0 C--N 1.307 -1.264 0 O-C-N 123.271 0.357 . . . . 73.54 111.341 -179.433 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -85.18 -174.32 1.66 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.643 2.229 . . . . 75.24 110.266 174.719 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -92.59 147.17 23.1 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.376 -0.601 . . . . 64.12 109.376 179.83 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 41.2 t -129.28 93.86 2.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 107.314 -1.365 . . . . 70.3 107.314 178.6 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -148.22 112.9 5.37 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 107.223 -1.399 . . . . 63.45 107.223 179.566 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 110.24 36.35 1.97 Allowed Glycine 0 N--CA 1.421 -2.314 0 N-CA-C 110.172 -1.171 . . . . 74.11 110.172 -178.016 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -143.1 166.79 23.7 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 108.33 -0.989 . . . . 75.3 108.33 178.651 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 532' ' ' GLY . 11.8 t -93.32 157.43 16.25 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.043 -1.465 . . . . 62.31 107.043 173.869 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 10.5 p -55.37 -40.43 57.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 112.235 0.457 . . . . 55.0 112.235 -178.599 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -58.32 -42.82 87.59 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.496 0.665 . . . . 52.32 110.949 179.503 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 99.6 t -76.37 -36.73 29.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.641 -0.708 . . . . 74.45 110.107 -179.219 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -61.35 -49.21 77.86 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.762 -0.654 . . . . 73.42 111.229 178.856 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -63.21 -37.19 86.26 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 120.485 -0.486 . . . . 71.52 110.32 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -62.64 -45.7 91.61 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.11 -0.7 . . . . 75.32 109.11 179.442 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -62.16 -48.66 79.07 Favored 'General case' 0 CA--C 1.494 -1.197 0 O-C-N 123.107 0.254 . . . . 62.5 111.291 179.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.77 -40.5 97.49 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 112.261 0.467 . . . . 64.32 112.261 -179.073 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -65.48 -37.98 88.42 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 120.718 -0.393 . . . . 63.23 110.99 179.146 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 68.7 t -68.92 -26.87 33.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.07 0.462 . . . . 63.1 110.741 176.755 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 17.4 m-30 -81.33 -1.78 46.59 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.262 -0.575 . . . . 75.25 110.14 178.951 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . 0.543 ' O ' ' HB ' ' A' ' 547' ' ' VAL . . . 101.78 -4.92 53.57 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.925 -0.655 . . . . 52.31 113.318 176.08 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -83.85 112.81 20.46 Favored 'General case' 0 CA--C 1.476 -1.899 0 N-CA-C 106.548 -1.649 . . . . 70.42 106.548 -177.541 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.3 m -89.19 -25.42 21.79 Favored 'General case' 0 N--CA 1.406 -2.656 0 CA-C-N 115.033 -0.985 . . . . 61.2 112.651 -167.66 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 96.8 mttt -116.15 125.06 51.82 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 120.117 -0.633 . . . . 52.32 111.035 -177.207 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -129.73 153.14 48.48 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 123.37 0.668 . . . . 74.42 109.909 -179.437 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 50.5 m -141.09 147.25 38.24 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 108.253 -1.017 . . . . 45.33 108.253 174.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -116.76 130.9 57.0 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-O 121.229 0.537 . . . . 74.15 110.417 179.81 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -105.34 119.79 39.95 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 107.68 -1.23 . . . . 71.32 107.68 176.149 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 42.3 m -90.0 121.27 31.93 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.271 0.558 . . . . 74.25 110.31 -178.423 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 26.9 m -121.77 153.64 25.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.427 -0.953 . . . . 55.34 108.427 178.345 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . 0.504 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 1.1 p-10 -89.04 136.44 33.01 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.036 -1.098 . . . . 54.41 108.036 178.135 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . 0.428 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 19.7 m -153.48 166.97 14.47 Favored Pre-proline 0 C--N 1.292 -1.912 0 N-CA-C 108.575 -0.898 . . . . 73.31 108.575 179.618 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -73.6 -3.71 14.19 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 121.775 1.65 . . . . 64.22 112.132 175.602 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.46 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 2.1 mpt_? -85.21 134.57 40.51 Favored Pre-proline 0 CA--C 1.515 -0.396 0 N-CA-C 108.093 -1.077 . . . . 72.22 108.093 179.476 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -56.23 143.95 83.2 Favored 'Trans proline' 0 C--O 1.242 0.724 0 C-N-CA 123.064 2.51 . . . . 34.43 113.723 -175.512 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -53.18 125.6 18.05 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 114.615 -1.175 . . . . 72.3 112.629 -174.801 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 504' ' ' THR . . . 114.41 -16.31 19.63 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.482 -0.781 . . . . 51.43 111.294 178.124 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -74.33 125.73 29.13 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.674 -0.491 . . . . 64.52 109.674 179.494 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 53.3 t -82.78 112.01 19.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.1 -1.444 . . . . 73.24 107.1 176.222 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 15.0 t -80.5 -18.51 48.37 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.755 -0.657 . . . . 75.43 111.114 -175.778 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 163.81 -170.0 38.96 Favored Glycine 0 CA--C 1.495 -1.182 0 C-N-CA 119.94 -1.124 . . . . 43.13 111.828 178.514 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 65.0 p -117.31 153.86 32.24 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.183 -1.043 . . . . 71.42 108.183 -179.95 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.559 ' CA ' HE22 ' A' ' 554' ' ' GLN . 34.5 t30 -77.25 -53.87 1.59 Allowed Pre-proline 0 C--N 1.314 -0.948 0 C-N-CA 120.116 -0.633 . . . . 73.21 110.565 177.813 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -70.63 126.94 13.25 Favored 'Trans proline' 0 C--N 1.357 0.993 0 N-CA-C 107.739 -1.677 . . . . 70.32 107.739 167.707 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.88 156.57 63.62 Favored 'Trans proline' 0 C--O 1.247 0.974 0 C-N-CA 122.499 2.132 . . . . 74.51 113.358 -175.348 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.09 138.71 58.43 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.661 -0.7 . . . . 55.21 109.914 178.423 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 98.12 -6.34 61.76 Favored Glycine 0 N--CA 1.433 -1.554 0 C-N-CA 120.261 -0.971 . . . . 42.02 112.088 -178.778 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 59.0 m -76.23 132.96 40.21 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 109.392 -0.595 . . . . 62.1 109.392 176.803 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 5.0 m -95.11 122.02 37.34 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 107.745 -1.205 . . . . 71.42 107.745 179.294 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 24.3 m -138.16 156.23 73.95 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 109.895 -0.409 . . . . 73.25 109.895 -178.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.52 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 37.5 Cg_exo -63.6 139.94 72.54 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.114 1.876 . . . . 64.01 111.375 175.417 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.543 ' HB ' ' O ' ' A' ' 516' ' ' GLY . 30.8 m -64.57 -20.31 26.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 121.841 0.829 . . . . 72.12 111.912 -179.746 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -77.88 -18.0 56.7 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.04 -0.982 . . . . 71.43 110.628 178.816 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 24.6 m -77.76 179.06 6.88 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 112.841 0.682 . . . . 75.21 112.841 -174.977 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 39.1 t -105.78 124.91 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 CA-C-N 115.108 -0.951 . . . . 74.42 109.644 -176.666 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . 0.488 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -104.87 135.87 40.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.96 -0.756 . . . . 72.23 108.96 173.43 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -106.85 119.71 40.08 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 116.02 -0.536 . . . . 62.23 111.21 -176.103 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -101.77 134.12 45.44 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.664 -1.153 . . . . 72.13 109.444 179.814 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . 0.559 HE22 ' CA ' ' A' ' 538' ' ' ASN . 2.0 mp0 -93.74 122.44 36.21 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.074 0.464 . . . . 75.12 109.844 175.659 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 50.3 t -112.58 130.37 66.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 107.95 -1.13 . . . . 73.42 107.95 -178.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 74.6 m -88.15 137.28 32.47 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-O 121.667 0.746 . . . . 63.33 112.318 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.504 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 4.1 ptpt -90.75 147.7 23.06 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 103.986 -2.598 . . . . 71.22 103.986 169.925 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -83.25 -24.9 50.15 Favored Glycine 0 CA--C 1.479 -2.158 0 C-N-CA 120.318 -0.944 . . . . 64.52 113.57 -171.08 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 615' ' ' ASN . 88.0 m-20 72.06 -44.03 0.58 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.578 1.151 . . . . 73.35 111.183 -177.283 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.465 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 97.5 mt-30 -119.81 141.73 49.24 Favored 'General case' 0 N--CA 1.424 -1.766 0 C-N-CA 123.548 0.739 . . . . 54.1 111.432 -175.767 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . 0.444 ' O ' ' HA2' ' A' ' 613' ' ' GLY . 45.4 p90 -126.99 149.74 49.74 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.489 -0.56 . . . . 74.31 109.489 178.46 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 99.8 t -59.49 120.3 5.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.06 0.457 . . . . 52.21 111.881 -177.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . 0.433 ' HA ' ' HD3' ' A' ' 564' ' ' PRO . 57.1 ttp -97.09 137.09 21.25 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 116.031 -0.532 . . . . 54.22 111.19 179.995 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 563' ' ' MET . 17.4 Cg_exo -68.68 170.28 15.59 Favored 'Trans proline' 0 CA--C 1.551 1.332 0 C-N-CA 123.5 2.8 . . . . 74.22 112.684 174.162 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.18 129.47 40.0 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 112.669 0.618 . . . . 53.53 112.669 179.385 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . 0.453 ' O ' ' HG2' ' A' ' 569' ' ' MET . 95.3 mt -114.74 12.38 17.04 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 122.271 1.034 . . . . 75.42 108.409 175.865 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 20.3 m -79.58 144.52 33.79 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.847 -1.069 . . . . 72.45 110.886 -178.863 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 80.62 9.62 86.19 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 114.616 0.606 . . . . 63.44 114.616 175.285 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . 0.453 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 26.5 ptm -112.44 164.05 13.73 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 117.427 0.614 . . . . 74.05 109.502 -179.006 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -103.98 163.97 12.02 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.487 0.661 . . . . 54.31 111.291 -177.281 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 19.6 t90 -62.07 -29.66 70.46 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 125.073 1.349 . . . . 72.11 109.488 176.422 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 34.3 m -71.29 -15.12 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 115.845 -0.616 . . . . 62.14 110.771 177.531 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -96.9 -34.84 11.1 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.336 -0.987 . . . . 72.31 108.336 175.904 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -60.86 -41.53 96.08 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.8 -1.091 . . . . 52.42 112.188 -178.259 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.492 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 38.7 mt-10 -59.73 -54.54 54.67 Favored Pre-proline 0 CA--C 1.554 1.127 0 N-CA-C 112.928 0.714 . . . . 73.34 112.928 -179.705 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 52.2 Cg_exo -59.58 -37.04 90.93 Favored 'Trans proline' 0 C--N 1.369 1.615 0 C-N-CA 121.388 1.392 . . . . 74.44 112.249 174.781 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -59.11 -47.88 83.65 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.347 0.659 . . . . 74.24 110.451 177.894 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.6 pp -67.16 -41.01 86.72 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.151 0.426 . . . . 73.04 112.151 -175.853 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -65.35 -40.03 93.1 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.571 -0.74 . . . . 75.42 110.968 -179.744 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.19 -38.34 87.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.611 -0.722 . . . . 64.24 112.025 -178.201 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.26 -8.51 48.17 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.676 0.621 . . . . 53.15 112.676 -178.851 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 68.09 40.37 88.36 Favored Glycine 0 C--N 1.311 -0.822 0 C-N-CA 119.927 -1.13 . . . . 74.42 110.567 -175.669 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . 0.426 ' HE3' ' HB2' ' A' ' 578' ' ' LEU . 83.2 t90 -82.25 135.33 35.25 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.469 -0.567 . . . . 62.2 109.469 179.113 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 9.0 t -148.06 87.58 1.62 Allowed 'General case' 0 N--CA 1.418 -2.042 0 CA-C-O 122.754 1.264 . . . . 54.04 111.045 175.762 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -123.76 -109.74 1.9 Allowed Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 109.094 -1.602 . . . . 72.33 109.094 177.867 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 69.7 mtp -137.27 124.15 21.33 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 120.714 -0.394 . . . . 74.32 111.99 176.78 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -87.39 121.58 30.02 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 103.073 -2.936 . . . . 71.11 103.073 166.251 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -122.3 111.54 17.03 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 119.362 -0.935 . . . . 74.11 113.15 -168.709 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . 0.483 ' HD3' ' O ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -113.33 110.24 20.02 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 109.412 -0.588 . . . . 75.14 109.412 170.853 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -90.48 -55.65 1.9 Allowed Glycine 0 CA--C 1.492 -1.352 0 C-N-CA 120.628 -0.796 . . . . 71.43 111.867 -178.214 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -127.42 134.62 49.87 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 109.817 -0.438 . . . . 74.22 109.817 -179.277 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -86.8 123.01 31.48 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 105.683 -1.969 . . . . 55.32 105.683 174.731 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 88.0 t -132.72 126.32 54.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.066 0.46 . . . . 71.33 111.343 -174.388 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . 0.548 ' HA ' ' NE2' ' A' ' 600' ' ' HIS . 21.5 t70 -83.14 110.68 18.24 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 109.067 -0.716 . . . . 64.24 109.067 175.628 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -131.32 2.14 4.2 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 120.988 0.423 . . . . 70.22 111.897 -179.608 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 111.81 155.99 13.3 Favored Glycine 0 CA--C 1.499 -0.954 0 N-CA-C 110.798 -0.921 . . . . 44.2 110.798 179.574 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -55.56 -37.06 65.99 Favored Glycine 0 N--CA 1.464 0.541 0 N-CA-C 114.418 0.527 . . . . 73.44 114.418 -171.614 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 23.6 m -64.81 -23.55 67.27 Favored 'General case' 0 CA--C 1.552 1.058 0 CA-C-O 120.943 0.402 . . . . 61.13 111.956 178.832 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -99.43 -13.07 19.7 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 121.968 -0.458 . . . . 73.23 111.308 -179.118 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . 0.548 ' NE2' ' HA ' ' A' ' 594' ' ' ASP . 12.0 m170 -85.66 137.21 32.99 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 109.518 -0.549 . . . . 65.23 109.518 -178.164 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 65.82 -11.11 0.2 Allowed 'General case' 0 C--O 1.206 -1.214 0 C-N-CA 124.505 1.122 . . . . 71.55 113.374 -175.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . 0.472 ' HD2' ' O ' ' A' ' 603' ' ' VAL . 3.3 tmm_? -86.68 138.37 31.71 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.417 -0.957 . . . . 74.4 108.417 -175.78 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . 0.472 ' O ' ' HD2' ' A' ' 602' ' ' ARG . 97.7 t -74.73 129.29 36.8 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 108.164 -1.05 . . . . 71.32 108.164 -179.889 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 68.9 t -84.97 -51.57 13.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 109.717 -0.475 . . . . 65.24 109.717 -172.991 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -147.09 157.96 43.78 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 107.647 -1.242 . . . . 52.54 107.647 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -113.43 120.88 42.56 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 106.407 -1.701 . . . . 63.14 106.407 174.077 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.484 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 51.2 t30 -52.75 -52.91 60.01 Favored Pre-proline 0 N--CA 1.477 0.876 0 N-CA-C 112.979 0.733 . . . . 63.14 112.979 -177.141 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 3.0 Cg_exo -83.69 119.26 2.57 Favored 'Trans proline' 0 C--O 1.253 1.245 0 C-N-CA 121.118 1.212 . . . . 73.22 109.425 171.073 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 608' ' ' PRO . 24.1 Cg_exo -63.97 145.46 89.99 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 122.609 2.206 . . . . 72.05 112.219 -178.443 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.68 131.41 45.53 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.695 -0.684 . . . . 75.14 109.219 178.216 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.67 -19.61 38.55 Favored Glycine 0 C--N 1.296 -1.674 0 N-CA-C 110.082 -1.207 . . . . 73.0 110.082 -173.416 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 27.8 m -91.06 158.53 16.62 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.911 -1.144 . . . . 72.41 107.911 176.562 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 561' ' ' PHE . . . -84.3 132.78 11.31 Favored Glycine 0 N--CA 1.419 -2.458 0 C-N-CA 121.527 -0.368 . . . . 75.22 112.238 -179.879 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 34.2 m -113.98 142.42 26.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 C-N-CA 123.67 0.788 . . . . 51.51 109.541 177.007 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.524 ' ND2' ' HB2' ' A' ' 617' ' ' ASP . 26.5 p-10 -52.66 162.02 0.64 Allowed 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 124.078 0.951 . . . . 72.34 112.98 177.65 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -58.41 -25.13 61.78 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 112.702 0.63 . . . . 73.32 112.702 177.406 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . 0.524 ' HB2' ' ND2' ' A' ' 615' ' ' ASN . 19.6 m-20 -70.53 -28.51 64.99 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.98 -0.554 . . . . 75.24 109.745 177.108 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 74.22 21.01 79.55 Favored Glycine 0 N--CA 1.432 -1.608 0 CA-C-N 115.689 -0.687 . . . . 15.01 112.488 177.401 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.83 118.83 13.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 122.322 1.058 . . . . 75.2 109.994 -169.963 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.476 HG22 ' HG2' ' A' ' 608' ' ' PRO . 2.8 pp -125.94 133.4 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.385 0 CA-C-N 114.218 -1.355 . . . . 71.35 109.702 -178.038 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.475 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 83.4 m -98.38 120.39 38.71 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 109.087 -0.709 . . . . 61.14 109.087 176.464 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . 0.411 ' HB2' HG13 ' A' ' 603' ' ' VAL . 2.7 pp -119.82 165.94 13.93 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.669 -1.151 . . . . 71.31 109.065 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -146.55 146.95 30.65 Favored 'General case' 0 C--N 1.269 -2.9 0 N-CA-C 106.364 -1.717 . . . . 73.3 106.364 177.912 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -138.79 165.53 26.77 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 105.691 -1.966 . . . . 74.2 105.691 175.581 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -66.12 -95.35 0.03 OUTLIER Glycine 0 C--N 1.313 -0.701 0 C-N-CA 120.112 -1.042 . . . . 63.21 111.372 178.865 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . 0.429 ' HB3' ' CE1' ' A' ' 600' ' ' HIS . 8.9 tt0 . . . . . 0 C--N 1.292 -1.897 0 N-CA-C 108.447 -0.945 . . . . 73.34 108.447 173.223 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 . . . . . 0 N--CA 1.421 -1.911 0 N-CA-C 105.848 -1.908 . . . . 50.33 105.848 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.7 m -125.83 161.44 30.98 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.48 0 N-CA-C 109.422 -0.584 . . . . 62.31 109.422 -177.19 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 409' ' ' SER . 42.4 tt0 -94.12 137.95 32.73 Favored 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 105.489 -2.041 . . . . 73.12 105.489 176.534 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.494 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 91.0 t -95.12 126.14 47.66 Favored Pre-proline 0 C--N 1.278 -2.542 0 N-CA-C 109.711 -0.477 . . . . 63.1 109.711 -166.34 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -62.22 123.49 12.6 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 122.095 1.864 . . . . 65.14 111.232 -178.495 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -81.64 143.2 32.08 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 107.713 -1.217 . . . . 72.21 107.713 179.974 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.537 HG13 ' HB1' ' A' ' 373' ' ' ALA . 7.1 p -126.93 18.02 3.51 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.699 0 CA-C-O 122.605 1.193 . . . . 62.35 110.595 -170.129 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.16 146.83 53.59 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.309 -1.314 . . . . 63.51 113.132 -179.289 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.02 0.5 41.67 Favored Glycine 0 CA--C 1.502 -0.744 0 CA-C-N 115.943 -0.571 . . . . 74.43 112.794 179.094 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -115.0 -158.48 0.67 Allowed 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 107.966 -1.124 . . . . 75.31 107.966 175.705 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 70.6 p -91.35 155.77 18.25 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 108.135 -1.061 . . . . 72.03 108.135 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 23.2 m -63.0 -33.99 76.6 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 120.688 0.28 . . . . 52.35 110.674 -179.029 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.9 -46.54 74.56 Favored 'General case' 0 C--O 1.212 -0.892 0 CA-C-O 119.435 -0.317 . . . . 74.35 111.051 178.807 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -69.12 -43.1 75.11 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-O 121.164 0.507 . . . . 75.22 110.579 179.659 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . 0.537 ' HB1' HG13 ' A' ' 365' ' ' VAL . . . -63.32 -49.11 75.27 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.371 -0.831 . . . . 64.32 111.728 -178.108 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.15 -38.1 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-N 116.52 -0.309 . . . . 73.24 110.834 179.322 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -60.64 -47.08 87.82 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.828 0.347 . . . . 64.55 110.885 178.839 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 60.0 m -60.91 -46.88 88.88 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.258 0.551 . . . . 75.35 110.215 179.678 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.503 HD22 HG23 ' A' ' 384' ' ' ILE . 7.6 tt -63.4 -38.87 92.83 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 115.546 -0.752 . . . . 54.54 110.752 -179.265 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -63.88 -40.37 96.38 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.135 0.574 . . . . 71.33 109.826 177.624 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -70.25 -17.61 63.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.166 0.508 . . . . 75.44 112.024 178.181 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -84.33 -14.72 48.86 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.077 0.465 . . . . 73.34 110.18 174.397 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 96.37 8.13 57.74 Favored Glycine 0 N--CA 1.435 -1.426 0 C-N-CA 120.586 -0.816 . . . . 71.12 112.728 175.822 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.482 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 66.4 m-85 -80.69 169.13 18.03 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-O 120.768 0.318 . . . . 62.22 110.688 178.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -112.44 150.24 31.46 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.17 -1.048 . . . . 74.01 108.17 -179.099 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . 0.503 HG23 HD22 ' A' ' 377' ' ' LEU . 0.1 OUTLIER -130.76 149.13 33.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 CA-C-O 121.572 0.701 . . . . 62.23 112.035 177.181 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.72 139.7 45.77 Favored 'General case' 0 N--CA 1.4 -2.954 0 N-CA-C 103.444 -2.798 . . . . 63.14 103.444 169.797 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 52.0 m -133.76 119.14 18.89 Favored 'General case' 0 C--N 1.252 -3.649 0 N-CA-C 108.468 -0.938 . . . . 63.34 108.468 -175.011 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -110.95 119.36 38.82 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.159 -0.682 . . . . 73.21 109.159 -179.664 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.518 HE21 ' N ' ' A' ' 388' ' ' GLN . 0.0 OUTLIER -102.08 120.78 40.99 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 107.054 -1.461 . . . . 74.44 107.054 176.485 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 421' ' ' SER . 55.8 mtmt -139.29 140.96 27.6 Favored Pre-proline 0 C--N 1.285 -2.198 0 CA-C-N 115.834 -0.621 . . . . 73.25 109.789 -175.755 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . 0.463 ' HA ' ' O ' ' A' ' 422' ' ' THR . 24.1 Cg_exo -69.14 174.31 9.15 Favored 'Trans proline' 0 C--O 1.246 0.911 0 C-N-CA 121.972 1.781 . . . . 74.11 110.016 169.286 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 90.15 173.74 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.768 1.627 . . . . 72.52 111.471 -179.2 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 38.6 m -119.53 13.48 12.58 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.642 0.734 . . . . 75.53 109.384 -176.818 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 10.7 m -78.02 -15.73 58.68 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 122.297 1.046 . . . . 70.53 109.45 -179.726 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.605 HG12 ' OG ' ' A' ' 421' ' ' SER . 0.1 OUTLIER -113.69 151.82 44.96 Favored Pre-proline 0 N--CA 1.42 -1.938 0 CA-C-N 114.54 -1.209 . . . . 65.03 108.975 179.339 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.31 158.0 2.79 Favored 'Trans proline' 0 CA--C 1.554 1.483 0 C-N-CA 124.756 3.637 . . . . 74.35 115.854 -175.487 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.13 161.41 8.89 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 123.967 3.111 . . . . 71.3 112.716 178.339 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . 0.516 ' HA ' HG23 ' A' ' 420' ' ' VAL . 6.6 p-10 -58.99 -9.42 1.88 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.889 0.876 . . . . 74.03 113.324 -176.867 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 59.6 m170 -114.51 145.99 41.25 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.265 -1.384 . . . . 70.45 107.265 177.016 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 30.6 m -72.28 118.95 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 N-CA-C 112.9 0.704 . . . . 73.44 112.9 -167.817 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . 0.446 HD13 ' O ' ' A' ' 400' ' ' ILE . 0.0 OUTLIER -97.97 -29.02 3.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 106.613 -1.625 . . . . 75.01 106.613 176.275 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.7 163.16 28.56 Favored Glycine 0 N--CA 1.409 -3.13 0 CA-C-N 114.808 -1.087 . . . . 63.43 110.446 -178.055 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.8 p -119.55 -176.56 3.18 Favored 'General case' 0 C--N 1.282 -2.331 0 C-N-CA 124.832 1.253 . . . . 71.54 109.265 179.101 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . 0.496 ' HB2' ' O ' ' A' ' 417' ' ' THR . 20.2 t70 -99.4 134.78 20.97 Favored Pre-proline 0 C--N 1.299 -1.612 0 N-CA-C 108.814 -0.81 . . . . 74.15 108.814 -174.581 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 403' ' ' ASP . 74.2 Cg_exo -53.24 -17.1 7.92 Favored 'Trans proline' 0 C--N 1.363 1.318 0 C-N-CA 124.335 3.357 . . . . 74.13 115.134 -176.389 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -61.0 -32.99 72.56 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.967 -0.383 . . . . 71.32 109.967 177.062 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . 0.494 ' HA ' ' HB ' ' A' ' 362' ' ' VAL . . . -72.75 -30.91 64.53 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.663 0.744 . . . . 54.02 110.052 179.256 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -81.0 -10.79 59.67 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.345 -0.843 . . . . 73.44 109.843 -178.722 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 40.0 m -96.5 150.09 21.01 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.928 -1.508 . . . . 60.21 106.928 175.727 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 361' ' ' GLN . 23.2 m -81.28 111.99 18.18 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 107.964 -1.125 . . . . 42.32 107.964 176.795 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.3 m -123.75 169.29 15.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-O 120.967 0.413 . . . . 65.51 110.587 -178.544 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 15.7 m -65.88 136.9 56.76 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.966 -0.753 . . . . 73.25 108.966 178.133 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -67.07 114.23 5.68 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.556 0.693 . . . . 72.32 111.223 -174.799 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 110.06 40.3 1.43 Allowed Glycine 0 N--CA 1.423 -2.193 0 CA-C-N 115.032 -0.985 . . . . 72.12 111.667 -179.798 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -114.53 -176.62 2.94 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.538 -0.465 . . . . 65.2 109.856 -179.015 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -87.21 119.51 27.52 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 123.842 0.857 . . . . 52.34 111.651 -167.619 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 38.8 mm -112.28 121.49 64.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 107.902 -1.147 . . . . 54.03 107.902 174.994 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 403' ' ' ASP . 35.5 m -93.05 129.32 39.03 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 113.348 0.87 . . . . 64.44 113.348 -173.98 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 4.2 p -124.42 135.84 62.47 Favored 'Isoleucine or valine' 0 C--O 1.247 0.934 0 CA-C-N 116.237 -0.438 . . . . 73.53 110.34 179.773 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -107.35 128.57 54.57 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.503 -0.317 . . . . 62.5 110.168 178.321 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.516 HG23 ' HA ' ' A' ' 397' ' ' ASP . 7.5 p -123.81 131.49 72.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 109.285 -0.635 . . . . 62.44 109.285 177.382 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . 0.605 ' OG ' HG12 ' A' ' 394' ' ' ILE . 43.4 m -95.83 122.9 39.11 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.544 0.687 . . . . 62.32 112.12 -177.208 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 390' ' ' PRO . 6.0 t -119.49 106.99 12.77 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.392 -0.822 . . . . 61.22 109.993 175.525 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.203 0 C-N-CA 120.318 -0.944 . . . . 74.0 113.134 179.041 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 . . . . . 0 N--CA 1.427 -1.61 0 N-CA-C 106.965 -1.494 . . . . 74.14 106.965 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.535 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 5.4 mmp_? -122.71 154.81 37.61 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 120.982 0.42 . . . . 65.24 110.847 176.337 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -83.57 138.99 33.13 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 115.292 -0.867 . . . . 51.11 110.117 -175.829 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.49 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 60.4 mt -86.39 127.49 60.85 Favored Pre-proline 0 N--CA 1.425 -1.695 0 N-CA-C 107.085 -1.45 . . . . 73.15 107.085 176.048 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.483 ' HG2' ' HB3' ' A' ' 443' ' ' LYS . 12.1 Cg_exo -70.19 151.16 66.49 Favored 'Trans proline' 0 C--O 1.239 0.527 0 C-N-CA 122.08 1.853 . . . . 74.15 110.918 176.157 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -69.19 137.73 53.51 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 107.868 -1.16 . . . . 71.54 107.868 178.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 2.4 p -116.97 111.27 34.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 C-N-CA 120.306 -0.557 . . . . 73.2 112.206 -176.462 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 1.8 p -65.63 139.52 58.43 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 107.265 -1.383 . . . . 75.13 107.265 171.622 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . 0.59 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 62.7 p -63.28 -30.87 71.93 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 113.767 1.025 . . . . 73.33 113.767 -164.117 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.458 ' H ' HD23 ' A' ' 435' ' ' LEU . 0.5 OUTLIER -90.42 -11.1 41.46 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 115.867 -0.606 . . . . 65.05 111.767 -179.947 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.456 HG22 ' CB ' ' A' ' 439' ' ' GLU . 1.4 m -105.66 45.75 0.95 Allowed 'General case' 0 CA--C 1.573 1.841 0 CA-C-O 122.462 1.125 . . . . 75.01 110.788 -173.158 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . 0.4 ' O ' HG23 ' A' ' 441' ' ' VAL . 49.5 t80 -58.58 -38.2 77.39 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.955 -1.021 . . . . 75.41 113.27 177.037 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -62.52 -36.52 82.85 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 118.508 0.595 . . . . 53.4 110.657 179.397 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.456 ' CB ' HG22 ' A' ' 436' ' ' THR . 9.6 tp10 -62.66 -39.41 93.83 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.729 -0.841 . . . . 74.53 108.729 175.645 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.42 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -63.82 -42.97 97.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.04 -0.527 . . . . 55.41 110.343 178.038 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 437' ' ' TYR . 78.5 t -58.28 -48.95 83.48 Favored 'Isoleucine or valine' 0 C--O 1.256 1.443 0 CA-C-N 115.998 -0.547 . . . . 64.03 111.034 -179.114 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -67.67 -40.85 84.42 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.134 -0.626 . . . . 71.33 110.804 -177.858 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . 0.483 ' HB3' ' HG2' ' A' ' 430' ' ' PRO . 27.5 mmtp -66.45 -40.87 89.66 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.622 -0.717 . . . . 55.34 112.032 -177.517 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.42 HD13 ' O ' ' A' ' 440' ' ' ALA . 8.2 mp -63.67 -38.46 91.19 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.25 0.344 . . . . 70.41 110.159 175.879 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.42 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 98.3 m -64.08 -47.49 79.9 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 120.984 0.421 . . . . 71.44 110.972 179.225 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.49 -15.65 62.32 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.167 -0.469 . . . . 72.14 112.11 -179.598 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -85.54 5.34 31.89 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.035 0.445 . . . . 64.41 111.724 179.699 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 104.56 -66.97 0.29 Allowed Glycine 0 CA--C 1.497 -1.045 0 C-N-CA 120.139 -1.029 . . . . 54.11 112.406 175.212 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . 0.424 ' HA ' ' O ' ' A' ' 480' ' ' ILE . 1.3 p90 -49.65 -61.44 2.11 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 113.193 0.812 . . . . 74.24 113.193 177.627 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . 0.42 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 57.94 25.12 55.92 Favored Glycine 0 CA--C 1.504 -0.611 0 O-C-N 123.056 0.222 . . . . 64.34 113.301 -179.923 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.404 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 62.7 mtt180 -106.63 113.72 27.39 Favored 'General case' 0 N--CA 1.419 -2.017 0 N-CA-C 108.989 -0.745 . . . . 75.01 108.989 -178.042 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 43.2 p90 -137.8 151.8 48.49 Favored 'General case' 0 C--N 1.279 -2.459 0 CA-C-N 115.192 -0.913 . . . . 72.51 110.012 -175.756 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -142.39 122.85 14.03 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.124 -0.944 . . . . 72.32 110.189 176.663 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -93.95 125.57 38.65 Favored 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 123.778 0.831 . . . . 52.4 109.654 178.626 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -119.18 147.15 44.54 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.99 -1.115 . . . . 72.54 107.99 175.314 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 488' ' ' VAL . 11.5 m120 -120.61 133.49 55.37 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 120.855 0.359 . . . . 72.33 111.365 -179.869 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 27.3 t -135.79 139.45 30.72 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 108.979 -0.749 . . . . 72.31 108.979 179.704 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.662 ' HA ' ' O ' ' A' ' 490' ' ' SER . 32.9 Cg_endo -65.94 127.39 17.63 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.292 1.994 . . . . 72.52 110.977 177.495 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 69.5 m -147.76 179.47 7.68 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 122.912 0.485 . . . . 75.52 109.945 -179.7 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . 0.477 ' O ' HG23 ' A' ' 464' ' ' VAL . 5.2 t -50.23 139.29 19.09 Favored Pre-proline 0 C--O 1.248 0.986 0 C-N-CA 125.125 1.37 . . . . 52.33 111.753 178.223 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.33 -29.8 31.62 Favored 'Trans proline' 0 C--N 1.36 1.132 0 C-N-CA 124.644 3.563 . . . . 73.04 113.45 -177.439 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -72.92 -25.12 60.93 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.293 0.479 . . . . 75.12 112.293 -178.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -104.13 -5.38 22.07 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.879 0.371 . . . . 65.23 111.488 177.427 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 460' ' ' THR . 54.0 t -60.36 127.75 20.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.19 -0.459 . . . . 74.34 110.025 177.117 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 90.02 0.5 77.61 Favored Glycine 0 N--CA 1.422 -2.236 0 C-N-CA 121.037 -0.602 . . . . 61.52 112.534 179.001 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.402 ' C ' HG13 ' A' ' 488' ' ' VAL . 0.0 OUTLIER -131.12 163.18 28.23 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 119.604 -0.838 . . . . 63.33 111.213 -179.813 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.59 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 67.7 t -67.01 133.42 31.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 114.711 -1.131 . . . . 54.55 111.216 -177.088 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 53.8 mt -98.3 -24.28 4.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.226 -1.027 . . . . 75.14 108.226 179.15 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 165.33 169.62 29.19 Favored Glycine 0 N--CA 1.427 -1.907 0 CA-C-N 115.471 -0.786 . . . . 73.42 112.65 177.317 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 1.7 t -116.89 137.94 51.87 Favored 'General case' 0 N--CA 1.406 -2.66 0 N-CA-C 106.341 -1.726 . . . . 62.13 106.341 174.783 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.503 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 49.0 t30 -65.52 -53.44 37.73 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 119.822 -0.751 . . . . 64.14 111.055 179.523 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 9.7 Cg_exo -74.84 122.43 7.27 Favored 'Trans proline' 0 C--N 1.366 1.497 0 N-CA-C 107.195 -1.887 . . . . 42.22 107.195 170.811 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.462 ' C ' ' H ' ' A' ' 475' ' ' ASN . 26.9 Cg_exo -62.61 139.26 74.69 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 121.743 1.629 . . . . 72.04 112.565 -176.142 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.49 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -74.67 11.6 1.0 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 122.611 1.196 . . . . 64.35 110.843 -179.632 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . 0.462 ' H ' ' C ' ' A' ' 473' ' ' PRO . 13.9 m120 -110.4 -4.8 15.4 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-N 114.385 -1.279 . . . . 53.34 108.852 -178.854 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -115.83 170.93 8.1 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 121.512 0.672 . . . . 70.34 111.808 -175.243 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.32 137.62 37.56 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.518 -1.219 . . . . 75.24 108.713 -178.378 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 21.1 p -126.27 149.2 49.27 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 120.999 0.428 . . . . 74.21 111.049 -179.146 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -72.97 160.72 31.66 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.431 -0.804 . . . . 70.24 110.537 178.213 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 449' ' ' PHE . 1.9 mp -72.65 -16.81 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-O 121.947 0.88 . . . . 74.44 111.014 -179.867 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 15.3 t -96.05 5.16 51.79 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-O 121.772 0.796 . . . . 51.13 109.853 177.48 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -89.55 137.61 32.18 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.993 -0.549 . . . . 75.35 109.941 -175.633 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.404 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.2 p -104.37 126.05 59.12 Favored 'Isoleucine or valine' 0 C--O 1.245 0.841 0 CA-C-O 121.336 0.588 . . . . 70.0 110.849 179.705 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 61.8 t -95.83 119.99 44.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.981 -0.554 . . . . 65.33 109.859 -179.271 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.18 123.98 55.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 108.863 -0.792 . . . . 71.1 108.863 178.598 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 39.5 mt -120.15 128.11 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 CA-C-N 114.723 -1.126 . . . . 61.23 110.184 -176.774 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 9.3 tt -101.9 125.15 56.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 115.891 -0.595 . . . . 75.3 110.074 -179.148 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 456' ' ' ASN . 10.6 t -113.18 139.03 40.53 Favored 'Isoleucine or valine' 0 C--O 1.251 1.14 0 N-CA-C 106.569 -1.641 . . . . 40.52 106.569 179.236 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -75.53 153.76 44.79 Favored Glycine 0 C--N 1.299 -1.522 0 CA-C-O 121.346 0.414 . . . . 75.12 113.275 -176.665 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.662 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 48.6 m . . . . . 0 C--N 1.285 -2.201 0 N-CA-C 106.6 -1.63 . . . . 64.03 106.6 176.012 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo . . . . . 0 N--CA 1.446 -1.312 0 CA-C-O 121.563 0.568 . . . . 60.31 112.69 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -95.6 99.94 11.74 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 109.219 -0.66 . . . . 54.15 109.219 176.705 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 13.7 p -117.83 143.0 46.68 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.35 -0.841 . . . . 64.05 109.595 179.208 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -144.76 154.23 42.5 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.674 -0.862 . . . . 70.42 108.674 176.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 11.9 p-10 -94.63 136.66 34.68 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.757 -0.831 . . . . 75.33 108.757 176.038 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 30.1 pt -75.62 137.38 70.58 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-N 115.369 -0.832 . . . . 75.35 112.038 -176.314 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -87.34 -170.18 0.57 Allowed 'Trans proline' 0 C--O 1.248 1.023 0 C-N-CA 122.995 2.464 . . . . 70.42 110.947 175.414 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -94.8 122.98 37.99 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.615 0.721 . . . . 62.04 109.687 177.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.6 p -113.42 7.57 7.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-O 122.374 1.083 . . . . 72.04 109.993 -177.62 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -73.72 121.22 20.44 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.204 -0.907 . . . . 31.11 109.788 -179.251 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 124.28 -17.75 7.44 Favored Glycine 0 C--N 1.289 -2.057 0 N-CA-C 110.105 -1.198 . . . . 63.34 110.105 -179.866 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -94.11 171.98 8.51 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 109.654 -0.498 . . . . 71.5 109.654 178.148 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 61.1 m -87.69 155.65 19.83 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.145 -1.057 . . . . 71.23 108.145 -179.302 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.6 p -54.17 -41.96 53.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 123.522 0.729 . . . . 74.53 112.316 -178.693 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -60.77 -42.24 97.1 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 123.368 0.667 . . . . 75.32 111.324 178.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.27 -40.75 50.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 115.419 -0.81 . . . . 60.34 109.769 -179.202 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -60.69 -49.51 77.23 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.464 -0.789 . . . . 41.23 111.339 -178.481 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -64.6 -36.05 82.98 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.596 -0.274 . . . . 71.15 110.264 -178.614 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.422 ' O ' HG23 ' A' ' 514' ' ' VAL . 87.7 tttt -61.47 -47.19 86.83 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.786 -0.643 . . . . 72.44 109.95 179.457 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -61.92 -48.17 81.63 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 116.192 -0.458 . . . . 74.4 110.818 -178.735 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.7 -45.65 93.4 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.4 -0.364 . . . . 55.35 111.182 178.793 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . 0.406 ' ND2' ' HA ' ' A' ' 518' ' ' THR . 0.9 OUTLIER -63.18 -37.96 89.3 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 120.727 0.299 . . . . 74.25 111.711 -178.681 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 510' ' ' LYS . 79.4 t -65.1 -33.73 65.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-N 116.266 -0.425 . . . . 54.0 110.967 177.392 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -79.63 -9.38 59.62 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.399 0.518 . . . . 55.12 112.399 179.953 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 115.53 -20.43 13.64 Favored Glycine 0 CA--C 1.495 -1.159 0 C-N-CA 120.454 -0.879 . . . . 52.44 111.747 179.109 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . 0.453 ' CE1' ' HA ' ' A' ' 547' ' ' VAL . 74.9 m-85 -78.25 81.74 4.6 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.41 -0.959 . . . . 74.32 108.41 179.625 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . 0.406 ' HA ' ' ND2' ' A' ' 513' ' ' ASN . 2.6 p -87.91 -8.99 54.99 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 114.96 -1.018 . . . . 45.13 113.355 -173.102 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -108.01 115.52 30.28 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-O 121.407 0.622 . . . . 75.02 109.725 -177.563 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -130.48 156.37 44.89 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.454 -0.794 . . . . 71.44 111.253 -178.847 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 38.4 m -132.45 140.79 48.55 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 106.301 -1.74 . . . . 70.35 106.301 173.423 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.54 139.43 50.96 Favored 'General case' 0 N--CA 1.422 -1.869 0 C-N-CA 120.018 -0.673 . . . . 72.3 110.312 179.634 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -115.94 124.38 50.43 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 107.349 -1.352 . . . . 75.32 107.349 175.269 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 39.5 m -89.33 114.54 25.96 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.403 -0.962 . . . . 71.43 108.403 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 33.4 m -121.32 165.99 16.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 N-CA-C 109.309 -0.626 . . . . 54.14 109.309 -177.454 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . 0.4 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 3.5 p-10 -104.43 137.48 42.24 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.607 -0.886 . . . . 72.12 108.607 177.367 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 17.3 m -151.27 179.95 1.14 Allowed Pre-proline 0 C--N 1.295 -1.801 0 N-CA-C 109.292 -0.633 . . . . 64.44 109.292 -177.77 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -80.42 -7.04 13.83 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 121.695 1.597 . . . . 74.2 110.49 170.05 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.42 ' HA ' ' HD3' ' A' ' 530' ' ' PRO . 15.7 mmm180 -82.72 137.43 44.22 Favored Pre-proline 0 N--CA 1.447 -0.611 0 N-CA-C 107.892 -1.151 . . . . 45.23 107.892 177.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 529' ' ' ARG . 36.8 Cg_exo -58.8 160.23 18.53 Favored 'Trans proline' 0 N--CA 1.484 0.946 0 C-N-CA 123.566 2.844 . . . . 74.11 115.267 -175.04 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -66.71 113.6 4.96 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.686 -1.143 . . . . 62.05 111.435 -178.977 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 117.25 -19.56 11.7 Favored Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 110.856 -0.898 . . . . 32.15 110.856 178.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -83.11 134.62 35.0 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.533 -0.914 . . . . 72.34 108.533 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 58.8 t -80.42 126.36 39.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 109.321 -0.622 . . . . 72.12 109.321 -179.609 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . 0.655 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 15.1 t -81.13 -18.03 47.85 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 121.506 0.669 . . . . 74.11 109.602 179.131 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.24 -161.44 28.61 Favored Glycine 0 N--CA 1.439 -1.148 0 C-N-CA 120.989 -0.624 . . . . 65.21 112.153 176.293 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . 0.469 HG22 HD13 ' A' ' 553' ' ' LEU . 15.4 p -117.2 160.26 21.33 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.543 -0.54 . . . . 75.44 109.543 179.226 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.458 ' HB2' HE22 ' A' ' 554' ' ' GLN . 50.7 t30 -68.99 -55.34 10.62 Favored Pre-proline 0 C--N 1.325 -0.491 0 C-N-CA 120.514 -0.475 . . . . 74.3 110.241 177.441 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.82 134.2 25.23 Favored 'Trans proline' 0 C--N 1.366 1.463 0 N-CA-C 109.191 -1.119 . . . . 62.12 109.191 171.447 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.59 157.52 58.02 Favored 'Trans proline' 0 C--O 1.253 1.245 0 C-N-CA 122.578 2.185 . . . . 74.1 112.724 179.971 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.88 134.96 57.34 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.044 -0.525 . . . . 64.23 109.812 178.315 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.57 -13.34 39.16 Favored Glycine 0 C--N 1.307 -1.048 0 C-N-CA 120.844 -0.693 . . . . 71.13 111.739 -177.731 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 496' ' ' ASP . 81.7 m -70.92 120.89 17.15 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 109.072 -0.714 . . . . 22.01 109.072 178.359 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 31.9 m -86.62 122.88 31.16 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.026 -0.731 . . . . 54.3 109.026 -179.661 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 12.2 m -135.1 154.93 79.32 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 109.686 -0.487 . . . . 64.23 109.686 -179.327 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.43 149.77 45.22 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.964 1.776 . . . . 64.31 110.029 175.805 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.453 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 25.8 m -59.54 -19.58 16.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 112.673 0.62 . . . . 74.44 112.673 178.961 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -81.21 3.55 23.38 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.24 1.016 . . . . 72.51 112.64 179.479 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 77.5 p -88.16 175.16 7.83 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 121.996 -0.44 . . . . 73.42 112.17 -176.869 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 39.0 t -112.58 119.24 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 108.79 -0.818 . . . . 43.52 108.79 179.086 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 1.8 mp -98.13 131.21 45.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-O 121.113 0.483 . . . . 75.13 110.223 -179.179 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -103.23 117.82 35.38 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-O 121.258 0.551 . . . . 75.2 110.9 179.822 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . 0.469 HD13 HG22 ' A' ' 537' ' ' THR . 2.4 mm? -98.89 132.89 43.88 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.311 -1.313 . . . . 64.14 108.746 179.002 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . 0.458 HE22 ' HB2' ' A' ' 538' ' ' ASN . 26.0 mp0 -100.48 118.59 37.0 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.849 -1.167 . . . . 71.13 107.849 172.157 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 46.0 t -104.42 131.18 53.93 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 107.385 -1.339 . . . . 62.54 107.385 -178.22 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.655 ' OG ' ' HB ' ' A' ' 535' ' ' THR . 50.2 m -95.92 158.13 15.59 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 114.044 1.127 . . . . 74.55 114.044 -175.131 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 19.0 ptpt -113.68 148.2 36.78 Favored 'General case' 0 N--CA 1.414 -2.272 0 N-CA-C 105.888 -1.894 . . . . 64.21 105.888 164.092 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -75.08 -22.26 76.87 Favored Glycine 0 C--N 1.292 -1.874 0 O-C-N 124.103 0.877 . . . . 74.44 111.929 -178.586 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 73.67 10.38 4.8 Favored 'General case' 0 CA--C 1.485 -1.524 0 C-N-CA 124.654 1.181 . . . . 64.45 109.284 -171.786 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 33.3 tt0 -128.39 141.26 51.47 Favored 'General case' 0 N--CA 1.408 -2.537 0 CA-C-N 115.525 -0.761 . . . . 73.33 109.42 -176.857 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -138.82 155.1 48.42 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.564 -0.743 . . . . 71.21 109.394 -179.33 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.4 p -63.64 130.58 28.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 O-C-N 123.614 0.571 . . . . 73.22 111.081 -179.157 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 56.4 ttp -94.78 126.41 47.38 Favored Pre-proline 0 C--O 1.253 1.263 0 CA-C-N 115.886 -0.597 . . . . 73.34 109.543 178.36 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -63.43 169.78 9.11 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.068 2.512 . . . . 61.22 112.551 175.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -75.19 133.61 41.39 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.871 -0.604 . . . . 73.45 111.29 -179.526 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . 0.436 ' HB3' ' SD ' ' A' ' 569' ' ' MET . 92.8 mt -137.66 27.97 2.72 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.828 -0.804 . . . . 75.01 108.828 -177.674 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 17.7 m -77.86 130.31 36.48 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.907 -0.588 . . . . 53.21 111.228 -174.705 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 67.48 38.05 90.46 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.957 -0.565 . . . . 61.11 112.937 176.447 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . 0.436 ' SD ' ' HB3' ' A' ' 566' ' ' LEU . 23.6 ptm -99.46 168.77 9.77 Favored 'General case' 0 C--O 1.255 1.363 0 N-CA-C 108.839 -0.8 . . . . 61.52 108.839 -179.413 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -106.76 148.98 27.81 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 109.471 -0.566 . . . . 62.05 109.471 -178.077 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . 0.449 ' HA ' ' HB3' ' A' ' 574' ' ' ALA . 61.2 t-105 -62.31 -25.01 67.64 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 124.129 0.972 . . . . 71.01 110.269 -178.976 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 13.7 p -68.82 -21.72 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 115.548 -0.751 . . . . 50.32 110.386 179.498 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -101.28 -29.76 11.89 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 109.501 -0.555 . . . . 70.25 109.501 176.103 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . 0.449 ' HB3' ' HA ' ' A' ' 571' ' ' TRP . . . -61.7 -49.96 74.39 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.164 -0.925 . . . . 65.54 111.92 -179.385 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.451 ' HB2' ' HD3' ' A' ' 576' ' ' PRO . 38.0 mt-10 -54.21 -53.85 54.37 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 113.283 0.846 . . . . 70.11 113.283 -179.267 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . 0.451 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 50.7 Cg_exo -53.87 -45.03 44.02 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 121.887 1.725 . . . . 63.4 112.337 176.825 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.556 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 20.6 mmm180 -64.0 -41.43 97.48 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.512 -0.313 . . . . 64.32 111.174 -179.961 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 7.1 tt -63.64 -49.27 73.89 Favored 'General case' 0 C--O 1.247 0.926 0 C-N-CA 123.403 0.681 . . . . 52.52 109.858 -176.094 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . 0.433 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 4.6 ptp180 -67.27 -37.9 84.21 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.616 -0.72 . . . . 74.25 112.595 179.03 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.22 -39.16 75.26 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 112.575 0.583 . . . . 73.43 112.575 -178.148 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 4.0 pp -84.62 -1.23 55.71 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.66 -0.816 . . . . 62.31 112.437 -179.117 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 67.03 47.46 65.17 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 115.366 -0.834 . . . . 43.4 112.093 177.351 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 22.5 t90 -63.67 127.15 30.06 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.923 -0.399 . . . . 74.14 109.923 179.039 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 3.6 m -125.23 24.22 7.46 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.122 -0.696 . . . . 72.0 109.122 -176.726 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -92.43 -170.2 40.7 Favored Glycine 0 CA--C 1.508 -0.406 0 C-N-CA 120.71 -0.757 . . . . 71.23 113.904 -175.438 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 64.7 mtt -98.7 126.39 44.29 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.87 0.367 . . . . 74.5 110.474 -179.311 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 55.0 tp -96.84 102.25 14.0 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.12 -1.067 . . . . 71.05 108.12 177.504 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -96.43 101.46 13.09 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.268 0.556 . . . . 71.4 110.463 -178.851 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.32 114.22 28.31 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.547 -1.279 . . . . 73.31 107.547 178.631 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -75.97 -88.45 0.27 Allowed Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 120.622 -0.799 . . . . 73.5 111.206 177.45 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -125.58 154.66 41.89 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 122.436 -0.449 . . . . 63.11 110.48 -178.898 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -82.15 141.47 33.05 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.346 -0.983 . . . . 75.32 108.346 173.933 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 42.5 t -124.24 116.53 48.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 108.935 -0.765 . . . . 73.31 108.935 -177.473 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -89.2 107.81 19.26 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 107.778 -1.193 . . . . 72.05 107.778 177.573 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -127.18 9.54 6.76 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.887 -0.597 . . . . 74.11 111.197 -178.814 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 128.65 169.73 12.66 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.302 -0.951 . . . . 62.44 111.701 178.175 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -57.11 -46.46 91.51 Favored Glycine 0 C--O 1.237 0.329 0 O-C-N 123.933 0.431 . . . . 71.12 113.034 -177.112 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 30.9 t -65.87 -29.69 70.18 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.313 0.578 . . . . 73.41 110.514 -178.722 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . 0.596 ' O ' ' HA3' ' A' ' 625' ' ' GLY . 87.4 mm-40 -87.31 -1.02 57.62 Favored 'General case' 0 C--O 1.211 -0.97 0 CA-C-N 115.65 -0.705 . . . . 74.31 112.788 -174.114 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . 0.522 ' HA ' ' H ' ' A' ' 626' ' ' GLN . 19.8 m80 -63.52 -71.77 0.16 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.952 0.882 . . . . 72.05 110.921 176.919 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -95.62 31.13 2.1 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.798 -0.637 . . . . 63.5 111.023 -173.575 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 1.3 mmm-85 -105.15 140.23 38.63 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 116.064 -0.516 . . . . 71.32 110.233 -177.904 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 97.3 t -73.7 138.18 21.78 Favored 'Isoleucine or valine' 0 C--O 1.252 1.218 0 N-CA-C 107.306 -1.368 . . . . 73.35 107.306 174.819 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 57.8 t -94.43 -50.55 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.973 0 CA-C-O 121.743 0.782 . . . . 62.13 109.421 -174.084 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -146.9 155.88 42.65 Favored 'General case' 0 N--CA 1.415 -2.219 0 N-CA-C 107.701 -1.222 . . . . 63.11 107.701 -178.537 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -120.84 121.88 39.08 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 106.465 -1.68 . . . . 71.2 106.465 171.123 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.563 ' HB2' ' HB ' ' A' ' 621' ' ' THR . 26.3 t-20 -59.03 -52.79 72.27 Favored Pre-proline 0 C--N 1.299 -1.623 0 CA-C-N 115.539 -0.755 . . . . 55.32 112.67 -177.893 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 1.0 OUTLIER -87.8 123.28 1.74 Allowed 'Trans proline' 0 N--CA 1.442 -1.544 0 C-N-CA 121.275 1.317 . . . . 74.23 109.668 173.546 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.06 156.15 60.53 Favored 'Trans proline' 0 C--O 1.244 0.793 0 C-N-CA 122.287 1.992 . . . . 65.21 111.36 177.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -59.09 127.96 34.79 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.828 -0.434 . . . . 72.33 109.828 178.559 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.18 -7.81 44.3 Favored Glycine 0 C--N 1.31 -0.891 0 C-N-CA 120.343 -0.932 . . . . 73.31 111.755 -177.613 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 26.9 m -89.13 157.26 18.36 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 107.988 -1.116 . . . . 70.33 107.988 178.247 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -90.98 143.52 16.68 Favored Glycine 0 N--CA 1.422 -2.238 0 C-N-CA 120.787 -0.721 . . . . 75.51 113.092 -177.42 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 19.0 m -115.71 141.65 32.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 109.376 -0.601 . . . . 62.44 109.376 174.388 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -70.82 -179.71 2.33 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 123.852 0.861 . . . . 72.15 113.066 -177.386 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -61.95 -36.03 80.21 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.072 0.949 . . . . 71.04 109.718 -179.728 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . 0.417 ' OD2' ' HB ' ' A' ' 619' ' ' ILE . 21.2 t70 -63.28 -40.33 97.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.008 -0.997 . . . . 52.53 108.656 174.588 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 87.97 22.03 43.83 Favored Glycine 0 N--CA 1.425 -2.09 0 C-N-CA 120.14 -1.029 . . . . 60.4 111.919 176.385 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . 0.417 ' HB ' ' OD2' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -68.76 118.46 12.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 122.422 1.106 . . . . 40.33 110.19 -170.398 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.34 130.38 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.743 0 N-CA-C 106.336 -1.727 . . . . 70.42 106.336 -179.923 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.563 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 6.4 m -100.77 117.19 34.36 Favored 'General case' 0 N--CA 1.421 -1.908 0 C-N-CA 119.455 -0.898 . . . . 73.31 109.428 -178.533 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -139.26 150.78 45.87 Favored 'General case' 0 CA--C 1.48 -1.736 0 N-CA-C 106.054 -1.832 . . . . 64.0 106.054 178.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -134.36 151.54 51.28 Favored 'General case' 0 C--N 1.266 -3.057 0 N-CA-C 105.132 -2.173 . . . . 75.43 105.132 176.523 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -120.4 165.55 14.76 Favored 'General case' 0 C--N 1.274 -2.705 0 N-CA-C 107.266 -1.383 . . . . 74.01 107.266 177.461 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . 0.596 ' HA3' ' O ' ' A' ' 599' ' ' GLN . . . -70.46 -108.29 0.04 OUTLIER Glycine 0 C--N 1.302 -1.344 0 O-C-N 123.915 0.759 . . . . 71.13 114.317 -174.409 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . 0.522 ' H ' ' HA ' ' A' ' 600' ' ' HIS . 8.6 tp-100 . . . . . 0 C--N 1.296 -1.746 0 CA-C-O 118.998 -0.525 . . . . 64.45 110.0 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.148 0 N-CA-C 110.827 -0.909 . . . . 65.33 110.827 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 49.9 mm -75.99 130.05 36.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-O 120.903 0.383 . . . . 73.42 109.98 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.81 133.75 47.76 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.531 -0.759 . . . . 62.21 110.839 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.21 -10.28 57.84 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 122.006 0.907 . . . . 73.41 108.682 175.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.66 150.56 44.47 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 106.196 -1.779 . . . . 71.04 106.196 172.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 24.4 m -113.85 142.35 26.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-O 121.779 0.799 . . . . 74.43 110.3 -170.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . 0.504 ' NE2' ' HA ' ' A' ' 407' ' ' ASN . 0.8 OUTLIER -95.01 126.64 40.49 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 106.291 -1.744 . . . . 75.41 106.291 -176.62 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.454 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 64.0 t -97.35 121.25 59.11 Favored Pre-proline 0 C--N 1.286 -2.18 0 CA-C-N 114.616 -1.174 . . . . 75.33 111.577 -169.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 24.5 Cg_exo -62.29 135.8 56.19 Favored 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 123.026 2.484 . . . . 74.32 111.658 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -105.14 149.81 25.57 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.917 -1.142 . . . . 72.53 107.917 -176.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.518 ' CG2' ' HA ' ' A' ' 373' ' ' ALA . 26.1 m -134.63 20.06 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 C-N-CA 122.415 0.286 . . . . 71.13 111.032 -177.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.54 146.5 9.83 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 112.797 0.666 . . . . 65.32 112.797 177.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . 0.435 ' H ' HG23 ' A' ' 399' ' ' VAL . . . 105.07 0.83 41.65 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 115.83 -0.623 . . . . 32.43 112.357 -178.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . 0.478 HE21 ' HB ' ' A' ' 365' ' ' VAL . 32.7 mt-30 -111.1 -89.35 0.5 Allowed 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 120.299 -0.561 . . . . 62.14 111.081 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 59.9 p -152.57 165.53 34.89 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.018 -0.734 . . . . 63.14 109.018 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.41 -46.14 87.76 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.721 -0.844 . . . . 73.14 108.721 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -59.53 -45.51 91.56 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 115.305 -0.861 . . . . 74.13 112.05 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -67.3 -41.38 85.46 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.087 0.47 . . . . 51.43 110.328 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . 0.518 ' HA ' ' CG2' ' A' ' 365' ' ' VAL . . . -65.79 -48.97 69.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.106 -0.497 . . . . 73.14 111.261 -179.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.17 -38.2 81.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.01 -0.541 . . . . 73.4 110.511 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.65 -42.03 87.41 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.259 0.623 . . . . 71.44 111.11 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 30.3 m -65.69 -49.02 70.05 Favored 'General case' 0 C--O 1.248 1.014 0 CA-C-O 121.58 0.705 . . . . 75.04 110.206 -178.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 9.9 mp -65.51 -42.63 91.84 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.572 -0.74 . . . . 73.41 111.74 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -64.46 -38.44 91.05 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.006 -0.543 . . . . 70.23 110.314 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -59.89 -39.08 84.15 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 116.023 -0.535 . . . . 62.12 110.687 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . 0.428 ' HA ' ' HD3' ' A' ' 380' ' ' ARG . 25.2 mmt180 -81.37 -12.35 59.01 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.613 -0.721 . . . . 74.0 112.193 -177.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.32 7.27 52.23 Favored Glycine 0 C--N 1.303 -1.27 0 C-N-CA 120.636 -0.792 . . . . 61.2 112.694 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.523 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 47.7 m-85 -81.66 159.46 23.97 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-O 121.355 0.598 . . . . 73.12 111.621 177.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.505 ' HB2' ' HG2' ' A' ' 415' ' ' GLU . 46.4 mtmt -115.23 161.8 17.95 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 115.005 -0.998 . . . . 43.12 108.826 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.21 157.38 41.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-O 120.862 0.363 . . . . 60.11 110.698 -177.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 61.6 ttp85 -120.16 126.84 51.66 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 107.138 -1.43 . . . . 72.44 107.138 170.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 17.6 m -108.27 125.13 51.33 Favored 'General case' 0 C--N 1.281 -2.408 0 N-CA-C 108.694 -0.854 . . . . 62.11 108.694 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -111.71 119.74 39.68 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.663 -0.866 . . . . 74.42 108.663 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -96.61 139.26 32.96 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 110.138 -0.319 . . . . 72.11 110.138 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -131.31 127.53 21.78 Favored Pre-proline 0 C--N 1.307 -1.247 0 N-CA-C 108.278 -1.008 . . . . 75.54 108.278 174.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -63.3 142.95 88.02 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.245 1.963 . . . . 74.23 111.794 177.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 7.3 t70 87.03 148.04 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 126.864 2.065 . . . . 65.23 110.368 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 13.0 t -103.12 11.96 36.44 Favored 'General case' 0 CA--C 1.552 1.058 0 CA-C-O 120.991 0.424 . . . . 64.41 110.546 -175.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 8.4 t -73.44 -18.08 61.17 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.97 0.891 . . . . 75.44 109.016 175.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.46 HD13 ' H ' ' A' ' 394' ' ' ILE . 0.1 OUTLIER -104.48 151.24 39.15 Favored Pre-proline 0 N--CA 1.427 -1.576 0 N-CA-C 107.459 -1.311 . . . . 61.31 107.459 173.098 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -23.33 114.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.678 1 C-N-CA 126.205 4.603 . . . . 64.52 115.7 -175.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.06 160.29 10.69 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 123.922 3.081 . . . . 64.2 112.833 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -57.97 -12.88 3.66 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 113.545 0.942 . . . . 75.5 113.545 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 28.7 m170 -91.89 148.46 22.2 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 108.257 -1.016 . . . . 71.32 108.257 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.435 HG23 ' H ' ' A' ' 367' ' ' GLY . 30.0 m -77.75 117.17 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.255 0 C-N-CA 118.687 -1.205 . . . . 70.34 111.089 -171.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 35.6 pt -106.68 -28.8 2.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 115.198 -0.91 . . . . 75.55 108.729 173.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.72 158.0 27.58 Favored Glycine 0 N--CA 1.417 -2.607 0 N-CA-C 109.489 -1.444 . . . . 31.53 109.489 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 3.9 p -137.93 -178.58 5.32 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 123.623 0.769 . . . . 73.04 109.476 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -102.1 132.16 21.85 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 108.154 -1.054 . . . . 61.42 108.154 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.34 3.09 0.89 Allowed 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.307 2.671 . . . . 72.41 115.632 -176.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -52.87 -47.59 67.72 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 109.673 -0.492 . . . . 65.33 109.673 175.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -69.95 -28.97 66.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.639 -0.71 . . . . 64.02 110.464 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . 0.504 ' HA ' ' NE2' ' A' ' 361' ' ' GLN . 5.9 m120 -81.35 -6.14 58.6 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 122.014 0.911 . . . . 75.32 109.753 -176.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 28.3 m -101.92 160.66 14.3 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.538 -1.653 . . . . 54.11 106.538 175.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 20.2 m -76.48 113.11 13.72 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 119.55 -0.86 . . . . 73.44 109.067 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.3 m -123.66 170.02 14.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 122.86 0.464 . . . . 65.24 111.018 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 19.2 m -74.25 141.05 45.39 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.887 -0.783 . . . . 54.32 108.887 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . 0.523 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -69.08 108.94 3.77 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.072 0.463 . . . . 73.31 110.468 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 121.38 37.76 0.67 Allowed Glycine 0 C--N 1.311 -0.819 0 CA-C-N 115.194 -0.912 . . . . 41.3 111.744 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -100.02 179.07 4.61 Favored 'General case' 0 C--O 1.245 0.861 0 N-CA-C 107.7 -1.222 . . . . 70.43 107.7 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . 0.505 ' HG2' ' HB2' ' A' ' 383' ' ' LYS . 44.8 mt-10 -116.41 115.0 25.05 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 118.249 0.477 . . . . 74.21 109.957 -178.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 42.6 mm -97.94 129.47 48.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 121.062 0.458 . . . . 75.14 110.072 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 2.2 p -79.81 131.21 35.84 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 123.866 0.866 . . . . 72.41 111.776 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 10.7 p -119.13 134.35 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.872 0 N-CA-C 109.01 -0.737 . . . . 61.51 109.01 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -95.4 120.77 36.21 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.546 -0.909 . . . . 74.45 108.546 -176.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 50.5 t -128.45 149.1 32.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 122.869 0.468 . . . . 72.4 109.885 -176.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 44.2 m -126.24 148.98 49.37 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.573 -0.529 . . . . 51.01 109.573 173.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 1.5 m -103.65 157.94 16.72 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 106.897 -1.52 . . . . 71.14 106.897 -175.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -53.9 179.76 0.15 Allowed Glycine 0 CA--C 1.542 1.73 0 N-CA-C 115.626 1.011 . . . . 74.55 115.626 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.7 142.8 91.27 Favored 'Trans proline' 0 C--O 1.246 0.888 0 C-N-CA 123.818 3.012 . . . . 75.25 113.213 -175.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -81.14 126.01 30.94 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.286 -0.87 . . . . 74.41 110.929 -175.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -136.14 155.5 50.08 Favored 'General case' 0 C--N 1.266 -3.057 0 N-CA-C 107.404 -1.332 . . . . 71.34 107.404 173.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 447' ' ' ALA . 2.4 mmp_? -122.78 143.74 49.63 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-O 120.717 0.294 . . . . 72.1 110.655 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -86.27 138.98 31.43 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 107.079 -1.452 . . . . 54.41 107.079 173.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 67.6 mt -78.78 121.97 84.14 Favored Pre-proline 0 C--N 1.3 -1.545 0 CA-C-O 121.115 0.483 . . . . 74.24 110.825 -172.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.91 148.62 58.0 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.636 2.224 . . . . 74.41 111.434 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -87.48 145.15 26.38 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.666 -0.494 . . . . 74.42 109.666 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.28 153.05 16.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.839 -0.8 . . . . 75.11 108.839 -175.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 2.7 p -64.47 137.0 57.63 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 121.399 0.618 . . . . 62.35 110.294 175.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 23.6 p -69.1 -21.21 64.07 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 125.053 1.341 . . . . 75.14 112.128 -171.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.511 ' H ' HD23 ' A' ' 435' ' ' LEU . 0.6 OUTLIER -88.56 -11.02 46.83 Favored 'General case' 0 C--N 1.275 -2.632 0 CA-C-N 115.668 -0.696 . . . . 63.01 110.502 179.422 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.8 m -108.61 66.4 0.64 Allowed 'General case' 0 N--CA 1.426 -1.637 0 CA-C-O 121.835 0.826 . . . . 60.31 111.125 -175.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -53.38 -38.52 63.43 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 124.462 1.105 . . . . 71.44 111.859 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -58.89 -42.65 90.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.89 0.376 . . . . 74.43 110.85 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -70.96 -36.21 72.47 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.925 -0.58 . . . . 74.24 109.988 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.623 ' O ' HD22 ' A' ' 444' ' ' LEU . . . -60.39 -52.58 64.65 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 116.686 -0.234 . . . . 72.44 111.551 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 26.9 m -63.63 -36.5 76.67 Favored 'Isoleucine or valine' 0 C--O 1.245 0.828 0 CA-C-O 121.402 0.62 . . . . 55.04 110.773 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 41.5 tptt -59.18 -45.79 90.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.911 -1.041 . . . . 63.33 109.464 175.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -64.21 -39.76 94.65 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 113.381 0.882 . . . . 72.23 113.381 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.623 HD22 ' O ' ' A' ' 440' ' ' ALA . 1.4 mm? -68.01 -33.03 73.83 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 119.056 -1.057 . . . . 74.31 110.762 175.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 45.5 m -70.12 -42.69 72.29 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.293 0.568 . . . . 70.13 110.074 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.98 -15.49 62.58 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.845 -0.616 . . . . 75.41 110.651 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . 0.465 ' O ' ' HG3' ' A' ' 427' ' ' ARG . . . -86.92 2.87 47.86 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.061 -0.518 . . . . 44.45 111.454 177.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 106.35 -76.59 0.23 Allowed Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.172 -1.013 . . . . 42.43 112.127 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -46.28 -57.3 4.7 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 114.377 1.251 . . . . 72.14 114.377 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 59.41 28.41 64.7 Favored Glycine 0 CA--C 1.508 -0.382 0 O-C-N 123.5 0.5 . . . . 61.45 112.271 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.485 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 16.1 mmt180 -105.04 111.0 23.62 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 107.385 -1.339 . . . . 73.42 107.385 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.516 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 18.1 p90 -144.89 157.38 44.17 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-O 120.81 0.338 . . . . 72.14 111.451 -175.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -131.1 149.08 52.76 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 124.483 1.113 . . . . 73.3 108.22 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -116.86 119.42 35.32 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.937 -0.764 . . . . 75.13 108.937 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.6 143.01 48.87 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.001 -0.741 . . . . 73.2 109.001 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -112.98 135.02 54.22 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 107.269 -1.382 . . . . 73.33 107.269 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 38.2 t -137.44 134.81 18.75 Favored Pre-proline 0 C--N 1.289 -2.032 0 N-CA-C 109.118 -0.697 . . . . 51.11 109.118 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.617 ' HA ' ' O ' ' A' ' 490' ' ' SER . 37.1 Cg_endo -65.89 122.45 10.03 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 121.715 1.61 . . . . 71.53 108.549 175.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 15.3 m -131.82 179.34 6.13 Favored 'General case' 0 C--N 1.286 -2.157 0 C-N-CA 120.06 -0.656 . . . . 71.33 110.893 -173.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.7 t -55.78 141.49 65.77 Favored Pre-proline 0 N--CA 1.422 -1.853 0 C-N-CA 125.008 1.323 . . . . 75.21 108.458 173.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . 0.417 ' HB3' ' OG1' ' A' ' 494' ' ' THR . 9.6 Cg_endo -50.58 -30.11 27.16 Favored 'Trans proline' 0 N--CA 1.481 0.777 0 C-N-CA 124.766 3.644 . . . . 71.45 114.781 -171.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -75.89 -27.2 57.61 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 113.103 0.779 . . . . 72.4 113.103 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -92.95 -19.88 21.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.939 0.4 . . . . 75.11 111.688 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 90.5 t -60.78 134.89 26.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 109.423 -0.584 . . . . 73.22 109.423 175.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 101.35 -15.74 57.33 Favored Glycine 0 N--CA 1.431 -1.647 0 C-N-CA 121.085 -0.579 . . . . 65.33 113.248 177.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.2 166.59 24.27 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 117.521 0.661 . . . . 53.21 110.751 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.479 ' O ' ' HB ' ' A' ' 434' ' ' THR . 54.6 t -67.12 142.5 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.336 0 N-CA-C 108.478 -0.934 . . . . 61.4 108.478 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 42.5 mt -97.59 -28.22 3.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 107.689 -1.226 . . . . 64.21 107.689 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 150.23 -150.99 23.12 Favored Glycine 0 N--CA 1.411 -2.997 0 CA-C-N 114.646 -1.161 . . . . 71.11 110.661 176.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . 0.706 HG22 HG12 ' A' ' 486' ' ' ILE . 43.7 p -115.26 151.62 34.17 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 105.352 -2.092 . . . . 62.24 105.352 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.41 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 8.8 t30 -69.91 -50.67 16.58 Favored Pre-proline 0 C--N 1.304 -1.378 0 C-N-CA 118.698 -1.201 . . . . 63.11 111.055 176.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.41 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 23.5 Cg_exo -68.46 162.07 42.31 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 121.289 1.326 . . . . 54.02 109.36 172.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.494 ' HB2' ' OE1' ' A' ' 476' ' ' GLN . 20.7 Cg_endo -61.64 127.73 22.52 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.294 1.996 . . . . 72.52 111.988 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.481 ' HB2' ' OG1' ' A' ' 470' ' ' THR . . . -91.27 0.39 57.53 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 113.556 0.947 . . . . 60.44 113.556 -170.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -108.96 -12.99 14.81 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 119.677 -0.809 . . . . 74.04 109.672 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . 0.494 ' OE1' ' HB2' ' A' ' 473' ' ' PRO . 20.1 mp0 -92.35 -175.28 3.97 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 114.143 -1.39 . . . . 63.22 111.474 -172.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 1.4 p -93.79 141.13 28.84 Favored 'General case' 0 N--CA 1.404 -2.746 0 N-CA-C 113.387 0.884 . . . . 71.33 113.387 -176.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 12.7 p -127.08 148.05 50.15 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-N 114.618 -1.174 . . . . 73.5 108.269 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -75.58 163.72 27.06 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 116.845 -0.161 . . . . 43.12 110.857 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 22.6 mm -80.04 -5.15 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.019 0 CA-C-O 122.264 1.03 . . . . 75.34 109.552 -176.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.5 t -110.64 5.13 20.77 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.726 0.774 . . . . 75.54 109.259 175.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -93.01 143.05 26.62 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.835 -0.621 . . . . 75.24 110.686 -175.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.485 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.1 p -108.25 127.1 64.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 C-N-CA 123.11 0.564 . . . . 53.13 111.475 -177.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 27.8 m -105.12 125.46 60.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-O 121.864 0.84 . . . . 73.11 111.788 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.66 125.19 45.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.813 -0.81 . . . . 62.44 108.813 177.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.706 HG12 HG22 ' A' ' 470' ' ' THR . 42.5 mt -110.28 128.65 66.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 C-N-CA 124.465 1.106 . . . . 75.25 110.999 -176.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 4.8 tt -111.15 127.13 68.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 115.357 -0.838 . . . . 70.12 111.122 -174.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 467' ' ' VAL . 2.5 p -115.19 135.47 55.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 115.218 -0.901 . . . . 71.51 109.92 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -72.66 125.87 10.5 Favored Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 110.517 -1.033 . . . . 64.53 110.517 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.617 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 8.6 t -142.52 148.36 37.51 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 108.268 -1.012 . . . . 60.24 108.268 -176.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 85.32 87.26 0.94 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.238 -0.982 . . . . 71.55 113.162 177.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -92.23 146.13 2.89 Favored 'Trans proline' 0 N--CA 1.44 -1.618 0 C-N-CA 122.391 2.061 . . . . 73.05 111.655 176.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -128.99 23.9 5.65 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 122.748 1.261 . . . . 60.11 108.261 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.417 ' OG1' ' HB3' ' A' ' 461' ' ' PRO . 14.6 p -127.22 143.54 51.23 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 112.909 -1.95 . . . . 70.15 109.309 -176.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -147.03 161.85 39.98 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.042 -1.096 . . . . 64.53 108.042 176.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.2 p-10 -93.87 135.24 35.4 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 109.517 -0.549 . . . . 73.35 109.517 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 40.3 pt -80.18 137.77 52.8 Favored Pre-proline 0 C--N 1.302 -1.467 0 CA-C-N 115.952 -0.567 . . . . 72.32 111.37 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.63 168.31 19.74 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.653 2.236 . . . . 72.41 112.859 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -70.87 121.73 18.62 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.642 -0.873 . . . . 70.32 108.642 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.01 87.89 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.178 0 CA-C-O 122.475 1.131 . . . . 71.35 110.845 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -146.97 122.5 10.42 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 113.703 -1.59 . . . . 71.04 108.08 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 112.43 -11.98 25.94 Favored Glycine 0 CA--C 1.493 -1.282 0 N-CA-C 109.888 -1.285 . . . . 73.45 109.888 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -94.71 169.32 10.25 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 114.888 -0.656 . . . . 71.02 109.677 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 5.5 m -84.39 157.16 21.51 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.458 -0.941 . . . . 72.31 108.458 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 17.5 t -55.65 -41.96 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.227 0.611 . . . . 63.23 110.933 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -62.1 -40.58 96.33 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.669 -0.696 . . . . 71.42 110.836 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 48.8 t -73.94 -38.9 50.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.839 -0.619 . . . . 71.44 109.558 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -62.81 -49.43 74.97 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.566 -0.743 . . . . 64.35 111.356 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -63.15 -35.71 81.21 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 109.629 -0.508 . . . . 74.12 109.629 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.468 ' O ' HG23 ' A' ' 514' ' ' VAL . 48.4 tttp -64.79 -45.33 86.74 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.674 -0.694 . . . . 62.02 109.976 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . 0.403 ' O ' ' HD1' ' A' ' 515' ' ' TYR . 92.1 m-20 -62.34 -42.39 99.35 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 120.6 0.238 . . . . 73.44 110.734 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.33 -42.83 96.07 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 116.596 -0.274 . . . . 74.43 111.381 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -63.23 -37.69 88.23 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.785 -0.189 . . . . 61.51 111.041 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 510' ' ' LYS . 56.9 t -59.88 -35.03 58.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.085 0.469 . . . . 65.33 110.844 176.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . 0.403 ' HD1' ' O ' ' A' ' 511' ' ' ASN . 31.3 m-85 -79.45 -8.21 58.96 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.881 0.372 . . . . 72.31 111.936 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 103.23 -0.4 47.24 Favored Glycine 0 C--N 1.303 -1.279 0 C-N-CA 120.075 -1.06 . . . . 62.23 112.55 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.601 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 79.2 m-85 -84.59 96.33 9.14 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.451 -1.314 . . . . 74.03 107.451 177.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 6.3 p -87.19 -13.89 42.71 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 113.234 0.827 . . . . 74.14 113.234 -174.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -108.83 114.73 28.75 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.166 0.508 . . . . 72.2 109.676 -178.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -131.42 154.44 48.67 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.755 -0.657 . . . . 75.42 110.619 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 43.8 m -141.54 140.94 33.54 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 107.772 -1.196 . . . . 43.32 107.772 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . 0.502 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 0.0 OUTLIER -117.56 128.46 54.97 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 118.468 0.576 . . . . 52.51 111.551 -177.273 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -111.66 116.22 30.41 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.039 -0.726 . . . . 53.11 109.039 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 35.4 m -95.08 124.72 39.28 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 120.743 0.306 . . . . 50.42 111.03 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 18.7 m -122.8 151.29 26.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 108.539 -0.912 . . . . 62.21 108.539 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 557' ' ' LYS . 3.8 p30 -66.59 136.13 55.15 Favored 'General case' 0 CA--C 1.495 -1.169 0 CA-C-O 121.681 0.753 . . . . 73.04 110.423 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 20.0 m -146.43 158.34 47.23 Favored Pre-proline 0 C--N 1.281 -2.404 0 CA-C-N 114.737 -1.119 . . . . 24.21 108.596 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -69.68 -21.76 33.43 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 121.551 1.501 . . . . 70.31 108.802 170.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.512 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 60.0 mtm-85 -69.71 135.12 88.05 Favored Pre-proline 0 N--CA 1.436 -1.152 0 CA-C-N 114.188 -1.369 . . . . 72.55 108.4 176.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.8 149.12 79.85 Favored 'Trans proline' 0 C--O 1.251 1.154 0 C-N-CA 123.26 2.64 . . . . 74.43 113.491 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -64.39 117.4 7.23 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.613 -0.721 . . . . 62.04 110.917 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 129.81 -23.41 4.73 Favored Glycine 0 C--N 1.302 -1.311 0 C-N-CA 120.212 -0.994 . . . . 71.13 111.99 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -79.4 125.74 29.92 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.235 -0.654 . . . . 74.34 109.235 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 88.8 t -73.19 119.41 20.08 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 109.774 -0.454 . . . . 72.3 109.774 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 57.6 m -66.36 -40.31 89.7 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 124.687 1.195 . . . . 71.42 109.436 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 162.86 -159.81 32.22 Favored Glycine 0 N--CA 1.424 -2.113 0 N-CA-C 109.392 -1.483 . . . . 34.12 109.392 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 7.1 p -126.57 161.07 28.86 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 117.056 0.428 . . . . 72.15 110.317 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.497 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 24.8 t-20 -59.63 -51.99 77.19 Favored Pre-proline 0 CA--C 1.545 0.78 0 O-C-N 123.537 0.523 . . . . 74.4 111.198 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.497 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 1.2 Cg_endo -87.37 143.08 6.36 Favored 'Trans proline' 0 N--CA 1.441 -1.595 0 CA-C-N 120.257 1.128 . . . . 53.04 109.301 170.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -70.16 163.6 37.98 Favored 'Trans proline' 0 C--O 1.249 1.065 0 C-N-CA 122.428 2.085 . . . . 73.23 112.556 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.8 142.49 57.27 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.777 -0.647 . . . . 64.14 110.61 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 88.94 -5.95 84.1 Favored Glycine 0 N--CA 1.431 -1.666 0 C-N-CA 120.844 -0.693 . . . . 71.22 112.212 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 30.8 m -77.91 123.28 26.59 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.646 -0.501 . . . . 73.24 109.646 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 33.3 m -80.56 122.44 27.05 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 108.697 -0.853 . . . . 62.12 108.697 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 19.7 m -136.71 160.38 66.68 Favored Pre-proline 0 C--N 1.311 -1.108 0 N-CA-C 109.179 -0.674 . . . . 73.51 109.179 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -68.35 141.13 50.49 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.25 1.966 . . . . 62.32 111.458 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.601 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 26.9 m -66.79 -20.52 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 121.749 0.785 . . . . 64.33 111.927 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -90.59 3.68 53.42 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.137 -0.938 . . . . 63.33 111.13 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.0 t -83.77 164.23 19.69 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.291 -0.633 . . . . 73.05 109.291 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 41.3 t -98.18 112.71 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 N-CA-C 107.998 -1.112 . . . . 72.25 107.998 178.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 1.8 mp -91.74 135.64 26.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-O 120.938 0.399 . . . . 74.44 110.272 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -101.9 122.26 43.68 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-O 121.473 0.654 . . . . 74.5 110.777 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . 0.502 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 65.3 mt -97.8 116.16 29.47 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 106.562 -1.644 . . . . 70.03 106.562 176.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -91.83 121.98 33.94 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 108.489 -0.93 . . . . 72.44 108.489 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 60.3 t -111.12 133.74 55.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-N 115.82 -0.627 . . . . 73.24 112.149 -170.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.578 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 9.6 m -71.69 128.66 36.51 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 114.925 -1.034 . . . . 63.22 109.065 174.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 526' ' ' ASP . 0.8 OUTLIER -116.97 110.74 18.66 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 109.317 -0.623 . . . . 64.11 109.317 175.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -72.49 -33.38 61.17 Favored Glycine 0 CA--C 1.49 -1.526 0 CA-C-N 115.707 -0.678 . . . . 71.42 111.448 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 44.32 36.34 1.56 Allowed 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 126.345 1.858 . . . . 73.23 113.007 178.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 12.1 tp60 -140.05 146.22 38.71 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.488 -1.301 . . . . 65.51 107.488 -174.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -147.16 142.62 27.51 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.604 -0.887 . . . . 74.1 108.604 174.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 54.2 t -76.62 128.38 37.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-O 120.911 0.386 . . . . 75.42 111.76 -174.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 58.7 ttp -97.7 132.4 25.11 Favored Pre-proline 0 C--O 1.247 0.951 0 CA-C-N 115.99 -0.55 . . . . 75.34 110.198 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -66.57 169.67 13.87 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 123.051 2.501 . . . . 55.41 112.932 176.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -72.16 132.27 43.92 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 113.299 0.851 . . . . 70.33 113.299 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 96.5 mt -136.22 21.85 3.22 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.566 0.746 . . . . 72.53 109.003 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 10.3 m -75.4 130.29 38.74 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 116.147 -0.479 . . . . 35.14 112.224 -173.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 65.65 29.22 74.66 Favored Glycine 0 C--O 1.212 -1.247 0 CA-C-N 115.498 -0.774 . . . . 74.23 114.873 173.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 18.1 ptp -112.61 178.85 4.15 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 117.798 0.799 . . . . 74.25 109.136 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . 0.402 ' HB3' ' OD1' ' A' ' 601' ' ' ASN . 89.7 m-85 -84.87 154.27 22.38 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 120.302 -0.559 . . . . 71.51 109.67 178.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 28.0 t90 -68.47 -20.15 64.59 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.387 -0.597 . . . . 74.22 109.387 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 33.8 m -71.28 -13.31 16.87 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.355 0 CA-C-N 115.936 -0.575 . . . . 45.34 110.985 176.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -101.06 -44.13 5.81 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 109.417 -0.586 . . . . 70.42 109.417 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -59.57 -46.27 89.4 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.817 -1.083 . . . . 71.13 112.214 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.488 ' O ' ' HG3' ' A' ' 579' ' ' ARG . 55.8 tt0 -57.92 -59.87 11.81 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 113.323 0.861 . . . . 55.42 113.323 -178.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.54 -35.59 89.55 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 121.183 1.255 . . . . 61.0 112.406 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.42 ' HD3' ' HA ' ' A' ' 577' ' ' ARG . 7.8 mmt85 -65.0 -43.38 92.76 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.031 0.382 . . . . 74.54 112.031 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.404 HD12 ' N ' ' A' ' 579' ' ' ARG . 4.4 pp -67.58 -40.71 84.85 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 119.607 -0.837 . . . . 44.4 111.259 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 575' ' ' GLU . 20.1 mtp180 -65.14 -40.32 94.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.085 -0.507 . . . . 75.52 110.094 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -63.96 -35.73 81.64 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.982 -0.554 . . . . 74.43 112.468 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 4.2 pp -81.66 2.03 31.43 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.988 0.736 . . . . 62.42 112.988 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 82.97 39.67 9.99 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.484 -0.865 . . . . 72.1 112.227 176.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 89.6 t90 -79.57 133.91 36.46 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.939 -0.393 . . . . 71.01 109.939 176.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 61.5 m -147.86 90.85 1.87 Allowed 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.375 -0.602 . . . . 73.21 109.375 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -147.01 -131.52 2.19 Favored Glycine 0 N--CA 1.433 -1.549 0 N-CA-C 111.088 -0.805 . . . . 74.2 111.088 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . 0.461 ' HB2' HG12 ' A' ' 619' ' ' ILE . 59.7 mtt -119.67 125.65 49.22 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.763 -0.829 . . . . 73.1 108.763 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -105.17 130.94 53.22 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 107.799 -1.185 . . . . 73.11 107.799 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -100.71 101.89 12.87 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 120.601 -0.439 . . . . 70.52 110.698 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . 0.408 ' C ' ' HD3' ' A' ' 589' ' ' LYS . 11.8 tmtt? -113.02 111.7 22.61 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 107.252 -1.388 . . . . 74.21 107.252 174.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -93.97 -149.52 25.48 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.958 -0.639 . . . . 74.32 113.197 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -76.16 146.23 39.33 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 120.776 0.322 . . . . 34.23 111.083 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -84.97 125.32 32.59 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 106.405 -1.702 . . . . 75.22 106.405 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 57.5 t -128.73 116.58 41.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 N-CA-C 109.956 -0.387 . . . . 70.02 109.956 -171.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -77.59 108.11 10.54 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.24 -1.393 . . . . 54.13 107.24 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -121.42 -5.12 9.33 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.717 -0.674 . . . . 64.21 111.744 -176.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 119.69 -177.97 16.46 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 120.507 -0.854 . . . . 44.51 112.341 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -58.71 -37.01 88.89 Favored Glycine 0 C--N 1.319 -0.365 0 O-C-N 124.084 0.52 . . . . 64.42 114.381 -175.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 14.4 m -64.89 -24.29 67.49 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 117.264 0.532 . . . . 64.44 111.365 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -108.11 -0.56 21.03 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 113.096 0.776 . . . . 72.43 113.096 -173.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . 0.503 ' HA ' ' O ' ' A' ' 626' ' ' GLN . 14.9 p-80 -70.39 103.22 2.36 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 119.194 -1.002 . . . . 74.35 111.644 -174.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . 0.402 ' OD1' ' HB3' ' A' ' 570' ' ' PHE . 18.9 t-20 58.37 5.32 0.42 Allowed 'General case' 0 CA--C 1.569 1.7 0 C-N-CA 125.924 1.69 . . . . 74.13 113.59 178.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 624' ' ' PHE . 13.6 mmt180 -78.98 140.22 38.05 Favored 'General case' 0 C--N 1.317 -0.804 0 O-C-N 121.66 -0.65 . . . . 75.1 110.455 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 97.6 t -69.48 131.63 33.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 107.911 -1.144 . . . . 74.45 107.911 174.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 56.9 t -87.71 -46.05 16.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-O 121.263 0.554 . . . . 64.31 109.649 -175.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -156.24 152.4 27.71 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 107.684 -1.228 . . . . 72.33 107.684 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -116.68 112.39 21.16 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.356 -1.35 . . . . 70.42 107.356 171.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.475 ' HB2' ' HB ' ' A' ' 621' ' ' THR . 38.7 t30 -48.45 -52.13 45.86 Favored Pre-proline 0 CA--C 1.556 1.204 0 N-CA-C 113.622 0.971 . . . . 73.12 113.622 -177.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 5.4 Cg_exo -82.29 124.64 4.3 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.121 1.214 . . . . 64.25 109.562 172.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . 0.49 ' O ' HG22 ' A' ' 612' ' ' THR . 13.4 Cg_endo -65.0 135.84 45.77 Favored 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 122.045 1.83 . . . . 60.01 113.144 -177.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -65.75 130.69 44.18 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.248 -0.887 . . . . 75.21 110.025 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.09 -8.44 45.37 Favored Glycine 0 N--CA 1.433 -1.537 0 C-N-CA 120.132 -1.032 . . . . 61.22 113.066 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . 0.49 HG22 ' O ' ' A' ' 609' ' ' PRO . 10.1 t -113.75 175.93 5.25 Favored 'General case' 0 C--O 1.258 1.514 0 C-N-CA 118.919 -1.112 . . . . 74.32 109.541 177.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -79.77 128.3 8.44 Favored Glycine 0 N--CA 1.416 -2.684 0 CA-C-N 115.448 -0.796 . . . . 33.54 111.546 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 23.4 m -102.2 144.49 13.33 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 C-N-CA 124.031 0.932 . . . . 75.2 108.709 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.48 HD21 HG22 ' A' ' 619' ' ' ILE . 24.8 p-10 -50.01 152.59 1.59 Allowed 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 124.452 1.101 . . . . 71.0 111.857 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -26.25 13.59 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.123 0.969 . . . . 61.41 113.061 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.34 -38.53 74.88 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.662 -0.866 . . . . 74.11 108.662 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 82.33 22.12 59.33 Favored Glycine 0 N--CA 1.424 -2.159 0 C-N-CA 120.923 -0.656 . . . . 34.43 111.886 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . 0.48 HG22 HD21 ' A' ' 615' ' ' ASN . 0.0 OUTLIER -68.16 119.19 13.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-O 122.621 1.2 . . . . 73.35 110.459 -168.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 4.4 tp -115.67 119.17 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.876 0 CA-C-N 113.899 -1.5 . . . . 75.14 109.614 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.475 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 25.7 m -105.4 117.45 34.06 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 106.543 -1.651 . . . . 72.45 106.543 174.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . 0.413 HD23 ' H ' ' A' ' 622' ' ' LEU . 2.1 pt? -138.96 153.77 48.23 Favored 'General case' 0 CA--C 1.479 -1.758 0 N-CA-C 106.447 -1.686 . . . . 54.25 106.447 -177.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -136.45 153.67 50.99 Favored 'General case' 0 C--N 1.268 -2.974 0 N-CA-C 107.464 -1.31 . . . . 74.33 107.464 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.415 ' HA ' ' O ' ' A' ' 602' ' ' ARG . 51.1 p90 -140.62 163.01 34.01 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 105.383 -2.081 . . . . 74.21 105.383 172.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -82.46 -86.52 0.76 Allowed Glycine 0 N--CA 1.424 -2.155 0 C-N-CA 119.677 -1.249 . . . . 63.35 110.282 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . 0.503 ' O ' ' HA ' ' A' ' 600' ' ' HIS . 35.6 tt0 . . . . . 0 C--N 1.29 -1.991 0 CA-C-O 117.7 -1.143 . . . . 53.14 108.428 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.918 0 N-CA-C 110.145 -1.182 . . . . 43.05 110.145 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 9.0 tp -75.46 124.07 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.559 0 CA-C-N 117.824 0.812 . . . . 71.14 110.047 177.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.82 137.95 31.99 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 109.031 -0.729 . . . . 53.31 109.031 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -90.76 -19.06 23.92 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.459 -0.941 . . . . 75.34 108.459 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -76.7 139.19 40.42 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 103.728 -2.693 . . . . 40.33 103.728 169.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 35.7 m -116.08 151.3 17.88 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.664 0 C-N-CA 120.074 -0.65 . . . . 72.23 109.805 -172.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -95.05 136.04 35.85 Favored 'General case' 0 N--CA 1.411 -2.406 0 N-CA-C 106.579 -1.637 . . . . 53.45 106.579 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 89.8 t -111.07 118.19 48.47 Favored Pre-proline 0 C--N 1.275 -2.632 0 CA-C-O 121.141 0.496 . . . . 65.32 111.198 -173.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -81.38 123.54 4.43 Favored 'Trans proline' 0 N--CA 1.44 -1.674 0 C-N-CA 121.814 1.676 . . . . 74.21 109.717 172.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . 0.569 ' OD2' ' HB3' ' A' ' 366' ' ' ARG . 7.5 p-10 -101.43 137.91 39.13 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 122.237 1.017 . . . . 64.45 110.646 -176.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.536 ' HB ' ' NE2' ' A' ' 368' ' ' GLN . 27.7 m -82.93 36.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 114.381 -1.281 . . . . 71.43 112.471 -174.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.569 ' HB3' ' OD2' ' A' ' 364' ' ' ASP . 0.0 OUTLIER -56.04 146.72 21.85 Favored 'General case' 0 C--O 1.247 0.934 0 C-N-CA 124.452 1.101 . . . . 71.22 110.97 176.314 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.28 1.21 41.13 Favored Glycine 0 C--N 1.309 -0.944 0 N-CA-C 111.927 -0.469 . . . . 71.32 111.927 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . 0.536 ' NE2' ' HB ' ' A' ' 365' ' ' VAL . 36.1 mt-30 -110.87 -153.2 0.51 Allowed 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 108.076 -1.083 . . . . 74.41 108.076 176.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 54.9 p -93.32 168.68 10.92 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.215 -0.661 . . . . 42.43 109.215 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 20.6 p -63.28 -46.36 87.12 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 109.828 -0.434 . . . . 74.53 109.828 176.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -63.36 -46.43 86.6 Favored 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 112.851 0.686 . . . . 73.52 112.851 -177.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -67.03 -45.23 78.12 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 120.546 -0.462 . . . . 70.41 110.095 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -66.59 -46.62 75.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.868 -0.606 . . . . 64.55 111.514 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 67.7 mt -64.73 -37.91 81.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.616 -0.266 . . . . 73.43 110.806 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.88 -43.29 99.14 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 110.273 -0.269 . . . . 73.32 110.273 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 33.3 m -63.45 -48.33 78.15 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.866 -0.606 . . . . 73.43 110.313 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.45 -41.6 96.44 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 112.353 0.501 . . . . 74.23 112.353 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -67.01 -38.79 86.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.666 -0.243 . . . . 64.12 110.515 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -70.19 -21.01 63.09 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.027 0.442 . . . . 63.22 111.601 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . 0.466 ' NE ' ' HA ' ' A' ' 380' ' ' ARG . 3.3 mmp_? -81.06 -15.09 57.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.027 0.441 . . . . 61.13 109.919 174.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.26 5.58 54.33 Favored Glycine 0 C--N 1.306 -1.114 0 CA-C-N 115.789 -0.641 . . . . 61.55 112.548 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -85.42 148.65 25.9 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-O 121.117 0.484 . . . . 62.11 110.73 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -101.13 149.39 24.02 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 107.741 -1.207 . . . . 75.21 107.741 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.415 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -134.62 157.19 41.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.891 0 C-N-CA 120.717 -0.393 . . . . 64.21 110.009 -178.549 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -132.46 126.86 34.01 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.165 -1.42 . . . . 63.02 107.165 173.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 28.8 m -109.12 126.53 53.31 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 108.367 -0.975 . . . . 74.3 108.367 -177.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 51.2 tp -111.46 120.09 41.0 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.57 -0.53 . . . . 75.02 109.57 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -89.83 122.09 32.57 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.148 -0.686 . . . . 64.31 109.148 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 421' ' ' SER . 56.9 mtpt -135.4 125.5 16.73 Favored Pre-proline 0 C--N 1.311 -1.069 0 N-CA-C 109.937 -0.394 . . . . 74.44 109.937 177.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -80.39 128.37 7.04 Favored 'Trans proline' 0 C--O 1.253 1.252 0 C-N-CA 121.39 1.393 . . . . 64.13 109.238 173.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.467 ' HA ' ' CG ' ' A' ' 425' ' ' GLU . 13.5 t70 174.99 158.46 0.18 Allowed 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.195 -1.409 . . . . 72.33 107.195 -174.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 13.5 m -100.72 -11.98 19.5 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 120.86 0.362 . . . . 54.22 111.697 -177.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 11.1 m -109.11 2.1 20.88 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 122.121 0.963 . . . . 70.41 110.343 -176.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 34.6 mm -88.86 140.52 29.37 Favored Pre-proline 0 C--N 1.306 -1.297 0 CA-C-N 115.769 -0.651 . . . . 65.52 109.33 178.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . 0.451 ' HA ' ' HD3' ' A' ' 396' ' ' PRO . 20.1 Cg_exo -39.97 129.92 2.11 Favored 'Trans proline' 0 C--N 1.365 1.401 0 C-N-CA 124.4 3.4 . . . . 62.32 113.719 176.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 395' ' ' PRO . 50.1 Cg_exo -57.8 161.24 13.07 Favored 'Trans proline' 0 N--CA 1.483 0.855 0 C-N-CA 123.535 2.824 . . . . 71.3 112.699 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . 0.589 ' HA ' HG13 ' A' ' 420' ' ' VAL . 2.5 p30 -59.78 -8.47 2.14 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 122.022 0.915 . . . . 62.21 112.853 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 43.8 m170 -102.42 123.71 46.68 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 105.188 -2.153 . . . . 72.2 105.188 173.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 32.4 m -68.08 119.54 13.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 112.98 0.733 . . . . 74.43 112.98 -165.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . 0.436 HD13 ' O ' ' A' ' 400' ' ' ILE . 0.0 OUTLIER -102.99 -28.12 3.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 106.767 -1.568 . . . . 72.4 106.767 175.361 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.52 166.3 27.76 Favored Glycine 0 N--CA 1.414 -2.793 0 N-CA-C 110.546 -1.022 . . . . 51.5 110.546 -177.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 40.5 p -146.8 -173.91 4.34 Favored 'General case' 0 C--N 1.286 -2.178 0 C-N-CA 126.078 1.751 . . . . 73.42 106.331 -174.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . 0.424 ' HA ' ' HD3' ' A' ' 404' ' ' PRO . 21.6 t70 -98.43 126.52 39.17 Favored Pre-proline 0 C--N 1.296 -1.756 0 N-CA-C 107.699 -1.223 . . . . 71.05 107.699 -177.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 403' ' ' ASP . 52.8 Cg_exo -56.31 -4.65 0.79 Allowed 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 124.864 3.709 . . . . 73.24 116.324 -174.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.67 -39.81 71.45 Favored 'General case' 0 C--O 1.204 -1.294 0 N-CA-C 109.767 -0.457 . . . . 70.12 109.767 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -63.53 -40.05 96.01 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-O 121.365 0.603 . . . . 72.31 110.77 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -80.61 -4.58 54.67 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.389 0.614 . . . . 71.0 110.456 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 27.8 m -98.23 160.61 14.18 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 105.423 -2.066 . . . . 55.13 105.423 173.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 13.4 m -76.52 112.6 13.22 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 118.829 -1.148 . . . . 75.54 108.871 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 23.0 m -128.33 170.05 18.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.077 0.465 . . . . 73.11 111.198 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 36.7 t -74.35 143.3 44.94 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 108.782 -0.822 . . . . 62.34 108.782 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -63.09 131.14 47.55 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.065 -0.516 . . . . 31.2 111.293 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 90.89 29.71 12.6 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.714 -0.676 . . . . 72.21 112.655 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -83.07 -175.7 5.97 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 109.52 -0.548 . . . . 72.31 109.52 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -110.72 117.47 33.54 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 123.358 0.663 . . . . 62.3 111.291 -174.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.0 mm -105.77 115.08 46.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.405 0.622 . . . . 51.43 110.358 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 40.6 p -87.05 130.8 34.33 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 123.655 0.782 . . . . 73.42 110.691 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 8.2 p -124.19 134.55 66.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 109.736 -0.468 . . . . 73.1 109.736 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . 0.411 ' H ' HD22 ' A' ' 419' ' ' ASN . 0.1 OUTLIER -104.66 122.81 46.43 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.851 -0.739 . . . . 65.3 110.357 176.715 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.589 HG13 ' HA ' ' A' ' 397' ' ' ASP . 34.7 t -111.75 131.87 61.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 114.705 -1.134 . . . . 72.4 110.588 -175.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 34.2 p -85.93 125.97 33.75 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 120.285 -0.566 . . . . 45.41 109.577 176.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.1 t -117.49 105.47 12.13 Favored 'General case' 0 N--CA 1.407 -2.621 0 C-N-CA 119.509 -0.876 . . . . 53.43 109.221 175.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 79.04 120.37 0.28 Allowed Glycine 0 N--CA 1.436 -1.303 0 CA-C-N 115.494 -0.776 . . . . 53.21 113.318 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -63.78 154.23 70.75 Favored 'Trans proline' 0 C--O 1.251 1.133 0 C-N-CA 121.776 1.651 . . . . 71.42 109.112 171.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.467 ' CG ' ' HA ' ' A' ' 391' ' ' ASP . 28.8 mt-10 -75.55 140.58 42.81 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 109.496 -0.557 . . . . 54.31 109.496 -177.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.504 ' OE1' ' HB ' ' A' ' 477' ' ' THR . 34.0 tt0 -102.58 144.86 30.45 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 107.387 -1.338 . . . . 73.01 107.387 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.618 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 1.6 mmp_? -122.32 139.87 53.31 Favored 'General case' 0 CA--C 1.479 -1.769 0 N-CA-C 112.795 0.665 . . . . 74.04 112.795 -174.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 42.2 tt0 -85.26 132.99 34.18 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.627 -1.17 . . . . 65.15 108.256 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 57.8 mt -80.92 124.43 81.47 Favored Pre-proline 0 C--N 1.307 -1.259 0 N-CA-C 109.812 -0.44 . . . . 72.14 109.812 -178.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -70.77 147.0 55.43 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.332 2.021 . . . . 72.15 110.397 175.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -81.21 102.19 10.17 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.494 0.664 . . . . 73.24 110.243 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 61.0 t -96.93 140.42 17.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 106.882 -1.525 . . . . 72.41 106.882 177.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 2.4 p -63.97 146.96 53.16 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 112.619 0.6 . . . . 71.01 112.619 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 25.7 p -60.63 -32.71 71.86 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 124.811 1.245 . . . . 72.41 113.774 -173.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.9 pp -81.04 -10.74 59.65 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.48 0.657 . . . . 74.24 111.588 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.3 m -106.61 40.95 1.52 Allowed 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.627 -0.879 . . . . 65.1 108.627 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -51.69 -37.98 53.07 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.943 1.297 . . . . 75.31 112.401 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -59.82 -38.85 83.18 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.046 0.45 . . . . 51.21 111.26 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.483 ' CD ' ' HE3' ' A' ' 442' ' ' LYS . 16.2 tp10 -70.4 -37.15 74.44 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.881 -0.785 . . . . 70.01 108.881 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.582 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -60.7 -51.24 70.19 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.518 -0.764 . . . . 75.1 111.162 -178.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 27.5 m -63.97 -40.55 89.48 Favored 'Isoleucine or valine' 0 C--O 1.249 1.029 0 N-CA-C 112.627 0.603 . . . . 73.31 112.627 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.483 ' HE3' ' CD ' ' A' ' 439' ' ' GLU . 41.9 pttt -68.61 -35.1 76.88 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 119.134 -1.026 . . . . 74.41 112.104 177.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -65.09 -38.31 90.33 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.347 -0.388 . . . . 75.33 110.882 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 94.3 mt -63.2 -38.59 91.78 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.332 -0.618 . . . . 74.31 109.332 177.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.446 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 86.4 m -66.14 -45.23 81.75 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.718 -0.674 . . . . 75.44 111.129 178.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.62 -15.87 63.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.038 0.447 . . . . 64.3 111.632 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -88.62 4.0 48.58 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.997 0.427 . . . . 51.44 111.396 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 112.47 -73.35 0.22 Allowed Glycine 0 CA--C 1.496 -1.152 0 C-N-CA 120.351 -0.928 . . . . 72.53 111.829 175.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . 0.56 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 0.4 OUTLIER -45.57 -68.27 0.21 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 114.021 1.119 . . . . 75.43 114.021 177.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . 0.446 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 60.36 27.33 65.41 Favored Glycine 0 C--N 1.315 -0.605 0 N-CA-C 111.38 -0.688 . . . . 62.44 111.38 -173.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.523 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 32.3 mmt180 -100.16 110.4 22.67 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 106.424 -1.695 . . . . 73.13 106.424 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.405 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 17.3 p90 -143.6 147.0 33.73 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 109.592 -0.521 . . . . 73.35 109.592 -177.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -137.75 123.1 19.46 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 108.43 -0.952 . . . . 65.3 108.43 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -87.38 124.71 33.68 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 123.598 0.561 . . . . 73.33 109.933 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -121.61 142.26 50.29 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 107.343 -1.354 . . . . 74.32 107.343 176.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -125.14 143.06 51.12 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 119.536 -0.865 . . . . 64.41 109.955 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 48.9 m -141.55 139.28 18.44 Favored Pre-proline 0 C--N 1.285 -2.197 0 N-CA-C 107.911 -1.144 . . . . 73.4 107.911 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.715 ' HA ' ' O ' ' A' ' 490' ' ' SER . 34.1 Cg_endo -65.44 122.56 10.28 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 121.746 1.631 . . . . 75.52 111.116 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 47.2 m -135.46 179.64 6.21 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.794 -1.094 . . . . 74.5 109.692 -174.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.9 t -49.3 133.71 17.07 Favored Pre-proline 0 C--O 1.251 1.179 0 O-C-N 124.103 0.877 . . . . 72.41 112.392 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.92 -29.62 35.95 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 124.566 3.51 . . . . 53.22 113.913 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -74.79 -23.8 58.56 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.652 0.612 . . . . 64.22 112.652 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -100.23 -6.05 26.64 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.975 0.416 . . . . 62.32 111.488 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 86.6 t -60.58 128.6 21.98 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 CA-C-N 116.192 -0.458 . . . . 62.33 109.841 176.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 97.07 -3.14 61.93 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.969 -0.634 . . . . 54.03 112.148 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -122.53 165.85 15.75 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 108.322 -0.992 . . . . 74.3 108.322 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 70.9 t -73.97 146.54 10.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.792 -1.188 . . . . 75.44 107.792 173.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 45.5 mt -98.08 -35.64 5.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 107.747 -1.205 . . . . 73.24 107.747 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 161.86 -162.24 33.93 Favored Glycine 0 N--CA 1.417 -2.631 0 N-CA-C 109.851 -1.3 . . . . 63.3 109.851 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . 0.433 HG22 HD13 ' A' ' 486' ' ' ILE . 28.5 p -130.52 153.86 48.4 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 109.869 -0.419 . . . . 70.02 109.869 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -75.03 -56.31 2.06 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 109.017 -0.734 . . . . 72.2 109.017 172.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.28 163.9 35.37 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 121.405 1.403 . . . . 51.3 108.927 172.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -71.88 126.98 12.44 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.168 1.245 . . . . 54.13 112.241 -177.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -99.93 2.04 43.27 Favored 'General case' 0 C--O 1.212 -0.893 0 CA-C-O 121.532 0.682 . . . . 62.41 110.55 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -110.7 5.49 20.93 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 120.202 -0.599 . . . . 73.34 110.48 175.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -122.92 -177.57 3.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.896 0.379 . . . . 74.01 110.507 -175.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 1.0 OUTLIER -71.37 132.12 44.39 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 124.987 1.315 . . . . 70.51 113.471 179.296 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 69.6 m -130.55 144.28 51.31 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 115.517 -0.765 . . . . 73.35 109.578 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -79.34 161.53 26.17 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.342 -0.845 . . . . 74.42 110.893 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.56 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 1.8 mp -70.08 -25.23 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.834 0.826 . . . . 74.55 111.265 -177.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 17.2 m -93.28 -9.28 39.55 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.543 0.687 . . . . 72.3 110.401 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -85.76 129.33 34.86 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.44 -0.8 . . . . 75.01 110.49 -175.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.523 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 10.7 p -97.52 126.81 50.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.176 0.512 . . . . 71.41 111.742 -178.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 35.9 m -100.2 127.31 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-O 121.711 0.767 . . . . 63.32 110.915 177.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.57 124.55 45.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.667 -0.697 . . . . 73.25 109.544 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.433 HD13 HG22 ' A' ' 470' ' ' THR . 34.3 mm -107.5 116.7 51.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.482 -1.303 . . . . 62.21 107.482 -177.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 11.7 tt -100.19 125.97 53.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 121.556 0.694 . . . . 50.35 110.025 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 33.6 m -110.3 151.13 12.59 Favored 'Isoleucine or valine' 0 C--O 1.258 1.536 0 CA-C-N 115.375 -0.829 . . . . 73.45 111.097 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -80.9 128.64 8.56 Favored Glycine 0 N--CA 1.419 -2.45 0 CA-C-N 115.307 -0.861 . . . . 64.14 111.158 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.715 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 31.3 t -130.59 160.64 33.58 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 104.113 -2.551 . . . . 65.14 104.113 177.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 156.07 107.25 0.26 Allowed Glycine 0 N--CA 1.423 -2.185 0 C-N-CA 117.604 -2.236 . . . . 70.02 114.329 177.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -85.74 101.76 0.68 Allowed 'Trans proline' 0 N--CA 1.416 -3.06 0 C-N-CA 121.959 1.772 . . . . 70.31 109.265 169.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . -88.99 65.45 7.52 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.442 -0.947 . . . . 65.41 108.442 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 2.6 p -117.44 143.31 46.15 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 114.464 -1.244 . . . . 73.43 111.579 -175.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -135.95 151.23 49.73 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.499 -0.926 . . . . 72.54 108.499 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.5 p-10 -85.41 130.49 34.58 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.469 -0.938 . . . . 75.13 108.469 176.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 543' ' ' THR . 28.8 pt -92.11 121.91 65.9 Favored Pre-proline 0 C--N 1.29 -2.01 0 CA-C-N 116.109 -0.496 . . . . 60.02 111.038 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -85.73 -164.08 0.21 Allowed 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.552 2.168 . . . . 74.33 110.24 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -94.35 145.93 24.41 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 118.722 -1.191 . . . . 63.11 108.449 177.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 10.2 p -137.58 16.84 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 122.826 1.298 . . . . 72.5 107.505 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . 0.526 ' HB2' ' HA2' ' A' ' 536' ' ' GLY . . . -87.75 145.65 26.03 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 113.706 -1.588 . . . . 61.12 110.363 -174.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 107.02 -10.33 40.29 Favored Glycine 0 C--N 1.293 -1.845 0 N-CA-C 108.922 -1.671 . . . . 52.52 108.922 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -103.84 175.42 5.49 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 114.351 -0.925 . . . . 74.23 108.836 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 20.7 p -85.75 163.97 17.88 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-O 120.584 0.231 . . . . 63.5 111.069 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.1 p -54.96 -41.44 58.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.73 -0.668 . . . . 75.23 112.331 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -66.27 -41.7 89.52 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 120.521 -0.471 . . . . 72.2 110.864 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 90.5 t -67.89 -41.27 84.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.223 -0.444 . . . . 72.02 110.184 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.3 -46.64 85.77 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.31 -0.404 . . . . 53.14 110.629 178.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -59.56 -43.32 93.6 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.313 0.645 . . . . 73.03 109.761 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.432 ' O ' HG23 ' A' ' 514' ' ' VAL . 17.9 ttmm -59.51 -46.98 87.27 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.804 -1.089 . . . . 73.23 109.776 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -62.48 -46.02 90.37 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.257 -0.429 . . . . 74.51 111.032 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 10.3 mp -60.15 -43.48 95.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.396 -0.365 . . . . 72.41 111.297 178.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.71 -39.84 92.92 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.336 0.397 . . . . 71.21 110.91 178.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 510' ' ' LYS . 70.3 t -64.86 -32.41 58.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 116.019 -0.537 . . . . 73.41 111.053 177.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -85.74 2.51 45.21 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.346 -0.542 . . . . 73.24 111.785 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 98.86 -18.07 57.35 Favored Glycine 0 C--O 1.243 0.696 0 C-N-CA 120.847 -0.692 . . . . 73.24 112.797 176.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.486 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 83.4 m-85 -68.7 98.89 0.94 Allowed 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.955 0.883 . . . . 65.31 109.706 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.54 9.99 29.37 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.797 -1.092 . . . . 74.1 112.674 -174.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . 0.443 ' HD2' ' O ' ' A' ' 548' ' ' ASP . 63.6 mttp -122.72 113.46 19.24 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.536 -0.913 . . . . 65.01 108.536 173.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -132.2 156.57 46.22 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.581 -0.736 . . . . 74.54 111.653 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 52.6 m -135.64 136.53 41.06 Favored 'General case' 0 C--N 1.276 -2.605 0 N-CA-C 106.987 -1.486 . . . . 70.51 106.987 173.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -117.08 124.27 48.83 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.418 0.628 . . . . 65.25 109.913 -177.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -110.81 125.54 53.68 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 115.682 -0.69 . . . . 53.42 109.189 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 2.9 p -92.01 120.73 32.92 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 109.085 -0.709 . . . . 64.33 109.085 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . 0.508 ' O ' ' HG2' ' A' ' 557' ' ' LYS . 26.9 m -121.24 152.22 24.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 116.548 -0.296 . . . . 73.03 110.465 -175.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -66.94 135.23 53.48 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 108.796 -0.816 . . . . 65.02 108.796 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 66.3 m -152.98 166.54 15.23 Favored Pre-proline 0 C--N 1.307 -1.278 0 C-N-CA 120.912 -0.315 . . . . 75.54 111.24 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -91.13 -7.16 3.73 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.099 1.866 . . . . 71.01 109.859 168.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.419 ' HA ' ' HD3' ' A' ' 530' ' ' PRO . 29.0 mmm180 -81.98 136.43 47.36 Favored Pre-proline 0 N--CA 1.42 -1.932 0 C-N-CA 124.924 1.29 . . . . 74.53 108.143 177.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 529' ' ' ARG . 33.8 Cg_exo -59.23 149.38 80.99 Favored 'Trans proline' 0 C--O 1.259 1.563 0 C-N-CA 122.61 2.207 . . . . 74.51 113.74 -177.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.641 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -61.61 126.16 26.35 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 114.114 -1.403 . . . . 42.32 111.59 -176.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 120.94 -24.23 7.52 Favored Glycine 0 C--N 1.305 -1.161 0 CA-C-N 115.646 -0.706 . . . . 61.13 111.973 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -82.67 125.79 31.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.801 0.334 . . . . 63.44 110.282 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 85.9 t -75.39 113.27 14.01 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 107.921 -1.14 . . . . 63.4 107.921 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . 0.621 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 12.6 t -78.35 -18.84 54.58 Favored 'General case' 0 C--N 1.314 -0.941 0 O-C-N 123.593 0.558 . . . . 72.43 110.998 -176.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.526 ' HA2' ' HB2' ' A' ' 501' ' ' ALA . . . 160.08 -174.27 36.83 Favored Glycine 0 N--CA 1.422 -2.25 0 C-N-CA 120.499 -0.858 . . . . 64.15 111.213 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 19.4 p -117.42 157.47 26.15 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 108.607 -0.886 . . . . 52.44 108.607 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.452 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 19.4 t30 -71.17 -52.3 9.39 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 109.987 -0.375 . . . . 55.11 109.987 176.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.457 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 38.1 Cg_exo -66.13 131.92 28.34 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 120.914 1.076 . . . . 75.24 109.563 171.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 23.6 Cg_exo -66.23 147.94 84.17 Favored 'Trans proline' 0 C--O 1.243 0.767 0 C-N-CA 122.84 2.36 . . . . 73.1 113.24 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.21 134.42 55.9 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.672 -0.695 . . . . 64.13 109.583 176.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.47 -20.51 32.24 Favored Glycine 0 C--N 1.301 -1.395 0 N-CA-C 111.191 -0.764 . . . . 41.53 111.191 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.428 ' O ' HG12 ' A' ' 497' ' ' ILE . 44.9 m -67.43 134.8 52.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.98 0.419 . . . . 75.32 110.655 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 30.6 m -96.4 122.59 39.45 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 108.924 -0.769 . . . . 71.02 108.924 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 22.1 m -136.45 155.21 77.18 Favored Pre-proline 0 C--N 1.312 -1.022 0 CA-C-N 116.158 -0.474 . . . . 62.33 109.963 -177.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 37.5 Cg_exo -62.72 148.11 93.83 Favored 'Trans proline' 0 C--O 1.221 -0.363 0 C-N-CA 122.411 2.074 . . . . 64.35 111.929 176.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.486 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 35.5 m -65.81 -19.92 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-O 121.864 0.84 . . . . 43.24 111.005 177.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . 0.443 ' O ' ' HD2' ' A' ' 519' ' ' LYS . 37.6 t70 -92.79 3.43 55.67 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.581 -1.19 . . . . 72.41 110.058 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 30.2 t -84.06 159.48 21.15 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.562 -0.903 . . . . 62.12 108.562 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 18.1 t -96.38 122.55 48.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 109.01 -0.737 . . . . 71.21 109.01 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 61.5 mt -100.56 131.72 47.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 109.585 -0.524 . . . . 75.12 109.585 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 521' ' ' SER . 35.6 tt0 -102.46 115.81 31.33 Favored 'General case' 0 N--CA 1.418 -2.03 0 N-CA-C 109.395 -0.595 . . . . 54.44 109.395 178.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . 0.503 HD13 ' H ' ' A' ' 553' ' ' LEU . 0.0 OUTLIER -105.01 134.04 48.78 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.023 -0.99 . . . . 70.11 110.238 175.884 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -102.81 119.72 39.34 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.471 0.653 . . . . 55.12 110.639 -175.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 41.7 t -100.06 138.94 22.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-N 115.138 -0.937 . . . . 42.32 108.627 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.641 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 5.0 m -85.52 141.5 29.84 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.929 -0.578 . . . . 70.22 110.41 -178.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 525' ' ' VAL . 23.0 ptmt -110.28 147.55 33.64 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 105.485 -2.042 . . . . 74.14 105.485 167.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -79.29 -23.7 62.64 Favored Glycine 0 C--N 1.3 -1.472 0 C-N-CA 119.881 -1.152 . . . . 61.01 112.126 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 17.2 m120 59.34 37.65 23.32 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.09 -0.707 . . . . 73.05 109.09 -174.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -112.16 141.91 45.27 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.806 -0.633 . . . . 54.43 110.286 -172.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -123.77 146.76 48.08 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.708 -0.849 . . . . 71.32 108.708 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 56.9 t -72.55 117.52 16.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 121.086 0.47 . . . . 64.33 110.024 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 55.9 ttp -97.23 126.15 43.04 Favored Pre-proline 0 C--N 1.309 -1.18 0 CA-C-N 115.473 -0.785 . . . . 72.41 110.352 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -61.27 170.53 5.05 Favored 'Trans proline' 0 CA--C 1.548 1.22 0 C-N-CA 123.143 2.562 . . . . 63.12 111.804 171.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -60.69 143.6 53.87 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 123.663 0.785 . . . . 73.51 111.466 -178.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -123.94 -42.53 2.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.051 0.453 . . . . 73.21 110.315 -176.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 22.7 t -76.37 144.73 39.9 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.473 -0.936 . . . . 61.44 108.473 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 110.7 -7.1 29.76 Favored Glycine 0 C--N 1.31 -0.915 0 N-CA-C 110.636 -0.986 . . . . 70.51 110.636 -176.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 14.8 mtm -114.69 156.39 24.87 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 122.886 0.475 . . . . 74.23 110.739 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -87.38 143.55 27.19 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 106.196 -1.779 . . . . 71.54 106.196 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 33.3 t90 -51.24 -31.73 21.84 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 113.195 0.813 . . . . 72.44 113.195 -175.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 29.7 m -78.27 -19.38 13.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-O 121.398 0.618 . . . . 70.43 110.909 -176.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -100.99 -35.54 9.34 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.991 0.9 . . . . 73.2 108.86 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -67.98 -40.19 83.15 Favored 'General case' 0 C--O 1.205 -1.257 0 CA-C-N 114.264 -1.335 . . . . 71.14 111.623 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.503 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 36.0 tt0 -54.08 -57.57 17.47 Favored Pre-proline 0 CA--C 1.563 1.48 0 N-CA-C 112.595 0.591 . . . . 71.15 112.595 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 44.8 Cg_exo -59.79 -39.66 70.69 Favored 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 121.514 1.476 . . . . 65.11 111.619 177.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -39.1 90.95 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-O 120.955 0.407 . . . . 65.15 109.921 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.535 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 58.3 tp -66.82 -48.15 69.84 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 123.482 0.713 . . . . 65.53 110.914 -178.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -66.34 -35.09 79.46 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.033 -0.667 . . . . 61.5 111.11 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -65.68 -29.58 70.15 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.962 -0.563 . . . . 73.24 111.735 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 578' ' ' LEU . 4.3 pp -81.62 1.39 34.15 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.066 0.46 . . . . 72.3 111.588 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 92.67 22.91 27.35 Favored Glycine 0 CA--C 1.496 -1.144 0 C-N-CA 120.809 -0.71 . . . . 33.13 113.509 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 84.0 t90 -80.92 136.94 36.12 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 120.352 -0.539 . . . . 64.12 111.128 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 10.8 m -154.24 101.68 2.4 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 106.933 -1.506 . . . . 63.35 106.933 172.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -158.24 -149.65 5.53 Favored Glycine 0 CA--C 1.491 -1.453 0 N-CA-C 109.714 -1.354 . . . . 55.44 109.714 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 58.5 ttp -94.75 127.13 40.53 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 117.68 0.74 . . . . 70.42 110.203 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -102.3 130.01 48.89 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.534 -1.654 . . . . 73.02 106.534 176.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -95.87 105.23 17.22 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.276 0.56 . . . . 73.24 110.517 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -94.42 126.52 39.75 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 106.709 -1.589 . . . . 61.1 106.709 177.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . 0.509 ' HA3' ' NH1' ' A' ' 623' ' ' ARG . . . -120.8 -116.32 2.48 Favored Glycine 0 N--CA 1.423 -2.184 0 C-N-CA 120.596 -0.812 . . . . 64.2 112.257 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -137.13 144.72 43.15 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.682 -0.488 . . . . 61.13 109.682 -177.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -80.47 140.46 35.92 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.114 -1.069 . . . . 73.42 108.114 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 57.3 t -137.2 120.74 21.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 109.517 -0.549 . . . . 72.11 109.517 -172.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.28 106.96 5.33 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.54 -1.281 . . . . 73.33 107.54 173.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -138.64 8.25 2.59 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.899 0.703 . . . . 72.04 112.899 -174.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 117.96 139.83 6.34 Favored Glycine 0 C--N 1.299 -1.503 0 C-N-CA 120.088 -1.053 . . . . 43.43 110.92 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -55.39 -33.73 58.84 Favored Glycine 0 C--O 1.223 -0.558 0 N-CA-C 114.845 0.698 . . . . 71.44 114.845 -173.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 18.5 m -65.63 -24.59 67.08 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 117.503 0.651 . . . . 74.5 111.727 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -98.58 -12.46 21.14 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.212 0.53 . . . . 64.44 109.759 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 67.1 m170 -76.67 137.27 39.31 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.981 -0.554 . . . . 75.54 111.183 -176.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 9.5 p30 46.34 12.8 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 126.929 2.092 . . . . 70.23 115.964 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -126.61 146.72 50.05 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.598 -0.89 . . . . 63.44 108.598 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.31 131.33 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.268 0.627 . . . . 73.01 111.392 -177.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 60.2 t -90.49 -38.85 11.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 120.992 0.425 . . . . 63.34 111.159 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -151.83 162.4 41.11 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.992 -0.373 . . . . 75.34 109.992 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -131.85 127.62 36.94 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 123.845 0.715 . . . . 75.42 109.669 -176.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.572 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 50.7 t-20 -71.86 -62.11 1.75 Allowed Pre-proline 0 CA--C 1.562 1.422 0 N-CA-C 112.744 0.646 . . . . 73.45 112.744 -178.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 3.3 Cg_endo -87.41 134.14 3.38 Favored 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 121.38 1.387 . . . . 71.01 110.7 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.49 137.39 59.62 Favored 'Trans proline' 0 C--O 1.252 1.213 0 C-N-CA 122.853 2.369 . . . . 40.44 114.042 -177.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.9 131.12 44.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.984 -1.007 . . . . 65.43 110.319 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 89.58 0.19 79.46 Favored Glycine 0 C--N 1.312 -0.779 0 C-N-CA 120.694 -0.765 . . . . 64.33 112.271 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 22.5 m -101.31 157.92 16.43 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.919 -0.771 . . . . 71.24 108.919 178.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -73.1 113.83 4.49 Favored Glycine 0 N--CA 1.429 -1.816 0 N-CA-C 108.767 -1.733 . . . . 55.24 108.767 174.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 24.4 m -96.01 141.94 14.57 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-O 121.24 0.543 . . . . 75.24 112.03 -176.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.412 HD22 ' CG ' ' A' ' 617' ' ' ASP . 1.3 p-10 -47.64 140.63 6.01 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 126.322 1.849 . . . . 74.02 111.518 175.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -54.06 -25.93 24.17 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 114.326 1.232 . . . . 62.21 114.326 -175.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . 0.412 ' CG ' HD22 ' A' ' 615' ' ' ASN . 9.3 p-10 -75.37 -25.49 57.74 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.165 -0.679 . . . . 72.14 109.165 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 67.79 21.36 73.06 Favored Glycine 0 N--CA 1.428 -1.897 0 CA-C-O 119.296 -0.725 . . . . 71.34 113.744 172.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.87 118.31 11.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-O 123.312 1.53 . . . . 71.14 111.138 -168.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 3.2 tp -112.12 119.13 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.958 0 CA-C-N 112.96 -1.927 . . . . 75.11 108.649 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 7.0 m -98.6 117.49 33.18 Favored 'General case' 0 N--CA 1.406 -2.665 0 N-CA-C 105.958 -1.867 . . . . 60.4 105.958 175.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -139.28 160.7 39.2 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.23 -1.396 . . . . 75.12 107.23 -178.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . 0.509 ' NH1' ' HA3' ' A' ' 590' ' ' GLY . 13.0 tpt180 -151.16 150.96 31.26 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 105.755 -1.943 . . . . 73.44 105.755 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -138.84 160.98 38.38 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 106.0 -1.852 . . . . 65.14 106.0 173.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -78.2 -96.02 0.24 Allowed Glycine 0 N--CA 1.421 -2.331 0 N-CA-C 110.987 -0.845 . . . . 54.14 110.987 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 . . . . . 0 C--N 1.283 -2.295 0 N-CA-C 108.159 -1.052 . . . . 75.12 108.159 179.277 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.752 0 N-CA-C 110.783 -0.927 . . . . 51.34 110.783 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 11.2 tp -90.98 152.5 3.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 109.529 -0.545 . . . . 74.13 109.529 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 23.7 m -92.85 161.32 14.54 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 108.392 -0.966 . . . . 54.44 108.392 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.24 81.24 1.45 Allowed 'General case' 0 N--CA 1.428 -1.55 0 CA-C-O 122.315 1.055 . . . . 73.35 110.376 -177.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.4 128.96 38.48 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 113.568 -1.651 . . . . 70.11 108.484 175.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 409' ' ' SER . 35.8 m -117.45 163.92 14.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 109.393 -0.595 . . . . 73.1 109.393 -174.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -93.19 138.0 32.0 Favored 'General case' 0 N--CA 1.421 -1.875 0 N-CA-C 106.378 -1.712 . . . . 72.44 106.378 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 60.5 t -95.24 120.04 64.66 Favored Pre-proline 0 C--N 1.28 -2.425 0 CA-C-N 115.744 -0.662 . . . . 61.14 110.005 -167.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -65.7 122.82 10.54 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.54 2.16 . . . . 61.13 112.225 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -108.59 153.72 22.98 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 114.523 -1.217 . . . . 62.43 108.894 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.523 ' HB ' HE21 ' A' ' 368' ' ' GLN . 15.9 m -134.84 28.52 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 115.361 -0.836 . . . . 64.44 109.852 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.47 148.0 24.84 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 115.221 -0.899 . . . . 73.54 112.304 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . 0.425 ' H ' HG23 ' A' ' 399' ' ' VAL . . . 105.95 -5.25 39.39 Favored Glycine 0 C--N 1.321 -0.285 0 CA-C-N 116.332 -0.395 . . . . 75.14 112.251 -176.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . 0.523 HE21 ' HB ' ' A' ' 365' ' ' VAL . 40.6 mt-30 -106.48 -85.08 0.51 Allowed 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 120.868 0.365 . . . . 65.2 110.831 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 41.9 p -153.46 157.82 40.45 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 108.449 -0.945 . . . . 64.2 108.449 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 49.0 m -63.95 -35.67 81.44 Favored 'General case' 0 C--O 1.203 -1.359 0 N-CA-C 109.692 -0.484 . . . . 72.22 109.692 175.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.81 -46.77 88.09 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 116.348 -0.387 . . . . 73.0 111.973 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -68.1 -38.78 82.7 Favored 'General case' 0 C--O 1.245 0.828 0 C-N-CA 120.289 -0.564 . . . . 54.41 110.163 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . 0.451 ' HA ' ' CG2' ' A' ' 365' ' ' VAL . . . -66.59 -51.09 60.23 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.66 -0.7 . . . . 51.31 111.092 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.434 HG23 HG12 ' A' ' 384' ' ' ILE . 60.1 mt -60.08 -43.52 92.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 123.167 0.587 . . . . 60.33 110.517 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -60.47 -47.22 87.07 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.101 0.477 . . . . 45.32 110.59 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . 0.526 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 58.9 m -66.61 -47.79 71.57 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.811 -0.631 . . . . 72.15 111.402 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 9.8 mp -64.24 -37.69 88.39 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 112.001 0.371 . . . . 75.03 112.001 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -64.02 -41.5 97.43 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 109.518 -0.549 . . . . 55.32 109.518 176.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -67.31 -22.38 65.63 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 116.24 -0.436 . . . . 64.34 111.452 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 376' ' ' THR . 13.7 mmm180 -80.94 -14.54 57.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.983 0.421 . . . . 73.52 109.963 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 96.8 14.9 41.56 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.904 -0.665 . . . . 13.42 112.244 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.504 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 55.1 m-85 -93.22 167.72 11.57 Favored 'General case' 0 N--CA 1.427 -1.621 0 O-C-N 122.488 -0.419 . . . . 70.32 110.969 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -105.51 143.83 33.13 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 106.528 -1.656 . . . . 73.44 106.528 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.434 HG12 HG23 ' A' ' 374' ' ' ILE . 1.2 pp -125.6 131.94 71.48 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 CA-C-O 121.593 0.711 . . . . 74.51 111.939 -177.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -111.04 129.34 55.94 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 114.707 -1.133 . . . . 71.51 108.035 -176.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 10.5 m -121.66 123.98 43.19 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 110.101 -0.333 . . . . 62.44 110.101 -176.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -111.57 122.82 48.83 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.536 -0.542 . . . . 64.22 109.536 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.93 126.97 50.31 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.962 0.41 . . . . 73.4 110.536 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -135.14 136.27 24.42 Favored Pre-proline 0 C--N 1.297 -1.696 0 CA-C-N 115.994 -0.548 . . . . 64.41 110.394 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.07 147.24 93.85 Favored 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 123.055 2.503 . . . . 73.24 111.846 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 6.4 t70 86.41 178.59 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.515 1.926 . . . . 72.02 108.949 -178.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 25.7 m -132.41 14.66 4.55 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 121.692 0.758 . . . . 72.4 110.366 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 10.1 t -69.08 -28.05 66.17 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 107.889 -1.152 . . . . 73.31 107.889 172.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.67 HD13 ' H ' ' A' ' 394' ' ' ILE . 0.2 OUTLIER -88.55 151.73 48.5 Favored Pre-proline 0 N--CA 1.433 -1.308 0 N-CA-C 107.59 -1.263 . . . . 74.21 107.59 174.003 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -28.97 116.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.306 0 C-N-CA 125.148 3.899 . . . . 71.23 115.034 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . 0.602 ' HA ' ' OG ' ' A' ' 421' ' ' SER . 48.5 Cg_exo -58.55 161.03 15.45 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 123.805 3.003 . . . . 61.44 113.626 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -57.63 -9.24 1.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.13 0.972 . . . . 63.31 113.077 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 32.6 m170 -107.37 119.86 40.55 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 104.504 -2.406 . . . . 64.52 104.504 171.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.425 HG23 ' H ' ' A' ' 367' ' ' GLY . 11.0 m -62.84 118.24 4.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.196 0 O-C-N 123.681 0.613 . . . . 51.23 111.574 -168.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.38 -34.96 8.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 108.029 -1.1 . . . . 65.35 108.029 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -152.73 157.92 27.58 Favored Glycine 0 N--CA 1.409 -3.153 0 N-CA-C 109.369 -1.492 . . . . 71.3 109.369 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.2 p -117.89 -178.82 3.58 Favored 'General case' 0 C--N 1.277 -2.58 0 N-CA-C 108.435 -0.95 . . . . 72.3 108.435 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -100.74 146.28 31.81 Favored Pre-proline 0 C--N 1.295 -1.795 0 C-N-CA 119.306 -0.958 . . . . 63.03 111.006 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.12 -16.36 1.78 Allowed 'Trans proline' 0 C--N 1.364 1.347 0 C-N-CA 125.221 3.947 . . . . 60.32 114.868 -176.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.43 -33.86 63.93 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.365 0.666 . . . . 72.03 111.042 176.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -82.34 -30.69 30.27 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.434 0.635 . . . . 71.35 111.135 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -86.56 -1.84 57.98 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.335 0.588 . . . . 64.33 110.573 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 47.2 m -107.54 148.38 29.32 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.094 -1.447 . . . . 75.44 107.094 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 360' ' ' VAL . 65.3 m -74.5 113.34 11.64 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 120.055 -0.658 . . . . 25.4 110.319 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 33.4 m -129.31 169.49 20.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.774 -0.648 . . . . 63.52 109.467 177.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 22.6 t -79.84 156.39 27.39 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.094 -0.706 . . . . 60.55 109.094 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . 0.504 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -70.87 143.13 51.13 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 116.101 -0.499 . . . . 21.43 110.703 -178.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 103.02 10.6 36.54 Favored Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 120.398 -0.906 . . . . 44.52 112.98 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -80.53 174.51 11.54 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.244 -1.021 . . . . 72.22 108.244 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -110.01 114.69 28.42 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.945 -0.761 . . . . 74.31 108.945 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 46.6 mm -97.7 127.37 50.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 109.179 -0.674 . . . . 61.34 109.179 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 1.7 p -86.66 130.67 34.39 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 114.028 1.121 . . . . 73.45 114.028 -176.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 2.1 t -123.34 134.89 64.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 C-N-CA 125.126 1.37 . . . . 75.43 110.007 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -106.49 129.12 54.5 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 115.457 -0.792 . . . . 53.04 109.871 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 5.3 p -118.76 131.22 72.17 Favored 'Isoleucine or valine' 0 C--O 1.256 1.408 0 N-CA-C 109.707 -0.479 . . . . 64.15 109.707 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . 0.602 ' OG ' ' HA ' ' A' ' 396' ' ' PRO . 54.6 p -84.75 125.54 32.64 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 115.904 -0.589 . . . . 75.14 110.43 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.8 m -97.82 156.9 16.37 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 107.132 -1.433 . . . . 62.14 107.132 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -44.08 148.78 0.96 Allowed Glycine 0 C--O 1.255 1.411 0 N-CA-C 114.815 0.686 . . . . 64.11 114.815 -177.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.07 152.12 19.3 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 123.788 2.992 . . . . 62.41 112.638 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.42 ' O ' HD13 ' A' ' 480' ' ' ILE . 31.6 mt-10 -72.36 145.76 47.53 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.276 -0.875 . . . . 64.55 109.593 -174.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -122.29 157.38 31.85 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.284 -1.006 . . . . 74.14 108.284 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.551 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 1.5 mmp_? -123.56 159.57 28.9 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 112.698 0.629 . . . . 62.34 112.698 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -82.66 141.18 32.68 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.534 -1.212 . . . . 72.44 108.169 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.443 HD12 ' O ' ' A' ' 473' ' ' PRO . 63.9 mt -77.84 125.98 84.77 Favored Pre-proline 0 N--CA 1.43 -1.449 0 N-CA-C 107.685 -1.228 . . . . 61.52 107.685 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 429' ' ' ILE . 16.9 Cg_exo -69.7 140.85 43.92 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.639 1.559 . . . . 73.1 111.35 178.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -95.4 130.2 42.28 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.302 -1.74 . . . . 71.01 106.302 175.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.541 HG11 ' HB2' ' A' ' 440' ' ' ALA . 13.2 p -129.59 150.51 34.69 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.259 0 C-N-CA 120.346 -0.542 . . . . 73.12 110.515 -172.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 5.7 m -63.23 137.89 58.36 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 107.657 -1.238 . . . . 52.44 107.657 173.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . 0.457 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 52.9 p -60.16 -28.77 68.19 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 123.989 0.916 . . . . 74.13 113.293 -171.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.403 ' HB3' ' HG3' ' A' ' 466' ' ' LYS . 1.1 pp -88.15 -10.73 49.04 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 113.558 0.947 . . . . 74.41 113.558 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 3.6 m -102.65 49.96 0.83 Allowed 'General case' 0 CA--C 1.563 1.459 0 CA-C-O 121.62 0.724 . . . . 75.52 111.056 -175.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -52.72 -37.63 59.51 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.93 0.892 . . . . 72.43 112.58 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' A' ' 442' ' ' LYS . . . -58.82 -40.1 83.18 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.101 0.477 . . . . 61.42 111.367 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -69.42 -35.47 75.74 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.604 -0.887 . . . . 61.51 108.604 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.541 ' HB2' HG11 ' A' ' 432' ' ' VAL . . . -60.78 -51.67 68.35 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.591 -0.732 . . . . 25.0 111.036 -178.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 33.5 m -62.31 -44.61 99.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 120.829 -0.348 . . . . 73.45 111.829 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 438' ' ' ALA 0.339 0.0 OUTLIER -68.66 -33.7 74.44 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 113.432 0.901 . . . . 71.42 113.432 178.881 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -65.01 -43.05 93.79 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 122.197 -0.314 . . . . 71.24 111.108 174.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.492 HD13 ' O ' ' A' ' 440' ' ' ALA . 8.9 mp -63.37 -35.24 79.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.347 -0.388 . . . . 75.12 110.325 177.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.461 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 38.6 m -67.28 -44.29 79.66 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 116.11 -0.495 . . . . 74.14 110.671 178.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.71 -22.94 65.24 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.22 -0.446 . . . . 72.14 111.435 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -80.09 5.16 15.02 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 116.061 -0.518 . . . . 53.11 111.737 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 102.23 -61.21 0.53 Allowed Glycine 0 CA--C 1.492 -1.374 0 C-N-CA 120.739 -0.743 . . . . 70.31 112.348 173.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . 0.44 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 0.9 OUTLIER -53.28 -63.4 1.16 Allowed 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 112.885 0.698 . . . . 70.1 112.885 178.224 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . 0.461 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 60.01 23.22 59.07 Favored Glycine 0 C--N 1.316 -0.572 0 O-C-N 123.199 0.312 . . . . 63.11 113.15 -178.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.446 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 35.6 mmt180 -108.2 110.82 22.54 Favored 'General case' 0 N--CA 1.422 -1.856 0 N-CA-C 107.337 -1.357 . . . . 74.31 107.337 -178.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -131.29 146.02 52.12 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.651 -0.704 . . . . 63.34 110.499 -175.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -131.58 132.79 44.39 Favored 'General case' 0 C--N 1.286 -2.196 0 N-CA-C 108.397 -0.964 . . . . 62.42 108.397 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -101.05 126.98 47.77 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 120.956 0.408 . . . . 75.13 110.244 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.27 153.31 36.55 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.539 -1.282 . . . . 70.22 107.539 175.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -127.36 144.84 50.98 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.602 -0.518 . . . . 74.42 109.602 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 28.2 t -141.81 142.99 27.1 Favored Pre-proline 0 C--N 1.291 -1.963 0 N-CA-C 107.932 -1.136 . . . . 60.34 107.932 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.659 ' HA ' ' O ' ' A' ' 490' ' ' SER . 19.3 Cg_exo -65.83 138.73 54.4 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.872 1.715 . . . . 63.22 110.251 176.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 65.9 m -150.82 174.42 13.09 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 109.522 -0.547 . . . . 73.41 109.522 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.0 t -52.83 136.91 45.52 Favored Pre-proline 0 N--CA 1.437 -1.112 0 C-N-CA 123.739 0.816 . . . . 52.45 110.571 174.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.89 -30.24 38.12 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 124.624 3.549 . . . . 63.04 113.478 -175.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -67.43 -27.83 67.39 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.184 -0.462 . . . . 74.13 111.624 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -99.23 -13.38 19.73 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 111.717 0.266 . . . . 64.43 111.717 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 56.9 t -59.25 130.56 22.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.268 -0.424 . . . . 73.13 110.79 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.08 -10.26 60.05 Favored Glycine 0 N--CA 1.435 -1.399 0 CA-C-N 115.92 -0.582 . . . . 65.34 111.84 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.403 ' HG3' ' HB3' ' A' ' 435' ' ' LEU . 3.8 mppt? -118.03 166.57 12.38 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-O 120.886 0.375 . . . . 53.42 110.899 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.457 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 74.4 t -73.35 143.07 14.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 108.167 -1.049 . . . . 71.24 108.167 176.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 48.9 mm -98.02 -27.07 3.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.313 -0.995 . . . . 74.12 108.313 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 157.94 -161.48 31.52 Favored Glycine 0 N--CA 1.428 -1.894 0 CA-C-N 115.643 -0.708 . . . . 52.14 111.572 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . 0.465 HG22 HG12 ' A' ' 486' ' ' ILE . 40.0 p -115.21 141.29 48.22 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.593 -1.262 . . . . 62.42 107.593 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.492 ' HB3' HG23 ' A' ' 485' ' ' ILE . 6.7 t30 -64.73 -50.42 64.28 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 109.791 -0.448 . . . . 63.12 109.791 176.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -75.29 155.44 41.62 Favored 'Trans proline' 0 C--N 1.377 2.035 0 N-CA-C 108.951 -1.211 . . . . 74.33 108.951 173.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.443 ' O ' HD12 ' A' ' 429' ' ' ILE . 37.3 Cg_exo -62.96 126.19 17.5 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.173 1.248 . . . . 52.4 109.819 177.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -74.4 -0.7 18.16 Favored 'General case' 0 C--O 1.194 -1.838 0 N-CA-C 112.984 0.735 . . . . 63.52 112.984 -173.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . 0.457 ' N ' HD22 ' A' ' 475' ' ' ASN . 0.7 OUTLIER -108.96 3.86 22.68 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 121.78 -0.575 . . . . 50.24 110.071 -179.374 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . 0.417 ' HG2' ' HB2' ' A' ' 473' ' ' PRO . 84.3 mm-40 -98.17 175.71 5.99 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 112.269 0.47 . . . . 74.24 112.269 -177.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 1.3 m -105.87 112.29 25.29 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.464 -0.789 . . . . 50.13 109.455 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 12.7 p -101.12 145.98 28.07 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.038 0.447 . . . . 65.45 110.858 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -75.33 150.57 38.42 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.547 -0.751 . . . . 61.45 110.739 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.44 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 1.7 mp -67.85 -26.05 33.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 123.519 0.728 . . . . 74.15 111.59 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 12.5 t -89.46 2.58 54.33 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.822 0.82 . . . . 74.22 110.342 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -102.82 144.14 31.54 Favored 'General case' 0 C--N 1.318 -0.802 0 O-C-N 121.936 -0.478 . . . . 62.15 110.78 -175.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.446 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 6.4 p -108.15 127.21 64.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 C-N-CA 123.067 0.547 . . . . 73.14 111.566 -177.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 35.7 m -104.73 141.86 19.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.771 -0.65 . . . . 33.34 111.391 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.492 HG23 ' HB3' ' A' ' 471' ' ' ASN . 0.0 OUTLIER -108.93 130.13 62.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.401 0.62 . . . . 64.41 111.795 -178.513 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.465 HG12 HG22 ' A' ' 470' ' ' THR . 13.1 mt -113.81 129.72 69.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 C-N-CA 125.084 1.354 . . . . 70.51 111.206 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 9.9 tt -105.33 126.96 60.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.586 -0.734 . . . . 73.31 111.388 -174.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.411 HG12 HG22 ' A' ' 467' ' ' VAL . 35.7 m -109.68 151.65 11.9 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 C-N-CA 123.519 0.728 . . . . 75.2 110.326 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -92.28 132.51 11.3 Favored Glycine 0 C--N 1.311 -0.809 0 N-CA-C 111.053 -0.819 . . . . 74.31 111.053 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.659 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 23.3 t -134.51 160.41 38.11 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 109.642 -0.503 . . . . 65.24 109.642 -177.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 108.5 80.51 1.24 Allowed Glycine 0 N--CA 1.443 -0.837 0 CA-C-O 119.704 -0.498 . . . . 74.43 112.725 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -68.42 146.27 67.94 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.346 2.031 . . . . 72.34 110.798 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . -112.19 25.9 11.1 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.582 0.706 . . . . 51.12 111.101 -176.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 6.6 p -116.94 143.47 45.67 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 114.93 -1.032 . . . . 72.31 110.659 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -151.2 147.09 26.59 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 108.419 -0.956 . . . . 72.25 108.419 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.524 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 7.6 p-10 -85.71 132.5 34.13 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.699 0.761 . . . . 75.23 112.543 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 33.7 pt -77.18 137.45 64.91 Favored Pre-proline 0 C--N 1.308 -1.22 0 CA-C-N 114.461 -1.245 . . . . 75.23 111.247 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -85.7 175.02 6.3 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.417 2.078 . . . . 60.35 112.528 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -97.21 132.46 42.94 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.59 -0.732 . . . . 60.52 109.654 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.2 104.11 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.626 0 CA-C-O 122.017 0.913 . . . . 61.23 110.598 -177.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -146.55 139.91 25.74 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.958 -1.019 . . . . 51.43 108.725 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 113.9 -18.48 19.24 Favored Glycine 0 CA--C 1.485 -1.837 0 N-CA-C 110.412 -1.075 . . . . 72.11 110.412 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.432 ' O ' HG12 ' A' ' 534' ' ' VAL . 50.6 mt-30 -95.87 -179.52 4.73 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 109.22 -0.659 . . . . 70.51 109.22 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 15.0 t -91.87 157.16 17.01 Favored 'General case' 0 N--CA 1.421 -1.896 0 C-N-CA 118.184 -1.406 . . . . 64.12 107.885 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 6.0 p -53.77 -42.5 52.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 O-C-N 123.742 0.651 . . . . 64.4 112.344 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -65.48 -41.52 93.19 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.265 0.353 . . . . 72.03 110.976 -176.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 81.8 t -70.59 -44.49 76.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.878 0.371 . . . . 71.25 110.798 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . 0.415 ' O ' ' HG ' ' A' ' 512' ' ' LEU . . . -61.44 -48.49 80.94 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.01 -0.541 . . . . 73.31 111.147 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -60.4 -43.11 96.98 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.249 -0.887 . . . . 75.32 109.939 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.483 ' O ' HG23 ' A' ' 514' ' ' VAL . 35.4 ttmt -63.21 -42.37 99.29 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.967 -1.015 . . . . 53.42 110.127 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -62.33 -41.7 98.77 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.057 0.456 . . . . 72.23 110.136 178.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . 0.442 HD13 HG13 ' A' ' 551' ' ' ILE . 89.4 mt -65.73 -37.1 85.47 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.717 -0.674 . . . . 72.13 110.923 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -64.23 -37.76 88.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.253 -0.431 . . . . 75.43 110.051 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 510' ' ' LYS . 93.3 t -62.55 -31.17 51.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 115.889 -0.596 . . . . 71.12 110.673 177.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -77.24 -6.75 54.25 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 120.818 0.342 . . . . 74.14 111.062 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 106.96 -0.06 35.9 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.401 -0.904 . . . . 51.35 113.239 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -90.86 99.37 12.42 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 107.56 -1.274 . . . . 75.3 107.56 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.1 m -91.0 -11.35 39.16 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.972 -1.013 . . . . 75.15 112.076 -172.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . 0.517 ' HD2' ' O ' ' A' ' 548' ' ' ASP . 95.7 mttt -108.62 118.18 36.12 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.239 -0.652 . . . . 74.42 109.239 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -129.63 155.0 46.55 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.147 0.498 . . . . 70.51 111.01 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 4.8 p -141.11 148.17 39.69 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 107.457 -1.312 . . . . 65.12 107.457 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . 0.459 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 4.0 pt20 -132.64 132.61 42.63 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-O 121.235 0.54 . . . . 71.44 111.062 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -113.56 141.51 47.08 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.457 -1.682 . . . . 61.43 106.457 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 45.3 p -121.22 129.16 53.06 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 120.397 -0.521 . . . . 64.54 111.459 -177.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . 0.57 ' O ' ' HB3' ' A' ' 557' ' ' LYS . 19.5 m -121.82 166.67 16.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 109.267 -0.642 . . . . 65.52 109.267 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -92.38 137.85 32.01 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.997 -1.483 . . . . 75.1 106.997 174.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 10.3 m -141.65 173.22 4.99 Favored Pre-proline 0 C--N 1.276 -2.625 0 N-CA-C 108.477 -0.934 . . . . 54.24 108.477 -172.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -79.22 -17.52 11.67 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 121.651 1.567 . . . . 64.32 109.19 168.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.603 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 18.0 mmm180 -67.38 152.19 96.41 Favored Pre-proline 0 N--CA 1.441 -0.905 0 C-N-CA 125.752 1.621 . . . . 65.31 108.581 177.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.44 156.32 61.82 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.335 2.023 . . . . 62.54 112.791 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 557' ' ' LYS . . . -70.93 124.92 25.48 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.937 -0.574 . . . . 73.22 111.038 -178.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 107.82 -10.95 38.14 Favored Glycine 0 C--N 1.305 -1.182 0 C-N-CA 120.589 -0.815 . . . . 42.1 111.395 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -82.46 138.64 34.31 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.469 -1.678 . . . . 70.32 106.469 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.432 HG12 ' O ' ' A' ' 503' ' ' GLN . 11.6 p -95.22 118.29 41.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 119.896 -0.722 . . . . 75.52 110.163 -178.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . 0.582 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 13.2 t -84.05 0.09 49.64 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.364 -0.38 . . . . 44.11 111.614 -175.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.424 ' H ' HG22 ' A' ' 534' ' ' VAL . . . 135.49 -160.94 24.63 Favored Glycine 0 CA--C 1.495 -1.204 0 C-N-CA 120.887 -0.673 . . . . 75.21 111.921 175.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 37.2 p -117.77 155.3 30.26 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.794 -0.817 . . . . 73.12 108.794 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -76.16 -50.34 2.98 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-O 119.437 -0.316 . . . . 64.21 110.507 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -66.95 135.95 39.6 Favored 'Trans proline' 0 C--N 1.369 1.609 0 N-CA-C 108.991 -1.196 . . . . 73.02 108.991 169.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.56 150.56 86.49 Favored 'Trans proline' 0 C--O 1.244 0.784 0 C-N-CA 122.378 2.052 . . . . 63.53 112.799 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.22 138.02 57.39 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.924 -0.769 . . . . 73.23 108.924 176.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.47 -11.34 58.13 Favored Glycine 0 C--N 1.294 -1.789 0 C-N-CA 120.606 -0.807 . . . . 53.21 111.767 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 59.5 m -69.87 120.86 16.24 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.595 -0.521 . . . . 72.3 109.595 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 11.5 t -85.89 123.16 30.92 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 109.079 -0.711 . . . . 71.41 109.079 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 29.1 m -135.88 159.96 69.22 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 108.349 -0.982 . . . . 72.04 108.349 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 32.3 Cg_exo -61.54 141.1 90.48 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 121.711 1.608 . . . . 74.0 110.8 174.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 35.2 m -61.05 -19.65 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-O 121.811 0.815 . . . . 74.52 111.978 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . 0.517 ' O ' ' HD2' ' A' ' 519' ' ' LYS . 25.1 t70 -90.12 -1.23 57.92 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.242 -0.89 . . . . 74.14 110.897 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 67.2 m -86.29 172.95 10.07 Favored 'General case' 0 C--N 1.313 -1.018 0 O-C-N 121.697 -0.627 . . . . 73.41 112.547 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 14.3 p -100.14 136.49 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 115.255 -0.884 . . . . 62.11 110.886 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . 0.502 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -108.97 145.67 15.51 Favored 'Isoleucine or valine' 0 C--O 1.252 1.228 0 N-CA-C 109.245 -0.65 . . . . 71.24 109.245 174.782 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -109.13 115.15 29.5 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 121.303 0.573 . . . . 74.23 111.035 -176.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 5.1 mp -95.5 135.2 37.45 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.612 -1.177 . . . . 55.04 109.425 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -110.43 118.12 35.41 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.68 0.752 . . . . 73.41 110.318 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.88 141.1 16.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 114.731 -1.122 . . . . 72.54 110.288 -174.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.603 ' HB3' ' HB2' ' A' ' 529' ' ' ARG . 7.8 m -86.29 147.95 25.84 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 115.35 -0.841 . . . . 63.11 110.653 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.57 ' HB3' ' O ' ' A' ' 525' ' ' VAL . 0.5 OUTLIER -123.58 130.12 52.19 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.111 -0.95 . . . . 73.54 109.691 173.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -66.25 -43.46 92.9 Favored Glycine 0 CA--C 1.486 -1.769 0 N-CA-C 111.36 -0.696 . . . . 31.14 111.36 -176.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 64.3 t30 72.53 -8.74 1.16 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.968 1.307 . . . . 74.23 110.56 176.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.463 ' H ' ' C ' ' A' ' 558' ' ' GLY . 97.0 mt-30 -127.21 155.34 43.58 Favored 'General case' 0 N--CA 1.423 -1.81 0 C-N-CA 125.567 1.547 . . . . 70.33 107.375 177.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -126.48 147.65 49.79 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.844 -0.798 . . . . 74.04 108.844 177.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 62.8 t -63.43 116.98 3.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 O-C-N 123.408 0.442 . . . . 74.33 110.079 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 58.3 ttp -75.49 124.77 89.12 Favored Pre-proline 0 C--N 1.306 -1.314 0 CA-C-N 115.979 -0.555 . . . . 73.25 110.788 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -65.89 169.41 13.32 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.095 2.53 . . . . 44.35 110.32 174.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -89.19 114.17 25.46 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 118.72 -1.192 . . . . 53.2 111.688 -177.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -125.81 0.18 7.37 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.567 -1.271 . . . . 64.25 107.567 173.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 23.9 m -65.07 151.2 46.63 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 113.777 -1.556 . . . . 54.31 112.238 -174.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 90.79 35.97 7.01 Favored Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 110.213 -1.155 . . . . 50.42 110.213 -175.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 15.9 ptm -117.53 157.5 26.21 Favored 'General case' 0 C--O 1.25 1.089 0 N-CA-C 109.529 -0.545 . . . . 73.15 109.529 -174.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . 0.59 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 86.3 m-85 -84.53 171.52 12.43 Favored 'General case' 0 CA--C 1.502 -0.9 0 O-C-N 123.322 0.389 . . . . 70.4 110.821 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 29.4 t90 -62.6 -34.0 76.12 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.941 -0.762 . . . . 72.45 108.941 172.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 29.1 m -72.33 -7.96 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.318 -0.855 . . . . 73.44 110.97 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . 0.584 ' O ' ' HD3' ' A' ' 577' ' ' ARG . 31.6 m-20 -100.92 -44.83 5.63 Favored 'General case' 0 CA--C 1.492 -1.276 0 N-CA-C 109.407 -0.59 . . . . 74.04 109.407 174.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . 0.646 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -61.04 -53.2 60.07 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.081 -0.963 . . . . 72.43 112.539 -175.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.417 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 1.0 OUTLIER -57.95 -50.69 86.67 Favored Pre-proline 0 CA--C 1.574 1.892 0 O-C-N 123.547 0.529 . . . . 70.41 112.005 -174.659 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . 0.417 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 67.1 Cg_exo -58.25 -38.42 91.04 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 121.847 1.698 . . . . 63.23 112.268 174.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.584 ' HD3' ' O ' ' A' ' 573' ' ' ASP . 5.7 mpt_? -67.67 -34.26 76.57 Favored 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 121.111 -0.236 . . . . 74.53 111.555 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 76.2 mt -60.7 -43.11 98.17 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.976 -0.75 . . . . 73.1 108.976 177.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -64.28 -45.9 85.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.147 -0.933 . . . . 72.3 109.302 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.11 92.27 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.854 -1.066 . . . . 64.51 113.44 -176.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 11.1 mp -82.22 -9.09 59.62 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 113.127 0.788 . . . . 72.5 113.127 -177.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 68.78 32.36 74.01 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 109.255 -1.538 . . . . 44.25 109.255 -174.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 44.8 t90 -60.61 134.07 56.72 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.021 0.928 . . . . 61.04 110.284 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 8.9 t -126.61 19.33 7.34 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.858 -0.61 . . . . 73.55 109.917 -176.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -79.97 -155.22 10.27 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 115.808 -0.633 . . . . 34.34 113.511 -176.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . 0.44 ' H ' HG12 ' A' ' 619' ' ' ILE . 86.1 mtp -124.94 132.62 53.26 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.551 -0.907 . . . . 54.22 108.551 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 61.9 tp -106.8 130.69 54.46 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.328 -0.619 . . . . 74.44 109.328 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -114.2 121.92 45.2 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 120.898 0.38 . . . . 72.15 110.206 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -105.5 118.38 36.42 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 116.153 -0.476 . . . . 72.13 110.216 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -88.19 -163.09 38.85 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.691 -0.964 . . . . 72.2 110.691 177.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -67.19 147.8 52.6 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 120.742 0.306 . . . . 72.33 110.699 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . 0.423 ' HB3' ' NE2' ' A' ' 626' ' ' GLN . 21.6 m-20 -93.72 124.51 37.76 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.138 0.494 . . . . 54.21 111.448 -178.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 91.2 t -114.73 126.39 72.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 106.664 -1.606 . . . . 62.13 106.664 175.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . 0.535 ' HA ' ' HB2' ' A' ' 626' ' ' GLN . 6.2 p-10 -102.44 125.35 49.13 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 120.445 -0.502 . . . . 65.02 109.877 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -133.04 -28.68 1.51 Allowed 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.464 -0.789 . . . . 74.32 110.428 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 130.37 125.29 2.69 Favored Glycine 0 CA--C 1.486 -1.752 0 N-CA-C 109.979 -1.248 . . . . 62.52 109.979 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.29 -36.07 67.81 Favored Glycine 0 C--O 1.21 -1.363 0 N-CA-C 114.641 0.617 . . . . 63.14 114.641 -172.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 18.6 m -62.67 -32.06 73.06 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 117.58 0.69 . . . . 75.54 112.194 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -109.37 -1.92 18.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.62 -0.264 . . . . 54.01 111.525 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . 0.502 ' CE1' ' HA3' ' A' ' 625' ' ' GLY . 5.9 t-160 -150.49 -148.92 0.28 Allowed 'General case' 0 C--O 1.204 -1.328 0 N-CA-C 108.78 -0.822 . . . . 65.43 108.78 -170.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 626' ' ' GLN . 3.1 t-20 62.22 2.87 0.9 Allowed 'General case' 0 N--CA 1.516 2.828 0 C-N-CA 125.1 1.36 . . . . 75.3 112.282 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . 0.59 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 9.2 ptp85 -110.64 171.58 7.38 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.036 -0.984 . . . . 73.43 109.355 -177.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . 0.422 HG23 ' HB2' ' A' ' 622' ' ' LEU . 7.6 p -57.03 130.78 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 O-C-N 124.469 1.105 . . . . 51.34 109.039 176.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 29.2 m -101.22 -37.17 5.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 121.504 0.669 . . . . 64.23 109.561 -175.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . 0.469 ' CE2' ' HD3' ' A' ' 623' ' ' ARG . 35.4 p90 -151.28 152.86 33.8 Favored 'General case' 0 N--CA 1.409 -2.524 0 N-CA-C 105.768 -1.938 . . . . 72.31 105.768 172.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -128.49 144.45 51.15 Favored 'General case' 0 C--N 1.27 -2.865 0 N-CA-C 107.972 -1.121 . . . . 73.12 107.972 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.501 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 42.8 t30 -72.44 -51.92 7.11 Favored Pre-proline 0 C--N 1.286 -2.162 0 CA-C-N 115.652 -0.704 . . . . 65.04 111.054 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.501 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 10.3 Cg_endo -97.78 111.48 0.1 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.582 0 C-N-CA 121.594 1.529 . . . . 74.41 110.309 170.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -68.25 159.07 54.81 Favored 'Trans proline' 0 C--O 1.248 0.978 0 C-N-CA 121.974 1.783 . . . . 64.4 110.465 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -60.11 132.91 55.4 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.789 -0.448 . . . . 61.03 109.789 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.25 -11.06 47.67 Favored Glycine 0 C--N 1.308 -0.997 0 C-N-CA 120.532 -0.842 . . . . 45.51 111.585 -176.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 22.7 m -89.95 156.34 18.5 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.775 -0.824 . . . . 71.41 108.775 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -80.84 125.17 6.75 Favored Glycine 0 N--CA 1.419 -2.454 0 N-CA-C 111.704 -0.558 . . . . 61.12 111.704 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 29.1 m -107.64 141.48 22.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 108.177 -1.045 . . . . 71.14 108.177 175.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.61 ' ND2' ' HB3' ' A' ' 617' ' ' ASP . 31.4 p-10 -63.22 164.52 8.62 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 122.903 0.481 . . . . 74.35 111.873 -177.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -61.84 -25.6 67.62 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.213 0.53 . . . . 62.45 111.242 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . 0.61 ' HB3' ' ND2' ' A' ' 615' ' ' ASN . 16.0 t70 -68.11 -37.44 81.16 Favored 'General case' 0 C--O 1.245 0.856 0 CA-C-N 115.535 -0.757 . . . . 63.44 109.321 176.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 89.65 19.71 47.23 Favored Glycine 0 N--CA 1.429 -1.79 0 CA-C-N 115.283 -0.872 . . . . 74.42 113.147 174.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . 0.44 HG12 ' H ' ' A' ' 586' ' ' MET . 0.0 OUTLIER -70.09 118.13 14.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 122.457 1.122 . . . . 63.01 109.192 -174.375 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.09 129.4 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 N-CA-C 107.691 -1.226 . . . . 71.02 107.691 -175.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.442 ' HB ' ' CB ' ' A' ' 607' ' ' ASN . 32.8 m -99.71 118.31 35.94 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 109.473 -0.566 . . . . 61.33 109.473 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . 0.422 ' HB2' HG23 ' A' ' 603' ' ' VAL . 2.2 pt? -133.86 150.47 51.37 Favored 'General case' 0 CA--C 1.477 -1.852 0 N-CA-C 105.089 -2.189 . . . . 61.12 105.089 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . 0.469 ' HD3' ' CE2' ' A' ' 605' ' ' TYR . 79.7 ttt180 -132.94 139.41 47.31 Favored 'General case' 0 C--N 1.262 -3.208 0 N-CA-C 107.17 -1.418 . . . . 75.12 107.17 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -140.16 163.8 31.76 Favored 'General case' 0 C--N 1.289 -2.052 0 O-C-N 124.048 0.842 . . . . 63.51 109.439 -175.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . 0.502 ' HA3' ' CE1' ' A' ' 600' ' ' HIS . . . -123.64 -141.67 5.88 Favored Glycine 0 N--CA 1.416 -2.685 0 N-CA-C 109.992 -1.243 . . . . 44.15 109.992 174.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . 0.535 ' HB2' ' HA ' ' A' ' 594' ' ' ASP . 38.6 mt-30 . . . . . 0 C--N 1.297 -1.681 0 N-CA-C 108.314 -0.995 . . . . 64.13 108.314 177.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.92 0 N-CA-C 110.668 -0.973 . . . . 45.13 110.668 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 8.6 tp -78.63 125.56 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.921 0 CA-C-O 121.364 0.602 . . . . 63.01 110.651 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.45 140.59 29.38 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.218 -0.66 . . . . 74.35 109.218 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -87.83 -12.5 44.78 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 122.219 1.009 . . . . 51.01 108.358 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -92.81 149.52 21.23 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.142 -1.39 . . . . 70.42 107.289 178.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.8 m -116.93 161.15 15.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 108.905 -0.776 . . . . 71.41 108.905 -177.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -95.04 136.84 34.87 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.008 -1.077 . . . . 61.02 108.142 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.413 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 95.6 t -97.58 127.81 36.55 Favored Pre-proline 0 C--N 1.285 -2.227 0 CA-C-N 115.798 -0.637 . . . . 74.34 110.281 -173.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 23.9 Cg_exo -64.17 137.66 57.7 Favored 'Trans proline' 0 C--O 1.242 0.695 0 C-N-CA 122.66 2.24 . . . . 53.4 111.015 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -79.1 130.36 35.42 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 122.055 0.931 . . . . 70.3 109.706 -178.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 7.9 p -107.94 5.25 9.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-O 122.656 1.217 . . . . 73.42 110.622 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.13 145.01 52.51 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.952 -1.022 . . . . 72.12 110.66 173.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 91.68 0.51 72.3 Favored Glycine 0 N--CA 1.434 -1.439 0 CA-C-N 116.216 -0.447 . . . . 70.53 112.303 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -107.82 -82.06 0.56 Allowed 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.263 0.468 . . . . 73.24 112.263 -176.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 11.8 t -154.29 150.88 28.47 Favored 'General case' 0 CA--C 1.503 -0.861 0 O-C-N 121.644 -0.66 . . . . 62.11 110.501 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.616 ' HB3' ' O ' ' A' ' 397' ' ' ASP . 1.4 p -63.68 -47.22 82.08 Favored 'General case' 0 N--CA 1.435 -1.181 0 O-C-N 123.799 0.687 . . . . 74.01 109.896 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -68.8 -45.59 70.86 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 115.158 -0.928 . . . . 61.32 110.691 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -68.88 -34.66 75.79 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 119.458 -0.897 . . . . 75.33 111.783 -176.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . 0.407 ' O ' HD13 ' A' ' 377' ' ' LEU . . . -67.93 -51.11 51.46 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.662 0.267 . . . . 61.54 110.834 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.37 -37.36 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 116.239 -0.437 . . . . 74.34 110.697 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.58 -47.08 85.5 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 120.893 0.378 . . . . 71.01 111.062 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 42.2 m -62.53 -47.77 82.43 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-O 121.576 0.703 . . . . 73.24 110.081 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.407 HD13 ' O ' ' A' ' 373' ' ' ALA . 9.6 mp -64.33 -39.1 93.22 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.495 -0.775 . . . . 73.21 112.096 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -61.79 -44.45 96.85 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.131 0.572 . . . . 44.23 110.373 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -68.35 -19.38 64.64 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.29 0.567 . . . . 71.51 112.07 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . 0.486 ' NE ' ' HA ' ' A' ' 380' ' ' ARG . 3.9 mmp_? -96.45 -13.95 22.74 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 112.515 0.561 . . . . 72.03 112.515 177.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.13 14.51 54.32 Favored Glycine 0 C--O 1.25 1.12 0 C-N-CA 120.87 -0.681 . . . . 63.52 112.367 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.406 ' CZ ' HG21 ' A' ' 362' ' ' VAL . 26.7 m-85 -76.62 140.05 40.84 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-O 121.141 0.496 . . . . 65.14 110.121 177.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -85.08 134.77 34.19 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 107.628 -1.249 . . . . 73.0 107.628 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.451 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -128.13 157.15 40.46 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 CA-C-O 120.999 0.428 . . . . 64.13 110.338 -175.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -134.99 137.36 42.95 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 106.636 -1.616 . . . . 61.42 106.636 172.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 13.1 m -135.09 116.76 14.94 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.802 -0.814 . . . . 62.13 108.802 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -113.78 123.43 49.83 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.491 -0.929 . . . . 62.03 108.491 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -89.79 125.22 35.22 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.54 -0.541 . . . . 75.43 109.54 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . 0.763 ' HZ2' ' HB2' ' A' ' 389' ' ' LYS . 7.2 mtmp? -114.84 133.31 22.62 Favored Pre-proline 0 C--N 1.307 -1.26 0 N-CA-C 108.159 -1.052 . . . . 73.33 108.159 176.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.425 ' O ' ' HB3' ' A' ' 391' ' ' ASP . 3.3 Cg_exo -85.76 128.47 3.35 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.769 1.646 . . . . 64.22 109.517 172.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.425 ' HB3' ' O ' ' A' ' 390' ' ' PRO . 2.0 p30 158.43 159.25 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.055 -1.461 . . . . 74.15 107.055 -175.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 20.3 p -126.68 23.9 6.67 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.456 0.646 . . . . 62.14 110.165 177.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 39.5 m -90.85 -37.72 13.41 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 108.624 -0.88 . . . . 70.44 108.624 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 37.6 mm -89.71 141.89 28.81 Favored Pre-proline 0 N--CA 1.432 -1.332 0 N-CA-C 106.666 -1.605 . . . . 73.4 106.666 178.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -51.39 161.04 2.0 Favored 'Trans proline' 0 CA--C 1.56 1.782 0 C-N-CA 123.267 2.645 . . . . 64.24 113.606 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -54.65 162.89 4.31 Favored 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 124.675 3.584 . . . . 72.05 114.155 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . 0.616 ' O ' ' HB3' ' A' ' 370' ' ' SER . 5.9 p-10 -56.38 -9.88 0.8 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.381 1.473 . . . . 62.02 113.973 -172.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -67.62 145.89 54.4 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.185 -1.413 . . . . 73.21 107.185 176.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.43 HG13 ' HA ' ' A' ' 370' ' ' SER . 10.3 m -63.29 118.43 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 C-N-CA 119.298 -0.961 . . . . 75.11 112.324 -171.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.29 -34.75 7.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.226 -1.027 . . . . 64.14 108.226 178.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -156.59 157.62 28.09 Favored Glycine 0 N--CA 1.423 -2.174 0 N-CA-C 110.731 -0.948 . . . . 72.2 110.731 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 11.5 p -126.77 -178.21 4.3 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.811 -1.181 . . . . 63.12 107.811 175.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -100.5 139.44 20.63 Favored Pre-proline 0 C--N 1.296 -1.731 0 C-N-CA 119.596 -0.842 . . . . 61.44 109.364 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -52.8 -3.09 0.11 Allowed 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 124.599 3.533 . . . . 41.5 115.765 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.7 -37.19 65.52 Favored 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 122.947 0.499 . . . . 20.42 109.673 173.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -69.11 -41.06 77.93 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-O 121.666 0.746 . . . . 52.14 109.988 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -77.65 -1.24 30.02 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.261 -0.881 . . . . 60.11 110.563 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 75.2 m -98.68 147.07 25.22 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.345 -1.724 . . . . 74.13 106.345 172.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 34.8 m -74.23 112.05 10.0 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 107.385 -1.339 . . . . 52.42 107.385 175.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 23.1 m -133.27 169.64 21.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 121.28 0.562 . . . . 65.41 110.772 -176.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 10.1 t -84.29 154.98 22.63 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 106.557 -1.646 . . . . 75.41 106.557 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -67.91 108.13 2.91 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 121.369 0.604 . . . . 44.33 110.411 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 133.06 54.4 0.08 OUTLIER Glycine 0 N--CA 1.427 -1.952 0 CA-C-N 115.262 -0.881 . . . . 73.34 112.005 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -104.28 -173.2 2.25 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.035 -1.468 . . . . 51.22 107.035 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -115.42 125.63 53.38 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 118.97 0.805 . . . . 64.04 111.085 -176.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.6 mm -122.56 117.99 53.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 121.158 0.504 . . . . 55.13 110.03 177.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 23.8 p -95.26 127.83 41.62 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 123.108 0.563 . . . . 73.2 110.392 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 18.5 t -120.77 134.91 62.68 Favored 'Isoleucine or valine' 0 C--O 1.25 1.131 0 C-N-CA 123.786 0.834 . . . . 64.13 111.843 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -108.78 128.59 55.02 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-O 121.47 0.652 . . . . 74.25 111.008 174.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.506 HG13 ' CB ' ' A' ' 397' ' ' ASP . 2.9 t -106.52 144.2 16.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 C-N-CA 125.075 1.35 . . . . 64.34 110.843 -175.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 10.4 m -118.66 123.36 44.76 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 109.556 -0.535 . . . . 64.02 109.556 176.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 20.6 p -107.78 107.93 18.91 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 105.879 -1.897 . . . . 74.54 105.879 173.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -44.21 -88.12 0.01 OUTLIER Glycine 0 C--O 1.252 1.27 0 N-CA-C 116.858 1.503 . . . . 44.02 116.858 -170.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.5 128.84 16.85 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.65 2.233 . . . . 63.11 114.551 -172.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.424 ' HB2' HG12 ' A' ' 480' ' ' ILE . 14.0 mt-10 -102.4 136.42 42.26 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.44 -1.689 . . . . 64.53 106.44 174.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 33.8 tt0 -133.5 137.52 45.67 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 120.673 -0.411 . . . . 74.54 110.758 -178.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -127.89 159.61 34.38 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 121.097 0.475 . . . . 75.13 111.322 -178.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -103.59 139.0 39.48 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.067 -0.969 . . . . 72.51 109.027 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.74 ' HB ' ' O ' ' A' ' 474' ' ' ALA . 2.7 mp -90.11 124.04 64.33 Favored Pre-proline 0 C--N 1.319 -0.753 0 C-N-CA 119.578 -0.849 . . . . 64.44 109.123 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -66.69 148.37 82.89 Favored 'Trans proline' 0 C--O 1.24 0.604 0 C-N-CA 122.32 2.013 . . . . 75.31 111.393 177.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -76.37 103.89 6.61 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-O 121.491 0.663 . . . . 71.42 110.926 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 60.9 t -98.24 150.01 5.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 107.222 -1.399 . . . . 70.11 107.222 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 35.6 m -73.43 154.88 39.8 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 121.07 0.462 . . . . 54.13 111.055 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . 0.564 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 33.5 p -68.3 -30.14 69.07 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 123.692 0.797 . . . . 74.02 112.403 -174.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 1.6 pp -80.09 -11.46 59.76 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 113.007 0.743 . . . . 73.54 113.007 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.414 ' HB ' ' HB3' ' A' ' 439' ' ' GLU . 0.9 OUTLIER -109.42 65.15 0.61 Allowed 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 113.582 0.956 . . . . 75.12 113.582 -178.595 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -59.01 -38.58 79.57 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.52 0.728 . . . . 74.24 111.908 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -62.48 -36.83 83.72 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.397 0.618 . . . . 74.42 110.548 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.414 ' HB3' ' HB ' ' A' ' 436' ' ' THR . 7.0 tp10 -70.12 -40.53 74.82 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.781 -0.822 . . . . 75.13 108.781 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.564 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -60.86 -51.13 70.61 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.8 -0.637 . . . . 41.44 111.269 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 32.5 m -64.26 -39.73 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 112.78 0.659 . . . . 73.1 112.78 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -68.43 -36.89 79.71 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 119.488 -0.885 . . . . 75.32 110.34 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -66.14 -38.29 87.75 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.96 -0.563 . . . . 61.31 110.936 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 93.7 mt -63.42 -36.3 83.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.157 0.504 . . . . 74.4 109.647 175.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.434 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 33.2 m -70.09 -43.81 70.33 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.579 -0.737 . . . . 70.01 110.444 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -66.96 -21.62 65.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.033 -0.53 . . . . 74.25 111.386 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.7 4.93 26.58 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.018 0.437 . . . . 53.4 111.418 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . 0.46 ' HA3' HD12 ' A' ' 480' ' ' ILE . . . 111.2 -84.94 0.38 Allowed Glycine 0 CA--C 1.484 -1.845 0 C-N-CA 120.525 -0.845 . . . . 64.11 111.793 175.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . 0.4 ' N ' HG23 ' A' ' 480' ' ' ILE . 2.0 p90 -38.53 -60.28 0.82 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.432 1.271 . . . . 74.02 114.432 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . 0.434 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 61.3 30.13 73.22 Favored Glycine 0 CA--C 1.501 -0.799 0 C-N-CA 121.22 -0.514 . . . . 74.33 112.047 -177.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.485 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 40.9 mmm-85 -104.37 110.92 23.35 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 108.477 -0.934 . . . . 74.5 108.477 -177.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -136.09 140.31 43.64 Favored 'General case' 0 N--CA 1.423 -1.778 0 CA-C-N 115.818 -0.628 . . . . 64.22 111.585 -176.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -131.67 140.04 49.23 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.936 -1.029 . . . . 54.42 108.238 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -109.33 129.28 55.53 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.128 0.49 . . . . 74.13 111.531 -176.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.88 150.67 40.7 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.112 -1.07 . . . . 51.33 108.112 176.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -121.97 140.68 52.16 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.762 -0.829 . . . . 71.1 108.762 -177.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 24.3 t -144.7 137.34 13.55 Favored Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 109.338 -0.616 . . . . 63.35 109.338 176.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 490' ' ' SER . 47.3 Cg_endo -71.03 134.56 25.55 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.939 1.759 . . . . 74.04 110.538 175.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 70.2 m -152.76 -179.42 7.61 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 122.801 0.44 . . . . 75.41 110.155 -177.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.2 t -47.64 137.28 9.75 Favored Pre-proline 0 C--O 1.254 1.316 0 C-N-CA 124.276 1.03 . . . . 71.23 110.899 173.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -52.81 -30.94 49.34 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 124.375 3.383 . . . . 51.33 113.451 -175.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -68.5 -26.79 65.64 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.712 0.634 . . . . 75.34 112.712 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -95.33 -15.78 22.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.935 0.398 . . . . 74.54 111.135 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 83.4 t -60.7 128.73 22.36 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 115.996 -0.547 . . . . 63.44 110.304 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.06 -11.23 60.42 Favored Glycine 0 N--CA 1.433 -1.531 0 CA-C-N 115.495 -0.775 . . . . 73.23 111.757 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -119.1 167.18 12.04 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.033 -0.729 . . . . 74.24 109.033 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.564 ' O ' ' HB ' ' A' ' 434' ' ' THR . 79.3 t -75.68 147.11 8.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.114 -1.439 . . . . 72.45 107.114 173.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 65.2 mt -97.88 -35.15 5.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 107.296 -1.372 . . . . 45.43 107.296 176.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 160.06 -160.38 31.57 Favored Glycine 0 N--CA 1.416 -2.682 0 N-CA-C 109.729 -1.348 . . . . 73.42 109.729 177.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 26.3 p -115.98 145.73 42.71 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 107.335 -1.357 . . . . 42.45 107.335 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -64.3 -56.15 25.61 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 119.968 -0.693 . . . . 61.34 110.401 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -80.69 149.49 18.42 Favored 'Trans proline' 0 C--N 1.37 1.699 0 N-CA-C 107.842 -1.638 . . . . 42.31 107.842 169.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -64.81 126.93 17.56 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.588 1.525 . . . . 63.41 113.039 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.74 ' O ' ' HB ' ' A' ' 429' ' ' ILE . . . -86.11 -34.67 20.56 Favored 'General case' 0 C--O 1.198 -1.631 0 CA-C-O 122.224 1.011 . . . . 63.34 108.383 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -72.21 12.37 0.44 Allowed 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.528 -1.215 . . . . 64.5 111.717 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -119.81 -165.49 1.18 Allowed 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 107.978 -1.119 . . . . 75.11 107.978 175.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.44 140.1 37.93 Favored 'General case' 0 N--CA 1.402 -2.874 0 CA-C-O 121.44 0.638 . . . . 62.33 111.883 -178.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 39.5 m -136.99 139.05 41.17 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.852 -0.613 . . . . 52.45 109.473 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -67.85 165.09 18.28 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.869 -0.605 . . . . 72.32 110.776 177.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.46 HD12 ' HA3' ' A' ' 448' ' ' GLY . 29.0 mm -70.57 -15.38 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 121.914 0.864 . . . . 70.12 110.616 -176.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.2 t -92.41 2.9 56.39 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.996 -0.547 . . . . 75.43 110.801 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -92.36 140.95 29.08 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.178 0.513 . . . . 73.14 111.798 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.485 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.3 p -108.31 127.07 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 CA-C-N 115.23 -0.895 . . . . 73.35 109.946 177.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 29.9 m -104.09 132.74 49.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-O 121.779 0.799 . . . . 72.01 111.029 178.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.72 124.25 55.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 115.258 -0.883 . . . . 75.2 110.552 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.443 HG23 HG13 ' A' ' 467' ' ' VAL . 1.7 mp -100.84 125.52 54.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 125.542 1.537 . . . . 61.23 108.671 -178.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 8.8 tt -107.03 126.41 63.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 109.479 -0.563 . . . . 65.42 109.479 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.447 HG12 HG22 ' A' ' 467' ' ' VAL . 33.6 m -110.29 151.21 12.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 116.18 -0.464 . . . . 61.3 110.7 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -83.58 121.58 5.53 Favored Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 109.43 -1.468 . . . . 61.13 109.43 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 23.3 t -141.07 128.99 21.82 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 108.28 -1.008 . . . . 42.45 108.28 -176.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 83.36 98.62 0.56 Allowed Glycine 0 N--CA 1.434 -1.454 0 C-N-CA 120.819 -0.705 . . . . 63.04 113.064 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -77.86 140.87 18.68 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.499 2.132 . . . . 70.35 110.923 177.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -94.77 26.58 3.47 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 122.422 1.106 . . . . 61.23 110.491 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 12.8 p -118.07 147.54 43.16 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 114.134 -1.394 . . . . 54.14 110.295 -178.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . 0.485 ' HD3' ' N ' ' A' ' 496' ' ' ASP . 6.8 tmtm? -150.6 140.2 21.6 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 105.559 -2.015 . . . . 73.1 105.559 175.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 11.4 p-10 -89.07 127.1 35.68 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.526 0.679 . . . . 72.32 111.179 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 28.3 pt -75.89 130.15 79.24 Favored Pre-proline 0 C--N 1.306 -1.321 0 CA-C-N 114.865 -1.061 . . . . 70.31 110.878 -177.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -85.61 -174.72 1.69 Allowed 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.342 2.028 . . . . 73.32 110.737 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -80.04 133.14 36.11 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.033 -1.099 . . . . 71.21 108.033 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.435 HG23 ' NE2' ' A' ' 503' ' ' GLN . 13.0 p -133.09 -7.25 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-O 121.551 0.691 . . . . 70.23 111.187 -174.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.97 114.8 9.39 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.273 0.559 . . . . 62.0 110.338 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 130.84 -21.94 4.63 Favored Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 109.685 -1.366 . . . . 44.14 109.685 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.435 ' NE2' HG23 ' A' ' 500' ' ' VAL . 21.3 mt-30 -87.08 168.9 12.86 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 109.285 -0.635 . . . . 74.24 109.285 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 47.5 p -85.59 162.32 18.91 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 109.817 -0.438 . . . . 52.41 109.817 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 18.8 m -54.24 -42.23 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.045 0 C-N-CA 123.667 0.787 . . . . 73.14 113.004 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -67.35 -42.27 83.78 Favored 'General case' 0 CA--C 1.507 -0.683 0 C-N-CA 120.643 -0.423 . . . . 73.31 110.856 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 97.7 t -69.74 -40.16 78.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.808 -0.633 . . . . 74.55 110.369 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.24 -49.4 74.32 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.55 -0.295 . . . . 52.12 111.026 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -63.11 -35.42 80.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.068 0.461 . . . . 63.24 110.121 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -62.47 -44.03 97.39 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.171 -0.922 . . . . 75.25 109.037 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.56 -49.0 78.4 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 109.723 -0.473 . . . . 71.12 109.723 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.89 -47.66 83.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.182 -0.463 . . . . 72.25 111.494 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -66.41 -39.19 88.83 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 112.231 0.456 . . . . 74.5 112.231 -176.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.43 -29.14 45.61 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 CA-C-O 121.164 0.507 . . . . 54.32 110.837 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 -87.11 -5.39 59.04 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.154 -0.618 . . . . 75.34 111.525 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . 0.444 ' O ' ' HB ' ' A' ' 547' ' ' VAL . . . 110.21 -4.7 30.05 Favored Glycine 0 CA--C 1.492 -1.369 0 C-N-CA 120.525 -0.845 . . . . 71.41 114.246 175.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.527 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 88.9 m-85 -77.8 119.0 20.68 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.849 -0.797 . . . . 64.45 108.849 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 17.0 p -89.9 -31.67 17.19 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 115.384 -0.826 . . . . 62.4 112.933 -174.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -108.59 119.23 38.92 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.681 0.753 . . . . 74.01 112.457 -172.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -130.32 145.82 51.83 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.071 -0.968 . . . . 73.31 109.442 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 61.2 m -141.23 142.89 33.92 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 108.319 -0.993 . . . . 53.12 108.319 175.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -117.55 135.3 54.04 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.501 -0.555 . . . . 71.14 109.501 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -124.05 119.44 29.51 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.973 -0.751 . . . . 74.43 108.973 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . 0.549 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 55.1 m -84.77 130.85 34.62 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.512 0.672 . . . . 71.12 112.545 -177.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 28.0 m -121.86 150.63 25.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 106.648 -1.612 . . . . 65.01 106.648 173.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . 0.548 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 1.4 p-10 -92.71 137.14 32.62 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 117.839 -1.545 . . . . 64.3 110.483 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 49.0 m -150.28 -179.02 0.91 Allowed Pre-proline 0 C--N 1.293 -1.867 0 N-CA-C 106.111 -1.811 . . . . 72.43 106.111 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -87.04 -11.34 5.43 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 121.549 1.499 . . . . 41.43 111.033 171.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -69.15 127.75 92.88 Favored Pre-proline 0 N--CA 1.441 -0.919 0 N-CA-C 108.344 -0.984 . . . . 71.52 108.344 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -55.7 141.51 84.07 Favored 'Trans proline' 0 C--O 1.255 1.373 0 C-N-CA 122.982 2.454 . . . . 75.23 114.371 -171.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -59.67 125.94 25.64 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 114.313 -1.312 . . . . 72.5 110.949 -176.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 123.83 -19.26 7.44 Favored Glycine 0 N--CA 1.427 -1.962 0 C-N-CA 120.732 -0.747 . . . . 52.32 111.244 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -82.78 129.61 35.01 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.801 -0.444 . . . . 74.53 109.801 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 91.0 t -78.6 110.3 14.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 107.909 -1.145 . . . . 74.31 107.909 174.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 18.3 m -75.89 -34.62 59.97 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 123.892 0.877 . . . . 72.23 111.232 -176.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -173.65 179.91 44.73 Favored Glycine 0 CA--C 1.496 -1.143 0 N-CA-C 110.79 -0.924 . . . . 65.35 110.79 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 35.7 p -128.66 152.7 48.08 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.434 -0.58 . . . . 75.54 109.434 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -62.88 -57.47 21.39 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-O 119.174 -0.441 . . . . 70.33 110.99 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -75.5 139.39 22.97 Favored 'Trans proline' 0 C--N 1.369 1.618 0 CA-C-N 120.135 1.084 . . . . 73.12 109.858 171.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -71.35 142.79 41.87 Favored 'Trans proline' 0 C--O 1.251 1.141 0 C-N-CA 122.531 2.154 . . . . 70.23 112.963 -178.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -65.11 135.32 55.38 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.514 -0.766 . . . . 63.21 110.92 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.61 -18.91 34.46 Favored Glycine 0 N--CA 1.433 -1.5 0 CA-C-N 115.709 -0.678 . . . . 72.24 111.421 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 25.9 m -77.77 132.26 38.0 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.767 0.318 . . . . 75.44 111.094 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 36.0 m -81.92 122.56 27.91 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 107.645 -1.242 . . . . 73.04 107.645 176.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.5 m -134.81 159.5 71.92 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 109.601 -0.518 . . . . 64.35 109.601 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -67.29 137.55 43.92 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.334 2.023 . . . . 75.22 111.545 176.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.527 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 34.1 m -63.04 -19.97 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-O 121.863 0.84 . . . . 54.44 112.044 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -80.83 -12.24 59.47 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.072 -0.967 . . . . 65.22 111.856 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 8.5 t -81.78 171.94 13.94 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 120.33 -0.548 . . . . 73.21 111.653 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 44.4 t -99.0 122.38 50.65 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 CA-C-N 115.636 -0.711 . . . . 73.23 110.107 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 2.5 mp -102.6 124.06 56.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.175 -1.046 . . . . 64.33 108.175 175.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -102.02 123.47 45.97 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-O 121.167 0.508 . . . . 74.35 109.897 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 53.3 mt -98.26 120.99 39.62 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 114.534 -1.212 . . . . 72.44 108.872 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -83.23 119.73 24.93 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 106.69 -1.596 . . . . 70.03 106.69 173.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 524' ' ' SER . 45.0 t -113.06 129.32 68.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 N-CA-C 109.252 -0.647 . . . . 61.52 109.252 -177.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.563 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 23.8 p -82.55 146.87 28.95 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-O 120.884 0.373 . . . . 65.32 111.457 178.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.548 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 14.5 ptpt -97.18 152.52 18.74 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 103.732 -2.692 . . . . 74.51 103.732 167.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -80.18 -32.82 34.24 Favored Glycine 0 CA--C 1.491 -1.437 0 C-N-CA 119.408 -1.377 . . . . 73.45 111.186 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 64.2 t30 61.9 17.02 8.54 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.614 1.166 . . . . 62.41 110.575 176.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -144.76 158.96 43.58 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 107.969 -1.123 . . . . 64.33 107.969 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -143.53 148.59 36.21 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.838 -1.171 . . . . 73.05 107.838 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 61.1 t -76.13 116.06 18.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.741 -0.837 . . . . 55.41 108.741 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . 0.406 ' HA ' ' HD3' ' A' ' 564' ' ' PRO . 54.0 ttp -89.96 138.21 27.79 Favored Pre-proline 0 C--N 1.298 -1.651 0 CA-C-N 115.761 -0.654 . . . . 73.11 111.156 -176.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 563' ' ' MET . 33.8 Cg_exo -63.51 170.47 8.19 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.321 2.681 . . . . 72.13 111.414 172.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . 0.481 ' HA ' ' HB1' ' A' ' 610' ' ' ALA . 25.1 t70 -84.33 115.14 22.34 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.04 0.448 . . . . 63.02 111.503 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 5.5 mp -125.89 -4.8 6.93 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.785 -0.643 . . . . 74.02 109.93 175.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 16.4 t -79.45 146.89 32.5 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 109.582 -0.525 . . . . 72.13 109.582 -176.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 91.14 3.53 69.82 Favored Glycine 0 C--N 1.312 -0.788 0 C-N-CA 120.83 -0.7 . . . . 51.32 112.231 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 85.8 mtp -100.72 177.64 4.93 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 107.332 -1.359 . . . . 75.21 107.332 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 63.2 m-85 -80.47 160.16 25.35 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 119.675 -0.81 . . . . 72.5 110.124 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 78.0 t90 -62.89 -28.76 70.27 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.821 -0.807 . . . . 71.4 108.821 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 21.8 m -76.42 -10.01 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.1 -0.954 . . . . 74.41 111.049 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . 0.431 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 20.6 m-20 -96.04 -44.45 7.33 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 107.567 -1.272 . . . . 74.2 107.567 173.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -56.51 -48.69 76.67 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 114.613 -1.176 . . . . 64.23 111.783 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -50.88 -59.61 7.16 Favored Pre-proline 0 CA--C 1.555 1.162 0 N-CA-C 114.045 1.128 . . . . 75.35 114.045 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . 0.414 ' HD2' ' O ' ' A' ' 573' ' ' ASP . 39.9 Cg_exo -61.99 -41.5 36.19 Favored 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 121.5 1.467 . . . . 71.21 113.115 176.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.431 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 11.9 mmt180 -61.29 -41.01 96.25 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 120.575 0.226 . . . . 73.2 111.016 -177.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 8.8 mp -65.79 -47.17 76.03 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 120.95 0.405 . . . . 75.23 110.987 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -65.14 -34.98 79.68 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.279 -0.419 . . . . 65.22 111.151 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -67.74 -38.27 83.29 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.344 -0.389 . . . . 74.51 111.75 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 4.2 pp -83.4 2.23 37.51 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.564 0.697 . . . . 72.44 111.639 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 83.92 29.46 31.6 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.391 -0.822 . . . . 34.32 113.718 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -81.09 127.49 32.69 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 117.14 0.47 . . . . 72.31 110.399 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 57.0 m -142.87 90.89 2.24 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.393 -1.336 . . . . 73.21 107.393 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -142.21 -133.73 2.87 Favored Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 110.86 -0.896 . . . . 72.41 110.86 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 51.5 ttm -126.6 128.56 46.99 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.445 -0.576 . . . . 65.44 109.445 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 7.3 tt -100.92 114.99 29.36 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.374 -1.343 . . . . 72.01 107.374 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 621' ' ' THR . 28.6 t70 -119.33 112.39 19.37 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.711 0.767 . . . . 54.24 111.954 -178.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . 0.536 ' HE3' ' H ' ' A' ' 624' ' ' PHE . 1.5 tmtp? -87.92 112.84 22.98 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.241 -1.762 . . . . 75.54 106.241 176.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -80.72 -111.67 0.3 Allowed Glycine 0 C--O 1.25 1.095 0 C-N-CA 121.308 -0.473 . . . . 33.32 113.682 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -65.74 144.76 56.68 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 110.032 -0.358 . . . . 74.52 110.032 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . 0.502 ' OD1' ' HB2' ' A' ' 626' ' ' GLN . 4.5 t0 -116.25 152.14 34.4 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 120.088 -0.645 . . . . 73.41 110.029 -177.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 96.1 t -137.4 116.32 14.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 108.593 -0.892 . . . . 64.53 108.593 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . 0.479 ' HA ' ' HB3' ' A' ' 626' ' ' GLN . 7.2 p-10 -78.15 124.53 28.16 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.211 -0.449 . . . . 65.22 109.854 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -156.33 -9.56 0.1 Allowed 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 113.11 0.782 . . . . 72.13 113.11 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 104.92 41.5 1.96 Allowed Glycine 0 CA--C 1.505 -0.568 0 N-CA-C 109.069 -1.613 . . . . 45.35 109.069 -174.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 626' ' ' GLN . . . -56.95 -31.04 60.92 Favored Glycine 0 C--O 1.203 -1.789 0 C-N-CA 125.78 1.657 . . . . 74.14 115.004 -174.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 2.4 p -55.2 -24.82 29.08 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 113.148 0.796 . . . . 74.43 113.148 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -102.31 -12.52 17.88 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 111.975 0.361 . . . . 73.44 111.975 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -145.09 37.29 1.14 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.081 0.771 . . . . 74.25 113.081 -173.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -68.7 90.37 0.41 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 122.222 1.01 . . . . 42.33 111.15 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 32.6 ttp85 -115.63 143.56 45.18 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.173 -1.376 . . . . 71.14 109.391 -176.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.48 130.02 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 106.757 -1.572 . . . . 73.34 106.757 176.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 94.6 t -96.46 -51.99 9.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 121.619 0.723 . . . . 70.22 109.065 -175.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -145.08 160.02 42.06 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 104.441 -2.429 . . . . 62.51 104.441 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . 0.53 ' HA ' ' O ' ' A' ' 621' ' ' THR . 13.8 pt20 -147.19 139.29 24.46 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 106.98 -1.489 . . . . 73.2 106.98 173.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . 0.255 93.9 m-20 -61.06 -42.67 87.66 Favored Pre-proline 0 C--N 1.306 -1.286 0 N-CA-C 114.668 1.359 . . . . 65.02 114.668 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -69.39 108.67 2.06 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 121.192 1.262 . . . . 74.31 109.946 171.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -70.74 135.23 27.64 Favored 'Trans proline' 0 C--O 1.25 1.113 0 C-N-CA 121.981 1.787 . . . . 54.11 112.403 -175.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . 0.481 ' HB1' ' HA ' ' A' ' 565' ' ' ASP . . . -67.69 134.76 51.65 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.573 -0.739 . . . . 54.43 109.538 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 86.67 -2.38 87.26 Favored Glycine 0 N--CA 1.434 -1.444 0 C-N-CA 120.707 -0.759 . . . . 52.23 112.466 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 9.6 m -111.54 161.72 15.89 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.488 -0.56 . . . . 63.21 109.488 -176.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -71.68 113.19 4.47 Favored Glycine 0 N--CA 1.435 -1.407 0 N-CA-C 110.084 -1.206 . . . . 65.43 110.084 174.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 32.3 m -107.74 143.05 18.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 123.065 0.546 . . . . 64.12 110.544 -177.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.474 HD21 HG22 ' A' ' 619' ' ' ILE . 23.8 p-10 -42.53 136.72 2.35 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 124.867 1.355 . . . . 73.44 112.079 176.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -58.71 -24.95 62.38 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 124.854 1.261 . . . . 73.41 110.014 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -55.67 -45.21 77.77 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.588 -0.733 . . . . 74.41 109.797 173.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 71.48 19.41 77.7 Favored Glycine 0 N--CA 1.423 -2.186 0 CA-C-N 115.649 -0.705 . . . . 71.44 112.396 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . 0.474 HG22 HD21 ' A' ' 615' ' ' ASN . 0.0 OUTLIER -69.7 119.78 16.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 107.879 -1.156 . . . . 73.32 107.879 -176.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.92 119.66 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.575 0 CA-C-O 122.345 1.069 . . . . 74.01 111.352 -170.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' A' ' 606' ' ' GLN . 0.2 OUTLIER -104.38 121.68 43.89 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-N 114.073 -1.421 . . . . 53.11 109.542 175.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 2.3 pt? -138.4 165.35 27.01 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 123.851 0.86 . . . . 73.05 110.345 -174.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 21.6 ttp85 -134.54 137.51 43.88 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 107.716 -1.216 . . . . 70.31 107.716 174.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.536 ' H ' ' HE3' ' A' ' 589' ' ' LYS . 35.3 p90 -141.52 157.76 44.72 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.862 -1.162 . . . . 73.52 107.862 176.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -56.9 150.94 27.01 Favored Glycine 0 C--N 1.314 -0.68 0 O-C-N 124.597 1.186 . . . . 33.42 114.711 -177.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . 0.502 ' HB2' ' OD1' ' A' ' 592' ' ' ASP . 8.9 tt0 . . . . . 0 C--N 1.302 -1.468 0 C-N-CA 124.741 1.216 . . . . 73.2 108.472 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.615 0 N-CA-C 110.537 -1.025 . . . . 63.11 110.537 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 9.2 tp -74.25 126.88 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.558 0 CA-C-O 121.668 0.747 . . . . 74.45 108.993 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 2.7 m -99.84 145.07 28.17 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 115.654 -0.703 . . . . 73.13 109.231 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.95 -33.29 0.93 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.174 0.512 . . . . 75.4 109.721 176.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -107.34 122.47 46.65 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 105.54 -2.022 . . . . 73.2 105.54 170.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 31.8 m -117.56 164.34 13.94 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 N-CA-C 109.836 -0.431 . . . . 63.34 109.836 -172.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -92.43 136.36 33.27 Favored 'General case' 1 N--CA 1.378 -4.037 0 N-CA-C 106.458 -1.682 . . . . 74.33 106.458 175.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 72.2 t -96.96 121.22 59.84 Favored Pre-proline 0 C--N 1.255 -3.517 0 CA-C-N 114.576 -1.193 . . . . 64.45 109.899 -171.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.48 114.81 3.78 Favored 'Trans proline' 0 N--CA 1.43 -2.231 0 C-N-CA 121.165 1.243 . . . . 71.34 109.877 174.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . 0.436 ' OD2' ' HB ' ' A' ' 402' ' ' THR . 8.1 p-10 -100.83 141.21 34.03 Favored 'General case' 0 C--N 1.272 -2.8 0 CA-C-N 115.18 -0.918 . . . . 71.0 109.728 -177.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.475 ' H ' HD21 ' A' ' 377' ' ' LEU . 38.2 t -89.23 15.69 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 CA-C-N 114.326 -1.307 . . . . 64.54 111.12 -171.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.467 ' HB2' HG22 ' A' ' 402' ' ' THR . 30.1 mtp180 -65.33 147.21 53.84 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.075 -0.966 . . . . 50.42 110.966 175.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . 0.576 ' H ' ' HB ' ' A' ' 399' ' ' VAL . . . 107.7 -6.14 35.39 Favored Glycine 0 C--N 1.307 -1.049 0 N-CA-C 110.956 -0.858 . . . . 63.44 110.956 -171.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -110.58 -154.0 0.53 Allowed 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 107.215 -1.402 . . . . 75.52 107.215 170.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 78.4 p -82.77 162.45 21.7 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 118.872 0.76 . . . . 74.1 109.305 -176.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 54.6 p -57.18 -46.67 82.61 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 123.265 0.353 . . . . 73.12 110.528 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.82 -46.24 82.8 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 116.086 -0.506 . . . . 52.01 112.226 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -67.07 -42.61 84.39 Favored 'General case' 0 C--O 1.255 1.349 0 CA-C-O 121.663 0.744 . . . . 72.15 109.673 -176.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.05 -51.14 63.18 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.751 -1.113 . . . . 75.34 110.795 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 74.6 mt -60.13 -43.29 92.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 CA-C-N 116.284 -0.417 . . . . 62.1 111.137 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.51 -44.38 89.44 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 123.63 0.581 . . . . 71.35 110.849 -177.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . 0.52 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 12.9 m -69.1 -46.81 66.8 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 116.013 -0.54 . . . . 75.12 111.359 -178.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.475 HD21 ' H ' ' A' ' 365' ' ' VAL . 4.5 mm? -59.66 -43.03 94.1 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 120.647 0.261 . . . . 74.15 111.486 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -64.42 -42.29 96.12 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.11 -0.495 . . . . 73.5 110.516 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -69.07 -17.82 63.92 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 111.941 0.348 . . . . 74.03 111.941 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 376' ' ' THR . 22.1 mmm180 -90.0 -11.76 40.64 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.183 0.516 . . . . 64.53 110.826 176.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.17 9.18 48.89 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.178 -1.01 . . . . 72.31 112.546 177.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -90.68 159.36 16.42 Favored 'General case' 0 N--CA 1.415 -2.223 0 N-CA-C 109.514 -0.551 . . . . 72.23 109.514 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.411 ' HB2' ' HG2' ' A' ' 415' ' ' GLU . 92.0 mttt -105.91 158.11 17.01 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 109.065 -0.717 . . . . 75.32 109.065 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.466 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -132.64 150.97 33.74 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.523 0 N-CA-C 108.19 -1.041 . . . . 71.33 108.19 177.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -118.28 126.88 53.05 Favored 'General case' 0 C--N 1.273 -2.741 0 N-CA-C 105.421 -2.066 . . . . 64.15 105.421 173.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 28.0 m -118.79 119.97 35.98 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 109.527 -0.546 . . . . 54.12 109.527 -173.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -112.15 125.59 54.29 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.369 -0.604 . . . . 64.32 109.369 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -100.31 121.92 42.26 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.175 -0.676 . . . . 74.0 109.175 177.067 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -120.86 117.52 30.97 Favored Pre-proline 0 C--N 1.304 -1.41 0 CA-C-N 115.674 -0.694 . . . . 71.44 110.222 -172.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -87.68 129.87 2.64 Favored 'Trans proline' 0 C--O 1.254 1.282 0 C-N-CA 122.27 1.98 . . . . 74.41 111.291 176.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.503 ' HB3' HG12 ' A' ' 394' ' ' ILE . 27.1 t70 176.85 162.47 0.43 Allowed 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.483 -0.562 . . . . 73.04 109.483 -177.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 7.7 m -89.64 -14.61 34.5 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 113.047 0.758 . . . . 73.31 113.047 -175.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 10.1 t -123.04 8.52 9.26 Favored 'General case' 0 C--O 1.249 1.079 0 C-N-CA 118.519 -1.272 . . . . 72.21 113.06 -175.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.503 HG12 ' HB3' ' A' ' 391' ' ' ASP . 33.6 mm -88.36 133.76 35.95 Favored Pre-proline 0 C--N 1.31 -1.151 0 N-CA-C 107.214 -1.402 . . . . 45.54 107.214 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 396' ' ' PRO . 11.0 Cg_endo -53.58 145.56 47.3 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.483 2.789 . . . . 73.21 114.429 -178.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 395' ' ' PRO . 81.1 Cg_exo -55.32 162.08 6.36 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 123.758 2.972 . . . . 63.21 111.804 175.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . 0.409 ' CB ' HG13 ' A' ' 420' ' ' VAL . 2.9 p-10 -57.21 -8.69 0.76 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.476 1.11 . . . . 71.42 113.311 -175.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 46.1 m170 -76.62 124.85 28.25 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.825 -1.176 . . . . 75.21 107.825 175.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.576 ' HB ' ' H ' ' A' ' 367' ' ' GLY . 8.9 t -76.48 132.43 33.01 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.577 0 CA-C-N 115.508 -0.769 . . . . 74.41 111.041 -167.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 28.9 pt -98.58 -27.97 3.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 114.959 -1.019 . . . . 64.14 113.504 -175.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.52 174.2 25.62 Favored Glycine 0 CA--C 1.503 -0.711 0 N-CA-C 110.439 -1.064 . . . . 73.32 110.439 -173.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.467 HG22 ' HB2' ' A' ' 366' ' ' ARG . 60.2 p -111.14 -178.67 3.52 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 118.164 0.982 . . . . 72.24 111.391 -174.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . 0.459 ' CB ' HG23 ' A' ' 416' ' ' ILE . 7.6 t70 -110.72 129.03 24.39 Favored Pre-proline 0 C--N 1.314 -0.96 0 N-CA-C 109.231 -0.655 . . . . 41.23 109.231 -176.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.67 -26.63 66.27 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 123.358 2.705 . . . . 53.23 113.804 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.95 -42.22 75.88 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.942 -0.572 . . . . 61.05 110.347 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -79.97 -31.84 39.86 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 121.688 0.756 . . . . 64.42 110.485 -178.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -84.74 2.39 42.25 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.721 -0.672 . . . . 71.21 111.099 -173.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 25.4 m -109.82 154.23 23.29 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.293 -1.743 . . . . 75.11 106.293 172.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 26.7 m -74.91 113.01 11.72 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 119.58 -0.848 . . . . 60.04 109.295 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 30.9 m -129.99 169.2 21.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-O 120.815 0.341 . . . . 61.5 110.283 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 33.5 m -69.75 143.45 53.02 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.17 -1.048 . . . . 40.41 108.17 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -68.04 109.03 3.31 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.174 0.512 . . . . 74.24 110.505 -177.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 129.97 69.1 0.11 Allowed Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 110.367 -1.093 . . . . 72.05 110.367 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -130.16 -175.38 3.61 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.227 -1.397 . . . . 73.52 107.227 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . 0.411 ' HG2' ' HB2' ' A' ' 383' ' ' LYS . 43.8 mt-10 -114.49 132.62 56.22 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.355 0.598 . . . . 75.43 111.342 -176.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . 0.459 HG23 ' CB ' ' A' ' 403' ' ' ASP . 36.4 mm -112.14 115.4 49.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 106.707 -1.59 . . . . 71.4 106.707 177.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 54.5 m -91.61 118.6 30.76 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.157 0.503 . . . . 54.15 111.987 -172.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 14.1 p -110.71 135.06 50.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 C-N-CA 124.294 1.038 . . . . 61.13 111.32 -175.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -102.53 116.1 31.91 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.05 -0.722 . . . . 74.22 109.05 176.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 72.6 t -108.54 131.63 58.61 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 106.66 -1.607 . . . . 72.14 106.66 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . 0.413 ' OG ' ' HB ' ' A' ' 394' ' ' ILE . 33.0 t -119.79 137.12 54.16 Favored 'General case' 0 C--N 1.288 -2.096 0 C-N-CA 119.276 -0.969 . . . . 65.11 111.93 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.1 p -96.1 156.33 16.38 Favored 'General case' 0 N--CA 1.408 -2.564 0 N-CA-C 106.148 -1.797 . . . . 70.03 106.148 170.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -66.42 -162.71 1.31 Allowed Glycine 0 C--O 1.262 1.886 0 N-CA-C 116.073 1.189 . . . . 75.34 116.073 -172.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.41 137.39 80.12 Favored 'Trans proline' 0 CA--C 1.503 -1.028 0 C-N-CA 123.626 2.884 . . . . 71.21 111.459 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.467 ' O ' HG12 ' A' ' 480' ' ' ILE . 28.7 mt-10 -74.87 145.5 42.7 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-O 121.897 0.856 . . . . 75.44 111.524 -177.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.441 ' HG2' ' HA ' ' A' ' 479' ' ' ALA . 45.9 mt-30 -134.06 142.63 47.63 Favored 'General case' 0 N--CA 1.409 -2.52 0 N-CA-C 107.277 -1.379 . . . . 72.52 107.277 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.559 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 3.4 mmp_? -122.91 147.63 46.38 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-O 121.217 0.532 . . . . 74.04 110.881 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.423 ' HG2' ' H ' ' A' ' 428' ' ' GLU . 8.9 pt-20 -83.36 133.68 34.94 Favored 'General case' 0 C--N 1.272 -2.792 0 CA-C-N 114.61 -1.177 . . . . 71.21 107.98 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.52 ' HB ' ' O ' ' A' ' 474' ' ' ALA . 63.5 mt -80.51 125.57 80.5 Favored Pre-proline 0 N--CA 1.429 -1.5 0 C-N-CA 120.121 -0.631 . . . . 72.34 109.461 -175.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.88 146.11 52.38 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 122.28 1.987 . . . . 54.42 111.014 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -78.9 144.56 34.79 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.718 -0.845 . . . . 74.41 108.718 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.473 HG11 ' HB2' ' A' ' 440' ' ' ALA . 13.1 p -143.25 160.87 17.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 108.379 -0.971 . . . . 72.41 108.379 -175.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 19.2 m -68.89 138.0 54.31 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 108.486 -0.931 . . . . 75.25 108.486 174.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 35.2 p -69.21 -29.57 67.55 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 123.088 0.555 . . . . 53.34 111.612 -175.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.2 pp -80.32 -10.47 59.75 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.103 0.477 . . . . 73.23 111.611 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 5.1 m -105.95 57.41 0.66 Allowed 'General case' 0 CA--C 1.566 1.562 0 CA-C-O 121.669 0.747 . . . . 64.2 110.609 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.26 -38.42 58.13 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.465 1.106 . . . . 73.23 112.0 175.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.82 -42.81 85.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.189 0.519 . . . . 70.41 110.764 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -71.59 -35.44 70.53 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 116.02 -0.536 . . . . 75.3 110.517 178.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.509 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -59.5 -51.31 70.41 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.548 -0.296 . . . . 61.44 111.016 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 22.2 m -64.65 -36.96 78.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 CA-C-O 120.648 0.261 . . . . 74.22 111.441 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 37.9 tptt -59.39 -47.54 85.05 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.815 -0.63 . . . . 73.11 109.507 175.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -64.97 -37.92 89.26 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.762 -0.654 . . . . 74.32 112.258 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 90.1 mt -63.39 -37.23 86.49 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.883 -0.414 . . . . 72.41 109.883 175.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.428 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 28.5 m -67.77 -44.55 77.16 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.958 -0.564 . . . . 60.23 109.972 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.13 -16.09 62.53 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.445 -0.798 . . . . 74.22 112.14 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . 0.482 ' O ' ' HG3' ' A' ' 427' ' ' ARG . . . -87.87 5.82 38.5 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.005 0.431 . . . . 75.2 111.666 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . 0.436 ' HA3' HD12 ' A' ' 480' ' ' ILE . . . 107.14 -73.57 0.21 Allowed Glycine 0 CA--C 1.491 -1.457 0 C-N-CA 120.006 -1.092 . . . . 23.01 111.883 175.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . 0.436 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 1.3 p90 -42.43 -65.97 0.41 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.806 1.039 . . . . 71.4 113.806 176.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . 0.428 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 62.9 17.34 58.27 Favored Glycine 0 C--N 1.317 -0.479 0 C-N-CA 121.447 -0.406 . . . . 64.34 112.545 -176.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 16.4 mmm-85 -93.07 110.73 22.21 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 106.416 -1.698 . . . . 71.24 106.416 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.526 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 15.4 p90 -141.03 150.12 42.6 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-O 121.066 0.46 . . . . 75.43 111.69 -177.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -132.22 123.33 26.77 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.147 -1.057 . . . . 74.21 108.147 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -90.46 132.56 35.58 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.037 -0.727 . . . . 71.53 109.037 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . 0.433 ' O ' HD12 ' A' ' 487' ' ' ILE . . . -132.72 134.62 45.01 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 109.175 -0.676 . . . . 70.41 109.175 176.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 488' ' ' VAL . 34.7 p30 -118.98 139.54 51.51 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 120.961 0.41 . . . . 74.14 110.397 174.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 34.2 t -135.44 143.01 43.43 Favored Pre-proline 0 C--N 1.288 -2.084 0 N-CA-C 108.299 -1.0 . . . . 70.14 108.299 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 490' ' ' SER . 24.5 Cg_exo -65.56 132.31 30.61 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 121.728 1.619 . . . . 65.41 109.519 174.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 28.5 p -152.19 179.68 8.3 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 108.32 -0.993 . . . . 32.33 108.32 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.8 t -47.18 137.25 8.45 Favored Pre-proline 0 C--O 1.247 0.949 0 C-N-CA 123.732 0.813 . . . . 74.41 111.959 176.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.81 -29.38 34.14 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 124.533 3.488 . . . . 73.33 113.842 -176.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -64.17 -29.28 70.41 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 120.955 0.407 . . . . 64.43 111.403 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 79.7 mt -94.87 11.79 30.44 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 112.334 0.494 . . . . 62.31 112.334 -176.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 13.0 p -60.71 127.18 19.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 C-N-CA 120.156 -0.617 . . . . 73.25 110.022 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 76.38 2.29 73.45 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.347 -0.842 . . . . 72.33 113.308 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -107.83 139.74 41.97 Favored 'General case' 0 N--CA 1.413 -2.303 0 CA-C-O 121.39 0.614 . . . . 65.11 110.908 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 79.0 t -67.2 134.22 30.44 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 CA-C-N 114.005 -1.452 . . . . 65.2 107.6 173.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 55.6 mt -96.64 -28.32 3.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 108.278 -1.008 . . . . 61.31 108.278 -176.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 159.72 -164.01 33.91 Favored Glycine 0 N--CA 1.416 -2.695 0 N-CA-C 110.659 -0.977 . . . . 54.54 110.659 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 12.1 p -135.66 145.4 46.75 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 107.218 -1.401 . . . . 75.21 107.218 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -62.89 -52.74 61.53 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 119.799 -0.761 . . . . 64.43 110.495 177.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 473' ' ' PRO . 29.9 Cg_endo -69.45 134.82 29.59 Favored 'Trans proline' 0 C--N 1.366 1.497 0 N-CA-C 107.408 -1.804 . . . . 72.14 107.408 168.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.488 ' HB2' ' CG ' ' A' ' 476' ' ' GLN . 28.7 Cg_exo -61.84 127.75 22.37 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 121.623 1.549 . . . . 71.14 112.231 -175.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.52 ' O ' ' HB ' ' A' ' 429' ' ' ILE . . . -77.89 -3.68 42.92 Favored 'General case' 0 C--O 1.204 -1.338 0 CA-C-N 115.073 -0.967 . . . . 72.13 113.514 -171.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -110.25 0.56 18.17 Favored 'General case' 0 C--N 1.283 -2.283 0 O-C-N 121.244 -0.91 . . . . 72.43 111.174 174.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . 0.488 ' CG ' ' HB2' ' A' ' 473' ' ' PRO . 15.5 mm100 -100.22 -177.35 3.5 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.671 -0.695 . . . . 73.32 110.613 -176.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.38 130.26 35.78 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 115.979 -0.555 . . . . 63.24 109.906 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 41.3 t -124.56 142.19 51.54 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.698 -0.853 . . . . 43.31 108.698 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.441 ' HA ' ' HG2' ' A' ' 426' ' ' GLN . . . -72.7 152.87 41.45 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 112.586 0.587 . . . . 62.21 112.586 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 425' ' ' GLU . 43.2 mm -64.68 -24.97 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-O 121.835 0.826 . . . . 70.12 110.874 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 7.8 p -96.9 5.7 50.03 Favored 'General case' 0 C--N 1.291 -1.977 0 O-C-N 121.839 -0.538 . . . . 74.22 111.589 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -100.15 144.91 28.62 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.018 -0.537 . . . . 72.12 110.641 -174.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.8 p -94.48 127.38 46.52 Favored 'Isoleucine or valine' 0 C--O 1.249 1.039 0 CA-C-O 121.531 0.681 . . . . 62.0 112.367 -177.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 56.4 t -101.34 120.59 51.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 108.838 -0.801 . . . . 60.12 108.838 177.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.73 123.37 50.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-O 121.128 0.489 . . . . 54.13 109.747 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 29.2 mm -100.83 110.11 27.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 C-N-CA 124.789 1.236 . . . . 71.41 109.293 -177.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.433 HD12 ' O ' ' A' ' 455' ' ' ALA . 5.9 tp -99.44 126.9 52.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 109.349 -0.611 . . . . 72.33 109.349 177.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 456' ' ' ASN . 2.4 p -120.53 142.06 38.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 C-N-CA 123.946 0.898 . . . . 75.35 108.882 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -90.01 142.48 16.53 Favored Glycine 0 N--CA 1.431 -1.681 0 C-N-CA 120.666 -0.778 . . . . 63.12 113.567 -176.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 22.8 t -114.36 129.74 56.66 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.152 -1.795 . . . . 70.45 106.152 174.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -156.64 90.85 0.12 Allowed Glycine 0 C--N 1.304 -1.247 0 C-N-CA 119.183 -1.484 . . . . 54.22 112.846 -177.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -64.85 148.63 90.02 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 122.998 2.465 . . . . 60.33 113.395 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -147.43 37.5 0.92 Allowed 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 106.869 -1.53 . . . . 71.5 106.869 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.521 ' HB ' HG22 ' A' ' 544' ' ' THR . 1.0 OUTLIER -116.45 146.17 42.74 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 113.493 -1.685 . . . . 62.23 113.055 -169.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . 0.454 ' HA ' ' HE3' ' A' ' 495' ' ' LYS . 1.0 OUTLIER -142.26 146.68 35.38 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 124.468 1.107 . . . . 73.23 108.395 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 7.3 m-20 -80.42 131.15 35.55 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 109.134 -0.691 . . . . 55.04 109.134 176.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 35.1 pt -77.09 130.45 75.29 Favored Pre-proline 0 C--N 1.3 -1.552 0 C-N-CA 120.532 -0.467 . . . . 65.13 111.55 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . 0.457 ' HD2' HD13 ' A' ' 512' ' ' LEU . 41.7 Cg_endo -69.02 165.97 28.28 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.615 2.21 . . . . 71.52 111.029 175.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -92.8 147.33 22.94 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.832 -0.622 . . . . 62.43 110.695 -177.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.3 p -162.54 89.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 122.401 1.096 . . . . 45.11 110.829 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -137.53 114.48 10.67 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.14 -0.936 . . . . 71.3 108.743 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 101.11 17.51 22.41 Favored Glycine 0 N--CA 1.429 -1.791 0 N-CA-C 109.899 -1.281 . . . . 43.33 109.899 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.477 ' OE1' HG11 ' A' ' 507' ' ' VAL . 44.7 mt-30 -124.65 174.23 8.0 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 108.044 -1.095 . . . . 63.43 108.044 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 9.4 t -92.2 168.16 11.54 Favored 'General case' 0 C--O 1.256 1.397 0 C-N-CA 119.694 -0.803 . . . . 63.14 110.791 -175.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 89.7 t -49.87 -41.38 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.832 1.253 . . . . 62.3 111.603 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -57.67 -39.25 76.64 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.556 -0.747 . . . . 62.55 111.381 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . 0.477 HG11 ' OE1' ' A' ' 503' ' ' GLN . 23.0 t -75.48 -38.54 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-N 115.686 -0.688 . . . . 71.22 110.107 -175.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . 0.436 ' O ' HD23 ' A' ' 512' ' ' LEU . . . -62.6 -49.76 73.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.624 -0.716 . . . . 63.35 110.998 -177.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.413 ' O ' ' HB2' ' A' ' 513' ' ' ASN . 10.3 pt20 -65.43 -35.83 82.11 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.318 -0.401 . . . . 73.2 110.862 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -50.7 67.92 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.734 -0.666 . . . . 63.42 109.837 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -62.01 -47.24 85.65 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 120.662 0.268 . . . . 75.04 111.125 -177.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . 0.457 HD13 ' HD2' ' A' ' 498' ' ' PRO . 4.3 mm? -63.93 -43.16 96.73 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.458 -0.337 . . . . 73.51 111.788 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 509' ' ' GLN . 1.8 t-20 -60.07 -42.75 95.23 Favored 'General case' 0 N--CA 1.423 -1.816 0 C-N-CA 122.859 0.464 . . . . 42.11 111.384 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 48.9 t -59.5 -31.98 47.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 123.322 0.649 . . . . 72.24 111.653 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -85.59 -5.0 59.32 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 112.045 0.387 . . . . 71.44 112.045 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 116.87 -10.94 15.45 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 119.826 -1.178 . . . . 61.43 113.742 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -74.01 125.69 28.83 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 117.335 0.567 . . . . 75.21 111.589 -176.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 11.7 p -104.54 -23.98 13.07 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.479 -0.782 . . . . 74.54 112.0 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . 0.432 ' O ' HD13 ' A' ' 551' ' ' ILE . 10.0 mtmp? -111.46 114.69 27.97 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 120.322 -0.551 . . . . 74.31 110.757 -176.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -114.59 132.63 56.28 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.135 -1.061 . . . . 74.42 108.135 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 25.4 p -115.52 134.21 55.29 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 107.305 -1.369 . . . . 72.33 107.305 173.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -117.27 120.37 38.04 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 109.156 -0.683 . . . . 73.24 109.156 -175.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -106.68 138.52 42.69 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.802 -0.635 . . . . 41.54 109.845 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 57.2 m -92.52 123.9 36.17 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.513 -0.551 . . . . 70.2 109.513 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 60.6 t -120.88 148.43 24.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 106.845 -1.539 . . . . 73.51 106.845 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.53 135.96 38.26 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-O 120.965 0.412 . . . . 74.4 111.607 -178.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . 0.429 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 38.7 m -154.13 172.5 5.72 Favored Pre-proline 0 N--CA 1.429 -1.521 0 N-CA-C 106.162 -1.792 . . . . 54.11 106.162 175.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -90.93 -0.91 4.98 Favored 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 121.938 1.759 . . . . 73.52 109.842 167.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.558 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 0.0 OUTLIER -78.31 132.6 65.8 Favored Pre-proline 0 C--O 1.216 -0.681 0 CA-C-N 114.912 -1.04 . . . . 64.13 109.229 178.406 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . 0.432 ' O ' ' HB2' ' A' ' 533' ' ' GLU . 31.2 Cg_exo -56.03 143.68 82.28 Favored 'Trans proline' 0 C--O 1.246 0.88 0 C-N-CA 123.1 2.534 . . . . 72.33 113.692 -175.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.61 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -56.7 132.01 50.76 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.287 -0.87 . . . . 72.31 111.045 -178.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 110.9 -8.91 29.64 Favored Glycine 0 C--N 1.306 -1.127 0 N-CA-C 110.357 -1.097 . . . . 72.34 110.357 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 530' ' ' PRO . 7.5 tp10 -82.62 125.55 31.32 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 106.811 -1.551 . . . . 71.24 106.811 178.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 91.2 t -89.1 110.03 20.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 107.564 -1.273 . . . . 73.03 107.564 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . 0.485 HG23 ' HG3' ' A' ' 554' ' ' GLN . 11.4 t -78.32 -12.48 60.01 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.884 -0.598 . . . . 72.24 110.683 -176.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.98 -159.45 28.33 Favored Glycine 0 N--CA 1.428 -1.844 0 C-N-CA 120.952 -0.642 . . . . 72.01 111.743 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 40.7 p -117.67 148.52 41.89 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 107.323 -1.362 . . . . 73.41 107.323 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.455 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 51.0 t30 -66.07 -50.57 50.88 Favored Pre-proline 0 C--N 1.315 -0.908 0 C-N-CA 120.603 -0.439 . . . . 75.54 111.543 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.455 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 11.2 Cg_exo -75.8 141.55 24.53 Favored 'Trans proline' 0 C--N 1.367 1.525 0 N-CA-C 108.304 -1.46 . . . . 71.42 108.304 170.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.51 143.35 97.16 Favored 'Trans proline' 0 C--O 1.249 1.063 0 C-N-CA 122.068 1.845 . . . . 63.55 111.756 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.02 138.15 58.34 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.289 0.566 . . . . 30.44 111.818 -177.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 96.1 -10.35 67.78 Favored Glycine 0 C--N 1.308 -0.977 0 CA-C-N 115.942 -0.572 . . . . 74.34 112.439 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 42.8 m -70.77 134.4 47.38 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.506 -0.553 . . . . 61.22 109.506 178.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.521 HG22 ' HB ' ' A' ' 494' ' ' THR . 24.8 m -84.06 123.08 29.65 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 109.177 -0.675 . . . . 70.43 109.177 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.68 157.47 78.08 Favored Pre-proline 0 C--N 1.313 -0.982 0 N-CA-C 108.444 -0.947 . . . . 50.14 108.444 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -68.19 141.68 53.07 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.804 1.67 . . . . 74.24 111.045 176.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 35.0 m -65.14 -20.2 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-O 121.842 0.829 . . . . 52.32 110.443 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -74.37 -18.63 60.65 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.607 -1.178 . . . . 74.41 110.493 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.1 t -87.37 150.96 23.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.113 -1.069 . . . . 64.42 108.113 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 12.5 p -88.82 135.84 24.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.003 -1.11 . . . . 74.01 108.003 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . 0.571 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -96.33 145.9 8.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 C-N-CA 118.738 -1.185 . . . . 72.11 109.701 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -109.74 115.83 30.57 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-O 121.579 0.704 . . . . 74.33 110.857 -175.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -94.94 133.88 38.21 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 106.169 -1.789 . . . . 65.23 106.169 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . 0.485 ' HG3' HG23 ' A' ' 535' ' ' THR . 3.1 pt20 -108.48 116.45 32.0 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 122.099 0.952 . . . . 72.2 110.143 -177.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 54.6 t -103.7 139.68 23.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 CA-C-N 114.403 -1.271 . . . . 74.34 108.573 -175.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.61 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 73.5 m -82.4 136.52 34.94 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-O 122.068 0.937 . . . . 64.5 113.006 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -85.18 139.45 31.67 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 104.5 -2.408 . . . . 74.13 104.5 167.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . 0.558 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -83.18 -43.87 7.3 Favored Glycine 0 CA--C 1.484 -1.845 0 C-N-CA 119.768 -1.206 . . . . 61.42 113.547 -174.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 64.46 18.72 11.5 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 112.69 0.626 . . . . 71.44 112.69 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -124.21 145.75 49.14 Favored 'General case' 0 N--CA 1.417 -2.111 0 C-N-CA 120.283 -0.567 . . . . 72.25 110.547 -169.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -139.54 153.06 47.36 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.883 -0.784 . . . . 65.43 108.883 174.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 8.9 p -78.17 125.4 37.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.448 0.642 . . . . 74.03 112.446 -173.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 52.8 ttp -97.34 130.81 28.63 Favored Pre-proline 0 C--O 1.248 1.009 0 CA-C-N 115.92 -0.582 . . . . 73.44 111.065 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -74.22 170.49 20.05 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.939 2.426 . . . . 64.1 111.298 174.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -69.36 120.07 14.61 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.51 0.671 . . . . 71.11 110.902 177.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 87.2 mt -104.05 -7.04 20.57 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.647 -0.706 . . . . 75.12 110.102 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 47.4 m -66.65 132.01 47.22 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.598 -0.728 . . . . 72.14 109.875 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 93.91 -11.51 70.8 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.716 -0.754 . . . . 64.53 112.327 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 89.4 mtp -83.84 146.17 28.25 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.493 -0.558 . . . . 75.52 109.493 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -92.21 137.95 31.94 Favored 'General case' 0 N--CA 1.414 -2.247 0 N-CA-C 107.027 -1.471 . . . . 75.11 107.027 177.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . 0.453 ' HA ' ' HB3' ' A' ' 574' ' ' ALA . 41.1 t90 -57.84 -25.82 61.18 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 123.399 0.437 . . . . 63.44 111.916 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 14.3 p -64.16 -29.95 48.73 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-O 120.996 0.427 . . . . 74.21 110.831 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -101.3 -34.3 9.69 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-O 121.687 0.756 . . . . 72.23 109.452 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . 0.46 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -63.6 -40.31 96.61 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-N 115.168 -0.924 . . . . 70.13 111.875 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.458 ' O ' ' HG2' ' A' ' 579' ' ' ARG . 17.4 tp10 -51.4 -59.34 8.06 Favored Pre-proline 0 CA--C 1.562 1.421 0 C-N-CA 123.074 0.55 . . . . 73.31 112.047 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.46 -35.26 83.64 Favored 'Trans proline' 0 C--N 1.375 1.929 0 CA-C-N 120.684 1.28 . . . . 60.54 112.6 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.513 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 83.2 mmt-85 -66.51 -39.77 88.84 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 120.469 -0.492 . . . . 74.41 111.817 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 93.8 mt -65.89 -43.71 87.48 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.459 -0.337 . . . . 75.44 111.134 -177.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 29.5 mmt180 -65.04 -37.41 87.48 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.731 -0.47 . . . . 74.12 109.731 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.13 -31.16 71.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.441 -0.799 . . . . 73.31 111.422 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 99.1 mt -81.88 -7.81 59.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.399 -0.364 . . . . 54.43 111.531 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 87.13 34.47 10.71 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.698 -0.763 . . . . 53.45 111.855 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 44.4 t90 -86.67 127.67 34.96 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.574 -0.528 . . . . 72.43 109.574 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 13.9 m -133.16 28.28 4.12 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 122.618 1.199 . . . . 75.41 108.117 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -82.97 -164.78 36.37 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 114.883 -1.053 . . . . 74.24 112.065 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 55.0 ttp -108.93 130.98 55.46 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 122.615 -0.344 . . . . 73.44 110.463 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 41.7 tp -90.56 116.28 28.34 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.401 -1.333 . . . . 74.1 107.401 175.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -107.26 107.73 18.8 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.408 0.623 . . . . 74.24 111.574 -177.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -112.77 124.7 53.17 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.675 -1.232 . . . . 74.34 107.675 174.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -88.54 -120.56 1.7 Allowed Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 109.944 -1.262 . . . . 61.5 109.944 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -82.09 133.6 35.29 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.524 -0.917 . . . . 73.42 108.524 176.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -78.82 124.9 28.68 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.262 -1.014 . . . . 74.14 108.262 177.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 44.0 t -121.85 116.2 48.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 116.064 -0.516 . . . . 63.21 110.555 -174.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -90.46 107.64 19.29 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.495 -1.298 . . . . 73.31 107.495 176.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -132.01 4.46 4.13 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.763 -0.775 . . . . 54.43 111.603 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 116.11 -175.75 16.01 Favored Glycine 0 N--CA 1.424 -2.12 0 C-N-CA 120.403 -0.903 . . . . 74.05 111.051 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -58.69 -33.32 72.11 Favored Glycine 0 C--N 1.322 -0.196 0 C-N-CA 123.455 0.55 . . . . 41.32 114.18 -175.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 19.9 m -64.41 -27.56 69.09 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 120.9 0.381 . . . . 64.13 111.433 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -109.13 -1.44 18.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.981 0.419 . . . . 73.22 111.329 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -81.73 113.01 19.42 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 112.241 0.46 . . . . 62.31 112.241 -173.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 57.48 -2.11 0.06 Allowed 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 126.506 1.922 . . . . 62.3 115.46 172.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -96.54 145.98 25.22 Favored 'General case' 0 CA--C 1.501 -0.91 0 O-C-N 121.015 -1.053 . . . . 74.11 111.722 -174.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 97.8 t -65.43 130.04 30.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 107.045 -1.465 . . . . 71.42 107.045 173.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 87.9 t -89.02 -41.81 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-O 121.311 0.577 . . . . 62.43 110.061 -175.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -151.03 158.15 43.75 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.823 -1.177 . . . . 72.22 107.823 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -119.19 127.24 53.12 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 107.517 -1.29 . . . . 71.21 107.517 175.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.549 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 27.0 t-20 -54.53 -58.07 15.85 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-O 118.785 -0.626 . . . . 64.4 112.623 -179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.549 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 2.9 Cg_endo -84.44 136.49 6.53 Favored 'Trans proline' 0 C--N 1.363 1.305 0 CA-C-N 120.926 1.366 . . . . 74.21 109.921 174.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 608' ' ' PRO . 22.9 Cg_exo -63.94 158.62 46.36 Favored 'Trans proline' 0 C--O 1.243 0.755 0 C-N-CA 122.37 2.047 . . . . 75.21 111.882 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.59 130.42 42.98 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 116.305 -0.407 . . . . 72.12 109.94 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 98.16 -2.27 59.52 Favored Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 120.532 -0.842 . . . . 75.31 111.663 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 15.0 m -92.76 155.87 17.39 Favored 'General case' 0 C--O 1.253 1.25 0 N-CA-C 108.484 -0.932 . . . . 74.32 108.484 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -80.8 134.08 12.92 Favored Glycine 0 N--CA 1.415 -2.725 0 C-N-CA 120.883 -0.675 . . . . 42.21 112.211 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 28.8 m -110.61 142.95 21.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 C-N-CA 123.0 0.52 . . . . 64.13 109.715 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.419 HD21 HG22 ' A' ' 619' ' ' ILE . 5.2 p-10 -54.99 172.57 0.11 Allowed 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 125.545 1.538 . . . . 63.45 113.256 -178.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . 0.531 ' H ' ' HD2' ' A' ' 616' ' ' ARG . 1.5 mpt_? -48.22 -43.44 32.11 Favored 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 124.279 1.032 . . . . 73.14 112.462 -174.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -85.99 -19.22 30.7 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.966 -0.561 . . . . 72.44 111.43 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 81.31 21.98 61.49 Favored Glycine 0 CA--C 1.494 -1.227 0 C-N-CA 120.233 -0.984 . . . . 63.4 113.722 173.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . 0.419 HG22 HD21 ' A' ' 615' ' ' ASN . 0.0 OUTLIER -67.95 119.26 13.36 Favored 'Isoleucine or valine' 0 C--O 1.252 1.218 0 CA-C-O 123.549 1.642 . . . . 75.55 110.545 -171.472 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.41 HG12 ' HD2' ' A' ' 608' ' ' PRO . 0.0 OUTLIER -117.76 132.34 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.521 0 CA-C-N 112.257 -2.247 . . . . 75.45 106.036 -178.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 31.5 m -96.41 118.88 33.84 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.789 -0.819 . . . . 72.45 108.789 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 1.6 pp -130.34 165.5 22.39 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 113.518 -1.674 . . . . 63.21 109.178 -176.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 7.7 tpp180 -142.45 139.06 31.46 Favored 'General case' 0 C--N 1.269 -2.918 0 N-CA-C 105.86 -1.904 . . . . 54.35 105.86 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -139.67 149.45 43.71 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.332 -0.988 . . . . 60.33 108.332 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -75.14 -98.44 0.11 Allowed Glycine 0 N--CA 1.438 -1.182 0 O-C-N 123.764 0.665 . . . . 64.43 113.628 -173.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 . . . . . 0 N--CA 1.429 -1.512 0 N-CA-C 108.991 -0.744 . . . . 74.54 108.991 179.84 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.646 0 N-CA-C 110.596 -1.002 . . . . 62.13 110.596 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 11.2 tp -87.06 143.67 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-N 117.187 0.493 . . . . 72.51 109.889 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 20.2 m -110.11 152.16 26.35 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.497 -1.668 . . . . 61.13 106.497 174.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.496 ' HD2' ' H ' ' A' ' 358' ' ' ARG 0.304 0.0 OUTLIER -100.38 72.44 1.61 Allowed 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 122.389 1.09 . . . . 74.24 112.497 -176.96 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -96.97 143.74 27.55 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 106.112 -1.81 . . . . 72.42 106.112 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 32.3 m -117.75 136.74 53.94 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.525 0 N-CA-C 108.908 -0.775 . . . . 63.4 108.908 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . 0.498 ' NE2' ' HA ' ' A' ' 407' ' ' ASN . 0.8 OUTLIER -97.94 122.26 40.84 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 105.262 -2.125 . . . . 71.21 105.262 178.452 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.412 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 59.1 t -96.82 122.86 55.65 Favored Pre-proline 0 C--N 1.285 -2.207 0 CA-C-N 115.723 -0.671 . . . . 73.41 111.844 -166.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 23.6 Cg_exo -65.14 140.91 67.23 Favored 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 122.857 2.371 . . . . 51.31 112.001 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -91.63 141.99 28.1 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 115.636 -0.711 . . . . 75.54 109.94 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 12.1 t -119.97 25.96 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.459 0 CA-C-O 122.74 1.257 . . . . 73.51 108.884 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? -63.38 144.62 56.81 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.175 -0.92 . . . . 63.12 113.181 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 91.29 0.38 73.72 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.968 -0.635 . . . . 74.43 112.847 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -104.08 -81.86 0.51 Allowed 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 120.543 -0.463 . . . . 63.51 110.46 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 87.8 p -169.1 163.34 11.14 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 107.512 -1.292 . . . . 73.41 107.512 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 12.0 m -63.77 -41.0 98.05 Favored 'General case' 0 N--CA 1.422 -1.873 0 O-C-N 123.987 0.804 . . . . 64.15 109.15 176.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.25 -46.69 87.71 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 115.871 -0.604 . . . . 75.11 111.484 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -64.97 -43.66 91.91 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 120.972 0.415 . . . . 64.55 110.978 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . 0.404 ' O ' HD13 ' A' ' 377' ' ' LEU . . . -66.53 -47.6 72.39 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.841 -0.618 . . . . 45.31 110.622 -178.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 80.5 mt -67.15 -40.32 84.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.933 -0.122 . . . . 71.34 111.296 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.91 -41.72 98.25 Favored 'General case' 0 C--O 1.246 0.877 0 N-CA-C 112.399 0.518 . . . . 25.01 112.399 -177.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . 0.408 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 21.2 m -67.19 -47.46 70.84 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.87 -0.605 . . . . 64.33 109.959 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.404 HD13 ' O ' ' A' ' 373' ' ' ALA . 10.8 mp -64.28 -38.21 90.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.918 -0.583 . . . . 74.13 111.508 178.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -60.29 -44.33 95.48 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 123.356 0.662 . . . . 73.24 109.722 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -70.26 -20.58 63.05 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 112.352 0.501 . . . . 72.54 112.352 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 376' ' ' THR . 35.2 mmt180 -85.52 -14.03 47.16 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.706 -0.398 . . . . 71.53 110.056 174.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 96.09 8.29 57.95 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.074 -0.584 . . . . 62.35 112.743 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -77.75 157.37 30.07 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 112.941 0.719 . . . . 74.33 112.941 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.444 ' HB2' ' HG2' ' A' ' 415' ' ' GLU . 27.4 mmtp -96.84 151.22 19.87 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.795 -1.093 . . . . 72.21 108.947 176.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.509 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 0.2 OUTLIER -129.94 136.39 59.01 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 CA-C-N 115.87 -0.604 . . . . 60.13 109.496 178.569 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -108.97 126.52 53.18 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 105.359 -2.089 . . . . 70.02 105.359 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 20.9 m -106.48 118.39 36.54 Favored 'General case' 0 C--N 1.282 -2.34 0 C-N-CA 120.351 -0.539 . . . . 74.41 110.429 -170.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -120.46 129.32 53.82 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.242 -1.021 . . . . 60.32 108.242 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -103.92 143.05 33.37 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.976 -0.379 . . . . 74.5 109.976 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -126.57 115.76 22.89 Favored Pre-proline 0 C--N 1.306 -1.289 0 N-CA-C 109.521 -0.548 . . . . 74.51 109.521 174.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.416 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 56.7 Cg_endo -98.46 129.76 0.23 Allowed 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.38 2.053 . . . . 75.52 112.526 175.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.591 ' HB3' HG12 ' A' ' 394' ' ' ILE . 9.7 t70 173.71 160.49 0.15 Allowed 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 109.302 -0.629 . . . . 75.21 109.302 174.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 35.3 t -75.57 -24.32 56.63 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.317 0.579 . . . . 75.34 110.084 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 3.3 m -83.42 -4.7 58.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.239 1.019 . . . . 64.31 108.986 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.591 HG12 ' HB3' ' A' ' 391' ' ' ASP . 15.1 mm -88.53 134.55 33.99 Favored Pre-proline 0 N--CA 1.427 -1.578 0 CA-C-N 114.568 -1.197 . . . . 53.45 110.367 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . 0.545 ' HG3' HD13 ' A' ' 400' ' ' ILE . 60.6 Cg_endo -66.14 -173.6 0.35 Allowed 'Trans proline' 0 CA--C 1.573 2.468 0 C-N-CA 125.003 3.802 . . . . 53.0 114.698 -176.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -58.47 159.41 19.9 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 122.872 2.381 . . . . 75.14 113.761 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -57.88 -9.81 1.47 Allowed 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 126.885 2.074 . . . . 74.33 113.362 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -90.18 177.38 6.45 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 116.112 -0.494 . . . . 63.14 111.56 -176.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 19.2 m -83.12 119.23 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 C-N-CA 120.51 -0.476 . . . . 62.54 110.912 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . 0.545 HD13 ' HG3' ' A' ' 395' ' ' PRO . 30.0 pt -86.77 -32.24 6.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.277 0.56 . . . . 73.42 109.707 177.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -147.99 170.36 28.64 Favored Glycine 0 N--CA 1.413 -2.845 0 N-CA-C 110.348 -1.101 . . . . 41.21 110.348 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.24 -179.42 3.63 Favored 'General case' 0 C--N 1.278 -2.54 0 CA-C-O 120.744 0.307 . . . . 64.5 110.678 178.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -102.1 129.74 25.73 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 107.974 -1.121 . . . . 72.01 107.974 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.94 -17.67 24.98 Favored 'Trans proline' 0 C--O 1.25 1.094 0 C-N-CA 124.01 3.14 . . . . 53.23 114.972 -173.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.5 -35.42 75.9 Favored 'General case' 0 C--O 1.21 -1.0 0 N-CA-C 109.657 -0.497 . . . . 51.11 109.657 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -69.33 -39.51 78.13 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.375 0.607 . . . . 33.1 110.265 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . 0.498 ' HA ' ' NE2' ' A' ' 361' ' ' GLN . 17.4 m120 -75.65 -7.28 53.9 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.434 0.635 . . . . 72.23 110.987 -178.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 29.6 m -98.67 153.91 18.35 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 106.998 -1.482 . . . . 74.21 106.998 174.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 61.0 m -75.07 113.04 11.94 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 118.974 -1.09 . . . . 53.25 109.104 176.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 18.7 m -121.24 169.81 12.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 122.867 0.467 . . . . 73.52 109.744 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 3.4 p -76.75 147.87 37.06 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 120.567 -0.453 . . . . 73.21 110.479 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -62.34 126.83 28.7 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 116.119 -0.492 . . . . 75.02 110.186 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 96.81 28.35 8.89 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 120.884 -0.674 . . . . 72.15 111.692 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -83.34 177.52 8.47 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.246 -1.02 . . . . 51.14 108.246 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . 0.444 ' HG2' ' HB2' ' A' ' 383' ' ' LYS . 39.0 mt-10 -111.3 108.94 18.72 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.216 0.531 . . . . 62.52 109.974 -174.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . 0.509 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 46.2 mm -102.22 129.13 54.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 115.215 -0.902 . . . . 74.2 108.83 -178.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 30.1 m -85.86 130.58 34.51 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.083 0.468 . . . . 72.11 111.205 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 7.5 p -110.81 134.87 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 107.676 -1.231 . . . . 72.31 107.676 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -110.76 122.19 47.21 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.069 0.461 . . . . 71.41 110.855 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 99.3 t -102.89 131.16 51.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 114.866 -1.061 . . . . 74.22 108.249 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . 0.434 ' HB3' ' CG2' ' A' ' 394' ' ' ILE . 8.8 m -98.7 125.04 43.89 Favored 'General case' 0 C--N 1.274 -2.7 0 CA-C-N 115.358 -0.837 . . . . 63.4 110.112 -176.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 2.5 p -111.07 149.95 30.07 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.152 -0.685 . . . . 53.22 109.152 176.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -64.81 -162.46 0.68 Allowed Glycine 0 C--O 1.25 1.11 0 N-CA-C 116.098 1.199 . . . . 72.22 116.098 -172.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.56 139.97 83.02 Favored 'Trans proline' 0 C--N 1.362 1.271 0 C-N-CA 123.342 2.695 . . . . 60.32 111.365 -178.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.443 ' HG3' ' HA ' ' A' ' 391' ' ' ASP . 33.7 mt-10 -73.29 146.85 45.05 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 113.773 1.027 . . . . 72.52 113.773 -172.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 41.2 mt-30 -131.84 151.16 51.87 Favored 'General case' 0 N--CA 1.415 -2.181 0 CA-C-N 113.273 -1.785 . . . . 63.24 106.781 172.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -133.59 144.89 49.58 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-O 121.0 0.428 . . . . 74.33 110.497 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.45 ' H ' ' CD ' ' A' ' 428' ' ' GLU . 0.5 OUTLIER -83.74 133.34 34.79 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 107.899 -1.149 . . . . 63.41 107.899 176.406 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 63.1 mt -80.82 129.92 65.99 Favored Pre-proline 0 C--N 1.312 -1.052 0 CA-C-N 116.612 -0.267 . . . . 73.13 111.714 -172.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.93 147.13 54.66 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.206 1.937 . . . . 64.31 111.498 173.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -83.57 105.26 14.35 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.485 -0.561 . . . . 75.15 109.485 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 11.6 p -94.77 161.18 2.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 107.972 -1.122 . . . . 55.11 107.972 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.449 ' HB3' ' OG1' ' A' ' 436' ' ' THR . 29.7 t -83.86 157.52 21.97 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 108.964 -0.754 . . . . 72.13 108.964 177.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 32.0 p -70.2 -27.02 64.16 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 112.987 0.736 . . . . 74.24 112.987 -172.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.424 ' H ' HD23 ' A' ' 435' ' ' LEU . 0.6 OUTLIER -87.54 -13.77 42.05 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.313 0.577 . . . . 75.41 110.778 179.458 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.566 HG22 ' HB3' ' A' ' 439' ' ' GLU . 1.4 m -92.54 41.4 1.07 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.782 -0.645 . . . . 62.42 110.409 -175.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -53.07 -40.35 63.97 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.974 0.909 . . . . 62.23 112.273 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.14 98.73 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 120.812 0.339 . . . . 73.05 110.918 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.566 ' HB3' HG22 ' A' ' 436' ' ' THR . 31.4 tt0 -71.14 -34.92 71.48 Favored 'General case' 0 C--O 1.201 -1.489 0 C-N-CA 120.441 -0.503 . . . . 75.33 110.684 175.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.61 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -58.52 -51.34 70.3 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 122.219 0.208 . . . . 44.01 111.018 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 36.0 m -61.39 -37.78 78.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-O 121.211 0.529 . . . . 72.43 110.401 177.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -60.43 -47.46 86.02 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.641 0.776 . . . . 64.42 111.147 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -64.8 -38.31 90.55 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 123.318 0.647 . . . . 74.23 111.184 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 83.9 mt -63.76 -37.86 88.96 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.683 -0.488 . . . . 73.23 109.683 176.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.532 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 37.1 m -70.03 -42.92 72.31 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.902 -0.59 . . . . 73.23 110.32 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -65.15 -26.44 68.18 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.051 -0.522 . . . . 74.32 111.111 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -81.04 4.95 17.98 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.065 -0.516 . . . . 45.52 111.879 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 108.03 -67.94 0.22 Allowed Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.334 -0.936 . . . . 63.24 112.795 174.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . 0.519 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 1.8 p90 -50.54 -60.75 2.7 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.679 0.992 . . . . 73.43 113.679 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . 0.532 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 60.92 23.46 61.45 Favored Glycine 0 CA--C 1.499 -0.914 0 C-N-CA 121.255 -0.497 . . . . 72.03 112.203 -176.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.405 ' HB3' HG22 ' A' ' 483' ' ' VAL . 25.3 mmt180 -105.04 110.98 23.59 Favored 'General case' 0 N--CA 1.414 -2.258 0 N-CA-C 109.073 -0.714 . . . . 74.34 109.073 -178.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -131.97 143.32 50.02 Favored 'General case' 0 N--CA 1.415 -2.223 0 CA-C-N 114.608 -1.178 . . . . 74.04 110.192 -177.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -134.52 123.1 23.36 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 107.499 -1.297 . . . . 73.02 107.499 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -100.03 133.33 44.57 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.35 0.595 . . . . 73.23 111.901 -174.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -119.28 144.98 46.5 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 108.437 -0.949 . . . . 65.43 108.437 176.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -114.8 135.75 53.83 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.593 -0.892 . . . . 51.23 108.593 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 40.2 m -147.48 142.33 16.69 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 109.38 -0.6 . . . . 72.54 109.38 176.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.446 ' HA ' ' O ' ' A' ' 490' ' ' SER . 12.2 Cg_exo -70.17 131.62 21.01 Favored 'Trans proline' 0 C--O 1.247 0.948 0 C-N-CA 122.204 1.936 . . . . 50.21 111.555 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 56.4 m -149.75 -179.95 7.53 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.365 -0.976 . . . . 70.01 108.365 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 10.1 t -45.12 135.72 5.12 Favored Pre-proline 0 C--O 1.246 0.903 0 C-N-CA 124.015 0.926 . . . . 73.31 112.387 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.63 -30.39 36.4 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 124.363 3.375 . . . . 70.13 113.638 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -71.37 -23.45 61.9 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.57 0.581 . . . . 62.11 112.57 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 84.5 mt -99.74 -6.33 27.23 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.66 -0.416 . . . . 60.12 110.913 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 98.0 t -61.38 127.72 21.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 116.154 -0.475 . . . . 72.51 110.716 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 91.82 -3.59 77.92 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 115.614 -0.721 . . . . 72.02 111.661 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -118.19 166.37 12.67 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 108.278 -1.008 . . . . 35.05 108.278 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 93.8 t -76.12 145.7 10.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 108.306 -0.998 . . . . 74.5 108.306 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 68.5 mt -97.61 -35.25 5.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.262 -1.384 . . . . 64.23 107.262 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 159.68 -167.33 35.2 Favored Glycine 0 N--CA 1.423 -2.212 0 CA-C-N 115.356 -0.838 . . . . 70.33 111.012 176.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . 0.656 HG22 HG12 ' A' ' 486' ' ' ILE . 72.8 p -116.2 144.85 43.64 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 106.969 -1.493 . . . . 73.51 106.969 178.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -67.1 -58.38 9.28 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 119.153 -1.019 . . . . 72.15 110.101 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 473' ' ' PRO . 31.3 Cg_endo -68.2 130.18 20.82 Favored 'Trans proline' 0 C--N 1.376 2.015 0 N-CA-C 106.364 -2.206 . . . . 61.14 106.364 168.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 472' ' ' PRO . 23.8 Cg_exo -61.82 138.6 75.22 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 121.55 1.5 . . . . 71.22 112.774 -172.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -75.85 11.17 1.48 Allowed 'General case' 0 C--O 1.202 -1.431 0 CA-C-N 115.324 -0.853 . . . . 53.12 111.468 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -109.56 -1.54 18.15 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.799 -0.637 . . . . 72.43 109.427 177.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . 0.401 ' HG2' ' HB2' ' A' ' 473' ' ' PRO . 85.7 mm-40 -94.24 172.55 8.14 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.867 -0.606 . . . . 43.41 111.778 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.438 HG22 ' HB3' ' A' ' 426' ' ' GLN . 1.9 m -99.42 108.16 20.57 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 107.994 -1.113 . . . . 71.4 107.994 -178.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 50.1 m -100.64 138.66 37.41 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 120.901 0.382 . . . . 61.41 110.815 -176.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -77.37 154.53 32.67 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.659 -0.7 . . . . 64.14 111.134 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.519 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 1.7 mp -65.32 -24.74 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-N 115.493 -0.776 . . . . 72.44 111.555 178.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 4.4 p -93.48 6.04 49.54 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.72 0.771 . . . . 74.1 111.565 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -107.88 131.71 54.22 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.693 -0.685 . . . . 55.01 111.435 -176.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.405 HG22 ' HB3' ' A' ' 451' ' ' ARG . 55.0 t -94.65 126.9 46.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.752 -0.658 . . . . 74.54 110.095 -177.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 34.4 m -98.36 133.7 39.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-O 121.51 0.672 . . . . 44.33 111.033 178.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.9 129.02 51.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.851 -0.613 . . . . 71.31 109.794 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.656 HG12 HG22 ' A' ' 470' ' ' THR . 4.9 mt -117.12 128.74 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 C-N-CA 124.43 1.092 . . . . 72.42 110.215 -176.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 5.8 tt -108.4 126.92 65.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-N 116.447 -0.342 . . . . 73.15 110.354 -177.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 34.6 m -111.43 152.0 13.42 Favored 'Isoleucine or valine' 0 C--O 1.252 1.236 0 CA-C-N 116.229 -0.441 . . . . 72.24 110.633 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.87 123.3 6.04 Favored Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 115.928 -0.578 . . . . 45.43 113.59 -176.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.446 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 31.0 t -101.89 153.72 19.59 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 107.728 -1.212 . . . . 54.42 107.728 177.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -92.62 179.19 40.06 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 120.914 -0.66 . . . . 63.41 113.751 -175.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.33 166.0 22.84 Favored 'Trans proline' 0 N--CA 1.443 -1.487 0 C-N-CA 122.644 2.229 . . . . 61.41 111.533 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . -90.36 119.73 30.89 Favored 'General case' 0 N--CA 1.41 -2.43 0 N-CA-C 107.513 -1.291 . . . . 52.0 107.513 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 51.5 p -116.59 143.36 45.71 Favored 'General case' 0 C--N 1.27 -2.859 0 N-CA-C 109.159 -0.682 . . . . 60.11 109.159 -178.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 544' ' ' THR . 10.3 ttpp -151.44 164.46 36.71 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 108.445 -0.946 . . . . 74.54 108.445 176.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 10.7 p-10 -79.67 136.54 36.83 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.85 -0.796 . . . . 62.04 108.85 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 40.6 pt -75.45 131.41 77.62 Favored Pre-proline 0 C--N 1.305 -1.355 0 N-CA-C 109.374 -0.602 . . . . 74.44 109.374 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -56.65 118.15 4.94 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.592 2.861 . . . . 65.3 114.285 -174.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -84.42 94.53 8.53 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-N 115.824 -0.625 . . . . 74.33 109.532 177.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.7 p -159.75 93.75 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-O 122.247 1.022 . . . . 62.1 110.947 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -108.09 162.84 13.68 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 107.862 -1.162 . . . . 75.1 107.862 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 98.1 23.38 13.17 Favored Glycine 0 C--N 1.295 -1.747 0 N-CA-C 108.967 -1.653 . . . . 63.25 108.967 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -129.38 165.5 21.39 Favored 'General case' 0 CA--C 1.471 -2.068 0 CA-C-N 114.402 -0.899 . . . . 70.35 109.336 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 6.9 m -88.67 156.44 19.01 Favored 'General case' 0 C--N 1.275 -2.67 0 C-N-CA 120.118 -0.633 . . . . 52.42 110.208 -173.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 12.2 p -50.53 -41.24 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 124.521 1.129 . . . . 72.35 113.522 -174.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -67.41 -39.67 85.54 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.372 0.606 . . . . 55.33 110.549 -178.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 48.8 t -70.37 -43.78 77.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.344 -0.844 . . . . 64.54 109.529 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -61.68 -47.11 86.81 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.226 -0.897 . . . . 50.42 112.26 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -64.2 -35.92 82.36 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.137 0.273 . . . . 72.51 110.708 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 52.5 tttm -58.69 -53.8 54.28 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.032 -0.531 . . . . 73.25 109.831 175.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -62.61 -41.69 99.13 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.286 -0.87 . . . . 74.14 110.914 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 9.0 tt -61.46 -47.87 83.72 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.955 -0.566 . . . . 73.33 110.408 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 12.8 m120 -66.68 -37.81 85.5 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 111.812 0.301 . . . . 70.23 111.812 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 54.4 t -62.74 -31.69 53.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.162 -0.472 . . . . 74.43 111.052 177.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -86.15 13.25 8.14 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 114.147 1.166 . . . . 74.03 114.147 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 102.07 -11.58 57.28 Favored Glycine 0 CA--C 1.499 -0.907 0 C-N-CA 119.925 -1.131 . . . . 54.11 114.214 171.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 88.8 m-85 -91.11 120.34 31.99 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.331 -0.618 . . . . 73.33 109.331 -177.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 22.7 p -97.96 -14.84 20.38 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 113.329 0.863 . . . . 72.12 113.329 -174.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -123.22 117.58 25.64 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.092 0.473 . . . . 63.43 112.102 -172.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -131.51 147.89 52.58 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.782 -0.645 . . . . 70.44 111.694 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 51.1 m -132.69 140.16 48.0 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.161 -1.422 . . . . 70.42 107.161 173.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 0.0 OUTLIER -117.77 128.77 55.2 Favored 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 119.945 -0.702 . . . . 74.24 112.191 -178.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -111.92 143.53 42.74 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.443 -0.947 . . . . 54.21 108.443 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 57.1 m -96.52 139.35 32.75 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 113.095 0.776 . . . . 54.32 113.095 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 40.6 t -122.22 159.14 25.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 106.778 -1.564 . . . . 73.42 106.778 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . 0.569 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 30.9 m-20 -85.0 134.58 34.22 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 107.741 -1.207 . . . . 62.03 107.741 177.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . 0.539 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 19.0 m -153.57 178.3 1.65 Allowed Pre-proline 0 C--N 1.313 -1.016 0 N-CA-C 109.197 -0.668 . . . . 62.33 109.197 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -89.0 -8.32 4.92 Favored 'Trans proline' 0 CA--C 1.55 1.28 0 C-N-CA 122.47 2.113 . . . . 62.02 111.114 170.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.9 142.07 48.17 Favored Pre-proline 0 C--O 1.213 -0.861 0 N-CA-C 108.675 -0.861 . . . . 64.24 108.675 176.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -63.42 160.36 35.83 Favored 'Trans proline' 0 C--O 1.247 0.972 0 C-N-CA 122.558 2.172 . . . . 64.42 113.419 -176.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -58.38 118.44 5.56 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.038 -0.983 . . . . 53.22 110.334 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 121.36 -12.46 9.62 Favored Glycine 0 C--N 1.3 -1.465 0 C-N-CA 120.45 -0.881 . . . . 42.55 112.201 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -82.71 131.46 35.2 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.927 -0.768 . . . . 72.42 108.927 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.435 HG22 HG22 ' A' ' 555' ' ' VAL . 54.3 t -90.84 112.67 25.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.676 -0.861 . . . . 72.41 108.676 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 45.8 m -111.04 14.55 21.93 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 122.661 1.22 . . . . 73.41 111.611 -175.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 161.97 -173.84 38.35 Favored Glycine 0 CA--C 1.494 -1.26 0 C-N-CA 119.903 -1.141 . . . . 75.11 112.251 173.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 31.6 p -130.43 153.86 48.32 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.856 -1.165 . . . . 71.34 107.856 176.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -67.75 -54.74 16.13 Favored Pre-proline 0 C--N 1.309 -1.163 0 CA-C-O 119.31 -0.376 . . . . 54.52 111.25 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.32 153.39 45.37 Favored 'Trans proline' 0 C--N 1.371 1.717 0 N-CA-C 108.026 -1.567 . . . . 71.22 108.026 170.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.84 137.86 46.63 Favored 'Trans proline' 0 C--O 1.249 1.055 0 CA-C-N 120.119 1.078 . . . . 60.31 110.932 -177.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -69.68 137.78 52.4 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.735 -0.666 . . . . 55.22 110.396 -178.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.73 -14.34 59.01 Favored Glycine 0 C--N 1.303 -1.286 0 C-N-CA 120.61 -0.805 . . . . 52.3 111.726 -178.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 27.0 m -72.67 137.45 46.03 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 109.407 -0.59 . . . . 70.02 109.407 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 8.9 t -87.2 127.12 35.16 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-O 121.536 0.684 . . . . 74.44 110.124 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.3 m -138.96 162.46 52.38 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 107.738 -1.208 . . . . 73.45 107.738 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 47.0 Cg_exo -60.77 134.59 54.74 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 121.734 1.623 . . . . 63.2 109.784 173.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.405 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 26.9 m -63.57 -20.25 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 113.728 1.011 . . . . 63.12 113.728 -174.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -83.65 -4.47 58.62 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.395 0.617 . . . . 74.24 111.4 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 14.6 m -74.27 160.39 31.18 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.505 -0.554 . . . . 61.34 109.505 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 38.2 t -97.44 115.39 37.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.52 -0.548 . . . . 73.21 109.52 -178.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 61.2 mt -85.01 131.74 33.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 109.108 -0.701 . . . . 65.14 109.108 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 521' ' ' SER . 34.8 tt0 -103.03 116.2 32.07 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 108.296 -1.001 . . . . 73.42 108.296 176.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . 0.48 ' H ' HD23 ' A' ' 553' ' ' LEU . 1.6 pt? -103.76 134.73 46.59 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.493 -0.776 . . . . 64.41 109.285 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -102.05 118.3 36.6 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-O 122.797 1.284 . . . . 74.44 111.409 -175.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 524' ' ' SER . 92.3 t -105.01 136.28 39.44 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 CA-C-N 112.914 -1.948 . . . . 73.34 110.271 -172.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.539 ' HB3' ' HB2' ' A' ' 527' ' ' SER . 75.0 m -75.47 148.94 38.64 Favored 'General case' 0 C--N 1.27 -2.86 0 N-CA-C 113.584 0.957 . . . . 61.41 113.584 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.569 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 9.8 ptpp? -108.84 156.01 20.14 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 105.12 -2.178 . . . . 71.45 105.12 165.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -71.73 -27.59 70.62 Favored Glycine 0 CA--C 1.496 -1.126 0 C-N-CA 120.797 -0.716 . . . . 71.4 111.683 -177.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 62.6 t30 57.85 28.98 16.81 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 122.879 1.324 . . . . 73.51 109.84 173.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.8 154.41 41.99 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 105.785 -1.932 . . . . 74.14 105.785 -175.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -143.07 156.19 44.77 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 120.354 -0.538 . . . . 70.52 110.222 175.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 78.1 t -79.15 119.66 28.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 108.519 -0.919 . . . . 75.15 108.519 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . 0.585 ' SD ' HD12 ' A' ' 620' ' ' ILE . 52.4 ttp -90.46 129.64 44.42 Favored Pre-proline 0 C--N 1.302 -1.488 0 CA-C-N 116.588 -0.278 . . . . 73.3 111.618 -176.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 563' ' ' MET . 19.5 Cg_exo -69.2 169.85 17.26 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.166 2.578 . . . . 64.32 111.649 174.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -77.23 139.38 39.85 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.83 -0.804 . . . . 64.53 108.83 177.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 25.5 tp -137.97 12.98 2.89 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.781 0.8 . . . . 74.34 109.546 -178.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 53.3 p -79.96 147.78 31.46 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.21 -0.45 . . . . 74.11 111.393 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 77.61 7.89 87.19 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.86 -0.686 . . . . 25.23 113.2 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 8.2 mmt -87.61 143.67 27.07 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.6 -0.889 . . . . 74.5 108.6 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -89.45 176.73 6.79 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 110.071 -0.344 . . . . 72.12 110.071 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -60.93 -34.14 74.25 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.999 -1.112 . . . . 74.51 107.999 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.6 m -73.72 -7.62 10.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.469 -1.241 . . . . 62.43 111.291 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -101.55 -44.06 5.7 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 108.866 -0.791 . . . . 74.04 108.866 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -53.75 -53.68 48.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.006 -0.997 . . . . 44.41 113.481 -175.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -65.45 -53.51 37.85 Favored Pre-proline 0 CA--C 1.553 1.093 0 N-CA-C 113.493 0.923 . . . . 73.21 113.493 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -60.27 -39.34 68.78 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 121.783 1.655 . . . . 75.15 112.196 177.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.561 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 30.2 mtt180 -68.95 -33.5 73.82 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 113.683 0.994 . . . . 72.31 113.683 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 6.8 tt -58.09 -50.19 74.34 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.663 -0.865 . . . . 74.13 108.663 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -68.23 -43.88 76.97 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.207 -0.906 . . . . 72.34 113.439 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -64.17 -40.42 96.07 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 113.389 0.885 . . . . 62.33 113.389 -175.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 577' ' ' ARG 0.308 3.7 pp -93.13 0.32 57.19 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.05 -1.06 . . . . 73.14 113.655 179.37 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 71.26 43.25 55.74 Favored Glycine 0 CA--C 1.504 -0.631 0 CA-C-N 115.986 -0.552 . . . . 75.12 112.395 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 22.4 t90 -73.21 126.85 31.02 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.073 -0.714 . . . . 74.32 109.073 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 2.5 m -105.76 2.38 27.85 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.753 -0.658 . . . . 70.21 110.491 -175.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -91.72 172.32 35.57 Favored Glycine 0 N--CA 1.436 -1.347 0 C-N-CA 120.594 -0.812 . . . . 73.55 112.433 -175.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 89.4 mmm -92.79 137.18 32.59 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.246 0.546 . . . . 74.11 111.665 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -83.0 128.19 34.25 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.623 -1.172 . . . . 74.54 108.113 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -95.39 103.37 15.23 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.992 -0.549 . . . . 73.41 109.81 -177.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . 0.482 ' HD3' ' CE2' ' A' ' 624' ' ' PHE . 52.4 tptt -112.51 110.76 21.14 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 109.107 -0.701 . . . . 62.42 109.107 176.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -91.37 -117.05 2.09 Favored Glycine 0 N--CA 1.428 -1.863 0 C-N-CA 120.512 -0.852 . . . . 63.12 112.313 178.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -84.03 155.64 22.63 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 123.132 0.573 . . . . 64.32 111.333 -177.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -94.21 124.45 38.23 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 109.657 -0.497 . . . . 73.04 109.657 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 49.9 t -125.91 127.62 71.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 107.7 -1.222 . . . . 54.51 107.7 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -73.73 121.14 20.33 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.478 -0.889 . . . . 62.54 108.924 176.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -118.95 -39.11 2.97 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.238 -0.892 . . . . 41.04 110.658 -175.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 60.5 -157.48 29.17 Favored Glycine 0 N--CA 1.423 -2.207 0 O-C-N 123.936 0.772 . . . . 62.31 111.339 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -65.33 -40.99 96.84 Favored Glycine 0 C--N 1.28 -2.528 0 N-CA-C 112.061 -0.415 . . . . 35.21 112.061 174.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 10.2 m -58.38 -40.53 82.55 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 113.121 0.786 . . . . 60.1 113.121 -171.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -108.85 -4.5 16.8 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 111.95 0.352 . . . . 74.43 111.95 177.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 65.8 m80 56.1 102.83 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.471 1.109 . . . . 73.45 113.263 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -77.15 80.25 3.67 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 122.711 1.243 . . . . 65.04 109.812 172.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -134.49 171.16 14.69 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.271 -1.751 . . . . 73.52 106.271 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . 0.425 HG11 HD22 ' A' ' 622' ' ' LEU . 76.1 t -61.08 129.67 24.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 107.58 -1.267 . . . . 64.54 107.58 173.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 97.6 t -87.25 -50.31 13.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-O 121.591 0.71 . . . . 71.01 109.27 -175.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -149.44 157.58 43.42 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 106.871 -1.529 . . . . 63.43 106.871 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . 0.517 ' HB2' HD11 ' A' ' 620' ' ' ILE . 17.0 pt20 -110.14 123.3 49.48 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 107.948 -1.131 . . . . 72.35 107.948 173.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.507 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 25.3 t-20 -48.58 -54.5 26.05 Favored Pre-proline 0 CA--C 1.553 1.084 0 N-CA-C 113.468 0.914 . . . . 70.22 113.468 -177.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.507 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 4.1 Cg_endo -90.26 138.74 2.83 Favored 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 121.473 1.448 . . . . 73.34 109.944 173.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . 0.445 ' HG2' ' OG1' ' A' ' 612' ' ' THR . 29.3 Cg_endo -67.92 147.57 74.67 Favored 'Trans proline' 0 C--O 1.249 1.066 0 C-N-CA 121.985 1.79 . . . . 71.0 113.13 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.55 133.63 49.79 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.283 -0.871 . . . . 62.33 110.456 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 95.96 -8.18 67.71 Favored Glycine 0 C--N 1.305 -1.181 0 C-N-CA 120.717 -0.754 . . . . 51.25 112.113 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . 0.445 ' OG1' ' HG2' ' A' ' 609' ' ' PRO . 15.7 m -91.28 157.91 16.87 Favored 'General case' 0 C--O 1.256 1.434 0 N-CA-C 109.052 -0.721 . . . . 73.34 109.052 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -77.01 128.63 9.15 Favored Glycine 0 N--CA 1.428 -1.861 0 N-CA-C 111.425 -0.67 . . . . 72.05 111.425 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . 0.413 ' CG2' ' HB2' ' A' ' 563' ' ' MET . 33.4 m -122.16 144.19 32.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 C-N-CA 123.528 0.731 . . . . 72.1 110.49 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -39.53 144.23 0.18 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 125.816 1.647 . . . . 70.45 112.115 174.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . 0.496 ' HG3' ' N ' ' A' ' 617' ' ' ASP . 3.2 ptp180 -54.9 -28.43 50.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 123.773 0.671 . . . . 75.01 111.021 -178.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . 0.496 ' N ' ' HG3' ' A' ' 616' ' ' ARG . 21.2 t70 -60.05 -42.06 93.65 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.783 -1.098 . . . . 74.5 109.652 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 87.08 12.54 67.88 Favored Glycine 0 N--CA 1.413 -2.846 0 CA-C-N 115.012 -0.995 . . . . 33.11 113.363 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . 0.466 ' HB ' ' OD2' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -69.4 119.76 15.89 Favored 'Isoleucine or valine' 0 C--O 1.251 1.143 0 CA-C-N 118.604 1.202 . . . . 61.45 109.631 -177.398 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.585 HD12 ' SD ' ' A' ' 563' ' ' MET . 4.1 tt -124.81 132.64 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.223 0 CA-C-N 113.287 -1.779 . . . . 73.41 107.581 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 87.6 m -96.64 122.37 39.5 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 121.814 0.816 . . . . 51.13 109.707 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . 0.425 HD22 HG11 ' A' ' 603' ' ' VAL . 61.2 mt -119.9 150.78 39.93 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 105.881 -1.896 . . . . 74.42 105.881 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -128.64 135.79 49.78 Favored 'General case' 0 C--N 1.27 -2.859 0 N-CA-C 106.729 -1.582 . . . . 60.44 106.729 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.482 ' CE2' ' HD3' ' A' ' 589' ' ' LYS . 26.5 p90 -143.24 164.05 31.28 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 108.557 -0.905 . . . . 70.01 108.557 176.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -77.15 -82.06 0.58 Allowed Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 120.582 -0.818 . . . . 64.45 112.932 -177.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 . . . . . 0 C--N 1.292 -1.899 0 N-CA-C 107.878 -1.156 . . . . 71.05 107.878 -177.029 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.488 0 N-CA-C 109.647 -1.381 . . . . 43.05 109.647 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 11.2 tp -78.42 137.16 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 CA-C-N 117.608 0.704 . . . . 75.21 111.568 -176.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 17.9 m -120.23 147.83 44.45 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 104.536 -2.394 . . . . 71.11 104.536 170.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 23.6 mtt85 -93.11 77.41 4.63 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 114.506 1.298 . . . . 75.22 114.506 -171.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -71.47 148.57 46.68 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 104.91 -2.255 . . . . 74.3 104.91 166.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 29.5 m -115.49 160.68 14.72 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 CA-C-O 121.303 0.573 . . . . 72.4 110.929 -170.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 409' ' ' SER . 33.8 tt0 -94.35 139.64 30.82 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 115.872 -0.603 . . . . 63.25 110.063 -175.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.685 HG22 ' CZ ' ' A' ' 382' ' ' PHE . 60.5 t -94.68 141.1 22.93 Favored Pre-proline 0 C--N 1.28 -2.436 0 N-CA-C 106.232 -1.766 . . . . 71.31 106.232 -176.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -73.15 119.34 5.97 Favored 'Trans proline' 0 N--CA 1.436 -1.861 0 C-N-CA 120.824 1.016 . . . . 63.14 111.678 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . 0.611 ' OD2' ' HD2' ' A' ' 366' ' ' ARG . 24.8 t70 -89.98 82.51 6.14 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 105.974 -1.862 . . . . 63.31 105.974 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.522 ' HB ' HE21 ' A' ' 368' ' ' GLN . 3.0 m -92.46 30.35 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 113.941 -1.482 . . . . 65.31 114.017 -171.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.611 ' HD2' ' OD2' ' A' ' 364' ' ' ASP . 0.0 OUTLIER -52.66 145.26 12.33 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 124.62 1.168 . . . . 62.53 112.399 174.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.56 -0.84 45.98 Favored Glycine 0 CA--C 1.492 -1.36 0 CA-C-N 115.81 -0.632 . . . . 70.45 112.821 175.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . 0.522 HE21 ' HB ' ' A' ' 365' ' ' VAL . 36.4 mt-30 -112.19 -155.84 0.57 Allowed 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.009 -1.108 . . . . 71.15 108.009 178.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 21.4 p -94.58 161.53 14.16 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 108.667 -0.864 . . . . 72.32 108.667 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 19.1 p -63.13 -40.01 96.34 Favored 'General case' 0 C--O 1.209 -1.033 0 C-N-CA 120.698 -0.401 . . . . 64.21 109.943 178.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.45 -46.31 89.11 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 116.201 -0.454 . . . . 65.32 111.727 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -69.06 -44.79 71.9 Favored 'General case' 0 C--O 1.253 1.255 0 CA-C-O 121.301 0.572 . . . . 74.42 110.69 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -63.83 -44.63 92.66 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.412 -0.813 . . . . 65.15 110.981 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 70.0 mt -69.31 -37.04 75.07 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.594 0 CA-C-N 116.304 -0.407 . . . . 52.22 110.966 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.78 -43.88 90.53 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.376 0.608 . . . . 32.5 109.986 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . 0.56 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 54.6 m -65.76 -47.41 75.29 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.288 -0.869 . . . . 65.51 109.859 177.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 26.1 tp -60.98 -40.18 92.46 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 123.898 0.879 . . . . 72.01 111.602 -176.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -70.29 -37.66 74.86 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.136 0.575 . . . . 64.53 110.077 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -67.98 -19.15 64.91 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 120.833 0.349 . . . . 63.33 111.527 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . 0.56 ' HG2' ' O ' ' A' ' 376' ' ' THR . 16.6 mmt85 -89.42 -8.71 52.48 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.07 0.462 . . . . 73.23 110.046 177.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 84.78 16.34 65.89 Favored Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 115.826 -0.624 . . . . 73.43 113.587 175.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.685 ' CZ ' HG22 ' A' ' 362' ' ' VAL . 71.0 m-85 -86.4 161.12 18.83 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 117.607 0.703 . . . . 74.22 111.786 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.429 ' HB2' ' HA ' ' A' ' 415' ' ' GLU . 34.2 mmtp -90.4 138.34 31.62 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 107.813 -1.18 . . . . 71.13 107.813 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.461 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -117.11 141.21 36.51 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 C-N-CA 119.864 -0.734 . . . . 63.44 109.574 -175.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 6.2 tpp180 -132.13 147.65 52.44 Favored 'General case' 0 N--CA 1.408 -2.547 0 N-CA-C 107.54 -1.282 . . . . 75.41 107.54 176.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 54.5 m -134.87 132.33 38.43 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 109.552 -0.536 . . . . 74.31 109.552 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -111.68 119.84 40.01 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 105.436 -2.061 . . . . 61.4 105.436 175.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.593 HE21 ' N ' ' A' ' 388' ' ' GLN . 0.0 OUTLIER -125.63 135.41 52.13 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.97 -0.692 . . . . 74.24 110.775 -177.041 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -136.75 135.04 19.73 Favored Pre-proline 0 C--N 1.297 -1.713 0 CA-C-N 115.525 -0.761 . . . . 72.13 109.102 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 422' ' ' THR . 20.7 Cg_exo -70.81 127.51 13.85 Favored 'Trans proline' 0 C--O 1.255 1.374 0 N-CA-C 106.236 -2.255 . . . . 74.23 106.236 166.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.547 ' OD1' HG22 ' A' ' 393' ' ' THR . 7.9 t0 169.15 -165.2 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 105.743 -1.947 . . . . 52.15 105.743 -169.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 10.6 t -151.93 -1.33 0.31 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 122.153 -0.342 . . . . 71.21 110.787 175.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.547 HG22 ' OD1' ' A' ' 391' ' ' ASP . 13.4 t -94.85 -7.92 38.83 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.807 -0.558 . . . . 72.24 112.331 -173.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.491 HD13 ' H ' ' A' ' 394' ' ' ILE . 0.2 OUTLIER -111.01 152.07 43.42 Favored Pre-proline 0 C--N 1.312 -1.061 0 N-CA-C 108.119 -1.067 . . . . 72.33 108.119 176.514 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_exo -29.95 133.5 0.05 OUTLIER 'Trans proline' 0 CA--C 1.553 1.459 0 C-N-CA 125.083 3.855 . . . . 74.13 117.18 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.9 163.76 27.08 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 123.908 3.072 . . . . 73.15 111.836 176.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . 0.584 ' HA ' HG13 ' A' ' 420' ' ' VAL . 5.4 p-10 -57.07 -7.84 0.56 Allowed 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 123.826 0.851 . . . . 73.12 112.64 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 53.9 m170 -104.88 124.02 48.74 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 105.102 -2.184 . . . . 73.44 105.102 172.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 28.5 m -72.11 118.79 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.647 0 CA-C-O 121.261 0.553 . . . . 72.4 110.938 -169.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.81 -36.98 10.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 107.274 -1.38 . . . . 75.42 107.274 177.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . 0.489 ' HA2' ' HB2' ' A' ' 366' ' ' ARG . . . -146.64 156.94 27.24 Favored Glycine 0 N--CA 1.412 -2.911 0 N-CA-C 109.207 -1.557 . . . . 65.2 109.207 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.476 ' OG1' ' HB3' ' A' ' 366' ' ' ARG . 2.1 p -124.46 -177.71 3.89 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 107.486 -1.302 . . . . 71.33 107.486 176.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -99.64 134.28 21.21 Favored Pre-proline 0 C--N 1.293 -1.887 0 C-N-CA 118.836 -1.146 . . . . 51.1 109.23 -174.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -49.02 -12.12 0.2 Allowed 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 124.787 3.658 . . . . 72.32 115.186 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.76 -29.89 55.13 Favored 'General case' 0 C--O 1.21 -0.986 0 C-N-CA 123.439 0.695 . . . . 72.34 110.021 172.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . 0.59 ' HA ' ' HB ' ' A' ' 362' ' ' VAL . . . -66.9 -50.42 62.48 Favored 'General case' 0 N--CA 1.437 -1.079 0 O-C-N 123.603 0.565 . . . . 52.55 111.079 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -72.8 -8.6 56.24 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 121.852 -0.53 . . . . 73.3 111.393 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 90.2 m -85.52 131.4 34.37 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 106.144 -1.799 . . . . 62.33 106.144 174.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 361' ' ' GLN . 47.1 p -74.5 112.95 11.19 Favored 'General case' 0 N--CA 1.417 -2.104 0 C-N-CA 118.653 -1.219 . . . . 71.44 108.859 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 23.7 m -114.56 169.51 5.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 109.911 -0.403 . . . . 44.34 109.911 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 17.1 m -65.11 136.51 56.79 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.808 -0.812 . . . . 74.43 108.808 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -58.02 109.56 0.76 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.144 0.497 . . . . 72.44 111.629 -175.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 105.89 36.65 2.71 Favored Glycine 0 N--CA 1.438 -1.23 0 CA-C-N 115.523 -0.762 . . . . 71.43 112.661 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -96.96 175.43 6.33 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 109.357 -0.609 . . . . 70.44 109.357 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . 0.429 ' HA ' ' HB2' ' A' ' 383' ' ' LYS . 40.9 mm-40 -86.74 120.1 27.68 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.278 0.631 . . . . 64.21 111.341 -172.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 43.0 mm -113.16 111.43 36.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 N-CA-C 108.808 -0.812 . . . . 74.31 108.808 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 30.5 p -90.85 130.48 36.8 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 112.772 0.656 . . . . 65.34 112.772 -175.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 4.1 p -121.62 135.24 62.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.957 -0.757 . . . . 74.4 108.957 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -109.18 127.4 54.18 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.588 -0.523 . . . . 73.03 109.588 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.584 HG13 ' HA ' ' A' ' 397' ' ' ASP . 44.6 t -126.54 137.72 56.95 Favored 'Isoleucine or valine' 0 C--O 1.25 1.126 0 CA-C-N 115.04 -0.982 . . . . 55.42 111.23 -174.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 10.0 t -98.03 121.4 39.91 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.557 -1.275 . . . . 72.12 107.557 176.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.523 ' O ' ' HA ' ' A' ' 390' ' ' PRO . 7.5 t -120.84 107.79 13.15 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.149 0.426 . . . . 71.23 112.149 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 103.46 128.88 6.45 Favored Glycine 0 C--N 1.308 -1.022 0 C-N-CA 119.388 -1.387 . . . . 55.52 112.869 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -64.05 157.83 51.03 Favored 'Trans proline' 0 C--O 1.245 0.866 0 C-N-CA 123.273 2.649 . . . . 73.5 112.395 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.453 ' HG2' ' HA ' ' A' ' 391' ' ' ASP . 38.4 mt-10 -74.73 156.05 37.02 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.836 -1.074 . . . . 71.01 111.184 -178.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -89.09 147.34 24.28 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 106.468 -1.679 . . . . 61.02 106.468 173.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 18.0 mmm-85 -122.51 154.33 38.0 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 120.022 -0.671 . . . . 71.33 110.512 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.424 ' CD ' ' H ' ' A' ' 428' ' ' GLU . 0.0 OUTLIER -85.66 141.24 29.91 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-N 114.738 -1.119 . . . . 73.25 109.401 -177.734 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.443 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 66.2 mt -77.38 126.9 84.24 Favored Pre-proline 0 N--CA 1.426 -1.631 0 N-CA-C 105.698 -1.964 . . . . 64.02 105.698 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.27 141.26 67.98 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 121.973 1.782 . . . . 62.44 112.477 -177.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -87.63 137.02 32.7 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.968 -1.123 . . . . 62.13 107.968 177.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.589 HG11 ' HB2' ' A' ' 440' ' ' ALA . 13.3 p -152.02 159.75 3.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 109.335 -0.616 . . . . 53.53 109.335 -175.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.618 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 13.6 m -78.76 152.77 31.29 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 109.068 -0.716 . . . . 74.13 109.068 177.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 32.7 p -69.07 -25.86 64.66 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 114.037 1.125 . . . . 74.5 114.037 -173.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.5 pp -90.01 -10.23 45.71 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.679 0.752 . . . . 61.44 111.245 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.618 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 1.0 OUTLIER -100.16 41.76 1.15 Allowed 'General case' 0 CA--C 1.569 1.674 0 CA-C-N 115.186 -0.915 . . . . 65.31 110.022 -175.731 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -52.99 -38.2 62.05 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 113.559 0.948 . . . . 63.11 113.559 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.01 -35.71 77.58 Favored 'General case' 0 C--O 1.247 0.961 0 CA-C-O 122.016 0.912 . . . . 52.11 110.836 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.403 ' CB ' HG22 ' A' ' 436' ' ' THR . 35.1 tp10 -69.63 -37.55 76.84 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.401 -0.592 . . . . 70.01 109.401 176.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.589 ' HB2' HG11 ' A' ' 432' ' ' VAL . . . -60.54 -51.3 70.04 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.867 -0.606 . . . . 50.2 111.095 -178.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 35.6 m -63.39 -41.56 93.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 112.104 0.409 . . . . 71.11 112.104 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -68.23 -41.61 80.97 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 119.651 -0.82 . . . . 74.11 110.713 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -65.34 -38.26 89.59 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-N 115.901 -0.59 . . . . 75.04 111.042 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.431 ' CD2' ' HB3' ' A' ' 452' ' ' PHE . 13.5 tp -63.49 -36.46 83.82 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.081 -0.711 . . . . 73.41 109.081 178.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.42 ' HA ' ' HA3' ' A' ' 450' ' ' GLY . 40.0 m -68.98 -39.48 79.39 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.573 -0.74 . . . . 74.01 110.129 178.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.05 -15.95 62.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.937 -0.574 . . . . 43.24 111.13 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -88.74 5.07 45.11 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.873 -0.603 . . . . 64.42 110.906 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 109.03 -87.93 0.5 Allowed Glycine 0 CA--C 1.484 -1.883 0 N-CA-C 111.077 -0.809 . . . . 65.4 111.077 174.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -35.49 -63.14 0.36 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.435 1.272 . . . . 74.13 114.435 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 445' ' ' THR . . . 55.42 30.75 56.15 Favored Glycine 0 C--O 1.217 -0.909 0 N-CA-C 114.204 0.442 . . . . 72.55 114.204 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.509 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 30.3 mmm180 -105.75 111.18 23.74 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.64 -0.874 . . . . 73.05 108.64 -177.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.431 ' HB3' ' CD2' ' A' ' 444' ' ' LEU . 40.8 p90 -133.1 150.37 52.07 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 121.405 0.622 . . . . 75.43 111.869 -174.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -137.17 126.75 25.21 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.774 -1.103 . . . . 72.5 108.84 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -94.74 128.64 41.58 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 120.831 0.348 . . . . 63.01 110.593 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -128.99 157.86 40.48 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.826 -0.805 . . . . 61.21 108.826 177.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -126.19 147.94 49.55 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.95 -0.3 . . . . 73.12 110.338 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 20.9 t -152.62 147.47 19.37 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 107.631 -1.248 . . . . 63.52 107.631 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 490' ' ' SER . 35.6 Cg_endo -65.84 135.78 42.68 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.237 1.958 . . . . 61.44 111.38 178.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 34.7 m -151.94 179.09 8.76 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.658 -0.867 . . . . 61.03 108.658 -177.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.5 t -47.92 133.5 11.58 Favored Pre-proline 0 C--O 1.248 1.012 0 O-C-N 123.958 0.786 . . . . 75.24 111.02 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.69 -30.87 38.74 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 124.331 3.354 . . . . 74.13 114.003 -174.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -73.21 -27.64 61.73 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 112.345 0.498 . . . . 62.14 112.345 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -94.18 -2.23 52.9 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 120.721 0.296 . . . . 70.41 111.41 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 76.7 t -61.13 127.77 21.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.091 -0.707 . . . . 72.04 109.091 174.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.99 -4.59 75.07 Favored Glycine 0 C--N 1.304 -1.205 0 N-CA-C 111.733 -0.547 . . . . 72.31 111.733 -177.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -117.68 166.45 12.41 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.135 -0.691 . . . . 71.12 109.135 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 81.6 t -75.42 144.74 11.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 115.516 -0.766 . . . . 55.12 109.771 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 47.6 mm -97.68 -30.38 3.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 107.676 -1.231 . . . . 73.44 107.676 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 158.56 -169.51 35.02 Favored Glycine 0 N--CA 1.418 -2.548 0 CA-C-N 115.179 -0.919 . . . . 75.44 112.131 174.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . 0.542 HG22 HG12 ' A' ' 486' ' ' ILE . 20.9 p -114.79 144.55 43.32 Favored 'General case' 0 C--N 1.28 -2.413 0 N-CA-C 106.565 -1.642 . . . . 72.43 106.565 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.499 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 22.4 t-20 -52.51 -53.41 53.86 Favored Pre-proline 0 N--CA 1.48 1.058 0 N-CA-C 112.744 0.646 . . . . 64.35 112.744 178.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 2.7 Cg_endo -85.83 147.62 9.45 Favored 'Trans proline' 0 N--CA 1.442 -1.516 0 N-CA-C 108.414 -1.418 . . . . 52.31 108.414 170.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.67 132.32 37.18 Favored 'Trans proline' 0 C--O 1.241 0.626 0 C-N-CA 121.633 1.555 . . . . 63.32 111.194 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.443 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -75.11 18.16 0.2 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.733 0.813 . . . . 72.02 112.239 -176.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -110.55 -10.3 14.53 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 123.491 0.716 . . . . 75.42 110.25 173.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -102.35 174.74 5.78 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.109 0.48 . . . . 73.21 111.995 -173.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.26 145.88 24.11 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.071 -0.968 . . . . 64.44 111.585 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 29.1 p -137.24 149.31 47.07 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.069 -0.715 . . . . 72.35 109.069 176.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.13 165.26 18.56 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.406 -0.361 . . . . 74.52 111.417 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 42.5 mm -74.88 -16.43 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-O 121.679 0.752 . . . . 72.24 110.444 -178.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 7.3 t -98.2 5.24 48.67 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.506 -0.746 . . . . 43.41 109.74 176.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -77.43 132.38 38.45 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.999 -0.546 . . . . 63.32 110.206 -175.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.509 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 43.1 t -105.04 126.17 60.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.913 -0.773 . . . . 75.32 108.913 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.449 HG12 ' HG2' ' A' ' 472' ' ' PRO . 20.2 m -108.29 126.38 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 CA-C-O 121.898 0.856 . . . . 61.12 111.048 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.425 HG23 ' HB2' ' A' ' 471' ' ' ASN . 0.0 OUTLIER -94.22 129.3 44.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 108.326 -0.99 . . . . 72.42 108.326 176.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.542 HG12 HG22 ' A' ' 470' ' ' THR . 18.2 mt -113.5 127.33 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 CA-C-N 115.17 -0.923 . . . . 72.2 109.808 -176.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 8.0 tt -107.18 126.79 63.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 115.429 -0.805 . . . . 74.5 110.161 -175.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 32.6 m -109.42 151.9 11.6 Favored 'Isoleucine or valine' 0 C--O 1.249 1.056 0 C-N-CA 123.209 0.603 . . . . 75.53 110.193 178.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.91 123.8 6.25 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 110.864 -0.894 . . . . 64.31 110.864 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 44.7 m -142.73 129.87 20.86 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 117.221 0.51 . . . . 71.12 111.118 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 107.77 82.47 1.46 Allowed Glycine 0 C--N 1.31 -0.897 0 C-N-CA 120.732 -0.747 . . . . 51.23 113.548 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -92.17 160.76 3.18 Favored 'Trans proline' 0 C--O 1.251 1.132 0 C-N-CA 122.299 1.999 . . . . 73.43 111.651 174.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -124.01 56.88 1.23 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.668 -0.864 . . . . 62.43 108.668 175.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 2.9 p -117.09 144.08 45.07 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 114.986 -1.006 . . . . 71.23 111.119 -176.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -140.61 163.81 31.86 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.588 -0.893 . . . . 72.12 108.588 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -97.25 126.66 42.6 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.822 -0.807 . . . . 70.22 108.822 -177.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.4 pt -78.55 127.06 81.73 Favored Pre-proline 0 C--N 1.313 -1.011 0 N-CA-C 113.138 0.792 . . . . 73.11 113.138 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -96.19 155.64 1.37 Allowed 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 122.97 2.447 . . . . 54.42 110.083 169.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -123.99 164.35 19.51 Favored 'General case' 0 C--N 1.314 -0.945 0 O-C-N 121.675 -0.641 . . . . 75.13 111.303 -176.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 6.4 p -151.9 96.28 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 CA-C-O 121.947 0.88 . . . . 73.32 110.179 177.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -102.85 100.67 10.67 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.468 -0.787 . . . . 74.2 110.732 -177.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 152.1 48.41 0.02 OUTLIER Glycine 0 C--N 1.302 -1.313 0 N-CA-C 110.329 -1.108 . . . . 63.45 110.329 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -156.15 -178.52 7.38 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.529 -1.656 . . . . 73.21 106.529 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 18.0 p -89.64 160.07 16.82 Favored 'General case' 0 C--N 1.286 -2.188 0 C-N-CA 120.0 -0.68 . . . . 64.25 109.424 174.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.461 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.3 p -52.51 -43.55 42.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 O-C-N 123.946 0.779 . . . . 72.12 111.745 178.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -62.67 -42.56 99.68 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.945 0.402 . . . . 75.21 111.069 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 57.6 t -73.44 -37.34 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 121.153 0.502 . . . . 64.22 110.283 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.6 -44.92 92.6 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.424 -0.353 . . . . 64.52 111.094 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 23.6 mt-30 -60.91 -40.76 94.38 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.448 0.467 . . . . 70.25 109.958 177.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.454 ' O ' HG23 ' A' ' 514' ' ' VAL . 58.8 tttp -57.9 -50.37 73.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.313 -0.858 . . . . 74.15 110.105 177.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -62.34 -40.82 97.62 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-N 115.479 -0.782 . . . . 51.44 111.421 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . 0.424 HD23 ' HB3' ' A' ' 520' ' ' PHE . 40.9 tp -61.1 -41.15 96.15 Favored 'General case' 0 C--O 1.238 0.485 0 O-C-N 123.369 0.418 . . . . 74.33 109.958 177.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . 0.432 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 12.1 m120 -65.35 -37.69 87.81 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 116.014 -0.539 . . . . 64.54 110.675 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 510' ' ' LYS . 95.5 t -66.06 -28.42 43.74 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 116.117 -0.492 . . . . 72.3 110.362 177.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -75.56 -4.29 39.06 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.814 0.34 . . . . 74.11 111.171 178.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 105.6 -10.61 45.91 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.892 -0.671 . . . . 74.15 112.854 175.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.432 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 70.6 m-85 -95.77 114.11 25.81 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.157 -0.683 . . . . 73.1 109.157 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 16.5 p -87.57 -17.95 30.83 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 113.709 1.003 . . . . 63.41 113.709 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . 0.454 ' HD2' ' O ' ' A' ' 548' ' ' ASP . 96.7 mttt -108.51 119.55 39.85 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.854 0.835 . . . . 71.02 113.208 -172.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . 0.424 ' HB3' HD23 ' A' ' 512' ' ' LEU . 15.3 p90 -130.46 152.14 50.18 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.507 -1.224 . . . . 74.33 111.195 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 63.5 m -142.03 156.54 45.43 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 107.51 -1.293 . . . . 63.2 107.51 170.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 3.9 pt20 -116.67 148.9 40.59 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-O 121.542 0.687 . . . . 71.23 111.056 -177.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . 0.512 ' HB3' ' HG2' ' A' ' 554' ' ' GLN . . . -120.38 119.03 31.91 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.145 -1.428 . . . . 54.33 107.145 175.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 17.0 m -86.25 123.26 31.32 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 116.243 -0.435 . . . . 42.31 110.528 -176.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 45.0 t -121.43 149.07 24.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 105.672 -1.973 . . . . 72.31 105.672 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -102.04 137.05 40.83 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.654 -0.819 . . . . 52.21 108.934 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 54.2 m -155.38 -176.83 0.65 Allowed Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 107.758 -1.201 . . . . 74.14 107.758 -176.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -87.5 3.59 6.32 Favored 'Trans proline' 0 CA--C 1.551 1.35 0 C-N-CA 121.699 1.599 . . . . 64.42 112.798 173.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.508 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 3.6 mpt_? -89.84 134.19 32.53 Favored Pre-proline 0 C--O 1.213 -0.832 0 N-CA-C 108.619 -0.882 . . . . 75.31 108.619 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -54.79 141.68 76.03 Favored 'Trans proline' 0 N--CA 1.483 0.866 0 C-N-CA 123.223 2.615 . . . . 72.14 114.315 -171.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.584 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -61.07 114.22 2.99 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 114.614 -1.176 . . . . 75.31 111.375 -175.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 132.49 -20.08 4.44 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 110.226 -1.15 . . . . 61.33 110.226 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -69.88 131.41 44.4 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 123.185 0.594 . . . . 74.44 109.895 177.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 7.6 p -86.58 106.15 15.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.13 -1.063 . . . . 62.21 108.13 174.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 12.0 t -78.56 -16.43 57.45 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.991 -0.55 . . . . 75.24 111.361 -174.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 163.25 -166.56 37.14 Favored Glycine 0 N--CA 1.429 -1.798 0 N-CA-C 111.194 -0.762 . . . . 72.12 111.194 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 42.4 p -128.71 149.19 50.79 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 107.706 -1.22 . . . . 75.21 107.706 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -71.71 -49.44 10.96 Favored Pre-proline 0 C--N 1.303 -1.423 0 C-N-CA 120.621 -0.431 . . . . 71.42 110.81 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -81.76 126.09 5.1 Favored 'Trans proline' 0 CA--C 1.555 1.531 0 N-CA-C 109.515 -0.994 . . . . 62.44 109.515 168.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.38 160.84 43.96 Favored 'Trans proline' 0 C--O 1.257 1.471 0 C-N-CA 122.716 2.278 . . . . 42.25 113.325 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.94 139.81 58.81 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.339 -0.846 . . . . 52.25 110.47 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.27 -17.79 43.25 Favored Glycine 0 C--N 1.297 -1.627 0 N-CA-C 111.343 -0.703 . . . . 35.12 111.343 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 34.9 m -67.57 123.05 19.37 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.827 -0.434 . . . . 71.0 109.827 178.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 10.8 m -82.77 123.22 29.12 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 108.075 -1.083 . . . . 34.25 108.075 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 32.0 m -136.5 155.0 77.23 Favored Pre-proline 0 C--N 1.308 -1.23 0 N-CA-C 108.786 -0.82 . . . . 75.13 108.786 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -60.59 146.89 96.24 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.182 1.921 . . . . 74.03 110.222 172.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 27.9 m -60.94 -20.53 22.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 113.58 0.955 . . . . 75.44 113.58 -176.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . 0.454 ' O ' ' HD2' ' A' ' 519' ' ' LYS . 11.6 t70 -97.96 4.08 49.48 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.315 0.579 . . . . 74.31 110.566 -178.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.0 t -69.7 154.48 41.92 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.12 0.486 . . . . 74.44 110.403 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 43.6 t -95.22 127.07 47.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.581 -0.896 . . . . 71.21 108.581 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 2.7 mp -103.97 136.24 38.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 109.204 -0.665 . . . . 70.54 109.204 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -102.97 119.23 38.47 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-O 121.515 0.674 . . . . 71.44 111.344 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 5.2 mp -100.23 133.87 44.0 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.64 -1.164 . . . . 70.03 108.372 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . 0.512 ' HG2' ' HB3' ' A' ' 523' ' ' ALA . 48.6 mt-30 -97.93 121.75 40.23 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-O 121.294 0.569 . . . . 44.23 110.283 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 60.7 t -109.94 133.41 55.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 115.194 -0.912 . . . . 73.3 108.797 -175.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.584 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 29.8 p -94.17 133.34 37.78 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-O 121.024 0.44 . . . . 61.51 111.811 -178.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -84.41 145.43 28.19 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 107.218 -1.401 . . . . 52.14 107.218 169.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . 0.508 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -81.6 -28.33 43.63 Favored Glycine 0 CA--C 1.478 -2.265 0 O-C-N 123.813 0.695 . . . . 72.23 113.381 -173.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 70.3 -35.19 0.31 Allowed 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 124.49 1.116 . . . . 64.25 113.946 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.44 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 48.2 mt-30 -125.65 146.16 49.84 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 121.306 0.574 . . . . 74.14 111.638 -172.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -124.72 139.76 53.56 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 115.039 -0.982 . . . . 65.05 109.184 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 91.2 t -61.46 121.71 10.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 123.393 0.677 . . . . 61.24 112.333 -175.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . 0.428 ' HG2' ' O ' ' A' ' 564' ' ' PRO . 54.2 ttp -97.25 132.83 24.79 Favored Pre-proline 0 C--O 1.245 0.864 0 CA-C-N 115.769 -0.651 . . . . 71.31 111.103 -178.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . 0.428 ' O ' ' HG2' ' A' ' 563' ' ' MET . 13.6 Cg_exo -73.39 170.27 20.3 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.268 2.645 . . . . 74.02 110.646 171.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -74.98 115.57 14.75 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.834 0.826 . . . . 72.22 111.418 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 94.8 mt -113.67 7.41 17.24 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 122.666 1.222 . . . . 74.45 107.76 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 1.4 p -79.63 153.27 29.52 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-N 113.695 -1.593 . . . . 63.13 111.18 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 88.81 14.44 61.08 Favored Glycine 0 N--CA 1.436 -1.366 0 CA-C-N 115.634 -0.712 . . . . 52.54 112.908 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 89.1 mtp -108.3 156.27 19.57 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.739 -0.467 . . . . 75.21 109.739 -175.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 96.2 m-85 -75.56 153.92 37.1 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 108.031 -1.1 . . . . 72.52 108.031 176.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 74.8 t-105 -68.13 -22.6 64.87 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.532 -0.544 . . . . 74.52 109.532 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 10.8 p -74.82 -16.92 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 115.229 -0.896 . . . . 74.12 109.358 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -101.3 -44.17 5.74 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.956 -0.565 . . . . 74.5 110.04 175.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -58.12 -52.28 66.22 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.281 -0.872 . . . . 72.01 112.674 -176.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.421 ' HA ' ' HG ' ' A' ' 578' ' ' LEU . 41.3 tt0 -60.7 -51.93 76.15 Favored Pre-proline 0 CA--C 1.557 1.22 0 N-CA-C 112.939 0.718 . . . . 74.34 112.939 -177.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -58.04 -37.23 96.66 Favored 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 121.132 1.221 . . . . 62.12 112.341 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -69.02 -37.74 78.83 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 112.915 0.709 . . . . 61.21 112.915 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.421 ' HG ' ' HA ' ' A' ' 575' ' ' GLU . 4.1 pp -67.0 -38.36 85.86 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.988 -0.685 . . . . 73.25 110.481 177.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . 0.407 ' N ' HD12 ' A' ' 578' ' ' LEU . 79.8 mtp180 -63.49 -44.52 94.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.307 -0.861 . . . . 64.22 110.136 176.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.96 -29.19 68.98 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.516 0.726 . . . . 43.02 111.873 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 64.6 tp -81.2 -7.26 59.53 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 121.381 0.61 . . . . 75.43 109.883 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 77.83 31.02 50.58 Favored Glycine 0 CA--C 1.492 -1.374 0 N-CA-C 111.305 -0.718 . . . . 54.12 111.305 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . 0.402 ' CE3' HD13 ' A' ' 578' ' ' LEU . 86.8 t90 -87.36 140.68 29.29 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 109.043 -0.725 . . . . 75.54 109.043 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 5.8 t -133.33 -50.15 0.86 Allowed 'General case' 0 N--CA 1.41 -2.426 0 CA-C-N 115.708 -0.678 . . . . 71.51 109.496 175.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . 29.59 -126.6 0.11 Allowed Glycine 0 C--N 1.365 2.186 0 C-N-CA 125.352 1.453 . . . . 63.15 114.16 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . 0.438 ' O ' HG12 ' A' ' 619' ' ' ILE . 51.6 ttm -138.03 125.13 21.48 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 105.18 -2.156 . . . . 64.1 105.18 172.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -99.15 125.2 44.65 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.912 -1.144 . . . . 72.33 107.912 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -105.14 101.47 11.02 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 115.901 -0.591 . . . . 45.0 109.61 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -99.89 109.88 22.25 Favored 'General case' 0 N--CA 1.416 -2.17 0 N-CA-C 106.833 -1.543 . . . . 42.03 106.833 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -103.85 -121.6 4.95 Favored Glycine 0 N--CA 1.425 -2.086 0 N-CA-C 110.535 -1.026 . . . . 51.5 110.535 178.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -86.9 119.75 27.45 Favored 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 120.702 -0.399 . . . . 72.21 110.788 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -77.86 152.57 33.31 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 105.273 -2.121 . . . . 72.3 105.273 169.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . 0.409 ' O ' ' HB2' ' A' ' 626' ' ' GLN . 59.5 t -103.84 116.04 46.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 C-N-CA 118.931 -1.108 . . . . 52.23 111.94 -169.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.33 107.08 17.17 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.951 -1.129 . . . . 73.1 107.951 175.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -139.47 17.98 2.55 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.288 -1.004 . . . . 75.2 108.288 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 98.33 144.21 16.41 Favored Glycine 0 N--CA 1.414 -2.816 0 CA-C-N 114.645 -1.161 . . . . 42.31 111.089 -176.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.76 -32.3 61.69 Favored Glycine 0 C--N 1.32 -0.315 0 O-C-N 123.935 0.432 . . . . 72.23 112.503 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 10.0 m -59.06 -23.61 62.17 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.212 1.005 . . . . 72.04 112.798 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -86.71 -13.72 44.57 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 121.852 -0.53 . . . . 60.45 110.397 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 56.92 161.59 0.02 OUTLIER 'General case' 0 C--O 1.243 0.757 0 N-CA-C 115.475 1.657 . . . . 75.53 115.475 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -79.56 89.62 5.09 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 114.745 -1.116 . . . . 72.14 109.455 172.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 49.4 ttt180 -117.65 148.78 41.64 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 106.569 -1.641 . . . . 73.24 106.569 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 67.9 t -61.77 131.12 26.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.468 -0.938 . . . . 75.34 108.468 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 83.7 t -86.87 -46.56 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.008 0 N-CA-C 109.142 -0.688 . . . . 75.44 109.142 -174.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -156.1 164.17 38.74 Favored 'General case' 0 N--CA 1.415 -2.217 0 N-CA-C 107.647 -1.242 . . . . 72.34 107.647 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.04 150.84 44.46 Favored 'General case' 0 C--N 1.279 -2.458 0 N-CA-C 106.928 -1.508 . . . . 60.41 106.928 173.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.648 ' HB3' ' HD3' ' A' ' 608' ' ' PRO 0.294 48.7 t-20 -70.3 -79.36 0.05 OUTLIER Pre-proline 0 CA--C 1.563 1.445 0 CA-C-O 117.555 -1.212 . . . . 74.14 113.587 -171.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.648 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 14.6 Cg_exo -73.24 127.39 11.91 Favored 'Trans proline' 0 C--N 1.374 1.875 0 CA-C-N 122.729 2.01 . . . . 73.05 108.866 174.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.86 160.18 34.49 Favored 'Trans proline' 0 C--O 1.24 0.61 0 C-N-CA 122.392 2.062 . . . . 55.01 112.594 -175.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.94 127.05 29.57 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.434 -0.58 . . . . 61.41 109.434 -178.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.47 -12.48 47.36 Favored Glycine 0 N--CA 1.431 -1.651 0 C-N-CA 120.573 -0.823 . . . . 45.54 111.231 -175.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 27.8 m -97.66 164.62 12.34 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 107.936 -1.135 . . . . 53.12 107.936 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -88.81 143.41 17.59 Favored Glycine 0 N--CA 1.427 -1.95 0 C-N-CA 121.197 -0.525 . . . . 72.21 113.59 -177.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 24.3 m -107.92 142.17 21.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.989 -1.115 . . . . 64.3 107.989 173.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.571 HD21 HG22 ' A' ' 619' ' ' ILE . 31.8 p30 -62.54 164.87 6.91 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 114.282 1.216 . . . . 44.52 114.282 -175.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -55.49 -25.8 39.02 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 114.788 1.403 . . . . 75.24 114.788 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -74.73 -44.53 49.44 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 106.845 -1.539 . . . . 72.32 106.845 174.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 97.56 20.65 21.6 Favored Glycine 0 N--CA 1.418 -2.511 0 CA-C-N 114.672 -1.149 . . . . 74.12 110.53 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . 0.571 HG22 HD21 ' A' ' 615' ' ' ASN . 0.0 OUTLIER -69.42 122.03 20.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 122.078 0.942 . . . . 73.41 109.928 -172.257 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 9.4 tp -121.89 132.59 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.098 0 CA-C-N 114.606 -1.179 . . . . 73.12 108.929 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.464 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 7.4 m -97.62 119.72 36.69 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.178 -1.045 . . . . 61.34 108.178 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 81.6 mt -130.76 154.43 47.99 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 123.739 0.815 . . . . 74.44 109.33 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 65.2 mmt-85 -136.71 154.9 50.47 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 104.583 -2.377 . . . . 71.33 104.583 173.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 602' ' ' ARG . 30.5 p90 -141.31 160.35 40.31 Favored 'General case' 0 C--N 1.288 -2.082 0 O-C-N 123.293 0.371 . . . . 72.35 110.403 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -73.44 -151.14 1.72 Allowed Glycine 0 C--N 1.309 -0.959 0 O-C-N 124.196 0.935 . . . . 45.22 113.446 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . 0.409 ' HB2' ' O ' ' A' ' 593' ' ' VAL . 6.9 tp-100 . . . . . 0 C--N 1.299 -1.602 0 CA-C-O 119.31 -0.376 . . . . 70.11 110.438 -175.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.592 0 N-CA-C 111.045 -0.822 . . . . 74.45 111.045 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 8.2 tp -75.48 126.28 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 CA-C-O 121.515 0.674 . . . . 63.32 109.391 177.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.61 140.94 51.76 Favored 'General case' 0 N--CA 1.389 -3.479 0 CA-C-N 115.384 -0.826 . . . . 61.23 112.12 -177.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 2.1 ppt_? -145.99 86.2 1.71 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 122.614 1.197 . . . . 72.53 110.8 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -107.56 148.08 29.73 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.063 -1.426 . . . . 72.44 109.725 -176.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.67 163.56 34.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 109.724 -0.473 . . . . 63.04 109.724 -177.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -93.67 137.36 33.0 Favored 'General case' 0 N--CA 1.404 -2.762 0 CA-C-O 121.619 0.723 . . . . 74.44 109.245 177.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.424 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 91.4 t -98.29 134.27 22.12 Favored Pre-proline 0 C--N 1.268 -2.972 0 CA-C-N 114.337 -1.302 . . . . 72.21 110.171 -173.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 3.6 Cg_exo -71.21 128.79 15.15 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.856 1.704 . . . . 74.11 110.214 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.39 157.92 18.44 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.288 -0.565 . . . . 75.43 109.485 -177.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.502 HG23 ' HA ' ' A' ' 373' ' ' ALA . 18.8 m -131.5 26.55 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-N 115.205 -0.907 . . . . 65.33 109.085 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -66.43 148.55 51.71 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 114.749 -1.114 . . . . 73.44 109.103 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . 0.416 ' H ' HG23 ' A' ' 399' ' ' VAL . . . 107.01 0.7 35.95 Favored Glycine 0 C--N 1.315 -0.625 0 N-CA-C 111.349 -0.7 . . . . 75.54 111.349 -173.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . 0.468 HE21 ' HB ' ' A' ' 365' ' ' VAL . 39.1 mt-30 -113.03 -146.83 0.41 Allowed 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.7 -0.852 . . . . 70.42 108.7 175.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 58.4 p -89.57 160.77 16.52 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 107.929 -1.137 . . . . 64.35 107.929 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 8.8 p -63.52 -34.89 78.78 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 120.078 -0.649 . . . . 73.35 110.568 177.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -65.81 -47.58 74.61 Favored 'General case' 0 C--O 1.216 -0.692 0 N-CA-C 111.902 0.334 . . . . 74.44 111.902 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -67.19 -42.85 83.5 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.716 0.77 . . . . 70.14 109.247 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . 0.502 ' HA ' HG23 ' A' ' 365' ' ' VAL . . . -65.35 -42.65 92.61 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 114.558 -1.201 . . . . 73.12 112.27 -177.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 58.1 mt -69.58 -45.58 77.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 116.592 -0.276 . . . . 74.23 110.55 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.81 -44.56 90.84 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 123.515 0.509 . . . . 73.35 111.647 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . 0.508 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 23.6 m -65.2 -46.64 79.89 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 116.13 -0.486 . . . . 71.31 110.597 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.418 HD23 ' O ' ' A' ' 373' ' ' ALA . 4.6 mm? -63.17 -38.07 89.71 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 111.803 0.297 . . . . 70.43 111.803 178.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -63.65 -38.05 89.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.056 0.455 . . . . 73.4 110.068 178.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -70.07 -21.24 63.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 73.14 111.644 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 376' ' ' THR . 38.4 mmt180 -82.6 -14.11 55.36 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.61 -0.515 . . . . 73.3 109.61 176.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 97.54 6.02 57.59 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 111.385 -0.686 . . . . 45.33 111.385 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -89.4 149.01 23.17 Favored 'General case' 0 N--CA 1.406 -2.653 0 CA-C-O 121.61 0.719 . . . . 75.53 111.244 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.483 ' HB2' ' HG2' ' A' ' 415' ' ' GLU . 45.8 mmtm -96.14 155.09 16.9 Favored 'General case' 0 N--CA 1.41 -2.466 0 CA-C-N 114.548 -1.205 . . . . 72.41 107.764 -177.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.479 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -130.42 141.94 45.01 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 N-CA-C 109.204 -0.665 . . . . 72.11 109.204 -177.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 28.2 ttm-85 -125.53 127.57 46.63 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 108.186 -1.042 . . . . 74.21 108.186 177.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 33.5 m -115.56 123.64 48.98 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-O 120.925 0.393 . . . . 62.2 110.691 -173.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -112.24 131.09 55.69 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.994 -1.484 . . . . 71.43 106.994 175.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.528 HE21 ' N ' ' A' ' 388' ' ' GLN . 0.0 OUTLIER -123.11 142.16 51.18 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 119.374 -0.931 . . . . 71.23 111.403 -179.079 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . 0.436 ' HB2' HG13 ' A' ' 394' ' ' ILE . 75.4 mmtt -131.88 131.26 22.53 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 108.646 -0.872 . . . . 74.11 108.646 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.449 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 60.6 Cg_endo -83.62 129.18 4.85 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 121.626 1.55 . . . . 64.21 111.538 176.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 14.8 t70 158.58 -158.06 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 104.308 -2.478 . . . . 61.34 104.308 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 19.3 m -136.36 2.37 2.74 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 119.213 0.915 . . . . 73.13 110.784 177.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 1.3 p -81.87 -27.65 33.36 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 112.792 0.664 . . . . 54.21 112.792 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.653 HD13 ' H ' ' A' ' 394' ' ' ILE . 0.2 OUTLIER -93.04 152.09 41.08 Favored Pre-proline 0 C--N 1.29 -1.997 0 CA-C-N 115.898 -0.592 . . . . 72.33 110.399 -176.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -43.01 129.46 5.65 Favored 'Trans proline' 0 C--N 1.363 1.339 0 C-N-CA 124.159 3.239 . . . . 52.03 114.528 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -61.04 161.61 21.91 Favored 'Trans proline' 0 N--CA 1.482 0.851 0 C-N-CA 124.212 3.275 . . . . 60.35 113.489 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -59.37 -8.08 1.6 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 112.975 0.732 . . . . 75.02 112.975 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -98.02 122.38 41.08 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 103.52 -2.77 . . . . 65.22 103.52 171.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.416 HG23 ' H ' ' A' ' 367' ' ' GLY . 26.8 m -77.92 117.05 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.351 0 C-N-CA 118.982 -1.087 . . . . 73.44 113.565 -162.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 43.6 pt -103.32 -27.4 3.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 114.523 -1.217 . . . . 73.34 108.548 174.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.8 157.13 27.27 Favored Glycine 1 CA--C 1.442 -4.525 0 CA-C-O 122.397 0.998 . . . . 63.12 111.647 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.484 HG22 ' H ' ' A' ' 403' ' ' ASP . 87.2 m -156.54 -177.89 6.93 Favored 'General case' 0 N--CA 1.383 -3.783 0 N-CA-C 104.592 -2.373 . . . . 63.44 104.592 -171.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . 0.484 ' H ' HG22 ' A' ' 402' ' ' THR . 15.0 m-20 -98.6 131.65 25.5 Favored Pre-proline 0 C--N 1.264 -3.111 0 N-CA-C 106.117 -1.808 . . . . 71.22 106.117 174.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.6 26.31 0.12 Allowed 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 124.472 3.448 . . . . 74.1 114.761 -171.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.414 ' H ' ' C ' ' A' ' 403' ' ' ASP . . . -56.92 -35.99 69.67 Favored 'General case' 0 C--O 1.209 -1.077 0 C-N-CA 123.658 0.783 . . . . 70.45 110.635 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -70.86 -33.61 70.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.33 0.586 . . . . 64.31 111.049 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -88.12 -1.34 57.95 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 122.081 0.943 . . . . 74.14 109.406 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 26.6 m -95.28 148.51 22.34 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 104.874 -2.269 . . . . 73.3 104.874 173.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 4.1 p -74.89 111.99 10.65 Favored 'General case' 0 N--CA 1.41 -2.46 0 C-N-CA 118.603 -1.239 . . . . 62.24 108.839 176.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 30.2 m -123.71 167.46 17.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.702 -0.681 . . . . 43.21 110.344 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 38.4 m -76.94 146.91 37.25 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 108.832 -0.803 . . . . 75.42 108.832 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -64.73 109.45 2.04 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.9 0.381 . . . . 72.13 111.184 -176.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 111.67 53.12 0.53 Allowed Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.819 -0.628 . . . . 64.31 112.614 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -115.61 -167.65 1.29 Allowed 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.46 -0.941 . . . . 71.31 108.46 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . 0.483 ' HG2' ' HB2' ' A' ' 383' ' ' LYS . 37.1 mt-10 -113.91 137.16 52.06 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.114 0.483 . . . . 72.13 110.305 -176.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 34.7 mm -110.28 110.73 33.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 108.712 -0.848 . . . . 44.3 108.712 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 21.0 p -84.1 131.22 34.81 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 123.098 0.559 . . . . 65.34 111.838 -177.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 10.6 p -127.25 135.2 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-N 115.673 -0.694 . . . . 73.23 111.441 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -105.27 124.61 49.83 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.992 -0.744 . . . . 73.43 108.992 172.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 16.7 m -126.04 152.7 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.545 0 CA-C-N 115.28 -0.873 . . . . 63.44 110.535 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . 0.415 ' HB2' HG12 ' A' ' 394' ' ' ILE . 27.1 t -99.38 129.64 45.59 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-O 121.718 0.77 . . . . 54.44 110.584 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 3.0 p -93.61 158.36 15.73 Favored 'General case' 0 N--CA 1.401 -2.906 0 N-CA-C 105.008 -2.219 . . . . 53.41 105.008 166.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -56.83 -141.85 0.01 OUTLIER Glycine 0 CA--C 1.553 2.419 0 N-CA-C 116.729 1.451 . . . . 74.25 116.729 -175.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -70.86 154.61 63.29 Favored 'Trans proline' 0 C--O 1.263 1.763 0 C-N-CA 121.782 1.655 . . . . 71.12 113.355 -173.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -74.79 166.57 23.39 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 114.561 -1.2 . . . . 71.24 110.015 177.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -113.23 157.58 21.55 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 106.676 -1.602 . . . . 75.34 106.676 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 -122.21 152.46 39.96 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 119.398 -0.921 . . . . 72.35 111.254 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -83.23 138.64 33.52 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 114.445 -1.252 . . . . 62.55 109.073 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 53.7 mt -84.12 122.95 75.89 Favored Pre-proline 0 N--CA 1.424 -1.733 0 N-CA-C 107.297 -1.371 . . . . 63.43 107.297 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.451 ' HG2' ' HB3' ' A' ' 443' ' ' LYS . 56.2 Cg_endo -70.74 150.42 62.2 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.802 1.668 . . . . 72.1 110.892 176.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -80.5 130.13 34.95 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.167 -1.049 . . . . 72.14 108.167 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 39.5 t -127.03 152.3 34.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 107.438 -1.319 . . . . 74.41 107.438 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 42.6 t -70.29 143.64 51.99 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.833 -0.803 . . . . 72.4 108.833 176.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 18.9 p -67.56 -28.44 67.79 Favored 'General case' 0 N--CA 1.424 -1.726 0 C-N-CA 123.658 0.783 . . . . 65.41 111.532 -175.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 2.3 pp -79.36 -12.53 59.92 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.339 0.59 . . . . 71.14 111.963 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 3.2 p -104.05 62.98 0.75 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 121.567 0.699 . . . . 74.45 112.41 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -56.95 -38.58 73.13 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.078 -0.964 . . . . 73.04 111.014 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -60.04 -42.49 94.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.424 0.63 . . . . 74.5 110.254 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.475 ' O ' ' HB3' ' A' ' 442' ' ' LYS . 25.8 tp10 -70.89 -34.95 72.1 Favored 'General case' 0 C--O 1.205 -1.237 0 CA-C-N 115.463 -0.79 . . . . 71.12 110.035 178.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.6 -51.42 69.47 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.303 0.112 . . . . 73.21 111.303 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 33.9 m -63.01 -36.57 76.39 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 CA-C-O 121.273 0.559 . . . . 75.3 110.839 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 439' ' ' GLU . 16.6 tppt? -60.04 -47.69 84.8 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.942 -1.026 . . . . 65.43 109.998 176.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . 0.451 ' HB3' ' HG2' ' A' ' 430' ' ' PRO . 28.5 mmtp -67.04 -38.51 86.0 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 113.067 0.765 . . . . 75.52 113.067 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 9.8 mp -63.71 -34.93 78.96 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.6 -0.44 . . . . 70.33 109.974 174.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 92.9 m -68.23 -42.2 80.09 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.884 -0.598 . . . . 74.51 110.182 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.82 -20.64 62.55 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.909 -0.587 . . . . 70.42 112.063 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -90.2 3.28 53.96 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 112.492 0.553 . . . . 65.54 112.492 -178.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 110.28 -75.28 0.21 Allowed Glycine 0 CA--C 1.497 -1.071 0 C-N-CA 119.581 -1.295 . . . . 71.55 112.98 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . 0.433 ' HA ' ' O ' ' A' ' 480' ' ' ILE . 0.2 OUTLIER -40.94 -62.36 0.83 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.902 1.075 . . . . 74.22 113.902 177.589 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 61.14 23.08 61.43 Favored Glycine 0 C--O 1.221 -0.701 0 C-N-CA 121.172 -0.537 . . . . 75.02 112.447 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.402 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 10.5 mmm180 -97.89 111.24 23.61 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 107.921 -1.14 . . . . 70.33 107.921 -177.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.433 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 19.7 p90 -137.6 149.49 46.69 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 121.215 0.531 . . . . 62.44 111.576 -177.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -136.19 142.48 44.12 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.446 -1.316 . . . . 62.32 107.446 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -112.7 126.03 54.96 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 120.601 0.239 . . . . 52.2 110.558 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -123.07 136.15 54.7 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.281 -1.007 . . . . 71.13 108.281 175.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -113.34 141.52 46.94 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.834 -1.173 . . . . 65.4 107.834 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 50.0 m -144.68 140.22 16.23 Favored Pre-proline 0 C--N 1.292 -1.931 0 N-CA-C 109.939 -0.393 . . . . 73.42 109.939 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.605 ' HA ' ' O ' ' A' ' 490' ' ' SER . 21.4 Cg_endo -64.93 122.6 10.45 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.625 1.55 . . . . 53.3 108.968 176.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 19.8 m -135.84 179.64 6.22 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.55 -0.75 . . . . 63.53 110.133 -171.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 464' ' ' VAL . 7.2 t -59.5 139.75 88.98 Favored Pre-proline 0 N--CA 1.42 -1.927 0 O-C-N 124.13 0.894 . . . . 71.31 109.399 174.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.37 -29.08 29.31 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.707 3.605 . . . . 70.01 113.492 -175.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -65.34 -37.18 86.29 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.541 -0.3 . . . . 63.35 111.807 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.07 -14.87 32.91 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 121.044 -0.262 . . . . 71.31 111.397 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 460' ' ' THR . 85.4 t -60.31 128.12 20.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-N 116.498 -0.319 . . . . 63.24 110.29 177.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 95.45 -12.11 68.1 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.519 -0.764 . . . . 72.14 112.229 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -122.47 167.45 13.33 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.204 -0.665 . . . . 51.43 109.204 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.456 HG13 HG23 ' A' ' 486' ' ' ILE . 62.4 t -72.63 143.89 13.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 107.567 -1.272 . . . . 73.44 107.567 171.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 55.3 mt -97.18 -34.03 4.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.372 -1.344 . . . . 23.34 107.372 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 163.06 -172.87 39.17 Favored Glycine 0 N--CA 1.409 -3.106 0 CA-C-N 114.802 -1.09 . . . . 64.32 110.508 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 24.5 p -116.1 147.83 40.91 Favored 'General case' 0 N--CA 1.404 -2.728 0 N-CA-C 105.931 -1.877 . . . . 72.41 105.931 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.432 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 20.3 t-20 -70.18 -49.99 16.83 Favored Pre-proline 0 C--N 1.313 -0.979 0 C-N-CA 118.237 -1.385 . . . . 72.22 110.756 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 19.2 Cg_exo -74.07 125.42 9.8 Favored 'Trans proline' 0 C--N 1.368 1.582 0 N-CA-C 106.837 -2.024 . . . . 64.15 106.837 165.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.438 ' HB2' ' HG2' ' A' ' 476' ' ' GLN . 21.8 Cg_exo -61.98 133.64 45.47 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 122.129 1.886 . . . . 71.24 113.562 -172.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -75.34 16.87 0.3 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.057 0.943 . . . . 64.43 112.188 -176.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -110.45 -10.93 14.54 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.887 -0.597 . . . . 64.21 109.551 177.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . 0.438 ' HG2' ' HB2' ' A' ' 473' ' ' PRO . 78.6 mm-40 -90.24 176.97 6.55 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.661 -0.699 . . . . 63.4 112.473 -174.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 6.1 m -107.57 114.98 29.34 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 107.412 -1.329 . . . . 74.11 107.412 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 13.4 p -112.61 147.85 35.82 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.157 0.503 . . . . 74.24 111.635 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.58 160.22 30.42 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.843 -0.617 . . . . 71.32 111.371 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 449' ' ' PHE . 1.8 mp -67.63 -15.16 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.394 0 CA-C-O 122.145 0.974 . . . . 74.2 112.059 -178.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 11.6 p -103.49 5.3 36.76 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.436 -0.79 . . . . 75.11 111.331 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -85.36 129.39 34.82 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.094 -0.706 . . . . 61.31 109.094 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.402 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 61.5 t -91.93 126.6 44.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.864 -0.607 . . . . 74.22 110.303 -177.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 30.2 t -106.38 120.05 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 N-CA-C 108.781 -0.822 . . . . 52.13 108.781 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.39 123.67 47.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-O 121.227 0.537 . . . . 63.4 110.124 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.456 HG23 HG13 ' A' ' 467' ' ' VAL . 1.7 mp -102.59 128.09 55.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 124.976 1.31 . . . . 72.41 108.795 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 8.2 tt -109.74 126.6 66.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 109.255 -0.646 . . . . 75.21 109.255 176.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 34.1 m -109.17 151.34 11.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 116.251 -0.431 . . . . 51.12 110.232 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -88.78 131.58 10.76 Favored Glycine 0 N--CA 1.439 -1.104 0 C-N-CA 120.592 -0.813 . . . . 75.01 111.851 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.605 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 19.5 m -123.64 155.78 37.09 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.65 -0.87 . . . . 71.12 108.65 177.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 135.08 90.88 0.35 Allowed Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.51 -0.852 . . . . 73.32 112.009 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.96 151.45 24.11 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.202 1.935 . . . . 74.1 112.603 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -84.65 67.08 9.88 Favored 'General case' 0 C--O 1.25 1.095 0 CA-C-O 122.158 0.98 . . . . 65.32 110.461 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.47 ' HB ' HG22 ' A' ' 544' ' ' THR . 11.1 p -117.64 153.67 32.9 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 114.735 -1.121 . . . . 62.43 110.559 -178.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -149.73 150.38 31.99 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.689 -0.856 . . . . 64.32 108.689 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.7 p-10 -81.74 138.95 35.13 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 123.588 0.755 . . . . 71.12 110.903 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 543' ' ' THR . 22.2 pt -92.85 117.92 67.72 Favored Pre-proline 0 C--N 1.307 -1.254 0 CA-C-N 115.954 -0.567 . . . . 72.23 110.876 176.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -92.99 146.45 2.44 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.422 2.081 . . . . 71.13 111.373 175.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -83.39 96.07 8.42 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 122.803 1.287 . . . . 72.2 110.634 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.6 p -100.44 23.26 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 123.258 1.504 . . . . 75.41 107.432 177.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -77.07 171.6 14.55 Favored 'General case' 0 N--CA 1.416 -2.149 0 CA-C-N 113.368 -1.742 . . . . 73.04 110.295 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 96.74 22.4 18.47 Favored Glycine 0 C--N 1.285 -2.278 0 N-CA-C 108.258 -1.937 . . . . 63.31 108.258 -177.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -133.68 174.73 10.13 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 108.265 -1.013 . . . . 61.23 108.265 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 41.7 p -77.91 164.32 25.24 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 117.966 0.348 . . . . 62.41 110.998 -176.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 17.4 m -51.42 -44.49 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.652 0 C-N-CA 123.79 0.836 . . . . 73.22 112.982 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -68.01 -41.78 81.68 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.215 0.531 . . . . 73.1 111.079 -178.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 62.5 t -72.55 -46.45 55.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 115.361 -0.836 . . . . 74.44 111.535 -175.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.72 -40.44 96.75 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.655 -0.248 . . . . 43.13 110.812 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -59.96 -43.55 94.98 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.387 -0.598 . . . . 75.04 109.387 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.502 ' O ' HG23 ' A' ' 514' ' ' VAL . 59.7 tttm -58.1 -50.95 71.71 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.729 -1.123 . . . . 70.02 109.801 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -62.59 -46.75 86.88 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.575 -0.739 . . . . 75.42 112.046 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.94 -40.51 89.19 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 120.878 -0.329 . . . . 64.11 110.729 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.97 -37.98 89.42 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.127 -0.488 . . . . 55.13 111.309 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 510' ' ' LYS . 77.3 t -62.48 -30.47 49.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 121.006 0.431 . . . . 72.11 110.785 178.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -83.07 7.96 14.28 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.161 0.505 . . . . 75.54 111.715 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 93.99 -10.47 71.95 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.988 -0.625 . . . . 72.41 111.81 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -87.56 81.45 7.74 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-O 121.882 0.849 . . . . 73.35 109.433 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 3.5 p -89.89 3.34 53.32 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.917 -1.038 . . . . 75.44 110.98 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -108.74 113.45 26.42 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.061 -1.089 . . . . 71.43 108.061 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' A' ' 551' ' ' ILE . 15.3 p90 -131.56 156.64 45.39 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.024 -0.989 . . . . 71.21 111.791 -174.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 50.3 m -137.0 145.55 44.26 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 106.041 -1.837 . . . . 73.51 106.041 171.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -117.09 132.99 56.55 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 120.856 0.36 . . . . 64.35 110.267 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -124.58 141.11 52.34 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.179 -1.045 . . . . 75.51 108.179 176.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 6.4 m -110.28 120.75 43.45 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.62 -0.881 . . . . 72.0 108.62 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 34.9 m -120.9 164.12 17.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 110.294 -0.262 . . . . 55.54 110.294 -175.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . 0.641 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 8.0 p-10 -90.63 135.26 33.82 Favored 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 120.274 -0.57 . . . . 74.01 111.343 -177.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . 0.455 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 67.5 m -160.75 -179.92 1.18 Allowed Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 108.914 -0.773 . . . . 61.5 108.914 176.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -85.55 -19.15 3.62 Favored 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 121.505 1.47 . . . . 72.5 111.158 171.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -69.11 137.16 89.36 Favored Pre-proline 0 N--CA 1.437 -1.092 0 C-N-CA 124.018 0.927 . . . . 75.13 109.628 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -56.73 144.56 86.4 Favored 'Trans proline' 0 C--O 1.245 0.863 0 C-N-CA 123.624 2.883 . . . . 52.41 115.505 -170.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.634 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -67.4 115.51 7.12 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 114.258 -1.337 . . . . 75.23 109.907 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 133.93 -21.47 3.94 Favored Glycine 0 C--N 1.297 -1.61 0 N-CA-C 110.777 -0.929 . . . . 54.31 110.777 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -83.07 128.9 34.9 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 120.951 0.405 . . . . 74.43 110.596 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.46 HG22 HG22 ' A' ' 555' ' ' VAL . 84.2 t -83.22 105.74 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 N-CA-C 104.791 -2.3 . . . . 72.32 104.791 170.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 74.1 m -83.69 -16.85 43.45 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 112.312 0.486 . . . . 75.44 112.312 -173.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 173.44 -161.78 32.66 Favored Glycine 0 CA--C 1.49 -1.505 0 C-N-CA 120.099 -1.048 . . . . 61.52 111.251 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 23.7 p -127.77 160.07 32.85 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.782 -0.822 . . . . 71.05 108.782 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -73.01 -51.57 6.1 Favored Pre-proline 0 C--N 1.307 -1.243 0 CA-C-O 119.337 -0.363 . . . . 73.5 110.034 176.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 29.6 Cg_endo -66.55 130.86 24.58 Favored 'Trans proline' 0 C--N 1.378 2.103 0 N-CA-C 108.487 -1.39 . . . . 71.34 108.487 170.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 38.9 Cg_exo -61.66 142.11 93.24 Favored 'Trans proline' 0 C--O 1.241 0.673 0 C-N-CA 122.59 2.193 . . . . 74.22 114.161 -176.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.54 141.72 57.76 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.125 -0.943 . . . . 44.13 109.996 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.11 -20.65 46.61 Favored Glycine 0 C--N 1.302 -1.322 0 N-CA-C 110.545 -1.022 . . . . 72.12 110.545 -177.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.433 ' O ' HG12 ' A' ' 497' ' ' ILE . 63.5 m -76.47 137.66 39.81 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-O 121.507 0.67 . . . . 40.44 109.868 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.47 HG22 ' HB ' ' A' ' 494' ' ' THR . 18.4 m -94.14 123.92 37.82 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 115.373 -0.83 . . . . 74.51 109.749 -176.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 31.6 m -129.12 157.96 74.36 Favored Pre-proline 0 C--N 1.312 -1.044 0 N-CA-C 109.217 -0.661 . . . . 75.21 109.217 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 494' ' ' THR . 25.0 Cg_exo -66.07 143.61 72.58 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.067 1.845 . . . . 74.43 110.793 175.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 36.0 m -66.26 -19.04 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-O 121.521 0.677 . . . . 51.51 111.842 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -87.53 -2.05 58.35 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 115.297 -0.865 . . . . 73.23 110.703 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 32.3 t -89.09 157.24 18.39 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.485 -0.561 . . . . 74.24 109.485 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 25.8 t -96.33 136.65 26.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 109.24 -0.652 . . . . 71.14 109.24 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 520' ' ' PHE . 2.7 mp -113.66 138.56 42.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.379 -0.6 . . . . 73.32 109.379 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -101.98 121.13 41.56 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 121.36 0.6 . . . . 74.35 110.472 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.3 mp -95.56 132.08 41.08 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.364 -1.289 . . . . 71.25 107.859 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -106.84 120.17 41.31 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 122.013 0.911 . . . . 63.34 110.953 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.46 HG22 HG22 ' A' ' 534' ' ' VAL . 47.0 t -99.61 135.65 34.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-N 114.111 -1.404 . . . . 53.34 108.211 -178.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.634 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 68.2 m -90.73 149.2 22.13 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 116.464 -0.335 . . . . 41.23 110.455 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.641 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 15.8 ptmt -105.65 146.68 29.39 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 105.226 -2.138 . . . . 74.51 105.226 172.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -84.15 -24.72 47.06 Favored Glycine 0 N--CA 1.433 -1.549 0 C-N-CA 119.479 -1.343 . . . . 64.12 112.239 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 70.02 5.91 5.5 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.687 1.195 . . . . 71.34 111.004 -177.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 15.3 tp60 -148.53 141.87 25.2 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 106.891 -1.522 . . . . 75.15 106.891 -171.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -143.86 149.52 37.06 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.945 -0.761 . . . . 74.24 108.945 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.52 119.79 32.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 121.286 0.565 . . . . 51.34 111.413 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 60.4 ttp -97.75 134.0 22.84 Favored Pre-proline 0 C--N 1.316 -0.873 0 N-CA-C 108.537 -0.912 . . . . 72.11 108.537 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -64.18 169.52 10.61 Favored 'Trans proline' 0 C--O 1.245 0.872 0 C-N-CA 122.864 2.376 . . . . 75.41 112.378 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . 0.549 ' HA ' ' HB1' ' A' ' 610' ' ' ALA . 31.9 t70 -69.0 131.07 44.48 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 113.802 1.038 . . . . 65.11 113.802 -177.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 93.8 mt -147.12 23.19 1.19 Allowed 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 125.141 1.377 . . . . 75.35 107.942 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 2.8 m -79.25 146.28 33.1 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 116.25 -0.432 . . . . 75.43 110.824 -175.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 82.75 33.63 24.02 Favored Glycine 0 CA--C 1.496 -1.105 0 C-N-CA 120.796 -0.716 . . . . 72.02 112.137 174.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 25.0 mmt -108.04 -175.12 2.69 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.089 0.471 . . . . 72.43 110.387 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -110.25 155.9 21.41 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 108.845 -0.798 . . . . 73.3 108.845 -176.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 26.6 t90 -59.9 -30.68 69.19 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 123.217 0.323 . . . . 73.41 111.207 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 11.7 p -63.9 -21.51 28.91 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 CA-C-O 121.355 0.597 . . . . 74.23 110.791 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . 0.646 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 17.9 t70 -101.69 -41.74 6.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.715 -0.675 . . . . 75.53 109.703 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -62.79 -46.76 86.48 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 113.189 0.811 . . . . 51.51 113.189 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -54.33 -55.32 38.41 Favored Pre-proline 0 CA--C 1.577 2.016 0 O-C-N 123.215 0.322 . . . . 73.31 110.76 -178.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.37 -28.48 84.23 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.446 2.098 . . . . 65.24 114.24 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.646 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 29.1 mmt180 -58.15 -47.13 84.3 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.818 -0.438 . . . . 72.25 109.818 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 9.9 mp -61.11 -40.41 93.66 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.589 -0.732 . . . . 63.33 110.993 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -64.76 -46.83 80.46 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.931 -0.577 . . . . 75.41 110.206 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -67.63 -34.95 78.0 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.739 -0.664 . . . . 62.3 112.786 -177.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 92.4 mt -81.49 -7.55 59.6 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 112.61 0.596 . . . . 63.21 112.61 -176.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 74.41 40.16 40.75 Favored Glycine 0 CA--C 1.504 -0.627 0 C-N-CA 119.712 -1.232 . . . . 62.41 110.128 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . 0.455 ' CH2' ' HB2' ' A' ' 587' ' ' LEU . 77.0 t90 -72.51 136.09 45.82 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.59 -0.805 . . . . 70.14 111.166 -178.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 34.1 m -146.94 95.28 2.55 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.578 -0.527 . . . . 74.31 109.578 175.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -161.73 -144.98 4.17 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 108.871 -1.692 . . . . 71.2 108.871 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 87.5 mtp -111.34 133.7 53.46 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 118.085 0.943 . . . . 63.23 110.827 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . 0.455 ' HB2' ' CH2' ' A' ' 583' ' ' TRP . 61.6 tp -114.52 129.23 56.65 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.964 -1.124 . . . . 73.41 107.964 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -101.55 100.07 10.45 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 119.16 -1.016 . . . . 62.01 109.007 176.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -114.38 110.56 20.07 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 115.269 -0.878 . . . . 53.45 108.954 175.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . 0.438 ' HA3' ' NH1' ' A' ' 623' ' ' ARG . . . -90.8 -151.08 25.77 Favored Glycine 0 N--CA 1.433 -1.512 0 C-N-CA 120.991 -0.623 . . . . 62.14 113.069 -178.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -100.21 154.49 18.42 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 110.025 -0.361 . . . . 65.34 110.025 -177.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . 0.403 ' HB2' ' HG3' ' A' ' 626' ' ' GLN . 4.5 p30 -73.49 149.82 42.04 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 123.896 0.748 . . . . 74.11 110.634 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 94.8 t -138.45 130.2 37.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 115.476 -0.784 . . . . 62.02 109.763 -177.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -77.68 106.73 9.67 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 107.4 -1.333 . . . . 62.23 107.4 173.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -126.39 -20.16 4.48 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 116.03 -0.532 . . . . 73.33 111.132 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 128.2 157.93 9.52 Favored Glycine 0 C--N 1.302 -1.343 0 N-CA-C 110.412 -1.075 . . . . 42.03 110.412 -177.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.35 -35.67 66.64 Favored Glycine 0 N--CA 1.46 0.279 0 N-CA-C 113.992 0.357 . . . . 71.11 113.992 -173.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 19.9 m -62.61 -24.54 67.63 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.036 0.446 . . . . 70.24 111.701 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -107.05 -11.57 15.62 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 122.057 -0.402 . . . . 71.43 111.809 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 41.6 m170 -77.78 133.64 38.2 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 122.204 -0.31 . . . . 71.15 111.707 -176.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 58.9 t30 70.03 -21.73 0.17 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 125.488 1.515 . . . . 53.3 114.254 174.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 17.7 ttp85 -91.38 149.69 21.61 Favored 'General case' 0 C--N 1.312 -1.059 0 O-C-N 121.976 -0.453 . . . . 74.34 111.184 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . 0.495 HG23 ' HB2' ' A' ' 622' ' ' LEU . 9.0 p -62.71 133.66 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 O-C-N 123.765 0.665 . . . . 70.02 109.911 174.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 90.8 t -90.94 -48.46 14.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 108.317 -0.994 . . . . 72.03 108.317 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 622' ' ' LEU . 49.1 p90 -151.89 152.65 32.84 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 107.124 -1.435 . . . . 71.33 107.124 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -126.48 139.36 53.3 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 109.156 -0.683 . . . . 63.45 109.156 176.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.604 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 25.3 t-20 -54.91 -66.85 0.81 Allowed Pre-proline 0 C--N 1.311 -1.071 0 CA-C-N 115.407 -0.815 . . . . 72.35 112.454 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.604 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 88.2 Cg_endo -93.04 132.99 0.95 Allowed 'Trans proline' 0 N--CA 1.442 -1.55 0 CA-C-N 121.481 1.564 . . . . 73.21 110.6 173.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -70.3 134.76 27.58 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 121.102 1.201 . . . . 73.23 110.834 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . 0.549 ' HB1' ' HA ' ' A' ' 565' ' ' ASP . . . -69.49 129.68 40.38 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.6 -0.889 . . . . 33.11 108.6 176.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.38 -2.89 39.96 Favored Glycine 0 C--N 1.299 -1.513 0 N-CA-C 109.707 -1.357 . . . . 53.45 109.707 -172.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 30.2 m -119.11 167.54 11.7 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 107.832 -1.174 . . . . 71.04 107.832 177.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -71.34 126.17 12.76 Favored Glycine 0 N--CA 1.432 -1.588 0 CA-C-O 120.984 0.214 . . . . 72.05 112.987 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . 0.44 HG12 ' HB2' ' A' ' 608' ' ' PRO . 35.6 m -106.15 143.6 16.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 C-N-CA 124.606 1.162 . . . . 55.1 108.385 177.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.435 ' ND2' ' HB2' ' A' ' 617' ' ' ASP . 32.2 p-10 -67.64 161.07 26.59 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.657 0.265 . . . . 63.24 111.506 -176.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . 0.51 ' HD3' ' H ' ' A' ' 616' ' ' ARG . 0.0 OUTLIER -52.95 -30.71 36.28 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.812 -0.631 . . . . 65.43 111.796 178.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . 0.435 ' HB2' ' ND2' ' A' ' 615' ' ' ASN . 4.8 m-20 -71.34 -37.81 71.68 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 116.394 -0.366 . . . . 74.4 111.064 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 85.05 22.88 51.21 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 118.553 -1.784 . . . . 31.4 111.524 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.96 122.04 17.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 122.637 1.208 . . . . 72.24 109.773 -169.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 5.1 tp -126.4 123.28 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 CA-C-N 114.068 -1.423 . . . . 75.22 111.209 -174.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.557 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 55.0 m -115.0 121.87 44.47 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 107.952 -1.129 . . . . 65.02 107.952 173.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . 0.495 ' HB2' HG23 ' A' ' 603' ' ' VAL . 0.0 OUTLIER -138.41 159.48 41.97 Favored 'General case' 0 CA--C 1.479 -1.781 0 N-CA-C 107.044 -1.465 . . . . 74.44 107.044 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . 0.438 ' NH1' ' HA3' ' A' ' 590' ' ' GLY . 18.2 tpt180 -135.42 149.48 49.63 Favored 'General case' 0 C--N 1.267 -2.999 0 N-CA-C 105.686 -1.968 . . . . 73.55 105.686 178.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -141.08 162.02 36.47 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 106.569 -1.641 . . . . 65.35 106.569 177.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -78.44 -101.57 0.21 Allowed Glycine 0 N--CA 1.427 -1.912 0 N-CA-C 109.832 -1.307 . . . . 74.23 109.832 177.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . 0.403 ' HG3' ' HB2' ' A' ' 592' ' ' ASP . 33.3 tt0 . . . . . 0 C--N 1.282 -2.329 0 N-CA-C 108.664 -0.865 . . . . 63.13 108.664 175.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.265 0 N-CA-C 110.105 -1.198 . . . . 60.14 110.105 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 9.9 tp -75.75 134.34 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 N-CA-C 109.062 -0.718 . . . . 74.13 109.062 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.04 128.85 36.6 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 108.415 -0.957 . . . . 64.13 108.415 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -92.82 -11.49 33.55 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.348 -0.842 . . . . 72.12 109.262 -176.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -112.26 149.12 32.79 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.859 -1.163 . . . . 74.34 107.859 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 35.9 m -117.42 159.25 17.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-O 120.864 0.364 . . . . 63.54 110.145 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.5 122.96 38.79 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.609 -1.626 . . . . 71.43 106.609 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.583 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 60.7 t -96.46 133.17 25.13 Favored Pre-proline 0 C--N 1.294 -1.843 0 CA-C-N 116.2 -0.455 . . . . 52.22 110.627 -170.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 6.9 Cg_exo -68.9 127.63 15.57 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 121.682 1.588 . . . . 73.15 111.3 178.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -82.35 100.48 10.0 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 122.575 1.179 . . . . 74.03 110.039 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 20.0 m -74.32 9.11 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 113.587 -1.642 . . . . 63.53 114.522 -174.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -63.34 144.62 56.8 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 123.025 0.53 . . . . 55.45 111.252 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.52 0.35 43.25 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.959 -0.564 . . . . 40.45 112.395 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -112.16 -160.6 0.72 Allowed 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.538 -1.282 . . . . 61.3 107.538 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 84.0 p -91.58 166.01 13.04 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 106.696 -1.594 . . . . 43.44 106.696 177.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 40.2 t -60.63 -42.33 96.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 118.376 0.534 . . . . 62.44 109.608 177.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.19 -46.56 76.92 Favored 'General case' 0 C--O 1.214 -0.804 0 CA-C-N 115.892 -0.594 . . . . 70.22 111.727 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -65.91 -44.55 84.89 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 120.648 0.261 . . . . 75.41 111.161 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -61.86 -48.64 79.62 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.762 -0.653 . . . . 71.41 111.121 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 66.7 mt -67.21 -40.0 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 116.049 -0.523 . . . . 62.21 110.936 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.19 -39.73 91.27 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-O 120.626 0.251 . . . . 61.43 111.212 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . 0.427 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 90.4 m -63.96 -48.52 76.17 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 116.088 -0.506 . . . . 63.54 109.953 177.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.9 -38.9 92.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.312 -0.404 . . . . 51.42 111.081 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -62.92 -43.8 97.82 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.824 -0.625 . . . . 74.03 111.113 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -67.64 -23.66 65.37 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.488 0.661 . . . . 74.32 111.569 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 376' ' ' THR . 27.9 mmt180 -84.7 -14.16 49.25 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.747 -0.66 . . . . 71.2 111.088 177.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.81 16.3 45.75 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.309 -0.948 . . . . 71.1 112.447 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.46 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 53.8 m-85 -83.99 173.73 10.92 Favored 'General case' 0 N--CA 1.421 -1.875 0 CA-C-O 120.946 0.403 . . . . 62.53 111.537 177.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -116.17 150.46 37.42 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 107.186 -1.413 . . . . 65.03 107.186 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.42 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -126.69 140.35 49.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 CA-C-O 121.094 0.473 . . . . 75.13 110.801 -178.25 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 417' ' ' THR . 39.9 ttt180 -116.06 127.95 55.3 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 105.995 -1.854 . . . . 72.33 105.995 174.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 22.8 m -111.87 131.88 55.07 Favored 'General case' 0 C--N 1.276 -2.623 0 C-N-CA 119.988 -0.685 . . . . 70.13 110.403 -175.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -111.11 119.46 39.06 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 105.264 -2.124 . . . . 71.41 105.264 175.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.716 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -129.73 123.13 30.32 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.774 0.321 . . . . 64.41 111.28 -176.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -138.52 138.04 21.46 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 116.252 -0.431 . . . . 74.2 111.525 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' A' ' 422' ' ' THR . 8.4 Cg_exo -77.84 131.29 11.07 Favored 'Trans proline' 0 C--O 1.259 1.541 0 C-N-CA 122.472 2.115 . . . . 74.33 110.223 169.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.434 ' HB3' HG12 ' A' ' 394' ' ' ILE . 22.8 t70 169.01 136.87 0.02 OUTLIER 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 124.304 1.042 . . . . 65.24 108.328 -177.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 14.3 m -93.64 4.59 53.72 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 113.015 0.746 . . . . 64.22 113.015 -173.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 86.0 m -99.8 -30.15 12.22 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.578 -0.701 . . . . 71.41 110.248 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.434 HG12 ' HB3' ' A' ' 391' ' ' ASP . 16.9 pt -87.6 148.63 44.51 Favored Pre-proline 0 N--CA 1.433 -1.323 0 CA-C-N 116.097 -0.501 . . . . 75.43 110.297 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 396' ' ' PRO . 13.8 Cg_endo -55.2 138.47 79.33 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.057 3.171 . . . . 63.32 115.397 -173.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 395' ' ' PRO . 62.5 Cg_exo -55.62 164.47 4.28 Favored 'Trans proline' 0 C--N 1.361 1.192 0 C-N-CA 124.949 3.766 . . . . 45.54 112.274 175.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -55.58 -7.93 0.32 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 113.176 0.806 . . . . 74.31 113.176 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 34.2 m170 -77.72 111.56 13.64 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 104.914 -2.254 . . . . 74.21 104.914 169.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 33.3 m -77.16 122.74 32.38 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 N-CA-C 113.329 0.863 . . . . 63.23 113.329 -165.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 47.3 pt -89.8 -27.79 5.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 115.861 -0.608 . . . . 74.02 109.942 176.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.05 162.61 28.13 Favored Glycine 0 N--CA 1.419 -2.445 0 C-N-CA 119.714 -1.232 . . . . 61.42 114.035 -175.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 12.9 p -142.09 -176.84 4.96 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 126.767 2.027 . . . . 65.33 105.955 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -98.34 134.54 21.83 Favored Pre-proline 0 C--N 1.299 -1.627 0 C-N-CA 119.339 -0.944 . . . . 72.21 109.981 -175.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -59.92 -0.89 0.98 Allowed 'Trans proline' 0 C--N 1.362 1.284 0 C-N-CA 124.589 3.526 . . . . 71.53 115.205 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.0 -29.56 68.56 Favored 'General case' 0 C--O 1.203 -1.385 0 N-CA-C 108.243 -1.021 . . . . 64.34 108.243 172.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . 0.583 ' HA ' ' HB ' ' A' ' 362' ' ' VAL . . . -62.93 -44.04 97.16 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.236 -0.893 . . . . 60.25 109.761 175.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -80.64 -4.04 52.74 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.234 -0.894 . . . . 73.13 111.555 -175.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 23.1 m -98.74 150.45 21.81 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 105.534 -2.024 . . . . 70.45 105.534 173.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 52.2 p -75.27 111.93 11.04 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 117.695 -1.602 . . . . 73.4 107.091 175.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.5 m -125.54 169.04 17.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 120.846 0.355 . . . . 72.22 111.136 -177.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 13.7 m -64.63 134.58 54.59 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.455 -0.793 . . . . 74.34 109.686 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -64.56 128.66 36.74 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 116.057 -0.519 . . . . 73.32 110.127 -176.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 89.36 47.43 4.06 Favored Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 120.412 -0.899 . . . . 73.11 111.016 -177.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -106.83 161.31 14.8 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.794 -1.187 . . . . 72.04 107.794 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -86.27 108.9 18.6 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 121.398 0.618 . . . . 74.54 110.698 -176.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 41.9 mm -97.24 120.77 47.01 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 N-CA-C 108.217 -1.031 . . . . 63.53 108.217 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 385' ' ' ARG . 22.5 m -79.24 129.26 34.28 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.298 0.57 . . . . 65.24 111.124 -177.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 9.0 p -116.84 135.7 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-N 114.885 -1.052 . . . . 73.11 108.456 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.5 120.95 36.65 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 120.889 0.376 . . . . 60.11 110.718 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.716 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 99.2 t -127.25 131.68 70.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 108.488 -0.931 . . . . 70.55 108.488 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 4.1 m -131.43 143.11 50.2 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.504 -0.878 . . . . 41.14 109.568 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.524 ' O ' ' HA ' ' A' ' 390' ' ' PRO . 63.6 p -98.68 118.06 34.54 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 105.459 -2.052 . . . . 64.45 105.459 172.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -51.04 -87.81 0.01 OUTLIER Glycine 0 C--O 1.252 1.254 0 N-CA-C 116.084 1.194 . . . . 52.25 116.084 -170.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -69.44 131.77 22.4 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.148 1.899 . . . . 54.23 113.366 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -94.51 123.18 37.78 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 107.824 -1.176 . . . . 53.02 107.824 177.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.422 ' HB3' HG22 ' A' ' 477' ' ' THR . 43.4 mt-30 -128.81 142.6 50.93 Favored 'General case' 0 C--N 1.253 -3.623 0 N-CA-C 107.139 -1.43 . . . . 72.24 107.139 174.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.644 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 1.1 mmp_? -122.6 149.49 43.91 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-O 121.495 0.664 . . . . 70.22 112.141 -176.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' A' ' 428' ' ' GLU . 10.4 pt-20 -83.12 138.17 33.78 Favored 'General case' 0 C--N 1.276 -2.615 0 CA-C-N 113.836 -1.529 . . . . 72.44 108.566 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 58.2 mt -98.46 125.91 41.34 Favored Pre-proline 0 C--N 1.286 -2.155 0 N-CA-C 108.007 -1.109 . . . . 62.54 108.007 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -70.35 142.85 46.37 Favored 'Trans proline' 0 C--O 1.24 0.603 0 C-N-CA 122.216 1.944 . . . . 75.32 110.191 174.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -68.13 116.42 8.73 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.854 0.359 . . . . 70.2 110.369 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.05 140.25 27.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 109.216 -0.661 . . . . 73.53 109.216 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.596 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 19.6 m -68.94 158.29 34.96 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-O 120.864 0.364 . . . . 72.5 111.124 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 36.9 p -69.76 -28.87 66.13 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 114.309 1.225 . . . . 64.42 114.309 -171.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.0 pp -88.39 -11.55 45.8 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.655 0.741 . . . . 73.24 111.57 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.596 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 0.2 OUTLIER -92.53 40.87 1.06 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.663 -0.699 . . . . 65.24 110.743 -175.188 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -52.87 -38.28 61.37 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.545 0.738 . . . . 62.22 112.503 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.18 -41.82 97.48 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.979 0.418 . . . . 51.31 110.703 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -70.49 -34.66 72.61 Favored 'General case' 0 C--O 1.207 -1.137 0 CA-C-N 116.195 -0.457 . . . . 72.41 110.185 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.58 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -59.69 -51.7 68.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 119.766 -0.159 . . . . 73.02 111.119 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.6 m -62.01 -38.18 80.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-O 121.305 0.574 . . . . 73.43 110.463 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -60.63 -47.77 84.77 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.341 1.057 . . . . 53.24 110.971 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -65.75 -38.84 90.21 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 123.189 0.596 . . . . 50.3 111.428 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 85.3 mt -64.02 -36.88 85.43 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.167 -0.47 . . . . 51.11 110.176 177.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 33.1 m -70.11 -44.37 69.12 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.016 -0.538 . . . . 62.33 110.164 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.21 -18.31 65.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.854 -0.612 . . . . 71.25 111.246 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -90.04 5.48 46.48 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.129 -0.487 . . . . 72.42 111.824 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 109.71 -83.7 0.34 Allowed Glycine 0 CA--C 1.494 -1.225 0 C-N-CA 120.039 -1.077 . . . . 74.41 112.081 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -36.71 -61.85 0.51 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.734 1.383 . . . . 75.1 114.734 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 60.05 27.71 65.26 Favored Glycine 0 CA--C 1.508 -0.355 0 C-N-CA 120.842 -0.694 . . . . 63.22 111.434 -175.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -102.36 111.17 23.35 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 109.28 -0.637 . . . . 71.24 109.28 -176.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 11.5 p90 -139.64 152.03 46.44 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.653 -0.703 . . . . 75.54 110.298 -177.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -142.65 122.95 13.87 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.906 -1.146 . . . . 72.33 107.906 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -96.36 130.81 43.39 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 120.96 0.409 . . . . 75.53 111.758 -177.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -135.15 150.04 50.09 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 123.498 0.719 . . . . 55.23 109.199 175.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -123.1 149.82 44.0 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 119.915 -0.714 . . . . 73.01 110.491 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 46.1 m -151.18 151.65 29.78 Favored Pre-proline 0 C--N 1.295 -1.798 0 N-CA-C 107.184 -1.413 . . . . 71.31 107.184 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 490' ' ' SER . 19.2 Cg_exo -65.48 144.58 79.94 Favored 'Trans proline' 0 C--O 1.243 0.738 0 C-N-CA 121.747 1.631 . . . . 72.53 112.018 -177.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 14.9 t -152.55 179.37 8.65 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 106.709 -1.589 . . . . 65.23 106.709 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.5 t -56.17 142.94 65.6 Favored Pre-proline 0 C--N 1.305 -1.347 0 C-N-CA 123.947 0.899 . . . . 74.21 110.621 177.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -51.49 -29.73 32.77 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 124.464 3.443 . . . . 75.41 113.121 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.51 -19.39 60.93 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.942 0.401 . . . . 71.14 112.057 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -108.13 -1.93 19.92 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.112 0.412 . . . . 65.54 112.112 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 84.4 t -61.06 127.14 20.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.266 -0.642 . . . . 64.1 109.266 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.68 -13.09 68.26 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 116.065 -0.516 . . . . 32.13 111.812 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.419 ' O ' HG23 ' A' ' 488' ' ' VAL . 11.8 mptt -109.76 159.0 17.55 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.167 0.508 . . . . 74.53 110.12 -178.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 76.8 t -71.85 145.8 11.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 115.071 -0.968 . . . . 73.22 109.711 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 62.1 mt -98.39 -35.44 5.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 107.83 -1.174 . . . . 70.23 107.83 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 164.72 -174.52 40.71 Favored Glycine 0 N--CA 1.43 -1.757 0 CA-C-N 115.468 -0.787 . . . . 72.12 112.176 176.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . 0.61 HG22 HG12 ' A' ' 486' ' ' ILE . 58.8 p -115.2 141.94 47.34 Favored 'General case' 0 N--CA 1.422 -1.825 0 N-CA-C 106.933 -1.506 . . . . 72.05 106.933 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.54 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 2.8 t-20 -64.46 -57.3 17.73 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 119.85 -0.74 . . . . 74.05 111.358 178.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.54 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 17.2 Cg_exo -74.19 138.53 25.31 Favored 'Trans proline' 0 C--N 1.363 1.311 0 N-CA-C 107.026 -1.951 . . . . 61.41 107.026 168.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -63.0 126.14 17.37 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 121.749 1.633 . . . . 72.21 113.669 -173.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -86.16 10.73 13.64 Favored 'General case' 0 C--O 1.205 -1.272 0 CA-C-N 115.275 -0.875 . . . . 61.04 111.047 -177.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -110.65 -0.68 17.1 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.54 -0.755 . . . . 75.02 110.455 176.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -124.46 -168.48 1.81 Allowed 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.024 -0.535 . . . . 74.24 110.548 -173.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.422 HG22 ' HB3' ' A' ' 426' ' ' GLN . 0.2 OUTLIER -89.09 131.46 35.24 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 115.54 -0.755 . . . . 42.35 110.544 -177.206 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 49.5 m -127.98 148.16 50.51 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 122.902 0.481 . . . . 63.04 110.097 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -77.87 158.77 29.3 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.932 -0.576 . . . . 71.42 110.931 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 35.0 mm -73.16 -23.06 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 121.552 0.692 . . . . 73.34 110.57 -175.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 17.0 m -95.94 1.8 53.1 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 122.081 0.943 . . . . 60.14 109.93 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -93.06 130.19 38.76 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.751 -0.659 . . . . 63.4 110.705 -175.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.2 p -100.34 126.41 53.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.25 0.548 . . . . 72.44 111.487 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 32.7 m -95.75 121.68 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-O 121.816 0.817 . . . . 42.11 110.327 178.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.61 129.28 43.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.971 -1.122 . . . . 75.14 107.971 177.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.61 HG12 HG22 ' A' ' 470' ' ' THR . 11.6 mt -113.73 124.61 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 CA-C-N 114.83 -1.077 . . . . 51.31 110.274 -175.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 8.5 tt -104.94 126.19 59.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 115.256 -0.883 . . . . 72.34 109.33 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 466' ' ' LYS . 2.3 p -111.41 145.53 17.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 C-N-CA 124.252 1.021 . . . . 64.21 109.447 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -80.14 124.41 6.48 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.991 -0.623 . . . . 72.23 111.662 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 18.3 t -142.78 132.15 23.5 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.84 -0.8 . . . . 74.4 108.84 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 138.52 107.07 0.75 Allowed Glycine 0 N--CA 1.437 -1.295 0 N-CA-C 109.89 -1.284 . . . . 74.45 109.89 -177.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -71.31 142.76 41.93 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.296 1.997 . . . . 54.41 112.414 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -136.7 21.38 3.1 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 122.154 0.978 . . . . 70.12 110.521 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 27.5 p -130.19 151.69 50.43 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-N 114.334 -1.303 . . . . 74.3 110.61 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 495' ' ' LYS . 18.7 mmtt -147.82 164.33 33.97 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.679 -0.691 . . . . 74.45 110.245 175.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -95.73 136.77 35.72 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.988 -0.551 . . . . 73.35 110.428 -175.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 27.7 pt -92.08 117.78 67.86 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 109.283 -0.636 . . . . 73.15 109.283 175.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.22 -179.39 5.38 Favored 'Trans proline' 0 C--O 1.249 1.058 0 C-N-CA 121.966 1.777 . . . . 54.55 111.934 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -79.07 111.26 15.1 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.471 -0.566 . . . . 74.42 109.471 177.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 9.9 p -113.35 18.97 7.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 122.424 1.107 . . . . 75.43 109.191 -176.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . 0.413 ' HB2' ' HA2' ' A' ' 536' ' ' GLY . . . -83.46 119.16 24.33 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.432 -0.803 . . . . 70.34 110.783 -177.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 120.33 22.12 3.22 Favored Glycine 0 N--CA 1.436 -1.338 0 C-N-CA 121.054 -0.593 . . . . 50.14 112.888 177.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.53 HE22 ' N ' ' A' ' 508' ' ' ALA . 0.0 OUTLIER -137.14 -172.19 3.14 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 122.591 -0.358 . . . . 74.42 110.876 178.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 8.6 m -91.01 154.88 19.11 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 118.483 -1.287 . . . . 64.42 110.303 -173.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 9.5 p -58.34 -41.3 80.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 123.342 0.657 . . . . 70.2 112.415 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -59.73 -39.8 85.93 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.455 0.645 . . . . 71.03 109.877 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 29.3 t -73.52 -36.7 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 CA-C-N 115.314 -0.857 . . . . 64.34 109.955 -177.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . 0.53 ' N ' HE22 ' A' ' 503' ' ' GLN . . . -63.39 -49.78 72.45 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.397 -0.365 . . . . 63.0 111.593 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -63.23 -35.15 79.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.012 0.434 . . . . 75.01 110.554 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.435 ' O ' HG23 ' A' ' 514' ' ' VAL . 5.0 tppp? -61.99 -53.1 60.31 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.249 -0.887 . . . . 51.34 109.893 176.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -61.59 -44.91 96.15 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-N 116.163 -0.471 . . . . 53.22 111.632 -176.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -61.0 -44.07 97.96 Favored 'General case' 0 C--O 1.247 0.924 0 O-C-N 123.236 0.335 . . . . 53.24 111.442 178.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 10.2 m120 -63.84 -38.8 92.42 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 120.317 -0.553 . . . . 63.54 111.109 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 510' ' ' LYS . 73.0 t -61.88 -35.04 65.73 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 CA-C-N 116.052 -0.522 . . . . 75.42 111.087 177.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -74.63 -13.87 60.7 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.573 -0.451 . . . . 73.43 111.017 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 115.24 -2.06 22.38 Favored Glycine 0 N--CA 1.436 -1.335 0 C-N-CA 120.437 -0.887 . . . . 72.14 112.503 178.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.462 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 65.7 m-85 -85.27 109.36 18.3 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.517 -0.919 . . . . 74.14 108.517 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 17.5 p -88.18 -14.7 37.97 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 113.674 0.99 . . . . 75.43 113.674 -173.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -117.64 122.5 43.75 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 120.952 0.406 . . . . 70.43 111.497 -175.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 551' ' ' ILE . 46.3 p90 -129.88 153.47 48.27 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 116.002 -0.545 . . . . 64.24 111.366 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 58.5 m -139.9 152.26 46.26 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.193 -1.41 . . . . 74.02 107.193 174.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.39 135.91 54.37 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-O 121.163 0.506 . . . . 70.14 111.068 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -131.55 130.79 42.73 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.28 -1.007 . . . . 75.23 108.28 176.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 19.8 m -96.03 132.55 41.27 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 110.129 -0.323 . . . . 60.41 110.129 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 34.0 m -121.54 149.57 24.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 108.154 -1.054 . . . . 63.33 108.154 178.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -74.6 135.47 42.04 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 121.029 -0.269 . . . . 74.21 111.432 -173.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . 0.486 ' HB2' ' OG ' ' A' ' 556' ' ' SER . 70.3 m -159.43 174.65 3.81 Favored Pre-proline 0 C--N 1.314 -0.968 0 C-N-CA 123.771 0.828 . . . . 70.22 108.789 178.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -89.44 -3.05 5.93 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.969 1.779 . . . . 70.24 111.147 174.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.503 ' HB2' ' OG ' ' A' ' 556' ' ' SER . 23.8 mmt85 -79.93 133.31 58.43 Favored Pre-proline 0 N--CA 1.444 -0.753 0 N-CA-C 107.741 -1.207 . . . . 72.32 107.741 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -56.14 144.44 80.47 Favored 'Trans proline' 0 C--O 1.254 1.314 0 C-N-CA 123.065 2.51 . . . . 64.52 113.4 -175.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -57.8 113.66 1.95 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.69 -1.141 . . . . 75.03 110.69 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 138.71 -26.79 2.74 Favored Glycine 0 C--N 1.306 -1.126 0 CA-C-N 115.785 -0.643 . . . . 40.2 111.536 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -76.49 127.86 33.65 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.166 -0.679 . . . . 71.33 109.166 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 83.6 t -79.6 117.76 25.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.041 -1.096 . . . . 70.42 108.041 176.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 13.7 t -91.92 -1.86 57.08 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.678 -0.692 . . . . 54.11 110.757 -176.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.413 ' HA2' ' HB2' ' A' ' 501' ' ' ALA . . . 149.95 -166.07 29.84 Favored Glycine 0 CA--C 1.489 -1.557 0 C-N-CA 120.685 -0.769 . . . . 61.43 111.874 177.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 13.3 p -119.0 158.7 25.25 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 109.391 -0.596 . . . . 74.54 109.391 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.503 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 27.3 t-20 -65.89 -52.36 41.79 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-O 119.083 -0.484 . . . . 52.15 111.097 177.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 4.8 Cg_exo -78.96 142.6 17.52 Favored 'Trans proline' 0 C--N 1.368 1.591 0 N-CA-C 108.2 -1.5 . . . . 70.42 108.2 171.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 31.5 Cg_exo -59.79 144.65 99.41 Favored 'Trans proline' 0 C--O 1.253 1.229 0 C-N-CA 122.297 1.998 . . . . 71.42 113.107 -177.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -64.33 137.37 57.87 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 115.896 -0.593 . . . . 73.34 109.819 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 102.44 -12.44 56.86 Favored Glycine 0 C--N 1.298 -1.578 0 C-N-CA 121.018 -0.61 . . . . 71.43 111.919 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 23.9 m -75.33 130.97 39.93 Favored 'General case' 0 C--O 1.245 0.843 0 N-CA-C 109.752 -0.462 . . . . 51.44 109.752 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 14.6 m -84.4 122.9 29.6 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 107.291 -1.374 . . . . 74.04 107.291 176.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.5 m -131.51 157.32 78.49 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.907 -0.405 . . . . 73.34 109.907 -177.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -64.86 140.47 67.01 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.4 2.066 . . . . 74.43 111.607 176.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.462 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 27.0 m -63.98 -20.14 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-O 121.761 0.791 . . . . 42.53 111.834 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -87.06 -11.2 50.99 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.058 -0.973 . . . . 41.25 111.873 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 80.5 p -82.09 175.98 9.89 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 120.017 -0.673 . . . . 71.13 112.343 -176.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 27.0 t -101.72 119.17 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 116.012 -0.54 . . . . 75.35 110.737 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 520' ' ' PHE . 1.8 mp -101.17 124.6 54.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 108.842 -0.799 . . . . 74.42 108.842 177.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 521' ' ' SER . 35.0 tt0 -102.86 128.84 49.47 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-O 121.211 0.529 . . . . 73.35 110.236 -178.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -93.37 133.98 36.07 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.329 -0.989 . . . . 74.13 108.329 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . 0.507 ' HA ' HE21 ' A' ' 554' ' ' GLN . 0.0 OUTLIER -95.85 114.25 25.96 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.944 -1.502 . . . . 65.44 106.944 176.037 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 524' ' ' SER . 40.5 t -99.79 141.3 17.21 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 108.391 -0.966 . . . . 72.1 108.391 -177.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.638 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 36.0 t -78.84 129.71 34.88 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 121.214 0.53 . . . . 72.33 111.27 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 12.2 ttpp -93.65 121.51 35.15 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 106.747 -1.575 . . . . 74.43 106.747 169.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -81.39 -24.24 57.12 Favored Glycine 0 CA--C 1.494 -1.269 0 C-N-CA 120.48 -0.867 . . . . 52.14 112.099 -177.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 4.8 p30 58.62 6.96 0.66 Allowed 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 127.257 2.223 . . . . 71.52 114.26 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -134.21 170.91 14.99 Favored 'General case' 0 C--O 1.253 1.244 0 CA-C-O 121.688 0.756 . . . . 73.21 112.286 -173.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -145.99 148.33 32.62 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.88 -1.526 . . . . 73.15 106.88 173.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 9.4 p -71.18 127.75 33.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-O 121.176 0.512 . . . . 71.3 110.229 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 58.7 ttp -96.26 115.29 65.52 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 109.272 -0.64 . . . . 75.31 109.272 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.98 154.9 72.1 Favored 'Trans proline' 0 C--O 1.242 0.684 0 C-N-CA 122.08 1.853 . . . . 44.05 110.367 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . 0.489 ' HA ' ' HB1' ' A' ' 610' ' ' ALA . 4.2 p-10 -76.03 118.1 18.44 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 121.822 0.82 . . . . 74.21 111.236 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 96.2 mt -137.52 34.09 2.49 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.009 -1.45 . . . . 65.24 107.184 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 14.8 m -71.25 132.72 45.35 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.008 -0.996 . . . . 64.24 111.342 -175.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 99.86 38.8 3.53 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 121.114 -0.565 . . . . 65.53 113.312 174.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 83.6 mtp -109.69 155.26 21.75 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.435 -0.58 . . . . 73.42 109.435 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 66.2 m-85 -74.96 149.73 39.27 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 107.286 -1.375 . . . . 72.31 107.286 175.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . 0.505 ' O ' ' HG3' ' A' ' 575' ' ' GLU . 41.0 t90 -60.47 -29.81 69.28 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 123.274 0.359 . . . . 64.42 110.855 -177.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 33.2 m -80.16 -10.42 12.49 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.612 0 CA-C-O 121.568 0.699 . . . . 65.02 110.894 -176.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -101.78 -31.84 10.56 Favored 'General case' 0 C--O 1.266 1.927 0 CA-C-O 122.885 1.326 . . . . 63.42 107.88 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . 0.45 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -68.77 -36.72 78.68 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 113.885 -1.507 . . . . 73.3 110.392 176.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.588 ' HB2' ' HD3' ' A' ' 576' ' ' PRO . 43.4 mt-10 -51.75 -57.79 13.42 Favored Pre-proline 0 CA--C 1.559 1.3 0 CA-C-O 118.87 -0.586 . . . . 73.51 111.66 177.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . 0.588 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 64.3 Cg_exo -56.63 -39.5 90.93 Favored 'Trans proline' 0 C--N 1.387 2.598 0 C-N-CA 121.768 1.645 . . . . 74.12 112.542 175.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -59.03 -43.59 91.64 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 119.782 -0.767 . . . . 74.54 112.269 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 96.2 mt -65.97 -47.22 75.33 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.521 0.677 . . . . 73.44 110.307 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -65.03 -34.98 79.72 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.412 -0.813 . . . . 75.51 111.643 -177.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.65 -33.38 70.91 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.367 0.506 . . . . 44.11 112.367 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 4.0 pp -88.4 -3.61 58.8 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.474 0.916 . . . . 72.43 113.474 -176.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 86.12 37.77 8.93 Favored Glycine 0 C--N 1.314 -0.648 0 C-N-CA 120.183 -1.008 . . . . 73.44 112.001 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 82.3 t90 -71.87 127.94 34.17 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 123.19 0.596 . . . . 74.01 110.808 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 23.0 m -138.3 67.9 1.4 Allowed 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 122.183 0.992 . . . . 70.12 109.404 174.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -124.44 -149.88 7.75 Favored Glycine 0 N--CA 1.436 -1.313 0 N-CA-C 110.07 -1.212 . . . . 73.33 110.07 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . 0.485 ' O ' HG12 ' A' ' 619' ' ' ILE . 8.6 mmt -122.79 139.03 54.44 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.6 -0.519 . . . . 72.21 109.6 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -101.16 127.55 47.67 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 106.524 -1.658 . . . . 75.24 106.524 174.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -97.25 99.85 11.31 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 120.19 -0.604 . . . . 72.01 110.822 -175.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -114.42 109.19 17.92 Favored 'General case' 0 N--CA 1.409 -2.51 0 N-CA-C 108.154 -1.054 . . . . 72.53 108.154 170.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -143.97 -62.36 0.02 OUTLIER Glycine 0 CA--C 1.477 -2.319 0 N-CA-C 108.849 -1.7 . . . . 40.25 108.849 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . 0.429 ' O ' ' HD2' ' A' ' 623' ' ' ARG . . . -89.86 136.54 32.98 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.541 -0.911 . . . . 62.15 108.541 173.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -116.72 157.08 26.05 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.608 -0.516 . . . . 75.44 109.608 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . 0.422 ' O ' ' HA2' ' A' ' 625' ' ' GLY . 38.5 t -107.15 132.01 55.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 120.336 -0.546 . . . . 71.44 110.232 -177.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . 0.603 ' HA ' ' OE1' ' A' ' 626' ' ' GLN . 5.8 p-10 -73.76 112.4 9.83 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.102 0.477 . . . . 73.54 112.255 -178.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -176.6 19.97 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 114.56 -1.2 . . . . 61.24 110.647 175.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 83.74 127.6 1.39 Allowed Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 110.326 -1.11 . . . . 61.33 110.326 -174.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.559 ' O ' ' HB2' ' A' ' 601' ' ' ASN . . . -62.12 -49.55 73.84 Favored Glycine 0 C--O 1.2 -2.0 0 C-N-CA 120.478 -0.868 . . . . 74.3 112.478 -176.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 47.0 m -71.56 -24.13 61.87 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.315 0.578 . . . . 53.15 111.689 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -89.64 -7.69 54.14 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.925 -0.58 . . . . 74.04 112.169 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -145.45 28.61 1.18 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.836 0.827 . . . . 74.54 109.547 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 597' ' ' GLY . 8.5 t30 -86.55 62.94 7.71 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 122.425 1.107 . . . . 64.41 108.575 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 37.1 ptt85 -143.0 171.84 13.51 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 107.453 -1.314 . . . . 73.54 107.453 -176.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 11.7 p -62.84 129.87 26.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 107.388 -1.338 . . . . 70.23 107.388 174.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 87.2 t -95.98 -36.4 6.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 119.833 -0.747 . . . . 53.33 109.09 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -154.79 158.96 40.26 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 105.892 -1.892 . . . . 71.01 105.892 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -128.86 124.93 36.54 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.047 -0.723 . . . . 73.03 109.047 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.498 ' HB2' ' HB ' ' A' ' 621' ' ' THR . 21.9 t-20 -59.36 -50.66 86.26 Favored Pre-proline 0 CA--C 1.559 1.327 0 CA-C-N 115.792 -0.64 . . . . 74.22 112.453 -177.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.494 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 4.3 Cg_exo -90.09 124.89 1.21 Allowed 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 121.908 1.739 . . . . 51.12 110.764 173.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.79 139.09 66.95 Favored 'Trans proline' 0 C--O 1.252 1.189 0 C-N-CA 122.414 2.076 . . . . 64.31 111.909 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . 0.489 ' HB1' ' HA ' ' A' ' 565' ' ' ASP . . . -64.09 138.44 58.46 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.594 -0.73 . . . . 54.42 110.363 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 99.69 -5.86 58.59 Favored Glycine 0 N--CA 1.435 -1.425 0 N-CA-C 111.441 -0.664 . . . . 72.54 111.441 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 12.1 m -99.96 160.22 14.48 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 108.772 -0.825 . . . . 62.02 108.772 -178.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -75.08 125.3 8.15 Favored Glycine 0 N--CA 1.423 -2.199 0 N-CA-C 109.883 -1.287 . . . . 41.23 109.883 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 34.7 m -112.22 142.62 24.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 108.612 -0.884 . . . . 73.3 108.612 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.42 HD21 ' CG2' ' A' ' 619' ' ' ILE . 30.5 p30 -43.68 152.79 0.14 Allowed 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.745 1.017 . . . . 73.3 113.745 177.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -56.8 -25.72 56.35 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.345 1.058 . . . . 71.45 112.604 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -63.84 -42.9 97.5 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 108.401 -0.963 . . . . 71.0 108.401 176.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . 0.411 ' O ' HG12 ' A' ' 620' ' ' ILE . . . 81.97 19.25 65.64 Favored Glycine 0 N--CA 1.42 -2.386 0 N-CA-C 109.324 -1.51 . . . . 62.1 109.324 -177.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 586' ' ' MET . 0.0 OUTLIER -70.71 117.76 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-O 122.274 1.035 . . . . 72.21 108.594 -175.407 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 618' ' ' GLY . 47.7 mm -115.32 130.31 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.195 0 N-CA-C 105.941 -1.874 . . . . 74.53 105.941 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.498 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 27.7 m -96.87 114.64 26.29 Favored 'General case' 0 N--CA 1.401 -2.918 0 C-N-CA 117.175 -1.81 . . . . 75.55 106.977 175.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 4.4 pp -140.9 150.3 43.01 Favored 'General case' 0 N--CA 1.406 -2.627 0 N-CA-C 105.753 -1.943 . . . . 73.43 105.753 176.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . 0.429 ' HD2' ' O ' ' A' ' 591' ' ' ALA . 28.5 mtm180 -133.81 156.71 47.53 Favored 'General case' 0 C--N 1.269 -2.893 0 N-CA-C 108.502 -0.925 . . . . 55.11 108.502 175.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -133.18 166.87 21.44 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 124.444 1.09 . . . . 74.22 111.405 -173.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 593' ' ' VAL . . . -66.18 139.41 37.97 Favored Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 115.214 0.846 . . . . 53.25 115.214 -176.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . 0.603 ' OE1' ' HA ' ' A' ' 594' ' ' ASP . 1.3 mp0 . . . . . 0 N--CA 1.473 0.689 0 N-CA-C 116.118 1.896 . . . . 72.5 116.118 176.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.076 0 N-CA-C 111.267 -0.733 . . . . 43.05 111.267 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 11.3 tp -85.14 146.6 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 N-CA-C 108.534 -0.913 . . . . 73.42 108.534 177.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 4.6 m -88.71 155.81 19.37 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 106.716 -1.587 . . . . 60.51 106.716 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -72.14 -24.56 61.48 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 120.045 -0.662 . . . . 75.04 110.035 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -83.24 126.76 33.0 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 106.972 -1.492 . . . . 64.32 106.972 170.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 409' ' ' SER . 24.0 m -121.54 163.56 19.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.354 0 N-CA-C 109.654 -0.499 . . . . 63.34 109.654 -177.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.37 129.81 39.37 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.365 -1.346 . . . . 72.02 107.365 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 55.6 t -97.16 129.85 31.18 Favored Pre-proline 0 C--N 1.282 -2.366 0 CA-C-N 115.427 -0.806 . . . . 65.41 109.494 -171.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -68.86 128.59 17.1 Favored 'Trans proline' 0 C--O 1.241 0.629 0 C-N-CA 122.124 1.883 . . . . 73.42 111.925 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -89.21 144.67 25.94 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-O 121.633 0.73 . . . . 73.13 109.291 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.418 ' HB ' HE21 ' A' ' 368' ' ' GLN . 2.8 m -126.05 21.69 3.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 CA-C-N 114.817 -1.083 . . . . 60.33 112.036 -174.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.414 ' HB3' HG23 ' A' ' 402' ' ' THR . 18.6 ptt180 -56.01 144.37 28.98 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.021 -0.99 . . . . 73.14 112.529 175.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.5 -0.08 46.46 Favored Glycine 0 C--N 1.311 -0.843 0 CA-C-N 115.71 -0.677 . . . . 34.42 112.486 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . 0.418 HE21 ' HB ' ' A' ' 365' ' ' VAL . 39.4 mt-30 -111.34 -150.77 0.47 Allowed 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.11 -1.07 . . . . 73.11 108.11 176.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 80.0 p -97.77 161.53 13.71 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.36 -1.348 . . . . 74.14 107.36 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 42.3 m -63.32 -37.6 87.87 Favored 'General case' 0 C--O 1.21 -1.022 0 C-N-CA 120.838 -0.345 . . . . 74.11 110.305 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.06 -46.14 85.69 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 111.831 0.308 . . . . 73.14 111.831 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -68.92 -41.66 77.85 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 121.618 0.723 . . . . 74.31 109.24 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.81 -50.88 69.25 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.983 -1.008 . . . . 72.05 111.197 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.404 HG23 HD13 ' A' ' 384' ' ' ILE . 78.7 mt -64.74 -40.11 87.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.904 -0.589 . . . . 71.44 110.68 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.79 -38.07 77.73 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.139 0.495 . . . . 73.13 111.054 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 27.3 m -65.64 -47.09 76.77 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.074 -0.512 . . . . 73.41 110.334 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.85 -37.57 87.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.294 -0.412 . . . . 74.32 111.873 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . 0.465 HE21 ' HA ' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -62.59 -37.91 88.09 Favored 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 122.296 0.239 . . . . 74.05 110.367 176.476 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -68.45 -21.22 64.65 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 121.19 0.519 . . . . 65.12 111.171 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -86.96 -14.13 42.63 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.982 -0.554 . . . . 71.13 110.224 174.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 95.63 9.48 57.56 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.567 -0.825 . . . . 64.21 112.474 176.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -82.55 155.48 24.48 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-O 121.13 0.49 . . . . 74.13 111.655 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -100.77 132.52 46.13 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 106.65 -1.611 . . . . 73.42 106.65 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.414 ' N ' HD12 ' A' ' 384' ' ' ILE . 1.8 mp -119.11 146.38 23.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 107.665 -1.235 . . . . 70.2 107.665 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 46.2 ttt180 -111.75 127.96 55.95 Favored 'General case' 0 C--N 1.259 -3.361 0 N-CA-C 106.542 -1.651 . . . . 75.04 106.542 177.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 27.4 m -113.72 117.87 32.74 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 106.998 -1.482 . . . . 60.52 106.998 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . 0.438 HD12 ' HG2' ' A' ' 389' ' ' LYS . 0.8 OUTLIER -112.17 119.99 40.27 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.406 -0.961 . . . . 73.21 108.406 -177.467 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -94.1 122.51 36.69 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.219 -0.66 . . . . 74.2 109.219 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . 0.48 ' HE2' ' HA ' ' A' ' 389' ' ' LYS . 4.5 mmpt? -125.51 119.44 24.65 Favored Pre-proline 0 C--N 1.3 -1.55 0 C-N-CA 121.141 -0.223 . . . . 72.14 111.058 176.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.618 ' HA ' ' O ' ' A' ' 422' ' ' THR . 38.0 Cg_exo -69.23 128.32 16.34 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.93 1.753 . . . . 71.3 108.993 171.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.586 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 7.0 t70 143.04 -171.42 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 104.923 -2.251 . . . . 75.04 104.923 -175.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 23.3 t -131.31 2.91 4.25 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.338 -0.616 . . . . 64.32 109.338 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 14.7 t -77.47 -5.6 50.48 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 122.918 0.487 . . . . 73.52 112.004 -178.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.512 HD13 ' H ' ' A' ' 394' ' ' ILE . 0.2 OUTLIER -114.8 151.96 45.93 Favored Pre-proline 0 C--N 1.303 -1.427 0 CA-C-O 118.998 -0.525 . . . . 74.34 109.69 -177.223 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -44.05 138.49 6.54 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 124.025 3.15 . . . . 74.14 114.105 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.5 161.71 16.73 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.417 2.745 . . . . 75.25 112.788 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . 0.422 ' HA ' HG13 ' A' ' 420' ' ' VAL . 6.0 p-10 -57.15 -8.3 0.67 Allowed 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 113.434 0.901 . . . . 71.52 113.434 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -111.56 130.2 55.82 Favored 'General case' 0 CA--C 1.478 -1.821 0 N-CA-C 106.581 -1.637 . . . . 55.11 106.581 171.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 20.1 m -66.37 119.32 11.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 O-C-N 123.787 0.679 . . . . 70.24 111.293 -169.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 8.7 tp -94.51 -29.33 4.16 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 108.508 -0.923 . . . . 71.33 108.508 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.84 170.6 27.77 Favored Glycine 0 N--CA 1.411 -3.025 0 N-CA-C 110.312 -1.115 . . . . 71.21 110.312 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.414 HG23 ' HB3' ' A' ' 366' ' ' ARG . 3.3 p -121.64 -179.28 4.05 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 107.712 -1.218 . . . . 75.14 107.712 176.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -101.4 134.58 20.19 Favored Pre-proline 0 C--N 1.293 -1.87 0 N-CA-C 107.703 -1.221 . . . . 70.1 107.703 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -51.59 -13.36 1.43 Allowed 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 124.33 3.353 . . . . 62.54 115.493 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.49 -39.4 70.39 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-O 120.703 0.287 . . . . 71.24 110.285 176.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -71.17 -33.54 70.11 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.859 0.838 . . . . 74.12 110.227 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -86.15 3.97 40.45 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.927 -1.033 . . . . 60.24 111.162 -177.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 27.1 m -109.7 154.36 22.99 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 105.514 -2.032 . . . . 74.41 105.514 171.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 360' ' ' VAL . 50.5 m -74.88 112.42 11.08 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 119.737 -0.785 . . . . 60.11 109.433 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 21.7 m -124.81 164.88 22.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 116.332 -0.394 . . . . 64.22 109.972 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 15.4 m -72.41 146.25 47.1 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.958 -0.386 . . . . 75.14 109.958 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -65.58 131.82 47.32 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.997 -0.371 . . . . 74.01 109.997 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 89.57 38.89 6.44 Favored Glycine 0 C--N 1.311 -0.836 0 C-N-CA 120.752 -0.737 . . . . 33.22 111.955 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -100.51 -175.99 3.07 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.328 -1.36 . . . . 73.13 107.328 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -108.83 123.25 48.76 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.137 0.494 . . . . 72.11 110.741 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 48.4 mm -112.18 137.4 45.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 106.538 -1.652 . . . . 73.33 106.538 175.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.4 t -116.76 132.0 56.81 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.842 -0.536 . . . . 65.43 110.892 -174.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 9.9 p -116.28 134.6 59.17 Favored 'Isoleucine or valine' 0 C--O 1.253 1.249 0 N-CA-C 109.567 -0.531 . . . . 73.24 109.567 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -102.42 116.07 31.86 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.997 -0.742 . . . . 64.2 108.997 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.422 HG13 ' HA ' ' A' ' 397' ' ' ASP . 77.0 t -104.93 130.88 55.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 116.116 -0.493 . . . . 71.32 110.775 -176.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 30.6 t -85.92 123.85 31.72 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 115.593 -0.731 . . . . 74.41 110.241 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.618 ' O ' ' HA ' ' A' ' 390' ' ' PRO . 12.2 p -116.39 138.92 50.96 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 106.216 -1.772 . . . . 75.14 106.216 171.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -55.22 -92.98 0.01 OUTLIER Glycine 0 CA--C 1.538 1.484 0 N-CA-C 116.598 1.399 . . . . 64.24 116.598 -172.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . 0.406 ' O ' ' HB3' ' A' ' 390' ' ' PRO . 57.1 Cg_endo -65.43 130.34 24.96 Favored 'Trans proline' 0 C--O 1.248 0.988 0 C-N-CA 123.296 2.664 . . . . 65.1 115.106 -171.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.554 ' HA ' ' CB ' ' A' ' 390' ' ' PRO . 35.3 mt-10 -72.77 158.15 36.13 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 113.597 -1.638 . . . . 73.14 111.882 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -92.71 133.87 35.59 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 106.308 -1.738 . . . . 74.21 106.308 177.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.428 ' HA ' ' HE ' ' A' ' 427' ' ' ARG . 1.2 mmp_? -120.79 165.32 15.3 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 109.469 -0.567 . . . . 44.13 109.469 -178.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -115.25 142.1 47.13 Favored 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 108.229 -1.026 . . . . 54.34 108.229 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.526 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 74.0 mt -77.17 121.02 83.95 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 108.95 -0.759 . . . . 41.41 108.95 -175.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 429' ' ' ILE . 20.8 Cg_exo -68.16 160.25 49.61 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 123.499 2.799 . . . . 64.12 114.411 -177.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -77.79 155.42 31.14 Favored 'General case' 0 C--O 1.249 1.077 0 CA-C-N 115.522 -0.763 . . . . 51.33 109.765 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 13.6 p -164.43 144.41 2.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 116.267 -0.424 . . . . 74.12 110.255 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 24.3 t -77.03 150.62 35.78 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 108.651 -0.87 . . . . 63.34 108.651 178.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . 0.516 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 25.1 p -67.09 -23.41 65.84 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 121.578 0.704 . . . . 73.21 111.807 -176.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 2.5 pp -86.69 -11.26 51.75 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 113.046 0.758 . . . . 73.11 113.046 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -113.9 69.53 0.71 Allowed 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 114.049 1.129 . . . . 73.23 114.049 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . 0.403 ' O ' HG23 ' A' ' 441' ' ' VAL . 64.9 t80 -61.91 -37.55 85.05 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.211 -0.45 . . . . 75.02 110.261 175.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -58.83 -37.22 75.95 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 120.707 0.289 . . . . 73.54 111.025 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -66.68 -36.78 83.35 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.712 -0.847 . . . . 72.2 108.712 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.416 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -63.55 -43.61 96.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.873 -0.603 . . . . 35.42 109.672 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 437' ' ' TYR . 86.6 t -58.73 -50.43 79.27 Favored 'Isoleucine or valine' 0 C--O 1.244 0.773 0 CA-C-N 115.532 -0.758 . . . . 63.34 110.764 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . 0.342 0.0 OUTLIER -68.63 -34.08 75.12 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 113.945 1.091 . . . . 52.33 113.945 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -62.91 -47.5 83.02 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.778 0.323 . . . . 71.52 110.898 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.416 HD13 ' O ' ' A' ' 440' ' ' ALA . 9.1 mp -65.5 -32.84 74.66 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.156 -0.475 . . . . 70.15 111.846 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.403 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 70.8 m -69.25 -46.77 66.5 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.913 0.387 . . . . 54.13 110.505 179.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.14 -15.49 62.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.146 0.498 . . . . 51.54 111.244 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.63 -1.4 37.92 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 116.007 -0.542 . . . . 43.31 111.2 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 114.58 -83.95 0.35 Allowed Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.807 -0.711 . . . . 45.15 111.584 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -40.68 -62.43 0.79 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 114.596 1.332 . . . . 75.25 114.596 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . 0.403 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 67.61 29.46 73.96 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.941 -0.647 . . . . 45.12 112.356 -177.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 31.7 mmm180 -105.54 111.44 24.15 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-O 121.507 0.67 . . . . 75.03 109.263 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -130.99 159.97 35.92 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 108.254 -1.017 . . . . 73.5 108.254 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -152.16 135.94 16.28 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 108.128 -1.064 . . . . 73.33 108.128 177.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -103.22 128.06 50.34 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.1 0.476 . . . . 65.51 109.964 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.37 149.08 42.9 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 107.364 -1.347 . . . . 70.34 107.364 174.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -125.53 138.8 53.98 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.142 0.496 . . . . 64.34 109.942 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . 0.498 ' HB2' HD11 ' A' ' 487' ' ' ILE . 48.5 t -128.37 142.38 44.5 Favored Pre-proline 0 C--N 1.291 -1.943 0 N-CA-C 108.019 -1.104 . . . . 74.41 108.019 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.656 ' HA ' ' O ' ' A' ' 490' ' ' SER . 58.1 Cg_endo -76.27 122.56 6.67 Favored 'Trans proline' 0 N--CA 1.428 -2.361 0 C-N-CA 121.204 1.27 . . . . 74.33 109.691 176.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 48.8 m -144.69 179.21 7.44 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 108.887 -0.783 . . . . 55.03 108.887 -177.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 9.7 t -49.93 134.34 21.51 Favored Pre-proline 0 C--O 1.255 1.386 0 O-C-N 123.982 0.802 . . . . 71.34 111.902 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . 0.462 ' HA ' ' CG2' ' A' ' 464' ' ' VAL . 6.2 Cg_endo -50.93 -29.93 28.8 Favored 'Trans proline' 0 C--N 1.361 1.193 0 C-N-CA 124.187 3.258 . . . . 71.44 113.935 -175.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -66.44 -21.38 66.2 Favored 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 113.217 0.821 . . . . 42.04 113.217 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -100.24 -7.23 24.89 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 122.005 -0.435 . . . . 72.05 111.566 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.462 ' CG2' ' HA ' ' A' ' 461' ' ' PRO . 82.4 t -60.84 131.37 25.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 116.165 -0.471 . . . . 72.12 111.757 -178.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 96.26 -10.64 67.47 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.779 -0.646 . . . . 63.45 112.145 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -118.73 166.16 13.11 Favored 'General case' 0 N--CA 1.416 -2.149 0 N-CA-C 109.075 -0.713 . . . . 71.22 109.075 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.516 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 68.9 t -77.8 145.31 10.11 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 108.635 -0.876 . . . . 72.24 108.635 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 51.5 mt -97.74 -25.77 4.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 107.202 -1.407 . . . . 53.2 107.202 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 154.42 -167.73 32.51 Favored Glycine 0 N--CA 1.419 -2.444 0 CA-C-N 114.868 -1.06 . . . . 75.34 111.304 175.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.22 137.17 52.32 Favored 'General case' 0 N--CA 1.405 -2.688 0 N-CA-C 105.482 -2.044 . . . . 42.13 105.482 176.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -66.14 -53.31 33.52 Favored Pre-proline 0 C--N 1.323 -0.584 0 C-N-CA 119.388 -0.925 . . . . 72.33 110.772 -177.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -68.98 124.72 11.7 Favored 'Trans proline' 0 C--N 1.364 1.394 0 N-CA-C 107.24 -1.869 . . . . 62.52 107.24 167.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.481 ' C ' ' H ' ' A' ' 475' ' ' ASN . 19.8 Cg_exo -62.34 145.47 95.89 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.928 1.752 . . . . 75.24 113.271 -174.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.526 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -69.05 11.31 0.21 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.237 1.015 . . . . 72.43 111.28 175.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . 0.481 ' H ' ' C ' ' A' ' 473' ' ' PRO . 12.9 m120 -108.62 -10.87 15.17 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 124.204 1.002 . . . . 63.34 108.623 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -98.49 171.12 8.36 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 121.485 0.659 . . . . 73.34 111.36 -176.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.02 129.71 51.65 Favored 'General case' 0 N--CA 1.402 -2.846 0 CA-C-N 114.664 -1.153 . . . . 72.02 111.721 -176.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 6.2 p -108.27 148.17 30.39 Favored 'General case' 0 N--CA 1.418 -2.059 0 C-N-CA 123.903 0.881 . . . . 54.34 110.038 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.434 ' H ' ' HB2' ' A' ' 482' ' ' ASN . . . -89.28 175.25 7.42 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 116.369 -0.378 . . . . 72.4 110.148 176.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 32.9 mm -81.15 -6.67 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-O 122.197 0.999 . . . . 54.43 109.871 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 40.1 m -112.76 5.04 17.39 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 122.238 1.018 . . . . 54.21 109.061 175.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . 0.434 ' HB2' ' H ' ' A' ' 479' ' ' ALA . 23.3 t-20 -80.69 134.49 35.86 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.597 -0.729 . . . . 63.33 111.514 -173.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.92 126.03 53.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 116.039 -0.528 . . . . 75.15 110.362 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 65.2 t -100.66 120.61 50.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 121.014 0.435 . . . . 73.41 110.093 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.62 118.96 44.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-O 121.828 0.823 . . . . 62.22 110.022 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 42.7 mt -111.3 128.64 67.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 114.534 -1.212 . . . . 74.3 109.976 -178.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.498 HD11 ' HB2' ' A' ' 457' ' ' SER . 17.3 tt -110.84 127.08 68.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.839 -0.619 . . . . 74.25 111.96 -173.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.499 HG12 HG22 ' A' ' 467' ' ' VAL . 35.5 m -108.32 152.35 10.21 Favored 'Isoleucine or valine' 0 C--O 1.248 1.023 0 C-N-CA 123.806 0.842 . . . . 75.31 111.156 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -88.1 133.5 11.85 Favored Glycine 0 N--CA 1.434 -1.44 0 CA-C-N 115.831 -0.622 . . . . 14.52 112.223 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.656 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 44.4 m -132.98 160.66 36.48 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.344 -1.354 . . . . 54.43 107.344 177.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 151.11 149.58 5.09 Favored Glycine 0 C--N 1.296 -1.684 0 C-N-CA 120.262 -0.97 . . . . 62.24 110.711 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -91.94 162.55 3.3 Favored 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 122.478 2.119 . . . . 71.32 113.735 -177.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -104.02 41.5 1.29 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.447 -1.316 . . . . 41.34 107.447 176.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 546' ' ' PRO . 72.7 p -117.24 153.77 32.33 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 114.34 -1.3 . . . . 64.14 108.945 -176.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . 0.504 ' HD3' ' H ' ' A' ' 496' ' ' ASP . 6.0 tmtt? -150.16 151.65 33.44 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 107.47 -1.307 . . . . 63.15 107.47 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.504 ' H ' ' HD3' ' A' ' 495' ' ' LYS . 9.8 p-10 -79.83 138.08 37.12 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 123.587 0.755 . . . . 62.43 109.489 177.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 36.4 pt -86.39 137.41 34.56 Favored Pre-proline 0 C--N 1.303 -1.418 0 CA-C-N 116.182 -0.463 . . . . 70.45 110.792 178.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -89.15 179.9 2.23 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.656 2.237 . . . . 75.51 112.339 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -84.38 142.05 30.43 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.832 -1.173 . . . . 73.14 107.832 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.416 ' HA ' HE21 ' A' ' 503' ' ' GLN . 10.6 p -139.32 19.23 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 CA-C-O 122.179 0.99 . . . . 61.15 110.052 -178.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -72.41 114.52 10.62 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.199 -0.91 . . . . 43.14 110.893 -177.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 115.3 -8.12 20.67 Favored Glycine 0 CA--C 1.482 -1.973 0 N-CA-C 111.311 -0.716 . . . . 65.2 111.311 176.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.416 HE21 ' HA ' ' A' ' 500' ' ' VAL . 45.8 mt-30 -100.47 165.75 11.28 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 108.199 -1.037 . . . . 65.04 108.199 177.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 5.6 t -91.73 164.73 13.61 Favored 'General case' 0 C--N 1.285 -2.239 0 C-N-CA 120.217 -0.593 . . . . 65.1 109.889 -175.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 48.4 t -54.27 -41.26 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.606 0.762 . . . . 61.04 110.976 -177.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -57.68 -42.6 83.94 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 115.506 -0.77 . . . . 74.54 111.12 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 63.8 t -75.35 -42.54 43.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 116.028 -0.533 . . . . 73.14 109.738 -178.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -61.26 -49.69 76.05 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.71 -0.677 . . . . 62.44 111.853 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 513' ' ' ASN . 10.2 tt0 -65.35 -37.03 85.82 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.374 0.607 . . . . 63.31 110.04 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.491 ' O ' HG23 ' A' ' 514' ' ' VAL . 37.6 ttmt -65.93 -48.79 70.2 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.82 -1.082 . . . . 70.34 111.696 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -62.03 -48.58 79.66 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 121.149 0.5 . . . . 73.24 110.924 -177.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 517' ' ' PHE . 4.2 mm? -64.9 -36.54 84.7 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.578 -0.737 . . . . 74.15 110.885 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 509' ' ' GLN . 0.6 OUTLIER -60.92 -39.86 90.97 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 122.564 0.346 . . . . 75.1 110.553 178.378 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 510' ' ' LYS . 78.4 t -59.37 -36.65 65.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.645 -0.707 . . . . 73.5 110.758 178.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -79.58 -21.55 44.89 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.105 0.479 . . . . 73.24 110.639 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 127.5 -2.78 7.1 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 120.524 -0.846 . . . . 63.42 113.902 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.582 ' HA ' ' O ' ' A' ' 547' ' ' VAL . 95.1 m-85 -82.8 117.25 22.56 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.738 -1.208 . . . . 72.34 107.738 -176.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.6 m -118.8 -4.24 10.72 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 118.823 -1.151 . . . . 74.15 112.375 -174.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . 0.423 ' HB3' HG22 ' A' ' 550' ' ' VAL . 64.3 mttp -112.26 115.21 28.42 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.637 -0.664 . . . . 65.31 110.82 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -126.25 154.37 43.45 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.256 -0.429 . . . . 73.21 110.909 -174.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 49.2 m -141.45 141.11 33.7 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.414 -1.328 . . . . 61.05 107.414 171.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -117.57 138.22 52.07 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-O 121.016 0.436 . . . . 71.35 110.94 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -124.39 116.77 23.11 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.038 -1.097 . . . . 63.52 108.038 176.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 19.7 m -97.82 136.03 38.73 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.601 0.238 . . . . 40.13 111.326 -176.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 61.5 t -129.47 148.87 33.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 107.031 -1.47 . . . . 53.22 107.031 177.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . 0.412 ' HB2' ' HB2' ' A' ' 559' ' ' ASN . 0.4 OUTLIER -78.38 136.63 37.71 Favored 'General case' 0 C--O 1.248 0.975 0 N-CA-C 108.727 -0.842 . . . . 72.53 108.727 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . 0.409 ' OG ' ' HB2' ' A' ' 556' ' ' SER . 77.6 p -153.33 179.56 1.26 Allowed Pre-proline 0 C--N 1.294 -1.819 0 N-CA-C 107.871 -1.159 . . . . 74.13 107.871 -176.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -85.09 -0.7 9.19 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 121.69 1.594 . . . . 64.13 111.367 172.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.427 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 12.7 mtp180 -88.39 139.74 30.14 Favored Pre-proline 0 N--CA 1.432 -1.345 0 N-CA-C 108.096 -1.075 . . . . 72.1 108.096 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.27 153.95 31.26 Favored 'Trans proline' 0 C--O 1.254 1.309 0 C-N-CA 123.304 2.669 . . . . 70.34 113.949 -176.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.634 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -74.75 116.29 15.29 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.347 -0.842 . . . . 71.21 110.527 -176.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 118.88 -7.42 13.15 Favored Glycine 0 CA--C 1.49 -1.481 0 C-N-CA 120.049 -1.072 . . . . 45.33 111.203 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -83.67 140.46 32.14 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 108.321 -0.992 . . . . 73.33 108.321 174.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 60.9 t -88.45 118.29 33.68 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 N-CA-C 108.063 -1.088 . . . . 74.22 108.063 178.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . 0.481 ' OG1' ' HB3' ' A' ' 556' ' ' SER . 90.5 m -78.19 -24.2 47.26 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.776 -1.102 . . . . 71.44 109.802 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 153.54 -164.75 31.22 Favored Glycine 0 N--CA 1.424 -2.132 0 N-CA-C 110.435 -1.066 . . . . 44.31 110.435 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 18.0 p -117.71 159.29 23.22 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 109.327 -0.62 . . . . 62.12 109.327 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -63.11 -57.49 20.67 Favored Pre-proline 0 C--N 1.315 -0.924 0 O-C-N 123.625 0.578 . . . . 53.24 110.328 177.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -73.23 133.01 18.73 Favored 'Trans proline' 0 C--N 1.363 1.319 0 N-CA-C 109.136 -1.14 . . . . 73.24 109.136 171.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.14 156.73 48.48 Favored 'Trans proline' 0 C--O 1.252 1.203 0 C-N-CA 122.492 2.128 . . . . 32.11 112.354 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -57.31 140.52 49.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.786 -0.643 . . . . 73.54 110.97 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.26 -16.38 56.94 Favored Glycine 0 N--CA 1.433 -1.528 0 CA-C-N 115.708 -0.678 . . . . 73.33 111.687 -178.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 99.7 m -65.28 123.93 20.86 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.071 0.462 . . . . 64.11 110.436 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 54.1 m -88.41 123.47 32.99 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 115.466 -0.788 . . . . 74.1 109.674 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 31.2 m -137.85 154.81 74.86 Favored Pre-proline 0 C--N 1.312 -1.053 0 N-CA-C 108.288 -1.004 . . . . 51.33 108.288 177.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' A' ' 494' ' ' THR . 52.6 Cg_exo -60.76 142.56 98.09 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.293 1.996 . . . . 74.23 110.863 173.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 517' ' ' PHE . 27.2 m -62.27 -20.45 24.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.799 0.809 . . . . 74.01 111.815 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . 0.402 ' O ' ' HD2' ' A' ' 519' ' ' LYS . 26.8 t70 -90.26 -5.59 56.15 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.38 -0.827 . . . . 64.14 111.713 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 72.1 m -83.35 166.01 18.81 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 121.751 -0.593 . . . . 74.21 111.567 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.423 HG22 ' HB3' ' A' ' 519' ' ' LYS . 21.5 t -92.67 129.54 43.08 Favored 'Isoleucine or valine' 0 C--O 1.254 1.294 0 CA-C-N 115.671 -0.695 . . . . 62.13 110.452 -176.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . 0.456 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -111.55 134.99 52.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.176 0.512 . . . . 74.45 110.256 174.383 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -102.98 121.11 41.86 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.566 -0.743 . . . . 74.51 109.885 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.2 mp -104.36 134.08 48.18 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.189 -0.914 . . . . 70.11 110.355 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -90.83 123.99 34.8 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.646 -0.872 . . . . 72.24 108.646 174.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 524' ' ' SER . 64.1 t -109.53 129.15 64.85 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 N-CA-C 108.509 -0.923 . . . . 70.42 108.509 -177.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.634 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 24.4 p -77.07 140.98 40.45 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-O 121.481 0.658 . . . . 75.34 112.183 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -104.3 131.92 51.11 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 107.057 -1.46 . . . . 75.12 107.057 168.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -69.5 -30.22 71.22 Favored Glycine 0 CA--C 1.489 -1.546 0 O-C-N 123.805 0.691 . . . . 65.22 111.515 -177.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 526' ' ' ASP . 63.2 t30 70.28 9.43 6.99 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.581 1.152 . . . . 74.25 110.423 174.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.448 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 96.3 mt-30 -121.99 145.14 48.41 Favored 'General case' 0 N--CA 1.412 -2.375 0 CA-C-N 114.773 -1.103 . . . . 71.44 110.482 -178.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -123.27 147.96 46.41 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.371 -0.974 . . . . 74.43 108.371 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 59.0 t -69.74 121.2 18.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-O 121.08 0.467 . . . . 73.42 112.163 -173.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . 0.421 ' HA ' ' HD3' ' A' ' 564' ' ' PRO . 53.7 ttp -97.88 132.01 25.64 Favored Pre-proline 0 C--O 1.25 1.102 0 CA-C-N 115.812 -0.631 . . . . 61.15 110.944 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 563' ' ' MET . 30.7 Cg_exo -65.52 170.63 10.73 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 123.306 2.671 . . . . 75.33 111.764 173.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -72.34 132.44 43.99 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.429 0.633 . . . . 74.35 110.823 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 94.9 mt -120.62 -4.64 9.77 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.157 -0.929 . . . . 53.1 108.597 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 38.3 t -79.11 149.39 32.08 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.783 -1.099 . . . . 74.0 109.829 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 72.88 39.97 53.39 Favored Glycine 0 C--O 1.221 -0.714 0 C-N-CA 120.894 -0.67 . . . . 73.02 111.64 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 89.3 mtp -146.06 158.11 43.87 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.337 -1.727 . . . . 74.33 106.337 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 96.6 m-85 -84.48 155.95 21.94 Favored 'General case' 0 N--CA 1.424 -1.741 0 C-N-CA 120.019 -0.673 . . . . 72.32 109.506 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 55.4 t90 -65.91 -22.87 66.53 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.148 0.499 . . . . 73.33 109.735 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 33.7 m -72.75 -12.06 15.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.803 -0.635 . . . . 53.14 110.697 177.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . 0.477 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 41.8 m-20 -101.48 -39.72 7.4 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 108.401 -0.963 . . . . 74.15 108.401 175.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -60.31 -40.72 91.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.436 -0.802 . . . . 72.35 111.503 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.485 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 1.2 tm-20 -57.32 -59.03 14.06 Favored Pre-proline 0 CA--C 1.578 2.052 0 C-N-CA 123.308 0.643 . . . . 54.55 110.477 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.33 -29.89 86.68 Favored 'Trans proline' 0 C--N 1.373 1.86 0 CA-C-N 120.912 1.362 . . . . 74.35 113.159 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 16.3 mmt180 -65.82 -43.32 88.95 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 121.103 -0.239 . . . . 72.25 110.808 177.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.4 pp -66.1 -38.03 87.23 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.046 0.451 . . . . 42.32 110.311 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -65.33 -35.29 80.54 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 115.863 -0.608 . . . . 71.34 110.794 175.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.55 -25.52 64.96 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 122.719 0.407 . . . . 44.0 110.928 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 89.9 mt -92.29 -8.17 45.94 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.85 -0.614 . . . . 64.24 110.503 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 65.4 41.95 96.21 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 110.71 -0.956 . . . . 45.03 110.71 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 74.2 t90 -77.51 136.63 38.34 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.296 0.57 . . . . 74.4 112.083 -175.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 81.7 m -151.79 99.53 2.59 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.526 -0.916 . . . . 74.22 108.526 173.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -140.26 -119.52 1.63 Allowed Glycine 0 N--CA 1.433 -1.507 0 N-CA-C 109.939 -1.264 . . . . 73.1 109.939 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -130.62 124.52 31.9 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.054 -0.721 . . . . 75.22 109.054 176.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -108.13 128.86 55.07 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 105.97 -1.863 . . . . 73.13 105.97 177.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -104.27 115.41 30.34 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.54 -0.911 . . . . 61.33 108.54 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -87.76 125.2 34.29 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 116.168 -0.469 . . . . 52.34 110.114 -176.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -103.9 173.9 22.04 Favored Glycine 0 N--CA 1.426 -2.008 0 N-CA-C 110.186 -1.166 . . . . 72.11 110.186 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -87.38 154.78 20.4 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.804 -0.443 . . . . 61.33 109.804 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' A' ' 625' ' ' GLY . 4.3 p-10 -69.59 124.8 24.88 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.261 0.553 . . . . 64.5 109.557 178.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 95.3 t -129.04 115.73 37.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.812 -0.81 . . . . 43.33 108.812 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . 0.402 ' HA ' ' HB2' ' A' ' 626' ' ' GLN . 4.3 p-10 -84.48 118.82 24.54 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.349 -0.982 . . . . 52.42 108.349 178.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . 0.437 ' HB3' ' HG3' ' A' ' 599' ' ' GLN . . . -142.8 9.0 1.73 Allowed 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.941 -0.704 . . . . 72.51 112.004 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 125.49 -176.71 17.22 Favored Glycine 0 N--CA 1.435 -1.375 0 C-N-CA 120.152 -1.023 . . . . 74.1 111.955 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -63.44 -40.48 98.88 Favored Glycine 0 N--CA 1.45 -0.393 0 O-C-N 124.215 0.597 . . . . 63.45 113.066 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 23.8 m -63.18 -23.87 67.63 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 122.895 0.478 . . . . 74.53 111.628 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . 0.437 ' HG3' ' HB3' ' A' ' 595' ' ' ALA . 82.4 mm-40 -105.08 -1.64 25.35 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 111.979 0.363 . . . . 74.02 111.979 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -84.81 109.96 18.47 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 119.861 -0.736 . . . . 74.35 110.621 -176.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 57.01 0.27 0.07 Allowed 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 126.805 2.042 . . . . 73.33 114.973 176.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 8.2 ptm180 -108.08 157.22 18.45 Favored 'General case' 0 C--N 1.289 -2.036 0 O-C-N 120.812 -1.18 . . . . 74.4 113.871 -173.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . 0.415 HG13 ' HB2' ' A' ' 622' ' ' LEU . 66.5 t -69.11 130.77 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 113.908 -1.497 . . . . 73.45 108.502 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 623' ' ' ARG . 46.5 t -84.31 -50.09 15.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 121.49 0.662 . . . . 71.34 109.669 -176.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -154.6 164.15 39.15 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 106.129 -1.804 . . . . 70.4 106.129 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -115.05 128.6 56.35 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 107.289 -1.374 . . . . 63.54 107.289 174.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.583 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 16.6 t-20 -48.25 -58.17 8.72 Favored Pre-proline 0 N--CA 1.48 1.025 0 O-C-N 123.798 0.686 . . . . 65.31 112.475 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.583 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 2.8 Cg_endo -86.34 120.87 1.88 Allowed 'Trans proline' 0 N--CA 1.442 -1.534 0 N-CA-C 108.097 -1.54 . . . . 75.12 108.097 169.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -63.31 160.27 35.85 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.371 2.047 . . . . 74.12 113.132 -177.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -57.85 127.28 31.29 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.437 -0.801 . . . . 72.44 111.055 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 91.95 -1.29 74.11 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.321 -0.942 . . . . 74.11 112.118 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 24.7 m -99.15 160.58 14.17 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.459 -0.941 . . . . 62.32 108.459 178.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -87.64 143.17 18.3 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 121.494 -0.384 . . . . 65.3 114.047 -175.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 27.8 m -113.81 142.55 25.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 C-N-CA 124.004 0.922 . . . . 63.32 109.42 176.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.408 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 29.7 p-10 -58.89 176.26 0.22 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.731 1.011 . . . . 73.55 113.731 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -60.92 -25.86 67.06 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.96 -0.564 . . . . 73.22 112.421 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.31 -33.67 65.29 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.698 -0.853 . . . . 70.42 108.698 174.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 79.51 21.93 65.76 Favored Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 110.428 -1.069 . . . . 63.14 110.428 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.16 119.5 15.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 122.319 1.057 . . . . 72.0 111.29 -168.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 2.8 tp -116.56 126.5 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 CA-C-N 113.582 -1.645 . . . . 64.41 109.561 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.532 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 93.8 m -100.98 118.79 37.69 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 108.851 -0.796 . . . . 72.32 108.851 173.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . 0.415 ' HB2' HG13 ' A' ' 603' ' ' VAL . 1.6 pt? -132.74 151.85 51.89 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 107.605 -1.257 . . . . 55.3 107.605 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . 0.407 ' O ' HG23 ' A' ' 604' ' ' VAL . 13.6 tpt180 -131.51 141.76 49.82 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 109.1 -0.704 . . . . 72.23 109.1 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -127.97 143.4 51.09 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 106.793 -1.558 . . . . 60.33 106.793 172.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 592' ' ' ASP . . . -85.87 -89.81 0.92 Allowed Glycine 0 N--CA 1.436 -1.319 0 C-N-CA 120.639 -0.791 . . . . 70.43 112.394 -176.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . 0.402 ' HB2' ' HA ' ' A' ' 594' ' ' ASP . 8.5 tp-100 . . . . . 0 C--N 1.309 -1.177 0 CA-C-O 118.866 -0.588 . . . . 62.01 110.554 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.79 0 N-CA-C 111.108 -0.797 . . . . 52.14 111.108 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 10.6 tp -76.46 134.48 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 N-CA-C 108.992 -0.744 . . . . 63.21 108.992 175.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 1.3 p -83.21 155.78 23.53 Favored 'General case' 0 N--CA 1.394 -3.227 0 C-N-CA 123.22 0.608 . . . . 64.01 110.677 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -98.03 72.17 2.18 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.665 -1.235 . . . . 73.44 107.665 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -82.05 148.52 28.55 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.224 -1.353 . . . . 53.03 110.39 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 30.2 m -137.56 162.98 31.85 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 107.671 -1.233 . . . . 54.42 107.671 178.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -94.09 139.37 31.06 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 106.067 -1.827 . . . . 75.23 106.067 175.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.528 HG22 ' CZ ' ' A' ' 382' ' ' PHE . 90.6 t -93.48 128.82 40.83 Favored Pre-proline 0 C--N 1.281 -2.389 0 N-CA-C 108.28 -1.007 . . . . 73.44 108.28 -168.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 13.6 Cg_exo -61.09 120.59 8.37 Favored 'Trans proline' 0 C--N 1.361 1.204 0 C-N-CA 122.468 2.112 . . . . 55.12 112.304 -174.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -87.71 84.36 7.08 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 114.571 -1.195 . . . . 75.2 108.053 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.509 ' HB ' HE21 ' A' ' 368' ' ' GLN . 28.2 m -92.09 16.03 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.078 -0.964 . . . . 72.33 112.707 -174.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . 0.296 0.2 OUTLIER -65.29 148.38 51.79 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.926 -0.579 . . . . 74.2 112.546 176.705 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 106.4 -1.78 37.2 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 110.125 -1.19 . . . . 63.11 110.125 -170.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . 0.509 HE21 ' HB ' ' A' ' 365' ' ' VAL . 39.5 mt-30 -109.27 -158.93 0.66 Allowed 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 107.588 -1.264 . . . . 71.31 107.588 173.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 65.4 p -90.52 160.56 15.91 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 109.94 -0.393 . . . . 73.14 109.94 -175.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 27.1 p -56.13 -46.47 79.18 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 123.556 0.535 . . . . 63.05 110.451 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.31 -46.27 84.31 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 115.843 -0.617 . . . . 43.43 112.291 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -66.67 -44.1 82.74 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 120.153 -0.619 . . . . 65.04 110.471 -178.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -63.17 -48.6 77.72 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.519 -0.764 . . . . 73.13 111.771 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 90.1 mt -65.83 -42.23 91.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 CA-C-N 116.547 -0.297 . . . . 74.43 110.301 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.79 -43.33 94.46 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.417 -0.356 . . . . 74.31 111.189 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 33.8 m -63.0 -47.51 82.8 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.026 -0.534 . . . . 70.35 111.457 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 11.1 mp -64.59 -41.64 96.12 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.137 -0.225 . . . . 72.41 111.545 178.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . 0.447 HE21 ' HA ' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -63.62 -38.72 92.19 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.301 -0.409 . . . . 74.34 110.186 -179.095 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -64.97 -30.81 71.82 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.894 0.378 . . . . 62.44 111.155 176.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -81.72 -8.66 59.72 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.131 -0.486 . . . . 71.51 110.826 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 99.49 0.18 56.79 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.603 -0.808 . . . . 72.34 112.491 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.528 ' CZ ' HG22 ' A' ' 362' ' ' VAL . 62.7 m-85 -78.26 147.67 34.24 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 109.124 -0.695 . . . . 74.0 109.124 178.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.527 ' HB2' ' HG2' ' A' ' 415' ' ' GLU . 40.9 mmtm -100.35 144.53 29.24 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.497 -1.668 . . . . 75.32 106.497 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 1.5 mp -129.0 140.46 49.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 108.353 -0.981 . . . . 74.23 108.353 -179.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -109.85 128.05 55.08 Favored 'General case' 0 C--N 1.264 -3.113 0 N-CA-C 104.893 -2.262 . . . . 72.55 104.893 175.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 19.3 m -115.26 127.86 55.76 Favored 'General case' 0 C--N 1.257 -3.446 0 N-CA-C 108.095 -1.076 . . . . 71.24 108.095 -175.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.87 120.83 43.27 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.67 -1.233 . . . . 63.12 107.67 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -95.89 132.82 40.77 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.823 -0.436 . . . . 54.24 109.823 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 421' ' ' SER . 93.3 mttt -136.04 134.24 20.22 Favored Pre-proline 0 C--N 1.297 -1.703 0 N-CA-C 108.39 -0.967 . . . . 71.03 108.39 173.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.515 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 29.5 Cg_endo -91.51 127.31 1.07 Allowed 'Trans proline' 0 C--O 1.251 1.146 0 C-N-CA 121.296 1.331 . . . . 53.34 111.259 175.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.515 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 12.2 t70 150.97 -164.92 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 103.203 -2.888 . . . . 74.1 103.203 -177.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 13.1 t -141.83 2.91 1.6 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 119.369 0.986 . . . . 72.23 110.539 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 11.5 t -87.74 -7.74 56.95 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.265 1.031 . . . . 63.14 109.787 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.569 HD13 ' H ' ' A' ' 394' ' ' ILE . 0.2 OUTLIER -109.25 151.81 42.25 Favored Pre-proline 0 N--CA 1.417 -2.088 0 N-CA-C 106.737 -1.579 . . . . 61.31 106.737 178.414 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . 0.434 ' HA ' ' HD2' ' A' ' 396' ' ' PRO . 1.1 Cg_exo -22.92 113.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.087 1 C-N-CA 125.739 4.293 . . . . 73.45 115.736 -179.064 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 395' ' ' PRO . 28.9 Cg_endo -61.63 164.09 16.71 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 124.252 3.301 . . . . 74.32 112.605 -178.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . 0.499 ' HA ' ' CG2' ' A' ' 420' ' ' VAL . 31.4 t70 -56.53 -9.23 0.68 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 122.504 1.145 . . . . 54.11 111.937 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 64.1 m170 -103.96 111.33 23.84 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 103.5 -2.778 . . . . 64.5 103.5 168.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 27.4 m -63.14 119.49 7.3 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 O-C-N 124.403 1.065 . . . . 72.43 112.425 -168.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 9.1 tp -91.19 -29.14 4.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-N 115.515 -0.766 . . . . 71.33 110.443 -176.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.93 162.37 28.32 Favored Glycine 0 N--CA 1.42 -2.375 0 C-N-CA 119.533 -1.318 . . . . 63.51 113.554 -174.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 10.6 p -132.36 -175.7 3.84 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 125.7 1.6 . . . . 62.21 109.116 -177.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -101.37 134.3 20.37 Favored Pre-proline 0 C--N 1.293 -1.879 0 N-CA-C 107.28 -1.378 . . . . 62.52 107.28 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -47.03 -24.95 3.62 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 124.412 3.408 . . . . 54.21 115.122 -177.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.51 -28.23 68.23 Favored 'General case' 0 C--O 1.209 -1.067 0 CA-C-N 116.27 -0.423 . . . . 54.05 111.327 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -73.99 -32.54 63.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.825 0.821 . . . . 71.02 110.014 178.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -87.27 -2.15 58.41 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.522 -0.763 . . . . 73.44 109.498 -178.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 24.9 m -102.18 151.85 21.71 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.44 -1.689 . . . . 73.42 106.44 173.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 46.2 m -79.92 112.41 17.18 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 119.125 -1.03 . . . . 54.5 109.306 176.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.8 m -121.36 168.67 13.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 116.371 -0.377 . . . . 71.11 110.124 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 57.1 m -61.88 133.17 55.11 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.245 0.545 . . . . 72.02 110.936 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -61.77 112.44 2.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.316 -0.856 . . . . 72.12 112.754 -174.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 119.55 6.5 10.46 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.602 -0.808 . . . . 65.23 113.383 177.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -69.49 179.19 2.16 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 122.442 0.297 . . . . 73.21 111.233 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . 0.527 ' HG2' ' HB2' ' A' ' 383' ' ' LYS . 40.2 mt-10 -106.49 122.8 47.02 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 122.848 0.459 . . . . 71.2 110.569 -174.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 49.2 mm -112.41 130.6 65.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 108.78 -0.822 . . . . 74.03 108.78 178.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 81.4 m -96.95 132.35 42.83 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.116 0.484 . . . . 52.31 111.003 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 5.6 p -122.86 134.59 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 CA-C-N 115.78 -0.646 . . . . 63.21 109.762 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -95.59 129.23 42.85 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.982 -0.747 . . . . 73.1 108.982 174.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.499 ' CG2' ' HA ' ' A' ' 397' ' ' ASP . 8.6 p -138.7 141.51 36.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 109.617 -0.512 . . . . 75.53 109.617 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 11.5 p -100.15 121.97 42.26 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-O 121.699 0.761 . . . . 65.11 112.184 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 9.3 t -121.44 121.33 37.33 Favored 'General case' 0 N--CA 1.41 -2.449 0 N-CA-C 108.001 -1.111 . . . . 72.22 108.001 170.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 121.08 137.36 5.27 Favored Glycine 0 C--N 1.297 -1.588 0 C-N-CA 119.701 -1.238 . . . . 62.21 112.597 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -74.69 157.87 43.77 Favored 'Trans proline' 0 C--O 1.251 1.142 0 C-N-CA 122.949 2.433 . . . . 74.44 113.272 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -74.75 164.79 26.18 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.042 -1.436 . . . . 75.31 110.13 178.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -92.94 156.72 16.74 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.727 -0.842 . . . . 73.35 108.727 175.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 447' ' ' ALA . 3.9 mmp_? -122.39 152.99 39.64 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.747 0.308 . . . . 74.51 111.162 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -91.02 139.04 31.14 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 115.759 -0.655 . . . . 54.15 110.642 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 50.4 mt -86.04 126.3 65.82 Favored Pre-proline 0 N--CA 1.421 -1.887 0 N-CA-C 106.914 -1.513 . . . . 71.4 106.914 176.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -73.12 141.43 32.64 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.174 1.916 . . . . 62.44 110.537 169.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -80.91 116.15 20.74 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.828 -1.175 . . . . 72.25 107.828 173.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.443 HG12 ' HB ' ' A' ' 436' ' ' THR . 61.4 t -107.34 154.17 8.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 108.035 -1.098 . . . . 74.14 108.035 -175.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.512 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 19.6 m -67.13 152.35 45.91 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 120.818 0.342 . . . . 63.33 110.805 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 35.5 p -67.28 -27.93 67.6 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 113.979 1.103 . . . . 63.34 113.979 -172.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 2.4 pp -88.38 -10.34 49.65 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.719 0.771 . . . . 73.41 111.439 176.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.512 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 1.6 m -96.84 37.0 1.33 Allowed 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.428 0.632 . . . . 74.33 110.35 -175.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -52.76 -38.78 61.5 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.705 0.802 . . . . 72.21 112.56 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.33 -40.31 93.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.932 0.396 . . . . 71.52 111.33 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.406 ' HB3' HG22 ' A' ' 436' ' ' THR . 29.3 tp10 -70.84 -34.53 71.77 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.523 -0.547 . . . . 75.15 109.523 176.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.52 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.02 -50.98 71.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.594 -0.276 . . . . 64.1 111.218 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.1 m -60.71 -37.34 75.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 121.301 0.572 . . . . 71.1 110.634 177.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -60.37 -47.66 85.1 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.257 -0.883 . . . . 62.33 110.81 175.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -65.02 -39.5 93.48 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.817 0.341 . . . . 71.54 111.609 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.52 HD13 ' O ' ' A' ' 440' ' ' ALA . 6.2 mp -65.21 -36.19 83.4 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.968 -0.56 . . . . 70.3 110.999 177.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 65.8 m -70.18 -42.7 72.09 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-O 120.825 0.345 . . . . 75.52 110.091 177.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -65.93 -21.87 66.46 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-O 121.438 0.637 . . . . 63.31 110.844 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 427' ' ' ARG . . . -82.65 5.42 21.18 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.451 -0.795 . . . . 72.42 111.465 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 100.69 -73.68 0.41 Allowed Glycine 0 CA--C 1.501 -0.79 0 C-N-CA 120.408 -0.901 . . . . 74.44 112.525 174.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -43.88 -59.36 2.3 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.955 1.094 . . . . 74.1 113.955 176.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 59.31 29.71 66.49 Favored Glycine 0 C--O 1.224 -0.53 0 C-N-CA 121.24 -0.505 . . . . 74.11 112.652 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -102.59 110.56 22.53 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 108.385 -0.968 . . . . 65.11 108.385 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -140.71 143.05 34.82 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.865 -0.607 . . . . 44.34 111.05 -177.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -131.22 122.95 27.42 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.592 -0.892 . . . . 74.52 108.592 178.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -91.36 128.16 37.08 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.371 -0.603 . . . . 64.31 109.371 176.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -116.74 139.44 50.57 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 106.911 -1.514 . . . . 64.43 106.911 175.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -115.32 130.87 57.03 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.374 -0.973 . . . . 64.42 108.374 -176.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 41.9 t -132.59 140.15 36.92 Favored Pre-proline 0 C--N 1.283 -2.306 0 N-CA-C 108.793 -0.817 . . . . 52.11 108.793 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.711 ' HA ' ' O ' ' A' ' 490' ' ' SER . 49.7 Cg_endo -72.52 121.76 7.7 Favored 'Trans proline' 0 N--CA 1.437 -1.805 0 C-N-CA 121.045 1.163 . . . . 71.23 109.726 174.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 48.8 m -142.69 179.38 7.02 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.661 -0.7 . . . . 71.3 110.55 -173.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 14.1 t -52.12 138.63 36.06 Favored Pre-proline 0 CA--C 1.562 1.412 0 C-N-CA 124.198 0.999 . . . . 61.32 111.274 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.77 -30.0 36.17 Favored 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 124.868 3.712 . . . . 61.22 114.058 -173.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -73.17 -19.84 61.03 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.608 0.596 . . . . 75.23 112.608 -176.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -101.79 -6.83 23.15 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.232 -0.292 . . . . 70.4 111.32 177.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 94.4 t -61.09 128.09 21.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 120.854 0.359 . . . . 63.2 110.341 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.42 -11.85 71.13 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.432 -0.804 . . . . 71.42 111.831 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -110.93 165.36 11.92 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 109.636 -0.505 . . . . 25.52 109.636 -177.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.416 HG22 HG12 ' A' ' 488' ' ' VAL . 80.6 t -76.98 145.3 10.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 107.086 -1.449 . . . . 72.34 107.086 171.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 64.8 mt -97.32 -31.96 3.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 107.031 -1.47 . . . . 71.02 107.031 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 160.39 -178.36 36.45 Favored Glycine 0 N--CA 1.417 -2.625 0 CA-C-N 114.983 -1.008 . . . . 61.43 110.858 175.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . 0.574 HG22 HG12 ' A' ' 486' ' ' ILE . 54.3 p -114.39 146.44 40.57 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 106.117 -1.809 . . . . 43.11 106.117 175.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -67.19 -54.51 19.28 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 120.054 -0.658 . . . . 55.42 110.675 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -73.15 138.81 28.53 Favored 'Trans proline' 0 C--N 1.368 1.585 0 N-CA-C 107.797 -1.655 . . . . 64.22 107.797 169.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.428 ' HB2' ' HG2' ' A' ' 476' ' ' GLN . 23.0 Cg_exo -62.62 132.28 37.13 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.611 1.541 . . . . 65.03 111.888 -177.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -73.75 16.69 0.2 Allowed 'General case' 0 C--O 1.195 -1.768 0 C-N-CA 124.214 1.006 . . . . 43.41 112.355 -177.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -111.8 -8.87 14.12 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 122.645 0.378 . . . . 65.53 111.2 173.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . 0.428 ' HG2' ' HB2' ' A' ' 473' ' ' PRO . 85.2 mm-40 -77.61 171.1 15.45 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 113.606 0.965 . . . . 74.31 113.606 -172.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 1.1 m -105.37 115.53 30.42 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 107.592 -1.262 . . . . 65.41 107.592 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 22.0 m -115.1 142.62 46.4 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 120.613 0.244 . . . . 74.13 110.401 -176.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -71.72 166.57 21.69 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.813 -0.63 . . . . 72.12 110.19 176.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 29.4 mm -70.95 -3.18 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.362 0 CA-C-O 121.821 0.82 . . . . 53.14 111.797 -173.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 14.6 t -112.19 5.29 18.38 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.18 -0.95 . . . . 51.15 110.711 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -79.79 132.66 36.2 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.803 -0.56 . . . . 72.21 111.377 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 46.0 t -106.61 121.7 59.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 108.35 -0.981 . . . . 70.41 108.35 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 28.7 m -104.72 134.62 45.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-O 121.518 0.675 . . . . 73.32 111.929 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.13 125.99 50.02 Favored 'Isoleucine or valine' 0 C--O 1.252 1.195 0 N-CA-C 108.91 -0.774 . . . . 74.51 108.91 178.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.574 HG12 HG22 ' A' ' 470' ' ' THR . 7.9 mt -119.62 127.44 75.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.259 -0.882 . . . . 64.15 109.381 -178.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 7.1 tt -108.38 127.14 64.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.07 0.462 . . . . 62.32 111.287 -177.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.416 HG12 HG22 ' A' ' 467' ' ' VAL . 31.9 m -111.23 151.75 13.3 Favored 'Isoleucine or valine' 0 C--O 1.252 1.203 0 CA-C-N 115.849 -0.614 . . . . 72.5 109.933 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.17 133.97 12.2 Favored Glycine 0 N--CA 1.43 -1.702 0 C-N-CA 121.022 -0.609 . . . . 74.0 111.946 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.711 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 33.4 m -135.01 161.02 36.48 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 105.779 -1.934 . . . . 74.42 105.779 176.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 151.29 134.02 2.11 Favored Glycine 0 C--N 1.295 -1.695 0 C-N-CA 118.468 -1.825 . . . . 45.13 113.925 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -97.97 152.7 0.85 Allowed 'Trans proline' 0 N--CA 1.44 -1.633 0 C-N-CA 122.756 2.304 . . . . 74.33 111.63 172.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -110.6 35.3 3.53 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 122.404 1.097 . . . . 75.33 108.506 177.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 546' ' ' PRO . 17.2 p -117.22 150.06 39.37 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 113.758 -1.564 . . . . 72.42 110.994 -174.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . 0.51 ' HA ' ' HE3' ' A' ' 495' ' ' LYS . 0.0 OUTLIER -137.04 164.28 28.75 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.694 -1.224 . . . . 71.12 107.694 175.474 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.7 m-20 -90.36 138.34 31.62 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 109.531 -0.544 . . . . 74.42 109.531 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 543' ' ' THR . 35.9 pt -95.54 124.54 52.72 Favored Pre-proline 0 C--N 1.306 -1.286 0 C-N-CA 120.787 -0.365 . . . . 45.23 110.754 177.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -89.38 171.14 4.51 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.391 2.061 . . . . 72.04 110.51 174.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -87.87 154.57 20.42 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.386 -0.968 . . . . 70.41 108.386 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.5 p -145.91 104.31 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 108.954 -0.758 . . . . 71.0 108.954 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -140.68 119.85 12.89 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.732 -0.667 . . . . 74.3 110.497 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 122.97 -12.38 8.63 Favored Glycine 0 CA--C 1.486 -1.77 0 C-N-CA 120.119 -1.039 . . . . 60.43 111.779 177.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.484 ' O ' HG12 ' A' ' 534' ' ' VAL . 20.2 mt-30 -99.0 171.09 8.26 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.438 -0.949 . . . . 65.15 108.438 176.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 14.5 t -90.15 157.78 17.57 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.358 -0.979 . . . . 72.42 108.358 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 12.4 p -52.78 -41.1 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 113.084 0.772 . . . . 64.25 113.084 -176.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -61.54 -41.87 98.0 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.125 0.488 . . . . 71.0 110.6 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 93.5 t -69.54 -43.38 80.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.441 -0.799 . . . . 73.41 110.196 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -61.31 -49.5 76.75 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.081 -0.508 . . . . 70.02 111.412 -178.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -63.07 -38.09 89.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.042 0.449 . . . . 73.23 111.285 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.462 ' O ' HG23 ' A' ' 514' ' ' VAL . 33.6 ttmt -62.54 -42.29 99.43 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.343 -0.844 . . . . 74.43 109.719 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -62.82 -48.37 79.36 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.056 -0.52 . . . . 72.12 110.79 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.93 -36.54 79.6 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.076 0.399 . . . . 71.42 112.076 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.36 -37.43 80.68 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 116.351 -0.386 . . . . 72.31 111.145 176.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 510' ' ' LYS . 94.2 t -61.48 -36.43 73.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.117 -0.492 . . . . 74.43 110.387 177.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -76.46 -15.03 60.0 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.573 -0.285 . . . . 74.41 111.354 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 110.91 -8.65 29.57 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.793 -0.717 . . . . 30.52 112.846 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.461 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 76.2 m-85 -80.06 113.82 18.52 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 108.085 -1.08 . . . . 75.52 108.085 -177.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.4 m -116.71 -8.95 11.37 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 118.548 -1.261 . . . . 71.14 114.113 -171.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -108.34 120.81 43.45 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.391 -0.818 . . . . 74.53 110.397 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -120.93 156.04 32.94 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 113.338 0.866 . . . . 65.43 113.338 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 46.9 m -141.85 138.52 32.2 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 106.296 -1.742 . . . . 61.51 106.296 169.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . 0.507 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 0.0 OUTLIER -121.63 141.35 51.2 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 119.601 -0.84 . . . . 73.22 111.094 179.523 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -119.89 122.61 41.66 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.683 -1.228 . . . . 74.41 107.683 176.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 67.1 m -88.86 128.02 35.65 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 121.214 0.531 . . . . 73.32 110.508 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 24.7 m -121.44 149.82 24.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.96 -0.756 . . . . 65.13 108.96 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . 0.408 ' HB3' ' HE3' ' A' ' 557' ' ' LYS . 10.0 p-10 -73.94 135.03 43.22 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 108.354 -0.98 . . . . 52.53 108.354 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . 0.405 ' HB3' ' HD2' ' A' ' 528' ' ' PRO . 45.4 m -152.16 172.55 5.37 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 108.628 -0.879 . . . . 72.32 108.628 -176.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 527' ' ' SER . 72.6 Cg_endo -82.67 -10.31 10.77 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 121.452 1.435 . . . . 64.4 110.424 174.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.433 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 27.3 mmt180 -81.36 138.18 48.43 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-N 114.862 -1.063 . . . . 64.53 108.18 -178.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -62.46 149.65 90.15 Favored 'Trans proline' 0 C--O 1.249 1.03 0 C-N-CA 122.351 2.034 . . . . 64.02 112.316 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -58.57 118.26 5.44 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.224 -0.898 . . . . 72.53 110.79 -178.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 127.59 -23.73 5.33 Favored Glycine 0 N--CA 1.434 -1.442 0 N-CA-C 111.113 -0.795 . . . . 70.32 111.113 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -81.14 134.96 35.73 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.468 -0.938 . . . . 74.35 108.468 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 503' ' ' GLN . 13.4 p -80.96 135.24 25.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 CA-C-O 121.3 0.571 . . . . 64.42 110.519 -178.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . 0.471 ' HB ' ' HG3' ' A' ' 554' ' ' GLN . 77.5 m -88.91 -32.83 17.53 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.168 -0.924 . . . . 70.42 109.889 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.38 -152.1 24.21 Favored Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 110.091 -1.203 . . . . 70.32 110.091 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 27.3 p -117.56 157.19 26.78 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.551 -0.537 . . . . 72.11 109.551 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -73.09 -50.04 6.87 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 109.59 -0.522 . . . . 74.41 109.59 175.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.12 146.92 78.29 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 121.217 1.278 . . . . 74.41 109.649 171.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.43 143.81 53.66 Favored 'Trans proline' 0 C--O 1.25 1.122 0 C-N-CA 122.181 1.921 . . . . 75.24 113.089 -176.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.86 133.51 50.2 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.815 -0.809 . . . . 74.13 108.815 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.47 -5.31 35.32 Favored Glycine 0 C--N 1.299 -1.506 0 C-N-CA 120.053 -1.07 . . . . 62.44 111.111 -176.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.47 ' O ' HG12 ' A' ' 497' ' ' ILE . 62.4 m -82.26 133.69 35.25 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.516 -0.55 . . . . 75.24 109.516 176.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 11.9 t -96.44 130.84 43.5 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 119.984 -0.686 . . . . 70.41 109.571 176.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.1 m -139.44 159.24 66.6 Favored Pre-proline 0 C--N 1.316 -0.891 0 N-CA-C 109.175 -0.676 . . . . 75.21 109.175 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 494' ' ' THR . 35.9 Cg_exo -63.39 142.04 83.69 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.367 2.045 . . . . 62.41 111.374 176.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.461 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 27.7 m -66.72 -23.19 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-O 121.445 0.64 . . . . 73.03 112.32 -177.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -79.68 -13.41 59.49 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.517 -0.765 . . . . 74.13 110.574 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 56.7 m -77.5 164.97 24.94 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 113.463 0.912 . . . . 72.2 113.463 -175.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 23.9 t -90.9 131.39 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-N 114.629 -1.169 . . . . 73.11 109.179 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . 0.47 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -116.51 142.39 30.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 109.721 -0.474 . . . . 54.2 109.721 175.317 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -103.78 116.66 32.72 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.839 -0.619 . . . . 74.22 110.713 -175.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 7.3 mp -103.27 134.4 46.74 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.238 -0.892 . . . . 75.12 109.738 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . 0.471 ' HG3' ' HB ' ' A' ' 535' ' ' THR . 1.6 pt20 -101.29 125.38 47.92 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 108.834 -0.802 . . . . 71.01 108.834 179.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 524' ' ' SER . 59.5 t -114.8 138.59 44.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-N 115.44 -0.8 . . . . 71.13 110.002 -174.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 63.2 m -69.35 140.57 54.28 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 113.606 0.965 . . . . 74.31 113.606 178.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' A' ' 526' ' ' ASP . 3.0 ttpt -103.26 139.76 38.29 Favored 'General case' 0 N--CA 1.422 -1.825 0 N-CA-C 104.915 -2.254 . . . . 73.1 104.915 166.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -67.68 -36.56 87.86 Favored Glycine 0 CA--C 1.484 -1.905 0 C-N-CA 120.55 -0.833 . . . . 41.44 112.395 -172.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 66.2 t30 67.33 -3.84 0.97 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.808 1.243 . . . . 64.34 112.857 171.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -151.38 142.06 22.74 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.172 -1.418 . . . . 70.11 107.172 -174.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -136.18 134.93 38.72 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 120.627 0.251 . . . . 74.43 111.092 174.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.1 p -60.27 123.23 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.737 0.815 . . . . 73.31 112.931 -175.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . 0.444 ' HG2' ' O ' ' A' ' 612' ' ' THR . 25.5 ptm -98.11 141.19 22.55 Favored Pre-proline 0 C--O 1.253 1.259 0 CA-C-N 115.9 -0.591 . . . . 55.34 111.421 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.35 169.85 21.55 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.793 2.328 . . . . 43.53 110.555 171.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -72.52 130.45 40.65 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.163 0.506 . . . . 74.01 110.021 177.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 93.2 mt -116.6 -9.78 11.3 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.656 -0.702 . . . . 55.4 110.943 -177.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 10.5 p -70.36 129.88 40.47 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 109.952 -0.388 . . . . 75.13 109.952 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 90.3 -0.26 77.87 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.581 -0.819 . . . . 74.41 111.942 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 26.4 mmt -91.32 151.21 20.96 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 108.845 -0.798 . . . . 62.41 108.845 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -93.28 140.79 29.15 Favored 'General case' 0 N--CA 1.416 -2.165 0 N-CA-C 109.35 -0.611 . . . . 74.23 109.35 -176.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . 0.435 ' HA ' ' HB3' ' A' ' 574' ' ' ALA . 60.7 t-105 -71.53 -15.65 62.3 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.659 -0.701 . . . . 75.42 110.276 -174.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 14.0 p -72.31 -19.3 19.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.896 0.855 . . . . 63.12 108.908 178.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -102.27 -44.77 5.32 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 114.511 -1.222 . . . . 60.34 110.359 176.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . 0.435 ' HB3' ' HA ' ' A' ' 571' ' ' TRP . . . -65.42 -41.34 93.68 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 113.923 1.083 . . . . 73.44 113.923 -176.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.585 ' O ' ' HG2' ' A' ' 579' ' ' ARG . 32.0 tt0 -65.54 -53.55 36.81 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 120.176 -0.61 . . . . 73.44 111.907 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 52.4 Cg_exo -55.88 -39.26 92.21 Favored 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 121.91 1.74 . . . . 74.14 113.136 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 574' ' ' ALA . 3.2 ppt_? -67.76 -37.19 81.76 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 119.536 -0.865 . . . . 75.43 110.809 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.452 HD12 ' N ' ' A' ' 579' ' ' ARG 0.275 3.5 pp -66.55 -36.41 82.59 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 120.498 -0.481 . . . . 64.31 111.507 179.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . 0.585 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 45.8 mmm-85 -57.21 -42.75 81.92 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.169 -0.923 . . . . 75.12 108.711 176.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -67.8 -28.05 67.26 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.716 -0.675 . . . . 74.54 111.912 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 10.5 mp -80.56 -8.06 59.46 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.145 0.498 . . . . 72.53 111.164 177.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 77.77 16.28 80.25 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-N 115.759 -0.655 . . . . 64.05 111.95 179.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -70.78 140.46 51.29 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 109.523 -0.547 . . . . 74.51 109.523 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 9.6 t -137.21 -50.01 0.62 Allowed 'General case' 0 N--CA 1.406 -2.638 0 CA-C-O 118.871 -0.585 . . . . 73.23 110.238 175.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . 30.67 -126.69 0.16 Allowed Glycine 0 C--N 1.371 2.488 0 O-C-N 124.631 1.207 . . . . 43.03 113.734 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 25.7 ptm -137.93 125.54 22.21 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.881 -1.526 . . . . 74.4 106.881 170.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -87.41 123.84 32.78 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.69 -0.855 . . . . 75.33 108.69 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -95.96 107.33 19.6 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.669 -0.696 . . . . 72.31 109.277 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -112.5 113.3 25.4 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 108.582 -0.895 . . . . 71.01 108.582 176.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -83.25 -126.09 1.1 Allowed Glycine 0 N--CA 1.435 -1.367 0 N-CA-C 111.066 -0.814 . . . . 62.13 111.066 175.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -70.98 137.73 49.35 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.873 0.368 . . . . 74.24 111.124 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -97.49 126.95 43.06 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 106.903 -1.518 . . . . 72.15 106.903 176.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 48.8 t -137.27 128.95 41.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 C-N-CA 120.955 -0.298 . . . . 73.35 110.463 -172.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -77.38 108.35 10.46 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 105.173 -2.158 . . . . 60.13 105.173 170.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -105.1 0.19 27.24 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-O 121.216 0.531 . . . . 75.45 111.44 -174.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 100.82 171.47 28.93 Favored Glycine 0 N--CA 1.433 -1.56 0 N-CA-C 109.584 -1.406 . . . . 51.14 109.584 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -63.46 -48.16 80.82 Favored Glycine 0 C--N 1.306 -1.126 0 C-N-CA 120.721 -0.752 . . . . 64.01 113.382 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 42.0 p -69.25 -26.79 64.95 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.502 0.668 . . . . 65.22 112.243 -175.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -105.91 -1.64 23.88 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 118.926 -0.559 . . . . 72.52 110.992 -174.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . 0.491 ' CG ' ' H ' ' A' ' 601' ' ' ASN . 0.3 OUTLIER -35.32 -115.74 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.616 0 N-CA-C 117.677 2.473 . . . . 54.51 117.677 -167.866 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . 0.491 ' H ' ' CG ' ' A' ' 600' ' ' HIS . 4.6 p30 -92.96 83.92 4.81 Favored 'General case' 0 C--N 1.287 -2.109 0 O-C-N 120.558 -1.339 . . . . 74.12 109.92 178.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -126.11 150.85 47.93 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 115.548 -0.751 . . . . 73.12 109.678 175.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 85.7 t -67.84 130.9 33.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 O-C-N 123.875 0.734 . . . . 74.15 109.358 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 60.1 t -93.11 -52.14 10.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.363 0.601 . . . . 74.45 109.786 -176.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -136.41 158.81 43.55 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.405 -0.961 . . . . 72.11 108.405 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . 0.415 ' HA ' HD23 ' A' ' 622' ' ' LEU . 19.5 pt20 -125.32 122.3 36.46 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.564 -1.273 . . . . 74.14 107.564 174.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.613 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 41.8 t30 -51.47 -59.0 8.81 Favored Pre-proline 0 CA--C 1.555 1.17 0 CA-C-O 119.094 -0.479 . . . . 71.21 112.175 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.613 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 2.7 Cg_endo -85.03 129.65 3.94 Favored 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 121.322 1.348 . . . . 72.34 109.123 171.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.81 161.52 35.84 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 122.696 2.264 . . . . 61.5 112.905 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -59.21 129.99 44.81 Favored 'General case' 0 C--O 1.249 1.051 0 CA-C-N 115.754 -0.657 . . . . 61.22 110.959 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 95.59 -10.76 68.83 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 120.863 -0.684 . . . . 63.23 111.706 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . 0.444 ' O ' ' HG2' ' A' ' 563' ' ' MET . 24.0 m -89.27 161.97 16.11 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.642 -1.244 . . . . 73.25 107.642 178.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -99.12 143.19 16.45 Favored Glycine 0 N--CA 1.418 -2.518 0 C-N-CA 119.985 -1.102 . . . . 52.44 113.237 -177.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . 0.406 HG12 ' HG2' ' A' ' 608' ' ' PRO . 13.6 m -94.12 143.42 11.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.374 -0.973 . . . . 75.4 108.374 175.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.438 HD21 HG22 ' A' ' 619' ' ' ILE . 31.1 p30 -58.24 175.41 0.23 Allowed 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 114.21 1.189 . . . . 72.53 114.21 -175.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -55.95 -38.36 70.24 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 125.458 1.503 . . . . 74.43 110.986 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.91 -33.91 68.67 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 115.607 -0.724 . . . . 63.24 109.501 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 82.5 19.74 63.48 Favored Glycine 0 N--CA 1.417 -2.618 0 N-CA-C 109.974 -1.25 . . . . 63.31 109.974 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . 0.438 HG22 HD21 ' A' ' 615' ' ' ASN . 0.0 OUTLIER -70.62 119.44 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 108.629 -0.878 . . . . 72.12 108.629 -174.561 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 8.5 tp -116.26 132.42 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 0 CA-C-N 114.73 -1.123 . . . . 73.52 109.678 -174.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.524 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 32.8 m -105.28 117.53 34.24 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 108.912 -0.773 . . . . 75.34 108.912 178.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 606' ' ' GLN . 72.9 mt -139.09 165.65 26.59 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 105.747 -1.946 . . . . 74.41 105.747 -177.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -142.94 139.54 30.75 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 106.468 -1.678 . . . . 74.21 106.468 173.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -138.77 160.89 38.57 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.145 -1.057 . . . . 63.41 108.145 -177.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -87.15 -117.46 1.14 Allowed Glycine 0 N--CA 1.43 -1.734 0 O-C-N 123.915 0.759 . . . . 54.41 113.35 -177.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 . . . . . 0 C--N 1.298 -1.666 0 N-CA-C 109.21 -0.663 . . . . 74.01 109.21 -174.682 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.822 0 N-CA-C 112.045 -0.422 . . . . 43.05 112.045 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 9.7 tp -75.41 122.3 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 CA-C-O 121.666 0.746 . . . . 75.1 109.224 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 1.5 m -76.47 151.81 36.34 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.342 -0.845 . . . . 61.32 110.166 -176.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -88.1 -28.39 21.33 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.636 -1.246 . . . . 54.51 107.636 176.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -73.41 141.48 46.95 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 107.179 -1.415 . . . . 75.03 107.179 175.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.15 163.51 34.06 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.46 0 N-CA-C 108.226 -1.028 . . . . 70.05 108.226 -177.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -94.46 138.15 32.74 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 105.007 -2.22 . . . . 61.4 105.007 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.407 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 91.9 t -95.3 123.53 56.53 Favored Pre-proline 0 C--N 1.271 -2.825 0 N-CA-C 109.308 -0.627 . . . . 35.41 109.308 -171.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 17.9 Cg_exo -60.89 126.28 19.25 Favored 'Trans proline' 0 N--CA 1.445 -1.349 0 C-N-CA 122.316 2.011 . . . . 70.34 110.995 -178.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -84.62 114.2 21.82 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-O 122.639 1.209 . . . . 75.23 109.326 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.499 HG13 ' HB1' ' A' ' 373' ' ' ALA . 9.2 p -88.21 15.12 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 CA-C-N 113.832 -1.531 . . . . 54.54 111.554 -173.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -56.5 146.69 23.98 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.191 1.396 . . . . 74.55 111.954 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.41 0.47 43.68 Favored Glycine 0 CA--C 1.503 -0.673 0 CA-C-N 116.263 -0.426 . . . . 72.43 113.354 177.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -115.75 -159.39 0.71 Allowed 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 108.273 -1.01 . . . . 75.52 108.273 177.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 60.1 p -90.96 166.83 12.82 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 108.66 -0.867 . . . . 72.51 108.66 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 66.7 m -62.85 -41.13 99.23 Favored 'General case' 0 C--O 1.208 -1.101 0 C-N-CA 120.004 -0.678 . . . . 74.13 110.026 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.49 -46.68 81.97 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 116.728 -0.214 . . . . 71.22 111.563 -178.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -69.09 -39.83 78.77 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.475 0.655 . . . . 72.03 110.002 -176.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . 0.499 ' HB1' HG13 ' A' ' 365' ' ' VAL . . . -67.24 -46.47 73.66 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.582 -0.735 . . . . 74.32 111.285 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.435 HG12 HG21 ' A' ' 384' ' ' ILE . 75.9 mt -64.44 -40.98 90.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-N 116.353 -0.385 . . . . 72.3 110.302 177.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.99 -41.85 88.61 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.378 0.608 . . . . 72.11 110.619 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 87.2 m -63.17 -47.62 81.86 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.655 -0.702 . . . . 51.11 110.756 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 97.6 mt -64.05 -37.99 89.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.337 -0.392 . . . . 65.53 110.7 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . 0.405 HE21 ' HB2' ' A' ' 378' ' ' GLN . 0.1 OUTLIER -63.67 -38.66 91.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.799 -0.637 . . . . 54.43 110.775 178.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -68.9 -24.63 64.33 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 120.981 0.42 . . . . 75.55 111.382 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -82.09 -14.76 55.32 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.153 -0.476 . . . . 75.35 110.757 176.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.95 16.82 43.16 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.212 -0.994 . . . . 53.13 112.257 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -88.16 159.59 18.12 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 121.395 0.617 . . . . 75.33 111.829 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -100.64 132.6 45.95 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 106.824 -1.547 . . . . 62.32 106.824 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.435 HG21 HG12 ' A' ' 374' ' ' ILE . 0.8 OUTLIER -122.89 137.29 56.87 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 N-CA-C 106.824 -1.547 . . . . 72.14 106.824 178.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 417' ' ' THR . 32.5 ttt180 -116.82 138.58 51.41 Favored 'General case' 0 C--N 1.255 -3.533 0 N-CA-C 105.724 -1.954 . . . . 72.2 105.724 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 41.0 m -130.23 132.51 46.0 Favored 'General case' 0 C--N 1.272 -2.786 0 O-C-N 121.771 -0.581 . . . . 63.41 109.483 -174.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.7 121.89 42.95 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.649 -1.241 . . . . 74.31 107.649 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -89.53 122.5 32.75 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.941 -0.763 . . . . 72.01 108.941 -178.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . 0.621 ' O ' ' HA ' ' A' ' 421' ' ' SER . 51.8 mtmt -132.98 135.78 26.49 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 109.028 -0.73 . . . . 74.32 109.028 177.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -76.14 176.6 9.83 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.32 2.014 . . . . 61.32 112.609 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 11.2 t70 87.92 167.82 0.06 Allowed 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 126.351 1.861 . . . . 73.44 110.707 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 32.6 t -105.7 -12.7 15.81 Favored 'General case' 0 N--CA 1.439 -1.022 0 O-C-N 122.35 -0.219 . . . . 64.22 111.222 -175.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 6.0 t -82.63 -3.38 56.12 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 119.198 -1.001 . . . . 70.34 109.548 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 47.6 mm -88.14 146.15 37.65 Favored Pre-proline 0 C--N 1.302 -1.475 0 N-CA-C 106.17 -1.789 . . . . 72.42 106.17 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . 0.44 ' HA ' ' HD2' ' A' ' 396' ' ' PRO . 28.3 Cg_exo -37.94 116.31 0.21 Allowed 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 123.772 2.981 . . . . 74.53 113.12 177.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . 0.528 ' HA ' ' OG ' ' A' ' 421' ' ' SER . 12.2 Cg_endo -57.72 151.99 52.02 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.041 2.494 . . . . 72.22 112.732 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . 0.46 ' HA ' HG23 ' A' ' 420' ' ' VAL . 8.7 p-10 -59.19 -8.17 1.49 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.874 1.27 . . . . 74.51 113.638 -178.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 31.4 m170 -106.55 109.96 22.03 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 104.327 -2.471 . . . . 61.54 104.327 171.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 28.0 m -62.78 119.07 5.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 124.647 1.217 . . . . 74.42 112.567 -165.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . 0.548 ' H ' HD13 ' A' ' 400' ' ' ILE . 0.2 OUTLIER -92.25 -28.22 4.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.4 -0.818 . . . . 73.15 109.89 179.132 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.75 160.11 28.06 Favored Glycine 0 N--CA 1.399 -3.824 0 CA-C-N 115.232 -0.895 . . . . 73.13 111.054 -176.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -114.83 -175.99 2.81 Favored 'General case' 0 C--N 1.27 -2.87 0 C-N-CA 125.351 1.46 . . . . 73.4 108.339 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -99.3 137.3 20.35 Favored Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 107.095 -1.446 . . . . 62.32 107.095 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -54.91 -16.28 11.49 Favored 'Trans proline' 0 C--N 1.365 1.411 0 C-N-CA 124.313 3.342 . . . . 72.32 114.662 -174.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.65 -28.69 68.76 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 116.308 -0.406 . . . . 64.35 110.249 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -73.96 -38.27 64.26 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.507 0.67 . . . . 61.15 110.392 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -81.2 -5.18 57.45 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.499 0.666 . . . . 74.22 110.629 -177.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 30.9 m -95.29 143.56 26.58 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.307 -1.738 . . . . 65.2 106.307 173.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 47.7 m -74.51 112.48 10.73 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 118.441 -1.304 . . . . 63.44 108.666 176.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 28.7 m -127.58 169.2 19.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 115.876 -0.602 . . . . 55.4 109.862 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 29.6 t -71.85 132.62 44.67 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 106.761 -1.57 . . . . 71.32 106.761 175.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -65.46 133.4 51.2 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-O 121.22 0.533 . . . . 61.22 111.157 -175.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 104.89 54.81 0.75 Allowed Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 110.816 -0.914 . . . . 22.51 110.816 -177.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -113.32 -177.23 3.08 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.818 -1.178 . . . . 61.15 107.818 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -107.67 108.88 20.32 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.153 -0.684 . . . . 71.11 109.153 -177.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.6 mm -98.01 116.77 41.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.37 -0.974 . . . . 61.42 108.37 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 385' ' ' ARG . 58.1 m -97.74 130.82 44.68 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 120.849 0.357 . . . . 72.23 110.535 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 4.8 p -118.96 136.18 56.99 Favored 'Isoleucine or valine' 0 C--O 1.252 1.223 0 C-N-CA 123.577 0.751 . . . . 60.44 110.232 -177.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -93.96 120.07 33.72 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.013 -0.736 . . . . 63.5 109.013 176.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.46 HG23 ' HA ' ' A' ' 397' ' ' ASP . 14.7 p -113.81 132.45 62.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 109.7 -0.481 . . . . 71.13 109.7 -178.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . 0.621 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 11.9 p -88.26 125.36 34.61 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.075 0.464 . . . . 72.25 111.301 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 5.6 t -118.36 106.52 12.83 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-O 121.191 0.519 . . . . 74.02 111.379 177.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 70.63 114.1 0.04 OUTLIER Glycine 0 CA--C 1.536 1.398 0 N-CA-C 115.226 0.85 . . . . 73.43 115.226 175.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.53 144.5 97.88 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 122.467 2.111 . . . . 63.01 111.104 174.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.437 ' O ' HD13 ' A' ' 480' ' ' ILE . 33.6 mt-10 -101.05 166.55 10.75 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 109.679 -0.489 . . . . 64.21 109.679 -177.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -88.32 157.58 18.69 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.634 0.254 . . . . 74.12 111.522 -176.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 10.9 mmp_? -122.23 153.81 38.35 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-N 116.312 -0.404 . . . . 72.31 110.456 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 40.6 tt0 -84.83 141.47 30.45 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.418 -1.327 . . . . 72.13 107.418 174.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.423 ' HA ' ' HD3' ' A' ' 430' ' ' PRO . 68.2 mt -78.08 125.92 84.48 Favored Pre-proline 0 N--CA 1.437 -1.121 0 N-CA-C 107.212 -1.403 . . . . 70.44 107.212 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 429' ' ' ILE . 23.4 Cg_exo -67.62 145.05 68.68 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.473 2.115 . . . . 75.15 113.093 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -75.44 104.81 6.16 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 108.992 -0.744 . . . . 64.41 108.992 175.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 46.1 t -116.78 138.01 48.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 107.93 -1.137 . . . . 54.23 107.93 178.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.41 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 18.5 m -68.97 152.33 45.4 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 121.053 0.454 . . . . 74.32 111.025 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 58.3 p -63.89 -34.44 77.95 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 113.535 0.939 . . . . 44.42 113.535 -170.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.6 pp -84.22 -11.32 56.71 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 120.98 0.419 . . . . 73.24 111.842 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.41 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 0.8 OUTLIER -93.95 42.77 1.1 Allowed 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 115.687 -0.688 . . . . 54.24 109.731 -177.6 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -52.14 -39.65 60.25 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.725 1.21 . . . . 75.35 112.989 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.19 -41.79 99.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.085 0.469 . . . . 74.21 110.218 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -71.17 -33.97 70.5 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 116.19 -0.459 . . . . 71.31 110.286 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.46 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -59.43 -51.25 70.68 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.497 -0.127 . . . . 63.14 110.888 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.4 m -61.45 -37.63 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 CA-C-O 121.111 0.481 . . . . 75.43 110.458 177.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -60.52 -48.19 82.86 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.244 1.018 . . . . 65.22 110.908 176.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -66.42 -38.5 87.57 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 123.777 0.831 . . . . 72.4 111.466 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.46 HD13 ' O ' ' A' ' 440' ' ' ALA . 6.9 mp -66.15 -33.96 76.95 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.877 -0.601 . . . . 73.32 110.927 176.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.508 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 56.2 m -70.13 -45.07 67.6 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.251 0.548 . . . . 73.53 109.874 177.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.69 -16.36 64.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.541 -0.754 . . . . 74.01 110.917 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.84 5.67 20.9 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.081 -0.509 . . . . 74.12 111.74 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 100.72 -67.39 0.5 Allowed Glycine 0 CA--C 1.497 -1.088 0 C-N-CA 120.552 -0.832 . . . . 53.33 111.938 175.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -51.54 -59.39 4.31 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.264 0.839 . . . . 71.43 113.264 178.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . 0.508 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 60.76 19.89 55.99 Favored Glycine 0 CA--C 1.505 -0.569 0 CA-C-O 121.25 0.361 . . . . 74.34 113.059 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.498 ' NH2' ' HA ' ' A' ' 481' ' ' THR . 13.6 mtm180 -105.29 111.35 24.06 Favored 'General case' 0 N--CA 1.415 -2.209 0 CA-C-O 121.258 0.552 . . . . 74.01 110.172 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.511 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 15.0 p90 -135.3 145.34 47.4 Favored 'General case' 0 N--CA 1.412 -2.364 0 CA-C-N 114.151 -1.386 . . . . 74.34 109.55 -175.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 26.1 mmtm -136.43 127.24 27.38 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.349 -0.842 . . . . 72.31 108.877 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -90.72 127.26 36.25 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 123.644 0.59 . . . . 74.4 111.369 -174.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -126.85 147.29 50.05 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.905 -1.146 . . . . 75.51 107.905 175.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -122.06 146.5 47.13 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 120.376 -0.53 . . . . 44.55 109.937 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 23.2 t -142.79 137.53 15.21 Favored Pre-proline 0 C--N 1.297 -1.713 0 N-CA-C 107.686 -1.227 . . . . 54.55 107.686 177.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.578 ' HA ' ' O ' ' A' ' 490' ' ' SER . 23.9 Cg_exo -64.92 123.01 10.98 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.738 1.625 . . . . 62.15 110.471 176.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 54.9 m -148.94 -178.31 6.29 Favored 'General case' 0 C--N 1.287 -2.117 0 C-N-CA 124.971 1.308 . . . . 55.42 108.136 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 11.2 t -45.27 134.39 5.58 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 123.727 0.811 . . . . 71.51 112.283 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . 0.463 ' HA ' HG23 ' A' ' 464' ' ' VAL . 9.5 Cg_endo -51.92 -29.21 34.34 Favored 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 124.814 3.676 . . . . 74.45 114.067 -175.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.405 ' O ' ' HD2' ' A' ' 466' ' ' LYS . 11.3 pt-20 -71.77 -19.42 62.02 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 112.055 0.391 . . . . 52.43 112.055 -178.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 72.6 mt -96.09 -2.54 46.4 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 111.601 0.223 . . . . 75.3 111.601 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.463 HG23 ' HA ' ' A' ' 461' ' ' PRO . 87.9 t -60.81 127.39 20.3 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 CA-C-O 120.891 0.377 . . . . 74.52 110.315 178.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 84.7 -10.57 61.86 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.312 -0.858 . . . . 74.05 112.065 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.405 ' HD2' ' O ' ' A' ' 462' ' ' GLU . 50.2 mttp -111.98 166.23 11.41 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 108.182 -1.044 . . . . 73.52 108.182 -176.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.498 ' O ' ' HB ' ' A' ' 434' ' ' THR . 87.2 t -80.41 146.83 7.01 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.294 0 CA-C-N 116.261 -0.427 . . . . 62.53 109.957 -177.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 63.9 mt -98.57 -35.21 4.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 107.439 -1.319 . . . . 42.25 107.439 174.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 156.68 -152.1 23.48 Favored Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 110.166 -1.174 . . . . 64.25 110.166 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 3.6 p -132.15 157.15 45.02 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.547 -0.908 . . . . 73.45 108.547 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -71.82 -46.46 12.17 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 119.728 -0.789 . . . . 75.51 110.625 175.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' ' 473' ' ' PRO . 18.0 Cg_exo -71.15 141.69 40.23 Favored 'Trans proline' 0 C--N 1.374 1.89 0 N-CA-C 107.304 -1.845 . . . . 70.22 107.304 167.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 472' ' ' PRO . 27.9 Cg_exo -62.34 127.54 21.26 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 121.508 1.472 . . . . 43.42 112.063 -177.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -73.99 2.03 9.6 Favored 'General case' 0 C--O 1.201 -1.448 0 C-N-CA 123.646 0.778 . . . . 73.23 112.444 -175.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -110.4 5.4 21.45 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.603 0.716 . . . . 73.22 110.005 175.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -109.12 176.78 4.97 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-N 115.616 -0.72 . . . . 62.33 111.529 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 2.3 p -96.8 145.9 25.41 Favored 'General case' 0 N--CA 1.391 -3.406 0 CA-C-N 114.663 -1.153 . . . . 73.4 110.773 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 49.7 m -137.29 148.06 46.11 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 107.548 -1.279 . . . . 73.3 107.548 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -77.96 159.57 28.74 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 120.715 0.293 . . . . 73.34 110.441 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.437 HD13 ' O ' ' A' ' 425' ' ' GLU . 1.7 mp -65.61 -18.37 23.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.524 0.678 . . . . 71.33 111.316 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . 0.498 ' HA ' ' NH2' ' A' ' 451' ' ' ARG . 7.7 t -87.28 1.91 51.77 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.943 -0.571 . . . . 45.32 111.065 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -93.05 148.91 21.6 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.045 0.45 . . . . 74.24 110.863 -177.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.9 p -108.6 126.34 65.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.568 -1.271 . . . . 72.31 107.568 172.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 26.9 m -105.33 134.25 47.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 121.903 0.859 . . . . 70.54 111.852 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.87 122.61 44.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 114.968 -1.015 . . . . 74.14 110.288 -178.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.416 HD11 HD21 ' A' ' 444' ' ' LEU . 36.2 mm -97.94 113.13 31.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 107.462 -1.31 . . . . 74.44 107.462 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 9.5 tt -99.08 126.24 52.38 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 108.911 -0.774 . . . . 54.24 108.911 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 27.2 m -111.25 151.92 13.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 123.345 0.658 . . . . 65.11 110.668 -178.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -77.37 132.64 12.25 Favored Glycine 0 N--CA 1.424 -2.136 0 CA-C-N 115.562 -0.744 . . . . 71.42 112.553 -178.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.578 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 31.3 t -122.64 160.69 25.25 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 104.401 -2.444 . . . . 53.51 104.401 175.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 169.45 128.49 1.01 Allowed Glycine 0 C--N 1.291 -1.94 0 C-N-CA 118.083 -2.008 . . . . 63.55 112.805 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -84.01 149.46 12.25 Favored 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 122.499 2.133 . . . . 74.1 110.731 176.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . -75.14 84.85 2.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.777 0.799 . . . . 63.33 109.305 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 9.7 p -122.5 144.3 49.16 Favored 'General case' 0 N--CA 1.419 -2.014 0 CA-C-N 114.776 -1.102 . . . . 73.15 111.393 -173.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -139.96 149.48 43.33 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.713 -0.847 . . . . 75.44 108.713 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.548 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 6.5 p-10 -90.65 137.35 32.42 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 109.465 -0.568 . . . . 72.05 109.465 177.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 28.0 pt -91.01 110.45 42.22 Favored Pre-proline 0 C--N 1.304 -1.409 0 CA-C-N 115.698 -0.683 . . . . 74.01 109.856 177.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 496' ' ' ASP . 66.0 Cg_endo -90.71 150.4 4.14 Favored 'Trans proline' 0 N--CA 1.441 -1.562 0 C-N-CA 122.292 1.995 . . . . 72.12 111.97 178.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -78.88 91.5 4.78 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 122.517 1.151 . . . . 54.1 109.976 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 15.3 t -104.37 2.91 10.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.336 -1.357 . . . . 64.14 107.336 177.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -53.79 107.56 0.27 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.293 -1.321 . . . . 55.14 112.754 -175.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 177.85 27.85 0.04 OUTLIER Glycine 0 C--N 1.306 -1.117 0 N-CA-C 111.327 -0.709 . . . . 42.44 111.327 176.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.05 -170.85 3.43 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.267 -0.642 . . . . 71.4 109.267 -178.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 532' ' ' GLY . 8.8 t -84.13 157.91 21.55 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 109.076 -0.713 . . . . 55.23 109.076 -176.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.4 p -48.67 -41.77 12.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 124.194 0.997 . . . . 54.2 112.304 -177.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -61.53 -41.54 97.48 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.72 0.295 . . . . 74.24 111.778 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 47.3 t -76.01 -40.74 38.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-O 121.185 0.517 . . . . 74.3 110.602 -176.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.36 -46.88 84.49 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.068 -0.515 . . . . 61.02 110.224 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -61.95 -35.69 79.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.679 -0.691 . . . . 73.15 110.232 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.452 ' O ' HG23 ' A' ' 514' ' ' VAL . 0.3 OUTLIER -60.55 -43.08 97.63 Favored 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 109.016 -0.735 . . . . 75.42 109.016 177.13 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -62.57 -47.29 84.47 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.598 -0.274 . . . . 72.12 111.445 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.84 -40.07 94.03 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.733 0.301 . . . . 72.03 111.135 178.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.31 -38.16 88.37 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.055 -0.52 . . . . 73.1 110.636 178.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 510' ' ' LYS . 70.1 t -65.99 -31.16 52.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 115.886 -0.597 . . . . 74.24 110.746 176.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -78.44 -8.6 58.68 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.725 -0.39 . . . . 71.21 111.572 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . 0.402 ' O ' ' HB ' ' A' ' 547' ' ' VAL . . . 104.73 0.36 42.58 Favored Glycine 0 CA--C 1.504 -0.624 0 C-N-CA 120.859 -0.686 . . . . 70.31 112.557 177.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.472 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 83.8 m-85 -82.1 101.54 10.45 Favored 'General case' 0 CA--C 1.484 -1.595 0 N-CA-C 108.161 -1.051 . . . . 74.32 108.161 -178.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.5 m -100.0 -4.06 30.83 Favored 'General case' 0 N--CA 1.415 -2.205 0 CA-C-N 114.693 -1.139 . . . . 74.12 110.988 -173.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 97.0 mttt -116.61 114.25 23.84 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.589 -0.893 . . . . 65.34 108.589 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -132.16 152.11 51.44 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.483 -0.78 . . . . 74.13 112.451 -175.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 46.4 m -141.04 134.17 29.39 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.49 -1.3 . . . . 65.25 107.49 171.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 0.0 OUTLIER -118.82 138.84 52.43 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 117.907 0.321 . . . . 54.23 110.214 179.631 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -131.77 143.52 50.28 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.348 -1.353 . . . . 70.11 107.348 177.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 14.9 t -121.24 132.61 54.92 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.083 0.468 . . . . 73.34 110.089 -178.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 34.0 t -124.9 149.57 29.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 106.998 -1.482 . . . . 73.34 106.998 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . 0.605 ' HA ' ' HB3' ' A' ' 557' ' ' LYS . 4.1 p30 -66.59 134.69 52.85 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.892 0.853 . . . . 75.25 109.172 178.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 70.8 m -153.14 167.09 14.12 Favored Pre-proline 0 C--N 1.28 -2.442 0 CA-C-N 114.472 -1.24 . . . . 74.54 108.526 -173.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.86 -24.91 45.9 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.655 1.57 . . . . 54.03 113.055 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.98 142.2 79.26 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.595 -0.275 . . . . 74.33 111.183 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.61 151.78 60.41 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 123.263 2.642 . . . . 75.11 113.232 -178.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -62.47 119.66 9.57 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.366 -0.834 . . . . 74.31 111.44 -176.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 504' ' ' THR . . . 118.09 -22.19 9.85 Favored Glycine 0 N--CA 1.425 -2.049 0 C-N-CA 120.403 -0.903 . . . . 65.44 112.351 177.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -80.1 127.59 32.49 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.496 -0.927 . . . . 65.32 108.496 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 57.4 t -75.98 122.95 31.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 109.212 -0.662 . . . . 75.02 109.212 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . 0.683 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 14.0 t -90.05 -14.86 32.96 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.186 -0.461 . . . . 53.33 110.898 -177.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 153.11 -158.01 27.67 Favored Glycine 0 N--CA 1.429 -1.819 0 N-CA-C 111.325 -0.71 . . . . 75.4 111.325 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 20.9 p -128.68 156.8 42.88 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 109.753 -0.462 . . . . 61.51 109.753 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -70.49 -50.39 14.43 Favored Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 116.298 -0.41 . . . . 72.15 110.077 176.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 18.0 Cg_endo -63.11 135.32 50.29 Favored 'Trans proline' 0 C--N 1.371 1.738 0 N-CA-C 108.368 -1.435 . . . . 71.44 108.368 168.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 31.6 Cg_exo -59.44 140.7 95.43 Favored 'Trans proline' 0 C--O 1.249 1.073 0 C-N-CA 122.656 2.237 . . . . 65.53 113.552 -176.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -67.83 134.66 51.3 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.646 -0.872 . . . . 73.04 108.646 176.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 103.82 -6.83 48.57 Favored Glycine 0 C--N 1.298 -1.551 0 C-N-CA 120.817 -0.706 . . . . 60.45 111.346 -176.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 23.6 m -81.57 131.6 35.28 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.891 -0.411 . . . . 74.42 109.891 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 27.9 m -90.33 122.89 33.62 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 108.087 -1.079 . . . . 70.13 108.087 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 13.0 m -134.88 157.72 76.51 Favored Pre-proline 0 C--N 1.309 -1.159 0 C-N-CA 122.659 0.384 . . . . 74.4 110.188 -177.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 22.6 Cg_exo -67.62 139.93 50.16 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.492 2.128 . . . . 74.13 111.746 177.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.472 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 33.2 m -65.87 -20.04 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 122.265 1.031 . . . . 63.03 110.819 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -78.67 -10.05 59.62 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 113.666 -1.606 . . . . 75.3 111.252 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 94.4 p -96.5 172.96 7.6 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 120.631 -0.428 . . . . 61.25 110.868 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 7.1 p -102.65 129.66 53.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-O 120.904 0.383 . . . . 70.24 111.604 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . 0.493 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -106.33 146.12 13.32 Favored 'Isoleucine or valine' 0 C--O 1.247 0.939 0 CA-C-O 121.181 0.515 . . . . 71.13 109.974 177.216 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -107.63 116.18 31.48 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-O 121.56 0.695 . . . . 73.25 110.861 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 51.7 mt -94.09 134.17 36.79 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 125.129 1.372 . . . . 71.32 108.864 -178.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -113.89 118.86 35.37 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 122.088 0.947 . . . . 73.24 110.921 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 524' ' ' SER . 39.7 t -101.26 139.75 21.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 CA-C-N 114.356 -1.293 . . . . 71.22 109.637 -175.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.683 ' OG ' ' HB ' ' A' ' 535' ' ' THR . 50.2 m -79.02 134.61 36.78 Favored 'General case' 0 N--CA 1.418 -2.032 0 CA-C-O 121.792 0.806 . . . . 72.32 111.172 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.605 ' HB3' ' HA ' ' A' ' 526' ' ' ASP . 11.3 tppt? -101.76 126.08 48.55 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 105.112 -2.181 . . . . 61.04 105.112 171.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -71.64 -45.29 45.85 Favored Glycine 0 CA--C 1.484 -1.906 0 C-N-CA 120.187 -1.006 . . . . 71.54 112.238 -172.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 57.1 t30 62.84 25.17 14.95 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-O 122.701 1.239 . . . . 71.01 109.042 177.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.565 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 94.4 mt-30 -129.35 156.96 43.2 Favored 'General case' 0 C--O 1.25 1.114 0 CA-C-N 114.538 -1.21 . . . . 70.43 110.733 -176.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -130.18 144.12 51.18 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.252 -0.885 . . . . 74.24 108.636 176.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 54.3 t -66.17 125.99 24.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 121.128 0.489 . . . . 64.31 112.278 -178.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . 0.454 ' HA ' ' HD3' ' A' ' 564' ' ' PRO . 53.8 ttp -92.08 130.02 39.59 Favored Pre-proline 0 C--O 1.25 1.126 0 CA-C-N 115.501 -0.772 . . . . 62.25 110.853 -178.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 563' ' ' MET . 15.9 Cg_exo -71.85 169.9 20.09 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.087 2.524 . . . . 75.53 111.512 173.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -67.96 142.19 56.06 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 116.179 -0.464 . . . . 62.41 111.295 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.16 16.92 5.58 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.6 0.714 . . . . 62.52 111.266 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 16.9 m -64.37 130.54 44.19 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.427 -0.806 . . . . 42.32 109.74 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . 0.428 ' H ' ' CG1' ' A' ' 603' ' ' VAL . . . 100.15 24.23 9.85 Favored Glycine 0 C--N 1.308 -1.025 0 C-N-CA 120.655 -0.783 . . . . 64.45 112.478 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 90.6 mtp -109.54 144.51 37.73 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.274 -0.639 . . . . 72.41 109.274 177.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . 0.538 ' CD2' ' HB3' ' A' ' 602' ' ' ARG . 80.5 m-85 -101.34 140.08 36.12 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 107.048 -1.464 . . . . 72.51 107.048 -176.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 55.2 t90 -57.96 -28.72 64.6 Favored 'General case' 0 C--O 1.25 1.108 0 CA-C-O 121.139 0.495 . . . . 74.41 111.886 -177.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 35.8 m -73.4 -22.63 19.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.389 0.614 . . . . 74.21 111.196 -177.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . 0.621 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 12.4 t70 -101.53 -35.43 9.16 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.679 -0.691 . . . . 71.14 109.901 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . 0.42 ' O ' HD13 ' A' ' 578' ' ' LEU . . . -57.82 -50.84 71.93 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.193 0.997 . . . . 73.24 112.818 -177.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.508 ' O ' ' HG2' ' A' ' 579' ' ' ARG . 49.5 mt-10 -55.51 -56.22 31.68 Favored Pre-proline 0 N--CA 1.469 0.515 0 N-CA-C 112.9 0.704 . . . . 64.55 112.9 -178.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -53.95 -33.61 73.06 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 121.54 1.494 . . . . 73.25 113.465 176.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.621 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 35.1 mmt180 -63.81 -47.59 80.22 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.894 -0.78 . . . . 63.41 108.894 177.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.42 HD13 ' O ' ' A' ' 574' ' ' ALA . 9.4 mp -66.08 -39.68 90.22 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.0 -1.0 . . . . 72.1 111.308 -177.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 11.6 mmm180 -65.05 -37.14 86.61 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.376 -0.375 . . . . 70.43 110.855 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.93 -30.87 69.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.362 0.601 . . . . 73.12 110.587 178.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 95.4 mt -81.65 -8.16 59.67 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.428 -0.805 . . . . 61.42 111.085 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 70.81 28.63 70.42 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.702 -0.559 . . . . 50.42 111.702 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 73.3 t90 -62.03 127.9 33.57 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 123.224 0.61 . . . . 71.43 110.569 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 12.1 m -128.24 84.5 2.25 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-O 121.24 0.543 . . . . 62.41 109.734 177.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -135.33 -145.21 5.1 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 109.243 -1.543 . . . . 65.12 109.243 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 26.5 ttt -134.77 125.92 27.91 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 117.262 0.531 . . . . 75.14 110.17 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -115.83 123.26 47.74 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 105.629 -1.989 . . . . 52.34 105.629 173.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -107.83 106.45 16.75 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 116.303 -0.408 . . . . 74.03 111.048 -175.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.62 110.14 22.62 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 106.239 -1.763 . . . . 74.54 106.239 174.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -98.92 -87.4 1.91 Allowed Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 109.663 -1.375 . . . . 73.33 109.663 176.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -102.53 133.02 48.19 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 120.763 0.316 . . . . 70.54 110.749 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -83.86 157.38 22.02 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.9 -1.148 . . . . 61.5 107.9 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 46.4 t -117.62 125.25 73.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 119.617 -0.833 . . . . 43.33 111.503 -175.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -81.63 106.66 13.75 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 105.495 -2.039 . . . . 75.21 105.495 172.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -132.69 -6.72 3.21 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 112.171 0.434 . . . . 43.42 112.171 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 82.94 -178.95 53.1 Favored Glycine 0 N--CA 1.418 -2.527 0 C-N-CA 120.79 -0.719 . . . . 22.22 111.565 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -62.92 -33.56 87.46 Favored Glycine 0 C--N 1.303 -1.28 0 CA-C-N 115.575 -0.312 . . . . 73.13 112.769 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 22.6 m -56.57 -33.63 66.34 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.782 0.66 . . . . 60.42 112.782 -176.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -108.23 -14.59 14.67 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 119.897 -0.721 . . . . 72.21 110.162 178.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 39.89 -160.19 0.0 OUTLIER 'General case' 0 CA--C 1.587 2.368 0 C-N-CA 126.095 1.758 . . . . 71.31 113.379 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -87.55 28.33 1.0 Allowed 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.288 -0.882 . . . . 73.22 110.053 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . 0.538 ' HB3' ' CD2' ' A' ' 570' ' ' PHE 0.254 3.1 ppt_? -102.15 168.5 9.33 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.833 -0.747 . . . . 74.45 112.824 -176.335 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . 0.428 ' CG1' ' H ' ' A' ' 568' ' ' GLY . 7.6 p -56.72 134.52 20.88 Favored 'Isoleucine or valine' 0 C--O 1.25 1.094 0 O-C-N 124.55 1.156 . . . . 62.25 112.23 -176.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 10.5 p -101.64 -32.57 3.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 119.581 -0.847 . . . . 63.53 109.018 177.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -154.81 140.47 18.0 Favored 'General case' 0 C--O 1.25 1.08 0 N-CA-C 107.168 -1.419 . . . . 63.22 107.168 174.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -98.23 122.12 41.0 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.745 -0.835 . . . . 72.14 108.745 173.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.4 ' CB ' ' HB ' ' A' ' 621' ' ' THR . 15.0 t-20 -55.08 -56.15 31.27 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 114.313 1.227 . . . . 73.23 114.313 -177.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -84.09 123.0 3.02 Favored 'Trans proline' 0 N--CA 1.438 -1.755 0 CA-C-N 120.643 1.265 . . . . 64.4 109.43 176.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -64.02 144.82 88.68 Favored 'Trans proline' 0 C--O 1.246 0.912 0 C-N-CA 122.159 1.906 . . . . 64.42 111.193 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -62.69 132.33 51.93 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.121 -0.696 . . . . 74.3 109.121 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 100.1 0.67 56.0 Favored Glycine 0 N--CA 1.437 -1.289 0 C-N-CA 119.766 -1.207 . . . . 71.31 111.994 -177.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 14.2 m -100.97 154.68 18.49 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.596 -0.89 . . . . 73.42 108.596 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -80.13 132.85 11.67 Favored Glycine 0 N--CA 1.431 -1.694 0 N-CA-C 112.111 -0.396 . . . . 71.02 112.111 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 34.9 m -114.5 142.48 27.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 109.35 -0.611 . . . . 51.5 109.35 176.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.565 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 23.3 m-20 -57.75 169.6 0.7 Allowed 'General case' 0 CA--C 1.492 -1.255 0 C-N-CA 124.235 1.014 . . . . 72.53 111.803 -177.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -60.74 -24.6 65.85 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 113.774 -1.557 . . . . 73.04 110.22 172.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -77.07 -35.58 56.53 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 119.831 -0.748 . . . . 72.32 110.058 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 81.02 22.71 60.64 Favored Glycine 0 N--CA 1.426 -2.024 0 C-N-CA 118.484 -1.817 . . . . 74.12 113.409 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.73 119.66 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 122.489 1.138 . . . . 63.0 108.876 -174.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.72 132.93 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 N-CA-C 107.281 -1.377 . . . . 52.04 107.281 -173.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.4 ' HB ' ' CB ' ' A' ' 607' ' ' ASN . 19.0 m -111.09 134.95 52.29 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 121.786 -0.571 . . . . 72.33 111.095 -177.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 84.3 mt -137.54 154.1 49.88 Favored 'General case' 0 CA--C 1.497 -1.087 0 C-N-CA 125.106 1.363 . . . . 62.23 107.775 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 51.0 mmm-85 -128.22 137.36 51.99 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 104.431 -2.433 . . . . 72.3 104.431 169.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -141.87 165.49 27.32 Favored 'General case' 0 C--N 1.28 -2.423 0 O-C-N 124.263 0.977 . . . . 74.43 109.627 -174.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -97.02 -134.62 8.25 Favored Glycine 0 N--CA 1.417 -2.598 0 C-N-CA 120.464 -0.874 . . . . 73.21 112.034 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 . . . . . 0 C--N 1.295 -1.767 0 C-N-CA 123.991 0.916 . . . . 63.22 109.381 -177.629 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.095 0 N-CA-C 110.521 -1.032 . . . . 43.05 110.521 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 9.6 tp -75.86 104.67 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 CA-C-O 122.728 1.251 . . . . 63.21 112.651 -178.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.71 -155.89 0.25 Allowed 'General case' 0 C--N 1.281 -2.377 0 CA-C-N 114.277 -1.329 . . . . 70.32 108.087 174.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -71.66 3.15 4.28 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 122.064 0.935 . . . . 71.3 111.132 174.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -70.06 151.21 45.76 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 125.396 1.479 . . . . 75.22 109.421 175.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.2 m -116.84 159.05 17.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 108.756 -0.831 . . . . 62.22 108.756 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -95.46 136.14 36.21 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 103.697 -2.705 . . . . 70.12 103.697 177.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.408 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 94.0 t -95.46 127.85 40.45 Favored Pre-proline 0 C--N 1.28 -2.443 0 C-N-CA 119.89 -0.724 . . . . 43.41 112.415 -163.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 13.4 Cg_exo -67.56 113.35 2.9 Favored 'Trans proline' 0 N--CA 1.441 -1.597 0 C-N-CA 122.529 2.153 . . . . 62.24 110.306 174.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . 0.505 ' HB2' HG21 ' A' ' 402' ' ' THR . 19.9 p-10 -101.3 111.94 24.31 Favored 'General case' 0 C--N 1.262 -3.196 0 CA-C-N 113.959 -1.473 . . . . 62.42 110.819 -176.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.707 ' HB ' ' NE2' ' A' ' 368' ' ' GLN . 7.0 m -85.73 37.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 114.132 -1.394 . . . . 61.45 113.598 -176.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.513 ' H ' ' HD2' ' A' ' 366' ' ' ARG . 0.0 OUTLIER -65.38 146.79 54.46 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.337 -0.847 . . . . 63.23 110.601 172.38 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.35 -4.53 44.18 Favored Glycine 0 C--N 1.304 -1.249 0 N-CA-C 110.781 -0.927 . . . . 53.32 110.781 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . 0.707 ' NE2' ' HB ' ' A' ' 365' ' ' VAL . 16.4 mt-30 -109.19 -156.8 0.59 Allowed 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 107.658 -1.238 . . . . 64.12 107.658 177.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 60.4 p -99.1 167.15 10.89 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 109.087 -0.708 . . . . 74.5 109.087 -177.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 18.2 p -57.87 -46.67 84.5 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 123.438 0.461 . . . . 72.32 110.63 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.31 -41.9 89.03 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.756 -0.656 . . . . 43.04 112.327 -177.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -69.3 -42.58 75.23 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 121.504 0.669 . . . . 73.44 109.307 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.77 -47.61 74.6 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.381 -0.827 . . . . 63.43 111.577 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 65.6 mt -62.77 -39.99 86.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 65.22 110.836 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.09 -43.86 91.87 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.125 0.488 . . . . 54.44 110.558 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 18.1 m -63.73 -47.22 81.95 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.59 -0.732 . . . . 75.02 109.963 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 98.4 mt -61.91 -41.78 98.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.833 -0.621 . . . . 64.35 110.824 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -63.83 -41.16 97.91 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.896 -0.593 . . . . 42.41 110.51 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -63.12 -27.14 69.18 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 120.907 0.384 . . . . 75.03 111.412 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -90.79 -7.68 51.72 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 112.304 0.483 . . . . 75.31 112.304 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 95.23 7.99 59.1 Favored Glycine 0 C--N 1.307 -1.071 0 C-N-CA 120.856 -0.688 . . . . 61.31 113.055 177.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.448 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 75.0 m-85 -80.13 145.11 32.54 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-O 121.18 0.514 . . . . 74.3 111.385 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -92.07 143.41 26.49 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.603 -1.258 . . . . 62.25 107.603 -178.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.461 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -125.82 154.75 35.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 121.274 0.559 . . . . 63.03 111.267 -178.781 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -136.35 135.2 38.64 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 107.507 -1.294 . . . . 72.13 107.507 174.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 26.4 m -103.06 120.9 41.5 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 108.279 -1.008 . . . . 72.51 108.279 178.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -111.46 119.68 39.62 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 106.786 -1.561 . . . . 73.14 106.786 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.522 HE21 ' N ' ' A' ' 388' ' ' GLN . 0.0 OUTLIER -102.61 131.87 49.09 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.56 0.695 . . . . 73.32 111.851 -177.218 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . 0.674 ' O ' ' HA ' ' A' ' 421' ' ' SER . 99.1 mttt -128.93 150.34 74.93 Favored Pre-proline 0 C--N 1.293 -1.855 0 N-CA-C 106.703 -1.591 . . . . 70.24 106.703 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -71.84 166.29 29.98 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 121.489 1.459 . . . . 75.13 110.558 176.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.463 ' HB2' ' HA ' ' A' ' 424' ' ' PRO . 3.4 m-20 -76.35 87.4 3.14 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-O 121.848 0.833 . . . . 75.44 110.526 176.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . 0.45 ' O ' ' HB ' ' A' ' 393' ' ' THR . 19.6 m -112.38 42.5 1.8 Allowed 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 106.735 -1.579 . . . . 74.41 106.735 173.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 392' ' ' SER . 99.6 m 70.88 29.32 3.1 Favored 'General case' 0 CA--C 1.573 1.861 0 CA-C-O 123.58 1.657 . . . . 33.02 109.551 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 1.7 pt -116.43 151.25 46.73 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 113.6 0.963 . . . . 73.23 113.6 -176.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -24.46 110.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.366 1.498 1 C-N-CA 126.584 4.856 . . . . 73.45 118.258 -175.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -68.45 162.3 41.28 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.262 3.308 . . . . 74.41 110.651 172.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . 0.46 ' HB3' HG23 ' A' ' 420' ' ' VAL . 0.6 OUTLIER -57.21 -13.88 3.6 Favored 'General case' 0 N--CA 1.507 2.396 0 CA-C-O 121.098 0.475 . . . . 74.11 111.882 -176.301 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -84.01 111.04 18.92 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 105.295 -2.113 . . . . 75.14 105.295 178.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.418 HG23 ' HA ' ' A' ' 366' ' ' ARG . 28.0 m -63.0 118.02 4.61 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 O-C-N 124.602 1.189 . . . . 72.33 112.335 -166.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . 0.404 HD13 ' O ' ' A' ' 400' ' ' ILE . 0.0 OUTLIER -106.04 -28.59 2.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 114.84 -1.073 . . . . 64.41 109.727 -176.501 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -144.77 165.46 27.62 Favored Glycine 0 N--CA 1.428 -1.858 0 N-CA-C 110.289 -1.124 . . . . 73.13 110.289 -175.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.505 HG21 ' HB2' ' A' ' 364' ' ' ASP . 9.1 p -118.03 -178.85 3.6 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 113.341 0.867 . . . . 75.11 113.341 -173.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -102.32 140.42 21.12 Favored Pre-proline 0 N--CA 1.437 -1.117 0 N-CA-C 106.607 -1.627 . . . . 73.35 106.607 176.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -55.77 -24.63 47.52 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.314 2.676 . . . . 75.13 114.131 -176.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -62.38 -35.02 77.87 Favored 'General case' 0 C--O 1.209 -1.051 0 CA-C-N 116.543 -0.299 . . . . 72.43 111.368 -177.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -77.92 -35.75 50.21 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.492 0.663 . . . . 63.44 110.928 -178.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -82.02 -10.92 59.08 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.911 -0.586 . . . . 74.41 111.711 -175.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 25.0 m -103.35 160.28 14.83 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 106.428 -1.693 . . . . 72.52 106.428 177.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 5.9 p -76.68 113.0 13.84 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 118.322 0.51 . . . . 72.11 110.744 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 33.4 m -130.76 166.85 27.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.443 -0.577 . . . . 61.14 109.443 177.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 56.3 m -70.07 139.4 52.58 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.819 -0.808 . . . . 65.14 108.819 175.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . 0.448 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -61.7 109.79 1.32 Allowed 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 120.92 0.391 . . . . 62.21 110.5 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 128.72 38.84 0.34 Allowed Glycine 0 N--CA 1.441 -1.003 0 CA-C-N 115.525 -0.761 . . . . 53.54 112.055 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -97.33 -171.7 2.26 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 108.028 -1.101 . . . . 64.35 108.028 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -111.86 124.78 53.1 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 122.771 0.429 . . . . 60.41 111.387 -173.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 46.7 mm -119.24 117.59 54.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 120.756 0.312 . . . . 73.23 110.17 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 13.5 t -89.86 131.03 36.0 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-O 121.348 0.594 . . . . 71.44 109.679 176.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 10.8 p -105.25 135.71 42.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 C-N-CA 124.105 0.962 . . . . 62.3 108.932 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.37 128.19 42.02 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 120.822 -0.351 . . . . 75.21 110.607 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.46 HG23 ' HB3' ' A' ' 397' ' ' ASP . 3.4 p -128.04 131.33 69.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 115.877 -0.601 . . . . 73.45 109.787 173.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . 0.674 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 3.0 p -94.72 122.77 37.67 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-O 121.051 0.453 . . . . 62.05 109.929 174.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.8 t -119.24 106.62 12.51 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-O 121.41 0.624 . . . . 73.01 111.86 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 77.1 124.38 0.24 Allowed Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 115.572 -0.74 . . . . 74.41 114.136 174.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . 0.463 ' HA ' ' HB2' ' A' ' 391' ' ' ASP . 38.2 Cg_exo -64.66 155.4 67.14 Favored 'Trans proline' 0 C--O 1.249 1.063 0 C-N-CA 122.264 1.976 . . . . 65.42 110.207 173.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -72.73 150.22 43.07 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 121.978 0.894 . . . . 73.42 112.414 -174.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.479 ' HG3' ' HB ' ' A' ' 477' ' ' THR . 16.3 tp60 -88.35 139.49 30.43 Favored 'General case' 0 N--CA 1.41 -2.468 0 N-CA-C 105.572 -2.01 . . . . 70.34 105.572 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.592 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 2.9 mmp_? -122.25 140.89 52.08 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.888 -0.725 . . . . 72.12 111.678 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.422 ' O ' ' HD3' ' A' ' 430' ' ' PRO . 9.5 pt-20 -83.74 139.06 32.97 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 114.393 -1.276 . . . . 71.23 110.186 -177.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 57.9 mt -98.41 112.61 62.71 Favored Pre-proline 0 N--CA 1.418 -2.068 0 N-CA-C 106.81 -1.552 . . . . 75.32 106.81 174.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 428' ' ' GLU . 16.3 Cg_exo -73.07 141.07 32.22 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 N-CA-C 107.885 -1.621 . . . . 72.22 107.885 165.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -84.43 132.71 34.54 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 118.205 -1.398 . . . . 34.24 108.833 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 59.4 t -105.7 151.7 7.73 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 N-CA-C 105.968 -1.864 . . . . 73.41 105.968 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 39.2 m -57.08 141.21 46.78 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.213 0.53 . . . . 72.1 111.138 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 36.5 p -64.26 -26.71 68.62 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 114.102 1.149 . . . . 44.14 114.102 -172.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.5 pp -82.93 -15.84 49.76 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 119.841 -0.744 . . . . 73.21 110.92 176.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.81 40.04 1.15 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.284 1.034 . . . . 73.01 109.362 -177.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -52.0 -38.76 57.93 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.522 1.129 . . . . 75.23 112.592 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -60.99 -41.8 97.15 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.037 0.446 . . . . 70.25 110.573 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -70.64 -35.97 73.19 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.963 -0.562 . . . . 61.25 109.602 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.514 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.47 -51.51 69.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.981 -0.554 . . . . 44.44 110.992 -178.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 36.0 m -63.08 -40.89 90.78 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 N-CA-C 112.279 0.474 . . . . 72.31 112.279 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . 0.267 0.1 OUTLIER -68.63 -34.54 75.91 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 113.338 0.866 . . . . 73.33 113.338 177.729 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -64.52 -41.03 96.64 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.284 -1.006 . . . . 75.52 108.284 179.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.514 HD13 ' O ' ' A' ' 440' ' ' ALA . 7.0 mp -63.49 -32.92 74.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.507 -0.77 . . . . 61.25 110.92 176.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.409 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 61.5 m -69.42 -43.02 74.25 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 116.067 -0.515 . . . . 74.03 110.354 177.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.44 -26.01 66.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.638 -0.71 . . . . 75.13 111.209 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.65 -6.15 56.55 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.072 0.463 . . . . 73.52 111.834 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 121.33 -77.1 0.33 Allowed Glycine 0 CA--C 1.495 -1.194 0 C-N-CA 120.314 -0.946 . . . . 60.23 112.227 176.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . 0.43 ' HA ' ' O ' ' A' ' 480' ' ' ILE . 0.5 OUTLIER -40.13 -68.51 0.17 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.134 1.161 . . . . 74.4 114.134 176.738 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . 0.409 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 58.93 25.68 59.7 Favored Glycine 0 C--N 1.318 -0.458 0 C-N-CA 121.589 -0.338 . . . . 34.41 112.645 -177.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.492 ' CB ' ' HA ' ' A' ' 483' ' ' VAL . 52.6 mmt-85 -101.82 111.82 24.22 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 107.258 -1.386 . . . . 73.12 107.258 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -139.14 145.77 39.81 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-O 120.973 0.416 . . . . 74.11 111.175 -176.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -131.47 123.42 28.04 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.046 -1.094 . . . . 55.43 108.046 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -99.3 121.46 41.11 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.98 0.419 . . . . 75.31 110.755 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -116.97 154.47 30.83 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.254 -1.017 . . . . 72.05 108.254 177.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -130.55 141.94 50.47 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.3 -0.63 . . . . 64.2 109.3 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 50.3 m -145.44 149.86 42.27 Favored Pre-proline 0 C--N 1.291 -1.938 0 N-CA-C 109.494 -0.558 . . . . 64.14 109.494 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.686 ' HA ' ' O ' ' A' ' 490' ' ' SER . 36.8 Cg_endo -67.49 127.38 16.35 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.321 2.014 . . . . 74.44 110.651 177.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 50.6 m -147.22 179.51 7.58 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.974 -0.38 . . . . 73.32 109.974 -177.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.8 t -54.31 135.97 60.44 Favored Pre-proline 0 N--CA 1.437 -1.079 0 C-N-CA 123.958 0.903 . . . . 61.14 110.315 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.16 -30.41 32.27 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 124.461 3.441 . . . . 63.14 115.192 -172.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -73.12 -27.83 61.91 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.829 -0.748 . . . . 71.44 112.546 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 83.5 mt -89.23 -11.86 42.44 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.217 0.532 . . . . 72.42 110.252 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.425 HG13 ' HA ' ' A' ' 490' ' ' SER . 70.6 t -60.61 128.76 22.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.447 -0.797 . . . . 74.44 110.457 177.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 96.22 -13.63 65.54 Favored Glycine 0 N--CA 1.432 -1.633 0 CA-C-N 115.058 -0.974 . . . . 73.52 111.553 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -117.27 166.65 12.02 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 109.201 -0.666 . . . . 75.23 109.201 -176.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.476 ' O ' ' HB ' ' A' ' 434' ' ' THR . 72.0 t -70.68 147.22 11.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 N-CA-C 107.993 -1.114 . . . . 75.44 107.993 173.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 64.3 mt -97.74 -35.88 5.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 107.008 -1.479 . . . . 53.13 107.008 176.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 169.3 -178.84 42.25 Favored Glycine 0 N--CA 1.416 -2.64 0 N-CA-C 109.789 -1.324 . . . . 62.43 109.789 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . 0.555 HG22 HG12 ' A' ' 486' ' ' ILE . 41.4 p -115.65 137.95 51.56 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 107.262 -1.384 . . . . 73.41 107.262 178.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.496 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 0.2 OUTLIER -62.85 -47.43 87.15 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 120.726 -0.389 . . . . 63.01 110.058 -179.494 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.496 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 12.9 Cg_exo -77.05 132.77 13.03 Favored 'Trans proline' 0 C--N 1.365 1.438 0 N-CA-C 106.852 -2.019 . . . . 63.52 106.852 167.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.88 127.04 20.29 Favored 'Trans proline' 0 C--O 1.239 0.564 0 C-N-CA 121.902 1.735 . . . . 65.14 112.739 -174.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -85.24 16.78 3.38 Favored 'General case' 0 C--O 1.203 -1.35 0 CA-C-N 114.949 -1.023 . . . . 74.43 110.89 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -112.27 -6.09 14.11 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.771 -0.65 . . . . 74.21 110.089 173.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -111.62 -175.29 2.66 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 115.598 -0.728 . . . . 71.11 110.96 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.479 ' HB ' ' HG3' ' A' ' 426' ' ' GLN . 0.6 OUTLIER -90.89 148.82 22.21 Favored 'General case' 0 N--CA 1.404 -2.774 0 CA-C-N 115.32 -0.854 . . . . 55.15 111.45 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 27.1 t -133.65 149.67 51.56 Favored 'General case' 0 C--O 1.26 1.658 0 N-CA-C 108.683 -0.858 . . . . 62.25 108.683 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -79.63 157.46 27.28 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.139 -0.482 . . . . 60.44 109.739 178.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 449' ' ' PHE . 37.6 mm -71.07 -21.03 21.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.877 0.846 . . . . 72.24 109.919 -176.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 17.4 p -100.02 5.92 45.08 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.786 -0.643 . . . . 72.33 112.045 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . 0.401 ' O ' ' HB2' ' A' ' 451' ' ' ARG . 54.4 t-20 -87.76 128.93 35.32 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.348 -0.612 . . . . 74.42 109.348 -176.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.492 ' HA ' ' CB ' ' A' ' 451' ' ' ARG . 40.0 t -96.81 113.47 31.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.318 -0.993 . . . . 74.34 108.318 177.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 21.2 m -91.37 129.04 42.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 121.479 0.656 . . . . 72.02 111.378 -177.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -94.27 125.43 46.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-O 121.537 0.684 . . . . 74.2 109.259 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.555 HG12 HG22 ' A' ' 470' ' ' THR . 6.0 mt -115.2 124.37 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 CA-C-N 114.658 -1.156 . . . . 73.02 109.566 -176.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 10.8 tt -104.75 126.82 59.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-O 121.021 0.439 . . . . 64.24 110.386 -176.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 32.9 m -108.22 151.77 10.27 Favored 'Isoleucine or valine' 0 C--O 1.252 1.232 0 CA-C-N 115.878 -0.601 . . . . 64.43 110.221 178.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.7 136.2 13.86 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 110.746 -0.942 . . . . 73.23 110.746 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.686 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 12.5 t -139.15 160.37 39.95 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.041 -0.726 . . . . 74.32 109.041 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 86.92 76.97 1.25 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 114.963 0.745 . . . . 74.43 114.963 176.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -87.26 122.23 1.77 Allowed 'Trans proline' 0 N--CA 1.439 -1.704 0 C-N-CA 121.892 1.728 . . . . 71.35 110.54 175.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . -101.09 23.95 10.09 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 122.465 1.126 . . . . 72.52 109.649 -178.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.458 ' HB ' ' OG1' ' A' ' 544' ' ' THR . 9.9 p -120.43 143.42 48.49 Favored 'General case' 0 C--N 1.273 -2.726 0 CA-C-N 113.695 -1.593 . . . . 72.04 110.267 -177.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -138.58 151.68 47.5 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.002 -1.111 . . . . 72.21 108.002 177.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.591 ' OD1' ' HB ' ' A' ' 544' ' ' THR . 69.0 m-20 -80.62 126.42 31.24 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.538 -1.282 . . . . 74.52 107.538 176.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 28.4 pt -76.06 126.54 86.66 Favored Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 123.381 0.425 . . . . 74.3 111.957 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -92.51 156.78 2.99 Favored 'Trans proline' 0 N--CA 1.445 -1.363 0 C-N-CA 122.674 2.249 . . . . 71.51 110.454 173.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -79.32 109.61 13.83 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 122.301 1.048 . . . . 61.03 109.972 178.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.2 p -95.05 17.08 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 122.871 1.32 . . . . 64.22 108.08 178.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -81.74 72.26 8.79 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 114.319 -1.309 . . . . 71.33 110.949 -177.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . -158.17 10.04 0.21 Allowed Glycine 0 C--N 1.291 -1.935 0 CA-C-N 114.793 -1.094 . . . . 42.22 110.71 177.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -139.92 176.44 8.75 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 106.378 -1.712 . . . . 73.01 106.378 -173.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 30.2 p -83.01 159.98 22.08 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 109.405 -0.591 . . . . 72.14 109.405 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.7 p -50.54 -41.11 19.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 123.84 0.856 . . . . 74.41 112.47 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -63.68 -42.41 98.03 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.344 0.593 . . . . 63.2 111.089 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 61.6 t -75.9 -38.62 36.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.806 -0.634 . . . . 71.5 110.105 -177.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.18 -48.56 77.86 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.105 -0.498 . . . . 52.35 111.442 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -61.95 -38.56 88.96 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.234 0.334 . . . . 60.35 110.541 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.487 ' O ' HG23 ' A' ' 514' ' ' VAL . 6.3 tmtm? -59.2 -48.96 79.66 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.937 -0.764 . . . . 65.31 108.937 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -62.65 -42.26 99.51 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 116.274 -0.421 . . . . 62.3 111.346 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 97.4 mt -65.26 -40.65 94.23 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.335 -0.393 . . . . 75.43 111.494 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -61.78 -37.98 86.37 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.951 -0.388 . . . . 62.02 109.951 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 510' ' ' LYS . 73.2 t -61.97 -35.75 70.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 115.633 -0.712 . . . . 54.23 110.83 176.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -78.92 -8.1 58.57 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 112.101 0.408 . . . . 73.02 112.101 -178.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 112.47 -13.44 25.48 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.439 -0.886 . . . . 74.34 112.381 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -81.43 95.75 7.16 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 106.905 -1.517 . . . . 73.22 106.905 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.8 m -98.17 -3.6 37.3 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 119.695 -0.802 . . . . 72.11 111.497 -172.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -120.54 114.56 21.92 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.457 -0.572 . . . . 71.33 109.457 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -131.35 150.76 52.02 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.903 -0.59 . . . . 71.2 110.775 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 49.7 m -127.94 143.23 51.09 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 107.445 -1.317 . . . . 73.31 107.445 174.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.31 125.6 51.34 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-O 120.906 0.384 . . . . 63.42 111.641 -178.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 554' ' ' GLN . . . -116.31 117.17 29.25 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.617 -0.883 . . . . 65.01 108.617 178.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 19.5 m -94.92 131.63 40.63 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.089 0.471 . . . . 71.23 112.144 -176.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 28.6 m -121.29 153.29 24.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 107.703 -1.221 . . . . 71.01 107.703 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -84.83 139.33 31.99 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.77 -0.772 . . . . 74.24 111.626 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 64.9 p -162.27 156.71 18.81 Favored Pre-proline 0 C--O 1.19 -2.066 0 N-CA-C 106.549 -1.649 . . . . 70.13 106.549 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -61.07 -12.89 24.82 Favored 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 122.005 1.803 . . . . 74.02 113.383 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -70.59 130.86 88.45 Favored Pre-proline 0 N--CA 1.45 -0.443 0 N-CA-C 108.52 -0.918 . . . . 74.4 108.52 178.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.3 147.26 78.07 Favored 'Trans proline' 0 C--O 1.253 1.25 0 C-N-CA 122.761 2.307 . . . . 74.41 113.301 -177.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.659 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -59.15 127.85 34.22 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.896 -1.047 . . . . 73.03 111.367 -175.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 119.43 -19.15 9.96 Favored Glycine 0 C--N 1.3 -1.424 0 N-CA-C 111.16 -0.776 . . . . 64.3 111.16 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -72.54 132.45 43.83 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.227 -0.657 . . . . 74.24 109.227 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 59.6 t -89.42 113.96 26.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 108.664 -0.865 . . . . 72.24 108.664 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . 0.444 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 11.4 t -86.96 -20.49 27.22 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.695 -0.402 . . . . 72.31 111.173 -176.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 169.92 -163.4 36.82 Favored Glycine 0 CA--C 1.494 -1.239 0 C-N-CA 120.412 -0.899 . . . . 75.34 111.29 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 46.0 p -129.45 154.8 46.61 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.181 -1.414 . . . . 75.42 107.181 176.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -68.53 -54.2 14.78 Favored Pre-proline 0 C--N 1.309 -1.153 0 C-N-CA 119.959 -0.697 . . . . 63.32 110.446 177.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.32 136.91 29.94 Favored 'Trans proline' 0 C--N 1.371 1.74 0 CA-C-N 119.887 0.996 . . . . 62.51 110.009 175.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.1 145.08 65.85 Favored 'Trans proline' 0 C--O 1.254 1.284 0 C-N-CA 122.692 2.262 . . . . 74.44 113.186 -178.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.94 141.72 57.86 Favored 'General case' 0 C--O 1.247 0.952 0 CA-C-N 115.804 -0.634 . . . . 74.52 110.5 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 99.32 -12.03 61.75 Favored Glycine 0 N--CA 1.432 -1.604 0 CA-C-N 115.695 -0.684 . . . . 72.33 111.428 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 49.8 m -77.28 132.7 38.79 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 108.875 -0.787 . . . . 52.11 108.875 177.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.591 ' HB ' ' OD1' ' A' ' 496' ' ' ASP . 10.0 t -87.69 124.05 33.16 Favored 'General case' 0 N--CA 1.419 -2.006 0 CA-C-O 121.304 0.573 . . . . 72.35 109.699 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 19.6 m -125.88 154.89 73.59 Favored Pre-proline 0 C--N 1.297 -1.697 0 N-CA-C 108.15 -1.056 . . . . 73.31 108.15 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 13.1 Cg_exo -71.82 136.22 27.28 Favored 'Trans proline' 0 N--CA 1.443 -1.472 0 C-N-CA 121.842 1.694 . . . . 75.32 110.168 175.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 32.6 m -64.96 -19.89 26.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.941 0.877 . . . . 75.22 110.512 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -76.12 -14.86 60.17 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.247 -1.342 . . . . 71.13 111.027 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 67.4 m -94.51 -171.93 2.63 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.215 -0.448 . . . . 73.12 111.92 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 18.1 t -116.02 126.61 73.59 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 CA-C-N 116.262 -0.426 . . . . 63.34 110.325 -174.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . 0.51 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -102.49 145.91 11.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.556 -0.535 . . . . 63.15 109.556 175.697 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -108.82 121.46 45.11 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-O 121.406 0.622 . . . . 75.12 111.085 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 59.4 mt -97.99 134.5 41.02 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.389 -1.278 . . . . 74.12 108.315 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 523' ' ' ALA . 2.0 pt20 -106.33 119.5 39.41 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-O 122.158 0.98 . . . . 73.3 109.847 177.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 524' ' ' SER . 57.2 t -105.82 145.5 13.77 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 CA-C-N 113.898 -1.501 . . . . 75.42 109.977 -171.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.659 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 63.3 m -83.41 133.65 34.92 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-O 121.602 0.715 . . . . 55.45 111.613 178.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.77 137.35 42.71 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 104.829 -2.285 . . . . 75.22 104.829 169.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . 0.481 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -75.87 -47.82 11.07 Favored Glycine 0 N--CA 1.433 -1.524 0 C-N-CA 118.42 -1.847 . . . . 54.2 110.763 -175.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 5.7 t30 61.24 -7.51 0.09 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 113.458 0.91 . . . . 71.51 113.458 175.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.481 ' H ' ' C ' ' A' ' 558' ' ' GLY . 25.4 tp60 -139.32 141.23 37.7 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 103.354 -2.832 . . . . 64.43 103.354 -177.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -141.82 153.26 44.39 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 118.653 0.66 . . . . 72.24 111.067 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 70.2 t -69.58 118.19 13.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 N-CA-C 108.764 -0.828 . . . . 75.41 108.764 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 58.8 ttp -88.87 134.36 33.78 Favored Pre-proline 0 C--N 1.304 -1.395 0 C-N-CA 120.376 -0.529 . . . . 52.24 110.392 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -66.03 161.92 37.72 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.518 2.146 . . . . 75.23 109.92 171.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -80.89 132.68 35.46 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.147 -0.621 . . . . 75.11 111.793 -177.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . 0.466 HD12 ' SD ' ' A' ' 569' ' ' MET . 39.7 tp -138.16 19.28 2.79 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.326 -1.361 . . . . 71.22 107.326 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 11.9 m -73.72 131.37 41.53 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.25 -0.886 . . . . 43.34 110.707 -173.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . 0.462 ' H ' ' HB ' ' A' ' 603' ' ' VAL . . . 71.56 9.87 69.95 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 114.397 0.519 . . . . 52.54 114.397 176.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . 0.466 ' SD ' HD12 ' A' ' 566' ' ' LEU . 86.7 mtp -90.73 153.63 20.13 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.197 -0.668 . . . . 73.54 109.197 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 98.8 m-85 -73.24 140.28 46.78 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 120.721 0.296 . . . . 75.31 110.757 -175.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . 0.409 ' HA ' ' HB3' ' A' ' 574' ' ' ALA . 32.1 t90 -66.01 -17.89 64.98 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 123.859 0.864 . . . . 74.0 110.335 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 35.3 m -78.05 -24.2 13.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.244 0.545 . . . . 64.44 109.96 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . 0.644 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 31.4 t70 -101.43 -28.26 12.68 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.341 -0.845 . . . . 73.23 109.637 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . 0.409 ' HB3' ' HA ' ' A' ' 571' ' ' TRP . . . -65.92 -32.37 73.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.86 -0.609 . . . . 52.04 110.851 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.54 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 12.9 tp10 -57.79 -53.29 67.24 Favored Pre-proline 0 CA--C 1.583 2.235 0 CA-C-N 115.879 -0.6 . . . . 73.23 111.136 177.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 573' ' ' ASP . 50.6 Cg_exo -59.56 -36.64 92.29 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 121.32 1.346 . . . . 71.31 112.699 171.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.644 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 22.8 mmt180 -59.8 -44.66 93.85 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 120.75 0.309 . . . . 65.2 110.677 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.4 pp -65.44 -40.43 93.27 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.024 -0.535 . . . . 74.01 112.247 -175.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . 0.452 ' N ' HD12 ' A' ' 578' ' ' LEU . 73.6 mtp180 -65.72 -35.39 80.61 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.148 0.499 . . . . 73.04 110.951 176.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.33 -39.11 74.93 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.001 -0.545 . . . . 74.43 111.192 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 89.0 mt -83.03 -7.27 59.68 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.385 0.513 . . . . 74.35 112.385 -177.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 74.28 39.52 43.49 Favored Glycine 0 C--O 1.241 0.585 0 C-N-CA 120.638 -0.791 . . . . 72.24 111.533 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 33.2 t90 -67.72 127.16 31.73 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 109.579 -0.526 . . . . 65.43 109.579 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 3.7 m -116.76 10.3 14.21 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.466 -0.938 . . . . 64.12 108.466 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -77.69 177.4 53.0 Favored Glycine 0 N--CA 1.431 -1.67 0 CA-C-N 115.354 -0.839 . . . . 74.5 113.51 -173.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 52.4 tpp -104.24 140.3 38.04 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 109.235 -0.654 . . . . 72.43 109.235 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -80.58 130.23 35.0 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.071 -1.826 . . . . 74.44 106.071 176.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -95.04 102.07 13.86 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.486 0.66 . . . . 73.24 110.592 -176.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -88.38 110.17 20.58 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.914 -1.039 . . . . 74.52 109.228 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . 0.435 ' HA3' ' NH2' ' A' ' 623' ' ' ARG . . . -114.22 -86.73 1.46 Allowed Glycine 0 N--CA 1.43 -1.706 0 N-CA-C 109.7 -1.36 . . . . 54.02 109.7 176.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.19 147.99 42.54 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.21 -1.034 . . . . 63.35 108.21 176.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -90.74 141.39 28.85 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.214 -1.032 . . . . 64.35 108.214 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 60.8 t -107.43 121.7 60.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 110.575 -0.157 . . . . 63.35 110.575 -173.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -86.55 107.5 18.15 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.165 -1.014 . . . . 42.15 108.577 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -150.03 22.67 0.86 Allowed 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.974 -0.75 . . . . 61.43 108.974 -177.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 92.06 82.35 1.46 Allowed Glycine 0 N--CA 1.424 -2.147 0 N-CA-C 109.385 -1.486 . . . . 41.42 109.385 -176.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.18 -43.85 88.9 Favored Glycine 0 C--O 1.208 -1.49 0 O-C-N 123.93 0.429 . . . . 72.2 112.645 -175.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 25.5 m -59.23 -28.72 66.94 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 113.377 0.88 . . . . 73.04 113.377 -178.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -106.85 -12.59 15.45 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.367 0.603 . . . . 62.23 111.456 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . 0.5 ' C ' ' H ' ' A' ' 602' ' ' ARG . 35.6 m80 -130.62 22.22 5.07 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 113.49 0.922 . . . . 65.15 113.49 -173.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -77.41 37.57 0.22 Allowed 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 122.429 1.109 . . . . 54.31 109.761 175.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 12.1 ptt180 -125.44 166.53 16.44 Favored 'General case' 0 N--CA 1.412 -2.368 0 C-N-CA 125.703 1.601 . . . . 74.34 108.305 -176.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . 0.462 ' HB ' ' H ' ' A' ' 568' ' ' GLY . 55.6 t -63.46 129.84 27.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.458 -0.941 . . . . 75.34 108.458 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 35.3 m -94.66 -45.02 13.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 119.999 -0.681 . . . . 72.44 110.464 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -131.02 146.59 52.44 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 106.062 -1.829 . . . . 73.24 106.062 174.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . 0.41 ' OE1' ' HD2' ' A' ' 608' ' ' PRO . 0.1 OUTLIER -120.51 129.33 53.78 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 107.331 -1.359 . . . . 70.25 107.331 -175.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.548 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 30.5 t30 -84.9 -71.76 0.1 Allowed Pre-proline 0 CA--C 1.563 1.465 0 N-CA-C 114.687 1.366 . . . . 64.1 114.687 -173.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 6.1 Cg_exo -76.14 114.77 3.98 Favored 'Trans proline' 0 C--N 1.372 1.775 0 CA-C-N 122.05 1.768 . . . . 51.02 109.547 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -63.29 135.57 50.98 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 122.476 2.117 . . . . 55.14 114.205 -171.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.84 138.69 56.3 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.041 -0.981 . . . . 63.43 109.379 177.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 94.45 -19.54 53.02 Favored Glycine 0 C--N 1.302 -1.319 0 N-CA-C 110.662 -0.975 . . . . 63.41 110.662 -176.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 28.9 m -98.58 162.75 12.97 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 107.878 -1.156 . . . . 72.03 107.878 178.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -74.39 116.47 5.2 Favored Glycine 0 N--CA 1.424 -2.137 0 CA-C-O 121.43 0.461 . . . . 55.14 112.462 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 20.5 m -104.94 144.48 14.68 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 107.194 -1.409 . . . . 64.3 107.194 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.517 HD21 HG22 ' A' ' 619' ' ' ILE . 28.4 p30 -48.43 148.59 1.9 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 112.513 0.561 . . . . 70.24 112.513 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -55.38 -24.42 29.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.598 -0.728 . . . . 72.25 112.408 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . 0.467 ' OD2' ' HB ' ' A' ' 619' ' ' ILE . 19.2 t70 -61.52 -53.22 59.19 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.569 -1.271 . . . . 73.34 107.569 175.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 96.5 19.33 27.93 Favored Glycine 0 N--CA 1.419 -2.445 0 CA-C-N 114.992 -1.004 . . . . 60.31 111.416 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . 0.517 HG22 HD21 ' A' ' 615' ' ' ASN . 0.0 OUTLIER -69.18 119.93 15.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 122.151 0.977 . . . . 55.51 109.73 -173.433 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.27 130.37 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.602 0 CA-C-N 114.611 -1.177 . . . . 75.03 108.158 -176.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 6.5 m -98.26 118.01 33.95 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.38 -0.97 . . . . 73.43 108.38 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . 0.604 ' O ' ' HD2' ' A' ' 623' ' ' ARG . 2.4 pt? -138.78 157.69 45.61 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.063 -0.517 . . . . 70.25 109.814 -177.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . 0.604 ' HD2' ' O ' ' A' ' 622' ' ' LEU . 6.9 mpt_? -129.63 143.08 50.66 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 105.202 -2.147 . . . . 73.43 105.202 171.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -141.22 165.23 28.1 Favored 'General case' 0 C--N 1.293 -1.861 0 O-C-N 123.896 0.747 . . . . 75.34 110.51 -178.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -66.55 138.74 36.23 Favored Glycine 0 N--CA 1.426 -2.004 0 CA-C-N 114.813 -1.085 . . . . 64.33 112.726 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 C--N 1.286 -2.158 0 C-N-CA 124.736 1.214 . . . . 74.44 109.02 -178.349 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.967 0 N-CA-C 110.188 -1.165 . . . . 43.05 110.188 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 10.3 tp -74.69 139.68 18.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.923 -0.769 . . . . 74.22 108.923 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 19.2 m -105.03 150.79 24.67 Favored 'General case' 0 N--CA 1.416 -2.138 0 N-CA-C 109.171 -0.678 . . . . 75.32 109.171 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.458 ' HD2' ' H ' ' A' ' 358' ' ' ARG . 0.1 OUTLIER -116.08 86.38 2.47 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 106.126 -1.805 . . . . 73.32 106.126 174.614 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.49 130.63 43.85 Favored 'General case' 0 CA--C 1.48 -1.725 0 CA-C-N 112.999 -1.91 . . . . 45.21 108.887 -176.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 409' ' ' SER . 31.2 m -133.81 159.51 42.45 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 CA-C-N 115.332 -0.849 . . . . 43.34 108.747 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . 0.408 HE21 ' HB3' ' A' ' 361' ' ' GLN . 9.6 mt-30 -93.99 138.26 32.3 Favored 'General case' 0 N--CA 1.39 -3.437 0 N-CA-C 107.45 -1.315 . . . . 72.43 107.45 174.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 78.1 t -95.72 129.43 34.52 Favored Pre-proline 0 C--N 1.267 -3.001 0 CA-C-N 115.297 -0.865 . . . . 63.44 109.056 -172.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -57.77 127.71 26.28 Favored 'Trans proline' 0 CA--C 1.498 -1.302 0 C-N-CA 122.233 1.955 . . . . 73.44 110.153 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -80.21 126.36 31.02 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.196 -1.039 . . . . 75.32 108.196 -174.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 10.7 m -88.88 1.24 7.15 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 N-CA-C 113.387 0.884 . . . . 71.45 113.387 -173.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -56.48 144.7 30.31 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 123.584 0.552 . . . . 73.25 111.206 176.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.69 -16.6 47.43 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.728 -0.669 . . . . 53.12 112.398 -178.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -99.27 -156.12 0.53 Allowed 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 108.368 -0.975 . . . . 73.13 108.368 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 95.8 p -98.86 175.1 6.07 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 107.375 -1.343 . . . . 53.21 107.375 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.0 p -63.17 -44.71 94.66 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 109.799 -0.445 . . . . 71.34 109.799 175.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.58 -46.27 83.44 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 116.216 -0.447 . . . . 72.03 111.299 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 369' ' ' SER . 4.1 m-20 -64.52 -38.47 91.14 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 121.0 0.429 . . . . 73.54 111.64 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -67.49 -47.88 68.72 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.98 -0.554 . . . . 64.22 110.575 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 82.1 mt -60.98 -43.72 96.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-N 115.728 -0.669 . . . . 75.52 110.411 176.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.76 -42.75 89.63 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 115.856 -0.611 . . . . 65.2 111.002 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . 0.564 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 31.2 m -67.37 -48.01 68.7 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.738 -0.664 . . . . 74.33 110.228 -178.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 92.0 mt -64.64 -39.0 92.92 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 112.152 0.427 . . . . 75.21 112.152 -178.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -64.43 -41.21 96.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.803 0.335 . . . . 72.22 110.176 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -70.05 -20.56 63.23 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 112.176 0.436 . . . . 70.03 112.176 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . 0.564 ' HG2' ' O ' ' A' ' 376' ' ' THR . 5.9 mmp_? -86.43 -12.62 48.6 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.023 0.439 . . . . 71.42 109.869 176.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.09 3.95 55.53 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 121.182 -0.532 . . . . 72.53 112.982 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -80.66 164.81 22.56 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-O 120.954 0.407 . . . . 74.4 110.301 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -108.43 141.52 40.17 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 107.531 -1.285 . . . . 71.12 107.531 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.472 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -124.58 152.79 30.86 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.491 0 CA-C-O 121.323 0.583 . . . . 71.05 110.199 -177.039 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -133.07 127.05 33.18 Favored 'General case' 0 N--CA 1.4 -2.974 0 N-CA-C 106.644 -1.613 . . . . 65.41 106.644 175.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 21.0 m -118.36 123.27 44.89 Favored 'General case' 0 C--N 1.271 -2.821 0 N-CA-C 107.887 -1.153 . . . . 74.24 107.887 -175.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.17 121.37 44.74 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.873 -1.158 . . . . 71.35 107.873 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.447 ' HB3' HG21 ' A' ' 422' ' ' THR . 1.4 mp0 -94.08 126.67 39.43 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.3 -0.629 . . . . 75.05 109.3 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . 0.409 ' HD2' HG21 ' A' ' 394' ' ' ILE . 97.3 mttt -130.87 136.57 29.11 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 110.055 -0.35 . . . . 64.03 110.055 175.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.57 ' HA ' ' O ' ' A' ' 422' ' ' THR . 23.5 Cg_exo -68.06 166.45 24.85 Favored 'Trans proline' 0 C--O 1.248 0.984 0 C-N-CA 122.066 1.844 . . . . 62.01 110.125 172.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 2.9 m-20 85.04 170.25 0.08 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.349 1.059 . . . . 64.14 110.645 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 69.3 p -108.82 9.28 26.84 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 120.677 0.275 . . . . 70.34 111.39 -176.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 15.4 t -78.43 -7.02 56.91 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.627 0.727 . . . . 50.22 110.901 -177.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.515 HD13 ' H ' ' A' ' 394' ' ' ILE . 0.2 OUTLIER -115.87 151.5 46.47 Favored Pre-proline 0 C--N 1.298 -1.656 0 N-CA-C 107.882 -1.155 . . . . 65.53 107.882 175.798 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -32.79 131.24 0.1 Allowed 'Trans proline' 0 C--N 1.363 1.316 0 C-N-CA 124.569 3.513 . . . . 75.43 114.928 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.25 164.37 3.85 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 124.476 3.451 . . . . 72.32 113.352 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -56.43 -8.64 0.56 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.525 1.13 . . . . 74.11 112.355 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 60.3 m170 -115.79 131.61 56.89 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 104.563 -2.384 . . . . 65.43 104.563 170.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 24.7 m -71.03 117.15 13.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-O 121.978 0.894 . . . . 65.4 111.453 -169.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 50.0 mm -102.99 -26.66 3.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.078 -1.082 . . . . 54.02 108.078 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -144.31 157.53 27.2 Favored Glycine 0 N--CA 1.399 -3.807 0 N-CA-C 109.486 -1.446 . . . . 42.21 109.486 -178.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 8.0 p -146.56 -176.17 5.08 Favored 'General case' 0 C--N 1.275 -2.662 0 C-N-CA 125.111 1.364 . . . . 71.44 107.808 -172.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -100.58 139.74 20.85 Favored Pre-proline 0 C--N 1.29 -2.004 0 N-CA-C 108.272 -1.01 . . . . 72.12 108.272 -174.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.21 -12.89 6.02 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 123.951 3.101 . . . . 74.32 114.691 -176.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -50.05 -41.29 47.44 Favored 'General case' 0 C--O 1.212 -0.902 0 C-N-CA 123.742 0.817 . . . . 73.35 111.584 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -71.46 -32.77 68.68 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.291 0.567 . . . . 54.11 111.398 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -85.32 -1.17 56.68 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.709 0.766 . . . . 70.34 110.683 -177.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 19.0 m -102.19 151.01 22.71 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 107.1 -1.444 . . . . 64.54 107.1 174.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 360' ' ' VAL . 20.2 m -74.68 113.83 12.4 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 108.876 -0.787 . . . . 64.33 108.876 178.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.6 m -120.24 170.3 10.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 116.272 -0.422 . . . . 73.23 110.551 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 25.8 t -77.38 150.97 35.04 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.096 -1.076 . . . . 73.43 108.096 176.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -65.61 122.12 16.52 Favored 'General case' 0 C--O 1.245 0.836 0 N-CA-C 109.413 -0.588 . . . . 52.13 109.413 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 94.62 68.25 1.04 Allowed Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 110.25 -1.14 . . . . 42.2 110.25 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -127.96 -179.51 5.01 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.528 -1.286 . . . . 50.33 107.528 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -111.4 119.65 39.53 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.049 0.452 . . . . 74.34 110.674 -174.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 46.1 mm -106.21 120.83 57.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 109.203 -0.666 . . . . 63.52 109.203 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 22.4 p -92.55 130.88 38.07 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.016 0.436 . . . . 74.45 111.307 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 5.4 p -126.82 135.33 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 109.072 -0.714 . . . . 54.1 109.072 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . 0.439 ' H ' HD22 ' A' ' 419' ' ' ASN . 0.0 OUTLIER -111.81 125.76 54.35 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 109.41 -0.589 . . . . 73.31 109.41 178.705 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 11.5 p -121.51 143.93 32.32 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 115.478 -0.783 . . . . 63.1 110.727 -174.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 31.3 t -84.16 121.46 27.48 Favored 'General case' 0 C--O 1.252 1.197 0 CA-C-N 115.682 -0.69 . . . . 54.43 109.679 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 390' ' ' PRO . 14.4 t -121.08 107.73 12.97 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 115.83 -0.623 . . . . 74.04 111.759 175.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 97.78 152.18 28.07 Favored Glycine 0 C--N 1.302 -1.357 0 C-N-CA 119.099 -1.524 . . . . 72.13 115.424 172.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -72.52 158.7 50.59 Favored 'Trans proline' 0 C--O 1.243 0.744 0 C-N-CA 124.205 3.27 . . . . 72.13 113.74 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.436 ' HG2' ' HA ' ' A' ' 391' ' ' ASP . 35.4 mt-10 -76.85 163.95 26.28 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.155 -1.384 . . . . 74.25 111.637 -175.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.415 ' HG3' ' HB ' ' A' ' 477' ' ' THR . 18.9 tp60 -88.73 138.99 30.92 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 106.291 -1.744 . . . . 72.35 106.291 178.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.545 ' HG3' ' O ' ' A' ' 447' ' ' ALA . 5.0 mmp_? -127.7 148.89 50.41 Favored 'General case' 0 C--O 1.209 -1.073 0 N-CA-C 113.815 1.043 . . . . 75.23 113.815 -178.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -83.42 138.52 33.44 Favored 'General case' 0 C--N 1.286 -2.157 0 C-N-CA 126.237 1.815 . . . . 74.42 110.548 178.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.457 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 66.5 mt -83.59 119.28 73.5 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 108.684 -0.858 . . . . 55.5 108.684 177.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.83 152.53 63.85 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.909 2.406 . . . . 63.12 113.823 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -91.42 110.1 21.39 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 115.763 -0.653 . . . . 71.22 109.457 176.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 42.2 t -116.77 150.34 18.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.354 -0.98 . . . . 61.13 108.354 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.595 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 17.0 m -68.62 150.88 47.47 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 121.071 0.462 . . . . 64.24 110.975 -179.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 40.5 p -69.77 -27.33 64.84 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 123.75 0.82 . . . . 71.53 113.179 -172.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.9 pp -88.07 -11.13 48.06 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.46 0.647 . . . . 65.2 111.349 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.595 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 0.8 OUTLIER -99.59 45.37 0.99 Allowed 'General case' 0 CA--C 1.56 1.341 0 CA-C-N 115.464 -0.789 . . . . 74.25 109.869 -175.672 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -52.65 -38.91 61.2 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 114.198 1.184 . . . . 65.44 114.198 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.49 ' O ' ' HG3' ' A' ' 442' ' ' LYS . . . -64.69 -39.56 93.87 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 120.527 -0.469 . . . . 52.44 110.544 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -65.77 -36.17 82.78 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 108.684 -0.858 . . . . 75.11 108.684 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.535 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.91 -51.63 68.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.172 -0.467 . . . . 63.32 111.46 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 27.2 m -65.86 -39.02 83.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 112.321 0.489 . . . . 65.43 112.321 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 438' ' ' ALA 0.3 0.0 OUTLIER -68.37 -34.07 75.4 Favored 'General case' 0 C--O 1.214 -0.764 0 N-CA-C 112.985 0.735 . . . . 73.2 112.985 176.483 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -61.25 -43.38 98.98 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.047 0.451 . . . . 73.34 110.056 175.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.535 HD13 ' O ' ' A' ' 440' ' ' ALA . 7.1 mp -63.67 -35.75 81.56 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.599 -0.728 . . . . 73.44 110.706 177.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.616 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 26.9 m -71.16 -45.98 62.41 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.108 -0.496 . . . . 64.23 111.078 178.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -65.41 -20.05 66.21 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.227 0.611 . . . . 74.42 110.995 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . 0.545 ' O ' ' HG3' ' A' ' 427' ' ' ARG . . . -79.35 -3.92 48.5 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.853 -0.612 . . . . 61.21 111.433 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 118.05 -78.6 0.3 Allowed Glycine 0 CA--C 1.49 -1.503 0 C-N-CA 120.716 -0.754 . . . . 73.42 111.562 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . 0.465 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 2.8 p90 -43.48 -66.82 0.33 Allowed 'General case' 0 C--O 1.241 0.652 0 N-CA-C 113.473 0.916 . . . . 61.3 113.473 177.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . 0.616 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 62.19 27.63 69.4 Favored Glycine 0 CA--C 1.487 -1.671 0 N-CA-C 111.037 -0.825 . . . . 74.42 111.037 -175.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -103.91 110.11 22.11 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 106.701 -1.592 . . . . 75.43 106.701 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 27.9 p90 -135.67 154.71 51.2 Favored 'General case' 0 N--CA 1.408 -2.547 0 CA-C-N 115.66 -0.7 . . . . 74.32 109.721 -176.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -130.77 122.9 28.03 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 107.783 -1.191 . . . . 74.15 107.783 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -86.8 129.98 34.65 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.975 -0.75 . . . . 64.11 108.975 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -136.43 140.95 43.52 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 116.358 -0.383 . . . . 63.32 110.084 177.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -114.14 146.24 40.57 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 106.903 -1.517 . . . . 75.13 106.903 175.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 52.7 m -148.6 150.22 33.08 Favored Pre-proline 0 C--N 1.28 -2.449 0 N-CA-C 108.487 -0.931 . . . . 60.43 108.487 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.681 ' HA ' ' O ' ' A' ' 490' ' ' SER . 37.5 Cg_endo -66.69 132.77 29.69 Favored 'Trans proline' 0 N--CA 1.442 -1.536 0 C-N-CA 121.667 1.578 . . . . 63.13 110.423 177.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 21.2 m -142.38 178.12 7.8 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.042 -0.725 . . . . 72.43 109.042 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 6.9 t -62.34 137.54 96.06 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 109.691 -0.485 . . . . 63.21 109.691 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.42 -29.36 30.73 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 124.415 3.41 . . . . 73.35 113.62 -176.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -67.92 -33.36 74.54 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-O 120.943 0.401 . . . . 73.22 111.398 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.35 -20.04 23.32 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 111.904 0.335 . . . . 75.45 111.904 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 78.0 t -52.28 133.35 14.25 Favored 'Isoleucine or valine' 0 C--O 1.245 0.85 0 O-C-N 123.603 0.564 . . . . 72.34 111.016 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.88 -20.3 48.48 Favored Glycine 0 N--CA 1.438 -1.191 0 CA-C-N 115.646 -0.706 . . . . 54.05 112.292 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -113.33 166.28 11.63 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 117.103 0.451 . . . . 74.5 110.21 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.439 HG22 HG12 ' A' ' 488' ' ' VAL . 77.6 t -72.85 143.3 14.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 115.563 -0.744 . . . . 71.34 109.237 177.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 50.5 mm -96.89 -31.78 4.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 107.532 -1.285 . . . . 61.02 107.532 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 153.4 -163.96 30.87 Favored Glycine 0 N--CA 1.422 -2.287 0 CA-C-N 115.539 -0.755 . . . . 42.51 111.893 175.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.71 139.14 50.89 Favored 'General case' 0 N--CA 1.413 -2.277 0 N-CA-C 106.62 -1.622 . . . . 74.32 106.62 176.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.483 ' HB3' HG23 ' A' ' 485' ' ' ILE . 27.4 t-20 -64.96 -51.04 59.14 Favored Pre-proline 0 N--CA 1.471 0.605 0 CA-C-O 119.228 -0.415 . . . . 74.01 111.003 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.458 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 21.8 Cg_exo -70.29 130.52 18.83 Favored 'Trans proline' 0 C--N 1.371 1.761 0 N-CA-C 107.131 -1.911 . . . . 72.14 107.131 169.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.468 ' C ' ' H ' ' A' ' 475' ' ' ASN . 39.7 Cg_exo -62.06 133.51 44.5 Favored 'Trans proline' 0 C--O 1.24 0.595 0 C-N-CA 121.856 1.704 . . . . 74.13 113.212 -174.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.457 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -70.92 14.49 0.14 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.159 1.384 . . . . 15.43 111.588 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . 0.468 ' H ' ' C ' ' A' ' 473' ' ' PRO . 16.3 m120 -109.19 -13.72 14.61 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 108.484 -0.932 . . . . 75.54 108.484 -178.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -104.79 178.86 4.44 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.547 -0.751 . . . . 73.44 111.344 -175.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.415 ' HB ' ' HG3' ' A' ' 426' ' ' GLN . 0.9 OUTLIER -106.59 137.84 43.86 Favored 'General case' 0 N--CA 1.396 -3.142 0 CA-C-N 115.573 -0.74 . . . . 72.13 110.898 -179.595 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 12.3 p -117.13 149.65 40.0 Favored 'General case' 0 N--CA 1.424 -1.75 0 C-N-CA 123.97 0.908 . . . . 62.41 110.145 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -80.83 158.53 25.36 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.916 -0.584 . . . . 44.21 110.129 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.465 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 37.0 mm -69.72 -17.53 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 122.231 1.015 . . . . 63.1 110.318 -178.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 7.4 p -100.09 2.02 42.8 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.654 -0.703 . . . . 71.44 111.403 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -95.75 134.9 38.14 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.048 -0.524 . . . . 60.45 110.846 -175.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 37.6 t -99.88 116.44 43.16 Favored 'Isoleucine or valine' 0 C--O 1.243 0.754 0 N-CA-C 109.228 -0.656 . . . . 71.22 109.228 -177.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 32.1 m -99.72 136.79 29.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 121.436 0.636 . . . . 65.52 111.384 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.483 HG23 ' HB3' ' A' ' 471' ' ' ASN . 0.0 OUTLIER -99.98 128.35 51.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 121.452 0.644 . . . . 73.55 111.742 -176.841 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 16.3 mt -112.56 128.25 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 CA-C-N 114.599 -1.182 . . . . 72.51 109.88 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 6.1 tt -111.03 126.71 68.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-N 115.151 -0.931 . . . . 63.01 110.515 -173.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.439 HG12 HG22 ' A' ' 467' ' ' VAL . 35.0 m -105.56 149.52 8.93 Favored 'Isoleucine or valine' 0 C--O 1.254 1.306 0 CA-C-N 115.933 -0.576 . . . . 72.34 110.032 177.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -84.22 125.97 7.37 Favored Glycine 0 N--CA 1.437 -1.279 0 N-CA-C 111.372 -0.691 . . . . 73.15 111.372 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.681 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 25.5 t -135.99 160.65 37.97 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 107.075 -1.454 . . . . 73.44 107.075 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 146.99 166.32 12.29 Favored Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 119.637 -1.268 . . . . 74.42 111.399 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -71.69 156.16 57.72 Favored 'Trans proline' 0 C--O 1.249 1.057 0 C-N-CA 123.254 2.636 . . . . 75.42 111.853 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -104.37 118.99 37.95 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-O 121.44 0.638 . . . . 54.12 109.677 -177.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 11.0 p -116.82 143.15 46.02 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 115.018 -0.992 . . . . 73.54 109.66 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . 0.43 ' HE2' ' HA ' ' A' ' 495' ' ' LYS . 3.5 mmpt? -146.86 151.67 37.45 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 123.168 0.587 . . . . 73.54 109.837 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.539 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.2 p-10 -87.24 135.38 33.33 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.84 -1.17 . . . . 73.32 107.84 174.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 26.2 pt -75.26 121.01 84.31 Favored Pre-proline 0 C--N 1.294 -1.813 0 CA-C-N 115.784 -0.644 . . . . 72.22 109.729 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -75.25 159.9 39.92 Favored 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 122.184 1.923 . . . . 61.22 111.765 -177.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -77.84 90.27 4.08 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 106.272 -1.751 . . . . 74.04 106.272 174.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 10.0 p -96.65 7.5 7.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-O 122.319 1.056 . . . . 53.24 110.427 -171.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -78.06 79.05 4.53 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.203 -0.908 . . . . 63.21 111.932 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . -178.13 31.75 0.07 OUTLIER Glycine 0 C--N 1.304 -1.197 0 N-CA-C 110.703 -0.959 . . . . 61.54 110.703 177.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -157.51 -177.37 6.54 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 107.956 -1.127 . . . . 73.3 107.956 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 5.9 t -91.23 156.81 17.56 Favored 'General case' 0 N--CA 1.426 -1.642 0 C-N-CA 119.02 -1.072 . . . . 42.22 109.738 -177.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.5 p -54.16 -40.27 46.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 C-N-CA 124.707 1.203 . . . . 71.41 111.271 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -60.9 -43.38 98.59 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.624 -0.716 . . . . 71.41 110.697 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 64.0 t -76.77 -37.13 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-N 116.042 -0.526 . . . . 72.21 110.241 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . 0.48 ' O ' ' HG ' ' A' ' 512' ' ' LEU . . . -62.9 -48.87 77.11 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.93 -0.577 . . . . 63.25 111.662 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -65.18 -35.66 81.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.762 0.315 . . . . 61.32 110.246 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.521 ' O ' HG23 ' A' ' 514' ' ' VAL . 26.2 tptp -64.15 -45.37 88.75 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.848 -0.797 . . . . 74.23 108.848 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -62.27 -42.69 99.56 Favored 'General case' 0 CA--C 1.505 -0.78 0 O-C-N 123.609 0.568 . . . . 71.23 110.775 177.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 508' ' ' ALA . 87.5 mt -59.93 -42.94 95.07 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 116.447 -0.342 . . . . 55.13 110.612 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -62.28 -37.86 87.09 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 116.253 -0.431 . . . . 54.34 110.586 177.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 510' ' ' LYS . 92.6 t -61.87 -35.68 69.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.898 -0.592 . . . . 63.23 110.735 177.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -78.26 -19.58 53.41 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.213 0.53 . . . . 75.44 110.213 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 117.93 -5.98 15.78 Favored Glycine 0 N--CA 1.436 -1.326 0 C-N-CA 120.639 -0.791 . . . . 71.53 112.678 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.607 ' HA ' ' O ' ' A' ' 547' ' ' VAL . 74.6 m-85 -68.83 122.18 18.07 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 121.214 0.53 . . . . 74.51 110.642 -178.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . 0.419 ' OG1' ' HA ' ' A' ' 548' ' ' ASP . 10.7 p -93.64 -39.7 10.67 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.567 -0.742 . . . . 71.42 112.357 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -108.43 114.94 29.18 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 122.152 0.977 . . . . 72.44 113.139 -171.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' A' ' 551' ' ' ILE . 46.2 p90 -130.72 151.58 51.01 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.566 -1.197 . . . . 73.11 110.167 176.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 25.1 m -125.17 143.03 51.14 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.111 -1.07 . . . . 74.24 108.111 176.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -117.91 119.71 35.67 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.827 -0.434 . . . . 73.33 109.827 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 554' ' ' GLN . . . -127.39 125.94 41.56 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.72 -0.844 . . . . 74.21 108.72 178.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 20.6 m -101.65 138.5 38.56 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.878 -0.329 . . . . 52.24 111.568 -178.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 30.1 m -123.71 149.38 27.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 108.415 -0.957 . . . . 62.35 108.415 176.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . 0.501 ' HA ' ' HB3' ' A' ' 557' ' ' LYS . 4.7 p-10 -69.57 136.02 50.77 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 121.248 0.547 . . . . 71.53 110.717 -177.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 25.6 p -163.01 167.56 11.64 Favored Pre-proline 0 C--N 1.307 -1.257 0 CA-C-N 115.237 -0.892 . . . . 75.02 109.046 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -77.39 6.56 4.31 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 122.483 2.122 . . . . 73.12 112.839 176.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -96.52 140.51 22.22 Favored Pre-proline 0 N--CA 1.445 -0.679 0 N-CA-C 108.206 -1.035 . . . . 74.31 108.206 175.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -64.42 161.4 34.96 Favored 'Trans proline' 0 C--O 1.246 0.908 0 C-N-CA 122.996 2.464 . . . . 75.53 113.962 -174.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.588 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -66.38 120.77 13.91 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.289 -0.868 . . . . 75.21 110.078 -178.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 122.94 -27.25 5.95 Favored Glycine 0 N--CA 1.434 -1.435 0 C-N-CA 120.657 -0.782 . . . . 71.44 111.594 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -69.63 125.61 27.23 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.358 -0.608 . . . . 65.34 109.358 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 94.0 t -81.48 111.6 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 N-CA-C 107.568 -1.271 . . . . 60.11 107.568 176.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 11.7 t -95.05 -16.22 22.86 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 120.63 -0.428 . . . . 62.13 111.982 -174.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 174.68 -175.13 46.89 Favored Glycine 0 CA--C 1.489 -1.564 0 C-N-CA 120.326 -0.94 . . . . 73.3 111.33 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 23.4 p -129.33 157.18 42.61 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.414 -0.958 . . . . 73.11 108.414 176.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.435 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 26.0 t-20 -73.06 -53.16 5.14 Favored Pre-proline 0 C--N 1.309 -1.186 0 C-N-CA 120.634 -0.427 . . . . 62.14 111.283 177.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.435 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 13.8 Cg_exo -72.86 136.45 25.24 Favored 'Trans proline' 0 C--N 1.368 1.605 0 N-CA-C 108.375 -1.433 . . . . 61.13 108.375 172.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -59.45 139.92 91.75 Favored 'Trans proline' 0 C--O 1.262 1.702 0 C-N-CA 122.2 1.933 . . . . 61.42 112.258 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -67.88 141.34 56.44 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.438 -0.801 . . . . 62.55 109.276 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 102.14 -12.27 57.28 Favored Glycine 0 N--CA 1.427 -1.932 0 C-N-CA 120.976 -0.63 . . . . 55.4 111.664 -176.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 45.8 m -72.57 126.94 31.08 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 116.943 0.372 . . . . 52.12 110.327 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 10.2 t -83.73 123.17 29.58 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.455 0.645 . . . . 73.53 110.029 177.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.9 m -138.21 157.46 72.69 Favored Pre-proline 0 C--N 1.305 -1.348 0 N-CA-C 108.972 -0.751 . . . . 74.54 108.972 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -65.89 150.5 85.69 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 121.554 1.503 . . . . 62.0 110.108 173.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' A' ' 517' ' ' PHE . 26.9 m -59.97 -20.2 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 113.316 0.858 . . . . 52.41 113.316 -177.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . 0.419 ' HA ' ' OG1' ' A' ' 518' ' ' THR . 9.7 t70 -95.09 4.92 53.17 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.603 0.716 . . . . 64.21 111.454 -177.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.1 t -71.62 171.58 11.2 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 109.4 -0.593 . . . . 74.11 109.4 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 49.1 t -101.12 112.82 35.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 109.836 -0.431 . . . . 52.13 109.836 -177.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 520' ' ' PHE . 2.9 mp -101.14 121.85 52.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.763 -0.829 . . . . 73.23 108.763 178.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -102.69 116.41 32.53 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.17 0.509 . . . . 73.52 110.082 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 4.6 mp -97.22 134.13 40.93 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.05 -0.977 . . . . 63.32 108.682 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 523' ' ' ALA . 49.6 mt-30 -105.21 114.83 29.26 Favored 'General case' 0 N--CA 1.414 -2.26 0 CA-C-O 122.03 0.919 . . . . 73.2 108.852 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 524' ' ' SER . 22.1 t -101.85 147.6 8.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 CA-C-N 113.967 -1.469 . . . . 70.01 108.855 -172.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.588 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 23.4 m -76.43 130.84 38.6 Favored 'General case' 0 N--CA 1.412 -2.35 0 CA-C-O 121.863 0.84 . . . . 52.4 112.447 177.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.501 ' HB3' ' HA ' ' A' ' 526' ' ' ASP . 10.2 tppt? -90.88 123.71 34.61 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 104.096 -2.557 . . . . 74.42 104.096 167.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -66.69 -42.3 93.34 Favored Glycine 0 CA--C 1.482 -2.009 0 N-CA-C 109.98 -1.248 . . . . 73.54 109.98 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 9.5 t30 65.57 21.15 11.72 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 122.171 0.986 . . . . 70.25 110.352 172.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -134.8 156.23 49.24 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.509 -0.769 . . . . 73.25 111.537 -176.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -133.4 156.73 47.14 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.395 -0.965 . . . . 73.53 108.395 176.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 54.9 t -73.22 124.47 30.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 120.777 0.322 . . . . 64.34 110.155 -178.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 52.9 ttp -97.26 137.52 21.18 Favored Pre-proline 0 C--N 1.311 -1.109 0 CA-C-N 116.159 -0.473 . . . . 72.52 111.962 -178.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -65.49 170.99 10.09 Favored 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 124.148 3.232 . . . . 72.34 112.535 172.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -82.14 134.25 35.31 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.31 -0.626 . . . . 60.04 109.31 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -120.38 -26.04 5.5 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.614 -0.884 . . . . 60.11 108.614 171.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 12.2 p -71.67 139.23 49.13 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.48 -0.782 . . . . 61.23 110.48 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 79.58 39.33 18.3 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 110.99 -0.844 . . . . 71.34 110.99 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 89.2 mtp -144.69 170.32 16.32 Favored 'General case' 0 C--O 1.249 1.075 0 N-CA-C 108.263 -1.014 . . . . 44.54 108.263 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -95.53 148.97 21.94 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 108.559 -0.904 . . . . 71.33 108.559 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 73.8 t-105 -61.73 -28.39 69.4 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 123.406 0.682 . . . . 74.23 109.968 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 13.8 p -71.54 -21.04 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-N 115.247 -0.888 . . . . 64.13 110.667 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -101.19 -30.82 11.33 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.812 -0.81 . . . . 62.43 108.812 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -59.06 -45.94 89.52 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.199 -0.91 . . . . 63.45 112.441 -178.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 579' ' ' ARG . 31.5 mt-10 -59.51 -57.65 25.34 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 113.7 1.0 . . . . 64.43 113.7 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -58.07 -34.75 98.81 Favored 'Trans proline' 0 C--N 1.364 1.394 0 C-N-CA 121.173 1.248 . . . . 63.33 112.26 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -59.21 -48.13 82.77 Favored 'General case' 0 N--CA 1.42 -1.925 0 C-N-CA 122.506 0.322 . . . . 74.41 110.526 177.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . 0.286 4.2 pp -68.04 -38.3 82.33 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 112.813 0.672 . . . . 72.31 112.813 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 35.3 mmt180 -65.12 -47.56 76.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.472 -0.331 . . . . 63.43 110.458 178.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.93 -17.15 62.69 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.904 -0.589 . . . . 71.54 112.365 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 60.4 tp -85.84 -9.11 57.54 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 109.603 -0.517 . . . . 51.13 109.603 178.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 73.87 38.66 48.8 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 111.219 -0.752 . . . . 61.23 111.219 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 50.5 t90 -83.36 135.08 34.85 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-O 121.266 0.555 . . . . 73.33 111.015 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 10.1 t -145.89 106.34 4.07 Favored 'General case' 0 N--CA 1.408 -2.545 0 CA-C-N 114.783 -1.099 . . . . 74.32 108.126 173.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -159.18 -154.68 7.34 Favored Glycine 0 N--CA 1.429 -1.828 0 N-CA-C 108.774 -1.73 . . . . 73.11 108.774 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 60.9 mtt -107.58 125.23 51.05 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.68 -0.808 . . . . 64.04 112.324 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 59.2 tp -93.88 130.16 40.04 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.642 -0.873 . . . . 73.31 108.642 178.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . 0.462 ' HB3' HG23 ' A' ' 621' ' ' THR . 23.6 t70 -99.28 113.22 25.38 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 120.972 0.415 . . . . 74.02 111.232 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -91.86 109.4 20.73 Favored 'General case' 0 N--CA 1.408 -2.554 0 N-CA-C 106.4 -1.704 . . . . 71.15 106.4 171.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -87.9 -95.25 0.96 Allowed Glycine 0 N--CA 1.424 -2.124 0 C-N-CA 120.599 -0.81 . . . . 70.14 111.399 -178.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.44 151.28 46.11 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.214 -0.662 . . . . 74.42 109.214 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -84.84 132.07 34.45 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.719 -1.215 . . . . 72.5 107.719 175.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 73.5 t -123.63 127.7 74.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 CA-C-N 116.275 -0.421 . . . . 73.52 110.539 -171.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -78.53 107.25 11.05 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.018 -1.475 . . . . 74.5 107.018 175.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -127.47 0.86 6.26 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.81 -0.632 . . . . 72.14 110.736 -176.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 104.99 141.33 10.77 Favored Glycine 0 N--CA 1.431 -1.639 0 N-CA-C 108.8 -1.72 . . . . 74.31 108.8 -177.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -55.77 -39.31 76.4 Favored Glycine 0 C--O 1.224 -0.491 0 CA-C-N 117.193 0.497 . . . . 43.45 112.793 -173.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 3.9 m -60.37 -24.63 65.25 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.995 0.918 . . . . 65.22 111.923 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -108.76 -1.57 19.23 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.137 0.421 . . . . 73.14 112.137 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 59.5 m170 -72.38 -42.28 65.41 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.463 0.542 . . . . 65.34 112.463 -176.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -92.77 32.4 1.25 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 122.04 0.924 . . . . 74.34 108.749 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 603' ' ' VAL . 29.9 ttt180 -118.7 141.8 48.27 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.609 -0.682 . . . . 62.11 109.729 -178.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . 0.412 ' O ' ' HG2' ' A' ' 602' ' ' ARG . 71.4 t -73.15 130.9 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 106.094 -1.817 . . . . 75.14 106.094 172.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 73.6 t -80.05 -53.35 13.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-O 121.71 0.767 . . . . 63.5 109.292 -172.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -156.78 164.23 38.34 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 104.67 -2.345 . . . . 65.33 104.67 177.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -115.86 142.51 46.67 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 107.571 -1.27 . . . . 64.34 107.571 174.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.513 ' HB2' ' HB ' ' A' ' 621' ' ' THR . 41.1 t30 -64.21 -52.52 54.17 Favored Pre-proline 0 C--N 1.285 -2.211 0 N-CA-C 114.441 1.275 . . . . 74.41 114.441 -176.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 609' ' ' PRO . 2.3 Cg_endo -87.38 148.99 7.72 Favored 'Trans proline' 0 CA--C 1.549 1.238 0 CA-C-N 121.444 1.551 . . . . 74.11 110.594 176.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 608' ' ' PRO . 15.8 Cg_exo -70.06 134.24 26.9 Favored 'Trans proline' 0 C--O 1.248 0.994 0 C-N-CA 121.731 1.621 . . . . 72.42 113.152 -177.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -68.56 134.32 49.83 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.678 -0.692 . . . . 75.3 110.724 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 86.48 -1.62 87.31 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.674 -0.774 . . . . 33.3 111.75 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . 0.421 ' OG1' ' HB2' ' A' ' 609' ' ' PRO . 19.8 m -105.52 161.04 14.69 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 108.26 -1.015 . . . . 74.41 108.26 -178.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -73.17 129.99 13.24 Favored Glycine 0 N--CA 1.432 -1.575 0 N-CA-C 111.877 -0.489 . . . . 60.22 111.877 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 34.0 m -118.44 144.12 27.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.922 -0.77 . . . . 44.21 108.922 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.452 ' ND2' ' HB3' ' A' ' 617' ' ' ASP . 27.4 p-10 -43.6 155.59 0.07 Allowed 'General case' 0 C--O 1.216 -0.699 0 C-N-CA 124.73 1.212 . . . . 73.02 113.158 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -56.24 -25.92 49.45 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.048 0.758 . . . . 74.34 113.048 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . 0.452 ' HB3' ' ND2' ' A' ' 615' ' ' ASN . 30.8 t70 -65.83 -37.94 87.55 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.262 -0.644 . . . . 74.45 109.262 174.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 85.69 21.56 53.15 Favored Glycine 0 N--CA 1.424 -2.14 0 CA-C-N 115.681 -0.69 . . . . 61.41 112.182 176.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . 0.4 ' HB ' ' OD2' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -68.44 118.52 12.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 122.448 1.118 . . . . 61.02 110.404 -169.351 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.97 124.55 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.946 0 N-CA-C 106.976 -1.49 . . . . 74.3 106.976 -177.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.513 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 3.0 m -105.36 127.39 52.94 Favored 'General case' 0 N--CA 1.42 -1.944 0 C-N-CA 120.492 -0.483 . . . . 70.14 109.908 -177.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.0 mp -120.98 149.81 42.09 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 105.434 -2.062 . . . . 72.33 105.434 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -137.53 148.16 45.74 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 107.615 -1.254 . . . . 64.0 107.615 173.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -123.78 167.6 13.82 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 107.713 -1.217 . . . . 63.23 107.713 -177.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -67.0 -105.19 0.02 OUTLIER Glycine 0 CA--C 1.533 1.157 0 O-C-N 123.927 0.767 . . . . 71.45 111.824 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 . . . . . 0 C--N 1.296 -1.751 0 CA-C-O 118.575 -0.726 . . . . 72.25 109.185 177.032 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.486 0 N-CA-C 110.061 -1.216 . . . . 51.14 110.061 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 10.1 tp -77.35 125.03 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.785 0 CA-C-O 121.869 0.842 . . . . 71.05 111.627 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 24.3 m -144.66 152.39 40.39 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 104.797 -2.297 . . . . 73.42 104.797 177.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . 0.338 0.0 OUTLIER -87.78 72.69 9.4 Favored 'General case' 0 CA--C 1.492 -1.253 0 CA-C-O 122.763 1.268 . . . . 73.35 112.445 -178.278 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -92.33 148.57 22.03 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 113.123 -1.853 . . . . 72.13 106.847 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 28.4 m -116.8 149.67 18.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.231 0 C-N-CA 120.538 -0.465 . . . . 53.25 110.417 -173.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . 0.552 ' NE2' ' HA ' ' A' ' 407' ' ' ASN . 0.8 OUTLIER -93.9 128.98 40.48 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 105.172 -2.159 . . . . 73.34 105.172 -179.072 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.438 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 92.9 t -95.43 122.37 59.52 Favored Pre-proline 0 C--N 1.28 -2.435 0 CA-C-N 115.266 -0.879 . . . . 63.54 110.864 -167.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 18.0 Cg_exo -61.94 125.61 16.93 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 122.312 2.008 . . . . 45.25 110.163 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . 0.475 ' HB2' ' HG3' ' A' ' 366' ' ' ARG . 3.7 p-10 -71.85 125.87 28.28 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.339 -0.846 . . . . 71.43 109.714 -176.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.418 HG11 ' HA ' ' A' ' 373' ' ' ALA . 17.9 t -98.33 0.11 10.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-O 122.085 0.945 . . . . 72.12 108.728 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.475 ' HG3' ' HB2' ' A' ' 364' ' ' ASP 0.298 0.0 OUTLIER -64.96 146.6 54.77 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.963 -1.017 . . . . 73.2 113.047 179.325 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.26 -9.34 45.81 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 109.806 -1.318 . . . . 72.15 109.806 -172.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -110.7 -163.53 0.86 Allowed 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 107.35 -1.352 . . . . 52.03 107.35 178.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 76.2 p -86.87 160.42 18.74 Favored 'General case' 0 C--N 1.286 -2.157 0 O-C-N 121.865 -0.522 . . . . 71.32 111.602 -170.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 34.2 p -58.95 -46.43 88.03 Favored 'General case' 0 N--CA 1.435 -1.208 0 O-C-N 123.622 0.576 . . . . 41.24 110.6 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.85 -46.79 80.41 Favored 'General case' 0 C--O 1.214 -0.797 0 CA-C-N 116.235 -0.439 . . . . 52.4 111.667 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -67.63 -37.74 82.9 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.259 0.552 . . . . 62.34 111.259 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . 0.418 ' HA ' HG11 ' A' ' 365' ' ' VAL . . . -69.46 -48.53 60.53 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.619 -0.719 . . . . 72.23 111.318 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 89.0 mt -64.9 -42.11 93.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 CA-C-N 116.449 -0.341 . . . . 53.11 110.922 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.95 -45.57 90.15 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 120.717 0.294 . . . . 63.01 111.348 -178.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 32.7 m -64.38 -47.57 78.75 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.998 -0.546 . . . . 73.41 111.147 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.1 -38.74 92.16 Favored 'General case' 0 C--O 1.24 0.597 0 O-C-N 122.094 -0.379 . . . . 70.42 111.709 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -63.43 -42.12 98.69 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.986 -0.552 . . . . 72.31 110.189 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -67.89 -28.13 67.25 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 112.027 0.381 . . . . 63.31 112.027 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -79.96 -15.7 56.75 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.494 -0.482 . . . . 70.13 110.253 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 96.07 15.89 40.28 Favored Glycine 0 N--CA 1.434 -1.461 0 C-N-CA 120.289 -0.957 . . . . 61.1 113.021 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -77.75 143.06 38.3 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 108.667 -0.864 . . . . 72.22 108.667 175.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -84.64 131.86 34.55 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 105.805 -1.924 . . . . 74.21 105.805 176.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 2.4 pp -130.83 138.24 54.05 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 CA-C-O 121.85 0.833 . . . . 72.35 113.23 -175.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 385' ' ' ARG . 33.0 ttp180 -113.8 141.28 47.49 Favored 'General case' 0 C--N 1.276 -2.588 0 N-CA-C 107.053 -1.462 . . . . 63.53 107.053 175.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 20.9 m -122.37 121.16 36.02 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 108.127 -1.064 . . . . 72.11 108.127 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -111.61 127.82 55.86 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.819 -1.178 . . . . 72.5 107.819 -176.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -93.04 131.91 37.63 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.925 0.393 . . . . 73.44 111.504 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . 0.615 ' O ' ' HA ' ' A' ' 421' ' ' SER . 71.6 mmtt -126.36 132.91 24.49 Favored Pre-proline 0 C--N 1.304 -1.393 0 CA-C-N 115.797 -0.638 . . . . 51.52 109.465 175.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.752 ' HA ' ' O ' ' A' ' 422' ' ' THR . 12.2 Cg_exo -72.37 140.26 33.21 Favored 'Trans proline' 0 C--O 1.247 0.95 0 C-N-CA 122.177 1.918 . . . . 74.13 109.901 175.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . 0.324 3.8 p30 -73.97 118.87 17.43 Favored 'General case' 0 CA--C 1.466 -2.26 0 C-N-CA 118.187 -1.405 . . . . 71.25 114.172 -178.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . 0.549 ' O ' ' HB ' ' A' ' 393' ' ' THR . 50.1 m -143.94 81.69 1.69 Allowed 'General case' 0 N--CA 1.39 -3.462 0 N-CA-C 105.335 -2.098 . . . . 72.24 105.335 166.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.549 ' HB ' ' O ' ' A' ' 392' ' ' SER . 85.5 m 96.52 2.52 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 113.961 -1.472 . . . . 72.22 110.98 174.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 5.6 pt -104.92 151.58 39.44 Favored Pre-proline 0 C--N 1.291 -1.971 0 CA-C-N 114.843 -1.072 . . . . 61.23 109.341 176.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . 0.415 ' HB2' ' HD2' ' A' ' 396' ' ' PRO . 83.2 Cg_endo -74.56 -172.94 1.33 Allowed 'Trans proline' 0 CA--C 1.563 1.962 0 C-N-CA 123.305 2.67 . . . . 61.22 113.927 -172.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 395' ' ' PRO . 79.8 Cg_exo -55.17 163.16 4.76 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 123.277 2.651 . . . . 61.35 112.018 172.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -56.02 -8.5 0.46 Allowed 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 125.43 1.492 . . . . 73.43 112.929 -174.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 50.0 m170 -64.88 121.57 14.93 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 107.187 -1.412 . . . . 73.2 107.187 175.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 29.6 m -68.7 117.92 11.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 115.167 -0.924 . . . . 61.22 110.927 -168.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . 0.453 HD13 ' O ' ' A' ' 400' ' ' ILE . 0.0 OUTLIER -92.52 -29.34 4.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 115.989 -0.551 . . . . 75.31 110.265 -174.677 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.55 160.53 28.11 Favored Glycine 0 N--CA 1.417 -2.592 0 C-N-CA 119.528 -1.32 . . . . 74.04 112.409 -174.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.43 ' OG1' ' HG2' ' A' ' 366' ' ' ARG . 2.9 p -145.01 -176.83 5.24 Favored 'General case' 0 C--N 1.283 -2.321 0 C-N-CA 125.963 1.705 . . . . 64.54 107.72 -176.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -99.52 138.19 20.42 Favored Pre-proline 0 C--N 1.291 -1.977 0 N-CA-C 107.718 -1.216 . . . . 75.31 107.718 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -48.11 -15.04 0.35 Allowed 'Trans proline' 0 C--N 1.364 1.375 0 C-N-CA 124.758 3.638 . . . . 73.41 115.509 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -52.73 -43.7 65.9 Favored 'General case' 0 C--O 1.213 -0.866 0 N-CA-C 109.947 -0.39 . . . . 61.44 109.947 176.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -65.96 -35.19 79.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.622 0.725 . . . . 75.33 109.887 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . 0.552 ' HA ' ' NE2' ' A' ' 361' ' ' GLN . 17.0 m120 -84.64 1.69 45.07 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.209 -0.905 . . . . 72.31 111.378 -177.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 29.6 m -109.27 167.51 10.06 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.324 -1.732 . . . . 73.25 106.324 174.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 15.9 m -76.56 112.79 13.48 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 108.615 -0.883 . . . . 73.32 108.615 175.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 14.2 m -122.13 170.39 12.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 120.807 0.337 . . . . 55.54 111.703 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 2.7 m -56.1 141.61 39.73 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.144 -0.935 . . . . 62.25 110.501 -178.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -66.56 109.69 2.89 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.058 -1.089 . . . . 74.41 108.058 176.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 86.51 42.7 6.41 Favored Glycine 0 N--CA 1.433 -1.536 0 N-CA-C 110.708 -0.957 . . . . 43.34 110.708 -176.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -79.94 -171.91 3.13 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.805 -0.813 . . . . 71.32 108.805 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -108.41 112.68 25.22 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 122.882 0.473 . . . . 73.4 110.412 -176.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 49.1 mm -116.57 137.47 50.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 109.575 -0.528 . . . . 71.1 109.575 -177.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 14.0 t -111.56 131.77 55.01 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.773 -0.825 . . . . 74.4 108.773 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 5.9 p -115.75 135.26 56.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.616 -0.512 . . . . 72.51 109.616 -177.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -100.8 128.6 46.78 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.277 -0.638 . . . . 72.54 109.277 178.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 8.3 p -126.3 137.31 58.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.794 -0.639 . . . . 73.52 109.871 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . 0.615 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 2.3 p -92.59 120.68 33.28 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-O 122.024 0.916 . . . . 64.52 112.017 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.752 ' O ' ' HA ' ' A' ' 390' ' ' PRO . 6.2 t -122.46 155.0 37.05 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 108.095 -1.076 . . . . 72.12 108.095 174.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 79.59 99.37 0.27 Allowed Glycine 0 C--N 1.307 -1.029 0 C-N-CA 119.984 -1.103 . . . . 25.22 113.643 174.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.38 152.8 75.19 Favored 'Trans proline' 0 C--O 1.253 1.235 0 C-N-CA 122.868 2.379 . . . . 75.21 112.517 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -72.46 164.41 26.43 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.24 -0.891 . . . . 72.34 112.537 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -135.2 160.61 37.82 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 114.529 -1.214 . . . . 72.1 108.279 -175.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.425 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 2.2 mmp_? -119.82 138.16 53.54 Favored 'General case' 0 CA--C 1.492 -1.268 0 CA-C-O 121.147 0.498 . . . . 75.41 109.938 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 13.7 pt-20 -88.16 136.28 33.04 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.493 -0.776 . . . . 63.33 109.489 178.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 59.5 mt -80.67 130.71 63.32 Favored Pre-proline 0 C--N 1.298 -1.661 0 CA-C-N 115.854 -0.612 . . . . 60.34 109.368 -177.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -71.71 141.77 38.34 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 121.877 1.718 . . . . 63.25 110.736 170.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -82.84 111.53 18.83 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.901 -1.148 . . . . 65.43 107.901 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 60.9 t -103.5 143.46 15.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.137 -1.06 . . . . 74.42 108.137 -175.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 15.8 m -60.41 155.06 18.97 Favored 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 112.632 0.604 . . . . 74.54 112.632 -176.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 21.9 p -69.14 -24.98 64.16 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 115.339 1.607 . . . . 74.24 115.339 -170.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.1 pp -90.3 -11.6 40.3 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.953 0.883 . . . . 72.24 110.414 177.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.425 HG22 ' CB ' ' A' ' 439' ' ' GLU . 0.2 OUTLIER -99.95 34.43 2.3 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 114.914 -1.039 . . . . 65.15 109.643 -175.327 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -55.84 -38.33 69.9 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.172 0.989 . . . . 71.22 113.028 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.46 -36.78 84.88 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.868 0.842 . . . . 64.24 110.102 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.505 ' OE2' ' HD2' ' A' ' 442' ' ' LYS . 24.9 tp10 -70.92 -35.4 72.23 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.121 -0.945 . . . . 65.43 109.336 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.562 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -63.63 -50.55 68.89 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.001 -0.545 . . . . 61.24 110.988 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 31.2 m -62.1 -38.67 81.45 Favored 'Isoleucine or valine' 0 C--O 1.25 1.129 0 N-CA-C 112.606 0.595 . . . . 51.03 112.606 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.505 ' HD2' ' OE2' ' A' ' 439' ' ' GLU . 17.4 ptpt -67.93 -38.44 82.88 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 120.061 -0.656 . . . . 70.4 109.973 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -62.76 -38.56 91.07 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.336 -0.393 . . . . 74.25 110.924 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 77.8 mt -63.42 -37.66 88.13 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.933 -0.576 . . . . 75.14 109.453 177.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 41.0 m -69.93 -43.2 72.12 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.278 -0.873 . . . . 53.04 110.321 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -65.72 -27.37 68.28 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.048 0.539 . . . . 71.3 111.707 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.7 -13.56 59.38 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.477 -0.329 . . . . 64.33 111.459 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . 0.417 ' HA3' HD12 ' A' ' 480' ' ' ILE . . . 130.05 -81.27 0.34 Allowed Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 120.868 -0.682 . . . . 74.25 111.749 178.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -36.64 -68.9 0.12 Allowed 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 115.003 1.483 . . . . 65.31 115.003 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 59.65 35.15 84.96 Favored Glycine 0 C--N 1.318 -0.463 0 C-N-CA 121.007 -0.616 . . . . 72.31 112.551 -177.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.494 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 36.1 mmt180 -107.2 110.95 23.14 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.516 -1.29 . . . . 75.02 107.516 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -143.97 146.57 33.01 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 121.087 0.47 . . . . 74.34 111.532 -173.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . 0.429 ' HB2' ' HA ' ' A' ' 485' ' ' ILE . 34.8 mmtp -131.58 148.35 52.61 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 115.421 -0.809 . . . . 71.05 109.215 178.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -113.64 125.94 54.71 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.798 -0.816 . . . . 53.42 108.798 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -126.17 137.22 53.55 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.923 -1.14 . . . . 61.23 107.923 176.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . 0.52 ' HB2' ' OG ' ' A' ' 490' ' ' SER . 8.3 p30 -114.25 144.64 42.9 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 109.29 -0.633 . . . . 74.14 109.29 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 50.9 m -148.69 148.59 28.44 Favored Pre-proline 0 C--N 1.296 -1.734 0 N-CA-C 108.507 -0.923 . . . . 74.54 108.507 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.69 ' HA ' ' O ' ' A' ' 490' ' ' SER . 19.6 Cg_endo -64.33 125.49 15.19 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.189 1.926 . . . . 74.13 112.238 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 49.7 m -133.49 179.53 6.16 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.187 -1.042 . . . . 71.11 108.187 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.8 t -59.1 137.38 88.06 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 109.907 -0.405 . . . . 72.53 109.907 176.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -51.27 -29.74 30.92 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 124.528 3.485 . . . . 75.42 113.228 -176.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -72.99 -23.61 60.67 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.555 0.576 . . . . 65.11 112.555 -178.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 67.0 mt -101.42 -3.3 28.93 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.669 0.248 . . . . 73.45 111.669 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.441 HG13 ' HA ' ' A' ' 490' ' ' SER . 76.9 t -60.12 128.96 21.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 116.089 -0.505 . . . . 63.51 110.489 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.48 -11.76 59.77 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 115.742 -0.663 . . . . 63.31 112.392 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -114.04 165.81 12.25 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 109.355 -0.609 . . . . 74.24 109.355 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 71.1 t -74.33 146.22 10.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 116.062 -0.517 . . . . 65.23 109.832 177.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 49.3 mm -98.18 -35.11 4.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 107.839 -1.171 . . . . 72.14 107.839 177.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 169.61 -179.49 42.05 Favored Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 110.813 -0.915 . . . . 63.53 110.813 177.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . 0.483 HG22 HG12 ' A' ' 486' ' ' ILE . 61.4 p -115.49 141.85 47.5 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 105.171 -2.159 . . . . 42.35 105.171 176.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.446 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 25.2 t-20 -69.1 -53.78 13.21 Favored Pre-proline 0 C--N 1.319 -0.733 0 C-N-CA 118.882 -1.127 . . . . 71.34 111.692 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.466 ' HG2' ' HA ' ' A' ' 484' ' ' VAL . 8.5 Cg_exo -76.61 139.88 20.68 Favored 'Trans proline' 0 C--N 1.364 1.389 0 N-CA-C 107.621 -1.723 . . . . 73.32 107.621 170.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.93 126.76 18.75 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.043 1.829 . . . . 71.43 112.461 -175.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -86.48 19.13 2.93 Favored 'General case' 0 C--O 1.206 -1.221 0 CA-C-N 115.111 -0.95 . . . . 74.1 109.797 -177.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -110.01 -13.64 14.37 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.449 -0.796 . . . . 72.53 109.563 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -93.18 168.87 10.82 Favored 'General case' 0 C--O 1.247 0.954 0 N-CA-C 114.396 1.258 . . . . 50.2 114.396 -170.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 0.4 OUTLIER -82.79 109.5 16.99 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-N 113.6 -1.636 . . . . 73.43 108.296 -179.704 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 64.7 m -104.97 145.7 30.06 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-O 121.465 0.65 . . . . 72.11 111.5 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -84.68 169.42 14.33 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 107.566 -1.272 . . . . 72.45 107.566 175.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.417 HD12 ' HA3' ' A' ' 448' ' ' GLY . 34.6 mm -72.46 -11.07 14.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 122.078 0.942 . . . . 54.42 110.356 -177.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 4.5 p -97.68 5.19 49.66 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.585 -0.734 . . . . 70.4 112.462 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -81.11 129.54 34.61 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 122.081 -0.387 . . . . 74.54 111.705 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.494 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.1 p -108.64 125.93 65.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.817 -0.628 . . . . 71.12 109.88 176.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.466 ' HA ' ' HG2' ' A' ' 472' ' ' PRO . 27.3 m -106.02 120.46 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 CA-C-O 121.941 0.877 . . . . 72.32 112.23 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.429 ' HA ' ' HB2' ' A' ' 453' ' ' LYS . 0.0 OUTLIER -92.86 121.52 43.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.415 -1.328 . . . . 62.22 107.415 175.35 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.483 HG12 HG22 ' A' ' 470' ' ' THR . 35.1 mt -114.35 128.75 71.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.044 -0.98 . . . . 73.34 111.379 -174.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 5.8 tt -101.87 126.56 55.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 116.031 -0.531 . . . . 71.33 110.649 -176.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 28.0 m -108.38 151.35 10.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 123.435 0.694 . . . . 42.11 109.893 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -84.14 128.9 8.86 Favored Glycine 0 N--CA 1.434 -1.465 0 C-N-CA 120.97 -0.633 . . . . 61.22 111.731 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.69 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 49.1 m -129.8 160.74 32.55 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.725 -0.842 . . . . 63.52 108.725 178.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 152.79 173.49 22.25 Favored Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 110.186 -1.166 . . . . 64.42 110.186 179.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -93.2 155.6 2.59 Favored 'Trans proline' 0 N--CA 1.442 -1.53 0 C-N-CA 122.661 2.241 . . . . 75.04 112.32 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -108.56 77.06 1.06 Allowed 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.661 -0.866 . . . . 71.1 108.661 177.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 19.1 p -117.86 144.9 45.0 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 114.911 -1.04 . . . . 54.01 110.918 -176.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 495' ' ' LYS . 16.0 mmtt -150.25 165.13 33.9 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 112.124 0.416 . . . . 72.52 112.124 175.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.79 133.74 36.32 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 107.399 -1.334 . . . . 71.13 107.399 -178.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 39.5 pt -78.85 133.16 62.41 Favored Pre-proline 0 C--N 1.294 -1.841 0 C-N-CA 120.137 -0.625 . . . . 64.45 109.968 175.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.84 -179.35 5.38 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.782 2.322 . . . . 75.1 111.893 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -108.68 141.49 40.57 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.911 -0.774 . . . . 73.54 108.911 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.402 ' O ' ' HA2' ' A' ' 536' ' ' GLY . 4.8 p -143.95 103.58 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 CA-C-O 121.555 0.693 . . . . 74.32 110.137 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -141.71 106.71 4.94 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.181 -0.918 . . . . 52.22 109.219 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 123.13 -16.13 8.17 Favored Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 120.173 -1.013 . . . . 74.11 111.376 178.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -89.74 173.45 8.27 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.854 -0.424 . . . . 74.43 109.854 177.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 13.9 t -91.79 157.74 16.72 Favored 'General case' 0 N--CA 1.425 -1.707 0 C-N-CA 119.771 -0.772 . . . . 52.12 109.984 -176.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.428 HG22 HE21 ' A' ' 509' ' ' GLN . 9.5 p -53.27 -41.19 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 124.229 1.012 . . . . 74.2 112.158 -178.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -62.57 -41.98 99.27 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.128 0.49 . . . . 60.55 111.2 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 86.3 t -71.79 -37.35 61.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-N 116.092 -0.504 . . . . 72.43 110.513 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . 0.465 ' O ' HD23 ' A' ' 512' ' ' LEU . . . -61.5 -49.12 78.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.835 -0.62 . . . . 72.22 111.242 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.428 HE21 HG22 ' A' ' 505' ' ' VAL . 79.3 mt-30 -60.23 -46.91 88.16 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.019 0.438 . . . . 71.24 110.72 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.454 ' O ' HG23 ' A' ' 514' ' ' VAL . 55.8 tptt -65.44 -49.97 67.17 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 113.027 0.751 . . . . 74.42 113.027 -174.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -63.07 -37.76 88.5 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 120.142 -0.623 . . . . 64.53 110.45 -175.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . 0.465 HD23 ' O ' ' A' ' 508' ' ' ALA . 4.6 mm? -62.75 -43.3 99.15 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 116.551 -0.295 . . . . 64.0 111.007 175.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -62.98 -38.25 90.41 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 120.987 0.422 . . . . 54.22 110.699 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 510' ' ' LYS . 81.2 t -62.96 -34.25 65.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.562 -0.745 . . . . 71.44 110.554 177.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -85.27 3.2 40.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.89 0.376 . . . . 64.53 111.12 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . 0.541 ' O ' ' HB ' ' A' ' 547' ' ' VAL . . . 109.62 -20.84 26.81 Favored Glycine 0 N--CA 1.437 -1.289 0 C-N-CA 120.827 -0.701 . . . . 43.1 113.811 174.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -77.32 98.58 5.24 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.437 -1.319 . . . . 73.54 107.437 -175.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.91 -17.11 30.27 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.592 -0.731 . . . . 71.33 112.307 -169.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 28.1 mtpp -112.18 122.15 46.95 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.168 0.509 . . . . 71.24 111.604 -176.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -129.77 152.44 49.26 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.496 -0.775 . . . . 73.43 110.725 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.9 m -141.39 152.68 44.53 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 108.134 -1.061 . . . . 70.24 108.134 173.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . 0.44 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 4.1 pt20 -117.19 151.07 37.66 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-O 121.365 0.602 . . . . 71.12 111.199 -178.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 554' ' ' GLN . . . -132.79 118.69 19.33 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.23 -1.396 . . . . 54.41 107.23 174.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 11.7 p -85.92 128.86 34.93 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.013 0.435 . . . . 55.42 111.341 -177.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 28.7 m -127.3 160.02 36.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 109.485 -0.561 . . . . 73.34 109.485 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -72.76 136.18 45.44 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.565 -0.531 . . . . 72.45 109.565 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 52.1 m -152.58 161.92 27.91 Favored Pre-proline 0 C--N 1.304 -1.38 0 O-C-N 121.958 -0.464 . . . . 62.21 110.58 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -84.4 -2.55 9.98 Favored 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 122.392 2.061 . . . . 75.41 110.322 173.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.454 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 23.3 mmt180 -84.73 145.67 44.77 Favored Pre-proline 0 N--CA 1.44 -0.935 0 N-CA-C 106.81 -1.552 . . . . 72.31 106.81 177.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.88 162.48 41.96 Favored 'Trans proline' 0 C--O 1.246 0.878 0 C-N-CA 122.148 1.899 . . . . 72.52 111.874 177.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -57.11 126.03 25.35 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.298 -0.864 . . . . 55.13 111.679 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 116.64 -17.45 13.66 Favored Glycine 0 C--N 1.309 -0.938 0 C-N-CA 120.917 -0.658 . . . . 70.02 111.903 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -78.18 144.77 36.05 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.346 -0.983 . . . . 53.33 108.346 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 64.0 t -95.03 121.51 45.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 O-C-N 121.675 -0.64 . . . . 74.22 110.409 176.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 36.6 m -72.59 -40.85 66.25 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 124.588 1.155 . . . . 75.41 110.85 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 500' ' ' VAL . . . 162.16 -157.31 29.13 Favored Glycine 0 N--CA 1.432 -1.577 0 N-CA-C 110.602 -0.999 . . . . 75.43 110.602 -178.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 57.7 p -118.89 151.86 37.35 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.046 -0.724 . . . . 63.43 109.046 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -73.24 -54.4 4.28 Favored Pre-proline 0 C--N 1.313 -1.0 0 CA-C-O 119.44 -0.314 . . . . 74.1 110.712 177.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -74.06 143.24 32.2 Favored 'Trans proline' 0 C--N 1.36 1.164 0 N-CA-C 109.089 -1.158 . . . . 73.3 109.089 170.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.26 149.82 85.04 Favored 'Trans proline' 0 C--O 1.253 1.241 0 C-N-CA 122.313 2.008 . . . . 73.41 112.448 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -65.89 144.31 56.88 Favored 'General case' 0 C--O 1.249 1.049 0 N-CA-C 109.574 -0.528 . . . . 55.21 109.574 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.8 -12.5 57.82 Favored Glycine 0 N--CA 1.423 -2.195 0 C-N-CA 120.23 -0.985 . . . . 74.42 111.489 -176.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 54.2 m -66.59 120.94 14.28 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.251 -0.648 . . . . 63.3 109.251 176.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 41.1 m -85.32 122.61 29.74 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 108.614 -0.884 . . . . 64.05 108.614 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.61 158.26 70.61 Favored Pre-proline 0 C--N 1.311 -1.082 0 N-CA-C 108.834 -0.802 . . . . 73.43 108.834 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -64.78 149.18 90.04 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.073 1.849 . . . . 74.31 110.921 174.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.541 ' HB ' ' O ' ' A' ' 516' ' ' GLY . 36.0 m -63.14 -20.14 25.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-O 121.952 0.882 . . . . 54.21 111.6 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -77.43 -16.16 58.95 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.416 -1.266 . . . . 71.53 110.768 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 42.3 m -81.79 158.6 24.06 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 121.273 0.559 . . . . 62.21 111.784 -176.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 92.1 t -89.03 128.74 40.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 115.073 -0.967 . . . . 64.43 110.159 -178.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . 0.49 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -100.05 132.77 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 108.023 -1.102 . . . . 62.53 108.023 171.472 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -103.24 115.91 31.46 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-O 121.536 0.684 . . . . 71.45 111.329 -176.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 1.9 mm? -98.3 133.79 42.21 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.275 -1.329 . . . . 73.31 109.03 -179.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 523' ' ' ALA . 45.2 mt-30 -97.62 121.79 39.94 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.517 -0.549 . . . . 65.45 109.517 176.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 48.3 t -103.63 137.53 31.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 115.573 -0.74 . . . . 53.32 110.373 -173.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.454 ' HB3' ' HB2' ' A' ' 529' ' ' ARG . 22.0 m -69.58 129.47 39.76 Favored 'General case' 0 N--CA 1.427 -1.612 0 C-N-CA 124.071 0.948 . . . . 72.53 112.211 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -110.57 123.02 49.18 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 106.502 -1.666 . . . . 75.4 106.502 170.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -80.23 -30.38 41.89 Favored Glycine 0 C--N 1.311 -0.841 0 C-N-CA 120.984 -0.627 . . . . 74.1 113.845 -172.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 73.52 -2.52 2.73 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.687 1.195 . . . . 73.4 112.152 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.438 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 87.5 mt-30 -113.25 141.95 46.39 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.767 0.317 . . . . 52.44 110.859 -176.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -125.41 136.51 53.49 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.026 -0.533 . . . . 74.42 109.816 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 59.1 t -68.89 116.01 8.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 120.999 0.428 . . . . 34.35 110.612 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 59.5 ttp -97.1 132.01 26.52 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 109.148 -0.686 . . . . 62.12 109.148 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.85 168.99 15.61 Favored 'Trans proline' 0 C--O 1.244 0.787 0 C-N-CA 122.255 1.97 . . . . 52.02 111.045 176.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . 0.404 ' HA ' ' HB1' ' A' ' 610' ' ' ALA . 9.5 p-10 -89.44 114.99 26.54 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-O 122.291 1.043 . . . . 63.44 112.395 -178.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . 0.487 HD23 ' HD2' ' A' ' 577' ' ' ARG . 4.5 mp -118.16 7.1 12.06 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 106.188 -1.782 . . . . 74.01 106.188 171.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 32.5 t -80.34 153.71 28.22 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 113.577 -1.647 . . . . 52.31 109.946 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 97.71 44.81 2.6 Favored Glycine 0 N--CA 1.432 -1.599 0 N-CA-C 110.293 -1.123 . . . . 60.42 110.293 -177.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 62.1 mtp -140.79 -176.79 4.79 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.41 -1.33 . . . . 74.15 107.41 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -97.03 156.41 16.37 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.072 -1.084 . . . . 71.4 108.072 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . 0.571 ' HA ' ' HB3' ' A' ' 574' ' ' ALA . 76.5 t-105 -59.01 -29.39 67.22 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 122.987 0.515 . . . . 74.35 111.204 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 31.4 m -62.57 -23.95 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 116.122 -0.49 . . . . 72.21 111.302 178.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . 0.537 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 1.3 m-20 -101.13 -25.88 13.87 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-N 115.983 -0.553 . . . . 74.41 110.524 176.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . 0.571 ' HB3' ' HA ' ' A' ' 571' ' ' TRP . . . -72.91 -33.35 65.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.724 -0.671 . . . . 53.43 112.26 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.444 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 32.4 tt0 -60.57 -49.6 89.24 Favored Pre-proline 0 CA--C 1.56 1.363 0 C-N-CA 120.237 -0.585 . . . . 63.13 111.05 176.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . 0.444 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 70.2 Cg_exo -56.22 -35.65 95.74 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 121.459 1.439 . . . . 75.43 111.999 171.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 37.0 mmt180 -59.27 -46.76 87.64 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 109.616 -0.512 . . . . 75.3 109.616 176.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.439 ' HB3' ' O ' ' A' ' 575' ' ' GLU . 6.6 tt -57.77 -46.62 84.31 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 125.011 1.324 . . . . 74.44 109.626 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 575' ' ' GLU . 64.8 mtt-85 -65.31 -44.33 88.21 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.072 -0.967 . . . . 73.3 111.157 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -69.78 -28.26 65.61 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.04 0.448 . . . . 62.44 112.074 -177.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 97.6 mt -84.35 -8.08 59.11 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.613 -0.267 . . . . 64.11 110.914 177.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 61.68 42.42 99.75 Favored Glycine 0 CA--C 1.505 -0.579 0 N-CA-C 110.85 -0.9 . . . . 61.35 110.85 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 83.2 t90 -71.32 135.13 47.23 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.246 0.546 . . . . 75.23 111.688 -176.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 23.3 m -147.42 102.85 3.5 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 108.365 -0.976 . . . . 51.51 108.365 174.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -161.64 -124.07 0.7 Allowed Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 111.241 -0.744 . . . . 60.52 111.241 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . 0.49 ' HB3' HG12 ' A' ' 619' ' ' ILE . 0.1 OUTLIER -137.5 125.68 23.06 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.926 -0.768 . . . . 74.14 108.926 177.041 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 59.9 tp -97.24 117.58 31.77 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.818 -0.808 . . . . 63.02 108.818 176.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . 0.439 ' OD2' HD11 ' A' ' 619' ' ' ILE . 13.4 m-20 -101.24 101.94 12.73 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.157 -0.683 . . . . 75.0 109.157 174.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -88.04 126.43 35.09 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 106.352 -1.721 . . . . 74.24 106.352 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -73.67 -151.91 2.12 Favored Glycine 0 C--N 1.302 -1.336 0 CA-C-N 115.828 -0.624 . . . . 52.34 114.631 -177.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -58.82 143.65 46.74 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.371 0.605 . . . . 75.12 112.435 -177.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -94.2 124.74 38.41 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.398 -0.964 . . . . 73.24 108.398 175.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 47.5 t -123.08 117.77 52.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 109.177 -0.675 . . . . 71.42 109.177 -177.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -80.14 106.71 12.36 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.244 -0.65 . . . . 74.04 109.244 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -153.52 17.44 0.53 Allowed 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.93 -0.577 . . . . 72.25 110.584 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 99.96 101.53 2.39 Favored Glycine 0 N--CA 1.427 -1.939 0 N-CA-C 110.213 -1.155 . . . . 55.23 110.213 -175.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -60.9 -40.3 98.14 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-O 119.893 -0.393 . . . . 75.04 113.387 -176.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 15.6 m -56.99 -33.19 66.88 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.341 0.867 . . . . 73.55 113.341 -174.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -108.19 -10.59 15.38 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 112.993 0.738 . . . . 74.53 112.993 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . 0.415 ' C ' ' H ' ' A' ' 602' ' ' ARG . 68.9 m-70 -107.54 14.97 25.26 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.737 0.78 . . . . 73.42 110.929 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -81.47 15.35 2.09 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.762 -1.108 . . . . 74.41 108.371 175.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . 0.415 ' H ' ' C ' ' A' ' 600' ' ' HIS . 33.1 ttp180 -97.32 152.09 19.25 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.345 -0.843 . . . . 74.52 109.064 -175.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 10.0 p -65.26 137.16 25.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 O-C-N 123.45 0.469 . . . . 71.35 109.959 175.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 92.1 t -102.27 -52.95 7.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 120.36 -0.536 . . . . 73.53 109.561 177.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -154.07 164.32 38.67 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 107.789 -1.189 . . . . 65.32 107.789 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . 0.473 ' HA ' ' O ' ' A' ' 621' ' ' THR . 18.6 pt20 -143.88 155.1 43.97 Favored 'General case' 0 C--N 1.314 -0.976 0 O-C-N 124.097 0.873 . . . . 74.44 109.414 177.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . 0.278 81.8 m-20 -80.64 -55.46 0.72 Allowed Pre-proline 0 C--N 1.312 -1.062 0 N-CA-C 114.306 1.224 . . . . 74.53 114.306 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -85.85 107.83 0.94 Allowed 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.912 1.741 . . . . 41.5 109.287 173.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -70.38 144.93 52.15 Favored 'Trans proline' 0 C--O 1.243 0.756 0 C-N-CA 122.846 2.364 . . . . 72.24 113.467 -176.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . 0.404 ' HB1' ' HA ' ' A' ' 565' ' ' ASP . . . -68.67 137.58 54.28 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 108.562 -0.903 . . . . 64.54 108.562 175.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 99.81 -12.95 60.99 Favored Glycine 0 C--N 1.299 -1.481 0 N-CA-C 110.427 -1.069 . . . . 54.2 110.427 -175.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 25.8 m -106.78 162.82 13.45 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 107.898 -1.149 . . . . 74.54 107.898 178.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -72.19 117.18 6.21 Favored Glycine 0 N--CA 1.431 -1.635 0 N-CA-C 110.435 -1.066 . . . . 72.34 110.435 175.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.7 m -91.29 141.66 14.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.154 0.502 . . . . 63.23 110.55 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.609 HD21 HG22 ' A' ' 619' ' ' ILE . 8.9 p-10 -58.0 145.41 36.17 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 114.099 -1.409 . . . . 73.11 112.786 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -57.55 -25.25 59.65 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.483 1.113 . . . . 71.45 111.39 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -59.78 -45.26 92.84 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 115.351 -0.84 . . . . 74.2 109.261 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 79.12 12.17 84.32 Favored Glycine 0 N--CA 1.412 -2.915 0 N-CA-C 110.159 -1.176 . . . . 72.13 110.159 -175.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . 0.609 HG22 HD21 ' A' ' 615' ' ' ASN . 0.0 OUTLIER -70.39 126.29 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 108.335 -0.987 . . . . 25.23 108.335 -176.594 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.457 ' N ' HD13 ' A' ' 619' ' ' ILE . 7.5 tp -126.54 129.91 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.675 0 CA-C-N 115.645 -0.707 . . . . 74.23 110.991 -174.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 606' ' ' GLN . 39.7 m -104.66 127.19 52.34 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.27 -1.011 . . . . 74.31 108.27 175.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 96.0 mt -138.0 150.79 47.3 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 108.558 -0.905 . . . . 73.0 108.558 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -128.24 136.98 51.79 Favored 'General case' 0 C--N 1.278 -2.506 0 N-CA-C 107.295 -1.372 . . . . 74.03 107.295 172.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -141.9 165.61 26.99 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 104.42 -2.437 . . . . 75.04 104.42 170.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -61.26 -100.08 0.01 OUTLIER Glycine 0 C--N 1.301 -1.374 0 O-C-N 124.056 0.847 . . . . 73.11 113.683 -174.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . 0.501 HE21 ' HA ' ' A' ' 626' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.291 -1.941 0 N-CA-C 108.123 -1.066 . . . . 61.31 108.123 178.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.823 0 N-CA-C 110.939 -0.864 . . . . 61.25 110.939 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 8.9 tp -74.73 151.61 6.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 C-N-CA 123.146 0.578 . . . . 52.54 110.181 -177.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 1.6 m -61.33 148.65 40.61 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.745 -0.835 . . . . 70.11 108.745 178.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.433 ' HD2' ' N ' ' A' ' 358' ' ' ARG . 3.3 mpt_? -100.11 70.81 1.58 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.316 -0.624 . . . . 74.2 109.316 -176.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -98.7 146.4 25.91 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 108.504 -0.925 . . . . 54.42 108.504 178.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 34.5 m -117.24 145.92 22.39 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 108.896 -0.779 . . . . 61.04 108.896 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -95.35 121.5 37.08 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 106.01 -1.848 . . . . 75.15 106.01 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.407 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 63.7 t -97.39 121.58 58.13 Favored Pre-proline 0 C--N 1.291 -1.94 0 CA-C-N 114.942 -1.026 . . . . 72.33 110.849 -171.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 24.6 Cg_exo -63.5 158.26 46.5 Favored 'Trans proline' 0 C--O 1.242 0.688 0 C-N-CA 122.217 1.944 . . . . 71.4 110.229 177.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -103.42 168.85 8.9 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 120.355 -0.538 . . . . 73.42 109.898 -173.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 9.9 t -128.61 2.57 2.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-O 121.638 0.732 . . . . 74.41 109.15 -177.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.531 ' HD3' ' OG1' ' A' ' 402' ' ' THR . 16.8 ptt-85 -58.2 144.46 40.66 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.439 0.638 . . . . 63.31 111.723 178.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.4 -7.11 50.62 Favored Glycine 0 N--CA 1.425 -2.041 0 CA-C-N 115.004 -0.998 . . . . 72.42 111.607 -178.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -109.76 -87.89 0.51 Allowed 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 113.018 0.747 . . . . 74.44 113.018 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 81.3 p -159.44 159.51 33.7 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 109.213 -0.662 . . . . 73.51 109.213 -175.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 46.4 t -63.12 -40.5 97.78 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.788 -0.819 . . . . 73.31 108.788 175.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -63.92 -47.15 81.68 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 118.997 -0.525 . . . . 71.12 112.188 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -69.77 -35.88 75.28 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 119.721 -0.792 . . . . 75.35 110.607 -178.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -64.87 -51.26 62.99 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.789 -0.641 . . . . 44.1 109.935 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 68.5 mt -60.98 -46.27 96.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.687 -0.233 . . . . 63.55 110.591 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.83 -44.45 90.89 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 116.073 -0.512 . . . . 72.42 112.065 -176.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 28.3 m -67.67 -48.95 65.18 Favored 'General case' 0 C--O 1.249 1.067 0 CA-C-O 120.865 0.364 . . . . 41.13 111.068 -177.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.04 -40.44 94.79 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.092 0.404 . . . . 65.53 112.092 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . 0.497 HE21 ' HA ' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -66.62 -36.62 83.03 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.263 -0.426 . . . . 74.0 110.484 -177.742 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -70.16 -24.71 63.2 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 120.721 0.296 . . . . 71.13 111.727 176.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -86.91 -8.69 57.02 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.087 0.47 . . . . 73.32 111.389 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 97.83 4.15 57.96 Favored Glycine 0 C--N 1.309 -0.922 0 C-N-CA 120.378 -0.915 . . . . 65.02 112.306 176.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -79.91 148.37 31.29 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 109.129 -0.693 . . . . 71.03 109.129 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -95.01 132.67 39.62 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 107.704 -1.221 . . . . 75.13 107.704 -177.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 1.4 pp -118.83 131.07 72.68 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 CA-C-O 121.755 0.788 . . . . 71.02 112.688 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -113.15 127.6 56.24 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 107.881 -1.155 . . . . 71.45 107.881 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 27.5 m -119.38 128.1 53.75 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 109.968 -0.382 . . . . 72.32 109.968 -177.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -111.3 119.76 39.97 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.645 -0.872 . . . . 74.12 108.645 176.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.518 HE21 ' N ' ' A' ' 388' ' ' GLN . 0.0 OUTLIER -100.57 122.72 43.72 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.054 -0.721 . . . . 74.31 109.054 179.502 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . 0.409 ' HB2' HG13 ' A' ' 394' ' ' ILE . 68.2 mttm -119.63 134.36 23.86 Favored Pre-proline 0 C--N 1.293 -1.877 0 CA-C-N 115.96 -0.564 . . . . 72.43 110.004 -177.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.49 ' O ' HD11 ' A' ' 394' ' ' ILE . 11.1 Cg_exo -72.52 157.47 52.73 Favored 'Trans proline' 0 C--O 1.248 0.979 0 C-N-CA 121.935 1.757 . . . . 73.1 110.116 175.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 32.7 t70 88.34 152.6 0.05 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 125.267 1.427 . . . . 73.1 111.938 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 17.9 m -101.5 13.0 36.32 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 113.262 0.838 . . . . 73.33 113.262 -174.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 26.9 m -76.03 -25.93 56.13 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.654 -1.239 . . . . 71.42 107.654 172.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.49 HD11 ' O ' ' A' ' 390' ' ' PRO . 0.0 OUTLIER -88.82 149.45 43.71 Favored Pre-proline 0 N--CA 1.433 -1.313 0 CA-C-N 114.764 -1.107 . . . . 73.31 108.67 172.524 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . 0.442 ' HA ' ' HD3' ' A' ' 396' ' ' PRO . 27.9 Cg_endo -63.31 133.66 41.5 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.198 2.599 . . . . 74.23 114.709 -174.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . 0.444 ' HA ' ' HB3' ' A' ' 421' ' ' SER . 53.8 Cg_exo -55.5 163.03 5.47 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 124.268 3.312 . . . . 72.02 111.934 175.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -56.47 -8.1 0.49 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.729 0.812 . . . . 53.51 113.165 -175.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 32.7 m170 -83.26 104.21 13.25 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 105.248 -2.13 . . . . 74.3 105.248 168.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.407 HG23 ' HA ' ' A' ' 366' ' ' ARG . 25.2 m -64.92 120.18 11.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 CA-C-N 114.798 -1.092 . . . . 72.34 111.216 -168.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 9.8 tp -98.17 -29.22 3.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 120.519 -0.472 . . . . 53.15 110.244 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.81 157.98 27.53 Favored Glycine 0 N--CA 1.428 -1.861 0 N-CA-C 110.867 -0.893 . . . . 75.4 110.867 -177.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.531 ' OG1' ' HD3' ' A' ' 366' ' ' ARG . 17.3 p -139.43 -177.69 5.05 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 124.213 1.005 . . . . 64.32 109.246 -177.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . 0.457 ' HA ' ' HD3' ' A' ' 404' ' ' PRO . 16.8 t70 -101.17 133.48 20.93 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 107.342 -1.355 . . . . 71.34 107.342 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 403' ' ' ASP . 17.4 Cg_exo -67.76 11.02 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 123.473 2.782 . . . . 71.41 115.147 -173.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.86 -49.12 71.92 Favored 'General case' 0 C--O 1.216 -0.686 0 N-CA-C 109.756 -0.461 . . . . 52.42 109.756 176.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -69.82 -30.96 68.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.522 0.677 . . . . 64.33 110.239 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -76.8 -6.67 53.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.741 0.781 . . . . 74.43 110.354 -176.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 31.9 m -101.73 155.97 17.79 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 106.337 -1.727 . . . . 53.54 106.337 174.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 46.0 m -74.49 112.06 10.29 Favored 'General case' 0 N--CA 1.415 -2.197 0 N-CA-C 107.485 -1.302 . . . . 61.43 107.485 177.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 24.2 m -128.33 162.13 35.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 110.274 -0.269 . . . . 73.3 110.274 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 11.4 m -67.14 131.65 46.23 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.75 -0.833 . . . . 62.23 108.75 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -59.94 136.94 58.17 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 112.719 0.637 . . . . 73.42 112.719 -174.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 88.92 49.36 3.59 Favored Glycine 0 N--CA 1.434 -1.497 0 CA-C-N 114.887 -1.051 . . . . 71.41 111.599 -178.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -103.64 -173.66 2.36 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.688 -0.856 . . . . 75.15 108.688 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -109.08 120.66 43.19 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 123.274 0.629 . . . . 74.32 110.009 -176.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 48.6 mm -110.7 122.47 65.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 109.086 -0.709 . . . . 73.14 109.086 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 41.6 m -101.46 131.15 47.73 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.86 0.362 . . . . 72.41 111.301 -178.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 4.8 p -126.58 135.94 62.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 123.829 0.852 . . . . 74.33 109.643 -179.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -113.75 125.34 54.0 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.181 0.515 . . . . 63.44 109.855 176.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 22.0 m -124.72 150.3 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.185 0 CA-C-N 115.097 -0.956 . . . . 72.22 111.483 -176.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . 0.444 ' HB3' ' HA ' ' A' ' 396' ' ' PRO . 16.3 t -88.77 145.57 25.53 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.214 1.007 . . . . 70.13 112.473 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.3 p -117.14 157.83 25.26 Favored 'General case' 0 N--CA 1.412 -2.369 0 CA-C-N 113.207 -1.815 . . . . 72.33 106.191 171.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -41.7 162.07 0.02 OUTLIER Glycine 0 C--O 1.259 1.667 0 N-CA-C 116.997 1.559 . . . . 40.13 116.997 -175.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.15 156.68 28.58 Favored 'Trans proline' 0 C--O 1.253 1.268 0 C-N-CA 123.864 3.043 . . . . 73.15 112.841 -176.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -87.6 165.65 15.29 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.435 -0.802 . . . . 65.54 111.347 -176.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -89.44 159.25 17.38 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 106.924 -1.509 . . . . 64.13 106.924 175.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -121.13 142.15 50.13 Favored 'General case' 0 CA--C 1.486 -1.483 0 C-N-CA 119.809 -0.756 . . . . 75.32 111.992 -178.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 11.2 pt-20 -83.09 131.83 35.13 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.172 -1.377 . . . . 74.32 110.191 -176.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 60.6 mt -88.52 127.77 55.37 Favored Pre-proline 0 C--N 1.305 -1.346 0 N-CA-C 108.722 -0.844 . . . . 71.53 108.722 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -71.41 142.82 41.68 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 121.624 1.55 . . . . 54.14 110.152 174.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -77.89 115.14 17.41 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.443 -0.577 . . . . 71.34 109.443 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 48.0 t -109.85 146.17 15.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 108.237 -1.023 . . . . 62.33 108.237 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 2.5 p -67.32 153.04 44.61 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 122.915 0.486 . . . . 64.44 112.105 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . 0.421 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 18.6 p -65.15 -31.77 73.12 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 113.302 0.853 . . . . 75.04 113.302 -173.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 2.2 pp -82.13 -10.95 59.01 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 112.272 0.471 . . . . 74.43 112.272 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.542 HG22 ' HB3' ' A' ' 439' ' ' GLU . 3.7 m -103.96 44.84 0.99 Allowed 'General case' 0 CA--C 1.563 1.463 0 CA-C-O 121.722 0.772 . . . . 73.15 110.214 -177.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -52.36 -38.22 58.21 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.153 0.981 . . . . 65.33 112.457 177.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -60.04 -42.7 95.01 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.551 0.691 . . . . 44.32 110.559 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.542 ' HB3' HG22 ' A' ' 436' ' ' THR . 36.7 tt0 -70.91 -35.64 72.37 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.724 -0.671 . . . . 65.11 110.47 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.564 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -60.18 -49.39 77.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.124 -0.489 . . . . 53.23 110.884 -178.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.7 m -66.05 -39.52 84.73 Favored 'Isoleucine or valine' 0 C--O 1.25 1.107 0 N-CA-C 112.292 0.478 . . . . 70.1 112.292 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.416 ' HG3' ' HA ' ' A' ' 439' ' ' GLU . 0.0 OUTLIER -68.31 -34.65 76.52 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 119.751 -0.78 . . . . 70.23 112.083 177.546 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -64.09 -38.85 92.56 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.54 -0.3 . . . . 75.23 110.738 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 92.9 mt -63.46 -39.67 95.08 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.962 -0.563 . . . . 74.02 110.219 178.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.514 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 15.7 m -70.89 -39.3 72.88 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.929 -0.578 . . . . 41.23 111.197 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.98 -20.96 64.18 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.384 0.611 . . . . 73.14 110.94 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -85.69 5.35 32.48 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 115.53 -0.759 . . . . 73.32 111.923 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 110.22 -85.13 0.39 Allowed Glycine 0 CA--C 1.491 -1.418 0 C-N-CA 120.052 -1.07 . . . . 62.33 112.054 175.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -35.3 -62.36 0.39 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.4 1.259 . . . . 73.42 114.4 176.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . 0.514 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 58.39 26.17 58.89 Favored Glycine 0 CA--C 1.504 -0.622 0 C-N-CA 121.343 -0.456 . . . . 74.23 113.183 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.471 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 21.9 mmt180 -105.3 110.8 23.3 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 107.892 -1.151 . . . . 72.13 107.892 -177.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 33.1 p90 -140.66 152.46 45.39 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 116.315 -0.402 . . . . 63.03 110.132 -177.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -138.0 123.01 19.05 Favored 'General case' 0 C--N 1.291 -1.943 0 O-C-N 124.002 0.813 . . . . 75.33 109.392 176.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -87.26 126.58 34.92 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.292 -1.003 . . . . 71.21 108.292 178.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.09 146.1 43.35 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 107.276 -1.379 . . . . 54.43 107.276 177.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -120.03 140.24 51.3 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 109.477 -0.564 . . . . 73.41 109.477 -175.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . 0.419 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 49.4 m -147.69 132.59 8.98 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 109.489 -0.559 . . . . 63.45 109.489 174.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.626 ' HA ' ' O ' ' A' ' 490' ' ' SER . 38.9 Cg_exo -64.75 122.73 10.67 Favored 'Trans proline' 0 C--O 1.238 0.505 0 C-N-CA 122.225 1.95 . . . . 72.42 110.684 177.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 17.6 m -143.4 175.03 10.23 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 108.142 -1.059 . . . . 61.33 108.142 -176.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.9 t -47.6 139.36 8.56 Favored Pre-proline 0 C--O 1.249 1.076 0 C-N-CA 124.259 1.023 . . . . 52.44 112.251 178.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.13 -29.29 28.12 Favored 'Trans proline' 0 C--N 1.36 1.175 0 C-N-CA 124.74 3.626 . . . . 75.41 113.612 -177.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.25 -22.87 63.82 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 112.089 0.403 . . . . 75.54 112.089 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -104.25 -8.91 18.98 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 111.681 0.252 . . . . 61.01 111.681 178.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 98.6 t -60.84 127.25 20.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.974 0.416 . . . . 72.55 110.179 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.05 -16.18 60.19 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.934 -0.576 . . . . 73.43 112.41 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -107.63 166.04 10.97 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 108.352 -0.981 . . . . 75.51 108.352 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.421 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 75.2 t -76.72 143.08 13.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 108.571 -0.9 . . . . 75.44 108.571 176.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 63.8 mt -98.18 -30.9 3.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 107.961 -1.125 . . . . 75.02 107.961 177.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 167.17 179.26 40.03 Favored Glycine 0 N--CA 1.425 -2.096 0 N-CA-C 110.862 -0.895 . . . . 74.55 110.862 177.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . 0.552 HG22 HG12 ' A' ' 486' ' ' ILE . 59.2 p -115.64 140.66 48.98 Favored 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 107.41 -1.329 . . . . 63.41 107.41 177.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.51 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 7.2 t30 -63.7 -50.31 72.31 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 120.756 -0.377 . . . . 44.21 110.471 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.51 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 1.4 Cg_endo -88.35 152.87 6.65 Favored 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 121.593 1.529 . . . . 74.41 108.94 171.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -63.74 126.76 18.1 Favored 'Trans proline' 0 C--O 1.243 0.726 0 C-N-CA 121.313 1.342 . . . . 72.42 111.681 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -93.88 14.38 19.66 Favored 'General case' 0 C--O 1.202 -1.432 0 CA-C-O 121.68 0.753 . . . . 75.43 110.12 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -110.02 -1.99 17.31 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.715 -0.675 . . . . 75.12 109.318 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -109.75 174.68 5.75 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.36 -0.836 . . . . 70.23 112.578 -173.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 2.5 m -86.33 114.32 23.02 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 114.108 -1.405 . . . . 72.02 108.776 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 15.7 m -109.42 148.08 31.72 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 109.877 -0.416 . . . . 71.34 109.877 -176.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.98 157.74 36.12 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.478 -0.328 . . . . 53.32 110.809 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 37.6 mm -72.35 -17.73 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-O 122.084 0.945 . . . . 72.45 110.518 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 2.7 p -99.52 5.47 46.08 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.898 -0.592 . . . . 73.52 111.437 177.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -84.61 129.97 34.78 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.519 -0.549 . . . . 73.11 109.519 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.471 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 42.7 t -102.43 120.59 52.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.748 -0.834 . . . . 73.55 108.748 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 28.3 m -100.66 120.92 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-O 122.022 0.915 . . . . 70.2 111.239 -178.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.403 HG23 ' HB3' ' A' ' 471' ' ' ASN . 0.0 OUTLIER -95.51 128.99 46.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 109.352 -0.61 . . . . 61.03 109.352 178.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.552 HG12 HG22 ' A' ' 470' ' ' THR . 9.8 mt -120.36 128.14 75.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 C-N-CA 124.393 1.077 . . . . 61.01 110.267 -174.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 6.4 tt -100.85 127.17 54.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 C-N-CA 122.587 0.355 . . . . 64.44 111.342 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 34.3 m -113.07 152.17 14.84 Favored 'Isoleucine or valine' 0 C--O 1.254 1.3 0 C-N-CA 123.347 0.659 . . . . 54.1 110.241 178.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -81.24 130.91 10.02 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 121.042 -0.599 . . . . 52.21 113.537 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.626 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 35.6 t -114.82 160.02 19.95 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 106.067 -1.827 . . . . 43.24 106.067 176.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -172.84 95.37 0.1 Allowed Glycine 0 C--N 1.316 -0.571 0 C-N-CA 120.078 -1.058 . . . . 73.34 112.712 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.58 134.26 9.81 Favored 'Trans proline' 0 C--O 1.249 1.026 0 C-N-CA 122.831 2.354 . . . . 73.02 111.091 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -129.19 32.32 4.73 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-O 121.879 0.847 . . . . 75.53 110.582 -177.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 546' ' ' PRO . 19.6 p -118.12 142.13 47.75 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 114.686 -1.143 . . . . 74.33 109.885 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? -139.65 163.2 33.2 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.393 -0.595 . . . . 75.12 109.393 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.4 p-10 -85.74 138.81 31.84 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.809 -0.632 . . . . 71.04 110.001 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 38.2 pt -88.1 133.74 36.47 Favored Pre-proline 0 C--N 1.295 -1.771 0 C-N-CA 120.536 -0.465 . . . . 72.42 109.823 175.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -87.04 175.18 5.05 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.649 2.233 . . . . 74.21 111.819 177.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -92.63 157.24 16.6 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.547 -0.909 . . . . 73.01 108.547 177.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.456 HG21 ' HA ' ' A' ' 508' ' ' ALA . 9.4 p -159.97 12.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.256 0 CA-C-O 121.531 0.681 . . . . 65.34 111.587 -177.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -74.59 95.05 2.74 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 121.417 0.627 . . . . 75.33 110.947 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 159.64 -22.64 0.28 Allowed Glycine 0 N--CA 1.427 -1.914 0 CA-C-N 115.39 -0.823 . . . . 74.01 111.497 -177.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -102.11 -177.85 3.53 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.02 -0.672 . . . . 70.01 109.241 176.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 20.3 p -83.41 158.93 21.92 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 110.036 -0.357 . . . . 70.31 110.036 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.491 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 9.5 p -52.99 -41.14 39.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 O-C-N 123.703 0.627 . . . . 73.54 111.92 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . 0.481 ' O ' ' HD3' ' A' ' 510' ' ' LYS . 3.4 m-20 -57.57 -42.02 82.26 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.746 0.419 . . . . 74.14 111.166 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 59.4 t -68.85 -38.29 78.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.231 0.538 . . . . 72.4 109.888 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . 0.456 ' HA ' HG21 ' A' ' 500' ' ' VAL . . . -62.96 -44.09 97.01 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.633 -0.712 . . . . 53.3 110.821 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.491 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 26.5 mt-30 -60.18 -39.58 86.97 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.0 -0.545 . . . . 72.13 110.836 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.481 ' HD3' ' O ' ' A' ' 506' ' ' ASP . 14.4 mptt -65.88 -50.62 63.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.698 -0.683 . . . . 72.33 111.047 177.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -61.89 -40.89 97.0 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 116.394 -0.367 . . . . 75.43 111.474 -177.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 94.0 mt -62.71 -44.76 95.38 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 110.358 -0.238 . . . . 73.01 110.358 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.46 -41.45 94.18 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.017 -0.538 . . . . 60.13 110.88 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 510' ' ' LYS . 73.5 t -57.85 -36.46 55.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.871 -0.604 . . . . 72.02 111.71 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -87.18 0.26 55.6 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.249 -0.58 . . . . 75.14 112.365 -177.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 98.97 14.16 37.5 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.754 -0.736 . . . . 75.24 113.719 175.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -101.03 110.19 22.19 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.344 -0.984 . . . . 74.43 108.344 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.39 -14.66 22.31 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 116.011 -0.54 . . . . 54.04 111.871 -175.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . 0.507 ' HD2' ' O ' ' A' ' 548' ' ' ASP . 99.2 mttt -108.03 115.5 30.25 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.608 0.718 . . . . 72.32 111.871 -175.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -130.21 150.94 51.23 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.084 -0.962 . . . . 53.34 109.65 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . 0.531 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 51.1 m -136.42 140.55 43.25 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 106.983 -1.488 . . . . 73.05 106.983 174.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . 0.472 ' NE2' HG21 ' A' ' 505' ' ' VAL . 3.6 pt20 -122.97 125.21 44.84 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.544 0.688 . . . . 75.01 112.35 -175.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -116.33 116.49 27.83 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.728 -1.124 . . . . 75.24 108.047 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 12.4 p -91.8 130.18 37.62 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.148 0.499 . . . . 51.41 111.173 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 27.2 m -121.89 158.54 25.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.252 -1.018 . . . . 75.43 108.252 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -73.35 137.72 44.92 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 119.87 -0.732 . . . . 71.2 109.189 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 24.6 m -148.35 171.06 6.73 Favored Pre-proline 0 C--N 1.287 -2.142 0 N-CA-C 107.941 -1.133 . . . . 73.2 107.941 -178.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -81.61 -11.08 11.75 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 121.508 1.472 . . . . 70.14 110.783 172.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.467 ' HD3' ' OE2' ' A' ' 533' ' ' GLU . 88.4 mtt180 -80.91 145.39 57.18 Favored Pre-proline 0 N--CA 1.444 -0.735 0 CA-C-N 115.276 -0.874 . . . . 71.21 108.932 178.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.26 151.47 82.16 Favored 'Trans proline' 0 C--O 1.253 1.235 0 C-N-CA 122.787 2.325 . . . . 64.25 112.855 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.682 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -62.43 112.12 2.31 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.932 -1.031 . . . . 70.24 111.739 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 134.11 -20.88 3.96 Favored Glycine 0 C--N 1.308 -0.977 0 C-N-CA 120.829 -0.701 . . . . 64.2 112.617 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . 0.467 ' OE2' ' HD3' ' A' ' 529' ' ' ARG . 34.3 tt0 -83.02 142.37 31.38 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.702 -0.481 . . . . 53.11 109.702 179.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 63.1 t -81.92 123.41 38.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 108.666 -0.864 . . . . 72.41 108.666 178.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . 0.69 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 10.3 t -96.44 -19.74 18.94 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.36 -0.536 . . . . 73.14 110.742 -178.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 177.48 179.13 47.58 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.244 -0.979 . . . . 73.21 111.509 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 72.1 p -124.16 149.82 45.86 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.562 -1.273 . . . . 60.52 107.562 177.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.424 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 47.6 t30 -67.75 -59.82 6.25 Favored Pre-proline 0 C--N 1.323 -0.555 0 C-N-CA 120.548 -0.461 . . . . 74.11 109.931 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 57.2 Cg_endo -76.29 130.56 12.1 Favored 'Trans proline' 0 N--CA 1.44 -1.653 0 N-CA-C 108.298 -1.462 . . . . 63.54 108.298 170.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -66.63 150.69 83.73 Favored 'Trans proline' 0 C--O 1.255 1.371 0 C-N-CA 122.01 1.807 . . . . 75.31 112.178 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -58.98 142.74 50.27 Favored 'General case' 0 C--O 1.249 1.067 0 CA-C-N 115.759 -0.655 . . . . 72.54 109.787 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 102.9 -17.33 52.9 Favored Glycine 0 C--N 1.291 -1.917 0 C-N-CA 120.508 -0.853 . . . . 55.45 111.677 -179.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 61.5 m -68.9 127.49 33.28 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 109.959 -0.385 . . . . 65.2 109.959 178.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 20.6 m -91.62 122.99 34.68 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.384 -0.969 . . . . 64.24 108.384 177.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 29.4 m -137.37 161.26 61.84 Favored Pre-proline 0 C--N 1.311 -1.102 0 N-CA-C 109.033 -0.728 . . . . 50.04 109.033 -176.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 494' ' ' THR . 13.6 Cg_endo -61.33 151.68 77.65 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 121.809 1.673 . . . . 74.34 110.821 173.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 30.5 m -63.3 -20.31 25.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.596 0.712 . . . . 42.13 112.166 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . 0.507 ' O ' ' HD2' ' A' ' 519' ' ' LYS . 26.8 t70 -90.42 4.25 51.5 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.628 -0.715 . . . . 73.33 110.863 178.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.1 t -71.15 162.61 29.14 Favored 'General case' 0 C--O 1.241 0.62 0 O-C-N 121.474 -0.766 . . . . 71.03 109.402 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 18.0 t -109.32 116.75 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 CA-C-O 121.152 0.501 . . . . 74.45 109.961 -176.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 2.5 mp -91.95 123.86 44.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 109.124 -0.695 . . . . 55.21 109.124 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 521' ' ' SER . 37.7 tt0 -102.87 120.14 40.08 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-O 121.056 0.455 . . . . 73.24 110.029 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -96.65 134.27 40.11 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.96 -1.018 . . . . 71.13 109.817 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -92.47 114.88 27.56 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.513 -1.291 . . . . 74.14 107.513 171.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 524' ' ' SER . 47.6 t -100.73 141.72 17.01 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.39 0 N-CA-C 108.684 -0.858 . . . . 72.42 108.684 -177.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.69 ' OG ' ' HB ' ' A' ' 535' ' ' THR . 71.7 m -81.45 138.76 35.5 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-O 121.124 0.488 . . . . 73.04 111.75 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.11 135.72 52.4 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 105.678 -1.971 . . . . 73.01 105.678 169.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -71.12 -41.95 59.45 Favored Glycine 0 CA--C 1.497 -1.039 0 N-CA-C 111.297 -0.721 . . . . 64.54 111.297 -175.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 65.4 t30 66.43 8.12 5.49 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.686 1.194 . . . . 75.5 111.21 175.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -113.78 162.3 16.48 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.127 -0.942 . . . . 71.21 109.152 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -137.19 144.92 43.12 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.414 -0.588 . . . . 74.43 109.414 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 96.8 t -72.83 122.61 25.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 123.528 0.517 . . . . 45.11 110.233 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 48.7 ttm -78.22 126.11 83.96 Favored Pre-proline 0 C--N 1.308 -1.231 0 CA-C-N 115.714 -0.676 . . . . 42.43 109.964 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.3 169.33 18.57 Favored 'Trans proline' 0 C--O 1.243 0.774 0 C-N-CA 122.569 2.18 . . . . 64.01 110.7 176.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -83.08 119.7 24.82 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.834 0.826 . . . . 71.22 111.338 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 95.0 mt -127.34 14.04 7.15 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.083 -1.417 . . . . 73.42 107.453 176.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 9.3 m -72.04 130.7 41.56 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.431 -1.258 . . . . 71.41 109.356 -178.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 85.02 22.91 51.24 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.345 -0.931 . . . . 64.3 112.028 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 87.9 mtp -116.14 -178.91 3.52 Favored 'General case' 0 C--O 1.25 1.105 0 N-CA-C 109.282 -0.636 . . . . 74.0 109.282 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . 0.409 ' HB3' ' OD1' ' A' ' 601' ' ' ASN . 97.1 m-85 -97.47 153.17 18.3 Favored 'General case' 0 N--CA 1.414 -2.226 0 N-CA-C 109.176 -0.676 . . . . 75.11 109.176 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 64.1 t90 -64.57 -27.37 68.91 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 123.441 0.697 . . . . 70.21 110.142 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 10.3 p -71.66 -16.44 18.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.779 -0.646 . . . . 73.11 109.694 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . 0.509 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 22.9 m-20 -101.14 -44.91 5.54 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.6 -0.519 . . . . 73.22 109.6 176.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -62.91 -52.68 62.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.596 -0.729 . . . . 72.34 112.664 -175.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.464 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 4.1 tm-20 -55.55 -52.11 74.59 Favored Pre-proline 0 CA--C 1.567 1.623 0 C-N-CA 122.784 0.434 . . . . 74.54 111.851 -176.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . 0.464 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 52.3 Cg_exo -61.12 -29.46 87.25 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 121.785 1.657 . . . . 44.42 113.038 174.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.542 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 20.0 mmt180 -66.43 -40.41 89.51 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 111.479 0.177 . . . . 73.54 111.479 178.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.13 -45.53 90.68 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.202 0.525 . . . . 64.54 109.952 177.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -59.68 -39.64 85.18 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.362 -0.835 . . . . 65.11 110.961 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.29 -21.39 62.95 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.341 -0.39 . . . . 44.42 111.717 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 92.3 mt -82.66 -6.8 59.57 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 120.956 0.407 . . . . 54.42 111.43 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 88.36 20.07 50.07 Favored Glycine 0 C--O 1.238 0.37 0 C-N-CA 120.135 -1.031 . . . . 60.14 111.495 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 89.9 t90 -70.92 129.84 40.07 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.006 -0.738 . . . . 72.5 109.006 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 1.2 m -127.56 13.92 7.02 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.606 -0.516 . . . . 63.34 109.606 -176.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -88.98 -156.82 32.07 Favored Glycine 0 CA--C 1.498 -1.029 0 C-N-CA 120.538 -0.839 . . . . 44.31 114.987 -173.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 50.0 ttm -108.1 131.36 54.7 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 122.873 0.469 . . . . 73.21 111.37 -178.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -101.37 128.96 47.32 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.653 -1.24 . . . . 64.13 107.653 176.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -107.0 122.36 46.28 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 116.2 -0.454 . . . . 75.41 109.837 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -90.28 132.97 35.24 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.404 -0.816 . . . . 71.33 110.158 -178.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -85.34 177.64 50.42 Favored Glycine 0 N--CA 1.431 -1.682 0 C-N-CA 120.987 -0.625 . . . . 64.11 112.227 175.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -72.53 144.74 47.85 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 123.067 0.547 . . . . 63.11 111.451 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -63.42 151.35 41.29 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.866 -0.607 . . . . 74.11 111.402 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 47.0 t -138.39 116.97 13.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 107.954 -1.128 . . . . 72.02 107.954 -178.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -74.43 124.06 25.84 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.085 -1.08 . . . . 73.13 108.085 177.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -160.19 12.9 0.12 Allowed 'General case' 0 C--O 1.244 0.801 0 N-CA-C 112.376 0.51 . . . . 74.21 112.376 -176.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 89.8 166.67 41.79 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.172 -1.013 . . . . 50.02 112.086 -178.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -59.56 -48.23 87.04 Favored Glycine 0 CA--C 1.519 0.301 0 N-CA-C 114.724 0.649 . . . . 71.52 114.724 -175.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 28.2 m -61.23 -25.22 66.92 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-O 121.224 0.535 . . . . 75.52 112.136 -176.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -108.36 -1.52 19.9 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 112.477 0.547 . . . . 75.44 112.477 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.53 -51.65 11.29 Favored 'General case' 0 C--O 1.195 -1.791 0 C-N-CA 119.624 -0.83 . . . . 74.04 111.864 -173.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . 0.409 ' OD1' ' HB3' ' A' ' 570' ' ' PHE . 16.7 t-20 -92.19 19.39 6.98 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 120.857 -1.152 . . . . 73.34 109.429 -177.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 20.0 tpp85 -91.08 139.77 30.45 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.015 -0.993 . . . . 63.3 109.936 -176.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 13.5 p -65.05 139.97 20.52 Favored 'Isoleucine or valine' 0 C--O 1.247 0.94 0 N-CA-C 108.597 -0.89 . . . . 63.44 108.597 175.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 95.5 t -100.15 -46.88 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.056 0 N-CA-C 108.427 -0.953 . . . . 64.41 108.427 -177.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -156.15 157.23 35.59 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 105.872 -1.899 . . . . 73.42 105.872 176.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -123.4 131.94 53.81 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 106.918 -1.512 . . . . 73.02 106.918 173.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.611 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 25.8 t-20 -50.8 -58.09 11.34 Favored Pre-proline 0 C--N 1.312 -1.028 0 CA-C-O 118.844 -0.598 . . . . 72.11 112.366 -177.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.611 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 11.1 Cg_endo -96.76 121.5 0.2 Allowed 'Trans proline' 0 N--CA 1.44 -1.674 0 C-N-CA 121.733 1.622 . . . . 75.45 109.716 173.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -66.46 158.36 55.79 Favored 'Trans proline' 0 C--O 1.25 1.077 0 C-N-CA 122.116 1.877 . . . . 72.11 112.277 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.86 130.91 47.92 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.854 -0.612 . . . . 62.31 110.679 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 104.29 -3.77 43.93 Favored Glycine 0 C--N 1.3 -1.425 0 C-N-CA 120.635 -0.793 . . . . 74.34 112.119 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 6.1 m -93.13 148.13 22.28 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.235 -0.654 . . . . 63.11 109.235 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -84.5 115.79 4.16 Favored Glycine 0 N--CA 1.425 -2.056 0 N-CA-C 109.272 -1.531 . . . . 61.4 109.272 175.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.4 m -100.98 143.7 13.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 C-N-CA 122.854 0.461 . . . . 52.01 111.067 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -44.4 166.53 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.637 1.975 . . . . 75.13 113.354 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.0 -26.08 61.93 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.943 0.401 . . . . 64.52 111.59 -176.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . 0.501 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 25.8 t70 -79.68 -37.23 36.27 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.592 -0.731 . . . . 75.21 109.315 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 81.42 22.76 59.83 Favored Glycine 0 N--CA 1.429 -1.789 0 C-N-CA 118.948 -1.596 . . . . 51.43 111.527 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.81 119.8 12.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 122.286 1.041 . . . . 65.42 109.165 -168.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.15 126.76 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-N 114.513 -1.221 . . . . 71.41 110.594 -172.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.527 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 32.2 m -100.9 125.8 47.48 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.128 -0.693 . . . . 74.43 109.128 175.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.5 pp -133.85 154.63 50.89 Favored 'General case' 0 CA--C 1.479 -1.759 0 N-CA-C 108.612 -0.885 . . . . 72.42 108.612 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -127.98 141.57 51.49 Favored 'General case' 0 C--N 1.257 -3.414 0 N-CA-C 105.43 -2.063 . . . . 72.24 105.43 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -137.41 166.82 22.91 Favored 'General case' 0 C--N 1.277 -2.561 0 N-CA-C 107.129 -1.434 . . . . 74.34 107.129 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -70.7 -137.34 0.14 Allowed Glycine 0 N--CA 1.427 -1.921 0 O-C-N 124.325 1.016 . . . . 65.01 115.343 -174.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 C--N 1.289 -2.05 0 CA-C-O 118.967 -0.54 . . . . 65.14 109.575 -171.159 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.818 0 N-CA-C 110.525 -1.03 . . . . 43.05 110.525 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 10.5 tp -76.03 145.93 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 N-CA-C 109.199 -0.667 . . . . 51.14 109.199 177.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.9 134.64 44.88 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 109.587 -0.523 . . . . 71.32 109.587 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -88.97 -21.22 23.64 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.786 -1.561 . . . . 53.33 106.786 176.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -86.36 150.62 24.2 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 106.019 -1.845 . . . . 73.44 106.019 174.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 31.4 m -115.51 154.14 16.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-O 121.633 0.73 . . . . 71.4 111.053 -172.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . 0.546 ' NE2' ' HA ' ' A' ' 407' ' ' ASN . 0.9 OUTLIER -94.92 136.77 34.83 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 106.425 -1.694 . . . . 74.43 106.425 -176.16 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.574 HG22 ' CZ ' ' A' ' 382' ' ' PHE . 98.0 t -95.12 118.63 66.49 Favored Pre-proline 0 C--N 1.297 -1.68 0 CA-C-N 116.028 -0.533 . . . . 74.3 110.773 -169.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 17.1 Cg_exo -64.59 130.92 27.86 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 123.027 2.485 . . . . 61.15 112.271 -178.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -93.66 121.16 34.8 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.238 -0.892 . . . . 70.34 110.342 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 5.7 m -104.65 23.91 2.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 122.005 0.907 . . . . 64.21 110.986 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.462 ' HA ' HG23 ' A' ' 399' ' ' VAL . 4.5 ppt_? -54.85 145.54 19.61 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.551 -1.204 . . . . 72.34 110.781 172.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.15 -11.8 51.94 Favored Glycine 0 C--N 1.302 -1.344 0 N-CA-C 110.356 -1.098 . . . . 71.3 110.356 -175.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -108.18 -151.66 0.47 Allowed 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 108.464 -0.939 . . . . 71.24 108.464 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 80.6 p -98.21 157.44 16.16 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.43 -0.582 . . . . 72.13 109.43 -174.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.5 p -63.67 -41.06 98.22 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 112.306 0.484 . . . . 75.24 112.306 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -67.14 -42.83 83.74 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-O 119.462 -0.304 . . . . 50.4 111.495 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.02 -35.12 74.09 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 119.558 -0.857 . . . . 62.41 110.594 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.22 -47.95 75.04 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.788 -0.642 . . . . 60.43 110.611 177.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.548 HG23 HG13 ' A' ' 384' ' ' ILE . 70.6 mt -61.71 -43.19 96.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-N 116.039 -0.528 . . . . 61.44 110.309 175.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.57 -44.77 89.87 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.126 -0.488 . . . . 74.43 110.112 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 87.9 m -60.74 -46.81 89.02 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.964 -0.562 . . . . 52.54 110.753 178.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 93.7 mt -62.98 -40.33 97.42 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.346 -0.388 . . . . 62.42 110.22 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -62.12 -43.29 99.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.671 -0.695 . . . . 64.15 110.3 178.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.0 -31.85 70.31 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 120.982 0.42 . . . . 63.25 111.384 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -85.86 -12.24 51.23 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.957 -0.565 . . . . 75.41 111.751 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 94.49 14.57 50.08 Favored Glycine 0 C--N 1.307 -1.059 0 C-N-CA 120.761 -0.733 . . . . 61.33 112.701 177.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.574 ' CZ ' HG22 ' A' ' 362' ' ' VAL . 52.2 m-85 -81.04 150.82 28.67 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-O 121.076 0.465 . . . . 75.53 111.221 177.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.419 ' CB ' ' HG2' ' A' ' 415' ' ' GLU . 7.7 mmtp -84.49 144.78 28.49 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.854 -1.165 . . . . 75.2 107.854 175.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.548 HG13 HG23 ' A' ' 374' ' ' ILE . 0.2 OUTLIER -129.93 133.83 63.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-O 121.495 0.664 . . . . 74.15 111.015 -177.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . 0.463 ' NE ' ' HA ' ' A' ' 385' ' ' ARG . 3.6 tpm_? -115.89 147.13 41.43 Favored 'General case' 0 N--CA 1.41 -2.437 0 N-CA-C 106.519 -1.66 . . . . 72.4 106.519 173.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 39.1 m -129.55 127.64 41.13 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 109.507 -0.553 . . . . 75.15 109.507 -177.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -119.12 130.52 55.61 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 105.488 -2.042 . . . . 73.35 105.488 176.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.506 HE21 ' N ' ' A' ' 388' ' ' GLN . 0.0 OUTLIER -121.55 135.9 54.98 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 118.452 0.569 . . . . 63.43 110.062 -178.716 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -134.42 115.92 12.83 Favored Pre-proline 0 C--N 1.314 -0.952 0 C-N-CA 121.335 -0.146 . . . . 55.41 111.1 177.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.495 ' CA ' ' HB ' ' A' ' 422' ' ' THR . 64.8 Cg_endo -87.91 135.49 3.4 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.43 2.087 . . . . 74.51 111.146 174.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.537 ' HB3' HG12 ' A' ' 394' ' ' ILE . 13.1 t70 -179.82 153.65 0.54 Allowed 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 109.022 -0.733 . . . . 50.43 109.022 177.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 9.9 m -73.87 -18.53 60.91 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 123.186 0.594 . . . . 64.35 111.959 -177.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 3.1 m -87.63 -17.37 32.02 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-O 121.741 0.781 . . . . 65.31 109.975 -178.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.571 HG22 ' HB3' ' A' ' 421' ' ' SER . 45.4 mm -90.22 135.68 29.55 Favored Pre-proline 0 C--N 1.301 -1.513 0 CA-C-N 115.446 -0.797 . . . . 44.03 111.311 -171.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . 0.456 ' HB3' ' HD2' ' A' ' 396' ' ' PRO . 95.7 Cg_exo -50.14 179.0 0.02 OUTLIER 'Trans proline' 0 CA--C 1.585 3.072 1 C-N-CA 126.104 4.536 . . . . 71.11 116.021 179.223 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 395' ' ' PRO . 37.6 Cg_endo -67.14 160.96 44.98 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 123.191 2.594 . . . . 72.34 113.13 173.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -62.58 -6.24 3.3 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 124.591 1.156 . . . . 73.24 113.618 -177.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -65.6 158.04 28.23 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.946 -0.761 . . . . 64.4 108.946 177.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.462 HG23 ' HA ' ' A' ' 366' ' ' ARG . 6.4 m -86.36 117.77 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 C-N-CA 118.49 -1.284 . . . . 70.03 108.893 176.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . 0.413 HD12 ' N ' ' A' ' 401' ' ' GLY . 2.7 pp -88.96 -28.52 5.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 113.007 0.743 . . . . 53.31 113.007 -177.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . 0.413 ' N ' HD12 ' A' ' 400' ' ' ILE . . . -167.97 169.3 41.28 Favored Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 110.659 -0.976 . . . . 61.4 110.659 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 18.6 p -114.95 172.71 6.88 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.69 -0.856 . . . . 72.42 108.69 177.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -102.71 155.42 36.56 Favored Pre-proline 0 C--N 1.292 -1.9 0 N-CA-C 109.028 -0.73 . . . . 61.45 109.028 177.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -50.1 -20.13 4.98 Favored 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 124.043 3.162 . . . . 74.11 115.384 -175.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -62.23 -42.82 99.65 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 110.044 -0.354 . . . . 73.21 110.044 -178.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . 0.421 ' O ' ' HB ' ' A' ' 362' ' ' VAL . . . -71.3 -33.09 69.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.87 0.843 . . . . 60.3 109.741 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . 0.546 ' HA ' ' NE2' ' A' ' 361' ' ' GLN . 18.2 m120 -86.52 2.18 48.92 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.326 -0.852 . . . . 74.11 112.27 -176.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 36.3 m -103.21 152.16 21.8 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 105.783 -1.932 . . . . 65.31 105.783 172.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 24.6 m -74.8 112.85 11.43 Favored 'General case' 0 N--CA 1.429 -1.517 0 C-N-CA 119.56 -0.856 . . . . 52.42 109.252 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 35.1 m -113.36 169.06 5.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 121.048 0.451 . . . . 75.42 110.256 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 19.9 m -66.45 134.7 53.01 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.637 -0.875 . . . . 74.24 108.637 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -54.78 112.37 1.02 Allowed 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 122.994 0.518 . . . . 61.11 111.086 -178.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 105.49 27.74 5.68 Favored Glycine 0 N--CA 1.433 -1.552 0 C-N-CA 120.591 -0.814 . . . . 55.32 112.86 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -85.16 177.22 7.95 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.418 -0.956 . . . . 75.44 108.418 177.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . 0.419 ' HG2' ' CB ' ' A' ' 383' ' ' LYS . 27.5 mt-10 -97.87 110.88 23.37 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.65 0.738 . . . . 71.15 110.97 -172.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 44.9 mm -98.33 122.62 50.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 CA-C-N 115.064 -0.971 . . . . 75.24 108.977 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . 0.423 HG22 ' HB3' ' A' ' 385' ' ' ARG . 15.6 p -89.22 130.73 35.58 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.831 -0.622 . . . . 75.4 111.419 -177.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 7.5 p -114.36 134.3 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 N-CA-C 109.118 -0.697 . . . . 73.23 109.118 175.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -106.03 115.39 30.15 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.993 -1.484 . . . . 64.41 106.993 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 48.6 t -106.93 130.64 58.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-O 122.047 0.927 . . . . 74.51 109.727 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . 0.571 ' HB3' HG22 ' A' ' 394' ' ' ILE . 49.6 m -87.71 123.34 32.43 Favored 'General case' 0 C--N 1.273 -2.751 0 CA-C-N 114.164 -1.38 . . . . 43.15 108.746 179.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.495 ' HB ' ' CA ' ' A' ' 390' ' ' PRO . 6.2 m -106.08 157.6 17.42 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 108.131 -1.063 . . . . 45.25 108.131 -177.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -52.79 168.96 0.8 Allowed Glycine 0 CA--C 1.54 1.651 0 N-CA-C 116.645 1.418 . . . . 71.3 116.645 -173.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.93 144.0 86.89 Favored 'Trans proline' 0 C--O 1.247 0.944 0 C-N-CA 123.372 2.715 . . . . 73.14 110.573 178.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -88.24 145.55 25.82 Favored 'General case' 0 N--CA 1.42 -1.949 0 CA-C-O 121.575 0.702 . . . . 72.22 111.758 -175.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.405 ' HB3' HG22 ' A' ' 477' ' ' THR . 43.5 mt-30 -135.43 157.26 47.34 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 107.677 -1.231 . . . . 74.41 107.677 176.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.573 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 4.2 mmp_? -126.17 141.8 51.79 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.369 0.604 . . . . 71.4 111.152 176.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.402 ' H ' ' HG2' ' A' ' 428' ' ' GLU . 8.7 pt-20 -83.11 129.63 35.04 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 106.724 -1.584 . . . . 75.04 106.724 175.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 53.0 mt -80.42 131.22 62.37 Favored Pre-proline 0 N--CA 1.428 -1.556 0 N-CA-C 108.947 -0.76 . . . . 63.12 108.947 -174.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -69.35 140.72 44.96 Favored 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 121.468 1.446 . . . . 70.24 110.993 176.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -89.46 114.39 25.87 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.305 -1.368 . . . . 74.52 107.305 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.444 HG11 ' HB2' ' A' ' 440' ' ' ALA . 14.7 p -110.82 159.29 10.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 108.663 -0.866 . . . . 74.13 108.663 -175.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 22.6 p -68.31 137.76 54.91 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 108.141 -1.059 . . . . 63.33 108.141 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . 0.426 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 18.3 p -63.38 -21.56 66.35 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 113.675 0.991 . . . . 74.12 113.675 -174.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.2 pp -78.2 -11.48 59.93 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 120.103 -0.639 . . . . 64.14 111.606 177.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.3 m -106.79 61.79 0.63 Allowed 'General case' 0 N--CA 1.432 -1.351 0 CA-C-O 121.725 0.774 . . . . 63.23 111.729 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -52.32 -38.25 58.08 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.363 1.065 . . . . 74.5 111.507 174.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -59.39 -42.53 91.9 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.34 0.591 . . . . 53.44 110.904 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -70.92 -36.89 72.86 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.574 -0.739 . . . . 74.44 109.23 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.527 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.03 -51.69 68.58 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.748 -0.66 . . . . 63.05 111.095 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 35.5 m -64.86 -40.73 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 N-CA-C 112.589 0.588 . . . . 51.41 112.589 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -68.77 -36.37 78.23 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 119.862 -0.735 . . . . 70.41 111.276 178.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -63.9 -41.86 97.59 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.27 -0.423 . . . . 74.22 110.908 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.527 HD13 ' O ' ' A' ' 440' ' ' ALA . 7.3 mp -63.75 -32.69 74.27 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.918 -0.583 . . . . 71.02 110.322 176.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 85.2 m -69.97 -44.9 68.52 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.653 -0.703 . . . . 64.31 110.293 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.22 -22.26 65.72 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.361 0.601 . . . . 71.35 110.814 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.83 5.09 14.58 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.44 -0.8 . . . . 71.31 112.321 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 104.31 -82.95 0.38 Allowed Glycine 0 CA--C 1.492 -1.366 0 C-N-CA 120.261 -0.971 . . . . 70.25 111.816 175.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -41.09 -56.16 2.4 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.012 1.116 . . . . 74.2 114.012 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 59.25 27.25 62.62 Favored Glycine 0 C--N 1.322 -0.202 0 C-N-CA 121.528 -0.368 . . . . 73.14 113.239 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -101.34 111.21 23.37 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 109.526 -0.546 . . . . 72.45 109.526 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.512 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 27.8 p90 -134.48 150.83 50.85 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 115.485 -0.78 . . . . 74.42 109.712 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 21.4 tptp -138.46 127.81 24.49 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 106.558 -1.645 . . . . 62.32 106.558 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -98.31 127.86 44.45 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.367 0.603 . . . . 74.3 111.938 -176.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -126.92 139.88 52.74 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.23 -1.026 . . . . 75.45 108.23 176.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -112.85 143.58 43.87 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.658 -0.867 . . . . 72.31 108.658 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 22.8 t -139.92 134.33 15.83 Favored Pre-proline 0 C--N 1.295 -1.779 0 N-CA-C 109.054 -0.721 . . . . 72.44 109.054 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 490' ' ' SER . 52.7 Cg_endo -74.27 128.15 11.83 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 121.859 1.706 . . . . 74.52 110.59 176.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 35.0 m -147.14 179.93 7.27 Favored 'General case' 0 C--N 1.288 -2.098 0 C-N-CA 123.247 0.619 . . . . 74.41 109.466 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.5 t -48.85 143.87 7.84 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 125.189 1.396 . . . . 74.24 112.148 178.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . 0.487 ' HA ' HG23 ' A' ' 464' ' ' VAL . 10.3 Cg_endo -51.68 -29.29 32.64 Favored 'Trans proline' 0 C--N 1.362 1.275 0 C-N-CA 124.761 3.64 . . . . 72.42 113.484 -178.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -74.89 -8.36 56.24 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 112.767 0.654 . . . . 65.43 112.767 -176.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -111.4 -6.93 14.41 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.969 0.359 . . . . 70.14 111.969 177.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.487 HG23 ' HA ' ' A' ' 461' ' ' PRO . 59.7 t -60.92 127.09 19.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.068 0.461 . . . . 74.01 111.736 -176.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.26 -8.12 77.74 Favored Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 115.754 -0.657 . . . . 33.24 112.49 177.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -108.06 151.68 25.53 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 109.826 -0.435 . . . . 74.43 109.826 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.44 HG22 HG12 ' A' ' 488' ' ' VAL . 67.1 t -68.68 142.92 15.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 106.41 -1.7 . . . . 73.41 106.41 170.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 60.0 mt -97.23 -35.22 5.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 108.704 -0.851 . . . . 64.22 108.704 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 164.99 -165.08 37.47 Favored Glycine 0 N--CA 1.418 -2.532 0 C-N-CA 120.43 -0.89 . . . . 33.11 111.292 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -143.37 149.92 38.4 Favored 'General case' 0 N--CA 1.408 -2.561 0 N-CA-C 107.453 -1.314 . . . . 61.44 107.453 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -67.49 -55.32 15.13 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 120.623 -0.431 . . . . 74.32 110.703 178.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -74.09 128.3 12.1 Favored 'Trans proline' 0 C--N 1.367 1.548 0 N-CA-C 108.009 -1.573 . . . . 72.22 108.009 169.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -62.54 129.85 27.92 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.248 1.966 . . . . 74.13 112.887 -176.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -81.98 13.68 3.21 Favored 'General case' 0 C--O 1.206 -1.188 0 CA-C-N 115.194 -0.912 . . . . 73.22 110.718 -178.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -110.07 0.13 18.25 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.583 0.706 . . . . 74.4 109.398 174.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -103.32 175.79 5.36 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.91 -0.587 . . . . 65.11 112.154 -176.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.405 HG22 ' HB3' ' A' ' 426' ' ' GLN . 2.3 m -98.38 114.43 26.77 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 108.056 -1.09 . . . . 53.41 108.056 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 23.0 p -110.02 147.01 34.33 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 116.283 -0.417 . . . . 62.34 110.057 -176.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -77.55 167.32 21.82 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.634 -0.257 . . . . 54.32 110.387 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 25.3 mm -71.61 -3.93 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-O 122.679 1.228 . . . . 62.42 110.398 -176.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 1.5 p -104.76 5.99 33.73 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.123 -0.944 . . . . 73.12 111.756 178.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -88.92 142.93 27.23 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.03 0.443 . . . . 72.14 111.821 -178.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.65 127.08 65.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.514 -0.767 . . . . 63.14 109.453 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 44.3 t -102.89 120.72 53.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 109.285 -0.635 . . . . 71.34 109.285 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.63 119.41 44.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 108.733 -0.84 . . . . 70.11 108.733 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 48.7 mm -104.48 109.26 26.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-N 115.599 -0.728 . . . . 72.25 109.558 -175.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 9.6 tt -99.96 121.82 51.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.719 -0.474 . . . . 34.33 109.719 178.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.44 HG12 HG22 ' A' ' 467' ' ' VAL . 35.9 m -103.61 151.13 6.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.943 -0.572 . . . . 62.12 110.817 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -92.8 127.31 8.93 Favored Glycine 0 N--CA 1.424 -2.12 0 CA-C-N 115.615 -0.721 . . . . 40.34 111.714 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 25.1 m -119.99 160.27 23.09 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 106.384 -1.71 . . . . 63.11 106.384 176.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -134.65 162.29 24.63 Favored Glycine 0 C--N 1.298 -1.576 0 C-N-CA 118.541 -1.79 . . . . 15.14 112.836 -176.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -75.51 109.72 2.96 Favored 'Trans proline' 0 N--CA 1.442 -1.506 0 C-N-CA 122.39 2.06 . . . . 53.33 110.287 178.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . -90.47 27.49 1.7 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.925 0.869 . . . . 72.41 111.408 -177.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 16.4 p -117.51 143.13 46.37 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 114.708 -1.133 . . . . 73.21 109.806 -178.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 495' ' ' LYS . 67.5 mmtt -139.9 155.2 47.31 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 116.356 -0.384 . . . . 63.35 110.578 177.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -84.17 119.48 25.06 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.831 -1.174 . . . . 71.32 107.831 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 27.2 pt -75.64 120.26 80.87 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 112.347 0.499 . . . . 75.11 112.347 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -93.33 138.45 1.44 Allowed 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 122.672 2.248 . . . . 64.22 111.677 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -90.81 135.35 33.78 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.745 -0.835 . . . . 74.42 108.745 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 19.1 t -134.75 94.08 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 107.523 -1.288 . . . . 72.33 107.523 175.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -88.73 123.99 33.69 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.71 -0.677 . . . . 60.51 109.822 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 125.18 9.69 4.99 Favored Glycine 0 N--CA 1.425 -2.074 0 C-N-CA 119.949 -1.119 . . . . 42.01 112.843 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -106.25 168.18 9.32 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.701 -0.851 . . . . 73.44 108.701 176.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 7.0 m -83.35 157.12 22.67 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.835 -1.172 . . . . 74.23 107.835 176.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 48.8 t -51.11 -44.61 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 122.911 0.484 . . . . 64.01 111.606 -178.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -63.37 -41.91 98.83 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.718 -0.674 . . . . 61.12 111.845 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 33.1 t -72.26 -40.41 65.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 116.121 -0.49 . . . . 72.21 109.912 -176.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.73 -49.44 73.02 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.641 -0.709 . . . . 71.1 111.243 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -65.08 -35.26 80.59 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.705 -0.225 . . . . 60.44 110.663 -178.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.447 ' O ' HG23 ' A' ' 514' ' ' VAL . 47.4 tttp -57.38 -52.29 65.97 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 124.088 0.867 . . . . 74.51 110.237 -178.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -62.74 -44.58 95.84 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 116.099 -0.501 . . . . 71.1 110.139 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.08 -45.81 91.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.751 -0.659 . . . . 74.44 111.137 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.26 -43.18 92.46 Favored 'General case' 0 CA--C 1.5 -0.949 0 O-C-N 123.495 0.497 . . . . 65.33 110.744 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 510' ' ' LYS . 78.7 t -59.72 -38.31 75.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.53 -0.759 . . . . 73.4 111.015 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -74.87 -22.76 58.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.041 0.448 . . . . 63.22 111.239 -178.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 134.44 -16.79 4.32 Favored Glycine 0 N--CA 1.428 -1.844 0 C-N-CA 119.747 -1.216 . . . . 44.51 112.665 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.681 ' HA ' ' O ' ' A' ' 547' ' ' VAL . 91.2 m-85 -75.89 96.79 3.79 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.744 -0.465 . . . . 65.22 109.744 -177.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 3.1 p -95.73 -12.81 24.84 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 113.38 0.882 . . . . 43.42 113.38 -175.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 64.6 mttp -108.74 115.85 30.88 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.434 -0.506 . . . . 73.42 110.364 178.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -130.2 151.25 50.93 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 109.739 -0.467 . . . . 72.33 109.739 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 61.3 m -141.1 140.82 34.23 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 107.909 -1.145 . . . . 75.55 107.909 175.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 0.0 OUTLIER -117.41 137.15 52.69 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 121.326 0.584 . . . . 61.13 111.332 -176.648 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -111.58 116.95 31.69 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.767 -1.197 . . . . 42.42 107.767 176.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 19.3 m -96.96 124.46 40.94 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.487 -0.561 . . . . 72.02 109.487 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 28.4 m -129.13 150.02 34.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.753 -0.832 . . . . 75.04 108.753 177.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -68.74 135.64 51.59 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.937 -0.764 . . . . 72.34 108.937 178.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 50.8 m -156.54 171.95 6.72 Favored Pre-proline 0 C--N 1.297 -1.697 0 N-CA-C 108.558 -0.904 . . . . 74.5 108.558 -176.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -71.72 -19.93 27.05 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 121.835 1.69 . . . . 61.21 113.356 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.01 138.59 49.46 Favored Pre-proline 0 N--CA 1.469 0.495 0 C-N-CA 120.535 -0.466 . . . . 64.31 110.204 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.89 141.56 93.19 Favored 'Trans proline' 0 C--O 1.261 1.652 0 C-N-CA 122.726 2.284 . . . . 70.35 112.068 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.675 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -57.99 118.37 5.32 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 115.128 -0.942 . . . . 35.13 111.513 -176.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 135.92 -25.79 3.18 Favored Glycine 0 N--CA 1.432 -1.616 0 CA-C-N 115.59 -0.732 . . . . 32.24 111.32 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -83.73 134.47 34.75 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.104 0.478 . . . . 72.3 111.523 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 57.3 t -79.5 128.81 38.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 115.834 -0.621 . . . . 73.31 110.307 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 90.7 m -81.64 -33.8 31.17 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 124.781 1.232 . . . . 52.15 110.049 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.59 -150.82 22.79 Favored Glycine 0 N--CA 1.434 -1.452 0 N-CA-C 109.758 -1.337 . . . . 62.42 109.758 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 40.0 p -116.87 156.83 26.66 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 117.291 0.545 . . . . 64.11 110.063 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -82.11 -48.29 0.93 Allowed Pre-proline 0 C--N 1.31 -1.131 0 CA-C-N 115.496 -0.774 . . . . 73.54 110.014 173.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 26.8 Cg_endo -66.63 133.55 32.32 Favored 'Trans proline' 0 C--N 1.37 1.675 0 N-CA-C 108.923 -1.222 . . . . 72.52 108.923 169.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 31.9 Cg_exo -58.96 140.63 96.16 Favored 'Trans proline' 0 C--O 1.251 1.171 0 C-N-CA 122.51 2.14 . . . . 43.11 112.961 -177.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.33 140.95 58.13 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.76 -0.654 . . . . 74.04 109.671 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 98.54 -9.98 62.73 Favored Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 111.385 -0.686 . . . . 62.02 111.385 -178.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 41.9 m -75.28 126.26 30.66 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.603 -0.517 . . . . 72.22 109.603 178.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 495' ' ' LYS . 15.2 t -83.48 129.81 34.99 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 108.12 -1.067 . . . . 43.14 108.12 174.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 11.4 p -142.43 153.43 62.4 Favored Pre-proline 0 C--N 1.294 -1.835 0 N-CA-C 106.649 -1.611 . . . . 63.1 106.649 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 51.3 Cg_exo -58.5 140.27 93.98 Favored 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 121.78 1.654 . . . . 51.31 111.185 175.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.681 ' O ' ' HA ' ' A' ' 517' ' ' PHE . 27.1 m -65.22 -23.16 32.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 121.234 0.54 . . . . 72.01 112.33 -176.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.89 2.12 52.32 Favored 'General case' 0 N--CA 1.421 -1.896 0 O-C-N 122.028 -0.42 . . . . 64.43 111.116 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 66.2 m -84.96 170.49 13.0 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 121.16 0.505 . . . . 55.42 111.172 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 10.0 p -93.0 128.53 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-O 121.605 0.717 . . . . 65.32 111.842 -178.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . 0.508 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -108.52 136.11 45.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 108.572 -0.899 . . . . 61.12 108.572 172.717 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -103.53 118.44 36.74 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.445 0.641 . . . . 74.53 111.091 -176.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 2.3 mm? -95.94 134.35 39.04 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.499 -1.228 . . . . 63.52 109.525 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -98.3 124.52 42.97 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 108.77 -0.826 . . . . 74.13 108.77 175.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 57.2 t -114.43 128.64 71.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 115.899 -0.591 . . . . 75.22 110.662 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.675 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 69.4 m -69.8 131.57 44.72 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.698 -0.683 . . . . 63.1 111.565 174.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt -104.45 133.32 49.53 Favored 'General case' 0 C--O 1.202 -1.412 0 N-CA-C 107.435 -1.32 . . . . 72.23 107.435 169.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -70.16 -37.69 72.36 Favored Glycine 0 CA--C 1.503 -0.667 0 C-N-CA 120.184 -1.008 . . . . 61.31 111.279 -177.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 65.7 t30 65.35 28.56 11.76 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.603 1.161 . . . . 75.35 108.486 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -137.09 150.59 48.11 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 114.513 -1.221 . . . . 73.21 108.887 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -130.34 157.18 43.27 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.313 -0.625 . . . . 73.03 109.313 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 58.8 t -71.96 118.54 17.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 109.984 -0.376 . . . . 63.15 109.984 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . 0.462 ' HB2' ' CG2' ' A' ' 614' ' ' VAL . 55.8 ttp -97.37 138.1 21.16 Favored Pre-proline 0 C--N 1.31 -1.145 0 CA-C-N 116.147 -0.478 . . . . 55.45 110.465 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.64 169.77 9.44 Favored 'Trans proline' 0 CA--C 1.552 1.395 0 C-N-CA 123.098 2.532 . . . . 72.34 111.422 172.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -88.37 129.78 35.32 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 113.064 0.764 . . . . 72.35 113.064 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . 0.421 ' O ' ' HB3' ' A' ' 569' ' ' MET . 2.8 mm? -114.25 -9.67 12.82 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.196 -1.039 . . . . 54.34 108.196 173.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 3.0 p -74.31 132.07 41.73 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 114.7 -1.136 . . . . 75.13 110.21 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 76.48 20.9 76.24 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 111.026 -0.829 . . . . 72.33 111.026 -176.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . 0.421 ' HB3' ' O ' ' A' ' 566' ' ' LEU . 51.7 ttm -121.76 149.47 43.24 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.732 -0.84 . . . . 55.43 108.732 -178.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -82.62 142.61 31.61 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 108.655 -0.869 . . . . 71.52 108.655 177.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 72.1 t-105 -51.62 -27.22 10.66 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 124.707 1.203 . . . . 73.44 111.877 177.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 34.9 m -70.53 -20.39 22.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.58 -0.282 . . . . 61.01 111.525 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . 0.415 ' O ' ' HG3' ' A' ' 577' ' ' ARG . 9.6 t70 -101.57 -36.14 8.88 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.151 -1.055 . . . . 65.1 108.151 177.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.02 95.65 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 114.964 -1.016 . . . . 64.14 112.678 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.47 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 37.4 tt0 -57.63 -51.1 84.24 Favored Pre-proline 0 CA--C 1.563 1.458 0 CA-C-O 119.524 -0.274 . . . . 71.41 111.487 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . 0.47 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 54.1 Cg_exo -56.12 -39.69 89.6 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 121.46 1.44 . . . . 74.2 112.662 173.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 573' ' ' ASP . 51.4 mtt180 -64.25 -41.91 96.74 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.51 -0.476 . . . . 75.14 112.062 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.491 HD12 ' N ' ' A' ' 579' ' ' ARG 0.25 4.1 pp -66.28 -43.73 85.59 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 119.91 -0.716 . . . . 73.23 111.792 -177.575 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . 0.491 ' N ' HD12 ' A' ' 578' ' ' LEU . 15.8 ptm180 -66.43 -35.75 81.08 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 120.914 -0.314 . . . . 74.04 111.197 176.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.72 -28.29 66.69 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 122.638 0.375 . . . . 64.33 111.801 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 9.7 mp -81.52 -7.37 59.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.037 0.446 . . . . 75.02 111.217 174.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 80.36 15.16 79.0 Favored Glycine 0 N--CA 1.437 -1.244 0 C-N-CA 121.126 -0.559 . . . . 71.24 111.883 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 73.4 t90 -66.02 130.73 44.24 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.386 0.613 . . . . 73.41 110.01 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 75.5 m -143.83 93.65 2.49 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.833 -1.173 . . . . 71.3 107.833 176.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -150.6 -161.42 9.94 Favored Glycine 0 N--CA 1.419 -2.448 0 N-CA-C 109.409 -1.476 . . . . 73.43 109.409 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 55.0 ttp -91.04 124.89 35.61 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 120.832 0.349 . . . . 75.35 110.271 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -98.46 121.3 40.22 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 105.738 -1.949 . . . . 74.44 105.738 173.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -98.52 101.59 13.08 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.948 -0.76 . . . . 63.54 108.948 -177.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -99.6 130.44 45.84 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.606 -1.257 . . . . 74.11 107.606 -177.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -77.17 -97.93 0.19 Allowed Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.387 -1.085 . . . . 75.21 110.387 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.2 153.79 47.94 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.878 -0.786 . . . . 74.22 108.878 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -83.7 124.9 31.33 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.055 -1.091 . . . . 65.11 108.055 175.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 58.4 t -127.79 116.88 44.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 CA-C-N 115.881 -0.6 . . . . 42.01 109.944 -175.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -78.4 111.46 14.42 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.29 -1.374 . . . . 74.41 107.29 175.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -133.46 2.82 3.55 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.305 -0.558 . . . . 65.2 112.251 -176.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 127.85 166.06 11.98 Favored Glycine 0 N--CA 1.437 -1.29 0 N-CA-C 111.145 -0.782 . . . . 75.23 111.145 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -59.05 -35.64 84.82 Favored Glycine 0 C--O 1.227 -0.339 0 O-C-N 123.639 0.258 . . . . 15.34 113.532 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 13.4 p -65.78 -23.92 66.82 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.203 0.525 . . . . 72.21 111.722 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -102.37 -1.54 30.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.077 -0.51 . . . . 72.33 110.034 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -77.81 111.09 13.27 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.605 -0.517 . . . . 72.32 109.605 -177.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 12.6 m120 62.9 -11.99 0.08 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.325 1.85 . . . . 73.33 115.159 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -77.51 138.68 39.34 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 118.449 0.568 . . . . 64.03 112.404 -174.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 71.7 t -72.86 131.82 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 114.835 -1.075 . . . . 41.43 108.689 176.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 623' ' ' ARG . 27.7 m -94.35 -41.14 12.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 C-N-CA 119.627 -0.829 . . . . 74.05 111.039 -176.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -151.4 154.69 37.14 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 106.678 -1.601 . . . . 71.1 106.678 175.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . 0.63 ' HA ' ' O ' ' A' ' 621' ' ' THR . 13.3 pt20 -133.82 142.43 47.85 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 106.646 -1.612 . . . . 72.25 106.646 174.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.443 ' HB2' ' OG1' ' A' ' 621' ' ' THR 0.33 91.4 m-20 -76.33 -57.39 1.37 Allowed Pre-proline 0 C--N 1.306 -1.29 0 N-CA-C 114.34 1.237 . . . . 71.31 114.34 -179.168 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' ' 609' ' ' PRO . 31.5 Cg_exo -63.66 119.53 6.62 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 121.785 1.657 . . . . 75.0 110.048 175.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . 0.42 ' HB2' ' OG1' ' A' ' 612' ' ' THR . 6.2 Cg_exo -70.97 134.52 25.61 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 121.8 1.667 . . . . 51.2 113.762 -176.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -69.33 132.17 46.0 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.082 -0.963 . . . . 52.42 110.317 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 89.34 -8.58 79.53 Favored Glycine 0 C--N 1.309 -0.923 0 N-CA-C 111.435 -0.666 . . . . 74.22 111.435 -178.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . 0.42 ' OG1' ' HB2' ' A' ' 609' ' ' PRO . 17.9 m -104.88 160.17 15.22 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 108.048 -1.093 . . . . 70.13 108.048 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -71.68 114.26 5.01 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.944 -0.862 . . . . 45.31 110.944 176.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . 0.462 ' CG2' ' HB2' ' A' ' 563' ' ' MET . 20.6 m -103.31 144.99 13.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 C-N-CA 124.234 1.013 . . . . 74.02 109.929 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -38.85 134.03 1.04 Allowed 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 125.665 1.586 . . . . 65.01 110.565 177.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . 0.408 ' HD3' ' N ' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -51.18 -25.06 4.83 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 114.494 1.294 . . . . 71.21 114.494 -171.367 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . 0.408 ' N ' ' HD3' ' A' ' 616' ' ' ARG . 3.4 p30 -77.43 -26.06 51.22 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.846 -0.616 . . . . 70.14 110.716 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 78.0 20.29 73.38 Favored Glycine 0 N--CA 1.433 -1.526 0 CA-C-O 119.081 -0.844 . . . . 74.22 114.461 173.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.76 119.58 13.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 118.429 1.115 . . . . 65.1 108.755 -176.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 7.0 tp -106.77 127.39 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.027 0 CA-C-N 114.207 -1.361 . . . . 74.43 110.504 -173.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.63 ' O ' ' HA ' ' A' ' 606' ' ' GLN . 1.6 p -107.71 117.72 34.86 Favored 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 109.241 -0.652 . . . . 54.42 109.241 176.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.1 pp -138.54 150.68 46.62 Favored 'General case' 0 CA--C 1.486 -1.496 0 C-N-CA 124.4 1.08 . . . . 74.3 108.431 -177.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . 0.437 ' O ' HG22 ' A' ' 604' ' ' VAL . 2.7 tmt_? -132.88 137.11 46.57 Favored 'General case' 0 C--N 1.273 -2.738 0 N-CA-C 104.861 -2.274 . . . . 72.42 104.861 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -129.78 165.23 22.35 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 107.962 -1.125 . . . . 65.41 107.962 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -82.5 -88.04 0.71 Allowed Glycine 0 N--CA 1.426 -1.985 0 N-CA-C 109.851 -1.3 . . . . 65.41 109.851 178.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 . . . . . 0 C--N 1.286 -2.176 0 N-CA-C 109.087 -0.708 . . . . 72.21 109.087 178.419 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.12 0 N-CA-C 110.969 -0.852 . . . . 75.02 110.969 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 9.3 tp -75.4 137.93 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 109.615 -0.513 . . . . 72.25 109.615 178.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 5.7 m -77.39 154.72 32.44 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.566 -0.902 . . . . 74.23 108.566 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.17 84.92 2.31 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 122.208 1.004 . . . . 75.35 110.66 178.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -76.88 148.22 36.6 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 113.739 -1.573 . . . . 64.4 111.042 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 28.0 m -127.74 156.75 39.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 C-N-CA 123.583 0.753 . . . . 75.31 109.66 -178.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . 0.489 HE21 ' C ' ' A' ' 361' ' ' GLN . 0.0 OUTLIER -95.89 122.79 39.07 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.221 -1.77 . . . . 63.23 106.221 179.328 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.439 HG21 ' CZ ' ' A' ' 382' ' ' PHE . 48.0 t -98.81 139.15 20.87 Favored Pre-proline 0 C--N 1.283 -2.313 0 CA-C-N 115.782 -0.645 . . . . 64.12 110.761 -171.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 14.9 Cg_exo -70.61 150.07 62.46 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.25 1.967 . . . . 73.32 111.442 175.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . 0.45 ' OD2' ' HD2' ' A' ' 366' ' ' ARG . 27.9 t0 -102.76 152.66 20.99 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 107.247 -1.39 . . . . 62.52 107.247 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 10.2 t -122.67 11.64 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.374 0 CA-C-O 121.818 0.818 . . . . 61.13 109.675 -174.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.537 ' HB3' ' OG1' ' A' ' 402' ' ' THR . 8.8 ptm180 -52.37 144.33 13.27 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 115.606 -0.724 . . . . 74.11 111.858 177.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.5 -11.07 54.02 Favored Glycine 0 C--N 1.312 -0.771 0 CA-C-N 115.593 -0.73 . . . . 71.15 111.843 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -110.39 -151.3 0.47 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 123.074 0.55 . . . . 74.21 110.312 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 71.8 p -97.81 159.28 15.03 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.253 -0.647 . . . . 60.33 109.253 -173.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 5.6 p -63.55 -35.89 81.98 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 120.862 -0.335 . . . . 55.32 110.839 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -65.78 -46.42 78.78 Favored 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 111.733 0.271 . . . . 75.43 111.733 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -68.11 -41.31 81.96 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 121.452 0.644 . . . . 74.24 109.281 -177.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.54 -51.52 59.27 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.005 -0.998 . . . . 64.42 111.53 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 77.1 mt -63.96 -39.2 84.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 CA-C-N 116.355 -0.384 . . . . 75.11 110.854 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.05 -44.05 91.76 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 120.946 0.403 . . . . 73.44 110.495 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 44.5 m -65.48 -47.13 77.13 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.834 -0.621 . . . . 71.12 111.455 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 10.8 mp -61.76 -45.43 93.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.812 -0.177 . . . . 75.54 111.193 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -65.81 -35.42 80.64 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.178 -0.465 . . . . 74.51 110.344 -178.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -67.2 -25.24 66.02 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 120.972 0.415 . . . . 63.33 111.786 176.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -86.45 -8.07 57.91 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.945 0.402 . . . . 74.22 110.25 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . 0.449 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 100.42 0.69 55.62 Favored Glycine 0 CA--C 1.502 -0.748 0 CA-C-N 115.587 -0.733 . . . . 72.22 112.389 178.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.628 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 47.4 m-85 -80.0 153.97 28.51 Favored 'General case' 0 N--CA 1.418 -2.074 0 CA-C-O 121.443 0.639 . . . . 74.12 110.901 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 74.8 mmtt -113.01 161.42 17.06 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 114.916 -1.038 . . . . 75.11 108.414 -176.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.446 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -127.31 146.0 33.85 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 CA-C-O 121.461 0.648 . . . . 43.23 111.207 -176.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -110.26 127.98 55.28 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 104.64 -2.356 . . . . 63.14 104.64 174.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 25.5 m -117.37 127.0 53.62 Favored 'General case' 0 C--N 1.271 -2.828 0 C-N-CA 120.185 -0.606 . . . . 73.14 110.073 -174.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -112.12 128.64 56.28 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 105.472 -2.047 . . . . 75.14 105.472 177.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.495 HE21 ' N ' ' A' ' 388' ' ' GLN . 0.0 OUTLIER -120.65 145.5 47.37 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.815 -0.754 . . . . 63.5 111.397 -177.661 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 421' ' ' SER . 54.7 mttp -139.38 143.01 34.26 Favored Pre-proline 0 C--N 1.298 -1.669 0 CA-C-N 115.431 -0.804 . . . . 72.22 109.263 176.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -74.89 158.03 42.87 Favored 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 122.229 1.953 . . . . 72.45 110.452 172.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 8.5 t70 87.43 -169.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 126.468 1.907 . . . . 73.13 108.869 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 37.4 m -144.02 14.29 1.68 Allowed 'General case' 0 C--N 1.316 -0.868 0 O-C-N 121.573 -0.704 . . . . 52.42 110.835 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 12.6 t -81.67 -19.12 42.31 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.807 -1.183 . . . . 70.22 107.807 176.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.606 HD13 ' H ' ' A' ' 394' ' ' ILE . 0.2 OUTLIER -97.61 152.84 38.38 Favored Pre-proline 0 N--CA 1.431 -1.418 0 N-CA-C 106.571 -1.64 . . . . 71.5 106.571 176.32 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . 0.428 ' HA ' ' HD2' ' A' ' 396' ' ' PRO . 1.0 OUTLIER -27.78 111.78 0.03 OUTLIER 'Trans proline' 0 CA--C 1.553 1.449 0 C-N-CA 125.089 3.86 . . . . 73.04 114.907 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . 0.592 ' HA ' ' OG ' ' A' ' 421' ' ' SER . 42.2 Cg_endo -63.73 160.92 34.39 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 124.159 3.239 . . . . 52.4 115.242 -174.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -60.11 -8.6 2.5 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 125.078 1.351 . . . . 74.21 113.091 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 37.0 m170 -106.39 132.31 52.56 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 105.746 -1.946 . . . . 74.44 105.746 175.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 27.7 m -75.21 117.6 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.256 0 C-N-CA 119.381 -0.927 . . . . 75.35 111.761 -165.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . 0.596 ' H ' HD13 ' A' ' 400' ' ' ILE . 0.2 OUTLIER -97.24 -28.76 3.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 107.292 -1.373 . . . . 70.03 107.292 174.042 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.54 157.53 27.43 Favored Glycine 1 N--CA 1.395 -4.079 0 N-CA-C 108.938 -1.665 . . . . 73.31 108.938 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.537 ' OG1' ' HB3' ' A' ' 366' ' ' ARG . 0.8 OUTLIER -146.25 -176.25 5.09 Favored 'General case' 0 C--N 1.262 -3.207 0 N-CA-C 105.878 -1.897 . . . . 72.44 105.878 -177.726 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -100.28 126.95 34.44 Favored Pre-proline 0 C--N 1.289 -2.025 0 C-N-CA 118.208 -1.397 . . . . 53.42 109.731 -173.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.84 0.18 1.7 Allowed 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 124.067 3.178 . . . . 61.41 114.791 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.1 -34.46 68.34 Favored 'General case' 0 C--O 1.209 -1.046 0 N-CA-C 109.206 -0.664 . . . . 64.42 109.206 173.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -63.85 -40.7 97.19 Favored 'General case' 0 C--O 1.212 -0.887 0 CA-C-N 115.805 -0.634 . . . . 65.31 110.042 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . 0.441 HD21 ' HB2' ' A' ' 364' ' ' ASP . 12.2 m120 -83.71 0.6 46.42 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.122 0.487 . . . . 64.14 111.513 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 34.0 m -95.21 157.41 15.91 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 104.92 -2.252 . . . . 72.23 104.92 171.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 49.0 m -74.35 112.47 10.55 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 118.55 -1.26 . . . . 71.41 108.928 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 18.6 m -128.48 169.1 20.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 C-N-CA 122.49 0.316 . . . . 44.5 110.366 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 15.6 m -79.86 145.18 32.87 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.762 -0.459 . . . . 73.04 109.762 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . 0.628 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -66.69 113.73 5.05 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.293 0.568 . . . . 52.4 110.56 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 110.35 44.68 0.98 Allowed Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 110.776 -0.93 . . . . 75.21 110.776 -178.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -109.21 166.29 10.97 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.198 -1.038 . . . . 75.12 108.198 -177.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 49.2 mt-10 -100.23 118.5 36.66 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 118.212 0.46 . . . . 63.22 110.837 -177.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 44.4 mm -103.61 133.18 48.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 109.188 -0.671 . . . . 73.33 109.188 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 11.5 t -85.18 130.46 34.6 Favored 'General case' 0 C--O 1.252 1.217 0 CA-C-O 121.303 0.573 . . . . 74.32 112.306 -176.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 5.3 p -127.3 135.78 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 C-N-CA 124.052 0.941 . . . . 72.21 109.544 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -101.99 129.18 48.22 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.77 -0.456 . . . . 71.21 109.77 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 8.9 p -123.1 133.1 70.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 109.356 -0.609 . . . . 73.01 109.356 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . 0.592 ' OG ' ' HA ' ' A' ' 396' ' ' PRO . 74.6 p -103.61 130.9 51.12 Favored 'General case' 0 N--CA 1.428 -1.541 0 O-C-N 122.086 -0.384 . . . . 62.32 110.55 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 41.0 p -97.02 107.97 20.61 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.987 -1.486 . . . . 72.05 106.987 173.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -44.82 -86.49 0.01 OUTLIER Glycine 0 N--CA 1.467 0.708 0 N-CA-C 116.653 1.421 . . . . 62.42 116.653 -170.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -71.95 128.46 14.08 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.697 1.598 . . . . 75.2 112.741 -175.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -92.02 153.4 19.45 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 107.737 -1.208 . . . . 75.3 107.737 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -88.47 156.23 19.22 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.09 -1.448 . . . . 62.12 107.09 174.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.458 ' HA ' ' HE ' ' A' ' 427' ' ' ARG . 8.5 mmp_? -121.98 150.17 42.43 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-O 121.017 0.437 . . . . 72.2 111.217 -176.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -85.8 138.51 32.02 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.427 -0.806 . . . . 72.21 109.729 -177.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 56.9 mt -87.55 131.57 43.42 Favored Pre-proline 0 C--N 1.295 -1.769 0 N-CA-C 108.733 -0.839 . . . . 64.24 108.733 178.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -70.76 141.45 41.21 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.715 1.61 . . . . 64.11 110.634 172.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -84.61 99.86 11.05 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.801 -1.185 . . . . 63.43 107.801 178.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 60.9 t -101.9 136.94 31.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 108.597 -0.89 . . . . 71.23 108.597 -174.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.408 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 18.9 m -57.22 149.8 19.11 Favored 'General case' 0 N--CA 1.435 -1.209 0 O-C-N 124.252 0.97 . . . . 73.4 112.517 -177.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . 0.424 ' HB ' ' O ' ' A' ' 467' ' ' VAL . 24.8 p -69.45 -25.06 63.91 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 115.283 1.586 . . . . 52.32 115.283 -170.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.7 pp -85.97 -11.67 52.42 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.628 -0.829 . . . . 72.53 110.768 176.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.408 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 0.2 OUTLIER -98.68 42.53 1.09 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.183 -0.917 . . . . 63.01 110.152 -175.123 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -52.56 -38.71 60.43 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.396 1.079 . . . . 62.55 112.749 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -62.27 -39.57 93.35 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.559 0.695 . . . . 42.41 110.681 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -70.53 -37.39 74.08 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.266 -0.879 . . . . 65.31 109.158 177.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -62.66 -51.82 65.74 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.936 -0.575 . . . . 72.14 111.078 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 28.8 m -61.88 -38.89 81.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 112.476 0.547 . . . . 65.44 112.476 -177.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -68.28 -38.08 81.35 Favored 'General case' 0 C--N 1.35 0.623 0 C-N-CA 119.255 -0.978 . . . . 62.41 110.908 177.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -66.35 -38.66 88.11 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.462 0.542 . . . . 75.12 112.462 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -63.38 -35.8 81.6 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.881 -0.414 . . . . 71.13 109.881 174.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.492 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 47.0 m -70.49 -48.3 56.37 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.918 -0.583 . . . . 74.52 110.804 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.5 -16.65 63.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.949 -0.569 . . . . 64.4 111.91 -177.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.05 -13.14 59.95 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.279 -0.419 . . . . 64.43 111.751 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 124.98 -69.88 0.48 Allowed Glycine 0 CA--C 1.492 -1.348 0 C-N-CA 120.068 -1.063 . . . . 53.23 111.932 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . 0.419 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 0.1 OUTLIER -48.52 -65.81 0.51 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.542 0.571 . . . . 74.23 112.542 177.108 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . 0.492 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 64.28 21.93 66.79 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 116.123 -0.49 . . . . 61.31 113.287 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.506 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 28.5 mmm180 -104.27 110.49 22.73 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 107.466 -1.309 . . . . 75.11 107.466 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -137.13 147.01 45.72 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 115.662 -0.699 . . . . 75.52 109.875 -177.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -132.77 148.95 52.33 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 108.264 -1.013 . . . . 65.02 108.264 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -117.67 125.75 51.27 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 110.212 -0.292 . . . . 65.43 110.212 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.19 148.13 41.88 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.293 -1.002 . . . . 73.31 108.293 176.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -114.17 140.85 48.19 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.141 -0.689 . . . . 74.53 109.141 -177.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 68.4 m -148.41 137.93 12.38 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 110.46 -0.2 . . . . 64.33 110.46 173.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.741 ' HA ' ' O ' ' A' ' 490' ' ' SER . 29.6 Cg_endo -65.75 128.09 19.24 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.348 2.032 . . . . 75.01 110.426 175.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 48.5 m -140.57 -179.83 6.25 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 116.489 -0.323 . . . . 64.33 110.589 -176.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . 0.406 ' O ' HG13 ' A' ' 464' ' ' VAL . 9.9 t -45.58 130.99 6.44 Favored Pre-proline 0 CA--C 1.556 1.192 0 C-N-CA 124.53 1.132 . . . . 72.34 111.934 178.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . 0.565 ' O ' HG22 ' A' ' 464' ' ' VAL . 11.3 Cg_endo -51.72 -28.24 29.28 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 125.18 3.92 . . . . 73.45 114.466 -174.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.74 -32.08 67.35 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.147 0.498 . . . . 72.25 111.83 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . 0.535 HD13 ' O ' ' A' ' 463' ' ' LEU . 3.3 tm? -97.2 -13.46 22.05 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.984 -0.553 . . . . 70.34 110.66 -171.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' ' 461' ' ' PRO . 19.4 m -60.09 131.09 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 CA-C-O 121.47 0.652 . . . . 70.52 111.174 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.65 2.18 55.34 Favored Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 115.294 -0.866 . . . . 55.25 111.655 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -128.28 166.46 18.56 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.978 -0.749 . . . . 75.1 108.978 176.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.437 HG22 HG12 ' A' ' 488' ' ' VAL . 70.8 t -72.41 148.8 9.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.354 -0.98 . . . . 74.22 108.354 175.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 47.5 mt -97.36 -35.25 5.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 106.61 -1.626 . . . . 71.0 106.61 174.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 153.6 -168.67 32.22 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 110.377 -1.089 . . . . 73.15 110.377 176.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . 0.524 ' HB ' HG12 ' A' ' 486' ' ' ILE . 0.6 OUTLIER -115.83 141.11 48.53 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 107.929 -1.137 . . . . 60.54 107.929 176.266 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.497 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 46.2 t-20 -63.36 -51.4 68.42 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 123.529 0.518 . . . . 74.43 110.512 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.497 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 27.3 Cg_exo -70.55 124.09 10.44 Favored 'Trans proline' 0 C--N 1.373 1.856 0 N-CA-C 107.0 -1.961 . . . . 72.35 107.0 166.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.421 ' C ' ' H ' ' A' ' 475' ' ' ASN . 18.2 Cg_endo -61.94 127.78 22.37 Favored 'Trans proline' 0 C--O 1.241 0.673 0 C-N-CA 122.467 2.112 . . . . 61.34 114.248 -172.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -77.68 16.53 0.66 Allowed 'General case' 0 C--O 1.198 -1.642 0 CA-C-N 114.676 -1.147 . . . . 63.21 110.475 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . 0.421 ' H ' ' C ' ' A' ' 473' ' ' PRO . 0.9 OUTLIER -109.14 -9.19 15.05 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.601 -0.727 . . . . 72.02 109.618 178.414 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -107.07 175.47 5.49 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-O 121.722 0.773 . . . . 74.0 112.902 -174.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 4.1 m -92.38 106.14 18.2 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 114.421 -1.263 . . . . 65.04 108.842 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 68.2 m -100.87 149.32 23.99 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 123.263 0.625 . . . . 72.24 111.119 -176.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -78.3 154.43 30.91 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.328 -0.396 . . . . 64.14 111.448 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.419 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 1.7 mp -68.56 -23.06 27.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 C-N-CA 123.61 0.764 . . . . 63.1 111.622 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 17.7 p -94.42 5.55 51.44 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.365 0.602 . . . . 75.22 111.16 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -98.83 140.71 32.61 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.17 -0.468 . . . . 75.55 111.113 -175.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.506 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.5 p -107.34 127.11 63.42 Favored 'Isoleucine or valine' 0 C--O 1.245 0.824 0 CA-C-N 115.977 -0.556 . . . . 73.34 111.803 -178.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.413 ' HA ' ' HG2' ' A' ' 472' ' ' PRO . 32.5 m -97.05 140.97 16.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.34 0.59 . . . . 63.43 110.392 177.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.95 114.0 45.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.893 -0.78 . . . . 73.02 108.893 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.524 HG12 ' HB ' ' A' ' 470' ' ' THR . 61.4 mt -98.69 124.84 52.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 114.618 -1.174 . . . . 72.54 109.707 -178.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 5.2 tt -109.43 126.72 66.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 109.458 -0.571 . . . . 63.13 109.458 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.437 HG12 HG22 ' A' ' 467' ' ' VAL . 32.6 m -105.34 151.13 7.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 115.871 -0.604 . . . . 62.24 110.758 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -90.16 122.89 6.76 Favored Glycine 0 N--CA 1.416 -2.635 0 N-CA-C 109.33 -1.508 . . . . 21.23 109.33 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.741 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 8.5 t -125.22 160.34 29.45 Favored 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 107.575 -1.269 . . . . 53.23 107.575 -178.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 161.5 174.52 31.47 Favored Glycine 0 N--CA 1.435 -1.372 0 C-N-CA 119.983 -1.103 . . . . 51.34 112.112 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -93.31 152.74 2.5 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 123.084 2.523 . . . . 74.31 113.129 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -81.07 92.61 6.27 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 108.929 -0.767 . . . . 60.35 108.929 177.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 9.4 p -117.22 143.82 45.46 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.0 -1.0 . . . . 54.41 109.727 -177.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -150.99 157.46 42.91 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.46 -0.941 . . . . 63.2 108.46 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.511 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.5 m-20 -80.37 128.23 33.32 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 107.544 -1.28 . . . . 63.22 107.544 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . 0.458 HD11 ' HB2' ' A' ' 539' ' ' PRO . 40.7 pt -76.11 136.49 69.3 Favored Pre-proline 0 C--N 1.299 -1.611 0 O-C-N 123.121 0.263 . . . . 73.34 111.42 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 497' ' ' ILE . 1.5 Cg_endo -88.55 155.59 6.42 Favored 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 122.265 1.977 . . . . 32.5 108.938 168.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.92 165.44 11.71 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.664 -1.236 . . . . 74.42 107.664 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.77 117.14 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.354 0 CA-C-O 121.989 0.9 . . . . 70.2 111.279 -174.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -131.32 110.33 11.0 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 114.423 -1.262 . . . . 72.24 107.968 174.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 135.89 -14.58 4.1 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 119.768 -1.206 . . . . 71.33 112.553 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -98.02 172.59 7.53 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.324 -0.551 . . . . 63.42 110.074 177.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 11.4 t -90.3 157.28 17.74 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 107.959 -1.126 . . . . 72.42 107.959 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.453 ' HA ' ' CG2' ' A' ' 534' ' ' VAL . 7.6 p -50.05 -46.92 24.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 O-C-N 124.26 0.975 . . . . 55.24 112.594 -175.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.24 -42.08 80.24 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.389 -0.524 . . . . 72.45 111.923 -177.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 95.6 t -72.42 -36.24 54.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.091 -0.504 . . . . 65.15 111.255 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.65 -49.02 74.86 Favored 'General case' 0 C--N 1.31 -1.111 0 O-C-N 122.21 -0.306 . . . . 73.35 110.859 178.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -60.22 -36.4 77.61 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.8 0.81 . . . . 73.4 109.823 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.401 ' O ' HG23 ' A' ' 514' ' ' VAL . 80.4 tttt -65.23 -46.54 80.2 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 114.401 -1.272 . . . . 73.12 109.666 -177.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -61.77 -47.97 82.77 Favored 'General case' 0 CA--C 1.495 -1.172 0 O-C-N 124.188 0.93 . . . . 74.2 111.263 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.75 -41.84 91.88 Favored 'General case' 0 CA--C 1.513 -0.468 0 O-C-N 123.159 0.287 . . . . 72.01 111.053 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 1.0 OUTLIER -62.68 -38.19 89.4 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.341 -0.391 . . . . 71.14 111.215 178.739 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 510' ' ' LYS . 73.9 t -70.13 -29.18 38.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.962 -0.563 . . . . 61.34 110.866 178.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -76.74 -12.13 59.94 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.191 0.519 . . . . 72.04 110.001 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . 0.489 ' O ' ' HB ' ' A' ' 547' ' ' VAL . . . 121.48 -25.52 6.92 Favored Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 120.837 -0.696 . . . . 71.31 111.974 177.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.591 ' HA ' ' O ' ' A' ' 547' ' ' VAL . 66.1 m-85 -76.22 103.81 6.43 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.529 0.68 . . . . 61.35 109.685 -176.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 3.3 p -86.17 -28.41 23.94 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 113.896 1.073 . . . . 72.52 113.896 -170.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 67.9 mttm -109.07 126.24 52.96 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.443 0.639 . . . . 70.53 112.34 -174.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -129.82 157.49 42.06 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 123.756 0.822 . . . . 72.43 110.398 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 71.1 m -137.44 143.55 41.87 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 107.022 -1.473 . . . . 73.44 107.022 170.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -125.06 147.68 48.86 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 120.75 0.309 . . . . 74.51 110.357 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -141.08 129.5 22.48 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 107.817 -1.179 . . . . 75.11 107.817 174.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 52.4 m -89.2 139.46 30.46 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 109.865 -0.42 . . . . 54.52 109.865 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 26.8 m -120.98 164.73 17.23 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 107.631 -1.248 . . . . 43.01 107.631 178.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . 0.627 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 2.2 p-10 -82.62 134.69 35.17 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 118.963 -1.095 . . . . 73.31 108.671 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 48.3 m -155.29 168.06 12.88 Favored Pre-proline 0 N--CA 1.441 -0.877 0 C-N-CA 120.482 -0.487 . . . . 73.2 110.554 -176.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -83.24 -10.7 9.99 Favored 'Trans proline' 0 CA--C 1.546 1.113 0 C-N-CA 122.014 1.809 . . . . 64.43 111.23 171.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.35 135.16 50.6 Favored Pre-proline 0 CA--C 1.506 -0.73 0 N-CA-C 107.695 -1.224 . . . . 75.23 107.695 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.95 150.88 52.73 Favored 'Trans proline' 0 C--O 1.256 1.417 0 C-N-CA 122.686 2.257 . . . . 73.43 113.446 -176.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -64.41 121.77 15.15 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.856 -1.066 . . . . 71.41 110.966 -175.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 126.7 -16.29 6.56 Favored Glycine 0 N--CA 1.424 -2.123 0 C-N-CA 120.455 -0.878 . . . . 63.45 111.864 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -83.19 128.43 34.48 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 120.448 -0.501 . . . . 71.03 110.143 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.453 ' CG2' ' HA ' ' A' ' 505' ' ' VAL . 59.9 t -84.66 114.19 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.337 0 N-CA-C 106.08 -1.822 . . . . 53.53 106.08 174.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 9.1 m -113.73 9.86 17.79 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 119.526 -0.87 . . . . 74.43 111.918 -173.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 179.02 168.51 38.24 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 119.284 -1.436 . . . . 71.42 112.821 176.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 45.4 p -132.1 155.08 48.74 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.789 -1.189 . . . . 74.31 107.789 176.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.487 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 23.3 t-20 -73.37 -57.46 2.73 Favored Pre-proline 0 C--N 1.314 -0.952 0 C-N-CA 120.189 -0.604 . . . . 72.24 111.477 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.487 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 1.1 Cg_endo -84.0 140.9 9.16 Favored 'Trans proline' 0 N--CA 1.436 -1.909 0 CA-C-N 120.053 1.055 . . . . 72.41 109.509 175.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 3.4 Cg_exo -73.45 158.42 48.03 Favored 'Trans proline' 0 C--O 1.267 1.97 0 C-N-CA 121.977 1.785 . . . . 62.32 112.528 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.17 139.88 58.82 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 115.113 -0.948 . . . . 72.2 109.81 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 104.21 -8.75 49.33 Favored Glycine 0 N--CA 1.422 -2.28 0 C-N-CA 120.347 -0.93 . . . . 43.34 111.625 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 26.4 m -75.76 120.45 21.15 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.732 -0.84 . . . . 63.45 108.732 175.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 10.9 t -88.16 124.88 34.26 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-O 121.366 0.603 . . . . 45.44 110.864 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 33.8 m -141.95 165.3 28.71 Favored Pre-proline 0 C--N 1.315 -0.895 0 N-CA-C 108.164 -1.05 . . . . 65.22 108.164 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.61 144.44 94.25 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 121.92 1.747 . . . . 72.12 110.399 172.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 517' ' ' PHE . 34.8 m -64.71 -20.29 27.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 121.942 0.877 . . . . 74.12 112.166 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -92.78 4.8 53.13 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 115.773 -0.649 . . . . 62.2 111.65 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 12.8 t -86.6 170.72 11.6 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.424 -0.954 . . . . 64.24 108.424 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 99.7 t -95.92 131.98 41.3 Favored 'Isoleucine or valine' 0 C--O 1.247 0.925 0 N-CA-C 112.586 0.587 . . . . 51.45 112.586 -175.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . 0.529 HD13 ' O ' ' A' ' 519' ' ' LYS . 0.2 OUTLIER -105.34 134.22 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 108.574 -0.899 . . . . 70.05 108.574 169.13 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -102.97 117.08 33.8 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 116.446 -0.343 . . . . 64.51 110.167 -176.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 5.3 mp -103.9 134.43 47.21 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.07 0.948 . . . . 63.01 111.239 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -96.89 121.84 39.21 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.66 -0.867 . . . . 72.21 108.66 174.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 524' ' ' SER . 24.5 t -107.9 139.6 29.35 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 N-CA-C 108.612 -0.885 . . . . 61.22 108.612 -178.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.585 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 69.1 m -81.42 143.79 31.88 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 111.88 0.326 . . . . 50.42 111.88 178.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.627 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 12.2 ptmt -105.47 156.43 18.22 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 104.591 -2.374 . . . . 74.3 104.591 167.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -83.5 -24.31 50.99 Favored Glycine 0 CA--C 1.498 -1.03 0 C-N-CA 119.864 -1.16 . . . . 55.33 115.446 -168.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . 0.492 ' HB3' ' HD2' ' A' ' 616' ' ' ARG . 85.6 m-20 62.67 27.62 16.22 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.112 0.482 . . . . 71.33 110.586 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -128.58 149.28 50.7 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.231 -1.026 . . . . 53.42 108.231 -172.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -140.89 149.2 41.61 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.167 -1.049 . . . . 51.43 108.167 173.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.4 p -83.67 116.86 28.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 121.849 0.833 . . . . 71.3 112.081 -176.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 60.0 ttp -89.5 127.05 56.21 Favored Pre-proline 0 C--N 1.312 -1.033 0 CA-C-N 115.283 -0.871 . . . . 52.05 108.689 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.62 154.8 66.83 Favored 'Trans proline' 0 C--O 1.239 0.555 0 C-N-CA 122.261 1.974 . . . . 72.44 111.811 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -83.13 115.5 21.93 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.351 0.596 . . . . 71.04 111.782 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . 0.581 ' O ' ' HG3' ' A' ' 569' ' ' MET . 95.2 mt -136.87 18.33 3.04 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.536 -1.211 . . . . 70.35 109.001 178.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 24.0 t -52.69 131.07 34.26 Favored 'General case' 0 CA--C 1.553 1.093 0 O-C-N 123.384 0.427 . . . . 73.22 110.748 -175.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 107.37 41.54 1.61 Allowed Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 109.382 -1.487 . . . . 74.54 109.382 -174.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . 0.581 ' HG3' ' O ' ' A' ' 566' ' ' LEU . 79.0 mtp -101.02 158.11 16.25 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.167 -0.517 . . . . 75.01 110.518 -177.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . 0.431 ' HB3' ' OD1' ' A' ' 601' ' ' ASN . 98.7 m-85 -102.69 168.13 9.45 Favored 'General case' 0 N--CA 1.416 -2.13 0 N-CA-C 106.886 -1.524 . . . . 75.32 106.886 170.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 79.9 t90 -64.23 -32.37 73.92 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.902 -0.777 . . . . 74.3 108.902 174.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.1 p -67.94 -20.19 25.66 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 CA-C-N 115.511 -0.768 . . . . 73.24 110.612 177.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -85.43 -38.06 19.08 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 108.444 -0.946 . . . . 71.54 108.444 175.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -57.66 -41.38 81.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.043 -0.981 . . . . 73.53 112.185 -177.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -55.59 -59.82 10.23 Favored Pre-proline 0 CA--C 1.591 2.529 0 N-CA-C 112.795 0.665 . . . . 71.34 112.795 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.1 -43.02 26.2 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 121.622 1.548 . . . . 62.44 112.88 175.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -59.79 -33.81 72.2 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 111.772 0.286 . . . . 72.11 111.772 -177.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 6.9 tt -57.4 -46.65 83.25 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.622 0.769 . . . . 52.13 109.422 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -65.38 -47.42 76.4 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.86 -0.609 . . . . 72.01 111.634 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.64 -39.16 88.12 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.605 -0.725 . . . . 53.43 112.598 -175.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 88.9 mt -84.49 -8.01 59.08 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 111.677 0.251 . . . . 62.32 111.677 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 66.76 41.57 93.61 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 111.481 -0.647 . . . . 73.14 111.481 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 90.9 t90 -83.61 134.77 34.78 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.039 0.447 . . . . 70.44 111.798 -176.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 91.4 m -154.13 96.38 1.94 Allowed 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 124.561 1.144 . . . . 72.43 108.314 170.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -147.19 -147.16 4.49 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 108.569 -1.812 . . . . 74.42 108.569 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . 0.571 ' HB3' HG12 ' A' ' 619' ' ' ILE . 23.2 ttt -98.28 124.23 42.78 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 117.888 0.844 . . . . 74.04 109.028 178.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 57.4 tp -94.92 115.53 27.57 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 107.361 -1.348 . . . . 74.33 107.361 177.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -95.67 104.5 16.42 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.639 -0.825 . . . . 74.24 109.697 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -110.6 134.25 52.58 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.996 -0.547 . . . . 73.33 109.686 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -102.8 -173.4 26.71 Favored Glycine 0 N--CA 1.432 -1.577 0 N-CA-C 110.072 -1.211 . . . . 73.11 110.072 174.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -65.85 148.74 51.29 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 122.449 0.3 . . . . 34.0 110.799 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . 0.413 ' HA ' ' O ' ' A' ' 625' ' ' GLY . 3.7 m-20 -78.98 123.61 27.45 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.688 -1.227 . . . . 44.1 107.688 177.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 88.6 t -137.54 120.3 20.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 116.291 -0.413 . . . . 62.11 110.538 -173.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -80.53 106.86 12.87 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.001 -1.111 . . . . 63.44 108.001 174.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -126.37 2.05 7.01 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.84 -0.618 . . . . 44.23 111.361 -176.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 123.2 163.58 11.83 Favored Glycine 0 N--CA 1.43 -1.704 0 C-N-CA 119.815 -1.183 . . . . 75.23 111.084 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.24 -36.6 69.38 Favored Glycine 0 C--O 1.223 -0.573 0 N-CA-C 114.151 0.421 . . . . 43.13 114.151 -173.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 25.8 m -64.59 -24.5 67.61 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 117.176 0.488 . . . . 73.45 111.939 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -107.05 -8.32 16.58 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 122.044 -0.41 . . . . 73.23 110.876 -178.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 59.3 m170 -74.38 103.48 4.77 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 112.901 0.704 . . . . 71.44 112.901 -175.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . 0.431 ' OD1' ' HB3' ' A' ' 570' ' ' PHE . 4.5 t-20 69.04 -4.27 1.29 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.14 1.776 . . . . 75.22 112.695 172.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -86.78 140.65 29.51 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.31 1.044 . . . . 71.22 108.254 -177.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . 0.403 HG13 ' HB2' ' A' ' 622' ' ' LEU . 96.8 t -69.82 130.79 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 107.444 -1.317 . . . . 73.43 107.444 176.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 623' ' ' ARG . 9.0 p -99.42 -32.89 3.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 119.204 -0.998 . . . . 65.01 110.899 -174.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -147.62 153.47 39.44 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 106.356 -1.72 . . . . 72.42 106.356 176.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -123.42 -172.09 2.44 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 108.557 -0.905 . . . . 63.02 108.557 177.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.509 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 55.2 t30 -113.36 -65.02 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.534 0 C-N-CA 119.152 -1.019 . . . . 64.5 112.277 -177.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.509 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 59.1 Cg_endo -88.99 157.96 5.87 Favored 'Trans proline' 0 CA--C 1.552 1.404 0 CA-C-N 120.835 1.334 . . . . 60.12 110.65 174.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -70.73 135.0 27.13 Favored 'Trans proline' 0 C--O 1.249 1.026 0 C-N-CA 122.304 2.002 . . . . 54.1 112.623 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -68.89 132.62 47.02 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.642 -0.708 . . . . 60.22 109.665 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 93.07 -0.48 69.2 Favored Glycine 0 C--N 1.316 -0.548 0 N-CA-C 111.153 -0.779 . . . . 65.1 111.153 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 43.2 m -110.98 164.36 12.88 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 108.429 -0.952 . . . . 63.4 108.429 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -70.4 122.66 11.09 Favored Glycine 0 N--CA 1.416 -2.683 0 N-CA-C 111.371 -0.692 . . . . 71.24 111.371 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 33.1 m -105.82 144.51 15.16 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 108.074 -1.084 . . . . 63.45 108.074 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.441 ' ND2' ' HB3' ' A' ' 617' ' ' ASP . 29.5 p-10 -53.85 149.21 9.06 Favored 'General case' 0 C--O 1.22 -0.482 0 O-C-N 123.309 0.38 . . . . 74.41 110.536 -178.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . 0.492 ' HD2' ' HB3' ' A' ' 559' ' ' ASN . 0.1 OUTLIER -54.71 -25.44 27.35 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 112.696 0.628 . . . . 74.22 112.696 -178.388 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . 0.441 ' HB3' ' ND2' ' A' ' 615' ' ' ASN . 31.5 t70 -67.73 -37.07 81.7 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.724 -0.671 . . . . 63.34 109.486 177.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 85.53 21.39 54.15 Favored Glycine 0 C--O 1.202 -1.876 0 C-N-CA 120.655 -0.784 . . . . 65.3 112.627 176.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . 0.571 HG12 ' HB3' ' A' ' 586' ' ' MET . 0.1 OUTLIER -68.69 119.72 14.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 122.563 1.173 . . . . 75.31 111.333 -170.548 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 40.2 mm -121.04 119.76 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-N 114.027 -1.442 . . . . 62.42 107.747 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 51.8 m -98.87 118.64 36.09 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.354 -1.351 . . . . 72.24 107.354 174.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . 0.403 ' HB2' HG13 ' A' ' 603' ' ' VAL . 2.2 pt? -138.04 165.39 26.7 Favored 'General case' 0 CA--C 1.484 -1.558 0 N-CA-C 108.162 -1.051 . . . . 74.32 108.162 -174.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . 0.445 ' O ' HG12 ' A' ' 604' ' ' VAL . 14.2 tpt180 -148.14 141.63 25.38 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 106.617 -1.623 . . . . 74.32 106.617 176.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -136.52 158.89 43.38 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 105.818 -1.919 . . . . 73.34 105.818 173.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 592' ' ' ASP . . . -77.8 -90.96 0.31 Allowed Glycine 0 N--CA 1.426 -1.99 0 N-CA-C 110.355 -1.098 . . . . 61.55 110.355 178.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 . . . . . 0 C--N 1.288 -2.098 0 CA-C-O 118.132 -0.937 . . . . 72.44 109.143 176.417 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.247 0 N-CA-C 109.745 -1.342 . . . . 43.05 109.745 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 9.8 tp -74.72 120.58 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.857 0 CA-C-O 122.29 1.043 . . . . 72.45 110.302 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 23.2 m -110.43 161.45 15.65 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 114.946 -1.024 . . . . 73.33 109.004 -177.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.09 83.76 2.06 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 107.579 -1.267 . . . . 61.43 107.579 175.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -66.5 149.35 50.58 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 113.058 -1.883 . . . . 74.22 110.89 -173.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 28.5 m -116.89 147.93 19.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 109.209 -0.663 . . . . 74.42 109.209 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . 0.424 ' NE2' ' HA ' ' A' ' 407' ' ' ASN . 0.8 OUTLIER -94.09 130.07 40.4 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 105.18 -2.156 . . . . 74.43 105.18 -178.759 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.461 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 79.8 t -95.8 132.13 27.84 Favored Pre-proline 0 C--N 1.288 -2.093 0 CA-C-N 115.46 -0.791 . . . . 71.53 111.025 -166.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 17.2 Cg_exo -61.5 122.43 11.06 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.531 2.154 . . . . 61.42 111.938 -178.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -89.08 111.42 22.16 Favored 'General case' 0 C--N 1.272 -2.779 0 CA-C-N 114.072 -1.422 . . . . 63.34 110.465 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 7.1 t -86.72 24.0 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.558 0 CA-C-O 122.807 1.289 . . . . 75.45 111.24 -174.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.531 ' O ' ' HD2' ' A' ' 366' ' ' ARG . 1.9 ppt_? -52.86 144.63 14.16 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.691 -1.14 . . . . 74.2 112.225 172.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 98.51 -14.47 62.03 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 120.82 -0.705 . . . . 64.35 112.54 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -102.07 -89.38 0.37 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 120.222 -0.591 . . . . 72.12 111.104 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 81.0 p -164.74 168.79 17.54 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.138 -1.06 . . . . 44.45 108.138 177.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 28.7 m -63.37 -40.82 98.3 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 109.053 -0.721 . . . . 63.12 109.053 176.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.79 -45.83 90.84 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.835 -0.621 . . . . 72.23 110.983 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -64.05 -42.38 97.05 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.355 0.41 . . . . 75.24 111.043 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . 0.402 ' O ' ' HG ' ' A' ' 377' ' ' LEU . . . -66.74 -50.11 63.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.14 -0.482 . . . . 62.21 111.06 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 78.4 mt -61.98 -40.23 86.54 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 CA-C-N 116.228 -0.442 . . . . 74.03 110.996 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.8 -47.2 85.6 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.195 0.522 . . . . 62.2 110.363 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . 0.668 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 27.9 m -66.04 -47.96 72.65 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 115.104 -0.953 . . . . 64.25 110.024 -179.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 373' ' ' ALA . 97.5 mt -61.89 -44.68 96.3 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.604 -0.271 . . . . 63.53 111.694 -177.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -63.37 -42.81 98.88 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.267 -0.424 . . . . 64.15 110.6 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -70.42 -17.5 63.01 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.102 0.477 . . . . 73.35 112.237 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . 0.668 ' HG2' ' O ' ' A' ' 376' ' ' THR . 17.5 mmm180 -89.56 -13.75 36.6 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 120.882 -0.327 . . . . 64.4 110.665 176.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.08 13.49 36.45 Favored Glycine 0 C--N 1.309 -0.968 0 C-N-CA 120.315 -0.945 . . . . 42.43 112.301 177.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -87.84 156.61 19.3 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 121.003 0.43 . . . . 61.53 110.725 175.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -105.6 154.27 20.64 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.946 -1.131 . . . . 73.33 107.946 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.418 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -127.68 149.09 32.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 119.65 -0.82 . . . . 72.13 112.406 -176.338 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . 0.431 ' HD2' ' OG1' ' A' ' 417' ' ' THR . 41.6 ttm180 -116.92 128.12 54.91 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 105.283 -2.117 . . . . 75.13 105.283 173.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 31.1 m -122.8 124.67 43.85 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 109.123 -0.695 . . . . 72.42 109.123 -175.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -111.76 119.8 39.85 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.141 -1.799 . . . . 64.33 106.141 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.549 HE21 ' N ' ' A' ' 388' ' ' GLN . 0.0 OUTLIER -116.9 134.85 54.25 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.455 -0.498 . . . . 53.35 110.891 -177.541 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 390' ' ' PRO . 28.3 mtpp -135.86 145.0 50.95 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-N 115.787 -0.642 . . . . 63.25 110.658 178.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 389' ' ' LYS . 33.9 Cg_exo -68.5 153.62 73.43 Favored 'Trans proline' 0 C--O 1.252 1.188 0 C-N-CA 122.628 2.219 . . . . 74.43 108.85 169.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -62.64 124.94 22.3 Favored 'General case' 0 CA--C 1.487 -1.453 0 CA-C-O 122.519 1.152 . . . . 70.14 112.739 -175.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 49.5 m -154.37 34.19 0.42 Allowed 'General case' 0 C--N 1.279 -2.5 0 CA-C-N 112.525 -2.125 . . . . 70.14 106.134 178.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 23.2 m 81.38 46.1 0.03 OUTLIER 'General case' 0 CA--C 1.57 1.736 0 C-N-CA 125.862 1.665 . . . . 72.15 111.515 -178.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.25 151.59 46.94 Favored Pre-proline 0 C--N 1.313 -1.009 0 CA-C-N 115.431 -0.804 . . . . 71.1 110.68 174.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . 0.412 ' HB3' HD13 ' A' ' 400' ' ' ILE . 81.9 Cg_exo -50.8 136.54 43.01 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 C-N-CA 124.007 3.138 . . . . 75.05 114.654 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.99 163.02 17.39 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.733 2.955 . . . . 75.14 111.841 176.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -56.86 -8.41 0.6 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 112.885 0.698 . . . . 63.43 112.885 -179.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 33.8 m170 -85.51 114.47 22.56 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 106.959 -1.497 . . . . 73.21 106.959 173.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 15.5 m -68.3 119.53 14.21 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-N 116.067 -0.515 . . . . 64.23 112.005 -174.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . 0.412 HD13 ' HB3' ' A' ' 395' ' ' PRO . 3.9 mp -87.25 -30.55 5.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 108.083 -1.08 . . . . 61.22 108.083 176.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.39 171.02 27.35 Favored Glycine 0 N--CA 1.422 -2.239 0 N-CA-C 110.774 -0.93 . . . . 34.14 110.774 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 4.1 p -114.6 -178.06 3.28 Favored 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 123.059 0.544 . . . . 74.03 110.75 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -100.62 136.93 19.79 Favored Pre-proline 0 C--N 1.293 -1.881 0 N-CA-C 107.862 -1.162 . . . . 64.32 107.862 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -47.51 -22.64 2.92 Favored 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 124.503 3.468 . . . . 61.43 115.275 -176.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -64.74 -29.29 70.27 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 120.729 0.3 . . . . 55.12 110.961 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -85.28 -40.78 16.2 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.571 0.7 . . . . 63.44 110.327 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . 0.424 ' HA ' ' NE2' ' A' ' 361' ' ' GLN . 13.0 m120 -77.14 -11.18 59.78 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.421 -0.809 . . . . 71.04 112.126 -173.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 57.2 m -100.94 157.51 16.69 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 107.558 -1.275 . . . . 70.11 107.558 177.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 44.1 m -74.53 112.77 11.04 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 108.066 -1.086 . . . . 72.33 108.066 177.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.5 169.33 20.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 120.972 0.415 . . . . 70.01 111.202 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 22.8 t -73.64 133.05 43.37 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 107.096 -1.446 . . . . 73.41 107.096 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -61.88 138.5 58.36 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.134 0.492 . . . . 72.22 111.56 -176.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 93.1 39.48 5.13 Favored Glycine 0 N--CA 1.437 -1.286 0 CA-C-N 115.704 -0.68 . . . . 53.53 111.943 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -102.49 -174.33 2.54 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.191 -1.411 . . . . 62.14 107.191 177.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -109.83 116.27 31.34 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 118.374 0.534 . . . . 74.31 109.897 -177.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 32.2 mm -99.37 129.19 50.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 109.154 -0.684 . . . . 71.32 109.154 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . 0.431 ' OG1' ' HD2' ' A' ' 385' ' ' ARG . 44.7 m -91.74 131.13 37.33 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 112.38 0.511 . . . . 71.32 112.38 -177.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 3.5 p -123.33 134.96 64.78 Favored 'Isoleucine or valine' 0 C--O 1.252 1.226 0 N-CA-C 108.351 -0.981 . . . . 75.51 108.351 176.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -107.24 124.99 50.56 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.244 -0.65 . . . . 65.33 109.244 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 2.7 p -125.79 131.46 71.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-N 115.49 -0.777 . . . . 73.24 111.176 -177.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 29.3 t -107.61 131.34 54.47 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-O 121.941 0.877 . . . . 45.01 110.23 176.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 24.2 p -87.15 158.48 19.15 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 105.363 -2.088 . . . . 42.41 105.363 170.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -65.46 -159.08 0.49 Allowed Glycine 0 CA--C 1.549 2.191 0 CA-C-N 118.679 0.672 . . . . 72.14 114.092 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.91 153.41 75.48 Favored 'Trans proline' 0 C--O 1.243 0.731 0 C-N-CA 122.283 1.989 . . . . 70.31 111.675 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.448 ' O ' HG12 ' A' ' 480' ' ' ILE . 36.1 mt-10 -86.95 166.12 15.34 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 122.118 0.961 . . . . 71.14 113.17 -175.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.588 ' HG2' HG22 ' A' ' 477' ' ' THR . 45.9 tt0 -132.51 131.87 42.06 Favored 'General case' 0 N--CA 1.408 -2.572 0 N-CA-C 104.23 -2.507 . . . . 71.34 104.23 171.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.46 ' HA ' ' HE ' ' A' ' 427' ' ' ARG . 3.2 mmp_? -122.53 156.68 33.68 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 120.492 -0.483 . . . . 74.32 111.847 -173.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -83.22 139.98 32.81 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.788 -1.19 . . . . 72.34 107.788 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 73.3 mt -78.96 122.5 84.62 Favored Pre-proline 0 N--CA 1.425 -1.693 0 N-CA-C 108.298 -1.001 . . . . 51.33 108.298 -178.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -69.97 140.82 42.79 Favored 'Trans proline' 0 N--CA 1.429 -2.323 0 C-N-CA 121.256 1.304 . . . . 60.42 110.05 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -100.85 155.95 17.64 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 115.677 -0.692 . . . . 73.22 109.479 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.588 HG11 ' HB2' ' A' ' 440' ' ' ALA . 8.5 p -153.2 170.94 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 N-CA-C 107.452 -1.314 . . . . 71.35 107.452 -174.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.459 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 14.5 m -73.09 146.36 45.84 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 108.713 -0.847 . . . . 63.32 108.713 176.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 15.7 p -68.4 -23.92 64.7 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 113.59 0.959 . . . . 72.34 113.59 -174.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.5 pp -80.39 -11.87 59.64 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 120.113 -0.635 . . . . 61.52 110.383 177.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.466 HG22 ' HB3' ' A' ' 439' ' ' GLU . 1.3 m -101.84 44.15 1.03 Allowed 'General case' 0 CA--C 1.555 1.135 0 CA-C-N 115.592 -0.731 . . . . 61.43 110.902 -175.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -52.42 -38.18 58.49 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.387 0.675 . . . . 71.33 112.389 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.0 -45.03 83.31 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.209 0.528 . . . . 65.54 111.025 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.466 ' HB3' HG22 ' A' ' 436' ' ' THR . 33.7 tt0 -70.7 -33.26 70.69 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.68 -0.691 . . . . 73.44 110.51 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.588 ' HB2' HG11 ' A' ' 432' ' ' VAL . . . -58.95 -51.27 70.78 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.088 0.155 . . . . 44.33 110.658 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 33.6 m -62.52 -37.12 78.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-O 121.201 0.524 . . . . 70.44 110.849 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -60.39 -47.99 83.71 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.312 -0.858 . . . . 64.34 110.437 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -66.03 -38.75 89.18 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.904 -0.589 . . . . 73.01 111.725 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 93.1 mt -63.66 -33.66 76.13 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.791 0.329 . . . . 74.32 110.383 176.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 66.3 m -70.28 -44.9 67.45 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 115.912 -0.586 . . . . 74.35 110.1 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.75 -21.69 65.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.597 -0.729 . . . . 63.13 110.907 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.22 5.09 21.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.622 -0.717 . . . . 74.41 112.436 -179.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 105.18 -79.47 0.28 Allowed Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.11 -1.043 . . . . 72.24 111.998 175.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -39.62 -61.07 0.87 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.358 1.244 . . . . 73.32 114.358 176.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 62.15 18.45 57.73 Favored Glycine 0 C--N 1.321 -0.293 0 C-N-CA 121.634 -0.317 . . . . 71.42 113.186 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 14.3 mmt180 -95.15 111.29 23.14 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.356 -0.979 . . . . 74.33 108.356 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -136.49 153.88 50.9 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 120.689 0.281 . . . . 72.44 110.795 -178.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -142.37 133.16 25.56 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.545 -1.28 . . . . 73.22 107.545 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -101.5 134.52 44.48 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.832 -0.433 . . . . 74.51 109.832 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -124.37 138.83 54.33 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.036 -1.468 . . . . 22.41 107.036 173.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -121.07 136.67 54.93 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 109.479 -0.563 . . . . 62.04 109.479 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 32.5 t -135.72 141.2 36.13 Favored Pre-proline 0 C--N 1.296 -1.746 0 N-CA-C 108.708 -0.849 . . . . 61.13 108.708 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.693 ' HA ' ' O ' ' A' ' 490' ' ' SER . 37.6 Cg_endo -69.43 131.16 21.11 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.18 1.92 . . . . 73.03 110.521 175.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 61.1 m -151.22 -179.38 7.29 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.638 -0.875 . . . . 60.32 108.638 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 11.9 t -48.22 138.81 10.62 Favored Pre-proline 0 C--O 1.25 1.104 0 C-N-CA 123.941 0.897 . . . . 51.43 111.11 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -51.39 -29.39 30.59 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 124.401 3.401 . . . . 72.21 113.817 -175.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -75.27 -26.57 58.9 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.026 -0.67 . . . . 53.01 111.939 -177.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -88.58 -14.96 36.33 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 120.689 0.28 . . . . 71.0 111.07 178.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 86.5 t -60.87 127.56 20.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 109.385 -0.598 . . . . 75.15 109.385 176.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 96.92 -5.81 63.94 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 115.799 -0.637 . . . . 72.02 112.945 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.411 ' HD2' ' N ' ' A' ' 466' ' ' LYS . 8.2 mptt -124.46 160.18 28.82 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 108.393 -0.965 . . . . 73.23 108.393 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.415 HG22 HG12 ' A' ' 488' ' ' VAL . 77.7 t -70.95 142.62 15.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 107.612 -1.255 . . . . 72.33 107.612 173.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 59.0 mt -97.57 -35.65 5.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 107.566 -1.272 . . . . 75.3 107.566 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 173.24 -172.43 45.15 Favored Glycine 0 N--CA 1.412 -2.931 0 N-CA-C 109.707 -1.357 . . . . 73.14 109.707 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 30.2 p -121.18 146.24 46.99 Favored 'General case' 0 C--N 1.271 -2.832 0 N-CA-C 107.216 -1.401 . . . . 74.05 107.216 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.453 ' HB3' HG23 ' A' ' 485' ' ' ILE . 58.0 t30 -72.07 -46.2 11.35 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 119.096 -1.042 . . . . 74.12 110.153 176.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -82.61 146.44 13.47 Favored 'Trans proline' 0 C--N 1.374 1.906 0 N-CA-C 108.517 -1.378 . . . . 73.44 108.517 169.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.478 ' HB2' ' HG2' ' A' ' 476' ' ' GLN . 19.5 Cg_exo -65.36 127.29 17.88 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 121.778 1.652 . . . . 73.44 111.691 -178.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -86.3 8.95 19.35 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.643 0.735 . . . . 70.54 111.299 -175.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -109.4 -6.73 15.36 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 116.039 -0.528 . . . . 72.51 110.364 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . 0.478 ' HG2' ' HB2' ' A' ' 473' ' ' PRO . 81.2 mm-40 -97.24 172.2 7.95 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 116.01 -0.541 . . . . 62.41 111.791 -174.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.588 HG22 ' HG2' ' A' ' 426' ' ' GLN . 1.3 m -92.91 119.01 31.77 Favored 'General case' 0 N--CA 1.418 -2.032 0 CA-C-N 115.272 -0.876 . . . . 51.13 108.688 -177.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 54.9 m -115.49 148.04 39.94 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 123.171 0.588 . . . . 74.01 110.719 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -73.26 159.07 33.97 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.767 -0.651 . . . . 50.55 111.066 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 425' ' ' GLU . 43.7 mm -69.09 -21.09 25.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.748 0.785 . . . . 63.23 110.295 -177.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 3.7 p -100.15 5.33 44.82 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.734 -0.604 . . . . 73.3 111.87 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -94.1 133.9 37.1 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.216 -0.447 . . . . 75.11 109.926 -177.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 33.0 t -100.64 126.77 54.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.082 -0.508 . . . . 72.32 110.621 -174.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 35.0 m -103.0 137.47 31.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.429 0.633 . . . . 72.33 111.143 178.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.453 HG23 ' HB3' ' A' ' 471' ' ' ASN . 0.0 OUTLIER -107.16 128.45 62.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.495 0.664 . . . . 73.31 110.096 -178.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 38.5 mm -109.21 128.23 65.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 C-N-CA 125.046 1.338 . . . . 75.54 108.858 -174.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 13.4 tt -112.07 126.47 69.47 Favored 'Isoleucine or valine' 0 C--O 1.246 0.887 0 CA-C-O 121.453 0.644 . . . . 71.13 110.977 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.415 HG12 HG22 ' A' ' 467' ' ' VAL . 34.5 m -113.29 151.64 15.13 Favored 'Isoleucine or valine' 0 C--O 1.255 1.352 0 CA-C-N 115.448 -0.796 . . . . 61.4 111.495 -177.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.0 132.53 11.22 Favored Glycine 0 N--CA 1.433 -1.548 0 N-CA-C 109.534 -1.426 . . . . 24.23 109.534 177.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.693 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 21.5 p -141.79 160.98 39.08 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 116.958 0.379 . . . . 74.12 110.48 -176.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 127.07 88.32 0.64 Allowed Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 120.138 -1.029 . . . . 65.5 113.013 175.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -73.94 143.37 32.8 Favored 'Trans proline' 0 C--O 1.252 1.205 0 C-N-CA 122.403 2.069 . . . . 75.42 110.891 177.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -91.32 78.09 5.79 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.718 0.771 . . . . 73.33 110.043 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 546' ' ' PRO . 18.2 p -117.79 142.94 46.72 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.98 -1.009 . . . . 72.41 110.697 -178.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 4.8 mmmp? -141.15 152.62 44.84 Favored 'General case' 0 CA--C 1.494 -1.183 0 CA-C-O 121.524 0.678 . . . . 74.14 110.792 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 12.4 p-10 -80.62 134.41 35.89 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 114.265 -1.334 . . . . 73.4 108.518 175.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 31.8 pt -83.35 125.28 74.6 Favored Pre-proline 0 C--N 1.3 -1.55 0 C-N-CA 120.527 -0.469 . . . . 74.44 109.834 177.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -79.8 -175.81 2.91 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.279 1.986 . . . . 64.44 111.107 178.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -84.22 90.17 7.46 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.678 0.752 . . . . 73.33 110.675 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 12.8 p -104.96 3.17 10.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 123.353 1.549 . . . . 53.22 106.985 175.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . 0.568 ' HB1' ' HA2' ' A' ' 536' ' ' GLY . . . -83.6 63.59 7.48 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 113.161 -1.836 . . . . 75.31 111.446 -174.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 165.95 28.65 0.02 OUTLIER Glycine 0 C--N 1.309 -0.962 0 C-N-CA 119.253 -1.451 . . . . 72.12 113.244 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -118.74 -169.13 1.66 Allowed 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 106.753 -1.573 . . . . 73.43 106.753 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 11.4 m -81.96 155.45 25.22 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.038 -1.467 . . . . 75.44 107.038 175.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.621 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 6.0 p -55.1 -46.36 77.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.231 0.456 . . . . 65.04 112.231 -176.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -66.51 -41.63 88.58 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 116.475 -0.329 . . . . 62.32 111.326 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 60.0 t -66.43 -42.04 89.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.694 -0.685 . . . . 71.41 109.817 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -61.86 -44.91 95.86 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 115.424 -0.807 . . . . 71.2 111.253 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.621 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 21.2 mt-30 -60.29 -40.41 90.38 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 121.191 0.519 . . . . 72.14 110.887 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.449 ' O ' HG23 ' A' ' 514' ' ' VAL . 64.0 mttm -64.47 -53.6 45.74 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.417 -0.81 . . . . 74.1 109.626 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -62.77 -37.8 88.08 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 115.514 -0.766 . . . . 75.14 111.288 -177.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 8.4 tt -59.04 -44.79 91.83 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 109.108 -0.701 . . . . 72.42 109.108 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . 0.546 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 0.8 OUTLIER -64.62 -37.64 88.28 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.173 -0.467 . . . . 72.04 111.426 177.292 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 510' ' ' LYS . 92.7 t -63.71 -30.25 49.42 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 CA-C-N 116.028 -0.533 . . . . 63.44 111.088 177.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -77.15 -4.53 45.01 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.82 0.343 . . . . 75.33 111.353 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 106.42 -10.69 42.81 Favored Glycine 0 CA--C 1.496 -1.122 0 C-N-CA 120.664 -0.779 . . . . 52.42 112.226 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 82.4 m-85 -88.52 114.42 25.12 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 107.377 -1.342 . . . . 63.32 107.377 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 5.0 p -89.56 -19.4 25.04 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 112.983 0.735 . . . . 70.41 112.983 -175.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -107.93 119.51 39.67 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.404 0.621 . . . . 63.4 111.924 -172.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -129.8 156.4 44.39 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.346 -0.843 . . . . 73.31 110.524 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 10.1 p -141.64 147.05 36.94 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.381 -1.34 . . . . 71.11 107.381 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.51 133.48 53.31 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 121.169 0.509 . . . . 60.15 111.427 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -132.97 126.39 31.88 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.436 -0.95 . . . . 71.15 108.436 178.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 11.0 m -98.1 134.64 40.9 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-O 120.828 0.347 . . . . 74.01 110.423 -177.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 557' ' ' LYS . 30.5 m -123.01 149.96 26.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.083 -1.081 . . . . 63.31 108.083 176.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -66.33 135.67 54.71 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.998 -0.741 . . . . 75.3 108.998 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 74.2 m -149.91 166.99 13.9 Favored Pre-proline 0 C--N 1.293 -1.863 0 CA-C-N 115.754 -0.657 . . . . 64.24 111.162 -173.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -79.48 -23.36 7.32 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 121.805 1.67 . . . . 54.52 110.658 170.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -70.79 147.28 94.2 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 108.607 -0.886 . . . . 73.11 108.607 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -61.77 158.95 35.13 Favored 'Trans proline' 0 C--O 1.251 1.13 0 C-N-CA 122.835 2.357 . . . . 72.35 113.129 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -67.24 120.46 13.83 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.581 -0.736 . . . . 31.3 110.783 -179.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 118.52 -17.21 11.28 Favored Glycine 0 C--N 1.309 -0.924 0 C-N-CA 120.651 -0.785 . . . . 54.4 111.646 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -77.42 133.1 38.74 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.095 -1.076 . . . . 71.3 108.095 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 77.3 t -82.41 117.58 28.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 108.216 -1.031 . . . . 63.23 108.216 177.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . 0.52 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 13.7 t -82.07 -17.66 45.83 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.781 0.8 . . . . 72.33 109.727 -177.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.568 ' HA2' ' HB1' ' A' ' 501' ' ' ALA . . . 162.35 -163.31 34.95 Favored Glycine 0 N--CA 1.411 -3.021 0 N-CA-C 110.618 -0.993 . . . . 31.44 110.618 177.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . 0.433 HG22 HD23 ' A' ' 553' ' ' LEU . 22.8 p -124.98 154.88 40.53 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 107.749 -1.204 . . . . 63.1 107.749 176.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -66.31 -55.88 18.29 Favored Pre-proline 0 C--N 1.306 -1.306 0 N-CA-C 109.606 -0.516 . . . . 64.2 109.606 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.46 127.06 10.09 Favored 'Trans proline' 0 C--N 1.368 1.561 0 N-CA-C 109.128 -1.143 . . . . 53.44 109.128 169.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.6 152.99 64.7 Favored 'Trans proline' 0 C--O 1.245 0.873 0 C-N-CA 123.14 2.56 . . . . 75.23 112.944 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -67.12 138.26 56.94 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.118 -0.492 . . . . 62.33 110.096 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 104.41 -20.82 38.83 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 111.469 -0.652 . . . . 64.25 111.469 -177.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 32.8 m -65.41 135.61 55.46 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.5 -0.556 . . . . 71.05 109.5 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 17.2 m -97.7 123.18 41.52 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 109.333 -0.617 . . . . 73.13 109.333 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.0 m -136.53 159.81 69.08 Favored Pre-proline 0 C--N 1.31 -1.141 0 N-CA-C 109.161 -0.681 . . . . 73.43 109.161 -178.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 494' ' ' THR . 41.7 Cg_exo -63.88 147.6 92.08 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.221 1.947 . . . . 74.54 111.435 174.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 29.5 m -64.97 -19.62 25.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.703 0.763 . . . . 61.51 111.557 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -93.55 3.64 55.21 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.169 -0.923 . . . . 64.11 110.256 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 11.7 t -85.71 162.19 18.86 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.546 -0.909 . . . . 44.3 108.546 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 21.6 t -97.36 128.06 49.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 109.604 -0.517 . . . . 42.31 109.604 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 2.3 mp -101.68 131.58 49.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 108.863 -0.791 . . . . 75.32 108.863 176.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -102.67 116.69 33.09 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 121.489 0.661 . . . . 71.45 110.669 -178.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . 0.433 HD23 HG22 ' A' ' 537' ' ' THR . 84.4 mt -90.31 128.84 36.55 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.768 -1.197 . . . . 34.42 107.768 177.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -103.82 113.76 27.53 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 122.379 1.085 . . . . 71.1 109.379 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 23.0 t -94.38 147.13 5.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-N 114.02 -1.446 . . . . 62.34 110.019 -172.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.52 ' OG ' ' HB ' ' A' ' 535' ' ' THR . 7.5 m -86.31 131.58 34.18 Favored 'General case' 0 N--CA 1.414 -2.268 0 CA-C-N 115.636 -0.711 . . . . 73.22 109.769 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 525' ' ' VAL . 9.4 ttmm -99.12 119.44 37.85 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 107.107 -1.442 . . . . 73.24 107.107 171.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -67.69 -37.48 89.06 Favored Glycine 0 CA--C 1.495 -1.203 0 N-CA-C 110.955 -0.858 . . . . 72.15 110.955 -177.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . 0.488 ' OD1' ' HD2' ' A' ' 616' ' ' ARG . 52.3 t30 65.8 4.47 2.94 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.964 1.706 . . . . 73.04 111.284 175.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 -142.89 141.24 31.48 Favored 'General case' 0 N--CA 1.415 -2.177 0 N-CA-C 104.702 -2.333 . . . . 74.25 104.702 -173.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -142.25 135.93 29.32 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 118.663 0.665 . . . . 75.11 111.027 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 6.6 p -70.14 116.42 11.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.732 0.777 . . . . 63.25 112.206 -176.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 61.4 ttp -98.2 139.77 21.44 Favored Pre-proline 0 C--N 1.309 -1.178 0 CA-C-N 115.222 -0.899 . . . . 63.53 108.774 177.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -60.68 161.86 20.01 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.764 2.309 . . . . 64.34 111.798 176.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . 0.658 ' HA ' ' HB1' ' A' ' 610' ' ' ALA . 0.5 OUTLIER -68.16 128.53 36.9 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.797 0.808 . . . . 51.03 112.761 -175.051 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 57.1 tp -131.13 4.29 4.41 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 107.509 -1.293 . . . . 65.24 107.509 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 7.7 m -77.34 134.68 38.42 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 113.983 -1.462 . . . . 42.53 109.842 -176.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 88.0 16.89 58.79 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.643 -0.789 . . . . 72.11 112.119 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 85.7 mtp -114.96 178.15 4.39 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.452 -0.944 . . . . 72.55 108.452 -178.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 66.7 m-85 -89.61 155.52 19.2 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 121.27 0.557 . . . . 74.13 111.492 -176.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -62.35 -29.18 70.27 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 124.909 1.283 . . . . 75.42 109.602 175.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 10.1 p -73.13 -12.51 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 CA-C-N 115.385 -0.825 . . . . 73.52 109.864 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -101.21 -37.23 8.63 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.737 -0.665 . . . . 74.02 109.653 175.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . 0.526 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -63.47 -54.76 31.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.114 -0.948 . . . . 75.35 113.343 -174.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' A' ' 579' ' ' ARG . 30.3 mt-10 -62.13 -50.2 81.32 Favored Pre-proline 0 N--CA 1.466 0.366 0 N-CA-C 113.921 1.082 . . . . 72.21 113.921 -179.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -52.77 -42.98 59.49 Favored 'Trans proline' 0 C--N 1.366 1.461 0 C-N-CA 122.082 1.855 . . . . 72.43 113.096 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -67.96 -37.62 81.79 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 119.948 -0.701 . . . . 71.23 111.012 179.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 94.5 mt -63.42 -47.16 83.09 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 121.427 0.632 . . . . 74.03 110.156 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' A' ' 575' ' ' GLU . 97.7 mtt180 -62.68 -38.05 88.85 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.271 -0.877 . . . . 75.32 110.26 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.2 -33.14 71.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.968 -0.56 . . . . 64.32 112.151 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 4.3 pp -82.64 -8.31 59.61 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 120.562 -0.455 . . . . 53.32 111.777 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 90.47 33.93 8.29 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.779 -0.724 . . . . 61.34 112.488 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 65.9 t90 -66.29 137.18 56.76 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 122.542 0.337 . . . . 74.2 110.153 176.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 49.9 m -145.04 102.0 3.7 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.573 -0.899 . . . . 75.13 108.573 176.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -172.5 -156.34 12.41 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 110.102 -1.199 . . . . 65.03 110.102 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . 0.508 ' HB3' HG12 ' A' ' 619' ' ' ILE . 14.4 tpt -102.71 127.93 49.65 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.082 0.467 . . . . 72.02 111.138 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -97.7 126.04 42.81 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.065 -1.458 . . . . 74.5 107.065 176.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -123.28 110.33 15.07 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.374 0.607 . . . . 74.25 110.196 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -99.96 135.41 41.43 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.094 -0.957 . . . . 62.23 111.399 -174.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -68.76 143.31 39.91 Favored Glycine 0 C--N 1.306 -1.089 0 N-CA-C 109.165 -1.574 . . . . 64.23 109.165 169.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -61.22 130.5 46.55 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 122.878 0.471 . . . . 62.41 111.001 -176.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -55.23 135.16 49.91 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.541 0.941 . . . . 65.14 113.541 -172.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 85.8 t -137.99 115.9 12.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 114.814 -1.084 . . . . 75.11 109.013 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -90.78 111.88 23.45 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.742 -1.183 . . . . 70.3 108.612 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -148.56 20.75 1.04 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.938 0.718 . . . . 71.0 112.938 -174.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 140.31 155.65 6.62 Favored Glycine 0 CA--C 1.498 -0.994 0 C-N-CA 118.482 -1.818 . . . . 62.34 112.936 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.465 ' HA2' ' CD2' ' A' ' 600' ' ' HIS . . . -62.96 -49.77 69.42 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 114.262 0.465 . . . . 31.12 114.262 -175.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 25.4 m -71.98 -24.6 61.61 Favored 'General case' 0 C--N 1.312 -1.063 0 O-C-N 122.118 -0.636 . . . . 60.02 111.535 -176.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -93.12 -11.39 33.01 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 115.955 -0.566 . . . . 75.33 112.4 -177.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . 0.63 ' HB2' ' H ' ' A' ' 626' ' ' GLN . 0.5 OUTLIER -101.04 143.37 31.25 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 118.073 -1.451 . . . . 72.45 110.544 -176.866 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 69.98 -30.9 0.2 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.573 1.549 . . . . 71.52 112.005 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . 0.561 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 46.4 ttt180 -72.88 139.54 46.95 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.598 -0.689 . . . . 61.05 110.74 -177.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . 0.419 HG13 ' HB2' ' A' ' 622' ' ' LEU . 94.2 t -77.99 130.79 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 107.604 -1.258 . . . . 72.23 107.604 177.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 58.8 t -98.23 -55.73 5.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 108.562 -0.903 . . . . 74.42 108.562 -177.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . 0.424 ' O ' ' HA ' ' A' ' 622' ' ' LEU . 49.7 p90 -129.9 151.84 50.03 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 108.294 -1.002 . . . . 71.41 108.294 175.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . 0.534 ' HA ' ' O ' ' A' ' 621' ' ' THR . 17.7 pt20 -127.71 139.3 52.78 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 107.138 -1.43 . . . . 72.51 107.138 175.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.603 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 24.5 t-20 -46.43 -66.9 0.44 Allowed Pre-proline 0 CA--C 1.55 0.964 0 O-C-N 124.167 0.917 . . . . 63.14 112.607 -176.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.603 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 84.2 Cg_endo -91.22 124.1 0.86 Allowed 'Trans proline' 0 N--CA 1.436 -1.887 0 CA-C-N 121.233 1.476 . . . . 72.24 108.822 169.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.5 134.9 32.04 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.934 1.756 . . . . 73.4 112.399 -175.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . 0.658 ' HB1' ' HA ' ' A' ' 565' ' ' ASP . . . -68.79 138.93 55.21 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 115.537 -0.756 . . . . 54.21 110.024 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 101.57 -12.82 58.2 Favored Glycine 0 C--N 1.302 -1.317 0 N-CA-C 108.963 -1.655 . . . . 70.24 108.963 -173.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 16.5 m -118.06 168.76 10.25 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 107.143 -1.428 . . . . 60.43 107.143 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -71.22 126.5 13.32 Favored Glycine 0 N--CA 1.423 -2.222 0 N-CA-C 111.756 -0.538 . . . . 74.43 111.756 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . 0.414 HG12 ' HB2' ' A' ' 608' ' ' PRO . 31.4 m -94.27 141.69 14.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 109.271 -0.64 . . . . 74.53 109.271 177.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.15 144.03 36.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.888 -0.596 . . . . 72.33 111.753 177.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . 0.488 ' HD2' ' OD1' ' A' ' 559' ' ' ASN . 0.9 OUTLIER -54.03 -25.74 22.92 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.066 0.946 . . . . 73.43 112.26 179.771 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -61.13 -32.1 71.8 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 123.738 0.815 . . . . 74.3 109.879 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 73.08 8.43 74.03 Favored Glycine 0 N--CA 1.418 -2.506 0 N-CA-C 110.805 -0.918 . . . . 71.53 110.805 -176.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . 0.508 HG12 ' HB3' ' A' ' 586' ' ' MET . 0.0 OUTLIER -68.99 121.08 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 CA-C-O 122.068 0.937 . . . . 73.32 108.516 -174.461 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.18 119.57 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.549 0 CA-C-N 114.183 -1.372 . . . . 60.43 109.591 -176.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 606' ' ' GLN . 55.8 m -101.68 128.86 47.8 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.027 -1.471 . . . . 73.54 107.027 175.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . 0.438 HD23 ' H ' ' A' ' 622' ' ' LEU . 2.3 pt? -132.06 154.46 49.39 Favored 'General case' 0 CA--C 1.475 -1.926 0 N-CA-C 108.829 -0.804 . . . . 74.14 108.829 -176.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.94 135.19 49.61 Favored 'General case' 0 N--CA 1.398 -3.067 0 N-CA-C 105.672 -1.973 . . . . 64.4 105.672 177.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -142.79 165.67 26.75 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 106.128 -1.804 . . . . 73.2 106.128 177.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -77.43 -102.72 0.17 Allowed Glycine 0 N--CA 1.428 -1.863 0 C-N-CA 119.705 -1.236 . . . . 54.22 110.214 172.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . 0.63 ' H ' ' HB2' ' A' ' 600' ' ' HIS . 8.4 tt0 . . . . . 0 C--N 1.298 -1.642 0 N-CA-C 108.7 -0.852 . . . . 75.11 108.7 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.409 0 N-CA-C 110.608 -0.997 . . . . 43.05 110.608 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 6.6 tp -81.06 116.07 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.041 0 CA-C-O 121.514 0.673 . . . . 62.0 111.012 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 2.0 m -76.08 137.33 40.09 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.754 -1.573 . . . . 63.21 106.754 175.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 411' ' ' SER . 13.6 mmm-85 -99.55 -145.39 0.33 Allowed 'General case' 0 N--CA 1.383 -3.809 0 N-CA-C 107.69 -1.226 . . . . 74.32 107.69 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -126.2 142.25 51.6 Favored 'General case' 0 C--N 1.267 -2.987 0 CA-C-N 115.542 -0.753 . . . . 52.12 110.159 -171.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 409' ' ' SER . 21.5 m -141.51 164.51 19.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 107.852 -1.166 . . . . 63.34 107.852 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . 0.405 HE21 ' HB3' ' A' ' 361' ' ' GLN . 8.3 mt-30 -92.59 138.07 31.82 Favored 'General case' 0 N--CA 1.397 -3.085 0 N-CA-C 107.076 -1.453 . . . . 54.34 107.076 174.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.465 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 76.0 t -94.91 125.05 52.44 Favored Pre-proline 0 C--N 1.266 -3.045 0 N-CA-C 107.218 -1.401 . . . . 72.54 107.218 -173.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 28.0 Cg_exo -57.35 136.82 78.5 Favored 'Trans proline' 0 CA--C 1.499 -1.234 0 C-N-CA 123.252 2.635 . . . . 71.34 113.185 -169.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -75.49 101.53 4.89 Favored 'General case' 0 N--CA 1.421 -1.915 0 CA-C-O 122.742 1.258 . . . . 73.41 109.699 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 365' ' ' VAL . 5.8 m -81.86 7.08 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-N 114.112 -1.404 . . . . 74.22 112.643 -178.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.527 ' HA ' HG23 ' A' ' 399' ' ' VAL . 36.4 ptt180 -58.66 146.01 37.83 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 125.132 1.373 . . . . 74.31 111.667 175.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.97 -10.46 51.9 Favored Glycine 0 N--CA 1.436 -1.345 0 N-CA-C 111.11 -0.796 . . . . 62.11 111.11 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -110.46 -161.62 0.76 Allowed 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.988 -1.115 . . . . 75.23 107.988 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 75.8 p -94.11 158.69 15.49 Favored 'General case' 0 C--N 1.276 -2.623 0 N-CA-C 108.24 -1.022 . . . . 74.32 108.24 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.439 ' O ' ' HB ' ' A' ' 374' ' ' ILE . 46.8 t -60.32 -36.06 77.06 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 109.722 -0.473 . . . . 72.34 109.722 176.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.56 -47.78 71.72 Favored 'General case' 0 C--O 1.213 -0.841 0 CA-C-O 119.24 -0.409 . . . . 74.41 111.763 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -70.09 -40.62 74.87 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 119.722 -0.791 . . . . 71.12 110.901 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -61.54 -47.31 86.11 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.257 -0.883 . . . . 64.33 110.599 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.439 ' HB ' ' O ' ' A' ' 370' ' ' SER . 1.6 mp -69.07 -38.3 78.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.926 -0.579 . . . . 72.11 111.209 177.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -60.14 -38.35 82.84 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.535 0.683 . . . . 63.13 110.353 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 86.1 m -63.76 -45.48 89.61 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.443 -0.799 . . . . 62.0 110.167 177.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 85.4 mt -64.24 -38.83 92.46 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.13 -0.486 . . . . 62.32 110.629 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -62.1 -40.41 95.77 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.56 -0.533 . . . . 74.12 109.56 177.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -63.13 -30.05 71.28 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.131 0.572 . . . . 64.41 111.585 176.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -84.48 -14.07 50.19 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.097 -0.502 . . . . 74.22 110.885 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 94.94 12.91 54.81 Favored Glycine 0 C--N 1.311 -0.836 0 C-N-CA 120.779 -0.724 . . . . 73.34 112.702 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -80.56 157.77 25.96 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-O 121.195 0.522 . . . . 75.22 111.395 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 74.9 mmtt -98.86 132.78 43.95 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 106.698 -1.593 . . . . 73.21 106.698 177.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.464 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -123.09 154.93 28.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 CA-C-O 121.822 0.82 . . . . 72.21 110.861 -177.124 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -135.58 134.04 38.93 Favored 'General case' 0 N--CA 1.399 -2.997 0 CA-C-N 114.235 -1.348 . . . . 71.31 107.432 173.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 52.2 m -125.0 121.98 35.97 Favored 'General case' 0 C--N 1.271 -2.838 0 N-CA-C 106.631 -1.618 . . . . 74.24 106.631 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.21 119.23 38.23 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 105.854 -1.906 . . . . 74.43 105.854 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.58 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -123.0 129.1 51.09 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 119.964 -0.694 . . . . 73.52 111.384 -176.395 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 421' ' ' SER . 96.1 mttt -134.7 148.68 68.24 Favored Pre-proline 0 C--N 1.308 -1.207 0 N-CA-C 107.61 -1.255 . . . . 74.03 107.61 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -69.28 127.47 15.02 Favored 'Trans proline' 0 C--O 1.249 1.027 0 N-CA-C 105.909 -2.381 . . . . 52.13 105.909 168.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -177.41 157.4 1.3 Allowed 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 118.993 -1.083 . . . . 64.32 110.962 -169.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 10.9 m -112.08 -4.95 14.32 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.776 0.322 . . . . 64.42 110.93 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 42.4 m -92.45 -42.2 9.87 Favored 'General case' 0 N--CA 1.435 -1.184 0 O-C-N 122.118 -0.364 . . . . 75.14 111.101 -175.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.434 HG13 ' HB3' ' A' ' 421' ' ' SER . 21.1 pt -88.02 148.36 42.98 Favored Pre-proline 0 C--N 1.31 -1.123 0 C-N-CA 120.47 -0.492 . . . . 72.34 110.623 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 396' ' ' PRO . 87.1 Cg_exo -49.04 147.08 11.21 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 124.493 3.462 . . . . 70.13 115.443 -177.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 395' ' ' PRO . 51.8 Cg_exo -56.5 165.64 4.3 Favored 'Trans proline' 0 C--O 1.22 -0.418 0 C-N-CA 124.593 3.529 . . . . 75.23 110.813 170.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . 0.666 ' HA ' HG13 ' A' ' 420' ' ' VAL . 6.1 p-10 -55.17 -7.84 0.24 Allowed 'General case' 0 N--CA 1.505 2.308 0 C-N-CA 123.468 0.707 . . . . 74.04 112.538 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -91.87 117.3 29.67 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 106.118 -1.808 . . . . 61.31 106.118 172.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.527 HG23 ' HA ' ' A' ' 366' ' ' ARG . 16.2 m -73.62 118.65 19.36 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-O 120.9 0.381 . . . . 72.14 110.827 -173.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 9.2 tp -89.78 -28.7 5.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-O 121.396 0.617 . . . . 71.03 110.51 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.43 169.59 27.65 Favored Glycine 0 N--CA 1.425 -2.068 0 N-CA-C 110.234 -1.147 . . . . 64.15 110.234 -177.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 10.5 p -114.15 -178.66 3.43 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 123.545 0.203 . . . . 64.13 110.59 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -100.74 139.79 20.85 Favored Pre-proline 0 C--N 1.307 -1.247 0 N-CA-C 107.777 -1.194 . . . . 63.45 107.777 -177.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -43.18 -30.25 2.06 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 124.391 3.394 . . . . 72.54 114.313 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.28 -31.53 70.32 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 123.309 0.381 . . . . 72.24 111.459 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . 0.401 ' HB2' HD12 ' A' ' 416' ' ' ILE . . . -86.14 -34.39 20.59 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.701 0.762 . . . . 70.24 110.188 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -82.8 -1.99 53.25 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.259 -0.882 . . . . 74.32 111.426 -175.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 26.8 m -110.76 153.54 25.18 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 106.194 -1.78 . . . . 74.55 106.194 175.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 360' ' ' VAL . 39.3 m -73.87 112.73 10.27 Favored 'General case' 0 N--CA 1.425 -1.686 0 C-N-CA 120.205 -0.598 . . . . 20.34 109.749 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 23.9 m -122.54 166.71 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 115.403 -0.817 . . . . 74.22 109.719 178.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 358' ' ' ARG . 42.7 m -75.74 138.77 41.47 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 109.228 -0.656 . . . . 63.42 109.228 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -61.31 109.43 1.14 Allowed 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.184 0.516 . . . . 33.52 110.55 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 116.79 67.26 0.38 Allowed Glycine 0 N--CA 1.428 -1.873 0 N-CA-C 110.203 -1.159 . . . . 61.21 110.203 -178.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -135.5 -168.58 2.22 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.888 -1.152 . . . . 74.22 107.888 -177.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 40.1 mt-10 -106.99 131.09 54.44 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 123.622 0.769 . . . . 71.13 110.518 -176.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . 0.401 HD12 ' HB2' ' A' ' 406' ' ' ALA . 42.4 mm -119.37 115.86 49.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.928 -0.767 . . . . 63.52 108.928 176.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 13.7 p -98.82 130.94 45.27 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 123.929 0.891 . . . . 73.3 111.127 -177.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 8.7 p -126.96 135.06 64.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 120.905 0.384 . . . . 64.25 111.496 178.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -101.15 120.83 40.81 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.099 0.476 . . . . 75.04 110.059 176.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.666 HG13 ' HA ' ' A' ' 397' ' ' ASP . 44.8 t -126.49 144.36 36.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 C-N-CA 123.939 0.896 . . . . 72.01 111.252 -174.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 27.3 p -101.25 127.13 47.98 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.384 0.611 . . . . 60.22 110.832 176.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.1 t -117.69 106.05 12.67 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 115.888 -0.597 . . . . 75.12 109.42 177.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.416 ' HA2' ' HD3' ' A' ' 424' ' ' PRO . . . 95.72 126.45 4.99 Favored Glycine 0 N--CA 1.428 -1.888 0 C-N-CA 119.589 -1.291 . . . . 43.24 112.344 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . 0.416 ' HD3' ' HA2' ' A' ' 423' ' ' GLY . 11.1 Cg_exo -73.34 157.68 49.38 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 122.851 2.367 . . . . 73.22 110.625 174.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -83.62 166.16 18.4 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.88 -0.6 . . . . 70.43 111.024 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -88.08 159.17 18.35 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.63 -0.714 . . . . 55.23 110.51 -176.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -121.03 152.92 38.05 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-O 121.803 0.811 . . . . 70.14 111.041 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.59 ' CD ' ' H ' ' A' ' 428' ' ' GLU . 0.3 OUTLIER -86.81 140.34 29.79 Favored 'General case' 0 C--N 1.268 -2.942 0 CA-C-N 114.05 -1.432 . . . . 65.51 111.764 -174.552 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.508 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 65.7 mt -79.79 116.6 62.2 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 109.239 -0.652 . . . . 64.24 109.239 -177.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.51 147.26 51.62 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.851 2.368 . . . . 72.52 113.081 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -92.32 131.89 37.15 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 106.553 -1.647 . . . . 75.35 106.553 175.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.6 HG11 ' HB2' ' A' ' 440' ' ' ALA . 11.4 p -132.33 159.68 42.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 C-N-CA 120.855 -0.338 . . . . 71.33 110.852 -171.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.606 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 15.3 m -68.6 152.93 44.68 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 108.772 -0.825 . . . . 63.14 108.772 175.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 81.8 p -69.13 -33.5 73.56 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 114.413 1.264 . . . . 74.14 114.413 -167.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 3.8 pp -90.65 -11.67 39.12 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.629 -1.228 . . . . 53.21 111.553 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.606 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 1.2 m -86.83 42.05 1.0 Allowed 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.472 -0.786 . . . . 73.04 111.081 -174.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -56.58 -37.05 70.07 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.953 0.901 . . . . 74.51 110.632 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -54.97 -41.42 71.15 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.158 -0.474 . . . . 72.32 111.254 175.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -70.4 -35.65 73.58 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.777 -0.453 . . . . 72.1 109.777 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.623 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -60.9 -51.41 69.4 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.543 -0.753 . . . . 53.52 110.477 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 33.8 m -65.53 -39.7 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 112.482 0.549 . . . . 63.44 112.482 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.422 ' HD3' ' N ' ' A' ' 443' ' ' LYS . 0.1 OUTLIER -67.89 -34.92 77.59 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 120.131 -0.628 . . . . 70.21 111.971 178.096 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . 0.422 ' N ' ' HD3' ' A' ' 442' ' ' LYS . 0.9 OUTLIER -66.14 -40.63 90.75 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.084 -0.507 . . . . 74.24 109.747 177.875 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 76.8 mt -67.45 -32.86 74.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.597 -0.729 . . . . 70.13 110.18 177.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 90.5 m -69.89 -42.55 73.27 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.128 0.49 . . . . 63.33 109.975 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.46 -15.75 62.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.434 0.635 . . . . 71.43 110.767 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -85.49 5.25 32.11 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.422 -0.808 . . . . 32.52 111.459 178.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 104.92 -74.48 0.24 Allowed Glycine 0 CA--C 1.495 -1.176 0 C-N-CA 120.747 -0.739 . . . . 51.44 111.874 176.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . 0.541 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 3.6 p90 -49.19 -59.57 3.55 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 113.975 1.102 . . . . 71.23 113.975 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 60.59 29.32 69.41 Favored Glycine 0 C--O 1.217 -0.912 0 N-CA-C 111.028 -0.829 . . . . 72.42 111.028 -174.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.411 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 27.9 mmt180 -103.55 111.42 23.87 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.965 -1.124 . . . . 70.2 107.965 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -141.54 150.11 41.69 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 120.84 0.352 . . . . 71.31 111.326 -176.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . 0.451 ' HE3' ' HB ' ' A' ' 485' ' ' ILE . 52.8 mtmt -136.79 146.83 46.18 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.768 -1.197 . . . . 72.14 107.768 178.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' ' 486' ' ' ILE . 53.4 tt0 -117.31 128.52 55.13 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 109.931 -0.396 . . . . 71.12 109.931 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -116.89 154.82 30.12 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.027 -1.101 . . . . 75.11 108.027 177.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -125.1 137.74 54.18 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 108.935 -0.765 . . . . 74.01 108.935 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 26.6 t -137.97 141.79 33.73 Favored Pre-proline 0 C--N 1.292 -1.929 0 N-CA-C 109.538 -0.541 . . . . 71.45 109.538 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.696 ' HA ' ' O ' ' A' ' 490' ' ' SER . 44.4 Cg_endo -70.32 124.28 10.7 Favored 'Trans proline' 0 C--O 1.25 1.079 0 C-N-CA 122.417 2.078 . . . . 64.53 111.679 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 50.3 m -152.04 179.85 8.12 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.51 -0.552 . . . . 64.04 109.51 -177.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.6 t -49.17 139.46 13.16 Favored Pre-proline 0 CA--C 1.56 1.333 0 C-N-CA 123.702 0.801 . . . . 62.35 112.126 176.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.57 -28.5 29.01 Favored 'Trans proline' 0 C--N 1.365 1.419 0 C-N-CA 125.112 3.875 . . . . 65.14 113.966 -177.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -68.63 -21.24 64.49 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 116.162 -0.472 . . . . 60.31 111.635 -178.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 91.6 mt -103.61 -13.18 16.63 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 120.859 0.361 . . . . 74.51 110.913 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 70.0 t -60.97 127.62 20.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.001 -0.545 . . . . 64.2 110.954 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 95.64 -15.82 62.41 Favored Glycine 0 N--CA 1.441 -1.031 0 CA-C-N 115.639 -0.71 . . . . 73.55 112.114 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.65 166.83 12.27 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 110.211 -0.292 . . . . 61.04 110.211 -178.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 73.2 t -72.19 143.39 14.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 115.826 -0.625 . . . . 64.42 109.643 179.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 70.0 mt -97.38 -31.04 3.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 107.244 -1.391 . . . . 75.3 107.244 176.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 159.74 -159.22 30.42 Favored Glycine 0 N--CA 1.425 -2.086 0 N-CA-C 109.977 -1.249 . . . . 54.5 109.977 177.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . 0.519 HG22 HG12 ' A' ' 486' ' ' ILE . 61.9 p -114.7 146.67 40.65 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 105.608 -1.997 . . . . 62.11 105.608 178.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.489 ' HB3' HG23 ' A' ' 485' ' ' ILE . 28.5 t-20 -72.85 -53.86 5.05 Favored Pre-proline 0 C--N 1.314 -0.947 0 C-N-CA 118.871 -1.132 . . . . 71.31 110.236 178.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -67.75 134.54 32.85 Favored 'Trans proline' 0 C--N 1.368 1.604 0 N-CA-C 107.904 -1.614 . . . . 75.33 107.904 168.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' A' ' 475' ' ' ASN . 24.7 Cg_exo -62.12 139.21 77.21 Favored 'Trans proline' 0 C--O 1.242 0.702 0 C-N-CA 122.216 1.944 . . . . 74.33 112.632 -175.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.508 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -75.84 19.91 0.2 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 122.163 0.983 . . . . 75.04 110.979 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . 0.438 ' H ' ' C ' ' A' ' 473' ' ' PRO . 10.1 m120 -109.21 -17.65 13.79 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.412 -0.959 . . . . 75.33 108.412 178.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -87.33 170.43 11.42 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.696 -0.683 . . . . 65.15 111.733 -174.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 4.5 m -106.3 127.02 52.94 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 108.304 -0.998 . . . . 72.42 108.304 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 9.8 p -105.95 146.06 30.52 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 123.031 0.533 . . . . 71.23 111.236 -177.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -90.26 162.75 15.05 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.452 -0.34 . . . . 74.14 110.815 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.541 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 1.7 mp -70.93 -20.58 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.966 0.889 . . . . 71.31 111.187 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 12.2 p -93.39 1.17 56.99 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.988 0.899 . . . . 54.31 111.029 178.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -104.93 138.17 41.57 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.004 -0.998 . . . . 75.12 111.649 -173.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.411 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.4 p -108.06 127.03 64.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.809 -0.632 . . . . 63.13 111.027 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 35.8 m -95.45 141.57 14.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-O 121.299 0.571 . . . . 74.3 111.294 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.489 HG23 ' HB3' ' A' ' 471' ' ' ASN . 0.0 OUTLIER -109.43 125.91 66.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.196 0 CA-C-O 121.485 0.66 . . . . 74.33 110.251 -178.441 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.519 HG12 HG22 ' A' ' 470' ' ' THR . 8.9 mt -112.62 128.61 69.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 115.067 -0.97 . . . . 74.41 110.919 -178.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 8.8 tt -105.17 127.21 59.99 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 123.41 0.684 . . . . 64.52 111.905 -174.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 28.6 m -111.61 152.07 13.57 Favored 'Isoleucine or valine' 0 C--O 1.25 1.097 0 C-N-CA 124.017 0.927 . . . . 54.33 110.241 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -81.9 140.76 21.15 Favored Glycine 0 C--O 1.246 0.854 0 C-N-CA 120.99 -0.624 . . . . 71.21 111.979 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.696 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 13.2 t -142.36 160.49 40.15 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.017 -0.735 . . . . 74.22 109.017 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 81.71 78.0 1.01 Allowed Glycine 0 CA--C 1.534 1.274 0 N-CA-C 115.693 1.037 . . . . 74.21 115.693 173.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -89.51 129.73 1.87 Allowed 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 122.703 2.269 . . . . 73.24 112.194 177.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -84.99 65.73 9.39 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-O 122.083 0.944 . . . . 72.04 111.875 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 1.3 p -118.03 143.42 46.43 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 114.899 -1.046 . . . . 65.01 109.673 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -146.34 148.83 32.78 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.84 -1.17 . . . . 63.44 107.84 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.562 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 9.5 p-10 -87.54 130.07 34.86 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.475 0.655 . . . . 73.12 110.985 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 38.3 pt -75.92 137.82 69.46 Favored Pre-proline 0 C--N 1.307 -1.28 0 CA-C-N 114.862 -1.063 . . . . 74.34 110.418 -178.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -93.86 -170.72 0.24 Allowed 'Trans proline' 0 N--CA 1.443 -1.482 0 C-N-CA 122.269 1.979 . . . . 61.44 111.211 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -83.9 145.91 28.34 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.666 -1.235 . . . . 72.45 107.666 174.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 9.2 p -136.22 8.58 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.455 0 CA-C-O 122.616 1.198 . . . . 65.23 108.469 177.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -71.17 121.43 18.32 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 114.019 -1.446 . . . . 62.1 109.628 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 108.73 30.57 3.7 Favored Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 110.789 -0.924 . . . . 74.14 110.789 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -142.03 176.09 9.22 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.907 -0.775 . . . . 74.0 108.907 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 29.6 p -91.67 160.02 15.58 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 110.021 -0.362 . . . . 74.21 110.021 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 30.7 m -53.73 -40.24 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 C-N-CA 124.181 0.993 . . . . 71.04 112.255 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -66.72 -42.44 86.35 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.655 -0.702 . . . . 64.22 110.791 -178.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 64.8 t -74.77 -35.06 35.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 116.432 -0.349 . . . . 73.33 110.253 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -59.61 -49.74 76.6 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.134 -0.485 . . . . 72.01 111.573 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -65.58 -35.89 82.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 74.03 110.725 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.416 ' O ' HG23 ' A' ' 514' ' ' VAL . 58.6 tptt -61.47 -47.35 86.06 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.706 -0.679 . . . . 64.45 109.647 178.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -62.08 -44.83 95.81 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 116.382 -0.372 . . . . 71.3 110.165 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.73 -47.52 85.31 Favored 'General case' 0 C--O 1.242 0.664 0 O-C-N 123.422 0.451 . . . . 73.54 110.376 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.92 -38.15 87.32 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 116.182 -0.463 . . . . 74.4 111.105 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 510' ' ' LYS . 55.2 t -64.01 -35.6 74.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 122.828 0.451 . . . . 74.23 111.366 177.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -79.29 -12.77 59.94 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.374 -0.53 . . . . 74.21 110.695 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . 0.439 ' O ' ' HB ' ' A' ' 547' ' ' VAL . . . 113.11 -0.14 25.41 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.69 -0.767 . . . . 62.23 113.154 177.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.457 ' HA ' ' O ' ' A' ' 547' ' ' VAL . 79.2 m-85 -82.82 115.77 21.86 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.454 -0.572 . . . . 71.45 109.454 -178.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.7 p -88.69 -26.04 22.04 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 113.643 0.979 . . . . 73.45 113.643 -176.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . 0.51 ' HE2' ' HA ' ' A' ' 519' ' ' LYS . 6.4 mmpt? -110.13 120.66 43.15 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 113.613 0.968 . . . . 74.45 113.613 -176.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -131.82 140.2 49.08 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 113.809 -1.541 . . . . 73.12 111.242 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 54.0 m -134.47 144.42 48.08 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.627 -0.879 . . . . 65.03 108.627 176.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -117.35 122.57 44.24 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.721 0.772 . . . . 63.25 110.807 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -100.89 140.29 35.38 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.685 -0.688 . . . . 71.21 109.663 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 15.9 m -88.79 116.01 26.75 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.982 -0.554 . . . . 73.32 109.646 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 35.7 m -121.98 158.56 25.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.935 -0.765 . . . . 73.24 108.935 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . 0.524 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 5.2 p-10 -94.71 136.83 34.55 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.838 -0.745 . . . . 62.24 109.89 179.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . 0.456 ' HB2' ' HB2' ' A' ' 556' ' ' SER . 38.6 m -153.81 173.57 4.56 Favored Pre-proline 0 C--N 1.305 -1.331 0 N-CA-C 106.442 -1.688 . . . . 35.33 106.442 174.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -81.88 -8.3 12.2 Favored 'Trans proline' 0 CA--C 1.547 1.16 0 CA-C-N 120.642 1.265 . . . . 44.13 111.6 173.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.435 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 4.1 mpt_? -76.39 134.61 69.94 Favored Pre-proline 0 C--O 1.223 -0.328 0 CA-C-N 116.046 -0.524 . . . . 71.32 109.813 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -57.08 154.93 30.89 Favored 'Trans proline' 0 C--O 1.255 1.368 0 C-N-CA 123.225 2.616 . . . . 75.3 114.032 -177.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.5 117.02 4.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.87 -1.059 . . . . 72.12 111.892 -178.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 132.21 -20.02 4.52 Favored Glycine 0 CA--C 1.49 -1.497 0 N-CA-C 110.797 -0.921 . . . . 42.01 110.797 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -74.27 125.25 28.02 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.922 -0.639 . . . . 74.23 110.04 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 85.9 t -84.34 107.39 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 N-CA-C 106.36 -1.718 . . . . 74.52 106.36 172.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 26.8 m -75.01 -25.96 59.19 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.632 -1.167 . . . . 61.11 111.002 -174.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 162.03 -163.78 35.02 Favored Glycine 0 N--CA 1.427 -1.963 0 N-CA-C 110.311 -1.115 . . . . 14.11 110.311 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 19.5 p -117.73 155.3 30.22 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.987 -0.746 . . . . 73.55 108.987 178.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -75.52 -52.97 2.73 Favored Pre-proline 0 C--N 1.305 -1.34 0 N-CA-C 109.614 -0.513 . . . . 70.34 109.614 176.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -64.32 130.33 26.64 Favored 'Trans proline' 0 C--N 1.365 1.405 0 N-CA-C 107.951 -1.596 . . . . 73.23 107.951 167.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -63.21 143.67 90.22 Favored 'Trans proline' 0 C--O 1.246 0.879 0 C-N-CA 122.226 1.951 . . . . 74.14 112.479 -177.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -65.14 136.1 56.29 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.604 -0.517 . . . . 63.02 109.604 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.95 -19.46 32.74 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 111.446 -0.662 . . . . 65.13 111.446 -176.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 35.2 m -68.51 134.48 50.13 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.699 0.285 . . . . 73.14 110.329 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 28.2 m -85.41 122.8 30.08 Favored 'General case' 0 N--CA 1.416 -2.138 0 N-CA-C 107.741 -1.207 . . . . 71.12 107.741 177.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 52.9 t -127.72 152.27 76.68 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 107.147 -1.427 . . . . 71.43 107.147 -176.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -66.2 139.52 55.6 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 121.512 1.475 . . . . 74.51 109.701 171.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 517' ' ' PHE . 28.7 m -63.28 -20.12 25.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.665 0.745 . . . . 71.35 112.548 -177.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -93.45 3.48 55.5 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.465 -0.788 . . . . 65.24 110.727 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 8.6 t -92.4 -178.43 4.92 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.761 -0.587 . . . . 72.24 109.916 -178.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 45.5 t -102.1 122.74 54.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 122.948 0.499 . . . . 65.42 111.181 -174.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 1.9 mp -103.58 126.77 58.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.158 -1.053 . . . . 54.55 108.158 175.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -103.56 120.48 40.96 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-O 121.488 0.661 . . . . 73.24 111.989 -176.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 69.2 mt -94.75 134.3 37.51 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 125.569 1.547 . . . . 72.21 108.249 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -104.02 118.66 37.19 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 109.15 -0.685 . . . . 73.44 109.15 176.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 43.4 t -109.79 129.5 64.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 CA-C-N 115.17 -0.923 . . . . 71.04 109.191 -175.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.456 ' HB2' ' HB2' ' A' ' 527' ' ' SER . 32.0 p -80.07 143.5 33.95 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 113.494 0.924 . . . . 62.22 113.494 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.524 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 45.1 pttt -92.41 152.42 19.73 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 102.863 -3.014 . . . . 74.53 102.863 165.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . 0.486 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -75.53 -32.14 55.28 Favored Glycine 0 CA--C 1.479 -2.17 0 C-N-CA 119.079 -1.534 . . . . 73.14 111.166 -176.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 64.3 t30 71.98 -28.99 0.19 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.516 1.526 . . . . 74.34 111.839 173.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.486 ' H ' ' C ' ' A' ' 558' ' ' GLY . 92.8 mt-30 -135.23 145.88 48.06 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 106.75 -1.574 . . . . 61.25 106.75 174.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -123.07 138.09 54.76 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 109.383 -0.599 . . . . 52.53 109.383 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 90.2 t -59.94 116.88 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 O-C-N 123.933 0.771 . . . . 64.14 110.321 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . 0.424 ' HA ' ' HD3' ' A' ' 564' ' ' PRO . 25.7 ptm -80.62 146.74 61.45 Favored Pre-proline 0 C--O 1.249 1.031 0 CA-C-N 116.103 -0.498 . . . . 75.32 110.475 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 563' ' ' MET . 15.5 Cg_exo -71.39 169.76 20.04 Favored 'Trans proline' 0 C--O 1.243 0.77 0 C-N-CA 122.862 2.374 . . . . 65.23 111.592 174.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -74.34 125.66 28.97 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 112.776 0.658 . . . . 45.05 112.776 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 96.1 mt -142.03 18.91 2.12 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.595 -1.184 . . . . 70.33 108.125 177.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 60.2 p -79.84 139.13 37.3 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 112.455 0.539 . . . . 55.34 112.455 -175.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 83.83 25.36 45.97 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 121.137 -0.554 . . . . 75.5 112.707 176.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 84.4 mtp -108.23 174.92 5.66 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.839 -0.43 . . . . 61.24 109.839 -178.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -102.5 136.96 41.4 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 106.922 -1.51 . . . . 75.13 106.922 177.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 81.8 t90 -54.66 -29.58 53.0 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 124.021 0.929 . . . . 63.23 112.356 -176.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 16.7 m -74.57 -19.16 16.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.342 0.592 . . . . 64.3 111.347 -177.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -102.29 -36.54 8.44 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.862 0.839 . . . . 72.43 109.644 178.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -67.46 -43.21 81.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.83 -1.077 . . . . 73.11 112.54 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.403 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 41.4 tt0 -57.15 -50.56 87.47 Favored Pre-proline 0 CA--C 1.558 1.283 0 CA-C-O 119.44 -0.314 . . . . 75.2 111.481 178.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 83.5 Cg_exo -53.53 -37.96 83.12 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.095 1.863 . . . . 65.54 112.617 172.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.527 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 45.4 mmt-85 -64.96 -39.14 93.04 Favored 'General case' 0 C--O 1.214 -0.799 0 C-N-CA 120.242 -0.583 . . . . 75.12 110.586 177.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 96.3 mt -62.24 -43.12 99.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.336 0.589 . . . . 71.51 109.452 177.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -61.85 -38.81 89.62 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.375 -0.83 . . . . 75.53 110.317 178.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.21 -30.0 66.98 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.063 -0.517 . . . . 52.25 111.415 177.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 93.0 mt -81.97 -7.19 59.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.826 0.346 . . . . 62.34 111.332 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 82.7 35.64 18.71 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 120.974 -0.632 . . . . 63.13 111.914 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 83.5 t90 -77.51 130.44 36.97 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.129 0.49 . . . . 74.51 110.177 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 50.4 m -145.05 89.43 1.96 Allowed 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.158 -1.052 . . . . 74.15 108.158 175.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -153.58 -146.84 4.48 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 110.208 -1.157 . . . . 65.52 110.208 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . 0.49 ' HB3' HG12 ' A' ' 619' ' ' ILE . 23.8 ttt -115.93 135.33 54.08 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 117.182 0.491 . . . . 74.34 110.894 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -100.47 130.78 46.59 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.05 -1.834 . . . . 70.34 106.05 175.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -102.36 118.67 37.38 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.867 -0.733 . . . . 64.12 110.637 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 4.0 mmmp? -87.76 111.94 21.88 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-O 121.5 0.666 . . . . 71.45 112.15 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -81.23 -173.41 47.75 Favored Glycine 0 N--CA 1.427 -1.907 0 N-CA-C 109.676 -1.37 . . . . 41.31 109.676 171.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -70.51 145.02 51.16 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.998 0.399 . . . . 64.31 110.977 -175.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -85.59 124.67 32.4 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.925 -1.139 . . . . 72.23 107.925 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.92 124.85 68.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 C-N-CA 122.903 0.481 . . . . 74.14 110.863 -174.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -75.67 111.8 11.38 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.489 -0.93 . . . . 74.12 108.489 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -114.19 -19.78 11.18 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 112.081 0.4 . . . . 53.23 112.081 -176.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 126.96 145.83 6.34 Favored Glycine 0 CA--C 1.492 -1.391 0 N-CA-C 108.663 -1.775 . . . . 74.14 108.663 -176.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.17 -40.1 82.86 Favored Glycine 0 N--CA 1.47 0.912 0 CA-C-N 117.512 0.656 . . . . 42.11 113.955 -173.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 15.8 m -66.38 -24.31 66.47 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 122.951 0.501 . . . . 65.23 111.46 -178.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -108.7 -1.11 19.69 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.269 0.841 . . . . 74.32 113.269 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -68.07 150.64 48.17 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.943 -0.392 . . . . 65.42 109.943 177.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 63.42 -6.31 0.21 Allowed 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 124.878 1.271 . . . . 54.2 114.122 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . 0.524 ' HD2' ' O ' ' A' ' 603' ' ' VAL . 5.5 tmm_? -79.15 138.62 37.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 118.459 0.572 . . . . 72.31 109.883 -178.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . 0.524 ' O ' ' HD2' ' A' ' 602' ' ' ARG . 13.9 p -64.0 142.2 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.85 0.86 . . . . 61.3 111.171 -177.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 623' ' ' ARG . 7.5 p -96.13 -47.79 12.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 118.687 -1.205 . . . . 64.4 109.216 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -156.99 155.82 31.91 Favored 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 105.337 -2.097 . . . . 65.53 105.337 173.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -115.75 128.78 56.12 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 107.356 -1.349 . . . . 73.04 107.356 173.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.595 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 25.2 t-20 -48.77 -52.55 44.71 Favored Pre-proline 0 CA--C 1.545 0.779 0 O-C-N 123.99 0.806 . . . . 65.11 111.634 -177.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 13.7 Cg_endo -100.86 110.19 0.05 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.054 0 C-N-CA 121.659 1.573 . . . . 50.22 109.441 169.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.95 160.37 34.01 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.494 2.13 . . . . 73.25 111.485 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -57.32 126.96 29.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.576 0.227 . . . . 65.22 110.46 -177.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 102.03 -5.43 53.15 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.227 -0.987 . . . . 22.54 112.329 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 23.7 m -92.24 155.33 18.05 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.946 -0.761 . . . . 63.34 108.946 177.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -82.98 126.05 7.28 Favored Glycine 0 N--CA 1.426 -1.988 0 N-CA-C 111.368 -0.693 . . . . 71.42 111.368 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.3 m -103.81 142.18 17.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-O 120.598 0.237 . . . . 74.21 110.419 178.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.05 146.12 11.83 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 123.822 0.849 . . . . 72.12 112.267 177.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.02 -35.97 16.71 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 125.976 1.71 . . . . 72.32 112.874 -175.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -73.94 -30.26 62.45 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.883 -1.053 . . . . 71.21 111.484 -175.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 93.29 12.13 57.69 Favored Glycine 0 N--CA 1.414 -2.776 0 CA-C-O 119.211 -0.772 . . . . 62.1 114.078 174.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . 0.49 HG12 ' HB3' ' A' ' 586' ' ' MET . 0.0 OUTLIER -69.67 119.78 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 C-N-CA 117.715 -1.594 . . . . 64.22 107.736 178.629 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.84 132.14 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 114.793 -1.094 . . . . 74.02 108.349 -175.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 90.2 m -106.23 116.89 32.71 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 121.221 0.534 . . . . 63.14 110.507 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . 0.489 ' HB2' HG23 ' A' ' 603' ' ' VAL . 0.0 OUTLIER -139.92 149.97 43.98 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 104.558 -2.386 . . . . 72.04 104.558 173.04 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . 0.4 ' O ' HG12 ' A' ' 604' ' ' VAL . 44.5 ttp180 -128.78 156.13 44.05 Favored 'General case' 0 C--N 1.254 -3.578 0 N-CA-C 105.987 -1.857 . . . . 73.52 105.987 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -125.2 166.08 17.11 Favored 'General case' 0 C--N 1.26 -3.292 0 N-CA-C 105.367 -2.086 . . . . 72.23 105.367 175.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -61.28 -89.25 0.02 OUTLIER Glycine 0 C--N 1.314 -0.687 0 C-N-CA 120.104 -1.046 . . . . 64.03 110.708 176.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 . . . . . 0 C--N 1.289 -2.054 0 N-CA-C 107.03 -1.47 . . . . 53.0 107.03 175.047 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.14 0 N-CA-C 110.039 -1.224 . . . . 43.05 110.039 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 9.4 tp -74.22 127.26 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-O 121.946 0.879 . . . . 74.31 110.485 -178.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.75 152.3 23.36 Favored 'General case' 0 N--CA 1.387 -3.585 0 CA-C-N 114.814 -1.085 . . . . 53.53 110.665 -179.277 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.15 14.11 21.82 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.606 0.717 . . . . 74.44 109.148 -179.122 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -67.48 148.14 51.91 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.717 -1.129 . . . . 74.32 108.477 178.426 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 31.5 m -121.49 163.67 19.17 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-O 120.76 0.314 . . . . 41.04 110.74 -175.031 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -94.41 136.59 34.54 Favored 'General case' 0 N--CA 1.383 -3.793 0 N-CA-C 107.439 -1.319 . . . . 60.42 107.439 175.569 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 72.1 t -97.42 135.06 21.93 Favored Pre-proline 0 C--N 1.265 -3.093 0 CA-C-N 114.624 -1.171 . . . . 74.15 109.911 -171.17 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -65.99 121.9 9.33 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 121.65 1.566 . . . . 72.34 110.948 179.244 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -88.77 147.48 24.42 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.749 -1.575 . . . . 74.24 106.749 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 4.8 t -120.84 11.54 6.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 CA-C-N 116.052 -0.522 . . . . 71.41 109.947 -172.511 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.5 ' HA ' HG23 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -60.69 143.11 54.9 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 119.158 -1.017 . . . . 74.11 110.03 176.535 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.94 -9.28 46.93 Favored Glycine 0 C--N 1.301 -1.395 0 N-CA-C 111.233 -0.747 . . . . 54.0 111.233 -172.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -109.03 -145.86 0.4 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.483 -0.932 . . . . 73.15 108.483 174.386 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 96.4 p -107.13 167.04 10.18 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.426 -0.909 . . . . 71.02 108.899 -176.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 25.2 t -59.69 -39.55 84.9 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 109.167 -0.679 . . . . 52.02 109.167 176.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.37 -46.66 75.95 Favored 'General case' 0 C--O 1.213 -0.843 0 CA-C-N 116.102 -0.499 . . . . 60.03 111.357 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -64.11 -41.42 97.25 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.359 0.599 . . . . 72.42 110.924 -179.251 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.06 -51.34 62.03 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.389 -0.823 . . . . 61.31 111.073 -178.539 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 39.8 mm -66.08 -39.98 85.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.042 -0.526 . . . . 73.51 110.955 -179.303 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.24 -38.82 88.01 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 120.937 0.399 . . . . 74.31 111.15 -179.111 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . 0.546 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 79.5 m -66.41 -47.28 73.78 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.845 -0.616 . . . . 74.04 111.177 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.75 -37.99 89.44 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.557 0.218 . . . . 63.2 111.159 178.83 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -59.9 -48.03 83.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.95 -0.568 . . . . 54.11 109.747 177.096 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -61.03 -30.88 70.57 Favored 'General case' 0 CA--C 1.495 -1.17 0 N-CA-C 113.096 0.776 . . . . 72.41 113.096 177.231 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . 0.546 ' HG2' ' O ' ' A' ' 376' ' ' THR . 13.3 mmt180 -78.44 -14.08 59.54 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.272 -0.422 . . . . 70.2 110.735 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 91.14 16.11 54.49 Favored Glycine 0 CA--C 1.501 -0.842 0 C-N-CA 119.772 -1.204 . . . . 53.42 111.506 177.412 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -88.92 162.89 15.85 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-O 121.385 0.612 . . . . 74.31 110.518 178.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.54 ' HB2' ' HG2' ' A' ' 415' ' ' GLU . 75.2 mmtt -94.43 148.87 21.8 Favored 'General case' 0 N--CA 1.411 -2.375 0 N-CA-C 106.862 -1.533 . . . . 62.33 106.862 178.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.481 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -123.28 141.3 44.11 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-O 121.622 0.725 . . . . 74.53 110.968 -175.546 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . 0.425 ' HB3' ' HA ' ' A' ' 417' ' ' THR . 44.3 ttt180 -125.08 127.53 47.05 Favored 'General case' 0 N--CA 1.406 -2.632 0 N-CA-C 106.384 -1.709 . . . . 75.14 106.384 174.362 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . 0.426 HG22 HE21 ' A' ' 388' ' ' GLN . 26.8 m -129.95 127.86 40.93 Favored 'General case' 0 C--N 1.276 -2.589 0 N-CA-C 108.97 -0.752 . . . . 62.22 108.97 -177.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -112.05 120.34 41.53 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.565 -0.531 . . . . 72.1 109.565 176.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.426 HE21 HG22 ' A' ' 386' ' ' THR . 0.9 OUTLIER -100.66 121.97 42.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.703 -0.851 . . . . 74.03 108.703 -179.007 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 421' ' ' SER . 44.5 mtmt -137.24 138.25 24.74 Favored Pre-proline 0 C--N 1.301 -1.509 0 C-N-CA 120.398 -0.521 . . . . 72.2 109.717 175.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -75.42 128.78 11.42 Favored 'Trans proline' 0 C--O 1.257 1.454 0 N-CA-C 107.972 -1.588 . . . . 63.43 107.972 172.54 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.446 ' OD1' HG22 ' A' ' 393' ' ' THR . 7.3 t70 -174.62 -172.67 0.67 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.086 -1.82 . . . . 73.41 106.086 -172.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 41.4 m -150.97 -2.6 0.34 Allowed 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 122.545 0.338 . . . . 73.52 111.605 175.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.446 HG22 ' OD1' ' A' ' 391' ' ' ASP . 10.7 t -105.91 -24.87 12.34 Favored 'General case' 0 C--O 1.244 0.764 0 O-C-N 121.696 -0.627 . . . . 65.5 109.898 -178.677 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.459 HG13 ' HB2' ' A' ' 421' ' ' SER . 49.1 pt -88.66 152.54 49.34 Favored Pre-proline 0 N--CA 1.439 -1.021 0 N-CA-C 107.805 -1.183 . . . . 63.5 107.805 176.525 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . 0.484 ' HB3' ' H ' ' A' ' 400' ' ' ILE . 21.7 Cg_exo -32.9 111.58 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 124.634 3.556 . . . . 73.44 116.398 179.616 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -56.48 166.86 3.14 Favored 'Trans proline' 0 C--O 1.221 -0.343 0 C-N-CA 124.943 3.762 . . . . 72.15 110.676 170.062 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . 0.485 ' HA ' ' CG2' ' A' ' 420' ' ' VAL . 4.6 p-10 -54.94 -8.58 0.27 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 112.684 0.624 . . . . 73.43 112.684 -178.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 63.1 m170 -98.01 106.16 18.41 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 103.319 -2.845 . . . . 70.44 103.319 166.59 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.5 HG23 ' HA ' ' A' ' 366' ' ' ARG . 18.6 m -63.08 118.43 5.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 O-C-N 124.185 0.928 . . . . 51.42 113.209 -166.608 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . 0.484 ' H ' ' HB3' ' A' ' 395' ' ' PRO . 41.7 mm -98.2 -27.47 3.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 114.575 -1.193 . . . . 73.2 109.881 179.837 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.42 157.14 27.25 Favored Glycine 0 N--CA 1.414 -2.777 0 C-N-CA 119.901 -1.142 . . . . 71.12 112.026 -176.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 4.7 p -148.08 -176.15 5.17 Favored 'General case' 0 C--N 1.284 -2.242 0 C-N-CA 126.253 1.821 . . . . 72.13 107.412 -175.36 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -99.82 137.26 20.14 Favored Pre-proline 0 C--N 1.299 -1.602 0 N-CA-C 107.894 -1.15 . . . . 64.01 107.894 176.337 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.27 -2.86 3.46 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.824 3.016 . . . . 72.32 113.36 -177.085 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -52.61 -35.28 54.17 Favored 'General case' 0 C--O 1.21 -1.013 0 C-N-CA 124.656 1.183 . . . . 62.2 111.165 176.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -68.35 -37.47 80.53 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 121.533 0.682 . . . . 74.32 110.211 178.157 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -82.69 -3.91 57.06 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.579 0.704 . . . . 75.02 109.452 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 32.0 m -93.55 152.5 18.99 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.398 -1.705 . . . . 42.31 106.398 176.506 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 13.2 p -77.37 111.57 13.18 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 108.554 -0.906 . . . . 74.24 108.554 176.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 28.8 m -127.51 169.16 19.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-O 121.095 0.474 . . . . 74.11 110.876 -179.524 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 3.4 m -78.69 146.74 33.82 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.961 -0.755 . . . . 61.14 108.961 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -71.51 109.91 5.77 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.015 0.435 . . . . 73.51 110.529 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 122.8 23.23 2.31 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 120.852 -0.69 . . . . 72.11 112.749 178.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -86.68 -173.77 4.65 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.642 -0.873 . . . . 70.04 108.642 177.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . 0.54 ' HG2' ' HB2' ' A' ' 383' ' ' LYS . 32.9 mt-10 -111.21 119.19 38.11 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.263 -0.643 . . . . 73.02 109.263 -175.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.1 mm -98.17 120.25 47.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-O 120.837 0.351 . . . . 72.31 110.091 -178.771 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . 0.425 ' HA ' ' HB3' ' A' ' 385' ' ' ARG . 36.4 m -90.7 125.88 35.81 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.972 -0.558 . . . . 73.23 111.726 -178.599 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 4.3 p -116.55 134.82 58.8 Favored 'Isoleucine or valine' 0 C--O 1.255 1.384 0 N-CA-C 109.261 -0.644 . . . . 71.53 109.261 174.533 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -99.29 116.89 32.52 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.515 -1.661 . . . . 75.34 106.515 177.028 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.485 ' CG2' ' HA ' ' A' ' 397' ' ' ASP . 10.7 p -127.61 136.0 61.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 121.32 0.581 . . . . 73.04 110.608 -175.531 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 14.1 t -102.39 122.58 44.56 Favored 'General case' 0 N--CA 1.415 -2.223 0 C-N-CA 119.839 -0.744 . . . . 64.14 110.031 178.295 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 8.9 t -118.94 107.53 13.68 Favored 'General case' 0 N--CA 1.411 -2.377 0 CA-C-N 115.175 -0.92 . . . . 61.23 108.753 176.387 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 106.82 103.33 2.87 Favored Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 120.871 -0.68 . . . . 43.42 111.923 -178.514 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -69.91 154.62 66.97 Favored 'Trans proline' 0 C--O 1.246 0.909 0 C-N-CA 122.223 1.949 . . . . 54.1 110.668 177.29 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -81.71 166.41 20.12 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.571 0.701 . . . . 73.31 112.509 -174.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -97.82 158.79 15.32 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 114.617 -1.174 . . . . 61.51 109.674 179.551 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.509 ' HG3' ' O ' ' A' ' 447' ' ' ALA . 4.3 mmp_? -120.33 155.6 33.01 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 109.653 -0.499 . . . . 75.52 109.653 -178.574 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -91.66 137.37 32.42 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 115.086 -0.961 . . . . 61.5 110.101 -176.153 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 59.7 mt -96.12 118.67 65.48 Favored Pre-proline 0 N--CA 1.421 -1.88 0 N-CA-C 107.519 -1.289 . . . . 70.2 107.519 177.017 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -71.6 141.48 38.14 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 N-CA-C 108.125 -1.529 . . . . 75.34 108.125 171.08 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -80.13 134.46 36.17 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 118.229 -1.389 . . . . 72.21 108.592 178.575 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.439 HG11 ' HB2' ' A' ' 440' ' ' ALA . 8.9 p -101.23 161.99 3.49 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.374 0 N-CA-C 108.39 -0.967 . . . . 61.2 108.39 -172.332 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 26.7 m -75.68 158.02 32.88 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 107.33 -1.359 . . . . 75.33 107.33 174.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . 0.448 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 74.3 p -67.99 -40.34 83.09 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.943 0.878 . . . . 75.21 111.32 -173.458 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.507 ' H ' HD23 ' A' ' 435' ' ' LEU . 0.6 OUTLIER -67.5 -28.78 68.12 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 113.784 1.031 . . . . 74.25 113.784 178.946 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.6 p -89.9 59.2 4.49 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 114.511 1.3 . . . . 62.13 114.511 -172.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -64.26 -37.86 88.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.115 -0.493 . . . . 74.24 111.364 177.294 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -62.43 -36.3 81.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.899 0.38 . . . . 72.24 110.457 178.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -67.51 -39.35 85.14 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.64 -0.504 . . . . 65.23 109.64 175.22 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.467 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.19 -50.38 73.89 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.969 -0.56 . . . . 74.14 110.924 -178.489 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.0 m -62.14 -40.77 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 111.935 0.346 . . . . 72.13 111.935 -179.178 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -36.41 80.03 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 120.366 -0.534 . . . . 71.51 112.3 178.455 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -63.22 -47.1 83.92 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 120.931 0.396 . . . . 72.11 110.384 177.008 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.467 HD13 ' O ' ' A' ' 440' ' ' ALA . 2.6 mp -63.68 -35.54 80.88 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.361 -0.836 . . . . 52.33 110.601 179.866 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 89.4 m -69.33 -45.8 68.61 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 116.172 -0.467 . . . . 61.44 110.488 177.162 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.13 -16.49 62.56 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 120.848 0.356 . . . . 74.31 111.88 -178.424 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . 0.509 ' O ' ' HG3' ' A' ' 427' ' ' ARG . . . -84.6 -4.66 59.11 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.177 -0.465 . . . . 62.21 111.488 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 117.66 -83.48 0.35 Allowed Glycine 0 CA--C 1.498 -1.017 0 C-N-CA 120.121 -1.038 . . . . 63.14 111.963 177.085 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -36.99 -63.52 0.42 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.374 1.249 . . . . 74.13 114.374 177.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 62.71 20.2 61.51 Favored Glycine 0 C--O 1.221 -0.668 0 CA-C-N 116.384 -0.371 . . . . 35.53 113.322 -178.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -96.97 110.43 22.97 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.079 -1.082 . . . . 65.54 108.079 -178.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.442 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 21.2 p90 -138.91 158.95 43.28 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 115.972 -0.558 . . . . 70.04 110.437 -177.453 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -144.98 148.23 33.54 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.447 -1.316 . . . . 75.41 107.447 179.177 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -119.05 127.36 53.34 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 117.877 0.308 . . . . 74.41 110.323 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -124.52 150.58 45.67 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.395 -0.965 . . . . 64.04 108.395 175.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -114.03 141.53 47.32 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.922 -0.399 . . . . 74.12 109.922 -177.201 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 23.2 t -138.37 137.59 20.9 Favored Pre-proline 0 C--N 1.307 -1.242 0 N-CA-C 108.898 -0.778 . . . . 74.12 108.898 176.285 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 490' ' ' SER . 8.0 Cg_exo -71.05 122.78 9.09 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 121.819 1.679 . . . . 62.12 111.36 177.19 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 49.5 m -147.09 179.88 7.31 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.09 -1.078 . . . . 74.52 108.09 -178.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 5.8 t -43.74 137.78 3.23 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 124.333 1.053 . . . . 52.2 113.193 179.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . 0.504 ' O ' HG12 ' A' ' 464' ' ' VAL . 9.3 Cg_endo -51.58 -28.84 30.25 Favored 'Trans proline' 0 C--N 1.363 1.298 0 C-N-CA 124.815 3.676 . . . . 65.33 113.963 -177.419 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.73 -18.6 63.53 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.315 0.579 . . . . 65.12 111.406 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 82.7 mt -102.73 6.62 39.55 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 116.176 -0.465 . . . . 63.22 112.02 -179.353 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 461' ' ' PRO . 14.8 p -61.54 127.35 21.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 119.491 -0.883 . . . . 65.22 109.406 176.716 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 78.85 -1.24 74.65 Favored Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 121.171 -0.538 . . . . 62.01 112.204 179.064 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -101.35 159.29 15.39 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 108.265 -1.013 . . . . 71.42 108.265 -178.552 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.448 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 75.1 t -80.54 140.9 15.99 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 CA-C-N 115.426 -0.806 . . . . 65.45 109.569 176.468 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 63.2 mt -98.28 -35.25 5.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 108.249 -1.019 . . . . 74.42 108.249 176.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 168.86 -177.4 42.71 Favored Glycine 0 N--CA 1.425 -2.064 0 C-N-CA 120.526 -0.845 . . . . 61.41 112.215 178.063 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . 0.524 HG22 HG12 ' A' ' 486' ' ' ILE . 72.3 p -116.14 144.24 44.43 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.432 -1.692 . . . . 73.1 106.432 179.081 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.512 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 22.3 t-20 -64.31 -57.68 16.74 Favored Pre-proline 0 C--N 1.319 -0.724 0 C-N-CA 120.064 -0.654 . . . . 71.11 112.051 177.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 24.4 Cg_exo -73.25 139.92 29.95 Favored 'Trans proline' 0 C--N 1.361 1.188 0 N-CA-C 108.041 -1.561 . . . . 54.41 108.041 170.152 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.418 ' C ' ' H ' ' A' ' 475' ' ' ASN . 23.8 Cg_exo -62.59 128.1 22.55 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.373 2.048 . . . . 75.04 114.234 -173.474 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -83.84 18.58 1.95 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 122.431 1.11 . . . . 52.2 109.375 179.383 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . 0.418 ' H ' ' C ' ' A' ' 473' ' ' PRO . 15.5 m120 -111.88 -9.96 14.02 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.038 -1.437 . . . . 74.42 109.427 -179.427 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -119.75 -179.35 3.87 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-O 121.454 0.645 . . . . 75.41 112.564 -170.144 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.97 134.38 34.52 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.621 -1.251 . . . . 71.13 107.621 178.136 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 24.4 m -128.96 145.56 51.2 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.151 -0.685 . . . . 63.53 109.151 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -78.44 167.48 21.24 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 120.861 0.362 . . . . 61.12 111.862 -178.098 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 40.0 mm -71.43 -17.17 19.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.633 0.73 . . . . 75.01 110.272 -178.217 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 15.9 p -94.88 5.24 52.46 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.658 -0.651 . . . . 54.54 112.14 179.254 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -83.69 139.54 32.71 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.273 0.559 . . . . 65.03 112.194 -177.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 60.2 t -108.3 126.52 64.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 107.842 -1.17 . . . . 74.54 107.842 176.27 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.45 HG12 ' HG2' ' A' ' 472' ' ' PRO . 34.1 m -110.11 120.57 61.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-O 121.426 0.631 . . . . 74.0 111.158 178.823 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.75 129.1 44.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.219 -1.03 . . . . 74.13 108.219 174.187 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.524 HG12 HG22 ' A' ' 470' ' ' THR . 18.4 mt -113.06 128.26 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 CA-C-N 115.117 -0.947 . . . . 73.2 110.366 -177.438 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 4.9 tt -104.48 126.6 59.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-N 115.566 -0.743 . . . . 71.13 109.695 -178.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 34.2 m -111.96 151.74 13.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 115.523 -0.762 . . . . 32.01 109.571 179.275 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -90.23 144.53 17.59 Favored Glycine 0 N--CA 1.424 -2.131 0 C-N-CA 121.167 -0.539 . . . . 62.23 112.959 -176.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.541 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 23.2 t -124.38 142.91 50.92 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 106.192 -1.781 . . . . 53.11 106.192 174.176 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -130.81 105.59 0.65 Allowed Glycine 0 N--CA 1.433 -1.529 0 C-N-CA 119.639 -1.267 . . . . 63.43 112.96 -175.455 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -66.09 147.7 84.48 Favored 'Trans proline' 0 C--O 1.248 0.983 0 C-N-CA 122.939 2.426 . . . . 72.11 110.476 174.326 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -88.57 72.41 8.77 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.749 0.785 . . . . 55.52 111.371 -177.098 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 22.1 p -126.0 146.46 49.87 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.361 -0.836 . . . . 73.44 110.823 -178.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -138.14 146.35 42.69 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.498 -0.927 . . . . 73.54 108.498 178.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 13.7 t70 -99.59 111.66 23.97 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.424 -0.954 . . . . 72.44 108.424 -178.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . 0.569 HD13 ' O ' ' A' ' 543' ' ' THR . 0.2 OUTLIER -75.79 127.1 86.27 Favored Pre-proline 0 C--O 1.236 0.357 0 N-CA-C 113.797 1.036 . . . . 71.23 113.797 -174.114 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -94.98 151.23 1.71 Allowed 'Trans proline' 0 CA--C 1.55 1.314 0 C-N-CA 123.111 2.54 . . . . 64.43 110.84 171.178 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . 0.441 ' HB3' ' HB2' ' A' ' 541' ' ' ALA . 7.3 p-10 -89.94 129.94 36.22 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.382 0.611 . . . . 53.14 110.323 -179.088 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.79 81.7 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-O 122.806 1.289 . . . . 73.1 109.533 177.268 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -97.44 145.78 25.85 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 113.814 -1.539 . . . . 64.13 108.885 -177.656 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 111.47 44.39 0.91 Allowed Glycine 0 CA--C 1.476 -2.378 0 N-CA-C 109.27 -1.532 . . . . 44.34 109.27 -177.082 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -141.22 167.05 23.11 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 108.826 -0.805 . . . . 65.33 108.826 -177.161 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 13.2 t -91.41 161.84 14.83 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 108.061 -1.088 . . . . 70.24 108.061 176.694 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 31.2 m -51.44 -42.07 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.668 0 C-N-CA 124.49 1.116 . . . . 72.24 113.396 -174.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -68.16 -41.8 81.02 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.253 0.549 . . . . 64.04 111.04 -177.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 51.7 t -72.66 -36.53 53.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.365 -0.834 . . . . 62.43 110.46 -176.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -62.51 -48.48 79.37 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.611 -0.268 . . . . 72.01 110.696 178.403 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -60.18 -41.77 93.61 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.298 0.571 . . . . 75.13 109.758 178.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.407 ' O ' HG23 ' A' ' 514' ' ' VAL . 0.6 OUTLIER -61.5 -43.19 99.3 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.546 -1.206 . . . . 70.23 110.173 -177.852 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -62.4 -42.91 99.79 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 116.438 -0.347 . . . . 74.1 111.281 179.416 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.31 -40.9 97.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.54 -0.3 . . . . 73.4 110.504 177.805 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -61.83 -43.02 99.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.965 0.412 . . . . 75.15 110.161 178.173 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 510' ' ' LYS . 93.7 t -67.1 -26.34 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-N 115.656 -0.702 . . . . 74.33 111.583 178.575 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -76.17 -25.38 55.18 Favored 'General case' 0 CA--C 1.514 -0.416 0 O-C-N 121.666 -0.646 . . . . 71.22 109.908 177.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 111.87 36.35 1.7 Allowed Glycine 0 N--CA 1.436 -1.359 0 C-N-CA 120.822 -0.704 . . . . 73.25 111.944 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -120.34 122.82 41.66 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 107.484 -1.302 . . . . 73.33 107.484 178.441 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.6 m -101.81 -18.17 15.89 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 115.831 -0.622 . . . . 73.53 110.628 -175.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -113.61 113.22 24.75 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.82 0.819 . . . . 70.11 110.907 -179.394 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -132.28 155.94 47.43 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.379 -1.282 . . . . 64.04 110.155 -177.611 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 48.8 m -141.34 138.84 33.37 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 108.122 -1.066 . . . . 72.45 108.122 173.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.09 119.57 35.16 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.644 0.735 . . . . 63.21 112.15 179.733 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -107.15 118.86 37.83 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.258 -0.883 . . . . 71.24 109.726 -178.255 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 67.4 m -84.54 123.01 29.82 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.087 -0.709 . . . . 53.24 109.087 176.023 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 32.7 m -121.4 150.98 24.55 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 N-CA-C 107.554 -1.276 . . . . 72.1 107.554 -179.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . 0.408 ' HB2' HD21 ' A' ' 559' ' ' ASN . 0.2 OUTLIER -90.53 137.54 32.27 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.58 -1.248 . . . . 61.21 109.981 -177.374 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 69.0 m -155.96 -176.12 0.58 Allowed Pre-proline 0 C--N 1.304 -1.413 0 N-CA-C 107.445 -1.317 . . . . 74.41 107.445 -176.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -73.45 -28.21 12.39 Favored 'Trans proline' 0 C--N 1.36 1.148 0 CA-C-N 120.941 1.372 . . . . 74.12 111.739 173.396 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -64.84 137.14 97.05 Favored Pre-proline 0 N--CA 1.475 0.812 0 CA-C-N 116.405 -0.362 . . . . 64.11 111.813 -178.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.58 151.9 43.91 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 124.032 3.155 . . . . 72.04 114.965 -173.318 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.59 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -69.35 107.97 3.52 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 115.047 -0.978 . . . . 35.24 110.875 -178.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 128.69 -10.87 6.35 Favored Glycine 0 C--N 1.292 -1.899 0 N-CA-C 110.393 -1.083 . . . . 63.24 110.393 -178.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -82.52 125.02 30.65 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 109.238 -0.653 . . . . 75.32 109.238 176.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 62.0 t -87.8 107.53 17.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 106.788 -1.56 . . . . 62.44 106.788 175.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 6.1 t -83.87 -8.7 59.13 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.631 -0.713 . . . . 74.22 111.336 -172.056 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.16 -155.5 26.46 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 120.693 -0.765 . . . . 64.53 111.299 177.448 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . 0.458 HG22 HD23 ' A' ' 553' ' ' LEU . 24.6 p -122.99 159.43 28.37 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 109.348 -0.612 . . . . 63.35 109.348 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -72.97 -53.05 5.33 Favored Pre-proline 0 C--N 1.306 -1.292 0 CA-C-O 118.876 -0.583 . . . . 64.54 110.578 174.062 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -61.57 128.09 23.68 Favored 'Trans proline' 0 C--N 1.378 2.084 0 N-CA-C 109.008 -1.189 . . . . 71.33 109.008 170.578 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -64.65 141.44 72.8 Favored 'Trans proline' 0 C--O 1.253 1.259 0 C-N-CA 122.177 1.918 . . . . 74.1 112.599 -177.656 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . 0.441 ' HB2' ' HB3' ' A' ' 499' ' ' ASP . . . -67.65 139.74 56.82 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 108.13 -1.063 . . . . 73.3 108.13 175.639 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.82 -5.0 39.54 Favored Glycine 0 N--CA 1.416 -2.668 0 N-CA-C 110.313 -1.115 . . . . 23.23 110.313 -175.513 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.569 ' O ' HD13 ' A' ' 497' ' ' ILE . 27.2 m -88.85 136.61 32.92 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 120.49 -0.484 . . . . 63.25 109.767 177.275 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 28.9 m -89.82 122.84 33.26 Favored 'General case' 0 N--CA 1.416 -2.147 0 N-CA-C 107.148 -1.427 . . . . 63.45 107.148 172.276 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.4 m -127.01 154.54 76.5 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 110.222 -0.288 . . . . 54.32 110.222 -177.453 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -68.84 151.88 73.98 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.305 2.003 . . . . 64.12 110.113 173.136 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 26.3 m -67.32 -20.28 26.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.724 0.773 . . . . 53.22 110.063 177.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -77.56 -11.4 59.85 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 114.94 -1.027 . . . . 72.22 112.258 -179.454 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 49.0 m -78.72 154.65 29.89 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 121.863 -0.523 . . . . 51.31 111.021 178.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 41.7 t -97.72 116.04 39.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 108.679 -0.859 . . . . 72.33 108.679 179.434 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.42 126.61 40.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.171 -0.677 . . . . 74.41 109.171 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -102.43 115.78 31.27 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-O 121.775 0.798 . . . . 62.11 109.636 -178.585 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . 0.458 HD23 HG22 ' A' ' 537' ' ' THR . 67.3 mt -87.65 134.25 33.68 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 113.856 -1.52 . . . . 75.51 107.551 178.096 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -112.32 115.36 28.63 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 122.257 1.027 . . . . 73.04 110.137 178.569 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 41.7 t -101.15 139.45 22.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 CA-C-N 114.441 -1.254 . . . . 75.02 108.446 -176.16 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.59 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 50.6 m -92.46 147.29 23.02 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-O 121.413 0.625 . . . . 54.11 112.093 179.786 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 0.2 OUTLIER -118.58 132.49 56.2 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 105.247 -2.131 . . . . 75.0 105.247 170.772 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -82.47 -24.1 54.78 Favored Glycine 0 CA--C 1.492 -1.371 0 N-CA-C 114.638 0.615 . . . . 72.12 114.638 -169.017 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . 0.408 HD21 ' HB2' ' A' ' 526' ' ' ASP . 43.8 m-80 68.13 31.81 5.19 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 107.548 -1.278 . . . . 60.45 107.548 -174.362 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 -135.11 141.72 46.08 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 106.281 -1.748 . . . . 73.34 106.281 -175.803 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -143.09 147.66 35.38 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 109.731 -0.47 . . . . 72.41 109.731 176.785 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 612' ' ' THR . 63.1 t -67.99 118.37 11.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-O 121.149 0.5 . . . . 75.15 110.303 -179.34 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . 0.408 ' HG2' ' O ' ' A' ' 564' ' ' PRO . 53.7 ttp -83.15 132.96 48.85 Favored Pre-proline 0 C--N 1.306 -1.293 0 CA-C-N 115.759 -0.655 . . . . 74.42 111.251 -177.553 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . 0.408 ' O ' ' HG2' ' A' ' 563' ' ' MET . 61.1 Cg_endo -74.29 170.14 20.87 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.048 2.498 . . . . 73.12 110.597 172.69 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -67.17 142.44 57.02 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.913 0.387 . . . . 74.43 110.905 179.529 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 94.0 mt -121.56 17.56 11.25 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.745 -0.661 . . . . 74.31 109.593 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 11.3 m -63.04 130.5 44.98 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.314 -0.857 . . . . 74.35 109.851 -179.785 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 88.43 46.2 4.72 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 119.916 -1.135 . . . . 54.04 112.197 177.427 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 26.8 ptm -118.71 157.72 26.92 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.162 -1.051 . . . . 71.22 108.162 176.401 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . 0.477 ' H ' ' HB3' ' A' ' 573' ' ' ASP . 91.9 m-85 -130.81 163.68 26.82 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.608 -1.256 . . . . 73.25 107.608 -176.502 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 35.8 t90 -65.44 -36.54 84.22 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.41 0.624 . . . . 74.12 109.612 176.803 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.7 m -75.58 -8.88 12.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.363 -0.835 . . . . 74.0 110.433 -178.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . 0.498 ' O ' ' HB2' ' A' ' 577' ' ' ARG . 13.7 t70 -101.21 -37.32 8.59 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.97 -1.013 . . . . 75.42 109.287 178.217 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -61.47 -34.71 75.92 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 124.314 1.046 . . . . 60.41 111.892 -179.404 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.476 ' HB2' ' HD3' ' A' ' 576' ' ' PRO . 9.3 mm-40 -60.1 -58.83 16.53 Favored Pre-proline 0 CA--C 1.559 1.291 0 N-CA-C 112.672 0.619 . . . . 34.34 112.672 177.241 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . 0.476 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 51.0 Cg_exo -61.59 -35.1 83.04 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 121.57 1.513 . . . . 64.24 111.782 171.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 573' ' ' ASP . 0.4 OUTLIER -59.54 -40.59 87.72 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.039 0.535 . . . . 73.42 110.394 -178.106 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 7.1 tt -57.63 -47.37 82.41 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.702 0.801 . . . . 75.13 109.237 179.666 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -66.63 -46.93 74.23 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.563 -0.744 . . . . 74.25 110.248 -178.65 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -62.79 -39.03 92.97 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.749 0.82 . . . . 75.01 112.803 -177.517 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 96.4 mt -89.45 -8.57 52.69 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 120.719 -0.392 . . . . 73.21 111.457 -179.029 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 63.52 43.38 98.19 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 109.679 -1.369 . . . . 50.44 109.679 -175.503 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 22.1 t90 -73.75 126.63 30.79 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 114.845 -0.677 . . . . 72.34 111.14 -172.389 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 24.0 m -99.86 -8.07 24.54 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.575 0.702 . . . . 63.33 109.749 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . 0.43 ' HA2' ' OD1' ' A' ' 617' ' ' ASP . . . -69.14 170.35 41.52 Favored Glycine 0 N--CA 1.428 -1.874 0 CA-C-N 115.127 -0.942 . . . . 74.45 113.804 -177.129 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 36.1 ttm -105.48 135.14 47.42 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.101 -1.05 . . . . 71.43 109.997 -177.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 56.7 tp -88.59 131.13 35.09 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.51 -0.922 . . . . 73.1 108.51 175.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -94.37 104.78 16.76 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.002 0.429 . . . . 72.3 110.797 -176.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -114.24 112.41 23.09 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 109.415 -0.587 . . . . 74.41 109.415 174.182 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -127.48 -40.76 0.31 Allowed Glycine 0 C--N 1.309 -0.97 0 C-N-CA 119.435 -1.364 . . . . 63.3 112.943 177.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . 0.484 ' HB3' ' NH2' ' A' ' 623' ' ' ARG . . . -139.58 157.5 45.7 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 122.577 0.351 . . . . 53.21 110.643 -177.788 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -110.39 124.26 51.39 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.457 -1.312 . . . . 71.34 107.457 176.422 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 35.9 t -109.02 115.89 50.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 C-N-CA 120.063 -0.655 . . . . 65.11 110.365 -176.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -100.03 116.78 32.86 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.995 -0.682 . . . . 64.03 110.425 179.658 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -132.69 -27.94 1.66 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 116.092 -0.504 . . . . 64.4 110.898 179.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 141.24 -169.41 25.05 Favored Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 110.494 -1.042 . . . . 53.33 110.494 -177.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.53 -35.18 65.58 Favored Glycine 0 CA--C 1.509 -0.307 0 O-C-N 123.877 0.398 . . . . 61.34 113.851 -175.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 42.6 m -58.68 -32.3 68.99 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.102 0.408 . . . . 63.13 112.102 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -108.61 -1.59 19.46 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.071 0.462 . . . . 75.44 110.651 -178.095 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -67.1 99.72 0.7 Allowed 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.211 -0.45 . . . . 75.44 112.051 -175.611 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . 0.458 ' OD1' ' HB3' ' A' ' 570' ' ' PHE . 11.7 t-20 67.15 -3.25 1.02 Allowed 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 125.251 1.42 . . . . 62.31 112.367 174.384 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -93.18 152.93 18.93 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 123.963 0.905 . . . . 75.15 111.326 -175.186 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . 0.477 HG23 ' HB2' ' A' ' 622' ' ' LEU . 12.9 p -57.06 138.76 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 124.554 1.142 . . . . 70.3 110.697 178.631 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 61.0 t -93.97 -56.12 5.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 108.118 -1.068 . . . . 74.43 108.118 179.119 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -151.42 154.62 36.98 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 107.78 -1.193 . . . . 62.0 107.78 -179.59 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . 0.413 ' HB2' HD11 ' A' ' 620' ' ' ILE . 16.7 pt20 -109.06 122.1 46.55 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.038 -1.467 . . . . 73.44 107.038 172.744 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.557 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 42.7 t-20 -53.21 -57.95 14.52 Favored Pre-proline 0 N--CA 1.483 1.189 0 CA-C-O 119.31 -0.376 . . . . 61.11 111.926 -178.659 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.557 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 1.2 Cg_endo -85.7 131.33 3.9 Favored 'Trans proline' 0 N--CA 1.44 -1.635 0 C-N-CA 121.262 1.308 . . . . 71.1 109.947 174.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . 0.493 ' O ' HG22 ' A' ' 612' ' ' THR . 53.2 Cg_endo -70.38 156.22 62.2 Favored 'Trans proline' 0 C--O 1.243 0.739 0 C-N-CA 122.069 1.846 . . . . 72.41 111.541 178.625 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -64.41 128.33 35.33 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.371 -0.603 . . . . 74.11 109.371 178.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 106.02 -3.57 38.38 Favored Glycine 0 C--N 1.3 -1.432 0 C-N-CA 120.394 -0.908 . . . . 22.23 112.92 -177.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . 0.493 HG22 ' O ' ' A' ' 609' ' ' PRO . 9.1 t -96.17 176.88 5.91 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-N 117.858 0.829 . . . . 73.15 109.111 175.504 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -97.87 119.47 6.44 Favored Glycine 0 N--CA 1.425 -2.082 0 CA-C-N 116.194 -0.457 . . . . 62.14 112.041 -177.075 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 26.8 m -104.95 144.3 14.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 C-N-CA 123.479 0.712 . . . . 73.55 109.523 177.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.557 ' ND2' ' HB3' ' A' ' 617' ' ' ASP . 36.6 p-10 -57.8 161.13 4.0 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 123.684 0.794 . . . . 74.32 111.968 -178.074 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -63.21 -25.9 68.55 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 120.82 0.343 . . . . 63.54 111.218 -178.015 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . 0.557 ' HB3' ' ND2' ' A' ' 615' ' ' ASN . 13.9 t70 -60.08 -40.05 88.21 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.667 -0.864 . . . . 74.44 108.667 174.308 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 87.96 20.98 48.14 Favored Glycine 0 N--CA 1.428 -1.885 0 CA-C-N 115.408 -0.814 . . . . 70.33 112.115 176.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . 0.425 ' HB ' ' OD1' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -69.24 119.28 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-O 122.762 1.268 . . . . 72.03 109.883 -173.523 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.413 HD11 ' HB2' ' A' ' 606' ' ' GLN . 3.2 tp -117.55 125.69 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.939 0 CA-C-N 113.422 -1.717 . . . . 74.22 107.714 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 17.5 m -98.26 116.39 30.39 Favored 'General case' 0 N--CA 1.412 -2.367 0 C-N-CA 118.877 -1.129 . . . . 74.51 108.097 178.436 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . 0.477 ' HB2' HG23 ' A' ' 603' ' ' VAL . 0.0 OUTLIER -139.64 155.4 47.43 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 106.961 -1.496 . . . . 62.35 106.961 179.653 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . 0.484 ' NH2' ' HB3' ' A' ' 591' ' ' ALA . 57.2 mtp180 -128.74 156.63 43.21 Favored 'General case' 0 C--N 1.272 -2.782 0 N-CA-C 105.271 -2.122 . . . . 70.24 105.271 175.186 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -131.14 158.05 41.5 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 106.637 -1.616 . . . . 73.33 106.637 175.184 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -81.88 -117.32 0.47 Allowed Glycine 0 N--CA 1.423 -2.181 0 C-N-CA 120.073 -1.06 . . . . 74.53 113.414 -177.252 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 . . . . . 0 C--N 1.297 -1.709 0 N-CA-C 108.886 -0.783 . . . . 73.15 108.886 -174.134 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.38 0 N-CA-C 109.715 -1.354 . . . . 43.05 109.715 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 10.7 tp -75.08 141.79 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 108.436 -0.95 . . . . 73.11 108.436 177.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 1.4 m -73.15 134.7 44.52 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 109.189 -0.671 . . . . 64.12 109.189 178.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -92.21 -37.29 12.78 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 108.494 -0.928 . . . . 64.32 108.494 -179.583 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -89.07 117.89 28.39 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.073 -0.967 . . . . 71.12 109.412 -176.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 34.6 m -121.22 153.93 24.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 N-CA-C 107.019 -1.474 . . . . 40.22 107.019 177.869 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -94.56 136.2 35.13 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 117.578 -1.649 . . . . 74.23 107.284 179.274 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 98.1 t -96.8 124.24 50.91 Favored Pre-proline 0 C--N 1.274 -2.704 0 N-CA-C 109.666 -0.494 . . . . 73.42 109.666 -172.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -64.12 125.87 16.06 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.935 1.757 . . . . 74.21 110.058 178.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . 0.571 ' OD1' ' HG2' ' A' ' 366' ' ' ARG . 16.5 t70 -85.69 138.36 32.18 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-O 121.726 0.774 . . . . 73.34 112.044 -176.608 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 18.5 m -108.22 4.93 9.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 113.981 -1.463 . . . . 60.05 111.777 -175.421 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.571 ' HG2' ' OD1' ' A' ' 364' ' ' ASP . 25.7 mmt-85 -62.54 147.48 48.87 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 112.624 0.602 . . . . 64.22 112.624 178.568 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.64 -9.59 44.7 Favored Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 110.709 -0.957 . . . . 74.34 110.709 -174.624 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -103.75 -150.68 0.42 Allowed 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.481 -0.933 . . . . 71.02 108.481 178.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 60.3 p -98.05 155.04 17.31 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.464 -0.939 . . . . 73.21 108.464 -178.162 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 23.0 t -61.42 -33.79 74.3 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.587 -0.523 . . . . 70.24 109.587 179.104 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -65.59 -46.46 79.3 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 116.24 -0.436 . . . . 73.35 111.138 178.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.54 -44.87 73.6 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-O 121.426 0.632 . . . . 61.1 110.376 -179.505 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -60.21 -48.11 83.13 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.582 -1.19 . . . . 40.43 111.567 -178.23 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.53 -39.31 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 116.644 -0.253 . . . . 52.11 111.27 177.721 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.9 -44.48 91.24 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-O 121.302 0.572 . . . . 74.3 111.112 -178.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . 0.443 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 70.9 m -64.18 -47.34 80.19 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.438 -0.801 . . . . 64.25 110.648 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 95.5 mt -64.16 -38.79 92.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.474 -0.33 . . . . 74.14 111.169 -179.265 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -62.29 -43.02 99.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.981 -0.554 . . . . 73.54 110.787 179.053 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -64.19 -31.86 73.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.274 0.559 . . . . 74.25 111.279 176.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . 0.443 ' HG2' ' O ' ' A' ' 376' ' ' THR . 29.8 mmm180 -80.11 -13.55 59.19 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.989 -0.55 . . . . 65.33 111.388 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 94.06 15.65 47.55 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.65 -0.786 . . . . 52.12 112.578 177.335 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -80.39 156.54 26.62 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 122.451 -0.441 . . . . 74.21 111.266 177.248 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -99.76 133.81 43.57 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 107.129 -1.434 . . . . 34.22 107.129 177.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.491 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -127.33 155.1 38.32 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 C-N-CA 120.1 -0.64 . . . . 72.11 111.124 -175.404 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . 0.412 ' HB3' HG22 ' A' ' 417' ' ' THR . 7.7 tpt180 -136.08 141.28 44.22 Favored 'General case' 0 N--CA 1.403 -2.817 0 CA-C-N 114.571 -1.195 . . . . 74.31 108.011 169.763 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . 0.474 HG22 HE22 ' A' ' 388' ' ' GLN . 6.2 m -127.22 134.9 50.04 Favored 'General case' 0 C--N 1.271 -2.846 0 N-CA-C 104.55 -2.389 . . . . 61.11 104.55 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.57 124.34 45.09 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 119.317 -0.953 . . . . 62.25 109.201 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.474 HE22 HG22 ' A' ' 386' ' ' THR . 14.1 mm-40 -91.34 121.79 33.39 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.086 -0.709 . . . . 74.1 109.086 -177.306 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 421' ' ' SER . 55.0 mtpt -136.79 130.32 17.68 Favored Pre-proline 0 C--N 1.308 -1.22 0 N-CA-C 110.215 -0.291 . . . . 73.41 110.215 176.352 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.528 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 54.0 Cg_endo -79.4 127.95 7.69 Favored 'Trans proline' 0 C--O 1.254 1.324 0 C-N-CA 120.956 1.104 . . . . 53.31 109.836 173.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.528 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 8.6 t70 154.33 -164.92 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 103.802 -2.666 . . . . 71.33 103.802 -177.649 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 26.7 t -142.7 4.7 1.53 Allowed 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 118.098 0.408 . . . . 60.21 110.187 176.512 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 15.3 t -79.62 -18.13 52.24 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-O 121.338 0.589 . . . . 54.24 109.781 179.661 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.616 HD13 ' H ' ' A' ' 394' ' ' ILE . 0.2 OUTLIER -99.58 150.43 36.78 Favored Pre-proline 0 N--CA 1.424 -1.743 0 N-CA-C 107.012 -1.477 . . . . 74.32 107.012 176.704 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . 0.427 ' HA ' ' HD2' ' A' ' 396' ' ' PRO . 77.8 Cg_exo -49.72 132.89 32.08 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.139 2.559 . . . . 65.53 114.228 -177.556 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . 0.574 ' HA ' ' OG ' ' A' ' 421' ' ' SER . 17.5 Cg_endo -60.75 164.03 14.58 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.595 2.863 . . . . 72.45 110.832 174.302 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . 0.425 ' HA ' HG13 ' A' ' 420' ' ' VAL . 0.9 OUTLIER -57.51 -8.91 0.93 Allowed 'General case' 0 N--CA 1.511 2.583 0 CA-C-O 121.915 0.864 . . . . 72.31 111.012 179.023 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -93.57 101.23 13.4 Favored 'General case' 0 CA--C 1.477 -1.841 0 N-CA-C 102.398 -3.186 . . . . 74.42 102.398 170.205 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 16.5 m -63.32 118.19 5.15 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.488 0 O-C-N 124.197 0.936 . . . . 64.52 112.491 -166.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 49.3 mm -103.61 -39.3 5.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 115.259 -0.882 . . . . 73.03 111.08 -177.34 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.41 157.32 27.35 Favored Glycine 0 N--CA 1.433 -1.54 0 C-N-CA 119.739 -1.219 . . . . 35.55 112.627 -175.51 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -156.31 -174.98 5.19 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 126.062 1.745 . . . . 73.52 109.797 -176.261 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . 0.424 ' C ' ' H ' ' A' ' 405' ' ' ALA . 10.7 t70 -96.96 136.15 21.7 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 105.942 -1.873 . . . . 74.42 105.942 176.252 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . 0.507 ' HA ' ' OD1' ' A' ' 407' ' ' ASN . 38.0 Cg_endo -63.01 23.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 124.823 3.682 . . . . 74.12 115.622 -173.092 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.424 ' H ' ' C ' ' A' ' 403' ' ' ASP . . . -54.01 -42.16 68.79 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 124.075 0.95 . . . . 72.1 110.92 177.569 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -79.24 -31.1 43.46 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.593 0.711 . . . . 73.5 110.516 -179.666 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . 0.507 ' OD1' ' HA ' ' A' ' 404' ' ' PRO . 8.9 m120 -79.68 -7.75 58.78 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.354 -0.839 . . . . 73.32 110.194 -175.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 89.9 m -99.42 148.71 23.93 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.564 -1.643 . . . . 74.25 106.564 176.623 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 17.3 m -74.45 111.89 10.09 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 107.814 -1.18 . . . . 62.32 107.814 177.445 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.36 169.86 20.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 C-N-CA 123.089 0.556 . . . . 61.42 110.262 -177.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 49.7 m -68.49 131.9 46.07 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.447 -0.946 . . . . 73.41 108.447 174.303 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -58.51 111.07 1.11 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.334 0.588 . . . . 64.02 110.683 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 111.1 73.81 0.72 Allowed Glycine 0 N--CA 1.432 -1.577 0 N-CA-C 110.58 -1.008 . . . . 65.21 110.58 -179.526 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -129.44 -175.0 3.44 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 105.853 -1.906 . . . . 34.3 105.853 179.935 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -102.76 123.45 46.45 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 118.401 0.546 . . . . 73.51 110.545 -177.02 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 27.1 mm -113.12 120.69 63.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 109.043 -0.725 . . . . 53.14 109.043 -179.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . 0.412 HG22 ' HB3' ' A' ' 385' ' ' ARG . 17.1 p -100.62 131.44 46.53 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 112.006 0.373 . . . . 72.31 112.006 -178.488 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 7.7 p -126.81 134.91 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-O 120.892 0.377 . . . . 65.43 110.846 176.279 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -101.6 128.46 47.87 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.816 -1.179 . . . . 73.41 107.816 175.201 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.425 HG13 ' HA ' ' A' ' 397' ' ' ASP . 54.0 t -124.55 135.92 62.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 C-N-CA 122.999 0.52 . . . . 73.01 110.352 -175.491 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . 0.574 ' OG ' ' HA ' ' A' ' 396' ' ' PRO . 77.7 p -84.9 121.12 27.29 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 109.086 -0.709 . . . . 61.13 109.086 177.897 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 33.8 m -118.69 106.2 12.35 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 109.07 -0.715 . . . . 60.32 109.07 177.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 92.21 118.52 2.45 Favored Glycine 0 N--CA 1.425 -2.045 0 C-N-CA 120.6 -0.81 . . . . 72.15 111.687 -178.514 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -77.96 158.12 30.87 Favored 'Trans proline' 0 C--O 1.243 0.747 0 C-N-CA 122.565 2.177 . . . . 70.22 109.692 174.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -71.72 166.1 22.65 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.726 0.774 . . . . 74.14 111.897 -175.371 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -87.63 158.32 18.89 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.502 -1.226 . . . . 72.22 108.036 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -121.08 143.03 49.29 Favored 'General case' 0 CA--C 1.479 -1.779 0 CA-C-O 121.367 0.603 . . . . 71.13 112.145 -173.694 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -82.96 134.71 35.05 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.271 -1.331 . . . . 75.45 108.755 178.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 474' ' ' ALA . 50.2 mt -83.02 125.96 73.67 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 109.144 -0.688 . . . . 71.23 109.144 -179.45 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -71.03 154.68 62.57 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.426 2.084 . . . . 74.24 110.905 173.077 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -74.07 158.86 33.51 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 108.986 -0.746 . . . . 74.42 108.986 178.068 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 12.2 p -142.4 147.05 21.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 109.949 -0.389 . . . . 64.03 109.949 -178.447 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 19.5 m -72.84 137.01 45.45 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 108.65 -0.87 . . . . 65.33 108.65 175.806 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 54.4 p -62.44 -31.19 71.86 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 113.822 1.045 . . . . 72.41 113.822 -171.349 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.4 pp -81.67 -11.5 59.05 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.224 -0.99 . . . . 63.13 111.382 179.11 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 5.5 m -105.41 62.68 0.68 Allowed 'General case' 0 N--CA 1.432 -1.341 0 CA-C-O 122.191 0.996 . . . . 70.43 112.0 -176.21 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -56.12 -37.1 68.99 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.593 1.157 . . . . 73.54 111.397 176.25 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.33 -40.61 78.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.124 0.488 . . . . 64.32 111.016 178.077 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -70.28 -34.97 73.4 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.308 -0.627 . . . . 73.44 109.308 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.555 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -60.8 -51.39 69.52 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.74 -0.664 . . . . 62.31 111.345 179.15 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 35.4 m -65.47 -39.11 84.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 112.31 0.485 . . . . 74.0 112.31 -177.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -34.76 77.41 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 120.607 -0.437 . . . . 72.21 111.572 178.111 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 27.3 mmtm -61.76 -39.81 92.95 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-N 116.4 -0.363 . . . . 75.42 110.452 177.427 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 75.5 mt -63.88 -43.25 96.6 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.369 -0.832 . . . . 52.31 110.073 179.252 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 61.1 m -65.35 -42.68 92.57 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.362 -0.381 . . . . 74.22 111.646 177.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -63.35 -29.25 70.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.708 0.766 . . . . 71.23 110.611 178.455 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -85.02 5.22 30.28 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.454 -0.794 . . . . 42.02 111.889 179.194 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 105.48 -66.5 0.27 Allowed Glycine 0 CA--C 1.496 -1.142 0 C-N-CA 120.374 -0.917 . . . . 42.2 112.96 172.749 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -46.65 -65.88 0.49 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 114.353 1.242 . . . . 73.05 114.353 177.767 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 59.09 26.22 60.83 Favored Glycine 0 N--CA 1.469 0.887 0 C-N-CA 120.948 -0.644 . . . . 73.32 112.65 -176.005 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.581 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 16.3 mmt85 -100.73 111.37 23.59 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 107.148 -1.427 . . . . 75.41 107.148 -177.221 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -140.2 153.44 46.59 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 112.487 0.551 . . . . 70.21 112.487 -174.247 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' A' ' 453' ' ' LYS . 72.0 mmtt -138.81 148.53 43.9 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 124.77 1.228 . . . . 51.14 108.996 176.814 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -121.1 124.94 45.99 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 122.967 0.507 . . . . 74.22 110.609 -176.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -128.19 162.79 26.13 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.016 -0.735 . . . . 71.25 109.016 178.05 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -129.11 146.76 50.98 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 120.969 0.414 . . . . 33.24 110.072 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 36.8 t -143.47 149.14 46.52 Favored Pre-proline 0 C--N 1.29 -1.985 0 N-CA-C 107.453 -1.314 . . . . 34.22 107.453 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.716 ' HA ' ' O ' ' A' ' 490' ' ' SER . 24.3 Cg_exo -64.83 134.77 41.74 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.874 1.716 . . . . 61.54 109.722 176.545 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 62.6 m -152.07 172.17 16.73 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 116.181 -0.463 . . . . 63.02 109.855 -178.191 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 7.0 t -53.78 141.46 46.79 Favored Pre-proline 0 N--CA 1.438 -1.043 0 C-N-CA 124.487 1.115 . . . . 70.54 111.072 177.22 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -52.72 -30.67 47.34 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 124.698 3.598 . . . . 74.5 113.342 -176.302 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -72.97 -28.63 62.51 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.958 -0.565 . . . . 50.43 111.791 -178.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 11.2 mp -98.57 -0.61 42.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.592 0.234 . . . . 63.32 111.555 178.736 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 53.3 t -61.69 126.65 20.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-O 121.035 0.445 . . . . 75.03 109.92 175.229 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 87.58 0.21 84.44 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.711 -0.677 . . . . 64.34 111.75 -178.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.32 158.95 17.87 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.861 -0.792 . . . . 72.23 108.861 179.363 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 70.2 t -75.19 138.78 20.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 N-CA-C 108.728 -0.842 . . . . 53.42 108.728 176.382 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 48.9 mm -97.26 -27.86 3.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.395 -1.335 . . . . 73.21 107.395 179.062 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 156.57 -168.79 33.82 Favored Glycine 0 N--CA 1.422 -2.272 0 CA-C-N 115.209 -0.905 . . . . 62.34 112.052 175.472 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . 0.701 HG22 HG12 ' A' ' 486' ' ' ILE . 39.7 p -115.64 147.2 41.08 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 104.905 -2.258 . . . . 73.21 104.905 177.375 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.429 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 9.8 t30 -68.38 -55.13 12.84 Favored Pre-proline 0 C--N 1.31 -1.12 0 C-N-CA 118.542 -1.263 . . . . 54.53 111.815 176.394 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.429 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 23.9 Cg_exo -70.01 155.42 65.16 Favored 'Trans proline' 0 C--N 1.371 1.725 0 N-CA-C 108.769 -1.281 . . . . 71.13 108.769 172.428 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -62.27 126.66 19.07 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 121.82 1.68 . . . . 73.11 112.123 -176.687 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.421 ' O ' ' HB ' ' A' ' 429' ' ' ILE . . . -84.7 -2.08 57.06 Favored 'General case' 0 C--O 1.204 -1.322 0 CA-C-N 115.437 -0.801 . . . . 73.22 112.068 -174.491 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -110.71 6.37 21.55 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 120.108 -0.637 . . . . 71.15 111.874 175.613 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -110.23 173.75 6.18 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.517 0.932 . . . . 72.3 113.517 -174.014 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.11 117.11 21.4 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.803 -1.09 . . . . 71.12 110.969 -177.368 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 49.0 m -117.12 148.26 41.71 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.709 -0.849 . . . . 73.23 108.709 177.449 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -81.32 161.11 23.98 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.601 -0.518 . . . . 65.15 109.601 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.01 -17.82 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 CA-C-O 121.732 0.777 . . . . 71.42 112.353 -178.179 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.1 t -95.96 4.79 52.41 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.583 -0.698 . . . . 52.52 111.772 179.093 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -86.92 129.49 34.86 Favored 'General case' 0 CA--C 1.508 -0.638 0 O-C-N 121.961 -0.462 . . . . 72.14 111.091 -177.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.581 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.1 p -104.79 123.51 58.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.459 0.647 . . . . 65.51 110.509 178.687 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 34.7 m -101.28 126.91 55.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 121.787 0.803 . . . . 72.1 111.122 -179.1 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.71 125.22 45.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 108.213 -1.032 . . . . 74.43 108.213 176.36 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.701 HG12 HG22 ' A' ' 470' ' ' THR . 37.1 mt -109.53 126.3 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 CA-C-N 115.076 -0.965 . . . . 54.32 110.809 -178.003 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 4.4 tt -104.64 127.0 59.41 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 CA-C-N 114.887 -1.051 . . . . 72.11 110.011 -177.213 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 33.1 m -110.18 151.57 12.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 C-N-CA 122.786 0.434 . . . . 72.52 110.012 177.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -84.62 135.48 13.64 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.674 -0.57 . . . . 63.52 111.674 -179.226 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.716 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 46.4 m -142.89 160.53 40.16 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 117.155 0.477 . . . . 73.54 110.176 178.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 81.17 86.9 0.65 Allowed Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 121.359 -0.448 . . . . 43.14 112.936 176.175 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -85.46 127.11 3.22 Favored 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 122.392 2.061 . . . . 72.1 111.122 178.155 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -85.02 45.87 1.22 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.682 0.754 . . . . 62.53 110.151 178.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 10.8 p -122.58 145.95 47.87 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.511 -0.768 . . . . 51.22 110.485 -178.29 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -143.39 150.04 38.53 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 123.104 0.561 . . . . 62.22 111.32 178.464 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 11.1 p-10 -86.85 127.83 35.03 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.164 -0.926 . . . . 65.4 110.319 178.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 31.1 pt -81.17 134.1 52.89 Favored Pre-proline 0 C--N 1.304 -1.396 0 CA-C-N 115.658 -0.701 . . . . 74.32 110.426 179.029 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -82.43 175.99 8.39 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.658 2.239 . . . . 75.23 112.978 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -83.08 142.13 31.51 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.365 -0.834 . . . . 71.12 108.765 177.048 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 51.3 t -138.57 91.11 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 N-CA-C 107.74 -1.207 . . . . 74.41 107.74 -179.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -151.1 121.08 7.13 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.775 -0.454 . . . . 70.55 109.775 178.455 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 102.69 25.63 7.56 Favored Glycine 0 CA--C 1.489 -1.557 0 C-N-CA 120.164 -1.017 . . . . 42.14 111.243 176.447 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -131.95 170.3 15.1 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 109.118 -0.697 . . . . 65.04 109.118 178.829 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 15.1 t -91.57 160.63 15.31 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.284 -1.006 . . . . 71.03 108.284 178.359 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 47.5 t -51.88 -42.5 33.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 C-N-CA 123.709 0.803 . . . . 73.03 111.788 -175.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -67.86 -42.34 81.46 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.25 0.463 . . . . 63.04 112.25 -177.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 66.3 t -75.2 -34.68 31.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-O 121.281 0.562 . . . . 64.23 110.172 -177.769 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -61.95 -50.0 73.89 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.911 -0.586 . . . . 63.15 110.661 178.526 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -65.89 -34.91 79.22 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 120.819 -0.352 . . . . 75.31 110.95 178.498 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.402 ' O ' HG23 ' A' ' 514' ' ' VAL . 78.7 tttt -55.84 -48.25 75.81 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.5 0.72 . . . . 72.21 110.166 178.437 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -62.31 -45.93 91.02 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-N 116.091 -0.504 . . . . 62.24 110.436 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 90.1 mt -61.76 -38.25 87.29 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.823 -0.626 . . . . 73.51 111.335 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -61.42 -42.48 98.8 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.954 0.407 . . . . 65.13 110.124 177.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 510' ' ' LYS . 85.8 t -66.61 -29.55 46.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-N 115.601 -0.727 . . . . 62.13 110.666 178.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -84.23 3.02 37.2 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 121.872 -0.518 . . . . 73.33 112.066 179.402 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 82.54 39.41 10.85 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 121.006 -0.616 . . . . 70.12 112.791 177.251 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -124.77 138.59 54.27 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.994 -1.113 . . . . 74.42 107.994 176.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 3.6 m -131.84 -11.58 3.4 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.708 -0.797 . . . . 72.41 111.677 -176.212 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -107.64 115.01 29.39 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.25 -0.648 . . . . 73.25 109.25 -174.394 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -130.01 155.94 45.29 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.565 -0.743 . . . . 73.23 110.005 -175.069 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 66.9 m -141.83 127.85 19.56 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 106.999 -1.482 . . . . 75.05 106.999 170.625 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . 0.503 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 0.0 OUTLIER -117.3 133.35 56.08 Favored 'General case' 0 N--CA 1.418 -2.053 0 CA-C-O 121.23 0.538 . . . . 54.35 111.129 -179.3 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -113.87 143.13 45.19 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.442 -0.948 . . . . 72.11 108.442 178.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 61.0 m -102.71 126.98 50.02 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.0 0.428 . . . . 73.12 110.833 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 26.7 m -121.3 168.3 13.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.68 -1.23 . . . . 62.12 107.68 177.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . 0.608 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 5.4 p-10 -102.65 136.42 42.52 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.31 -0.956 . . . . 51.13 111.178 -179.476 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . 0.419 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 18.7 m -152.85 178.15 1.68 Allowed Pre-proline 0 C--N 1.308 -1.219 0 N-CA-C 108.343 -0.984 . . . . 73.41 108.343 178.368 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -83.8 -0.37 9.65 Favored 'Trans proline' 0 C--N 1.361 1.216 0 C-N-CA 121.848 1.699 . . . . 51.41 111.135 173.435 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.51 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 8.1 mmm180 -76.73 138.84 66.28 Favored Pre-proline 0 C--O 1.211 -0.943 0 N-CA-C 106.826 -1.546 . . . . 70.5 106.826 178.532 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.08 150.41 86.66 Favored 'Trans proline' 0 C--O 1.246 0.879 0 C-N-CA 122.387 2.058 . . . . 75.12 112.074 -177.651 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.67 107.9 0.76 Allowed 'General case' 0 C--O 1.239 0.534 0 CA-C-N 116.21 -0.45 . . . . 45.03 110.439 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 133.51 -17.77 4.44 Favored Glycine 0 C--N 1.298 -1.562 0 N-CA-C 110.602 -0.999 . . . . 73.32 110.602 -177.612 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -75.58 124.73 27.7 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.272 -1.011 . . . . 73.25 108.272 177.292 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 47.1 t -82.92 115.61 25.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 106.711 -1.588 . . . . 62.12 106.711 175.172 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . 0.424 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 10.6 t -83.48 -20.44 33.99 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.055 0.455 . . . . 62.22 110.5 -175.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 166.12 -159.37 32.62 Favored Glycine 0 N--CA 1.428 -1.849 0 C-N-CA 120.638 -0.791 . . . . 33.11 111.169 178.573 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 21.7 p -132.77 158.74 41.66 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.668 -0.864 . . . . 74.43 108.668 178.653 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -74.84 -53.35 3.11 Favored Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 109.886 -0.412 . . . . 70.13 109.886 176.34 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.458 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 45.8 Cg_endo -70.42 140.22 39.72 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 120.906 1.071 . . . . 65.21 110.176 173.476 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 17.2 Cg_exo -68.23 142.01 53.97 Favored 'Trans proline' 0 C--O 1.247 0.938 0 C-N-CA 122.592 2.195 . . . . 45.12 112.731 -179.123 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -65.76 135.58 55.09 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.746 -0.661 . . . . 72.32 109.683 178.605 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 103.67 -14.34 53.52 Favored Glycine 0 C--N 1.304 -1.199 0 C-N-CA 120.78 -0.724 . . . . 64.31 112.31 -179.853 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 27.6 m -67.2 129.77 40.98 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 110.349 -0.241 . . . . 72.23 110.349 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 56.7 m -92.11 122.69 34.84 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 108.223 -1.029 . . . . 71.32 108.223 177.265 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 26.0 m -132.4 164.72 41.43 Favored Pre-proline 0 C--N 1.307 -1.271 0 N-CA-C 109.404 -0.591 . . . . 74.54 109.404 -176.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -62.61 150.86 86.36 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.194 1.929 . . . . 72.01 110.18 174.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 27.4 m -64.21 -20.53 27.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 112.661 0.615 . . . . 72.12 112.661 -177.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -83.14 3.43 30.81 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 123.841 0.856 . . . . 51.44 111.805 178.764 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 11.7 t -80.46 158.67 25.84 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.111 0.482 . . . . 61.3 111.041 -176.481 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 70.0 t -101.37 135.12 39.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.842 -0.617 . . . . 51.42 110.19 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . 0.428 ' N ' HD12 ' A' ' 551' ' ' ILE . 2.6 mp -97.15 126.13 50.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 107.462 -1.31 . . . . 52.24 107.462 176.282 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 521' ' ' SER . 36.6 tt0 -103.53 116.29 32.1 Favored 'General case' 0 N--CA 1.428 -1.56 0 C-N-CA 120.602 -0.439 . . . . 72.24 109.978 -179.237 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 4.6 mp -101.5 134.48 44.53 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.154 -0.93 . . . . 74.32 109.032 -178.652 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -110.01 114.14 27.42 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 122.11 0.957 . . . . 60.52 109.553 177.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 48.6 t -103.0 141.44 18.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-N 114.342 -1.299 . . . . 72.22 109.087 -174.464 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 67.9 m -96.65 147.6 23.73 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.205 0.526 . . . . 64.14 112.212 -179.161 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.608 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 15.1 ptpt -96.78 150.72 20.38 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 105.282 -2.118 . . . . 72.34 105.282 170.692 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -73.39 -37.55 53.76 Favored Glycine 0 CA--C 1.485 -1.842 0 N-CA-C 110.931 -0.868 . . . . 34.22 110.931 -178.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 63.2 t30 69.79 -0.86 2.52 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 122.54 1.162 . . . . 73.13 110.609 175.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 77.9 mt-30 -142.57 144.42 32.88 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 106.509 -1.663 . . . . 75.42 106.509 179.565 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -123.71 140.94 52.49 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 120.75 -0.38 . . . . 73.32 110.402 179.33 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.99 123.16 11.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.575 0.702 . . . . 31.03 112.037 -178.122 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 59.6 ttp -97.28 134.66 22.45 Favored Pre-proline 0 C--N 1.305 -1.352 0 CA-C-N 115.43 -0.805 . . . . 70.34 109.874 178.463 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.15 169.62 13.34 Favored 'Trans proline' 0 C--O 1.244 0.821 0 C-N-CA 122.805 2.336 . . . . 72.22 111.197 175.496 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . 0.537 ' HA ' ' HB1' ' A' ' 610' ' ' ALA . 28.1 t70 -66.83 114.69 5.88 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.401 0.62 . . . . 71.31 112.085 -178.274 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 93.2 mt -133.87 10.0 3.91 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.208 -1.034 . . . . 72.43 108.208 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 14.6 m -79.17 134.08 36.7 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.935 -1.03 . . . . 63.42 110.575 -175.238 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 77.19 33.98 42.91 Favored Glycine 0 C--O 1.221 -0.66 0 C-N-CA 120.724 -0.751 . . . . 71.54 111.94 -179.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . 0.544 ' SD ' ' HD3' ' A' ' 577' ' ' ARG . 36.0 ttp -100.27 146.37 26.99 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.814 -0.439 . . . . 73.43 109.814 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 93.4 m-85 -76.59 147.87 37.36 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.279 -1.008 . . . . 63.15 108.279 178.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . 0.497 ' HA ' ' HB3' ' A' ' 574' ' ' ALA . 72.4 t-105 -59.67 -22.84 62.5 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 112.057 0.392 . . . . 75.34 112.057 -178.231 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 29.5 m -70.52 -23.14 24.14 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.438 0 CA-C-N 115.951 -0.568 . . . . 64.34 111.335 -178.582 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -101.06 -33.37 10.18 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.939 -0.763 . . . . 74.14 108.939 175.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . 0.497 ' HB3' ' HA ' ' A' ' 571' ' ' TRP . . . -58.23 -53.48 57.8 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.469 0.914 . . . . 62.33 113.469 -176.03 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.449 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 34.7 tt0 -58.5 -51.9 78.49 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 120.51 -0.476 . . . . 71.5 112.021 -178.253 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . 0.449 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 51.2 Cg_exo -57.8 -40.76 76.26 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 121.918 1.745 . . . . 52.51 112.789 176.58 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.544 ' HD3' ' SD ' ' A' ' 569' ' ' MET . 80.9 mtp180 -69.09 -33.94 74.32 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 120.326 -0.55 . . . . 72.21 112.139 -179.249 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 92.8 mt -65.36 -47.55 76.04 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.008 0.433 . . . . 72.53 110.454 178.706 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -65.31 -34.81 79.22 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.964 -0.562 . . . . 74.34 111.176 177.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -65.4 -32.43 74.05 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.924 0.393 . . . . 41.24 111.093 178.417 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 577' ' ' ARG . 4.1 mm? -81.46 -5.2 57.69 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.251 -0.431 . . . . 73.41 111.179 177.42 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 72.78 31.71 62.12 Favored Glycine 0 N--CA 1.431 -1.649 0 C-N-CA 121.018 -0.61 . . . . 63.24 111.6 -179.783 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 78.6 t90 -65.1 139.05 58.67 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.678 0.275 . . . . 73.51 110.286 177.093 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 29.2 m -151.62 103.03 2.92 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.361 -0.607 . . . . 75.04 109.361 175.357 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -161.39 -138.26 2.38 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 109.497 -1.441 . . . . 22.15 109.497 177.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 16.4 mmt -117.71 132.09 56.53 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.214 0.53 . . . . 25.34 110.766 175.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 24.8 tp -98.91 118.18 35.09 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 106.347 -1.723 . . . . 55.11 106.347 178.375 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -120.35 100.45 7.17 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 118.112 -1.435 . . . . 52.32 111.962 178.447 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . 0.419 ' O ' ' HD2' ' A' ' 589' ' ' LYS . 0.1 OUTLIER -113.79 133.8 55.16 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.143 -1.389 . . . . 63.31 108.391 171.476 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -73.2 -102.33 0.07 OUTLIER Glycine 0 C--N 1.301 -1.361 0 C-N-CA 120.745 -0.741 . . . . 64.31 113.842 -176.31 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -91.81 135.8 33.64 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 120.591 0.234 . . . . 73.03 111.489 -177.612 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -89.3 125.97 35.33 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 106.915 -1.513 . . . . 41.04 106.915 177.995 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 78.4 t -124.67 115.63 45.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 110.158 -0.312 . . . . 70.03 110.158 -175.127 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -74.49 113.42 11.71 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.683 -0.858 . . . . 74.14 108.683 177.06 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -125.32 -28.98 3.3 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 115.648 -0.705 . . . . 75.42 110.373 177.593 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 107.74 147.97 13.78 Favored Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 110.015 -1.234 . . . . 74.23 110.015 -176.351 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -62.5 -33.57 86.83 Favored Glycine 0 C--N 1.32 -0.348 0 CA-C-N 116.915 0.357 . . . . 42.12 112.776 -177.602 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 27.4 m -65.89 -23.97 66.75 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-O 121.144 0.497 . . . . 75.14 111.206 178.333 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -87.11 0.47 55.22 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.54 0.736 . . . . 63.34 110.765 -179.573 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . 0.4 10.3 p-80 69.65 92.0 0.09 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 126.545 1.938 . . . . 75.44 116.123 176.671 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -90.66 69.35 6.66 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 123.033 1.397 . . . . 54.12 107.999 171.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . 0.441 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 37.2 ptt85 -106.82 162.44 13.8 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.227 -1.351 . . . . 72.14 110.178 -176.574 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . 0.413 HG13 ' HB2' ' A' ' 622' ' ' LEU . 75.9 t -68.98 130.86 34.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 106.133 -1.803 . . . . 62.33 106.133 172.72 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 28.3 m -107.48 -31.18 2.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 119.494 -0.882 . . . . 54.31 111.937 -176.332 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -145.05 157.13 44.21 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 106.942 -1.503 . . . . 73.04 106.942 176.058 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . 0.416 ' HB2' HD11 ' A' ' 620' ' ' ILE . 10.7 pt20 -148.98 160.2 43.52 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 106.872 -1.529 . . . . 65.43 106.872 -179.321 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.527 ' HB2' ' HD3' ' A' ' 608' ' ' PRO . 88.6 m-20 -68.56 -57.85 7.85 Favored Pre-proline 0 C--N 1.315 -0.893 0 C-N-CA 120.185 -0.606 . . . . 72.33 112.022 -179.492 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.527 ' HD3' ' HB2' ' A' ' 607' ' ' ASN . 10.1 Cg_endo -99.07 127.02 0.17 Allowed 'Trans proline' 0 N--CA 1.44 -1.674 0 C-N-CA 122.123 1.882 . . . . 53.14 112.245 178.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.45 158.67 54.21 Favored 'Trans proline' 0 C--O 1.246 0.891 0 C-N-CA 121.927 1.751 . . . . 64.11 111.432 176.545 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . 0.537 ' HB1' ' HA ' ' A' ' 565' ' ' ASP . . . -68.02 137.39 55.03 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.776 -0.824 . . . . 74.34 108.776 177.337 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 90.04 -0.05 78.35 Favored Glycine 0 C--N 1.309 -0.932 0 C-N-CA 120.337 -0.935 . . . . 62.43 111.144 -177.469 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 27.6 m -111.48 159.62 17.91 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 107.514 -1.291 . . . . 73.35 107.514 177.5 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -77.92 133.62 13.26 Favored Glycine 0 N--CA 1.427 -1.944 0 N-CA-C 111.743 -0.543 . . . . 50.23 111.743 177.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 21.6 m -96.72 141.18 15.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 109.032 -0.729 . . . . 75.25 109.032 177.336 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.499 HD21 HG22 ' A' ' 619' ' ' ILE . 6.5 p-10 -55.77 148.85 15.68 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.91 0.884 . . . . 71.53 110.358 179.86 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -52.63 -30.68 32.84 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 112.962 0.727 . . . . 74.03 112.962 -174.143 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . 0.574 ' OD2' ' HB ' ' A' ' 619' ' ' ILE . 32.7 t70 -79.78 -31.42 40.82 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.951 0.405 . . . . 75.12 110.739 -178.535 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 77.74 20.71 73.35 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.902 -0.666 . . . . 54.51 112.789 179.013 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . 0.574 ' HB ' ' OD2' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -68.3 121.01 16.69 Favored 'Isoleucine or valine' 0 C--O 1.246 0.872 0 CA-C-O 122.536 1.16 . . . . 72.3 109.209 -173.796 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.416 HD11 ' HB2' ' A' ' 606' ' ' GLN . 6.3 tp -115.08 120.09 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.093 0 CA-C-N 113.957 -1.474 . . . . 75.33 112.379 -171.763 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 14.5 m -99.4 117.25 33.4 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 105.565 -2.013 . . . . 73.55 105.565 170.834 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . 0.43 HD23 ' H ' ' A' ' 622' ' ' LEU . 2.2 pt? -140.09 162.69 34.63 Favored 'General case' 0 CA--C 1.483 -1.631 0 N-CA-C 108.987 -0.746 . . . . 73.0 108.987 -175.429 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -134.79 137.23 43.19 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 107.442 -1.318 . . . . 75.41 107.442 172.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -142.02 166.06 25.74 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 105.281 -2.118 . . . . 75.44 105.281 173.389 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -66.4 -86.74 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.426 -1.07 . . . . 45.43 110.426 175.616 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 . . . . . 0 C--N 1.299 -1.624 0 N-CA-C 105.95 -1.87 . . . . 74.52 105.95 175.763 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.986 0 N-CA-C 109.968 -1.253 . . . . 61.51 109.968 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 10.3 tp -75.77 131.96 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 CA-C-N 117.566 0.683 . . . . 70.11 109.77 177.075 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.4 -175.15 4.99 Favored 'General case' 0 N--CA 1.409 -2.51 0 C-N-CA 124.282 1.033 . . . . 74.42 112.288 -177.642 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -72.6 20.23 0.07 Allowed 'General case' 0 C--O 1.242 0.66 0 C-N-CA 124.496 1.119 . . . . 74.32 113.521 -177.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -74.74 127.55 33.41 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.241 -1.022 . . . . 74.53 108.241 176.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.9 m -134.52 163.27 37.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.494 -0.928 . . . . 63.51 108.494 178.027 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -94.23 140.59 29.58 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 106.455 -1.683 . . . . 70.34 106.455 175.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.517 HG22 ' CZ ' ' A' ' 382' ' ' PHE . 75.7 t -93.92 134.48 26.07 Favored Pre-proline 0 C--N 1.277 -2.565 0 N-CA-C 107.559 -1.274 . . . . 73.5 107.559 -174.719 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.84 149.48 66.46 Favored 'Trans proline' 0 C--O 1.253 1.259 0 C-N-CA 123.042 2.495 . . . . 63.15 113.308 -171.279 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -87.24 75.15 9.39 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 115.076 -0.966 . . . . 35.11 111.258 -177.409 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 27.7 m -91.54 -5.25 10.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 122.917 1.341 . . . . 72.03 108.005 173.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -66.39 146.43 54.57 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 112.329 -2.214 . . . . 72.21 108.21 177.05 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . 0.508 ' H ' HG23 ' A' ' 399' ' ' VAL . . . 104.53 1.23 43.51 Favored Glycine 0 C--N 1.304 -1.237 0 C-N-CA 119.475 -1.345 . . . . 41.33 114.042 178.674 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -110.29 -77.39 0.59 Allowed 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.094 -0.706 . . . . 73.44 109.094 -177.65 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 78.7 p -149.78 153.13 36.34 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 106.767 -1.568 . . . . 65.32 106.767 178.248 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.409 ' O ' ' HB ' ' A' ' 374' ' ' ILE . 22.6 t -62.64 -33.72 75.61 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.964 -0.754 . . . . 63.41 108.964 177.278 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -68.69 -47.83 65.43 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 112.53 0.567 . . . . 51.43 112.53 -178.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -69.69 -45.27 68.66 Favored 'General case' 0 CA--C 1.503 -0.859 0 C-N-CA 119.482 -0.887 . . . . 75.01 110.631 -178.097 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . 0.467 ' O ' ' HG ' ' A' ' 377' ' ' LEU . . . -61.17 -50.57 72.61 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.407 -0.815 . . . . 73.22 110.96 -178.361 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.409 ' HB ' ' O ' ' A' ' 370' ' ' SER . 1.7 mp -69.28 -38.97 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 120.727 -0.389 . . . . 73.12 111.778 -177.862 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.71 -44.02 93.88 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.226 0.536 . . . . 64.1 110.884 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . 0.406 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 21.0 m -66.52 -47.1 74.03 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.572 -0.74 . . . . 73.34 110.104 -179.171 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 373' ' ' ALA . 94.0 mt -61.49 -42.45 98.8 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.271 -0.422 . . . . 74.44 110.629 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -61.21 -42.46 98.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.129 -0.487 . . . . 75.32 111.157 -179.532 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -67.57 -24.52 65.52 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 112.072 0.397 . . . . 75.24 112.072 179.31 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 376' ' ' THR . 37.8 mmt180 -81.42 -13.76 57.88 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.106 0.479 . . . . 73.42 110.123 176.518 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.67 7.43 51.06 Favored Glycine 0 N--CA 1.437 -1.297 0 CA-C-N 115.701 -0.681 . . . . 74.53 112.337 178.381 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.517 ' CZ ' HG22 ' A' ' 362' ' ' VAL . 57.4 m-85 -74.36 148.72 41.03 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-O 121.431 0.634 . . . . 74.42 110.322 178.159 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.653 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 47.0 mmtm -98.61 146.24 26.02 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 106.548 -1.649 . . . . 72.4 106.548 178.293 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.71 150.68 27.16 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.302 0 C-N-CA 119.735 -0.786 . . . . 73.45 110.095 -179.14 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -117.06 146.15 43.28 Favored 'General case' 0 N--CA 1.404 -2.769 0 N-CA-C 106.372 -1.714 . . . . 73.44 106.372 171.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 89.0 m -135.02 117.85 16.18 Favored 'General case' 0 C--N 1.256 -3.496 0 N-CA-C 106.371 -1.714 . . . . 73.24 106.371 -179.342 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 20.8 tp -117.83 130.89 56.54 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 108.967 -0.753 . . . . 65.52 108.967 -176.107 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -91.12 131.0 36.96 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-O 121.099 0.476 . . . . 74.41 110.311 -178.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 421' ' ' SER . 76.0 mmtt -125.85 143.31 44.86 Favored Pre-proline 0 C--N 1.297 -1.69 0 N-CA-C 107.396 -1.335 . . . . 75.21 107.396 177.643 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.419 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 13.7 Cg_endo -98.14 127.25 0.22 Allowed 'Trans proline' 0 N--CA 1.449 -1.137 0 N-CA-C 108.867 -1.243 . . . . 74.51 108.867 166.563 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 6.7 t70 168.09 -170.04 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.286 -1.375 . . . . 74.15 107.286 -174.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 31.7 t -136.74 -11.36 1.79 Allowed 'General case' 0 N--CA 1.428 -1.573 0 C-N-CA 123.22 0.608 . . . . 71.24 110.376 178.136 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 14.6 t -71.42 -28.85 64.28 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 108.089 -1.078 . . . . 74.23 108.089 176.604 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.467 HD13 ' H ' ' A' ' 394' ' ' ILE . 0.2 OUTLIER -110.1 129.97 23.36 Favored Pre-proline 0 N--CA 1.41 -2.426 0 N-CA-C 104.278 -2.49 . . . . 74.54 104.278 167.051 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -92.91 -175.49 0.54 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.698 2.265 . . . . 73.24 113.798 -172.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -53.16 167.25 0.78 Allowed 'Trans proline' 0 C--N 1.365 1.419 0 C-N-CA 124.25 3.3 . . . . 74.02 111.351 169.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -53.08 -6.22 0.06 Allowed 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 126.427 1.891 . . . . 73.24 113.667 -170.573 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 27.9 m170 -77.21 93.1 3.9 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 105.453 -2.055 . . . . 75.33 105.453 170.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.508 HG23 ' H ' ' A' ' 367' ' ' GLY . 16.6 m -67.54 119.57 13.41 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 113.546 -1.661 . . . . 62.14 112.534 -166.911 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.88 -35.81 8.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 108.763 -0.828 . . . . 71.34 108.763 178.756 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.84 163.53 28.58 Favored Glycine 0 N--CA 1.414 -2.77 0 CA-C-N 115.513 -0.767 . . . . 34.03 111.198 -177.391 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.3 p -150.06 -176.4 5.43 Favored 'General case' 0 C--N 1.288 -2.109 0 C-N-CA 126.207 1.803 . . . . 52.5 107.558 -178.358 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . 0.433 ' HA ' ' HD3' ' A' ' 404' ' ' PRO . 17.3 t70 -98.88 139.72 21.25 Favored Pre-proline 0 C--N 1.3 -1.563 0 C-N-CA 120.157 -0.617 . . . . 64.21 109.476 -174.16 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 403' ' ' ASP . 50.3 Cg_exo -57.86 1.61 0.21 Allowed 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 124.93 3.753 . . . . 64.31 115.624 -179.569 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.08 -33.82 63.09 Favored 'General case' 0 C--O 1.213 -0.854 0 CA-C-O 120.968 0.413 . . . . 63.23 110.084 175.56 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -70.49 -30.84 67.73 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-N 115.515 -0.766 . . . . 44.52 111.06 178.455 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -87.74 -5.02 58.86 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.841 0.829 . . . . 72.32 109.286 -178.271 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 31.0 m -91.8 149.13 21.75 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 105.821 -1.918 . . . . 63.44 105.821 175.159 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 12.6 p -78.73 112.25 15.66 Favored 'General case' 0 N--CA 1.418 -2.049 0 C-N-CA 119.23 -0.988 . . . . 64.34 109.624 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 35.2 m -119.57 159.92 20.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 115.971 -0.559 . . . . 73.54 109.714 178.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 56.0 m -67.0 134.86 52.79 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.347 -0.612 . . . . 74.2 109.347 178.102 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -53.71 114.5 1.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.125 0.57 . . . . 74.2 111.62 -178.046 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 112.42 14.05 11.07 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.663 -0.698 . . . . 55.33 112.042 -178.706 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -75.27 -174.56 2.4 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 109.907 -0.405 . . . . 73.11 109.907 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . 0.653 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 9.7 pt-20 -119.38 130.93 55.57 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 113.275 0.843 . . . . 75.22 113.275 -171.101 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.4 mm -116.89 127.49 74.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.916 -0.584 . . . . 64.21 110.551 -179.314 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 35.3 m -93.06 130.72 38.57 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 120.733 0.302 . . . . 52.53 111.307 178.663 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 5.2 p -120.41 135.35 60.94 Favored 'Isoleucine or valine' 0 C--O 1.248 0.994 0 N-CA-C 109.565 -0.532 . . . . 62.55 109.565 178.003 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -100.39 124.83 46.39 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.121 -0.696 . . . . 70.05 109.121 177.137 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 70.8 t -118.54 131.79 70.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 107.717 -1.216 . . . . 71.52 107.717 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . 0.568 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 32.6 t -101.74 120.89 41.08 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 117.635 -1.626 . . . . 62.41 110.497 179.777 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 4.1 t -121.67 107.29 12.19 Favored 'General case' 0 N--CA 1.403 -2.781 0 CA-C-N 114.492 -1.231 . . . . 75.44 108.624 171.677 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 120.58 106.44 2.07 Favored Glycine 0 N--CA 1.426 -2.004 0 C-N-CA 119.695 -1.241 . . . . 63.21 112.274 179.532 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -70.22 157.94 57.91 Favored 'Trans proline' 0 C--O 1.247 0.965 0 C-N-CA 122.996 2.464 . . . . 74.02 110.613 174.712 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -72.15 167.43 20.3 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.883 0.849 . . . . 73.34 112.565 -174.377 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -87.13 158.08 19.24 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 106.891 -1.522 . . . . 71.05 106.891 178.147 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.529 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 5.0 mmp_? -121.49 151.96 39.69 Favored 'General case' 0 CA--C 1.485 -1.534 0 CA-C-O 121.594 0.711 . . . . 53.35 111.527 -177.241 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.85 140.42 32.92 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 114.355 -1.293 . . . . 75.42 108.109 -176.218 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.47 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 78.2 mt -78.86 113.43 35.28 Favored Pre-proline 0 C--N 1.299 -1.588 0 N-CA-C 108.215 -1.031 . . . . 64.43 108.215 -179.641 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.77 141.06 40.24 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 121.849 1.7 . . . . 63.22 110.936 178.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -92.0 127.09 37.33 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.935 -1.135 . . . . 70.32 107.935 176.315 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 90.6 t -121.73 150.03 24.99 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 N-CA-C 108.104 -1.072 . . . . 73.23 108.104 -176.054 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.512 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 19.4 m -55.3 144.84 23.56 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 123.818 0.699 . . . . 34.31 110.579 -179.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . 0.481 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 41.8 p -69.16 -25.77 64.53 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 113.341 0.867 . . . . 62.41 113.341 -169.386 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.435 ' H ' HD23 ' A' ' 435' ' ' LEU . 0.6 OUTLIER -90.16 -12.07 39.28 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 116.05 -0.523 . . . . 71.23 110.744 178.084 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.512 ' OG1' ' HB2' ' A' ' 433' ' ' SER . 2.6 m -98.06 43.42 1.06 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.956 0.884 . . . . 74.13 109.176 -176.691 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -53.48 -38.93 64.12 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.351 1.061 . . . . 74.13 112.954 179.736 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -62.07 -40.51 96.04 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 121.537 0.684 . . . . 65.11 109.992 179.543 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.499 ' HB3' HG22 ' A' ' 436' ' ' THR . 40.9 tt0 -71.47 -34.06 69.87 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.862 -0.608 . . . . 64.41 111.199 177.154 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.477 ' O ' ' HG ' ' A' ' 444' ' ' LEU . . . -59.35 -47.02 87.0 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.389 0.137 . . . . 71.14 110.833 -178.726 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 21.5 m -65.53 -36.98 78.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-O 121.337 0.589 . . . . 71.13 110.189 177.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -60.23 -47.25 86.79 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.803 0.841 . . . . 73.44 110.952 176.295 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -64.17 -38.79 92.33 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 123.663 0.785 . . . . 71.05 111.6 179.726 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 93.8 mt -63.93 -34.7 78.55 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.0 0.428 . . . . 60.42 109.988 175.619 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.451 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 43.8 m -70.16 -42.76 72.09 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.884 -0.598 . . . . 65.11 110.625 178.618 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.49 -23.09 65.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.364 0.602 . . . . 74.01 111.064 179.123 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.95 5.21 22.74 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.016 -0.538 . . . . 53.01 111.495 178.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 108.61 -84.15 0.36 Allowed Glycine 0 N--CA 1.435 -1.42 0 C-N-CA 120.429 -0.891 . . . . 61.34 112.072 175.552 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -37.08 -57.3 0.86 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.133 1.16 . . . . 73.11 114.133 179.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . 0.451 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 56.15 30.89 58.49 Favored Glycine 0 CA--C 1.505 -0.559 0 O-C-N 123.362 0.414 . . . . 64.11 113.347 179.44 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 61.3 mmt-85 -112.73 122.86 48.91 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 108.096 -1.076 . . . . 74.42 108.096 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 18.0 p90 -144.28 152.11 40.34 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.98 -0.554 . . . . 73.4 111.448 -174.632 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -131.72 138.58 48.71 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.565 -0.902 . . . . 63.44 108.565 175.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -98.08 121.08 39.56 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.628 -0.879 . . . . 63.41 108.628 176.598 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -116.98 148.55 41.34 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 107.881 -1.155 . . . . 72.33 107.881 178.011 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 -113.86 146.19 40.37 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 108.481 -0.933 . . . . 74.22 108.481 -176.477 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 26.9 t -143.92 134.46 12.17 Favored Pre-proline 0 C--N 1.294 -1.813 0 N-CA-C 108.645 -0.872 . . . . 72.0 108.645 175.296 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.64 ' HA ' ' O ' ' A' ' 490' ' ' SER . 68.1 Cg_endo -76.78 124.13 7.3 Favored 'Trans proline' 0 N--CA 1.439 -1.691 0 C-N-CA 121.898 1.732 . . . . 74.4 111.134 178.253 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 69.6 m -151.17 179.87 7.92 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.779 -0.646 . . . . 70.31 109.416 -178.738 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.9 t -46.77 139.22 6.67 Favored Pre-proline 0 C--O 1.25 1.114 0 C-N-CA 125.061 1.344 . . . . 72.23 112.684 178.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . 0.415 ' HA ' ' CG2' ' A' ' 464' ' ' VAL . 10.2 Cg_endo -51.61 -29.55 33.08 Favored 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 124.609 3.54 . . . . 63.43 113.567 -177.734 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -66.95 -24.51 66.07 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 120.959 0.409 . . . . 41.34 111.582 -178.603 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 91.1 mt -99.27 -13.47 19.66 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 120.707 0.289 . . . . 51.43 111.289 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.415 ' CG2' ' HA ' ' A' ' 461' ' ' PRO . 88.8 t -60.73 127.61 20.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.154 -0.475 . . . . 44.04 110.481 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 92.57 -11.7 71.5 Favored Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 116.083 -0.508 . . . . 73.54 112.175 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.97 159.42 16.56 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 107.577 -1.268 . . . . 74.11 107.577 179.37 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 76.1 t -75.45 146.97 8.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 106.998 -1.482 . . . . 71.42 106.998 173.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 61.3 mt -97.53 -29.82 3.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 107.557 -1.275 . . . . 64.31 107.557 177.33 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 158.8 -160.65 31.27 Favored Glycine 0 N--CA 1.423 -2.178 0 N-CA-C 111.014 -0.834 . . . . 43.14 111.014 176.163 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . 0.562 HG22 HG12 ' A' ' 486' ' ' ILE . 52.8 p -115.04 140.88 48.69 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 105.016 -2.216 . . . . 35.32 105.016 177.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -65.11 -54.6 32.42 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 119.135 -1.026 . . . . 73.34 110.03 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.84 135.03 29.24 Favored 'Trans proline' 0 C--N 1.368 1.594 0 N-CA-C 108.42 -1.416 . . . . 72.22 108.42 170.756 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.513 ' C ' ' H ' ' A' ' 475' ' ' ASN . 35.5 Cg_exo -62.3 141.82 88.97 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 122.177 1.918 . . . . 64.34 112.482 -177.054 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.47 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -75.16 22.86 0.11 Allowed 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 122.441 1.115 . . . . 72.35 110.792 178.812 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . 0.513 ' H ' ' C ' ' A' ' 473' ' ' PRO . 10.2 m120 -109.36 -17.65 13.75 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 114.293 -1.321 . . . . 61.33 108.25 179.342 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -95.78 165.6 12.22 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 113.226 0.824 . . . . 63.23 113.226 -172.603 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.7 113.46 26.97 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 113.944 -1.48 . . . . 71.31 108.203 -179.735 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 18.5 p -102.67 145.55 29.51 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 110.132 -0.321 . . . . 70.34 110.132 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -71.73 164.36 26.1 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.284 -0.416 . . . . 63.01 110.519 179.234 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 37.6 mm -74.78 -8.67 11.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 122.122 0.963 . . . . 50.31 110.745 -174.564 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.0 t -100.1 5.16 44.92 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.844 -0.616 . . . . 75.15 110.53 177.4 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -87.12 147.45 25.64 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 112.628 0.603 . . . . 44.15 112.628 -176.198 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 44.2 t -107.38 117.49 53.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 108.737 -0.838 . . . . 75.33 108.737 177.606 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 58.8 t -89.55 120.08 37.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-O 121.289 0.566 . . . . 63.24 109.772 -179.119 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.93 123.76 46.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 121.491 0.662 . . . . 73.3 110.006 179.104 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.562 HG12 HG22 ' A' ' 470' ' ' THR . 14.1 mt -113.59 128.28 70.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 114.766 -1.106 . . . . 72.1 110.547 -178.072 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 5.1 tt -103.89 126.41 58.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 115.386 -0.825 . . . . 64.22 110.816 -175.481 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 33.5 m -110.1 151.35 12.35 Favored 'Isoleucine or valine' 0 C--O 1.251 1.152 0 CA-C-N 115.824 -0.625 . . . . 73.41 109.714 178.658 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.78 132.19 10.92 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 120.65 -0.786 . . . . 71.12 112.156 -179.268 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.64 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 49.0 m -126.32 156.93 39.65 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.267 -1.383 . . . . 54.34 107.267 176.392 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -144.64 129.56 3.6 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 118.976 -1.583 . . . . 70.0 113.275 -176.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -75.61 166.57 28.21 Favored 'Trans proline' 0 C--O 1.244 0.778 0 C-N-CA 122.839 2.36 . . . . 74.53 110.822 176.562 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -81.89 55.47 2.76 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.931 0.872 . . . . 73.33 110.963 -178.215 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 58.0 p -120.23 142.93 48.58 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.29 -1.004 . . . . 70.45 108.29 -179.066 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -130.48 152.78 49.5 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.798 0.332 . . . . 74.05 110.872 -179.873 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -83.88 115.9 22.5 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 124.007 0.923 . . . . 75.4 109.905 -176.485 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 543' ' ' THR . 38.0 pt -83.82 130.09 56.69 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 116.396 -0.365 . . . . 75.22 111.156 -178.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -83.26 -169.27 0.69 Allowed 'Trans proline' 0 C--O 1.239 0.534 0 C-N-CA 122.969 2.446 . . . . 65.52 112.165 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -78.49 138.59 38.51 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.804 -0.813 . . . . 72.44 108.804 177.301 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 14.7 p -126.92 -15.0 3.49 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-O 121.448 0.642 . . . . 74.14 110.737 -177.338 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -66.73 112.18 4.08 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.082 -0.71 . . . . 51.42 109.082 178.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 136.81 -25.54 3.07 Favored Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.901 -0.666 . . . . 62.35 111.715 -178.374 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -103.01 172.33 6.88 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 122.47 -0.429 . . . . 54.25 111.068 178.336 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 21.8 p -89.77 160.97 16.26 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 116.495 -0.32 . . . . 74.5 111.069 -176.654 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 532' ' ' GLY . 25.0 t -54.1 -42.08 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 123.645 0.59 . . . . 54.05 111.403 -177.13 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.67 -42.13 95.6 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.075 -0.511 . . . . 55.54 112.007 -178.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 67.2 t -71.35 -41.76 73.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 109.657 -0.498 . . . . 73.24 109.657 179.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -60.38 -49.64 76.78 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.254 -0.885 . . . . 72.34 111.645 -179.393 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -64.96 -35.66 81.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.712 0.292 . . . . 70.33 110.691 -178.387 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.478 ' O ' HG23 ' A' ' 514' ' ' VAL . 4.6 tppp? -64.84 -47.13 79.07 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.846 -0.615 . . . . 73.34 109.364 179.192 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -63.38 -48.15 79.12 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.882 -0.599 . . . . 73.12 111.952 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -61.77 -39.75 92.74 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 116.658 -0.246 . . . . 75.25 111.467 178.8 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.79 -37.79 85.65 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 120.682 0.277 . . . . 72.3 111.011 177.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 510' ' ' LYS . 73.3 t -62.34 -37.14 77.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.011 -0.541 . . . . 74.44 110.416 176.885 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -71.91 -23.57 61.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.906 0.384 . . . . 74.41 111.553 178.357 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 124.59 -12.69 7.84 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 120.394 -0.908 . . . . 74.33 112.317 178.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.46 ' HA ' ' O ' ' A' ' 547' ' ' VAL . 90.5 m-85 -80.44 101.17 8.88 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 107.591 -1.263 . . . . 74.2 107.591 -177.349 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.87 -8.89 27.33 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 120.058 -0.657 . . . . 73.21 112.413 -171.736 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . 0.501 ' O ' HD13 ' A' ' 551' ' ' ILE . 63.6 mttp -108.21 114.59 28.59 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.037 -0.665 . . . . 60.42 109.984 -178.037 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -131.01 140.34 50.11 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 116.01 -0.541 . . . . 73.23 111.218 -177.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 552' ' ' GLU . 33.0 m -128.43 142.29 51.14 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.277 -1.379 . . . . 71.54 107.277 175.866 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.94 141.04 48.88 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.043 0.449 . . . . 63.13 111.091 179.778 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -135.43 128.51 31.65 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.894 -1.15 . . . . 45.23 107.894 178.045 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 70.2 m -93.74 134.07 36.46 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.096 0.475 . . . . 70.1 111.818 -177.463 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 557' ' ' LYS . 35.2 m -121.98 150.11 25.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 107.972 -1.121 . . . . 72.32 107.972 177.795 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . 0.414 ' HB2' HD21 ' A' ' 559' ' ' ASN . 4.8 p-10 -66.75 136.74 55.93 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.525 -0.47 . . . . 63.55 110.547 -179.226 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 20.2 m -149.93 169.1 9.71 Favored Pre-proline 0 C--N 1.307 -1.278 0 CA-C-N 116.049 -0.523 . . . . 42.35 109.985 -177.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -84.41 -25.46 2.08 Favored 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 121.892 1.728 . . . . 54.1 111.5 173.508 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.427 ' HD3' ' OE2' ' A' ' 533' ' ' GLU . 15.2 ptp180 -81.06 150.03 67.67 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 109.7 -0.481 . . . . 74.24 109.7 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.78 149.0 62.68 Favored 'Trans proline' 0 C--O 1.26 1.601 0 C-N-CA 123.82 3.014 . . . . 72.43 115.909 -175.206 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.666 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -62.87 121.2 12.91 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 113.914 -1.494 . . . . 74.11 110.701 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . 0.456 ' O ' HG23 ' A' ' 505' ' ' VAL . . . 130.69 -23.46 4.47 Favored Glycine 0 C--N 1.303 -1.25 0 C-N-CA 120.763 -0.732 . . . . 72.52 111.462 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . 0.427 ' OE2' ' HD3' ' A' ' 529' ' ' ARG . 29.2 tt0 -83.48 144.29 29.65 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.422 -0.584 . . . . 75.14 109.422 177.614 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 67.0 t -89.54 125.75 42.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 109.275 -0.639 . . . . 73.21 109.275 179.395 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . 0.586 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 14.4 t -100.84 -10.57 20.58 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-O 120.66 0.267 . . . . 52.41 111.611 -178.261 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 171.46 -175.41 44.98 Favored Glycine 0 CA--C 1.498 -0.984 0 C-N-CA 119.912 -1.137 . . . . 63.12 111.411 179.156 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . 0.401 HG22 HD23 ' A' ' 553' ' ' LEU . 8.1 p -139.29 157.97 44.98 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 117.168 0.484 . . . . 75.01 111.314 179.495 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.438 ' HB3' ' HB3' ' A' ' 552' ' ' GLU . 21.2 t-20 -64.01 -54.87 36.8 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-N 115.27 -0.877 . . . . 73.45 109.72 176.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -73.53 122.59 7.98 Favored 'Trans proline' 0 C--N 1.373 1.867 0 N-CA-C 108.014 -1.571 . . . . 70.2 108.014 169.127 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.17 141.13 61.92 Favored 'Trans proline' 0 C--O 1.254 1.317 0 C-N-CA 122.01 1.807 . . . . 53.24 112.519 -176.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -58.78 134.26 56.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.498 -0.774 . . . . 41.22 109.963 -179.191 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 102.73 -5.93 51.57 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 120.544 -0.836 . . . . 54.33 111.973 -177.639 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.501 ' O ' HG12 ' A' ' 497' ' ' ILE . 79.3 m -88.94 137.74 32.04 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.852 0.326 . . . . 64.44 110.794 177.134 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 17.9 m -89.27 122.73 32.81 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.03 -1.47 . . . . 64.15 107.03 173.461 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 16.1 m -131.73 156.15 80.48 Favored Pre-proline 0 C--N 1.313 -0.981 0 CA-C-O 119.423 -0.323 . . . . 73.5 110.56 -177.278 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -59.54 139.55 89.75 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 123.043 2.495 . . . . 75.23 111.774 178.645 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 517' ' ' PHE . 27.3 m -65.41 -21.31 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 113.487 0.921 . . . . 73.34 113.487 -175.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -87.15 -11.96 48.44 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.045 0.45 . . . . 74.11 111.108 178.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 73.7 m -69.88 155.11 41.04 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.61 0.719 . . . . 71.33 112.719 -177.375 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 27.3 t -88.79 125.97 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-N 114.884 -1.053 . . . . 44.22 110.065 -176.282 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . 0.501 HD13 ' O ' ' A' ' 519' ' ' LYS . 0.2 OUTLIER -102.39 129.03 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 119.684 -0.807 . . . . 74.25 109.228 174.228 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 521' ' ' SER . 38.1 tt0 -102.73 119.27 38.54 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 108.899 -0.778 . . . . 73.24 108.899 -179.427 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . 0.401 HD23 HG22 ' A' ' 537' ' ' THR . 47.6 mt -92.19 122.88 35.09 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.117 -0.947 . . . . 65.33 109.443 -179.107 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -85.93 112.71 21.43 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.782 -1.192 . . . . 73.24 107.782 171.78 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 42.8 t -95.64 140.16 17.56 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 CA-C-N 115.207 -0.906 . . . . 63.53 109.283 -176.505 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.666 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 66.5 m -76.17 141.33 41.89 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-O 121.448 0.642 . . . . 73.22 111.533 177.45 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 525' ' ' VAL . 16.7 ttmt -114.66 119.64 37.41 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 125.613 1.565 . . . . 71.1 107.003 173.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -74.74 -24.31 72.66 Favored Glycine 0 C--N 1.314 -0.662 0 C-N-CA 120.574 -0.822 . . . . 75.21 113.831 -174.072 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' A' ' 615' ' ' ASN . 48.5 m-80 74.53 18.14 2.92 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.069 1.348 . . . . 74.14 110.658 -178.539 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -131.89 141.19 49.3 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.566 -0.531 . . . . 71.0 109.566 -173.462 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -137.74 139.24 40.01 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 108.342 -0.984 . . . . 72.34 108.342 173.137 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 11.4 p -62.77 129.27 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 N-CA-C 113.3 0.852 . . . . 73.32 113.3 -173.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 57.2 ttp -97.56 128.94 32.88 Favored Pre-proline 0 C--O 1.254 1.328 0 CA-C-N 115.649 -0.705 . . . . 75.41 110.006 177.11 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.35 170.23 19.72 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.072 2.514 . . . . 62.22 112.048 176.224 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . 0.416 ' HB3' ' CB ' ' A' ' 610' ' ' ALA . 6.4 p-10 -86.34 122.37 30.21 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.424 0.63 . . . . 65.53 112.368 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.08 13.2 1.11 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 122.24 1.019 . . . . 71.12 109.423 174.102 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 1.8 m -72.57 153.19 41.41 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 114.588 -1.187 . . . . 62.32 111.355 -175.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 77.14 36.24 35.85 Favored Glycine 0 CA--C 1.519 0.297 0 N-CA-C 114.637 0.615 . . . . 74.14 114.637 174.667 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 25.1 ptm -129.12 174.67 9.35 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.421 -0.585 . . . . 73.4 109.421 -179.627 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 90.6 m-85 -79.63 144.34 33.88 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-O 120.881 0.372 . . . . 75.2 110.527 -174.856 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . 0.564 ' HA ' ' HB3' ' A' ' 574' ' ' ALA . 74.9 t-105 -67.76 -17.83 64.67 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.729 -0.668 . . . . 62.12 111.292 -174.574 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 30.1 m -68.24 -28.24 40.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.755 -0.657 . . . . 71.32 110.444 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . 0.596 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 26.0 m-20 -101.77 -34.21 9.53 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 115.904 -0.589 . . . . 63.33 109.966 176.33 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . 0.564 ' HB3' ' HA ' ' A' ' 571' ' ' TRP . . . -57.27 -46.8 82.74 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.942 1.09 . . . . 64.14 113.942 -175.663 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.543 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 5.9 tm-20 -59.14 -53.11 69.58 Favored Pre-proline 0 CA--C 1.566 1.566 0 N-CA-C 109.438 -0.579 . . . . 74.43 109.438 179.063 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . 0.543 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 79.6 Cg_exo -53.95 -38.06 86.18 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.329 2.019 . . . . 62.05 113.27 171.587 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.596 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 69.0 mmt-85 -58.92 -43.17 91.08 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 110.344 -0.243 . . . . 60.44 110.344 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.09 -42.31 99.58 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.959 -0.564 . . . . 63.4 109.938 -179.076 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -64.36 -41.12 96.89 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.753 -0.658 . . . . 74.14 110.554 178.178 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.18 -24.1 64.93 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.803 -0.635 . . . . 71.33 111.636 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 89.0 mt -83.82 -8.0 59.32 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.006 0.431 . . . . 61.41 110.16 176.789 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 86.02 20.74 54.8 Favored Glycine 0 N--CA 1.438 -1.23 0 C-N-CA 120.622 -0.799 . . . . 75.42 111.476 -179.244 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 86.9 t90 -88.09 127.88 35.41 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 121.077 0.465 . . . . 74.11 109.829 178.133 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 36.4 m -149.92 66.24 0.98 Allowed 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.608 -1.256 . . . . 61.21 107.608 170.777 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -103.44 -129.75 6.72 Favored Glycine 0 N--CA 1.434 -1.498 0 CA-C-N 114.627 -1.169 . . . . 53.41 110.189 179.414 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 24.5 ttt -121.03 126.8 50.82 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.49 -0.559 . . . . 63.43 109.49 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -103.58 131.14 50.97 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.16 -1.422 . . . . 74.22 107.16 177.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -94.56 108.46 20.41 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.82 -0.807 . . . . 64.11 108.82 177.321 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -89.61 113.16 24.56 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.594 -1.262 . . . . 72.45 107.594 179.509 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -83.23 -105.3 0.51 Allowed Glycine 0 N--CA 1.432 -1.595 0 C-N-CA 120.464 -0.874 . . . . 60.42 110.968 178.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.99 146.72 39.45 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.121 -1.437 . . . . 61.42 107.121 176.277 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -75.44 129.07 36.71 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.293 0.568 . . . . 63.23 109.816 -178.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 26.0 t -112.16 132.53 60.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 116.253 -0.43 . . . . 74.41 111.616 -172.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -76.13 107.21 8.2 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 106.734 -1.58 . . . . 72.3 106.734 171.291 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -111.82 -10.49 14.01 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 112.673 0.62 . . . . 74.45 112.673 -172.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 600' ' ' HIS . . . 127.16 170.67 12.91 Favored Glycine 0 CA--C 1.49 -1.516 0 N-CA-C 109.653 -1.379 . . . . 61.31 109.653 179.472 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -64.59 -50.5 58.7 Favored Glycine 0 C--N 1.316 -0.567 0 C-N-CA 119.478 -1.344 . . . . 63.34 112.531 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 10.4 p -70.44 -23.71 62.77 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 112.485 0.55 . . . . 55.13 112.485 -176.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -108.01 -0.72 21.11 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 118.709 -0.662 . . . . 73.33 112.619 -175.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . 0.482 ' HB3' ' O ' ' A' ' 596' ' ' GLY 0.289 25.1 p-80 -55.39 -74.69 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 114.675 1.361 . . . . 71.33 114.675 -169.473 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . 0.438 ' OD1' ' HB3' ' A' ' 571' ' ' TRP . 13.5 t-20 -97.13 71.14 2.41 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.247 -0.908 . . . . 75.3 108.965 -175.636 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 44.1 ttt180 -143.15 150.97 40.15 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.552 -0.749 . . . . 74.55 110.558 -173.62 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 93.0 t -66.78 132.46 32.13 Favored 'Isoleucine or valine' 0 C--O 1.246 0.921 0 N-CA-C 107.3 -1.37 . . . . 73.03 107.3 174.611 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 54.9 t -92.25 -52.96 9.32 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 N-CA-C 108.307 -0.997 . . . . 54.24 108.307 -172.408 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . 0.416 ' O ' ' HA ' ' A' ' 622' ' ' LEU . 45.1 p90 -156.08 160.39 39.92 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 107.297 -1.372 . . . . 71.02 107.297 177.422 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.54 140.18 52.29 Favored 'General case' 0 C--N 1.283 -2.296 0 O-C-N 124.364 1.04 . . . . 72.13 110.047 176.012 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.555 ' HB2' ' HB ' ' A' ' 621' ' ' THR . 25.6 t-20 -52.22 -55.27 32.92 Favored Pre-proline 0 CA--C 1.558 1.272 0 C-N-CA 124.611 1.165 . . . . 71.03 113.822 -177.721 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.554 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 9.4 Cg_endo -97.42 128.69 0.27 Allowed 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 122.176 1.918 . . . . 74.05 111.572 177.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.87 154.71 66.98 Favored 'Trans proline' 0 C--O 1.247 0.945 0 C-N-CA 121.661 1.574 . . . . 63.34 110.59 176.554 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . 0.416 ' CB ' ' HB3' ' A' ' 565' ' ' ASP . . . -53.44 130.29 35.03 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 123.184 0.594 . . . . 60.54 111.774 -178.379 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 97.79 -0.0 59.17 Favored Glycine 0 N--CA 1.432 -1.569 0 C-N-CA 119.875 -1.155 . . . . 72.41 112.379 -179.142 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 22.5 m -98.36 155.64 17.12 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.882 -1.155 . . . . 71.44 107.882 176.388 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -88.15 138.3 14.96 Favored Glycine 0 N--CA 1.412 -2.963 0 C-N-CA 120.871 -0.68 . . . . 43.51 111.956 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 18.7 m -104.09 143.59 15.6 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 C-N-CA 123.637 0.775 . . . . 63.22 109.918 176.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.635 HD21 HG22 ' A' ' 619' ' ' ILE . 1.9 p-10 -55.96 140.78 41.98 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 125.336 1.454 . . . . 75.21 111.347 178.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -50.63 -31.59 16.52 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 113.939 1.088 . . . . 75.13 113.939 -174.048 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -71.77 -23.86 61.66 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 120.829 0.347 . . . . 75.23 110.696 -177.417 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 86.09 19.52 57.25 Favored Glycine 0 N--CA 1.41 -3.079 0 C-N-CA 120.465 -0.874 . . . . 74.52 114.155 172.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . 0.635 HG22 HD21 ' A' ' 615' ' ' ASN . 0.2 OUTLIER -73.51 124.43 30.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 C-N-CA 116.823 -1.951 . . . . 73.22 108.94 176.198 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.447 ' N ' HD13 ' A' ' 619' ' ' ILE . 6.6 tp -120.05 128.87 75.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.5 -0.773 . . . . 53.12 109.423 -178.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.555 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 35.9 m -102.68 116.8 33.31 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 108.925 -0.768 . . . . 33.41 108.925 178.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 605' ' ' TYR . 3.9 pp -139.89 160.3 40.22 Favored 'General case' 0 CA--C 1.478 -1.814 0 N-CA-C 106.41 -1.7 . . . . 72.21 106.41 178.646 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -128.7 147.14 50.73 Favored 'General case' 0 C--N 1.259 -3.353 0 N-CA-C 106.394 -1.706 . . . . 74.3 106.394 179.598 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -128.62 165.25 21.17 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.347 -0.983 . . . . 74.51 108.347 176.119 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -92.95 -114.37 2.25 Favored Glycine 0 N--CA 1.413 -2.884 0 O-C-N 123.889 0.743 . . . . 72.33 112.748 -179.383 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . 0.469 HE21 ' HA ' ' A' ' 626' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.46 0 CA-C-O 118.876 -0.583 . . . . 74.12 110.822 -173.865 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.285 0 N-CA-C 110.363 -1.095 . . . . 70.02 110.363 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 9.3 tp -75.45 119.66 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-O 121.543 0.687 . . . . 62.22 111.392 -179.836 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 3.7 m -86.3 150.68 24.18 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 105.788 -1.93 . . . . 64.4 105.788 173.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 358' ' ' ARG . 5.2 mmm180 -92.52 42.81 1.11 Allowed 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.928 -0.709 . . . . 73.41 111.454 -171.505 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -75.96 148.26 38.28 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.54 -0.911 . . . . 52.23 108.54 177.158 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 30.3 m -119.56 151.83 22.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.517 -0.92 . . . . 63.34 108.517 -178.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -95.08 135.84 36.13 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 106.169 -1.789 . . . . 72.45 106.169 176.589 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.468 HG22 ' CZ ' ' A' ' 382' ' ' PHE . 59.4 t -97.39 132.06 26.1 Favored Pre-proline 0 C--N 1.286 -2.178 0 CA-C-N 115.987 -0.551 . . . . 65.13 110.826 -169.249 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 13.3 Cg_exo -66.56 134.03 34.11 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.17 1.913 . . . . 72.51 112.389 -179.301 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . 0.402 ' OD1' ' HG2' ' A' ' 366' ' ' ARG . 3.5 p30 -100.5 144.15 29.84 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.705 -1.22 . . . . 63.32 107.705 176.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 4.3 t -123.09 28.2 2.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 107.544 -1.28 . . . . 75.32 107.544 -179.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.52 ' HB3' HG23 ' A' ' 402' ' ' THR . 14.1 ptt180 -61.07 143.91 54.49 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.597 -1.183 . . . . 72.53 110.61 178.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.06 -13.89 55.74 Favored Glycine 0 N--CA 1.429 -1.779 0 CA-C-N 116.063 -0.517 . . . . 74.4 112.294 178.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -105.16 -87.29 0.45 Allowed 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 121.173 -0.211 . . . . 70.32 111.323 -178.722 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 89.5 p -156.32 160.67 39.93 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 108.227 -1.027 . . . . 63.05 108.227 179.557 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 1.4 p -63.49 -34.68 78.31 Favored 'General case' 0 N--CA 1.422 -1.847 0 O-C-N 123.498 0.499 . . . . 65.51 109.716 174.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.07 -46.37 89.4 Favored 'General case' 0 C--O 1.214 -0.771 0 CA-C-N 116.044 -0.525 . . . . 72.13 110.487 178.22 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -63.91 -41.91 97.56 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 120.826 0.346 . . . . 54.21 111.206 178.157 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -68.33 -45.6 72.48 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.237 -0.438 . . . . 64.31 111.356 -178.39 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 73.6 mt -65.9 -44.43 92.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.408 -0.36 . . . . 71.43 110.818 178.881 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.9 -43.89 91.1 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 120.922 0.392 . . . . 64.15 111.607 -177.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 38.9 m -64.29 -48.46 75.57 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.006 -0.543 . . . . 74.24 110.435 -178.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 10.8 mp -65.19 -37.92 88.84 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.163 -0.471 . . . . 61.4 111.862 178.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -61.11 -42.35 98.37 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.795 0.838 . . . . 75.12 109.867 178.541 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -66.2 -28.53 68.83 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.988 -0.551 . . . . 70.43 111.333 177.745 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -86.18 -14.41 44.1 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.907 0.384 . . . . 64.12 111.416 178.419 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 90.57 16.21 55.47 Favored Glycine 0 C--N 1.307 -1.076 0 C-N-CA 120.444 -0.884 . . . . 71.25 112.633 177.892 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.468 ' CZ ' HG22 ' A' ' 362' ' ' VAL . 26.1 m-85 -78.23 161.24 27.44 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-O 121.374 0.606 . . . . 52.23 111.542 178.02 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 48.5 mmtm -100.73 132.43 46.13 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 108.946 -0.761 . . . . 73.44 108.946 178.164 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.423 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -118.0 154.8 19.98 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.721 0 N-CA-C 108.615 -0.883 . . . . 74.35 108.615 175.998 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -124.99 135.22 52.58 Favored 'General case' 0 C--N 1.265 -3.069 0 N-CA-C 106.182 -1.785 . . . . 73.24 106.182 177.508 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 31.1 m -119.04 117.58 29.14 Favored 'General case' 0 C--N 1.271 -2.841 0 N-CA-C 109.157 -0.683 . . . . 70.21 109.157 -177.383 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' A' ' 419' ' ' ASN . 2.9 tm? -116.07 127.58 54.99 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 106.292 -1.744 . . . . 74.14 106.292 179.479 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.488 HE21 ' N ' ' A' ' 388' ' ' GLN . 0.0 OUTLIER -114.22 147.5 38.84 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.997 -0.681 . . . . 74.42 111.439 -177.979 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -136.39 137.52 24.49 Favored Pre-proline 0 C--N 1.308 -1.234 0 N-CA-C 107.849 -1.167 . . . . 74.42 107.849 175.193 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.481 ' HB2' ' HG2' ' A' ' 425' ' ' GLU . 53.9 Cg_endo -72.64 148.73 47.79 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 121.425 1.417 . . . . 74.0 109.505 172.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . 0.279 27.8 t70 -61.55 115.37 3.86 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 116.934 2.198 . . . . 45.53 116.934 -171.916 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . 0.453 ' O ' ' HB ' ' A' ' 393' ' ' THR . 3.2 p -143.75 65.89 1.3 Allowed 'General case' 0 N--CA 1.383 -3.778 0 CA-C-N 111.822 -2.444 . . . . 64.0 106.744 166.622 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.497 HG22 ' O ' ' A' ' 393' ' ' THR . 63.4 m 87.38 39.08 0.02 OUTLIER 'General case' 0 CA--C 1.571 1.771 0 CA-C-O 123.703 1.716 . . . . 64.42 111.471 176.545 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -117.14 149.51 44.48 Favored Pre-proline 0 C--N 1.291 -1.967 0 O-C-N 121.032 -1.042 . . . . 73.23 112.125 175.917 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.02 178.49 6.44 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.911 2.407 . . . . 71.13 111.131 -179.051 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -55.91 161.11 8.86 Favored 'Trans proline' 0 C--N 1.362 1.252 0 C-N-CA 122.765 2.31 . . . . 71.41 112.328 176.034 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . 0.433 ' HB2' HG13 ' A' ' 420' ' ' VAL . 5.4 p-10 -58.09 -8.35 1.04 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.953 1.301 . . . . 71.51 113.142 -178.815 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -74.25 172.05 12.52 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.285 -0.635 . . . . 74.14 109.285 -179.468 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 13.9 m -97.32 118.7 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.999 0 N-CA-C 108.417 -0.957 . . . . 71.34 108.417 176.677 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 2.2 mp -94.88 -32.05 4.46 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 107.592 -1.262 . . . . 70.02 107.592 178.345 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.88 170.85 27.75 Favored Glycine 0 N--CA 1.418 -2.536 0 N-CA-C 109.101 -1.599 . . . . 35.02 109.101 179.307 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.52 HG23 ' HB3' ' A' ' 366' ' ' ARG . 2.5 p -129.34 -177.87 4.42 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 122.572 0.349 . . . . 75.34 110.443 -179.262 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -100.14 135.96 20.22 Favored Pre-proline 0 C--N 1.293 -1.866 0 N-CA-C 106.626 -1.62 . . . . 63.45 106.626 178.771 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -55.52 -12.18 5.77 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 124.034 3.156 . . . . 72.52 114.836 -175.469 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -53.88 -35.61 61.76 Favored 'General case' 0 C--O 1.212 -0.874 0 C-N-CA 122.899 0.48 . . . . 75.44 110.548 176.641 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.11 -39.51 68.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.338 0.589 . . . . 71.34 110.879 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -83.61 2.28 38.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.365 0.602 . . . . 72.3 110.639 -179.048 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 27.1 m -102.17 145.89 28.74 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 106.326 -1.731 . . . . 52.54 106.326 172.686 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 48.8 m -75.01 113.03 11.85 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 119.039 -1.064 . . . . 74.51 108.822 175.255 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.5 m -118.95 170.24 8.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.889 -0.596 . . . . 74.04 110.037 179.766 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 22.8 t -69.19 152.08 45.54 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.797 -0.445 . . . . 74.33 109.797 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -63.91 109.4 1.76 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.362 0.601 . . . . 74.41 111.185 -178.649 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 100.56 44.64 2.1 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 115.185 -0.916 . . . . 73.51 113.05 178.074 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -92.03 -174.21 3.71 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.984 -1.117 . . . . 62.44 107.984 178.456 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 44.8 mt-10 -109.16 133.0 53.58 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 121.53 0.681 . . . . 72.15 112.582 -177.624 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 44.6 mm -118.76 113.82 42.9 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 107.697 -1.223 . . . . 64.41 107.697 174.087 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 14.8 t -89.63 131.16 35.76 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.441 0.638 . . . . 73.14 111.274 -179.541 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 9.2 p -115.49 135.1 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 CA-C-N 115.329 -0.85 . . . . 42.33 109.562 -177.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . 0.493 ' HA ' ' O ' ' A' ' 387' ' ' LEU . 2.8 t-20 -97.74 116.0 29.09 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.887 -0.725 . . . . 63.34 109.339 176.236 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 98.4 t -102.44 136.0 36.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.109 -1.071 . . . . 60.05 108.109 179.232 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 15.8 m -99.09 135.05 41.05 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-O 121.543 0.687 . . . . 63.55 111.418 -178.847 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 17.6 p -105.95 160.06 15.56 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.492 -1.299 . . . . 71.52 107.492 172.409 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -44.04 159.94 0.1 Allowed Glycine 0 CA--C 1.546 1.999 0 N-CA-C 114.789 0.675 . . . . 45.35 114.789 -178.063 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -52.5 149.9 22.53 Favored 'Trans proline' 0 C--O 1.248 0.987 0 C-N-CA 124.085 3.19 . . . . 64.51 113.163 -176.688 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.481 ' HG2' ' HB2' ' A' ' 390' ' ' PRO . 33.3 mt-10 -71.71 127.77 33.63 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-O 122.602 1.192 . . . . 55.43 111.906 -175.285 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -136.8 158.49 44.33 Favored 'General case' 0 C--N 1.27 -2.862 0 CA-C-N 112.877 -1.965 . . . . 74.41 106.975 177.54 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.5 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 4.2 mmp_? -122.35 147.37 46.34 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-O 120.797 0.332 . . . . 74.44 110.472 177.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -88.71 139.1 30.81 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 107.496 -1.298 . . . . 74.15 107.496 178.624 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 63.4 mt -80.43 118.99 75.01 Favored Pre-proline 0 N--CA 1.428 -1.536 0 N-CA-C 108.241 -1.022 . . . . 64.4 108.241 179.569 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -71.08 154.12 62.56 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 121.872 1.715 . . . . 75.2 110.549 177.409 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -77.4 89.43 3.79 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.53 0.681 . . . . 64.43 110.079 177.667 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 42.0 t -93.18 131.19 40.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 105.765 -1.939 . . . . 73.24 105.765 175.572 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.484 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 15.7 m -64.44 151.89 43.01 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 120.929 0.395 . . . . 52.35 111.197 -176.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 26.9 p -59.76 -33.41 71.64 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 123.427 0.691 . . . . 63.24 112.275 -176.621 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.496 ' HB3' ' HG3' ' A' ' 466' ' ' LYS . 1.9 pp -81.56 -11.23 59.23 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.465 0.65 . . . . 72.41 112.601 178.336 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.547 HG22 ' HB3' ' A' ' 439' ' ' GLU . 3.5 m -97.9 34.27 1.94 Allowed 'General case' 0 CA--C 1.564 1.509 0 N-CA-C 108.971 -0.752 . . . . 52.33 108.971 -178.703 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -51.41 -39.27 56.92 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.495 1.118 . . . . 71.4 113.391 179.745 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.1 -42.27 99.54 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-O 121.866 0.841 . . . . 72.33 110.268 -179.676 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.547 ' HB3' HG22 ' A' ' 436' ' ' THR . 26.8 tt0 -70.56 -33.96 71.69 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.451 -0.795 . . . . 71.21 109.468 178.691 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.621 ' O ' HD22 ' A' ' 444' ' ' LEU . . . -59.51 -50.19 74.89 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.378 -0.374 . . . . 72.01 110.961 -179.35 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.4 m -62.53 -38.61 81.88 Favored 'Isoleucine or valine' 0 C--O 1.257 1.46 0 N-CA-C 112.058 0.392 . . . . 74.44 112.058 179.637 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 442' ' ' LYS . 0.0 OUTLIER -68.0 -33.51 74.75 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 119.33 -0.948 . . . . 42.32 111.329 175.321 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -61.61 -42.96 99.61 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.368 -0.378 . . . . 62.32 111.262 175.559 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.621 HD22 ' O ' ' A' ' 440' ' ' ALA . 0.9 OUTLIER -63.79 -33.14 75.01 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 119.714 -0.794 . . . . 63.03 110.395 177.147 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 91.3 m -65.42 -44.02 88.69 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 116.174 -0.466 . . . . 74.43 110.456 177.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.76 -22.28 63.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.465 0.65 . . . . 44.31 110.979 179.225 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.69 5.46 13.26 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.64 -0.709 . . . . 61.5 112.182 -178.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 101.53 -73.79 0.36 Allowed Glycine 0 CA--C 1.493 -1.338 0 C-N-CA 119.977 -1.106 . . . . 61.4 112.232 174.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -47.83 -56.81 6.63 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 113.255 0.835 . . . . 73.44 113.255 178.041 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 61.97 25.43 66.04 Favored Glycine 0 CA--C 1.507 -0.418 0 C-N-CA 121.27 -0.49 . . . . 60.35 112.664 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -100.98 110.86 22.94 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.596 -1.261 . . . . 71.44 107.596 -177.628 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.612 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 32.3 p90 -139.12 151.33 46.58 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 120.731 0.301 . . . . 72.31 110.826 -179.194 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -131.25 130.2 42.56 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.435 -0.95 . . . . 71.41 108.435 177.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -97.62 123.16 41.42 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 123.649 0.593 . . . . 61.33 110.039 179.204 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -117.22 135.47 53.77 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 107.043 -1.466 . . . . 31.54 107.043 173.191 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -112.67 139.42 48.29 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.771 -0.825 . . . . 74.2 108.771 179.703 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . 0.488 ' O ' ' HA2' ' A' ' 489' ' ' GLY . 23.2 t -141.94 136.34 15.1 Favored Pre-proline 0 C--N 1.287 -2.118 0 N-CA-C 108.898 -0.778 . . . . 74.25 108.898 179.708 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.687 ' HA ' ' O ' ' A' ' 490' ' ' SER . 30.4 Cg_endo -65.8 131.35 27.18 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.169 1.913 . . . . 72.12 110.54 175.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 46.1 m -147.34 174.88 11.24 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 122.259 -0.276 . . . . 61.43 110.402 -177.491 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 3.9 t -50.66 142.98 15.16 Favored Pre-proline 0 N--CA 1.446 -0.658 0 C-N-CA 124.973 1.309 . . . . 74.42 111.716 176.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.54 -29.73 33.13 Favored 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 124.653 3.569 . . . . 74.51 113.153 -177.481 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -68.53 -35.06 76.94 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.379 -0.373 . . . . 72.52 111.197 179.29 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -96.18 -9.11 31.32 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 113.057 0.762 . . . . 51.33 113.057 -178.345 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 92.9 t -60.5 127.11 19.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.795 -0.817 . . . . 74.42 108.795 175.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.98 -1.43 67.92 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 111.788 -0.525 . . . . 65.52 111.788 -178.567 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.496 ' HG3' ' HB3' ' A' ' 435' ' ' LEU . 10.0 mptt -122.89 155.18 37.2 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-O 121.595 0.712 . . . . 74.02 111.336 -178.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 73.4 t -68.45 137.77 23.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 114.115 -1.402 . . . . 75.02 109.718 175.861 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 40.3 mm -97.95 -28.02 3.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 108.386 -0.968 . . . . 72.42 108.386 -179.811 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 168.36 164.43 24.04 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.238 -0.982 . . . . 60.34 113.088 177.556 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 1.1 t -116.96 142.8 46.47 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 107.468 -1.308 . . . . 75.13 107.468 176.369 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.423 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 3.3 t-20 -70.65 -53.14 9.81 Favored Pre-proline 0 C--N 1.321 -0.642 0 C-N-CA 119.493 -0.883 . . . . 73.2 111.242 177.457 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.465 ' HG2' ' HA ' ' A' ' 484' ' ' VAL . 27.6 Cg_exo -65.95 134.79 38.52 Favored 'Trans proline' 0 C--N 1.368 1.589 0 N-CA-C 108.269 -1.473 . . . . 74.31 108.269 171.58 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 472' ' ' PRO . 21.0 Cg_exo -62.48 127.6 21.29 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.213 1.942 . . . . 72.42 111.791 -176.823 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -71.43 2.17 5.33 Favored 'General case' 0 C--O 1.209 -1.058 0 CA-C-N 115.816 -0.629 . . . . 72.43 112.578 -177.401 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -108.89 -12.96 14.83 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.164 0.507 . . . . 75.14 111.402 179.283 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -102.26 173.05 6.54 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.235 0.54 . . . . 74.2 112.02 -172.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 1.3 m -91.69 119.92 31.98 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 115.277 -0.874 . . . . 62.33 108.902 -177.646 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 13.1 p -102.46 145.96 28.8 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.148 0.499 . . . . 63.43 110.925 -177.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -80.38 154.16 27.89 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.909 -0.587 . . . . 73.13 111.376 -176.252 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 425' ' ' GLU . 23.1 mm -74.02 -6.19 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 CA-C-O 122.154 0.978 . . . . 72.12 110.498 -177.793 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 6.4 p -108.48 5.42 25.22 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.488 0.661 . . . . 51.3 111.156 177.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -97.36 150.59 20.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.52 -0.764 . . . . 71.41 111.251 -173.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 59.8 t -108.14 126.4 64.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 123.667 0.787 . . . . 63.33 110.452 -177.054 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.612 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 61.0 t -101.03 120.03 49.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 120.892 0.377 . . . . 74.44 110.361 -179.985 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.98 126.03 59.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 109.022 -0.732 . . . . 72.31 109.022 177.525 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 16.8 mt -120.55 128.35 76.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 114.749 -1.114 . . . . 64.15 111.506 -177.132 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 6.9 tt -103.62 126.95 58.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 115.481 -0.781 . . . . 73.12 109.849 177.795 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 2.4 p -119.02 139.04 47.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 123.39 0.676 . . . . 74.11 110.076 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 457' ' ' SER . . . -77.08 127.64 8.55 Favored Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 111.034 -0.827 . . . . 72.42 111.034 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.687 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 23.0 t -143.44 160.62 40.23 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.05 -1.093 . . . . 71.35 108.05 -178.289 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 150.0 83.66 0.04 OUTLIER Glycine 0 C--N 1.31 -0.904 0 C-N-CA 120.21 -0.995 . . . . 60.32 111.731 179.344 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -79.03 112.87 3.14 Favored 'Trans proline' 0 N--CA 1.444 -1.403 0 C-N-CA 122.505 2.137 . . . . 43.21 112.312 -178.459 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -96.7 24.28 6.19 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 122.655 1.217 . . . . 65.11 108.601 178.012 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 546' ' ' PRO . 18.7 p -117.07 149.25 40.6 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 112.615 -2.084 . . . . 72.24 109.296 -175.805 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . 0.4 ' HD2' ' O ' ' A' ' 515' ' ' TYR . 64.9 mttm -137.01 147.71 46.41 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.263 -0.643 . . . . 61.25 109.263 174.873 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 6.3 p-10 -80.7 129.92 34.8 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 124.014 0.821 . . . . 72.54 109.418 179.071 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 543' ' ' THR . 36.3 pt -87.19 131.31 44.87 Favored Pre-proline 0 C--N 1.295 -1.762 0 CA-C-N 115.825 -0.625 . . . . 75.3 110.506 179.391 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.56 -172.34 1.46 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.216 1.944 . . . . 73.15 109.377 173.302 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -82.01 149.47 28.11 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.4 -1.334 . . . . 71.51 107.4 176.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.56 85.98 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 CA-C-O 122.59 1.186 . . . . 73.15 108.94 177.111 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -149.86 128.54 12.4 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 114.218 -1.355 . . . . 72.14 108.876 -178.038 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 122.77 -20.8 7.66 Favored Glycine 0 N--CA 1.435 -1.429 0 C-N-CA 120.246 -0.978 . . . . 73.21 111.673 177.354 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.87 177.39 4.86 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 120.952 0.406 . . . . 63.25 110.843 178.619 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 9.4 t -87.95 157.88 18.82 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.102 -0.703 . . . . 61.14 109.102 -178.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.3 p -50.6 -41.63 20.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 124.317 1.047 . . . . 73.11 112.043 -179.181 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -61.74 -41.53 97.79 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.043 0.386 . . . . 74.41 112.043 179.129 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 89.6 t -71.21 -42.43 75.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-O 121.243 0.544 . . . . 65.55 109.891 179.084 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -60.41 -42.45 96.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.489 -0.778 . . . . 53.12 110.633 179.143 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -59.41 -46.22 89.33 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.27 -0.877 . . . . 54.33 109.953 179.673 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.425 ' O ' HG23 ' A' ' 514' ' ' VAL . 2.8 tmmm? -60.49 -44.3 96.09 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.163 -0.926 . . . . 71.43 108.904 -179.09 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -61.97 -48.09 81.91 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 116.117 -0.492 . . . . 70.3 111.035 -179.407 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.93 -38.89 92.76 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 111.804 0.298 . . . . 75.35 111.804 179.402 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . 0.406 HD22 ' HA ' ' A' ' 513' ' ' ASN . 10.7 m120 -63.14 -38.17 90.12 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 121.232 -0.187 . . . . 73.33 110.939 179.014 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 510' ' ' LYS . 72.2 t -61.17 -35.46 65.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.027 0.441 . . . . 72.5 110.648 176.605 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . 0.4 ' O ' ' HD2' ' A' ' 495' ' ' LYS . 22.8 m-85 -79.06 -4.53 50.67 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 120.886 0.374 . . . . 75.52 110.99 -178.631 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 97.62 3.12 58.48 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 120.653 -0.784 . . . . 35.13 112.685 177.021 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.497 ' CD1' ' HA ' ' A' ' 547' ' ' VAL . 85.2 m-85 -86.44 115.24 23.82 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 108.032 -1.099 . . . . 73.53 108.032 -178.881 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.4 m -114.77 11.26 16.74 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 119.489 -0.884 . . . . 72.0 111.166 -176.27 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . 0.409 ' HB3' HG22 ' A' ' 550' ' ' VAL . 67.7 mttm -129.41 114.23 15.9 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.279 -0.637 . . . . 72.41 109.279 176.249 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -130.86 150.54 51.97 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 115.645 -0.707 . . . . 74.34 110.075 178.743 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 68.9 m -126.73 146.76 50.1 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 107.174 -1.417 . . . . 74.22 107.174 172.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -117.94 129.37 55.57 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 120.251 -0.58 . . . . 73.24 109.956 -179.392 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -105.33 115.99 31.19 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 106.867 -1.531 . . . . 71.35 106.867 175.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 19.4 m -88.89 114.74 25.84 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 121.676 0.751 . . . . 61.21 110.602 -176.509 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 28.1 m -121.47 168.83 13.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-N 114.464 -1.244 . . . . 75.33 108.232 -178.014 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . 0.544 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 7.0 p-10 -103.74 149.65 24.8 Favored 'General case' 0 C--N 1.282 -2.336 0 C-N-CA 120.049 -0.66 . . . . 73.11 111.748 -177.778 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 19.8 m -149.44 178.13 1.58 Allowed Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 105.286 -2.116 . . . . 72.44 105.286 177.012 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -87.65 -12.44 4.46 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 121.29 1.327 . . . . 73.53 111.523 172.168 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.4 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 35.5 mtp85 -87.01 148.42 45.25 Favored Pre-proline 0 N--CA 1.428 -1.546 0 C-N-CA 123.484 0.714 . . . . 72.41 109.332 179.033 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -56.14 148.47 59.28 Favored 'Trans proline' 0 C--O 1.259 1.556 0 C-N-CA 124.019 3.146 . . . . 74.34 117.13 -170.598 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.56 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -61.2 137.39 58.24 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 113.367 -1.742 . . . . 73.43 111.054 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 108.9 -17.95 32.0 Favored Glycine 0 N--CA 1.429 -1.828 0 N-CA-C 110.895 -0.882 . . . . 53.35 110.895 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -80.38 136.63 36.41 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 109.731 -0.47 . . . . 74.21 109.731 178.314 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 60.0 t -86.14 120.74 36.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.037 -1.097 . . . . 53.3 108.037 178.329 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . 0.509 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 9.7 t -92.91 -1.97 56.25 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.946 -0.57 . . . . 73.45 110.78 -176.882 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 144.27 -167.19 26.99 Favored Glycine 0 CA--C 1.496 -1.095 0 N-CA-C 111.216 -0.754 . . . . 73.33 111.216 176.238 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 12.6 p -118.55 160.1 22.37 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 117.398 0.599 . . . . 61.05 110.288 176.036 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.454 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 35.4 t30 -71.2 -51.64 10.05 Favored Pre-proline 0 C--N 1.31 -1.144 0 CA-C-N 116.244 -0.434 . . . . 71.12 110.104 175.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.454 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 14.0 Cg_exo -72.59 135.87 24.84 Favored 'Trans proline' 0 C--N 1.38 2.208 0 N-CA-C 109.134 -1.141 . . . . 75.0 109.134 171.287 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.69 154.51 67.92 Favored 'Trans proline' 0 C--O 1.254 1.285 0 C-N-CA 122.364 2.042 . . . . 74.23 113.415 -177.094 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.06 138.11 58.21 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.429 -0.805 . . . . 73.22 110.163 178.747 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.56 -20.4 34.63 Favored Glycine 0 C--N 1.305 -1.174 0 N-CA-C 111.755 -0.538 . . . . 75.53 111.755 -179.362 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.428 ' O ' HG12 ' A' ' 497' ' ' ILE . 25.6 m -70.63 133.39 46.64 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.34 -0.245 . . . . 75.31 110.34 -178.443 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 15.0 t -98.12 129.58 44.92 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 109.083 -0.71 . . . . 72.22 109.083 177.037 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 7.1 m -136.43 154.4 76.91 Favored Pre-proline 0 C--N 1.297 -1.675 0 CA-C-N 115.668 -0.696 . . . . 63.21 109.218 179.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 494' ' ' THR . 26.9 Cg_exo -64.57 139.01 62.02 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.435 2.09 . . . . 64.23 111.244 178.414 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.497 ' HA ' ' CD1' ' A' ' 517' ' ' PHE . 35.3 m -63.85 -20.87 27.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 113.313 0.857 . . . . 74.22 113.313 -175.643 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -94.43 4.03 54.39 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.848 0.832 . . . . 44.44 110.508 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 39.4 m -93.54 179.49 5.37 Favored 'General case' 0 N--CA 1.437 -1.101 0 O-C-N 121.911 -0.493 . . . . 74.53 110.524 178.606 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.409 HG22 ' HB3' ' A' ' 519' ' ' LYS . 19.8 t -106.83 131.6 56.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 116.468 -0.333 . . . . 74.42 111.078 -174.117 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . 0.503 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -114.44 136.69 50.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 108.396 -0.964 . . . . 54.11 108.396 172.164 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -103.68 124.14 48.3 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 121.421 0.629 . . . . 53.23 111.726 -178.622 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.3 mp -97.37 134.77 40.2 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.681 -1.145 . . . . 70.33 110.014 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . 0.474 ' HA ' HE21 ' A' ' 554' ' ' GLN . 0.0 OUTLIER -86.97 119.06 26.78 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.505 -1.665 . . . . 73.23 106.505 177.313 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 59.6 t -114.41 131.07 67.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.793 -0.567 . . . . 53.0 109.866 -178.13 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.56 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 69.8 m -81.35 157.89 24.88 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 113.407 0.892 . . . . 73.02 113.407 -178.242 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.544 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 14.2 ptpt -119.08 158.34 26.06 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 105.326 -2.102 . . . . 74.5 105.326 167.519 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -75.03 -42.65 29.01 Favored Glycine 0 CA--C 1.485 -1.808 0 C-N-CA 119.949 -1.12 . . . . 63.23 112.432 -174.597 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 55.7 t30 67.35 -12.4 0.26 Allowed 'General case' 0 CA--C 1.569 1.696 0 C-N-CA 124.186 0.994 . . . . 74.43 112.759 173.48 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.477 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 71.3 mt-30 -136.63 160.73 37.92 Favored 'General case' 0 C--O 1.253 1.289 0 C-N-CA 125.859 1.663 . . . . 72.24 107.505 176.373 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -138.92 136.6 35.65 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 110.117 -0.327 . . . . 65.02 110.117 176.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 8.3 p -59.89 121.68 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 121.599 0.714 . . . . 74.43 112.176 -178.013 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 21.4 ptm -87.6 147.05 40.72 Favored Pre-proline 0 C--O 1.252 1.211 0 CA-C-N 115.654 -0.703 . . . . 73.05 112.803 -175.085 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.69 170.78 19.56 Favored 'Trans proline' 0 CA--C 1.551 1.329 0 C-N-CA 124.566 3.511 . . . . 64.42 112.902 175.457 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.5 124.07 28.62 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.995 -0.548 . . . . 75.21 112.15 177.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -112.61 -3.31 14.35 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 122.045 0.926 . . . . 71.24 108.815 174.398 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 11.1 m -68.24 137.53 54.83 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.103 -1.408 . . . . 72.12 111.455 -177.587 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 80.4 30.92 39.15 Favored Glycine 0 N--CA 1.438 -1.203 0 C-N-CA 121.103 -0.57 . . . . 62.11 112.019 176.338 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 64.6 mtt -137.3 173.23 11.9 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.899 -0.778 . . . . 74.21 108.899 -178.677 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . 0.495 ' HA ' ' HA ' ' A' ' 602' ' ' ARG . 89.0 m-85 -100.28 166.26 11.07 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 109.29 -0.633 . . . . 75.12 109.29 179.252 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 69.9 t90 -67.73 -28.47 67.67 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.327 -0.619 . . . . 71.11 109.327 178.059 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 10.2 p -68.56 -10.02 12.41 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 CA-C-N 115.63 -0.713 . . . . 72.45 110.409 176.739 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . 0.454 ' O ' ' HG3' ' A' ' 577' ' ' ARG . 38.0 m-20 -100.59 -44.51 5.82 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 108.163 -1.051 . . . . 73.23 108.163 173.611 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . 0.461 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -59.35 -51.74 68.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.112 -0.949 . . . . 65.11 112.564 -177.33 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.573 ' OE2' ' HD3' ' A' ' 579' ' ' ARG . 21.0 tp10 -52.95 -56.77 20.27 Favored Pre-proline 0 CA--C 1.562 1.431 0 CA-C-O 119.02 -0.514 . . . . 73.34 112.09 -179.666 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . 0.446 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 53.5 Cg_exo -57.77 -38.16 93.91 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.126 1.884 . . . . 74.23 112.595 176.332 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 573' ' ' ASP . 80.8 mtp180 -65.79 -36.85 84.69 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 120.864 -0.335 . . . . 74.34 111.332 -179.558 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 96.1 mt -63.36 -38.77 92.45 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.128 0.49 . . . . 73.51 109.797 178.192 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . 0.573 ' HD3' ' OE2' ' A' ' 575' ' ' GLU . 7.0 mmm180 -65.3 -45.79 82.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.509 -0.769 . . . . 74.13 108.941 179.562 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.22 -29.81 70.14 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.369 -0.832 . . . . 70.41 112.213 -178.318 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 95.5 mt -81.59 -6.3 58.86 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.843 0.354 . . . . 74.02 110.833 178.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 72.87 35.77 58.08 Favored Glycine 0 N--CA 1.439 -1.114 0 N-CA-C 111.456 -0.657 . . . . 54.3 111.456 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . 0.405 ' CH2' ' HB2' ' A' ' 587' ' ' LEU . 79.1 t90 -76.22 128.65 35.35 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.782 -0.451 . . . . 74.12 109.782 -179.79 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 17.6 m -150.54 86.56 1.4 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.899 -0.778 . . . . 62.24 108.899 174.106 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -147.73 -142.92 3.74 Favored Glycine 0 C--N 1.309 -0.943 0 N-CA-C 110.244 -1.142 . . . . 63.24 110.244 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 47.7 tpp -96.51 125.21 40.84 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 117.538 0.669 . . . . 70.45 110.964 177.409 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . 0.405 ' HB2' ' CH2' ' A' ' 583' ' ' TRP . 3.4 tm? -96.23 128.96 43.62 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.54 -1.652 . . . . 71.05 106.54 175.434 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -94.99 123.26 38.37 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 105.241 -2.133 . . . . 65.11 105.241 178.439 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -85.52 121.42 28.2 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 113.251 0.834 . . . . 73.23 113.251 -162.483 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -105.47 144.0 15.74 Favored Glycine 0 N--CA 1.407 -3.237 0 N-CA-C 107.875 -2.09 . . . . 63.44 107.875 171.3 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -94.21 150.93 19.85 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 117.072 0.436 . . . . 75.33 110.018 -179.251 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -73.44 124.8 26.51 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.314 -1.365 . . . . 75.24 107.314 173.271 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 41.1 t -105.94 123.35 60.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 CA-C-N 116.188 -0.46 . . . . 73.51 111.367 -175.235 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . 0.446 ' HA ' ' HB2' ' A' ' 626' ' ' GLN . 6.3 p-10 -81.32 107.8 14.41 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.477 -1.305 . . . . 75.42 107.477 173.938 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -136.08 21.1 3.24 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.615 -0.72 . . . . 73.24 109.725 -177.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 101.18 173.46 28.75 Favored Glycine 0 N--CA 1.427 -1.914 0 C-N-CA 120.267 -0.968 . . . . 33.04 110.812 -177.505 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -62.18 -33.42 85.84 Favored Glycine 0 C--O 1.218 -0.865 0 N-CA-C 114.188 0.435 . . . . 53.33 114.188 -175.093 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 13.7 m -58.31 -24.44 59.64 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 113.806 1.039 . . . . 52.0 113.806 -175.828 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -98.49 -0.31 43.63 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 113.343 0.868 . . . . 74.45 113.343 -175.339 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . 0.476 ' HA ' ' OXT' ' A' ' 626' ' ' GLN . 5.7 p80 -35.46 98.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 115.682 1.734 . . . . 65.44 115.682 -174.264 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 52.95 10.29 0.15 Allowed 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 126.075 1.75 . . . . 63.22 115.381 172.09 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 570' ' ' PHE . 38.4 ttt180 -79.83 143.34 34.46 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.945 -1.097 . . . . 71.35 110.945 -175.408 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 87.9 t -74.58 131.0 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 108.224 -1.028 . . . . 71.03 108.224 179.818 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 46.5 t -94.04 -48.09 13.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.332 0.587 . . . . 74.34 110.248 -175.345 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -148.34 151.19 34.93 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.635 -0.711 . . . . 63.41 110.049 179.099 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . 0.461 ' HA ' ' O ' ' A' ' 621' ' ' THR . 14.4 pt20 -115.57 141.7 47.71 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.869 -1.16 . . . . 71.14 107.869 174.372 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.612 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 17.0 t-20 -51.35 -57.16 15.16 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 123.66 0.6 . . . . 74.31 112.274 -175.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.612 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 9.6 Cg_endo -100.01 138.66 0.27 Allowed 'Trans proline' 0 N--CA 1.433 -2.069 0 C-N-CA 121.742 1.628 . . . . 73.14 110.096 172.271 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -70.13 147.14 59.82 Favored 'Trans proline' 0 C--O 1.252 1.177 0 C-N-CA 121.313 1.342 . . . . 53.05 109.918 175.753 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -62.37 138.98 58.55 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.886 0.375 . . . . 52.54 110.551 -178.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.16 -8.21 44.84 Favored Glycine 0 N--CA 1.431 -1.649 0 N-CA-C 110.598 -1.001 . . . . 61.15 110.598 -175.032 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 6.1 m -100.83 157.29 16.83 Favored 'General case' 0 C--O 1.249 1.066 0 N-CA-C 108.384 -0.969 . . . . 63.23 108.384 178.174 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -85.69 132.18 10.95 Favored Glycine 0 N--CA 1.428 -1.867 0 N-CA-C 111.227 -0.749 . . . . 55.31 111.227 178.35 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 21.8 m -97.43 142.47 14.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 110.055 -0.35 . . . . 70.43 110.055 178.166 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.477 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 30.1 p-10 -57.05 167.13 0.88 Allowed 'General case' 0 N--CA 1.436 -1.164 0 O-C-N 124.476 1.11 . . . . 74.04 112.478 -178.821 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -61.02 -25.33 66.83 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.832 -1.077 . . . . 63.04 111.847 -178.035 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -78.44 -37.04 44.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.445 -0.343 . . . . 65.24 110.536 176.298 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 90.5 22.4 34.45 Favored Glycine 0 C--O 1.211 -1.307 0 C-N-CA 119.254 -1.451 . . . . 31.42 112.444 179.153 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.82 123.14 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 CA-C-O 122.63 1.205 . . . . 62.41 110.819 -168.754 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 6.3 tp -129.34 132.37 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 113.839 -1.528 . . . . 71.44 111.256 -174.085 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 606' ' ' GLN . 44.2 m -104.45 137.27 42.57 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 107.971 -1.122 . . . . 71.02 107.971 174.629 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 88.7 mt -138.15 157.01 47.16 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.243 -1.391 . . . . 63.42 107.243 178.638 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -144.25 136.6 26.59 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 104.178 -2.527 . . . . 64.34 104.178 177.063 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 602' ' ' ARG . 6.8 p90 -143.06 161.65 37.6 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 123.658 0.599 . . . . 71.4 111.526 -177.463 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -88.18 -163.62 39.4 Favored Glycine 0 N--CA 1.426 -2.004 0 C-N-CA 120.836 -0.697 . . . . 41.13 111.797 177.648 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . 0.476 ' OXT' ' HA ' ' A' ' 600' ' ' HIS . 8.7 tp-100 . . . . . 0 C--N 1.303 -1.444 0 C-N-CA 123.166 0.586 . . . . 72.34 110.352 -177.72 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.646 0 N-CA-C 110.855 -0.898 . . . . 64.52 110.855 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 10.0 tp -74.78 117.7 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-O 121.986 0.898 . . . . 72.32 109.808 179.636 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 10.5 m -122.54 158.78 29.13 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.353 -0.839 . . . . 62.13 109.87 -174.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.5 96.78 4.65 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 124.326 1.05 . . . . 74.44 108.313 179.782 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.7 133.81 49.97 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 113.143 -1.844 . . . . 72.44 109.944 -179.664 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 409' ' ' SER . 35.9 m -120.73 163.06 18.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 115.724 -0.671 . . . . 64.32 109.411 -175.475 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -94.05 136.94 33.8 Favored 'General case' 0 N--CA 1.39 -3.45 0 N-CA-C 108.733 -0.84 . . . . 52.31 108.733 176.103 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 94.7 t -97.8 129.28 31.67 Favored Pre-proline 0 C--N 1.269 -2.908 0 CA-C-N 114.289 -1.323 . . . . 62.43 109.566 -173.521 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -65.33 120.3 7.48 Favored 'Trans proline' 0 N--CA 1.443 -1.489 0 C-N-CA 121.769 1.646 . . . . 73.33 110.37 176.905 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -97.03 83.17 3.31 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 106.981 -1.488 . . . . 73.42 106.981 -175.473 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.487 ' HB ' ' NE2' ' A' ' 368' ' ' GLN . 30.2 m -71.65 34.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 125.997 1.719 . . . . 73.34 115.053 -171.748 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.431 ' HG3' ' OG1' ' A' ' 402' ' ' THR . 21.0 mmt180 -65.41 148.38 51.81 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 125.315 1.446 . . . . 71.34 111.795 177.377 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 106.47 0.67 37.52 Favored Glycine 0 CA--C 1.501 -0.791 0 N-CA-C 111.028 -0.829 . . . . 65.32 111.028 -175.704 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . 0.487 ' NE2' ' HB ' ' A' ' 365' ' ' VAL . 41.8 mt-30 -111.03 -154.53 0.54 Allowed 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 108.392 -0.966 . . . . 70.41 108.392 175.025 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 61.8 p -96.26 168.24 10.7 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 109.765 -0.457 . . . . 74.54 109.765 -176.701 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.88 -46.99 85.25 Favored 'General case' 0 N--CA 1.421 -1.918 0 CA-C-N 115.339 -0.846 . . . . 54.04 109.329 179.706 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.38 -44.83 82.04 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.701 -0.681 . . . . 71.2 112.411 -176.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -66.94 -47.2 72.39 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.885 0.374 . . . . 61.54 110.097 -177.144 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -67.35 -41.12 85.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.87 -0.604 . . . . 73.02 111.873 -177.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 66.5 mt -68.09 -39.8 81.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 116.692 -0.231 . . . . 71.33 110.399 177.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.16 -38.65 89.85 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 120.799 0.333 . . . . 50.13 110.34 179.61 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . 0.608 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 52.0 m -63.14 -47.9 80.75 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.725 -0.67 . . . . 71.54 110.199 179.307 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 98.2 mt -64.01 -42.33 97.18 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 116.33 -0.396 . . . . 74.22 110.506 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . 0.475 HE21 ' HA ' ' A' ' 378' ' ' GLN . 0.1 OUTLIER -64.21 -41.67 96.95 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.967 -0.561 . . . . 72.1 109.758 179.826 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -69.82 -17.64 63.41 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 112.969 0.729 . . . . 75.1 112.969 177.404 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . 0.608 ' HG2' ' O ' ' A' ' 376' ' ' THR . 6.9 mmp_? -88.78 -10.8 46.89 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.653 -0.499 . . . . 73.11 109.653 175.468 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.48 2.9 55.51 Favored Glycine 0 C--N 1.32 -0.36 0 CA-C-N 115.948 -0.569 . . . . 65.3 112.786 178.157 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -82.62 154.23 25.04 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-O 121.254 0.55 . . . . 33.44 111.895 -177.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -101.26 145.8 28.38 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.224 -1.399 . . . . 75.14 107.224 179.8 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 1.1 mp -129.38 144.01 39.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.171 -1.048 . . . . 71.31 108.171 179.252 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 385' ' ' ARG . 13.9 ttm180 -110.56 127.87 55.4 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 105.714 -1.958 . . . . 72.32 105.714 174.203 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 23.7 m -114.04 117.41 31.22 Favored 'General case' 0 C--N 1.271 -2.827 0 N-CA-C 108.074 -1.084 . . . . 74.4 108.074 -178.828 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.55 128.77 56.56 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.361 -0.977 . . . . 53.32 108.361 -177.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.405 ' HB3' ' OG1' ' A' ' 422' ' ' THR . 1.7 mp0 -99.78 127.94 45.9 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.666 -0.494 . . . . 73.11 109.666 -178.507 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 421' ' ' SER . 98.0 mttt -132.74 123.35 18.23 Favored Pre-proline 0 C--N 1.313 -1.017 0 N-CA-C 111.781 0.289 . . . . 73.34 111.781 178.61 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 389' ' ' LYS . 4.2 Cg_exo -82.69 128.09 5.16 Favored 'Trans proline' 0 C--O 1.254 1.288 0 C-N-CA 121.865 1.71 . . . . 72.21 109.032 171.779 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.563 ' HB3' ' CD1' ' A' ' 394' ' ' ILE . 10.2 t70 171.95 -162.17 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 105.174 -2.158 . . . . 63.5 105.174 -174.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 36.1 p -141.57 2.3 1.61 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.171 0.51 . . . . 61.5 111.186 178.157 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 25.6 m -98.92 -25.99 14.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.395 0.617 . . . . 75.52 111.381 -175.011 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.563 ' CD1' ' HB3' ' A' ' 391' ' ' ASP . 0.2 OUTLIER -88.53 152.29 49.31 Favored Pre-proline 0 C--N 1.298 -1.636 0 CA-C-N 116.075 -0.511 . . . . 72.34 109.911 -178.167 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . 0.428 ' HB3' HG22 ' A' ' 400' ' ' ILE . 7.6 Cg_exo -35.59 150.71 0.03 OUTLIER 'Trans proline' 0 CA--C 1.553 1.453 1 C-N-CA 125.468 4.112 . . . . 74.15 116.924 177.631 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.72 162.58 10.46 Favored 'Trans proline' 0 C--N 1.364 1.388 0 C-N-CA 124.147 3.231 . . . . 64.22 110.619 172.088 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . 0.548 ' HA ' HG13 ' A' ' 420' ' ' VAL . 0.9 OUTLIER -59.12 -9.69 2.22 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 113.181 0.808 . . . . 72.43 113.181 -176.232 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -95.06 -178.82 4.61 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 108.77 -0.826 . . . . 72.32 108.77 178.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 27.6 m -97.73 117.46 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.825 0 C-N-CA 117.065 -1.854 . . . . 72.01 110.575 179.597 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . 0.428 HG22 ' HB3' ' A' ' 395' ' ' PRO . 0.0 OUTLIER -107.89 -47.4 7.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 109.44 -0.578 . . . . 71.23 109.44 175.337 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.75 169.19 27.94 Favored Glycine 0 N--CA 1.427 -1.947 0 N-CA-C 111.141 -0.784 . . . . 60.01 111.141 -177.5 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.431 ' OG1' ' HG3' ' A' ' 366' ' ' ARG . 0.6 OUTLIER -155.67 -176.08 5.77 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 125.479 1.511 . . . . 54.23 109.935 -176.911 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -99.0 155.41 36.6 Favored Pre-proline 0 C--N 1.299 -1.61 0 N-CA-C 106.605 -1.628 . . . . 54.34 106.605 -178.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -59.93 10.56 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 124.575 3.517 . . . . 73.21 116.156 -172.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -53.45 -43.94 68.47 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 122.868 0.467 . . . . 60.44 111.855 -179.355 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -79.53 -32.33 42.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.251 0.548 . . . . 61.51 111.019 -179.177 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -79.74 1.57 26.1 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.108 0.48 . . . . 72.12 111.211 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 51.0 m -105.47 149.56 26.07 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.676 -1.601 . . . . 75.1 106.676 172.382 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 360' ' ' VAL . 15.0 p -76.0 113.48 13.56 Favored 'General case' 0 N--CA 1.422 -1.826 0 C-N-CA 119.806 -0.758 . . . . 63.21 110.975 178.77 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.4 m -121.93 170.0 12.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.377 -0.829 . . . . 44.44 109.482 178.869 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 33.3 t -76.52 157.15 32.34 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.145 -0.687 . . . . 63.11 109.145 179.759 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -69.24 109.87 4.32 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-O 121.289 0.566 . . . . 52.2 110.079 179.754 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 108.38 55.61 0.59 Allowed Glycine 0 N--CA 1.433 -1.514 0 CA-C-N 115.095 -0.957 . . . . 71.13 111.413 179.152 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -100.32 -173.18 2.35 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.739 -1.208 . . . . 74.44 107.739 178.057 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -120.08 113.86 21.12 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.414 -0.587 . . . . 74.15 109.414 -177.34 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 44.9 mm -104.32 133.71 47.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 108.822 -0.807 . . . . 74.3 108.822 -179.058 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 80.3 m -101.82 132.24 47.68 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 122.022 -0.424 . . . . 62.21 110.192 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 9.7 p -115.44 134.36 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 108.888 -0.782 . . . . 70.11 108.888 176.622 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -105.26 114.2 28.24 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.812 0.815 . . . . 75.43 109.286 177.805 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.548 HG13 ' HA ' ' A' ' 397' ' ' ASP . 96.3 t -111.22 131.39 62.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 114.569 -1.196 . . . . 71.13 108.846 -174.209 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . 0.465 ' HB2' HG12 ' A' ' 394' ' ' ILE . 17.3 t -92.67 121.82 34.47 Favored 'General case' 0 N--CA 1.428 -1.553 0 C-N-CA 119.53 -0.868 . . . . 74.32 110.0 179.265 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.405 ' OG1' ' HB3' ' A' ' 388' ' ' GLN . 33.9 p -120.09 107.28 12.85 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 116.152 -0.476 . . . . 73.14 110.225 174.244 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 101.7 124.03 5.33 Favored Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 119.94 -1.124 . . . . 63.31 113.438 176.255 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -83.31 158.95 15.01 Favored 'Trans proline' 0 C--O 1.254 1.295 0 C-N-CA 123.2 2.6 . . . . 70.35 111.227 176.149 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -72.37 166.27 22.87 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.563 -0.744 . . . . 61.32 110.798 -178.201 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -87.07 157.88 19.32 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 107.334 -1.358 . . . . 63.35 107.334 179.725 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -121.22 151.79 39.58 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 119.585 -0.846 . . . . 74.55 112.428 -169.817 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 34.9 tt0 -83.63 138.77 33.19 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.299 -1.319 . . . . 75.44 109.009 -176.488 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 70.7 mt -80.59 116.65 63.44 Favored Pre-proline 0 C--N 1.306 -1.305 0 N-CA-C 108.082 -1.081 . . . . 70.2 108.082 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -71.29 140.62 37.42 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.476 1.451 . . . . 75.13 110.201 176.398 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.28 128.62 35.48 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.413 -1.328 . . . . 74.22 107.413 175.603 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 42.9 t -118.28 157.45 19.72 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 107.514 -1.291 . . . . 73.43 107.514 -177.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.524 ' HB2' ' OG1' ' A' ' 436' ' ' THR . 15.4 m -63.74 146.64 53.49 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-O 120.961 0.41 . . . . 71.45 110.985 -179.511 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 34.8 p -69.14 -25.91 64.62 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 124.66 1.184 . . . . 71.45 112.574 -170.511 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.493 ' H ' HD23 ' A' ' 435' ' ' LEU . 0.6 OUTLIER -90.61 -10.94 41.47 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 115.431 -0.804 . . . . 72.31 111.109 179.334 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.617 HG22 ' HB3' ' A' ' 439' ' ' GLU . 2.4 m -100.66 46.14 0.96 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.424 0.63 . . . . 74.44 109.729 -176.197 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -52.24 -42.79 63.92 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 113.892 1.071 . . . . 73.55 113.892 -178.944 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.52 -44.48 94.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.633 0.254 . . . . 45.34 110.996 -176.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.617 ' HB3' HG22 ' A' ' 436' ' ' THR . 28.1 tt0 -70.62 -33.11 70.66 Favored 'General case' 0 C--O 1.195 -1.775 0 CA-C-N 116.474 -0.33 . . . . 73.11 110.777 174.484 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.417 ' O ' HD23 ' A' ' 444' ' ' LEU . . . -59.66 -52.28 66.18 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.988 -0.285 . . . . 54.44 110.75 179.127 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 33.7 m -62.48 -36.33 74.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.614 0.721 . . . . 71.11 110.398 177.437 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.532 ' HB3' ' HA ' ' A' ' 439' ' ' GLU . 20.7 ttmm -59.46 -46.79 87.76 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 124.97 1.308 . . . . 60.23 110.229 176.019 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -65.9 -38.76 89.59 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 123.282 0.633 . . . . 73.31 111.727 -179.64 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 440' ' ' ALA . 4.6 mm? -63.32 -34.64 78.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.054 -0.35 . . . . 71.43 110.054 174.859 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.527 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 32.4 m -69.66 -45.67 67.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.25 0.548 . . . . 71.33 110.221 178.129 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.63 -24.95 64.62 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.635 -0.711 . . . . 52.33 112.455 -178.118 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.57 -4.77 53.01 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.326 0.491 . . . . 73.22 112.326 -177.651 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 125.88 -79.59 0.37 Allowed Glycine 0 CA--C 1.497 -1.074 0 C-N-CA 119.96 -1.114 . . . . 71.11 111.98 177.447 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -42.65 -66.87 0.32 Allowed 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.372 1.069 . . . . 54.23 113.858 178.354 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . 0.527 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 63.1 25.54 68.24 Favored Glycine 0 CA--C 1.502 -0.766 0 O-C-N 123.362 0.414 . . . . 65.43 112.626 -178.338 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.504 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 8.6 mmt180 -105.31 110.61 23.03 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.432 -1.692 . . . . 72.31 106.432 -179.711 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.415 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 30.5 p90 -141.03 154.42 45.99 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-O 121.228 0.537 . . . . 64.03 112.091 -176.177 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 5.4 tppp? -137.11 135.0 37.04 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.477 -1.305 . . . . 63.44 107.477 177.681 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -100.03 133.08 44.93 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.312 -0.625 . . . . 74.4 109.312 176.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -126.67 151.73 47.69 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.724 -0.473 . . . . 71.14 109.724 177.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -113.9 141.3 47.53 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.589 -1.263 . . . . 74.42 107.589 179.245 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 37.3 t -138.1 135.34 18.48 Favored Pre-proline 0 C--N 1.283 -2.323 0 N-CA-C 109.122 -0.695 . . . . 41.4 109.122 178.394 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.642 ' HA ' ' O ' ' A' ' 490' ' ' SER . 51.0 Cg_endo -73.07 122.9 8.45 Favored 'Trans proline' 0 N--CA 1.439 -1.679 0 C-N-CA 121.521 1.481 . . . . 72.13 109.403 174.608 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 51.0 m -148.44 -179.79 7.22 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 109.685 -0.487 . . . . 64.24 109.685 -175.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.1 t -47.69 137.86 9.6 Favored Pre-proline 0 C--O 1.251 1.158 0 C-N-CA 124.556 1.143 . . . . 73.24 112.03 178.371 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -52.73 -29.31 41.49 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 124.642 3.562 . . . . 63.35 113.668 -175.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.403 ' HG2' ' H ' ' A' ' 462' ' ' GLU . 8.8 pt-20 -71.33 -26.61 62.91 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 112.718 0.636 . . . . 74.1 112.718 -178.53 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -93.89 -4.52 49.81 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.806 -0.559 . . . . 55.0 111.624 179.566 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 85.3 t -60.68 127.79 20.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-N 116.006 -0.543 . . . . 71.31 110.524 178.224 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 95.88 -7.27 67.5 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 115.613 -0.721 . . . . 61.35 113.862 176.456 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.443 ' O ' HG23 ' A' ' 488' ' ' VAL . 6.8 mptt -122.35 158.96 28.47 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.586 -0.894 . . . . 65.41 108.586 -179.707 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 488' ' ' VAL . 66.2 t -72.13 143.81 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.739 0 N-CA-C 107.999 -1.112 . . . . 61.31 107.999 176.624 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 58.3 mt -97.26 -27.73 3.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 107.492 -1.299 . . . . 70.3 107.492 179.409 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 153.18 -165.83 31.38 Favored Glycine 0 N--CA 1.419 -2.457 0 C-N-CA 120.541 -0.837 . . . . 61.14 111.956 175.558 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.13 142.69 46.48 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 106.991 -1.485 . . . . 72.01 106.991 176.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -67.68 -55.72 13.64 Favored Pre-proline 0 CA--C 1.548 0.879 0 N-CA-C 109.712 -0.477 . . . . 53.51 109.712 179.064 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.461 ' HA ' ' HD3' ' A' ' 473' ' ' PRO . 12.2 Cg_endo -61.15 133.84 49.16 Favored 'Trans proline' 0 C--N 1.37 1.659 0 N-CA-C 108.276 -1.471 . . . . 72.25 108.276 168.917 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 472' ' ' PRO . 32.5 Cg_exo -62.14 127.96 22.65 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.742 2.295 . . . . 72.42 113.821 -173.862 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -74.03 12.8 0.63 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.968 0.907 . . . . 63.22 111.234 178.59 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -111.03 -7.65 14.51 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.852 -0.613 . . . . 74.5 109.846 176.188 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -116.25 174.7 5.91 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 113.542 0.942 . . . . 60.44 113.542 -170.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 0.9 OUTLIER -99.09 141.12 32.27 Favored 'General case' 0 N--CA 1.411 -2.414 0 C-N-CA 124.513 1.125 . . . . 70.11 112.6 -179.173 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 28.3 p -137.82 149.17 46.12 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.11 -0.95 . . . . 64.25 109.362 177.765 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -68.93 162.11 27.37 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 120.846 0.355 . . . . 63.04 110.948 178.477 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.9 mp -67.57 -15.19 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-O 122.133 0.968 . . . . 74.41 110.976 -178.543 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.2 p -94.41 0.75 55.66 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 115.953 -0.567 . . . . 71.3 112.067 177.437 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -83.69 133.88 34.79 Favored 'General case' 0 CA--C 1.503 -0.855 0 O-C-N 122.005 -0.434 . . . . 73.44 111.414 -178.581 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.504 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.3 p -96.53 126.71 49.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.658 -0.701 . . . . 63.4 109.728 178.089 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 22.3 m -101.48 136.75 31.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-O 121.313 0.578 . . . . 64.33 110.346 178.703 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.79 120.24 58.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 109.005 -0.739 . . . . 52.32 109.005 178.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 37.2 mt -109.49 122.91 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 114.663 -1.153 . . . . 73.3 109.9 -177.249 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.4 tt -106.61 127.0 62.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 115.062 -0.972 . . . . 74.52 111.631 -173.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 466' ' ' LYS . 2.5 p -111.34 142.78 22.72 Favored 'Isoleucine or valine' 0 C--O 1.247 0.967 0 N-CA-C 109.088 -0.708 . . . . 64.11 109.088 176.411 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -88.17 141.11 16.69 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.88 -0.676 . . . . 25.14 113.468 -176.059 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.642 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 11.1 t -138.8 160.73 38.97 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.804 -1.554 . . . . 63.22 106.804 176.131 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 167.52 156.95 10.32 Favored Glycine 0 N--CA 1.44 -1.068 0 C-N-CA 119.174 -1.488 . . . . 61.31 113.062 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -89.6 167.15 5.07 Favored 'Trans proline' 0 C--O 1.244 0.805 0 C-N-CA 123.705 2.937 . . . . 74.14 112.535 179.38 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -118.19 53.46 0.96 Allowed 'General case' 0 C--O 1.244 0.805 0 CA-C-O 122.302 1.048 . . . . 74.42 108.239 177.446 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 22.8 p -117.78 147.95 42.52 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.762 -1.108 . . . . 75.21 111.233 -176.022 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -141.47 161.79 37.05 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.139 -1.06 . . . . 62.12 108.139 177.495 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.3 p-10 -100.4 138.25 37.72 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.267 0.556 . . . . 74.33 110.754 178.951 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 30.9 pt -77.04 137.51 65.46 Favored Pre-proline 0 C--N 1.308 -1.234 0 CA-C-N 115.293 -0.867 . . . . 73.12 111.967 -178.56 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -81.79 176.32 8.51 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.692 2.261 . . . . 73.41 111.22 176.636 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -86.7 118.88 26.39 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 108.843 -0.799 . . . . 75.45 108.843 178.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.09 8.78 7.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-O 122.107 0.956 . . . . 65.4 109.967 -177.426 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -68.19 108.02 3.0 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.93 -1.032 . . . . 55.35 109.719 -179.343 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 132.13 -19.11 4.66 Favored Glycine 0 N--CA 1.432 -1.621 0 C-N-CA 120.689 -0.767 . . . . 53.02 111.36 -177.892 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -99.58 172.94 6.98 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.045 -0.662 . . . . 63.11 109.344 177.542 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 533' ' ' GLU . 40.2 p -90.81 157.69 17.23 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.105 -0.638 . . . . 64.55 110.866 -176.078 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 10.0 p -53.7 -40.75 44.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.848 0.685 . . . . 65.11 112.848 -175.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -62.76 -42.93 99.91 Favored 'General case' 0 C--O 1.249 1.064 0 CA-C-O 121.236 0.541 . . . . 73.4 110.387 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 87.8 t -74.66 -37.05 42.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.631 -0.713 . . . . 74.31 110.065 -178.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . 0.461 ' HA ' ' ND2' ' A' ' 511' ' ' ASN . . . -63.29 -50.24 70.87 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.261 -0.882 . . . . 71.33 111.957 -179.015 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -64.82 -35.53 81.41 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.853 0.359 . . . . 72.03 110.712 -178.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.447 ' O ' HG23 ' A' ' 514' ' ' VAL . 3.6 tppp? -65.63 -52.97 47.78 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.672 -0.695 . . . . 74.14 111.627 179.756 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . 0.461 ' ND2' ' HA ' ' A' ' 508' ' ' ALA . 8.0 p30 -66.02 -37.82 86.85 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 120.342 -0.543 . . . . 75.04 111.539 -176.452 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . 0.427 HD23 ' O ' ' A' ' 508' ' ' ALA . 4.6 mm? -60.08 -41.32 92.18 Favored 'General case' 0 C--O 1.246 0.904 0 C-N-CA 121.032 -0.267 . . . . 75.03 110.617 176.052 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.11 -38.22 90.31 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 116.414 -0.357 . . . . 64.14 111.158 178.336 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 510' ' ' LYS . 96.9 t -63.77 -30.98 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 CA-C-N 115.889 -0.596 . . . . 73.54 111.223 179.198 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -80.26 -13.22 59.39 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 120.502 -0.479 . . . . 72.24 111.647 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 119.0 -14.7 11.16 Favored Glycine 0 N--CA 1.434 -1.445 0 C-N-CA 119.955 -1.117 . . . . 64.4 112.504 178.716 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -77.44 102.56 6.91 Favored 'General case' 0 CA--C 1.481 -1.692 0 N-CA-C 106.182 -1.784 . . . . 71.45 106.182 -178.678 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.5 m -88.91 -28.86 20.03 Favored 'General case' 0 N--CA 1.407 -2.58 0 C-N-CA 119.479 -0.888 . . . . 74.25 113.03 -167.152 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 61.7 mttp -108.32 125.36 51.62 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.736 -0.785 . . . . 71.41 111.659 -174.508 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -130.64 149.49 52.27 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.727 -0.669 . . . . 75.44 110.851 -178.38 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 46.9 m -132.29 143.71 50.08 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.33 -1.359 . . . . 72.45 107.33 173.786 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.04 144.32 44.74 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 109.381 -0.6 . . . . 72.44 109.381 179.327 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -130.64 129.99 43.37 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.3 -0.63 . . . . 54.14 109.3 178.814 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 50.8 m -84.11 120.97 26.8 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.542 -0.54 . . . . 51.12 109.542 179.529 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 32.3 m -121.4 162.71 20.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 108.149 -1.056 . . . . 33.42 108.149 179.229 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . 0.622 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 6.9 p-10 -82.52 134.38 35.2 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 119.26 -0.976 . . . . 73.53 109.378 -178.57 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . 0.506 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 51.1 m -152.73 167.99 12.28 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 110.231 -0.285 . . . . 72.41 110.231 177.13 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -85.7 -8.05 8.35 Favored 'Trans proline' 0 C--N 1.36 1.148 0 C-N-CA 122.284 1.99 . . . . 63.13 111.295 174.555 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.523 ' HD3' ' OE2' ' A' ' 533' ' ' GLU . 50.4 mtt180 -80.07 145.53 61.18 Favored Pre-proline 0 N--CA 1.445 -0.71 0 N-CA-C 107.589 -1.263 . . . . 73.21 107.589 178.467 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -61.31 152.29 73.42 Favored 'Trans proline' 0 C--O 1.256 1.422 0 C-N-CA 122.364 2.043 . . . . 44.31 112.585 -179.327 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.658 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -62.93 115.58 4.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.132 -0.94 . . . . 74.13 111.352 -176.238 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 134.3 -24.64 3.55 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 120.564 -0.827 . . . . 35.15 112.224 178.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . 0.523 ' OE2' ' HD3' ' A' ' 529' ' ' ARG . 32.0 tt0 -82.99 137.85 33.99 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.349 -0.541 . . . . 73.32 109.797 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 88.2 t -81.83 120.2 32.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.86 -0.793 . . . . 74.31 108.86 178.413 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . 0.463 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 9.3 t -80.94 -13.27 59.05 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.314 -0.403 . . . . 61.43 110.154 -179.075 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.91 -170.76 29.29 Favored Glycine 0 N--CA 1.426 -2.005 0 N-CA-C 109.987 -1.245 . . . . 50.22 109.987 178.222 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 14.1 p -116.88 160.4 20.93 Favored 'General case' 0 C--N 1.273 -2.729 0 N-CA-C 108.384 -0.969 . . . . 74.14 108.384 178.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.504 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 38.1 t30 -67.02 -51.75 35.03 Favored Pre-proline 0 C--N 1.317 -0.841 0 C-N-CA 120.443 -0.503 . . . . 64.42 110.762 178.305 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.504 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 3.9 Cg_exo -77.45 131.13 11.35 Favored 'Trans proline' 0 C--N 1.367 1.538 0 N-CA-C 107.601 -1.73 . . . . 74.43 107.601 170.576 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.93 162.15 39.23 Favored 'Trans proline' 0 C--O 1.25 1.117 0 C-N-CA 122.142 1.895 . . . . 53.15 112.555 -177.215 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -56.99 131.33 49.52 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 109.415 -0.587 . . . . 35.12 109.415 175.783 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.9 -12.06 38.04 Favored Glycine 0 C--N 1.301 -1.399 0 C-N-CA 120.928 -0.654 . . . . 42.34 111.929 -177.656 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 56.5 m -68.16 120.68 14.74 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.222 -0.659 . . . . 75.53 109.222 177.111 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 31.8 m -90.77 122.18 33.28 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 109.266 -0.642 . . . . 63.33 109.266 -179.464 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 28.7 m -136.88 158.68 72.47 Favored Pre-proline 0 C--N 1.311 -1.087 0 N-CA-C 108.96 -0.756 . . . . 75.3 108.96 -177.57 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -62.5 148.02 93.95 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 122.28 1.986 . . . . 73.2 110.723 175.527 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 27.0 m -64.13 -27.52 42.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 121.482 0.658 . . . . 75.53 111.882 -178.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -88.85 2.91 52.88 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 116.159 -0.473 . . . . 63.53 110.755 -179.25 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 9.7 t -82.14 172.16 13.5 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 120.862 0.363 . . . . 65.21 110.243 -176.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 7.8 t -110.58 124.01 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 CA-C-N 115.883 -0.599 . . . . 75.43 109.618 -176.653 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . 0.504 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -107.39 145.87 14.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 120.313 -0.555 . . . . 71.04 110.297 176.567 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -103.3 117.25 34.07 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.209 0.528 . . . . 73.31 111.037 -176.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 5.5 mp -98.77 130.7 45.23 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.562 -1.199 . . . . 75.23 108.6 178.641 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -102.08 120.03 39.76 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 121.489 0.661 . . . . 65.11 109.651 179.759 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 40.0 t -100.37 137.35 28.17 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 CA-C-N 115.191 -0.913 . . . . 73.41 109.413 -175.629 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.658 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 6.2 m -79.64 123.23 27.44 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.99 -1.004 . . . . 70.34 109.239 -179.015 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.622 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 17.6 ptmt -92.17 145.7 24.3 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 104.313 -2.477 . . . . 51.54 104.313 169.351 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -79.14 -30.42 46.54 Favored Glycine 0 CA--C 1.486 -1.775 0 C-N-CA 118.964 -1.589 . . . . 51.24 113.486 -172.344 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 70.34 -29.15 0.18 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.663 1.185 . . . . 71.23 113.008 179.491 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.498 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 76.6 mt-30 -128.14 154.4 45.8 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 123.839 0.856 . . . . 74.45 112.015 -176.099 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -138.96 151.09 46.6 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.76 -0.83 . . . . 70.34 108.76 176.528 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 8.5 p -65.78 122.71 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 CA-C-O 121.262 0.554 . . . . 73.44 111.745 -178.912 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . 0.484 ' HG2' ' O ' ' A' ' 564' ' ' PRO . 57.6 ttp -97.82 137.56 20.96 Favored Pre-proline 0 C--O 1.249 1.046 0 CA-C-N 116.182 -0.463 . . . . 45.52 111.311 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . 0.484 ' O ' ' HG2' ' A' ' 563' ' ' MET . 12.6 Cg_exo -73.4 169.39 22.4 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.633 2.222 . . . . 54.23 109.829 169.674 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -83.04 141.13 32.28 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.165 0.507 . . . . 62.42 110.722 -179.25 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 89.4 mt -122.99 15.32 9.96 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.96 -1.126 . . . . 72.32 107.96 177.034 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 7.7 m -72.17 141.21 49.07 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 114.437 -1.256 . . . . 72.4 109.837 -178.046 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 80.37 13.99 80.91 Favored Glycine 0 C--O 1.217 -0.945 0 C-N-CA 120.523 -0.846 . . . . 61.42 113.185 178.271 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 26.2 mmt -105.13 165.14 11.3 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 122.295 -0.532 . . . . 75.54 110.485 178.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -86.42 161.21 18.77 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.858 -1.164 . . . . 63.13 107.858 -179.658 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 30.8 t90 -71.22 -25.93 62.72 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.946 -0.761 . . . . 72.22 108.946 177.667 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.0 p -73.78 -17.72 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 115.27 -0.877 . . . . 62.35 109.407 179.475 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . 0.625 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 25.0 t70 -97.26 -34.97 10.89 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.362 -0.607 . . . . 74.44 109.362 178.5 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -64.03 -33.62 76.17 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.736 -0.665 . . . . 71.01 111.436 178.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.519 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 40.0 tt0 -55.99 -57.11 23.94 Favored Pre-proline 0 CA--C 1.576 1.953 0 CA-C-N 115.923 -0.58 . . . . 61.31 111.973 177.472 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 38.9 Cg_exo -61.05 -31.46 90.99 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 121.59 1.527 . . . . 74.34 112.835 173.656 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.625 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 24.2 mmt180 -58.9 -47.82 83.63 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 110.123 -0.325 . . . . 75.51 110.123 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.513 HD12 ' N ' ' A' ' 579' ' ' ARG . 4.4 pp -64.09 -45.98 86.29 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 112.372 0.508 . . . . 60.15 112.372 -174.595 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . 0.513 ' N ' HD12 ' A' ' 578' ' ' LEU . 4.1 ptp180 -66.02 -35.23 80.0 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.682 -0.407 . . . . 73.23 112.074 178.618 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.85 -36.42 72.86 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.23 0.538 . . . . 23.11 111.605 178.44 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 86.8 mt -81.84 -3.3 53.7 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 112.418 0.525 . . . . 55.42 112.418 -177.42 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 73.39 40.68 47.68 Favored Glycine 0 CA--C 1.506 -0.528 0 C-N-CA 120.581 -0.818 . . . . 61.2 111.178 -179.632 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 75.6 t90 -70.04 137.64 51.46 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.999 -0.6 . . . . 72.02 110.739 -179.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 5.9 t -156.49 75.23 0.85 Allowed 'General case' 0 N--CA 1.424 -1.748 0 CA-C-O 122.283 1.04 . . . . 75.3 109.399 178.432 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -141.38 -137.71 3.44 Favored Glycine 0 N--CA 1.434 -1.457 0 N-CA-C 110.923 -0.871 . . . . 70.42 110.923 -178.587 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 65.7 mtt -126.8 136.87 52.96 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.057 -1.09 . . . . 53.35 108.057 177.622 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -97.38 128.51 44.25 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.796 -1.187 . . . . 72.44 107.796 -176.837 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -105.01 101.86 11.4 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.949 -0.7 . . . . 74.44 110.346 179.453 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -102.45 133.57 47.19 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 107.746 -1.205 . . . . 73.41 107.746 175.597 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -90.99 -154.44 30.52 Favored Glycine 0 N--CA 1.418 -2.558 0 N-CA-C 110.312 -1.115 . . . . 60.02 110.312 177.107 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -71.0 133.6 46.48 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 110.153 -0.314 . . . . 73.21 110.153 179.048 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -77.23 123.24 26.18 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 105.469 -2.048 . . . . 72.34 105.469 177.282 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 94.5 t -136.03 135.68 50.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-O 120.971 0.415 . . . . 74.24 111.895 -171.315 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . 0.425 ' HB2' HE21 ' A' ' 626' ' ' GLN . 17.7 t70 -97.58 106.54 18.87 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 105.86 -1.904 . . . . 71.11 105.86 173.16 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -145.15 9.54 1.26 Allowed 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 112.777 0.658 . . . . 71.35 112.777 -175.561 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 122.91 167.04 12.82 Favored Glycine 0 C--N 1.302 -1.327 0 C-N-CA 119.84 -1.171 . . . . 72.21 111.583 179.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.75 -43.13 91.93 Favored Glycine 0 C--O 1.239 0.433 0 O-C-N 123.864 0.391 . . . . 45.11 114.052 -172.565 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 15.8 m -65.65 -34.11 77.46 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.181 0.515 . . . . 71.02 111.231 -179.112 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . 0.427 ' O ' ' HA3' ' A' ' 625' ' ' GLY . 80.9 mm-40 -92.49 -0.97 57.28 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 112.511 0.56 . . . . 54.22 112.511 -178.644 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -89.86 -106.56 0.09 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.424 0.898 . . . . 73.0 113.424 -178.515 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -92.46 54.86 2.38 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.185 0.517 . . . . 74.4 110.005 -173.227 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -144.12 140.85 29.65 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.891 -0.781 . . . . 71.01 108.891 176.802 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 95.8 t -64.34 130.15 29.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 107.509 -1.293 . . . . 72.32 107.509 173.322 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 58.0 t -89.2 -52.32 11.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.046 0.45 . . . . 61.34 110.429 -177.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -135.52 155.85 49.83 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.134 -1.061 . . . . 74.43 108.134 179.391 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -118.9 100.29 7.28 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 107.194 -1.41 . . . . 72.04 107.194 178.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.499 ' CB ' ' HB ' ' A' ' 621' ' ' THR . 26.7 t-20 -54.75 -51.58 77.7 Favored Pre-proline 0 CA--C 1.554 1.111 0 N-CA-C 113.772 1.027 . . . . 63.04 113.772 -177.72 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 609' ' ' PRO . 7.8 Cg_exo -75.84 128.95 11.2 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 121.094 1.196 . . . . 51.03 109.229 173.072 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . 0.521 ' HB2' ' OG1' ' A' ' 612' ' ' THR . 12.6 Cg_exo -70.31 135.8 30.02 Favored 'Trans proline' 0 C--O 1.242 0.7 0 C-N-CA 122.395 2.064 . . . . 51.34 113.196 -177.533 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -68.35 134.47 50.32 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.216 -0.661 . . . . 60.21 109.216 176.125 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 88.27 0.39 82.73 Favored Glycine 0 C--N 1.305 -1.182 0 C-N-CA 120.136 -1.031 . . . . 73.13 111.108 -178.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . 0.521 ' OG1' ' HB2' ' A' ' 609' ' ' PRO . 39.7 m -111.8 160.6 17.18 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.631 -1.248 . . . . 72.11 107.631 178.321 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -75.89 135.68 18.35 Favored Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 111.223 -0.751 . . . . 74.35 111.223 178.697 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.18 142.18 37.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 108.113 -1.069 . . . . 62.41 108.113 176.894 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.498 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 34.9 p-10 -50.61 153.09 1.75 Allowed 'General case' 0 C--O 1.217 -0.648 0 N-CA-C 113.169 0.803 . . . . 72.23 113.169 179.174 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . 0.509 ' HD3' ' H ' ' A' ' 616' ' ' ARG . 0.0 OUTLIER -48.65 -30.82 5.86 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.952 1.301 . . . . 73.43 112.196 177.624 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . 0.491 ' HB2' ' ND2' ' A' ' 615' ' ' ASN . 1.0 OUTLIER -66.04 -44.41 84.69 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.578 -0.737 . . . . 71.43 110.325 176.736 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 87.45 23.1 41.19 Favored Glycine 0 N--CA 1.426 -1.986 0 C-N-CA 118.65 -1.738 . . . . 64.32 111.34 -178.266 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.84 119.2 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 123.238 1.494 . . . . 62.13 109.359 -167.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 4.2 tp -115.19 119.94 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.118 0 CA-C-N 113.215 -1.811 . . . . 73.32 110.528 -172.596 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.499 ' HB ' ' CB ' ' A' ' 607' ' ' ASN . 24.9 m -98.98 117.13 32.8 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 106.181 -1.785 . . . . 73.4 106.181 171.912 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -138.93 165.37 27.26 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 107.536 -1.283 . . . . 54.32 107.536 -175.835 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -134.11 135.77 43.42 Favored 'General case' 0 C--N 1.272 -2.786 0 N-CA-C 107.623 -1.251 . . . . 71.35 107.623 178.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -143.68 165.41 27.7 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 124.857 1.348 . . . . 72.23 107.578 172.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' A' ' 599' ' ' GLN . . . -113.37 -110.87 2.99 Favored Glycine 0 C--N 1.279 -2.623 0 N-CA-C 111.586 -0.606 . . . . 63.12 111.586 -179.092 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . 0.425 HE21 ' HB2' ' A' ' 594' ' ' ASP . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.17 0 C-N-CA 121.034 -0.266 . . . . 74.42 111.03 179.02 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.049 0 N-CA-C 110.6 -1.0 . . . . 70.03 110.6 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 8.4 tp -74.36 109.71 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 CA-C-O 122.268 1.032 . . . . 73.41 111.068 -176.594 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 3.1 m -77.17 151.16 35.41 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.636 -1.166 . . . . 72.23 108.869 -179.814 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 21.3 mtp180 -79.32 -20.18 48.56 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.16 0.505 . . . . 71.32 110.422 -179.468 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.65 129.96 41.52 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 105.424 -2.065 . . . . 72.52 105.424 167.312 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 31.5 m -116.12 157.79 16.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-O 121.488 0.661 . . . . 73.01 111.63 -169.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . 0.473 HE21 ' C ' ' A' ' 361' ' ' GLN . 0.0 OUTLIER -94.76 124.3 38.72 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 106.606 -1.627 . . . . 71.25 106.606 -176.196 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 406' ' ' ALA . 89.7 t -101.35 129.53 26.76 Favored Pre-proline 0 C--N 1.287 -2.109 0 CA-C-N 114.993 -1.003 . . . . 73.41 111.335 -172.58 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -73.41 132.75 18.11 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.138 1.892 . . . . 73.01 109.42 174.637 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . 0.43 ' HB2' HD21 ' A' ' 407' ' ' ASN . 6.5 t0 -91.76 158.89 16.1 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 120.291 -0.564 . . . . 74.33 109.648 -175.551 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.522 HG21 ' HA ' ' A' ' 373' ' ' ALA . 4.0 m -114.17 6.34 7.71 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 C-N-CA 124.203 1.001 . . . . 72.03 111.673 -176.026 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.77 145.38 12.39 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 112.757 0.651 . . . . 72.0 112.757 172.725 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . 0.404 ' H ' HG23 ' A' ' 399' ' ' VAL . . . 104.85 -6.02 43.54 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.254 -0.884 . . . . 54.33 112.307 -176.478 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -104.97 -92.44 0.37 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.73 0.3 . . . . 44.41 111.075 179.608 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 64.9 p -156.31 157.11 35.15 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 107.619 -1.252 . . . . 74.34 107.619 -179.133 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 7.9 p -64.1 -37.52 87.75 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 118.307 0.503 . . . . 64.11 111.221 179.702 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.21 -45.45 94.5 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 116.07 -0.514 . . . . 61.52 111.206 178.789 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -69.12 -39.24 79.03 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.609 -0.515 . . . . 65.11 109.609 179.692 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . 0.522 ' HA ' HG21 ' A' ' 365' ' ' VAL . . . -61.91 -51.36 68.45 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.679 -0.692 . . . . 71.44 111.403 -178.964 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 78.5 mt -65.56 -39.97 86.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.188 -0.46 . . . . 60.31 110.124 179.122 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.26 -47.35 85.7 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.063 -0.517 . . . . 63.1 110.907 -179.496 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . 0.527 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 51.3 m -64.97 -47.46 77.51 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.953 -0.567 . . . . 71.52 110.982 -179.085 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 10.8 mp -62.9 -39.02 93.23 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 112.145 0.424 . . . . 71.41 112.145 -179.248 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -64.99 -38.81 92.2 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.764 0.316 . . . . 53.41 110.205 179.349 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -68.37 -26.59 65.65 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.142 0.496 . . . . 51.41 111.355 176.744 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 376' ' ' THR . 9.7 mmm180 -82.15 -14.26 55.94 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.284 -0.416 . . . . 55.41 110.846 178.71 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 92.88 16.37 48.43 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.475 -0.869 . . . . 63.14 111.157 179.639 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.455 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 29.3 m-85 -93.16 154.77 17.87 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-O 121.454 0.645 . . . . 70.32 110.427 179.396 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.428 ' HB2' ' HG2' ' A' ' 415' ' ' GLU . 32.6 mmtp -103.75 145.01 30.72 Favored 'General case' 0 N--CA 1.409 -2.508 0 N-CA-C 107.184 -1.413 . . . . 75.54 107.184 -176.626 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.524 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -118.86 142.45 33.8 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 C-N-CA 119.868 -0.733 . . . . 74.2 110.545 -176.726 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 23.7 tpt180 -111.75 147.32 35.89 Favored 'General case' 0 N--CA 1.408 -2.527 0 N-CA-C 105.172 -2.158 . . . . 72.35 105.172 171.829 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 42.9 m -132.77 121.67 23.37 Favored 'General case' 0 C--N 1.269 -2.925 0 C-N-CA 120.229 -0.588 . . . . 71.24 109.56 -175.782 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 66.0 tp -111.22 119.1 37.81 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 107.406 -1.331 . . . . 62.02 107.406 -179.783 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -102.96 131.7 49.74 Favored 'General case' 0 N--CA 1.425 -1.702 0 C-N-CA 119.845 -0.742 . . . . 42.42 110.408 177.966 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . 0.548 ' O ' ' HA ' ' A' ' 421' ' ' SER . 13.2 mmmm -126.01 148.32 62.49 Favored Pre-proline 0 C--N 1.282 -2.367 0 N-CA-C 106.152 -1.796 . . . . 73.24 106.152 -178.264 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -69.35 158.04 58.97 Favored 'Trans proline' 0 C--O 1.243 0.765 0 N-CA-C 108.751 -1.288 . . . . 73.24 108.751 173.135 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.439 ' HB2' ' HA ' ' A' ' 424' ' ' PRO . 6.1 m-20 -74.82 82.88 2.14 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-O 121.818 0.818 . . . . 72.02 109.688 178.019 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . 0.467 ' O ' ' HB ' ' A' ' 393' ' ' THR . 17.1 m -103.29 49.3 0.83 Allowed 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 114.593 -1.185 . . . . 74.41 108.843 178.709 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 392' ' ' SER . 99.2 m 69.54 20.28 7.17 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-O 123.206 1.479 . . . . 71.31 110.02 -179.715 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 5.4 pt -115.75 152.3 47.22 Favored Pre-proline 0 C--N 1.301 -1.536 0 CA-C-N 114.85 -1.068 . . . . 63.23 111.155 -174.357 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 396' ' ' PRO . 0.6 OUTLIER -21.5 116.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.364 1.388 1 C-N-CA 126.48 4.786 . . . . 45.43 116.831 -177.82 . . . . . . . . 4 4 . 1 . 026 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . 0.52 ' HA ' ' OG ' ' A' ' 421' ' ' SER . 41.9 Cg_exo -59.02 161.86 14.89 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 124.267 3.311 . . . . 52.11 114.52 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -57.89 -8.46 0.99 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.996 1.318 . . . . 74.44 113.438 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -98.72 137.14 37.76 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.016 -1.846 . . . . 73.31 106.016 176.21 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 367' ' ' GLY . 18.8 m -72.34 118.2 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 C-N-CA 119.039 -1.064 . . . . 74.31 112.514 -167.86 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.4 -30.6 2.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 105.843 -1.91 . . . . 74.23 105.843 171.386 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.7 157.89 27.55 Favored Glycine 0 N--CA 1.416 -2.673 0 CA-C-N 114.618 -1.174 . . . . 64.03 111.099 -178.399 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 9.3 p -144.83 -175.71 4.78 Favored 'General case' 0 C--N 1.278 -2.523 0 C-N-CA 127.314 2.246 . . . . 51.24 105.369 -177.119 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -98.92 125.95 40.22 Favored Pre-proline 0 C--N 1.295 -1.789 0 C-N-CA 118.118 -1.433 . . . . 72.12 107.673 178.895 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -59.29 6.25 0.09 OUTLIER 'Trans proline' 0 C--N 1.365 1.397 0 C-N-CA 124.691 3.594 . . . . 71.44 115.91 -176.585 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.26 -33.58 67.74 Favored 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 109.467 -0.568 . . . . 73.04 109.467 174.907 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . 0.402 ' O ' ' HB ' ' A' ' 362' ' ' VAL . . . -67.04 -36.32 81.82 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-O 121.512 0.672 . . . . 61.34 110.319 177.275 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . 0.43 HD21 ' HB2' ' A' ' 364' ' ' ASP . 13.0 m120 -85.77 0.72 52.12 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.914 0.864 . . . . 63.44 110.16 -179.147 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 28.5 m -97.33 158.39 15.48 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 104.896 -2.261 . . . . 74.22 104.896 171.588 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 33.7 p -74.32 112.08 10.13 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 118.649 -1.22 . . . . 72.15 108.712 179.236 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 17.1 m -129.53 159.11 41.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 121.296 0.569 . . . . 61.32 112.037 -179.456 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 3.0 p -60.94 140.82 57.66 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.083 -0.962 . . . . 62.32 110.869 177.944 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -65.0 111.01 2.67 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 121.477 0.656 . . . . 64.11 110.372 -177.538 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 107.07 39.92 1.9 Allowed Glycine 0 N--CA 1.423 -2.21 0 CA-C-N 115.05 -0.977 . . . . 73.52 112.001 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -92.18 -179.31 5.21 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.931 -0.766 . . . . 55.23 108.931 -178.319 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . 0.428 ' HG2' ' HB2' ' A' ' 383' ' ' LYS . 43.9 mt-10 -104.69 114.91 29.43 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 110.005 -0.368 . . . . 75.13 110.005 -176.855 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 45.4 mm -107.41 128.78 62.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 109.188 -0.671 . . . . 63.32 109.188 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 25.5 m -85.2 130.29 34.63 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.307 0.575 . . . . 65.41 111.782 -178.023 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 9.4 p -114.68 135.49 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 CA-C-N 115.041 -0.981 . . . . 61.43 108.902 177.861 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -97.67 128.71 44.56 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 110.153 -0.314 . . . . 75.04 110.153 179.27 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 94.6 t -123.72 131.11 73.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 109.235 -0.654 . . . . 63.54 109.235 176.667 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 95.8 p -99.49 123.66 43.96 Favored 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 120.403 -0.519 . . . . 63.44 109.912 177.152 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 5.5 t -119.7 108.68 14.73 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 112.735 0.642 . . . . 71.43 112.735 -179.712 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 81.99 120.54 0.58 Allowed Glycine 0 CA--C 1.535 1.332 0 N-CA-C 115.373 0.909 . . . . 74.43 115.373 171.871 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . 0.439 ' HA ' ' HB2' ' A' ' 391' ' ' ASP . 34.8 Cg_exo -61.89 158.54 37.75 Favored 'Trans proline' 0 C--O 1.251 1.152 0 C-N-CA 123.814 3.009 . . . . 73.41 112.144 174.77 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -71.53 155.94 40.0 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.283 -0.871 . . . . 53.4 111.76 -174.721 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -127.38 150.14 49.75 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 104.775 -2.306 . . . . 54.32 104.775 172.809 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 477' ' ' THR . 20.5 mmm180 -121.66 147.16 46.23 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 119.593 -0.843 . . . . 73.15 111.679 -173.54 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 15.6 pt-20 -82.05 139.19 34.62 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.184 -0.916 . . . . 74.54 108.635 -178.963 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 65.1 mt -78.93 125.79 83.31 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 107.806 -1.183 . . . . 74.33 107.806 -178.878 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -70.51 141.49 42.31 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 121.848 1.699 . . . . 71.33 110.693 175.612 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -80.63 112.55 18.1 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.603 -0.517 . . . . 63.13 109.603 177.981 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 28.2 t -115.78 147.16 19.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 107.528 -1.286 . . . . 61.1 107.528 -179.045 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 1.6 p -58.01 138.17 56.18 Favored 'General case' 0 N--CA 1.432 -1.355 0 O-C-N 123.638 0.586 . . . . 74.32 111.463 179.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 31.7 p -64.57 -34.88 79.28 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 123.931 0.893 . . . . 74.14 112.05 -171.047 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.57 ' H ' HD23 ' A' ' 435' ' ' LEU . 0.7 OUTLIER -75.02 -16.88 60.59 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-N 115.198 -0.91 . . . . 61.53 111.464 -179.775 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.427 HG22 ' HB2' ' A' ' 439' ' ' GLU . 2.1 m -105.03 50.6 0.78 Allowed 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.517 0.675 . . . . 73.13 109.26 -175.075 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . 0.421 ' O ' HG23 ' A' ' 441' ' ' VAL . 38.9 t80 -52.61 -38.82 60.88 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.893 0.877 . . . . 73.44 112.913 -179.683 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -59.44 -40.6 87.35 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-O 121.066 0.46 . . . . 62.12 110.918 179.444 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.427 ' HB2' HG22 ' A' ' 436' ' ' THR . 42.9 tp10 -70.04 -35.63 74.43 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.968 -0.753 . . . . 61.41 108.968 179.621 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.96 -43.62 98.48 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.893 -0.594 . . . . 71.53 110.054 178.732 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 437' ' ' TYR . 84.9 t -58.48 -47.85 87.04 Favored 'Isoleucine or valine' 0 C--O 1.246 0.9 0 CA-C-N 115.232 -0.894 . . . . 74.02 110.911 178.669 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -67.38 -34.53 77.47 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 119.789 -0.765 . . . . 74.0 110.708 -179.376 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -62.53 -42.63 99.65 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 116.826 -0.17 . . . . 75.24 111.291 178.515 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 10.2 mp -63.76 -35.09 79.43 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 120.871 0.367 . . . . 61.3 110.389 176.277 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.46 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 22.2 m -68.19 -46.23 71.23 Favored 'General case' 0 C--O 1.249 1.033 0 CA-C-N 115.936 -0.574 . . . . 42.12 110.557 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.36 -17.39 62.42 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-O 121.105 0.479 . . . . 64.43 111.401 179.53 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.34 5.26 24.0 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.888 -0.596 . . . . 64.01 112.272 -179.871 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 110.48 -82.08 0.3 Allowed Glycine 0 CA--C 1.488 -1.615 0 C-N-CA 119.514 -1.327 . . . . 42.5 112.034 175.778 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . 0.415 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 0.6 OUTLIER -39.91 -65.22 0.41 Allowed 'General case' 0 C--O 1.248 0.995 0 N-CA-C 113.917 1.08 . . . . 71.03 113.917 175.573 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . 0.46 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 59.35 29.69 66.59 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.859 -0.496 . . . . 74.34 111.859 -175.232 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.453 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 16.1 mmm180 -105.06 111.23 23.93 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.472 -1.677 . . . . 62.41 106.472 -179.291 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 35.5 p90 -134.17 153.4 51.86 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 120.871 0.367 . . . . 71.43 110.939 -175.422 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -148.32 122.9 9.79 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.944 -0.761 . . . . 70.41 108.944 177.825 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -83.83 129.39 34.94 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 123.359 0.664 . . . . 73.03 111.458 179.752 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.08 144.66 47.47 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.274 -1.38 . . . . 64.3 107.274 173.342 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -122.29 136.83 54.97 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.521 -0.918 . . . . 71.34 108.521 -177.635 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . 0.427 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 49.4 m -149.45 138.31 12.39 Favored Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 122.356 -0.215 . . . . 70.04 110.595 176.785 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.73 ' HA ' ' O ' ' A' ' 490' ' ' SER . 22.5 Cg_exo -65.82 129.39 22.02 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.404 2.07 . . . . 74.24 111.014 176.358 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 60.6 m -152.21 -179.28 7.39 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.951 -0.568 . . . . 42.43 109.884 -178.042 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 9.7 t -45.0 136.71 4.74 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.952 1.301 . . . . 64.02 112.432 178.643 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.76 -29.48 34.12 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 124.752 3.635 . . . . 73.44 113.933 -175.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -70.38 -30.7 67.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.571 -0.286 . . . . 51.31 111.722 -178.932 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -95.75 -8.81 33.44 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 111.66 0.244 . . . . 63.35 111.66 179.738 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 80.5 t -60.57 127.66 20.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.473 -0.566 . . . . 74.23 109.473 176.696 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 91.06 -15.07 61.82 Favored Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 116.002 -0.544 . . . . 43.31 112.107 -179.529 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -108.69 166.55 10.71 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 109.424 -0.584 . . . . 63.43 109.424 -177.852 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 79.4 t -73.51 140.82 17.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 108.182 -1.044 . . . . 63.15 108.182 173.572 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 65.5 mt -97.33 -35.28 5.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.56 -1.274 . . . . 55.34 107.56 177.253 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 172.76 -179.06 44.49 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 120.297 -0.954 . . . . 74.1 112.031 177.741 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . 0.506 HG22 HG12 ' A' ' 486' ' ' ILE . 33.1 p -115.17 143.93 44.46 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 105.929 -1.878 . . . . 65.52 105.929 178.805 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -60.32 -57.19 28.45 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 119.888 -0.725 . . . . 72.52 112.146 178.607 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -71.94 152.57 57.7 Favored 'Trans proline' 0 C--N 1.361 1.196 0 N-CA-C 108.001 -1.577 . . . . 72.54 108.001 170.58 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.31 127.82 22.09 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 121.601 1.534 . . . . 75.44 111.44 -179.035 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -76.63 6.45 5.89 Favored 'General case' 0 C--O 1.211 -0.928 0 C-N-CA 124.239 1.016 . . . . 64.24 111.932 -175.981 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -109.78 -4.97 15.73 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 116.106 -0.497 . . . . 73.23 109.808 172.625 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -117.26 176.0 5.35 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 112.981 0.734 . . . . 71.44 112.981 -171.421 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 3.7 p -83.41 131.14 35.05 Favored 'General case' 0 N--CA 1.413 -2.295 0 C-N-CA 124.633 1.173 . . . . 74.42 113.145 -177.782 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 43.8 m -121.23 148.64 43.99 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 106.971 -1.492 . . . . 73.22 106.971 175.611 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.457 ' HB3' ' HB2' ' A' ' 482' ' ' ASN . . . -74.48 156.44 36.93 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.725 -0.39 . . . . 73.25 111.442 -176.585 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.415 ' HA ' ' HB3' ' A' ' 449' ' ' PHE . 43.5 mm -69.36 -26.8 32.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.823 0.82 . . . . 73.34 110.25 -177.006 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.4 t -97.9 5.07 49.39 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.69 0.757 . . . . 75.44 109.904 179.021 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . 0.457 ' HB2' ' HB3' ' A' ' 479' ' ' ALA . 5.8 t30 -94.63 135.63 35.87 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.54 -0.755 . . . . 62.35 110.301 -176.597 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.453 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.3 p -89.86 126.75 42.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-O 121.283 0.564 . . . . 72.12 111.444 -177.043 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 60.6 t -96.77 118.53 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.91 0 N-CA-C 107.844 -1.169 . . . . 72.53 107.844 176.207 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.27 129.08 50.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 108.063 -1.088 . . . . 70.42 108.063 177.606 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.506 HG12 HG22 ' A' ' 470' ' ' THR . 15.2 mt -118.54 128.23 75.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-N 115.158 -0.928 . . . . 73.21 110.635 -174.758 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 6.2 tt -103.19 126.17 57.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 115.69 -0.687 . . . . 73.32 110.428 -179.452 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 33.8 m -109.26 151.2 11.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 115.692 -0.685 . . . . 72.14 109.547 178.387 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.42 135.55 14.29 Favored Glycine 0 N--CA 1.423 -2.179 0 C-N-CA 121.125 -0.56 . . . . 70.15 111.744 -178.482 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.73 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 12.8 t -126.05 160.19 30.76 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 105.825 -1.917 . . . . 55.23 105.825 177.234 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . 153.77 100.78 0.19 Allowed Glycine 0 C--N 1.297 -1.618 0 C-N-CA 119.048 -1.548 . . . . 73.24 112.157 178.864 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -72.5 150.0 50.88 Favored 'Trans proline' 0 C--O 1.251 1.129 0 C-N-CA 122.45 2.1 . . . . 64.44 111.736 179.06 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -91.25 81.17 5.52 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.532 -0.914 . . . . 62.1 108.532 175.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 5.9 p -117.81 153.56 33.26 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.263 -0.88 . . . . 72.42 112.209 -175.193 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 8.0 mmtm -137.24 136.85 38.47 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.242 -0.89 . . . . 72.44 109.746 179.986 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -82.27 121.61 26.87 Favored 'General case' 0 CA--C 1.485 -1.527 0 N-CA-C 105.508 -2.034 . . . . 62.41 105.508 168.876 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 543' ' ' THR . 44.1 pt -75.38 123.69 88.75 Favored Pre-proline 0 C--N 1.292 -1.905 0 N-CA-C 113.348 0.87 . . . . 64.13 113.348 -172.6 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -86.58 164.6 9.31 Favored 'Trans proline' 0 N--CA 1.429 -2.301 0 C-N-CA 122.472 2.114 . . . . 60.14 108.871 171.784 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -82.35 147.26 28.93 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 120.383 -0.527 . . . . 52.24 109.99 -178.487 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 11.1 p -130.35 8.29 2.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-O 122.045 0.926 . . . . 75.43 109.832 -176.824 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -81.23 157.11 25.31 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 115.43 -0.805 . . . . 72.52 110.185 -175.994 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 108.55 1.51 32.77 Favored Glycine 0 C--N 1.287 -2.145 0 N-CA-C 109.573 -1.411 . . . . 61.52 109.573 -178.49 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -120.62 175.43 6.01 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.414 -0.958 . . . . 65.53 108.414 -179.267 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 15.0 t -83.89 159.83 21.24 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.82 -1.178 . . . . 74.1 107.82 178.544 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 532' ' ' GLY . 48.2 t -46.84 -48.94 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 123.905 0.882 . . . . 73.42 111.239 -176.54 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -63.46 -41.85 98.62 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.188 -0.915 . . . . 72.44 111.571 -175.158 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 88.2 t -76.35 -40.61 35.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.908 -0.587 . . . . 54.1 110.857 -177.695 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.26 -45.8 89.8 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.378 -0.374 . . . . 72.2 110.881 -179.307 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -65.21 -35.45 81.11 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.402 -0.363 . . . . 74.32 110.893 178.573 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.429 ' O ' HG23 ' A' ' 514' ' ' VAL . 51.1 tptt -62.79 -45.88 90.6 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.37 -0.604 . . . . 73.02 109.37 178.204 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -63.62 -37.42 87.28 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 115.951 -0.568 . . . . 74.54 111.08 177.37 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . 0.455 HD11 HD12 ' A' ' 551' ' ' ILE . 59.4 tp -59.8 -43.18 94.6 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.826 -0.625 . . . . 44.33 109.457 177.122 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 517' ' ' PHE . 13.5 m120 -63.25 -38.03 89.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.611 -0.722 . . . . 71.53 110.192 177.711 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 510' ' ' LYS . 94.9 t -63.69 -33.37 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 115.564 -0.743 . . . . 51.04 110.651 176.829 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -68.01 -27.49 66.6 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.85 0.357 . . . . 64.41 110.138 178.568 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 131.57 -18.31 4.91 Favored Glycine 0 CA--C 1.506 -0.499 0 C-N-CA 121.006 -0.616 . . . . 64.1 112.267 178.721 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.46 ' O ' ' HA ' ' A' ' 513' ' ' ASN . 85.9 m-85 -78.63 115.15 18.14 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.347 0.594 . . . . 71.55 110.001 -177.025 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 12.5 p -86.87 -16.69 35.28 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.796 -0.638 . . . . 72.13 112.71 -176.83 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 36.2 mtmm -117.29 130.87 56.83 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.232 0.539 . . . . 64.2 112.001 -174.612 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . 0.444 ' HB3' HD23 ' A' ' 512' ' ' LEU . 12.2 p90 -130.07 156.81 43.9 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.346 -0.843 . . . . 73.05 112.398 -177.852 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 49.2 m -140.17 158.36 44.16 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 106.831 -1.544 . . . . 55.25 106.831 173.174 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . 0.524 ' HA ' ' O ' ' A' ' 553' ' ' LEU . 0.0 OUTLIER -135.37 145.24 47.16 Favored 'General case' 0 N--CA 1.413 -2.312 0 CA-C-N 118.293 0.497 . . . . 62.51 109.986 179.395 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -129.82 116.13 18.25 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.239 -1.022 . . . . 41.25 108.239 176.072 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 18.4 m -88.12 120.89 29.9 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.726 -0.472 . . . . 61.31 109.726 178.91 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 47.5 t -120.8 148.12 24.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 107.258 -1.386 . . . . 75.5 107.258 -179.616 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . 0.453 ' HB2' HD21 ' A' ' 559' ' ' ASN . 9.5 p-10 -68.86 136.41 52.63 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.185 0.517 . . . . 44.42 111.55 -175.978 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 69.6 m -156.78 176.36 2.65 Favored Pre-proline 0 C--N 1.3 -1.549 0 N-CA-C 108.709 -0.849 . . . . 54.33 108.709 -179.285 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -83.32 -14.48 8.2 Favored 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 121.947 1.764 . . . . 62.21 111.598 171.349 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.588 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 0.0 OUTLIER -76.04 140.75 70.35 Favored Pre-proline 0 C--O 1.215 -0.716 0 CA-C-N 115.925 -0.579 . . . . 74.01 109.542 -179.743 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -56.61 144.82 84.22 Favored 'Trans proline' 0 C--O 1.249 1.026 0 C-N-CA 123.399 2.733 . . . . 74.25 113.432 -176.962 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.64 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -62.7 117.51 6.39 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 114.498 -1.228 . . . . 73.14 110.472 -178.329 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . 0.438 ' O ' HG23 ' A' ' 505' ' ' VAL . . . 126.82 -19.3 6.18 Favored Glycine 0 C--N 1.3 -1.431 0 C-N-CA 120.48 -0.867 . . . . 74.12 111.48 179.828 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -83.58 125.81 32.18 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 120.735 0.302 . . . . 74.25 110.548 177.752 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 62.0 t -81.92 118.84 30.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.093 -1.077 . . . . 64.24 108.093 178.357 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 99.2 m -104.66 -21.54 13.38 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 120.295 -0.562 . . . . 71.04 112.46 -177.013 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -159.16 -178.4 33.13 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 119.433 -1.365 . . . . 42.11 112.12 178.964 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 25.5 p -124.84 156.6 37.58 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.409 -1.33 . . . . 73.14 107.409 175.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.526 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 23.0 t-20 -60.03 -56.99 30.05 Favored Pre-proline 0 CA--C 1.55 0.965 0 CA-C-O 119.307 -0.377 . . . . 44.3 110.777 179.617 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.526 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 98.1 Cg_endo -84.09 143.65 10.37 Favored 'Trans proline' 0 C--N 1.367 1.51 0 CA-C-N 120.307 1.146 . . . . 74.51 110.095 172.849 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.97 148.98 58.42 Favored 'Trans proline' 0 C--O 1.258 1.506 0 C-N-CA 122.164 1.909 . . . . 62.04 112.026 179.642 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.06 134.53 57.07 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 115.908 -0.587 . . . . 75.5 109.681 178.179 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.83 -5.8 34.88 Favored Glycine 0 C--N 1.304 -1.235 0 C-N-CA 120.058 -1.068 . . . . 55.25 111.365 -175.266 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.477 ' O ' HG12 ' A' ' 497' ' ' ILE . 88.5 m -82.65 131.08 35.21 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.266 -1.013 . . . . 74.21 108.266 173.636 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 9.7 t -101.03 127.5 47.52 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-O 121.172 0.511 . . . . 52.31 109.891 178.669 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 31.0 m -138.55 165.12 35.16 Favored Pre-proline 0 C--N 1.313 -1.015 0 N-CA-C 108.547 -0.909 . . . . 65.54 108.547 -178.244 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -62.49 143.28 92.9 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.214 1.943 . . . . 51.43 111.547 175.094 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 32.4 m -62.38 -19.78 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.606 0.762 . . . . 73.45 113.016 -176.848 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -87.96 -14.88 38.03 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.251 -0.431 . . . . 73.13 111.246 -175.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 51.8 m -62.71 161.87 11.69 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 114.677 1.362 . . . . 65.42 114.677 -173.397 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 7.7 p -93.95 123.89 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-N 115.193 -0.912 . . . . 65.55 110.269 -179.507 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . 0.455 HD12 HD11 ' A' ' 512' ' ' LEU . 52.3 mt -108.17 138.85 32.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 120.379 -0.528 . . . . 74.23 111.094 179.472 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -101.77 120.93 41.14 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 115.617 -0.719 . . . . 72.03 109.782 -179.077 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 522' ' ' GLN . 1.5 mm? -95.73 126.34 40.93 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.153 -1.425 . . . . 75.32 107.153 176.671 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . 0.29 1.7 pt20 -102.19 120.5 40.57 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 122.698 1.237 . . . . 74.0 111.091 179.716 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 42.7 t -101.38 145.04 12.16 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-N 112.83 -1.986 . . . . 71.41 109.986 -169.076 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.64 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 73.9 m -82.07 133.06 35.26 Favored 'General case' 0 N--CA 1.41 -2.452 0 CA-C-O 121.552 0.691 . . . . 61.11 111.529 175.631 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -88.26 137.95 31.87 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 104.966 -2.235 . . . . 61.41 104.966 168.577 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . 0.588 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -81.69 -43.15 8.55 Favored Glycine 0 CA--C 1.475 -2.446 0 C-N-CA 120.252 -0.975 . . . . 54.1 113.786 -170.434 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . 0.453 HD21 ' HB2' ' A' ' 526' ' ' ASP . 78.5 m-20 67.83 -31.77 0.19 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.043 0.937 . . . . 74.44 113.286 -176.785 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.457 ' H ' ' C ' ' A' ' 558' ' ' GLY . 3.0 tp60 -126.57 140.48 52.41 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 108.903 -0.777 . . . . 72.31 108.903 -175.047 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -143.45 139.09 29.73 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.765 -0.828 . . . . 61.23 108.765 174.741 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 9.6 p -59.81 124.11 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-O 121.647 0.737 . . . . 72.43 112.709 -176.252 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 57.9 ttp -95.34 137.76 22.03 Favored Pre-proline 0 C--O 1.249 1.039 0 CA-C-N 115.886 -0.597 . . . . 74.41 110.512 -179.93 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -64.22 170.01 9.91 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 123.246 2.631 . . . . 44.33 111.311 172.165 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . 0.455 ' HA ' ' HB2' ' A' ' 610' ' ' ALA . 3.5 p-10 -70.92 138.26 49.96 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.723 0.773 . . . . 63.1 112.51 -176.554 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 94.5 mt -136.15 15.53 3.26 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.287 -1.324 . . . . 75.01 107.938 174.844 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 27.7 t -67.37 134.2 51.05 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 115.302 -0.863 . . . . 72.44 109.885 -177.407 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 86.07 40.11 7.68 Favored Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 110.41 -1.076 . . . . 42.05 110.41 179.953 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 21.5 ptm -109.29 158.0 18.3 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.979 -0.749 . . . . 44.52 108.979 -179.831 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . 0.493 ' H ' ' HB3' ' A' ' 573' ' ' ASP . 77.3 m-85 -108.75 165.16 11.76 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 106.739 -1.578 . . . . 73.2 106.739 175.603 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 24.6 t90 -71.59 -30.31 65.68 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 108.979 -0.749 . . . . 75.33 108.979 177.101 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 30.0 m -80.08 -6.06 9.07 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 CA-C-O 121.793 0.806 . . . . 64.52 109.798 176.677 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . 0.493 ' HB3' ' H ' ' A' ' 570' ' ' PHE . 14.1 t70 -99.38 -30.03 12.43 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.905 -1.146 . . . . 73.52 107.905 177.199 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -62.86 -42.01 99.59 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 114.496 -1.229 . . . . 35.11 110.735 177.476 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 578' ' ' LEU . 44.2 tt0 -57.4 -52.25 75.62 Favored Pre-proline 0 CA--C 1.577 1.982 0 N-CA-C 113.014 0.746 . . . . 73.13 113.014 179.261 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . 0.42 ' HD2' ' C ' ' A' ' 573' ' ' ASP . 75.0 Cg_exo -55.38 -40.03 87.77 Favored 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 121.963 1.776 . . . . 65.44 112.172 173.114 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -68.3 -34.1 75.54 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.43 -0.508 . . . . 64.44 112.078 177.853 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.427 ' HB3' ' O ' ' A' ' 575' ' ' GLU . 5.9 tt -58.77 -49.47 77.54 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.268 0.627 . . . . 62.22 109.724 178.848 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -67.37 -40.96 85.78 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.286 0.847 . . . . 74.13 113.286 177.138 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.57 -39.86 88.69 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.186 0.439 . . . . 62.4 112.186 -177.666 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 10.4 mp -86.3 -8.97 57.31 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 111.971 0.36 . . . . 75.34 111.971 -179.276 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 68.34 21.81 74.35 Favored Glycine 0 C--O 1.241 0.559 0 N-CA-C 111.317 -0.713 . . . . 62.41 111.317 -177.54 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . 0.402 ' CZ2' HG22 ' A' ' 620' ' ' ILE . 42.9 t90 -60.61 126.96 29.37 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 123.198 0.599 . . . . 73.44 111.031 -177.359 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 8.8 m -130.41 89.44 2.78 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 115.517 -0.765 . . . . 71.51 109.122 178.153 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -144.14 -142.67 3.94 Favored Glycine 0 N--CA 1.426 -2.023 0 N-CA-C 109.479 -1.448 . . . . 65.13 109.479 177.43 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 14.4 tpt -129.0 131.41 47.42 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.768 -0.827 . . . . 71.31 108.768 179.099 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -98.03 123.1 41.89 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.07 -1.456 . . . . 73.32 107.07 177.066 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -98.11 107.38 19.85 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.995 -0.548 . . . . 72.43 109.994 -178.422 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.49 133.26 36.97 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.98 -0.554 . . . . 53.55 110.954 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -97.95 -164.83 31.38 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.737 -0.665 . . . . 62.33 113.406 -175.086 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -74.84 141.3 44.26 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 123.178 0.591 . . . . 53.43 110.834 -178.266 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -85.64 133.26 34.04 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.622 -0.717 . . . . 73.43 109.646 -177.096 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 73.4 t -125.34 115.41 43.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 107.206 -1.405 . . . . 75.42 107.206 175.337 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -86.02 107.64 17.88 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.221 -0.992 . . . . 51.32 110.213 -179.736 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -124.05 -11.17 7.59 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.212 -0.904 . . . . 74.25 111.495 -178.788 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 119.18 -172.67 14.7 Favored Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 121.099 -0.572 . . . . 73.32 111.673 177.779 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.87 -34.03 64.56 Favored Glycine 0 C--O 1.222 -0.623 0 N-CA-C 114.514 0.566 . . . . 40.43 114.514 -175.53 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 19.0 m -66.14 -24.72 66.72 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 117.344 0.572 . . . . 72.53 111.997 -178.445 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -109.66 -0.83 18.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.282 0.563 . . . . 74.1 111.286 178.616 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -67.62 105.42 1.87 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.195 -0.911 . . . . 62.51 113.099 -175.261 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 62.87 0.94 0.75 Allowed 'General case' 0 CA--C 1.56 1.352 0 C-N-CA 125.773 1.629 . . . . 70.52 114.081 171.713 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . 0.431 ' HD2' ' O ' ' A' ' 603' ' ' VAL . 8.7 tmm_? -90.93 148.47 22.42 Favored 'General case' 0 C--N 1.313 -0.995 0 O-C-N 121.911 -0.493 . . . . 71.32 110.607 -178.174 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . 0.469 HG23 ' HB2' ' A' ' 622' ' ' LEU . 7.1 p -56.11 131.76 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.01 0.924 . . . . 51.15 111.465 -177.634 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 14.7 p -106.91 -34.89 2.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 C-N-CA 119.9 -0.72 . . . . 60.14 109.385 -178.728 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -154.12 148.43 26.0 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 105.114 -2.18 . . . . 70.13 105.114 171.559 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -122.39 136.56 54.92 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 108.713 -0.847 . . . . 74.01 108.713 176.627 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.575 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 24.5 t-20 -59.37 -52.39 74.65 Favored Pre-proline 0 C--N 1.309 -1.164 0 CA-C-N 115.443 -0.799 . . . . 65.52 111.298 -178.436 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.575 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 29.6 Cg_endo -105.27 110.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.962 0 C-N-CA 121.883 1.722 . . . . 40.22 111.389 173.341 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -67.76 156.86 64.33 Favored 'Trans proline' 0 C--O 1.239 0.545 0 C-N-CA 122.139 1.893 . . . . 54.21 110.705 176.408 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . 0.455 ' HB2' ' HA ' ' A' ' 565' ' ' ASP . . . -60.07 137.35 58.11 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 110.009 -0.367 . . . . 72.01 110.009 178.975 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 90.05 0.96 76.83 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 119.44 -1.362 . . . . 63.24 111.564 -178.355 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 9.8 m -107.95 155.62 20.11 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.999 -1.111 . . . . 75.14 107.999 178.182 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -81.64 132.16 10.96 Favored Glycine 0 N--CA 1.418 -2.515 0 CA-C-N 116.352 -0.386 . . . . 74.2 112.525 -179.433 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 22.2 m -101.14 142.55 15.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 123.222 0.609 . . . . 73.44 110.375 177.008 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.516 ' OD1' HG22 ' A' ' 619' ' ' ILE . 0.0 OUTLIER -54.55 149.39 10.69 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.234 0.959 . . . . 74.44 111.96 178.171 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . 0.255 0.0 OUTLIER -61.0 -24.38 66.1 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.752 1.019 . . . . 75.51 113.752 179.929 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -68.62 -31.3 70.36 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 109.159 -0.682 . . . . 74.54 109.159 176.062 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 88.91 9.52 67.93 Favored Glycine 0 N--CA 1.418 -2.525 0 CA-C-N 115.006 -0.997 . . . . 75.52 113.264 176.855 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . 0.516 HG22 ' OD1' ' A' ' 615' ' ' ASN . 0.0 OUTLIER -69.59 119.57 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 CA-C-N 118.547 1.174 . . . . 54.5 109.103 -175.675 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.402 HG22 ' CZ2' ' A' ' 583' ' ' TRP . 0.0 OUTLIER -118.51 131.93 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 N-CA-C 108.836 -0.801 . . . . 63.2 108.836 -176.881 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.501 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 60.1 m -118.08 127.84 54.18 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 120.867 0.365 . . . . 63.12 111.627 -178.585 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . 0.469 ' HB2' HG23 ' A' ' 603' ' ' VAL . 0.0 OUTLIER -138.5 150.91 46.89 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 105.455 -2.054 . . . . 74.51 105.455 174.048 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -127.74 156.17 42.85 Favored 'General case' 0 C--N 1.266 -3.044 0 N-CA-C 106.079 -1.823 . . . . 70.33 106.079 179.248 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -131.13 165.63 22.86 Favored 'General case' 0 C--N 1.275 -2.634 0 N-CA-C 106.847 -1.538 . . . . 71.45 106.847 179.644 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -71.72 -84.96 0.2 Allowed Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 109.224 -1.551 . . . . 71.53 109.224 175.408 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 . . . . . 0 C--N 1.299 -1.594 0 N-CA-C 108.697 -0.853 . . . . 74.14 108.697 174.346 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.162 0 N-CA-C 110.1 -1.2 . . . . 74.53 110.1 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 9.2 tp -74.81 122.7 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 CA-C-N 117.787 0.794 . . . . 72.12 110.474 -179.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 1.3 m -70.57 150.7 45.82 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 108.367 -0.975 . . . . 64.25 108.367 179.411 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -84.79 -28.87 25.87 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.732 -1.21 . . . . 74.51 107.732 179.316 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -97.56 150.46 21.09 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.837 -1.528 . . . . 74.14 109.012 179.815 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.76 142.93 27.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 109.725 -0.472 . . . . 63.13 109.725 -176.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . 0.495 HE21 ' C ' ' A' ' 361' ' ' GLN . 0.0 OUTLIER -95.41 118.63 32.5 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.934 -1.506 . . . . 70.03 106.934 -176.853 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.44 ' HB ' ' O ' ' A' ' 406' ' ' ALA . 65.3 t -97.09 141.07 22.5 Favored Pre-proline 0 C--N 1.288 -2.093 0 CA-C-N 115.181 -0.918 . . . . 62.34 110.927 -170.284 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -66.49 142.87 66.97 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 121.84 1.693 . . . . 75.5 109.741 174.859 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . 0.465 ' HB2' ' ND2' ' A' ' 407' ' ' ASN . 35.1 t0 -95.83 142.61 27.89 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.915 -1.143 . . . . 72.33 107.915 -177.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.521 ' CG2' ' HA ' ' A' ' 373' ' ' ALA . 11.4 p -106.2 -7.47 10.22 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.676 0 CA-C-N 115.253 -0.885 . . . . 62.32 112.45 -168.472 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . 0.254 2.2 ppt_? -54.39 146.56 15.51 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.834 1.42 . . . . 74.22 114.834 175.884 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.44 0.79 40.55 Favored Glycine 0 C--O 1.24 0.482 0 CA-C-N 115.333 -0.848 . . . . 62.31 111.698 -177.219 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -119.33 -153.48 0.54 Allowed 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.545 -0.909 . . . . 75.2 108.545 177.672 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 51.5 p -96.35 153.47 17.8 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.503 -0.925 . . . . 74.23 108.503 -178.215 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 32.1 t -57.39 -37.34 72.52 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 123.322 0.389 . . . . 71.14 110.14 178.503 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.09 -47.04 75.51 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 119.287 -0.387 . . . . 70.33 111.412 179.78 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -70.05 -34.72 73.58 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 119.734 -0.786 . . . . 60.3 109.999 179.685 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . 0.521 ' HA ' ' CG2' ' A' ' 365' ' ' VAL . . . -63.39 -51.47 65.7 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.107 -0.951 . . . . 51.32 111.162 179.801 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.41 HG23 HG13 ' A' ' 384' ' ' ILE . 82.3 mt -64.05 -40.26 88.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.957 -0.565 . . . . 74.41 109.908 176.654 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.71 -47.35 84.88 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.107 -0.497 . . . . 52.05 111.007 -178.12 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . 0.466 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 37.3 m -63.14 -47.27 83.44 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.794 -0.639 . . . . 72.12 110.16 -178.901 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 95.4 mt -64.04 -41.4 97.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.006 -0.543 . . . . 45.21 111.11 -178.842 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -63.12 -42.43 99.53 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.284 -0.416 . . . . 64.31 110.662 179.375 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -68.52 -20.33 64.56 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 111.915 0.339 . . . . 74.23 111.915 179.323 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 376' ' ' THR . 34.0 mmt180 -88.05 -14.18 39.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.345 -0.389 . . . . 72.33 110.335 176.164 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.46 16.72 45.13 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 120.655 -0.783 . . . . 74.51 112.463 179.231 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -88.85 156.21 19.07 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-O 121.327 0.584 . . . . 75.43 112.062 179.597 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -93.16 143.78 25.92 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 115.014 -0.993 . . . . 72.14 108.741 -177.712 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.446 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -130.37 146.04 34.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-O 121.172 0.51 . . . . 74.52 110.223 -178.356 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -128.02 126.85 42.1 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 105.971 -1.863 . . . . 74.44 105.971 171.233 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 8.0 m -115.06 123.62 49.49 Favored 'General case' 0 C--N 1.274 -2.713 0 N-CA-C 107.212 -1.403 . . . . 64.41 107.212 -178.137 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -110.87 121.47 45.42 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.527 -0.916 . . . . 73.43 108.527 -177.774 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -90.55 133.79 34.83 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.678 -0.692 . . . . 72.13 110.441 -176.626 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 421' ' ' SER . 98.1 mttt -136.93 145.34 50.28 Favored Pre-proline 0 C--N 1.312 -1.044 0 N-CA-C 108.896 -0.779 . . . . 74.34 108.896 172.918 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.503 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 56.7 Cg_endo -101.28 135.78 0.16 Allowed 'Trans proline' 0 CA--C 1.554 1.498 0 C-N-CA 122.0 1.8 . . . . 64.43 111.5 169.569 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.571 ' OD2' HG22 ' A' ' 393' ' ' THR . 12.9 t70 161.64 -168.03 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 126.073 1.749 . . . . 72.13 107.339 174.911 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . 0.413 ' H ' ' CG ' ' A' ' 391' ' ' ASP . 32.3 t -128.17 -15.6 4.67 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 118.03 0.377 . . . . 61.4 110.558 179.421 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.571 HG22 ' OD2' ' A' ' 391' ' ' ASP . 13.1 t -79.75 -29.97 40.64 Favored 'General case' 0 C--O 1.252 1.209 0 N-CA-C 108.836 -0.802 . . . . 73.15 108.836 177.125 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.88 126.02 55.06 Favored Pre-proline 0 N--CA 1.417 -2.101 0 N-CA-C 105.22 -2.141 . . . . 70.52 105.22 165.519 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . 0.498 ' HG3' HD12 ' A' ' 400' ' ' ILE . 95.1 Cg_endo -78.51 155.06 27.93 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 N-CA-C 117.343 2.017 . . . . 64.23 117.343 -167.23 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . 0.518 ' HA ' ' O ' ' A' ' 421' ' ' SER . 74.0 Cg_exo -53.9 167.73 1.02 Allowed 'Trans proline' 0 CA--C 1.492 -1.585 1 C-N-CA 126.081 4.52 . . . . 62.14 111.709 170.888 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . 0.514 ' HA ' HG23 ' A' ' 420' ' ' VAL . 4.5 p-10 -51.57 -5.93 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 127.149 2.18 . . . . 74.21 115.836 -164.523 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -80.42 109.06 14.56 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.069 -1.456 . . . . 63.23 107.069 170.104 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 24.7 m -83.94 120.99 35.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 115.14 -0.937 . . . . 63.54 113.418 -168.558 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . 0.498 HD12 ' HG3' ' A' ' 395' ' ' PRO . 0.2 OUTLIER -84.92 -27.71 6.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.611 -0.722 . . . . 73.34 109.822 177.18 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.9 157.53 27.4 Favored Glycine 0 N--CA 1.42 -2.427 0 C-N-CA 119.389 -1.386 . . . . 73.23 113.988 -176.597 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 11.7 p -136.29 -173.83 3.51 Favored 'General case' 0 C--N 1.273 -2.721 0 C-N-CA 128.701 2.8 . . . . 45.23 104.825 -177.588 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -97.8 129.34 31.52 Favored Pre-proline 0 C--N 1.286 -2.154 0 N-CA-C 106.633 -1.617 . . . . 62.43 106.633 179.688 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.18 -1.26 0.17 Allowed 'Trans proline' 0 C--N 1.367 1.548 0 C-N-CA 124.731 3.621 . . . . 61.43 115.512 -176.368 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -50.45 -36.88 35.31 Favored 'General case' 0 C--O 1.209 -1.074 0 C-N-CA 124.15 0.98 . . . . 33.13 109.484 173.511 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . 0.44 ' O ' ' HB ' ' A' ' 362' ' ' VAL . . . -59.31 -50.05 75.47 Favored 'General case' 0 C--O 1.217 -0.651 0 O-C-N 123.54 0.525 . . . . 33.41 110.902 178.678 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . 0.465 ' ND2' ' HB2' ' A' ' 364' ' ' ASP . 13.3 m120 -82.56 0.16 44.05 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 120.448 -0.501 . . . . 73.15 111.991 -178.989 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 30.2 m -86.31 150.07 24.6 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 105.134 -2.173 . . . . 64.35 105.134 173.104 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 19.4 m -75.79 112.34 12.07 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 106.372 -1.714 . . . . 42.31 106.372 175.862 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 31.0 m -125.92 169.52 17.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-O 121.009 0.433 . . . . 65.22 111.192 -174.941 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 21.4 t -77.46 140.79 39.89 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 107.353 -1.351 . . . . 71.41 107.353 176.896 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -57.86 109.71 0.78 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.026 0.441 . . . . 72.4 111.277 -178.652 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 105.32 61.64 0.64 Allowed Glycine 0 N--CA 1.436 -1.358 0 N-CA-C 111.183 -0.767 . . . . 53.51 111.183 -179.99 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -111.01 177.18 4.74 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.163 -0.68 . . . . 31.1 109.163 179.92 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -90.06 112.67 24.18 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 124.296 1.038 . . . . 62.42 111.345 -174.38 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 39.5 mm -107.11 109.23 27.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 109.71 -0.478 . . . . 73.4 109.71 177.657 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 40.9 p -88.38 131.18 34.95 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 122.705 0.402 . . . . 60.32 110.308 179.765 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 6.1 p -127.19 133.29 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 109.448 -0.575 . . . . 63.11 109.448 176.736 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -97.41 128.94 44.63 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.736 -0.839 . . . . 64.44 108.736 174.552 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.514 HG23 ' HA ' ' A' ' 397' ' ' ASP . 7.0 p -129.57 143.89 39.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.886 -0.783 . . . . 72.34 108.886 -176.509 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . 0.557 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 14.5 m -119.58 130.01 54.92 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 119.156 -1.017 . . . . 54.2 111.359 -178.821 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 5.3 t -119.09 107.06 13.02 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.483 -0.78 . . . . 71.2 111.285 -179.504 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 78.55 141.61 1.94 Allowed Glycine 0 CA--C 1.528 0.903 0 CA-C-N 116.276 -0.42 . . . . 71.42 113.63 177.159 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -83.77 156.66 13.75 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.368 2.046 . . . . 53.05 111.922 178.565 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -88.8 166.72 13.83 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 121.565 0.698 . . . . 73.41 110.867 -179.146 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.416 ' CB ' HG22 ' A' ' 477' ' ' THR . 15.6 mt-30 -125.29 157.15 37.38 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.434 -1.691 . . . . 73.31 106.434 178.087 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.479 ' HG2' HD11 ' A' ' 480' ' ' ILE . 57.4 mmm-85 -126.61 163.73 22.79 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.594 -0.691 . . . . 74.4 111.977 -178.891 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.1 138.74 33.57 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 114.535 -1.211 . . . . 62.01 108.832 -179.084 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 62.4 mt -91.27 123.72 63.41 Favored Pre-proline 0 N--CA 1.425 -1.701 0 N-CA-C 108.515 -0.921 . . . . 74.11 108.515 177.103 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -71.4 141.01 37.85 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 121.617 1.545 . . . . 63.52 109.733 171.588 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -87.75 168.34 13.05 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.261 -1.014 . . . . 72.03 108.261 177.372 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.681 HG11 ' HB2' ' A' ' 440' ' ' ALA . 13.8 p -153.98 164.94 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.266 -1.013 . . . . 75.14 108.266 -175.546 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 37.6 m -75.95 147.9 38.57 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.435 -0.95 . . . . 62.15 108.435 174.139 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 47.0 p -66.45 -27.99 68.24 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 114.486 1.291 . . . . 51.44 114.486 -170.877 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.1 pp -79.49 -15.83 57.08 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.295 -0.878 . . . . 54.11 112.35 176.522 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.01 47.91 1.16 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.09 0.471 . . . . 72.02 111.34 -174.568 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . 0.479 ' OH ' ' HB2' ' A' ' 454' ' ' GLN . 71.2 t80 -52.95 -38.65 62.23 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.27 0.628 . . . . 74.2 112.634 178.629 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.36 -39.61 91.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.427 0.632 . . . . 73.23 110.731 179.79 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -70.3 -35.37 73.64 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.509 -0.769 . . . . 64.34 109.879 178.857 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.681 ' HB2' HG11 ' A' ' 432' ' ' VAL . . . -59.64 -51.23 70.69 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.839 -0.619 . . . . 63.13 111.092 -178.892 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.1 m -65.44 -39.09 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 112.275 0.472 . . . . 64.24 112.275 -178.28 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . 0.273 0.1 OUTLIER -68.17 -34.43 76.29 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 119.556 -0.858 . . . . 74.53 112.1 176.602 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -63.35 -42.01 98.9 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 116.565 -0.289 . . . . 61.34 110.584 174.885 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 440' ' ' ALA . 93.3 mt -63.57 -33.15 74.96 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.11 -0.495 . . . . 73.3 110.551 178.916 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 48.2 m -70.08 -43.84 70.29 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.13 -0.486 . . . . 63.41 110.065 179.493 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.23 -15.36 62.45 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.675 0.75 . . . . 63.43 110.706 178.801 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -87.01 -0.9 57.38 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.451 -0.795 . . . . 74.43 111.659 179.531 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 112.79 -77.56 0.24 Allowed Glycine 0 CA--C 1.499 -0.963 0 C-N-CA 120.201 -1.0 . . . . 74.44 112.28 176.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . 0.431 ' HB3' ' HA ' ' A' ' 480' ' ' ILE . 0.1 OUTLIER -43.55 -65.55 0.48 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.521 0.934 . . . . 74.41 113.521 177.318 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 62.11 21.64 61.85 Favored Glycine 0 C--O 1.226 -0.354 0 C-N-CA 121.077 -0.582 . . . . 74.34 111.704 -175.421 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -102.91 110.78 22.83 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 108.213 -1.032 . . . . 70.14 108.213 -178.004 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.452 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 27.8 p90 -142.68 163.93 31.49 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 115.59 -0.732 . . . . 73.34 109.665 -175.95 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -151.89 124.14 8.22 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.862 -0.792 . . . . 72.33 108.862 176.356 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . 0.479 ' HB2' ' OH ' ' A' ' 437' ' ' TYR . 57.3 tt0 -87.22 128.4 35.15 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 123.454 0.471 . . . . 74.34 109.959 179.897 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -122.17 138.03 54.62 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.23 -1.026 . . . . 73.33 108.23 175.025 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -114.44 133.16 55.95 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.84 -1.171 . . . . 75.52 107.84 -179.13 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 49.1 m -151.73 145.35 17.69 Favored Pre-proline 0 C--N 1.298 -1.638 0 N-CA-C 109.676 -0.49 . . . . 63.33 109.676 176.846 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.684 ' HA ' ' O ' ' A' ' 490' ' ' SER . 29.2 Cg_endo -65.3 122.54 10.29 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.147 1.898 . . . . 63.12 109.264 177.398 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 35.2 m -134.04 179.88 5.98 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 115.634 -0.712 . . . . 35.22 109.734 -173.276 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 6.0 t -54.16 135.84 59.12 Favored Pre-proline 0 N--CA 1.436 -1.166 0 O-C-N 124.26 0.975 . . . . 71.44 109.552 178.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -50.97 -29.76 28.47 Favored 'Trans proline' 0 N--CA 1.477 0.512 0 C-N-CA 124.689 3.592 . . . . 55.31 115.085 -171.679 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -75.58 -22.38 57.01 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.973 0.416 . . . . 64.13 112.018 179.272 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -98.37 -5.91 31.8 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.842 0.353 . . . . 64.22 110.692 177.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 62.3 t -61.42 127.72 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 109.163 -0.681 . . . . 74.32 109.163 174.233 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 85.93 -4.02 86.41 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 111.415 -0.674 . . . . 63.32 111.415 -179.162 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -122.46 156.82 33.28 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 121.558 0.695 . . . . 55.43 109.433 -177.064 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 47.4 t -71.09 142.59 15.38 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.503 0 CA-C-N 114.599 -1.182 . . . . 73.51 108.128 173.089 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 52.1 mt -97.59 -28.99 3.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 108.809 -0.811 . . . . 73.45 108.809 179.71 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 154.74 -170.11 33.01 Favored Glycine 0 N--CA 1.427 -1.957 0 C-N-CA 120.337 -0.935 . . . . 64.41 112.16 177.042 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . 0.565 HG22 HG12 ' A' ' 486' ' ' ILE . 36.1 p -115.45 139.9 49.62 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.803 -1.555 . . . . 72.42 106.803 -179.824 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.435 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 9.0 t30 -63.43 -50.9 71.36 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 119.361 -0.935 . . . . 74.13 112.037 177.481 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.435 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 22.0 Cg_exo -75.06 151.11 38.84 Favored 'Trans proline' 0 C--N 1.36 1.157 0 N-CA-C 108.5 -1.385 . . . . 62.33 108.5 170.456 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.24 127.07 20.06 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.004 1.802 . . . . 73.15 112.173 -178.508 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -89.06 3.86 50.32 Favored 'General case' 0 C--O 1.207 -1.175 0 CA-C-N 115.511 -0.768 . . . . 75.21 110.732 -177.928 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -111.08 8.14 21.7 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.524 -0.762 . . . . 72.3 109.933 179.499 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -125.69 179.59 5.09 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 116.198 -0.455 . . . . 74.21 111.043 -174.247 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.416 HG22 ' CB ' ' A' ' 426' ' ' GLN . 3.6 m -89.84 117.57 28.78 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 115.516 -0.766 . . . . 42.11 109.481 179.917 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 50.1 m -118.94 148.68 42.69 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.471 -0.566 . . . . 53.11 109.471 -179.172 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -73.16 153.38 40.75 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.67 0.619 . . . . 70.1 112.67 -174.503 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.479 HD11 ' HG2' ' A' ' 427' ' ' ARG . 2.2 mp -65.03 -26.82 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-O 121.756 0.788 . . . . 70.43 110.695 178.75 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 12.2 p -90.85 5.38 48.7 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.477 -0.783 . . . . 62.04 111.502 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -103.33 129.6 50.41 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.084 -0.507 . . . . 61.24 109.958 -176.55 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.2 p -98.58 127.19 51.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.706 -0.679 . . . . 70.05 111.408 -176.086 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 33.5 m -96.67 123.45 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-O 121.403 0.62 . . . . 71.54 110.618 178.121 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.95 128.99 43.27 Favored 'Isoleucine or valine' 0 C--O 1.256 1.435 0 N-CA-C 107.994 -1.113 . . . . 70.11 107.994 176.844 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.565 HG12 HG22 ' A' ' 470' ' ' THR . 42.2 mt -119.72 119.59 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 CA-C-N 114.996 -1.002 . . . . 60.13 110.269 -175.692 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 5.8 tt -103.03 127.12 57.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 115.295 -0.866 . . . . 73.53 111.176 -178.513 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 1.9 p -107.93 136.21 44.09 Favored 'Isoleucine or valine' 0 C--O 1.256 1.403 0 CA-C-N 115.361 -0.836 . . . . 64.12 108.973 176.05 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -73.53 127.95 11.0 Favored Glycine 0 N--CA 1.419 -2.483 0 N-CA-C 110.619 -0.993 . . . . 71.21 110.619 179.328 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.684 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 14.4 t -115.88 158.56 22.79 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 106.907 -1.516 . . . . 71.45 106.907 178.345 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -171.57 84.25 0.08 OUTLIER Glycine 0 N--CA 1.431 -1.649 0 N-CA-C 110.417 -1.073 . . . . 72.35 110.417 -179.806 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -69.89 113.04 3.26 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.059 1.839 . . . . 73.23 110.897 -178.128 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . -84.86 52.78 2.51 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.997 -0.742 . . . . 54.4 108.997 179.888 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 546' ' ' PRO . 24.3 p -116.5 148.14 41.08 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 115.231 -0.895 . . . . 63.24 110.423 -174.234 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -145.45 155.06 42.89 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 108.138 -1.06 . . . . 65.43 108.138 178.353 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -89.82 122.9 33.32 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.638 -0.505 . . . . 60.35 109.638 -177.565 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 37.0 pt -79.55 136.29 55.95 Favored Pre-proline 0 C--N 1.307 -1.264 0 O-C-N 123.271 0.357 . . . . 73.54 111.341 -179.433 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -85.18 -174.32 1.66 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.643 2.229 . . . . 75.24 110.266 174.719 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -92.59 147.17 23.1 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.376 -0.601 . . . . 64.12 109.376 179.83 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 41.2 t -129.28 93.86 2.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 107.314 -1.365 . . . . 70.3 107.314 178.6 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -148.22 112.9 5.37 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 107.223 -1.399 . . . . 63.45 107.223 179.566 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 110.24 36.35 1.97 Allowed Glycine 0 N--CA 1.421 -2.314 0 N-CA-C 110.172 -1.171 . . . . 74.11 110.172 -178.016 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -143.1 166.79 23.7 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 108.33 -0.989 . . . . 75.3 108.33 178.651 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 532' ' ' GLY . 11.8 t -93.32 157.43 16.25 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.043 -1.465 . . . . 62.31 107.043 173.869 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 10.5 p -55.37 -40.43 57.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 112.235 0.457 . . . . 55.0 112.235 -178.599 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -58.32 -42.82 87.59 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.496 0.665 . . . . 52.32 110.949 179.503 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 99.6 t -76.37 -36.73 29.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.641 -0.708 . . . . 74.45 110.107 -179.219 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -61.35 -49.21 77.86 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.762 -0.654 . . . . 73.42 111.229 178.856 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -63.21 -37.19 86.26 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 120.485 -0.486 . . . . 71.52 110.32 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -62.64 -45.7 91.61 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.11 -0.7 . . . . 75.32 109.11 179.442 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -62.16 -48.66 79.07 Favored 'General case' 0 CA--C 1.494 -1.197 0 O-C-N 123.107 0.254 . . . . 62.5 111.291 179.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.77 -40.5 97.49 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 112.261 0.467 . . . . 64.32 112.261 -179.073 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -65.48 -37.98 88.42 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 120.718 -0.393 . . . . 63.23 110.99 179.146 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 68.7 t -68.92 -26.87 33.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.07 0.462 . . . . 63.1 110.741 176.755 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 17.4 m-30 -81.33 -1.78 46.59 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.262 -0.575 . . . . 75.25 110.14 178.951 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . 0.543 ' O ' ' HB ' ' A' ' 547' ' ' VAL . . . 101.78 -4.92 53.57 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.925 -0.655 . . . . 52.31 113.318 176.08 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -83.85 112.81 20.46 Favored 'General case' 0 CA--C 1.476 -1.899 0 N-CA-C 106.548 -1.649 . . . . 70.42 106.548 -177.541 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.3 m -89.19 -25.42 21.79 Favored 'General case' 0 N--CA 1.406 -2.656 0 CA-C-N 115.033 -0.985 . . . . 61.2 112.651 -167.66 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 96.8 mttt -116.15 125.06 51.82 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 120.117 -0.633 . . . . 52.32 111.035 -177.207 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -129.73 153.14 48.48 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 123.37 0.668 . . . . 74.42 109.909 -179.437 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 50.5 m -141.09 147.25 38.24 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 108.253 -1.017 . . . . 45.33 108.253 174.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -116.76 130.9 57.0 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-O 121.229 0.537 . . . . 74.15 110.417 179.81 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -105.34 119.79 39.95 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 107.68 -1.23 . . . . 71.32 107.68 176.149 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 42.3 m -90.0 121.27 31.93 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.271 0.558 . . . . 74.25 110.31 -178.423 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 26.9 m -121.77 153.64 25.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.427 -0.953 . . . . 55.34 108.427 178.345 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . 0.504 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 1.1 p-10 -89.04 136.44 33.01 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.036 -1.098 . . . . 54.41 108.036 178.135 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . 0.428 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 19.7 m -153.48 166.97 14.47 Favored Pre-proline 0 C--N 1.292 -1.912 0 N-CA-C 108.575 -0.898 . . . . 73.31 108.575 179.618 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -73.6 -3.71 14.19 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 121.775 1.65 . . . . 64.22 112.132 175.602 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.46 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 2.1 mpt_? -85.21 134.57 40.51 Favored Pre-proline 0 CA--C 1.515 -0.396 0 N-CA-C 108.093 -1.077 . . . . 72.22 108.093 179.476 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -56.23 143.95 83.2 Favored 'Trans proline' 0 C--O 1.242 0.724 0 C-N-CA 123.064 2.51 . . . . 34.43 113.723 -175.512 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -53.18 125.6 18.05 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 114.615 -1.175 . . . . 72.3 112.629 -174.801 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 504' ' ' THR . . . 114.41 -16.31 19.63 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.482 -0.781 . . . . 51.43 111.294 178.124 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -74.33 125.73 29.13 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.674 -0.491 . . . . 64.52 109.674 179.494 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 53.3 t -82.78 112.01 19.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.1 -1.444 . . . . 73.24 107.1 176.222 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 15.0 t -80.5 -18.51 48.37 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.755 -0.657 . . . . 75.43 111.114 -175.778 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 163.81 -170.0 38.96 Favored Glycine 0 CA--C 1.495 -1.182 0 C-N-CA 119.94 -1.124 . . . . 43.13 111.828 178.514 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 65.0 p -117.31 153.86 32.24 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.183 -1.043 . . . . 71.42 108.183 -179.95 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.559 ' CA ' HE22 ' A' ' 554' ' ' GLN . 34.5 t30 -77.25 -53.87 1.59 Allowed Pre-proline 0 C--N 1.314 -0.948 0 C-N-CA 120.116 -0.633 . . . . 73.21 110.565 177.813 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -70.63 126.94 13.25 Favored 'Trans proline' 0 C--N 1.357 0.993 0 N-CA-C 107.739 -1.677 . . . . 70.32 107.739 167.707 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.88 156.57 63.62 Favored 'Trans proline' 0 C--O 1.247 0.974 0 C-N-CA 122.499 2.132 . . . . 74.51 113.358 -175.348 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.09 138.71 58.43 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.661 -0.7 . . . . 55.21 109.914 178.423 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 98.12 -6.34 61.76 Favored Glycine 0 N--CA 1.433 -1.554 0 C-N-CA 120.261 -0.971 . . . . 42.02 112.088 -178.778 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 59.0 m -76.23 132.96 40.21 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 109.392 -0.595 . . . . 62.1 109.392 176.803 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 5.0 m -95.11 122.02 37.34 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 107.745 -1.205 . . . . 71.42 107.745 179.294 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 24.3 m -138.16 156.23 73.95 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 109.895 -0.409 . . . . 73.25 109.895 -178.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.52 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 37.5 Cg_exo -63.6 139.94 72.54 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.114 1.876 . . . . 64.01 111.375 175.417 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.543 ' HB ' ' O ' ' A' ' 516' ' ' GLY . 30.8 m -64.57 -20.31 26.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 121.841 0.829 . . . . 72.12 111.912 -179.746 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -77.88 -18.0 56.7 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.04 -0.982 . . . . 71.43 110.628 178.816 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 24.6 m -77.76 179.06 6.88 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 112.841 0.682 . . . . 75.21 112.841 -174.977 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 39.1 t -105.78 124.91 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 CA-C-N 115.108 -0.951 . . . . 74.42 109.644 -176.666 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . 0.488 HD13 ' H ' ' A' ' 551' ' ' ILE . 0.2 OUTLIER -104.87 135.87 40.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.96 -0.756 . . . . 72.23 108.96 173.43 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -106.85 119.71 40.08 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 116.02 -0.536 . . . . 62.23 111.21 -176.103 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -101.77 134.12 45.44 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.664 -1.153 . . . . 72.13 109.444 179.814 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . 0.559 HE22 ' CA ' ' A' ' 538' ' ' ASN . 2.0 mp0 -93.74 122.44 36.21 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.074 0.464 . . . . 75.12 109.844 175.659 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 50.3 t -112.58 130.37 66.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 107.95 -1.13 . . . . 73.42 107.95 -178.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 74.6 m -88.15 137.28 32.47 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-O 121.667 0.746 . . . . 63.33 112.318 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.504 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 4.1 ptpt -90.75 147.7 23.06 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 103.986 -2.598 . . . . 71.22 103.986 169.925 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -83.25 -24.9 50.15 Favored Glycine 0 CA--C 1.479 -2.158 0 C-N-CA 120.318 -0.944 . . . . 64.52 113.57 -171.08 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 615' ' ' ASN . 88.0 m-20 72.06 -44.03 0.58 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.578 1.151 . . . . 73.35 111.183 -177.283 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.465 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 97.5 mt-30 -119.81 141.73 49.24 Favored 'General case' 0 N--CA 1.424 -1.766 0 C-N-CA 123.548 0.739 . . . . 54.1 111.432 -175.767 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . 0.444 ' O ' ' HA2' ' A' ' 613' ' ' GLY . 45.4 p90 -126.99 149.74 49.74 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.489 -0.56 . . . . 74.31 109.489 178.46 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 99.8 t -59.49 120.3 5.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.06 0.457 . . . . 52.21 111.881 -177.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . 0.433 ' HA ' ' HD3' ' A' ' 564' ' ' PRO . 57.1 ttp -97.09 137.09 21.25 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 116.031 -0.532 . . . . 54.22 111.19 179.995 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 563' ' ' MET . 17.4 Cg_exo -68.68 170.28 15.59 Favored 'Trans proline' 0 CA--C 1.551 1.332 0 C-N-CA 123.5 2.8 . . . . 74.22 112.684 174.162 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.18 129.47 40.0 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 112.669 0.618 . . . . 53.53 112.669 179.385 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . 0.453 ' O ' ' HG2' ' A' ' 569' ' ' MET . 95.3 mt -114.74 12.38 17.04 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 122.271 1.034 . . . . 75.42 108.409 175.865 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 20.3 m -79.58 144.52 33.79 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.847 -1.069 . . . . 72.45 110.886 -178.863 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 80.62 9.62 86.19 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 114.616 0.606 . . . . 63.44 114.616 175.285 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . 0.453 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 26.5 ptm -112.44 164.05 13.73 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 117.427 0.614 . . . . 74.05 109.502 -179.006 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -103.98 163.97 12.02 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.487 0.661 . . . . 54.31 111.291 -177.281 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 19.6 t90 -62.07 -29.66 70.46 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 125.073 1.349 . . . . 72.11 109.488 176.422 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 34.3 m -71.29 -15.12 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 115.845 -0.616 . . . . 62.14 110.771 177.531 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -96.9 -34.84 11.1 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.336 -0.987 . . . . 72.31 108.336 175.904 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -60.86 -41.53 96.08 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.8 -1.091 . . . . 52.42 112.188 -178.259 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.492 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 38.7 mt-10 -59.73 -54.54 54.67 Favored Pre-proline 0 CA--C 1.554 1.127 0 N-CA-C 112.928 0.714 . . . . 73.34 112.928 -179.705 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 52.2 Cg_exo -59.58 -37.04 90.93 Favored 'Trans proline' 0 C--N 1.369 1.615 0 C-N-CA 121.388 1.392 . . . . 74.44 112.249 174.781 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -59.11 -47.88 83.65 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.347 0.659 . . . . 74.24 110.451 177.894 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.6 pp -67.16 -41.01 86.72 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.151 0.426 . . . . 73.04 112.151 -175.853 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -65.35 -40.03 93.1 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.571 -0.74 . . . . 75.42 110.968 -179.744 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.19 -38.34 87.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.611 -0.722 . . . . 64.24 112.025 -178.201 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.26 -8.51 48.17 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.676 0.621 . . . . 53.15 112.676 -178.851 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 68.09 40.37 88.36 Favored Glycine 0 C--N 1.311 -0.822 0 C-N-CA 119.927 -1.13 . . . . 74.42 110.567 -175.669 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . 0.426 ' HE3' ' HB2' ' A' ' 578' ' ' LEU . 83.2 t90 -82.25 135.33 35.25 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.469 -0.567 . . . . 62.2 109.469 179.113 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 9.0 t -148.06 87.58 1.62 Allowed 'General case' 0 N--CA 1.418 -2.042 0 CA-C-O 122.754 1.264 . . . . 54.04 111.045 175.762 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -123.76 -109.74 1.9 Allowed Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 109.094 -1.602 . . . . 72.33 109.094 177.867 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 69.7 mtp -137.27 124.15 21.33 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 120.714 -0.394 . . . . 74.32 111.99 176.78 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -87.39 121.58 30.02 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 103.073 -2.936 . . . . 71.11 103.073 166.251 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -122.3 111.54 17.03 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 119.362 -0.935 . . . . 74.11 113.15 -168.709 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . 0.483 ' HD3' ' O ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -113.33 110.24 20.02 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 109.412 -0.588 . . . . 75.14 109.412 170.853 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -90.48 -55.65 1.9 Allowed Glycine 0 CA--C 1.492 -1.352 0 C-N-CA 120.628 -0.796 . . . . 71.43 111.867 -178.214 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -127.42 134.62 49.87 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 109.817 -0.438 . . . . 74.22 109.817 -179.277 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -86.8 123.01 31.48 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 105.683 -1.969 . . . . 55.32 105.683 174.731 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 88.0 t -132.72 126.32 54.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.066 0.46 . . . . 71.33 111.343 -174.388 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . 0.548 ' HA ' ' NE2' ' A' ' 600' ' ' HIS . 21.5 t70 -83.14 110.68 18.24 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 109.067 -0.716 . . . . 64.24 109.067 175.628 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -131.32 2.14 4.2 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 120.988 0.423 . . . . 70.22 111.897 -179.608 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 111.81 155.99 13.3 Favored Glycine 0 CA--C 1.499 -0.954 0 N-CA-C 110.798 -0.921 . . . . 44.2 110.798 179.574 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -55.56 -37.06 65.99 Favored Glycine 0 N--CA 1.464 0.541 0 N-CA-C 114.418 0.527 . . . . 73.44 114.418 -171.614 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 23.6 m -64.81 -23.55 67.27 Favored 'General case' 0 CA--C 1.552 1.058 0 CA-C-O 120.943 0.402 . . . . 61.13 111.956 178.832 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -99.43 -13.07 19.7 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 121.968 -0.458 . . . . 73.23 111.308 -179.118 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . 0.548 ' NE2' ' HA ' ' A' ' 594' ' ' ASP . 12.0 m170 -85.66 137.21 32.99 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 109.518 -0.549 . . . . 65.23 109.518 -178.164 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 65.82 -11.11 0.2 Allowed 'General case' 0 C--O 1.206 -1.214 0 C-N-CA 124.505 1.122 . . . . 71.55 113.374 -175.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . 0.472 ' HD2' ' O ' ' A' ' 603' ' ' VAL . 3.3 tmm_? -86.68 138.37 31.71 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.417 -0.957 . . . . 74.4 108.417 -175.78 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . 0.472 ' O ' ' HD2' ' A' ' 602' ' ' ARG . 97.7 t -74.73 129.29 36.8 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 108.164 -1.05 . . . . 71.32 108.164 -179.889 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 68.9 t -84.97 -51.57 13.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 109.717 -0.475 . . . . 65.24 109.717 -172.991 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -147.09 157.96 43.78 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 107.647 -1.242 . . . . 52.54 107.647 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -113.43 120.88 42.56 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 106.407 -1.701 . . . . 63.14 106.407 174.077 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.484 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 51.2 t30 -52.75 -52.91 60.01 Favored Pre-proline 0 N--CA 1.477 0.876 0 N-CA-C 112.979 0.733 . . . . 63.14 112.979 -177.141 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 3.0 Cg_exo -83.69 119.26 2.57 Favored 'Trans proline' 0 C--O 1.253 1.245 0 C-N-CA 121.118 1.212 . . . . 73.22 109.425 171.073 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 608' ' ' PRO . 24.1 Cg_exo -63.97 145.46 89.99 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 122.609 2.206 . . . . 72.05 112.219 -178.443 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.68 131.41 45.53 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.695 -0.684 . . . . 75.14 109.219 178.216 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.67 -19.61 38.55 Favored Glycine 0 C--N 1.296 -1.674 0 N-CA-C 110.082 -1.207 . . . . 73.0 110.082 -173.416 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 27.8 m -91.06 158.53 16.62 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.911 -1.144 . . . . 72.41 107.911 176.562 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 561' ' ' PHE . . . -84.3 132.78 11.31 Favored Glycine 0 N--CA 1.419 -2.458 0 C-N-CA 121.527 -0.368 . . . . 75.22 112.238 -179.879 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 34.2 m -113.98 142.42 26.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 C-N-CA 123.67 0.788 . . . . 51.51 109.541 177.007 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.524 ' ND2' ' HB2' ' A' ' 617' ' ' ASP . 26.5 p-10 -52.66 162.02 0.64 Allowed 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 124.078 0.951 . . . . 72.34 112.98 177.65 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -58.41 -25.13 61.78 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 112.702 0.63 . . . . 73.32 112.702 177.406 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . 0.524 ' HB2' ' ND2' ' A' ' 615' ' ' ASN . 19.6 m-20 -70.53 -28.51 64.99 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.98 -0.554 . . . . 75.24 109.745 177.108 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 74.22 21.01 79.55 Favored Glycine 0 N--CA 1.432 -1.608 0 CA-C-N 115.689 -0.687 . . . . 15.01 112.488 177.401 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.83 118.83 13.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 122.322 1.058 . . . . 75.2 109.994 -169.963 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.476 HG22 ' HG2' ' A' ' 608' ' ' PRO . 2.8 pp -125.94 133.4 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.385 0 CA-C-N 114.218 -1.355 . . . . 71.35 109.702 -178.038 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.475 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 83.4 m -98.38 120.39 38.71 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 109.087 -0.709 . . . . 61.14 109.087 176.464 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . 0.411 ' HB2' HG13 ' A' ' 603' ' ' VAL . 2.7 pp -119.82 165.94 13.93 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.669 -1.151 . . . . 71.31 109.065 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -146.55 146.95 30.65 Favored 'General case' 0 C--N 1.269 -2.9 0 N-CA-C 106.364 -1.717 . . . . 73.3 106.364 177.912 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -138.79 165.53 26.77 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 105.691 -1.966 . . . . 74.2 105.691 175.581 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -66.12 -95.35 0.03 OUTLIER Glycine 0 C--N 1.313 -0.701 0 C-N-CA 120.112 -1.042 . . . . 63.21 111.372 178.865 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . 0.429 ' HB3' ' CE1' ' A' ' 600' ' ' HIS . 8.9 tt0 . . . . . 0 C--N 1.292 -1.897 0 N-CA-C 108.447 -0.945 . . . . 73.34 108.447 173.223 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.937 0 N-CA-C 110.077 -1.209 . . . . 71.41 110.077 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 7.0 tp -75.03 115.27 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.943 0 CA-C-O 122.375 1.083 . . . . 70.31 112.61 -179.125 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 7.4 m -116.89 151.91 35.61 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 103.933 -2.617 . . . . 73.02 103.933 173.605 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 64.9 mtp180 -80.84 48.79 1.12 Allowed 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 119.089 0.859 . . . . 64.13 112.432 -176.357 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -105.11 148.53 26.74 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 105.848 -1.908 . . . . 50.33 105.848 175.536 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.7 m -125.83 161.44 30.98 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.48 0 N-CA-C 109.422 -0.584 . . . . 62.31 109.422 -177.19 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 409' ' ' SER . 42.4 tt0 -94.12 137.95 32.73 Favored 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 105.489 -2.041 . . . . 73.12 105.489 176.534 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.494 ' HB ' ' HA ' ' A' ' 406' ' ' ALA . 91.0 t -95.12 126.14 47.66 Favored Pre-proline 0 C--N 1.278 -2.542 0 N-CA-C 109.711 -0.477 . . . . 63.1 109.711 -166.34 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -62.22 123.49 12.6 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 122.095 1.864 . . . . 65.14 111.232 -178.495 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -81.64 143.2 32.08 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 107.713 -1.217 . . . . 72.21 107.713 179.974 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.537 HG13 ' HB1' ' A' ' 373' ' ' ALA . 7.1 p -126.93 18.02 3.51 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.699 0 CA-C-O 122.605 1.193 . . . . 62.35 110.595 -170.129 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.16 146.83 53.59 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.309 -1.314 . . . . 63.51 113.132 -179.289 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.02 0.5 41.67 Favored Glycine 0 CA--C 1.502 -0.744 0 CA-C-N 115.943 -0.571 . . . . 74.43 112.794 179.094 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -115.0 -158.48 0.67 Allowed 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 107.966 -1.124 . . . . 75.31 107.966 175.705 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 70.6 p -91.35 155.77 18.25 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 108.135 -1.061 . . . . 72.03 108.135 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 23.2 m -63.0 -33.99 76.6 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 120.688 0.28 . . . . 52.35 110.674 -179.029 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.9 -46.54 74.56 Favored 'General case' 0 C--O 1.212 -0.892 0 CA-C-O 119.435 -0.317 . . . . 74.35 111.051 178.807 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -69.12 -43.1 75.11 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-O 121.164 0.507 . . . . 75.22 110.579 179.659 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . 0.537 ' HB1' HG13 ' A' ' 365' ' ' VAL . . . -63.32 -49.11 75.27 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.371 -0.831 . . . . 64.32 111.728 -178.108 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.15 -38.1 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-N 116.52 -0.309 . . . . 73.24 110.834 179.322 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -60.64 -47.08 87.82 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.828 0.347 . . . . 64.55 110.885 178.839 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 60.0 m -60.91 -46.88 88.88 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.258 0.551 . . . . 75.35 110.215 179.678 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.503 HD22 HG23 ' A' ' 384' ' ' ILE . 7.6 tt -63.4 -38.87 92.83 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 115.546 -0.752 . . . . 54.54 110.752 -179.265 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -63.88 -40.37 96.38 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.135 0.574 . . . . 71.33 109.826 177.624 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -70.25 -17.61 63.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.166 0.508 . . . . 75.44 112.024 178.181 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -84.33 -14.72 48.86 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.077 0.465 . . . . 73.34 110.18 174.397 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 96.37 8.13 57.74 Favored Glycine 0 N--CA 1.435 -1.426 0 C-N-CA 120.586 -0.816 . . . . 71.12 112.728 175.822 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.482 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 66.4 m-85 -80.69 169.13 18.03 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-O 120.768 0.318 . . . . 62.22 110.688 178.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -112.44 150.24 31.46 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.17 -1.048 . . . . 74.01 108.17 -179.099 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.503 HG23 HD22 ' A' ' 377' ' ' LEU . 0.1 OUTLIER -130.76 149.13 33.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 CA-C-O 121.572 0.701 . . . . 62.23 112.035 177.181 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.72 139.7 45.77 Favored 'General case' 0 N--CA 1.4 -2.954 0 N-CA-C 103.444 -2.798 . . . . 63.14 103.444 169.797 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 52.0 m -133.76 119.14 18.89 Favored 'General case' 0 C--N 1.252 -3.649 0 N-CA-C 108.468 -0.938 . . . . 63.34 108.468 -175.011 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -110.95 119.36 38.82 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.159 -0.682 . . . . 73.21 109.159 -179.664 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.518 HE21 ' N ' ' A' ' 388' ' ' GLN . 0.0 OUTLIER -102.08 120.78 40.99 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 107.054 -1.461 . . . . 74.44 107.054 176.485 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 421' ' ' SER . 55.8 mtmt -139.29 140.96 27.6 Favored Pre-proline 0 C--N 1.285 -2.198 0 CA-C-N 115.834 -0.621 . . . . 73.25 109.789 -175.755 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.463 ' HA ' ' O ' ' A' ' 422' ' ' THR . 24.1 Cg_exo -69.14 174.31 9.15 Favored 'Trans proline' 0 C--O 1.246 0.911 0 C-N-CA 121.972 1.781 . . . . 74.11 110.016 169.286 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 90.15 173.74 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.768 1.627 . . . . 72.52 111.471 -179.2 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . 0.437 ' N ' ' HG3' ' A' ' 425' ' ' GLU . 38.6 m -119.53 13.48 12.58 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.642 0.734 . . . . 75.53 109.384 -176.818 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 10.7 m -78.02 -15.73 58.68 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 122.297 1.046 . . . . 70.53 109.45 -179.726 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.605 HG12 ' OG ' ' A' ' 421' ' ' SER . 0.1 OUTLIER -113.69 151.82 44.96 Favored Pre-proline 0 N--CA 1.42 -1.938 0 CA-C-N 114.54 -1.209 . . . . 65.03 108.975 179.339 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.31 158.0 2.79 Favored 'Trans proline' 0 CA--C 1.554 1.483 0 C-N-CA 124.756 3.637 . . . . 74.35 115.854 -175.487 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.13 161.41 8.89 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 123.967 3.111 . . . . 71.3 112.716 178.339 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . 0.516 ' HA ' HG23 ' A' ' 420' ' ' VAL . 6.6 p-10 -58.99 -9.42 1.88 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.889 0.876 . . . . 74.03 113.324 -176.867 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 59.6 m170 -114.51 145.99 41.25 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.265 -1.384 . . . . 70.45 107.265 177.016 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 30.6 m -72.28 118.95 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 N-CA-C 112.9 0.704 . . . . 73.44 112.9 -167.817 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . 0.446 HD13 ' O ' ' A' ' 400' ' ' ILE . 0.0 OUTLIER -97.97 -29.02 3.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 106.613 -1.625 . . . . 75.01 106.613 176.275 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.7 163.16 28.56 Favored Glycine 0 N--CA 1.409 -3.13 0 CA-C-N 114.808 -1.087 . . . . 63.43 110.446 -178.055 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.8 p -119.55 -176.56 3.18 Favored 'General case' 0 C--N 1.282 -2.331 0 C-N-CA 124.832 1.253 . . . . 71.54 109.265 179.101 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . 0.496 ' HB2' ' O ' ' A' ' 417' ' ' THR . 20.2 t70 -99.4 134.78 20.97 Favored Pre-proline 0 C--N 1.299 -1.612 0 N-CA-C 108.814 -0.81 . . . . 74.15 108.814 -174.581 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 403' ' ' ASP . 74.2 Cg_exo -53.24 -17.1 7.92 Favored 'Trans proline' 0 C--N 1.363 1.318 0 C-N-CA 124.335 3.357 . . . . 74.13 115.134 -176.389 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -61.0 -32.99 72.56 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.967 -0.383 . . . . 71.32 109.967 177.062 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . 0.494 ' HA ' ' HB ' ' A' ' 362' ' ' VAL . . . -72.75 -30.91 64.53 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.663 0.744 . . . . 54.02 110.052 179.256 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -81.0 -10.79 59.67 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.345 -0.843 . . . . 73.44 109.843 -178.722 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 40.0 m -96.5 150.09 21.01 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.928 -1.508 . . . . 60.21 106.928 175.727 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 361' ' ' GLN . 23.2 m -81.28 111.99 18.18 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 107.964 -1.125 . . . . 42.32 107.964 176.795 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.3 m -123.75 169.29 15.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-O 120.967 0.413 . . . . 65.51 110.587 -178.544 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 15.7 m -65.88 136.9 56.76 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.966 -0.753 . . . . 73.25 108.966 178.133 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -67.07 114.23 5.68 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.556 0.693 . . . . 72.32 111.223 -174.799 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 110.06 40.3 1.43 Allowed Glycine 0 N--CA 1.423 -2.193 0 CA-C-N 115.032 -0.985 . . . . 72.12 111.667 -179.798 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -114.53 -176.62 2.94 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.538 -0.465 . . . . 65.2 109.856 -179.015 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -87.21 119.51 27.52 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 123.842 0.857 . . . . 52.34 111.651 -167.619 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 38.8 mm -112.28 121.49 64.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 107.902 -1.147 . . . . 54.03 107.902 174.994 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 403' ' ' ASP . 35.5 m -93.05 129.32 39.03 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 113.348 0.87 . . . . 64.44 113.348 -173.98 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 4.2 p -124.42 135.84 62.47 Favored 'Isoleucine or valine' 0 C--O 1.247 0.934 0 CA-C-N 116.237 -0.438 . . . . 73.53 110.34 179.773 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -107.35 128.57 54.57 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.503 -0.317 . . . . 62.5 110.168 178.321 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.516 HG23 ' HA ' ' A' ' 397' ' ' ASP . 7.5 p -123.81 131.49 72.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 109.285 -0.635 . . . . 62.44 109.285 177.382 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . 0.605 ' OG ' HG12 ' A' ' 394' ' ' ILE . 43.4 m -95.83 122.9 39.11 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.544 0.687 . . . . 62.32 112.12 -177.208 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 390' ' ' PRO . 6.0 t -119.49 106.99 12.77 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.392 -0.822 . . . . 61.22 109.993 175.525 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 103.22 90.98 2.18 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 120.318 -0.944 . . . . 74.0 113.134 179.041 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.02 158.08 26.75 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 123.831 3.02 . . . . 43.43 113.075 179.463 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 392' ' ' SER . 46.0 mt-10 -72.02 144.16 48.9 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 122.126 0.965 . . . . 74.33 113.063 -175.939 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -116.79 151.82 35.69 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 113.382 -1.735 . . . . 74.14 106.965 179.584 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.535 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 5.4 mmp_? -122.71 154.81 37.61 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 120.982 0.42 . . . . 65.24 110.847 176.337 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -83.57 138.99 33.13 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 115.292 -0.867 . . . . 51.11 110.117 -175.829 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.49 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 60.4 mt -86.39 127.49 60.85 Favored Pre-proline 0 N--CA 1.425 -1.695 0 N-CA-C 107.085 -1.45 . . . . 73.15 107.085 176.048 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.483 ' HG2' ' HB3' ' A' ' 443' ' ' LYS . 12.1 Cg_exo -70.19 151.16 66.49 Favored 'Trans proline' 0 C--O 1.239 0.527 0 C-N-CA 122.08 1.853 . . . . 74.15 110.918 176.157 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -69.19 137.73 53.51 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 107.868 -1.16 . . . . 71.54 107.868 178.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 2.4 p -116.97 111.27 34.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 C-N-CA 120.306 -0.557 . . . . 73.2 112.206 -176.462 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 1.8 p -65.63 139.52 58.43 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 107.265 -1.383 . . . . 75.13 107.265 171.622 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . 0.59 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 62.7 p -63.28 -30.87 71.93 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 113.767 1.025 . . . . 73.33 113.767 -164.117 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.458 ' H ' HD23 ' A' ' 435' ' ' LEU . 0.5 OUTLIER -90.42 -11.1 41.46 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 115.867 -0.606 . . . . 65.05 111.767 -179.947 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.456 HG22 ' CB ' ' A' ' 439' ' ' GLU . 1.4 m -105.66 45.75 0.95 Allowed 'General case' 0 CA--C 1.573 1.841 0 CA-C-O 122.462 1.125 . . . . 75.01 110.788 -173.158 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . 0.4 ' O ' HG23 ' A' ' 441' ' ' VAL . 49.5 t80 -58.58 -38.2 77.39 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.955 -1.021 . . . . 75.41 113.27 177.037 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -62.52 -36.52 82.85 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 118.508 0.595 . . . . 53.4 110.657 179.397 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.456 ' CB ' HG22 ' A' ' 436' ' ' THR . 9.6 tp10 -62.66 -39.41 93.83 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.729 -0.841 . . . . 74.53 108.729 175.645 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.42 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -63.82 -42.97 97.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.04 -0.527 . . . . 55.41 110.343 178.038 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 437' ' ' TYR . 78.5 t -58.28 -48.95 83.48 Favored 'Isoleucine or valine' 0 C--O 1.256 1.443 0 CA-C-N 115.998 -0.547 . . . . 64.03 111.034 -179.114 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -67.67 -40.85 84.42 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.134 -0.626 . . . . 71.33 110.804 -177.858 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . 0.483 ' HB3' ' HG2' ' A' ' 430' ' ' PRO . 27.5 mmtp -66.45 -40.87 89.66 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.622 -0.717 . . . . 55.34 112.032 -177.517 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.42 HD13 ' O ' ' A' ' 440' ' ' ALA . 8.2 mp -63.67 -38.46 91.19 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.25 0.344 . . . . 70.41 110.159 175.879 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.42 ' HA ' ' CA ' ' A' ' 450' ' ' GLY . 98.3 m -64.08 -47.49 79.9 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 120.984 0.421 . . . . 71.44 110.972 179.225 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.49 -15.65 62.32 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.167 -0.469 . . . . 72.14 112.11 -179.598 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -85.54 5.34 31.89 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.035 0.445 . . . . 64.41 111.724 179.699 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 104.56 -66.97 0.29 Allowed Glycine 0 CA--C 1.497 -1.045 0 C-N-CA 120.139 -1.029 . . . . 54.11 112.406 175.212 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . 0.424 ' HA ' ' O ' ' A' ' 480' ' ' ILE . 1.3 p90 -49.65 -61.44 2.11 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 113.193 0.812 . . . . 74.24 113.193 177.627 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . 0.42 ' CA ' ' HA ' ' A' ' 445' ' ' THR . . . 57.94 25.12 55.92 Favored Glycine 0 CA--C 1.504 -0.611 0 O-C-N 123.056 0.222 . . . . 64.34 113.301 -179.923 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.404 ' HB2' ' HA ' ' A' ' 483' ' ' VAL . 62.7 mtt180 -106.63 113.72 27.39 Favored 'General case' 0 N--CA 1.419 -2.017 0 N-CA-C 108.989 -0.745 . . . . 75.01 108.989 -178.042 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 484' ' ' VAL . 43.2 p90 -137.8 151.8 48.49 Favored 'General case' 0 C--N 1.279 -2.459 0 CA-C-N 115.192 -0.913 . . . . 72.51 110.012 -175.756 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -142.39 122.85 14.03 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.124 -0.944 . . . . 72.32 110.189 176.663 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -93.95 125.57 38.65 Favored 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 123.778 0.831 . . . . 52.4 109.654 178.626 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -119.18 147.15 44.54 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.99 -1.115 . . . . 72.54 107.99 175.314 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 488' ' ' VAL . 11.5 m120 -120.61 133.49 55.37 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 120.855 0.359 . . . . 72.33 111.365 -179.869 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 27.3 t -135.79 139.45 30.72 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 108.979 -0.749 . . . . 72.31 108.979 179.704 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.662 ' HA ' ' O ' ' A' ' 490' ' ' SER . 32.9 Cg_endo -65.94 127.39 17.63 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.292 1.994 . . . . 72.52 110.977 177.495 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 69.5 m -147.76 179.47 7.68 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 122.912 0.485 . . . . 75.52 109.945 -179.7 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . 0.477 ' O ' HG23 ' A' ' 464' ' ' VAL . 5.2 t -50.23 139.29 19.09 Favored Pre-proline 0 C--O 1.248 0.986 0 C-N-CA 125.125 1.37 . . . . 52.33 111.753 178.223 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.33 -29.8 31.62 Favored 'Trans proline' 0 C--N 1.36 1.132 0 C-N-CA 124.644 3.563 . . . . 73.04 113.45 -177.439 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -72.92 -25.12 60.93 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.293 0.479 . . . . 75.12 112.293 -178.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -104.13 -5.38 22.07 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.879 0.371 . . . . 65.23 111.488 177.427 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 460' ' ' THR . 54.0 t -60.36 127.75 20.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.19 -0.459 . . . . 74.34 110.025 177.117 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 90.02 0.5 77.61 Favored Glycine 0 N--CA 1.422 -2.236 0 C-N-CA 121.037 -0.602 . . . . 61.52 112.534 179.001 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.402 ' C ' HG13 ' A' ' 488' ' ' VAL . 0.0 OUTLIER -131.12 163.18 28.23 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 119.604 -0.838 . . . . 63.33 111.213 -179.813 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.59 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 67.7 t -67.01 133.42 31.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 114.711 -1.131 . . . . 54.55 111.216 -177.088 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 53.8 mt -98.3 -24.28 4.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.226 -1.027 . . . . 75.14 108.226 179.15 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 165.33 169.62 29.19 Favored Glycine 0 N--CA 1.427 -1.907 0 CA-C-N 115.471 -0.786 . . . . 73.42 112.65 177.317 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 1.7 t -116.89 137.94 51.87 Favored 'General case' 0 N--CA 1.406 -2.66 0 N-CA-C 106.341 -1.726 . . . . 62.13 106.341 174.783 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.503 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 49.0 t30 -65.52 -53.44 37.73 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 119.822 -0.751 . . . . 64.14 111.055 179.523 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 9.7 Cg_exo -74.84 122.43 7.27 Favored 'Trans proline' 0 C--N 1.366 1.497 0 N-CA-C 107.195 -1.887 . . . . 42.22 107.195 170.811 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.462 ' C ' ' H ' ' A' ' 475' ' ' ASN . 26.9 Cg_exo -62.61 139.26 74.69 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 121.743 1.629 . . . . 72.04 112.565 -176.142 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.49 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -74.67 11.6 1.0 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 122.611 1.196 . . . . 64.35 110.843 -179.632 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . 0.462 ' H ' ' C ' ' A' ' 473' ' ' PRO . 13.9 m120 -110.4 -4.8 15.4 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-N 114.385 -1.279 . . . . 53.34 108.852 -178.854 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -115.83 170.93 8.1 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 121.512 0.672 . . . . 70.34 111.808 -175.243 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.32 137.62 37.56 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.518 -1.219 . . . . 75.24 108.713 -178.378 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 21.1 p -126.27 149.2 49.27 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 120.999 0.428 . . . . 74.21 111.049 -179.146 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -72.97 160.72 31.66 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.431 -0.804 . . . . 70.24 110.537 178.213 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 449' ' ' PHE . 1.9 mp -72.65 -16.81 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-O 121.947 0.88 . . . . 74.44 111.014 -179.867 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 15.3 t -96.05 5.16 51.79 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-O 121.772 0.796 . . . . 51.13 109.853 177.48 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -89.55 137.61 32.18 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.993 -0.549 . . . . 75.35 109.941 -175.633 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.404 ' HA ' ' HB2' ' A' ' 451' ' ' ARG . 7.2 p -104.37 126.05 59.12 Favored 'Isoleucine or valine' 0 C--O 1.245 0.841 0 CA-C-O 121.336 0.588 . . . . 70.0 110.849 179.705 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 452' ' ' PHE . 61.8 t -95.83 119.99 44.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.981 -0.554 . . . . 65.33 109.859 -179.271 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.18 123.98 55.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 108.863 -0.792 . . . . 71.1 108.863 178.598 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 39.5 mt -120.15 128.11 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 CA-C-N 114.723 -1.126 . . . . 61.23 110.184 -176.774 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 9.3 tt -101.9 125.15 56.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 115.891 -0.595 . . . . 75.3 110.074 -179.148 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 456' ' ' ASN . 10.6 t -113.18 139.03 40.53 Favored 'Isoleucine or valine' 0 C--O 1.251 1.14 0 N-CA-C 106.569 -1.641 . . . . 40.52 106.569 179.236 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -75.53 153.76 44.79 Favored Glycine 0 C--N 1.299 -1.522 0 CA-C-O 121.346 0.414 . . . . 75.12 113.275 -176.665 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.662 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 48.6 m -141.22 160.69 39.58 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 106.6 -1.63 . . . . 64.03 106.6 176.012 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . -178.0 -156.84 17.49 Favored Glycine 0 N--CA 1.435 -1.396 0 C-N-CA 119.384 -1.388 . . . . 72.44 112.081 -178.775 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -92.56 166.18 2.8 Favored 'Trans proline' 0 N--CA 1.446 -1.312 0 C-N-CA 122.857 2.372 . . . . 60.31 112.69 -179.381 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -95.6 99.94 11.74 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 109.219 -0.66 . . . . 54.15 109.219 176.705 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 13.7 p -117.83 143.0 46.68 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.35 -0.841 . . . . 64.05 109.595 179.208 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -144.76 154.23 42.5 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.674 -0.862 . . . . 70.42 108.674 176.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 11.9 p-10 -94.63 136.66 34.68 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.757 -0.831 . . . . 75.33 108.757 176.038 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 30.1 pt -75.62 137.38 70.58 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-N 115.369 -0.832 . . . . 75.35 112.038 -176.314 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -87.34 -170.18 0.57 Allowed 'Trans proline' 0 C--O 1.248 1.023 0 C-N-CA 122.995 2.464 . . . . 70.42 110.947 175.414 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -94.8 122.98 37.99 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.615 0.721 . . . . 62.04 109.687 177.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 7.6 p -113.42 7.57 7.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-O 122.374 1.083 . . . . 72.04 109.993 -177.62 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -73.72 121.22 20.44 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.204 -0.907 . . . . 31.11 109.788 -179.251 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 124.28 -17.75 7.44 Favored Glycine 0 C--N 1.289 -2.057 0 N-CA-C 110.105 -1.198 . . . . 63.34 110.105 -179.866 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -94.11 171.98 8.51 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 109.654 -0.498 . . . . 71.5 109.654 178.148 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 61.1 m -87.69 155.65 19.83 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.145 -1.057 . . . . 71.23 108.145 -179.302 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.6 p -54.17 -41.96 53.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 123.522 0.729 . . . . 74.53 112.316 -178.693 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -60.77 -42.24 97.1 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 123.368 0.667 . . . . 75.32 111.324 178.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.27 -40.75 50.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 115.419 -0.81 . . . . 60.34 109.769 -179.202 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -60.69 -49.51 77.23 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.464 -0.789 . . . . 41.23 111.339 -178.481 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -64.6 -36.05 82.98 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.596 -0.274 . . . . 71.15 110.264 -178.614 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.422 ' O ' HG23 ' A' ' 514' ' ' VAL . 87.7 tttt -61.47 -47.19 86.83 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.786 -0.643 . . . . 72.44 109.95 179.457 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -61.92 -48.17 81.63 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 116.192 -0.458 . . . . 74.4 110.818 -178.735 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.7 -45.65 93.4 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.4 -0.364 . . . . 55.35 111.182 178.793 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . 0.406 ' ND2' ' HA ' ' A' ' 518' ' ' THR . 0.9 OUTLIER -63.18 -37.96 89.3 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 120.727 0.299 . . . . 74.25 111.711 -178.681 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 510' ' ' LYS . 79.4 t -65.1 -33.73 65.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-N 116.266 -0.425 . . . . 54.0 110.967 177.392 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -79.63 -9.38 59.62 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.399 0.518 . . . . 55.12 112.399 179.953 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 115.53 -20.43 13.64 Favored Glycine 0 CA--C 1.495 -1.159 0 C-N-CA 120.454 -0.879 . . . . 52.44 111.747 179.109 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . 0.453 ' CE1' ' HA ' ' A' ' 547' ' ' VAL . 74.9 m-85 -78.25 81.74 4.6 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.41 -0.959 . . . . 74.32 108.41 179.625 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . 0.406 ' HA ' ' ND2' ' A' ' 513' ' ' ASN . 2.6 p -87.91 -8.99 54.99 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 114.96 -1.018 . . . . 45.13 113.355 -173.102 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -108.01 115.52 30.28 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-O 121.407 0.622 . . . . 75.02 109.725 -177.563 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -130.48 156.37 44.89 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.454 -0.794 . . . . 71.44 111.253 -178.847 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 38.4 m -132.45 140.79 48.55 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 106.301 -1.74 . . . . 70.35 106.301 173.423 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.54 139.43 50.96 Favored 'General case' 0 N--CA 1.422 -1.869 0 C-N-CA 120.018 -0.673 . . . . 72.3 110.312 179.634 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -115.94 124.38 50.43 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 107.349 -1.352 . . . . 75.32 107.349 175.269 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 39.5 m -89.33 114.54 25.96 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.403 -0.962 . . . . 71.43 108.403 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 33.4 m -121.32 165.99 16.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 N-CA-C 109.309 -0.626 . . . . 54.14 109.309 -177.454 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . 0.4 ' HA ' ' HG2' ' A' ' 557' ' ' LYS . 3.5 p-10 -104.43 137.48 42.24 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.607 -0.886 . . . . 72.12 108.607 177.367 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 17.3 m -151.27 179.95 1.14 Allowed Pre-proline 0 C--N 1.295 -1.801 0 N-CA-C 109.292 -0.633 . . . . 64.44 109.292 -177.77 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -80.42 -7.04 13.83 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 121.695 1.597 . . . . 74.2 110.49 170.05 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.42 ' HA ' ' HD3' ' A' ' 530' ' ' PRO . 15.7 mmm180 -82.72 137.43 44.22 Favored Pre-proline 0 N--CA 1.447 -0.611 0 N-CA-C 107.892 -1.151 . . . . 45.23 107.892 177.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 529' ' ' ARG . 36.8 Cg_exo -58.8 160.23 18.53 Favored 'Trans proline' 0 N--CA 1.484 0.946 0 C-N-CA 123.566 2.844 . . . . 74.11 115.267 -175.04 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -66.71 113.6 4.96 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.686 -1.143 . . . . 62.05 111.435 -178.977 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 117.25 -19.56 11.7 Favored Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 110.856 -0.898 . . . . 32.15 110.856 178.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -83.11 134.62 35.0 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.533 -0.914 . . . . 72.34 108.533 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 58.8 t -80.42 126.36 39.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 109.321 -0.622 . . . . 72.12 109.321 -179.609 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . 0.655 ' HB ' ' OG ' ' A' ' 556' ' ' SER . 15.1 t -81.13 -18.03 47.85 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 121.506 0.669 . . . . 74.11 109.602 179.131 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.24 -161.44 28.61 Favored Glycine 0 N--CA 1.439 -1.148 0 C-N-CA 120.989 -0.624 . . . . 65.21 112.153 176.293 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . 0.469 HG22 HD13 ' A' ' 553' ' ' LEU . 15.4 p -117.2 160.26 21.33 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.543 -0.54 . . . . 75.44 109.543 179.226 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.458 ' HB2' HE22 ' A' ' 554' ' ' GLN . 50.7 t30 -68.99 -55.34 10.62 Favored Pre-proline 0 C--N 1.325 -0.491 0 C-N-CA 120.514 -0.475 . . . . 74.3 110.241 177.441 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.82 134.2 25.23 Favored 'Trans proline' 0 C--N 1.366 1.463 0 N-CA-C 109.191 -1.119 . . . . 62.12 109.191 171.447 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.59 157.52 58.02 Favored 'Trans proline' 0 C--O 1.253 1.245 0 C-N-CA 122.578 2.185 . . . . 74.1 112.724 179.971 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.88 134.96 57.34 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.044 -0.525 . . . . 64.23 109.812 178.315 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.57 -13.34 39.16 Favored Glycine 0 C--N 1.307 -1.048 0 C-N-CA 120.844 -0.693 . . . . 71.13 111.739 -177.731 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 496' ' ' ASP . 81.7 m -70.92 120.89 17.15 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 109.072 -0.714 . . . . 22.01 109.072 178.359 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 31.9 m -86.62 122.88 31.16 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.026 -0.731 . . . . 54.3 109.026 -179.661 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 12.2 m -135.1 154.93 79.32 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 109.686 -0.487 . . . . 64.23 109.686 -179.327 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.43 149.77 45.22 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.964 1.776 . . . . 64.31 110.029 175.805 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.453 ' HA ' ' CE1' ' A' ' 517' ' ' PHE . 25.8 m -59.54 -19.58 16.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 112.673 0.62 . . . . 74.44 112.673 178.961 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -81.21 3.55 23.38 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.24 1.016 . . . . 72.51 112.64 179.479 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 77.5 p -88.16 175.16 7.83 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 121.996 -0.44 . . . . 73.42 112.17 -176.869 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 39.0 t -112.58 119.24 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 108.79 -0.818 . . . . 43.52 108.79 179.086 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 1.8 mp -98.13 131.21 45.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-O 121.113 0.483 . . . . 75.13 110.223 -179.179 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -103.23 117.82 35.38 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-O 121.258 0.551 . . . . 75.2 110.9 179.822 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . 0.469 HD13 HG22 ' A' ' 537' ' ' THR . 2.4 mm? -98.89 132.89 43.88 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.311 -1.313 . . . . 64.14 108.746 179.002 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . 0.458 HE22 ' HB2' ' A' ' 538' ' ' ASN . 26.0 mp0 -100.48 118.59 37.0 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.849 -1.167 . . . . 71.13 107.849 172.157 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 46.0 t -104.42 131.18 53.93 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 107.385 -1.339 . . . . 62.54 107.385 -178.22 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.655 ' OG ' ' HB ' ' A' ' 535' ' ' THR . 50.2 m -95.92 158.13 15.59 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 114.044 1.127 . . . . 74.55 114.044 -175.131 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 19.0 ptpt -113.68 148.2 36.78 Favored 'General case' 0 N--CA 1.414 -2.272 0 N-CA-C 105.888 -1.894 . . . . 64.21 105.888 164.092 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -75.08 -22.26 76.87 Favored Glycine 0 C--N 1.292 -1.874 0 O-C-N 124.103 0.877 . . . . 74.44 111.929 -178.586 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 73.67 10.38 4.8 Favored 'General case' 0 CA--C 1.485 -1.524 0 C-N-CA 124.654 1.181 . . . . 64.45 109.284 -171.786 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 33.3 tt0 -128.39 141.26 51.47 Favored 'General case' 0 N--CA 1.408 -2.537 0 CA-C-N 115.525 -0.761 . . . . 73.33 109.42 -176.857 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -138.82 155.1 48.42 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.564 -0.743 . . . . 71.21 109.394 -179.33 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.4 p -63.64 130.58 28.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 O-C-N 123.614 0.571 . . . . 73.22 111.081 -179.157 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 56.4 ttp -94.78 126.41 47.38 Favored Pre-proline 0 C--O 1.253 1.263 0 CA-C-N 115.886 -0.597 . . . . 73.34 109.543 178.36 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -63.43 169.78 9.11 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.068 2.512 . . . . 61.22 112.551 175.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -75.19 133.61 41.39 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.871 -0.604 . . . . 73.45 111.29 -179.526 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . 0.436 ' HB3' ' SD ' ' A' ' 569' ' ' MET . 92.8 mt -137.66 27.97 2.72 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.828 -0.804 . . . . 75.01 108.828 -177.674 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 17.7 m -77.86 130.31 36.48 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.907 -0.588 . . . . 53.21 111.228 -174.705 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 67.48 38.05 90.46 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.957 -0.565 . . . . 61.11 112.937 176.447 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . 0.436 ' SD ' ' HB3' ' A' ' 566' ' ' LEU . 23.6 ptm -99.46 168.77 9.77 Favored 'General case' 0 C--O 1.255 1.363 0 N-CA-C 108.839 -0.8 . . . . 61.52 108.839 -179.413 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -106.76 148.98 27.81 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 109.471 -0.566 . . . . 62.05 109.471 -178.077 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . 0.449 ' HA ' ' HB3' ' A' ' 574' ' ' ALA . 61.2 t-105 -62.31 -25.01 67.64 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 124.129 0.972 . . . . 71.01 110.269 -178.976 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 13.7 p -68.82 -21.72 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 115.548 -0.751 . . . . 50.32 110.386 179.498 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -101.28 -29.76 11.89 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 109.501 -0.555 . . . . 70.25 109.501 176.103 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . 0.449 ' HB3' ' HA ' ' A' ' 571' ' ' TRP . . . -61.7 -49.96 74.39 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.164 -0.925 . . . . 65.54 111.92 -179.385 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.451 ' HB2' ' HD3' ' A' ' 576' ' ' PRO . 38.0 mt-10 -54.21 -53.85 54.37 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 113.283 0.846 . . . . 70.11 113.283 -179.267 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . 0.451 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 50.7 Cg_exo -53.87 -45.03 44.02 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 121.887 1.725 . . . . 63.4 112.337 176.825 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.556 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 20.6 mmm180 -64.0 -41.43 97.48 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.512 -0.313 . . . . 64.32 111.174 -179.961 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 7.1 tt -63.64 -49.27 73.89 Favored 'General case' 0 C--O 1.247 0.926 0 C-N-CA 123.403 0.681 . . . . 52.52 109.858 -176.094 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . 0.433 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 4.6 ptp180 -67.27 -37.9 84.21 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.616 -0.72 . . . . 74.25 112.595 179.03 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.22 -39.16 75.26 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 112.575 0.583 . . . . 73.43 112.575 -178.148 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 577' ' ' ARG . 4.0 pp -84.62 -1.23 55.71 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.66 -0.816 . . . . 62.31 112.437 -179.117 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 67.03 47.46 65.17 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 115.366 -0.834 . . . . 43.4 112.093 177.351 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 22.5 t90 -63.67 127.15 30.06 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.923 -0.399 . . . . 74.14 109.923 179.039 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 3.6 m -125.23 24.22 7.46 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.122 -0.696 . . . . 72.0 109.122 -176.726 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -92.43 -170.2 40.7 Favored Glycine 0 CA--C 1.508 -0.406 0 C-N-CA 120.71 -0.757 . . . . 71.23 113.904 -175.438 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 64.7 mtt -98.7 126.39 44.29 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.87 0.367 . . . . 74.5 110.474 -179.311 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 55.0 tp -96.84 102.25 14.0 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.12 -1.067 . . . . 71.05 108.12 177.504 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -96.43 101.46 13.09 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.268 0.556 . . . . 71.4 110.463 -178.851 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.32 114.22 28.31 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.547 -1.279 . . . . 73.31 107.547 178.631 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -75.97 -88.45 0.27 Allowed Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 120.622 -0.799 . . . . 73.5 111.206 177.45 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -125.58 154.66 41.89 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 122.436 -0.449 . . . . 63.11 110.48 -178.898 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -82.15 141.47 33.05 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.346 -0.983 . . . . 75.32 108.346 173.933 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 42.5 t -124.24 116.53 48.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 108.935 -0.765 . . . . 73.31 108.935 -177.473 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -89.2 107.81 19.26 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 107.778 -1.193 . . . . 72.05 107.778 177.573 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -127.18 9.54 6.76 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.887 -0.597 . . . . 74.11 111.197 -178.814 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 128.65 169.73 12.66 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.302 -0.951 . . . . 62.44 111.701 178.175 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -57.11 -46.46 91.51 Favored Glycine 0 C--O 1.237 0.329 0 O-C-N 123.933 0.431 . . . . 71.12 113.034 -177.112 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 30.9 t -65.87 -29.69 70.18 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.313 0.578 . . . . 73.41 110.514 -178.722 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . 0.596 ' O ' ' HA3' ' A' ' 625' ' ' GLY . 87.4 mm-40 -87.31 -1.02 57.62 Favored 'General case' 0 C--O 1.211 -0.97 0 CA-C-N 115.65 -0.705 . . . . 74.31 112.788 -174.114 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . 0.522 ' HA ' ' H ' ' A' ' 626' ' ' GLN . 19.8 m80 -63.52 -71.77 0.16 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.952 0.882 . . . . 72.05 110.921 176.919 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -95.62 31.13 2.1 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.798 -0.637 . . . . 63.5 111.023 -173.575 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 1.3 mmm-85 -105.15 140.23 38.63 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 116.064 -0.516 . . . . 71.32 110.233 -177.904 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 97.3 t -73.7 138.18 21.78 Favored 'Isoleucine or valine' 0 C--O 1.252 1.218 0 N-CA-C 107.306 -1.368 . . . . 73.35 107.306 174.819 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 57.8 t -94.43 -50.55 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.973 0 CA-C-O 121.743 0.782 . . . . 62.13 109.421 -174.084 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -146.9 155.88 42.65 Favored 'General case' 0 N--CA 1.415 -2.219 0 N-CA-C 107.701 -1.222 . . . . 63.11 107.701 -178.537 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -120.84 121.88 39.08 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 106.465 -1.68 . . . . 71.2 106.465 171.123 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.563 ' HB2' ' HB ' ' A' ' 621' ' ' THR . 26.3 t-20 -59.03 -52.79 72.27 Favored Pre-proline 0 C--N 1.299 -1.623 0 CA-C-N 115.539 -0.755 . . . . 55.32 112.67 -177.893 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 1.0 OUTLIER -87.8 123.28 1.74 Allowed 'Trans proline' 0 N--CA 1.442 -1.544 0 C-N-CA 121.275 1.317 . . . . 74.23 109.668 173.546 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.06 156.15 60.53 Favored 'Trans proline' 0 C--O 1.244 0.793 0 C-N-CA 122.287 1.992 . . . . 65.21 111.36 177.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -59.09 127.96 34.79 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.828 -0.434 . . . . 72.33 109.828 178.559 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.18 -7.81 44.3 Favored Glycine 0 C--N 1.31 -0.891 0 C-N-CA 120.343 -0.932 . . . . 73.31 111.755 -177.613 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 26.9 m -89.13 157.26 18.36 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 107.988 -1.116 . . . . 70.33 107.988 178.247 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -90.98 143.52 16.68 Favored Glycine 0 N--CA 1.422 -2.238 0 C-N-CA 120.787 -0.721 . . . . 75.51 113.092 -177.42 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 19.0 m -115.71 141.65 32.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 109.376 -0.601 . . . . 62.44 109.376 174.388 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -70.82 -179.71 2.33 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 123.852 0.861 . . . . 72.15 113.066 -177.386 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -61.95 -36.03 80.21 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.072 0.949 . . . . 71.04 109.718 -179.728 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . 0.417 ' OD2' ' HB ' ' A' ' 619' ' ' ILE . 21.2 t70 -63.28 -40.33 97.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.008 -0.997 . . . . 52.53 108.656 174.588 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 87.97 22.03 43.83 Favored Glycine 0 N--CA 1.425 -2.09 0 C-N-CA 120.14 -1.029 . . . . 60.4 111.919 176.385 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . 0.417 ' HB ' ' OD2' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -68.76 118.46 12.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 122.422 1.106 . . . . 40.33 110.19 -170.398 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.34 130.38 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.743 0 N-CA-C 106.336 -1.727 . . . . 70.42 106.336 -179.923 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.563 ' HB ' ' HB2' ' A' ' 607' ' ' ASN . 6.4 m -100.77 117.19 34.36 Favored 'General case' 0 N--CA 1.421 -1.908 0 C-N-CA 119.455 -0.898 . . . . 73.31 109.428 -178.533 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -139.26 150.78 45.87 Favored 'General case' 0 CA--C 1.48 -1.736 0 N-CA-C 106.054 -1.832 . . . . 64.0 106.054 178.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -134.36 151.54 51.28 Favored 'General case' 0 C--N 1.266 -3.057 0 N-CA-C 105.132 -2.173 . . . . 75.43 105.132 176.523 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -120.4 165.55 14.76 Favored 'General case' 0 C--N 1.274 -2.705 0 N-CA-C 107.266 -1.383 . . . . 74.01 107.266 177.461 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . 0.596 ' HA3' ' O ' ' A' ' 599' ' ' GLN . . . -70.46 -108.29 0.04 OUTLIER Glycine 0 C--N 1.302 -1.344 0 O-C-N 123.915 0.759 . . . . 71.13 114.317 -174.409 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . 0.522 ' H ' ' HA ' ' A' ' 600' ' ' HIS . 8.6 tp-100 . . . . . 0 C--N 1.296 -1.746 0 CA-C-O 118.998 -0.525 . . . . 64.45 110.0 -179.55 . . . . . . . . 1 1 . 1 stop_ save_